Citrus Sinensis ID: 004400
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 756 | 2.2.26 [Sep-21-2011] | |||||||
| C0LGG9 | 1035 | Probable LRR receptor-lik | yes | no | 0.370 | 0.270 | 0.748 | 1e-124 | |
| C0LGG8 | 1038 | Probable LRR receptor-lik | no | no | 0.370 | 0.269 | 0.744 | 1e-123 | |
| C0LGN2 | 1020 | Probable leucine-rich rep | no | no | 0.452 | 0.335 | 0.628 | 1e-123 | |
| C0LGE0 | 1014 | Probable LRR receptor-lik | no | no | 0.435 | 0.324 | 0.645 | 1e-122 | |
| C0LGG7 | 953 | Probable LRR receptor-lik | no | no | 0.414 | 0.328 | 0.660 | 1e-121 | |
| Q9ASQ6 | 1019 | Probable LRR receptor-lik | no | no | 0.448 | 0.332 | 0.560 | 1e-109 | |
| Q9FXF2 | 1021 | Probable LRR receptor-lik | no | no | 0.363 | 0.269 | 0.637 | 4e-97 | |
| C0LGH3 | 1033 | Probable LRR receptor-lik | no | no | 0.443 | 0.324 | 0.527 | 4e-93 | |
| C0LGH2 | 1032 | Probable LRR receptor-lik | no | no | 0.445 | 0.326 | 0.504 | 2e-90 | |
| Q9LVP0 | 1102 | Probable leucine-rich rep | no | no | 0.839 | 0.576 | 0.317 | 4e-80 |
| >sp|C0LGG9|Y5344_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g53440 OS=Arabidopsis thaliana GN=At1g53440 PE=1 SV=2 | Back alignment and function desciption |
|---|
Score = 447 bits (1150), Expect = e-124, Method: Compositional matrix adjust.
Identities = 214/286 (74%), Positives = 246/286 (86%), Gaps = 6/286 (2%)
Query: 410 QIKAATNNFATDNNIGEGGFGPVYKGLLADGTAIAVKQLSSKSKQGNREFINEIGMISAL 469
QIK ATNNF +N IGEGGFGPVYKG+LADG IAVKQLSSKSKQGNREF+ EIGMISAL
Sbjct: 659 QIKRATNNFDPENKIGEGGFGPVYKGVLADGMTIAVKQLSSKSKQGNREFVTEIGMISAL 718
Query: 470 QHPNLVKLYGCCIEGNQLLLIYEYLENNSLARALF---EHRLKLDWPTRRRICLGIARGL 526
QHPNLVKLYGCCIEG +LLL+YEYLENNSLARALF + RL LDW TR ++C+GIA+GL
Sbjct: 719 QHPNLVKLYGCCIEGKELLLVYEYLENNSLARALFGTEKQRLHLDWSTRNKVCIGIAKGL 778
Query: 527 AYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAP 586
AYLH ESR+K+VHRDIKATNVLLD LN+KISDFGLAKLDEEENTHISTR+AGTIGYMAP
Sbjct: 779 AYLHEESRLKIVHRDIKATNVLLDLSLNAKISDFGLAKLDEEENTHISTRIAGTIGYMAP 838
Query: 587 EYAMRGHLTEKADVYSFGIVALEIVSGRSNVT---KEDMFYLLDWALVLKEQGKLMELVD 643
EYAMRG+LT+KADVYSFG+V LEIVSG+SN KE+ YLLDWA VL+EQG L+ELVD
Sbjct: 839 EYAMRGYLTDKADVYSFGVVCLEIVSGKSNTNYRPKEEFIYLLDWAYVLQEQGSLLELVD 898
Query: 644 TNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLECGVDV 689
+ G++F K++ M M+N+ALLC N SPT+RP MSSV+ ML+ + V
Sbjct: 899 PDLGTSFSKKEAMRMLNIALLCTNPSPTLRPPMSSVVSMLQGKIKV 944
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|C0LGG8|Y5343_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g53430 OS=Arabidopsis thaliana GN=At1g53430 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 444 bits (1141), Expect = e-123, Method: Compositional matrix adjust.
Identities = 213/286 (74%), Positives = 246/286 (86%), Gaps = 6/286 (2%)
Query: 410 QIKAATNNFATDNNIGEGGFGPVYKGLLADGTAIAVKQLSSKSKQGNREFINEIGMISAL 469
QIK ATNNF +N IGEGGFGPVYKG+LADG IAVKQLSSKSKQGNREF+ EIGMISAL
Sbjct: 661 QIKRATNNFDPENKIGEGGFGPVYKGVLADGMTIAVKQLSSKSKQGNREFVTEIGMISAL 720
Query: 470 QHPNLVKLYGCCIEGNQLLLIYEYLENNSLARALF---EHRLKLDWPTRRRICLGIARGL 526
QHPNLVKLYGCCIEG +LLL+YEYLENNSLARALF + RL LDW TR +IC+GIA+GL
Sbjct: 721 QHPNLVKLYGCCIEGKELLLVYEYLENNSLARALFGTEKQRLHLDWSTRNKICIGIAKGL 780
Query: 527 AYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAP 586
AYLH ESR+K+VHRDIKATNVLLD LN+KISDFGLAKL+++ENTHISTR+AGTIGYMAP
Sbjct: 781 AYLHEESRLKIVHRDIKATNVLLDLSLNAKISDFGLAKLNDDENTHISTRIAGTIGYMAP 840
Query: 587 EYAMRGHLTEKADVYSFGIVALEIVSGRSNVT---KEDMFYLLDWALVLKEQGKLMELVD 643
EYAMRG+LT+KADVYSFG+V LEIVSG+SN KE+ YLLDWA VL+EQG L+ELVD
Sbjct: 841 EYAMRGYLTDKADVYSFGVVCLEIVSGKSNTNYRPKEEFVYLLDWAYVLQEQGSLLELVD 900
Query: 644 TNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLECGVDV 689
+ G++F K++ M M+N+ALLC N SPT+RP MSSV+ MLE + V
Sbjct: 901 PDLGTSFSKKEAMRMLNIALLCTNPSPTLRPPMSSVVSMLEGKIKV 946
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGN2|Y3148_ARATH Probable leucine-rich repeat receptor-like serine/threonine-protein kinase At3g14840 OS=Arabidopsis thaliana GN=LRR-RLK PE=1 SV=1 | Back alignment and function description |
|---|
Score = 442 bits (1138), Expect = e-123, Method: Compositional matrix adjust.
Identities = 220/350 (62%), Positives = 273/350 (78%), Gaps = 8/350 (2%)
Query: 410 QIKAATNNFATDNNIGEGGFGPVYKGLLADGTAIAVKQLSSKSKQGNREFINEIGMISAL 469
QIK AT+NF N IGEGGFGPV+KG++ DGT IAVKQLS+KSKQGNREF+NEI MISAL
Sbjct: 664 QIKVATDNFDPANKIGEGGFGPVHKGIMTDGTVIAVKQLSAKSKQGNREFLNEIAMISAL 723
Query: 470 QHPNLVKLYGCCIEGNQLLLIYEYLENNSLARALF---EHRLKLDWPTRRRICLGIARGL 526
QHP+LVKLYGCC+EG+QLLL+YEYLENNSLARALF E ++ L+WP R++IC+GIARGL
Sbjct: 724 QHPHLVKLYGCCVEGDQLLLVYEYLENNSLARALFGPQETQIPLNWPMRQKICVGIARGL 783
Query: 527 AYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAP 586
AYLH ESR+K+VHRDIKATNVLLDK+LN KISDFGLAKLDEEENTHISTRVAGT GYMAP
Sbjct: 784 AYLHEESRLKIVHRDIKATNVLLDKELNPKISDFGLAKLDEEENTHISTRVAGTYGYMAP 843
Query: 587 EYAMRGHLTEKADVYSFGIVALEIVSGRSNV---TKEDMFYLLDWALVLKEQGKLMELVD 643
EYAMRGHLT+KADVYSFG+VALEIV G+SN +K D FYLLDW VL+EQ L+E+VD
Sbjct: 844 EYAMRGHLTDKADVYSFGVVALEIVHGKSNTSSRSKADTFYLLDWVHVLREQNTLLEVVD 903
Query: 644 TNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLE--CGVDVLDLVSDSSVSDI 701
G++++K++ ++MI + +LC + +P RPSMS+V+ MLE V+V L+ S ++
Sbjct: 904 PRLGTDYNKQEALMMIQIGMLCTSPAPGDRPSMSTVVSMLEGHSTVNVEKLLEASVNNEK 963
Query: 702 DETKAEAMRKYYQFCVENTASTTQSTSSIYGPPPGSSTAGVDLHPFSVDS 751
DE AM+++Y E + T +T + S+ DL+P +DS
Sbjct: 964 DEESVRAMKRHYATIGEEEITNTTTTDGPFTSSSTSTANANDLYPVKLDS 1013
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGE0|Y1765_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g07650 OS=Arabidopsis thaliana GN=At1g07650 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 438 bits (1126), Expect = e-122, Method: Compositional matrix adjust.
Identities = 220/341 (64%), Positives = 273/341 (80%), Gaps = 12/341 (3%)
Query: 410 QIKAATNNFATDNNIGEGGFGPVYKGLLADGTAIAVKQLSSKSKQGNREFINEIGMISAL 469
QIKAAT+NF IGEGGFG VYKG L++G IAVKQLS+KS+QGNREF+NEIGMISAL
Sbjct: 670 QIKAATDNFDVTRKIGEGGFGSVYKGELSEGKLIAVKQLSAKSRQGNREFVNEIGMISAL 729
Query: 470 QHPNLVKLYGCCIEGNQLLLIYEYLENNSLARALF----EHRLKLDWPTRRRICLGIARG 525
QHPNLVKLYGCC+EGNQL+L+YEYLENN L+RALF RLKLDW TR++I LGIA+G
Sbjct: 730 QHPNLVKLYGCCVEGNQLILVYEYLENNCLSRALFGKDESSRLKLDWSTRKKIFLGIAKG 789
Query: 526 LAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMA 585
L +LH ESRIK+VHRDIKA+NVLLDKDLN+KISDFGLAKL+++ NTHISTR+AGTIGYMA
Sbjct: 790 LTFLHEESRIKIVHRDIKASNVLLDKDLNAKISDFGLAKLNDDGNTHISTRIAGTIGYMA 849
Query: 586 PEYAMRGHLTEKADVYSFGIVALEIVSGRSNVT---KEDMFYLLDWALVLKEQGKLMELV 642
PEYAMRG+LTEKADVYSFG+VALEIVSG+SN ED YLLDWA VL+E+G L+ELV
Sbjct: 850 PEYAMRGYLTEKADVYSFGVVALEIVSGKSNTNFRPTEDFVYLLDWAYVLQERGSLLELV 909
Query: 643 DTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLECGVDVLDLVSDSSVSDID 702
D S++ +E+ M+M+NVAL+C NASPT+RP+MS V+ ++E + +L+SD S S ++
Sbjct: 910 DPTLASDYSEEEAMLMLNVALMCTNASPTLRPTMSQVVSLIEGKTAMQELLSDPSFSTVN 969
Query: 703 ETKAEAMRKYYQFCVENTASTTQSTSSIYGPPPGSSTAGVD 743
K +A+R ++ +N S + S S+ GP S+ + VD
Sbjct: 970 P-KLKALRNHFW---QNELSRSLSFST-SGPRTASANSLVD 1005
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGG7|Y1534_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g53420 OS=Arabidopsis thaliana GN=At1g53420 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 437 bits (1125), Expect = e-121, Method: Compositional matrix adjust.
Identities = 214/324 (66%), Positives = 259/324 (79%), Gaps = 11/324 (3%)
Query: 410 QIKAATNNFATDNNIGEGGFGPVYKGLLADGTAIAVKQLSSKSKQGNREFINEIGMISAL 469
QIK ATNNF + N IGEGGFGPVYKG L DGT IAVKQLS+ SKQGNREF+NEIGMISAL
Sbjct: 616 QIKIATNNFDSANRIGEGGFGPVYKGKLFDGTIIAVKQLSTGSKQGNREFLNEIGMISAL 675
Query: 470 QHPNLVKLYGCCIEGNQLLLIYEYLENNSLARALF---EHRLKLDWPTRRRICLGIARGL 526
HPNLVKLYGCC+EG QLLL+YE++ENNSLARALF E +L+LDWPTRR+IC+G+ARGL
Sbjct: 676 HHPNLVKLYGCCVEGGQLLLVYEFVENNSLARALFGPQETQLRLDWPTRRKICIGVARGL 735
Query: 527 AYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAP 586
AYLH ESR+K+VHRDIKATNVLLDK LN KISDFGLAKLDEE++THISTR+AGT GYMAP
Sbjct: 736 AYLHEESRLKIVHRDIKATNVLLDKQLNPKISDFGLAKLDEEDSTHISTRIAGTFGYMAP 795
Query: 587 EYAMRGHLTEKADVYSFGIVALEIVSGRSNV---TKEDMFYLLDWALVLKEQGKLMELVD 643
EYAMRGHLT+KADVYSFGIVALEIV GRSN +K + FYL+DW VL+E+ L+ELVD
Sbjct: 796 EYAMRGHLTDKADVYSFGIVALEIVHGRSNKIERSKNNTFYLIDWVEVLREKNNLLELVD 855
Query: 644 TNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLECGVDVLDLVSDSSVSDIDE 703
GS +++E+ M MI +A++C ++ P RPSMS V++MLE G ++++ S E
Sbjct: 856 PRLGSEYNREEAMTMIQIAIMCTSSEPCERPSMSEVVKMLE-GKKMVEVEKLEEASVHRE 914
Query: 704 TK----AEAMRKYYQFCVENTAST 723
TK M+KYY+ + +++
Sbjct: 915 TKRLENMNTMKKYYEMIGQEISTS 938
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9ASQ6|Y1972_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g29720 OS=Arabidopsis thaliana GN=RFK1 PE=2 SV=3 | Back alignment and function description |
|---|
Score = 396 bits (1017), Expect = e-109, Method: Compositional matrix adjust.
Identities = 195/348 (56%), Positives = 260/348 (74%), Gaps = 9/348 (2%)
Query: 408 YLQIKAATNNFATDNNIGEGGFGPVYKGLLADGTAIAVKQLSSKSKQGNREFINEIGMIS 467
+ Q++ ATNNF N +GEGGFG V+KG L+DGT IAVKQLSSKS QGNREF+NEIGMIS
Sbjct: 663 WRQLQTATNNFDQANKLGEGGFGSVFKGELSDGTIIAVKQLSSKSSQGNREFVNEIGMIS 722
Query: 468 ALQHPNLVKLYGCCIEGNQLLLIYEYLENNSLARALF-EHRLKLDWPTRRRICLGIARGL 526
L HPNLVKLYGCC+E +QLLL+YEY+ENNSLA ALF ++ LKLDW R++IC+GIARGL
Sbjct: 723 GLNHPNLVKLYGCCVERDQLLLVYEYMENNSLALALFGQNSLKLDWAARQKICVGIARGL 782
Query: 527 AYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAP 586
+LH S +++VHRDIK TNVLLD DLN+KISDFGLA+L E E+THIST+VAGTIGYMAP
Sbjct: 783 EFLHDGSAMRMVHRDIKTTNVLLDTDLNAKISDFGLARLHEAEHTHISTKVAGTIGYMAP 842
Query: 587 EYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKE---DMFYLLDWALVLKEQGKLMELVD 643
EYA+ G LTEKADVYSFG+VA+EIVSG+SN ++ D L++WAL L++ G ++E+VD
Sbjct: 843 EYALWGQLTEKADVYSFGVVAMEIVSGKSNTKQQGNADSVSLINWALTLQQTGDILEIVD 902
Query: 644 TNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLECGVDVLDLVSDSSVSDIDE 703
F++ + + MI VAL+C N+SP++RP+MS ++MLE +++ ++SD + D
Sbjct: 903 RMLEGEFNRSEAVRMIKVALVCTNSSPSLRPTMSEAVKMLEGEIEITQVMSDPGIYGHDW 962
Query: 704 TKAEAMRKYYQFCVENTASTTQSTSSIYGPPPGSSTAGVDLHPFSVDS 751
+ ++ +R +T+ T T++ SS +G DL+P +S
Sbjct: 963 SISK-LRDIDTHSSSSTSGVTDQTTTTM----KSSVSGCDLYPLYPES 1005
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FXF2|RKF1_ARATH Probable LRR receptor-like serine/threonine-protein kinase RFK1 OS=Arabidopsis thaliana GN=RKF1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 356 bits (913), Expect = 4e-97, Method: Compositional matrix adjust.
Identities = 179/281 (63%), Positives = 218/281 (77%), Gaps = 6/281 (2%)
Query: 410 QIKAATNNFATDNNIGEGGFGPVYKGLLADGTAIAVKQLSSKSKQGNREFINEIGMISAL 469
QIK AT++F N IGEGGFG V+KG+LADG +AVKQLSSKS+QGNREF+NEIG IS L
Sbjct: 673 QIKFATDDFNPTNKIGEGGFGAVFKGVLADGRVVAVKQLSSKSRQGNREFLNEIGAISCL 732
Query: 470 QHPNLVKLYGCCIEGNQLLLIYEYLENNSLARALFEHRLK---LDWPTRRRICLGIARGL 526
QHPNLVKL+G C+E QLLL YEY+ENNSL+ ALF + K +DWPTR +IC GIA+GL
Sbjct: 733 QHPNLVKLHGFCVERAQLLLAYEYMENNSLSSALFSPKHKQIPMDWPTRFKICCGIAKGL 792
Query: 527 AYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAP 586
A+LH ES +K VHRDIKATN+LLDKDL KISDFGLA+LDEEE THIST+VAGTIGYMAP
Sbjct: 793 AFLHEESPLKFVHRDIKATNILLDKDLTPKISDFGLARLDEEEKTHISTKVAGTIGYMAP 852
Query: 587 EYAMRGHLTEKADVYSFGIVALEIVSGRSN---VTKEDMFYLLDWALVLKEQGKLMELVD 643
EYA+ G+LT KADVYSFG++ LEIV+G +N + D LL++A E G LM++VD
Sbjct: 853 EYALWGYLTFKADVYSFGVLVLEIVAGITNSNFMGAGDSVCLLEFANECVESGHLMQVVD 912
Query: 644 TNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLE 684
D+++ +I VAL+C++ASPT RP MS V+ MLE
Sbjct: 913 ERLRPEVDRKEAEAVIKVALVCSSASPTDRPLMSEVVAMLE 953
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGH3|Y5614_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g56140 OS=Arabidopsis thaliana GN=At1g56140 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 343 bits (879), Expect = 4e-93, Method: Compositional matrix adjust.
Identities = 183/347 (52%), Positives = 238/347 (68%), Gaps = 12/347 (3%)
Query: 408 YLQIKAATNNFATDNNIGEGGFGPVYKGLLADGTAIAVKQLSSKSKQGNREFINEIGMIS 467
Y ++K+AT +F N +GEGGFGPVYKG L DG +AVK LS S+QG +F+ EI IS
Sbjct: 683 YSELKSATQDFDPSNKLGEGGFGPVYKGKLNDGREVAVKLLSVGSRQGKGQFVAEIVAIS 742
Query: 468 ALQHPNLVKLYGCCIEGNQLLLIYEYLENNSLARALF-EHRLKLDWPTRRRICLGIARGL 526
A+QH NLVKLYGCC EG LL+YEYL N SL +ALF E L LDW TR ICLG+ARGL
Sbjct: 743 AVQHRNLVKLYGCCYEGEHRLLVYEYLPNGSLDQALFGEKTLHLDWSTRYEICLGVARGL 802
Query: 527 AYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAP 586
YLH E+R+++VHRD+KA+N+LLD L K+SDFGLAKL +++ THISTRVAGTIGY+AP
Sbjct: 803 VYLHEEARLRIVHRDVKASNILLDSKLVPKVSDFGLAKLYDDKKTHISTRVAGTIGYLAP 862
Query: 587 EYAMRGHLTEKADVYSFGIVALEIVSGRSNVT---KEDMFYLLDWALVLKEQGKLMELVD 643
EYAMRGHLTEK DVY+FG+VALE+VSGR N +++ YLL+WA L E+G+ +EL+D
Sbjct: 863 EYAMRGHLTEKTDVYAFGVVALELVSGRPNSDENLEDEKRYLLEWAWNLHEKGREVELID 922
Query: 644 TNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLECGVDVLDLVSDSS-VSD-- 700
+ + F+ E+ MI +ALLC S +RP MS V+ ML V+V D+ S ++D
Sbjct: 923 -HQLTEFNMEEGKRMIGIALLCTQTSHALRPPMSRVVAMLSGDVEVSDVTSKPGYLTDWR 981
Query: 701 IDETKAEAMRKYYQFCVENTASTTQSTSSIYGPPPGSSTAGVDLHPF 747
D+T A ++ F + NT + ++S +S P S D P
Sbjct: 982 FDDTTASSISG---FPLRNTQA-SESFTSFVAPRSEISPRNNDARPM 1024
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGH2|Y1561_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g56130 OS=Arabidopsis thaliana GN=At1g56130 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 333 bits (855), Expect = 2e-90, Method: Compositional matrix adjust.
Identities = 177/351 (50%), Positives = 232/351 (66%), Gaps = 14/351 (3%)
Query: 404 YYGFYLQIKAATNNFATDNNIGEGGFGPVYKGLLADGTAIAVKQLSSKSKQGNREFINEI 463
Y Y ++K+AT +F N +GEGGFGPVYKG L DG +AVK LS S+QG +F+ EI
Sbjct: 680 YIFTYSELKSATQDFDPSNKLGEGGFGPVYKGNLNDGRVVAVKLLSVGSRQGKGQFVAEI 739
Query: 464 GMISALQHPNLVKLYGCCIEGNQLLLIYEYLENNSLARALF-EHRLKLDWPTRRRICLGI 522
IS++ H NLVKLYGCC EG +L+YEYL N SL +ALF + L LDW TR ICLG+
Sbjct: 740 VAISSVLHRNLVKLYGCCFEGEHRMLVYEYLPNGSLDQALFGDKTLHLDWSTRYEICLGV 799
Query: 523 ARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIG 582
ARGL YLH E+ +++VHRD+KA+N+LLD L +ISDFGLAKL +++ THISTRVAGTIG
Sbjct: 800 ARGLVYLHEEASVRIVHRDVKASNILLDSRLVPQISDFGLAKLYDDKKTHISTRVAGTIG 859
Query: 583 YMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVT---KEDMFYLLDWALVLKEQGKLM 639
Y+APEYAMRGHLTEK DVY+FG+VALE+VSGR N +E+ YLL+WA L E+ + +
Sbjct: 860 YLAPEYAMRGHLTEKTDVYAFGVVALELVSGRPNSDENLEEEKKYLLEWAWNLHEKSRDI 919
Query: 640 ELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLECGVDVLDLVSDSS-V 698
EL+D + ++F+ E+ MI +ALLC S +RP MS V+ ML V++ D+ S V
Sbjct: 920 ELID-DKLTDFNMEEAKRMIGIALLCTQTSHALRPPMSRVVAMLSGDVEIGDVTSKPGYV 978
Query: 699 SD--IDETKAEAMRKYYQFCVENTASTTQSTSSIYGPPPGSSTAGVDLHPF 747
SD D+T ++ + TT + S+ P S D P
Sbjct: 979 SDWRFDDTTGSSLSGF------QIKDTTGYSMSLVAPGSEISPRDSDFKPM 1023
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LVP0|Y5639_ARATH Probable leucine-rich repeat receptor-like protein kinase At5g63930 OS=Arabidopsis thaliana GN=At5g63930 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 300 bits (767), Expect = 4e-80, Method: Compositional matrix adjust.
Identities = 226/712 (31%), Positives = 357/712 (50%), Gaps = 77/712 (10%)
Query: 24 LKEQNLTGVLPPKLAELTFLQDIDLTLNYLSGTIPSQW---ASLPLLNISLIANRLKGPI 80
L + +L+G +PPKL + L +D++ N+LSG IPS +++ +LN+ N L G I
Sbjct: 392 LFQNSLSGTIPPKLGWYSDLWVLDMSDNHLSGRIPSYLCLHSNMIILNLG--TNNLSGNI 449
Query: 81 PKYLANISTLVNLTVQ------------------------YNQFSGELPEELGSLLNLEK 116
P + TLV L + N+F G +P E+G+ L++
Sbjct: 450 PTGITTCKTLVQLRLARNNLVGRFPSNLCKQVNVTAIELGQNRFRGSIPREVGNCSALQR 509
Query: 117 LHLSSNNFTGELPKTFAKLTNMKDFRISDNQFTGQIPSFIQNWTKLEKLFIQPSGLAGPI 176
L L+ N FTGELP+ L+ + IS N+ TG++PS I N L++L + + +G +
Sbjct: 510 LQLADNGFTGELPREIGMLSQLGTLNISSNKLTGEVPSEIFNCKMLQRLDMCCNNFSGTL 569
Query: 177 PSGIFSLENLTDLRISDLNGPEATFP-QLGNM-KMTKLILRNCNITGELPRYLGKMTKLK 234
PS + SL L L++S+ N T P LGN+ ++T+L + G +PR LG +T L+
Sbjct: 570 PSEVGSLYQLELLKLSN-NNLSGTIPVALGNLSRLTELQMGGNLFNGSIPRELGSLTGLQ 628
Query: 235 V-LDLSFNRLRGQIPSNFDDLYDVDYIYFAGNLLTGAIPPWMLERGDKI--DLSYNNFTD 291
+ L+LS+N+L G+IP +L ++++ N L+G IP + + SYN
Sbjct: 629 IALNLSYNKLTGEIPPELSNLVMLEFLLLNNNNLSGEIPSSFANLSSLLGYNFSYN---- 684
Query: 292 GSAESSCQKRSVTGIVSCLRSVQCPKTYYSLHINCGGKQVTANGNTTFEEDTSEAGPSTF 351
S+TG + LR++ ++ CG F S P
Sbjct: 685 ----------SLTGPIPLLRNISM-SSFIGNEGLCGPPLNQCIQTQPFAPSQSTGKPGGM 733
Query: 352 SQSG----TNWVLSSTGHFLENGLKLGPYIQTNTSRLLMNDYQLYTTARLSAISLTYY-- 405
S T V+ L + L Y+ R + + Q + S +SL Y
Sbjct: 734 RSSKIIAITAAVIGGVSLML---IALIVYLMRRPVRTVASSAQ---DGQPSEMSLDIYFP 787
Query: 406 ---GFYLQ-IKAATNNFATDNNIGEGGFGPVYKGLLADGTAIAVKQLSSKSKQGNR---- 457
GF Q + AAT+NF +G G G VYK +L G +AVK+L+S + GN
Sbjct: 788 PKEGFTFQDLVAATDNFDESFVVGRGACGTVYKAVLPAGYTLAVKKLASNHEGGNNNNVD 847
Query: 458 -EFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRR 516
F EI + ++H N+VKL+G C LL+YEY+ SL L + LDW R
Sbjct: 848 NSFRAEILTLGNIRHRNIVKLHGFCNHQGSNLLLYEYMPKGSLGEILHDPSCNLDWSKRF 907
Query: 517 RICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTR 576
+I LG A+GLAYLH + + ++ HRDIK+ N+LLD + + DFGLAK+ + ++ +
Sbjct: 908 KIALGAAQGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPHSKSMSA 967
Query: 577 VAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFY-LLDWALVLKEQ 635
+AG+ GY+APEYA +TEK+D+YS+G+V LE+++G++ V D +++W +
Sbjct: 968 IAGSYGYIAPEYAYTMKVTEKSDIYSYGVVLLELLTGKAPVQPIDQGGDVVNWVRSYIRR 1027
Query: 636 GKLMELVDTNPGSNFDKEQV----MVMINVALLCANASPTIRPSMSSVLRML 683
L V + + E++ + ++ +ALLC + SP RPSM V+ ML
Sbjct: 1028 DALSSGV-LDARLTLEDERIVSHMLTVLKIALLCTSVSPVARPSMRQVVLML 1078
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 756 | ||||||
| 359493983 | 1007 | PREDICTED: probable leucine-rich repeat | 0.511 | 0.384 | 0.637 | 1e-144 | |
| 302142829 | 1036 | unnamed protein product [Vitis vinifera] | 0.511 | 0.373 | 0.637 | 1e-144 | |
| 359493981 | 1007 | PREDICTED: probable leucine-rich repeat | 0.511 | 0.384 | 0.63 | 1e-142 | |
| 302142826 | 869 | unnamed protein product [Vitis vinifera] | 0.511 | 0.445 | 0.63 | 1e-141 | |
| 255567058 | 985 | ATP binding protein, putative [Ricinus c | 0.453 | 0.348 | 0.727 | 1e-141 | |
| 359493985 | 1011 | PREDICTED: probable leucine-rich repeat | 0.511 | 0.382 | 0.63 | 1e-141 | |
| 302142832 | 906 | unnamed protein product [Vitis vinifera] | 0.511 | 0.427 | 0.63 | 1e-140 | |
| 255567064 | 1007 | ATP binding protein, putative [Ricinus c | 0.452 | 0.339 | 0.710 | 1e-137 | |
| 147807566 | 561 | hypothetical protein VITISV_025180 [Viti | 0.452 | 0.609 | 0.694 | 1e-134 | |
| 302142841 | 710 | unnamed protein product [Vitis vinifera] | 0.451 | 0.480 | 0.704 | 1e-134 |
| >gi|359493983|ref|XP_002283596.2| PREDICTED: probable leucine-rich repeat receptor-like serine/threonine-protein kinase At3g14840-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 519 bits (1337), Expect = e-144, Method: Compositional matrix adjust.
Identities = 255/400 (63%), Positives = 307/400 (76%), Gaps = 13/400 (3%)
Query: 23 VLKEQNLTGVLPPKLAELTFLQDIDLTLNYLSGTIPSQWASLPLLNISLIANRLKGPIPK 82
VLK QNL G LPP+L +L +LQ+ID T NYL G+IP +W ++ L+NISLI NRL G IPK
Sbjct: 90 VLKTQNLPGSLPPELVKLPYLQEIDFTRNYLDGSIPPEWGTMQLVNISLIGNRLTGSIPK 149
Query: 83 YLANISTLVNLTVQYNQFSGELPEELGSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFR 142
L NISTL NLTV++NQ SG LP+ELG+L ++E++ L+SNNFTGELP+TFA LT +KDFR
Sbjct: 150 ELGNISTLANLTVEFNQLSGVLPQELGNLPSIERILLTSNNFTGELPQTFAGLTTLKDFR 209
Query: 143 ISDNQFTGQIPSFIQNWTKLEKLFIQPSGLAGPIPSGIFSLENLTDLRISDLNGPEATFP 202
+ DNQFTG+IP+FIQNWTKLEKL IQ SG +GPIPSGI L +TDLRISDLNG EATFP
Sbjct: 210 VGDNQFTGKIPNFIQNWTKLEKLVIQGSGFSGPIPSGIALLTKITDLRISDLNGTEATFP 269
Query: 203 QLGNMKMTK-LILRNCNITGELPRYLGKMTKLKVLDLSFNRLRGQIPSNFDDLYDVDYIY 261
L +M+ K LILR+CNI G LP YLG+MTKLK LDLSFN+L G+IPS+F L + DY+Y
Sbjct: 270 PLSDMRNLKTLILRSCNIVGPLPDYLGEMTKLKTLDLSFNKLTGEIPSSFVGLSNADYMY 329
Query: 262 FAGNLLTGAIPPWMLERGDKIDLSYNNFTDGSAESSCQKRSVT-----------GIVSCL 310
F GN+LTGA+P WML+RGD DLSYNNFT S+ CQ+RSV GIVSCL
Sbjct: 330 FTGNMLTGAVPDWMLKRGDNYDLSYNNFTSESSR-GCQERSVNLFGSSSGGNNFGIVSCL 388
Query: 311 RSVQCPKTYYSLHINCGGKQVTANGNTTFEEDTSEAGPSTFSQSGTNWVLSSTGHFLENG 370
RS CPK +YS+HINCGGK+V +GNTT+E+DT GPS F QS TNW SSTGHF+++
Sbjct: 389 RSFNCPKKFYSMHINCGGKEVIVDGNTTYEDDTDSGGPSKFYQSRTNWAFSSTGHFMDDD 448
Query: 371 LKLGPYIQTNTSRLLMNDYQLYTTARLSAISLTYYGFYLQ 410
+I TN SRL M + LYTTARLSA+SLTYYGF L+
Sbjct: 449 RPTDSFIGTNVSRLTMENSGLYTTARLSALSLTYYGFCLE 488
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|302142829|emb|CBI20124.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 519 bits (1336), Expect = e-144, Method: Compositional matrix adjust.
Identities = 255/400 (63%), Positives = 307/400 (76%), Gaps = 13/400 (3%)
Query: 23 VLKEQNLTGVLPPKLAELTFLQDIDLTLNYLSGTIPSQWASLPLLNISLIANRLKGPIPK 82
VLK QNL G LPP+L +L +LQ+ID T NYL G+IP +W ++ L+NISLI NRL G IPK
Sbjct: 119 VLKTQNLPGSLPPELVKLPYLQEIDFTRNYLDGSIPPEWGTMQLVNISLIGNRLTGSIPK 178
Query: 83 YLANISTLVNLTVQYNQFSGELPEELGSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFR 142
L NISTL NLTV++NQ SG LP+ELG+L ++E++ L+SNNFTGELP+TFA LT +KDFR
Sbjct: 179 ELGNISTLANLTVEFNQLSGVLPQELGNLPSIERILLTSNNFTGELPQTFAGLTTLKDFR 238
Query: 143 ISDNQFTGQIPSFIQNWTKLEKLFIQPSGLAGPIPSGIFSLENLTDLRISDLNGPEATFP 202
+ DNQFTG+IP+FIQNWTKLEKL IQ SG +GPIPSGI L +TDLRISDLNG EATFP
Sbjct: 239 VGDNQFTGKIPNFIQNWTKLEKLVIQGSGFSGPIPSGIALLTKITDLRISDLNGTEATFP 298
Query: 203 QLGNMKMTK-LILRNCNITGELPRYLGKMTKLKVLDLSFNRLRGQIPSNFDDLYDVDYIY 261
L +M+ K LILR+CNI G LP YLG+MTKLK LDLSFN+L G+IPS+F L + DY+Y
Sbjct: 299 PLSDMRNLKTLILRSCNIVGPLPDYLGEMTKLKTLDLSFNKLTGEIPSSFVGLSNADYMY 358
Query: 262 FAGNLLTGAIPPWMLERGDKIDLSYNNFTDGSAESSCQKRSVT-----------GIVSCL 310
F GN+LTGA+P WML+RGD DLSYNNFT S+ CQ+RSV GIVSCL
Sbjct: 359 FTGNMLTGAVPDWMLKRGDNYDLSYNNFTSESSR-GCQERSVNLFGSSSGGNNFGIVSCL 417
Query: 311 RSVQCPKTYYSLHINCGGKQVTANGNTTFEEDTSEAGPSTFSQSGTNWVLSSTGHFLENG 370
RS CPK +YS+HINCGGK+V +GNTT+E+DT GPS F QS TNW SSTGHF+++
Sbjct: 418 RSFNCPKKFYSMHINCGGKEVIVDGNTTYEDDTDSGGPSKFYQSRTNWAFSSTGHFMDDD 477
Query: 371 LKLGPYIQTNTSRLLMNDYQLYTTARLSAISLTYYGFYLQ 410
+I TN SRL M + LYTTARLSA+SLTYYGF L+
Sbjct: 478 RPTDSFIGTNVSRLTMENSGLYTTARLSALSLTYYGFCLE 517
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359493981|ref|XP_003634703.1| PREDICTED: probable leucine-rich repeat receptor-like serine/threonine-protein kinase At3g14840-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 511 bits (1317), Expect = e-142, Method: Compositional matrix adjust.
Identities = 252/400 (63%), Positives = 309/400 (77%), Gaps = 13/400 (3%)
Query: 23 VLKEQNLTGVLPPKLAELTFLQDIDLTLNYLSGTIPSQWASLPLLNISLIANRLKGPIPK 82
VLK QNL G LPP+L +L +LQ+ID T NYL+G+IP +W ++ L+NISLI N+L G IPK
Sbjct: 90 VLKTQNLPGSLPPELVKLPYLQEIDFTRNYLNGSIPPEWGTMQLVNISLIGNQLTGSIPK 149
Query: 83 YLANISTLVNLTVQYNQFSGELPEELGSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFR 142
L NISTL NLTV++NQ SG LP+ELG+L ++E++ L+SNNFTGELP+TFA LT +KDFR
Sbjct: 150 ELGNISTLANLTVEFNQLSGVLPQELGNLPSIERILLTSNNFTGELPQTFAGLTTLKDFR 209
Query: 143 ISDNQFTGQIPSFIQNWTKLEKLFIQPSGLAGPIPSGIFSLENLTDLRISDLNGPEATFP 202
+ DNQFTG+IP+FIQNWTKLEKL IQ SG +GPIPSGI L +TDLRISDLNG EATFP
Sbjct: 210 VGDNQFTGKIPNFIQNWTKLEKLVIQGSGFSGPIPSGIALLTKITDLRISDLNGTEATFP 269
Query: 203 QLGNMK-MTKLILRNCNITGELPRYLGKMTKLKVLDLSFNRLRGQIPSNFDDLYDVDYIY 261
L +M+ + LILR+CNI LP YLG+MTKLK LDLSFN+L G+IPS+F L + DY+Y
Sbjct: 270 PLSDMRDLKTLILRSCNIVDPLPDYLGEMTKLKTLDLSFNKLTGEIPSSFVGLSNADYMY 329
Query: 262 FAGNLLTGAIPPWMLERGDKIDLSYNNFTDGSAESSCQKRSV-----------TGIVSCL 310
F GN+LTGA+P WML+RGD DLSYNNFT S+ CQ+RSV +GIVSCL
Sbjct: 330 FTGNMLTGAVPDWMLKRGDNYDLSYNNFTSESSR-GCQERSVNLFGSSSGGNNSGIVSCL 388
Query: 311 RSVQCPKTYYSLHINCGGKQVTANGNTTFEEDTSEAGPSTFSQSGTNWVLSSTGHFLENG 370
RS CPK +YS+HINCGGK+V +GNTT+E+DT GPS F QS TNW SSTGHF+++
Sbjct: 389 RSFNCPKKFYSMHINCGGKEVIVDGNTTYEDDTDSGGPSKFYQSRTNWAFSSTGHFMDDD 448
Query: 371 LKLGPYIQTNTSRLLMNDYQLYTTARLSAISLTYYGFYLQ 410
+I TN SRL+M + LYTTARLSA+SLTYYGF L+
Sbjct: 449 RPTDSFIGTNVSRLIMENSGLYTTARLSALSLTYYGFCLE 488
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|302142826|emb|CBI20121.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 510 bits (1313), Expect = e-141, Method: Compositional matrix adjust.
Identities = 252/400 (63%), Positives = 308/400 (77%), Gaps = 13/400 (3%)
Query: 23 VLKEQNLTGVLPPKLAELTFLQDIDLTLNYLSGTIPSQWASLPLLNISLIANRLKGPIPK 82
VLK QNL G LPP+L +L +LQ+ID T NYL+G+IP +W ++ L+NISLI N+L G IPK
Sbjct: 90 VLKTQNLPGSLPPELVKLPYLQEIDFTRNYLNGSIPPEWGTMQLVNISLIGNQLTGSIPK 149
Query: 83 YLANISTLVNLTVQYNQFSGELPEELGSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFR 142
L NISTL NLTV++NQ SG LP+ELG+L ++E++ L+SNNFTGELP+TFA LT +KDFR
Sbjct: 150 ELGNISTLANLTVEFNQLSGVLPQELGNLPSIERILLTSNNFTGELPQTFAGLTTLKDFR 209
Query: 143 ISDNQFTGQIPSFIQNWTKLEKLFIQPSGLAGPIPSGIFSLENLTDLRISDLNGPEATFP 202
+ DNQFTG+IP+FIQNWTKLEKL IQ SG +GPIPSGI L +TDLRISDLNG EATFP
Sbjct: 210 VGDNQFTGKIPNFIQNWTKLEKLVIQGSGFSGPIPSGIALLTKITDLRISDLNGTEATFP 269
Query: 203 QLGNMK-MTKLILRNCNITGELPRYLGKMTKLKVLDLSFNRLRGQIPSNFDDLYDVDYIY 261
L +M+ + LILR+CNI LP YLG+MTKLK LDLSFN+L G+IPS+F L + DY+Y
Sbjct: 270 PLSDMRDLKTLILRSCNIVDPLPDYLGEMTKLKTLDLSFNKLTGEIPSSFVGLSNADYMY 329
Query: 262 FAGNLLTGAIPPWMLERGDKIDLSYNNFTDGSAESSCQKRSVT-----------GIVSCL 310
F GN+LTGA+P WML+RGD DLSYNNFT S+ CQ+RSV GIVSCL
Sbjct: 330 FTGNMLTGAVPDWMLKRGDNYDLSYNNFTSESSR-GCQERSVNLFGSSSGGNNSGIVSCL 388
Query: 311 RSVQCPKTYYSLHINCGGKQVTANGNTTFEEDTSEAGPSTFSQSGTNWVLSSTGHFLENG 370
RS CPK +YS+HINCGGK+V +GNTT+E+DT GPS F QS TNW SSTGHF+++
Sbjct: 389 RSFNCPKKFYSMHINCGGKEVIVDGNTTYEDDTDSGGPSKFYQSRTNWAFSSTGHFMDDD 448
Query: 371 LKLGPYIQTNTSRLLMNDYQLYTTARLSAISLTYYGFYLQ 410
+I TN SRL+M + LYTTARLSA+SLTYYGF L+
Sbjct: 449 RPTDSFIGTNVSRLIMENSGLYTTARLSALSLTYYGFCLE 488
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255567058|ref|XP_002524511.1| ATP binding protein, putative [Ricinus communis] gi|223536185|gb|EEF37838.1| ATP binding protein, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 509 bits (1310), Expect = e-141, Method: Compositional matrix adjust.
Identities = 256/352 (72%), Positives = 292/352 (82%), Gaps = 9/352 (2%)
Query: 410 QIKAATNNFATDNNIGEGGFGPVYKGLLADGTAIAVKQLSSKSKQGNREFINEIGMISAL 469
QIKAATNNF DN IGEGGFG VYKGLL+DGTAIAVKQLSSKSKQGNREFI EIGMISAL
Sbjct: 628 QIKAATNNFDPDNKIGEGGFGSVYKGLLSDGTAIAVKQLSSKSKQGNREFITEIGMISAL 687
Query: 470 QHPNLVKLYGCCIEGNQLLLIYEYLENNSLARALF---EHRLKLDWPTRRRICLGIARGL 526
QHP+LVKLYGCCI+GNQL L+YEY+ENNSLARALF E +L LDWPTR +IC+GIARGL
Sbjct: 688 QHPHLVKLYGCCIDGNQLFLLYEYMENNSLARALFGPEECQLNLDWPTRHKICVGIARGL 747
Query: 527 AYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAP 586
A+LH ESR+K+VHRDIKATNVLLDK+L+ KISDFGLAKLDEEENTHISTRVAGT GYMAP
Sbjct: 748 AFLHEESRLKIVHRDIKATNVLLDKNLDPKISDFGLAKLDEEENTHISTRVAGTFGYMAP 807
Query: 587 EYAMRGHLTEKADVYSFGIVALEIVSGRSNVT-----KEDMFYLLDWALVLKEQGKLMEL 641
EYAMRGHLT+KADVYSFGIVALEIVSGRSN + KED FYLLDWALVLKE+G L+EL
Sbjct: 808 EYAMRGHLTDKADVYSFGIVALEIVSGRSNTSLRQNMKEDCFYLLDWALVLKEKGSLLEL 867
Query: 642 VDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLECGVDVLDLVSDSSVSDI 701
VD G+N+DK QVM MINVAL CA+ S RP+MSSV+ +LE V DLV D S
Sbjct: 868 VDPRMGTNYDKNQVMTMINVALQCASVSSVARPAMSSVVSILEGKTTVQDLVLDDSNVSH 927
Query: 702 DETKAEAMRKYYQFCVENTASTTQSTS-SIYGPPPGSSTAGVDLHPFSVDSD 752
DE K EAMRK++Q +E+ S +Q+ S S+ GP GSS++ DL+P ++DS+
Sbjct: 928 DEKKIEAMRKHFQHNIESQTSESQTQSMSLDGPWTGSSSSAGDLYPITLDSN 979
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359493985|ref|XP_002283578.2| PREDICTED: probable leucine-rich repeat receptor-like serine/threonine-protein kinase At3g14840-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 508 bits (1308), Expect = e-141, Method: Compositional matrix adjust.
Identities = 252/400 (63%), Positives = 305/400 (76%), Gaps = 13/400 (3%)
Query: 23 VLKEQNLTGVLPPKLAELTFLQDIDLTLNYLSGTIPSQWASLPLLNISLIANRLKGPIPK 82
VLK QNL G LPP+L +L +LQ+ID T NYL+G+IP +W ++ L+NISL+ NRL G IPK
Sbjct: 90 VLKTQNLPGSLPPELVKLPYLQEIDFTRNYLNGSIPPEWGTMQLVNISLMGNRLTGSIPK 149
Query: 83 YLANISTLVNLTVQYNQFSGELPEELGSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFR 142
L NISTL NLTV+ NQ SG LP+ELG+L ++E++ L+SNNFTGELP+TFA LT +KDFR
Sbjct: 150 ELGNISTLANLTVESNQLSGVLPQELGNLPSIERILLTSNNFTGELPETFAGLTTLKDFR 209
Query: 143 ISDNQFTGQIPSFIQNWTKLEKLFIQPSGLAGPIPSGIFSLENLTDLRISDLNGPEATFP 202
++DNQFTG+IP+FIQNWTKLEKL I SG +GPIPSGI L +TDLRISDLNG EATFP
Sbjct: 210 VADNQFTGKIPNFIQNWTKLEKLVIHGSGFSGPIPSGIALLTKITDLRISDLNGTEATFP 269
Query: 203 QLGNMKMTK-LILRNCNITGELPRYLGKMTKLKVLDLSFNRLRGQIPSNFDDLYDVDYIY 261
L +M+ K LILR+C+I G LP YLG+MTKLK LDLSFN+L G+IPS+F L DYIY
Sbjct: 270 PLSDMRNLKTLILRSCSIVGPLPDYLGEMTKLKTLDLSFNKLTGEIPSSFVGLSKADYIY 329
Query: 262 FAGNLLTGAIPPWMLERGDKIDLSYNNFTDGSAESSCQKRSVT-----------GIVSCL 310
F GN+LTGA+P WML+RGD DLSYNNFT S+ CQ+RSV GIVSCL
Sbjct: 330 FTGNMLTGAVPDWMLKRGDNYDLSYNNFTSESSR-GCQERSVNLFGSSSGGNNSGIVSCL 388
Query: 311 RSVQCPKTYYSLHINCGGKQVTANGNTTFEEDTSEAGPSTFSQSGTNWVLSSTGHFLENG 370
RS CPK +YS+HINCGGK+V +GNTT+E+D GPS F QS TNW SSTGHF+++
Sbjct: 389 RSFNCPKKFYSMHINCGGKEVIVDGNTTYEDDKDSGGPSKFYQSRTNWAFSSTGHFMDDD 448
Query: 371 LKLGPYIQTNTSRLLMNDYQLYTTARLSAISLTYYGFYLQ 410
+I TN SRL M + LYTTARLSA+SLTYYGF L+
Sbjct: 449 HPTDSFIGTNVSRLAMENSGLYTTARLSALSLTYYGFCLE 488
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|302142832|emb|CBI20127.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 506 bits (1304), Expect = e-140, Method: Compositional matrix adjust.
Identities = 252/400 (63%), Positives = 306/400 (76%), Gaps = 13/400 (3%)
Query: 23 VLKEQNLTGVLPPKLAELTFLQDIDLTLNYLSGTIPSQWASLPLLNISLIANRLKGPIPK 82
VLK QNL G LPP+L +L +LQ+ID T NYL+G+IP +W ++ L+NISL+ NRL G IPK
Sbjct: 90 VLKTQNLPGSLPPELVKLPYLQEIDFTRNYLNGSIPPEWGTMQLVNISLMGNRLTGSIPK 149
Query: 83 YLANISTLVNLTVQYNQFSGELPEELGSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFR 142
L NISTL NLTV+ NQ SG LP+ELG+L ++E++ L+SNNFTGELP+TFA LT +KDFR
Sbjct: 150 ELGNISTLANLTVESNQLSGVLPQELGNLPSIERILLTSNNFTGELPETFAGLTTLKDFR 209
Query: 143 ISDNQFTGQIPSFIQNWTKLEKLFIQPSGLAGPIPSGIFSLENLTDLRISDLNGPEATFP 202
++DNQFTG+IP+FIQNWTKLEKL I SG +GPIPSGI L +TDLRISDLNG EATFP
Sbjct: 210 VADNQFTGKIPNFIQNWTKLEKLVIHGSGFSGPIPSGIALLTKITDLRISDLNGTEATFP 269
Query: 203 QLGNMKMTK-LILRNCNITGELPRYLGKMTKLKVLDLSFNRLRGQIPSNFDDLYDVDYIY 261
L +M+ K LILR+C+I G LP YLG+MTKLK LDLSFN+L G+IPS+F L DYIY
Sbjct: 270 PLSDMRNLKTLILRSCSIVGPLPDYLGEMTKLKTLDLSFNKLTGEIPSSFVGLSKADYIY 329
Query: 262 FAGNLLTGAIPPWMLERGDKIDLSYNNFTDGSAESSCQKRSV-----------TGIVSCL 310
F GN+LTGA+P WML+RGD DLSYNNFT S+ CQ+RSV +GIVSCL
Sbjct: 330 FTGNMLTGAVPDWMLKRGDNYDLSYNNFTSESSR-GCQERSVNLFGSSSGGNNSGIVSCL 388
Query: 311 RSVQCPKTYYSLHINCGGKQVTANGNTTFEEDTSEAGPSTFSQSGTNWVLSSTGHFLENG 370
RS CPK +YS+HINCGGK+V +GNTT+E+D GPS F QS TNW SSTGHF+++
Sbjct: 389 RSFNCPKKFYSMHINCGGKEVIVDGNTTYEDDKDSGGPSKFYQSRTNWAFSSTGHFMDDD 448
Query: 371 LKLGPYIQTNTSRLLMNDYQLYTTARLSAISLTYYGFYLQ 410
+I TN SRL M + LYTTARLSA+SLTYYGF L+
Sbjct: 449 HPTDSFIGTNVSRLAMENSGLYTTARLSALSLTYYGFCLE 488
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255567064|ref|XP_002524514.1| ATP binding protein, putative [Ricinus communis] gi|223536188|gb|EEF37841.1| ATP binding protein, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 494 bits (1272), Expect = e-137, Method: Compositional matrix adjust.
Identities = 250/352 (71%), Positives = 290/352 (82%), Gaps = 10/352 (2%)
Query: 410 QIKAATNNFATDNNIGEGGFGPVYKGLLADGTAIAVKQLSSKSKQGNREFINEIGMISAL 469
QIKAAT+NF DN IGEGGFG VYKGLL+DGT IAVKQLSSKSKQGNREF+NEIGMISAL
Sbjct: 651 QIKAATHNFNLDNKIGEGGFGSVYKGLLSDGTIIAVKQLSSKSKQGNREFVNEIGMISAL 710
Query: 470 QHPNLVKLYGCCIEGNQLLLIYEYLENNSLARALF---EHRLKLDWPTRRRICLGIARGL 526
QHP+LVKLYGCCIE NQLLL+YEY+ENNSLARALF E +L LDWPTR +IC+GIARGL
Sbjct: 711 QHPHLVKLYGCCIEENQLLLVYEYMENNSLARALFGPEECQLDLDWPTRHKICVGIARGL 770
Query: 527 AYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAP 586
A+LH ESR+K+VHRDIKATNVLLDK+LN KISDFGLAKLDEEENTHISTRVAGT GYMAP
Sbjct: 771 AFLHEESRLKIVHRDIKATNVLLDKNLNPKISDFGLAKLDEEENTHISTRVAGTFGYMAP 830
Query: 587 EYAMRGHLTEKADVYSFGIVALEIVSGRSNVT-----KEDMFYLLDWALVLKEQGKLMEL 641
EYAMRGHLT+KADVYSFGIVALEIVSGRSN + KE+ YLLDWALVLKE+G L+EL
Sbjct: 831 EYAMRGHLTDKADVYSFGIVALEIVSGRSNTSYRLNLKENCVYLLDWALVLKEKGSLLEL 890
Query: 642 VDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLECGVDVLDLVSDSSVSDI 701
VD G+N++K +VM +INVAL CA+ SP +RP+MSSV+ MLE V D ++S S
Sbjct: 891 VDPRMGTNYNKAEVMTVINVALQCASVSPGVRPAMSSVVSMLEGKTVVQDFTQETS-SSF 949
Query: 702 DETKAEAMRKYYQFCVENTASTTQSTS-SIYGPPPGSSTAGVDLHPFSVDSD 752
DE K EAM K++Q +E+ S +Q S S+ GP SST+ DL+P ++DS+
Sbjct: 950 DEMKDEAMSKHFQHSIEHKTSESQIQSMSLDGPWVASSTSEQDLYPVTLDSN 1001
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|147807566|emb|CAN66180.1| hypothetical protein VITISV_025180 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 485 bits (1248), Expect = e-134, Method: Compositional matrix adjust.
Identities = 243/350 (69%), Positives = 288/350 (82%), Gaps = 8/350 (2%)
Query: 410 QIKAATNNFATDNNIGEGGFGPVYKGLLADGTAIAVKQLSSKSKQGNREFINEIGMISAL 469
QIKAATNNF N IGEGGFG VYKG+L+DGT IAVKQLSSKSKQGNREF+NEIGMISAL
Sbjct: 207 QIKAATNNFDAANKIGEGGFGSVYKGILSDGTIIAVKQLSSKSKQGNREFVNEIGMISAL 266
Query: 470 QHPNLVKLYGCCIEGNQLLLIYEYLENNSLARALF---EHRLKLDWPTRRRICLGIARGL 526
QHP+LVKLYGCCIEGNQLLLIYEY+ENNSLARALF E +L+LDWPTR RIC+GIARGL
Sbjct: 267 QHPHLVKLYGCCIEGNQLLLIYEYMENNSLARALFGPEECQLQLDWPTRHRICVGIARGL 326
Query: 527 AYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAP 586
YLH ESR+K+VHRDIKATNVLLDKDLN KISDFGLAKLDEE+NTHISTR+AGT GYMAP
Sbjct: 327 TYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRIAGTFGYMAP 386
Query: 587 EYAMRGHLTEKADVYSFGIVALEIVSGRSNVT---KEDMFYLLDWALVLKEQGKLMELVD 643
EYAMRG+LT+KADVYSFGIVALEIVSGRSN T KE+ YLLDWAL LKE+G LM+LVD
Sbjct: 387 EYAMRGYLTDKADVYSFGIVALEIVSGRSNTTYRPKEECTYLLDWALSLKEKGNLMDLVD 446
Query: 644 TNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLECGVDVLDLVSDSSVSDIDE 703
GS+F+KE+VM M+N+ALLC N S +RP+MSSV+ MLE V D+VSD S D+
Sbjct: 447 PRLGSDFNKEEVMAMLNLALLCTNISSAVRPAMSSVVSMLEGITAVQDIVSDPSAPS-DD 505
Query: 704 TKAEAMRKYYQFCVENTASTTQSTS-SIYGPPPGSSTAGVDLHPFSVDSD 752
K + ++++Y+ E + ++S + S+ P +S++ DL+P ++DS+
Sbjct: 506 LKLKELKQHYRHIQEKSMDVSESKAQSMPDGPWTASSSITDLYPVTLDSE 555
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|302142841|emb|CBI20136.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 485 bits (1248), Expect = e-134, Method: Compositional matrix adjust.
Identities = 246/349 (70%), Positives = 282/349 (80%), Gaps = 8/349 (2%)
Query: 410 QIKAATNNFATDNNIGEGGFGPVYKGLLADGTAIAVKQLSSKSKQGNREFINEIGMISAL 469
QIKAATNNF N IGEGGFG VYKGLL DGT IAVKQLSSKSKQGNREF+NEIGMISAL
Sbjct: 355 QIKAATNNFDAANKIGEGGFGSVYKGLLLDGTIIAVKQLSSKSKQGNREFVNEIGMISAL 414
Query: 470 QHPNLVKLYGCCIEGNQLLLIYEYLENNSLARALF---EHRLKLDWPTRRRICLGIARGL 526
QHP+LVKLYGCCIEGNQLLL+YEY+ENNSLARALF + +LKLDWPTR +IC+GIARGL
Sbjct: 415 QHPHLVKLYGCCIEGNQLLLVYEYMENNSLARALFGPKDSQLKLDWPTRHKICVGIARGL 474
Query: 527 AYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAP 586
AYLH ESR+K+VHRDIKATNVLLDKDLN KISDFGLAKLDEEENTHISTR+AGT GYMAP
Sbjct: 475 AYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEENTHISTRIAGTFGYMAP 534
Query: 587 EYAMRGHLTEKADVYSFGIVALEIVSGRSN---VTKEDMFYLLDWALVLKEQGKLMELVD 643
EYAMRGHLTEKADVYSFG+VALEIVSG+SN + K+ YLLDWAL+LKE G L+ELVD
Sbjct: 535 EYAMRGHLTEKADVYSFGVVALEIVSGKSNTNHILKDGCVYLLDWALLLKENGNLLELVD 594
Query: 644 TNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLECGVDVLDLVSDSSVSDIDE 703
SNF KE+VM MINVALLC + SP RP+MSSV+ +LE V ++ S S+S DE
Sbjct: 595 PILESNFKKEEVMAMINVALLCTSFSPVARPTMSSVVSILEGRAHVQEISSGLSISS-DE 653
Query: 704 TKAEAMRKYYQ-FCVENTASTTQSTSSIYGPPPGSSTAGVDLHPFSVDS 751
K + +R+ Y + +NT+ S GP SST+G DL+P +++S
Sbjct: 654 IKLKELRQQYDLYHAKNTSEGQIPCLSTDGPWTASSTSGADLYPITMNS 702
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | LOW CONFIDENCE prediction! |
| 3rd Layer | 2.7.11 | 0.691 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 756 | |||
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 3e-56 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 2e-54 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 1e-53 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 1e-52 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 2e-52 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 1e-50 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-50 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 2e-47 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 1e-44 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 4e-43 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 4e-39 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 7e-38 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 1e-37 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 3e-37 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 5e-35 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 1e-34 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 1e-34 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 8e-34 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-33 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 2e-33 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 3e-32 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 2e-31 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 2e-31 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 3e-31 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 5e-31 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 1e-30 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 1e-30 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 5e-30 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 6e-30 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 1e-29 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 1e-29 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 7e-29 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 1e-28 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 3e-28 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 4e-28 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 7e-28 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 7e-28 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 1e-27 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 4e-27 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 5e-27 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 8e-27 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 8e-27 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 1e-26 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 1e-26 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 1e-26 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 2e-26 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 2e-26 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 2e-26 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 6e-26 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 7e-26 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 9e-26 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 1e-25 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 2e-25 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 2e-25 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 3e-25 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 4e-25 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 4e-25 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 4e-25 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 7e-25 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 1e-24 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 1e-24 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 2e-24 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 2e-24 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 2e-24 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 3e-24 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 3e-24 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 4e-24 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 5e-24 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 7e-24 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 8e-24 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 8e-24 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 8e-24 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 9e-24 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 1e-23 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 1e-23 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 2e-23 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 2e-23 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 4e-23 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 4e-23 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 5e-23 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 5e-23 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 9e-23 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 1e-22 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 2e-22 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 2e-22 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 2e-22 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 2e-22 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 2e-22 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 2e-22 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 2e-22 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 4e-22 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 5e-22 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 5e-22 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 6e-22 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 6e-22 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 6e-22 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 7e-22 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 7e-22 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 8e-22 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 1e-21 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 1e-21 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 1e-21 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 1e-21 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 2e-21 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 2e-21 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 2e-21 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 2e-21 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 2e-21 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 3e-21 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 4e-21 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 4e-21 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 8e-21 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 8e-21 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 1e-20 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 2e-20 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 2e-20 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 3e-20 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 3e-20 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 4e-20 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 8e-20 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 1e-19 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 1e-19 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-19 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 2e-19 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 3e-19 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 3e-19 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 3e-19 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 5e-19 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 9e-19 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 1e-18 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 1e-18 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 2e-18 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 2e-18 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 3e-18 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 3e-18 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 4e-18 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 5e-18 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 5e-18 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 6e-18 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 6e-18 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 7e-18 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 8e-18 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 1e-17 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 1e-17 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 1e-17 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 2e-17 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 2e-17 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 2e-17 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 2e-17 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 3e-17 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 3e-17 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 3e-17 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 3e-17 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 4e-17 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 6e-17 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 7e-17 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 7e-17 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 7e-17 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 1e-16 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 2e-16 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 2e-16 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 2e-16 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 3e-16 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 3e-16 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 8e-16 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 8e-16 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 9e-16 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 1e-15 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 1e-15 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 1e-15 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 1e-15 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 2e-15 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 2e-15 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 3e-15 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 5e-15 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 6e-15 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 6e-15 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 9e-15 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 1e-14 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 1e-14 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 1e-14 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 1e-14 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 1e-14 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 1e-14 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 1e-14 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 2e-14 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 2e-14 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 3e-14 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 3e-14 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 3e-14 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 3e-14 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 3e-14 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 4e-14 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 4e-14 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 5e-14 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 5e-14 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 6e-14 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 6e-14 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 6e-14 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 7e-14 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 7e-14 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 7e-14 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 9e-14 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 1e-13 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 2e-13 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 2e-13 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 2e-13 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 2e-13 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 3e-13 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 4e-13 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 4e-13 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 5e-13 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 7e-13 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 7e-13 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 1e-12 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 1e-12 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 2e-12 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 2e-12 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 2e-12 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 2e-12 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 3e-12 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 4e-12 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 4e-12 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 6e-12 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 6e-12 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 8e-12 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 8e-12 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 9e-12 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 9e-12 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 1e-11 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 1e-11 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 1e-11 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 2e-11 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 2e-11 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 3e-11 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 4e-11 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 4e-11 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 4e-11 | |
| pfam11721 | 164 | pfam11721, Malectin, Di-glucose binding within end | 5e-11 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 5e-11 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 5e-11 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 8e-11 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 8e-11 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 8e-11 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 1e-10 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 1e-10 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 1e-10 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 1e-10 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 1e-10 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 2e-10 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 2e-10 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 2e-10 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 2e-10 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 2e-10 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 3e-10 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 3e-10 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 4e-10 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 5e-10 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 6e-10 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 6e-10 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 7e-10 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 8e-10 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 1e-09 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 1e-09 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 2e-09 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 2e-09 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 3e-09 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 3e-09 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 4e-09 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 4e-09 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 4e-09 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 4e-09 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 4e-09 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 1e-08 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 1e-08 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 2e-08 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 3e-08 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 3e-08 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 3e-08 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 3e-08 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 4e-08 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 5e-08 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 6e-08 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 6e-08 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 6e-08 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 7e-08 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 1e-07 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 1e-07 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 1e-07 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 2e-07 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 2e-07 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 2e-07 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 2e-07 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 3e-07 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 4e-07 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 5e-07 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 6e-07 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 7e-07 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 7e-07 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 7e-07 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 9e-07 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 1e-06 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 1e-06 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 1e-06 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 4e-06 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 4e-06 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 4e-06 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 9e-06 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 2e-05 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 2e-05 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 2e-05 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 2e-05 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 3e-05 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 4e-05 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 5e-05 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 6e-05 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 6e-05 | |
| cd00116 | 319 | cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribo | 1e-04 | |
| smart00750 | 176 | smart00750, KIND, kinase non-catalytic C-lobe doma | 2e-04 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 4e-04 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 5e-04 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 6e-04 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 0.003 | |
| cd08227 | 327 | cd08227, PK_STRAD_alpha, Pseudokinase domain of ST | 0.004 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 192 bits (491), Expect = 3e-56
Identities = 87/272 (31%), Positives = 130/272 (47%), Gaps = 33/272 (12%)
Query: 424 IGEGGFGPVYKGLL-----ADGTAIAVKQL-SSKSKQGNREFINEIGMISALQHPNLVKL 477
+GEG FG VYKG L +AVK L S+Q EF+ E ++ L HPN+VKL
Sbjct: 7 LGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNVVKL 66
Query: 478 YGCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKV 537
G C E L ++ EY+E L L ++R KL L IARG+ YL
Sbjct: 67 LGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARGMEYLE---SKNF 123
Query: 538 VHRDIKATNVLLDKDLNSKISDFGLAKL--DEEENTHISTRVAGTIGYMAPEYAMRGHLT 595
+HRD+ A N L+ ++L KISDFGL++ D++ ++ I +MAPE G T
Sbjct: 124 IHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKL--PIRWMAPESLKEGKFT 181
Query: 596 EKADVYSFGIVALEIVS-GRS---NVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFD 651
K+DV+SFG++ EI + G ++ E++ L + G + P
Sbjct: 182 SKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLEYL-------KNGYRLPQPPNCPPE--- 231
Query: 652 KEQVMVMINVALLCANASPTIRPSMSSVLRML 683
+ ++ L C P RP+ S ++ +L
Sbjct: 232 ------LYDLMLQCWAEDPEDRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 187 bits (478), Expect = 2e-54
Identities = 85/273 (31%), Positives = 129/273 (47%), Gaps = 34/273 (12%)
Query: 424 IGEGGFGPVYKGLLADG-----TAIAVKQL-SSKSKQGNREFINEIGMISALQHPNLVKL 477
+GEG FG VYKG L +AVK L S+Q EF+ E ++ L HPN+VKL
Sbjct: 7 LGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNIVKL 66
Query: 478 YGCCIEGNQLLLIYEYLENNSLARALFEHRLK-LDWPTRRRICLGIARGLAYLHGESRIK 536
G C E L+++ EY+ L L ++R K L L IARG+ YL
Sbjct: 67 LGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLE---SKN 123
Query: 537 VVHRDIKATNVLLDKDLNSKISDFGLAKL--DEEENTHISTRVAGTIGYMAPEYAMRGHL 594
+HRD+ A N L+ ++L KISDFGL++ D++ ++ I +MAPE G
Sbjct: 124 FIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKL--PIRWMAPESLKEGKF 181
Query: 595 TEKADVYSFGIVALEIVS-GRS---NVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNF 650
T K+DV+SFG++ EI + G ++ ++ L ++G + P
Sbjct: 182 TSKSDVWSFGVLLWEIFTLGEEPYPGMSNAEVLEYL-------KKGYRLPKPPNCPPE-- 232
Query: 651 DKEQVMVMINVALLCANASPTIRPSMSSVLRML 683
+ + L C P RP+ S ++ +L
Sbjct: 233 -------LYKLMLQCWAEDPEDRPTFSELVEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 186 bits (474), Expect = 1e-53
Identities = 88/279 (31%), Positives = 133/279 (47%), Gaps = 37/279 (13%)
Query: 424 IGEGGFGPVYKGLLADG----TAIAVKQL-SSKSKQGNREFINEIGMISALQHPNLVKLY 478
+GEG FG VYKG L T +AVK L S++ ++F+ E ++ L HPN+V+L
Sbjct: 3 LGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLL 62
Query: 479 GCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRR--------RICLGIARGLAYLH 530
G C E L L+ EY+E L L + R P + + IA+G+ YL
Sbjct: 63 GVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLA 122
Query: 531 GESRIKVVHRDIKATNVLLDKDLNSKISDFGLAK-LDEEENTHISTRVAGTIGYMAPEYA 589
K VHRD+ A N L+ +DL KISDFGL++ + +++ T I +MAPE
Sbjct: 123 ---SKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPESL 179
Query: 590 MRGHLTEKADVYSFGIVALEIVS-GRS---NVTKEDMFYLLDWALVLKEQGKLMELVDTN 645
G T K+DV+SFG++ EI + G + ++ E++ L +G +
Sbjct: 180 KDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYL-------RKGYRLP----K 228
Query: 646 PGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLE 684
P E + + L C P RP+ S ++ LE
Sbjct: 229 P-EYCPDE----LYELMLSCWQLDPEDRPTFSELVERLE 262
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 182 bits (465), Expect = 1e-52
Identities = 89/271 (32%), Positives = 132/271 (48%), Gaps = 30/271 (11%)
Query: 424 IGEGGFGPVYKGLL-----ADGTAIAVKQL-SSKSKQGNREFINEIGMISALQHPNLVKL 477
+GEG FG VYKG L T +AVK L S++ EF+ E ++ L HPN+V+L
Sbjct: 7 LGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVRL 66
Query: 478 YGCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKV 537
G C +G L ++ EY+ L L +H KL ++ L IA+G+ YL
Sbjct: 67 LGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGMEYLE---SKNF 123
Query: 538 VHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGT-IGYMAPEYAMRGHLTE 596
VHRD+ A N L+ ++L KISDFGL++ E++ + I +MAPE G T
Sbjct: 124 VHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWMAPESLKDGKFTS 183
Query: 597 KADVYSFGIVALEIVS-GRS---NVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDK 652
K+DV+SFG++ EI + G ++ E++ LL E G + + P
Sbjct: 184 KSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLELL-------EDGYRLPRPENCP-----D 231
Query: 653 EQVMVMINVALLCANASPTIRPSMSSVLRML 683
E +M L C P RP+ S ++ L
Sbjct: 232 ELYELM----LQCWAYDPEDRPTFSELVEDL 258
|
Length = 258 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 180 bits (460), Expect = 2e-52
Identities = 76/191 (39%), Positives = 107/191 (56%), Gaps = 8/191 (4%)
Query: 424 IGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQGNRE-FINEIGMISALQHPNLVKLYGCC 481
+GEGGFG VY G +A+K + + E + EI ++ L HPN+VKLYG
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 482 IEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRD 541
+ N L L+ EY E SL L E+ KL RI L I GL YLH ++HRD
Sbjct: 61 EDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLH---SNGIIHRD 117
Query: 542 IKATNVLLDKDLNS-KISDFGLAKLDEEENTHISTRVAGTIGYMAPE-YAMRGHLTEKAD 599
+K N+LLD D K++DFGL+KL + + + T V GT YMAPE +G+ +EK+D
Sbjct: 118 LKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIV-GTPAYMAPEVLLGKGYYSEKSD 176
Query: 600 VYSFGIVALEI 610
++S G++ E+
Sbjct: 177 IWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 177 bits (451), Expect = 1e-50
Identities = 73/211 (34%), Positives = 108/211 (51%), Gaps = 12/211 (5%)
Query: 424 IGEGGFGPVYKG-LLADGTAIAVKQL--SSKSKQGNREFINEIGMISALQHPNLVKLYGC 480
+G G FG VYK G +AVK L S+ + ++ EI ++ L HPN+V+L
Sbjct: 7 LGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLIDA 66
Query: 481 CIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHR 540
+ + L L+ EY E L L L ++I L I RGL YLH ++HR
Sbjct: 67 FEDKDHLYLVMEYCEGGDLFDYLSRGG-PLSEDEAKKIALQILRGLEYLHSNG---IIHR 122
Query: 541 DIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPE-YAMRGHLTEKAD 599
D+K N+LLD++ KI+DFGLAK + ++ ++T V GT YMAPE K D
Sbjct: 123 DLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTFV-GTPWYMAPEVLLGGNGYGPKVD 181
Query: 600 VYSFGIVALEIVSGR---SNVTKEDMFYLLD 627
V+S G++ E+++G+ S D L+
Sbjct: 182 VWSLGVILYELLTGKPPFSGENILDQLQLIR 212
|
Length = 260 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 190 bits (484), Expect = 2e-50
Identities = 190/692 (27%), Positives = 310/692 (44%), Gaps = 64/692 (9%)
Query: 24 LKEQNLTGVLPPKLAELTFLQDIDLTLNYLSGTIPSQWASLPLLNI-SLIANRLKGPIPK 82
L + +L+G +P + +L L+ + L N +G IP SLP L + L +N+ G IPK
Sbjct: 291 LSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPK 350
Query: 83 YLANISTLVNLTVQYNQFSGELPEELGSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFR 142
L + L L + N +GE+PE L S NL KL L SN+ GE+PK+ +++ R
Sbjct: 351 NLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVR 410
Query: 143 ISDNQFTGQIPSFIQNWTKLEKLF---IQPSGLAGPIPSGIFSLENLTDLRISDLNGPEA 199
+ DN F+G++PS +TKL ++ I + L G I S + + +L L ++ N
Sbjct: 411 LQDNSFSGELPS---EFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLA-RNKFFG 466
Query: 200 TFPQL-GNMKMTKLILRNCNITGELPRYLGKMTKLKVLDLSFNRLRGQIPSNFDDLYDVD 258
P G+ ++ L L +G +PR LG +++L L LS N+L G+IP +
Sbjct: 467 GLPDSFGSKRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLV 526
Query: 259 YIYFAGNLLTGAIPPWMLERG--DKIDLSYNNFTD------GSAESSCQKRSVTGIVSCL 310
+ + N L+G IP E ++DLS N + G+ ES Q I
Sbjct: 527 SLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQ----VNISHNH 582
Query: 311 RSVQCPKTYYSLHINCGGKQVTANGNTTFEEDTSEAGPSTFSQSGTNW---VLSSTGHFL 367
P T L IN V N + + TS P + +W + + G FL
Sbjct: 583 LHGSLPSTGAFLAIN--ASAVAGNIDLCGGDTTSGLPPCKRVRKTPSWWFYITCTLGAFL 640
Query: 368 ENGLKLGPYIQTNTSRLL----------MNDYQLYTTARLSAISLTYYGFYLQIKAATNN 417
L ++ L + Q + + +I+ I ++
Sbjct: 641 VLALVAFGFVFIRGRNNLELKRVENEDGTWELQFFDSKVSKSIT---------INDILSS 691
Query: 418 FATDNNIGEGGFGPVYKG-LLADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVK 476
+N I G G YKG + +G VK++ N +EI + LQHPN+VK
Sbjct: 692 LKEENVISRGKKGASYKGKSIKNGMQFVVKEI----NDVNSIPSSEIADMGKLQHPNIVK 747
Query: 477 LYGCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIK 536
L G C LI+EY+E +L+ L L W RR+I +GIA+ L +LH
Sbjct: 748 LIGLCRSEKGAYLIHEYIEGKNLSEVL----RNLSWERRRKIAIGIAKALRFLHCRCSPA 803
Query: 537 VVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPEYAMRGHLTE 596
VV ++ +++D D +L T+ + Y+APE +TE
Sbjct: 804 VVVGNLSPEKIIID------GKDEPHLRLSLPGLLCTDTKCFISSAYVAPETRETKDITE 857
Query: 597 KADVYSFGIVALEIVSGRSNVTKEDMFY--LLDWALVLKEQGKLMELVDTNPGSN--FDK 652
K+D+Y FG++ +E+++G+S E + +++WA L +D + + ++
Sbjct: 858 KSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDVSVNQ 917
Query: 653 EQVMVMINVALLCANASPTIRPSMSSVLRMLE 684
+++ ++N+AL C PT RP + VL+ LE
Sbjct: 918 NEIVEVMNLALHCTATDPTARPCANDVLKTLE 949
|
Length = 968 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 168 bits (428), Expect = 2e-47
Identities = 66/194 (34%), Positives = 105/194 (54%), Gaps = 8/194 (4%)
Query: 424 IGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQGNRE-FINEIGMISALQHPNLVKLYGCC 481
+GEG FG VY G +A+K + K + +RE + EI ++ L+HPN+V+LY
Sbjct: 7 LGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRLYDVF 66
Query: 482 IEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRD 541
+ ++L L+ EY E L L + +L R I L YLH +VHRD
Sbjct: 67 EDEDKLYLVMEYCEGGDLFDLLKKRG-RLSEDEARFYLRQILSALEYLH---SKGIVHRD 122
Query: 542 IKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPEYAMRGHLTEKADVY 601
+K N+LLD+D + K++DFGLA+ + ++T V GT YMAPE + + D++
Sbjct: 123 LKPENILLDEDGHVKLADFGLARQ-LDPGEKLTTFV-GTPEYMAPEVLLGKGYGKAVDIW 180
Query: 602 SFGIVALEIVSGRS 615
S G++ E+++G+
Sbjct: 181 SLGVILYELLTGKP 194
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 161 bits (409), Expect = 1e-44
Identities = 76/197 (38%), Positives = 104/197 (52%), Gaps = 10/197 (5%)
Query: 424 IGEGGFGPVYKGLLAD-GTAIAVKQ--LSSKSKQGNREFINEIGMISALQHPNLVKLYGC 480
+G G FG VY L D G +AVK LS S++ EI ++S+LQHPN+V+ YG
Sbjct: 8 LGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGS 67
Query: 481 CI--EGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVV 538
E N L + EY+ SL+ L + KL P R+ I GLAYLH +V
Sbjct: 68 ERDEEKNTLNIFLEYVSGGSLSSLL-KKFGKLPEPVIRKYTRQILEGLAYLHSN---GIV 123
Query: 539 HRDIKATNVLLDKDLNSKISDFGLAK-LDEEENTHISTRVAGTIGYMAPEYAMRGHLTEK 597
HRDIK N+L+D D K++DFG AK L + E + V GT +MAPE
Sbjct: 124 HRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEEYGRA 183
Query: 598 ADVYSFGIVALEIVSGR 614
AD++S G +E+ +G+
Sbjct: 184 ADIWSLGCTVIEMATGK 200
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 156 bits (396), Expect = 4e-43
Identities = 68/192 (35%), Positives = 103/192 (53%), Gaps = 6/192 (3%)
Query: 424 IGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCCI 482
IG+GGFG VYK G +A+K + +SK+ + INEI ++ +HPN+VK YG +
Sbjct: 8 IGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYL 67
Query: 483 EGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDI 542
+ ++L ++ E+ SL L L +C + +GL YLH ++HRDI
Sbjct: 68 KKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSN---GIIHRDI 124
Query: 543 KATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPEYAMRGHLTEKADVYS 602
KA N+LL D K+ DFGL+ + +T + GT +MAPE KAD++S
Sbjct: 125 KAANILLTSDGEVKLIDFGLSA--QLSDTKARNTMVGTPYWMAPEVINGKPYDYKADIWS 182
Query: 603 FGIVALEIVSGR 614
GI A+E+ G+
Sbjct: 183 LGITAIELAEGK 194
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 146 bits (370), Expect = 4e-39
Identities = 70/194 (36%), Positives = 114/194 (58%), Gaps = 12/194 (6%)
Query: 424 IGEGGFGPVYKGL-LADGTAIAVKQ--LSSKSKQGNREFINEIGMISALQHPNLVKLYGC 480
IGEG G VYK A G +A+K+ L ++K+ INEI ++ +HPN+V Y
Sbjct: 27 IGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELI---INEILIMKDCKHPNIVDYYDS 83
Query: 481 CIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHR 540
+ G++L ++ EY++ SL + ++ ++++ P +C + +GL YLH ++ I HR
Sbjct: 84 YLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVI---HR 140
Query: 541 DIKATNVLLDKDLNSKISDFGL-AKLDEEENTHISTRVAGTIGYMAPEYAMRGHLTEKAD 599
DIK+ N+LL KD + K++DFG A+L +E++ S V GT +MAPE R K D
Sbjct: 141 DIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNS--VVGTPYWMAPEVIKRKDYGPKVD 198
Query: 600 VYSFGIVALEIVSG 613
++S GI+ +E+ G
Sbjct: 199 IWSLGIMCIEMAEG 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 151 bits (384), Expect = 7e-38
Identities = 95/254 (37%), Positives = 141/254 (55%), Gaps = 10/254 (3%)
Query: 24 LKEQNLTGVLPPKLAELTFLQDIDLTLNYLSGTIPSQWASLPLLNI-SLIANRLKGPIPK 82
L N TG +P + L+ +DL+ N LSG IP+ S L + L N L G IP
Sbjct: 125 LSNNNFTGSIPR--GSIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPN 182
Query: 83 YLANISTLVNLTVQYNQFSGELPEELGSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFR 142
L N+++L LT+ NQ G++P ELG + +L+ ++L NN +GE+P LT++
Sbjct: 183 SLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLD 242
Query: 143 ISDNQFTGQIPSFIQNWTKLEKLFIQPSGLAGPIPSGIFSLENLTDLRISD--LNG--PE 198
+ N TG IPS + N L+ LF+ + L+GPIP IFSL+ L L +SD L+G PE
Sbjct: 243 LVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPE 302
Query: 199 ATFPQLGNMKMTKLILRNCNITGELPRYLGKMTKLKVLDLSFNRLRGQIPSNFDDLYDVD 258
QL N+++ L L + N TG++P L + +L+VL L N+ G+IP N ++
Sbjct: 303 LVI-QLQNLEI--LHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLT 359
Query: 259 YIYFAGNLLTGAIP 272
+ + N LTG IP
Sbjct: 360 VLDLSTNNLTGEIP 373
|
Length = 968 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 140 bits (356), Expect = 1e-37
Identities = 73/204 (35%), Positives = 109/204 (53%), Gaps = 28/204 (13%)
Query: 424 IGEGGFGPVYKGL-LADGTAIAVKQLS--SKSKQGNREFINEIGMISALQHPNLVKLYGC 480
IG G FG VYKGL L G +A+KQ+S ++ + + EI ++ L+HPN+VK G
Sbjct: 8 IGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGS 67
Query: 481 CIEGNQLLLIYEYLENNSLARAL-----FEHRLKLDWPTRRRICLGIA---RGLAYLHGE 532
+ L +I EY EN SL + + F L + + + +GLAYLH +
Sbjct: 68 IETSDSLYIILEYAENGSLRQIIKKFGPFPESL---------VAVYVYQVLQGLAYLHEQ 118
Query: 533 SRIKVVHRDIKATNVLLDKDLNSKISDFGLA-KLDEEENTHISTRVAGTIGYMAPE-YAM 590
V+HRDIKA N+L KD K++DFG+A KL++ V GT +MAPE M
Sbjct: 119 ---GVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKD--DASVVGTPYWMAPEVIEM 173
Query: 591 RGHLTEKADVYSFGIVALEIVSGR 614
G + +D++S G +E+++G
Sbjct: 174 SGA-STASDIWSLGCTVIELLTGN 196
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 139 bits (353), Expect = 3e-37
Identities = 85/269 (31%), Positives = 127/269 (47%), Gaps = 36/269 (13%)
Query: 424 IGEGGFGPVYKGLLADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCCIE 483
IG+G FG V G G +AVK L S F+ E +++ L+HPNLV+L G ++
Sbjct: 14 IGKGEFGDVMLGDYR-GQKVAVKCLKDDSTAAQ-AFLAEASVMTTLRHPNLVQLLGVVLQ 71
Query: 484 GNQLLLIYEYLENNSL-------ARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIK 536
GN L ++ EY+ SL RA+ +L + L + G+ YL E +
Sbjct: 72 GNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGF------ALDVCEGMEYL--EEK-N 122
Query: 537 VVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPEYAMRGHLTE 596
VHRD+ A NVL+ +DL +K+SDFGLAK E S ++ + + APE +
Sbjct: 123 FVHRDLAARNVLVSEDLVAKVSDFGLAK--EASQGQDSGKLP--VKWTAPEALREKKFST 178
Query: 597 KADVYSFGIVALEIVS-GRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDKEQV 655
K+DV+SFGI+ EI S GR + + ++ E+G ME + P + +V
Sbjct: 179 KSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHV----EKGYRMEAPEGCPPEVY---KV 231
Query: 656 MVMINVALLCANASPTIRPSMSSVLRMLE 684
M C P RP+ + L
Sbjct: 232 MKD------CWELDPAKRPTFKQLREQLA 254
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 133 bits (337), Expect = 5e-35
Identities = 68/199 (34%), Positives = 106/199 (53%), Gaps = 11/199 (5%)
Query: 421 DNNIGEGGFGPVYKGLLA----DGTAIAVKQLSSKSKQGNR-EFINEIGMISALQHPNLV 475
+ IG G FG V +G L +A+K L + S R +F+ E ++ HPN++
Sbjct: 9 EKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNII 68
Query: 476 KLYGCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRI 535
+L G + +++I EY+EN SL + L E+ K + GIA G+ YL S +
Sbjct: 69 RLEGVVTKSRPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYL---SEM 125
Query: 536 KVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIG--YMAPEYAMRGH 593
VHRD+ A N+L++ +L K+SDFGL++ E+ +T+ G I + APE
Sbjct: 126 NYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTK-GGKIPIRWTAPEAIAYRK 184
Query: 594 LTEKADVYSFGIVALEIVS 612
T +DV+SFGIV E++S
Sbjct: 185 FTSASDVWSFGIVMWEVMS 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 132 bits (335), Expect = 1e-34
Identities = 72/202 (35%), Positives = 99/202 (49%), Gaps = 13/202 (6%)
Query: 422 NNIGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQGN--REFINEIGMISALQHPNLVKLY 478
N IG G FG VY + L G +AVK++ + +E +E+ ++ L+HPNLVK Y
Sbjct: 6 NKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYY 65
Query: 479 GCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVV 538
G + ++ + EY +L L EH LD R L + GLAYLH I V
Sbjct: 66 GVEVHREKVYIFMEYCSGGTLEELL-EHGRILDEHVIRVYTLQLLEGLAYLH-SHGI--V 121
Query: 539 HRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIG---YMAPEYAMRGHLT 595
HRDIK N+ LD + K+ DFG A + T + V G YMAPE G
Sbjct: 122 HRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGK 181
Query: 596 EK---ADVYSFGIVALEIVSGR 614
AD++S G V LE+ +G+
Sbjct: 182 GHGRAADIWSLGCVVLEMATGK 203
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 132 bits (335), Expect = 1e-34
Identities = 82/285 (28%), Positives = 129/285 (45%), Gaps = 35/285 (12%)
Query: 422 NNIGEGGFGPVYKG---LLADGTA--IAVKQLS-SKSKQGNREFINEIGMISALQHPNLV 475
+GEG FG V L D T +AVK L+ S +Q +F EI ++ L H N+V
Sbjct: 10 KQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIV 69
Query: 476 KLYGCCIE--GNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGES 533
K G C + G L LI EYL + SL L HR +++ I +G+ YL +
Sbjct: 70 KYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQ- 128
Query: 534 RIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGT--IGYMAPEYAMR 591
+ +HRD+ A N+L++ + KISDFGLAK+ E+ + + G I + APE
Sbjct: 129 --RYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLRT 186
Query: 592 GHLTEKADVYSFGIVALEIVS-GRSN-----------VTKEDMFYLLDWALVLKEQGKLM 639
+ +DV+SFG+ E+ + G + + + +LKE +L
Sbjct: 187 SKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLKEGERL- 245
Query: 640 ELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLE 684
+ E +M LC A P RPS + ++ +++
Sbjct: 246 -----PRPPSCPDEVYDLMK----LCWEAEPQDRPSFADLILIVD 281
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 130 bits (328), Expect = 8e-34
Identities = 62/199 (31%), Positives = 99/199 (49%), Gaps = 21/199 (10%)
Query: 424 IGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCCI 482
+GEG +G VYK + G +A+K + + +E I EI ++ P +VK YG
Sbjct: 11 LGEGSYGSVYKAIHKETGQVVAIKVVPVEE--DLQEIIKEISILKQCDSPYIVKYYGSYF 68
Query: 483 EGNQLLLIYEYLENNSLA-------RALFEHRLKLDWPTRRRICLGIARGLAYLHGESRI 535
+ L ++ EY S++ + L E + I +GL YLH
Sbjct: 69 KNTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAA-------ILYQTLKGLEYLH---SN 118
Query: 536 KVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPEYAMRGHLT 595
K +HRDIKA N+LL+++ +K++DFG++ + +T V GT +MAPE
Sbjct: 119 KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNT-VIGTPFWMAPEVIQEIGYN 177
Query: 596 EKADVYSFGIVALEIVSGR 614
KAD++S GI A+E+ G+
Sbjct: 178 NKADIWSLGITAIEMAEGK 196
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 138 bits (348), Expect = 2e-33
Identities = 94/267 (35%), Positives = 146/267 (54%), Gaps = 5/267 (1%)
Query: 28 NLTGVLPPKLAELTFLQDIDLTLNYLSGTIPSQWASLPLLN-ISLIANRLKGPIPKYLAN 86
NL+G +P ++ LT L +DL N L+G IPS +L L + L N+L GPIP + +
Sbjct: 223 NLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFS 282
Query: 87 ISTLVNLTVQYNQFSGELPEELGSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRISDN 146
+ L++L + N SGE+PE + L NLE LHL SNNFTG++P L ++ ++ N
Sbjct: 283 LQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSN 342
Query: 147 QFTGQIPSFIQNWTKLEKLFIQPSGLAGPIPSGIFSLENLTDLRISDLNGPEATFPQ-LG 205
+F+G+IP + L L + + L G IP G+ S NL L I N E P+ LG
Sbjct: 343 KFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKL-ILFSNSLEGEIPKSLG 401
Query: 206 NMK-MTKLILRNCNITGELPRYLGKMTKLKVLDLSFNRLRGQIPSNFDDLYDVDYIYFAG 264
+ + ++ L++ + +GELP K+ + LD+S N L+G+I S D+ + + A
Sbjct: 402 ACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLAR 461
Query: 265 NLLTGAIPPWM-LERGDKIDLSYNNFT 290
N G +P +R + +DLS N F+
Sbjct: 462 NKFFGGLPDSFGSKRLENLDLSRNQFS 488
|
Length = 968 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 128 bits (325), Expect = 2e-33
Identities = 76/200 (38%), Positives = 107/200 (53%), Gaps = 20/200 (10%)
Query: 424 IGEGGFGPVYKGLLADGTAIAVKQLSSKSKQGN---REFINEIGMISALQHPNLVKLYGC 480
+G G FG V+ G T +AVK L K G F+ E ++ L+H LV+LY
Sbjct: 14 LGAGQFGEVWMGTWNGTTKVAVKTL----KPGTMSPEAFLQEAQIMKKLRHDKLVQLYAV 69
Query: 481 CIEGNQLLLIYEYLENNSLARALFE---HRLKLDWPTRRRICLGIARGLAYLHGESRIKV 537
C E + ++ EY+ SL L +L+L P + IA G+AYL ESR
Sbjct: 70 CSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRL--PQLVDMAAQIAEGMAYL--ESR-NY 124
Query: 538 VHRDIKATNVLLDKDLNSKISDFGLAKL--DEEENTHISTRVAGTIGYMAPEYAMRGHLT 595
+HRD+ A N+L+ ++L KI+DFGLA+L D+E + I + APE A G T
Sbjct: 125 IHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFP--IKWTAPEAANYGRFT 182
Query: 596 EKADVYSFGIVALEIVS-GR 614
K+DV+SFGI+ EIV+ GR
Sbjct: 183 IKSDVWSFGILLTEIVTYGR 202
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 126 bits (318), Expect = 3e-32
Identities = 78/285 (27%), Positives = 132/285 (46%), Gaps = 46/285 (16%)
Query: 424 IGEGGFGPVYKGLLAD------GTAIAVKQLSSKSKQGNR-EFINEIGMISALQHPNLVK 476
+G+G FG VY+GL T +A+K ++ + R EF+NE ++ ++V+
Sbjct: 14 LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVR 73
Query: 477 LYGCCIEGNQLLLIYEYLENNSLARALFEHRLK------LDWPTRRRI---CLGIARGLA 527
L G G L++ E + L L R + L PT ++ IA G+A
Sbjct: 74 LLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMA 133
Query: 528 YLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAK-LDEEENTHISTRVAGTIGYMAP 586
YL + K VHRD+ A N ++ +DL KI DFG+ + + E + + + +MAP
Sbjct: 134 YLAAK---KFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAP 190
Query: 587 EYAMRGHLTEKADVYSFGIVALEIVS-------GRSNVTKEDMFYLLDWALVLKEQGKLM 639
E G T K+DV+SFG+V E+ + G SN +E + +++D G +
Sbjct: 191 ESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSN--EEVLKFVID--------GGHL 240
Query: 640 ELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLE 684
+L + P + +M M C +P +RP+ ++ L+
Sbjct: 241 DLPENCPDKLLE---LMRM------CWQYNPKMRPTFLEIVSSLK 276
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 124 bits (312), Expect = 2e-31
Identities = 70/213 (32%), Positives = 103/213 (48%), Gaps = 30/213 (14%)
Query: 424 IGEGGFGPVYKGLLA------DGTAIAVKQLS-SKSKQGNREFINEIGMISALQHPNLVK 476
+GEG FG V+ G D +AVK L + S ++F E +++ QH N+VK
Sbjct: 13 LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVK 72
Query: 477 LYGCCIEGNQLLLIYEYLENNSLARALFEH-----RLKLDWPTRRR--------ICLGIA 523
YG C EG+ ++++EY+E+ L + L H LK I + IA
Sbjct: 73 FYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIA 132
Query: 524 RGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGT--- 580
G+ YL + VHRD+ N L+ DL KI DFG+++ D + RV G
Sbjct: 133 SGMVYLASQ---HFVHRDLATRNCLVGYDLVVKIGDFGMSR-DVYTTDYY--RVGGHTML 186
Query: 581 -IGYMAPEYAMRGHLTEKADVYSFGIVALEIVS 612
I +M PE M T ++DV+SFG+V EI +
Sbjct: 187 PIRWMPPESIMYRKFTTESDVWSFGVVLWEIFT 219
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 123 bits (310), Expect = 2e-31
Identities = 63/201 (31%), Positives = 105/201 (52%), Gaps = 15/201 (7%)
Query: 418 FATDNNIGEGGFGPVYKGLLADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKL 477
F + +G G FG V++GL + +A+K L S ++F E+ + L+H +L+ L
Sbjct: 8 FTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISL 67
Query: 478 YGCCIEGNQLLLIYEYLENNSLARALFEHRLK-LDWPTRRRICLGIARGLAYLHGESRIK 536
+ C G + +I E +E SL L + L + + +A G+AYL E +
Sbjct: 68 FAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYL--EEQ-N 124
Query: 537 VVHRDIKATNVLLDKDLNSKISDFGLAKLDEE-----ENTHISTRVAGTIGYMAPEYAMR 591
+HRD+ A N+L+ +DL K++DFGLA+L +E + I + + APE A
Sbjct: 125 SIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKIPYK------WTAPEAASH 178
Query: 592 GHLTEKADVYSFGIVALEIVS 612
G + K+DV+SFGI+ E+ +
Sbjct: 179 GTFSTKSDVWSFGILLYEMFT 199
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 123 bits (310), Expect = 3e-31
Identities = 65/196 (33%), Positives = 112/196 (57%), Gaps = 11/196 (5%)
Query: 424 IGEGGFGPVYKGL-LADG----TAIAVKQL-SSKSKQGNREFINEIGMISALQHPNLVKL 477
+G G FG VYKG+ + +G +A+K L S + N+E ++E +++++ HP++V+L
Sbjct: 15 LGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRL 74
Query: 478 YGCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKV 537
G C+ +Q+ LI + + L + H+ + C+ IA+G++YL E R+
Sbjct: 75 LGICL-SSQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLE-EKRL-- 130
Query: 538 VHRDIKATNVLLDKDLNSKISDFGLAK-LDEEENTHISTRVAGTIGYMAPEYAMRGHLTE 596
VHRD+ A NVL+ + KI+DFGLAK LD +E + + I +MA E + T
Sbjct: 131 VHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESILHRIYTH 190
Query: 597 KADVYSFGIVALEIVS 612
K+DV+S+G+ E+++
Sbjct: 191 KSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 122 bits (307), Expect = 5e-31
Identities = 70/198 (35%), Positives = 102/198 (51%), Gaps = 13/198 (6%)
Query: 424 IGEGGFGPVYKGL-LADGTAIAVKQLS-----SKSKQGNREFINEIGMISALQHPNLVKL 477
+G G FG VY+GL L DG AVK++S ++ ++ EI ++S LQHPN+V+
Sbjct: 8 LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67
Query: 478 YGCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKV 537
G E + L + E + SLA+ L + P R I GL YLH
Sbjct: 68 LGTEREEDNLYIFLELVPGGSLAK-LLKKYGSFPEPVIRLYTRQILLGLEYLHDR---NT 123
Query: 538 VHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPEYAMR-GHLTE 596
VHRDIK N+L+D + K++DFG+AK E + S G+ +MAPE + G
Sbjct: 124 VHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFAKS--FKGSPYWMAPEVIAQQGGYGL 181
Query: 597 KADVYSFGIVALEIVSGR 614
AD++S G LE+ +G+
Sbjct: 182 AADIWSLGCTVLEMATGK 199
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 121 bits (305), Expect = 1e-30
Identities = 61/203 (30%), Positives = 101/203 (49%), Gaps = 22/203 (10%)
Query: 424 IGEGGFGPVYKGL-LADGTAIAVKQLS-SKSKQGNREF-INEIGMISALQHPNLVKLYGC 480
IG+G FG VY +DG +K++ S + RE +NE+ ++ L HPN++K Y
Sbjct: 8 IGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYES 67
Query: 481 CIEGNQLLLIYEYLENNSLARALFEHRLK---------LDWPTRRRICLGIARGLAYLHG 531
E +L ++ EY + L++ + + + + LDW + +CL L YLH
Sbjct: 68 FEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQ--LCLA----LKYLHS 121
Query: 532 ESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPEYAMR 591
K++HRDIK N+ L + K+ DFG++K+ T V GT Y++PE
Sbjct: 122 R---KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVV-GTPYYLSPELCQN 177
Query: 592 GHLTEKADVYSFGIVALEIVSGR 614
K+D++S G V E+ + +
Sbjct: 178 KPYNYKSDIWSLGCVLYELCTLK 200
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 121 bits (305), Expect = 1e-30
Identities = 67/192 (34%), Positives = 100/192 (52%), Gaps = 8/192 (4%)
Query: 424 IGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQGNREFIN-EIGMISALQHPNLVKLYGCC 481
IG+G FG VYK + +A+K + + + E I EI +S + P + K YG
Sbjct: 9 IGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSF 68
Query: 482 IEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRD 541
++G++L +I EY S L KLD I + GL YLH E +HRD
Sbjct: 69 LKGSKLWIIMEYCGGGSCLDLL--KPGKLDETYIAFILREVLLGLEYLHEE---GKIHRD 123
Query: 542 IKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPEYAMRGHLTEKADVY 601
IKA N+LL ++ + K++DFG++ + +T V GT +MAPE + EKAD++
Sbjct: 124 IKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTFV-GTPFWMAPEVIKQSGYDEKADIW 182
Query: 602 SFGIVALEIVSG 613
S GI A+E+ G
Sbjct: 183 SLGITAIELAKG 194
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 119 bits (299), Expect = 5e-30
Identities = 69/206 (33%), Positives = 111/206 (53%), Gaps = 16/206 (7%)
Query: 417 NFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQ--LSSKSKQGNREFINEIGMISALQHPN 473
+F N IG+G FG V+K + AD A+KQ LS +++ E I+E +++ L
Sbjct: 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSY 60
Query: 474 LVKLYGCCIEGNQLLLIYEYLENNSLARALFEHRLK-----LDWPTRRRICLGIARGLAY 528
+++ Y ++ +L ++ EY EN L + L R + W R + I GLA+
Sbjct: 61 IIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVW----RFFIQILLGLAH 116
Query: 529 LHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPEY 588
LH + K++HRDIK+ N+ LD N KI D G+AKL +NT+ + + GT Y++PE
Sbjct: 117 LHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKL-LSDNTNFANTIVGTPYYLSPEL 172
Query: 589 AMRGHLTEKADVYSFGIVALEIVSGR 614
EK+DV++ G+V E +G+
Sbjct: 173 CEDKPYNEKSDVWALGVVLYECCTGK 198
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 126 bits (319), Expect = 6e-30
Identities = 80/272 (29%), Positives = 127/272 (46%), Gaps = 55/272 (20%)
Query: 24 LKEQNLTGVLPPKLAELTFLQDIDLTLNYLSGTIPSQ--WASLPLLNISLIANRLKGPIP 81
L +N++G + + L ++Q I+L+ N LSG IP S L ++L N G IP
Sbjct: 76 LSGKNISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIP 135
Query: 82 KYLANISTLVNLTVQYNQFSGELPEELGSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDF 141
+ +I L L + N SGE+P ++GS +L+ L L N G++P + LT+++
Sbjct: 136 R--GSIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLTNLTSLEFL 193
Query: 142 RISDNQFTGQIPSFIQNWTKLEKLFIQPSGLAGPIPSGIFSLENLTDLRISDLNGPEATF 201
++ NQ GQIP
Sbjct: 194 TLASNQLVGQIPR----------------------------------------------- 206
Query: 202 PQLGNMKMTKLI-LRNCNITGELPRYLGKMTKLKVLDLSFNRLRGQIPSNFDDLYDVDYI 260
+LG MK K I L N++GE+P +G +T L LDL +N L G IPS+ +L ++ Y+
Sbjct: 207 -ELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYL 265
Query: 261 YFAGNLLTGAIPP--WMLERGDKIDLSYNNFT 290
+ N L+G IPP + L++ +DLS N+ +
Sbjct: 266 FLYQNKLSGPIPPSIFSLQKLISLDLSDNSLS 297
|
Length = 968 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 118 bits (298), Expect = 1e-29
Identities = 96/304 (31%), Positives = 143/304 (47%), Gaps = 56/304 (18%)
Query: 417 NFATDNNIGEGGFGPVYKGL------LADGTAIAVKQLSSKSKQGN-REFINEIGMISAL 469
N +GEG FG V K A T +AVK L + R+ ++E ++ +
Sbjct: 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQV 60
Query: 470 QHPNLVKLYGCCIEGNQLLLIYEYLENNSLARALFEHR---------------LKLDWPT 514
HP+++KLYG C + LLLI EY + SL L E R LD P
Sbjct: 61 NHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPD 120
Query: 515 RRRICLG--------IARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLD 566
R + +G I+RG+ YL + +K+VHRD+ A NVL+ + KISDFGL++
Sbjct: 121 ERALTMGDLISFAWQISRGMQYL---AEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDV 177
Query: 567 EEENTHISTRVAGTI--GYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSN----VTKE 620
EE++++ R G I +MA E T ++DV+SFG++ EIV+ N + E
Sbjct: 178 YEEDSYVK-RSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPE 236
Query: 621 DMFYLLDWALVLKEQGKLMELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVL 680
+F LL + G ME + N +E M N+ L C P RP+ + +
Sbjct: 237 RLFNLL-------KTGYRMERPE-----NCSEE----MYNLMLTCWKQEPDKRPTFADIS 280
Query: 681 RMLE 684
+ LE
Sbjct: 281 KELE 284
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 117 bits (296), Expect = 1e-29
Identities = 59/192 (30%), Positives = 96/192 (50%), Gaps = 8/192 (4%)
Query: 424 IGEGGFGPVYKGLLADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCCIE 483
+G G FG V+ G +A+K + + +FI E ++ L HPNLV+LYG C +
Sbjct: 12 LGSGQFGVVHLGKWRGKIDVAIKMIREGA-MSEDDFIEEAKVMMKLSHPNLVQLYGVCTK 70
Query: 484 GNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIK 543
+ ++ EY+ N L L E + KL +C + + YL +HRD+
Sbjct: 71 QRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLE---SNGFIHRDLA 127
Query: 544 ATNVLLDKDLNSKISDFGLAK--LDEEENTHISTRVAGTIGYMAPEYAMRGHLTEKADVY 601
A N L+ +D K+SDFGLA+ LD++ + T+ + + PE + K+DV+
Sbjct: 128 ARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKFP--VKWAPPEVFDYSRFSSKSDVW 185
Query: 602 SFGIVALEIVSG 613
SFG++ E+ S
Sbjct: 186 SFGVLMWEVFSE 197
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 116 bits (292), Expect = 7e-29
Identities = 89/313 (28%), Positives = 139/313 (44%), Gaps = 74/313 (23%)
Query: 416 NNFATDNNIGEGGFGPVYK----GLLA--DGTAIAVKQLSSK-SKQGNREFINEIGMISA 468
NN +IG+G FG V++ GLL T +AVK L + S +F E +++
Sbjct: 5 NNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAE 64
Query: 469 LQHPNLVKLYGCCIEGNQLLLIYEYLE----NNSL-----------------ARALFEHR 507
HPN+VKL G C G + L++EY+ N L AR +
Sbjct: 65 FDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNP 124
Query: 508 LKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLA---- 563
L L + I +A G+AYL S K VHRD+ N L+ +++ KI+DFGL+
Sbjct: 125 LPLSCTEQLCIAKQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSRNIY 181
Query: 564 -----KLDEEENTHISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVS------ 612
K E + A I +M PE T ++DV+++G+V EI S
Sbjct: 182 SADYYKASEND--------AIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPY 233
Query: 613 -GRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDKEQVMVMINVALLCANASPT 671
G ++ +E ++Y+ D G ++ D P + N+ LC + P+
Sbjct: 234 YGMAH--EEVIYYVRD--------GNVLSCPDNCPLE---------LYNLMRLCWSKLPS 274
Query: 672 IRPSMSSVLRMLE 684
RPS +S+ R+L+
Sbjct: 275 DRPSFASINRILQ 287
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 115 bits (289), Expect = 1e-28
Identities = 63/195 (32%), Positives = 104/195 (53%), Gaps = 10/195 (5%)
Query: 424 IGEGGFGPVYKGLLADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCCIE 483
+G G FG V++GL + T +AVK L + +F+ E ++ L+HP L++LY C
Sbjct: 14 LGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDPK-DFLAEAQIMKKLRHPKLIQLYAVCTL 72
Query: 484 GNQLLLIYEYLENNSLARAL-FEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDI 542
+ ++ E ++ SL L L P + +A G+AYL ++ I HRD+
Sbjct: 73 EEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYI---HRDL 129
Query: 543 KATNVLLDKDLNSKISDFGLAKL--DEEENTHISTRVAGTIGYMAPEYAMRGHLTEKADV 600
A NVL+ ++ K++DFGLA++ ++ + I + APE A+ + K+DV
Sbjct: 130 AARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFP--IKWTAPEAALYNRFSIKSDV 187
Query: 601 YSFGIVALEIVS-GR 614
+SFGI+ EIV+ GR
Sbjct: 188 WSFGILLTEIVTYGR 202
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 3e-28
Identities = 60/189 (31%), Positives = 101/189 (53%), Gaps = 4/189 (2%)
Query: 424 IGEGGFGPVYKGLLADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCCIE 483
IG G FG V+ G + +A+K + + +FI E ++ L HP LV+LYG C E
Sbjct: 12 IGSGQFGLVWLGYWLEKRKVAIKTIR-EGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCTE 70
Query: 484 GNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIK 543
+ + L++E++E+ L+ L R K T +CL + G+AYL + V+HRD+
Sbjct: 71 RSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSN---VIHRDLA 127
Query: 544 ATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPEYAMRGHLTEKADVYSF 603
A N L+ ++ K+SDFG+ + ++ ST + + +PE + K+DV+SF
Sbjct: 128 ARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSF 187
Query: 604 GIVALEIVS 612
G++ E+ S
Sbjct: 188 GVLMWEVFS 196
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 113 bits (286), Expect = 4e-28
Identities = 84/272 (30%), Positives = 129/272 (47%), Gaps = 31/272 (11%)
Query: 424 IGEGGFGPVYKGL-LADGTAIAVKQLS-SKSKQGNREFINEIGMISALQHPNLVKLYGCC 481
IG G VY + L + +A+K++ K + E E+ +S HPN+VK Y
Sbjct: 9 IGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSF 68
Query: 482 IEGNQLLLIYEYLENNSLARALFEHRLK---LDWPTRRRICLGIARGLAYLHGESRIKVV 538
+ G++L L+ YL SL + + LD + + +GL YLH +I
Sbjct: 69 VVGDELWLVMPYLSGGSLLD-IMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQI--- 124
Query: 539 HRDIKATNVLLDKDLNSKISDFGL-AKLDEEENTHISTRV----AGTIGYMAPEYAMRGH 593
HRDIKA N+LL +D + KI+DFG+ A L + + +V GT +MAPE + H
Sbjct: 125 HRDIKAGNILLGEDGSVKIADFGVSASL--ADGGDRTRKVRKTFVGTPCWMAPEVMEQVH 182
Query: 594 -LTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQG---KLMELVDTNPGSN 649
KAD++SFGI A+E+ +G + +K Y L+L Q L D S
Sbjct: 183 GYDFKADIWSFGITAIELATGAAPYSK----YPPMKVLMLTLQNDPPSLETGADYKKYSK 238
Query: 650 FDKEQVMVMINVALLCANASPTIRPSMSSVLR 681
++ MI+ LC P+ RP+ +L+
Sbjct: 239 SFRK----MIS---LCLQKDPSKRPTAEELLK 263
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 112 bits (283), Expect = 7e-28
Identities = 60/203 (29%), Positives = 94/203 (46%), Gaps = 9/203 (4%)
Query: 424 IGEGGFGPVYK-GLLADGTAIAVKQLSSKSKQGNREF---INEIGMISALQHPNLVKLYG 479
+G+G FG V G A+K L K +E + E ++S + HP +VKL+
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHY 60
Query: 480 CCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVH 539
+L L+ EY L L + R I L YLH + +++
Sbjct: 61 AFQTEEKLYLVLEYAPGGELFSHL-SKEGRFSEERARFYAAEIVLALEYLH---SLGIIY 116
Query: 540 RDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPEYAMRGHLTEKAD 599
RD+K N+LLD D + K++DFGLAK E + +T GT Y+APE + + D
Sbjct: 117 RDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNT-FCGTPEYLAPEVLLGKGYGKAVD 175
Query: 600 VYSFGIVALEIVSGRSNVTKEDM 622
+S G++ E+++G+ ED
Sbjct: 176 WWSLGVLLYEMLTGKPPFYAEDR 198
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 113 bits (283), Expect = 7e-28
Identities = 71/206 (34%), Positives = 109/206 (52%), Gaps = 19/206 (9%)
Query: 424 IGEGGFGPVYKGLLA-DGTAIAVKQL-----SSKSKQGNREFIN----EIGMISALQHPN 473
IG G FG VY G+ A G +AVKQ+ S+ SK R ++ EI ++ LQH N
Sbjct: 8 IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67
Query: 474 LVKLYGCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGES 533
+V+ G ++ + L + EY+ S+A AL + + R I +GL YLH
Sbjct: 68 IVQYLGSSLDADHLNIFLEYVPGGSVA-ALLNNYGAFEETLVRNFVRQILKGLNYLHNR- 125
Query: 534 RIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVA-----GTIGYMAPEY 588
++HRDIK N+L+D KISDFG++K E + T A G++ +MAPE
Sbjct: 126 --GIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEV 183
Query: 589 AMRGHLTEKADVYSFGIVALEIVSGR 614
+ T KAD++S G + +E+++G+
Sbjct: 184 VKQTSYTRKADIWSLGCLVVEMLTGK 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 115 bits (287), Expect = 1e-27
Identities = 70/215 (32%), Positives = 104/215 (48%), Gaps = 22/215 (10%)
Query: 417 NFATDNNIGEGGFGPVYKGLLADGTAIAVKQLSSK---SKQGNREFINEIGMISALQHP- 472
++ +GEG FG VY D +A+K L+ K + F+ EI ++++L HP
Sbjct: 1 SYRILRKLGEGSFGEVYLAR--DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPP 58
Query: 473 NLVKLYGCCIEGNQLLLIYEYLENNSLARALFEHR---LKLDWPTRRRICLGIARGLAYL 529
N+VKLY + L L+ EY++ SL L + L I I L YL
Sbjct: 59 NIVKLYDFFQDEGSLYLVMEYVDGGSL-EDLLKKIGRKGPLSESEALFILAQILSALEYL 117
Query: 530 HGESRIKVVHRDIKATNVLLDKDLN-SKISDFGLAKLDEEENTHISTR-----VAGTIGY 583
H ++HRDIK N+LLD+D K+ DFGLAKL + + S GT GY
Sbjct: 118 H---SKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGY 174
Query: 584 MAPEYAM---RGHLTEKADVYSFGIVALEIVSGRS 615
MAPE + + + +D++S GI E+++G
Sbjct: 175 MAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLP 209
|
Length = 384 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 4e-27
Identities = 78/269 (28%), Positives = 127/269 (47%), Gaps = 32/269 (11%)
Query: 424 IGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQGNREFI-NEIGMISALQH---PNLVKLY 478
IG G +G VY+G + G +A+K ++ + + I E+ ++S L+ PN+ K Y
Sbjct: 9 IGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYY 68
Query: 479 GCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIAR----GLAYLHGESR 534
G ++G +L +I EY E S+ R L + P + I R L Y+H +
Sbjct: 69 GSYLKGPRLWIIMEYAEGGSV-RTLMKAG-----PIAEKYISVIIREVLVALKYIH---K 119
Query: 535 IKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPEYAMRGHL 594
+ V+HRDIKA N+L+ N K+ DFG+A L + ++ ST V GT +MAPE G
Sbjct: 120 VGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFV-GTPYWMAPEVITEGKY 178
Query: 595 TE-KADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDKE 653
+ KAD++S GI E+ +G + D F + L+ K + + + + K
Sbjct: 179 YDTKADIWSLGITIYEMATGNPPYSDVDAFRAMM--LIPKSKPPRL------EDNGYSKL 230
Query: 654 QVMVMINVALLCANASPTIRPSMSSVLRM 682
+ C + P R S +L+
Sbjct: 231 ----LREFVAACLDEEPKERLSAEELLKS 255
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 5e-27
Identities = 63/194 (32%), Positives = 96/194 (49%), Gaps = 16/194 (8%)
Query: 424 IGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCCI 482
IG G +G VYK +A G +A+K + + EI M+ +HPN+V +G +
Sbjct: 11 IGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYL 70
Query: 483 EGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDI 542
++L ++ EY SL R L +C +GLAYLH +HRDI
Sbjct: 71 RRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHE---TGKIHRDI 127
Query: 543 KATNVLLDKDLNSKISDFGL-AKLDE---EENTHISTRVAGTIGYMAPEYA---MRGHLT 595
K N+LL +D + K++DFG+ A+L + + I GT +MAPE A +G
Sbjct: 128 KGANILLTEDGDVKLADFGVSAQLTATIAKRKSFI-----GTPYWMAPEVAAVERKGGYD 182
Query: 596 EKADVYSFGIVALE 609
K D+++ GI A+E
Sbjct: 183 GKCDIWALGITAIE 196
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 8e-27
Identities = 66/203 (32%), Positives = 110/203 (54%), Gaps = 17/203 (8%)
Query: 417 NFATDNNIGEGGFGPVYKGLLA----DGTAIAVKQLSSKSKQGNREFI-NEIGMISALQH 471
IGEG G V +A G +AVK++ + KQ RE + NE+ ++ QH
Sbjct: 20 YLDNFVKIGEGSTGIV---CIATDKSTGRQVAVKKMDLR-KQQRRELLFNEVVIMRDYQH 75
Query: 472 PNLVKLYGCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHG 531
PN+V++Y + G++L ++ E+LE +L + R ++ +CL + + L++LH
Sbjct: 76 PNIVEMYSSYLVGDELWVVMEFLEGGALTDIVTHTR--MNEEQIATVCLAVLKALSFLHA 133
Query: 532 ESRIKVVHRDIKATNVLLDKDLNSKISDFGL-AKLDEEENTHISTRVAGTIGYMAPEYAM 590
+ V+HRDIK+ ++LL D K+SDFG A++ +E S + GT +MAPE
Sbjct: 134 Q---GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKS--LVGTPYWMAPEVIS 188
Query: 591 RGHLTEKADVYSFGIVALEIVSG 613
R + D++S GI+ +E+V G
Sbjct: 189 RLPYGTEVDIWSLGIMVIEMVDG 211
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 8e-27
Identities = 71/215 (33%), Positives = 104/215 (48%), Gaps = 32/215 (14%)
Query: 424 IGEGGFGPVYKGLL------ADGTAIAVKQLSSK-SKQGNREFINEIGMISALQHPNLVK 476
+GEG FG VYKG L T++A+K L + +EF E ++S LQHPN+V
Sbjct: 13 LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVC 72
Query: 477 LYGCCIEGNQLLLIYEYLENNSLARALFEH---------------RLKLDWPTRRRICLG 521
L G C + +++EYL + L L + + LD I +
Sbjct: 73 LLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQ 132
Query: 522 IARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGT- 580
IA G+ YL S VHRD+ A N L+ + L KISDFGL++ + + RV
Sbjct: 133 IAAGMEYL---SSHHFVHRDLAARNCLVGEGLTVKISDFGLSR---DIYSADYYRVQSKS 186
Query: 581 ---IGYMAPEYAMRGHLTEKADVYSFGIVALEIVS 612
+ +M PE + G T ++D++SFG+V EI S
Sbjct: 187 LLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 1e-26
Identities = 72/196 (36%), Positives = 104/196 (53%), Gaps = 13/196 (6%)
Query: 424 IGEGGFGPVYKGLLADGTAIAVKQLSSKSKQGNRE---FINEIGMISALQHPNLVKLYGC 480
+G G FG V+ G T +A+K L KQG+ F+ E ++ LQHP LV+LY
Sbjct: 14 LGAGQFGEVWMGYYNGHTKVAIKSL----KQGSMSPEAFLAEANLMKQLQHPRLVRLYAV 69
Query: 481 CIEGNQLLLIYEYLENNSLARAL-FEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVH 539
+ + +I EY+EN SL L +KL + IA G+A++ R +H
Sbjct: 70 -VTQEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIE---RKNYIH 125
Query: 540 RDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPEYAMRGHLTEKAD 599
RD++A N+L+ + L KI+DFGLA+L E+ I + APE G T K+D
Sbjct: 126 RDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSD 185
Query: 600 VYSFGIVALEIVS-GR 614
V+SFGI+ EIV+ GR
Sbjct: 186 VWSFGILLTEIVTYGR 201
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 1e-26
Identities = 65/196 (33%), Positives = 108/196 (55%), Gaps = 10/196 (5%)
Query: 424 IGEGGFGPVYKGLLA----DGTAIAVKQLSSKSKQGNR-EFINEIGMISALQHPNLVKLY 478
IG G FG V++G+L A+A+K L + R +F++E ++ H N+++L
Sbjct: 13 IGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLE 72
Query: 479 GCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVV 538
G + ++I EY+EN +L + L +H + + GIA G+ YL S + V
Sbjct: 73 GVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYL---SDMNYV 129
Query: 539 HRDIKATNVLLDKDLNSKISDFGLAKL--DEEENTHISTRVAGTIGYMAPEYAMRGHLTE 596
HRD+ A N+L++ +L K+SDFGL+++ D+ E T+ ++ I + APE T
Sbjct: 130 HRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTS 189
Query: 597 KADVYSFGIVALEIVS 612
+DV+SFGIV E++S
Sbjct: 190 ASDVWSFGIVMWEVMS 205
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 109 bits (273), Expect = 1e-26
Identities = 67/195 (34%), Positives = 102/195 (52%), Gaps = 11/195 (5%)
Query: 424 IGEGGFGPVYKGLLADGTAIAVKQLSSKSKQGNRE-FINEIGMISALQHPNLVKLYGCCI 482
IG+G FG VYKG+L T +AVK S + F+ E ++ HPN+VKL G C+
Sbjct: 3 IGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCV 62
Query: 483 EGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDI 542
+ + ++ E + SL L + + +L ++ L A G+ YL ES+ +HRD+
Sbjct: 63 QKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYL--ESK-NCIHRDL 119
Query: 543 KATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGT----IGYMAPEYAMRGHLTEKA 598
A N L+ ++ KISDFG+++ EE I T G I + APE G T ++
Sbjct: 120 AARNCLVGENNVLKISDFGMSR---EEEGGIYTVSDGLKQIPIKWTAPEALNYGRYTSES 176
Query: 599 DVYSFGIVALEIVSG 613
DV+S+GI+ E S
Sbjct: 177 DVWSYGILLWETFSL 191
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 2e-26
Identities = 68/260 (26%), Positives = 120/260 (46%), Gaps = 26/260 (10%)
Query: 424 IGEGGFGPVYKGL-LADGTAIAVK--QLSSKSKQGNREFINEIGMISALQHPNLVKLYGC 480
+G G G V K L G +AVK +L ++ + E+ ++ P +V YG
Sbjct: 9 LGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAI-QKQILRELDILHKCNSPYIVGFYGA 67
Query: 481 CIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHR 540
+ + EY++ SL + L E + ++ +I + + +GL YLH + K++HR
Sbjct: 68 FYNNGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLH--EKHKIIHR 125
Query: 541 DIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPEYAMRGHLTEKADV 600
D+K +N+L++ K+ DFG++ + N+ ++ GT YMAPE + K+D+
Sbjct: 126 DVKPSNILVNSRGQIKLCDFGVSG--QLVNS-LAKTFVGTSSYMAPERIQGNDYSVKSDI 182
Query: 601 YSFGIVALEIVSGR-----SNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDKEQV 655
+S G+ +E+ +GR N + +F LL +V + +L P F +
Sbjct: 183 WSLGLSLIELATGRFPYPPENDPPDGIFELLQ-YIVNEPPPRL-------PSGKFSPD-- 232
Query: 656 MVMINVALLCANASPTIRPS 675
+ LC P RPS
Sbjct: 233 --FQDFVNLCLIKDPRERPS 250
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 108 bits (273), Expect = 2e-26
Identities = 61/207 (29%), Positives = 103/207 (49%), Gaps = 34/207 (16%)
Query: 424 IGEGGFGPVYKGLL-ADGTAIAVKQLSSKSKQGNREFI-NEIGMISALQHPNLVKLYGCC 481
+G+G G VYK G A+K++ + R+ + E+ + + + P +VK YG
Sbjct: 9 LGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAF 68
Query: 482 IEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIAR----GLAYLHGESRIKV 537
+ ++ ++ EY++ SLA L + P + IAR GL YLH + I
Sbjct: 69 YKEGEISIVLEYMDGGSLADLLKKVGK---IP--EPVLAYIARQILKGLDYLHTKRHI-- 121
Query: 538 VHRDIKATNVLLDKDLNSKISDFGLAKL----DEEENTHISTRVAGTIGYMAPE------ 587
+HRDIK +N+L++ KI+DFG++K+ ++ NT + GT+ YM+PE
Sbjct: 122 IHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFV-----GTVTYMSPERIQGES 176
Query: 588 YAMRGHLTEKADVYSFGIVALEIVSGR 614
Y+ AD++S G+ LE G+
Sbjct: 177 YSY------AADIWSLGLTLLECALGK 197
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 109 bits (275), Expect = 2e-26
Identities = 59/206 (28%), Positives = 100/206 (48%), Gaps = 28/206 (13%)
Query: 424 IGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQGNREF----INEIGMISALQHPNLVKLY 478
IGEG +G VYK G +A+K++ + + F I EI ++ L+HPN+V+L
Sbjct: 7 IGEGTYGQVYKARNKKTGELVALKKI--RMENEKEGFPITAIREIKLLQKLRHPNIVRLK 64
Query: 479 GCCIE--GNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIK 536
+ +++EY++++ L L +K + + GL YLH
Sbjct: 65 EIVTSKGKGSIYMVFEYMDHD-LTGLLDSPEVKFTESQIKCYMKQLLEGLQYLH---SNG 120
Query: 537 VVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHIST-RVAGTIGYMAPE-------Y 588
++HRDIK +N+L++ D K++DFGLA+ + N+ T RV T+ Y PE Y
Sbjct: 121 ILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVI-TLWYRPPELLLGATRY 179
Query: 589 AMRGHLTEKADVYSFGIVALEIVSGR 614
+ D++S G + E+ G+
Sbjct: 180 ------GPEVDMWSVGCILAELFLGK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 107 bits (270), Expect = 6e-26
Identities = 61/205 (29%), Positives = 103/205 (50%), Gaps = 18/205 (8%)
Query: 424 IGEGGFGPVYKGLLAD-GTAIAVKQL------SSKSKQGNREFI----NEIGMISALQHP 472
IG+G +G VY L G +AVKQ+ + + ++ + +EI + L H
Sbjct: 9 IGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHL 68
Query: 473 NLVKLYGCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGE 532
N+V+ G L + EY+ S+ L + + + R + GLAYLH +
Sbjct: 69 NIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYG-RFEEQLVRFFTEQVLEGLAYLHSK 127
Query: 533 SRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHIS-TRVAGTIGYMAPE--YA 589
++HRD+KA N+L+D D KISDFG++K ++ + + G++ +MAPE ++
Sbjct: 128 G---ILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHS 184
Query: 590 MRGHLTEKADVYSFGIVALEIVSGR 614
+ K D++S G V LE+ +GR
Sbjct: 185 YSQGYSAKVDIWSLGCVVLEMFAGR 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 7e-26
Identities = 66/204 (32%), Positives = 99/204 (48%), Gaps = 24/204 (11%)
Query: 422 NNIGEGGFGPVYKG--LLADGT--AIAVKQLS-SKSKQGNREFINEIGMISALQHPNLVK 476
+G G FG V KG L+ G +AVK L G +EF+ E +++ L HP +V+
Sbjct: 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVR 60
Query: 477 LYGCCIEGNQLLLIYEYLENNSLARALFEHR------LKLDWPTRRRICLGIARGLAYLH 530
L G C +G L+L+ E L + L + R LK + +A G+AYL
Sbjct: 61 LIGVC-KGEPLMLVMELAPLGPLLKYLKKRREIPVSDLKE-LAHQ------VAMGMAYLE 112
Query: 531 GESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGT--IGYMAPEY 588
+ VHRD+ A NVLL +KISDFG+++ + + AG + + APE
Sbjct: 113 SK---HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPEC 169
Query: 589 AMRGHLTEKADVYSFGIVALEIVS 612
G + K+DV+S+G+ E S
Sbjct: 170 INYGKFSSKSDVWSYGVTLWEAFS 193
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 9e-26
Identities = 65/210 (30%), Positives = 102/210 (48%), Gaps = 24/210 (11%)
Query: 424 IGEGGFGPVY----KGLL--ADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKL 477
+GEG FG V+ LL D +AVK L S+ ++F E +++ LQH ++V+
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRF 72
Query: 478 YGCCIEGNQLLLIYEYLENNSLARALFEHRL--------------KLDWPTRRRICLGIA 523
YG C EG LL+++EY+ + L R L H +L I IA
Sbjct: 73 YGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIA 132
Query: 524 RGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAK-LDEEENTHISTRVAGTIG 582
G+ YL + VHRD+ N L+ + L KI DFG+++ + + + R I
Sbjct: 133 SGMVYLAS---LHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIR 189
Query: 583 YMAPEYAMRGHLTEKADVYSFGIVALEIVS 612
+M PE + T ++D++SFG+V EI +
Sbjct: 190 WMPPESILYRKFTTESDIWSFGVVLWEIFT 219
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 1e-25
Identities = 77/290 (26%), Positives = 131/290 (45%), Gaps = 49/290 (16%)
Query: 424 IGEGGFGPVYKGLLAD------GTAIAVKQL-SSKSKQGNREFINEIGMISAL-QHPNLV 475
+GEG FG V K + +AVK L +++ + ++E+ M+ + +H N++
Sbjct: 20 LGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNII 79
Query: 476 KLYGCCIEGNQLLLIYEYLENNSLARALFEHR-------LKLDWPTRRRI--------CL 520
L G C + L ++ EY + +L L R P +
Sbjct: 80 NLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAY 139
Query: 521 GIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAG- 579
+ARG+ +L S+ K +HRD+ A NVL+ +D KI+DFGLA+ D + G
Sbjct: 140 QVARGMEFL--ASK-KCIHRDLAARNVLVTEDHVMKIADFGLAR-DIHHIDYYRKTTNGR 195
Query: 580 -TIGYMAPEYAMRGHLTEKADVYSFGIVALEIVS-GRS---NVTKEDMFYLLDWALVLKE 634
+ +MAPE T ++DV+SFG++ EI + G S + E++F LL +
Sbjct: 196 LPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLL-------K 248
Query: 635 QGKLMELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLE 684
+G ME N +E +M + C + P+ RP+ ++ L+
Sbjct: 249 EGYRME-----KPQNCTQELYHLMRD----CWHEVPSQRPTFKQLVEDLD 289
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 2e-25
Identities = 71/194 (36%), Positives = 99/194 (51%), Gaps = 16/194 (8%)
Query: 424 IGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQGN---REFINEIGMISALQHPNLVKLYG 479
IG G FG VY + +A+K++S KQ N ++ I E+ + L+HPN ++ G
Sbjct: 23 IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKG 82
Query: 480 CCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVH 539
C + + L+ EY S + L H+ L IC G +GLAYLH RI H
Sbjct: 83 CYLREHTAWLVMEYCLG-SASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERI---H 138
Query: 540 RDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPE--YAM-RGHLTE 596
RDIKA N+LL + K++DFG A L N+ + GT +MAPE AM G
Sbjct: 139 RDIKAGNILLTEPGTVKLADFGSASLVSPANSFV-----GTPYWMAPEVILAMDEGQYDG 193
Query: 597 KADVYSFGIVALEI 610
K DV+S GI +E+
Sbjct: 194 KVDVWSLGITCIEL 207
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 2e-25
Identities = 74/222 (33%), Positives = 99/222 (44%), Gaps = 33/222 (14%)
Query: 414 ATNNFATDNNIGEGGFGPVYKGLLAD-GTAIAVKQLSSKSKQGNREFINEIGMISAL-QH 471
T F IGEG +G VYK G +A+K + + E E ++ H
Sbjct: 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDE-EEEIKEEYNILRKYSNH 62
Query: 472 PNLVKLYGC------CIEGNQLLLIYEYLENNS---LARALFEH--RLKLDWPTRRRICL 520
PN+ YG +QL L+ E S L + L + RLK +W I
Sbjct: 63 PNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAY--ILR 120
Query: 521 GIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGL-AKLDEEE---NTHISTR 576
RGLAYLH KV+HRDIK N+LL K+ K+ DFG+ A+LD NT I
Sbjct: 121 ETLRGLAYLH---ENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTFI--- 174
Query: 577 VAGTIGYMAPE-----YAMRGHLTEKADVYSFGIVALEIVSG 613
GT +MAPE ++DV+S GI A+E+ G
Sbjct: 175 --GTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADG 214
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 3e-25
Identities = 60/191 (31%), Positives = 100/191 (52%), Gaps = 8/191 (4%)
Query: 424 IGEGGFGPVYKGLLADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCCIE 483
+G G FG V G +A+K + S + EFI E ++ L H LV+LYG C +
Sbjct: 12 LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSED-EFIEEAKVMMKLSHEKLVQLYGVCTK 70
Query: 484 GNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIK 543
+ ++ EY+ N L L EH + +C + G+AYL ES+ + +HRD+
Sbjct: 71 QRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYL--ESK-QFIHRDLA 127
Query: 544 ATNVLLDKDLNSKISDFGLAK--LDEEENTHISTRVAGTIGYMAPEYAMRGHLTEKADVY 601
A N L+D K+SDFGL++ LD+E + + ++ + + PE + + K+DV+
Sbjct: 128 ARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGSKFP--VRWSPPEVLLYSKFSSKSDVW 185
Query: 602 SFGIVALEIVS 612
+FG++ E+ S
Sbjct: 186 AFGVLMWEVYS 196
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 105 bits (265), Expect = 4e-25
Identities = 63/197 (31%), Positives = 102/197 (51%), Gaps = 12/197 (6%)
Query: 424 IGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQGN--REFINEIGMISALQHPNLVKLYGC 480
IGEG G V+K G +A+K+++ + +G + + EI + A QHP +VKL
Sbjct: 8 IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDV 67
Query: 481 CIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHR 540
G+ +L+ EY+ + L+ L + L + + +G+AY+H ++HR
Sbjct: 68 FPHGSGFVLVMEYMPS-DLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHAN---GIMHR 123
Query: 541 DIKATNVLLDKDLNSKISDFGLAKL-DEEENTHISTRVAGTIGYMAPE--YAMRGHLTEK 597
D+K N+L+ D KI+DFGLA+L EEE S +VA T Y APE Y R
Sbjct: 124 DLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVA-TRWYRAPELLYGAR-KYDPG 181
Query: 598 ADVYSFGIVALEIVSGR 614
D+++ G + E+++G
Sbjct: 182 VDLWAVGCIFAELLNGS 198
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 4e-25
Identities = 66/191 (34%), Positives = 103/191 (53%), Gaps = 7/191 (3%)
Query: 424 IGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCCI 482
IG+G G VY + +A G +A+KQ++ + + INEI ++ +HPN+V +
Sbjct: 27 IGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYL 86
Query: 483 EGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDI 542
G++L ++ EYL SL + E +D +C + L +LH +V+HRDI
Sbjct: 87 VGDELWVVMEYLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLHSN---QVIHRDI 141
Query: 543 KATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPEYAMRGHLTEKADVYS 602
K+ N+LL D + K++DFG E + ST V GT +MAPE R K D++S
Sbjct: 142 KSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKVDIWS 200
Query: 603 FGIVALEIVSG 613
GI+A+E+V G
Sbjct: 201 LGIMAIEMVEG 211
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 4e-25
Identities = 58/199 (29%), Positives = 101/199 (50%), Gaps = 15/199 (7%)
Query: 423 NIGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQGNREF----INEIGMISALQHPNLVKL 477
+GEG +G VYK G +A+K++ + + EI ++ L+HPN+VKL
Sbjct: 6 KLGEGTYGVVYKARDKKTGEIVALKKI--RLDNEEEGIPSTALREISLLKELKHPNIVKL 63
Query: 478 YGCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKV 537
+L L++EY + + L + L + L + I + RGLAY H ++
Sbjct: 64 LDVIHTERKLYLVFEYCDMD-LKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCH---SHRI 119
Query: 538 VHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPE--YAMRGHLT 595
+HRD+K N+L+++D K++DFGLA+ + V T+ Y APE + + T
Sbjct: 120 LHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVV-TLWYRAPEILLGSKHYST 178
Query: 596 EKADVYSFGIVALEIVSGR 614
D++S G + E+++G+
Sbjct: 179 A-VDIWSVGCIFAEMITGK 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 7e-25
Identities = 83/286 (29%), Positives = 130/286 (45%), Gaps = 41/286 (14%)
Query: 424 IGEGGFGPVYK---GLLADGTA--IAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLY 478
+G+G FG V L D T +AVK+L + + R+F EI ++ +LQH N+VK
Sbjct: 12 LGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYK 71
Query: 479 GCCIEG--NQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIK 536
G C L L+ EYL SL L +HR +LD I +G+ YL + +
Sbjct: 72 GVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSK---R 128
Query: 537 VVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGT--IGYMAPEYAMRGHL 594
VHRD+ N+L++ + KI DFGL K+ ++ + R G I + APE
Sbjct: 129 YVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESLTESKF 188
Query: 595 TEKADVYSFGIVALEIVS----------------GRSNVTKEDMFYLLDWALVLKEQGKL 638
+ +DV+SFG+V E+ + G + +++L++ +LK G+L
Sbjct: 189 SVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIE---LLKNNGRL 245
Query: 639 MELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLE 684
PG + +M C N P+ RPS S + +E
Sbjct: 246 ----PAPPGCPAEIYAIM------KECWNNDPSQRPSFSELALQVE 281
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 1e-24
Identities = 57/223 (25%), Positives = 99/223 (44%), Gaps = 28/223 (12%)
Query: 416 NNFATDNNIGEGGFGPVYKG-LLADGTAIAVKQLSSK--SKQGNREFIN-EIGMISAL-Q 470
++F IGEG F V A+K L + K+ +++ E +++ L
Sbjct: 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNG 60
Query: 471 HPNLVKLYGCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLH 530
HP ++KLY + L + EY N L + + LD R I L YLH
Sbjct: 61 HPGIIKLYYTFQDEENLYFVLEYAPNGELLQYI-RKYGSLDEKCTRFYAAEILLALEYLH 119
Query: 531 GESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVA------------ 578
++HRD+K N+LLDKD++ KI+DFG AK+ + ++ S +
Sbjct: 120 S---KGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNR 176
Query: 579 -------GTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGR 614
GT Y++PE + +D+++ G + ++++G+
Sbjct: 177 RRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGK 219
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 1e-24
Identities = 69/201 (34%), Positives = 101/201 (50%), Gaps = 12/201 (5%)
Query: 424 IGEGGFGPVYKGLLADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCCIE 483
+G G FG V+ G + T +AVK L + + F+ E ++ LQH LV+LY +
Sbjct: 14 LGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVTK 72
Query: 484 GNQLLLIYEYLENNSLARAL-FEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDI 542
+ +I EY+ SL L + K+ P IA G+AY+ R +HRD+
Sbjct: 73 EEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIE---RKNYIHRDL 129
Query: 543 KATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPEYAMRGHLTEKADVYS 602
+A NVL+ + L KI+DFGLA++ E+ I + APE G T K+DV+S
Sbjct: 130 RAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWS 189
Query: 603 FGIVALEIVS-------GRSN 616
FGI+ EIV+ G SN
Sbjct: 190 FGILLYEIVTYGKIPYPGMSN 210
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 2e-24
Identities = 82/285 (28%), Positives = 129/285 (45%), Gaps = 46/285 (16%)
Query: 424 IGEGGFGPVYKGLLA--DGTA----IAVKQL-SSKSKQGNREFINEIGMISALQHPNLVK 476
+G G FG VY+GL DG A +AVK L S S+Q +F+ E ++S H N+V+
Sbjct: 14 LGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVR 73
Query: 477 LYGCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRR------ICLGIARGLAYLH 530
L G E ++ E + L L E+R + + P+ +A+G YL
Sbjct: 74 LIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLE 133
Query: 531 GESRIKVVHRDIKATNVLLD---KDLNSKISDFGLAK-LDEEENTHISTRVAGTIGYMAP 586
E+ +HRDI A N LL +KI+DFG+A+ + R I +M P
Sbjct: 134 -ENHF--IHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPIKWMPP 190
Query: 587 EYAMRGHLTEKADVYSFGIVALEIVS-------GRSNVTKEDMFYLLDWALVLKEQGKLM 639
E + G T K DV+SFG++ EI S GR+N +E M ++ G +
Sbjct: 191 EAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTN--QEVMEFVT--------GGGRL 240
Query: 640 ELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLE 684
+ PG + ++M C +P RP+ +++L ++
Sbjct: 241 DPPKGCPGPVY---RIMTD------CWQHTPEDRPNFATILERIQ 276
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 2e-24
Identities = 70/210 (33%), Positives = 108/210 (51%), Gaps = 25/210 (11%)
Query: 424 IGEGGFGPVYKG----LLADGTA---IAVKQLSSKSK-QGNREFINEIGMISALQHPNLV 475
+G G FG VY+G +L G+ +AVK L + Q +EF+ E ++S HPN+V
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIV 62
Query: 476 KLYGCCIEGNQLLLIYEYLENNSLARALFEHRLK------LDWPTRRRICLGIARGLAYL 529
KL G C+ +I E +E L L + R++ L ICL +A+G YL
Sbjct: 63 KLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYL 122
Query: 530 HGESRIKVVHRDIKATNVLL-----DKDLNSKISDFGLAKLDEEENTHISTRVAGTIG-- 582
++ +HRD+ A N L+ D D KI DFGLA+ D ++ + G +
Sbjct: 123 E---QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLAR-DIYKSDYYRKEGEGLLPVR 178
Query: 583 YMAPEYAMRGHLTEKADVYSFGIVALEIVS 612
+MAPE + G T ++DV+SFG++ EI++
Sbjct: 179 WMAPESLLDGKFTTQSDVWSFGVLMWEILT 208
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 103 bits (257), Expect = 2e-24
Identities = 64/196 (32%), Positives = 105/196 (53%), Gaps = 10/196 (5%)
Query: 424 IGEGGFGPVYKGLLA----DGTAIAVKQLSSK-SKQGNREFINEIGMISALQHPNLVKLY 478
IG G FG V G L +A+K L + +++ R+F++E ++ HPN++ L
Sbjct: 12 IGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLE 71
Query: 479 GCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVV 538
G + ++++ EY+EN SL L +H + + GIA G+ YL S + V
Sbjct: 72 GVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYL---SDMGYV 128
Query: 539 HRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIG--YMAPEYAMRGHLTE 596
HRD+ A N+L++ +L K+SDFGL+++ E++ T G I + APE T
Sbjct: 129 HRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTS 188
Query: 597 KADVYSFGIVALEIVS 612
+DV+S+GIV E++S
Sbjct: 189 ASDVWSYGIVMWEVMS 204
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 3e-24
Identities = 65/206 (31%), Positives = 102/206 (49%), Gaps = 17/206 (8%)
Query: 422 NNIGEGGFGPVYKGL-LADGTAIAVKQLS-----SKSKQGNREFINEIGMISALQHPNLV 475
IG+G FG V K +DG + K++ K KQ + ++E+ ++ L+HPN+V
Sbjct: 6 ETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQ---QLVSEVNILRELKHPNIV 62
Query: 476 KLYGCCI-EGNQLLLIY-EYLENNSLARAL---FEHRLKLDWPTRRRICLGIARGLAYLH 530
+ Y I NQ L I EY E LA+ + + R ++ RI + L H
Sbjct: 63 RYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECH 122
Query: 531 --GESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPEY 588
+ V+HRD+K N+ LD + N K+ DFGLAK+ +++ T V GT YM+PE
Sbjct: 123 NRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYV-GTPYYMSPEQ 181
Query: 589 AMRGHLTEKADVYSFGIVALEIVSGR 614
EK+D++S G + E+ +
Sbjct: 182 LNHMSYDEKSDIWSLGCLIYELCALS 207
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 103 bits (257), Expect = 3e-24
Identities = 92/282 (32%), Positives = 132/282 (46%), Gaps = 35/282 (12%)
Query: 424 IGEGGFGPV--YKGLLA-DGTA--IAVKQLSSKSKQGNRE-FINEIGMISALQHPNLVKL 477
+GEG FG V Y A DGT +AVK L + Q N + EI ++ L H N+VK
Sbjct: 12 LGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKY 71
Query: 478 YGCCIEGNQ--LLLIYEYLENNSLARALFEHRLKLDWPT--RRRICLGIARGLAYLHGES 533
GCC E L LI EY+ SL L +H+L L ++IC G+AYLH +
Sbjct: 72 KGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHKLNLAQLLLFAQQIC----EGMAYLHSQH 127
Query: 534 RIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGT--IGYMAPEYAMR 591
I HRD+ A NVLLD D KI DFGLAK E + + R G + + A E
Sbjct: 128 YI---HRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLKE 184
Query: 592 GHLTEKADVYSFGIVALEIV----SGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTN-- 645
+ +DV+SFG+ E++ S +S K ++ +L+EL++
Sbjct: 185 NKFSYASDVWSFGVTLYELLTHCDSKQSPPKK--FEEMIGPKQGQMTVVRLIELLERGMR 242
Query: 646 ---PGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLE 684
P N +E ++M N C RP+ S++ +L+
Sbjct: 243 LPCP-KNCPQEVYILMKN----CWETEAKFRPTFRSLIPILK 279
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 4e-24
Identities = 62/194 (31%), Positives = 96/194 (49%), Gaps = 9/194 (4%)
Query: 424 IGEGGFGPVYKG----LLADGTAIAVKQLSSKSKQGNRE-FINEIGMISALQHPNLVKLY 478
IGEG FG VY+G + A+AVK + + RE F+ E ++ HP++VKL
Sbjct: 14 IGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLI 73
Query: 479 GCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVV 538
G E N + ++ E L L ++ LD + ++ LAYL + V
Sbjct: 74 GVITE-NPVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLES---KRFV 129
Query: 539 HRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPEYAMRGHLTEKA 598
HRDI A NVL+ K+ DFGL++ E+E+ + +++ I +MAPE T +
Sbjct: 130 HRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPESINFRRFTSAS 189
Query: 599 DVYSFGIVALEIVS 612
DV+ FG+ EI+
Sbjct: 190 DVWMFGVCMWEILM 203
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 5e-24
Identities = 65/206 (31%), Positives = 103/206 (50%), Gaps = 28/206 (13%)
Query: 424 IGEGGFGPVYK------GLLADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKL 477
+G+G FG VYK GL A A K + +S++ +F+ EI ++S +HPN+V L
Sbjct: 13 LGDGAFGKVYKAQHKETGLFA-----AAKIIQIESEEELEDFMVEIDILSECKHPNIVGL 67
Query: 478 YGCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKV 537
Y N+L ++ E+ + +L + E L P R +C + L +LH KV
Sbjct: 68 YEAYFYENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSH---KV 124
Query: 538 VHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPEYAMRGHLTE- 596
+HRD+KA N+LL D + K++DFG++ ++ T + GT +MAPE E
Sbjct: 125 IHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFI-GTPYWMAPEVVA----CET 179
Query: 597 --------KADVYSFGIVALEIVSGR 614
KAD++S GI +E+
Sbjct: 180 FKDNPYDYKADIWSLGITLIELAQME 205
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 7e-24
Identities = 66/199 (33%), Positives = 105/199 (52%), Gaps = 7/199 (3%)
Query: 424 IGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCCI 482
IG+G G VY + +A G +A+KQ++ + + INEI ++ ++PN+V +
Sbjct: 27 IGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 86
Query: 483 EGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDI 542
G++L ++ EYL SL + E +D +C + L +LH +V+HRDI
Sbjct: 87 VGDELWVVMEYLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALDFLHSN---QVIHRDI 141
Query: 543 KATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPEYAMRGHLTEKADVYS 602
K+ N+LL D + K++DFG E + ST V GT +MAPE R K D++S
Sbjct: 142 KSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKVDIWS 200
Query: 603 FGIVALEIVSGRSNVTKED 621
GI+A+E+V G E+
Sbjct: 201 LGIMAIEMVEGEPPYLNEN 219
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 8e-24
Identities = 80/265 (30%), Positives = 128/265 (48%), Gaps = 30/265 (11%)
Query: 424 IGEGGFGPVYKGLLADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCCIE 483
IGEG FG V +G G +AVK + K + F+ E +++ L H NLV+L G I
Sbjct: 14 IGEGEFGAVLQGEYT-GQKVAVKNI--KCDVTAQAFLEETAVMTKLHHKNLVRLLGV-IL 69
Query: 484 GNQLLLIYEYLENNSLARALFEH-RLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDI 542
N L ++ E + +L L R + + L +A G+ YL ES+ K+VHRD+
Sbjct: 70 HNGLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYL--ESK-KLVHRDL 126
Query: 543 KATNVLLDKDLNSKISDFGLAKLDEE--ENTHISTRVAGTIGYMAPEYAMRGHLTEKADV 600
A N+L+ +D +K+SDFGLA++ +N+ + + + APE + K+DV
Sbjct: 127 AARNILVSEDGVAKVSDFGLARVGSMGVDNSKLPVK------WTAPEALKHKKFSSKSDV 180
Query: 601 YSFGIVALEIVS-GRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDKEQVMVMI 659
+S+G++ E+ S GR+ K + + + E+G ME + P V V++
Sbjct: 181 WSYGVLLWEVFSYGRAPYPKMSLKEVKECV----EKGYRMEPPEGCPAD------VYVLM 230
Query: 660 NVALLCANASPTIRPSMSSVLRMLE 684
C P RPS + LE
Sbjct: 231 TS---CWETEPKKRPSFHKLREKLE 252
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 8e-24
Identities = 66/193 (34%), Positives = 102/193 (52%), Gaps = 7/193 (3%)
Query: 424 IGEGGFGPVYKGLLADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCCIE 483
+G+G FG V+ G T +A+K L + F+ E ++ L+H LV+LY E
Sbjct: 14 LGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 72
Query: 484 GNQLLLIYEYLENNSLARALF-EHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDI 542
+ ++ EY+ SL L E L P + IA G+AY+ R+ VHRD+
Sbjct: 73 -EPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDL 128
Query: 543 KATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPEYAMRGHLTEKADVYS 602
+A N+L+ ++L K++DFGLA+L E+ I + APE A+ G T K+DV+S
Sbjct: 129 RAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWS 188
Query: 603 FGIVALEIVS-GR 614
FGI+ E+ + GR
Sbjct: 189 FGILLTELTTKGR 201
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 8e-24
Identities = 75/269 (27%), Positives = 122/269 (45%), Gaps = 26/269 (9%)
Query: 421 DNNIGEGGFGPVYKGLLADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGC 480
+ +G G FG V+ T +AVK + S F+ E ++ LQH LVKL+
Sbjct: 11 EKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAV 69
Query: 481 CIEGNQLLLIYEYLENNSLARAL-FEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVH 539
+ + +I E++ SL L + K P IA G+A++ E R +H
Sbjct: 70 -VTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFI--EQR-NYIH 125
Query: 540 RDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPEYAMRGHLTEKAD 599
RD++A N+L+ L KI+DFGLA++ E+ I + APE G T K+D
Sbjct: 126 RDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSD 185
Query: 600 VYSFGIVALEIVS-GRS---NVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDKEQV 655
V+SFGI+ +EIV+ GR ++ ++ L E+G M + P ++
Sbjct: 186 VWSFGILLMEIVTYGRIPYPGMSNPEVIRAL-------ERGYRMPRPENCPEELYN---- 234
Query: 656 MVMINVALLCANASPTIRPSMSSVLRMLE 684
+ + C P RP+ + +L+
Sbjct: 235 -----IMMRCWKNRPEERPTFEYIQSVLD 258
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 100 bits (252), Expect = 9e-24
Identities = 61/199 (30%), Positives = 98/199 (49%), Gaps = 16/199 (8%)
Query: 424 IGEGGFGPVYKG--LLADGTAI--AVKQLSSKSKQGN-REFINEIGMISALQHPNLVKLY 478
+G+G FG V +G + G I AVK L S +F+ E ++ +L H NL++LY
Sbjct: 3 LGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLY 62
Query: 479 GCCIEGNQLLLIYEYLENNSLARALFEHRLK-LDWPTRRRICLGIARGLAYLHGESRIKV 537
G + + L+++ E SL L + L T + IA G+ YL ES+ +
Sbjct: 63 GVVLT-HPLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYL--ESK-RF 118
Query: 538 VHRDIKATNVLLDKDLNSKISDFGLAK-LDEEENTHIST---RVAGTIGYMAPEYAMRGH 593
+HRD+ A N+LL D KI DFGL + L + E+ ++ +V + APE
Sbjct: 119 IHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVP--FAWCAPESLRTRT 176
Query: 594 LTEKADVYSFGIVALEIVS 612
+ +DV+ FG+ E+ +
Sbjct: 177 FSHASDVWMFGVTLWEMFT 195
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 1e-23
Identities = 67/199 (33%), Positives = 106/199 (53%), Gaps = 7/199 (3%)
Query: 424 IGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCCI 482
IG+G G V+ + +A G +A+KQ++ + + INEI ++ L++PN+V +
Sbjct: 27 IGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFL 86
Query: 483 EGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDI 542
G++L ++ EYL SL + E +D +C + L +LH +V+HRDI
Sbjct: 87 VGDELFVVMEYLAGGSLTDVVTE--TCMDEAQIAAVCRECLQALEFLHAN---QVIHRDI 141
Query: 543 KATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPEYAMRGHLTEKADVYS 602
K+ NVLL D + K++DFG E + ST V GT +MAPE R K D++S
Sbjct: 142 KSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKVDIWS 200
Query: 603 FGIVALEIVSGRSNVTKED 621
GI+A+E+V G E+
Sbjct: 201 LGIMAIEMVEGEPPYLNEN 219
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 100 bits (252), Expect = 1e-23
Identities = 76/278 (27%), Positives = 134/278 (48%), Gaps = 31/278 (11%)
Query: 415 TNNFATDNNIGEGGFGPVYKGL-LADGTAIAVKQ------LSSKSKQGNREFINEIGMIS 467
NF + IG+G F VYK + L DG +A+K+ + +K++Q + + EI ++
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQ---DCLKEIDLLK 57
Query: 468 ALQHPNLVKLYGCCIEGNQLLLIYEYLENNSLARALFEHRLK----LDWPTRRRICLGIA 523
L HPN++K IE N+L ++ E + L+R + +H K + T + + +
Sbjct: 58 QLDHPNVIKYLASFIENNELNIVLELADAGDLSR-MIKHFKKQKRLIPERTIWKYFVQLC 116
Query: 524 RGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGY 583
L ++H S+ +++HRDIK NV + K+ D GL + + T + V GT Y
Sbjct: 117 SALEHMH--SK-RIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYY 172
Query: 584 MAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLK-EQGKLMELV 642
M+PE K+D++S G + E+ + +S + M ++L K E+ L
Sbjct: 173 MSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL---YSLCKKIEKCDYPPL- 228
Query: 643 DTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVL 680
P ++ E++ +++ C N P RP +S VL
Sbjct: 229 ---PADHY-SEELRDLVSR---CINPDPEKRPDISYVL 259
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 100 bits (249), Expect = 2e-23
Identities = 68/196 (34%), Positives = 103/196 (52%), Gaps = 7/196 (3%)
Query: 421 DNNIGEGGFGPVYKGLLADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGC 480
D +G+G FG V+ G T +A+K L + F+ E ++ L+H LV LY
Sbjct: 11 DVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTMM-PEAFLQEAQIMKKLRHDKLVPLYAV 69
Query: 481 CIEGNQLLLIYEYLENNSLARALFEHRLK-LDWPTRRRICLGIARGLAYLHGESRIKVVH 539
E + ++ E++ SL L E K L P + IA G+AY+ R+ +H
Sbjct: 70 VSE-EPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIE---RMNYIH 125
Query: 540 RDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPEYAMRGHLTEKAD 599
RD++A N+L+ +L KI+DFGLA+L E+ I + APE A+ G T K+D
Sbjct: 126 RDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 185
Query: 600 VYSFGIVALEIVS-GR 614
V+SFGI+ E+V+ GR
Sbjct: 186 VWSFGILLTELVTKGR 201
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 100 bits (249), Expect = 2e-23
Identities = 67/195 (34%), Positives = 102/195 (52%), Gaps = 11/195 (5%)
Query: 424 IGEGGFGPVYKGLLADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCCIE 483
+G G FG V+ G T +AVK L + F+ E ++ L+H LV+LY E
Sbjct: 14 LGNGQFGEVWMGTWNGNTKVAVKTLKPGT-MSPESFLEEAQIMKKLRHDKLVQLYAVVSE 72
Query: 484 GNQLLLIYEYLENNSLARALFE---HRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHR 540
+ ++ EY+ SL L + LKL P + +A G+AY+ R+ +HR
Sbjct: 73 -EPIYIVTEYMSKGSLLDFLKDGEGRALKL--PNLVDMAAQVAAGMAYIE---RMNYIHR 126
Query: 541 DIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPEYAMRGHLTEKADV 600
D+++ N+L+ L KI+DFGLA+L E+ I + APE A+ G T K+DV
Sbjct: 127 DLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 186
Query: 601 YSFGIVALEIVS-GR 614
+SFGI+ E+V+ GR
Sbjct: 187 WSFGILLTELVTKGR 201
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 99.6 bits (248), Expect = 4e-23
Identities = 63/198 (31%), Positives = 107/198 (54%), Gaps = 12/198 (6%)
Query: 424 IGEGGFGPVYKGLLA----DGTAIAVKQLSSK-SKQGNREFINEIGMISALQHPNLVKLY 478
IG G FG V +G L +A+K L S +++ R+F++E ++ HPN++ L
Sbjct: 12 IGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLE 71
Query: 479 GCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVV 538
G + +++I E++EN +L L ++ + + GIA G+ YL S + V
Sbjct: 72 GVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYL---SEMNYV 128
Query: 539 HRDIKATNVLLDKDLNSKISDFGLAK-LDEEENTHISTRVAG---TIGYMAPEYAMRGHL 594
HRD+ A N+L++ +L K+SDFGL++ L+++ + T G I + APE
Sbjct: 129 HRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKF 188
Query: 595 TEKADVYSFGIVALEIVS 612
T +DV+S+GIV E++S
Sbjct: 189 TSASDVWSYGIVMWEVMS 206
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 99.1 bits (247), Expect = 4e-23
Identities = 65/199 (32%), Positives = 97/199 (48%), Gaps = 14/199 (7%)
Query: 424 IGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCCI 482
+G+G +G VY L+ IA+K++ + + + EI + S L+H N+V+ G
Sbjct: 16 LGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDS 75
Query: 483 EGNQLLLIYEYLENNSLARALFEHR---LKLDWPTRRRICLGIARGLAYLHGESRIKVVH 539
E + E + SL+ AL + LK + T I GL YLH ++VH
Sbjct: 76 ENGFFKIFMEQVPGGSLS-ALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDN---QIVH 131
Query: 540 RDIKATNVLLDKDLNS-KISDFGLAKLDEEENTHISTRVAGTIGYMAPE---YAMRGHLT 595
RDIK NVL++ KISDFG +K N T GT+ YMAPE RG+
Sbjct: 132 RDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTET-FTGTLQYMAPEVIDKGPRGY-G 189
Query: 596 EKADVYSFGIVALEIVSGR 614
AD++S G +E+ +G+
Sbjct: 190 APADIWSLGCTIVEMATGK 208
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 99.8 bits (248), Expect = 5e-23
Identities = 79/293 (26%), Positives = 134/293 (45%), Gaps = 44/293 (15%)
Query: 416 NNFATDNNIGEGGFGPVYKGLL------ADGTAIAVKQLSSKSKQGNREFINEIGMISAL 469
+N +GEG FG V+ D +AVK L S ++F E +++ L
Sbjct: 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNL 64
Query: 470 QHPNLVKLYGCCIEGNQLLLIYEYLENNSLARALFEH------------RLKLDWPTRRR 517
QH ++VK YG C+EG+ L++++EY+++ L + L H +L
Sbjct: 65 QHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLH 124
Query: 518 ICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRV 577
I IA G+ YL + VHRD+ N L+ ++L KI DFG+++ + + RV
Sbjct: 125 IAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYY---RV 178
Query: 578 AG----TIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLK 633
G I +M PE M T ++DV+S G+V EI + + +Y L V++
Sbjct: 179 GGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFT-----YGKQPWYQLSNNEVIE 233
Query: 634 --EQGKLMELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLE 684
QG++++ T P +D + L C P +R ++ + +L+
Sbjct: 234 CITQGRVLQRPRTCPKEVYD---------LMLGCWQREPHMRLNIKEIHSLLQ 277
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 98.8 bits (246), Expect = 5e-23
Identities = 67/220 (30%), Positives = 107/220 (48%), Gaps = 21/220 (9%)
Query: 422 NNIGEGGFGPVYKGLLADGTAIAVKQL---SSKSKQGNREFIN---EIGMISALQHPNLV 475
+G+G +G VY GL G IAVKQ+ +S +E+ E+ ++ +L+H N+V
Sbjct: 6 EVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIV 65
Query: 476 KLYGCCIEGNQLLLIYEYLENNSLARALFEHRL-KLDWPTRRRICLGIARGLAYLHGESR 534
+ G C++ N + + E++ S++ L +R L P + I G+AYLH
Sbjct: 66 QYLGTCLDDNTISIFMEFVPGGSISSIL--NRFGPLPEPVFCKYTKQILDGVAYLHNNC- 122
Query: 535 IKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHIS-----TRVAGTIGYMAPEYA 589
VVHRDIK NV+L + K+ DFG A+ H + + GT +MAPE
Sbjct: 123 --VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVI 180
Query: 590 MRGHLTEKADVYSFGIVALEIVSGRSNVTKED----MFYL 625
K+D++S G E+ +G+ + D MFY+
Sbjct: 181 NESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYI 220
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 97.9 bits (244), Expect = 9e-23
Identities = 71/276 (25%), Positives = 129/276 (46%), Gaps = 37/276 (13%)
Query: 417 NFATDNNIGEGGFGPVYK-GLLADGTAIAVKQ--LSSKSKQGNREFINEIGMISALQHPN 473
+F +G+G +G VYK L+D A+K+ L S S++ + +NEI +++++ HPN
Sbjct: 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPN 60
Query: 474 LVKLYGCCIEGNQLLLIYEYLENNSLARALFEHRLK-------LDWPTRRRICLGIARGL 526
++ ++GN+L ++ EY L++A+ + + K W RI + + RGL
Sbjct: 61 IISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIW----RIFIQLLRGL 116
Query: 527 AYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEE--NTHISTRVAGTIGYM 584
LH + K++HRD+K+ N+LL + KI D G++K+ ++ T I GT YM
Sbjct: 117 QALHEQ---KILHRDLKSANILLVANDLVKIGDLGISKVLKKNMAKTQI-----GTPHYM 168
Query: 585 APEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDT 644
APE + K+D++S G + E+ + M L + K+
Sbjct: 169 APEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDL---------RYKVQRGKYP 219
Query: 645 NPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVL 680
+ ++ + N P +RP+ +L
Sbjct: 220 PIPPIYSQD----LQNFIRSMLQVKPKLRPNCDKIL 251
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 98.6 bits (245), Expect = 1e-22
Identities = 61/192 (31%), Positives = 105/192 (54%), Gaps = 9/192 (4%)
Query: 424 IGEGGFGPV-YKGLLADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCCI 482
IGEG G V + + G +AVK++ + +Q NE+ ++ QH N+V++Y +
Sbjct: 28 IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 87
Query: 483 EGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDI 542
G++L ++ E+LE +L + R+ + +CL + + L+ LH + V+HRDI
Sbjct: 88 VGDELWVVMEFLEGGALTDIVTHTRMNEEQIA--AVCLAVLKALSVLHAQG---VIHRDI 142
Query: 543 KATNVLLDKDLNSKISDFGL-AKLDEEENTHISTRVAGTIGYMAPEYAMRGHLTEKADVY 601
K+ ++LL D K+SDFG A++ +E S + GT +MAPE R + D++
Sbjct: 143 KSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKS--LVGTPYWMAPELISRLPYGPEVDIW 200
Query: 602 SFGIVALEIVSG 613
S GI+ +E+V G
Sbjct: 201 SLGIMVIEMVDG 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 98.3 bits (244), Expect = 2e-22
Identities = 62/200 (31%), Positives = 108/200 (54%), Gaps = 9/200 (4%)
Query: 424 IGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCCI 482
IG+G G VY + +A G +A++Q++ + + INEI ++ ++PN+V +
Sbjct: 28 IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 87
Query: 483 EGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDI 542
G++L ++ EYL SL + E +D +C + L +LH +V+HRDI
Sbjct: 88 VGDELWVVMEYLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLHSN---QVIHRDI 142
Query: 543 KATNVLLDKDLNSKISDFGL-AKLDEEENTHISTRVAGTIGYMAPEYAMRGHLTEKADVY 601
K+ N+LL D + K++DFG A++ E++ + + GT +MAPE R K D++
Sbjct: 143 KSDNILLGMDGSVKLTDFGFCAQITPEQSKR--STMVGTPYWMAPEVVTRKAYGPKVDIW 200
Query: 602 SFGIVALEIVSGRSNVTKED 621
S GI+A+E++ G E+
Sbjct: 201 SLGIMAIEMIEGEPPYLNEN 220
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 97.8 bits (243), Expect = 2e-22
Identities = 81/269 (30%), Positives = 123/269 (45%), Gaps = 27/269 (10%)
Query: 418 FATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQGNREFIN-EIGMISALQHPNLV 475
F IG+G FG V+KG+ +A+K + + + E I EI ++S P +
Sbjct: 6 FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65
Query: 476 KLYGCCIEGNQLLLIYEYLENNS---LARALFEHRLKLDWPTRRRICLGIARGLAYLHGE 532
K YG ++G +L +I EYL S L RA ++ + I +GL YLH E
Sbjct: 66 KYYGSYLKGTKLWIIMEYLGGGSALDLLRAGPFDEFQIATMLKE-----ILKGLDYLHSE 120
Query: 533 SRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPEYAMRG 592
+I HRDIKA NVLL + + K++DFG+A + +T V GT +MAPE +
Sbjct: 121 KKI---HRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVIQQS 176
Query: 593 HLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDK 652
KAD++S GI A+E+ G DM + +++ L+ N
Sbjct: 177 AYDSKADIWSLGITAIELAKGEP--PNSDMHPM-----------RVLFLIPKNNPPTLTG 223
Query: 653 EQVMVMINVALLCANASPTIRPSMSSVLR 681
E C N P+ RP+ +L+
Sbjct: 224 EFSKPFKEFIDACLNKDPSFRPTAKELLK 252
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 97.8 bits (244), Expect = 2e-22
Identities = 55/200 (27%), Positives = 101/200 (50%), Gaps = 19/200 (9%)
Query: 424 IGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQG--NREFINEIGMISALQHPNLVKLYGC 480
IGEG +G VYK G +A+K++ + + + + EI ++ L HPN++KL
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDV 66
Query: 481 CIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHR 540
L L++E+++ + L + + + + L + + +GLA+ H ++HR
Sbjct: 67 FRHKGDLYLVFEFMDTD-LYKLIKDRQRGLPESLIKSYLYQLLQGLAFCH---SHGILHR 122
Query: 541 DIKATNVLLDKDLNSKISDFGLAKL---DEEENTH-ISTRVAGTIGYMAPE--YAMRGHL 594
D+K N+L++ + K++DFGLA+ TH + TR Y APE +G+
Sbjct: 123 DLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVVTR-----WYRAPELLLGDKGY- 176
Query: 595 TEKADVYSFGIVALEIVSGR 614
+ D++S G + E++S R
Sbjct: 177 STPVDIWSVGCIFAELLSRR 196
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 97.7 bits (243), Expect = 2e-22
Identities = 76/272 (27%), Positives = 130/272 (47%), Gaps = 31/272 (11%)
Query: 424 IGEGGFGPVYKGL-LADGTAI----AVKQLSSKS-KQGNREFINEIGMISALQHPNLVKL 477
+G G FG V+KG+ + +G +I A+K + +S +Q +E + + + +L H +V+L
Sbjct: 15 LGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRL 74
Query: 478 YGCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKV 537
G C G L L+ + SL + +HR LD C+ IA+G+ YL E R+
Sbjct: 75 LGIC-PGASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLE-EHRM-- 130
Query: 538 VHRDIKATNVLLDKDLNSKISDFGLAK-LDEEENTHISTRVAGTIGYMAPEYAMRGHLTE 596
VHR++ A N+LL D +I+DFG+A L ++ + + I +MA E + G T
Sbjct: 131 VHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFGRYTH 190
Query: 597 KADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDKEQV- 655
++DV+S+G+ E++S + + E L+E G + Q+
Sbjct: 191 QSDVWSYGVTVWEMMSYGAEPYA---------GMRPHEVPDLLE-----KGERLAQPQIC 236
Query: 656 -----MVMINVALLCANASPTIRPSMSSVLRM 682
MVM+ ++ N PT + + RM
Sbjct: 237 TIDVYMVMVKCWMIDENVRPTFKELANEFTRM 268
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 97.2 bits (242), Expect = 2e-22
Identities = 63/212 (29%), Positives = 106/212 (50%), Gaps = 20/212 (9%)
Query: 417 NFATDNNIGEGGFGPVYKGLLADGTA--IAVKQLS---------SKSKQGN-REFINEIG 464
+A ++G G FG VYK + +A+K+++ + + + + ++E+
Sbjct: 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVT 60
Query: 465 MI-SALQHPNLVKLYGCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRR---ICL 520
+I L+HPN+V+ Y +E ++L ++ + +E L + K T R I +
Sbjct: 61 IIKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFV 120
Query: 521 GIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGT 580
+ L YLH E RI VHRD+ N++L +D I+DFGLAK + E+ T V GT
Sbjct: 121 QMVLALRYLHKEKRI--VHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESK--LTSVVGT 176
Query: 581 IGYMAPEYAMRGHLTEKADVYSFGIVALEIVS 612
I Y PE EKADV++FG + ++ +
Sbjct: 177 ILYSCPEIVKNEPYGEKADVWAFGCILYQMCT 208
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 97.0 bits (242), Expect = 2e-22
Identities = 61/203 (30%), Positives = 94/203 (46%), Gaps = 12/203 (5%)
Query: 417 NFATDNNIGEGGFGPVYKGLLAD-GTAIAVKQLSSK---SKQGNREFINEIGMISALQHP 472
+F IG+G FG V D A+K ++ + K R +NE ++ L HP
Sbjct: 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHP 60
Query: 473 NLVKLYGCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGE 532
LV L+ + + L+ + L L R ++K + I L YLH +
Sbjct: 61 FLVNLWYSFQDEENMYLVVDLLLGGDL-RYHLSQKVKFSEEQVKFWICEIVLALEYLHSK 119
Query: 533 SRIKVVHRDIKATNVLLDKDLNSKISDFGLA-KLDEEENTHISTRVAGTIGYMAPEYAMR 591
++HRDIK N+LLD+ + I+DF +A K+ + T T +GT GYMAPE R
Sbjct: 120 ---GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLT---TSTSGTPGYMAPEVLCR 173
Query: 592 GHLTEKADVYSFGIVALEIVSGR 614
+ D +S G+ A E + G+
Sbjct: 174 QGYSVAVDWWSLGVTAYECLRGK 196
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 97.4 bits (242), Expect = 2e-22
Identities = 82/266 (30%), Positives = 123/266 (46%), Gaps = 21/266 (7%)
Query: 418 FATDNNIGEGGFGPVYKGLLADGT-AIAVKQLSSKSKQGNREFIN-EIGMISALQHPNLV 475
F IG+G FG VYKG+ +A+K + + + E I EI ++S P +
Sbjct: 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYIT 65
Query: 476 KLYGCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRI 535
+ YG ++G +L +I EYL S L L+ + I I +GL YLH E +I
Sbjct: 66 RYYGSYLKGTKLWIIMEYLGGGSALDLLKPGPLEETYIAT--ILREILKGLDYLHSERKI 123
Query: 536 KVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPEYAMRGHLT 595
HRDIKA NVLL + + K++DFG+A + +T V GT +MAPE +
Sbjct: 124 ---HRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVIKQSAYD 179
Query: 596 EKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDKEQV 655
KAD++S GI A+E+ G D+ + L+ K +E + P F +
Sbjct: 180 FKADIWSLGITAIELAKGEP--PNSDLHPMRVLFLIPKNSPPTLEGQYSKPFKEFVEA-- 235
Query: 656 MVMINVALLCANASPTIRPSMSSVLR 681
C N P RP+ +L+
Sbjct: 236 ---------CLNKDPRFRPTAKELLK 252
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 97.4 bits (242), Expect = 4e-22
Identities = 68/243 (27%), Positives = 116/243 (47%), Gaps = 35/243 (14%)
Query: 424 IGEGGFGPVY----KGLLA-----------DGTAIAVKQLSSK-SKQGNREFINEIGMIS 467
+GEG FG V+ +GL +AVK L + +K +F+ EI ++S
Sbjct: 13 LGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMS 72
Query: 468 ALQHPNLVKLYGCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRI--------- 518
L++PN+++L G C+ + L +I EY+EN L + L + ++ + I
Sbjct: 73 RLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLL 132
Query: 519 --CLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAK-LDEEENTHIST 575
+ IA G+ YL + + VHRD+ N L+ KI+DFG+++ L + I
Sbjct: 133 YMAVQIASGMKYL---ASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQG 189
Query: 576 RVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQ 635
R I +MA E + G T +DV++FG+ E+ + + KE + LL V++
Sbjct: 190 RAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFT----LCKEQPYSLLSDEQVIENT 245
Query: 636 GKL 638
G+
Sbjct: 246 GEF 248
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 97.4 bits (242), Expect = 5e-22
Identities = 68/210 (32%), Positives = 117/210 (55%), Gaps = 27/210 (12%)
Query: 418 FATDNNIGEGGFGPVYKGL-LADGTAI----AVKQL-SSKSKQGNREFINEIGMISALQH 471
F +G G FG VYKGL + +G + A+K+L + S + N+E ++E +++++ +
Sbjct: 9 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 68
Query: 472 PNLVKLYGCCIEGNQLLLIYEYLENNSLARALFEHRLK------LDWPTRRRICLGIARG 525
P++ +L G C+ + + LI + + L + EH+ L+W C+ IA+G
Sbjct: 69 PHVCRLLGICLT-STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKG 121
Query: 526 LAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKL---DEEENTHISTRVAGTIG 582
+ YL E R ++VHRD+ A NVL+ + KI+DFGLAKL DE+E +V I
Sbjct: 122 MNYL--EER-RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVP--IK 176
Query: 583 YMAPEYAMRGHLTEKADVYSFGIVALEIVS 612
+MA E + T ++DV+S+G+ E+++
Sbjct: 177 WMALESILHRIYTHQSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 95.7 bits (238), Expect = 5e-22
Identities = 58/192 (30%), Positives = 97/192 (50%), Gaps = 10/192 (5%)
Query: 424 IGEGGFGPVYKGLLADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCCIE 483
+G G FG V+ G +A+K ++ + +FI E ++ L HP LV+LYG C +
Sbjct: 12 LGSGQFGVVHLGKWRAQIKVAIKAINEGA-MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQ 70
Query: 484 GNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIK 543
L ++ E++EN L L + + KL +C + G+ YL R +HRD+
Sbjct: 71 QKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLE---RNSFIHRDLA 127
Query: 544 ATNVLLDKDLNSKISDFGLAK--LDEEENTHISTRVAG-TIGYMAPEYAMRGHLTEKADV 600
A N L+ K+SDFG+ + LD+E + S+ A + + PE + K+DV
Sbjct: 128 ARNCLVSSTGVVKVSDFGMTRYVLDDE---YTSSSGAKFPVKWSPPEVFNFSKYSSKSDV 184
Query: 601 YSFGIVALEIVS 612
+SFG++ E+ +
Sbjct: 185 WSFGVLMWEVFT 196
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 95.6 bits (238), Expect = 6e-22
Identities = 70/271 (25%), Positives = 123/271 (45%), Gaps = 35/271 (12%)
Query: 424 IGEGGFGP--VYKGLLADGTAIAVKQ--LSSKSKQGNREFINEIGMISALQHPNLVKLYG 479
+G+G FG +Y+ D + + K+ L+ S++ R+ +NEI ++S LQHPN++ Y
Sbjct: 8 LGKGAFGEATLYRRT-EDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYN 66
Query: 480 CCIEGNQLLLIYEYLENNSLA-------RALFEHRLKLDWPTRRRICLGIARGLAYLHGE 532
++ N LL+ EY +L LFE + L + I ++Y+H
Sbjct: 67 HFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWY------LFQIVSAVSYIHKA 120
Query: 533 SRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPEYAMRG 592
++HRDIK N+ L K K+ DFG++K+ E + T V GT YM+PE
Sbjct: 121 G---ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAET-VVGTPYYMSPELCQGV 176
Query: 593 HLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDK 652
K+D+++ G V E+++ + + L+ K+++ T S +
Sbjct: 177 KYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVV---------KIVQGNYTPVVSVYSS 227
Query: 653 EQVMVMINVALLCANASPTIRPSMSSVLRML 683
E + ++ + P RP+ VL
Sbjct: 228 ELISLVHS----LLQQDPEKRPTADEVLDQP 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 96.5 bits (240), Expect = 6e-22
Identities = 65/218 (29%), Positives = 106/218 (48%), Gaps = 32/218 (14%)
Query: 424 IGEGGFGPVY------------KGLLADGTA-----IAVKQLSSKSKQGNR-EFINEIGM 465
+GEG FG V+ K D + +AVK L + + R +F+ EI +
Sbjct: 13 LGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKI 72
Query: 466 ISALQHPNLVKLYGCCIEGNQLLLIYEYLENNSLARALFEHRLK----------LDWPTR 515
+S L+ PN+++L CI + L +I EY+EN L + L H + + + T
Sbjct: 73 MSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTL 132
Query: 516 RRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAK-LDEEENTHIS 574
+ IA G+ YL S + VHRD+ N L+ K+ KI+DFG+++ L + I
Sbjct: 133 IFMATQIASGMKYL---SSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRIQ 189
Query: 575 TRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVS 612
R I +M+ E + G T +DV++FG+ EI++
Sbjct: 190 GRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 95.4 bits (237), Expect = 6e-22
Identities = 82/266 (30%), Positives = 124/266 (46%), Gaps = 30/266 (11%)
Query: 424 IGEGGFGPVYKGLLAD--GTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCC 481
IG+G FG V +L D G +AVK + K+ + F+ E +++ L+H NLV+L G
Sbjct: 14 IGKGEFGDV---MLGDYRGNKVAVKCI--KNDATAQAFLAEASVMTQLRHSNLVQLLGVI 68
Query: 482 IEGN-QLLLIYEYLENNSLARALFEH-RLKLDWPTRRRICLGIARGLAYLHGESRIKVVH 539
+E L ++ EY+ SL L R L + L + + YL + VH
Sbjct: 69 VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANN---FVH 125
Query: 540 RDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPEYAMRGHLTEKAD 599
RD+ A NVL+ +D +K+SDFGL K E +T + ++ + + APE + K+D
Sbjct: 126 RDLAARNVLVSEDNVAKVSDFGLTK--EASSTQDTGKLP--VKWTAPEALREKKFSTKSD 181
Query: 600 VYSFGIVALEIVS-GRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDKEQVMVM 658
V+SFGI+ EI S GR + L + E+G M+ D P +D VM
Sbjct: 182 VWSFGILLWEIYSFGRVPYPR----IPLKDVVPRVEKGYKMDAPDGCPPVVYD-----VM 232
Query: 659 INVALLCANASPTIRPSMSSVLRMLE 684
C + RPS + LE
Sbjct: 233 KQ----CWHLDAATRPSFLQLREQLE 254
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 96.7 bits (240), Expect = 7e-22
Identities = 67/204 (32%), Positives = 116/204 (56%), Gaps = 27/204 (13%)
Query: 424 IGEGGFGPVYKGL-LADGTAI----AVKQLSSKS-KQGNREFINEIGMISALQHPNLVKL 477
+G G FG VYKG+ + +G + A+K L+ + + N EF++E +++++ HP+LV+L
Sbjct: 15 LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRL 74
Query: 478 YGCCIEGNQLLLIYEYLENNSLARALFEHR------LKLDWPTRRRICLGIARGLAYLHG 531
G C+ + L+ + + + L + EH+ L L+W C+ IA+G+ YL
Sbjct: 75 LGVCLSPT-IQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNW------CVQIAKGMMYL-- 125
Query: 532 ESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKL---DEEENTHISTRVAGTIGYMAPEY 588
E R ++VHRD+ A NVL+ + KI+DFGLA+L DE+E ++ I +MA E
Sbjct: 126 EER-RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMP--IKWMALEC 182
Query: 589 AMRGHLTEKADVYSFGIVALEIVS 612
T ++DV+S+G+ E+++
Sbjct: 183 IHYRKFTHQSDVWSYGVTIWELMT 206
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 96.2 bits (239), Expect = 7e-22
Identities = 80/290 (27%), Positives = 135/290 (46%), Gaps = 53/290 (18%)
Query: 424 IGEGGFGPVYKGLLA---------DGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNL 474
+GEG FG V+ LA D +AVK L + ++F E +++ LQH ++
Sbjct: 13 LGEGAFGKVF---LAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHI 69
Query: 475 VKLYGCCIEGNQLLLIYEYLENNSLARALFEH----RLKLDWPTRR-----------RIC 519
VK YG C +G+ L++++EY+++ L + L H + +D R+ I
Sbjct: 70 VKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIA 129
Query: 520 LGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAG 579
IA G+ YL + VHRD+ N L+ +L KI DFG+++ + + RV G
Sbjct: 130 SQIASGMVYLASQ---HFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYY---RVGG 183
Query: 580 ----TIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLK-- 633
I +M PE M T ++DV+SFG++ EI + K+ F L + V++
Sbjct: 184 HTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFT----YGKQPWFQLSN-TEVIECI 238
Query: 634 EQGKLMELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRML 683
QG+++E P +D + L C P R ++ + ++L
Sbjct: 239 TQGRVLERPRVCPKEVYD---------IMLGCWQREPQQRLNIKEIYKIL 279
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 95.1 bits (236), Expect = 8e-22
Identities = 61/191 (31%), Positives = 103/191 (53%), Gaps = 6/191 (3%)
Query: 424 IGEGGFGPVYKGLLADGTAIAVKQLSSKSKQGNR-EFINEIGMISALQHPNLVKLYGCCI 482
+G+G FG V+KG L D T +AVK Q + +F++E ++ HPN+VKL G C
Sbjct: 3 LGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCT 62
Query: 483 EGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDI 542
+ + ++ E + L + + +L + L A G+AYL ES+ +HRD+
Sbjct: 63 QRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYL--ESK-NCIHRDL 119
Query: 543 KATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGT-IGYMAPEYAMRGHLTEKADVY 601
A N L+ ++ KISDFG+++ E++ + S+ + I + APE G + ++DV+
Sbjct: 120 AARNCLVGENNVLKISDFGMSR-QEDDGIYSSSGLKQIPIKWTAPEALNYGRYSSESDVW 178
Query: 602 SFGIVALEIVS 612
S+GI+ E S
Sbjct: 179 SYGILLWETFS 189
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 95.3 bits (237), Expect = 1e-21
Identities = 63/197 (31%), Positives = 95/197 (48%), Gaps = 12/197 (6%)
Query: 424 IGEGGFGPVYKGLLAD-GTAIAVKQ-----LSSKSKQGNREFINEIGMISALQHPNLVKL 477
+G+G FG VY D G +AVKQ S ++K+ EI ++ LQH +V+
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQY 69
Query: 478 YGCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKV 537
YGC + L + EY+ S+ L + + TR+ I G+ YLH +
Sbjct: 70 YGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRK-YTRQILEGVEYLH---SNMI 125
Query: 538 VHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHIS--TRVAGTIGYMAPEYAMRGHLT 595
VHRDIK N+L D N K+ DFG +K + + + V GT +M+PE
Sbjct: 126 VHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEGYG 185
Query: 596 EKADVYSFGIVALEIVS 612
KADV+S G +E+++
Sbjct: 186 RKADVWSVGCTVVEMLT 202
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 94.9 bits (236), Expect = 1e-21
Identities = 72/272 (26%), Positives = 129/272 (47%), Gaps = 32/272 (11%)
Query: 422 NNIGEGGFGPVYKGLLAD-GTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGC 480
+ +G G +G VY+G+ +AVK L + + EF+ E ++ ++HPNLV+L G
Sbjct: 12 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGV 70
Query: 481 CIEGNQLLLIYEYLENNSLARALFE-HRLKLDWPTRRRICLGIARGLAYLHGESRIKVVH 539
C +I E++ +L L E +R +++ + I+ + YL ++ I H
Sbjct: 71 CTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFI---H 127
Query: 540 RDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGT---IGYMAPEYAMRGHLTE 596
RD+ A N L+ ++ K++DFGL++L + T AG I + APE +
Sbjct: 128 RDLAARNCLVGENHLVKVADFGLSRLMTGD---TYTAHAGAKFPIKWTAPESLAYNKFSI 184
Query: 597 KADVYSFGIVALEIVS-GRS---NVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDK 652
K+DV++FG++ EI + G S + ++ LL E+G ME + P ++
Sbjct: 185 KSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL-------EKGYRMERPEGCPPKVYE- 236
Query: 653 EQVMVMINVALLCANASPTIRPSMSSVLRMLE 684
+ C +P+ RPS + + + E
Sbjct: 237 --------LMRACWQWNPSDRPSFAEIHQAFE 260
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 95.5 bits (237), Expect = 1e-21
Identities = 61/192 (31%), Positives = 102/192 (53%), Gaps = 9/192 (4%)
Query: 424 IGEGGFGPVYKGLLA-DGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCCI 482
IGEG G V G +AVK++ + +Q NE+ ++ H N+V +Y +
Sbjct: 30 IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYL 89
Query: 483 EGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDI 542
G++L ++ E+LE +L + R+ + +CL + R L+YLH + V+HRDI
Sbjct: 90 VGDELWVVMEFLEGGALTDIVTHTRMNEEQIA--TVCLSVLRALSYLHNQG---VIHRDI 144
Query: 543 KATNVLLDKDLNSKISDFGL-AKLDEEENTHISTRVAGTIGYMAPEYAMRGHLTEKADVY 601
K+ ++LL D K+SDFG A++ +E S + GT +MAPE R + D++
Sbjct: 145 KSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKS--LVGTPYWMAPEVISRLPYGTEVDIW 202
Query: 602 SFGIVALEIVSG 613
S GI+ +E++ G
Sbjct: 203 SLGIMVIEMIDG 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 94.9 bits (236), Expect = 1e-21
Identities = 61/210 (29%), Positives = 106/210 (50%), Gaps = 31/210 (14%)
Query: 424 IGEGGFGPVYKGL-LADGTAIAVKQLS----SKSKQGN--REFINEIGMISALQHPNLVK 476
+G G F Y+ + GT +AVKQ++ + S+Q EI +++ L HP++++
Sbjct: 8 LGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIR 67
Query: 477 LYGCCIEGNQLLLIYEYLENNSLARAL-----FEHRLKLDWPTRRRICLGIARGLAYLHG 531
+ G E + L E++ S++ L F+ + + + RGL+YLH
Sbjct: 68 MLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVII------NYTEQLLRGLSYLH- 120
Query: 532 ESRIKVVHRDIKATNVLLD---KDLNSKISDFGLAKLDEEENT---HISTRVAGTIGYMA 585
E++I +HRD+K N+L+D + L +I+DFG A + T ++ GTI +MA
Sbjct: 121 ENQI--IHRDVKGANLLIDSTGQRL--RIADFGAAARLAAKGTGAGEFQGQLLGTIAFMA 176
Query: 586 PEYAMRGH-LTEKADVYSFGIVALEIVSGR 614
PE +RG DV+S G V +E+ + +
Sbjct: 177 PE-VLRGEQYGRSCDVWSVGCVIIEMATAK 205
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 95.5 bits (237), Expect = 2e-21
Identities = 65/201 (32%), Positives = 100/201 (49%), Gaps = 18/201 (8%)
Query: 418 FATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQGN---REFINEIGMISALQHPN 473
F+ IG G FG VY + + +A+K++S KQ N ++ I E+ + L+HPN
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 474 LVKLYGCCIEGNQLLLIYEYLENNSLARALFE-HRLKLDWPTRRRICLGIARGLAYLHGE 532
++ GC + + L+ EY + A L E H+ L + G +GLAYLH
Sbjct: 77 TIQYRGCYLREHTAWLVMEYCLGS--ASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSH 134
Query: 533 SRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPEYAM-- 590
+ ++HRD+KA N+LL + K+ DFG A + N + GT +MAPE +
Sbjct: 135 N---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXFV-----GTPYWMAPEVILAM 186
Query: 591 -RGHLTEKADVYSFGIVALEI 610
G K DV+S GI +E+
Sbjct: 187 DEGQYDGKVDVWSLGITCIEL 207
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 95.5 bits (237), Expect = 2e-21
Identities = 61/195 (31%), Positives = 103/195 (52%), Gaps = 15/195 (7%)
Query: 424 IGEGGFGPVYKGLLA----DGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYG 479
IGEG G V +A G +AVK + + +Q NE+ ++ QH N+V++Y
Sbjct: 29 IGEGSTGIV---CIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYK 85
Query: 480 CCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVH 539
+ G +L ++ E+L+ +L + + RL + +C + + L YLH + V+H
Sbjct: 86 SYLVGEELWVLMEFLQGGALTDIVSQTRLNEEQIA--TVCESVLQALCYLHSQG---VIH 140
Query: 540 RDIKATNVLLDKDLNSKISDFGL-AKLDEEENTHISTRVAGTIGYMAPEYAMRGHLTEKA 598
RDIK+ ++LL D K+SDFG A++ ++ S + GT +MAPE R +
Sbjct: 141 RDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKS--LVGTPYWMAPEVISRTPYGTEV 198
Query: 599 DVYSFGIVALEIVSG 613
D++S GI+ +E+V G
Sbjct: 199 DIWSLGIMVIEMVDG 213
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 95.5 bits (237), Expect = 2e-21
Identities = 69/201 (34%), Positives = 100/201 (49%), Gaps = 18/201 (8%)
Query: 418 FATDNNIGEGGFGPVYKGLLADGTAI-AVKQLSSKSKQGN---REFINEIGMISALQHPN 473
F + IG G FG VY + + AVK++S KQ N ++ I E+ + L+HPN
Sbjct: 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPN 82
Query: 474 LVKLYGCCIEGNQLLLIYEYLENNSLARALFE-HRLKLDWPTRRRICLGIARGLAYLHGE 532
++ GC ++ + L+ EY + A L E H+ L I G +GLAYLH
Sbjct: 83 TIEYKGCYLKEHTAWLVMEYCLGS--ASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSH 140
Query: 533 SRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPEYAM-- 590
+ I HRDIKA N+LL + K++DFG A N+ + GT +MAPE +
Sbjct: 141 NMI---HRDIKAGNILLTEPGQVKLADFGSASKSSPANSFV-----GTPYWMAPEVILAM 192
Query: 591 -RGHLTEKADVYSFGIVALEI 610
G K DV+S GI +E+
Sbjct: 193 DEGQYDGKVDVWSLGITCIEL 213
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 94.7 bits (235), Expect = 2e-21
Identities = 62/196 (31%), Positives = 102/196 (52%), Gaps = 16/196 (8%)
Query: 424 IGEGGFGPVYKGLLAD-GTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCCI 482
+G+G FG VYK + G A K + +KS++ +++ EI +++ HP +VKL G
Sbjct: 20 LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFY 79
Query: 483 EGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDI 542
+L ++ E+ ++ + E L P + IC + L YLH +K++HRD+
Sbjct: 80 WDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHS---MKIIHRDL 136
Query: 543 KATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIG---YMAPEYAMRGHLTE--- 596
KA NVLL D + K++DFG++ +N R IG +MAPE M + +
Sbjct: 137 KAGNVLLTLDGDIKLADFGVSA----KNVKTLQRRDSFIGTPYWMAPEVVMCETMKDTPY 192
Query: 597 --KADVYSFGIVALEI 610
KAD++S GI +E+
Sbjct: 193 DYKADIWSLGITLIEM 208
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 94.4 bits (234), Expect = 2e-21
Identities = 84/267 (31%), Positives = 124/267 (46%), Gaps = 23/267 (8%)
Query: 418 FATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQGNREFIN-EIGMISALQHPNLV 475
F IG+G FG V+KG+ +A+K + + + E I EI ++S P +
Sbjct: 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65
Query: 476 KLYGCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRI 535
K YG ++ +L +I EYL S A L E LD I I +GL YLH E +I
Sbjct: 66 KYYGSYLKDTKLWIIMEYLGGGS-ALDLLEPG-PLDETQIATILREILKGLDYLHSEKKI 123
Query: 536 KVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHIS-TRVAGTIGYMAPEYAMRGHL 594
HRDIKA NVLL + K++DFG+A + +T I GT +MAPE +
Sbjct: 124 ---HRDIKAANVLLSEHGEVKLADFGVA--GQLTDTQIKRNTFVGTPFWMAPEVIKQSAY 178
Query: 595 TEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDKEQ 654
KAD++S GI A+E+ G ++ +L L+ K +E + P F +
Sbjct: 179 DSKADIWSLGITAIELAKGEPPHSELHPMKVL--FLIPKNNPPTLEGNYSKPLKEFVEA- 235
Query: 655 VMVMINVALLCANASPTIRPSMSSVLR 681
C N P+ RP+ +L+
Sbjct: 236 ----------CLNKEPSFRPTAKELLK 252
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 94.3 bits (234), Expect = 3e-21
Identities = 60/198 (30%), Positives = 109/198 (55%), Gaps = 15/198 (7%)
Query: 424 IGEGGFGPVYKGLLA-DG----TAIAVKQL-SSKSKQGNREFINEIGMISALQHPNLVKL 477
+G G FG VYKG+ DG +A+K L + S + N+E ++E +++ + P + +L
Sbjct: 15 LGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRL 74
Query: 478 YGCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKV 537
G C+ + + L+ + + L + E++ ++ C+ IA+G++YL +++
Sbjct: 75 LGICLT-STVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLE---EVRL 130
Query: 538 VHRDIKATNVLLDKDLNSKISDFGLAKL---DEEENTHISTRVAGTIGYMAPEYAMRGHL 594
VHRD+ A NVL+ + KI+DFGLA+L DE E +V I +MA E +
Sbjct: 131 VHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVP--IKWMALESILHRRF 188
Query: 595 TEKADVYSFGIVALEIVS 612
T ++DV+S+G+ E+++
Sbjct: 189 THQSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 93.5 bits (232), Expect = 4e-21
Identities = 78/278 (28%), Positives = 133/278 (47%), Gaps = 31/278 (11%)
Query: 417 NFATDNNIGEGGFGPVYKG-LLADGTAIAVKQ------LSSKSKQGNREFINEIGMISAL 469
NF + IG G F VY+ L DG +A+K+ + +K++ + I EI ++ L
Sbjct: 3 NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARA---DCIKEIDLLKQL 59
Query: 470 QHPNLVKLYGCCIEGNQLLLIYEYLENNSLARAL--FEHRLKLDWPTRR--RICLGIARG 525
HPN++K Y IE N+L ++ E + L+R + F+ + +L P + + + +
Sbjct: 60 NHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRL-IPEKTVWKYFVQLCSA 118
Query: 526 LAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMA 585
L ++H SR +V+HRDIK NV + K+ D GL + + T + V GT YM+
Sbjct: 119 LEHMH--SR-RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYMS 174
Query: 586 PEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTN 645
PE K+D++S G + E+ + +S + M L K +E D
Sbjct: 175 PERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM--------NLYSLCKKIEQCDYP 226
Query: 646 P-GSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRM 682
P S+ E++ ++N +C N P RP ++ V +
Sbjct: 227 PLPSDHYSEELRQLVN---MCINPDPEKRPDITYVYDV 261
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 94.0 bits (234), Expect = 4e-21
Identities = 61/207 (29%), Positives = 102/207 (49%), Gaps = 15/207 (7%)
Query: 416 NNFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSKSKQG-NREFINEIGMISALQHPN 473
+ +GEG G V K L G A+K +++ ++ + E+ + + + P
Sbjct: 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPY 60
Query: 474 LVKLYGCCIE--GNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIA----RGLA 527
+VK YG ++ + + + EY E SL ++++ K ++ IA +GL+
Sbjct: 61 IVKYYGAFLDESSSSIGIAMEYCEGGSL-DSIYKKVKKRGGRIGEKVLGKIAESVLKGLS 119
Query: 528 YLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPE 587
YLH SR K++HRDIK +N+LL + K+ DFG++ E N+ T GT YMAPE
Sbjct: 120 YLH--SR-KIIHRDIKPSNILLTRKGQVKLCDFGVS--GELVNSLAGTFT-GTSFYMAPE 173
Query: 588 YAMRGHLTEKADVYSFGIVALEIVSGR 614
+ +DV+S G+ LE+ R
Sbjct: 174 RIQGKPYSITSDVWSLGLTLLEVAQNR 200
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 92.7 bits (230), Expect = 8e-21
Identities = 58/194 (29%), Positives = 96/194 (49%), Gaps = 8/194 (4%)
Query: 424 IGEGGFGPVYKGLLA----DGTAIAVKQL-SSKSKQGNREFINEIGMISALQHPNLVKLY 478
+G G FG + +G L +A+ L + S + R F+ E + H N+V+L
Sbjct: 13 LGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLE 72
Query: 479 GCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVV 538
G GN ++++ EY+ N +L L +H +L + G+A G+ YL S + V
Sbjct: 73 GVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYL---SEMGYV 129
Query: 539 HRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPEYAMRGHLTEKA 598
H+ + A VL++ DL KIS F + D+ E + + + + APE H + +
Sbjct: 130 HKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAIYTTMSGKSPVLWAAPEAIQYHHFSSAS 189
Query: 599 DVYSFGIVALEIVS 612
DV+SFGIV E++S
Sbjct: 190 DVWSFGIVMWEVMS 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 93.6 bits (232), Expect = 8e-21
Identities = 66/201 (32%), Positives = 99/201 (49%), Gaps = 18/201 (8%)
Query: 418 FATDNNIGEGGFGPVYKGLLA-DGTAIAVKQLSSKSKQGN---REFINEIGMISALQHPN 473
F IG G FG VY +A+K++S KQ N ++ I E+ + ++HPN
Sbjct: 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPN 86
Query: 474 LVKLYGCCIEGNQLLLIYEYLENNSLARALFE-HRLKLDWPTRRRICLGIARGLAYLHGE 532
++ GC + + L+ EY + A L E H+ L I G +GLAYLH
Sbjct: 87 SIEYKGCYLREHTAWLVMEYCLGS--ASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSH 144
Query: 533 SRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPEYAM-- 590
+ ++HRDIKA N+LL + K++DFG A + N+ + GT +MAPE +
Sbjct: 145 N---MIHRDIKAGNILLTEPGQVKLADFGSASIASPANSFV-----GTPYWMAPEVILAM 196
Query: 591 -RGHLTEKADVYSFGIVALEI 610
G K DV+S GI +E+
Sbjct: 197 DEGQYDGKVDVWSLGITCIEL 217
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 92.8 bits (231), Expect = 1e-20
Identities = 65/219 (29%), Positives = 102/219 (46%), Gaps = 32/219 (14%)
Query: 423 NIGEGGFGPVY------------KGLLADGTA-----IAVKQL-SSKSKQGNREFINEIG 464
+GEG FG V+ K + A +AVK L S +F+ E+
Sbjct: 12 KLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVK 71
Query: 465 MISALQHPNLVKLYGCCIEGNQLLLIYEYLENNSLARALFEHRLK----------LDWPT 514
++S L PN+ +L G C L +I EY+EN L + L +H + L + T
Sbjct: 72 ILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFST 131
Query: 515 RRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAK-LDEEENTHI 573
+ IA G+ YL + VHRD+ N L+ K+ KI+DFG+++ L + +
Sbjct: 132 LLYMATQIASGMRYL---ESLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSDYYRV 188
Query: 574 STRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVS 612
R I +MA E + G T K+DV++FG+ EI++
Sbjct: 189 QGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 91.4 bits (228), Expect = 2e-20
Identities = 61/207 (29%), Positives = 99/207 (47%), Gaps = 31/207 (14%)
Query: 423 NIGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQGNREFIN--EIGMISALQ-HPNLVKLY 478
+G+G FG VY G +A+K++ K E +N E+ + L HPN+VKL
Sbjct: 6 QLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWE-ECMNLREVKSLRKLNEHPNIVKLK 64
Query: 479 GCCIEGNQLLLIYEYLENNSLARALFE----HRLK-LDWPTRRRICLGIARGLAYLHGES 533
E ++L ++EY+E N L++ + K R I I +GLA++H
Sbjct: 65 EVFRENDELYFVFEYMEGN-----LYQLMKDRKGKPFSESVIRSIIYQILQGLAHIH--- 116
Query: 534 RIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEEN-----THISTRVAGTIGYMAPEY 588
+ HRD+K N+L+ KI+DFGLA+ E + ++STR Y APE
Sbjct: 117 KHGFFHRDLKPENLLVSGPEVVKIADFGLAR--EIRSRPPYTDYVSTR-----WYRAPEI 169
Query: 589 AMR-GHLTEKADVYSFGIVALEIVSGR 614
+R + D+++ G + E+ + R
Sbjct: 170 LLRSTSYSSPVDIWALGCIMAELYTLR 196
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 91.4 bits (227), Expect = 2e-20
Identities = 59/206 (28%), Positives = 94/206 (45%), Gaps = 22/206 (10%)
Query: 424 IGEGGFGPVY----KGLLADG--TAIAVKQLSSKSKQG-NREFINEIGMISALQHPNLVK 476
+G G FG V+ KG+ +G T + VK L + EF E+ M L H N+V+
Sbjct: 13 LGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVR 72
Query: 477 LYGCCIEGNQLLLIYEYLENNSLARALFEHRLK--------LDWPTRRRICLGIARGLAY 528
L G C E +I EY + L + L + K L + +C IA G+ +
Sbjct: 73 LLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDH 132
Query: 529 LHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAK--LDEEENTHISTRVAGTIGYMAP 586
L S + VHRD+ A N L+ K+S L+K + E + + + ++AP
Sbjct: 133 L---SNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALIP--LRWLAP 187
Query: 587 EYAMRGHLTEKADVYSFGIVALEIVS 612
E + K+DV+SFG++ E+ +
Sbjct: 188 EAVQEDDFSTKSDVWSFGVLMWEVFT 213
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 91.6 bits (227), Expect = 3e-20
Identities = 63/196 (32%), Positives = 100/196 (51%), Gaps = 16/196 (8%)
Query: 424 IGEGGFGPVYKGLLAD-GTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCCI 482
+G+G FG VYK + G A K + +KS++ +++ EI ++++ HPN+VKL
Sbjct: 13 LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 72
Query: 483 EGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDI 542
N L ++ E+ ++ + E L P R +C L YLH K++HRD+
Sbjct: 73 YENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHEN---KIIHRDL 129
Query: 543 KATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIG---YMAPEYAMRGHLTE--- 596
KA N+L D + K++DFG++ +NT R IG +MAPE M +
Sbjct: 130 KAGNILFTLDGDIKLADFGVSA----KNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPY 185
Query: 597 --KADVYSFGIVALEI 610
KADV+S GI +E+
Sbjct: 186 DYKADVWSLGITLIEM 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 91.4 bits (227), Expect = 3e-20
Identities = 77/287 (26%), Positives = 130/287 (45%), Gaps = 38/287 (13%)
Query: 416 NNFATDNNIGEGGFGPVYK----GLLADGTAI--AVKQLSSKSKQGNRE-FINEIGMISA 468
NN + +G G FG V + GL + AVK L + RE ++E+ ++S
Sbjct: 35 NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSH 94
Query: 469 L-QHPNLVKLYGCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLG--IARG 525
L H N+V L G C G +L+I EY L L R + +A+G
Sbjct: 95 LGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESF-LTLEDLLSFSYQVAKG 153
Query: 526 LAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHI---STRVAGTIG 582
+A+L ++ +HRD+ A NVLL KI DFGLA+ ++ ++ + R+ +
Sbjct: 154 MAFLASKN---CIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLP--VK 208
Query: 583 YMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSN----VTKEDMFYLLDWALVLKEQGKL 638
+MAPE T ++DV+S+GI+ EI S SN + + FY L +KE ++
Sbjct: 209 WMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKL-----IKEGYRM 263
Query: 639 MELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLEC 685
+ ++ ++ C +A P RP+ +++++
Sbjct: 264 AQPE-------HAPAEIYDIMKT---CWDADPLKRPTFKQIVQLIGK 300
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 90.8 bits (226), Expect = 4e-20
Identities = 67/249 (26%), Positives = 108/249 (43%), Gaps = 34/249 (13%)
Query: 416 NNFATDNNIGEGGFGPVYKGL-LADGTAIAVKQL--SSKSKQGNREFINEIGMISALQHP 472
N + +GEG +G V K A G +A+K+ S + + + E+ ++ L+H
Sbjct: 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHE 60
Query: 473 NLVKLYGCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGE 532
N+V L +L L++EY+E L L L R + + +AY H
Sbjct: 61 NIVNLKEAFRRKGRLYLVFEYVERTLL-ELLEASPGGLPPDAVRSYIWQLLQAIAYCH-- 117
Query: 533 SRIKVVHRDIKATNVLLDKDLNSKISDFGLAK-LDEEENTHISTRVAGTIGYMAPE---- 587
++HRDIK N+L+ + K+ DFG A+ L + ++ VA T Y APE
Sbjct: 118 -SHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVA-TRWYRAPELLVG 175
Query: 588 YAMRGHLTEKADVYSFGIVALEIVSGR------SNVTKEDMFYLLDWALVLKEQGKL--- 638
G + DV++ G + E++ G S++ D Y L+ K G L
Sbjct: 176 DTNYG---KPVDVWAIGCIMAELLDGEPLFPGDSDI---DQLY-----LIQKCLGPLPPS 224
Query: 639 -MELVDTNP 646
EL +NP
Sbjct: 225 HQELFSSNP 233
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 89.9 bits (223), Expect = 8e-20
Identities = 64/207 (30%), Positives = 105/207 (50%), Gaps = 21/207 (10%)
Query: 424 IGEGGFGPVYKGLLA--DGTA--IAVK--QLSSKSKQGNREFINEIGMISALQHPNLVKL 477
+GEG FG V +G L+ DG+ +AVK +L + EF++E + HPN++KL
Sbjct: 7 LGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKL 66
Query: 478 YGCCIEGNQL------LLIYEYLENNSLARALFEHRL-----KLDWPTRRRICLGIARGL 526
G C E + L ++I ++++ L L RL KL T + + IA G+
Sbjct: 67 IGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGM 126
Query: 527 AYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGT-IGYMA 585
YL S +HRD+ A N +L +D+ ++DFGL+K + + R+A + ++A
Sbjct: 127 EYL---SNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIA 183
Query: 586 PEYAMRGHLTEKADVYSFGIVALEIVS 612
E T K+DV++FG+ EI +
Sbjct: 184 IESLADRVYTSKSDVWAFGVTMWEIAT 210
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 90.0 bits (223), Expect = 1e-19
Identities = 58/190 (30%), Positives = 97/190 (51%), Gaps = 23/190 (12%)
Query: 443 IAVKQL-SSKSKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYEYLENNSLAR 501
+AVK L +K +F+ E+ ++S L+ PN+++L G C++ + L +I EY+EN L +
Sbjct: 49 VAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQ 108
Query: 502 ALFEHRLK------------------LDWPTRRRICLGIARGLAYLHGESRIKVVHRDIK 543
L H L + + + + L IA G+ YL S + VHRD+
Sbjct: 109 FLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYL---SSLNFVHRDLA 165
Query: 544 ATNVLLDKDLNSKISDFGLAK-LDEEENTHISTRVAGTIGYMAPEYAMRGHLTEKADVYS 602
N L+ ++L KI+DFG+++ L + I R I +MA E + G T +DV++
Sbjct: 166 TRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWA 225
Query: 603 FGIVALEIVS 612
FG+ EI+
Sbjct: 226 FGVTLWEILM 235
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 91.0 bits (226), Expect = 1e-19
Identities = 63/208 (30%), Positives = 98/208 (47%), Gaps = 32/208 (15%)
Query: 422 NNIGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQGNREFI-NEIGMISALQHPNLVKLYG 479
N IG G G VYK + G A+K + + R I EI ++ + HPN+VK +
Sbjct: 80 NRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHD 139
Query: 480 CCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVH 539
++ ++ E+++ SL L R+ I G+AYLH R +VH
Sbjct: 140 MFDHNGEIQVLLEFMDGGSLEGTHIADEQFLADVARQ-----ILSGIAYLH---RRHIVH 191
Query: 540 RDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPE------------ 587
RDIK +N+L++ N KI+DFG++++ + ++ V GTI YM+PE
Sbjct: 192 RDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSSV-GTIAYMSPERINTDLNHGAYD 250
Query: 588 -YAMRGHLTEKADVYSFGIVALEIVSGR 614
YA D++S G+ LE GR
Sbjct: 251 GYA--------GDIWSLGVSILEFYLGR 270
|
Length = 353 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 93.4 bits (232), Expect = 2e-19
Identities = 71/243 (29%), Positives = 107/243 (44%), Gaps = 54/243 (22%)
Query: 46 IDLTLNYLSGTIPSQWASLPLLN-ISLIANRLKGPIPKYLANIS-TLVNLTVQYNQFSGE 103
IDL+ +SG I S LP + I+L N+L GPIP + S +L L + N F+G
Sbjct: 74 IDLSGKNISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGS 133
Query: 104 LPEELGSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRISDNQFTGQIPSFIQNWTKLE 163
+P GS+ NLE L LS+N +GE+P +++K + N G+IP+ + N T LE
Sbjct: 134 IPR--GSIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLTNLTSLE 191
Query: 164 KLFIQPSGLAGPIPSGIFSLENLTDLRISDLNGPEATFPQLGNMKMTKLILRNCNITGEL 223
L L + + G++
Sbjct: 192 FL-----------------------------------------------TLASNQLVGQI 204
Query: 224 PRYLGKMTKLKVLDLSFNRLRGQIPSNFDDLYDVDYIYFAGNLLTGAIPPWMLERGDKID 283
PR LG+M LK + L +N L G+IP L ++++ N LTG IP + G+ +
Sbjct: 205 PRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSL---GNLKN 261
Query: 284 LSY 286
L Y
Sbjct: 262 LQY 264
|
Length = 968 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 88.7 bits (220), Expect = 2e-19
Identities = 56/198 (28%), Positives = 87/198 (43%), Gaps = 12/198 (6%)
Query: 424 IGEGGFGPVYKGLLAD-GTAIAVKQLSSK---SKQGNREFINEIGMISALQHPNLVKLYG 479
+G+GGFG V + G A K+L K ++G + +NE ++ + +V L
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60
Query: 480 CCIEGNQLLLIYEYLENNSLARALFEHRLK-LDWPTRRRICLGIARGLAYLHGESRIKVV 538
+ L L+ + L ++ I GL +LH + ++V
Sbjct: 61 AFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLH---QRRIV 117
Query: 539 HRDIKATNVLLDKDLNSKISDFGLA-KLDEEENTHISTRVAGTIGYMAPEYAMRGHLTEK 597
+RD+K NVLLD N +ISD GLA +L + AGT GYMAPE
Sbjct: 118 YRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGR---AGTPGYMAPEVLQGEVYDFS 174
Query: 598 ADVYSFGIVALEIVSGRS 615
D ++ G E+++GRS
Sbjct: 175 VDWFALGCTLYEMIAGRS 192
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 87.7 bits (217), Expect = 3e-19
Identities = 70/283 (24%), Positives = 129/283 (45%), Gaps = 48/283 (16%)
Query: 417 NFATDNNIGEGGFGPVYKGLLADGTA---------IAVKQLSSKSKQGNREFINEIGMIS 467
+ IGEG FG +Y LA + I + ++ K K+ ++ E+ +++
Sbjct: 1 RYEIIKKIGEGSFGKIY---LAKAKSDSEHCVIKEIDLTKMPVKEKEASK---KEVILLA 54
Query: 468 ALQHPNLVKLYGCCIEGNQLLLIYEYLENNSLAR-------ALFEHRLKLDWPTRRRICL 520
++HPN+V + E +L ++ EY + L + LF L W +
Sbjct: 55 KMKHPNIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQ----- 109
Query: 521 GIARGLAYLHGESRIKVVHRDIKATNVLLDKD-LNSKISDFGLAKLDEEENTHISTRVAG 579
I+ GL ++H K++HRDIK+ N+ L K+ + +K+ DFG+A+ ++ ++ G
Sbjct: 110 -ISLGLKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQ-LNDSMELAYTCVG 164
Query: 580 TIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKE-QGKL 638
T Y++PE K D++S G V E+ + + ++ LVLK QG
Sbjct: 165 TPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQ-----LVLKICQGYF 219
Query: 639 MELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLR 681
+ +P + D ++ + SP RPS++S+L+
Sbjct: 220 API---SPNFSRDLRSLISQL------FKVSPRDRPSITSILK 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 87.9 bits (218), Expect = 3e-19
Identities = 81/275 (29%), Positives = 134/275 (48%), Gaps = 34/275 (12%)
Query: 424 IGEGGFGPVYKGLLADGTAI----AVKQLSSKSKQGNRE-FINEIGMISALQHPNLVKLY 478
IG+G FG VY G L D AVK L+ + E F+ E ++ HPN++ L
Sbjct: 3 IGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLL 62
Query: 479 GCCI--EGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRIC---LGIARGLAYLHGES 533
G C+ EG+ L+++ Y+++ L + R + PT + + L +A+G+ YL +
Sbjct: 63 GICLPSEGSPLVVL-PYMKHGDLRNFI---RSETHNPTVKDLIGFGLQVAKGMEYLASK- 117
Query: 534 RIKVVHRDIKATNVLLDKDLNSKISDFGLAK--LDEE-ENTHISTRVAGTIGYMAPEYAM 590
K VHRD+ A N +LD+ K++DFGLA+ D+E + H T + +MA E
Sbjct: 118 --KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQ 175
Query: 591 RGHLTEKADVYSFGIVALEIVS-GRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSN 649
T K+DV+SFG++ E+++ G D F + + L QG+ + + P
Sbjct: 176 TQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLL----QGRRLLQPEYCPDP- 230
Query: 650 FDKEQVMVMINVALLCANASPTIRPSMSSVLRMLE 684
+ V L C + P +RP+ S ++ +E
Sbjct: 231 --------LYEVMLSCWHPKPEMRPTFSELVSRIE 257
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 88.0 bits (218), Expect = 3e-19
Identities = 58/203 (28%), Positives = 93/203 (45%), Gaps = 19/203 (9%)
Query: 424 IGEGGFGPVYKGLLADGTAIA---VKQL-SSKSKQGNREFINEIGMISALQHPNLVKLYG 479
IG G FG V G G + A VK+L +S + F+ E+ L HPN+++ G
Sbjct: 3 IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLG 62
Query: 480 CCIEGNQLLLIYEYLENNSLARALFEHRLKL----DWPTRRRICLGIARGLAYLHGESRI 535
CIE LL+ E+ L L +R + +R+ +A GL +LH +
Sbjct: 63 QCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLH---QA 119
Query: 536 KVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHIST-RVAGTIGYMAPEYAMRGH- 593
+H D+ N L DL+ KI D+GLA E+ +I+ A + ++APE
Sbjct: 120 DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIRGQ 179
Query: 594 ------LTEKADVYSFGIVALEI 610
T+K++++S G+ E+
Sbjct: 180 DLLPKDQTKKSNIWSLGVTMWEL 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 87.7 bits (217), Expect = 5e-19
Identities = 76/283 (26%), Positives = 128/283 (45%), Gaps = 42/283 (14%)
Query: 424 IGEGGFGPVYKGLLAD------GTAIAVKQLSSKSKQGNR-EFINEIGMISALQHPNLVK 476
+G+G FG VY+G D T +AVK ++ + R EF+NE ++ ++V+
Sbjct: 14 LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 73
Query: 477 LYGCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRR---------RICLGIARGLA 527
L G +G L++ E + + L L R + + R ++ IA G+A
Sbjct: 74 LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 133
Query: 528 YLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGT----IGY 583
YL+ + K VHRD+ A N ++ D KI DFG+ + E + + R G + +
Sbjct: 134 YLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYY---RKGGKGLLPVRW 187
Query: 584 MAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLK--EQGKLMEL 641
MAPE G T +D++SFG+V EI S E + L VLK G ++
Sbjct: 188 MAPESLKDGVFTTSSDMWSFGVVLWEITS-----LAEQPYQGLSNEQVLKFVMDGGYLDQ 242
Query: 642 VDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLE 684
D P + ++ +C +P +RP+ ++ +L+
Sbjct: 243 PDNCPER---------VTDLMRMCWQFNPKMRPTFLEIVNLLK 276
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 91.1 bits (226), Expect = 9e-19
Identities = 58/174 (33%), Positives = 95/174 (54%), Gaps = 3/174 (1%)
Query: 21 KRV-LKEQNLTGVLPPKLAELTFLQDIDLTLNYLSGTIPSQWASLPLLN-ISLIANRLKG 78
+RV L++ + +G LP + +L + +D++ N L G I S+ +P L +SL N+ G
Sbjct: 407 RRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFG 466
Query: 79 PIPKYLANISTLVNLTVQYNQFSGELPEELGSLLNLEKLHLSSNNFTGELPKTFAKLTNM 138
+P + L NL + NQFSG +P +LGSL L +L LS N +GE+P + +
Sbjct: 467 GLPDSFGS-KRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKL 525
Query: 139 KDFRISDNQFTGQIPSFIQNWTKLEKLFIQPSGLAGPIPSGIFSLENLTDLRIS 192
+S NQ +GQIP+ L +L + + L+G IP + ++E+L + IS
Sbjct: 526 VSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNIS 579
|
Length = 968 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 85.8 bits (212), Expect = 1e-18
Identities = 74/270 (27%), Positives = 123/270 (45%), Gaps = 32/270 (11%)
Query: 424 IGEGGFGPVYKGLL-ADGTAIAVKQL-SSKSKQGNREFINEIGMISALQHPNLVKLYGCC 481
IG G FG V+ G L AD T +AVK + +F+ E ++ HPN+V+L G C
Sbjct: 3 IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 62
Query: 482 IEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRD 541
+ + ++ E ++ L +L ++ A G+ YL ES+ +HRD
Sbjct: 63 TQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYL--ESK-HCIHRD 119
Query: 542 IKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGT----IGYMAPEYAMRGHLTEK 597
+ A N L+ + KISDFG+++ +EE+ + ST G + + APE G + +
Sbjct: 120 LAARNCLVTEKNVLKISDFGMSR-EEEDGVYAST--GGMKQIPVKWTAPEALNYGRYSSE 176
Query: 598 ADVYSFGIVALEIVSGRS----NVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDKE 653
+DV+SFGI+ E S + N++ + + EQG + + P + +
Sbjct: 177 SDVWSFGILLWEAFSLGAVPYANLSNQQTREAI-------EQGVRLPCPELCPDAVY--- 226
Query: 654 QVMVMINVALLCANASPTIRPSMSSVLRML 683
+ C P RPS S+V + L
Sbjct: 227 ------RLMERCWEYDPGQRPSFSTVHQEL 250
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 86.6 bits (215), Expect = 1e-18
Identities = 62/199 (31%), Positives = 103/199 (51%), Gaps = 16/199 (8%)
Query: 424 IGEGGFGPVYKGL-LADGTAIAVKQ--LSSKSKQGNREFINEIGMISALQHPNLVKLYGC 480
IGEG +G VYK G +A+K+ L ++ + I EI ++ L HPN+V+L
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDV 66
Query: 481 CIEGNQLLLIYEYLENNSLARALFEH-RLKLDWPTRRRICLGIARGLAYLHGESRIKVVH 539
N+L L++E+L + L + + LD P + + +G+AY H +V+H
Sbjct: 67 VHSENKLYLVFEFL-DLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSH---RVLH 122
Query: 540 RDIKATNVLLDKDLNSKISDFGLAK---LDEEENTHISTRVAGTIGYMAPEYAMRG-HLT 595
RD+K N+L+D++ K++DFGLA+ + TH V T+ Y APE + +
Sbjct: 123 RDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTH---EVV-TLWYRAPEILLGSRQYS 178
Query: 596 EKADVYSFGIVALEIVSGR 614
D++S G + E+V+ R
Sbjct: 179 TPVDIWSIGCIFAEMVNRR 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 86.2 bits (213), Expect = 2e-18
Identities = 75/278 (26%), Positives = 129/278 (46%), Gaps = 40/278 (14%)
Query: 424 IGEGGFGPVYKGLLADG-------TAIAVKQLSSKSKQGNR-EFINEIGMISALQHPNLV 475
+G+G FG VY+G+ A G T +A+K ++ + R EF+NE ++ ++V
Sbjct: 14 LGQGSFGMVYEGI-AKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 72
Query: 476 KLYGCCIEGNQLLLIYEYLENNSLARALFEHRLKLDW-------PTRRRICLG--IARGL 526
+L G +G L+I E + L L R +++ ++ I + IA G+
Sbjct: 73 RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGM 132
Query: 527 AYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAG--TIGYM 584
AYL+ K VHRD+ A N ++ +D KI DFG+ + D E + G + +M
Sbjct: 133 AYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR-DIYETDYYRKGGKGLLPVRWM 188
Query: 585 APEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLK--EQGKLMELV 642
+PE G T +DV+SFG+V EI + E + + VL+ +G L++
Sbjct: 189 SPESLKDGVFTTYSDVWSFGVVLWEIAT-----LAEQPYQGMSNEQVLRFVMEGGLLDKP 243
Query: 643 DTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVL 680
D P ++ + +C +P +RPS ++
Sbjct: 244 DNCPD---------MLFELMRMCWQYNPKMRPSFLEII 272
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 86.1 bits (213), Expect = 2e-18
Identities = 68/267 (25%), Positives = 119/267 (44%), Gaps = 34/267 (12%)
Query: 424 IGEGGFGPVYKGL-LADGTAIAVKQLS-SKSKQGNREFINEIGMISALQHPNLVKLYGCC 481
+G G G VYK L +AVK + + + ++ ++E+ ++ P ++ YG
Sbjct: 9 LGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAF 68
Query: 482 IEGNQLLLIYEYLENNSLA--RALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVH 539
N++ + E+++ SL R + EH L RI + + +GL YL +K++H
Sbjct: 69 FVENRISICTEFMDGGSLDVYRKIPEHVLG-------RIAVAVVKGLTYLWS---LKILH 118
Query: 540 RDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPEYAMRGHLTEKAD 599
RD+K +N+L++ K+ DFG++ + I+ GT YMAPE +D
Sbjct: 119 RDVKPSNMLVNTRGQVKLCDFGVST---QLVNSIAKTYVGTNAYMAPERISGEQYGIHSD 175
Query: 600 VYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMEL------VDTNPGSNFDKE 653
V+S GI +E+ GR + + K QG LM L VD +P +
Sbjct: 176 VWSLGISFMELALGR-----------FPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPVGQ 224
Query: 654 QVMVMINVALLCANASPTIRPSMSSVL 680
++ C P RP+ +++
Sbjct: 225 FSEKFVHFITQCMRKQPKERPAPENLM 251
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 85.6 bits (212), Expect = 3e-18
Identities = 66/205 (32%), Positives = 115/205 (56%), Gaps = 14/205 (6%)
Query: 417 NFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQGN-REFINEIGMISALQHPNL 474
NF +GEG + VYKG G +A+K++ +++G I EI ++ L+H N+
Sbjct: 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENI 60
Query: 475 VKLYGCCIEGNQLLLIYEYLENNSLARALFEH--RLKLDWPTRRRICLGIARGLAYLHGE 532
V+L+ N+L+L++EY++ + L + + H R LD T + + +G+A+ H E
Sbjct: 61 VRLHDVIHTENKLMLVFEYMDKD-LKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCH-E 118
Query: 533 SRIKVVHRDIKATNVLLDKDLNSKISDFGLAK-LDEEENTHISTRVAGTIGYMAPEYAM- 590
+R V+HRD+K N+L++K K++DFGLA+ NT + V T+ Y AP+ +
Sbjct: 119 NR--VLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVV--TLWYRAPDVLLG 174
Query: 591 -RGHLTEKADVYSFGIVALEIVSGR 614
R + T D++S G + E+++GR
Sbjct: 175 SRTYSTS-IDIWSVGCIMAEMITGR 198
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 85.8 bits (212), Expect = 3e-18
Identities = 67/209 (32%), Positives = 105/209 (50%), Gaps = 25/209 (11%)
Query: 424 IGEGGFGPVYKGLLA-DGTAI--AVKQLSS-KSKQGNREFINEIGMISAL-QHPNLVKLY 478
IGEG FG V + ++ DG + A+K L S+ +R+F E+ ++ L HPN++ L
Sbjct: 10 IGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLL 69
Query: 479 GCCIEGNQLLLIYEYLENNSLARALFEHR-LKLDWPTRR--------------RICLGIA 523
G C L + EY +L L + R L+ D + + +A
Sbjct: 70 GACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVA 129
Query: 524 RGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGY 583
G+ YL S + +HRD+ A NVL+ ++L SKI+DFGL++ +E R+ + +
Sbjct: 130 TGMQYL---SEKQFIHRDLAARNVLVGENLASKIADFGLSRGEEVYVKKTMGRLP--VRW 184
Query: 584 MAPEYAMRGHLTEKADVYSFGIVALEIVS 612
MA E T K+DV+SFG++ EIVS
Sbjct: 185 MAIESLNYSVYTTKSDVWSFGVLLWEIVS 213
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 85.0 bits (210), Expect = 4e-18
Identities = 64/201 (31%), Positives = 105/201 (52%), Gaps = 15/201 (7%)
Query: 423 NIGEGGFGPVY------KGLLADGTAIAVKQLSSKSKQGN-REFINEIGMISALQHPNLV 475
++GEG FG V +G G +AVK L +S + + EI ++ L H N+V
Sbjct: 11 DLGEGHFGKVELCRYDPEGD-NTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIV 69
Query: 476 KLYGCCIE--GNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGES 533
K G C E GN + LI E+L + SL L ++ K++ + + + I +G+ YL S
Sbjct: 70 KYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLG--S 127
Query: 534 RIKVVHRDIKATNVLLDKDLNSKISDFGLAKL--DEEENTHISTRVAGTIGYMAPEYAMR 591
R + VHRD+ A NVL++ + KI DFGL K ++E + + + + APE ++
Sbjct: 128 R-QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQ 186
Query: 592 GHLTEKADVYSFGIVALEIVS 612
+DV+SFG+ E+++
Sbjct: 187 SKFYIASDVWSFGVTLYELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 85.4 bits (211), Expect = 5e-18
Identities = 87/303 (28%), Positives = 135/303 (44%), Gaps = 73/303 (24%)
Query: 424 IGEGGFGPVYKGLLADG-----------TAIAVKQLSSKSKQGN-REFINEIGMISAL-Q 470
+GEG FG V ++A+ T +AVK L S + + + + I+E+ M+ + +
Sbjct: 26 LGEGCFGQV---VMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 82
Query: 471 HPNLVKLYGCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLG--------- 521
H N++ L G C + L +I EY +L L R P C
Sbjct: 83 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARR-----PPGMEYCYNPTQVPEEQL 137
Query: 522 -----------IARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEEN 570
+ARG+ YL + K +HRD+ A NVL+ +D KI+DFGLA+ +
Sbjct: 138 SFKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLAR----DI 190
Query: 571 THISTRVAGTIG-----YMAPEYAMRGHLTEKADVYSFGIVALEIV----SGRSNVTKED 621
HI T G +MAPE T ++DV+SFG++ EI S V E+
Sbjct: 191 HHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE 250
Query: 622 MFYLLDWALVLKEQGKLMELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLR 681
+F LL ++G M+ P SN E M+M + C +A P+ RP+ ++
Sbjct: 251 LFKLL-------KEGHRMD----KP-SNCTNELYMMMRD----CWHAVPSQRPTFKQLVE 294
Query: 682 MLE 684
L+
Sbjct: 295 DLD 297
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 84.7 bits (209), Expect = 5e-18
Identities = 70/209 (33%), Positives = 99/209 (47%), Gaps = 29/209 (13%)
Query: 424 IGEGGFGPVYKGLLADGTAIAVKQLSSKSKQGNREFINEIGMISAL-QHPNLVKLYGCCI 482
+G G +G VYKG +A ++ ++ E EI M+ H N+ YG I
Sbjct: 24 VGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGAFI 83
Query: 483 E------GNQLLLIYEYLENNS---LARALFEHRLKLDWPTRRRICLGIARGLAYLHGES 533
+ +QL L+ E+ S L + + LK DW IC I RGLA+LH
Sbjct: 84 KKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAY--ICREILRGLAHLHAH- 140
Query: 534 RIKVVHRDIKATNVLLDKDLNSKISDFGL-AKLDE---EENTHISTRVAGTIGYMAPEYA 589
KV+HRDIK NVLL ++ K+ DFG+ A+LD NT I GT +MAPE
Sbjct: 141 --KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI-----GTPYWMAPEVI 193
Query: 590 M-----RGHLTEKADVYSFGIVALEIVSG 613
++D++S GI A+E+ G
Sbjct: 194 ACDENPDATYDYRSDIWSLGITAIEMAEG 222
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 84.2 bits (209), Expect = 6e-18
Identities = 61/201 (30%), Positives = 92/201 (45%), Gaps = 15/201 (7%)
Query: 424 IGEGGFGPVY---KGLLADGTAI-AVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYG 479
I +G +G V+ K D AI +K+ K + + E ++S Q P +VKLY
Sbjct: 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYY 60
Query: 480 CCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVH 539
L L+ EYL LA L E+ LD R I L YLH ++H
Sbjct: 61 SFQGKKNLYLVMEYLPGGDLAS-LLENVGSLDEDVARIYIAEIVLALEYLH---SNGIIH 116
Query: 540 RDIKATNVLLDKDLNSKISDFGLAK--LDEEENTHIST-----RVAGTIGYMAPEYAMRG 592
RD+K N+L+D + + K++DFGL+K L + R+ GT Y+APE +
Sbjct: 117 RDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQ 176
Query: 593 HLTEKADVYSFGIVALEIVSG 613
++ D +S G + E + G
Sbjct: 177 GHSKTVDWWSLGCILYEFLVG 197
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 84.3 bits (208), Expect = 6e-18
Identities = 62/212 (29%), Positives = 97/212 (45%), Gaps = 26/212 (12%)
Query: 424 IGEGGFGPVYKGLL-----ADGTAIAVKQLSS-KSKQGNREFINEIGMISALQHPNLVKL 477
+GE FG +YKG L +A+K L + Q EF E +++ L HPN+V L
Sbjct: 13 LGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCL 72
Query: 478 YGCCIEGNQLLLIYEYLENNSLARALFEH----------------RLKLDWPTRRRICLG 521
G + + +++EYL L L + LD I +
Sbjct: 73 LGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQ 132
Query: 522 IARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAK-LDEEENTHISTRVAGT 580
IA G+ YL VH+D+ A N+L+ + L+ KISD GL++ + + + +
Sbjct: 133 IAAGMEYLSSHF---FVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLP 189
Query: 581 IGYMAPEYAMRGHLTEKADVYSFGIVALEIVS 612
I +M PE M G + +D++SFG+V EI S
Sbjct: 190 IRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 84.3 bits (208), Expect = 7e-18
Identities = 72/229 (31%), Positives = 106/229 (46%), Gaps = 34/229 (14%)
Query: 410 QIKAATNNFATDNNIGEGGFGPVYKGLLADGT------AIAVKQLSSKSKQGNRE-FINE 462
+I +T F + +GE FG VYKG L A+A+K L K++ RE F +E
Sbjct: 1 EINLSTVRFMEE--LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHE 58
Query: 463 IGMISALQHPNLVKLYGCCIEGNQLLLIYEYLENNSLARALFEH---------------R 507
M S LQHPN+V L G + L +I+ Y ++ L L +
Sbjct: 59 AMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVK 118
Query: 508 LKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDE 567
L+ I IA G+ +L S VVH+D+ NVL+ LN KISD GL +
Sbjct: 119 STLEPADFVHIVTQIAAGMEFL---SSHHVVHKDLATRNVLVFDKLNVKISDLGLFR--- 172
Query: 568 EENTHISTRVAGT----IGYMAPEYAMRGHLTEKADVYSFGIVALEIVS 612
E ++ G I +M+PE M G + +D++S+G+V E+ S
Sbjct: 173 EVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 83.9 bits (207), Expect = 8e-18
Identities = 72/281 (25%), Positives = 127/281 (45%), Gaps = 37/281 (13%)
Query: 417 NFATDNNIGEGGFGPVYKGL-LADGTAIAVKQ------LSSKSKQGNREFINEIGMISAL 469
NF + IG G F VY+ L D +A+K+ + +K++Q + + EI ++ L
Sbjct: 3 NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQ---DCVKEIDLLKQL 59
Query: 470 QHPNLVKLYGCCIEGNQLLLIYEYLENNSLARAL--FEHRLKLD-----WPTRRRICLGI 522
HPN++K IE N+L ++ E + L++ + F+ + +L W ++C +
Sbjct: 60 NHPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAV 119
Query: 523 ARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIG 582
H SR +V+HRDIK NV + K+ D GL + + T + V GT
Sbjct: 120 E------HMHSR-RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPY 171
Query: 583 YMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLK-EQGKLMEL 641
YM+PE K+D++S G + E+ + +S + M +L K EQ L
Sbjct: 172 YMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLF---SLCQKIEQCDYPPL 228
Query: 642 VDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRM 682
P ++ ++ + + +C P RP + V ++
Sbjct: 229 ----PTEHYSEK----LRELVSMCIYPDPDQRPDIGYVHQI 261
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 83.6 bits (206), Expect = 1e-17
Identities = 65/209 (31%), Positives = 103/209 (49%), Gaps = 25/209 (11%)
Query: 424 IGEGGFGPVYKGLLA-DGTAI--AVKQLSS-KSKQGNREFINEIGMISAL-QHPNLVKLY 478
IGEG FG V K + DG + A+K++ SK +R+F E+ ++ L HPN++ L
Sbjct: 3 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 62
Query: 479 GCCIEGNQLLLIYEYLENNSLARALFEHR-LKLDWPTRR--------------RICLGIA 523
G C L L EY + +L L + R L+ D +A
Sbjct: 63 GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 122
Query: 524 RGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGY 583
RG+ YL S+ + +HRD+ A N+L+ ++ +KI+DFGL++ E R+ + +
Sbjct: 123 RGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLP--VRW 177
Query: 584 MAPEYAMRGHLTEKADVYSFGIVALEIVS 612
MA E T +DV+S+G++ EIVS
Sbjct: 178 MAIESLNYSVYTTNSDVWSYGVLLWEIVS 206
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 83.8 bits (208), Expect = 1e-17
Identities = 62/199 (31%), Positives = 102/199 (51%), Gaps = 19/199 (9%)
Query: 422 NNIGEGGFGPVYKGL-LADGTAIAVKQLS-SKSKQGNREF-INEIGM---ISALQHPNLV 475
IGEG +G VYK L G +A+K++ S++G + EI + + + +HPN+V
Sbjct: 5 AEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIV 64
Query: 476 KLYGCCI-----EGNQLLLIYEYLENNSLARALFEHRLK-LDWPTRRRICLGIARGLAYL 529
+L C +L L++E+++ + LA L + L T + + + RG+ +L
Sbjct: 65 RLLDVCHGPRTDRELKLTLVFEHVDQD-LATYLSKCPKPGLPPETIKDLMRQLLRGVDFL 123
Query: 530 HGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPEYA 589
H ++VHRD+K N+L+ D KI+DFGLA++ E T V T+ Y APE
Sbjct: 124 HSH---RIVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMA--LTSVVVTLWYRAPEVL 178
Query: 590 MRGHLTEKADVYSFG-IVA 607
++ D++S G I A
Sbjct: 179 LQSSYATPVDMWSVGCIFA 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 82.6 bits (204), Expect = 1e-17
Identities = 69/269 (25%), Positives = 125/269 (46%), Gaps = 37/269 (13%)
Query: 424 IGEGGFGPVYKGL-LADGTAIAVKQLSSK--SKQGNREFINEIGMISALQHPNLVKLYGC 480
+G G FG V+ AD + +KQ+ + +K NE ++ L HPN+++ Y
Sbjct: 8 VGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYEN 67
Query: 481 CIEGNQLLLIYEYLENNSLA-------RALFEHRLKLDWPTRRRICLGIARGLAYLHGES 533
+E L+++ EY +LA +L + L + + I L ++H +
Sbjct: 68 FLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQ------ILLALHHVHTK- 120
Query: 534 RIKVVHRDIKATNVLLDKDLN-SKISDFGLAKLDEEENTHISTRVAGTIGYMAPEYAMRG 592
++HRD+K N+LLDK KI DFG++K+ ++ + V GT Y++PE
Sbjct: 121 --LILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSK--AYTVVGTPCYISPELCEGK 176
Query: 593 HLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLK-EQGKLMELVDTNPGSNFD 651
+K+D+++ G V E+ S + ++ ALVLK G + D S
Sbjct: 177 PYNQKSDIWALGCVLYELASLKRAFEAANLP-----ALVLKIMSGTFAPISDRY--SPDL 229
Query: 652 KEQVMVMINVALLCANASPTIRPSMSSVL 680
++ ++ M+N+ P+ RP +S ++
Sbjct: 230 RQLILSMLNL-------DPSKRPQLSQIM 251
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 83.4 bits (207), Expect = 2e-17
Identities = 66/212 (31%), Positives = 100/212 (47%), Gaps = 32/212 (15%)
Query: 416 NNFATDNNIGEGGFGPVYKGLLADGTAI-AVKQLSS----KSKQGNREFINEIGMISALQ 470
++F +G G FG V A+K LS K KQ +NE ++ +++
Sbjct: 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQ-VEHVLNEKRILQSIR 59
Query: 471 HPNLVKLYGCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIAR------ 524
HP LV LYG + + L L+ EY+ L F H K R +AR
Sbjct: 60 HPFLVNLYGSFQDDSNLYLVMEYVPGGEL----FSHLRK-----SGRFPEPVARFYAAQV 110
Query: 525 --GLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIG 582
L YLH +V+RD+K N+LLD D KI+DFG AK + T+ + GT
Sbjct: 111 VLALEYLHSL---DIVYRDLKPENLLLDSDGYIKITDFGFAKR-VKGRTYT---LCGTPE 163
Query: 583 YMAPEYAM-RGHLTEKADVYSFGIVALEIVSG 613
Y+APE + +G+ + D ++ GI+ E+++G
Sbjct: 164 YLAPEIILSKGY-GKAVDWWALGILIYEMLAG 194
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 82.9 bits (205), Expect = 2e-17
Identities = 64/197 (32%), Positives = 97/197 (49%), Gaps = 16/197 (8%)
Query: 424 IGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQGNREFI-NEIGMISALQHPNLVKLYGCC 481
+G G G V K + GT +A K + +K R+ I E+ ++ + P +V YG
Sbjct: 13 LGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAF 72
Query: 482 IEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIA----RGLAYLHGESRIKV 537
+ N + + E+++ SL R K P I IA GL YL+ RI
Sbjct: 73 LNENNICMCMEFMDCGSLDRIY-----KKGGPIPVEILGKIAVAVVEGLTYLYNVHRI-- 125
Query: 538 VHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPEYAMRGHLTEK 597
+HRDIK +N+L++ K+ DFG++ E N+ T V GT YM+PE G T K
Sbjct: 126 MHRDIKPSNILVNSRGQIKLCDFGVS--GELINSIADTFV-GTSTYMSPERIQGGKYTVK 182
Query: 598 ADVYSFGIVALEIVSGR 614
+DV+S GI +E+ G+
Sbjct: 183 SDVWSLGISIIELALGK 199
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 83.6 bits (207), Expect = 2e-17
Identities = 61/206 (29%), Positives = 100/206 (48%), Gaps = 15/206 (7%)
Query: 417 NFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLS-SKSKQG-NREFINEIGMISALQHPN 473
F N IGEG +G VY+ G +A+K++ + G + EI ++ L+HPN
Sbjct: 8 EFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPN 67
Query: 474 LVKLYGCCIEGNQL---LLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLH 530
+V+L + G L L+ EY E + LA L + + L + RGL YLH
Sbjct: 68 IVELKE-VVVGKHLDSIFLVMEYCEQD-LASLLDNMPTPFSESQVKCLMLQLLRGLQYLH 125
Query: 531 GESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPE--Y 588
++HRD+K +N+LL KI+DFGLA+ ++ +V T+ Y APE
Sbjct: 126 ENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVV-TLWYRAPELLL 181
Query: 589 AMRGHLTEKADVYSFGIVALEIVSGR 614
+ T D+++ G + E+++ +
Sbjct: 182 GCTTY-TTAIDMWAVGCILAELLAHK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 82.9 bits (205), Expect = 2e-17
Identities = 57/203 (28%), Positives = 103/203 (50%), Gaps = 17/203 (8%)
Query: 423 NIGEGGFGPVYKGL-LADGTAIAVKQL-SSKSKQGNREFINE--IGMISALQHPNLVKLY 478
+G G +G V K + GT +AVK++ ++ + Q + + + I M S P V Y
Sbjct: 8 ELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSV-DCPYTVTFY 66
Query: 479 GCCIEGNQLLLIYEYLEN--NSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIK 536
G + + E ++ + + +++ L + +I + I + L YLH S++
Sbjct: 67 GALFREGDVWICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLH--SKLS 124
Query: 537 VVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPE-----YAMR 591
V+HRD+K +NVL++++ K+ DFG++ ++ T AG YMAPE +
Sbjct: 125 VIHRDVKPSNVLINRNGQVKLCDFGIS--GYLVDSVAKTIDAGCKPYMAPERINPELNQK 182
Query: 592 GHLTEKADVYSFGIVALEIVSGR 614
G+ K+DV+S GI +E+ +GR
Sbjct: 183 GY-DVKSDVWSLGITMIELATGR 204
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 82.5 bits (203), Expect = 3e-17
Identities = 69/209 (33%), Positives = 99/209 (47%), Gaps = 29/209 (13%)
Query: 424 IGEGGFGPVYKGLLADGTAIAVKQLSSKSKQGNREFINEIGMISAL-QHPNLVKLYGCCI 482
+G G +G VYKG +A ++ + E EI M+ H N+ YG I
Sbjct: 14 VGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFI 73
Query: 483 EGN------QLLLIYEYLENNSLARALFEHR---LKLDWPTRRRICLGIARGLAYLHGES 533
+ N QL L+ E+ S+ + + LK +W IC I RGL++LH
Sbjct: 74 KKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAY--ICREILRGLSHLHQH- 130
Query: 534 RIKVVHRDIKATNVLLDKDLNSKISDFGL-AKLDE---EENTHISTRVAGTIGYMAPEYA 589
KV+HRDIK NVLL ++ K+ DFG+ A+LD NT I GT +MAPE
Sbjct: 131 --KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI-----GTPYWMAPEVI 183
Query: 590 MRGHLTE-----KADVYSFGIVALEIVSG 613
+ K+D++S GI A+E+ G
Sbjct: 184 ACDENPDATYDFKSDLWSLGITAIEMAEG 212
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 82.8 bits (205), Expect = 3e-17
Identities = 76/237 (32%), Positives = 103/237 (43%), Gaps = 53/237 (22%)
Query: 408 YLQI-----KAATNNFATDNNIGEGGFGPVYKG-LLADGTAIAVKQLSSKSKQGNREFIN 461
YL I A N+ IG G G VYK G +AVKQ+ + GN+E
Sbjct: 2 YLTIDGQKYPADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMR---RTGNKEENK 58
Query: 462 EIGM---ISALQH--PNLVKLYGCCIEGNQLLLIYEYLENNSLARALFEHRLK-LDWPTR 515
I M + H P +VK YG I + + + E L + LK + P
Sbjct: 59 RILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICME------LMSTCLDKLLKRIQGPIP 112
Query: 516 RRICLG-----IARGLAYL---HGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDE 567
I LG I + L YL HG V+HRD+K +N+LLD N K+ DFG++
Sbjct: 113 EDI-LGKMTVAIVKALHYLKEKHG-----VIHRDVKPSNILLDASGNVKLCDFGISGRLV 166
Query: 568 EENTHISTRVAGTIGYMAPE----------YAMRGHLTEKADVYSFGIVALEIVSGR 614
+ TR AG YMAPE Y +R ADV+S GI +E+ +G+
Sbjct: 167 DSKAK--TRSAGCAAYMAPERIDPPDPNPKYDIR------ADVWSLGISLVELATGQ 215
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 83.1 bits (205), Expect = 3e-17
Identities = 88/341 (25%), Positives = 150/341 (43%), Gaps = 62/341 (18%)
Query: 424 IGEGGFGPVY--------KGLLADGTAIAVKQLSSKSKQGN-REFINEIGMISAL-QHPN 473
+GEG FG V K +AVK L + + + ++E+ M+ + +H N
Sbjct: 20 LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKN 79
Query: 474 LVKLYGCCIEGNQLLLIYEYLENNSLARALFEHRLK-LDW-------PTRRRIC------ 519
++ L G C + L ++ EY +L L R +D+ P +
Sbjct: 80 IINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSC 139
Query: 520 -LGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAK----LDEEENTHIS 574
+ARG+ YL + K +HRD+ A NVL+ +D KI+DFGLA+ +D + T
Sbjct: 140 AYQVARGMEYLASQ---KCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKT--- 193
Query: 575 TRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIV----SGRSNVTKEDMFYLLDWAL 630
T + +MAPE T ++DV+SFG++ EI S + E++F LL
Sbjct: 194 TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLL---- 249
Query: 631 VLKEQGKLMELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLECGVDVL 690
++G M+ P +N E M+M C +A P+ RP+ ++ L+ VL
Sbjct: 250 ---KEGHRMD----KP-ANCTHELYMIMRE----CWHAVPSQRPTFKQLVEDLD---RVL 294
Query: 691 DLVSDSSVSDIDETKAEAMRKYYQFCVENTASTTQSTSSIY 731
+ S D+ + +Y C ++ +S + S++
Sbjct: 295 TVTSTDEYLDL----SVPFEQYSPGCPDSPSSCSSGDDSVF 331
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 82.6 bits (205), Expect = 3e-17
Identities = 57/206 (27%), Positives = 96/206 (46%), Gaps = 34/206 (16%)
Query: 417 NFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQGNREFIN-----EIGMISALQ 470
+ +GEG + VYK G +A+K++ ++ ++ IN EI ++ L+
Sbjct: 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELK 60
Query: 471 HPNLVKLYGCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIA------- 523
HPN++ L + + L++E++E + E +K + I L A
Sbjct: 61 HPNIIGLLDVFGHKSNINLVFEFMETD------LEKVIK-----DKSIVLTPADIKSYML 109
Query: 524 ---RGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGT 580
RGL YLH ++HRD+K N+L+ D K++DFGLA+ N ++ +V T
Sbjct: 110 MTLRGLEYLH---SNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVV-T 165
Query: 581 IGYMAPE--YAMRGHLTEKADVYSFG 604
Y APE + R H D++S G
Sbjct: 166 RWYRAPELLFGAR-HYGVGVDMWSVG 190
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 82.7 bits (204), Expect = 4e-17
Identities = 85/294 (28%), Positives = 135/294 (45%), Gaps = 55/294 (18%)
Query: 424 IGEGGFGPVYK----GLLAD----GTAIAVKQLSSKSKQGN-REFINEIGMISAL-QHPN 473
+GEG FG V + G+ +AVK L + + + I+E+ ++ + +H N
Sbjct: 20 LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKN 79
Query: 474 LVKLYGCCIEGNQLLLIYEYLENNSLARALFEHRL---------------KLDWPTRRRI 518
++ L G C + L +I EY +L L R +L +
Sbjct: 80 IINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSC 139
Query: 519 CLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAK----LDEEENTHIS 574
+ARG+ YL ESR + +HRD+ A NVL+ +D KI+DFGLA+ +D + T +
Sbjct: 140 AYQVARGMEYL--ESR-RCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTS-N 195
Query: 575 TRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIV----SGRSNVTKEDMFYLLDWAL 630
R+ + +MAPE T ++DV+SFGI+ EI S + E++F LL
Sbjct: 196 GRLP--VKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEELFKLL---- 249
Query: 631 VLKEQGKLMELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLE 684
+G M+ P SN E M+M C +A PT RP+ ++ L+
Sbjct: 250 ---REGHRMD----KP-SNCTHELYMLMRE----CWHAVPTQRPTFKQLVEALD 291
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 81.1 bits (200), Expect = 6e-17
Identities = 62/203 (30%), Positives = 99/203 (48%), Gaps = 19/203 (9%)
Query: 424 IGEGGFGPVYKGLLADG---TAIAVKQL-SSKSKQGNREFINEIGMISALQHPNLVKLYG 479
IG G FG V G + G + VK+L S S Q +F+ E +LQH NL++ G
Sbjct: 3 IGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLG 62
Query: 480 CCIEGNQLLLIYEYLENNSLARALFEHR----LKLDWPTRRRICLGIARGLAYLHGESRI 535
C E LL+ E+ L L R + D T +R+ IA GL +LH +
Sbjct: 63 QCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLH---KN 119
Query: 536 KVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHI-STRVAGTIGYMAPEYA--MRG 592
+H D+ N LL DL KI D+GL+ +E+ ++ ++ + ++APE + G
Sbjct: 120 NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEVHG 179
Query: 593 HL-----TEKADVYSFGIVALEI 610
+L T++++V+S G+ E+
Sbjct: 180 NLLVVDQTKESNVWSLGVTIWEL 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 80.8 bits (199), Expect = 7e-17
Identities = 74/267 (27%), Positives = 128/267 (47%), Gaps = 30/267 (11%)
Query: 424 IGEGGFGPVYKGLL---ADGTAIAVKQLSSK--SKQGNREFINEIGMISALQHPNLVKLY 478
+G+G +G V L+ DG +K+L+ + S++ + E ++S L+HPN+V Y
Sbjct: 8 VGKGSYGEV--SLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIV-AY 64
Query: 479 GCCIEGN--QLLLIYEYLENNSLARALFEHRLKLDWPTRRRI--CLGIARGLAYLHGESR 534
EG L ++ + E L L E + KL P + + + IA L YLH +
Sbjct: 65 RESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKL-LPENQVVEWFVQIAMALQYLHEK-- 121
Query: 535 IKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPEYAMRGHL 594
++HRD+K NV L + K+ D G+A++ E + ST + GT YM+PE
Sbjct: 122 -HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMASTLI-GTPYYMSPELFSNKPY 179
Query: 595 TEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDKEQ 654
K+DV++ G E+ + + +DM L+ + ++ +GKL + ++ E
Sbjct: 180 NYKSDVWALGCCVYEMATLKHAFNAKDMNSLV-YRII---EGKLPPM-----PKDYSPE- 229
Query: 655 VMVMINVALLCANASPTIRPSMSSVLR 681
+ + +L P RPS+ S+LR
Sbjct: 230 -LGELIATMLSKR--PEKRPSVKSILR 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 7e-17
Identities = 67/201 (33%), Positives = 101/201 (50%), Gaps = 18/201 (8%)
Query: 424 IGEGGFGPVYKGLLAD-GTAIAVKQL--SSKSKQGNREFIN----EIGMISALQHPNLVK 476
+G G FG VY AD G +AVKQ+ S++ ++E +N EI ++ L+H +V+
Sbjct: 10 LGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKE-VNALECEIQLLKNLRHDRIVQ 68
Query: 477 LYGCC--IEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESR 534
YGC E +L + EY+ S+ L + L RR I +G++YLH
Sbjct: 69 YYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYG-ALTENVTRRYTRQILQGVSYLHSN-- 125
Query: 535 IKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEE---ENTHISTRVAGTIGYMAPEYAMR 591
+VHRDIK N+L D N K+ DFG +K + T I + V GT +M+PE
Sbjct: 126 -MIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKS-VTGTPYWMSPEVISG 183
Query: 592 GHLTEKADVYSFGIVALEIVS 612
KADV+S +E+++
Sbjct: 184 EGYGRKADVWSVACTVVEMLT 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 80.8 bits (199), Expect = 7e-17
Identities = 58/195 (29%), Positives = 100/195 (51%), Gaps = 10/195 (5%)
Query: 424 IGEGGFGPVYKG---LLADGTAIAVKQLSSKSKQGNR-EFINEIGMISALQHPNLVKLYG 479
+G G FG V KG + +A+K L +++++ R E + E ++ L +P +V++ G
Sbjct: 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIG 62
Query: 480 CCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVH 539
C E L+L+ E L + L + ++ + ++ G+ YL G++ VH
Sbjct: 63 VC-EAEALMLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKN---FVH 118
Query: 540 RDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGT--IGYMAPEYAMRGHLTEK 597
RD+ A NVLL +KISDFGL+K ++++ R AG + + APE + +
Sbjct: 119 RDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRKFSSR 178
Query: 598 ADVYSFGIVALEIVS 612
+DV+S+GI E S
Sbjct: 179 SDVWSYGITMWEAFS 193
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 80.5 bits (198), Expect = 1e-16
Identities = 60/211 (28%), Positives = 107/211 (50%), Gaps = 20/211 (9%)
Query: 419 ATDNNIGEGGFGPVYKGLLADGTAI---AVK--QLSSKSKQGNREFINEIGMISALQHPN 473
A +GEG FG V +G L +I AVK +++ ++ +F++E + HPN
Sbjct: 2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPN 61
Query: 474 LVKLYGCCIEGNQL------LLIYEYLENNSLARALFEHRL---KLDWPTRR--RICLGI 522
+++L G C++ + ++I ++++ L L RL PT+ + I
Sbjct: 62 VMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDI 121
Query: 523 ARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGT-I 581
A G+ YL +S I HRD+ A N +L++++N ++DFGL+K + + R+A +
Sbjct: 122 ASGMEYLSSKSFI---HRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPV 178
Query: 582 GYMAPEYAMRGHLTEKADVYSFGIVALEIVS 612
++A E T K+DV+SFG+ EI +
Sbjct: 179 KWIAIESLADRVYTTKSDVWSFGVTMWEIAT 209
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 80.8 bits (200), Expect = 2e-16
Identities = 64/227 (28%), Positives = 102/227 (44%), Gaps = 34/227 (14%)
Query: 414 ATNNFATDNNIGEGGFGPVYKGL-LADGTAIAVKQ-LSSKSKQGNREF----INEIGMIS 467
++ +GEG FG VYK + G +A+K+ L K G F + EI ++
Sbjct: 6 KLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDG---FPITALREIKILK 62
Query: 468 ALQHPNLVKLYGCCIE-----GNQLLLIY---EYLENNSLARALFEHRLKLDWPTRRRIC 519
L+HPN+V L +E + +Y Y++++ L+ L +KL +
Sbjct: 63 KLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHD-LSGLLENPSVKLTESQIKCYM 121
Query: 520 LGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEE----------E 569
L + G+ YLH ++HRDIKA N+L+D KI+DFGLA+ +
Sbjct: 122 LQLLEGINYLH---ENHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGG 178
Query: 570 NTHISTRVAGTIGYMAPEYAM--RGHLTEKADVYSFGIVALEIVSGR 614
T T + T Y PE + R + T D++ G V E+ + R
Sbjct: 179 GTRKYTNLVVTRWYRPPELLLGERRYTTA-VDIWGIGCVFAEMFTRR 224
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 80.5 bits (198), Expect = 2e-16
Identities = 77/291 (26%), Positives = 134/291 (46%), Gaps = 49/291 (16%)
Query: 424 IGEGGFGPVY--------KGLLADGTAIAVKQLSSKSKQGN-REFINEIGMISAL-QHPN 473
+GEG FG V K + +AVK L + + + + ++E+ M+ + +H N
Sbjct: 23 LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 82
Query: 474 LVKLYGCCIEGNQLLLIYEYLENNSLARALFEHR---LKLDWPTRR------------RI 518
++ L G C + L +I EY +L L R ++ + R
Sbjct: 83 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSC 142
Query: 519 CLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAK-LDEEENTHISTRV 577
+ARG+ YL + K +HRD+ A NVL+ ++ KI+DFGLA+ ++ + +T
Sbjct: 143 TYQVARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNG 199
Query: 578 AGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIV----SGRSNVTKEDMFYLLDWALVLK 633
+ +MAPE T ++DV+SFG++ EI S + E++F LL
Sbjct: 200 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLL------- 252
Query: 634 EQGKLMELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLE 684
++G M+ P +N E M+M + C +A P+ RP+ ++ L+
Sbjct: 253 KEGHRMD----KP-ANCTNELYMMMRD----CWHAIPSHRPTFKQLVEDLD 294
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 2e-16
Identities = 65/202 (32%), Positives = 100/202 (49%), Gaps = 16/202 (7%)
Query: 424 IGEGGFGPVYKGLLAD-GTAIAVKQLS--SKSKQGNREFIN---EIGMISALQHPNLVKL 477
+G+G FG VY D G +A KQ+ +S + ++E EI ++ LQH +V+
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQY 69
Query: 478 YGCCIE-GNQLLLIY-EYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRI 535
YGC + + L I+ EY+ S+ L + L R+ I G++YLH
Sbjct: 70 YGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYG-ALTESVTRKYTRQILEGMSYLHSN--- 125
Query: 536 KVVHRDIKATNVLLDKDLNSKISDFGLAKLDEE---ENTHISTRVAGTIGYMAPEYAMRG 592
+VHRDIK N+L D N K+ DFG +K + T I + V GT +M+PE
Sbjct: 126 MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRS-VTGTPYWMSPEVISGE 184
Query: 593 HLTEKADVYSFGIVALEIVSGR 614
KADV+S G +E+++ +
Sbjct: 185 GYGRKADVWSLGCTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 79.1 bits (195), Expect = 3e-16
Identities = 60/202 (29%), Positives = 97/202 (48%), Gaps = 26/202 (12%)
Query: 424 IGEGGFGPVYKGLLA----DGTAIAVKQL--SSKSKQGNREFINEIGMISALQHPNLVKL 477
IGEG FG K +L DG +K++ S S + E E+ ++S ++HPN+V+
Sbjct: 8 IGEGSFG---KAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQY 64
Query: 478 YGCCIEGNQLLLIYEYLENNSLAR-------ALFEHRLKLDWPTRRRICLGIARGLAYLH 530
E L ++ +Y E L + LF LDW + ICL L ++H
Sbjct: 65 QESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQ--ICLA----LKHVH 118
Query: 531 GESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPEYAM 590
K++HRDIK+ N+ L KD K+ DFG+A++ ++ GT Y++PE
Sbjct: 119 DR---KILHRDIKSQNIFLTKDGTIKLGDFGIARV-LNSTVELARTCIGTPYYLSPEICE 174
Query: 591 RGHLTEKADVYSFGIVALEIVS 612
K+D+++ G V E+ +
Sbjct: 175 NRPYNNKSDIWALGCVLYEMCT 196
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 79.7 bits (197), Expect = 3e-16
Identities = 80/286 (27%), Positives = 132/286 (46%), Gaps = 57/286 (19%)
Query: 424 IGEGGFGPVYKGLLAD-GTAIAVKQLSSKS-KQGNREFINEIGMISALQH-PNLVKLYG- 479
IG G FG V K L GT +AVK++ S ++ + + ++ ++ P +VK YG
Sbjct: 12 IGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGA 71
Query: 480 ------C--CIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTR--RRICLGIARGLAYL 529
C C+E L+ L+ + ++E LK P +I + + L YL
Sbjct: 72 LFREGDCWICME-----LMDISLDK--FYKYVYEV-LKSVIPEEILGKIAVATVKALNYL 123
Query: 530 HGESRIKVVHRDIKATNVLLDKDLNSKISDFGLA-KLDEEENTHISTRVAGTIGYMAPE- 587
E +K++HRD+K +N+LLD++ N K+ DFG++ +L ++ TR AG YMAPE
Sbjct: 124 KEE--LKIIHRDVKPSNILLDRNGNIKLCDFGISGQL---VDSIAKTRDAGCRPYMAPER 178
Query: 588 --------YAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLM 639
Y +R +DV+S GI E+ +G+ F W V +Q L
Sbjct: 179 IDPSARDGYDVR------SDVWSLGITLYEVATGK--------FPYPKWNSVF-DQ--LT 221
Query: 640 ELVDTNP---GSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRM 682
++V +P ++ ++E +N LC + RP +L
Sbjct: 222 QVVKGDPPILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEH 267
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 8e-16
Identities = 68/214 (31%), Positives = 98/214 (45%), Gaps = 20/214 (9%)
Query: 415 TNNFATDNNIGEGGFGPVYK-GLLADGTAIAVKQLSSKSKQGNREFINEIGMISAL-QHP 472
T+ + IG+G +G VYK DG+ AVK L S + E E ++ +L HP
Sbjct: 21 TDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDV-DEEIEAEYNILQSLPNHP 79
Query: 473 NLVKLYGCCIE-----GNQLLLIYEYLENNS---LARALFEHRLKLDWPTRRRICLGIAR 524
N+VK YG + G QL L+ E S L + L +LD I G
Sbjct: 80 NVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALL 139
Query: 525 GLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYM 584
GL +LH +++HRD+K N+LL + K+ DFG++ +T V GT +M
Sbjct: 140 GLQHLHNN---RIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSV-GTPFWM 195
Query: 585 APEY-----AMRGHLTEKADVYSFGIVALEIVSG 613
APE + DV+S GI A+E+ G
Sbjct: 196 APEVIACEQQYDYSYDARCDVWSLGITAIELGDG 229
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 78.3 bits (193), Expect = 8e-16
Identities = 63/207 (30%), Positives = 105/207 (50%), Gaps = 16/207 (7%)
Query: 417 NFATDNNIGEGGFGPVYKGL-LADGTAIAVKQ--LSSKSKQGNREFINEIGMISALQHPN 473
NF IGEG +G VYK G +A+K+ L ++++ I EI ++ L HPN
Sbjct: 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 60
Query: 474 LVKLYGCCIEGNQLLLIYEYLENNSLARALFEHRLK-LDWPTRRRICLGIARGLAYLHGE 532
+VKL N+L L++E+L + L + + L + P + + +GLA+ H
Sbjct: 61 IVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSH 119
Query: 533 SRIKVVHRDIKATNVLLDKDLNSKISDFGLAK---LDEEENTHISTRVAGTIGYMAPEYA 589
+V+HRD+K N+L++ + K++DFGLA+ + TH T+ Y APE
Sbjct: 120 ---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV----TLWYRAPEIL 172
Query: 590 MRGHLTEKA-DVYSFGIVALEIVSGRS 615
+ A D++S G + E+V+ R+
Sbjct: 173 LGCKYYSTAVDIWSLGCIFAEMVTRRA 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 78.6 bits (194), Expect = 9e-16
Identities = 56/184 (30%), Positives = 89/184 (48%), Gaps = 26/184 (14%)
Query: 422 NNIGEGGFGPVYKGL-LADGTAIAVKQ-LSSKSKQGNREF----INEIGMISALQHPNLV 475
IG+G FG V+K +A+K+ L K+G F + EI ++ L+H N+V
Sbjct: 18 AKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEG---FPITALREIKILQLLKHENVV 74
Query: 476 KLYGCC----IEGN----QLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLA 527
L C N L++E+ E++ LA L +K +++ + GL
Sbjct: 75 NLIEICRTKATPYNRYKGSFYLVFEFCEHD-LAGLLSNKNVKFTLSEIKKVMKMLLNGLY 133
Query: 528 YLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKL----DEEENTHISTRVAGTIGY 583
Y+H R K++HRD+KA N+L+ KD K++DFGLA+ + + RV T+ Y
Sbjct: 134 YIH---RNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVV-TLWY 189
Query: 584 MAPE 587
PE
Sbjct: 190 RPPE 193
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 78.2 bits (193), Expect = 1e-15
Identities = 58/218 (26%), Positives = 104/218 (47%), Gaps = 28/218 (12%)
Query: 424 IGEGGFGPVYKGLLAD-GTAIAVKQL--SSKSKQGNREFINEIGMISALQHPNLVKLYGC 480
IGEG +G V+K + G +A+K+ S + + EI M+ L+HPNLV L
Sbjct: 9 IGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEV 68
Query: 481 CIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHR 540
+L L++EY ++ ++ L ++ + ++I + + + H +HR
Sbjct: 69 FRRKRKLHLVFEYCDH-TVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKH---NCIHR 124
Query: 541 DIKATNVLLDKDLNSKISDFGLAKL----DEEENTHISTRVAGTIGYMAPEYAMRGHLTE 596
D+K N+L+ K K+ DFG A++ ++ +++TR Y APE + G
Sbjct: 125 DVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVATR-----WYRAPEL-LVGDTQY 178
Query: 597 KA--DVYSFGIVALEIVS------GRSNVTKEDMFYLL 626
DV++ G V E+++ G+S+V D YL+
Sbjct: 179 GPPVDVWAIGCVFAELLTGQPLWPGKSDV---DQLYLI 213
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 1e-15
Identities = 64/217 (29%), Positives = 108/217 (49%), Gaps = 25/217 (11%)
Query: 416 NNFATDNNIGEGGFGPVYKGLL-ADGTAI--AVKQLSS-KSKQGNREFINEIGMISAL-Q 470
N+ + IGEG FG V K + DG + A+K++ SK +R+F E+ ++ L
Sbjct: 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 66
Query: 471 HPNLVKLYGCCIEGNQLLLIYEYLENNSL------ARAL-------FEHRLKLDWPTRRR 517
HPN++ L G C L L EY + +L +R L + +++
Sbjct: 67 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 126
Query: 518 ICLG--IARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHIST 575
+ +ARG+ YL S+ + +HRD+ A N+L+ ++ +KI+DFGL++ E
Sbjct: 127 LHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMG 183
Query: 576 RVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVS 612
R+ + +MA E T +DV+S+G++ EIVS
Sbjct: 184 RLP--VRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 218
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 77.5 bits (191), Expect = 1e-15
Identities = 61/201 (30%), Positives = 100/201 (49%), Gaps = 19/201 (9%)
Query: 424 IGEGGFGPVYKGL-LADGTAIAVKQ--LSSKSKQGNREFINEIGMISALQHPNLVKLYGC 480
IGEG +G VYKG G +A+K+ L S+ + I EI ++ LQHPN+V L
Sbjct: 8 IGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDV 67
Query: 481 CIEGNQLLLIYEYLENNSLARAL--FEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVV 538
++ ++L LI+E+L + L + L +D + I +G+ + H +V+
Sbjct: 68 LMQESRLYLIFEFLSMD-LKKYLDSLPKGQYMDAELVKSYLYQILQGILFCH---SRRVL 123
Query: 539 HRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRV----AGTIGYMAPEYAMRGHL 594
HRD+K N+L+D K++DFGLA+ I RV T+ Y APE +
Sbjct: 124 HRDLKPQNLLIDNKGVIKLADFGLAR-----AFGIPVRVYTHEVVTLWYRAPEVLLGSPR 178
Query: 595 -TEKADVYSFGIVALEIVSGR 614
+ D++S G + E+ + +
Sbjct: 179 YSTPVDIWSIGTIFAEMATKK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.1 bits (190), Expect = 1e-15
Identities = 60/199 (30%), Positives = 92/199 (46%), Gaps = 22/199 (11%)
Query: 424 IGEGGFGPVY---KGLLADGTAIAV---KQLSSKSKQGNREFINEIGMISALQHPNLVKL 477
I +G FG VY K D AI V + +K++ N + I MI + P + KL
Sbjct: 4 ISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQG-ESPYVAKL 62
Query: 478 YGCCIEGNQLLLIYEYLENN---SLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESR 534
Y + L L+ EYL SL + L L DW ++ + G+ LH
Sbjct: 63 YYSFQSKDYLYLVMEYLNGGDCASLIKTL--GGLPEDWA--KQYIAEVVLGVEDLHQRG- 117
Query: 535 IKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPEYAMRGHL 594
++HRDIK N+L+D+ + K++DFGL+ N + + GT Y+APE +
Sbjct: 118 --IIHRDIKPENLLIDQTGHLKLTDFGLS-----RNGLENKKFVGTPDYLAPETILGVGD 170
Query: 595 TEKADVYSFGIVALEIVSG 613
+ +D +S G V E + G
Sbjct: 171 DKMSDWWSLGCVIFEFLFG 189
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.7 bits (192), Expect = 2e-15
Identities = 59/216 (27%), Positives = 96/216 (44%), Gaps = 39/216 (18%)
Query: 424 IGEGGFGPVYKGLL---ADGTAIAVKQLSSKSKQG---NREFINEIGMISALQHPNLVKL 477
IG G +G VYK DG A+K+ +Q ++ EI ++ L+H N+V L
Sbjct: 8 IGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSL 67
Query: 478 YGCCIEGNQ--LLLIYEYLENNSLARALFEHRLK----LDWPTRRRICLGIARGLAYLHG 531
+E + L+++Y E++ F HR + + + I G+ YLH
Sbjct: 68 VEVFLEHADKSVYLLFDYAEHDLWQIIKF-HRQAKRVSIPPSMVKSLLWQILNGVHYLHS 126
Query: 532 ESRIKVVHRDIKATNVLLDKDLNS----KISDFGLAKL---------DEEENTHISTRVA 578
V+HRD+K N+L+ + KI D GLA+L D + V
Sbjct: 127 NW---VLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLD-------PVV 176
Query: 579 GTIGYMAPEYAMRG--HLTEKADVYSFGIVALEIVS 612
TI Y APE + G H T+ D+++ G + E+++
Sbjct: 177 VTIWYRAPELLL-GARHYTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 76.9 bits (189), Expect = 2e-15
Identities = 56/194 (28%), Positives = 102/194 (52%), Gaps = 8/194 (4%)
Query: 424 IGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQG-NREFINEIGMISALQHPNLVKLYGCC 481
+GEG + VYKG+ +G +A+K +S K+++G I E ++ L+H N+V L+
Sbjct: 13 LGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDII 72
Query: 482 IEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRD 541
L ++EY+ + LA+ + +H L R + RGLAY+HG+ ++HRD
Sbjct: 73 HTKETLTFVFEYMHTD-LAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQ---HILHRD 128
Query: 542 IKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPEYAMRG-HLTEKADV 600
+K N+L+ K++DFGLA+ + S+ V T+ Y P+ + + D+
Sbjct: 129 LKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVV-TLWYRPPDVLLGATDYSSALDI 187
Query: 601 YSFGIVALEIVSGR 614
+ G + +E++ G+
Sbjct: 188 WGAGCIFIEMLQGQ 201
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 76.7 bits (189), Expect = 3e-15
Identities = 42/144 (29%), Positives = 75/144 (52%), Gaps = 7/144 (4%)
Query: 424 IGEGGFGPVYKGLLAD-GTAIAVK--QLSSKSKQGNREFINEIGMISALQHPNLVKLYGC 480
IGEG +G V+K + +A+K +L + + EI ++ L+H N+V+LY
Sbjct: 8 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDV 67
Query: 481 CIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHR 540
+L L++EY + + L + +D + + +GLA+ H V+HR
Sbjct: 68 LHSDKKLTLVFEYCDQD-LKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSH---NVLHR 123
Query: 541 DIKATNVLLDKDLNSKISDFGLAK 564
D+K N+L++K+ K++DFGLA+
Sbjct: 124 DLKPQNLLINKNGELKLADFGLAR 147
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 79.0 bits (195), Expect = 5e-15
Identities = 57/220 (25%), Positives = 97/220 (44%), Gaps = 34/220 (15%)
Query: 424 IGEGGFGPVYKGL-LADGTAIAVKQLS---SKSKQGNREFINEIGMISALQHPNLVKLYG 479
IG+GG G VY +A+K++ S++ + F+ E + + L HP +V +Y
Sbjct: 10 IGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYS 69
Query: 480 CCIEGNQLLLIYEYLENNSLARAL----------FEHRLKLDWPTRRRICLGIARGLAYL 529
C +G+ + Y+E +L L E K I I + Y+
Sbjct: 70 ICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYV 129
Query: 530 HGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAK---LDEEE--------------NTH 572
H S+ V+HRD+K N+LL I D+G A L+EE+ +
Sbjct: 130 H--SK-GVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSMT 186
Query: 573 ISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVS 612
I ++ GT YMAPE + +E D+Y+ G++ ++++
Sbjct: 187 IPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLT 226
|
Length = 932 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 6e-15
Identities = 55/210 (26%), Positives = 105/210 (50%), Gaps = 12/210 (5%)
Query: 416 NNFATDNNIGEGGFGPVYK-GLLADGTAIAVKQLSSKSKQGNR-EFINEIGMISALQHPN 473
++F + +G G G V K G +A K + + K R + I E+ ++ P
Sbjct: 5 DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 64
Query: 474 LVKLYGCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGES 533
+V YG ++ + E+++ SL + L E + ++ ++ + + RGLAYL +
Sbjct: 65 IVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAK-RIPEEILGKVSIAVLRGLAYLREKH 123
Query: 534 RIKVVHRDIKATNVLLDKDLNSKISDFGLAK--LDEEENTHISTRVAGTIGYMAPEYAMR 591
+I +HRD+K +N+L++ K+ DFG++ +D N+ + TR YM+PE
Sbjct: 124 QI--MHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTR-----SYMSPERLQG 176
Query: 592 GHLTEKADVYSFGIVALEIVSGRSNVTKED 621
H + ++D++S G+ +E+ GR + D
Sbjct: 177 THYSVQSDIWSMGLSLVELAIGRYPIPPPD 206
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 76.4 bits (188), Expect = 6e-15
Identities = 65/200 (32%), Positives = 109/200 (54%), Gaps = 19/200 (9%)
Query: 424 IGEGGFGPVY---KGLLAD-GTAIAVKQLSSKS-KQGNR-EFINEIGMISALQHPNLVKL 477
+G+G FG V+ K D G A+K L + K +R E +++ + HP +VKL
Sbjct: 4 LGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKL 63
Query: 478 -YGCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIK 536
Y EG +L LI ++L L L + + + + + +A L +LH +
Sbjct: 64 HYAFQTEG-KLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLA-ELALALDHLHS---LG 118
Query: 537 VVHRDIKATNVLLDKDLNSKISDFGLAK--LDEEENTHISTRVAGTIGYMAPEYAMR-GH 593
+++RD+K N+LLD++ + K++DFGL+K +D E+ + GT+ YMAPE R GH
Sbjct: 119 IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAY---SFCGTVEYMAPEVVNRRGH 175
Query: 594 LTEKADVYSFGIVALEIVSG 613
T+ AD +SFG++ E+++G
Sbjct: 176 -TQSADWWSFGVLMFEMLTG 194
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 9e-15
Identities = 61/216 (28%), Positives = 105/216 (48%), Gaps = 25/216 (11%)
Query: 424 IGEGGFGPVYKGL--LADGTAIAVKQLSSKSKQGNR-EFINEIGMISALQHPNLVKLYGC 480
+GEG + V+KG L + +A+K++ + ++G I E+ ++ L+H N+V L+
Sbjct: 14 LGEGTYATVFKGRSKLTE-NLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 72
Query: 481 CIEGNQLLLIYEYLENN------SLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESR 534
L L++EYL+ + + H +K+ I RGLAY H R
Sbjct: 73 VHTDKSLTLVFEYLDKDLKQYMDDCGNIMSMHNVKI-------FLYQILRGLAYCH---R 122
Query: 535 IKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPEYAM-RGH 593
KV+HRD+K N+L+++ K++DFGLA+ S V T+ Y P+ +
Sbjct: 123 RKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVV-TLWYRPPDVLLGSSE 181
Query: 594 LTEKADVYSFGIVALEIVSGR---SNVTKEDMFYLL 626
+ + D++ G + E+ SGR T ED +L+
Sbjct: 182 YSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLI 217
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 77.2 bits (190), Expect = 1e-14
Identities = 71/269 (26%), Positives = 116/269 (43%), Gaps = 53/269 (19%)
Query: 500 ARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISD 559
R EH L L I LA H S+ ++HRDIK+ N+LL + K+ D
Sbjct: 137 NRTFREHEAGL---------LFIQVLLAVHHVHSK-HMIHRDIKSANILLCSNGLVKLGD 186
Query: 560 FGLAKLDEEENTHISTRVAGTIG--------YMAPEYAMRGHLTEKADVYSFGIVALEIV 611
FG +K + V+ +G Y+APE R ++KAD++S G++ E++
Sbjct: 187 FGFSK-------MYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELL 239
Query: 612 SGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDKEQVMVMINVALLCANASPT 671
+ + E+M ++ L G+ L + E M I ALL ++ P
Sbjct: 240 TLKRPFDGENMEEVMHKTLA----GRYDPLPP-----SISPE--MQEIVTALLSSD--PK 286
Query: 672 IRPSMSSVLRMLECGV---DVLDLVS----------DSSVSDIDETKAE--AMRKYYQFC 716
RPS S +L M C + +L++V D+ I +TK R+
Sbjct: 287 RRPSSSKLLNMPICKLFISGLLEIVQTQPGFSGPLRDTISRQIQQTKQLLQVERRRIVRQ 346
Query: 717 VENTASTTQSTSSIYGPPPGSSTAGVDLH 745
+E + ST ST+ + G P ++ G+ L+
Sbjct: 347 MEESLSTAASTTILEGATPLTTLGGLTLY 375
|
Length = 496 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 75.0 bits (184), Expect = 1e-14
Identities = 57/208 (27%), Positives = 103/208 (49%), Gaps = 27/208 (12%)
Query: 424 IGEGGFGPVYKG--LLADGTAIAVKQLSSKSKQGNREF--INEIGMISALQ---HPNLVK 476
IGEG +G V+K L G +A+K++ ++ + I E+ ++ L+ HPN+V+
Sbjct: 9 IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 68
Query: 477 LYGCCI-----EGNQLLLIYEYLENNSLARALFEHRLKLDWP-----TRRRICLGIARGL 526
L+ C +L L++E+++ + L + K+ P T + + + RGL
Sbjct: 69 LFDVCTVSRTDRETKLTLVFEHVDQD-----LTTYLDKVPEPGVPTETIKDMMFQLLRGL 123
Query: 527 AYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAP 586
+LH +VVHRD+K N+L+ K++DFGLA++ + T V T+ Y AP
Sbjct: 124 DFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQ--MALTSVVVTLWYRAP 178
Query: 587 EYAMRGHLTEKADVYSFGIVALEIVSGR 614
E ++ D++S G + E+ +
Sbjct: 179 EVLLQSSYATPVDLWSVGCIFAEMFRRK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 1e-14
Identities = 63/203 (31%), Positives = 102/203 (50%), Gaps = 18/203 (8%)
Query: 424 IGEGGFGPVYKGLLAD-GTAIAVKQL--SSKSKQGNREFIN----EIGMISALQHPNLVK 476
+G+G FG VY AD G +AVKQ+ +S + ++E +N EI ++ L H +V+
Sbjct: 10 LGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKE-VNALECEIQLLKNLLHERIVQ 68
Query: 477 LYGCCIEGNQ--LLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESR 534
YGC + + L + E++ S+ L + L R+ I G++YLH
Sbjct: 69 YYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYG-ALTENVTRKYTRQILEGVSYLHSN-- 125
Query: 535 IKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEE---ENTHISTRVAGTIGYMAPEYAMR 591
+VHRDIK N+L D N K+ DFG +K + T + + V GT +M+PE
Sbjct: 126 -MIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKS-VTGTPYWMSPEVISG 183
Query: 592 GHLTEKADVYSFGIVALEIVSGR 614
KAD++S G +E+++ +
Sbjct: 184 EGYGRKADIWSVGCTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 74.9 bits (184), Expect = 1e-14
Identities = 62/205 (30%), Positives = 99/205 (48%), Gaps = 27/205 (13%)
Query: 424 IGEGGFGPVYKGL-LADGTAIAVKQ--LSSKSKQGNREFINEIGMISALQHPNLVKLYGC 480
IGEG +G VYK IA+K+ L + + I EI ++ +QH N+V+L
Sbjct: 10 IGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDV 69
Query: 481 CIEGNQLLLIYEYLE------NNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESR 534
+L L++EYL+ +S RL + I RG+AY H
Sbjct: 70 VHSEKRLYLVFEYLDLDLKKHMDSSPDFAKNPRLI------KTYLYQILRGIAYCHSH-- 121
Query: 535 IKVVHRDIKATNVLLDKDLNS-KISDFGLAK---LDEEENTHISTRVAGTIGYMAPEYAM 590
+V+HRD+K N+L+D+ N+ K++DFGLA+ + TH T+ Y APE +
Sbjct: 122 -RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVV----TLWYRAPEILL 176
Query: 591 RG-HLTEKADVYSFGIVALEIVSGR 614
H + D++S G + E+V+ +
Sbjct: 177 GSRHYSTPVDIWSVGCIFAEMVNQK 201
|
Length = 294 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 1e-14
Identities = 55/204 (26%), Positives = 96/204 (47%), Gaps = 21/204 (10%)
Query: 417 NFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLV 475
+F IG G +G VYK + G A+K + + + EI M+ +H N+V
Sbjct: 10 DFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIV 69
Query: 476 KLYGCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRI 535
+G + ++L + E+ SL + ++ L + +GL YLH + ++
Sbjct: 70 AYFGSYLRRDKLWICMEFCGGGSL-QDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGKM 128
Query: 536 KVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVA------GTIGYMAPEYA 589
HRDIK N+LL + + K++DFG++ I+ +A GT +MAPE A
Sbjct: 129 ---HRDIKGANILLTDNGHVKLADFGVS-------AQITATIAKRKSFIGTPYWMAPEVA 178
Query: 590 M---RGHLTEKADVYSFGIVALEI 610
+G + D+++ GI A+E+
Sbjct: 179 AVERKGGYNQLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 1e-14
Identities = 65/200 (32%), Positives = 95/200 (47%), Gaps = 15/200 (7%)
Query: 424 IGEGGFGPVYKGLLAD-GTAIAVKQLSSKS---KQGNREFINE---IGMISALQHPNLVK 476
IG GGFG VY AD G A+K L K KQG +NE + ++S P +V
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61
Query: 477 LYGCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIK 536
+ ++L I + + L L +H + R I GL ++H
Sbjct: 62 MTYAFHTPDKLCFILDLMNGGDLHYHLSQHGV-FSEKEMRFYATEIILGLEHMHNRF--- 117
Query: 537 VVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPEYAMRGHLTE 596
VV+RD+K N+LLD+ + +ISD GLA ++ H S GT GYMAPE +G +
Sbjct: 118 VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GTHGYMAPEVLQKGTAYD 174
Query: 597 -KADVYSFGIVALEIVSGRS 615
AD +S G + +++ G S
Sbjct: 175 SSADWFSLGCMLFKLLRGHS 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 1e-14
Identities = 61/198 (30%), Positives = 95/198 (47%), Gaps = 12/198 (6%)
Query: 424 IGEGGFGPVYK-GLLADGTAIAVKQLSSK---SKQGNREFINEIGMISALQHPNLVKLYG 479
+G+GGFG V + A G A K+L K ++G +NE ++ + +V L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAY 67
Query: 480 CCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLG--IARGLAYLHGESRIKV 537
+ L L+ + L ++ H + + R + I GL LH E ++
Sbjct: 68 AYETKDALCLVLTLMNGGDLKFHIY-HMGEAGFEEGRAVFYAAEICCGLEDLHQE---RI 123
Query: 538 VHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPEYAMRGHLTEK 597
V+RD+K N+LLD + +ISD GLA E T I RV GT+GYMAPE T
Sbjct: 124 VYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT-IKGRV-GTVGYMAPEVVKNERYTFS 181
Query: 598 ADVYSFGIVALEIVSGRS 615
D ++ G + E+++G+S
Sbjct: 182 PDWWALGCLLYEMIAGQS 199
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 74.0 bits (182), Expect = 2e-14
Identities = 55/195 (28%), Positives = 95/195 (48%), Gaps = 11/195 (5%)
Query: 424 IGEGGFGPVYKGLLAD-GTAIAVKQL--SSKSKQGNREFINEIGMISALQHPNLVKLYGC 480
+GEG +G V K + G +A+K+ S K + + EI M+ L+H NLV L
Sbjct: 9 VGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEV 68
Query: 481 CIEGNQLLLIYEYLENNSLAR-ALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVH 539
+L L++E++++ L + + LD R+ I RG+ + H + ++H
Sbjct: 69 FRRKKRLYLVFEFVDHTVLDDLEKYPN--GLDESRVRKYLFQILRGIEFCHSHN---IIH 123
Query: 540 RDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPEYAMRGHLTEKA- 598
RDIK N+L+ + K+ DFG A+ + VA T Y APE + +A
Sbjct: 124 RDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYVA-TRWYRAPELLVGDTKYGRAV 182
Query: 599 DVYSFGIVALEIVSG 613
D+++ G + E+++G
Sbjct: 183 DIWAVGCLVTEMLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 73.4 bits (181), Expect = 2e-14
Identities = 64/221 (28%), Positives = 102/221 (46%), Gaps = 14/221 (6%)
Query: 424 IGEGGFGPVYK-GLLADGTAIAVKQLSSKSKQGNR--EFI-NEIGMISALQHPNLVKLYG 479
+G GGFG V + + A+K + + E I +E ++ HP +VKLY
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60
Query: 480 CCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVH 539
+ + ++ EY L L + L D T R + YLH +++
Sbjct: 61 TFKDKKYIYMLMEYCLGGELWTILRDRGL-FDEYTARFYIACVVLAFEYLH---NRGIIY 116
Query: 540 RDIKATNVLLDKDLNSKISDFGLAK-LDEEENTHISTRVAGTIGYMAPEYAM-RGHLTEK 597
RD+K N+LLD + K+ DFG AK L + T T GT Y+APE + +G+
Sbjct: 117 RDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTW--TFC-GTPEYVAPEIILNKGY-DFS 172
Query: 598 ADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKL 638
D +S GI+ E+++GR ++D + + +LK GKL
Sbjct: 173 VDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKL 213
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 74.8 bits (184), Expect = 3e-14
Identities = 59/210 (28%), Positives = 103/210 (49%), Gaps = 25/210 (11%)
Query: 424 IGEGGFGPVYKGLLAD-GTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLY---- 478
+G G G V+ + +D +AVK++ Q + + EI +I L H N+VK+Y
Sbjct: 13 LGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLG 72
Query: 479 ----------GCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAY 528
G E N + ++ EY+E + LA L + L + R + RGL Y
Sbjct: 73 PSGSDLTEDVGSLTELNSVYIVQEYMETD-LANVLEQGPLSEEHA--RLFMYQLLRGLKY 129
Query: 529 LHGESRIKVVHRDIKATNVLLD-KDLNSKISDFGLAKLDEEENTHISTRVAGTIG--YMA 585
+H + V+HRD+K NV ++ +DL KI DFGLA++ + +H G + Y +
Sbjct: 130 IHSAN---VLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRS 186
Query: 586 PEYAMR-GHLTEKADVYSFGIVALEIVSGR 614
P + + T+ D+++ G + E+++G+
Sbjct: 187 PRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 216
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 3e-14
Identities = 61/210 (29%), Positives = 103/210 (49%), Gaps = 17/210 (8%)
Query: 409 LQIKAATNNFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQGNREFI--NEIGM 465
+ + +++ +G G +G VYK L G AVK + K + G+ + EI M
Sbjct: 2 ILRRNPQHDYELIQRVGSGTYGDVYKARNLHTGELAAVKII--KLEPGDDFSLIQQEIFM 59
Query: 466 ISALQHPNLVKLYGCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARG 525
+ +H N+V +G + +L + EY SL + ++ L +C +G
Sbjct: 60 VKECKHCNIVAYFGSYLSREKLWICMEYCGGGSL-QDIYHVTGPLSELQIAYVCRETLQG 118
Query: 526 LAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVA--GTIGY 583
LAYLH + ++ HRDIK N+LL + + K++DFG+A + I+ R + GT +
Sbjct: 119 LAYLHSKGKM---HRDIKGANILLTDNGDVKLADFGVAA---KITATIAKRKSFIGTPYW 172
Query: 584 MAPEYAM---RGHLTEKADVYSFGIVALEI 610
MAPE A G + D+++ GI A+E+
Sbjct: 173 MAPEVAAVEKNGGYNQLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 73.0 bits (179), Expect = 3e-14
Identities = 74/274 (27%), Positives = 130/274 (47%), Gaps = 41/274 (14%)
Query: 424 IGEGGFGPVYKGLLADGTAIAVKQLS------------SKSKQGNREFINEIGMISALQH 471
+G+G FG VY L+ D A+A ++L +++ Q N+E ++S L H
Sbjct: 8 LGKGSFGTVY--LVKDKKAVAEERLKVLKEIPVGELNPNETVQANQE----AQLLSKLDH 61
Query: 472 PNLVKLYGCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRIC---LGIARGLAY 528
P +VK + +E + +I EY E L L E + + ++C + + G+ Y
Sbjct: 62 PAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHY 121
Query: 529 LHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPEY 588
+H + RI +HRD+KA N+ L +L KI DFG+++L + ++T GT YM+PE
Sbjct: 122 MH-QRRI--LHRDLKAKNIFLKNNL-LKIGDFGVSRL-LMGSCDLATTFTGTPYYMSPEA 176
Query: 589 AMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLK-EQGKLMELVDTNPG 647
K+D++S G + E+ ++ ++VL+ +G L +T
Sbjct: 177 LKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFL-----SVVLRIVEGPTPSLPETYS- 230
Query: 648 SNFDKEQVMVMINVALLCANASPTIRPSMSSVLR 681
Q+ ++ L N P++RPS + +LR
Sbjct: 231 -----RQLNSIMQSML---NKDPSLRPSAAEILR 256
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 74.1 bits (182), Expect = 3e-14
Identities = 52/158 (32%), Positives = 78/158 (49%), Gaps = 7/158 (4%)
Query: 465 MISALQHPNLVKLYGCCIEGNQ-LLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIA 523
+ A +HP L L+ C + + L + EYL L + + + D R I
Sbjct: 49 LALAWEHPFLTHLF-CTFQTKEHLFFVMEYLNGGDLMFHI-QSSGRFDEARARFYAAEII 106
Query: 524 RGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGY 583
GL +LH + +++RD+K NVLLDKD + KI+DFG+ K + ST GT Y
Sbjct: 107 CGLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKAST-FCGTPDY 162
Query: 584 MAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKED 621
+APE E D +SFG++ E++ G+S ED
Sbjct: 163 IAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGED 200
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 3e-14
Identities = 64/205 (31%), Positives = 95/205 (46%), Gaps = 20/205 (9%)
Query: 424 IGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQGNREFINEIGMISALQ-HPNLVKLYGC- 480
IG+G +G V+K L +G+ AVK L + E E ++ AL HPN+VK YG
Sbjct: 26 IGKGTYGKVFKVLNKKNGSKAAVKILDP-IHDIDEEIEAEYNILKALSDHPNVVKFYGMY 84
Query: 481 ----CIEGNQLLLIYEYLENNS---LARALFEHRLKLDWPTRRRICLGIARGLAYLHGES 533
G+QL L+ E S L + + +++ P I GL +LH
Sbjct: 85 YKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVN- 143
Query: 534 RIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPEY----- 588
K +HRD+K N+LL + K+ DFG++ +T V GT +MAPE
Sbjct: 144 --KTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSV-GTPFWMAPEVIACEQ 200
Query: 589 AMRGHLTEKADVYSFGIVALEIVSG 613
+ + DV+S GI A+E+ G
Sbjct: 201 QLDSTYDARCDVWSLGITAIELGDG 225
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 73.0 bits (179), Expect = 4e-14
Identities = 58/208 (27%), Positives = 97/208 (46%), Gaps = 30/208 (14%)
Query: 424 IGEGGFGPVYKGLLADGTAIA---VKQL--SSKSKQGNREFINEIGMISALQHPNLVKLY 478
IG G FG V + T +A VK+L ++ SK+ N EF+ + LQHPN+++
Sbjct: 3 IGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQN-EFLQQGDPYRILQHPNILQCL 61
Query: 479 GCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTR-------RRICLGIARGLAYLHG 531
G C+E LL++EY E L L + W R +R+ IA G+ ++H
Sbjct: 62 GQCVEAIPYLLVFEYCELGDLKSYLSQE----QWHRRNSQLLLLQRMACEIAAGVTHMH- 116
Query: 532 ESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHIST--RVAGTIGYMAPEYA 589
+ +H D+ N L DL K+ D+G+ +E+ +I T + ++APE
Sbjct: 117 --KHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKED-YIETEDDKCVPLRWLAPELV 173
Query: 590 MRGH-------LTEKADVYSFGIVALEI 610
H T+ ++V++ G+ E+
Sbjct: 174 GEFHGGLITAEQTKPSNVWALGVTLWEL 201
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 4e-14
Identities = 59/196 (30%), Positives = 95/196 (48%), Gaps = 12/196 (6%)
Query: 424 IGEGGFGPVYKG---LLADGTAIAVKQLSSKSKQG--NREFINEIGMISALQHPNLVKLY 478
+G G FG V KG + +AVK L + + E + E ++ L +P +V++
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62
Query: 479 GCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVV 538
G C E +L+ E E L + L +++ + + ++ G+ YL + V
Sbjct: 63 GIC-EAESWMLVMELAELGPLNKFLQKNKHVTE-KNITELVHQVSMGMKYLEETN---FV 117
Query: 539 HRDIKATNVLLDKDLNSKISDFGLAK-LDEEENTH-ISTRVAGTIGYMAPEYAMRGHLTE 596
HRD+ A NVLL +KISDFGL+K L +EN + T + + APE +
Sbjct: 118 HRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYKFSS 177
Query: 597 KADVYSFGIVALEIVS 612
K+DV+SFG++ E S
Sbjct: 178 KSDVWSFGVLMWEAFS 193
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 5e-14
Identities = 63/198 (31%), Positives = 95/198 (47%), Gaps = 16/198 (8%)
Query: 424 IGEGGFGPVYKGLLA----DGTAIAVKQLSSKS---KQGNREFINEIG-MISALQHPNLV 475
IG+G FG V LLA + AVK L K+ K+ + ++E ++ ++HP LV
Sbjct: 3 IGKGSFGKV---LLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLV 59
Query: 476 KLYGCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRI 535
L+ ++L + +Y+ L L R L+ P R IA L YLH +
Sbjct: 60 GLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLE-PRARFYAAEIASALGYLHS---L 115
Query: 536 KVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPEYAMRGHLT 595
+V+RD+K N+LLD + ++DFGL K + E N ST GT Y+APE +
Sbjct: 116 NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTST-FCGTPEYLAPEVLHKQPYD 174
Query: 596 EKADVYSFGIVALEIVSG 613
D + G V E++ G
Sbjct: 175 RTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 72.8 bits (179), Expect = 5e-14
Identities = 53/214 (24%), Positives = 98/214 (45%), Gaps = 42/214 (19%)
Query: 426 EGGFGPVYKGLLADGT-----AIAVKQLSSKSKQGNRE-FINEIGMISALQHPNLVKLYG 479
EG FG ++ G+L D + VK + + + + E ++ L H N++ +
Sbjct: 16 EGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILH 75
Query: 480 CCIEGNQ---LLLIYE-------YLENNSLARALFEHRLKLDWPTRRRICLG--IARGLA 527
CIE + +L Y +L+ L A L T++ + + IA G++
Sbjct: 76 VCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALS----TQQLVHMAIQIACGMS 131
Query: 528 YLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAK---------LDEEENTHISTRVA 578
YLH + V+H+DI A N ++D++L KI+D L++ L + EN +
Sbjct: 132 YLH---KRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPVK---- 184
Query: 579 GTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVS 612
+MA E + + +DV+SFG++ E+++
Sbjct: 185 ----WMALESLVNKEYSSASDVWSFGVLLWELMT 214
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 75.7 bits (186), Expect = 6e-14
Identities = 56/197 (28%), Positives = 93/197 (47%), Gaps = 23/197 (11%)
Query: 440 GTAIAVKQLSSKSKQGNRE---FINEIGMISALQHPNLVKLY--GCCIEGNQLLLIYEYL 494
G +A+K L + + + + F E + + L HPN+V L G G L ++EY+
Sbjct: 3 GHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPG-LLFAVFEYV 61
Query: 495 ENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLL---DK 551
+L R + L R+ L + LA H +VHRD+K N+++
Sbjct: 62 PGRTL-REVLAADGALPAGETGRLMLQVLDALACAH---NQGIVHRDLKPQNIMVSQTGV 117
Query: 552 DLNSKISDFGLAKL-------DEEENTHISTRVAGTIGYMAPEYAMRGH-LTEKADVYSF 603
++K+ DFG+ L D T +T V GT Y APE +RG +T +D+Y++
Sbjct: 118 RPHAKVLDFGIGTLLPGVRDADVATLT-RTTEVLGTPTYCAPE-QLRGEPVTPNSDLYAW 175
Query: 604 GIVALEIVSGRSNVTKE 620
G++ LE ++G+ V
Sbjct: 176 GLIFLECLTGQRVVQGA 192
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 73.6 bits (181), Expect = 6e-14
Identities = 39/112 (34%), Positives = 59/112 (52%), Gaps = 10/112 (8%)
Query: 522 IARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTI 581
I RGL YLH ++HRDIK N+L++ + KI DFGLA+++E + + T+ T
Sbjct: 112 ILRGLKYLHSA---GILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQ 168
Query: 582 GYMAPEYAMRG-HLTEKADVYSFGIVALEIVSGR------SNVTKEDMFYLL 626
Y APE M H T D++S G + E++ R S + + D+ L
Sbjct: 169 YYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDL 220
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 6e-14
Identities = 57/203 (28%), Positives = 100/203 (49%), Gaps = 22/203 (10%)
Query: 422 NNIGEGGFGPVYKGL--LADGTAIAVKQLSSKSKQGNR-EFINEIGMISALQHPNLVKLY 478
+ +GEG + VYKG L D +A+K++ + ++G I E+ ++ L+H N+V L+
Sbjct: 12 DKLGEGTYATVYKGRSKLTD-NLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLH 70
Query: 479 GCCIEGNQLLLIYEYLENN------SLARALFEHRLKLDWPTRRRICLGIARGLAYLHGE 532
L L++EYL+ + ++ H +KL + RGL Y H
Sbjct: 71 DIIHTEKSLTLVFEYLDKDLKQYLDDCGNSINMHNVKL-------FLFQLLRGLNYCH-- 121
Query: 533 SRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPEYAM-R 591
R KV+HRD+K N+L+++ K++DFGLA+ S V T+ Y P+ +
Sbjct: 122 -RRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVV-TLWYRPPDILLGS 179
Query: 592 GHLTEKADVYSFGIVALEIVSGR 614
+ + D++ G + E+ +GR
Sbjct: 180 TDYSTQIDMWGVGCIFYEMSTGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.1 bits (180), Expect = 7e-14
Identities = 60/205 (29%), Positives = 98/205 (47%), Gaps = 24/205 (11%)
Query: 424 IGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQ--GNREFINEIGMISALQHPNLVKLYGC 480
IGEG +G V G +A+K++S Q R + EI ++ +H N++ +
Sbjct: 13 IGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRT-LREIKILRRFKHENIIGILDI 71
Query: 481 CIEG-----NQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICL---GIARGLAYLHGE 532
N + ++ E +E + L + + L D I I RGL Y+H
Sbjct: 72 IRPPSFESFNDVYIVQELMETD-LYKLIKTQHLSND-----HIQYFLYQILRGLKYIHSA 125
Query: 533 SRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLD--EEENTHISTRVAGTIGYMAPEYAM 590
+ V+HRD+K +N+LL+ + + KI DFGLA++ E ++T T T Y APE +
Sbjct: 126 N---VLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATRWYRAPEIML 182
Query: 591 RGHLTEKA-DVYSFGIVALEIVSGR 614
KA D++S G + E++S R
Sbjct: 183 NSKGYTKAIDIWSVGCILAEMLSNR 207
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 72.3 bits (177), Expect = 7e-14
Identities = 65/200 (32%), Positives = 94/200 (47%), Gaps = 15/200 (7%)
Query: 424 IGEGGFGPVYKGLLAD-GTAIAVKQLSSKS---KQGNREFINE---IGMISALQHPNLVK 476
IG GGFG VY AD G A+K L K KQG +NE + ++S P +V
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61
Query: 477 LYGCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIK 536
+ ++L I + + L L +H + R I GL ++H
Sbjct: 62 MSYAFHTPDKLSFILDLMNGGDLHYHLSQHGV-FSEAEMRFYAAEIILGLEHMHNRF--- 117
Query: 537 VVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPEYAMRG-HLT 595
VV+RD+K N+LLD+ + +ISD GLA ++ H S GT GYMAPE +G
Sbjct: 118 VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GTHGYMAPEVLQKGVAYD 174
Query: 596 EKADVYSFGIVALEIVSGRS 615
AD +S G + +++ G S
Sbjct: 175 SSADWFSLGCMLFKLLRGHS 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 7e-14
Identities = 62/218 (28%), Positives = 100/218 (45%), Gaps = 19/218 (8%)
Query: 417 NFATDNNIGEGGFGPVY----KGLLADGTAIAVKQLSSKS---KQGNREFI-NEIGMISA 468
NF +G G +G V+ G G A+K L + K E E ++ A
Sbjct: 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEA 60
Query: 469 LQH-PNLVKLYGCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLG-IARGL 526
++ P LV L+ +L LI +Y+ L L+ R + R+ + I L
Sbjct: 61 VRRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLY-QREHFT-ESEVRVYIAEIVLAL 118
Query: 527 AYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAP 586
+LH ++ +++RDIK N+LLD + + ++DFGL+K E + GTI YMAP
Sbjct: 119 DHLH---QLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAP 175
Query: 587 EYAMR---GHLTEKADVYSFGIVALEIVSGRSNVTKED 621
E GH + D +S G++ E+++G S T +
Sbjct: 176 EVIRGGSGGH-DKAVDWWSLGVLTFELLTGASPFTVDG 212
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 9e-14
Identities = 62/198 (31%), Positives = 91/198 (45%), Gaps = 16/198 (8%)
Query: 424 IGEGGFGPVYKGLLA----DGTAIAVKQLSSKS----KQGNREFINEIGMISALQHPNLV 475
IG+G FG V LLA DG+ AVK L K+ K+ N ++ L+HP LV
Sbjct: 3 IGKGSFGKV---LLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLV 59
Query: 476 KLYGCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRI 535
L+ +L + +Y+ L L R L+ P R +A + YLH +
Sbjct: 60 GLHYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLE-PRARFYAAEVASAIGYLHS---L 115
Query: 536 KVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPEYAMRGHLT 595
+++RD+K N+LLD + ++DFGL K E ST GT Y+APE +
Sbjct: 116 NIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTST-FCGTPEYLAPEVLRKEPYD 174
Query: 596 EKADVYSFGIVALEIVSG 613
D + G V E++ G
Sbjct: 175 RTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 1e-13
Identities = 55/205 (26%), Positives = 97/205 (47%), Gaps = 15/205 (7%)
Query: 415 TNNFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSS--KSKQGNREFINEIGMISALQH 471
TN + +G G FG V G +A+K++ + + E+ ++ L+H
Sbjct: 9 TNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRH 68
Query: 472 PNLVKLYGCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHG 531
N++ L I + + L L R L L+ + + I RGL Y+H
Sbjct: 69 ENIISLSDIFISPLEDIYFVTELLGTDLHRLLTSRPLEKQFI--QYFLYQILRGLKYVHS 126
Query: 532 ESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENT-HISTRVAGTIGYMAPEYAM 590
VVHRD+K +N+L++++ + KI DFGLA++ + + T ++STR Y APE +
Sbjct: 127 AG---VVHRDLKPSNILINENCDLKICDFGLARIQDPQMTGYVSTRY-----YRAPEIML 178
Query: 591 RGH-LTEKADVYSFGIVALEIVSGR 614
+ D++S G + E++ G+
Sbjct: 179 TWQKYDVEVDIWSAGCIFAEMLEGK 203
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 71.7 bits (176), Expect = 2e-13
Identities = 55/202 (27%), Positives = 100/202 (49%), Gaps = 12/202 (5%)
Query: 417 NFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQGNR-EFINEIGMISALQHPNL 474
+F +G G G V K L G +A K + + K R + I E+ ++ P +
Sbjct: 2 DFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYI 61
Query: 475 VKLYGCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESR 534
V YG ++ + E+++ SL + L + ++ +I + + RGL YL +
Sbjct: 62 VGFYGAFYSDGEISICMEHMDGGSLDQVLKKAG-RIPENILGKISIAVLRGLTYLREK-- 118
Query: 535 IKVVHRDIKATNVLLDKDLNSKISDFGLAK--LDEEENTHISTRVAGTIGYMAPEYAMRG 592
K++HRD+K +N+L++ K+ DFG++ +D N+ + TR YM+PE
Sbjct: 119 HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTR-----SYMSPERLQGT 173
Query: 593 HLTEKADVYSFGIVALEIVSGR 614
H T ++D++S G+ +E+ GR
Sbjct: 174 HYTVQSDIWSLGLSLVEMAIGR 195
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 2e-13
Identities = 52/210 (24%), Positives = 104/210 (49%), Gaps = 12/210 (5%)
Query: 416 NNFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQGNR-EFINEIGMISALQHPN 473
++F + +G G G V+K G +A K + + K R + I E+ ++ P
Sbjct: 5 DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 64
Query: 474 LVKLYGCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGES 533
+V YG ++ + E+++ SL + L + ++ ++ + + +GL YL
Sbjct: 65 IVGFYGAFYSDGEISICMEHMDGGSLDQVL-KKAGRIPEQILGKVSIAVIKGLTYL--RE 121
Query: 534 RIKVVHRDIKATNVLLDKDLNSKISDFGLAK--LDEEENTHISTRVAGTIGYMAPEYAMR 591
+ K++HRD+K +N+L++ K+ DFG++ +D N+ + TR YM+PE
Sbjct: 122 KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTR-----SYMSPERLQG 176
Query: 592 GHLTEKADVYSFGIVALEIVSGRSNVTKED 621
H + ++D++S G+ +E+ GR + D
Sbjct: 177 THYSVQSDIWSMGLSLVEMAIGRYPIPPPD 206
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 71.7 bits (176), Expect = 2e-13
Identities = 52/224 (23%), Positives = 104/224 (46%), Gaps = 36/224 (16%)
Query: 421 DNNIGEGGFGPVYKGL-LADGTAIAVKQLS----SKSKQGNREFINEIGM---------- 465
++GEG +G V K G +A+K++ S +R+ + G+
Sbjct: 14 GAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKI 73
Query: 466 ISALQHPNLVKLYGCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARG 525
++ ++H N++ L +EG+ + L+ + + ++ + + + +++L + I L I G
Sbjct: 74 MNEIKHENIMGLVDVYVEGDFINLVMDIMASD--LKKVVDRKIRLTESQVKCILLQILNG 131
Query: 526 LAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLA----------KLDEEENT---- 571
L LH +HRD+ N+ ++ KI+DFGLA L ++E
Sbjct: 132 LNVLHKWY---FMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRRE 188
Query: 572 HISTRVAGTIGYMAPEYAMRGHLTEKA-DVYSFGIVALEIVSGR 614
++++V T+ Y APE M A D++S G + E+++G+
Sbjct: 189 EMTSKVV-TLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGK 231
|
Length = 335 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 71.4 bits (176), Expect = 2e-13
Identities = 57/213 (26%), Positives = 100/213 (46%), Gaps = 34/213 (15%)
Query: 422 NNIGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQGNREFIN---------EIGMISALQH 471
IG G +G V + G +A+K++ + F + EI ++ L+H
Sbjct: 6 KPIGSGAYGVVCSAVDKRTGRKVAIKKI-------SNVFDDLIDAKRILREIKLLRHLRH 58
Query: 472 PNLVKLYGCCI-----EGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGL 526
N++ L + N + ++ E +E + L + + + L + I RGL
Sbjct: 59 ENIIGLLDILRPPSPEDFNDVYIVTELMETD-LHK-VIKSPQPLTDDHIQYFLYQILRGL 116
Query: 527 AYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKL---DEEENTHISTRVAGTIGY 583
YLH V+HRD+K +N+L++ + + KI DFGLA+ DE+E ++ V T Y
Sbjct: 117 KYLH---SANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVV-TRWY 172
Query: 584 MAPEYAMRG-HLTEKADVYSFG-IVALEIVSGR 614
APE + T+ D++S G I A E+++ +
Sbjct: 173 RAPELLLSSSRYTKAIDIWSVGCIFA-ELLTRK 204
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 70.7 bits (174), Expect = 3e-13
Identities = 60/206 (29%), Positives = 107/206 (51%), Gaps = 25/206 (12%)
Query: 422 NNIGEGGFGPVYKGL-LADGTAIAVKQLS-SKSKQGNREF----INEIGMISALQHPNLV 475
N I EG +G VY+ G +A+K+L K K+G F + EI ++ LQHPN+V
Sbjct: 11 NRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEG---FPITSLREINILLKLQHPNIV 67
Query: 476 KL----YGCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICL--GIARGLAYL 529
+ G + +++ ++ EY+E++ ++L E +K + CL + G+A+L
Sbjct: 68 TVKEVVVGSNL--DKIYMVMEYVEHD--LKSLMET-MKQPFLQSEVKCLMLQLLSGVAHL 122
Query: 530 HGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPEYA 589
H ++HRD+K +N+LL+ KI DFGLA+ + T++ T+ Y APE
Sbjct: 123 H---DNWILHRDLKTSNLLLNNRGILKICDFGLAR-EYGSPLKPYTQLVVTLWYRAPELL 178
Query: 590 M-RGHLTEKADVYSFGIVALEIVSGR 614
+ + D++S G + E+++ +
Sbjct: 179 LGAKEYSTAIDMWSVGCIFAELLTKK 204
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 4e-13
Identities = 61/210 (29%), Positives = 94/210 (44%), Gaps = 17/210 (8%)
Query: 424 IGEGGFGPVYKG-LLADGTAIAVKQLSSKSKQGNREFINEIGMIS------ALQHPNLVK 476
+G+G FG V+ L A+K L + + E M+ A +HP L
Sbjct: 3 LGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDV--ECTMVEKRVLSLAWEHPFLTH 60
Query: 477 LYGCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIK 536
LY L + EYL L + + K D P I GL +LH +
Sbjct: 61 LYCTFQTKENLFFVMEYLNGGDLMFHI-QSCHKFDLPRATFYAAEIICGLQFLHSKG--- 116
Query: 537 VVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPEYAMRGHLTE 596
+V+RD+K N+LLD D + KI+DFG+ K + + T GT Y+APE +
Sbjct: 117 IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCT-FCGTPDYIAPEILLGQKYNT 175
Query: 597 KADVYSFGIVALEIVSGRS---NVTKEDMF 623
D +SFG++ E++ G+S +E++F
Sbjct: 176 SVDWWSFGVLLYEMLIGQSPFHGHDEEELF 205
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 72.2 bits (177), Expect = 4e-13
Identities = 37/107 (34%), Positives = 60/107 (56%), Gaps = 2/107 (1%)
Query: 42 FLQDIDLTLNYLSGTIPSQWASLP-LLNISLIANRLKGPIPKYLANISTLVNLTVQYNQF 100
F+ + L L G IP+ + L L +I+L N ++G IP L +I++L L + YN F
Sbjct: 419 FIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSF 478
Query: 101 SGELPEELGSLLNLEKLHLSSNNFTGELPKTF-AKLTNMKDFRISDN 146
+G +PE LG L +L L+L+ N+ +G +P +L + F +DN
Sbjct: 479 NGSIPESLGQLTSLRILNLNGNSLSGRVPAALGGRLLHRASFNFTDN 525
|
Length = 623 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 70.5 bits (173), Expect = 5e-13
Identities = 46/158 (29%), Positives = 74/158 (46%), Gaps = 5/158 (3%)
Query: 470 QHPNLVKLYGCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYL 529
+HP L +L+ C ++L + EY+ L + + D P R I GL +L
Sbjct: 54 KHPFLTQLHSCFQTKDRLFFVMEYVNGGDLMFHIQRSG-RFDEPRARFYAAEIVLGLQFL 112
Query: 530 HGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPEYA 589
H +++RD+K NVLLD + + KI+DFG+ K ST GT Y+APE
Sbjct: 113 HER---GIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTST-FCGTPDYIAPEIL 168
Query: 590 MRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLD 627
D ++ G++ E+++G+S +D L
Sbjct: 169 SYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQ 206
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 7e-13
Identities = 62/209 (29%), Positives = 98/209 (46%), Gaps = 19/209 (9%)
Query: 424 IGEGGFGPVYKGLLADGTA----IAVKQLSS----KSKQGNREFINEIGMISALQHPNLV 475
+G+GG+G V++ G A+K L ++++ E ++ A++HP +V
Sbjct: 4 LGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIV 63
Query: 476 KLYGCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICL---GIARGLAYLHGE 532
L G +L LI EYL L F H + C I+ L +LH
Sbjct: 64 DLIYAFQTGGKLYLILEYLSGGEL----FMHLEREGIFMEDTACFYLSEISLALEHLH-- 117
Query: 533 SRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPEYAMRG 592
+ +++RD+K N+LLD + K++DFGL K E T T GTI YMAPE MR
Sbjct: 118 -QQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHT-FCGTIEYMAPEILMRS 175
Query: 593 HLTEKADVYSFGIVALEIVSGRSNVTKED 621
+ D +S G + ++++G T E+
Sbjct: 176 GHGKAVDWWSLGALMYDMLTGAPPFTAEN 204
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 69.6 bits (171), Expect = 7e-13
Identities = 59/204 (28%), Positives = 96/204 (47%), Gaps = 31/204 (15%)
Query: 424 IGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQGNREFINEIGMISALQ----HPNLVKLY 478
IGEG F V K G A+K + K + E +N + I AL+ HPN+++L
Sbjct: 7 IGEGTFSEVLKAQSRKTGKYYAIKCM--KKHFKSLEQVNNLREIQALRRLSPHPNILRLI 64
Query: 479 GCCIE--GNQLLLIYEYLENNSLARALFE----HRLKLDWPTRRRICLGIARGLAYLHGE 532
+ +L L++E ++ N L+E + L + + + L ++H
Sbjct: 65 EVLFDRKTGRLALVFELMDMN-----LYELIKGRKRPLPEKRVKSYMYQLLKSLDHMH-- 117
Query: 533 SRIKVVHRDIKATNVLLDKDLNSKISDFGLAK--LDEEENT-HISTRVAGTIGYMAPEYA 589
R + HRDIK N+L+ D+ K++DFG + + T +ISTR Y APE
Sbjct: 118 -RNGIFHRDIKPENILIKDDI-LKLADFGSCRGIYSKPPYTEYISTR-----WYRAPECL 170
Query: 590 MR-GHLTEKADVYSFGIVALEIVS 612
+ G+ K D+++ G V EI+S
Sbjct: 171 LTDGYYGPKMDIWAVGCVFFEILS 194
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 69.4 bits (170), Expect = 1e-12
Identities = 61/198 (30%), Positives = 92/198 (46%), Gaps = 16/198 (8%)
Query: 424 IGEGGFGPVYKGLLA----DGTAIAVKQLSSKS---KQGNREFINEIG-MISALQHPNLV 475
IG+G FG V LA DG AVK L K+ K+ + + E ++ ++HP LV
Sbjct: 3 IGKGSFGKVL---LAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLV 59
Query: 476 KLYGCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRI 535
L+ ++L + +Y+ L L R + P R IA L YLH +
Sbjct: 60 GLHYSFQTADKLYFVLDYVNGGELFFHLQRERSFPE-PRARFYAAEIASALGYLHS---L 115
Query: 536 KVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPEYAMRGHLT 595
+++RD+K N+LLD + ++DFGL K E + ST GT Y+APE +
Sbjct: 116 NIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTST-FCGTPEYLAPEVLRKQPYD 174
Query: 596 EKADVYSFGIVALEIVSG 613
D + G V E++ G
Sbjct: 175 RTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.0 bits (169), Expect = 1e-12
Identities = 55/204 (26%), Positives = 94/204 (46%), Gaps = 18/204 (8%)
Query: 417 NFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSKS----KQGNREFINEIGMISALQH 471
+ +G G FG V+ A+K ++ KQ + NE ++ + H
Sbjct: 2 DLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQ-EQHVHNEKRVLKEVSH 60
Query: 472 PNLVKLYGCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHG 531
P +++L+ + L ++ EY+ L L + + T I L YLH
Sbjct: 61 PFIIRLFWTEHDQRFLYMLMEYVPGGELFSYL-RNSGRFSNSTGLFYASEIVCALEYLHS 119
Query: 532 ESRIKVVHRDIKATNVLLDKDLNSKISDFGLAK-LDEEENTHISTRVAGTIGYMAPE-YA 589
+ +V+RD+K N+LLDK+ + K++DFG AK L + T + GT Y+APE
Sbjct: 120 KE---IVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRTWT-----LCGTPEYLAPEVIQ 171
Query: 590 MRGHLTEKADVYSFGIVALEIVSG 613
+GH + D ++ GI+ E++ G
Sbjct: 172 SKGH-NKAVDWWALGILIYEMLVG 194
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 2e-12
Identities = 51/202 (25%), Positives = 99/202 (49%), Gaps = 20/202 (9%)
Query: 422 NNIGEGGFGPVYKGLLA-DGTAIAVKQLSSKSKQGNR-EFINEIGMISALQHPNLVKLYG 479
+ +GEG + V+KG +A+K++ + ++G I E+ ++ L+H N+V L+
Sbjct: 11 DKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHD 70
Query: 480 CCIEGNQLLLIYEYLENN------SLARALFEHRLKLDWPTRRRICLGIARGLAYLHGES 533
L L++EYL+++ + + H +K+ + RGL+Y H
Sbjct: 71 IIHTERCLTLVFEYLDSDLKQYLDNCGNLMSMHNVKI-------FMFQLLRGLSYCH--- 120
Query: 534 RIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPEYAM-RG 592
+ K++HRD+K N+L+++ K++DFGLA+ S V T+ Y P+ +
Sbjct: 121 KRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVV-TLWYRPPDVLLGST 179
Query: 593 HLTEKADVYSFGIVALEIVSGR 614
+ D++ G + E+ +GR
Sbjct: 180 EYSTPIDMWGVGCILYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 2e-12
Identities = 60/211 (28%), Positives = 95/211 (45%), Gaps = 17/211 (8%)
Query: 424 IGEGGFGPVYKGLLAD-GTAIAVKQLSSK---SKQGNREFINEIGMISALQHPNLVKLYG 479
+G+GGFG V + + G A K+L K K G + + E ++ + P +V L
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAY 60
Query: 480 CCIEGNQLLLIYEYLENNSLARALFE-HRLKLDWPTRRRICLGIARGLAYLHGESRIKVV 538
L L+ + L ++ L+ I G+ +LH + +V
Sbjct: 61 AFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLH---SMDIV 117
Query: 539 HRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPEYAMRGHLTEKA 598
+RD+K NVLLD N ++SD GLA E ++ T+ AGT GYMAPE +
Sbjct: 118 YRDMKPENVLLDDQGNCRLSDLGLAV--ELKDGKTITQRAGTNGYMAPEILKEEPYSYPV 175
Query: 599 DVYSFGIVALEIVSGRS-------NVTKEDM 622
D ++ G E+V+GR+ V KE++
Sbjct: 176 DWFAMGCSIYEMVAGRTPFKDHKEKVAKEEL 206
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 2e-12
Identities = 59/202 (29%), Positives = 92/202 (45%), Gaps = 20/202 (9%)
Query: 424 IGEGGFGPVYK-GLLADGTAIAVKQLSSK---SKQGNREFINEIGMISALQHPNLVKLYG 479
+G+GGFG V + A G A K+L K ++G +NE ++ + +V L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAY 67
Query: 480 CCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRR------RICLGIARGLAYLHGES 533
+ L L+ + L ++ + + R I G L LH E
Sbjct: 68 AYETKDALCLVLTLMNGGDLKFHIY-NMGNPGFDEERAVFYAAEITCG----LEDLHRE- 121
Query: 534 RIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPEYAMRGH 593
++V+RD+K N+LLD + +ISD GLA ++ E I RV GT+GYMAPE
Sbjct: 122 --RIVYRDLKPENILLDDYGHIRISDLGLA-VEIPEGETIRGRV-GTVGYMAPEVVKNER 177
Query: 594 LTEKADVYSFGIVALEIVSGRS 615
T D + G + E++ G+S
Sbjct: 178 YTFSPDWWGLGCLIYEMIEGKS 199
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 2e-12
Identities = 56/205 (27%), Positives = 99/205 (48%), Gaps = 33/205 (16%)
Query: 424 IGEGGFGPVYKGLLA----DGTAIAVKQL----SSKSKQGNREFINEIGMISALQHPNLV 475
+GEG FG + LL A+K++ SS + + +R+ E +++ ++HPN+V
Sbjct: 8 VGEGSFG---RALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRK---EAVLLAKMKHPNIV 61
Query: 476 KLYGCCIEGN-QLLLIYEYLENNSLARA-------LFEHRLKLDWPTRRRICLGIARGLA 527
+ E + L ++ EY + L + LF L W + +CLG+
Sbjct: 62 A-FKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQ--MCLGVQ---- 114
Query: 528 YLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPE 587
++H + +V+HRDIK+ N+ L ++ K+ DFG A+L + T V GT Y+ PE
Sbjct: 115 HIHEK---RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYV-GTPYYVPPE 170
Query: 588 YAMRGHLTEKADVYSFGIVALEIVS 612
K+D++S G + E+ +
Sbjct: 171 IWENMPYNNKSDIWSLGCILYELCT 195
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 67.8 bits (165), Expect = 3e-12
Identities = 51/193 (26%), Positives = 95/193 (49%), Gaps = 8/193 (4%)
Query: 424 IGEGGFGPVYKGLL-ADGTAIAVKQLSSKSKQGNR-EFINEIGMISALQHPNLVKLYGCC 481
+GEG + VYKG +G +A+K + + ++G I E ++ L+H N+V L+
Sbjct: 13 LGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDII 72
Query: 482 IEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRD 541
L L++EY+ + L + + +H L + + RGL+Y+H ++HRD
Sbjct: 73 HTKETLTLVFEYVHTD-LCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRY---ILHRD 128
Query: 542 IKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPEYAM-RGHLTEKADV 600
+K N+L+ K++DFGLA+ + S V T+ Y P+ + + D+
Sbjct: 129 LKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEVV-TLWYRPPDVLLGSTEYSTCLDM 187
Query: 601 YSFGIVALEIVSG 613
+ G + +E++ G
Sbjct: 188 WGVGCIFVEMIQG 200
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 67.7 bits (166), Expect = 4e-12
Identities = 33/95 (34%), Positives = 57/95 (60%), Gaps = 10/95 (10%)
Query: 522 IARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENT-HISTRVAGT 580
I RGL Y+H ++HRD+K +N+ +++D KI DFGLA+ ++E T +++TR
Sbjct: 127 ILRGLKYIHSAG---IIHRDLKPSNIAVNEDCELKILDFGLARHTDDEMTGYVATR---- 179
Query: 581 IGYMAPEYAM-RGHLTEKADVYSFGIVALEIVSGR 614
Y APE + H + D++S G + E+++G+
Sbjct: 180 -WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGK 213
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 67.2 bits (164), Expect = 4e-12
Identities = 56/201 (27%), Positives = 94/201 (46%), Gaps = 15/201 (7%)
Query: 424 IGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQGN-REFINEIGMISALQHPNLVKLYGCC 481
+G+G +G VYK L G +A+K++ + + + I E+ ++ P +V YG
Sbjct: 9 LGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAF 68
Query: 482 IEGNQLLLIYEYLENNSLAR--ALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVH 539
+ + EY++ SL + A + RRI + +GL +L E I +H
Sbjct: 69 FIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNI--IH 126
Query: 540 RDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPEY------AMRGH 593
RD+K TNVL++ + K+ DFG++ ++ G YMAPE
Sbjct: 127 RDVKPTNVLVNGNGQVKLCDFGVSGNLVAS---LAKTNIGCQSYMAPERIKSGGPNQNPT 183
Query: 594 LTEKADVYSFGIVALEIVSGR 614
T ++DV+S G+ LE+ GR
Sbjct: 184 YTVQSDVWSLGLSILEMALGR 204
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 67.6 bits (165), Expect = 6e-12
Identities = 40/158 (25%), Positives = 71/158 (44%), Gaps = 26/158 (16%)
Query: 465 MISALQHPNLVKLYGCCIEGNQLLLI--------YEYLENNSLARALFEHRLKLDWPTRR 516
++ + HP+++++ + G ++ Y YL S R L P +
Sbjct: 110 LLQNVNHPSVIRMKDTLVSGAITCMVLPHYSSDLYTYLTKRS--RPL---------PIDQ 158
Query: 517 RICL--GIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHIS 574
+ + I GL YLH + +++HRD+K N+ ++ I D G A+ +
Sbjct: 159 ALIIEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFLG 215
Query: 575 TRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVS 612
+AGT+ APE R KAD++S GIV E+++
Sbjct: 216 --LAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLA 251
|
Length = 357 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 67.2 bits (164), Expect = 6e-12
Identities = 57/211 (27%), Positives = 99/211 (46%), Gaps = 19/211 (9%)
Query: 424 IGEGGFGPVYKGLLA----DGTAIAVKQLSSKSKQGNREF---INEIGMIS-ALQHPNLV 475
+G+G FG V +LA G AVK L + + + E ++S A HP L
Sbjct: 3 LGKGSFGKV---MLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLT 59
Query: 476 KLYGCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRI 535
+LY C ++L + E++ L + + R + D R I L +LH +
Sbjct: 60 QLYCCFQTPDRLFFVMEFVNGGDLMFHIQKSR-RFDEARARFYAAEITSALMFLHDKG-- 116
Query: 536 KVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPEYAMRGHLT 595
+++RD+K NVLLD + + K++DFG+ K + N ++ GT Y+APE
Sbjct: 117 -IIYRDLKLDNVLLDHEGHCKLADFGMCK-EGIFNGKTTSTFCGTPDYIAPEILQEMLYG 174
Query: 596 EKADVYSFGIVALEIVSGRSNV---TKEDMF 623
D ++ G++ E++ G + ++D+F
Sbjct: 175 PSVDWWAMGVLLYEMLCGHAPFEAENEDDLF 205
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 8e-12
Identities = 71/286 (24%), Positives = 122/286 (42%), Gaps = 55/286 (19%)
Query: 423 NIGEGGFGPVYKGL---LADG-----TAIAVKQLSSKSKQGNREFINEIGMISALQHPNL 474
++G+G F ++KG+ + D T + +K L + + F M+S L H +L
Sbjct: 2 SLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHL 61
Query: 475 VKLYGCCIEGNQLLLIYEYLENNSLARALFE--HRLKLDWPTRRRICLGIARGLAY-LHG 531
V YG C+ G++ +++ EY++ SL L + + + + W L +A+ LA+ LH
Sbjct: 62 VLNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISWK------LEVAKQLAWALHF 115
Query: 532 ESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGT------IGYMA 585
+ H ++ A NVLL ++ + K + KL + IS V I ++
Sbjct: 116 LEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSD---PGISITVLPKEILLERIPWVP 172
Query: 586 PEYAMRG-HLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDT 644
PE +L+ AD +SFG EI SG K + +D+
Sbjct: 173 PECIENPQNLSLAADKWSFGTTLWEIFSGGD---------------------KPLSALDS 211
Query: 645 NPGSNF--DKEQVMV--MINVALL---CANASPTIRPSMSSVLRML 683
F D+ Q+ +A L C + P RPS +++R L
Sbjct: 212 QKKLQFYEDRHQLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDL 257
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 8e-12
Identities = 63/204 (30%), Positives = 93/204 (45%), Gaps = 24/204 (11%)
Query: 424 IGEGGFGPVYK-GLLADGTAIAVKQLSSK---SKQGNREFINEIGMISALQHPNLVKLYG 479
+G+GGFG V + A G A K+L K ++G +NE ++ + +V L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAY 67
Query: 480 CCIEGNQLLLIYEYLENNSLARAL-------FEHRLKLDWPTRRRICLGIARGLAYLHGE 532
+ L L+ + L + FE L + I GL LH E
Sbjct: 68 AYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAE------ILCGLEDLHRE 121
Query: 533 SRIKVVHRDIKATNVLLDKDLNSKISDFGLA-KLDEEENTHISTRVAGTIGYMAPEYAMR 591
+ V+RD+K N+LLD + +ISD GLA K+ E E+ I RV GT+GYMAPE
Sbjct: 122 N---TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGES--IRGRV-GTVGYMAPEVLNN 175
Query: 592 GHLTEKADVYSFGIVALEIVSGRS 615
T D + G + E++ G+S
Sbjct: 176 QRYTLSPDYWGLGCLIYEMIEGQS 199
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 66.9 bits (163), Expect = 9e-12
Identities = 55/158 (34%), Positives = 80/158 (50%), Gaps = 17/158 (10%)
Query: 470 QHPNLVKLYGCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRR--RICLG-IARGL 526
Q P LV L+ +L LI +Y+ + F H + D + R G I L
Sbjct: 63 QSPFLVTLHYAFQTEAKLHLILDYVSGGEM----FTHLYQRDNFSEDEVRFYSGEIILAL 118
Query: 527 AYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAK--LDEEENTHISTRVAGTIGYM 584
+LH ++ +V+RDIK N+LLD + + ++DFGL+K L EE+ S GTI YM
Sbjct: 119 EHLH---KLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYS--FCGTIEYM 173
Query: 585 APEY--AMRGHLTEKADVYSFGIVALEIVSGRSNVTKE 620
APE GH + D +S GI+ E+++G S T E
Sbjct: 174 APEIIRGKGGH-GKAVDWWSLGILIFELLTGASPFTLE 210
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 66.1 bits (161), Expect = 9e-12
Identities = 55/207 (26%), Positives = 97/207 (46%), Gaps = 21/207 (10%)
Query: 424 IGEGGFGPVYKGLLA--DGT--AIAVKQLSSK--SKQGNREFINEIGMISALQHPNLVKL 477
+G+G FG V + L DG+ +AVK L + S EF+ E + HPN++KL
Sbjct: 7 LGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKL 66
Query: 478 YGCCIEGNQL------LLIYEYLENNSLARALFEHRL-----KLDWPTRRRICLGIARGL 526
G + ++I ++++ L L R+ L T R + IA G+
Sbjct: 67 IGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGM 126
Query: 527 AYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAG-TIGYMA 585
YL S +HRD+ A N +L++++ ++DFGL+K + + + + ++A
Sbjct: 127 EYL---SSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKWLA 183
Query: 586 PEYAMRGHLTEKADVYSFGIVALEIVS 612
E T +DV++FG+ EI++
Sbjct: 184 LESLADNVYTTHSDVWAFGVTMWEIMT 210
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 1e-11
Identities = 55/204 (26%), Positives = 92/204 (45%), Gaps = 11/204 (5%)
Query: 416 NNFATDNNIGEGGFGPVYKGLLADGTAI-AVKQLSSKSKQGNREF----INEIGMISALQ 470
N F +GEG +G V K + I A+K+ K + N E + E+ M+ L+
Sbjct: 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKF--KDSEENEEVKETTLRELKMLRTLK 58
Query: 471 HPNLVKLYGCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLH 530
N+V+L +L L++EY+E N L L E + R + + + + H
Sbjct: 59 QENIVELKEAFRRRGKLYLVFEYVEKNML-ELLEEMPNGVPPEKVRSYIYQLIKAIHWCH 117
Query: 531 GESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPEYAM 590
+ +VHRDIK N+L+ + K+ DFG A+ E + T T Y +PE +
Sbjct: 118 ---KNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLL 174
Query: 591 RGHLTEKADVYSFGIVALEIVSGR 614
+ D++S G + E+ G+
Sbjct: 175 GAPYGKAVDMWSVGCILGELSDGQ 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 1e-11
Identities = 55/210 (26%), Positives = 94/210 (44%), Gaps = 30/210 (14%)
Query: 424 IGEGGFGPVYKGL-LADGTAIAVKQ--LSSKSKQGNREFINEIGMISALQH-PNLVKLYG 479
IGEG +G VYK G +A+K+ L + + EI ++ L +V+L
Sbjct: 9 IGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLL- 67
Query: 480 CCIEGN-------QLLLIYEYLENNSLARALFEHRLK----LDWPTRRRICLGIARGLAY 528
+E L L++EYL+++ L + + + L T + + +G+A+
Sbjct: 68 -DVEHVEEKNGKPSLYLVFEYLDSD-LKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAH 125
Query: 529 LHGESRIKVVHRDIKATNVLLDKDLNS-KISDFGLAK---LDEEENTHISTRVAGTIGYM 584
H V+HRD+K N+L+DK KI+D GL + + + TH T+ Y
Sbjct: 126 CHKHG---VMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIV----TLWYR 178
Query: 585 APEYAMRG-HLTEKADVYSFGIVALEIVSG 613
APE + H + D++S G + E+
Sbjct: 179 APEVLLGSTHYSTPVDIWSVGCIFAEMSRK 208
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 1e-11
Identities = 52/201 (25%), Positives = 96/201 (47%), Gaps = 22/201 (10%)
Query: 424 IGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQGNREF--INEIGMISALQ---HPNLVKL 477
IG G +G VYK G +A+K + ++ + + E+ ++ L+ HPN+V+L
Sbjct: 8 IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRL 67
Query: 478 YGCCIEGN-----QLLLIYEYLENNSLARALFEHRLKLDWP--TRRRICLGIARGLAYLH 530
C ++ L++E+++ + R + P T + + RGL +LH
Sbjct: 68 MDVCATSRTDRETKVTLVFEHVDQD--LRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLH 125
Query: 531 GESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHIS-TRVAGTIGYMAPEYA 589
+VHRD+K N+L+ K++DFGLA++ + ++ T V T+ Y APE
Sbjct: 126 AN---CIVHRDLKPENILVTSGGQVKLADFGLARI---YSCQMALTPVVVTLWYRAPEVL 179
Query: 590 MRGHLTEKADVYSFGIVALEI 610
++ D++S G + E+
Sbjct: 180 LQSTYATPVDMWSVGCIFAEM 200
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 2e-11
Identities = 60/198 (30%), Positives = 89/198 (44%), Gaps = 16/198 (8%)
Query: 424 IGEGGFGPVYKGLLA----DGTAIAVKQLSSKSKQGNREFINEIG----MISALQHPNLV 475
IG+G FG V LLA DG AVK L K +E + + ++ ++HP LV
Sbjct: 3 IGKGSFGKV---LLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLV 59
Query: 476 KLYGCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRI 535
L+ +L + +++ L L R P R IA L YLH I
Sbjct: 60 GLHYSFQTTEKLYFVLDFVNGGELFFHLQRER-SFPEPRARFYAAEIASALGYLHS---I 115
Query: 536 KVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPEYAMRGHLT 595
+V+RD+K N+LLD + ++DFGL K + + +T GT Y+APE +
Sbjct: 116 NIVYRDLKPENILLDSQGHVVLTDFGLCK-EGIAQSDTTTTFCGTPEYLAPEVIRKQPYD 174
Query: 596 EKADVYSFGIVALEIVSG 613
D + G V E++ G
Sbjct: 175 NTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 2e-11
Identities = 61/215 (28%), Positives = 97/215 (45%), Gaps = 26/215 (12%)
Query: 418 FATDNNIGEGGFGPVYKGLLAD-GTAIAVKQLS-SKSKQGNREF----INEIGMISALQH 471
F IGEG +G VYK D G +A+K++ K+G F I EI ++ L H
Sbjct: 9 FDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEG---FPITAIREIKILRQLNH 65
Query: 472 PNLVKLYGCCIEGNQLL----------LIYEYLENNSLARALFEHRL-KLDWPTRRRICL 520
N+V L + L L++EY++++ + L E L +
Sbjct: 66 RNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMG--LLESGLVHFSEDHIKSFMK 123
Query: 521 GIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGT 580
+ GL Y H ++ +HRDIK +N+LL+ K++DFGLA+L E + T T
Sbjct: 124 QLLEGLNYCHKKN---FLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVIT 180
Query: 581 IGYMAPEYAM-RGHLTEKADVYSFGIVALEIVSGR 614
+ Y PE + DV+S G + E+ + +
Sbjct: 181 LWYRPPELLLGEERYGPAIDVWSCGCILGELFTKK 215
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 3e-11
Identities = 65/210 (30%), Positives = 98/210 (46%), Gaps = 21/210 (10%)
Query: 424 IGEGGFGPVYKGLLADGTAI-AVKQLSSKSKQGNREFINEIGMISALQH------PNLVK 476
IG+G FG VY+ D I A+K LS K +E + IG + L P +V
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60
Query: 477 LYGCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIAR---GLAYLHGES 533
L + L L+ +Y+ L F H K + R IA L +LH
Sbjct: 61 LKFSFQTDSDLYLVTDYMSGGEL----FWHLQKEGRFSEDRAKFYIAELVLALEHLH--- 113
Query: 534 RIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPEYAM--R 591
+ +V+RD+K N+LLD + + DFGL+K + +N +T GT Y+APE + +
Sbjct: 114 KYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNT-FCGTTEYLAPEVLLDEK 172
Query: 592 GHLTEKADVYSFGIVALEIVSGRSNVTKED 621
G+ T+ D +S G++ E+ G S ED
Sbjct: 173 GY-TKHVDFWSLGVLVFEMCCGWSPFYAED 201
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 64.7 bits (158), Expect = 4e-11
Identities = 62/275 (22%), Positives = 108/275 (39%), Gaps = 40/275 (14%)
Query: 440 GTAIAVKQ--LSSKSKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYEYLENN 497
T +AVK+ L S SK+ + EI LQHPN++ I ++L ++ +
Sbjct: 25 NTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYG 84
Query: 498 SLARALFEHRLKLDWPTR--RRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNS 555
S L + P I + L Y+H +HR +KA+++LL D
Sbjct: 85 S-CEDLLKTHFPEGLPELAIAFILKDVLNALDYIH---SKGFIHRSVKASHILLSGDGKV 140
Query: 556 KISDF----GLAKLDEEENT-HISTR-VAGTIGYMAPEY---AMRGHLTEKADVYSFGIV 606
+S + K + + H + + +++PE ++G+ EK+D+YS GI
Sbjct: 141 VLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGY-NEKSDIYSVGIT 199
Query: 607 ALEIVSGR---SNVTKEDMF---------YLLDWALVLKEQGKLMELVDTNPGSNFDKEQ 654
A E+ +G ++ M LLD + + + + +N N +++
Sbjct: 200 ACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYEDSMSQSRSSNEHPN-NRDS 258
Query: 655 VMVMIN---------VALLCANASPTIRPSMSSVL 680
V LC P RPS S +L
Sbjct: 259 VDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLL 293
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 64.5 bits (158), Expect = 4e-11
Identities = 60/215 (27%), Positives = 104/215 (48%), Gaps = 43/215 (20%)
Query: 424 IGEGGFGPVYKGLLAD---GTAIAVK------QLSSKSKQGNRE--FINEIGMISALQHP 472
+G+G +G V+K + D +A+K + ++ +++ RE F+ E+G HP
Sbjct: 15 LGKGAYGIVWKAI--DRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELG-----DHP 67
Query: 473 NLVKLYGC--CIEGNQLLLIYEYLE---NNSLARALFE--HRLKLDWPTRRRICLGIARG 525
N+VKL + L++EY+E + + + E H+ R I + +
Sbjct: 68 NIVKLLNVIKAENDKDIYLVFEYMETDLHAVIRANILEDVHK--------RYIMYQLLKA 119
Query: 526 LAYLH-GESRIKVVHRDIKATNVLLDKDLNSKISDFGLAK----LDEEENTHISTRVAGT 580
L Y+H G V+HRD+K +N+LL+ D K++DFGLA+ L+E + T T
Sbjct: 120 LKYIHSGN----VIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVAT 175
Query: 581 IGYMAPEYAMRGHLTEKA-DVYSFGIVALEIVSGR 614
Y APE + K D++S G + E++ G+
Sbjct: 176 RWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGK 210
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 64.5 bits (157), Expect = 4e-11
Identities = 44/147 (29%), Positives = 73/147 (49%), Gaps = 5/147 (3%)
Query: 468 ALQHPNLVKLYGCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLA 527
A +HP L L+ C ++L + EY+ L + R K D P R + L
Sbjct: 52 AAKHPFLTALHCCFQTKDRLFFVMEYVNGGDLMFQIQRSR-KFDEPRSRFYAAEVTLALM 110
Query: 528 YLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPE 587
+LH R V++RD+K N+LLD + + K++DFG+ K + N +T GT Y+APE
Sbjct: 111 FLH---RHGVIYRDLKLDNILLDAEGHCKLADFGMCK-EGILNGVTTTTFCGTPDYIAPE 166
Query: 588 YAMRGHLTEKADVYSFGIVALEIVSGR 614
D ++ G++ E+++G+
Sbjct: 167 ILQELEYGPSVDWWALGVLMYEMMAGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|221187 pfam11721, Malectin, Di-glucose binding within endoplasmic reticulum | Back alignment and domain information |
|---|
Score = 61.5 bits (150), Expect = 5e-11
Identities = 27/92 (29%), Positives = 35/92 (38%), Gaps = 22/92 (23%)
Query: 320 YSLHINCGGKQVTANGNTTFEEDT-SEAGPSTFSQSGTNWVLSSTGHFLENGLKLGPYIQ 378
L INCGG + T + T+E DT G + + S TN S G
Sbjct: 1 VVLAINCGGPEHTDSDGITYEADTYFTGGSADYYVSDTNGSSSIAG-------------- 46
Query: 379 TNTSRLLMNDYQLYTTARLSAISLTYYGFYLQ 410
D +LY T R S S +YY L+
Sbjct: 47 -------TTDPELYQTERYSPSSFSYYIPCLE 71
|
Malectin is a membrane-anchored protein of the endoplasmic reticulum that recognises and binds Glc2-N-glycan. It carries a signal peptide from residues 1-26, a C-terminal transmembrane helix from residues 255-274, and a highly conserved central part of approximately 190 residues followed by an acidic, glutamate-rich region. Carbohydrate-binding is mediated by the four aromatic residues, Y67, Y89, Y116, and F117 and the aspartate at D186. NMR-based ligand-screening studies has shown binding of the protein to maltose and related oligosaccharides, on the basis of which the protein has been designated "malectin", and its endogenous ligand is found to be Glc2-high-mannose N-glycan. Length = 164 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 5e-11
Identities = 65/213 (30%), Positives = 92/213 (43%), Gaps = 17/213 (7%)
Query: 424 IGEGGFGPVYKGLL----ADGTAIAVKQLSSKSKQGNREFINEIGMISALQ---HPNLVK 476
+G+G FG V +L A G A+K L + E + + LQ HP L
Sbjct: 3 LGKGTFGKV---ILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTA 59
Query: 477 LYGCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIK 536
L ++L + EY L L R+ R I L YLH E
Sbjct: 60 LKYSFQTHDRLCFVMEYANGGELFFHLSRERV-FSEDRARFYGAEIVSALDYLHSEK--N 116
Query: 537 VVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPEYAMRGHLTE 596
VV+RD+K N++LDKD + KI+DFGL K ++ + T GT Y+APE
Sbjct: 117 VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT-FCGTPEYLAPEVLEDNDYGR 175
Query: 597 KADVYSFGIVALEIVSGR---SNVTKEDMFYLL 626
D + G+V E++ GR N E +F L+
Sbjct: 176 AVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELI 208
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 5e-11
Identities = 67/232 (28%), Positives = 102/232 (43%), Gaps = 17/232 (7%)
Query: 424 IGEGGFGPVYKGLL----ADGTAIAVKQLSSK---SKQGNREFINEIGMISALQHPNLVK 476
+G+G FG V +L A G A+K L + +K + E ++ +HP L
Sbjct: 3 LGKGTFGKV---ILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTS 59
Query: 477 LYGCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIK 536
L ++L + EY+ L L R+ + TR I L YLH K
Sbjct: 60 LKYSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRF-YGAEIVSALDYLHSG---K 115
Query: 537 VVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPEYAMRGHLTE 596
+V+RD+K N++LDKD + KI+DFGL K + + T GT Y+APE
Sbjct: 116 IVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKT-FCGTPEYLAPEVLEDNDYGR 174
Query: 597 KADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGS 648
D + G+V E++ GR +D L + L+L E K + + S
Sbjct: 175 AVDWWGLGVVMYEMMCGRLPFYNQDHEKLFE--LILMEDIKFPRTLSADAKS 224
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 8e-11
Identities = 48/156 (30%), Positives = 79/156 (50%), Gaps = 16/156 (10%)
Query: 470 QHPNLVKLYGCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICL---GIARGL 526
Q P LV L+ +L LI +Y+ L F H + + + + + I L
Sbjct: 63 QSPFLVTLHYAFQTDTKLHLILDYINGGEL----FTHLSQRERFKEQEVQIYSGEIVLAL 118
Query: 527 AYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAP 586
+LH ++ +++RDIK N+LLD + + ++DFGL+K E+ + GTI YMAP
Sbjct: 119 EHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAP 175
Query: 587 EYAM---RGHLTEKA-DVYSFGIVALEIVSGRSNVT 618
+ GH +KA D +S G++ E+++G S T
Sbjct: 176 DIVRGGDGGH--DKAVDWWSMGVLMYELLTGASPFT 209
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 8e-11
Identities = 44/148 (29%), Positives = 72/148 (48%), Gaps = 5/148 (3%)
Query: 468 ALQHPNLVKLYGCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLA 527
A HP LV L+ C ++L + EY+ L + R KL R I+ L
Sbjct: 52 ASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQR-KLPEEHARFYSAEISLALN 110
Query: 528 YLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPE 587
YLH +++RD+K NVLLD + + K++D+G+ K + ++ GT Y+APE
Sbjct: 111 YLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCK-EGLRPGDTTSTFCGTPNYIAPE 166
Query: 588 YAMRGHLTEKADVYSFGIVALEIVSGRS 615
D ++ G++ E+++GRS
Sbjct: 167 ILRGEDYGFSVDWWALGVLMFEMMAGRS 194
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 63.8 bits (155), Expect = 8e-11
Identities = 61/207 (29%), Positives = 94/207 (45%), Gaps = 18/207 (8%)
Query: 424 IGEGGFGPVYKG-LLADGTAIAVKQLSSKSKQGNREFINEIGMIS------ALQHPNLVK 476
+G+G FG V L G AVK L + + E M+ A ++P L
Sbjct: 3 LGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDV--ECTMVEKRVLALAWENPFLTH 60
Query: 477 LYGCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLG--IARGLAYLHGESR 534
LY L + E+L L +F + K + R I GL +LH +
Sbjct: 61 LYCTFQTKEHLFFVMEFLNGGDL---MFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKG- 116
Query: 535 IKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPEYAMRGHL 594
+++RD+K NV+LD+D + KI+DFG+ K + + ST GT Y+APE
Sbjct: 117 --IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRAST-FCGTPDYIAPEILQGLKY 173
Query: 595 TEKADVYSFGIVALEIVSGRSNVTKED 621
T D +SFG++ E++ G+S +D
Sbjct: 174 TFSVDWWSFGVLLYEMLIGQSPFHGDD 200
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 63.5 bits (155), Expect = 1e-10
Identities = 60/207 (28%), Positives = 85/207 (41%), Gaps = 29/207 (14%)
Query: 424 IGEGGFGPVYKGLLAD----GTAIAVKQLSSKSKQGNREF--------INEIGMISALQH 471
+G G FG V LLA+ G A+K L E I E ++ +H
Sbjct: 7 LGRGHFGKV---LLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFET--ANSERH 61
Query: 472 PNLVKLYGCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIAR---GLAY 528
P LV L+ C + + + EY L + + R A GL Y
Sbjct: 62 PFLVNLFACFQTEDHVCFVMEYAAGGDLMMHIHTDVF-----SEPRAVFYAACVVLGLQY 116
Query: 529 LHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPEY 588
LH K+V+RD+K N+LLD + KI+DFGL K ST GT ++APE
Sbjct: 117 LHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRTST-FCGTPEFLAPEV 172
Query: 589 AMRGHLTEKADVYSFGIVALEIVSGRS 615
T D + G++ E++ G S
Sbjct: 173 LTETSYTRAVDWWGLGVLIYEMLVGES 199
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 1e-10
Identities = 56/203 (27%), Positives = 99/203 (48%), Gaps = 22/203 (10%)
Query: 424 IGEGGFGPVYKGLLAD-GTAIAVKQLSS--KSKQGNREFINEIGMISALQHPNLVKLYGC 480
+G G +G V G +AVK+LS +S + E+ ++ ++H N++ L
Sbjct: 25 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 84
Query: 481 CI------EGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESR 534
E N + L+ +L L + +L D + + I RGL Y+H
Sbjct: 85 FTPARSLEEFNDVYLV-THLMGADLNNIVKCQKLTDD--HVQFLIYQILRGLKYIHSAD- 140
Query: 535 IKVVHRDIKATNVLLDKDLNSKISDFGLAK-LDEEENTHISTRVAGTIGYMAPEYAMRG- 592
++HRD+K +N+ +++D KI DFGLA+ D+E +++TR Y APE +
Sbjct: 141 --IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRAPEIMLNWM 193
Query: 593 HLTEKADVYSFGIVALEIVSGRS 615
H + D++S G + E+++GR+
Sbjct: 194 HYNQTVDIWSVGCIMAELLTGRT 216
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 1e-10
Identities = 55/207 (26%), Positives = 93/207 (44%), Gaps = 24/207 (11%)
Query: 417 NFATDNNIGEGGFGPV-YKGLLADGTAIAVKQLSS----KSKQGNREFINEIGMISALQH 471
+F +G G FG V G A+K L K KQ + E ++ L H
Sbjct: 19 DFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQ-VQHVAQEKSILMELSH 77
Query: 472 PNLVKLYGCCIEGNQLLLIYEYLENNSLARALFEH-RLKLDWPT--RRRICLGIARGLAY 528
P +V + + N++ + E++ + LF H R +P + + Y
Sbjct: 78 PFIVNMMCSFQDENRVYFLLEFV----VGGELFTHLRKAGRFPNDVAKFYHAELVLAFEY 133
Query: 529 LHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPEY 588
LH + +++RD+K N+LLD + K++DFG AK + + + GT Y+APE
Sbjct: 134 LHSKD---IIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR----TFTLCGTPEYLAPEV 186
Query: 589 AM-RGHLTEKA-DVYSFGIVALEIVSG 613
+GH KA D ++ G++ E ++G
Sbjct: 187 IQSKGH--GKAVDWWTMGVLLYEFIAG 211
|
Length = 329 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.8 bits (153), Expect = 1e-10
Identities = 45/143 (31%), Positives = 76/143 (53%), Gaps = 6/143 (4%)
Query: 424 IGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQGNR-EFINEIGMISALQHPNLVKLYGCC 481
+GEG + VYKG G +A+K++ + ++G I E ++ L+H N+V L+
Sbjct: 13 LGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDII 72
Query: 482 IEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRD 541
L L++EYL+ + L + + + L R + RGLAY H +V+HRD
Sbjct: 73 HTKKTLTLVFEYLDTD-LKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQR---RVLHRD 128
Query: 542 IKATNVLLDKDLNSKISDFGLAK 564
+K N+L+ + K++DFGLA+
Sbjct: 129 LKPQNLLISERGELKLADFGLAR 151
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 1e-10
Identities = 46/148 (31%), Positives = 71/148 (47%), Gaps = 5/148 (3%)
Query: 468 ALQHPNLVKLYGCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLA 527
A +P LV L+ C ++L L+ EY+ L + R KL R I L
Sbjct: 52 ASSNPFLVGLHSCFQTTSRLFLVIEYVNGGDLMFHMQRQR-KLPEEHARFYAAEICIALN 110
Query: 528 YLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPE 587
+LH +++RD+K NVLLD D + K++D+G+ K ST GT Y+APE
Sbjct: 111 FLHERG---IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTST-FCGTPNYIAPE 166
Query: 588 YAMRGHLTEKADVYSFGIVALEIVSGRS 615
D ++ G++ E+++GRS
Sbjct: 167 ILRGEEYGFSVDWWALGVLMFEMMAGRS 194
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 2e-10
Identities = 53/176 (30%), Positives = 85/176 (48%), Gaps = 29/176 (16%)
Query: 517 RICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTR 576
R +A+G+ +L ++ I HRD+ A NVLL +KI DFGLA+ ++ ++
Sbjct: 216 RFSSQVAQGMDFLASKNCI---HRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYV--- 269
Query: 577 VAGT----IGYMAPEYAMRGHLTEKADVYSFGIVALEIVS-GRS---NVTKEDMFYLLDW 628
V G + +MAPE T ++DV+S+GI+ EI S G+S + FY +
Sbjct: 270 VKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKM-- 327
Query: 629 ALVLKEQGKLMELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLE 684
+K G M D P E +M +C N PT RP+ S + ++++
Sbjct: 328 ---VKR-GYQMSRPDFAP-----PEIYSIM----KMCWNLEPTERPTFSQISQLIQ 370
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.7 bits (153), Expect = 2e-10
Identities = 59/240 (24%), Positives = 91/240 (37%), Gaps = 56/240 (23%)
Query: 416 NNFATDNNIGEGGFGPVYKGLLA----DGTAIAVKQLSSKSKQGNREFI------NEIGM 465
++F IG G FG V+ L G A+K L KS R I +I +
Sbjct: 1 DDFEVIKVIGRGAFGEVW---LVRDKDTGQVYAMKVLR-KSDMIKRNQIAHVRAERDI-L 55
Query: 466 ISALQHPNLVKLYGCCIEGNQLLLIYEYLENNSLARALFE-HRLKLDWPTR---RRICLG 521
A P +VKLY + L L+ EY+ L L + R + L
Sbjct: 56 ADA-DSPWIVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEET-ARFYIAELVLA 113
Query: 522 IARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAK----------------- 564
+ +H ++ +HRDIK N+L+D D + K++DFGL K
Sbjct: 114 LD----SVH---KLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHN 166
Query: 565 -----------LDEEENTHISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSG 613
D ++ + GT Y+APE + D +S G++ E++ G
Sbjct: 167 LLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYG 226
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 2e-10
Identities = 65/219 (29%), Positives = 96/219 (43%), Gaps = 17/219 (7%)
Query: 424 IGEGGFGPVYKGLL----ADGTAIAVKQLSSK---SKQGNREFINEIGMISALQHPNLVK 476
+G+G FG V +L A G A+K L + +K + E ++ +HP L
Sbjct: 3 LGKGTFGKV---ILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTA 59
Query: 477 LYGCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIK 536
L ++L + EY L L R+ + R I L YLH
Sbjct: 60 LKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTE-ERARFYGAEIVSALEYLHSRD--- 115
Query: 537 VVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPEYAMRGHLTE 596
VV+RDIK N++LDKD + KI+DFGL K + + T GT Y+APE
Sbjct: 116 VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT-FCGTPEYLAPEVLEDNDYGR 174
Query: 597 KADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQ 635
D + G+V E++ GR +D L + L+L E+
Sbjct: 175 AVDWWGLGVVMYEMMCGRLPFYNQDHERLFE--LILMEE 211
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 61.8 bits (150), Expect = 2e-10
Identities = 56/201 (27%), Positives = 88/201 (43%), Gaps = 17/201 (8%)
Query: 424 IGEGGFGPVYK-GLLADGTAIAVKQLSSKSKQGNREFINEIGM----ISALQHPNLVKLY 478
+G+GGFG V + A G A K+L+ K + + + E M I A H +
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGY--EGAMVEKRILAKVHSRFIVSL 58
Query: 479 GCCIEGNQLLLIYEYLENNSLAR----ALFEHRLKLDWPTRRRICLGIARGLAYLHGESR 534
+ L + + N R + E P I GL +LH
Sbjct: 59 AYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR-- 116
Query: 535 IKVVHRDIKATNVLLDKDLNSKISDFGLA-KLDEEENTHISTRVAGTIGYMAPEYAMRGH 593
++++RD+K NVLLD D N +ISD GLA +L + ++ + AGT G+MAPE
Sbjct: 117 -RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSK--TKGYAGTPGFMAPELLQGEE 173
Query: 594 LTEKADVYSFGIVALEIVSGR 614
D ++ G+ E+++ R
Sbjct: 174 YDFSVDYFALGVTLYEMIAAR 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 62.4 bits (151), Expect = 2e-10
Identities = 62/238 (26%), Positives = 109/238 (45%), Gaps = 26/238 (10%)
Query: 424 IGEGGFGPVYKGLLAD-GTAIAVKQLSS--KSKQGNREFINEIGMISALQHPNLVKLYGC 480
+G G +G V +AVK+LS +S R E+ ++ ++H N++ L
Sbjct: 23 VGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDV 82
Query: 481 CIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGI---ARGLAYLHGESRIKV 537
+ E +L A + +K + + I RGL Y+H +
Sbjct: 83 FTPATSIENFNEVYLVTNLMGADLNNIVKCQKLSDEHVQFLIYQLLRGLKYIHSAG---I 139
Query: 538 VHRDIKATNVLLDKDLNSKISDFGLAK-LDEEENTHISTRVAGTIGYMAPEYAMRG-HLT 595
+HRD+K +NV +++D +I DFGLA+ D+E +++TR Y APE + H
Sbjct: 140 IHRDLKPSNVAVNEDCELRILDFGLARQADDEMTGYVATR-----WYRAPEIMLNWMHYN 194
Query: 596 EKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDKE 653
+ D++S G + E++ G++ +F D+ LK ++ME+V T P K+
Sbjct: 195 QTVDIWSVGCIMAELLKGKA------LFPGNDYIDQLK---RIMEVVGT-PSPEVLKK 242
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 3e-10
Identities = 46/145 (31%), Positives = 64/145 (44%), Gaps = 5/145 (3%)
Query: 470 QHPNLVKLYGCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYL 529
+HP L L ++L + EY L L R+ R I L YL
Sbjct: 53 RHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERV-FSEDRARFYGAEIVSALGYL 111
Query: 530 HGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPEYA 589
H VV+RD+K N++LDKD + KI+DFGL K + + T GT Y+APE
Sbjct: 112 H---SCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKT-FCGTPEYLAPEVL 167
Query: 590 MRGHLTEKADVYSFGIVALEIVSGR 614
D + G+V E++ GR
Sbjct: 168 EDNDYGRAVDWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 61.3 bits (149), Expect = 3e-10
Identities = 49/262 (18%), Positives = 102/262 (38%), Gaps = 29/262 (11%)
Query: 432 VYKGLLADGTAIAVKQL---SSKSKQGNREFINEIGMISALQHPNLVKLYGCCIEGN--- 485
+YKG+ + + ++ K NEI + + N++K+YG I+
Sbjct: 36 IYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDL 94
Query: 486 -QLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKA 544
+L LI EY L L + + L + T+ + + +GL L+ ++++ +
Sbjct: 95 PRLSLILEYCTRGYLREVLDKEK-DLSFKTKLDMAIDCCKGLYNLY--KYTNKPYKNLTS 151
Query: 545 TNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPEYAMR--GHLTEKADVYS 602
+ L+ ++ KI GL K+ + + Y + + T K D+YS
Sbjct: 152 VSFLVTENYKLKIICHGLEKILSSP----PFKNVNFMVYFSYKMLNDIFSEYTIKDDIYS 207
Query: 603 FGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDKEQVMVMINVA 662
G+V EI +G + E++ + L++ + N + + + +
Sbjct: 208 LGVVLWEIFTG--KIPFENLTTKEIYDLIINK----------NNSLKLPLDCPLEIKCIV 255
Query: 663 LLCANASPTIRPSMSSVLRMLE 684
C + RP++ +L L
Sbjct: 256 EACTSHDSIKRPNIKEILYNLS 277
|
Length = 283 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 62.2 bits (151), Expect = 4e-10
Identities = 54/197 (27%), Positives = 93/197 (47%), Gaps = 23/197 (11%)
Query: 493 YLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKD 552
Y++ + + L E L LD +A+G+++L ++ I HRD+ A N+LL
Sbjct: 194 YIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCI---HRDLAARNILLTHG 250
Query: 553 LNSKISDFGLAK-LDEEENTHISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIV 611
+KI DFGLA+ + + N + + +MAPE T ++DV+S+GI+ EI
Sbjct: 251 RITKICDFGLARDIRNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIF 310
Query: 612 S-GRS---NVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDKEQVMVMINVALLCAN 667
S G S + + FY + +KE G M + P M ++ C +
Sbjct: 311 SLGSSPYPGMPVDSKFYKM-----IKE-GYRMLSPECAPSE---------MYDIMKSCWD 355
Query: 668 ASPTIRPSMSSVLRMLE 684
A P RP+ +++++E
Sbjct: 356 ADPLKRPTFKQIVQLIE 372
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 61.5 bits (149), Expect = 5e-10
Identities = 57/208 (27%), Positives = 94/208 (45%), Gaps = 15/208 (7%)
Query: 412 KAATNNFATDNNIGEGGFGPVYKGLLADGT--AIAVKQLSS----KSKQGNREFINEIGM 465
K +F +G G FG V + +A+K+ K KQ + F +E +
Sbjct: 26 KMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVF-SERKI 84
Query: 466 ISALQHPNLVKLYGCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARG 525
++ + HP V LYG + + L L+ E++ L R +P C A+
Sbjct: 85 LNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFL---RRNKRFPNDVG-CFYAAQI 140
Query: 526 LAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMA 585
+ + +V+RD+K N+LLDKD K++DFG AK+ + + + GT Y+A
Sbjct: 141 VLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTR----TYTLCGTPEYIA 196
Query: 586 PEYAMRGHLTEKADVYSFGIVALEIVSG 613
PE + + AD ++ GI EI+ G
Sbjct: 197 PEILLNVGHGKAADWWTLGIFIYEILVG 224
|
Length = 340 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 6e-10
Identities = 58/202 (28%), Positives = 92/202 (45%), Gaps = 12/202 (5%)
Query: 424 IGEGGFGPVYK-GLLADGTAIAVKQLSSK---SKQGNREFINEIGMISALQHPNLVKLYG 479
+G+GGFG V + A G A K+L K ++G +NE ++ + +V L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAY 67
Query: 480 CCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLG--IARGLAYLHGESRIKV 537
+ L L+ + L ++ + +R I + GL L E ++
Sbjct: 68 AYETKDALCLVLTIMNGGDLKFHIYNMG-NPGFDEQRAIFYAAELCCGLEDLQRE---RI 123
Query: 538 VHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPEYAMRGHLTEK 597
V+RD+K N+LLD + +ISD GLA + E + RV GT+GYMAPE T
Sbjct: 124 VYRDLKPENILLDDRGHIRISDLGLA-VQIPEGETVRGRV-GTVGYMAPEVINNEKYTFS 181
Query: 598 ADVYSFGIVALEIVSGRSNVTK 619
D + G + E++ G+S K
Sbjct: 182 PDWWGLGCLIYEMIQGQSPFRK 203
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 6e-10
Identities = 43/151 (28%), Positives = 77/151 (50%), Gaps = 7/151 (4%)
Query: 472 PNLVKLYGCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHG 531
P L +L+ C ++L + EY+ L + + + P IA GL +LH
Sbjct: 61 PFLTQLHSCFQTMDRLYFVMEYVNGGDLMYQI-QQVGRFKEPHAVFYAAEIAIGLFFLHS 119
Query: 532 ESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRV-AGTIGYMAPEYAM 590
+ +++RD+K NV+LD + + KI+DFG+ K E ++T+ GT Y+APE
Sbjct: 120 KG---IIYRDLKLDNVMLDSEGHIKIADFGMCK--ENMWDGVTTKTFCGTPDYIAPEIIA 174
Query: 591 RGHLTEKADVYSFGIVALEIVSGRSNVTKED 621
+ D ++FG++ E+++G++ ED
Sbjct: 175 YQPYGKSVDWWAFGVLLYEMLAGQAPFEGED 205
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 7e-10
Identities = 44/151 (29%), Positives = 76/151 (50%), Gaps = 7/151 (4%)
Query: 472 PNLVKLYGCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHG 531
P L +L+ C ++L + EY+ L + + K P I+ GL +LH
Sbjct: 61 PFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHI-QQVGKFKEPQAVFYAAEISVGLFFLH- 118
Query: 532 ESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRV-AGTIGYMAPEYAM 590
R +++RD+K NV+LD + + KI+DFG+ K E ++TR GT Y+APE
Sbjct: 119 --RRGIIYRDLKLDNVMLDSEGHIKIADFGMCK--EHMVDGVTTRTFCGTPDYIAPEIIA 174
Query: 591 RGHLTEKADVYSFGIVALEIVSGRSNVTKED 621
+ D +++G++ E+++G+ ED
Sbjct: 175 YQPYGKSVDWWAYGVLLYEMLAGQPPFDGED 205
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 8e-10
Identities = 46/150 (30%), Positives = 75/150 (50%), Gaps = 7/150 (4%)
Query: 467 SALQHPNLVKLYGCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGL 526
+A HP LV L+ C ++L + E++ L + R KL R I+ L
Sbjct: 51 TASNHPFLVGLHSCFQTESRLFFVIEFVSGGDLMFHMQRQR-KLPEEHARFYSAEISLAL 109
Query: 527 AYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAP 586
+LH +++RD+K NVLLD + + K++D+G+ K ST GT Y+AP
Sbjct: 110 NFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTST-FCGTPNYIAP 165
Query: 587 EYAMRGHLTE-KADVYSFGIVALEIVSGRS 615
E +RG D ++ G++ E+++GRS
Sbjct: 166 E-ILRGEDYGFSVDWWALGVLMFEMMAGRS 194
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 60.4 bits (147), Expect = 1e-09
Identities = 53/220 (24%), Positives = 99/220 (45%), Gaps = 39/220 (17%)
Query: 417 NFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSKSK--QGNREFINEIGMISALQHPN 473
+ NIG G +G V + G +A+K++ + + E+ ++ +H N
Sbjct: 6 RYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDN 65
Query: 474 LVKLYGCCI---------EGNQLLLIYEYLENNSLARALFEHRLKLDWP-TRRRIC--LG 521
++ I + + ++ + +E++ H + D P T I L
Sbjct: 66 II-----AIRDILRPPGADFKDVYVVMDLMESD------LHHIIHSDQPLTEEHIRYFLY 114
Query: 522 -IARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKL----DEEENTHISTR 576
+ RGL Y+H V+HRD+K +N+L+++D +I DFG+A+ E ++
Sbjct: 115 QLLRGLKYIHSA---NVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEY 171
Query: 577 VAGTIGYMAPE--YAMRGHLTEKADVYSFGIVALEIVSGR 614
VA T Y APE ++ + T D++S G + E++ GR
Sbjct: 172 VA-TRWYRAPELLLSLPEY-TTAIDMWSVGCIFAEML-GR 208
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.1 bits (146), Expect = 1e-09
Identities = 55/226 (24%), Positives = 89/226 (39%), Gaps = 16/226 (7%)
Query: 416 NNFATDNNIGEGGFGPVYKGLLAD-GTAIAVKQLSSK---SKQGNREFINEIGMISALQH 471
+F +G+GG+G V+ D G +A+K++ R + E +++ +
Sbjct: 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKS 60
Query: 472 PNLVKLYGCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHG 531
LVKL + L L EY+ R L + L R + + LH
Sbjct: 61 EWLVKLLYAFQDDEYLYLAMEYVPGGDF-RTLLNNLGVLSEDHARFYMAEMFEAVDALH- 118
Query: 532 ESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPEYAMR 591
+ +HRD+K N L+D + K++DFGL+K + V G+ YMAPE
Sbjct: 119 --ELGYIHRDLKPENFLIDASGHIKLTDFGLSK----GIVTYANSVVGSPDYMAPEVLRG 172
Query: 592 GHLTEKADVYSFGIVALEIVSG----RSNVTKEDMFYLLDWALVLK 633
D +S G + E + G + E L W L+
Sbjct: 173 KGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQ 218
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 2e-09
Identities = 35/101 (34%), Positives = 57/101 (56%), Gaps = 6/101 (5%)
Query: 522 IARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRV-AGT 580
IA GL +LH + +++RD+K NV+LD + + KI+DFG+ K E +TR GT
Sbjct: 110 IAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCK--ENIFGGKTTRTFCGT 164
Query: 581 IGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKED 621
Y+APE + D ++FG++ E+++G+ ED
Sbjct: 165 PDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGED 205
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 58.6 bits (142), Expect = 2e-09
Identities = 83/291 (28%), Positives = 124/291 (42%), Gaps = 66/291 (22%)
Query: 424 IGEGGFGPVYKGLL-------ADGTAIAVKQLSSKSKQGNR---EFINEIGMISALQHPN 473
+G+G F +YKG+L G V + +R F ++S L H +
Sbjct: 3 LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKH 62
Query: 474 LVKLYGCCI-EGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICL--GIARGLAYLH 530
LVKLYG C+ + N ++ EY++ L +F HR K + ++ + +A L YL
Sbjct: 63 LVKLYGVCVRDENIMVE--EYVKFGPL--DVFLHREKNNVSLHWKLDVAKQLASALHYL- 117
Query: 531 GESRIKVVHRDIKATNVLLDK-DLNS------KISDFGLAK--LDEEENTHISTRVAGTI 581
E + K+VH ++ N+L+ + LN K+SD G+ L EE RV I
Sbjct: 118 -EDK-KLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSREE------RVE-RI 168
Query: 582 GYMAPEYAMRGH--LTEKADVYSFGIVALEIVSG-------RSNVTKEDMFYLLDWALVL 632
++APE G LT AD +SFG LEI S S+ KE FY L +
Sbjct: 169 PWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKE-RFYQDQHRLPM 227
Query: 633 KEQGKLMELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRML 683
+ +L L++ C PT RPS ++LR L
Sbjct: 228 PDCAELANLINQ--------------------CWTYDPTKRPSFRAILRDL 258
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 3e-09
Identities = 50/202 (24%), Positives = 96/202 (47%), Gaps = 22/202 (10%)
Query: 424 IGEGGFGPVYKGL-LADGTAIAVKQLSS--KSKQGNREFINEIGMISALQHPNLVKLYGC 480
+G G +G V L G +A+K+L +S+ + E+ ++ ++H N++ L
Sbjct: 23 VGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDV 82
Query: 481 CI------EGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESR 534
+ L+ ++ L + + +L D + + + +GL Y+H
Sbjct: 83 FTPDLSLDRFHDFYLVMPFM-GTDLGKLMKHEKLSED--RIQFLVYQMLKGLKYIHAAG- 138
Query: 535 IKVVHRDIKATNVLLDKDLNSKISDFGLAK-LDEEENTHISTRVAGTIGYMAPEYAMRG- 592
++HRD+K N+ +++D KI DFGLA+ D E ++ TR Y APE +
Sbjct: 139 --IIHRDLKPGNLAVNEDCELKILDFGLARQTDSEMTGYVVTR-----WYRAPEVILNWM 191
Query: 593 HLTEKADVYSFGIVALEIVSGR 614
H T+ D++S G + E+++G+
Sbjct: 192 HYTQTVDIWSVGCIMAEMLTGK 213
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 3e-09
Identities = 45/178 (25%), Positives = 77/178 (43%), Gaps = 22/178 (12%)
Query: 453 KQGNRE-FINEIGMISALQHPNLVKLYGCCIEGNQLLLIYEYLENNSLARALFEHRLKLD 511
K G R E ++ A+ HP++++L G + Y + L ++ L
Sbjct: 123 KAGQRGGTATEAHILRAINHPSIIQLKG----------TFTYNKFTCLILPRYKTDLYCY 172
Query: 512 WPTRRRICL--------GIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLA 563
+R I + + R + YLH ++HRDIKA N+ ++ + + DFG A
Sbjct: 173 LAAKRNIAICDILAIERSVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFGAA 229
Query: 564 KLDEEENTHISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKED 621
+ N + AGTI APE R D++S GIV E+ + ++ ++D
Sbjct: 230 CFPVDINANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKD 287
|
Length = 391 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 4e-09
Identities = 46/157 (29%), Positives = 82/157 (52%), Gaps = 9/157 (5%)
Query: 461 NEIGMISALQHPNLVKLYGCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRR--- 517
+E+ ++A H +VK + ++LLLI EY L + + + RLK P +
Sbjct: 114 SELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQI-KQRLKEHLPFQEYEVG 172
Query: 518 -ICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAK-LDEEENTHIST 575
+ I L +H SR K++HRD+K+ N+ L K+ DFG +K + + +++
Sbjct: 173 LLFYQIVLALDEVH--SR-KMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVAS 229
Query: 576 RVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVS 612
GT Y+APE R ++KAD++S G++ E+++
Sbjct: 230 SFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLT 266
|
Length = 478 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 58.7 bits (142), Expect = 4e-09
Identities = 59/213 (27%), Positives = 93/213 (43%), Gaps = 19/213 (8%)
Query: 416 NNFATDNNIGEGGFGPVYKGLL---ADGTAIAVKQLSSKSKQGNRE----FINEIGMISA 468
+F + +G G FG V ++ A G A+K + KS +E F E ++S
Sbjct: 1 KDFDVKSLVGRGHFGEVQ--VVREKATGDIYAMKVMK-KSVLLAQETVSFFEEERDILSI 57
Query: 469 LQHPNLVKLYGCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAY 528
P + +L + + L L+ EY L L + + D + +A +
Sbjct: 58 SNSPWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQ---FYLAELVLA 114
Query: 529 LHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPEY 588
+H ++ VHRDIK NVL+D+ + K++DFG A S GT Y+APE
Sbjct: 115 IHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEV 174
Query: 589 --AMRGHLTEKADV----YSFGIVALEIVSGRS 615
M G V +S G++A E++ GRS
Sbjct: 175 LTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRS 207
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 4e-09
Identities = 55/214 (25%), Positives = 92/214 (42%), Gaps = 17/214 (7%)
Query: 409 LQIKAATNNFATDNNIGEGGFGPVYKGLLADGTAIAVKQLSSKSKQGNRE----FINEIG 464
LQ+KA ++ IG G FG V + +L SK + R F E
Sbjct: 38 LQMKA--EDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERD 95
Query: 465 MISALQHPNLVKLYGCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIAR 524
+++ P +V+L+ + L ++ EY+ L + + + W A
Sbjct: 96 IMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEKWAK-----FYTAE 150
Query: 525 GLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLA-KLDEEENTHISTRVAGTIGY 583
+ L + ++HRD+K N+LLDK + K++DFG K+DE T V GT Y
Sbjct: 151 VVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAV-GTPDY 209
Query: 584 MAPEYAMR----GHLTEKADVYSFGIVALEIVSG 613
++PE G+ + D +S G+ E++ G
Sbjct: 210 ISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVG 243
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 58.4 bits (141), Expect = 4e-09
Identities = 62/241 (25%), Positives = 114/241 (47%), Gaps = 39/241 (16%)
Query: 424 IGEGGFGPVYKGL-LADGTAIAVKQLSS--KSKQGNREFINEIGMISALQHPNLVKL--- 477
+G G +G V + G +A+K+LS +S+ + E+ ++ +QH N++ L
Sbjct: 23 VGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDV 82
Query: 478 YGCCIEGNQL---LLIYEYLENNSLARALFEHRL---KLDWPTRRRICLGIARGLAYLHG 531
+ + G++ L+ Y++ + + + H L K+ + + +C GL Y+H
Sbjct: 83 FTSAVSGDEFQDFYLVMPYMQTD--LQKIMGHPLSEDKVQYLVYQMLC-----GLKYIHS 135
Query: 532 ESRIKVVHRDIKATNVLLDKDLNSKISDFGLAK-LDEEENTHISTRVAGTIGYMAPEYAM 590
++HRD+K N+ +++D KI DFGLA+ D E ++ TR Y APE +
Sbjct: 136 AG---IIHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTR-----WYRAPEVIL 187
Query: 591 RG-HLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSN 649
H + D++S G + E+++G++ +D YL +LK G PG
Sbjct: 188 NWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKD--YLDQLTQILKVTG--------VPGPE 237
Query: 650 F 650
F
Sbjct: 238 F 238
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 4e-09
Identities = 64/262 (24%), Positives = 114/262 (43%), Gaps = 39/262 (14%)
Query: 388 DYQLYTTARLSAISLTYYGFYLQIKAATNNFATDNNIGEGGFGPVYKGL-LADGTAIAVK 446
D Q Y+ +++ + T Y Q+K IG G G V G +AVK
Sbjct: 4 DSQFYSV-QVADSTFTVLKRYQQLKP----------IGSGAQGIVCAAFDTVLGINVAVK 52
Query: 447 QLS------SKSKQGNREFINEIGMISALQHPNLVKLYGCCI------EGNQLLLIYEYL 494
+LS + +K+ RE + ++ + H N++ L E + L+ E +
Sbjct: 53 KLSRPFQNQTHAKRAYRELV----LLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELM 108
Query: 495 ENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLN 554
+ N L + + ++LD + + G+ +LH ++HRD+K +N+++ D
Sbjct: 109 DAN-LCQVI---HMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCT 161
Query: 555 SKISDFGLAKLDEEENTHISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGR 614
KI DFGLA+ + T T Y APE + E D++S G + E+V G
Sbjct: 162 LKILDFGLAR--TACTNFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKG- 218
Query: 615 SNVTKEDMFYLLDWALVLKEQG 636
+V + ++ W V+++ G
Sbjct: 219 -SVIFQGTDHIDQWNKVIEQLG 239
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 1e-08
Identities = 36/94 (38%), Positives = 57/94 (60%), Gaps = 8/94 (8%)
Query: 522 IARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHI---STRVA 578
+ARG+ +L SR K +HRD+ A N+LL ++ KI DFGLA+ ++ ++ S R+
Sbjct: 183 VARGMEFL--ASR-KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLP 239
Query: 579 GTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVS 612
+ +MAPE T ++DV+SFG++ EI S
Sbjct: 240 --LKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS 271
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 1e-08
Identities = 53/208 (25%), Positives = 96/208 (46%), Gaps = 24/208 (11%)
Query: 424 IGEGGFGPVYKGLLADGT---AIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGC 480
+G G +G VYK DG A+KQ+ + EI ++ L+HPN++ L
Sbjct: 9 VGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI--SMSACREIALLRELKHPNVIALQKV 66
Query: 481 CIEGN--QLLLIYEYLENN-----SLARALFEHRLKLDWPTR--RRICLGIARGLAYLHG 531
+ + ++ L+++Y E++ RA ++ + P + + I G+ YLH
Sbjct: 67 FLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHA 126
Query: 532 ESRIKVVHRDIKATNVLL----DKDLNSKISDFGLAKLDEEENTHIS--TRVAGTIGYMA 585
V+HRD+K N+L+ + KI+D G A+L ++ V T Y A
Sbjct: 127 NW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRA 183
Query: 586 PEYAMRG-HLTEKADVYSFGIVALEIVS 612
PE + H T+ D+++ G + E+++
Sbjct: 184 PELLLGARHYTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 2e-08
Identities = 35/92 (38%), Positives = 55/92 (59%), Gaps = 4/92 (4%)
Query: 522 IARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAG-T 580
+ARG+ +L SR K +HRD+ A N+LL ++ KI DFGLA+ ++ ++ A
Sbjct: 182 VARGMEFL--ASR-KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLP 238
Query: 581 IGYMAPEYAMRGHLTEKADVYSFGIVALEIVS 612
+ +MAPE T ++DV+SFG++ EI S
Sbjct: 239 LKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS 270
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 3e-08
Identities = 47/177 (26%), Positives = 82/177 (46%), Gaps = 17/177 (9%)
Query: 446 KQLSSKSKQGNREFI---NEIGMISALQHPNLVKLYGCC-IEGNQLLLIYEYLENNSLAR 501
+ ++ + K G+R I NEI + L H N++K+ E N ++ +Y + L
Sbjct: 194 RLIAKRVKAGSRAAIQLENEILALGRLNHENILKIEEILRSEANTYMITQKY--DFDLYS 251
Query: 502 ALFEHRLKLDWPTR------RRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNS 555
+++ DW R R I + + Y+H + K++HRDIK N+ L+ D
Sbjct: 252 FMYDE--AFDWKDRPLLKQTRAIMKQLLCAVEYIHDK---KLIHRDIKLENIFLNCDGKI 306
Query: 556 KISDFGLAKLDEEENTHISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVS 612
+ DFG A E+E GT+ +PE E D++S G++ L+++S
Sbjct: 307 VLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLS 363
|
Length = 501 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 55.9 bits (135), Expect = 3e-08
Identities = 56/206 (27%), Positives = 90/206 (43%), Gaps = 21/206 (10%)
Query: 424 IGEGGFGPV----YKGLLADGTAIAVKQLS---SKSKQGNREFINEIGMISALQ-HPNLV 475
+G+G +G V ++ +A+K+++ SK R + E+ ++ + H N+
Sbjct: 8 LGQGAYGIVCSARNAET-SEEETVAIKKITNVFSKKILAKRA-LRELKLLRHFRGHKNIT 65
Query: 476 KLYGCCI---EGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGE 532
LY I L +YE L L + L + I GL Y+H
Sbjct: 66 CLYDMDIVFPGNFNELYLYEELMEADLH-QIIRSGQPLTDAHFQSFIYQILCGLKYIHSA 124
Query: 533 SRIKVVHRDIKATNVLLDKDLNSKISDFGLAK---LDEEENTHISTRVAGTIGYMAPEYA 589
+ V+HRD+K N+L++ D KI DFGLA+ + EN T T Y APE
Sbjct: 125 N---VLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATRWYRAPEIM 181
Query: 590 MRGHLTEKA-DVYSFGIVALEIVSGR 614
+ KA DV+S G + E++ +
Sbjct: 182 LSFQSYTKAIDVWSVGCILAELLGRK 207
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 3e-08
Identities = 32/91 (35%), Positives = 48/91 (52%), Gaps = 4/91 (4%)
Query: 521 GIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLA-KLDEEENTHISTRVAG 579
+ LAYLHG ++HRD+K N+ LD+ N+ + DFG A KLD +T +G
Sbjct: 193 RLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYGWSG 249
Query: 580 TIGYMAPEYAMRGHLTEKADVYSFGIVALEI 610
T+ +PE K D++S G+V E+
Sbjct: 250 TLETNSPELLALDPYCAKTDIWSAGLVLFEM 280
|
Length = 392 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 3e-08
Identities = 53/208 (25%), Positives = 95/208 (45%), Gaps = 24/208 (11%)
Query: 424 IGEGGFGPVYKGLLADGTA---IAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGC 480
+G G +G VYK DG A+KQ+ + EI ++ L+HPN++ L
Sbjct: 9 VGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI--SMSACREIALLRELKHPNVISLQKV 66
Query: 481 CIE--GNQLLLIYEYLENN-----SLARALFEHRLKLDWP--TRRRICLGIARGLAYLHG 531
+ ++ L+++Y E++ RA ++ + P + + I G+ YLH
Sbjct: 67 FLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHA 126
Query: 532 ESRIKVVHRDIKATNVLL----DKDLNSKISDFGLAKLDEEENTHIS--TRVAGTIGYMA 585
V+HRD+K N+L+ + KI+D G A+L ++ V T Y A
Sbjct: 127 NW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRA 183
Query: 586 PEYAMRG-HLTEKADVYSFGIVALEIVS 612
PE + H T+ D+++ G + E+++
Sbjct: 184 PELLLGARHYTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 4e-08
Identities = 25/79 (31%), Positives = 49/79 (62%)
Query: 76 LKGPIPKYLANISTLVNLTVQYNQFSGELPEELGSLLNLEKLHLSSNNFTGELPKTFAKL 135
L+G IP ++ + L ++ + N G +P LGS+ +LE L LS N+F G +P++ +L
Sbjct: 430 LRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQL 489
Query: 136 TNMKDFRISDNQFTGQIPS 154
T+++ ++ N +G++P+
Sbjct: 490 TSLRILNLNGNSLSGRVPA 508
|
Length = 623 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 54.5 bits (131), Expect = 5e-08
Identities = 63/242 (26%), Positives = 112/242 (46%), Gaps = 48/242 (19%)
Query: 459 FINEIGMISALQHPNLVKLYGCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRI 518
F ++S + H +L ++G C+ G++ +++ E++E+ L L + + ++ + +
Sbjct: 63 FFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITV 122
Query: 519 CLGIARGLAYLHGESRIKVVHRDIKATNVLLDK----DLNS---KISDFG--LAKLDEEE 569
+A L+YL ++ +VH ++ A N+LL + + S K+SD G L EE
Sbjct: 123 AQQLASALSYLEDKN---LVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVSFTALSREE 179
Query: 570 NTHISTRVAGTIGYMAPEYAMRG-HLTEKADVYSFGIVALEI-------VSGRSNVTKED 621
RV I ++APE G L+ AD +SFG LEI + R+ KE
Sbjct: 180 ------RVE-RIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKE- 231
Query: 622 MFYLLDWALVLKEQGKLMELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLR 681
FY +++ +L E P +++ +I+ C PT RPS ++LR
Sbjct: 232 RFY--------EKKHRLPE-----PSC----KELATLIS---QCLTYEPTQRPSFRTILR 271
Query: 682 ML 683
L
Sbjct: 272 DL 273
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 6e-08
Identities = 34/92 (36%), Positives = 52/92 (56%), Gaps = 4/92 (4%)
Query: 522 IARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHIST-RVAGT 580
+ARG+ +L ++ VHRD+ A NVLL + KI DFGLA+ ++ ++S
Sbjct: 246 VARGMEFLASKN---CVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLP 302
Query: 581 IGYMAPEYAMRGHLTEKADVYSFGIVALEIVS 612
+ +MAPE T +DV+S+GI+ EI S
Sbjct: 303 VKWMAPESIFDNLYTTLSDVWSYGILLWEIFS 334
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 6e-08
Identities = 42/159 (26%), Positives = 74/159 (46%), Gaps = 20/159 (12%)
Query: 470 QHPNLVKLYGCCIEGNQ-LLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAY 528
++P +V ++ C E + L ++ EY+E A L ++ L R L Y
Sbjct: 59 ENPFVVSMF-CSFETKRHLCMVMEYVEGGDCA-TLLKNIGALPVDMARMYFAETVLALEY 116
Query: 529 LHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAK--------------LDEEENTHIS 574
LH +VHRD+K N+L+ + K++DFGL+K ++++ +
Sbjct: 117 LHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLD 173
Query: 575 TRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSG 613
+V GT Y+APE +R + D ++ GI+ E + G
Sbjct: 174 KQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVG 212
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 55.1 bits (132), Expect = 6e-08
Identities = 57/228 (25%), Positives = 103/228 (45%), Gaps = 32/228 (14%)
Query: 424 IGEGGFGPV---YKGLLADGTAIAVKQLS------SKSKQGNREFINEIGMISALQHPNL 474
IG G G V Y +L +A+K+LS + +K+ RE + ++ + H N+
Sbjct: 25 IGSGAQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAYRELV----LMKCVNHKNI 78
Query: 475 VKLYGCCI------EGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAY 528
+ L E + L+ E ++ N L + + +++LD + + G+ +
Sbjct: 79 ISLLNVFTPQKSLEEFQDVYLVMELMDAN-LCQVI---QMELDHERMSYLLYQMLCGIKH 134
Query: 529 LHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPEY 588
LH ++HRD+K +N+++ D KI DFGLA+ + + T T Y APE
Sbjct: 135 LHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEV 189
Query: 589 AMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQG 636
+ E D++S G + E+V + D Y+ W V+++ G
Sbjct: 190 ILGMGYKENVDIWSVGCIMGEMVRHKILFPGRD--YIDQWNKVIEQLG 235
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 7e-08
Identities = 58/228 (25%), Positives = 106/228 (46%), Gaps = 34/228 (14%)
Query: 412 KAATNNFATDNNIGEGGFGPVYKGLLADGT-AIAVKQLSSKSKQGNREFINEIGMISALQ 470
++ ++ N IG G FG VY+ + D + +A+K++ + NRE + ++ L
Sbjct: 62 RSPNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKNRELL----IMKNLN 117
Query: 471 HPNLVKL----YGCCIEGNQ----LLLIYEYLENNSLARALFEHRLKLDWPTR--RRICL 520
H N++ L Y C + N+ L ++ E++ R P +
Sbjct: 118 HINIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSY 177
Query: 521 GIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNS-KISDFGLAK---LDEEENTHISTR 576
+ R LAY+H + + HRD+K N+L+D + ++ K+ DFG AK + ++I +R
Sbjct: 178 QLCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSYICSR 234
Query: 577 VAGTIGYMAPEYAMRG-HLTEKADVYSFGIVALEIV------SGRSNV 617
Y APE + + T D++S G + E++ SG+S+V
Sbjct: 235 F-----YRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSV 277
|
Length = 440 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 1e-07
Identities = 34/92 (36%), Positives = 55/92 (59%), Gaps = 4/92 (4%)
Query: 522 IARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAG-T 580
+A+G+ +L SR K +HRD+ A N+LL ++ KI DFGLA+ ++ ++ A
Sbjct: 188 VAKGMEFL--ASR-KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLP 244
Query: 581 IGYMAPEYAMRGHLTEKADVYSFGIVALEIVS 612
+ +MAPE T ++DV+SFG++ EI S
Sbjct: 245 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 276
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 1e-07
Identities = 56/227 (24%), Positives = 103/227 (45%), Gaps = 30/227 (13%)
Query: 424 IGEGGFGPV---YKGLLADGTAIAVKQLS------SKSKQGNREFINEIGMISALQHPNL 474
IG G G V Y +L +A+K+LS + +K+ RE + ++ + H N+
Sbjct: 32 IGSGAQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHAKRAYRELV----LMKCVNHKNI 85
Query: 475 VKLYGC-----CIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYL 529
+ L +E Q + I L + +L + + +++LD + + G+ +L
Sbjct: 86 IGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVI---QMELDHERMSYLLYQMLCGIKHL 142
Query: 530 HGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPEYA 589
H ++HRD+K +N+++ D KI DFGLA+ + + T T Y APE
Sbjct: 143 HSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEVI 197
Query: 590 MRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQG 636
+ E D++S G + E++ G D ++ W V+++ G
Sbjct: 198 LGMGYKENVDIWSVGCIMGEMIKGGVLFPGTD--HIDQWNKVIEQLG 242
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 53.3 bits (129), Expect = 1e-07
Identities = 39/148 (26%), Positives = 73/148 (49%), Gaps = 18/148 (12%)
Query: 471 HPNLVKLYGCCIEGNQLLLIYEYLENNSLARALFE---HRLKLDWPTRRRICLGIARGLA 527
+PN +KLY +LI +Y+++ L F+ KL ++I + L
Sbjct: 68 NPNFIKLYYSVTTLKGHVLIMDYIKDGDL----FDLLKKEGKLSEAEVKKIIRQLVEALN 123
Query: 528 YLHGESRIKVVHRDIKATNVLLDKDLNS-KISDFGLAKLDEEENTHISTRVAGTIGYMAP 586
LH + ++H DIK NVL D+ + + D+GL K+ + + GT+ Y +P
Sbjct: 124 DLH---KHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPSCY-----DGTLDYFSP 175
Query: 587 EYAMRGHLTEKA-DVYSFGIVALEIVSG 613
E ++GH + + D ++ G++ E+++G
Sbjct: 176 E-KIKGHNYDVSFDWWAVGVLTYELLTG 202
|
Length = 267 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.7 bits (129), Expect = 2e-07
Identities = 43/153 (28%), Positives = 71/153 (46%), Gaps = 10/153 (6%)
Query: 416 NNFATDNNIGEGGFGPV-YKGLLADGTAIAVKQLSSKSKQGNREFIN----EIGMISALQ 470
+F T IG+G FG V G A+K L KS+ ++ + E +++
Sbjct: 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLL-KSEMFKKDQLAHVKAERDVLAESD 59
Query: 471 HPNLVKLYGCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLH 530
P +V LY + L LI E+L L L ++ + TR +A + +
Sbjct: 60 SPWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTR----FYMAECVLAIE 115
Query: 531 GESRIKVVHRDIKATNVLLDKDLNSKISDFGLA 563
++ +HRDIK N+L+D+ + K+SDFGL+
Sbjct: 116 AVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLS 148
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.2 bits (128), Expect = 2e-07
Identities = 30/87 (34%), Positives = 47/87 (54%), Gaps = 5/87 (5%)
Query: 534 RIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPEY--AM- 590
++ VHRDIK NVLLDK+ + +++DFG + T S GT Y++PE AM
Sbjct: 120 QLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPEILQAME 179
Query: 591 --RGHLTEKADVYSFGIVALEIVSGRS 615
+G + D +S G+ E++ G +
Sbjct: 180 DGKGRYGPECDWWSLGVCMYEMLYGET 206
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 53.1 bits (128), Expect = 2e-07
Identities = 35/94 (37%), Positives = 54/94 (57%), Gaps = 6/94 (6%)
Query: 522 IARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTI 581
+ RGL Y+H + V+HRD+K +N+LL+ + + KI DFGLA+ E+ ++ V T
Sbjct: 117 LLRGLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEYVV-TR 172
Query: 582 GYMAPEYAMR-GHLTEKADVYSFGIVALEIVSGR 614
Y APE + T DV+S G + E++ GR
Sbjct: 173 WYRAPELLLNCSEYTTAIDVWSVGCIFAELL-GR 205
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 53.2 bits (128), Expect = 2e-07
Identities = 52/212 (24%), Positives = 94/212 (44%), Gaps = 35/212 (16%)
Query: 424 IGEGGFGPVYKGL-LADGTAIAVKQLSS--KSKQGNREFINEIGMISALQHPNLVKLYGC 480
IG+G +G V + G +A+K+++ + + EI ++ L+HP++V++
Sbjct: 8 IGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHI 67
Query: 481 CI-----EGNQLLLIYEYLE---------NNSLARALFEHRLKLDWPTRRRICLGIARGL 526
+ E + +++E +E N+ L EH + + R L
Sbjct: 68 MLPPSRREFKDIYVVFELMESDLHQVIKANDDLTP---EHH--------QFFLYQLLRAL 116
Query: 527 AYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAK--LDEEENTHISTRVAGTIGYM 584
Y+H + V HRD+K N+L + D KI DFGLA+ ++ T T Y
Sbjct: 117 KYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYR 173
Query: 585 APEY--AMRGHLTEKADVYSFGIVALEIVSGR 614
APE + T D++S G + E+++G+
Sbjct: 174 APELCGSFFSKYTPAIDIWSIGCIFAEVLTGK 205
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.1 bits (128), Expect = 3e-07
Identities = 65/240 (27%), Positives = 99/240 (41%), Gaps = 47/240 (19%)
Query: 416 NNFATDNNIGEGGFGPVYKGLLAD-GTAIAVKQLSSKSKQGNREFI----NEIGMISALQ 470
++F + IG G FG V D G A+K+L KS+ +E + E +++
Sbjct: 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLR-KSEMLEKEQVAHVRAERDILAEAD 59
Query: 471 HPNLVKLYGCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLH 530
+P +VKLY + N L LI EYL + L +K D T IA + +
Sbjct: 60 NPWVVKLYYSFQDENYLYLIMEYLPGGDMMTLL----MKKDTFTEEETRFYIAETILAID 115
Query: 531 GESRIKVVHRDIKATNVLLDKDLNSKISDFGL----------------------AKLDEE 568
++ +HRDIK N+LLD + K+SDFGL LD
Sbjct: 116 SIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFI 175
Query: 569 ENTHISTRVA---------------GTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSG 613
S R A GT Y+APE ++ ++ D +S G++ E++ G
Sbjct: 176 SKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVG 235
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 53.3 bits (128), Expect = 4e-07
Identities = 33/102 (32%), Positives = 47/102 (46%), Gaps = 23/102 (22%)
Query: 171 GLAGPIPSGIFSLENLTDLRISDLNGPEATFPQLGNMKMTKLILRNCNITGELPRYLGKM 230
GL G IP+ I L +L + +S GN +I G +P LG +
Sbjct: 429 GLRGFIPNDISKLRHLQSINLS------------GN-----------SIRGNIPPSLGSI 465
Query: 231 TKLKVLDLSFNRLRGQIPSNFDDLYDVDYIYFAGNLLTGAIP 272
T L+VLDLS+N G IP + L + + GN L+G +P
Sbjct: 466 TSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVP 507
|
Length = 623 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 5e-07
Identities = 56/202 (27%), Positives = 93/202 (46%), Gaps = 32/202 (15%)
Query: 440 GTAIAVK--QLSSKSKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYEYLENN 497
GT + V+ L + +++ + NE+ + +HPN++ + G+ L +I ++
Sbjct: 25 GTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYG 84
Query: 498 SLARALFEHRLKLDWPTR------RRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDK 551
S A +L LK +P I G RGL YLH I HR+IKA+++L+
Sbjct: 85 S-ANSL----LKTYFPEGMSEALIGNILFGALRGLNYLHQNGYI---HRNIKASHILISG 136
Query: 552 DLNSKISDFGLAKLDEEENTHISTRVA--------GTIGYMAPEYAMRGHL---TEKADV 600
D +S GL+ L +V + +++PE +R L K+D+
Sbjct: 137 D--GLVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPEL-LRQDLYGYNVKSDI 193
Query: 601 YSFGIVALEIVSGRSNVTKEDM 622
YS GI A E+ +GR V +DM
Sbjct: 194 YSVGITACELATGR--VPFQDM 213
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 6e-07
Identities = 48/194 (24%), Positives = 87/194 (44%), Gaps = 9/194 (4%)
Query: 424 IGEGGFGPVYKGLLADGTAI----AVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYG 479
IG+G FG V + D I +++ S+ + E +++ + P +V L
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60
Query: 480 CCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVH 539
+L L+ ++ L F H + R A L L + V++
Sbjct: 61 SFQSPEKLYLVLAFINGGEL----FHHLQREGRFDLSRARFYTAELLCALENLHKFNVIY 116
Query: 540 RDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPEYAMRGHLTEKAD 599
RD+K N+LLD + + DFGL KL+ +++ +T GT Y+APE + T+ D
Sbjct: 117 RDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNT-FCGTPEYLAPELLLGHGYTKAVD 175
Query: 600 VYSFGIVALEIVSG 613
++ G++ E+++G
Sbjct: 176 WWTLGVLLYEMLTG 189
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 7e-07
Identities = 44/145 (30%), Positives = 67/145 (46%), Gaps = 12/145 (8%)
Query: 485 NQLLLIYEYLENNSLARAL--FEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDI 542
N L L+ +Y L L FE RL D IA + +H ++ VHRDI
Sbjct: 74 NYLYLVMDYYVGGDLLTLLSKFEDRLPEDMAR-----FYIAEMVLAIHSIHQLHYVHRDI 128
Query: 543 KATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPEY--AMR---GHLTEK 597
K NVLLD + + +++DFG ++ T S+ GT Y++PE AM G +
Sbjct: 129 KPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPE 188
Query: 598 ADVYSFGIVALEIVSGRSNVTKEDM 622
D +S G+ E++ G + E +
Sbjct: 189 CDWWSLGVCMYEMLYGETPFYAESL 213
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 7e-07
Identities = 51/199 (25%), Positives = 87/199 (43%), Gaps = 15/199 (7%)
Query: 424 IGEGGFGPVYKGLLADGTAIAVKQLSSKSKQGNRE----FINEIGMISALQHPNLVKLYG 479
IG G FG V + +L SK + R F E +++ P +V+L+
Sbjct: 51 IGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFY 110
Query: 480 CCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVH 539
+ L ++ EY+ L + + + W R + L +H + +H
Sbjct: 111 AFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWA--RFYTAEVVLALDAIHS---MGFIH 165
Query: 540 RDIKATNVLLDKDLNSKISDFGLA-KLDEEENTHISTRVAGTIGYMAPEYAMR----GHL 594
RD+K N+LLDK + K++DFG K+++E T V GT Y++PE G+
Sbjct: 166 RDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV-GTPDYISPEVLKSQGGDGYY 224
Query: 595 TEKADVYSFGIVALEIVSG 613
+ D +S G+ E++ G
Sbjct: 225 GRECDWWSVGVFLYEMLVG 243
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 7e-07
Identities = 53/210 (25%), Positives = 91/210 (43%), Gaps = 16/210 (7%)
Query: 424 IGEGGFGPVYKGLLADGTAIAVKQLSSKSKQGNRE----FINEIGMISALQHPNLVKLYG 479
IG G FG V L + + ++ +K + R F E ++ + + L+
Sbjct: 9 IGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHY 68
Query: 480 CCIEGNQLLLIYEYLENNSLARAL--FEHRLKLDWPTRRRICLGIARGLAYLHGESRIKV 537
+ N L L+ +Y L L FE RL D +A + + ++
Sbjct: 69 AFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMAR-----FYLAEMVIAIDSVHQLHY 123
Query: 538 VHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPEY--AM---RG 592
VHRDIK N+L+D + + +++DFG E+ T S+ GT Y++PE AM +G
Sbjct: 124 VHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEDGKG 183
Query: 593 HLTEKADVYSFGIVALEIVSGRSNVTKEDM 622
+ D +S G+ E++ G + E +
Sbjct: 184 KYGPECDWWSLGVCMYEMLYGETPFYAESL 213
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 51.3 bits (123), Expect = 9e-07
Identities = 58/217 (26%), Positives = 94/217 (43%), Gaps = 23/217 (10%)
Query: 409 LQIKAATNNFATDNNIGEGGFGPV----YKGLLADGTAIAVKQLSSKS--KQGNREFINE 462
L++KA +F IG G FG V +K + A+K LS K+ + F E
Sbjct: 38 LRMKAE--DFDVIKVIGRGAFGEVQLVRHK---SSKQVYAMKLLSKFEMIKRSDSAFFWE 92
Query: 463 IGMISAL-QHPNLVKLYGCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLG 521
I A +V+L+ + L ++ EY+ L + + + W R
Sbjct: 93 ERDIMAHANSEWIVQLHYAFQDDKYLYMVMEYMPGGDLVNLMSNYDIPEKWA--RFYTAE 150
Query: 522 IARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLA-KLDEEENTHISTRVAGT 580
+ L +H + +HRD+K N+LLDK + K++DFG K+D T V GT
Sbjct: 151 VVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAV-GT 206
Query: 581 IGYMAPEYAMR----GHLTEKADVYSFGIVALEIVSG 613
Y++PE G+ + D +S G+ E++ G
Sbjct: 207 PDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 243
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 51.7 bits (123), Expect = 1e-06
Identities = 73/295 (24%), Positives = 129/295 (43%), Gaps = 58/295 (19%)
Query: 416 NNFATDNNIGEGGFGPVYKGLLADG--------TAIAVKQLSSKSKQGNREFINEIGMIS 467
N + IG G FG V+ L+ AI+ + L + K + + E+ ++
Sbjct: 13 NEYEVIKKIGNGRFGEVF--LVKHKRTQEFFCWKAISYRGLKEREKS---QLVIEVNVMR 67
Query: 468 ALQHPNLVKLYGCCI-EGNQ-LLLIYEYLENNSLARAL---FEHRLKLDWPTRRRICLGI 522
L+H N+V+ + + NQ L ++ E+ + L+R + ++ K++ I +
Sbjct: 68 ELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQL 127
Query: 523 ARGLAYLH----GESRIKVVHRDIKATNVLLD-------------KDLN----SKISDFG 561
LAY H G + +V+HRD+K N+ L +LN +KI DFG
Sbjct: 128 LHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFG 187
Query: 562 LAK-LDEEENTHISTRVAGTIGYMAPEYAMRGHLT----EKADVYSFGIVALEIVSGRSN 616
L+K + E H GT Y +PE + H T +K+D+++ G + E+ SG++
Sbjct: 188 LSKNIGIESMAH---SCVGTPYYWSPELLL--HETKSYDDKSDMWALGCIIYELCSGKTP 242
Query: 617 VTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDKEQVMVMINVALLCANASPT 671
K + F L + E + +L P KE +++ N+ L A P+
Sbjct: 243 FHKANNFSQL-----ISELKRGPDL----PIKGKSKELNILIKNLLNLSAKERPS 288
|
Length = 1021 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 1e-06
Identities = 33/92 (35%), Positives = 51/92 (55%), Gaps = 4/92 (4%)
Query: 522 IARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHIST-RVAGT 580
+A G+ +L ++ VHRD+ A NVL+ + KI DFGLA+ ++ +IS
Sbjct: 248 VANGMEFLASKN---CVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLP 304
Query: 581 IGYMAPEYAMRGHLTEKADVYSFGIVALEIVS 612
+ +MAPE T +DV+SFGI+ EI +
Sbjct: 305 LKWMAPESIFNNLYTTLSDVWSFGILLWEIFT 336
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 50.9 bits (122), Expect = 1e-06
Identities = 51/211 (24%), Positives = 94/211 (44%), Gaps = 40/211 (18%)
Query: 424 IGEGGFGPV---YKGLLADGTAIAVKQLS------SKSKQGNREFINEIGMISALQHPNL 474
IG G G V Y + G +A+K+LS + +K+ RE + ++ + H N+
Sbjct: 24 IGSGAQGIVCAAYDTVT--GQNVAIKKLSRPFQNVTHAKRAYRELV----LMKLVNHKNI 77
Query: 475 VKLYGCCI------EGNQLLLIYEYLENN--SLARALFEHRLKLDWPTRRRICLGIARGL 526
+ L E + L+ E ++ N + + +H ++ + + +C G+
Sbjct: 78 IGLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQMDLDHE-RMSYLLYQMLC-----GI 131
Query: 527 AYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENT---HISTRVAGTIGY 583
+LH ++HRD+K +N+++ D KI DFGLA+ ++ TR Y
Sbjct: 132 KHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRY-----Y 183
Query: 584 MAPEYAMRGHLTEKADVYSFGIVALEIVSGR 614
APE + E D++S G + E++ G
Sbjct: 184 RAPEVILGMGYKENVDIWSVGCIMGEMIRGT 214
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 4e-06
Identities = 22/79 (27%), Positives = 44/79 (55%)
Query: 102 GELPEELGSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRISDNQFTGQIPSFIQNWTK 161
G +P ++ L +L+ ++LS N+ G +P + +T+++ +S N F G IP + T
Sbjct: 432 GFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTS 491
Query: 162 LEKLFIQPSGLAGPIPSGI 180
L L + + L+G +P+ +
Sbjct: 492 LRILNLNGNSLSGRVPAAL 510
|
Length = 623 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 4e-06
Identities = 53/213 (24%), Positives = 92/213 (43%), Gaps = 32/213 (15%)
Query: 410 QIKAATNNFATDNNIGEGGFGPVYKGLLADGTAIAVKQLSSKSKQGNREFINEIGMISAL 469
QI A N+ D+ + K +L K L + + F M+ +
Sbjct: 10 QIYAGILNYKDDDEDDGYSYEKEIKVIL--------KVLDPSHRDISLAFFETASMMRQV 61
Query: 470 QHPNLVKLYGCCIEGNQLLLIYEYLENNSLARALFEHRLK--LDWPTRRRICLGIARGLA 527
H ++V LYG C+ + +++ E++E L LF HR L P + ++ +A L+
Sbjct: 62 SHKHIVLLYGVCVRDVENIMVEEFVEFGPL--DLFMHRKSDVLTTPWKFKVAKQLASALS 119
Query: 528 YLHGESRIKVVHRDIKATNVLLDKD-LNS------KISDFG--LAKLDEEENTHISTRVA 578
YL + +VH ++ N+LL ++ ++ K+SD G + L +E
Sbjct: 120 YLEDK---DLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITVLSRQECVE------ 170
Query: 579 GTIGYMAPEYAM-RGHLTEKADVYSFGIVALEI 610
I ++APE +L+ AD +SFG EI
Sbjct: 171 -RIPWIAPECVEDSKNLSIAADKWSFGTTLWEI 202
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 48.8 bits (117), Expect = 4e-06
Identities = 47/190 (24%), Positives = 72/190 (37%), Gaps = 48/190 (25%)
Query: 462 EIGMISALQHPNLVKLYGCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLG 521
E +++ L HP L LY L L+ +Y L R L + +
Sbjct: 51 EQEILATLDHPFLPTLYASFQTETYLCLVMDYCPGGELFRLLQRQP-------GKCLSEE 103
Query: 522 IAR--------GLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHI 573
+AR L YLH +V+RD+K N+LL + + +SDF L+K + E +
Sbjct: 104 VARFYAAEVLLALEYLHLLG---IVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPV 160
Query: 574 S------------------TRVA----------GTIGYMAPEY-AMRGHLTEKADVYSFG 604
S T GT Y+APE + GH D ++ G
Sbjct: 161 SKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGH-GSAVDWWTLG 219
Query: 605 IVALEIVSGR 614
I+ E++ G
Sbjct: 220 ILLYEMLYGT 229
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 48.7 bits (116), Expect = 9e-06
Identities = 39/147 (26%), Positives = 69/147 (46%), Gaps = 8/147 (5%)
Query: 424 IGEGGFGPVYKGLLADGTAIAVKQLSSKSKQGNR----EFINEIGMISALQHPNLVKLYG 479
I G FG VY G + + + ++ K+ N+ + E ++ + P +V LY
Sbjct: 12 ISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYY 71
Query: 480 CCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVH 539
N + L+ EYL + ++L D + +A L YLH R ++H
Sbjct: 72 SLQSANNVYLVMEYLIGGDV-KSLLHIYGYFDEEMAVKYISEVALALDYLH---RHGIIH 127
Query: 540 RDIKATNVLLDKDLNSKISDFGLAKLD 566
RD+K N+L+ + + K++DFGL+K+
Sbjct: 128 RDLKPDNMLISNEGHIKLTDFGLSKVT 154
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 42.5 bits (101), Expect = 2e-05
Identities = 19/60 (31%), Positives = 25/60 (41%)
Query: 208 KMTKLILRNCNITGELPRYLGKMTKLKVLDLSFNRLRGQIPSNFDDLYDVDYIYFAGNLL 267
+ L L N +T + LKVLDLS N L P F L + + +GN L
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 47.1 bits (112), Expect = 2e-05
Identities = 56/246 (22%), Positives = 95/246 (38%), Gaps = 68/246 (27%)
Query: 424 IGEGGFGPVYKGLLADGTAI-AVKQLSSKSKQGNREFINEIGMISA-------LQHPNLV 475
IG G FG V D A+ A+K L K+ R N+ + A + +V
Sbjct: 9 IGIGAFGEVCLVRKVDTNALYAMKTLR-KADVLMR---NQAAHVKAERDILAEADNEWVV 64
Query: 476 KLYGCCIEGNQLLLIYEYLENNSLARAL-----FEHRLKLDWPTRRRICLGIARGLAYLH 530
KLY + + L + +Y+ + L FE L R + + +H
Sbjct: 65 KLYYSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDLA------RFYIAELTCAIESVH 118
Query: 531 GESRIKVVHRDIKATNVLLDKDLNSKISDFGL---------------------------- 562
++ +HRDIK N+L+D+D + K++DFGL
Sbjct: 119 ---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSE 175
Query: 563 --AKLDEEENTHISTR------------VAGTIGYMAPEYAMRGHLTEKADVYSFGIVAL 608
+++D + R + GT Y+APE +R T+ D +S G++
Sbjct: 176 EWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILY 235
Query: 609 EIVSGR 614
E++ G+
Sbjct: 236 EMLVGQ 241
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 2e-05
Identities = 66/255 (25%), Positives = 104/255 (40%), Gaps = 38/255 (14%)
Query: 27 QNLTGVLPPKLAELTFLQDIDLTLNYLSGTIPSQ-WASLPLLNISLIANRLKGPIPKYLA 85
N +L ELT L +DL N ++ P L + L N+++ +P L
Sbjct: 102 LNRLRSNISELLELTNLTSLDLDNNNITDIPPLIGLLKSNLKELDLSDNKIE-SLPSPLR 160
Query: 86 NISTLVNLTVQYNQFSGELPEELGSLLNLEKLHLS----------------------SNN 123
N+ L NL + +N S +LP+ L +L NL L LS SNN
Sbjct: 161 NLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLDLSGNKISDLPPEIELLSALEELDLSNN 219
Query: 124 FTGELPKTFAKLTNMKDFRISDNQFTGQIPSFIQNWTKLEKLFIQPSGLAGPIPSGIFSL 183
EL + + L N+ +S+N+ +P I N + LE L + S S + SL
Sbjct: 220 SIIELLSSLSNLKNLSGLELSNNKLE-DLPESIGNLSNLETLDL--SNNQISSISSLGSL 276
Query: 184 ENLTDLRISDLNGPEAT--FPQLGNMKMTKLILRNCNITGELPRYLGKMTKLKVLDLSFN 241
NL +L DL+G + P + + + +L N +T + KL + L+ N
Sbjct: 277 TNLREL---DLSGNSLSNALPLIALLLLLLELLLNLLLTLKALEL-----KLNSILLNNN 328
Query: 242 RLRGQIPSNFDDLYD 256
L S+ + L
Sbjct: 329 ILSNGETSSPEALSI 343
|
Length = 394 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 47.2 bits (112), Expect = 2e-05
Identities = 29/83 (34%), Positives = 42/83 (50%), Gaps = 4/83 (4%)
Query: 528 YLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDE-EENTHISTRVAGTIGYMAP 586
Y+HGE ++HRDIK NVL++ + + DFG A +T +AGT+ AP
Sbjct: 275 YIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYGIAGTVDTNAP 331
Query: 587 EYAMRGHLTEKADVYSFGIVALE 609
E T D++S G+V E
Sbjct: 332 EVLAGDPYTPSVDIWSAGLVIFE 354
|
Length = 461 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 46.6 bits (110), Expect = 3e-05
Identities = 55/255 (21%), Positives = 98/255 (38%), Gaps = 46/255 (18%)
Query: 416 NNFATDNNIGEGGFGPVYKGLLADGTAIAVKQLSSKSKQGNREFINEI----GMISALQH 471
++F + IG G FG V D I ++ K+ +E + I ++
Sbjct: 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADG 60
Query: 472 PNLVKLYGCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHG 531
+VK++ + L LI E+L + L +K D + IA + +
Sbjct: 61 AWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLL----MKKDTLSEEATQFYIAETVLAIDA 116
Query: 532 ESRIKVVHRDIKATNVLLDKDLNSKISDFGL----------------------------- 562
++ +HRDIK N+LLD + K+SDFGL
Sbjct: 117 IHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNM 176
Query: 563 -----AKLDEEENTHISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGR--- 614
A+ ++ ++ GT Y+APE M+ + D +S G++ E++ G
Sbjct: 177 NSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPF 236
Query: 615 -SNVTKEDMFYLLDW 628
S +E +++W
Sbjct: 237 CSETPQETYRKVMNW 251
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 4e-05
Identities = 58/257 (22%), Positives = 100/257 (38%), Gaps = 52/257 (20%)
Query: 417 NFATDNNIGEGGFGPVYKGLLADGTAIAVKQLSSKSKQGNREFINEIGMISA-----LQH 471
+F + IG G FG V D + ++ K+ +E ++G I A ++
Sbjct: 2 DFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKE---QVGHIRAERDILVEA 58
Query: 472 PNL--VKLYGCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYL 529
+L VK++ + L LI E+L + L +K D T IA + +
Sbjct: 59 DSLWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLL----MKKDTLTEEETQFYIAETVLAI 114
Query: 530 HGESRIKVVHRDIKATNVLLDKDLNSKISDFGL--------------------------- 562
++ +HRDIK N+LLD + K+SDFGL
Sbjct: 115 DSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQ 174
Query: 563 -------AKLDEEENTHISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGR- 614
A+ + ++ GT Y+APE M+ + D +S G++ E++ G
Sbjct: 175 NMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP 234
Query: 615 ---SNVTKEDMFYLLDW 628
S +E +++W
Sbjct: 235 PFCSETPQETYKKVMNW 251
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 46.3 bits (110), Expect = 5e-05
Identities = 30/102 (29%), Positives = 42/102 (41%), Gaps = 27/102 (26%)
Query: 24 LKEQNLTGVLPPKLAELTFLQDIDLTLNYLSGTIPSQWASLPLLNISLIANRLKGPIPKY 83
L ++ G +PP L +T L+ +DL+ N +G+IP L L I
Sbjct: 449 LSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRI-------------- 494
Query: 84 LANISTLVNLTVQYNQFSGELPEELGSLLNLEKLHLSSNNFT 125
L + N SG +P LG L LH +S NFT
Sbjct: 495 ---------LNLNGNSLSGRVPAALGGRL----LHRASFNFT 523
|
Length = 623 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 46.0 bits (109), Expect = 6e-05
Identities = 28/80 (35%), Positives = 40/80 (50%), Gaps = 3/80 (3%)
Query: 117 LHLSSNNFTGELPKTFAKLTNMKDFRISDNQFTGQIPSFIQNWTKLEKLFIQPSGLAGPI 176
L L + G +P +KL +++ +S N G IP + + T LE L + + G I
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 177 PSGIFSLENLTDLRISDLNG 196
P SL LT LRI +LNG
Sbjct: 483 PE---SLGQLTSLRILNLNG 499
|
Length = 623 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 43.5 bits (103), Expect = 6e-05
Identities = 32/145 (22%), Positives = 53/145 (36%), Gaps = 13/145 (8%)
Query: 424 IGEGGFGPVYKGLLADGTAIAVKQLSSKSKQGNREFINEIGMISAL-QHPNLV-KLYGCC 481
+ G VY L +K S+ K +RE E+ ++ L + V K+
Sbjct: 6 LKGGLTNRVYL-LGTKDEDYVLKINPSREKGADRE--REVAILQLLARKGLPVPKVLASG 62
Query: 482 IEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRD 541
L+ E++E +L E + I +A LA LH + + H D
Sbjct: 63 ESDGWSYLLMEWIEGETLDEVSEEEKED--------IAEQLAELLAKLHQLPLLVLCHGD 114
Query: 542 IKATNVLLDKDLNSKISDFGLAKLD 566
+ N+L+D I D+ A
Sbjct: 115 LHPGNILVDDGKILGIIDWEYAGYG 139
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|238064 cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Score = 44.7 bits (106), Expect = 1e-04
Identities = 52/239 (21%), Positives = 83/239 (34%), Gaps = 43/239 (17%)
Query: 30 TGVLPPKLAELTFLQDIDLTLNYLSGTIPSQWASL----PLLNISLIANRLKGPIPKYLA 85
L L + LQ++DL+ N L SL L + L N L + LA
Sbjct: 70 LQSLLQGLTKGCGLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLA 129
Query: 86 -----NISTLVNLTVQYNQFSGELPEELGSLL----NLEKLHLSSNNFTGE----LPKTF 132
L L + N+ G E L L +L++L+L++N L +
Sbjct: 130 KGLKDLPPALEKLVLGRNRLEGASCEALAKALRANRDLKELNLANNGIGDAGIRALAEGL 189
Query: 133 AKLTNMKDFRISDNQFT----GQIPSFIQNWTKLEKLFIQPSGLAGPIPSGIFSLENLTD 188
N++ +++N T + + + LE L NLTD
Sbjct: 190 KANCNLEVLDLNNNGLTDEGASALAETLASLKSLEVLN--------------LGDNNLTD 235
Query: 189 LRISDLNGPEATFPQLGNMKMTKLILRNCNITGE----LPRYLGKMTKLKVLDLSFNRL 243
+ L A+ N+ + L L +IT + L L + L LDL N+
Sbjct: 236 AGAAAL----ASALLSPNISLLTLSLSCNDITDDGAKDLAEVLAEKESLLELDLRGNKF 290
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). Length = 319 |
| >gnl|CDD|214801 smart00750, KIND, kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Score = 42.4 bits (100), Expect = 2e-04
Identities = 28/92 (30%), Positives = 34/92 (36%), Gaps = 17/92 (18%)
Query: 518 ICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRV 577
+CL L LH R K+ N+LL D K+ G E
Sbjct: 22 VCLQCLGALRELH---------RQAKSGNILLTWDGLLKL--DGSVAFKTPEQ-SRPDPY 69
Query: 578 AGTIGYMAPEYAMRGHLTEKADVYSFGIVALE 609
+MAPE TEKAD+YS GI E
Sbjct: 70 -----FMAPEVIQGQSYTEKADIYSLGITLYE 96
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features. Length = 176 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 42.9 bits (101), Expect = 4e-04
Identities = 29/86 (33%), Positives = 44/86 (51%), Gaps = 8/86 (9%)
Query: 416 NNFATDNNIGEGGFGPVYK----GLLADGTA--IAVKQLSSKSKQGNRE-FINEIGMISA 468
+N +G G FG V + GL + +AVK L + + RE ++E+ ++S
Sbjct: 38 DNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSH 97
Query: 469 L-QHPNLVKLYGCCIEGNQLLLIYEY 493
L QH N+V L G C G +L+I EY
Sbjct: 98 LGQHKNIVNLLGACTHGGPVLVITEY 123
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 5e-04
Identities = 29/127 (22%), Positives = 50/127 (39%), Gaps = 46/127 (36%)
Query: 534 RIKVVHRDIKATNVLLDKDLNSKISDFGLA---------------------------KLD 566
++ +HRDIK N+L+D+D + K++DFGL +
Sbjct: 119 KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWG 178
Query: 567 EEENTHISTR-------------------VAGTIGYMAPEYAMRGHLTEKADVYSFGIVA 607
+ N R + GT Y+APE +R T+ D +S G++
Sbjct: 179 DPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVIL 238
Query: 608 LEIVSGR 614
E++ G+
Sbjct: 239 YEMLVGQ 245
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 6e-04
Identities = 52/247 (21%), Positives = 92/247 (37%), Gaps = 54/247 (21%)
Query: 418 FATDNNIGEGGFGPVYKGLLADGTAI-AVKQLSSKSKQGNREFIN---EIGMISALQHPN 473
F +G G FG V D A+ A+K L K + + E +++ +
Sbjct: 3 FVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEW 62
Query: 474 LVKLYGCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGES 533
+VKLY + + L + +Y+ + L ++++ IA +
Sbjct: 63 VVKLYYSFQDKDNLYFVMDYIPGGDMMSLL----IRMEVFPEVLARFYIAELTLAIESVH 118
Query: 534 RIKVVHRDIKATNVLLDKDLNSKISDFGLAK---------------------------LD 566
++ +HRDIK N+L+D D + K++DFGL D
Sbjct: 119 KMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWD 178
Query: 567 EEENTHISTR-------------------VAGTIGYMAPEYAMRGHLTEKADVYSFGIVA 607
+ N R + GT Y+APE +R T+ D +S G++
Sbjct: 179 DVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVIL 238
Query: 608 LEIVSGR 614
E++ G+
Sbjct: 239 FEMLVGQ 245
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 36.4 bits (85), Expect = 0.003
Identities = 22/60 (36%), Positives = 27/60 (45%), Gaps = 2/60 (3%)
Query: 232 KLKVLDLSFNRLRGQIPSNFDDLYDVDYIYFAGNLLTGAIPPWM--LERGDKIDLSYNNF 289
LK LDLS NRL F L ++ + +GN LT P L +DLS NN
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Score = 39.9 bits (93), Expect = 0.004
Identities = 42/164 (25%), Positives = 74/164 (45%), Gaps = 20/164 (12%)
Query: 471 HPNLVKLYGCCIEGNQLLLIYEYLENNSLARALFEHRLK-LDWPTRRRICLGIARGLAYL 529
HPN+V I N+L ++ ++ S + H + + I G+ + L Y+
Sbjct: 58 HPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYI 117
Query: 530 HGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRV--------AGTI 581
H + VHR +KA+++L+ D K+ GL N RV +
Sbjct: 118 H---HMGYVHRSVKASHILISVD--GKVYLSGLRSNLSMINHGQRLRVVHDFPKYSVKVL 172
Query: 582 GYMAPEYA---MRGHLTEKADVYSFGIVALEIVSGRSNVTKEDM 622
+++PE ++G+ K+D+YS GI A E+ +G +V +DM
Sbjct: 173 PWLSPEVLQQNLQGY-DAKSDIYSVGITACELANG--HVPFKDM 213
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 756 | |||
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.98 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.98 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.98 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.97 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.97 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.97 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.97 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.97 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.97 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.97 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.96 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.96 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.96 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.96 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 99.96 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.95 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.95 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.95 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.95 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 99.95 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.94 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.94 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 99.93 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.93 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.92 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 99.92 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.91 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.91 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.9 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 99.9 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.89 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.89 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 99.88 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.88 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.86 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.86 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.85 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.84 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.84 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.83 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.83 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.83 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 99.82 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 99.82 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 99.81 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 99.8 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.8 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.8 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.79 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 99.79 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 99.77 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 99.76 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 99.76 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 99.76 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.75 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.75 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 99.74 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 99.74 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.74 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.73 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.73 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.72 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.72 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.72 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.71 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.71 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 99.7 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.63 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.62 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.59 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.57 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 99.47 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.47 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 99.45 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.38 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.37 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 99.35 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.31 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 99.3 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.27 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.26 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.23 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.2 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.17 | |
| KOG1909 | 382 | consensus Ran GTPase-activating protein [RNA proce | 99.16 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.15 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.14 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.14 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.14 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 99.1 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 99.09 | |
| KOG3207 | 505 | consensus Beta-tubulin folding cofactor E [Posttra | 99.07 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 99.06 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.05 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 99.03 | |
| KOG3207 | 505 | consensus Beta-tubulin folding cofactor E [Posttra | 99.02 | |
| KOG0531 | 414 | consensus Protein phosphatase 1, regulatory subuni | 99.0 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.96 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 98.95 | |
| KOG1909 | 382 | consensus Ran GTPase-activating protein [RNA proce | 98.9 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.89 | |
| KOG0531 | 414 | consensus Protein phosphatase 1, regulatory subuni | 98.88 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.88 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.83 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.8 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.8 | |
| KOG4658 | 889 | consensus Apoptotic ATPase [Signal transduction me | 98.63 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.62 | |
| KOG4658 | 889 | consensus Apoptotic ATPase [Signal transduction me | 98.62 | |
| KOG1859 | 1096 | consensus Leucine-rich repeat proteins [General fu | 98.61 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.59 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.54 | |
| KOG1859 | 1096 | consensus Leucine-rich repeat proteins [General fu | 98.49 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.49 | |
| KOG4579 | 177 | consensus Leucine-rich repeat (LRR) protein associ | 98.48 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.45 |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-72 Score=687.42 Aligned_cols=660 Identities=27% Similarity=0.422 Sum_probs=412.5
Q ss_pred eeccceeccccccccCcccccCCcccCCCCCCCEEEccCCcccCccCcccccCCcce-eeccCccccccCCccCcCcCCC
Q 004400 12 FWKQKTVNQKRVLKEQNLTGVLPPKLAELTFLQDIDLTLNYLSGTIPSQWASLPLLN-ISLIANRLKGPIPKYLANISTL 90 (756)
Q Consensus 12 ~~~~~~~~~~l~L~~~~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~-l~l~~n~~~~~~p~~l~~l~~L 90 (756)
.+.+++.++.|+|++|++++.+|..+.++++|+.|+|++|.+++.+|..+..++.|+ +++.+|.+.+.+|..+.++++|
T Consensus 255 ~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L 334 (968)
T PLN00113 255 SLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSLPRL 334 (968)
T ss_pred hHhCCCCCCEEECcCCeeeccCchhHhhccCcCEEECcCCeeccCCChhHcCCCCCcEEECCCCccCCcCChhHhcCCCC
Confidence 355566666666666666666666666666666666666666666666665555553 5555565555555555555556
Q ss_pred cEEEeecCcccccCCcccCCCCCCcEEeccCCeecccCCcc------------------------ccCCCCCCEEEeeCC
Q 004400 91 VNLTVQYNQFSGELPEELGSLLNLEKLHLSSNNFTGELPKT------------------------FAKLTNMKDFRISDN 146 (756)
Q Consensus 91 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~------------------------~~~l~~L~~L~L~~N 146 (756)
+.|+|++|.+.+.+|..++.+++|+.|+|++|++++.+|.. +..+++|+.|+|++|
T Consensus 335 ~~L~L~~n~l~~~~p~~l~~~~~L~~L~Ls~n~l~~~~p~~~~~~~~L~~L~l~~n~l~~~~p~~~~~~~~L~~L~L~~n 414 (968)
T PLN00113 335 QVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDN 414 (968)
T ss_pred CEEECcCCCCcCcCChHHhCCCCCcEEECCCCeeEeeCChhHhCcCCCCEEECcCCEecccCCHHHhCCCCCCEEECcCC
Confidence 66666555555555555555555555555555555544444 444555555555555
Q ss_pred cccccCChhhcCcCCCcEEEccCCcCcCCCCccccCCCCCCeEEccCCCCCCCCccccccccccEEEcccccccCCCCcc
Q 004400 147 QFTGQIPSFIQNWTKLEKLFIQPSGLAGPIPSGIFSLENLTDLRISDLNGPEATFPQLGNMKMTKLILRNCNITGELPRY 226 (756)
Q Consensus 147 ~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~L~~L~L~~n~l~~~~p~~ 226 (756)
++++.+|..|.++++|+.|+|++|++++.+|..+..+++|+.|++++|.+....+..+...+|+.|+|++|++++.+|..
T Consensus 415 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~~~~~~p~~~~~~~L~~L~ls~n~l~~~~~~~ 494 (968)
T PLN00113 415 SFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSFGSKRLENLDLSRNQFSGAVPRK 494 (968)
T ss_pred EeeeECChhHhcCCCCCEEECcCCcccCccChhhccCCCCcEEECcCceeeeecCcccccccceEEECcCCccCCccChh
Confidence 55555555555555555555555555555555555555666666666655554444444456778888888888888888
Q ss_pred ccCCCCCcEEEccCCcCCCCCCccCcCCCCCCeEEecCccccccCCchh--hcCCCeeEeecCCCCCCCCcccccccCcc
Q 004400 227 LGKMTKLKVLDLSFNRLRGQIPSNFDDLYDVDYIYFAGNLLTGAIPPWM--LERGDKIDLSYNNFTDGSAESSCQKRSVT 304 (756)
Q Consensus 227 ~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~--~~~l~~l~ls~N~l~~~~~~~~~~~~~~~ 304 (756)
|..+++|+.|+|++|.+.+.+|..+..+++|+.|++++|.+++.+|..+ ++.|+.|++++|++++..+........+.
T Consensus 495 ~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~ 574 (968)
T PLN00113 495 LGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLV 574 (968)
T ss_pred hhhhhccCEEECcCCcceeeCChHHcCccCCCEEECCCCcccccCChhHhCcccCCEEECCCCcccccCChhHhcCcccC
Confidence 8888888888888888888888888888888888888888888888776 67788888888888776655544444343
Q ss_pred cccccccccccCCccccccccccCcceeecCcccccC-CCCCC-CCCccccCCceeEE---cchhhhhh-hcccccccee
Q 004400 305 GIVSCLRSVQCPKTYYSLHINCGGKQVTANGNTTFEE-DTSEA-GPSTFSQSGTNWVL---SSTGHFLE-NGLKLGPYIQ 378 (756)
Q Consensus 305 ~~~~~~~~~~c~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~-~~~~~~~~~~~~~~---~~~~~~~~-~~~~~~~~~~ 378 (756)
.+....+...+........... ......|+..... ..... .+.........|.. ...+..+. ..+....++.
T Consensus 575 ~l~ls~N~l~~~~p~~~~~~~~--~~~~~~~n~~lc~~~~~~~~~~c~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 652 (968)
T PLN00113 575 QVNISHNHLHGSLPSTGAFLAI--NASAVAGNIDLCGGDTTSGLPPCKRVRKTPSWWFYITCTLGAFLVLALVAFGFVFI 652 (968)
T ss_pred EEeccCCcceeeCCCcchhccc--ChhhhcCCccccCCccccCCCCCccccccceeeeehhHHHHHHHHHHHHHHHHHHH
Confidence 3333222222110000000000 0000001100000 00000 00000000111211 11111111 0000001111
Q ss_pred ccccccccccchh-hhhhhcccccchhhhhhhhHHHhhcCccccCcccCCCCccEEEeec-cCCcEEEEEEccccCcccH
Q 004400 379 TNTSRLLMNDYQL-YTTARLSAISLTYYGFYLQIKAATNNFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSKSKQGN 456 (756)
Q Consensus 379 ~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~ 456 (756)
....+........ ........... ..............|...+.||+|+||.||+|+. .++..||||++......
T Consensus 653 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-- 729 (968)
T PLN00113 653 RGRNNLELKRVENEDGTWELQFFDS-KVSKSITINDILSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI-- 729 (968)
T ss_pred Hhhhccccccccccccccccccccc-ccchhhhHHHHHhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc--
Confidence 1100000000000 00000000000 0000112233345678889999999999999995 68899999998643221
Q ss_pred HHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCC
Q 004400 457 REFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIK 536 (756)
Q Consensus 457 ~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~ 536 (756)
...|++++++++|||||+++++|.+++..++|||||++|+|.++++ .++|..+.+++.|+|+||+|||+.+.++
T Consensus 730 --~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~----~l~~~~~~~i~~~ia~~L~yLH~~~~~~ 803 (968)
T PLN00113 730 --PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLR----NLSWERRRKIAIGIAKALRFLHCRCSPA 803 (968)
T ss_pred --cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCCCCCcHHHHHh----cCCHHHHHHHHHHHHHHHHHhccCCCCC
Confidence 2346889999999999999999999999999999999999999985 4899999999999999999999776667
Q ss_pred eEcCCCCCCceEecCCCCEEEccCCccccCcccCcceeeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHhCCCC
Q 004400 537 VVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSN 616 (756)
Q Consensus 537 iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p 616 (756)
|+||||||+||+++.++.+++. ||.+...... ....||+.|+|||++.+..++.++|||||||++|||+||+.|
T Consensus 804 iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p 877 (968)
T PLN00113 804 VVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTD-----TKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSP 877 (968)
T ss_pred eecCCCCHHhEEECCCCceEEE-eccccccccC-----CCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCC
Confidence 9999999999999999888875 6655432211 223688999999999999999999999999999999999999
Q ss_pred CCcc--chhhHHHHHHHHHhcCccccccccCCCC--CCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhccCcc
Q 004400 617 VTKE--DMFYLLDWALVLKEQGKLMELVDTNPGS--NFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLECGVD 688 (756)
Q Consensus 617 ~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~L~~~~~ 688 (756)
|... .......|+............+++.... ....++...+.+++.+||+.+|++||+|.||++.|++...
T Consensus 878 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~ 953 (968)
T PLN00113 878 ADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASR 953 (968)
T ss_pred CCcccCCCCcHHHHHHHhcCccchhheeCccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhc
Confidence 8533 2234556665544444344444443322 3345667788999999999999999999999999996544
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-54 Score=462.23 Aligned_cols=280 Identities=53% Similarity=0.883 Sum_probs=248.7
Q ss_pred hhhhHHHhhcCccccCcccCCCCccEEEeeccCCcEEEEEEccccCcccHHHHHHHHHHHHhCCCCceeeEeeEEEeCC-
Q 004400 407 FYLQIKAATNNFATDNNIGEGGFGPVYKGLLADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCCIEGN- 485 (756)
Q Consensus 407 ~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~- 485 (756)
.|.+++.||++|...+.||+|+||.||+|.+.+|+.||||++........++|.+|++++.+++|||+|+++|||.+.+
T Consensus 66 s~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~ 145 (361)
T KOG1187|consen 66 SYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYCLEGGE 145 (361)
T ss_pred eHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEEecCCc
Confidence 3789999999999999999999999999999999999999887643321567999999999999999999999999999
Q ss_pred eEEEEEEecCCCCHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccc
Q 004400 486 QLLLIYEYLENNSLARALFEHRL-KLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAK 564 (756)
Q Consensus 486 ~~~lV~e~~~~gsL~~~l~~~~~-~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~ 564 (756)
..+||||||++|+|.++|+.... .++|..|.+||.++|+||+|||+.+.++||||||||+|||+|+++.+||+|||+|+
T Consensus 146 ~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsDFGLa~ 225 (361)
T KOG1187|consen 146 HRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSDFGLAK 225 (361)
T ss_pred eEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccCccCcc
Confidence 59999999999999999997665 89999999999999999999999998899999999999999999999999999997
Q ss_pred cCcccCcceeeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHhCCCCCCc---cchhhHHHHHHHHHhcCccccc
Q 004400 565 LDEEENTHISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTK---EDMFYLLDWALVLKEQGKLMEL 641 (756)
Q Consensus 565 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~---~~~~~~~~~~~~~~~~~~~~~~ 641 (756)
..........+...||.+|+|||++..+..+.|+|||||||+++|++||+.|... .....+.+|+......+++.++
T Consensus 226 ~~~~~~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~~~~~ei 305 (361)
T KOG1187|consen 226 LGPEGDTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEEGKLREI 305 (361)
T ss_pred cCCccccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHCcchhhe
Confidence 6554222222211799999999999999999999999999999999999988853 2345589999888888899999
Q ss_pred cccCCC-CCCCH-HHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhccC
Q 004400 642 VDTNPG-SNFDK-EQVMVMINVALLCANASPTIRPSMSSVLRMLECG 686 (756)
Q Consensus 642 ~~~~~~-~~~~~-~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~L~~~ 686 (756)
+|+... ..++. ++...+..++.+|++.+|++||+|.||+++|+..
T Consensus 306 iD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~ 352 (361)
T KOG1187|consen 306 VDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGI 352 (361)
T ss_pred eCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhh
Confidence 999976 55664 6888899999999999999999999999999654
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-47 Score=404.25 Aligned_cols=256 Identities=34% Similarity=0.529 Sum_probs=212.8
Q ss_pred cccCcccCCCCccEEEeeccCCcEEEEEEccccCccc--HHHHHHHHHHHHhCCCCceeeEeeEEEeCC-eEEEEEEecC
Q 004400 419 ATDNNIGEGGFGPVYKGLLADGTAIAVKQLSSKSKQG--NREFINEIGMISALQHPNLVKLYGCCIEGN-QLLLIYEYLE 495 (756)
Q Consensus 419 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~lV~e~~~ 495 (756)
...+.||+|+||+||+|.+.....||||++....... .+.|.+|+.+|++++|||||+++|+|.++. ..++|||||+
T Consensus 44 ~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~ 123 (362)
T KOG0192|consen 44 PIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMP 123 (362)
T ss_pred hhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCC
Confidence 3445699999999999999866669999997653322 458999999999999999999999999988 7999999999
Q ss_pred CCCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCC-CEEEccCCccccCcccCcce
Q 004400 496 NNSLARALFE-HRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDL-NSKISDFGLAKLDEEENTHI 573 (756)
Q Consensus 496 ~gsL~~~l~~-~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~-~~kl~DFGla~~~~~~~~~~ 573 (756)
+|+|.++++. ....+++..+.+++.|||+||+|||+++ +||||||||+|||++.++ ++||+|||+++...... ..
T Consensus 124 ~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~--~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~-~~ 200 (362)
T KOG0192|consen 124 GGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEG--PIIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK-TS 200 (362)
T ss_pred CCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCC--CeeecccChhhEEEcCCCCEEEECCCccceeecccc-cc
Confidence 9999999987 4778999999999999999999999985 299999999999999998 99999999998655432 22
Q ss_pred eeccccCccCCchHhhh--cCCCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhcCccccccccCCCCCCC
Q 004400 574 STRVAGTIGYMAPEYAM--RGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFD 651 (756)
Q Consensus 574 ~~~~~gt~~y~aPE~~~--~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 651 (756)
.+...||+.|||||++. ...|+.|+|||||||++|||+||+.||.......... .....+.+..+...
T Consensus 201 ~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~---~v~~~~~Rp~~p~~------- 270 (362)
T KOG0192|consen 201 MTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVAS---AVVVGGLRPPIPKE------- 270 (362)
T ss_pred ccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHH---HHHhcCCCCCCCcc-------
Confidence 33368999999999999 6689999999999999999999999997765522222 22223333332222
Q ss_pred HHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhccCccc
Q 004400 652 KEQVMVMINVALLCANASPTIRPSMSSVLRMLECGVDV 689 (756)
Q Consensus 652 ~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~L~~~~~~ 689 (756)
....+..++.+||+.||++||++.+++..|+.+...
T Consensus 271 --~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~ 306 (362)
T KOG0192|consen 271 --CPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSH 306 (362)
T ss_pred --CCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHh
Confidence 233488899999999999999999999999976553
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-47 Score=382.13 Aligned_cols=247 Identities=29% Similarity=0.479 Sum_probs=207.2
Q ss_pred CccccCcccCCCCccEEEeec-cCCcEEEEEEcccc-CcccHHHHHHHHHHHHhCCCCceeeEeeEEEeCC-eEEEEEEe
Q 004400 417 NFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSK-SKQGNREFINEIGMISALQHPNLVKLYGCCIEGN-QLLLIYEY 493 (756)
Q Consensus 417 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~lV~e~ 493 (756)
+.+..+.||+|..|+||++++ .+++.+|+|.+... .....+++.+|++++++.+||+||.+||+|..+. .++++|||
T Consensus 80 dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEY 159 (364)
T KOG0581|consen 80 DLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEY 159 (364)
T ss_pred HhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhh
Confidence 455678999999999999995 47889999999544 3344578999999999999999999999999998 59999999
Q ss_pred cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCcccCcce
Q 004400 494 LENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHI 573 (756)
Q Consensus 494 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~~~~~~ 573 (756)
|++|+|++.+... .++++....+|+.+|++||.|||+.. +||||||||+|||++..|.|||||||.++...+. .
T Consensus 160 MDgGSLd~~~k~~-g~i~E~~L~~ia~~VL~GL~YLh~~~--~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS---~ 233 (364)
T KOG0581|consen 160 MDGGSLDDILKRV-GRIPEPVLGKIARAVLRGLSYLHEER--KIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS---I 233 (364)
T ss_pred cCCCCHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhhcc--CeeeccCCHHHeeeccCCCEEeccccccHHhhhh---h
Confidence 9999999998755 47999999999999999999999632 5999999999999999999999999999876554 4
Q ss_pred eeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHhCCCCCCcc-----chhhHHHHHHHHHhcCccccccccCCCC
Q 004400 574 STRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKE-----DMFYLLDWALVLKEQGKLMELVDTNPGS 648 (756)
Q Consensus 574 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 648 (756)
..+++||..|||||.+++..|+.++||||||+.++|+.+|+.|+... +.+.++.+ +++..+ .
T Consensus 234 a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~------------Iv~~pp-P 300 (364)
T KOG0581|consen 234 ANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCA------------IVDEPP-P 300 (364)
T ss_pred cccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHH------------HhcCCC-C
Confidence 45688999999999999999999999999999999999999999664 23333322 111111 1
Q ss_pred CCCH-HHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004400 649 NFDK-EQVMVMINVALLCANASPTIRPSMSSVLRM 682 (756)
Q Consensus 649 ~~~~-~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~ 682 (756)
..+. ....++..++..|+++||.+||++.|+++.
T Consensus 301 ~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~H 335 (364)
T KOG0581|consen 301 RLPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQH 335 (364)
T ss_pred CCCcccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 1122 234459999999999999999999998764
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-47 Score=380.40 Aligned_cols=207 Identities=30% Similarity=0.537 Sum_probs=187.0
Q ss_pred hcCccccCcccCCCCccEEEeec-cCCcEEEEEEcccc--CcccHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEE
Q 004400 415 TNNFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSK--SKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIY 491 (756)
Q Consensus 415 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 491 (756)
..+|...+.||+|+||+||+|++ .++..||||.+..+ .+...+.+..|+.+|+.++|||||.+++++..++.+|+||
T Consensus 9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVM 88 (429)
T KOG0595|consen 9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVM 88 (429)
T ss_pred cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEE
Confidence 45788888999999999999994 56899999999776 4555667889999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCC------CCEEEccCCcccc
Q 004400 492 EYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKD------LNSKISDFGLAKL 565 (756)
Q Consensus 492 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~------~~~kl~DFGla~~ 565 (756)
|||.||+|.++++..+ .+++.+++.++.|+|.||++||+++ ||||||||.|||++.. -.+||+|||+|+.
T Consensus 89 EyC~gGDLs~yi~~~~-~l~e~t~r~Fm~QLA~alq~L~~~~---IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~ 164 (429)
T KOG0595|consen 89 EYCNGGDLSDYIRRRG-RLPEATARHFMQQLASALQFLHENN---IIHRDLKPQNILLSTTARNDTSPVLKIADFGFARF 164 (429)
T ss_pred EeCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCcceEEeccCCCCCCCceEEecccchhhh
Confidence 9999999999998665 8999999999999999999999996 9999999999999865 4589999999998
Q ss_pred CcccCcceeeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHhCCCCCCccchhhHHH
Q 004400 566 DEEENTHISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLD 627 (756)
Q Consensus 566 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~ 627 (756)
..+. ....+.+|++-|||||+++..+|+.|+|+||+|+++|+|++|+.||...+..++..
T Consensus 165 L~~~--~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~ 224 (429)
T KOG0595|consen 165 LQPG--SMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLL 224 (429)
T ss_pred CCch--hHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHH
Confidence 7743 33466899999999999999999999999999999999999999998887776665
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-46 Score=390.38 Aligned_cols=252 Identities=31% Similarity=0.476 Sum_probs=217.4
Q ss_pred ccccCcccCCCCccEEEeeccCCcEEEEEEccccCcccHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEEecCCC
Q 004400 418 FATDNNIGEGGFGPVYKGLLADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYEYLENN 497 (756)
Q Consensus 418 ~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~g 497 (756)
+...+.||+|-||.||.|.+.....||+|.++.. ....+.|.+|+++|++|+|++||+++|+|..++.++||||||+.|
T Consensus 208 l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~-~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~G 286 (468)
T KOG0197|consen 208 LKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEG-SMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPKG 286 (468)
T ss_pred HHHHHHhcCCccceEEEEEEcCCCcccceEEecc-ccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecccC
Confidence 4456899999999999999998889999999764 344578999999999999999999999999999999999999999
Q ss_pred CHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCcccCcceeec
Q 004400 498 SLARALFE-HRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTR 576 (756)
Q Consensus 498 sL~~~l~~-~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~ 576 (756)
+|.++|+. .+..+...+.+.++.|||+||+||+++. +|||||.++||||+++..+||+|||+|+...++.......
T Consensus 287 sLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~---~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~~~~~ 363 (468)
T KOG0197|consen 287 SLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKN---YIHRDLAARNILVDEDLVVKISDFGLARLIGDDEYTASEG 363 (468)
T ss_pred cHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCC---ccchhhhhhheeeccCceEEEcccccccccCCCceeecCC
Confidence 99999986 6678999999999999999999999985 9999999999999999999999999999666655555555
Q ss_pred cccCccCCchHhhhcCCCCcccchhhHHHHHHHHHh-CCCCCCccchhhHHHHHHHHHhcCccccccccCCCCCCCHHHH
Q 004400 577 VAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVS-GRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDKEQV 655 (756)
Q Consensus 577 ~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 655 (756)
..-++.|.|||.+..+.++.|+|||||||+||||+| |+.|+......+.+. ..+.+.++..++.+ +
T Consensus 364 ~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~----~le~GyRlp~P~~C---------P 430 (468)
T KOG0197|consen 364 GKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLE----LLERGYRLPRPEGC---------P 430 (468)
T ss_pred CCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHH----HHhccCcCCCCCCC---------C
Confidence 556789999999999999999999999999999999 889987666544333 23445554444333 3
Q ss_pred HHHHHHHHHhhcCCCCCCCCHHHHHHHhccC
Q 004400 656 MVMINVALLCANASPTIRPSMSSVLRMLECG 686 (756)
Q Consensus 656 ~~l~~l~~~c~~~~P~~RPt~~ev~~~L~~~ 686 (756)
..+.+++..||+.+|++|||+..+...|+..
T Consensus 431 ~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~ 461 (468)
T KOG0197|consen 431 DEVYELMKSCWHEDPEDRPTFETLREVLEDF 461 (468)
T ss_pred HHHHHHHHHHhhCCcccCCCHHHHHHHHHHh
Confidence 3488999999999999999999998888854
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-46 Score=391.04 Aligned_cols=247 Identities=28% Similarity=0.443 Sum_probs=213.1
Q ss_pred cCccccCcccCCCCccEEEeec-cCCcEEEEEEcccc---CcccHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEE
Q 004400 416 NNFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSK---SKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIY 491 (756)
Q Consensus 416 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 491 (756)
..|...+.||+|||+.||+++. .+|..||+|++.++ .....+...+|+++.+.++|||||+++++|++.+++|+|.
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 4688899999999999999995 88999999999764 4445677899999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCcccCc
Q 004400 492 EYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENT 571 (756)
Q Consensus 492 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~~~~ 571 (756)
|+|++|+|..++. .++.+++.+++.++.||+.||.|||+.+ |||||||..|++++++.++||+|||+|.....+..
T Consensus 98 ELC~~~sL~el~K-rrk~ltEpEary~l~QIv~GlkYLH~~~---IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~E 173 (592)
T KOG0575|consen 98 ELCHRGSLMELLK-RRKPLTEPEARYFLRQIVEGLKYLHSLG---IIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDGE 173 (592)
T ss_pred EecCCccHHHHHH-hcCCCCcHHHHHHHHHHHHHHHHHHhcC---ceecccchhheeecCcCcEEecccceeeeecCccc
Confidence 9999999999886 5669999999999999999999999996 99999999999999999999999999997764422
Q ss_pred ceeeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhcCccccccccCCCCCCC
Q 004400 572 HISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFD 651 (756)
Q Consensus 572 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 651 (756)
...+.+|||.|+|||++.+..++..+||||+|||||-|++|++||...+..+..... +..... +|
T Consensus 174 -rk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~I---k~~~Y~-----------~P 238 (592)
T KOG0575|consen 174 -RKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKI---KLNEYS-----------MP 238 (592)
T ss_pred -ccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHH---HhcCcc-----------cc
Confidence 235689999999999999999999999999999999999999999777655444321 111111 11
Q ss_pred HHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 004400 652 KEQVMVMINVALLCANASPTIRPSMSSVLR 681 (756)
Q Consensus 652 ~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~ 681 (756)
........++|.++++.+|.+|||+++|++
T Consensus 239 ~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~ 268 (592)
T KOG0575|consen 239 SHLSAEAKDLIRKLLRPNPSERPSLDEVLD 268 (592)
T ss_pred cccCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 122334789999999999999999999985
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-46 Score=371.10 Aligned_cols=244 Identities=27% Similarity=0.401 Sum_probs=205.7
Q ss_pred hhcCccccCcccCCCCccEEEee-ccCCcEEEEEEcccc---CcccHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEE
Q 004400 414 ATNNFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSK---SKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLL 489 (756)
Q Consensus 414 ~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 489 (756)
..++|+..+.||+|+||+||.++ ..+++.+|+|+++++ .....+...+|..+|.+++||+||+++..|++.+.+|+
T Consensus 23 ~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLyl 102 (357)
T KOG0598|consen 23 GPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYL 102 (357)
T ss_pred ChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEE
Confidence 34689999999999999999999 557899999999875 23345678899999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCccc
Q 004400 490 IYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEE 569 (756)
Q Consensus 490 V~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~~ 569 (756)
|+||+.||.|..+|.+.+ .+++..+..++..|+.||.|||+.| |||||+||+|||+|++|+++|+|||+++..-..
T Consensus 103 Vld~~~GGeLf~hL~~eg-~F~E~~arfYlaEi~lAL~~LH~~g---IiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~ 178 (357)
T KOG0598|consen 103 VLDYLNGGELFYHLQREG-RFSEDRARFYLAEIVLALGYLHSKG---IIYRDLKPENILLDEQGHIKLTDFGLCKEDLKD 178 (357)
T ss_pred EEeccCCccHHHHHHhcC-CcchhHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHeeecCCCcEEEeccccchhcccC
Confidence 999999999999997554 7999999999999999999999997 999999999999999999999999999854433
Q ss_pred CcceeeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhcCccccccccCCCCC
Q 004400 570 NTHISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSN 649 (756)
Q Consensus 570 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 649 (756)
. ..+.+++||+.|||||++.+..|+.++|.||+|+++|||++|.+||...+.....+. +...+ . ..+
T Consensus 179 ~-~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~---I~~~k-~-----~~~--- 245 (357)
T KOG0598|consen 179 G-DATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDK---ILKGK-L-----PLP--- 245 (357)
T ss_pred C-CccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHH---HhcCc-C-----CCC---
Confidence 2 234558999999999999999999999999999999999999999988875544332 11111 0 011
Q ss_pred CCHHHHHHHHHHHHHhhcCCCCCCCC
Q 004400 650 FDKEQVMVMINVALLCANASPTIRPS 675 (756)
Q Consensus 650 ~~~~~~~~l~~l~~~c~~~~P~~RPt 675 (756)
+.-.....++++.+.+..||++|--
T Consensus 246 -p~~ls~~ardll~~LL~rdp~~RLg 270 (357)
T KOG0598|consen 246 -PGYLSEEARDLLKKLLKRDPRQRLG 270 (357)
T ss_pred -CccCCHHHHHHHHHHhccCHHHhcC
Confidence 1112234788999999999999963
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-46 Score=374.03 Aligned_cols=255 Identities=25% Similarity=0.399 Sum_probs=206.6
Q ss_pred HhhcCccccCcccCCCCccEEEee-ccCCcEEEEEEccccCcc-------cHHHHHHHHHHHHhCCCCceeeEeeEEEeC
Q 004400 413 AATNNFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQ-------GNREFINEIGMISALQHPNLVKLYGCCIEG 484 (756)
Q Consensus 413 ~~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~-------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 484 (756)
...+.|...+.||+|+||.|-+|. .++|+.||||++++..-. ......+|+++|++++|||||+++++|..+
T Consensus 169 s~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ 248 (475)
T KOG0615|consen 169 SFNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVP 248 (475)
T ss_pred hhcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecC
Confidence 345677888999999999999998 778999999999764211 123457899999999999999999999999
Q ss_pred CeEEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCC---CCEEEccCC
Q 004400 485 NQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKD---LNSKISDFG 561 (756)
Q Consensus 485 ~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~---~~~kl~DFG 561 (756)
+..|||||||+||+|.+.+..++ .+.+.....++.|++.|+.|||++| |+||||||+|||+..+ ..+||+|||
T Consensus 249 ds~YmVlE~v~GGeLfd~vv~nk-~l~ed~~K~~f~Qll~avkYLH~~G---I~HRDiKPeNILl~~~~e~~llKItDFG 324 (475)
T KOG0615|consen 249 DSSYMVLEYVEGGELFDKVVANK-YLREDLGKLLFKQLLTAVKYLHSQG---IIHRDIKPENILLSNDAEDCLLKITDFG 324 (475)
T ss_pred CceEEEEEEecCccHHHHHHhcc-ccccchhHHHHHHHHHHHHHHHHcC---cccccCCcceEEeccCCcceEEEecccc
Confidence 99999999999999999997654 6888889999999999999999998 9999999999999766 679999999
Q ss_pred ccccCcccCcceeeccccCccCCchHhhhcCC---CCcccchhhHHHHHHHHHhCCCCCCccchhh-HHHHHHHHHhcCc
Q 004400 562 LAKLDEEENTHISTRVAGTIGYMAPEYAMRGH---LTEKADVYSFGIVALEIVSGRSNVTKEDMFY-LLDWALVLKEQGK 637 (756)
Q Consensus 562 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~Dv~slGv~l~elltg~~p~~~~~~~~-~~~~~~~~~~~~~ 637 (756)
+|+..++ .....+.+||+.|.|||++.+.. +..++|+||+||++|-+++|.+||..+.... +.+ .+. .+.
T Consensus 325 lAK~~g~--~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~e---QI~-~G~ 398 (475)
T KOG0615|consen 325 LAKVSGE--GSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKE---QIL-KGR 398 (475)
T ss_pred hhhcccc--ceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHH---HHh-cCc
Confidence 9998763 33456789999999999998754 3348899999999999999999996543221 111 111 111
Q ss_pred cccccccCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHh
Q 004400 638 LMELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRML 683 (756)
Q Consensus 638 ~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~L 683 (756)
.. .......+...+..+++.+++..||++||++.|+++.-
T Consensus 399 y~------f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hp 438 (475)
T KOG0615|consen 399 YA------FGPLQWDRISEEALDLINWMLVVDPENRPSADEALNHP 438 (475)
T ss_pred cc------ccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcCh
Confidence 10 01112334556788999999999999999999998753
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-46 Score=358.64 Aligned_cols=253 Identities=26% Similarity=0.451 Sum_probs=210.2
Q ss_pred cCccccCcccCCCCccEEEee-ccCCcEEEEEEcccc--CcccHHHHHHHHHHHHhCCCCceeeEee-EEEeCCe-EEEE
Q 004400 416 NNFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSK--SKQGNREFINEIGMISALQHPNLVKLYG-CCIEGNQ-LLLI 490 (756)
Q Consensus 416 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~-~~~~~~~-~~lV 490 (756)
.+|.+.++||+|.||+||++. ..+|..||.|.+.-. .....+....|+.+|++++|||||++++ .|.++.+ +++|
T Consensus 19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlniv 98 (375)
T KOG0591|consen 19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIV 98 (375)
T ss_pred HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHH
Confidence 367788999999999999998 789999999988643 3344567899999999999999999999 5666666 8999
Q ss_pred EEecCCCCHHHHHH---hcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCC--eEcCCCCCCceEecCCCCEEEccCCcccc
Q 004400 491 YEYLENNSLARALF---EHRLKLDWPTRRRICLGIARGLAYLHGESRIK--VVHRDIKATNVLLDKDLNSKISDFGLAKL 565 (756)
Q Consensus 491 ~e~~~~gsL~~~l~---~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~--iiH~Dikp~Nill~~~~~~kl~DFGla~~ 565 (756)
||||..|+|...+. +.++.+++.++++++.|++.||.++|+.- ++ |+||||||.||+++.+|.|||+|||+++.
T Consensus 99 mE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~-~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~ 177 (375)
T KOG0591|consen 99 MELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKI-PRGTVMHRDIKPANIFLTANGVVKLGDFGLGRF 177 (375)
T ss_pred HHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccc-cccceeeccCcchheEEcCCCceeeccchhHhH
Confidence 99999999999986 45668999999999999999999999842 23 89999999999999999999999999998
Q ss_pred CcccCcceeeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhcCccccccccC
Q 004400 566 DEEENTHISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTN 645 (756)
Q Consensus 566 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 645 (756)
+....+ .....+|||.||+||.+....|+.|+||||+||++|||+.-+.||.+.+...+.... ..++.
T Consensus 178 l~s~~t-fA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI----~qgd~------- 245 (375)
T KOG0591|consen 178 LSSKTT-FAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKI----EQGDY------- 245 (375)
T ss_pred hcchhH-HHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccHHHHHHHH----HcCCC-------
Confidence 776443 345678999999999999999999999999999999999999999988655544311 11211
Q ss_pred CCCCCC-HHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHh
Q 004400 646 PGSNFD-KEQVMVMINVALLCANASPTIRPSMSSVLRML 683 (756)
Q Consensus 646 ~~~~~~-~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~L 683 (756)
...+ .-.+..+..++..|+..||+.||+...+++.+
T Consensus 246 --~~~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di 282 (375)
T KOG0591|consen 246 --PPLPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDI 282 (375)
T ss_pred --CCCcHHHhhhHHHHHHHHHccCCcccCCCcchHHHHH
Confidence 1122 33456689999999999999999855554443
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=368.68 Aligned_cols=252 Identities=24% Similarity=0.368 Sum_probs=213.8
Q ss_pred HhhcCccccCcccCCCCccEEEee-ccCCcEEEEEEcccc---CcccHHHHHHHHHHHHhC-CCCceeeEeeEEEeCCeE
Q 004400 413 AATNNFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSK---SKQGNREFINEIGMISAL-QHPNLVKLYGCCIEGNQL 487 (756)
Q Consensus 413 ~~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 487 (756)
...++|...+.||+|+|++||+|+ ..+++.||||++.+. .....+.+.+|-.+|.+| .||.||+++..|+++..+
T Consensus 70 k~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sL 149 (604)
T KOG0592|consen 70 KTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESL 149 (604)
T ss_pred CChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccce
Confidence 345789999999999999999999 668999999999764 222335567899999999 899999999999999999
Q ss_pred EEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCc
Q 004400 488 LLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDE 567 (756)
Q Consensus 488 ~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~ 567 (756)
|+|+||+++|+|.++|... ..+++...+.++.+|+.||+|||++| ||||||||+|||+|+||++||+|||-|+.+.
T Consensus 150 YFvLe~A~nGdll~~i~K~-Gsfde~caR~YAAeIldAleylH~~G---IIHRDlKPENILLd~dmhikITDFGsAK~l~ 225 (604)
T KOG0592|consen 150 YFVLEYAPNGDLLDLIKKY-GSFDETCARFYAAEILDALEYLHSNG---IIHRDLKPENILLDKDGHIKITDFGSAKILS 225 (604)
T ss_pred EEEEEecCCCcHHHHHHHh-CcchHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeEcCCCcEEEeeccccccCC
Confidence 9999999999999999766 48999999999999999999999997 9999999999999999999999999999775
Q ss_pred ccCcc----------ee--eccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhc
Q 004400 568 EENTH----------IS--TRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQ 635 (756)
Q Consensus 568 ~~~~~----------~~--~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~ 635 (756)
+.... .+ ..++||..|.+||++..+..+..+|+|+||||+|+|+.|++||.+.+++.++..+. .-
T Consensus 226 ~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~--~l- 302 (604)
T KOG0592|consen 226 PSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQ--AL- 302 (604)
T ss_pred hhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHH--Hh-
Confidence 43211 12 45899999999999999999999999999999999999999999888766654321 11
Q ss_pred CccccccccCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004400 636 GKLMELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRM 682 (756)
Q Consensus 636 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~ 682 (756)
+-.....++ ..+.+|+.+.+..||.+|++..||-+.
T Consensus 303 -------~y~fp~~fp----~~a~dLv~KLLv~dp~~Rlt~~qIk~H 338 (604)
T KOG0592|consen 303 -------DYEFPEGFP----EDARDLIKKLLVRDPSDRLTSQQIKAH 338 (604)
T ss_pred -------cccCCCCCC----HHHHHHHHHHHccCccccccHHHHhhC
Confidence 111122333 348899999999999999999888654
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-44 Score=345.05 Aligned_cols=261 Identities=21% Similarity=0.312 Sum_probs=206.6
Q ss_pred cCccccCcccCCCCccEEEeec-cCCcEEEEEEccccC--cccHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEE
Q 004400 416 NNFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSKS--KQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYE 492 (756)
Q Consensus 416 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 492 (756)
+.|+....+|+|+||.||+++. .+|+.||||++.... +...+-.++|+++|++++|+|+|.++++|......++|+|
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE 81 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE 81 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence 3577788999999999999995 569999999986542 2334567899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCcccCcc
Q 004400 493 YLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTH 572 (756)
Q Consensus 493 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~~~~~ 572 (756)
||+..-|.+ |......++.....+++.|+++|+.|+|++. +|||||||+|||++.++.+||||||+|+..... ..
T Consensus 82 ~~dhTvL~e-Le~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n---~IHRDIKPENILit~~gvvKLCDFGFAR~L~~p-gd 156 (396)
T KOG0593|consen 82 YCDHTVLHE-LERYPNGVPSELVKKYLYQLLKAIHFCHKNN---CIHRDIKPENILITQNGVVKLCDFGFARTLSAP-GD 156 (396)
T ss_pred ecchHHHHH-HHhccCCCCHHHHHHHHHHHHHHhhhhhhcC---eecccCChhheEEecCCcEEeccchhhHhhcCC-cc
Confidence 999865554 4455567899999999999999999999985 999999999999999999999999999987642 22
Q ss_pred eeeccccCccCCchHhhhc-CCCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHH------------HHhcCccc
Q 004400 573 ISTRVAGTIGYMAPEYAMR-GHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALV------------LKEQGKLM 639 (756)
Q Consensus 573 ~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~------------~~~~~~~~ 639 (756)
..+..+.|.+|.|||.+.+ .+|+..+||||+||++.||++|.+-|.+....+.+-.... +....-..
T Consensus 157 ~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~ 236 (396)
T KOG0593|consen 157 NYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFH 236 (396)
T ss_pred hhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCcee
Confidence 3355678999999999988 7899999999999999999999999977765543321111 11111111
Q ss_pred ccc-----ccCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 004400 640 ELV-----DTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLR 681 (756)
Q Consensus 640 ~~~-----~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~ 681 (756)
.+. +..+.+...+....-++++++.|++.||.+|++-+|++.
T Consensus 237 Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~ 283 (396)
T KOG0593|consen 237 GVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLH 283 (396)
T ss_pred eeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence 111 111111112233446889999999999999999999863
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-43 Score=359.02 Aligned_cols=264 Identities=26% Similarity=0.392 Sum_probs=215.7
Q ss_pred hcCccccCcccCCCCccEEEee-ccCCcEEEEEEccccC--cccHHHHHHHHHHHHhCCCCceeeEeeEEEeC--CeEEE
Q 004400 415 TNNFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSKS--KQGNREFINEIGMISALQHPNLVKLYGCCIEG--NQLLL 489 (756)
Q Consensus 415 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~l 489 (756)
.+.|+.+++||+|.||.||+|+ ..+|+.||+|++.... ........+|+.+|++++||||+++.+...+. ..+||
T Consensus 116 ~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYl 195 (560)
T KOG0600|consen 116 ADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYL 195 (560)
T ss_pred hHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEE
Confidence 4567788999999999999999 7789999999987653 33445678999999999999999999998876 78999
Q ss_pred EEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCccc
Q 004400 490 IYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEE 569 (756)
Q Consensus 490 V~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~~ 569 (756)
|+|||+. +|.-++.....+++..++..++.|++.||+|+|++| |+|||||.+|||||.+|.+||+|||+|+++...
T Consensus 196 VFeYMdh-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~g---vlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~ 271 (560)
T KOG0600|consen 196 VFEYMDH-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRG---VLHRDIKGSNILIDNNGVLKIADFGLARFYTPS 271 (560)
T ss_pred EEecccc-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcC---eeeccccccceEEcCCCCEEeccccceeeccCC
Confidence 9999987 888888887889999999999999999999999997 999999999999999999999999999988776
Q ss_pred CcceeeccccCccCCchHhhhc-CCCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhcCccc-----cccc
Q 004400 570 NTHISTRVAGTIGYMAPEYAMR-GHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLM-----ELVD 643 (756)
Q Consensus 570 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~-----~~~~ 643 (756)
.....+..+-|.+|.|||.+.+ ..|+.++|+||.|||+.||++|+..|.+.++...+..+..+....... .+..
T Consensus 272 ~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~kLP~ 351 (560)
T KOG0600|consen 272 GSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKLPH 351 (560)
T ss_pred CCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccccCCc
Confidence 6555566677999999999987 469999999999999999999999998887766555444333221110 1110
Q ss_pred ---cCCCCCCCH-------HHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004400 644 ---TNPGSNFDK-------EQVMVMINVALLCANASPTIRPSMSSVLRM 682 (756)
Q Consensus 644 ---~~~~~~~~~-------~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~ 682 (756)
..+...+.. ......++|+..++..||.+|.|+.++++.
T Consensus 352 ~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~s 400 (560)
T KOG0600|consen 352 ATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQS 400 (560)
T ss_pred ccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcC
Confidence 011111111 112257788999999999999999998753
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-43 Score=357.50 Aligned_cols=255 Identities=30% Similarity=0.460 Sum_probs=205.3
Q ss_pred cCccccCcccCCCCccEEEeecc-CCcEEEEEEccccCcccHHHHHHHHHHHHhCCCCceeeEeeEEEeCC--eEEEEEE
Q 004400 416 NNFATDNNIGEGGFGPVYKGLLA-DGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCCIEGN--QLLLIYE 492 (756)
Q Consensus 416 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--~~~lV~e 492 (756)
.+|...+.||+|+||+||.+... +|...|||.+........+.+.+|+.+|++++|||||+++|...... .+++.||
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mE 96 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFME 96 (313)
T ss_pred chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeee
Confidence 35667789999999999999954 59999999987653333567899999999999999999999855444 6999999
Q ss_pred ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecC-CCCEEEccCCccccCcc--c
Q 004400 493 YLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDK-DLNSKISDFGLAKLDEE--E 569 (756)
Q Consensus 493 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~-~~~~kl~DFGla~~~~~--~ 569 (756)
|+++|+|.+++...+..+++..+.+++.||++||+|||++| ||||||||+|||++. ++.+||+|||+++.... .
T Consensus 97 y~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g---~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~~ 173 (313)
T KOG0198|consen 97 YAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKG---IVHCDIKPANILLDPSNGDVKLADFGLAKKLESKGT 173 (313)
T ss_pred ccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCcccceEEEeCCCCeEEeccCccccccccccc
Confidence 99999999999876658999999999999999999999997 999999999999999 79999999999987663 2
Q ss_pred CcceeeccccCccCCchHhhhcC-CCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhcCccccccccCCCC
Q 004400 570 NTHISTRVAGTIGYMAPEYAMRG-HLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGS 648 (756)
Q Consensus 570 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 648 (756)
.......+.||+.|||||++..+ ....++||||+||++.||+||+.||... .....+...........
T Consensus 174 ~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~--~~~~~~~~~ig~~~~~P--------- 242 (313)
T KOG0198|consen 174 KSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF--FEEAEALLLIGREDSLP--------- 242 (313)
T ss_pred cccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh--cchHHHHHHHhccCCCC---------
Confidence 22223457899999999999864 3445999999999999999999999653 12222222222222222
Q ss_pred CCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhc
Q 004400 649 NFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLE 684 (756)
Q Consensus 649 ~~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~L~ 684 (756)
.++...+....+++.+|+..+|++|||++++++..-
T Consensus 243 ~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf 278 (313)
T KOG0198|consen 243 EIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPF 278 (313)
T ss_pred CCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChh
Confidence 222223445889999999999999999999987643
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-43 Score=367.96 Aligned_cols=251 Identities=27% Similarity=0.480 Sum_probs=213.6
Q ss_pred hcCccccCcccCCCCccEEEee-ccCCcEEEEEEccccCcccHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEEe
Q 004400 415 TNNFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYEY 493 (756)
Q Consensus 415 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 493 (756)
...|..-..||+|+.|.||.|. ..+++.||||++........+-+.+|+.+|+..+|+|||++++.|..++++|.||||
T Consensus 272 ~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEy 351 (550)
T KOG0578|consen 272 RSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEY 351 (550)
T ss_pred hhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEee
Confidence 3467778899999999999998 678899999999876555566789999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCcccCcce
Q 004400 494 LENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHI 573 (756)
Q Consensus 494 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~~~~~~ 573 (756)
|+||+|.|.+... .+++.++..|+.++++||+|||.+| |+|||||.+|||++.+|.+||+|||++..+..... .
T Consensus 352 m~ggsLTDvVt~~--~~~E~qIA~Icre~l~aL~fLH~~g---IiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~-K 425 (550)
T KOG0578|consen 352 MEGGSLTDVVTKT--RMTEGQIAAICREILQGLKFLHARG---IIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS-K 425 (550)
T ss_pred cCCCchhhhhhcc--cccHHHHHHHHHHHHHHHHHHHhcc---eeeeccccceeEeccCCcEEEeeeeeeeccccccC-c
Confidence 9999999998544 5999999999999999999999997 99999999999999999999999999987665544 3
Q ss_pred eeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhcCccccccccCCCCCCCHH
Q 004400 574 STRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDKE 653 (756)
Q Consensus 574 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 653 (756)
..+.+||+.|||||+.....|++|+||||||++++||+.|.+||..++...... .+...+ .+....+..
T Consensus 426 R~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAly---LIa~ng--------~P~lk~~~k 494 (550)
T KOG0578|consen 426 RSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY---LIATNG--------TPKLKNPEK 494 (550)
T ss_pred cccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHH---HHhhcC--------CCCcCCccc
Confidence 456789999999999999999999999999999999999999997765533211 111111 111222334
Q ss_pred HHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004400 654 QVMVMINVALLCANASPTIRPSMSSVLRM 682 (756)
Q Consensus 654 ~~~~l~~l~~~c~~~~P~~RPt~~ev~~~ 682 (756)
....+.+++.+|++.||++||++.|+++.
T Consensus 495 lS~~~kdFL~~cL~~dv~~RasA~eLL~H 523 (550)
T KOG0578|consen 495 LSPELKDFLDRCLVVDVEQRASAKELLEH 523 (550)
T ss_pred cCHHHHHHHHHHhhcchhcCCCHHHHhcC
Confidence 45569999999999999999999999864
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-43 Score=385.95 Aligned_cols=258 Identities=30% Similarity=0.506 Sum_probs=216.5
Q ss_pred hcCccccCcccCCCCccEEEeecc------CCcEEEEEEccccCcc-cHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeE
Q 004400 415 TNNFATDNNIGEGGFGPVYKGLLA------DGTAIAVKQLSSKSKQ-GNREFINEIGMISALQHPNLVKLYGCCIEGNQL 487 (756)
Q Consensus 415 ~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 487 (756)
..+....+.||+|+||+||+|+.. +...||||.++.+... ..++|++|++.++.++|||||+++|+|.+++..
T Consensus 485 r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~ 564 (774)
T KOG1026|consen 485 RSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPL 564 (774)
T ss_pred hhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCee
Confidence 355667789999999999999842 3567999999887555 678999999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHHHhc---------CC----CCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCC
Q 004400 488 LLIYEYLENNSLARALFEH---------RL----KLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLN 554 (756)
Q Consensus 488 ~lV~e~~~~gsL~~~l~~~---------~~----~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~ 554 (756)
++|+|||..|+|.++|..+ +. .++..+.+.||.|||.||+||-++. +|||||..+|+||.++..
T Consensus 565 ~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~---FVHRDLATRNCLVge~l~ 641 (774)
T KOG1026|consen 565 CMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHH---FVHRDLATRNCLVGENLV 641 (774)
T ss_pred EEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCc---ccccchhhhhceeccceE
Confidence 9999999999999999732 12 2888999999999999999999885 999999999999999999
Q ss_pred EEEccCCccccCcccCcce-eeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHh-CCCCCCccchhhHHHHHHHH
Q 004400 555 SKISDFGLAKLDEEENTHI-STRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVS-GRSNVTKEDMFYLLDWALVL 632 (756)
Q Consensus 555 ~kl~DFGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~~~~~~~ 632 (756)
|||+|||++|..-..+.+. .....-+++|||||.++.++|++++|||||||+|||+++ |+.|+.+....+..+ .
T Consensus 642 VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe----~ 717 (774)
T KOG1026|consen 642 VKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIE----C 717 (774)
T ss_pred EEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHHHH----H
Confidence 9999999999654444433 224456789999999999999999999999999999998 999997665433322 3
Q ss_pred HhcCccccccccCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhccCcc
Q 004400 633 KEQGKLMELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLECGVD 688 (756)
Q Consensus 633 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~L~~~~~ 688 (756)
.+++.+.+..+.+| .++.+|+..||+.+|.+||+++||-..|+.+..
T Consensus 718 i~~g~lL~~Pe~CP---------~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~ 764 (774)
T KOG1026|consen 718 IRAGQLLSCPENCP---------TEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQ 764 (774)
T ss_pred HHcCCcccCCCCCC---------HHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHh
Confidence 34555544443333 359999999999999999999999999997754
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-42 Score=328.17 Aligned_cols=262 Identities=23% Similarity=0.343 Sum_probs=213.4
Q ss_pred cCccccCcccCCCCccEEEee-ccCCcEEEEEEccccCcc--cHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEE
Q 004400 416 NNFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQ--GNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYE 492 (756)
Q Consensus 416 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 492 (756)
.+|...+.+|+|.||.||+|+ ..+|+.||||+++..... -.....+|+..|+.++|+||+.++++|-..+...+|+|
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE 81 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE 81 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence 357778899999999999999 678999999999765322 24568999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCcccCcc
Q 004400 493 YLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTH 572 (756)
Q Consensus 493 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~~~~~ 572 (756)
||+. +|+..++.....++..++..++.++++|++|||++. |+||||||.|+|++++|.+||+|||+|+.+......
T Consensus 82 fm~t-dLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~---IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~ 157 (318)
T KOG0659|consen 82 FMPT-DLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKW---ILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRI 157 (318)
T ss_pred eccc-cHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhh---hhcccCCccceEEcCCCcEEeecccchhccCCCCcc
Confidence 9976 899999988889999999999999999999999996 999999999999999999999999999988765544
Q ss_pred eeeccccCccCCchHhhhc-CCCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhcCcccccc------c--
Q 004400 573 ISTRVAGTIGYMAPEYAMR-GHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELV------D-- 643 (756)
Q Consensus 573 ~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~------~-- 643 (756)
... .+-|.+|.|||.+.+ +.|+..+||||.|||+.||+-|.+-|.+++..+.+.............+.. |
T Consensus 158 ~~~-~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY~ 236 (318)
T KOG0659|consen 158 QTH-QVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDYV 236 (318)
T ss_pred ccc-ceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccHH
Confidence 333 256899999999987 569999999999999999999887777777665554433333222111111 1
Q ss_pred ------cCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004400 644 ------TNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRM 682 (756)
Q Consensus 644 ------~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~ 682 (756)
..+....-........+++..++..||.+|.+++|++++
T Consensus 237 ~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~ 281 (318)
T KOG0659|consen 237 KIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKH 281 (318)
T ss_pred HHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence 111111222233456899999999999999999998764
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-42 Score=330.09 Aligned_cols=238 Identities=26% Similarity=0.381 Sum_probs=203.0
Q ss_pred hhcCccccCcccCCCCccEEEee-ccCCcEEEEEEccccC---cccHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEE
Q 004400 414 ATNNFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSKS---KQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLL 489 (756)
Q Consensus 414 ~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 489 (756)
..++|+..+.||.|+||+|..++ ..+|..+|+|.+.+.. -...+...+|..+|+.+.||+++++++.|.+.+..||
T Consensus 42 ~l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lym 121 (355)
T KOG0616|consen 42 SLQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYM 121 (355)
T ss_pred chhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEE
Confidence 34688999999999999999999 4568899999997652 2234557789999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCccc
Q 004400 490 IYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEE 569 (756)
Q Consensus 490 V~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~~ 569 (756)
||||++||.|..++++.+ ++++..++.++.||+.||+|||+.+ |++||+||+|||+|.+|.+||+|||+|+.....
T Consensus 122 vmeyv~GGElFS~Lrk~~-rF~e~~arFYAAeivlAleylH~~~---iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r 197 (355)
T KOG0616|consen 122 VMEYVPGGELFSYLRKSG-RFSEPHARFYAAEIVLALEYLHSLD---IIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR 197 (355)
T ss_pred EEeccCCccHHHHHHhcC-CCCchhHHHHHHHHHHHHHHHHhcC---eeeccCChHHeeeccCCcEEEEeccceEEecCc
Confidence 999999999999997654 8999999999999999999999996 999999999999999999999999999875543
Q ss_pred CcceeeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhcCccccccccCCCCC
Q 004400 570 NTHISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSN 649 (756)
Q Consensus 570 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 649 (756)
.-+.+||+.|+|||+++...|..++|.|||||++|||+.|..||...+...+.+ ++...+- .
T Consensus 198 ----T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~--KI~~~~v------------~ 259 (355)
T KOG0616|consen 198 ----TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYE--KILEGKV------------K 259 (355)
T ss_pred ----EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHH--HHHhCcc------------c
Confidence 345899999999999999999999999999999999999999998877654432 1121111 1
Q ss_pred CCHHHHHHHHHHHHHhhcCCCCCC
Q 004400 650 FDKEQVMVMINVALLCANASPTIR 673 (756)
Q Consensus 650 ~~~~~~~~l~~l~~~c~~~~P~~R 673 (756)
++.-....+.+++...++.|-.+|
T Consensus 260 fP~~fs~~~kdLl~~LL~vD~t~R 283 (355)
T KOG0616|consen 260 FPSYFSSDAKDLLKKLLQVDLTKR 283 (355)
T ss_pred CCcccCHHHHHHHHHHHhhhhHhh
Confidence 222223348889999999999988
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=355.64 Aligned_cols=261 Identities=22% Similarity=0.315 Sum_probs=211.1
Q ss_pred hcCccccCcccCCCCccEEEee-ccCCcEEEEEEccccCcccH-HHHHHHHHHHHhCC-CCceeeEeeEEEeCC-eEEEE
Q 004400 415 TNNFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQGN-REFINEIGMISALQ-HPNLVKLYGCCIEGN-QLLLI 490 (756)
Q Consensus 415 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~-~~~~~E~~~l~~l~-h~niv~l~~~~~~~~-~~~lV 490 (756)
.++|...+.||.|.||.||+|+ ..+|..||||+++++..... -.=.||+..|++++ |||||++.+++.+.+ .+++|
T Consensus 9 m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~fV 88 (538)
T KOG0661|consen 9 MDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYFV 88 (538)
T ss_pred HHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEeee
Confidence 4577888999999999999999 67899999999987644322 23478999999998 999999999999988 99999
Q ss_pred EEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCcccC
Q 004400 491 YEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEEN 570 (756)
Q Consensus 491 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~~~ 570 (756)
||||+. +|.+.+..+++.+++.+++.|+.||++||+|+|.+| +.|||+||+|||+.....+||+|||+||-.....
T Consensus 89 fE~Md~-NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~G---fFHRDlKPENiLi~~~~~iKiaDFGLARev~Skp 164 (538)
T KOG0661|consen 89 FEFMDC-NLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHG---FFHRDLKPENILISGNDVIKIADFGLAREVRSKP 164 (538)
T ss_pred HHhhhh-hHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcC---cccccCChhheEecccceeEecccccccccccCC
Confidence 999976 899999988889999999999999999999999998 9999999999999988899999999999655433
Q ss_pred cceeeccccCccCCchHhhhc-CCCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhcCcccc---------
Q 004400 571 THISTRVAGTIGYMAPEYAMR-GHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLME--------- 640 (756)
Q Consensus 571 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~--------- 640 (756)
. .+..+.|.+|.|||++.+ +.|+.+.|+||+|||++|+.+-++-|.+.++.+..-..-.+.......+
T Consensus 165 P--YTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~La~ 242 (538)
T KOG0661|consen 165 P--YTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNLAS 242 (538)
T ss_pred C--cchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHHHHH
Confidence 3 355778999999999865 6799999999999999999999999988776554322211111111111
Q ss_pred --------ccccCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004400 641 --------LVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRM 682 (756)
Q Consensus 641 --------~~~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~ 682 (756)
+...... ..-+....+.++++.+|+..||.+|||+.|.++.
T Consensus 243 ~mnf~~P~~~~~~l~-~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~ 291 (538)
T KOG0661|consen 243 AMNFRFPQVKPSPLK-DLLPNASSEAASLIERLLAWDPDKRPTASQALQH 291 (538)
T ss_pred HhccCCCcCCCCChH-HhCcccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence 1000110 1111245568899999999999999999999876
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-41 Score=343.57 Aligned_cols=260 Identities=25% Similarity=0.385 Sum_probs=206.6
Q ss_pred hcCccccCcccCCCCccEEEee-ccCCcEEEEEEccccC-cccHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEE
Q 004400 415 TNNFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSKS-KQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYE 492 (756)
Q Consensus 415 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 492 (756)
.++|+....||.|..++||+|+ .+.+..||||++.... ......+.+|++.|+.++||||++++..|..+..+|+||.
T Consensus 25 ~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmp 104 (516)
T KOG0582|consen 25 AKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMP 104 (516)
T ss_pred ccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeeh
Confidence 3578889999999999999999 6778999999997643 2335788999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCcccCc
Q 004400 493 YLENNSLARALFEH-RLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENT 571 (756)
Q Consensus 493 ~~~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~~~~ 571 (756)
||.+|++.+.+... ...+++..+..|.+++++||.|||.+| .||||||+.|||++++|.|||+|||.+........
T Consensus 105 fMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G---~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G~ 181 (516)
T KOG0582|consen 105 FMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNG---HIHRDVKAGNILIDSDGTVKLADFGVSASLFDSGD 181 (516)
T ss_pred hhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcC---ceecccccccEEEcCCCcEEEcCceeeeeecccCc
Confidence 99999999999743 346899999999999999999999998 99999999999999999999999999865433222
Q ss_pred c---eeeccccCccCCchHhhhc--CCCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhcCccccccccCC
Q 004400 572 H---ISTRVAGTIGYMAPEYAMR--GHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNP 646 (756)
Q Consensus 572 ~---~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 646 (756)
. ....+.||++|||||+++. ..|+.|+||||||+...|+.+|..||..-.....+- +.-.+......-...
T Consensus 182 R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl----~tLqn~pp~~~t~~~ 257 (516)
T KOG0582|consen 182 RQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLL----LTLQNDPPTLLTSGL 257 (516)
T ss_pred eeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHH----HHhcCCCCCcccccC
Confidence 1 1255789999999999654 469999999999999999999999995444332211 111122111110000
Q ss_pred CCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 004400 647 GSNFDKEQVMVMINVALLCANASPTIRPSMSSVLR 681 (756)
Q Consensus 647 ~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~ 681 (756)
...-.......+.+++..|++.||++|||++++++
T Consensus 258 ~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlk 292 (516)
T KOG0582|consen 258 DKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLK 292 (516)
T ss_pred ChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence 00001112336889999999999999999999964
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-41 Score=358.12 Aligned_cols=249 Identities=23% Similarity=0.389 Sum_probs=208.0
Q ss_pred hhcCccccCcccCCCCccEEEee-ccCCcEEEEEEcccc----Cc-ccHHHHHHHHHHHHhCC-CCceeeEeeEEEeCCe
Q 004400 414 ATNNFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSK----SK-QGNREFINEIGMISALQ-HPNLVKLYGCCIEGNQ 486 (756)
Q Consensus 414 ~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~----~~-~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~ 486 (756)
..+.|...+.||+|+||+||.|. ..++..||+|++.+. .. ...+.+.+|+.+++.++ ||||+++++++.....
T Consensus 15 ~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~ 94 (370)
T KOG0583|consen 15 SIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTK 94 (370)
T ss_pred ccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCe
Confidence 45688999999999999999998 567899999977653 11 23456678999999999 9999999999999999
Q ss_pred EEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCC-CCEEEccCCcccc
Q 004400 487 LLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKD-LNSKISDFGLAKL 565 (756)
Q Consensus 487 ~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~-~~~kl~DFGla~~ 565 (756)
.++||||+.||+|.+++.+ ..++.+..+.++++|++.|++|||++| |+||||||+|||+|.+ +.+||+|||++..
T Consensus 95 ~~ivmEy~~gGdL~~~i~~-~g~l~E~~ar~~F~Qlisav~y~H~~g---i~HRDLK~ENilld~~~~~~Kl~DFG~s~~ 170 (370)
T KOG0583|consen 95 IYIVMEYCSGGDLFDYIVN-KGRLKEDEARKYFRQLISAVAYCHSRG---IVHRDLKPENILLDGNEGNLKLSDFGLSAI 170 (370)
T ss_pred EEEEEEecCCccHHHHHHH-cCCCChHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEecCCCCCEEEeccccccc
Confidence 9999999999999999988 668999999999999999999999997 9999999999999999 9999999999997
Q ss_pred CcccCcceeeccccCccCCchHhhhcCC-CC-cccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhcCccccccc
Q 004400 566 DEEENTHISTRVAGTIGYMAPEYAMRGH-LT-EKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVD 643 (756)
Q Consensus 566 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 643 (756)
.. .......+.+||+.|+|||++.+.. |+ .++||||+||++|.|++|+.||...+...+... .....-.+...
T Consensus 171 ~~-~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~k--i~~~~~~~p~~-- 245 (370)
T KOG0583|consen 171 SP-GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRK--IRKGEFKIPSY-- 245 (370)
T ss_pred cC-CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHH--HhcCCccCCCC--
Confidence 74 2223345689999999999999877 75 789999999999999999999977654433321 11111111111
Q ss_pred cCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHH
Q 004400 644 TNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVL 680 (756)
Q Consensus 644 ~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~ 680 (756)
.. ...+..++.+|+..+|.+|+++.+|+
T Consensus 246 ------~~---S~~~~~Li~~mL~~~P~~R~t~~~i~ 273 (370)
T KOG0583|consen 246 ------LL---SPEARSLIEKMLVPDPSTRITLLEIL 273 (370)
T ss_pred ------cC---CHHHHHHHHHHcCCCcccCCCHHHHh
Confidence 10 34488999999999999999999998
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-41 Score=351.70 Aligned_cols=252 Identities=23% Similarity=0.323 Sum_probs=207.2
Q ss_pred hHHHhhcCccccCcccCCCCccEEEee-ccCCcEEEEEEcccc---CcccHHHHHHHHHHHHhCCCCceeeEeeEEEeCC
Q 004400 410 QIKAATNNFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSK---SKQGNREFINEIGMISALQHPNLVKLYGCCIEGN 485 (756)
Q Consensus 410 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 485 (756)
+.+...++|+....||+|+||.||.|+ ..+|..+|+|++++. .....+.+..|-.+|...++|.||++|..|++.+
T Consensus 135 R~r~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~ 214 (550)
T KOG0605|consen 135 RTRLSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKE 214 (550)
T ss_pred cccCCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCC
Confidence 345567899999999999999999999 567999999999875 3445567888999999999999999999999999
Q ss_pred eEEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCcccc
Q 004400 486 QLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKL 565 (756)
Q Consensus 486 ~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~ 565 (756)
++||||||++||++..+|...+ .|++..+..++.+++.|++.+|+.| +|||||||+|+|||..|++||+|||++.-
T Consensus 215 ~LYLiMEylPGGD~mTLL~~~~-~L~e~~arfYiaE~vlAI~~iH~~g---yIHRDIKPdNlLiD~~GHiKLSDFGLs~g 290 (550)
T KOG0605|consen 215 YLYLIMEYLPGGDMMTLLMRKD-TLTEDWARFYIAETVLAIESIHQLG---YIHRDIKPDNLLIDAKGHIKLSDFGLSTG 290 (550)
T ss_pred eeEEEEEecCCccHHHHHHhcC-cCchHHHHHHHHHHHHHHHHHHHcC---cccccCChhheeecCCCCEeeccccccch
Confidence 9999999999999999997654 8999999999999999999999997 99999999999999999999999999852
Q ss_pred Ccc-----------------------cCc----ce-------------------eeccccCccCCchHhhhcCCCCcccc
Q 004400 566 DEE-----------------------ENT----HI-------------------STRVAGTIGYMAPEYAMRGHLTEKAD 599 (756)
Q Consensus 566 ~~~-----------------------~~~----~~-------------------~~~~~gt~~y~aPE~~~~~~~~~~~D 599 (756)
... +.. .. ...++|||.|||||++.+..|+..+|
T Consensus 291 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cD 370 (550)
T KOG0605|consen 291 LDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECD 370 (550)
T ss_pred hhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCcccc
Confidence 211 000 00 01257999999999999999999999
Q ss_pred hhhHHHHHHHHHhCCCCCCccchhhHH----HHHHHHHhcCccccccccCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCC
Q 004400 600 VYSFGIVALEIVSGRSNVTKEDMFYLL----DWALVLKEQGKLMELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPS 675 (756)
Q Consensus 600 v~slGv~l~elltg~~p~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt 675 (756)
.||+|||+|||+.|-+||.+++..... .|..... .++ ..... .+..++|.+|+. ||++|--
T Consensus 371 wWSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~-------fP~---~~~~s----~eA~DLI~rll~-d~~~RLG 435 (550)
T KOG0605|consen 371 WWSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRETLK-------FPE---EVDLS----DEAKDLITRLLC-DPENRLG 435 (550)
T ss_pred HHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhcc-------CCC---cCccc----HHHHHHHHHHhc-CHHHhcC
Confidence 999999999999999999888765433 2321111 111 11111 347889999999 9999985
Q ss_pred ---HHHHH
Q 004400 676 ---MSSVL 680 (756)
Q Consensus 676 ---~~ev~ 680 (756)
+.||-
T Consensus 436 ~~G~~EIK 443 (550)
T KOG0605|consen 436 SKGAEEIK 443 (550)
T ss_pred cccHHHHh
Confidence 55553
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-41 Score=362.41 Aligned_cols=258 Identities=26% Similarity=0.421 Sum_probs=203.2
Q ss_pred hhcCccccCcccCCCCccEEEeec------cCCcEEEEEEccccC-cccHHHHHHHHHHHHhC-CCCceeeEeeEEEeC-
Q 004400 414 ATNNFATDNNIGEGGFGPVYKGLL------ADGTAIAVKQLSSKS-KQGNREFINEIGMISAL-QHPNLVKLYGCCIEG- 484 (756)
Q Consensus 414 ~~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~- 484 (756)
..++|...+.||+|+||.||+|.. .+++.||||.+.... ......+.+|+.+++++ +|||||+++++|...
T Consensus 5 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 84 (338)
T cd05102 5 PRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPN 84 (338)
T ss_pred chhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCC
Confidence 346788999999999999999973 235689999987542 23346789999999999 899999999998764
Q ss_pred CeEEEEEEecCCCCHHHHHHhcC---------------------------------------------------------
Q 004400 485 NQLLLIYEYLENNSLARALFEHR--------------------------------------------------------- 507 (756)
Q Consensus 485 ~~~~lV~e~~~~gsL~~~l~~~~--------------------------------------------------------- 507 (756)
+..++||||+++|+|.+++....
T Consensus 85 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (338)
T cd05102 85 GPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETD 164 (338)
T ss_pred CceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhcc
Confidence 46899999999999999987431
Q ss_pred ----CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCcccCcc-eeeccccCcc
Q 004400 508 ----LKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTH-ISTRVAGTIG 582 (756)
Q Consensus 508 ----~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~ 582 (756)
..+++.++..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++........ ......+++.
T Consensus 165 ~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~ 241 (338)
T cd05102 165 DLWKSPLTMEDLICYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLK 241 (338)
T ss_pred ccccCCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCcc
Confidence 24788899999999999999999986 999999999999999999999999999865332221 1223456788
Q ss_pred CCchHhhhcCCCCcccchhhHHHHHHHHHh-CCCCCCccchhhHHHHHHHHHhcCccccccccCCCCCCCHHHHHHHHHH
Q 004400 583 YMAPEYAMRGHLTEKADVYSFGIVALEIVS-GRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDKEQVMVMINV 661 (756)
Q Consensus 583 y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 661 (756)
|+|||++.+..++.++|||||||++|||++ |+.||......... .... ..+.... .... ....+.++
T Consensus 242 y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~--~~~~-~~~~~~~-----~~~~----~~~~l~~l 309 (338)
T cd05102 242 WMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEF--CQRL-KDGTRMR-----APEN----ATPEIYRI 309 (338)
T ss_pred ccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHH--HHHH-hcCCCCC-----CCCC----CCHHHHHH
Confidence 999999999899999999999999999997 99999654322111 1111 1111111 1111 22348899
Q ss_pred HHHhhcCCCCCCCCHHHHHHHhccC
Q 004400 662 ALLCANASPTIRPSMSSVLRMLECG 686 (756)
Q Consensus 662 ~~~c~~~~P~~RPt~~ev~~~L~~~ 686 (756)
+.+||+.||++||++.|+++.|+.+
T Consensus 310 i~~cl~~dp~~RPs~~el~~~l~~~ 334 (338)
T cd05102 310 MLACWQGDPKERPTFSALVEILGDL 334 (338)
T ss_pred HHHHccCChhhCcCHHHHHHHHHHH
Confidence 9999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=363.39 Aligned_cols=261 Identities=31% Similarity=0.475 Sum_probs=214.1
Q ss_pred hhcCccccCcccCCCCccEEEeeccC--C--cE-EEEEEcccc---CcccHHHHHHHHHHHHhCCCCceeeEeeEEEeCC
Q 004400 414 ATNNFATDNNIGEGGFGPVYKGLLAD--G--TA-IAVKQLSSK---SKQGNREFINEIGMISALQHPNLVKLYGCCIEGN 485 (756)
Q Consensus 414 ~~~~~~~~~~lg~G~~g~Vy~~~~~~--~--~~-vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 485 (756)
..++....+.||+|+||.||+|++.. + .. ||||..+.. ......+|++|+++|++++|||||++||++..+.
T Consensus 155 ~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~ 234 (474)
T KOG0194|consen 155 SHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEE 234 (474)
T ss_pred eccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCC
Confidence 34555666999999999999999543 2 23 899998853 4566788999999999999999999999999999
Q ss_pred eEEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCcccc
Q 004400 486 QLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKL 565 (756)
Q Consensus 486 ~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~ 565 (756)
.+++|||+|.||+|.++|......++..++.+++.+.|.||+|||++. +|||||.++|+|++.++.+||+|||+++.
T Consensus 235 Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~---~IHRDIAARNcL~~~~~~vKISDFGLs~~ 311 (474)
T KOG0194|consen 235 PLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKN---CIHRDIAARNCLYSKKGVVKISDFGLSRA 311 (474)
T ss_pred ccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCC---CcchhHhHHHheecCCCeEEeCccccccC
Confidence 999999999999999999987778999999999999999999999995 99999999999999999999999999986
Q ss_pred CcccCcceeeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHh-CCCCCCccchhhHHHHHHHHHhcCcccccccc
Q 004400 566 DEEENTHISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVS-GRSNVTKEDMFYLLDWALVLKEQGKLMELVDT 644 (756)
Q Consensus 566 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 644 (756)
........ ....-+..|+|||.+..+.|+.++|||||||++||+++ |..||.+........++ ...+..+....
T Consensus 312 ~~~~~~~~-~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI---~~~~~r~~~~~- 386 (474)
T KOG0194|consen 312 GSQYVMKK-FLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKI---VKNGYRMPIPS- 386 (474)
T ss_pred Ccceeecc-ccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHH---HhcCccCCCCC-
Confidence 44211111 11124679999999999999999999999999999999 88899887766544432 12222222222
Q ss_pred CCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhccCcccc
Q 004400 645 NPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLECGVDVL 690 (756)
Q Consensus 645 ~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~L~~~~~~~ 690 (756)
..+..+..++..||..+|++||+|.++.+.++.+....
T Consensus 387 --------~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~ 424 (474)
T KOG0194|consen 387 --------KTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKK 424 (474)
T ss_pred --------CCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhcc
Confidence 23345778888999999999999999999999765543
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=351.47 Aligned_cols=246 Identities=27% Similarity=0.413 Sum_probs=211.3
Q ss_pred cCccccCcccCCCCccEEEeec-cCCcEEEEEEcccc--CcccHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEE
Q 004400 416 NNFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSK--SKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYE 492 (756)
Q Consensus 416 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 492 (756)
++|...+.||+|.||+||||+. .+.+.||+|.+.+. .+...+.+.+|+++++.++|||||.++++|+...+.|+|.|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 4667778999999999999994 56889999999764 23345678999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCcccCcc
Q 004400 493 YLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTH 572 (756)
Q Consensus 493 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~~~~~ 572 (756)
|+.| +|..+|... ..++++.+..++.++..||.|||+.+ |+|||+||.|||++..+.+|+||||+|+.... ++.
T Consensus 82 ~a~g-~L~~il~~d-~~lpEe~v~~~a~~LVsaL~yLhs~r---ilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~-~t~ 155 (808)
T KOG0597|consen 82 YAVG-DLFTILEQD-GKLPEEQVRAIAYDLVSALYYLHSNR---ILHRDMKPQNILLEKGGTLKLCDFGLARAMST-NTS 155 (808)
T ss_pred hhhh-hHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHhcC---cccccCCcceeeecCCCceeechhhhhhhccc-Cce
Confidence 9988 999999654 58999999999999999999999986 99999999999999999999999999997665 455
Q ss_pred eeeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhcCccccccccCCCCCCCH
Q 004400 573 ISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDK 652 (756)
Q Consensus 573 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 652 (756)
..+.+.||+-|||||...++.|+..+|.||+||++||+.+|++||.......++... ..+ + ..++.
T Consensus 156 vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I---~~d----------~-v~~p~ 221 (808)
T KOG0597|consen 156 VLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARSITQLVKSI---LKD----------P-VKPPS 221 (808)
T ss_pred eeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHH---hcC----------C-CCCcc
Confidence 567788999999999999999999999999999999999999999877655544321 111 1 12233
Q ss_pred HHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 004400 653 EQVMVMINVALLCANASPTIRPSMSSVLR 681 (756)
Q Consensus 653 ~~~~~l~~l~~~c~~~~P~~RPt~~ev~~ 681 (756)
.....++.++...+.+||.+|-+..+++.
T Consensus 222 ~~S~~f~nfl~gLL~kdP~~RltW~~Ll~ 250 (808)
T KOG0597|consen 222 TASSSFVNFLQGLLIKDPAQRLTWTDLLG 250 (808)
T ss_pred cccHHHHHHHHHHhhcChhhcccHHHHhc
Confidence 45566999999999999999999999864
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-42 Score=359.42 Aligned_cols=259 Identities=28% Similarity=0.464 Sum_probs=208.3
Q ss_pred hcCccccCcccCCCCccEEEeeccCCcEEEEEEcccc--CcccHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEE
Q 004400 415 TNNFATDNNIGEGGFGPVYKGLLADGTAIAVKQLSSK--SKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYE 492 (756)
Q Consensus 415 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 492 (756)
.+.+.....||+|.||+||+|+|. ..||||.+... .....+.|+.|+.++++-+|.||+-+.|||..+.. .+|+.
T Consensus 391 ~~ev~l~~rIGsGsFGtV~Rg~wh--GdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~-AIiTq 467 (678)
T KOG0193|consen 391 PEEVLLGERIGSGSFGTVYRGRWH--GDVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL-AIITQ 467 (678)
T ss_pred HHHhhccceeccccccceeecccc--cceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce-eeeeh
Confidence 345667889999999999999975 35999999765 34456789999999999999999999999999888 99999
Q ss_pred ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCcccC-c
Q 004400 493 YLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEEN-T 571 (756)
Q Consensus 493 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~~~-~ 571 (756)
||+|-+|..+++..+.+++..+.+.|++|||+|+.|||.++ |||||||..||++.+++.|||+|||++....... .
T Consensus 468 wCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~---IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~w~g~ 544 (678)
T KOG0193|consen 468 WCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKN---IIHRDLKSNNIFLHEDLKVKIGDFGLATVKTRWSGE 544 (678)
T ss_pred hccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhh---hhhhhccccceEEccCCcEEEecccceeeeeeeccc
Confidence 99999999999988889999999999999999999999996 9999999999999999999999999997432211 1
Q ss_pred ceeeccccCccCCchHhhhc---CCCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhcCccccccccCCCC
Q 004400 572 HISTRVAGTIGYMAPEYAMR---GHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGS 648 (756)
Q Consensus 572 ~~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 648 (756)
.....--|...|||||+++. ..|+..+||||||+++|||+||..||.......+ ..+...+..+.-..
T Consensus 545 ~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqI----ifmVGrG~l~pd~s----- 615 (678)
T KOG0193|consen 545 QQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQI----IFMVGRGYLMPDLS----- 615 (678)
T ss_pred cccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhhe----EEEecccccCccch-----
Confidence 11122347789999999975 4689999999999999999999999974332211 11222222211110
Q ss_pred CCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhccCcc
Q 004400 649 NFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLECGVD 688 (756)
Q Consensus 649 ~~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~L~~~~~ 688 (756)
.........+.+|+..||..++++||.+.+|+..|+....
T Consensus 616 ~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~ 655 (678)
T KOG0193|consen 616 KIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLP 655 (678)
T ss_pred hhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhh
Confidence 1122334468899999999999999999999998886644
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-41 Score=342.53 Aligned_cols=254 Identities=25% Similarity=0.335 Sum_probs=205.3
Q ss_pred hhcCccccCcccCCCCccEEEee-ccCCcEEEEEEccccCc--------------ccHHHHHHHHHHHHhCCCCceeeEe
Q 004400 414 ATNNFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSKSK--------------QGNREFINEIGMISALQHPNLVKLY 478 (756)
Q Consensus 414 ~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~--------------~~~~~~~~E~~~l~~l~h~niv~l~ 478 (756)
..++|++.+.||+|.||.|-+|+ ..+++.||||++.+... ...+...+|+.+|++++|||||+++
T Consensus 95 ~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~Li 174 (576)
T KOG0585|consen 95 QLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLI 174 (576)
T ss_pred ehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEE
Confidence 45789999999999999999999 56899999999976411 1125788999999999999999999
Q ss_pred eEEEeC--CeEEEEEEecCCCCHHHHHHhcCCC-CCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCE
Q 004400 479 GCCIEG--NQLLLIYEYLENNSLARALFEHRLK-LDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNS 555 (756)
Q Consensus 479 ~~~~~~--~~~~lV~e~~~~gsL~~~l~~~~~~-l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~ 555 (756)
.+..+. +.+|||+|||..|.+... ..... +++.++++|+.++..||+|||.+| ||||||||+|+|++++|+|
T Consensus 175 EvLDDP~s~~~YlVley~s~G~v~w~--p~d~~els~~~Ar~ylrDvv~GLEYLH~Qg---iiHRDIKPsNLLl~~~g~V 249 (576)
T KOG0585|consen 175 EVLDDPESDKLYLVLEYCSKGEVKWC--PPDKPELSEQQARKYLRDVVLGLEYLHYQG---IIHRDIKPSNLLLSSDGTV 249 (576)
T ss_pred EeecCcccCceEEEEEeccCCccccC--CCCcccccHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEEcCCCcE
Confidence 998864 689999999999977432 22334 899999999999999999999997 9999999999999999999
Q ss_pred EEccCCccccCccc----CcceeeccccCccCCchHhhhcCC----CCcccchhhHHHHHHHHHhCCCCCCccchhhHHH
Q 004400 556 KISDFGLAKLDEEE----NTHISTRVAGTIGYMAPEYAMRGH----LTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLD 627 (756)
Q Consensus 556 kl~DFGla~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~ 627 (756)
||+|||.+...... ........+||+.|+|||.+.++. .+.+.||||+||+||.|+.|+.||.++..+.+.+
T Consensus 250 KIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l~~ 329 (576)
T KOG0585|consen 250 KISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELELFD 329 (576)
T ss_pred EeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHHHHH
Confidence 99999999865322 111123468999999999998732 4678999999999999999999998877666554
Q ss_pred HHHHHHhcCccccccccCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhc
Q 004400 628 WALVLKEQGKLMELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLE 684 (756)
Q Consensus 628 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~L~ 684 (756)
.. +...+.....++....+.+++++++++||++|.+..+|.....
T Consensus 330 KI------------vn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpw 374 (576)
T KOG0585|consen 330 KI------------VNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPW 374 (576)
T ss_pred HH------------hcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecce
Confidence 21 2222222222344556899999999999999999999976654
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-40 Score=346.20 Aligned_cols=246 Identities=20% Similarity=0.301 Sum_probs=200.3
Q ss_pred cCcccCCCCccEEEeeccCCcEEEEEEccccCccc---HHHHHHHHHHHHhCCCCceeeEeeEEEe----CCeEEEEEEe
Q 004400 421 DNNIGEGGFGPVYKGLLADGTAIAVKQLSSKSKQG---NREFINEIGMISALQHPNLVKLYGCCIE----GNQLLLIYEY 493 (756)
Q Consensus 421 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~lV~e~ 493 (756)
...||+|++|.||+|.+ +|+.||||.++...... .+.|.+|+.++++++|||||++++++.+ ....++||||
T Consensus 25 ~~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey 103 (283)
T PHA02988 25 SVLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEY 103 (283)
T ss_pred CeEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEe
Confidence 36899999999999998 68899999997643332 4667899999999999999999999977 3578999999
Q ss_pred cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCcccCcce
Q 004400 494 LENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHI 573 (756)
Q Consensus 494 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~~~~~~ 573 (756)
+++|+|.+++... ..+++..+.+++.|++.||+|||+.. +++||||||+||++++++.+||+|||+++......
T Consensus 104 ~~~g~L~~~l~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~--~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~--- 177 (283)
T PHA02988 104 CTRGYLREVLDKE-KDLSFKTKLDMAIDCCKGLYNLYKYT--NKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP--- 177 (283)
T ss_pred CCCCcHHHHHhhC-CCCChhHHHHHHHHHHHHHHHHHhcC--CCCCCcCChhhEEECCCCcEEEcccchHhhhcccc---
Confidence 9999999999754 47899999999999999999999742 37899999999999999999999999998644321
Q ss_pred eeccccCccCCchHhhhc--CCCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhcCccccccccCCCCCCC
Q 004400 574 STRVAGTIGYMAPEYAMR--GHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFD 651 (756)
Q Consensus 574 ~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 651 (756)
....|+..|+|||++.+ ..++.++|||||||++|||++|+.||...+....... ......... .+
T Consensus 178 -~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~---i~~~~~~~~---------~~ 244 (283)
T PHA02988 178 -FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDL---IINKNNSLK---------LP 244 (283)
T ss_pred -ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHH---HHhcCCCCC---------CC
Confidence 23458899999999976 6799999999999999999999999976554333221 111111111 11
Q ss_pred HHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhccC
Q 004400 652 KEQVMVMINVALLCANASPTIRPSMSSVLRMLECG 686 (756)
Q Consensus 652 ~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~L~~~ 686 (756)
......+.+++.+||+.||++|||+.|+++.|+..
T Consensus 245 ~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~ 279 (283)
T PHA02988 245 LDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLY 279 (283)
T ss_pred CcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHH
Confidence 12234588999999999999999999999999864
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-41 Score=380.58 Aligned_cols=259 Identities=31% Similarity=0.483 Sum_probs=213.8
Q ss_pred hcCccccCcccCCCCccEEEeeccC--Cc----EEEEEEcccc-CcccHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeE
Q 004400 415 TNNFATDNNIGEGGFGPVYKGLLAD--GT----AIAVKQLSSK-SKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQL 487 (756)
Q Consensus 415 ~~~~~~~~~lg~G~~g~Vy~~~~~~--~~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 487 (756)
....+..+.||+|+||.||+|...+ |. .||||.+++. +.....+|.+|..+|++++|||||+++|+|.+....
T Consensus 691 ~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~ 770 (1025)
T KOG1095|consen 691 RKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPP 770 (1025)
T ss_pred hhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCc
Confidence 3455677899999999999999543 43 4999999775 445567899999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHHHhc------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCC
Q 004400 488 LLIYEYLENNSLARALFEH------RLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFG 561 (756)
Q Consensus 488 ~lV~e~~~~gsL~~~l~~~------~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFG 561 (756)
++++|||++|+|..+|++. ...++..+.+.++.|||+|+.|||+++ +|||||..+|+||++...|||+|||
T Consensus 771 ~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~---fvHRDLAaRNCLL~~~r~VKIaDFG 847 (1025)
T KOG1095|consen 771 LILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKH---FVHRDLAARNCLLDERRVVKIADFG 847 (1025)
T ss_pred EEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCC---CcCcchhhhheeecccCcEEEcccc
Confidence 9999999999999999976 567999999999999999999999985 9999999999999999999999999
Q ss_pred ccccCcccCcc-eeeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHh-CCCCCCccchhhHHHHHHHHHhcCccc
Q 004400 562 LAKLDEEENTH-ISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVS-GRSNVTKEDMFYLLDWALVLKEQGKLM 639 (756)
Q Consensus 562 la~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 639 (756)
+|+........ ......-+..|||||.++.+.++.|+|||||||++||++| |..||...+..+.... ..+.+ +.
T Consensus 848 lArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~---~~~gg-RL 923 (1025)
T KOG1095|consen 848 LARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLD---VLEGG-RL 923 (1025)
T ss_pred hhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHH---HHhCC-cc
Confidence 99944333322 2222234579999999999999999999999999999999 8899977666554431 11223 22
Q ss_pred cccccCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhccCccc
Q 004400 640 ELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLECGVDV 689 (756)
Q Consensus 640 ~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~L~~~~~~ 689 (756)
+.+ ..++..+.+++..||+.+|++||++..|++.++++...
T Consensus 924 ~~P---------~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~ 964 (1025)
T KOG1095|consen 924 DPP---------SYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNA 964 (1025)
T ss_pred CCC---------CCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhh
Confidence 221 12333488999999999999999999999988876553
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-40 Score=346.93 Aligned_cols=260 Identities=27% Similarity=0.425 Sum_probs=203.6
Q ss_pred cCccccCcccCCCCccEEEeeccC-----------------CcEEEEEEccccC-cccHHHHHHHHHHHHhCCCCceeeE
Q 004400 416 NNFATDNNIGEGGFGPVYKGLLAD-----------------GTAIAVKQLSSKS-KQGNREFINEIGMISALQHPNLVKL 477 (756)
Q Consensus 416 ~~~~~~~~lg~G~~g~Vy~~~~~~-----------------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l 477 (756)
++|...+.||+|+||.||+|.+.+ +..||+|.+.... .....+|.+|++++++++||||+++
T Consensus 5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~ 84 (304)
T cd05096 5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRL 84 (304)
T ss_pred hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence 577888999999999999997532 3469999987542 3344679999999999999999999
Q ss_pred eeEEEeCCeEEEEEEecCCCCHHHHHHhcC------------------CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEc
Q 004400 478 YGCCIEGNQLLLIYEYLENNSLARALFEHR------------------LKLDWPTRRRICLGIARGLAYLHGESRIKVVH 539 (756)
Q Consensus 478 ~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~------------------~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH 539 (756)
++++.+.+..++||||+++|+|.+++.... ..+++..+.+++.||+.||+|||+.| |+|
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---ivH 161 (304)
T cd05096 85 LGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN---FVH 161 (304)
T ss_pred EEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC---ccc
Confidence 999999999999999999999999986421 24688899999999999999999986 999
Q ss_pred CCCCCCceEecCCCCEEEccCCccccCcccCc-ceeeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHh--CCCC
Q 004400 540 RDIKATNVLLDKDLNSKISDFGLAKLDEEENT-HISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVS--GRSN 616 (756)
Q Consensus 540 ~Dikp~Nill~~~~~~kl~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt--g~~p 616 (756)
|||||+||+++.++.+||+|||+++....... .......++..|+|||++..+.++.++||||||+++|||++ +..|
T Consensus 162 ~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p 241 (304)
T cd05096 162 RDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQP 241 (304)
T ss_pred cCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCC
Confidence 99999999999999999999999986543322 12233456789999999998899999999999999999987 5667
Q ss_pred CCccchhhHHHHHHHHHhcCccccccccCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhc
Q 004400 617 VTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLE 684 (756)
Q Consensus 617 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~L~ 684 (756)
|..........+................ ... .+..+.+++.+||+.+|++|||+.+|++.|+
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~----~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~ 303 (304)
T cd05096 242 YGELTDEQVIENAGEFFRDQGRQVYLFR--PPP----CPQGLYELMLQCWSRDCRERPSFSDIHAFLT 303 (304)
T ss_pred CCcCCHHHHHHHHHHHhhhccccccccC--CCC----CCHHHHHHHHHHccCCchhCcCHHHHHHHHh
Confidence 7554433333332222111111111110 111 2234889999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-40 Score=342.51 Aligned_cols=256 Identities=25% Similarity=0.393 Sum_probs=207.1
Q ss_pred hcCccccCcccCCCCccEEEeecc----CCcEEEEEEccccC-cccHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEE
Q 004400 415 TNNFATDNNIGEGGFGPVYKGLLA----DGTAIAVKQLSSKS-KQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLL 489 (756)
Q Consensus 415 ~~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 489 (756)
.++|+..+.||+|+||.||+|.+. .+..||+|.++... ......|.+|+.++++++||||+++++++..++..++
T Consensus 4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 83 (266)
T cd05064 4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMI 83 (266)
T ss_pred hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEE
Confidence 356888899999999999999743 35689999987643 2334578999999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCccc
Q 004400 490 IYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEE 569 (756)
Q Consensus 490 V~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~~ 569 (756)
||||+++|+|.+++......+++..++.++.|++.||+|||+.+ ++||||||+||+++.++.+|++|||.+......
T Consensus 84 v~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~---iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~ 160 (266)
T cd05064 84 VTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMG---YVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSE 160 (266)
T ss_pred EEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeeccccHhhEEEcCCCcEEECCCccccccccc
Confidence 99999999999999876668999999999999999999999986 999999999999999999999999987654322
Q ss_pred CcceeeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHh-CCCCCCccchhhHHHHHHHHHhcCccccccccCCCC
Q 004400 570 NTHISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVS-GRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGS 648 (756)
Q Consensus 570 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 648 (756)
.........++..|+|||.+.+..++.++|||||||++||+++ |+.||........... . ..+.... .
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~---~-~~~~~~~-----~-- 229 (266)
T cd05064 161 AIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKA---V-EDGFRLP-----A-- 229 (266)
T ss_pred chhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHH---H-HCCCCCC-----C--
Confidence 2221222345678999999999999999999999999999775 9999976554333221 1 1111111 1
Q ss_pred CCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhccC
Q 004400 649 NFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLECG 686 (756)
Q Consensus 649 ~~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~L~~~ 686 (756)
+...+..+.+++.+||+.+|++||++.+|++.|+..
T Consensus 230 --~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 230 --PRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred --CCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 112233488999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=344.97 Aligned_cols=248 Identities=29% Similarity=0.456 Sum_probs=208.7
Q ss_pred cCccccCcccCCCCccEEEee-ccCCcEEEEEEcccc-CcccHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEEe
Q 004400 416 NNFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSK-SKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYEY 493 (756)
Q Consensus 416 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 493 (756)
..|...+.||+|.||.||+|. ...++.||+|++... .....+++.+|+.++..++++||.++|+.+..+..++++|||
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey 92 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEY 92 (467)
T ss_pred cccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHH
Confidence 456777899999999999999 567899999999765 344567889999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCcccCcce
Q 004400 494 LENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHI 573 (756)
Q Consensus 494 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~~~~~~ 573 (756)
|.||++.+.+... ..+++..+.-+++++..|+.|||.++ .+|||||+.||++..+|.+|++|||.+..........
T Consensus 93 ~~gGsv~~lL~~~-~~~~E~~i~~ilre~l~~l~ylH~~~---kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~rr 168 (467)
T KOG0201|consen 93 CGGGSVLDLLKSG-NILDEFEIAVILREVLKGLDYLHSEK---KIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKRR 168 (467)
T ss_pred hcCcchhhhhccC-CCCccceeeeehHHHHHHhhhhhhcc---eecccccccceeEeccCcEEEEecceeeeeechhhcc
Confidence 9999999998644 35588888999999999999999996 9999999999999999999999999997655443333
Q ss_pred eeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhcCccccccccCCCCCCCHH
Q 004400 574 STRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDKE 653 (756)
Q Consensus 574 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 653 (756)
.+++||+.|||||++....|+.|+||||||++.+||++|.+|+.....+ ...-.+.+.........
T Consensus 169 -~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPm-------------rvlflIpk~~PP~L~~~ 234 (467)
T KOG0201|consen 169 -KTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPM-------------RVLFLIPKSAPPRLDGD 234 (467)
T ss_pred -ccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcc-------------eEEEeccCCCCCccccc
Confidence 5689999999999999889999999999999999999999999544331 12222333332333334
Q ss_pred HHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 004400 654 QVMVMINVALLCANASPTIRPSMSSVLR 681 (756)
Q Consensus 654 ~~~~l~~l~~~c~~~~P~~RPt~~ev~~ 681 (756)
....+.+++..|++.+|+.||++.++++
T Consensus 235 ~S~~~kEFV~~CL~k~P~~RpsA~~LLK 262 (467)
T KOG0201|consen 235 FSPPFKEFVEACLDKNPEFRPSAKELLK 262 (467)
T ss_pred cCHHHHHHHHHHhhcCcccCcCHHHHhh
Confidence 4455999999999999999999999964
|
|
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-40 Score=337.63 Aligned_cols=252 Identities=26% Similarity=0.474 Sum_probs=207.0
Q ss_pred cCccccCcccCCCCccEEEeeccCCcEEEEEEccccCcccHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEEecC
Q 004400 416 NNFATDNNIGEGGFGPVYKGLLADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYEYLE 495 (756)
Q Consensus 416 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~ 495 (756)
++|+..+.||+|+||.||+|.+.++..+|+|.+... ......+.+|++++++++||||++++++|.+++..++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~ 82 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEG-AMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFME 82 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEeccCceEEEEecccC-CccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCC
Confidence 457788899999999999999888889999988643 3345678999999999999999999999999999999999999
Q ss_pred CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCcccCcceee
Q 004400 496 NNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHIST 575 (756)
Q Consensus 496 ~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~ 575 (756)
+|+|.+++......+++..+..++.|++.||+|||+.+ |+||||||+||++++++.+||+|||.++...........
T Consensus 83 ~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~~~ 159 (256)
T cd05114 83 NGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNS---FIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSS 159 (256)
T ss_pred CCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcceEEEcCCCeEEECCCCCccccCCCceeccC
Confidence 99999999765557899999999999999999999986 999999999999999999999999999865433222222
Q ss_pred ccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHh-CCCCCCccchhhHHHHHHHHHhcCccccccccCCCCCCCHHH
Q 004400 576 RVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVS-GRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDKEQ 654 (756)
Q Consensus 576 ~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 654 (756)
...++..|+|||.+....++.++||||||+++|||++ |+.||...+........ .. ..... . +...
T Consensus 160 ~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i---~~-~~~~~--~-------~~~~ 226 (256)
T cd05114 160 GAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMI---SR-GFRLY--R-------PKLA 226 (256)
T ss_pred CCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH---HC-CCCCC--C-------CCCC
Confidence 3345678999999988889999999999999999999 89999766544433322 11 11110 0 1111
Q ss_pred HHHHHHHHHHhhcCCCCCCCCHHHHHHHhc
Q 004400 655 VMVMINVALLCANASPTIRPSMSSVLRMLE 684 (756)
Q Consensus 655 ~~~l~~l~~~c~~~~P~~RPt~~ev~~~L~ 684 (756)
...+.+++.+||+.+|++||++.++++.|.
T Consensus 227 ~~~~~~li~~c~~~~p~~Rps~~~l~~~l~ 256 (256)
T cd05114 227 SMTVYEVMYSCWHEKPEGRPTFAELLRAIT 256 (256)
T ss_pred CHHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 235889999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-41 Score=348.28 Aligned_cols=241 Identities=28% Similarity=0.422 Sum_probs=198.8
Q ss_pred cccCcccCCCCccEEEeeccCCcEEEEEEccccCcccHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEEecCCCC
Q 004400 419 ATDNNIGEGGFGPVYKGLLADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYEYLENNS 498 (756)
Q Consensus 419 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gs 498 (756)
...+-||.|+.|.||.|++. ++.||||+++.-. ..++.-|++|+||||+.+.|+|.....+|+|||||..|-
T Consensus 127 sELeWlGSGaQGAVF~Grl~-netVAVKKV~elk-------ETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~Gq 198 (904)
T KOG4721|consen 127 SELEWLGSGAQGAVFLGRLH-NETVAVKKVRELK-------ETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQ 198 (904)
T ss_pred hhhhhhccCcccceeeeecc-CceehhHHHhhhh-------hhhHHHHHhccCcceeeEeeeecCCceeEEeeecccccc
Confidence 45678999999999999986 5789999885321 347888999999999999999999999999999999999
Q ss_pred HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCcccCcceeeccc
Q 004400 499 LARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVA 578 (756)
Q Consensus 499 L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~~ 578 (756)
|..+|+.. ..+.......+..+||.|+.|||.+ +|||||||.-||||..+..|||+|||-++...+. .....++
T Consensus 199 L~~VLka~-~~itp~llv~Wsk~IA~GM~YLH~h---KIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~--STkMSFa 272 (904)
T KOG4721|consen 199 LYEVLKAG-RPITPSLLVDWSKGIAGGMNYLHLH---KIIHRDLKSPNILISYDDVVKISDFGTSKELSDK--STKMSFA 272 (904)
T ss_pred HHHHHhcc-CccCHHHHHHHHHHhhhhhHHHHHh---hHhhhccCCCceEeeccceEEeccccchHhhhhh--hhhhhhh
Confidence 99999654 4788888999999999999999988 4999999999999999999999999999866554 2235689
Q ss_pred cCccCCchHhhhcCCCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhcCccccccccCCCCCCCHHHHHHH
Q 004400 579 GTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDKEQVMVM 658 (756)
Q Consensus 579 gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 658 (756)
||..|||||++.+...++|+|||||||+||||+||..||...+..-+ +..-+ ...+.-..+..++.-+
T Consensus 273 GTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAI------IwGVG------sNsL~LpvPstcP~Gf 340 (904)
T KOG4721|consen 273 GTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAI------IWGVG------SNSLHLPVPSTCPDGF 340 (904)
T ss_pred hhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchhee------EEecc------CCcccccCcccCchHH
Confidence 99999999999999999999999999999999999999954332111 00000 0111112223334447
Q ss_pred HHHHHHhhcCCCCCCCCHHHHHHHhcc
Q 004400 659 INVALLCANASPTIRPSMSSVLRMLEC 685 (756)
Q Consensus 659 ~~l~~~c~~~~P~~RPt~~ev~~~L~~ 685 (756)
.-|++.||+..|..||+|++++..|+-
T Consensus 341 klL~Kqcw~sKpRNRPSFrqil~HldI 367 (904)
T KOG4721|consen 341 KLLLKQCWNSKPRNRPSFRQILLHLDI 367 (904)
T ss_pred HHHHHHHHhcCCCCCccHHHHHHHHhh
Confidence 888999999999999999999999883
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=353.65 Aligned_cols=245 Identities=24% Similarity=0.381 Sum_probs=208.2
Q ss_pred HHhhcCccccCcccCCCCccEEEeec-cCCcEEEEEEcccc---CcccHHHHHHHHHHHHhC-CCCceeeEeeEEEeCCe
Q 004400 412 KAATNNFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSK---SKQGNREFINEIGMISAL-QHPNLVKLYGCCIEGNQ 486 (756)
Q Consensus 412 ~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~ 486 (756)
+...++|...++||+|.||+|+.|.. .+++.+|||.+++. ..+..+..+.|.+++... +||++++++.+|+..++
T Consensus 364 ~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~ 443 (694)
T KOG0694|consen 364 PLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEH 443 (694)
T ss_pred cccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCe
Confidence 34567899999999999999999994 56889999999876 345567788899988877 59999999999999999
Q ss_pred EEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccC
Q 004400 487 LLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLD 566 (756)
Q Consensus 487 ~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~ 566 (756)
+|+||||+.||++..+ .+...+++..+..++..|+.||.|||++| |||||||.+|||+|.+|.+||+|||+++..
T Consensus 444 l~fvmey~~Ggdm~~~--~~~~~F~e~rarfyaAev~l~L~fLH~~~---IIYRDlKLdNiLLD~eGh~kiADFGlcKe~ 518 (694)
T KOG0694|consen 444 LFFVMEYVAGGDLMHH--IHTDVFSEPRARFYAAEVVLGLQFLHENG---IIYRDLKLDNLLLDTEGHVKIADFGLCKEG 518 (694)
T ss_pred EEEEEEecCCCcEEEE--EecccccHHHHHHHHHHHHHHHHHHHhcC---ceeeecchhheEEcccCcEEeccccccccc
Confidence 9999999999994333 44568999999999999999999999997 999999999999999999999999999853
Q ss_pred cccCcceeeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhcCccccccccCC
Q 004400 567 EEENTHISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNP 646 (756)
Q Consensus 567 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 646 (756)
-.. ...+++++||+.|||||++....|+.++|.|||||+||||+.|..||.++++.++.+... .|.
T Consensus 519 m~~-g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~-----------~d~-- 584 (694)
T KOG0694|consen 519 MGQ-GDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIV-----------NDE-- 584 (694)
T ss_pred CCC-CCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHh-----------cCC--
Confidence 322 224567999999999999999999999999999999999999999999888777665321 111
Q ss_pred CCCCCHHHHHHHHHHHHHhhcCCCCCCCCH
Q 004400 647 GSNFDKEQVMVMINVALLCANASPTIRPSM 676 (756)
Q Consensus 647 ~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~ 676 (756)
..|+.-.+.+.+.++++.+..+|++|--+
T Consensus 585 -~~yP~~ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 585 -VRYPRFLSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred -CCCCCcccHHHHHHHHHHhccCcccccCC
Confidence 12344445568899999999999999976
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=341.13 Aligned_cols=249 Identities=24% Similarity=0.316 Sum_probs=199.7
Q ss_pred ccccCcccCCCCccEEEeec-cCCcEEEEEEccccC---cccHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEEe
Q 004400 418 FATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSKS---KQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYEY 493 (756)
Q Consensus 418 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 493 (756)
|...+.||+|+||.||+|.. .+|+.||+|.+.... ......+.+|+.++++++|+||+++++++.+++..++||||
T Consensus 2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05631 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEe
Confidence 66778999999999999984 679999999986532 22334678899999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCcccCcc
Q 004400 494 LENNSLARALFEH-RLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTH 572 (756)
Q Consensus 494 ~~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~~~~~ 572 (756)
+++|+|.+++... ...+++..+..++.|++.||+|||+.+ |+||||||+||++++++.+||+|||++........
T Consensus 82 ~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~- 157 (285)
T cd05631 82 MNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRER---IVYRDLKPENILLDDRGHIRISDLGLAVQIPEGET- 157 (285)
T ss_pred cCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCCe-
Confidence 9999999888643 346899999999999999999999986 99999999999999999999999999986533221
Q ss_pred eeeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhcCccccccccCCCCCCCH
Q 004400 573 ISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDK 652 (756)
Q Consensus 573 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 652 (756)
.....||..|+|||++.+..++.++|||||||++|||++|+.||................... ...++.
T Consensus 158 -~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~----------~~~~~~ 226 (285)
T cd05631 158 -VRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKED----------QEEYSE 226 (285)
T ss_pred -ecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhcc----------cccCCc
Confidence 234578999999999999999999999999999999999999996543321111110000000 011112
Q ss_pred HHHHHHHHHHHHhhcCCCCCCCC-----HHHHHH
Q 004400 653 EQVMVMINVALLCANASPTIRPS-----MSSVLR 681 (756)
Q Consensus 653 ~~~~~l~~l~~~c~~~~P~~RPt-----~~ev~~ 681 (756)
.....+.+++.+||+.||++||+ ++++++
T Consensus 227 ~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~ 260 (285)
T cd05631 227 KFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQ 260 (285)
T ss_pred cCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhc
Confidence 22335889999999999999997 677765
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-40 Score=345.40 Aligned_cols=257 Identities=27% Similarity=0.453 Sum_probs=216.4
Q ss_pred hcCccccCcccCCCCccEEEeeccC---C--cEEEEEEcccc-CcccHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEE
Q 004400 415 TNNFATDNNIGEGGFGPVYKGLLAD---G--TAIAVKQLSSK-SKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLL 488 (756)
Q Consensus 415 ~~~~~~~~~lg~G~~g~Vy~~~~~~---~--~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 488 (756)
.+.....++||+|-||.||+|++.+ | -.||||..+.+ .....+.|.+|..+|++++|||||+++|+|.+ ...|
T Consensus 388 Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e-~P~W 466 (974)
T KOG4257|consen 388 RELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE-QPMW 466 (974)
T ss_pred hhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeec-ccee
Confidence 3445567899999999999998532 3 36889998874 44556789999999999999999999999976 5789
Q ss_pred EEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCcc
Q 004400 489 LIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEE 568 (756)
Q Consensus 489 lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~ 568 (756)
+|||.++-|.|..+|......++..+...++.||+.||+|||+. ++|||||..+|||+.....||++|||++|....
T Consensus 467 ivmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSk---rfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed 543 (974)
T KOG4257|consen 467 IVMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESK---RFVHRDIAARNILVSSPQCVKLADFGLSRYLED 543 (974)
T ss_pred EEEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhh---chhhhhhhhhheeecCcceeeecccchhhhccc
Confidence 99999999999999998888999999999999999999999988 499999999999999999999999999999988
Q ss_pred cCcceeeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHh-CCCCCCccchhhHHHHHHHHHhcCccccccccCCC
Q 004400 569 ENTHISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVS-GRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPG 647 (756)
Q Consensus 569 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 647 (756)
+.....+...-++.|||||.+.-++++.++|||.|||.+||++. |..||.+....+ ....+.....
T Consensus 544 ~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsD-------------VI~~iEnGeR 610 (974)
T KOG4257|consen 544 DAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSD-------------VIGHIENGER 610 (974)
T ss_pred cchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccc-------------eEEEecCCCC
Confidence 87777776677889999999999999999999999999999987 999996543322 1122222222
Q ss_pred CCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhccCcc
Q 004400 648 SNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLECGVD 688 (756)
Q Consensus 648 ~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~L~~~~~ 688 (756)
...++.++..+..++.+||..+|.+||.+.|+...|+.+..
T Consensus 611 lP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~q 651 (974)
T KOG4257|consen 611 LPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQ 651 (974)
T ss_pred CCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHH
Confidence 23334444558899999999999999999999999986543
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-40 Score=347.17 Aligned_cols=247 Identities=25% Similarity=0.398 Sum_probs=210.7
Q ss_pred cCccccCcccCCCCccEEEee-ccCCcEEEEEEccccC---cccHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEE
Q 004400 416 NNFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSKS---KQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIY 491 (756)
Q Consensus 416 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 491 (756)
+-|+..+.||.|+-|.|-.|+ ..+|+.+|||++.+.. ......+.+|+.+|+-++|||++++|+++.+..++|+|.
T Consensus 12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvl 91 (786)
T KOG0588|consen 12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVL 91 (786)
T ss_pred cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEE
Confidence 467888999999999999999 5689999999997652 223456889999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCcccCc
Q 004400 492 EYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENT 571 (756)
Q Consensus 492 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~~~~ 571 (756)
||+++|.|.+++..++ .+++.++.+++.||+.|+.|+|..+ |+|||+||+|+|+|..+.+||+|||+|.+..++.-
T Consensus 92 Eyv~gGELFdylv~kG-~l~e~eaa~ff~QIi~gv~yCH~~~---icHRDLKpENlLLd~~~nIKIADFGMAsLe~~gkl 167 (786)
T KOG0588|consen 92 EYVPGGELFDYLVRKG-PLPEREAAHFFRQILDGVSYCHAFN---ICHRDLKPENLLLDVKNNIKIADFGMASLEVPGKL 167 (786)
T ss_pred EecCCchhHHHHHhhC-CCCCHHHHHHHHHHHHHHHHHhhhc---ceeccCCchhhhhhcccCEeeeccceeecccCCcc
Confidence 9999999999997665 7999999999999999999999986 99999999999999999999999999987554433
Q ss_pred ceeeccccCccCCchHhhhcCCC-CcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhcCccccccccCCCCCC
Q 004400 572 HISTRVAGTIGYMAPEYAMRGHL-TEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNF 650 (756)
Q Consensus 572 ~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 650 (756)
-.+.||++.|.|||++++..| +.++||||+|||+|.|+||+.||..++...++..+ ..+.. ++. ...
T Consensus 168 --LeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV----~~G~f-~MP-----s~I 235 (786)
T KOG0588|consen 168 --LETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKV----QRGVF-EMP-----SNI 235 (786)
T ss_pred --ccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHH----HcCcc-cCC-----CcC
Confidence 345799999999999999887 56999999999999999999999877766655432 12221 121 122
Q ss_pred CHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004400 651 DKEQVMVMINVALLCANASPTIRPSMSSVLRM 682 (756)
Q Consensus 651 ~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~ 682 (756)
..+..+|+.+|+..||++|.|+.||++.
T Consensus 236 ----s~eaQdLLr~ml~VDp~~RiT~~eI~kH 263 (786)
T KOG0588|consen 236 ----SSEAQDLLRRMLDVDPSTRITTEEILKH 263 (786)
T ss_pred ----CHHHHHHHHHHhccCccccccHHHHhhC
Confidence 2348899999999999999999999875
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-40 Score=309.37 Aligned_cols=250 Identities=25% Similarity=0.357 Sum_probs=210.3
Q ss_pred HhhcCccccCcccCCCCccEEEee-ccCCcEEEEEEcccc---CcccHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEE
Q 004400 413 AATNNFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSK---SKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLL 488 (756)
Q Consensus 413 ~~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 488 (756)
.+.++|+..+.||+|.||.||.|+ .+++-.||+|++.+. ......++.+|+++-+.|+||||+++|++|.+....|
T Consensus 19 ~~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riy 98 (281)
T KOG0580|consen 19 WTLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIY 98 (281)
T ss_pred cchhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeE
Confidence 456799999999999999999999 557788999998764 2334567899999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCc
Q 004400 489 LIYEYLENNSLARALFE-HRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDE 567 (756)
Q Consensus 489 lV~e~~~~gsL~~~l~~-~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~ 567 (756)
+++||..+|++...|.+ ...++++.....++.|+|.|+.|+|... ||||||||+|+|++..+..||+|||-+....
T Consensus 99 LilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~---VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p 175 (281)
T KOG0580|consen 99 LILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAP 175 (281)
T ss_pred EEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCC---cccCCCCHHHhccCCCCCeeccCCCceeecC
Confidence 99999999999999983 3456999999999999999999999885 9999999999999999999999999986433
Q ss_pred ccCcceeeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhcCccccccccCCC
Q 004400 568 EENTHISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPG 647 (756)
Q Consensus 568 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 647 (756)
.....+.+||+.|.+||...+..++.++|+|++|++.||++.|..||.......... ..... +...
T Consensus 176 ---~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYk--rI~k~-----~~~~---- 241 (281)
T KOG0580|consen 176 ---SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYK--RIRKV-----DLKF---- 241 (281)
T ss_pred ---CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHH--HHHHc-----cccC----
Confidence 333456899999999999999999999999999999999999999997665433222 11111 1111
Q ss_pred CCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004400 648 SNFDKEQVMVMINVALLCANASPTIRPSMSSVLRM 682 (756)
Q Consensus 648 ~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~ 682 (756)
+........+++.+|+..+|.+|.+..|+++.
T Consensus 242 ---p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~h 273 (281)
T KOG0580|consen 242 ---PSTISGGAADLISRLLVKNPIERLALTEVMDH 273 (281)
T ss_pred ---CcccChhHHHHHHHHhccCccccccHHHHhhh
Confidence 12223348899999999999999999998764
|
|
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-39 Score=334.23 Aligned_cols=254 Identities=29% Similarity=0.446 Sum_probs=209.2
Q ss_pred hcCccccCcccCCCCccEEEeeccCCcEEEEEEccccCcccHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEEec
Q 004400 415 TNNFATDNNIGEGGFGPVYKGLLADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYEYL 494 (756)
Q Consensus 415 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~ 494 (756)
.++|+..+.||+|+||.||+|...++..||+|.+... ....+.+.+|+.++++++|+||+++++++.+++..++||||+
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 83 (261)
T cd05072 5 RESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPG-TMSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYM 83 (261)
T ss_pred hHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCC-chhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecC
Confidence 3578889999999999999999888889999998653 234578899999999999999999999999999999999999
Q ss_pred CCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCcccCcce
Q 004400 495 ENNSLARALFEH-RLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHI 573 (756)
Q Consensus 495 ~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~~~~~~ 573 (756)
++|+|.+++... ...+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||+++.........
T Consensus 84 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~ 160 (261)
T cd05072 84 AKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKN---YIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTA 160 (261)
T ss_pred CCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEecCCCcEEECCCccceecCCCceec
Confidence 999999999743 456899999999999999999999986 9999999999999999999999999998765433222
Q ss_pred eeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHh-CCCCCCccchhhHHHHHHHHHhcCccccccccCCCCCCCH
Q 004400 574 STRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVS-GRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDK 652 (756)
Q Consensus 574 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 652 (756)
.....++..|+|||++....++.++|||||||++|+|++ |+.||..........+. . ..... .....++
T Consensus 161 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~---~-~~~~~-----~~~~~~~- 230 (261)
T cd05072 161 REGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSAL---Q-RGYRM-----PRMENCP- 230 (261)
T ss_pred cCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHH---H-cCCCC-----CCCCCCC-
Confidence 233446778999999988889999999999999999998 99999655443332221 1 11110 0111222
Q ss_pred HHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhcc
Q 004400 653 EQVMVMINVALLCANASPTIRPSMSSVLRMLEC 685 (756)
Q Consensus 653 ~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~L~~ 685 (756)
..+.+++.+|++.+|++||+++++.+.|+.
T Consensus 231 ---~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 260 (261)
T cd05072 231 ---DELYDIMKTCWKEKAEERPTFDYLQSVLDD 260 (261)
T ss_pred ---HHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 348899999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=319.55 Aligned_cols=263 Identities=22% Similarity=0.299 Sum_probs=209.9
Q ss_pred hcCccccCcccCCCCccEEEee-ccCCcEEEEEEccccCccc--HHHHHHHHHHHHhCCCCceeeEeeEEE--eCCeEEE
Q 004400 415 TNNFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQG--NREFINEIGMISALQHPNLVKLYGCCI--EGNQLLL 489 (756)
Q Consensus 415 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~h~niv~l~~~~~--~~~~~~l 489 (756)
.++|+..+.|++|+||.||+|+ .+++..||+|+++...... --...+|+.+|.+.+|||||.+-.+.. +-+.+|+
T Consensus 75 v~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~ 154 (419)
T KOG0663|consen 75 VEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYI 154 (419)
T ss_pred HHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeee
Confidence 4578899999999999999999 5678999999997653221 234689999999999999999988875 3467999
Q ss_pred EEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCccc
Q 004400 490 IYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEE 569 (756)
Q Consensus 490 V~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~~ 569 (756)
|||||+. +|..++..-..++...++..++.|+++|++|||..+ |+|||||++|+|+...|.+||+|||+||.++..
T Consensus 155 VMe~~Eh-DLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~w---ilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp 230 (419)
T KOG0663|consen 155 VMEYVEH-DLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNW---ILHRDLKTSNLLLSHKGILKIADFGLAREYGSP 230 (419)
T ss_pred eHHHHHh-hHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhce---eEecccchhheeeccCCcEEecccchhhhhcCC
Confidence 9999987 899999887789999999999999999999999997 999999999999999999999999999987765
Q ss_pred CcceeeccccCccCCchHhhhcC-CCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhcCccccc-------
Q 004400 570 NTHISTRVAGTIGYMAPEYAMRG-HLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMEL------- 641 (756)
Q Consensus 570 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~------- 641 (756)
.. ..+..+-|.+|.|||.+.+. .|+++.|+||+|||+.|++++++-|.+....+.++..........-...
T Consensus 231 ~k-~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~lp 309 (419)
T KOG0663|consen 231 LK-PYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSELP 309 (419)
T ss_pred cc-cCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccccc
Confidence 33 23456679999999999874 5999999999999999999999999888777666544433322111100
Q ss_pred ----------cccCCCCCCCHH-HHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004400 642 ----------VDTNPGSNFDKE-QVMVMINVALLCANASPTIRPSMSSVLRM 682 (756)
Q Consensus 642 ----------~~~~~~~~~~~~-~~~~l~~l~~~c~~~~P~~RPt~~ev~~~ 682 (756)
........|... ....-.+++...+..||.+|-|++|.++.
T Consensus 310 ~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h 361 (419)
T KOG0663|consen 310 AVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKH 361 (419)
T ss_pred hhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcc
Confidence 001111111111 22345688889999999999999998764
|
|
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-39 Score=344.97 Aligned_cols=262 Identities=22% Similarity=0.346 Sum_probs=205.1
Q ss_pred hcCccccCcccCCCCccEEEeec-cCCcEEEEEEccccC-cccHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEE
Q 004400 415 TNNFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSKS-KQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYE 492 (756)
Q Consensus 415 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 492 (756)
.++|+..+.||+|+||.||+|+. .++..||+|.+.... ......+.+|++++++++||||+++++++.+++..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence 46889999999999999999995 478899999987542 2334678999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCcccCcc
Q 004400 493 YLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTH 572 (756)
Q Consensus 493 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~~~~~ 572 (756)
|+++|+|.+++... ..+++..+..++.|++.||+|||+.+ +|+||||||+||+++.++.+||+|||+++......
T Consensus 84 ~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-- 158 (331)
T cd06649 84 HMDGGSLDQVLKEA-KRIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM-- 158 (331)
T ss_pred cCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCcccccccccc--
Confidence 99999999999754 36899999999999999999999863 49999999999999999999999999997553321
Q ss_pred eeeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHh---cCccc----------
Q 004400 573 ISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKE---QGKLM---------- 639 (756)
Q Consensus 573 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~---~~~~~---------- 639 (756)
.....||..|+|||++.+..++.++|||||||++|||++|+.||...+...+......... .+...
T Consensus 159 -~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (331)
T cd06649 159 -ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRPRPPG 237 (331)
T ss_pred -cccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccccCccccccc
Confidence 2345689999999999988999999999999999999999999965443322111100000 00000
Q ss_pred --------------------c-ccccCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004400 640 --------------------E-LVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRM 682 (756)
Q Consensus 640 --------------------~-~~~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~ 682 (756)
+ +................+.+++.+||+.||++|||+.|+++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h 301 (331)
T cd06649 238 RPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNH 301 (331)
T ss_pred ccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 0 000000000011123458899999999999999999999865
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=353.71 Aligned_cols=255 Identities=28% Similarity=0.448 Sum_probs=202.4
Q ss_pred hcCccccCcccCCCCccEEEeec------cCCcEEEEEEccccC-cccHHHHHHHHHHHHhC-CCCceeeEeeEEEeCCe
Q 004400 415 TNNFATDNNIGEGGFGPVYKGLL------ADGTAIAVKQLSSKS-KQGNREFINEIGMISAL-QHPNLVKLYGCCIEGNQ 486 (756)
Q Consensus 415 ~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~ 486 (756)
.++|+..+.||+|+||.||+|++ .++..||||+++... ....+.+.+|+.+++.+ +|||||+++++|.+++.
T Consensus 34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~ 113 (375)
T cd05104 34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGP 113 (375)
T ss_pred hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCc
Confidence 45788899999999999999963 245689999986542 23346788999999999 89999999999999999
Q ss_pred EEEEEEecCCCCHHHHHHhcC-----------------------------------------------------------
Q 004400 487 LLLIYEYLENNSLARALFEHR----------------------------------------------------------- 507 (756)
Q Consensus 487 ~~lV~e~~~~gsL~~~l~~~~----------------------------------------------------------- 507 (756)
.++|||||++|+|.+++....
T Consensus 114 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (375)
T cd05104 114 TLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGS 193 (375)
T ss_pred ceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccce
Confidence 999999999999999986422
Q ss_pred ---------------CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCcccCcc
Q 004400 508 ---------------LKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTH 572 (756)
Q Consensus 508 ---------------~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~~~~~ 572 (756)
..+++..+.+++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++........
T Consensus 194 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~ 270 (375)
T cd05104 194 YIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIRNDSNY 270 (375)
T ss_pred ecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCchhhEEEECCCcEEEecCccceeccCcccc
Confidence 24788999999999999999999986 999999999999999999999999999865433221
Q ss_pred -eeeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHh-CCCCCCccchh-hHHHHHHHHHhcCccccccccCCCCC
Q 004400 573 -ISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVS-GRSNVTKEDMF-YLLDWALVLKEQGKLMELVDTNPGSN 649 (756)
Q Consensus 573 -~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~ 649 (756)
......++..|+|||++.+..++.++|||||||++|||++ |..||...... .... ... .+..... ...
T Consensus 271 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~---~~~-~~~~~~~-----~~~ 341 (375)
T cd05104 271 VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYK---MIK-EGYRMLS-----PEC 341 (375)
T ss_pred cccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHH---HHH-hCccCCC-----CCC
Confidence 1222345678999999999999999999999999999998 88888543221 1111 111 1111110 011
Q ss_pred CCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhcc
Q 004400 650 FDKEQVMVMINVALLCANASPTIRPSMSSVLRMLEC 685 (756)
Q Consensus 650 ~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~L~~ 685 (756)
....+.+++.+||+.||++||++.||++.|++
T Consensus 342 ----~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~ 373 (375)
T cd05104 342 ----APSEMYDIMKSCWDADPLKRPTFKQIVQLIEQ 373 (375)
T ss_pred ----CCHHHHHHHHHHccCChhHCcCHHHHHHHHHh
Confidence 12348899999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=353.87 Aligned_cols=258 Identities=28% Similarity=0.436 Sum_probs=203.2
Q ss_pred hhcCccccCcccCCCCccEEEeec------cCCcEEEEEEccccC-cccHHHHHHHHHHHHhC-CCCceeeEeeEEEeCC
Q 004400 414 ATNNFATDNNIGEGGFGPVYKGLL------ADGTAIAVKQLSSKS-KQGNREFINEIGMISAL-QHPNLVKLYGCCIEGN 485 (756)
Q Consensus 414 ~~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~ 485 (756)
..++|+..+.||+|+||.||+|+. .++..||+|.+.... ......+.+|+++++.+ +|+|||+++++|.+.+
T Consensus 36 ~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~ 115 (374)
T cd05106 36 PRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGG 115 (374)
T ss_pred cHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCC
Confidence 345788999999999999999873 234579999997542 23345688999999999 8999999999999999
Q ss_pred eEEEEEEecCCCCHHHHHHhcC----------------------------------------------------------
Q 004400 486 QLLLIYEYLENNSLARALFEHR---------------------------------------------------------- 507 (756)
Q Consensus 486 ~~~lV~e~~~~gsL~~~l~~~~---------------------------------------------------------- 507 (756)
..++||||+++|+|.+++....
T Consensus 116 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (374)
T cd05106 116 PVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSS 195 (374)
T ss_pred CeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccccc
Confidence 9999999999999999986321
Q ss_pred -----------CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCcccCcc-eee
Q 004400 508 -----------LKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTH-IST 575 (756)
Q Consensus 508 -----------~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~~~~~-~~~ 575 (756)
..+++..+.+++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+++........ ...
T Consensus 196 ~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---iiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~ 272 (374)
T cd05106 196 DSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKN---CIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKG 272 (374)
T ss_pred cccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---EEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeecc
Confidence 24788899999999999999999986 999999999999999999999999999754432221 122
Q ss_pred ccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHh-CCCCCCccchhhHHHHHHHHHhcCccccccccCCCCCCCHHH
Q 004400 576 RVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVS-GRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDKEQ 654 (756)
Q Consensus 576 ~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 654 (756)
...++..|+|||++.+..++.++|||||||++|||++ |+.||......... .... ..+..... ....
T Consensus 273 ~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~--~~~~-~~~~~~~~-----~~~~---- 340 (374)
T cd05106 273 NARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKF--YKMV-KRGYQMSR-----PDFA---- 340 (374)
T ss_pred CCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHHH--HHHH-HcccCccC-----CCCC----
Confidence 2345678999999998899999999999999999997 99999654321111 1111 11110000 0111
Q ss_pred HHHHHHHHHHhhcCCCCCCCCHHHHHHHhccC
Q 004400 655 VMVMINVALLCANASPTIRPSMSSVLRMLECG 686 (756)
Q Consensus 655 ~~~l~~l~~~c~~~~P~~RPt~~ev~~~L~~~ 686 (756)
...+.+++.+||+.||.+||++.+|+++|+++
T Consensus 341 ~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~ 372 (374)
T cd05106 341 PPEIYSIMKMCWNLEPTERPTFSQISQLIQRQ 372 (374)
T ss_pred CHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 23488999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=348.04 Aligned_cols=253 Identities=20% Similarity=0.227 Sum_probs=205.1
Q ss_pred cCccccCcccCCCCccEEEeecc-CCcEEEEEEccccC---cccHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEE
Q 004400 416 NNFATDNNIGEGGFGPVYKGLLA-DGTAIAVKQLSSKS---KQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIY 491 (756)
Q Consensus 416 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 491 (756)
++|...+.||+|+||.||+|+.. +++.||+|++.... ......+.+|+++++.++||||+++++++.+++..++||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 36888999999999999999954 68999999987542 223456888999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCcccCc
Q 004400 492 EYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENT 571 (756)
Q Consensus 492 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~~~~ 571 (756)
||+++|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++....
T Consensus 81 e~~~g~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~--- 153 (333)
T cd05600 81 EYVPGGDFRTLLNNL-GVLSEDHARFYMAEMFEAVDALHELG---YIHRDLKPENFLIDASGHIKLTDFGLSKGIVT--- 153 (333)
T ss_pred eCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEEEeCcCCccccc---
Confidence 999999999999654 46899999999999999999999986 99999999999999999999999999985443
Q ss_pred ceeeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhcCccccccccCCCCCCC
Q 004400 572 HISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFD 651 (756)
Q Consensus 572 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 651 (756)
......||+.|+|||++.+..++.++|||||||++|||++|+.||...+......... ......... ......
T Consensus 154 -~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~---~~~~~~~~~---~~~~~~ 226 (333)
T cd05600 154 -YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLK---YWKETLQRP---VYDDPR 226 (333)
T ss_pred -ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHH---hccccccCC---CCCccc
Confidence 2234579999999999999899999999999999999999999997655433322111 101110100 000000
Q ss_pred HHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004400 652 KEQVMVMINVALLCANASPTIRPSMSSVLRM 682 (756)
Q Consensus 652 ~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~ 682 (756)
......+.+++.+|+..+|.+||++.++++.
T Consensus 227 ~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 227 FNLSDEAWDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred cccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence 1123458899999999999999999999865
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-39 Score=331.00 Aligned_cols=252 Identities=25% Similarity=0.434 Sum_probs=205.9
Q ss_pred cCccccCcccCCCCccEEEeeccCCcEEEEEEccccCcccHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEEecC
Q 004400 416 NNFATDNNIGEGGFGPVYKGLLADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYEYLE 495 (756)
Q Consensus 416 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~ 495 (756)
++|...+.||+|+||.||+|...++..+|+|.+.... .....+.+|+.++++++||||+++++++.+.+..++||||+.
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMS 82 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCc-ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCC
Confidence 3577888999999999999998777789999987532 345679999999999999999999999999999999999999
Q ss_pred CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCcccCcceee
Q 004400 496 NNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHIST 575 (756)
Q Consensus 496 ~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~ 575 (756)
+|+|.+++......+++..++.++.||+.||+|||+.+ ++|+||||+||+++.++.+||+|||.++...........
T Consensus 83 ~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~~~ 159 (256)
T cd05113 83 NGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQ---FIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSV 159 (256)
T ss_pred CCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCCEEECCCccceecCCCceeecC
Confidence 99999999765557899999999999999999999986 999999999999999999999999999865433222222
Q ss_pred ccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHh-CCCCCCccchhhHHHHHHHHHhcCccccccccCCCCCCCHHH
Q 004400 576 RVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVS-GRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDKEQ 654 (756)
Q Consensus 576 ~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 654 (756)
...++..|+|||......++.++|||||||++|||++ |+.||...+........ ..+..... ....
T Consensus 160 ~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~----~~~~~~~~-----~~~~---- 226 (256)
T cd05113 160 GSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKV----SQGLRLYR-----PHLA---- 226 (256)
T ss_pred CCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHH----hcCCCCCC-----CCCC----
Confidence 2346678999999988889999999999999999998 99998654433222211 11111110 0111
Q ss_pred HHHHHHHHHHhhcCCCCCCCCHHHHHHHhc
Q 004400 655 VMVMINVALLCANASPTIRPSMSSVLRMLE 684 (756)
Q Consensus 655 ~~~l~~l~~~c~~~~P~~RPt~~ev~~~L~ 684 (756)
...+.+++.+||+.+|.+||++.++++.|+
T Consensus 227 ~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 227 SEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred CHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 245889999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=346.13 Aligned_cols=242 Identities=25% Similarity=0.321 Sum_probs=198.2
Q ss_pred CcccCCCCccEEEee-ccCCcEEEEEEccccC---cccHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEEecCCC
Q 004400 422 NNIGEGGFGPVYKGL-LADGTAIAVKQLSSKS---KQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYEYLENN 497 (756)
Q Consensus 422 ~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~g 497 (756)
+.||+|+||.||+|. ..+|+.||+|++.... ......+.+|+.++++++||||+++++++.+++..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 469999999999998 4578999999987532 223456788999999999999999999999999999999999999
Q ss_pred CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCcccCcceeecc
Q 004400 498 SLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRV 577 (756)
Q Consensus 498 sL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~ 577 (756)
+|.+++... ..+++..+..++.||+.||+|||+.| |+||||||+||+++.++.+||+|||+++....... .....
T Consensus 81 ~L~~~l~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~-~~~~~ 155 (323)
T cd05571 81 ELFFHLSRE-RVFSEDRARFYGAEIVSALGYLHSCD---VVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGA-TMKTF 155 (323)
T ss_pred cHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCC-cccce
Confidence 999998754 47899999999999999999999997 99999999999999999999999999875322211 12345
Q ss_pred ccCccCCchHhhhcCCCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhcCccccccccCCCCCCCHHHHHH
Q 004400 578 AGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDKEQVMV 657 (756)
Q Consensus 578 ~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 657 (756)
.||+.|+|||++.+..++.++||||+||++|||++|+.||...+........ .. ... .++......
T Consensus 156 ~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~---~~-~~~----------~~p~~~~~~ 221 (323)
T cd05571 156 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELI---LM-EEI----------RFPRTLSPE 221 (323)
T ss_pred ecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHH---Hc-CCC----------CCCCCCCHH
Confidence 7999999999999989999999999999999999999999765543332211 10 100 111122334
Q ss_pred HHHHHHHhhcCCCCCCC-----CHHHHHHH
Q 004400 658 MINVALLCANASPTIRP-----SMSSVLRM 682 (756)
Q Consensus 658 l~~l~~~c~~~~P~~RP-----t~~ev~~~ 682 (756)
+.+++.+|++.||++|| ++.++++.
T Consensus 222 ~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 251 (323)
T cd05571 222 AKSLLAGLLKKDPKQRLGGGPEDAKEIMEH 251 (323)
T ss_pred HHHHHHHHccCCHHHcCCCCCCCHHHHHcC
Confidence 88999999999999999 78888653
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-39 Score=333.05 Aligned_cols=255 Identities=29% Similarity=0.466 Sum_probs=208.3
Q ss_pred hhcCccccCcccCCCCccEEEeeccCCcEEEEEEccccCcccHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEEe
Q 004400 414 ATNNFATDNNIGEGGFGPVYKGLLADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYEY 493 (756)
Q Consensus 414 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 493 (756)
..++|+..+.||+|++|.||+|...+++.||+|.++... ...+.+.+|++++++++||||+++++++...+..++||||
T Consensus 4 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 82 (261)
T cd05068 4 DRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTEL 82 (261)
T ss_pred chhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeec
Confidence 345788899999999999999998788899999986543 3456789999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCcccCcc
Q 004400 494 LENNSLARALFEHR-LKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTH 572 (756)
Q Consensus 494 ~~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~~~~~ 572 (756)
+++++|.+++.... ..+++..+..++.|++.|++|||+.| |+||||||+||++++++.+||+|||+++........
T Consensus 83 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~ 159 (261)
T cd05068 83 MKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQN---YIHRDLAARNVLVGENNICKVADFGLARVIKEDIYE 159 (261)
T ss_pred ccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCcceEEEcCCCCEEECCcceEEEccCCccc
Confidence 99999999997543 56899999999999999999999987 999999999999999999999999999866533222
Q ss_pred eeeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHh-CCCCCCccchhhHHHHHHHHHhcCccccccccCCCCCCC
Q 004400 573 ISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVS-GRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFD 651 (756)
Q Consensus 573 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 651 (756)
......++..|+|||++.+..++.++||||||+++|||++ |+.||............ .. .... ..+
T Consensus 160 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~---~~-~~~~---------~~~ 226 (261)
T cd05068 160 AREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQV---DQ-GYRM---------PCP 226 (261)
T ss_pred ccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH---Hc-CCCC---------CCC
Confidence 1222233468999999988889999999999999999999 99998665433322211 11 1100 011
Q ss_pred HHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhcc
Q 004400 652 KEQVMVMINVALLCANASPTIRPSMSSVLRMLEC 685 (756)
Q Consensus 652 ~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~L~~ 685 (756)
......+.+++.+|++.+|++||++.++++.||.
T Consensus 227 ~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~ 260 (261)
T cd05068 227 PGCPKELYDIMLDCWKEDPDDRPTFETLQWKLED 260 (261)
T ss_pred CcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence 1123458899999999999999999999999984
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-39 Score=338.89 Aligned_cols=262 Identities=22% Similarity=0.285 Sum_probs=203.3
Q ss_pred cCccccCcccCCCCccEEEeec-cCCcEEEEEEccccC--cccHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEE
Q 004400 416 NNFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSKS--KQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYE 492 (756)
Q Consensus 416 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 492 (756)
++|+..+.||+|+||.||+|+. .+++.||+|++.... ....+.+.+|+++++.++||||+++++++.+++..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 4688899999999999999995 468899999986542 2334678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCcccCcc
Q 004400 493 YLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTH 572 (756)
Q Consensus 493 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~~~~~ 572 (756)
|++++.+..+. .....+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++........
T Consensus 81 ~~~~~~l~~~~-~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 156 (287)
T cd07848 81 YVEKNMLELLE-EMPNGVPPEKVRSYIYQLIKAIHWCHKND---IVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNA 156 (287)
T ss_pred cCCCCHHHHHH-hcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccCcccccccccc
Confidence 99998776554 44457899999999999999999999986 999999999999999999999999999865443332
Q ss_pred eeeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHH------------HhcCcccc
Q 004400 573 ISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVL------------KEQGKLME 640 (756)
Q Consensus 573 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~------------~~~~~~~~ 640 (756)
......||+.|+|||++.+..++.++|||||||++|||++|+.||............... ........
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (287)
T cd07848 157 NYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHG 236 (287)
T ss_pred cccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhcc
Confidence 333457899999999999888999999999999999999999999765432221111100 00000000
Q ss_pred ccccCCCC------CCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 004400 641 LVDTNPGS------NFDKEQVMVMINVALLCANASPTIRPSMSSVLR 681 (756)
Q Consensus 641 ~~~~~~~~------~~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~ 681 (756)
...+.... .+.......+.+++.+|++.||++|||++|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~ 283 (287)
T cd07848 237 LRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN 283 (287)
T ss_pred cccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 00000000 001112345899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-40 Score=326.39 Aligned_cols=248 Identities=23% Similarity=0.379 Sum_probs=210.5
Q ss_pred hcCccccCcccCCCCccEEEee-ccCCcEEEEEEccccCcc---cHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEE
Q 004400 415 TNNFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQ---GNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLI 490 (756)
Q Consensus 415 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 490 (756)
..+|++.+.||+|.||.|-+|. ...|+.||||.+++..-. +.-.+.+|++||+.++||||+.+|.+|...+.+.+|
T Consensus 52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIviv 131 (668)
T KOG0611|consen 52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIV 131 (668)
T ss_pred hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEE
Confidence 3578888999999999999999 688999999999875433 334578899999999999999999999999999999
Q ss_pred EEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCcccC
Q 004400 491 YEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEEN 570 (756)
Q Consensus 491 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~~~ 570 (756)
|||..+|.|.|++.+. ..+++.+++.++.||..|+.|+|.++ ++|||+|.+|||+|.++.+||+|||++-++....
T Consensus 132 MEYaS~GeLYDYiSer-~~LsErEaRhfFRQIvSAVhYCHknr---VvHRDLKLENILLD~N~NiKIADFGLSNly~~~k 207 (668)
T KOG0611|consen 132 MEYASGGELYDYISER-GSLSEREARHFFRQIVSAVHYCHKNR---VVHRDLKLENILLDQNNNIKIADFGLSNLYADKK 207 (668)
T ss_pred EEecCCccHHHHHHHh-ccccHHHHHHHHHHHHHHHHHHhhcc---ceecccchhheeecCCCCeeeeccchhhhhcccc
Confidence 9999999999999765 48999999999999999999999986 9999999999999999999999999998776544
Q ss_pred cceeeccccCccCCchHhhhcCCC-CcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhcCccccccccCCCCC
Q 004400 571 THISTRVAGTIGYMAPEYAMRGHL-TEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSN 649 (756)
Q Consensus 571 ~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 649 (756)
. .++++|++-|.+||+..+..| ++.+|.||+||++|-++.|..||.+.+...++... . .+...+
T Consensus 208 f--LqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQI---s-~GaYrE--------- 272 (668)
T KOG0611|consen 208 F--LQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQI---S-RGAYRE--------- 272 (668)
T ss_pred H--HHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHh---h-cccccC---------
Confidence 3 467899999999999998876 67899999999999999999999887765554322 1 111111
Q ss_pred CCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHh
Q 004400 650 FDKEQVMVMINVALLCANASPTIRPSMSSVLRML 683 (756)
Q Consensus 650 ~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~L 683 (756)
++.+....-+|++|+..+|++|.|+.+|....
T Consensus 273 --P~~PSdA~gLIRwmLmVNP~RRATieDiAsHW 304 (668)
T KOG0611|consen 273 --PETPSDASGLIRWMLMVNPERRATIEDIASHW 304 (668)
T ss_pred --CCCCchHHHHHHHHHhcCcccchhHHHHhhhh
Confidence 11112256788899999999999999996654
|
|
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-39 Score=336.94 Aligned_cols=261 Identities=21% Similarity=0.322 Sum_probs=202.5
Q ss_pred cCccccCcccCCCCccEEEeec-cCCcEEEEEEccccC-cccHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEEe
Q 004400 416 NNFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSKS-KQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYEY 493 (756)
Q Consensus 416 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 493 (756)
++|...+.||+|+||.||+|+. .+++.||+|.++... ......+.+|++++++++||||+++++++.+++..++||||
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 84 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY 84 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence 4688899999999999999984 578999999986542 22345678999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCcccCcce
Q 004400 494 LENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHI 573 (756)
Q Consensus 494 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~~~~~~ 573 (756)
+++ +|.+++......+++..+..++.||+.||+|||++| |+||||||+|||++.++.+||+|||+++........
T Consensus 85 ~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~~- 159 (288)
T cd07871 85 LDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRK---ILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKT- 159 (288)
T ss_pred CCc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEECcCcceeeccCCCcc-
Confidence 985 899988766667899999999999999999999986 999999999999999999999999999754332221
Q ss_pred eeccccCccCCchHhhhc-CCCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhcC------------cccc
Q 004400 574 STRVAGTIGYMAPEYAMR-GHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQG------------KLME 640 (756)
Q Consensus 574 ~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~------------~~~~ 640 (756)
.....|++.|+|||++.+ ..++.++||||+||++|||++|+.||...+............... +...
T Consensus 160 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (288)
T cd07871 160 YSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFRS 239 (288)
T ss_pred ccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhhhc
Confidence 233468999999999875 568999999999999999999999997665443332221111100 0000
Q ss_pred ccccCCCC----CCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 004400 641 LVDTNPGS----NFDKEQVMVMINVALLCANASPTIRPSMSSVLR 681 (756)
Q Consensus 641 ~~~~~~~~----~~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~ 681 (756)
...+.... ...+.......+++.+|++.||.+|||++|+++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~ 284 (288)
T cd07871 240 YLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR 284 (288)
T ss_pred cccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 00000000 000112235789999999999999999999975
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=341.22 Aligned_cols=245 Identities=23% Similarity=0.326 Sum_probs=201.6
Q ss_pred cCccccCcccCCCCccEEEeec-cCCcEEEEEEccccC---cccHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEE
Q 004400 416 NNFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSKS---KQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIY 491 (756)
Q Consensus 416 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 491 (756)
++|...+.||+|+||.||+|.. .+++.||+|.+.... ....+.+.+|++++++++||||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 3688889999999999999995 478999999986432 223456889999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCcccCc
Q 004400 492 EYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENT 571 (756)
Q Consensus 492 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~~~~ 571 (756)
||+++|+|.+++... ..+++..+..++.|++.||+|||++| |+||||||+||+++.++.+||+|||+++.....
T Consensus 81 e~~~~~~L~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~-- 154 (291)
T cd05612 81 EYVPGGELFSYLRNS-GRFSNSTGLFYASEIVCALEYLHSKE---IVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR-- 154 (291)
T ss_pred eCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEEecCcchhccCC--
Confidence 999999999999754 47899999999999999999999987 999999999999999999999999999865432
Q ss_pred ceeeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhcCccccccccCCCCCCC
Q 004400 572 HISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFD 651 (756)
Q Consensus 572 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 651 (756)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||...+........ .. ... .++
T Consensus 155 --~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i---~~-~~~----------~~~ 218 (291)
T cd05612 155 --TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKI---LA-GKL----------EFP 218 (291)
T ss_pred --cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH---Hh-CCc----------CCC
Confidence 12356899999999999888999999999999999999999999766543332211 11 110 011
Q ss_pred HHHHHHHHHHHHHhhcCCCCCCCC-----HHHHHHH
Q 004400 652 KEQVMVMINVALLCANASPTIRPS-----MSSVLRM 682 (756)
Q Consensus 652 ~~~~~~l~~l~~~c~~~~P~~RPt-----~~ev~~~ 682 (756)
......+.+++.+|++.||.+||+ ++++++.
T Consensus 219 ~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 254 (291)
T cd05612 219 RHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNH 254 (291)
T ss_pred ccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcC
Confidence 111234889999999999999995 7776643
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-39 Score=336.04 Aligned_cols=255 Identities=30% Similarity=0.496 Sum_probs=206.5
Q ss_pred cCccccCcccCCCCccEEEeeccC------CcEEEEEEccccC-cccHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEE
Q 004400 416 NNFATDNNIGEGGFGPVYKGLLAD------GTAIAVKQLSSKS-KQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLL 488 (756)
Q Consensus 416 ~~~~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 488 (756)
++|+..+.||+|+||.||+|.... ...||+|.+.... ......|.+|++++++++||||+++++++.+.+..+
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC 84 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence 467888999999999999998532 2579999986543 233457899999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCC
Q 004400 489 LIYEYLENNSLARALFEHR---------------LKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDL 553 (756)
Q Consensus 489 lV~e~~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~ 553 (756)
++|||+++|+|.+++.... ..+++..+..++.|++.||+|||+.+ ++||||||+||++++++
T Consensus 85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nil~~~~~ 161 (283)
T cd05048 85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH---FVHRDLAARNCLVGEGL 161 (283)
T ss_pred EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccccceEEEcCCC
Confidence 9999999999999997432 45788999999999999999999986 99999999999999999
Q ss_pred CEEEccCCccccCcccCc-ceeeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHh-CCCCCCccchhhHHHHHHH
Q 004400 554 NSKISDFGLAKLDEEENT-HISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVS-GRSNVTKEDMFYLLDWALV 631 (756)
Q Consensus 554 ~~kl~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~~~~~~ 631 (756)
.+||+|||+++....... .......+++.|+|||.+....++.++|||||||++|||++ |..||............
T Consensus 162 ~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~~~i-- 239 (283)
T cd05048 162 TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMI-- 239 (283)
T ss_pred cEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH--
Confidence 999999999986533222 12233456889999999998899999999999999999998 99999765443332211
Q ss_pred HHhcCccccccccCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhccC
Q 004400 632 LKEQGKLMELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLECG 686 (756)
Q Consensus 632 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~L~~~ 686 (756)
..+.... .+...+..+.+++.+||+.+|.+||++.||++.|+++
T Consensus 240 --~~~~~~~---------~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~~ 283 (283)
T cd05048 240 --RSRQLLP---------CPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRSW 283 (283)
T ss_pred --HcCCcCC---------CcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhcC
Confidence 1111111 1222334589999999999999999999999999853
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-41 Score=358.45 Aligned_cols=257 Identities=27% Similarity=0.451 Sum_probs=216.4
Q ss_pred CccccCcccCCCCccEEEeecc----CCcEEEEEEcccc-CcccHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEE
Q 004400 417 NFATDNNIGEGGFGPVYKGLLA----DGTAIAVKQLSSK-SKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIY 491 (756)
Q Consensus 417 ~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 491 (756)
...+.++||.|.||.||+|+++ ....||||.++.. ......+|..|+.||.++.||||+++-|+.......++|.
T Consensus 630 ~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIiT 709 (996)
T KOG0196|consen 630 CVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMIIT 709 (996)
T ss_pred heEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEEh
Confidence 3456799999999999999964 2357999999875 3455678999999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCcccCc
Q 004400 492 EYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENT 571 (756)
Q Consensus 492 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~~~~ 571 (756)
|||++|+|+.+|+.+...+++.+...+.++||.|++||-+.+ +|||||.++|||++.+..+||+|||++|...++..
T Consensus 710 EyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~---YVHRDLAARNILVNsnLvCKVsDFGLSRvledd~~ 786 (996)
T KOG0196|consen 710 EYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPE 786 (996)
T ss_pred hhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcC---chhhhhhhhheeeccceEEEeccccceeecccCCC
Confidence 999999999999988889999999999999999999999886 99999999999999999999999999997765543
Q ss_pred ceeecccc--CccCCchHhhhcCCCCcccchhhHHHHHHHHHh-CCCCCCccchhhHHHHHHHHHhcCccccccccCCCC
Q 004400 572 HISTRVAG--TIGYMAPEYAMRGHLTEKADVYSFGIVALEIVS-GRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGS 648 (756)
Q Consensus 572 ~~~~~~~g--t~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 648 (756)
...++.-| +++|.|||.+..++++.++|||||||+|||.++ |.+||+.....+.... +.+ ...-
T Consensus 787 ~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIka---Ie~----------gyRL 853 (996)
T KOG0196|consen 787 AAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKA---IEQ----------GYRL 853 (996)
T ss_pred ccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHHHHHH---HHh----------ccCC
Confidence 33333323 469999999999999999999999999999886 9999977655443321 111 1112
Q ss_pred CCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhccCccc
Q 004400 649 NFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLECGVDV 689 (756)
Q Consensus 649 ~~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~L~~~~~~ 689 (756)
..+++++..+.+|+..||++|-.+||++.||+..|++....
T Consensus 854 PpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrn 894 (996)
T KOG0196|consen 854 PPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRN 894 (996)
T ss_pred CCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcC
Confidence 22344555699999999999999999999999999976553
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-39 Score=346.10 Aligned_cols=245 Identities=21% Similarity=0.347 Sum_probs=201.8
Q ss_pred cCccccCcccCCCCccEEEeec-cCCcEEEEEEccccC---cccHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEE
Q 004400 416 NNFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSKS---KQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIY 491 (756)
Q Consensus 416 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 491 (756)
++|...+.||+|+||.||+|+. .+++.||+|.+.... ....+.+.+|+.++++++||||+++++++.+++..++||
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 97 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL 97 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence 5788899999999999999995 468999999986531 223456889999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCcccCc
Q 004400 492 EYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENT 571 (756)
Q Consensus 492 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~~~~ 571 (756)
||+++|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 98 e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~- 172 (329)
T PTZ00263 98 EFVVGGELFTHLRKA-GRFPNDVAKFYHAELVLAFEYLHSKD---IIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRT- 172 (329)
T ss_pred cCCCCChHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEECCCCCEEEeeccCceEcCCCc-
Confidence 999999999999754 47899999999999999999999986 9999999999999999999999999998654322
Q ss_pred ceeeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhcCccccccccCCCCCCC
Q 004400 572 HISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFD 651 (756)
Q Consensus 572 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 651 (756)
....||+.|+|||++.+..++.++|||||||++|||++|+.||........... .. .+.. .+ ...+
T Consensus 173 ---~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~---i~-~~~~-~~-----p~~~- 238 (329)
T PTZ00263 173 ---FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEK---IL-AGRL-KF-----PNWF- 238 (329)
T ss_pred ---ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHH---Hh-cCCc-CC-----CCCC-
Confidence 235799999999999998899999999999999999999999976654332211 11 1110 00 1112
Q ss_pred HHHHHHHHHHHHHhhcCCCCCCCC-----HHHHHHH
Q 004400 652 KEQVMVMINVALLCANASPTIRPS-----MSSVLRM 682 (756)
Q Consensus 652 ~~~~~~l~~l~~~c~~~~P~~RPt-----~~ev~~~ 682 (756)
...+.+++.+||+.||++||+ +.++++.
T Consensus 239 ---~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 271 (329)
T PTZ00263 239 ---DGRARDLVKGLLQTDHTKRLGTLKGGVADVKNH 271 (329)
T ss_pred ---CHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 234789999999999999997 5666543
|
|
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-39 Score=331.75 Aligned_cols=254 Identities=26% Similarity=0.447 Sum_probs=206.6
Q ss_pred cCccccCcccCCCCccEEEeec-cCCcEEEEEEccccCcccHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEEec
Q 004400 416 NNFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYEYL 494 (756)
Q Consensus 416 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~ 494 (756)
.+|...+.||+|+||.||+|.. .+++.||+|.+... ......+.+|++++++++||||+++++++..++..++||||+
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM 84 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC-chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeC
Confidence 4577889999999999999995 45889999998653 334567899999999999999999999999999999999999
Q ss_pred CCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCcccCcce
Q 004400 495 ENNSLARALFEH-RLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHI 573 (756)
Q Consensus 495 ~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~~~~~~ 573 (756)
++++|.+++... ...+++..+..++.|++.||+|||+.| ++||||||+||++++++.+||+|||+++.........
T Consensus 85 ~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~~ 161 (263)
T cd05052 85 TYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTA 161 (263)
T ss_pred CCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCcEEeCCCccccccccceeec
Confidence 999999999754 346899999999999999999999986 9999999999999999999999999998655433222
Q ss_pred eeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHh-CCCCCCccchhhHHHHHHHHHhcCccccccccCCCCCCCH
Q 004400 574 STRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVS-GRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDK 652 (756)
Q Consensus 574 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 652 (756)
.....++..|+|||.+.+..++.++|||||||++|||++ |..||...+....... ... ..... .....
T Consensus 162 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~---~~~-~~~~~-----~~~~~-- 230 (263)
T cd05052 162 HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYEL---LEK-GYRME-----RPEGC-- 230 (263)
T ss_pred cCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH---HHC-CCCCC-----CCCCC--
Confidence 222334678999999998899999999999999999998 8999865543322211 111 11111 11122
Q ss_pred HHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhccC
Q 004400 653 EQVMVMINVALLCANASPTIRPSMSSVLRMLECG 686 (756)
Q Consensus 653 ~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~L~~~ 686 (756)
+..+.+++.+||+.+|++||++.+++++|+.+
T Consensus 231 --~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 231 --PPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred --CHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 24488999999999999999999999999853
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=339.08 Aligned_cols=250 Identities=27% Similarity=0.400 Sum_probs=213.3
Q ss_pred cCccccCcccCCCCccEEEeec-cCCcEEEEEEccccC--cccHHHHHHHHHHHHhCCCCceeeEeeEEEeCCe-EEEEE
Q 004400 416 NNFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSKS--KQGNREFINEIGMISALQHPNLVKLYGCCIEGNQ-LLLIY 491 (756)
Q Consensus 416 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-~~lV~ 491 (756)
++|...+.+|+|+||.++..++ .+++.|++|.+.... ....+...+|+.++++++|||||.+.+.|.+++. .++||
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm 83 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM 83 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence 5788889999999999999984 467899999986542 3334567899999999999999999999999888 99999
Q ss_pred EecCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCcccC
Q 004400 492 EYLENNSLARALFEHR-LKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEEN 570 (756)
Q Consensus 492 e~~~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~~~ 570 (756)
+||+||++.+.+...+ ..++++.+.+++.|++.|+.|||++. |+|||||+.||+++.+..|||+|||+|+......
T Consensus 84 ~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~---iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~ 160 (426)
T KOG0589|consen 84 EYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENR---VLHRDLKCANIFLTKDKKVKLGDFGLAKILNPED 160 (426)
T ss_pred eecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhh---hhcccchhhhhhccccCceeecchhhhhhcCCch
Confidence 9999999999998554 77999999999999999999999774 9999999999999999999999999999887765
Q ss_pred cceeeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhcCccccccccCCCCCC
Q 004400 571 THISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNF 650 (756)
Q Consensus 571 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 650 (756)
. ...++.||+.||+||.+.+..|+.|+||||+||++|||++-+.+|...+...+..... ... ....
T Consensus 161 ~-~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~---------~~~----~~Pl 226 (426)
T KOG0589|consen 161 S-LASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKIN---------RGL----YSPL 226 (426)
T ss_pred h-hhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHHHHHHh---------hcc----CCCC
Confidence 3 3455789999999999999999999999999999999999999998887765543211 111 1112
Q ss_pred CHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004400 651 DKEQVMVMINVALLCANASPTIRPSMSSVLRM 682 (756)
Q Consensus 651 ~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~ 682 (756)
+......+..++..|++.+|+.||++.+++.+
T Consensus 227 p~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 227 PSMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred CccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 23334458899999999999999999999876
|
|
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=329.85 Aligned_cols=255 Identities=29% Similarity=0.460 Sum_probs=207.4
Q ss_pred cCccccCcccCCCCccEEEeecc----CCcEEEEEEccccC-cccHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEE
Q 004400 416 NNFATDNNIGEGGFGPVYKGLLA----DGTAIAVKQLSSKS-KQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLI 490 (756)
Q Consensus 416 ~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 490 (756)
++|+..+.||+|+||.||+|.+. +...||||.+.... ......|.+|+.++++++||||+++++++.+.+..++|
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv 83 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMII 83 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEE
Confidence 57889999999999999999864 24579999987543 33346789999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCcccC
Q 004400 491 YEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEEN 570 (756)
Q Consensus 491 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~~~ 570 (756)
|||+++++|.+++......+++..+.+++.|++.||+|||+.+ |+||||||+||++++++.+||+|||+++......
T Consensus 84 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~ 160 (266)
T cd05033 84 TEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSE 160 (266)
T ss_pred EEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCCEEECccchhhcccccc
Confidence 9999999999999876668999999999999999999999986 9999999999999999999999999998765222
Q ss_pred c-ceeeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHh-CCCCCCccchhhHHHHHHHHHhcCccccccccCCCC
Q 004400 571 T-HISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVS-GRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGS 648 (756)
Q Consensus 571 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 648 (756)
. .......++..|+|||.+.+..++.++||||||+++||+++ |..||............ ....... ...
T Consensus 161 ~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~----~~~~~~~-----~~~ 231 (266)
T cd05033 161 ATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAV----EDGYRLP-----PPM 231 (266)
T ss_pred cceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHH----HcCCCCC-----CCC
Confidence 2 12222345678999999998899999999999999999998 99998654433322211 1111100 011
Q ss_pred CCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhccC
Q 004400 649 NFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLECG 686 (756)
Q Consensus 649 ~~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~L~~~ 686 (756)
. .+..+.+++.+||+.+|++||++.||++.|+++
T Consensus 232 ~----~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 232 D----CPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred C----CCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 1 223488999999999999999999999999854
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=328.79 Aligned_cols=250 Identities=26% Similarity=0.444 Sum_probs=203.8
Q ss_pred CccccCcccCCCCccEEEeeccCCcEEEEEEccccCcccHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEEecCC
Q 004400 417 NFATDNNIGEGGFGPVYKGLLADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYEYLEN 496 (756)
Q Consensus 417 ~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~ 496 (756)
+|+..+.||+|+||.||+|...++..+|+|.+.... .....+.+|++++++++||||+++++++.+.+..++||||+++
T Consensus 5 ~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 83 (256)
T cd05059 5 ELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGA-MSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMAN 83 (256)
T ss_pred HcchhhhhccCCCceEEEeEecCCccEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCCC
Confidence 577889999999999999998777889999986432 2345788999999999999999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCcccCcceeec
Q 004400 497 NSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTR 576 (756)
Q Consensus 497 gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~ 576 (756)
++|.+++......+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++............
T Consensus 84 ~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~~~~ 160 (256)
T cd05059 84 GCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNG---FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQG 160 (256)
T ss_pred CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHhhEEECCCCcEEECCcccceecccccccccCC
Confidence 9999999866567899999999999999999999987 9999999999999999999999999998654322221222
Q ss_pred cccCccCCchHhhhcCCCCcccchhhHHHHHHHHHh-CCCCCCccchhhHHHHHHHHHhcCccccccccCCCCCCCHHHH
Q 004400 577 VAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVS-GRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDKEQV 655 (756)
Q Consensus 577 ~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 655 (756)
..++..|+|||.+.+..++.++||||||+++||+++ |+.||........... .. ...... .+...+
T Consensus 161 ~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~---~~-~~~~~~---------~~~~~~ 227 (256)
T cd05059 161 TKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVES---VS-AGYRLY---------RPKLAP 227 (256)
T ss_pred CCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHH---HH-cCCcCC---------CCCCCC
Confidence 234568999999998899999999999999999999 7889865443322211 11 111000 011123
Q ss_pred HHHHHHHHHhhcCCCCCCCCHHHHHHHh
Q 004400 656 MVMINVALLCANASPTIRPSMSSVLRML 683 (756)
Q Consensus 656 ~~l~~l~~~c~~~~P~~RPt~~ev~~~L 683 (756)
..+.+++.+||+.+|++||++.|+++.|
T Consensus 228 ~~~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 228 TEVYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred HHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 3588999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=310.63 Aligned_cols=252 Identities=22% Similarity=0.332 Sum_probs=207.5
Q ss_pred hcCccccCcccCCCCccEEEee-ccCCcEEEEEEcccc--CcccHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEE
Q 004400 415 TNNFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSK--SKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIY 491 (756)
Q Consensus 415 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 491 (756)
+++|+..+.||+|+|+.||++. .++|+.+|+|++..+ +..+.+++.+|+.+-+.++|||||++.+.+.+....|+|+
T Consensus 10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvF 89 (355)
T KOG0033|consen 10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 89 (355)
T ss_pred chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEE
Confidence 4677888899999999999998 567999999988654 3446788999999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCC---CCEEEccCCccccCcc
Q 004400 492 EYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKD---LNSKISDFGLAKLDEE 568 (756)
Q Consensus 492 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~---~~~kl~DFGla~~~~~ 568 (756)
|+|.||+|..-+-.. ...++..+..+++||++||.|+|.++ |||||+||+|+++-.. .-+|++|||+|....
T Consensus 90 e~m~G~dl~~eIV~R-~~ySEa~aSH~~rQiLeal~yCH~n~---IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~- 164 (355)
T KOG0033|consen 90 DLVTGGELFEDIVAR-EFYSEADASHCIQQILEALAYCHSNG---IVHRDLKPENLLLASKAKGAAVKLADFGLAIEVN- 164 (355)
T ss_pred ecccchHHHHHHHHH-HHHHHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeeeeccCCCceeecccceEEEeC-
Confidence 999999998777544 36788899999999999999999997 9999999999999543 348999999998766
Q ss_pred cCcceeeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhcCccccccccCCCC
Q 004400 569 ENTHISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGS 648 (756)
Q Consensus 569 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 648 (756)
........+||++|||||++.+.+|+..+|||+.||++|-++.|..||++++...+.+... ...- -++.....
T Consensus 165 -~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~--~g~y----d~~~~~w~ 237 (355)
T KOG0033|consen 165 -DGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIK--AGAY----DYPSPEWD 237 (355)
T ss_pred -CccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHh--cccc----CCCCcccC
Confidence 3333455789999999999999999999999999999999999999999877665554221 1110 11111222
Q ss_pred CCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004400 649 NFDKEQVMVMINVALLCANASPTIRPSMSSVLRM 682 (756)
Q Consensus 649 ~~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~ 682 (756)
... ....+++.+|+..||.+|.|+.|.++.
T Consensus 238 ~is----~~Ak~LvrrML~~dP~kRIta~EAL~H 267 (355)
T KOG0033|consen 238 TVT----PEAKSLIRRMLTVNPKKRITADEALKH 267 (355)
T ss_pred cCC----HHHHHHHHHHhccChhhhccHHHHhCC
Confidence 223 347889999999999999999998765
|
|
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-39 Score=340.74 Aligned_cols=241 Identities=22% Similarity=0.324 Sum_probs=194.8
Q ss_pred ccCCCCccEEEeec-cCCcEEEEEEcccc---CcccHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEEecCCCCH
Q 004400 424 IGEGGFGPVYKGLL-ADGTAIAVKQLSSK---SKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYEYLENNSL 499 (756)
Q Consensus 424 lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL 499 (756)
||+|+||.||+|+. .+++.||+|.+... .......+.+|+.++++++||||+++++++.+++..++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 79999999999995 46889999998653 233345678899999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCcccCcceeecccc
Q 004400 500 ARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAG 579 (756)
Q Consensus 500 ~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~~g 579 (756)
.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++...... .......|
T Consensus 81 ~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~g 155 (312)
T cd05585 81 FHHLQRE-GRFDLSRARFYTAELLCALENLHKFN---VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD-DKTNTFCG 155 (312)
T ss_pred HHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHeEECCCCcEEEEECcccccCccCC-CccccccC
Confidence 9999754 46899999999999999999999986 9999999999999999999999999998543222 22334679
Q ss_pred CccCCchHhhhcCCCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhcCccccccccCCCCCCCHHHHHHHH
Q 004400 580 TIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDKEQVMVMI 659 (756)
Q Consensus 580 t~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 659 (756)
|+.|+|||++.+..++.++|||||||++|||++|+.||...+...... ..... . . .++......+.
T Consensus 156 t~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~---~~~~~-~-~---------~~~~~~~~~~~ 221 (312)
T cd05585 156 TPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYR---KILQE-P-L---------RFPDGFDRDAK 221 (312)
T ss_pred CcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHHHHH---HHHcC-C-C---------CCCCcCCHHHH
Confidence 999999999999899999999999999999999999997654432221 11110 0 0 11112223488
Q ss_pred HHHHHhhcCCCCCCCCHHHHHHHh
Q 004400 660 NVALLCANASPTIRPSMSSVLRML 683 (756)
Q Consensus 660 ~l~~~c~~~~P~~RPt~~ev~~~L 683 (756)
+++.+||+.||++||++..+.+.|
T Consensus 222 ~li~~~L~~dp~~R~~~~~~~e~l 245 (312)
T cd05585 222 DLLIGLLSRDPTRRLGYNGAQEIK 245 (312)
T ss_pred HHHHHHcCCCHHHcCCCCCHHHHH
Confidence 999999999999998654443333
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-39 Score=333.29 Aligned_cols=248 Identities=35% Similarity=0.596 Sum_probs=194.9
Q ss_pred ccCcccCCCCccEEEeecc-----CCcEEEEEEccccC-cccHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEEe
Q 004400 420 TDNNIGEGGFGPVYKGLLA-----DGTAIAVKQLSSKS-KQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYEY 493 (756)
Q Consensus 420 ~~~~lg~G~~g~Vy~~~~~-----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 493 (756)
..+.||.|.||.||+|.+. .+..|+||.++... ....+.|.+|++.+++++||||++++|+|...+..++|+||
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~ 82 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY 82 (259)
T ss_dssp EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence 4578999999999999966 35689999996532 33467899999999999999999999999988889999999
Q ss_pred cCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCcccCc-
Q 004400 494 LENNSLARALFEH-RLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENT- 571 (756)
Q Consensus 494 ~~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~~~~- 571 (756)
+++|+|.+++... ...+++..+..|+.|||+||+|||+.+ ++||||+++||++++++.+||+|||+++.......
T Consensus 83 ~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~---iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~ 159 (259)
T PF07714_consen 83 CPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNN---IIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKY 159 (259)
T ss_dssp -TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTT---EEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSE
T ss_pred ccccccccccccccccccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccccc
Confidence 9999999999876 668999999999999999999999986 99999999999999999999999999986632222
Q ss_pred ceeeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHh-CCCCCCccchhhHHHHHHHHHhcCccccccccCCCCCC
Q 004400 572 HISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVS-GRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNF 650 (756)
Q Consensus 572 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 650 (756)
.......+...|+|||.+....++.++||||||+++||+++ |+.||.......... .. .......... .+
T Consensus 160 ~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~---~~-~~~~~~~~~~-----~~ 230 (259)
T PF07714_consen 160 KNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIE---KL-KQGQRLPIPD-----NC 230 (259)
T ss_dssp EESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHH---HH-HTTEETTSBT-----TS
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccccccc---cc-cccccceecc-----ch
Confidence 22233457789999999999999999999999999999999 678885544333222 12 2222211111 12
Q ss_pred CHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHh
Q 004400 651 DKEQVMVMINVALLCANASPTIRPSMSSVLRML 683 (756)
Q Consensus 651 ~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~L 683 (756)
...+.+++..||+.+|++||++.++++.|
T Consensus 231 ----~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 231 ----PKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp ----BHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred ----hHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 23488999999999999999999999876
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=330.07 Aligned_cols=255 Identities=29% Similarity=0.472 Sum_probs=211.9
Q ss_pred hhcCccccCcccCCCCccEEEeeccCCcEEEEEEccccCcccHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEEe
Q 004400 414 ATNNFATDNNIGEGGFGPVYKGLLADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYEY 493 (756)
Q Consensus 414 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 493 (756)
+..+|+..+.||+|+||.||+|...+++.+|+|.+..........+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus 4 ~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 83 (261)
T cd05148 4 PREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITEL 83 (261)
T ss_pred cHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEee
Confidence 44678889999999999999999888999999999876555567889999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCcccCcc
Q 004400 494 LENNSLARALFEH-RLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTH 572 (756)
Q Consensus 494 ~~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~~~~~ 572 (756)
+++|+|.+++... ...+++..+.+++.|++.||+|||+.| |+||||||+||++++++.+||+|||.+.........
T Consensus 84 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~~ 160 (261)
T cd05148 84 MEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQN---SIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYL 160 (261)
T ss_pred cccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccCcceEEEcCCceEEEccccchhhcCCcccc
Confidence 9999999999753 446899999999999999999999987 999999999999999999999999999765433222
Q ss_pred eeeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHh-CCCCCCccchhhHHHHHHHHHhcCccccccccCCCCCCC
Q 004400 573 ISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVS-GRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFD 651 (756)
Q Consensus 573 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 651 (756)
.....++..|+|||.+....++.++||||||+++|+|++ |+.||............. ...... .+
T Consensus 161 -~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~----~~~~~~---------~~ 226 (261)
T cd05148 161 -SSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQIT----AGYRMP---------CP 226 (261)
T ss_pred -ccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHH----hCCcCC---------CC
Confidence 223346778999999988889999999999999999998 899996655433333221 111111 11
Q ss_pred HHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhcc
Q 004400 652 KEQVMVMINVALLCANASPTIRPSMSSVLRMLEC 685 (756)
Q Consensus 652 ~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~L~~ 685 (756)
......+.+++.+||+.+|++|||+.++++.|+.
T Consensus 227 ~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~ 260 (261)
T cd05148 227 AKCPQEIYKIMLECWAAEPEDRPSFKALREELDN 260 (261)
T ss_pred CCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhc
Confidence 1222348899999999999999999999999984
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-39 Score=344.78 Aligned_cols=253 Identities=22% Similarity=0.281 Sum_probs=204.5
Q ss_pred cCccccCcccCCCCccEEEee-ccCCcEEEEEEccccC---cccHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEE
Q 004400 416 NNFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSKS---KQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIY 491 (756)
Q Consensus 416 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 491 (756)
++|...+.||+|+||.||+|. ..+++.||+|.++... ....+.+.+|+.+++.++||||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 468889999999999999999 4578999999987542 223456888999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCcccCc
Q 004400 492 EYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENT 571 (756)
Q Consensus 492 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~~~~ 571 (756)
||+++|+|.+++......+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++.......
T Consensus 81 e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~---i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~ 157 (330)
T cd05601 81 EYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMG---YVHRDIKPENVLIDRTGHIKLADFGSAARLTANKM 157 (330)
T ss_pred CCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEcccCchHheEECCCCCEEeccCCCCeECCCCCc
Confidence 999999999999876568999999999999999999999986 99999999999999999999999999986654443
Q ss_pred ceeeccccCccCCchHhhh------cCCCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhcCccccccccC
Q 004400 572 HISTRVAGTIGYMAPEYAM------RGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTN 645 (756)
Q Consensus 572 ~~~~~~~gt~~y~aPE~~~------~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 645 (756)
.......||+.|+|||++. ...++.++|||||||++|||++|+.||.......... .+...........
T Consensus 158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~---~i~~~~~~~~~~~-- 232 (330)
T cd05601 158 VNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYN---NIMNFQRFLKFPE-- 232 (330)
T ss_pred eeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHH---HHHcCCCccCCCC--
Confidence 3334457999999999987 4567899999999999999999999996654332211 1111111111111
Q ss_pred CCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004400 646 PGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRM 682 (756)
Q Consensus 646 ~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~ 682 (756)
.... ...+.+++..|++ +|.+||++.++++.
T Consensus 233 -~~~~----~~~~~~li~~ll~-~p~~R~t~~~l~~h 263 (330)
T cd05601 233 -DPKV----SSDFLDLIQSLLC-GQKERLGYEGLCCH 263 (330)
T ss_pred -CCCC----CHHHHHHHHHHcc-ChhhCCCHHHHhCC
Confidence 1112 2347888999998 99999999998753
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-38 Score=338.27 Aligned_cols=261 Identities=21% Similarity=0.350 Sum_probs=202.6
Q ss_pred hcCccccCcccCCCCccEEEeecc-CCcEEEEEEccccC-cccHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEE
Q 004400 415 TNNFATDNNIGEGGFGPVYKGLLA-DGTAIAVKQLSSKS-KQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYE 492 (756)
Q Consensus 415 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 492 (756)
.++|+..+.||+|+||.||+|... ++..+|+|.+.... ......+.+|++++++++||||++++++|.+++..++|||
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEe
Confidence 468899999999999999999954 68899999886542 2334678999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCcccCcc
Q 004400 493 YLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTH 572 (756)
Q Consensus 493 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~~~~~ 572 (756)
|+++|+|.+++... ..+++..+..++.|++.||+|||+.+ +|+||||||+|||++.++.+||+|||++.......
T Consensus 84 ~~~~~~L~~~l~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~--~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~-- 158 (333)
T cd06650 84 HMDGGSLDQVLKKA-GRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM-- 158 (333)
T ss_pred cCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChhhEEEcCCCCEEEeeCCcchhhhhhc--
Confidence 99999999999754 36899999999999999999999753 49999999999999999999999999987543321
Q ss_pred eeeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhcCccc-------------
Q 004400 573 ISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLM------------- 639 (756)
Q Consensus 573 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~------------- 639 (756)
.....|+..|+|||++.+..++.++|||||||++|||++|+.||............... ..+...
T Consensus 159 -~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~ 236 (333)
T cd06650 159 -ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCP-VEGDPAESETSPRPRPPGR 236 (333)
T ss_pred -cccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCc-ccCCccccccCcccCCccc
Confidence 22356899999999999888999999999999999999999999654332211100000 000000
Q ss_pred -------------------cccccCCCCCCC-HHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004400 640 -------------------ELVDTNPGSNFD-KEQVMVMINVALLCANASPTIRPSMSSVLRM 682 (756)
Q Consensus 640 -------------------~~~~~~~~~~~~-~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~ 682 (756)
+.+........+ ......+.+++.+||+.||++||++.|+++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h 299 (333)
T cd06650 237 PLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVH 299 (333)
T ss_pred hhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhC
Confidence 000000000000 0112347899999999999999999999753
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=331.98 Aligned_cols=255 Identities=27% Similarity=0.458 Sum_probs=204.6
Q ss_pred cCccccCcccCCCCccEEEeec-----cCCcEEEEEEccccCc-ccHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEE
Q 004400 416 NNFATDNNIGEGGFGPVYKGLL-----ADGTAIAVKQLSSKSK-QGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLL 489 (756)
Q Consensus 416 ~~~~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 489 (756)
++|+..+.||+|+||.||+|.. .++..||+|.+..... .....+.+|++++++++||||+++++++..++..++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 84 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM 84 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence 4677889999999999999973 3567899999975432 334678899999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHHhc----------------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCC
Q 004400 490 IYEYLENNSLARALFEH----------------RLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDL 553 (756)
Q Consensus 490 V~e~~~~gsL~~~l~~~----------------~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~ 553 (756)
||||+++|+|.+++... ...+++.....++.|++.||+|||+++ |+||||||+||++++++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~nili~~~~ 161 (283)
T cd05090 85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQL 161 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcC---eehhccccceEEEcCCC
Confidence 99999999999998632 134788999999999999999999987 99999999999999999
Q ss_pred CEEEccCCccccCcccCc-ceeeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHh-CCCCCCccchhhHHHHHHH
Q 004400 554 NSKISDFGLAKLDEEENT-HISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVS-GRSNVTKEDMFYLLDWALV 631 (756)
Q Consensus 554 ~~kl~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~~~~~~ 631 (756)
.+||+|||+++....... .......++..|+|||++.+..++.++|||||||++|||++ |..||............
T Consensus 162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~~~~-- 239 (283)
T cd05090 162 HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMV-- 239 (283)
T ss_pred cEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH--
Confidence 999999999986533221 22233446778999999988889999999999999999998 88898665433222211
Q ss_pred HHhcCccccccccCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhccC
Q 004400 632 LKEQGKLMELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLECG 686 (756)
Q Consensus 632 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~L~~~ 686 (756)
....... ....++ ..+.+++.+||+.+|++||++.+|.+.|.+|
T Consensus 240 --~~~~~~~-----~~~~~~----~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~~ 283 (283)
T cd05090 240 --RKRQLLP-----CSEDCP----PRMYSLMTECWQEGPSRRPRFKDIHTRLRSW 283 (283)
T ss_pred --HcCCcCC-----CCCCCC----HHHHHHHHHHcccCcccCcCHHHHHHHhhcC
Confidence 1111111 111222 3488899999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=326.95 Aligned_cols=253 Identities=29% Similarity=0.477 Sum_probs=205.9
Q ss_pred cCccccCcccCCCCccEEEeeccCCcEEEEEEccccCcccHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEEecC
Q 004400 416 NNFATDNNIGEGGFGPVYKGLLADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYEYLE 495 (756)
Q Consensus 416 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~ 495 (756)
++|+..+.||+|+||.||+|...++..||+|.+..... ..+.+.+|+.++++++|+|++++++++. ....++||||++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~ 83 (260)
T cd05070 6 ESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYMS 83 (260)
T ss_pred HHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEecC
Confidence 46788899999999999999988888999999875432 3467999999999999999999999875 456899999999
Q ss_pred CCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCcccCccee
Q 004400 496 NNSLARALFEH-RLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHIS 574 (756)
Q Consensus 496 ~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~~~~~~~ 574 (756)
+++|.+++... ...+++.++..++.|++.||+|||+.+ |+||||||+||++++++.++|+|||++...........
T Consensus 84 ~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~~~ 160 (260)
T cd05070 84 KGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMN---YIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTAR 160 (260)
T ss_pred CCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEEeCCceEEeCCceeeeeccCcccccc
Confidence 99999999753 346899999999999999999999986 99999999999999999999999999986544332222
Q ss_pred eccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHh-CCCCCCccchhhHHHHHHHHHhcCccccccccCCCCCCCHH
Q 004400 575 TRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVS-GRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDKE 653 (756)
Q Consensus 575 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 653 (756)
....++..|+|||.+.+..++.++||||||+++|||++ |+.||...+......+. .. .... ..+..
T Consensus 161 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~---~~-~~~~---------~~~~~ 227 (260)
T cd05070 161 QGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQV---ER-GYRM---------PCPQD 227 (260)
T ss_pred cCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH---Hc-CCCC---------CCCCc
Confidence 23345678999999988889999999999999999999 88898665543333221 11 1010 11112
Q ss_pred HHHHHHHHHHHhhcCCCCCCCCHHHHHHHhccC
Q 004400 654 QVMVMINVALLCANASPTIRPSMSSVLRMLECG 686 (756)
Q Consensus 654 ~~~~l~~l~~~c~~~~P~~RPt~~ev~~~L~~~ 686 (756)
....+.+++.+|++.+|++|||+.++.+.|+.+
T Consensus 228 ~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~ 260 (260)
T cd05070 228 CPISLHELMLQCWKKDPEERPTFEYLQSFLEDY 260 (260)
T ss_pred CCHHHHHHHHHHcccCcccCcCHHHHHHHHhcC
Confidence 234588999999999999999999999998853
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=342.48 Aligned_cols=252 Identities=25% Similarity=0.261 Sum_probs=198.6
Q ss_pred CccccCcccCCCCccEEEeec----cCCcEEEEEEccccC----cccHHHHHHHHHHHHhC-CCCceeeEeeEEEeCCeE
Q 004400 417 NFATDNNIGEGGFGPVYKGLL----ADGTAIAVKQLSSKS----KQGNREFINEIGMISAL-QHPNLVKLYGCCIEGNQL 487 (756)
Q Consensus 417 ~~~~~~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 487 (756)
+|+..+.||+|+||.||+++. .+++.||+|++.... ....+.+.+|+++++.+ +||||+++++++.+++..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 477889999999999999874 368899999986531 22335678899999999 599999999999999999
Q ss_pred EEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCc
Q 004400 488 LLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDE 567 (756)
Q Consensus 488 ~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~ 567 (756)
++||||+++|+|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 81 ~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~ 156 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQR-DNFSEDEVRFYSGEIILALEHLHKLG---IVYRDIKLENILLDSEGHVVLTDFGLSKEFL 156 (332)
T ss_pred EEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHeEECCCCCEEEeeCcCCcccc
Confidence 9999999999999998754 46899999999999999999999987 9999999999999999999999999998654
Q ss_pred ccCcceeeccccCccCCchHhhhcC-CCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhcCccccccccCC
Q 004400 568 EENTHISTRVAGTIGYMAPEYAMRG-HLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNP 646 (756)
Q Consensus 568 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 646 (756)
...........||+.|+|||++.+. .++.++|||||||++|||++|+.||.................. .+...
T Consensus 157 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~------~~~~~ 230 (332)
T cd05614 157 SEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILK------CDPPF 230 (332)
T ss_pred ccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhc------CCCCC
Confidence 3333333346799999999999765 4789999999999999999999999543322111111100000 01111
Q ss_pred CCCCCHHHHHHHHHHHHHhhcCCCCCCC-----CHHHHHHH
Q 004400 647 GSNFDKEQVMVMINVALLCANASPTIRP-----SMSSVLRM 682 (756)
Q Consensus 647 ~~~~~~~~~~~l~~l~~~c~~~~P~~RP-----t~~ev~~~ 682 (756)
.... ...+.+++.+|++.||++|| +++++++.
T Consensus 231 ~~~~----~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 267 (332)
T cd05614 231 PSFI----GPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEH 267 (332)
T ss_pred CCCC----CHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcC
Confidence 1122 23478999999999999999 67777654
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=356.14 Aligned_cols=249 Identities=20% Similarity=0.291 Sum_probs=203.3
Q ss_pred CccccCcccCCCCccEEEeec-cC-CcEEEEEEccccCcccHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEEec
Q 004400 417 NFATDNNIGEGGFGPVYKGLL-AD-GTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYEYL 494 (756)
Q Consensus 417 ~~~~~~~lg~G~~g~Vy~~~~-~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~ 494 (756)
.|...+.||+|+||.||+|.. .+ +..||+|.+..........+.+|+.+++.++|||||+++++|..++..++||||+
T Consensus 68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~ 147 (478)
T PTZ00267 68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYG 147 (478)
T ss_pred eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECC
Confidence 478889999999999999984 34 6788889876555555567788999999999999999999999999999999999
Q ss_pred CCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCcccCc
Q 004400 495 ENNSLARALFE---HRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENT 571 (756)
Q Consensus 495 ~~gsL~~~l~~---~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~~~~ 571 (756)
++|+|.+++.. ....+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 148 ~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~ 224 (478)
T PTZ00267 148 SGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVS 224 (478)
T ss_pred CCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCcCHHhEEECCCCcEEEEeCcCceecCCccc
Confidence 99999998863 2446889999999999999999999986 99999999999999999999999999986543322
Q ss_pred -ceeeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhcCccccccccCCCCCC
Q 004400 572 -HISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNF 650 (756)
Q Consensus 572 -~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 650 (756)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||...+........ .. +.... .
T Consensus 225 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~---~~-~~~~~---------~ 291 (478)
T PTZ00267 225 LDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQV---LY-GKYDP---------F 291 (478)
T ss_pred cccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH---Hh-CCCCC---------C
Confidence 2234567999999999999989999999999999999999999999765443322211 11 11110 1
Q ss_pred CHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 004400 651 DKEQVMVMINVALLCANASPTIRPSMSSVLR 681 (756)
Q Consensus 651 ~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~ 681 (756)
+......+.+++.+||+.+|++||++.+++.
T Consensus 292 ~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~ 322 (478)
T PTZ00267 292 PCPVSSGMKALLDPLLSKNPALRPTTQQLLH 322 (478)
T ss_pred CccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence 1112234889999999999999999999864
|
|
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=339.23 Aligned_cols=242 Identities=25% Similarity=0.316 Sum_probs=197.5
Q ss_pred CcccCCCCccEEEee-ccCCcEEEEEEcccc---CcccHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEEecCCC
Q 004400 422 NNIGEGGFGPVYKGL-LADGTAIAVKQLSSK---SKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYEYLENN 497 (756)
Q Consensus 422 ~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~g 497 (756)
+.||+|+||.||+|. ..+++.||+|++... .......+.+|+++++.++||||+++++++.+++..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 468999999999998 457899999998754 2233467888999999999999999999999999999999999999
Q ss_pred CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCcccCcceeecc
Q 004400 498 SLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRV 577 (756)
Q Consensus 498 sL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~ 577 (756)
+|.+++... ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++....... .....
T Consensus 81 ~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~-~~~~~ 155 (328)
T cd05593 81 ELFFHLSRE-RVFSEDRTRFYGAEIVSALDYLHSGK---IVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAA-TMKTF 155 (328)
T ss_pred CHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeEECCCCcEEEecCcCCccCCCccc-ccccc
Confidence 999988654 47899999999999999999999986 99999999999999999999999999875322211 22345
Q ss_pred ccCccCCchHhhhcCCCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhcCccccccccCCCCCCCHHHHHH
Q 004400 578 AGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDKEQVMV 657 (756)
Q Consensus 578 ~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 657 (756)
.||+.|+|||++.+..++.++|||||||++|||++|+.||...+....... ... .. ......+ ...
T Consensus 156 ~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~---~~~-~~------~~~p~~~----~~~ 221 (328)
T cd05593 156 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFEL---ILM-ED------IKFPRTL----SAD 221 (328)
T ss_pred cCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHH---hcc-CC------ccCCCCC----CHH
Confidence 799999999999988999999999999999999999999976544322211 100 00 0111122 334
Q ss_pred HHHHHHHhhcCCCCCCC-----CHHHHHHH
Q 004400 658 MINVALLCANASPTIRP-----SMSSVLRM 682 (756)
Q Consensus 658 l~~l~~~c~~~~P~~RP-----t~~ev~~~ 682 (756)
+.+++.+|++.||++|| ++.|+++.
T Consensus 222 ~~~li~~~L~~dP~~R~~~~~~~~~~il~h 251 (328)
T cd05593 222 AKSLLSGLLIKDPNKRLGGGPDDAKEIMRH 251 (328)
T ss_pred HHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence 88999999999999997 88888764
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=339.23 Aligned_cols=255 Identities=25% Similarity=0.446 Sum_probs=204.4
Q ss_pred cCccccCcccCCCCccEEEeecc-CCc----EEEEEEccccC-cccHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEE
Q 004400 416 NNFATDNNIGEGGFGPVYKGLLA-DGT----AIAVKQLSSKS-KQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLL 489 (756)
Q Consensus 416 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 489 (756)
.+|+..+.||+|+||.||+|++. ++. .||+|.++... ....+++.+|+.+++.++||||++++++|..+ ..++
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~ 85 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 85 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Ccee
Confidence 47889999999999999999853 343 38999986542 33456789999999999999999999999864 5789
Q ss_pred EEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCccc
Q 004400 490 IYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEE 569 (756)
Q Consensus 490 V~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~~ 569 (756)
|+||+++|+|.+++......+++..+.+++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||+++.....
T Consensus 86 v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~ 162 (316)
T cd05108 86 ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAD 162 (316)
T ss_pred eeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEecCCCcEEEccccccccccCC
Confidence 99999999999999877667899999999999999999999986 999999999999999999999999999876543
Q ss_pred Ccce-eeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHh-CCCCCCccchhhHHHHHHHHHhcCccccccccCCC
Q 004400 570 NTHI-STRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVS-GRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPG 647 (756)
Q Consensus 570 ~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 647 (756)
.... .....++..|+|||++.+..++.++|||||||++|||++ |+.||.......... ....+..... .
T Consensus 163 ~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~~----~~~~~~~~~~-----~ 233 (316)
T cd05108 163 EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISS----ILEKGERLPQ-----P 233 (316)
T ss_pred CcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHH----HHhCCCCCCC-----C
Confidence 3222 122334678999999999999999999999999999998 999986554332221 1111111110 0
Q ss_pred CCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhccCc
Q 004400 648 SNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLECGV 687 (756)
Q Consensus 648 ~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~L~~~~ 687 (756)
... ...+.+++.+||+.+|.+||++.+++..+....
T Consensus 234 ~~~----~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~ 269 (316)
T cd05108 234 PIC----TIDVYMIMVKCWMIDADSRPKFRELIIEFSKMA 269 (316)
T ss_pred CCC----CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 112 234788999999999999999999999988653
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=330.53 Aligned_cols=254 Identities=29% Similarity=0.506 Sum_probs=206.6
Q ss_pred hcCccccCcccCCCCccEEEeecc------CCcEEEEEEccccCcc-cHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeE
Q 004400 415 TNNFATDNNIGEGGFGPVYKGLLA------DGTAIAVKQLSSKSKQ-GNREFINEIGMISALQHPNLVKLYGCCIEGNQL 487 (756)
Q Consensus 415 ~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 487 (756)
.++|...+.||+|+||.||+|... +++.||||.++..... ..+.+.+|++++++++|+||+++++++..+...
T Consensus 4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 83 (280)
T cd05049 4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPP 83 (280)
T ss_pred hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCe
Confidence 346788899999999999999853 3478999998765433 457899999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHHHhcC-------------CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCC
Q 004400 488 LLIYEYLENNSLARALFEHR-------------LKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLN 554 (756)
Q Consensus 488 ~lV~e~~~~gsL~~~l~~~~-------------~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~ 554 (756)
++||||+++|+|.+++...+ ..+++..+..++.|++.|++|||+.+ ++||||||+||+++.++.
T Consensus 84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~ 160 (280)
T cd05049 84 IMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH---FVHRDLATRNCLVGYDLV 160 (280)
T ss_pred EEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eeccccccceEEEcCCCe
Confidence 99999999999999997432 35789999999999999999999986 999999999999999999
Q ss_pred EEEccCCccccCcccCc-ceeeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHh-CCCCCCccchhhHHHHHHHH
Q 004400 555 SKISDFGLAKLDEEENT-HISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVS-GRSNVTKEDMFYLLDWALVL 632 (756)
Q Consensus 555 ~kl~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~~~~~~~ 632 (756)
+||+|||+++....... .......+++.|+|||++.+..++.++|||||||++|||++ |+.||...+.........
T Consensus 161 ~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~~~-- 238 (280)
T cd05049 161 VKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECIT-- 238 (280)
T ss_pred EEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH--
Confidence 99999999975432221 11233456788999999999999999999999999999998 999986554443332221
Q ss_pred HhcCccccccccCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhc
Q 004400 633 KEQGKLMELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLE 684 (756)
Q Consensus 633 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~L~ 684 (756)
.+..... .... ...+.+++.+||+.+|++||++.||++.|+
T Consensus 239 --~~~~~~~-----~~~~----~~~~~~li~~~l~~~p~~Rp~~~eil~~l~ 279 (280)
T cd05049 239 --QGRLLQR-----PRTC----PSEVYDIMLGCWKRDPQQRINIKDIHERLQ 279 (280)
T ss_pred --cCCcCCC-----CCCC----CHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence 1111111 1112 234889999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-38 Score=333.51 Aligned_cols=262 Identities=21% Similarity=0.338 Sum_probs=199.9
Q ss_pred hcCccccCcccCCCCccEEEeec-cCCcEEEEEEccccCc-ccHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEE
Q 004400 415 TNNFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSKSK-QGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYE 492 (756)
Q Consensus 415 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 492 (756)
.++|+..+.||+|+||.||+|.. .+++.||||.+..... .....+.+|+.+++.++||||+++++++.+++..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE 83 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence 46899999999999999999995 4789999999875432 223467889999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCcccCcc
Q 004400 493 YLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTH 572 (756)
Q Consensus 493 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~~~~~ 572 (756)
|+. ++|.+++......+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++.......
T Consensus 84 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~- 158 (303)
T cd07869 84 YVH-TDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRY---ILHRDLKPQNLLISDTGELKLADFGLARAKSVPSH- 158 (303)
T ss_pred CCC-cCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECCCCcceeccCCCc-
Confidence 996 5788888766667899999999999999999999997 99999999999999999999999999975432221
Q ss_pred eeeccccCccCCchHhhhc-CCCCcccchhhHHHHHHHHHhCCCCCCccchh-hHHHHHHHHHhcCcc---c---cc--c
Q 004400 573 ISTRVAGTIGYMAPEYAMR-GHLTEKADVYSFGIVALEIVSGRSNVTKEDMF-YLLDWALVLKEQGKL---M---EL--V 642 (756)
Q Consensus 573 ~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~-~~~~~~~~~~~~~~~---~---~~--~ 642 (756)
......||+.|+|||++.+ ..++.++||||+||++|||++|+.||...... ............... . .. .
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (303)
T cd07869 159 TYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPHF 238 (303)
T ss_pred cCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhcccc
Confidence 1233568999999999875 45889999999999999999999999654321 111111111000000 0 00 0
Q ss_pred ccCCCCCCCH----------HHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 004400 643 DTNPGSNFDK----------EQVMVMINVALLCANASPTIRPSMSSVLR 681 (756)
Q Consensus 643 ~~~~~~~~~~----------~~~~~l~~l~~~c~~~~P~~RPt~~ev~~ 681 (756)
.+.......+ .....+.+++.+|++.||++|||+.|+++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~ 287 (303)
T cd07869 239 KPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS 287 (303)
T ss_pred ccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence 0000000000 01134778999999999999999999975
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=338.57 Aligned_cols=242 Identities=26% Similarity=0.322 Sum_probs=196.8
Q ss_pred CcccCCCCccEEEee-ccCCcEEEEEEcccc---CcccHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEEecCCC
Q 004400 422 NNIGEGGFGPVYKGL-LADGTAIAVKQLSSK---SKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYEYLENN 497 (756)
Q Consensus 422 ~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~g 497 (756)
+.||+|+||.||+|. ..+|+.||+|.+... .......+.+|+++++.++||||++++++|...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 469999999999999 457899999998754 2233456788999999999999999999999999999999999999
Q ss_pred CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCcccCcceeecc
Q 004400 498 SLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRV 577 (756)
Q Consensus 498 sL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~ 577 (756)
+|.+++... ..+++..+..++.||+.||+|||+.| |+||||||+|||++.++.+||+|||+++....... .....
T Consensus 81 ~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~-~~~~~ 155 (323)
T cd05595 81 ELFFHLSRE-RVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA-TMKTF 155 (323)
T ss_pred cHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEEcCCCCEEecccHHhccccCCCC-ccccc
Confidence 999888654 37899999999999999999999986 99999999999999999999999999875322211 12345
Q ss_pred ccCccCCchHhhhcCCCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhcCccccccccCCCCCCCHHHHHH
Q 004400 578 AGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDKEQVMV 657 (756)
Q Consensus 578 ~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 657 (756)
.||+.|+|||++.+..++.++|||||||++|||++|+.||...+........ ..... .....+ ...
T Consensus 156 ~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~--~~~~~--------~~p~~~----~~~ 221 (323)
T cd05595 156 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELI--LMEEI--------RFPRTL----SPE 221 (323)
T ss_pred cCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHH--hcCCC--------CCCCCC----CHH
Confidence 7999999999999889999999999999999999999999765543322211 00000 011122 234
Q ss_pred HHHHHHHhhcCCCCCCC-----CHHHHHHH
Q 004400 658 MINVALLCANASPTIRP-----SMSSVLRM 682 (756)
Q Consensus 658 l~~l~~~c~~~~P~~RP-----t~~ev~~~ 682 (756)
+.+++.+|++.||++|| ++.++++.
T Consensus 222 ~~~li~~~L~~dP~~R~~~~~~~~~~~l~h 251 (323)
T cd05595 222 AKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 251 (323)
T ss_pred HHHHHHHHccCCHHHhCCCCCCCHHHHHcC
Confidence 78999999999999998 78888653
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-38 Score=323.63 Aligned_cols=247 Identities=28% Similarity=0.429 Sum_probs=201.4
Q ss_pred CcccCCCCccEEEeeccCCcEEEEEEccccCc-ccHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEEecCCCCHH
Q 004400 422 NNIGEGGFGPVYKGLLADGTAIAVKQLSSKSK-QGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYEYLENNSLA 500 (756)
Q Consensus 422 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL~ 500 (756)
+.||+|+||.||+|...+++.||+|.+..... .....+.+|++++++++||||+++++++...+..++||||+++++|.
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL 80 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence 36899999999999988899999999875432 23456889999999999999999999999999999999999999999
Q ss_pred HHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCcccCcceeeccccC
Q 004400 501 RALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGT 580 (756)
Q Consensus 501 ~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~~gt 580 (756)
+++......+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++...............++
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~ 157 (250)
T cd05085 81 SFLRKKKDELKTKQLVKFALDAAAGMAYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIP 157 (250)
T ss_pred HHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccChheEEEcCCCeEEECCCccceeccccccccCCCCCCc
Confidence 999766667899999999999999999999986 99999999999999999999999999975433222222223456
Q ss_pred ccCCchHhhhcCCCCcccchhhHHHHHHHHHh-CCCCCCccchhhHHHHHHHHHhcCccccccccCCCCCCCHHHHHHHH
Q 004400 581 IGYMAPEYAMRGHLTEKADVYSFGIVALEIVS-GRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDKEQVMVMI 659 (756)
Q Consensus 581 ~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 659 (756)
+.|+|||++.++.++.++||||||+++||+++ |..||............ ........ +......+.
T Consensus 158 ~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~----~~~~~~~~---------~~~~~~~~~ 224 (250)
T cd05085 158 IKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQV----EKGYRMSC---------PQKCPDDVY 224 (250)
T ss_pred ccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHH----HcCCCCCC---------CCCCCHHHH
Confidence 78999999998889999999999999999998 99999655433222111 11111111 111234588
Q ss_pred HHHHHhhcCCCCCCCCHHHHHHHhc
Q 004400 660 NVALLCANASPTIRPSMSSVLRMLE 684 (756)
Q Consensus 660 ~l~~~c~~~~P~~RPt~~ev~~~L~ 684 (756)
+++.+|++.+|++||++.|+++.|.
T Consensus 225 ~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 225 KVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred HHHHHHcccCcccCCCHHHHHHHhc
Confidence 9999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=337.28 Aligned_cols=244 Identities=28% Similarity=0.453 Sum_probs=205.6
Q ss_pred CccccCcccCCCCccEEEee-ccCCcEEEEEEccccC---cccHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEE
Q 004400 417 NFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSKS---KQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYE 492 (756)
Q Consensus 417 ~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 492 (756)
-|...+.||.|+||.||-|+ ..+...||||++.-.. .....++..|+..|++++|||+|.+-|+|..+...|||||
T Consensus 27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVME 106 (948)
T KOG0577|consen 27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVME 106 (948)
T ss_pred HHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHH
Confidence 45667889999999999999 5678899999987543 3345789999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCcccCcc
Q 004400 493 YLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTH 572 (756)
Q Consensus 493 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~~~~~ 572 (756)
||-| +-.|.+.-+++++-+.++..|+.+.+.||+|||+.+ .||||||+.|||+++.|.|||+|||.|.+..+.
T Consensus 107 YClG-SAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~---~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PA--- 179 (948)
T KOG0577|consen 107 YCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHN---RIHRDIKAGNILLSEPGLVKLADFGSASIMAPA--- 179 (948)
T ss_pred HHhc-cHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhh---HHhhhccccceEecCCCeeeeccccchhhcCch---
Confidence 9955 888888888889999999999999999999999986 999999999999999999999999999876553
Q ss_pred eeeccccCccCCchHhhh---cCCCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhcCccccccccCCCCC
Q 004400 573 ISTRVAGTIGYMAPEYAM---RGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSN 649 (756)
Q Consensus 573 ~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 649 (756)
..++|||.|||||++. .+.|+-|+||||+|+.+.|+...++|+...+-+..+-. +.. .+-+. -
T Consensus 180 --nsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYH---IAQ-NesPt--------L 245 (948)
T KOG0577|consen 180 --NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYH---IAQ-NESPT--------L 245 (948)
T ss_pred --hcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHH---HHh-cCCCC--------C
Confidence 3478999999999986 47899999999999999999999999977765443211 111 11111 1
Q ss_pred CCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 004400 650 FDKEQVMVMINVALLCANASPTIRPSMSSVLR 681 (756)
Q Consensus 650 ~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~ 681 (756)
-..+....+..++..|++.-|.+|||..++++
T Consensus 246 qs~eWS~~F~~Fvd~CLqKipqeRptse~ll~ 277 (948)
T KOG0577|consen 246 QSNEWSDYFRNFVDSCLQKIPQERPTSEELLK 277 (948)
T ss_pred CCchhHHHHHHHHHHHHhhCcccCCcHHHHhh
Confidence 13345667999999999999999999999854
|
|
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=341.91 Aligned_cols=246 Identities=23% Similarity=0.316 Sum_probs=201.1
Q ss_pred hcCccccCcccCCCCccEEEeeccC--CcEEEEEEcccc---CcccHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEE
Q 004400 415 TNNFATDNNIGEGGFGPVYKGLLAD--GTAIAVKQLSSK---SKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLL 489 (756)
Q Consensus 415 ~~~~~~~~~lg~G~~g~Vy~~~~~~--~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 489 (756)
.++|...+.||+|+||.||+|.... +..||+|.+... .......+.+|+.+++.++||||+++++++.+++..++
T Consensus 29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l 108 (340)
T PTZ00426 29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYL 108 (340)
T ss_pred hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEE
Confidence 3578889999999999999998543 368999998643 22334568899999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCccc
Q 004400 490 IYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEE 569 (756)
Q Consensus 490 V~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~~ 569 (756)
||||+++|+|.+++... ..+++..+..++.|++.||+|||+.| |+||||||+|||++.++.+||+|||+++.....
T Consensus 109 v~Ey~~~g~L~~~i~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~~ 184 (340)
T PTZ00426 109 VLEFVIGGEFFTFLRRN-KRFPNDVGCFYAAQIVLIFEYLQSLN---IVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTR 184 (340)
T ss_pred EEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEecCCCCeecCCC
Confidence 99999999999999754 36899999999999999999999997 999999999999999999999999999865432
Q ss_pred CcceeeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhcCccccccccCCCCC
Q 004400 570 NTHISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSN 649 (756)
Q Consensus 570 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 649 (756)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||...+....... ... +. .. ....
T Consensus 185 ----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~---i~~-~~-~~-----~p~~ 250 (340)
T PTZ00426 185 ----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQK---ILE-GI-IY-----FPKF 250 (340)
T ss_pred ----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHH---Hhc-CC-CC-----CCCC
Confidence 2245799999999999988899999999999999999999999976654322211 111 11 00 0111
Q ss_pred CCHHHHHHHHHHHHHhhcCCCCCCC-----CHHHHHHH
Q 004400 650 FDKEQVMVMINVALLCANASPTIRP-----SMSSVLRM 682 (756)
Q Consensus 650 ~~~~~~~~l~~l~~~c~~~~P~~RP-----t~~ev~~~ 682 (756)
.+ ..+.+++.+|++.+|++|+ +++++++.
T Consensus 251 ~~----~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h 284 (340)
T PTZ00426 251 LD----NNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH 284 (340)
T ss_pred CC----HHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence 22 3478899999999999995 78887654
|
|
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=346.07 Aligned_cols=257 Identities=26% Similarity=0.398 Sum_probs=203.3
Q ss_pred hcCccccCcccCCCCccEEEeecc------CCcEEEEEEccccC-cccHHHHHHHHHHHHhCC-CCceeeEeeEEEeCCe
Q 004400 415 TNNFATDNNIGEGGFGPVYKGLLA------DGTAIAVKQLSSKS-KQGNREFINEIGMISALQ-HPNLVKLYGCCIEGNQ 486 (756)
Q Consensus 415 ~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~ 486 (756)
.++|.+.+.||+|+||.||+|+.. .+..||||++.... ....+.+.+|+++++++. |||||+++++|.+.+.
T Consensus 36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~ 115 (400)
T cd05105 36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGP 115 (400)
T ss_pred ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCc
Confidence 467888999999999999999842 23469999996543 233467899999999996 9999999999999999
Q ss_pred EEEEEEecCCCCHHHHHHhcC-----------------------------------------------------------
Q 004400 487 LLLIYEYLENNSLARALFEHR----------------------------------------------------------- 507 (756)
Q Consensus 487 ~~lV~e~~~~gsL~~~l~~~~----------------------------------------------------------- 507 (756)
.++|||||++|+|.+++....
T Consensus 116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (400)
T cd05105 116 IYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIK 195 (400)
T ss_pred eEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhh
Confidence 999999999999999886421
Q ss_pred ------------------------------------CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecC
Q 004400 508 ------------------------------------LKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDK 551 (756)
Q Consensus 508 ------------------------------------~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~ 551 (756)
..+++..+..++.|+++||+|||+.+ |+||||||+|||++.
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dikp~Nill~~ 272 (400)
T cd05105 196 EASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKN---CVHRDLAARNVLLAQ 272 (400)
T ss_pred hhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHhEEEeC
Confidence 24788889999999999999999986 999999999999999
Q ss_pred CCCEEEccCCccccCcccCcc-eeeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHh-CCCCCCccchhhHHHHH
Q 004400 552 DLNSKISDFGLAKLDEEENTH-ISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVS-GRSNVTKEDMFYLLDWA 629 (756)
Q Consensus 552 ~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~~~~ 629 (756)
++.+||+|||+++........ ......++..|+|||.+.+..++.++|||||||++|||++ |+.||......... +
T Consensus 273 ~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~-~- 350 (400)
T cd05105 273 GKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTF-Y- 350 (400)
T ss_pred CCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHHH-H-
Confidence 999999999999865432221 1223457788999999998889999999999999999997 88998543221111 0
Q ss_pred HHHHhcCccccccccCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhccC
Q 004400 630 LVLKEQGKLMELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLECG 686 (756)
Q Consensus 630 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~L~~~ 686 (756)
... ..+.... .+......+.+++.+||+.+|++||++.+|.++|++.
T Consensus 351 ~~~-~~~~~~~---------~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l 397 (400)
T cd05105 351 NKI-KSGYRMA---------KPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESL 397 (400)
T ss_pred HHH-hcCCCCC---------CCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHH
Confidence 011 1111111 1112234588999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-39 Score=322.32 Aligned_cols=256 Identities=26% Similarity=0.347 Sum_probs=198.1
Q ss_pred CccccCcccCCCCccEEEee-ccCCcEEEEEEccccCcccHHHHHHHHHHHHhCCCCceeeEeeEEEeCC-----eEEEE
Q 004400 417 NFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCCIEGN-----QLLLI 490 (756)
Q Consensus 417 ~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~~lV 490 (756)
.|...+++|.|+||.||+|. ..++..||||+...+... --+|+++|+++.|||||++..+|.... ...+|
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~----knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlV 100 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRY----KNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLV 100 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCc----CcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHH
Confidence 46677899999999999999 456799999998654321 236999999999999999999887432 34689
Q ss_pred EEecCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCC-CCEEEccCCccccC
Q 004400 491 YEYLENNSLARALFE---HRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKD-LNSKISDFGLAKLD 566 (756)
Q Consensus 491 ~e~~~~gsL~~~l~~---~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~-~~~kl~DFGla~~~ 566 (756)
||||+. +|.+.++. .+..++.-.+.-+..||.+||+|||+.+ |+||||||.|+|+|.+ |.+||||||.|+..
T Consensus 101 leymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~---IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L 176 (364)
T KOG0658|consen 101 LEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHG---ICHRDIKPQNLLVDPDTGVLKICDFGSAKVL 176 (364)
T ss_pred HHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcC---cccCCCChheEEEcCCCCeEEeccCCcceee
Confidence 999987 89888873 3567888899999999999999999986 9999999999999977 88999999999977
Q ss_pred cccCcceeeccccCccCCchHhhhc-CCCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhcCcccccc---
Q 004400 567 EEENTHISTRVAGTIGYMAPEYAMR-GHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELV--- 642 (756)
Q Consensus 567 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~--- 642 (756)
....... ...-|..|.|||.+.+ ..|+.+.||||.||++.||+-|++-|.+++..+.+.....+.......++.
T Consensus 177 ~~~epni--SYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~mn 254 (364)
T KOG0658|consen 177 VKGEPNI--SYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSMN 254 (364)
T ss_pred ccCCCce--eEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhcC
Confidence 6544432 2345778999999988 569999999999999999999999998876655443333332221111111
Q ss_pred -----------ccCCCCC-CCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004400 643 -----------DTNPGSN-FDKEQVMVMINVALLCANASPTIRPSMSSVLRM 682 (756)
Q Consensus 643 -----------~~~~~~~-~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~ 682 (756)
.+.+... +......+..+++.++++.+|.+|.++.|++..
T Consensus 255 ~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h 306 (364)
T KOG0658|consen 255 PNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAH 306 (364)
T ss_pred cccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcc
Confidence 0111101 222334468899999999999999999998643
|
|
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-38 Score=330.63 Aligned_cols=258 Identities=28% Similarity=0.499 Sum_probs=208.9
Q ss_pred hcCccccCcccCCCCccEEEeec------cCCcEEEEEEccccCcccHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEE
Q 004400 415 TNNFATDNNIGEGGFGPVYKGLL------ADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLL 488 (756)
Q Consensus 415 ~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 488 (756)
.++|...+.||+|+||.||++.. .++..+|+|.+..........+.+|++++++++||||+++++++...+..+
T Consensus 4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (288)
T cd05093 4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLI 83 (288)
T ss_pred hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccE
Confidence 35788899999999999999974 234568999987665555678999999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHHhcC------------CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEE
Q 004400 489 LIYEYLENNSLARALFEHR------------LKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSK 556 (756)
Q Consensus 489 lV~e~~~~gsL~~~l~~~~------------~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~k 556 (756)
+||||+++++|.+++.... ..+++..+..++.|++.||+|||+.| ++||||||+||++++++.+|
T Consensus 84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~---i~H~dlkp~Nili~~~~~~k 160 (288)
T cd05093 84 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVK 160 (288)
T ss_pred EEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCcEE
Confidence 9999999999999997432 24899999999999999999999986 99999999999999999999
Q ss_pred EccCCccccCcccCcc-eeeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHh-CCCCCCccchhhHHHHHHHHHh
Q 004400 557 ISDFGLAKLDEEENTH-ISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVS-GRSNVTKEDMFYLLDWALVLKE 634 (756)
Q Consensus 557 l~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~ 634 (756)
|+|||+++........ ......++..|+|||++.+..++.++|||||||++|||++ |+.||............ .
T Consensus 161 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i----~ 236 (288)
T cd05093 161 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECI----T 236 (288)
T ss_pred eccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH----H
Confidence 9999999865432221 1223446788999999988889999999999999999998 89998655433322211 1
Q ss_pred cCccccccccCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhccCcc
Q 004400 635 QGKLMELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLECGVD 688 (756)
Q Consensus 635 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~L~~~~~ 688 (756)
.+..... ....+ ..+.+++.+||+.+|.+||++.++++.|+.+..
T Consensus 237 ~~~~~~~-----~~~~~----~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~ 281 (288)
T cd05093 237 QGRVLQR-----PRTCP----KEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAK 281 (288)
T ss_pred cCCcCCC-----CCCCC----HHHHHHHHHHccCChhhCCCHHHHHHHHHHHHH
Confidence 1111111 11222 348999999999999999999999999986643
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=318.19 Aligned_cols=262 Identities=24% Similarity=0.323 Sum_probs=205.5
Q ss_pred cCccccCcccCCCCccEEEee-ccCCcEEEEEEccccCcc--cHHHHHHHHHHHHhCCCCc-eeeEeeEEEeCC------
Q 004400 416 NNFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQ--GNREFINEIGMISALQHPN-LVKLYGCCIEGN------ 485 (756)
Q Consensus 416 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~------ 485 (756)
..|...++||+|+||+||+|+ ..+|+.||+|++...... .-....+|+.++++++|+| ||++++++....
T Consensus 11 ~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~ 90 (323)
T KOG0594|consen 11 FDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIG 90 (323)
T ss_pred HHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccc
Confidence 346666789999999999999 668899999999765432 3356789999999999999 999999999877
Q ss_pred eEEEEEEecCCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCc
Q 004400 486 QLLLIYEYLENNSLARALFEHR---LKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGL 562 (756)
Q Consensus 486 ~~~lV~e~~~~gsL~~~l~~~~---~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGl 562 (756)
..++|+||++. +|..++.... ..++...+..++.||++||+|||+++ |+||||||.|||++++|.+||+|||+
T Consensus 91 ~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~---IlHRDLKPQNlLi~~~G~lKlaDFGl 166 (323)
T KOG0594|consen 91 KLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHG---ILHRDLKPQNLLISSSGVLKLADFGL 166 (323)
T ss_pred eEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCcceEEECCCCcEeeeccch
Confidence 88999999976 8999997655 45777899999999999999999997 99999999999999999999999999
Q ss_pred cccCcccCcceeeccccCccCCchHhhhcC-CCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhcCc---c
Q 004400 563 AKLDEEENTHISTRVAGTIGYMAPEYAMRG-HLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGK---L 638 (756)
Q Consensus 563 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~---~ 638 (756)
|+........ .+..++|.+|.|||++.+. .|+...||||+|||++||++++.-|.+.................. .
T Consensus 167 Ara~~ip~~~-yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~W 245 (323)
T KOG0594|consen 167 ARAFSIPMRT-YTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDW 245 (323)
T ss_pred HHHhcCCccc-ccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCC
Confidence 9966533332 3445789999999999886 799999999999999999999998977766544332222222111 1
Q ss_pred c---cccccCC-------CCCCCHHH---HHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004400 639 M---ELVDTNP-------GSNFDKEQ---VMVMINVALLCANASPTIRPSMSSVLRM 682 (756)
Q Consensus 639 ~---~~~~~~~-------~~~~~~~~---~~~l~~l~~~c~~~~P~~RPt~~ev~~~ 682 (756)
. ...+-.. ........ .....+++.+|++.+|.+|.+++.++.+
T Consensus 246 p~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h 302 (323)
T KOG0594|consen 246 PGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH 302 (323)
T ss_pred CCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence 1 1111110 00111111 1267899999999999999999998775
|
|
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=333.49 Aligned_cols=260 Identities=25% Similarity=0.388 Sum_probs=197.4
Q ss_pred cCccccCcccCCCCccEEEeec-c-CCcEEEEEEccccC--cccHHHHHHHHHHHHhC---CCCceeeEeeEEEe-----
Q 004400 416 NNFATDNNIGEGGFGPVYKGLL-A-DGTAIAVKQLSSKS--KQGNREFINEIGMISAL---QHPNLVKLYGCCIE----- 483 (756)
Q Consensus 416 ~~~~~~~~lg~G~~g~Vy~~~~-~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~----- 483 (756)
++|...+.||+|+||.||+|+. . +++.||+|.+.... ......+.+|+.+++.+ +||||++++++|..
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 3688889999999999999985 3 46889999886542 22234567788777766 69999999999863
Q ss_pred CCeEEEEEEecCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCc
Q 004400 484 GNQLLLIYEYLENNSLARALFEH-RLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGL 562 (756)
Q Consensus 484 ~~~~~lV~e~~~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGl 562 (756)
....++||||++ ++|.+++... ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 81 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~---iiH~dlkp~Nil~~~~~~~kl~Dfg~ 156 (290)
T cd07862 81 ETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGL 156 (290)
T ss_pred CCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEcCCCCEEEccccc
Confidence 456899999997 5899888643 345899999999999999999999986 99999999999999999999999999
Q ss_pred cccCcccCcceeeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhcC---ccc
Q 004400 563 AKLDEEENTHISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQG---KLM 639 (756)
Q Consensus 563 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~---~~~ 639 (756)
++..... .......||+.|+|||.+....++.++|||||||++|||++|+.||................... ...
T Consensus 157 ~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~ 234 (290)
T cd07862 157 ARIYSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWP 234 (290)
T ss_pred eEeccCC--cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhch
Confidence 9865433 22334568999999999988899999999999999999999999997765544333222111100 000
Q ss_pred -------cccccCCCC---CCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 004400 640 -------ELVDTNPGS---NFDKEQVMVMINVALLCANASPTIRPSMSSVLR 681 (756)
Q Consensus 640 -------~~~~~~~~~---~~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~ 681 (756)
......... ...+.....+.+++.+|++.||++|||+.|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 286 (290)
T cd07862 235 RDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 286 (290)
T ss_pred hhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence 000000000 001112335789999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=343.96 Aligned_cols=253 Identities=21% Similarity=0.275 Sum_probs=196.6
Q ss_pred cCccccCcccCCCCccEEEee-ccCCcEEEEEEccccC---cccHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEE
Q 004400 416 NNFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSKS---KQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIY 491 (756)
Q Consensus 416 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 491 (756)
++|+..+.||+|+||+||+|. ..+++.||+|++.... ......+.+|+.++.+++||||+++++++.++...++||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 478889999999999999998 4568999999986532 223356788999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCcccCc
Q 004400 492 EYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENT 571 (756)
Q Consensus 492 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~~~~ 571 (756)
||+++|+|.+++... ..+++..+..++.|++.||+|||++| |+||||||+|||++.++.+||+|||+++.......
T Consensus 81 E~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~lH~~g---ivHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~ 156 (363)
T cd05628 81 EFLPGGDMMTLLMKK-DTLTEEETQFYIAETVLAIDSIHQLG---FIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHR 156 (363)
T ss_pred cCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCCEEEeeccCccccccccc
Confidence 999999999999754 47899999999999999999999986 99999999999999999999999999875432110
Q ss_pred ----------------------------------ceeeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHhCCCCC
Q 004400 572 ----------------------------------HISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNV 617 (756)
Q Consensus 572 ----------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~ 617 (756)
......+||+.|+|||++.+..++.++|||||||++|||++|+.||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf 236 (363)
T cd05628 157 TEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPF 236 (363)
T ss_pred ccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCC
Confidence 0012357999999999999989999999999999999999999999
Q ss_pred CccchhhHHHHHHHHHhcCccccccccCCCCCCCHHHHHHHHHHHHHhh--cCCCCCCCCHHHHHHH
Q 004400 618 TKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDKEQVMVMINVALLCA--NASPTIRPSMSSVLRM 682 (756)
Q Consensus 618 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~--~~~P~~RPt~~ev~~~ 682 (756)
...+........ ........+ + .....+. .+.+++.+++ ..++..||+++||++.
T Consensus 237 ~~~~~~~~~~~i---~~~~~~~~~--p-~~~~~s~----~~~~li~~l~~~~~~r~~r~~~~ei~~h 293 (363)
T cd05628 237 CSETPQETYKKV---MNWKETLIF--P-PEVPISE----KAKDLILRFCCEWEHRIGAPGVEEIKTN 293 (363)
T ss_pred CCCCHHHHHHHH---HcCcCcccC--C-CcCCCCH----HHHHHHHHHcCChhhcCCCCCHHHHhCC
Confidence 766543322211 110000111 1 1111232 2555555533 3344567999999764
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=345.98 Aligned_cols=252 Identities=20% Similarity=0.300 Sum_probs=197.6
Q ss_pred CccccCcccCCCCccEEEee-ccCCcEEEEEEccccC---cccHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEE
Q 004400 417 NFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSKS---KQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYE 492 (756)
Q Consensus 417 ~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 492 (756)
.|...+.||+|+||+||+|+ ..+++.||+|++.... ......+.+|++++++++||||+++++++.+++..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 57788999999999999998 4578899999986532 2334568899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCcccC--
Q 004400 493 YLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEEN-- 570 (756)
Q Consensus 493 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~~~-- 570 (756)
|+++|+|.+++.... .+++..+..++.||+.||+|||+.| |+||||||+|||++.++.+||+|||+++......
T Consensus 82 ~~~gg~L~~~l~~~~-~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~ 157 (381)
T cd05626 82 YIPGGDMMSLLIRME-VFPEVLARFYIAELTLAIESVHKMG---FIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNS 157 (381)
T ss_pred cCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCcHHHEEECCCCCEEEeeCcCCccccccccc
Confidence 999999999987543 6899999999999999999999986 9999999999999999999999999976331100
Q ss_pred --------------------------------------------cceeeccccCccCCchHhhhcCCCCcccchhhHHHH
Q 004400 571 --------------------------------------------THISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIV 606 (756)
Q Consensus 571 --------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~ 606 (756)
........||+.|+|||++.+..++.++|||||||+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~i 237 (381)
T cd05626 158 KYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVI 237 (381)
T ss_pred ccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhhH
Confidence 000123579999999999998889999999999999
Q ss_pred HHHHHhCCCCCCccchhhHHHHHHHHHhcCccccccccCCCCCCCHHHHHHHHHHHHH--hhcCCCCCCCCHHHHHHH
Q 004400 607 ALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDKEQVMVMINVALL--CANASPTIRPSMSSVLRM 682 (756)
Q Consensus 607 l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~--c~~~~P~~RPt~~ev~~~ 682 (756)
+|||++|+.||...+....... .......... ......++ .+.+++.+ |+..+|..||++.++++.
T Consensus 238 l~elltG~~Pf~~~~~~~~~~~---i~~~~~~~~~---~~~~~~s~----~~~dli~~ll~~~~~~~~R~~~~~~l~h 305 (381)
T cd05626 238 LFEMLVGQPPFLAPTPTETQLK---VINWENTLHI---PPQVKLSP----EAVDLITKLCCSAEERLGRNGADDIKAH 305 (381)
T ss_pred HHHHHhCCCCCcCCCHHHHHHH---HHccccccCC---CCCCCCCH----HHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 9999999999966543322111 1110000011 11112233 36677766 556677779999999764
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=332.36 Aligned_cols=257 Identities=27% Similarity=0.486 Sum_probs=208.8
Q ss_pred cCccccCcccCCCCccEEEeec------cCCcEEEEEEccccCcccHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEE
Q 004400 416 NNFATDNNIGEGGFGPVYKGLL------ADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLL 489 (756)
Q Consensus 416 ~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 489 (756)
++|...+.||+|+||.||+|.. .++..+++|.+........+.+.+|++++++++|+||+++++++..++..++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM 84 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence 4677889999999999999973 2456799999876655555789999999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCC
Q 004400 490 IYEYLENNSLARALFEHR---------------LKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLN 554 (756)
Q Consensus 490 V~e~~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~ 554 (756)
||||+++++|.+++.... ..+++..+++++.|++.||+|||++| |+||||||+||+++.++.
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil~~~~~~ 161 (291)
T cd05094 85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH---FVHRDLATRNCLVGANLL 161 (291)
T ss_pred EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCc
Confidence 999999999999997432 34899999999999999999999997 999999999999999999
Q ss_pred EEEccCCccccCcccCc-ceeeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHh-CCCCCCccchhhHHHHHHHH
Q 004400 555 SKISDFGLAKLDEEENT-HISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVS-GRSNVTKEDMFYLLDWALVL 632 (756)
Q Consensus 555 ~kl~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~~~~~~~ 632 (756)
+||+|||+++....... .......++..|+|||++....++.++|||||||++|||++ |+.||...........
T Consensus 162 ~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~---- 237 (291)
T cd05094 162 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIEC---- 237 (291)
T ss_pred EEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH----
Confidence 99999999975543222 12233457889999999998899999999999999999999 9999865544332221
Q ss_pred HhcCccccccccCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhccCcc
Q 004400 633 KEQGKLMELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLECGVD 688 (756)
Q Consensus 633 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~L~~~~~ 688 (756)
...+..... +...+..+.+++.+||+.+|++||++.+|+++|+++..
T Consensus 238 ~~~~~~~~~---------~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~ 284 (291)
T cd05094 238 ITQGRVLER---------PRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGK 284 (291)
T ss_pred HhCCCCCCC---------CccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHh
Confidence 111111111 11123358899999999999999999999999986633
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-38 Score=324.06 Aligned_cols=247 Identities=27% Similarity=0.422 Sum_probs=198.1
Q ss_pred CcccCCCCccEEEeec-cCCcEEEEEEccccC-cccHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEEecCCCCH
Q 004400 422 NNIGEGGFGPVYKGLL-ADGTAIAVKQLSSKS-KQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYEYLENNSL 499 (756)
Q Consensus 422 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL 499 (756)
+.||+|+||.||+|+. .+++.||+|.+.... ......+.+|++++++++||||++++++|..+...++||||+++++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 4699999999999995 578999999876542 33446789999999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCcccCccee-eccc
Q 004400 500 ARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHIS-TRVA 578 (756)
Q Consensus 500 ~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~~~~~~~-~~~~ 578 (756)
.+++......+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++.......... ....
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 157 (252)
T cd05084 81 LTFLRTEGPRLKVKELIQMVENAAAGMEYLESKH---CIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQ 157 (252)
T ss_pred HHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEEcCCCcEEECccccCcccccccccccCCCCC
Confidence 9999766667899999999999999999999986 99999999999999999999999999975443211111 1112
Q ss_pred cCccCCchHhhhcCCCCcccchhhHHHHHHHHHh-CCCCCCccchhhHHHHHHHHHhcCccccccccCCCCCCCHHHHHH
Q 004400 579 GTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVS-GRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDKEQVMV 657 (756)
Q Consensus 579 gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 657 (756)
++..|+|||.+.++.++.++||||||+++|||++ |..||........... . ...... ..+...+..
T Consensus 158 ~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~---~-~~~~~~---------~~~~~~~~~ 224 (252)
T cd05084 158 IPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREA---I-EQGVRL---------PCPELCPDA 224 (252)
T ss_pred CceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHH---H-HcCCCC---------CCcccCCHH
Confidence 3467999999998889999999999999999998 8888854433221111 1 111000 111122345
Q ss_pred HHHHHHHhhcCCCCCCCCHHHHHHHhc
Q 004400 658 MINVALLCANASPTIRPSMSSVLRMLE 684 (756)
Q Consensus 658 l~~l~~~c~~~~P~~RPt~~ev~~~L~ 684 (756)
+.+++.+|++.+|++||++.++.++|+
T Consensus 225 ~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 225 VYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred HHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 889999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-38 Score=325.24 Aligned_cols=254 Identities=29% Similarity=0.452 Sum_probs=205.4
Q ss_pred hcCccccCcccCCCCccEEEeeccCCcEEEEEEccccCcccHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEEec
Q 004400 415 TNNFATDNNIGEGGFGPVYKGLLADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYEYL 494 (756)
Q Consensus 415 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~ 494 (756)
.++|...+.||+|+||.||+|...++..||+|.+.... ...+.+.+|++++++++||||+++++++. +...++||||+
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~ 82 (262)
T cd05071 5 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYM 82 (262)
T ss_pred hHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCc-cCHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEEcC
Confidence 35688999999999999999997777789999997532 34467899999999999999999999875 45689999999
Q ss_pred CCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCcccCcce
Q 004400 495 ENNSLARALFEH-RLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHI 573 (756)
Q Consensus 495 ~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~~~~~~ 573 (756)
++|+|.+++... ...+++..+..++.|++.||+|||+.+ ++||||||+||++++++.+||+|||.++.........
T Consensus 83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~~ 159 (262)
T cd05071 83 SKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTA 159 (262)
T ss_pred CCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcccEEEcCCCcEEeccCCceeecccccccc
Confidence 999999999753 346899999999999999999999986 9999999999999999999999999998655433322
Q ss_pred eeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHh-CCCCCCccchhhHHHHHHHHHhcCccccccccCCCCCCCH
Q 004400 574 STRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVS-GRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDK 652 (756)
Q Consensus 574 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 652 (756)
.....++..|+|||+..+..++.++||||||+++||+++ |+.||.......... .. ..... ...+.
T Consensus 160 ~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~---~~-~~~~~---------~~~~~ 226 (262)
T cd05071 160 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLD---QV-ERGYR---------MPCPP 226 (262)
T ss_pred ccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHH---HH-hcCCC---------CCCcc
Confidence 233456778999999988899999999999999999999 788886543322211 01 11100 01122
Q ss_pred HHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhccC
Q 004400 653 EQVMVMINVALLCANASPTIRPSMSSVLRMLECG 686 (756)
Q Consensus 653 ~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~L~~~ 686 (756)
+.+..+.+++.+|++.+|++||++.++++.|+.+
T Consensus 227 ~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~ 260 (262)
T cd05071 227 ECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 260 (262)
T ss_pred ccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence 3344588999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-39 Score=332.85 Aligned_cols=261 Identities=28% Similarity=0.439 Sum_probs=212.9
Q ss_pred cCccccCcccCCCCccEEEeeccCCcEEEEEEccccC-cccHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEEec
Q 004400 416 NNFATDNNIGEGGFGPVYKGLLADGTAIAVKQLSSKS-KQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYEYL 494 (756)
Q Consensus 416 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~ 494 (756)
....+.++||+|-||.|..+....+..||||.++... +....+|.+|+++|.+++|||||+++|+|..++.+++|+|||
T Consensus 538 s~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EYm 617 (807)
T KOG1094|consen 538 SRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEYM 617 (807)
T ss_pred hheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHHH
Confidence 4456778999999999999999888999999998764 344588999999999999999999999999999999999999
Q ss_pred CCCCHHHHHHhcCCC-CCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCcc-cCcc
Q 004400 495 ENNSLARALFEHRLK-LDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEE-ENTH 572 (756)
Q Consensus 495 ~~gsL~~~l~~~~~~-l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~-~~~~ 572 (756)
++|+|.+++.++... ..-....+|+.|||.||+||.+. ++|||||.+.|+|+|.++++||+|||++|-.-. +...
T Consensus 618 EnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~---nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy~ 694 (807)
T KOG1094|consen 618 ENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESL---NFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYYR 694 (807)
T ss_pred hcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhh---chhhccccccceeecCcccEEecCcccccccccCCcee
Confidence 999999999876433 35566788999999999999987 599999999999999999999999999995443 3333
Q ss_pred eeeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHh--CCCCCCccchhhHHHHHHHHHhcCccccccccCCCCCC
Q 004400 573 ISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVS--GRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNF 650 (756)
Q Consensus 573 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt--g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 650 (756)
...+.+-+++|||||.+.-++++.++|||+||+.+||+++ ...||.........+-...+.........+..
T Consensus 695 vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~~~~~l~~------ 768 (807)
T KOG1094|consen 695 VQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQGRQVVLSR------ 768 (807)
T ss_pred eecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCCcceeccC------
Confidence 4445667889999999999999999999999999999875 77888655444444433333333322222221
Q ss_pred CHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhcc
Q 004400 651 DKEQVMVMINVALLCANASPTIRPSMSSVLRMLEC 685 (756)
Q Consensus 651 ~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~L~~ 685 (756)
++.++..+.+++.+||..|-++||+++++...|.+
T Consensus 769 P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~ 803 (807)
T KOG1094|consen 769 PPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQE 803 (807)
T ss_pred CCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHH
Confidence 22233458899999999999999999999988864
|
|
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-39 Score=345.60 Aligned_cols=252 Identities=23% Similarity=0.316 Sum_probs=204.6
Q ss_pred cCccccCcccCCCCccEEEeec-cCCcEEEEEEccccC---cccHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEE
Q 004400 416 NNFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSKS---KQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIY 491 (756)
Q Consensus 416 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 491 (756)
++|...+.||+|+||.||+|+. .+++.||||++.... ......+.+|+++++.++||||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 3688899999999999999995 478999999987532 234467889999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCcccC-
Q 004400 492 EYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEEN- 570 (756)
Q Consensus 492 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~~~- 570 (756)
||+++|+|.+++... ..+++..+..++.||+.||+|||+.| |+||||||+||+++.++.+||+|||+++......
T Consensus 81 e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~g---iiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~ 156 (350)
T cd05573 81 EYMPGGDLMNLLIRK-DVFPEETARFYIAELVLALDSVHKLG---FIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKD 156 (350)
T ss_pred cCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEeecCCCCccCcccCc
Confidence 999999999999765 57899999999999999999999986 9999999999999999999999999998654432
Q ss_pred ---------------------------cceeeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHhCCCCCCccchh
Q 004400 571 ---------------------------THISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMF 623 (756)
Q Consensus 571 ---------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~ 623 (756)
........||+.|+|||++.+..++.++|||||||++|||++|+.||...+..
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~ 236 (350)
T cd05573 157 REYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQ 236 (350)
T ss_pred ccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCHH
Confidence 11223456999999999999999999999999999999999999999766533
Q ss_pred hHHHHHHHHHhcCccccccccCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCC-HHHHHHH
Q 004400 624 YLLDWALVLKEQGKLMELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPS-MSSVLRM 682 (756)
Q Consensus 624 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt-~~ev~~~ 682 (756)
.... . +.......... ....+ ...+.+++.+|+. +|.+||+ +.++++.
T Consensus 237 ~~~~--~-i~~~~~~~~~p---~~~~~----~~~~~~li~~ll~-dp~~R~~s~~~ll~h 285 (350)
T cd05573 237 ETYN--K-IINWKESLRFP---PDPPV----SPEAIDLICRLLC-DPEDRLGSFEEIKSH 285 (350)
T ss_pred HHHH--H-HhccCCcccCC---CCCCC----CHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence 2211 1 11100000110 01112 3348889999997 9999999 9999874
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=340.25 Aligned_cols=261 Identities=22% Similarity=0.376 Sum_probs=197.7
Q ss_pred CccccCcccCCCCccEEEee-ccCCcEEEEEEcccc--CcccHHHHHHHHHHHHhCCCCceeeEeeEEEeC-----CeEE
Q 004400 417 NFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSK--SKQGNREFINEIGMISALQHPNLVKLYGCCIEG-----NQLL 488 (756)
Q Consensus 417 ~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~~~ 488 (756)
+|+..+.||+|+||.||+|+ ..+++.||||.+... .......+.+|++++++++||||+++++++... ...+
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 47788999999999999999 457899999998643 223345688999999999999999999998643 3589
Q ss_pred EEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCcc
Q 004400 489 LIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEE 568 (756)
Q Consensus 489 lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~ 568 (756)
+||||+. ++|.+++... ..+++..+..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 81 lv~e~~~-~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~ 155 (338)
T cd07859 81 VVFELME-SDLHQVIKAN-DDLTPEHHQFFLYQLLRALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARVAFN 155 (338)
T ss_pred EEEecCC-CCHHHHHHhc-ccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEccCcccccccc
Confidence 9999995 6898888654 36899999999999999999999997 99999999999999999999999999985432
Q ss_pred cCc--ceeeccccCccCCchHhhhc--CCCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhcC--------
Q 004400 569 ENT--HISTRVAGTIGYMAPEYAMR--GHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQG-------- 636 (756)
Q Consensus 569 ~~~--~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~-------- 636 (756)
... .......||..|+|||++.+ ..++.++|||||||++|||++|+.||...+...............
T Consensus 156 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i 235 (338)
T cd07859 156 DTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRV 235 (338)
T ss_pred ccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHh
Confidence 221 11234579999999999876 678999999999999999999999997655433222111110000
Q ss_pred ---c---cccccccCCCCCCC---HHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004400 637 ---K---LMELVDTNPGSNFD---KEQVMVMINVALLCANASPTIRPSMSSVLRM 682 (756)
Q Consensus 637 ---~---~~~~~~~~~~~~~~---~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~ 682 (756)
. ....+.......+. +.....+.+++.+||+.+|++||+++|+++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h 290 (338)
T cd07859 236 RNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALAD 290 (338)
T ss_pred hhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 0 00000000000000 0112347899999999999999999999864
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-38 Score=328.85 Aligned_cols=255 Identities=27% Similarity=0.425 Sum_probs=202.9
Q ss_pred cCccccCcccCCCCccEEEeec-cCCc----EEEEEEccccCc-ccHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEE
Q 004400 416 NNFATDNNIGEGGFGPVYKGLL-ADGT----AIAVKQLSSKSK-QGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLL 489 (756)
Q Consensus 416 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~----~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 489 (756)
++|...+.||+|+||.||+|.+ .+++ .|++|.+..... ....++..|+.++++++||||+++++++. +...++
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~~~~~~ 85 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-GASLQL 85 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-CCccEE
Confidence 4778889999999999999985 3454 477787754322 23356778888999999999999999875 456789
Q ss_pred EEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCccc
Q 004400 490 IYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEE 569 (756)
Q Consensus 490 V~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~~ 569 (756)
|+||+++|+|.+++......+++..+..++.||+.||+|||+.+ ++||||||+||++++++.+||+|||+++.....
T Consensus 86 i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~~ 162 (279)
T cd05111 86 VTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLYPD 162 (279)
T ss_pred EEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEEcCCccceeccCC
Confidence 99999999999999877778999999999999999999999986 999999999999999999999999999865433
Q ss_pred Ccc-eeeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHh-CCCCCCccchhhHHHHHHHHHhcCccccccccCCC
Q 004400 570 NTH-ISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVS-GRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPG 647 (756)
Q Consensus 570 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 647 (756)
... ......++..|+|||.+.++.++.++|||||||++||+++ |+.||.........+.. ..+......
T Consensus 163 ~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~----~~~~~~~~~----- 233 (279)
T cd05111 163 DKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLL----EKGERLAQP----- 233 (279)
T ss_pred CcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH----HCCCcCCCC-----
Confidence 222 2234557789999999998899999999999999999998 99999665443332221 222211110
Q ss_pred CCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhccCc
Q 004400 648 SNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLECGV 687 (756)
Q Consensus 648 ~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~L~~~~ 687 (756)
...+ ..+.+++.+||..+|.+||++.|+++.|+.+.
T Consensus 234 ~~~~----~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~ 269 (279)
T cd05111 234 QICT----IDVYMVMVKCWMIDENVRPTFKELANEFTRMA 269 (279)
T ss_pred CCCC----HHHHHHHHHHcCCCcccCcCHHHHHHHHHHHH
Confidence 1112 23678899999999999999999999988654
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=345.88 Aligned_cols=255 Identities=18% Similarity=0.249 Sum_probs=204.3
Q ss_pred HhhcCccccCcccCCCCccEEEeec-cCCcEEEEEEcccc---CcccHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEE
Q 004400 413 AATNNFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSK---SKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLL 488 (756)
Q Consensus 413 ~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 488 (756)
...++|+..+.||+|+||.||+|+. .+++.||+|.+... .......+.+|+.+++.++||||+++++++.+++..+
T Consensus 40 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~ 119 (370)
T cd05596 40 MKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLY 119 (370)
T ss_pred CCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEE
Confidence 3567899999999999999999994 57889999998643 2223355788999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCcc
Q 004400 489 LIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEE 568 (756)
Q Consensus 489 lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~ 568 (756)
+||||+++|+|.+++... .+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 120 lv~Ey~~gg~L~~~l~~~--~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~ 194 (370)
T cd05596 120 MVMEYMPGGDLVNLMSNY--DIPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMDA 194 (370)
T ss_pred EEEcCCCCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEcCCCCEEEEeccceeeccC
Confidence 999999999999988653 5788899999999999999999986 99999999999999999999999999986544
Q ss_pred cCcceeeccccCccCCchHhhhcC----CCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhcCcccccccc
Q 004400 569 ENTHISTRVAGTIGYMAPEYAMRG----HLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDT 644 (756)
Q Consensus 569 ~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 644 (756)
..........||+.|+|||++.+. .++.++|||||||++|||++|+.||...+....... +..........+
T Consensus 195 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~---i~~~~~~~~~~~- 270 (370)
T cd05596 195 NGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSK---IMDHKNSLTFPD- 270 (370)
T ss_pred CCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHH---HHcCCCcCCCCC-
Confidence 333233446799999999998653 478999999999999999999999977654332211 111111111111
Q ss_pred CCCCCCCHHHHHHHHHHHHHhhcCCCCC--CCCHHHHHHH
Q 004400 645 NPGSNFDKEQVMVMINVALLCANASPTI--RPSMSSVLRM 682 (756)
Q Consensus 645 ~~~~~~~~~~~~~l~~l~~~c~~~~P~~--RPt~~ev~~~ 682 (756)
... ....+.+++.+|++.+|.+ ||++.|+++.
T Consensus 271 --~~~----~s~~~~~li~~~L~~~p~r~~R~s~~ell~h 304 (370)
T cd05596 271 --DIE----ISKQAKDLICAFLTDREVRLGRNGVDEIKSH 304 (370)
T ss_pred --cCC----CCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence 011 2334888999999999988 9999999765
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=338.58 Aligned_cols=242 Identities=27% Similarity=0.382 Sum_probs=195.7
Q ss_pred CcccCCCCccEEEeec----cCCcEEEEEEccccC----cccHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEEe
Q 004400 422 NNIGEGGFGPVYKGLL----ADGTAIAVKQLSSKS----KQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYEY 493 (756)
Q Consensus 422 ~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 493 (756)
+.||+|+||.||+++. .+++.||+|.++... ......+.+|+++++.++||||++++++|.+++..++||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 6799999999999984 357899999986531 22335678899999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCcccCcce
Q 004400 494 LENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHI 573 (756)
Q Consensus 494 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~~~~~~ 573 (756)
+++|+|.+++... ..+.+..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++....... .
T Consensus 82 ~~~~~L~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~ 156 (323)
T cd05584 82 LSGGELFMHLERE-GIFMEDTACFYLSEISLALEHLHQQG---IIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGT-V 156 (323)
T ss_pred CCCchHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEeeCcCCeecccCCC-c
Confidence 9999999998654 36788899999999999999999986 99999999999999999999999999874332222 2
Q ss_pred eeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhcCccccccccCCCCCCCHH
Q 004400 574 STRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDKE 653 (756)
Q Consensus 574 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 653 (756)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||...+....... ... +. .. .+..
T Consensus 157 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~---~~~-~~-~~---------~~~~ 222 (323)
T cd05584 157 THTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDK---ILK-GK-LN---------LPPY 222 (323)
T ss_pred ccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHH---HHc-CC-CC---------CCCC
Confidence 2345799999999999988899999999999999999999999976554322211 111 11 01 1111
Q ss_pred HHHHHHHHHHHhhcCCCCCCC-----CHHHHHHH
Q 004400 654 QVMVMINVALLCANASPTIRP-----SMSSVLRM 682 (756)
Q Consensus 654 ~~~~l~~l~~~c~~~~P~~RP-----t~~ev~~~ 682 (756)
....+.+++.+|++.+|++|| ++.++++.
T Consensus 223 ~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h 256 (323)
T cd05584 223 LTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSH 256 (323)
T ss_pred CCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcC
Confidence 223488999999999999999 78887663
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-38 Score=343.21 Aligned_cols=256 Identities=22% Similarity=0.284 Sum_probs=197.8
Q ss_pred hcCccccCcccCCCCccEEEee-ccCCcEEEEEEccccCcccHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEEe
Q 004400 415 TNNFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYEY 493 (756)
Q Consensus 415 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 493 (756)
.++|...+.||+|+||.||+|. ..+++.||+|.... ..+.+|++++++++|||||+++++|..+...++|+|+
T Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~ 164 (391)
T PHA03212 91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR------GGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPR 164 (391)
T ss_pred cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh------hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEec
Confidence 4679999999999999999999 46789999997532 3567899999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCcccCcce
Q 004400 494 LENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHI 573 (756)
Q Consensus 494 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~~~~~~ 573 (756)
+. ++|..++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+|+.........
T Consensus 165 ~~-~~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~ylH~~~---IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~~~ 239 (391)
T PHA03212 165 YK-TDLYCYLAAK-RNIAICDILAIERSVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANK 239 (391)
T ss_pred CC-CCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHhEEEcCCCCEEEEeCCcccccccccccc
Confidence 95 6888888654 46899999999999999999999986 9999999999999999999999999997543322223
Q ss_pred eeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHhCCCCCCccchhh-----HHHHHHHHHhcCcc----------
Q 004400 574 STRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFY-----LLDWALVLKEQGKL---------- 638 (756)
Q Consensus 574 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~-----~~~~~~~~~~~~~~---------- 638 (756)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||....... ...........+..
T Consensus 240 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~~ 319 (391)
T PHA03212 240 YYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQA 319 (391)
T ss_pred cccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcchhH
Confidence 344679999999999998899999999999999999999998875432110 00000000000000
Q ss_pred --c-------cccccCCCCC--C--CHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 004400 639 --M-------ELVDTNPGSN--F--DKEQVMVMINVALLCANASPTIRPSMSSVLR 681 (756)
Q Consensus 639 --~-------~~~~~~~~~~--~--~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~ 681 (756)
. ......+... + .......+.+++.+|++.||++|||+.|+++
T Consensus 320 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~ 375 (391)
T PHA03212 320 NLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLD 375 (391)
T ss_pred HHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhc
Confidence 0 0000000000 0 0122446889999999999999999999985
|
|
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=343.54 Aligned_cols=257 Identities=19% Similarity=0.288 Sum_probs=202.7
Q ss_pred HHHhhcCccccCcccCCCCccEEEeec-cCCcEEEEEEcccc---CcccHHHHHHHHHHHHhCCCCceeeEeeEEEeCCe
Q 004400 411 IKAATNNFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSK---SKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQ 486 (756)
Q Consensus 411 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 486 (756)
+....++|+..+.||+|+||.||+|+. .+++.||+|.+.+. .......+.+|+.+++.++||||+++++++.+++.
T Consensus 38 ~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~ 117 (370)
T cd05621 38 LQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKY 117 (370)
T ss_pred cCCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCE
Confidence 344567899999999999999999995 46889999998642 22234567889999999999999999999999999
Q ss_pred EEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccC
Q 004400 487 LLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLD 566 (756)
Q Consensus 487 ~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~ 566 (756)
.++||||+++|+|.+++... .+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++..
T Consensus 118 ~~lv~Ey~~gg~L~~~l~~~--~~~~~~~~~~~~qil~aL~~LH~~~---IvHrDLKp~NILl~~~~~~kL~DFG~a~~~ 192 (370)
T cd05621 118 LYMVMEYMPGGDLVNLMSNY--DVPEKWAKFYTAEVVLALDAIHSMG---LIHRDVKPDNMLLDKHGHLKLADFGTCMKM 192 (370)
T ss_pred EEEEEcCCCCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEEecccceec
Confidence 99999999999999998643 5889999999999999999999986 999999999999999999999999999865
Q ss_pred cccCcceeeccccCccCCchHhhhcC----CCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhcCcccccc
Q 004400 567 EEENTHISTRVAGTIGYMAPEYAMRG----HLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELV 642 (756)
Q Consensus 567 ~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 642 (756)
............||+.|+|||++.+. .++.++||||+||++|||++|+.||...+...... . ...........
T Consensus 193 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~--~-i~~~~~~~~~p 269 (370)
T cd05621 193 DETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYS--K-IMDHKNSLNFP 269 (370)
T ss_pred ccCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHH--H-HHhCCcccCCC
Confidence 44333233456799999999999764 37889999999999999999999997665433221 1 11111111111
Q ss_pred ccCCCCCCCHHHHHHHHHHHHHhhcCCCCC--CCCHHHHHHH
Q 004400 643 DTNPGSNFDKEQVMVMINVALLCANASPTI--RPSMSSVLRM 682 (756)
Q Consensus 643 ~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~--RPt~~ev~~~ 682 (756)
. .......+.+++..|+..++.+ ||++.|+++.
T Consensus 270 ~-------~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h 304 (370)
T cd05621 270 E-------DVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH 304 (370)
T ss_pred C-------cccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence 0 0112334778888899755543 8899999875
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-38 Score=324.08 Aligned_cols=253 Identities=31% Similarity=0.484 Sum_probs=206.6
Q ss_pred hcCccccCcccCCCCccEEEeeccCCcEEEEEEccccCcccHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEEec
Q 004400 415 TNNFATDNNIGEGGFGPVYKGLLADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYEYL 494 (756)
Q Consensus 415 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~ 494 (756)
.++|...+.||+|+||.||+|...+++.||+|.+.... .....+.+|+.++++++|+||+++++++. ++..++||||+
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~ 82 (260)
T cd05067 5 RETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGS-MSPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEYM 82 (260)
T ss_pred hHHceeeeeeccCccceEEeeecCCCceEEEEEecCCC-CcHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEcC
Confidence 35788889999999999999998889999999987543 34568899999999999999999999874 56789999999
Q ss_pred CCCCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCcccCcce
Q 004400 495 ENNSLARALFE-HRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHI 573 (756)
Q Consensus 495 ~~gsL~~~l~~-~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~~~~~~ 573 (756)
.+|+|.+++.. ....+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.++|+|||++..........
T Consensus 83 ~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~ 159 (260)
T cd05067 83 ENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKN---YIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTA 159 (260)
T ss_pred CCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHHhEEEcCCCCEEEccCcceeecCCCCccc
Confidence 99999999874 3457899999999999999999999986 9999999999999999999999999998655333222
Q ss_pred eeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHh-CCCCCCccchhhHHHHHHHHHhcCccccccccCCCCCCCH
Q 004400 574 STRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVS-GRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDK 652 (756)
Q Consensus 574 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 652 (756)
.....++..|+|||++....++.++||||||+++||+++ |+.||...+........ . ....... ....
T Consensus 160 ~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~---~-~~~~~~~-----~~~~-- 228 (260)
T cd05067 160 REGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNL---E-RGYRMPR-----PDNC-- 228 (260)
T ss_pred ccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHH---H-cCCCCCC-----CCCC--
Confidence 233456788999999988889999999999999999999 99999665543332211 1 1111111 1112
Q ss_pred HHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhcc
Q 004400 653 EQVMVMINVALLCANASPTIRPSMSSVLRMLEC 685 (756)
Q Consensus 653 ~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~L~~ 685 (756)
...+.+++.+|++.+|++||+++++++.|+.
T Consensus 229 --~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 229 --PEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred --CHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 2348999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=315.95 Aligned_cols=272 Identities=24% Similarity=0.354 Sum_probs=208.3
Q ss_pred hcCccccCcccCCCCccEEEee-ccCCcEEEEEEcccc--CcccHHHHHHHHHHHHhCCCCceeeEeeEEEe-----CCe
Q 004400 415 TNNFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSK--SKQGNREFINEIGMISALQHPNLVKLYGCCIE-----GNQ 486 (756)
Q Consensus 415 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-----~~~ 486 (756)
...|...+.||+|+||.|..|. ..+|..||||++... .....++..+|+..|+.++|+||+.+++.+.. -..
T Consensus 21 ~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~D 100 (359)
T KOG0660|consen 21 PRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFND 100 (359)
T ss_pred cceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccce
Confidence 4456667899999999999999 568899999999743 44456788999999999999999999999875 357
Q ss_pred EEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccC
Q 004400 487 LLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLD 566 (756)
Q Consensus 487 ~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~ 566 (756)
+|+|+|+| +.+|...++.. ..++...+..++.|+++||+|+|+.+ |+|||+||+|++++.+..+||+|||+|+..
T Consensus 101 vYiV~elM-etDL~~iik~~-~~L~d~H~q~f~YQiLrgLKyiHSAn---ViHRDLKPsNll~n~~c~lKI~DFGLAR~~ 175 (359)
T KOG0660|consen 101 VYLVFELM-ETDLHQIIKSQ-QDLTDDHAQYFLYQILRGLKYIHSAN---VIHRDLKPSNLLLNADCDLKICDFGLARYL 175 (359)
T ss_pred eEEehhHH-hhHHHHHHHcC-ccccHHHHHHHHHHHHHhcchhhccc---ccccccchhheeeccCCCEEeccccceeec
Confidence 89999999 55888888644 46999999999999999999999986 999999999999999999999999999977
Q ss_pred cccC-cceeeccccCccCCchHhhhc-CCCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhc---------
Q 004400 567 EEEN-THISTRVAGTIGYMAPEYAMR-GHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQ--------- 635 (756)
Q Consensus 567 ~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~--------- 635 (756)
.... ....+..+-|.+|.|||++.. ..|+.+.||||.|||+.||++|+.-|.+.+......-.......
T Consensus 176 ~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i 255 (359)
T KOG0660|consen 176 DKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKI 255 (359)
T ss_pred cccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHh
Confidence 5431 112345678999999999875 57999999999999999999999999777654433221111110
Q ss_pred --Ccccccc---ccCCCCCC---CHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH--hccCccccc
Q 004400 636 --GKLMELV---DTNPGSNF---DKEQVMVMINVALLCANASPTIRPSMSSVLRM--LECGVDVLD 691 (756)
Q Consensus 636 --~~~~~~~---~~~~~~~~---~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~--L~~~~~~~~ 691 (756)
......+ ...+...+ -+......++++.+++..||.+|+|++|.++. |+.+-+..+
T Consensus 256 ~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~hdp~d 321 (359)
T KOG0660|consen 256 RSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPYHDPED 321 (359)
T ss_pred ccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhhcCCcc
Confidence 0000011 11111111 11222357899999999999999999999864 555544443
|
|
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-38 Score=348.49 Aligned_cols=260 Identities=22% Similarity=0.284 Sum_probs=211.7
Q ss_pred hhcCccccCcccCCCCccEEEeeccCC-cEEEEEEccccCcccHHHHHHHHHHHHhCC-CCceeeEeeEE-Ee------C
Q 004400 414 ATNNFATDNNIGEGGFGPVYKGLLADG-TAIAVKQLSSKSKQGNREFINEIGMISALQ-HPNLVKLYGCC-IE------G 484 (756)
Q Consensus 414 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~-~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~-~~------~ 484 (756)
...++++.+.|.+|||+.||.|....+ ..||+|++-.......+...+|+++|++|+ |+|||.+++.. .. .
T Consensus 35 g~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~ 114 (738)
T KOG1989|consen 35 GSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGV 114 (738)
T ss_pred CCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCce
Confidence 455677889999999999999996555 999999998777777888999999999996 99999999942 21 2
Q ss_pred CeEEEEEEecCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCcc
Q 004400 485 NQLLLIYEYLENNSLARALFEH-RLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLA 563 (756)
Q Consensus 485 ~~~~lV~e~~~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla 563 (756)
.+++|.||||.||.|-|++... ...|++.++++|+.++++|+++||.. .++|||||||-+||||+.++..||||||.|
T Consensus 115 ~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~KLCDFGSa 193 (738)
T KOG1989|consen 115 WEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNYKLCDFGSA 193 (738)
T ss_pred eEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCCEEeCccccc
Confidence 4689999999999999999732 33599999999999999999999998 578999999999999999999999999999
Q ss_pred ccCcccCcce--------eeccccCccCCchHhhh---cCCCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHH
Q 004400 564 KLDEEENTHI--------STRVAGTIGYMAPEYAM---RGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVL 632 (756)
Q Consensus 564 ~~~~~~~~~~--------~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~ 632 (756)
.-.-...... .-...-|+.|+|||++. +..+++|+|||+|||+||-|+....||......
T Consensus 194 tt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~l--------- 264 (738)
T KOG1989|consen 194 TTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKL--------- 264 (738)
T ss_pred ccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcce---------
Confidence 7332211110 01134689999999984 567999999999999999999999999655322
Q ss_pred HhcCccccccccCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhccCcccc
Q 004400 633 KEQGKLMELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLECGVDVL 690 (756)
Q Consensus 633 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~L~~~~~~~ 690 (756)
.+++........+.+...|.+||..|++.+|.+||++-||+..+-.++...
T Consensus 265 -------aIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~~ 315 (738)
T KOG1989|consen 265 -------AILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANKP 315 (738)
T ss_pred -------eEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcCC
Confidence 233333322223456778999999999999999999999998887766544
|
|
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=345.59 Aligned_cols=252 Identities=22% Similarity=0.306 Sum_probs=200.6
Q ss_pred cCccccCcccCCCCccEEEeec-cCCcEEEEEEccccC---cccHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEE
Q 004400 416 NNFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSKS---KQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIY 491 (756)
Q Consensus 416 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 491 (756)
++|+..+.||+|+||.||+|+. .+++.||||++.... ......+.+|+.+++.++||||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 4788899999999999999994 578999999996531 233456788999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCcccCc
Q 004400 492 EYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENT 571 (756)
Q Consensus 492 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~~~~ 571 (756)
||+++|+|.+++.... .+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 81 E~~~~g~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~ 156 (364)
T cd05599 81 EYLPGGDMMTLLMKKD-TFTEEETRFYIAETILAIDSIHKLG---YIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHR 156 (364)
T ss_pred CCCCCcHHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEeecccceecccccc
Confidence 9999999999997544 6899999999999999999999997 99999999999999999999999999875422110
Q ss_pred c-------------------------------------eeeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHhCC
Q 004400 572 H-------------------------------------ISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGR 614 (756)
Q Consensus 572 ~-------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~ 614 (756)
. .....+||+.|+|||++.+..++.++|||||||++|||++|+
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~ 236 (364)
T cd05599 157 TEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGY 236 (364)
T ss_pred ccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCC
Confidence 0 011246999999999999989999999999999999999999
Q ss_pred CCCCccchhhHHHHHHHHHhcCccccccccCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCC---HHHHHHH
Q 004400 615 SNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPS---MSSVLRM 682 (756)
Q Consensus 615 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt---~~ev~~~ 682 (756)
.||...+........ ........... ...++ ..+.+++.+|+. +|.+|++ +.|+++.
T Consensus 237 ~Pf~~~~~~~~~~~i---~~~~~~~~~~~---~~~~s----~~~~~li~~ll~-~p~~R~~~~~~~~ll~h 296 (364)
T cd05599 237 PPFCSDNPQETYRKI---INWKETLQFPD---EVPLS----PEAKDLIKRLCC-EAERRLGNNGVNEIKSH 296 (364)
T ss_pred CCCCCCCHHHHHHHH---HcCCCccCCCC---CCCCC----HHHHHHHHHHcc-CHhhcCCCCCHHHHhcC
Confidence 999766543322211 11111111111 11122 347788889986 9999998 8888664
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-38 Score=328.71 Aligned_cols=255 Identities=25% Similarity=0.442 Sum_probs=203.7
Q ss_pred hhcCccccCcccCCCCccEEEeecc------CCcEEEEEEccccC-cccHHHHHHHHHHHHhCCCCceeeEeeEEEeCCe
Q 004400 414 ATNNFATDNNIGEGGFGPVYKGLLA------DGTAIAVKQLSSKS-KQGNREFINEIGMISALQHPNLVKLYGCCIEGNQ 486 (756)
Q Consensus 414 ~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 486 (756)
.+++|+..+.||+|+||.||+|... ++..||+|.+.... .....++.+|+.+++.++||||+++++++.++..
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~ 83 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP 83 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 4678999999999999999998743 35679999986432 2234568899999999999999999999999999
Q ss_pred EEEEEEecCCCCHHHHHHhcC---------CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEE
Q 004400 487 LLLIYEYLENNSLARALFEHR---------LKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKI 557 (756)
Q Consensus 487 ~~lV~e~~~~gsL~~~l~~~~---------~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl 557 (756)
.++||||+++|+|.+++.... ..+++..+..++.|++.||+|||+.+ ++||||||+||++++++.+||
T Consensus 84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~vH~dlkp~Nil~~~~~~~~l 160 (277)
T cd05062 84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKI 160 (277)
T ss_pred eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCcchheEEEcCCCCEEE
Confidence 999999999999999997432 23678899999999999999999986 999999999999999999999
Q ss_pred ccCCccccCcccCcc-eeeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHh-CCCCCCccchhhHHHHHHHHHhc
Q 004400 558 SDFGLAKLDEEENTH-ISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVS-GRSNVTKEDMFYLLDWALVLKEQ 635 (756)
Q Consensus 558 ~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 635 (756)
+|||+++........ ......+++.|+|||++.+..++.++|||||||++|||++ |..||............ ..
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~----~~ 236 (277)
T cd05062 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFV----ME 236 (277)
T ss_pred CCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH----Hc
Confidence 999999755432221 1122345788999999998889999999999999999999 68888655443322211 11
Q ss_pred CccccccccCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhc
Q 004400 636 GKLMELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLE 684 (756)
Q Consensus 636 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~L~ 684 (756)
...... +......+.+++.+|++.+|++||++.|+++.|+
T Consensus 237 ~~~~~~---------~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~ 276 (277)
T cd05062 237 GGLLDK---------PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 276 (277)
T ss_pred CCcCCC---------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhh
Confidence 111111 1112235889999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-38 Score=338.69 Aligned_cols=257 Identities=26% Similarity=0.423 Sum_probs=202.0
Q ss_pred hcCccccCcccCCCCccEEEeecc------CCcEEEEEEccccC-cccHHHHHHHHHHHHhC-CCCceeeEeeEEEe-CC
Q 004400 415 TNNFATDNNIGEGGFGPVYKGLLA------DGTAIAVKQLSSKS-KQGNREFINEIGMISAL-QHPNLVKLYGCCIE-GN 485 (756)
Q Consensus 415 ~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~-~~ 485 (756)
.++|++.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|++++.++ +|+||++++++|.. +.
T Consensus 6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~ 85 (337)
T cd05054 6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGG 85 (337)
T ss_pred HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCC
Confidence 357889999999999999999632 35789999987532 22345678899999999 89999999998865 46
Q ss_pred eEEEEEEecCCCCHHHHHHhcC----------------------------------------------------------
Q 004400 486 QLLLIYEYLENNSLARALFEHR---------------------------------------------------------- 507 (756)
Q Consensus 486 ~~~lV~e~~~~gsL~~~l~~~~---------------------------------------------------------- 507 (756)
..++||||+++|+|.+++....
T Consensus 86 ~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (337)
T cd05054 86 PLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDEL 165 (337)
T ss_pred CEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHH
Confidence 7899999999999999986421
Q ss_pred --CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCcccCcce-eeccccCccCC
Q 004400 508 --LKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHI-STRVAGTIGYM 584 (756)
Q Consensus 508 --~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~~~~~~-~~~~~gt~~y~ 584 (756)
..++|..+.+++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++......... .....++..|+
T Consensus 166 ~~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~ 242 (337)
T cd05054 166 YKEPLTLEDLISYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWM 242 (337)
T ss_pred hhcCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCcccc
Confidence 26799999999999999999999986 9999999999999999999999999998654332221 22345677899
Q ss_pred chHhhhcCCCCcccchhhHHHHHHHHHh-CCCCCCccchhhHHHHHHHHHhcCccccccccCCCCCCCHHHHHHHHHHHH
Q 004400 585 APEYAMRGHLTEKADVYSFGIVALEIVS-GRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDKEQVMVMINVAL 663 (756)
Q Consensus 585 aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~ 663 (756)
|||++.+..++.++|||||||++|||++ |+.||......... .... ........ +......+.+++.
T Consensus 243 aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~--~~~~-~~~~~~~~---------~~~~~~~~~~l~~ 310 (337)
T cd05054 243 APESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEF--CRRL-KEGTRMRA---------PEYATPEIYSIML 310 (337)
T ss_pred CcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHH--HHHH-hccCCCCC---------CccCCHHHHHHHH
Confidence 9999999999999999999999999998 99998653322111 1111 11111111 1112235889999
Q ss_pred HhhcCCCCCCCCHHHHHHHhccC
Q 004400 664 LCANASPTIRPSMSSVLRMLECG 686 (756)
Q Consensus 664 ~c~~~~P~~RPt~~ev~~~L~~~ 686 (756)
+||+.+|++||++.||++.|++.
T Consensus 311 ~cl~~~p~~RPs~~ell~~l~~~ 333 (337)
T cd05054 311 DCWHNNPEDRPTFSELVEILGDL 333 (337)
T ss_pred HHccCChhhCcCHHHHHHHHHHH
Confidence 99999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=341.94 Aligned_cols=248 Identities=26% Similarity=0.384 Sum_probs=193.4
Q ss_pred cCccccCcccCCCCccEEEeec-cCCcEEEEEEccccC-cccHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEEe
Q 004400 416 NNFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSKS-KQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYEY 493 (756)
Q Consensus 416 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 493 (756)
++|+..+.||+|+||.||+|+. .+++.||||.+.... ......+.+|+++++.++|+||+++++++.+++..++||||
T Consensus 74 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 153 (353)
T PLN00034 74 SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEF 153 (353)
T ss_pred HHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEec
Confidence 4566778999999999999994 578999999986542 23346788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCcccCcce
Q 004400 494 LENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHI 573 (756)
Q Consensus 494 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~~~~~~ 573 (756)
+++|+|.+. ...++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++....... .
T Consensus 154 ~~~~~L~~~-----~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~-~ 224 (353)
T PLN00034 154 MDGGSLEGT-----HIADEQFLADVARQILSGIAYLHRRH---IVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMD-P 224 (353)
T ss_pred CCCCccccc-----ccCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEcccccceecccccc-c
Confidence 999998643 24567788899999999999999986 99999999999999999999999999986543221 1
Q ss_pred eeccccCccCCchHhhhc-----CCCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhcCccccccccCCCC
Q 004400 574 STRVAGTIGYMAPEYAMR-----GHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGS 648 (756)
Q Consensus 574 ~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 648 (756)
.....||..|+|||++.. ...+.++|||||||++|||++|+.||...... +|.......... . ..
T Consensus 225 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~---~~~~~~~~~~~~-~--~~---- 294 (353)
T PLN00034 225 CNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQG---DWASLMCAICMS-Q--PP---- 294 (353)
T ss_pred ccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCc---cHHHHHHHHhcc-C--CC----
Confidence 233579999999998743 23456899999999999999999999633221 121111110000 0 00
Q ss_pred CCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004400 649 NFDKEQVMVMINVALLCANASPTIRPSMSSVLRM 682 (756)
Q Consensus 649 ~~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~ 682 (756)
.........+.+++.+||+.||++||++.|+++.
T Consensus 295 ~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h 328 (353)
T PLN00034 295 EAPATASREFRHFISCCLQREPAKRWSAMQLLQH 328 (353)
T ss_pred CCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0111223348899999999999999999999874
|
|
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-38 Score=333.68 Aligned_cols=238 Identities=27% Similarity=0.380 Sum_probs=191.2
Q ss_pred CcccCCCCccEEEeec-cCCcEEEEEEccccC---cccHHHHHHHHHHHHhC-CCCceeeEeeEEEeCCeEEEEEEecCC
Q 004400 422 NNIGEGGFGPVYKGLL-ADGTAIAVKQLSSKS---KQGNREFINEIGMISAL-QHPNLVKLYGCCIEGNQLLLIYEYLEN 496 (756)
Q Consensus 422 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~e~~~~ 496 (756)
+.||+|+||.||+|.. .+++.||+|.++... ....+.+..|..++... +||||+++++++..++..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 4699999999999995 568899999987532 22334556677777654 899999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCcccCcceeec
Q 004400 497 NSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTR 576 (756)
Q Consensus 497 gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~ 576 (756)
|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++...... .....
T Consensus 81 g~L~~~~~~~-~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~-~~~~~ 155 (316)
T cd05592 81 GDLMFHIQSS-GRFDEARARFYAAEIICGLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE-GKAST 155 (316)
T ss_pred CcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC-Ccccc
Confidence 9999998654 37899999999999999999999986 9999999999999999999999999997543222 22334
Q ss_pred cccCccCCchHhhhcCCCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhcCccccccccCCCCCCCHHHHH
Q 004400 577 VAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDKEQVM 656 (756)
Q Consensus 577 ~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 656 (756)
..||+.|+|||++.+..++.++|||||||++|||++|+.||...+....... ... .. . .++.....
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~---i~~--~~-----~----~~~~~~~~ 221 (316)
T cd05592 156 FCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDS---ILN--DR-----P----HFPRWISK 221 (316)
T ss_pred ccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHH---HHc--CC-----C----CCCCCCCH
Confidence 6799999999999988899999999999999999999999976654332221 111 00 0 01111223
Q ss_pred HHHHHHHHhhcCCCCCCCCHHH
Q 004400 657 VMINVALLCANASPTIRPSMSS 678 (756)
Q Consensus 657 ~l~~l~~~c~~~~P~~RPt~~e 678 (756)
.+.+++.+||+.+|++||++.+
T Consensus 222 ~~~~ll~~~l~~~P~~R~~~~~ 243 (316)
T cd05592 222 EAKDCLSKLFERDPTKRLGVDG 243 (316)
T ss_pred HHHHHHHHHccCCHHHcCCChH
Confidence 4788999999999999999764
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-38 Score=329.34 Aligned_cols=264 Identities=29% Similarity=0.388 Sum_probs=200.8
Q ss_pred ccccCcccCCCCccEEEee-----ccCCcEEEEEEccccC-cccHHHHHHHHHHHHhCCCCceeeEeeEEEeC--CeEEE
Q 004400 418 FATDNNIGEGGFGPVYKGL-----LADGTAIAVKQLSSKS-KQGNREFINEIGMISALQHPNLVKLYGCCIEG--NQLLL 489 (756)
Q Consensus 418 ~~~~~~lg~G~~g~Vy~~~-----~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~l 489 (756)
|...+.||+|+||+||.+. ..+++.||+|.+.... ......+.+|++++++++||||+++++++... ...++
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (283)
T cd05080 6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQL 85 (283)
T ss_pred ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEE
Confidence 3778999999999998764 2467899999987543 23456788999999999999999999998763 46899
Q ss_pred EEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCccc
Q 004400 490 IYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEE 569 (756)
Q Consensus 490 V~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~~ 569 (756)
||||+++|+|.+++... .+++..+..++.|++.||+|||+.+ |+||||||+||++++++.+||+|||+++.....
T Consensus 86 v~e~~~~~~l~~~~~~~--~l~~~~~~~i~~~l~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~ 160 (283)
T cd05080 86 IMEYVPLGSLRDYLPKH--KLNLAQLLLFAQQICEGMAYLHSQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEG 160 (283)
T ss_pred EecCCCCCCHHHHHHHc--CCCHHHHHHHHHHHHHHHHHHHHCC---eeccccChheEEEcCCCcEEEeecccccccCCc
Confidence 99999999999998654 5899999999999999999999986 999999999999999999999999999865433
Q ss_pred Ccce--eeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHhCCCCCCccch--hhHHHHHHHHHhcCccccccccC
Q 004400 570 NTHI--STRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDM--FYLLDWALVLKEQGKLMELVDTN 645 (756)
Q Consensus 570 ~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~ 645 (756)
.... .....++..|+|||.+....++.++||||||+++|||++|+.|+..... .....+...........+..+..
T Consensus 161 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (283)
T cd05080 161 HEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLERG 240 (283)
T ss_pred chhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhhhhhcC
Confidence 2211 1223456679999999888899999999999999999999999843221 11111100000000111111111
Q ss_pred CCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhccC
Q 004400 646 PGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLECG 686 (756)
Q Consensus 646 ~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~L~~~ 686 (756)
.....+......+.+++.+||+.+|++||+++++++.|+++
T Consensus 241 ~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~ 281 (283)
T cd05080 241 MRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEM 281 (283)
T ss_pred CCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHh
Confidence 11111222334588999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-38 Score=329.21 Aligned_cols=254 Identities=29% Similarity=0.424 Sum_probs=203.0
Q ss_pred CccccCcccCCCCccEEEeecc------CCcEEEEEEccccCcc-cHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEE
Q 004400 417 NFATDNNIGEGGFGPVYKGLLA------DGTAIAVKQLSSKSKQ-GNREFINEIGMISALQHPNLVKLYGCCIEGNQLLL 489 (756)
Q Consensus 417 ~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 489 (756)
+|...+.||+|+||.||+|... +++.||+|.+...... ....+.+|+.+++.++||||+++++++.+.+..++
T Consensus 6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~ 85 (283)
T cd05091 6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSM 85 (283)
T ss_pred HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEE
Confidence 4667789999999999999853 3578999999754332 23568899999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHHhc---------------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCC
Q 004400 490 IYEYLENNSLARALFEH---------------RLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLN 554 (756)
Q Consensus 490 V~e~~~~gsL~~~l~~~---------------~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~ 554 (756)
++||+.+++|.+++... ...+++..+.+++.|++.||+|||+.| |+||||||+||++++++.
T Consensus 86 ~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~ 162 (283)
T cd05091 86 IFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH---VVHKDLATRNVLVFDKLN 162 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhheEecCCCc
Confidence 99999999999998522 234788999999999999999999987 999999999999999999
Q ss_pred EEEccCCccccCcccCc-ceeeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHh-CCCCCCccchhhHHHHHHHH
Q 004400 555 SKISDFGLAKLDEEENT-HISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVS-GRSNVTKEDMFYLLDWALVL 632 (756)
Q Consensus 555 ~kl~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~~~~~~~ 632 (756)
+||+|||+++....... .......+++.|+|||.+..+.++.++|||||||++|||++ |..||........... .
T Consensus 163 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~---i 239 (283)
T cd05091 163 VKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEM---I 239 (283)
T ss_pred eEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH---H
Confidence 99999999886543222 11223456789999999988889999999999999999998 8888865544332221 1
Q ss_pred HhcCccccccccCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhccC
Q 004400 633 KEQGKLMELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLECG 686 (756)
Q Consensus 633 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~L~~~ 686 (756)
....... .+......+.+++.+||+.+|.+||++.+|++.|+.|
T Consensus 240 -~~~~~~~---------~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~ 283 (283)
T cd05091 240 -RNRQVLP---------CPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRTW 283 (283)
T ss_pred -HcCCcCC---------CCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhCC
Confidence 1111111 1112234488999999999999999999999999854
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=323.46 Aligned_cols=256 Identities=28% Similarity=0.479 Sum_probs=206.3
Q ss_pred hcCccccCcccCCCCccEEEeecc-CC---cEEEEEEccccC-cccHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEE
Q 004400 415 TNNFATDNNIGEGGFGPVYKGLLA-DG---TAIAVKQLSSKS-KQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLL 489 (756)
Q Consensus 415 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~---~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 489 (756)
.++|+..+.||+|+||.||+|+.. ++ ..+|+|.+.... ....+.+.+|++++++++||||+++++++.+.+..++
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (268)
T cd05063 4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMI 83 (268)
T ss_pred hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEE
Confidence 357888899999999999999854 33 379999986542 3335678999999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCccc
Q 004400 490 IYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEE 569 (756)
Q Consensus 490 V~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~~ 569 (756)
||||+++++|.+++......+++..+..++.|++.|++|||+.+ ++||||||+||+++.++.+||+|||++......
T Consensus 84 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~ 160 (268)
T cd05063 84 ITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMN---YVHRDLAARNILVNSNLECKVSDFGLSRVLEDD 160 (268)
T ss_pred EEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEEcCCCcEEECCCccceecccc
Confidence 99999999999999876668999999999999999999999986 999999999999999999999999999865433
Q ss_pred Ccceee--ccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHh-CCCCCCccchhhHHHHHHHHHhcCccccccccCC
Q 004400 570 NTHIST--RVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVS-GRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNP 646 (756)
Q Consensus 570 ~~~~~~--~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 646 (756)
...... ....+..|+|||++....++.++|||||||++||+++ |+.||.......... ........ +
T Consensus 161 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~---~i~~~~~~-------~ 230 (268)
T cd05063 161 PEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMK---AINDGFRL-------P 230 (268)
T ss_pred cccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHH---HHhcCCCC-------C
Confidence 222111 1223567999999998889999999999999999997 999996554332221 11111110 0
Q ss_pred CCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhccC
Q 004400 647 GSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLECG 686 (756)
Q Consensus 647 ~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~L~~~ 686 (756)
........+.+++.+||+.+|++||++.+|++.|+++
T Consensus 231 ---~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 231 ---APMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred ---CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 0111233588999999999999999999999999854
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=321.02 Aligned_cols=247 Identities=26% Similarity=0.411 Sum_probs=197.2
Q ss_pred cccCCCCccEEEeecc---CCcEEEEEEccccCc-ccHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEEecCCCC
Q 004400 423 NIGEGGFGPVYKGLLA---DGTAIAVKQLSSKSK-QGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYEYLENNS 498 (756)
Q Consensus 423 ~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gs 498 (756)
.||+|+||.||+|.+. ++..||+|.+..... ...+.+.+|+.++++++||||+++++++. .+..++||||+++|+
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~ 80 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGP 80 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCC
Confidence 4899999999999753 456799999876532 23466899999999999999999999885 457899999999999
Q ss_pred HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCcccCcceee--c
Q 004400 499 LARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHIST--R 576 (756)
Q Consensus 499 L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~--~ 576 (756)
|.+++......+++..+.+++.|++.||+|||++| ++||||||+||+++.++.+||+|||+++........... .
T Consensus 81 L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 157 (257)
T cd05115 81 LNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKN---FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSA 157 (257)
T ss_pred HHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcC---eeecccchheEEEcCCCcEEeccCCccccccCCccceeccCC
Confidence 99999866668999999999999999999999986 999999999999999999999999999865433222111 1
Q ss_pred cccCccCCchHhhhcCCCCcccchhhHHHHHHHHHh-CCCCCCccchhhHHHHHHHHHhcCccccccccCCCCCCCHHHH
Q 004400 577 VAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVS-GRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDKEQV 655 (756)
Q Consensus 577 ~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 655 (756)
..++..|+|||.+....++.++|||||||++||+++ |+.||........... . ..+.... .+....
T Consensus 158 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~---~-~~~~~~~---------~~~~~~ 224 (257)
T cd05115 158 GKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSF---I-EQGKRLD---------CPAECP 224 (257)
T ss_pred CCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHH---H-HCCCCCC---------CCCCCC
Confidence 233578999999988889999999999999999996 9999965543332211 1 1111111 111223
Q ss_pred HHHHHHHHHhhcCCCCCCCCHHHHHHHhccC
Q 004400 656 MVMINVALLCANASPTIRPSMSSVLRMLECG 686 (756)
Q Consensus 656 ~~l~~l~~~c~~~~P~~RPt~~ev~~~L~~~ 686 (756)
..+.+++.+||..+|++||++.+|.+.|+.+
T Consensus 225 ~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 225 PEMYALMKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred HHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence 4588999999999999999999999998853
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=321.42 Aligned_cols=252 Identities=30% Similarity=0.464 Sum_probs=203.8
Q ss_pred cCccccCcccCCCCccEEEeeccCCcEEEEEEccccCcccHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEEecC
Q 004400 416 NNFATDNNIGEGGFGPVYKGLLADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYEYLE 495 (756)
Q Consensus 416 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~ 495 (756)
++|.....||+|+||.||+|...++..+|+|.+.... ...+.+.+|++++++++|||++++++++. .+..++||||++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~ 83 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFMG 83 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcCC
Confidence 4578889999999999999998777789999886532 34467899999999999999999999875 456899999999
Q ss_pred CCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCcccCccee
Q 004400 496 NNSLARALFEH-RLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHIS 574 (756)
Q Consensus 496 ~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~~~~~~~ 574 (756)
+|+|.+++... ...+++..+..++.|++.||+|||+.| ++||||||+||++++++.++|+|||+++..........
T Consensus 84 ~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~~~ 160 (260)
T cd05069 84 KGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMN---YIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTAR 160 (260)
T ss_pred CCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCeEEECCCccceEccCCccccc
Confidence 99999999753 345899999999999999999999986 99999999999999999999999999976543322222
Q ss_pred eccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHh-CCCCCCccchhhHHHHHHHHHhcCccccccccCCCCCCCHH
Q 004400 575 TRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVS-GRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDKE 653 (756)
Q Consensus 575 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 653 (756)
....++..|+|||...+..++.++||||||+++|||++ |+.||..........+. .. .... ..+..
T Consensus 161 ~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~---~~-~~~~---------~~~~~ 227 (260)
T cd05069 161 QGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQV---ER-GYRM---------PCPQG 227 (260)
T ss_pred CCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH---Hc-CCCC---------CCCcc
Confidence 23346778999999988889999999999999999999 89998665433322221 11 1100 11112
Q ss_pred HHHHHHHHHHHhhcCCCCCCCCHHHHHHHhcc
Q 004400 654 QVMVMINVALLCANASPTIRPSMSSVLRMLEC 685 (756)
Q Consensus 654 ~~~~l~~l~~~c~~~~P~~RPt~~ev~~~L~~ 685 (756)
.+..+.+++.+||+.+|++||++++|++.|+.
T Consensus 228 ~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 228 CPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred cCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 33458899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-38 Score=336.03 Aligned_cols=242 Identities=25% Similarity=0.316 Sum_probs=196.3
Q ss_pred CcccCCCCccEEEee-ccCCcEEEEEEcccc---CcccHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEEecCCC
Q 004400 422 NNIGEGGFGPVYKGL-LADGTAIAVKQLSSK---SKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYEYLENN 497 (756)
Q Consensus 422 ~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~g 497 (756)
+.||+|+||.||+|. ..+++.||+|.+... .......+..|+++++.++||||+++++++.+++..++||||+++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 469999999999998 457899999998753 2233456788999999999999999999999999999999999999
Q ss_pred CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHc-CCCCCeEcCCCCCCceEecCCCCEEEccCCccccCcccCcceeec
Q 004400 498 SLARALFEHRLKLDWPTRRRICLGIARGLAYLHG-ESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTR 576 (756)
Q Consensus 498 sL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~-~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~ 576 (756)
+|.+++... ..+++..+..++.||+.||+|||+ .| |+||||||+|||++.++.+||+|||+++....... ....
T Consensus 81 ~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~lH~~~~---ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~-~~~~ 155 (325)
T cd05594 81 ELFFHLSRE-RVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA-TMKT 155 (325)
T ss_pred cHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCCCCeEEECCCCCEEEecCCCCeecCCCCc-cccc
Confidence 999888654 478999999999999999999997 55 99999999999999999999999999875332221 1234
Q ss_pred cccCccCCchHhhhcCCCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhcCccccccccCCCCCCCHHHHH
Q 004400 577 VAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDKEQVM 656 (756)
Q Consensus 577 ~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 656 (756)
..||+.|+|||++.+..++.++|||||||++|||++|+.||...+........ .. .. .. ....++ .
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i---~~-~~-~~-----~p~~~~----~ 221 (325)
T cd05594 156 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELI---LM-EE-IR-----FPRTLS----P 221 (325)
T ss_pred ccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHH---hc-CC-CC-----CCCCCC----H
Confidence 57999999999999989999999999999999999999999765543322211 00 00 00 111222 3
Q ss_pred HHHHHHHHhhcCCCCCCC-----CHHHHHHH
Q 004400 657 VMINVALLCANASPTIRP-----SMSSVLRM 682 (756)
Q Consensus 657 ~l~~l~~~c~~~~P~~RP-----t~~ev~~~ 682 (756)
.+.+++.+|++.||++|+ ++.++++.
T Consensus 222 ~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 252 (325)
T cd05594 222 EAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH 252 (325)
T ss_pred HHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence 488999999999999996 89998754
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-38 Score=328.02 Aligned_cols=251 Identities=24% Similarity=0.315 Sum_probs=200.7
Q ss_pred CccccCcccCCCCccEEEeec-cCCcEEEEEEccccC---cccHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEE
Q 004400 417 NFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSKS---KQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYE 492 (756)
Q Consensus 417 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 492 (756)
.|+..+.||+|+||.||++.. .+++.||+|.+.... ......+.+|+.++++++||||+++++++.+++..++|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 367788999999999999994 578999999986532 2223457889999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCcccCc
Q 004400 493 YLENNSLARALFEH-RLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENT 571 (756)
Q Consensus 493 ~~~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~~~~ 571 (756)
|+++|+|.+++... ...+++..+..++.|++.||+|||+.+ |+||||||+||++++++.++|+|||+++.......
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~ 157 (285)
T cd05605 81 LMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRER---IVYRDLKPENILLDDYGHIRISDLGLAVEIPEGET 157 (285)
T ss_pred ccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHEEECCCCCEEEeeCCCceecCCCCc
Confidence 99999999988653 346899999999999999999999987 99999999999999999999999999986543222
Q ss_pred ceeeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhcCccccccccCCCCCCC
Q 004400 572 HISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFD 651 (756)
Q Consensus 572 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 651 (756)
.....|+..|+|||++.+..++.++||||+||++||+++|+.||................... ...++
T Consensus 158 --~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~----------~~~~~ 225 (285)
T cd05605 158 --IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKED----------QEEYS 225 (285)
T ss_pred --cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhc----------ccccC
Confidence 123468999999999998889999999999999999999999997654322211111110000 01112
Q ss_pred HHHHHHHHHHHHHhhcCCCCCCC-----CHHHHHHH
Q 004400 652 KEQVMVMINVALLCANASPTIRP-----SMSSVLRM 682 (756)
Q Consensus 652 ~~~~~~l~~l~~~c~~~~P~~RP-----t~~ev~~~ 682 (756)
......+.+++.+||+.||.+|| ++.++++.
T Consensus 226 ~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05605 226 EKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAH 261 (285)
T ss_pred cccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence 22334588999999999999999 67776543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-38 Score=330.90 Aligned_cols=260 Identities=26% Similarity=0.423 Sum_probs=207.7
Q ss_pred HHhhcCccccCcccCCCCccEEEeecc------CCcEEEEEEcccc-CcccHHHHHHHHHHHHhC-CCCceeeEeeEEEe
Q 004400 412 KAATNNFATDNNIGEGGFGPVYKGLLA------DGTAIAVKQLSSK-SKQGNREFINEIGMISAL-QHPNLVKLYGCCIE 483 (756)
Q Consensus 412 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~ 483 (756)
+...++|+..+.||+|+||.||+|... ....+|+|.+... .......+.+|+++++++ +|+||+++++++..
T Consensus 8 ~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~ 87 (293)
T cd05053 8 ELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQ 87 (293)
T ss_pred ccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcC
Confidence 345567889999999999999999853 2368999998753 223345688999999999 89999999999999
Q ss_pred CCeEEEEEEecCCCCHHHHHHhc---------------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceE
Q 004400 484 GNQLLLIYEYLENNSLARALFEH---------------RLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVL 548 (756)
Q Consensus 484 ~~~~~lV~e~~~~gsL~~~l~~~---------------~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nil 548 (756)
++..++||||+++|+|.+++... ...+++..+++++.|++.||+|||+.+ |+||||||+||+
T Consensus 88 ~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~Nil 164 (293)
T cd05053 88 EGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK---CIHRDLAARNVL 164 (293)
T ss_pred CCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---ccccccceeeEE
Confidence 99999999999999999998632 346899999999999999999999886 999999999999
Q ss_pred ecCCCCEEEccCCccccCcccCcce-eeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHh-CCCCCCccchhhHH
Q 004400 549 LDKDLNSKISDFGLAKLDEEENTHI-STRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVS-GRSNVTKEDMFYLL 626 (756)
Q Consensus 549 l~~~~~~kl~DFGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~ 626 (756)
++.++.+||+|||+++......... .....++..|+|||++.+..++.++|||||||++||+++ |..||.........
T Consensus 165 ~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~ 244 (293)
T cd05053 165 VTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELF 244 (293)
T ss_pred EcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHHHH
Confidence 9999999999999998655432211 222345678999999988899999999999999999998 99998655433322
Q ss_pred HHHHHHHhcCccccccccCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhccCc
Q 004400 627 DWALVLKEQGKLMELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLECGV 687 (756)
Q Consensus 627 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~L~~~~ 687 (756)
... ....... .+......+.+++.+||+.+|++|||+.|+++.|+.+.
T Consensus 245 ~~~----~~~~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~ 292 (293)
T cd05053 245 KLL----KEGYRME---------KPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292 (293)
T ss_pred HHH----HcCCcCC---------CCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence 211 1111111 11122335889999999999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-38 Score=344.51 Aligned_cols=251 Identities=20% Similarity=0.284 Sum_probs=197.3
Q ss_pred CccccCcccCCCCccEEEee-ccCCcEEEEEEccccC---cccHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEE
Q 004400 417 NFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSKS---KQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYE 492 (756)
Q Consensus 417 ~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 492 (756)
+|+..+.||+|+||.||+|+ ..+++.||||.+.... ......+.+|++++++++||||+++++.+.+++..++|||
T Consensus 2 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E 81 (376)
T cd05598 2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (376)
T ss_pred CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEe
Confidence 68889999999999999999 4568999999986532 2234568899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCccc---
Q 004400 493 YLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEE--- 569 (756)
Q Consensus 493 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~~--- 569 (756)
|+++|+|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+|..+...
T Consensus 82 ~~~~g~L~~~i~~~-~~~~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~ 157 (376)
T cd05598 82 YIPGGDMMSLLIRL-GIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDS 157 (376)
T ss_pred CCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHEEECCCCCEEEEeCCCCccccccccc
Confidence 99999999999754 36889999999999999999999987 999999999999999999999999997532100
Q ss_pred ---------------------------------------CcceeeccccCccCCchHhhhcCCCCcccchhhHHHHHHHH
Q 004400 570 ---------------------------------------NTHISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEI 610 (756)
Q Consensus 570 ---------------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~el 610 (756)
.........||+.|+|||++.+..++.++|||||||++|||
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyel 237 (376)
T cd05598 158 KYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEM 237 (376)
T ss_pred cccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeeeh
Confidence 00001235799999999999998999999999999999999
Q ss_pred HhCCCCCCccchhhHHHHHHHHHhcCccccccccCCCCCCCHHHHHHHHHHHHHhhcCCCCCCC---CHHHHHHH
Q 004400 611 VSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDKEQVMVMINVALLCANASPTIRP---SMSSVLRM 682 (756)
Q Consensus 611 ltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RP---t~~ev~~~ 682 (756)
++|+.||...+....... .......... ......+. .+.+++.+|+ .+|.+|+ ++.|+++.
T Consensus 238 l~G~~Pf~~~~~~~~~~~---i~~~~~~~~~---~~~~~~s~----~~~~li~~l~-~~p~~R~~~~t~~ell~h 301 (376)
T cd05598 238 LVGQPPFLADTPAETQLK---VINWETTLHI---PSQAKLSR----EASDLILRLC-CGAEDRLGKNGADEIKAH 301 (376)
T ss_pred hhCCCCCCCCCHHHHHHH---HhccCccccC---CCCCCCCH----HHHHHHHHHh-cCHhhcCCCCCHHHHhCC
Confidence 999999976654322111 1110000011 11112233 3667777766 4999999 88888755
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-38 Score=344.13 Aligned_cols=252 Identities=22% Similarity=0.288 Sum_probs=198.2
Q ss_pred cCccccCcccCCCCccEEEee-ccCCcEEEEEEccccC---cccHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEE
Q 004400 416 NNFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSKS---KQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIY 491 (756)
Q Consensus 416 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 491 (756)
++|...+.||+|+||.||+|. ..+++.||||++.... ....+.+.+|++++++++|||||++++++.+++..|+||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 368888999999999999998 5578999999986532 223456788999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCcccCc
Q 004400 492 EYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENT 571 (756)
Q Consensus 492 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~~~~ 571 (756)
||+++|+|.+++... ..+++..+..++.|++.||+|||+.| |+||||||+|||++.++.+||+|||+++.......
T Consensus 81 E~~~gg~L~~~l~~~-~~~~~~~~~~~~~ql~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~ 156 (377)
T cd05629 81 EFLPGGDLMTMLIKY-DTFSEDVTRFYMAECVLAIEAVHKLG---FIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHD 156 (377)
T ss_pred eCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEEeecccccccccccc
Confidence 999999999999754 46899999999999999999999997 99999999999999999999999999963221000
Q ss_pred c----------------------------------------------eeeccccCccCCchHhhhcCCCCcccchhhHHH
Q 004400 572 H----------------------------------------------ISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGI 605 (756)
Q Consensus 572 ~----------------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv 605 (756)
. .....+||+.|+|||++.+..++.++|||||||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGv 236 (377)
T cd05629 157 SAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGA 236 (377)
T ss_pred cccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecch
Confidence 0 001246999999999999989999999999999
Q ss_pred HHHHHHhCCCCCCccchhhHHHHHHHHHhcCccccccccCCCCCCCHHHHHHHHHHHHHhhcCCCCCC---CCHHHHHHH
Q 004400 606 VALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDKEQVMVMINVALLCANASPTIR---PSMSSVLRM 682 (756)
Q Consensus 606 ~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~R---Pt~~ev~~~ 682 (756)
++|||++|+.||........... ...........+ ....+ ..+.+++.+|+. +|.+| +++.|+++.
T Consensus 237 il~elltG~~Pf~~~~~~~~~~~---i~~~~~~~~~p~---~~~~s----~~~~dli~~lL~-~~~~r~~r~~~~~~l~h 305 (377)
T cd05629 237 IMFECLIGWPPFCSENSHETYRK---IINWRETLYFPD---DIHLS----VEAEDLIRRLIT-NAENRLGRGGAHEIKSH 305 (377)
T ss_pred hhhhhhcCCCCCCCCCHHHHHHH---HHccCCccCCCC---CCCCC----HHHHHHHHHHhc-CHhhcCCCCCHHHHhcC
Confidence 99999999999976554332211 111011111111 01122 347888999997 66665 599998765
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=325.82 Aligned_cols=255 Identities=27% Similarity=0.422 Sum_probs=203.3
Q ss_pred hhcCccccCcccCCCCccEEEeecc------CCcEEEEEEccccC-cccHHHHHHHHHHHHhCCCCceeeEeeEEEeCCe
Q 004400 414 ATNNFATDNNIGEGGFGPVYKGLLA------DGTAIAVKQLSSKS-KQGNREFINEIGMISALQHPNLVKLYGCCIEGNQ 486 (756)
Q Consensus 414 ~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 486 (756)
.+++|...+.||+|+||.||+|... .+..||+|.+.... ......|.+|+.++++++|+||+++++++.+.+.
T Consensus 4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (277)
T cd05036 4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLP 83 (277)
T ss_pred CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCC
Confidence 4567899999999999999999864 35689999886543 3334578999999999999999999999999999
Q ss_pred EEEEEEecCCCCHHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCC---CEEE
Q 004400 487 LLLIYEYLENNSLARALFEHR------LKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDL---NSKI 557 (756)
Q Consensus 487 ~~lV~e~~~~gsL~~~l~~~~------~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~---~~kl 557 (756)
.++||||+++|+|.+++.... ..+++..+.+++.||+.||+|||+.+ ++||||||+||+++.++ .+||
T Consensus 84 ~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~nil~~~~~~~~~~kl 160 (277)
T cd05036 84 RFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH---FIHRDIAARNCLLTCKGPGRVAKI 160 (277)
T ss_pred cEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchheEEEeccCCCcceEe
Confidence 999999999999999997543 25899999999999999999999986 99999999999998754 5999
Q ss_pred ccCCccccCcccCcce-eeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHh-CCCCCCccchhhHHHHHHHHHhc
Q 004400 558 SDFGLAKLDEEENTHI-STRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVS-GRSNVTKEDMFYLLDWALVLKEQ 635 (756)
Q Consensus 558 ~DFGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 635 (756)
+|||+++......... .....++..|+|||++.+..++.++|||||||++|||++ |+.||........... ....
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~---~~~~ 237 (277)
T cd05036 161 ADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEF---VTGG 237 (277)
T ss_pred ccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH---HHcC
Confidence 9999998653322211 112234568999999999999999999999999999997 9999866544332221 1111
Q ss_pred CccccccccCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhc
Q 004400 636 GKLMELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLE 684 (756)
Q Consensus 636 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~L~ 684 (756)
.. . ..+...+..+.+++.+|++.+|++||++.+|++.|.
T Consensus 238 ~~-~---------~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 238 GR-L---------DPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred Cc-C---------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 11 1 111112345889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=327.20 Aligned_cols=264 Identities=28% Similarity=0.424 Sum_probs=203.2
Q ss_pred cCccccCcccCCCCccEEEeec-----cCCcEEEEEEccccCcccHHHHHHHHHHHHhCCCCceeeEeeEEEe--CCeEE
Q 004400 416 NNFATDNNIGEGGFGPVYKGLL-----ADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCCIE--GNQLL 488 (756)
Q Consensus 416 ~~~~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~ 488 (756)
.+|...+.||+|+||.||+|.. .++..||+|.+........+.+.+|++++++++||||+++++++.. ....+
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 83 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR 83 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence 4678889999999999999974 3578999999877665566789999999999999999999998754 34689
Q ss_pred EEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCcc
Q 004400 489 LIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEE 568 (756)
Q Consensus 489 lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~ 568 (756)
+||||+++|+|.+++......+++..+..++.|++.||+|||+.| |+||||||+||++++++.+||+|||+++....
T Consensus 84 lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~ 160 (284)
T cd05081 84 LVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKR---YVHRDLATRNILVESENRVKIGDFGLTKVLPQ 160 (284)
T ss_pred EEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHhhEEECCCCeEEECCCcccccccC
Confidence 999999999999999766667999999999999999999999986 99999999999999999999999999986543
Q ss_pred cCcce--eeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhcCc-------cc
Q 004400 569 ENTHI--STRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGK-------LM 639 (756)
Q Consensus 569 ~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~-------~~ 639 (756)
..... .....++..|+|||++.+..++.++|||||||++|||++|..|+...... +......... ..
T Consensus 161 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~ 236 (284)
T cd05081 161 DKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAE----FMRMMGNDKQGQMIVYHLI 236 (284)
T ss_pred CCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchh----hhhhcccccccccchHHHH
Confidence 32211 11223445699999998888999999999999999999987765322110 0000000000 00
Q ss_pred cccccCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhccC
Q 004400 640 ELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLECG 686 (756)
Q Consensus 640 ~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~L~~~ 686 (756)
+.+........+......+.+++.+||+.+|++|||+.||++.|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 237 ELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred HHHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 00000000001111233588999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-38 Score=352.61 Aligned_cols=255 Identities=22% Similarity=0.323 Sum_probs=205.4
Q ss_pred HHhhcCccccCcccCCCCccEEEee-ccCCcEEEEEEcccc--CcccHHHHHHHHHHHHhCCCCceeeEeeEEEeCC---
Q 004400 412 KAATNNFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSK--SKQGNREFINEIGMISALQHPNLVKLYGCCIEGN--- 485 (756)
Q Consensus 412 ~~~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--- 485 (756)
+...++|...+.||+|+||.||+|+ ..+|+.||||.+... .......+.+|+.++..++|+||+++++.+...+
T Consensus 28 ~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~ 107 (496)
T PTZ00283 28 KEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRN 107 (496)
T ss_pred cccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccC
Confidence 3456799999999999999999998 567999999998654 2334456888999999999999999988775432
Q ss_pred -----eEEEEEEecCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEE
Q 004400 486 -----QLLLIYEYLENNSLARALFEH---RLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKI 557 (756)
Q Consensus 486 -----~~~lV~e~~~~gsL~~~l~~~---~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl 557 (756)
..++||||+++|+|.+++... ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||
T Consensus 108 ~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~---IiHrDLKP~NILl~~~~~vkL 184 (496)
T PTZ00283 108 PENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKH---MIHRDIKSANILLCSNGLVKL 184 (496)
T ss_pred cccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEeCCCCEEE
Confidence 368999999999999998642 346899999999999999999999986 999999999999999999999
Q ss_pred ccCCccccCcccCc-ceeeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhcC
Q 004400 558 SDFGLAKLDEEENT-HISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQG 636 (756)
Q Consensus 558 ~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~ 636 (756)
+|||+++....... .......||+.|+|||++.+..++.++|||||||++|||++|+.||...+....... .. .+
T Consensus 185 ~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~---~~-~~ 260 (496)
T PTZ00283 185 GDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHK---TL-AG 260 (496)
T ss_pred EecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHH---Hh-cC
Confidence 99999986543221 223446799999999999998999999999999999999999999976654332221 11 11
Q ss_pred ccccccccCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004400 637 KLMELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRM 682 (756)
Q Consensus 637 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~ 682 (756)
.... .+......+.+++.+||+.+|.+||++.++++.
T Consensus 261 ~~~~---------~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 261 RYDP---------LPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred CCCC---------CCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 1111 111223348899999999999999999999764
|
|
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=321.79 Aligned_cols=254 Identities=31% Similarity=0.498 Sum_probs=208.5
Q ss_pred hcCccccCcccCCCCccEEEeeccCCcEEEEEEccccCcccHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEEec
Q 004400 415 TNNFATDNNIGEGGFGPVYKGLLADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYEYL 494 (756)
Q Consensus 415 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~ 494 (756)
.++|...+.||+|+||.||+|...+++.||||.+... ....+++.+|+.++++++|+||+++++++..+...++||||+
T Consensus 5 ~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 83 (261)
T cd05034 5 RESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPG-TMSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYM 83 (261)
T ss_pred hhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCC-ccCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEecc
Confidence 4678899999999999999999888889999998753 334567999999999999999999999999989999999999
Q ss_pred CCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCcccCcce
Q 004400 495 ENNSLARALFEHR-LKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHI 573 (756)
Q Consensus 495 ~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~~~~~~ 573 (756)
++++|.+++.... ..+++..+..++.|++.|++|||+.+ ++||||||+||++++++.+||+|||.++.........
T Consensus 84 ~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~ 160 (261)
T cd05034 84 SKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRN---YIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTA 160 (261)
T ss_pred CCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcchheEEEcCCCCEEECccccceeccchhhhh
Confidence 9999999997543 57899999999999999999999986 9999999999999999999999999998665432222
Q ss_pred eeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHh-CCCCCCccchhhHHHHHHHHHhcCccccccccCCCCCCCH
Q 004400 574 STRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVS-GRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDK 652 (756)
Q Consensus 574 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 652 (756)
.....++..|+|||.+.+..++.++||||||+++||+++ |+.||...+........ .. .... . .+.
T Consensus 161 ~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~---~~-~~~~-----~----~~~ 227 (261)
T cd05034 161 REGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQV---ER-GYRM-----P----RPP 227 (261)
T ss_pred hhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH---Hc-CCCC-----C----CCC
Confidence 222335678999999998889999999999999999998 99999655433322211 11 0000 0 011
Q ss_pred HHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhcc
Q 004400 653 EQVMVMINVALLCANASPTIRPSMSSVLRMLEC 685 (756)
Q Consensus 653 ~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~L~~ 685 (756)
..+..+.+++.+|++.+|++||+++++++.|+.
T Consensus 228 ~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 228 NCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred CCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 113358899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-38 Score=334.01 Aligned_cols=242 Identities=22% Similarity=0.354 Sum_probs=195.6
Q ss_pred CcccCCCCccEEEeec-cCCcEEEEEEcccc---CcccHHHHHHHHHHHHhC-CCCceeeEeeEEEeCCeEEEEEEecCC
Q 004400 422 NNIGEGGFGPVYKGLL-ADGTAIAVKQLSSK---SKQGNREFINEIGMISAL-QHPNLVKLYGCCIEGNQLLLIYEYLEN 496 (756)
Q Consensus 422 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~e~~~~ 496 (756)
+.||+|+||.||+|+. .+++.||+|.+... .......+..|.+++..+ +||||+++++++.+++..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 4699999999999985 46789999998753 223345677899998876 799999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCcccCcceeec
Q 004400 497 NSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTR 576 (756)
Q Consensus 497 gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~ 576 (756)
|+|.+++... ..+++..+..++.|++.||+|||+.| |+||||||+||+++.++.+||+|||+++....... ....
T Consensus 81 ~~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~-~~~~ 155 (321)
T cd05591 81 GDLMFQIQRS-RKFDEPRSRFYAAEVTLALMFLHRHG---VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGV-TTTT 155 (321)
T ss_pred CcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeecccceecccCCc-cccc
Confidence 9999988654 47899999999999999999999997 99999999999999999999999999875332222 2234
Q ss_pred cccCccCCchHhhhcCCCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhcCccccccccCCCCCCCHHHHH
Q 004400 577 VAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDKEQVM 656 (756)
Q Consensus 577 ~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 656 (756)
..||+.|+|||++.+..++.++|||||||++|||++|+.||...+........ .... . . ..... ..
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i---~~~~-~---~---~p~~~----~~ 221 (321)
T cd05591 156 FCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESI---LHDD-V---L---YPVWL----SK 221 (321)
T ss_pred cccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHH---HcCC-C---C---CCCCC----CH
Confidence 57999999999999889999999999999999999999999766554433211 1111 0 0 01112 23
Q ss_pred HHHHHHHHhhcCCCCCCC-------CHHHHHHH
Q 004400 657 VMINVALLCANASPTIRP-------SMSSVLRM 682 (756)
Q Consensus 657 ~l~~l~~~c~~~~P~~RP-------t~~ev~~~ 682 (756)
.+.+++.+|++.||++|| ++.++++.
T Consensus 222 ~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~h 254 (321)
T cd05591 222 EAVSILKAFMTKNPNKRLGCVASQGGEDAIKQH 254 (321)
T ss_pred HHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcC
Confidence 488999999999999999 67776543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=325.13 Aligned_cols=254 Identities=28% Similarity=0.470 Sum_probs=204.9
Q ss_pred cCccccCcccCCCCccEEEeec------cCCcEEEEEEccccCcccHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEE
Q 004400 416 NNFATDNNIGEGGFGPVYKGLL------ADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLL 489 (756)
Q Consensus 416 ~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 489 (756)
++|...+.||+|+||.||+|.. .++..+|+|.+..........+.+|+++++.++|+||+++++++.+++..++
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLM 84 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEE
Confidence 4677789999999999999963 2466899999876666666789999999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHHhcC--------------CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCE
Q 004400 490 IYEYLENNSLARALFEHR--------------LKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNS 555 (756)
Q Consensus 490 V~e~~~~gsL~~~l~~~~--------------~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~ 555 (756)
||||+++|+|.+++.... ..+++..+..++.|++.|++|||+.+ ++||||||+||++++++.+
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~nil~~~~~~~ 161 (280)
T cd05092 85 VFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLH---FVHRDLATRNCLVGQGLVV 161 (280)
T ss_pred EEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCC---eecccccHhhEEEcCCCCE
Confidence 999999999999997543 25889999999999999999999986 9999999999999999999
Q ss_pred EEccCCccccCcccCc-ceeeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHh-CCCCCCccchhhHHHHHHHHH
Q 004400 556 KISDFGLAKLDEEENT-HISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVS-GRSNVTKEDMFYLLDWALVLK 633 (756)
Q Consensus 556 kl~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~ 633 (756)
||+|||+++....... .......+++.|+|||.+.+..++.++|||||||++|||++ |+.||............
T Consensus 162 kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~---- 237 (280)
T cd05092 162 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECI---- 237 (280)
T ss_pred EECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHHH----
Confidence 9999999975433221 11223345788999999998899999999999999999998 89998654433222111
Q ss_pred hcCccccccccCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhcc
Q 004400 634 EQGKLMELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLEC 685 (756)
Q Consensus 634 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~L~~ 685 (756)
......... ...+ ..+.+++.+||+.||.+||++.+|++.|++
T Consensus 238 ~~~~~~~~~-----~~~~----~~~~~li~~cl~~~P~~Rp~~~~l~~~l~~ 280 (280)
T cd05092 238 TQGRELERP-----RTCP----PEVYAIMQGCWQREPQQRMVIKDIHSRLQA 280 (280)
T ss_pred HcCccCCCC-----CCCC----HHHHHHHHHHccCChhhCCCHHHHHHHHhC
Confidence 111111111 1222 348899999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=327.87 Aligned_cols=255 Identities=32% Similarity=0.481 Sum_probs=203.7
Q ss_pred CccccCcccCCCCccEEEeecc------CCcEEEEEEccccCc-ccHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEE
Q 004400 417 NFATDNNIGEGGFGPVYKGLLA------DGTAIAVKQLSSKSK-QGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLL 489 (756)
Q Consensus 417 ~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 489 (756)
+|...+.||+|+||.||+|+.. ....+++|.+..... .....+.+|+.+++.++||||++++++|..++..++
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL 80 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence 4677899999999999999842 235789998865432 334678899999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHHhcC-----------------------CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCc
Q 004400 490 IYEYLENNSLARALFEHR-----------------------LKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATN 546 (756)
Q Consensus 490 V~e~~~~gsL~~~l~~~~-----------------------~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~N 546 (756)
|+||+.+|+|.+++.... ..+++..+..++.|++.||+|||+.+ |+||||||+|
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---ivH~dikp~n 157 (290)
T cd05045 81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMK---LVHRDLAARN 157 (290)
T ss_pred EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCC---eehhhhhhhe
Confidence 999999999999986421 34789999999999999999999986 9999999999
Q ss_pred eEecCCCCEEEccCCccccCcccCcce-eeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHh-CCCCCCccchhh
Q 004400 547 VLLDKDLNSKISDFGLAKLDEEENTHI-STRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVS-GRSNVTKEDMFY 624 (756)
Q Consensus 547 ill~~~~~~kl~DFGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~ 624 (756)
|++++++.+||+|||+++......... .....++..|+|||.+.+..++.++||||||+++|||++ |+.||.......
T Consensus 158 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~ 237 (290)
T cd05045 158 VLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPER 237 (290)
T ss_pred EEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHHH
Confidence 999999999999999998654332221 222346778999999988889999999999999999998 999996655433
Q ss_pred HHHHHHHHHhcCccccccccCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhccCc
Q 004400 625 LLDWALVLKEQGKLMELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLECGV 687 (756)
Q Consensus 625 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~L~~~~ 687 (756)
...+. ...... ...... ...+.+++.+||+.+|++||++.++++.|++..
T Consensus 238 ~~~~~----~~~~~~-----~~~~~~----~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~ 287 (290)
T cd05045 238 LFNLL----KTGYRM-----ERPENC----SEEMYNLMLTCWKQEPDKRPTFADISKELEKMM 287 (290)
T ss_pred HHHHH----hCCCCC-----CCCCCC----CHHHHHHHHHHccCCcccCCCHHHHHHHHHHHH
Confidence 33221 111110 011122 234889999999999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=322.08 Aligned_cols=257 Identities=23% Similarity=0.382 Sum_probs=206.7
Q ss_pred cCccccCcccCCCCccEEEeec-cCCcEEEEEEcccc---CcccHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEE
Q 004400 416 NNFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSK---SKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIY 491 (756)
Q Consensus 416 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 491 (756)
++|+..+.||+|+||.||+|+. .+++.||||.+... .......+.+|+++++.++||||+++++++.+.+..++|+
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 5788999999999999999994 57899999987542 2233456889999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCcc
Q 004400 492 EYLENNSLARALFE---HRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEE 568 (756)
Q Consensus 492 e~~~~gsL~~~l~~---~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~ 568 (756)
||+++|+|.+++.. ....+++..+..++.|++.||+|||+++ ++||||||+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~ 158 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence 99999999988852 3345889999999999999999999986 99999999999999999999999999986543
Q ss_pred cCcceeeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhcCccccccccCCCC
Q 004400 569 ENTHISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGS 648 (756)
Q Consensus 569 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 648 (756)
.... .....|++.|+|||.+.+..++.++||||||+++|||++|+.||...... ...+...... .....
T Consensus 159 ~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~-~~~~~~~~~~-~~~~~-------- 227 (267)
T cd08228 159 KTTA-AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN-LFSLCQKIEQ-CDYPP-------- 227 (267)
T ss_pred hhHH-HhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCcccccc-HHHHHHHHhc-CCCCC--------
Confidence 3221 12346888999999999888999999999999999999999998554321 1122211111 11100
Q ss_pred CCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhccC
Q 004400 649 NFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLECG 686 (756)
Q Consensus 649 ~~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~L~~~ 686 (756)
.........+.+++.+||+.+|++||++.+|++.+++.
T Consensus 228 ~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~ 265 (267)
T cd08228 228 LPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQM 265 (267)
T ss_pred CChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHh
Confidence 01112334588999999999999999999999998854
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-38 Score=333.83 Aligned_cols=237 Identities=24% Similarity=0.377 Sum_probs=192.8
Q ss_pred CcccCCCCccEEEeec-cCCcEEEEEEcccc---CcccHHHHHHHHHHHHhC-CCCceeeEeeEEEeCCeEEEEEEecCC
Q 004400 422 NNIGEGGFGPVYKGLL-ADGTAIAVKQLSSK---SKQGNREFINEIGMISAL-QHPNLVKLYGCCIEGNQLLLIYEYLEN 496 (756)
Q Consensus 422 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~e~~~~ 496 (756)
+.||+|+||.||+|+. .+++.||+|.+... .....+.+..|..++..+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 4699999999999995 46889999998653 223345677888888876 699999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCcccCcceeec
Q 004400 497 NSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTR 576 (756)
Q Consensus 497 gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~ 576 (756)
|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++....... ....
T Consensus 81 g~L~~~i~~~-~~l~~~~~~~~~~ql~~~L~~lH~~~---ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~-~~~~ 155 (320)
T cd05590 81 GDLMFHIQKS-RRFDEARARFYAAEITSALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGK-TTST 155 (320)
T ss_pred chHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCC-cccc
Confidence 9999988655 47899999999999999999999986 99999999999999999999999999875322221 2234
Q ss_pred cccCccCCchHhhhcCCCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhcCccccccccCCCCCCCHHHHH
Q 004400 577 VAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDKEQVM 656 (756)
Q Consensus 577 ~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 656 (756)
..||+.|+|||++.+..++.++|||||||++|||++|+.||...+........ .. ... . ..... ..
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i---~~-~~~-~-----~~~~~----~~ 221 (320)
T cd05590 156 FCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAI---LN-DEV-V-----YPTWL----SQ 221 (320)
T ss_pred cccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHH---hc-CCC-C-----CCCCC----CH
Confidence 57999999999999889999999999999999999999999766544333211 11 110 0 01112 23
Q ss_pred HHHHHHHHhhcCCCCCCCCHH
Q 004400 657 VMINVALLCANASPTIRPSMS 677 (756)
Q Consensus 657 ~l~~l~~~c~~~~P~~RPt~~ 677 (756)
.+.+++.+|++.||++||++.
T Consensus 222 ~~~~li~~~L~~dP~~R~~~~ 242 (320)
T cd05590 222 DAVDILKAFMTKNPTMRLGSL 242 (320)
T ss_pred HHHHHHHHHcccCHHHCCCCC
Confidence 478999999999999999983
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=326.58 Aligned_cols=261 Identities=26% Similarity=0.394 Sum_probs=206.0
Q ss_pred hcCccccCcccCCCCccEEEeeccC-----------------CcEEEEEEccccC-cccHHHHHHHHHHHHhCCCCceee
Q 004400 415 TNNFATDNNIGEGGFGPVYKGLLAD-----------------GTAIAVKQLSSKS-KQGNREFINEIGMISALQHPNLVK 476 (756)
Q Consensus 415 ~~~~~~~~~lg~G~~g~Vy~~~~~~-----------------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~ 476 (756)
..+|+..+.||+|+||.||+|...+ +..||+|.+.... ....+.+.+|++++++++||||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~ 83 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR 83 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 3578889999999999999987432 2468999987543 334567899999999999999999
Q ss_pred EeeEEEeCCeEEEEEEecCCCCHHHHHHhcC----------CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCc
Q 004400 477 LYGCCIEGNQLLLIYEYLENNSLARALFEHR----------LKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATN 546 (756)
Q Consensus 477 l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~----------~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~N 546 (756)
++++|..++..++||||+++++|.+++.... ..+++..+..++.|++.||+|||+.+ |+||||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~---i~H~dlkp~N 160 (296)
T cd05051 84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN---FVHRDLATRN 160 (296)
T ss_pred EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhc
Confidence 9999999999999999999999999997543 26899999999999999999999986 9999999999
Q ss_pred eEecCCCCEEEccCCccccCcccCc-ceeeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHh--CCCCCCccchh
Q 004400 547 VLLDKDLNSKISDFGLAKLDEEENT-HISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVS--GRSNVTKEDMF 623 (756)
Q Consensus 547 ill~~~~~~kl~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt--g~~p~~~~~~~ 623 (756)
|+++.++.++|+|||+++....... .......++..|+|||++.+..++.++|||||||++|||++ |..||......
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~ 240 (296)
T cd05051 161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQ 240 (296)
T ss_pred eeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcChH
Confidence 9999999999999999975433221 12233456789999999998889999999999999999998 67787554433
Q ss_pred hHHHHHHHHHhcCccccccccCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhc
Q 004400 624 YLLDWALVLKEQGKLMELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLE 684 (756)
Q Consensus 624 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~L~ 684 (756)
..................... +...+..+.+++.+|++.+|++||++.||++.|+
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~------~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~ 295 (296)
T cd05051 241 QVIENAGHFFRDDGRQIYLPR------PPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ 295 (296)
T ss_pred HHHHHHHhccccccccccCCC------ccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence 333332222111111111111 1112245899999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=325.26 Aligned_cols=244 Identities=23% Similarity=0.311 Sum_probs=193.2
Q ss_pred ccCCCCccEEEeec-cCCcEEEEEEccccCc---ccHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEEecCCCCH
Q 004400 424 IGEGGFGPVYKGLL-ADGTAIAVKQLSSKSK---QGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYEYLENNSL 499 (756)
Q Consensus 424 lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL 499 (756)
||+|+||+||+|.. .+++.||+|.+..... ...+.+..|+++++.++||||+++.+++..+...++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 79999999999984 5789999999865322 2235678899999999999999999999999999999999999999
Q ss_pred HHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCcccCcceeec
Q 004400 500 ARALFE---HRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTR 576 (756)
Q Consensus 500 ~~~l~~---~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~ 576 (756)
.+++.. ....+++..+..++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||++........ ....
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~-~~~~ 156 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR---IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS-KTKG 156 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCccceecCCCCc-cccc
Confidence 988753 3346899999999999999999999986 99999999999999999999999999976543322 1234
Q ss_pred cccCccCCchHhhhcCCCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhcCccccccccCCCCCCCHHHHH
Q 004400 577 VAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDKEQVM 656 (756)
Q Consensus 577 ~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 656 (756)
..||+.|+|||++.+..++.++|||||||++|||++|+.||............. . ..... ...++.....
T Consensus 157 ~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~---~-----~~~~~--~~~~~~~~~~ 226 (280)
T cd05608 157 YAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELK---Q-----RILND--SVTYPDKFSP 226 (280)
T ss_pred cCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHH---H-----hhccc--CCCCcccCCH
Confidence 578999999999999999999999999999999999999996543211110000 0 00000 0111222334
Q ss_pred HHHHHHHHhhcCCCCCCC-----CHHHHHH
Q 004400 657 VMINVALLCANASPTIRP-----SMSSVLR 681 (756)
Q Consensus 657 ~l~~l~~~c~~~~P~~RP-----t~~ev~~ 681 (756)
.+.+++.+|++.||++|| +++++++
T Consensus 227 ~~~~li~~~l~~~P~~R~~~~~~~~~~~l~ 256 (280)
T cd05608 227 ASKSFCEALLAKDPEKRLGFRDGNCDGLRT 256 (280)
T ss_pred HHHHHHHHHhcCCHHHhcCCCCCCHHHHhc
Confidence 588999999999999999 5566654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=322.66 Aligned_cols=255 Identities=27% Similarity=0.446 Sum_probs=205.8
Q ss_pred cCccccCcccCCCCccEEEeecc----CCcEEEEEEccccC-cccHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEE
Q 004400 416 NNFATDNNIGEGGFGPVYKGLLA----DGTAIAVKQLSSKS-KQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLI 490 (756)
Q Consensus 416 ~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 490 (756)
.+|+..+.||+|+||.||+|... .+..+|+|.++... ....+.+.+|+.++++++||||+++++++.+++..++|
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 83 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV 83 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence 46788899999999999999853 23479999986542 23346789999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCcccC
Q 004400 491 YEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEEN 570 (756)
Q Consensus 491 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~~~ 570 (756)
|||+++++|.+++......+++.++..++.|++.||+|||+.+ ++||||||+||+++.++.++|+|||+++......
T Consensus 84 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd05066 84 TEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP 160 (267)
T ss_pred EEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeehhhchhcEEECCCCeEEeCCCCccccccccc
Confidence 9999999999999876667899999999999999999999986 9999999999999999999999999998665433
Q ss_pred cceee--ccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHh-CCCCCCccchhhHHHHHHHHHhcCccccccccCCC
Q 004400 571 THIST--RVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVS-GRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPG 647 (756)
Q Consensus 571 ~~~~~--~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 647 (756)
..... ...++..|+|||++.+..++.++||||||+++||+++ |+.||..........+. .+ ..... ..
T Consensus 161 ~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~---~~-~~~~~-----~~ 231 (267)
T cd05066 161 EAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAI---EE-GYRLP-----AP 231 (267)
T ss_pred ceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHH---hC-CCcCC-----CC
Confidence 22211 1233568999999998899999999999999999886 99999655433332221 11 11000 01
Q ss_pred CCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhccC
Q 004400 648 SNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLECG 686 (756)
Q Consensus 648 ~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~L~~~ 686 (756)
.. .+..+.+++.+|++.+|.+||++.++++.|++.
T Consensus 232 ~~----~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 232 MD----CPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred CC----CCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 11 223478999999999999999999999998853
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=320.11 Aligned_cols=245 Identities=27% Similarity=0.409 Sum_probs=197.0
Q ss_pred cccCCCCccEEEeec---cCCcEEEEEEccccCc--ccHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEEecCCC
Q 004400 423 NIGEGGFGPVYKGLL---ADGTAIAVKQLSSKSK--QGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYEYLENN 497 (756)
Q Consensus 423 ~lg~G~~g~Vy~~~~---~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~g 497 (756)
.||+|+||.||+|.+ .++..+|+|+++.... ...+.+.+|+.+++.++||||+++++++. .+..++||||+++|
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence 689999999999964 3678999999865432 23467899999999999999999999885 45678999999999
Q ss_pred CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCcccCcce--ee
Q 004400 498 SLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHI--ST 575 (756)
Q Consensus 498 sL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~~~~~~--~~ 575 (756)
+|.+++... ..+++..+.+++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++......... ..
T Consensus 81 ~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 156 (257)
T cd05116 81 PLNKFLQKN-KHVTEKNITELVHQVSMGMKYLEETN---FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKT 156 (257)
T ss_pred cHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeecC
Confidence 999999654 46899999999999999999999986 9999999999999999999999999998654433221 12
Q ss_pred ccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHh-CCCCCCccchhhHHHHHHHHHhcCccccccccCCCCCCCHHH
Q 004400 576 RVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVS-GRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDKEQ 654 (756)
Q Consensus 576 ~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 654 (756)
...++..|+|||.+....++.++|||||||++|||++ |+.||........... . ..+..... ....+
T Consensus 157 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~---i-~~~~~~~~-----~~~~~--- 224 (257)
T cd05116 157 HGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQM---I-ESGERMEC-----PQRCP--- 224 (257)
T ss_pred CCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH---H-HCCCCCCC-----CCCCC---
Confidence 2334678999999988889999999999999999998 9999966544333221 1 11111111 11222
Q ss_pred HHHHHHHHHHhhcCCCCCCCCHHHHHHHhcc
Q 004400 655 VMVMINVALLCANASPTIRPSMSSVLRMLEC 685 (756)
Q Consensus 655 ~~~l~~l~~~c~~~~P~~RPt~~ev~~~L~~ 685 (756)
..+.+++.+||+.+|++||++.+|++.|+.
T Consensus 225 -~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~ 254 (257)
T cd05116 225 -PEMYDLMKLCWTYGVDERPGFAVVELRLRN 254 (257)
T ss_pred -HHHHHHHHHHhccCchhCcCHHHHHHHHhc
Confidence 348899999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=319.59 Aligned_cols=249 Identities=28% Similarity=0.426 Sum_probs=205.3
Q ss_pred CccccCcccCCCCccEEEeec-cCCcEEEEEEcccc--CcccHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEEe
Q 004400 417 NFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSK--SKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYEY 493 (756)
Q Consensus 417 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 493 (756)
+|...+.||+|++|.||+|.. .+++.|++|.+... .......+.+|++++++++||||+++++++.+++..++||||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 467788999999999999995 57899999998643 334456788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCcccCcc
Q 004400 494 LENNSLARALFEH-RLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTH 572 (756)
Q Consensus 494 ~~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~~~~~ 572 (756)
+++++|.+++... ...+++..+..++.|++.||+|||+.| ++||||||+||+++.++.+||+|||+++........
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~---i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~~ 157 (256)
T cd08529 81 AENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKK---ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNF 157 (256)
T ss_pred CCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEeCCCCEEEcccccceeccCccch
Confidence 9999999999764 457899999999999999999999986 999999999999999999999999998865543222
Q ss_pred eeeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhcCccccccccCCCCCCCH
Q 004400 573 ISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDK 652 (756)
Q Consensus 573 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 652 (756)
.....|++.|+|||+..+..++.++||||||+++|||++|+.||...+........ ..+.... .+.
T Consensus 158 -~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~----~~~~~~~---------~~~ 223 (256)
T cd08529 158 -ANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKI----IRGVFPP---------VSQ 223 (256)
T ss_pred -hhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHH----HcCCCCC---------Ccc
Confidence 23356889999999999988999999999999999999999999765533322211 1111111 111
Q ss_pred HHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004400 653 EQVMVMINVALLCANASPTIRPSMSSVLRM 682 (756)
Q Consensus 653 ~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~ 682 (756)
.....+.+++.+||+.+|++||++.++++.
T Consensus 224 ~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 224 MYSQQLAQLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred ccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence 223458899999999999999999999864
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=326.90 Aligned_cols=261 Identities=24% Similarity=0.383 Sum_probs=202.0
Q ss_pred hcCccccCcccCCCCccEEEeeccC---------------CcEEEEEEccccC-cccHHHHHHHHHHHHhCCCCceeeEe
Q 004400 415 TNNFATDNNIGEGGFGPVYKGLLAD---------------GTAIAVKQLSSKS-KQGNREFINEIGMISALQHPNLVKLY 478 (756)
Q Consensus 415 ~~~~~~~~~lg~G~~g~Vy~~~~~~---------------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~ 478 (756)
.++|...+.||+|+||.||+|+... ...||+|.++... ......|.+|++++++++|+||++++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~ 83 (295)
T cd05097 4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLL 83 (295)
T ss_pred hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEE
Confidence 3578889999999999999987532 2358999987542 33345789999999999999999999
Q ss_pred eEEEeCCeEEEEEEecCCCCHHHHHHhcC-----------CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCce
Q 004400 479 GCCIEGNQLLLIYEYLENNSLARALFEHR-----------LKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNV 547 (756)
Q Consensus 479 ~~~~~~~~~~lV~e~~~~gsL~~~l~~~~-----------~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Ni 547 (756)
+++..++..++||||+++++|.+++.... ..+++..+..++.|++.||+|||+.+ ++||||||+||
T Consensus 84 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Ni 160 (295)
T cd05097 84 GVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN---FVHRDLATRNC 160 (295)
T ss_pred EEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcC---eeccccChhhE
Confidence 99999999999999999999999986432 24688999999999999999999986 99999999999
Q ss_pred EecCCCCEEEccCCccccCcccCcc-eeeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHh--CCCCCCccchhh
Q 004400 548 LLDKDLNSKISDFGLAKLDEEENTH-ISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVS--GRSNVTKEDMFY 624 (756)
Q Consensus 548 ll~~~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt--g~~p~~~~~~~~ 624 (756)
+++.++.+||+|||+++........ ......++..|+|||++..+.++.++|||||||++|||++ |..||.......
T Consensus 161 ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~ 240 (295)
T cd05097 161 LVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQ 240 (295)
T ss_pred EEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHH
Confidence 9999999999999999754432211 1222345778999999998899999999999999999998 566775543333
Q ss_pred HHHHHHHHHhcCccccccccCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhc
Q 004400 625 LLDWALVLKEQGKLMELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLE 684 (756)
Q Consensus 625 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~L~ 684 (756)
.................... .... +..+.+++.+||+.+|++||++.+|++.|+
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~--~~~~----~~~l~~li~~~l~~~p~~RPs~~~i~~~l~ 294 (295)
T cd05097 241 VIENTGEFFRNQGRQIYLSQ--TPLC----PSPVFKLMMRCWSRDIKDRPTFNKIHHFLR 294 (295)
T ss_pred HHHHHHHhhhhccccccCCC--CCCC----CHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence 22221111111111111110 1112 235899999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=329.53 Aligned_cols=240 Identities=25% Similarity=0.378 Sum_probs=193.2
Q ss_pred CcccCCCCccEEEeec-cCCcEEEEEEccccC---cccHHHHHHHHHHHHhC-CCCceeeEeeEEEeCCeEEEEEEecCC
Q 004400 422 NNIGEGGFGPVYKGLL-ADGTAIAVKQLSSKS---KQGNREFINEIGMISAL-QHPNLVKLYGCCIEGNQLLLIYEYLEN 496 (756)
Q Consensus 422 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~e~~~~ 496 (756)
+.||+|+||.||+|+. .+++.||||.++... ......+..|..++... +||||+++++++.+++..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 4699999999999995 467899999987542 23345567788888764 899999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCcccCcceeec
Q 004400 497 NSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTR 576 (756)
Q Consensus 497 gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~ 576 (756)
|+|.+++... ..+++..+..++.|++.||+|||+++ |+||||||+||+++.++.+||+|||+++....... ....
T Consensus 81 g~L~~~l~~~-~~~~~~~~~~~~~qi~~al~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~ 155 (316)
T cd05619 81 GDLMFHIQSC-HKFDLPRATFYAAEIICGLQFLHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDA-KTCT 155 (316)
T ss_pred CcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEccCCcceECCCCCC-ceee
Confidence 9999998654 47899999999999999999999986 99999999999999999999999999874322111 2234
Q ss_pred cccCccCCchHhhhcCCCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhcCccccccccCCCCCCCHHHHH
Q 004400 577 VAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDKEQVM 656 (756)
Q Consensus 577 ~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 656 (756)
..||+.|+|||++.+..++.++|||||||++|||++|+.||...+......... ... .. ++.....
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~---~~~-------~~----~~~~~~~ 221 (316)
T cd05619 156 FCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIR---MDN-------PC----YPRWLTR 221 (316)
T ss_pred ecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHH---hCC-------CC----CCccCCH
Confidence 579999999999998899999999999999999999999997655433322211 000 00 1111223
Q ss_pred HHHHHHHHhhcCCCCCCCCHH-HHH
Q 004400 657 VMINVALLCANASPTIRPSMS-SVL 680 (756)
Q Consensus 657 ~l~~l~~~c~~~~P~~RPt~~-ev~ 680 (756)
.+.+++.+|++.+|++||++. ++.
T Consensus 222 ~~~~li~~~l~~~P~~R~~~~~~l~ 246 (316)
T cd05619 222 EAKDILVKLFVREPERRLGVKGDIR 246 (316)
T ss_pred HHHHHHHHHhccCHhhcCCChHHHH
Confidence 478899999999999999997 553
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=333.20 Aligned_cols=241 Identities=24% Similarity=0.344 Sum_probs=194.9
Q ss_pred CccccCcccCCCCccEEEeec-cCCcEEEEEEcccc---CcccHHHHHHHHHHHHhCCC-CceeeEeeEEEeCCeEEEEE
Q 004400 417 NFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSK---SKQGNREFINEIGMISALQH-PNLVKLYGCCIEGNQLLLIY 491 (756)
Q Consensus 417 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~~~lV~ 491 (756)
+|+..+.||+|+||.||+|.. .+++.||+|++... .....+.+..|.+++..++| ++|+++++++.+.+..|+||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 477889999999999999984 46789999998753 22344667889999999976 46888999999999999999
Q ss_pred EecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCcccCc
Q 004400 492 EYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENT 571 (756)
Q Consensus 492 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~~~~ 571 (756)
||+++|+|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 81 E~~~~g~L~~~~~~~-~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~ 156 (324)
T cd05587 81 EYVNGGDLMYHIQQV-GKFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGK 156 (324)
T ss_pred cCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEEcCCCCEEEeecCcceecCCCCC
Confidence 999999999998654 36899999999999999999999986 99999999999999999999999999874322111
Q ss_pred ceeeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhcCccccccccCCCCCCC
Q 004400 572 HISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFD 651 (756)
Q Consensus 572 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 651 (756)
......||+.|+|||++.+..++.++||||+||++|||++|+.||...+......... . .. . .++
T Consensus 157 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~---~-~~-~---------~~~ 221 (324)
T cd05587 157 -TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIM---E-HN-V---------SYP 221 (324)
T ss_pred -ceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHH---c-CC-C---------CCC
Confidence 2234579999999999999899999999999999999999999997665433322111 1 00 0 011
Q ss_pred HHHHHHHHHHHHHhhcCCCCCCCCH
Q 004400 652 KEQVMVMINVALLCANASPTIRPSM 676 (756)
Q Consensus 652 ~~~~~~l~~l~~~c~~~~P~~RPt~ 676 (756)
......+.+++.+|++.+|.+|++.
T Consensus 222 ~~~~~~~~~li~~~l~~~P~~R~~~ 246 (324)
T cd05587 222 KSLSKEAVSICKGLLTKHPAKRLGC 246 (324)
T ss_pred CCCCHHHHHHHHHHhhcCHHHcCCC
Confidence 1122347899999999999999986
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=318.21 Aligned_cols=251 Identities=28% Similarity=0.507 Sum_probs=205.4
Q ss_pred cCccccCcccCCCCccEEEeeccCCcEEEEEEccccCcccHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEEecC
Q 004400 416 NNFATDNNIGEGGFGPVYKGLLADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYEYLE 495 (756)
Q Consensus 416 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~ 495 (756)
.+|+..+.||+|+||.||+|.+.+++.+|+|.+.... .....|.+|++++++++|||++++++++......++||||++
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 82 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGA-MSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFME 82 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCC-CCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCC
Confidence 4677889999999999999998778899999986542 234678999999999999999999999999999999999999
Q ss_pred CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCcccCcceee
Q 004400 496 NNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHIST 575 (756)
Q Consensus 496 ~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~ 575 (756)
+++|.+++......+++..+..++.|++.|++|||+.+ ++||||||+||+++.++.+||+|||+++...........
T Consensus 83 ~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~~ 159 (256)
T cd05112 83 HGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSN---VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSST 159 (256)
T ss_pred CCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccccceEEEcCCCeEEECCCcceeecccCcccccC
Confidence 99999999876667899999999999999999999986 999999999999999999999999998755433222222
Q ss_pred ccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHh-CCCCCCccchhhHHHHHHHHHhcCccccccccCCCCCCCHHH
Q 004400 576 RVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVS-GRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDKEQ 654 (756)
Q Consensus 576 ~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 654 (756)
...++.+|+|||.+.++.++.++||||||+++||+++ |+.||............ .. +. ....+ .. .
T Consensus 160 ~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~---~~-~~--~~~~~---~~----~ 226 (256)
T cd05112 160 GTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETI---NA-GF--RLYKP---RL----A 226 (256)
T ss_pred CCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHH---hC-CC--CCCCC---CC----C
Confidence 2345678999999998889999999999999999998 99998655443322211 11 10 11111 11 1
Q ss_pred HHHHHHHHHHhhcCCCCCCCCHHHHHHHh
Q 004400 655 VMVMINVALLCANASPTIRPSMSSVLRML 683 (756)
Q Consensus 655 ~~~l~~l~~~c~~~~P~~RPt~~ev~~~L 683 (756)
...+.+++.+||+.+|++||++.++++.|
T Consensus 227 ~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l 255 (256)
T cd05112 227 SQSVYELMQHCWKERPEDRPSFSLLLHQL 255 (256)
T ss_pred CHHHHHHHHHHcccChhhCCCHHHHHHhh
Confidence 24588999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=331.59 Aligned_cols=254 Identities=27% Similarity=0.440 Sum_probs=215.2
Q ss_pred cCccccCcccCCCCccEEEeeccC-CcEEEEEEccccCcccHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEEec
Q 004400 416 NNFATDNNIGEGGFGPVYKGLLAD-GTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYEYL 494 (756)
Q Consensus 416 ~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~ 494 (756)
.+..-.++||-|-||.||.|+|+. .-.||||.++.+ ....++|..|+.+|+.++|||+|+++|+|..+..+|+|+|||
T Consensus 267 tdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKED-tMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTEfM 345 (1157)
T KOG4278|consen 267 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITEFM 345 (1157)
T ss_pred hheeeeeccCCCcccceeeeeeeccceeeehhhhhhc-chhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEecc
Confidence 345567899999999999999864 567999999754 456689999999999999999999999999999999999999
Q ss_pred CCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCcccCcce
Q 004400 495 ENNSLARALFEHR-LKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHI 573 (756)
Q Consensus 495 ~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~~~~~~ 573 (756)
..|+|.++|++.. ..++.-..+.++.||+.|++||..+. +|||||..+|+|+.++..|||+|||+++++..+....
T Consensus 346 ~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkkn---FIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDTYTA 422 (1157)
T KOG4278|consen 346 CYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHIVKVADFGLSRLMTGDTYTA 422 (1157)
T ss_pred cCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhh---hhhhhhhhhhccccccceEEeeccchhhhhcCCceec
Confidence 9999999998654 34677778899999999999999884 9999999999999999999999999999887665544
Q ss_pred eeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHh-CCCCCCccchhhHHHHHHHHHhcCccccccccCCCCCCCH
Q 004400 574 STRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVS-GRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDK 652 (756)
Q Consensus 574 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 652 (756)
.....-++.|.|||.+....++.|+|||+|||+|||+.| |..||.+-+... +..+.+.+.+++....++
T Consensus 423 HAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSq----VY~LLEkgyRM~~PeGCP------ 492 (1157)
T KOG4278|consen 423 HAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ----VYGLLEKGYRMDGPEGCP------ 492 (1157)
T ss_pred ccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHHH----HHHHHhccccccCCCCCC------
Confidence 433445779999999999999999999999999999998 889987665432 333445555555444433
Q ss_pred HHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhccC
Q 004400 653 EQVMVMINVALLCANASPTIRPSMSSVLRMLECG 686 (756)
Q Consensus 653 ~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~L~~~ 686 (756)
..+.++++.||+.+|.+||++.|+.+.+|..
T Consensus 493 ---pkVYeLMraCW~WsPsDRPsFaeiHqafEtm 523 (1157)
T KOG4278|consen 493 ---PKVYELMRACWNWSPSDRPSFAEIHQAFETM 523 (1157)
T ss_pred ---HHHHHHHHHHhcCCcccCccHHHHHHHHHHH
Confidence 3589999999999999999999999998854
|
|
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=334.16 Aligned_cols=255 Identities=21% Similarity=0.257 Sum_probs=199.5
Q ss_pred cCccccCcccCCCCccEEEeec-cCCcEEEEEEcccc---CcccHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEE
Q 004400 416 NNFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSK---SKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIY 491 (756)
Q Consensus 416 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 491 (756)
++|+..+.||+|+||.||+|+. .+++.||+|.+... .....+.+.+|+.++..++|+||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 4688899999999999999994 56899999998642 2223456888999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCcccCc
Q 004400 492 EYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENT 571 (756)
Q Consensus 492 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~~~~ 571 (756)
||+++|+|.+++......+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++........
T Consensus 81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 157 (331)
T cd05597 81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLG---YVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGT 157 (331)
T ss_pred ecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEECCCCHHHEEECCCCCEEEEECCceeecCCCCC
Confidence 999999999999766667999999999999999999999996 99999999999999999999999999876544333
Q ss_pred ceeeccccCccCCchHhhhc-----CCCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhcCccccccccCC
Q 004400 572 HISTRVAGTIGYMAPEYAMR-----GHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNP 646 (756)
Q Consensus 572 ~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 646 (756)
.......||+.|+|||++.. ..++.++|||||||++|||++|+.||.......... ..........+...
T Consensus 158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~---~i~~~~~~~~~~~~-- 232 (331)
T cd05597 158 VQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYG---KIMNHKEHFQFPPD-- 232 (331)
T ss_pred ccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHH---HHHcCCCcccCCCc--
Confidence 33334569999999999873 457889999999999999999999997654432221 11111111111111
Q ss_pred CCCCCHHHHHHHHHHHHHhhcC--CCCCCCCHHHHHHH
Q 004400 647 GSNFDKEQVMVMINVALLCANA--SPTIRPSMSSVLRM 682 (756)
Q Consensus 647 ~~~~~~~~~~~l~~l~~~c~~~--~P~~RPt~~ev~~~ 682 (756)
....+ ..+.+++.+|+.. ++..||++.++++.
T Consensus 233 ~~~~~----~~~~~li~~ll~~~~~r~~r~~~~~~l~h 266 (331)
T cd05597 233 VTDVS----EEAKDLIRRLICSPETRLGRNGLQDFKDH 266 (331)
T ss_pred cCCCC----HHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 11122 3467777787654 33347899988765
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-38 Score=342.60 Aligned_cols=250 Identities=20% Similarity=0.302 Sum_probs=194.6
Q ss_pred CccccCcccCCCCccEEEee-ccCCcEEEEEEccccC---cccHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEE
Q 004400 417 NFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSKS---KQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYE 492 (756)
Q Consensus 417 ~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 492 (756)
.|...+.||+|+||.||+|+ ..+++.||+|.+.... ......+.+|+.++++++|||||+++++|.+++..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 57888999999999999999 4578899999986532 2234568889999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCcccC--
Q 004400 493 YLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEEN-- 570 (756)
Q Consensus 493 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~~~-- 570 (756)
||++|+|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 82 ~~~gg~L~~~l~~~-~~~~e~~~~~~~~qi~~al~~lH~~~---ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~ 157 (382)
T cd05625 82 YIPGGDMMSLLIRM-GIFPEDLARFYIAELTCAVESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDS 157 (382)
T ss_pred CCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEeECCCCccccccccc
Confidence 99999999998754 36889999999999999999999986 9999999999999999999999999975321000
Q ss_pred --------------------------------------------cceeeccccCccCCchHhhhcCCCCcccchhhHHHH
Q 004400 571 --------------------------------------------THISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIV 606 (756)
Q Consensus 571 --------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~ 606 (756)
........||+.|+|||++.+..++.++||||+||+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvi 237 (382)
T cd05625 158 KYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVI 237 (382)
T ss_pred cccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechHH
Confidence 000123579999999999999899999999999999
Q ss_pred HHHHHhCCCCCCccchhhHHHHHHHHHhcCccccccccCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCC---HHHHHH
Q 004400 607 ALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPS---MSSVLR 681 (756)
Q Consensus 607 l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt---~~ev~~ 681 (756)
+|||++|+.||...+....... .......... ......++ ...+++.++. .+|++|++ +.++++
T Consensus 238 l~elltG~~Pf~~~~~~~~~~~---i~~~~~~~~~---p~~~~~s~----~~~~li~~l~-~~p~~R~~~~~~~ei~~ 304 (382)
T cd05625 238 LYEMLVGQPPFLAQTPLETQMK---VINWQTSLHI---PPQAKLSP----EASDLIIKLC-RGPEDRLGKNGADEIKA 304 (382)
T ss_pred HHHHHhCCCCCCCCCHHHHHHH---HHccCCCcCC---CCcccCCH----HHHHHHHHHc-cCHhHcCCCCCHHHHhc
Confidence 9999999999976554322111 1110000011 01112233 3566666654 59999997 777654
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=335.59 Aligned_cols=246 Identities=29% Similarity=0.402 Sum_probs=205.8
Q ss_pred CcccCCCCccEEEeec-cCCcEEEEEEccccCcccHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEEecCCCCHH
Q 004400 422 NNIGEGGFGPVYKGLL-ADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYEYLENNSLA 500 (756)
Q Consensus 422 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL~ 500 (756)
-+||+|.||+||-|+. .+...+|||.+..+.....+-+..|+..-+.++|.|||+++|.|.+++.+-+.||-++||+|.
T Consensus 581 vVLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLS 660 (1226)
T KOG4279|consen 581 VVLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLS 660 (1226)
T ss_pred EEeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHH
Confidence 3699999999999994 456789999998776666677899999999999999999999999999999999999999999
Q ss_pred HHHHhcCCCC--CHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecC-CCCEEEccCCccccCcccCcceeecc
Q 004400 501 RALFEHRLKL--DWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDK-DLNSKISDFGLAKLDEEENTHISTRV 577 (756)
Q Consensus 501 ~~l~~~~~~l--~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~-~~~~kl~DFGla~~~~~~~~~~~~~~ 577 (756)
+.|.....++ .+.+.-.+..||++||.|||++. |||||||-+|||++. .|.+||+|||-++.... ....+.++
T Consensus 661 sLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~---IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAg-inP~TETF 736 (1226)
T KOG4279|consen 661 SLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENK---IVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAG-INPCTETF 736 (1226)
T ss_pred HHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcc---eeeccccCCcEEEeeccceEEecccccchhhcc-CCcccccc
Confidence 9999877777 88899999999999999999985 999999999999964 68899999999986543 23345678
Q ss_pred ccCccCCchHhhhcC--CCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhcCccccccccCCCCCCCHHHH
Q 004400 578 AGTIGYMAPEYAMRG--HLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDKEQV 655 (756)
Q Consensus 578 ~gt~~y~aPE~~~~~--~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 655 (756)
.||..|||||++..+ .|+.++|||||||.+.||.||++||..-...... +.+- .+.... ...+.+..
T Consensus 737 TGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAA-----MFkV----GmyKvH--P~iPeels 805 (1226)
T KOG4279|consen 737 TGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAA-----MFKV----GMYKVH--PPIPEELS 805 (1226)
T ss_pred ccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHh-----hhhh----cceecC--CCCcHHHH
Confidence 899999999999875 4899999999999999999999999543322111 1111 111111 24567778
Q ss_pred HHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004400 656 MVMINVALLCANASPTIRPSMSSVLRM 682 (756)
Q Consensus 656 ~~l~~l~~~c~~~~P~~RPt~~ev~~~ 682 (756)
.+...++.+|+..||.+||++.++++.
T Consensus 806 aeak~FilrcFepd~~~R~sA~~LL~D 832 (1226)
T KOG4279|consen 806 AEAKNFILRCFEPDPCDRPSAKDLLQD 832 (1226)
T ss_pred HHHHHHHHHHcCCCcccCccHHHhccC
Confidence 889999999999999999999999753
|
|
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=338.92 Aligned_cols=261 Identities=24% Similarity=0.357 Sum_probs=200.6
Q ss_pred CccccCcccCCCCccEEEeec-cCCcEEEEEEcccc--CcccHHHHHHHHHHHHhCCCCceeeEeeEEEeCC-----eEE
Q 004400 417 NFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSK--SKQGNREFINEIGMISALQHPNLVKLYGCCIEGN-----QLL 488 (756)
Q Consensus 417 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~~ 488 (756)
+|+..+.||+|+||.||+|.. .+++.||||.+... .....+.+.+|+++++.++||||+++++++..++ ..|
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 477889999999999999994 57899999998653 2233467889999999999999999999998776 789
Q ss_pred EEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCcc
Q 004400 489 LIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEE 568 (756)
Q Consensus 489 lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~ 568 (756)
+|+||+. ++|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 81 lv~e~~~-~~l~~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~ 155 (372)
T cd07853 81 VVTELMQ-SDLHKIIVSP-QPLSSDHVKVFLYQILRGLKYLHSAG---ILHRDIKPGNLLVNSNCVLKICDFGLARVEEP 155 (372)
T ss_pred EEeeccc-cCHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHHEEECCCCCEEeccccceeeccc
Confidence 9999997 5787777543 47899999999999999999999997 99999999999999999999999999986544
Q ss_pred cCcceeeccccCccCCchHhhhcC-CCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhcCccc--------
Q 004400 569 ENTHISTRVAGTIGYMAPEYAMRG-HLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLM-------- 639 (756)
Q Consensus 569 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~-------- 639 (756)
..........+|..|+|||++.+. .++.++||||+||++|||++|+.||...+..................
T Consensus 156 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~ 235 (372)
T cd07853 156 DESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEG 235 (372)
T ss_pred CccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhHH
Confidence 333333345688999999998774 57999999999999999999999997665433222111110000000
Q ss_pred --cccccCCC--------CCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004400 640 --ELVDTNPG--------SNFDKEQVMVMINVALLCANASPTIRPSMSSVLRM 682 (756)
Q Consensus 640 --~~~~~~~~--------~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~ 682 (756)
..+..... ..........+.+++.+|++.||++|||+.|+++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 288 (372)
T cd07853 236 ARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH 288 (372)
T ss_pred HHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence 00000000 00111123458899999999999999999999864
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=321.93 Aligned_cols=255 Identities=25% Similarity=0.364 Sum_probs=202.0
Q ss_pred hcCccccCcccCCCCccEEEeec-cCCcEEEEEEccccCcccHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEEe
Q 004400 415 TNNFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYEY 493 (756)
Q Consensus 415 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 493 (756)
.++|+..+.||+|+||.||+|+. .+++.||+|++..........+.+|+.++++++||||+++++++..++..++||||
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~ 87 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEY 87 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeC
Confidence 35788999999999999999994 67889999998765444556788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCcccCcce
Q 004400 494 LENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHI 573 (756)
Q Consensus 494 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~~~~~~ 573 (756)
+++++|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++....... .
T Consensus 88 ~~~~~L~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~-~ 162 (267)
T cd06646 88 CGGGSLQDIYHVT-GPLSELQIAYVCRETLQGLAYLHSKG---KMHRDIKGANILLTDNGDVKLADFGVAAKITATIA-K 162 (267)
T ss_pred CCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEECcCccceeeccccc-c
Confidence 9999999998654 47899999999999999999999986 99999999999999999999999999986533221 1
Q ss_pred eeccccCccCCchHhhh---cCCCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhcCccccccccCCCCCC
Q 004400 574 STRVAGTIGYMAPEYAM---RGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNF 650 (756)
Q Consensus 574 ~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 650 (756)
.....|+..|+|||.+. ...++.++|||||||++|||++|+.||.......... .. .... ...... ..
T Consensus 163 ~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~---~~-~~~~---~~~~~~--~~ 233 (267)
T cd06646 163 RKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALF---LM-SKSN---FQPPKL--KD 233 (267)
T ss_pred cCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhhe---ee-ecCC---CCCCCC--cc
Confidence 22346889999999985 3457889999999999999999999985433211100 00 0000 000000 00
Q ss_pred CHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHh
Q 004400 651 DKEQVMVMINVALLCANASPTIRPSMSSVLRML 683 (756)
Q Consensus 651 ~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~L 683 (756)
.......+.+++.+||+.+|++||+++++++.+
T Consensus 234 ~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 234 KTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred ccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 111234588999999999999999999998754
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-38 Score=339.86 Aligned_cols=259 Identities=20% Similarity=0.287 Sum_probs=203.8
Q ss_pred hHHHhhcCccccCcccCCCCccEEEeec-cCCcEEEEEEcccc---CcccHHHHHHHHHHHHhCCCCceeeEeeEEEeCC
Q 004400 410 QIKAATNNFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSK---SKQGNREFINEIGMISALQHPNLVKLYGCCIEGN 485 (756)
Q Consensus 410 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 485 (756)
++....++|+..+.||+|+||.||+|+. .+++.||+|.+... .......+.+|+.+++.++||||+++++++.+++
T Consensus 37 ~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~ 116 (371)
T cd05622 37 DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDR 116 (371)
T ss_pred hcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCC
Confidence 4455668999999999999999999995 46889999998642 1223355788999999999999999999999999
Q ss_pred eEEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCcccc
Q 004400 486 QLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKL 565 (756)
Q Consensus 486 ~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~ 565 (756)
..++||||+++|+|.+++... .++...+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.
T Consensus 117 ~~~lv~Ey~~gg~L~~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NIll~~~~~ikL~DfG~a~~ 191 (371)
T cd05622 117 YLYMVMEYMPGGDLVNLMSNY--DVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMK 191 (371)
T ss_pred EEEEEEcCCCCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHEEECCCCCEEEEeCCceeE
Confidence 999999999999999998643 5788999999999999999999997 99999999999999999999999999986
Q ss_pred CcccCcceeeccccCccCCchHhhhcC----CCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhcCccccc
Q 004400 566 DEEENTHISTRVAGTIGYMAPEYAMRG----HLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMEL 641 (756)
Q Consensus 566 ~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 641 (756)
.............||+.|+|||++... .++.++|||||||++|||++|+.||...+...... .+.........
T Consensus 192 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~---~i~~~~~~~~~ 268 (371)
T cd05622 192 MNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYS---KIMNHKNSLTF 268 (371)
T ss_pred cCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHH---HHHcCCCcccC
Confidence 554333333456799999999998753 37899999999999999999999997665433221 11111111111
Q ss_pred cccCCCCCCCHHHHHHHHHHHHHhhcCCCCC--CCCHHHHHHHh
Q 004400 642 VDTNPGSNFDKEQVMVMINVALLCANASPTI--RPSMSSVLRML 683 (756)
Q Consensus 642 ~~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~--RPt~~ev~~~L 683 (756)
.+. .. ....+.+++.+|+..++.+ ||++.|+++..
T Consensus 269 ~~~---~~----~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~ 305 (371)
T cd05622 269 PDD---ND----ISKEAKNLICAFLTDREVRLGRNGVEEIKRHL 305 (371)
T ss_pred CCc---CC----CCHHHHHHHHHHcCChhhhcCCCCHHHHhcCc
Confidence 111 11 2334788899999844433 77899888754
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=329.33 Aligned_cols=256 Identities=30% Similarity=0.448 Sum_probs=202.4
Q ss_pred cCccccCcccCCCCccEEEeecc-CCc--EEEEEEcccc-CcccHHHHHHHHHHHHhC-CCCceeeEeeEEEeCCeEEEE
Q 004400 416 NNFATDNNIGEGGFGPVYKGLLA-DGT--AIAVKQLSSK-SKQGNREFINEIGMISAL-QHPNLVKLYGCCIEGNQLLLI 490 (756)
Q Consensus 416 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~--~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV 490 (756)
++|...+.||+|+||.||+|... ++. .+++|.++.. .....+.+.+|+++++++ +||||+++++++.+.+..++|
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 81 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA 81 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence 57888999999999999999864 333 4788888643 233456789999999999 799999999999999999999
Q ss_pred EEecCCCCHHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCE
Q 004400 491 YEYLENNSLARALFEHR---------------LKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNS 555 (756)
Q Consensus 491 ~e~~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~ 555 (756)
+||+++|+|.+++.... ..+++..+..++.|++.||+|||+.+ |+||||||+||++++++.+
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~ 158 (297)
T cd05089 82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ---FIHRDLAARNVLVGENLAS 158 (297)
T ss_pred EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCcCCcceEEECCCCeE
Confidence 99999999999997432 25889999999999999999999986 9999999999999999999
Q ss_pred EEccCCccccCcccCcceeeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHh-CCCCCCccchhhHHHHHHHHHh
Q 004400 556 KISDFGLAKLDEEENTHISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVS-GRSNVTKEDMFYLLDWALVLKE 634 (756)
Q Consensus 556 kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~ 634 (756)
||+|||++........ ......+..|+|||++....++.++|||||||++|||++ |+.||........... ..
T Consensus 159 kl~dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~---~~- 232 (297)
T cd05089 159 KIADFGLSRGEEVYVK--KTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEK---LP- 232 (297)
T ss_pred EECCcCCCccccceec--cCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH---Hh-
Confidence 9999999864322111 111223567999999988889999999999999999997 9999966544332221 11
Q ss_pred cCccccccccCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhccCccc
Q 004400 635 QGKLMELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLECGVDV 689 (756)
Q Consensus 635 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~L~~~~~~ 689 (756)
.+... .....+ ...+.+++.+||+.+|.+||++.++++.|+.+...
T Consensus 233 ~~~~~-----~~~~~~----~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~ 278 (297)
T cd05089 233 QGYRM-----EKPRNC----DDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEA 278 (297)
T ss_pred cCCCC-----CCCCCC----CHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence 11110 011112 23488999999999999999999999999866543
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=333.02 Aligned_cols=244 Identities=24% Similarity=0.356 Sum_probs=194.1
Q ss_pred ccccCcccCCCCccEEEeec-cCCcEEEEEEccccC---cccHHHHHHHHHHH---HhCCCCceeeEeeEEEeCCeEEEE
Q 004400 418 FATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSKS---KQGNREFINEIGMI---SALQHPNLVKLYGCCIEGNQLLLI 490 (756)
Q Consensus 418 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l---~~l~h~niv~l~~~~~~~~~~~lV 490 (756)
|+..+.||+|+||.||+|.. .+++.||||.++... ....+.+.+|+.++ +.++||||+++++++.+++..|+|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 56678999999999999984 578999999987532 22334566676654 566899999999999999999999
Q ss_pred EEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCcccC
Q 004400 491 YEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEEN 570 (756)
Q Consensus 491 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~~~ 570 (756)
|||+++|+|..++.. ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++......
T Consensus 81 ~E~~~~~~L~~~~~~--~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~~ 155 (324)
T cd05589 81 MEYAAGGDLMMHIHT--DVFSEPRAVFYAACVVLGLQYLHENK---IVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFG 155 (324)
T ss_pred EcCCCCCcHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCcEEeCcccCCccCCCCC
Confidence 999999999988754 36899999999999999999999986 9999999999999999999999999987432222
Q ss_pred cceeeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhcCccccccccCCCCCC
Q 004400 571 THISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNF 650 (756)
Q Consensus 571 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 650 (756)
. ......|++.|+|||.+.+..++.++|||||||++|||++|+.||...+....... .... .. ......
T Consensus 156 ~-~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~---i~~~-~~------~~p~~~ 224 (324)
T cd05589 156 D-RTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDS---IVND-EV------RYPRFL 224 (324)
T ss_pred C-cccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHH---HHhC-CC------CCCCCC
Confidence 1 22346799999999999988999999999999999999999999976654333221 1111 00 011112
Q ss_pred CHHHHHHHHHHHHHhhcCCCCCCCC-----HHHHHH
Q 004400 651 DKEQVMVMINVALLCANASPTIRPS-----MSSVLR 681 (756)
Q Consensus 651 ~~~~~~~l~~l~~~c~~~~P~~RPt-----~~ev~~ 681 (756)
...+.+++.+|++.||.+||+ +.++++
T Consensus 225 ----~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~ 256 (324)
T cd05589 225 ----SREAISIMRRLLRRNPERRLGSGEKDAEDVKK 256 (324)
T ss_pred ----CHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhh
Confidence 234788999999999999994 555554
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=332.47 Aligned_cols=241 Identities=23% Similarity=0.341 Sum_probs=195.4
Q ss_pred CccccCcccCCCCccEEEeec-cCCcEEEEEEccccC---cccHHHHHHHHHHHHhC-CCCceeeEeeEEEeCCeEEEEE
Q 004400 417 NFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSKS---KQGNREFINEIGMISAL-QHPNLVKLYGCCIEGNQLLLIY 491 (756)
Q Consensus 417 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~ 491 (756)
+|...+.||+|+||.||+|+. .+++.||+|.+.... ......+..|..++..+ +|++|+++++++.+.+..++||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 477889999999999999985 467899999987542 22334567788888877 5899999999999999999999
Q ss_pred EecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCcccCc
Q 004400 492 EYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENT 571 (756)
Q Consensus 492 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~~~~ 571 (756)
||+++|+|.+++... ..+++..+..++.|++.||+|||+.| |+||||||+|||++.++.+||+|||+++.......
T Consensus 81 E~~~~g~L~~~~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~~ 156 (323)
T cd05616 81 EYVNGGDLMYQIQQV-GRFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGV 156 (323)
T ss_pred cCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---EEecCCCHHHeEECCCCcEEEccCCCceecCCCCC
Confidence 999999999988654 36899999999999999999999986 99999999999999999999999999975332221
Q ss_pred ceeeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhcCccccccccCCCCCCC
Q 004400 572 HISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFD 651 (756)
Q Consensus 572 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 651 (756)
......||+.|+|||++.+..++.++|||||||++|||++|+.||...+........ .. ... .++
T Consensus 157 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i---~~-~~~----------~~p 221 (323)
T cd05616 157 -TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSI---ME-HNV----------AYP 221 (323)
T ss_pred -ccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHH---Hh-CCC----------CCC
Confidence 223467999999999999999999999999999999999999999766544333211 11 100 111
Q ss_pred HHHHHHHHHHHHHhhcCCCCCCCCH
Q 004400 652 KEQVMVMINVALLCANASPTIRPSM 676 (756)
Q Consensus 652 ~~~~~~l~~l~~~c~~~~P~~RPt~ 676 (756)
......+.+++.+|++.+|++|++.
T Consensus 222 ~~~s~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05616 222 KSMSKEAVAICKGLMTKHPGKRLGC 246 (323)
T ss_pred CcCCHHHHHHHHHHcccCHHhcCCC
Confidence 1223457899999999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=333.29 Aligned_cols=255 Identities=20% Similarity=0.240 Sum_probs=200.1
Q ss_pred cCccccCcccCCCCccEEEeec-cCCcEEEEEEcccc---CcccHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEE
Q 004400 416 NNFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSK---SKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIY 491 (756)
Q Consensus 416 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 491 (756)
++|...+.||+|+||.||+++. .+++.||+|.+... .......+.+|..++..++|+||+++++++.+++..|+||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 4788899999999999999994 46889999998642 1223345788999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCcccCc
Q 004400 492 EYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENT 571 (756)
Q Consensus 492 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~~~~ 571 (756)
||+++|+|.+++......+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 81 Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~---iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~ 157 (331)
T cd05624 81 DYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLH---YVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGT 157 (331)
T ss_pred eCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCchHHEEEcCCCCEEEEeccceeeccCCCc
Confidence 999999999999875567899999999999999999999986 99999999999999999999999999986554433
Q ss_pred ceeeccccCccCCchHhhhc-----CCCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhcCccccccccCC
Q 004400 572 HISTRVAGTIGYMAPEYAMR-----GHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNP 646 (756)
Q Consensus 572 ~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 646 (756)
.......||+.|+|||++.+ +.++.++|||||||++|||++|+.||...+....... ............ .
T Consensus 158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~---i~~~~~~~~~p~--~ 232 (331)
T cd05624 158 VQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGK---IMNHEERFQFPS--H 232 (331)
T ss_pred eeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHH---HHcCCCcccCCC--c
Confidence 33344679999999999875 4688899999999999999999999976554332211 111111111100 0
Q ss_pred CCCCCHHHHHHHHHHHHHhhcCCCCC--CCCHHHHHHH
Q 004400 647 GSNFDKEQVMVMINVALLCANASPTI--RPSMSSVLRM 682 (756)
Q Consensus 647 ~~~~~~~~~~~l~~l~~~c~~~~P~~--RPt~~ev~~~ 682 (756)
.......+.+++.+|+..++++ |++++++++.
T Consensus 233 ----~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h 266 (331)
T cd05624 233 ----ITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKH 266 (331)
T ss_pred ----cccCCHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence 0112335788888988865544 4578777654
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=328.56 Aligned_cols=240 Identities=25% Similarity=0.353 Sum_probs=193.1
Q ss_pred CcccCCCCccEEEeec-cCCcEEEEEEccccC---cccHHHHHHHHHHHHhC-CCCceeeEeeEEEeCCeEEEEEEecCC
Q 004400 422 NNIGEGGFGPVYKGLL-ADGTAIAVKQLSSKS---KQGNREFINEIGMISAL-QHPNLVKLYGCCIEGNQLLLIYEYLEN 496 (756)
Q Consensus 422 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~e~~~~ 496 (756)
+.||+|+||.||+|+. .+|+.||+|.++... ......+..|..++... +||||+++++++.+++..++||||+.+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 4699999999999995 468899999987532 23345567788888764 899999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCcccCcceeec
Q 004400 497 NSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTR 576 (756)
Q Consensus 497 gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~ 576 (756)
|+|.+++... ..+++..+..++.|++.||+|||+.| |+||||||+||+++.++.+||+|||+++...... .....
T Consensus 81 g~L~~~i~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~~ 155 (316)
T cd05620 81 GDLMFHIQDK-GRFDLYRATFYAAEIVCGLQFLHSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGD-NRAST 155 (316)
T ss_pred CcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEeCccCCCeecccCC-Cceec
Confidence 9999998654 46899999999999999999999986 9999999999999999999999999987432211 12344
Q ss_pred cccCccCCchHhhhcCCCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhcCccccccccCCCCCCCHHHHH
Q 004400 577 VAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDKEQVM 656 (756)
Q Consensus 577 ~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 656 (756)
..||+.|+|||++.+..++.++||||+||++|||++|+.||...+........ ... ........ ..
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~---~~~-------~~~~~~~~----~~ 221 (316)
T cd05620 156 FCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESI---RVD-------TPHYPRWI----TK 221 (316)
T ss_pred cCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHH---HhC-------CCCCCCCC----CH
Confidence 67999999999999999999999999999999999999999766543332211 100 00111112 23
Q ss_pred HHHHHHHHhhcCCCCCCCCHH-HHH
Q 004400 657 VMINVALLCANASPTIRPSMS-SVL 680 (756)
Q Consensus 657 ~l~~l~~~c~~~~P~~RPt~~-ev~ 680 (756)
.+.+++.+|++.||++||++. ++.
T Consensus 222 ~~~~li~~~l~~dP~~R~~~~~~~~ 246 (316)
T cd05620 222 ESKDILEKLFERDPTRRLGVVGNIR 246 (316)
T ss_pred HHHHHHHHHccCCHHHcCCChHHHH
Confidence 478999999999999999985 554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=332.80 Aligned_cols=240 Identities=23% Similarity=0.323 Sum_probs=189.7
Q ss_pred CcccCCCCccEEEeec-cCCcEEEEEEccccC---cccHHHHHHHHHHHHhC-CCCceeeEeeEEEeCCeEEEEEEecCC
Q 004400 422 NNIGEGGFGPVYKGLL-ADGTAIAVKQLSSKS---KQGNREFINEIGMISAL-QHPNLVKLYGCCIEGNQLLLIYEYLEN 496 (756)
Q Consensus 422 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~e~~~~ 496 (756)
+.||+|+||.||+|+. .+++.||+|.++... ......+.+|+.++.++ +||||+++++++.+++..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 4699999999999994 568899999987542 22335577898888877 899999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCcccCcceeec
Q 004400 497 NSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTR 576 (756)
Q Consensus 497 gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~ 576 (756)
|+|.+++... ..+++..+..++.|++.||+|||+++ |+||||||+||+++.++.+||+|||+++....... ....
T Consensus 81 ~~L~~~~~~~-~~l~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~-~~~~ 155 (329)
T cd05618 81 GDLMFHMQRQ-RKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD-TTST 155 (329)
T ss_pred CCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCCEEEeeCCccccccCCCC-cccc
Confidence 9999888654 47899999999999999999999986 99999999999999999999999999975322211 2234
Q ss_pred cccCccCCchHhhhcCCCCcccchhhHHHHHHHHHhCCCCCCccch-----hhHHHHHHHHHhcCccccccccCCCCCCC
Q 004400 577 VAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDM-----FYLLDWALVLKEQGKLMELVDTNPGSNFD 651 (756)
Q Consensus 577 ~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 651 (756)
..||+.|+|||++.+..++.++|||||||++|||++|+.||..... .....+.......... .++
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~----------~~p 225 (329)
T cd05618 156 FCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI----------RIP 225 (329)
T ss_pred ccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCC----------CCC
Confidence 6799999999999999999999999999999999999999942111 1111111111111110 111
Q ss_pred HHHHHHHHHHHHHhhcCCCCCCCCH
Q 004400 652 KEQVMVMINVALLCANASPTIRPSM 676 (756)
Q Consensus 652 ~~~~~~l~~l~~~c~~~~P~~RPt~ 676 (756)
......+.+++.+|++.||++||+.
T Consensus 226 ~~~~~~~~~ll~~~L~~dP~~R~~~ 250 (329)
T cd05618 226 RSLSVKAASVLKSFLNKDPKERLGC 250 (329)
T ss_pred CCCCHHHHHHHHHHhcCCHHHcCCC
Confidence 1223347899999999999999984
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=329.42 Aligned_cols=251 Identities=24% Similarity=0.347 Sum_probs=211.0
Q ss_pred hcCccccCcccCCCCccEEEeecc-CCcEEEEEEccccCcc---cHHHHHHHHHHHHhCC-CCceeeEeeEEEeCCeEEE
Q 004400 415 TNNFATDNNIGEGGFGPVYKGLLA-DGTAIAVKQLSSKSKQ---GNREFINEIGMISALQ-HPNLVKLYGCCIEGNQLLL 489 (756)
Q Consensus 415 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~l 489 (756)
...|+..+.||+|.||.||+++.+ +|+.+|+|.+.+.... ....+.+|+++|+++. |||||.++++|.+....++
T Consensus 34 ~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~l 113 (382)
T KOG0032|consen 34 KEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYL 113 (382)
T ss_pred cccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEE
Confidence 456778899999999999999954 5999999999776443 3458899999999998 9999999999999999999
Q ss_pred EEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCC----CCEEEccCCcccc
Q 004400 490 IYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKD----LNSKISDFGLAKL 565 (756)
Q Consensus 490 V~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~----~~~kl~DFGla~~ 565 (756)
|||++.||.|.+.+... .+++.++..++.|++.|++|||+.| |+|||+||+|+|+... +.+|++|||++..
T Consensus 114 vmEL~~GGeLfd~i~~~--~~sE~da~~~~~~il~av~~lH~~g---vvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~ 188 (382)
T KOG0032|consen 114 VMELCEGGELFDRIVKK--HYSERDAAGIIRQILEAVKYLHSLG---VVHRDLKPENLLLASKDEGSGRIKLIDFGLAKF 188 (382)
T ss_pred EEEecCCchHHHHHHHc--cCCHHHHHHHHHHHHHHHHHHHhCC---ceeccCCHHHeeeccccCCCCcEEEeeCCCceE
Confidence 99999999999999866 3999999999999999999999987 9999999999999643 4799999999998
Q ss_pred CcccCcceeeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhcCccccccccC
Q 004400 566 DEEENTHISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTN 645 (756)
Q Consensus 566 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 645 (756)
... .......+||+.|+|||++....|+..+||||+||++|.|++|..||..+........ + ..++. -+..
T Consensus 189 ~~~--~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~---i-~~~~~--~f~~- 259 (382)
T KOG0032|consen 189 IKP--GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLA---I-LRGDF--DFTS- 259 (382)
T ss_pred ccC--CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHH---H-HcCCC--CCCC-
Confidence 766 3345668999999999999989999999999999999999999999988775443331 1 11111 1111
Q ss_pred CCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004400 646 PGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRM 682 (756)
Q Consensus 646 ~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~ 682 (756)
...+.....+.+++..++..||.+|+|+.++++.
T Consensus 260 ---~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~H 293 (382)
T KOG0032|consen 260 ---EPWDDISESAKDFIRKLLEFDPRKRLTAAQALQH 293 (382)
T ss_pred ---CCccccCHHHHHHHHHhcccCcccCCCHHHHhcC
Confidence 1222334558899999999999999999999995
|
|
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=322.20 Aligned_cols=254 Identities=27% Similarity=0.468 Sum_probs=204.7
Q ss_pred CccccCcccCCCCccEEEeecc-CC---cEEEEEEcccc-CcccHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEE
Q 004400 417 NFATDNNIGEGGFGPVYKGLLA-DG---TAIAVKQLSSK-SKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIY 491 (756)
Q Consensus 417 ~~~~~~~lg~G~~g~Vy~~~~~-~~---~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 491 (756)
+|+..+.||+|+||.||+|... ++ ..||||.+... .......|..|+.+++.++||||+++++++.++...++||
T Consensus 5 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 84 (269)
T cd05065 5 CVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIIT 84 (269)
T ss_pred HeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEEE
Confidence 5778899999999999999854 33 36999998754 3334568999999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCcccCc
Q 004400 492 EYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENT 571 (756)
Q Consensus 492 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~~~~ 571 (756)
||+++|+|.+++......+++.+++.++.|++.||+|||+.| ++||||||+||+++.++.+||+|||+++.......
T Consensus 85 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g---~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~~ 161 (269)
T cd05065 85 EFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTS 161 (269)
T ss_pred ecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccChheEEEcCCCcEEECCCccccccccCcc
Confidence 999999999999876667899999999999999999999986 99999999999999999999999999876543222
Q ss_pred ce--eeccc--cCccCCchHhhhcCCCCcccchhhHHHHHHHHHh-CCCCCCccchhhHHHHHHHHHhcCccccccccCC
Q 004400 572 HI--STRVA--GTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVS-GRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNP 646 (756)
Q Consensus 572 ~~--~~~~~--gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 646 (756)
.. ..... .+..|+|||.+.+..++.++|||||||++||+++ |..||..........+.. ..... ..
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~---~~~~~------~~ 232 (269)
T cd05065 162 DPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIE---QDYRL------PP 232 (269)
T ss_pred ccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHH---cCCcC------CC
Confidence 11 11111 2457999999998899999999999999999886 999997655444333221 11000 01
Q ss_pred CCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhccC
Q 004400 647 GSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLECG 686 (756)
Q Consensus 647 ~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~L~~~ 686 (756)
+.+.+..+.+++.+||+.+|.+||++.+|++.|++.
T Consensus 233 ----~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 233 ----PMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred ----cccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 111233488999999999999999999999998854
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-37 Score=322.58 Aligned_cols=261 Identities=26% Similarity=0.409 Sum_probs=202.4
Q ss_pred hcCccccCcccCCCCccEEEeecc-----------------CCcEEEEEEccccC-cccHHHHHHHHHHHHhCCCCceee
Q 004400 415 TNNFATDNNIGEGGFGPVYKGLLA-----------------DGTAIAVKQLSSKS-KQGNREFINEIGMISALQHPNLVK 476 (756)
Q Consensus 415 ~~~~~~~~~lg~G~~g~Vy~~~~~-----------------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~ 476 (756)
.++|+..+.||+|+||.||++... ++..||+|.+.... ......+.+|+++++.++|+||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~ 83 (296)
T cd05095 4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIR 83 (296)
T ss_pred hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcce
Confidence 356889999999999999998532 24478999987542 334467899999999999999999
Q ss_pred EeeEEEeCCeEEEEEEecCCCCHHHHHHhcC----------CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCc
Q 004400 477 LYGCCIEGNQLLLIYEYLENNSLARALFEHR----------LKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATN 546 (756)
Q Consensus 477 l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~----------~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~N 546 (756)
+++++.+++..++||||+++|+|.+++.... ..+++.++.+++.|++.||+|||+.| ++||||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dlkp~N 160 (296)
T cd05095 84 LLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN---FVHRDLATRN 160 (296)
T ss_pred EEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhe
Confidence 9999999999999999999999999997432 24778899999999999999999986 9999999999
Q ss_pred eEecCCCCEEEccCCccccCcccCcce-eeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHh--CCCCCCccchh
Q 004400 547 VLLDKDLNSKISDFGLAKLDEEENTHI-STRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVS--GRSNVTKEDMF 623 (756)
Q Consensus 547 ill~~~~~~kl~DFGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt--g~~p~~~~~~~ 623 (756)
|+++.++.++|+|||+++......... .....++..|+|||....+.++.++|||||||++|||++ |..||......
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~ 240 (296)
T cd05095 161 CLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDE 240 (296)
T ss_pred EEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChH
Confidence 999999999999999998654332211 222345678999999988899999999999999999998 77888544333
Q ss_pred hHHHHHHHHHhcCccccccccCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhc
Q 004400 624 YLLDWALVLKEQGKLMELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLE 684 (756)
Q Consensus 624 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~L~ 684 (756)
............... ....+.+ ... ...+.+++.+||+.||++||++.+|++.|+
T Consensus 241 ~~~~~~~~~~~~~~~-~~~~~~~-~~~----~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~ 295 (296)
T cd05095 241 QVIENTGEFFRDQGR-QVYLPKP-ALC----PDSLYKLMLSCWRRNAKERPSFQEIHATLL 295 (296)
T ss_pred HHHHHHHHHHhhccc-cccCCCC-CCC----CHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 322211111111110 0111111 112 245889999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=319.78 Aligned_cols=251 Identities=27% Similarity=0.363 Sum_probs=203.1
Q ss_pred cCccccCcccCCCCccEEEeec-cCCcEEEEEEccccCc-----ccHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEE
Q 004400 416 NNFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSKSK-----QGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLL 489 (756)
Q Consensus 416 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 489 (756)
++|...+.||+|++|.||+|.. .+++.||+|.+..... .....+.+|++++++++||||+++++++.+++..++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 4788999999999999999984 5789999998864321 123568889999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCccc
Q 004400 490 IYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEE 569 (756)
Q Consensus 490 V~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~~ 569 (756)
|+||+++++|.+++... ..+++..+.+++.|++.||+|||+.+ |+||||||+||++++++.++|+|||+++.....
T Consensus 82 v~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~ 157 (263)
T cd06625 82 FMEYMPGGSVKDQLKAY-GALTETVTRKYTRQILEGVEYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTI 157 (263)
T ss_pred EEEECCCCcHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecccc
Confidence 99999999999998654 36889999999999999999999986 999999999999999999999999999765432
Q ss_pred Cccee--eccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhcCccccccccCCC
Q 004400 570 NTHIS--TRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPG 647 (756)
Q Consensus 570 ~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 647 (756)
..... ....|+..|+|||.+.+..++.++||||+|+++||+++|+.||...+......+. .......
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~---~~~~~~~-------- 226 (263)
T cd06625 158 CSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKI---ATQPTNP-------- 226 (263)
T ss_pred ccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHHHHH---hccCCCC--------
Confidence 22111 2356788999999999888999999999999999999999999655433222111 1111111
Q ss_pred CCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004400 648 SNFDKEQVMVMINVALLCANASPTIRPSMSSVLRM 682 (756)
Q Consensus 648 ~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~ 682 (756)
..+......+.+++.+||..+|.+||++.++++.
T Consensus 227 -~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 227 -QLPSHVSPDARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred -CCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence 1111223348899999999999999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=322.09 Aligned_cols=244 Identities=26% Similarity=0.333 Sum_probs=193.0
Q ss_pred ccCCCCccEEEeec-cCCcEEEEEEccccC---cccHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEEecCCCCH
Q 004400 424 IGEGGFGPVYKGLL-ADGTAIAVKQLSSKS---KQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYEYLENNSL 499 (756)
Q Consensus 424 lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL 499 (756)
||+|+||.||+++. .+|+.||+|.+.... ......+..|++++++++||||+++++++.++...++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 79999999999984 568999999986432 12234566799999999999999999999999999999999999999
Q ss_pred HHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCcccCcceeeccc
Q 004400 500 ARALFEH-RLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVA 578 (756)
Q Consensus 500 ~~~l~~~-~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~~ 578 (756)
.+++... ...+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.++|+|||++....... ......
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~--~~~~~~ 155 (277)
T cd05607 81 KYHIYNVGERGLEMERVIHYSAQITCGILHLHSMD---IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK--TITQRA 155 (277)
T ss_pred HHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCC---EEEccCChHhEEEcCCCCEEEeeceeeeecCCCc--eeeccC
Confidence 9888643 346899999999999999999999986 9999999999999999999999999997654322 123356
Q ss_pred cCccCCchHhhhcCCCCcccchhhHHHHHHHHHhCCCCCCccchh-hHHHHHHHHHhcCccccccccCCCCCCCHHHHHH
Q 004400 579 GTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMF-YLLDWALVLKEQGKLMELVDTNPGSNFDKEQVMV 657 (756)
Q Consensus 579 gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 657 (756)
|+..|+|||++.+..++.++||||+||++|||++|+.||...... ........... .. +.. ....+ ...
T Consensus 156 ~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~-~~----~~~-~~~~~----~~~ 225 (277)
T cd05607 156 GTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLE-DE----VKF-EHQNF----TEE 225 (277)
T ss_pred CCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhc-cc----ccc-ccccC----CHH
Confidence 899999999999888999999999999999999999999643221 11111111100 00 000 01122 234
Q ss_pred HHHHHHHhhcCCCCCCCCHHHHHHH
Q 004400 658 MINVALLCANASPTIRPSMSSVLRM 682 (756)
Q Consensus 658 l~~l~~~c~~~~P~~RPt~~ev~~~ 682 (756)
+.+++.+|++.||++||++.|+++.
T Consensus 226 ~~~li~~~L~~~P~~R~~~~~~~~~ 250 (277)
T cd05607 226 SKDICRLFLAKKPEDRLGSREKNDD 250 (277)
T ss_pred HHHHHHHHhccCHhhCCCCccchhh
Confidence 8899999999999999999877643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=330.43 Aligned_cols=242 Identities=24% Similarity=0.365 Sum_probs=195.8
Q ss_pred CcccCCCCccEEEeec-cCCcEEEEEEccccC---cccHHHHHHHHHHHHhC-CCCceeeEeeEEEeCCeEEEEEEecCC
Q 004400 422 NNIGEGGFGPVYKGLL-ADGTAIAVKQLSSKS---KQGNREFINEIGMISAL-QHPNLVKLYGCCIEGNQLLLIYEYLEN 496 (756)
Q Consensus 422 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~e~~~~ 496 (756)
+.||+|+||.||+|.. .+++.||+|.++... ......+.+|.++++.+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 4699999999999985 467899999987542 23345677899999888 799999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCcccCcceeec
Q 004400 497 NSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTR 576 (756)
Q Consensus 497 gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~ 576 (756)
|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+||++++++.+||+|||+++....... ....
T Consensus 81 ~~L~~~~~~~-~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-~~~~ 155 (318)
T cd05570 81 GDLMFHIQRS-GRFDEPRARFYAAEIVLGLQFLHERG---IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGV-TTST 155 (318)
T ss_pred CCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCC---eEccCCCHHHeEECCCCcEEecccCCCeecCcCCC-cccc
Confidence 9999988654 37999999999999999999999986 99999999999999999999999999874322211 1234
Q ss_pred cccCccCCchHhhhcCCCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhcCccccccccCCCCCCCHHHHH
Q 004400 577 VAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDKEQVM 656 (756)
Q Consensus 577 ~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 656 (756)
..||+.|+|||++.+..++.++|||||||++|||++|+.||...+....... ... ... .++.....
T Consensus 156 ~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~---i~~-~~~----------~~~~~~~~ 221 (318)
T cd05570 156 FCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQS---ILE-DEV----------RYPRWLSK 221 (318)
T ss_pred eecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHH---HHc-CCC----------CCCCcCCH
Confidence 5789999999999999999999999999999999999999976554332221 111 100 01111233
Q ss_pred HHHHHHHHhhcCCCCCCCCH-----HHHHHH
Q 004400 657 VMINVALLCANASPTIRPSM-----SSVLRM 682 (756)
Q Consensus 657 ~l~~l~~~c~~~~P~~RPt~-----~ev~~~ 682 (756)
.+.+++.+||+.||.+||++ .++++.
T Consensus 222 ~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~ 252 (318)
T cd05570 222 EAKSILKSFLTKNPEKRLGCLPTGEQDIKGH 252 (318)
T ss_pred HHHHHHHHHccCCHHHcCCCCCCCHHHHhcC
Confidence 48899999999999999999 777653
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=327.19 Aligned_cols=257 Identities=27% Similarity=0.420 Sum_probs=204.7
Q ss_pred hcCccccCcccCCCCccEEEeec------cCCcEEEEEEccccC-cccHHHHHHHHHHHHhC-CCCceeeEeeEEEeCCe
Q 004400 415 TNNFATDNNIGEGGFGPVYKGLL------ADGTAIAVKQLSSKS-KQGNREFINEIGMISAL-QHPNLVKLYGCCIEGNQ 486 (756)
Q Consensus 415 ~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~ 486 (756)
.++|...+.||+|+||.||+|.. .++..||+|.++... ....+.+.+|+++++++ +||||+++++++...+.
T Consensus 34 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 113 (302)
T cd05055 34 RNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGP 113 (302)
T ss_pred HHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCc
Confidence 45788999999999999999973 235579999987543 23345788999999999 79999999999999999
Q ss_pred EEEEEEecCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCcccc
Q 004400 487 LLLIYEYLENNSLARALFEHR-LKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKL 565 (756)
Q Consensus 487 ~~lV~e~~~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~ 565 (756)
.++||||+.+|+|.+++.... ..+++.++..++.|++.||+|||+.+ |+||||||+||+++.++.+|++|||+++.
T Consensus 114 ~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~dfg~~~~ 190 (302)
T cd05055 114 ILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNVLLTHGKIVKICDFGLARD 190 (302)
T ss_pred eEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eehhhhccceEEEcCCCeEEECCCccccc
Confidence 999999999999999997543 34899999999999999999999986 99999999999999999999999999986
Q ss_pred CcccCcc-eeeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHh-CCCCCCccchhhHHHHHHHHHhcCccccccc
Q 004400 566 DEEENTH-ISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVS-GRSNVTKEDMFYLLDWALVLKEQGKLMELVD 643 (756)
Q Consensus 566 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 643 (756)
....... ......++..|+|||.+....++.++|||||||++|||++ |+.||.......... . ....+....
T Consensus 191 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~--~-~~~~~~~~~--- 264 (302)
T cd05055 191 IMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFY--K-LIKEGYRMA--- 264 (302)
T ss_pred ccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHH--H-HHHcCCcCC---
Confidence 5433221 1222346788999999998899999999999999999998 999986543322110 0 111111100
Q ss_pred cCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhccC
Q 004400 644 TNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLECG 686 (756)
Q Consensus 644 ~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~L~~~ 686 (756)
..... ...+.+++.+|++.+|++||++.|+++.|++.
T Consensus 265 --~~~~~----~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 265 --QPEHA----PAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred --CCCCC----CHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 01111 23588999999999999999999999999853
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=331.32 Aligned_cols=237 Identities=27% Similarity=0.372 Sum_probs=189.9
Q ss_pred CcccCCCCccEEEeec-cCCcEEEEEEccccC---cccHHHHHHHHH-HHHhCCCCceeeEeeEEEeCCeEEEEEEecCC
Q 004400 422 NNIGEGGFGPVYKGLL-ADGTAIAVKQLSSKS---KQGNREFINEIG-MISALQHPNLVKLYGCCIEGNQLLLIYEYLEN 496 (756)
Q Consensus 422 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~ 496 (756)
+.||+|+||.||+|+. .+|+.||+|++.... ......+..|.. +++.++||||+++++++.+++..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 4699999999999995 578999999986531 222344555555 56789999999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCcccCcceeec
Q 004400 497 NSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTR 576 (756)
Q Consensus 497 gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~ 576 (756)
|+|.+++... ..+++..+..++.||+.||+|||+.| |+||||||+|||++.++.+||+|||+++...... .....
T Consensus 81 g~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~g---ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~-~~~~~ 155 (323)
T cd05575 81 GELFFHLQRE-RSFPEPRARFYAAEIASALGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHS-KTTST 155 (323)
T ss_pred CCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeccCCCcccccCC-Ccccc
Confidence 9999998654 47899999999999999999999987 9999999999999999999999999987532221 12334
Q ss_pred cccCccCCchHhhhcCCCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhcCccccccccCCCCCCCHHHHH
Q 004400 577 VAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDKEQVM 656 (756)
Q Consensus 577 ~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 656 (756)
..||+.|+|||++.+..++.++|||||||++|||++|+.||...+....... ... ... . ..... ..
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~---i~~-~~~-~-----~~~~~----~~ 221 (323)
T cd05575 156 FCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDN---ILN-KPL-R-----LKPNI----SV 221 (323)
T ss_pred ccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHHHHHH---HHc-CCC-C-----CCCCC----CH
Confidence 5799999999999998999999999999999999999999976654332211 111 000 0 11112 33
Q ss_pred HHHHHHHHhhcCCCCCCCCHH
Q 004400 657 VMINVALLCANASPTIRPSMS 677 (756)
Q Consensus 657 ~l~~l~~~c~~~~P~~RPt~~ 677 (756)
.+.+++.+|++.||.+||++.
T Consensus 222 ~~~~li~~~l~~~p~~R~~~~ 242 (323)
T cd05575 222 SARHLLEGLLQKDRTKRLGAK 242 (323)
T ss_pred HHHHHHHHHhhcCHHhCCCCC
Confidence 488999999999999999985
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=298.30 Aligned_cols=260 Identities=23% Similarity=0.303 Sum_probs=206.3
Q ss_pred hhcCccccCcccCCCCccEEEee-ccCCcEEEEEEccccCcccHHHHHHHHHHHHhCCCCceeeEeeEEEeCC-----eE
Q 004400 414 ATNNFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCCIEGN-----QL 487 (756)
Q Consensus 414 ~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~ 487 (756)
..++|.+.+.||+|||+-||.+. ..+++.||+|++.-.+.++.+..++|++.-++++|||+++++++...+. ..
T Consensus 19 n~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~ 98 (302)
T KOG2345|consen 19 NNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEA 98 (302)
T ss_pred cCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeE
Confidence 34678899999999999999999 7889999999997777777888999999999999999999999976544 48
Q ss_pred EEEEEecCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccc
Q 004400 488 LLIYEYLENNSLARALFE---HRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAK 564 (756)
Q Consensus 488 ~lV~e~~~~gsL~~~l~~---~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~ 564 (756)
|++++|...|+|.+.+.. .+..+++.++..|+.+|++||++||+.. ++.+||||||.|||+.+.+.++|.|||.++
T Consensus 99 yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~-~~yAH~DiKP~NILls~~~~~vl~D~GS~~ 177 (302)
T KOG2345|consen 99 YLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKE-PPYAHRDIKPANILLSDSGLPVLMDLGSAT 177 (302)
T ss_pred EEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccC-CcccccCCCcceeEecCCCceEEEeccCcc
Confidence 999999999999999973 3447899999999999999999999984 579999999999999999999999999987
Q ss_pred cCcccCcce--------eeccccCccCCchHhhhc---CCCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHH
Q 004400 565 LDEEENTHI--------STRVAGTIGYMAPEYAMR---GHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLK 633 (756)
Q Consensus 565 ~~~~~~~~~--------~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~ 633 (756)
...-..... ...-.-|..|.|||.+.- ...++++|||||||++|.|+.|..||...-.
T Consensus 178 ~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~----------- 246 (302)
T KOG2345|consen 178 QAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQ----------- 246 (302)
T ss_pred ccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhh-----------
Confidence 543211110 011235889999999853 4578999999999999999999999943211
Q ss_pred hcCcccc-ccccCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhcc
Q 004400 634 EQGKLME-LVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLEC 685 (756)
Q Consensus 634 ~~~~~~~-~~~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~L~~ 685 (756)
+.+.+.- +........-....+..+.+++++|++.||.+||++.+++..++.
T Consensus 247 ~GgSlaLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~ 299 (302)
T KOG2345|consen 247 QGGSLALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDD 299 (302)
T ss_pred cCCeEEEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHh
Confidence 1111111 111111000011144569999999999999999999999988774
|
|
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=321.76 Aligned_cols=254 Identities=26% Similarity=0.452 Sum_probs=205.7
Q ss_pred hcCccccCcccCCCCccEEEeecc------CCcEEEEEEccccC-cccHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeE
Q 004400 415 TNNFATDNNIGEGGFGPVYKGLLA------DGTAIAVKQLSSKS-KQGNREFINEIGMISALQHPNLVKLYGCCIEGNQL 487 (756)
Q Consensus 415 ~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 487 (756)
.++|...+.||+|+||.||+|... .+..||+|.+.... ......+.+|+++++.++||||+++++++..+...
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPT 84 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCc
Confidence 357888899999999999999853 24689999986542 23345788999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHHHhcC---------CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEc
Q 004400 488 LLIYEYLENNSLARALFEHR---------LKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKIS 558 (756)
Q Consensus 488 ~lV~e~~~~gsL~~~l~~~~---------~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~ 558 (756)
++||||+++|+|.+++.... ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+
T Consensus 85 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~di~p~nill~~~~~~kl~ 161 (277)
T cd05032 85 LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK---FVHRDLAARNCMVAEDLTVKIG 161 (277)
T ss_pred EEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccChheEEEcCCCCEEEC
Confidence 99999999999999996422 24788999999999999999999986 9999999999999999999999
Q ss_pred cCCccccCcccCc-ceeeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHh-CCCCCCccchhhHHHHHHHHHhcC
Q 004400 559 DFGLAKLDEEENT-HISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVS-GRSNVTKEDMFYLLDWALVLKEQG 636 (756)
Q Consensus 559 DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~ 636 (756)
|||+++....... .......++..|+|||.+..+.++.++|||||||++||+++ |+.||...+......+.. .+
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~----~~ 237 (277)
T cd05032 162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVI----DG 237 (277)
T ss_pred CcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHHh----cC
Confidence 9999986543322 12233457889999999988889999999999999999998 899986555443333221 11
Q ss_pred ccccccccCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhc
Q 004400 637 KLMELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLE 684 (756)
Q Consensus 637 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~L~ 684 (756)
...... ..+ ...+.+++.+||+.+|++|||+.++++.|+
T Consensus 238 ~~~~~~-----~~~----~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~ 276 (277)
T cd05032 238 GHLDLP-----ENC----PDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276 (277)
T ss_pred CCCCCC-----CCC----CHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence 111111 112 345889999999999999999999999887
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-37 Score=320.64 Aligned_cols=251 Identities=26% Similarity=0.432 Sum_probs=197.3
Q ss_pred cccCcccCCCCccEEEeeccC-Cc--EEEEEEcccc--CcccHHHHHHHHHHHHhCCCCceeeEeeEEEeC------CeE
Q 004400 419 ATDNNIGEGGFGPVYKGLLAD-GT--AIAVKQLSSK--SKQGNREFINEIGMISALQHPNLVKLYGCCIEG------NQL 487 (756)
Q Consensus 419 ~~~~~lg~G~~g~Vy~~~~~~-~~--~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~~ 487 (756)
...+.||+|+||.||+|...+ +. .||+|.++.. .....+.+.+|+++++.++||||+++++++... ...
T Consensus 2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 81 (272)
T cd05075 2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSP 81 (272)
T ss_pred ccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCc
Confidence 456899999999999999654 33 6899988654 233456788999999999999999999987532 256
Q ss_pred EEEEEecCCCCHHHHHHh-----cCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCc
Q 004400 488 LLIYEYLENNSLARALFE-----HRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGL 562 (756)
Q Consensus 488 ~lV~e~~~~gsL~~~l~~-----~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGl 562 (756)
++||||+++|+|.+++.. ....+++..+..++.|++.||+|||+.+ |+||||||+||++++++.+||+|||+
T Consensus 82 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~ 158 (272)
T cd05075 82 VVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKS---FIHRDLAARNCMLNENMNVCVADFGL 158 (272)
T ss_pred EEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhheEEcCCCCEEECCCCc
Confidence 899999999999998852 2235899999999999999999999986 99999999999999999999999999
Q ss_pred cccCcccCcce-eeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHh-CCCCCCccchhhHHHHHHHHHhcCcccc
Q 004400 563 AKLDEEENTHI-STRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVS-GRSNVTKEDMFYLLDWALVLKEQGKLME 640 (756)
Q Consensus 563 a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 640 (756)
++......... .....+++.|+|||...+..++.++||||||+++|||++ |+.||........... . ..+....
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~---~-~~~~~~~ 234 (272)
T cd05075 159 SKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDY---L-RQGNRLK 234 (272)
T ss_pred ccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH---H-HcCCCCC
Confidence 98654332211 122346778999999998899999999999999999999 7888865443332221 1 1111111
Q ss_pred ccccCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhcc
Q 004400 641 LVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLEC 685 (756)
Q Consensus 641 ~~~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~L~~ 685 (756)
. ...+ ...+.+++.+||+.+|++||++.++++.|+.
T Consensus 235 ~-----~~~~----~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~ 270 (272)
T cd05075 235 Q-----PPDC----LDGLYSLMSSCWLLNPKDRPSFETLRCELEK 270 (272)
T ss_pred C-----CCCC----CHHHHHHHHHHcCCCcccCcCHHHHHHHHHh
Confidence 0 1112 2348899999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=322.48 Aligned_cols=257 Identities=25% Similarity=0.439 Sum_probs=204.7
Q ss_pred hcCccccCcccCCCCccEEEeec-cCCc----EEEEEEcccc-CcccHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEE
Q 004400 415 TNNFATDNNIGEGGFGPVYKGLL-ADGT----AIAVKQLSSK-SKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLL 488 (756)
Q Consensus 415 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 488 (756)
.++|+..+.||+|+||.||+|.+ .++. .||+|.+... .....+.+.+|+.+++.++||||+++++++.. ...+
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~ 84 (279)
T cd05109 6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STVQ 84 (279)
T ss_pred hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCcE
Confidence 35788889999999999999984 4454 4899998654 33345678899999999999999999999975 4578
Q ss_pred EEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCcc
Q 004400 489 LIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEE 568 (756)
Q Consensus 489 lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~ 568 (756)
+++||+++|+|.+++......+++..+..++.|++.||+|||+.+ |+||||||+||++++++.+||+|||+++....
T Consensus 85 l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~ 161 (279)
T cd05109 85 LVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVR---LVHRDLAARNVLVKSPNHVKITDFGLARLLDI 161 (279)
T ss_pred EEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEcCCCcEEECCCCceeeccc
Confidence 999999999999999876667999999999999999999999986 99999999999999999999999999986643
Q ss_pred cCcce-eeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHh-CCCCCCccchhhHHHHHHHHHhcCccccccccCC
Q 004400 569 ENTHI-STRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVS-GRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNP 646 (756)
Q Consensus 569 ~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 646 (756)
..... .....++..|+|||...+..++.++|||||||++|||++ |..||..........+. ........
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~----~~~~~~~~----- 232 (279)
T cd05109 162 DETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLL----EKGERLPQ----- 232 (279)
T ss_pred ccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH----HCCCcCCC-----
Confidence 32221 112335678999999998899999999999999999998 88998654433332221 11111110
Q ss_pred CCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhccCcc
Q 004400 647 GSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLECGVD 688 (756)
Q Consensus 647 ~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~L~~~~~ 688 (756)
...+ ...+.+++.+||+.||++||++.++++.|+....
T Consensus 233 ~~~~----~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~ 270 (279)
T cd05109 233 PPIC----TIDVYMIMVKCWMIDSECRPRFRELVDEFSRMAR 270 (279)
T ss_pred CccC----CHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence 1112 2348899999999999999999999999876533
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-37 Score=320.42 Aligned_cols=253 Identities=26% Similarity=0.447 Sum_probs=200.6
Q ss_pred ccccCcccCCCCccEEEeecc-C---CcEEEEEEccccC--cccHHHHHHHHHHHHhCCCCceeeEeeEEEeCCe-----
Q 004400 418 FATDNNIGEGGFGPVYKGLLA-D---GTAIAVKQLSSKS--KQGNREFINEIGMISALQHPNLVKLYGCCIEGNQ----- 486 (756)
Q Consensus 418 ~~~~~~lg~G~~g~Vy~~~~~-~---~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~----- 486 (756)
|...+.||+|+||.||+|... + +..||+|.++... ......+.+|++.++.++||||+++++++.+...
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 456789999999999999853 2 3679999987542 2334578999999999999999999999876554
Q ss_pred -EEEEEEecCCCCHHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccC
Q 004400 487 -LLLIYEYLENNSLARALFEH-----RLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDF 560 (756)
Q Consensus 487 -~~lV~e~~~~gsL~~~l~~~-----~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DF 560 (756)
.++|+||+++|+|..++... ...+++..+..++.|++.||+|||+.+ |+||||||+||++++++.+||+||
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~df 157 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRN---FIHRDLAARNCMLREDMTVCVADF 157 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchheEEECCCCeEEECCc
Confidence 79999999999999998632 236899999999999999999999986 999999999999999999999999
Q ss_pred CccccCcccCcce-eeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHh-CCCCCCccchhhHHHHHHHHHhcCcc
Q 004400 561 GLAKLDEEENTHI-STRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVS-GRSNVTKEDMFYLLDWALVLKEQGKL 638 (756)
Q Consensus 561 Gla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~ 638 (756)
|+++......... .....++..|+|||++....++.++|||||||++|||++ |..||.........++. .. +..
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~---~~-~~~ 233 (273)
T cd05035 158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYL---RH-GNR 233 (273)
T ss_pred cceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH---Hc-CCC
Confidence 9998654433221 122335678999999988889999999999999999999 88888655443333222 11 111
Q ss_pred ccccccCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhccC
Q 004400 639 MELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLECG 686 (756)
Q Consensus 639 ~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~L~~~ 686 (756)
.. .+......+.+++.+||+.||++||++.|+++.|+++
T Consensus 234 ~~---------~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 234 LK---------QPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred CC---------CCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 11 1112233588999999999999999999999998854
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=316.87 Aligned_cols=251 Identities=27% Similarity=0.401 Sum_probs=192.6
Q ss_pred CcccCCCCccEEEeeccC---CcEEEEEEccccCc-ccHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEEecCCC
Q 004400 422 NNIGEGGFGPVYKGLLAD---GTAIAVKQLSSKSK-QGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYEYLENN 497 (756)
Q Consensus 422 ~~lg~G~~g~Vy~~~~~~---~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~g 497 (756)
+.||+|+||.||+|...+ +..+|+|.++.... .....+.+|+.++++++||||+++++++.+....++||||+++|
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG 80 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence 368999999999998543 45799998865432 23357889999999999999999999999999999999999999
Q ss_pred CHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCcccCcce
Q 004400 498 SLARALFEHR----LKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHI 573 (756)
Q Consensus 498 sL~~~l~~~~----~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~~~~~~ 573 (756)
+|.+++.... ...++..+..++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||+++.........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~ 157 (269)
T cd05087 81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN---FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV 157 (269)
T ss_pred cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence 9999997432 24677888899999999999999986 9999999999999999999999999997543332211
Q ss_pred -eeccccCccCCchHhhhcC-------CCCcccchhhHHHHHHHHHh-CCCCCCccchhhHHHHHHHHHhcCcccccccc
Q 004400 574 -STRVAGTIGYMAPEYAMRG-------HLTEKADVYSFGIVALEIVS-GRSNVTKEDMFYLLDWALVLKEQGKLMELVDT 644 (756)
Q Consensus 574 -~~~~~gt~~y~aPE~~~~~-------~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 644 (756)
.....|+..|+|||++... .++.++||||||+++|||++ |+.||............ . .........+
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~--~--~~~~~~~~~~ 233 (269)
T cd05087 158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYT--V--REQQLKLPKP 233 (269)
T ss_pred cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHH--h--hcccCCCCCC
Confidence 2234578899999998642 35789999999999999996 99999654433322211 1 1111111122
Q ss_pred CCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhc
Q 004400 645 NPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLE 684 (756)
Q Consensus 645 ~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~L~ 684 (756)
...... ...+.+++..|| .+|++|||++||++.|+
T Consensus 234 ~~~~~~----~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 234 RLKLPL----SDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred ccCCCC----ChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 111112 223778889999 58999999999998875
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=320.24 Aligned_cols=257 Identities=25% Similarity=0.417 Sum_probs=206.7
Q ss_pred cCccccCcccCCCCccEEEee-ccCCcEEEEEEccccC---cccHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEE
Q 004400 416 NNFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSKS---KQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIY 491 (756)
Q Consensus 416 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 491 (756)
++|...+.||+|+||.||+|. ..+++.||||.+.... .....++.+|+.+++.++||||+++++++.+++..++||
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 467888999999999999999 4689999999876432 223457889999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCcc
Q 004400 492 EYLENNSLARALFE---HRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEE 568 (756)
Q Consensus 492 e~~~~gsL~~~l~~---~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~ 568 (756)
||+++++|.+++.. ....+++..+..++.|++.||+|||+.+ ++|+||||+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence 99999999998863 2446899999999999999999999986 99999999999999999999999999876543
Q ss_pred cCcceeeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhcCccccccccCCCC
Q 004400 569 ENTHISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGS 648 (756)
Q Consensus 569 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 648 (756)
.... .....|+..|+|||.+.+..++.++||||||+++|+|++|..||...... ......... ....+..
T Consensus 159 ~~~~-~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-~~~~~~~~~------~~~~~~~-- 228 (267)
T cd08229 159 KTTA-AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN-LYSLCKKIE------QCDYPPL-- 228 (267)
T ss_pred CCcc-cccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccch-HHHHhhhhh------cCCCCCC--
Confidence 3221 22346889999999998888999999999999999999999999644321 111111111 1111100
Q ss_pred CCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhccC
Q 004400 649 NFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLECG 686 (756)
Q Consensus 649 ~~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~L~~~ 686 (756)
........+.+++.+||+.+|++|||+.+|++++++.
T Consensus 229 -~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~ 265 (267)
T cd08229 229 -PSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRM 265 (267)
T ss_pred -CcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhh
Confidence 0112334588999999999999999999999998853
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=323.95 Aligned_cols=257 Identities=26% Similarity=0.432 Sum_probs=207.5
Q ss_pred hhcCccccCcccCCCCccEEEeeccC-----CcEEEEEEcccc-CcccHHHHHHHHHHHHhCCCCceeeEeeEEEe-CCe
Q 004400 414 ATNNFATDNNIGEGGFGPVYKGLLAD-----GTAIAVKQLSSK-SKQGNREFINEIGMISALQHPNLVKLYGCCIE-GNQ 486 (756)
Q Consensus 414 ~~~~~~~~~~lg~G~~g~Vy~~~~~~-----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~ 486 (756)
..++|...+.||+|+||.||+|...+ +..|++|.+... .......+.+|+.++++++|+||+++++++.+ +..
T Consensus 4 ~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~ 83 (280)
T cd05043 4 SRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEP 83 (280)
T ss_pred chhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 35688899999999999999999665 788999988654 23335668899999999999999999999876 577
Q ss_pred EEEEEEecCCCCHHHHHHhcC-------CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEcc
Q 004400 487 LLLIYEYLENNSLARALFEHR-------LKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISD 559 (756)
Q Consensus 487 ~~lV~e~~~~gsL~~~l~~~~-------~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~D 559 (756)
.++++||+++|+|.+++.... ..+++..+..++.|++.||+|||+.+ ++||||||+||++++++.+||+|
T Consensus 84 ~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kl~d 160 (280)
T cd05043 84 PFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRG---VIHKDIAARNCVIDEELQVKITD 160 (280)
T ss_pred CEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCHhhEEEcCCCcEEECC
Confidence 899999999999999997532 45899999999999999999999986 99999999999999999999999
Q ss_pred CCccccCcccCcc-eeeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHh-CCCCCCccchhhHHHHHHHHHhcCc
Q 004400 560 FGLAKLDEEENTH-ISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVS-GRSNVTKEDMFYLLDWALVLKEQGK 637 (756)
Q Consensus 560 FGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~ 637 (756)
||+++........ ......++..|+|||++....++.++||||||+++||+++ |+.||...+......+. .....
T Consensus 161 ~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~---~~~~~ 237 (280)
T cd05043 161 NALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYL---KDGYR 237 (280)
T ss_pred CCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHHHH---HcCCC
Confidence 9999865433222 1223456778999999988889999999999999999999 99999765544433221 11111
Q ss_pred cccccccCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhccC
Q 004400 638 LMELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLECG 686 (756)
Q Consensus 638 ~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~L~~~ 686 (756)
. . ....++ ..+.+++.+||+.+|++||++.++++.|+..
T Consensus 238 ~-~-----~~~~~~----~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~ 276 (280)
T cd05043 238 L-A-----QPINCP----DELFAVMACCWALDPEERPSFSQLVQCLTDF 276 (280)
T ss_pred C-C-----CCCcCC----HHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 0 0 011122 3488999999999999999999999999854
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=327.09 Aligned_cols=261 Identities=22% Similarity=0.347 Sum_probs=201.0
Q ss_pred cCccccCcccCCCCccEEEeec-cCCcEEEEEEccccC-cccHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEEe
Q 004400 416 NNFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSKS-KQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYEY 493 (756)
Q Consensus 416 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 493 (756)
++|...+.||+|+||.||+|+. .+++.||+|.+.... ......+.+|++++++++||||+++++++..++..++||||
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 85 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY 85 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence 5688899999999999999984 468899999986542 22335678899999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCcccCcce
Q 004400 494 LENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHI 573 (756)
Q Consensus 494 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~~~~~~ 573 (756)
+++ +|.+++......+++..+..++.|++.||+|||+.| |+||||||+||+++.++.+||+|||+++........
T Consensus 86 ~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~- 160 (309)
T cd07872 86 LDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSVPTKT- 160 (309)
T ss_pred CCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECccccceecCCCccc-
Confidence 985 888888766667899999999999999999999986 999999999999999999999999999754332221
Q ss_pred eeccccCccCCchHhhhc-CCCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhcC------------ccc-
Q 004400 574 STRVAGTIGYMAPEYAMR-GHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQG------------KLM- 639 (756)
Q Consensus 574 ~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~------------~~~- 639 (756)
.....+|+.|+|||.+.+ ..++.++|||||||++|||++|+.||...+............... ...
T Consensus 161 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (309)
T cd07872 161 YSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFKN 240 (309)
T ss_pred cccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhhhh
Confidence 223467899999999865 468999999999999999999999997655433222111110000 000
Q ss_pred -cccccCCCC--CCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 004400 640 -ELVDTNPGS--NFDKEQVMVMINVALLCANASPTIRPSMSSVLR 681 (756)
Q Consensus 640 -~~~~~~~~~--~~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~ 681 (756)
......+.. ...+.....+.+++.+|++.||.+|||+.|+++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 285 (309)
T cd07872 241 YNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK 285 (309)
T ss_pred hhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence 000000000 000112335789999999999999999999976
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-38 Score=334.97 Aligned_cols=238 Identities=25% Similarity=0.340 Sum_probs=194.0
Q ss_pred CcccCCCCccEEEeec----cCCcEEEEEEccccCc--ccHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEEecC
Q 004400 422 NNIGEGGFGPVYKGLL----ADGTAIAVKQLSSKSK--QGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYEYLE 495 (756)
Q Consensus 422 ~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~ 495 (756)
+.||+|+||.||++.. .+|+.||+|++..... .....+.+|++++++++||||+++++++.+++..|+||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 5799999999999874 3688999999875421 233457789999999999999999999999999999999999
Q ss_pred CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCcccCcceee
Q 004400 496 NNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHIST 575 (756)
Q Consensus 496 ~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~ 575 (756)
+|+|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||+++....... ...
T Consensus 82 ~~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~-~~~ 156 (318)
T cd05582 82 GGDLFTRLSKE-VMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK-KAY 156 (318)
T ss_pred CCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHeEECCCCcEEEeeccCCcccCCCCC-cee
Confidence 99999998654 46899999999999999999999986 99999999999999999999999999976443322 223
Q ss_pred ccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhcCccccccccCCCCCCCHHHH
Q 004400 576 RVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDKEQV 655 (756)
Q Consensus 576 ~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 655 (756)
...||+.|+|||.+.+..++.++|||||||++|||++|+.||...+........ .. ... . .+....
T Consensus 157 ~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i---~~-~~~-~---------~p~~~~ 222 (318)
T cd05582 157 SFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMI---LK-AKL-G---------MPQFLS 222 (318)
T ss_pred cccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHHHHHH---Hc-CCC-C---------CCCCCC
Confidence 467999999999999888999999999999999999999999765543322211 11 100 0 111122
Q ss_pred HHHHHHHHHhhcCCCCCCCCHHH
Q 004400 656 MVMINVALLCANASPTIRPSMSS 678 (756)
Q Consensus 656 ~~l~~l~~~c~~~~P~~RPt~~e 678 (756)
..+.+++.+||+.||++||++.+
T Consensus 223 ~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 223 PEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred HHHHHHHHHHhhcCHhHcCCCCC
Confidence 34789999999999999999655
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-37 Score=324.69 Aligned_cols=251 Identities=27% Similarity=0.468 Sum_probs=205.5
Q ss_pred hcCccccCcccCCCCccEEEee-ccCCcEEEEEEccccCcccHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEEe
Q 004400 415 TNNFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYEY 493 (756)
Q Consensus 415 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 493 (756)
..+|+..+.||+|+||.||+|. ..+++.||+|.+..........+.+|+.+++.++|+||++++++|..+...++||||
T Consensus 19 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~ 98 (296)
T cd06654 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (296)
T ss_pred ccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeecc
Confidence 3578889999999999999998 457899999998765555567789999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCcccCcce
Q 004400 494 LENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHI 573 (756)
Q Consensus 494 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~~~~~~ 573 (756)
+++++|.+++... .+++.++..++.|++.||+|||+.| |+||||||+||+++.++.+||+|||++........ .
T Consensus 99 ~~~~~L~~~~~~~--~~~~~~~~~i~~ql~~aL~~LH~~g---i~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~-~ 172 (296)
T cd06654 99 LAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-K 172 (296)
T ss_pred cCCCCHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEECccccchhcccccc-c
Confidence 9999999998643 5789999999999999999999987 99999999999999999999999999875433221 1
Q ss_pred eeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhcCccccccccCCCCCCCHH
Q 004400 574 STRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDKE 653 (756)
Q Consensus 574 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 653 (756)
.....|++.|+|||.+.+..++.++|||||||++|+|++|+.||...+..... .. ..... ... ...+..
T Consensus 173 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~--~~-~~~~~-~~~-------~~~~~~ 241 (296)
T cd06654 173 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRAL--YL-IATNG-TPE-------LQNPEK 241 (296)
T ss_pred cCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhH--HH-HhcCC-CCC-------CCCccc
Confidence 22346889999999999888999999999999999999999999665432211 11 11100 000 011122
Q ss_pred HHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004400 654 QVMVMINVALLCANASPTIRPSMSSVLRM 682 (756)
Q Consensus 654 ~~~~l~~l~~~c~~~~P~~RPt~~ev~~~ 682 (756)
....+.+++.+||..+|++||++.++++.
T Consensus 242 ~~~~l~~li~~~l~~~p~~Rpt~~eil~~ 270 (296)
T cd06654 242 LSAIFRDFLNRCLDMDVEKRGSAKELLQH 270 (296)
T ss_pred cCHHHHHHHHHHCcCCcccCcCHHHHhhC
Confidence 33458899999999999999999999874
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=314.57 Aligned_cols=252 Identities=23% Similarity=0.268 Sum_probs=205.3
Q ss_pred hcCccccCcccCCCCccEEEeecc-CCcEEEEEEccccC---cccHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEE
Q 004400 415 TNNFATDNNIGEGGFGPVYKGLLA-DGTAIAVKQLSSKS---KQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLI 490 (756)
Q Consensus 415 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 490 (756)
.+.|+..+.||+|.-|+||.++.. ++..+|+|++.+.. .....+...|.+||+.++||.++.+|..|+.+...|+|
T Consensus 76 l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~ 155 (459)
T KOG0610|consen 76 LRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLV 155 (459)
T ss_pred HHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEE
Confidence 356778899999999999999965 46899999997752 33345677899999999999999999999999999999
Q ss_pred EEecCCCCHHHHHH-hcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCcc-
Q 004400 491 YEYLENNSLARALF-EHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEE- 568 (756)
Q Consensus 491 ~e~~~~gsL~~~l~-~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~- 568 (756)
||||+||+|....+ +....+++..++.++..|+-||+|||-.| ||+|||||+||||-++|++.|+||.++.....
T Consensus 156 meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlG---ivYRDLKPENILvredGHIMLsDFDLS~~~~~~ 232 (459)
T KOG0610|consen 156 MEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLG---IVYRDLKPENILVREDGHIMLSDFDLSLRCPVS 232 (459)
T ss_pred EecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhc---eeeccCCcceeEEecCCcEEeeeccccccCCCC
Confidence 99999999999987 44667999999999999999999999998 99999999999999999999999998753210
Q ss_pred --------------------------------cCc----------------------ceeeccccCccCCchHhhhcCCC
Q 004400 569 --------------------------------ENT----------------------HISTRVAGTIGYMAPEYAMRGHL 594 (756)
Q Consensus 569 --------------------------------~~~----------------------~~~~~~~gt~~y~aPE~~~~~~~ 594 (756)
... ..+..++||-.|+|||++.+...
T Consensus 233 Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GH 312 (459)
T KOG0610|consen 233 PTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGH 312 (459)
T ss_pred CeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCC
Confidence 000 01223679999999999999999
Q ss_pred CcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhcCccccccccCCCCCCCHHHHHHHHHHHHHhhcCCCCCCC
Q 004400 595 TEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDKEQVMVMINVALLCANASPTIRP 674 (756)
Q Consensus 595 ~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RP 674 (756)
+.++|+|+|||++|||+.|+.||.+.+....+. .++...+.-...+..+....+||++.+.+||++|-
T Consensus 313 gsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~------------NIv~~~l~Fp~~~~vs~~akDLIr~LLvKdP~kRl 380 (459)
T KOG0610|consen 313 GSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLR------------NIVGQPLKFPEEPEVSSAAKDLIRKLLVKDPSKRL 380 (459)
T ss_pred CchhhHHHHHHHHHHHHhCCCCcCCCCchhhHH------------HHhcCCCcCCCCCcchhHHHHHHHHHhccChhhhh
Confidence 999999999999999999999997766433221 11222221111223445689999999999999999
Q ss_pred C----HHHHHH
Q 004400 675 S----MSSVLR 681 (756)
Q Consensus 675 t----~~ev~~ 681 (756)
. +.||-+
T Consensus 381 g~~rGA~eIK~ 391 (459)
T KOG0610|consen 381 GSKRGAAEIKR 391 (459)
T ss_pred ccccchHHhhc
Confidence 8 777643
|
|
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=328.67 Aligned_cols=254 Identities=30% Similarity=0.445 Sum_probs=201.0
Q ss_pred hcCccccCcccCCCCccEEEeecc-CCc--EEEEEEcccc-CcccHHHHHHHHHHHHhC-CCCceeeEeeEEEeCCeEEE
Q 004400 415 TNNFATDNNIGEGGFGPVYKGLLA-DGT--AIAVKQLSSK-SKQGNREFINEIGMISAL-QHPNLVKLYGCCIEGNQLLL 489 (756)
Q Consensus 415 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~--~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l 489 (756)
.++|+..+.||+|+||.||+|... ++. .+|+|.+... .......+.+|++++.++ +||||+++++++.+++..++
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~l 85 (303)
T cd05088 6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL 85 (303)
T ss_pred hhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceE
Confidence 457888899999999999999954 454 4677777643 233456788999999999 89999999999999999999
Q ss_pred EEEecCCCCHHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCC
Q 004400 490 IYEYLENNSLARALFEHR---------------LKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLN 554 (756)
Q Consensus 490 V~e~~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~ 554 (756)
||||+++|+|.+++.... ..+++.++..++.|++.||+|||+.| |+||||||+|||++.++.
T Consensus 86 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dlkp~Nili~~~~~ 162 (303)
T cd05088 86 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYV 162 (303)
T ss_pred EEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEecCCCc
Confidence 999999999999997432 25789999999999999999999986 999999999999999999
Q ss_pred EEEccCCccccCcccCcceeeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHh-CCCCCCccchhhHHHHHHHHH
Q 004400 555 SKISDFGLAKLDEEENTHISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVS-GRSNVTKEDMFYLLDWALVLK 633 (756)
Q Consensus 555 ~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~ 633 (756)
+||+|||+++...... ......++..|+|||++.+..++.++|||||||++|||+| |..||...+....... ..
T Consensus 163 ~kl~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~---~~ 237 (303)
T cd05088 163 AKIADFGLSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEK---LP 237 (303)
T ss_pred EEeCccccCcccchhh--hcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHHHHHH---Hh
Confidence 9999999986422111 1111234668999999988889999999999999999998 9999965544332221 11
Q ss_pred hcCccccccccCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhccC
Q 004400 634 EQGKLMELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLECG 686 (756)
Q Consensus 634 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~L~~~ 686 (756)
. ..... ..... ...+.+++.+||+.+|++||++.++++.|+.+
T Consensus 238 ~-~~~~~-----~~~~~----~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~ 280 (303)
T cd05088 238 Q-GYRLE-----KPLNC----DDEVYDLMRQCWREKPYERPSFAQILVSLNRM 280 (303)
T ss_pred c-CCcCC-----CCCCC----CHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 1 00000 01112 23478999999999999999999999998854
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-39 Score=310.12 Aligned_cols=247 Identities=28% Similarity=0.420 Sum_probs=210.6
Q ss_pred cCccccCcccCCCCccEEEeec-cCCcEEEEEEccccCcccHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEEec
Q 004400 416 NNFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYEYL 494 (756)
Q Consensus 416 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~ 494 (756)
+-|++..+||+|+||.||+|.+ ..|..+|||.+... .+.+++..|+.++++.+.|++|++||.|.....+|+|||||
T Consensus 33 EVFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~--sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYC 110 (502)
T KOG0574|consen 33 EVFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD--TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYC 110 (502)
T ss_pred HHHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc--chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhc
Confidence 4577888999999999999995 57999999998653 45688999999999999999999999999999999999999
Q ss_pred CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCcccCccee
Q 004400 495 ENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHIS 574 (756)
Q Consensus 495 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~~~~~~~ 574 (756)
..|+..|.++.+++.+++.++..++...++||+|||.. +-||||||+.|||++.+|.+|++|||.|-...+... ..
T Consensus 111 GAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~---~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMA-KR 186 (502)
T KOG0574|consen 111 GAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDL---KKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMA-KR 186 (502)
T ss_pred CCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHH---HHHHhhcccccEEEcccchhhhhhccccchhhhhHH-hh
Confidence 99999999998888999999999999999999999987 479999999999999999999999999975443222 23
Q ss_pred eccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhcCccccccccCCCC--CCCH
Q 004400 575 TRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGS--NFDK 652 (756)
Q Consensus 575 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~ 652 (756)
.++.||+.|||||++..-.|+.++||||+|+...||..|++||..-... ...-++...+.. ..+.
T Consensus 187 NTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPM-------------RAIFMIPT~PPPTF~KPE 253 (502)
T KOG0574|consen 187 NTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPM-------------RAIFMIPTKPPPTFKKPE 253 (502)
T ss_pred CccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCccccccc-------------ceeEeccCCCCCCCCChH
Confidence 4578999999999999999999999999999999999999998433221 112223333333 3355
Q ss_pred HHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 004400 653 EQVMVMINVALLCANASPTIRPSMSSVLR 681 (756)
Q Consensus 653 ~~~~~l~~l~~~c~~~~P~~RPt~~ev~~ 681 (756)
.....+-++++.|+-..|++|-|+.++.+
T Consensus 254 ~WS~~F~DFi~~CLiK~PE~R~TA~~L~~ 282 (502)
T KOG0574|consen 254 EWSSEFNDFIRSCLIKKPEERKTALRLCE 282 (502)
T ss_pred hhhhHHHHHHHHHhcCCHHHHHHHHHHhh
Confidence 56778999999999999999999998854
|
|
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-37 Score=318.35 Aligned_cols=253 Identities=28% Similarity=0.439 Sum_probs=206.0
Q ss_pred hcCccccCcccCCCCccEEEeeccCCcEEEEEEccccCcccHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEEec
Q 004400 415 TNNFATDNNIGEGGFGPVYKGLLADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYEYL 494 (756)
Q Consensus 415 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~ 494 (756)
.++|...+.||+|+||.||+|...++..+|+|.+... ......+.+|++++++++|+||+++++++.+ ...++||||+
T Consensus 5 ~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~ 82 (260)
T cd05073 5 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPG-SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFM 82 (260)
T ss_pred ccceeEEeEecCccceEEEEEEecCCccEEEEecCCC-hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEeC
Confidence 3578889999999999999999878888999988653 2345678999999999999999999999887 7789999999
Q ss_pred CCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCcccCcce
Q 004400 495 ENNSLARALFEH-RLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHI 573 (756)
Q Consensus 495 ~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~~~~~~ 573 (756)
++|+|.+++... ...+++..+..++.|++.||+|||+.| ++||||||+||+++.++.+||+|||.+..........
T Consensus 83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~ 159 (260)
T cd05073 83 AKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTA 159 (260)
T ss_pred CCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCCcceeeccCCCccc
Confidence 999999999753 446899999999999999999999986 9999999999999999999999999997654332222
Q ss_pred eeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHh-CCCCCCccchhhHHHHHHHHHhcCccccccccCCCCCCCH
Q 004400 574 STRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVS-GRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDK 652 (756)
Q Consensus 574 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 652 (756)
.....++..|+|||++....++.++|||||||++|++++ |+.||...+......+. ..+..... ..
T Consensus 160 ~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~----~~~~~~~~---------~~ 226 (260)
T cd05073 160 REGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRAL----ERGYRMPR---------PE 226 (260)
T ss_pred ccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHH----hCCCCCCC---------cc
Confidence 223346678999999998889999999999999999999 89998665443333221 11111110 11
Q ss_pred HHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhcc
Q 004400 653 EQVMVMINVALLCANASPTIRPSMSSVLRMLEC 685 (756)
Q Consensus 653 ~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~L~~ 685 (756)
.....+.+++.+|++.+|++||++.++.+.|+.
T Consensus 227 ~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 227 NCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred cCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 123348899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=332.53 Aligned_cols=255 Identities=20% Similarity=0.246 Sum_probs=199.4
Q ss_pred cCccccCcccCCCCccEEEeecc-CCcEEEEEEcccc---CcccHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEE
Q 004400 416 NNFATDNNIGEGGFGPVYKGLLA-DGTAIAVKQLSSK---SKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIY 491 (756)
Q Consensus 416 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 491 (756)
++|+..+.||+|+||.||+++.. +++.||+|.+.+. .......+.+|+.++..++|++|+++++++.+++..++||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 46888999999999999999954 5788999998642 1222345788999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCcccCc
Q 004400 492 EYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENT 571 (756)
Q Consensus 492 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~~~~ 571 (756)
||+++|+|.+++......+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++........
T Consensus 81 ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~---iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~ 157 (332)
T cd05623 81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGT 157 (332)
T ss_pred eccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEeecchheecccCCc
Confidence 999999999999876667999999999999999999999986 99999999999999999999999999975543333
Q ss_pred ceeeccccCccCCchHhhh-----cCCCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhcCccccccccCC
Q 004400 572 HISTRVAGTIGYMAPEYAM-----RGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNP 646 (756)
Q Consensus 572 ~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 646 (756)
.......||+.|+|||++. ...++.++|||||||++|||++|+.||...+....... ............ .
T Consensus 158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~---i~~~~~~~~~p~--~ 232 (332)
T cd05623 158 VQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGK---IMNHKERFQFPA--Q 232 (332)
T ss_pred ceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHH---HhCCCccccCCC--c
Confidence 3334467999999999986 34688999999999999999999999976654332221 111111111110 0
Q ss_pred CCCCCHHHHHHHHHHHHHhhcCCCC--CCCCHHHHHHH
Q 004400 647 GSNFDKEQVMVMINVALLCANASPT--IRPSMSSVLRM 682 (756)
Q Consensus 647 ~~~~~~~~~~~l~~l~~~c~~~~P~--~RPt~~ev~~~ 682 (756)
.... ...+.+++.+|+..++. .|+++.|+++.
T Consensus 233 ~~~~----s~~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 233 VTDV----SEDAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred cccC----CHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 0112 23477888887755444 46889888765
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=331.18 Aligned_cols=237 Identities=24% Similarity=0.365 Sum_probs=189.2
Q ss_pred CcccCCCCccEEEeec-cCCcEEEEEEccccC---cccHHHHHHHHH-HHHhCCCCceeeEeeEEEeCCeEEEEEEecCC
Q 004400 422 NNIGEGGFGPVYKGLL-ADGTAIAVKQLSSKS---KQGNREFINEIG-MISALQHPNLVKLYGCCIEGNQLLLIYEYLEN 496 (756)
Q Consensus 422 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~ 496 (756)
+.||+|+||.||+|+. .+++.||+|.+.... ......+.+|.. +++.++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 4699999999999995 568899999986532 222344555654 57889999999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCcccCcceeec
Q 004400 497 NSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTR 576 (756)
Q Consensus 497 gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~ 576 (756)
|+|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||+++...... .....
T Consensus 81 ~~L~~~l~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~-~~~~~ 155 (321)
T cd05603 81 GELFFHLQRE-RCFLEPRARFYAAEVASAIGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPE-ETTST 155 (321)
T ss_pred CCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEccCCCCccCCCCC-Ccccc
Confidence 9999888654 46888999999999999999999986 9999999999999999999999999987532221 12334
Q ss_pred cccCccCCchHhhhcCCCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhcCccccccccCCCCCCCHHHHH
Q 004400 577 VAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDKEQVM 656 (756)
Q Consensus 577 ~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 656 (756)
..||+.|+|||++.+..++.++|||||||++|||++|+.||...+........ .. .. .. .+.....
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i---~~-~~-~~---------~~~~~~~ 221 (321)
T cd05603 156 FCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNI---LH-KP-LQ---------LPGGKTV 221 (321)
T ss_pred ccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHH---hc-CC-CC---------CCCCCCH
Confidence 67999999999999888999999999999999999999999776543322211 11 10 01 1111233
Q ss_pred HHHHHHHHhhcCCCCCCCCHH
Q 004400 657 VMINVALLCANASPTIRPSMS 677 (756)
Q Consensus 657 ~l~~l~~~c~~~~P~~RPt~~ 677 (756)
.+.+++.+|++.+|.+||+..
T Consensus 222 ~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 222 AACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred HHHHHHHHHccCCHhhcCCCC
Confidence 488999999999999999764
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=338.05 Aligned_cols=257 Identities=26% Similarity=0.406 Sum_probs=202.7
Q ss_pred hcCccccCcccCCCCccEEEeecc------CCcEEEEEEccccCc-ccHHHHHHHHHHHHhCC-CCceeeEeeEEEeCCe
Q 004400 415 TNNFATDNNIGEGGFGPVYKGLLA------DGTAIAVKQLSSKSK-QGNREFINEIGMISALQ-HPNLVKLYGCCIEGNQ 486 (756)
Q Consensus 415 ~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~ 486 (756)
.++|...+.||+|+||.||+|++. .++.||+|+++.... ...+.+.+|+.++.++. |||||+++++|...+.
T Consensus 36 ~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~~ 115 (401)
T cd05107 36 RDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGGP 115 (401)
T ss_pred HHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCCC
Confidence 346778899999999999999853 346899999975432 22357889999999997 9999999999999999
Q ss_pred EEEEEEecCCCCHHHHHHhcC-----------------------------------------------------------
Q 004400 487 LLLIYEYLENNSLARALFEHR----------------------------------------------------------- 507 (756)
Q Consensus 487 ~~lV~e~~~~gsL~~~l~~~~----------------------------------------------------------- 507 (756)
.++||||+++|+|.++++...
T Consensus 116 ~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (401)
T cd05107 116 IYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQDM 195 (401)
T ss_pred cEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhcc
Confidence 999999999999999996432
Q ss_pred --------------------------------------CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEe
Q 004400 508 --------------------------------------LKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLL 549 (756)
Q Consensus 508 --------------------------------------~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill 549 (756)
..+++..+.+++.|++.||+|||+.+ |+||||||+||++
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrdlkp~NiLl 272 (401)
T cd05107 196 KGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKN---CVHRDLAARNVLI 272 (401)
T ss_pred hhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC---cCcccCCcceEEE
Confidence 23677888999999999999999886 9999999999999
Q ss_pred cCCCCEEEccCCccccCcccCc-ceeeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHh-CCCCCCccchhhHHH
Q 004400 550 DKDLNSKISDFGLAKLDEEENT-HISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVS-GRSNVTKEDMFYLLD 627 (756)
Q Consensus 550 ~~~~~~kl~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~~ 627 (756)
++++.+||+|||+++....... .......++..|+|||.+....++.++|||||||++|||++ |+.||..........
T Consensus 273 ~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~~~ 352 (401)
T cd05107 273 CEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQFY 352 (401)
T ss_pred eCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchHHHH
Confidence 9999999999999986433221 11223457889999999998889999999999999999998 888985433222111
Q ss_pred HHHHHHhcCccccccccCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhccC
Q 004400 628 WALVLKEQGKLMELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLECG 686 (756)
Q Consensus 628 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~L~~~ 686 (756)
... ..+.... .+......+.+++.+||+.+|.+||++++|++.|+..
T Consensus 353 --~~~-~~~~~~~---------~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~ 399 (401)
T cd05107 353 --NAI-KRGYRMA---------KPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDL 399 (401)
T ss_pred --HHH-HcCCCCC---------CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 111 1111111 1111223588999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-37 Score=316.95 Aligned_cols=247 Identities=30% Similarity=0.445 Sum_probs=200.5
Q ss_pred cCccccCcccCCCCccEEEeeccCCcEEEEEEccccCcccHHHHHHHHHHHHhCCCCceeeEeeEEE-eCCeEEEEEEec
Q 004400 416 NNFATDNNIGEGGFGPVYKGLLADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCCI-EGNQLLLIYEYL 494 (756)
Q Consensus 416 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~-~~~~~~lV~e~~ 494 (756)
++|...+.||+|+||.||+|... |..||+|.+... ...+.+.+|+.++++++|+|++++++++. +++..++||||+
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~ 82 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 82 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCC--chHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECC
Confidence 47788899999999999999765 778999998643 23467899999999999999999999765 456789999999
Q ss_pred CCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCcccCcce
Q 004400 495 ENNSLARALFEHR-LKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHI 573 (756)
Q Consensus 495 ~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~~~~~~ 573 (756)
++++|.+++.... ..+++..+..++.|++.||+|||++| |+||||||+||++++++.+||+|||+++......
T Consensus 83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~--- 156 (256)
T cd05082 83 AKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ--- 156 (256)
T ss_pred CCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccccchheEEEcCCCcEEecCCccceeccccC---
Confidence 9999999997543 35899999999999999999999986 9999999999999999999999999987543221
Q ss_pred eeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHh-CCCCCCccchhhHHHHHHHHHhcCccccccccCCCCCCCH
Q 004400 574 STRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVS-GRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDK 652 (756)
Q Consensus 574 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 652 (756)
....++..|+|||++....++.++|||||||++|||++ |+.||...+......+. ..+..... ..
T Consensus 157 -~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~----~~~~~~~~---------~~ 222 (256)
T cd05082 157 -DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRV----EKGYKMDA---------PD 222 (256)
T ss_pred -CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH----hcCCCCCC---------CC
Confidence 22345678999999988889999999999999999998 99998655443332221 11111111 11
Q ss_pred HHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhcc
Q 004400 653 EQVMVMINVALLCANASPTIRPSMSSVLRMLEC 685 (756)
Q Consensus 653 ~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~L~~ 685 (756)
.....+.+++.+||+.+|++|||+.++++.|+.
T Consensus 223 ~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 255 (256)
T cd05082 223 GCPPVVYDVMKQCWHLDAATRPSFLQLREQLEH 255 (256)
T ss_pred CCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhc
Confidence 123358899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-37 Score=319.31 Aligned_cols=257 Identities=26% Similarity=0.350 Sum_probs=205.1
Q ss_pred HHHhhcCccccCcccCCCCccEEEee-ccCCcEEEEEEccccCcccHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEE
Q 004400 411 IKAATNNFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLL 489 (756)
Q Consensus 411 ~~~~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 489 (756)
++.+++++.....||+|+||.||+|. ..++..||+|.+........+.+.+|+.++++++|+||+++++++..++..++
T Consensus 3 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 82 (268)
T cd06624 3 YEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKI 82 (268)
T ss_pred cccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEE
Confidence 44567778888899999999999999 45678899999877655566789999999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHHhcCCCC--CHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecC-CCCEEEccCCccccC
Q 004400 490 IYEYLENNSLARALFEHRLKL--DWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDK-DLNSKISDFGLAKLD 566 (756)
Q Consensus 490 V~e~~~~gsL~~~l~~~~~~l--~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~-~~~~kl~DFGla~~~ 566 (756)
|+||+++++|.+++......+ ++..+..++.|++.||+|||+.+ |+||||||+||+++. ++.++|+|||.+...
T Consensus 83 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~ 159 (268)
T cd06624 83 FMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLVNTYSGVVKISDFGTSKRL 159 (268)
T ss_pred EEecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCeEEEecchhheec
Confidence 999999999999998654455 88899999999999999999986 999999999999986 678999999998765
Q ss_pred cccCcceeeccccCccCCchHhhhcCC--CCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhcCcccccccc
Q 004400 567 EEENTHISTRVAGTIGYMAPEYAMRGH--LTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDT 644 (756)
Q Consensus 567 ~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 644 (756)
...... .....|+..|+|||++.+.. ++.++||||||+++|+|++|+.||...+......+...... .
T Consensus 160 ~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~~~~--~------- 229 (268)
T cd06624 160 AGINPC-TETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFK--I------- 229 (268)
T ss_pred ccCCCc-cccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhhhhc--c-------
Confidence 432221 22345889999999987643 78899999999999999999999854332221111110000 0
Q ss_pred CCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004400 645 NPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRM 682 (756)
Q Consensus 645 ~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~ 682 (756)
....+......+.+++.+||+.+|++||++.|+++.
T Consensus 230 --~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 265 (268)
T cd06624 230 --HPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQD 265 (268)
T ss_pred --CCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHhC
Confidence 011122233458899999999999999999998763
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-37 Score=318.24 Aligned_cols=257 Identities=25% Similarity=0.432 Sum_probs=207.5
Q ss_pred cCccccCcccCCCCccEEEeecc-CCcEEEEEEcccc---CcccHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEE
Q 004400 416 NNFATDNNIGEGGFGPVYKGLLA-DGTAIAVKQLSSK---SKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIY 491 (756)
Q Consensus 416 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 491 (756)
++|+..+.||+|+||.||+|... +|+.||+|.++.. .....+.+.+|++++++++|+|++++++++.+++..++||
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 57889999999999999999965 8999999988642 2233567899999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCcc
Q 004400 492 EYLENNSLARALFE---HRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEE 568 (756)
Q Consensus 492 e~~~~gsL~~~l~~---~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~ 568 (756)
||+++|+|.+++.. ....+++..+..++.+++.||+|||+.| |+||||||+||+++.++.++|+|||+++....
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~ 158 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKR---IMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence 99999999998863 2446899999999999999999999986 99999999999999999999999999876543
Q ss_pred cCcceeeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhcCccccccccCCCC
Q 004400 569 ENTHISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGS 648 (756)
Q Consensus 569 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 648 (756)
.... .....|+..|+|||.+.+..++.++|||||||++|+|++|+.||..... ...+...... .+... +.+.
T Consensus 159 ~~~~-~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-~~~~~~~~~~-~~~~~----~~~~- 230 (267)
T cd08224 159 KTTA-AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM-NLYSLCKKIE-KCDYP----PLPA- 230 (267)
T ss_pred CCcc-cceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCc-cHHHHHhhhh-cCCCC----CCCh-
Confidence 3221 2234688899999999888899999999999999999999999854431 1111111111 11111 1111
Q ss_pred CCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhccC
Q 004400 649 NFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLECG 686 (756)
Q Consensus 649 ~~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~L~~~ 686 (756)
......+.+++.+||+.+|++||++.+|+++|+.+
T Consensus 231 ---~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~ 265 (267)
T cd08224 231 ---DHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEM 265 (267)
T ss_pred ---hhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHh
Confidence 12234588999999999999999999999999854
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-37 Score=317.18 Aligned_cols=249 Identities=31% Similarity=0.501 Sum_probs=205.6
Q ss_pred hcCccccCcccCCCCccEEEeeccCCcEEEEEEccccCcccHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEEec
Q 004400 415 TNNFATDNNIGEGGFGPVYKGLLADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYEYL 494 (756)
Q Consensus 415 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~ 494 (756)
.++|...+.||+|+||.||+|... |+.||+|.+..... ..+.+.+|+.++++++|+||+++++++.++...++||||+
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 82 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYM 82 (256)
T ss_pred hhhccceeeeecCCCceEEEEEec-CcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEec
Confidence 457888899999999999999865 78899999976544 4678999999999999999999999999999999999999
Q ss_pred CCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCcccCcce
Q 004400 495 ENNSLARALFEHR-LKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHI 573 (756)
Q Consensus 495 ~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~~~~~~ 573 (756)
++++|.+++.... ..+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||.++.......
T Consensus 83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~-- 157 (256)
T cd05039 83 AKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKN---FVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD-- 157 (256)
T ss_pred CCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccchhcccceEEEeCCCCEEEcccccccccccccc--
Confidence 9999999997543 36899999999999999999999986 99999999999999999999999999986533221
Q ss_pred eeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHh-CCCCCCccchhhHHHHHHHHHhcCccccccccCCCCCCCH
Q 004400 574 STRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVS-GRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDK 652 (756)
Q Consensus 574 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 652 (756)
...++..|+|||++..+.++.++||||||+++||+++ |+.||............ ..+..... ...+
T Consensus 158 --~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~----~~~~~~~~-----~~~~-- 224 (256)
T cd05039 158 --SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHV----EKGYRMEA-----PEGC-- 224 (256)
T ss_pred --cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH----hcCCCCCC-----ccCC--
Confidence 2335678999999988889999999999999999997 99998655433322211 11111111 1112
Q ss_pred HHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhcc
Q 004400 653 EQVMVMINVALLCANASPTIRPSMSSVLRMLEC 685 (756)
Q Consensus 653 ~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~L~~ 685 (756)
+..+.+++.+|+..+|++||++.+++++|+.
T Consensus 225 --~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 255 (256)
T cd05039 225 --PPEVYKVMKDCWELDPAKRPTFKQLREQLAL 255 (256)
T ss_pred --CHHHHHHHHHHhccChhhCcCHHHHHHHHhc
Confidence 2348899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=330.31 Aligned_cols=245 Identities=22% Similarity=0.313 Sum_probs=192.9
Q ss_pred CcccCCCCccEEEeec-cCCcEEEEEEccccC---cccHHHHHHHHHHHHhC-CCCceeeEeeEEEeCCeEEEEEEecCC
Q 004400 422 NNIGEGGFGPVYKGLL-ADGTAIAVKQLSSKS---KQGNREFINEIGMISAL-QHPNLVKLYGCCIEGNQLLLIYEYLEN 496 (756)
Q Consensus 422 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~e~~~~ 496 (756)
+.||+|+||.||+|.. .+++.||+|+++... ......+.+|..++..+ +||||++++++|.+++..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 4689999999999994 578999999997532 22335578899999988 799999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCcccCcceeec
Q 004400 497 NSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTR 576 (756)
Q Consensus 497 gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~ 576 (756)
|+|.+++... ..+++..+..++.|++.||+|||++| |+||||||+||+++.++.+||+|||+++...... .....
T Consensus 81 g~L~~~~~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~-~~~~~ 155 (329)
T cd05588 81 GDLMFHMQRQ-RKLPEEHARFYSAEISLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPG-DTTST 155 (329)
T ss_pred CCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEECcCccccccccCC-Ccccc
Confidence 9999988654 47999999999999999999999987 9999999999999999999999999987422211 12234
Q ss_pred cccCccCCchHhhhcCCCCcccchhhHHHHHHHHHhCCCCCCccchh-----hHHHHHHHHHhcCccccccccCCCCCCC
Q 004400 577 VAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMF-----YLLDWALVLKEQGKLMELVDTNPGSNFD 651 (756)
Q Consensus 577 ~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 651 (756)
..||+.|+|||++.+..++.++|||||||++|||++|+.||...... ...++.......... . .....
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~-~-----~p~~~- 228 (329)
T cd05588 156 FCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQI-R-----IPRSL- 228 (329)
T ss_pred ccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCC-C-----CCCCC-
Confidence 67999999999999989999999999999999999999999532111 111111111111110 0 11112
Q ss_pred HHHHHHHHHHHHHhhcCCCCCCCC------HHHHHH
Q 004400 652 KEQVMVMINVALLCANASPTIRPS------MSSVLR 681 (756)
Q Consensus 652 ~~~~~~l~~l~~~c~~~~P~~RPt------~~ev~~ 681 (756)
...+.+++.+|++.||.+||+ +.++++
T Consensus 229 ---~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~ 261 (329)
T cd05588 229 ---SVKASSVLKGFLNKDPKERLGCHPQTGFRDIKS 261 (329)
T ss_pred ---CHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhc
Confidence 234788999999999999998 556543
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=327.68 Aligned_cols=259 Identities=27% Similarity=0.438 Sum_probs=206.5
Q ss_pred hhcCccccCcccCCCCccEEEeec--------cCCcEEEEEEccccC-cccHHHHHHHHHHHHhC-CCCceeeEeeEEEe
Q 004400 414 ATNNFATDNNIGEGGFGPVYKGLL--------ADGTAIAVKQLSSKS-KQGNREFINEIGMISAL-QHPNLVKLYGCCIE 483 (756)
Q Consensus 414 ~~~~~~~~~~lg~G~~g~Vy~~~~--------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~ 483 (756)
..++|...+.||+|+||.||+|+. .++..||+|.+.... ....+.+.+|+.+++.+ +||||+++++++..
T Consensus 13 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~ 92 (304)
T cd05101 13 SRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 92 (304)
T ss_pred cHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEec
Confidence 346788889999999999999963 134579999986542 33456789999999999 89999999999999
Q ss_pred CCeEEEEEEecCCCCHHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceE
Q 004400 484 GNQLLLIYEYLENNSLARALFEHR---------------LKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVL 548 (756)
Q Consensus 484 ~~~~~lV~e~~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nil 548 (756)
+...++||||+++|+|.+++.... ..+++.++..++.||+.||+|||+.| |+||||||+||+
T Consensus 93 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nil 169 (304)
T cd05101 93 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK---CIHRDLAARNVL 169 (304)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCC---eeecccccceEE
Confidence 999999999999999999997532 35788999999999999999999986 999999999999
Q ss_pred ecCCCCEEEccCCccccCcccCcce-eeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHh-CCCCCCccchhhHH
Q 004400 549 LDKDLNSKISDFGLAKLDEEENTHI-STRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVS-GRSNVTKEDMFYLL 626 (756)
Q Consensus 549 l~~~~~~kl~DFGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~ 626 (756)
+++++.+||+|||+++......... .....++..|+|||++.+..++.++||||||+++||+++ |..||.........
T Consensus 170 i~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~ 249 (304)
T cd05101 170 VTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELF 249 (304)
T ss_pred EcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHH
Confidence 9999999999999998664432221 222346778999999988889999999999999999998 78888654433322
Q ss_pred HHHHHHHhcCccccccccCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhccCcc
Q 004400 627 DWALVLKEQGKLMELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLECGVD 688 (756)
Q Consensus 627 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~L~~~~~ 688 (756)
.. .. ....... +......+.+++.+||+.+|.+||++.|+++.|+++..
T Consensus 250 ~~---~~-~~~~~~~---------~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~ 298 (304)
T cd05101 250 KL---LK-EGHRMDK---------PANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILT 298 (304)
T ss_pred HH---HH-cCCcCCC---------CCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHH
Confidence 21 11 1111111 11123458889999999999999999999999987644
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-37 Score=316.11 Aligned_cols=250 Identities=27% Similarity=0.430 Sum_probs=206.3
Q ss_pred hcCccccCcccCCCCccEEEeecc-CCcEEEEEEccccCcccHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEEe
Q 004400 415 TNNFATDNNIGEGGFGPVYKGLLA-DGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYEY 493 (756)
Q Consensus 415 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 493 (756)
.++|+..+.||+|+||.||+|... +++.|++|.+..... .+.+.+|++++++++||||+++++++.++...++++||
T Consensus 2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~ 79 (256)
T cd06612 2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEY 79 (256)
T ss_pred cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEec
Confidence 357888999999999999999965 488999999865432 67899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCcccCcce
Q 004400 494 LENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHI 573 (756)
Q Consensus 494 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~~~~~~ 573 (756)
+++++|.+++......+++..+..++.|++.||+|||+.+ ++||||+|+||+++.++.+||+|||++........ .
T Consensus 80 ~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~-~ 155 (256)
T cd06612 80 CGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNK---KIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA-K 155 (256)
T ss_pred CCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEECCCCcEEEcccccchhcccCcc-c
Confidence 9999999999876778999999999999999999999986 99999999999999999999999999986554322 2
Q ss_pred eeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhcCccccccccCCCCCCCHH
Q 004400 574 STRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDKE 653 (756)
Q Consensus 574 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 653 (756)
.....|+..|+|||++.+..++.++||||||+++|+|++|+.||........... . ... .......+..
T Consensus 156 ~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~---~-~~~-------~~~~~~~~~~ 224 (256)
T cd06612 156 RNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFM---I-PNK-------PPPTLSDPEK 224 (256)
T ss_pred cccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhh---h-ccC-------CCCCCCchhh
Confidence 2334588999999999988999999999999999999999999965433221110 0 000 0000111222
Q ss_pred HHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 004400 654 QVMVMINVALLCANASPTIRPSMSSVLR 681 (756)
Q Consensus 654 ~~~~l~~l~~~c~~~~P~~RPt~~ev~~ 681 (756)
....+.+++.+||+.+|++||++.||++
T Consensus 225 ~~~~~~~~i~~~l~~~P~~Rps~~~il~ 252 (256)
T cd06612 225 WSPEFNDFVKKCLVKDPEERPSAIQLLQ 252 (256)
T ss_pred cCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence 3345889999999999999999999976
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-37 Score=314.55 Aligned_cols=247 Identities=30% Similarity=0.460 Sum_probs=201.2
Q ss_pred CcccCCCCccEEEeeccCCcEEEEEEccccCcc-cHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEEecCCCCHH
Q 004400 422 NNIGEGGFGPVYKGLLADGTAIAVKQLSSKSKQ-GNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYEYLENNSLA 500 (756)
Q Consensus 422 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL~ 500 (756)
+.||+|+||.||+|...+++.||+|.+...... ....+.+|++++++++|+||+++++++.+....++||||+++++|.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~ 80 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL 80 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence 479999999999999777999999998765333 4567899999999999999999999999999999999999999999
Q ss_pred HHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCcccCccee-ecccc
Q 004400 501 RALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHIS-TRVAG 579 (756)
Q Consensus 501 ~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~~~~~~~-~~~~g 579 (756)
+++......+++..+..++.+++.||+|||+++ ++||||||+||+++.++.+||+|||++........... ....+
T Consensus 81 ~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~ 157 (251)
T cd05041 81 TFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQI 157 (251)
T ss_pred HHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---EehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCcc
Confidence 999766667899999999999999999999986 99999999999999999999999999986542221111 12234
Q ss_pred CccCCchHhhhcCCCCcccchhhHHHHHHHHHh-CCCCCCccchhhHHHHHHHHHhcCccccccccCCCCCCCHHHHHHH
Q 004400 580 TIGYMAPEYAMRGHLTEKADVYSFGIVALEIVS-GRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDKEQVMVM 658 (756)
Q Consensus 580 t~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 658 (756)
+..|+|||.+.++.++.++|||||||++|||++ |..||............ ..... ...+...+..+
T Consensus 158 ~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~----~~~~~---------~~~~~~~~~~~ 224 (251)
T cd05041 158 PIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERI----ESGYR---------MPAPQLCPEEI 224 (251)
T ss_pred eeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHH----hcCCC---------CCCCccCCHHH
Confidence 667999999988899999999999999999999 78888655432222211 11100 01111223458
Q ss_pred HHHHHHhhcCCCCCCCCHHHHHHHhc
Q 004400 659 INVALLCANASPTIRPSMSSVLRMLE 684 (756)
Q Consensus 659 ~~l~~~c~~~~P~~RPt~~ev~~~L~ 684 (756)
.+++.+|++.+|.+||++.|+++.|+
T Consensus 225 ~~li~~~l~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 225 YRLMLQCWAYDPENRPSFSEIYNELQ 250 (251)
T ss_pred HHHHHHHhccChhhCcCHHHHHHHhh
Confidence 99999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=343.67 Aligned_cols=259 Identities=21% Similarity=0.287 Sum_probs=194.2
Q ss_pred hhcCccccCcccCCCCccEEEeec-cCCcEEEEEEccccCcccHHHHHHHHHHHHhCCCCceeeEeeEEEeC--------
Q 004400 414 ATNNFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCCIEG-------- 484 (756)
Q Consensus 414 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-------- 484 (756)
..++|...+.||+|+||.||+|.. .+++.||||++.... ....+|+.+++.++|||||++++++...
T Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~ 139 (440)
T PTZ00036 64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKN 139 (440)
T ss_pred cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCc
Confidence 346799999999999999999995 568899999885432 2345799999999999999999987532
Q ss_pred CeEEEEEEecCCCCHHHHHH---hcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCC-CEEEccC
Q 004400 485 NQLLLIYEYLENNSLARALF---EHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDL-NSKISDF 560 (756)
Q Consensus 485 ~~~~lV~e~~~~gsL~~~l~---~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~-~~kl~DF 560 (756)
...++||||+++ +|.+++. .....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++ .+||+||
T Consensus 140 ~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~---IiHrDLKp~NILl~~~~~~vkL~DF 215 (440)
T PTZ00036 140 IFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDF 215 (440)
T ss_pred eEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCcCHHHEEEcCCCCceeeecc
Confidence 246799999985 6766664 24457899999999999999999999997 99999999999999665 6999999
Q ss_pred CccccCcccCcceeeccccCccCCchHhhhcC-CCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhcCc--
Q 004400 561 GLAKLDEEENTHISTRVAGTIGYMAPEYAMRG-HLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGK-- 637 (756)
Q Consensus 561 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~-- 637 (756)
|+|+....... .....||+.|+|||++.+. .++.++|||||||++|||++|+.||.+..................
T Consensus 216 Gla~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~ 293 (440)
T PTZ00036 216 GSAKNLLAGQR--SVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTED 293 (440)
T ss_pred ccchhccCCCC--cccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Confidence 99986543222 2335689999999998764 689999999999999999999999976654333222111111000
Q ss_pred --------cccc-----cccCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004400 638 --------LMEL-----VDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRM 682 (756)
Q Consensus 638 --------~~~~-----~~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~ 682 (756)
.... ........++......+.+++.+||+.||.+|||+.|+++.
T Consensus 294 ~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~h 351 (440)
T PTZ00036 294 QLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALAD 351 (440)
T ss_pred HHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCC
Confidence 0000 00000000111123458899999999999999999999743
|
|
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-37 Score=320.93 Aligned_cols=239 Identities=24% Similarity=0.368 Sum_probs=190.0
Q ss_pred cccCCCCccEEEeeccC-------------------------CcEEEEEEccccCcccHHHHHHHHHHHHhCCCCceeeE
Q 004400 423 NIGEGGFGPVYKGLLAD-------------------------GTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKL 477 (756)
Q Consensus 423 ~lg~G~~g~Vy~~~~~~-------------------------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l 477 (756)
.||+|+||.||+|.+.. ...||+|.+..........|.+|+.+++.++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 69999999999997421 13588999876544445678899999999999999999
Q ss_pred eeEEEeCCeEEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCC----
Q 004400 478 YGCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDL---- 553 (756)
Q Consensus 478 ~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~---- 553 (756)
+++|.++...++||||+++|+|..++......+++..+.+++.|+++||+|||+++ |+||||||+||+++.++
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~Nill~~~~~~~~ 158 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKN---LVHGNVCAKNILLARLGLAEG 158 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCC---ccCCCCCcccEEEeccCcccC
Confidence 99999999999999999999999999766668999999999999999999999986 99999999999997643
Q ss_pred ---CEEEccCCccccCcccCcceeeccccCccCCchHhhhc-CCCCcccchhhHHHHHHHHH-hCCCCCCccchhhHHHH
Q 004400 554 ---NSKISDFGLAKLDEEENTHISTRVAGTIGYMAPEYAMR-GHLTEKADVYSFGIVALEIV-SGRSNVTKEDMFYLLDW 628 (756)
Q Consensus 554 ---~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slGv~l~ell-tg~~p~~~~~~~~~~~~ 628 (756)
.+|++|||.+...... ....++..|+|||.+.+ ..++.++|||||||++||++ +|+.||..........+
T Consensus 159 ~~~~~kl~d~g~~~~~~~~-----~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~ 233 (274)
T cd05076 159 TSPFIKLSDPGVSFTALSR-----EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKERF 233 (274)
T ss_pred ccceeeecCCccccccccc-----cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHHHHH
Confidence 3799999998643221 12357888999998875 56899999999999999985 68999865433222111
Q ss_pred HHHHHhcCccccccccCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhc
Q 004400 629 ALVLKEQGKLMELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLE 684 (756)
Q Consensus 629 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~L~ 684 (756)
. .... .. ..... ..+.+++.+||+.+|++||++.+|++.|+
T Consensus 234 ~----~~~~--~~-----~~~~~----~~~~~li~~cl~~~p~~Rps~~~il~~L~ 274 (274)
T cd05076 234 Y----EKKH--RL-----PEPSC----KELATLISQCLTYEPTQRPSFRTILRDLT 274 (274)
T ss_pred H----Hhcc--CC-----CCCCC----hHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence 1 1000 00 01111 24889999999999999999999998774
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=327.61 Aligned_cols=258 Identities=28% Similarity=0.437 Sum_probs=204.2
Q ss_pred hcCccccCcccCCCCccEEEeecc--------CCcEEEEEEccccC-cccHHHHHHHHHHHHhC-CCCceeeEeeEEEeC
Q 004400 415 TNNFATDNNIGEGGFGPVYKGLLA--------DGTAIAVKQLSSKS-KQGNREFINEIGMISAL-QHPNLVKLYGCCIEG 484 (756)
Q Consensus 415 ~~~~~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 484 (756)
.++|...+.||+|+||.||+|... ++..+|+|.+.... .....++.+|+++++++ +||||++++++|..+
T Consensus 17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 96 (307)
T cd05098 17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 96 (307)
T ss_pred hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence 357889999999999999999742 23579999997542 23345688899999999 799999999999999
Q ss_pred CeEEEEEEecCCCCHHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEe
Q 004400 485 NQLLLIYEYLENNSLARALFEHR---------------LKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLL 549 (756)
Q Consensus 485 ~~~~lV~e~~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill 549 (756)
+..++||||+++|+|.+++.... ..+++.++.+++.|++.||+|||+.| ++||||||+||++
T Consensus 97 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill 173 (307)
T cd05098 97 GPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLV 173 (307)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHHheEE
Confidence 99999999999999999997532 25889999999999999999999986 9999999999999
Q ss_pred cCCCCEEEccCCccccCcccCcce-eeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHh-CCCCCCccchhhHHH
Q 004400 550 DKDLNSKISDFGLAKLDEEENTHI-STRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVS-GRSNVTKEDMFYLLD 627 (756)
Q Consensus 550 ~~~~~~kl~DFGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~~ 627 (756)
+.++.+||+|||.++......... .....++..|+|||.+.+..++.++|||||||++|||++ |+.||..........
T Consensus 174 ~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~~~~~ 253 (307)
T cd05098 174 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFK 253 (307)
T ss_pred cCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHH
Confidence 999999999999997654322111 112234568999999998889999999999999999998 888885544322221
Q ss_pred HHHHHHhcCccccccccCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhccCcc
Q 004400 628 WALVLKEQGKLMELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLECGVD 688 (756)
Q Consensus 628 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~L~~~~~ 688 (756)
.. ......+ .+......+.+++.+||+.+|++||++.+|++.|+++..
T Consensus 254 ---~~-~~~~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~ 301 (307)
T cd05098 254 ---LL-KEGHRMD---------KPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILA 301 (307)
T ss_pred ---HH-HcCCCCC---------CCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHH
Confidence 11 1111111 111123358889999999999999999999999986543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=323.67 Aligned_cols=255 Identities=29% Similarity=0.493 Sum_probs=204.3
Q ss_pred hhcCccccCcccCCCCccEEEeecc------CCcEEEEEEccccC-cccHHHHHHHHHHHHhCCCCceeeEeeEEEeCCe
Q 004400 414 ATNNFATDNNIGEGGFGPVYKGLLA------DGTAIAVKQLSSKS-KQGNREFINEIGMISALQHPNLVKLYGCCIEGNQ 486 (756)
Q Consensus 414 ~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 486 (756)
..++|+..+.||+|+||.||+|... ++..||+|.+.... ......+.+|+.++++++||||+++++++.+++.
T Consensus 3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~ 82 (288)
T cd05050 3 PRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKP 82 (288)
T ss_pred ChHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCc
Confidence 3467899999999999999999853 46789999987542 2334678999999999999999999999999999
Q ss_pred EEEEEEecCCCCHHHHHHhcC---------------------CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCC
Q 004400 487 LLLIYEYLENNSLARALFEHR---------------------LKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKAT 545 (756)
Q Consensus 487 ~~lV~e~~~~gsL~~~l~~~~---------------------~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~ 545 (756)
.++||||+++|+|.+++.... ..+++..++.++.|++.||+|||+.+ ++||||||+
T Consensus 83 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~---i~H~dl~p~ 159 (288)
T cd05050 83 MCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK---FVHRDLATR 159 (288)
T ss_pred cEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---eecccccHh
Confidence 999999999999999997422 24788899999999999999999986 999999999
Q ss_pred ceEecCCCCEEEccCCccccCcccCc-ceeeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHh-CCCCCCccchh
Q 004400 546 NVLLDKDLNSKISDFGLAKLDEEENT-HISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVS-GRSNVTKEDMF 623 (756)
Q Consensus 546 Nill~~~~~~kl~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~ 623 (756)
||++++++.+||+|||+++....... .......++..|+|||.+.+..++.++|||||||++|||++ |..||.+....
T Consensus 160 nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~ 239 (288)
T cd05050 160 NCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHE 239 (288)
T ss_pred heEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence 99999999999999999875433221 11222345678999999998899999999999999999998 88888655433
Q ss_pred hHHHHHHHHHhcCccccccccCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhc
Q 004400 624 YLLDWALVLKEQGKLMELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLE 684 (756)
Q Consensus 624 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~L~ 684 (756)
..... . ..+..... +......+.+++.+|++.+|++||++.|+++.|+
T Consensus 240 ~~~~~---~-~~~~~~~~---------~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~ 287 (288)
T cd05050 240 EVIYY---V-RDGNVLSC---------PDNCPLELYNLMRLCWSKLPSDRPSFASINRILQ 287 (288)
T ss_pred HHHHH---H-hcCCCCCC---------CCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhh
Confidence 32221 1 11111111 1112235889999999999999999999999987
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=320.63 Aligned_cols=255 Identities=27% Similarity=0.398 Sum_probs=205.6
Q ss_pred cCccccCcccCCCCccEEEeeccC----CcEEEEEEccccC-cccHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEE
Q 004400 416 NNFATDNNIGEGGFGPVYKGLLAD----GTAIAVKQLSSKS-KQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLI 490 (756)
Q Consensus 416 ~~~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 490 (756)
++|...+.||+|+||.||+|...+ ...||||...... ....+.+.+|+.++++++||||+++++++.+ +..++|
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv 84 (270)
T cd05056 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIV 84 (270)
T ss_pred hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEEE
Confidence 467788999999999999998543 3478999887654 3445679999999999999999999999875 557899
Q ss_pred EEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCcccC
Q 004400 491 YEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEEN 570 (756)
Q Consensus 491 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~~~ 570 (756)
|||+++|+|.+++......+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||+++......
T Consensus 85 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~ 161 (270)
T cd05056 85 MELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKR---FVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDES 161 (270)
T ss_pred EEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccChheEEEecCCCeEEccCceeeeccccc
Confidence 9999999999999876667899999999999999999999986 9999999999999999999999999998655443
Q ss_pred cceeeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHh-CCCCCCccchhhHHHHHHHHHhcCccccccccCCCCC
Q 004400 571 THISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVS-GRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSN 649 (756)
Q Consensus 571 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 649 (756)
........++..|+|||.+....++.++||||||+++||+++ |..||..........+. ........
T Consensus 162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~----~~~~~~~~-------- 229 (270)
T cd05056 162 YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRI----ENGERLPM-------- 229 (270)
T ss_pred ceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHH----HcCCcCCC--------
Confidence 322233345678999999988889999999999999999986 99999665543333221 11111111
Q ss_pred CCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhccCc
Q 004400 650 FDKEQVMVMINVALLCANASPTIRPSMSSVLRMLECGV 687 (756)
Q Consensus 650 ~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~L~~~~ 687 (756)
+...+..+.+++.+|+..+|.+||++.++++.|+++.
T Consensus 230 -~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~ 266 (270)
T cd05056 230 -PPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDIL 266 (270)
T ss_pred -CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 1112235889999999999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-37 Score=316.65 Aligned_cols=240 Identities=23% Similarity=0.395 Sum_probs=191.1
Q ss_pred CcccCCCCccEEEeeccC-------------CcEEEEEEccccCcccHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEE
Q 004400 422 NNIGEGGFGPVYKGLLAD-------------GTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLL 488 (756)
Q Consensus 422 ~~lg~G~~g~Vy~~~~~~-------------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 488 (756)
+.||+|+||.||+|.+.+ ...|++|.+..........|.+|+.+++.++||||+++++++..+...+
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~ 80 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI 80 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence 368999999999998532 2358899887655555567889999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCC-------EEEccCC
Q 004400 489 LIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLN-------SKISDFG 561 (756)
Q Consensus 489 lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~-------~kl~DFG 561 (756)
+||||+++|+|..++......+++..+.+++.||++||+|||+.+ |+||||||+|||++.++. +|++|||
T Consensus 81 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g 157 (262)
T cd05077 81 MVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKD---LVHGNVCTKNILLAREGIDGECGPFIKLSDPG 157 (262)
T ss_pred EEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCC---eECCCCCcccEEEecCCccCCCCceeEeCCCC
Confidence 999999999999998766667999999999999999999999986 999999999999987664 8999999
Q ss_pred ccccCcccCcceeeccccCccCCchHhhh-cCCCCcccchhhHHHHHHHHH-hCCCCCCccchhhHHHHHHHHHhcCccc
Q 004400 562 LAKLDEEENTHISTRVAGTIGYMAPEYAM-RGHLTEKADVYSFGIVALEIV-SGRSNVTKEDMFYLLDWALVLKEQGKLM 639 (756)
Q Consensus 562 la~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~Dv~slGv~l~ell-tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 639 (756)
++...... ....|+..|+|||.+. +..++.++|||||||++|||+ +|+.|+.......... ... ...
T Consensus 158 ~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~----~~~-~~~- 226 (262)
T cd05077 158 IPITVLSR-----QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKER----FYE-GQC- 226 (262)
T ss_pred CCccccCc-----ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHHH----HHh-cCc-
Confidence 98754321 2245788999999886 466899999999999999998 5888875443221110 000 100
Q ss_pred cccccCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhc
Q 004400 640 ELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLE 684 (756)
Q Consensus 640 ~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~L~ 684 (756)
.. ... ....+.+++.+||+.||++||++.+|++.++
T Consensus 227 ~~-----~~~----~~~~~~~li~~cl~~dp~~Rp~~~~il~~~~ 262 (262)
T cd05077 227 ML-----VTP----SCKELADLMTHCMNYDPNQRPFFRAIMRDIN 262 (262)
T ss_pred cC-----CCC----ChHHHHHHHHHHcCCChhhCcCHHHHHHhcC
Confidence 00 011 1234789999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-37 Score=315.08 Aligned_cols=247 Identities=28% Similarity=0.469 Sum_probs=198.3
Q ss_pred CcccCCCCccEEEeecc--C--CcEEEEEEccccCc-ccHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEEecCC
Q 004400 422 NNIGEGGFGPVYKGLLA--D--GTAIAVKQLSSKSK-QGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYEYLEN 496 (756)
Q Consensus 422 ~~lg~G~~g~Vy~~~~~--~--~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~ 496 (756)
+.||+|+||.||+|.+. + +..||+|.+..... ...+++.+|+++++.+.|+||+++++++. .+..++||||+++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence 47999999999999742 2 26899999875533 24567899999999999999999999876 4568999999999
Q ss_pred CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCcccCccee--
Q 004400 497 NSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHIS-- 574 (756)
Q Consensus 497 gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~~~~~~~-- 574 (756)
|+|.+++.... .+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||+++..........
T Consensus 80 ~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~~ 155 (257)
T cd05060 80 GPLLKYLKKRR-EIPVSDLKELAHQVAMGMAYLESKH---FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRAT 155 (257)
T ss_pred CcHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHhhcC---eeccCcccceEEEcCCCcEEeccccccceeecCCcccccc
Confidence 99999997654 7899999999999999999999986 99999999999999999999999999986654332221
Q ss_pred eccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHh-CCCCCCccchhhHHHHHHHHHhcCccccccccCCCCCCCHH
Q 004400 575 TRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVS-GRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDKE 653 (756)
Q Consensus 575 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 653 (756)
....++..|+|||.+....++.++|||||||++||+++ |+.||...+......+.. . ...... +..
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~---~-~~~~~~---------~~~ 222 (257)
T cd05060 156 TAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLE---S-GERLPR---------PEE 222 (257)
T ss_pred cCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHH---c-CCcCCC---------CCC
Confidence 11234568999999988899999999999999999998 999996655433332221 1 111111 111
Q ss_pred HHHHHHHHHHHhhcCCCCCCCCHHHHHHHhccC
Q 004400 654 QVMVMINVALLCANASPTIRPSMSSVLRMLECG 686 (756)
Q Consensus 654 ~~~~l~~l~~~c~~~~P~~RPt~~ev~~~L~~~ 686 (756)
....+.+++.+||..+|++||++.++++.|++.
T Consensus 223 ~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 255 (257)
T cd05060 223 CPQEIYSIMLSCWKYRPEDRPTFSELESTFRRD 255 (257)
T ss_pred CCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhc
Confidence 223588999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-37 Score=320.92 Aligned_cols=250 Identities=26% Similarity=0.402 Sum_probs=201.4
Q ss_pred ccccCcccCCCCccEEEeec-cCCcEEEEEEccccCcccHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEEecCC
Q 004400 418 FATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYEYLEN 496 (756)
Q Consensus 418 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~ 496 (756)
|+..+.||+|+||.||+|.. .++..+++|.+........+.+.+|+++++.++||||++++++|..++..++|+||+++
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~ 86 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG 86 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCC
Confidence 56678899999999999995 45788999998765555567789999999999999999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCcccCcceeec
Q 004400 497 NSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTR 576 (756)
Q Consensus 497 gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~ 576 (756)
++|.+++......+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++........ ....
T Consensus 87 ~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~---i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~-~~~~ 162 (282)
T cd06643 87 GAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ-RRDS 162 (282)
T ss_pred CcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEccCCCEEEcccccccccccccc-cccc
Confidence 9999988765667999999999999999999999986 99999999999999999999999999875433221 2233
Q ss_pred cccCccCCchHhhh-----cCCCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhcCccccccccCCCCCCC
Q 004400 577 VAGTIGYMAPEYAM-----RGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFD 651 (756)
Q Consensus 577 ~~gt~~y~aPE~~~-----~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 651 (756)
..|+..|+|||++. +..++.++|||||||++|||++|+.||...+....... .... ...... .+
T Consensus 163 ~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~---~~~~-~~~~~~-------~~ 231 (282)
T cd06643 163 FIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLK---IAKS-EPPTLA-------QP 231 (282)
T ss_pred ccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHH---Hhhc-CCCCCC-------Cc
Confidence 56899999999984 34578899999999999999999999965543222111 1111 000110 11
Q ss_pred HHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004400 652 KEQVMVMINVALLCANASPTIRPSMSSVLRM 682 (756)
Q Consensus 652 ~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~ 682 (756)
......+.+++.+||+.+|.+||++.++++.
T Consensus 232 ~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 262 (282)
T cd06643 232 SRWSSEFKDFLKKCLEKNVDARWTTTQLLQH 262 (282)
T ss_pred cccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 1122358899999999999999999998765
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-37 Score=320.62 Aligned_cols=259 Identities=26% Similarity=0.415 Sum_probs=202.6
Q ss_pred cCccccCcccCCCCccEEEeec-----cCCcEEEEEEccccC-cccHHHHHHHHHHHHhCCCCceeeEeeEEEeC--CeE
Q 004400 416 NNFATDNNIGEGGFGPVYKGLL-----ADGTAIAVKQLSSKS-KQGNREFINEIGMISALQHPNLVKLYGCCIEG--NQL 487 (756)
Q Consensus 416 ~~~~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~ 487 (756)
+.|...+.||+|+||.||.|.. .++..||+|.++... ......+.+|++++++++||||+++++++.+. ...
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 83 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence 3467889999999999999973 357899999987543 33346789999999999999999999999875 578
Q ss_pred EEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCc
Q 004400 488 LLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDE 567 (756)
Q Consensus 488 ~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~ 567 (756)
++||||+++++|.+++......+++..+..++.|++.||+|||+.| |+||||||+||+++.++.+||+|||+++...
T Consensus 84 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~ 160 (284)
T cd05079 84 KLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKAIE 160 (284)
T ss_pred EEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccchheEEEcCCCCEEECCCccccccc
Confidence 9999999999999999766557899999999999999999999987 9999999999999999999999999998654
Q ss_pred ccCcc--eeeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHhCCCCCCccchh-----------hHHHHHHHHHh
Q 004400 568 EENTH--ISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMF-----------YLLDWALVLKE 634 (756)
Q Consensus 568 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~-----------~~~~~~~~~~~ 634 (756)
..... ......|+..|+|||++.+..++.++|||||||++||+++++.|....... ...........
T Consensus 161 ~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (284)
T cd05079 161 TDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVLE 240 (284)
T ss_pred cCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHHHH
Confidence 33221 122345677899999998888999999999999999999987765221100 00010101111
Q ss_pred cCccccccccCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhccC
Q 004400 635 QGKLMELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLECG 686 (756)
Q Consensus 635 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~L~~~ 686 (756)
...... .... ....+.+++.+|++.+|++||++.++++.|+++
T Consensus 241 ~~~~~~-----~~~~----~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 241 EGKRLP-----RPPN----CPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred cCccCC-----CCCC----CCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 111110 0111 234589999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=353.65 Aligned_cols=259 Identities=23% Similarity=0.359 Sum_probs=203.3
Q ss_pred cCccccCcccCCCCccEEEeec-cCCcEEEEEEccccC---cccHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEE
Q 004400 416 NNFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSKS---KQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIY 491 (756)
Q Consensus 416 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 491 (756)
++|+..+.||+|+||.||+|+. .+|+.||+|++.... ....+++.+|++++++++||||+++++++.+++..++||
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 4788999999999999999994 468999999987532 223457899999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHhc----------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCC
Q 004400 492 EYLENNSLARALFEH----------RLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFG 561 (756)
Q Consensus 492 e~~~~gsL~~~l~~~----------~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFG 561 (756)
||++||+|.+++... ....++..+.+++.||++||+|||+.| |+||||||+||+++.++.+||+|||
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~G---IIHRDLKPeNILLd~dg~vKLiDFG 158 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKG---VLHRDLKPDNILLGLFGEVVILDWG 158 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchheEEEcCCCCEEEEecC
Confidence 999999999998632 124567788999999999999999986 9999999999999999999999999
Q ss_pred ccccCcccC-----------------cceeeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHhCCCCCCccchhh
Q 004400 562 LAKLDEEEN-----------------THISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFY 624 (756)
Q Consensus 562 la~~~~~~~-----------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~ 624 (756)
+++...... ........||+.|+|||++.+..++.++|||||||++|||+||+.||.......
T Consensus 159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~k 238 (932)
T PRK13184 159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRK 238 (932)
T ss_pred cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhh
Confidence 998652110 001123569999999999999999999999999999999999999996543322
Q ss_pred HHHHHHHHHhcCccccccccCCCCCCCHHHHHHHHHHHHHhhcCCCCCCC-CHHHHHHHhccCcc
Q 004400 625 LLDWALVLKEQGKLMELVDTNPGSNFDKEQVMVMINVALLCANASPTIRP-SMSSVLRMLECGVD 688 (756)
Q Consensus 625 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RP-t~~ev~~~L~~~~~ 688 (756)
.... ..........+... .+..+.+++.+|++.||++|| +++++.+.|+.+..
T Consensus 239 i~~~-------~~i~~P~~~~p~~~----iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq 292 (932)
T PRK13184 239 ISYR-------DVILSPIEVAPYRE----IPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQ 292 (932)
T ss_pred hhhh-------hhccChhhcccccc----CCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 1110 00000000011112 223478899999999999996 66777777776533
|
|
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-37 Score=318.57 Aligned_cols=247 Identities=30% Similarity=0.452 Sum_probs=195.2
Q ss_pred CcccCCCCccEEEeecc-CCc--EEEEEEcccc-CcccHHHHHHHHHHHHhC-CCCceeeEeeEEEeCCeEEEEEEecCC
Q 004400 422 NNIGEGGFGPVYKGLLA-DGT--AIAVKQLSSK-SKQGNREFINEIGMISAL-QHPNLVKLYGCCIEGNQLLLIYEYLEN 496 (756)
Q Consensus 422 ~~lg~G~~g~Vy~~~~~-~~~--~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~e~~~~ 496 (756)
+.||+|+||.||+|... ++. .+|+|.++.. .....+.+.+|++++.++ +||||++++++|...+..++||||+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 46899999999999964 443 4688888643 234456788999999999 799999999999999999999999999
Q ss_pred CCHHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCC
Q 004400 497 NSLARALFEHR---------------LKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFG 561 (756)
Q Consensus 497 gsL~~~l~~~~---------------~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFG 561 (756)
|+|.+++.... ..+++..+..++.|++.||+|||+.+ ++||||||+||++++++.+||+|||
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nili~~~~~~kl~dfg 157 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFG 157 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccccceEEEcCCCeEEECCCC
Confidence 99999997432 24789999999999999999999986 9999999999999999999999999
Q ss_pred ccccCcccCcceeeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHh-CCCCCCccchhhHHHHHHHHHhcCcccc
Q 004400 562 LAKLDEEENTHISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVS-GRSNVTKEDMFYLLDWALVLKEQGKLME 640 (756)
Q Consensus 562 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 640 (756)
++........ ......+..|+|||++....++.++|||||||++|||++ |+.||...+....... ... ....+
T Consensus 158 l~~~~~~~~~--~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~---~~~-~~~~~ 231 (270)
T cd05047 158 LSRGQEVYVK--KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEK---LPQ-GYRLE 231 (270)
T ss_pred Cccccchhhh--ccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHH---HhC-CCCCC
Confidence 9863221111 111234667999999988889999999999999999997 9999965543322211 111 11111
Q ss_pred ccccCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhccC
Q 004400 641 LVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLECG 686 (756)
Q Consensus 641 ~~~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~L~~~ 686 (756)
. +......+.+++.+||+.+|.+||++.++++.|+++
T Consensus 232 ~---------~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~ 268 (270)
T cd05047 232 K---------PLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM 268 (270)
T ss_pred C---------CCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHh
Confidence 1 111223488999999999999999999999999854
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-38 Score=299.60 Aligned_cols=253 Identities=23% Similarity=0.365 Sum_probs=203.9
Q ss_pred hhcCccccCcccCCCCccEEEee-ccCCcEEEEEEccccCc----cc----HHHHHHHHHHHHhC-CCCceeeEeeEEEe
Q 004400 414 ATNNFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSKSK----QG----NREFINEIGMISAL-QHPNLVKLYGCCIE 483 (756)
Q Consensus 414 ~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~----~~----~~~~~~E~~~l~~l-~h~niv~l~~~~~~ 483 (756)
.-+.|...+.||+|..++|-++. ..+|+.+|+|++..... .. .+.-.+|+.+|+++ .||+|+++.++|+.
T Consensus 15 fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes 94 (411)
T KOG0599|consen 15 FYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYES 94 (411)
T ss_pred HHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccC
Confidence 34577888999999999999998 45789999999864311 11 23456799999998 69999999999999
Q ss_pred CCeEEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCcc
Q 004400 484 GNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLA 563 (756)
Q Consensus 484 ~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla 563 (756)
+...++|+|.|+.|.|.|+|.+. ..+++...++|+.|+.+|++|||... |||||+||+|||+|++.++||+|||+|
T Consensus 95 ~sF~FlVFdl~prGELFDyLts~-VtlSEK~tR~iMrqlfegVeylHa~~---IVHRDLKpENILlddn~~i~isDFGFa 170 (411)
T KOG0599|consen 95 DAFVFLVFDLMPRGELFDYLTSK-VTLSEKETRRIMRQLFEGVEYLHARN---IVHRDLKPENILLDDNMNIKISDFGFA 170 (411)
T ss_pred cchhhhhhhhcccchHHHHhhhh-eeecHHHHHHHHHHHHHHHHHHHHhh---hhhcccChhheeeccccceEEecccee
Confidence 99999999999999999999654 58999999999999999999999984 999999999999999999999999999
Q ss_pred ccCcccCcceeeccccCccCCchHhhhc------CCCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhcCc
Q 004400 564 KLDEEENTHISTRVAGTIGYMAPEYAMR------GHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGK 637 (756)
Q Consensus 564 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 637 (756)
....+... -...+||++|.|||.+.. ..|+..+|+||+|||||-++.|-.||+.....-.+... .+++
T Consensus 171 ~~l~~Gek--LrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~I----meGk 244 (411)
T KOG0599|consen 171 CQLEPGEK--LRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMI----MEGK 244 (411)
T ss_pred eccCCchh--HHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHH----Hhcc
Confidence 87665433 356899999999999864 45888999999999999999999999655433332211 1111
Q ss_pred cccccccCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004400 638 LMELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRM 682 (756)
Q Consensus 638 ~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~ 682 (756)
.. +. ..-..+......+++.+|++.||++|-|++|+++.
T Consensus 245 yq--F~----speWadis~~~KdLIsrlLqVdp~~Ritake~LaH 283 (411)
T KOG0599|consen 245 YQ--FR----SPEWADISATVKDLISRLLQVDPTKRITAKEALAH 283 (411)
T ss_pred cc--cC----CcchhhccccHHHHHHHHHeeCchhcccHHHHhcC
Confidence 10 00 01112334458899999999999999999999653
|
|
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-37 Score=324.67 Aligned_cols=261 Identities=23% Similarity=0.352 Sum_probs=202.1
Q ss_pred cCccccCcccCCCCccEEEeec-cCCcEEEEEEccccC-cccHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEEe
Q 004400 416 NNFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSKS-KQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYEY 493 (756)
Q Consensus 416 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 493 (756)
++|+..+.||+|+||.||+|.. .++..+|+|.+.... ......+.+|++++++++||||++++++|.+++..++||||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey 80 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH 80 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence 3688899999999999999984 468889999886542 22345688999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCcccCcce
Q 004400 494 LENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHI 573 (756)
Q Consensus 494 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~~~~~~ 573 (756)
+++++|.+++... ..+++..+..++.|+++||+|||+.. +++||||||+||+++.++.+||+|||++.......
T Consensus 81 ~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~--- 154 (308)
T cd06615 81 MDGGSLDQVLKKA-GRIPENILGKISIAVLRGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM--- 154 (308)
T ss_pred cCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhhC--CEEECCCChHHEEEecCCcEEEccCCCcccccccc---
Confidence 9999999999755 47899999999999999999999742 49999999999999999999999999987543321
Q ss_pred eeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhcCccc--------------
Q 004400 574 STRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLM-------------- 639 (756)
Q Consensus 574 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~-------------- 639 (756)
.....|+..|+|||.+.+..++.++|||||||++|||++|+.||...+......+...........
T Consensus 155 ~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (308)
T cd06615 155 ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPDSP 234 (308)
T ss_pred cccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCCCCcc
Confidence 233568999999999988889999999999999999999999996544322221110000000000
Q ss_pred ----------cccccCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004400 640 ----------ELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRM 682 (756)
Q Consensus 640 ----------~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~ 682 (756)
..................+.+++.+|+..+|++||++.+|++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 287 (308)
T cd06615 235 RPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKH 287 (308)
T ss_pred chhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0000000000000123358899999999999999999999876
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-37 Score=315.24 Aligned_cols=247 Identities=27% Similarity=0.440 Sum_probs=200.6
Q ss_pred CcccCCCCccEEEeeccC--Cc--EEEEEEccccCc-ccHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEEecCC
Q 004400 422 NNIGEGGFGPVYKGLLAD--GT--AIAVKQLSSKSK-QGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYEYLEN 496 (756)
Q Consensus 422 ~~lg~G~~g~Vy~~~~~~--~~--~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~ 496 (756)
+.||+|++|.||+|.+.+ ++ .||+|.+..... ...+.+.+|++++++++||||+++++++.+ ...++||||+++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 468999999999998543 33 689999987655 456789999999999999999999999988 899999999999
Q ss_pred CCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCcccCcce--
Q 004400 497 NSLARALFEHR-LKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHI-- 573 (756)
Q Consensus 497 gsL~~~l~~~~-~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~~~~~~-- 573 (756)
|+|.+++.... ..+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||+++.........
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 156 (257)
T cd05040 80 GSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKR---FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVM 156 (257)
T ss_pred CcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCC---ccccccCcccEEEecCCEEEeccccccccccccccceec
Confidence 99999997654 57899999999999999999999986 9999999999999999999999999998765432221
Q ss_pred eeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHh-CCCCCCccchhhHHHHHHHHHhcCccccccccCCCCCCCH
Q 004400 574 STRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVS-GRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDK 652 (756)
Q Consensus 574 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 652 (756)
.....++..|+|||++....++.++|||||||++|||++ |+.||............. ....... .+.
T Consensus 157 ~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~---~~~~~~~---------~~~ 224 (257)
T cd05040 157 EEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKID---KEGERLE---------RPE 224 (257)
T ss_pred ccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH---hcCCcCC---------CCc
Confidence 123457889999999998899999999999999999999 999996544433222111 1111110 011
Q ss_pred HHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhc
Q 004400 653 EQVMVMINVALLCANASPTIRPSMSSVLRMLE 684 (756)
Q Consensus 653 ~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~L~ 684 (756)
..+..+.+++.+|++.+|++||++.++++.|.
T Consensus 225 ~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 225 ACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred cCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 12345889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-37 Score=328.07 Aligned_cols=241 Identities=23% Similarity=0.341 Sum_probs=194.8
Q ss_pred CccccCcccCCCCccEEEee-ccCCcEEEEEEccccC---cccHHHHHHHHHHHHhCC-CCceeeEeeEEEeCCeEEEEE
Q 004400 417 NFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSKS---KQGNREFINEIGMISALQ-HPNLVKLYGCCIEGNQLLLIY 491 (756)
Q Consensus 417 ~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lV~ 491 (756)
+|+..+.||+|+||.||+|. ..+|+.||+|++.... ....+.+..|..+++.+. |++|+++++++.+.+..++||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 46778899999999999998 4578999999987532 233456788999998885 577888999999999999999
Q ss_pred EecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCcccCc
Q 004400 492 EYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENT 571 (756)
Q Consensus 492 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~~~~ 571 (756)
||+++|+|.+++... ..+++..+..++.|++.||+|||++| |+||||||+|||++.++.+||+|||+++.......
T Consensus 81 Ey~~~g~L~~~i~~~-~~l~~~~~~~i~~qi~~al~~lH~~~---ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~~ 156 (323)
T cd05615 81 EYVNGGDLMYHIQQV-GKFKEPQAVFYAAEISVGLFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGV 156 (323)
T ss_pred cCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeccccccccCCCCc
Confidence 999999999998654 36999999999999999999999987 99999999999999999999999999875432221
Q ss_pred ceeeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhcCccccccccCCCCCCC
Q 004400 572 HISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFD 651 (756)
Q Consensus 572 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 651 (756)
......||+.|+|||++.+..++.++||||+||++|||++|+.||...+........ .. ... .++
T Consensus 157 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i---~~-~~~----------~~p 221 (323)
T cd05615 157 -TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSI---ME-HNV----------SYP 221 (323)
T ss_pred -cccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHH---Hh-CCC----------CCC
Confidence 223456999999999999888999999999999999999999999766543332211 11 000 011
Q ss_pred HHHHHHHHHHHHHhhcCCCCCCCCH
Q 004400 652 KEQVMVMINVALLCANASPTIRPSM 676 (756)
Q Consensus 652 ~~~~~~l~~l~~~c~~~~P~~RPt~ 676 (756)
......+.+++.+|++.+|.+|++.
T Consensus 222 ~~~~~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05615 222 KSLSKEAVSICKGLMTKHPSKRLGC 246 (323)
T ss_pred ccCCHHHHHHHHHHcccCHhhCCCC
Confidence 1122347889999999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-37 Score=315.39 Aligned_cols=249 Identities=21% Similarity=0.313 Sum_probs=203.2
Q ss_pred CccccCcccCCCCccEEEeec-cCCcEEEEEEcccc-CcccHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEEec
Q 004400 417 NFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSK-SKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYEYL 494 (756)
Q Consensus 417 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~ 494 (756)
+|+..+.||+|+||.||++.. .+++.||+|.+... .....+.+.+|+.+++.++|+||+++++++.+++..++||||+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC 80 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence 467789999999999999984 47899999988543 3334567888999999999999999999999999999999999
Q ss_pred CCCCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCcccCcce
Q 004400 495 ENNSLARALFE-HRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHI 573 (756)
Q Consensus 495 ~~gsL~~~l~~-~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~~~~~~ 573 (756)
++|+|.+++.. ....+++..+..++.|++.||+|||+.+ |+|+||||+||++++++.++++|||.++....... .
T Consensus 81 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~-~ 156 (255)
T cd08219 81 DGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKR---VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA-Y 156 (255)
T ss_pred CCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEECCCCcEEEcccCcceeeccccc-c
Confidence 99999998864 3446899999999999999999999986 99999999999999999999999999976543322 2
Q ss_pred eeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhcCccccccccCCCCCCCHH
Q 004400 574 STRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDKE 653 (756)
Q Consensus 574 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 653 (756)
.....|+..|+|||++.+..++.++||||||+++|+|++|+.||...+...... .. ..+..... +..
T Consensus 157 ~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~---~~-~~~~~~~~---------~~~ 223 (255)
T cd08219 157 ACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLIL---KV-CQGSYKPL---------PSH 223 (255)
T ss_pred cccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHHHH---HH-hcCCCCCC---------Ccc
Confidence 234568899999999998889999999999999999999999997654332211 11 11111111 111
Q ss_pred HHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004400 654 QVMVMINVALLCANASPTIRPSMSSVLRM 682 (756)
Q Consensus 654 ~~~~l~~l~~~c~~~~P~~RPt~~ev~~~ 682 (756)
....+.+++.+||+.+|++||++.+++..
T Consensus 224 ~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 224 YSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred cCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 22348899999999999999999999764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-37 Score=322.37 Aligned_cols=257 Identities=25% Similarity=0.423 Sum_probs=203.4
Q ss_pred hhcCccccCcccCCCCccEEEeecc------CCcEEEEEEccccC-cccHHHHHHHHHHHHhCCCCceeeEeeEEEeCCe
Q 004400 414 ATNNFATDNNIGEGGFGPVYKGLLA------DGTAIAVKQLSSKS-KQGNREFINEIGMISALQHPNLVKLYGCCIEGNQ 486 (756)
Q Consensus 414 ~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 486 (756)
..++|+..+.||+|+||.||+|... .+..||+|.+.... ......+.+|+.+++.++||||+++++++.+.+.
T Consensus 4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (288)
T cd05061 4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQP 83 (288)
T ss_pred cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 4568899999999999999999743 24589999886442 2234568889999999999999999999999999
Q ss_pred EEEEEEecCCCCHHHHHHhcC---------CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEE
Q 004400 487 LLLIYEYLENNSLARALFEHR---------LKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKI 557 (756)
Q Consensus 487 ~~lV~e~~~~gsL~~~l~~~~---------~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl 557 (756)
.++||||+++|+|.+++.... ...++..+.+++.|++.||+|||+.+ |+||||||+||++++++.+||
T Consensus 84 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dikp~nili~~~~~~~L 160 (288)
T cd05061 84 TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK---FVHRDLAARNCMVAHDFTVKI 160 (288)
T ss_pred cEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCCChheEEEcCCCcEEE
Confidence 999999999999999997421 34567788999999999999999986 999999999999999999999
Q ss_pred ccCCccccCcccCcc-eeeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHh-CCCCCCccchhhHHHHHHHHHhc
Q 004400 558 SDFGLAKLDEEENTH-ISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVS-GRSNVTKEDMFYLLDWALVLKEQ 635 (756)
Q Consensus 558 ~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 635 (756)
+|||+++........ ......++..|+|||.+.++.++.++|||||||++|||++ |..||........... ...
T Consensus 161 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~---~~~- 236 (288)
T cd05061 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKF---VMD- 236 (288)
T ss_pred CcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH---HHc-
Confidence 999999854332221 1222345778999999998899999999999999999998 7888865443332221 111
Q ss_pred CccccccccCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhccC
Q 004400 636 GKLMELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLECG 686 (756)
Q Consensus 636 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~L~~~ 686 (756)
...... +......+.+++.+|++.+|++||++.++++.|+..
T Consensus 237 ~~~~~~---------~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~ 278 (288)
T cd05061 237 GGYLDQ---------PDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDD 278 (288)
T ss_pred CCCCCC---------CCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhh
Confidence 111111 111124589999999999999999999999998853
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=330.16 Aligned_cols=242 Identities=26% Similarity=0.335 Sum_probs=191.7
Q ss_pred CcccCCCCccEEEeec-cCCcEEEEEEccccC---cccHHHHHHHHH-HHHhCCCCceeeEeeEEEeCCeEEEEEEecCC
Q 004400 422 NNIGEGGFGPVYKGLL-ADGTAIAVKQLSSKS---KQGNREFINEIG-MISALQHPNLVKLYGCCIEGNQLLLIYEYLEN 496 (756)
Q Consensus 422 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~ 496 (756)
+.||+|+||.||+|+. .+++.||+|++.... ......+..|.. +++.++||||+++++++.+++..++||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 4699999999999995 467889999986532 122334455544 56788999999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCcccCcceeec
Q 004400 497 NSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTR 576 (756)
Q Consensus 497 gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~ 576 (756)
|+|.+++... ..+.+..+..++.||++||+|||+.| |+||||||+|||++.++.+||+|||+++....... ....
T Consensus 81 ~~L~~~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~g---iiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~-~~~~ 155 (325)
T cd05602 81 GELFYHLQRE-RCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNG-TTST 155 (325)
T ss_pred CcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEEccCCCCcccccCCC-Cccc
Confidence 9999998754 46788899999999999999999997 99999999999999999999999999975322211 2334
Q ss_pred cccCccCCchHhhhcCCCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhcCccccccccCCCCCCCHHHHH
Q 004400 577 VAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDKEQVM 656 (756)
Q Consensus 577 ~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 656 (756)
..||+.|+|||++.+..++.++||||+||++|||++|+.||...+........ .. ... . ..... ..
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i---~~-~~~-~-----~~~~~----~~ 221 (325)
T cd05602 156 FCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNI---LN-KPL-Q-----LKPNI----TN 221 (325)
T ss_pred ccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHH---Hh-CCc-C-----CCCCC----CH
Confidence 67999999999999999999999999999999999999999766544333221 11 000 0 01112 23
Q ss_pred HHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004400 657 VMINVALLCANASPTIRPSMSSVLRM 682 (756)
Q Consensus 657 ~l~~l~~~c~~~~P~~RPt~~ev~~~ 682 (756)
.+.+++.+|++.+|.+||++.+.+..
T Consensus 222 ~~~~li~~~l~~~p~~R~~~~~~~~~ 247 (325)
T cd05602 222 SARHLLEGLLQKDRTKRLGAKDDFME 247 (325)
T ss_pred HHHHHHHHHcccCHHHCCCCCCCHHH
Confidence 48899999999999999998754433
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=314.01 Aligned_cols=247 Identities=33% Similarity=0.541 Sum_probs=203.6
Q ss_pred CcccCCCCccEEEeeccC----CcEEEEEEccccCcc-cHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEEecCC
Q 004400 422 NNIGEGGFGPVYKGLLAD----GTAIAVKQLSSKSKQ-GNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYEYLEN 496 (756)
Q Consensus 422 ~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~ 496 (756)
+.||+|+||.||+|.... +..|++|.+...... ..+.+.+|+++++.++|+||+++++++.++...++||||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 479999999999999643 789999999765333 257889999999999999999999999999999999999999
Q ss_pred CCHHHHHHhc--------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCcc
Q 004400 497 NSLARALFEH--------RLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEE 568 (756)
Q Consensus 497 gsL~~~l~~~--------~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~ 568 (756)
++|.+++... ...+++..+..++.|++.||+|||+.+ ++||||||+||++++++.+||+|||.+.....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 157 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKK---FVHRDLAARNCLVGEDLVVKISDFGLSRDVYD 157 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCC---cccCccCcceEEECCCCcEEEccccccccccc
Confidence 9999999865 467999999999999999999999986 99999999999999999999999999987654
Q ss_pred cCc-ceeeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHh-CCCCCCccchhhHHHHHHHHHhcCccccccccCC
Q 004400 569 ENT-HISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVS-GRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNP 646 (756)
Q Consensus 569 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 646 (756)
... .......++..|+|||.+....++.++||||+|+++|||++ |+.||............ .. .....
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~---~~-~~~~~------ 227 (262)
T cd00192 158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYL---RK-GYRLP------ 227 (262)
T ss_pred ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH---Hc-CCCCC------
Confidence 321 12234567889999999988889999999999999999999 68998665443332221 11 11111
Q ss_pred CCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhc
Q 004400 647 GSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLE 684 (756)
Q Consensus 647 ~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~L~ 684 (756)
.+......+.+++.+||+.+|++||++.|+++.|+
T Consensus 228 ---~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 228 ---KPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred ---CCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 11112345889999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-37 Score=325.32 Aligned_cols=258 Identities=27% Similarity=0.437 Sum_probs=204.5
Q ss_pred hcCccccCcccCCCCccEEEeecc--------CCcEEEEEEccccC-cccHHHHHHHHHHHHhC-CCCceeeEeeEEEeC
Q 004400 415 TNNFATDNNIGEGGFGPVYKGLLA--------DGTAIAVKQLSSKS-KQGNREFINEIGMISAL-QHPNLVKLYGCCIEG 484 (756)
Q Consensus 415 ~~~~~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 484 (756)
.++|...+.||+|+||.||+|... +...||+|.++... ......+.+|+++++++ +||||++++++|.++
T Consensus 11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 90 (314)
T cd05099 11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQE 90 (314)
T ss_pred HHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccC
Confidence 357888999999999999999731 34579999987542 23345788999999999 699999999999999
Q ss_pred CeEEEEEEecCCCCHHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEe
Q 004400 485 NQLLLIYEYLENNSLARALFEHR---------------LKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLL 549 (756)
Q Consensus 485 ~~~~lV~e~~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill 549 (756)
+..++||||+++|+|.+++.... ..+++.++.+++.|++.||+|||++| |+||||||+||++
T Consensus 91 ~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill 167 (314)
T cd05099 91 GPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR---CIHRDLAARNVLV 167 (314)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCC---eeeccccceeEEE
Confidence 99999999999999999997532 35889999999999999999999986 9999999999999
Q ss_pred cCCCCEEEccCCccccCcccCcce-eeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHh-CCCCCCccchhhHHH
Q 004400 550 DKDLNSKISDFGLAKLDEEENTHI-STRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVS-GRSNVTKEDMFYLLD 627 (756)
Q Consensus 550 ~~~~~~kl~DFGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~~ 627 (756)
+.++.+||+|||+++......... .....++..|+|||.+.+..++.++|||||||++|||++ |+.||..........
T Consensus 168 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~ 247 (314)
T cd05099 168 TEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEELFK 247 (314)
T ss_pred cCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence 999999999999998654322211 112234567999999998889999999999999999999 888886554333222
Q ss_pred HHHHHHhcCccccccccCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhccCcc
Q 004400 628 WALVLKEQGKLMELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLECGVD 688 (756)
Q Consensus 628 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~L~~~~~ 688 (756)
.. ........ +......+.+++.+||+.+|++||++.++++.|++...
T Consensus 248 ~~----~~~~~~~~---------~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~ 295 (314)
T cd05099 248 LL----REGHRMDK---------PSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLA 295 (314)
T ss_pred HH----HcCCCCCC---------CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHH
Confidence 11 11111111 11122348899999999999999999999999986543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-37 Score=318.58 Aligned_cols=252 Identities=27% Similarity=0.409 Sum_probs=200.0
Q ss_pred HhhcCccccCcccCCCCccEEEeec-cCCcEEEEEEccccCcccHHHHHHHHHHHHhC-CCCceeeEeeEEEeC------
Q 004400 413 AATNNFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSKSKQGNREFINEIGMISAL-QHPNLVKLYGCCIEG------ 484 (756)
Q Consensus 413 ~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~------ 484 (756)
.+++.|+..+.||+|+||.||+|.. .+++.||+|.+... ......+.+|+.+++++ +||||++++++|...
T Consensus 3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~-~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (272)
T cd06637 3 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVT-GDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD 81 (272)
T ss_pred ChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcC-CccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCC
Confidence 4567888899999999999999984 56889999998654 33456788999999998 799999999998753
Q ss_pred CeEEEEEEecCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCcc
Q 004400 485 NQLLLIYEYLENNSLARALFEH-RLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLA 563 (756)
Q Consensus 485 ~~~~lV~e~~~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla 563 (756)
...++||||+++|+|.+++... ...+++..+..++.|++.||+|||+++ |+||||||+||++++++.+||+|||++
T Consensus 82 ~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivh~dl~~~nili~~~~~~~l~Dfg~~ 158 (272)
T cd06637 82 DQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGVS 158 (272)
T ss_pred cEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHEEECCCCCEEEccCCCc
Confidence 4689999999999999998753 346899999999999999999999986 999999999999999999999999999
Q ss_pred ccCcccCcceeeccccCccCCchHhhh-----cCCCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhcCcc
Q 004400 564 KLDEEENTHISTRVAGTIGYMAPEYAM-----RGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKL 638 (756)
Q Consensus 564 ~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 638 (756)
+....... ......|+..|+|||++. ...++.++|||||||++|||++|+.||........... ... ...
T Consensus 159 ~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~---~~~-~~~ 233 (272)
T cd06637 159 AQLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFL---IPR-NPA 233 (272)
T ss_pred eecccccc-cCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHH---Hhc-CCC
Confidence 76543222 223457899999999986 34588899999999999999999999954432221110 001 100
Q ss_pred ccccccCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 004400 639 MELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLR 681 (756)
Q Consensus 639 ~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~ 681 (756)
... ....+ ...+.+++.+||..+|.+||++.++++
T Consensus 234 ~~~----~~~~~----~~~~~~li~~~l~~~p~~Rpt~~~il~ 268 (272)
T cd06637 234 PRL----KSKKW----SKKFQSFIESCLVKNHSQRPTTEQLMK 268 (272)
T ss_pred CCC----CCCCc----CHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence 011 11112 234889999999999999999999875
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=319.12 Aligned_cols=245 Identities=24% Similarity=0.305 Sum_probs=195.2
Q ss_pred ccccCcccCCCCccEEEeec-cCCcEEEEEEccccC---cccHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEEe
Q 004400 418 FATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSKS---KQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYEY 493 (756)
Q Consensus 418 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 493 (756)
|...+.||+|+||+||+|.. .+++.||+|.+.... ......+.+|++++++++|+||+++++++.+++..++||||
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence 56678899999999999984 578999999986532 12234578899999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCcccCcc
Q 004400 494 LENNSLARALFEH-RLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTH 572 (756)
Q Consensus 494 ~~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~~~~~ 572 (756)
+++++|.+++... ...+++..+..++.|++.||+|||+.+ |+||||||+||++++++.+||+|||++........
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~---iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~- 157 (285)
T cd05632 82 MNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHREN---TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGES- 157 (285)
T ss_pred ccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEECCCCCEEEecCCcceecCCCCc-
Confidence 9999999988753 346999999999999999999999987 99999999999999999999999999975433221
Q ss_pred eeeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhcCccccccccCCCCCCCH
Q 004400 573 ISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDK 652 (756)
Q Consensus 573 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 652 (756)
.....|+..|+|||++.+..++.++|+|||||++|||++|+.||.................... . .+..
T Consensus 158 -~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~--~--------~~~~ 226 (285)
T cd05632 158 -IRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETE--E--------VYSA 226 (285)
T ss_pred -ccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhccc--c--------ccCc
Confidence 2335789999999999988999999999999999999999999965433221111110001000 0 1111
Q ss_pred HHHHHHHHHHHHhhcCCCCCCCCHH
Q 004400 653 EQVMVMINVALLCANASPTIRPSMS 677 (756)
Q Consensus 653 ~~~~~l~~l~~~c~~~~P~~RPt~~ 677 (756)
.....+.+++.+|++.+|++||++.
T Consensus 227 ~~~~~~~~li~~~l~~~P~~R~~~~ 251 (285)
T cd05632 227 KFSEEAKSICKMLLTKDPKQRLGCQ 251 (285)
T ss_pred cCCHHHHHHHHHHccCCHhHcCCCc
Confidence 1223478899999999999999943
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-37 Score=319.36 Aligned_cols=253 Identities=26% Similarity=0.430 Sum_probs=205.5
Q ss_pred hcCccccCcccCCCCccEEEeec-cCCcEEEEEEccccCcccHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEEe
Q 004400 415 TNNFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYEY 493 (756)
Q Consensus 415 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 493 (756)
.++|++.+.||+|+||.||+|.. .++..||+|.+........+.+.+|++++++++||||+++++++.++...++||||
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEF 83 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeec
Confidence 45788889999999999999995 46899999999766555667899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCcccCcce
Q 004400 494 LENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHI 573 (756)
Q Consensus 494 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~~~~~~ 573 (756)
+++++|.+++......+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||++........ .
T Consensus 84 ~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~-~ 159 (280)
T cd06611 84 CDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHK---VIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQ-K 159 (280)
T ss_pred cCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEECCCCCEEEccCccchhhccccc-c
Confidence 9999999999876667999999999999999999999997 99999999999999999999999999875433222 1
Q ss_pred eeccccCccCCchHhhhc-----CCCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhcCccccccccCCCC
Q 004400 574 STRVAGTIGYMAPEYAMR-----GHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGS 648 (756)
Q Consensus 574 ~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 648 (756)
.....|++.|+|||.+.. ..++.++||||||+++|||++|+.||...+...... .. ........
T Consensus 160 ~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~---~~-~~~~~~~~------- 228 (280)
T cd06611 160 RDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLL---KI-LKSEPPTL------- 228 (280)
T ss_pred cceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHH---HH-hcCCCCCc-------
Confidence 233568999999999853 446789999999999999999999996654332111 11 11111000
Q ss_pred CCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004400 649 NFDKEQVMVMINVALLCANASPTIRPSMSSVLRM 682 (756)
Q Consensus 649 ~~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~ 682 (756)
..+......+.+++.+||+.+|.+||++.++++.
T Consensus 229 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (280)
T cd06611 229 DQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH 262 (280)
T ss_pred CCcccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence 0111122348899999999999999999999764
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=330.89 Aligned_cols=241 Identities=24% Similarity=0.334 Sum_probs=191.7
Q ss_pred CcccCCCCccEEEee-ccCCcEEEEEEccccC---cccHHHHHHHHH-HHHhCCCCceeeEeeEEEeCCeEEEEEEecCC
Q 004400 422 NNIGEGGFGPVYKGL-LADGTAIAVKQLSSKS---KQGNREFINEIG-MISALQHPNLVKLYGCCIEGNQLLLIYEYLEN 496 (756)
Q Consensus 422 ~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~ 496 (756)
+.||+|+||.||+|. ..+|+.||+|++.... ......+..|.. +++.++||||+++++++..++..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 469999999999998 4578999999986531 223345566655 46778999999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCcccCcceeec
Q 004400 497 NSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTR 576 (756)
Q Consensus 497 gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~ 576 (756)
|+|.+++... ..+++..+..++.||+.||+|||+.| |+||||||+|||++.++.+||+|||+++...... .....
T Consensus 81 ~~L~~~l~~~-~~~~~~~~~~~~~qi~~al~~lH~~g---ivH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~-~~~~~ 155 (325)
T cd05604 81 GELFFHLQRE-RSFPEPRARFYAAEIASALGYLHSIN---IVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQS-DTTTT 155 (325)
T ss_pred CCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEeecCCcccCCCCC-CCccc
Confidence 9999888654 47899999999999999999999987 9999999999999999999999999987432211 12234
Q ss_pred cccCccCCchHhhhcCCCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhcCccccccccCCCCCCCHHHHH
Q 004400 577 VAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDKEQVM 656 (756)
Q Consensus 577 ~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 656 (756)
..||+.|+|||++.+..++.++|||||||++|||++|+.||...+........ .. ... . .... ...
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~---~~-~~~----~--~~~~----~~~ 221 (325)
T cd05604 156 FCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNI---LH-KPL----V--LRPG----ASL 221 (325)
T ss_pred ccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHHHHHH---Hc-CCc----c--CCCC----CCH
Confidence 67999999999999999999999999999999999999999766543332211 11 110 0 0011 223
Q ss_pred HHHHHHHHhhcCCCCCCCCHHHHHH
Q 004400 657 VMINVALLCANASPTIRPSMSSVLR 681 (756)
Q Consensus 657 ~l~~l~~~c~~~~P~~RPt~~ev~~ 681 (756)
.+.+++.+|++.+|.+||++.+.++
T Consensus 222 ~~~~ll~~ll~~~p~~R~~~~~~~~ 246 (325)
T cd05604 222 TAWSILEELLEKDRQRRLGAKEDFL 246 (325)
T ss_pred HHHHHHHHHhccCHHhcCCCCCCHH
Confidence 4778999999999999998864433
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=315.46 Aligned_cols=249 Identities=27% Similarity=0.435 Sum_probs=194.9
Q ss_pred CcccCCCCccEEEeecc----CCcEEEEEEcccc-CcccHHHHHHHHHHHHhCCCCceeeEeeEEE-eCCeEEEEEEecC
Q 004400 422 NNIGEGGFGPVYKGLLA----DGTAIAVKQLSSK-SKQGNREFINEIGMISALQHPNLVKLYGCCI-EGNQLLLIYEYLE 495 (756)
Q Consensus 422 ~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~-~~~~~~lV~e~~~ 495 (756)
+.||+|+||.||+|... +...||+|.+... .....+.+.+|+.+++.++||||+++++++. .++..++||||+.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 46899999999999853 2457999998543 2334567889999999999999999999876 4566899999999
Q ss_pred CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCcccCcc---
Q 004400 496 NNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTH--- 572 (756)
Q Consensus 496 ~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~~~~~--- 572 (756)
+|+|.+++.......++..+..++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||+++........
T Consensus 81 ~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~~ 157 (262)
T cd05058 81 HGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKK---FVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVH 157 (262)
T ss_pred CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCccccccccCCcceeec
Confidence 99999999866666788889999999999999999986 999999999999999999999999999754332111
Q ss_pred eeeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHhCC-CCCCccchhhHHHHHHHHHhcCccccccccCCCCCCC
Q 004400 573 ISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGR-SNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFD 651 (756)
Q Consensus 573 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 651 (756)
......++..|+|||.+.+..++.++|||||||++|||++|+ .||...+....... ... +.... .....
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~---~~~-~~~~~-----~~~~~- 227 (262)
T cd05058 158 NHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVY---LLQ-GRRLL-----QPEYC- 227 (262)
T ss_pred ccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH---Hhc-CCCCC-----CCCcC-
Confidence 112334677899999998889999999999999999999964 55554443332221 111 11100 01111
Q ss_pred HHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhccC
Q 004400 652 KEQVMVMINVALLCANASPTIRPSMSSVLRMLECG 686 (756)
Q Consensus 652 ~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~L~~~ 686 (756)
+..+.+++.+||+.+|++||++.+|++.|+.+
T Consensus 228 ---~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~ 259 (262)
T cd05058 228 ---PDPLYEVMLSCWHPKPEMRPTFSELVSRIEQI 259 (262)
T ss_pred ---CHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 23488999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=321.16 Aligned_cols=251 Identities=28% Similarity=0.457 Sum_probs=205.3
Q ss_pred hcCccccCcccCCCCccEEEee-ccCCcEEEEEEccccCcccHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEEe
Q 004400 415 TNNFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYEY 493 (756)
Q Consensus 415 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 493 (756)
..+|...+.||+|+||.||+|. ..+++.||+|.+........+.+.+|+.+++.++|+||++++++|..++..++||||
T Consensus 18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 97 (297)
T cd06656 18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 97 (297)
T ss_pred hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeecc
Confidence 3688899999999999999999 467999999999765555556788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCcccCcce
Q 004400 494 LENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHI 573 (756)
Q Consensus 494 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~~~~~~ 573 (756)
+++++|.+++.+. .+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||++.........
T Consensus 98 ~~~~~L~~~~~~~--~~~~~~~~~~~~~l~~~L~~LH~~~---i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~~- 171 (297)
T cd06656 98 LAGGSLTDVVTET--CMDEGQIAAVCRECLQALDFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK- 171 (297)
T ss_pred cCCCCHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEECcCccceEccCCccC-
Confidence 9999999998643 5789999999999999999999986 999999999999999999999999998765433221
Q ss_pred eeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhcCccccccccCCCCCCCHH
Q 004400 574 STRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDKE 653 (756)
Q Consensus 574 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 653 (756)
.....|++.|+|||.+.+..++.++|||||||++|++++|+.||...+....... ......+....+..
T Consensus 172 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~-----------~~~~~~~~~~~~~~ 240 (297)
T cd06656 172 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL-----------IATNGTPELQNPER 240 (297)
T ss_pred cCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheee-----------eccCCCCCCCCccc
Confidence 2234688999999999988899999999999999999999999965543211100 00000111111222
Q ss_pred HHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004400 654 QVMVMINVALLCANASPTIRPSMSSVLRM 682 (756)
Q Consensus 654 ~~~~l~~l~~~c~~~~P~~RPt~~ev~~~ 682 (756)
....+.+++.+||+.+|++||++.++++.
T Consensus 241 ~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (297)
T cd06656 241 LSAVFRDFLNRCLEMDVDRRGSAKELLQH 269 (297)
T ss_pred cCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 33457889999999999999999999873
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=334.76 Aligned_cols=251 Identities=22% Similarity=0.288 Sum_probs=196.2
Q ss_pred cCccccCcccCCCCccEEEeec-cCCcEEEEEEcccc---CcccHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEE
Q 004400 416 NNFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSK---SKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIY 491 (756)
Q Consensus 416 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 491 (756)
++|+..+.||+|+||.||+|+. .+++.||+|++... .......+.+|+.++..++||||+++++++.+++..++||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 3688889999999999999985 56899999998643 2233456788999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCcccCc
Q 004400 492 EYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENT 571 (756)
Q Consensus 492 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~~~~ 571 (756)
||+++|+|.+++... ..+++..+..++.|++.||+|||+.| |+||||||+|||++.++.+||+|||+++.......
T Consensus 81 E~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~~L~~lH~~g---ivHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~ 156 (360)
T cd05627 81 EFLPGGDMMTLLMKK-DTLSEEATQFYIAETVLAIDAIHQLG---FIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHR 156 (360)
T ss_pred eCCCCccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEeeccCCcccccccc
Confidence 999999999998754 46899999999999999999999987 99999999999999999999999999874422110
Q ss_pred ----------------------------------ceeeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHhCCCCC
Q 004400 572 ----------------------------------HISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNV 617 (756)
Q Consensus 572 ----------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~ 617 (756)
......+||+.|+|||++.+..++.++|||||||++|||++|+.||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf 236 (360)
T cd05627 157 TEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPF 236 (360)
T ss_pred cccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCC
Confidence 0012357999999999999999999999999999999999999999
Q ss_pred CccchhhHHHHHHHHHhcCccccccccCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCC---HHHHHH
Q 004400 618 TKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPS---MSSVLR 681 (756)
Q Consensus 618 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt---~~ev~~ 681 (756)
...+....... .........+. .....+ ..+.+++.+++ .+|.+|++ +.|+++
T Consensus 237 ~~~~~~~~~~~---i~~~~~~~~~p---~~~~~s----~~~~~li~~l~-~~p~~R~~~~~~~ei~~ 292 (360)
T cd05627 237 CSETPQETYRK---VMNWKETLVFP---PEVPIS----EKAKDLILRFC-TDSENRIGSNGVEEIKS 292 (360)
T ss_pred CCCCHHHHHHH---HHcCCCceecC---CCCCCC----HHHHHHHHHhc-cChhhcCCCCCHHHHhc
Confidence 76654332211 11101111111 111122 23667777765 49999996 555543
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=319.84 Aligned_cols=252 Identities=27% Similarity=0.425 Sum_probs=203.3
Q ss_pred cCccccCcccCCCCccEEEeec-cCCcEEEEEEccccCcccHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEEec
Q 004400 416 NNFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYEYL 494 (756)
Q Consensus 416 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~ 494 (756)
+.|+..+.||+|+||.||+|.. .+++.|++|.+........+.+.+|+.+++.++||||+++++++..+...++||||+
T Consensus 12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 91 (292)
T cd06644 12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFC 91 (292)
T ss_pred hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecC
Confidence 5688889999999999999995 468999999997766556678899999999999999999999999999999999999
Q ss_pred CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCcccCccee
Q 004400 495 ENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHIS 574 (756)
Q Consensus 495 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~~~~~~~ 574 (756)
++++|..++.+....+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||++........ ..
T Consensus 92 ~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~-~~ 167 (292)
T cd06644 92 PGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMK---IIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQ-RR 167 (292)
T ss_pred CCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCC---eeecCCCcceEEEcCCCCEEEccCccceecccccc-cc
Confidence 999999988766667999999999999999999999986 99999999999999999999999999875432211 12
Q ss_pred eccccCccCCchHhhh-----cCCCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhcCccccccccCCCCC
Q 004400 575 TRVAGTIGYMAPEYAM-----RGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSN 649 (756)
Q Consensus 575 ~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 649 (756)
....++..|+|||++. ...++.++|||||||++|||++|+.||...+..... ..... ...... .
T Consensus 168 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~---~~~~~-~~~~~~-------~ 236 (292)
T cd06644 168 DSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVL---LKIAK-SEPPTL-------S 236 (292)
T ss_pred ceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHH---HHHhc-CCCccC-------C
Confidence 3346888999999985 345788999999999999999999998654432211 11111 111000 0
Q ss_pred CCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004400 650 FDKEQVMVMINVALLCANASPTIRPSMSSVLRM 682 (756)
Q Consensus 650 ~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~ 682 (756)
.+......+.+++.+||+.+|++||++.++++.
T Consensus 237 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 269 (292)
T cd06644 237 QPSKWSMEFRDFLKTALDKHPETRPSAAQLLEH 269 (292)
T ss_pred CCcccCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 111223348889999999999999999999763
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=313.81 Aligned_cols=253 Identities=26% Similarity=0.417 Sum_probs=206.8
Q ss_pred cCccccCcccCCCCccEEEeec-cCCcEEEEEEccccCcccHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEEec
Q 004400 416 NNFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYEYL 494 (756)
Q Consensus 416 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~ 494 (756)
++|+..+.||+|+||.||+|.. .+++.+++|.+........+.+.+|++++++++||||+++++++.+++..+++|||+
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~ 82 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYC 82 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCC
Confidence 5788889999999999999995 467899999997665556678999999999999999999999999999999999999
Q ss_pred CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCcccCccee
Q 004400 495 ENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHIS 574 (756)
Q Consensus 495 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~~~~~~~ 574 (756)
++++|.+++......+++..+..++.|++.||+|||+.+ |+||||||+||++++++.+||+|||.+........ ..
T Consensus 83 ~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~-~~ 158 (262)
T cd06613 83 GGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETG---KIHRDIKGANILLTEDGDVKLADFGVSAQLTATIA-KR 158 (262)
T ss_pred CCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCC---ceecCCChhhEEECCCCCEEECccccchhhhhhhh-cc
Confidence 999999998776568999999999999999999999986 99999999999999999999999999976543221 12
Q ss_pred eccccCccCCchHhhhcC---CCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhcCccccccccCCCCCCC
Q 004400 575 TRVAGTIGYMAPEYAMRG---HLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFD 651 (756)
Q Consensus 575 ~~~~gt~~y~aPE~~~~~---~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 651 (756)
....++..|+|||.+.+. .++.++||||||+++|||++|+.||........... . ...... .......
T Consensus 159 ~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~---~-~~~~~~-----~~~~~~~ 229 (262)
T cd06613 159 KSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFL---I-SKSNFP-----PPKLKDK 229 (262)
T ss_pred ccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHH---H-HhccCC-----Cccccch
Confidence 335688899999999776 789999999999999999999999965443221110 0 011000 0001112
Q ss_pred HHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 004400 652 KEQVMVMINVALLCANASPTIRPSMSSVLR 681 (756)
Q Consensus 652 ~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~ 681 (756)
......+.+++.+||+.+|.+||++.+|+.
T Consensus 230 ~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 259 (262)
T cd06613 230 EKWSPVFHDFIKKCLTKDPKKRPTATKLLQ 259 (262)
T ss_pred hhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 233456889999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=316.40 Aligned_cols=254 Identities=23% Similarity=0.353 Sum_probs=201.5
Q ss_pred hcCccccCcccCCCCccEEEee-ccCCcEEEEEEccccCcccHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEEe
Q 004400 415 TNNFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYEY 493 (756)
Q Consensus 415 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 493 (756)
.++|...+.||+|+||.||+|. ..+++.||+|.++.........+.+|+.+++.++||||+++++++.+++..++||||
T Consensus 8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~ 87 (267)
T cd06645 8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEF 87 (267)
T ss_pred HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEec
Confidence 3577888999999999999998 457899999998765444456688899999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCcccCcce
Q 004400 494 LENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHI 573 (756)
Q Consensus 494 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~~~~~~ 573 (756)
+++++|.+++... ..+++.++..++.|++.||+|||+.| ++|+||||+||+++.++.+||+|||++....... ..
T Consensus 88 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~-~~ 162 (267)
T cd06645 88 CGGGSLQDIYHVT-GPLSESQIAYVSRETLQGLYYLHSKG---KMHRDIKGANILLTDNGHVKLADFGVSAQITATI-AK 162 (267)
T ss_pred cCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECcceeeeEccCcc-cc
Confidence 9999999988654 47899999999999999999999986 9999999999999999999999999987543322 12
Q ss_pred eeccccCccCCchHhhh---cCCCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhcCccccccccCCCCCC
Q 004400 574 STRVAGTIGYMAPEYAM---RGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNF 650 (756)
Q Consensus 574 ~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 650 (756)
.....|+..|+|||++. ...++.++|||||||++|||++|+.||.......... ............. ....+
T Consensus 163 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~---~~~~~~~~~~~~~--~~~~~ 237 (267)
T cd06645 163 RKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALF---LMTKSNFQPPKLK--DKMKW 237 (267)
T ss_pred cccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHH---hhhccCCCCCccc--ccCCC
Confidence 23456899999999975 4568899999999999999999999985443221110 0001100000000 00112
Q ss_pred CHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004400 651 DKEQVMVMINVALLCANASPTIRPSMSSVLRM 682 (756)
Q Consensus 651 ~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~ 682 (756)
+ ..+.+++.+|++.+|++||++.+|++.
T Consensus 238 ~----~~~~~li~~~l~~~P~~R~~~~~ll~~ 265 (267)
T cd06645 238 S----NSFHHFVKMALTKNPKKRPTAEKLLQH 265 (267)
T ss_pred C----HHHHHHHHHHccCCchhCcCHHHHhcC
Confidence 2 347899999999999999999998763
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=318.57 Aligned_cols=246 Identities=23% Similarity=0.392 Sum_probs=196.8
Q ss_pred CccccCcccCCCCccEEEee-ccCCcEEEEEEcccc-CcccHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEEec
Q 004400 417 NFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSK-SKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYEYL 494 (756)
Q Consensus 417 ~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~ 494 (756)
+|+..+.||+|+||.||+|. ..+++.||+|.+... .....+.+.+|++++++++||||++++++|..++..++||||+
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 81 (279)
T cd06619 2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFM 81 (279)
T ss_pred cchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEecC
Confidence 57778899999999999998 467899999998654 2333467889999999999999999999999999999999999
Q ss_pred CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCcccCccee
Q 004400 495 ENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHIS 574 (756)
Q Consensus 495 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~~~~~~~ 574 (756)
++++|..+ ..+++..+..++.|++.||+|||+.+ |+|+||||+||+++.++.+||+|||++....... .
T Consensus 82 ~~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~---~ 150 (279)
T cd06619 82 DGGSLDVY-----RKIPEHVLGRIAVAVVKGLTYLWSLK---ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSI---A 150 (279)
T ss_pred CCCChHHh-----hcCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCCHHHEEECCCCCEEEeeCCcceeccccc---c
Confidence 99999654 25788899999999999999999987 9999999999999999999999999997543321 2
Q ss_pred eccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHhCCCCCCccchhh----HHHHHHHHHhcCccccccccCCCCCC
Q 004400 575 TRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFY----LLDWALVLKEQGKLMELVDTNPGSNF 650 (756)
Q Consensus 575 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~ 650 (756)
....||..|+|||++.+..++.++||||||+++|+|++|+.||....... ...+........ ... .+....
T Consensus 151 ~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~-~~~----~~~~~~ 225 (279)
T cd06619 151 KTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDED-PPV----LPVGQF 225 (279)
T ss_pred cCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccC-CCC----CCCCcC
Confidence 33578999999999998889999999999999999999999995422111 001111010000 000 011112
Q ss_pred CHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004400 651 DKEQVMVMINVALLCANASPTIRPSMSSVLRM 682 (756)
Q Consensus 651 ~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~ 682 (756)
...+.+++.+|++.+|++||++.|+++.
T Consensus 226 ----~~~~~~li~~~l~~~P~~Rp~~~eil~~ 253 (279)
T cd06619 226 ----SEKFVHFITQCMRKQPKERPAPENLMDH 253 (279)
T ss_pred ----CHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 2348899999999999999999999875
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-37 Score=326.86 Aligned_cols=241 Identities=23% Similarity=0.307 Sum_probs=190.3
Q ss_pred CcccCCCCccEEEeec-cCCcEEEEEEccccC---cccHHHHHHHHHHHHhC-CCCceeeEeeEEEeCCeEEEEEEecCC
Q 004400 422 NNIGEGGFGPVYKGLL-ADGTAIAVKQLSSKS---KQGNREFINEIGMISAL-QHPNLVKLYGCCIEGNQLLLIYEYLEN 496 (756)
Q Consensus 422 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~e~~~~ 496 (756)
+.||+|+||.||+|.. .+++.||+|++.... ....+.+.+|+.++.++ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 4699999999999994 567899999997542 22345678899999888 699999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCcccCcceeec
Q 004400 497 NSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTR 576 (756)
Q Consensus 497 gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~ 576 (756)
|+|.+++... ..+++..+..++.|++.||+|||++| |+||||||+|||++.++.+||+|||+++....... ....
T Consensus 81 ~~L~~~~~~~-~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~-~~~~ 155 (327)
T cd05617 81 GDLMFHMQRQ-RKLPEEHARFYAAEICIALNFLHERG---IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGD-TTST 155 (327)
T ss_pred CcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEeCCCCEEEeccccceeccCCCC-ceec
Confidence 9999888654 47999999999999999999999987 99999999999999999999999999874322211 2234
Q ss_pred cccCccCCchHhhhcCCCCcccchhhHHHHHHHHHhCCCCCCccch---hhHHHHHHHHHhcCccccccccCCCCCCCHH
Q 004400 577 VAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDM---FYLLDWALVLKEQGKLMELVDTNPGSNFDKE 653 (756)
Q Consensus 577 ~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 653 (756)
..||+.|+|||++.+..++.++|||||||++|||++|+.||..... .....+.......... ..+..
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~----------~~p~~ 225 (327)
T cd05617 156 FCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPI----------RIPRF 225 (327)
T ss_pred ccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCC----------CCCCC
Confidence 6799999999999999999999999999999999999999953211 1111111111111100 01111
Q ss_pred HHHHHHHHHHHhhcCCCCCCCCHH
Q 004400 654 QVMVMINVALLCANASPTIRPSMS 677 (756)
Q Consensus 654 ~~~~l~~l~~~c~~~~P~~RPt~~ 677 (756)
....+.+++.+|++.||++|+++.
T Consensus 226 ~~~~~~~li~~~L~~dP~~R~~~~ 249 (327)
T cd05617 226 LSVKASHVLKGFLNKDPKERLGCQ 249 (327)
T ss_pred CCHHHHHHHHHHhccCHHHcCCCC
Confidence 223478999999999999999853
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=334.93 Aligned_cols=259 Identities=21% Similarity=0.277 Sum_probs=197.3
Q ss_pred hhcCccccCcccCCCCccEEEeecc-CCcEEEEEEccccCcccHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEE
Q 004400 414 ATNNFATDNNIGEGGFGPVYKGLLA-DGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYE 492 (756)
Q Consensus 414 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 492 (756)
....|.+.+.||+|+||.||+|... .++.||||.... ..+.+|++++++++|+|||++++++..++..++|||
T Consensus 167 ~~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e 240 (461)
T PHA03211 167 AGLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLP 240 (461)
T ss_pred ccCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEE
Confidence 3457999999999999999999954 578899996432 346789999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCcccCc-
Q 004400 493 YLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENT- 571 (756)
Q Consensus 493 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~~~~- 571 (756)
++. ++|.+++......+++..+..++.|++.||+|||+.| ||||||||+|||++.++.+||+|||+++.......
T Consensus 241 ~~~-~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~ 316 (461)
T PHA03211 241 KYR-SDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAACFARGSWST 316 (461)
T ss_pred ccC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEECcCCHHHEEECCCCCEEEcccCCceeccccccc
Confidence 995 6898888766667999999999999999999999987 99999999999999999999999999986543222
Q ss_pred ceeeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHhCCCCCCccchh-----hHHHHHHHHHhcCcc-ccccc--
Q 004400 572 HISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMF-----YLLDWALVLKEQGKL-MELVD-- 643 (756)
Q Consensus 572 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~-----~~~~~~~~~~~~~~~-~~~~~-- 643 (756)
.......||+.|+|||++.+..++.++|||||||++|||++|..|+...... ........+...... .+...
T Consensus 317 ~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~ 396 (461)
T PHA03211 317 PFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHA 396 (461)
T ss_pred ccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCc
Confidence 1223467999999999999999999999999999999999988765322100 000000111110000 00000
Q ss_pred ---------------cCCC---CCCC--HHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004400 644 ---------------TNPG---SNFD--KEQVMVMINVALLCANASPTIRPSMSSVLRM 682 (756)
Q Consensus 644 ---------------~~~~---~~~~--~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~ 682 (756)
..+. ..+. ......+.+++.+|++.||.+|||+.|+++.
T Consensus 397 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h 455 (461)
T PHA03211 397 GSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL 455 (461)
T ss_pred chHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence 0000 0000 0112257889999999999999999999875
|
|
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=318.33 Aligned_cols=249 Identities=25% Similarity=0.324 Sum_probs=197.1
Q ss_pred ccccCcccCCCCccEEEee-ccCCcEEEEEEccccCc---ccHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEEe
Q 004400 418 FATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSKSK---QGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYEY 493 (756)
Q Consensus 418 ~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 493 (756)
|+..+.||+|+||.||+|. ..+++.||+|.+..... .....+.+|+.++++++|++|+++++.+.+++..++||||
T Consensus 2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05630 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL 81 (285)
T ss_pred ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence 5667889999999999998 45789999999865322 2234577899999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCcccCcc
Q 004400 494 LENNSLARALFEH-RLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTH 572 (756)
Q Consensus 494 ~~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~~~~~ 572 (756)
+++|+|.+++... ...+++..+..++.|++.||+|||+.+ |+||||||+||++++++.++|+|||++........
T Consensus 82 ~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~- 157 (285)
T cd05630 82 MNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT- 157 (285)
T ss_pred cCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeccceeecCCCcc-
Confidence 9999999998643 346899999999999999999999986 99999999999999999999999999875443222
Q ss_pred eeeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhcCccccccccCCCCCCCH
Q 004400 573 ISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDK 652 (756)
Q Consensus 573 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 652 (756)
.....|+..|+|||++.+..++.++|||||||++|||++|+.||................. .... .....++
T Consensus 158 -~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~--~~~~----~~~~~~~- 229 (285)
T cd05630 158 -IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVK--EVQE----EYSEKFS- 229 (285)
T ss_pred -ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhh--hhhh----hcCccCC-
Confidence 1234689999999999998999999999999999999999999965332111000000000 0000 0111222
Q ss_pred HHHHHHHHHHHHhhcCCCCCCCC-----HHHHHH
Q 004400 653 EQVMVMINVALLCANASPTIRPS-----MSSVLR 681 (756)
Q Consensus 653 ~~~~~l~~l~~~c~~~~P~~RPt-----~~ev~~ 681 (756)
..+.+++.+||+.||++||+ +.|+++
T Consensus 230 ---~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~ 260 (285)
T cd05630 230 ---PDARSLCKMLLCKDPKERLGCQGGGAREVKE 260 (285)
T ss_pred ---HHHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence 34789999999999999999 777765
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-37 Score=328.82 Aligned_cols=258 Identities=27% Similarity=0.412 Sum_probs=200.3
Q ss_pred hcCccccCcccCCCCccEEEeec------cCCcEEEEEEccccC-cccHHHHHHHHHHHHhC-CCCceeeEeeEEEeC-C
Q 004400 415 TNNFATDNNIGEGGFGPVYKGLL------ADGTAIAVKQLSSKS-KQGNREFINEIGMISAL-QHPNLVKLYGCCIEG-N 485 (756)
Q Consensus 415 ~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~-~ 485 (756)
.++|...+.||+|+||.||+|.. .+++.||||.++... ......+.+|+.++.++ +||||++++++|... .
T Consensus 6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (343)
T cd05103 6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 85 (343)
T ss_pred hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCC
Confidence 35788999999999999999973 357899999997543 22345688999999999 689999999988654 5
Q ss_pred eEEEEEEecCCCCHHHHHHhcC----------------------------------------------------------
Q 004400 486 QLLLIYEYLENNSLARALFEHR---------------------------------------------------------- 507 (756)
Q Consensus 486 ~~~lV~e~~~~gsL~~~l~~~~---------------------------------------------------------- 507 (756)
..++||||+++|+|.+++....
T Consensus 86 ~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (343)
T cd05103 86 PLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEE 165 (343)
T ss_pred ceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhh
Confidence 6899999999999999986421
Q ss_pred --------CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCcccCcc-eeeccc
Q 004400 508 --------LKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTH-ISTRVA 578 (756)
Q Consensus 508 --------~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~~~~~-~~~~~~ 578 (756)
..+++..+.+++.|++.||+|||+++ |+||||||+||++++++.+||+|||+++........ ......
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 242 (343)
T cd05103 166 AEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDAR 242 (343)
T ss_pred hhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCC
Confidence 23688889999999999999999986 999999999999999999999999999764332211 122234
Q ss_pred cCccCCchHhhhcCCCCcccchhhHHHHHHHHHh-CCCCCCccchhhHHHHHHHHHhcCccccccccCCCCCCCHHHHHH
Q 004400 579 GTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVS-GRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDKEQVMV 657 (756)
Q Consensus 579 gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 657 (756)
+++.|+|||.+.+..++.++||||||+++|||++ |..||......... .... ..+..... + ...+ ..
T Consensus 243 ~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~--~~~~-~~~~~~~~----~-~~~~----~~ 310 (343)
T cd05103 243 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF--CRRL-KEGTRMRA----P-DYTT----PE 310 (343)
T ss_pred CCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHH--HHHH-hccCCCCC----C-CCCC----HH
Confidence 5678999999988899999999999999999997 88898543321111 1111 11111111 0 1112 24
Q ss_pred HHHHHHHhhcCCCCCCCCHHHHHHHhccCc
Q 004400 658 MINVALLCANASPTIRPSMSSVLRMLECGV 687 (756)
Q Consensus 658 l~~l~~~c~~~~P~~RPt~~ev~~~L~~~~ 687 (756)
+.+++.+||+.+|++||++.||++.|+...
T Consensus 311 ~~~~~~~cl~~~p~~Rps~~eil~~l~~~~ 340 (343)
T cd05103 311 MYQTMLDCWHGEPSQRPTFSELVEHLGNLL 340 (343)
T ss_pred HHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 889999999999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=318.69 Aligned_cols=259 Identities=24% Similarity=0.330 Sum_probs=194.7
Q ss_pred CccccCcccCCCCccEEEeec-cCCcEEEEEEccccCc--ccHHHHHHHHHHHHhC---CCCceeeEeeEEEe-----CC
Q 004400 417 NFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSKSK--QGNREFINEIGMISAL---QHPNLVKLYGCCIE-----GN 485 (756)
Q Consensus 417 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~-----~~ 485 (756)
+|+..+.||+|+||.||+|+. .+++.||+|.+..... .....+.+|+++++.+ +||||+++++++.. ..
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 477889999999999999984 5789999999875422 2234566777777665 69999999999864 34
Q ss_pred eEEEEEEecCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccc
Q 004400 486 QLLLIYEYLENNSLARALFEH-RLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAK 564 (756)
Q Consensus 486 ~~~lV~e~~~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~ 564 (756)
..++||||+.+ +|.+++... ...+++..+..++.|++.||+|||+.| |+||||||+||+++.++.+||+|||+++
T Consensus 81 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~kl~dfg~~~ 156 (288)
T cd07863 81 KVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLAR 156 (288)
T ss_pred eEEEEEccccc-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccCccc
Confidence 58999999985 888888643 345899999999999999999999997 9999999999999999999999999998
Q ss_pred cCcccCcceeeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhcC---cccc-
Q 004400 565 LDEEENTHISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQG---KLME- 640 (756)
Q Consensus 565 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~---~~~~- 640 (756)
....... .....||..|+|||++.+..++.++||||+||++|||++|+.||................... ....
T Consensus 157 ~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (288)
T cd07863 157 IYSCQMA--LTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRD 234 (288)
T ss_pred cccCccc--CCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCccc
Confidence 6543221 233568999999999998899999999999999999999999996554332221111111000 0000
Q ss_pred ------ccccCCC---CCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 004400 641 ------LVDTNPG---SNFDKEQVMVMINVALLCANASPTIRPSMSSVLR 681 (756)
Q Consensus 641 ------~~~~~~~---~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~ 681 (756)
....... ....+.....+.+++.+|++.||++|||+.|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~ 284 (288)
T cd07863 235 VTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ 284 (288)
T ss_pred ccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 0000000 0011122345789999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-36 Score=312.26 Aligned_cols=251 Identities=25% Similarity=0.385 Sum_probs=189.6
Q ss_pred CcccCCCCccEEEeeccC---CcEEEEEEccccCc-ccHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEEecCCC
Q 004400 422 NNIGEGGFGPVYKGLLAD---GTAIAVKQLSSKSK-QGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYEYLENN 497 (756)
Q Consensus 422 ~~lg~G~~g~Vy~~~~~~---~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~g 497 (756)
+.||+|+||.||+|...+ ...+|+|.+..... .....+.+|+++++.++||||++++++|.+....++||||+++|
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG 80 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence 368999999999997433 35688888764332 23456889999999999999999999999999999999999999
Q ss_pred CHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCcccCcc-
Q 004400 498 SLARALFEHR----LKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTH- 572 (756)
Q Consensus 498 sL~~~l~~~~----~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~~~~~- 572 (756)
+|.+++.... ...++.....++.||+.||+|||+.+ |+||||||+||++++++.+||+|||+++........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~ 157 (269)
T cd05042 81 DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD---FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYI 157 (269)
T ss_pred cHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcC---EecccccHhheEecCCCcEEEeccccccccccchhee
Confidence 9999997543 23467888999999999999999986 999999999999999999999999998754332211
Q ss_pred eeeccccCccCCchHhhhc-------CCCCcccchhhHHHHHHHHHh-CCCCCCccchhhHHHHHHHHHhcCcccccccc
Q 004400 573 ISTRVAGTIGYMAPEYAMR-------GHLTEKADVYSFGIVALEIVS-GRSNVTKEDMFYLLDWALVLKEQGKLMELVDT 644 (756)
Q Consensus 573 ~~~~~~gt~~y~aPE~~~~-------~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 644 (756)
......+++.|+|||+... ..++.++|||||||++|||++ |..||............ . .. .......+
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~--~-~~-~~~~~~~~ 233 (269)
T cd05042 158 TKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQV--V-RE-QDIKLPKP 233 (269)
T ss_pred ccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHH--h-hc-cCccCCCC
Confidence 1223346778999999753 356889999999999999999 77788554433222111 1 11 11111111
Q ss_pred CCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhc
Q 004400 645 NPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLE 684 (756)
Q Consensus 645 ~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~L~ 684 (756)
.. +......+.+++..|| .||++||++++|++.|.
T Consensus 234 ~~----~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 234 QL----DLKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT 268 (269)
T ss_pred cc----cccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence 11 1122334677888999 59999999999999874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=312.33 Aligned_cols=238 Identities=27% Similarity=0.453 Sum_probs=190.5
Q ss_pred CcccCCCCccEEEeeccCCc-----------EEEEEEccccCcccHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEE
Q 004400 422 NNIGEGGFGPVYKGLLADGT-----------AIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLI 490 (756)
Q Consensus 422 ~~lg~G~~g~Vy~~~~~~~~-----------~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 490 (756)
+.||+|+||.||+|...+.. .|++|.+...... ...|.+|+.++++++||||+++++++.. ...++|
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv 78 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV 78 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence 46899999999999965433 5788877654332 6789999999999999999999999988 778999
Q ss_pred EEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCC-------CEEEccCCcc
Q 004400 491 YEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDL-------NSKISDFGLA 563 (756)
Q Consensus 491 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~-------~~kl~DFGla 563 (756)
|||+++|+|.+++......+++..+..++.||+.||+|||+++ |+||||||+||+++.++ .+||+|||++
T Consensus 79 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a 155 (259)
T cd05037 79 EEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKK---LVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIP 155 (259)
T ss_pred EEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCC---eecccCccceEEEecCccccCCceeEEeCCCCcc
Confidence 9999999999999866557899999999999999999999986 99999999999999887 7999999999
Q ss_pred ccCcccCcceeeccccCccCCchHhhhcC--CCCcccchhhHHHHHHHHHh-CCCCCCccchhhHHHHHHHHHhcCcccc
Q 004400 564 KLDEEENTHISTRVAGTIGYMAPEYAMRG--HLTEKADVYSFGIVALEIVS-GRSNVTKEDMFYLLDWALVLKEQGKLME 640 (756)
Q Consensus 564 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 640 (756)
..... .....++..|+|||++... .++.++|||||||++||+++ |..|+..........+ ... .....
T Consensus 156 ~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~---~~~-~~~~~ 226 (259)
T cd05037 156 ITVLS-----REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERF---YQD-QHRLP 226 (259)
T ss_pred ccccc-----ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHH---Hhc-CCCCC
Confidence 86443 1223567789999999876 78999999999999999999 5667644322111111 111 10000
Q ss_pred ccccCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhc
Q 004400 641 LVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLE 684 (756)
Q Consensus 641 ~~~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~L~ 684 (756)
.+ ....+.+++.+||..+|++||++.++++.|+
T Consensus 227 ----~~-------~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 259 (259)
T cd05037 227 ----MP-------DCAELANLINQCWTYDPTKRPSFRAILRDLN 259 (259)
T ss_pred ----CC-------CchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 00 0145889999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=312.16 Aligned_cols=248 Identities=27% Similarity=0.449 Sum_probs=199.6
Q ss_pred CccccCcccCCCCccEEEeec-cCCcEEEEEEccccCcc---------cHHHHHHHHHHHHhCCCCceeeEeeEEEeCCe
Q 004400 417 NFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSKSKQ---------GNREFINEIGMISALQHPNLVKLYGCCIEGNQ 486 (756)
Q Consensus 417 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~---------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 486 (756)
+|.....||+|+||.||+|.. .+++.||+|.+...... ..+.+.+|+.++++++||||+++++++.+++.
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 366778999999999999984 56889999988654222 12467889999999999999999999999999
Q ss_pred EEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccC
Q 004400 487 LLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLD 566 (756)
Q Consensus 487 ~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~ 566 (756)
.++||||+++++|.+++... ..+++..+..++.|++.||+|||+.+ ++||||+|+||++++++.+||+|||.++..
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~~l~~~l~~lH~~~---ivH~di~p~nil~~~~~~~~l~dfg~~~~~ 156 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNNY-GAFEETLVRNFVRQILKGLNYLHNRG---IIHRDIKGANILVDNKGGIKISDFGISKKL 156 (267)
T ss_pred cEEEEEecCCCCHHHHHHhc-cCccHHHHHHHHHHHHHHHHHHHhcC---cccccCCHHHEEEcCCCCEEecccCCCccc
Confidence 99999999999999999754 46899999999999999999999986 999999999999999999999999999865
Q ss_pred cccCcc-----eeeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhcCccccc
Q 004400 567 EEENTH-----ISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMEL 641 (756)
Q Consensus 567 ~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 641 (756)
...... ......|+..|+|||.+.+..++.++|||||||++|+|++|+.||...+...... .. ...
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~---~~-~~~----- 227 (267)
T cd06628 157 EANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIF---KI-GEN----- 227 (267)
T ss_pred ccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHH---HH-hcc-----
Confidence 422111 1123458899999999998889999999999999999999999996543322111 00 000
Q ss_pred cccCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 004400 642 VDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLR 681 (756)
Q Consensus 642 ~~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~ 681 (756)
..+. .+......+.+++.+||+.+|.+||++.|+++
T Consensus 228 ~~~~----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 263 (267)
T cd06628 228 ASPE----IPSNISSEAIDFLEKTFEIDHNKRPTAAELLK 263 (267)
T ss_pred CCCc----CCcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence 1111 11122345889999999999999999999876
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-37 Score=316.33 Aligned_cols=253 Identities=30% Similarity=0.453 Sum_probs=199.8
Q ss_pred ccccCcccCCCCccEEEeec-cCCcEEEEEEccccCcccH--HHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEEec
Q 004400 418 FATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSKSKQGN--REFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYEYL 494 (756)
Q Consensus 418 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~--~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~ 494 (756)
|+..+.||+|+||+||+|.. .+++.||+|.+........ ....+|+.++++++||||+++++++.++...++||||+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 56678999999999999994 4667899999977643322 23456999999999999999999999999999999999
Q ss_pred CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCcccCccee
Q 004400 495 ENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHIS 574 (756)
Q Consensus 495 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~~~~~~~ 574 (756)
++++|.+++. ....+++..+..++.|+++||+|||+.+ |+||||||+||++++++.++|+|||.+..... .....
T Consensus 81 ~~~~L~~~l~-~~~~~~~~~~~~~~~qi~~~L~~Lh~~~---i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~-~~~~~ 155 (260)
T PF00069_consen 81 PGGSLQDYLQ-KNKPLSEEEILKIAYQILEALAYLHSKG---IVHRDIKPENILLDENGEVKLIDFGSSVKLSE-NNENF 155 (260)
T ss_dssp TTEBHHHHHH-HHSSBBHHHHHHHHHHHHHHHHHHHHTT---EEESSBSGGGEEESTTSEEEESSGTTTEESTS-TTSEB
T ss_pred cccccccccc-cccccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccc-ccccc
Confidence 9999999997 3347899999999999999999999996 99999999999999999999999999975421 12233
Q ss_pred eccccCccCCchHhhh-cCCCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhcCccccccccCCCCCCCHH
Q 004400 575 TRVAGTIGYMAPEYAM-RGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDKE 653 (756)
Q Consensus 575 ~~~~gt~~y~aPE~~~-~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 653 (756)
....++..|+|||++. ...++.++||||+|+++|+|++|+.||................. ..... .... ...
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~-~~~~~---~~~~---~~~ 228 (260)
T PF00069_consen 156 NPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILK-RPLPS---SSQQ---SRE 228 (260)
T ss_dssp SSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHH-THHHH---HTTS---HTT
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhccc-ccccc---cccc---cch
Confidence 4467899999999998 78899999999999999999999999976522221111111110 00000 0000 000
Q ss_pred HHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004400 654 QVMVMINVALLCANASPTIRPSMSSVLRM 682 (756)
Q Consensus 654 ~~~~l~~l~~~c~~~~P~~RPt~~ev~~~ 682 (756)
....+.+++.+|++.||++||++.++++.
T Consensus 229 ~~~~l~~li~~~l~~~p~~R~~~~~l~~~ 257 (260)
T PF00069_consen 229 KSEELRDLIKKMLSKDPEQRPSAEELLKH 257 (260)
T ss_dssp SHHHHHHHHHHHSSSSGGGSTTHHHHHTS
T ss_pred hHHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 01458999999999999999999999763
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=329.59 Aligned_cols=259 Identities=24% Similarity=0.325 Sum_probs=196.6
Q ss_pred hcCccccCcccCCCCccEEEeec-cCCcEEEEEEcccc--CcccHHHHHHHHHHHHhCCCCceeeEeeEEEeCC------
Q 004400 415 TNNFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSK--SKQGNREFINEIGMISALQHPNLVKLYGCCIEGN------ 485 (756)
Q Consensus 415 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------ 485 (756)
.++|...+.||+|+||.||+|.. .+|+.||+|.+... .......+.+|+.+++.++||||+++++++...+
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 99 (359)
T cd07876 20 LKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQ 99 (359)
T ss_pred hhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccc
Confidence 46889999999999999999984 56899999998653 2233467889999999999999999999986543
Q ss_pred eEEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCcccc
Q 004400 486 QLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKL 565 (756)
Q Consensus 486 ~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~ 565 (756)
..++||||+++ +|.+.+. ..+++..+..++.|++.||+|||+.| |+||||||+||+++.++.+||+|||+++.
T Consensus 100 ~~~lv~e~~~~-~l~~~~~---~~~~~~~~~~~~~qi~~~L~~LH~~~---ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~ 172 (359)
T cd07876 100 DVYLVMELMDA-NLCQVIH---MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLART 172 (359)
T ss_pred eeEEEEeCCCc-CHHHHHh---ccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEecCCCccc
Confidence 57999999976 5655553 25788999999999999999999997 99999999999999999999999999975
Q ss_pred CcccCcceeeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHH--------------
Q 004400 566 DEEENTHISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALV-------------- 631 (756)
Q Consensus 566 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~-------------- 631 (756)
..... ......||+.|+|||.+.+..++.++|||||||++|||++|+.||...+..........
T Consensus 173 ~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (359)
T cd07876 173 ACTNF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQ 250 (359)
T ss_pred cccCc--cCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHHH
Confidence 43221 12345689999999999998999999999999999999999999976543321110000
Q ss_pred -----HHhc-Cccc-----cccccC---CCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004400 632 -----LKEQ-GKLM-----ELVDTN---PGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRM 682 (756)
Q Consensus 632 -----~~~~-~~~~-----~~~~~~---~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~ 682 (756)
.... .... +....- ............+.+++.+|++.||++|||+.|+++.
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 315 (359)
T cd07876 251 PTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRH 315 (359)
T ss_pred HHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcC
Confidence 0000 0000 000000 0000011123357899999999999999999999874
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-37 Score=316.81 Aligned_cols=240 Identities=25% Similarity=0.436 Sum_probs=191.2
Q ss_pred CcccCCCCccEEEeeccC--------CcEEEEEEccccCcccHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEEe
Q 004400 422 NNIGEGGFGPVYKGLLAD--------GTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYEY 493 (756)
Q Consensus 422 ~~lg~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 493 (756)
+.||+|+||.||+|.... ...||+|.+........+.+.+|+.+++.++||||+++++++..++..++||||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 80 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY 80 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence 369999999999998532 234888887655444556788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCC--------EEEccCCcccc
Q 004400 494 LENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLN--------SKISDFGLAKL 565 (756)
Q Consensus 494 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~--------~kl~DFGla~~ 565 (756)
+++|+|.+++......+++..+..++.||+.||+|||+.+ |+||||||+||+++.++. ++++|||++..
T Consensus 81 ~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~ 157 (258)
T cd05078 81 VKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKG---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISIT 157 (258)
T ss_pred CCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEEecccccccCCCceEEecccccccc
Confidence 9999999999876667899999999999999999999986 999999999999987765 69999999875
Q ss_pred CcccCcceeeccccCccCCchHhhhc-CCCCcccchhhHHHHHHHHHhCC-CCCCccchhhHHHHHHHHHhcCccccccc
Q 004400 566 DEEENTHISTRVAGTIGYMAPEYAMR-GHLTEKADVYSFGIVALEIVSGR-SNVTKEDMFYLLDWALVLKEQGKLMELVD 643 (756)
Q Consensus 566 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slGv~l~elltg~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 643 (756)
.... ....+++.|+|||++.+ ..++.++|||||||++|||++|. .|+...+...... ..... ...
T Consensus 158 ~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~---~~~~~---~~~-- 224 (258)
T cd05078 158 VLPK-----EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQ---FYEDR---HQL-- 224 (258)
T ss_pred cCCc-----hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHH---HHHcc---ccC--
Confidence 4321 23467889999999986 45899999999999999999995 5554333221111 11110 111
Q ss_pred cCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhc
Q 004400 644 TNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLE 684 (756)
Q Consensus 644 ~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~L~ 684 (756)
+......+.+++.+||+.+|++|||++++++.|+
T Consensus 225 -------~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 225 -------PAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred -------CCCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 1111234889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=327.07 Aligned_cols=258 Identities=28% Similarity=0.446 Sum_probs=204.6
Q ss_pred hcCccccCcccCCCCccEEEeecc--------CCcEEEEEEccccC-cccHHHHHHHHHHHHhC-CCCceeeEeeEEEeC
Q 004400 415 TNNFATDNNIGEGGFGPVYKGLLA--------DGTAIAVKQLSSKS-KQGNREFINEIGMISAL-QHPNLVKLYGCCIEG 484 (756)
Q Consensus 415 ~~~~~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 484 (756)
..+|...+.||+|+||.||+|... .+..||+|.+.... ....+.+.+|+++++++ +||||++++++|.++
T Consensus 11 ~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 90 (334)
T cd05100 11 RTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 90 (334)
T ss_pred HhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccC
Confidence 346888999999999999999732 12368999887542 33456789999999999 799999999999999
Q ss_pred CeEEEEEEecCCCCHHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEe
Q 004400 485 NQLLLIYEYLENNSLARALFEHR---------------LKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLL 549 (756)
Q Consensus 485 ~~~~lV~e~~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill 549 (756)
+..++||||+++|+|.+++.... ..+++.++..++.|++.||+|||+.| |+||||||+||++
T Consensus 91 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nill 167 (334)
T cd05100 91 GPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK---CIHRDLAARNVLV 167 (334)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEE
Confidence 99999999999999999997432 35789999999999999999999986 9999999999999
Q ss_pred cCCCCEEEccCCccccCcccCcce-eeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHh-CCCCCCccchhhHHH
Q 004400 550 DKDLNSKISDFGLAKLDEEENTHI-STRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVS-GRSNVTKEDMFYLLD 627 (756)
Q Consensus 550 ~~~~~~kl~DFGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~~ 627 (756)
+.++.+||+|||+++......... .....++..|+|||++.+..++.++|||||||++|||++ |..||..........
T Consensus 168 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~ 247 (334)
T cd05100 168 TEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFK 247 (334)
T ss_pred cCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Confidence 999999999999998654322211 122234568999999999899999999999999999998 888886554333222
Q ss_pred HHHHHHhcCccccccccCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhccCcc
Q 004400 628 WALVLKEQGKLMELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLECGVD 688 (756)
Q Consensus 628 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~L~~~~~ 688 (756)
. .. ........ ... ...+.+++.+||+.+|++||++.|+++.|+.+..
T Consensus 248 ~---~~-~~~~~~~~-----~~~----~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~ 295 (334)
T cd05100 248 L---LK-EGHRMDKP-----ANC----THELYMIMRECWHAVPSQRPTFKQLVEDLDRVLT 295 (334)
T ss_pred H---HH-cCCCCCCC-----CCC----CHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhh
Confidence 1 11 11111111 112 2348899999999999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=311.02 Aligned_cols=250 Identities=25% Similarity=0.396 Sum_probs=205.4
Q ss_pred CccccCcccCCCCccEEEee-ccCCcEEEEEEcccc--CcccHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEEe
Q 004400 417 NFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSK--SKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYEY 493 (756)
Q Consensus 417 ~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 493 (756)
+|+..+.||+|+||.||.+. ..+++.+++|.+... .......+.+|++++++++|+||+++++++.+.+..++||||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 47788999999999999998 567899999987654 234456788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCcccCcc
Q 004400 494 LENNSLARALFEH-RLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTH 572 (756)
Q Consensus 494 ~~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~~~~~ 572 (756)
+++|+|.+++... ...+++..+..++.|++.||+|||+.+ ++||||+|+||++++++.+||+|||++........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~- 156 (256)
T cd08221 81 ANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS- 156 (256)
T ss_pred cCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChHhEEEeCCCCEEECcCcceEEcccccc-
Confidence 9999999999754 456899999999999999999999986 99999999999999999999999999986544332
Q ss_pred eeeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhcCccccccccCCCCCCCH
Q 004400 573 ISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDK 652 (756)
Q Consensus 573 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 652 (756)
......|++.|+|||...+..++.++||||||+++|||++|+.||...+....... .. .+..... +.
T Consensus 157 ~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~---~~-~~~~~~~---------~~ 223 (256)
T cd08221 157 MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVK---IV-QGNYTPV---------VS 223 (256)
T ss_pred cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHH---HH-cCCCCCC---------cc
Confidence 22345689999999999888899999999999999999999999966544332211 11 1111111 11
Q ss_pred HHHHHHHHHHHHhhcCCCCCCCCHHHHHHHh
Q 004400 653 EQVMVMINVALLCANASPTIRPSMSSVLRML 683 (756)
Q Consensus 653 ~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~L 683 (756)
.....+.+++.+||+.+|.+||++.++++.+
T Consensus 224 ~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~ 254 (256)
T cd08221 224 VYSSELISLVHSLLQQDPEKRPTADEVLDQP 254 (256)
T ss_pred ccCHHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence 2233488999999999999999999998753
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=328.88 Aligned_cols=246 Identities=26% Similarity=0.402 Sum_probs=203.7
Q ss_pred cccCcccCCCCccEEEeecc--CCc--EEEEEEccccCcc-cHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEEe
Q 004400 419 ATDNNIGEGGFGPVYKGLLA--DGT--AIAVKQLSSKSKQ-GNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYEY 493 (756)
Q Consensus 419 ~~~~~lg~G~~g~Vy~~~~~--~~~--~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 493 (756)
...++||+|.||.|++|.|. .|+ .||||.+...... ...+|.+|+.+|.+|+|||+|++||+..+ ....||+|.
T Consensus 113 ~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~EL 191 (1039)
T KOG0199|consen 113 KLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFEL 191 (1039)
T ss_pred HHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhhh
Confidence 34578999999999999975 344 5899999876554 55789999999999999999999999887 788999999
Q ss_pred cCCCCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCcccCcc
Q 004400 494 LENNSLARALFE-HRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTH 572 (756)
Q Consensus 494 ~~~gsL~~~l~~-~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~~~~~ 572 (756)
++.|+|.+.|++ ....|-......++.|||.||.||..++ +||||+..+|+++-....|||+|||+.+-.+.....
T Consensus 192 aplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskr---lvHRDLAARNlllasprtVKI~DFGLmRaLg~ned~ 268 (1039)
T KOG0199|consen 192 APLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKR---LVHRDLAARNLLLASPRTVKICDFGLMRALGENEDM 268 (1039)
T ss_pred cccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhh---hhhhhhhhhhheecccceeeeecccceeccCCCCcc
Confidence 999999999986 5556888899999999999999999986 999999999999999889999999999977654333
Q ss_pred e-ee-ccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHh-CCCCCCccchhhHHHHHHHHHhcCccccccccCCCCC
Q 004400 573 I-ST-RVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVS-GRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSN 649 (756)
Q Consensus 573 ~-~~-~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 649 (756)
. .. ...-.+.|+|||.+..+.++.++|||+|||.+|||+| |..||.+.....++... +++++. .
T Consensus 269 Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~i----D~~erL---------p 335 (1039)
T KOG0199|consen 269 YVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNI----DAGERL---------P 335 (1039)
T ss_pred eEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhc----cccccC---------C
Confidence 2 11 1223568999999999999999999999999999998 78899877766555321 112111 1
Q ss_pred CCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 004400 650 FDKEQVMVMINVALLCANASPTIRPSMSSVLR 681 (756)
Q Consensus 650 ~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~ 681 (756)
-++.+.+.+.++++.||..+|.+||||..|++
T Consensus 336 RPk~csedIY~imk~cWah~paDRptFsair~ 367 (1039)
T KOG0199|consen 336 RPKYCSEDIYQIMKNCWAHNPADRPTFSAIRE 367 (1039)
T ss_pred CCCCChHHHHHHHHHhccCCccccccHHHHHH
Confidence 23334556999999999999999999999973
|
|
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=317.18 Aligned_cols=258 Identities=28% Similarity=0.428 Sum_probs=205.1
Q ss_pred cCccccCcccCCCCccEEEeecc-----CCcEEEEEEccccCcc-cHHHHHHHHHHHHhCCCCceeeEeeEEEe--CCeE
Q 004400 416 NNFATDNNIGEGGFGPVYKGLLA-----DGTAIAVKQLSSKSKQ-GNREFINEIGMISALQHPNLVKLYGCCIE--GNQL 487 (756)
Q Consensus 416 ~~~~~~~~lg~G~~g~Vy~~~~~-----~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~ 487 (756)
++|...+.||+|+||.||+|.+. +++.||||.+...... ..+.|.+|+++++.++||||+++++++.. +...
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL 83 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence 35677789999999999999853 3689999999765443 45789999999999999999999999987 5678
Q ss_pred EEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCc
Q 004400 488 LLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDE 567 (756)
Q Consensus 488 ~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~ 567 (756)
++||||+++++|.+++......+++..+..++.|++.||+|||+.| ++||||||+||+++.++.++|+|||.+....
T Consensus 84 ~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 160 (284)
T cd05038 84 RLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQR---YIHRDLAARNILVESEDLVKISDFGLAKVLP 160 (284)
T ss_pred EEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccccccccc
Confidence 9999999999999999876667999999999999999999999986 9999999999999999999999999998765
Q ss_pred ccCcce--eeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHhCCCCCCccchhh------------HHHHHHHHH
Q 004400 568 EENTHI--STRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFY------------LLDWALVLK 633 (756)
Q Consensus 568 ~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~------------~~~~~~~~~ 633 (756)
...... .....++..|+|||......++.++||||||+++|||++|+.|+....... ...+.....
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (284)
T cd05038 161 EDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLK 240 (284)
T ss_pred cCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHHHH
Confidence 322211 112345667999999988889999999999999999999999984432111 001111111
Q ss_pred hcCccccccccCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhccC
Q 004400 634 EQGKLMELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLECG 686 (756)
Q Consensus 634 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~L~~~ 686 (756)
.... ...+......+.+++.+||+.+|++||++.||+++|+.+
T Consensus 241 -~~~~---------~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 241 -EGER---------LPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred -cCCc---------CCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 1110 001111224588999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=320.01 Aligned_cols=262 Identities=20% Similarity=0.325 Sum_probs=201.3
Q ss_pred cCccccCcccCCCCccEEEeec-cCCcEEEEEEccccC-cccHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEEe
Q 004400 416 NNFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSKS-KQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYEY 493 (756)
Q Consensus 416 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 493 (756)
++|...+.||+|+||.||+|.. .+++.||+|.+.... ......+.+|+.++++++||||+++++++.+++..++||||
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~ 85 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 85 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence 4688899999999999999985 468899999986542 23345678899999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCcccCcce
Q 004400 494 LENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHI 573 (756)
Q Consensus 494 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~~~~~~ 573 (756)
++ ++|.+++......+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++.........
T Consensus 86 ~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~- 160 (301)
T cd07873 86 LD-KDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPTKT- 160 (301)
T ss_pred cc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHHHEEECCCCcEEECcCcchhccCCCCCc-
Confidence 97 5899988776667899999999999999999999986 999999999999999999999999999754332221
Q ss_pred eeccccCccCCchHhhhcC-CCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhc---Cccccccc------
Q 004400 574 STRVAGTIGYMAPEYAMRG-HLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQ---GKLMELVD------ 643 (756)
Q Consensus 574 ~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~------ 643 (756)
.....+++.|+|||.+.+. .++.++|||||||++|||++|+.||...+.............. ........
T Consensus 161 ~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (301)
T cd07873 161 YSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKS 240 (301)
T ss_pred ccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhccccccc
Confidence 1234578899999998754 5788999999999999999999999765543222211111000 00000000
Q ss_pred ---cCCCCC----CCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004400 644 ---TNPGSN----FDKEQVMVMINVALLCANASPTIRPSMSSVLRM 682 (756)
Q Consensus 644 ---~~~~~~----~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~ 682 (756)
+..... ........+.+++.+|++.||.+|||+.|+++.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h 286 (301)
T cd07873 241 YNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKH 286 (301)
T ss_pred cccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 000000 001122357899999999999999999999863
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=316.12 Aligned_cols=254 Identities=26% Similarity=0.383 Sum_probs=203.2
Q ss_pred cCccccCcccCCCCccEEEeecc------CCcEEEEEEccccCcc-cHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEE
Q 004400 416 NNFATDNNIGEGGFGPVYKGLLA------DGTAIAVKQLSSKSKQ-GNREFINEIGMISALQHPNLVKLYGCCIEGNQLL 488 (756)
Q Consensus 416 ~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 488 (756)
++|...+.||+|+||.||+|+.. +.+.|++|.+...... ....+.+|++++++++|+||+++++++.+.+..+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY 84 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence 46788899999999999999853 3467999988654333 3467999999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHHhcC--------CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccC
Q 004400 489 LIYEYLENNSLARALFEHR--------LKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDF 560 (756)
Q Consensus 489 lV~e~~~~gsL~~~l~~~~--------~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DF 560 (756)
+||||+++|+|.+++.... ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.++++||
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~~~ 161 (275)
T cd05046 85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR---FVHRDLAARNCLVSSQREVKVSLL 161 (275)
T ss_pred EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcC---cccCcCccceEEEeCCCcEEEccc
Confidence 9999999999999997433 15899999999999999999999986 999999999999999999999999
Q ss_pred CccccCcccCcceeeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHh-CCCCCCccchhhHHHHHHHHHhcCccc
Q 004400 561 GLAKLDEEENTHISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVS-GRSNVTKEDMFYLLDWALVLKEQGKLM 639 (756)
Q Consensus 561 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 639 (756)
|+++..............++..|+|||.+.+..++.++||||||+++|++++ |..||............ ..+...
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~----~~~~~~ 237 (275)
T cd05046 162 SLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRL----QAGKLE 237 (275)
T ss_pred ccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHHHHHHH----HcCCcC
Confidence 9987543322222233456788999999988889999999999999999999 78888543332222211 111111
Q ss_pred cccccCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhc
Q 004400 640 ELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLE 684 (756)
Q Consensus 640 ~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~L~ 684 (756)
.. ....++ ..+.+++.+||+.+|++||++.|+++.|.
T Consensus 238 -~~---~~~~~~----~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 238 -LP---VPEGCP----SRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred -CC---CCCCCC----HHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 00 011222 34889999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=310.81 Aligned_cols=250 Identities=34% Similarity=0.555 Sum_probs=202.8
Q ss_pred ccccCcccCCCCccEEEeeccC-----CcEEEEEEccccCcc-cHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEE
Q 004400 418 FATDNNIGEGGFGPVYKGLLAD-----GTAIAVKQLSSKSKQ-GNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIY 491 (756)
Q Consensus 418 ~~~~~~lg~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 491 (756)
|+..+.||+|+||.||+|...+ +..||+|.+...... ..+.+.+|+++++.++|+||+++++++.+.+..++||
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~ 80 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM 80 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence 3456899999999999999543 388999999765333 5678999999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHhcCCC-CCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCcccC
Q 004400 492 EYLENNSLARALFEHRLK-LDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEEN 570 (756)
Q Consensus 492 e~~~~gsL~~~l~~~~~~-l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~~~ 570 (756)
||+++++|.+++...... +++..+..++.|++.||+|||+.+ ++||||||+||+++.++.++|+|||+++......
T Consensus 81 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~---~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~ 157 (258)
T smart00219 81 EYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKN---FIHRDLAARNCLVGENLVVKISDFGLSRDLYDDD 157 (258)
T ss_pred eccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCC---eeecccccceEEEccCCeEEEcccCCceeccccc
Confidence 999999999999755434 899999999999999999999996 9999999999999999999999999998665443
Q ss_pred cceeeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHh-CCCCCCccchhhHHHHHHHHHhcCccccccccCCCCC
Q 004400 571 THISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVS-GRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSN 649 (756)
Q Consensus 571 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 649 (756)
........+++.|+|||.+....++.++||||+|+++|+|++ |+.||............ ........ ...
T Consensus 158 ~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~----~~~~~~~~-----~~~ 228 (258)
T smart00219 158 YYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYL----KKGYRLPK-----PEN 228 (258)
T ss_pred ccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH----hcCCCCCC-----CCc
Confidence 322222347789999999988889999999999999999998 78888654433332221 11111111 111
Q ss_pred CCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHh
Q 004400 650 FDKEQVMVMINVALLCANASPTIRPSMSSVLRML 683 (756)
Q Consensus 650 ~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~L 683 (756)
....+.+++.+|+..+|++|||+.|+++.|
T Consensus 229 ----~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 229 ----CPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred ----CCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 233588899999999999999999998864
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=314.65 Aligned_cols=247 Identities=30% Similarity=0.492 Sum_probs=197.4
Q ss_pred CcccCCCCccEEEeeccC-------CcEEEEEEccccC-cccHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEEe
Q 004400 422 NNIGEGGFGPVYKGLLAD-------GTAIAVKQLSSKS-KQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYEY 493 (756)
Q Consensus 422 ~~lg~G~~g~Vy~~~~~~-------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 493 (756)
+.||+|+||.||+|...+ +..||+|.+.... ......+.+|+++++.++||||++++++|...+..++||||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL 80 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence 469999999999998542 2579999886543 23456789999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhc------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCC-----CEEEccCCc
Q 004400 494 LENNSLARALFEH------RLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDL-----NSKISDFGL 562 (756)
Q Consensus 494 ~~~gsL~~~l~~~------~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~-----~~kl~DFGl 562 (756)
+++|+|.+++... ...+++.++..++.|++.||+|||+.+ ++|+||||+||+++.++ .++++|||+
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~ 157 (269)
T cd05044 81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMH---FIHRDLAARNCLVSEKGYDADRVVKIGDFGL 157 (269)
T ss_pred cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCC---cccCCCChheEEEecCCCCCCcceEECCccc
Confidence 9999999999742 234789999999999999999999986 99999999999999887 899999999
Q ss_pred cccCcccCc-ceeeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHh-CCCCCCccchhhHHHHHHHHHhcCcccc
Q 004400 563 AKLDEEENT-HISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVS-GRSNVTKEDMFYLLDWALVLKEQGKLME 640 (756)
Q Consensus 563 a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 640 (756)
++....... .......++..|+|||++.++.++.++|||||||++|||++ |+.||...+........ ..+....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~----~~~~~~~ 233 (269)
T cd05044 158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHV----TAGGRLQ 233 (269)
T ss_pred ccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHH----hcCCccC
Confidence 975433221 11222345788999999999999999999999999999998 99998655443332211 1111111
Q ss_pred ccccCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhc
Q 004400 641 LVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLE 684 (756)
Q Consensus 641 ~~~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~L~ 684 (756)
.+...+..+.+++.+||..+|.+||++.++++.|+
T Consensus 234 ---------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~ 268 (269)
T cd05044 234 ---------KPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQ 268 (269)
T ss_pred ---------CcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 11122345889999999999999999999999886
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=328.69 Aligned_cols=260 Identities=22% Similarity=0.299 Sum_probs=198.2
Q ss_pred hhcCccccCcccCCCCccEEEeec-cCCcEEEEEEccccC--cccHHHHHHHHHHHHhCCCCceeeEeeEEEeC------
Q 004400 414 ATNNFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSKS--KQGNREFINEIGMISALQHPNLVKLYGCCIEG------ 484 (756)
Q Consensus 414 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------ 484 (756)
..++|...+.||+|+||.||+|.. ..++.||||.+.... ......+.+|+.+++.++||||+++++++...
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 94 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF 94 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence 356899999999999999999984 568899999987542 23346778899999999999999999998654
Q ss_pred CeEEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccc
Q 004400 485 NQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAK 564 (756)
Q Consensus 485 ~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~ 564 (756)
...++||||+++ ++.+.+. ..+++..+..++.|+++||+|||+.| |+||||||+||+++.++.+||+|||+++
T Consensus 95 ~~~~lv~e~~~~-~l~~~~~---~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDikp~Nill~~~~~~kl~Dfg~~~ 167 (355)
T cd07874 95 QDVYLVMELMDA-NLCQVIQ---MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR 167 (355)
T ss_pred ceeEEEhhhhcc-cHHHHHh---hcCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEECCCCCEEEeeCcccc
Confidence 357999999976 5666654 25889999999999999999999987 9999999999999999999999999998
Q ss_pred cCcccCcceeeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHH------------
Q 004400 565 LDEEENTHISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVL------------ 632 (756)
Q Consensus 565 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~------------ 632 (756)
...... ......||..|+|||++.+..++.++|||||||++|||++|+.||...+...........
T Consensus 168 ~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (355)
T cd07874 168 TAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKL 245 (355)
T ss_pred cCCCcc--ccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhh
Confidence 644322 223457899999999999889999999999999999999999999765533221111000
Q ss_pred -------Hhc-Ccccccc-----ccCC---CCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004400 633 -------KEQ-GKLMELV-----DTNP---GSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRM 682 (756)
Q Consensus 633 -------~~~-~~~~~~~-----~~~~---~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~ 682 (756)
... ....... .... ...........+.+++.+|++.||++|||+.|+++.
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h 311 (355)
T cd07874 246 QPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH 311 (355)
T ss_pred cHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence 000 0000000 0000 000111123457899999999999999999999875
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=321.25 Aligned_cols=255 Identities=27% Similarity=0.462 Sum_probs=202.5
Q ss_pred hcCccccCcccCCCCccEEEeec-cCCc----EEEEEEccccCc-ccHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEE
Q 004400 415 TNNFATDNNIGEGGFGPVYKGLL-ADGT----AIAVKQLSSKSK-QGNREFINEIGMISALQHPNLVKLYGCCIEGNQLL 488 (756)
Q Consensus 415 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~----~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 488 (756)
.++|+..+.||+|+||.||+|.. .+|. .||+|.+..... ....++.+|+.+++.++||||++++++|..+ ..+
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~ 84 (303)
T cd05110 6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQ 84 (303)
T ss_pred hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cce
Confidence 35778889999999999999985 3444 478888865422 2234688999999999999999999998754 467
Q ss_pred EEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCcc
Q 004400 489 LIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEE 568 (756)
Q Consensus 489 lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~ 568 (756)
+|+||+++|+|.+++......+++..+..++.|++.||+|||+++ |+||||||+||+++.++.+||+|||+++....
T Consensus 85 ~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~ 161 (303)
T cd05110 85 LVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERR---LVHRDLAARNVLVKSPNHVKITDFGLARLLEG 161 (303)
T ss_pred eeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcC---eeccccccceeeecCCCceEEccccccccccC
Confidence 999999999999999877667899999999999999999999986 99999999999999999999999999986543
Q ss_pred cCcce-eeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHh-CCCCCCccchhhHHHHHHHHHhcCccccccccCC
Q 004400 569 ENTHI-STRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVS-GRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNP 646 (756)
Q Consensus 569 ~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 646 (756)
..... .....++..|+|||.+.+..++.++|||||||++||+++ |+.||..........+. ..+.....
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~~~----~~~~~~~~----- 232 (303)
T cd05110 162 DEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLL----EKGERLPQ----- 232 (303)
T ss_pred cccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH----HCCCCCCC-----
Confidence 32211 222345778999999988889999999999999999997 89998655433332221 11111100
Q ss_pred CCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhccC
Q 004400 647 GSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLECG 686 (756)
Q Consensus 647 ~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~L~~~ 686 (756)
.... ...+.+++.+||..+|++||++.++++.|+.+
T Consensus 233 ~~~~----~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~ 268 (303)
T cd05110 233 PPIC----TIDVYMVMVKCWMIDADSRPKFKELAAEFSRM 268 (303)
T ss_pred CCCC----CHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 0111 23478899999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=314.59 Aligned_cols=249 Identities=30% Similarity=0.467 Sum_probs=203.4
Q ss_pred cCccccCcccCCCCccEEEeec-cCCcEEEEEEccccC-cccHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEEe
Q 004400 416 NNFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSKS-KQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYEY 493 (756)
Q Consensus 416 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 493 (756)
++|...+.||.|+||.||+|.. .+++.||+|.+.... ......+.+|+++++.++|+||+++++++.++...++|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY 80 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence 3677889999999999999994 478999999986543 33346788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCcccCcce
Q 004400 494 LENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHI 573 (756)
Q Consensus 494 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~~~~~~ 573 (756)
+++++|.+++... .+++..+..++.|++.|+.|||+.+ ++||||+|+||++++++.++|+|||+++....... .
T Consensus 81 ~~~~~L~~~~~~~--~~~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~-~ 154 (274)
T cd06609 81 CGGGSCLDLLKPG--KLDETYIAFILREVLLGLEYLHEEG---KIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMS-K 154 (274)
T ss_pred eCCCcHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEcccccceeeccccc-c
Confidence 9999999998754 7899999999999999999999986 99999999999999999999999999986654322 2
Q ss_pred eeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhcCccccccccCCCCCCCHH
Q 004400 574 STRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDKE 653 (756)
Q Consensus 574 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 653 (756)
.....|+..|+|||++.+..++.++||||||+++|||++|+.||...+...... .. .......... ..+
T Consensus 155 ~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~---~~-~~~~~~~~~~----~~~--- 223 (274)
T cd06609 155 RNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLF---LI-PKNNPPSLEG----NKF--- 223 (274)
T ss_pred cccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHH---Hh-hhcCCCCCcc----ccc---
Confidence 233568889999999998889999999999999999999999996544222111 01 1111111111 012
Q ss_pred HHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004400 654 QVMVMINVALLCANASPTIRPSMSSVLRM 682 (756)
Q Consensus 654 ~~~~l~~l~~~c~~~~P~~RPt~~ev~~~ 682 (756)
...+.+++.+||..+|++||+++++++.
T Consensus 224 -~~~~~~~l~~~l~~~p~~Rpt~~~il~~ 251 (274)
T cd06609 224 -SKPFKDFVSLCLNKDPKERPSAKELLKH 251 (274)
T ss_pred -CHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 2348899999999999999999999774
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-37 Score=313.41 Aligned_cols=248 Identities=22% Similarity=0.361 Sum_probs=210.2
Q ss_pred cCccccCcccCCCCccEEEee-ccCCcEEEEEEccccCcc--cHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEE
Q 004400 416 NNFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQ--GNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYE 492 (756)
Q Consensus 416 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 492 (756)
+-|+..+.||+|.|+.|-.|+ .-+|..||||++.+..-+ ....+.+|++.|+.++|||||++|.+...+..+|||+|
T Consensus 18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLE 97 (864)
T KOG4717|consen 18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILE 97 (864)
T ss_pred eeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEE
Confidence 357788999999999999999 458999999999765322 34568899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEe-cCCCCEEEccCCccccCcccCc
Q 004400 493 YLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLL-DKDLNSKISDFGLAKLDEEENT 571 (756)
Q Consensus 493 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill-~~~~~~kl~DFGla~~~~~~~~ 571 (756)
.-++|+|.|++..+...+.+.-+.+++.||+.|+.|+|+.. +|||||||+||.+ .+-|-|||+|||++-.+.+...
T Consensus 98 LGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLH---VVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG~k 174 (864)
T KOG4717|consen 98 LGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLH---VVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPGKK 174 (864)
T ss_pred ecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhh---hhcccCCcceeEEeeecCceEeeeccccccCCCcch
Confidence 99999999999999889999999999999999999999885 9999999999766 5567899999999976655433
Q ss_pred ceeeccccCccCCchHhhhcCCCC-cccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhcCccccccccCCCCCC
Q 004400 572 HISTRVAGTIGYMAPEYAMRGHLT-EKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNF 650 (756)
Q Consensus 572 ~~~~~~~gt~~y~aPE~~~~~~~~-~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 650 (756)
-++.+|+..|.|||++.+..|+ +++||||+|||+|.+++|+.||...+....+. .++|-. -..
T Consensus 175 --L~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLT------------mImDCK--Ytv 238 (864)
T KOG4717|consen 175 --LTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLT------------MIMDCK--YTV 238 (864)
T ss_pred --hhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhh------------hhhccc--ccC
Confidence 3567999999999999998886 58999999999999999999997665443322 222211 123
Q ss_pred CHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004400 651 DKEQVMVMINVALLCANASPTIRPSMSSVLRM 682 (756)
Q Consensus 651 ~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~ 682 (756)
+.....+..++|..|+..||.+|.+.+||+..
T Consensus 239 PshvS~eCrdLI~sMLvRdPkkRAslEeI~s~ 270 (864)
T KOG4717|consen 239 PSHVSKECRDLIQSMLVRDPKKRASLEEIVST 270 (864)
T ss_pred chhhhHHHHHHHHHHHhcCchhhccHHHHhcc
Confidence 44566679999999999999999999999653
|
|
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=315.36 Aligned_cols=255 Identities=27% Similarity=0.466 Sum_probs=204.7
Q ss_pred cCccccCcccCCCCccEEEeecc-CCc----EEEEEEccccCc-ccHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEE
Q 004400 416 NNFATDNNIGEGGFGPVYKGLLA-DGT----AIAVKQLSSKSK-QGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLL 489 (756)
Q Consensus 416 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 489 (756)
.+|...+.||+|+||.||+|... +|. .||+|.+..... .....+.+|+.++++++||||++++++|.. ...++
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~ 85 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQL 85 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEE
Confidence 56788899999999999999854 333 589998865532 344678899999999999999999999987 78899
Q ss_pred EEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCccc
Q 004400 490 IYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEE 569 (756)
Q Consensus 490 V~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~~ 569 (756)
||||+++|+|.+++......+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||.++.....
T Consensus 86 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~~ 162 (279)
T cd05057 86 ITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLDVD 162 (279)
T ss_pred EEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecccCcceEEEcCCCeEEECCCcccccccCc
Confidence 99999999999999877667999999999999999999999986 999999999999999999999999999866533
Q ss_pred Cccee-eccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHh-CCCCCCccchhhHHHHHHHHHhcCccccccccCCC
Q 004400 570 NTHIS-TRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVS-GRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPG 647 (756)
Q Consensus 570 ~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 647 (756)
..... ....++..|+|||.+....++.++||||||+++||+++ |+.||........... ... ...... .
T Consensus 163 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~---~~~-~~~~~~-----~ 233 (279)
T cd05057 163 EKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDL---LEK-GERLPQ-----P 233 (279)
T ss_pred ccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH---HhC-CCCCCC-----C
Confidence 22211 12234568999999988889999999999999999998 9999966543332221 111 111000 0
Q ss_pred CCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhccCc
Q 004400 648 SNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLECGV 687 (756)
Q Consensus 648 ~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~L~~~~ 687 (756)
...+ ..+.+++.+||..+|.+||++.++++.|+.+.
T Consensus 234 ~~~~----~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~ 269 (279)
T cd05057 234 PICT----IDVYMVLVKCWMIDAESRPTFKELINEFSKMA 269 (279)
T ss_pred CCCC----HHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence 1122 34788999999999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=317.20 Aligned_cols=255 Identities=24% Similarity=0.372 Sum_probs=203.8
Q ss_pred hcCccccCcccCCCCccEEEeec-cCCcEEEEEEccccC-cccHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEE
Q 004400 415 TNNFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSKS-KQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYE 492 (756)
Q Consensus 415 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 492 (756)
.++|+..+.||+|+||.||+|.. .+++.||+|++.... ....+.+.+|+++++.++||||+++++++......++|||
T Consensus 4 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (284)
T cd06620 4 NEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCME 83 (284)
T ss_pred HHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEe
Confidence 35778889999999999999994 568899999876542 3345678999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCcccCcc
Q 004400 493 YLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTH 572 (756)
Q Consensus 493 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~~~~~ 572 (756)
|+++++|.+++... ..+++..+..++.+++.||.|||+.. +++||||||+||++++++.++|+|||++.......
T Consensus 84 ~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~-- 158 (284)
T cd06620 84 FMDCGSLDRIYKKG-GPIPVEILGKIAVAVVEGLTYLYNVH--RIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSI-- 158 (284)
T ss_pred cCCCCCHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHHhc--CeeccCCCHHHEEECCCCcEEEccCCcccchhhhc--
Confidence 99999999988654 46899999999999999999999742 49999999999999999999999999987543221
Q ss_pred eeeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHhCCCCCCccchh--------hHHHHHHHHHhcCcccccccc
Q 004400 573 ISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMF--------YLLDWALVLKEQGKLMELVDT 644 (756)
Q Consensus 573 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~ 644 (756)
.....|+..|+|||++.+..++.++|||||||++|++++|+.||...... ...++........ . .
T Consensus 159 -~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~-----~ 231 (284)
T cd06620 159 -ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEP-P-----P 231 (284)
T ss_pred -cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhcc-C-----C
Confidence 12356899999999998888999999999999999999999999654321 1112211111110 0 0
Q ss_pred CCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhc
Q 004400 645 NPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLE 684 (756)
Q Consensus 645 ~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~L~ 684 (756)
... .......+.+++.+|++.||++||++.|++++..
T Consensus 232 ~~~---~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~ 268 (284)
T cd06620 232 RLP---SSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPP 268 (284)
T ss_pred CCC---chhcCHHHHHHHHHHhcCCcccCcCHHHHhcCcc
Confidence 000 1112345889999999999999999999998743
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=318.35 Aligned_cols=250 Identities=28% Similarity=0.475 Sum_probs=205.0
Q ss_pred cCccccCcccCCCCccEEEee-ccCCcEEEEEEccccCcccHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEEec
Q 004400 416 NNFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYEYL 494 (756)
Q Consensus 416 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~ 494 (756)
.+|+..+.||.|+||.||+|. ..+++.||+|.+........+.+.+|+.+++.++||||+++++++.+++..++|+||+
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 98 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYL 98 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEec
Confidence 468899999999999999998 4678999999987655555677899999999999999999999999999999999999
Q ss_pred CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCcccCccee
Q 004400 495 ENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHIS 574 (756)
Q Consensus 495 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~~~~~~~ 574 (756)
++++|.+++... .+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||++......... .
T Consensus 99 ~~~~L~~~~~~~--~l~~~~~~~i~~~l~~al~~LH~~~---i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~~-~ 172 (296)
T cd06655 99 AGGSLTDVVTET--CMDEAQIAAVCRECLQALEFLHANQ---VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSK-R 172 (296)
T ss_pred CCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccchhccccccc-C
Confidence 999999988643 5899999999999999999999986 999999999999999999999999998765433221 2
Q ss_pred eccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhcCccccccccCCCCCCCHHH
Q 004400 575 TRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDKEQ 654 (756)
Q Consensus 575 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 654 (756)
....|+..|+|||.+.+..++.++|||||||++|++++|+.||...+........ .. ....... ....+
T Consensus 173 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~---~~-~~~~~~~---~~~~~---- 241 (296)
T cd06655 173 STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLI---AT-NGTPELQ---NPEKL---- 241 (296)
T ss_pred CCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH---Hh-cCCcccC---CcccC----
Confidence 2346889999999998888999999999999999999999999765543222111 11 1110000 01112
Q ss_pred HHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004400 655 VMVMINVALLCANASPTIRPSMSSVLRM 682 (756)
Q Consensus 655 ~~~l~~l~~~c~~~~P~~RPt~~ev~~~ 682 (756)
...+.+++.+||..+|++||++.++++.
T Consensus 242 ~~~~~~li~~~l~~dp~~Rpt~~~il~~ 269 (296)
T cd06655 242 SPIFRDFLNRCLEMDVEKRGSAKELLQH 269 (296)
T ss_pred CHHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence 2348889999999999999999999754
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=349.91 Aligned_cols=256 Identities=25% Similarity=0.376 Sum_probs=199.7
Q ss_pred HHHhhcCccccCcccCCCCccEEEeec-cCCcEEEEEEcccc--CcccHHHHHHHHHHHHhCCCCceeeEeeEEEe--CC
Q 004400 411 IKAATNNFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSK--SKQGNREFINEIGMISALQHPNLVKLYGCCIE--GN 485 (756)
Q Consensus 411 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~ 485 (756)
-....++|.+.+.||+|+||+||+|.. .++..||+|.+... .......|..|+.++++++|||||+++++|.+ ..
T Consensus 8 ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~ 87 (1021)
T PTZ00266 8 GESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQ 87 (1021)
T ss_pred CccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCC
Confidence 344567899999999999999999994 56788999988643 22334678999999999999999999999865 45
Q ss_pred eEEEEEEecCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHcCCC----CCeEcCCCCCCceEecCC------
Q 004400 486 QLLLIYEYLENNSLARALFEH---RLKLDWPTRRRICLGIARGLAYLHGESR----IKVVHRDIKATNVLLDKD------ 552 (756)
Q Consensus 486 ~~~lV~e~~~~gsL~~~l~~~---~~~l~~~~~~~i~~~ia~~L~~LH~~g~----~~iiH~Dikp~Nill~~~------ 552 (756)
.+|+||||+++|+|.++|... ...+++..++.|+.||+.||+|||+.+. .+||||||||+|||++.+
T Consensus 88 ~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~ 167 (1021)
T PTZ00266 88 KLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGK 167 (1021)
T ss_pred EEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccc
Confidence 789999999999999999742 3469999999999999999999998541 249999999999999642
Q ss_pred -----------CCEEEccCCccccCcccCcceeeccccCccCCchHhhhc--CCCCcccchhhHHHHHHHHHhCCCCCCc
Q 004400 553 -----------LNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPEYAMR--GHLTEKADVYSFGIVALEIVSGRSNVTK 619 (756)
Q Consensus 553 -----------~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~slGv~l~elltg~~p~~~ 619 (756)
+.+||+|||+++...... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||..
T Consensus 168 i~~~~~n~ng~~iVKLsDFGlAr~l~~~s--~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~ 245 (1021)
T PTZ00266 168 ITAQANNLNGRPIAKIGDFGLSKNIGIES--MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHK 245 (1021)
T ss_pred ccccccccCCCCceEEccCCccccccccc--cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCc
Confidence 348999999998654322 2234579999999999864 4589999999999999999999999965
Q ss_pred cchhhHHHHHHHHHhcCccccccccCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 004400 620 EDMFYLLDWALVLKEQGKLMELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLR 681 (756)
Q Consensus 620 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~ 681 (756)
....... ...... . ... +...++ ..+.+++..||+.+|.+||++.|++.
T Consensus 246 ~~~~~ql--i~~lk~-~--p~l----pi~~~S----~eL~dLI~~~L~~dPeeRPSa~QlL~ 294 (1021)
T PTZ00266 246 ANNFSQL--ISELKR-G--PDL----PIKGKS----KELNILIKNLLNLSAKERPSALQCLG 294 (1021)
T ss_pred CCcHHHH--HHHHhc-C--CCC----CcCCCC----HHHHHHHHHHhcCChhHCcCHHHHhc
Confidence 4432211 111111 1 010 111122 34889999999999999999999984
|
|
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=328.15 Aligned_cols=259 Identities=20% Similarity=0.279 Sum_probs=197.7
Q ss_pred hcCccccCcccCCCCccEEEee-ccCCcEEEEEEccccC--cccHHHHHHHHHHHHhCCCCceeeEeeEEEeC------C
Q 004400 415 TNNFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSKS--KQGNREFINEIGMISALQHPNLVKLYGCCIEG------N 485 (756)
Q Consensus 415 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~ 485 (756)
.++|...+.||+|+||.||+|. ...++.||||++.... ......+.+|+.+++.++||||+++++++... .
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~ 102 (364)
T cd07875 23 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 102 (364)
T ss_pred hcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccC
Confidence 4688899999999999999998 4568899999987532 23346788999999999999999999987643 3
Q ss_pred eEEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCcccc
Q 004400 486 QLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKL 565 (756)
Q Consensus 486 ~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~ 565 (756)
..|+||||+++ +|.+.+.. .+++..+..++.|++.||+|||++| |+||||||+||+++.++.+||+|||+++.
T Consensus 103 ~~~lv~e~~~~-~l~~~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~ 175 (364)
T cd07875 103 DVYIVMELMDA-NLCQVIQM---ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLART 175 (364)
T ss_pred eEEEEEeCCCC-CHHHHHHh---cCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEECCCCcEEEEeCCCccc
Confidence 57999999976 67776642 4789999999999999999999986 99999999999999999999999999986
Q ss_pred CcccCcceeeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHh-----------
Q 004400 566 DEEENTHISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKE----------- 634 (756)
Q Consensus 566 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~----------- 634 (756)
..... ......||..|+|||++.+..++.++|||||||++|||++|+.||...+.............
T Consensus 176 ~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (364)
T cd07875 176 AGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQ 253 (364)
T ss_pred cCCCC--cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhh
Confidence 54322 12345689999999999999999999999999999999999999976554332221110000
Q ss_pred ---------cCcccc-----ccccCC---CCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004400 635 ---------QGKLME-----LVDTNP---GSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRM 682 (756)
Q Consensus 635 ---------~~~~~~-----~~~~~~---~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~ 682 (756)
...... ...... ...........+.+++.+|++.||.+|||+.|+++.
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h 318 (364)
T cd07875 254 PTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 318 (364)
T ss_pred HHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 000000 000000 000011122357899999999999999999999874
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-36 Score=310.88 Aligned_cols=250 Identities=28% Similarity=0.463 Sum_probs=200.8
Q ss_pred CccccCcccCCCCccEEEeeccCCcEEEEEEccccCc------ccHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEE
Q 004400 417 NFATDNNIGEGGFGPVYKGLLADGTAIAVKQLSSKSK------QGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLI 490 (756)
Q Consensus 417 ~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 490 (756)
+|...+.||+|+||.||+|...+++.+|+|.+..... .....+.+|++++++++|+||++++++|.+.+..++|
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 4677889999999999999988899999998864321 1235688899999999999999999999999999999
Q ss_pred EEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCcccC
Q 004400 491 YEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEEN 570 (756)
Q Consensus 491 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~~~ 570 (756)
+||+++++|.+++.+. ..+++..+..++.|++.||+|||+.+ |+|+||+|+||++++++.++|+|||++.......
T Consensus 81 ~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 156 (265)
T cd06631 81 MEFVPGGSISSILNRF-GPLPEPVFCKYTKQILDGVAYLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVG 156 (265)
T ss_pred EecCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHhEEECCCCeEEeccchhhHhhhhcc
Confidence 9999999999999654 36889999999999999999999986 9999999999999999999999999987543211
Q ss_pred -----cceeeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhcCccccccccC
Q 004400 571 -----THISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTN 645 (756)
Q Consensus 571 -----~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 645 (756)
........|+..|+|||++.+..++.++||||||+++|++++|+.||...+....... ..........
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~--~~~~~~~~~~----- 229 (265)
T cd06631 157 LHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFY--IGAHRGLMPR----- 229 (265)
T ss_pred ccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHH--hhhccCCCCC-----
Confidence 1112235689999999999988899999999999999999999999965443221110 0001011111
Q ss_pred CCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 004400 646 PGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLR 681 (756)
Q Consensus 646 ~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~ 681 (756)
....+ ...+.+++.+||+.+|.+||++.|+++
T Consensus 230 ~~~~~----~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 230 LPDSF----SAAAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred CCCCC----CHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 11122 334889999999999999999999875
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=326.54 Aligned_cols=192 Identities=23% Similarity=0.341 Sum_probs=167.3
Q ss_pred hhcCccccCcccCCCCccEEEeec-cCCcEEEEEEccccCcccHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEE
Q 004400 414 ATNNFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYE 492 (756)
Q Consensus 414 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 492 (756)
...+|...+.||+|+||.||+|.. .+++.||+|..... ....|+.++++++||||+++++++.+++..++|+|
T Consensus 64 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 137 (357)
T PHA03209 64 ASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLP 137 (357)
T ss_pred hhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEE
Confidence 456899999999999999999995 45788999975432 23569999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCcccCcc
Q 004400 493 YLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTH 572 (756)
Q Consensus 493 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~~~~~ 572 (756)
|+. ++|.+++......+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 138 ~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~-- 211 (357)
T PHA03209 138 HYS-SDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQR---IIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAP-- 211 (357)
T ss_pred ccC-CcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEecCccccccccCc--
Confidence 995 5888888776678999999999999999999999986 9999999999999999999999999997533221
Q ss_pred eeeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHhCCCCC
Q 004400 573 ISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNV 617 (756)
Q Consensus 573 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~ 617 (756)
......||+.|+|||++.+..++.++|||||||++|||+++..|+
T Consensus 212 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~ 256 (357)
T PHA03209 212 AFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI 256 (357)
T ss_pred ccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence 123456999999999999989999999999999999999976655
|
|
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-36 Score=311.42 Aligned_cols=251 Identities=24% Similarity=0.408 Sum_probs=189.1
Q ss_pred CcccCCCCccEEEeeccCC---cEEEEEEccccC-cccHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEEecCCC
Q 004400 422 NNIGEGGFGPVYKGLLADG---TAIAVKQLSSKS-KQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYEYLENN 497 (756)
Q Consensus 422 ~~lg~G~~g~Vy~~~~~~~---~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~g 497 (756)
+.||+|+||.||+|...++ ..+++|.+.... ....+.|.+|+.+++.++||||++++++|.+....++||||+++|
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 80 (268)
T cd05086 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELG 80 (268)
T ss_pred CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCC
Confidence 3699999999999975433 346677665432 234568999999999999999999999999999999999999999
Q ss_pred CHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCcccC-cce
Q 004400 498 SLARALFEH---RLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEEN-THI 573 (756)
Q Consensus 498 sL~~~l~~~---~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~~~-~~~ 573 (756)
+|.+++.+. ....++..+..++.||+.||+|||+.+ ++||||||+|||++.++.+||+|||++....... ...
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~ 157 (268)
T cd05086 81 DLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN---FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIET 157 (268)
T ss_pred cHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---eeccCCccceEEEcCCccEEecccccccccCcchhhhc
Confidence 999999753 234667778899999999999999986 9999999999999999999999999986432211 112
Q ss_pred eeccccCccCCchHhhhc-------CCCCcccchhhHHHHHHHHHh-CCCCCCccchhhHHHHHHHHHhcCccccccccC
Q 004400 574 STRVAGTIGYMAPEYAMR-------GHLTEKADVYSFGIVALEIVS-GRSNVTKEDMFYLLDWALVLKEQGKLMELVDTN 645 (756)
Q Consensus 574 ~~~~~gt~~y~aPE~~~~-------~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 645 (756)
.....|+..|+|||++.. ..++.++|||||||++|||++ |..||............ .. +......++.
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~--~~--~~~~~~~~~~ 233 (268)
T cd05086 158 EDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHV--IK--DQQVKLFKPQ 233 (268)
T ss_pred ccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH--Hh--hcccccCCCc
Confidence 234568899999999753 245789999999999999997 46677544433222211 11 1112222222
Q ss_pred CCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhc
Q 004400 646 PGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLE 684 (756)
Q Consensus 646 ~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~L~ 684 (756)
....++ ..+.+++..|| .+|++||++.+|++.|-
T Consensus 234 ~~~~~~----~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 234 LELPYS----ERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred cCCCCc----HHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 222233 34778888999 67999999999998873
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=331.24 Aligned_cols=258 Identities=18% Similarity=0.224 Sum_probs=197.8
Q ss_pred hcCccccCcccCCCCccEEEeecc---CCcEEEEEEccccCcccHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEE
Q 004400 415 TNNFATDNNIGEGGFGPVYKGLLA---DGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIY 491 (756)
Q Consensus 415 ~~~~~~~~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 491 (756)
..+|...+.||+|+||.||+|... .++.||+|.+... ..+.+|++++++++|||||++++++......++||
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 165 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVM 165 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEe
Confidence 357899999999999999999743 4578999988543 34568999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCcccCc
Q 004400 492 EYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENT 571 (756)
Q Consensus 492 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~~~~ 571 (756)
||+. ++|.+++. ....+++..+..++.||+.||+|||+.| |+||||||+|||++.++.+||+|||+++.......
T Consensus 166 e~~~-~~l~~~l~-~~~~l~~~~~~~i~~ql~~aL~~LH~~g---ivHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~~ 240 (392)
T PHA03207 166 PKYK-CDLFTYVD-RSGPLPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPD 240 (392)
T ss_pred hhcC-CCHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEccCccccccCcccc
Confidence 9996 58888884 4457999999999999999999999987 99999999999999999999999999976544322
Q ss_pred c-eeeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhc-Cc-cccc-------
Q 004400 572 H-ISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQ-GK-LMEL------- 641 (756)
Q Consensus 572 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~-~~-~~~~------- 641 (756)
. ......||+.|+|||++....++.++|||||||++|||++|+.||.+............+... +. ..+.
T Consensus 241 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~ 320 (392)
T PHA03207 241 TPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGSTN 320 (392)
T ss_pred cccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccchh
Confidence 2 223467999999999999889999999999999999999999999654321111000000000 00 0000
Q ss_pred -------cc--cCCCCCCC-----HHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004400 642 -------VD--TNPGSNFD-----KEQVMVMINVALLCANASPTIRPSMSSVLRM 682 (756)
Q Consensus 642 -------~~--~~~~~~~~-----~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~ 682 (756)
.. ..+....+ ......+.+++.+|+..||++||++.|++..
T Consensus 321 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~ 375 (392)
T PHA03207 321 LCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL 375 (392)
T ss_pred HHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence 00 00000000 0112357789999999999999999999875
|
|
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=315.85 Aligned_cols=262 Identities=24% Similarity=0.346 Sum_probs=204.7
Q ss_pred CccccCcccCCCCccEEEeec-cCCcEEEEEEccccC--cccHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEEe
Q 004400 417 NFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSKS--KQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYEY 493 (756)
Q Consensus 417 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 493 (756)
+|...+.||+|+||.||+|.. .+|+.||+|++.... ......+.+|+.++++++||||+++++++.++...++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 477888999999999999995 578999999987643 23346789999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCcccCcce
Q 004400 494 LENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHI 573 (756)
Q Consensus 494 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~~~~~~ 573 (756)
+ +++|.+++......+++..+..++.||++||+|||+.+ ++|+||||+||+++.++.++|+|||++..........
T Consensus 81 ~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~ 156 (286)
T cd07832 81 M-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANG---IMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRL 156 (286)
T ss_pred c-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCHHHEEEcCCCcEEEeeeeecccccCCCCCc
Confidence 9 99999999866678999999999999999999999986 9999999999999999999999999998665433222
Q ss_pred eeccccCccCCchHhhhcC-CCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhcCcc------cc------
Q 004400 574 STRVAGTIGYMAPEYAMRG-HLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKL------ME------ 640 (756)
Q Consensus 574 ~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~------~~------ 640 (756)
.....|+..|+|||.+.+. .++.++||||+|+++|||++|+.||..........+.......... .+
T Consensus 157 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (286)
T cd07832 157 YSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYNK 236 (286)
T ss_pred cccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcchhhc
Confidence 3345689999999998654 4689999999999999999998888655443332222111110000 00
Q ss_pred cc-ccCCCC---CCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004400 641 LV-DTNPGS---NFDKEQVMVMINVALLCANASPTIRPSMSSVLRM 682 (756)
Q Consensus 641 ~~-~~~~~~---~~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~ 682 (756)
.. ...... ...++....+.+++.+|++.+|++||+++++++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h 282 (286)
T cd07832 237 ITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH 282 (286)
T ss_pred ccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 00 000000 0001123568899999999999999999999764
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-36 Score=309.62 Aligned_cols=249 Identities=27% Similarity=0.392 Sum_probs=195.5
Q ss_pred cCccccCcccCCCCccEEEeec-cCCcEEEEEEccccC-----cccHHHHHHHHHHHHhCCCCceeeEeeEEEe--CCeE
Q 004400 416 NNFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSKS-----KQGNREFINEIGMISALQHPNLVKLYGCCIE--GNQL 487 (756)
Q Consensus 416 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~ 487 (756)
.+|...+.||+|+||.||+|.. .+++.||+|.+.... ......+.+|+.++++++||||+++++++.+ +...
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 3688899999999999999985 568999999886432 1223568889999999999999999999875 3678
Q ss_pred EEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCc
Q 004400 488 LLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDE 567 (756)
Q Consensus 488 ~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~ 567 (756)
++++||+++++|.+++.... .+++.....++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++...
T Consensus 82 ~l~~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~LH~~~---i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~ 157 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKAYG-ALTESVTRKYTRQILEGMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQ 157 (266)
T ss_pred EEEEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCCCccccc
Confidence 99999999999999997543 5899999999999999999999886 9999999999999999999999999997543
Q ss_pred ccCcc--eeeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhcCccccccccC
Q 004400 568 EENTH--ISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTN 645 (756)
Q Consensus 568 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 645 (756)
..... ......++..|+|||.+.+..++.++|||||||++||+++|+.||.......... .......
T Consensus 158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~---~~~~~~~-------- 226 (266)
T cd06651 158 TICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIF---KIATQPT-------- 226 (266)
T ss_pred cccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHHHH---HHhcCCC--------
Confidence 32111 1123458899999999998889999999999999999999999996543221111 1111000
Q ss_pred CCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 004400 646 PGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLR 681 (756)
Q Consensus 646 ~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~ 681 (756)
...++......+.+++ +||..+|++||+++||++
T Consensus 227 -~~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~ 260 (266)
T cd06651 227 -NPQLPSHISEHARDFL-GCIFVEARHRPSAEELLR 260 (266)
T ss_pred -CCCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence 0111222233456666 788899999999999975
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-36 Score=311.33 Aligned_cols=247 Identities=30% Similarity=0.459 Sum_probs=203.2
Q ss_pred CccccCcccCCCCccEEEeec-cCCcEEEEEEccccC-cccHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEEec
Q 004400 417 NFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSKS-KQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYEYL 494 (756)
Q Consensus 417 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~ 494 (756)
.|+..+.||+|+||.||+|.. .++..||+|.+.... ......+.+|++++++++||||+++++++.++...++||||+
T Consensus 5 ~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06640 5 LFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYL 84 (277)
T ss_pred hhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEecC
Confidence 466778999999999999995 468899999986542 334567889999999999999999999999999999999999
Q ss_pred CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCcccCccee
Q 004400 495 ENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHIS 574 (756)
Q Consensus 495 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~~~~~~~ 574 (756)
++|+|.+++.. ..+++..+..++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++........ ..
T Consensus 85 ~~~~L~~~i~~--~~l~~~~~~~~~~~l~~~l~~lh~~~---ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~-~~ 158 (277)
T cd06640 85 GGGSALDLLRA--GPFDEFQIATMLKEILKGLDYLHSEK---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI-KR 158 (277)
T ss_pred CCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCcCCChhhEEEcCCCCEEEcccccceeccCCcc-cc
Confidence 99999998864 36889999999999999999999986 99999999999999999999999999976543322 12
Q ss_pred eccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhcCccccccccCCCCCCCHHH
Q 004400 575 TRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDKEQ 654 (756)
Q Consensus 575 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 654 (756)
....++..|+|||++.+..++.++|||||||++|||++|+.||........... .............
T Consensus 159 ~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~-------------~~~~~~~~~~~~~ 225 (277)
T cd06640 159 NTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFL-------------IPKNNPPTLTGEF 225 (277)
T ss_pred ccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhh-------------hhcCCCCCCchhh
Confidence 334688899999999888899999999999999999999999965543221110 0001111223344
Q ss_pred HHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004400 655 VMVMINVALLCANASPTIRPSMSSVLRM 682 (756)
Q Consensus 655 ~~~l~~l~~~c~~~~P~~RPt~~ev~~~ 682 (756)
...+.+++.+||+.+|++||++.++++.
T Consensus 226 ~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 226 SKPFKEFIDACLNKDPSFRPTAKELLKH 253 (277)
T ss_pred hHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence 5668899999999999999999999775
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-36 Score=309.25 Aligned_cols=249 Identities=26% Similarity=0.390 Sum_probs=201.0
Q ss_pred CccccCcccCCCCccEEEeec-cCCcEEEEEEccccC--cccHHHHHHHHHHHHhCCCCceeeEeeEEEe-CCeEEEEEE
Q 004400 417 NFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSKS--KQGNREFINEIGMISALQHPNLVKLYGCCIE-GNQLLLIYE 492 (756)
Q Consensus 417 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~lV~e 492 (756)
+|+..+.||+|++|.||++.. .+++.||+|.+.... ....+.+.+|++++++++|+|++++++.+.. +...++|||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 477889999999999999994 467899999986532 2344568899999999999999999998764 456899999
Q ss_pred ecCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCcccCc
Q 004400 493 YLENNSLARALFEH-RLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENT 571 (756)
Q Consensus 493 ~~~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~~~~ 571 (756)
|+++++|.+++... ...+++.++..++.|++.|++|||+.| ++||||||+||+++.++.++|+|||++........
T Consensus 81 ~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~---i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~~ 157 (257)
T cd08223 81 FCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKH---ILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCD 157 (257)
T ss_pred ccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCchhEEEecCCcEEEecccceEEecccCC
Confidence 99999999999753 346899999999999999999999987 99999999999999999999999999976543222
Q ss_pred ceeeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhcCccccccccCCCCCCC
Q 004400 572 HISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFD 651 (756)
Q Consensus 572 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 651 (756)
......|++.|+|||++.+..++.++||||||+++|++++|+.||...+..... .... .+.... .+
T Consensus 158 -~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~---~~~~-~~~~~~---------~~ 223 (257)
T cd08223 158 -MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLV---YRII-EGKLPP---------MP 223 (257)
T ss_pred -ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHH---HHHH-hcCCCC---------Cc
Confidence 223456889999999999999999999999999999999999999655432211 1111 111111 11
Q ss_pred HHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004400 652 KEQVMVMINVALLCANASPTIRPSMSSVLRM 682 (756)
Q Consensus 652 ~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~ 682 (756)
......+.+++.+|++.+|++||++.++++.
T Consensus 224 ~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 254 (257)
T cd08223 224 KDYSPELGELIATMLSKRPEKRPSVKSILRQ 254 (257)
T ss_pred cccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 2233458899999999999999999999764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=315.84 Aligned_cols=260 Identities=25% Similarity=0.332 Sum_probs=196.3
Q ss_pred CccccCcccCCCCccEEEeec-cCCcEEEEEEccccC--cccHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEEe
Q 004400 417 NFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSKS--KQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYEY 493 (756)
Q Consensus 417 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 493 (756)
+|+..+.||+|++|.||+|+. .++..||+|.+.... ......+.+|+.+++.++||||+++++++.+++..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 477888999999999999995 478999999986532 22346788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCcccCc
Q 004400 494 LENNSLARALFEH--RLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENT 571 (756)
Q Consensus 494 ~~~gsL~~~l~~~--~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~~~~ 571 (756)
++ ++|.+++... ...+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++........
T Consensus 81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 156 (285)
T cd07861 81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRR---VLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVR 156 (285)
T ss_pred CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEEcCCCcEEECcccceeecCCCcc
Confidence 98 5888888643 256899999999999999999999986 99999999999999999999999999975443221
Q ss_pred ceeeccccCccCCchHhhhcC-CCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHH-HHHHhc-----------Ccc
Q 004400 572 HISTRVAGTIGYMAPEYAMRG-HLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWA-LVLKEQ-----------GKL 638 (756)
Q Consensus 572 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~-~~~~~~-----------~~~ 638 (756)
......+++.|+|||.+.+. .++.++|||||||++|||++|+.||............ ...... ...
T Consensus 157 -~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (285)
T cd07861 157 -VYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDY 235 (285)
T ss_pred -cccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHHH
Confidence 12234578899999988654 4789999999999999999999999655432211100 000000 000
Q ss_pred ccccccCCCC---CCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 004400 639 MELVDTNPGS---NFDKEQVMVMINVALLCANASPTIRPSMSSVLR 681 (756)
Q Consensus 639 ~~~~~~~~~~---~~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~ 681 (756)
.......... .........+.+++.+|++.||++|||+.+|++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~ 281 (285)
T cd07861 236 KNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN 281 (285)
T ss_pred HhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence 0000000000 000011234779999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-36 Score=314.17 Aligned_cols=262 Identities=23% Similarity=0.329 Sum_probs=201.1
Q ss_pred cCccccCcccCCCCccEEEeecc-CCcEEEEEEccccC--cccHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEE
Q 004400 416 NNFATDNNIGEGGFGPVYKGLLA-DGTAIAVKQLSSKS--KQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYE 492 (756)
Q Consensus 416 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 492 (756)
++|+..+.||+|+||.||+|+.. +++.||+|++.... ....+.+.+|++++++++||||+++++++..+...++|||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 46888899999999999999954 68999999886432 2234568899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCcccCcc
Q 004400 493 YLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTH 572 (756)
Q Consensus 493 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~~~~~ 572 (756)
|+++++|..++.. ...+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||++........
T Consensus 81 ~~~~~~l~~~~~~-~~~~~~~~~~~~~~ql~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~- 155 (286)
T cd07847 81 YCDHTVLNELEKN-PRGVPEHLIKKIIWQTLQAVNFCHKHN---CIHRDVKPENILITKQGQIKLCDFGFARILTGPGD- 155 (286)
T ss_pred ccCccHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCChhhEEEcCCCcEEECccccceecCCCcc-
Confidence 9999988877653 346899999999999999999999986 99999999999999999999999999986544322
Q ss_pred eeeccccCccCCchHhhhc-CCCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHH-HHh----------cCcc-c
Q 004400 573 ISTRVAGTIGYMAPEYAMR-GHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALV-LKE----------QGKL-M 639 (756)
Q Consensus 573 ~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~-~~~----------~~~~-~ 639 (756)
......++..|+|||++.+ ..++.++||||||+++|||++|+.||.............. ... .... .
T Consensus 156 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (286)
T cd07847 156 DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFK 235 (286)
T ss_pred cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccccccc
Confidence 1223457889999999876 4588999999999999999999999965543322111110 000 0000 0
Q ss_pred cccccCCCCCCC-----HHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004400 640 ELVDTNPGSNFD-----KEQVMVMINVALLCANASPTIRPSMSSVLRM 682 (756)
Q Consensus 640 ~~~~~~~~~~~~-----~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~ 682 (756)
....+.+....+ +.....+.+++.+||+.+|++||++.|+++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~ 283 (286)
T cd07847 236 GLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEH 283 (286)
T ss_pred cccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcC
Confidence 000011100000 1123458899999999999999999998753
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-36 Score=310.87 Aligned_cols=252 Identities=27% Similarity=0.481 Sum_probs=201.3
Q ss_pred CccccCcccCCCCccEEEeeccC--CcEEEEEEccccC----------cccHHHHHHHHHHHHh-CCCCceeeEeeEEEe
Q 004400 417 NFATDNNIGEGGFGPVYKGLLAD--GTAIAVKQLSSKS----------KQGNREFINEIGMISA-LQHPNLVKLYGCCIE 483 (756)
Q Consensus 417 ~~~~~~~lg~G~~g~Vy~~~~~~--~~~vavK~~~~~~----------~~~~~~~~~E~~~l~~-l~h~niv~l~~~~~~ 483 (756)
+|+..+.||+|+||.||+|.... ++.+|+|.+.... .....++.+|+.++.+ ++||||+++++++.+
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 47778899999999999999654 7889999875321 1223457788888875 799999999999999
Q ss_pred CCeEEEEEEecCCCCHHHHHH---hcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccC
Q 004400 484 GNQLLLIYEYLENNSLARALF---EHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDF 560 (756)
Q Consensus 484 ~~~~~lV~e~~~~gsL~~~l~---~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DF 560 (756)
++..++||||+++++|.+++. .....+++..+++++.|++.||.|||+.+ +++||||||+||+++.++.+||+||
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--~i~H~dl~~~nil~~~~~~~~l~df 158 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEK--RIVHRDLTPNNIMLGEDDKVTITDF 158 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCC--ceeecCCCHHHEEECCCCcEEEecc
Confidence 999999999999999999875 34457899999999999999999999632 4999999999999999999999999
Q ss_pred CccccCcccCcceeeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhcCcccc
Q 004400 561 GLAKLDEEENTHISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLME 640 (756)
Q Consensus 561 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 640 (756)
|.+....... ......|+..|+|||.+.+..++.++||||||+++|||++|+.||...+....... ... .....
T Consensus 159 g~~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~---~~~-~~~~~ 232 (269)
T cd08528 159 GLAKQKQPES--KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATK---IVE-AVYEP 232 (269)
T ss_pred cceeeccccc--ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHHHH---Hhh-ccCCc
Confidence 9998654432 22345689999999999988899999999999999999999999965543322211 111 11111
Q ss_pred ccccCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhc
Q 004400 641 LVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLE 684 (756)
Q Consensus 641 ~~~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~L~ 684 (756)
.....++ ..+.+++.+||+.||++||++.|+..+++
T Consensus 233 ----~~~~~~~----~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 233 ----LPEGMYS----EDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred ----CCcccCC----HHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 1111222 34889999999999999999999999886
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=322.62 Aligned_cols=193 Identities=27% Similarity=0.442 Sum_probs=160.3
Q ss_pred cCcccCCCCccEEEeecc---CCcEEEEEEccccCcccHHHHHHHHHHHHhCCCCceeeEeeEEEe--CCeEEEEEEecC
Q 004400 421 DNNIGEGGFGPVYKGLLA---DGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCCIE--GNQLLLIYEYLE 495 (756)
Q Consensus 421 ~~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lV~e~~~ 495 (756)
.+.||+|+||.||+|+.. +++.||+|.+.... ....+.+|++++++++||||+++++++.. +...++||||+.
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE 83 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC--CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence 468999999999999854 56789999986532 23567889999999999999999999864 456899999986
Q ss_pred CCCHHHHHHhc--------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEe----cCCCCEEEccCCcc
Q 004400 496 NNSLARALFEH--------RLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLL----DKDLNSKISDFGLA 563 (756)
Q Consensus 496 ~gsL~~~l~~~--------~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill----~~~~~~kl~DFGla 563 (756)
+ +|.+++... ...+++..+..++.||+.||+|||++| |+||||||+|||+ +.++.+||+|||++
T Consensus 84 ~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07868 84 H-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred C-CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence 5 788777522 225889999999999999999999997 9999999999999 45678999999999
Q ss_pred ccCcccCcc--eeeccccCccCCchHhhhc-CCCCcccchhhHHHHHHHHHhCCCCCCc
Q 004400 564 KLDEEENTH--ISTRVAGTIGYMAPEYAMR-GHLTEKADVYSFGIVALEIVSGRSNVTK 619 (756)
Q Consensus 564 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slGv~l~elltg~~p~~~ 619 (756)
+........ ......||+.|+|||++.+ ..++.++||||+||++|||++|+.||..
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~ 218 (317)
T cd07868 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC 218 (317)
T ss_pred eccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccC
Confidence 865433221 1234678999999999977 4589999999999999999999999953
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=315.63 Aligned_cols=247 Identities=29% Similarity=0.465 Sum_probs=200.0
Q ss_pred CccccCcccCCCCccEEEeec-cCCcEEEEEEccccC-cccHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEEec
Q 004400 417 NFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSKS-KQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYEYL 494 (756)
Q Consensus 417 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~ 494 (756)
.|...+.||+|+||.||+|.. .+++.||+|.+.... ....+.+.+|++++++++||||+++++++..+...++||||+
T Consensus 5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06642 5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYL 84 (277)
T ss_pred HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEcc
Confidence 355667899999999999984 567899999986442 334467889999999999999999999999999999999999
Q ss_pred CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCcccCccee
Q 004400 495 ENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHIS 574 (756)
Q Consensus 495 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~~~~~~~ 574 (756)
++++|.+++.. ..+++..+..++.|+++|+.|||+.+ ++|+||+|+||++++++.++|+|||++......... .
T Consensus 85 ~~~~L~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~-~ 158 (277)
T cd06642 85 GGGSALDLLKP--GPLEETYIATILREILKGLDYLHSER---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIK-R 158 (277)
T ss_pred CCCcHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhcCC---eeccCCChheEEEeCCCCEEEccccccccccCcchh-h
Confidence 99999998854 36899999999999999999999986 999999999999999999999999999765433221 2
Q ss_pred eccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhcCccccccccCCCCCCCHHH
Q 004400 575 TRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDKEQ 654 (756)
Q Consensus 575 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 654 (756)
....|+..|+|||++.+..++.++|||||||++|||++|+.|+..........+ . .... . .......
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~---~-~~~~-----~----~~~~~~~ 225 (277)
T cd06642 159 NTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFL---I-PKNS-----P----PTLEGQY 225 (277)
T ss_pred hcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhh---h-hcCC-----C----CCCCccc
Confidence 234688899999999988899999999999999999999999854432221111 0 0010 0 1111123
Q ss_pred HHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004400 655 VMVMINVALLCANASPTIRPSMSSVLRM 682 (756)
Q Consensus 655 ~~~l~~l~~~c~~~~P~~RPt~~ev~~~ 682 (756)
...+.+++.+||+.+|++||++.++++.
T Consensus 226 ~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06642 226 SKPFKEFVEACLNKDPRFRPTAKELLKH 253 (277)
T ss_pred CHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 3458899999999999999999999884
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-37 Score=318.59 Aligned_cols=256 Identities=25% Similarity=0.348 Sum_probs=203.4
Q ss_pred HHHhhcCccccCcccCCCCccEEEeeccCCcEEEEEEcccc--CcccHHHHHHHHHHHHhC-CCCceeeEeeEEEeCCeE
Q 004400 411 IKAATNNFATDNNIGEGGFGPVYKGLLADGTAIAVKQLSSK--SKQGNREFINEIGMISAL-QHPNLVKLYGCCIEGNQL 487 (756)
Q Consensus 411 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 487 (756)
++...+.|++.+.||+||.+.||++...+.+.||+|++... +......|.+|+..|.++ .|.+||++|+|-..++++
T Consensus 356 i~Vkg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~l 435 (677)
T KOG0596|consen 356 IKVKGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYL 435 (677)
T ss_pred EEECcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceE
Confidence 34456788999999999999999999988899999887543 444567799999999999 499999999999999999
Q ss_pred EEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCc
Q 004400 488 LLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDE 567 (756)
Q Consensus 488 ~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~ 567 (756)
||||||= ..+|..+|.+.........++.+..|++.|+.+.|.+| |||.||||.|+|+-. |.+||+|||+|..+.
T Consensus 436 YmvmE~G-d~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~g---IVHSDLKPANFLlVk-G~LKLIDFGIA~aI~ 510 (677)
T KOG0596|consen 436 YMVMECG-DIDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHG---IVHSDLKPANFLLVK-GRLKLIDFGIANAIQ 510 (677)
T ss_pred EEEeecc-cccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhc---eeecCCCcccEEEEe-eeEEeeeechhcccC
Confidence 9999974 55999999876655553488999999999999999997 999999999999875 589999999999877
Q ss_pred ccCcce-eeccccCccCCchHhhhcC-----------CCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhc
Q 004400 568 EENTHI-STRVAGTIGYMAPEYAMRG-----------HLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQ 635 (756)
Q Consensus 568 ~~~~~~-~~~~~gt~~y~aPE~~~~~-----------~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~ 635 (756)
.+.+.. ....+||+.||+||.+... +.++++||||+|||+|+|+.|+.||..-. ..|++.
T Consensus 511 ~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~----n~~aKl---- 582 (677)
T KOG0596|consen 511 PDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQII----NQIAKL---- 582 (677)
T ss_pred ccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHH----HHHHHH----
Confidence 665544 4457899999999998643 25689999999999999999999994211 122221
Q ss_pred CccccccccCCCCCCCHH-HHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004400 636 GKLMELVDTNPGSNFDKE-QVMVMINVALLCANASPTIRPSMSSVLRM 682 (756)
Q Consensus 636 ~~~~~~~~~~~~~~~~~~-~~~~l~~l~~~c~~~~P~~RPt~~ev~~~ 682 (756)
..+.+++-...|+.- ....++++++.|++.||.+||+..|+++.
T Consensus 583 ---~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqh 627 (677)
T KOG0596|consen 583 ---HAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQH 627 (677)
T ss_pred ---HhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcC
Confidence 122222221112111 01128999999999999999999999864
|
|
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-36 Score=320.33 Aligned_cols=256 Identities=20% Similarity=0.292 Sum_probs=193.6
Q ss_pred ccCcccCC--CCccEEEee-ccCCcEEEEEEccccC--cccHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEEec
Q 004400 420 TDNNIGEG--GFGPVYKGL-LADGTAIAVKQLSSKS--KQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYEYL 494 (756)
Q Consensus 420 ~~~~lg~G--~~g~Vy~~~-~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~ 494 (756)
..++||+| +||+||++. ..+|+.||+|++.... ....+.+.+|+++++.++||||++++++|..++..++||||+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 35689999 688999998 4678999999986542 223356778999999999999999999999999999999999
Q ss_pred CCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCcccCc--
Q 004400 495 ENNSLARALFEH-RLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENT-- 571 (756)
Q Consensus 495 ~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~~~~-- 571 (756)
++|+|.+++... ...+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.++++|||.+........
T Consensus 82 ~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~ 158 (327)
T cd08227 82 AYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRL 158 (327)
T ss_pred CCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCChhhEEEecCCcEEEcccchhhccccccccc
Confidence 999999999753 345899999999999999999999986 99999999999999999999999986543211110
Q ss_pred ----ceeeccccCccCCchHhhhc--CCCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhcCcccccccc-
Q 004400 572 ----HISTRVAGTIGYMAPEYAMR--GHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDT- 644 (756)
Q Consensus 572 ----~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 644 (756)
.......++..|+|||++.+ ..++.++|||||||++|||++|+.||............ .........+.
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~----~~~~~~~~~~~~ 234 (327)
T cd08227 159 RVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEK----LNGTVPCLLDTT 234 (327)
T ss_pred cccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHH----hcCCcccccccc
Confidence 01122356778999999976 45899999999999999999999999643322111100 00000000000
Q ss_pred -----------------------------------CCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004400 645 -----------------------------------NPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRM 682 (756)
Q Consensus 645 -----------------------------------~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~ 682 (756)
.............+.+++.+||+.||++|||++|+++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~ 307 (327)
T cd08227 235 TIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNH 307 (327)
T ss_pred chhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcC
Confidence 00000111233468899999999999999999999763
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-36 Score=336.44 Aligned_cols=263 Identities=18% Similarity=0.212 Sum_probs=195.6
Q ss_pred hHHHhhcCccccCcccCCCCccEEEeec-cCCcEEEEEEccccCcccHHHHHHHHHHHHhCCC------CceeeEeeEEE
Q 004400 410 QIKAATNNFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSKSKQGNREFINEIGMISALQH------PNLVKLYGCCI 482 (756)
Q Consensus 410 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h------~niv~l~~~~~ 482 (756)
++...+++|.+.+.||+|+||+||+|.. .+++.||||+++... .....+..|+++++.++| .++++++++|.
T Consensus 123 ~~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~ 201 (467)
T PTZ00284 123 DIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQ 201 (467)
T ss_pred ccccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEE
Confidence 3445678999999999999999999984 568899999986432 223456678877777755 45899999987
Q ss_pred eC-CeEEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcC-CCCCeEcCCCCCCceEecCCC-------
Q 004400 483 EG-NQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGE-SRIKVVHRDIKATNVLLDKDL------- 553 (756)
Q Consensus 483 ~~-~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~-g~~~iiH~Dikp~Nill~~~~------- 553 (756)
.+ ...++|||++ +++|.+++... ..+++..+..|+.||+.||+|||++ | ||||||||+|||++.++
T Consensus 202 ~~~~~~~iv~~~~-g~~l~~~l~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~g---IiHrDlKP~NILl~~~~~~~~~~~ 276 (467)
T PTZ00284 202 NETGHMCIVMPKY-GPCLLDWIMKH-GPFSHRHLAQIIFQTGVALDYFHTELH---LMHTDLKPENILMETSDTVVDPVT 276 (467)
T ss_pred cCCceEEEEEecc-CCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEEecCCccccccc
Confidence 65 5788999988 67888888654 4799999999999999999999974 5 99999999999998765
Q ss_pred ---------CEEEccCCccccCcccCcceeeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHhCCCCCCccchhh
Q 004400 554 ---------NSKISDFGLAKLDEEENTHISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFY 624 (756)
Q Consensus 554 ---------~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~ 624 (756)
.+||+|||.+..... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...+...
T Consensus 277 ~~~~~~~~~~vkl~DfG~~~~~~~----~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~ 352 (467)
T PTZ00284 277 NRALPPDPCRVRICDLGGCCDERH----SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLE 352 (467)
T ss_pred ccccCCCCceEEECCCCccccCcc----ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH
Confidence 499999998864322 2234679999999999999999999999999999999999999997655433
Q ss_pred HHHHHHHHHhc-----------CccccccccC--CCCCCC---------------HHHHHHHHHHHHHhhcCCCCCCCCH
Q 004400 625 LLDWALVLKEQ-----------GKLMELVDTN--PGSNFD---------------KEQVMVMINVALLCANASPTIRPSM 676 (756)
Q Consensus 625 ~~~~~~~~~~~-----------~~~~~~~~~~--~~~~~~---------------~~~~~~l~~l~~~c~~~~P~~RPt~ 676 (756)
........... .+...+.+.. ...... ......+.+|+.+|++.||++|||+
T Consensus 353 ~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta 432 (467)
T PTZ00284 353 HLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNA 432 (467)
T ss_pred HHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCH
Confidence 22211110000 0000000000 000000 0112357799999999999999999
Q ss_pred HHHHHH
Q 004400 677 SSVLRM 682 (756)
Q Consensus 677 ~ev~~~ 682 (756)
.|+++.
T Consensus 433 ~e~L~H 438 (467)
T PTZ00284 433 RQMTTH 438 (467)
T ss_pred HHHhcC
Confidence 999863
|
|
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=325.43 Aligned_cols=240 Identities=25% Similarity=0.332 Sum_probs=187.9
Q ss_pred ccCCCCccEEEeec-cCCcEEEEEEccccCc---ccHHHHHHHHHHHHhC---CCCceeeEeeEEEeCCeEEEEEEecCC
Q 004400 424 IGEGGFGPVYKGLL-ADGTAIAVKQLSSKSK---QGNREFINEIGMISAL---QHPNLVKLYGCCIEGNQLLLIYEYLEN 496 (756)
Q Consensus 424 lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~~~~~~lV~e~~~~ 496 (756)
||+|+||+||+|+. .+++.||||++..... .....+..|..++... +||||+++++++.++...++||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 79999999999994 5689999999865321 2223455677777665 699999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCcccCcceeec
Q 004400 497 NSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTR 576 (756)
Q Consensus 497 gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~ 576 (756)
|+|.+++... ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++....... ....
T Consensus 81 g~L~~~l~~~-~~~~~~~~~~~~~qil~al~~LH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~-~~~~ 155 (330)
T cd05586 81 GELFWHLQKE-GRFSEDRAKFYIAELVLALEHLHKYD---IVYRDLKPENILLDATGHIALCDFGLSKANLTDNK-TTNT 155 (330)
T ss_pred ChHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCC-CccC
Confidence 9999988654 47899999999999999999999987 99999999999999999999999999975332221 1234
Q ss_pred cccCccCCchHhhhcC-CCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhcCccccccccCCCCCCCHHHH
Q 004400 577 VAGTIGYMAPEYAMRG-HLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDKEQV 655 (756)
Q Consensus 577 ~~gt~~y~aPE~~~~~-~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 655 (756)
..||+.|+|||++.+. .++.++|||||||++|||++|+.||...+....... ... +.. .. +.... .
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~---i~~-~~~-~~----~~~~~----~ 222 (330)
T cd05586 156 FCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRN---IAF-GKV-RF----PKNVL----S 222 (330)
T ss_pred ccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHH---HHc-CCC-CC----CCccC----C
Confidence 6799999999998764 489999999999999999999999976654332211 111 110 11 11112 2
Q ss_pred HHHHHHHHHhhcCCCCCCC----CHHHHHH
Q 004400 656 MVMINVALLCANASPTIRP----SMSSVLR 681 (756)
Q Consensus 656 ~~l~~l~~~c~~~~P~~RP----t~~ev~~ 681 (756)
..+.+++.+|++.+|.+|| ++.++++
T Consensus 223 ~~~~~li~~~L~~~P~~R~~~~~~~~~ll~ 252 (330)
T cd05586 223 DEGRQFVKGLLNRNPQHRLGAHRDAVELKE 252 (330)
T ss_pred HHHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence 3477899999999999998 4566554
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-36 Score=308.82 Aligned_cols=246 Identities=29% Similarity=0.487 Sum_probs=198.7
Q ss_pred cCccccCcccCCCCccEEEeeccCCcEEEEEEccccCcccHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEEecC
Q 004400 416 NNFATDNNIGEGGFGPVYKGLLADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYEYLE 495 (756)
Q Consensus 416 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~ 495 (756)
++|+..+.||+|+||.||+|.. +++.||+|.+.... ....+.+|+.++++++|||++++++++..+ ..++||||++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~ 81 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMS 81 (254)
T ss_pred HHceeeeeeccCCCCceEeccc-CCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCC
Confidence 4678889999999999999975 57889999986532 346789999999999999999999998765 4799999999
Q ss_pred CCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCcccCccee
Q 004400 496 NNSLARALFEH-RLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHIS 574 (756)
Q Consensus 496 ~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~~~~~~~ 574 (756)
+|+|.+++... ...+++..+..++.|++.||+|||+.| ++||||||+||+++.++.+||+|||+++......
T Consensus 82 ~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~---- 154 (254)
T cd05083 82 KGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKK---LVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV---- 154 (254)
T ss_pred CCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCcEEECCCccceeccccC----
Confidence 99999999754 346899999999999999999999986 9999999999999999999999999987543221
Q ss_pred eccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHh-CCCCCCccchhhHHHHHHHHHhcCccccccccCCCCCCCHH
Q 004400 575 TRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVS-GRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDKE 653 (756)
Q Consensus 575 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 653 (756)
.....+..|+|||.+.+..++.++|||||||++|||++ |+.||........... . ..+.... +...+
T Consensus 155 ~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~---~-~~~~~~~-----~~~~~--- 222 (254)
T cd05083 155 DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKEC---V-EKGYRME-----PPEGC--- 222 (254)
T ss_pred CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHH---H-hCCCCCC-----CCCcC---
Confidence 12234568999999988899999999999999999998 9999865544332211 1 1111111 11112
Q ss_pred HHHHHHHHHHHhhcCCCCCCCCHHHHHHHhcc
Q 004400 654 QVMVMINVALLCANASPTIRPSMSSVLRMLEC 685 (756)
Q Consensus 654 ~~~~l~~l~~~c~~~~P~~RPt~~ev~~~L~~ 685 (756)
+..+.+++.+||+.+|++||++.++++.|+.
T Consensus 223 -~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 223 -PADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred -CHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 2448899999999999999999999998873
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-36 Score=314.59 Aligned_cols=257 Identities=26% Similarity=0.376 Sum_probs=201.1
Q ss_pred hHHHhhcCccccCcccCCCCccEEEeec-cCCcEEEEEEccccCcccHHHHHHHHHHHHhC-CCCceeeEeeEEE-----
Q 004400 410 QIKAATNNFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSKSKQGNREFINEIGMISAL-QHPNLVKLYGCCI----- 482 (756)
Q Consensus 410 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~----- 482 (756)
.+..++++|+..+.||+|+||.||+|.. .+++.+|+|.+... ......+.+|+.+++++ +||||+++++++.
T Consensus 12 ~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~-~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~ 90 (286)
T cd06638 12 SFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPI-HDIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVK 90 (286)
T ss_pred cCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccc-cchHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccC
Confidence 3456788999999999999999999984 56889999987643 22345688899999999 6999999999984
Q ss_pred eCCeEEEEEEecCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEcc
Q 004400 483 EGNQLLLIYEYLENNSLARALFE---HRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISD 559 (756)
Q Consensus 483 ~~~~~~lV~e~~~~gsL~~~l~~---~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~D 559 (756)
.++..++||||+++++|.+++.. ....+++..+..++.|++.||.|||+.+ |+||||||+||++++++.+||+|
T Consensus 91 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~kl~d 167 (286)
T cd06638 91 NGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNK---TIHRDVKGNNILLTTEGGVKLVD 167 (286)
T ss_pred CCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCC---ccccCCCHHhEEECCCCCEEEcc
Confidence 34578999999999999998752 3356889999999999999999999986 99999999999999999999999
Q ss_pred CCccccCcccCcceeeccccCccCCchHhhhc-----CCCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHh
Q 004400 560 FGLAKLDEEENTHISTRVAGTIGYMAPEYAMR-----GHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKE 634 (756)
Q Consensus 560 FGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~ 634 (756)
||+++....... ......|+..|+|||++.. ..++.++||||+||++|||++|+.||........... . .
T Consensus 168 fg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~---~-~ 242 (286)
T cd06638 168 FGVSAQLTSTRL-RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFK---I-P 242 (286)
T ss_pred CCceeecccCCC-ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhh---c-c
Confidence 999976543222 1223468999999999753 4578899999999999999999999965443221110 0 0
Q ss_pred cCccccccccCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004400 635 QGKLMELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRM 682 (756)
Q Consensus 635 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~ 682 (756)
.........+ .. ....+.+++.+||+.+|++||++.|+++.
T Consensus 243 ~~~~~~~~~~---~~----~~~~~~~li~~~l~~~p~~Rps~~ell~~ 283 (286)
T cd06638 243 RNPPPTLHQP---EL----WSNEFNDFIRKCLTKDYEKRPTVSDLLQH 283 (286)
T ss_pred ccCCCcccCC---CC----cCHHHHHHHHHHccCCcccCCCHHHHhhc
Confidence 0000111111 11 12348899999999999999999999874
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=317.43 Aligned_cols=261 Identities=23% Similarity=0.356 Sum_probs=200.1
Q ss_pred cCccccCcccCCCCccEEEeecc-CCcEEEEEEccccCc--ccHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEE
Q 004400 416 NNFATDNNIGEGGFGPVYKGLLA-DGTAIAVKQLSSKSK--QGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYE 492 (756)
Q Consensus 416 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 492 (756)
++|+..+.||+|+||.||+|... +++.||+|.+..... ...+.+.+|+++++.++||||+++++++..++..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 36788899999999999999964 689999999865422 234568899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCcccCcc
Q 004400 493 YLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTH 572 (756)
Q Consensus 493 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~~~~~ 572 (756)
|+++++|.++.... ..+++..+..++.|++.||+|||+.+ ++||||+|+||++++++.++|+|||++........
T Consensus 81 ~~~~~~l~~~~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~---i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~- 155 (286)
T cd07846 81 FVDHTVLDDLEKYP-NGLDESRVRKYLFQILRGIEFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE- 155 (286)
T ss_pred cCCccHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCcEEEEeeeeeeeccCCcc-
Confidence 99999998876543 35899999999999999999999986 99999999999999999999999999986544332
Q ss_pred eeeccccCccCCchHhhhc-CCCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhc-----------Cccc-
Q 004400 573 ISTRVAGTIGYMAPEYAMR-GHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQ-----------GKLM- 639 (756)
Q Consensus 573 ~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~-----------~~~~- 639 (756)
......++..|+|||++.+ ..++.++||||||+++|||++|+.||.................. ....
T Consensus 156 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (286)
T cd07846 156 VYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFA 235 (286)
T ss_pred ccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHhh
Confidence 2233467899999999875 45788999999999999999999998655432211110000000 0000
Q ss_pred cccccCCCC-----CCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 004400 640 ELVDTNPGS-----NFDKEQVMVMINVALLCANASPTIRPSMSSVLR 681 (756)
Q Consensus 640 ~~~~~~~~~-----~~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~ 681 (756)
....+.... ...+.....+.+++.+||+.+|++||++.++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 282 (286)
T cd07846 236 GMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH 282 (286)
T ss_pred ccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence 000000000 001122345889999999999999999999876
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=306.57 Aligned_cols=249 Identities=24% Similarity=0.373 Sum_probs=203.5
Q ss_pred CccccCcccCCCCccEEEee-ccCCcEEEEEEcccc--CcccHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEEe
Q 004400 417 NFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSK--SKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYEY 493 (756)
Q Consensus 417 ~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 493 (756)
+|+..+.||+|+||.||++. ..+|+.||+|.+... .....+++.+|+.++++++||||+++++++.+.+..++|+||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 47788999999999999998 457899999998643 233346789999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCcccCcc
Q 004400 494 LENNSLARALFEH-RLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTH 572 (756)
Q Consensus 494 ~~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~~~~~ 572 (756)
+.+++|.+++... ...+++..+.+++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++.........
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~~ 157 (256)
T cd08218 81 CEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVEL 157 (256)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEEeeccceeecCcchhh
Confidence 9999999998754 346889999999999999999999986 999999999999999999999999999765433221
Q ss_pred eeeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhcCccccccccCCCCCCCH
Q 004400 573 ISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDK 652 (756)
Q Consensus 573 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 652 (756)
.....|++.|+|||++.+..++.++|||||||++|++++|+.||...+....... .. .+.... .+.
T Consensus 158 -~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~---~~-~~~~~~---------~~~ 223 (256)
T cd08218 158 -ARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLK---II-RGSYPP---------VSS 223 (256)
T ss_pred -hhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHH---Hh-cCCCCC---------Ccc
Confidence 2234688899999999888899999999999999999999999976544332221 11 111111 111
Q ss_pred HHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004400 653 EQVMVMINVALLCANASPTIRPSMSSVLRM 682 (756)
Q Consensus 653 ~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~ 682 (756)
.....+.+++.+||+.+|.+||++.+|++.
T Consensus 224 ~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~ 253 (256)
T cd08218 224 HYSYDLRNLVSQLFKRNPRDRPSVNSILEK 253 (256)
T ss_pred cCCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 223348899999999999999999999873
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-36 Score=308.48 Aligned_cols=251 Identities=31% Similarity=0.500 Sum_probs=201.7
Q ss_pred CccccCcccCCCCccEEEeec-cCCcEEEEEEccccCc--ccHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEEe
Q 004400 417 NFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSKSK--QGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYEY 493 (756)
Q Consensus 417 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 493 (756)
+|...+.||+|+||.||+|.. .+++.||+|.+..... ...+.+.+|++++++++|+||+++++++.+.+..++|+||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 477789999999999999984 5789999999876533 2567889999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCcccCcce
Q 004400 494 LENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHI 573 (756)
Q Consensus 494 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~~~~~~ 573 (756)
+++++|.+++... ..+++..+..++.|+++||+|||+.| |+||||+|+||++++++.+||+|||++..........
T Consensus 81 ~~~~~L~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~ 156 (264)
T cd06626 81 CSGGTLEELLEHG-RILDEHVIRVYTLQLLEGLAYLHSHG---IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTM 156 (264)
T ss_pred CCCCcHHHHHhhc-CCCChHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEcccccccccCCCCCcc
Confidence 9999999998754 35899999999999999999999987 9999999999999999999999999998765433322
Q ss_pred ee---ccccCccCCchHhhhcCC---CCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhcCccccccccCCC
Q 004400 574 ST---RVAGTIGYMAPEYAMRGH---LTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPG 647 (756)
Q Consensus 574 ~~---~~~gt~~y~aPE~~~~~~---~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 647 (756)
.. ...++..|+|||++.... ++.++||||||+++||+++|+.||...+......+. ... ........
T Consensus 157 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~--~~~-~~~~~~~~---- 229 (264)
T cd06626 157 GEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFH--VGA-GHKPPIPD---- 229 (264)
T ss_pred cccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHH--Hhc-CCCCCCCc----
Confidence 22 356788999999998766 889999999999999999999999654321111111 111 11111111
Q ss_pred CCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 004400 648 SNFDKEQVMVMINVALLCANASPTIRPSMSSVLR 681 (756)
Q Consensus 648 ~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~ 681 (756)
.......+.+++.+||+.+|++||++.+++.
T Consensus 230 ---~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 230 ---SLQLSPEGKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred ---ccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 0111334789999999999999999999865
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=315.93 Aligned_cols=260 Identities=22% Similarity=0.317 Sum_probs=197.2
Q ss_pred CccccCcccCCCCccEEEeec-cCCcEEEEEEccccC--cccHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEEe
Q 004400 417 NFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSKS--KQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYEY 493 (756)
Q Consensus 417 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 493 (756)
+|+..+.||+|+||.||+|+. .+|+.||+|.+.... ......+.+|++++++++||||+++++++.+....++|+||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 467788999999999999995 578999999986532 22235678899999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCcccCcce
Q 004400 494 LENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHI 573 (756)
Q Consensus 494 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~~~~~~ 573 (756)
+++ +|.+++......+++..+..++.||++||+|||+.+ |+||||||+||+++.++.+||+|||+++........
T Consensus 81 ~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~- 155 (284)
T cd07839 81 CDQ-DLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHN---VLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRC- 155 (284)
T ss_pred CCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEcCCCcEEECccchhhccCCCCCC-
Confidence 974 788888765667999999999999999999999986 999999999999999999999999999865432221
Q ss_pred eeccccCccCCchHhhhcC-CCCcccchhhHHHHHHHHHhCCCCCCccch-hhHHHHHHHHHhcC------ccccccccC
Q 004400 574 STRVAGTIGYMAPEYAMRG-HLTEKADVYSFGIVALEIVSGRSNVTKEDM-FYLLDWALVLKEQG------KLMELVDTN 645 (756)
Q Consensus 574 ~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slGv~l~elltg~~p~~~~~~-~~~~~~~~~~~~~~------~~~~~~~~~ 645 (756)
.....++..|+|||.+.+. .++.++|||||||++|||++|+.|+..... .............. ......+..
T Consensus 156 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (284)
T cd07839 156 YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYK 235 (284)
T ss_pred cCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhccccc
Confidence 2234578899999998764 478999999999999999999998743322 11111110000000 000000000
Q ss_pred CCC---------CCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 004400 646 PGS---------NFDKEQVMVMINVALLCANASPTIRPSMSSVLR 681 (756)
Q Consensus 646 ~~~---------~~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~ 681 (756)
... ...+.....+.+++.+|++.||.+|||+.++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~ 280 (284)
T cd07839 236 PYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ 280 (284)
T ss_pred ccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence 000 001112345789999999999999999999876
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-36 Score=307.28 Aligned_cols=248 Identities=30% Similarity=0.468 Sum_probs=201.1
Q ss_pred CccccCcccCCCCccEEEeecc-CCcEEEEEEccccC-----cccHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEE
Q 004400 417 NFATDNNIGEGGFGPVYKGLLA-DGTAIAVKQLSSKS-----KQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLI 490 (756)
Q Consensus 417 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 490 (756)
+|...+.||+|+||.||+|... +++.|++|.+.... ....+.+.+|+++++.++|+||+++++++.++...++|
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 3667789999999999999965 78999999886532 22446788999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCcccC
Q 004400 491 YEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEEN 570 (756)
Q Consensus 491 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~~~ 570 (756)
+||+++++|.+++... ..+++..+..++.|++.||+|||+.| |+||||+|+||+++.++.+||+|||++.......
T Consensus 81 ~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~ 156 (258)
T cd06632 81 LELVPGGSLAKLLKKY-GSFPEPVIRLYTRQILLGLEYLHDRN---TVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS 156 (258)
T ss_pred EEecCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccceeccccc
Confidence 9999999999998755 36899999999999999999999986 9999999999999999999999999987654332
Q ss_pred cceeeccccCccCCchHhhhcCC-CCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhcCccccccccCCCCC
Q 004400 571 THISTRVAGTIGYMAPEYAMRGH-LTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSN 649 (756)
Q Consensus 571 ~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 649 (756)
......|+..|+|||.+.... ++.++|+||||+++|++++|+.||......... ...........
T Consensus 157 --~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~---~~~~~~~~~~~--------- 222 (258)
T cd06632 157 --FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAV---FKIGRSKELPP--------- 222 (258)
T ss_pred --cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHH---HHHHhcccCCC---------
Confidence 223456889999999998766 899999999999999999999999654422111 11111111111
Q ss_pred CCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004400 650 FDKEQVMVMINVALLCANASPTIRPSMSSVLRM 682 (756)
Q Consensus 650 ~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~ 682 (756)
.+......+.+++.+||+.+|.+||++.++++.
T Consensus 223 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 255 (258)
T cd06632 223 IPDHLSDEAKDFILKCLQRDPSLRPTAAELLEH 255 (258)
T ss_pred cCCCcCHHHHHHHHHHhhcCcccCcCHHHHhcC
Confidence 111123447889999999999999999998763
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=316.57 Aligned_cols=249 Identities=27% Similarity=0.446 Sum_probs=200.4
Q ss_pred CccccCcccCCCCccEEEeec-cCCcEEEEEEccccCcccHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEEecC
Q 004400 417 NFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYEYLE 495 (756)
Q Consensus 417 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~ 495 (756)
.|.....||+|+||.||++.. .++..||||.+........+.+.+|+.+++.++|+||+++++.+..++..++||||++
T Consensus 23 ~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~ 102 (292)
T cd06658 23 YLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLE 102 (292)
T ss_pred HHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCC
Confidence 344456799999999999984 5688999999866554555678999999999999999999999999999999999999
Q ss_pred CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCcccCcceee
Q 004400 496 NNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHIST 575 (756)
Q Consensus 496 ~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~ 575 (756)
+++|.+++.. ..+++..+..++.||+.||+|||+.+ |+||||||+||++++++.+||+|||++......... ..
T Consensus 103 ~~~L~~~~~~--~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~~-~~ 176 (292)
T cd06658 103 GGALTDIVTH--TRMNEEQIATVCLSVLRALSYLHNQG---VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPK-RK 176 (292)
T ss_pred CCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEccCcchhhccccccc-Cc
Confidence 9999998853 36899999999999999999999986 999999999999999999999999998754332221 22
Q ss_pred ccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhcCccccccccCCCCCCCHHHH
Q 004400 576 RVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDKEQV 655 (756)
Q Consensus 576 ~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 655 (756)
...|+..|+|||...+..++.++||||||+++|||++|+.||........... ... .....+. ......
T Consensus 177 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~---~~~--~~~~~~~------~~~~~~ 245 (292)
T cd06658 177 SLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRR---IRD--NLPPRVK------DSHKVS 245 (292)
T ss_pred eeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH---HHh--cCCCccc------cccccC
Confidence 35689999999999888899999999999999999999999976544322211 100 0001000 011122
Q ss_pred HHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004400 656 MVMINVALLCANASPTIRPSMSSVLRM 682 (756)
Q Consensus 656 ~~l~~l~~~c~~~~P~~RPt~~ev~~~ 682 (756)
..+.+++.+||..+|.+|||+.++++.
T Consensus 246 ~~~~~li~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 246 SVLRGFLDLMLVREPSQRATAQELLQH 272 (292)
T ss_pred HHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 347889999999999999999999874
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=307.02 Aligned_cols=250 Identities=26% Similarity=0.345 Sum_probs=197.8
Q ss_pred cCccccCcccCCCCccEEEeec-cCCcEEEEEEccccC-----cccHHHHHHHHHHHHhCCCCceeeEeeEEEeC--CeE
Q 004400 416 NNFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSKS-----KQGNREFINEIGMISALQHPNLVKLYGCCIEG--NQL 487 (756)
Q Consensus 416 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~ 487 (756)
++|+..+.||+|+||.||+|.. .+++.||+|.+.... ....+.+.+|++++++++||||+++++++.++ ...
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 4788899999999999999985 568999999875321 12235788899999999999999999998764 568
Q ss_pred EEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCc
Q 004400 488 LLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDE 567 (756)
Q Consensus 488 ~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~ 567 (756)
++||||+++++|.+++... ..+++..+.+++.|++.||+|||+.+ |+||||||+||+++.++.++|+|||+++...
T Consensus 82 ~~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~ 157 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSY-GALTENVTRKYTRQILEGVSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASKRLQ 157 (265)
T ss_pred EEEEEecCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEecCCCCEEECcCccccccc
Confidence 8999999999999998754 36889999999999999999999986 9999999999999999999999999998544
Q ss_pred ccCcc--eeeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhcCccccccccC
Q 004400 568 EENTH--ISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTN 645 (756)
Q Consensus 568 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 645 (756)
..... ......|+..|+|||.+.+..++.++|||||||++|||++|+.||.......... ......
T Consensus 158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~---~~~~~~--------- 225 (265)
T cd06652 158 TICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIF---KIATQP--------- 225 (265)
T ss_pred cccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHHH---HHhcCC---------
Confidence 32111 1223568899999999988889999999999999999999999996443221111 011000
Q ss_pred CCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004400 646 PGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRM 682 (756)
Q Consensus 646 ~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~ 682 (756)
.....+......+.+++.+|+. +|.+||+++||++.
T Consensus 226 ~~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~ 261 (265)
T cd06652 226 TNPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLRH 261 (265)
T ss_pred CCCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcC
Confidence 0111233344557888899995 99999999998763
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-36 Score=313.59 Aligned_cols=263 Identities=21% Similarity=0.326 Sum_probs=204.1
Q ss_pred cCccccCcccCCCCccEEEeecc-CCcEEEEEEcccc--CcccHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEE
Q 004400 416 NNFATDNNIGEGGFGPVYKGLLA-DGTAIAVKQLSSK--SKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYE 492 (756)
Q Consensus 416 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 492 (756)
++|+..+.||+|+||.||+|... +++.||+|.++.. .......+.+|++++++++|+||+++++++.+++..++|||
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 80 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE 80 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence 36888899999999999999954 6889999998653 23334678999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCcccCcc
Q 004400 493 YLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTH 572 (756)
Q Consensus 493 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~~~~~ 572 (756)
|++++.+..+.. ....+++..+..++.|++.||+|||+.+ ++||||+|+||++++++.+||+|||++.........
T Consensus 81 ~~~~~~l~~~~~-~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~ 156 (288)
T cd07833 81 YVERTLLELLEA-SPGGLPPDAVRSYIWQLLQAIAYCHSHN---IIHRDIKPENILVSESGVLKLCDFGFARALRARPAS 156 (288)
T ss_pred cCCCCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEEeeecccccCCCccc
Confidence 999877766554 3456899999999999999999999986 999999999999999999999999999876554432
Q ss_pred eeeccccCccCCchHhhhcC-CCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHh------------cCccc
Q 004400 573 ISTRVAGTIGYMAPEYAMRG-HLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKE------------QGKLM 639 (756)
Q Consensus 573 ~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~------------~~~~~ 639 (756)
......++..|+|||++... .++.++||||||+++|+|++|+.||................. .....
T Consensus 157 ~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (288)
T cd07833 157 PLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFA 236 (288)
T ss_pred cccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCcccc
Confidence 33445688999999999887 789999999999999999999999965543322211111000 00000
Q ss_pred --cccccCCC----CCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004400 640 --ELVDTNPG----SNFDKEQVMVMINVALLCANASPTIRPSMSSVLRM 682 (756)
Q Consensus 640 --~~~~~~~~----~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~ 682 (756)
+....... ..++......+.+++.+||..+|++||+++++++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 285 (288)
T cd07833 237 GVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQH 285 (288)
T ss_pred ccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcC
Confidence 00000000 00111124568999999999999999999998763
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-36 Score=313.32 Aligned_cols=252 Identities=25% Similarity=0.426 Sum_probs=200.3
Q ss_pred cCccccCcccCCCCccEEEeecc-CCcEEEEEEcccc-CcccHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEEe
Q 004400 416 NNFATDNNIGEGGFGPVYKGLLA-DGTAIAVKQLSSK-SKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYEY 493 (756)
Q Consensus 416 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 493 (756)
++|+..+.||+|+||.||+|... +++.||+|.+... .......+.+|++++++++||||+++++++..++..++||||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY 80 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence 36788899999999999999954 7899999988654 223346788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCcccCc
Q 004400 494 LENNSLARALFEH--RLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENT 571 (756)
Q Consensus 494 ~~~gsL~~~l~~~--~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~~~~ 571 (756)
+++++|..++... ...+++..+..++.|++.||.|||+.. +|+||||||+||+++.++.+||+|||++.......
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~- 157 (286)
T cd06622 81 MDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEH--NIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASL- 157 (286)
T ss_pred cCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcC--CEeeCCCCHHHEEECCCCCEEEeecCCcccccCCc-
Confidence 9999999988653 236899999999999999999999742 49999999999999999999999999987543221
Q ss_pred ceeeccccCccCCchHhhhcC------CCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhcCccccccccC
Q 004400 572 HISTRVAGTIGYMAPEYAMRG------HLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTN 645 (756)
Q Consensus 572 ~~~~~~~gt~~y~aPE~~~~~------~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 645 (756)
.....|+..|+|||.+.+. .++.++|||||||++|+|++|+.||................ ....
T Consensus 158 --~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~-~~~~------- 227 (286)
T cd06622 158 --AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIV-DGDP------- 227 (286)
T ss_pred --cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHh-hcCC-------
Confidence 2234578899999998543 35889999999999999999999996543322221111111 1111
Q ss_pred CCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004400 646 PGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRM 682 (756)
Q Consensus 646 ~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~ 682 (756)
...+......+.+++.+||+.+|++||++.++++.
T Consensus 228 --~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~ 262 (286)
T cd06622 228 --PTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEH 262 (286)
T ss_pred --CCCCcccCHHHHHHHHHHcccCcccCCCHHHHhcC
Confidence 11122234458899999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=305.67 Aligned_cols=255 Identities=29% Similarity=0.462 Sum_probs=203.8
Q ss_pred cCccccCcccCCCCccEEEeec-cCCcEEEEEEccccC-cccHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEEe
Q 004400 416 NNFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSKS-KQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYEY 493 (756)
Q Consensus 416 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 493 (756)
++|+..+.||.|+||+||+|.. .++..+|+|++.... ......+.+|+++++.++|+||+++++.+..++..++|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 80 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY 80 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence 4688899999999999999994 468899999986532 23457789999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCcccCc
Q 004400 494 LENNSLARALFEH--RLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENT 571 (756)
Q Consensus 494 ~~~gsL~~~l~~~--~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~~~~ 571 (756)
+++++|.+++... ...+++..+..++.|++.||+|||+.| |+||||||+||++++++.++|+|||++........
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~---i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~ 157 (267)
T cd06610 81 LSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNG---QIHRDIKAGNILLGEDGSVKIADFGVSASLADGGD 157 (267)
T ss_pred cCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccchHHHhccCcc
Confidence 9999999999753 246899999999999999999999986 99999999999999999999999999876544322
Q ss_pred c---eeeccccCccCCchHhhhcC-CCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhcCccccccccCCC
Q 004400 572 H---ISTRVAGTIGYMAPEYAMRG-HLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPG 647 (756)
Q Consensus 572 ~---~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 647 (756)
. ......|+..|+|||++... .++.++|||||||++|||++|+.||.......... ..... .. .......
T Consensus 158 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~--~~~~~--~~-~~~~~~~- 231 (267)
T cd06610 158 RTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLM--LTLQN--DP-PSLETGA- 231 (267)
T ss_pred ccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHH--HHhcC--CC-CCcCCcc-
Confidence 2 22335689999999999877 78999999999999999999999996544322111 00101 00 0000000
Q ss_pred CCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 004400 648 SNFDKEQVMVMINVALLCANASPTIRPSMSSVLR 681 (756)
Q Consensus 648 ~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~ 681 (756)
........+.+++.+||+.+|++||++.++++
T Consensus 232 --~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~ 263 (267)
T cd06610 232 --DYKKYSKSFRKMISLCLQKDPSKRPTAEELLK 263 (267)
T ss_pred --ccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 01122345889999999999999999999976
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=308.62 Aligned_cols=252 Identities=25% Similarity=0.425 Sum_probs=201.8
Q ss_pred CccccCcccCCCCccEEEee-ccCCcEEEEEEccccCc------ccHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEE
Q 004400 417 NFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSKSK------QGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLL 489 (756)
Q Consensus 417 ~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 489 (756)
+|+..+.||+|+||.||+|. ..+++.||+|.+..... ...+.+.+|+.++++++|+||+++++++.+.+..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 47788999999999999998 46789999999865321 124678899999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCC-CEEEccCCccccCcc
Q 004400 490 IYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDL-NSKISDFGLAKLDEE 568 (756)
Q Consensus 490 V~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~-~~kl~DFGla~~~~~ 568 (756)
|+||+++++|.+++... ..+++..+..++.|++.||+|||+.+ ++||||||+||+++.++ .+||+|||.+.....
T Consensus 81 v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~ql~~al~~LH~~~---i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~ 156 (268)
T cd06630 81 FVEWMAGGSVSHLLSKY-GAFKEAVIINYTEQLLRGLSYLHENQ---IIHRDVKGANLLIDSTGQRLRIADFGAAARLAA 156 (268)
T ss_pred EEeccCCCcHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccccccccccc
Confidence 99999999999998754 36899999999999999999999996 99999999999998776 599999999976543
Q ss_pred cCcc---eeeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhcCccccccccC
Q 004400 569 ENTH---ISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTN 645 (756)
Q Consensus 569 ~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 645 (756)
.... ......|+..|+|||.+.+..++.++||||+|+++|++++|+.||...................
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~--------- 227 (268)
T cd06630 157 KGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASAT--------- 227 (268)
T ss_pred ccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhccC---------
Confidence 3211 1223568899999999988889999999999999999999999995443322211111111100
Q ss_pred CCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 004400 646 PGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLR 681 (756)
Q Consensus 646 ~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~ 681 (756)
.....+......+.+++.+|++.+|.+||++.++++
T Consensus 228 ~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~ 263 (268)
T cd06630 228 TAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK 263 (268)
T ss_pred CCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence 011222333455889999999999999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=315.26 Aligned_cols=255 Identities=21% Similarity=0.302 Sum_probs=202.2
Q ss_pred cCccccCcccCCCCccEEEeec-cCCcEEEEEEccccC---cccHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEE
Q 004400 416 NNFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSKS---KQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIY 491 (756)
Q Consensus 416 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 491 (756)
++|+..+.||+|+||.||+|.. .+++.||+|.+.... ......+.+|+++++.++||||+++++++..++..++||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 3688889999999999999995 467899999986542 223456789999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCcccC-
Q 004400 492 EYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEEN- 570 (756)
Q Consensus 492 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~~~- 570 (756)
||+++++|.+++... ..+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||+++......
T Consensus 81 e~~~g~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~ 156 (305)
T cd05609 81 EYVEGGDCATLLKNI-GALPVDMARMYFAETVLALEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLT 156 (305)
T ss_pred ecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHEEECCCCCEEEeeCCCccccCcCcc
Confidence 999999999999655 46899999999999999999999986 9999999999999999999999999987421100
Q ss_pred -------------cceeeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhcCc
Q 004400 571 -------------THISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGK 637 (756)
Q Consensus 571 -------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 637 (756)
........|+..|+|||.+....++.++|||||||++||+++|+.||.+........ .... ..
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~---~~~~-~~ 232 (305)
T cd05609 157 TNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFG---QVIS-DD 232 (305)
T ss_pred ccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH---HHHh-cc
Confidence 001122457889999999988889999999999999999999999997654332221 1111 11
Q ss_pred cccccccCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhcc
Q 004400 638 LMELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLEC 685 (756)
Q Consensus 638 ~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~L~~ 685 (756)
...+.....++ ..+.+++.+||+.+|++||++.++.+.|+.
T Consensus 233 ---~~~~~~~~~~~----~~~~~li~~~l~~~P~~R~~~~~~~~ll~~ 273 (305)
T cd05609 233 ---IEWPEGDEALP----ADAQDLISRLLRQNPLERLGTGGAFEVKQH 273 (305)
T ss_pred ---cCCCCccccCC----HHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence 01111111122 347899999999999999998777777663
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-36 Score=314.83 Aligned_cols=248 Identities=25% Similarity=0.405 Sum_probs=200.5
Q ss_pred ccccCcccCCCCccEEEeec-cCCcEEEEEEccccCcccHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEEecCC
Q 004400 418 FATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYEYLEN 496 (756)
Q Consensus 418 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~ 496 (756)
|+....||+|+||.||+|.. .+++.||+|.+........+.+.+|+.+++.++||||+++++++..++..++|+||+++
T Consensus 23 ~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~ 102 (297)
T cd06659 23 LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQG 102 (297)
T ss_pred HHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCC
Confidence 33445799999999999984 57899999998665444556788999999999999999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCcccCcceeec
Q 004400 497 NSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTR 576 (756)
Q Consensus 497 gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~ 576 (756)
++|.+++.. ..+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||++........ ....
T Consensus 103 ~~L~~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~-~~~~ 176 (297)
T cd06659 103 GALTDIVSQ--TRLNEEQIATVCESVLQALCYLHSQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP-KRKS 176 (297)
T ss_pred CCHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHeEEccCCcEEEeechhHhhcccccc-cccc
Confidence 999987754 36899999999999999999999986 99999999999999999999999999875443222 1233
Q ss_pred cccCccCCchHhhhcCCCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhcCccccccccCCCCCCCHHHHH
Q 004400 577 VAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDKEQVM 656 (756)
Q Consensus 577 ~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 656 (756)
..|+..|+|||++.+..++.++|||||||++|||++|+.||...+........ .. ..... .. ....+ ..
T Consensus 177 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~---~~-~~~~~--~~-~~~~~----~~ 245 (297)
T cd06659 177 LVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRL---RD-SPPPK--LK-NAHKI----SP 245 (297)
T ss_pred eecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH---hc-cCCCC--cc-ccCCC----CH
Confidence 56899999999999888999999999999999999999999655433322111 11 10000 00 00112 23
Q ss_pred HHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004400 657 VMINVALLCANASPTIRPSMSSVLRM 682 (756)
Q Consensus 657 ~l~~l~~~c~~~~P~~RPt~~ev~~~ 682 (756)
.+.+++.+|++.+|++||++.++++.
T Consensus 246 ~l~~~i~~~l~~~P~~Rps~~~ll~~ 271 (297)
T cd06659 246 VLRDFLERMLTREPQERATAQELLDH 271 (297)
T ss_pred HHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 47889999999999999999999884
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=313.14 Aligned_cols=250 Identities=28% Similarity=0.469 Sum_probs=204.5
Q ss_pred cCccccCcccCCCCccEEEee-ccCCcEEEEEEccccCcccHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEEec
Q 004400 416 NNFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYEYL 494 (756)
Q Consensus 416 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~ 494 (756)
++|...+.||+|+||.||+|. ..+++.||+|.+........+.+.+|+.++++++||||++++++|..++..++|+||+
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~ 98 (293)
T cd06647 19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYL 98 (293)
T ss_pred hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecC
Confidence 578889999999999999998 4578899999986554455577899999999999999999999999999999999999
Q ss_pred CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCcccCccee
Q 004400 495 ENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHIS 574 (756)
Q Consensus 495 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~~~~~~~ 574 (756)
++++|.+++.+. .+++..+..++.|++.||+|||+.| ++||||||+||+++.++.+||+|||++......... .
T Consensus 99 ~~~~L~~~~~~~--~l~~~~~~~i~~~l~~al~~LH~~g---i~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~~-~ 172 (293)
T cd06647 99 AGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK-R 172 (293)
T ss_pred CCCcHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHhCC---EeeccCCHHHEEEcCCCCEEEccCcceecccccccc-c
Confidence 999999998643 5789999999999999999999986 999999999999999999999999998755433222 2
Q ss_pred eccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhcCccccccccCCCCCCCHHH
Q 004400 575 TRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDKEQ 654 (756)
Q Consensus 575 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 654 (756)
....|++.|+|||.+....++.++||||||+++|++++|+.||...+........ .. ...+....+...
T Consensus 173 ~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~---~~--------~~~~~~~~~~~~ 241 (293)
T cd06647 173 STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLI---AT--------NGTPELQNPEKL 241 (293)
T ss_pred ccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeeh---hc--------CCCCCCCCcccc
Confidence 2346889999999998888999999999999999999999999655432211100 00 000111111223
Q ss_pred HHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004400 655 VMVMINVALLCANASPTIRPSMSSVLRM 682 (756)
Q Consensus 655 ~~~l~~l~~~c~~~~P~~RPt~~ev~~~ 682 (756)
...+.+++.+||+.+|++||++.+++..
T Consensus 242 ~~~l~~li~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 242 SAIFRDFLNRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 3458899999999999999999999865
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=307.38 Aligned_cols=252 Identities=27% Similarity=0.442 Sum_probs=202.3
Q ss_pred CccccCcccCCCCccEEEee-ccCCcEEEEEEcccc--CcccHHHHHHHHHHHHhCCCCceeeEeeEEEe--CCeEEEEE
Q 004400 417 NFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSK--SKQGNREFINEIGMISALQHPNLVKLYGCCIE--GNQLLLIY 491 (756)
Q Consensus 417 ~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lV~ 491 (756)
+|+..+.||.|+||.||+|. ..+++.||+|.+... .....+.+..|++++++++||||+++++++.. +...+++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 47788999999999999998 457889999998643 23334578889999999999999999998864 45689999
Q ss_pred EecCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHcCC--CCCeEcCCCCCCceEecCCCCEEEccCCccccC
Q 004400 492 EYLENNSLARALFEH---RLKLDWPTRRRICLGIARGLAYLHGES--RIKVVHRDIKATNVLLDKDLNSKISDFGLAKLD 566 (756)
Q Consensus 492 e~~~~gsL~~~l~~~---~~~l~~~~~~~i~~~ia~~L~~LH~~g--~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~ 566 (756)
||+++++|.+++... ...+++..++.++.|++.||+|||..| ..+++||||||+||+++.++.+||+|||++...
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~ 160 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL 160 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccc
Confidence 999999999999743 457899999999999999999999332 235999999999999999999999999999876
Q ss_pred cccCcceeeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhcCccccccccCC
Q 004400 567 EEENTHISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNP 646 (756)
Q Consensus 567 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 646 (756)
...... .....|+..|+|||.+....++.++||||||+++|+|++|+.||...+........ ..+..
T Consensus 161 ~~~~~~-~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~----~~~~~-------- 227 (265)
T cd08217 161 GHDSSF-AKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKI----KEGKF-------- 227 (265)
T ss_pred cCCccc-ccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHHHHHHHH----hcCCC--------
Confidence 543321 23346899999999999888999999999999999999999999765532222111 11111
Q ss_pred CCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004400 647 GSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRM 682 (756)
Q Consensus 647 ~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~ 682 (756)
...+......+.+++.+|++.+|++||++.+|++.
T Consensus 228 -~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 228 -RRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred -CCCccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 11222233458899999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-36 Score=318.84 Aligned_cols=193 Identities=27% Similarity=0.446 Sum_probs=159.5
Q ss_pred cCcccCCCCccEEEeecc---CCcEEEEEEccccCcccHHHHHHHHHHHHhCCCCceeeEeeEEEe--CCeEEEEEEecC
Q 004400 421 DNNIGEGGFGPVYKGLLA---DGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCCIE--GNQLLLIYEYLE 495 (756)
Q Consensus 421 ~~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lV~e~~~ 495 (756)
...||+|+||.||+|+.. ++..||+|.+.... ....+.+|++++++++||||+++++++.. +...++||||++
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE 83 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC
Confidence 358999999999999854 45789999986532 23567899999999999999999999854 567899999987
Q ss_pred CCCHHHHHHhc--------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEe----cCCCCEEEccCCcc
Q 004400 496 NNSLARALFEH--------RLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLL----DKDLNSKISDFGLA 563 (756)
Q Consensus 496 ~gsL~~~l~~~--------~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill----~~~~~~kl~DFGla 563 (756)
+ +|.+++... ...+++..+..++.|++.||+|||+.+ |+||||||+||++ +.++.+||+|||++
T Consensus 84 ~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07867 84 H-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred C-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEccCCCCCCcEEEeeccce
Confidence 5 677776421 235889999999999999999999986 9999999999999 56678999999999
Q ss_pred ccCcccCcc--eeeccccCccCCchHhhhc-CCCCcccchhhHHHHHHHHHhCCCCCCc
Q 004400 564 KLDEEENTH--ISTRVAGTIGYMAPEYAMR-GHLTEKADVYSFGIVALEIVSGRSNVTK 619 (756)
Q Consensus 564 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slGv~l~elltg~~p~~~ 619 (756)
+........ ......||+.|+|||++.+ ..++.++|||||||++|||+||+.||..
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~ 218 (317)
T cd07867 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC 218 (317)
T ss_pred eccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCccc
Confidence 865443221 1234568999999999876 4589999999999999999999999954
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=313.47 Aligned_cols=261 Identities=23% Similarity=0.332 Sum_probs=201.0
Q ss_pred CccccCcccCCCCccEEEeec-cCCcEEEEEEccccCcc-----cHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEE
Q 004400 417 NFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSKSKQ-----GNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLI 490 (756)
Q Consensus 417 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 490 (756)
+|+..+.||+|+||.||+|.. .+++.||||.+...... ....+..|++++++++|+||+++++++.+++..++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 467788999999999999995 57899999999754322 335677899999999999999999999999999999
Q ss_pred EEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCcccC
Q 004400 491 YEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEEN 570 (756)
Q Consensus 491 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~~~ 570 (756)
|||+ +|+|.+++......+++..+..++.||++||+|||+.+ |+||||||+||+++.++.+||+|||+++......
T Consensus 81 ~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~ 156 (298)
T cd07841 81 FEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFGSPN 156 (298)
T ss_pred Eccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCChhhEEEcCCCCEEEccceeeeeccCCC
Confidence 9999 89999999765457999999999999999999999997 9999999999999999999999999998654432
Q ss_pred cceeeccccCccCCchHhhhc-CCCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhc---------Ccccc
Q 004400 571 THISTRVAGTIGYMAPEYAMR-GHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQ---------GKLME 640 (756)
Q Consensus 571 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~---------~~~~~ 640 (756)
.. .....+++.|+|||.+.+ ..++.++|||||||++|||++|..||...+.............. .....
T Consensus 157 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (298)
T cd07841 157 RK-MTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPD 235 (298)
T ss_pred cc-ccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhcccccc
Confidence 21 222356788999999865 45789999999999999999998777655443322111100000 00000
Q ss_pred ccccCCCCCC-----CHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004400 641 LVDTNPGSNF-----DKEQVMVMINVALLCANASPTIRPSMSSVLRM 682 (756)
Q Consensus 641 ~~~~~~~~~~-----~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~ 682 (756)
.......... .......+.+++.+||+.+|++||++.|+++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~ 282 (298)
T cd07841 236 YVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH 282 (298)
T ss_pred cccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 0000000001 11223468899999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-36 Score=323.34 Aligned_cols=259 Identities=22% Similarity=0.347 Sum_probs=196.5
Q ss_pred hhcCccccCcccCCCCccEEEee-ccCCcEEEEEEccccC--cccHHHHHHHHHHHHhCCCCceeeEeeEEEeC------
Q 004400 414 ATNNFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSKS--KQGNREFINEIGMISALQHPNLVKLYGCCIEG------ 484 (756)
Q Consensus 414 ~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------ 484 (756)
..++|...+.||+|+||.||+|. ..+++.||||.+.... ....+.+.+|++++++++||||+++++++...
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07878 13 VPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENF 92 (343)
T ss_pred hhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhccccccccc
Confidence 34678899999999999999998 4578899999986532 22345678899999999999999999988643
Q ss_pred CeEEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccc
Q 004400 485 NQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAK 564 (756)
Q Consensus 485 ~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~ 564 (756)
...+++++++ +++|.+++.. ..+++..+..++.||+.||+|||+.| |+||||||+||+++.++.+||+|||+++
T Consensus 93 ~~~~~~~~~~-~~~l~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~~~ 166 (343)
T cd07878 93 NEVYLVTNLM-GADLNNIVKC--QKLSDEHVQFLIYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFGLAR 166 (343)
T ss_pred CcEEEEeecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhhEEECCCCCEEEcCCccce
Confidence 4578999988 7799887743 36899999999999999999999997 9999999999999999999999999998
Q ss_pred cCcccCcceeeccccCccCCchHhhhc-CCCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhcCc------
Q 004400 565 LDEEENTHISTRVAGTIGYMAPEYAMR-GHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGK------ 637 (756)
Q Consensus 565 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~------ 637 (756)
..... .....||..|+|||++.+ ..++.++|||||||++|||++|+.||...+................
T Consensus 167 ~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (343)
T cd07878 167 QADDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKK 242 (343)
T ss_pred ecCCC----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence 65432 233568999999999877 5689999999999999999999999966543322211111000000
Q ss_pred --------cccccccCCCCCC---CHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004400 638 --------LMELVDTNPGSNF---DKEQVMVMINVALLCANASPTIRPSMSSVLRM 682 (756)
Q Consensus 638 --------~~~~~~~~~~~~~---~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~ 682 (756)
....+...+.... .......+.+++.+|++.||.+|||+.|+++.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h 298 (343)
T cd07878 243 ISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAH 298 (343)
T ss_pred cchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0000000000000 00011247799999999999999999999864
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=307.34 Aligned_cols=254 Identities=27% Similarity=0.436 Sum_probs=199.2
Q ss_pred CccccCcccCCCCccEEEee-ccCCcEEEEEEccccCc----------ccHHHHHHHHHHHHhCCCCceeeEeeEEEeCC
Q 004400 417 NFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSKSK----------QGNREFINEIGMISALQHPNLVKLYGCCIEGN 485 (756)
Q Consensus 417 ~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~----------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 485 (756)
+|...+.||+|+||.||+|. ..+|+.||+|.+..... ...+.+.+|+.+++.++|||++++++++..++
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 46778899999999999998 45789999998753211 01245788999999999999999999999999
Q ss_pred eEEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCcccc
Q 004400 486 QLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKL 565 (756)
Q Consensus 486 ~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~ 565 (756)
..++||||+++|+|.+++... ..+++..+..++.|++.||.|||+.+ ++||||+|+||+++.++.++|+|||+++.
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~~~nil~~~~~~~~l~d~~~~~~ 157 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTY-GRFEEQLVRFFTEQVLEGLAYLHSKG---ILHRDLKADNLLVDADGICKISDFGISKK 157 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHhhCC---eeecCCChhhEEEcCCCeEEEeecccccc
Confidence 999999999999999999765 47899999999999999999999986 99999999999999999999999999976
Q ss_pred CcccCcc-eeeccccCccCCchHhhhcCC--CCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhcCcccccc
Q 004400 566 DEEENTH-ISTRVAGTIGYMAPEYAMRGH--LTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELV 642 (756)
Q Consensus 566 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~--~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 642 (756)
....... ......|+..|+|||.+.... ++.++||||||+++||+++|+.||...+...... ...........
T Consensus 158 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~---~~~~~~~~~~~- 233 (272)
T cd06629 158 SDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMF---KLGNKRSAPPI- 233 (272)
T ss_pred ccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHH---HhhccccCCcC-
Confidence 5432211 123356889999999987654 8899999999999999999999995443321110 00011111111
Q ss_pred ccCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004400 643 DTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRM 682 (756)
Q Consensus 643 ~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~ 682 (756)
.. .........+.+++.+||..+|++||++.+|++.
T Consensus 234 ~~----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (272)
T cd06629 234 PP----DVSMNLSPVALDFLNACFTINPDNRPTARELLQH 269 (272)
T ss_pred Cc----cccccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence 11 1111223458899999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-36 Score=320.57 Aligned_cols=257 Identities=23% Similarity=0.346 Sum_probs=203.7
Q ss_pred CccccCcccCCCCccEEEee-ccCCcEEEEEEccccCcccHHHHHHHHHHHHhCC-C-----CceeeEeeEEEeCCeEEE
Q 004400 417 NFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQGNREFINEIGMISALQ-H-----PNLVKLYGCCIEGNQLLL 489 (756)
Q Consensus 417 ~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h-----~niv~l~~~~~~~~~~~l 489 (756)
+|.+.+.||+|+||.|.+|. ..+++.||||+++.. +.-..+-..|+.+|..++ | -|+|+++++|...++.||
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~-k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlci 265 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNK-KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCI 265 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccC-hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceee
Confidence 78899999999999999999 677999999999764 333455577999999997 4 489999999999999999
Q ss_pred EEEecCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCC--CEEEccCCccccC
Q 004400 490 IYEYLENNSLARALFEH-RLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDL--NSKISDFGLAKLD 566 (756)
Q Consensus 490 V~e~~~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~--~~kl~DFGla~~~ 566 (756)
|+|.++. +|.+++..+ ...++...++.++.||+.||.+||+.+ |||+||||+||||.+-. .+||+|||.|...
T Consensus 266 VfELL~~-NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~---IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~ 341 (586)
T KOG0667|consen 266 VFELLST-NLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELG---IIHCDLKPENILLKDPKRSRIKVIDFGSSCFE 341 (586)
T ss_pred eehhhhh-hHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCChhheeeccCCcCceeEEeccccccc
Confidence 9999865 999999843 456899999999999999999999986 99999999999997543 5999999999865
Q ss_pred cccCcceeeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHh---------cCc
Q 004400 567 EEENTHISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKE---------QGK 637 (756)
Q Consensus 567 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~---------~~~ 637 (756)
.+... ...-+..|.|||++.+..|+.+.||||||||++||++|.+-|.++++.+.+........ ..+
T Consensus 342 ~q~vy----tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~~~~ 417 (586)
T KOG0667|consen 342 SQRVY----TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDTAKK 417 (586)
T ss_pred CCcce----eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHHhccc
Confidence 54322 34557789999999999999999999999999999999888888887665443322211 000
Q ss_pred ccccccc----------------------------------CC-----CC-CCCHHHHHHHHHHHHHhhcCCCCCCCCHH
Q 004400 638 LMELVDT----------------------------------NP-----GS-NFDKEQVMVMINVALLCANASPTIRPSMS 677 (756)
Q Consensus 638 ~~~~~~~----------------------------------~~-----~~-~~~~~~~~~l~~l~~~c~~~~P~~RPt~~ 677 (756)
....++. .+ .. .........+++++++|+..||.+|+|..
T Consensus 418 ~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~tp~ 497 (586)
T KOG0667|consen 418 AHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERITPA 497 (586)
T ss_pred cceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcCCHH
Confidence 0000000 00 00 01113344789999999999999999999
Q ss_pred HHHHH
Q 004400 678 SVLRM 682 (756)
Q Consensus 678 ev~~~ 682 (756)
|.++.
T Consensus 498 qal~H 502 (586)
T KOG0667|consen 498 QALNH 502 (586)
T ss_pred HHhcC
Confidence 99765
|
|
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=311.42 Aligned_cols=258 Identities=27% Similarity=0.383 Sum_probs=202.6
Q ss_pred hhHHHhhcCccccCcccCCCCccEEEeec-cCCcEEEEEEccccCcccHHHHHHHHHHHHhC-CCCceeeEeeEEEeC--
Q 004400 409 LQIKAATNNFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSKSKQGNREFINEIGMISAL-QHPNLVKLYGCCIEG-- 484 (756)
Q Consensus 409 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~-- 484 (756)
.++..++++|...+.||+|+||.||+|.. .+++.+|+|.+.... .....+.+|+.+++++ +|||+++++++|...
T Consensus 15 ~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~ 93 (291)
T cd06639 15 ESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADK 93 (291)
T ss_pred ccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccc
Confidence 34556788999999999999999999995 578899999986532 2345678899999999 899999999998754
Q ss_pred ---CeEEEEEEecCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEc
Q 004400 485 ---NQLLLIYEYLENNSLARALFE---HRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKIS 558 (756)
Q Consensus 485 ---~~~~lV~e~~~~gsL~~~l~~---~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~ 558 (756)
+..++||||+++|+|.+++.. ....+++..++.++.|++.||+|||+.+ |+||||||+||+++.++.+||+
T Consensus 94 ~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~nili~~~~~~kl~ 170 (291)
T cd06639 94 LVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNR---IIHRDVKGNNILLTTEGGVKLV 170 (291)
T ss_pred cCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEEEe
Confidence 358999999999999998863 3457899999999999999999999986 9999999999999999999999
Q ss_pred cCCccccCcccCcceeeccccCccCCchHhhhcC-----CCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHH
Q 004400 559 DFGLAKLDEEENTHISTRVAGTIGYMAPEYAMRG-----HLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLK 633 (756)
Q Consensus 559 DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~ 633 (756)
|||+++........ .....|+..|+|||.+... .++.++|||||||++|||++|+.||........... .
T Consensus 171 dfg~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~---~- 245 (291)
T cd06639 171 DFGVSAQLTSTRLR-RNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFK---I- 245 (291)
T ss_pred ecccchhccccccc-ccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHH---H-
Confidence 99998865432211 2234688999999998643 368899999999999999999999965543221110 0
Q ss_pred hcCccccccccCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004400 634 EQGKLMELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRM 682 (756)
Q Consensus 634 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~ 682 (756)
.........+ +......+.+++.+||+.+|++||++.|+++.
T Consensus 246 ~~~~~~~~~~-------~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~ 287 (291)
T cd06639 246 PRNPPPTLLH-------PEKWCRSFNHFISQCLIKDFEARPSVTHLLEH 287 (291)
T ss_pred hcCCCCCCCc-------ccccCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 0111111111 11223358899999999999999999999763
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=307.93 Aligned_cols=251 Identities=24% Similarity=0.409 Sum_probs=203.5
Q ss_pred cCccccCcccCCCCccEEEeecc-CCcEEEEEEccccC-cccHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEEe
Q 004400 416 NNFATDNNIGEGGFGPVYKGLLA-DGTAIAVKQLSSKS-KQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYEY 493 (756)
Q Consensus 416 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 493 (756)
++|+..+.||+|+||.||+|... +++.||+|.+.... ....+.+.+|++++++++||||+++++++..+...++|+||
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEY 80 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEe
Confidence 35777889999999999999954 78999999987653 33456789999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHc-CCCCCeEcCCCCCCceEecCCCCEEEccCCccccCcccCcc
Q 004400 494 LENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHG-ESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTH 572 (756)
Q Consensus 494 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~-~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~~~~~ 572 (756)
+++++|.+++......+++..+..++.|++.||+|||+ .+ ++||||||+||+++.++.++|+|||.+.........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~---i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~ 157 (265)
T cd06605 81 MDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHK---IIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAK 157 (265)
T ss_pred cCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCC---eecCCCCHHHEEECCCCCEEEeecccchhhHHHHhh
Confidence 99999999998665688999999999999999999999 75 999999999999999999999999998755432221
Q ss_pred eeeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHhCCCCCCccch--hhHHHHHHHHHhcCccccccccCCCCCC
Q 004400 573 ISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDM--FYLLDWALVLKEQGKLMELVDTNPGSNF 650 (756)
Q Consensus 573 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 650 (756)
...|+..|+|||.+.+..++.++||||||+++|+|++|+.||..... ....+........ .. ...
T Consensus 158 ---~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~-~~---------~~~ 224 (265)
T cd06605 158 ---TFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNE-PP---------PRL 224 (265)
T ss_pred ---cccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcC-CC---------CCC
Confidence 25688999999999988999999999999999999999999955421 1111111111111 00 011
Q ss_pred CHH-HHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004400 651 DKE-QVMVMINVALLCANASPTIRPSMSSVLRM 682 (756)
Q Consensus 651 ~~~-~~~~l~~l~~~c~~~~P~~RPt~~ev~~~ 682 (756)
+.. ....+.+++.+||..+|++||++.++++.
T Consensus 225 ~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 257 (265)
T cd06605 225 PSGKFSPDFQDFVNLCLIKDPRERPSYKELLEH 257 (265)
T ss_pred ChhhcCHHHHHHHHHHcCCCchhCcCHHHHhhC
Confidence 111 33448899999999999999999999764
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=315.65 Aligned_cols=249 Identities=24% Similarity=0.293 Sum_probs=198.9
Q ss_pred cCccccCcccCCCCccEEEeecc-CCcEEEEEEccccCcc---cHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEE
Q 004400 416 NNFATDNNIGEGGFGPVYKGLLA-DGTAIAVKQLSSKSKQ---GNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIY 491 (756)
Q Consensus 416 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 491 (756)
++|+..+.||+|+||.||+|... +++.||+|.+...... ..+.+..|+++++.++||||+++++.+.++...++||
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 36888899999999999999954 5899999998754322 3456889999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCcccC
Q 004400 492 EYLENNSLARALFEH-RLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEEN 570 (756)
Q Consensus 492 e~~~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~~~ 570 (756)
||+.+++|.+++... ...+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.++|+|||++.......
T Consensus 81 e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~ 157 (316)
T cd05574 81 DYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLG---IVYRDLKPENILLHESGHIMLSDFDLSKQSDVEP 157 (316)
T ss_pred EecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChHHeEEcCCCCEEEeecchhhcccccc
Confidence 999999999998743 357899999999999999999999986 9999999999999999999999999987543211
Q ss_pred cc----------------------------eeeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHhCCCCCCccch
Q 004400 571 TH----------------------------ISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDM 622 (756)
Q Consensus 571 ~~----------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~ 622 (756)
.. ......||..|+|||++.+..++.++||||||+++|+|++|+.||...+.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~ 237 (316)
T cd05574 158 PPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNR 237 (316)
T ss_pred cccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCch
Confidence 10 11134688999999999988899999999999999999999999965543
Q ss_pred hhHHHHHHHHHhcCccccccccCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHH
Q 004400 623 FYLLDWALVLKEQGKLMELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSV 679 (756)
Q Consensus 623 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev 679 (756)
..... ....... .. .........+.+++.+|++.+|++||++...
T Consensus 238 ~~~~~--~~~~~~~---~~-------~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~ 282 (316)
T cd05574 238 DETFS--NILKKEV---TF-------PGSPPVSSSARDLIRKLLVKDPSKRLGSKRG 282 (316)
T ss_pred HHHHH--HHhcCCc---cC-------CCccccCHHHHHHHHHHccCCHhHCCCchhh
Confidence 32211 1110000 00 0011133458999999999999999994333
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=309.13 Aligned_cols=248 Identities=26% Similarity=0.426 Sum_probs=201.7
Q ss_pred CccccCcccCCCCccEEEeec-cCCcEEEEEEccccCcccHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEEecC
Q 004400 417 NFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYEYLE 495 (756)
Q Consensus 417 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~ 495 (756)
.|...+.||+|++|.||+|.. .+++.|++|.+........+.+.+|+.+++.++||||+++++++..++..++|+||++
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~ 99 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLE 99 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccC
Confidence 344557999999999999984 5789999999865544455678899999999999999999999999999999999999
Q ss_pred CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCcccCcceee
Q 004400 496 NNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHIST 575 (756)
Q Consensus 496 ~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~ 575 (756)
+++|.+++.. ..+++..+..++.|++.||+|||+.| |+||||+|+||+++.++.++|+|||.+........ ...
T Consensus 100 ~~~L~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~-~~~ 173 (285)
T cd06648 100 GGALTDIVTH--TRMNEEQIATVCLAVLKALSFLHAQG---VIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP-RRK 173 (285)
T ss_pred CCCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChhhEEEcCCCcEEEcccccchhhccCCc-ccc
Confidence 9999999876 46899999999999999999999987 99999999999999999999999999875443222 123
Q ss_pred ccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhcCccccccccCCCCCCCHHHH
Q 004400 576 RVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDKEQV 655 (756)
Q Consensus 576 ~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 655 (756)
...|++.|+|||.+.+..++.++|||||||++|||++|+.||...+...... ..... ...... ......
T Consensus 174 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~---~~~~~-~~~~~~-------~~~~~~ 242 (285)
T cd06648 174 SLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMK---RIRDN-LPPKLK-------NLHKVS 242 (285)
T ss_pred cccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHH---HHHhc-CCCCCc-------ccccCC
Confidence 3568999999999988889999999999999999999999997655432221 11111 100000 011122
Q ss_pred HHHHHHHHHhhcCCCCCCCCHHHHHH
Q 004400 656 MVMINVALLCANASPTIRPSMSSVLR 681 (756)
Q Consensus 656 ~~l~~l~~~c~~~~P~~RPt~~ev~~ 681 (756)
..+.+++.+||+.+|++||++.++++
T Consensus 243 ~~l~~li~~~l~~~p~~Rpt~~~il~ 268 (285)
T cd06648 243 PRLRSFLDRMLVRDPAQRATAAELLN 268 (285)
T ss_pred HHHHHHHHHHcccChhhCcCHHHHcc
Confidence 35889999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=308.70 Aligned_cols=254 Identities=29% Similarity=0.499 Sum_probs=207.7
Q ss_pred HhhcCccccCcccCCCCccEEEeecc-CCcEEEEEEccccCcccHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEE
Q 004400 413 AATNNFATDNNIGEGGFGPVYKGLLA-DGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIY 491 (756)
Q Consensus 413 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 491 (756)
..++.|+..+.||+|+||.||+|... +++.|++|.+..... ..+.+.+|+++++.++|+|++++++++..++..++|+
T Consensus 16 ~~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 94 (286)
T cd06614 16 DPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVM 94 (286)
T ss_pred CccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEE
Confidence 45677888999999999999999965 789999999976544 4577899999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCcccCc
Q 004400 492 EYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENT 571 (756)
Q Consensus 492 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~~~~ 571 (756)
||+++++|.+++......+++..+..++.|++.||+|||+.| |+|+||+|+||+++.++.++|+|||++........
T Consensus 95 e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~g---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 171 (286)
T cd06614 95 EYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQN---VIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKS 171 (286)
T ss_pred eccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCChhhEEEcCCCCEEECccchhhhhccchh
Confidence 999999999999876557999999999999999999999986 99999999999999999999999999875443221
Q ss_pred ceeeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhcCccccccccCCCCCCC
Q 004400 572 HISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFD 651 (756)
Q Consensus 572 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 651 (756)
......++..|+|||.+.+..++.++|||||||++|+|++|+.||............ . ......... .
T Consensus 172 -~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~---~-~~~~~~~~~-------~ 239 (286)
T cd06614 172 -KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLI---T-TKGIPPLKN-------P 239 (286)
T ss_pred -hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHH---H-hcCCCCCcc-------h
Confidence 122345788999999998888999999999999999999999999655443222111 1 111111100 1
Q ss_pred HHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004400 652 KEQVMVMINVALLCANASPTIRPSMSSVLRM 682 (756)
Q Consensus 652 ~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~ 682 (756)
......+.+++.+||+.+|.+||++.++++.
T Consensus 240 ~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~ 270 (286)
T cd06614 240 EKWSPEFKDFLNKCLVKDPEKRPSAEELLQH 270 (286)
T ss_pred hhCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 1123358899999999999999999999763
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=307.71 Aligned_cols=253 Identities=24% Similarity=0.417 Sum_probs=198.7
Q ss_pred ccccCcccCCCCccEEEeecc----CCcEEEEEEccccC--cccHHHHHHHHHHHHhCCCCceeeEeeEEEeCC------
Q 004400 418 FATDNNIGEGGFGPVYKGLLA----DGTAIAVKQLSSKS--KQGNREFINEIGMISALQHPNLVKLYGCCIEGN------ 485 (756)
Q Consensus 418 ~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------ 485 (756)
|...+.||+|+||.||+|... ++..||||.+.... ....+++.+|++++++++||||+++++++...+
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 456789999999999999843 36889999986542 234567889999999999999999999986542
Q ss_pred eEEEEEEecCCCCHHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccC
Q 004400 486 QLLLIYEYLENNSLARALFEH-----RLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDF 560 (756)
Q Consensus 486 ~~~lV~e~~~~gsL~~~l~~~-----~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DF 560 (756)
..++++||+.+|+|.+++... ...+++..+.+++.|++.||+|||+.+ |+||||||+||+++.++.+||+||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~nili~~~~~~kl~df 157 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKN---FIHRDLAARNCMLNENMTVCVADF 157 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccchhhEEEcCCCCEEECcc
Confidence 347899999999999887532 225789999999999999999999986 999999999999999999999999
Q ss_pred CccccCcccCcc-eeeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHh-CCCCCCccchhhHHHHHHHHHhcCcc
Q 004400 561 GLAKLDEEENTH-ISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVS-GRSNVTKEDMFYLLDWALVLKEQGKL 638 (756)
Q Consensus 561 Gla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~ 638 (756)
|+++........ ......++..|++||.+....++.++|||||||++|||++ |+.||...+......+.. .....
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~---~~~~~ 234 (273)
T cd05074 158 GLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLI---KGNRL 234 (273)
T ss_pred cccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHH---cCCcC
Confidence 999865432211 1222345678999999998889999999999999999999 888886655443332211 11110
Q ss_pred ccccccCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhccC
Q 004400 639 MELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLECG 686 (756)
Q Consensus 639 ~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~L~~~ 686 (756)
. . +......+.+++.+||+.+|++||++.++++.|+++
T Consensus 235 -~-----~----~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 235 -K-----Q----PPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred -C-----C----CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 0 0 111223588999999999999999999999999854
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=312.59 Aligned_cols=261 Identities=23% Similarity=0.346 Sum_probs=197.5
Q ss_pred cCccccCcccCCCCccEEEeecc-CCcEEEEEEccccCc-ccHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEEe
Q 004400 416 NNFATDNNIGEGGFGPVYKGLLA-DGTAIAVKQLSSKSK-QGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYEY 493 (756)
Q Consensus 416 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 493 (756)
++|+..+.||+|++|.||+|... +++.||+|.+..... .....+.+|++++++++|+||+++++++.+++..++||||
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEY 84 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEec
Confidence 57888999999999999999954 789999999865432 2234577899999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCcccCcce
Q 004400 494 LENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHI 573 (756)
Q Consensus 494 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~~~~~~ 573 (756)
+.+ +|.+++......+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++........
T Consensus 85 ~~~-~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~- 159 (291)
T cd07844 85 LDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRR---VLHRDLKPQNLLISERGELKLADFGLARAKSVPSKT- 159 (291)
T ss_pred CCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCHHHEEEcCCCCEEECccccccccCCCCcc-
Confidence 985 999998876667899999999999999999999986 999999999999999999999999998754322111
Q ss_pred eeccccCccCCchHhhhc-CCCCcccchhhHHHHHHHHHhCCCCCCccch-hhHHHHHHHHHhc---Ccccc--------
Q 004400 574 STRVAGTIGYMAPEYAMR-GHLTEKADVYSFGIVALEIVSGRSNVTKEDM-FYLLDWALVLKEQ---GKLME-------- 640 (756)
Q Consensus 574 ~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slGv~l~elltg~~p~~~~~~-~~~~~~~~~~~~~---~~~~~-------- 640 (756)
.....++..|+|||++.+ ..++.++||||+|+++|||++|+.||..... ............. .....
T Consensus 160 ~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (291)
T cd07844 160 YSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPEFK 239 (291)
T ss_pred ccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhccccc
Confidence 122346889999999875 4588999999999999999999999955431 1111100000000 00000
Q ss_pred -----ccccCC-CCCC-CHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 004400 641 -----LVDTNP-GSNF-DKEQVMVMINVALLCANASPTIRPSMSSVLR 681 (756)
Q Consensus 641 -----~~~~~~-~~~~-~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~ 681 (756)
...... .... .......+.+++.+|++.+|++||++.|+++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~ 287 (291)
T cd07844 240 PYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK 287 (291)
T ss_pred cccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence 000000 0000 0001145778999999999999999999875
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-35 Score=307.81 Aligned_cols=257 Identities=25% Similarity=0.390 Sum_probs=200.6
Q ss_pred cCccccCcccCCCCccEEEeec-cCCcEEEEEEccccCc-ccHHHHHHHHHHHHhCCCCceeeEeeEEEeC--CeEEEEE
Q 004400 416 NNFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSKSK-QGNREFINEIGMISALQHPNLVKLYGCCIEG--NQLLLIY 491 (756)
Q Consensus 416 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lV~ 491 (756)
++|+..+.||.|++|.||+|.. .+++.+|+|.+..... .....+.+|++++++++||||++++++|.+. +..++||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 80 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM 80 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence 3678889999999999999995 5688999999875422 3456789999999999999999999998654 4789999
Q ss_pred EecCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCcc
Q 004400 492 EYLENNSLARALFE---HRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEE 568 (756)
Q Consensus 492 e~~~~gsL~~~l~~---~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~ 568 (756)
||+++++|.+++.. ....+++..+..++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++.....
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~ 157 (287)
T cd06621 81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRK---IIHRDIKPSNILLTRKGQVKLCDFGVSGELVN 157 (287)
T ss_pred EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecCCeEEEeeccccccccc
Confidence 99999999988752 3456889999999999999999999986 99999999999999999999999999875433
Q ss_pred cCcceeeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHhCCCCCCccch--hhHHHHHHHHHhcCccccccccCC
Q 004400 569 ENTHISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDM--FYLLDWALVLKEQGKLMELVDTNP 646 (756)
Q Consensus 569 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~ 646 (756)
... ....++..|+|||.+.+..++.++||||+||++|+|++|+.||..... ....+....... .......+ .+
T Consensus 158 ~~~---~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~-~~ 232 (287)
T cd06621 158 SLA---GTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVN-MPNPELKD-EP 232 (287)
T ss_pred ccc---ccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhc-CCchhhcc-CC
Confidence 221 234578899999999988999999999999999999999999965421 111111111111 11111111 11
Q ss_pred CCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004400 647 GSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRM 682 (756)
Q Consensus 647 ~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~ 682 (756)
.. .......+.+++.+||+.+|++|||+.|+++.
T Consensus 233 ~~--~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~ 266 (287)
T cd06621 233 GN--GIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEH 266 (287)
T ss_pred CC--CCchHHHHHHHHHHHcCCCcccCCCHHHHHhC
Confidence 10 01123458899999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=307.99 Aligned_cols=254 Identities=28% Similarity=0.381 Sum_probs=201.2
Q ss_pred HhhcCccccCcccCCCCccEEEeec-cCCcEEEEEEccccCcccHHHHHHHHHHHHhC-CCCceeeEeeEEEeCC-----
Q 004400 413 AATNNFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSKSKQGNREFINEIGMISAL-QHPNLVKLYGCCIEGN----- 485 (756)
Q Consensus 413 ~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~----- 485 (756)
.++++|+..+.||+|++|.||+|.. .+++.+++|.+..... ....+.+|+.+++++ +|+||+++++++.+..
T Consensus 3 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (275)
T cd06608 3 DPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGND 81 (275)
T ss_pred CchhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcc
Confidence 4578999999999999999999995 4678999999865433 346789999999999 7999999999997644
Q ss_pred -eEEEEEEecCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCC
Q 004400 486 -QLLLIYEYLENNSLARALFEH---RLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFG 561 (756)
Q Consensus 486 -~~~lV~e~~~~gsL~~~l~~~---~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFG 561 (756)
..++||||+++++|.+++... ...+++..+..++.|++.||+|||+.+ ++||||+|+||++++++.+||+|||
T Consensus 82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~~l~p~ni~~~~~~~~~l~d~~ 158 (275)
T cd06608 82 DQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENK---VIHRDIKGQNILLTKNAEVKLVDFG 158 (275)
T ss_pred eEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEEccCCeEEECCCc
Confidence 489999999999999988642 357899999999999999999999986 9999999999999999999999999
Q ss_pred ccccCcccCcceeeccccCccCCchHhhhc-----CCCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhcC
Q 004400 562 LAKLDEEENTHISTRVAGTIGYMAPEYAMR-----GHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQG 636 (756)
Q Consensus 562 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~ 636 (756)
++........ ......|+..|+|||++.. ..++.++|||||||++|+|++|+.||.......... .... .
T Consensus 159 ~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~---~~~~-~ 233 (275)
T cd06608 159 VSAQLDSTLG-RRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALF---KIPR-N 233 (275)
T ss_pred cceecccchh-hhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHH---Hhhc-c
Confidence 9875443222 1233568999999998753 347789999999999999999999996543221111 0000 0
Q ss_pred ccccccccCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004400 637 KLMELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRM 682 (756)
Q Consensus 637 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~ 682 (756)
.... ...+......+.+++.+||..||++|||+.++++.
T Consensus 234 ~~~~-------~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~ 272 (275)
T cd06608 234 PPPT-------LKSPENWSKKFNDFISECLIKNYEQRPFMEELLEH 272 (275)
T ss_pred CCCC-------CCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 0000 11112234458899999999999999999999863
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=312.55 Aligned_cols=248 Identities=30% Similarity=0.458 Sum_probs=199.9
Q ss_pred hcCccccCcccCCCCccEEEeec-cCCcEEEEEEccccCc---ccHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEE
Q 004400 415 TNNFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSKSK---QGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLI 490 (756)
Q Consensus 415 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 490 (756)
...|...+.||+|+||.||+|.. .+++.||+|.+..... ...+++.+|+++++.++||||++++++|.+++..++|
T Consensus 14 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv 93 (307)
T cd06607 14 EKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLV 93 (307)
T ss_pred chhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEE
Confidence 35688889999999999999985 4789999998864322 2335688999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCcccC
Q 004400 491 YEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEEN 570 (756)
Q Consensus 491 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~~~ 570 (756)
|||+. |++.+.+......+++..+..++.|++.||.|||+.+ |+||||+|+||++++++.+||+|||++......
T Consensus 94 ~e~~~-g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~---i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~- 168 (307)
T cd06607 94 MEYCL-GSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHE---RIHRDIKAGNILLTEPGTVKLADFGSASLVSPA- 168 (307)
T ss_pred HHhhC-CCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEECCCCCEEEeecCcceecCCC-
Confidence 99997 5777777655567999999999999999999999986 999999999999999999999999998754432
Q ss_pred cceeeccccCccCCchHhhh---cCCCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhcCccccccccCCC
Q 004400 571 THISTRVAGTIGYMAPEYAM---RGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPG 647 (756)
Q Consensus 571 ~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 647 (756)
....|+..|+|||++. .+.++.++||||||+++|||++|+.||...+....... .. .....
T Consensus 169 ----~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~---~~-~~~~~-------- 232 (307)
T cd06607 169 ----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYH---IA-QNDSP-------- 232 (307)
T ss_pred ----CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHH---Hh-cCCCC--------
Confidence 2346788999999874 35688999999999999999999999966544332211 10 01100
Q ss_pred CCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHh
Q 004400 648 SNFDKEQVMVMINVALLCANASPTIRPSMSSVLRML 683 (756)
Q Consensus 648 ~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~L 683 (756)
..........+.+++.+||+.+|++||++.+|++..
T Consensus 233 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~ 268 (307)
T cd06607 233 TLSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHR 268 (307)
T ss_pred CCCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcCh
Confidence 001112334588999999999999999999998753
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=309.32 Aligned_cols=249 Identities=25% Similarity=0.328 Sum_probs=203.4
Q ss_pred hhcCccccCcccCCCCccEEEee-ccCCcEEEEEEcccc---CcccHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEE
Q 004400 414 ATNNFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSK---SKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLL 489 (756)
Q Consensus 414 ~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 489 (756)
..+.|..-++||+||||.||-++ ..+|+.||.|.+.++ ...+......|-++|.+++.++||.+-.+|+.++.+++
T Consensus 183 t~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LCl 262 (591)
T KOG0986|consen 183 TKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCL 262 (591)
T ss_pred cccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEE
Confidence 34678889999999999999998 557999999998664 34455677889999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCcc
Q 004400 490 IYEYLENNSLARALFEHR-LKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEE 568 (756)
Q Consensus 490 V~e~~~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~ 568 (756)
|+..|.||+|.-+|.+.+ ..+++..+..++.+|+.||++||.++ ||+||+||+|||+|+.|+++|+|.|+|..+..
T Consensus 263 VLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~---iVYRDLKPeNILLDd~GhvRISDLGLAvei~~ 339 (591)
T KOG0986|consen 263 VLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRR---IVYRDLKPENILLDDHGHVRISDLGLAVEIPE 339 (591)
T ss_pred EEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcc---eeeccCChhheeeccCCCeEeeccceEEecCC
Confidence 999999999999998554 46999999999999999999999986 99999999999999999999999999987766
Q ss_pred cCcceeeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhcCccccccccCCCC
Q 004400 569 ENTHISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGS 648 (756)
Q Consensus 569 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 648 (756)
..... ..+||.+|||||++.+..|+...|.||+||++|||+.|+.||....... .|. ++...+.. ...
T Consensus 340 g~~~~--~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKv--k~e-------Evdrr~~~-~~~ 407 (591)
T KOG0986|consen 340 GKPIR--GRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKV--KRE-------EVDRRTLE-DPE 407 (591)
T ss_pred CCccc--cccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhh--hHH-------HHHHHHhc-chh
Confidence 54442 2379999999999999999999999999999999999999995432211 110 00000000 112
Q ss_pred CCCHHHHHHHHHHHHHhhcCCCCCCCCHH
Q 004400 649 NFDKEQVMVMINVALLCANASPTIRPSMS 677 (756)
Q Consensus 649 ~~~~~~~~~l~~l~~~c~~~~P~~RPt~~ 677 (756)
.++.....+...+....++.||++|---.
T Consensus 408 ey~~kFS~eakslc~~LL~Kdp~~RLGcr 436 (591)
T KOG0986|consen 408 EYSDKFSEEAKSLCEGLLTKDPEKRLGCR 436 (591)
T ss_pred hcccccCHHHHHHHHHHHccCHHHhccCC
Confidence 23334444578888899999999997433
|
|
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=310.62 Aligned_cols=261 Identities=23% Similarity=0.322 Sum_probs=200.6
Q ss_pred cCccccCcccCCCCccEEEeecc-CCcEEEEEEccccCc--ccHHHHHHHHHHHHhCCCCceeeEeeEEEeC--CeEEEE
Q 004400 416 NNFATDNNIGEGGFGPVYKGLLA-DGTAIAVKQLSSKSK--QGNREFINEIGMISALQHPNLVKLYGCCIEG--NQLLLI 490 (756)
Q Consensus 416 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lV 490 (756)
++|+..+.||+|+||.||+|... +++.+|+|.++.... .....+.+|+.++++++||||+++++++..+ ...++|
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv 84 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV 84 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence 47888899999999999999954 688999999865422 2234567899999999999999999999887 899999
Q ss_pred EEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCcccC
Q 004400 491 YEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEEN 570 (756)
Q Consensus 491 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~~~ 570 (756)
|||+++ +|.+++......+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||+++......
T Consensus 85 ~e~~~~-~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~ 160 (293)
T cd07843 85 MEYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYGSPL 160 (293)
T ss_pred ehhcCc-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCcEEEeecCceeeccCCc
Confidence 999985 999988766667999999999999999999999987 9999999999999999999999999998655432
Q ss_pred cceeeccccCccCCchHhhhcC-CCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHh---------------
Q 004400 571 THISTRVAGTIGYMAPEYAMRG-HLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKE--------------- 634 (756)
Q Consensus 571 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~--------------- 634 (756)
.. .....++..|+|||.+.+. .++.++|+||+|+++|||++|+.||.................
T Consensus 161 ~~-~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (293)
T cd07843 161 KP-YTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPG 239 (293)
T ss_pred cc-cccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccch
Confidence 21 1234578899999998764 468999999999999999999999965543322211110000
Q ss_pred --cCccccccccCCCCCCCHH-HHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 004400 635 --QGKLMELVDTNPGSNFDKE-QVMVMINVALLCANASPTIRPSMSSVLR 681 (756)
Q Consensus 635 --~~~~~~~~~~~~~~~~~~~-~~~~l~~l~~~c~~~~P~~RPt~~ev~~ 681 (756)
...............++.. ....+.+++.+|++.+|++|||+.|+++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~ 289 (293)
T cd07843 240 AKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK 289 (293)
T ss_pred hcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence 0000000000111111111 2445889999999999999999999975
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=303.92 Aligned_cols=248 Identities=26% Similarity=0.410 Sum_probs=201.4
Q ss_pred CccccCcccCCCCccEEEeec-cCCcEEEEEEcccc--CcccHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEEe
Q 004400 417 NFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSK--SKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYEY 493 (756)
Q Consensus 417 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 493 (756)
+|...+.||+|+||.||+|.. .+++.+|+|.+... .......+.+|+++++.++||||+++++.+..++..++||||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 477889999999999999984 57889999998654 223456788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCC-CEEEccCCccccCcccCc
Q 004400 494 LENNSLARALFEH-RLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDL-NSKISDFGLAKLDEEENT 571 (756)
Q Consensus 494 ~~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~-~~kl~DFGla~~~~~~~~ 571 (756)
+++++|.+++... ...+++..+.+++.|++.||+|||+++ ++||||||+||++++++ .+||+|||.+........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~ 157 (256)
T cd08220 81 APGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKL---ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSK 157 (256)
T ss_pred CCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccCCCceecCCCcc
Confidence 9999999999754 345899999999999999999999986 99999999999998654 589999999986543321
Q ss_pred ceeeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhcCccccccccCCCCCCC
Q 004400 572 HISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFD 651 (756)
Q Consensus 572 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 651 (756)
.....|+..|+|||.+.+..++.++||||||+++|+|++|+.||...+........ .. ....... ..+
T Consensus 158 --~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~---~~-~~~~~~~-----~~~- 225 (256)
T cd08220 158 --AYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKI---MS-GTFAPIS-----DRY- 225 (256)
T ss_pred --ccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHH---Hh-cCCCCCC-----CCc-
Confidence 22356889999999998888999999999999999999999999665543322211 11 1111111 112
Q ss_pred HHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004400 652 KEQVMVMINVALLCANASPTIRPSMSSVLRM 682 (756)
Q Consensus 652 ~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~ 682 (756)
...+.+++.+||+.+|.+|||+.|+++.
T Consensus 226 ---~~~l~~li~~~l~~~p~~Rpt~~~ll~~ 253 (256)
T cd08220 226 ---SPDLRQLILSMLNLDPSKRPQLSQIMAQ 253 (256)
T ss_pred ---CHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 2348899999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=306.85 Aligned_cols=248 Identities=28% Similarity=0.463 Sum_probs=200.1
Q ss_pred CccccCcccCCCCccEEEeec-cCCcEEEEEEcccc-CcccHHHHHHHHHHHHhCC---CCceeeEeeEEEeCCeEEEEE
Q 004400 417 NFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSK-SKQGNREFINEIGMISALQ---HPNLVKLYGCCIEGNQLLLIY 491 (756)
Q Consensus 417 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~lV~ 491 (756)
.|+..+.||+|+||.||+|.. .+++.||+|.+... ......++.+|+.++++++ |||++++++++.++...++||
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~ 81 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM 81 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence 467778999999999999994 67899999998654 3334567889999999997 999999999999999999999
Q ss_pred EecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCcccCc
Q 004400 492 EYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENT 571 (756)
Q Consensus 492 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~~~~ 571 (756)
||+++++|.+++... .+++..+..++.|++.||+|||+.| |+||||+|+||+++.++.++|+|||++........
T Consensus 82 e~~~~~~L~~~~~~~--~l~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06917 82 EYAEGGSVRTLMKAG--PIAEKYISVIIREVLVALKYIHKVG---VIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSS 156 (277)
T ss_pred ecCCCCcHHHHHHcc--CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHHEEEcCCCCEEEccCCceeecCCCcc
Confidence 999999999988543 7899999999999999999999987 99999999999999999999999999986654332
Q ss_pred ceeeccccCccCCchHhhhcC-CCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhcCccccccccCCCCCC
Q 004400 572 HISTRVAGTIGYMAPEYAMRG-HLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNF 650 (756)
Q Consensus 572 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 650 (756)
. .....|+..|+|||.+.++ .++.++|||||||++|+|++|+.||..........+ . ....... ....
T Consensus 157 ~-~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~---~-~~~~~~~-----~~~~- 225 (277)
T cd06917 157 K-RSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMML---I-PKSKPPR-----LEDN- 225 (277)
T ss_pred c-cccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhc---c-ccCCCCC-----CCcc-
Confidence 2 2334689999999998754 478999999999999999999999965543221111 0 0010001 1110
Q ss_pred CHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004400 651 DKEQVMVMINVALLCANASPTIRPSMSSVLRM 682 (756)
Q Consensus 651 ~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~ 682 (756)
.....+.+++.+||+.+|++||++.++++.
T Consensus 226 --~~~~~~~~~i~~~l~~~p~~R~~~~~il~~ 255 (277)
T cd06917 226 --GYSKLLREFVAACLDEEPKERLSAEELLKS 255 (277)
T ss_pred --cCCHHHHHHHHHHcCCCcccCcCHHHHhhC
Confidence 123358899999999999999999999764
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-37 Score=297.74 Aligned_cols=242 Identities=26% Similarity=0.335 Sum_probs=201.5
Q ss_pred hhcCccccCcccCCCCccEEEee-ccCCcEEEEEEccccCc---ccHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEE
Q 004400 414 ATNNFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSKSK---QGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLL 489 (756)
Q Consensus 414 ~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 489 (756)
..++|+..++||+|.||+|..++ ..+++.+|+|++++..- +....-..|-++|+..+||.+..+-..|+..+.+|+
T Consensus 166 Tm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCF 245 (516)
T KOG0690|consen 166 TMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCF 245 (516)
T ss_pred ccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEE
Confidence 34688899999999999999998 66899999999987532 233445678999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCccc
Q 004400 490 IYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEE 569 (756)
Q Consensus 490 V~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~~ 569 (756)
||||..||.|.-+|... ..+++...+.+-..|..||.|||+++ ||.||+|.+|.|+|.+|++||+|||+++..- .
T Consensus 246 VMeyanGGeLf~HLsre-r~FsE~RtRFYGaEIvsAL~YLHs~~---ivYRDlKLENLlLDkDGHIKitDFGLCKE~I-~ 320 (516)
T KOG0690|consen 246 VMEYANGGELFFHLSRE-RVFSEDRTRFYGAEIVSALGYLHSRN---IVYRDLKLENLLLDKDGHIKITDFGLCKEEI-K 320 (516)
T ss_pred EEEEccCceEeeehhhh-hcccchhhhhhhHHHHHHhhhhhhCC---eeeeechhhhheeccCCceEeeecccchhcc-c
Confidence 99999999999988654 47899999999999999999999985 9999999999999999999999999998422 2
Q ss_pred CcceeeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhcCccccccccCCCCC
Q 004400 570 NTHISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSN 649 (756)
Q Consensus 570 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 649 (756)
......+++||+.|+|||++....|+.++|.|.+||++|||++|+.||+..+...++.... .+ +- .
T Consensus 321 ~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl--~e--------d~----k 386 (516)
T KOG0690|consen 321 YGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELIL--ME--------DL----K 386 (516)
T ss_pred ccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHH--hh--------hc----c
Confidence 2233567899999999999999999999999999999999999999998877655543221 11 11 1
Q ss_pred CCHHHHHHHHHHHHHhhcCCCCCCC
Q 004400 650 FDKEQVMVMINVALLCANASPTIRP 674 (756)
Q Consensus 650 ~~~~~~~~l~~l~~~c~~~~P~~RP 674 (756)
++.....+...++...+..||.+|-
T Consensus 387 FPr~ls~eAktLLsGLL~kdP~kRL 411 (516)
T KOG0690|consen 387 FPRTLSPEAKTLLSGLLKKDPKKRL 411 (516)
T ss_pred CCccCCHHHHHHHHHHhhcChHhhc
Confidence 2222223366777888999999996
|
|
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=309.86 Aligned_cols=244 Identities=27% Similarity=0.404 Sum_probs=200.0
Q ss_pred cCccccCcccCCCCccEEEeec-cCCcEEEEEEccccC---cccHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEE
Q 004400 416 NNFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSKS---KQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIY 491 (756)
Q Consensus 416 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 491 (756)
++|...+.||+|+||.||+|.. .+++.||+|.+.... ......+.+|++++++++||||+++++++.+++..++||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 3688889999999999999995 468999999986532 233466889999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCcccCc
Q 004400 492 EYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENT 571 (756)
Q Consensus 492 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~~~~ 571 (756)
||+++++|.+++... ..+++..+..++.|++.||+|||+.| |+||||+|+||+++.++.+||+|||+++.....
T Consensus 81 e~~~~~~L~~~~~~~-~~l~~~~~~~~~~qil~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~-- 154 (290)
T cd05580 81 EYVPGGELFSHLRKS-GRFPEPVARFYAAQVVLALEYLHSLD---IVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR-- 154 (290)
T ss_pred ecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEeeCCCccccCCC--
Confidence 999999999999755 47899999999999999999999986 999999999999999999999999999865443
Q ss_pred ceeeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhcCccccccccCCCCCCC
Q 004400 572 HISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFD 651 (756)
Q Consensus 572 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 651 (756)
.....|++.|+|||.+.+...+.++||||||+++|+|++|+.||...+....... .. .+.. . ++
T Consensus 155 --~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~--~~--~~~~-~---------~~ 218 (290)
T cd05580 155 --TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEK--IL--EGKV-R---------FP 218 (290)
T ss_pred --CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHH--Hh--cCCc-c---------CC
Confidence 2335689999999999888899999999999999999999999966553221111 11 1110 0 11
Q ss_pred HHHHHHHHHHHHHhhcCCCCCCC-----CHHHHHH
Q 004400 652 KEQVMVMINVALLCANASPTIRP-----SMSSVLR 681 (756)
Q Consensus 652 ~~~~~~l~~l~~~c~~~~P~~RP-----t~~ev~~ 681 (756)
......+.+++.+||..+|.+|| +++|+++
T Consensus 219 ~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~ 253 (290)
T cd05580 219 SFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKN 253 (290)
T ss_pred ccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHc
Confidence 11134588999999999999999 5666543
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-37 Score=320.03 Aligned_cols=252 Identities=24% Similarity=0.411 Sum_probs=207.1
Q ss_pred cCccccCcccCCCCccEEEeeccCCc-EEEEEEccccCcccHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEEec
Q 004400 416 NNFATDNNIGEGGFGPVYKGLLADGT-AIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYEYL 494 (756)
Q Consensus 416 ~~~~~~~~lg~G~~g~Vy~~~~~~~~-~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~ 494 (756)
+-|.++-.||-|+||.||+|..++.. ..|.|++..++....++|+-|++||+.+.||+||++++.|..++.+|+..|||
T Consensus 32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC 111 (1187)
T KOG0579|consen 32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFC 111 (1187)
T ss_pred HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeec
Confidence 45677788999999999999966544 45678888777778889999999999999999999999999999999999999
Q ss_pred CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCcccCccee
Q 004400 495 ENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHIS 574 (756)
Q Consensus 495 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~~~~~~~ 574 (756)
.||-.+..+.+-+..+.+.++..+++|++.||.|||++. |||||||+.|||++-+|.++|+|||.+...... ....
T Consensus 112 ~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~---iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t-~qkR 187 (1187)
T KOG0579|consen 112 GGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQN---IIHRDLKAGNILLTLDGDIRLADFGVSAKNKST-RQKR 187 (1187)
T ss_pred CCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcc---hhhhhccccceEEEecCcEeeecccccccchhH-Hhhh
Confidence 999999999888889999999999999999999999984 999999999999999999999999998643221 1223
Q ss_pred eccccCccCCchHhhhc-----CCCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhcCccccccccCCCCC
Q 004400 575 TRVAGTIGYMAPEYAMR-----GHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSN 649 (756)
Q Consensus 575 ~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 649 (756)
..+.||+.|||||+.+. ..|+.++||||||+.+.||..+.+|-..-+.+..+-. +. ..+.+.++-
T Consensus 188 DsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllK--ia--KSePPTLlq------ 257 (1187)
T KOG0579|consen 188 DSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLK--IA--KSEPPTLLQ------ 257 (1187)
T ss_pred ccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHH--Hh--hcCCCcccC------
Confidence 45889999999999864 5799999999999999999999999765554332210 11 111111111
Q ss_pred CCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004400 650 FDKEQVMVMINVALLCANASPTIRPSMSSVLRM 682 (756)
Q Consensus 650 ~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~ 682 (756)
+......+.+++.+|+..+|..||++.++++.
T Consensus 258 -PS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~H 289 (1187)
T KOG0579|consen 258 -PSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKH 289 (1187)
T ss_pred -cchhhhHHHHHHHHHHhcCCccCCCHHHHhhC
Confidence 22334458999999999999999999999654
|
|
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=309.81 Aligned_cols=255 Identities=28% Similarity=0.419 Sum_probs=199.9
Q ss_pred hHHHhhcCccccCcccCCCCccEEEeec-cCCcEEEEEEccccCcccHHHHHHHHHHHHhC-CCCceeeEeeEEEe----
Q 004400 410 QIKAATNNFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSKSKQGNREFINEIGMISAL-QHPNLVKLYGCCIE---- 483 (756)
Q Consensus 410 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~---- 483 (756)
++..+.+.|+..+.||+|+||.||+|.. .+++.||+|.+.... .....+..|+.+++++ +|+||+++++++..
T Consensus 10 ~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~ 88 (282)
T cd06636 10 ALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPP 88 (282)
T ss_pred hhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhccccc
Confidence 3445678899999999999999999994 578899999986542 3345688899999998 79999999999863
Q ss_pred --CCeEEEEEEecCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccC
Q 004400 484 --GNQLLLIYEYLENNSLARALFEH-RLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDF 560 (756)
Q Consensus 484 --~~~~~lV~e~~~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DF 560 (756)
....++||||+++|+|.+++... ...+++..+..++.|++.||+|||+.+ |+||||||+||++++++.++|+||
T Consensus 89 ~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dl~~~nili~~~~~~~l~df 165 (282)
T cd06636 89 GHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHK---VIHRDIKGQNVLLTENAEVKLVDF 165 (282)
T ss_pred CCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeC
Confidence 46789999999999999998753 345888899999999999999999986 999999999999999999999999
Q ss_pred CccccCcccCcceeeccccCccCCchHhhh-----cCCCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhc
Q 004400 561 GLAKLDEEENTHISTRVAGTIGYMAPEYAM-----RGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQ 635 (756)
Q Consensus 561 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~ 635 (756)
|++......... .....|+..|+|||.+. ...++.++|||||||++|||++|+.||.......... ....
T Consensus 166 g~~~~~~~~~~~-~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~---~~~~- 240 (282)
T cd06636 166 GVSAQLDRTVGR-RNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALF---LIPR- 240 (282)
T ss_pred cchhhhhccccC-CCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhh---hHhh-
Confidence 998754432211 23356899999999986 3467889999999999999999999996543221110 0000
Q ss_pred CccccccccCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 004400 636 GKLMELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLR 681 (756)
Q Consensus 636 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~ 681 (756)
. . ............+.+++.+||+.+|.+||++.|+++
T Consensus 241 ~-----~---~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~ 278 (282)
T cd06636 241 N-----P---PPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK 278 (282)
T ss_pred C-----C---CCCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence 0 0 000001112335889999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=310.07 Aligned_cols=263 Identities=23% Similarity=0.338 Sum_probs=198.1
Q ss_pred hhcCccccCcccCCCCccEEEee-ccCCcEEEEEEccccCc-ccHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEE
Q 004400 414 ATNNFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSKSK-QGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIY 491 (756)
Q Consensus 414 ~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 491 (756)
++++|...+.||+|+||.||+|. ..+++.||+|.+..... .....+.+|+++++.++|+||+++++++.+++..++||
T Consensus 3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 82 (291)
T cd07870 3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF 82 (291)
T ss_pred ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence 45789999999999999999998 45789999999865432 22346788999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCcccCc
Q 004400 492 EYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENT 571 (756)
Q Consensus 492 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~~~~ 571 (756)
||+. +++.+++......+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++.......
T Consensus 83 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~ 158 (291)
T cd07870 83 EYMH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQH---ILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQ 158 (291)
T ss_pred eccc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEEcCCCcEEEeccccccccCCCCC
Confidence 9996 6777777655556888999999999999999999986 99999999999999999999999999975433222
Q ss_pred ceeeccccCccCCchHhhhcC-CCCcccchhhHHHHHHHHHhCCCCCCccchh-hHHHHHHHHHh-------------cC
Q 004400 572 HISTRVAGTIGYMAPEYAMRG-HLTEKADVYSFGIVALEIVSGRSNVTKEDMF-YLLDWALVLKE-------------QG 636 (756)
Q Consensus 572 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slGv~l~elltg~~p~~~~~~~-~~~~~~~~~~~-------------~~ 636 (756)
. .....++..|+|||.+.+. .++.++|||||||++|||++|+.||...... ........... ..
T Consensus 159 ~-~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (291)
T cd07870 159 T-YSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPN 237 (291)
T ss_pred C-CCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhccc
Confidence 1 1234578899999998754 5788999999999999999999999644321 11110000000 00
Q ss_pred ccccccccCCCCCCC-----HHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 004400 637 KLMELVDTNPGSNFD-----KEQVMVMINVALLCANASPTIRPSMSSVLR 681 (756)
Q Consensus 637 ~~~~~~~~~~~~~~~-----~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~ 681 (756)
............... ......+.+++.+|++.||++|||+.|++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~ 287 (291)
T cd07870 238 YKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL 287 (291)
T ss_pred ccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence 000000000000000 001235788999999999999999999865
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=306.40 Aligned_cols=247 Identities=29% Similarity=0.460 Sum_probs=200.6
Q ss_pred CccccCcccCCCCccEEEeec-cCCcEEEEEEccccC-cccHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEEec
Q 004400 417 NFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSKS-KQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYEYL 494 (756)
Q Consensus 417 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~ 494 (756)
-|...+.||+|+||.||+|.. .++..||+|.+.... ......+.+|+.++++++||||+++++++.+++..++||||+
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYL 84 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeC
Confidence 356778999999999999984 578899999876432 233467889999999999999999999999999999999999
Q ss_pred CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCcccCccee
Q 004400 495 ENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHIS 574 (756)
Q Consensus 495 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~~~~~~~ 574 (756)
++++|.+++.. ..+++..+..++.|++.|++|||+.+ ++|+||||+||+++.++.++|+|||++......... .
T Consensus 85 ~~~~l~~~i~~--~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~~-~ 158 (277)
T cd06641 85 GGGSALDLLEP--GPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIK-R 158 (277)
T ss_pred CCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHccCC---eecCCCCHHhEEECCCCCEEEeecccceecccchhh-h
Confidence 99999998854 36899999999999999999999986 999999999999999999999999998765432221 2
Q ss_pred eccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhcCccccccccCCCCCCCHHH
Q 004400 575 TRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDKEQ 654 (756)
Q Consensus 575 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 654 (756)
....|+..|+|||.+.+..++.++|||||||++|+|++|..||........... . ...... ......
T Consensus 159 ~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~---~-~~~~~~---------~~~~~~ 225 (277)
T cd06641 159 NTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFL---I-PKNNPP---------TLEGNY 225 (277)
T ss_pred ccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHH---H-hcCCCC---------CCCccc
Confidence 234688899999999888899999999999999999999999965443222111 1 111110 111122
Q ss_pred HHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004400 655 VMVMINVALLCANASPTIRPSMSSVLRM 682 (756)
Q Consensus 655 ~~~l~~l~~~c~~~~P~~RPt~~ev~~~ 682 (756)
...+.+++.+||+.+|.+||++.++++.
T Consensus 226 ~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 226 SKPLKEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 3448899999999999999999999984
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-35 Score=299.64 Aligned_cols=250 Identities=30% Similarity=0.485 Sum_probs=206.5
Q ss_pred CccccCcccCCCCccEEEeecc-CCcEEEEEEccccCcccHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEEecC
Q 004400 417 NFATDNNIGEGGFGPVYKGLLA-DGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYEYLE 495 (756)
Q Consensus 417 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~ 495 (756)
+|...+.||+|++|.||+|... +++.+++|++..........+.+|++++++++|+|++++++++..+...++++||++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~ 80 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS 80 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence 4677889999999999999964 789999999977654456789999999999999999999999999999999999999
Q ss_pred CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCcccCcceee
Q 004400 496 NNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHIST 575 (756)
Q Consensus 496 ~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~ 575 (756)
+++|.+++......+++..+..++.|++.||+|||+.+ ++||||+|+||++++++.++|+|||.+........ ..
T Consensus 81 ~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~--~~ 155 (253)
T cd05122 81 GGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNG---IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA--RN 155 (253)
T ss_pred CCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCC---EecCCCCHHHEEEccCCeEEEeecccccccccccc--cc
Confidence 99999999766568999999999999999999999986 99999999999999999999999999986654332 23
Q ss_pred ccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhcCccccccccCCCCCCCHHHH
Q 004400 576 RVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDKEQV 655 (756)
Q Consensus 576 ~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 655 (756)
...|+..|+|||.+....++.++||||||+++|+|++|+.||...+........ .. ........ .....
T Consensus 156 ~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~---~~-~~~~~~~~-------~~~~~ 224 (253)
T cd05122 156 TMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKI---AT-NGPPGLRN-------PEKWS 224 (253)
T ss_pred ceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHH---Hh-cCCCCcCc-------ccccC
Confidence 456889999999998888999999999999999999999999665432222111 11 11111111 11113
Q ss_pred HHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004400 656 MVMINVALLCANASPTIRPSMSSVLRM 682 (756)
Q Consensus 656 ~~l~~l~~~c~~~~P~~RPt~~ev~~~ 682 (756)
..+.+++.+||+.+|++|||+.++++.
T Consensus 225 ~~~~~~i~~~l~~~p~~R~t~~~~l~~ 251 (253)
T cd05122 225 DEFKDFLKKCLQKNPEKRPTAEQLLKH 251 (253)
T ss_pred HHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 458899999999999999999998763
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=309.65 Aligned_cols=250 Identities=26% Similarity=0.428 Sum_probs=193.0
Q ss_pred cCccccCcccCCCCccEEEeec-cCCcEEEEEEccccC-cccHHHHHHHHHH-HHhCCCCceeeEeeEEEeCCeEEEEEE
Q 004400 416 NNFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSKS-KQGNREFINEIGM-ISALQHPNLVKLYGCCIEGNQLLLIYE 492 (756)
Q Consensus 416 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~-l~~l~h~niv~l~~~~~~~~~~~lV~e 492 (756)
++|+..+.||+|+||.||+|+. .+|+.||+|++.... ......+..|+.. ++..+||||+++++++..++..++|||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e 80 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME 80 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence 4688889999999999999995 479999999987542 2233456667665 666789999999999999999999999
Q ss_pred ecCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCccc
Q 004400 493 YLENNSLARALFE---HRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEE 569 (756)
Q Consensus 493 ~~~~gsL~~~l~~---~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~~ 569 (756)
|++ |+|.+++.. ....+++..+..++.|++.||+|||++. +++||||||+||+++.++.+||+|||+++.....
T Consensus 81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~ 157 (283)
T cd06617 81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKL--SVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDS 157 (283)
T ss_pred hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCEEEeecccccccccc
Confidence 997 688877753 3346899999999999999999999862 3999999999999999999999999999865432
Q ss_pred CcceeeccccCccCCchHhhhc----CCCCcccchhhHHHHHHHHHhCCCCCCccc-hhhHHHHHHHHHhcCcccccccc
Q 004400 570 NTHISTRVAGTIGYMAPEYAMR----GHLTEKADVYSFGIVALEIVSGRSNVTKED-MFYLLDWALVLKEQGKLMELVDT 644 (756)
Q Consensus 570 ~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~Dv~slGv~l~elltg~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 644 (756)
.. .....|+..|+|||.+.+ ..++.++|+|||||++|||++|+.||.... ....... ... ......
T Consensus 158 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~---~~~-~~~~~~--- 228 (283)
T cd06617 158 VA--KTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQ---VVE-EPSPQL--- 228 (283)
T ss_pred cc--cccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHH---HHh-cCCCCC---
Confidence 21 223468899999998864 456889999999999999999999985322 1111110 001 111111
Q ss_pred CCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004400 645 NPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRM 682 (756)
Q Consensus 645 ~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~ 682 (756)
+...+ ...+.+++.+||..+|.+||++.++++.
T Consensus 229 -~~~~~----~~~l~~li~~~l~~~p~~Rp~~~~il~~ 261 (283)
T cd06617 229 -PAEKF----SPEFQDFVNKCLKKNYKERPNYPELLQH 261 (283)
T ss_pred -Ccccc----CHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 11112 2348899999999999999999999763
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-35 Score=310.62 Aligned_cols=249 Identities=28% Similarity=0.438 Sum_probs=199.9
Q ss_pred CccccCcccCCCCccEEEeec-cCCcEEEEEEccccCc---ccHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEE
Q 004400 417 NFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSKSK---QGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYE 492 (756)
Q Consensus 417 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 492 (756)
.|...+.||+|+||.||+|.. .++..||+|.+..... .....+.+|++++++++|||++++++++.++...++|||
T Consensus 26 ~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 105 (317)
T cd06635 26 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVME 105 (317)
T ss_pred hhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEe
Confidence 377788999999999999994 5789999999864322 233568889999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCcccCcc
Q 004400 493 YLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTH 572 (756)
Q Consensus 493 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~~~~~ 572 (756)
|+.+ +|.+.+......+++..+..++.|++.||.|||+.+ |+||||+|+||+++.++.+||+|||++......
T Consensus 106 ~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~---i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~--- 178 (317)
T cd06635 106 YCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASIASPA--- 178 (317)
T ss_pred CCCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcccEEECCCCCEEEecCCCccccCCc---
Confidence 9974 788887766667999999999999999999999986 999999999999999999999999998754332
Q ss_pred eeeccccCccCCchHhhh---cCCCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhcCccccccccCCCCC
Q 004400 573 ISTRVAGTIGYMAPEYAM---RGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSN 649 (756)
Q Consensus 573 ~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 649 (756)
....|++.|+|||++. .+.++.++|||||||++|||++|+.||...+....... ..... ... ..
T Consensus 179 --~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~---~~~~~-~~~----~~--- 245 (317)
T cd06635 179 --NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYH---IAQNE-SPT----LQ--- 245 (317)
T ss_pred --ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHH---HHhcc-CCC----CC---
Confidence 2346888999999984 35688999999999999999999999865543222111 11111 000 00
Q ss_pred CCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhccC
Q 004400 650 FDKEQVMVMINVALLCANASPTIRPSMSSVLRMLECG 686 (756)
Q Consensus 650 ~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~L~~~ 686 (756)
.......+.+++.+||+.+|.+||++.++++.+...
T Consensus 246 -~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~ 281 (317)
T cd06635 246 -SNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVL 281 (317)
T ss_pred -CccccHHHHHHHHHHccCCcccCcCHHHHHhChhhh
Confidence 111233488999999999999999999999876544
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=306.95 Aligned_cols=258 Identities=22% Similarity=0.271 Sum_probs=198.0
Q ss_pred ccccCcccCCCCccEEEee-ccCCcEEEEEEccccCc-ccHHHHHHHHHHHHhCC-CCceeeEeeEEEeC--CeEEEEEE
Q 004400 418 FATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSKSK-QGNREFINEIGMISALQ-HPNLVKLYGCCIEG--NQLLLIYE 492 (756)
Q Consensus 418 ~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~--~~~~lV~e 492 (756)
|+..+.||+|+||.||+|. ..+++.||+|.++.... .......+|+.+++++. |+|++++++++.++ +..++|||
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 5567899999999999998 45789999999876422 22234567999999885 99999999999987 89999999
Q ss_pred ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCcccCcc
Q 004400 493 YLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTH 572 (756)
Q Consensus 493 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~~~~~ 572 (756)
|++ |+|.+.+......+++..+..++.|++.||+|||+.+ ++||||||+||+++. +.+||+|||+++........
T Consensus 81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~~ 155 (282)
T cd07831 81 LMD-MNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNG---IFHRDIKPENILIKD-DILKLADFGSCRGIYSKPPY 155 (282)
T ss_pred cCC-ccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEcC-CCeEEEecccccccccCCCc
Confidence 997 5888888765567999999999999999999999986 999999999999999 99999999999865433221
Q ss_pred eeeccccCccCCchHhhhc-CCCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhcCc-----------ccc
Q 004400 573 ISTRVAGTIGYMAPEYAMR-GHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGK-----------LME 640 (756)
Q Consensus 573 ~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~-----------~~~ 640 (756)
....++..|+|||.+.. ..++.++|||||||++|||++|+.||...+......+......... ...
T Consensus 156 --~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (282)
T cd07831 156 --TEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMN 233 (282)
T ss_pred --CCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhccccccc
Confidence 23457889999997654 5578899999999999999999999977665544433322111000 000
Q ss_pred ccccC-CCC---CCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004400 641 LVDTN-PGS---NFDKEQVMVMINVALLCANASPTIRPSMSSVLRM 682 (756)
Q Consensus 641 ~~~~~-~~~---~~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~ 682 (756)
...+. ... .........+.+++.+|++.+|++||++.++++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 279 (282)
T cd07831 234 YNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRH 279 (282)
T ss_pred ccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhC
Confidence 00000 000 0011234568999999999999999999999763
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-35 Score=309.88 Aligned_cols=266 Identities=23% Similarity=0.313 Sum_probs=202.4
Q ss_pred HhhcCccccCcccCCCCccEEEeec-cCCcEEEEEEccccC--cccHHHHHHHHHHHHhCCCCceeeEeeEEEeCC----
Q 004400 413 AATNNFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSKS--KQGNREFINEIGMISALQHPNLVKLYGCCIEGN---- 485 (756)
Q Consensus 413 ~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~---- 485 (756)
.+.++|+..+.||+|+||.||+|.. .+++.||+|.++... ......+.+|++++++++||||+++++++.+..
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~ 83 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD 83 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence 4567899999999999999999995 468899999986542 223356788999999999999999999987655
Q ss_pred ------eEEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEcc
Q 004400 486 ------QLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISD 559 (756)
Q Consensus 486 ------~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~D 559 (756)
..++|+||+++ ++.+.+......+++..+..++.|++.||+|||+.+ |+||||||+||++++++.+||+|
T Consensus 84 ~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~kl~d 159 (302)
T cd07864 84 FKKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKN---FLHRDIKCSNILLNNKGQIKLAD 159 (302)
T ss_pred ccccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCcEEeCc
Confidence 78999999986 677777655557999999999999999999999986 99999999999999999999999
Q ss_pred CCccccCcccCcceeeccccCccCCchHhhhc-CCCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhcCcc
Q 004400 560 FGLAKLDEEENTHISTRVAGTIGYMAPEYAMR-GHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKL 638 (756)
Q Consensus 560 FGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 638 (756)
||++...............++..|+|||.+.+ ..++.++|||||||++|||++|+.||...+.................
T Consensus 160 fg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (302)
T cd07864 160 FGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCP 239 (302)
T ss_pred ccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCh
Confidence 99998655433222233456788999998865 35788999999999999999999999765544333222221111000
Q ss_pred ---ccccc--------cCCC--C---CCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004400 639 ---MELVD--------TNPG--S---NFDKEQVMVMINVALLCANASPTIRPSMSSVLRM 682 (756)
Q Consensus 639 ---~~~~~--------~~~~--~---~~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~ 682 (756)
..+.. .... . ......+..+.+++.+||+.+|.+||++.++++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 299 (302)
T cd07864 240 AVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNS 299 (302)
T ss_pred hhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 00000 0000 0 0000123458899999999999999999998753
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-35 Score=301.48 Aligned_cols=252 Identities=26% Similarity=0.436 Sum_probs=205.4
Q ss_pred cCccccCcccCCCCccEEEeecc-CCcEEEEEEccccCc-ccHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEEe
Q 004400 416 NNFATDNNIGEGGFGPVYKGLLA-DGTAIAVKQLSSKSK-QGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYEY 493 (756)
Q Consensus 416 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 493 (756)
++|+..+.||+|++|.||+|... +++.|++|++..... .....+.+|+.++.+++|+||+++++++..++..++||||
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY 80 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence 36788899999999999999955 599999999876543 3457799999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHc-CCCCCeEcCCCCCCceEecCCCCEEEccCCccccCcccCcc
Q 004400 494 LENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHG-ESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTH 572 (756)
Q Consensus 494 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~-~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~~~~~ 572 (756)
+++++|.+++... ..+++..+..++.|+++|++|||+ .+ ++||||+|+||+++.++.++|+|||.+.........
T Consensus 81 ~~~~~L~~~l~~~-~~l~~~~~~~~~~~l~~~l~~lh~~~~---~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~ 156 (264)
T cd06623 81 MDGGSLADLLKKV-GKIPEPVLAYIARQILKGLDYLHTKRH---IIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQ 156 (264)
T ss_pred cCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhccCC---CccCCCCHHHEEECCCCCEEEccCccceecccCCCc
Confidence 9999999999755 578999999999999999999999 86 999999999999999999999999999865443322
Q ss_pred eeeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhcCccccccccCCCCCCCH
Q 004400 573 ISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDK 652 (756)
Q Consensus 573 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 652 (756)
.....++..|+|||.+.+..++.++||||||+++|+|++|+.||...+.....+....... ... ...+.
T Consensus 157 -~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~-~~~---------~~~~~ 225 (264)
T cd06623 157 -CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICD-GPP---------PSLPA 225 (264)
T ss_pred -ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhc-CCC---------CCCCc
Confidence 1234678899999999988899999999999999999999999965532111111111111 000 01111
Q ss_pred H-HHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004400 653 E-QVMVMINVALLCANASPTIRPSMSSVLRM 682 (756)
Q Consensus 653 ~-~~~~l~~l~~~c~~~~P~~RPt~~ev~~~ 682 (756)
. ....+.+++.+|++.+|++||++.++++.
T Consensus 226 ~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 226 EEFSPEFRDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred ccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 1 23458899999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=308.92 Aligned_cols=261 Identities=24% Similarity=0.365 Sum_probs=201.3
Q ss_pred ccccCcccCCCCccEEEeecc-CCcEEEEEEccccC--cccHHHHHHHHHHHHhCCCCceeeEeeEEEeC--CeEEEEEE
Q 004400 418 FATDNNIGEGGFGPVYKGLLA-DGTAIAVKQLSSKS--KQGNREFINEIGMISALQHPNLVKLYGCCIEG--NQLLLIYE 492 (756)
Q Consensus 418 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lV~e 492 (756)
|+..+.||+|+||.||+|... +++.||+|.+.... ......+.+|+++++.++|+|++++++++.+. +..++|+|
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 566789999999999999954 58899999997653 33346788999999999999999999999988 89999999
Q ss_pred ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCcccCcc
Q 004400 493 YLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTH 572 (756)
Q Consensus 493 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~~~~~ 572 (756)
|+++ +|.+++......+++..+..++.|+++||+|||+.+ ++|+||||+||++++++.+||+|||++.........
T Consensus 81 ~~~~-~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~---~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~~ 156 (287)
T cd07840 81 YMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNG---ILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSA 156 (287)
T ss_pred cccc-cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEEcCCCCEEEccccceeeccCCCcc
Confidence 9985 898888765568999999999999999999999986 999999999999999999999999999866544322
Q ss_pred eeeccccCccCCchHhhhc-CCCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhcCc---cccccc-----
Q 004400 573 ISTRVAGTIGYMAPEYAMR-GHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGK---LMELVD----- 643 (756)
Q Consensus 573 ~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~----- 643 (756)
......++..|+|||.+.+ ..++.++||||||+++|||++|+.||...+................ .....+
T Consensus 157 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (287)
T cd07840 157 DYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWFE 236 (287)
T ss_pred cccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccchhhh
Confidence 2233457889999998765 4578999999999999999999999976654333222211111000 000000
Q ss_pred -cCCCCC--------CCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004400 644 -TNPGSN--------FDKEQVMVMINVALLCANASPTIRPSMSSVLRM 682 (756)
Q Consensus 644 -~~~~~~--------~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~ 682 (756)
...... +.......+.+++.+||+.+|++||++.++++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 284 (287)
T cd07840 237 NLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQH 284 (287)
T ss_pred hccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 000000 000014468899999999999999999998763
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-35 Score=315.06 Aligned_cols=259 Identities=22% Similarity=0.306 Sum_probs=198.0
Q ss_pred hcCccccCcccCCCCccEEEee-ccCCcEEEEEEcccc--CcccHHHHHHHHHHHHhCCCCceeeEeeEEEeC------C
Q 004400 415 TNNFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSK--SKQGNREFINEIGMISALQHPNLVKLYGCCIEG------N 485 (756)
Q Consensus 415 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~ 485 (756)
.++|+..+.||+|+||.||+|. ..+++.||+|.+... .......+.+|+.++++++||||++++++|... .
T Consensus 15 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 94 (353)
T cd07850 15 LKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQ 94 (353)
T ss_pred hcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccC
Confidence 4689999999999999999999 457899999998643 223345677899999999999999999998644 3
Q ss_pred eEEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCcccc
Q 004400 486 QLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKL 565 (756)
Q Consensus 486 ~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~ 565 (756)
..++||||+.+ +|.+.+... +++..+..++.|++.||+|||+.| |+||||||+||+++.++.+||+|||+++.
T Consensus 95 ~~~lv~e~~~~-~l~~~~~~~---l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~ 167 (353)
T cd07850 95 DVYLVMELMDA-NLCQVIQMD---LDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLART 167 (353)
T ss_pred cEEEEEeccCC-CHHHHHhhc---CCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCcccee
Confidence 57999999965 888877532 889999999999999999999986 99999999999999999999999999986
Q ss_pred CcccCcceeeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHH------------
Q 004400 566 DEEENTHISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLK------------ 633 (756)
Q Consensus 566 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~------------ 633 (756)
...... .....|+..|+|||.+.+..++.++|||||||++|+|++|+.||...+............
T Consensus 168 ~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (353)
T cd07850 168 AGTSFM--MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQ 245 (353)
T ss_pred CCCCCC--CCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhh
Confidence 543221 233467899999999999999999999999999999999999997654332211110000
Q ss_pred --------hcCc-----cccccccC----CCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004400 634 --------EQGK-----LMELVDTN----PGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRM 682 (756)
Q Consensus 634 --------~~~~-----~~~~~~~~----~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~ 682 (756)
.... ..+..... ............+.+++.+|++.||++||++.|+++.
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~ 311 (353)
T cd07850 246 PTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQH 311 (353)
T ss_pred hhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 0000 00000000 0000011234457899999999999999999999864
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=308.68 Aligned_cols=260 Identities=25% Similarity=0.345 Sum_probs=197.5
Q ss_pred CccccCcccCCCCccEEEeec-cCCcEEEEEEccccC--cccHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEEe
Q 004400 417 NFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSKS--KQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYEY 493 (756)
Q Consensus 417 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 493 (756)
+|+..+.||+|++|.||+|+. .+++.||||.+.... ......+.+|++++++++||||+++++++.+++..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 478889999999999999985 578999999986542 22335788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCcccCcc
Q 004400 494 LENNSLARALFEH-RLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTH 572 (756)
Q Consensus 494 ~~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~~~~~ 572 (756)
+. ++|.+++... ...+++..+..++.|++.||+|||+.+ ++||||+|+||+++.++.+||+|||+++........
T Consensus 81 ~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~---i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~~ 156 (284)
T cd07860 81 LH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT 156 (284)
T ss_pred cc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEeeccchhhcccCccc
Confidence 96 5898888643 356899999999999999999999986 999999999999999999999999998765432221
Q ss_pred eeeccccCccCCchHhhhcCC-CCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhcC---------------
Q 004400 573 ISTRVAGTIGYMAPEYAMRGH-LTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQG--------------- 636 (756)
Q Consensus 573 ~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~--------------- 636 (756)
.....++..|+|||.+.+.. ++.++||||||+++|||+||+.||...+...............
T Consensus 157 -~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (284)
T cd07860 157 -YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYK 235 (284)
T ss_pred -cccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHHH
Confidence 22335788999999886644 6889999999999999999999996654332211110000000
Q ss_pred -ccccccccCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004400 637 -KLMELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRM 682 (756)
Q Consensus 637 -~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~ 682 (756)
.......... ....+.....+.+++.+|++.||++||++.++++.
T Consensus 236 ~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 281 (284)
T cd07860 236 PSFPKWARQDF-SKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAH 281 (284)
T ss_pred hhcccccccCH-HHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcC
Confidence 0000000000 00001122347789999999999999999998753
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-35 Score=302.29 Aligned_cols=249 Identities=23% Similarity=0.420 Sum_probs=200.4
Q ss_pred CccccCcccCCCCccEEEeec-cCCcEEEEEEccccC--cccHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEEe
Q 004400 417 NFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSKS--KQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYEY 493 (756)
Q Consensus 417 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 493 (756)
+|...+.||+|+||.||+|.. .+|..||+|.+.... ....+.+.+|+++++.++|+||+++++++.++...++|+||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 467788999999999999995 468899999986531 23345788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCC-EEEccCCccccCcccCc
Q 004400 494 LENNSLARALFEH-RLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLN-SKISDFGLAKLDEEENT 571 (756)
Q Consensus 494 ~~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~-~kl~DFGla~~~~~~~~ 571 (756)
+++++|.+++... ...+++..+..++.|++.||+|||+.+ ++|+||||+||++++++. +||+|||.+........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~ 157 (257)
T cd08225 81 CDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRK---ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSME 157 (257)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEcCCCCeEEecccccchhccCCcc
Confidence 9999999999753 335899999999999999999999986 999999999999998854 69999999986543322
Q ss_pred ceeeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhcCccccccccCCCCCCC
Q 004400 572 HISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFD 651 (756)
Q Consensus 572 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 651 (756)
......|++.|+|||+..+..++.++||||||+++||+++|+.||...+.... ...... ...... .
T Consensus 158 -~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~---~~~~~~-~~~~~~---------~ 223 (257)
T cd08225 158 -LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQL---VLKICQ-GYFAPI---------S 223 (257)
T ss_pred -cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHH---HHHHhc-ccCCCC---------C
Confidence 22234689999999999888899999999999999999999999965443221 111111 111111 1
Q ss_pred HHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004400 652 KEQVMVMINVALLCANASPTIRPSMSSVLRM 682 (756)
Q Consensus 652 ~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~ 682 (756)
+.....+.+++.+||+.+|++||++.++++.
T Consensus 224 ~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~ 254 (257)
T cd08225 224 PNFSRDLRSLISQLFKVSPRDRPSITSILKR 254 (257)
T ss_pred CCCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 1122348899999999999999999999764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-36 Score=316.95 Aligned_cols=245 Identities=25% Similarity=0.440 Sum_probs=194.7
Q ss_pred cccCcccCCCCccEEEeec-cCCcEEEEEEccc----cCcccHHHHHHHHHHHHhCCCCceeeEeeEEEeCCe--EEEEE
Q 004400 419 ATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSS----KSKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQ--LLLIY 491 (756)
Q Consensus 419 ~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~----~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~--~~lV~ 491 (756)
....+||+|+|-+||+|.. .+|..||=-.++. .+....++|..|+.+|+.|+|||||++|+++.+... +-+|+
T Consensus 43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iT 122 (632)
T KOG0584|consen 43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFIT 122 (632)
T ss_pred ehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeee
Confidence 4457899999999999995 4577776432221 133445789999999999999999999999987655 88999
Q ss_pred EecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCC-CCEEEccCCccccCcccC
Q 004400 492 EYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKD-LNSKISDFGLAKLDEEEN 570 (756)
Q Consensus 492 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~-~~~kl~DFGla~~~~~~~ 570 (756)
|.|..|+|..++.+.+ .++......|++||++||.|||++ .|||||||||-+||+|+.+ |.|||+|.|+|+......
T Consensus 123 EL~TSGtLr~Y~kk~~-~vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s~ 200 (632)
T KOG0584|consen 123 ELFTSGTLREYRKKHR-RVNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKSH 200 (632)
T ss_pred ecccCCcHHHHHHHhc-cCCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhHHHHhhccc
Confidence 9999999999997664 789999999999999999999998 6899999999999999865 789999999998765432
Q ss_pred cceeeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHhCCCCCCcc-chhhHHHHHHHHHhcCccccccccCCCCC
Q 004400 571 THISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKE-DMFYLLDWALVLKEQGKLMELVDTNPGSN 649 (756)
Q Consensus 571 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 649 (756)
...+.|||.|||||+.. ..|++.+||||||+.++||+|+..||..- +...+... ...+..+..+.+-
T Consensus 201 ---aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKK----V~SGiKP~sl~kV---- 268 (632)
T KOG0584|consen 201 ---AKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKK----VTSGIKPAALSKV---- 268 (632)
T ss_pred ---cceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHH----HHcCCCHHHhhcc----
Confidence 23378999999999887 68999999999999999999999999433 22222221 1122222222111
Q ss_pred CCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004400 650 FDKEQVMVMINVALLCANASPTIRPSMSSVLRM 682 (756)
Q Consensus 650 ~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~ 682 (756)
....+.++|.+|+.. .++|||+.|+++.
T Consensus 269 ----~dPevr~fIekCl~~-~~~R~sa~eLL~d 296 (632)
T KOG0584|consen 269 ----KDPEVREFIEKCLAT-KSERLSAKELLKD 296 (632)
T ss_pred ----CCHHHHHHHHHHhcC-chhccCHHHHhhC
Confidence 112488999999998 9999999999753
|
|
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-35 Score=307.84 Aligned_cols=253 Identities=27% Similarity=0.438 Sum_probs=193.4
Q ss_pred CccccCcccCCCCccEEEee-ccCCcEEEEEEccccC-cccHHHHHHHHHHHHhCC-CCceeeEeeEEEeCCeEEEEEEe
Q 004400 417 NFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSKS-KQGNREFINEIGMISALQ-HPNLVKLYGCCIEGNQLLLIYEY 493 (756)
Q Consensus 417 ~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lV~e~ 493 (756)
+|...+.||+|+||.||++. ..+++.||+|.+.... ......+.+|+.++.++. |+||+++++++..++..+++|||
T Consensus 5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~ 84 (288)
T cd06616 5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMEL 84 (288)
T ss_pred HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEec
Confidence 55667899999999999999 4568999999987542 234457889999999996 99999999999999999999999
Q ss_pred cCCCCHHHHH---Hh-cCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCccc
Q 004400 494 LENNSLARAL---FE-HRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEE 569 (756)
Q Consensus 494 ~~~gsL~~~l---~~-~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~~ 569 (756)
+.. ++.++. .. ....+++..+.+++.|++.||+|||+.. +|+||||||+||+++.++.+||+|||+++.....
T Consensus 85 ~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~ 161 (288)
T cd06616 85 MDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEEL--KIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDS 161 (288)
T ss_pred ccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcC--CeeccCCCHHHEEEccCCcEEEeecchhHHhccC
Confidence 875 554433 22 2357899999999999999999999752 4999999999999999999999999999754332
Q ss_pred CcceeeccccCccCCchHhhhcC---CCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhcCccccccccCC
Q 004400 570 NTHISTRVAGTIGYMAPEYAMRG---HLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNP 646 (756)
Q Consensus 570 ~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 646 (756)
.. .....|+..|+|||++.+. .++.++|||||||++|||++|+.||..... .......... ......
T Consensus 162 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~--~~~~~~~~~~-~~~~~~----- 231 (288)
T cd06616 162 IA--KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNS--VFDQLTQVVK-GDPPIL----- 231 (288)
T ss_pred Cc--cccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcch--HHHHHhhhcC-CCCCcC-----
Confidence 21 1234688999999999876 689999999999999999999999954431 1111110000 111111
Q ss_pred CCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004400 647 GSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRM 682 (756)
Q Consensus 647 ~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~ 682 (756)
...........+.+++.+||+.+|++||++.+|++.
T Consensus 232 ~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~ 267 (288)
T cd06616 232 SNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEH 267 (288)
T ss_pred CCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 111111233458899999999999999999999764
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-35 Score=302.88 Aligned_cols=247 Identities=26% Similarity=0.348 Sum_probs=201.3
Q ss_pred CccccCcccCCCCccEEEeecc-CCcEEEEEEccccC---cccHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEE
Q 004400 417 NFATDNNIGEGGFGPVYKGLLA-DGTAIAVKQLSSKS---KQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYE 492 (756)
Q Consensus 417 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 492 (756)
+|+..+.||+|+||.||+|... +++.||+|.+.... ....+.+.+|++++++++||||+++++++.++...++|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 4778899999999999999954 68999999987542 2345678999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCcccCcc
Q 004400 493 YLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTH 572 (756)
Q Consensus 493 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~~~~~ 572 (756)
|+.+++|.+++... ..+++..+..++.|+++||+|||+.+ ++|+||+|+||++++++.++|+|||.+.......
T Consensus 81 ~~~~~~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~-- 154 (258)
T cd05578 81 LLLGGDLRYHLSQK-VKFSEEQVKFWICEIVLALEYLHSKG---IIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT-- 154 (258)
T ss_pred CCCCCCHHHHHHhc-CCcCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEEcCCCCEEEeecccccccCCCc--
Confidence 99999999998755 57899999999999999999999986 9999999999999999999999999998654432
Q ss_pred eeeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhcCccccccccCCCCCCCH
Q 004400 573 ISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDK 652 (756)
Q Consensus 573 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 652 (756)
......|+..|+|||.+.+..++.++|+||||+++|+|++|+.||........ .+....... .. ...+.
T Consensus 155 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~-~~~~~~~~~-~~---------~~~~~ 223 (258)
T cd05578 155 LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIR-DQIRAKQET-AD---------VLYPA 223 (258)
T ss_pred cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHH-HHHHHHhcc-cc---------ccCcc
Confidence 12335688899999999888899999999999999999999999965543211 111111110 11 11112
Q ss_pred HHHHHHHHHHHHhhcCCCCCCCCH--HHHH
Q 004400 653 EQVMVMINVALLCANASPTIRPSM--SSVL 680 (756)
Q Consensus 653 ~~~~~l~~l~~~c~~~~P~~RPt~--~ev~ 680 (756)
.....+.+++.+||+.+|.+||++ +|++
T Consensus 224 ~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~ 253 (258)
T cd05578 224 TWSTEAIDAINKLLERDPQKRLGDNLKDLK 253 (258)
T ss_pred cCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence 223458899999999999999999 6654
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=307.63 Aligned_cols=263 Identities=25% Similarity=0.363 Sum_probs=200.4
Q ss_pred hcCccccCcccCCCCccEEEeec-cCCcEEEEEEccccCc--ccHHHHHHHHHHHHhCCCCceeeEeeEEEeC--CeEEE
Q 004400 415 TNNFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSKSK--QGNREFINEIGMISALQHPNLVKLYGCCIEG--NQLLL 489 (756)
Q Consensus 415 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~l 489 (756)
.++|+..+.||+|+||.||+|.. .+|+.||+|.+..... .....+.+|+.++++++|+||+++++++.+. +..++
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL 85 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence 46789999999999999999995 5689999999864422 2233567899999999999999999998765 56899
Q ss_pred EEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCccc
Q 004400 490 IYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEE 569 (756)
Q Consensus 490 V~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~~ 569 (756)
||||+.+ +|.+++......+++..+..++.|++.||+|||+.| ++||||||+||+++.++.+||+|||++......
T Consensus 86 v~e~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~ 161 (309)
T cd07845 86 VMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLP 161 (309)
T ss_pred EEecCCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccceeeecCCc
Confidence 9999975 888888766667999999999999999999999997 999999999999999999999999999865433
Q ss_pred CcceeeccccCccCCchHhhhc-CCCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhcCc--cc-------
Q 004400 570 NTHISTRVAGTIGYMAPEYAMR-GHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGK--LM------- 639 (756)
Q Consensus 570 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~--~~------- 639 (756)
... .....++..|+|||.+.+ ..++.++||||+||++|||++|+.||...+................ ..
T Consensus 162 ~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (309)
T cd07845 162 AKP-MTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLP 240 (309)
T ss_pred cCC-CCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhccc
Confidence 211 122345788999999875 4588999999999999999999999976655443322221111000 00
Q ss_pred --cc--cccCCCCCCC---HHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004400 640 --EL--VDTNPGSNFD---KEQVMVMINVALLCANASPTIRPSMSSVLRM 682 (756)
Q Consensus 640 --~~--~~~~~~~~~~---~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~ 682 (756)
.. .......... ......+.+++.+|++.||++|||+.|+++.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h 290 (309)
T cd07845 241 LVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALES 290 (309)
T ss_pred ccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 00 0000000000 0123457789999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-35 Score=313.32 Aligned_cols=268 Identities=24% Similarity=0.351 Sum_probs=201.3
Q ss_pred hcCccccCcccCCCCccEEEee-ccCCcEEEEEEccccC-cccHHHHHHHHHHHHhCCCCceeeEeeEEEeCC-----eE
Q 004400 415 TNNFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSKS-KQGNREFINEIGMISALQHPNLVKLYGCCIEGN-----QL 487 (756)
Q Consensus 415 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~ 487 (756)
+++|...+.||+|+||.||+|. ..+|+.||+|.+.... ......+.+|+.++++++||||+++++++.... ..
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 83 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV 83 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence 4689999999999999999998 4578999999986432 223456888999999999999999999876543 57
Q ss_pred EEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCc
Q 004400 488 LLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDE 567 (756)
Q Consensus 488 ~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~ 567 (756)
++|+||+.+ +|.+.+.. ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++...
T Consensus 84 ~lv~e~~~~-~l~~~~~~--~~l~~~~~~~i~~ql~~aL~~LH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~ 157 (336)
T cd07849 84 YIVQELMET-DLYKLIKT--QHLSNDHIQYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLARIAD 157 (336)
T ss_pred EEEehhccc-CHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEECcccceeecc
Confidence 999999975 78777643 36899999999999999999999996 9999999999999999999999999997654
Q ss_pred ccCcc--eeeccccCccCCchHhhhc-CCCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhcCcc---cc-
Q 004400 568 EENTH--ISTRVAGTIGYMAPEYAMR-GHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKL---ME- 640 (756)
Q Consensus 568 ~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~---~~- 640 (756)
..... ......||..|+|||.+.+ ..++.++||||+||++|+|++|+.||...+......+.......... ..
T Consensus 158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (336)
T cd07849 158 PEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCI 237 (336)
T ss_pred ccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHh
Confidence 32221 1223568999999998765 46899999999999999999999999665443322221111110000 00
Q ss_pred -------c---cccCCCCCC---CHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH--hccCcc
Q 004400 641 -------L---VDTNPGSNF---DKEQVMVMINVALLCANASPTIRPSMSSVLRM--LECGVD 688 (756)
Q Consensus 641 -------~---~~~~~~~~~---~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~--L~~~~~ 688 (756)
. ......... .+.....+.+++.+||+.+|++||++.|+++. ++.+.+
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~~ 300 (336)
T cd07849 238 ISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYHD 300 (336)
T ss_pred hchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccCC
Confidence 0 000000000 01123458899999999999999999999876 555433
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=299.73 Aligned_cols=242 Identities=23% Similarity=0.322 Sum_probs=194.8
Q ss_pred ccCCCCccEEEeec-cCCcEEEEEEccccC---cccHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEEecCCCCH
Q 004400 424 IGEGGFGPVYKGLL-ADGTAIAVKQLSSKS---KQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYEYLENNSL 499 (756)
Q Consensus 424 lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL 499 (756)
||+|+||.||+|+. .+++.||+|.+.... ....+.+.+|+++++.++||||+++++++.++...++|+||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 69999999999995 458999999986532 23346789999999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCcccCcceeecccc
Q 004400 500 ARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAG 579 (756)
Q Consensus 500 ~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~~g 579 (756)
.+++... ..+++..+..++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||+++...... ......|
T Consensus 81 ~~~l~~~-~~l~~~~~~~~~~~i~~~l~~lH~~~---~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~--~~~~~~~ 154 (262)
T cd05572 81 WTILRDR-GLFDEYTARFYIACVVLAFEYLHNRG---IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ--KTWTFCG 154 (262)
T ss_pred HHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEEcCCCCEEEeeCCcccccCccc--ccccccC
Confidence 9999754 36899999999999999999999986 9999999999999999999999999998665432 1223468
Q ss_pred CccCCchHhhhcCCCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhcCccccccccCCCCCCCHHHHHHHH
Q 004400 580 TIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDKEQVMVMI 659 (756)
Q Consensus 580 t~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 659 (756)
+..|+|||.+....++.++|+||+|+++|+|++|+.||...... .............. ..++......+.
T Consensus 155 ~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-~~~~~~~~~~~~~~---------~~~~~~~~~~~~ 224 (262)
T cd05572 155 TPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDED-PMEIYNDILKGNGK---------LEFPNYIDKAAK 224 (262)
T ss_pred CcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCC-HHHHHHHHhccCCC---------CCCCcccCHHHH
Confidence 89999999998888999999999999999999999999655421 11111111110111 111111234589
Q ss_pred HHHHHhhcCCCCCCCC-----HHHHHH
Q 004400 660 NVALLCANASPTIRPS-----MSSVLR 681 (756)
Q Consensus 660 ~l~~~c~~~~P~~RPt-----~~ev~~ 681 (756)
+++.+||+.+|++||+ +.|+++
T Consensus 225 ~~i~~~l~~~p~~R~~~~~~~~~~l~~ 251 (262)
T cd05572 225 DLIKQLLRRNPEERLGNLKGGIKDIKK 251 (262)
T ss_pred HHHHHHccCChhhCcCCcccCHHHHhc
Confidence 9999999999999999 666655
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=305.18 Aligned_cols=262 Identities=23% Similarity=0.275 Sum_probs=195.7
Q ss_pred cCccccCcccCCCCccEEEeec-cCCcEEEEEEccccCc--ccHHHHHHHHHHHHhCC-CCceeeEeeEEEeCCe-----
Q 004400 416 NNFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSKSK--QGNREFINEIGMISALQ-HPNLVKLYGCCIEGNQ----- 486 (756)
Q Consensus 416 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~----- 486 (756)
++|+..+.||+|+||.||+|.. .+++.||+|.+..... .....+.+|+.++++++ ||||+++++++...+.
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 4688899999999999999994 5789999998765422 23457888999999995 6999999999987665
Q ss_pred EEEEEEecCCCCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecC-CCCEEEccCC
Q 004400 487 LLLIYEYLENNSLARALFEH----RLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDK-DLNSKISDFG 561 (756)
Q Consensus 487 ~~lV~e~~~~gsL~~~l~~~----~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~-~~~~kl~DFG 561 (756)
.++||||+++ +|.+++... ...+++..+..++.||+.||+|||+.+ |+||||||+||+++. ++.+||+|||
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~~~nil~~~~~~~~kl~dfg 156 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLG 156 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEecCCCeEEEeecc
Confidence 8999999986 788888643 235899999999999999999999986 999999999999998 8899999999
Q ss_pred ccccCcccCcceeeccccCccCCchHhhhc-CCCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhcCccc-
Q 004400 562 LAKLDEEENTHISTRVAGTIGYMAPEYAMR-GHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLM- 639 (756)
Q Consensus 562 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~- 639 (756)
+++........ .....+++.|+|||++.+ ..++.++||||||+++|+|++|..||...+..................
T Consensus 157 ~~~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (295)
T cd07837 157 LGRAFSIPVKS-YTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQV 235 (295)
T ss_pred cceecCCCccc-cCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhh
Confidence 99754332111 122356889999998865 457999999999999999999999997654432211110000000000
Q ss_pred --cc---cc---cCCC-----CCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004400 640 --EL---VD---TNPG-----SNFDKEQVMVMINVALLCANASPTIRPSMSSVLRM 682 (756)
Q Consensus 640 --~~---~~---~~~~-----~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~ 682 (756)
.. .+ .... ....+.....+.+++.+|++.+|.+||++.|++..
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~ 291 (295)
T cd07837 236 WPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTH 291 (295)
T ss_pred CcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 00 00 0000 00001123458899999999999999999998753
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-35 Score=305.81 Aligned_cols=260 Identities=25% Similarity=0.364 Sum_probs=196.8
Q ss_pred ccccCcccCCCCccEEEeec-cCCcEEEEEEccccC--cccHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEEec
Q 004400 418 FATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSKS--KQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYEYL 494 (756)
Q Consensus 418 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~ 494 (756)
|+..+.||+|++|.||+|.. .+|+.||+|++.... ......+.+|+++++.++|||++++++++.+++..++||||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 56678999999999999984 579999999986542 223357889999999999999999999999999999999999
Q ss_pred CCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCcccCcce
Q 004400 495 ENNSLARALFEHR-LKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHI 573 (756)
Q Consensus 495 ~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~~~~~~ 573 (756)
+ ++|.+++.... ..+++..+..++.|+++||+|||+.+ ++||||+|+||+++.++.++|+|||+++........
T Consensus 81 ~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~---~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~- 155 (283)
T cd07835 81 D-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHR---VLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRT- 155 (283)
T ss_pred C-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCcEEEeecccccccCCCccc-
Confidence 5 68999886543 46899999999999999999999986 999999999999999999999999999765432221
Q ss_pred eeccccCccCCchHhhhcC-CCCcccchhhHHHHHHHHHhCCCCCCccchhhH-HHHHHHHHhcC--------ccccc--
Q 004400 574 STRVAGTIGYMAPEYAMRG-HLTEKADVYSFGIVALEIVSGRSNVTKEDMFYL-LDWALVLKEQG--------KLMEL-- 641 (756)
Q Consensus 574 ~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~-~~~~~~~~~~~--------~~~~~-- 641 (756)
.....++..|+|||++.+. .++.++||||||+++|+|++|+.||...+.... ........... ...+.
T Consensus 156 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (283)
T cd07835 156 YTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYKP 235 (283)
T ss_pred cCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhhhh
Confidence 1223568899999987654 578999999999999999999999965543221 11100000000 00000
Q ss_pred -ccc---CCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004400 642 -VDT---NPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRM 682 (756)
Q Consensus 642 -~~~---~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~ 682 (756)
... .......+.....+.+++.+|++.+|++||++.|+++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 280 (283)
T cd07835 236 TFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQH 280 (283)
T ss_pred hcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 000 00000011122358899999999999999999999753
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=303.17 Aligned_cols=260 Identities=26% Similarity=0.389 Sum_probs=199.0
Q ss_pred CccccCcccCCCCccEEEeec-cCCcEEEEEEccccCc-ccHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEEec
Q 004400 417 NFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSKSK-QGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYEYL 494 (756)
Q Consensus 417 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~ 494 (756)
+|+..+.||+|++|.||+|+. .+|+.||||.+..... .....+.+|++++++++||||+++++++.+.+..++||||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM 80 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence 477889999999999999995 4689999999875432 23466788999999999999999999999999999999999
Q ss_pred CCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCcccCcc
Q 004400 495 ENNSLARALFEHR--LKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTH 572 (756)
Q Consensus 495 ~~gsL~~~l~~~~--~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~~~~~ 572 (756)
++ +|.+++.... ..+++..+.+++.|++.||+|||+.+ ++||||||+||++++++.++|+|||+++........
T Consensus 81 ~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~~ 156 (284)
T cd07836 81 DK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENR---VLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNT 156 (284)
T ss_pred Cc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCcEEEeecchhhhhcCCccc
Confidence 85 8888886443 46899999999999999999999986 999999999999999999999999999754432221
Q ss_pred eeeccccCccCCchHhhhcC-CCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhcC---------cccccc
Q 004400 573 ISTRVAGTIGYMAPEYAMRG-HLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQG---------KLMELV 642 (756)
Q Consensus 573 ~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~---------~~~~~~ 642 (756)
.....++..|++||.+.+. .++.++|||||||++|++++|+.||...+............... ......
T Consensus 157 -~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (284)
T cd07836 157 -FSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYK 235 (284)
T ss_pred -cccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchhc
Confidence 1234578899999998664 57889999999999999999999996554332222111100000 000000
Q ss_pred ccCCC------CCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 004400 643 DTNPG------SNFDKEQVMVMINVALLCANASPTIRPSMSSVLR 681 (756)
Q Consensus 643 ~~~~~------~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~ 681 (756)
...+. ....+.....+.+++.+|++.+|.+||++.++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 280 (284)
T cd07836 236 PTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ 280 (284)
T ss_pred ccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 00000 0001122345789999999999999999999875
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=301.51 Aligned_cols=240 Identities=25% Similarity=0.315 Sum_probs=189.6
Q ss_pred ccCCCCccEEEee-ccCCcEEEEEEccccC---cccHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEEecCCCCH
Q 004400 424 IGEGGFGPVYKGL-LADGTAIAVKQLSSKS---KQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYEYLENNSL 499 (756)
Q Consensus 424 lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL 499 (756)
||+|+||+||+|. ..+|+.||+|.+.... ......+..|+++++.++||||+++++++...+..|+||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 6999999999998 4578999999986532 22345677899999999999999999999999999999999999999
Q ss_pred HHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCcccCcceeeccc
Q 004400 500 ARALFEHR-LKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVA 578 (756)
Q Consensus 500 ~~~l~~~~-~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~~ 578 (756)
.+++.... ..+++..+..++.|++.||.|||+.+ ++||||+|+||++++++.+||+|||.+....... ......
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~--~~~~~~ 155 (277)
T cd05577 81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRR---IVYRDLKPENVLLDDHGNVRISDLGLAVELKGGK--KIKGRA 155 (277)
T ss_pred HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEccCcchhhhccCC--cccccc
Confidence 99997543 36899999999999999999999987 9999999999999999999999999987654321 122345
Q ss_pred cCccCCchHhhhcCCCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhcCccccccccCCCCCCCHHHHHHH
Q 004400 579 GTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDKEQVMVM 658 (756)
Q Consensus 579 gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 658 (756)
++..|+|||++.+..++.++|||||||++|+|++|+.||............ .. ... .. . ...+......+
T Consensus 156 ~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~---~~-~~~-~~-~----~~~~~~~~~~~ 225 (277)
T cd05577 156 GTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEEL---KR-RTL-EM-A----VEYPDKFSPEA 225 (277)
T ss_pred CCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHH---Hh-ccc-cc-c----ccCCccCCHHH
Confidence 788999999998888999999999999999999999999654331111100 00 000 00 0 01111123348
Q ss_pred HHHHHHhhcCCCCCCCCHHH
Q 004400 659 INVALLCANASPTIRPSMSS 678 (756)
Q Consensus 659 ~~l~~~c~~~~P~~RPt~~e 678 (756)
.+++.+||+.+|++||++.+
T Consensus 226 ~~li~~~l~~~p~~R~~~~~ 245 (277)
T cd05577 226 KDLCEALLQKDPEKRLGCRG 245 (277)
T ss_pred HHHHHHHccCChhHccCCCc
Confidence 89999999999999994444
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=302.96 Aligned_cols=242 Identities=26% Similarity=0.299 Sum_probs=186.3
Q ss_pred cccCCCCccEEEeec-cCCcEEEEEEccccCc---ccHHHHHHHHHHHHh---CCCCceeeEeeEEEeCCeEEEEEEecC
Q 004400 423 NIGEGGFGPVYKGLL-ADGTAIAVKQLSSKSK---QGNREFINEIGMISA---LQHPNLVKLYGCCIEGNQLLLIYEYLE 495 (756)
Q Consensus 423 ~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~---l~h~niv~l~~~~~~~~~~~lV~e~~~ 495 (756)
.||+|+||.||+|.. .+++.||+|.+..... .....+.+|..+++. .+||||+.+++++..++..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 489999999999995 5689999998865321 122334555544443 479999999999999999999999999
Q ss_pred CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCcccCcceee
Q 004400 496 NNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHIST 575 (756)
Q Consensus 496 ~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~ 575 (756)
+|+|.+++.... .+++..+..++.|++.||+|||+.+ |+||||||+||++++++.++|+|||++........ .
T Consensus 81 ~~~L~~~i~~~~-~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~~---~ 153 (279)
T cd05633 81 GGDLHYHLSQHG-VFSEKEMRFYATEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP---H 153 (279)
T ss_pred CCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCC---cCCCCCCHHHEEECCCCCEEEccCCcceeccccCc---c
Confidence 999999886543 6999999999999999999999987 99999999999999999999999999875433221 2
Q ss_pred ccccCccCCchHhhhc-CCCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhcCccccccccCCCCCCCHHH
Q 004400 576 RVAGTIGYMAPEYAMR-GHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDKEQ 654 (756)
Q Consensus 576 ~~~gt~~y~aPE~~~~-~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 654 (756)
...|+..|+|||.+.+ ..++.++||||+||++|||++|+.||............. ... .... ..+...
T Consensus 154 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~-~~~------~~~~----~~~~~~ 222 (279)
T cd05633 154 ASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDR-MTL------TVNV----ELPDSF 222 (279)
T ss_pred CcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHH-Hhh------cCCc----CCcccc
Confidence 3468999999999874 458999999999999999999999995432211111100 000 0011 112222
Q ss_pred HHHHHHHHHHhhcCCCCCCC-----CHHHHHHH
Q 004400 655 VMVMINVALLCANASPTIRP-----SMSSVLRM 682 (756)
Q Consensus 655 ~~~l~~l~~~c~~~~P~~RP-----t~~ev~~~ 682 (756)
...+.+++.+|++.||.+|| +++|+++.
T Consensus 223 ~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h 255 (279)
T cd05633 223 SPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH 255 (279)
T ss_pred CHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence 34588999999999999999 58888664
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=296.02 Aligned_cols=251 Identities=30% Similarity=0.457 Sum_probs=205.0
Q ss_pred CccccCcccCCCCccEEEeecc-CCcEEEEEEccccCc--ccHHHHHHHHHHHHhCCCCceeeEeeEEEeC--CeEEEEE
Q 004400 417 NFATDNNIGEGGFGPVYKGLLA-DGTAIAVKQLSSKSK--QGNREFINEIGMISALQHPNLVKLYGCCIEG--NQLLLIY 491 (756)
Q Consensus 417 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lV~ 491 (756)
+|...+.||+|++|.||+|... +++.|++|.+..... ...+.+.+|++++++++||||+++++.+.+. ...++|+
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 4677789999999999999955 789999999876532 3457889999999999999999999999988 8999999
Q ss_pred EecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCcccCc
Q 004400 492 EYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENT 571 (756)
Q Consensus 492 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~~~~ 571 (756)
||+++++|.+++.... .+++..+..++.|+++||+|||+.+ ++|+||+|+||+++.++.++|+|||.+........
T Consensus 81 e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh~~~---~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 156 (260)
T cd06606 81 EYVSGGSLSSLLKKFG-KLPEPVIRKYTRQILEGLAYLHSNG---IVHRDIKGANILVDSDGVVKLADFGCAKRLGDIET 156 (260)
T ss_pred EecCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEcccccEEecccccc
Confidence 9999999999997654 8999999999999999999999986 99999999999999999999999999986654432
Q ss_pred c-eeeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhcCccccccccCCCCCC
Q 004400 572 H-ISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNF 650 (756)
Q Consensus 572 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 650 (756)
. ......++..|+|||.......+.++||||||+++|+|++|+.||...+......+. ........ ..
T Consensus 157 ~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~--~~~~~~~~---------~~ 225 (260)
T cd06606 157 GEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYK--IGSSGEPP---------EI 225 (260)
T ss_pred cccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHh--ccccCCCc---------CC
Confidence 1 123356889999999998888999999999999999999999999665421111111 00001111 11
Q ss_pred CHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004400 651 DKEQVMVMINVALLCANASPTIRPSMSSVLRM 682 (756)
Q Consensus 651 ~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~ 682 (756)
+......+.+++.+|++.+|++||++.++++.
T Consensus 226 ~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~ 257 (260)
T cd06606 226 PEHLSEEAKDFLRKCLRRDPKKRPTADELLQH 257 (260)
T ss_pred CcccCHHHHHHHHHhCcCChhhCCCHHHHhhC
Confidence 22223458999999999999999999999863
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=303.53 Aligned_cols=244 Identities=26% Similarity=0.432 Sum_probs=197.7
Q ss_pred CcccCCCCccEEEeec-cCCcEEEEEEccccCcccHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEEecCCCCHH
Q 004400 422 NNIGEGGFGPVYKGLL-ADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYEYLENNSLA 500 (756)
Q Consensus 422 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL~ 500 (756)
..||+|+||.||+|.. .++..||||.+..........+.+|+.+++.++|+||+++++++..++..++||||+++++|.
T Consensus 26 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 105 (292)
T cd06657 26 IKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALT 105 (292)
T ss_pred HHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcHH
Confidence 5799999999999985 578999999986554445567899999999999999999999999999999999999999999
Q ss_pred HHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCcccCcceeeccccC
Q 004400 501 RALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGT 580 (756)
Q Consensus 501 ~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~~gt 580 (756)
+++.. ..+++..+..++.|++.||+|||+.| ++||||+|+||++++++.++|+|||++........ ......|+
T Consensus 106 ~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~g---ivH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~ 179 (292)
T cd06657 106 DIVTH--TRMNEEQIAAVCLAVLKALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP-RRKSLVGT 179 (292)
T ss_pred HHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEcccccceecccccc-cccccccC
Confidence 98753 35899999999999999999999986 99999999999999999999999999875443221 12335688
Q ss_pred ccCCchHhhhcCCCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhcCccccccccCCCCCCCHHHHHHHHH
Q 004400 581 IGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDKEQVMVMIN 660 (756)
Q Consensus 581 ~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 660 (756)
..|+|||.+.+..++.++||||+|+++|||++|+.||............. . . ...... .. .. ....+.+
T Consensus 180 ~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~---~-~-~~~~~~-~~-~~----~~~~l~~ 248 (292)
T cd06657 180 PYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIR---D-N-LPPKLK-NL-HK----VSPSLKG 248 (292)
T ss_pred ccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH---h-h-CCcccC-Cc-cc----CCHHHHH
Confidence 99999999988889999999999999999999999997654433222111 1 0 000000 00 11 1234788
Q ss_pred HHHHhhcCCCCCCCCHHHHHHH
Q 004400 661 VALLCANASPTIRPSMSSVLRM 682 (756)
Q Consensus 661 l~~~c~~~~P~~RPt~~ev~~~ 682 (756)
++.+||+.+|.+||++.++++.
T Consensus 249 li~~~l~~~P~~R~~~~~ll~~ 270 (292)
T cd06657 249 FLDRLLVRDPAQRATAAELLKH 270 (292)
T ss_pred HHHHHHhCCcccCcCHHHHhcC
Confidence 9999999999999999998873
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=283.43 Aligned_cols=253 Identities=25% Similarity=0.414 Sum_probs=200.6
Q ss_pred hhcCccccCcccCCCCccEEEeec-cCCcEEEEEEcccc-CcccHHHHHHHHHHHHhC-CCCceeeEeeEEEeCCeEEEE
Q 004400 414 ATNNFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSK-SKQGNREFINEIGMISAL-QHPNLVKLYGCCIEGNQLLLI 490 (756)
Q Consensus 414 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV 490 (756)
..++.+....||.|.-|.|++++. .+|..+|||.+.+. .++..+++...+.++.+- .+|.||+.+|||..+...++.
T Consensus 90 dindl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~Ic 169 (391)
T KOG0983|consen 90 DINDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFIC 169 (391)
T ss_pred ChHHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHH
Confidence 345556677899999999999994 56899999999765 444556777788876665 489999999999999999999
Q ss_pred EEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCcccC
Q 004400 491 YEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEEN 570 (756)
Q Consensus 491 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~~~ 570 (756)
||.|.. -++.++..-...+++..+-++...+.+||.||.+++ .|||||+||+|||+|+.|.+|+||||++-..-+..
T Consensus 170 MelMs~-C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSk 246 (391)
T KOG0983|consen 170 MELMST-CAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSK 246 (391)
T ss_pred HHHHHH-HHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeecccccceeeccc
Confidence 999854 466667666678999999999999999999998875 69999999999999999999999999997655443
Q ss_pred cceeeccccCccCCchHhhhc---CCCCcccchhhHHHHHHHHHhCCCCCCccc-hhhHHHHHHHHHhcCccccccccCC
Q 004400 571 THISTRVAGTIGYMAPEYAMR---GHLTEKADVYSFGIVALEIVSGRSNVTKED-MFYLLDWALVLKEQGKLMELVDTNP 646 (756)
Q Consensus 571 ~~~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~slGv~l~elltg~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 646 (756)
.+ +..+|-+.|||||.+.- ..|+.++||||||+.++|+.||+.||.+.+ .++.+..+ .. .+ ...++..
T Consensus 247 Ah--trsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkv---ln-~e-PP~L~~~- 318 (391)
T KOG0983|consen 247 AH--TRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKV---LN-EE-PPLLPGH- 318 (391)
T ss_pred cc--ccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHH---Hh-cC-CCCCCcc-
Confidence 33 45678999999999864 468999999999999999999999997643 33333221 11 11 1122111
Q ss_pred CCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004400 647 GSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRM 682 (756)
Q Consensus 647 ~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~ 682 (756)
..|++ .+.+++..|+..|+.+||...++++.
T Consensus 319 -~gFSp----~F~~fv~~CL~kd~r~RP~Y~~Ll~h 349 (391)
T KOG0983|consen 319 -MGFSP----DFQSFVKDCLTKDHRKRPKYNKLLEH 349 (391)
T ss_pred -cCcCH----HHHHHHHHHhhcCcccCcchHHHhcC
Confidence 12444 48999999999999999999998764
|
|
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=295.27 Aligned_cols=249 Identities=24% Similarity=0.423 Sum_probs=205.4
Q ss_pred CccccCcccCCCCccEEEeec-cCCcEEEEEEccccCc--ccHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEEe
Q 004400 417 NFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSKSK--QGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYEY 493 (756)
Q Consensus 417 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 493 (756)
+|...+.||+|+||.||+|.. .++..||+|++..... .....+.+|+++++.++|||++++++.+..++..++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 477788999999999999995 4689999999876432 4556788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCcccC
Q 004400 494 LENNSLARALFEH---RLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEEN 570 (756)
Q Consensus 494 ~~~gsL~~~l~~~---~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~~~ 570 (756)
+++++|.+++... ...+++..+..++.+++.||+|||+.| ++|+||+|+||+++.++.++|+|||.+.......
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~---~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 157 (258)
T cd08215 81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRK---ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV 157 (258)
T ss_pred cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence 9999999999764 367999999999999999999999986 9999999999999999999999999998655443
Q ss_pred cceeeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhcCccccccccCCCCCC
Q 004400 571 THISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNF 650 (756)
Q Consensus 571 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 650 (756)
.......|++.|+|||......++.++||||+|+++|+|++|+.||...+....... .. .......
T Consensus 158 -~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~---~~-~~~~~~~--------- 223 (258)
T cd08215 158 -DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALK---IL-KGQYPPI--------- 223 (258)
T ss_pred -ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHH---Hh-cCCCCCC---------
Confidence 223345688999999999888899999999999999999999999966543322211 11 1111111
Q ss_pred CHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004400 651 DKEQVMVMINVALLCANASPTIRPSMSSVLRM 682 (756)
Q Consensus 651 ~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~ 682 (756)
+......+.+++.+||..+|++||++.++++.
T Consensus 224 ~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 255 (258)
T cd08215 224 PSQYSSELRNLVSSLLQKDPEERPSIAQILQS 255 (258)
T ss_pred CCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 11122348899999999999999999998763
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=303.77 Aligned_cols=261 Identities=25% Similarity=0.341 Sum_probs=195.6
Q ss_pred cCccccCcccCCCCccEEEeec-cCCcEEEEEEccccCc--ccHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEE
Q 004400 416 NNFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSKSK--QGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYE 492 (756)
Q Consensus 416 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 492 (756)
++|+..+.||+|++|.||+|.. .+++.||+|.+..... .....+.+|++++++++||||+++++++.++...++|||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 4688889999999999999995 4789999999865422 233578899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecC-CCCEEEccCCccccCcccC
Q 004400 493 YLENNSLARALFEH-RLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDK-DLNSKISDFGLAKLDEEEN 570 (756)
Q Consensus 493 ~~~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~-~~~~kl~DFGla~~~~~~~ 570 (756)
|++ ++|.+++... ...+++..+..++.||+.||+|||+++ ++||||+|+||+++. ++.+||+|||++.......
T Consensus 82 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~ 157 (294)
T PLN00009 82 YLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHR---VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPV 157 (294)
T ss_pred ccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCcceEEEECCCCEEEEcccccccccCCCc
Confidence 996 4787777543 334688889999999999999999986 999999999999985 5579999999997654322
Q ss_pred cceeeccccCccCCchHhhhcC-CCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhcCccccc-------c
Q 004400 571 THISTRVAGTIGYMAPEYAMRG-HLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMEL-------V 642 (756)
Q Consensus 571 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~-------~ 642 (756)
. ......+++.|+|||++.+. .++.++|||||||++|+|+||+.||...+.............. ..... .
T Consensus 158 ~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 235 (294)
T PLN00009 158 R-TFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGT-PNEETWPGVTSLP 235 (294)
T ss_pred c-ccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC-CChhhccccccch
Confidence 1 12234578899999998764 5789999999999999999999999655433221111000000 00000 0
Q ss_pred c---cCC---CC---CCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004400 643 D---TNP---GS---NFDKEQVMVMINVALLCANASPTIRPSMSSVLRM 682 (756)
Q Consensus 643 ~---~~~---~~---~~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~ 682 (756)
+ ..+ .. ...+.....+.+++.+|++.+|++||++.++++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~ 284 (294)
T PLN00009 236 DYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEH 284 (294)
T ss_pred hhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0 000 00 0011123347899999999999999999999863
|
|
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=307.33 Aligned_cols=200 Identities=28% Similarity=0.444 Sum_probs=168.1
Q ss_pred CccccCcccCCCCccEEEeecc---CCcEEEEEEccccC---cccHHHHHHHHHHHHhCCCCceeeEeeEEEeC--CeEE
Q 004400 417 NFATDNNIGEGGFGPVYKGLLA---DGTAIAVKQLSSKS---KQGNREFINEIGMISALQHPNLVKLYGCCIEG--NQLL 488 (756)
Q Consensus 417 ~~~~~~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~ 488 (756)
+|...+.||+|+||.||+|... +++.||+|.+.... ....+.+.+|+.++++++||||+++++++.+. +..+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 3677889999999999999954 57899999997632 33346778899999999999999999999988 8899
Q ss_pred EEEEecCCCCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecC----CCCEEEccC
Q 004400 489 LIYEYLENNSLARALFEH----RLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDK----DLNSKISDF 560 (756)
Q Consensus 489 lV~e~~~~gsL~~~l~~~----~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~----~~~~kl~DF 560 (756)
+||||+++ ++.+.+... ...+++..+..++.|++.||+|||+.+ |+||||||+||+++. ++.+||+||
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~h~dlkp~Nil~~~~~~~~~~~kl~Df 156 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDL 156 (316)
T ss_pred EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEEcCCCCccceEEECCC
Confidence 99999986 676666422 236889999999999999999999986 999999999999999 899999999
Q ss_pred CccccCcccCc--ceeeccccCccCCchHhhhcC-CCCcccchhhHHHHHHHHHhCCCCCCcc
Q 004400 561 GLAKLDEEENT--HISTRVAGTIGYMAPEYAMRG-HLTEKADVYSFGIVALEIVSGRSNVTKE 620 (756)
Q Consensus 561 Gla~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slGv~l~elltg~~p~~~~ 620 (756)
|+++....... .......+++.|+|||++.+. .++.++|||||||++|||++|+.||...
T Consensus 157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~ 219 (316)
T cd07842 157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGR 219 (316)
T ss_pred ccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCC
Confidence 99986543322 112335688999999988764 5889999999999999999999999544
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-34 Score=296.19 Aligned_cols=249 Identities=26% Similarity=0.358 Sum_probs=197.5
Q ss_pred cCccccCcccCCCCccEEEeec-cCCcEEEEEEcccc-----CcccHHHHHHHHHHHHhCCCCceeeEeeEEEeC--CeE
Q 004400 416 NNFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSK-----SKQGNREFINEIGMISALQHPNLVKLYGCCIEG--NQL 487 (756)
Q Consensus 416 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~ 487 (756)
.+|...+.||+|+||.||+|.. .+++.||+|.+... .......+.+|++++++++|+||+++++++.+. ...
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 4688899999999999999994 56899999987432 122345788999999999999999999998764 568
Q ss_pred EEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCc
Q 004400 488 LLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDE 567 (756)
Q Consensus 488 ~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~ 567 (756)
++|+||+++++|.+++.... .+++..+..++.|++.||+|||+.| ++||||||+||+++.++.++|+|||+++...
T Consensus 82 ~~v~e~~~~~~L~~~~~~~~-~l~~~~~~~~~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~ 157 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAYG-ALTENVTRRYTRQILQGVSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRIQ 157 (264)
T ss_pred EEEEEeCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECccccccccc
Confidence 89999999999999987543 5889999999999999999999987 9999999999999999999999999998643
Q ss_pred ccCc--ceeeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhcCccccccccC
Q 004400 568 EENT--HISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTN 645 (756)
Q Consensus 568 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 645 (756)
.... .......|+..|+|||.+.+..++.++|||||||++||+++|+.||.......... .......
T Consensus 158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~---~~~~~~~-------- 226 (264)
T cd06653 158 TICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIF---KIATQPT-------- 226 (264)
T ss_pred cccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHHHH---HHHcCCC--------
Confidence 2111 11223568999999999988889999999999999999999999996543322111 0111111
Q ss_pred CCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 004400 646 PGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLR 681 (756)
Q Consensus 646 ~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~ 681 (756)
....+......+.+++.+|++ +|..||+..+++.
T Consensus 227 -~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~ 260 (264)
T cd06653 227 -KPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLR 260 (264)
T ss_pred -CCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence 111222333458899999999 5799999998765
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=304.85 Aligned_cols=249 Identities=28% Similarity=0.436 Sum_probs=198.5
Q ss_pred hcCccccCcccCCCCccEEEeec-cCCcEEEEEEcccc---CcccHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEE
Q 004400 415 TNNFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSK---SKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLI 490 (756)
Q Consensus 415 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 490 (756)
.+.|+..+.||+|+||.||+|+. .++..||+|.+... ......++.+|+++++.++|+|++++++++..+...++|
T Consensus 14 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 93 (308)
T cd06634 14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV 93 (308)
T ss_pred HHHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEE
Confidence 34577778999999999999994 56889999988642 223345688899999999999999999999999999999
Q ss_pred EEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCcccC
Q 004400 491 YEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEEN 570 (756)
Q Consensus 491 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~~~ 570 (756)
|||+. |++.+.+......+++.++..++.|++.|+.|||+.+ ++||||||+||+++.++.+||+|||++......
T Consensus 94 ~e~~~-~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~- 168 (308)
T cd06634 94 MEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA- 168 (308)
T ss_pred EEccC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHhEEECCCCcEEECCcccceeecCc-
Confidence 99997 5888887666667899999999999999999999986 999999999999999999999999998754332
Q ss_pred cceeeccccCccCCchHhhhc---CCCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhcCccccccccCCC
Q 004400 571 THISTRVAGTIGYMAPEYAMR---GHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPG 647 (756)
Q Consensus 571 ~~~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 647 (756)
....|+..|+|||.+.+ ..++.++|||||||++|||++|+.||...+...... ... ....... .
T Consensus 169 ----~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~---~~~-~~~~~~~----~- 235 (308)
T cd06634 169 ----NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY---HIA-QNESPAL----Q- 235 (308)
T ss_pred ----ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHH---HHh-hcCCCCc----C-
Confidence 23468889999999853 467889999999999999999999986543322111 111 1111110 0
Q ss_pred CCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhc
Q 004400 648 SNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLE 684 (756)
Q Consensus 648 ~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~L~ 684 (756)
.......+.+++.+||+.+|++||++.++++...
T Consensus 236 ---~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~ 269 (308)
T cd06634 236 ---SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRF 269 (308)
T ss_pred ---cccccHHHHHHHHHHhhCCcccCCCHHHHhhCcc
Confidence 1122344889999999999999999999987744
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=305.18 Aligned_cols=264 Identities=22% Similarity=0.305 Sum_probs=197.7
Q ss_pred hcCccccCcccCCCCccEEEeec-cCCcEEEEEEccccC--cccHHHHHHHHHHHHhCCCCceeeEeeEEEeCC------
Q 004400 415 TNNFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSKS--KQGNREFINEIGMISALQHPNLVKLYGCCIEGN------ 485 (756)
Q Consensus 415 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------ 485 (756)
.++|+..+.||+|+||.||+|.. .+++.||||.+.... ......+.+|++++++++||||++++++|...+
T Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 90 (310)
T cd07865 11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRY 90 (310)
T ss_pred hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCC
Confidence 35788999999999999999994 578999999886432 222345678999999999999999999987654
Q ss_pred --eEEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCcc
Q 004400 486 --QLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLA 563 (756)
Q Consensus 486 --~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla 563 (756)
..++||||+.+ +|.+.+......+++.++..++.|++.||+|||+++ ++||||||+||+++.++.+||+|||++
T Consensus 91 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~ 166 (310)
T cd07865 91 KGSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNK---ILHRDMKAANILITKDGILKLADFGLA 166 (310)
T ss_pred CceEEEEEcCCCc-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEECCCCcEEECcCCCc
Confidence 45999999975 888888766567899999999999999999999986 999999999999999999999999999
Q ss_pred ccCcccCcc---eeeccccCccCCchHhhhcC-CCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhcCc--
Q 004400 564 KLDEEENTH---ISTRVAGTIGYMAPEYAMRG-HLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGK-- 637 (756)
Q Consensus 564 ~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~-- 637 (756)
......... ......++..|+|||.+.+. .++.++||||||+++|||++|+.||...+..............-.
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (310)
T cd07865 167 RAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPE 246 (310)
T ss_pred ccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChh
Confidence 765432211 12234578899999988664 478899999999999999999999976654333222211111000
Q ss_pred ------cccccc-----cCCCCCC-----CHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004400 638 ------LMELVD-----TNPGSNF-----DKEQVMVMINVALLCANASPTIRPSMSSVLRM 682 (756)
Q Consensus 638 ------~~~~~~-----~~~~~~~-----~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~ 682 (756)
.....+ ....... .......+.+++.+||+.+|.+||+++|+++.
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h 307 (310)
T cd07865 247 VWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNH 307 (310)
T ss_pred hcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcC
Confidence 000000 0000000 00012346789999999999999999998753
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=297.00 Aligned_cols=247 Identities=27% Similarity=0.425 Sum_probs=203.8
Q ss_pred CccccCcccCCCCccEEEee-ccCCcEEEEEEccccC--cccHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEEe
Q 004400 417 NFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSKS--KQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYEY 493 (756)
Q Consensus 417 ~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 493 (756)
+|+..+.||+|+||.||++. ..+++.+|+|.+.... ......+.+|++++++++|+||+++++++.+....++||||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 47788999999999999998 4578899999987542 23345778899999999999999999999999999999999
Q ss_pred cCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCcccC
Q 004400 494 LENNSLARALFE---HRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEEN 570 (756)
Q Consensus 494 ~~~gsL~~~l~~---~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~~~ 570 (756)
+++++|.+++.. ....+++..+..++.|++.||+|||+.| ++||||+|+||+++.++.+||+|||+++......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~---i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~~ 157 (256)
T cd08530 81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQK---ILHRDLKSANILLVANDLVKIGDLGISKVLKKNM 157 (256)
T ss_pred cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEEecCCcEEEeeccchhhhccCC
Confidence 999999999864 2356899999999999999999999987 9999999999999999999999999998765441
Q ss_pred cceeeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhcCccccccccCCCCCC
Q 004400 571 THISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNF 650 (756)
Q Consensus 571 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 650 (756)
.....|+..|+|||...+..++.++|+||+|+++||+++|+.||...+........ ...... ..
T Consensus 158 ---~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~----~~~~~~---------~~ 221 (256)
T cd08530 158 ---AKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKV----QRGKYP---------PI 221 (256)
T ss_pred ---cccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH----hcCCCC---------CC
Confidence 22345788999999999888999999999999999999999999766543322211 111111 11
Q ss_pred CHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004400 651 DKEQVMVMINVALLCANASPTIRPSMSSVLRM 682 (756)
Q Consensus 651 ~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~ 682 (756)
+......+.+++.+|++.+|.+||++.++++.
T Consensus 222 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 253 (256)
T cd08530 222 PPIYSQDLQNFIRSMLQVKPKLRPNCDKILAS 253 (256)
T ss_pred chhhCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 12334458999999999999999999999764
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=330.97 Aligned_cols=256 Identities=22% Similarity=0.284 Sum_probs=211.7
Q ss_pred hHHHhhcCccccCcccCCCCccEEEeec-cCCcEEEEEEcccc---CcccHHHHHHHHHHHHhCCCCceeeEeeEEEeCC
Q 004400 410 QIKAATNNFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSK---SKQGNREFINEIGMISALQHPNLVKLYGCCIEGN 485 (756)
Q Consensus 410 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 485 (756)
+++...++|.+.++||+|+||.|..++. .+++.||+|++.+- ......-|+.|-.+|..-+.+=||++...|+++.
T Consensus 69 ~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~ 148 (1317)
T KOG0612|consen 69 ELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDER 148 (1317)
T ss_pred HHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCcc
Confidence 4455568999999999999999999995 57899999999762 2334467899999999999999999999999999
Q ss_pred eEEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCcccc
Q 004400 486 QLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKL 565 (756)
Q Consensus 486 ~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~ 565 (756)
++|+|||||+||+|-..+.... .+++..++.++..|.-||.-+|+.| +|||||||+|||+|..|++||+|||.+-.
T Consensus 149 ~LYlVMdY~pGGDlltLlSk~~-~~pE~~ArFY~aEiVlAldslH~mg---yVHRDiKPDNvLld~~GHikLADFGsClk 224 (1317)
T KOG0612|consen 149 YLYLVMDYMPGGDLLTLLSKFD-RLPEDWARFYTAEIVLALDSLHSMG---YVHRDIKPDNVLLDKSGHIKLADFGSCLK 224 (1317)
T ss_pred ceEEEEecccCchHHHHHhhcC-CChHHHHHHHHHHHHHHHHHHHhcc---ceeccCCcceeEecccCcEeeccchhHHh
Confidence 9999999999999999997766 8999999999999999999999997 99999999999999999999999999988
Q ss_pred CcccCcceeeccccCccCCchHhhhc-----CCCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhcCcccc
Q 004400 566 DEEENTHISTRVAGTIGYMAPEYAMR-----GHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLME 640 (756)
Q Consensus 566 ~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 640 (756)
+..++...+...+|||.|++||++.. +.|++.+|.||+||++|||+.|..||+.+.......... ...+...
T Consensus 225 m~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm---~hk~~l~ 301 (1317)
T KOG0612|consen 225 MDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIM---NHKESLS 301 (1317)
T ss_pred cCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHh---chhhhcC
Confidence 88777777778899999999999963 579999999999999999999999998876554333221 1112222
Q ss_pred ccccCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCC---HHHHH
Q 004400 641 LVDTNPGSNFDKEQVMVMINVALLCANASPTIRPS---MSSVL 680 (756)
Q Consensus 641 ~~~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt---~~ev~ 680 (756)
+++. .+.+....++|++.+. +|+.|-. +.++-
T Consensus 302 FP~~-------~~VSeeakdLI~~ll~-~~e~RLgrngiedik 336 (1317)
T KOG0612|consen 302 FPDE-------TDVSEEAKDLIEALLC-DREVRLGRNGIEDIK 336 (1317)
T ss_pred CCcc-------cccCHHHHHHHHHHhc-ChhhhcccccHHHHH
Confidence 2211 1123346777777765 7888887 66664
|
|
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-34 Score=301.43 Aligned_cols=253 Identities=20% Similarity=0.246 Sum_probs=183.9
Q ss_pred hcCccccCcccCCCCccEEEeeccC----CcEEEEEEccccCcccH-----------HHHHHHHHHHHhCCCCceeeEee
Q 004400 415 TNNFATDNNIGEGGFGPVYKGLLAD----GTAIAVKQLSSKSKQGN-----------REFINEIGMISALQHPNLVKLYG 479 (756)
Q Consensus 415 ~~~~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~-----------~~~~~E~~~l~~l~h~niv~l~~ 479 (756)
.++|.+.+.||+|+||.||+|...+ +..+|+|.......... .....+...+..+.|++++++++
T Consensus 11 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~ 90 (294)
T PHA02882 11 GKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYG 90 (294)
T ss_pred CCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEE
Confidence 3578999999999999999999544 45666665432221110 11223444566778999999999
Q ss_pred EEEeCC----eEEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCE
Q 004400 480 CCIEGN----QLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNS 555 (756)
Q Consensus 480 ~~~~~~----~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~ 555 (756)
++.... ..++++|++.. ++.+.+... ...++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+
T Consensus 91 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~---iiHrDiKp~Nill~~~~~~ 165 (294)
T PHA02882 91 CGSFKRCRMYYRFILLEKLVE-NTKEIFKRI-KCKNKKLIKNIMKDMLTTLEYIHEHG---ISHGDIKPENIMVDGNNRG 165 (294)
T ss_pred eeeEecCCceEEEEEEehhcc-CHHHHHHhh-ccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCcE
Confidence 876543 45778887754 566555432 34678889999999999999999986 9999999999999999999
Q ss_pred EEccCCccccCcccCcc------eeeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHhCCCCCCccch-hhHHH-
Q 004400 556 KISDFGLAKLDEEENTH------ISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDM-FYLLD- 627 (756)
Q Consensus 556 kl~DFGla~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~-~~~~~- 627 (756)
+|+|||+|+........ ......||+.|+|||++.+..++.++|||||||++|||++|+.||..... .....
T Consensus 166 ~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~~ 245 (294)
T PHA02882 166 YIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIHA 245 (294)
T ss_pred EEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHHHH
Confidence 99999999865432211 11234699999999999999999999999999999999999999965422 11111
Q ss_pred ----HHHHHHhcCccccccccCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhc
Q 004400 628 ----WALVLKEQGKLMELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLE 684 (756)
Q Consensus 628 ----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~L~ 684 (756)
+...... ++. . .... ...+.+++..||+.+|++||++.++++.++
T Consensus 246 ~~~~~~~~~~~-~~~-~------~~~~----~~~~~~~~~~~~~~~~~~rp~~~~l~~~~~ 294 (294)
T PHA02882 246 AKCDFIKRLHE-GKI-K------IKNA----NKFIYDFIECVTKLSYEEKPDYDALIKIFD 294 (294)
T ss_pred hHHHHHHHhhh-hhh-c------cCCC----CHHHHHHHHHHHhCCCCCCCCHHHHHHhhC
Confidence 1111110 000 0 0111 234889999999999999999999998764
|
|
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=301.66 Aligned_cols=260 Identities=22% Similarity=0.322 Sum_probs=202.6
Q ss_pred ccccCcccCCCCccEEEeec-cCCcEEEEEEccccCcc--cHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEEec
Q 004400 418 FATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSKSKQ--GNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYEYL 494 (756)
Q Consensus 418 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~ 494 (756)
|+..+.||+|++|.||+|.. .+++.+++|.+...... ....+.+|++++++++|+||+++++++.+++..++|+||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 45668899999999999985 47899999998754322 3467888999999999999999999999999999999999
Q ss_pred CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCcccCccee
Q 004400 495 ENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHIS 574 (756)
Q Consensus 495 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~~~~~~~ 574 (756)
++ ++.+++......+++..+..++.|++.||+|||+.+ |+|+||||+||+++.++.+||+|||.+........ ..
T Consensus 81 ~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~-~~ 155 (283)
T cd05118 81 DT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHG---ILHRDLKPENLLINTEGVLKLADFGLARSFGSPVR-PY 155 (283)
T ss_pred CC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCC---eeecCcCHHHEEECCCCcEEEeeeeeeEecCCCcc-cc
Confidence 75 888888765568999999999999999999999986 99999999999999999999999999986654331 12
Q ss_pred eccccCccCCchHhhhcC-CCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhcC------ccc--------
Q 004400 575 TRVAGTIGYMAPEYAMRG-HLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQG------KLM-------- 639 (756)
Q Consensus 575 ~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~------~~~-------- 639 (756)
....++..|+|||.+.+. .++.++||||+|+++|+|++|+.||...+............... ...
T Consensus 156 ~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (283)
T cd05118 156 THYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKF 235 (283)
T ss_pred cCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhhhh
Confidence 234578899999999876 78999999999999999999999996655433222111110000 000
Q ss_pred cccccCCC--CCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004400 640 ELVDTNPG--SNFDKEQVMVMINVALLCANASPTIRPSMSSVLRM 682 (756)
Q Consensus 640 ~~~~~~~~--~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~ 682 (756)
........ ....+.....+.+++.+||+.||.+||++.+++..
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~ 280 (283)
T cd05118 236 SFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAH 280 (283)
T ss_pred hhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 00000000 00112234578999999999999999999999763
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=299.18 Aligned_cols=245 Identities=26% Similarity=0.377 Sum_probs=197.9
Q ss_pred ccCCCCccEEEeecc-CCcEEEEEEccccCc---ccHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEEecCCCCH
Q 004400 424 IGEGGFGPVYKGLLA-DGTAIAVKQLSSKSK---QGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYEYLENNSL 499 (756)
Q Consensus 424 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL 499 (756)
||+|+||.||+|+.. +|+.|++|.+..... ...+.+.+|++++++++||||+++++.+..+...++||||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 689999999999965 589999999865432 3456788999999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCcccCc-------c
Q 004400 500 ARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENT-------H 572 (756)
Q Consensus 500 ~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~~~~-------~ 572 (756)
.+++.... .+++..+..++.|++.||+|||+.+ ++||||+|+||++++++.++|+|||++........ .
T Consensus 81 ~~~l~~~~-~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~ 156 (265)
T cd05579 81 ASLLENVG-SLDEDVARIYIAEIVLALEYLHSNG---IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEK 156 (265)
T ss_pred HHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHcC---eecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccccc
Confidence 99997654 7899999999999999999999986 99999999999999999999999999875433211 1
Q ss_pred eeeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhcCccccccccCCCCCCCH
Q 004400 573 ISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDK 652 (756)
Q Consensus 573 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 652 (756)
......++..|+|||......++.++||||||+++|++++|+.||............ .. +.. ... ....
T Consensus 157 ~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~---~~-~~~-~~~---~~~~--- 225 (265)
T cd05579 157 EDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNI---LN-GKI-EWP---EDVE--- 225 (265)
T ss_pred cccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHH---hc-CCc-CCC---cccc---
Confidence 223356888999999998888999999999999999999999999665543322211 11 110 000 0000
Q ss_pred HHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhc
Q 004400 653 EQVMVMINVALLCANASPTIRPSMSSVLRMLE 684 (756)
Q Consensus 653 ~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~L~ 684 (756)
....+.+++.+||+.+|++||++.++.+.|+
T Consensus 226 -~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~ 256 (265)
T cd05579 226 -VSDEAIDLISKLLVPDPEKRLGAKSIEEIKN 256 (265)
T ss_pred -CCHHHHHHHHHHhcCCHhhcCCCccHHHHhc
Confidence 1345889999999999999999966666655
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-34 Score=293.80 Aligned_cols=247 Identities=30% Similarity=0.492 Sum_probs=203.1
Q ss_pred CccccCcccCCCCccEEEeec-cCCcEEEEEEccccCc--ccHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEEe
Q 004400 417 NFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSKSK--QGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYEY 493 (756)
Q Consensus 417 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 493 (756)
+|...+.||+|++|.||+|.. .+++.|++|.+..... .....+.+|++++++++|||++++++++.+++..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 467789999999999999985 4688999999976543 3456789999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCcccCcce
Q 004400 494 LENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHI 573 (756)
Q Consensus 494 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~~~~~~ 573 (756)
+++++|.+++... ..+++..+..++.|++.||.|||+.| |+||||||+||+++.++.++|+|||.+.........
T Consensus 81 ~~~~~L~~~~~~~-~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~- 155 (254)
T cd06627 81 AENGSLRQIIKKF-GPFPESLVAVYVYQVLQGLAYLHEQG---VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKD- 155 (254)
T ss_pred CCCCcHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEECCCCCEEEeccccceecCCCccc-
Confidence 9999999998755 57899999999999999999999986 999999999999999999999999999866543332
Q ss_pred eeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhcCccccccccCCCCCCCHH
Q 004400 574 STRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDKE 653 (756)
Q Consensus 574 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 653 (756)
.....|+..|+|||...+..++.++||||+|+++|+|++|+.||......... |.. . ...... .+..
T Consensus 156 ~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~-~~~--~-~~~~~~---------~~~~ 222 (254)
T cd06627 156 DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAAL-FRI--V-QDDHPP---------LPEG 222 (254)
T ss_pred ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHH-HHH--h-ccCCCC---------CCCC
Confidence 23356889999999998888899999999999999999999999654432211 111 0 111111 1111
Q ss_pred HHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 004400 654 QVMVMINVALLCANASPTIRPSMSSVLR 681 (756)
Q Consensus 654 ~~~~l~~l~~~c~~~~P~~RPt~~ev~~ 681 (756)
....+.+++.+|+..+|++||++.+++.
T Consensus 223 ~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 223 ISPELKDFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred CCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence 2335889999999999999999999875
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=341.77 Aligned_cols=254 Identities=31% Similarity=0.458 Sum_probs=206.1
Q ss_pred HHhhcCccccCcccCCCCccEEEee-ccCCcEEEEEEcccc--CcccHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEE
Q 004400 412 KAATNNFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSK--SKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLL 488 (756)
Q Consensus 412 ~~~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 488 (756)
..-+-+|.....||.|.||.||.|. ..+|...|||.++.. .....+...+|..++..++|||+|++||+=.+.+..+
T Consensus 1231 snV~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~ 1310 (1509)
T KOG4645|consen 1231 SNVTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVY 1310 (1509)
T ss_pred ccceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHH
Confidence 3345577888999999999999999 677888999987654 2334456788999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCcc
Q 004400 489 LIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEE 568 (756)
Q Consensus 489 lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~ 568 (756)
+.||||++|+|.+.+. ++...++.....+..|++.|++|||++| ||||||||.||+++.+|.+|++|||.|.....
T Consensus 1311 IFMEyC~~GsLa~ll~-~gri~dE~vt~vyt~qll~gla~LH~~g---IVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~ 1386 (1509)
T KOG4645|consen 1311 IFMEYCEGGSLASLLE-HGRIEDEMVTRVYTKQLLEGLAYLHEHG---IVHRDIKPANILLDFNGLIKYGDFGSAVKIKN 1386 (1509)
T ss_pred HHHHHhccCcHHHHHH-hcchhhhhHHHHHHHHHHHHHHHHHhcC---ceecCCCccceeeecCCcEEeecccceeEecC
Confidence 9999999999999884 4456788888889999999999999998 99999999999999999999999999987655
Q ss_pred cCcce---eeccccCccCCchHhhhcC---CCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHH-HhcCccccc
Q 004400 569 ENTHI---STRVAGTIGYMAPEYAMRG---HLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVL-KEQGKLMEL 641 (756)
Q Consensus 569 ~~~~~---~~~~~gt~~y~aPE~~~~~---~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~-~~~~~~~~~ 641 (756)
..... ....+||+-|||||++.+. ....++||||+||++.||+||++||..-+. .|+... ...+..+++
T Consensus 1387 ~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dn----e~aIMy~V~~gh~Pq~ 1462 (1509)
T KOG4645|consen 1387 NAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDN----EWAIMYHVAAGHKPQI 1462 (1509)
T ss_pred chhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccc----hhHHHhHHhccCCCCC
Confidence 43221 2346899999999999763 356789999999999999999999954432 233322 223333332
Q ss_pred cccCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004400 642 VDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRM 682 (756)
Q Consensus 642 ~~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~ 682 (756)
+......-.+++.+|+..||++|.++.|+++.
T Consensus 1463 ---------P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1463 ---------PERLSSEGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred ---------chhhhHhHHHHHHHHHhcCchhhhHHHHHHHh
Confidence 22344457789999999999999999887654
|
|
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=311.58 Aligned_cols=263 Identities=20% Similarity=0.342 Sum_probs=200.5
Q ss_pred hcCccccCcccCCCCccEEEee-ccCCcEEEEEEccccC--cccHHHHHHHHHHHHhCCCCceeeEeeEEEe----CCeE
Q 004400 415 TNNFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSKS--KQGNREFINEIGMISALQHPNLVKLYGCCIE----GNQL 487 (756)
Q Consensus 415 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~ 487 (756)
.++|+..+.||+|+||.||+|. ..+|+.||+|++.... ......+.+|+.++++++||||+++++++.. ....
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 83 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV 83 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence 3688999999999999999999 4579999999987542 2334667889999999999999999998763 3568
Q ss_pred EEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCc
Q 004400 488 LLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDE 567 (756)
Q Consensus 488 ~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~ 567 (756)
++||||+. |+|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+||++++++.+||+|||+++...
T Consensus 84 ~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~ 158 (334)
T cd07855 84 YVVMDLME-SDLHHIIHSD-QPLTEEHIRYFLYQLLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGLS 158 (334)
T ss_pred EEEEehhh-hhHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEecccccceeec
Confidence 99999996 5898888644 45999999999999999999999986 9999999999999999999999999997554
Q ss_pred ccCcc---eeeccccCccCCchHhhhc-CCCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhc--------
Q 004400 568 EENTH---ISTRVAGTIGYMAPEYAMR-GHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQ-------- 635 (756)
Q Consensus 568 ~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~-------- 635 (756)
..... ......|+..|+|||.+.. ..++.++|||||||++|||++|+.||...+..............
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~ 238 (334)
T cd07855 159 SSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNR 238 (334)
T ss_pred ccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhh
Confidence 32221 1234578999999999865 46899999999999999999999999665543322211111000
Q ss_pred ---CccccccccCC-CCCC-----CHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004400 636 ---GKLMELVDTNP-GSNF-----DKEQVMVMINVALLCANASPTIRPSMSSVLRM 682 (756)
Q Consensus 636 ---~~~~~~~~~~~-~~~~-----~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~ 682 (756)
........... .... .+.....+.+++.+|++.+|++||++.++++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 294 (334)
T cd07855 239 IGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQH 294 (334)
T ss_pred hchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 00000000000 0000 11224568999999999999999999999874
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-35 Score=309.45 Aligned_cols=249 Identities=24% Similarity=0.387 Sum_probs=207.0
Q ss_pred hhcCccccCcccCCCCccEEEee-ccCCcEEEEEEccccCcc--cHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEE
Q 004400 414 ATNNFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQ--GNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLI 490 (756)
Q Consensus 414 ~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 490 (756)
....|.+...||+|.|++|..|+ ..++..||||.+.+.... ..+.+.+|+++|..++|||||+++.+...+..+|+|
T Consensus 54 ~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV 133 (596)
T KOG0586|consen 54 SVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLV 133 (596)
T ss_pred cccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEE
Confidence 35678899999999999999999 457999999999775332 335588999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCcccC
Q 004400 491 YEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEEN 570 (756)
Q Consensus 491 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~~~ 570 (756)
|||+.+|.+.+++..++ ...+.++..++.|+.+|++|||+++ |||||||++||||+.+..+||+|||++..+..
T Consensus 134 ~eya~~ge~~~yl~~~g-r~~e~~ar~~F~q~vsaveYcH~k~---ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~-- 207 (596)
T KOG0586|consen 134 MEYASGGELFDYLVKHG-RMKEKEARAKFRQIVSAVEYCHSKN---IVHRDLKAENILLDENMNIKIADFGFSTFFDY-- 207 (596)
T ss_pred EEeccCchhHHHHHhcc-cchhhhhhhhhHHHHHHHHHHhhcc---eeccccchhhcccccccceeeeccccceeecc--
Confidence 99999999999998776 4455899999999999999999996 99999999999999999999999999987663
Q ss_pred cceeeccccCccCCchHhhhcCCC-CcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhcCccccccccCCCCC
Q 004400 571 THISTRVAGTIGYMAPEYAMRGHL-TEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSN 649 (756)
Q Consensus 571 ~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 649 (756)
.....+.+|++.|.|||++.+..| ++++|+||+|+++|-|+.|..||.+.+...+.. ..+.......
T Consensus 208 ~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~------------rvl~gk~rIp 275 (596)
T KOG0586|consen 208 GLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRP------------RVLRGKYRIP 275 (596)
T ss_pred cccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccc------------hheeeeeccc
Confidence 333466899999999999998765 679999999999999999999997766543322 1111111111
Q ss_pred CCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004400 650 FDKEQVMVMINVALLCANASPTIRPSMSSVLRM 682 (756)
Q Consensus 650 ~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~ 682 (756)
+ -......+++++++-.+|.+|++++++.+.
T Consensus 276 ~--~ms~dce~lLrk~lvl~Pskr~~~dqim~~ 306 (596)
T KOG0586|consen 276 F--YMSCDCEDLLRKFLVLNPSKRGPCDQIMKD 306 (596)
T ss_pred c--eeechhHHHHHHhhccCccccCCHHHhhhh
Confidence 1 122246788889999999999999999654
|
|
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=314.84 Aligned_cols=265 Identities=24% Similarity=0.371 Sum_probs=202.5
Q ss_pred CccccCcccCCCCccEEEee-ccCCcEEEEEEcccc-CcccHHHHHHHHHHHHhCCCCceeeEeeEEEeC------CeEE
Q 004400 417 NFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSK-SKQGNREFINEIGMISALQHPNLVKLYGCCIEG------NQLL 488 (756)
Q Consensus 417 ~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~~~ 488 (756)
.|...+.||+||||.||+|+ ..+|+.||||.+... .....+...+|+++|++++|+|||+++++=.+. ....
T Consensus 14 ~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~v 93 (732)
T KOG4250|consen 14 LWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPV 93 (732)
T ss_pred ceeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccce
Confidence 34566899999999999999 678999999999764 334456778999999999999999999985543 3568
Q ss_pred EEEEecCCCCHHHHHH--hcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEec--CCCC--EEEccCCc
Q 004400 489 LIYEYLENNSLARALF--EHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLD--KDLN--SKISDFGL 562 (756)
Q Consensus 489 lV~e~~~~gsL~~~l~--~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~--~~~~--~kl~DFGl 562 (756)
+|||||.+|||...|. ++...+++.+.+.+..+++.||.|||++| ||||||||.||++- ++|+ -||+|||.
T Consensus 94 lvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~---IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~ 170 (732)
T KOG4250|consen 94 LVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENG---IVHRDLKPGNIVLQIGEDGQSIYKLTDFGA 170 (732)
T ss_pred EEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcC---ceeccCCCCcEEEeecCCCceEEeeecccc
Confidence 9999999999999998 44568999999999999999999999986 99999999999983 3344 69999999
Q ss_pred cccCcccCcceeeccccCccCCchHhhhc-CCCCcccchhhHHHHHHHHHhCCCCCCccchh---hHHHHHHHHHhcCcc
Q 004400 563 AKLDEEENTHISTRVAGTIGYMAPEYAMR-GHLTEKADVYSFGIVALEIVSGRSNVTKEDMF---YLLDWALVLKEQGKL 638 (756)
Q Consensus 563 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~---~~~~~~~~~~~~~~~ 638 (756)
|+-.++.. ....++||..|.+||.+.. +.|+..+|.|||||++||++||..||.+.... ....|..........
T Consensus 171 Arel~d~s--~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~~v 248 (732)
T KOG4250|consen 171 ARELDDNS--LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPSGV 248 (732)
T ss_pred cccCCCCC--eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCCce
Confidence 99776544 4566899999999999985 88999999999999999999999999544321 123333322222111
Q ss_pred ccccccC------------CCCCCCHHHHHHHHHHHHHhhcCCCCCCC--CHHHHHHHhccC
Q 004400 639 MELVDTN------------PGSNFDKEQVMVMINVALLCANASPTIRP--SMSSVLRMLECG 686 (756)
Q Consensus 639 ~~~~~~~------------~~~~~~~~~~~~l~~l~~~c~~~~P~~RP--t~~ev~~~L~~~ 686 (756)
.-..... ............+-..+..++..+|++|. .+.+....+..+
T Consensus 249 ~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dI 310 (732)
T KOG4250|consen 249 AIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDI 310 (732)
T ss_pred eEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHH
Confidence 1111110 11122334444666777788888999998 666665555443
|
|
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-34 Score=302.85 Aligned_cols=244 Identities=30% Similarity=0.476 Sum_probs=196.2
Q ss_pred ccccCcccCCCCccEEEeec-cCCcEEEEEEccccCc---ccHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEEe
Q 004400 418 FATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSKSK---QGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYEY 493 (756)
Q Consensus 418 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 493 (756)
|...+.||+|+||.||+|.. .+++.|++|.+..... .....+.+|+++++.++|||++++++++.++...++||||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 55667899999999999984 5688999999864322 2335688899999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCcccCcce
Q 004400 494 LENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHI 573 (756)
Q Consensus 494 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~~~~~~ 573 (756)
+. |++.+.+......+++.++..++.|++.||+|||+.| ++||||||+||+++.++.+||+|||++.....
T Consensus 103 ~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dl~p~nili~~~~~~kL~dfg~~~~~~~----- 173 (313)
T cd06633 103 CL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASKSSP----- 173 (313)
T ss_pred CC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChhhEEECCCCCEEEeecCCCcccCC-----
Confidence 96 5788888766667999999999999999999999987 99999999999999999999999999864322
Q ss_pred eeccccCccCCchHhhh---cCCCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhcCccccccccCCCCCC
Q 004400 574 STRVAGTIGYMAPEYAM---RGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNF 650 (756)
Q Consensus 574 ~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 650 (756)
.....|+..|+|||++. ...++.++|||||||++|||++|+.||...+........ .. ...... ....+
T Consensus 174 ~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~---~~-~~~~~~----~~~~~ 245 (313)
T cd06633 174 ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI---AQ-NDSPTL----QSNEW 245 (313)
T ss_pred CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHH---Hh-cCCCCC----Ccccc
Confidence 12356889999999984 356888999999999999999999999765543332211 11 111111 11112
Q ss_pred CHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004400 651 DKEQVMVMINVALLCANASPTIRPSMSSVLRM 682 (756)
Q Consensus 651 ~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~ 682 (756)
...+.+++.+||+.+|.+||++.++++.
T Consensus 246 ----~~~l~~li~~~l~~~P~~Rp~~~~~l~~ 273 (313)
T cd06633 246 ----TDSFRGFVDYCLQKIPQERPASAELLRH 273 (313)
T ss_pred ----CHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 2348889999999999999999999864
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=320.31 Aligned_cols=253 Identities=29% Similarity=0.451 Sum_probs=209.2
Q ss_pred CccccCcccCCCCccEEEee-ccCCc----EEEEEEcccc-CcccHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEE
Q 004400 417 NFATDNNIGEGGFGPVYKGL-LADGT----AIAVKQLSSK-SKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLI 490 (756)
Q Consensus 417 ~~~~~~~lg~G~~g~Vy~~~-~~~~~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 490 (756)
....+++||+|+||+||+|. .+.|. +||+|++... ..+...++.+|+-+|.+++|||+++++|+|.... ..||
T Consensus 697 elkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlv 775 (1177)
T KOG1025|consen 697 ELKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLV 775 (1177)
T ss_pred hhhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHH
Confidence 34567899999999999998 45554 5888888654 3445678999999999999999999999998766 8899
Q ss_pred EEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCcccC
Q 004400 491 YEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEEN 570 (756)
Q Consensus 491 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~~~ 570 (756)
++||+.|+|.|+++.++..+.-...+.|+.|||+||.|||++. +|||||..+|||+.+-..+||+|||+|+....+.
T Consensus 776 tq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qr---lVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~ 852 (1177)
T KOG1025|consen 776 TQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQR---LVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDE 852 (1177)
T ss_pred HHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcc---hhhhhhhhhheeecCCCeEEEEecchhhccCccc
Confidence 9999999999999999999999999999999999999999885 9999999999999999999999999999877655
Q ss_pred cceeec-cccCccCCchHhhhcCCCCcccchhhHHHHHHHHHh-CCCCCCccchhhHHHHHHHHHhcCccccccccCCCC
Q 004400 571 THISTR-VAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVS-GRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGS 648 (756)
Q Consensus 571 ~~~~~~-~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 648 (756)
...... ..-.+.|||-|.+..+.|+.++|||||||.+||++| |..|+.+....++.+ ..+.+++ -
T Consensus 853 ~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~d----lle~geR---------L 919 (1177)
T KOG1025|consen 853 KEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPD----LLEKGER---------L 919 (1177)
T ss_pred ccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhH----HHhcccc---------C
Confidence 443322 233568999999999999999999999999999998 999986654433322 2222222 1
Q ss_pred CCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhccC
Q 004400 649 NFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLECG 686 (756)
Q Consensus 649 ~~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~L~~~ 686 (756)
.-++.....+..++.+||..|+..||+++++...+...
T Consensus 920 sqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ 957 (1177)
T KOG1025|consen 920 SQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRM 957 (1177)
T ss_pred CCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHH
Confidence 22333445588889999999999999999998887654
|
|
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-34 Score=306.95 Aligned_cols=266 Identities=23% Similarity=0.351 Sum_probs=200.7
Q ss_pred hcCccccCcccCCCCccEEEee-ccCCcEEEEEEcccc--CcccHHHHHHHHHHHHhCCCCceeeEeeEEEeC-----Ce
Q 004400 415 TNNFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSK--SKQGNREFINEIGMISALQHPNLVKLYGCCIEG-----NQ 486 (756)
Q Consensus 415 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~ 486 (756)
.++|...+.||+|+||.||+|+ ..+++.||||.+... .......+.+|+.+++.++|+||+++++++... ..
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 4578889999999999999999 457899999998653 233345678899999999999999999988654 34
Q ss_pred EEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccC
Q 004400 487 LLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLD 566 (756)
Q Consensus 487 ~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~ 566 (756)
.++|+||+. ++|.+++... ..+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||+++..
T Consensus 84 ~~lv~e~~~-~~L~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~ 158 (337)
T cd07858 84 VYIVYELMD-TDLHQIIRSS-QTLSDDHCQYFLYQLLRGLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLARTT 158 (337)
T ss_pred EEEEEeCCC-CCHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECcCcccccc
Confidence 799999996 6888888644 47999999999999999999999986 999999999999999999999999999865
Q ss_pred cccCcceeeccccCccCCchHhhhc-CCCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhc----------
Q 004400 567 EEENTHISTRVAGTIGYMAPEYAMR-GHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQ---------- 635 (756)
Q Consensus 567 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~---------- 635 (756)
.... .......++..|+|||.+.. ..++.++|||||||++|+|++|+.||...+..............
T Consensus 159 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (337)
T cd07858 159 SEKG-DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIR 237 (337)
T ss_pred CCCc-ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcC
Confidence 4332 12233467889999999875 46899999999999999999999999655432211111100000
Q ss_pred -Cccccc---cccCCCC---CCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH--hccC
Q 004400 636 -GKLMEL---VDTNPGS---NFDKEQVMVMINVALLCANASPTIRPSMSSVLRM--LECG 686 (756)
Q Consensus 636 -~~~~~~---~~~~~~~---~~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~--L~~~ 686 (756)
...... ....... ...+.....+.+++.+|++.+|++||++.++++. ++..
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~ 297 (337)
T cd07858 238 NEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASL 297 (337)
T ss_pred chhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhh
Confidence 000000 0000000 0011223458899999999999999999999876 5543
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=309.76 Aligned_cols=263 Identities=23% Similarity=0.386 Sum_probs=198.1
Q ss_pred hhcCccccCcccCCCCccEEEeecc-CCcEEEEEEcccc--CcccHHHHHHHHHHHHhC-CCCceeeEeeEEEeC--CeE
Q 004400 414 ATNNFATDNNIGEGGFGPVYKGLLA-DGTAIAVKQLSSK--SKQGNREFINEIGMISAL-QHPNLVKLYGCCIEG--NQL 487 (756)
Q Consensus 414 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~--~~~ 487 (756)
..++|+..+.||+|+||.||+|... +++.||+|++... .......+.+|+.+++++ +||||++++++|... ...
T Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~ 84 (337)
T cd07852 5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI 84 (337)
T ss_pred hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence 3467888899999999999999954 6889999988542 223345677899999999 999999999998654 468
Q ss_pred EEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCc
Q 004400 488 LLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDE 567 (756)
Q Consensus 488 ~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~ 567 (756)
++||||++ ++|..++... .+++..+..++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||+++...
T Consensus 85 ~lv~e~~~-~~L~~~~~~~--~~~~~~~~~i~~qi~~~L~~LH~~~---i~H~dl~p~nill~~~~~~kl~d~g~~~~~~ 158 (337)
T cd07852 85 YLVFEYME-TDLHAVIRAN--ILEDVHKRYIMYQLLKALKYIHSGN---VIHRDLKPSNILLNSDCRVKLADFGLARSLS 158 (337)
T ss_pred EEEecccc-cCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccchhccc
Confidence 99999997 5898888654 7899999999999999999999986 9999999999999999999999999998654
Q ss_pred ccCc----ceeeccccCccCCchHhhhc-CCCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHh--------
Q 004400 568 EENT----HISTRVAGTIGYMAPEYAMR-GHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKE-------- 634 (756)
Q Consensus 568 ~~~~----~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~-------- 634 (756)
.... .......|+..|+|||.+.+ ..++.++||||||+++|+|++|+.||.................
T Consensus 159 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (337)
T cd07852 159 ELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIE 238 (337)
T ss_pred cccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHH
Confidence 3322 12234568999999998765 4578899999999999999999999965443322111100000
Q ss_pred ------cCccccccccCCC---CCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004400 635 ------QGKLMELVDTNPG---SNFDKEQVMVMINVALLCANASPTIRPSMSSVLRM 682 (756)
Q Consensus 635 ------~~~~~~~~~~~~~---~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~ 682 (756)
............. ....+.....+.+++.+||+.+|++||++.++++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~ 295 (337)
T cd07852 239 SIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH 295 (337)
T ss_pred HHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence 0000000000000 00011123458899999999999999999999864
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-34 Score=295.05 Aligned_cols=244 Identities=23% Similarity=0.298 Sum_probs=190.2
Q ss_pred CcccCCCCccEEEeec-cCCcEEEEEEccccCc---ccHHHHHHHHHHH-HhCCCCceeeEeeEEEeCCeEEEEEEecCC
Q 004400 422 NNIGEGGFGPVYKGLL-ADGTAIAVKQLSSKSK---QGNREFINEIGMI-SALQHPNLVKLYGCCIEGNQLLLIYEYLEN 496 (756)
Q Consensus 422 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~~~l-~~l~h~niv~l~~~~~~~~~~~lV~e~~~~ 496 (756)
+.||+|+||.||+|.. .+++.||+|.+..... .....+..|..++ ...+|+|++++++++.+++..++|+||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 5689999999999985 5689999999865422 1223445555544 445899999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCcccCcceeec
Q 004400 497 NSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTR 576 (756)
Q Consensus 497 gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~ 576 (756)
++|.+++... ..+++..+..++.|++.||.|||+.+ ++||||+|+||++++++.+||+|||+++.... ...
T Consensus 82 ~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~-----~~~ 152 (260)
T cd05611 82 GDCASLIKTL-GGLPEDWAKQYIAEVVLGVEDLHQRG---IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE-----NKK 152 (260)
T ss_pred CCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEeecccceeccc-----ccc
Confidence 9999998654 36899999999999999999999986 99999999999999999999999999875433 223
Q ss_pred cccCccCCchHhhhcCCCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhcCccccccccCCCCCCCHHHHH
Q 004400 577 VAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDKEQVM 656 (756)
Q Consensus 577 ~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 656 (756)
..|+..|+|||.+.+..++.++||||||+++|||++|..||...+....... .. ..... . ... .......
T Consensus 153 ~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~---~~-~~~~~-~-~~~----~~~~~~~ 222 (260)
T cd05611 153 FVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDN---IL-SRRIN-W-PEE----VKEFCSP 222 (260)
T ss_pred CCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHH---HH-hcccC-C-CCc----ccccCCH
Confidence 4688999999999888899999999999999999999999966544332211 11 11100 0 000 0111233
Q ss_pred HHHHHHHHhhcCCCCCCCCHHHHHHHhc
Q 004400 657 VMINVALLCANASPTIRPSMSSVLRMLE 684 (756)
Q Consensus 657 ~l~~l~~~c~~~~P~~RPt~~ev~~~L~ 684 (756)
.+.+++.+||+.+|++||++.++.+.|+
T Consensus 223 ~~~~~i~~~l~~~p~~R~~~~~~~~~l~ 250 (260)
T cd05611 223 EAVDLINRLLCMDPAKRLGANGYQEIKS 250 (260)
T ss_pred HHHHHHHHHccCCHHHccCCCcHHHHHc
Confidence 4889999999999999998876655544
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-34 Score=294.82 Aligned_cols=244 Identities=20% Similarity=0.273 Sum_probs=190.0
Q ss_pred HHhhcCccccCcc--cCCCCccEEEee-ccCCcEEEEEEccccCcccHHHHHHHHHHHHhC-CCCceeeEeeEEEeCCeE
Q 004400 412 KAATNNFATDNNI--GEGGFGPVYKGL-LADGTAIAVKQLSSKSKQGNREFINEIGMISAL-QHPNLVKLYGCCIEGNQL 487 (756)
Q Consensus 412 ~~~~~~~~~~~~l--g~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 487 (756)
....++|+..+.+ |+|+||.||++. ..++..+|+|.+....... .|+.....+ +||||++++++|..++..
T Consensus 10 ~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~-----~e~~~~~~~~~h~~iv~~~~~~~~~~~~ 84 (267)
T PHA03390 10 VQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA-----IEPMVHQLMKDNPNFIKLYYSVTTLKGH 84 (267)
T ss_pred HHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch-----hhHHHHHHhhcCCCEEEEEEEEecCCee
Confidence 3344566776666 999999999999 4578899999986532211 122222222 799999999999999999
Q ss_pred EEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCC-CEEEccCCccccC
Q 004400 488 LLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDL-NSKISDFGLAKLD 566 (756)
Q Consensus 488 ~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~-~~kl~DFGla~~~ 566 (756)
++||||+++|+|.+++.... .+++..+..++.|+++||+|||+.| ++||||||+||+++.++ .++|+|||+++..
T Consensus 85 ~iv~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~ 160 (267)
T PHA03390 85 VLIMDYIKDGDLFDLLKKEG-KLSEAEVKKIIRQLVEALNDLHKHN---IIHNDIKLENVLYDRAKDRIYLCDYGLCKII 160 (267)
T ss_pred EEEEEcCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEeCCCCeEEEecCccceec
Confidence 99999999999999997654 8999999999999999999999997 99999999999999998 9999999998755
Q ss_pred cccCcceeeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHhCCCCCCccchh--hHHHHHHHHHhcCcccccccc
Q 004400 567 EEENTHISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMF--YLLDWALVLKEQGKLMELVDT 644 (756)
Q Consensus 567 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~ 644 (756)
... ....|+..|+|||++.+..++.++||||||+++|||++|+.||...... ....+.... .....
T Consensus 161 ~~~-----~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~---~~~~~---- 228 (267)
T PHA03390 161 GTP-----SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQ---QKKLP---- 228 (267)
T ss_pred CCC-----ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhh---cccCC----
Confidence 432 2245889999999999888999999999999999999999999643321 112221111 11001
Q ss_pred CCCCCCCHHHHHHHHHHHHHhhcCCCCCCCC-HHHHHH
Q 004400 645 NPGSNFDKEQVMVMINVALLCANASPTIRPS-MSSVLR 681 (756)
Q Consensus 645 ~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt-~~ev~~ 681 (756)
........+.+++.+|++.+|.+||+ ++|+++
T Consensus 229 -----~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~ 261 (267)
T PHA03390 229 -----FIKNVSKNANDFVQSMLKYNINYRLTNYNEIIK 261 (267)
T ss_pred -----cccccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence 11123345889999999999999996 688874
|
|
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=305.41 Aligned_cols=263 Identities=25% Similarity=0.357 Sum_probs=197.1
Q ss_pred hcCccccCcccCCCCccEEEeec-cCCcEEEEEEccccCcc--cHHHHHHHHHHHHhCCCCceeeEeeEEEeC-------
Q 004400 415 TNNFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSKSKQ--GNREFINEIGMISALQHPNLVKLYGCCIEG------- 484 (756)
Q Consensus 415 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------- 484 (756)
.++|...+.||+|+||.||+|.. .+++.||+|.+...... ....+.+|++++++++||||+++++++.+.
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 57899999999999999999994 57899999988654222 234678899999999999999999987543
Q ss_pred -CeEEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCcc
Q 004400 485 -NQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLA 563 (756)
Q Consensus 485 -~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla 563 (756)
...++|+||+.+ ++...+......+++..+..++.|+++||+|||+.| |+||||||+||++++++.+||+|||++
T Consensus 87 ~~~~~lv~~~~~~-~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~ 162 (311)
T cd07866 87 RGSVYMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENH---ILHRDIKAANILIDNQGILKIADFGLA 162 (311)
T ss_pred CceEEEEEecCCc-CHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECcCccc
Confidence 356999999975 677777665668999999999999999999999997 999999999999999999999999999
Q ss_pred ccCcccCcc----------eeeccccCccCCchHhhhcC-CCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHH
Q 004400 564 KLDEEENTH----------ISTRVAGTIGYMAPEYAMRG-HLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVL 632 (756)
Q Consensus 564 ~~~~~~~~~----------~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~ 632 (756)
+........ ..+...|++.|+|||.+.+. .++.++|||||||++|||++|+.||...+...........
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~~ 242 (311)
T cd07866 163 RPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKL 242 (311)
T ss_pred hhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Confidence 755432211 11234678899999988654 5889999999999999999999999665543322211111
Q ss_pred HhcC---------ccccccccCCCCCCC-------HHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 004400 633 KEQG---------KLMELVDTNPGSNFD-------KEQVMVMINVALLCANASPTIRPSMSSVLR 681 (756)
Q Consensus 633 ~~~~---------~~~~~~~~~~~~~~~-------~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~ 681 (756)
.... ......+.......+ ......+.+++.+|++.+|++|||+.|++.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~ 307 (311)
T cd07866 243 CGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALE 307 (311)
T ss_pred hCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence 0000 000000000000000 011235889999999999999999999875
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=325.04 Aligned_cols=265 Identities=18% Similarity=0.250 Sum_probs=187.3
Q ss_pred hhcCccccCcccCCCCccEEEeeccC--CcEEEEEE--------------ccc---cCcccHHHHHHHHHHHHhCCCCce
Q 004400 414 ATNNFATDNNIGEGGFGPVYKGLLAD--GTAIAVKQ--------------LSS---KSKQGNREFINEIGMISALQHPNL 474 (756)
Q Consensus 414 ~~~~~~~~~~lg~G~~g~Vy~~~~~~--~~~vavK~--------------~~~---~~~~~~~~~~~E~~~l~~l~h~ni 474 (756)
..++|...+.||+|+||+||+|.... +..+++|. +.+ ........+.+|+.++++++||||
T Consensus 146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnI 225 (501)
T PHA03210 146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENI 225 (501)
T ss_pred hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCc
Confidence 35689999999999999999987432 22222221 111 111233567899999999999999
Q ss_pred eeEeeEEEeCCeEEEEEEecCCCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEec
Q 004400 475 VKLYGCCIEGNQLLLIYEYLENNSLARALFEHR----LKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLD 550 (756)
Q Consensus 475 v~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~----~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~ 550 (756)
|++++++.+++..|+|++++. ++|.+++.... .......+..++.||+.||+|||+++ ||||||||+|||++
T Consensus 226 v~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~g---IiHrDLKP~NILl~ 301 (501)
T PHA03210 226 LKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKK---LIHRDIKLENIFLN 301 (501)
T ss_pred CcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEC
Confidence 999999999999999999985 46777665321 22345667889999999999999986 99999999999999
Q ss_pred CCCCEEEccCCccccCcccCcceeeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHhCCCCCCcc-chhhHHHHH
Q 004400 551 KDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKE-DMFYLLDWA 629 (756)
Q Consensus 551 ~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~-~~~~~~~~~ 629 (756)
.++.+||+|||+++..............||..|+|||++.+..++.++|||||||++|||++|+.++... .........
T Consensus 302 ~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~ 381 (501)
T PHA03210 302 CDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLL 381 (501)
T ss_pred CCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHH
Confidence 9999999999999876554433344567999999999999999999999999999999999988654322 111111100
Q ss_pred HHHHhc----Cccc-------cccccC----CCCCCCH-----HHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004400 630 LVLKEQ----GKLM-------ELVDTN----PGSNFDK-----EQVMVMINVALLCANASPTIRPSMSSVLRM 682 (756)
Q Consensus 630 ~~~~~~----~~~~-------~~~~~~----~~~~~~~-----~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~ 682 (756)
..+..- .+.. +.++.. .....+. .....+.+++.+|++.||.+|||+.|+++.
T Consensus 382 ~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~h 454 (501)
T PHA03210 382 KIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLAL 454 (501)
T ss_pred HHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 000000 0000 000000 0000000 011246778899999999999999999864
|
|
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-34 Score=301.11 Aligned_cols=254 Identities=23% Similarity=0.296 Sum_probs=200.1
Q ss_pred CccccCcccCCCCccEEEeec----cCCcEEEEEEccccC----cccHHHHHHHHHHHHhC-CCCceeeEeeEEEeCCeE
Q 004400 417 NFATDNNIGEGGFGPVYKGLL----ADGTAIAVKQLSSKS----KQGNREFINEIGMISAL-QHPNLVKLYGCCIEGNQL 487 (756)
Q Consensus 417 ~~~~~~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 487 (756)
+|...+.||+|+||.||+|+. .+++.||||.++... ....+.+.+|++++.++ +||||+++++.+..+...
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 367778999999999999873 357889999986432 22335678899999999 599999999999999999
Q ss_pred EEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCc
Q 004400 488 LLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDE 567 (756)
Q Consensus 488 ~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~ 567 (756)
++||||+++|+|.+++... ..+++..+..++.|+++||+|||+.+ ++||||||+||+++.++.++|+|||+++...
T Consensus 81 ~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~---~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 156 (288)
T cd05583 81 HLILDYVNGGELFTHLYQR-EHFTESEVRVYIAEIVLALDHLHQLG---IIYRDIKLENILLDSEGHVVLTDFGLSKEFL 156 (288)
T ss_pred EEEEecCCCCcHHHHHhhc-CCcCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEEECccccccc
Confidence 9999999999999998754 46899999999999999999999886 9999999999999999999999999998654
Q ss_pred ccCcceeeccccCccCCchHhhhcCC--CCcccchhhHHHHHHHHHhCCCCCCccchhh-HHHHHHHHHhcCcccccccc
Q 004400 568 EENTHISTRVAGTIGYMAPEYAMRGH--LTEKADVYSFGIVALEIVSGRSNVTKEDMFY-LLDWALVLKEQGKLMELVDT 644 (756)
Q Consensus 568 ~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~Dv~slGv~l~elltg~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~ 644 (756)
...........|+..|+|||...+.. .+.++||||||+++|||++|+.||...+... ........... ..
T Consensus 157 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~-------~~ 229 (288)
T cd05583 157 AEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKS-------KP 229 (288)
T ss_pred cccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHcc-------CC
Confidence 43333333456899999999987654 7889999999999999999999995432211 11111111110 00
Q ss_pred CCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhcc
Q 004400 645 NPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLEC 685 (756)
Q Consensus 645 ~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~L~~ 685 (756)
.....+ ...+.+++.+||+.+|++|||+.++.+.|+.
T Consensus 230 ~~~~~~----~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~ 266 (288)
T cd05583 230 PFPKTM----SAEARDFIQKLLEKDPKKRLGANGADEIKNH 266 (288)
T ss_pred CCCccc----CHHHHHHHHHHhcCCHhhccCcchHHHHhcC
Confidence 111112 2347889999999999999999988887773
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=296.64 Aligned_cols=261 Identities=28% Similarity=0.397 Sum_probs=197.1
Q ss_pred cCccccCcccCCCCccEEEeeccCCcEEEEEEccccCcccHHHHHHHHHHHHh--CCCCceeeEeeEEEeCC----eEEE
Q 004400 416 NNFATDNNIGEGGFGPVYKGLLADGTAIAVKQLSSKSKQGNREFINEIGMISA--LQHPNLVKLYGCCIEGN----QLLL 489 (756)
Q Consensus 416 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~~~~~----~~~l 489 (756)
......+.||+|.||.||||.+.+ +.||||++.. ...+.|..|-++.+. ++|+||++++++-.... +.+|
T Consensus 210 ~pl~l~eli~~Grfg~V~KaqL~~-~~VAVKifp~---~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywL 285 (534)
T KOG3653|consen 210 DPLQLLELIGRGRFGCVWKAQLDN-RLVAVKIFPE---QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWL 285 (534)
T ss_pred CchhhHHHhhcCccceeehhhccC-ceeEEEecCH---HHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeE
Confidence 345567899999999999999864 8999999964 445678888887765 58999999999976555 8999
Q ss_pred EEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcC------CCCCeEcCCCCCCceEecCCCCEEEccCCcc
Q 004400 490 IYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGE------SRIKVVHRDIKATNVLLDKDLNSKISDFGLA 563 (756)
Q Consensus 490 V~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~------g~~~iiH~Dikp~Nill~~~~~~kl~DFGla 563 (756)
|++|.+.|+|.++|..+ .++|....+|+.-+++||+|||+. ..++|+|||||++|||+..|+.+.|+|||+|
T Consensus 286 Vt~fh~kGsL~dyL~~n--tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLA 363 (534)
T KOG3653|consen 286 VTEFHPKGSLCDYLKAN--TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLA 363 (534)
T ss_pred EeeeccCCcHHHHHHhc--cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeecccee
Confidence 99999999999999765 789999999999999999999975 2467999999999999999999999999999
Q ss_pred ccCcccCcc-eeeccccCccCCchHhhhcCC-CC-----cccchhhHHHHHHHHHhCCCCCCcc--c------------h
Q 004400 564 KLDEEENTH-ISTRVAGTIGYMAPEYAMRGH-LT-----EKADVYSFGIVALEIVSGRSNVTKE--D------------M 622 (756)
Q Consensus 564 ~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~-~~-----~~~Dv~slGv~l~elltg~~p~~~~--~------------~ 622 (756)
..+...... .....+||.+|||||++.+.- +. .+.||||+|.++|||++.-..+.+. . .
T Consensus 364 l~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~h 443 (534)
T KOG3653|consen 364 LRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNH 443 (534)
T ss_pred EEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcCC
Confidence 877643322 223368999999999997632 22 3689999999999999854322110 0 0
Q ss_pred hhHHHHHHHHHhcCccccccccCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhccC
Q 004400 623 FYLLDWALVLKEQGKLMELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLECG 686 (756)
Q Consensus 623 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~L~~~ 686 (756)
...-+......+++.+..+.+.=.. ...+..+.+.+..||+.||+.|-|+.=+-+.+.+.
T Consensus 444 Pt~e~mq~~VV~kK~RP~~p~~W~~----h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l 503 (534)
T KOG3653|consen 444 PTLEEMQELVVRKKQRPKIPDAWRK----HAGMAVLCETIEECWDHDAEARLTAGCVEERMAEL 503 (534)
T ss_pred CCHHHHHHHHHhhccCCCChhhhhc----CccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHH
Confidence 0011111122233333333322111 12344588999999999999999998877666543
|
|
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=297.20 Aligned_cols=258 Identities=26% Similarity=0.362 Sum_probs=195.5
Q ss_pred ccccCcccCCCCccEEEeecc-CCcEEEEEEccccCcc--cHHHHHHHHHHHHhC---CCCceeeEeeEEEeCCe-----
Q 004400 418 FATDNNIGEGGFGPVYKGLLA-DGTAIAVKQLSSKSKQ--GNREFINEIGMISAL---QHPNLVKLYGCCIEGNQ----- 486 (756)
Q Consensus 418 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l---~h~niv~l~~~~~~~~~----- 486 (756)
|+..+.||+|+||.||+|+.. +++.||+|.+...... ....+.+|+.+++++ +|||++++++++.+.+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 566789999999999999965 5899999999754222 234566788777666 59999999999998776
Q ss_pred EEEEEEecCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCcccc
Q 004400 487 LLLIYEYLENNSLARALFEHR-LKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKL 565 (756)
Q Consensus 487 ~~lV~e~~~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~ 565 (756)
.+++|||+.+ +|.+++.... ..+++..+..++.|++.||+|||+.+ ++|+||+|+||+++.++.+||+|||++..
T Consensus 81 ~~l~~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~---i~h~~l~~~nili~~~~~~~l~dfg~~~~ 156 (287)
T cd07838 81 LTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLARI 156 (287)
T ss_pred eEEEehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhEEEccCCCEEEeccCccee
Confidence 9999999975 8988886533 36899999999999999999999986 99999999999999999999999999976
Q ss_pred CcccCcceeeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhc-Cc--cc---
Q 004400 566 DEEENTHISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQ-GK--LM--- 639 (756)
Q Consensus 566 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~-~~--~~--- 639 (756)
....... ....++..|+|||++.+..++.++|||||||++|||++|+.||.................. .. ..
T Consensus 157 ~~~~~~~--~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (287)
T cd07838 157 YSFEMAL--TSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNV 234 (287)
T ss_pred ccCCccc--ccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCCc
Confidence 5433221 2335788999999999888999999999999999999999998665443222111100000 00 00
Q ss_pred ----cccccCCC---CCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 004400 640 ----ELVDTNPG---SNFDKEQVMVMINVALLCANASPTIRPSMSSVLR 681 (756)
Q Consensus 640 ----~~~~~~~~---~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~ 681 (756)
........ ....+.....+.+++.+||+.||.+||++.++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~ 283 (287)
T cd07838 235 SLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ 283 (287)
T ss_pred ccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence 00000000 0111233456789999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-34 Score=301.60 Aligned_cols=252 Identities=27% Similarity=0.436 Sum_probs=195.0
Q ss_pred hcCccccCcccCCCCccEEEeecc-CCcEEEEEEccccC-cccHHHHHHHHHHHHhCC-CCceeeEeeEEEeCCeEEEEE
Q 004400 415 TNNFATDNNIGEGGFGPVYKGLLA-DGTAIAVKQLSSKS-KQGNREFINEIGMISALQ-HPNLVKLYGCCIEGNQLLLIY 491 (756)
Q Consensus 415 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lV~ 491 (756)
.++|+..+.||+|+||.||+|... +++.||||.++... ......+..|+.++.+.. ||||++++++|.++...++||
T Consensus 14 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~ 93 (296)
T cd06618 14 LNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICM 93 (296)
T ss_pred cchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEe
Confidence 467888999999999999999965 48999999987542 223456677887777764 999999999999999999999
Q ss_pred EecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCcccCc
Q 004400 492 EYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENT 571 (756)
Q Consensus 492 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~~~~ 571 (756)
||+.+ ++.+........+++..+..++.|++.||+|||+.. +|+||||+|+||++++++.+||+|||++........
T Consensus 94 e~~~~-~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~--~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~~ 170 (296)
T cd06618 94 ELMST-CLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKH--GVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKA 170 (296)
T ss_pred eccCc-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhC--CEecCCCcHHHEEEcCCCCEEECccccchhccCCCc
Confidence 99854 777777655557999999999999999999999742 399999999999999999999999999976543222
Q ss_pred ceeeccccCccCCchHhhhcCC----CCcccchhhHHHHHHHHHhCCCCCCccch-hhHHHHHHHHHhcCccccccccCC
Q 004400 572 HISTRVAGTIGYMAPEYAMRGH----LTEKADVYSFGIVALEIVSGRSNVTKEDM-FYLLDWALVLKEQGKLMELVDTNP 646 (756)
Q Consensus 572 ~~~~~~~gt~~y~aPE~~~~~~----~~~~~Dv~slGv~l~elltg~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~ 646 (756)
. ....++..|+|||.+.+.. ++.++||||||+++|||++|+.||..... ..... ..... .......
T Consensus 171 ~--~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~---~~~~~-~~~~~~~--- 241 (296)
T cd06618 171 K--TRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLT---KILQE-EPPSLPP--- 241 (296)
T ss_pred c--cCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHH---HHhcC-CCCCCCC---
Confidence 1 2335788999999987543 78899999999999999999999954321 11111 11111 1111100
Q ss_pred CCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004400 647 GSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRM 682 (756)
Q Consensus 647 ~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~ 682 (756)
...+ ...+.+++.+||+.+|++||++.++++.
T Consensus 242 ~~~~----~~~l~~li~~~l~~~p~~Rp~~~~il~~ 273 (296)
T cd06618 242 NEGF----SPDFCSFVDLCLTKDHRKRPKYRELLQH 273 (296)
T ss_pred CCCC----CHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 0112 2348899999999999999999999865
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-35 Score=327.77 Aligned_cols=253 Identities=29% Similarity=0.443 Sum_probs=190.8
Q ss_pred hhcCccccCcccCCCCccEEEeec-cCCcEEEEEEcccc-CcccHHHHHHHHHHHHhCCCCceeeEeeEEEeC-------
Q 004400 414 ATNNFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSK-SKQGNREFINEIGMISALQHPNLVKLYGCCIEG------- 484 (756)
Q Consensus 414 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------- 484 (756)
...+|++...||+||||.||+++. -||+.||||++... +......+.+|+..+++++|||||+++..+.+.
T Consensus 477 Y~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~ 556 (1351)
T KOG1035|consen 477 YLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVL 556 (1351)
T ss_pred HhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccccc
Confidence 456899999999999999999994 49999999998765 333456788999999999999999988442110
Q ss_pred --------------------------------------------------------------------------------
Q 004400 485 -------------------------------------------------------------------------------- 484 (756)
Q Consensus 485 -------------------------------------------------------------------------------- 484 (756)
T Consensus 557 ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~ 636 (1351)
T KOG1035|consen 557 EIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDS 636 (1351)
T ss_pred cccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccccc
Confidence
Q ss_pred --------------------------------CeEEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcC
Q 004400 485 --------------------------------NQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGE 532 (756)
Q Consensus 485 --------------------------------~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~ 532 (756)
..+|+-||||+..++.+++..+...-.....++++++|++||+|+|++
T Consensus 637 e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH~~ 716 (1351)
T KOG1035|consen 637 EGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIHDQ 716 (1351)
T ss_pred CCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHHhC
Confidence 125788999999888888765543325778899999999999999999
Q ss_pred CCCCeEcCCCCCCceEecCCCCEEEccCCccccCc-------c----------cCcceeeccccCccCCchHhhhcC---
Q 004400 533 SRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDE-------E----------ENTHISTRVAGTIGYMAPEYAMRG--- 592 (756)
Q Consensus 533 g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~-------~----------~~~~~~~~~~gt~~y~aPE~~~~~--- 592 (756)
| ||||||||.||++|++..|||+|||+|+... . ......+..+||.-|+|||++.+.
T Consensus 717 g---iIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~ 793 (1351)
T KOG1035|consen 717 G---IIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSN 793 (1351)
T ss_pred c---eeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccc
Confidence 8 9999999999999999999999999998621 0 011123457899999999999764
Q ss_pred CCCcccchhhHHHHHHHHHhCCCCCCcc-chhhHHHHHHHHHhcCccccccccCCCCCCCHHHHHHHHHHHHHhhcCCCC
Q 004400 593 HLTEKADVYSFGIVALEIVSGRSNVTKE-DMFYLLDWALVLKEQGKLMELVDTNPGSNFDKEQVMVMINVALLCANASPT 671 (756)
Q Consensus 593 ~~~~~~Dv~slGv~l~elltg~~p~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~P~ 671 (756)
.|+.|+|+||+|||++||+. ||... +-...+. -.+.+.++.- ..+.......=..++.++++.||.
T Consensus 794 ~Yn~KiDmYSLGIVlFEM~y---PF~TsMERa~iL~----~LR~g~iP~~------~~f~~~~~~~e~slI~~Ll~hdP~ 860 (1351)
T KOG1035|consen 794 KYNSKIDMYSLGIVLFEMLY---PFGTSMERASILT----NLRKGSIPEP------ADFFDPEHPEEASLIRWLLSHDPS 860 (1351)
T ss_pred cccchhhhHHHHHHHHHHhc---cCCchHHHHHHHH----hcccCCCCCC------cccccccchHHHHHHHHHhcCCCc
Confidence 49999999999999999994 45322 1111111 1112222211 122223333456788899999999
Q ss_pred CCCCHHHHHHH
Q 004400 672 IRPSMSSVLRM 682 (756)
Q Consensus 672 ~RPt~~ev~~~ 682 (756)
+|||+.|+++.
T Consensus 861 kRPtA~eLL~s 871 (1351)
T KOG1035|consen 861 KRPTATELLNS 871 (1351)
T ss_pred cCCCHHHHhhc
Confidence 99999999753
|
|
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-34 Score=299.42 Aligned_cols=250 Identities=23% Similarity=0.318 Sum_probs=195.5
Q ss_pred CccccCcccCCCCccEEEeec----cCCcEEEEEEccccC----cccHHHHHHHHHHHHhC-CCCceeeEeeEEEeCCeE
Q 004400 417 NFATDNNIGEGGFGPVYKGLL----ADGTAIAVKQLSSKS----KQGNREFINEIGMISAL-QHPNLVKLYGCCIEGNQL 487 (756)
Q Consensus 417 ~~~~~~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 487 (756)
+|+..+.||+|+||.||+|.. .+|+.||+|.+.... ....+.+.+|+++++++ +|+||+++++++..+...
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 467788999999999999984 378999999986532 22345678899999999 599999999999999999
Q ss_pred EEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCc
Q 004400 488 LLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDE 567 (756)
Q Consensus 488 ~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~ 567 (756)
++||||+++++|.+++... ..+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||+++...
T Consensus 81 ~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~ 156 (290)
T cd05613 81 HLILDYINGGELFTHLSQR-ERFKEQEVQIYSGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKEFH 156 (290)
T ss_pred EEEEecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEECCCCCEEEeeCccceecc
Confidence 9999999999999999754 46889999999999999999999986 9999999999999999999999999998654
Q ss_pred ccCcceeeccccCccCCchHhhhcC--CCCcccchhhHHHHHHHHHhCCCCCCccchh-hHHHHHHHHHhcCcccccccc
Q 004400 568 EENTHISTRVAGTIGYMAPEYAMRG--HLTEKADVYSFGIVALEIVSGRSNVTKEDMF-YLLDWALVLKEQGKLMELVDT 644 (756)
Q Consensus 568 ~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Dv~slGv~l~elltg~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~ 644 (756)
...........|+..|+|||.+... .++.++||||||+++|+|++|+.||...... ............. .
T Consensus 157 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~-------~ 229 (290)
T cd05613 157 EDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSE-------P 229 (290)
T ss_pred cccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhccC-------C
Confidence 4332223345689999999998753 4678999999999999999999998543221 1111111111100 0
Q ss_pred CCCCCCCHHHHHHHHHHHHHhhcCCCCCCC-----CHHHHHH
Q 004400 645 NPGSNFDKEQVMVMINVALLCANASPTIRP-----SMSSVLR 681 (756)
Q Consensus 645 ~~~~~~~~~~~~~l~~l~~~c~~~~P~~RP-----t~~ev~~ 681 (756)
.++......+.+++.+||+.+|++|| +..++++
T Consensus 230 ----~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~ 267 (290)
T cd05613 230 ----PYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKK 267 (290)
T ss_pred ----CCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHc
Confidence 01112233488999999999999997 5565543
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-34 Score=298.39 Aligned_cols=260 Identities=26% Similarity=0.362 Sum_probs=201.6
Q ss_pred ccccCcccCCCCccEEEeecc-CCcEEEEEEccccC--cccHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEEec
Q 004400 418 FATDNNIGEGGFGPVYKGLLA-DGTAIAVKQLSSKS--KQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYEYL 494 (756)
Q Consensus 418 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~ 494 (756)
|+..+.||+|++|.||+|... +++.||+|.+.... ....+.+.+|++++++++|+||+++++++.+.+..++||||+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 456688999999999999954 58999999987653 333467888999999999999999999999999999999999
Q ss_pred CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCcccCccee
Q 004400 495 ENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHIS 574 (756)
Q Consensus 495 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~~~~~~~ 574 (756)
+ ++|.+++......+++..+..++.|++.||+|||+.+ |+||||+|+||++++++.+||+|||.++........ .
T Consensus 81 ~-~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~-~ 155 (282)
T cd07829 81 D-MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHR---ILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRT-Y 155 (282)
T ss_pred C-cCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChheEEEcCCCCEEEecCCcccccCCCccc-c
Confidence 8 5899999866557999999999999999999999996 999999999999999999999999999865443221 2
Q ss_pred eccccCccCCchHhhhcC-CCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhcC---------cc---ccc
Q 004400 575 TRVAGTIGYMAPEYAMRG-HLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQG---------KL---MEL 641 (756)
Q Consensus 575 ~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~---------~~---~~~ 641 (756)
....++..|+|||.+.+. .++.++|||||||++||+++|+.||...+............... .. ...
T Consensus 156 ~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (282)
T cd07829 156 THEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKPT 235 (282)
T ss_pred CccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhccccccccc
Confidence 233467789999998776 78999999999999999999999997665433322211111000 00 000
Q ss_pred cccCCCC---CCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004400 642 VDTNPGS---NFDKEQVMVMINVALLCANASPTIRPSMSSVLRM 682 (756)
Q Consensus 642 ~~~~~~~---~~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~ 682 (756)
....... ...+.....+.+++.+||+.+|++||++.+++..
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 279 (282)
T cd07829 236 FPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKH 279 (282)
T ss_pred ccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhC
Confidence 0000000 0001113468999999999999999999999763
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-34 Score=298.76 Aligned_cols=248 Identities=24% Similarity=0.390 Sum_probs=202.5
Q ss_pred cCccccCcccCCCCccEEEeec-cCCcEEEEEEcccc---CcccHHHHHHHHHHHHhCC-CCceeeEeeEEEeCCeEEEE
Q 004400 416 NNFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSK---SKQGNREFINEIGMISALQ-HPNLVKLYGCCIEGNQLLLI 490 (756)
Q Consensus 416 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lV 490 (756)
++|...+.||+|+||.||+|.. .+++.||+|.+... .....+.+.+|++++++++ ||||+++++++.+++..++|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 3688889999999999999995 47999999998653 2233467888999999998 99999999999999999999
Q ss_pred EEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCcccC
Q 004400 491 YEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEEN 570 (756)
Q Consensus 491 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~~~ 570 (756)
|||+++++|.+++.... .+++..+..++.|++.||+|||+.+ ++|+||+|+||+++.++.++++|||++.......
T Consensus 81 ~e~~~~~~L~~~l~~~~-~l~~~~~~~i~~ql~~~l~~Lh~~~---~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~ 156 (280)
T cd05581 81 LEYAPNGELLQYIRKYG-SLDEKCTRFYAAEILLALEYLHSKG---IIHRDLKPENILLDKDMHIKITDFGTAKVLDPNS 156 (280)
T ss_pred EcCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEecCCccccccCCcc
Confidence 99999999999997654 7999999999999999999999986 9999999999999999999999999998654433
Q ss_pred c-------------------ceeeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHH
Q 004400 571 T-------------------HISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALV 631 (756)
Q Consensus 571 ~-------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~ 631 (756)
. .......|+..|+|||......++.++||||||++++++++|+.||.............
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~- 235 (280)
T cd05581 157 SPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKIL- 235 (280)
T ss_pred ccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHH-
Confidence 2 12233568899999999988889999999999999999999999997655332221111
Q ss_pred HHhcCccccccccCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCH----HHHHH
Q 004400 632 LKEQGKLMELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSM----SSVLR 681 (756)
Q Consensus 632 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~----~ev~~ 681 (756)
. . . ..++......+.+++.+||+.+|.+||++ .++++
T Consensus 236 --~---~----~----~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~ 276 (280)
T cd05581 236 --K---L----E----YSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA 276 (280)
T ss_pred --h---c----C----CCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence 0 0 0 01111123448899999999999999999 77654
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=294.33 Aligned_cols=241 Identities=26% Similarity=0.299 Sum_probs=186.3
Q ss_pred cccCCCCccEEEeec-cCCcEEEEEEccccCc---ccHHHHHHHHH---HHHhCCCCceeeEeeEEEeCCeEEEEEEecC
Q 004400 423 NIGEGGFGPVYKGLL-ADGTAIAVKQLSSKSK---QGNREFINEIG---MISALQHPNLVKLYGCCIEGNQLLLIYEYLE 495 (756)
Q Consensus 423 ~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~~---~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~ 495 (756)
.||+|+||.||+|.. .+++.||+|.+..... .....+..|.. .++...||+|+++++++.+++..++||||+.
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 489999999999985 5688999999865421 11223444443 3445579999999999999999999999999
Q ss_pred CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCcccCcceee
Q 004400 496 NNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHIST 575 (756)
Q Consensus 496 ~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~ 575 (756)
+|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+||++++++.+||+|||++........ .
T Consensus 81 g~~L~~~l~~~-~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~~---~ 153 (278)
T cd05606 81 GGDLHYHLSQH-GVFSEAEMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP---H 153 (278)
T ss_pred CCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCCCCHHHEEECCCCCEEEccCcCccccCccCC---c
Confidence 99999988654 47999999999999999999999986 99999999999999999999999999875433221 2
Q ss_pred ccccCccCCchHhhhcC-CCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhcCccccccccCCCCCCCHHH
Q 004400 576 RVAGTIGYMAPEYAMRG-HLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDKEQ 654 (756)
Q Consensus 576 ~~~gt~~y~aPE~~~~~-~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 654 (756)
...|+..|+|||.+.++ .++.++||||+||++|||++|+.||................ ..... .+...
T Consensus 154 ~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~-------~~~~~----~~~~~ 222 (278)
T cd05606 154 ASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTL-------TMAVE----LPDSF 222 (278)
T ss_pred CcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHhh-------ccCCC----CCCcC
Confidence 34689999999999754 68999999999999999999999996542221111110000 00111 11112
Q ss_pred HHHHHHHHHHhhcCCCCCCC-----CHHHHHH
Q 004400 655 VMVMINVALLCANASPTIRP-----SMSSVLR 681 (756)
Q Consensus 655 ~~~l~~l~~~c~~~~P~~RP-----t~~ev~~ 681 (756)
...+.+++.+|+..+|.+|| ++.++++
T Consensus 223 s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 254 (278)
T cd05606 223 SPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 254 (278)
T ss_pred CHHHHHHHHHHhhcCHHhccCCCCCCHHHHHh
Confidence 33588999999999999999 8989875
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=285.20 Aligned_cols=201 Identities=28% Similarity=0.445 Sum_probs=170.1
Q ss_pred hcCccccCcccCCCCccEEEeecc---C--CcEEEEEEccccCc--ccHHHHHHHHHHHHhCCCCceeeEeeEEEe-CCe
Q 004400 415 TNNFATDNNIGEGGFGPVYKGLLA---D--GTAIAVKQLSSKSK--QGNREFINEIGMISALQHPNLVKLYGCCIE-GNQ 486 (756)
Q Consensus 415 ~~~~~~~~~lg~G~~g~Vy~~~~~---~--~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~ 486 (756)
...|+....||+|.||.||+|.-. + .+.+|+|.++...+ .......+|+..++.++|||+|.+..+|.. +..
T Consensus 23 l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~ 102 (438)
T KOG0666|consen 23 LFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKK 102 (438)
T ss_pred HHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCce
Confidence 357888899999999999999632 2 33799999976532 223678899999999999999999999887 889
Q ss_pred EEEEEEecCCCCHHHHHH----hcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCC----CCEEEc
Q 004400 487 LLLIYEYLENNSLARALF----EHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKD----LNSKIS 558 (756)
Q Consensus 487 ~~lV~e~~~~gsL~~~l~----~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~----~~~kl~ 558 (756)
+++++||.+. +|...++ .....++......|+.||+.|+.|||++. |+|||+||.|||+..+ |.|||+
T Consensus 103 v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NW---vlHRDLKPaNIlvmgdgperG~VKIa 178 (438)
T KOG0666|consen 103 VWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNW---VLHRDLKPANILVMGDGPERGRVKIA 178 (438)
T ss_pred EEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhh---eeeccCCcceEEEeccCCccCeeEee
Confidence 9999999987 7888776 22346889999999999999999999996 9999999999999888 899999
Q ss_pred cCCccccCcccCcce--eeccccCccCCchHhhhcC-CCCcccchhhHHHHHHHHHhCCCCCCc
Q 004400 559 DFGLAKLDEEENTHI--STRVAGTIGYMAPEYAMRG-HLTEKADVYSFGIVALEIVSGRSNVTK 619 (756)
Q Consensus 559 DFGla~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slGv~l~elltg~~p~~~ 619 (756)
|||++|++...-... ...++-|++|.|||.+.+. .|+.+.||||.|||+.||+|-++-|.+
T Consensus 179 DlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g 242 (438)
T KOG0666|consen 179 DLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKG 242 (438)
T ss_pred cccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccc
Confidence 999999887654332 3456779999999999884 699999999999999999998877743
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-34 Score=324.71 Aligned_cols=254 Identities=33% Similarity=0.511 Sum_probs=207.7
Q ss_pred cCccccCcccCCCCccEEEeecc----C----CcEEEEEEcccc-CcccHHHHHHHHHHHHhC-CCCceeeEeeEEEeCC
Q 004400 416 NNFATDNNIGEGGFGPVYKGLLA----D----GTAIAVKQLSSK-SKQGNREFINEIGMISAL-QHPNLVKLYGCCIEGN 485 (756)
Q Consensus 416 ~~~~~~~~lg~G~~g~Vy~~~~~----~----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~ 485 (756)
++....+.||+|+||.|++|... . ...||||.++.. .....+.+..|+++|+.+ +|+||+.++|+|...+
T Consensus 296 ~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~~~ 375 (609)
T KOG0200|consen 296 ENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQDG 375 (609)
T ss_pred hhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeeccCC
Confidence 34455669999999999999732 1 457999998764 334567899999999999 6999999999999999
Q ss_pred eEEEEEEecCCCCHHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEec
Q 004400 486 QLLLIYEYLENNSLARALFEHR---------------LKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLD 550 (756)
Q Consensus 486 ~~~lV~e~~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~ 550 (756)
..++|+||+..|+|.++++..+ ..++..+...++.|||.|++||++.. +||||+..+|||+.
T Consensus 376 ~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~---~vHRDLAaRNVLi~ 452 (609)
T KOG0200|consen 376 PLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVP---CVHRDLAARNVLIT 452 (609)
T ss_pred ceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCC---ccchhhhhhhEEec
Confidence 9999999999999999998766 34889999999999999999999884 99999999999999
Q ss_pred CCCCEEEccCCccccCcccCcceeecccc--CccCCchHhhhcCCCCcccchhhHHHHHHHHHh-CCCCCCccc-hhhHH
Q 004400 551 KDLNSKISDFGLAKLDEEENTHISTRVAG--TIGYMAPEYAMRGHLTEKADVYSFGIVALEIVS-GRSNVTKED-MFYLL 626 (756)
Q Consensus 551 ~~~~~kl~DFGla~~~~~~~~~~~~~~~g--t~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~-~~~~~ 626 (756)
++..+||+|||+|+..............| +..|||||.+....|+.|+|||||||++||++| |..|+.+.. ..++.
T Consensus 453 ~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~~~l~ 532 (609)
T KOG0200|consen 453 KNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPTEELL 532 (609)
T ss_pred CCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCcHHHHH
Confidence 99999999999999665554443332333 456999999999999999999999999999999 788886532 22222
Q ss_pred HHHHHHHhcCccccccccCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhcc
Q 004400 627 DWALVLKEQGKLMELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLEC 685 (756)
Q Consensus 627 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~L~~ 685 (756)
. ...++.+.+....+ ..++.++++.||+.+|++||++.++++.++.
T Consensus 533 ~----~l~~G~r~~~P~~c---------~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~ 578 (609)
T KOG0200|consen 533 E----FLKEGNRMEQPEHC---------SDEIYDLMKSCWNADPEDRPTFSECVEFFEK 578 (609)
T ss_pred H----HHhcCCCCCCCCCC---------CHHHHHHHHHHhCCCcccCCCHHHHHHHHHH
Confidence 1 33444444433332 2348899999999999999999999999986
|
|
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=300.31 Aligned_cols=255 Identities=21% Similarity=0.262 Sum_probs=190.7
Q ss_pred CcccCCCCccEEEeeccCCcEEEEEEcccc--CcccHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEEecCCCCH
Q 004400 422 NNIGEGGFGPVYKGLLADGTAIAVKQLSSK--SKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYEYLENNSL 499 (756)
Q Consensus 422 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL 499 (756)
+.+|.|+++.||++.. +++.||||++... .......+.+|+++++.++|+||+++++++.+++..+++|||+++|+|
T Consensus 8 ~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l 86 (314)
T cd08216 8 KCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSC 86 (314)
T ss_pred HhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCH
Confidence 4445555555555544 7899999998654 334456789999999999999999999999999999999999999999
Q ss_pred HHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCcccCc------c
Q 004400 500 ARALFEH-RLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENT------H 572 (756)
Q Consensus 500 ~~~l~~~-~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~~~~------~ 572 (756)
.+++... ...+++..+..++.|++.||+|||+++ |+||||||+||+++.++.+||+|||.+........ .
T Consensus 87 ~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~---ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~ 163 (314)
T cd08216 87 EDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKG---FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHD 163 (314)
T ss_pred HHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCcceEEEecCCceEEecCccceeecccccccccccc
Confidence 9999753 346899999999999999999999986 99999999999999999999999999864432111 1
Q ss_pred eeeccccCccCCchHhhhc--CCCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhc-------C-------
Q 004400 573 ISTRVAGTIGYMAPEYAMR--GHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQ-------G------- 636 (756)
Q Consensus 573 ~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~-------~------- 636 (756)
......++..|+|||++.. ..++.++|||||||++|||++|+.||.......... ...... .
T Consensus 164 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~ 241 (314)
T cd08216 164 FPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLL--EKVRGTVPCLLDKSTYPLYED 241 (314)
T ss_pred ccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHH--HHHhccCccccccCchhhhcC
Confidence 1223457889999999876 358899999999999999999999996543222110 000000 0
Q ss_pred cccc----cccc----CCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004400 637 KLME----LVDT----NPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRM 682 (756)
Q Consensus 637 ~~~~----~~~~----~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~ 682 (756)
.... ..+. .............+.+++.+||+.+|++|||+.++++.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 295 (314)
T cd08216 242 SMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNH 295 (314)
T ss_pred CcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcC
Confidence 0000 0000 00011122334568899999999999999999999764
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=301.87 Aligned_cols=256 Identities=23% Similarity=0.319 Sum_probs=190.9
Q ss_pred CcccCC--CCccEEEeec-cCCcEEEEEEccccC--cccHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEEecCC
Q 004400 422 NNIGEG--GFGPVYKGLL-ADGTAIAVKQLSSKS--KQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYEYLEN 496 (756)
Q Consensus 422 ~~lg~G--~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~ 496 (756)
..||+| +||+||+|.. .+|+.||+|.+.... ....+.+.+|+.+++.++||||++++++|..++..++|+||+.+
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~ 83 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence 356666 9999999995 579999999986532 22346788899999999999999999999999999999999999
Q ss_pred CCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCcccCcce--
Q 004400 497 NSLARALFEH-RLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHI-- 573 (756)
Q Consensus 497 gsL~~~l~~~-~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~~~~~~-- 573 (756)
|+|.+++... ...+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.++++||+.+..........
T Consensus 84 ~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (328)
T cd08226 84 GSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNG---YIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKV 160 (328)
T ss_pred CCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccccc
Confidence 9999998754 235899999999999999999999986 9999999999999999999999998654322111100
Q ss_pred ----eeccccCccCCchHhhhcC--CCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhcCc----------
Q 004400 574 ----STRVAGTIGYMAPEYAMRG--HLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGK---------- 637 (756)
Q Consensus 574 ----~~~~~gt~~y~aPE~~~~~--~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~---------- 637 (756)
.....++..|+|||++.+. .++.++|||||||++|||++|+.||.......... ........
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~ 238 (328)
T cd08226 161 VYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLL--QKLKGPPYSPLDITTFPC 238 (328)
T ss_pred cccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHH--HHhcCCCCCCccccccch
Confidence 1112356679999999763 47899999999999999999999996543221110 00000000
Q ss_pred ---------------cc----------cccccCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004400 638 ---------------LM----------ELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRM 682 (756)
Q Consensus 638 ---------------~~----------~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~ 682 (756)
.. ..................+.+++.+||+.||++|||+.|+++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~ 308 (328)
T cd08226 239 EESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSH 308 (328)
T ss_pred hhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 00 0000000111122345568999999999999999999999764
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-34 Score=305.59 Aligned_cols=261 Identities=22% Similarity=0.340 Sum_probs=202.5
Q ss_pred CccccCcccCCCCccEEEeecc-CCcEEEEEEccccC--cccHHHHHHHHHHHHhCCCCceeeEeeEEEeCC-----eEE
Q 004400 417 NFATDNNIGEGGFGPVYKGLLA-DGTAIAVKQLSSKS--KQGNREFINEIGMISALQHPNLVKLYGCCIEGN-----QLL 488 (756)
Q Consensus 417 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~~ 488 (756)
+|...+.||+|+||.||+|... +++.||+|.+.... ....+.+.+|+.+++.++|+||+++++++.+.+ ..+
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 4778899999999999999954 58999999987643 334567899999999999999999999998875 789
Q ss_pred EEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCcc
Q 004400 489 LIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEE 568 (756)
Q Consensus 489 lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~ 568 (756)
+||||+++ +|.+++.... .+++..+..++.|++.||+|||+.| |+||||||+||+++.++.++|+|||++.....
T Consensus 81 lv~e~~~~-~l~~~l~~~~-~l~~~~~~~i~~~l~~~l~~LH~~g---i~H~dlkp~nili~~~~~~~L~dfg~~~~~~~ 155 (330)
T cd07834 81 IVTELMET-DLHKVIKSPQ-PLTDDHIQYFLYQILRGLKYLHSAN---VIHRDLKPSNILVNSNCDLKICDFGLARGVDP 155 (330)
T ss_pred EEecchhh-hHHHHHhCCC-CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccCceEeecc
Confidence 99999984 8888886544 8999999999999999999999997 99999999999999999999999999986554
Q ss_pred cCc--ceeeccccCccCCchHhhhcC-CCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhcCc--------
Q 004400 569 ENT--HISTRVAGTIGYMAPEYAMRG-HLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGK-------- 637 (756)
Q Consensus 569 ~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~-------- 637 (756)
... .......++..|+|||.+.+. .++.++||||||+++|+|++|+.||...+................
T Consensus 156 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 235 (330)
T cd07834 156 DEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFIT 235 (330)
T ss_pred cccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhcc
Confidence 321 112334678899999999887 789999999999999999999999976654332221111110000
Q ss_pred ---cccccc---cCCCCC---CCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004400 638 ---LMELVD---TNPGSN---FDKEQVMVMINVALLCANASPTIRPSMSSVLRM 682 (756)
Q Consensus 638 ---~~~~~~---~~~~~~---~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~ 682 (756)
....+. ...... ..+.....+.+++.+||+.+|.+||++.++++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 289 (330)
T cd07834 236 SEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAH 289 (330)
T ss_pred ccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 000000 000000 011123458899999999999999999999874
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=303.15 Aligned_cols=261 Identities=21% Similarity=0.304 Sum_probs=196.5
Q ss_pred Ccc-ccCcccCCCCccEEEeec-cCCcEEEEEEccccCccc--------------HHHHHHHHHHHHhCCCCceeeEeeE
Q 004400 417 NFA-TDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSKSKQG--------------NREFINEIGMISALQHPNLVKLYGC 480 (756)
Q Consensus 417 ~~~-~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~--------------~~~~~~E~~~l~~l~h~niv~l~~~ 480 (756)
+|. ..+.||+|+||.||+|.. .+++.||||.+....... ...+.+|+++++.++|+||++++++
T Consensus 9 ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 88 (335)
T PTZ00024 9 RYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVDV 88 (335)
T ss_pred chhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeEE
Confidence 444 457799999999999994 578999999986532211 1257789999999999999999999
Q ss_pred EEeCCeEEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccC
Q 004400 481 CIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDF 560 (756)
Q Consensus 481 ~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DF 560 (756)
+..++..++||||+. |+|.+++.. ...+++.....++.|++.||+|||+.| |+||||||+||+++.++.+||+||
T Consensus 89 ~~~~~~~~lv~e~~~-~~l~~~l~~-~~~~~~~~~~~~~~ql~~aL~~LH~~~---i~H~dl~~~nill~~~~~~kl~df 163 (335)
T PTZ00024 89 YVEGDFINLVMDIMA-SDLKKVVDR-KIRLTESQVKCILLQILNGLNVLHKWY---FMHRDLSPANIFINSKGICKIADF 163 (335)
T ss_pred EecCCcEEEEEeccc-cCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHeEECCCCCEEECCc
Confidence 999999999999997 589888864 346899999999999999999999987 999999999999999999999999
Q ss_pred CccccCcccC-------------cceeeccccCccCCchHhhhcC-CCCcccchhhHHHHHHHHHhCCCCCCccchhhHH
Q 004400 561 GLAKLDEEEN-------------THISTRVAGTIGYMAPEYAMRG-HLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLL 626 (756)
Q Consensus 561 Gla~~~~~~~-------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~ 626 (756)
|+++...... ........++..|+|||.+.+. .++.++|||||||++|||++|+.||...+.....
T Consensus 164 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~ 243 (335)
T PTZ00024 164 GLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQL 243 (335)
T ss_pred cceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 9997654111 1111223568899999998764 4789999999999999999999999766554433
Q ss_pred HHHHHHHhcCccc---ccc--------ccCCCCC---CCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004400 627 DWALVLKEQGKLM---ELV--------DTNPGSN---FDKEQVMVMINVALLCANASPTIRPSMSSVLRM 682 (756)
Q Consensus 627 ~~~~~~~~~~~~~---~~~--------~~~~~~~---~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~ 682 (756)
............. ... ....... ........+.+++.+|++.+|++||++.|++..
T Consensus 244 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~ 313 (335)
T PTZ00024 244 GRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKH 313 (335)
T ss_pred HHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcC
Confidence 2222111111000 000 0000000 001123458899999999999999999999864
|
|
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-34 Score=298.84 Aligned_cols=259 Identities=25% Similarity=0.352 Sum_probs=197.1
Q ss_pred ccccCcccCCCCccEEEeecc-CCcEEEEEEccccCc-ccHHHHHHHHHHHHhCC-CCceeeEeeEEEeCCeEEEEEEec
Q 004400 418 FATDNNIGEGGFGPVYKGLLA-DGTAIAVKQLSSKSK-QGNREFINEIGMISALQ-HPNLVKLYGCCIEGNQLLLIYEYL 494 (756)
Q Consensus 418 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lV~e~~ 494 (756)
|...+.||+|+||.||+|... +++.|+||++..... .......+|+..+++++ |+||+++++++.+++..++||||+
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM 80 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence 566789999999999999964 578999999865432 22334567999999998 999999999999999999999999
Q ss_pred CCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCcccCcce
Q 004400 495 ENNSLARALFEHR-LKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHI 573 (756)
Q Consensus 495 ~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~~~~~~ 573 (756)
+|+|.+++.... ..+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||++........
T Consensus 81 -~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~-- 154 (283)
T cd07830 81 -EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHG---FFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP-- 154 (283)
T ss_pred -CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCCEEEeecccceeccCCCC--
Confidence 889999887543 57899999999999999999999986 99999999999999999999999999986543222
Q ss_pred eeccccCccCCchHhhhc-CCCCcccchhhHHHHHHHHHhCCCCCCccchhhHHH-------------HHHHHHhcCccc
Q 004400 574 STRVAGTIGYMAPEYAMR-GHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLD-------------WALVLKEQGKLM 639 (756)
Q Consensus 574 ~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~-------------~~~~~~~~~~~~ 639 (756)
.....|+..|+|||++.+ ..++.++||||||+++|||++|+.||.......... |...........
T Consensus 155 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (283)
T cd07830 155 YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLG 234 (283)
T ss_pred cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhcccc
Confidence 123457889999998754 457899999999999999999999996554332221 111110000110
Q ss_pred cccccCCCC---CCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004400 640 ELVDTNPGS---NFDKEQVMVMINVALLCANASPTIRPSMSSVLRM 682 (756)
Q Consensus 640 ~~~~~~~~~---~~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~ 682 (756)
..+...... ...+.....+.+++.+||+.+|++||++.|++..
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~ 280 (283)
T cd07830 235 FRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQH 280 (283)
T ss_pred ccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhC
Confidence 000000000 0000113458899999999999999999998763
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-34 Score=305.08 Aligned_cols=263 Identities=21% Similarity=0.360 Sum_probs=197.4
Q ss_pred hcCccccCcccCCCCccEEEeec-cCCcEEEEEEccccC--cccHHHHHHHHHHHHhCCCCceeeEeeEEEeC------C
Q 004400 415 TNNFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSKS--KQGNREFINEIGMISALQHPNLVKLYGCCIEG------N 485 (756)
Q Consensus 415 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~ 485 (756)
.++|...+.||+|+||.||+|+. .+|+.||+|.+.... ......+.+|++++++++||||+++++++... .
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 93 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ 93 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence 36889999999999999999994 578999999986532 22335688999999999999999999998754 3
Q ss_pred eEEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCcccc
Q 004400 486 QLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKL 565 (756)
Q Consensus 486 ~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~ 565 (756)
..++|+||+.. +|.++. ...+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++.
T Consensus 94 ~~~lv~e~~~~-~l~~~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dlkp~NIll~~~~~~kL~dfg~~~~ 166 (342)
T cd07879 94 DFYLVMPYMQT-DLQKIM---GHPLSEDKVQYLVYQMLCGLKYIHSAG---IIHRDLKPGNLAVNEDCELKILDFGLARH 166 (342)
T ss_pred eEEEEeccccc-CHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCCCCcC
Confidence 46999999975 676654 236899999999999999999999986 99999999999999999999999999976
Q ss_pred CcccCcceeeccccCccCCchHhhhc-CCCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHh----------
Q 004400 566 DEEENTHISTRVAGTIGYMAPEYAMR-GHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKE---------- 634 (756)
Q Consensus 566 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~---------- 634 (756)
..... ....++..|+|||.+.+ ..++.++|||||||++|||++|+.||...+.............
T Consensus 167 ~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (342)
T cd07879 167 ADAEM----TGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKL 242 (342)
T ss_pred CCCCC----CCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHh
Confidence 43321 23467889999999876 4688999999999999999999999976553322211111000
Q ss_pred -cCccc---cccccCCCCCC---CHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH--hccCcc
Q 004400 635 -QGKLM---ELVDTNPGSNF---DKEQVMVMINVALLCANASPTIRPSMSSVLRM--LECGVD 688 (756)
Q Consensus 635 -~~~~~---~~~~~~~~~~~---~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~--L~~~~~ 688 (756)
..... ......+.... .+.....+.+++.+||+.||++||++.++++. ++...+
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~ 305 (342)
T cd07879 243 EDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRD 305 (342)
T ss_pred cccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhccc
Confidence 00000 00000000000 00122347899999999999999999999854 665544
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-34 Score=305.84 Aligned_cols=261 Identities=23% Similarity=0.345 Sum_probs=194.6
Q ss_pred cCccccCcccCCCCccEEEeec-cCCcEEEEEEccccCcccHHHHHHHHHHHHhCCCCceeeEeeEEEeC----------
Q 004400 416 NNFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCCIEG---------- 484 (756)
Q Consensus 416 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~---------- 484 (756)
.+|...+.||+|+||.||+|.. .+++.||+|.+........+.+.+|++++++++||||+++++++...
T Consensus 5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~ 84 (342)
T cd07854 5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGS 84 (342)
T ss_pred cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccccc
Confidence 5788999999999999999994 57899999998766555667789999999999999999999876543
Q ss_pred ----CeEEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecC-CCCEEEcc
Q 004400 485 ----NQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDK-DLNSKISD 559 (756)
Q Consensus 485 ----~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~-~~~~kl~D 559 (756)
...++||||++ ++|.+++.. ..+++..+..++.||+.||+|||+.| |+||||||+||+++. ++.+||+|
T Consensus 85 ~~~~~~~~lv~e~~~-~~L~~~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~g---ivH~dikp~Nili~~~~~~~kl~d 158 (342)
T cd07854 85 LTELNSVYIVQEYME-TDLANVLEQ--GPLSEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANVFINTEDLVLKIGD 158 (342)
T ss_pred ccccceEEEEeeccc-ccHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCceEEECC
Confidence 35799999997 588888753 36899999999999999999999987 999999999999974 55789999
Q ss_pred CCccccCcccCcc--eeeccccCccCCchHhhhc-CCCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHH---
Q 004400 560 FGLAKLDEEENTH--ISTRVAGTIGYMAPEYAMR-GHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLK--- 633 (756)
Q Consensus 560 FGla~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~--- 633 (756)
||.++........ ......|+..|+|||.+.. ..++.++|||||||++|||++|+.||...+............
T Consensus 159 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~ 238 (342)
T cd07854 159 FGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVV 238 (342)
T ss_pred cccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCC
Confidence 9999765332211 1122457889999998755 568889999999999999999999996554322211100000
Q ss_pred ---hcCc----cccccc-cCCCCC-----CCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004400 634 ---EQGK----LMELVD-TNPGSN-----FDKEQVMVMINVALLCANASPTIRPSMSSVLRM 682 (756)
Q Consensus 634 ---~~~~----~~~~~~-~~~~~~-----~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~ 682 (756)
.... ...... ...... ..+.....+.+++.+|++.||++||++.|+++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h 300 (342)
T cd07854 239 REEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMH 300 (342)
T ss_pred ChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCC
Confidence 0000 000000 000000 001123458899999999999999999999753
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=291.48 Aligned_cols=248 Identities=24% Similarity=0.375 Sum_probs=194.7
Q ss_pred CccccCcccCCCCccEEEeecc-CCcEEEEEEcccc-----CcccHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEE
Q 004400 417 NFATDNNIGEGGFGPVYKGLLA-DGTAIAVKQLSSK-----SKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLI 490 (756)
Q Consensus 417 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 490 (756)
+|...+.||+|+||.||+|... .+..+++|.++.. .......+.+|+.++++++||||+++++++.++...++|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 4677899999999999999854 3445556655432 122334577899999999999999999999999999999
Q ss_pred EEecCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCc
Q 004400 491 YEYLENNSLARALFE---HRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDE 567 (756)
Q Consensus 491 ~e~~~~gsL~~~l~~---~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~ 567 (756)
|||+++++|.+++.. ....+++..+..++.|++.||+|||+.| ++|+||||+||+++. +.+||+|||+++...
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~~l~~~nili~~-~~~~l~d~g~~~~~~ 156 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRR---ILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM 156 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcC---ccccCCChhheEeec-CCEeecccCceeecC
Confidence 999999999998863 3457899999999999999999999986 999999999999986 569999999987654
Q ss_pred ccCcceeeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhcCccccccccCCC
Q 004400 568 EENTHISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPG 647 (756)
Q Consensus 568 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 647 (756)
.... ......|+..|+|||...+..++.++||||||+++|+|++|+.||........... .. .+..
T Consensus 157 ~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~---~~-~~~~--------- 222 (260)
T cd08222 157 GSCD-LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLR---IV-EGPT--------- 222 (260)
T ss_pred CCcc-cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHH---HH-cCCC---------
Confidence 3222 22335688899999999888899999999999999999999999965443222211 11 1111
Q ss_pred CCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004400 648 SNFDKEQVMVMINVALLCANASPTIRPSMSSVLRM 682 (756)
Q Consensus 648 ~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~ 682 (756)
...+......+.+++.+||+.+|++||++.|+++.
T Consensus 223 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 257 (260)
T cd08222 223 PSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILRN 257 (260)
T ss_pred CCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhhC
Confidence 11122334458899999999999999999999763
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-34 Score=288.41 Aligned_cols=264 Identities=28% Similarity=0.394 Sum_probs=201.4
Q ss_pred hhcCccccCcccCCCCccEEEeeccCCcEEEEEEccccCcccHHHHHHHHHHHHh--CCCCceeeEeeEEEeC----CeE
Q 004400 414 ATNNFATDNNIGEGGFGPVYKGLLADGTAIAVKQLSSKSKQGNREFINEIGMISA--LQHPNLVKLYGCCIEG----NQL 487 (756)
Q Consensus 414 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~~~~----~~~ 487 (756)
..++....+.||+|.||.||+|.|. |..||||++... +++.+.+|.++.+. ++|+||+.+++.=..+ .++
T Consensus 209 iarqI~L~e~IGkGRyGEVwrG~wr-Ge~VAVKiF~sr---dE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQL 284 (513)
T KOG2052|consen 209 IARQIVLQEIIGKGRFGEVWRGRWR-GEDVAVKIFSSR---DERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQL 284 (513)
T ss_pred hhheeEEEEEecCccccceeecccc-CCceEEEEeccc---chhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEE
Confidence 3457778899999999999999997 788999999643 44677788887765 5999999999885433 368
Q ss_pred EEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHc-----CCCCCeEcCCCCCCceEecCCCCEEEccCCc
Q 004400 488 LLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHG-----ESRIKVVHRDIKATNVLLDKDLNSKISDFGL 562 (756)
Q Consensus 488 ~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~-----~g~~~iiH~Dikp~Nill~~~~~~kl~DFGl 562 (756)
|||.+|.+.|||.|+|.. ..++.....+++..+|.||++||. +|.|.|.|||||+.|||+.+++...|+|+|+
T Consensus 285 wLvTdYHe~GSL~DyL~r--~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGL 362 (513)
T KOG2052|consen 285 WLVTDYHEHGSLYDYLNR--NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL 362 (513)
T ss_pred EEeeecccCCcHHHHHhh--ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeecee
Confidence 999999999999999976 479999999999999999999994 4788999999999999999999999999999
Q ss_pred cccCcccCcce---eeccccCccCCchHhhhcC----CC--CcccchhhHHHHHHHHHh----C------CCCCCccchh
Q 004400 563 AKLDEEENTHI---STRVAGTIGYMAPEYAMRG----HL--TEKADVYSFGIVALEIVS----G------RSNVTKEDMF 623 (756)
Q Consensus 563 a~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~----~~--~~~~Dv~slGv~l~ellt----g------~~p~~~~~~~ 623 (756)
|-......... ....+||-+|||||++... .+ -..+||||||.++||++. | +.||...-+.
T Consensus 363 Av~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~ 442 (513)
T KOG2052|consen 363 AVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVPS 442 (513)
T ss_pred eEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCCC
Confidence 97655442221 3346899999999999642 12 236999999999999975 2 2465322111
Q ss_pred h--HHHHHHHHHhcCccccccccCCC-CCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhccCcc
Q 004400 624 Y--LLDWALVLKEQGKLMELVDTNPG-SNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLECGVD 688 (756)
Q Consensus 624 ~--~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~L~~~~~ 688 (756)
+ .-+...++. .+.+.+... ...+.+.+..+.++++.||..+|..|-|+-.+-+.|.+..+
T Consensus 443 DPs~eeMrkVVC-----v~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~ 505 (513)
T KOG2052|consen 443 DPSFEEMRKVVC-----VQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSN 505 (513)
T ss_pred CCCHHHHhccee-----ecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhc
Confidence 1 001000011 111122222 23345677789999999999999999999999988886544
|
|
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-33 Score=299.92 Aligned_cols=263 Identities=24% Similarity=0.366 Sum_probs=198.5
Q ss_pred hHHHhhcCccccCcccCCCCccEEEee-ccCCcEEEEEEccccC--cccHHHHHHHHHHHHhCCCCceeeEeeEEEeC--
Q 004400 410 QIKAATNNFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSKS--KQGNREFINEIGMISALQHPNLVKLYGCCIEG-- 484 (756)
Q Consensus 410 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-- 484 (756)
.+...+++|...+.||+|+||.||+|. ..+++.||+|++.... ....+.+.+|++++++++||||+++++++...
T Consensus 11 ~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~ 90 (345)
T cd07877 11 TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARS 90 (345)
T ss_pred HHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeeccc
Confidence 455577899999999999999999998 5678999999986532 22345688899999999999999999988643
Q ss_pred ----CeEEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccC
Q 004400 485 ----NQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDF 560 (756)
Q Consensus 485 ----~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DF 560 (756)
...+++++++ +++|.+++.. ..+++..+..++.|+++||+|||+.+ |+||||||+||++++++.+||+||
T Consensus 91 ~~~~~~~~lv~~~~-~~~L~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl~df 164 (345)
T cd07877 91 LEEFNDVYLVTHLM-GADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDF 164 (345)
T ss_pred ccccccEEEEehhc-ccCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEcCCCCEEEecc
Confidence 3467888876 7799887753 36899999999999999999999987 999999999999999999999999
Q ss_pred CccccCcccCcceeeccccCccCCchHhhhc-CCCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhc----
Q 004400 561 GLAKLDEEENTHISTRVAGTIGYMAPEYAMR-GHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQ---- 635 (756)
Q Consensus 561 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~---- 635 (756)
|+++..... .....|+..|+|||.+.+ ..++.++|||||||++|||++|+.||...+..............
T Consensus 165 g~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 240 (345)
T cd07877 165 GLARHTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAE 240 (345)
T ss_pred ccccccccc----ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHH
Confidence 999754332 223467889999999876 46889999999999999999999999654432221111000000
Q ss_pred -------C---ccccccccCCCCCCC---HHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004400 636 -------G---KLMELVDTNPGSNFD---KEQVMVMINVALLCANASPTIRPSMSSVLRM 682 (756)
Q Consensus 636 -------~---~~~~~~~~~~~~~~~---~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~ 682 (756)
. .........+...+. ......+.+++.+|++.+|.+||++.++++.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 300 (345)
T cd07877 241 LLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 300 (345)
T ss_pred HHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence 0 000000000000000 0123357899999999999999999998764
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=301.70 Aligned_cols=258 Identities=22% Similarity=0.345 Sum_probs=195.8
Q ss_pred hhcCccccCcccCCCCccEEEee-ccCCcEEEEEEccccC--cccHHHHHHHHHHHHhCCCCceeeEeeEEEeCC-----
Q 004400 414 ATNNFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSKS--KQGNREFINEIGMISALQHPNLVKLYGCCIEGN----- 485 (756)
Q Consensus 414 ~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----- 485 (756)
..++|...+.||+|+||.||+|. ..+++.||||++.... ......+.+|++++++++||||+++++++..+.
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07880 13 VPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRF 92 (343)
T ss_pred cccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccccc
Confidence 46789999999999999999998 5679999999986432 223356889999999999999999999987653
Q ss_pred -eEEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccc
Q 004400 486 -QLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAK 564 (756)
Q Consensus 486 -~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~ 564 (756)
..++||||+ +++|.+++.. ..+++..+..++.|++.||+|||+.| |+||||||+||+++.++.+||+|||++.
T Consensus 93 ~~~~lv~e~~-~~~l~~~~~~--~~l~~~~~~~i~~qi~~al~~LH~~g---i~H~dlkp~Nill~~~~~~kl~dfg~~~ 166 (343)
T cd07880 93 HDFYLVMPFM-GTDLGKLMKH--EKLSEDRIQFLVYQMLKGLKYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLAR 166 (343)
T ss_pred ceEEEEEecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeeccccc
Confidence 468999999 7799888753 36899999999999999999999986 9999999999999999999999999998
Q ss_pred cCcccCcceeeccccCccCCchHhhhc-CCCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhc--------
Q 004400 565 LDEEENTHISTRVAGTIGYMAPEYAMR-GHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQ-------- 635 (756)
Q Consensus 565 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~-------- 635 (756)
...... ....+++.|+|||.+.+ ..++.++||||+||++|++++|+.||...+..............
T Consensus 167 ~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (343)
T cd07880 167 QTDSEM----TGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQK 242 (343)
T ss_pred ccccCc----cccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHh
Confidence 654321 23467889999999876 45889999999999999999999999755432211100000000
Q ss_pred ---CccccccccCCCC------CCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 004400 636 ---GKLMELVDTNPGS------NFDKEQVMVMINVALLCANASPTIRPSMSSVLR 681 (756)
Q Consensus 636 ---~~~~~~~~~~~~~------~~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~ 681 (756)
..........+.. .........+.+++.+|++.||++|||+.++++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~ 297 (343)
T cd07880 243 LQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALA 297 (343)
T ss_pred hcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 0000000000000 000112234789999999999999999999983
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-33 Score=299.29 Aligned_cols=261 Identities=25% Similarity=0.325 Sum_probs=193.1
Q ss_pred CccccCcccCCCCccEEEeecc-C--CcEEEEEEcccc--CcccHHHHHHHHHHHHhC-CCCceeeEeeEEEeC----Ce
Q 004400 417 NFATDNNIGEGGFGPVYKGLLA-D--GTAIAVKQLSSK--SKQGNREFINEIGMISAL-QHPNLVKLYGCCIEG----NQ 486 (756)
Q Consensus 417 ~~~~~~~lg~G~~g~Vy~~~~~-~--~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~----~~ 486 (756)
+|+..+.||+|+||.||+|... + +..||+|.+... .....+.+.+|+++++++ +||||+++++++... ..
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 4677889999999999999954 4 789999998643 222346788899999999 599999999976432 45
Q ss_pred EEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccC
Q 004400 487 LLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLD 566 (756)
Q Consensus 487 ~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~ 566 (756)
.++++||+. ++|.+++... ..+++..+..++.||+.||+|||+.| |+||||||+||+++.++.+||+|||+++..
T Consensus 81 ~~~~~e~~~-~~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~g---ivH~dlkp~Nili~~~~~~kl~Dfg~a~~~ 155 (332)
T cd07857 81 LYLYEELME-ADLHQIIRSG-QPLTDAHFQSFIYQILCGLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLARGF 155 (332)
T ss_pred EEEEEeccc-CCHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHeEEcCCCCEEeCcCCCceec
Confidence 788899886 5898888543 47899999999999999999999987 999999999999999999999999999865
Q ss_pred cccCcc---eeeccccCccCCchHhhhc-CCCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhc-------
Q 004400 567 EEENTH---ISTRVAGTIGYMAPEYAMR-GHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQ------- 635 (756)
Q Consensus 567 ~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~------- 635 (756)
...... ......||..|+|||++.+ ..++.++||||+||++|++++|+.||...+..............
T Consensus 156 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (332)
T cd07857 156 SENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLS 235 (332)
T ss_pred ccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence 432211 1233568999999998866 46899999999999999999999999665433222111110000
Q ss_pred ----Ccc---ccccccCCCCC---CCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004400 636 ----GKL---MELVDTNPGSN---FDKEQVMVMINVALLCANASPTIRPSMSSVLRM 682 (756)
Q Consensus 636 ----~~~---~~~~~~~~~~~---~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~ 682 (756)
... .......+... ..+.....+.+++.+|++.+|++|||+.++++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~ 292 (332)
T cd07857 236 RIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEH 292 (332)
T ss_pred hhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 000 00000000000 001123458899999999999999999998643
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-33 Score=299.06 Aligned_cols=260 Identities=24% Similarity=0.346 Sum_probs=198.0
Q ss_pred HhhcCccccCcccCCCCccEEEee-ccCCcEEEEEEcccc--CcccHHHHHHHHHHHHhCCCCceeeEeeEEEe-CCeEE
Q 004400 413 AATNNFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSK--SKQGNREFINEIGMISALQHPNLVKLYGCCIE-GNQLL 488 (756)
Q Consensus 413 ~~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~ 488 (756)
..+++|...+.||+|+||.||+|. ..+++.||+|++... .....+.+.+|++++++++||||++++++|.. ....+
T Consensus 7 ~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~ 86 (328)
T cd07856 7 EITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIY 86 (328)
T ss_pred ccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEE
Confidence 467889999999999999999998 558999999987543 22334678899999999999999999999876 56789
Q ss_pred EEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCcc
Q 004400 489 LIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEE 568 (756)
Q Consensus 489 lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~ 568 (756)
+|+||+ +++|.+++.. ..+++..+..++.|++.||+|||+.+ |+||||+|+||++++++.+||+|||.+.....
T Consensus 87 lv~e~~-~~~L~~~~~~--~~~~~~~~~~~~~ql~~aL~~LH~~~---iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~ 160 (328)
T cd07856 87 FVTELL-GTDLHRLLTS--RPLEKQFIQYFLYQILRGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLARIQDP 160 (328)
T ss_pred EEeehh-ccCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEeECCCCCEEeCccccccccCC
Confidence 999998 5689888753 35788889999999999999999986 99999999999999999999999999975432
Q ss_pred cCcceeeccccCccCCchHhhhc-CCCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHh-----------cC
Q 004400 569 ENTHISTRVAGTIGYMAPEYAMR-GHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKE-----------QG 636 (756)
Q Consensus 569 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~-----------~~ 636 (756)
.. ....++..|+|||.+.+ ..++.++|||||||++|+|++|+.||...+............. ..
T Consensus 161 ~~----~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (328)
T cd07856 161 QM----TGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSE 236 (328)
T ss_pred Cc----CCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccch
Confidence 21 23457889999998766 5689999999999999999999999965543222111110000 00
Q ss_pred ccccccccC-CCCCCCH-----HHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004400 637 KLMELVDTN-PGSNFDK-----EQVMVMINVALLCANASPTIRPSMSSVLRM 682 (756)
Q Consensus 637 ~~~~~~~~~-~~~~~~~-----~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~ 682 (756)
...+.+... .....+. .....+.+++.+|++.+|++||++.+++..
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~ 288 (328)
T cd07856 237 NTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH 288 (328)
T ss_pred hhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 000000000 0000111 123458899999999999999999999765
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=289.49 Aligned_cols=242 Identities=24% Similarity=0.352 Sum_probs=201.4
Q ss_pred hcCccccCcccCCCCccEEEeecc-CCcEEEEEEccccC---cccHHHHHHHHHHHHhC-CCCceeeEeeEEEeCCeEEE
Q 004400 415 TNNFATDNNIGEGGFGPVYKGLLA-DGTAIAVKQLSSKS---KQGNREFINEIGMISAL-QHPNLVKLYGCCIEGNQLLL 489 (756)
Q Consensus 415 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l 489 (756)
..+|.....||+|+||.|..|..+ +...+|||+++++. .++.+--+.|-++|+.. +-|.++++..+|+.-+++|+
T Consensus 348 ~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyF 427 (683)
T KOG0696|consen 348 ATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYF 427 (683)
T ss_pred ecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheee
Confidence 347888999999999999999854 56789999998762 22333445677787766 56899999999999999999
Q ss_pred EEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCccc
Q 004400 490 IYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEE 569 (756)
Q Consensus 490 V~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~~ 569 (756)
||||+.||+|--++++-+ ++.++.+..+|..||-||-+||++| ||+||||.+|||+|.+|.+||+|||+++.---+
T Consensus 428 VMEyvnGGDLMyhiQQ~G-kFKEp~AvFYAaEiaigLFFLh~kg---IiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~~ 503 (683)
T KOG0696|consen 428 VMEYVNGGDLMYHIQQVG-KFKEPVAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENIFD 503 (683)
T ss_pred EEEEecCchhhhHHHHhc-ccCCchhhhhhHHHHHHhhhhhcCC---eeeeeccccceEeccCCceEeeecccccccccC
Confidence 999999999998887654 7899999999999999999999997 999999999999999999999999999843222
Q ss_pred CcceeeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhcCccccccccCCCCC
Q 004400 570 NTHISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSN 649 (756)
Q Consensus 570 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 649 (756)
. ....+++||+.|+|||++....|+..+|.|||||++|||+.|+.||.++++..+.... .+.+ ..
T Consensus 504 ~-~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI------------~ehn--vs 568 (683)
T KOG0696|consen 504 G-VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAI------------MEHN--VS 568 (683)
T ss_pred C-cceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHH------------HHcc--Cc
Confidence 2 2245689999999999999999999999999999999999999999998877665422 1111 23
Q ss_pred CCHHHHHHHHHHHHHhhcCCCCCCCC
Q 004400 650 FDKEQVMVMINVALLCANASPTIRPS 675 (756)
Q Consensus 650 ~~~~~~~~l~~l~~~c~~~~P~~RPt 675 (756)
++...+.+.+.++...+...|.+|--
T Consensus 569 yPKslSkEAv~ickg~ltK~P~kRLG 594 (683)
T KOG0696|consen 569 YPKSLSKEAVAICKGLLTKHPGKRLG 594 (683)
T ss_pred CcccccHHHHHHHHHHhhcCCccccC
Confidence 44455566888899999999999964
|
|
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-34 Score=277.42 Aligned_cols=254 Identities=19% Similarity=0.298 Sum_probs=196.9
Q ss_pred cCcccCCCCccEEEee-ccCCcEEEEEEccccCcccHHHHHHHHHHHHhC-CCCceeeEeeEEEeCCeEEEEEEecCCCC
Q 004400 421 DNNIGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQGNREFINEIGMISAL-QHPNLVKLYGCCIEGNQLLLIYEYLENNS 498 (756)
Q Consensus 421 ~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~e~~~~gs 498 (756)
.+.||+|+|+.|--++ +.+|.+||||++.+.......++.+|++++... .|+||++++++|+++..+|||||-|.||+
T Consensus 83 ~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GGp 162 (463)
T KOG0607|consen 83 SELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGGP 162 (463)
T ss_pred HHHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCch
Confidence 3689999999999998 789999999999887777778899999999998 59999999999999999999999999999
Q ss_pred HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCC---EEEccCCccccCcc--cC---
Q 004400 499 LARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLN---SKISDFGLAKLDEE--EN--- 570 (756)
Q Consensus 499 L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~---~kl~DFGla~~~~~--~~--- 570 (756)
|..+++++. .+++.++.++..+||.||.+||.+| |.|||+||+|||-..... +|||||.++.-... +-
T Consensus 163 lLshI~~~~-~F~E~EAs~vvkdia~aLdFlH~kg---IAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~spa 238 (463)
T KOG0607|consen 163 LLSHIQKRK-HFNEREASRVVKDIASALDFLHTKG---IAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCSPA 238 (463)
T ss_pred HHHHHHHhh-hccHHHHHHHHHHHHHHHHHHhhcC---cccccCCccceeecCCCCcCceeeeccccccccccCCCCCCC
Confidence 999997654 7999999999999999999999997 999999999999976544 79999988753321 11
Q ss_pred -cceeeccccCccCCchHhhh-----cCCCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHH----HHhcCcccc
Q 004400 571 -THISTRVAGTIGYMAPEYAM-----RGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALV----LKEQGKLME 640 (756)
Q Consensus 571 -~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~----~~~~~~~~~ 640 (756)
+..-.+.+|+..|||||+.. ...|+.++|.||+|||+|-|++|..||.+.-.. ...|... ..+..-...
T Consensus 239 stP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~-dCGWdrGe~Cr~CQ~~LFes 317 (463)
T KOG0607|consen 239 STPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGA-DCGWDRGEVCRVCQNKLFES 317 (463)
T ss_pred CCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCC-cCCccCCCccHHHHHHHHHH
Confidence 11223457889999999874 246899999999999999999999999544321 1112110 000000000
Q ss_pred ccccCCCCCCCH----HHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 004400 641 LVDTNPGSNFDK----EQVMVMINVALLCANASPTIRPSMSSVLR 681 (756)
Q Consensus 641 ~~~~~~~~~~~~----~~~~~l~~l~~~c~~~~P~~RPt~~ev~~ 681 (756)
+-+. .-.|+. .......+++...+..++.+|-++.+++.
T Consensus 318 IQEG--kYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vln 360 (463)
T KOG0607|consen 318 IQEG--KYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLN 360 (463)
T ss_pred Hhcc--CCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence 0000 011222 22335667888888999999999999977
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=289.84 Aligned_cols=255 Identities=25% Similarity=0.393 Sum_probs=198.9
Q ss_pred hhcCccccCcccCCCCccEEEee-ccCCcEEEEEEccccCcc-------cHHHHHHHHHHHHhCCCCceeeEeeEEE-eC
Q 004400 414 ATNNFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQ-------GNREFINEIGMISALQHPNLVKLYGCCI-EG 484 (756)
Q Consensus 414 ~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~-------~~~~~~~E~~~l~~l~h~niv~l~~~~~-~~ 484 (756)
..++|-..++||+|||+.||+|. +...+.||||+-.....+ -.+...+|..|-+.+.||-||++|+||. +.
T Consensus 461 Ln~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDt 540 (775)
T KOG1151|consen 461 LNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDT 540 (775)
T ss_pred hHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeecc
Confidence 34567788999999999999998 677899999987543222 1245678999999999999999999997 55
Q ss_pred CeEEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecC---CCCEEEccCC
Q 004400 485 NQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDK---DLNSKISDFG 561 (756)
Q Consensus 485 ~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~---~~~~kl~DFG 561 (756)
+.+|-|+|||+|.+|+.+|..++ .+++.+++.|+.||..||.||.+. .++|||-||||.|||+.. -|.+||+|||
T Consensus 541 dsFCTVLEYceGNDLDFYLKQhk-lmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGeIKITDFG 618 (775)
T KOG1151|consen 541 DSFCTVLEYCEGNDLDFYLKQHK-LMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGEIKITDFG 618 (775)
T ss_pred ccceeeeeecCCCchhHHHHhhh-hhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccceeEeeecc
Confidence 77899999999999999997664 789999999999999999999988 578999999999999954 4679999999
Q ss_pred ccccCcccCcc------eeeccccCccCCchHhhhc----CCCCcccchhhHHHHHHHHHhCCCCCCccc-hhhHHHHHH
Q 004400 562 LAKLDEEENTH------ISTRVAGTIGYMAPEYAMR----GHLTEKADVYSFGIVALEIVSGRSNVTKED-MFYLLDWAL 630 (756)
Q Consensus 562 la~~~~~~~~~------~~~~~~gt~~y~aPE~~~~----~~~~~~~Dv~slGv~l~elltg~~p~~~~~-~~~~~~~~~ 630 (756)
++++++.+... .....+||.+|++||.+.- ...+.|+||||.|||+|+++.|+.||.... ..+++....
T Consensus 619 LSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILqeNT 698 (775)
T KOG1151|consen 619 LSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQENT 698 (775)
T ss_pred hhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHhhhc
Confidence 99988754332 3456789999999998854 357899999999999999999999995442 223332221
Q ss_pred HHHhcCccccccccCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHH
Q 004400 631 VLKEQGKLMELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSV 679 (756)
Q Consensus 631 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev 679 (756)
++.. .++ .+. +.. ........+|++|++..-++|....++
T Consensus 699 IlkA-tEV-qFP---~KP----vVsseAkaFIRRCLaYRKeDR~DV~qL 738 (775)
T KOG1151|consen 699 ILKA-TEV-QFP---PKP----VVSSEAKAFIRRCLAYRKEDRIDVQQL 738 (775)
T ss_pred hhcc-eec-cCC---CCC----ccCHHHHHHHHHHHHhhhhhhhhHHHH
Confidence 1111 000 111 111 122346788999999999999887765
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-34 Score=294.11 Aligned_cols=244 Identities=25% Similarity=0.362 Sum_probs=202.2
Q ss_pred ccCcccCCCCccEEEee-ccCCcEEEEEEcccc--CcccHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEEecCC
Q 004400 420 TDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSK--SKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYEYLEN 496 (756)
Q Consensus 420 ~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~ 496 (756)
.++.||+|-||+||-|. .++|+.||||++.+. .+.....+.+|+.||++++||.||.+--.|+..++++.|||-+.|
T Consensus 568 ~devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~G 647 (888)
T KOG4236|consen 568 ADEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHG 647 (888)
T ss_pred hHhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcc
Confidence 35799999999999999 568999999999764 344557889999999999999999999999999999999999987
Q ss_pred CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecC---CCCEEEccCCccccCcccCcce
Q 004400 497 NSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDK---DLNSKISDFGLAKLDEEENTHI 573 (756)
Q Consensus 497 gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~---~~~~kl~DFGla~~~~~~~~~~ 573 (756)
.=|+-.|.....++++.....++.||+.||.|||.++ |+|+|+||+|||+.+ ..++||||||+||++++....
T Consensus 648 DMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~kn---IvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksFR- 723 (888)
T KOG4236|consen 648 DMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKN---IVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSFR- 723 (888)
T ss_pred hHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcc---eeeccCCchheeeccCCCCCceeeccccceeecchhhhh-
Confidence 6666666677778999999999999999999999986 999999999999964 356999999999998875433
Q ss_pred eeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhcCccccccccCCCCCCCHH
Q 004400 574 STRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDKE 653 (756)
Q Consensus 574 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 653 (756)
..++||+.|+|||+++.+.|...-|+||.|||+|.-++|..||..++..... . ....-+..+.++...++
T Consensus 724 -rsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdIndQ--I------QNAaFMyPp~PW~eis~- 793 (888)
T KOG4236|consen 724 -RSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDINDQ--I------QNAAFMYPPNPWSEISP- 793 (888)
T ss_pred -hhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccchhHH--h------hccccccCCCchhhcCH-
Confidence 4578999999999999999999999999999999999999999655432211 1 11222334444444443
Q ss_pred HHHHHHHHHHHhhcCCCCCCCCHHHHH
Q 004400 654 QVMVMINVALLCANASPTIRPSMSSVL 680 (756)
Q Consensus 654 ~~~~l~~l~~~c~~~~P~~RPt~~ev~ 680 (756)
..+++|...++..-++|-+.++-+
T Consensus 794 ---~AidlIn~LLqVkm~kRysvdk~l 817 (888)
T KOG4236|consen 794 ---EAIDLINNLLQVKMRKRYSVDKSL 817 (888)
T ss_pred ---HHHHHHHHHHHHHHHHhcchHhhc
Confidence 477888888999889999988764
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=251.28 Aligned_cols=260 Identities=23% Similarity=0.353 Sum_probs=201.7
Q ss_pred CccccCcccCCCCccEEEee-ccCCcEEEEEEccccC--cccHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEEe
Q 004400 417 NFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSKS--KQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYEY 493 (756)
Q Consensus 417 ~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 493 (756)
+|+..++||+|.||+||+|+ +.++..||+|++..+. ...-....+|+.+++.++|+|||++++....+...-+|+||
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~ 82 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence 46667899999999999999 6678899999987543 23346789999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCcccCcce
Q 004400 494 LENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHI 573 (756)
Q Consensus 494 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~~~~~~ 573 (756)
|.. +|..+.......++.+.+..++.|+++||.++|++. +.|||+||.|.+++.+|..|++|||+++.++-.....
T Consensus 83 cdq-dlkkyfdslng~~d~~~~rsfmlqllrgl~fchshn---vlhrdlkpqnllin~ngelkladfglarafgipvrcy 158 (292)
T KOG0662|consen 83 CDQ-DLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHN---VLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRCY 158 (292)
T ss_pred hhH-HHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhh---hhhccCCcceEEeccCCcEEecccchhhhcCCceEee
Confidence 965 788887777778999999999999999999999985 9999999999999999999999999999877655443
Q ss_pred eeccccCccCCchHhhhcCC-CCcccchhhHHHHHHHHHhC-CCCCCccchhhHHHHHHHHHh---cCc---cccccccC
Q 004400 574 STRVAGTIGYMAPEYAMRGH-LTEKADVYSFGIVALEIVSG-RSNVTKEDMFYLLDWALVLKE---QGK---LMELVDTN 645 (756)
Q Consensus 574 ~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~slGv~l~elltg-~~p~~~~~~~~~~~~~~~~~~---~~~---~~~~~~~~ 645 (756)
+.. +-|.+|.+|.++.+.+ |++..|+||-||++.|+... ++.|.+.+..+.+........ ++. ...+.|-.
T Consensus 159 sae-vvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdyk 237 (292)
T KOG0662|consen 159 SAE-VVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDYK 237 (292)
T ss_pred ece-eeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCCc
Confidence 333 4589999999999865 89999999999999999974 444555554443332222211 111 12233333
Q ss_pred CCCCCCHHH---------HHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 004400 646 PGSNFDKEQ---------VMVMINVALLCANASPTIRPSMSSVLR 681 (756)
Q Consensus 646 ~~~~~~~~~---------~~~l~~l~~~c~~~~P~~RPt~~ev~~ 681 (756)
+...+++.. ...=.++++..+.-+|.+|.++++.++
T Consensus 238 ~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalq 282 (292)
T KOG0662|consen 238 PYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQ 282 (292)
T ss_pred ccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhc
Confidence 333333221 113456777888888999998887665
|
|
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=301.98 Aligned_cols=259 Identities=23% Similarity=0.383 Sum_probs=198.4
Q ss_pred hhcCccccCcccCCCCccEEEeec-cCCcEEEEEEcccc--CcccHHHHHHHHHHHHhCCCCceeeEeeEEEeCCe----
Q 004400 414 ATNNFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSK--SKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQ---- 486 (756)
Q Consensus 414 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~---- 486 (756)
..++|...+.||+|+||.||+|+. .+++.||+|.+... .......+.+|+.++++++||||+++++++..++.
T Consensus 13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07851 13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF 92 (343)
T ss_pred ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence 457899999999999999999995 46889999998653 22234567789999999999999999998876654
Q ss_pred --EEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccc
Q 004400 487 --LLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAK 564 (756)
Q Consensus 487 --~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~ 564 (756)
.++|+||+ +++|.+++.. ..+++..+..++.|++.||+|||+.| |+||||||+||+++.++.+||+|||++.
T Consensus 93 ~~~~lv~e~~-~~~L~~~~~~--~~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nill~~~~~~kL~dfg~~~ 166 (343)
T cd07851 93 QDVYLVTHLM-GADLNNIVKC--QKLSDDHIQFLVYQILRGLKYIHSAG---IIHRDLKPSNIAVNEDCELKILDFGLAR 166 (343)
T ss_pred ccEEEEEecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEccccccc
Confidence 89999999 5699998864 36899999999999999999999986 9999999999999999999999999998
Q ss_pred cCcccCcceeeccccCccCCchHhhhc-CCCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhcCc------
Q 004400 565 LDEEENTHISTRVAGTIGYMAPEYAMR-GHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGK------ 637 (756)
Q Consensus 565 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~------ 637 (756)
..... .....++..|+|||.+.+ ..++.++|||||||++||+++|+.||...+................
T Consensus 167 ~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 242 (343)
T cd07851 167 HTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQK 242 (343)
T ss_pred ccccc----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhh
Confidence 65432 223467889999999875 3678999999999999999999999966554332221111100000
Q ss_pred --------cccccccCCCCCCC---HHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004400 638 --------LMELVDTNPGSNFD---KEQVMVMINVALLCANASPTIRPSMSSVLRM 682 (756)
Q Consensus 638 --------~~~~~~~~~~~~~~---~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~ 682 (756)
....+.......+. ......+.+++.+|++.+|++|||+.+|++.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h 298 (343)
T cd07851 243 ISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAH 298 (343)
T ss_pred ccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcC
Confidence 00000000000000 0123458899999999999999999999763
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-35 Score=277.12 Aligned_cols=254 Identities=26% Similarity=0.372 Sum_probs=193.5
Q ss_pred CccccCcccCCCCccEEEee-ccCCcEEEEEEccccCc-ccHHHHHHHHHHHH-hCCCCceeeEeeEEEeCCeEEEEEEe
Q 004400 417 NFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSKSK-QGNREFINEIGMIS-ALQHPNLVKLYGCCIEGNQLLLIYEY 493 (756)
Q Consensus 417 ~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~-~l~h~niv~l~~~~~~~~~~~lV~e~ 493 (756)
+.+....||.|+||+|+|.. .+.|+..|||+++.... ...+++..|.+... .-+.||||++||++..++..|+.||.
T Consensus 65 ~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMEL 144 (361)
T KOG1006|consen 65 NLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMEL 144 (361)
T ss_pred hHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHH
Confidence 34455689999999999998 45799999999976543 45567888888654 45799999999999999999999999
Q ss_pred cCCCCHHHHHH----hcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCccc
Q 004400 494 LENNSLARALF----EHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEE 569 (756)
Q Consensus 494 ~~~gsL~~~l~----~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~~ 569 (756)
|+- |++.+-. .....+++.-.-+|.....+||.||-+.- +|||||+||+|||+|..|.+||||||++-...+.
T Consensus 145 Md~-SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~l--kiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~S 221 (361)
T KOG1006|consen 145 MDI-SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEEL--KIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDS 221 (361)
T ss_pred Hhh-hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHh--hhhhccCChhheEEecCCCEeeecccchHhHHHH
Confidence 965 6654332 23457888888999999999999998764 7999999999999999999999999998654432
Q ss_pred CcceeeccccCccCCchHhhhc--CCCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhcCccccccccCCC
Q 004400 570 NTHISTRVAGTIGYMAPEYAMR--GHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPG 647 (756)
Q Consensus 570 ~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 647 (756)
...+.-+|-..|||||.+.. ..|+-++||||+|+.+||+.||+.|+...+. .++....... +....+....-
T Consensus 222 --iAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~s--vfeql~~Vv~-gdpp~l~~~~~- 295 (361)
T KOG1006|consen 222 --IAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDS--VFEQLCQVVI-GDPPILLFDKE- 295 (361)
T ss_pred --HHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHH--HHHHHHHHHc-CCCCeecCccc-
Confidence 22344578889999999864 3489999999999999999999999965432 2222211111 11111111111
Q ss_pred CCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004400 648 SNFDKEQVMVMINVALLCANASPTIRPSMSSVLRM 682 (756)
Q Consensus 648 ~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~ 682 (756)
..+....+..++..|+.+|-++||.+.++.++
T Consensus 296 ---~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~ 327 (361)
T KOG1006|consen 296 ---CVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF 327 (361)
T ss_pred ---ccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence 11234458999999999999999999998654
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=282.87 Aligned_cols=236 Identities=26% Similarity=0.352 Sum_probs=192.8
Q ss_pred ccCCCCccEEEeecc-CCcEEEEEEccccCc---ccHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEEecCCCCH
Q 004400 424 IGEGGFGPVYKGLLA-DGTAIAVKQLSSKSK---QGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYEYLENNSL 499 (756)
Q Consensus 424 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL 499 (756)
||+|+||.||++... +++.||+|.+..... .....+..|++++++++||||+++++.+..++..++||||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 699999999999954 689999999875422 2345788999999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCcccCcceeecccc
Q 004400 500 ARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAG 579 (756)
Q Consensus 500 ~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~~g 579 (756)
.+++.... .+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++........ ......+
T Consensus 81 ~~~l~~~~-~l~~~~~~~~~~qi~~~l~~lh~~~---~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~ 155 (250)
T cd05123 81 FSHLSKEG-RFSEERARFYAAEIVLALEYLHSLG---IIYRDLKPENILLDADGHIKLTDFGLAKELSSEGS-RTNTFCG 155 (250)
T ss_pred HHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcceEEEcCCCcEEEeecCcceecccCCC-cccCCcC
Confidence 99997553 6899999999999999999999986 99999999999999999999999999976544321 2234568
Q ss_pred CccCCchHhhhcCCCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhcCccccccccCCCCCCCHHHHHHHH
Q 004400 580 TIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDKEQVMVMI 659 (756)
Q Consensus 580 t~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 659 (756)
+..|+|||...+...+.++|+||||+++|++++|+.||...+........ .. .. ..++......+.
T Consensus 156 ~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~---~~-~~----------~~~~~~~~~~l~ 221 (250)
T cd05123 156 TPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKI---LK-DP----------LRFPEFLSPEAR 221 (250)
T ss_pred CccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHH---hc-CC----------CCCCCCCCHHHH
Confidence 88999999998888899999999999999999999999655432222211 11 00 011111134488
Q ss_pred HHHHHhhcCCCCCCCCHHH
Q 004400 660 NVALLCANASPTIRPSMSS 678 (756)
Q Consensus 660 ~l~~~c~~~~P~~RPt~~e 678 (756)
+++.+||..||++||++.+
T Consensus 222 ~~i~~~l~~~p~~R~~~~~ 240 (250)
T cd05123 222 DLISGLLQKDPTKRLGSGG 240 (250)
T ss_pred HHHHHHhcCCHhhCCCccc
Confidence 9999999999999999943
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=319.09 Aligned_cols=145 Identities=28% Similarity=0.423 Sum_probs=130.6
Q ss_pred cCccccCcccCCCCccEEEeecc-CCcEEEEEEccccC---cccHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEE
Q 004400 416 NNFATDNNIGEGGFGPVYKGLLA-DGTAIAVKQLSSKS---KQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIY 491 (756)
Q Consensus 416 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 491 (756)
++|.+.+.||+|+||.||+|... +++.||||++.... ......+.+|+.+++.++||||+++++++...+..|+||
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm 83 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM 83 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence 57888999999999999999954 78999999986542 222367888999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccc
Q 004400 492 EYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAK 564 (756)
Q Consensus 492 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~ 564 (756)
||+.+++|.+++... ..+++..++.++.||+.||+|||..+ ||||||||+|||++.++.+||+|||+++
T Consensus 84 Ey~~g~~L~~li~~~-~~l~~~~~~~i~~qil~aL~yLH~~g---IiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 84 EYLIGGDVKSLLHIY-GYFDEEMAVKYISEVALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred eCCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 999999999998654 36889999999999999999999986 9999999999999999999999999986
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-33 Score=297.95 Aligned_cols=240 Identities=23% Similarity=0.329 Sum_probs=194.0
Q ss_pred hhcCccccCcccCCCCccEEEee-ccCCcEEEEEEccccCcccHHHHHHHHHHHHhC-CCCceeeEeeEEEeCCeEEEEE
Q 004400 414 ATNNFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQGNREFINEIGMISAL-QHPNLVKLYGCCIEGNQLLLIY 491 (756)
Q Consensus 414 ~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~ 491 (756)
.+..|.....+|.|+|+.|-.+. ..+++..+||++.+.. .+-.+|+.++... .||||+++.+.+.++.+.|+||
T Consensus 320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~----~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~ 395 (612)
T KOG0603|consen 320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA----DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVM 395 (612)
T ss_pred cchhhccccccCCCCccceeeeeccccccchhheeccccc----cccccccchhhhhcCCCcceeecceecCCceeeeee
Confidence 46778888889999999999998 5678999999997652 2334577666665 7999999999999999999999
Q ss_pred EecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEe-cCCCCEEEccCCccccCcccC
Q 004400 492 EYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLL-DKDLNSKISDFGLAKLDEEEN 570 (756)
Q Consensus 492 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill-~~~~~~kl~DFGla~~~~~~~ 570 (756)
|.+.||-+.+.+.... .+. ..+..|+.+|+.|+.|||++| |||||+||+|||+ ++.+.++|+|||.++.....
T Consensus 396 e~l~g~ell~ri~~~~-~~~-~e~~~w~~~lv~Av~~LH~~g---vvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~- 469 (612)
T KOG0603|consen 396 ELLDGGELLRRIRSKP-EFC-SEASQWAAELVSAVDYLHEQG---VVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS- 469 (612)
T ss_pred hhccccHHHHHHHhcc-hhH-HHHHHHHHHHHHHHHHHHhcC---eeecCCChhheeecCCCCcEEEEEechhhhCchh-
Confidence 9999999888886543 222 778889999999999999997 9999999999999 58899999999999876554
Q ss_pred cceeeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHhCCCCCCccchh-hHHHHHHHHHhcCccccccccCCCCC
Q 004400 571 THISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMF-YLLDWALVLKEQGKLMELVDTNPGSN 649 (756)
Q Consensus 571 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~ 649 (756)
..+.+-|..|.|||++....|++++|+||||++||+|++|+.||...... .+.. .+. ...
T Consensus 470 ---~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~-------------~i~---~~~ 530 (612)
T KOG0603|consen 470 ---CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIEIHT-------------RIQ---MPK 530 (612)
T ss_pred ---hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCchHHHHH-------------hhc---CCc
Confidence 22335688999999999999999999999999999999999999543221 1111 111 111
Q ss_pred CCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004400 650 FDKEQVMVMINVALLCANASPTIRPSMSSVLRM 682 (756)
Q Consensus 650 ~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~ 682 (756)
+....+....+++.+|++.||.+||+|.++...
T Consensus 531 ~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h 563 (612)
T KOG0603|consen 531 FSECVSDEAKDLLQQLLQVDPALRLGADEIGAH 563 (612)
T ss_pred cccccCHHHHHHHHHhccCChhhCcChhhhccC
Confidence 223334458899999999999999999999764
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-34 Score=293.59 Aligned_cols=243 Identities=22% Similarity=0.314 Sum_probs=202.4
Q ss_pred hcCccccCcccCCCCccEEEeeccCCc-EEEEEEcccc---CcccHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEE
Q 004400 415 TNNFATDNNIGEGGFGPVYKGLLADGT-AIAVKQLSSK---SKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLI 490 (756)
Q Consensus 415 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~-~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 490 (756)
..+++....||-||||.|=.+...... .+|+|.+++. .....+.+..|-.+|...+.|.||++|..|.+..++|+.
T Consensus 419 l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmL 498 (732)
T KOG0614|consen 419 LSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYML 498 (732)
T ss_pred hhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhh
Confidence 456677788999999999998865443 4888888764 344556678899999999999999999999999999999
Q ss_pred EEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCcccC
Q 004400 491 YEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEEN 570 (756)
Q Consensus 491 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~~~ 570 (756)
||-|-||.+...|+.. ..++..++..++..+.+|++|||.+| ||+|||||+|.++|.+|.+||.|||+|+......
T Consensus 499 mEaClGGElWTiLrdR-g~Fdd~tarF~~acv~EAfeYLH~k~---iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g~ 574 (732)
T KOG0614|consen 499 MEACLGGELWTILRDR-GSFDDYTARFYVACVLEAFEYLHRKG---IIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSGR 574 (732)
T ss_pred HHhhcCchhhhhhhhc-CCcccchhhhhHHHHHHHHHHHHhcC---ceeccCChhheeeccCCceEEeehhhHHHhccCC
Confidence 9999999999999655 47999999999999999999999997 9999999999999999999999999999877655
Q ss_pred cceeeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhcCccccccccCCCCCC
Q 004400 571 THISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNF 650 (756)
Q Consensus 571 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 650 (756)
.. -+++||+.|.|||++..+..+.++|.||+|+++||+++|.+||.+.+.+..... +.+. -+.. .+
T Consensus 575 KT--wTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~--ILkG-id~i---------~~ 640 (732)
T KOG0614|consen 575 KT--WTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNL--ILKG-IDKI---------EF 640 (732)
T ss_pred ce--eeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHH--HHhh-hhhh---------hc
Confidence 44 358999999999999999999999999999999999999999988776544322 2221 1111 22
Q ss_pred CHHHHHHHHHHHHHhhcCCCCCCCC
Q 004400 651 DKEQVMVMINVALLCANASPTIRPS 675 (756)
Q Consensus 651 ~~~~~~~l~~l~~~c~~~~P~~RPt 675 (756)
+........+++++....+|.+|--
T Consensus 641 Pr~I~k~a~~Lik~LCr~~P~ERLG 665 (732)
T KOG0614|consen 641 PRRITKTATDLIKKLCRDNPTERLG 665 (732)
T ss_pred ccccchhHHHHHHHHHhcCcHhhhc
Confidence 3333345778888888899999975
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-33 Score=266.81 Aligned_cols=252 Identities=20% Similarity=0.252 Sum_probs=192.9
Q ss_pred hcCccc-cCcccCCCCccEEEee-ccCCcEEEEEEccccCcccHHHHHHHHHHHHh-CCCCceeeEeeEEEe----CCeE
Q 004400 415 TNNFAT-DNNIGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQGNREFINEIGMISA-LQHPNLVKLYGCCIE----GNQL 487 (756)
Q Consensus 415 ~~~~~~-~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~-l~h~niv~l~~~~~~----~~~~ 487 (756)
+++|.+ .++||-|-.|.|-.+. ..+|..+|+|++... ....+|++.--. -.|||||.++++|.. ...+
T Consensus 60 tedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-----~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcL 134 (400)
T KOG0604|consen 60 TEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-----PKARREVELHWMASGHPHIVSIIDVYENSYQGRKCL 134 (400)
T ss_pred hhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC-----HHHHhHhhhhhhhcCCCceEEeehhhhhhccCceee
Confidence 444544 2689999999999998 457899999998543 345778886433 479999999999864 4567
Q ss_pred EEEEEecCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecC---CCCEEEccCCcc
Q 004400 488 LLIYEYLENNSLARALFEHR-LKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDK---DLNSKISDFGLA 563 (756)
Q Consensus 488 ~lV~e~~~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~---~~~~kl~DFGla 563 (756)
.+|||.|+||.|...+.+++ ..+++.++..|+.||+.|+.|||+. +|.||||||+|+|... |..+||+|||+|
T Consensus 135 LiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~---nIAHRDlKpENLLyt~t~~na~lKLtDfGFA 211 (400)
T KOG0604|consen 135 LIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSM---NIAHRDLKPENLLYTTTSPNAPLKLTDFGFA 211 (400)
T ss_pred EeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhc---chhhccCChhheeeecCCCCcceEecccccc
Confidence 89999999999999998554 4699999999999999999999988 5999999999999975 455899999999
Q ss_pred ccCcccCcceeeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhcCccccccc
Q 004400 564 KLDEEENTHISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVD 643 (756)
Q Consensus 564 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 643 (756)
+....... ..+.+-|+.|.|||++-..+|+..+|+||+||++|-|++|.+||+......+--- +.......+.-
T Consensus 212 K~t~~~~~--L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispg---Mk~rI~~gqy~- 285 (400)
T KOG0604|consen 212 KETQEPGD--LMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPG---MKRRIRTGQYE- 285 (400)
T ss_pred cccCCCcc--ccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCChh---HHhHhhccCcc-
Confidence 96554222 2445779999999999999999999999999999999999999976543221110 00000000000
Q ss_pred cCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004400 644 TNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRM 682 (756)
Q Consensus 644 ~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~ 682 (756)
-+... ....++...++++..+..+|++|-|+.++++.
T Consensus 286 -FP~pE-Ws~VSe~aKdlIR~LLkt~PteRlTI~~~m~h 322 (400)
T KOG0604|consen 286 -FPEPE-WSCVSEAAKDLIRKLLKTEPTERLTIEEVMDH 322 (400)
T ss_pred -CCChh-HhHHHHHHHHHHHHHhcCCchhheeHHHhhcC
Confidence 01011 12345567889999999999999999999764
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-32 Score=277.10 Aligned_cols=220 Identities=21% Similarity=0.197 Sum_probs=176.1
Q ss_pred CCCccEEEee-ccCCcEEEEEEccccCcccHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEEecCCCCHHHHHHh
Q 004400 427 GGFGPVYKGL-LADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYEYLENNSLARALFE 505 (756)
Q Consensus 427 G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~ 505 (756)
|.+|.||+++ ..+++.||+|.+.... .+.+|...+....||||+++++++.+.+..++||||+++|+|.+++..
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 78 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK 78 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence 8999999999 4678999999986542 234455566666799999999999999999999999999999999875
Q ss_pred cCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCcccCcceeeccccCccCCc
Q 004400 506 HRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMA 585 (756)
Q Consensus 506 ~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~a 585 (756)
.. .+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.++++|||.+....... ....++..|+|
T Consensus 79 ~~-~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~----~~~~~~~~y~a 150 (237)
T cd05576 79 FL-NIPEECVKRWAAEMVVALDALHREG---IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSC----DGEAVENMYCA 150 (237)
T ss_pred hc-CCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEEEecccchhcccccc----ccCCcCccccC
Confidence 43 6899999999999999999999986 9999999999999999999999999876544321 22345778999
Q ss_pred hHhhhcCCCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhcCccccccccCCCCCCCHHHHHHHHHHHHHh
Q 004400 586 PEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDKEQVMVMINVALLC 665 (756)
Q Consensus 586 PE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c 665 (756)
||.+.+..++.++||||+|+++|||++|+.|+...... ....... ..+......+.+++.+|
T Consensus 151 PE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~--------------~~~~~~~----~~~~~~~~~~~~li~~~ 212 (237)
T cd05576 151 PEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSG--------------INTHTTL----NIPEWVSEEARSLLQQL 212 (237)
T ss_pred CcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchh--------------ccccccc----CCcccCCHHHHHHHHHH
Confidence 99998888999999999999999999999876422110 0000000 01111233488899999
Q ss_pred hcCCCCCCCCHH
Q 004400 666 ANASPTIRPSMS 677 (756)
Q Consensus 666 ~~~~P~~RPt~~ 677 (756)
++.||++||++.
T Consensus 213 l~~dp~~R~~~~ 224 (237)
T cd05576 213 LQFNPTERLGAG 224 (237)
T ss_pred ccCCHHHhcCCC
Confidence 999999999973
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.6e-32 Score=296.31 Aligned_cols=256 Identities=28% Similarity=0.414 Sum_probs=208.5
Q ss_pred hHHHhhcCccccCcccCCCCccEEEee-ccCCcEEEEEEccccCcccHHHHHHHHHHHHhC-CCCceeeEeeEEEe----
Q 004400 410 QIKAATNNFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQGNREFINEIGMISAL-QHPNLVKLYGCCIE---- 483 (756)
Q Consensus 410 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~---- 483 (756)
.+...++-|++.+.||.|.+|.||+++ .++++.+|+|+..... ...+++..|.++++.+ .|||++.+||+|..
T Consensus 13 ~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~-d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~ 91 (953)
T KOG0587|consen 13 SLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTE-DEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPG 91 (953)
T ss_pred hCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCc-cccHHHHHHHHHHHhccCCCCcceEEEEEEEecCC
Confidence 344567789999999999999999999 6678999999987653 3456788899999988 69999999999864
Q ss_pred -CCeEEEEEEecCCCCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCC
Q 004400 484 -GNQLLLIYEYLENNSLARALFE-HRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFG 561 (756)
Q Consensus 484 -~~~~~lV~e~~~~gsL~~~l~~-~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFG 561 (756)
++.+|||||||.+||..|++.. .+..+.|..+..|++.++.|+.+||... ++|||||-.|||++.++.||++|||
T Consensus 92 ~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nk---viHRDikG~NiLLT~e~~VKLvDFG 168 (953)
T KOG0587|consen 92 NGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNK---VIHRDIKGQNVLLTENAEVKLVDFG 168 (953)
T ss_pred CCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcc---eeeecccCceEEEeccCcEEEeeee
Confidence 5789999999999999999973 3668999999999999999999999884 9999999999999999999999999
Q ss_pred ccccCcccCcceeeccccCccCCchHhhhc-----CCCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhcC
Q 004400 562 LAKLDEEENTHISTRVAGTIGYMAPEYAMR-----GHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQG 636 (756)
Q Consensus 562 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~ 636 (756)
.+....... ....+..||+.|||||++.. ..|+..+|+||+|++..||.-|.+|+...-....
T Consensus 169 vSaQldsT~-grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmra----------- 236 (953)
T KOG0587|consen 169 VSAQLDSTV-GRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRA----------- 236 (953)
T ss_pred eeeeeeccc-ccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhh-----------
Confidence 997544322 22345789999999999964 3477899999999999999999999854432211
Q ss_pred ccccccc-cCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004400 637 KLMELVD-TNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRM 682 (756)
Q Consensus 637 ~~~~~~~-~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~ 682 (756)
+..++. +.+...-+.....++.++|..|+..|.++||++.++++.
T Consensus 237 -LF~IpRNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~h 282 (953)
T KOG0587|consen 237 -LFLIPRNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKH 282 (953)
T ss_pred -hccCCCCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhccC
Confidence 111221 122223355667789999999999999999999998654
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.3e-32 Score=285.69 Aligned_cols=209 Identities=24% Similarity=0.417 Sum_probs=177.4
Q ss_pred hhhHHHhh---cCccccCcccCCCCccEEEee-ccCCcEEEEEEccccC---cccHHHHHHHHHHHHhCCCCceeeEeeE
Q 004400 408 YLQIKAAT---NNFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSKS---KQGNREFINEIGMISALQHPNLVKLYGC 480 (756)
Q Consensus 408 ~~~~~~~~---~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~ 480 (756)
|.+++.+. .-|..++.||-|+||.|..++ ..+...||+|.+.+++ .........|-.||.....+=||++|..
T Consensus 618 YiRLkRaKMdKSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyyS 697 (1034)
T KOG0608|consen 618 YIRLKRAKMDKSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYS 697 (1034)
T ss_pred HHHHHHhhccccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEE
Confidence 44555543 458889999999999999998 5556789999998753 3334567889999999999999999999
Q ss_pred EEeCCeEEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccC
Q 004400 481 CIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDF 560 (756)
Q Consensus 481 ~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DF 560 (756)
|.+++.+|+||||++||++-.+|.+.+ .+.+.-++.++..+..|+++.|..| +|||||||+|||||.+|.+||+||
T Consensus 698 FQDkdnLYFVMdYIPGGDmMSLLIrmg-IFeE~LARFYIAEltcAiesVHkmG---FIHRDiKPDNILIDrdGHIKLTDF 773 (1034)
T KOG0608|consen 698 FQDKDNLYFVMDYIPGGDMMSLLIRMG-IFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDF 773 (1034)
T ss_pred eccCCceEEEEeccCCccHHHHHHHhc-cCHHHHHHHHHHHHHHHHHHHHhcc---ceecccCccceEEccCCceeeeec
Confidence 999999999999999999999998765 6888999999999999999999997 999999999999999999999999
Q ss_pred CccccCc---c-----cCcc---------------------------------eeeccccCccCCchHhhhcCCCCcccc
Q 004400 561 GLAKLDE---E-----ENTH---------------------------------ISTRVAGTIGYMAPEYAMRGHLTEKAD 599 (756)
Q Consensus 561 Gla~~~~---~-----~~~~---------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~D 599 (756)
|++.-+. + .+.+ .....+||+.|+|||++.+..|+.-+|
T Consensus 774 GLCTGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cd 853 (1034)
T KOG0608|consen 774 GLCTGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCD 853 (1034)
T ss_pred cccccceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccch
Confidence 9986221 1 0000 001246999999999999999999999
Q ss_pred hhhHHHHHHHHHhCCCCCCcc
Q 004400 600 VYSFGIVALEIVSGRSNVTKE 620 (756)
Q Consensus 600 v~slGv~l~elltg~~p~~~~ 620 (756)
.||.|||||||+.|+.||...
T Consensus 854 wws~gvil~em~~g~~pf~~~ 874 (1034)
T KOG0608|consen 854 WWSVGVILYEMLVGQPPFLAD 874 (1034)
T ss_pred hhHhhHHHHHHhhCCCCccCC
Confidence 999999999999999999544
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1e-33 Score=267.00 Aligned_cols=264 Identities=24% Similarity=0.374 Sum_probs=199.3
Q ss_pred hcCccccCcccCCCCccEEEeec-cCCcEEEEEEcccc-Cc-ccHHHHHHHHHHHHhCCCCceeeEeeEEEe--------
Q 004400 415 TNNFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSK-SK-QGNREFINEIGMISALQHPNLVKLYGCCIE-------- 483 (756)
Q Consensus 415 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~-~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-------- 483 (756)
...|....+||+|.||.||+|+. .+|+.||+|++-.. .+ .--....+|+.+|..++|+|++.+++.|..
T Consensus 16 ~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~ 95 (376)
T KOG0669|consen 16 VSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRD 95 (376)
T ss_pred chHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccc
Confidence 34566678999999999999994 56788898765432 22 223567899999999999999999998864
Q ss_pred CCeEEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCcc
Q 004400 484 GNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLA 563 (756)
Q Consensus 484 ~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla 563 (756)
...+|+|+++|+. +|.-.|.....+++..++.+++.++..||.|+|.. .|+|||+||.|+|++.++.+||+|||++
T Consensus 96 r~t~ylVf~~ceh-DLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~---kilHRDmKaaNvLIt~dgilklADFGla 171 (376)
T KOG0669|consen 96 RATFYLVFDFCEH-DLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRN---KILHRDMKAANVLITKDGILKLADFGLA 171 (376)
T ss_pred cceeeeeHHHhhh-hHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHh---hHHhhcccHhhEEEcCCceEEeeccccc
Confidence 2358999999987 78888877778899999999999999999999987 4999999999999999999999999999
Q ss_pred ccCcccCcce---eeccccCccCCchHhhhc-CCCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhcCc--
Q 004400 564 KLDEEENTHI---STRVAGTIGYMAPEYAMR-GHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGK-- 637 (756)
Q Consensus 564 ~~~~~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~-- 637 (756)
+.+....... .+..+-|.+|.+||.+.+ ++|+++.|||+-||++.||+||.+-+.+......+.........-.
T Consensus 172 r~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tke 251 (376)
T KOG0669|consen 172 RAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKE 251 (376)
T ss_pred cceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCcc
Confidence 8654332221 233455899999999987 5799999999999999999999888877665544443333322110
Q ss_pred ---------cccccccC--CCCCCC--HHHH------HHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004400 638 ---------LMELVDTN--PGSNFD--KEQV------MVMINVALLCANASPTIRPSMSSVLRM 682 (756)
Q Consensus 638 ---------~~~~~~~~--~~~~~~--~~~~------~~l~~l~~~c~~~~P~~RPt~~ev~~~ 682 (756)
+.+.+... +...+. ++.. ....+++..++..||.+|+++++++..
T Consensus 252 vWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh 315 (376)
T KOG0669|consen 252 VWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNH 315 (376)
T ss_pred cCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhch
Confidence 11111000 111110 0111 146688889999999999999998764
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5e-32 Score=270.30 Aligned_cols=261 Identities=22% Similarity=0.326 Sum_probs=210.2
Q ss_pred hhhHHHhhcCccccCcccCCCCccEEEeecc------CCcEEEEEEcccc-CcccHHHHHHHHHHHHhCCCCceeeEeeE
Q 004400 408 YLQIKAATNNFATDNNIGEGGFGPVYKGLLA------DGTAIAVKQLSSK-SKQGNREFINEIGMISALQHPNLVKLYGC 480 (756)
Q Consensus 408 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~ 480 (756)
..++.....++.....+-+|.||+||+|.|. +.+.|.+|.++.. +......+.+|.-.+..+.|||+.++.++
T Consensus 276 ~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V 355 (563)
T KOG1024|consen 276 LQELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGV 355 (563)
T ss_pred HHhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEE
Confidence 3455555667888899999999999999654 3456778877653 44455678999999999999999999999
Q ss_pred EEeC-CeEEEEEEecCCCCHHHHHHh-------cCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCC
Q 004400 481 CIEG-NQLLLIYEYLENNSLARALFE-------HRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKD 552 (756)
Q Consensus 481 ~~~~-~~~~lV~e~~~~gsL~~~l~~-------~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~ 552 (756)
+.++ ...+.+|.++.-|+|..+|.. ..+.++..+...++.|++.|++|||.+| |||.||..+|+++|+.
T Consensus 356 ~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~---ViHkDiAaRNCvIdd~ 432 (563)
T KOG1024|consen 356 SIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHG---VIHKDIAARNCVIDDQ 432 (563)
T ss_pred EeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcC---cccchhhhhcceehhh
Confidence 8765 567889999999999999982 2345677788899999999999999997 9999999999999999
Q ss_pred CCEEEccCCccccCcccCcce-eeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHh-CCCCCCccchhhHHHHHH
Q 004400 553 LNSKISDFGLAKLDEEENTHI-STRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVS-GRSNVTKEDMFYLLDWAL 630 (756)
Q Consensus 553 ~~~kl~DFGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~~~~~ 630 (756)
.++||+|=.++|..-+.+.+. ...--.+..||+||.+.+..|+.++|||||||++|||+| |+.|+..-++++...+.
T Consensus 433 LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~yl- 511 (563)
T KOG1024|consen 433 LQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYL- 511 (563)
T ss_pred eeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHH-
Confidence 999999999999765554443 223345678999999999999999999999999999998 99999766666544332
Q ss_pred HHHhcCccccccccCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhc
Q 004400 631 VLKEQGKLMELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLE 684 (756)
Q Consensus 631 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~L~ 684 (756)
.++.+...+.. ++.++..++..||...|++||+++|++..|.
T Consensus 512 ---kdGyRlaQP~N---------CPDeLf~vMacCWallpeeRPsf~Qlv~cLs 553 (563)
T KOG1024|consen 512 ---KDGYRLAQPFN---------CPDELFTVMACCWALLPEERPSFSQLVICLS 553 (563)
T ss_pred ---hccceecCCCC---------CcHHHHHHHHHHHhcCcccCCCHHHHHHHHH
Confidence 23333332222 2234889999999999999999999998886
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.5e-32 Score=264.03 Aligned_cols=247 Identities=22% Similarity=0.318 Sum_probs=194.8
Q ss_pred hhcCccccCcccCCCCccEEEeec-cCCcEEEEEEcccc---CcccHHHHHHHHHHHHhC-CCCceeeEeeEEEeCCeEE
Q 004400 414 ATNNFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSK---SKQGNREFINEIGMISAL-QHPNLVKLYGCCIEGNQLL 488 (756)
Q Consensus 414 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~ 488 (756)
..++|+..+.||+|+|++|..+++ ++.+.||+|++++. ..++..-...|-.+..+. +||.+|-+..+|+.+..++
T Consensus 248 ~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlf 327 (593)
T KOG0695|consen 248 GLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLF 327 (593)
T ss_pred ccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEE
Confidence 356899999999999999999994 56788999999764 233334456677777666 7999999999999999999
Q ss_pred EEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCcc
Q 004400 489 LIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEE 568 (756)
Q Consensus 489 lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~ 568 (756)
+|.||++||+|..++++.+ +++++.++.+...|.-||.|||++| ||.||+|.+|||+|.+|.+|++|+|+++.--.
T Consensus 328 fvieyv~ggdlmfhmqrqr-klpeeharfys~ei~lal~flh~rg---iiyrdlkldnvlldaeghikltdygmcke~l~ 403 (593)
T KOG0695|consen 328 FVIEYVNGGDLMFHMQRQR-KLPEEHARFYSAEICLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLG 403 (593)
T ss_pred EEEEEecCcceeeehhhhh-cCcHHHhhhhhHHHHHHHHHHhhcC---eeeeeccccceEEccCCceeecccchhhcCCC
Confidence 9999999999988886554 8999999999999999999999998 99999999999999999999999999984322
Q ss_pred cCcceeeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHhCCCCCCccc----hhhHHHHHHHHHhcCcccccccc
Q 004400 569 ENTHISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKED----MFYLLDWALVLKEQGKLMELVDT 644 (756)
Q Consensus 569 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~----~~~~~~~~~~~~~~~~~~~~~~~ 644 (756)
+ ...+++++||+.|.|||++.+..|+..+|.|++||+++||+.|+.||.-.. ....-++...+.-++.+
T Consensus 404 ~-gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqi------ 476 (593)
T KOG0695|consen 404 P-GDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQI------ 476 (593)
T ss_pred C-CcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhcc------
Confidence 2 233567899999999999999999999999999999999999999993211 11111221111111111
Q ss_pred CCCCCCCHHHHHHHHHHHHHhhcCCCCCCCC
Q 004400 645 NPGSNFDKEQVMVMINVALLCANASPTIRPS 675 (756)
Q Consensus 645 ~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt 675 (756)
..+....-+...+++..+.+||.+|--
T Consensus 477 ----riprslsvkas~vlkgflnkdp~erlg 503 (593)
T KOG0695|consen 477 ----RIPRSLSVKASHVLKGFLNKDPKERLG 503 (593)
T ss_pred ----cccceeehhhHHHHHHhhcCCcHHhcC
Confidence 111222223556778889999999863
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-31 Score=293.43 Aligned_cols=257 Identities=20% Similarity=0.240 Sum_probs=181.8
Q ss_pred HhhcCccccCcccCCCCccEEEeec-----------------cCCcEEEEEEccccCcccHH--------------HHHH
Q 004400 413 AATNNFATDNNIGEGGFGPVYKGLL-----------------ADGTAIAVKQLSSKSKQGNR--------------EFIN 461 (756)
Q Consensus 413 ~~~~~~~~~~~lg~G~~g~Vy~~~~-----------------~~~~~vavK~~~~~~~~~~~--------------~~~~ 461 (756)
...++|+..++||+|+||.||+|.. .+++.||||++........+ .+..
T Consensus 142 ~~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~v 221 (507)
T PLN03224 142 WSSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMV 221 (507)
T ss_pred ccccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHH
Confidence 4578999999999999999999963 24568999998654322222 2345
Q ss_pred HHHHHHhCCCCce-----eeEeeEEEe--------CCeEEEEEEecCCCCHHHHHHhcC---------------------
Q 004400 462 EIGMISALQHPNL-----VKLYGCCIE--------GNQLLLIYEYLENNSLARALFEHR--------------------- 507 (756)
Q Consensus 462 E~~~l~~l~h~ni-----v~l~~~~~~--------~~~~~lV~e~~~~gsL~~~l~~~~--------------------- 507 (756)
|+.++.+++|.++ ++++++|.. ++..++||||+++|+|.++++...
T Consensus 222 E~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~ 301 (507)
T PLN03224 222 EAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNM 301 (507)
T ss_pred HHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhc
Confidence 7777888876654 677888753 356899999999999999986421
Q ss_pred --CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCcccCcceeeccccCccCCc
Q 004400 508 --LKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMA 585 (756)
Q Consensus 508 --~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~a 585 (756)
..++|..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++..............+|+.|+|
T Consensus 302 ~~~~~~~~~~~~i~~ql~~aL~~lH~~~---ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~a 378 (507)
T PLN03224 302 PQDKRDINVIKGVMRQVLTGLRKLHRIG---IVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSP 378 (507)
T ss_pred ccccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeC
Confidence 13467889999999999999999986 9999999999999999999999999997544322221222345889999
Q ss_pred hHhhhcCCC----------------------CcccchhhHHHHHHHHHhCCC-CCCccchhh---------HHHHHHHHH
Q 004400 586 PEYAMRGHL----------------------TEKADVYSFGIVALEIVSGRS-NVTKEDMFY---------LLDWALVLK 633 (756)
Q Consensus 586 PE~~~~~~~----------------------~~~~Dv~slGv~l~elltg~~-p~~~~~~~~---------~~~~~~~~~ 633 (756)
||.+..... ..+.||||+||++|||++|.. |+.....+. ...|....
T Consensus 379 PE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~- 457 (507)
T PLN03224 379 PEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYK- 457 (507)
T ss_pred hhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhc-
Confidence 998854321 234799999999999999875 663221111 11111100
Q ss_pred hcCccccccccCCCCCCCHHHHHHHHHHHHHhhcCCC---CCCCCHHHHHHH
Q 004400 634 EQGKLMELVDTNPGSNFDKEQVMVMINVALLCANASP---TIRPSMSSVLRM 682 (756)
Q Consensus 634 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~P---~~RPt~~ev~~~ 682 (756)
. ...+-.. .........+++.+++..+| .+|+|+.|+++.
T Consensus 458 -~----~~~~~~~----~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~H 500 (507)
T PLN03224 458 -G----QKYDFSL----LDRNKEAGWDLACKLITKRDQANRGRLSVGQALSH 500 (507)
T ss_pred -c----cCCCccc----ccccChHHHHHHHHHhccCCCCcccCCCHHHHhCC
Confidence 0 0001111 11123347788899998766 789999998764
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.9e-32 Score=329.19 Aligned_cols=277 Identities=30% Similarity=0.447 Sum_probs=132.7
Q ss_pred ceeccccccccCcccccCCcccCCCCCCCEEEccCCcccCccCcccccCCcce-eeccCccccccCCccCcCcCCCcEEE
Q 004400 16 KTVNQKRVLKEQNLTGVLPPKLAELTFLQDIDLTLNYLSGTIPSQWASLPLLN-ISLIANRLKGPIPKYLANISTLVNLT 94 (756)
Q Consensus 16 ~~~~~~l~L~~~~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~-l~l~~n~~~~~~p~~l~~l~~L~~L~ 94 (756)
+..++.|+|++|.+++.+|..|.++++|+.|+|++|.+.+.+|..+..++.|+ |++.+|++.+.+|..|+++++|+.|+
T Consensus 139 l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~ 218 (968)
T PLN00113 139 IPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIY 218 (968)
T ss_pred cCCCCEEECcCCcccccCChHHhcCCCCCEEECccCcccccCChhhhhCcCCCeeeccCCCCcCcCChHHcCcCCccEEE
Confidence 34445555555555555555555555555555555555444454444444442 44444444444444444444555555
Q ss_pred eecCcccccCCcccCCCCCCcEEeccCCeecccCCccccCCCCCCEEEeeCCcccccCChhhcCcCCCcEEEccCCcCcC
Q 004400 95 VQYNQFSGELPEELGSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRISDNQFTGQIPSFIQNWTKLEKLFIQPSGLAG 174 (756)
Q Consensus 95 L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~ 174 (756)
|++|++.+.+|..|+++++|++|+|++|++++.+|..|.++++|+.|+|++|++++.+|..+.++++|++|+|++|.+.+
T Consensus 219 L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~ 298 (968)
T PLN00113 219 LGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSG 298 (968)
T ss_pred CcCCccCCcCChhHhcCCCCCEEECcCceeccccChhHhCCCCCCEEECcCCeeeccCchhHhhccCcCEEECcCCeecc
Confidence 55554444444444444444444444444444444444444444444444444444444444444444444444444444
Q ss_pred CCCc------------------------cccCCCCCCeEEccCCCCCCCCccccccc-cccEEEcccccccCCCCccccC
Q 004400 175 PIPS------------------------GIFSLENLTDLRISDLNGPEATFPQLGNM-KMTKLILRNCNITGELPRYLGK 229 (756)
Q Consensus 175 ~~p~------------------------~~~~l~~L~~L~l~~n~~~~~~~~~~~~~-~L~~L~L~~n~l~~~~p~~~~~ 229 (756)
.+|. .+..+++|+.|++++|.+....+..++.. +|+.|+|++|++++.+|..+..
T Consensus 299 ~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~~~~L~~L~Ls~n~l~~~~p~~~~~ 378 (968)
T PLN00113 299 EIPELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCS 378 (968)
T ss_pred CCChhHcCCCCCcEEECCCCccCCcCChhHhcCCCCCEEECcCCCCcCcCChHHhCCCCCcEEECCCCeeEeeCChhHhC
Confidence 4444 44444444444444444443333333322 2444444444444444444444
Q ss_pred CCCCcEEEccCCcCCCCCCccCcCCCCCCeEEecCccccccCCchh--hcCCCeeEeecCCCCCC
Q 004400 230 MTKLKVLDLSFNRLRGQIPSNFDDLYDVDYIYFAGNLLTGAIPPWM--LERGDKIDLSYNNFTDG 292 (756)
Q Consensus 230 l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~--~~~l~~l~ls~N~l~~~ 292 (756)
+++|+.|++++|.+.+.+|..+..+++|+.|++++|++++.+|..+ ++.++.+++++|.+++.
T Consensus 379 ~~~L~~L~l~~n~l~~~~p~~~~~~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ 443 (968)
T PLN00113 379 SGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGR 443 (968)
T ss_pred cCCCCEEECcCCEecccCCHHHhCCCCCCEEECcCCEeeeECChhHhcCCCCCEEECcCCcccCc
Confidence 4444444444444444444444445555555555555555555444 44455555555555443
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.5e-31 Score=267.98 Aligned_cols=237 Identities=27% Similarity=0.439 Sum_probs=193.7
Q ss_pred CCccEEEeecc-CCcEEEEEEccccCccc-HHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEEecCCCCHHHHHHh
Q 004400 428 GFGPVYKGLLA-DGTAIAVKQLSSKSKQG-NREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYEYLENNSLARALFE 505 (756)
Q Consensus 428 ~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~ 505 (756)
+||.||+|... +++.+|+|++....... .+.+.+|++.+++++|+||+++++++......++|+||+++++|.+++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 58999999965 58999999997654444 67899999999999999999999999999999999999999999999875
Q ss_pred cCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCcccCcceeeccccCccCCc
Q 004400 506 HRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMA 585 (756)
Q Consensus 506 ~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~a 585 (756)
.. .+++..+..++.++++++.|||+.+ ++|+||+|+||++++++.++|+|||.+....... ......++..|++
T Consensus 81 ~~-~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~~~ 154 (244)
T smart00220 81 RG-RLSEDEARFYARQILSALEYLHSNG---IIHRDLKPENILLDEDGHVKLADFGLARQLDPGG--LLTTFVGTPEYMA 154 (244)
T ss_pred cc-CCCHHHHHHHHHHHHHHHHHHHHcC---eecCCcCHHHeEECCCCcEEEccccceeeecccc--ccccccCCcCCCC
Confidence 44 3899999999999999999999986 9999999999999999999999999998765432 2234568889999
Q ss_pred hHhhhcCCCCcccchhhHHHHHHHHHhCCCCCCc-cchhhHHHHHHHHHhcCccccccccCCCCCCCHHHHHHHHHHHHH
Q 004400 586 PEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTK-EDMFYLLDWALVLKEQGKLMELVDTNPGSNFDKEQVMVMINVALL 664 (756)
Q Consensus 586 PE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~ 664 (756)
||......++.++||||||++++++++|..||.. .+......+. ....... ..... .....+.+++.+
T Consensus 155 pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~----~~~~~~~----~~~~~---~~~~~~~~~i~~ 223 (244)
T smart00220 155 PEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKI----GKPKPPF----PPPEW---KISPEAKDLIRK 223 (244)
T ss_pred HHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHH----hccCCCC----ccccc---cCCHHHHHHHHH
Confidence 9999888899999999999999999999999965 3332222211 1111100 00000 022358899999
Q ss_pred hhcCCCCCCCCHHHHHH
Q 004400 665 CANASPTIRPSMSSVLR 681 (756)
Q Consensus 665 c~~~~P~~RPt~~ev~~ 681 (756)
|+..+|++||++.++++
T Consensus 224 ~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 224 LLVKDPEKRLTAEEALQ 240 (244)
T ss_pred HccCCchhccCHHHHhh
Confidence 99999999999999986
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-31 Score=301.11 Aligned_cols=258 Identities=21% Similarity=0.255 Sum_probs=171.4
Q ss_pred hhcCccccCcccCCCCccEEEeecc-C----CcEEEEEEccccCcccHHHHHHHHHHHHhCCCCceeeEeeE------EE
Q 004400 414 ATNNFATDNNIGEGGFGPVYKGLLA-D----GTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGC------CI 482 (756)
Q Consensus 414 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~----~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~------~~ 482 (756)
..++|...+.||+|+||.||+|+.. + +..||+|++..... .+....| .++...+.+++.++.. +.
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~--~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~ 205 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA--VEIWMNE--RVRRACPNSCADFVYGFLEPVSSK 205 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch--hHHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence 5689999999999999999999954 5 68999998754321 1111111 1222222333222221 24
Q ss_pred eCCeEEEEEEecCCCCHHHHHHhcCCC-------------------CCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCC
Q 004400 483 EGNQLLLIYEYLENNSLARALFEHRLK-------------------LDWPTRRRICLGIARGLAYLHGESRIKVVHRDIK 543 (756)
Q Consensus 483 ~~~~~~lV~e~~~~gsL~~~l~~~~~~-------------------l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dik 543 (756)
.+...++||||+++++|.+++...... .....+..++.|++.||+|||+.+ |+|||||
T Consensus 206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g---IiHRDLK 282 (566)
T PLN03225 206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG---IVHRDVK 282 (566)
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC---EEeCcCC
Confidence 567899999999999999998743211 112345679999999999999986 9999999
Q ss_pred CCceEecC-CCCEEEccCCccccCcccCcceeeccccCccCCchHhhhcC----------------------CCCcccch
Q 004400 544 ATNVLLDK-DLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPEYAMRG----------------------HLTEKADV 600 (756)
Q Consensus 544 p~Nill~~-~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------~~~~~~Dv 600 (756)
|+|||++. ++.+||+|||+|+..............||+.|+|||.+... .++.++||
T Consensus 283 P~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DV 362 (566)
T PLN03225 283 PQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDI 362 (566)
T ss_pred HHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCccc
Confidence 99999986 57899999999986654444444567899999999976422 23456799
Q ss_pred hhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhcCc-c---ccccccCCCCC----C--CHHHHHHHHHHHHHhhcCCC
Q 004400 601 YSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGK-L---MELVDTNPGSN----F--DKEQVMVMINVALLCANASP 670 (756)
Q Consensus 601 ~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~-~---~~~~~~~~~~~----~--~~~~~~~l~~l~~~c~~~~P 670 (756)
|||||++|||+++..++.... ......+...+. . ........... + .........+++.+|++.||
T Consensus 363 wSlGviL~el~~~~~~~~~~~----~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP 438 (566)
T PLN03225 363 YSAGLIFLQMAFPNLRSDSNL----IQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKG 438 (566)
T ss_pred HHHHHHHHHHHhCcCCCchHH----HHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCc
Confidence 999999999999776643221 111111111000 0 00000000000 0 00011235589999999999
Q ss_pred CCCCCHHHHHHH
Q 004400 671 TIRPSMSSVLRM 682 (756)
Q Consensus 671 ~~RPt~~ev~~~ 682 (756)
++|||+.|+++.
T Consensus 439 ~kR~ta~e~L~H 450 (566)
T PLN03225 439 RQRISAKAALAH 450 (566)
T ss_pred ccCCCHHHHhCC
Confidence 999999999875
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-31 Score=244.35 Aligned_cols=201 Identities=26% Similarity=0.431 Sum_probs=166.8
Q ss_pred hhcCccccCcccCCCCccEEEee-ccCCcEEEEEEccccC-cccHHHHHHHHHHHHh-CCCCceeeEeeEEEeCCeEEEE
Q 004400 414 ATNNFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSKS-KQGNREFINEIGMISA-LQHPNLVKLYGCCIEGNQLLLI 490 (756)
Q Consensus 414 ~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~-l~h~niv~l~~~~~~~~~~~lV 490 (756)
..++......||+|++|.|-+.+ ..+|+..|+|.+.... .+..++..+|+.+..+ ..+|.+|.+||.+.++...++.
T Consensus 44 ~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIc 123 (282)
T KOG0984|consen 44 PADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWIC 123 (282)
T ss_pred chhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEe
Confidence 34455566789999999999988 5689999999997653 2334567788887555 4799999999999999999999
Q ss_pred EEecCCCCHHHHHH---hcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCc
Q 004400 491 YEYLENNSLARALF---EHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDE 567 (756)
Q Consensus 491 ~e~~~~gsL~~~l~---~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~ 567 (756)
||.|.. ||+.+-. ..+..+++...-+|+..+.+||.|||++- .|||||+||+|||++.+|++||||||++-+..
T Consensus 124 ME~M~t-Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL--~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~ 200 (282)
T KOG0984|consen 124 MELMDT-SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKL--SVIHRDVKPSNILINYDGQVKICDFGISGYLV 200 (282)
T ss_pred HHHhhh-hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHh--hhhhccCCcceEEEccCCcEEEcccccceeeh
Confidence 999965 6765443 56778999999999999999999999974 79999999999999999999999999998665
Q ss_pred ccCcceeeccccCccCCchHhhhc----CCCCcccchhhHHHHHHHHHhCCCCCCc
Q 004400 568 EENTHISTRVAGTIGYMAPEYAMR----GHLTEKADVYSFGIVALEIVSGRSNVTK 619 (756)
Q Consensus 568 ~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~Dv~slGv~l~elltg~~p~~~ 619 (756)
+... .+...|--.|||||.+.. ..|+-|+||||+|+.+.||.+++.||..
T Consensus 201 dSiA--kt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~ 254 (282)
T KOG0984|consen 201 DSIA--KTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYES 254 (282)
T ss_pred hhhH--HHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccc
Confidence 4322 222457778999999853 3689999999999999999999999943
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4e-31 Score=264.68 Aligned_cols=258 Identities=21% Similarity=0.308 Sum_probs=198.4
Q ss_pred hhcCccccCcccCCCCccEEEee-ccCCcEEEEEEccccCcccHHHHHHHHHHHHhCCC--Cc----eeeEeeEEEeCCe
Q 004400 414 ATNNFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQGNREFINEIGMISALQH--PN----LVKLYGCCIEGNQ 486 (756)
Q Consensus 414 ~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--~n----iv~l~~~~~~~~~ 486 (756)
.+++|.+...+|+|.||.|-.+. ...+..||||+++...+ -.+..+-|++++.++.+ |+ +|.+.++|...+.
T Consensus 87 l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~k-YreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrgh 165 (415)
T KOG0671|consen 87 LTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDK-YREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGH 165 (415)
T ss_pred cccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHH-HhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCc
Confidence 36789999999999999999998 44578999999975432 33456779999999942 32 7888899999999
Q ss_pred EEEEEEecCCCCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecC--------------
Q 004400 487 LLLIYEYLENNSLARALFE-HRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDK-------------- 551 (756)
Q Consensus 487 ~~lV~e~~~~gsL~~~l~~-~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~-------------- 551 (756)
.|+|+|.+ |-|+.+++.+ +...++...+..++.|+++++++||+.+ ++|-||||+|||+.+
T Consensus 166 iCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~k---l~HTDLKPENILfvss~~~~~~~~k~~~~ 241 (415)
T KOG0671|consen 166 ICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLK---LTHTDLKPENILFVSSEYFKTYNPKKKVC 241 (415)
T ss_pred eEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcc---eeecCCChheEEEeccceEEEeccCCccc
Confidence 99999987 5589999975 4567899999999999999999999986 999999999999931
Q ss_pred ------CCCEEEccCCccccCcccCcceeeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHhCCCCCCccchhhH
Q 004400 552 ------DLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYL 625 (756)
Q Consensus 552 ------~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~ 625 (756)
+..+||+|||.|+...+.. ..++.|..|.|||++.+-.++..+||||+||||+|+.||...|+..+....
T Consensus 242 ~~r~~ks~~I~vIDFGsAtf~~e~h----s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~EH 317 (415)
T KOG0671|consen 242 FIRPLKSTAIKVIDFGSATFDHEHH----STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENLEH 317 (415)
T ss_pred eeccCCCcceEEEecCCcceeccCc----ceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcHHH
Confidence 2348999999999765544 345678899999999999999999999999999999999999965553332
Q ss_pred HHHHHHHHh-----------------cCcccccc------------ccCCC----CCCCHHHHHHHHHHHHHhhcCCCCC
Q 004400 626 LDWALVLKE-----------------QGKLMELV------------DTNPG----SNFDKEQVMVMINVALLCANASPTI 672 (756)
Q Consensus 626 ~~~~~~~~~-----------------~~~~~~~~------------~~~~~----~~~~~~~~~~l~~l~~~c~~~~P~~ 672 (756)
+.....+.+ .+ ..+.. +.+.. ......+...+.+++++++..||.+
T Consensus 318 LaMMerIlGp~P~~mi~r~~~~Kyf~~~-rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~ 396 (415)
T KOG0671|consen 318 LAMMERILGPIPSRMIKKTRKEKYFRRG-RLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPAR 396 (415)
T ss_pred HHHHHHhhCCCcHHHhhhhhhHhhhhcc-cccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCccc
Confidence 221111111 01 00000 00000 0112234457999999999999999
Q ss_pred CCCHHHHHH
Q 004400 673 RPSMSSVLR 681 (756)
Q Consensus 673 RPt~~ev~~ 681 (756)
|+|+.|+++
T Consensus 397 RiTl~EAL~ 405 (415)
T KOG0671|consen 397 RITLREALS 405 (415)
T ss_pred cccHHHHhc
Confidence 999999875
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-32 Score=259.85 Aligned_cols=262 Identities=23% Similarity=0.329 Sum_probs=198.7
Q ss_pred CccccCcccCCCCccEEEee-ccCCcEEEEEEcccc--CcccHHHHHHHHHHHHhCCCCceeeEeeEEEeC-----CeEE
Q 004400 417 NFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSK--SKQGNREFINEIGMISALQHPNLVKLYGCCIEG-----NQLL 488 (756)
Q Consensus 417 ~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~~~ 488 (756)
+.+.++.||-|+||.||.++ -++|+.||.|++... .-...+.+.+|+.+|..++|.|++..++..... .++|
T Consensus 54 Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiY 133 (449)
T KOG0664|consen 54 DIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELY 133 (449)
T ss_pred cCCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHH
Confidence 45678999999999999998 568999999988653 223457789999999999999999998887654 3567
Q ss_pred EEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCcc
Q 004400 489 LIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEE 568 (756)
Q Consensus 489 lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~ 568 (756)
.|+|.|.. +|...+- ....++...+.-+..||++||+|||+.+ |.||||||.|.|++.+...||||||+|+..+.
T Consensus 134 V~TELmQS-DLHKIIV-SPQ~Ls~DHvKVFlYQILRGLKYLHsA~---ILHRDIKPGNLLVNSNCvLKICDFGLARvee~ 208 (449)
T KOG0664|consen 134 VLTELMQS-DLHKIIV-SPQALTPDHVKVFVYQILRGLKYLHTAN---ILHRDIKPGNLLVNSNCILKICDFGLARTWDQ 208 (449)
T ss_pred HHHHHHHh-hhhheec-cCCCCCcchhhhhHHHHHhhhHHHhhcc---hhhccCCCccEEeccCceEEecccccccccch
Confidence 78888754 6666553 3457888899999999999999999986 99999999999999999999999999998776
Q ss_pred cCcceeeccccCccCCchHhhhc-CCCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhcCc----------
Q 004400 569 ENTHISTRVAGTIGYMAPEYAMR-GHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGK---------- 637 (756)
Q Consensus 569 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~---------- 637 (756)
+.....+..+-|-.|.|||++++ +.|+.+.||||.|||+.|++..+..|...+....++..........
T Consensus 209 d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEG 288 (449)
T KOG0664|consen 209 RDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEG 288 (449)
T ss_pred hhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhh
Confidence 65555555556889999999998 4699999999999999999999988876665554443332222111
Q ss_pred -cccccccCCCC-CC--------CHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHh
Q 004400 638 -LMELVDTNPGS-NF--------DKEQVMVMINVALLCANASPTIRPSMSSVLRML 683 (756)
Q Consensus 638 -~~~~~~~~~~~-~~--------~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~L 683 (756)
...++...+.. .+ +.........+...++..||++|.+..+.+..+
T Consensus 289 Ak~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~ 344 (449)
T KOG0664|consen 289 AKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHR 344 (449)
T ss_pred hHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccc
Confidence 11111111100 00 112223456777788999999999999886654
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.9e-30 Score=238.95 Aligned_cols=255 Identities=18% Similarity=0.331 Sum_probs=192.4
Q ss_pred hcCccccCcccCCCCccEEEee-ccCCcEEEEEEccccCcccHHHHHHHHHHHHhCC-CCceeeEeeEEEeC--CeEEEE
Q 004400 415 TNNFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQGNREFINEIGMISALQ-HPNLVKLYGCCIEG--NQLLLI 490 (756)
Q Consensus 415 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~--~~~~lV 490 (756)
.++|++.+.+|+|.++.||.|. ..+...++||.++.. ..+.+.+|+.+|+.++ ||||+++++...++ ....+|
T Consensus 37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV---kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLi 113 (338)
T KOG0668|consen 37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPV---KKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLI 113 (338)
T ss_pred cchHHHHHHHcCccHhhHhcccccCCCceEEEeeechH---HHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhH
Confidence 4688899999999999999999 667888999999754 3367899999999997 99999999999875 457899
Q ss_pred EEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCC-CEEEccCCccccCccc
Q 004400 491 YEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDL-NSKISDFGLAKLDEEE 569 (756)
Q Consensus 491 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~-~~kl~DFGla~~~~~~ 569 (756)
+||+.+.+....- ..++..++..++.+++.||.|+|++| |+|||+||.|+|+|... .++|+|+|+|.+..+.
T Consensus 114 FE~v~n~Dfk~ly----~tl~d~dIryY~~elLkALdyCHS~G---ImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~ 186 (338)
T KOG0668|consen 114 FEYVNNTDFKQLY----PTLTDYDIRYYIYELLKALDYCHSMG---IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG 186 (338)
T ss_pred hhhhccccHHHHh----hhhchhhHHHHHHHHHHHHhHHHhcC---cccccCCcceeeechhhceeeeeecchHhhcCCC
Confidence 9999998776543 36788899999999999999999998 99999999999999654 4999999999887654
Q ss_pred CcceeeccccCccCCchHhhhc-CCCCcccchhhHHHHHHHHHhCCCCCC-ccc-hhhHHHHHHHHHh------------
Q 004400 570 NTHISTRVAGTIGYMAPEYAMR-GHLTEKADVYSFGIVALEIVSGRSNVT-KED-MFYLLDWALVLKE------------ 634 (756)
Q Consensus 570 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slGv~l~elltg~~p~~-~~~-~~~~~~~~~~~~~------------ 634 (756)
... ...+.+..|--||.+.. ..|+..-|+|||||++..|+..+.||. +.+ ...++.-+.....
T Consensus 187 ~eY--nVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~i 264 (338)
T KOG0668|consen 187 KEY--NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQI 264 (338)
T ss_pred cee--eeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHcc
Confidence 332 11234667889999876 558889999999999999999999993 322 2223322222111
Q ss_pred --cCccccccccCCCCCC-------CHH-HHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 004400 635 --QGKLMELVDTNPGSNF-------DKE-QVMVMINVALLCANASPTIRPSMSSVLR 681 (756)
Q Consensus 635 --~~~~~~~~~~~~~~~~-------~~~-~~~~l~~l~~~c~~~~P~~RPt~~ev~~ 681 (756)
+.+...++.......+ ... ...+.++++.+.+..|-.+|+|+.|...
T Consensus 265 ~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~ 321 (338)
T KOG0668|consen 265 DLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMA 321 (338)
T ss_pred CCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhc
Confidence 1111111111111110 000 1135788999999999999999999754
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.1e-30 Score=280.79 Aligned_cols=244 Identities=28% Similarity=0.383 Sum_probs=187.0
Q ss_pred CccccCcccCCCCcc-EEEeeccCCcEEEEEEccccCcccHHHHHHHHHHHHhC-CCCceeeEeeEEEeCCeEEEEEEec
Q 004400 417 NFATDNNIGEGGFGP-VYKGLLADGTAIAVKQLSSKSKQGNREFINEIGMISAL-QHPNLVKLYGCCIEGNQLLLIYEYL 494 (756)
Q Consensus 417 ~~~~~~~lg~G~~g~-Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~e~~ 494 (756)
-|...+++|.|+-|+ ||+|... |+.||||++-.. ...-..+|+..|+.- +|||||++|+.=.+++..|++.|.|
T Consensus 510 ~~~~~eilG~Gs~Gt~Vf~G~ye-~R~VAVKrll~e---~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC 585 (903)
T KOG1027|consen 510 FFSPKEILGYGSNGTVVFRGVYE-GREVAVKRLLEE---FFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC 585 (903)
T ss_pred eeccHHHcccCCCCcEEEEEeeC-CceehHHHHhhH---hHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh
Confidence 355667899999877 8999985 789999998543 234567899999888 6999999999988999999999999
Q ss_pred CCCCHHHHHHhcCCCC---CHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecC---C--CCEEEccCCccccC
Q 004400 495 ENNSLARALFEHRLKL---DWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDK---D--LNSKISDFGLAKLD 566 (756)
Q Consensus 495 ~~gsL~~~l~~~~~~l---~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~---~--~~~kl~DFGla~~~ 566 (756)
.. +|.+++....... .-...+.+..|++.||++||+.+ ||||||||.||||+. + .+++|+|||+++..
T Consensus 586 ~~-sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~---iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl 661 (903)
T KOG1027|consen 586 AC-SLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLK---IVHRDLKPQNILISVPSADGTLRAKISDFGLSKKL 661 (903)
T ss_pred hh-hHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcc---cccccCCCceEEEEccCCCcceeEEeccccccccc
Confidence 65 9999997531111 11445788899999999999975 999999999999976 3 46899999999987
Q ss_pred cccCcce--eeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHhC-CCCCCccchhhHHHHHHHHHhcCccccccc
Q 004400 567 EEENTHI--STRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSG-RSNVTKEDMFYLLDWALVLKEQGKLMELVD 643 (756)
Q Consensus 567 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 643 (756)
....... .....||-||+|||++....-+.++||||+||++|+.++| ..||...-. ..+.+......+..+..
T Consensus 662 ~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~----R~~NIl~~~~~L~~L~~ 737 (903)
T KOG1027|consen 662 AGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLE----RQANILTGNYTLVHLEP 737 (903)
T ss_pred CCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHH----hhhhhhcCccceeeecc
Confidence 6554433 3457899999999999988888899999999999999996 899843311 11111222222211111
Q ss_pred cCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 004400 644 TNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLR 681 (756)
Q Consensus 644 ~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~ 681 (756)
. .+. ...++|.+|++.+|..||++.+|+.
T Consensus 738 ---~----~d~--eA~dLI~~ml~~dP~~RPsa~~VL~ 766 (903)
T KOG1027|consen 738 ---L----PDC--EAKDLISRMLNPDPQLRPSATDVLN 766 (903)
T ss_pred ---C----chH--HHHHHHHHhcCCCcccCCCHHHHhC
Confidence 0 011 4788999999999999999999954
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.7e-28 Score=240.86 Aligned_cols=211 Identities=37% Similarity=0.612 Sum_probs=184.2
Q ss_pred ccCCCCccEEEeecc-CCcEEEEEEccccCcc-cHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEEecCCCCHHH
Q 004400 424 IGEGGFGPVYKGLLA-DGTAIAVKQLSSKSKQ-GNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYEYLENNSLAR 501 (756)
Q Consensus 424 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL~~ 501 (756)
||+|++|.||++... +++.+++|.+...... ....+.+|++.++.++|++|+++++++......++++||+++++|.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 689999999999965 4899999999765332 34679999999999999999999999999999999999999999999
Q ss_pred HHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecC-CCCEEEccCCccccCcccCcceeeccccC
Q 004400 502 ALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDK-DLNSKISDFGLAKLDEEENTHISTRVAGT 580 (756)
Q Consensus 502 ~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~-~~~~kl~DFGla~~~~~~~~~~~~~~~gt 580 (756)
++......+++..+..++.+++++++|||+.+ ++|+||+|.||+++. ++.++|+|||.+........ ......+.
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~ 156 (215)
T cd00180 81 LLKENEGKLSEDEILRILLQILEGLEYLHSNG---IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS-LLKTIVGT 156 (215)
T ss_pred HHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc-hhhcccCC
Confidence 98765457899999999999999999999996 999999999999999 89999999999986554321 12234578
Q ss_pred ccCCchHhhhcC-CCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhcCccccccccCCCCCCCHHHHHHHH
Q 004400 581 IGYMAPEYAMRG-HLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDKEQVMVMI 659 (756)
Q Consensus 581 ~~y~aPE~~~~~-~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 659 (756)
..|++||..... .++.+.|+|++|++++++ ..+.
T Consensus 157 ~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l---------------------------------------------~~~~ 191 (215)
T cd00180 157 PAYMAPEVLLGKGYYSEKSDIWSLGVILYEL---------------------------------------------PELK 191 (215)
T ss_pred CCccChhHhcccCCCCchhhhHHHHHHHHHH---------------------------------------------HHHH
Confidence 899999999877 788999999999999998 2388
Q ss_pred HHHHHhhcCCCCCCCCHHHHHHHh
Q 004400 660 NVALLCANASPTIRPSMSSVLRML 683 (756)
Q Consensus 660 ~l~~~c~~~~P~~RPt~~ev~~~L 683 (756)
+++..|++.+|++||++.++++.+
T Consensus 192 ~~l~~~l~~~p~~R~~~~~l~~~~ 215 (215)
T cd00180 192 DLIRKMLQKDPEKRPSAKEILEHL 215 (215)
T ss_pred HHHHHHhhCCcccCcCHHHHhhCC
Confidence 999999999999999999998653
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.3e-30 Score=270.34 Aligned_cols=253 Identities=26% Similarity=0.394 Sum_probs=201.7
Q ss_pred hhcCccccCcccCCCCccEEEee-ccCCcEEEEEEccccCcccHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEE
Q 004400 414 ATNNFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYE 492 (756)
Q Consensus 414 ~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 492 (756)
..++|+....+|.|.||.||||+ ...++..|+|.++...........+|+-+++..+|||||.++|.+...+..|++||
T Consensus 13 P~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicME 92 (829)
T KOG0576|consen 13 PQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICME 92 (829)
T ss_pred CccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEE
Confidence 34688899999999999999999 56899999999987766677778899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCcccCcc
Q 004400 493 YLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTH 572 (756)
Q Consensus 493 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~~~~~ 572 (756)
||.+|+|.+.-+..+ .+++.++..+++...+|++|||+.| -+|||||-.||++++.|.+|++|||.+..+.... .
T Consensus 93 ycgggslQdiy~~Tg-plselqiayvcRetl~gl~ylhs~g---k~hRdiKGanilltd~gDvklaDfgvsaqitati-~ 167 (829)
T KOG0576|consen 93 YCGGGSLQDIYHVTG-PLSELQIAYVCRETLQGLKYLHSQG---KIHRDIKGANILLTDEGDVKLADFGVSAQITATI-A 167 (829)
T ss_pred ecCCCcccceeeecc-cchhHHHHHHHhhhhccchhhhcCC---cccccccccceeecccCceeecccCchhhhhhhh-h
Confidence 999999998765443 7899999999999999999999997 7999999999999999999999999987544322 2
Q ss_pred eeeccccCccCCchHhhh---cCCCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhcCccccccccCCCCC
Q 004400 573 ISTRVAGTIGYMAPEYAM---RGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSN 649 (756)
Q Consensus 573 ~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 649 (756)
....+.||+.|||||+.. .+.|..++|||+.|+...|+-.-+.|...--... .....-+..-+-...-|+.
T Consensus 168 KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr--~l~LmTkS~~qpp~lkDk~---- 241 (829)
T KOG0576|consen 168 KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMR--ALFLMTKSGFQPPTLKDKT---- 241 (829)
T ss_pred hhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHH--HHHHhhccCCCCCcccCCc----
Confidence 234578999999999874 5679999999999999999887766653221111 1000111111111122221
Q ss_pred CCHHHHHHHHHHHHHhhcCCCCCCCCHHHHH
Q 004400 650 FDKEQVMVMINVALLCANASPTIRPSMSSVL 680 (756)
Q Consensus 650 ~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~ 680 (756)
.....+-++++.|+..+|++||+++.++
T Consensus 242 ---kws~~fh~fvK~altknpKkRptaeklL 269 (829)
T KOG0576|consen 242 ---KWSEFFHNFVKGALTKNPKKRPTAEKLL 269 (829)
T ss_pred ---cchHHHHHHHHHHhcCCCccCCChhhhe
Confidence 1233488999999999999999998763
|
|
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.2e-30 Score=270.41 Aligned_cols=309 Identities=18% Similarity=0.193 Sum_probs=244.1
Q ss_pred eccceeccccccccCcccccCCcccCCCCCCCEEEccCCcccCccCcccccCCcc-eeeccCccccccCCccCcCcCCCc
Q 004400 13 WKQKTVNQKRVLKEQNLTGVLPPKLAELTFLQDIDLTLNYLSGTIPSQWASLPLL-NISLIANRLKGPIPKYLANISTLV 91 (756)
Q Consensus 13 ~~~~~~~~~l~L~~~~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L-~l~l~~n~~~~~~p~~l~~l~~L~ 91 (756)
.+-+..++.|||+.|.|+.+....|..-.+|+.|+|++|.|+..--..|.++..| .|-|++|+++..-+..|.+|++|+
T Consensus 145 L~~l~alrslDLSrN~is~i~~~sfp~~~ni~~L~La~N~It~l~~~~F~~lnsL~tlkLsrNrittLp~r~Fk~L~~L~ 224 (873)
T KOG4194|consen 145 LSALPALRSLDLSRNLISEIPKPSFPAKVNIKKLNLASNRITTLETGHFDSLNSLLTLKLSRNRITTLPQRSFKRLPKLE 224 (873)
T ss_pred HHhHhhhhhhhhhhchhhcccCCCCCCCCCceEEeeccccccccccccccccchheeeecccCcccccCHHHhhhcchhh
Confidence 3444566777777777776666667666677777777777776666677777655 567777777766666777777777
Q ss_pred EEEeecCcccccCCcccCCCCCCcEEeccCCeecccCCccccCCCCCCEEEeeCCcccccCChhhcCcCCCcEEEccCCc
Q 004400 92 NLTVQYNQFSGELPEELGSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRISDNQFTGQIPSFIQNWTKLEKLFIQPSG 171 (756)
Q Consensus 92 ~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~ 171 (756)
.|+|..|+|.-.---.|..|++|+.|.|..|.++..-.+.|..|.++++|+|+.|+++..-.+++-+++.|+.|+|++|.
T Consensus 225 ~LdLnrN~irive~ltFqgL~Sl~nlklqrN~I~kL~DG~Fy~l~kme~l~L~~N~l~~vn~g~lfgLt~L~~L~lS~Na 304 (873)
T KOG4194|consen 225 SLDLNRNRIRIVEGLTFQGLPSLQNLKLQRNDISKLDDGAFYGLEKMEHLNLETNRLQAVNEGWLFGLTSLEQLDLSYNA 304 (873)
T ss_pred hhhccccceeeehhhhhcCchhhhhhhhhhcCcccccCcceeeecccceeecccchhhhhhcccccccchhhhhccchhh
Confidence 77777777772224467777777777777777776666778888889999999999887777888889999999999999
Q ss_pred CcCCCCccccCCCCCCeEEccCCCCCCCCcccccccc-ccEEEcccccccCCCCccccCCCCCcEEEccCCcCCCCCCc-
Q 004400 172 LAGPIPSGIFSLENLTDLRISDLNGPEATFPQLGNMK-MTKLILRNCNITGELPRYLGKMTKLKVLDLSFNRLRGQIPS- 249 (756)
Q Consensus 172 l~~~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~-L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~- 249 (756)
|....++++..+++|++|+|+.|.++......|..++ |+.|.|+.|.+...-...|..+.+|+.|||++|.|+..+-+
T Consensus 305 I~rih~d~WsftqkL~~LdLs~N~i~~l~~~sf~~L~~Le~LnLs~Nsi~~l~e~af~~lssL~~LdLr~N~ls~~IEDa 384 (873)
T KOG4194|consen 305 IQRIHIDSWSFTQKLKELDLSSNRITRLDEGSFRVLSQLEELNLSHNSIDHLAEGAFVGLSSLHKLDLRSNELSWCIEDA 384 (873)
T ss_pred hheeecchhhhcccceeEeccccccccCChhHHHHHHHhhhhcccccchHHHHhhHHHHhhhhhhhcCcCCeEEEEEecc
Confidence 9888888899999999999999999999888888774 89999999999877778899999999999999999876553
Q ss_pred --cCcCCCCCCeEEecCccccccCCch-h--hcCCCeeEeecCCCCCCCCcccccccCcccccccccccccCCcccccc
Q 004400 250 --NFDDLYDVDYIYFAGNLLTGAIPPW-M--LERGDKIDLSYNNFTDGSAESSCQKRSVTGIVSCLRSVQCPKTYYSLH 323 (756)
Q Consensus 250 --~~~~l~~L~~L~ls~N~l~~~~p~~-~--~~~l~~l~ls~N~l~~~~~~~~~~~~~~~~~~~~~~~~~c~~~~~~~~ 323 (756)
.|.+|++|+.|+|.+|+|. .+|.. + ++.|+.|||.+|.+....+.++-++ .+..++....++.|.+...++.
T Consensus 385 a~~f~gl~~LrkL~l~gNqlk-~I~krAfsgl~~LE~LdL~~NaiaSIq~nAFe~m-~Lk~Lv~nSssflCDCql~Wl~ 461 (873)
T KOG4194|consen 385 AVAFNGLPSLRKLRLTGNQLK-SIPKRAFSGLEALEHLDLGDNAIASIQPNAFEPM-ELKELVMNSSSFLCDCQLKWLA 461 (873)
T ss_pred hhhhccchhhhheeecCceee-ecchhhhccCcccceecCCCCcceeecccccccc-hhhhhhhcccceEEeccHHHHH
Confidence 5888999999999999998 55554 3 7889999999999999888888877 5666777777778877654443
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.1e-28 Score=248.62 Aligned_cols=260 Identities=22% Similarity=0.334 Sum_probs=194.4
Q ss_pred hcCccccCcccCCCCccEEEee-ccCCcEEEEEEccccCcccHHHHHHHHHHHHhCC-----C---CceeeEeeEEEe--
Q 004400 415 TNNFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQGNREFINEIGMISALQ-----H---PNLVKLYGCCIE-- 483 (756)
Q Consensus 415 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----h---~niv~l~~~~~~-- 483 (756)
.++|...++||.|.|++||.|. ..+.+.||+|+.+.+.. -.+..+.|+.+|++++ | ..||++++.|..
T Consensus 77 ~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAqh-YtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsG 155 (590)
T KOG1290|consen 77 GGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQH-YTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSG 155 (590)
T ss_pred CceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhhH-HHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecC
Confidence 4688899999999999999998 56778999999976532 3356688999999984 3 469999999975
Q ss_pred --CCeEEEEEEecCCCCHHHHHH-hcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCC--------
Q 004400 484 --GNQLLLIYEYLENNSLARALF-EHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKD-------- 552 (756)
Q Consensus 484 --~~~~~lV~e~~~~gsL~~~l~-~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~-------- 552 (756)
+..+|||+|++.. +|..+|. ...+.++...+.+|++||+.||.|||.+| +|||-||||+|||+..+
T Consensus 156 pNG~HVCMVfEvLGd-nLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl~~~e~~~~~~~ 232 (590)
T KOG1290|consen 156 PNGQHVCMVFEVLGD-NLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLLCSTEIDPAKDA 232 (590)
T ss_pred CCCcEEEEEehhhhh-HHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeeeeccccchhhhh
Confidence 5689999999954 7777776 45567999999999999999999999998 89999999999999300
Q ss_pred --------------------------------------------------------------------------------
Q 004400 553 -------------------------------------------------------------------------------- 552 (756)
Q Consensus 553 -------------------------------------------------------------------------------- 552 (756)
T Consensus 233 ~~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~~~~~~~~~~s~n~~~~~n~~ 312 (590)
T KOG1290|consen 233 REAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLEGIEEEPNQESYNNEPRINGN 312 (590)
T ss_pred hhhccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhcccccccccccccccccccCCCcc
Confidence
Q ss_pred ------------------------------------------------------------------------------CC
Q 004400 553 ------------------------------------------------------------------------------LN 554 (756)
Q Consensus 553 ------------------------------------------------------------------------------~~ 554 (756)
-+
T Consensus 313 ~~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~~~~~n~~v~p~~~~~~~di~ 392 (590)
T KOG1290|consen 313 ESTVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPGTIASNPLVNPDIPLPECDIR 392 (590)
T ss_pred ccchhhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcCCccccccccccCCCCCCCcccee
Confidence 01
Q ss_pred EEEccCCccccCcccCcceeeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHhCCCCCCccchh------hHHH-
Q 004400 555 SKISDFGLAKLDEEENTHISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMF------YLLD- 627 (756)
Q Consensus 555 ~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~------~~~~- 627 (756)
+||+|||-|.+....- +.-.-|..|.|||++.+..|++.+||||++|++|||+||...|.+.... +...
T Consensus 393 vKIaDlGNACW~~khF----T~DIQTRQYRapEVllGsgY~~~ADiWS~AC~~FELaTGDyLFePhsG~~Y~rDEDHiA~ 468 (590)
T KOG1290|consen 393 VKIADLGNACWVHKHF----TEDIQTRQYRAPEVLLGSGYSTSADIWSTACMAFELATGDYLFEPHSGENYSRDEDHIAL 468 (590)
T ss_pred EEEeeccchhhhhhhh----chhhhhhhccCcceeecCCCCCchhHHHHHHHHHHhhcCceeecCCCCCCCCccHHHHHH
Confidence 4555555555433221 1234577899999999999999999999999999999999888432211 1111
Q ss_pred ------------------HHHHHHhcCccccccccCCC---------CCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHH
Q 004400 628 ------------------WALVLKEQGKLMELVDTNPG---------SNFDKEQVMVMINVALLCANASPTIRPSMSSVL 680 (756)
Q Consensus 628 ------------------~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~ 680 (756)
+...+.+.+++..+-.-.+. -.++.++...+.+++.-|++.+|++|||+.+.+
T Consensus 469 i~ELLG~iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A~~fsdFL~PmLef~PeKR~tA~~cl 548 (590)
T KOG1290|consen 469 IMELLGKIPRKIALGGKYSRDFFNRRGELRHIRRLKPWPLYEVLIEKYEWSEEDAQQFSDFLSPMLEFDPEKRPTAAQCL 548 (590)
T ss_pred HHHHHhhccHHHHhcCcchHhhhccccceecccccCCCcHHHHHHHHhCCCHHHHHHHHHHHHHHHhcCccccccHHHHh
Confidence 11111112222222111111 135778888999999999999999999999988
Q ss_pred HH
Q 004400 681 RM 682 (756)
Q Consensus 681 ~~ 682 (756)
+.
T Consensus 549 ~h 550 (590)
T KOG1290|consen 549 KH 550 (590)
T ss_pred cC
Confidence 65
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.8e-29 Score=260.33 Aligned_cols=196 Identities=24% Similarity=0.370 Sum_probs=167.1
Q ss_pred cCccccCcccCCCCccEEEeecc-CCcEEEEEEccccCc----c----cHHHHHHHHHHHHhCC---CCceeeEeeEEEe
Q 004400 416 NNFATDNNIGEGGFGPVYKGLLA-DGTAIAVKQLSSKSK----Q----GNREFINEIGMISALQ---HPNLVKLYGCCIE 483 (756)
Q Consensus 416 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----~----~~~~~~~E~~~l~~l~---h~niv~l~~~~~~ 483 (756)
.+|...+.+|+|+||.|+.|.++ +...|+||.+.+..- + ..-.+-.|++||+.++ |+||++++++|++
T Consensus 561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd 640 (772)
T KOG1152|consen 561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED 640 (772)
T ss_pred ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec
Confidence 46889999999999999999965 567889998865311 0 1112345999999997 9999999999999
Q ss_pred CCeEEEEEEecC-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCc
Q 004400 484 GNQLLLIYEYLE-NNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGL 562 (756)
Q Consensus 484 ~~~~~lV~e~~~-~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGl 562 (756)
++++|++||--. +-+|.+++. .+..+++.++..|+.||+-|+++||+.| |||||||-+||.++.+|-+||+|||.
T Consensus 641 dd~yyl~te~hg~gIDLFd~IE-~kp~m~E~eAk~IFkQV~agi~hlh~~~---ivhrdikdenvivd~~g~~klidfgs 716 (772)
T KOG1152|consen 641 DDYYYLETEVHGEGIDLFDFIE-FKPRMDEPEAKLIFKQVVAGIKHLHDQG---IVHRDIKDENVIVDSNGFVKLIDFGS 716 (772)
T ss_pred CCeeEEEecCCCCCcchhhhhh-ccCccchHHHHHHHHHHHhccccccccC---ceecccccccEEEecCCeEEEeeccc
Confidence 999999999864 558888884 4458999999999999999999999997 99999999999999999999999999
Q ss_pred cccCcccCcceeeccccCccCCchHhhhcCCC-CcccchhhHHHHHHHHHhCCCCCC
Q 004400 563 AKLDEEENTHISTRVAGTIGYMAPEYAMRGHL-TEKADVYSFGIVALEIVSGRSNVT 618 (756)
Q Consensus 563 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~slGv~l~elltg~~p~~ 618 (756)
|.+..... ...++||.+|.|||++.+..| +..-|||++|+++|-++....||+
T Consensus 717 aa~~ksgp---fd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 717 AAYTKSGP---FDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred hhhhcCCC---cceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 98755433 345789999999999998776 566899999999999998888875
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.95 E-value=2e-27 Score=239.61 Aligned_cols=199 Identities=34% Similarity=0.527 Sum_probs=173.5
Q ss_pred ccccCcccCCCCccEEEeeccC-CcEEEEEEccccCcc-cHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEEecC
Q 004400 418 FATDNNIGEGGFGPVYKGLLAD-GTAIAVKQLSSKSKQ-GNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYEYLE 495 (756)
Q Consensus 418 ~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~ 495 (756)
|...+.||+|++|.||+|...+ ++.+|+|.+...... ..+.+.+|++.+++++|+|++++++++......++++||++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE 80 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence 4566889999999999999654 899999999865444 56788999999999999999999999999999999999999
Q ss_pred CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCcccCcceee
Q 004400 496 NNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHIST 575 (756)
Q Consensus 496 ~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~ 575 (756)
+++|.+++......+++..+..++.+++.++.+||+.+ ++|+||+|+||+++.++.++|+|||.+............
T Consensus 81 ~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~~~~ 157 (225)
T smart00221 81 GGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLG---IVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAALLK 157 (225)
T ss_pred CCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeeCceeeEecCccccccc
Confidence 99999999765433899999999999999999999986 999999999999999999999999999876544311223
Q ss_pred ccccCccCCchHhh-hcCCCCcccchhhHHHHHHHHHhCCCCCCc
Q 004400 576 RVAGTIGYMAPEYA-MRGHLTEKADVYSFGIVALEIVSGRSNVTK 619 (756)
Q Consensus 576 ~~~gt~~y~aPE~~-~~~~~~~~~Dv~slGv~l~elltg~~p~~~ 619 (756)
...++..|++||.. ....++.++|||+||++++||++|+.||..
T Consensus 158 ~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 158 TVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred ceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 35678899999998 666788899999999999999999999955
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2e-28 Score=239.83 Aligned_cols=255 Identities=24% Similarity=0.386 Sum_probs=194.7
Q ss_pred cCccccCcccCCCCccEEEee-ccCCcEEEEEEcccc--CcccHHHHHHHHHHHHhCCCCceeeEeeEEEeC------Ce
Q 004400 416 NNFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSK--SKQGNREFINEIGMISALQHPNLVKLYGCCIEG------NQ 486 (756)
Q Consensus 416 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~ 486 (756)
.+|...+.+|.|+. .|-.|. .-.++.||+|++... .....++..+|...+..++|+||++++.+|.-. ..
T Consensus 17 ~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e 95 (369)
T KOG0665|consen 17 KRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQE 95 (369)
T ss_pred eeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHh
Confidence 35666778888888 555555 346889999988654 223346778899999999999999999998743 46
Q ss_pred EEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccC
Q 004400 487 LLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLD 566 (756)
Q Consensus 487 ~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~ 566 (756)
.|+|||||.. +|...+. ..++-.+...+..|++.|++|||+.| |+||||||+||++..++.+||.|||+|+..
T Consensus 96 ~y~v~e~m~~-nl~~vi~---~elDH~tis~i~yq~~~~ik~lhs~~---IihRdLkPsnivv~~~~~lKi~dfg~ar~e 168 (369)
T KOG0665|consen 96 VYLVMELMDA-NLCQVIL---MELDHETISYILYQMLCGIKHLHSAG---IIHRDLKPSNIVVNSDCTLKILDFGLARTE 168 (369)
T ss_pred HHHHHHhhhh-HHHHHHH---HhcchHHHHHHHHHHHHHHHHHHhcc---eeecccCcccceecchhheeeccchhhccc
Confidence 8999999965 8888876 35788899999999999999999997 999999999999999999999999999864
Q ss_pred cccCcceeeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhcCc---------
Q 004400 567 EEENTHISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGK--------- 637 (756)
Q Consensus 567 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~--------- 637 (756)
... ...+..+.|..|.|||++.+..+.+.+||||.||++.||++|+.-|.+.+..+ .|.+....-+.
T Consensus 169 ~~~--~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~id--Q~~ki~~~lgtpd~~F~~qL 244 (369)
T KOG0665|consen 169 DTD--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHID--QWNKIIEQLGTPDPSFMKQL 244 (369)
T ss_pred Ccc--cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHH--HHHHHHHHhcCCCHHHHHHh
Confidence 443 33455678889999999999889999999999999999999999997665433 22222211100
Q ss_pred ------------------cccc-cccCCC--CCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004400 638 ------------------LMEL-VDTNPG--SNFDKEQVMVMINVALLCANASPTIRPSMSSVLRM 682 (756)
Q Consensus 638 ------------------~~~~-~~~~~~--~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~ 682 (756)
..+. .|.... ...++.......+++.+|+..+|++|-+.+++++.
T Consensus 245 ~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~H 310 (369)
T KOG0665|consen 245 QPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRH 310 (369)
T ss_pred hHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcC
Confidence 0000 000000 01111233357889999999999999999999875
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.7e-28 Score=230.27 Aligned_cols=255 Identities=18% Similarity=0.298 Sum_probs=189.7
Q ss_pred hhcCccccCcccCCCCccEEEeecc-CCcEEEEEEccccCcccHHHHHHHHHHHHhC-CCCceeeEeeE-EEeCCeEEEE
Q 004400 414 ATNNFATDNNIGEGGFGPVYKGLLA-DGTAIAVKQLSSKSKQGNREFINEIGMISAL-QHPNLVKLYGC-CIEGNQLLLI 490 (756)
Q Consensus 414 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~-~~~~~~~~lV 490 (756)
..+.|++.+.+|+|.||.+-.++++ +.+.+++|.+... ....++|.+|..---.| .|.||+.-|+. |+..+..+++
T Consensus 22 l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p-~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~ 100 (378)
T KOG1345|consen 22 LEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRP-QTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFV 100 (378)
T ss_pred hhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcc-hhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEe
Confidence 3467899999999999999999964 5778999998654 33457899998764445 58999988765 7788899999
Q ss_pred EEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEe-c-CCCCEEEccCCccccCcc
Q 004400 491 YEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLL-D-KDLNSKISDFGLAKLDEE 568 (756)
Q Consensus 491 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill-~-~~~~~kl~DFGla~~~~~ 568 (756)
+||++.|+|.+.+.. ..+.+....+++.|++.|+.|||++ ++||||||.+|||+ + +..++|+||||+.+..+.
T Consensus 101 qE~aP~gdL~snv~~--~GigE~~~K~v~~ql~SAi~fMHsk---nlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~ 175 (378)
T KOG1345|consen 101 QEFAPRGDLRSNVEA--AGIGEANTKKVFAQLLSAIEFMHSK---NLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGT 175 (378)
T ss_pred eccCccchhhhhcCc--ccccHHHHHHHHHHHHHHHHHhhcc---chhhcccccceEEEecCCccEEEeeecccccccCc
Confidence 999999999988754 3578889999999999999999998 49999999999999 3 345799999999875432
Q ss_pred cCcceeeccccCccCCchHhhhcC-----CCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhcCccccccc
Q 004400 569 ENTHISTRVAGTIGYMAPEYAMRG-----HLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVD 643 (756)
Q Consensus 569 ~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 643 (756)
.- ...--+..|.+||..... ...+.+|||.||+++|.++||+.||......+..-|.......+..+..++
T Consensus 176 tV----~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~~~~P~ 251 (378)
T KOG1345|consen 176 TV----KYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKNPALPK 251 (378)
T ss_pred ee----hhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcccCccCch
Confidence 11 112235569999988642 357789999999999999999999964433332223333333333332222
Q ss_pred cCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhc
Q 004400 644 TNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLE 684 (756)
Q Consensus 644 ~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~L~ 684 (756)
. -..+.+ .++++.++-+..+|++|-...++-++..
T Consensus 252 ~--F~~fs~----~a~r~Fkk~lt~~~~drcki~~~kk~rk 286 (378)
T KOG1345|consen 252 K--FNPFSE----KALRLFKKSLTPRFKDRCKIWTAKKMRK 286 (378)
T ss_pred h--hcccCH----HHHHHHHHhcCCcccccchhHHHHHHHH
Confidence 1 112333 3677788899999999966666655543
|
|
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.9e-29 Score=262.03 Aligned_cols=294 Identities=20% Similarity=0.206 Sum_probs=180.6
Q ss_pred eeccceeccccccccCcccccCCcccCCCCCCCEEEccCCcccCccCcccccCCcce-eeccCccccccCCccCcCcCCC
Q 004400 12 FWKQKTVNQKRVLKEQNLTGVLPPKLAELTFLQDIDLTLNYLSGTIPSQWASLPLLN-ISLIANRLKGPIPKYLANISTL 90 (756)
Q Consensus 12 ~~~~~~~~~~l~L~~~~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~-l~l~~n~~~~~~p~~l~~l~~L 90 (756)
+|.++..+|++.|.+|-++ .+|.......+|+.|+|.+|.|+..-..++..++.|+ +||+.|.|+..--.+|..-.++
T Consensus 97 ~f~nl~nLq~v~l~~N~Lt-~IP~f~~~sghl~~L~L~~N~I~sv~se~L~~l~alrslDLSrN~is~i~~~sfp~~~ni 175 (873)
T KOG4194|consen 97 FFYNLPNLQEVNLNKNELT-RIPRFGHESGHLEKLDLRHNLISSVTSEELSALPALRSLDLSRNLISEIPKPSFPAKVNI 175 (873)
T ss_pred HHhcCCcceeeeeccchhh-hcccccccccceeEEeeeccccccccHHHHHhHhhhhhhhhhhchhhcccCCCCCCCCCc
Confidence 4566666777777666666 5555555555566666666666655555555555553 5566666554444455555556
Q ss_pred cEEEeecCcccccCCcccCCCCCCcEEeccCCeecccCCccccCCCCCCEEEeeCCccc---------------------
Q 004400 91 VNLTVQYNQFSGELPEELGSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRISDNQFT--------------------- 149 (756)
Q Consensus 91 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~--------------------- 149 (756)
++|+|++|.|+..--+.|.++.+|..|.|+.|+++...+..|.+|++|+.|+|..|+|.
T Consensus 176 ~~L~La~N~It~l~~~~F~~lnsL~tlkLsrNrittLp~r~Fk~L~~L~~LdLnrN~irive~ltFqgL~Sl~nlklqrN 255 (873)
T KOG4194|consen 176 KKLNLASNRITTLETGHFDSLNSLLTLKLSRNRITTLPQRSFKRLPKLESLDLNRNRIRIVEGLTFQGLPSLQNLKLQRN 255 (873)
T ss_pred eEEeeccccccccccccccccchheeeecccCcccccCHHHhhhcchhhhhhccccceeeehhhhhcCchhhhhhhhhhc
Confidence 66666666665555555555556666666666665444445555566666665555555
Q ss_pred ---ccCChhhcCcCCCcEEEccCCcCcCCCCccccCCCCCCeEEccCCCCCCCCccccccc-cccEEEcccccccCCCCc
Q 004400 150 ---GQIPSFIQNWTKLEKLFIQPSGLAGPIPSGIFSLENLTDLRISDLNGPEATFPQLGNM-KMTKLILRNCNITGELPR 225 (756)
Q Consensus 150 ---~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~-~L~~L~L~~n~l~~~~p~ 225 (756)
..--+.|..|.+++.|+|..|+++..-..++++++.|+.|++|+|.|..+....+... +|++|+|++|+|+...+.
T Consensus 256 ~I~kL~DG~Fy~l~kme~l~L~~N~l~~vn~g~lfgLt~L~~L~lS~NaI~rih~d~WsftqkL~~LdLs~N~i~~l~~~ 335 (873)
T KOG4194|consen 256 DISKLDDGAFYGLEKMEHLNLETNRLQAVNEGWLFGLTSLEQLDLSYNAIQRIHIDSWSFTQKLKELDLSSNRITRLDEG 335 (873)
T ss_pred CcccccCcceeeecccceeecccchhhhhhcccccccchhhhhccchhhhheeecchhhhcccceeEeccccccccCChh
Confidence 3333444555555555555555554455566666666666666666666666665554 477777777777766666
Q ss_pred cccCCCCCcEEEccCCcCCCCCCccCcCCCCCCeEEecCccccccCCchh-----hcCCCeeEeecCCCCCCCCcccccc
Q 004400 226 YLGKMTKLKVLDLSFNRLRGQIPSNFDDLYDVDYIYFAGNLLTGAIPPWM-----LERGDKIDLSYNNFTDGSAESSCQK 300 (756)
Q Consensus 226 ~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~-----~~~l~~l~ls~N~l~~~~~~~~~~~ 300 (756)
.|..|..|+.|+|++|++...-...|..+.+|+.|||++|.|+..+-+.. ++.|+.|++.||++...+..+.-..
T Consensus 336 sf~~L~~Le~LnLs~Nsi~~l~e~af~~lssL~~LdLr~N~ls~~IEDaa~~f~gl~~LrkL~l~gNqlk~I~krAfsgl 415 (873)
T KOG4194|consen 336 SFRVLSQLEELNLSHNSIDHLAEGAFVGLSSLHKLDLRSNELSWCIEDAAVAFNGLPSLRKLRLTGNQLKSIPKRAFSGL 415 (873)
T ss_pred HHHHHHHhhhhcccccchHHHHhhHHHHhhhhhhhcCcCCeEEEEEecchhhhccchhhhheeecCceeeecchhhhccC
Confidence 67777777777777777765555667777777777777777765554432 6677777777777776665555554
Q ss_pred cCcccc
Q 004400 301 RSVTGI 306 (756)
Q Consensus 301 ~~~~~~ 306 (756)
.++..+
T Consensus 416 ~~LE~L 421 (873)
T KOG4194|consen 416 EALEHL 421 (873)
T ss_pred ccccee
Confidence 444433
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.1e-27 Score=238.76 Aligned_cols=200 Identities=30% Similarity=0.478 Sum_probs=167.7
Q ss_pred hHHHhhcCccccCcccCCCCccEEEeecc----CCcEEEEEEccccCcccHHHHHHHHHHHHhC-CCCceeeEeeEEEeC
Q 004400 410 QIKAATNNFATDNNIGEGGFGPVYKGLLA----DGTAIAVKQLSSKSKQGNREFINEIGMISAL-QHPNLVKLYGCCIEG 484 (756)
Q Consensus 410 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 484 (756)
.+....+.|...++||+|.|++||+|+.. ..+.||+|.+...+.. .++.+|+++|..+ .+.||+++.+++...
T Consensus 30 ~~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~p--~ri~~El~~L~~~gG~~ni~~~~~~~rnn 107 (418)
T KOG1167|consen 30 DIPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSSP--SRILNELEMLYRLGGSDNIIKLNGCFRNN 107 (418)
T ss_pred hhhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccCc--hHHHHHHHHHHHhccchhhhcchhhhccC
Confidence 34455678899999999999999999843 4678999998765443 5688999999999 599999999999999
Q ss_pred CeEEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCC-CCEEEccCCcc
Q 004400 485 NQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKD-LNSKISDFGLA 563 (756)
Q Consensus 485 ~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~-~~~kl~DFGla 563 (756)
+...+|+||++.....++.. .++...+..+++.+..||+++|..| ||||||||+|+|.+.. ++-.|.|||+|
T Consensus 108 d~v~ivlp~~~H~~f~~l~~----~l~~~~i~~Yl~~ll~Al~~~h~~G---IvHRDiKpsNFL~n~~t~rg~LvDFgLA 180 (418)
T KOG1167|consen 108 DQVAIVLPYFEHDRFRDLYR----SLSLAEIRWYLRNLLKALAHLHKNG---IVHRDIKPSNFLYNRRTQRGVLVDFGLA 180 (418)
T ss_pred CeeEEEecccCccCHHHHHh----cCCHHHHHHHHHHHHHHhhhhhccC---ccccCCCccccccccccCCceEEechhH
Confidence 99999999999998888774 4678999999999999999999998 9999999999999854 56789999999
Q ss_pred ccCcccC------c-------------------------------------ceeeccccCccCCchHhhhc-CCCCcccc
Q 004400 564 KLDEEEN------T-------------------------------------HISTRVAGTIGYMAPEYAMR-GHLTEKAD 599 (756)
Q Consensus 564 ~~~~~~~------~-------------------------------------~~~~~~~gt~~y~aPE~~~~-~~~~~~~D 599 (756)
...+... . ......+||+||.|||++.+ ...++++|
T Consensus 181 ~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiD 260 (418)
T KOG1167|consen 181 QRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAID 260 (418)
T ss_pred HHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccc
Confidence 7211000 0 00112469999999999986 56889999
Q ss_pred hhhHHHHHHHHHhCCCCCC
Q 004400 600 VYSFGIVALEIVSGRSNVT 618 (756)
Q Consensus 600 v~slGv~l~elltg~~p~~ 618 (756)
|||.|||++.+++++.||.
T Consensus 261 iws~GVI~Lslls~~~PFf 279 (418)
T KOG1167|consen 261 IWSAGVILLSLLSRRYPFF 279 (418)
T ss_pred eeeccceeehhhccccccc
Confidence 9999999999999999993
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.4e-27 Score=243.52 Aligned_cols=261 Identities=21% Similarity=0.278 Sum_probs=199.9
Q ss_pred HhhcCccccCcccCCCCccEEEee-ccCCcEEEEEEccccCcccHHHHHHHHHHHHhCCC------CceeeEeeEEEeCC
Q 004400 413 AATNNFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQGNREFINEIGMISALQH------PNLVKLYGCCIEGN 485 (756)
Q Consensus 413 ~~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h------~niv~l~~~~~~~~ 485 (756)
.....|...-..|+|-|++|.+|. ...|..||||++.... ...+.=..|+++|++|+. -|+++++..|...+
T Consensus 429 ~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE-~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hkn 507 (752)
T KOG0670|consen 429 LLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNE-VMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHKN 507 (752)
T ss_pred hhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecch-HHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhcc
Confidence 345688888999999999999999 4568899999997642 233445779999999963 48999999999999
Q ss_pred eEEEEEEecCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCC-CEEEccCCc
Q 004400 486 QLLLIYEYLENNSLARALFEHR--LKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDL-NSKISDFGL 562 (756)
Q Consensus 486 ~~~lV~e~~~~gsL~~~l~~~~--~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~-~~kl~DFGl 562 (756)
.+|||+|.+.- +|.++|...+ ..|....+..++.|+.-||..|-..| |+|.||||+|||+++.- .+||||||.
T Consensus 508 HLClVFE~Lsl-NLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~---vlHaDIKPDNiLVNE~k~iLKLCDfGS 583 (752)
T KOG0670|consen 508 HLCLVFEPLSL-NLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCG---VLHADIKPDNILVNESKNILKLCDFGS 583 (752)
T ss_pred eeEEEehhhhc-hHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcC---eeecccCccceEeccCcceeeeccCcc
Confidence 99999998855 8999997543 45778899999999999999999886 99999999999999764 479999999
Q ss_pred cccCcccCcceeeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHh--------
Q 004400 563 AKLDEEENTHISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKE-------- 634 (756)
Q Consensus 563 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~-------- 634 (756)
|....+... +...-+..|.|||++.+-.|+...|+||.||.|||+.||+.-|.+.....++.....++.
T Consensus 584 A~~~~enei---tPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~KmlR 660 (752)
T KOG0670|consen 584 ASFASENEI---TPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPNKMLR 660 (752)
T ss_pred ccccccccc---cHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcHHHhh
Confidence 986554322 222334569999999999999999999999999999999999976654444332222111
Q ss_pred cC-------------------------ccccccccCC-------------CCCCCHHHHHHHHHHHHHhhcCCCCCCCCH
Q 004400 635 QG-------------------------KLMELVDTNP-------------GSNFDKEQVMVMINVALLCANASPTIRPSM 676 (756)
Q Consensus 635 ~~-------------------------~~~~~~~~~~-------------~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~ 676 (756)
.+ .+.-+..-.| ...-.+.....+.+|+..|+..||++|-|.
T Consensus 661 KgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KRit~ 740 (752)
T KOG0670|consen 661 KGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKRITV 740 (752)
T ss_pred hcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhcCCH
Confidence 00 0000111111 011123445578899999999999999999
Q ss_pred HHHHH
Q 004400 677 SSVLR 681 (756)
Q Consensus 677 ~ev~~ 681 (756)
.+.++
T Consensus 741 nqAL~ 745 (752)
T KOG0670|consen 741 NQALK 745 (752)
T ss_pred HHHhc
Confidence 99875
|
|
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.93 E-value=6.5e-28 Score=253.11 Aligned_cols=274 Identities=22% Similarity=0.292 Sum_probs=202.6
Q ss_pred eeeccceeccccccccCcccc-cCCcccCCCCCCCEEEccCCcccCccCcccccCCcc-eeeccCccccccCCccCcCcC
Q 004400 11 HFWKQKTVNQKRVLKEQNLTG-VLPPKLAELTFLQDIDLTLNYLSGTIPSQWASLPLL-NISLIANRLKGPIPKYLANIS 88 (756)
Q Consensus 11 ~~~~~~~~~~~l~L~~~~l~~-~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L-~l~l~~n~~~~~~p~~l~~l~ 88 (756)
+....+.+++.+++..|++.. -+|..|-.|..|+.||||+|+++ ..|..+..-+.+ -|+|++|+|..+.-..|.+|+
T Consensus 72 GELs~Lp~LRsv~~R~N~LKnsGiP~diF~l~dLt~lDLShNqL~-EvP~~LE~AKn~iVLNLS~N~IetIPn~lfinLt 150 (1255)
T KOG0444|consen 72 GELSDLPRLRSVIVRDNNLKNSGIPTDIFRLKDLTILDLSHNQLR-EVPTNLEYAKNSIVLNLSYNNIETIPNSLFINLT 150 (1255)
T ss_pred hhhccchhhHHHhhhccccccCCCCchhcccccceeeecchhhhh-hcchhhhhhcCcEEEEcccCccccCCchHHHhhH
Confidence 456778889999999998864 56777889999999999999998 888888888765 688999998855445688999
Q ss_pred CCcEEEeecCcccccCCcccCCCCCCcEEeccCCeecc-------------------------cCCccccCCCCCCEEEe
Q 004400 89 TLVNLTVQYNQFSGELPEELGSLLNLEKLHLSSNNFTG-------------------------ELPKTFAKLTNMKDFRI 143 (756)
Q Consensus 89 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~-------------------------~~p~~~~~l~~L~~L~L 143 (756)
.|-.||||+|++. .+|+.+..|.+|++|+|++|.|.- -+|.++..|.||..+||
T Consensus 151 DLLfLDLS~NrLe-~LPPQ~RRL~~LqtL~Ls~NPL~hfQLrQLPsmtsL~vLhms~TqRTl~N~Ptsld~l~NL~dvDl 229 (1255)
T KOG0444|consen 151 DLLFLDLSNNRLE-MLPPQIRRLSMLQTLKLSNNPLNHFQLRQLPSMTSLSVLHMSNTQRTLDNIPTSLDDLHNLRDVDL 229 (1255)
T ss_pred hHhhhccccchhh-hcCHHHHHHhhhhhhhcCCChhhHHHHhcCccchhhhhhhcccccchhhcCCCchhhhhhhhhccc
Confidence 9999999999999 888889999999999999997541 24445555555666666
Q ss_pred eCCcccccCChhhcCcCCCcEEEccCCcCcCCCCccccCCCCCCeEEccCCCCCCCCccccccccccEEEcccccccC-C
Q 004400 144 SDNQFTGQIPSFIQNWTKLEKLFIQPSGLAGPIPSGIFSLENLTDLRISDLNGPEATFPQLGNMKMTKLILRNCNITG-E 222 (756)
Q Consensus 144 ~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~L~~L~L~~n~l~~-~ 222 (756)
|.|.+. .+|+.+-++++|+.|+|++|+|+ .+.-......+|++|++|.|.++..+.......+|+.|.+.+|+|+- -
T Consensus 230 S~N~Lp-~vPecly~l~~LrrLNLS~N~it-eL~~~~~~W~~lEtLNlSrNQLt~LP~avcKL~kL~kLy~n~NkL~FeG 307 (1255)
T KOG0444|consen 230 SENNLP-IVPECLYKLRNLRRLNLSGNKIT-ELNMTEGEWENLETLNLSRNQLTVLPDAVCKLTKLTKLYANNNKLTFEG 307 (1255)
T ss_pred cccCCC-cchHHHhhhhhhheeccCcCcee-eeeccHHHHhhhhhhccccchhccchHHHhhhHHHHHHHhccCcccccC
Confidence 666665 55666666666666666666665 34444555556666666666665555555555566666666666643 3
Q ss_pred CCccccCCCCCcEEEccCCcCCCCCCccCcCCCCCCeEEecCccccccCCchh--hcCCCeeEeecCCCC
Q 004400 223 LPRYLGKMTKLKVLDLSFNRLRGQIPSNFDDLYDVDYIYFAGNLLTGAIPPWM--LERGDKIDLSYNNFT 290 (756)
Q Consensus 223 ~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~--~~~l~~l~ls~N~l~ 290 (756)
+|..++++.+|+.+..++|.+. .+|+.++.+..|+.|.|+.|+|- .+|..+ ++.+..||+..|+-.
T Consensus 308 iPSGIGKL~~Levf~aanN~LE-lVPEglcRC~kL~kL~L~~NrLi-TLPeaIHlL~~l~vLDlreNpnL 375 (1255)
T KOG0444|consen 308 IPSGIGKLIQLEVFHAANNKLE-LVPEGLCRCVKLQKLKLDHNRLI-TLPEAIHLLPDLKVLDLRENPNL 375 (1255)
T ss_pred CccchhhhhhhHHHHhhccccc-cCchhhhhhHHHHHhccccccee-echhhhhhcCCcceeeccCCcCc
Confidence 5666777777777777777776 78888888888888888888887 677776 888999999888643
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.9e-26 Score=274.50 Aligned_cols=196 Identities=17% Similarity=0.219 Sum_probs=141.6
Q ss_pred hCCC-CceeeEeeEE-------EeCCeEEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEc
Q 004400 468 ALQH-PNLVKLYGCC-------IEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVH 539 (756)
Q Consensus 468 ~l~h-~niv~l~~~~-------~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH 539 (756)
.++| +||++++++| .+.+.+++++||+ +++|.+++......+++.++..++.||++||+|||++| |||
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~g---IvH 103 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQG---IVV 103 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCC---eee
Confidence 3455 5888888887 2335678889987 55999999765667999999999999999999999987 999
Q ss_pred CCCCCCceEecC-------------------CCCEEEccCCccccCcccCc---------------ceeeccccCccCCc
Q 004400 540 RDIKATNVLLDK-------------------DLNSKISDFGLAKLDEEENT---------------HISTRVAGTIGYMA 585 (756)
Q Consensus 540 ~Dikp~Nill~~-------------------~~~~kl~DFGla~~~~~~~~---------------~~~~~~~gt~~y~a 585 (756)
|||||+|||++. ++.+|++|||+++....... .......||+.|||
T Consensus 104 rDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~A 183 (793)
T PLN00181 104 HNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTS 183 (793)
T ss_pred ccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEC
Confidence 999999999954 44567777777764221000 00112458899999
Q ss_pred hHhhhcCCCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhcCccccccccCCCCCCCHHHHHHHHHHHHHh
Q 004400 586 PEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDKEQVMVMINVALLC 665 (756)
Q Consensus 586 PE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c 665 (756)
||++.+..++.++|||||||++|||++|..|+...... ... ... . ...+.. .........++.+|
T Consensus 184 PE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~~-~~~----~~~-~----~~~~~~-----~~~~~~~~~~~~~~ 248 (793)
T PLN00181 184 PEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSRT-MSS----LRH-R----VLPPQI-----LLNWPKEASFCLWL 248 (793)
T ss_pred hhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHHH-HHH----HHH-h----hcChhh-----hhcCHHHHHHHHHh
Confidence 99999999999999999999999999998876432110 000 000 0 000000 01122356788899
Q ss_pred hcCCCCCCCCHHHHHHH
Q 004400 666 ANASPTIRPSMSSVLRM 682 (756)
Q Consensus 666 ~~~~P~~RPt~~ev~~~ 682 (756)
|+.+|.+||++.|+++.
T Consensus 249 L~~~P~~Rps~~eil~h 265 (793)
T PLN00181 249 LHPEPSCRPSMSELLQS 265 (793)
T ss_pred CCCChhhCcChHHHhhc
Confidence 99999999999999764
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.92 E-value=7.5e-25 Score=212.22 Aligned_cols=166 Identities=24% Similarity=0.213 Sum_probs=126.4
Q ss_pred CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCcccCcceeec
Q 004400 497 NSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTR 576 (756)
Q Consensus 497 gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~ 576 (756)
|+|.+++...+..+++.++..++.|++.||+|||+++ ||+||+++.++.+|+ ||+++......
T Consensus 1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~---------kp~Nil~~~~~~~~~--fG~~~~~~~~~------ 63 (176)
T smart00750 1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA---------KSGNILLTWDGLLKL--DGSVAFKTPEQ------ 63 (176)
T ss_pred CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC---------CcccEeEcCccceee--ccceEeecccc------
Confidence 7899999876667999999999999999999999874 999999999999999 99998654322
Q ss_pred cccCccCCchHhhhcCCCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhcCccccccccCCCCCCCHHHHH
Q 004400 577 VAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDKEQVM 656 (756)
Q Consensus 577 ~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 656 (756)
..||+.|+|||++.+..++.++|||||||++|||++|+.||........ .......... ...... .........
T Consensus 64 ~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~--~~~~~~~~~~-~~~~~~---~~~~~~~~~ 137 (176)
T smart00750 64 SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSA--ILEILLNGMP-ADDPRD---RSNLESVSA 137 (176)
T ss_pred CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcH--HHHHHHHHhc-cCCccc---cccHHHHHh
Confidence 2589999999999999999999999999999999999999955432111 1111111000 000000 001112222
Q ss_pred --HHHHHHHHhhcCCCCCCCCHHHHHHHhcc
Q 004400 657 --VMINVALLCANASPTIRPSMSSVLRMLEC 685 (756)
Q Consensus 657 --~l~~l~~~c~~~~P~~RPt~~ev~~~L~~ 685 (756)
.+.+++.+||+.+|.+||++.|+++.+..
T Consensus 138 ~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~ 168 (176)
T smart00750 138 ARSFADFMRVCASRLPQRREAANHYLAHCRA 168 (176)
T ss_pred hhhHHHHHHHHHhcccccccCHHHHHHHHHH
Confidence 58999999999999999999999988763
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.2e-27 Score=249.20 Aligned_cols=269 Identities=24% Similarity=0.341 Sum_probs=124.2
Q ss_pred ceeccccccccCcccccCCcccCCCCCCCEEEccCCcccC-ccCcccccCCcce-eeccCccccccCCccCcCcCCCcEE
Q 004400 16 KTVNQKRVLKEQNLTGVLPPKLAELTFLQDIDLTLNYLSG-TIPSQWASLPLLN-ISLIANRLKGPIPKYLANISTLVNL 93 (756)
Q Consensus 16 ~~~~~~l~L~~~~l~~~~p~~l~~l~~L~~L~L~~n~l~~-~~p~~~~~l~~L~-l~l~~n~~~~~~p~~l~~l~~L~~L 93 (756)
+..+..|.+.+|++. .+..+++.++.|+.+++.+|++.. -+|..+..+.-|. ++|++|++. ..|..+...+++..|
T Consensus 54 lqkLEHLs~~HN~L~-~vhGELs~Lp~LRsv~~R~N~LKnsGiP~diF~l~dLt~lDLShNqL~-EvP~~LE~AKn~iVL 131 (1255)
T KOG0444|consen 54 LQKLEHLSMAHNQLI-SVHGELSDLPRLRSVIVRDNNLKNSGIPTDIFRLKDLTILDLSHNQLR-EVPTNLEYAKNSIVL 131 (1255)
T ss_pred HhhhhhhhhhhhhhH-hhhhhhccchhhHHHhhhccccccCCCCchhcccccceeeecchhhhh-hcchhhhhhcCcEEE
Confidence 334444444444444 233344444444444444444431 2444444444442 455555544 455555555555555
Q ss_pred EeecCcccccCC-cccCCCCCCcEEeccCCeecccCCccccCCCCCCEEEeeCCccccc---------------------
Q 004400 94 TVQYNQFSGELP-EELGSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRISDNQFTGQ--------------------- 151 (756)
Q Consensus 94 ~L~~N~l~~~~p-~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~--------------------- 151 (756)
+||+|+|. .|| .-|-+|+.|-.||||+|+|. .+|..+..|.+|++|.|++|.+...
T Consensus 132 NLS~N~Ie-tIPn~lfinLtDLLfLDLS~NrLe-~LPPQ~RRL~~LqtL~Ls~NPL~hfQLrQLPsmtsL~vLhms~TqR 209 (1255)
T KOG0444|consen 132 NLSYNNIE-TIPNSLFINLTDLLFLDLSNNRLE-MLPPQIRRLSMLQTLKLSNNPLNHFQLRQLPSMTSLSVLHMSNTQR 209 (1255)
T ss_pred EcccCccc-cCCchHHHhhHhHhhhccccchhh-hcCHHHHHHhhhhhhhcCCChhhHHHHhcCccchhhhhhhcccccc
Confidence 55555555 333 23445555555555555555 4444455555555555555544321
Q ss_pred ----CChhhcCcCCCcEEEccCCcCcCCCCccccCCCCCCeEEccCCCCCCCCccccccccccEEEcccccccCCCCccc
Q 004400 152 ----IPSFIQNWTKLEKLFIQPSGLAGPIPSGIFSLENLTDLRISDLNGPEATFPQLGNMKMTKLILRNCNITGELPRYL 227 (756)
Q Consensus 152 ----~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~L~~L~L~~n~l~~~~p~~~ 227 (756)
+|..+..+.+|..++|+.|.+. .+|..+.++++|+.|+||+|.+++.....-.-.+|+.|+|+.|+|+ .+|+++
T Consensus 210 Tl~N~Ptsld~l~NL~dvDlS~N~Lp-~vPecly~l~~LrrLNLS~N~iteL~~~~~~W~~lEtLNlSrNQLt-~LP~av 287 (1255)
T KOG0444|consen 210 TLDNIPTSLDDLHNLRDVDLSENNLP-IVPECLYKLRNLRRLNLSGNKITELNMTEGEWENLETLNLSRNQLT-VLPDAV 287 (1255)
T ss_pred hhhcCCCchhhhhhhhhccccccCCC-cchHHHhhhhhhheeccCcCceeeeeccHHHHhhhhhhccccchhc-cchHHH
Confidence 2233333334444444444443 3444444444444444444444443322211123444444444444 444444
Q ss_pred cCCCCCcEEEccCCcCC-CCCCccCcCCCCCCeEEecCccccccCCchh--hcCCCeeEeecCCCCC
Q 004400 228 GKMTKLKVLDLSFNRLR-GQIPSNFDDLYDVDYIYFAGNLLTGAIPPWM--LERGDKIDLSYNNFTD 291 (756)
Q Consensus 228 ~~l~~L~~L~Ls~N~l~-~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~--~~~l~~l~ls~N~l~~ 291 (756)
.++++|+.|.+.+|+++ .-+|+.++++.+|+.+..++|.|. .+|..+ ...|+.|.++.|.+..
T Consensus 288 cKL~kL~kLy~n~NkL~FeGiPSGIGKL~~Levf~aanN~LE-lVPEglcRC~kL~kL~L~~NrLiT 353 (1255)
T KOG0444|consen 288 CKLTKLTKLYANNNKLTFEGIPSGIGKLIQLEVFHAANNKLE-LVPEGLCRCVKLQKLKLDHNRLIT 353 (1255)
T ss_pred hhhHHHHHHHhccCcccccCCccchhhhhhhHHHHhhccccc-cCchhhhhhHHHHHhcccccceee
Confidence 44444444444444443 124444444444444444444444 444444 3344555555555443
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.6e-23 Score=222.70 Aligned_cols=259 Identities=19% Similarity=0.184 Sum_probs=194.7
Q ss_pred CccccCcccCCCCccEEEeeccCC--cEEEEEEccccCcccHHHHHHHHHHHHhCCC----CceeeEeeEE-EeCCeEEE
Q 004400 417 NFATDNNIGEGGFGPVYKGLLADG--TAIAVKQLSSKSKQGNREFINEIGMISALQH----PNLVKLYGCC-IEGNQLLL 489 (756)
Q Consensus 417 ~~~~~~~lg~G~~g~Vy~~~~~~~--~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h----~niv~l~~~~-~~~~~~~l 489 (756)
+|...+.||+|+||.||.|..... ..+|+|............+..|+.++..+.. +++..+++.. ..+...++
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i 98 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI 98 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence 789999999999999999995543 5788888765433333367889999988873 6899999999 57888999
Q ss_pred EEEecCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCC-----CCEEEccCCcc
Q 004400 490 IYEYLENNSLARALFEHR-LKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKD-----LNSKISDFGLA 563 (756)
Q Consensus 490 V~e~~~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~-----~~~kl~DFGla 563 (756)
||+.+ |.+|.++..... ..++..+..+|+.|++.+|++||+.| ++||||||.|+++... ..+.|.|||++
T Consensus 99 VM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G---~iHRDiKp~N~~~g~~~~~~~~~~~llDfGla 174 (322)
T KOG1164|consen 99 VMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKG---FIHRDIKPENFVVGQSSRSEVRTLYLLDFGLA 174 (322)
T ss_pred EEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcC---cccCCcCHHHeeecCCCCcccceEEEEecCCC
Confidence 99977 679999875444 78999999999999999999999997 9999999999999865 35899999999
Q ss_pred ccCc--ccCc----ce---eeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHh
Q 004400 564 KLDE--EENT----HI---STRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKE 634 (756)
Q Consensus 564 ~~~~--~~~~----~~---~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~ 634 (756)
+... .... .. ...+.||..|+++....+.+.+.+.|+||++.++.|+..|..||.................
T Consensus 175 r~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~~~ 254 (322)
T KOG1164|consen 175 RRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKDPR 254 (322)
T ss_pred ccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHHhh
Confidence 8322 1111 11 2346699999999999999999999999999999999999999955432211111111111
Q ss_pred cCccccccccCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhccCcc
Q 004400 635 QGKLMELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLECGVD 688 (756)
Q Consensus 635 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~L~~~~~ 688 (756)
...... .....+ ..+.++...+-..+..++|....+...+++...
T Consensus 255 ~~~~~~------~~~~~~---~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~ 299 (322)
T KOG1164|consen 255 KLLTDR------FGDLKP---EEFAKILEYIDSLDYEDKPDYEKLAELLKDVFD 299 (322)
T ss_pred hhcccc------ccCCCh---HHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHH
Confidence 111111 111122 235566666667899999999999998876544
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.1e-24 Score=226.91 Aligned_cols=167 Identities=22% Similarity=0.209 Sum_probs=130.6
Q ss_pred HHHhhcCccccCcccCCCCccEEEeecc--CCcEEEEEEcccc-----CcccHHHHHHHHHHHHhCCCCceeeEeeEEEe
Q 004400 411 IKAATNNFATDNNIGEGGFGPVYKGLLA--DGTAIAVKQLSSK-----SKQGNREFINEIGMISALQHPNLVKLYGCCIE 483 (756)
Q Consensus 411 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 483 (756)
.....++|...+.||+|+||+||+|... +++.||||++... .....+.|.+|+++|++++|+|+++.+..
T Consensus 13 ~~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~--- 89 (365)
T PRK09188 13 IPALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA--- 89 (365)
T ss_pred cccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE---
Confidence 3445678999999999999999999854 5778899986532 12234568999999999999999853322
Q ss_pred CCeEEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCC-CCCceEecCCCCEEEccCCc
Q 004400 484 GNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDI-KATNVLLDKDLNSKISDFGL 562 (756)
Q Consensus 484 ~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Di-kp~Nill~~~~~~kl~DFGl 562 (756)
.+..++||||++|++|... . . .. ...++.++++||+|||+.| |+|||| ||+|||++.++.+||+|||+
T Consensus 90 ~~~~~LVmE~~~G~~L~~~-~-~---~~---~~~~~~~i~~aL~~lH~~g---IiHrDL~KP~NILv~~~~~ikLiDFGl 158 (365)
T PRK09188 90 TGKDGLVRGWTEGVPLHLA-R-P---HG---DPAWFRSAHRALRDLHRAG---ITHNDLAKPQNWLMGPDGEAAVIDFQL 158 (365)
T ss_pred cCCcEEEEEccCCCCHHHh-C-c---cc---hHHHHHHHHHHHHHHHHCC---CeeCCCCCcceEEEcCCCCEEEEECcc
Confidence 2467999999999999632 1 1 11 2467889999999999987 999999 99999999999999999999
Q ss_pred cccCcccCcce-------eeccccCccCCchHhhhc
Q 004400 563 AKLDEEENTHI-------STRVAGTIGYMAPEYAMR 591 (756)
Q Consensus 563 a~~~~~~~~~~-------~~~~~gt~~y~aPE~~~~ 591 (756)
|+......... .+...+++.|+|||++..
T Consensus 159 A~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~ 194 (365)
T PRK09188 159 ASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTP 194 (365)
T ss_pred ceecccCcchhhhhhhhhhhhhhccCccCCcccCCh
Confidence 98665433211 135678999999999864
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.6e-24 Score=206.99 Aligned_cols=246 Identities=24% Similarity=0.370 Sum_probs=187.1
Q ss_pred cccCcccCCCCccEEEeeccCCcEEEEEEcccc--CcccHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEEecCC
Q 004400 419 ATDNNIGEGGFGPVYKGLLADGTAIAVKQLSSK--SKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYEYLEN 496 (756)
Q Consensus 419 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~ 496 (756)
....+|.+...|..|+|+|+.+ .+++|++... .....++|..|.-.|+-+.||||.+++|.|..+....++..||+.
T Consensus 193 nl~tkl~e~hsgelwrgrwqgn-divakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~ 271 (448)
T KOG0195|consen 193 NLITKLAESHSGELWRGRWQGN-DIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPF 271 (448)
T ss_pred hhhhhhccCCCcccccccccCc-chhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccc
Confidence 3445788999999999999744 4556666543 333446899999999999999999999999999999999999999
Q ss_pred CCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEc--cCCccccCcccCcce
Q 004400 497 NSLARALFEH-RLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKIS--DFGLAKLDEEENTHI 573 (756)
Q Consensus 497 gsL~~~l~~~-~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~--DFGla~~~~~~~~~~ 573 (756)
|+|...+++. ....+..++.+++.++|+|++|||+.. +-|.---+.+..+++|++.+++|+ |--++. ..
T Consensus 272 gslynvlhe~t~vvvd~sqav~faldiargmaflhsle-p~ipr~~lns~hvmidedltarismad~kfsf--qe----- 343 (448)
T KOG0195|consen 272 GSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLE-PMIPRFYLNSKHVMIDEDLTARISMADTKFSF--QE----- 343 (448)
T ss_pred hHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcc-hhhhhhhcccceEEecchhhhheecccceeee--ec-----
Confidence 9999999854 445788899999999999999999985 334445688999999999888764 322221 11
Q ss_pred eeccccCccCCchHhhhcCCC---CcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhcCccccccccCCCCCC
Q 004400 574 STRVAGTIGYMAPEYAMRGHL---TEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNF 650 (756)
Q Consensus 574 ~~~~~gt~~y~aPE~~~~~~~---~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 650 (756)
....-.+.||+||.+++.+- -.++|+|||++++||+.|...||..-.....- +.+.-..+....
T Consensus 344 -~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecg------------mkialeglrv~i 410 (448)
T KOG0195|consen 344 -VGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECG------------MKIALEGLRVHI 410 (448)
T ss_pred -cccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhh------------hhhhhccccccC
Confidence 11234678999999987653 35799999999999999999999544332211 011111222334
Q ss_pred CHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhccC
Q 004400 651 DKEQVMVMINVALLCANASPTIRPSMSSVLRMLECG 686 (756)
Q Consensus 651 ~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~L~~~ 686 (756)
++.....+.+++.-|+..||.+||.++.|+-.||+.
T Consensus 411 ppgis~hm~klm~icmnedpgkrpkfdmivpilekm 446 (448)
T KOG0195|consen 411 PPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKM 446 (448)
T ss_pred CCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHh
Confidence 445556688999999999999999999999998864
|
|
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.90 E-value=4.9e-26 Score=228.53 Aligned_cols=271 Identities=27% Similarity=0.375 Sum_probs=199.1
Q ss_pred eeeeccceeccccccccCcccccCCcccCCCCCCCEEEccCCcccCccCcccccCCcce-eeccCccccccCCccCcCcC
Q 004400 10 FHFWKQKTVNQKRVLKEQNLTGVLPPKLAELTFLQDIDLTLNYLSGTIPSQWASLPLLN-ISLIANRLKGPIPKYLANIS 88 (756)
Q Consensus 10 ~~~~~~~~~~~~l~L~~~~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~-l~l~~n~~~~~~p~~l~~l~ 88 (756)
++.+..+.++.++++.+|+++...|+.+. |+.|+.||+.+|.++ .+|..++.+..|. +++.+|.+. .+| .|.+++
T Consensus 153 p~~~~~~~~l~~l~~~~n~l~~l~~~~i~-m~~L~~ld~~~N~L~-tlP~~lg~l~~L~~LyL~~Nki~-~lP-ef~gcs 228 (565)
T KOG0472|consen 153 PEDMVNLSKLSKLDLEGNKLKALPENHIA-MKRLKHLDCNSNLLE-TLPPELGGLESLELLYLRRNKIR-FLP-EFPGCS 228 (565)
T ss_pred chHHHHHHHHHHhhccccchhhCCHHHHH-HHHHHhcccchhhhh-cCChhhcchhhhHHHHhhhcccc-cCC-CCCccH
Confidence 35567778888899999999966666555 999999999999987 8888999998885 788888887 777 799999
Q ss_pred CCcEEEeecCcccccCCcccC-CCCCCcEEeccCCeecccCCccccCCCCCCEEEeeCCcccccCChhhcCcCCCcEEEc
Q 004400 89 TLVNLTVQYNQFSGELPEELG-SLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRISDNQFTGQIPSFIQNWTKLEKLFI 167 (756)
Q Consensus 89 ~L~~L~L~~N~l~~~~p~~~~-~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l 167 (756)
.|++|+++.|+|+ .+|.+.+ +|.+|..|||.+|+++ ..|+.+.-+.+|..||+|+|.|+ .+|..++++ .|+.|.+
T Consensus 229 ~L~Elh~g~N~i~-~lpae~~~~L~~l~vLDLRdNklk-e~Pde~clLrsL~rLDlSNN~is-~Lp~sLgnl-hL~~L~l 304 (565)
T KOG0472|consen 229 LLKELHVGENQIE-MLPAEHLKHLNSLLVLDLRDNKLK-EVPDEICLLRSLERLDLSNNDIS-SLPYSLGNL-HLKFLAL 304 (565)
T ss_pred HHHHHHhcccHHH-hhHHHHhcccccceeeeccccccc-cCchHHHHhhhhhhhcccCCccc-cCCcccccc-eeeehhh
Confidence 9999999999998 8888777 8999999999999999 89999999999999999999999 678889999 8999999
Q ss_pred cCCcCcC-------------------------------------CCCcc----ccCCCCCCeEEccC-------------
Q 004400 168 QPSGLAG-------------------------------------PIPSG----IFSLENLTDLRISD------------- 193 (756)
Q Consensus 168 ~~N~l~~-------------------------------------~~p~~----~~~l~~L~~L~l~~------------- 193 (756)
.+|.+.. ..|.. ...+.+.+.|++++
T Consensus 305 eGNPlrTiRr~ii~~gT~~vLKyLrs~~~~dglS~se~~~e~~~t~~~~~~~~~~~~i~tkiL~~s~~qlt~VPdEVfea 384 (565)
T KOG0472|consen 305 EGNPLRTIRREIISKGTQEVLKYLRSKIKDDGLSQSEGGTETAMTLPSESFPDIYAIITTKILDVSDKQLTLVPDEVFEA 384 (565)
T ss_pred cCCchHHHHHHHHcccHHHHHHHHHHhhccCCCCCCcccccccCCCCCCcccchhhhhhhhhhcccccccccCCHHHHHH
Confidence 9998751 00100 01122333333333
Q ss_pred -------------CCCCCCC-----------------------cccccc-ccccEEEcccccccCCCCccccCCCCCcEE
Q 004400 194 -------------LNGPEAT-----------------------FPQLGN-MKMTKLILRNCNITGELPRYLGKMTKLKVL 236 (756)
Q Consensus 194 -------------n~~~~~~-----------------------~~~~~~-~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L 236 (756)
|.+.+.+ +..+.. .+|+-|+|++|-+. .+|..++.+..|+.|
T Consensus 385 ~~~~~Vt~VnfskNqL~elPk~L~~lkelvT~l~lsnn~isfv~~~l~~l~kLt~L~L~NN~Ln-~LP~e~~~lv~Lq~L 463 (565)
T KOG0472|consen 385 AKSEIVTSVNFSKNQLCELPKRLVELKELVTDLVLSNNKISFVPLELSQLQKLTFLDLSNNLLN-DLPEEMGSLVRLQTL 463 (565)
T ss_pred hhhcceEEEecccchHhhhhhhhHHHHHHHHHHHhhcCccccchHHHHhhhcceeeecccchhh-hcchhhhhhhhhhee
Confidence 2222211 111111 14667788887777 677777778778888
Q ss_pred EccCCcCCC-----------------------CCCccCcCCCCCCeEEecCccccccCCchh--hcCCCeeEeecCCCC
Q 004400 237 DLSFNRLRG-----------------------QIPSNFDDLYDVDYIYFAGNLLTGAIPPWM--LERGDKIDLSYNNFT 290 (756)
Q Consensus 237 ~Ls~N~l~~-----------------------~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~--~~~l~~l~ls~N~l~ 290 (756)
|+|+|+|.. ..|+.+.+|.+|..|||.+|.+. .+|+.+ +.+++.|++.||+|.
T Consensus 464 nlS~NrFr~lP~~~y~lq~lEtllas~nqi~~vd~~~l~nm~nL~tLDL~nNdlq-~IPp~LgnmtnL~hLeL~gNpfr 541 (565)
T KOG0472|consen 464 NLSFNRFRMLPECLYELQTLETLLASNNQIGSVDPSGLKNMRNLTTLDLQNNDLQ-QIPPILGNMTNLRHLELDGNPFR 541 (565)
T ss_pred cccccccccchHHHhhHHHHHHHHhccccccccChHHhhhhhhcceeccCCCchh-hCChhhccccceeEEEecCCccC
Confidence 888887761 22233666777777777777776 556555 667777777777776
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=8.4e-23 Score=192.37 Aligned_cols=265 Identities=21% Similarity=0.250 Sum_probs=202.0
Q ss_pred hhcCccccCcccCCCCccEEEee-ccCCcEEEEEEccccCcccHHHHHHHHHHHHhCCC-CceeeEeeEEEeCCeEEEEE
Q 004400 414 ATNNFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQGNREFINEIGMISALQH-PNLVKLYGCCIEGNQLLLIY 491 (756)
Q Consensus 414 ~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~~~lV~ 491 (756)
..++|...+.||.|+||.+|.|. ..+|..||||.-+.+... ..+..|..+.+.+++ ..|..+..+..+..+-.+||
T Consensus 13 v~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~h--pqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVM 90 (341)
T KOG1163|consen 13 VGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKH--PQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVM 90 (341)
T ss_pred eccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCC--cchhHHHHHHHHhccCCCCchhhhhccccccceeee
Confidence 34688999999999999999999 788999999997654333 567789999999975 67888888888999999999
Q ss_pred EecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCC---CCEEEccCCccccCcc
Q 004400 492 EYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKD---LNSKISDFGLAKLDEE 568 (756)
Q Consensus 492 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~---~~~kl~DFGla~~~~~ 568 (756)
|.+ |.+|++...-+...++..+..-++-|++.-++|+|.++ +|||||||+|+|..-+ ..+.++|||+|+.+.+
T Consensus 91 dLL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~---fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d 166 (341)
T KOG1163|consen 91 DLL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRN---FIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRD 166 (341)
T ss_pred ecc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhc---cccccCCccceeeccccccceEEEEeccchhhhcc
Confidence 987 77999999877778999999999999999999999997 9999999999999654 3489999999986543
Q ss_pred cCc--c----eeeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhcCcccccc
Q 004400 569 ENT--H----ISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELV 642 (756)
Q Consensus 569 ~~~--~----~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 642 (756)
..+ + ......||.+|.+-....+.+.+.+.|+-|+|.++.++.-|..||.+-....-......+.+. +. ...
T Consensus 167 ~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~Ek-K~-s~~ 244 (341)
T KOG1163|consen 167 IRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEK-KM-STP 244 (341)
T ss_pred ccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHh-hc-CCC
Confidence 222 1 133467999999998888888899999999999999999999999654332221111111111 11 111
Q ss_pred ccCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhccCcccc
Q 004400 643 DTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLECGVDVL 690 (756)
Q Consensus 643 ~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~L~~~~~~~ 690 (756)
-..+=..+|.+ +.-.+..|-...-++-|...-+-+.+.-....+
T Consensus 245 ie~LC~G~P~E----F~myl~Y~R~L~F~E~Pdy~ylrqlFriLfr~l 288 (341)
T KOG1163|consen 245 IEVLCKGFPAE----FAMYLNYCRGLGFEEKPDYMYLRQLFRILFRTL 288 (341)
T ss_pred HHHHhCCCcHH----HHHHHHHHhhcCCCCCCcHHHHHHHHHHHHhhc
Confidence 01111223333 566677899999999999887777766544433
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=2e-22 Score=198.28 Aligned_cols=257 Identities=19% Similarity=0.235 Sum_probs=198.2
Q ss_pred CccccCcccCCCCccEEEee-ccCCcEEEEEEccccCcccHHHHHHHHHHHHhCC-CCceeeEeeEEEeCCeEEEEEEec
Q 004400 417 NFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQGNREFINEIGMISALQ-HPNLVKLYGCCIEGNQLLLIYEYL 494 (756)
Q Consensus 417 ~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lV~e~~ 494 (756)
.|.+.++||+|.||..+.|. +-++..||||.-..++ ...++..|....+.|. .++|..+|.+..++.+-.||+|.+
T Consensus 29 hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS--~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidLL 106 (449)
T KOG1165|consen 29 HYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKS--EAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDLL 106 (449)
T ss_pred cceeccccccCcceeeecccccccCceEEEEeccccC--CcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhhh
Confidence 67889999999999999999 6789999999876543 3367788998888884 699999999989999999999987
Q ss_pred CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCC-----CEEEccCCccccCccc
Q 004400 495 ENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDL-----NSKISDFGLAKLDEEE 569 (756)
Q Consensus 495 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~-----~~kl~DFGla~~~~~~ 569 (756)
|.||+|+..-++.+++..+..-+|.|++.-++|+|++. +|.|||||+|+||...+ .+.|+|||+|+.+.+.
T Consensus 107 -GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~---LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrDp 182 (449)
T KOG1165|consen 107 -GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKD---LIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRDP 182 (449)
T ss_pred -CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcc---eeecccCccceeecCCCCCCCceEEEEeccchhhhcCc
Confidence 77999999888899999999999999999999999985 99999999999997543 3899999999976654
Q ss_pred Ccce------eeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhcCccccccc
Q 004400 570 NTHI------STRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVD 643 (756)
Q Consensus 570 ~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 643 (756)
.+.. .....||.+||+-....+++.+.+.|.-|+|-++.+++-|..||.+-.-...-.....+.+.+....+-+
T Consensus 183 ~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe~Kr~T~i~~ 262 (449)
T KOG1165|consen 183 KTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGETKRSTPIEV 262 (449)
T ss_pred cccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhccccccCCHHH
Confidence 4332 2346799999999999999999999999999999999999999965432222111111222222111111
Q ss_pred cCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhcc
Q 004400 644 TNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLEC 685 (756)
Q Consensus 644 ~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~L~~ 685 (756)
-+. .++ .++...+...-..+..+-|..+-+...+..
T Consensus 263 Lc~--g~P----~efa~Yl~yvR~L~F~E~PDYdylr~Lf~d 298 (449)
T KOG1165|consen 263 LCE--GFP----EEFATYLRYVRRLDFFETPDYDYLRKLFDD 298 (449)
T ss_pred HHh--cCH----HHHHHHHHHHHhcCcccCCCHHHHHHHHHH
Confidence 111 122 235555555667788888988777665543
|
|
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.1e-25 Score=226.15 Aligned_cols=274 Identities=23% Similarity=0.320 Sum_probs=236.6
Q ss_pred ceeeeeccceeccccccccCcccccCCcccCCCCCCCEEEccCCcccCccCcccccCCcc-eeeccCccccccCCccCcC
Q 004400 8 LVFHFWKQKTVNQKRVLKEQNLTGVLPPKLAELTFLQDIDLTLNYLSGTIPSQWASLPLL-NISLIANRLKGPIPKYLAN 86 (756)
Q Consensus 8 ~~~~~~~~~~~~~~l~L~~~~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L-~l~l~~n~~~~~~p~~l~~ 86 (756)
-+.+.|-....++++.|++|++.-. -+.+.++.-|++|++++|++. ..|++++.+..+ +++.++|+++ .+|..++.
T Consensus 36 ~e~e~wW~qv~l~~lils~N~l~~l-~~dl~nL~~l~vl~~~~n~l~-~lp~aig~l~~l~~l~vs~n~ls-~lp~~i~s 112 (565)
T KOG0472|consen 36 GEGENWWEQVDLQKLILSHNDLEVL-REDLKNLACLTVLNVHDNKLS-QLPAAIGELEALKSLNVSHNKLS-ELPEQIGS 112 (565)
T ss_pred cchhhhhhhcchhhhhhccCchhhc-cHhhhcccceeEEEeccchhh-hCCHHHHHHHHHHHhhcccchHh-hccHHHhh
Confidence 3445577788999999999999954 455889999999999999998 788888888766 6899999988 88999999
Q ss_pred cCCCcEEEeecCcccccCCcccCCCCCCcEEeccCCeecccCCccccCCCCCCEEEeeCCcccccCChhhcCcCCCcEEE
Q 004400 87 ISTLVNLTVQYNQFSGELPEELGSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRISDNQFTGQIPSFIQNWTKLEKLF 166 (756)
Q Consensus 87 l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 166 (756)
+.+|+.|+.++|.+. .+|++++.+..|+.|+..+|+++ ..|..+..+.+|..|++.+|+++...|+.+ +++.|+.|+
T Consensus 113 ~~~l~~l~~s~n~~~-el~~~i~~~~~l~dl~~~~N~i~-slp~~~~~~~~l~~l~~~~n~l~~l~~~~i-~m~~L~~ld 189 (565)
T KOG0472|consen 113 LISLVKLDCSSNELK-ELPDSIGRLLDLEDLDATNNQIS-SLPEDMVNLSKLSKLDLEGNKLKALPENHI-AMKRLKHLD 189 (565)
T ss_pred hhhhhhhhcccccee-ecCchHHHHhhhhhhhccccccc-cCchHHHHHHHHHHhhccccchhhCCHHHH-HHHHHHhcc
Confidence 999999999999999 88999999999999999999999 888899999999999999999995555544 499999999
Q ss_pred ccCCcCcCCCCccccCCCCCCeEEccCCCCCCCCccccccccccEEEcccccccCCCCcccc-CCCCCcEEEccCCcCCC
Q 004400 167 IQPSGLAGPIPSGIFSLENLTDLRISDLNGPEATFPQLGNMKMTKLILRNCNITGELPRYLG-KMTKLKVLDLSFNRLRG 245 (756)
Q Consensus 167 l~~N~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~L~~L~L~~n~l~~~~p~~~~-~l~~L~~L~Ls~N~l~~ 245 (756)
+..|.+. .+|..++.+.+|..|++..|.+...+ ..-+...|..|++..|.+. .+|.+.. .+++|..|||..|++.
T Consensus 190 ~~~N~L~-tlP~~lg~l~~L~~LyL~~Nki~~lP-ef~gcs~L~Elh~g~N~i~-~lpae~~~~L~~l~vLDLRdNklk- 265 (565)
T KOG0472|consen 190 CNSNLLE-TLPPELGGLESLELLYLRRNKIRFLP-EFPGCSLLKELHVGENQIE-MLPAEHLKHLNSLLVLDLRDNKLK- 265 (565)
T ss_pred cchhhhh-cCChhhcchhhhHHHHhhhcccccCC-CCCccHHHHHHHhcccHHH-hhHHHHhcccccceeeeccccccc-
Confidence 9999998 79999999999999999999998776 3333345899999999999 5666554 8999999999999999
Q ss_pred CCCccCcCCCCCCeEEecCccccccCCchh-hcCCCeeEeecCCCCCC
Q 004400 246 QIPSNFDDLYDVDYIYFAGNLLTGAIPPWM-LERGDKIDLSYNNFTDG 292 (756)
Q Consensus 246 ~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~-~~~l~~l~ls~N~l~~~ 292 (756)
..|..+.-+.+|++||+|+|.++ .+|..+ --.++.|.+.||++...
T Consensus 266 e~Pde~clLrsL~rLDlSNN~is-~Lp~sLgnlhL~~L~leGNPlrTi 312 (565)
T KOG0472|consen 266 EVPDEICLLRSLERLDLSNNDIS-SLPYSLGNLHLKFLALEGNPLRTI 312 (565)
T ss_pred cCchHHHHhhhhhhhcccCCccc-cCCcccccceeeehhhcCCchHHH
Confidence 89999999999999999999999 455554 22788888999997653
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.3e-21 Score=205.81 Aligned_cols=255 Identities=30% Similarity=0.422 Sum_probs=197.6
Q ss_pred ccccCcccCCCCccEEEeeccCCcEEEEEEccccCcc---cHHHHHHHHHHHHhCCCC-ceeeEeeEEEeCCeEEEEEEe
Q 004400 418 FATDNNIGEGGFGPVYKGLLADGTAIAVKQLSSKSKQ---GNREFINEIGMISALQHP-NLVKLYGCCIEGNQLLLIYEY 493 (756)
Q Consensus 418 ~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~-niv~l~~~~~~~~~~~lV~e~ 493 (756)
|...+.||.|+||.||++... ..+++|.+...... ....+.+|+.+++.+.|+ +++++++++......+++++|
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 79 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY 79 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence 566788999999999999976 78999998765332 367899999999999988 799999999888888999999
Q ss_pred cCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCC-CEEEccCCccccCcccC
Q 004400 494 LENNSLARALFEHR--LKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDL-NSKISDFGLAKLDEEEN 570 (756)
Q Consensus 494 ~~~gsL~~~l~~~~--~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~-~~kl~DFGla~~~~~~~ 570 (756)
+.++++.+++.... ..+.......++.|++.+++|+|+.+ ++|||+||+||+++..+ .++++|||.++......
T Consensus 80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~---~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~ 156 (384)
T COG0515 80 VDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKG---IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPG 156 (384)
T ss_pred CCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeecCCCCeEEEeccCcceecCCCC
Confidence 99999997765443 26899999999999999999999997 99999999999999988 69999999998555433
Q ss_pred cc-----eeeccccCccCCchHhhhc---CCCCcccchhhHHHHHHHHHhCCCCCCccch----hhHHHHHHHHHhcCcc
Q 004400 571 TH-----ISTRVAGTIGYMAPEYAMR---GHLTEKADVYSFGIVALEIVSGRSNVTKEDM----FYLLDWALVLKEQGKL 638 (756)
Q Consensus 571 ~~-----~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~slGv~l~elltg~~p~~~~~~----~~~~~~~~~~~~~~~~ 638 (756)
.. ......||..|+|||.+.. ..++...|+||+|++++++++|..||..... ........ .....
T Consensus 157 ~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~--~~~~~- 233 (384)
T COG0515 157 STSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIIL--ELPTP- 233 (384)
T ss_pred ccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHH--hcCCc-
Confidence 22 2355789999999999987 5788999999999999999999999755442 11111111 11110
Q ss_pred ccccccCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004400 639 MELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRM 682 (756)
Q Consensus 639 ~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~ 682 (756)
.................+.+++..|+..+|..|.+..+....
T Consensus 234 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 234 --SLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred --ccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 000000000001122457888999999999999999987654
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.2e-22 Score=229.14 Aligned_cols=254 Identities=22% Similarity=0.240 Sum_probs=188.6
Q ss_pred cccCcccCCCCccEEEee-ccCCcEEEEEEcccc--Cccc----HHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEE
Q 004400 419 ATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSK--SKQG----NREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIY 491 (756)
Q Consensus 419 ~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~--~~~~----~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 491 (756)
...+++|.|++|.|+.+. ....+.++.|.+... .... ...+..|+.+=..++|+|++..+..+.+.....-+|
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m 400 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM 400 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence 456899999999888876 344444555544311 1111 122566888888899999999888887777776679
Q ss_pred EecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCcccC-
Q 004400 492 EYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEEN- 570 (756)
Q Consensus 492 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~~~- 570 (756)
|||++ +|...+... ..+...++..++.|++.|++|+|+.| |.|||+|++|++++.+|.+||+|||.+..+....
T Consensus 401 E~~~~-Dlf~~~~~~-~~~~~~e~~c~fKqL~~Gv~y~h~~G---iahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e 475 (601)
T KOG0590|consen 401 EYCPY-DLFSLVMSN-GKLTPLEADCFFKQLLRGVKYLHSMG---LAHRDLKLENLLVTENGILKIIDFGAASVFRYPWE 475 (601)
T ss_pred hcccH-HHHHHHhcc-cccchhhhhHHHHHHHHHHHHHHhcC---ceeccCccccEEEecCCceEEeecCcceeeccCcc
Confidence 99999 999988654 36888899999999999999999998 9999999999999999999999999998654332
Q ss_pred --cceeeccccCccCCchHhhhcCCCCc-ccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhcCccccccccCCC
Q 004400 571 --THISTRVAGTIGYMAPEYAMRGHLTE-KADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPG 647 (756)
Q Consensus 571 --~~~~~~~~gt~~y~aPE~~~~~~~~~-~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 647 (756)
......++|+-.|+|||++...+|.+ ..||||.|+++..|++|+.||......+..- .........-.....
T Consensus 476 ~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~-----~~~~~~~~~~~~~~~ 550 (601)
T KOG0590|consen 476 KNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSF-----KTNNYSDQRNIFEGP 550 (601)
T ss_pred hhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccch-----hhhccccccccccCh
Confidence 24566788999999999999999877 5899999999999999999994332211000 000001111111111
Q ss_pred CCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004400 648 SNFDKEQVMVMINVALLCANASPTIRPSMSSVLRM 682 (756)
Q Consensus 648 ~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~ 682 (756)
.......+.....++.++++.+|.+|-|+.+|++.
T Consensus 551 ~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d 585 (601)
T KOG0590|consen 551 NRLLSLLPRETRIIIYRMLQLDPTKRITIEQILND 585 (601)
T ss_pred HHHHHhchhhHHHHHHHHccCChhheecHHHHhhC
Confidence 12233445568889999999999999999999764
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.86 E-value=9.3e-22 Score=193.23 Aligned_cols=171 Identities=17% Similarity=0.161 Sum_probs=135.0
Q ss_pred hhcCccccCcccCCCCccEEEeeccCCcEEEEEEccccCcccHHH---------HHHHHHHHHhCCCCceeeEeeEEEeC
Q 004400 414 ATNNFATDNNIGEGGFGPVYKGLLADGTAIAVKQLSSKSKQGNRE---------FINEIGMISALQHPNLVKLYGCCIEG 484 (756)
Q Consensus 414 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~---------~~~E~~~l~~l~h~niv~l~~~~~~~ 484 (756)
..++|...+++|.|+||.||.+.. +++.+|+|.+.......... +.+|++.+.+++|++|..+.+++...
T Consensus 29 l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~ 107 (232)
T PRK10359 29 LSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLA 107 (232)
T ss_pred hhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeec
Confidence 467999999999999999999766 57789999997543322222 67899999999999999999887643
Q ss_pred --------CeEEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEE
Q 004400 485 --------NQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSK 556 (756)
Q Consensus 485 --------~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~k 556 (756)
...++||||++|.+|.++. .++. ....+++.++..+|..| ++|||+||+||+++.++ ++
T Consensus 108 ~~~~~~~~~~~~lvmEyi~G~tL~~~~-----~~~~----~~~~~i~~~l~~lH~~g---i~H~Dikp~Nili~~~g-i~ 174 (232)
T PRK10359 108 ERKTLRYAHTYIMLIEYIEGVELNDMP-----EISE----DVKAKIKASIESLHQHG---MVSGDPHKGNFIVSKNG-LR 174 (232)
T ss_pred ccccccccCCeEEEEEEECCccHHHhh-----hccH----HHHHHHHHHHHHHHHcC---CccCCCChHHEEEeCCC-EE
Confidence 3579999999999998873 2222 34569999999999997 99999999999999988 99
Q ss_pred EccCCccccCcccCcceeeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHH
Q 004400 557 ISDFGLAKLDEEENTHISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIV 611 (756)
Q Consensus 557 l~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell 611 (756)
|+|||......+.... ..+.....+..++|+||||+.+..+.
T Consensus 175 liDfg~~~~~~e~~a~-------------d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 175 IIDLSGKRCTAQRKAK-------------DRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred EEECCCcccccchhhH-------------HHHHHHhHhcccccccceeEeehHHH
Confidence 9999988754322111 11344556778999999999987654
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.85 E-value=3.3e-21 Score=187.69 Aligned_cols=140 Identities=18% Similarity=0.210 Sum_probs=109.1
Q ss_pred cCcccCCCCccEEEeeccCCcEEEEEEccccCcc--c-------HHH-----------------HHHHHHHHHhCCCCce
Q 004400 421 DNNIGEGGFGPVYKGLLADGTAIAVKQLSSKSKQ--G-------NRE-----------------FINEIGMISALQHPNL 474 (756)
Q Consensus 421 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--~-------~~~-----------------~~~E~~~l~~l~h~ni 474 (756)
...||+|+||.||+|...+|+.||||+++..... . ... ..+|++.+.++.++++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 4689999999999999879999999998654211 1 112 2349999999988776
Q ss_pred eeEeeEEEeCCeEEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH-HcCCCCCeEcCCCCCCceEecCCC
Q 004400 475 VKLYGCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYL-HGESRIKVVHRDIKATNVLLDKDL 553 (756)
Q Consensus 475 v~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~L-H~~g~~~iiH~Dikp~Nill~~~~ 553 (756)
.....+.. ...++||||++++++...... ...+++.+...++.|++.+|+|+ |+.| |+||||||+|||++ ++
T Consensus 82 ~~p~~~~~--~~~~iVmE~i~g~~l~~~~~~-~~~~~~~~~~~i~~qi~~~L~~l~H~~g---iiHrDlkP~NIli~-~~ 154 (190)
T cd05147 82 PCPEPILL--KSHVLVMEFIGDDGWAAPRLK-DAPLSESKARELYLQVIQIMRILYQDCR---LVHADLSEYNLLYH-DG 154 (190)
T ss_pred CCCcEEEe--cCCEEEEEEeCCCCCcchhhh-cCCCCHHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEE-CC
Confidence 43333222 223899999999887655433 34789999999999999999999 6776 99999999999998 47
Q ss_pred CEEEccCCccccCc
Q 004400 554 NSKISDFGLAKLDE 567 (756)
Q Consensus 554 ~~kl~DFGla~~~~ 567 (756)
.++|+|||+|....
T Consensus 155 ~v~LiDFG~a~~~~ 168 (190)
T cd05147 155 KLYIIDVSQSVEHD 168 (190)
T ss_pred cEEEEEccccccCC
Confidence 89999999997543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=4.6e-21 Score=205.97 Aligned_cols=216 Identities=28% Similarity=0.421 Sum_probs=161.8
Q ss_pred HHhCCCCceeeEeeEEEeCCeEEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCe-EcCCCCC
Q 004400 466 ISALQHPNLVKLYGCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKV-VHRDIKA 544 (756)
Q Consensus 466 l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~i-iH~Dikp 544 (756)
|+.+.|.|+.+++|.+.++...+.|.+||..|+|.|.+......++|.....++.+|+.||+|+|... | .|+.+++
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~---i~~hg~l~s 77 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSP---IGYHGALKS 77 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCc---ceeeeeecc
Confidence 35688999999999999999999999999999999999988889999999999999999999999873 4 9999999
Q ss_pred CceEecCCCCEEEccCCccccCccc-CcceeeccccCccCCchHhhhcC-------CCCcccchhhHHHHHHHHHhCCCC
Q 004400 545 TNVLLDKDLNSKISDFGLAKLDEEE-NTHISTRVAGTIGYMAPEYAMRG-------HLTEKADVYSFGIVALEIVSGRSN 616 (756)
Q Consensus 545 ~Nill~~~~~~kl~DFGla~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~-------~~~~~~Dv~slGv~l~elltg~~p 616 (756)
+|+++|....+||+|||+....... .........-..-|.|||.+... ..+.++||||||++++|+++.+.|
T Consensus 78 ~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~ 157 (484)
T KOG1023|consen 78 SNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGP 157 (484)
T ss_pred ccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCc
Confidence 9999999999999999998866421 11111112234579999999763 146789999999999999999999
Q ss_pred CCccchhhHHH-HHHHHHhcCccccccccCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhccCcc
Q 004400 617 VTKEDMFYLLD-WALVLKEQGKLMELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLECGVD 688 (756)
Q Consensus 617 ~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~L~~~~~ 688 (756)
|.........+ -+..+...+. ..+.+..... .+....+..++..||..+|.+||++.+|-..++....
T Consensus 158 ~~~~~~~~~~~eii~~~~~~~~--~~~rP~i~~~--~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~ 226 (484)
T KOG1023|consen 158 FDLRNLVEDPDEIILRVKKGGS--NPFRPSIELL--NELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINK 226 (484)
T ss_pred cccccccCChHHHHHHHHhcCC--CCcCcchhhh--hhcchHHHHHHHHhcccChhhCccHHHHHhhhhhhcc
Confidence 95532221111 1111111011 1111111100 0223358899999999999999999999777765433
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.3e-21 Score=218.92 Aligned_cols=250 Identities=23% Similarity=0.259 Sum_probs=183.7
Q ss_pred CccccCcccCCCCccEEEeeccCCcEEEEEEccccC-cccHHHHHHHHHH--HHhCCCCceeeEeeEEEeCCeEEEEEEe
Q 004400 417 NFATDNNIGEGGFGPVYKGLLADGTAIAVKQLSSKS-KQGNREFINEIGM--ISALQHPNLVKLYGCCIEGNQLLLIYEY 493 (756)
Q Consensus 417 ~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~--l~~l~h~niv~l~~~~~~~~~~~lV~e~ 493 (756)
++...+.||++.|=+|.+|..+.|. |+||++-+.. .-..+.|.++++- ...++|||.+++.-.-..+...|||-+|
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRqy 102 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQY 102 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHHH
Confidence 6778899999999999999988887 8899886543 3344555554443 4456899999998887788888999999
Q ss_pred cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccc--cCcccCc
Q 004400 494 LENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAK--LDEEENT 571 (756)
Q Consensus 494 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~--~~~~~~~ 571 (756)
... +|.|.+. .+..+..-+.+.|+.|++.||..+|..| |+|||||.+|||++.-.-+.|+||.--+ +..+++.
T Consensus 103 vkh-nLyDRlS-TRPFL~~iEKkWiaFQLL~al~qcH~~g---VcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDNP 177 (1431)
T KOG1240|consen 103 VKH-NLYDRLS-TRPFLVLIEKKWIAFQLLKALSQCHKLG---VCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDNP 177 (1431)
T ss_pred Hhh-hhhhhhc-cchHHHHHHHHHHHHHHHHHHHHHHHcC---ccccccccceEEEeeechhhhhcccccCCccCCCCCc
Confidence 976 8888884 4446778888999999999999999997 9999999999999999899999997765 3334433
Q ss_pred ceeeccccC----ccCCchHhhhcC-----------CCCcccchhhHHHHHHHHHh-CCCCCCccchhhHHHHHHHHHhc
Q 004400 572 HISTRVAGT----IGYMAPEYAMRG-----------HLTEKADVYSFGIVALEIVS-GRSNVTKEDMFYLLDWALVLKEQ 635 (756)
Q Consensus 572 ~~~~~~~gt----~~y~aPE~~~~~-----------~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 635 (756)
...+-+..| .+|.|||.+... ..+++-||||+||+++|+++ |++||.-. .++.+...- .
T Consensus 178 adf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LS---QL~aYr~~~--~ 252 (1431)
T KOG1240|consen 178 ADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLS---QLLAYRSGN--A 252 (1431)
T ss_pred ccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHH---HHHhHhccC--c
Confidence 332323333 379999987541 15778999999999999988 67777332 222221110 0
Q ss_pred CccccccccCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhcc
Q 004400 636 GKLMELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLEC 685 (756)
Q Consensus 636 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~L~~ 685 (756)
......+.... ...+++++..|++.||++|-++++.++.-.+
T Consensus 253 ~~~e~~Le~Ie--------d~~~Rnlil~Mi~rdPs~RlSAedyL~~yrG 294 (1431)
T KOG1240|consen 253 DDPEQLLEKIE--------DVSLRNLILSMIQRDPSKRLSAEDYLQKYRG 294 (1431)
T ss_pred cCHHHHHHhCc--------CccHHHHHHHHHccCchhccCHHHHHHhhhc
Confidence 01111111100 0138899999999999999999999887554
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.83 E-value=4e-20 Score=177.51 Aligned_cols=187 Identities=17% Similarity=0.096 Sum_probs=142.2
Q ss_pred cccCcccCCCCccEEEeeccCCcEEEEEEccccCccc----HHHHHHHHHHHHhCC-CCceeeEeeEEEeCCeEEEEEEe
Q 004400 419 ATDNNIGEGGFGPVYKGLLADGTAIAVKQLSSKSKQG----NREFINEIGMISALQ-HPNLVKLYGCCIEGNQLLLIYEY 493 (756)
Q Consensus 419 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~----~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lV~e~ 493 (756)
.....|++|+||+||.+.. ++..++.+.+....... ...|.+|+++|+++. |+++++++++ +..+++|||
T Consensus 5 ~~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmey 79 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSY 79 (218)
T ss_pred ccceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEee
Confidence 4567899999999997766 57778877776542211 125789999999995 5889999886 446999999
Q ss_pred cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCC-CCCceEecCCCCEEEccCCccccCcccCcc
Q 004400 494 LENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDI-KATNVLLDKDLNSKISDFGLAKLDEEENTH 572 (756)
Q Consensus 494 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Di-kp~Nill~~~~~~kl~DFGla~~~~~~~~~ 572 (756)
+.|.+|.+.+.. ....++.|++++|+++|+.| |+|||| ||+|||++.++.++|+|||+|.........
T Consensus 80 I~G~~L~~~~~~--------~~~~~~~qi~~~L~~lH~~G---IvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~ 148 (218)
T PRK12274 80 LAGAAMYQRPPR--------GDLAYFRAARRLLQQLHRCG---VAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARW 148 (218)
T ss_pred ecCccHHhhhhh--------hhHHHHHHHHHHHHHHHHCc---CccCCCCCcceEEEcCCCCEEEEECCCceecCCcchH
Confidence 999998754321 12357789999999999997 999999 799999999999999999999865543311
Q ss_pred ----e--------eeccccCccCCchHhhhcC-CCC-cccchhhHHHHHHHHHhCCCCCCccc
Q 004400 573 ----I--------STRVAGTIGYMAPEYAMRG-HLT-EKADVYSFGIVALEIVSGRSNVTKED 621 (756)
Q Consensus 573 ----~--------~~~~~gt~~y~aPE~~~~~-~~~-~~~Dv~slGv~l~elltg~~p~~~~~ 621 (756)
. ......++.|++|+...-- ..+ .+.+.++-|..+|.++|++.+..+++
T Consensus 149 ~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~ 211 (218)
T PRK12274 149 MRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDN 211 (218)
T ss_pred HHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccC
Confidence 0 1112368889999865431 233 56789999999999999999876543
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=1.7e-21 Score=208.69 Aligned_cols=225 Identities=26% Similarity=0.305 Sum_probs=181.8
Q ss_pred cccCCCCccEEEee----ccCCcEEEEEEccccCccc--HHHHHHHHHHHHhCC-CCceeeEeeEEEeCCeEEEEEEecC
Q 004400 423 NIGEGGFGPVYKGL----LADGTAIAVKQLSSKSKQG--NREFINEIGMISALQ-HPNLVKLYGCCIEGNQLLLIYEYLE 495 (756)
Q Consensus 423 ~lg~G~~g~Vy~~~----~~~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lV~e~~~ 495 (756)
.+|+|+||.|+.++ ...|..+|+|.++++.... ......|..++...+ ||.+|++...++.+...+++++|..
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 37999999999876 3357889999987753221 124566888899987 9999999999999999999999999
Q ss_pred CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCcccCcceee
Q 004400 496 NNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHIST 575 (756)
Q Consensus 496 ~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~ 575 (756)
+|.|...+... ..+++.....+...++-|++++|+.+ |+|||+|++||+++.+|.+++.|||+++..-.....
T Consensus 81 gg~lft~l~~~-~~f~~~~~~~~~aelaLald~lh~l~---iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~--- 153 (612)
T KOG0603|consen 81 GGDLFTRLSKE-VMFDELDVAFYLAELALALDHLHKLG---IAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIA--- 153 (612)
T ss_pred cchhhhccccC-CchHHHHHHHHHHHHHHHHhhcchhH---HHHhcccccceeecccCccccCCchhhhHhHhhhhc---
Confidence 99998888544 46778888888999999999999997 999999999999999999999999999865433222
Q ss_pred ccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhcCccccccccCCCCCCCHHHH
Q 004400 576 RVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDKEQV 655 (756)
Q Consensus 576 ~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 655 (756)
+||..|||||++. ....++|.||||++++||+||..||..+....+. .. ....+.+..
T Consensus 154 --cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~~~~~~Il----------------~~--~~~~p~~l~ 211 (612)
T KOG0603|consen 154 --CGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGGDTMKRIL----------------KA--ELEMPRELS 211 (612)
T ss_pred --ccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCchHHHHHHh----------------hh--ccCCchhhh
Confidence 8999999999987 5778999999999999999999999773221111 10 112345556
Q ss_pred HHHHHHHHHhhcCCCCCCCCH
Q 004400 656 MVMINVALLCANASPTIRPSM 676 (756)
Q Consensus 656 ~~l~~l~~~c~~~~P~~RPt~ 676 (756)
....+++..+...+|..|--.
T Consensus 212 ~~a~~~~~~l~~r~p~nrLg~ 232 (612)
T KOG0603|consen 212 AEARSLFRQLFKRNPENRLGA 232 (612)
T ss_pred HHHHHHHHHHHhhCHHHHhcc
Confidence 667888888999999988755
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.83 E-value=6.8e-20 Score=179.26 Aligned_cols=141 Identities=17% Similarity=0.198 Sum_probs=110.8
Q ss_pred cCcccCCCCccEEEeeccCCcEEEEEEccccCcc---------------------c-----HHHHHHHHHHHHhCCCCce
Q 004400 421 DNNIGEGGFGPVYKGLLADGTAIAVKQLSSKSKQ---------------------G-----NREFINEIGMISALQHPNL 474 (756)
Q Consensus 421 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~---------------------~-----~~~~~~E~~~l~~l~h~ni 474 (756)
...||+|+||.||+|...+|+.||||++...... . ...+..|.+.+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 4689999999999999778999999998754211 0 1123578999999999987
Q ss_pred eeEeeEEEeCCeEEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHc-CCCCCeEcCCCCCCceEecCCC
Q 004400 475 VKLYGCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHG-ESRIKVVHRDIKATNVLLDKDL 553 (756)
Q Consensus 475 v~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~-~g~~~iiH~Dikp~Nill~~~~ 553 (756)
.....+... ..++||||++++++...... ...++.....+++.|++.++.++|+ .| |+||||||+||+++ ++
T Consensus 82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~-~~~~~~~~~~~i~~~l~~~l~~lH~~~g---ivHrDlkP~NIll~-~~ 154 (190)
T cd05145 82 PVPEPILLK--KNVLVMEFIGDDGSPAPRLK-DVPLEEEEAEELYEQVVEQMRRLYQEAG---LVHGDLSEYNILYH-DG 154 (190)
T ss_pred CCceEEEec--CCEEEEEEecCCCchhhhhh-hccCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCChhhEEEE-CC
Confidence 544433332 24899999999865443222 2357888999999999999999999 76 99999999999999 78
Q ss_pred CEEEccCCccccCcc
Q 004400 554 NSKISDFGLAKLDEE 568 (756)
Q Consensus 554 ~~kl~DFGla~~~~~ 568 (756)
.++|+|||+++....
T Consensus 155 ~~~liDFG~a~~~~~ 169 (190)
T cd05145 155 KPYIIDVSQAVELDH 169 (190)
T ss_pred CEEEEEcccceecCC
Confidence 999999999986543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=9.1e-23 Score=205.06 Aligned_cols=251 Identities=18% Similarity=0.207 Sum_probs=118.3
Q ss_pred CCEEEccCCcccCccCcccccCCcc-eeeccCccccccCCccCcCcCCCcEEEeec-CcccccCCcccCCCCCCcEEecc
Q 004400 43 LQDIDLTLNYLSGTIPSQWASLPLL-NISLIANRLKGPIPKYLANISTLVNLTVQY-NQFSGELPEELGSLLNLEKLHLS 120 (756)
Q Consensus 43 L~~L~L~~n~l~~~~p~~~~~l~~L-~l~l~~n~~~~~~p~~l~~l~~L~~L~L~~-N~l~~~~p~~~~~l~~L~~L~L~ 120 (756)
.+.|+|..|+|+.+.|.+|+.++.| +++|++|+|+.+-|++|.++.+|.+|-+.+ |+|+...-+.|++|..|+.|.+.
T Consensus 69 tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~NkI~~l~k~~F~gL~slqrLllN 148 (498)
T KOG4237|consen 69 TVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGNNKITDLPKGAFGGLSSLQRLLLN 148 (498)
T ss_pred ceEEEeccCCcccCChhhccchhhhceecccccchhhcChHhhhhhHhhhHHHhhcCCchhhhhhhHhhhHHHHHHHhcC
Confidence 3445555555554444455555444 245555555555555555555444443333 45553333345555555555555
Q ss_pred CCeecccCCccccCCCCCCEEEeeCCcccccCChhhcCcCCCcEEEccCCcCc------------CCCCccccCCCCCCe
Q 004400 121 SNNFTGELPKTFAKLTNMKDFRISDNQFTGQIPSFIQNWTKLEKLFIQPSGLA------------GPIPSGIFSLENLTD 188 (756)
Q Consensus 121 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~------------~~~p~~~~~l~~L~~ 188 (756)
-|++.-...+.|..|++|..|.+.+|.+...--..|..+..++.+.+..|.+. ...|..++.......
T Consensus 149 an~i~Cir~~al~dL~~l~lLslyDn~~q~i~~~tf~~l~~i~tlhlA~np~icdCnL~wla~~~a~~~ietsgarc~~p 228 (498)
T KOG4237|consen 149 ANHINCIRQDALRDLPSLSLLSLYDNKIQSICKGTFQGLAAIKTLHLAQNPFICDCNLPWLADDLAMNPIETSGARCVSP 228 (498)
T ss_pred hhhhcchhHHHHHHhhhcchhcccchhhhhhccccccchhccchHhhhcCccccccccchhhhHHhhchhhcccceecch
Confidence 55555444444555555555555555554222224455555555555544421 111222222222222
Q ss_pred EEccCCCCCC--------------------------CCccccccc-cccEEEcccccccCCCCccccCCCCCcEEEccCC
Q 004400 189 LRISDLNGPE--------------------------ATFPQLGNM-KMTKLILRNCNITGELPRYLGKMTKLKVLDLSFN 241 (756)
Q Consensus 189 L~l~~n~~~~--------------------------~~~~~~~~~-~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N 241 (756)
..+..+++.. -+...|..+ +|++|+|++|+++++-+.+|.++..|++|.|..|
T Consensus 229 ~rl~~~Ri~q~~a~kf~c~~esl~s~~~~~d~~d~~cP~~cf~~L~~L~~lnlsnN~i~~i~~~aFe~~a~l~eL~L~~N 308 (498)
T KOG4237|consen 229 YRLYYKRINQEDARKFLCSLESLPSRLSSEDFPDSICPAKCFKKLPNLRKLNLSNNKITRIEDGAFEGAAELQELYLTRN 308 (498)
T ss_pred HHHHHHHhcccchhhhhhhHHhHHHhhccccCcCCcChHHHHhhcccceEeccCCCccchhhhhhhcchhhhhhhhcCcc
Confidence 2222211111 111122222 3555566666666555555666666666666666
Q ss_pred cCCCCCCccCcCCCCCCeEEecCccccccCCchh--hcCCCeeEeecCCCCCCC
Q 004400 242 RLRGQIPSNFDDLYDVDYIYFAGNLLTGAIPPWM--LERGDKIDLSYNNFTDGS 293 (756)
Q Consensus 242 ~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~--~~~l~~l~ls~N~l~~~~ 293 (756)
+|.......|.++..|+.|+|.+|+|++..|-.+ +..+..|++-.|+|.|..
T Consensus 309 ~l~~v~~~~f~~ls~L~tL~L~~N~it~~~~~aF~~~~~l~~l~l~~Np~~CnC 362 (498)
T KOG4237|consen 309 KLEFVSSGMFQGLSGLKTLSLYDNQITTVAPGAFQTLFSLSTLNLLSNPFNCNC 362 (498)
T ss_pred hHHHHHHHhhhccccceeeeecCCeeEEEecccccccceeeeeehccCcccCcc
Confidence 5554444555555566666666666655555544 444555555555555543
|
|
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.8e-22 Score=203.03 Aligned_cols=279 Identities=16% Similarity=0.145 Sum_probs=219.3
Q ss_pred CEEEccCCcccCccCcccccCCcceeeccCccccccCCccCcCcCCCcEEEeecCcccccCCcccCCCCCCcEEeccC-C
Q 004400 44 QDIDLTLNYLSGTIPSQWASLPLLNISLIANRLKGPIPKYLANISTLVNLTVQYNQFSGELPEELGSLLNLEKLHLSS-N 122 (756)
Q Consensus 44 ~~L~L~~n~l~~~~p~~~~~l~~L~l~l~~n~~~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~-N 122 (756)
...+.++-+|+ .+|..+..-+ ..+.|..|.|+.+-|.+|+.+++|++|||++|+|+-+-|++|..|.+|..|-+.+ |
T Consensus 49 ~~VdCr~~GL~-eVP~~LP~~t-veirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~N 126 (498)
T KOG4237|consen 49 GIVDCRGKGLT-EVPANLPPET-VEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGNN 126 (498)
T ss_pred ceEEccCCCcc-cCcccCCCcc-eEEEeccCCcccCChhhccchhhhceecccccchhhcChHhhhhhHhhhHHHhhcCC
Confidence 35677777887 6776554322 2466778999988888999999999999999999999999999999988887776 9
Q ss_pred eecccCCccccCCCCCCEEEeeCCcccccCChhhcCcCCCcEEEccCCcCcCCCCc-cccCCCCCCeEEccCCCCC----
Q 004400 123 NFTGELPKTFAKLTNMKDFRISDNQFTGQIPSFIQNWTKLEKLFIQPSGLAGPIPS-GIFSLENLTDLRISDLNGP---- 197 (756)
Q Consensus 123 ~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~-~~~~l~~L~~L~l~~n~~~---- 197 (756)
+|+....+.|.+|..|+.|.+.-|++.-...++|..+++|..|.+..|.+. .+++ .|..+.+++.+.+..|.+.
T Consensus 127 kI~~l~k~~F~gL~slqrLllNan~i~Cir~~al~dL~~l~lLslyDn~~q-~i~~~tf~~l~~i~tlhlA~np~icdCn 205 (498)
T KOG4237|consen 127 KITDLPKGAFGGLSSLQRLLLNANHINCIRQDALRDLPSLSLLSLYDNKIQ-SICKGTFQGLAAIKTLHLAQNPFICDCN 205 (498)
T ss_pred chhhhhhhHhhhHHHHHHHhcChhhhcchhHHHHHHhhhcchhcccchhhh-hhccccccchhccchHhhhcCccccccc
Confidence 999666678999999999999999999888999999999999999999998 4555 8888999999988776521
Q ss_pred --CC------Cccccccc-----------------------cccEE--E-cccccccCCCC-ccccCCCCCcEEEccCCc
Q 004400 198 --EA------TFPQLGNM-----------------------KMTKL--I-LRNCNITGELP-RYLGKMTKLKVLDLSFNR 242 (756)
Q Consensus 198 --~~------~~~~~~~~-----------------------~L~~L--~-L~~n~l~~~~p-~~~~~l~~L~~L~Ls~N~ 242 (756)
.. .+-.++.. .++.+ . .+.+...+.-| ..|.++++|+.|+|++|+
T Consensus 206 L~wla~~~a~~~ietsgarc~~p~rl~~~Ri~q~~a~kf~c~~esl~s~~~~~d~~d~~cP~~cf~~L~~L~~lnlsnN~ 285 (498)
T KOG4237|consen 206 LPWLADDLAMNPIETSGARCVSPYRLYYKRINQEDARKFLCSLESLPSRLSSEDFPDSICPAKCFKKLPNLRKLNLSNNK 285 (498)
T ss_pred cchhhhHHhhchhhcccceecchHHHHHHHhcccchhhhhhhHHhHHHhhccccCcCCcChHHHHhhcccceEeccCCCc
Confidence 11 00000000 01111 1 12222332333 469999999999999999
Q ss_pred CCCCCCccCcCCCCCCeEEecCccccccCCchh--hcCCCeeEeecCCCCCCCCcccccccCcccccccccccccCCccc
Q 004400 243 LRGQIPSNFDDLYDVDYIYFAGNLLTGAIPPWM--LERGDKIDLSYNNFTDGSAESSCQKRSVTGIVSCLRSVQCPKTYY 320 (756)
Q Consensus 243 l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~--~~~l~~l~ls~N~l~~~~~~~~~~~~~~~~~~~~~~~~~c~~~~~ 320 (756)
|+++-+..|.++..++.|.|.+|+|...-...+ +..|+.|++.+|++++..+.++-....+..+..-.+++.|.+...
T Consensus 286 i~~i~~~aFe~~a~l~eL~L~~N~l~~v~~~~f~~ls~L~tL~L~~N~it~~~~~aF~~~~~l~~l~l~~Np~~CnC~l~ 365 (498)
T KOG4237|consen 286 ITRIEDGAFEGAAELQELYLTRNKLEFVSSGMFQGLSGLKTLSLYDNQITTVAPGAFQTLFSLSTLNLLSNPFNCNCRLA 365 (498)
T ss_pred cchhhhhhhcchhhhhhhhcCcchHHHHHHHhhhccccceeeeecCCeeEEEecccccccceeeeeehccCcccCccchH
Confidence 999999999999999999999999973333333 678899999999999999988888888888877889999988765
Q ss_pred ccccc
Q 004400 321 SLHIN 325 (756)
Q Consensus 321 ~~~~~ 325 (756)
++.-+
T Consensus 366 wl~~W 370 (498)
T KOG4237|consen 366 WLGEW 370 (498)
T ss_pred HHHHH
Confidence 55433
|
|
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=99.81 E-value=2.3e-19 Score=204.78 Aligned_cols=239 Identities=25% Similarity=0.335 Sum_probs=120.5
Q ss_pred ccccccccCcccccCCcccCCCCCCCEEEccCCcccCccCcccccCCcc-eeeccCccccccCCccCcCcCCCcEEEeec
Q 004400 19 NQKRVLKEQNLTGVLPPKLAELTFLQDIDLTLNYLSGTIPSQWASLPLL-NISLIANRLKGPIPKYLANISTLVNLTVQY 97 (756)
Q Consensus 19 ~~~l~L~~~~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L-~l~l~~n~~~~~~p~~l~~l~~L~~L~L~~ 97 (756)
...|+|++|+|+ .+|+.+. ++|+.|++.+|+|+ .+|.. .+.| .|++.+|+++ .+|.. .++|+.|+|++
T Consensus 203 ~~~LdLs~~~Lt-sLP~~l~--~~L~~L~L~~N~Lt-~LP~l---p~~Lk~LdLs~N~Lt-sLP~l---p~sL~~L~Ls~ 271 (788)
T PRK15387 203 NAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLT-SLPAL---PPELRTLEVSGNQLT-SLPVL---PPGLLELSIFS 271 (788)
T ss_pred CcEEEcCCCCCC-cCCcchh--cCCCEEEccCCcCC-CCCCC---CCCCcEEEecCCccC-cccCc---ccccceeeccC
Confidence 345667777776 4565554 35667777777766 34432 2344 3556666666 33432 24556666666
Q ss_pred CcccccCCcccCCCCCCcEEeccCCeecccCCccccCCCCCCEEEeeCCcccccCChhhcC-----------------cC
Q 004400 98 NQFSGELPEELGSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRISDNQFTGQIPSFIQN-----------------WT 160 (756)
Q Consensus 98 N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~-----------------l~ 160 (756)
|.|+ .+|..+ .+|+.|+|++|+|+ .+|.. +++|+.|+|++|+|++ +|..... ..
T Consensus 272 N~L~-~Lp~lp---~~L~~L~Ls~N~Lt-~LP~~---p~~L~~LdLS~N~L~~-Lp~lp~~L~~L~Ls~N~L~~LP~lp~ 342 (788)
T PRK15387 272 NPLT-HLPALP---SGLCKLWIFGNQLT-SLPVL---PPGLQELSVSDNQLAS-LPALPSELCKLWAYNNQLTSLPTLPS 342 (788)
T ss_pred Cchh-hhhhch---hhcCEEECcCCccc-ccccc---ccccceeECCCCcccc-CCCCcccccccccccCcccccccccc
Confidence 6665 333322 34555555555555 33331 2445555555555552 3321110 12
Q ss_pred CCcEEEccCCcCcCCCCccccCCCCCCeEEccCCCCCCCCccccccccccEEEcccccccCCCCccccCCCCCcEEEccC
Q 004400 161 KLEKLFIQPSGLAGPIPSGIFSLENLTDLRISDLNGPEATFPQLGNMKMTKLILRNCNITGELPRYLGKMTKLKVLDLSF 240 (756)
Q Consensus 161 ~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~ 240 (756)
+|+.|+|++|+|++ +|.. ..+|+.|++++|.+..++.. ..+|+.|+|++|+|++ +|.. .++|+.|++++
T Consensus 343 ~Lq~LdLS~N~Ls~-LP~l---p~~L~~L~Ls~N~L~~LP~l---~~~L~~LdLs~N~Lt~-LP~l---~s~L~~LdLS~ 411 (788)
T PRK15387 343 GLQELSVSDNQLAS-LPTL---PSELYKLWAYNNRLTSLPAL---PSGLKELIVSGNRLTS-LPVL---PSELKELMVSG 411 (788)
T ss_pred ccceEecCCCccCC-CCCC---CcccceehhhccccccCccc---ccccceEEecCCcccC-CCCc---ccCCCEEEccC
Confidence 45555555555552 3322 13444455555554432211 1235556666666653 3322 24556666666
Q ss_pred CcCCCCCCccCcCCCCCCeEEecCccccccCCchh--hcCCCeeEeecCCCCCCC
Q 004400 241 NRLRGQIPSNFDDLYDVDYIYFAGNLLTGAIPPWM--LERGDKIDLSYNNFTDGS 293 (756)
Q Consensus 241 N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~--~~~l~~l~ls~N~l~~~~ 293 (756)
|+|++ +|..+ .+|+.|++++|+|+ .+|..+ ++.+..|++++|++++..
T Consensus 412 N~Lss-IP~l~---~~L~~L~Ls~NqLt-~LP~sl~~L~~L~~LdLs~N~Ls~~~ 461 (788)
T PRK15387 412 NRLTS-LPMLP---SGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERT 461 (788)
T ss_pred CcCCC-CCcch---hhhhhhhhccCccc-ccChHHhhccCCCeEECCCCCCCchH
Confidence 66653 44322 34555666666665 455544 455666666666666543
|
|
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=99.80 E-value=1e-19 Score=209.07 Aligned_cols=244 Identities=23% Similarity=0.366 Sum_probs=188.5
Q ss_pred eccccccccCcccccCCcccCCCCCCCEEEccCCcccCccCcccccCCcc-eeeccCccccccCCccCcCcCCCcEEEee
Q 004400 18 VNQKRVLKEQNLTGVLPPKLAELTFLQDIDLTLNYLSGTIPSQWASLPLL-NISLIANRLKGPIPKYLANISTLVNLTVQ 96 (756)
Q Consensus 18 ~~~~l~L~~~~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L-~l~l~~n~~~~~~p~~l~~l~~L~~L~L~ 96 (756)
....|+|++++++ .+|..+. +.|+.|+|++|+|+ .+|..+. +.| .|++.+|++. .+|..+. .+|+.|+|+
T Consensus 179 ~~~~L~L~~~~Lt-sLP~~Ip--~~L~~L~Ls~N~Lt-sLP~~l~--~nL~~L~Ls~N~Lt-sLP~~l~--~~L~~L~Ls 249 (754)
T PRK15370 179 NKTELRLKILGLT-TIPACIP--EQITTLILDNNELK-SLPENLQ--GNIKTLYANSNQLT-SIPATLP--DTIQEMELS 249 (754)
T ss_pred CceEEEeCCCCcC-cCCcccc--cCCcEEEecCCCCC-cCChhhc--cCCCEEECCCCccc-cCChhhh--ccccEEECc
Confidence 3567889999988 4676664 67999999999999 5665443 345 5788888887 5677664 479999999
Q ss_pred cCcccccCCcccCCCCCCcEEeccCCeecccCCccccCCCCCCEEEeeCCcccccCChhhcCcCCCcEEEccCCcCcCCC
Q 004400 97 YNQFSGELPEELGSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRISDNQFTGQIPSFIQNWTKLEKLFIQPSGLAGPI 176 (756)
Q Consensus 97 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~ 176 (756)
+|++. .+|..+. .+|+.|+|++|+|+ .+|..+. ++|+.|+|++|+|+ .+|..+. ++|+.|++++|+++. +
T Consensus 250 ~N~L~-~LP~~l~--s~L~~L~Ls~N~L~-~LP~~l~--~sL~~L~Ls~N~Lt-~LP~~lp--~sL~~L~Ls~N~Lt~-L 319 (754)
T PRK15370 250 INRIT-ELPERLP--SALQSLDLFHNKIS-CLPENLP--EELRYLSVYDNSIR-TLPAHLP--SGITHLNVQSNSLTA-L 319 (754)
T ss_pred CCccC-cCChhHh--CCCCEEECcCCccC-ccccccC--CCCcEEECCCCccc-cCcccch--hhHHHHHhcCCcccc-C
Confidence 99998 7787765 48999999999999 5777664 58999999999999 4665443 478999999999984 5
Q ss_pred CccccCCCCCCeEEccCCCCCCCCccccccccccEEEcccccccCCCCccccCCCCCcEEEccCCcCCCCCCccCcCCCC
Q 004400 177 PSGIFSLENLTDLRISDLNGPEATFPQLGNMKMTKLILRNCNITGELPRYLGKMTKLKVLDLSFNRLRGQIPSNFDDLYD 256 (756)
Q Consensus 177 p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~ 256 (756)
|..+. ++|+.|++++|.++.++.. +. .+|+.|+|++|+|+ .+|..+. ++|+.|+|++|.|+ .+|..+. .+
T Consensus 320 P~~l~--~sL~~L~Ls~N~Lt~LP~~-l~-~sL~~L~Ls~N~L~-~LP~~lp--~~L~~LdLs~N~Lt-~LP~~l~--~s 389 (754)
T PRK15370 320 PETLP--PGLKTLEAGENALTSLPAS-LP-PELQVLDVSKNQIT-VLPETLP--PTITTLDVSRNALT-NLPENLP--AA 389 (754)
T ss_pred Ccccc--ccceeccccCCccccCChh-hc-CcccEEECCCCCCC-cCChhhc--CCcCEEECCCCcCC-CCCHhHH--HH
Confidence 65543 6899999999988875432 22 46999999999998 5676553 68999999999999 4665554 36
Q ss_pred CCeEEecCccccccCCchh------hcCCCeeEeecCCCCC
Q 004400 257 VDYIYFAGNLLTGAIPPWM------LERGDKIDLSYNNFTD 291 (756)
Q Consensus 257 L~~L~ls~N~l~~~~p~~~------~~~l~~l~ls~N~l~~ 291 (756)
|+.|++++|+|+ .+|..+ .+.+..+++.+|+++.
T Consensus 390 L~~LdLs~N~L~-~LP~sl~~~~~~~~~l~~L~L~~Npls~ 429 (754)
T PRK15370 390 LQIMQASRNNLV-RLPESLPHFRGEGPQPTRIIVEYNPFSE 429 (754)
T ss_pred HHHHhhccCCcc-cCchhHHHHhhcCCCccEEEeeCCCccH
Confidence 889999999998 666554 3567889999999874
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.80 E-value=6.5e-19 Score=172.98 Aligned_cols=136 Identities=15% Similarity=0.241 Sum_probs=107.0
Q ss_pred cccCcccCCCCccEEEeeccCCcEEEEEEccccCcccHHHHHHHHHHHHhC-----CCCceeeEeeEEEeCC---e-EEE
Q 004400 419 ATDNNIGEGGFGPVYKGLLADGTAIAVKQLSSKSKQGNREFINEIGMISAL-----QHPNLVKLYGCCIEGN---Q-LLL 489 (756)
Q Consensus 419 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-----~h~niv~l~~~~~~~~---~-~~l 489 (756)
...+.||+|+||.||. +++....+||++........+.+.+|+.+++.+ .||||++++|++.++. . ..+
T Consensus 5 ~~~~~LG~G~~~~Vy~--hp~~~~k~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~ 82 (210)
T PRK10345 5 SEQSPLGTGRHRKCYA--HPEDAQRCIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDV 82 (210)
T ss_pred CCcceecCCCceEEEE--CCCCcCeEEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEE
Confidence 4567999999999995 443344479988665444567899999999999 5799999999998863 4 347
Q ss_pred EEEe--cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHH-HHHHcCCCCCeEcCCCCCCceEecC----CCCEEEccCCc
Q 004400 490 IYEY--LENNSLARALFEHRLKLDWPTRRRICLGIARGL-AYLHGESRIKVVHRDIKATNVLLDK----DLNSKISDFGL 562 (756)
Q Consensus 490 V~e~--~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L-~~LH~~g~~~iiH~Dikp~Nill~~----~~~~kl~DFGl 562 (756)
|+|| +.+|+|.+++.+. .+++. ..++.+++.++ +|||+++ ||||||||+|||++. ++.++|+||+-
T Consensus 83 I~e~~G~~~~tL~~~l~~~--~~~e~--~~~~~~~L~~l~~yLh~~~---IvhrDlKp~NILl~~~~~~~~~~~LiDg~G 155 (210)
T PRK10345 83 IADFDGKPSITLTEFAEQC--RYEED--VAQLRQLLKKLKRYLLDNR---IVTMELKPQNILCQRISESEVIPVVCDNIG 155 (210)
T ss_pred EecCCCCcchhHHHHHHcc--cccHh--HHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEeccCCCCCcEEEEECCC
Confidence 8999 5589999999653 35555 35677888777 9999997 999999999999974 34799999554
Q ss_pred c
Q 004400 563 A 563 (756)
Q Consensus 563 a 563 (756)
+
T Consensus 156 ~ 156 (210)
T PRK10345 156 E 156 (210)
T ss_pred C
Confidence 4
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.80 E-value=2.7e-19 Score=181.21 Aligned_cols=231 Identities=19% Similarity=0.206 Sum_probs=148.8
Q ss_pred CccccCcccCCCCccEEEeec-cCCcEEEEEEccccC---cccHHHHHHHHHHHHhCCC----------CceeeEeeEEE
Q 004400 417 NFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSKS---KQGNREFINEIGMISALQH----------PNLVKLYGCCI 482 (756)
Q Consensus 417 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h----------~niv~l~~~~~ 482 (756)
.+.....||.|+++.||.++. .+++.+|+|.+.... ....+.+.+|.-....+.+ -.++-.++...
T Consensus 13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~ 92 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR 92 (288)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence 445668999999999999995 568999999875432 2234566767655555332 12222233322
Q ss_pred e---------CC--------eEEEEEEecCCCCHHHHHH---hcCC---CCCHHHHHHHHHHHHHHHHHHHcCCCCCeEc
Q 004400 483 E---------GN--------QLLLIYEYLENNSLARALF---EHRL---KLDWPTRRRICLGIARGLAYLHGESRIKVVH 539 (756)
Q Consensus 483 ~---------~~--------~~~lV~e~~~~gsL~~~l~---~~~~---~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH 539 (756)
. .. ..+++|+-+ -++|.+.+. .... .+....+..+..|+++.+++||+.| ++|
T Consensus 93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~G---lVH 168 (288)
T PF14531_consen 93 IPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYG---LVH 168 (288)
T ss_dssp ETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---EEE
T ss_pred EcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcc---eEe
Confidence 1 11 235677777 458887764 2221 2344556777799999999999998 999
Q ss_pred CCCCCCceEecCCCCEEEccCCccccCcccCcceeeccccCccCCchHhhhcC--------CCCcccchhhHHHHHHHHH
Q 004400 540 RDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPEYAMRG--------HLTEKADVYSFGIVALEIV 611 (756)
Q Consensus 540 ~Dikp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--------~~~~~~Dv~slGv~l~ell 611 (756)
+||||+|++++.+|.++|+||+.....+..... ...+..|.+||..... .++.+.|.|++|+++|.|+
T Consensus 169 gdi~~~nfll~~~G~v~Lg~F~~~~r~g~~~~~----~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lW 244 (288)
T PF14531_consen 169 GDIKPENFLLDQDGGVFLGDFSSLVRAGTRYRC----SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLW 244 (288)
T ss_dssp ST-SGGGEEE-TTS-EEE--GGGEEETTEEEEG----GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHH
T ss_pred cccceeeEEEcCCCCEEEcChHHHeecCceeec----cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHH
Confidence 999999999999999999999887754432221 2345789999987542 4788999999999999999
Q ss_pred hCCCCCCccchhhHHHHHHHHHhcCccccccccCCCCCCCHHHHHHHHHHHHHhhcCCCCCC
Q 004400 612 SGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDKEQVMVMINVALLCANASPTIR 673 (756)
Q Consensus 612 tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~R 673 (756)
+|+.||.........+| .+ ..+. +.+..+..++..+++.+|++|
T Consensus 245 C~~lPf~~~~~~~~~~~------------~f-----~~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 245 CGRLPFGLSSPEADPEW------------DF-----SRCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp HSS-STCCCGGGSTSGG------------GG-----TTSS----HHHHHHHHHHT-SSGGGS
T ss_pred HccCCCCCCCccccccc------------cc-----hhcC-CcCHHHHHHHHHHccCCcccC
Confidence 99999965543222221 11 1223 455668999999999999988
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.79 E-value=3.3e-19 Score=204.52 Aligned_cols=251 Identities=20% Similarity=0.214 Sum_probs=187.2
Q ss_pred hHHHhhcCccccCcccCCCCccEEEeeccCCcEEEEEEccccCcccHHHHHHHHHHHHhCC---CCceeeEeeEEEeCCe
Q 004400 410 QIKAATNNFATDNNIGEGGFGPVYKGLLADGTAIAVKQLSSKSKQGNREFINEIGMISALQ---HPNLVKLYGCCIEGNQ 486 (756)
Q Consensus 410 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~ 486 (756)
+.+.....|.+.+.||+|+||+||+|...+|+.||+|+-+....+ +|.--.+++.+|+ -+-|..+..++.-.+.
T Consensus 692 ~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~W---EfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~ 768 (974)
T KOG1166|consen 692 EFEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPW---EFYICLQVMERLKPQMLPSIMHISSAHVFQNA 768 (974)
T ss_pred eeeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCce---eeeehHHHHHhhchhhhcchHHHHHHHccCCc
Confidence 344556789999999999999999999888999999998776655 2333334555555 3456666677777888
Q ss_pred EEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecC-------CCCEEEcc
Q 004400 487 LLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDK-------DLNSKISD 559 (756)
Q Consensus 487 ~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~-------~~~~kl~D 559 (756)
.++|+||.+.|+|.+++. ....++|.-.+.++.|+++.+++||..+ ||||||||+|+||.. ...++|+|
T Consensus 769 S~lv~ey~~~Gtlld~~N-~~~~m~e~lv~~~~~qml~ive~lH~~~---IIHgDiKPDNfll~~~~~~~~~~~~l~lID 844 (974)
T KOG1166|consen 769 SVLVSEYSPYGTLLDLIN-TNKVMDEYLVMFFSCQMLRIVEHLHAMG---IIHGDIKPDNFLLRREICADSDSKGLYLID 844 (974)
T ss_pred ceeeeeccccccHHHhhc-cCCCCCchhhhHHHHHHHHHHHHHHhcc---eecccCCcceeEeecccCCCCcccceEEEe
Confidence 999999999999999997 5568999999999999999999999997 999999999999942 34589999
Q ss_pred CCccccCc-ccCcceeeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhcCcc
Q 004400 560 FGLAKLDE-EENTHISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKL 638 (756)
Q Consensus 560 FGla~~~~-~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 638 (756)
||.+-.+. ..+......+++|-.+-.+|+..++.++.++|-|.++-+++.|+.|+.- . ...+.
T Consensus 845 fG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~-------------q--~~~g~- 908 (974)
T KOG1166|consen 845 FGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYM-------------E--VKNGS- 908 (974)
T ss_pred cccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHH-------------H--hcCCc-
Confidence 99986432 1222345567899999999999999999999999999999999998631 0 01111
Q ss_pred ccccccCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhccC
Q 004400 639 MELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLECG 686 (756)
Q Consensus 639 ~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~L~~~ 686 (756)
...++......+..+. .-+++...+..|-..=|...++...|+++
T Consensus 909 ~~~~~~~~~Ry~~~~~---W~~~F~~lLN~~~~~~p~l~~lr~~~~~~ 953 (974)
T KOG1166|consen 909 SWMVKTNFPRYWKRDM---WNKFFDLLLNPDCDTLPNLQELRTELEEV 953 (974)
T ss_pred ceeccccchhhhhHHH---HHHHHHHHhCcCcccchhHHHHHHHHHHH
Confidence 1112222111222222 34555566666656667777887777755
|
|
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=99.79 E-value=4.5e-19 Score=202.44 Aligned_cols=226 Identities=24% Similarity=0.338 Sum_probs=158.5
Q ss_pred eccccccccCcccccCCcccCCCCCCCEEEccCCcccCccCcccccCCcceeeccCccccccCCccCc------------
Q 004400 18 VNQKRVLKEQNLTGVLPPKLAELTFLQDIDLTLNYLSGTIPSQWASLPLLNISLIANRLKGPIPKYLA------------ 85 (756)
Q Consensus 18 ~~~~l~L~~~~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~l~l~~n~~~~~~p~~l~------------ 85 (756)
.++.|+|.+|+++. +|. .+++|+.|+|++|+|+ .+|....+|. .|++.+|.+. .+|..+.
T Consensus 223 ~L~~L~L~~N~Lt~-LP~---lp~~Lk~LdLs~N~Lt-sLP~lp~sL~--~L~Ls~N~L~-~Lp~lp~~L~~L~Ls~N~L 294 (788)
T PRK15387 223 HITTLVIPDNNLTS-LPA---LPPELRTLEVSGNQLT-SLPVLPPGLL--ELSIFSNPLT-HLPALPSGLCKLWIFGNQL 294 (788)
T ss_pred CCCEEEccCCcCCC-CCC---CCCCCcEEEecCCccC-cccCcccccc--eeeccCCchh-hhhhchhhcCEEECcCCcc
Confidence 57888888888885 454 2477888888888888 4554433222 2444455444 2222111
Q ss_pred -----CcCCCcEEEeecCcccccCCcccCCCCCCcEEeccCCeecccCCccccCCCCCCEEEeeCCcccccCChhhcCcC
Q 004400 86 -----NISTLVNLTVQYNQFSGELPEELGSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRISDNQFTGQIPSFIQNWT 160 (756)
Q Consensus 86 -----~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~ 160 (756)
.+++|+.|+|++|+|++ +|... .+|+.|++++|+|+ .+|.. ..+|+.|+|++|+|+ .+|.. ..
T Consensus 295 t~LP~~p~~L~~LdLS~N~L~~-Lp~lp---~~L~~L~Ls~N~L~-~LP~l---p~~Lq~LdLS~N~Ls-~LP~l---p~ 362 (788)
T PRK15387 295 TSLPVLPPGLQELSVSDNQLAS-LPALP---SELCKLWAYNNQLT-SLPTL---PSGLQELSVSDNQLA-SLPTL---PS 362 (788)
T ss_pred ccccccccccceeECCCCcccc-CCCCc---ccccccccccCccc-ccccc---ccccceEecCCCccC-CCCCC---Cc
Confidence 12455666666666652 33311 24555566666665 34431 147999999999999 46653 35
Q ss_pred CCcEEEccCCcCcCCCCccccCCCCCCeEEccCCCCCCCCccccccccccEEEcccccccCCCCccccCCCCCcEEEccC
Q 004400 161 KLEKLFIQPSGLAGPIPSGIFSLENLTDLRISDLNGPEATFPQLGNMKMTKLILRNCNITGELPRYLGKMTKLKVLDLSF 240 (756)
Q Consensus 161 ~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~ 240 (756)
+|+.|++++|+|.. +|.. ..+|+.|++++|.+...+.. ..+|+.|++++|.|++ +|..+ .+|+.|+|++
T Consensus 363 ~L~~L~Ls~N~L~~-LP~l---~~~L~~LdLs~N~Lt~LP~l---~s~L~~LdLS~N~Lss-IP~l~---~~L~~L~Ls~ 431 (788)
T PRK15387 363 ELYKLWAYNNRLTS-LPAL---PSGLKELIVSGNRLTSLPVL---PSELKELMVSGNRLTS-LPMLP---SGLLSLSVYR 431 (788)
T ss_pred ccceehhhcccccc-Cccc---ccccceEEecCCcccCCCCc---ccCCCEEEccCCcCCC-CCcch---hhhhhhhhcc
Confidence 78889999999994 6654 35799999999999875532 2369999999999995 66543 5788999999
Q ss_pred CcCCCCCCccCcCCCCCCeEEecCccccccCCchh
Q 004400 241 NRLRGQIPSNFDDLYDVDYIYFAGNLLTGAIPPWM 275 (756)
Q Consensus 241 N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~ 275 (756)
|+|+ .+|..+..+++|+.|+|++|+|++.+|..+
T Consensus 432 NqLt-~LP~sl~~L~~L~~LdLs~N~Ls~~~~~~L 465 (788)
T PRK15387 432 NQLT-RLPESLIHLSSETTVNLEGNPLSERTLQAL 465 (788)
T ss_pred Cccc-ccChHHhhccCCCeEECCCCCCCchHHHHH
Confidence 9999 789999999999999999999998887755
|
|
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=99.77 E-value=3.5e-18 Score=209.94 Aligned_cols=260 Identities=20% Similarity=0.254 Sum_probs=175.4
Q ss_pred cceeccccccccCcccccCCcccCCCCCCCEEEccCCcccCccCcccccCCcc-eeeccCccccccCCccCcCcCCCcEE
Q 004400 15 QKTVNQKRVLKEQNLTGVLPPKLAELTFLQDIDLTLNYLSGTIPSQWASLPLL-NISLIANRLKGPIPKYLANISTLVNL 93 (756)
Q Consensus 15 ~~~~~~~l~L~~~~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L-~l~l~~n~~~~~~p~~l~~l~~L~~L 93 (756)
....++.|+|.+|++. .++..+..+++|+.|+|++|...+.+|. +..++.| .|++.+|.....+|..+.++++|+.|
T Consensus 609 ~~~~L~~L~L~~s~l~-~L~~~~~~l~~Lk~L~Ls~~~~l~~ip~-ls~l~~Le~L~L~~c~~L~~lp~si~~L~~L~~L 686 (1153)
T PLN03210 609 RPENLVKLQMQGSKLE-KLWDGVHSLTGLRNIDLRGSKNLKEIPD-LSMATNLETLKLSDCSSLVELPSSIQYLNKLEDL 686 (1153)
T ss_pred CccCCcEEECcCcccc-ccccccccCCCCCEEECCCCCCcCcCCc-cccCCcccEEEecCCCCccccchhhhccCCCCEE
Confidence 4578889999999887 5677888899999999998765456774 7777888 48888888888899999999999999
Q ss_pred EeecCcccccCCcccCCCCCCcEEeccCCeecccCCccccCCCCCCEEEeeCCcccccCChhhcCc--------------
Q 004400 94 TVQYNQFSGELPEELGSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRISDNQFTGQIPSFIQNW-------------- 159 (756)
Q Consensus 94 ~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l-------------- 159 (756)
++++|..-+.+|..+ ++++|+.|+|++|.....+|.. .++|+.|+|++|.++ .+|..+ .+
T Consensus 687 ~L~~c~~L~~Lp~~i-~l~sL~~L~Lsgc~~L~~~p~~---~~nL~~L~L~~n~i~-~lP~~~-~l~~L~~L~l~~~~~~ 760 (1153)
T PLN03210 687 DMSRCENLEILPTGI-NLKSLYRLNLSGCSRLKSFPDI---STNISWLDLDETAIE-EFPSNL-RLENLDELILCEMKSE 760 (1153)
T ss_pred eCCCCCCcCccCCcC-CCCCCCEEeCCCCCCccccccc---cCCcCeeecCCCccc-cccccc-cccccccccccccchh
Confidence 999875444777665 7889999999988655556643 457888888888877 455433 23
Q ss_pred -----------------CCCcEEEccCCcCcCCCCccccCCCCCCeEEccCCCCCCCCccccccccccEEEcccccccCC
Q 004400 160 -----------------TKLEKLFIQPSGLAGPIPSGIFSLENLTDLRISDLNGPEATFPQLGNMKMTKLILRNCNITGE 222 (756)
Q Consensus 160 -----------------~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~L~~L~L~~n~l~~~ 222 (756)
++|+.|+|++|...+.+|..++++++|+.|++++|......+......+|+.|+|++|.....
T Consensus 761 ~l~~~~~~l~~~~~~~~~sL~~L~Ls~n~~l~~lP~si~~L~~L~~L~Ls~C~~L~~LP~~~~L~sL~~L~Ls~c~~L~~ 840 (1153)
T PLN03210 761 KLWERVQPLTPLMTMLSPSLTRLFLSDIPSLVELPSSIQNLHKLEHLEIENCINLETLPTGINLESLESLDLSGCSRLRT 840 (1153)
T ss_pred hccccccccchhhhhccccchheeCCCCCCccccChhhhCCCCCCEEECCCCCCcCeeCCCCCccccCEEECCCCCcccc
Confidence 355666666666555666666666666666666654433333333333566666666654444
Q ss_pred CCccccCCCCCcEEEccCCcCCCCCCccCcCCCCCCeEEecCc-cccccCCchh--hcCCCeeEeecC
Q 004400 223 LPRYLGKMTKLKVLDLSFNRLRGQIPSNFDDLYDVDYIYFAGN-LLTGAIPPWM--LERGDKIDLSYN 287 (756)
Q Consensus 223 ~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N-~l~~~~p~~~--~~~l~~l~ls~N 287 (756)
+|.. .++|+.|+|++|.++ .+|..+..+++|+.|+|++| .+. .+|... ++.++.++++++
T Consensus 841 ~p~~---~~nL~~L~Ls~n~i~-~iP~si~~l~~L~~L~L~~C~~L~-~l~~~~~~L~~L~~L~l~~C 903 (1153)
T PLN03210 841 FPDI---STNISDLNLSRTGIE-EVPWWIEKFSNLSFLDMNGCNNLQ-RVSLNISKLKHLETVDFSDC 903 (1153)
T ss_pred cccc---ccccCEeECCCCCCc-cChHHHhcCCCCCEEECCCCCCcC-ccCcccccccCCCeeecCCC
Confidence 4432 345666666666666 45666666666666666663 344 344333 455555565544
|
syringae 6; Provisional |
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=99.76 E-value=1.7e-18 Score=199.15 Aligned_cols=226 Identities=22% Similarity=0.321 Sum_probs=184.1
Q ss_pred CCCCEEEccCCcccCccCcccccCCcc-eeeccCccccccCCccCcCcCCCcEEEeecCcccccCCcccCCCCCCcEEec
Q 004400 41 TFLQDIDLTLNYLSGTIPSQWASLPLL-NISLIANRLKGPIPKYLANISTLVNLTVQYNQFSGELPEELGSLLNLEKLHL 119 (756)
Q Consensus 41 ~~L~~L~L~~n~l~~~~p~~~~~l~~L-~l~l~~n~~~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L 119 (756)
.+...|++++++++ .+|..+. +.+ .|++.+|++. .+|..+. ++|+.|+|++|+|+ .+|..+. .+|+.|+|
T Consensus 178 ~~~~~L~L~~~~Lt-sLP~~Ip--~~L~~L~Ls~N~Lt-sLP~~l~--~nL~~L~Ls~N~Lt-sLP~~l~--~~L~~L~L 248 (754)
T PRK15370 178 NNKTELRLKILGLT-TIPACIP--EQITTLILDNNELK-SLPENLQ--GNIKTLYANSNQLT-SIPATLP--DTIQEMEL 248 (754)
T ss_pred cCceEEEeCCCCcC-cCCcccc--cCCcEEEecCCCCC-cCChhhc--cCCCEEECCCCccc-cCChhhh--ccccEEEC
Confidence 45789999999999 5776554 344 5888899888 5676654 58999999999999 6777654 47999999
Q ss_pred cCCeecccCCccccCCCCCCEEEeeCCcccccCChhhcCcCCCcEEEccCCcCcCCCCccccCCCCCCeEEccCCCCCCC
Q 004400 120 SSNNFTGELPKTFAKLTNMKDFRISDNQFTGQIPSFIQNWTKLEKLFIQPSGLAGPIPSGIFSLENLTDLRISDLNGPEA 199 (756)
Q Consensus 120 ~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~n~~~~~ 199 (756)
++|++. .+|..+. ++|+.|+|++|+|+ .+|..+. ++|+.|+|++|+|++ +|..+. ++|+.|++++|.+...
T Consensus 249 s~N~L~-~LP~~l~--s~L~~L~Ls~N~L~-~LP~~l~--~sL~~L~Ls~N~Lt~-LP~~lp--~sL~~L~Ls~N~Lt~L 319 (754)
T PRK15370 249 SINRIT-ELPERLP--SALQSLDLFHNKIS-CLPENLP--EELRYLSVYDNSIRT-LPAHLP--SGITHLNVQSNSLTAL 319 (754)
T ss_pred cCCccC-cCChhHh--CCCCEEECcCCccC-ccccccC--CCCcEEECCCCcccc-Ccccch--hhHHHHHhcCCccccC
Confidence 999999 7787764 58999999999999 5777664 589999999999994 666554 5799999999999875
Q ss_pred CccccccccccEEEcccccccCCCCccccCCCCCcEEEccCCcCCCCCCccCcCCCCCCeEEecCccccccCCchhhcCC
Q 004400 200 TFPQLGNMKMTKLILRNCNITGELPRYLGKMTKLKVLDLSFNRLRGQIPSNFDDLYDVDYIYFAGNLLTGAIPPWMLERG 279 (756)
Q Consensus 200 ~~~~~~~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~~l 279 (756)
+... ..+|+.|++++|.+++ +|..+. ++|+.|+|++|+|+ .+|..+. ++|+.|++++|.|+ .+|..+...+
T Consensus 320 P~~l--~~sL~~L~Ls~N~Lt~-LP~~l~--~sL~~L~Ls~N~L~-~LP~~lp--~~L~~LdLs~N~Lt-~LP~~l~~sL 390 (754)
T PRK15370 320 PETL--PPGLKTLEAGENALTS-LPASLP--PELQVLDVSKNQIT-VLPETLP--PTITTLDVSRNALT-NLPENLPAAL 390 (754)
T ss_pred Cccc--cccceeccccCCcccc-CChhhc--CcccEEECCCCCCC-cCChhhc--CCcCEEECCCCcCC-CCCHhHHHHH
Confidence 4322 2469999999999995 676653 79999999999998 5776553 68999999999999 6787777789
Q ss_pred CeeEeecCCCCCCC
Q 004400 280 DKIDLSYNNFTDGS 293 (756)
Q Consensus 280 ~~l~ls~N~l~~~~ 293 (756)
+.|++++|+++..+
T Consensus 391 ~~LdLs~N~L~~LP 404 (754)
T PRK15370 391 QIMQASRNNLVRLP 404 (754)
T ss_pred HHHhhccCCcccCc
Confidence 99999999998653
|
|
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.76 E-value=1.2e-20 Score=208.42 Aligned_cols=262 Identities=24% Similarity=0.322 Sum_probs=153.2
Q ss_pred eccccccccCcccccCCcccCCCCCCCEEEccCCcccCccCcccccCCcce-eeccCccccccCCccCcCcCCCcEEEee
Q 004400 18 VNQKRVLKEQNLTGVLPPKLAELTFLQDIDLTLNYLSGTIPSQWASLPLLN-ISLIANRLKGPIPKYLANISTLVNLTVQ 96 (756)
Q Consensus 18 ~~~~l~L~~~~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~-l~l~~n~~~~~~p~~l~~l~~L~~L~L~ 96 (756)
+++.|+...|-++...+.... .+|+++++++|+++ .+|.+++.+..|+ +...+|++ ..+|..+..+++|+.|.+.
T Consensus 220 ~l~~L~a~~n~l~~~~~~p~p--~nl~~~dis~n~l~-~lp~wi~~~~nle~l~~n~N~l-~~lp~ri~~~~~L~~l~~~ 295 (1081)
T KOG0618|consen 220 SLTALYADHNPLTTLDVHPVP--LNLQYLDISHNNLS-NLPEWIGACANLEALNANHNRL-VALPLRISRITSLVSLSAA 295 (1081)
T ss_pred chheeeeccCcceeecccccc--ccceeeecchhhhh-cchHHHHhcccceEecccchhH-HhhHHHHhhhhhHHHHHhh
Confidence 445555555555533332221 45666666666666 4446666666664 45555555 3666666666666666666
Q ss_pred cCcccccCCcccCCCCCCcEEeccCCeecccCCccc-cCCC-CCCEEEeeCCcccccCChhhcCcCCCcEEEccCCcCcC
Q 004400 97 YNQFSGELPEELGSLLNLEKLHLSSNNFTGELPKTF-AKLT-NMKDFRISDNQFTGQIPSFIQNWTKLEKLFIQPSGLAG 174 (756)
Q Consensus 97 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~-~~l~-~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~ 174 (756)
+|.++ .+|+....+++|++|+|..|+|. ..|+.+ ..+. .|..|+.+.|++.......=..++.|+.|++.+|.|+.
T Consensus 296 ~nel~-yip~~le~~~sL~tLdL~~N~L~-~lp~~~l~v~~~~l~~ln~s~n~l~~lp~~~e~~~~~Lq~LylanN~Ltd 373 (1081)
T KOG0618|consen 296 YNELE-YIPPFLEGLKSLRTLDLQSNNLP-SLPDNFLAVLNASLNTLNVSSNKLSTLPSYEENNHAALQELYLANNHLTD 373 (1081)
T ss_pred hhhhh-hCCCcccccceeeeeeehhcccc-ccchHHHhhhhHHHHHHhhhhccccccccccchhhHHHHHHHHhcCcccc
Confidence 66666 56666666666666666666666 444432 2222 14445555555542211111223456666666666665
Q ss_pred CCCccccCCCCCCeEEccCCCCCCCCcccccccc-ccEEEcccccccCCCCccccCCCCCcEEEccCCcCCCCCCccCcC
Q 004400 175 PIPSGIFSLENLTDLRISDLNGPEATFPQLGNMK-MTKLILRNCNITGELPRYLGKMTKLKVLDLSFNRLRGQIPSNFDD 253 (756)
Q Consensus 175 ~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~-L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~ 253 (756)
..-..+.+..+|+.|+|++|.+..++...+.++. |+.|+|++|+|+ .+|+.+..+..|+.|...+|++. ..| .+..
T Consensus 374 ~c~p~l~~~~hLKVLhLsyNrL~~fpas~~~kle~LeeL~LSGNkL~-~Lp~tva~~~~L~tL~ahsN~l~-~fP-e~~~ 450 (1081)
T KOG0618|consen 374 SCFPVLVNFKHLKVLHLSYNRLNSFPASKLRKLEELEELNLSGNKLT-TLPDTVANLGRLHTLRAHSNQLL-SFP-ELAQ 450 (1081)
T ss_pred cchhhhccccceeeeeecccccccCCHHHHhchHHhHHHhcccchhh-hhhHHHHhhhhhHHHhhcCCcee-ech-hhhh
Confidence 5555566666666666666666666666555553 666677777776 55666666677777777667666 555 5666
Q ss_pred CCCCCeEEecCcccc-ccCCchhh-cCCCeeEeecCC
Q 004400 254 LYDVDYIYFAGNLLT-GAIPPWML-ERGDKIDLSYNN 288 (756)
Q Consensus 254 l~~L~~L~ls~N~l~-~~~p~~~~-~~l~~l~ls~N~ 288 (756)
+++|+.+|+|.|.|+ ..+|.... ++|+.||++||.
T Consensus 451 l~qL~~lDlS~N~L~~~~l~~~~p~p~LkyLdlSGN~ 487 (1081)
T KOG0618|consen 451 LPQLKVLDLSCNNLSEVTLPEALPSPNLKYLDLSGNT 487 (1081)
T ss_pred cCcceEEecccchhhhhhhhhhCCCcccceeeccCCc
Confidence 677777777777665 23343333 666777777766
|
|
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=99.76 E-value=9.9e-18 Score=206.02 Aligned_cols=271 Identities=19% Similarity=0.211 Sum_probs=168.5
Q ss_pred eeccceeccccccccC------cccccCCcccCCCC-CCCEEEccCCcccCccCcccccCCcc-eeeccCccccccCCcc
Q 004400 12 FWKQKTVNQKRVLKEQ------NLTGVLPPKLAELT-FLQDIDLTLNYLSGTIPSQWASLPLL-NISLIANRLKGPIPKY 83 (756)
Q Consensus 12 ~~~~~~~~~~l~L~~~------~l~~~~p~~l~~l~-~L~~L~L~~n~l~~~~p~~~~~l~~L-~l~l~~n~~~~~~p~~ 83 (756)
.|+++..++.|.+..+ ++...+|+.|..++ +|+.|++.+|.++ .+|..|. ...| +|++.+|++. .+|..
T Consensus 553 aF~~m~~L~~L~~~~~~~~~~~~~~~~lp~~~~~lp~~Lr~L~~~~~~l~-~lP~~f~-~~~L~~L~L~~s~l~-~L~~~ 629 (1153)
T PLN03210 553 AFKGMRNLLFLKFYTKKWDQKKEVRWHLPEGFDYLPPKLRLLRWDKYPLR-CMPSNFR-PENLVKLQMQGSKLE-KLWDG 629 (1153)
T ss_pred HHhcCccccEEEEecccccccccceeecCcchhhcCcccEEEEecCCCCC-CCCCcCC-ccCCcEEECcCcccc-ccccc
Confidence 3677777777776543 23345566565553 4666666666665 5555553 2333 4666666554 45555
Q ss_pred CcCcCCCcEEEeecCcccccCCcccCCCCCCcEEeccCCeecccCCccccCCCCCCEEEeeCCcccccCChhhcCcCCCc
Q 004400 84 LANISTLVNLTVQYNQFSGELPEELGSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRISDNQFTGQIPSFIQNWTKLE 163 (756)
Q Consensus 84 l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~ 163 (756)
+..+++|+.|+|++|...+.+|. ++.+++|+.|+|++|.....+|..+..+++|+.|++++|.....+|..+ ++++|+
T Consensus 630 ~~~l~~Lk~L~Ls~~~~l~~ip~-ls~l~~Le~L~L~~c~~L~~lp~si~~L~~L~~L~L~~c~~L~~Lp~~i-~l~sL~ 707 (1153)
T PLN03210 630 VHSLTGLRNIDLRGSKNLKEIPD-LSMATNLETLKLSDCSSLVELPSSIQYLNKLEDLDMSRCENLEILPTGI-NLKSLY 707 (1153)
T ss_pred cccCCCCCEEECCCCCCcCcCCc-cccCCcccEEEecCCCCccccchhhhccCCCCEEeCCCCCCcCccCCcC-CCCCCC
Confidence 66666666666666543335543 6666666666666665444666666666666666666654333555544 566666
Q ss_pred EEEccCCcCcCCCCccccCCCCCCeEEccCCCCCCCCcc-----------------------------cc-ccccccEEE
Q 004400 164 KLFIQPSGLAGPIPSGIFSLENLTDLRISDLNGPEATFP-----------------------------QL-GNMKMTKLI 213 (756)
Q Consensus 164 ~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~~~-----------------------------~~-~~~~L~~L~ 213 (756)
.|+|++|...+.+|.. .++|+.|++++|.+...+.. .. ...+|+.|+
T Consensus 708 ~L~Lsgc~~L~~~p~~---~~nL~~L~L~~n~i~~lP~~~~l~~L~~L~l~~~~~~~l~~~~~~l~~~~~~~~~sL~~L~ 784 (1153)
T PLN03210 708 RLNLSGCSRLKSFPDI---STNISWLDLDETAIEEFPSNLRLENLDELILCEMKSEKLWERVQPLTPLMTMLSPSLTRLF 784 (1153)
T ss_pred EEeCCCCCCccccccc---cCCcCeeecCCCccccccccccccccccccccccchhhccccccccchhhhhccccchhee
Confidence 6666666544444432 23455555555554432211 00 112588889
Q ss_pred cccccccCCCCccccCCCCCcEEEccCCcCCCCCCccCcCCCCCCeEEecCccccccCCchhhcCCCeeEeecCCCCCC
Q 004400 214 LRNCNITGELPRYLGKMTKLKVLDLSFNRLRGQIPSNFDDLYDVDYIYFAGNLLTGAIPPWMLERGDKIDLSYNNFTDG 292 (756)
Q Consensus 214 L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~~l~~l~ls~N~l~~~ 292 (756)
|++|...+.+|..++++++|+.|+|++|..-+.+|..+ .+++|+.|++++|.....+|. ...+++.|++++|.++..
T Consensus 785 Ls~n~~l~~lP~si~~L~~L~~L~Ls~C~~L~~LP~~~-~L~sL~~L~Ls~c~~L~~~p~-~~~nL~~L~Ls~n~i~~i 861 (1153)
T PLN03210 785 LSDIPSLVELPSSIQNLHKLEHLEIENCINLETLPTGI-NLESLESLDLSGCSRLRTFPD-ISTNISDLNLSRTGIEEV 861 (1153)
T ss_pred CCCCCCccccChhhhCCCCCCEEECCCCCCcCeeCCCC-CccccCEEECCCCCccccccc-cccccCEeECCCCCCccC
Confidence 99998877889999999999999999886555777665 688888888888765445553 246778888888887754
|
syringae 6; Provisional |
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.75 E-value=1.1e-17 Score=167.07 Aligned_cols=134 Identities=19% Similarity=0.305 Sum_probs=113.8
Q ss_pred CcccCCCCccEEEeeccCCcEEEEEEccccCcc--------cHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEEe
Q 004400 422 NNIGEGGFGPVYKGLLADGTAIAVKQLSSKSKQ--------GNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYEY 493 (756)
Q Consensus 422 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 493 (756)
+.||+|++|.||+|.. +|..|++|........ ....+.+|++++..++|++++....++.+....++||||
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 80 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY 80 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence 5799999999999987 6778899976543211 124577899999999999988877787788889999999
Q ss_pred cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCcccc
Q 004400 494 LENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKL 565 (756)
Q Consensus 494 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~ 565 (756)
++|++|.+++.... + .+..++.+++.+|.++|+.+ ++|||++|.||+++ ++.++|+|||.++.
T Consensus 81 ~~G~~L~~~~~~~~----~-~~~~i~~~i~~~l~~lH~~~---i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 81 IEGEPLKDLINSNG----M-EELELSREIGRLVGKLHSAG---IIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred eCCcCHHHHHHhcc----H-HHHHHHHHHHHHHHHHHhCC---cccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 99999999986432 2 88899999999999999986 99999999999999 78899999999875
|
|
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.75 E-value=2.7e-20 Score=166.62 Aligned_cols=161 Identities=30% Similarity=0.518 Sum_probs=122.1
Q ss_pred CcCcCCCcEEEeecCcccccCCcccCCCCCCcEEeccCCeecccCCccccCCCCCCEEEeeCCcccccCChhhcCcCCCc
Q 004400 84 LANISTLVNLTVQYNQFSGELPEELGSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRISDNQFTGQIPSFIQNWTKLE 163 (756)
Q Consensus 84 l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~ 163 (756)
+.++++.+.|.||+|+++ .+|+.+..|.+|+.|++++|+++ .+|..++.+++|+.|+++-|++. .+|..|+.++.|+
T Consensus 29 Lf~~s~ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~le 105 (264)
T KOG0617|consen 29 LFNMSNITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPALE 105 (264)
T ss_pred ccchhhhhhhhcccCcee-ecCCcHHHhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhh-cCccccCCCchhh
Confidence 556778888889999998 77888888999999999999988 78888888999999999999888 7888888888888
Q ss_pred EEEccCCcCcC-CCCccccCCCCCCeEEccCCCCCCCCccccccccccEEEcccccccCCCCccccCCCCCcEEEccCCc
Q 004400 164 KLFIQPSGLAG-PIPSGIFSLENLTDLRISDLNGPEATFPQLGNMKMTKLILRNCNITGELPRYLGKMTKLKVLDLSFNR 242 (756)
Q Consensus 164 ~L~l~~N~l~~-~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~ 242 (756)
.|+|.+|++.. .+|..|+.++.|+.|++++|. +. .+|..++++++|+.|.+..|.
T Consensus 106 vldltynnl~e~~lpgnff~m~tlralyl~dnd-----------------------fe-~lp~dvg~lt~lqil~lrdnd 161 (264)
T KOG0617|consen 106 VLDLTYNNLNENSLPGNFFYMTTLRALYLGDND-----------------------FE-ILPPDVGKLTNLQILSLRDND 161 (264)
T ss_pred hhhccccccccccCCcchhHHHHHHHHHhcCCC-----------------------cc-cCChhhhhhcceeEEeeccCc
Confidence 88888888863 478888888877777766654 44 445556666666666666666
Q ss_pred CCCCCCccCcCCCCCCeEEecCccccccCCc
Q 004400 243 LRGQIPSNFDDLYDVDYIYFAGNLLTGAIPP 273 (756)
Q Consensus 243 l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~ 273 (756)
+- .+|..++.+..|+.|.+.+|+++ .+|+
T Consensus 162 ll-~lpkeig~lt~lrelhiqgnrl~-vlpp 190 (264)
T KOG0617|consen 162 LL-SLPKEIGDLTRLRELHIQGNRLT-VLPP 190 (264)
T ss_pred hh-hCcHHHHHHHHHHHHhcccceee-ecCh
Confidence 65 56666666666666666666665 4443
|
|
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.74 E-value=6.3e-20 Score=202.69 Aligned_cols=269 Identities=23% Similarity=0.342 Sum_probs=215.5
Q ss_pred ceeccccccccCcccccCCcccCCCCCCCEEEccCCcccCccCcccccCCcce-eeccCccccccCCccCcCcCCCcEEE
Q 004400 16 KTVNQKRVLKEQNLTGVLPPKLAELTFLQDIDLTLNYLSGTIPSQWASLPLLN-ISLIANRLKGPIPKYLANISTLVNLT 94 (756)
Q Consensus 16 ~~~~~~l~L~~~~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~-l~l~~n~~~~~~p~~l~~l~~L~~L~ 94 (756)
-..+++++++.|++++. |+.+..+.+|+.|+..+|+|. .+|..+...+.|+ ++...|.+. -+|+.+.++++|+.|+
T Consensus 240 p~nl~~~dis~n~l~~l-p~wi~~~~nle~l~~n~N~l~-~lp~ri~~~~~L~~l~~~~nel~-yip~~le~~~sL~tLd 316 (1081)
T KOG0618|consen 240 PLNLQYLDISHNNLSNL-PEWIGACANLEALNANHNRLV-ALPLRISRITSLVSLSAAYNELE-YIPPFLEGLKSLRTLD 316 (1081)
T ss_pred cccceeeecchhhhhcc-hHHHHhcccceEecccchhHH-hhHHHHhhhhhHHHHHhhhhhhh-hCCCcccccceeeeee
Confidence 35789999999999955 699999999999999999996 8998888888885 666667666 7888899999999999
Q ss_pred eecCcccccCCcccCCC-C-CCcEEeccCCeecccCCc-cccCCCCCCEEEeeCCcccccCChhhcCcCCCcEEEccCCc
Q 004400 95 VQYNQFSGELPEELGSL-L-NLEKLHLSSNNFTGELPK-TFAKLTNMKDFRISDNQFTGQIPSFIQNWTKLEKLFIQPSG 171 (756)
Q Consensus 95 L~~N~l~~~~p~~~~~l-~-~L~~L~L~~N~l~~~~p~-~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~ 171 (756)
|..|+|. .+|+.+... . .|..|+.+.|++. ..|. .=...+.|+.|+|.+|.|+...-..+.+..+|+.|+|++|+
T Consensus 317 L~~N~L~-~lp~~~l~v~~~~l~~ln~s~n~l~-~lp~~~e~~~~~Lq~LylanN~Ltd~c~p~l~~~~hLKVLhLsyNr 394 (1081)
T KOG0618|consen 317 LQSNNLP-SLPDNFLAVLNASLNTLNVSSNKLS-TLPSYEENNHAALQELYLANNHLTDSCFPVLVNFKHLKVLHLSYNR 394 (1081)
T ss_pred ehhcccc-ccchHHHhhhhHHHHHHhhhhcccc-ccccccchhhHHHHHHHHhcCcccccchhhhccccceeeeeecccc
Confidence 9999999 777654433 2 3788999999998 4552 22246789999999999998888889999999999999999
Q ss_pred CcCCCCccccCCCCCCeEEccCCCCCCCCccccccccccEEEcccccccCCCCccccCCCCCcEEEccCCcCCCC-CCcc
Q 004400 172 LAGPIPSGIFSLENLTDLRISDLNGPEATFPQLGNMKMTKLILRNCNITGELPRYLGKMTKLKVLDLSFNRLRGQ-IPSN 250 (756)
Q Consensus 172 l~~~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~-~p~~ 250 (756)
|.......+.++..|++|++|+|.++.++........|+.|...+|++. ..| .+..++.|+.+|||.|+|+.. +|..
T Consensus 395 L~~fpas~~~kle~LeeL~LSGNkL~~Lp~tva~~~~L~tL~ahsN~l~-~fP-e~~~l~qL~~lDlS~N~L~~~~l~~~ 472 (1081)
T KOG0618|consen 395 LNSFPASKLRKLEELEELNLSGNKLTTLPDTVANLGRLHTLRAHSNQLL-SFP-ELAQLPQLKVLDLSCNNLSEVTLPEA 472 (1081)
T ss_pred cccCCHHHHhchHHhHHHhcccchhhhhhHHHHhhhhhHHHhhcCCcee-ech-hhhhcCcceEEecccchhhhhhhhhh
Confidence 9955556788899999999999999998854444456999999999999 777 799999999999999999843 4443
Q ss_pred CcCCCCCCeEEecCccccccCCchh---hcCCCeeEeecCCCCCCC
Q 004400 251 FDDLYDVDYIYFAGNLLTGAIPPWM---LERGDKIDLSYNNFTDGS 293 (756)
Q Consensus 251 ~~~l~~L~~L~ls~N~l~~~~p~~~---~~~l~~l~ls~N~l~~~~ 293 (756)
..+ ++|++|||++|... ...... +..+...+++-|+..++.
T Consensus 473 ~p~-p~LkyLdlSGN~~l-~~d~~~l~~l~~l~~~~i~~~~~~d~~ 516 (1081)
T KOG0618|consen 473 LPS-PNLKYLDLSGNTRL-VFDHKTLKVLKSLSQMDITLNNTPDGN 516 (1081)
T ss_pred CCC-cccceeeccCCccc-ccchhhhHHhhhhhheecccCCCCccc
Confidence 333 89999999999863 222222 344455555555444433
|
|
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=99.74 E-value=6.8e-20 Score=195.50 Aligned_cols=269 Identities=20% Similarity=0.216 Sum_probs=175.4
Q ss_pred ccccccCccc-ccCCcccCCCCCCCEEEccCCcccCc----cCcccccCCcc-eeeccCcccc------ccCCccCcCcC
Q 004400 21 KRVLKEQNLT-GVLPPKLAELTFLQDIDLTLNYLSGT----IPSQWASLPLL-NISLIANRLK------GPIPKYLANIS 88 (756)
Q Consensus 21 ~l~L~~~~l~-~~~p~~l~~l~~L~~L~L~~n~l~~~----~p~~~~~l~~L-~l~l~~n~~~------~~~p~~l~~l~ 88 (756)
.|+|..++++ +.....+..+..|+.|++++|.++.. ++..+...+.+ ++.+..+.+. ..++..+.+++
T Consensus 2 ~l~L~~~~l~~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~i~~~l~~~~~l~~l~l~~~~~~~~~~~~~~~~~~l~~~~ 81 (319)
T cd00116 2 QLSLKGELLKTERATELLPKLLCLQVLRLEGNTLGEEAAKALASALRPQPSLKELCLSLNETGRIPRGLQSLLQGLTKGC 81 (319)
T ss_pred ccccccCcccccchHHHHHHHhhccEEeecCCCCcHHHHHHHHHHHhhCCCceEEeccccccCCcchHHHHHHHHHHhcC
Confidence 4667777776 34445566677788888888887532 34444455544 4666666555 23455677788
Q ss_pred CCcEEEeecCcccccCCcccCCCCC---CcEEeccCCeecc----cCCccccCC-CCCCEEEeeCCccccc----CChhh
Q 004400 89 TLVNLTVQYNQFSGELPEELGSLLN---LEKLHLSSNNFTG----ELPKTFAKL-TNMKDFRISDNQFTGQ----IPSFI 156 (756)
Q Consensus 89 ~L~~L~L~~N~l~~~~p~~~~~l~~---L~~L~L~~N~l~~----~~p~~~~~l-~~L~~L~L~~N~l~~~----~p~~~ 156 (756)
+|+.|+|++|.+.+..+..+..+.+ |++|++++|++++ .+...+..+ ++|+.|+|++|.+++. ++..+
T Consensus 82 ~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~ls~~~~~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~~~~~~ 161 (319)
T cd00116 82 GLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKLVLGRNRLEGASCEALAKAL 161 (319)
T ss_pred ceeEEEccCCCCChhHHHHHHHHhccCcccEEEeeCCccchHHHHHHHHHHHhCCCCceEEEcCCCcCCchHHHHHHHHH
Confidence 8888888888887666666665555 8888888888873 233445566 7888888888888832 34456
Q ss_pred cCcCCCcEEEccCCcCcCC----CCccccCCCCCCeEEccCCCCCCCCcccc----c-cccccEEEcccccccCCCCccc
Q 004400 157 QNWTKLEKLFIQPSGLAGP----IPSGIFSLENLTDLRISDLNGPEATFPQL----G-NMKMTKLILRNCNITGELPRYL 227 (756)
Q Consensus 157 ~~l~~L~~L~l~~N~l~~~----~p~~~~~l~~L~~L~l~~n~~~~~~~~~~----~-~~~L~~L~L~~n~l~~~~p~~~ 227 (756)
..+++|+.|+|++|.+++. ++..+..+++|+.|++++|.+.......+ . ..+|+.|++++|.+++.....+
T Consensus 162 ~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~~~~~~~L~~L~ls~n~l~~~~~~~l 241 (319)
T cd00116 162 RANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDEGASALAETLASLKSLEVLNLGDNNLTDAGAAAL 241 (319)
T ss_pred HhCCCcCEEECcCCCCchHHHHHHHHHHHhCCCCCEEeccCCccChHHHHHHHHHhcccCCCCEEecCCCcCchHHHHHH
Confidence 6777888888888888742 33445566788888888887765433221 1 2247888888887775333222
Q ss_pred c-----CCCCCcEEEccCCcCCC----CCCccCcCCCCCCeEEecCccccccCCc----hh--h-cCCCeeEeecCCC
Q 004400 228 G-----KMTKLKVLDLSFNRLRG----QIPSNFDDLYDVDYIYFAGNLLTGAIPP----WM--L-ERGDKIDLSYNNF 289 (756)
Q Consensus 228 ~-----~l~~L~~L~Ls~N~l~~----~~p~~~~~l~~L~~L~ls~N~l~~~~p~----~~--~-~~l~~l~ls~N~l 289 (756)
. ..+.|+.|++++|.++. .+...+..+++|+++++++|.++..-.. .+ . ..++.+|+.+|++
T Consensus 242 ~~~~~~~~~~L~~L~l~~n~i~~~~~~~l~~~~~~~~~L~~l~l~~N~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (319)
T cd00116 242 ASALLSPNISLLTLSLSCNDITDDGAKDLAEVLAEKESLLELDLRGNKFGEEGAQLLAESLLEPGNELESLWVKDDSF 319 (319)
T ss_pred HHHHhccCCCceEEEccCCCCCcHHHHHHHHHHhcCCCccEEECCCCCCcHHHHHHHHHHHhhcCCchhhcccCCCCC
Confidence 2 23678888888887762 2334455667788888888887743211 11 2 4566777766653
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.74 E-value=1e-17 Score=168.78 Aligned_cols=144 Identities=19% Similarity=0.179 Sum_probs=111.9
Q ss_pred CccccCcccCCCCccEEEee--ccCCcEEEEEEccccCcc------------------------cHHHHHHHHHHHHhCC
Q 004400 417 NFATDNNIGEGGFGPVYKGL--LADGTAIAVKQLSSKSKQ------------------------GNREFINEIGMISALQ 470 (756)
Q Consensus 417 ~~~~~~~lg~G~~g~Vy~~~--~~~~~~vavK~~~~~~~~------------------------~~~~~~~E~~~l~~l~ 470 (756)
.|.+.+.||+|+||.||+|+ ..+|+.||+|.+...... ....+.+|++.+.++.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 47788999999999999998 578999999998643210 0123568999999997
Q ss_pred CC--ceeeEeeEEEeCCeEEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceE
Q 004400 471 HP--NLVKLYGCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVL 548 (756)
Q Consensus 471 h~--niv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nil 548 (756)
+. .+.+++++ ...++||||+++++|....... ..+.......++.|++.++++||+.| .|+||||||+||+
T Consensus 109 ~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~g--~iiH~Dikp~NIl 181 (237)
T smart00090 109 EAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKD-VEPEEEEEFELYDDILEEMRKLYKEG--ELVHGDLSEYNIL 181 (237)
T ss_pred hcCCCCCeeeEe----cCceEEEEEecCCccccccccc-CCcchHHHHHHHHHHHHHHHHHHhcC--CEEeCCCChhhEE
Confidence 53 33444443 2358999999998887654322 34566677899999999999999885 4999999999999
Q ss_pred ecCCCCEEEccCCccccCcc
Q 004400 549 LDKDLNSKISDFGLAKLDEE 568 (756)
Q Consensus 549 l~~~~~~kl~DFGla~~~~~ 568 (756)
++ ++.++|+|||.+...++
T Consensus 182 i~-~~~i~LiDFg~a~~~~~ 200 (237)
T smart00090 182 VH-DGKVVIIDVSQSVELDH 200 (237)
T ss_pred EE-CCCEEEEEChhhhccCC
Confidence 99 78999999999875443
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.73 E-value=2.3e-17 Score=163.16 Aligned_cols=130 Identities=23% Similarity=0.324 Sum_probs=107.1
Q ss_pred cccCCCCccEEEeeccCCcEEEEEEccccCcc--------cHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEEec
Q 004400 423 NIGEGGFGPVYKGLLADGTAIAVKQLSSKSKQ--------GNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYEYL 494 (756)
Q Consensus 423 ~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~ 494 (756)
.||+|+||.||+|.+ ++..|++|........ ...++.+|+++++.++|+++.....++......++||||+
T Consensus 1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence 489999999999985 5688999986543211 1255778999999999887665555666777789999999
Q ss_pred CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCcccc
Q 004400 495 ENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKL 565 (756)
Q Consensus 495 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~ 565 (756)
+|++|.+.+..... .++.+++.+|++||+.| ++|||++|.||+++ ++.++++|||+++.
T Consensus 80 ~g~~l~~~~~~~~~--------~~~~~i~~~l~~lH~~g---i~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 80 EGKPLKDVIEEGND--------ELLREIGRLVGKLHKAG---IVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred CCccHHHHHhhcHH--------HHHHHHHHHHHHHHHCC---eecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 99999988754321 78999999999999987 99999999999999 78999999999875
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.73 E-value=3e-17 Score=165.50 Aligned_cols=196 Identities=26% Similarity=0.353 Sum_probs=140.0
Q ss_pred CCCceeeEeeEEEe---------------------------CCeEEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHH
Q 004400 470 QHPNLVKLYGCCIE---------------------------GNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGI 522 (756)
Q Consensus 470 ~h~niv~l~~~~~~---------------------------~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i 522 (756)
+|||||++.++|.+ +...|+||.-.+. +|..++-.. ..+...+.-++.|+
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~--~~s~r~~~~~laQl 350 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTR--HRSYRTGRVILAQL 350 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcC--CCchHHHHHHHHHH
Confidence 59999999998764 2347899987765 788887543 45677788899999
Q ss_pred HHHHHHHHcCCCCCeEcCCCCCCceEec--CCC--CEEEccCCccccCcccCc-----ceeeccccCccCCchHhhhcCC
Q 004400 523 ARGLAYLHGESRIKVVHRDIKATNVLLD--KDL--NSKISDFGLAKLDEEENT-----HISTRVAGTIGYMAPEYAMRGH 593 (756)
Q Consensus 523 a~~L~~LH~~g~~~iiH~Dikp~Nill~--~~~--~~kl~DFGla~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~ 593 (756)
++|+.|||.+| |.|||+|++|||+. +|+ ...|+|||.+--.+...- ......-|.-.-||||+.....
T Consensus 351 LEav~hL~~hg---vAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~P 427 (598)
T KOG4158|consen 351 LEAVTHLHKHG---VAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVP 427 (598)
T ss_pred HHHHHHHHHcc---chhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCC
Confidence 99999999997 99999999999994 333 368999998753332111 1111234777899999986422
Q ss_pred ------CCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhcCccccccccCCCCCCCHHHHHHHHHHHHHhhc
Q 004400 594 ------LTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDKEQVMVMINVALLCAN 667 (756)
Q Consensus 594 ------~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~ 667 (756)
--.|+|.|+.|.+.||+++...||+...+..+-... .++.++..+.+.. ++ .+.+++...++
T Consensus 428 Gp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~---Yqe~qLPalp~~v-----pp----~~rqlV~~lL~ 495 (598)
T KOG4158|consen 428 GPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRT---YQESQLPALPSRV-----PP----VARQLVFDLLK 495 (598)
T ss_pred CCceeeccchhhhhhhhhhHHHHhccCCcccccchheechhh---hhhhhCCCCcccC-----Ch----HHHHHHHHHhc
Confidence 134899999999999999999999775544322111 2333343333332 22 37888899999
Q ss_pred CCCCCCCCHHHHHHHh
Q 004400 668 ASPTIRPSMSSVLRML 683 (756)
Q Consensus 668 ~~P~~RPt~~ev~~~L 683 (756)
.||++|++..-....|
T Consensus 496 r~pskRvsp~iAANvl 511 (598)
T KOG4158|consen 496 RDPSKRVSPNIAANVL 511 (598)
T ss_pred CCccccCCccHHHhHH
Confidence 9999999876554443
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.72 E-value=3.7e-18 Score=179.72 Aligned_cols=172 Identities=23% Similarity=0.338 Sum_probs=127.9
Q ss_pred CeEEEEEEecCCCCHHHHHH--hcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCc
Q 004400 485 NQLLLIYEYLENNSLARALF--EHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGL 562 (756)
Q Consensus 485 ~~~~lV~e~~~~gsL~~~l~--~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGl 562 (756)
.+.|+.|++|...+|.+||. ......++.....++.|++.|++| ++ .+|||+||.||++..+..+||+|||+
T Consensus 329 ~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~---~ihrdlkp~nif~~~d~q~kIgDFgl 402 (516)
T KOG1033|consen 329 VYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KG---LIHRDLKPSNIFFSDDDQLKIGDFGL 402 (516)
T ss_pred cchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---cc---chhhhccccccccccchhhhhhhhhh
Confidence 35789999999999999996 334567889999999999999999 54 89999999999999999999999999
Q ss_pred cccCcccC-----cceeeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHh-CCCCCCccchhhHHHHHHHHHhcC
Q 004400 563 AKLDEEEN-----THISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVS-GRSNVTKEDMFYLLDWALVLKEQG 636 (756)
Q Consensus 563 a~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~ 636 (756)
........ ....+...||..||+||.+.+..|+.|+||||+|++++|+++ =..++.....+ ...+.+
T Consensus 403 ~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er~~t~-------~d~r~g 475 (516)
T KOG1033|consen 403 VTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFERIATL-------TDIRDG 475 (516)
T ss_pred eeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHHHHhh-------hhhhcC
Confidence 87655444 223455679999999999999999999999999999999996 12221110000 001122
Q ss_pred ccccccccCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHH
Q 004400 637 KLMELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSS 678 (756)
Q Consensus 637 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~e 678 (756)
.+. +....+++. =..++.+++...|.+||++.+
T Consensus 476 ~ip----~~~~~d~p~-----e~~ll~~lls~~p~~RP~~~~ 508 (516)
T KOG1033|consen 476 IIP----PEFLQDYPE-----EYTLLQQLLSPSPEERPSAIE 508 (516)
T ss_pred CCC----hHHhhcCcH-----HHHHHHHhcCCCcccCchHHH
Confidence 221 111111221 346788999999999995444
|
|
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.72 E-value=1.3e-19 Score=162.29 Aligned_cols=161 Identities=28% Similarity=0.373 Sum_probs=143.8
Q ss_pred cCCCCCCcEEeccCCeecccCCccccCCCCCCEEEeeCCcccccCChhhcCcCCCcEEEccCCcCcCCCCccccCCCCCC
Q 004400 108 LGSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRISDNQFTGQIPSFIQNWTKLEKLFIQPSGLAGPIPSGIFSLENLT 187 (756)
Q Consensus 108 ~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~ 187 (756)
+.++.+.+.|.|++|+++ .+|..++.|.+|+.|++++|+++ .+|..++.++.|+.|+++-|++. .+|.+|+.++.|+
T Consensus 29 Lf~~s~ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~le 105 (264)
T KOG0617|consen 29 LFNMSNITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPALE 105 (264)
T ss_pred ccchhhhhhhhcccCcee-ecCCcHHHhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhh-cCccccCCCchhh
Confidence 557888999999999999 77778999999999999999999 89999999999999999999998 8999999999999
Q ss_pred eEEccCCCCCCCCccccccccccEEEcccccccCCCCccccCCCCCcEEEccCCcCCCCCCccCcCCCCCCeEEecCccc
Q 004400 188 DLRISDLNGPEATFPQLGNMKMTKLILRNCNITGELPRYLGKMTKLKVLDLSFNRLRGQIPSNFDDLYDVDYIYFAGNLL 267 (756)
Q Consensus 188 ~L~l~~n~~~~~~~~~~~~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l 267 (756)
.||+..|++.+. .+|..|..++.|+.|+|++|.+. .+|..++++++|+.|.+.+|.+
T Consensus 106 vldltynnl~e~----------------------~lpgnff~m~tlralyl~dndfe-~lp~dvg~lt~lqil~lrdndl 162 (264)
T KOG0617|consen 106 VLDLTYNNLNEN----------------------SLPGNFFYMTTLRALYLGDNDFE-ILPPDVGKLTNLQILSLRDNDL 162 (264)
T ss_pred hhhccccccccc----------------------cCCcchhHHHHHHHHHhcCCCcc-cCChhhhhhcceeEEeeccCch
Confidence 988877654432 45667888999999999999999 8899999999999999999999
Q ss_pred cccCCchh--hcCCCeeEeecCCCCCCCCc
Q 004400 268 TGAIPPWM--LERGDKIDLSYNNFTDGSAE 295 (756)
Q Consensus 268 ~~~~p~~~--~~~l~~l~ls~N~l~~~~~~ 295 (756)
- .+|..+ +..++.|.+.+|.++-.+++
T Consensus 163 l-~lpkeig~lt~lrelhiqgnrl~vlppe 191 (264)
T KOG0617|consen 163 L-SLPKEIGDLTRLRELHIQGNRLTVLPPE 191 (264)
T ss_pred h-hCcHHHHHHHHHHHHhcccceeeecChh
Confidence 8 788877 88899999999999876653
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.72 E-value=3.4e-17 Score=161.58 Aligned_cols=140 Identities=21% Similarity=0.217 Sum_probs=110.4
Q ss_pred hcCccccCcccCCCCccEEEeeccCCcEEEEEEccccCc----------------------ccHHHHHHHHHHHHhCCCC
Q 004400 415 TNNFATDNNIGEGGFGPVYKGLLADGTAIAVKQLSSKSK----------------------QGNREFINEIGMISALQHP 472 (756)
Q Consensus 415 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~----------------------~~~~~~~~E~~~l~~l~h~ 472 (756)
...|...+.||+|+||.||+|...+|+.||||++..... .....+..|..++.++.|+
T Consensus 14 ~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~ 93 (198)
T cd05144 14 GVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEE 93 (198)
T ss_pred CchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHc
Confidence 334778899999999999999988899999998654210 0112356788899999887
Q ss_pred c--eeeEeeEEEeCCeEEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEec
Q 004400 473 N--LVKLYGCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLD 550 (756)
Q Consensus 473 n--iv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~ 550 (756)
+ +.+.++ ....++||||+++++|.+.... .....++.+++.++.++|+.| |+||||||+||+++
T Consensus 94 ~i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~-------~~~~~~~~~i~~~l~~lh~~g---i~H~Dl~p~Nill~ 159 (198)
T cd05144 94 GFPVPKPID----WNRHAVVMEYIDGVELYRVRVL-------EDPEEVLDEILEEIVKAYKHG---IIHGDLSEFNILVD 159 (198)
T ss_pred CCCCCceee----cCCceEEEEEeCCcchhhcccc-------ccHHHHHHHHHHHHHHHHHCC---CCcCCCCcccEEEc
Confidence 4 444443 2455899999999998765321 345678899999999999986 99999999999999
Q ss_pred CCCCEEEccCCccccCcc
Q 004400 551 KDLNSKISDFGLAKLDEE 568 (756)
Q Consensus 551 ~~~~~kl~DFGla~~~~~ 568 (756)
+++.++|+|||++.....
T Consensus 160 ~~~~~~liDfg~~~~~~~ 177 (198)
T cd05144 160 DDEKIYIIDWPQMVSTDH 177 (198)
T ss_pred CCCcEEEEECCccccCCC
Confidence 999999999999965443
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.71 E-value=5.1e-17 Score=184.66 Aligned_cols=138 Identities=19% Similarity=0.278 Sum_probs=112.5
Q ss_pred hcCccccCcccCCCCccEEEeeccCCcEEEEEEccccCc-------ccHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeE
Q 004400 415 TNNFATDNNIGEGGFGPVYKGLLADGTAIAVKQLSSKSK-------QGNREFINEIGMISALQHPNLVKLYGCCIEGNQL 487 (756)
Q Consensus 415 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~-------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 487 (756)
...|...+.||+|+||+||+|.+.+...++.+...+... ...+.+.+|+++++.++|++++..+.++.++...
T Consensus 332 ~~~~~~~~~iG~G~~g~Vy~~~~~~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~ 411 (535)
T PRK09605 332 KRRKIPDHLIGKGAEADIKKGEYLGRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEK 411 (535)
T ss_pred ccccCccceeccCCcEEEEEEeecCccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCC
Confidence 445567899999999999999876544333322222111 1235688999999999999999888888888888
Q ss_pred EEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCcccc
Q 004400 488 LLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKL 565 (756)
Q Consensus 488 ~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~ 565 (756)
++||||+++++|.+++. .+..++.+++++|+|||+.+ ++||||||+||++ +++.++|+|||+++.
T Consensus 412 ~lv~E~~~g~~L~~~l~---------~~~~~~~~i~~~L~~lH~~g---iiHrDlkp~NILl-~~~~~~liDFGla~~ 476 (535)
T PRK09605 412 TIVMEYIGGKDLKDVLE---------GNPELVRKVGEIVAKLHKAG---IVHGDLTTSNFIV-RDDRLYLIDFGLGKY 476 (535)
T ss_pred EEEEEecCCCcHHHHHH---------HHHHHHHHHHHHHHHHHhCC---CccCCCChHHEEE-ECCcEEEEeCccccc
Confidence 99999999999999874 45778999999999999986 9999999999999 577899999999975
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.71 E-value=1.6e-17 Score=186.66 Aligned_cols=212 Identities=23% Similarity=0.303 Sum_probs=149.4
Q ss_pred hhcCccccCcccCCCCccEEEeecc-CCcEEEEEEccccCcccHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEE
Q 004400 414 ATNNFATDNNIGEGGFGPVYKGLLA-DGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYE 492 (756)
Q Consensus 414 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 492 (756)
...+|+.++.|..|+||.||..+++ ..+.+|+|.-+.. . +.+- ++.....|.+|
T Consensus 81 ~e~df~~IklisngAygavylvrh~~trqrfa~kiNkq~-l-----ilRn--ilt~a~npfvv----------------- 135 (1205)
T KOG0606|consen 81 SESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKINKQN-L-----ILRN--ILTFAGNPFVV----------------- 135 (1205)
T ss_pred CccccceeEeeccCCCCceeeeeccccccchhhcccccc-h-----hhhc--cccccCCccee-----------------
Confidence 3468999999999999999999865 4667888432211 1 1110 34444455554
Q ss_pred ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCcccCc-
Q 004400 493 YLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENT- 571 (756)
Q Consensus 493 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~~~~- 571 (756)
|+-...+... ..++. +++.+++|||+-| |+|||+||+|.+++.-|.+|++|||+++.......
T Consensus 136 ----gDc~tllk~~-g~lPv--------dmvla~Eylh~yg---ivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~at 199 (1205)
T KOG0606|consen 136 ----GDCATLLKNI-GPLPV--------DMVLAVEYLHSYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLAT 199 (1205)
T ss_pred ----chhhhhcccC-CCCcc--------hhhHHhHhhccCC---eecCCCCCCcceeeecccccccchhhhhhhhhhccc
Confidence 4444444322 23332 2378999999987 99999999999999999999999999874322110
Q ss_pred -----------c--eeeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhcCcc
Q 004400 572 -----------H--ISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKL 638 (756)
Q Consensus 572 -----------~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 638 (756)
+ ....++||+.|.|||++....|+..+|+|++|+|+||.+.|..||.++....++.... ....+.
T Consensus 200 nl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~vi--sd~i~w 277 (1205)
T KOG0606|consen 200 NLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVI--SDDIEW 277 (1205)
T ss_pred hhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhh--hhhccc
Confidence 0 1234789999999999999999999999999999999999999999887766665332 111222
Q ss_pred ccccccCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHH
Q 004400 639 MELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMS 677 (756)
Q Consensus 639 ~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~ 677 (756)
.+- ....++ +..+++.+.++.+|.+|--..
T Consensus 278 pE~-----dea~p~----Ea~dli~~LL~qnp~~Rlgt~ 307 (1205)
T KOG0606|consen 278 PEE-----DEALPP----EAQDLIEQLLRQNPLCRLGTG 307 (1205)
T ss_pred ccc-----CcCCCH----HHHHHHHHHHHhChHhhcccc
Confidence 221 122233 377888899999999997433
|
|
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=99.70 E-value=7.3e-19 Score=187.56 Aligned_cols=255 Identities=22% Similarity=0.264 Sum_probs=198.7
Q ss_pred eccceeccccccccCcccc----cCCcccCCCCCCCEEEccCCcccC------ccCcccccCCcc-eeeccCccccccCC
Q 004400 13 WKQKTVNQKRVLKEQNLTG----VLPPKLAELTFLQDIDLTLNYLSG------TIPSQWASLPLL-NISLIANRLKGPIP 81 (756)
Q Consensus 13 ~~~~~~~~~l~L~~~~l~~----~~p~~l~~l~~L~~L~L~~n~l~~------~~p~~~~~l~~L-~l~l~~n~~~~~~p 81 (756)
+..+..++.|+|+++.+++ .++..+...+.|+.|+++++.+.+ .++..+..++.| ++++.+|.+.+..+
T Consensus 19 ~~~l~~L~~l~l~~~~l~~~~~~~i~~~l~~~~~l~~l~l~~~~~~~~~~~~~~~~~~l~~~~~L~~L~l~~~~~~~~~~ 98 (319)
T cd00116 19 LPKLLCLQVLRLEGNTLGEEAAKALASALRPQPSLKELCLSLNETGRIPRGLQSLLQGLTKGCGLQELDLSDNALGPDGC 98 (319)
T ss_pred HHHHhhccEEeecCCCCcHHHHHHHHHHHhhCCCceEEeccccccCCcchHHHHHHHHHHhcCceeEEEccCCCCChhHH
Confidence 4666779999999999864 366677888899999999998872 234556677777 58899999987777
Q ss_pred ccCcCcCC---CcEEEeecCcccc----cCCcccCCC-CCCcEEeccCCeeccc----CCccccCCCCCCEEEeeCCccc
Q 004400 82 KYLANIST---LVNLTVQYNQFSG----ELPEELGSL-LNLEKLHLSSNNFTGE----LPKTFAKLTNMKDFRISDNQFT 149 (756)
Q Consensus 82 ~~l~~l~~---L~~L~L~~N~l~~----~~p~~~~~l-~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~L~~N~l~ 149 (756)
..+..+.+ |++|++++|++++ .+...+..+ ++|+.|+|++|.+++. ++..+..+++|+.|+|++|.++
T Consensus 99 ~~~~~l~~~~~L~~L~ls~~~~~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~L~~L~l~~n~l~ 178 (319)
T cd00116 99 GVLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKLVLGRNRLEGASCEALAKALRANRDLKELNLANNGIG 178 (319)
T ss_pred HHHHHHhccCcccEEEeeCCccchHHHHHHHHHHHhCCCCceEEEcCCCcCCchHHHHHHHHHHhCCCcCEEECcCCCCc
Confidence 77777766 9999999999983 334456677 8999999999999842 3445677889999999999998
Q ss_pred cc----CChhhcCcCCCcEEEccCCcCcCC----CCccccCCCCCCeEEccCCCCCCCCccccc------cccccEEEcc
Q 004400 150 GQ----IPSFIQNWTKLEKLFIQPSGLAGP----IPSGIFSLENLTDLRISDLNGPEATFPQLG------NMKMTKLILR 215 (756)
Q Consensus 150 ~~----~p~~~~~l~~L~~L~l~~N~l~~~----~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~------~~~L~~L~L~ 215 (756)
+. ++..+..+++|+.|+|++|.+.+. ++..+..+++|+.|++++|.+.......+. ..+|+.|+++
T Consensus 179 ~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~~~~~~~L~~L~ls~n~l~~~~~~~l~~~~~~~~~~L~~L~l~ 258 (319)
T cd00116 179 DAGIRALAEGLKANCNLEVLDLNNNGLTDEGASALAETLASLKSLEVLNLGDNNLTDAGAAALASALLSPNISLLTLSLS 258 (319)
T ss_pred hHHHHHHHHHHHhCCCCCEEeccCCccChHHHHHHHHHhcccCCCCEEecCCCcCchHHHHHHHHHHhccCCCceEEEcc
Confidence 42 344566678999999999999743 345567789999999999998864333221 2479999999
Q ss_pred cccccC----CCCccccCCCCCcEEEccCCcCCCC----CCccCcCC-CCCCeEEecCccc
Q 004400 216 NCNITG----ELPRYLGKMTKLKVLDLSFNRLRGQ----IPSNFDDL-YDVDYIYFAGNLL 267 (756)
Q Consensus 216 ~n~l~~----~~p~~~~~l~~L~~L~Ls~N~l~~~----~p~~~~~l-~~L~~L~ls~N~l 267 (756)
+|.++. .+...+..+++|++|++++|.++.. ....+... +.|+.|++.+|++
T Consensus 259 ~n~i~~~~~~~l~~~~~~~~~L~~l~l~~N~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (319)
T cd00116 259 CNDITDDGAKDLAEVLAEKESLLELDLRGNKFGEEGAQLLAESLLEPGNELESLWVKDDSF 319 (319)
T ss_pred CCCCCcHHHHHHHHHHhcCCCccEEECCCCCCcHHHHHHHHHHHhhcCCchhhcccCCCCC
Confidence 999973 2344567779999999999999954 44455555 7899999999875
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.63 E-value=2.2e-15 Score=141.48 Aligned_cols=135 Identities=21% Similarity=0.215 Sum_probs=115.0
Q ss_pred ccCcccCCCCccEEEeeccCCcEEEEEEccccCcccHHHHHHHHHHHHhCCC--CceeeEeeEEEeCCeEEEEEEecCCC
Q 004400 420 TDNNIGEGGFGPVYKGLLADGTAIAVKQLSSKSKQGNREFINEIGMISALQH--PNLVKLYGCCIEGNQLLLIYEYLENN 497 (756)
Q Consensus 420 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~~~~lV~e~~~~g 497 (756)
+.+.||+|.++.||++...+ ..+++|....... ...+.+|+.+++.++| .+++++++++..++..+++|||++++
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~ 78 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGE 78 (155)
T ss_pred cceecccccccceEEEEecC-CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCe
Confidence 34689999999999999754 7899999865433 4678999999999976 58999999988888999999999998
Q ss_pred CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCcccc
Q 004400 498 SLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKL 565 (756)
Q Consensus 498 sL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~ 565 (756)
.+... +......++.+++++++++|......++|||++|+||++++.+.+++.|||.++.
T Consensus 79 ~~~~~--------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 79 TLDEV--------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred ecccC--------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 76543 5667788899999999999986444599999999999999988999999999874
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.62 E-value=2.3e-15 Score=147.14 Aligned_cols=136 Identities=24% Similarity=0.290 Sum_probs=97.5
Q ss_pred cCcccCCCCccEEEeeccCCcEEEEEEccccCcc--cHHHH----------------------HHHHHHHHhCCCCc--e
Q 004400 421 DNNIGEGGFGPVYKGLLADGTAIAVKQLSSKSKQ--GNREF----------------------INEIGMISALQHPN--L 474 (756)
Q Consensus 421 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--~~~~~----------------------~~E~~~l~~l~h~n--i 474 (756)
.+.||+|+||.||+|...+++.||||++...... ....+ ..|.+.+.++.+.. +
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 4689999999999999888999999988653211 11111 34566666664432 4
Q ss_pred eeEeeEEEeCCeEEEEEEecCCCCHHH-HHHhcCCCCCHHHHHHHHHHHHHHHHHHHc-CCCCCeEcCCCCCCceEecCC
Q 004400 475 VKLYGCCIEGNQLLLIYEYLENNSLAR-ALFEHRLKLDWPTRRRICLGIARGLAYLHG-ESRIKVVHRDIKATNVLLDKD 552 (756)
Q Consensus 475 v~l~~~~~~~~~~~lV~e~~~~gsL~~-~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~-~g~~~iiH~Dikp~Nill~~~ 552 (756)
.+.+++ ...++||||++++.+.. .+.... .. ..+..++.+++.++.++|. .+ |+||||||+||+++ +
T Consensus 82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~--~~-~~~~~~~~~~~~~l~~lh~~~~---ivH~Dl~p~Nili~-~ 150 (187)
T cd05119 82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR--LL-EDPEELYDQILELMRKLYREAG---LVHGDLSEYNILVD-D 150 (187)
T ss_pred CceEec----CCCEEEEEEeCCCCccChhhhhhh--hc-ccHHHHHHHHHHHHHHHhhccC---cCcCCCChhhEEEE-C
Confidence 444443 24589999999954321 111111 11 5678899999999999998 65 99999999999999 8
Q ss_pred CCEEEccCCccccCc
Q 004400 553 LNSKISDFGLAKLDE 567 (756)
Q Consensus 553 ~~~kl~DFGla~~~~ 567 (756)
+.++++|||.+....
T Consensus 151 ~~~~liDfg~a~~~~ 165 (187)
T cd05119 151 GKVYIIDVPQAVEID 165 (187)
T ss_pred CcEEEEECccccccc
Confidence 899999999997433
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.59 E-value=1.2e-14 Score=146.85 Aligned_cols=135 Identities=21% Similarity=0.260 Sum_probs=105.5
Q ss_pred cCccc-CCCCccEEEeeccCCcEEEEEEccccC-------------cccHHHHHHHHHHHHhCCCCce--eeEeeEEEeC
Q 004400 421 DNNIG-EGGFGPVYKGLLADGTAIAVKQLSSKS-------------KQGNREFINEIGMISALQHPNL--VKLYGCCIEG 484 (756)
Q Consensus 421 ~~~lg-~G~~g~Vy~~~~~~~~~vavK~~~~~~-------------~~~~~~~~~E~~~l~~l~h~ni--v~l~~~~~~~ 484 (756)
...|| .||.|+||.+... +..++||.+.... ......+.+|++++.+++|++| ++.+++....
T Consensus 36 ~~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 36 ARVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR 114 (239)
T ss_pred CceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence 35787 8999999999875 6778998875321 1223567889999999998875 6777765432
Q ss_pred -C---eEEEEEEecCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEcc
Q 004400 485 -N---QLLLIYEYLEN-NSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISD 559 (756)
Q Consensus 485 -~---~~~lV~e~~~~-gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~D 559 (756)
. ..++||||++| .+|.+++... .++.. .+.+++.++.+||+.| |+||||||.|||++.++.++|+|
T Consensus 115 ~~~~~~~~lV~e~l~G~~~L~~~l~~~--~l~~~----~~~~i~~~l~~lH~~G---I~HrDlkp~NILv~~~~~v~LID 185 (239)
T PRK01723 115 HGLFYRADILIERIEGARDLVALLQEA--PLSEE----QWQAIGQLIARFHDAG---VYHADLNAHNILLDPDGKFWLID 185 (239)
T ss_pred cCcceeeeEEEEecCCCCCHHHHHhcC--CCCHH----HHHHHHHHHHHHHHCC---CCCCCCCchhEEEcCCCCEEEEE
Confidence 2 23599999997 6998887542 34433 3678999999999997 99999999999999988999999
Q ss_pred CCcccc
Q 004400 560 FGLAKL 565 (756)
Q Consensus 560 FGla~~ 565 (756)
||.++.
T Consensus 186 fg~~~~ 191 (239)
T PRK01723 186 FDRGEL 191 (239)
T ss_pred CCCccc
Confidence 999874
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.57 E-value=3.1e-16 Score=177.25 Aligned_cols=251 Identities=23% Similarity=0.280 Sum_probs=186.4
Q ss_pred cCccccCcccCCCCccEEEeecc--CCcEEEEEEccccC--cccHHHHHHHHHHHHhCC-CCceeeEeeEEEeCCeEEEE
Q 004400 416 NNFATDNNIGEGGFGPVYKGLLA--DGTAIAVKQLSSKS--KQGNREFINEIGMISALQ-HPNLVKLYGCCIEGNQLLLI 490 (756)
Q Consensus 416 ~~~~~~~~lg~G~~g~Vy~~~~~--~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lV 490 (756)
..|...+.||+|+|+.|-.+... ....+|+|.+.... .........|..+-..+. |+|++.+++...+.+..+++
T Consensus 20 ~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~ 99 (601)
T KOG0590|consen 20 SQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLS 99 (601)
T ss_pred ccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccc
Confidence 35666678999999999988753 34556777765543 222334445777767776 99999999999999999999
Q ss_pred EEecCCCCHHHHH-HhcCCCCCHHHHHHHHHHHHHHHHHHH-cCCCCCeEcCCCCCCceEecCCC-CEEEccCCccccCc
Q 004400 491 YEYLENNSLARAL-FEHRLKLDWPTRRRICLGIARGLAYLH-GESRIKVVHRDIKATNVLLDKDL-NSKISDFGLAKLDE 567 (756)
Q Consensus 491 ~e~~~~gsL~~~l-~~~~~~l~~~~~~~i~~~ia~~L~~LH-~~g~~~iiH~Dikp~Nill~~~~-~~kl~DFGla~~~~ 567 (756)
++|..+|++.+.+ .......+...+..++.|+..++.|+| +.+ +.||||||+|.+++..+ ..+++|||+|....
T Consensus 100 ~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~---~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~ 176 (601)
T KOG0590|consen 100 LSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENG---VTHRDIKPSNSLLDESGSALKIADFGLATAYR 176 (601)
T ss_pred cCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccc---cccCCCCCccchhccCCCcccCCCchhhcccc
Confidence 9999999999888 444336777888899999999999999 776 99999999999999999 99999999998766
Q ss_pred c-cC-cceeecccc-CccCCchHhhhcC-CCCcccchhhHHHHHHHHHhCCCCCCccchhh--HHHHHHHHHhcCccccc
Q 004400 568 E-EN-THISTRVAG-TIGYMAPEYAMRG-HLTEKADVYSFGIVALEIVSGRSNVTKEDMFY--LLDWALVLKEQGKLMEL 641 (756)
Q Consensus 568 ~-~~-~~~~~~~~g-t~~y~aPE~~~~~-~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~--~~~~~~~~~~~~~~~~~ 641 (756)
. .+ .......+| ++.|+|||...+. ...+..|+||.|+++.-+++|..|+....... ...|.. . . ..
T Consensus 177 ~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~---~-~---~~ 249 (601)
T KOG0590|consen 177 NKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKS---N-K---GR 249 (601)
T ss_pred ccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeecc---c-c---cc
Confidence 5 22 222344578 9999999999884 56788999999999999999999984332211 111211 0 0 01
Q ss_pred cccCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHH
Q 004400 642 VDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVL 680 (756)
Q Consensus 642 ~~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~ 680 (756)
....+..... ....++..+++..+|..|.+.+++.
T Consensus 250 ~~~~~~~~~~----~~~~~~l~k~l~~~~~~r~s~~~~~ 284 (601)
T KOG0590|consen 250 FTQLPWNSIS----DQAHDLLHKILKENPSNRLSIEELK 284 (601)
T ss_pred cccCccccCC----hhhhhcccccccCCchhcccccccc
Confidence 0111112222 2356677788889999999988864
|
|
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.47 E-value=1.6e-15 Score=159.76 Aligned_cols=168 Identities=27% Similarity=0.431 Sum_probs=96.5
Q ss_pred eeccCccccccCCccCcCcCCCcEEEeecCcccccCCcccCCCCCCcEEeccCCeecccCCccccCCCCCCEEEeeCCcc
Q 004400 69 ISLIANRLKGPIPKYLANISTLVNLTVQYNQFSGELPEELGSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRISDNQF 148 (756)
Q Consensus 69 l~l~~n~~~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l 148 (756)
.+++.|++. .+|..+..+..|+.|.|++|.|. .+|..+++|..|++|+|+.|+++ .+|..++.|+ |+.|-+++|++
T Consensus 80 aDlsrNR~~-elp~~~~~f~~Le~liLy~n~~r-~ip~~i~~L~~lt~l~ls~NqlS-~lp~~lC~lp-Lkvli~sNNkl 155 (722)
T KOG0532|consen 80 ADLSRNRFS-ELPEEACAFVSLESLILYHNCIR-TIPEAICNLEALTFLDLSSNQLS-HLPDGLCDLP-LKVLIVSNNKL 155 (722)
T ss_pred hhccccccc-cCchHHHHHHHHHHHHHHhccce-ecchhhhhhhHHHHhhhccchhh-cCChhhhcCc-ceeEEEecCcc
Confidence 455555554 55555555566666666666666 56666666666666666666666 5565565555 66666666666
Q ss_pred cccCChhhcCcCCCcEEEccCCcCcCCCCccccCCCCCCeEEccCCCCCCCCccccccccccEEEcccccccCCCCcccc
Q 004400 149 TGQIPSFIQNWTKLEKLFIQPSGLAGPIPSGIFSLENLTDLRISDLNGPEATFPQLGNMKMTKLILRNCNITGELPRYLG 228 (756)
Q Consensus 149 ~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~L~~L~L~~n~l~~~~p~~~~ 228 (756)
+ .+|..++.+..|..|+.+.|.+. .+|..++.+.+|+.|.+. .|++. .+|..+.
T Consensus 156 ~-~lp~~ig~~~tl~~ld~s~nei~-slpsql~~l~slr~l~vr-----------------------Rn~l~-~lp~El~ 209 (722)
T KOG0532|consen 156 T-SLPEEIGLLPTLAHLDVSKNEIQ-SLPSQLGYLTSLRDLNVR-----------------------RNHLE-DLPEELC 209 (722)
T ss_pred c-cCCcccccchhHHHhhhhhhhhh-hchHHhhhHHHHHHHHHh-----------------------hhhhh-hCCHHHh
Confidence 6 55656665566666666666665 455555555555555444 44444 3333344
Q ss_pred CCCCCcEEEccCCcCCCCCCccCcCCCCCCeEEecCcccc
Q 004400 229 KMTKLKVLDLSFNRLRGQIPSNFDDLYDVDYIYFAGNLLT 268 (756)
Q Consensus 229 ~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~ 268 (756)
.| .|..||+|.|+++ .+|-.|..|..|++|-|.+|+|+
T Consensus 210 ~L-pLi~lDfScNkis-~iPv~fr~m~~Lq~l~LenNPLq 247 (722)
T KOG0532|consen 210 SL-PLIRLDFSCNKIS-YLPVDFRKMRHLQVLQLENNPLQ 247 (722)
T ss_pred CC-ceeeeecccCcee-ecchhhhhhhhheeeeeccCCCC
Confidence 22 3555555555555 45555555555555555555555
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.47 E-value=1.9e-13 Score=150.14 Aligned_cols=145 Identities=21% Similarity=0.262 Sum_probs=103.5
Q ss_pred CccccCcccCCCCccEEEeeccCCcEEEEEEccccCccc----------------------------------------H
Q 004400 417 NFATDNNIGEGGFGPVYKGLLADGTAIAVKQLSSKSKQG----------------------------------------N 456 (756)
Q Consensus 417 ~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~----------------------------------------~ 456 (756)
.|+ .+.||.|++|.||+|++.+|+.||||+.+...... +
T Consensus 119 ~fd-~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~E 197 (437)
T TIGR01982 119 EFE-EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRE 197 (437)
T ss_pred hCC-CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHH
Confidence 344 36899999999999999999999999986531110 0
Q ss_pred HHHHHHHHHHHhCC----CCceeeEeeEEE-eCCeEEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHH-HHHHHH
Q 004400 457 REFINEIGMISALQ----HPNLVKLYGCCI-EGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIAR-GLAYLH 530 (756)
Q Consensus 457 ~~~~~E~~~l~~l~----h~niv~l~~~~~-~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~-~L~~LH 530 (756)
-+|.+|+..+.+++ |.+-+.+-.++. .....++||||++|++|.+......... .+.+++..+++ .+..+|
T Consensus 198 ldf~~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~~---~~~~ia~~~~~~~l~ql~ 274 (437)
T TIGR01982 198 LDLRREAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAGL---DRKALAENLARSFLNQVL 274 (437)
T ss_pred HCHHHHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcCC---CHHHHHHHHHHHHHHHHH
Confidence 12455666555552 333334333332 2455799999999999988765322222 34556666666 478889
Q ss_pred cCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCcc
Q 004400 531 GESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEE 568 (756)
Q Consensus 531 ~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~ 568 (756)
..| ++|+|+||.||+++.+++++++|||++....+
T Consensus 275 ~~g---~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~ 309 (437)
T TIGR01982 275 RDG---FFHADLHPGNIFVLKDGKIIALDFGIVGRLSE 309 (437)
T ss_pred hCC---ceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence 886 99999999999999999999999999976543
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.45 E-value=3.9e-15 Score=156.94 Aligned_cols=184 Identities=26% Similarity=0.416 Sum_probs=151.8
Q ss_pred cCcCCCcEEEeecCcccccCCcccCCCCCCcEEeccCCeecccCCccccCCCCCCEEEeeCCcccccCChhhcCcCCCcE
Q 004400 85 ANISTLVNLTVQYNQFSGELPEELGSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRISDNQFTGQIPSFIQNWTKLEK 164 (756)
Q Consensus 85 ~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~ 164 (756)
..++--...||+.|++. .+|.++..+..|+.|.|++|.+. .+|..++.|..|+.|||+.|+++ .+|..++.|+ |+.
T Consensus 72 ~~ltdt~~aDlsrNR~~-elp~~~~~f~~Le~liLy~n~~r-~ip~~i~~L~~lt~l~ls~NqlS-~lp~~lC~lp-Lkv 147 (722)
T KOG0532|consen 72 YDLTDTVFADLSRNRFS-ELPEEACAFVSLESLILYHNCIR-TIPEAICNLEALTFLDLSSNQLS-HLPDGLCDLP-LKV 147 (722)
T ss_pred ccccchhhhhccccccc-cCchHHHHHHHHHHHHHHhccce-ecchhhhhhhHHHHhhhccchhh-cCChhhhcCc-cee
Confidence 44566678889999998 88888888888999999999988 88888889999999999999988 7777777776 888
Q ss_pred EEccCCcCcCCCCccccCCCCCCeEEccCCCCCCCCccccccccccEEEcccccccCCCCccccCCCCCcEEEccCCcCC
Q 004400 165 LFIQPSGLAGPIPSGIFSLENLTDLRISDLNGPEATFPQLGNMKMTKLILRNCNITGELPRYLGKMTKLKVLDLSFNRLR 244 (756)
Q Consensus 165 L~l~~N~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 244 (756)
|.+++|+++ .+|..++.+..|..|| .+.|.+. .+|..++++.+|+.|++..|++.
T Consensus 148 li~sNNkl~-~lp~~ig~~~tl~~ld-----------------------~s~nei~-slpsql~~l~slr~l~vrRn~l~ 202 (722)
T KOG0532|consen 148 LIVSNNKLT-SLPEEIGLLPTLAHLD-----------------------VSKNEIQ-SLPSQLGYLTSLRDLNVRRNHLE 202 (722)
T ss_pred EEEecCccc-cCCcccccchhHHHhh-----------------------hhhhhhh-hchHHhhhHHHHHHHHHhhhhhh
Confidence 888888888 6787777666666555 5557776 67788999999999999999999
Q ss_pred CCCCccCcCCCCCCeEEecCccccccCCchh--hcCCCeeEeecCCCCCCCCccccccc
Q 004400 245 GQIPSNFDDLYDVDYIYFAGNLLTGAIPPWM--LERGDKIDLSYNNFTDGSAESSCQKR 301 (756)
Q Consensus 245 ~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~--~~~l~~l~ls~N~l~~~~~~~~~~~~ 301 (756)
.+|..+..| .|..||+|.|+++ .+|-.+ +..|+.|-|.+|+++.. +...|.+.
T Consensus 203 -~lp~El~~L-pLi~lDfScNkis-~iPv~fr~m~~Lq~l~LenNPLqSP-PAqIC~kG 257 (722)
T KOG0532|consen 203 -DLPEELCSL-PLIRLDFSCNKIS-YLPVDFRKMRHLQVLQLENNPLQSP-PAQICEKG 257 (722)
T ss_pred -hCCHHHhCC-ceeeeecccCcee-ecchhhhhhhhheeeeeccCCCCCC-hHHHHhcc
Confidence 678778855 5889999999999 889888 89999999999999854 34455443
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.38 E-value=5.6e-13 Score=132.07 Aligned_cols=198 Identities=21% Similarity=0.305 Sum_probs=137.9
Q ss_pred HHHHhCCCCceeeEeeEEEeC-----CeEEEEEEecCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHcCCCC
Q 004400 464 GMISALQHPNLVKLYGCCIEG-----NQLLLIYEYLENNSLARALFE---HRLKLDWPTRRRICLGIARGLAYLHGESRI 535 (756)
Q Consensus 464 ~~l~~l~h~niv~l~~~~~~~-----~~~~lV~e~~~~gsL~~~l~~---~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~ 535 (756)
.-|-.+.|.|||++..|+.+. .+..++.|||+.|++..+|++ ....+......+++.||..||.|||+. .|
T Consensus 119 dnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~-~P 197 (458)
T KOG1266|consen 119 DNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSC-DP 197 (458)
T ss_pred HHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhcc-CC
Confidence 345566799999999998654 457999999999999999973 344677888899999999999999987 78
Q ss_pred CeEcCCCCCCceEecCCCCEEEccCCccccCccc----CcceeeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHH
Q 004400 536 KVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEE----NTHISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIV 611 (756)
Q Consensus 536 ~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell 611 (756)
+|+|+++.-+-|++..++-+||+----.. .... .......-.|-++|.|||+=.....+.++|||+||....||.
T Consensus 198 piihgnlTc~tifiq~ngLIkig~~ap~s-~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlema 276 (458)
T KOG1266|consen 198 PIIHGNLTCDTIFIQHNGLIKIGSVAPDS-THPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMA 276 (458)
T ss_pred ccccCCcchhheeecCCceEEecccCccc-cchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHH
Confidence 99999999999999999888874221111 1100 001112234678999999877777788999999999999998
Q ss_pred hCCCCCCccchhhHHHHHHHHHhcCc-cccccccCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHH
Q 004400 612 SGRSNVTKEDMFYLLDWALVLKEQGK-LMELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVL 680 (756)
Q Consensus 612 tg~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~ 680 (756)
.+..--...+...... .... ......... -.+++..|++..|..||+|++++
T Consensus 277 ilEiq~tnseS~~~~e------e~ia~~i~~len~l-----------qr~~i~kcl~~eP~~rp~ar~ll 329 (458)
T KOG1266|consen 277 ILEIQSTNSESKVEVE------ENIANVIIGLENGL-----------QRGSITKCLEGEPNGRPDARLLL 329 (458)
T ss_pred HheeccCCCcceeehh------hhhhhheeeccCcc-----------ccCcCcccccCCCCCCcchhhhh
Confidence 8764321111111000 0000 000011111 23456789999999999999984
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.37 E-value=2.1e-12 Score=124.03 Aligned_cols=130 Identities=21% Similarity=0.164 Sum_probs=97.4
Q ss_pred CcccCCCCccEEEeeccCCcEEEEEEccccCcccHHHHHHHHHHHHhCCCCceee-EeeEEEeCCeEEEEEEecCCCCHH
Q 004400 422 NNIGEGGFGPVYKGLLADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVK-LYGCCIEGNQLLLIYEYLENNSLA 500 (756)
Q Consensus 422 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~-l~~~~~~~~~~~lV~e~~~~gsL~ 500 (756)
+.++.|.++.||+++.. ++.|++|....... ....+.+|+.+++.+.+.++++ ++.+. ....++||||++|.++.
T Consensus 4 ~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~l~ 79 (170)
T cd05151 4 SPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSELL 79 (170)
T ss_pred eecCCcccCceEEEEEC-CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCccc
Confidence 57889999999999865 77899999765432 2345678999999987655554 44433 33458999999998775
Q ss_pred HHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCC--CCCeEcCCCCCCceEecCCCCEEEccCCcccc
Q 004400 501 RALFEHRLKLDWPTRRRICLGIARGLAYLHGES--RIKVVHRDIKATNVLLDKDLNSKISDFGLAKL 565 (756)
Q Consensus 501 ~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g--~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~ 565 (756)
+. . .....++.+++++|+.||..+ ...++|||++|.||+++ ++.++++|||.+..
T Consensus 80 ~~------~---~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 80 TE------D---FSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred cc------c---ccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 43 0 112345679999999999885 22369999999999999 66899999999863
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.35 E-value=9.9e-13 Score=144.56 Aligned_cols=184 Identities=28% Similarity=0.474 Sum_probs=117.1
Q ss_pred CcCcCCCcEEEeecCcccccCCcccCCCC-CCcEEeccCCeecccCCccccCCCCCCEEEeeCCcccccCChhhcCcCCC
Q 004400 84 LANISTLVNLTVQYNQFSGELPEELGSLL-NLEKLHLSSNNFTGELPKTFAKLTNMKDFRISDNQFTGQIPSFIQNWTKL 162 (756)
Q Consensus 84 l~~l~~L~~L~L~~N~l~~~~p~~~~~l~-~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L 162 (756)
+..++.++.|++.+|.++ .++...+.+. +|+.|++++|++. .+|..+..+++|+.|++++|+++ .+|...+.+++|
T Consensus 112 ~~~~~~l~~L~l~~n~i~-~i~~~~~~~~~nL~~L~l~~N~i~-~l~~~~~~l~~L~~L~l~~N~l~-~l~~~~~~~~~L 188 (394)
T COG4886 112 LLELTNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNL 188 (394)
T ss_pred hhcccceeEEecCCcccc-cCccccccchhhcccccccccchh-hhhhhhhccccccccccCCchhh-hhhhhhhhhhhh
Confidence 444566777777777776 5666666664 7777777777776 55555666777777777777777 555555566777
Q ss_pred cEEEccCCcCcCCCCccccCCCCCCeEEccCCCCCCCCccccccccccEEEcccccccCCCCccccCCCCCcEEEccCCc
Q 004400 163 EKLFIQPSGLAGPIPSGIFSLENLTDLRISDLNGPEATFPQLGNMKMTKLILRNCNITGELPRYLGKMTKLKVLDLSFNR 242 (756)
Q Consensus 163 ~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~ 242 (756)
+.|++++|+++ .+|..+..+..|++|.+++|.+...........++..|.+.+|++. ..+..++.+++|+.|++++|.
T Consensus 189 ~~L~ls~N~i~-~l~~~~~~~~~L~~l~~~~N~~~~~~~~~~~~~~l~~l~l~~n~~~-~~~~~~~~l~~l~~L~~s~n~ 266 (394)
T COG4886 189 NNLDLSGNKIS-DLPPEIELLSALEELDLSNNSIIELLSSLSNLKNLSGLELSNNKLE-DLPESIGNLSNLETLDLSNNQ 266 (394)
T ss_pred hheeccCCccc-cCchhhhhhhhhhhhhhcCCcceecchhhhhcccccccccCCceee-eccchhccccccceecccccc
Confidence 77777777776 5666555555667776666654333333333334555556666666 335566777777777777777
Q ss_pred CCCCCCccCcCCCCCCeEEecCccccccCCch
Q 004400 243 LRGQIPSNFDDLYDVDYIYFAGNLLTGAIPPW 274 (756)
Q Consensus 243 l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~ 274 (756)
++ .++. +..+.+++.|++++|.+....|..
T Consensus 267 i~-~i~~-~~~~~~l~~L~~s~n~~~~~~~~~ 296 (394)
T COG4886 267 IS-SISS-LGSLTNLRELDLSGNSLSNALPLI 296 (394)
T ss_pred cc-cccc-ccccCccCEEeccCccccccchhh
Confidence 77 3333 677777777777777776555543
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.31 E-value=4e-12 Score=137.28 Aligned_cols=247 Identities=22% Similarity=0.248 Sum_probs=180.5
Q ss_pred CccccCcccC--CCCccEEEeec---cCCcEEEEEEccccCc--ccHHHHHHHHHHHHhC-CCCceeeEeeEEEeCCeEE
Q 004400 417 NFATDNNIGE--GGFGPVYKGLL---ADGTAIAVKQLSSKSK--QGNREFINEIGMISAL-QHPNLVKLYGCCIEGNQLL 488 (756)
Q Consensus 417 ~~~~~~~lg~--G~~g~Vy~~~~---~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~ 488 (756)
.|.....+|. |.+|.||.+.. .++..+|+|.-+.... .....=.+|+..-+.+ .|+|.++.+..+...+..+
T Consensus 115 ~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~lf 194 (524)
T KOG0601|consen 115 RFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGILF 194 (524)
T ss_pred hcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcce
Confidence 4567788999 99999999986 4678899988443221 2223335577766666 4999999999999999999
Q ss_pred EEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHH----HHHHHHcCCCCCeEcCCCCCCceEecCC-CCEEEccCCcc
Q 004400 489 LIYEYLENNSLARALFEHRLKLDWPTRRRICLGIAR----GLAYLHGESRIKVVHRDIKATNVLLDKD-LNSKISDFGLA 563 (756)
Q Consensus 489 lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~----~L~~LH~~g~~~iiH~Dikp~Nill~~~-~~~kl~DFGla 563 (756)
+-+|++. .+|..+.+.....++....+.+..+... |+.++|... ++|-|+||.||+..++ ...+++|||+.
T Consensus 195 iqtE~~~-~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~---~~~~~~kp~~i~~~~~~~s~~~~df~~v 270 (524)
T KOG0601|consen 195 IQTELCG-ESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNN---IVHDDLKPANIFTTSDWTSCKLTDFGLV 270 (524)
T ss_pred eeecccc-chhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCc---ccccccchhheecccccceeecCCccee
Confidence 9999986 6888887766666788888888888888 999999985 9999999999999999 88999999999
Q ss_pred ccCcccCcce----eeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhcCccc
Q 004400 564 KLDEEENTHI----STRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLM 639 (756)
Q Consensus 564 ~~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 639 (756)
..+....... .....|...|++||... +-++.+.|+|++|.++.+...|.......-. -.|... +...+
T Consensus 271 ~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~-~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~---~~W~~~--r~~~i- 343 (524)
T KOG0601|consen 271 SKISDGNFSSVFKVSKRPEGDCIYAAKELLN-GLATFASDIFSLGEVILEAILGSHLPSVGKN---SSWSQL--RQGYI- 343 (524)
T ss_pred EEccCCccccceeeeecCCCCceEeChhhhc-cccchHhhhcchhhhhHhhHhhcccccCCCC---CCcccc--ccccC-
Confidence 8776544221 22336788899999764 5688899999999999999988765532200 012110 00000
Q ss_pred cccccCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 004400 640 ELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLR 681 (756)
Q Consensus 640 ~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~ 681 (756)
. ..+.......+...+..+++.+|..|++...+..
T Consensus 344 --p-----~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~ 378 (524)
T KOG0601|consen 344 --P-----LEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTA 378 (524)
T ss_pred --c-----hhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence 0 1111111223455788899999999999888754
|
|
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.30 E-value=1.9e-12 Score=142.24 Aligned_cols=200 Identities=28% Similarity=0.394 Sum_probs=159.3
Q ss_pred ccccccCcccccCCcccCCCCCCCEEEccCCcccCccCcccccCC-cc-eeeccCccccccCCccCcCcCCCcEEEeecC
Q 004400 21 KRVLKEQNLTGVLPPKLAELTFLQDIDLTLNYLSGTIPSQWASLP-LL-NISLIANRLKGPIPKYLANISTLVNLTVQYN 98 (756)
Q Consensus 21 ~l~L~~~~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~-~L-~l~l~~n~~~~~~p~~l~~l~~L~~L~L~~N 98 (756)
.+.+..+.+... ...+..++.++.|++.+|.++ .+|.....++ .| .+++.+|++. .+|..+..+++|+.|++++|
T Consensus 97 ~l~~~~~~~~~~-~~~~~~~~~l~~L~l~~n~i~-~i~~~~~~~~~nL~~L~l~~N~i~-~l~~~~~~l~~L~~L~l~~N 173 (394)
T COG4886 97 SLDLNLNRLRSN-ISELLELTNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFN 173 (394)
T ss_pred eeeccccccccC-chhhhcccceeEEecCCcccc-cCccccccchhhcccccccccchh-hhhhhhhccccccccccCCc
Confidence 466666666433 233556688999999999998 7777777774 66 4778888877 56667889999999999999
Q ss_pred cccccCCcccCCCCCCcEEeccCCeecccCCccccCCCCCCEEEeeCCcccccCChhhcCcCCCcEEEccCCcCcCCCCc
Q 004400 99 QFSGELPEELGSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRISDNQFTGQIPSFIQNWTKLEKLFIQPSGLAGPIPS 178 (756)
Q Consensus 99 ~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~ 178 (756)
+++ .+|...+.+++|+.|++++|+++ .+|.....+..|++|.+++|++. ..+..+.++.++..|.+.+|++. .++.
T Consensus 174 ~l~-~l~~~~~~~~~L~~L~ls~N~i~-~l~~~~~~~~~L~~l~~~~N~~~-~~~~~~~~~~~l~~l~l~~n~~~-~~~~ 249 (394)
T COG4886 174 DLS-DLPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEELDLSNNSII-ELLSSLSNLKNLSGLELSNNKLE-DLPE 249 (394)
T ss_pred hhh-hhhhhhhhhhhhhheeccCCccc-cCchhhhhhhhhhhhhhcCCcce-ecchhhhhcccccccccCCceee-eccc
Confidence 999 77777778899999999999999 77876666777999999999755 57778889999999999999987 4578
Q ss_pred cccCCCCCCeEEccCCCCCCCCccccccccccEEEcccccccCCCCcccc
Q 004400 179 GIFSLENLTDLRISDLNGPEATFPQLGNMKMTKLILRNCNITGELPRYLG 228 (756)
Q Consensus 179 ~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~L~~L~L~~n~l~~~~p~~~~ 228 (756)
.+..+++|+.|++++|.+..... .....+++.|++++|.+....+....
T Consensus 250 ~~~~l~~l~~L~~s~n~i~~i~~-~~~~~~l~~L~~s~n~~~~~~~~~~~ 298 (394)
T COG4886 250 SIGNLSNLETLDLSNNQISSISS-LGSLTNLRELDLSGNSLSNALPLIAL 298 (394)
T ss_pred hhccccccceecccccccccccc-ccccCccCEEeccCccccccchhhhc
Confidence 88889999999999999888877 33334699999999999877665543
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.27 E-value=2.7e-11 Score=134.51 Aligned_cols=148 Identities=14% Similarity=0.180 Sum_probs=96.4
Q ss_pred hcCccccCcccCCCCccEEEeeccC-CcEEEEEEccccCccc----------------------------------H---
Q 004400 415 TNNFATDNNIGEGGFGPVYKGLLAD-GTAIAVKQLSSKSKQG----------------------------------N--- 456 (756)
Q Consensus 415 ~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~----------------------------------~--- 456 (756)
...|+. +.||+|++|.||+|++.+ |+.||||+.+...... .
T Consensus 119 F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l 197 (537)
T PRK04750 119 FDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTL 197 (537)
T ss_pred HHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHH
Confidence 346776 799999999999999877 9999999997531100 0
Q ss_pred ---HHHHHHHHHHHhCC----CCceeeEeeEEEe-CCeEEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHH-HHHHH
Q 004400 457 ---REFINEIGMISALQ----HPNLVKLYGCCIE-GNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGI-ARGLA 527 (756)
Q Consensus 457 ---~~~~~E~~~l~~l~----h~niv~l~~~~~~-~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i-a~~L~ 527 (756)
-+|.+|+..+.+++ +...+.+-.++.+ ....++||||++|+.+.+.-.-.....+... ++... ..-+.
T Consensus 198 ~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~---la~~~v~~~~~ 274 (537)
T PRK04750 198 HDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKL---LAERGVEVFFT 274 (537)
T ss_pred HHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHH---HHHHHHHHHHH
Confidence 12445555544442 4444444444433 4567899999999999875321111222111 22111 11223
Q ss_pred HHHcCCCCCeEcCCCCCCceEecCCC----CEEEccCCccccCccc
Q 004400 528 YLHGESRIKVVHRDIKATNVLLDKDL----NSKISDFGLAKLDEEE 569 (756)
Q Consensus 528 ~LH~~g~~~iiH~Dikp~Nill~~~~----~~kl~DFGla~~~~~~ 569 (756)
.++..| ++|+|+||.||+++.++ ++++.|||++....+.
T Consensus 275 Qif~~G---ffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~~ 317 (537)
T PRK04750 275 QVFRDG---FFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNKE 317 (537)
T ss_pred HHHhCC---eeeCCCChHHeEEecCCCCCCeEEEEecceEEECCHH
Confidence 334455 99999999999999988 8999999999866543
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.26 E-value=7.1e-11 Score=128.69 Aligned_cols=228 Identities=18% Similarity=0.177 Sum_probs=151.7
Q ss_pred ccCCcEEEEEEccccCcccHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEEecCCCCHHHHHHhcCCCCCHHHHH
Q 004400 437 LADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRR 516 (756)
Q Consensus 437 ~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~ 516 (756)
..++.+|.|...+...........+-++.|+.++||||+++++.+..++..|+|+|-+.- |..++.+. +.....
T Consensus 34 k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~P--l~~~lk~l----~~~~v~ 107 (690)
T KOG1243|consen 34 KADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVRP--LETVLKEL----GKEEVC 107 (690)
T ss_pred eccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeecccc--HHHHHHHh----HHHHHH
Confidence 557888999888766553345567788899999999999999999999999999999854 56666533 245556
Q ss_pred HHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCcccCcceeeccccCccCCchHhhhcCCCCc
Q 004400 517 RICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPEYAMRGHLTE 596 (756)
Q Consensus 517 ~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ 596 (756)
--+.||+.||.+||+.| +++|++|.-+.|++++.|..||++|-++........ ......---.|..|+.+.... -
T Consensus 108 ~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~-~~~~~~~~~s~~~P~~~~~s~--~ 182 (690)
T KOG1243|consen 108 LGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA-PAKSLYLIESFDDPEEIDPSE--W 182 (690)
T ss_pred HHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc-ccccchhhhcccChhhcCccc--c
Confidence 67889999999999887 799999999999999999999999988764332221 001111122466777553322 3
Q ss_pred ccchhhHHHHHHHHHhCCCCCCcc--chhhHHHHHHHHHhcCccccccccCCCCCCCHHHHHHHHHHHHHhhcCCCCCCC
Q 004400 597 KADVYSFGIVALEIVSGRSNVTKE--DMFYLLDWALVLKEQGKLMELVDTNPGSNFDKEQVMVMINVALLCANASPTIRP 674 (756)
Q Consensus 597 ~~Dv~slGv~l~elltg~~p~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RP 674 (756)
..|.|-||++++|++.|..+-..+ ....+.. .......++. .... ..... ..+++..|....+-.|-
T Consensus 183 s~D~~~Lg~li~el~ng~~~~~~~~~~~~~ipk-~~~~~~~k~~----~~~~-----~~r~n-~~~~~~~~~~~~gff~n 251 (690)
T KOG1243|consen 183 SIDSWGLGCLIEELFNGSLLTKTDLSNTGKIPK-ALIELYCKKL----GATE-----LKRPN-KLRFILECRLLGGFFRN 251 (690)
T ss_pred chhhhhHHHHHHHHhCcccCcchhhhccCccch-hHHHHHHHHh----cccc-----ccccc-hhhHHHHHHhccccccc
Confidence 479999999999999983222110 0000000 0000000000 0000 00011 45667778888888888
Q ss_pred CHHHHHHHhccC
Q 004400 675 SMSSVLRMLECG 686 (756)
Q Consensus 675 t~~ev~~~L~~~ 686 (756)
.+-+++..|+.+
T Consensus 252 ~fvd~~~fLeel 263 (690)
T KOG1243|consen 252 DFVDTLLFLEEL 263 (690)
T ss_pred hHHHHHHHHHhc
Confidence 888888888754
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.23 E-value=1.1e-10 Score=112.72 Aligned_cols=136 Identities=14% Similarity=0.135 Sum_probs=98.5
Q ss_pred CcccCCCCccEEEeeccC-------CcEEEEEEccccC------------c----------ccHHHHH----HHHHHHHh
Q 004400 422 NNIGEGGFGPVYKGLLAD-------GTAIAVKQLSSKS------------K----------QGNREFI----NEIGMISA 468 (756)
Q Consensus 422 ~~lg~G~~g~Vy~~~~~~-------~~~vavK~~~~~~------------~----------~~~~~~~----~E~~~l~~ 468 (756)
..||.|--+.||.|...+ +..+|||+.+... . ...+.+. +|+..|++
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 478999999999998543 5799999875320 0 0112223 79999998
Q ss_pred CCC--CceeeEeeEEEeCCeEEEEEEecCCCCHHH-HHHhcCCCCCHHHHHHHHHHHHHHHHHH-HcCCCCCeEcCCCCC
Q 004400 469 LQH--PNLVKLYGCCIEGNQLLLIYEYLENNSLAR-ALFEHRLKLDWPTRRRICLGIARGLAYL-HGESRIKVVHRDIKA 544 (756)
Q Consensus 469 l~h--~niv~l~~~~~~~~~~~lV~e~~~~gsL~~-~l~~~~~~l~~~~~~~i~~~ia~~L~~L-H~~g~~~iiH~Dikp 544 (756)
+.. -++.+++++ ...++||||+.++.+.. .+.. ..++..+...+..+++.+|.+| |..| |||||+++
T Consensus 83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd--~~~~~~~~~~i~~~i~~~l~~l~H~~g---lVHGDLs~ 153 (197)
T cd05146 83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD--AKLNDEEMKNAYYQVLSMMKQLYKECN---LVHADLSE 153 (197)
T ss_pred HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc--cccCHHHHHHHHHHHHHHHHHHHHhCC---eecCCCCH
Confidence 853 355566654 56789999998754422 2221 2345556778889999999999 7775 99999999
Q ss_pred CceEecCCCCEEEccCCccccCc
Q 004400 545 TNVLLDKDLNSKISDFGLAKLDE 567 (756)
Q Consensus 545 ~Nill~~~~~~kl~DFGla~~~~ 567 (756)
.||++++ +.++|+|||.+....
T Consensus 154 ~NIL~~~-~~v~iIDF~qav~~~ 175 (197)
T cd05146 154 YNMLWHD-GKVWFIDVSQSVEPT 175 (197)
T ss_pred HHEEEEC-CcEEEEECCCceeCC
Confidence 9999974 679999999987543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.20 E-value=1.4e-10 Score=107.43 Aligned_cols=131 Identities=21% Similarity=0.278 Sum_probs=102.1
Q ss_pred CcccCCCCccEEEeeccCCcEEEEEEccccCc--------ccHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEEe
Q 004400 422 NNIGEGGFGPVYKGLLADGTAIAVKQLSSKSK--------QGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYEY 493 (756)
Q Consensus 422 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 493 (756)
..+++|+-+.+|.+.+.+.. +++|.-..+.. -...+-.+|+.++++++--.|.-.+-+..+++...++|||
T Consensus 2 ~~i~~GAEa~i~~~~~~g~~-av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~ 80 (204)
T COG3642 2 DLIKQGAEAIIYLTDFLGLP-AVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY 80 (204)
T ss_pred chhhCCcceeEEeeeccCcc-eEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence 46889999999999875434 56665333211 1123457799999998766666666677788889999999
Q ss_pred cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCcccc
Q 004400 494 LENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKL 565 (756)
Q Consensus 494 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~ 565 (756)
++|..|.+.+... ...++..+-.-+.-||..| |||+|+.++||++..+. +.++|||++..
T Consensus 81 I~G~~lkd~l~~~--------~~~~~r~vG~~vg~lH~~g---ivHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 81 IEGELLKDALEEA--------RPDLLREVGRLVGKLHKAG---IVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred eCChhHHHHHHhc--------chHHHHHHHHHHHHHHhcC---eecCCCccceEEEeCCc-EEEEECCcccc
Confidence 9999999888654 2567777888889999997 99999999999998764 99999999974
|
|
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.17 E-value=4e-11 Score=138.02 Aligned_cols=93 Identities=25% Similarity=0.512 Sum_probs=73.2
Q ss_pred CcEEEeecCcccccCCcccCCCCCCcEEeccCCeecccCCccccCCCCCCEEEeeCCcccccCChhhcCcCCCcEEEccC
Q 004400 90 LVNLTVQYNQFSGELPEELGSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRISDNQFTGQIPSFIQNWTKLEKLFIQP 169 (756)
Q Consensus 90 L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~ 169 (756)
++.|+|++|.+.|.+|..|+.|++|+.|+|++|+|+|.+|..++.+++|+.|+|++|+|+|.+|..++++++|+.|+|++
T Consensus 420 v~~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls~ 499 (623)
T PLN03150 420 IDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNG 499 (623)
T ss_pred EEEEECCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECcC
Confidence 67778888888777777788888888888888888777777777788888888888888777777777888888888888
Q ss_pred CcCcCCCCccccC
Q 004400 170 SGLAGPIPSGIFS 182 (756)
Q Consensus 170 N~l~~~~p~~~~~ 182 (756)
|+++|.+|..+..
T Consensus 500 N~l~g~iP~~l~~ 512 (623)
T PLN03150 500 NSLSGRVPAALGG 512 (623)
T ss_pred CcccccCChHHhh
Confidence 8887777776654
|
|
| >KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.16 E-value=9.2e-13 Score=132.01 Aligned_cols=166 Identities=22% Similarity=0.218 Sum_probs=111.5
Q ss_pred cccCCCCCCCEEEccCCcccCc----cCcccccCCcceeeccC----ccccccCCc-------cCcCcCCCcEEEeecCc
Q 004400 35 PKLAELTFLQDIDLTLNYLSGT----IPSQWASLPLLNISLIA----NRLKGPIPK-------YLANISTLVNLTVQYNQ 99 (756)
Q Consensus 35 ~~l~~l~~L~~L~L~~n~l~~~----~p~~~~~l~~L~l~l~~----n~~~~~~p~-------~l~~l~~L~~L~L~~N~ 99 (756)
+.+..+..++.|+|++|.+... +...+.+.+.|+.-..+ .+....+|. ++...++|+.||||+|-
T Consensus 24 ~~~~~~~s~~~l~lsgnt~G~EAa~~i~~~L~~~~~L~~v~~sd~ftGR~~~Ei~e~L~~l~~aL~~~~~L~~ldLSDNA 103 (382)
T KOG1909|consen 24 EELEPMDSLTKLDLSGNTFGTEAARAIAKVLASKKELREVNLSDMFTGRLKDEIPEALKMLSKALLGCPKLQKLDLSDNA 103 (382)
T ss_pred HHhcccCceEEEeccCCchhHHHHHHHHHHHhhcccceeeehHhhhcCCcHHHHHHHHHHHHHHHhcCCceeEeeccccc
Confidence 4456677788888888877522 33345555666432222 233334444 34456799999999999
Q ss_pred ccccCCcc----cCCCCCCcEEeccCCeecccCCc-------------cccCCCCCCEEEeeCCcccccC----ChhhcC
Q 004400 100 FSGELPEE----LGSLLNLEKLHLSSNNFTGELPK-------------TFAKLTNMKDFRISDNQFTGQI----PSFIQN 158 (756)
Q Consensus 100 l~~~~p~~----~~~l~~L~~L~L~~N~l~~~~p~-------------~~~~l~~L~~L~L~~N~l~~~~----p~~~~~ 158 (756)
|.-..+.. +.++..|++|+|.+|.+.-.-.. ..+.-+.|+++..++|++.... ...|..
T Consensus 104 ~G~~g~~~l~~ll~s~~~L~eL~L~N~Glg~~ag~~l~~al~~l~~~kk~~~~~~Lrv~i~~rNrlen~ga~~~A~~~~~ 183 (382)
T KOG1909|consen 104 FGPKGIRGLEELLSSCTDLEELYLNNCGLGPEAGGRLGRALFELAVNKKAASKPKLRVFICGRNRLENGGATALAEAFQS 183 (382)
T ss_pred cCccchHHHHHHHHhccCHHHHhhhcCCCChhHHHHHHHHHHHHHHHhccCCCcceEEEEeeccccccccHHHHHHHHHh
Confidence 87655554 45678899999999998721111 1234568999999999987433 345667
Q ss_pred cCCCcEEEccCCcCcCC----CCccccCCCCCCeEEccCCCCCCCC
Q 004400 159 WTKLEKLFIQPSGLAGP----IPSGIFSLENLTDLRISDLNGPEAT 200 (756)
Q Consensus 159 l~~L~~L~l~~N~l~~~----~p~~~~~l~~L~~L~l~~n~~~~~~ 200 (756)
.+.|+.+.+..|.+... +..++..+++|+.|||.+|.++...
T Consensus 184 ~~~leevr~~qN~I~~eG~~al~eal~~~~~LevLdl~DNtft~eg 229 (382)
T KOG1909|consen 184 HPTLEEVRLSQNGIRPEGVTALAEALEHCPHLEVLDLRDNTFTLEG 229 (382)
T ss_pred ccccceEEEecccccCchhHHHHHHHHhCCcceeeecccchhhhHH
Confidence 78899999999988632 3345677888888888887776544
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.15 E-value=4.4e-11 Score=129.35 Aligned_cols=246 Identities=21% Similarity=0.158 Sum_probs=175.5
Q ss_pred hhcCccccCcccCCCCccEEEeec--cCCcEEEEEEccccCcccH--HHHHHHHHHHHhC-CCCceeeEeeEEEeCCeEE
Q 004400 414 ATNNFATDNNIGEGGFGPVYKGLL--ADGTAIAVKQLSSKSKQGN--REFINEIGMISAL-QHPNLVKLYGCCIEGNQLL 488 (756)
Q Consensus 414 ~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~~vavK~~~~~~~~~~--~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~ 488 (756)
.+.+|.....||.|.|+.||+... .++..|++|.+........ ..-..|+.+...+ .|.+++..+..+..-+..|
T Consensus 263 ~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ 342 (524)
T KOG0601|consen 263 KLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGY 342 (524)
T ss_pred ecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCcccccccc
Confidence 346788999999999999999873 4678899998876533322 2235577776666 5899999888888888888
Q ss_pred EEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCC-CCEEEccCCccccCc
Q 004400 489 LIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKD-LNSKISDFGLAKLDE 567 (756)
Q Consensus 489 lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~-~~~kl~DFGla~~~~ 567 (756)
+--|||+++++...+ .....++...++++..|++.++.++|+.. ++|+|+||+||++..+ +.-+++|||.+....
T Consensus 343 ip~e~~~~~s~~l~~-~~~~~~d~~~~~~~~~q~~~~l~~i~s~~---~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~ 418 (524)
T KOG0601|consen 343 IPLEFCEGGSSSLRS-VTSQMLDEDPRLRLTAQILTALNVIHSKL---FVHLDVKPSNILISNDGFFSKLGDFGCWTRLA 418 (524)
T ss_pred CchhhhcCcchhhhh-HHHHhcCcchhhhhHHHHHhccccccchh---hhcccccccceeeccchhhhhccccccccccc
Confidence 999999999987776 33446788889999999999999999885 9999999999999886 778999999986422
Q ss_pred ccCcceeeccccCccCC--chHhhhcCCCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhcCccccccccC
Q 004400 568 EENTHISTRVAGTIGYM--APEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTN 645 (756)
Q Consensus 568 ~~~~~~~~~~~gt~~y~--aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 645 (756)
.. .....++-+++ +++......+..+.|+||||.-+.|.++|..--..... |.. +..-.-+.
T Consensus 419 ~~----~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~-----~~~-------i~~~~~p~ 482 (524)
T KOG0601|consen 419 FS----SGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQ-----SLT-------IRSGDTPN 482 (524)
T ss_pred ee----cccccccccccccchhhccccccccccccccccccccccccCcccCccccc-----cee-------eecccccC
Confidence 11 11122333444 45555556788999999999999999988653222111 110 00000000
Q ss_pred CCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhc
Q 004400 646 PGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLE 684 (756)
Q Consensus 646 ~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~L~ 684 (756)
.+. ....+..+.+.+...++..||.+.++....+
T Consensus 483 ----~~~-~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~ 516 (524)
T KOG0601|consen 483 ----LPG-LKLQLQVLLKVMINPDRKRRPSAVELSLHSE 516 (524)
T ss_pred ----CCc-hHHhhhhhhhhhcCCccccchhhhhhcccch
Confidence 011 1134666777888999999999988766544
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.14 E-value=2e-10 Score=115.43 Aligned_cols=142 Identities=21% Similarity=0.297 Sum_probs=110.5
Q ss_pred CcccCCCCccEEEeeccCCcEEEEEEccccCc-ccHHHHHHHHHHHHhCCCC--ceeeEeeEEEeC---CeEEEEEEecC
Q 004400 422 NNIGEGGFGPVYKGLLADGTAIAVKQLSSKSK-QGNREFINEIGMISALQHP--NLVKLYGCCIEG---NQLLLIYEYLE 495 (756)
Q Consensus 422 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~--niv~l~~~~~~~---~~~~lV~e~~~ 495 (756)
+.|+.|..+.||+++..+|+.+++|....... .....+.+|+++++.+++. .+.+++.+.... +..++||||++
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~ 83 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD 83 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence 56899999999999987778999999765322 1345788999999999764 456677776654 36689999999
Q ss_pred CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCC------------------------------------------
Q 004400 496 NNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGES------------------------------------------ 533 (756)
Q Consensus 496 ~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g------------------------------------------ 533 (756)
|.++.+.+.. ..++...+..++.+++++|.+||+..
T Consensus 84 G~~l~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (223)
T cd05154 84 GRVLRDRLLR--PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERLL 161 (223)
T ss_pred CEecCCCCCC--CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHHH
Confidence 9888665421 24677788888999999999998531
Q ss_pred -----------CCCeEcCCCCCCceEecC--CCCEEEccCCcccc
Q 004400 534 -----------RIKVVHRDIKATNVLLDK--DLNSKISDFGLAKL 565 (756)
Q Consensus 534 -----------~~~iiH~Dikp~Nill~~--~~~~kl~DFGla~~ 565 (756)
...++|+|++|.||+++. ++.+.|+||+.+..
T Consensus 162 ~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 162 RWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 234799999999999998 56689999998864
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.14 E-value=3.3e-10 Score=104.35 Aligned_cols=142 Identities=18% Similarity=0.265 Sum_probs=107.2
Q ss_pred ccCcccCCCCccEEEeeccCCcEEEEEEc-ccc-------CcccHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEE
Q 004400 420 TDNNIGEGGFGPVYKGLLADGTAIAVKQL-SSK-------SKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIY 491 (756)
Q Consensus 420 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~-~~~-------~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 491 (756)
....+-||+-+.|+++.+. |+...||.- .+. .+-..++..+|++.+.+++--.|.-..-++.+...-.++|
T Consensus 11 ~l~likQGAEArv~~~~~~-Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M 89 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFS-GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM 89 (229)
T ss_pred cceeeeccceeeEeeeccC-CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence 5578899999999999886 566666643 222 1123356788999999987656655555677777888999
Q ss_pred EecCC-CCHHHHHHhcCCCCCHHHH-HHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCC---EEEccCCcccc
Q 004400 492 EYLEN-NSLARALFEHRLKLDWPTR-RRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLN---SKISDFGLAKL 565 (756)
Q Consensus 492 e~~~~-gsL~~~l~~~~~~l~~~~~-~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~---~kl~DFGla~~ 565 (756)
||++| .++.+++......-..... ..++..|-+.+.-||..+ |||+||..+||++..++. +.++|||++..
T Consensus 90 E~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~nd---iiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 90 EFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDND---IIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred EeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCC---eecccccccceEEecCCCcCceEEEeecchhc
Confidence 99987 4778888754433333333 788999999999999986 999999999999976554 58999999864
|
|
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.14 E-value=6.8e-11 Score=136.15 Aligned_cols=106 Identities=25% Similarity=0.490 Sum_probs=97.9
Q ss_pred eeeccCccccccCCccCcCcCCCcEEEeecCcccccCCcccCCCCCCcEEeccCCeecccCCccccCCCCCCEEEeeCCc
Q 004400 68 NISLIANRLKGPIPKYLANISTLVNLTVQYNQFSGELPEELGSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRISDNQ 147 (756)
Q Consensus 68 ~l~l~~n~~~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~ 147 (756)
.|+|.+|++.+.+|..|.++++|+.|+|++|.|+|.+|..++.+++|+.|+|++|+|+|.+|..++++++|+.|+|++|+
T Consensus 422 ~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls~N~ 501 (623)
T PLN03150 422 GLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNS 501 (623)
T ss_pred EEECCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECcCCc
Confidence 47899999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred ccccCChhhcCc-CCCcEEEccCCcCc
Q 004400 148 FTGQIPSFIQNW-TKLEKLFIQPSGLA 173 (756)
Q Consensus 148 l~~~~p~~~~~l-~~L~~L~l~~N~l~ 173 (756)
++|.+|..+..+ .++..+++.+|...
T Consensus 502 l~g~iP~~l~~~~~~~~~l~~~~N~~l 528 (623)
T PLN03150 502 LSGRVPAALGGRLLHRASFNFTDNAGL 528 (623)
T ss_pred ccccCChHHhhccccCceEEecCCccc
Confidence 999999998764 46677888877654
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.10 E-value=1.6e-09 Score=114.55 Aligned_cols=168 Identities=20% Similarity=0.308 Sum_probs=130.7
Q ss_pred CCccEEEee-ccCCcEEEEEEccccCcccHHHHHHHHHHHHhCCCCceeeEeeEEEe----CCeEEEEEEecCC-CCHHH
Q 004400 428 GFGPVYKGL-LADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCCIE----GNQLLLIYEYLEN-NSLAR 501 (756)
Q Consensus 428 ~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~lV~e~~~~-gsL~~ 501 (756)
--.+.|++. ..||..|+.|+++.........-..-+++++++.|+|||++.++|.. +..+++||+|.++ ++|.+
T Consensus 288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d 367 (655)
T KOG3741|consen 288 FSITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYD 367 (655)
T ss_pred ccceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHH
Confidence 346789998 66899999999965433322223446789999999999999999873 4568999999986 57776
Q ss_pred HHHh--------------cCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCc
Q 004400 502 ALFE--------------HRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDE 567 (756)
Q Consensus 502 ~l~~--------------~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~ 567 (756)
.-.. ...+.++...+.++.|++.||.++|+.| ...+-+.+.+|+++.+.+++|+..|......
T Consensus 368 ~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssG---LAck~L~~~kIlv~G~~RIriS~C~i~Dvl~ 444 (655)
T KOG3741|consen 368 LYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSG---LACKTLDLKKILVTGKMRIRISGCGIMDVLQ 444 (655)
T ss_pred HHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcC---ceeecccHhHeEeeCcceEEEecccceeeec
Confidence 5542 1235778999999999999999999998 8889999999999999999999999887665
Q ss_pred ccCcceeeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHhCCCC
Q 004400 568 EENTHISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSN 616 (756)
Q Consensus 568 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p 616 (756)
++.... -| --.+-|.-.||.+++.|.||...
T Consensus 445 ~d~~~~------------le------~~Qq~D~~~lG~ll~aLAt~~~n 475 (655)
T KOG3741|consen 445 EDPTEP------------LE------SQQQNDLRDLGLLLLALATGTEN 475 (655)
T ss_pred CCCCcc------------hh------HHhhhhHHHHHHHHHHHhhcccc
Confidence 543110 01 12356888999999999999643
|
|
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.09 E-value=1.8e-11 Score=119.78 Aligned_cols=128 Identities=21% Similarity=0.288 Sum_probs=65.2
Q ss_pred CCcEEEeecCcccccCCcccCCCCCCcEEeccCCeecccCCccccCCCCCCEEEeeCCcccccCChhhcCcCCCcEEEcc
Q 004400 89 TLVNLTVQYNQFSGELPEELGSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRISDNQFTGQIPSFIQNWTKLEKLFIQ 168 (756)
Q Consensus 89 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~ 168 (756)
.|++||||+|.|+ .+..+..-++.++.|++|+|+|. .+.. ++.|++|+.||||+|.++ .+-.+-.++.+.+.|.|+
T Consensus 285 ~LtelDLS~N~I~-~iDESvKL~Pkir~L~lS~N~i~-~v~n-La~L~~L~~LDLS~N~Ls-~~~Gwh~KLGNIKtL~La 360 (490)
T KOG1259|consen 285 ELTELDLSGNLIT-QIDESVKLAPKLRRLILSQNRIR-TVQN-LAELPQLQLLDLSGNLLA-ECVGWHLKLGNIKTLKLA 360 (490)
T ss_pred hhhhccccccchh-hhhhhhhhccceeEEecccccee-eehh-hhhcccceEeecccchhH-hhhhhHhhhcCEeeeehh
Confidence 4555555555555 44444444555555555555554 2222 445555555555555555 333333344444444444
Q ss_pred CCcCcCCCCccccCCCCCCeEEccCCCCCCCCccccccccccEEEcccccccCCCCccccCCCCCcEEEccCCcCCCC-C
Q 004400 169 PSGLAGPIPSGIFSLENLTDLRISDLNGPEATFPQLGNMKMTKLILRNCNITGELPRYLGKMTKLKVLDLSFNRLRGQ-I 247 (756)
Q Consensus 169 ~N~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~-~ 247 (756)
+|.+. .. ..++++-+|..||+++|+|... .
T Consensus 361 ~N~iE-----------------------------------------------~L--SGL~KLYSLvnLDl~~N~Ie~lde 391 (490)
T KOG1259|consen 361 QNKIE-----------------------------------------------TL--SGLRKLYSLVNLDLSSNQIEELDE 391 (490)
T ss_pred hhhHh-----------------------------------------------hh--hhhHhhhhheeccccccchhhHHH
Confidence 44443 11 1245555666666666666532 1
Q ss_pred CccCcCCCCCCeEEecCccccc
Q 004400 248 PSNFDDLYDVDYIYFAGNLLTG 269 (756)
Q Consensus 248 p~~~~~l~~L~~L~ls~N~l~~ 269 (756)
...++++|-|+.+.|.+|++.+
T Consensus 392 V~~IG~LPCLE~l~L~~NPl~~ 413 (490)
T KOG1259|consen 392 VNHIGNLPCLETLRLTGNPLAG 413 (490)
T ss_pred hcccccccHHHHHhhcCCCccc
Confidence 2346666667777777777763
|
|
| >KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=99.07 E-value=2.4e-11 Score=125.16 Aligned_cols=116 Identities=20% Similarity=0.296 Sum_probs=57.3
Q ss_pred cCcCcCCCcEEEeecCcccccCC--cccCCCCCCcEEeccCCeecccCCcc-ccCCCCCCEEEeeCCccccc-CChhhcC
Q 004400 83 YLANISTLVNLTVQYNQFSGELP--EELGSLLNLEKLHLSSNNFTGELPKT-FAKLTNMKDFRISDNQFTGQ-IPSFIQN 158 (756)
Q Consensus 83 ~l~~l~~L~~L~L~~N~l~~~~p--~~~~~l~~L~~L~L~~N~l~~~~p~~-~~~l~~L~~L~L~~N~l~~~-~p~~~~~ 158 (756)
....+++++.|||+.|-|....+ .-...|++|+.|+|+.|++....... -..++.|+.|.|+.|.|+-. +-.....
T Consensus 141 ~~k~~~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~LNls~Nrl~~~~~s~~~~~l~~lK~L~l~~CGls~k~V~~~~~~ 220 (505)
T KOG3207|consen 141 YSKILPNVRDLDLSRNLFHNWFPVLKIAEQLPSLENLNLSSNRLSNFISSNTTLLLSHLKQLVLNSCGLSWKDVQWILLT 220 (505)
T ss_pred hhhhCCcceeecchhhhHHhHHHHHHHHHhcccchhcccccccccCCccccchhhhhhhheEEeccCCCCHHHHHHHHHh
Confidence 45556666666666665553221 22345666666666666665222111 11345666666666666521 1222334
Q ss_pred cCCCcEEEccCCcCcCCCCccccCCCCCCeEEccCCCCCC
Q 004400 159 WTKLEKLFIQPSGLAGPIPSGIFSLENLTDLRISDLNGPE 198 (756)
Q Consensus 159 l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~n~~~~ 198 (756)
+++|+.|+|..|...+.-.....-++.|+.|||++|++..
T Consensus 221 fPsl~~L~L~~N~~~~~~~~~~~i~~~L~~LdLs~N~li~ 260 (505)
T KOG3207|consen 221 FPSLEVLYLEANEIILIKATSTKILQTLQELDLSNNNLID 260 (505)
T ss_pred CCcHHHhhhhcccccceecchhhhhhHHhhccccCCcccc
Confidence 5666666666664222222222234455555555554444
|
|
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.06 E-value=2.4e-11 Score=118.93 Aligned_cols=212 Identities=15% Similarity=0.139 Sum_probs=124.3
Q ss_pred ccccccCCccCcCcCCCcEEEeecCcccccCCcccCCCCCCcEEeccCCeecccCCccccCCCCCCEEEeeCCc-ccccC
Q 004400 74 NRLKGPIPKYLANISTLVNLTVQYNQFSGELPEELGSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRISDNQ-FTGQI 152 (756)
Q Consensus 74 n~~~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~-l~~~~ 152 (756)
|-+...+|..+.-+++|..+.++++.-. .+.+-...-+.|+++...+.-++ ..|. +-....+..+.-+.-. .+|..
T Consensus 200 ni~~~~l~f~l~~f~~l~~~~~s~~~~~-~i~~~~~~kptl~t~~v~~s~~~-~~~~-l~pe~~~~D~~~~E~~t~~G~~ 276 (490)
T KOG1259|consen 200 NIIPNRLSFNLNAFRNLKTLKFSALSTE-NIVDIELLKPTLQTICVHNTTIQ-DVPS-LLPETILADPSGSEPSTSNGSA 276 (490)
T ss_pred cccccccccchHHhhhhheeeeeccchh-heeceeecCchhheeeeeccccc-cccc-ccchhhhcCccCCCCCccCCce
Confidence 3334445555666677777777777544 33343344566777777665544 2221 1111111111111110 11222
Q ss_pred ChhhcCcCCCcEEEccCCcCcCCCCccccCCCCCCeEEccCCCCCCCCccccccccccEEEcccccccCCCCccccCCCC
Q 004400 153 PSFIQNWTKLEKLFIQPSGLAGPIPSGIFSLENLTDLRISDLNGPEATFPQLGNMKMTKLILRNCNITGELPRYLGKMTK 232 (756)
Q Consensus 153 p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~L~~L~L~~n~l~~~~p~~~~~l~~ 232 (756)
-..+--...|++|+|++|.++ .+..+.--++.++.|++|+|.+..... .-...+|+.|+|++|.++ .+..+-.++-+
T Consensus 277 ~~~~dTWq~LtelDLS~N~I~-~iDESvKL~Pkir~L~lS~N~i~~v~n-La~L~~L~~LDLS~N~Ls-~~~Gwh~KLGN 353 (490)
T KOG1259|consen 277 LVSADTWQELTELDLSGNLIT-QIDESVKLAPKLRRLILSQNRIRTVQN-LAELPQLQLLDLSGNLLA-ECVGWHLKLGN 353 (490)
T ss_pred EEecchHhhhhhccccccchh-hhhhhhhhccceeEEeccccceeeehh-hhhcccceEeecccchhH-hhhhhHhhhcC
Confidence 222223345666666666665 444455556666666666666665544 112225777888888888 55566678899
Q ss_pred CcEEEccCCcCCCCCCccCcCCCCCCeEEecCcccccc--CCc-hhhcCCCeeEeecCCCCCCC
Q 004400 233 LKVLDLSFNRLRGQIPSNFDDLYDVDYIYFAGNLLTGA--IPP-WMLERGDKIDLSYNNFTDGS 293 (756)
Q Consensus 233 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~--~p~-~~~~~l~~l~ls~N~l~~~~ 293 (756)
++.|.|+.|.|.. + +.+.++-+|.+||+++|++... +-. .-++.++.+.+.+|++.+..
T Consensus 354 IKtL~La~N~iE~-L-SGL~KLYSLvnLDl~~N~Ie~ldeV~~IG~LPCLE~l~L~~NPl~~~v 415 (490)
T KOG1259|consen 354 IKTLKLAQNKIET-L-SGLRKLYSLVNLDLSSNQIEELDEVNHIGNLPCLETLRLTGNPLAGSV 415 (490)
T ss_pred EeeeehhhhhHhh-h-hhhHhhhhheeccccccchhhHHHhcccccccHHHHHhhcCCCccccc
Confidence 9999999999872 2 2477888999999999998611 000 11566788889999998754
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.05 E-value=1.1e-10 Score=132.41 Aligned_cols=249 Identities=18% Similarity=0.206 Sum_probs=174.2
Q ss_pred hhcCccccCcccCCCCccEEEee-ccCCcEEEEEEcccc---CcccHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEE
Q 004400 414 ATNNFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSK---SKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLL 489 (756)
Q Consensus 414 ~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 489 (756)
..+.|.+.+-+-+|+++.++.+. -..|...++|..... .....+...++-.++-..+||.++.....+......++
T Consensus 802 S~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L 881 (1205)
T KOG0606|consen 802 SPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPL 881 (1205)
T ss_pred CCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcch
Confidence 44667777888899999999887 334444444444322 12222333444444444566777776666666778899
Q ss_pred EEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCccc
Q 004400 490 IYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEE 569 (756)
Q Consensus 490 V~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~~ 569 (756)
|++|..+++|...++... ..+..-.......+..+++|||.. .+.|||++|.|++...++..+++|||......-.
T Consensus 882 ~~~~~~~~~~~Skl~~~~-~~saepaRs~i~~~vqs~e~L~s~---~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~ 957 (1205)
T KOG0606|consen 882 VGHYLNGGDLPSKLHNSG-CLSAEPARSPILERVQSLESLHSS---LRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLI 957 (1205)
T ss_pred hhHHhccCCchhhhhcCC-CcccccccchhHHHHhhhhccccc---hhhcccccccchhhcccCCcccCccccccccccc
Confidence 999999999999998655 455555566677788999999987 3899999999999999999999999843311100
Q ss_pred ------------------------Cc------ceeeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHhCCCCCCc
Q 004400 570 ------------------------NT------HISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTK 619 (756)
Q Consensus 570 ------------------------~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~ 619 (756)
.. .......||+.|.+||...+......+|.|+.|+.++|.++|..||..
T Consensus 958 ~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~na 1037 (1205)
T KOG0606|consen 958 PPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFNA 1037 (1205)
T ss_pred cCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCCC
Confidence 00 012235799999999999999999999999999999999999999977
Q ss_pred cchhhHHHHHHHHHhcCccccccccCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHH
Q 004400 620 EDMFYLLDWALVLKEQGKLMELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMS 677 (756)
Q Consensus 620 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~ 677 (756)
......++ ..-...+. +...+.+......+++...+..+|.+|-.+.
T Consensus 1038 ~tpq~~f~-------ni~~~~~~----~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1038 ETPQQIFE-------NILNRDIP----WPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred cchhhhhh-------ccccCCCC----CCCCccccChhhhhhhhhhhccCchhccCcc
Confidence 66544332 11111111 1112223334467777788899999998877
|
|
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=99.03 E-value=1.2e-10 Score=110.02 Aligned_cols=104 Identities=22% Similarity=0.298 Sum_probs=43.4
Q ss_pred CcCCCcEEEeecCcccccCCcccCCCCCCcEEeccCCeecccCCccc-cCCCCCCEEEeeCCcccccC-ChhhcCcCCCc
Q 004400 86 NISTLVNLTVQYNQFSGELPEELGSLLNLEKLHLSSNNFTGELPKTF-AKLTNMKDFRISDNQFTGQI-PSFIQNWTKLE 163 (756)
Q Consensus 86 ~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~-~~l~~L~~L~L~~N~l~~~~-p~~~~~l~~L~ 163 (756)
.+.+|+.|+|++|.|+ .+. .+..+++|+.|+|++|+|+ .+...+ ..+++|++|+|++|+|...- -..+..+++|+
T Consensus 40 ~l~~L~~L~Ls~N~I~-~l~-~l~~L~~L~~L~L~~N~I~-~i~~~l~~~lp~L~~L~L~~N~I~~l~~l~~L~~l~~L~ 116 (175)
T PF14580_consen 40 TLDKLEVLDLSNNQIT-KLE-GLPGLPRLKTLDLSNNRIS-SISEGLDKNLPNLQELYLSNNKISDLNELEPLSSLPKLR 116 (175)
T ss_dssp T-TT--EEE-TTS--S---T-T----TT--EEE--SS----S-CHHHHHH-TT--EEE-TTS---SCCCCGGGGG-TT--
T ss_pred hhcCCCEEECCCCCCc-ccc-CccChhhhhhcccCCCCCC-ccccchHHhCCcCCEEECcCCcCCChHHhHHHHcCCCcc
Confidence 4567777778887777 343 4667777888888888877 444444 35777888888888776321 14556677788
Q ss_pred EEEccCCcCcCCC---CccccCCCCCCeEEcc
Q 004400 164 KLFIQPSGLAGPI---PSGIFSLENLTDLRIS 192 (756)
Q Consensus 164 ~L~l~~N~l~~~~---p~~~~~l~~L~~L~l~ 192 (756)
.|+|.+|.++... ...+..+|+|+.||-.
T Consensus 117 ~L~L~~NPv~~~~~YR~~vi~~lP~Lk~LD~~ 148 (175)
T PF14580_consen 117 VLSLEGNPVCEKKNYRLFVIYKLPSLKVLDGQ 148 (175)
T ss_dssp EEE-TT-GGGGSTTHHHHHHHH-TT-SEETTE
T ss_pred eeeccCCcccchhhHHHHHHHHcChhheeCCE
Confidence 8888888776331 1235567777777644
|
|
| >KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=99.02 E-value=4.5e-11 Score=123.18 Aligned_cols=205 Identities=19% Similarity=0.235 Sum_probs=144.4
Q ss_pred cCcCCCcEEEeecCcccccCC--cccCCCCCCcEEeccCCeecccCC--ccccCCCCCCEEEeeCCcccccCChhh-cCc
Q 004400 85 ANISTLVNLTVQYNQFSGELP--EELGSLLNLEKLHLSSNNFTGELP--KTFAKLTNMKDFRISDNQFTGQIPSFI-QNW 159 (756)
Q Consensus 85 ~~l~~L~~L~L~~N~l~~~~p--~~~~~l~~L~~L~L~~N~l~~~~p--~~~~~l~~L~~L~L~~N~l~~~~p~~~-~~l 159 (756)
+++.+|++..|.+..+. ..+ .....|++++.|||++|-|....+ .....|++|+.|+|+.|++........ ..+
T Consensus 118 sn~kkL~~IsLdn~~V~-~~~~~~~~k~~~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~LNls~Nrl~~~~~s~~~~~l 196 (505)
T KOG3207|consen 118 SNLKKLREISLDNYRVE-DAGIEEYSKILPNVRDLDLSRNLFHNWFPVLKIAEQLPSLENLNLSSNRLSNFISSNTTLLL 196 (505)
T ss_pred hhHHhhhheeecCcccc-ccchhhhhhhCCcceeecchhhhHHhHHHHHHHHHhcccchhcccccccccCCccccchhhh
Confidence 35678999999999887 444 356789999999999999884332 334568999999999999884433322 356
Q ss_pred CCCcEEEccCCcCcCC-CCccccCCCCCCeEEccCCCCCCCCccccccc-cccEEEcccccccCCC-CccccCCCCCcEE
Q 004400 160 TKLEKLFIQPSGLAGP-IPSGIFSLENLTDLRISDLNGPEATFPQLGNM-KMTKLILRNCNITGEL-PRYLGKMTKLKVL 236 (756)
Q Consensus 160 ~~L~~L~l~~N~l~~~-~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~-~L~~L~L~~n~l~~~~-p~~~~~l~~L~~L 236 (756)
++|+.|.|+.|.|+.. +......+++|+.|+++.|............+ .|+.|+|++|++-... -...+.++.|+.|
T Consensus 197 ~~lK~L~l~~CGls~k~V~~~~~~fPsl~~L~L~~N~~~~~~~~~~~i~~~L~~LdLs~N~li~~~~~~~~~~l~~L~~L 276 (505)
T KOG3207|consen 197 SHLKQLVLNSCGLSWKDVQWILLTFPSLEVLYLEANEIILIKATSTKILQTLQELDLSNNNLIDFDQGYKVGTLPGLNQL 276 (505)
T ss_pred hhhheEEeccCCCCHHHHHHHHHhCCcHHHhhhhcccccceecchhhhhhHHhhccccCCcccccccccccccccchhhh
Confidence 8899999999999732 33445568999999999986333333333333 4899999999987332 1346788999999
Q ss_pred EccCCcCCCC-CCcc-----CcCCCCCCeEEecCccccccCCc----hhhcCCCeeEeecCCCCC
Q 004400 237 DLSFNRLRGQ-IPSN-----FDDLYDVDYIYFAGNLLTGAIPP----WMLERGDKIDLSYNNFTD 291 (756)
Q Consensus 237 ~Ls~N~l~~~-~p~~-----~~~l~~L~~L~ls~N~l~~~~p~----~~~~~l~~l~ls~N~l~~ 291 (756)
+++.|.+... +|+. ...+++|++|+++.|++. ..+. ..+++++.+.+..|.++-
T Consensus 277 nls~tgi~si~~~d~~s~~kt~~f~kL~~L~i~~N~I~-~w~sl~~l~~l~nlk~l~~~~n~ln~ 340 (505)
T KOG3207|consen 277 NLSSTGIASIAEPDVESLDKTHTFPKLEYLNISENNIR-DWRSLNHLRTLENLKHLRITLNYLNK 340 (505)
T ss_pred hccccCcchhcCCCccchhhhcccccceeeecccCccc-cccccchhhccchhhhhhcccccccc
Confidence 9999988743 3333 456788999999999885 2221 115566666666666653
|
|
| >KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.00 E-value=5e-11 Score=131.36 Aligned_cols=218 Identities=23% Similarity=0.306 Sum_probs=127.9
Q ss_pred CCCCCCEEEccCCcccCccCcccccCCcce-eeccCccccccCCccCcCcCCCcEEEeecCcccccCCcccCCCCCCcEE
Q 004400 39 ELTFLQDIDLTLNYLSGTIPSQWASLPLLN-ISLIANRLKGPIPKYLANISTLVNLTVQYNQFSGELPEELGSLLNLEKL 117 (756)
Q Consensus 39 ~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~-l~l~~n~~~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L 117 (756)
.+..+..+.+..|.|.. +-..+..++.|+ +++..|++.. +...+..+++|+.|+|++|.|+.+.+ +..++.|+.|
T Consensus 70 ~l~~l~~l~l~~n~i~~-~~~~l~~~~~l~~l~l~~n~i~~-i~~~l~~~~~L~~L~ls~N~I~~i~~--l~~l~~L~~L 145 (414)
T KOG0531|consen 70 SLTSLKELNLRQNLIAK-ILNHLSKLKSLEALDLYDNKIEK-IENLLSSLVNLQVLDLSFNKITKLEG--LSTLTLLKEL 145 (414)
T ss_pred HhHhHHhhccchhhhhh-hhcccccccceeeeeccccchhh-cccchhhhhcchheeccccccccccc--hhhccchhhh
Confidence 34445555555555552 222334444442 4444444442 22226667788888888888874333 6667778888
Q ss_pred eccCCeecccCCccccCCCCCCEEEeeCCcccccCChh-hcCcCCCcEEEccCCcCcCCCCccccCCCCCCeEEccCCCC
Q 004400 118 HLSSNNFTGELPKTFAKLTNMKDFRISDNQFTGQIPSF-IQNWTKLEKLFIQPSGLAGPIPSGIFSLENLTDLRISDLNG 196 (756)
Q Consensus 118 ~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~-~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~n~~ 196 (756)
++++|.|+ .+. .+..+++|+.+++++|+++...+ . ...+.+|+.+++.+|.+. ....+..+..+..+++.+|.+
T Consensus 146 ~l~~N~i~-~~~-~~~~l~~L~~l~l~~n~i~~ie~-~~~~~~~~l~~l~l~~n~i~--~i~~~~~~~~l~~~~l~~n~i 220 (414)
T KOG0531|consen 146 NLSGNLIS-DIS-GLESLKSLKLLDLSYNRIVDIEN-DELSELISLEELDLGGNSIR--EIEGLDLLKKLVLLSLLDNKI 220 (414)
T ss_pred eeccCcch-hcc-CCccchhhhcccCCcchhhhhhh-hhhhhccchHHHhccCCchh--cccchHHHHHHHHhhcccccc
Confidence 88888877 232 35557788888888888773333 2 466777778888888776 233334444555556666666
Q ss_pred CCCCccccccc-cccEEEcccccccCCCCccccCCCCCcEEEccCCcCCCCCCccCcCCCCCCeEEecCcccc
Q 004400 197 PEATFPQLGNM-KMTKLILRNCNITGELPRYLGKMTKLKVLDLSFNRLRGQIPSNFDDLYDVDYIYFAGNLLT 268 (756)
Q Consensus 197 ~~~~~~~~~~~-~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~ 268 (756)
........... .|+.+++++|.+. ..+..+..+..+..|++++|++...- .+...+.+..+.+..|.+.
T Consensus 221 ~~~~~l~~~~~~~L~~l~l~~n~i~-~~~~~~~~~~~l~~l~~~~n~~~~~~--~~~~~~~~~~~~~~~~~~~ 290 (414)
T KOG0531|consen 221 SKLEGLNELVMLHLRELYLSGNRIS-RSPEGLENLKNLPVLDLSSNRISNLE--GLERLPKLSELWLNDNKLA 290 (414)
T ss_pred eeccCcccchhHHHHHHhcccCccc-cccccccccccccccchhhccccccc--cccccchHHHhccCcchhc
Confidence 65443222111 3666777777776 33345566777777777777766322 2444555666666666654
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.96 E-value=2.1e-08 Score=103.48 Aligned_cols=258 Identities=14% Similarity=0.168 Sum_probs=156.4
Q ss_pred ccCcccCCCCccEEEeeccCCcEEEEEEccccCcccHHHHHHHHHHHHhC-CCCceeeEeeEE-------EeCCeEEEEE
Q 004400 420 TDNNIGEGGFGPVYKGLLADGTAIAVKQLSSKSKQGNREFINEIGMISAL-QHPNLVKLYGCC-------IEGNQLLLIY 491 (756)
Q Consensus 420 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~-------~~~~~~~lV~ 491 (756)
..+.||+|+-+.+|-.- .-+..+.|+++....-.. .+.++.|.+. .||-+-.-+.+= ..+....+.|
T Consensus 15 ~gr~LgqGgea~ly~l~--e~~d~VAKIYh~Pppa~~---aqk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGflm 89 (637)
T COG4248 15 PGRPLGQGGEADLYTLG--EVRDQVAKIYHAPPPAAQ---AQKVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFLM 89 (637)
T ss_pred CCccccCCccceeeecc--hhhchhheeecCCCchHH---HHHHHHhccCCCCcchhhhhcccHHHhhCCCccceeEEec
Confidence 45789999999999532 112234566655433222 2234445444 566443312110 1223377888
Q ss_pred EecCCCCHHHHHH------hcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCcccc
Q 004400 492 EYLENNSLARALF------EHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKL 565 (756)
Q Consensus 492 e~~~~gsL~~~l~------~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~ 565 (756)
..+++..=...+. ++....+|....+++..+|.+.+.||+.| .+-+|+.++|+|+.+++.+.+.|=..-.+
T Consensus 90 P~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~G---h~vGDVn~~~~lVsd~~~V~LVdsDsfqi 166 (637)
T COG4248 90 PKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHG---HVVGDVNQNSFLVSDDSKVVLVDSDSFQI 166 (637)
T ss_pred ccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcC---CcccccCccceeeecCceEEEEcccceee
Confidence 8887753222222 23345799999999999999999999998 88999999999999999999988655443
Q ss_pred CcccCcceeeccccCccCCchHhhh-----cCCCCcccchhhHHHHHHHHHhC-CCCCCccchh----hHH--HHHH-HH
Q 004400 566 DEEENTHISTRVAGTIGYMAPEYAM-----RGHLTEKADVYSFGIVALEIVSG-RSNVTKEDMF----YLL--DWAL-VL 632 (756)
Q Consensus 566 ~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~slGv~l~elltg-~~p~~~~~~~----~~~--~~~~-~~ 632 (756)
..+.. ....-+|...|.+||... +...+...|-|.+||++++++.| +.||.+-... ... +-+. .+
T Consensus 167 ~~ng~--~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g~f 244 (637)
T COG4248 167 NANGT--LHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHGRF 244 (637)
T ss_pred ccCCc--eEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhccee
Confidence 32221 222346888999999865 23467789999999999999986 8998432110 000 0000 00
Q ss_pred HhcCccccccccCCCCCCCHH-HHHHHHHHHHHhhcC--CCCCCCCHHHHHHHhccCcc
Q 004400 633 KEQGKLMELVDTNPGSNFDKE-QVMVMINVALLCANA--SPTIRPSMSSVLRMLECGVD 688 (756)
Q Consensus 633 ~~~~~~~~~~~~~~~~~~~~~-~~~~l~~l~~~c~~~--~P~~RPt~~ev~~~L~~~~~ 688 (756)
....+...-..+.+ ..++-. ....+..+..+|+.. .+.-||+++.-+..|.+..+
T Consensus 245 ~ya~~~~~g~~p~P-~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~ 302 (637)
T COG4248 245 AYASDQRRGLKPPP-RSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQ 302 (637)
T ss_pred eechhccCCCCCCC-CCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHH
Confidence 00000000001111 111111 223466777788865 36789999988777665443
|
|
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=98.95 E-value=6.2e-10 Score=105.29 Aligned_cols=106 Identities=28% Similarity=0.398 Sum_probs=34.7
Q ss_pred CcCcCCCcEEEeecCcccccCCcccC-CCCCCcEEeccCCeecccCCccccCCCCCCEEEeeCCcccccCChhh-cCcCC
Q 004400 84 LANISTLVNLTVQYNQFSGELPEELG-SLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRISDNQFTGQIPSFI-QNWTK 161 (756)
Q Consensus 84 l~~l~~L~~L~L~~N~l~~~~p~~~~-~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~-~~l~~ 161 (756)
+.+..++++|+|.+|.|+ .+ ..++ .+.+|+.|+|++|+|+ .+. .+..+++|++|++++|+|+ .+...+ ..+++
T Consensus 15 ~~n~~~~~~L~L~~n~I~-~I-e~L~~~l~~L~~L~Ls~N~I~-~l~-~l~~L~~L~~L~L~~N~I~-~i~~~l~~~lp~ 89 (175)
T PF14580_consen 15 YNNPVKLRELNLRGNQIS-TI-ENLGATLDKLEVLDLSNNQIT-KLE-GLPGLPRLKTLDLSNNRIS-SISEGLDKNLPN 89 (175)
T ss_dssp -----------------------S--TT-TT--EEE-TTS--S---T-T----TT--EEE--SS----S-CHHHHHH-TT
T ss_pred cccccccccccccccccc-cc-cchhhhhcCCCEEECCCCCCc-ccc-CccChhhhhhcccCCCCCC-ccccchHHhCCc
Confidence 445567899999999998 45 3466 5889999999999998 444 4888999999999999999 454444 46899
Q ss_pred CcEEEccCCcCcCCC-CccccCCCCCCeEEccCC
Q 004400 162 LEKLFIQPSGLAGPI-PSGIFSLENLTDLRISDL 194 (756)
Q Consensus 162 L~~L~l~~N~l~~~~-p~~~~~l~~L~~L~l~~n 194 (756)
|++|+|++|+|...- -..+..+++|+.|++.+|
T Consensus 90 L~~L~L~~N~I~~l~~l~~L~~l~~L~~L~L~~N 123 (175)
T PF14580_consen 90 LQELYLSNNKISDLNELEPLSSLPKLRVLSLEGN 123 (175)
T ss_dssp --EEE-TTS---SCCCCGGGGG-TT--EEE-TT-
T ss_pred CCEEECcCCcCCChHHhHHHHcCCCcceeeccCC
Confidence 999999999997421 133444555555554443
|
|
| >KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.90 E-value=5e-11 Score=119.73 Aligned_cols=236 Identities=17% Similarity=0.215 Sum_probs=165.0
Q ss_pred ccceeccccccccCcccc----cCCcccCCCCCCCEEEccCCcc---cCccCcc-------cccCCcc-eeeccCccccc
Q 004400 14 KQKTVNQKRVLKEQNLTG----VLPPKLAELTFLQDIDLTLNYL---SGTIPSQ-------WASLPLL-NISLIANRLKG 78 (756)
Q Consensus 14 ~~~~~~~~l~L~~~~l~~----~~p~~l~~l~~L~~L~L~~n~l---~~~~p~~-------~~~l~~L-~l~l~~n~~~~ 78 (756)
-.+.++.+++|++|-+.. .+.+.+.+.++|+..++++-.. ...+|.. +...+.| .++|+.|-+..
T Consensus 27 ~~~~s~~~l~lsgnt~G~EAa~~i~~~L~~~~~L~~v~~sd~ftGR~~~Ei~e~L~~l~~aL~~~~~L~~ldLSDNA~G~ 106 (382)
T KOG1909|consen 27 EPMDSLTKLDLSGNTFGTEAARAIAKVLASKKELREVNLSDMFTGRLKDEIPEALKMLSKALLGCPKLQKLDLSDNAFGP 106 (382)
T ss_pred cccCceEEEeccCCchhHHHHHHHHHHHhhcccceeeehHhhhcCCcHHHHHHHHHHHHHHHhcCCceeEeeccccccCc
Confidence 345788899999998874 4556778888999999987432 2234443 2333455 58999998886
Q ss_pred cCCcc----CcCcCCCcEEEeecCcccccCC-------------cccCCCCCCcEEeccCCeeccc----CCccccCCCC
Q 004400 79 PIPKY----LANISTLVNLTVQYNQFSGELP-------------EELGSLLNLEKLHLSSNNFTGE----LPKTFAKLTN 137 (756)
Q Consensus 79 ~~p~~----l~~l~~L~~L~L~~N~l~~~~p-------------~~~~~l~~L~~L~L~~N~l~~~----~p~~~~~l~~ 137 (756)
..+.. +..++.|++|+|.+|.+.-.-- ...++-++|+.+...+|++... +...|...+.
T Consensus 107 ~g~~~l~~ll~s~~~L~eL~L~N~Glg~~ag~~l~~al~~l~~~kk~~~~~~Lrv~i~~rNrlen~ga~~~A~~~~~~~~ 186 (382)
T KOG1909|consen 107 KGIRGLEELLSSCTDLEELYLNNCGLGPEAGGRLGRALFELAVNKKAASKPKLRVFICGRNRLENGGATALAEAFQSHPT 186 (382)
T ss_pred cchHHHHHHHHhccCHHHHhhhcCCCChhHHHHHHHHHHHHHHHhccCCCcceEEEEeeccccccccHHHHHHHHHhccc
Confidence 65553 4567899999999998862111 1234557899999999999732 2334667789
Q ss_pred CCEEEeeCCcccc----cCChhhcCcCCCcEEEccCCcCcCC----CCccccCCCCCCeEEccCCCCCCCCccccccccc
Q 004400 138 MKDFRISDNQFTG----QIPSFIQNWTKLEKLFIQPSGLAGP----IPSGIFSLENLTDLRISDLNGPEATFPQLGNMKM 209 (756)
Q Consensus 138 L~~L~L~~N~l~~----~~p~~~~~l~~L~~L~l~~N~l~~~----~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~L 209 (756)
|+.+.++.|.|.. .+...|..+++|+.|+|..|-++.. +...+..+++|+.|++++|.+.......+..
T Consensus 187 leevr~~qN~I~~eG~~al~eal~~~~~LevLdl~DNtft~egs~~LakaL~s~~~L~El~l~dcll~~~Ga~a~~~--- 263 (382)
T KOG1909|consen 187 LEEVRLSQNGIRPEGVTALAEALEHCPHLEVLDLRDNTFTLEGSVALAKALSSWPHLRELNLGDCLLENEGAIAFVD--- 263 (382)
T ss_pred cceEEEecccccCchhHHHHHHHHhCCcceeeecccchhhhHHHHHHHHHhcccchheeecccccccccccHHHHHH---
Confidence 9999999999872 2345778999999999999999743 4566777888999888887776654433211
Q ss_pred cEEEcccccccCCCCccc-cCCCCCcEEEccCCcCCC----CCCccCcCCCCCCeEEecCcccc
Q 004400 210 TKLILRNCNITGELPRYL-GKMTKLKVLDLSFNRLRG----QIPSNFDDLYDVDYIYFAGNLLT 268 (756)
Q Consensus 210 ~~L~L~~n~l~~~~p~~~-~~l~~L~~L~Ls~N~l~~----~~p~~~~~l~~L~~L~ls~N~l~ 268 (756)
.| ...++|+.|.+.+|.++. .+..++...+.|..|+|++|.+.
T Consensus 264 ----------------al~~~~p~L~vl~l~gNeIt~da~~~la~~~~ek~dL~kLnLngN~l~ 311 (382)
T KOG1909|consen 264 ----------------ALKESAPSLEVLELAGNEITRDAALALAACMAEKPDLEKLNLNGNRLG 311 (382)
T ss_pred ----------------HHhccCCCCceeccCcchhHHHHHHHHHHHHhcchhhHHhcCCccccc
Confidence 11 225667777777777662 23334455677777777777773
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.89 E-value=2e-08 Score=102.63 Aligned_cols=139 Identities=18% Similarity=0.077 Sum_probs=100.4
Q ss_pred cccCCCCccEEEeeccCCcEEEEEEccccCc-----------ccHHHHHHHHHHHHhCCCCce--eeEeeEEEe-----C
Q 004400 423 NIGEGGFGPVYKGLLADGTAIAVKQLSSKSK-----------QGNREFINEIGMISALQHPNL--VKLYGCCIE-----G 484 (756)
Q Consensus 423 ~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~-----------~~~~~~~~E~~~l~~l~h~ni--v~l~~~~~~-----~ 484 (756)
.+-+.....|++..+ +|+.|.||....... .....+.+|...+.++...+| .+++++... .
T Consensus 29 ~v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~ 107 (268)
T PRK15123 29 VFRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPAT 107 (268)
T ss_pred EEecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCcc
Confidence 334444445777665 577899997754321 111247889998888854333 344555543 2
Q ss_pred CeEEEEEEecCCC-CHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecC-------CCCE
Q 004400 485 NQLLLIYEYLENN-SLARALFEH-RLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDK-------DLNS 555 (756)
Q Consensus 485 ~~~~lV~e~~~~g-sL~~~l~~~-~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~-------~~~~ 555 (756)
...++|+|++++. +|.+++... ....+...+..++.+++..+.-||..| |+|+|++++|||++. ++.+
T Consensus 108 ~~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~G---i~HgDL~~~NiLl~~~~~~~~~~~~~ 184 (268)
T PRK15123 108 RTSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAG---INHRDCYICHFLLHLPFPGREEDLKL 184 (268)
T ss_pred ceeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCc---CccCCCChhhEEEeccccCCCCCceE
Confidence 3578999999986 899887532 234566778899999999999999997 999999999999985 4679
Q ss_pred EEccCCcccc
Q 004400 556 KISDFGLAKL 565 (756)
Q Consensus 556 kl~DFGla~~ 565 (756)
.++||+.++.
T Consensus 185 ~LIDl~r~~~ 194 (268)
T PRK15123 185 SVIDLHRAQI 194 (268)
T ss_pred EEEECCcccc
Confidence 9999998863
|
|
| >KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.88 E-value=1.4e-10 Score=127.73 Aligned_cols=238 Identities=23% Similarity=0.240 Sum_probs=153.5
Q ss_pred CCCCEEEccCCcccCccCcccccCCcc-eeeccCccccccCCccCcCcCCCcEEEeecCcccccCCcccCCCCCCcEEec
Q 004400 41 TFLQDIDLTLNYLSGTIPSQWASLPLL-NISLIANRLKGPIPKYLANISTLVNLTVQYNQFSGELPEELGSLLNLEKLHL 119 (756)
Q Consensus 41 ~~L~~L~L~~n~l~~~~p~~~~~l~~L-~l~l~~n~~~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L 119 (756)
+.++.++..++.+...--. ...+..+ .+.+..|.+.. +-..+..+++|..|+|.+|+|. .+...+..+++|++|+|
T Consensus 49 ~~~~~~~~~~~~~~~~~~~-~~~l~~l~~l~l~~n~i~~-~~~~l~~~~~l~~l~l~~n~i~-~i~~~l~~~~~L~~L~l 125 (414)
T KOG0531|consen 49 SDLEEIDLIFNLDGSDEDL-VESLTSLKELNLRQNLIAK-ILNHLSKLKSLEALDLYDNKIE-KIENLLSSLVNLQVLDL 125 (414)
T ss_pred chhhhhcchhccccchhhh-HHHhHhHHhhccchhhhhh-hhcccccccceeeeeccccchh-hcccchhhhhcchheec
Confidence 3445555555544311111 1233333 24456666553 4455778888999999999988 44444778889999999
Q ss_pred cCCeecccCCccccCCCCCCEEEeeCCcccccCChhhcCcCCCcEEEccCCcCcCCCC-ccccCCCCCCeEEccCCCCCC
Q 004400 120 SSNNFTGELPKTFAKLTNMKDFRISDNQFTGQIPSFIQNWTKLEKLFIQPSGLAGPIP-SGIFSLENLTDLRISDLNGPE 198 (756)
Q Consensus 120 ~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p-~~~~~l~~L~~L~l~~n~~~~ 198 (756)
++|+|+...+ +..++.|+.|++++|.|+ .+. .+..++.|+.+++++|++...-+ . ...+.+|+.+++.+|.+..
T Consensus 126 s~N~I~~i~~--l~~l~~L~~L~l~~N~i~-~~~-~~~~l~~L~~l~l~~n~i~~ie~~~-~~~~~~l~~l~l~~n~i~~ 200 (414)
T KOG0531|consen 126 SFNKITKLEG--LSTLTLLKELNLSGNLIS-DIS-GLESLKSLKLLDLSYNRIVDIENDE-LSELISLEELDLGGNSIRE 200 (414)
T ss_pred cccccccccc--hhhccchhhheeccCcch-hcc-CCccchhhhcccCCcchhhhhhhhh-hhhccchHHHhccCCchhc
Confidence 9999884443 667778999999999988 333 45668888889999998884333 2 4677888888888887776
Q ss_pred CCccccccccccEEEcccccccCCCCccccCCCC--CcEEEccCCcCCCCCCccCcCCCCCCeEEecCccccccCCchhh
Q 004400 199 ATFPQLGNMKMTKLILRNCNITGELPRYLGKMTK--LKVLDLSFNRLRGQIPSNFDDLYDVDYIYFAGNLLTGAIPPWML 276 (756)
Q Consensus 199 ~~~~~~~~~~L~~L~L~~n~l~~~~p~~~~~l~~--L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~ 276 (756)
....... ..+..+.+..|.++..-+ +..+.. |+.+++++|.+. .++..+..++.+..+++++|.+.........
T Consensus 201 i~~~~~~-~~l~~~~l~~n~i~~~~~--l~~~~~~~L~~l~l~~n~i~-~~~~~~~~~~~l~~l~~~~n~~~~~~~~~~~ 276 (414)
T KOG0531|consen 201 IEGLDLL-KKLVLLSLLDNKISKLEG--LNELVMLHLRELYLSGNRIS-RSPEGLENLKNLPVLDLSSNRISNLEGLERL 276 (414)
T ss_pred ccchHHH-HHHHHhhcccccceeccC--cccchhHHHHHHhcccCccc-cccccccccccccccchhhcccccccccccc
Confidence 5432211 123344777777774332 223333 788888888887 4446677778888888888887754444444
Q ss_pred cCCCeeEeecCCCC
Q 004400 277 ERGDKIDLSYNNFT 290 (756)
Q Consensus 277 ~~l~~l~ls~N~l~ 290 (756)
..+..+....|.+.
T Consensus 277 ~~~~~~~~~~~~~~ 290 (414)
T KOG0531|consen 277 PKLSELWLNDNKLA 290 (414)
T ss_pred chHHHhccCcchhc
Confidence 44445555555544
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.88 E-value=8.3e-09 Score=99.31 Aligned_cols=125 Identities=24% Similarity=0.313 Sum_probs=82.9
Q ss_pred cEEEeeccCCcEEEEEEcccc---------------C------ccc-----HHHHHHHHHHHHhCCCC--ceeeEeeEEE
Q 004400 431 PVYKGLLADGTAIAVKQLSSK---------------S------KQG-----NREFINEIGMISALQHP--NLVKLYGCCI 482 (756)
Q Consensus 431 ~Vy~~~~~~~~~vavK~~~~~---------------~------~~~-----~~~~~~E~~~l~~l~h~--niv~l~~~~~ 482 (756)
.||.|...+|..+|||+.+.. . ... .....+|.+.|.++..- ++.+++++-
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~- 79 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN- 79 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence 489999989999999987532 0 000 13456799999999766 455665442
Q ss_pred eCCeEEEEEEecC--CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH-HcCCCCCeEcCCCCCCceEecCCCCEEEcc
Q 004400 483 EGNQLLLIYEYLE--NNSLARALFEHRLKLDWPTRRRICLGIARGLAYL-HGESRIKVVHRDIKATNVLLDKDLNSKISD 559 (756)
Q Consensus 483 ~~~~~~lV~e~~~--~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~L-H~~g~~~iiH~Dikp~Nill~~~~~~kl~D 559 (756)
..++||||++ |..+..+.. . .++......++.+++..+..+ |..| |+|||+.+.||+++++ .+.|+|
T Consensus 80 ---~~~ivME~I~~~G~~~~~l~~-~--~~~~~~~~~~~~~il~~~~~~~~~~g---ivHGDLs~~NIlv~~~-~~~iID 149 (188)
T PF01163_consen 80 ---RNVIVMEYIGEDGVPLPRLKD-V--DLSPEEPKELLEEILEEIIKMLHKAG---IVHGDLSEYNILVDDG-KVYIID 149 (188)
T ss_dssp ---TTEEEEE--EETTEEGGCHHH-C--GGGGSTHHHHHHHHHHHHHHHHHCTT---EEESS-STTSEEEETT-CEEE--
T ss_pred ---CCEEEEEecCCCccchhhHHh-c--cccchhHHHHHHHHHHHHHHHHHhcC---ceecCCChhhEEeecc-eEEEEe
Confidence 3479999999 655544322 1 112345667788888866664 6776 9999999999999988 899999
Q ss_pred CCccccC
Q 004400 560 FGLAKLD 566 (756)
Q Consensus 560 FGla~~~ 566 (756)
||.+...
T Consensus 150 f~qav~~ 156 (188)
T PF01163_consen 150 FGQAVDS 156 (188)
T ss_dssp GTTEEET
T ss_pred cCcceec
Confidence 9998643
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.83 E-value=2.5e-09 Score=83.06 Aligned_cols=59 Identities=34% Similarity=0.558 Sum_probs=30.6
Q ss_pred CCcEEEeecCcccccCCcccCCCCCCcEEeccCCeecccCCccccCCCCCCEEEeeCCc
Q 004400 89 TLVNLTVQYNQFSGELPEELGSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRISDNQ 147 (756)
Q Consensus 89 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~ 147 (756)
+|+.|+|++|+|+...+..|.++++|++|+|++|+++...++.|.++++|+.|++++|+
T Consensus 2 ~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~ 60 (61)
T PF13855_consen 2 NLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNN 60 (61)
T ss_dssp TESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSS
T ss_pred cCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCc
Confidence 44555555555554444455555555555555555554444455555555555555554
|
... |
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.80 E-value=4.3e-09 Score=81.78 Aligned_cols=61 Identities=33% Similarity=0.484 Sum_probs=47.6
Q ss_pred CCCcEEeccCCeecccCCccccCCCCCCEEEeeCCcccccCChhhcCcCCCcEEEccCCcC
Q 004400 112 LNLEKLHLSSNNFTGELPKTFAKLTNMKDFRISDNQFTGQIPSFIQNWTKLEKLFIQPSGL 172 (756)
Q Consensus 112 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l 172 (756)
++|++|+|++|+|+...+..|.++++|++|++++|+++...+..|.++++|++|++++|+|
T Consensus 1 p~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l 61 (61)
T PF13855_consen 1 PNLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL 61 (61)
T ss_dssp TTESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred CcCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence 4678888888888866566777888888888888888877777788888888888887765
|
... |
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.80 E-value=3e-08 Score=97.76 Aligned_cols=135 Identities=23% Similarity=0.236 Sum_probs=100.2
Q ss_pred ccccCcccCCCCccEEEeeccCCcEEEEEEccccC-----------------c-----ccHHHHHHHHHHHHhCCCC--c
Q 004400 418 FATDNNIGEGGFGPVYKGLLADGTAIAVKQLSSKS-----------------K-----QGNREFINEIGMISALQHP--N 473 (756)
Q Consensus 418 ~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-----------------~-----~~~~~~~~E~~~l~~l~h~--n 473 (756)
..+.+.||.|--+.||.|..+.|.++|||.-+... . .......+|.++|.++.-. .
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~ 172 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK 172 (304)
T ss_pred HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence 34568999999999999999999999999753210 0 0113457799999998654 5
Q ss_pred eeeEeeEEEeCCeEEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCC
Q 004400 474 LVKLYGCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDL 553 (756)
Q Consensus 474 iv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~ 553 (756)
+.+.+++ +...+||||++|-.|... +++......++..|++-+.-+-..| |||+|+.+-||++++||
T Consensus 173 VP~P~~~----nRHaVvMe~ieG~eL~~~------r~~~en~~~il~~il~~~~~~~~~G---iVHGDlSefNIlV~~dg 239 (304)
T COG0478 173 VPKPIAW----NRHAVVMEYIEGVELYRL------RLDVENPDEILDKILEEVRKAYRRG---IVHGDLSEFNILVTEDG 239 (304)
T ss_pred CCCcccc----ccceeeeehcccceeecc------cCcccCHHHHHHHHHHHHHHHHHcC---ccccCCchheEEEecCC
Confidence 5555544 567899999999766432 2234455556666666666666665 99999999999999999
Q ss_pred CEEEccCCcccc
Q 004400 554 NSKISDFGLAKL 565 (756)
Q Consensus 554 ~~kl~DFGla~~ 565 (756)
.+.++||=.+..
T Consensus 240 ~~~vIDwPQ~v~ 251 (304)
T COG0478 240 DIVVIDWPQAVP 251 (304)
T ss_pred CEEEEeCccccc
Confidence 999999977653
|
|
| >KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.63 E-value=9.1e-09 Score=121.19 Aligned_cols=252 Identities=21% Similarity=0.264 Sum_probs=168.3
Q ss_pred ccceeccccccccCc--ccccCCcccCCCCCCCEEEccCCcccCccCcccccCCcce-eeccCccccccCCccCcCcCCC
Q 004400 14 KQKTVNQKRVLKEQN--LTGVLPPKLAELTFLQDIDLTLNYLSGTIPSQWASLPLLN-ISLIANRLKGPIPKYLANISTL 90 (756)
Q Consensus 14 ~~~~~~~~l~L~~~~--l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~-l~l~~n~~~~~~p~~l~~l~~L 90 (756)
..+..+++|.+.+|. +.....+.|..|+.|++|||++|.=-+.+|..++.|-+|+ |++....+. .+|..|++|+.|
T Consensus 542 ~~~~~L~tLll~~n~~~l~~is~~ff~~m~~LrVLDLs~~~~l~~LP~~I~~Li~LryL~L~~t~I~-~LP~~l~~Lk~L 620 (889)
T KOG4658|consen 542 SENPKLRTLLLQRNSDWLLEISGEFFRSLPLLRVLDLSGNSSLSKLPSSIGELVHLRYLDLSDTGIS-HLPSGLGNLKKL 620 (889)
T ss_pred CCCCccceEEEeecchhhhhcCHHHHhhCcceEEEECCCCCccCcCChHHhhhhhhhcccccCCCcc-ccchHHHHHHhh
Confidence 445578899999996 6655556788999999999999876679999999999997 677777777 899999999999
Q ss_pred cEEEeecCcccccCCcccCCCCCCcEEeccCCeec--ccCCccccCCCCCCEEEeeCCcccccCChhhcCcCCCc----E
Q 004400 91 VNLTVQYNQFSGELPEELGSLLNLEKLHLSSNNFT--GELPKTFAKLTNMKDFRISDNQFTGQIPSFIQNWTKLE----K 164 (756)
Q Consensus 91 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~--~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~----~ 164 (756)
.+|++..+.-...+|..+..|++|++|.|..-... ...-..+..|.+|+.|....... .+-..+..++.|. .
T Consensus 621 ~~Lnl~~~~~l~~~~~i~~~L~~Lr~L~l~~s~~~~~~~~l~el~~Le~L~~ls~~~~s~--~~~e~l~~~~~L~~~~~~ 698 (889)
T KOG4658|consen 621 IYLNLEVTGRLESIPGILLELQSLRVLRLPRSALSNDKLLLKELENLEHLENLSITISSV--LLLEDLLGMTRLRSLLQS 698 (889)
T ss_pred heeccccccccccccchhhhcccccEEEeeccccccchhhHHhhhcccchhhheeecchh--HhHhhhhhhHHHHHHhHh
Confidence 99999999766567787888999999999766422 22333345566666666644443 1112233344433 3
Q ss_pred EEccCCcCcCCCCccccCCCCCCeEEccCCCCCCCCccccccc-------cccEEEcccccccCCCCccccCCCCCcEEE
Q 004400 165 LFIQPSGLAGPIPSGIFSLENLTDLRISDLNGPEATFPQLGNM-------KMTKLILRNCNITGELPRYLGKMTKLKVLD 237 (756)
Q Consensus 165 L~l~~N~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~-------~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~ 237 (756)
+.+.++... ..+..+..+.+|+.|.+.++.+.+......... .+..+...++..- ..+.+.-..++|+.|+
T Consensus 699 l~~~~~~~~-~~~~~~~~l~~L~~L~i~~~~~~e~~~~~~~~~~~~~~f~~l~~~~~~~~~~~-r~l~~~~f~~~L~~l~ 776 (889)
T KOG4658|consen 699 LSIEGCSKR-TLISSLGSLGNLEELSILDCGISEIVIEWEESLIVLLCFPNLSKVSILNCHML-RDLTWLLFAPHLTSLS 776 (889)
T ss_pred hhhcccccc-eeecccccccCcceEEEEcCCCchhhcccccccchhhhHHHHHHHHhhccccc-cccchhhccCcccEEE
Confidence 443333333 467778888999999998888865433221111 1222222222221 2233334578889999
Q ss_pred ccCCcCCCCCCccCcCCCCCCeEEecCcccccc
Q 004400 238 LSFNRLRGQIPSNFDDLYDVDYIYFAGNLLTGA 270 (756)
Q Consensus 238 Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~ 270 (756)
+..+.....+......+..++.+-+..+.+.+.
T Consensus 777 l~~~~~~e~~i~~~k~~~~l~~~i~~f~~~~~l 809 (889)
T KOG4658|consen 777 LVSCRLLEDIIPKLKALLELKELILPFNKLEGL 809 (889)
T ss_pred EecccccccCCCHHHHhhhcccEEecccccccc
Confidence 988877766666666666676666666666543
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.62 E-value=3.2e-07 Score=90.78 Aligned_cols=123 Identities=23% Similarity=0.225 Sum_probs=92.3
Q ss_pred CCcEEEEEEccccC-------cccHHHHHHHHHHHHhCCCC--ceeeEeeEEEeC----CeEEEEEEecCCC-CHHHHHH
Q 004400 439 DGTAIAVKQLSSKS-------KQGNREFINEIGMISALQHP--NLVKLYGCCIEG----NQLLLIYEYLENN-SLARALF 504 (756)
Q Consensus 439 ~~~~vavK~~~~~~-------~~~~~~~~~E~~~l~~l~h~--niv~l~~~~~~~----~~~~lV~e~~~~g-sL~~~l~ 504 (756)
.++.+.+|...... ........+|...+..+... ...+.+++.... ...++|+|++++. +|.+++.
T Consensus 31 ~~~~y~~k~~~~~~~~~~~~~~~~~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~ 110 (206)
T PF06293_consen 31 VGRRYYRKRLWNKLRRDRLRFPLRRSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQ 110 (206)
T ss_pred cceEEEECCeechhccchhhhcccchHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHH
Confidence 35566666543221 12345678899888887543 345566666542 2458999999985 7998886
Q ss_pred hcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCC---CEEEccCCcccc
Q 004400 505 EHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDL---NSKISDFGLAKL 565 (756)
Q Consensus 505 ~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~---~~kl~DFGla~~ 565 (756)
... ..+......++.+++..++-||..| |+|+|+++.|||++.+. .+.++||+-++.
T Consensus 111 ~~~-~~~~~~~~~ll~~l~~~i~~lH~~g---i~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 111 QWE-QLDPSQRRELLRALARLIAKLHDAG---IYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred hhc-ccchhhHHHHHHHHHHHHHHHHHCc---CCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence 533 2667788899999999999999997 99999999999999887 799999998874
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.62 E-value=2.4e-08 Score=117.63 Aligned_cols=250 Identities=18% Similarity=0.202 Sum_probs=154.8
Q ss_pred CCCCCCEEEccCCcccCccCcccccCCcceeeccCcc--ccccCCccCcCcCCCcEEEeecCcccccCCcccCCCCCCcE
Q 004400 39 ELTFLQDIDLTLNYLSGTIPSQWASLPLLNISLIANR--LKGPIPKYLANISTLVNLTVQYNQFSGELPEELGSLLNLEK 116 (756)
Q Consensus 39 ~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~l~l~~n~--~~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~ 116 (756)
+....+.+.+-+|.+. .++....+-..-.|.+..|. +.......|..++.|+.|||++|.=-+.+|..+++|-+|++
T Consensus 521 ~~~~~rr~s~~~~~~~-~~~~~~~~~~L~tLll~~n~~~l~~is~~ff~~m~~LrVLDLs~~~~l~~LP~~I~~Li~Lry 599 (889)
T KOG4658|consen 521 SWNSVRRMSLMNNKIE-HIAGSSENPKLRTLLLQRNSDWLLEISGEFFRSLPLLRVLDLSGNSSLSKLPSSIGELVHLRY 599 (889)
T ss_pred chhheeEEEEeccchh-hccCCCCCCccceEEEeecchhhhhcCHHHHhhCcceEEEECCCCCccCcCChHHhhhhhhhc
Confidence 3466778888888776 55555544433356777775 44444445777888999999988666688888888999999
Q ss_pred EeccCCeecccCCccccCCCCCCEEEeeCCcccccCChhhcCcCCCcEEEccCCcCc--CCCCccccCCCCCCeEEccCC
Q 004400 117 LHLSSNNFTGELPKTFAKLTNMKDFRISDNQFTGQIPSFIQNWTKLEKLFIQPSGLA--GPIPSGIFSLENLTDLRISDL 194 (756)
Q Consensus 117 L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~--~~~p~~~~~l~~L~~L~l~~n 194 (756)
|+|++..++ .+|..+.+|..|.+|++..+.-...+|..+..+.+|++|.+..-... ...-..+.++.+|+.|.+...
T Consensus 600 L~L~~t~I~-~LP~~l~~Lk~L~~Lnl~~~~~l~~~~~i~~~L~~Lr~L~l~~s~~~~~~~~l~el~~Le~L~~ls~~~~ 678 (889)
T KOG4658|consen 600 LDLSDTGIS-HLPSGLGNLKKLIYLNLEVTGRLESIPGILLELQSLRVLRLPRSALSNDKLLLKELENLEHLENLSITIS 678 (889)
T ss_pred ccccCCCcc-ccchHHHHHHhhheeccccccccccccchhhhcccccEEEeeccccccchhhHHhhhcccchhhheeecc
Confidence 999988888 88888888888999998888766566777777888988888766522 223344455666666655432
Q ss_pred CCCCCCcccccccc----ccEEEcccccccCCCCccccCCCCCcEEEccCCcCCCCCCccCcCCC------CCCeEEecC
Q 004400 195 NGPEATFPQLGNMK----MTKLILRNCNITGELPRYLGKMTKLKVLDLSFNRLRGQIPSNFDDLY------DVDYIYFAG 264 (756)
Q Consensus 195 ~~~~~~~~~~~~~~----L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~------~L~~L~ls~ 264 (756)
.. ..........+ .+.+.+.++... ..+..+..+.+|+.|.+.++.+.......+.... ++..+...+
T Consensus 679 s~-~~~e~l~~~~~L~~~~~~l~~~~~~~~-~~~~~~~~l~~L~~L~i~~~~~~e~~~~~~~~~~~~~~f~~l~~~~~~~ 756 (889)
T KOG4658|consen 679 SV-LLLEDLLGMTRLRSLLQSLSIEGCSKR-TLISSLGSLGNLEELSILDCGISEIVIEWEESLIVLLCFPNLSKVSILN 756 (889)
T ss_pred hh-HhHhhhhhhHHHHHHhHhhhhcccccc-eeecccccccCcceEEEEcCCCchhhcccccccchhhhHHHHHHHHhhc
Confidence 22 11111111112 223333333433 4455678899999999999988643332222221 222222222
Q ss_pred cc-ccccCCchhhcCCCeeEeecCCCCCC
Q 004400 265 NL-LTGAIPPWMLERGDKIDLSYNNFTDG 292 (756)
Q Consensus 265 N~-l~~~~p~~~~~~l~~l~ls~N~l~~~ 292 (756)
.. +...-+..+.++++.+.+..-.....
T Consensus 757 ~~~~r~l~~~~f~~~L~~l~l~~~~~~e~ 785 (889)
T KOG4658|consen 757 CHMLRDLTWLLFAPHLTSLSLVSCRLLED 785 (889)
T ss_pred cccccccchhhccCcccEEEEeccccccc
Confidence 21 11111222377888888876655443
|
|
| >KOG1859 consensus Leucine-rich repeat proteins [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.61 E-value=5.6e-10 Score=121.45 Aligned_cols=180 Identities=22% Similarity=0.207 Sum_probs=133.1
Q ss_pred CccCcCcCCCcEEEeecCcccccCCcccCCC-CCCcEEeccCCeec----------ccCCccccCCCCCCEEEeeCCccc
Q 004400 81 PKYLANISTLVNLTVQYNQFSGELPEELGSL-LNLEKLHLSSNNFT----------GELPKTFAKLTNMKDFRISDNQFT 149 (756)
Q Consensus 81 p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l-~~L~~L~L~~N~l~----------~~~p~~~~~l~~L~~L~L~~N~l~ 149 (756)
|-.+..+++|+.|.|.++.|.. . ..+..+ ..|++|..+ |.+. |.+-+++. --.|...+.+.|.+.
T Consensus 102 pi~ifpF~sLr~LElrg~~L~~-~-~GL~~lr~qLe~LIC~-~Sl~Al~~v~ascggd~~ns~~-Wn~L~~a~fsyN~L~ 177 (1096)
T KOG1859|consen 102 PISIFPFRSLRVLELRGCDLST-A-KGLQELRHQLEKLICH-NSLDALRHVFASCGGDISNSPV-WNKLATASFSYNRLV 177 (1096)
T ss_pred CceeccccceeeEEecCcchhh-h-hhhHHHHHhhhhhhhh-ccHHHHHHHHHHhccccccchh-hhhHhhhhcchhhHH
Confidence 5577888899999999998873 2 222222 245665443 3322 11211111 135888899999998
Q ss_pred ccCChhhcCcCCCcEEEccCCcCcCCCCccccCCCCCCeEEccCCCCCCCCccccccccccEEEcccccccCCCCccccC
Q 004400 150 GQIPSFIQNWTKLEKLFIQPSGLAGPIPSGIFSLENLTDLRISDLNGPEATFPQLGNMKMTKLILRNCNITGELPRYLGK 229 (756)
Q Consensus 150 ~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~L~~L~L~~n~l~~~~p~~~~~ 229 (756)
.+-.++.-++.|+.|+|++|+++... .+..|+.|+.|||+.|.+...+.-.....+|..|.|++|.++... .+.+
T Consensus 178 -~mD~SLqll~ale~LnLshNk~~~v~--~Lr~l~~LkhLDlsyN~L~~vp~l~~~gc~L~~L~lrnN~l~tL~--gie~ 252 (1096)
T KOG1859|consen 178 -LMDESLQLLPALESLNLSHNKFTKVD--NLRRLPKLKHLDLSYNCLRHVPQLSMVGCKLQLLNLRNNALTTLR--GIEN 252 (1096)
T ss_pred -hHHHHHHHHHHhhhhccchhhhhhhH--HHHhcccccccccccchhccccccchhhhhheeeeecccHHHhhh--hHHh
Confidence 77888888999999999999998543 788899999999999999888776666667999999999998442 4788
Q ss_pred CCCCcEEEccCCcCCCCCC-ccCcCCCCCCeEEecCccccc
Q 004400 230 MTKLKVLDLSFNRLRGQIP-SNFDDLYDVDYIYFAGNLLTG 269 (756)
Q Consensus 230 l~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~ls~N~l~~ 269 (756)
|.+|+.|||++|-|.+.-- ..++.+..|+.|+|.||++.+
T Consensus 253 LksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~c 293 (1096)
T KOG1859|consen 253 LKSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLCC 293 (1096)
T ss_pred hhhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCcccc
Confidence 9999999999998885322 235667788888999998864
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.59 E-value=7e-07 Score=86.39 Aligned_cols=141 Identities=16% Similarity=0.179 Sum_probs=106.3
Q ss_pred cccCcccCCCCccEEEeeccCCcEEEEEEcccc------CcccHHHHHHHHHHHHhCCCCc--eeeEeeEEE-e----CC
Q 004400 419 ATDNNIGEGGFGPVYKGLLADGTAIAVKQLSSK------SKQGNREFINEIGMISALQHPN--LVKLYGCCI-E----GN 485 (756)
Q Consensus 419 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~------~~~~~~~~~~E~~~l~~l~h~n--iv~l~~~~~-~----~~ 485 (756)
-..---|+||-+.|++-.+. |+.+-+|+-... -+.+...|.+|...|.++..-+ +.+++ ++. . ..
T Consensus 21 ve~pN~~rgG~SgV~r~~~~-g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~ 98 (216)
T PRK09902 21 VEEPNYRRNGMSGVQCVERN-GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEW 98 (216)
T ss_pred ecCCCcCCCCcceEEEEEeC-CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCce
Confidence 33345578999999997765 446888887532 1446688999999999985422 44444 332 1 23
Q ss_pred eEEEEEEecCC-CCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCC--EEEccCC
Q 004400 486 QLLLIYEYLEN-NSLARALFEHR-LKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLN--SKISDFG 561 (756)
Q Consensus 486 ~~~lV~e~~~~-gsL~~~l~~~~-~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~--~kl~DFG 561 (756)
..+||+|-++| -+|.+++.+.. ...+...+..+..+++..++-||..| +.|+|+.+.||+++.++. ++++||.
T Consensus 99 rA~LVTe~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~G---v~Hgdly~khIll~~~g~~~v~lIDlE 175 (216)
T PRK09902 99 RALLVTEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVN---RQHGCCYVRHIYVKTEGKAEAGFLDLE 175 (216)
T ss_pred EEEEEEEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHhheeecCCCCeeEEEEEhh
Confidence 46899998764 58988886432 35577788899999999999999997 999999999999986667 9999998
Q ss_pred ccc
Q 004400 562 LAK 564 (756)
Q Consensus 562 la~ 564 (756)
-++
T Consensus 176 k~r 178 (216)
T PRK09902 176 KSR 178 (216)
T ss_pred ccc
Confidence 776
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.54 E-value=3.5e-08 Score=108.53 Aligned_cols=150 Identities=19% Similarity=0.337 Sum_probs=101.7
Q ss_pred HHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCcccCcce--------eeccccCccCCchHhhhc
Q 004400 520 LGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHI--------STRVAGTIGYMAPEYAMR 591 (756)
Q Consensus 520 ~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~~~~~~--------~~~~~gt~~y~aPE~~~~ 591 (756)
.+++.|+.|+|..- ++||++|.|++|.++..+..||+.|+.+.......... ..-..-...|.|||++..
T Consensus 106 ~~v~dgl~flh~sA--k~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~ 183 (700)
T KOG2137|consen 106 GNVADGLAFLHRSA--KVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG 183 (700)
T ss_pred hcccchhhhhccCc--ceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc
Confidence 35669999999764 79999999999999999999999999886443311111 011123457999999999
Q ss_pred CCCCcccchhhHHHHHHHHHhCCCCC-CccchhhHHHHHHHHHhcCccccccccCCCCCCCHHHHHHHHHHHHHhhcCCC
Q 004400 592 GHLTEKADVYSFGIVALEIVSGRSNV-TKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDKEQVMVMINVALLCANASP 670 (756)
Q Consensus 592 ~~~~~~~Dv~slGv~l~elltg~~p~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~P 670 (756)
...+.++|+||+||++|.+..|..+. ...+........ ...+......++.+.+.++.+-+.+.+..++
T Consensus 184 ~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~----------~~~~~~~~~~~s~~~p~el~~~l~k~l~~~~ 253 (700)
T KOG2137|consen 184 TTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFS----------RNLLNAGAFGYSNNLPSELRESLKKLLNGDS 253 (700)
T ss_pred ccccccccceeeeeEEEEEecCCcchhhccCCcchhhhh----------hcccccccccccccCcHHHHHHHHHHhcCCc
Confidence 88899999999999999998554443 332221111100 0111111111222333457788889999999
Q ss_pred CCCCCHHHHHH
Q 004400 671 TIRPSMSSVLR 681 (756)
Q Consensus 671 ~~RPt~~ev~~ 681 (756)
..||++.++..
T Consensus 254 ~~rp~~~~l~~ 264 (700)
T KOG2137|consen 254 AVRPTLDLLLS 264 (700)
T ss_pred ccCcchhhhhc
Confidence 99998888744
|
|
| >KOG1859 consensus Leucine-rich repeat proteins [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.49 E-value=2e-09 Score=117.21 Aligned_cols=177 Identities=24% Similarity=0.265 Sum_probs=110.7
Q ss_pred CcccCCCCCCCEEEccCCcccCccCcccccC-CcceeeccCcccc----------ccCCccCcCcCCCcEEEeecCcccc
Q 004400 34 PPKLAELTFLQDIDLTLNYLSGTIPSQWASL-PLLNISLIANRLK----------GPIPKYLANISTLVNLTVQYNQFSG 102 (756)
Q Consensus 34 p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l-~~L~l~l~~n~~~----------~~~p~~l~~l~~L~~L~L~~N~l~~ 102 (756)
|-.|..++.|+.|.|+++.|.. . ..+..+ ..|+-++.+|.+. |.+-+++.- -.|...+.++|.+.
T Consensus 102 pi~ifpF~sLr~LElrg~~L~~-~-~GL~~lr~qLe~LIC~~Sl~Al~~v~ascggd~~ns~~W-n~L~~a~fsyN~L~- 177 (1096)
T KOG1859|consen 102 PISIFPFRSLRVLELRGCDLST-A-KGLQELRHQLEKLICHNSLDALRHVFASCGGDISNSPVW-NKLATASFSYNRLV- 177 (1096)
T ss_pred CceeccccceeeEEecCcchhh-h-hhhHHHHHhhhhhhhhccHHHHHHHHHHhccccccchhh-hhHhhhhcchhhHH-
Confidence 5567788999999999999973 1 112222 1233333333322 111111111 24677788888887
Q ss_pred cCCcccCCCCCCcEEeccCCeecccCCccccCCCCCCEEEeeCCcccccCCh-hhcCcCCCcEEEccCCcCcCCCCcccc
Q 004400 103 ELPEELGSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRISDNQFTGQIPS-FIQNWTKLEKLFIQPSGLAGPIPSGIF 181 (756)
Q Consensus 103 ~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~-~~~~l~~L~~L~l~~N~l~~~~p~~~~ 181 (756)
....++.-++.|+.|+|++|+++... .+..|+.|++|||+.|+++ .+|. .-.++. |+.|.|++|-++. -..+.
T Consensus 178 ~mD~SLqll~ale~LnLshNk~~~v~--~Lr~l~~LkhLDlsyN~L~-~vp~l~~~gc~-L~~L~lrnN~l~t--L~gie 251 (1096)
T KOG1859|consen 178 LMDESLQLLPALESLNLSHNKFTKVD--NLRRLPKLKHLDLSYNCLR-HVPQLSMVGCK-LQLLNLRNNALTT--LRGIE 251 (1096)
T ss_pred hHHHHHHHHHHhhhhccchhhhhhhH--HHHhcccccccccccchhc-cccccchhhhh-heeeeecccHHHh--hhhHH
Confidence 66677777888888888888887333 5777888888888888888 4443 223344 8888888888862 34566
Q ss_pred CCCCCCeEEccCCCCCCCCc--cccccccccEEEccccccc
Q 004400 182 SLENLTDLRISDLNGPEATF--PQLGNMKMTKLILRNCNIT 220 (756)
Q Consensus 182 ~l~~L~~L~l~~n~~~~~~~--~~~~~~~L~~L~L~~n~l~ 220 (756)
+|.+|..||+++|-+.+..- +.+....|..|+|.+|.+-
T Consensus 252 ~LksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~ 292 (1096)
T KOG1859|consen 252 NLKSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLC 292 (1096)
T ss_pred hhhhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCccc
Confidence 77778888888776655321 1122234666666666664
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.49 E-value=2.1e-06 Score=86.00 Aligned_cols=138 Identities=16% Similarity=0.217 Sum_probs=86.3
Q ss_pred CcccCCCCccEEEeeccCCcEEEEEEccccCcccHHHHHHHHHHHHhCCCCc--eeeEeeEEEeCCeEEEEEEecCCCC-
Q 004400 422 NNIGEGGFGPVYKGLLADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPN--LVKLYGCCIEGNQLLLIYEYLENNS- 498 (756)
Q Consensus 422 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~~~~~~~~~~~lV~e~~~~gs- 498 (756)
..||+|..+.||+. .|..+++|...... ......+|.++++.+..-. +.+.+++..+.+...+|||+++|..
T Consensus 7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~ 81 (226)
T TIGR02172 7 TQTGEGGNGESYTH---KTGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRS 81 (226)
T ss_pred eeecCCCCcceeEe---cCCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccc
Confidence 47899999999984 25567888876432 3355788999999986443 4677888878888899999999963
Q ss_pred HHHHH---------------------HhcC-CCCCHHHHHH-HHH----------HHHH-HHHHHHcC-CCCCeEcCCCC
Q 004400 499 LARAL---------------------FEHR-LKLDWPTRRR-ICL----------GIAR-GLAYLHGE-SRIKVVHRDIK 543 (756)
Q Consensus 499 L~~~l---------------------~~~~-~~l~~~~~~~-i~~----------~ia~-~L~~LH~~-g~~~iiH~Dik 543 (756)
+...+ +.-. ...+...... +.. .+.. ..++|... ..+.++|+|+.
T Consensus 82 ~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~~ 161 (226)
T TIGR02172 82 FSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDFQ 161 (226)
T ss_pred hhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCCC
Confidence 21111 1100 0111111000 000 0001 11222211 13357899999
Q ss_pred CCceEecCCCCEEEccCCcccc
Q 004400 544 ATNVLLDKDLNSKISDFGLAKL 565 (756)
Q Consensus 544 p~Nill~~~~~~kl~DFGla~~ 565 (756)
|.||++++++ +.|+||+.+..
T Consensus 162 ~~Nii~~~~~-~~iIDwe~a~~ 182 (226)
T TIGR02172 162 IGNLITSGKG-TYWIDLGDFGY 182 (226)
T ss_pred CCcEEEcCCC-cEEEechhcCc
Confidence 9999999888 99999998763
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.48 E-value=5.6e-09 Score=91.16 Aligned_cols=109 Identities=21% Similarity=0.294 Sum_probs=59.7
Q ss_pred CcEEEeecCcccccCCcccC---CCCCCcEEeccCCeecccCCccccC-CCCCCEEEeeCCcccccCChhhcCcCCCcEE
Q 004400 90 LVNLTVQYNQFSGELPEELG---SLLNLEKLHLSSNNFTGELPKTFAK-LTNMKDFRISDNQFTGQIPSFIQNWTKLEKL 165 (756)
Q Consensus 90 L~~L~L~~N~l~~~~p~~~~---~l~~L~~L~L~~N~l~~~~p~~~~~-l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L 165 (756)
+-.|+|+.++|. .+++... ....|+..+|++|.+. ..|..|.. .+.++.|+|++|+|+ .+|..++.++.|+.|
T Consensus 29 ~h~ldLssc~lm-~i~davy~l~~~~el~~i~ls~N~fk-~fp~kft~kf~t~t~lNl~~neis-dvPeE~Aam~aLr~l 105 (177)
T KOG4579|consen 29 LHFLDLSSCQLM-YIADAVYMLSKGYELTKISLSDNGFK-KFPKKFTIKFPTATTLNLANNEIS-DVPEELAAMPALRSL 105 (177)
T ss_pred hhhcccccchhh-HHHHHHHHHhCCceEEEEecccchhh-hCCHHHhhccchhhhhhcchhhhh-hchHHHhhhHHhhhc
Confidence 344555555554 3444332 3334555566666665 44444433 345666666666666 555556666666666
Q ss_pred EccCCcCcCCCCccccCCCCCCeEEccCCCCCCCCcc
Q 004400 166 FIQPSGLAGPIPSGIFSLENLTDLRISDLNGPEATFP 202 (756)
Q Consensus 166 ~l~~N~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~~~ 202 (756)
+++.|.+. ..|..+..+.+|-.|+..+|.+.+++.+
T Consensus 106 Nl~~N~l~-~~p~vi~~L~~l~~Lds~~na~~eid~d 141 (177)
T KOG4579|consen 106 NLRFNPLN-AEPRVIAPLIKLDMLDSPENARAEIDVD 141 (177)
T ss_pred ccccCccc-cchHHHHHHHhHHHhcCCCCccccCcHH
Confidence 66666665 4555555566666666555555554444
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.45 E-value=2.4e-08 Score=108.26 Aligned_cols=190 Identities=19% Similarity=0.133 Sum_probs=141.2
Q ss_pred HhhcCccccCcccCCCCccEEEeeccCCcEEEEEEccccCcccHHHHHHHHHHHHhCCCCc-eeeEeeEEEeCCeEEEEE
Q 004400 413 AATNNFATDNNIGEGGFGPVYKGLLADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPN-LVKLYGCCIEGNQLLLIY 491 (756)
Q Consensus 413 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~~~~lV~ 491 (756)
..+.-+..-+..++|+++++||.+-...+....+.+... ....-++++|.+++||| .+..++-+..++..++++
T Consensus 239 Dk~kws~~fh~fvK~altknpKkRptaeklL~h~fvs~~-----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~ 313 (829)
T KOG0576|consen 239 DKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT-----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPM 313 (829)
T ss_pred CCccchHHHHHHHHHHhcCCCccCCChhhheeceeeccc-----hhhHHHHHHHHHccCCCCcccccccCCcccccchhh
Confidence 344445555678899999999998554555556666433 34556889999999999 777777777888999999
Q ss_pred EecCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCcccC
Q 004400 492 EYLENN-SLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEEN 570 (756)
Q Consensus 492 e~~~~g-sL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~~~ 570 (756)
+|+.+| +-..........+...+...++..-+++++|+|+.- -+||| ||+..+ +..|..||+.+.......
T Consensus 314 ~i~s~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~---~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~ 385 (829)
T KOG0576|consen 314 RICSTGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSSY---KVHRD----NILGSE-EEVKLLDFAVPPQLTRTM 385 (829)
T ss_pred hhhcCCccccccCChhhHhhhhhhhhhhhhhhccccccccccc---ccCcc----cccccc-cccccccccCCcccCccc
Confidence 999988 222222122223444555667777889999999863 48999 777766 578999999987655443
Q ss_pred cceeeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHhCCCCC
Q 004400 571 THISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNV 617 (756)
Q Consensus 571 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~ 617 (756)
......+|+.++|||+.....+..+.|+|+.|+-..++.-|-.|-
T Consensus 386 --~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr 430 (829)
T KOG0576|consen 386 --KPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPR 430 (829)
T ss_pred --ccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCC
Confidence 334567999999999999999999999999998777777776654
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 756 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 4e-67 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 1e-65 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 6e-56 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 2e-55 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 3e-41 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 5e-41 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 2e-40 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 3e-38 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 2e-26 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 3e-26 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 6e-26 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 3e-25 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 3e-25 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 4e-24 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 9e-24 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 2e-23 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-23 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 3e-23 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 3e-23 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 3e-23 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 3e-23 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 4e-23 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 4e-23 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 4e-23 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-23 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 5e-23 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 5e-23 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 5e-23 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 5e-23 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 5e-23 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 6e-23 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 6e-23 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 6e-23 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 6e-23 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 6e-23 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 6e-23 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 6e-23 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 6e-23 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 6e-23 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 8e-23 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 8e-23 | ||
| 3riz_A | 772 | Crystal Structure Of The Plant Steroid Receptor Bri | 8e-23 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 8e-23 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 9e-23 | ||
| 3rgx_A | 768 | Structural Insight Into Brassinosteroid Perception | 1e-22 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 1e-22 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 1e-22 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 2e-22 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 2e-22 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 2e-22 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-22 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 3e-22 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 4e-22 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 5e-22 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 5e-22 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 6e-22 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 7e-22 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 7e-22 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 7e-22 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 7e-22 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 8e-22 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 8e-22 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 9e-22 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 9e-22 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 9e-22 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 1e-21 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 1e-21 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 1e-21 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 1e-21 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 2e-21 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 2e-21 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 3e-21 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 3e-21 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 3e-21 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 3e-21 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 3e-21 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 3e-21 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 3e-21 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 3e-21 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 4e-21 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 4e-21 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 4e-21 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 5e-21 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 5e-21 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 5e-21 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 5e-21 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 5e-21 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 5e-21 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 6e-21 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 6e-21 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 6e-21 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 6e-21 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 8e-21 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 8e-21 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 9e-21 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 1e-20 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 1e-20 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 1e-20 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 1e-20 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 1e-20 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 2e-20 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 2e-20 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 2e-20 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-20 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-20 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 2e-20 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 2e-20 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 2e-20 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 2e-20 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 2e-20 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 2e-20 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 3e-20 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 3e-20 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 3e-20 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 3e-20 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 6e-20 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 6e-20 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 6e-20 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 6e-20 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 7e-20 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 9e-20 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 1e-19 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 1e-19 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 1e-19 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 1e-19 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 1e-19 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 1e-19 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 1e-19 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 1e-19 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 1e-19 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 1e-19 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 1e-19 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 1e-19 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 1e-19 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 1e-19 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 1e-19 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 1e-19 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 1e-19 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 1e-19 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 1e-19 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 1e-19 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-19 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 2e-19 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 2e-19 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 2e-19 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 2e-19 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 2e-19 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 3e-19 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 3e-19 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 4e-19 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 4e-19 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 5e-19 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 5e-19 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 5e-19 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 5e-19 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 5e-19 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 6e-19 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 6e-19 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 6e-19 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 6e-19 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 6e-19 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 6e-19 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 6e-19 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 6e-19 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 6e-19 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 6e-19 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 6e-19 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 6e-19 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 7e-19 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 7e-19 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 7e-19 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 7e-19 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 7e-19 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 7e-19 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 7e-19 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 7e-19 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 7e-19 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 7e-19 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 7e-19 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 7e-19 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 8e-19 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 8e-19 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 8e-19 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 8e-19 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 8e-19 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 8e-19 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 8e-19 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 8e-19 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 8e-19 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 9e-19 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 9e-19 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 9e-19 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 9e-19 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 1e-18 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-18 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 1e-18 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 1e-18 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-18 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 2e-18 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 2e-18 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 2e-18 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 2e-18 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 3e-18 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 3e-18 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 3e-18 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 3e-18 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 3e-18 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 3e-18 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 3e-18 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 3e-18 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-18 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 4e-18 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 4e-18 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 4e-18 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 4e-18 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 4e-18 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 4e-18 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 6e-18 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 6e-18 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 6e-18 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 7e-18 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 7e-18 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 7e-18 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 8e-18 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 9e-18 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-17 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-17 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 2e-17 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 2e-17 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 2e-17 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 2e-17 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 2e-17 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 2e-17 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 2e-17 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 2e-17 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 2e-17 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 2e-17 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-17 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 2e-17 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-17 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 3e-17 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 3e-17 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 3e-17 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 3e-17 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 3e-17 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 3e-17 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-17 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 3e-17 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 3e-17 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 3e-17 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 3e-17 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 4e-17 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 4e-17 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 4e-17 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-17 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 5e-17 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 5e-17 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 5e-17 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 5e-17 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 5e-17 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 5e-17 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 5e-17 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 5e-17 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 6e-17 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 6e-17 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 6e-17 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 6e-17 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 6e-17 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 6e-17 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 7e-17 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 7e-17 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 7e-17 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 7e-17 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 7e-17 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 7e-17 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 8e-17 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 8e-17 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 8e-17 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 8e-17 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 8e-17 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 8e-17 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 8e-17 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 8e-17 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 8e-17 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 8e-17 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 9e-17 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 9e-17 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 9e-17 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 9e-17 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 1e-16 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 1e-16 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 1e-16 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 1e-16 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 1e-16 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 1e-16 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 1e-16 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 1e-16 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 1e-16 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 1e-16 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 1e-16 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 1e-16 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-16 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 1e-16 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 1e-16 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 1e-16 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 1e-16 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 1e-16 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 2e-16 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-16 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 2e-16 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 2e-16 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 2e-16 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 2e-16 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 2e-16 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 2e-16 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 2e-16 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 2e-16 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-16 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 2e-16 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-16 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 2e-16 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 2e-16 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 2e-16 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-16 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 2e-16 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-16 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 2e-16 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 3e-16 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 3e-16 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 3e-16 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 3e-16 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 3e-16 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 3e-16 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 3e-16 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 3e-16 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 3e-16 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 3e-16 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 3e-16 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 3e-16 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 3e-16 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 3e-16 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 3e-16 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 3e-16 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-16 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 3e-16 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 3e-16 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 3e-16 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 3e-16 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 3e-16 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 3e-16 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 3e-16 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 3e-16 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 3e-16 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 3e-16 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 3e-16 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 3e-16 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 3e-16 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 3e-16 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 3e-16 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 4e-16 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 4e-16 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 4e-16 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 4e-16 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 4e-16 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 4e-16 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 4e-16 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 4e-16 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 4e-16 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 4e-16 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 4e-16 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-16 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 4e-16 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 4e-16 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 4e-16 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 4e-16 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 5e-16 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 5e-16 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 5e-16 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 5e-16 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 5e-16 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 6e-16 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 6e-16 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 7e-16 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 7e-16 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 7e-16 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 8e-16 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 8e-16 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 8e-16 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 8e-16 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 9e-16 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 9e-16 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-15 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-15 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-15 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 1e-15 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-15 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 1e-15 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-15 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-15 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-15 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 1e-15 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 1e-15 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 1e-15 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-15 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 1e-15 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 1e-15 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 2e-15 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 2e-15 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 2e-15 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 2e-15 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 2e-15 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 2e-15 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 2e-15 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 2e-15 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 2e-15 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-15 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 3e-15 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-15 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 3e-15 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-15 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 3e-15 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 3e-15 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 3e-15 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 4e-15 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 4e-15 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 4e-15 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 4e-15 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 4e-15 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 4e-15 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 5e-15 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 5e-15 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 5e-15 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 5e-15 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 5e-15 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 5e-15 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 5e-15 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 5e-15 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 5e-15 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 5e-15 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 5e-15 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 5e-15 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 6e-15 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 6e-15 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 6e-15 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-15 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 6e-15 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 6e-15 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 6e-15 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 6e-15 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 6e-15 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 6e-15 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 7e-15 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 7e-15 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 7e-15 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 7e-15 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 7e-15 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 7e-15 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 8e-15 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 9e-15 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 9e-15 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 9e-15 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 1e-14 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 1e-14 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 1e-14 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 1e-14 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 1e-14 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 1e-14 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 1e-14 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 1e-14 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 1e-14 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 1e-14 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 1e-14 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-14 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 1e-14 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 1e-14 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 1e-14 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 1e-14 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-14 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-14 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-14 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 2e-14 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 2e-14 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-14 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 2e-14 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 2e-14 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-14 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 2e-14 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 2e-14 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 2e-14 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 2e-14 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 2e-14 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-14 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 2e-14 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 2e-14 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 2e-14 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 2e-14 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 2e-14 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-14 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-14 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 2e-14 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 2e-14 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 2e-14 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 2e-14 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 2e-14 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-14 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 2e-14 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 3e-14 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 3e-14 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-14 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 3e-14 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 4e-14 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 4e-14 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 4e-14 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 4e-14 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 5e-14 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 5e-14 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 6e-14 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 6e-14 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 6e-14 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 6e-14 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 6e-14 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 6e-14 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 7e-14 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 9e-14 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 9e-14 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 1e-13 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-13 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 1e-13 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 1e-13 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-13 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 1e-13 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 1e-13 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-13 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 1e-13 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 1e-13 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 1e-13 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-13 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 2e-13 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 2e-13 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-13 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-13 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 2e-13 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 2e-13 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 2e-13 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 2e-13 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-13 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 3e-13 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 3e-13 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 3e-13 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 3e-13 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 3e-13 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 3e-13 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 3e-13 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 3e-13 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 3e-13 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 3e-13 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 3e-13 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 4e-13 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 4e-13 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 4e-13 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 4e-13 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 4e-13 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 5e-13 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 5e-13 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 6e-13 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 6e-13 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 7e-13 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 8e-13 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 9e-13 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 9e-13 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 9e-13 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 1e-12 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 1e-12 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 1e-12 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 1e-12 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-12 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 1e-12 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 1e-12 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 1e-12 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 2e-12 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-12 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 2e-12 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 2e-12 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 2e-12 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 2e-12 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 2e-12 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 2e-12 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 2e-12 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 2e-12 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 2e-12 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 2e-12 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 2e-12 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 2e-12 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 2e-12 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-12 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 2e-12 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 2e-12 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 2e-12 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-12 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 2e-12 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 2e-12 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 2e-12 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 2e-12 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 2e-12 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 2e-12 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 3e-12 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 3e-12 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 3e-12 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 3e-12 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 3e-12 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 3e-12 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 3e-12 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 3e-12 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 3e-12 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 4e-12 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 4e-12 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 5e-12 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 5e-12 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 5e-12 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 5e-12 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 6e-12 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 6e-12 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 6e-12 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 6e-12 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-12 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 7e-12 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 7e-12 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 7e-12 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 7e-12 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 7e-12 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 7e-12 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 8e-12 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 8e-12 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 8e-12 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 8e-12 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 8e-12 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 8e-12 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 1e-11 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 1e-11 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 1e-11 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 1e-11 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 1e-11 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-11 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 1e-11 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 1e-11 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 1e-11 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 1e-11 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 1e-11 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-11 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 1e-11 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 1e-11 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 1e-11 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 1e-11 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 2e-11 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 2e-11 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 2e-11 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 2e-11 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 2e-11 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 2e-11 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 2e-11 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 2e-11 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 2e-11 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 2e-11 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 2e-11 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 2e-11 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 2e-11 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 2e-11 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 2e-11 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 2e-11 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 2e-11 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 2e-11 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 2e-11 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 2e-11 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 2e-11 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-11 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 2e-11 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 2e-11 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 2e-11 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 2e-11 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 2e-11 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 2e-11 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 2e-11 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 2e-11 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 2e-11 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 2e-11 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 2e-11 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 2e-11 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 2e-11 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 2e-11 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 2e-11 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 3e-11 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 3e-11 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 3e-11 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 3e-11 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 3e-11 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 3e-11 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 3e-11 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 3e-11 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-11 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 3e-11 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 3e-11 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 3e-11 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 3e-11 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 3e-11 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 3e-11 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 4e-11 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 4e-11 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 4e-11 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 4e-11 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 4e-11 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 5e-11 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 5e-11 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 5e-11 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 5e-11 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 5e-11 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 5e-11 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 6e-11 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 6e-11 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 6e-11 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 6e-11 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 6e-11 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 6e-11 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 6e-11 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 6e-11 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 6e-11 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 7e-11 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 7e-11 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 7e-11 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 7e-11 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 7e-11 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 7e-11 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 7e-11 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 8e-11 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 8e-11 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 9e-11 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 1e-10 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 1e-10 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 1e-10 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 1e-10 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 1e-10 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 1e-10 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 1e-10 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 2e-10 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 2e-10 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 2e-10 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-10 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 2e-10 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 2e-10 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 2e-10 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 2e-10 | ||
| 1ogq_A | 313 | The Crystal Structure Of Pgip (Polygalacturonase In | 2e-10 | ||
| 1ogq_A | 313 | The Crystal Structure Of Pgip (Polygalacturonase In | 2e-07 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 2e-10 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 2e-10 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 2e-10 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 2e-10 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 2e-10 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 2e-10 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 2e-10 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 2e-10 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-10 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 2e-10 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 2e-10 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 2e-10 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 3e-10 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 3e-10 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 3e-10 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 3e-10 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 4e-10 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 4e-10 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 4e-10 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 4e-10 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 4e-10 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 4e-10 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 5e-10 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 5e-10 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 5e-10 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 6e-10 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 6e-10 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 6e-10 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 6e-10 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 6e-10 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 7e-10 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 7e-10 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 7e-10 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 7e-10 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 7e-10 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 8e-10 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 8e-10 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 8e-10 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 8e-10 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 8e-10 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 8e-10 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 8e-10 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 8e-10 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 8e-10 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 9e-10 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 9e-10 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 1e-09 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 1e-09 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 1e-09 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 1e-09 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 1e-09 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 1e-09 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 1e-09 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 1e-09 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 1e-09 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 1e-09 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 1e-09 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 1e-09 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 2e-09 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 2e-09 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 2e-09 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 2e-09 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 2e-09 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 2e-09 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 2e-09 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 3e-09 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 3e-09 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-09 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 3e-09 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 3e-09 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 4e-09 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 4e-09 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 4e-09 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 4e-09 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 5e-09 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 5e-09 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 5e-09 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 5e-09 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 5e-09 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 5e-09 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 5e-09 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 5e-09 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 5e-09 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 6e-09 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 6e-09 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 6e-09 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 6e-09 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 6e-09 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 6e-09 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 7e-09 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 7e-09 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 8e-09 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 8e-09 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 8e-09 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 8e-09 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 9e-09 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 9e-09 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 9e-09 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 9e-09 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 9e-09 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 9e-09 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 9e-09 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 9e-09 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 9e-09 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 1e-08 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 1e-08 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-08 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 1e-08 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-08 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 1e-08 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 1e-08 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 1e-08 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 1e-08 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 1e-08 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 1e-08 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 1e-08 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 1e-08 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 1e-08 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 1e-08 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 1e-08 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 1e-08 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 1e-08 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 1e-08 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 1e-08 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 1e-08 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 1e-08 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 1e-08 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 2e-08 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 2e-08 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 2e-08 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 2e-08 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 2e-08 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 2e-08 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 2e-08 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 2e-08 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 2e-08 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 2e-08 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 2e-08 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 2e-08 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 2e-08 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 2e-08 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 2e-08 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 2e-08 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 2e-08 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 2e-08 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 2e-08 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 2e-08 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 2e-08 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 2e-08 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 2e-08 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 2e-08 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 2e-08 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 2e-08 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 2e-08 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 2e-08 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 3e-08 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 3e-08 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 3e-08 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 3e-08 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 3e-08 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 3e-08 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 3e-08 | ||
| 3e6j_A | 229 | Crystal Structure Of Variable Lymphocyte Receptor ( | 3e-08 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 4e-08 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 4e-08 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 4e-08 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 4e-08 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 4e-08 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 5e-08 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 5e-08 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 5e-08 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 5e-08 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 5e-08 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 6e-08 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 6e-08 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 6e-08 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 6e-08 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 6e-08 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 6e-08 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 7e-08 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 7e-08 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 7e-08 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 8e-08 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 8e-08 | ||
| 2in6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd311839 Length | 8e-08 | ||
| 3bi6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd352396 Length | 8e-08 | ||
| 2z2w_A | 285 | Humand Wee1 Kinase Complexed With Inhibitor Pf03357 | 8e-08 | ||
| 1x8b_A | 289 | Structure Of Human Wee1a Kinase: Kinase Domain Comp | 9e-08 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 9e-08 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 9e-08 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 1e-07 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 1e-07 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 2e-07 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 2e-07 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-07 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 2e-07 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 2e-07 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 2e-07 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 2e-07 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 2e-07 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 4e-07 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 4e-07 | ||
| 4f99_A | 361 | Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti | 4e-07 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 4e-07 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 4e-07 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 4e-07 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 5e-07 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 5e-07 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 5e-07 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 5e-07 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 6e-07 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 7e-07 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 8e-07 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 1e-06 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 1e-06 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 1e-06 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 1e-06 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 1e-06 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 1e-06 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 1e-06 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-06 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 2e-06 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 3e-06 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 3e-06 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 3e-06 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 4e-06 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 6e-06 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 6e-06 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 1e-05 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 2e-05 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 2e-05 | ||
| 3kmu_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 2e-05 | ||
| 4b8c_D | 727 | Nuclease Module Of The Yeast Ccr4-Not Complex Lengt | 3e-05 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 4e-05 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 4e-05 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 4e-05 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 5e-05 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 5e-05 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 5e-05 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 5e-05 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 5e-05 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 5e-05 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 5e-05 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 5e-05 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 5e-05 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 5e-05 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 5e-05 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 6e-05 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 6e-05 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313 | Back alignment and structure |
|
| >pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3E6J|A Chain A, Crystal Structure Of Variable Lymphocyte Receptor (Vlr) Rbc36 In Complex With H-Trisaccharide Length = 229 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287 | Back alignment and structure |
|
| >pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287 | Back alignment and structure |
|
| >pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285 | Back alignment and structure |
|
| >pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271 | Back alignment and structure |
|
| >pdb|4B8C|D Chain D, Nuclease Module Of The Yeast Ccr4-Not Complex Length = 727 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 511 bits (1318), Expect = e-178
Identities = 131/293 (44%), Positives = 187/293 (63%), Gaps = 10/293 (3%)
Query: 408 YLQIKAATNNFATDNNIGEGGFGPVYKGLLADGTAIAVKQLSSKSKQGN-REFINEIGMI 466
+++ A++NF+ N +G GGFG VYKG LADGT +AVK+L + QG +F E+ MI
Sbjct: 22 LRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMI 81
Query: 467 SALQHPNLVKLYGCCIEGNQLLLIYEYLENNSLARALFEH---RLKLDWPTRRRICLGIA 523
S H NL++L G C+ + LL+Y Y+ N S+A L E + LDWP R+RI LG A
Sbjct: 82 SMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSA 141
Query: 524 RGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGY 583
RGLAYLH K++HRD+KA N+LLD++ + + DFGLAKL + ++TH++T V GTIG+
Sbjct: 142 RGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGH 201
Query: 584 MAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNV-----TKEDMFYLLDWALVLKEQGKL 638
+APEY G +EK DV+ +G++ LE+++G+ +D LLDW L ++ KL
Sbjct: 202 IAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKL 261
Query: 639 MELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLECGVDVLD 691
LVD + N+ E+V +I VALLC +SP RP MS V+RMLE G + +
Sbjct: 262 EALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLE-GDGLAE 313
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 456 bits (1175), Expect = e-156
Identities = 120/284 (42%), Positives = 174/284 (61%), Gaps = 10/284 (3%)
Query: 408 YLQIKAATNNFATDNNIGEGGFGPVYKGLLADGTAIAVKQLSSKSKQGNREFINEIGMIS 467
+ ++ ATNNF IG G FG VYKG+L DG +A+K+ + +S QG EF EI +S
Sbjct: 31 LVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLS 90
Query: 468 ALQHPNLVKLYGCCIEGNQLLLIYEYLENNSLARALF---EHRLKLDWPTRRRICLGIAR 524
+HP+LV L G C E N+++LIY+Y+EN +L R L+ + + W R IC+G AR
Sbjct: 91 FCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAAR 150
Query: 525 GLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKL-DEEENTHISTRVAGTIGY 583
GL YLH + ++HRD+K+ N+LLD++ KI+DFG++K E + TH+ST V GT+GY
Sbjct: 151 GLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLSTVVKGTLGY 207
Query: 584 MAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTK---EDMFYLLDWALVLKEQGKLME 640
+ PEY ++G LTEK+DVYSFG+V E++ RS + + +M L +WA+ G+L +
Sbjct: 208 IDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQ 267
Query: 641 LVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLE 684
+VD N E + + A+ C S RPSM VL LE
Sbjct: 268 IVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLE 311
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 451 bits (1162), Expect = e-155
Identities = 106/292 (36%), Positives = 164/292 (56%), Gaps = 21/292 (7%)
Query: 408 YLQIKAATNNF------ATDNNIGEGGFGPVYKGLLADGTAIAVKQLSS----KSKQGNR 457
+ ++K TNNF N +GEGGFG VYKG + + T +AVK+L++ +++ +
Sbjct: 17 FYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQ 75
Query: 458 EFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYEYLENNSLARALF--EHRLKLDWPTR 515
+F EI +++ QH NLV+L G +G+ L L+Y Y+ N SL L + L W R
Sbjct: 76 QFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMR 135
Query: 516 RRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKL-DEEENTHIS 574
+I G A G+ +LH I HRDIK+ N+LLD+ +KISDFGLA+ ++ T ++
Sbjct: 136 CKIAQGAANGINFLHENHHI---HRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMT 192
Query: 575 TRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNV-TKEDMFYLLDWAL-VL 632
+R+ GT YMAPE +RG +T K+D+YSFG+V LEI++G V + LLD +
Sbjct: 193 SRIVGTTAYMAPEA-LRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIE 251
Query: 633 KEQGKLMELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLE 684
E+ + + +D + D V M +VA C + RP + V ++L+
Sbjct: 252 DEEKTIEDYIDKKMN-DADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQ 302
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 278 bits (713), Expect = 8e-88
Identities = 69/300 (23%), Positives = 114/300 (38%), Gaps = 30/300 (10%)
Query: 411 IKAATNNFATDNNIGEGGFGPVYKGLLADGTAIAVKQLSSKSKQGNREFINEIGMISALQ 470
+ + G FG V+K L +AVK + KQ + E+ + ++
Sbjct: 19 LYFQSMPLQLLEVKARGRFGCVWKAQL-LNEYVAVKIFPIQDKQS-WQNEYEVYSLPGMK 76
Query: 471 HPNLVKLYGCCIEGN----QLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGL 526
H N+++ G G L LI + E SL+ L + W I +ARGL
Sbjct: 77 HENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFL--KANVVSWNELCHIAETMARGL 134
Query: 527 AYLH-------GESRIKVVHRDIKATNVLLDKDLNSKISDFGLAK-LDEEENTHISTRVA 578
AYLH + + HRDIK+ NVLL +L + I+DFGLA + ++ +
Sbjct: 135 AYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQV 194
Query: 579 GTIGYMAPEYAMRGHL-----TEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLK 633
GT YMAPE + D+Y+ G+V E+ S + Y+L + +
Sbjct: 195 GTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIG 254
Query: 634 EQGKLMELVDTN---------PGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLE 684
+ L ++ + + ++ C + R S V +
Sbjct: 255 QHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERIT 314
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 240 bits (615), Expect = 2e-73
Identities = 73/310 (23%), Positives = 117/310 (37%), Gaps = 45/310 (14%)
Query: 414 ATNNFATDNNIGEGGFGPVYKGLLADGTAIAVKQLSSKSKQGNREFINE--IGMISALQH 471
+N IG G +G VYKG L D +AVK S ++Q FINE I + ++H
Sbjct: 11 DLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANRQ---NFINEKNIYRVPLMEH 66
Query: 472 PNLVKLYGCCIEGN-----QLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGL 526
N+ + + LL+ EY N SL + L DW + R+ + RGL
Sbjct: 67 DNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYL--SLHTSDWVSSCRLAHSVTRGL 124
Query: 527 AYLHGE------SRIKVVHRDIKATNVLLDKDLNSKISDFGLAKL-------DEEENTHI 573
AYLH E + + HRD+ + NVL+ D ISDFGL+ E +
Sbjct: 125 AYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNA 184
Query: 574 STRVAGTIGYMAPEYAM-------RGHLTEKADVYSFGIVALEIVSGRSNVTKEDMF--Y 624
+ GTI YMAPE ++ D+Y+ G++ EI +++ + Y
Sbjct: 185 AISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEY 244
Query: 625 LLDWALVLKEQGKLMELVDT----------NPGSNFDKEQVMVMINVALLCANASPTIRP 674
+ + + ++ + V + C + R
Sbjct: 245 QMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARL 304
Query: 675 SMSSVLRMLE 684
+ +
Sbjct: 305 TAQXAEERMA 314
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 217 bits (556), Expect = 5e-65
Identities = 77/268 (28%), Positives = 127/268 (47%), Gaps = 25/268 (9%)
Query: 424 IGEGGFGPVYKGLLADGTAIAVKQLSSKSKQGN--REFINEIGMISALQHPNLVKLYGCC 481
IG G FG V++ G+ +AVK L + EF+ E+ ++ L+HPN+V G
Sbjct: 45 IGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAV 103
Query: 482 IEGNQLLLIYEYLENNSLARALFEH--RLKLDWPTRRRICLGIARGLAYLHGESRIKVVH 539
+ L ++ EYL SL R L + R +LD R + +A+G+ YLH + +VH
Sbjct: 104 TQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNP-PIVH 162
Query: 540 RDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPEYAMRGHLTEKAD 599
R++K+ N+L+DK K+ DFGL++L + S AGT +MAPE EK+D
Sbjct: 163 RNLKSPNLLVDKKYTVKVCDFGLSRL-KASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSD 221
Query: 600 VYSFGIVALEIVSGR---SNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDKEQVM 656
VYSFG++ E+ + + N+ + + K +E+
Sbjct: 222 VYSFGVILWELATLQQPWGNLN------PAQVVAAVGFKCKRLEIPRNLNPQ-------- 267
Query: 657 VMINVALLCANASPTIRPSMSSVLRMLE 684
+ + C P RPS ++++ +L
Sbjct: 268 -VAAIIEGCWTNEPWKRPSFATIMDLLR 294
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 216 bits (551), Expect = 1e-64
Identities = 79/279 (28%), Positives = 136/279 (48%), Gaps = 38/279 (13%)
Query: 424 IGEGGFGPVYKG-LLADGTAIAVKQLSSKSKQGN-------REFINEIGMISALQHPNLV 475
IG+GGFG V+KG L+ D + +A+K L +G +EF E+ ++S L HPN+V
Sbjct: 27 IGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIV 86
Query: 476 KLYGCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRI 535
KLYG N ++ E++ L L + + W + R+ L IA G+ Y+ ++
Sbjct: 87 KLYGLMH--NPPRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNP- 143
Query: 536 KVVHRDIKATNVLLDK-----DLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPE--Y 588
+VHRD+++ N+ L + +K++DFGL++ ++ H + + G +MAPE
Sbjct: 144 PIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ----QSVHSVSGLLGNFQWMAPETIG 199
Query: 589 AMRGHLTEKADVYSFGIVALEIVSGR---SNVTKEDMFYLLDWALVLKEQGKLMELVDTN 645
A TEKAD YSF ++ I++G + + ++ + E+G + +
Sbjct: 200 AEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFI--NMIR--EEGLRPTIPEDC 255
Query: 646 PGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLE 684
P + NV LC + P RP S +++ L
Sbjct: 256 PPR---------LRNVIELCWSGDPKKRPHFSYIVKELS 285
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 214 bits (548), Expect = 2e-64
Identities = 74/276 (26%), Positives = 123/276 (44%), Gaps = 36/276 (13%)
Query: 424 IGEGGFGPVYKGLLADGTAIAVKQL----SSKSKQGNREFINEIGMISALQHPNLVKLYG 479
IG GGFG VY+ G +AVK Q E + + L+HPN++ L G
Sbjct: 15 IGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRG 73
Query: 480 CCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVH 539
C++ L L+ E+ L R L ++ + IARG+ YLH E+ + ++H
Sbjct: 74 VCLKEPNLCLVMEFARGGPLNRVL--SGKRIPPDILVNWAVQIARGMNYLHDEAIVPIIH 131
Query: 540 RDIKATNVLLDKDLNS--------KISDFGLAKLDEEENTHISTRVAGTIGYMAPEYAMR 591
RD+K++N+L+ + + + KI+DFGLA+ E T + AG +MAPE
Sbjct: 132 RDLKSSNILILQKVENGDLSNKILKITDFGLAR--EWHRTTKMSA-AGAYAWMAPEVIRA 188
Query: 592 GHLTEKADVYSFGIVALEIVSGR---SNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGS 648
++ +DV+S+G++ E+++G + L A + + + T P
Sbjct: 189 SMFSKGSDVWSYGVLLWELLTGEVPFRGID------GLAVAYGVAMNKLALPIPSTCPEP 242
Query: 649 NFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLE 684
+ C N P RPS +++L L
Sbjct: 243 ---------FAKLMEDCWNPDPHSRPSFTNILDQLT 269
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 214 bits (548), Expect = 5e-64
Identities = 76/264 (28%), Positives = 123/264 (46%), Gaps = 23/264 (8%)
Query: 424 IGEGGFGPVYKGLLADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCCIE 483
+G G FG V K +A+KQ+ +S+ + FI E+ +S + HPN+VKLYG C+
Sbjct: 16 VGRGAFGVVCKAKW-RAKDVAIKQI--ESESERKAFIVELRQLSRVNHPNIVKLYGACL- 71
Query: 484 GNQLLLIYEYLENNSLARAL--FEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRD 541
N + L+ EY E SL L E CL ++G+AYLH ++HRD
Sbjct: 72 -NPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRD 130
Query: 542 IKATNVLLDKDLNS-KISDFGLAKLDEEENTHISTRVAGTIGYMAPEYAMRGHLTEKADV 600
+K N+LL KI DFG A + T G+ +MAPE + +EK DV
Sbjct: 131 LKPPNLLLVAGGTVLKICDFGTAC----DIQTHMTNNKGSAAWMAPEVFEGSNYSEKCDV 186
Query: 601 YSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDKEQVMVMIN 660
+S+GI+ E+++ R +++ + G L+ P + +
Sbjct: 187 FSWGIILWEVITRR--KPFDEIGGPAFRIMWAVHNGTRPPLIKNLPKP---------IES 235
Query: 661 VALLCANASPTIRPSMSSVLRMLE 684
+ C + P+ RPSM +++++
Sbjct: 236 LMTRCWSKDPSQRPSMEEIVKIMT 259
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 214 bits (548), Expect = 5e-64
Identities = 71/275 (25%), Positives = 113/275 (41%), Gaps = 28/275 (10%)
Query: 424 IGEGGFGPVYKGLL-ADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCCI 482
+G+G FG K G + +K+L ++ R F+ E+ ++ L+HPN++K G
Sbjct: 18 LGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLY 77
Query: 483 EGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDI 542
+ +L I EY++ +L + + W R IA G+AYLH + ++HRD+
Sbjct: 78 KDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLH---SMNIIHRDL 134
Query: 543 KATNVLLDKDLNSKISDFGLAKLDEEENTH-------------ISTRVAGTIGYMAPEYA 589
+ N L+ ++ N ++DFGLA+L +E T V G +MAPE
Sbjct: 135 NSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMI 194
Query: 590 MRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSN 649
EK DV+SFGIV EI+ D + P
Sbjct: 195 NGRSYDEKVDVFSFGIVLCEIIGRV--NADPDYLPRTMDFGLNVRGFLDRYCPPNCP--- 249
Query: 650 FDKEQVMVMINVALLCANASPTIRPSMSSVLRMLE 684
+ + C + P RPS + LE
Sbjct: 250 ------PSFFPITVRCCDLDPEKRPSFVKLEHWLE 278
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 212 bits (542), Expect = 2e-63
Identities = 76/268 (28%), Positives = 123/268 (45%), Gaps = 22/268 (8%)
Query: 424 IGEGGFGPVYKGLLADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCCIE 483
IG G FG VYKG A+ + +++ + Q + F NE+G++ +H N++ G
Sbjct: 32 IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA 91
Query: 484 GNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIK 543
L ++ ++ E +SL L K + I ARG+ YLH ++HRD+K
Sbjct: 92 PQ-LAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLH---AKSIIHRDLK 147
Query: 544 ATNVLLDKDLNSKISDFGLAKL-DEEENTHISTRVAGTIGYMAPE---YAMRGHLTEKAD 599
+ N+ L +D KI DFGLA +H +++G+I +MAPE + ++D
Sbjct: 148 SNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSD 207
Query: 600 VYSFGIVALEIVSGR---SNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDKEQVM 656
VY+FGIV E+++G+ SN+ D + +G L + SN K
Sbjct: 208 VYAFGIVLYELMTGQLPYSNINNRDQII---EMV---GRGSLSPDLSKVR-SNCPKRMKR 260
Query: 657 VMINVALLCANASPTIRPSMSSVLRMLE 684
+M C RPS +L +E
Sbjct: 261 LM----AECLKKKRDERPSFPRILAEIE 284
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 209 bits (533), Expect = 6e-62
Identities = 70/290 (24%), Positives = 117/290 (40%), Gaps = 36/290 (12%)
Query: 424 IGEGGFGPVYKGLLADGTAIAVKQLSSKSKQGNREFINE--IGMISALQHPNLVKLYGCC 481
+G+G +G V++G G +AVK SS + + + E + L+H N++
Sbjct: 16 VGKGRYGEVWRGSW-QGENVAVKIFSS---RDEKSWFRETELYNTVMLRHENILGFIASD 71
Query: 482 IEGN----QLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGE----- 532
+ QL LI Y E SL L LD + RI L IA GLA+LH E
Sbjct: 72 MTSRHSSTQLWLITHYHEMGSLYDYL--QLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQ 129
Query: 533 SRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHI---STRVAGTIGYMAPE-- 587
+ + HRD+K+ N+L+ K+ I+D GLA + + + + GT YMAPE
Sbjct: 130 GKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVL 189
Query: 588 ----YAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVD 643
++ D+++FG+V E+ R Y + V+ ++
Sbjct: 190 DETIQVDCFDSYKRVDIWAFGLVLWEVAR-RMVSNGIVEDYKPPFYDVVPNDPSFEDMRK 248
Query: 644 ---------TNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLE 684
P F + + + C +P+ R + + + L
Sbjct: 249 VVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLT 298
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 208 bits (531), Expect = 4e-61
Identities = 69/290 (23%), Positives = 111/290 (38%), Gaps = 36/290 (12%)
Query: 424 IGEGGFGPVYKGLLADGTAIAVKQLSSKSKQGNREFINE--IGMISALQHPNLVKLYGCC 481
IG+G +G V+ G G +AVK + + E I ++H N++
Sbjct: 45 IGKGRYGEVWMGKW-RGEKVAVKVFFT---TEEASWFRETEIYQTVLMRHENILGFIAAD 100
Query: 482 IEGN----QLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGE----- 532
I+G QL LI +Y EN SL L LD + ++ GL +LH E
Sbjct: 101 IKGTGSWTQLYLITDYHENGSLYDYL--KSTTLDAKSMLKLAYSSVSGLCHLHTEIFSTQ 158
Query: 533 SRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHI---STRVAGTIGYMAPE-- 587
+ + HRD+K+ N+L+ K+ I+D GLA + + GT YM PE
Sbjct: 159 GKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVL 218
Query: 588 ----YAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVD 643
AD+YSFG++ E+ R Y L + ++ ++ +
Sbjct: 219 DESLNRNHFQSYIMADMYSFGLILWEVAR-RCVSGGIVEEYQLPYHDLVPSDPSYEDMRE 277
Query: 644 ---------TNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLE 684
+ P E + M + C +P R + V + L
Sbjct: 278 IVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLA 327
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 205 bits (523), Expect = 7e-61
Identities = 56/273 (20%), Positives = 113/273 (41%), Gaps = 36/273 (13%)
Query: 424 IGEGGFGPVYKGLLADGTAIAVKQLSSK--SKQGNREFINEIGMISALQHPNLVKLYGCC 481
+ E G ++KG G I VK L + S + +R+F E + HPN++ + G C
Sbjct: 18 LNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGAC 76
Query: 482 IE--GNQLLLIYEYLENNSLARALFEHR-LKLDWPTRRRICLGIARGLAYLHGESRIKVV 538
LI ++ SL L E +D + L +ARG+A+LH + +
Sbjct: 77 QSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPL-IP 135
Query: 539 HRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPEYAMRG----HL 594
+ + +V++D+D+ ++IS + + S ++APE A++
Sbjct: 136 RHALNSRSVMIDEDMTARISMADVKFSFQ------SPGRMYAPAWVAPE-ALQKKPEDTN 188
Query: 595 TEKADVYSFGIVALEIVSGR---SNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFD 651
AD++SF ++ E+V+ ++++ ++ + + +G +
Sbjct: 189 RRSADMWSFAVLLWELVTREVPFADLS------NMEIGMKVALEGLRPTIPPGISPH--- 239
Query: 652 KEQVMVMINVALLCANASPTIRPSMSSVLRMLE 684
+ + +C N P RP ++ +LE
Sbjct: 240 ------VSKLMKICMNEDPAKRPKFDMIVPILE 266
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 206 bits (527), Expect = 7e-61
Identities = 60/279 (21%), Positives = 111/279 (39%), Gaps = 39/279 (13%)
Query: 424 IGEGGFGPVYKGLLADGTAIAVKQLSSKSKQGN--REFINEIGMISALQHPNLVKLYGCC 481
IG+G FG VY G G +A++ + + + + F E+ +H N+V G C
Sbjct: 41 IGKGRFGQVYHGRW-HGE-VAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGAC 98
Query: 482 IEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRD 541
+ L +I + +L + + ++ LD R+I I +G+ YLH + ++H+D
Sbjct: 99 MSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAK---GILHKD 155
Query: 542 IKATNVLLDKDLNSKISDFGLAKL----DEEENTHISTRVAGTIGYMAPE---------Y 588
+K+ NV D I+DFGL + G + ++APE
Sbjct: 156 LKSKNVFYDNG-KVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTE 214
Query: 589 AMRGHLTEKADVYSFGIVALEIVSGR---SNVTKEDMFYLLDWALVLKEQGKLMELVDTN 645
+ ++ +DV++ G + E+ + E + + + G L
Sbjct: 215 EDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQM-------GTGMKPNL---- 263
Query: 646 PGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLE 684
KE ++ L C RP+ + ++ MLE
Sbjct: 264 SQIGMGKEISDIL----LFCWAFEQEERPTFTKLMDMLE 298
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 203 bits (517), Expect = 4e-59
Identities = 76/291 (26%), Positives = 123/291 (42%), Gaps = 38/291 (13%)
Query: 424 IGEGGFGPVYKGLLADGTAIAVKQLSSKSKQGNREFINE--IGMISALQHPNLVKLYGCC 481
IG+G FG V++G G +AVK SS + R + E I L+H N++
Sbjct: 50 IGKGRFGEVWRGKW-RGEEVAVKIFSS---REERSWFREAEIYQTVMLRHENILGFIAAD 105
Query: 482 IEGN----QLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGE----- 532
+ N QL L+ +Y E+ SL L +R + ++ L A GLA+LH E
Sbjct: 106 NKDNGTWTQLWLVSDYHEHGSLFDYL--NRYTVTVEGMIKLALSTASGLAHLHMEIVGTQ 163
Query: 533 SRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHI---STRVAGTIGYMAPEYA 589
+ + HRD+K+ N+L+ K+ I+D GLA + I GT YMAPE
Sbjct: 164 GKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPE-V 222
Query: 590 MRGHL-------TEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELV 642
+ + ++AD+Y+ G+V EI R ++ Y L + ++ + E+
Sbjct: 223 LDDSINMKHFESFKRADIYAMGLVFWEIAR-RCSIGGIHEDYQLPYYDLVPSDPSVEEMR 281
Query: 643 D---------TNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLE 684
P E + VM + C A+ R + + + L
Sbjct: 282 KVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLS 332
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 195 bits (498), Expect = 9e-57
Identities = 79/261 (30%), Positives = 118/261 (45%), Gaps = 18/261 (6%)
Query: 24 LKEQNLTGV--LPPKLAELTFLQDIDLT-LNYLSGTIPSQWASLPLLN-ISLIANRLKGP 79
L NL +P LA L +L + + +N L G IP A L L+ + + + G
Sbjct: 57 LSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGA 116
Query: 80 IPKYLANISTLVNLTVQYNQFSGELPEELGSLLNLEKLHLSSNNFTGELPKTFAKLTNM- 138
IP +L+ I TLV L YN SG LP + SL NL + N +G +P ++ + +
Sbjct: 117 IPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLF 176
Query: 139 KDFRISDNQFTGQIPSFIQNWTKLEKLFIQPSGLAGPIPSGIFSLENLTDLRISD--LNG 196
IS N+ TG+IP N L + + + L G S +N + ++ L
Sbjct: 177 TSMTISRNRLTGKIPPTFANL-NLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAF 235
Query: 197 PEATFPQLGNMK-MTKLILRNCNITGELPRYLGKMTKLKVLDLSFNRLRGQIPS--NFDD 253
++G K + L LRN I G LP+ L ++ L L++SFN L G+IP N
Sbjct: 236 D---LGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQR 292
Query: 254 LYDVDYIYFAGN-LLTGAIPP 273
D +A N L G+ P
Sbjct: 293 F---DVSAYANNKCLCGSPLP 310
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 190 bits (485), Expect = 6e-55
Identities = 81/282 (28%), Positives = 124/282 (43%), Gaps = 17/282 (6%)
Query: 28 NLTGVLPPKLAELTFLQDIDLTLNYLSGT--IPSQWASLPLLNISLIA--NRLKGPIPKY 83
GVL + + ++DL+ L IPS A+LP LN I N L GPIP
Sbjct: 37 TWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPA 96
Query: 84 LANISTLVNLTVQYNQFSGELPEELGSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRI 143
+A ++ L L + + SG +P+ L + L L S N +G LP + + L N+
Sbjct: 97 IAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITF 156
Query: 144 SDNQFTGQIPSFIQNWTKL-EKLFIQPSGLAGPIPSGIFSLENLTDLRISD--LNG--PE 198
N+ +G IP +++KL + I + L G IP +L NL + +S L G
Sbjct: 157 DGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANL-NLAFVDLSRNMLEGDAS- 214
Query: 199 ATFPQLGNMKM-TKLILRNCNITGELPRYLGKMTKLKVLDLSFNRLRGQIPSNFDDLYDV 257
G+ K K+ L ++ +L + +G L LDL NR+ G +P L +
Sbjct: 215 ---VLFGSDKNTQKIHLAKNSLAFDLGK-VGLSKNLNGLDLRNNRIYGTLPQGLTQLKFL 270
Query: 258 DYIYFAGNLLTGAIPP-WMLERGDKIDLSYNNFTDGSAESSC 298
+ + N L G IP L+R D + N GS +C
Sbjct: 271 HSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCGSPLPAC 312
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 168 bits (427), Expect = 7e-47
Identities = 56/249 (22%), Positives = 89/249 (35%), Gaps = 20/249 (8%)
Query: 57 IPSQWASLPLL-----NISLIANRLKGPIPKYLANISTLVNLTVQYNQFSGE--LPEELG 109
I + L G + + NL + +P L
Sbjct: 14 IKKDLGNPTTLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLA 73
Query: 110 SLLNLEKLHLSS-NNFTGELPKTFAKLTNMKDFRISDNQFTGQIPSFIQNWTKLEKLFIQ 168
+L L L++ NN G +P AKLT + I+ +G IP F+ L L
Sbjct: 74 NLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFS 133
Query: 169 PSGLAGPIPSGIFSLENLTDLRISD--LNG--PEATFPQLGNMKM--TKLILRNCNITGE 222
+ L+G +P I SL NL + ++G P G+ T + + +TG+
Sbjct: 134 YNALSGTLPPSISSLPNLVGITFDGNRISGAIP----DSYGSFSKLFTSMTISRNRLTGK 189
Query: 223 LPRYLGKMTKLKVLDLSFNRLRGQIPSNFDDLYDVDYIYFAGNLLTGAIPPWMLERG-DK 281
+P + L +DLS N L G F + I+ A N L + L + +
Sbjct: 190 IPPTFANL-NLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGKVGLSKNLNG 248
Query: 282 IDLSYNNFT 290
+DL N
Sbjct: 249 LDLRNNRIY 257
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 1e-28
Identities = 49/204 (24%), Positives = 78/204 (38%), Gaps = 22/204 (10%)
Query: 103 ELPEELGSLLNL----EKLHLSSNNFTGELPKTFAKLTNMKDFRISDNQFTGQ--IPSFI 156
++ ++LG+ L + + G L T + + + +S IPS +
Sbjct: 13 QIKKDLGNPTTLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSL 72
Query: 157 QNWTKLEKLFIQPS-GLAGPIPSGIFSLENLTDLRISD--LNGPEATFPQ-LGNMK-MTK 211
N L L+I L GPIP I L L L I+ ++G P L +K +
Sbjct: 73 ANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGA---IPDFLSQIKTLVT 129
Query: 212 LILRNCNITGELPRYLGKMTKLKVLDLSFNRLRGQIPSNFDDLYD-VDYIYFAGNLLTGA 270
L ++G LP + + L + NR+ G IP ++ + + N LTG
Sbjct: 130 LDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGK 189
Query: 271 IPPWMLERG----DKIDLSYNNFT 290
IPP +DLS N
Sbjct: 190 IPP---TFANLNLAFVDLSRNMLE 210
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 206 bits (526), Expect = 1e-56
Identities = 85/279 (30%), Positives = 130/279 (46%), Gaps = 23/279 (8%)
Query: 28 NLTGVLPPKLAELTFLQDIDLTLNYLSGTIP-SQWASLPLLNISLIANRLKGPIPKYLA- 85
L+G ++ T L+ ++++ N G IP SL L+++ N+ G IP +L+
Sbjct: 234 KLSGDFSRAISTCTELKLLNISSNQFVGPIPPLPLKSLQYLSLA--ENKFTGEIPDFLSG 291
Query: 86 NISTLVNLTVQYNQFSGELPEELGSLLNLEKLHLSSNNFTGELPK-TFAKLTNMKDFRIS 144
TL L + N F G +P GS LE L LSSNNF+GELP T K+ +K +S
Sbjct: 292 ACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLS 351
Query: 145 DNQFTGQIPSFIQN-WTKLEKLFIQPSGLAGPIPSGIF--SLENLTDLRISD--LNGPEA 199
N+F+G++P + N L L + + +GPI + L +L + + G
Sbjct: 352 FNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGK-- 409
Query: 200 TFPQ-LGNMK-MTKLILRNCNITGELPRYLGKMTKLKVLDLSFNRLRGQIPSNFDDLYDV 257
P L N + L L ++G +P LG ++KL+ L L N L G+IP + +
Sbjct: 410 -IPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTL 468
Query: 258 DYIYFAGNLLTGAIPPWM-----LERGDKIDLSYNNFTD 291
+ + N LTG IP + L I LS N T
Sbjct: 469 ETLILDFNDLTGEIPSGLSNCTNLNW---ISLSNNRLTG 504
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 205 bits (524), Expect = 2e-56
Identities = 72/266 (27%), Positives = 123/266 (46%), Gaps = 4/266 (1%)
Query: 28 NLTGVLPPKLAELTFLQDIDLTLNYLSGTIPSQWASLP-LLNISLIANRLKGPIPKYLAN 86
TG +PP L+ + L + L+ NYLSGTIPS SL L ++ L N L+G IP+ L
Sbjct: 405 GFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMY 464
Query: 87 ISTLVNLTVQYNQFSGELPEELGSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRISDN 146
+ TL L + +N +GE+P L + NL + LS+N TGE+PK +L N+ ++S+N
Sbjct: 465 VKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNN 524
Query: 147 QFTGQIPSFIQNWTKLEKLFIQPSGLAGPIPSGIFSLENLTDLRISDLNGPEATFPQLGN 206
F+G IP+ + + L L + + G IP+ +F G
Sbjct: 525 SFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGKIAANFIAGKRY-VYIKNDGM 583
Query: 207 MKMTKLILRNCNITGELPRYLGKMTKLKVLDLSFNRLRGQIPSNFDDLYDVDYIYFAGNL 266
K G L +++ +++ G FD+ + ++ + N+
Sbjct: 584 KKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNM 643
Query: 267 LTGAIPPWM--LERGDKIDLSYNNFT 290
L+G IP + + ++L +N+ +
Sbjct: 644 LSGYIPKEIGSMPYLFILNLGHNDIS 669
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 198 bits (507), Expect = 4e-54
Identities = 78/279 (27%), Positives = 123/279 (44%), Gaps = 24/279 (8%)
Query: 28 NLTGVLP-PKLAELTFLQDIDLTLNYLSGTIPSQWASLP----LLNISLIANRLKGPIPK 82
L +L L+ +DL+ N +SG W L ++++ N++ G +
Sbjct: 137 TLDFPGKVSGGLKLNSLEVLDLSANSISGANVVGWVLSDGCGELKHLAISGNKISGDVD- 195
Query: 83 YLANISTLVNLTVQYNQFSGELPEELGSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFR 142
++ L L V N FS +P LG L+ L +S N +G+ + + T +K
Sbjct: 196 -VSRCVNLEFLDVSSNNFSTGIPF-LGDCSALQHLDISGNKLSGDFSRAISTCTELKLLN 253
Query: 143 ISDNQFTGQIPSFIQNWTKLEKLFIQPSGLAGPIPSGIF-SLENLTDLRISD--LNGPEA 199
IS NQF G IP L+ L + + G IP + + + LT L +S G
Sbjct: 254 ISSNQFVGPIPPL--PLKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGA-- 309
Query: 200 TFP-QLGNM-KMTKLILRNCNITGELPR-YLGKMTKLKVLDLSFNRLRGQIPSNFDDL-Y 255
P G+ + L L + N +GELP L KM LKVLDLSFN G++P + +L
Sbjct: 310 -VPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSA 368
Query: 256 DVDYIYFAGNLLTGAIPPWMLERG----DKIDLSYNNFT 290
+ + + N +G I P + + ++ L N FT
Sbjct: 369 SLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFT 407
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 193 bits (494), Expect = 2e-52
Identities = 81/269 (30%), Positives = 123/269 (45%), Gaps = 10/269 (3%)
Query: 28 NLTGVLPPKLAELTFLQDIDLTLNYLSGTIPSQWASLPLLN-ISLIANRLKGPIPKYLAN 86
L G +P +L + L+ + L N L+G IPS ++ LN ISL NRL G IPK++
Sbjct: 453 MLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGR 512
Query: 87 ISTLVNLTVQYNQFSGELPEELGSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRISDN 146
+ L L + N FSG +P ELG +L L L++N F G +P K + I+ N
Sbjct: 513 LENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGK----IAAN 568
Query: 147 QFTGQIPSFIQNWTKLEKLFIQPSG--LAGPIPSGIFSLENLTDLRISDLNGPEATFPQL 204
G+ +I+N ++ + G + L I+ T P
Sbjct: 569 FIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTF 628
Query: 205 GNMK-MTKLILRNCNITGELPRYLGKMTKLKVLDLSFNRLRGQIPSNFDDLYDVDYIYFA 263
N M L + ++G +P+ +G M L +L+L N + G IP DL ++ + +
Sbjct: 629 DNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLS 688
Query: 264 GNLLTGAIPPWM--LERGDKIDLSYNNFT 290
N L G IP M L +IDLS NN +
Sbjct: 689 SNKLDGRIPQAMSALTMLTEIDLSNNNLS 717
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 190 bits (486), Expect = 2e-51
Identities = 78/291 (26%), Positives = 111/291 (38%), Gaps = 51/291 (17%)
Query: 28 NLTGVLPPKLAELTF-LQDIDLTLNYLSGTIPSQWASLPLLN---ISLIANRLKGPIPKY 83
+G LP L L+ L +DL+ N SG I P + L N G IP
Sbjct: 354 EFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPT 413
Query: 84 LANISTLVNLTVQYNQFSGELPEELGSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRI 143
L+N S LV+L + +N SG +P LGSL L L L N GE+P+ + ++ +
Sbjct: 414 LSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLIL 473
Query: 144 SDNQFTGQIPSFIQNWTKLEKLFIQPSGLAGPIPSGIFSLENLTDLRISDLNGPEATFPQ 203
N TG+IPS + N T L + + + L G IP I LENL
Sbjct: 474 DFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENL----------------- 516
Query: 204 LGNMKMTKLILRNCNITGELPRYLGKMTKLKVLDLSFNRLRGQIPSNF------------ 251
L L N + +G +P LG L LDL+ N G IP+
Sbjct: 517 ------AILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGKIAANFI 570
Query: 252 --------DDLYDVDYIYFAGNL--LTGAIPP--WMLERGDKIDLSYNNFT 290
+ + AGNL G L + +++ +
Sbjct: 571 AGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYG 621
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 190 bits (485), Expect = 3e-51
Identities = 69/277 (24%), Positives = 116/277 (41%), Gaps = 20/277 (7%)
Query: 28 NLTGVLPPKLAELTFLQDIDLTLNYLSGTIPSQW--ASLPLL-NISLIANRLKGPIPK-Y 83
++ G + L +DL+ N LSG + + S L +++ +N L P
Sbjct: 88 HINGSVSG-FKCSASLTSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSG 146
Query: 84 LANISTLVNLTVQYNQFSGELPEEL---GSLLNLEKLHLSSNNFTGELPKTFAKLTNMKD 140
+++L L + N SG L+ L +S N +G++ ++ N++
Sbjct: 147 GLKLNSLEVLDLSANSISGANVVGWVLSDGCGELKHLAISGNKISGDVD--VSRCVNLEF 204
Query: 141 FRISDNQFTGQIPSFIQNWTKLEKLFIQPSGLAGPIPSGIFSLENLTDLRISD--LNGPE 198
+S N F+ IP + + + L+ L I + L+G I + L L IS GP
Sbjct: 205 LDVSSNNFSTGIPF-LGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGP- 262
Query: 199 ATFPQLGNMKMTKLILRNCNITGELPRYL-GKMTKLKVLDLSFNRLRGQIPSNFDDLYDV 257
P L + L L TGE+P +L G L LDLS N G +P F +
Sbjct: 263 --IPPLPLKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLL 320
Query: 258 DYIYFAGNLLTGAIPPWMLERGDK---IDLSYNNFTD 291
+ + + N +G +P L + +DLS+N F+
Sbjct: 321 ESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSG 357
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 178 bits (455), Expect = 2e-47
Identities = 67/280 (23%), Positives = 116/280 (41%), Gaps = 27/280 (9%)
Query: 27 QNLTGVLPPKLAELTFLQDIDLTLNYLSGTIPSQWASLPLLNISLIANRLKGPIPKY--L 84
+ L LT L+ + L+ ++++G++ S L ++ L N L GP+ L
Sbjct: 63 NVGFSAVSSSLLSLTGLESLFLSNSHINGSVSGFKCSASLTSLDLSRNSLSGPVTTLTSL 122
Query: 85 ANISTLVNLTVQYNQFSGELP-EELGSLLNLEKLHLSSNNFTGELPKTFA---KLTNMKD 140
+ S L L V N L +LE L LS+N+ +G + +K
Sbjct: 123 GSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANVVGWVLSDGCGELKH 182
Query: 141 FRISDNQFTGQIPSFIQNWTKLEKLFIQPSGLAGPIPSGIFSLENLTDLRISD--LNGPE 198
IS N+ +G + + LE L + + + IP + L L IS L+G
Sbjct: 183 LAISGNKISGDVD--VSRCVNLEFLDVSSNNFSTGIPF-LGDCSALQHLDISGNKLSGD- 238
Query: 199 ATFPQ-LGNM-KMTKLILRNCNITGELPRYLGKMTKLKVLDLSFNRLRGQIPSN-FDDLY 255
F + + ++ L + + G +P + L+ L L+ N+ G+IP
Sbjct: 239 --FSRAISTCTELKLLNISSNQFVGPIPP--LPLKSLQYLSLAENKFTGEIPDFLSGACD 294
Query: 256 DVDYIYFAGNLLTGAIPPW-----MLERGDKIDLSYNNFT 290
+ + +GN GA+PP+ +LE + LS NNF+
Sbjct: 295 TLTGLDLSGNHFYGAVPPFFGSCSLLES---LALSSNNFS 331
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 168 bits (428), Expect = 8e-44
Identities = 66/265 (24%), Positives = 114/265 (43%), Gaps = 26/265 (9%)
Query: 43 LQDIDLT---LNYLSGTIPSQWASLP-LLNISLIANRLKGPIPKYLANISTLVNLTVQYN 98
+ IDL+ LN + S SL L ++ L + + G + ++L +L + N
Sbjct: 52 VTSIDLSSKPLNVGFSAVSSSLLSLTGLESLFLSNSHINGSVSG-FKCSASLTSLDLSRN 110
Query: 99 QFSGELPE--ELGSLLNLEKLHLSSNNFTGELPKT-FAKLTNMKDFRISDNQFTGQIPSF 155
SG + LGS L+ L++SSN + KL +++ +S N +G
Sbjct: 111 SLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANVVG 170
Query: 156 IQ---NWTKLEKLFIQPSGLAGPIPSGIFSLENLTDLRISD--LNGPEATFPQLGNM-KM 209
+L+ L I + ++G + + NL L +S + P LG+ +
Sbjct: 171 WVLSDGCGELKHLAISGNKISGDVD--VSRCVNLEFLDVSSNNFSTG---IPFLGDCSAL 225
Query: 210 TKLILRNCNITGELPRYLGKMTKLKVLDLSFNRLRGQIP-SNFDDLYDVDYIYFAGNLLT 268
L + ++G+ R + T+LK+L++S N+ G IP L Y+ A N T
Sbjct: 226 QHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPPLPLKSL---QYLSLAENKFT 282
Query: 269 GAIPPWMLERGDK---IDLSYNNFT 290
G IP ++ D +DLS N+F
Sbjct: 283 GEIPDFLSGACDTLTGLDLSGNHFY 307
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 154 bits (392), Expect = 3e-39
Identities = 60/247 (24%), Positives = 95/247 (38%), Gaps = 33/247 (13%)
Query: 23 VLKEQNLTGVLPPKLAELTFLQDIDLTLNYLSGTIPSQWASLPLLNISLIANRLKGPIPK 82
L + +G +P +L + L +DL N +GTIP+ + AN + G
Sbjct: 520 KLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGK---IAANFIAGKRYV 576
Query: 83 YLANISTLVNLTVQYN--QFSGELPEELGSLLNLEKLHLSSNNFTGELPKTFAKLTNMKD 140
Y+ N N +F G E+L L +++S + G TF +M
Sbjct: 577 YIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMF 636
Query: 141 FRISDNQFTGQIPSFIQNWTKLEKLFIQPSGLAGPIPSGIFSLENLTDLRISDLNGPEAT 200
+S N +G IP I + L L + + ++G IP + +L L I DL+
Sbjct: 637 LDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPD---EVGDLRGLNILDLS----- 688
Query: 201 FPQLGNMKMTKLILRNCNITGELPRYLGKMTKLKVLDLSFNRLRGQIPSN--FDDLYDVD 258
N + G +P+ + +T L +DLS N L G IP F+
Sbjct: 689 --------------SN-KLDGRIPQAMSALTMLTEIDLSNNNLSGPIPEMGQFETF---P 730
Query: 259 YIYFAGN 265
F N
Sbjct: 731 PAKFLNN 737
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 2e-30
Identities = 37/164 (22%), Positives = 67/164 (40%), Gaps = 3/164 (1%)
Query: 19 NQKRVLKEQNLTGVLPPKLAELTFLQDIDLTLNY--LSGTIPSQWASLPLLN-ISLIANR 75
Q + + G + ++ N G Q L N ++ +
Sbjct: 560 KQSGKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRV 619
Query: 76 LKGPIPKYLANISTLVNLTVQYNQFSGELPEELGSLLNLEKLHLSSNNFTGELPKTFAKL 135
G N +++ L + YN SG +P+E+GS+ L L+L N+ +G +P L
Sbjct: 620 YGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDL 679
Query: 136 TNMKDFRISDNQFTGQIPSFIQNWTKLEKLFIQPSGLAGPIPSG 179
+ +S N+ G+IP + T L ++ + + L+GPIP
Sbjct: 680 RGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIPEM 723
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 1e-23
Identities = 37/191 (19%), Positives = 74/191 (38%), Gaps = 18/191 (9%)
Query: 113 NLEKLHLSSNNFT---GELPKTFAKLTNMKDFRISDNQFTGQIPSFIQNWTKLEKLFIQP 169
+ + LSS + + LT ++ +S++ G + F + L L +
Sbjct: 51 KVTSIDLSSKPLNVGFSAVSSSLLSLTGLESLFLSNSHINGSVSGF-KCSASLTSLDLSR 109
Query: 170 SGLAGPIPSG--IFSLENLTDLRISD--LNGPEATFPQLGNM-KMTKLILRNCNITGELP 224
+ L+GP+ + + S L L +S L+ P + + L L +I+G
Sbjct: 110 NSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPG-KVSGGLKLNSLEVLDLSANSISGANV 168
Query: 225 ---RYLGKMTKLKVLDLSFNRLRGQIP-SNFDDLYDVDYIYFAGNLLTGAIPP-WMLERG 279
+LK L +S N++ G + S +L +++ + N + IP
Sbjct: 169 VGWVLSDGCGELKHLAISGNKISGDVDVSRCVNL---EFLDVSSNNFSTGIPFLGDCSAL 225
Query: 280 DKIDLSYNNFT 290
+D+S N +
Sbjct: 226 QHLDISGNKLS 236
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 178 bits (454), Expect = 6e-50
Identities = 70/274 (25%), Positives = 119/274 (43%), Gaps = 38/274 (13%)
Query: 424 IGEGGFGPVYKGLL-ADGTAIAVKQL-SSKSKQGNREFINEIGMISALQHPNLVKLYGCC 481
IG G FG V+ G L AD T +AVK + +F+ E ++ HPN+V+L G C
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 181
Query: 482 IEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRD 541
+ + ++ E ++ L +L T ++ A G+ YL +HRD
Sbjct: 182 TQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLE---SKCCIHRD 238
Query: 542 IKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGT--IGYMAPEYAMRGHLTEKAD 599
+ A N L+ + KISDFG+++ +E + + ++ + + APE G + ++D
Sbjct: 239 LAARNCLVTEKNVLKISDFGMSR-EEADGVYAASGGLRQVPVKWTAPEALNYGRYSSESD 297
Query: 600 VYSFGIVALEIVS-------GRSNVTKEDMFYLLDWALVLK--EQGKLMELVDTNPGSNF 650
V+SFGI+ E S SN + E+G + + P + F
Sbjct: 298 VWSFGILLWETFSLGASPYPNLSN------------QQTREFVEKGGRLPCPELCPDAVF 345
Query: 651 DKEQVMVMINVALLCANASPTIRPSMSSVLRMLE 684
++M C P RPS S++ + L+
Sbjct: 346 ---RLM------EQCWAYEPGQRPSFSTIYQELQ 370
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 168 bits (428), Expect = 3e-47
Identities = 59/199 (29%), Positives = 89/199 (44%), Gaps = 14/199 (7%)
Query: 424 IGEGGFGPVYKGL-LADGTAIAVKQ--LSSKSKQGNREFINEIGMISALQHPNLVKLYGC 480
IG G F VYKGL +A + +K + F E M+ LQHPN+V+ Y
Sbjct: 34 IGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDS 93
Query: 481 CI----EGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIK 536
++L+ E + + +L L + + R C I +GL +LH +
Sbjct: 94 WESTVKGKKCIVLVTELMTSGTLKTYLKRFK-VMKIKVLRSWCRQILKGLQFLHTRTP-P 151
Query: 537 VVHRDIKATNVLLD-KDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPEYAMRGHLT 595
++HRD+K N+ + + KI D GLA L V GT +MAPE +
Sbjct: 152 IIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAK---AVIGTPEFMAPEMYEEKY-D 207
Query: 596 EKADVYSFGIVALEIVSGR 614
E DVY+FG+ LE+ +
Sbjct: 208 ESVDVYAFGMCMLEMATSE 226
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 167 bits (426), Expect = 6e-47
Identities = 64/198 (32%), Positives = 99/198 (50%), Gaps = 12/198 (6%)
Query: 424 IGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCCI 482
+G+G +G VY G L++ IA+K++ + + ++ EI + L+H N+V+ G
Sbjct: 30 LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFS 89
Query: 483 EGNQLLLIYEYLENNSLARALFEH--RLKLDWPTRRRICLGIARGLAYLHGESRIKVVHR 540
E + + E + SL+ L LK + T I GL YLH ++VHR
Sbjct: 90 ENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDN---QIVHR 146
Query: 541 DIKATNVLLD-KDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPE---YAMRGHLTE 596
DIK NVL++ KISDFG +K N T GT+ YMAPE RG+ +
Sbjct: 147 DIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTET-FTGTLQYMAPEIIDKGPRGY-GK 204
Query: 597 KADVYSFGIVALEIVSGR 614
AD++S G +E+ +G+
Sbjct: 205 AADIWSLGCTIIEMATGK 222
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 167 bits (426), Expect = 8e-47
Identities = 75/282 (26%), Positives = 126/282 (44%), Gaps = 33/282 (11%)
Query: 424 IGEGGFGPVYKGLLA-----DGTAIAVKQL-SSKSKQGNREFINEIGMISALQHPNLVKL 477
+GEG FG V G +AVK L + EI ++ L H N+VK
Sbjct: 29 LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 88
Query: 478 YGCCIE--GNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRI 535
G C E GN + LI E+L + SL L +++ K++ + + + I +G+ YL SR
Sbjct: 89 KGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYL--GSR- 145
Query: 536 KVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGT--IGYMAPEYAMRGH 593
+ VHRD+ A NVL++ + KI DFGL K E + + + + + + APE M+
Sbjct: 146 QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSK 205
Query: 594 LTEKADVYSFGIVALEIVS-GRSNVTKEDMFYL--------LDWALVLK--EQGKLMELV 642
+DV+SFG+ E+++ S+ + +F + ++ ++GK +
Sbjct: 206 FYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTLKEGKRLPCP 265
Query: 643 DTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLE 684
P E +M C P+ R S +++ E
Sbjct: 266 PNCP-----DEVYQLM----RKCWEFQPSNRTSFQNLIEGFE 298
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 165 bits (419), Expect = 3e-46
Identities = 73/270 (27%), Positives = 118/270 (43%), Gaps = 34/270 (12%)
Query: 424 IGEGGFGPVYKGLLADGTAIAVKQL--SSKSKQGNREFINEIGMISALQHPNLVKLYGCC 481
+G G FG V G +AVK + S S+ EF E + L HP LVK YG C
Sbjct: 16 LGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSED---EFFQEAQTMMKLSHPKLVKFYGVC 72
Query: 482 IEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRD 541
+ + ++ EY+ N L L H L+ +C + G+A+L + +HRD
Sbjct: 73 SKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFL---ESHQFIHRD 129
Query: 542 IKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGT---IGYMAPEYAMRGHLTEKA 598
+ A N L+D+DL K+SDFG+ + ++ GT + + APE + K+
Sbjct: 130 LAARNCLVDRDLCVKVSDFGMTRYVLDDQY---VSSVGTKFPVKWSAPEVFHYFKYSSKS 186
Query: 599 DVYSFGIVALEIVS-GRS---NVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDKEQ 654
DV++FGI+ E+ S G+ T ++ + QG + + + Q
Sbjct: 187 DVWAFGILMWEVFSLGKMPYDLYTNSEVVLKV-------SQGHRLYRPHLASDTIY---Q 236
Query: 655 VMVMINVALLCANASPTIRPSMSSVLRMLE 684
+M C + P RP+ +L +E
Sbjct: 237 IM------YSCWHELPEKRPTFQQLLSSIE 260
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 165 bits (419), Expect = 5e-46
Identities = 65/275 (23%), Positives = 111/275 (40%), Gaps = 44/275 (16%)
Query: 424 IGEGGFGPVYKGLLADGTAIAVKQL--SSKSKQGNREFINEIGMISALQHPNLVKLYGCC 481
+G G FG V G +A+K + S S+ EFI E ++ L H LV+LYG C
Sbjct: 32 LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSED---EFIEEAKVMMNLSHEKLVQLYGVC 88
Query: 482 IEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRD 541
+ + +I EY+ N L L E R + +C + + YL + +HRD
Sbjct: 89 TKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYL---ESKQFLHRD 145
Query: 542 IKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGT---IGYMAPEYAMRGHLTEKA 598
+ A N L++ K+SDFGL++ ++ T G+ + + PE M + K+
Sbjct: 146 LAARNCLVNDQGVVKVSDFGLSRYVLDDEY---TSSVGSKFPVRWSPPEVLMYSKFSSKS 202
Query: 599 DVYSFGIVALEIVS-------GRSNVTKEDMFYLLDWALVLK--EQGKLMELVDTNPGSN 649
D+++FG++ EI S +N + + QG +
Sbjct: 203 DIWAFGVLMWEIYSLGKMPYERFTN------------SETAEHIAQGLRLYRPHLASEKV 250
Query: 650 FDKEQVMVMINVALLCANASPTIRPSMSSVLRMLE 684
+ +M C + RP+ +L +
Sbjct: 251 Y---TIM------YSCWHEKADERPTFKILLSNIL 276
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 166 bits (422), Expect = 5e-46
Identities = 74/292 (25%), Positives = 120/292 (41%), Gaps = 56/292 (19%)
Query: 424 IGEGGFGPVYKGLLADG------TAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKL 477
+GEG FG V+ + +AVK L S+ ++F E +++ LQH ++V+
Sbjct: 49 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 108
Query: 478 YGCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRR--------------ICLGIA 523
+G C EG LL+++EY+ + L R L H + +A
Sbjct: 109 FGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVA 168
Query: 524 RGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGT--- 580
G+ YL + + VHRD+ N L+ + L KI DFG+++ + RV G
Sbjct: 169 AGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDY---YRVGGRTML 222
Query: 581 -IGYMAPEYAMRGHLTEKADVYSFGIVALEIVS-------GRSNVTKEDMFYLLDWALVL 632
I +M PE + T ++DV+SFG+V EI + SN + +
Sbjct: 223 PIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSN---TEAIDCI------ 273
Query: 633 KEQGKLMELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLE 684
QG+ +E P + +M C P R S+ V L+
Sbjct: 274 -TQGRELERPRACPPEVY---AIM------RGCWQREPQQRHSIKDVHARLQ 315
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 165 bits (419), Expect = 5e-46
Identities = 70/283 (24%), Positives = 125/283 (44%), Gaps = 35/283 (12%)
Query: 424 IGEGGFGPVYKGLL-----ADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLY 478
+G+G FG V G +AVK+L +++ R+F EI ++ +LQH N+VK
Sbjct: 18 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 77
Query: 479 GCCIEGNQ--LLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIK 536
G C + L LI EYL SL L +H+ ++D + I +G+ YL ++ +
Sbjct: 78 GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYL--GTK-R 134
Query: 537 VVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGT--IGYMAPEYAMRGHL 594
+HRD+ N+L++ + KI DFGL K+ ++ + G I + APE
Sbjct: 135 YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKF 194
Query: 595 TEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWAL----------VLK--EQGKLMELV 642
+ +DV+SFG+V E+ + ++ +++ + +
Sbjct: 195 SVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRP 254
Query: 643 DTNPGSNFDKEQV-MVMINVALLCANASPTIRPSMSSVLRMLE 684
D P +++ M+M C N + RPS + ++
Sbjct: 255 DGCP------DEIYMIM----TECWNNNVNQRPSFRDLALRVD 287
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 163 bits (416), Expect = 7e-46
Identities = 74/270 (27%), Positives = 125/270 (46%), Gaps = 34/270 (12%)
Query: 424 IGEGGFGPVYKGLLADGTAIAVKQL--SSKSKQGNREFINEIGMISALQHPNLVKLYGCC 481
IG G FG V+ G + +A+K + + S++ +FI E ++ L HP LV+LYG C
Sbjct: 16 IGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEE---DFIEEAEVMMKLSHPKLVQLYGVC 72
Query: 482 IEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRD 541
+E + L+ E++E+ L+ L R T +CL + G+AYL V+HRD
Sbjct: 73 LEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYL---EEACVIHRD 129
Query: 542 IKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGT---IGYMAPEYAMRGHLTEKA 598
+ A N L+ ++ K+SDFG+ + ++ T GT + + +PE + K+
Sbjct: 130 LAARNCLVGENQVIKVSDFGMTRFVLDDQY---TSSTGTKFPVKWASPEVFSFSRYSSKS 186
Query: 599 DVYSFGIVALEIVS-GRS---NVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDKEQ 654
DV+SFG++ E+ S G+ N + ++ + G + + Q
Sbjct: 187 DVWSFGVLMWEVFSEGKIPYENRSNSEVVEDI-------STGFRLYKPRLASTHVY---Q 236
Query: 655 VMVMINVALLCANASPTIRPSMSSVLRMLE 684
+M C P RP+ S +LR L
Sbjct: 237 IM------NHCWRERPEDRPAFSRLLRQLA 260
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 165 bits (420), Expect = 8e-46
Identities = 70/283 (24%), Positives = 126/283 (44%), Gaps = 35/283 (12%)
Query: 424 IGEGGFGPVYKGLL-----ADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLY 478
+G+G FG V G +AVK+L +++ R+F EI ++ +LQH N+VK
Sbjct: 49 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 108
Query: 479 GCCIEGNQ--LLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIK 536
G C + L LI EYL SL L +H+ ++D + I +G+ YL ++ +
Sbjct: 109 GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYL--GTK-R 165
Query: 537 VVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGT--IGYMAPEYAMRGHL 594
+HRD+ N+L++ + KI DFGL K+ ++ + + G I + APE
Sbjct: 166 YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKF 225
Query: 595 TEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWAL----------VLK--EQGKLMELV 642
+ +DV+SFG+V E+ + ++ +++ + +
Sbjct: 226 SVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRP 285
Query: 643 DTNPGSNFDKEQV-MVMINVALLCANASPTIRPSMSSVLRMLE 684
D P +++ M+M C N + RPS + ++
Sbjct: 286 DGCP------DEIYMIM----TECWNNNVNQRPSFRDLALRVD 318
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 164 bits (418), Expect = 8e-46
Identities = 75/293 (25%), Positives = 127/293 (43%), Gaps = 57/293 (19%)
Query: 424 IGEGGFGPVYKGLLADG------TAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKL 477
+GEG FG V+ + +AVK L + ++F E +++ LQH ++VK
Sbjct: 23 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 82
Query: 478 YGCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRR---------------ICLGI 522
YG C +G+ L++++EY+++ L + L H + I I
Sbjct: 83 YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 142
Query: 523 ARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGT-- 580
A G+ YL + VHRD+ N L+ +L KI DFG+++ + + RV G
Sbjct: 143 ASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYY---RVGGHTM 196
Query: 581 --IGYMAPEYAMRGHLTEKADVYSFGIVALEIVS-------GRSNVTKEDMFYLLDWALV 631
I +M PE M T ++DV+SFG++ EI + SN ++ +
Sbjct: 197 LPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSN---TEVIECI----- 248
Query: 632 LKEQGKLMELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLE 684
QG+++E P +D VM L C P R ++ + ++L
Sbjct: 249 --TQGRVLERPRVCPKEVYD---VM------LGCWQREPQQRLNIKEIYKILH 290
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 164 bits (418), Expect = 1e-45
Identities = 82/281 (29%), Positives = 125/281 (44%), Gaps = 32/281 (11%)
Query: 424 IGEGGFGPVYKGLL-----ADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLY 478
+G+G FG V G +AVKQL R+F EI ++ AL +VK
Sbjct: 31 LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYR 90
Query: 479 GCCIEGNQ--LLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIK 536
G + L L+ EYL + L L HR +LD I +G+ YL SR +
Sbjct: 91 GVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYL--GSR-R 147
Query: 537 VVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGT--IGYMAPEYAMRGHL 594
VHRD+ A N+L++ + + KI+DFGLAKL + + R G I + APE
Sbjct: 148 CVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIF 207
Query: 595 TEKADVYSFGIVALEIVS-GRSNVTKEDMFYLLDWAL--------VLK--EQGKLMELVD 643
+ ++DV+SFG+V E+ + + + F + +L+ E+G+ +
Sbjct: 208 SRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELLEEGQRLPAPP 267
Query: 644 TNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLE 684
P E +M LC SP RPS S++ L+
Sbjct: 268 ACP-----AEVHELM----KLCWAPSPQDRPSFSALGPQLD 299
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 164 bits (418), Expect = 2e-45
Identities = 71/273 (26%), Positives = 126/273 (46%), Gaps = 33/273 (12%)
Query: 424 IGEGGFGPVYKGLLADG-----TAIAVKQL-SSKSKQGNREFINEIGMISALQHPNLVKL 477
+G G FG VYKGL +A+K+L + S + N+E ++E +++++ +P++ +L
Sbjct: 23 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82
Query: 478 YGCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKV 537
G C+ + + LI + + L + EH+ + C+ IA+G+ YL E R ++
Sbjct: 83 LGICLT-STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL--EDR-RL 138
Query: 538 VHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGT-IGYMAPEYAMRGHLTE 596
VHRD+ A NVL+ + KI+DFGLAKL E I +MA E + T
Sbjct: 139 VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTH 198
Query: 597 KADVYSFGIVALEIVS-GRS---NVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDK 652
++DV+S+G+ E+++ G + ++ +L E+G+ +
Sbjct: 199 QSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL-------EKGERLPQPPICT------ 245
Query: 653 EQV-MVMINVALLCANASPTIRPSMSSVLRMLE 684
V M+M C RP ++
Sbjct: 246 IDVYMIM----RKCWMIDADSRPKFRELIIEFS 274
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 163 bits (414), Expect = 3e-45
Identities = 74/274 (27%), Positives = 123/274 (44%), Gaps = 32/274 (11%)
Query: 424 IGEGGFGPVYKGLLADG----TAIAVKQLSSKSKQGNR-EFINEIGMISALQHPNLVKLY 478
IG G FG VY G L D AVK L+ + G +F+ E ++ HPN++ L
Sbjct: 33 IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 92
Query: 479 GCCIEG-NQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKV 537
G C+ L++ Y+++ L + L +A+G+ YL S+ K
Sbjct: 93 GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYL--ASK-KF 149
Query: 538 VHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGT---IGYMAPEYAMRGHL 594
VHRD+ A N +LD+ K++DFGLA+ ++ + G + +MA E
Sbjct: 150 VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKF 209
Query: 595 TEKADVYSFGIVALEIVS-GRS---NVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNF 650
T K+DV+SFG++ E+++ G +V D+ L QG+ + + P +
Sbjct: 210 TTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYL-------LQGRRLLQPEYCPDPLY 262
Query: 651 DKEQVMVMINVALLCANASPTIRPSMSSVLRMLE 684
+VM L C + +RPS S ++ +
Sbjct: 263 ---EVM------LKCWHPKAEMRPSFSELVSRIS 287
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 163 bits (414), Expect = 3e-45
Identities = 70/274 (25%), Positives = 121/274 (44%), Gaps = 32/274 (11%)
Query: 424 IGEGGFGPVYKGLLADG----TAIAVKQLSSKSKQGNR-EFINEIGMISALQHPNLVKLY 478
IG+G FG VY G D A+K LS ++ F+ E ++ L HPN++ L
Sbjct: 29 IGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALI 88
Query: 479 GCCIEGN-QLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKV 537
G + ++ Y+ + L + + + L +ARG+ YL + K
Sbjct: 89 GIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYL---AEQKF 145
Query: 538 VHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGT---IGYMAPEYAMRGHL 594
VHRD+ A N +LD+ K++DFGLA+ + + + + + A E
Sbjct: 146 VHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALESLQTYRF 205
Query: 595 TEKADVYSFGIVALEIVS-GRS---NVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNF 650
T K+DV+SFG++ E+++ G ++ D+ + L QG+ + + P S +
Sbjct: 206 TTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFL-------AQGRRLPQPEYCPDSLY 258
Query: 651 DKEQVMVMINVALLCANASPTIRPSMSSVLRMLE 684
QVM C A P +RP+ ++ +E
Sbjct: 259 ---QVM------QQCWEADPAVRPTFRVLVGEVE 283
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 164 bits (418), Expect = 6e-45
Identities = 74/274 (27%), Positives = 131/274 (47%), Gaps = 34/274 (12%)
Query: 424 IGEGGFGPVYKGLL----ADGTAIAVKQL-SSKSKQGNREFINEIGMISALQHPNLVKLY 478
+G G FG V G L ++A+K L +++ R+F+ E ++ HPN+++L
Sbjct: 53 VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLE 112
Query: 479 GCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVV 538
G + ++++ EY+EN SL L +H + + GIA G+ YL S + V
Sbjct: 113 GVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYL---SDMGYV 169
Query: 539 HRDIKATNVLLDKDLNSKISDFGLAKL--DEEENTHISTRVAGTIGYMAPEYAMRGHLTE 596
HRD+ A N+L++ +L K+SDFGL ++ D+ E + + I + +PE T
Sbjct: 170 HRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTS 229
Query: 597 KADVYSFGIVALEIVS-GRS---NVTKEDMFYLLDWALVLK--EQGKLMELVDTNPGSNF 650
+DV+S+GIV E++S G ++ +D V+K ++G + P + +
Sbjct: 230 ASDVWSYGIVLWEVMSYGERPYWEMSNQD---------VIKAVDEGYRLPPPMDCPAALY 280
Query: 651 DKEQVMVMINVALLCANASPTIRPSMSSVLRMLE 684
Q+M L C RP ++ +L+
Sbjct: 281 ---QLM------LDCWQKDRNNRPKFEQIVSILD 305
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 162 bits (413), Expect = 8e-45
Identities = 76/272 (27%), Positives = 130/272 (47%), Gaps = 30/272 (11%)
Query: 424 IGEGGFGPVYKGLL----ADGTAIAVKQL-SSKSKQGNREFINEIGMISALQHPNLVKLY 478
IG G G V G L +A+K L + +++ R+F++E ++ HPN+++L
Sbjct: 57 IGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLE 116
Query: 479 GCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVV 538
G G +++ EY+EN SL L H + + G+ G+ YL S + V
Sbjct: 117 GVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYL---SDLGYV 173
Query: 539 HRDIKATNVLLDKDLNSKISDFGLAKL--DEEENTHISTRVAGTIGYMAPEYAMRGHLTE 596
HRD+ A NVL+D +L K+SDFGL+++ D+ + + +T I + APE +
Sbjct: 174 HRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSS 233
Query: 597 KADVYSFGIVALEIVS-GRS---NVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDK 652
+DV+SFG+V E+++ G N+T D+ + E+G + P +
Sbjct: 234 ASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSV-------EEGYRLPAPMGCPHALH-- 284
Query: 653 EQVMVMINVALLCANASPTIRPSMSSVLRMLE 684
Q+M L C + RP S ++ +L+
Sbjct: 285 -QLM------LDCWHKDRAQRPRFSQIVSVLD 309
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 162 bits (413), Expect = 9e-45
Identities = 75/275 (27%), Positives = 133/275 (48%), Gaps = 35/275 (12%)
Query: 424 IGEGGFGPVYKGLLADGTA-----IAVKQL-SSKSKQGNREFINEIGMISALQHPNLVKL 477
IG G FG VYKG+L + +A+K L + +++ +F+ E G++ H N+++L
Sbjct: 52 IGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRL 111
Query: 478 YGCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKV 537
G + +++I EY+EN +L + L E + + GIA G+ YL + +
Sbjct: 112 EGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYL---ANMNY 168
Query: 538 VHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGT--IGYMAPEYAMRGHLT 595
VHRD+ A N+L++ +L K+SDFGL+++ E++ T G I + APE T
Sbjct: 169 VHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFT 228
Query: 596 EKADVYSFGIVALEIVS-GRS---NVTKEDMFYLLDWALVLK--EQGKLMELVDTNPGSN 649
+DV+SFGIV E+++ G ++ + V+K G + P +
Sbjct: 229 SASDVWSFGIVMWEVMTYGERPYWELSNHE---------VMKAINDGFRLPTPMDCPSAI 279
Query: 650 FDKEQVMVMINVALLCANASPTIRPSMSSVLRMLE 684
+ Q+M + C RP + ++ +L+
Sbjct: 280 Y---QLM------MQCWQQERARRPKFADIVSILD 305
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 162 bits (411), Expect = 1e-44
Identities = 78/282 (27%), Positives = 119/282 (42%), Gaps = 35/282 (12%)
Query: 424 IGEGGFGPVYKGLL-----ADGTAIAVKQL-SSKSKQGNREFINEIGMISALQHPNLVKL 477
+GEG FG V G +AVK L + Q + EI ++ L H +++K
Sbjct: 39 LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKY 98
Query: 478 YGCCIE--GNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRI 535
GCC + L L+ EY+ SL L H + L I G+AYL ++
Sbjct: 99 KGCCEDAGAASLQLVMEYVPLGSLRDYLPRHSIGL--AQLLLFAQQICEGMAYL--HAQ- 153
Query: 536 KVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGT--IGYMAPEYAMRGH 593
+HRD+ A NVLLD D KI DFGLAK E + + R G + + APE
Sbjct: 154 HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYK 213
Query: 594 LTEKADVYSFGIVALEIVS-GRSNVTKEDMFYLLDWA----------LVLKEQGKLMELV 642
+DV+SFG+ E+++ S+ + F L L E+G+ +
Sbjct: 214 FYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLERGERLPRP 273
Query: 643 DTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLE 684
D P E +M C + RP+ +++ +L+
Sbjct: 274 DKCP-----AEVYHLM----KNCWETEASFRPTFENLIPILK 306
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 162 bits (411), Expect = 2e-44
Identities = 56/197 (28%), Positives = 86/197 (43%), Gaps = 15/197 (7%)
Query: 424 IGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCCI 482
+G G FG V++ G AVK++ + + + E+ + L P +V LYG
Sbjct: 66 VGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFR-----VEELVACAGLSSPRIVPLYGAVR 120
Query: 483 EGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDI 542
EG + + E LE SL L + L GL YLH +++H D+
Sbjct: 121 EGPWVNIFMELLEGGSLG-QLIKQMGCLPEDRALYYLGQALEGLEYLHTR---RILHGDV 176
Query: 543 KATNVLLDKD-LNSKISDFGLAKLDEEENTHISTR----VAGTIGYMAPEYAMRGHLTEK 597
KA NVLL D + + DFG A + + S + GT +MAPE M K
Sbjct: 177 KADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAK 236
Query: 598 ADVYSFGIVALEIVSGR 614
D++S + L +++G
Sbjct: 237 VDIWSSCCMMLHMLNGC 253
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 160 bits (406), Expect = 2e-44
Identities = 71/270 (26%), Positives = 115/270 (42%), Gaps = 29/270 (10%)
Query: 424 IGEGGFGPVYKGLLADG----TAIAVKQL-SSKSKQGNREFINEIGMISALQHPNLVKLY 478
IGEG FG V++G+ A+A+K + S +F+ E + HP++VKL
Sbjct: 23 IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 82
Query: 479 GCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVV 538
G E N + +I E L L + LD + ++ LAYL + V
Sbjct: 83 GVITE-NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYL---ESKRFV 138
Query: 539 HRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPEYAMRGHLTEKA 598
HRDI A NVL+ + K+ DFGL++ E+ + +++ I +MAPE T +
Sbjct: 139 HRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSAS 198
Query: 599 DVYSFGIVALEIVS-GRS---NVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDKEQ 654
DV+ FG+ EI+ G V D+ + E G+ + + P + +
Sbjct: 199 DVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI-------ENGERLPMPPNCPPTLY---S 248
Query: 655 VMVMINVALLCANASPTIRPSMSSVLRMLE 684
+M C P+ RP + + L
Sbjct: 249 LM------TKCWAYDPSRRPRFTELKAQLS 272
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 165 bits (420), Expect = 3e-44
Identities = 73/296 (24%), Positives = 131/296 (44%), Gaps = 38/296 (12%)
Query: 424 IGEGGFGPVYKGLL-ADGTAIAVKQLSSKSKQGN---REFINEIGMISALQHPNLVKLYG 479
+G G +G VY+G+ +AVK L K+ EF+ E ++ ++HPNLV+L G
Sbjct: 228 LGGGQYGEVYEGVWKKYSLTVAVKTL----KEDTMEVEEFLKEAAVMKEIKHPNLVQLLG 283
Query: 480 CCIEGNQLLLIYEYLENNSLARALFEHR-LKLDWPTRRRICLGIARGLAYLHGESRIKVV 538
C +I E++ +L L E ++ + I+ + YL E + +
Sbjct: 284 VCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYL--EKK-NFI 340
Query: 539 HRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPEYAMRGHLTEKA 598
HR++ A N L+ ++ K++DFGL++L + I + APE + K+
Sbjct: 341 HRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKS 400
Query: 599 DVYSFGIVALEIVS-GRS---NVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDKEQ 654
DV++FG++ EI + G S + ++ LL E+ ME + P ++
Sbjct: 401 DVWAFGVLLWEIATYGMSPYPGIDLSQVYELL-------EKDYRMERPEGCP-----EKV 448
Query: 655 VMVMINVALLCANASPTIRPSMSSVLRMLECGVDVLDLVSDSSVSDIDETKAEAMR 710
+M C +P+ RPS + + + E + +SS+SD E +
Sbjct: 449 YELMRA----CWQWNPSDRPSFAEIHQAFE------TMFQESSISDEVEKELGKRG 494
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 162 bits (412), Expect = 3e-44
Identities = 72/274 (26%), Positives = 119/274 (43%), Gaps = 32/274 (11%)
Query: 424 IGEGGFGPVYKGLLADG----TAIAVKQL-SSKSKQGNREFINEIGMISALQHPNLVKLY 478
IG G FG VY G L D AVK L +F+ E ++ HPN++ L
Sbjct: 97 IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 156
Query: 479 GCCIEG-NQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKV 537
G C+ L++ Y+++ L + L +A+G+ +L S+ K
Sbjct: 157 GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFL--ASK-KF 213
Query: 538 VHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGT---IGYMAPEYAMRGHL 594
VHRD+ A N +LD+ K++DFGLA+ ++ G + +MA E
Sbjct: 214 VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKF 273
Query: 595 TEKADVYSFGIVALEIVS-GRS---NVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNF 650
T K+DV+SFG++ E+++ G +V D+ L QG+ + + P +
Sbjct: 274 TTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYL-------LQGRRLLQPEYCPDPLY 326
Query: 651 DKEQVMVMINVALLCANASPTIRPSMSSVLRMLE 684
+VM L C + +RPS S ++ +
Sbjct: 327 ---EVM------LKCWHPKAEMRPSFSELVSRIS 351
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 160 bits (406), Expect = 3e-44
Identities = 79/294 (26%), Positives = 120/294 (40%), Gaps = 58/294 (19%)
Query: 424 IGEGGFGPVYKGLLADG------TAIAVKQLSSK-SKQGNREFINEIGMISALQHPNLVK 476
+GE FG VYKG L A+A+K L K EF +E + + LQHPN+V
Sbjct: 17 LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVC 76
Query: 477 LYGCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRR---------------ICLG 521
L G + L +I+ Y + L L D + +
Sbjct: 77 LLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQ 136
Query: 522 IARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGT- 580
IA G+ YL S VVH+D+ NVL+ LN KISD GL + + ++ G
Sbjct: 137 IAAGMEYL---SSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADY---YKLLGNS 190
Query: 581 ---IGYMAPEYAMRGHLTEKADVYSFGIVALEIVS-------GRSNVTKEDMFYLLDWAL 630
I +MAPE M G + +D++S+G+V E+ S G SN +D+ ++
Sbjct: 191 LLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN---QDVVEMI---- 243
Query: 631 VLKEQGKLMELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLE 684
+++ D P + +M + C N P+ RP + L
Sbjct: 244 ---RNRQVLPCPDDCPAWVY---ALM------IECWNEFPSRRPRFKDIHSRLR 285
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 159 bits (405), Expect = 3e-44
Identities = 69/271 (25%), Positives = 117/271 (43%), Gaps = 30/271 (11%)
Query: 424 IGEGGFGPVYKGLLADG---TAIAVKQL-SSKSKQGNREFINEIGMISALQHPNLVKLYG 479
+G G FG V +G+ +A+K L K E + E ++ L +P +V+L G
Sbjct: 18 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 77
Query: 480 CCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVH 539
C + L+L+ E L + L R ++ + ++ G+ YL VH
Sbjct: 78 VC-QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYL---EEKNFVH 133
Query: 540 RDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGT--IGYMAPEYAMRGHLTEK 597
RD+ A NVLL +KISDFGL+K ++++ + R AG + + APE + +
Sbjct: 134 RDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSR 193
Query: 598 ADVYSFGIVALEIVS-GRS---NVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDKE 653
+DV+S+G+ E +S G+ + ++ + EQGK ME P +
Sbjct: 194 SDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFI-------EQGKRMECPPECPPELY--- 243
Query: 654 QVMVMINVALLCANASPTIRPSMSSVLRMLE 684
+M C RP +V + +
Sbjct: 244 ALM------SDCWIYKWEDRPDFLTVEQRMR 268
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 160 bits (407), Expect = 5e-44
Identities = 86/315 (27%), Positives = 137/315 (43%), Gaps = 51/315 (16%)
Query: 424 IGEGGFGPVYKGLLADG---TAIAVKQL-SSKSKQGNREFINEIGMISAL-QHPNLVKLY 478
IGEG FG V K + A+K++ SK +R+F E+ ++ L HPN++ L
Sbjct: 33 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 92
Query: 479 GCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRR---------------RICLGIA 523
G C L L EY + +L L + R+ P +A
Sbjct: 93 GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 152
Query: 524 RGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGY 583
RG+ YL S+ + +HRD+ A N+L+ ++ +KI+DFGL++ E R+ + +
Sbjct: 153 RGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLP--VRW 207
Query: 584 MAPEYAMRGHLTEKADVYSFGIVALEIVS-GRS---NVTKEDMFYLLDWALVLKEQGKLM 639
MA E T +DV+S+G++ EIVS G + +T +++ L QG +
Sbjct: 208 MAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKL-------PQGYRL 260
Query: 640 ELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVL----RMLECGVDVLDL--V 693
E N D E +M C P RPS + +L RMLE ++
Sbjct: 261 E-----KPLNCDDEVYDLM----RQCWREKPYERPSFAQILVSLNRMLEERKTYVNTTLY 311
Query: 694 SDSSVSDIDETKAEA 708
+ + ID + EA
Sbjct: 312 EKFTYAGIDCSAEEA 326
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 158 bits (403), Expect = 7e-44
Identities = 75/298 (25%), Positives = 133/298 (44%), Gaps = 42/298 (14%)
Query: 424 IGEGGFGPVYKGLL-ADGTAIAVKQLSSKSKQGN---REFINEIGMISALQHPNLVKLYG 479
+G G +G VY+G+ +AVK L K+ EF+ E ++ ++HPNLV+L G
Sbjct: 21 LGGGQYGEVYEGVWKKYSLTVAVKTL----KEDTMEVEEFLKEAAVMKEIKHPNLVQLLG 76
Query: 480 CCIEGNQLLLIYEYLENNSLARALFEHR-LKLDWPTRRRICLGIARGLAYLHGESRIKVV 538
C +I E++ +L L E ++ + I+ + YL E + +
Sbjct: 77 VCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYL--EKK-NFI 133
Query: 539 HRDIKATNVLLDKDLNSKISDFGLAKL--DEEENTHISTRVAGTIGYMAPEYAMRGHLTE 596
HRD+ A N L+ ++ K++DFGL++L + H + I + APE +
Sbjct: 134 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFP--IKWTAPESLAYNKFSI 191
Query: 597 KADVYSFGIVALEIVS-GRS---NVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDK 652
K+DV++FG++ EI + G S + ++ LL E+ ME + P +
Sbjct: 192 KSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL-------EKDYRMERPEGCPEKVY-- 242
Query: 653 EQVMVMINVALLCANASPTIRPSMSSVLRMLECGVDVLDLVSDSSVSDIDETKAEAMR 710
++M C +P+ RPS + + + E + +SS+SD E +
Sbjct: 243 -ELM------RACWQWNPSDRPSFAEIHQAFE------TMFQESSISDEVEKELGKRG 287
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 159 bits (405), Expect = 1e-43
Identities = 68/274 (24%), Positives = 121/274 (44%), Gaps = 35/274 (12%)
Query: 424 IGEGGFGPVYKGLLADG-----TAIAVKQL-SSKSKQGNREFINEIGMISALQHPNLVKL 477
+G G FG V+KG+ + +K + +Q + + + I +L H ++V+L
Sbjct: 21 LGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRL 80
Query: 478 YGCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKV 537
G C + L L+ +YL SL + +HR L + IA+G+ YL E +
Sbjct: 81 LGLCPG-SSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYL--EEH-GM 136
Query: 538 VHRDIKATNVLLDKDLNSKISDFGLAKL---DEEENTHISTRVAGTIGYMAPEYAMRGHL 594
VHR++ A NVLL +++DFG+A L D+++ + + I +MA E G
Sbjct: 137 VHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTP--IKWMALESIHFGKY 194
Query: 595 TEKADVYSFGIVALEIVS-GRS---NVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNF 650
T ++DV+S+G+ E+++ G + ++ LL E+G+ +
Sbjct: 195 THQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLL-------EKGERLAQPQICT---- 243
Query: 651 DKEQVMVMINVALLCANASPTIRPSMSSVLRMLE 684
+ MVM + C IRP+ +
Sbjct: 244 -IDVYMVM----VKCWMIDENIRPTFKELANEFT 272
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 159 bits (404), Expect = 1e-43
Identities = 76/288 (26%), Positives = 125/288 (43%), Gaps = 52/288 (18%)
Query: 424 IGEGGFGPVYKGLLADG------TAIAVKQLSSKSKQGNR-EFINEIGMISALQHPNLVK 476
+G+G FG VY+G+ T +A+K ++ + R EF+NE ++ ++V+
Sbjct: 33 LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 92
Query: 477 LYGCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRR---------ICLGIARGLA 527
L G +G L+I E + L L R + + IA G+A
Sbjct: 93 LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMA 152
Query: 528 YLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGT----IGY 583
YL + K VHRD+ A N ++ +D KI DFG+ + E + R G + +
Sbjct: 153 YL--NAN-KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDY---YRKGGKGLLPVRW 206
Query: 584 MAPEYAMRGHLTEKADVYSFGIVALEIVS-------GRSNVTKEDMFYLLDWALVLKEQG 636
M+PE G T +DV+SFG+V EI + G SN E + + +G
Sbjct: 207 MSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN---EQVLRFV-------MEG 256
Query: 637 KLMELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLE 684
L++ D P F+ +M M C +P +RPS ++ ++
Sbjct: 257 GLLDKPDNCPDMLFE---LMRM------CWQYNPKMRPSFLEIISSIK 295
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 158 bits (401), Expect = 4e-43
Identities = 71/272 (26%), Positives = 130/272 (47%), Gaps = 31/272 (11%)
Query: 424 IGEGGFGPVYKGLLADG-----TAIAVKQL-SSKSKQGNREFINEIGMISALQHPNLVKL 477
+G G FG VYKGL +A+K+L + S + N+E ++E +++++ +P++ +L
Sbjct: 23 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82
Query: 478 YGCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKV 537
G C+ + + LI + + L + EH+ + C+ IA+G+ YL E R ++
Sbjct: 83 LGICLT-STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL--EDR-RL 138
Query: 538 VHRDIKATNVLLDKDLNSKISDFGLAK-LDEEENTHISTRVAGTIGYMAPEYAMRGHLTE 596
VHRD+ A NVL+ + KI+DFGLAK L EE + + I +MA E + T
Sbjct: 139 VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTH 198
Query: 597 KADVYSFGIVALEIVS-GRS---NVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDK 652
++DV+S+G+ E+++ G + ++ +L E+G+ +
Sbjct: 199 QSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL-------EKGERLPQPPICT-----I 246
Query: 653 EQVMVMINVALLCANASPTIRPSMSSVLRMLE 684
+ M+M + C RP ++
Sbjct: 247 DVYMIM----VKCWMIDADSRPKFRELIIEFS 274
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 156 bits (397), Expect = 4e-43
Identities = 72/275 (26%), Positives = 118/275 (42%), Gaps = 39/275 (14%)
Query: 424 IGEGGFGPVYKGLL----ADGTAIAVKQL-SSKSKQGNREFINEIGMISALQHPNLVKLY 478
+GEG FG VY+G+ + +AVK + +F++E ++ L HP++VKL
Sbjct: 20 LGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLI 79
Query: 479 GCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVV 538
G E +I E L L ++ L T L I + +AYL I V
Sbjct: 80 GII-EEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYL---ESINCV 135
Query: 539 HRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGT---IGYMAPEYAMRGHLT 595
HRDI N+L+ K+ DFGL++ E+E+ + + T I +M+PE T
Sbjct: 136 HRDIAVRNILVASPECVKLGDFGLSRYIEDEDY---YKASVTRLPIKWMSPESINFRRFT 192
Query: 596 EKADVYSFGIVALEIVS-GRS---NVTKEDMFYLLDWALVLK--EQGKLMELVDTNPGSN 649
+DV+ F + EI+S G+ + +D V+ E+G + D P
Sbjct: 193 TASDVWMFAVCMWEILSFGKQPFFWLENKD---------VIGVLEKGDRLPKPDLCPPVL 243
Query: 650 FDKEQVMVMINVALLCANASPTIRPSMSSVLRMLE 684
+ +M C + P+ RP + ++ L
Sbjct: 244 Y---TLM------TRCWDYDPSDRPRFTELVCSLS 269
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 156 bits (396), Expect = 5e-43
Identities = 81/267 (30%), Positives = 126/267 (47%), Gaps = 32/267 (11%)
Query: 424 IGEGGFGPVYKGLLADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCCIE 483
IG+G FG V G G +AVK + K+ + F+ E +++ L+H NLV+L G +E
Sbjct: 29 IGKGEFGDVMLGD-YRGNKVAVKCI--KNDATAQAFLAEASVMTQLRHSNLVQLLGVIVE 85
Query: 484 GN-QLLLIYEYLENNSLARALFEH-RLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRD 541
L ++ EY+ SL L R L + L + + YL E VHRD
Sbjct: 86 EKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL--EGN-NFVHRD 142
Query: 542 IKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPEYAMRGHLTEKADVY 601
+ A NVL+ +D +K+SDFGL K E +T + ++ + + APE + K+DV+
Sbjct: 143 LAARNVLVSEDNVAKVSDFGLTK--EASSTQDTGKLP--VKWTAPEALREKKFSTKSDVW 198
Query: 602 SFGIVALEIVS-GRS---NVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDKEQVMV 657
SFGI+ EI S GR + +D+ + E+G M+ D P + + +VM
Sbjct: 199 SFGILLWEIYSFGRVPYPRIPLKDVVPRV-------EKGYKMDAPDGCPPAVY---EVM- 247
Query: 658 MINVALLCANASPTIRPSMSSVLRMLE 684
C + +RPS + LE
Sbjct: 248 -----KNCWHLDAAMRPSFLQLREQLE 269
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 157 bits (398), Expect = 6e-43
Identities = 71/286 (24%), Positives = 123/286 (43%), Gaps = 48/286 (16%)
Query: 424 IGEGGFGPVYKGLLADG----TAIAVKQL--SSKSKQGNREFINEIGMISALQHPNLVKL 477
+GEG FG V +G L +AVK + + S++ EF++E + HPN+++L
Sbjct: 42 LGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRL 101
Query: 478 YGCCIEGN-----QLLLIYEYLENNSLARALFEHRLKLD--WPTRR---RICLGIARGLA 527
G CIE + + ++I +++ L L RL+ + + + IA G+
Sbjct: 102 LGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGME 161
Query: 528 YLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIG----- 582
YL S +HRD+ A N +L D+ ++DFGL+K + + G I
Sbjct: 162 YL---SNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYY----RQGRIAKMPVK 214
Query: 583 YMAPEYAMRGHLTEKADVYSFGIVALEIVS-GRS---NVTKEDMFYLLDWALVLKEQGKL 638
++A E T K+DV++FG+ EI + G + V +M+ L G
Sbjct: 215 WIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYL-------LHGHR 267
Query: 639 MELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLE 684
++ + + ++M C P RP+ S + LE
Sbjct: 268 LKQPEDCLDELY---EIM------YSCWRTDPLDRPTFSVLRLQLE 304
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 157 bits (398), Expect = 8e-43
Identities = 76/314 (24%), Positives = 124/314 (39%), Gaps = 55/314 (17%)
Query: 424 IGEGGFGPVYKGLLADG------TAIAVKQLSSKSKQGNR-EFINEIGMISALQHPNLVK 476
+G G FG VY+G ++ +AVK L + + +F+ E +IS H N+V+
Sbjct: 38 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 97
Query: 477 LYGCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTR------RRICLGIARGLAYLH 530
G ++ ++ E + L L E R + P+ + IA G YL
Sbjct: 98 CIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL- 156
Query: 531 GESRIKVVHRDIKATNVLLDK---DLNSKISDFGLAKLDEEENTHISTRVAGT----IGY 583
+HRDI A N LL +KI DFG+A+ + R G + +
Sbjct: 157 --EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASY---YRKGGCAMLPVKW 211
Query: 584 MAPEYAMRGHLTEKADVYSFGIVALEIVS-------GRSNVTKEDMFYLLDWALVLKEQG 636
M PE M G T K D +SFG++ EI S +SN +++ + G
Sbjct: 212 MPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN---QEVLEFV-------TSG 261
Query: 637 KLMELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLECGV---DVLDLV 693
M+ PG + ++M C P RP+ + +L +E DV++
Sbjct: 262 GRMDPPKNCPGPVY---RIM------TQCWQHQPEDRPNFAIILERIEYCTQDPDVINTA 312
Query: 694 SDSSVSDIDETKAE 707
+ E + +
Sbjct: 313 LPIEYGPLVEEEEK 326
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 155 bits (395), Expect = 9e-43
Identities = 71/272 (26%), Positives = 115/272 (42%), Gaps = 32/272 (11%)
Query: 424 IGEGGFGPVYKGLL---ADGTAIAVKQL--SSKSKQGNREFINEIGMISALQHPNLVKLY 478
+G G FG V KG +AVK L + E + E ++ L +P +V++
Sbjct: 25 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 84
Query: 479 GCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVV 538
G C E +L+ E E L + L ++R + + ++ G+ YL E V
Sbjct: 85 GIC-EAESWMLVMEMAELGPLNKYLQQNR-HVKDKNIIELVHQVSMGMKYL--EES-NFV 139
Query: 539 HRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGT--IGYMAPEYAMRGHLTE 596
HRD+ A NVLL +KISDFGL+K + + + G + + APE +
Sbjct: 140 HRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSS 199
Query: 597 KADVYSFGIVALEIVS-GRS---NVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDK 652
K+DV+SFG++ E S G+ + ++ +L E+G+ M P +
Sbjct: 200 KSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAML-------EKGERMGCPAGCPREMY-- 250
Query: 653 EQVMVMINVALLCANASPTIRPSMSSVLRMLE 684
+M LC RP ++V L
Sbjct: 251 -DLM------NLCWTYDVENRPGFAAVELRLR 275
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 164 bits (416), Expect = 9e-43
Identities = 71/270 (26%), Positives = 115/270 (42%), Gaps = 29/270 (10%)
Query: 424 IGEGGFGPVYKGLLADG----TAIAVKQL-SSKSKQGNREFINEIGMISALQHPNLVKLY 478
IGEG FG V++G+ A+A+K + S +F+ E + HP++VKL
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 457
Query: 479 GCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVV 538
G E N + +I E L L + LD + ++ LAYL + V
Sbjct: 458 GVITE-NPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYL---ESKRFV 513
Query: 539 HRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPEYAMRGHLTEKA 598
HRDI A NVL+ + K+ DFGL++ E+ + +++ I +MAPE T +
Sbjct: 514 HRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSAS 573
Query: 599 DVYSFGIVALEIVS-GRS---NVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDKEQ 654
DV+ FG+ EI+ G V D+ + E G+ + + P + +
Sbjct: 574 DVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI-------ENGERLPMPPNCPPTLY---S 623
Query: 655 VMVMINVALLCANASPTIRPSMSSVLRMLE 684
+M C P+ RP + + L
Sbjct: 624 LM------TKCWAYDPSRRPRFTELKAQLS 647
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 157 bits (398), Expect = 9e-43
Identities = 66/286 (23%), Positives = 118/286 (41%), Gaps = 47/286 (16%)
Query: 424 IGEGGFGPVYKGLLADG----TAIAVKQL--SSKSKQGNREFINEIGMISALQHPNLVKL 477
+G+G FG V + L +AVK L + EF+ E + HP++ KL
Sbjct: 31 LGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKL 90
Query: 478 YGCCIEG------NQLLLIYEYLENNSLARALFEHRL-----KLDWPTRRRICLGIARGL 526
G + ++I ++++ L L R+ L T R + IA G+
Sbjct: 91 VGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGM 150
Query: 527 AYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGT----IG 582
YL SR +HRD+ A N +L +D+ ++DFGL++ + + R +
Sbjct: 151 EYL--SSR-NFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYY---RQGCASKLPVK 204
Query: 583 YMAPEYAMRGHLTEKADVYSFGIVALEIVS-GRS---NVTKEDMFYLLDWALVLKEQGKL 638
++A E T +DV++FG+ EI++ G++ + +++ L G
Sbjct: 205 WLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYL-------IGGNR 257
Query: 639 MELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLE 684
++ +D +M C +A P RPS + + LE
Sbjct: 258 LKQPPECMEEVYD---LM------YQCWSADPKQRPSFTCLRMELE 294
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 155 bits (394), Expect = 9e-43
Identities = 91/272 (33%), Positives = 131/272 (48%), Gaps = 38/272 (13%)
Query: 424 IGEGGFGPVYKGLLADGTAIAVKQLSSKSKQGN---REFINEIGMISALQHPNLVKLYGC 480
+G G FG V+ G T +AVK L KQG+ F+ E ++ LQH LV+LY
Sbjct: 21 LGAGQFGEVWMGYYNGHTKVAVKSL----KQGSMSPDAFLAEANLMKQLQHQRLVRLYAV 76
Query: 481 CIEGNQLLLIYEYLENNSLARALFEHR-LKLDWPTRRRICLGIARGLAYLHGESRIKVVH 539
+ + +I EY+EN SL L +KL + IA G+A++ E R +H
Sbjct: 77 VTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFI--EER-NYIH 132
Query: 540 RDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGT---IGYMAPEYAMRGHLTE 596
RD++A N+L+ L+ KI+DFGLA+L E+ T G I + APE G T
Sbjct: 133 RDLRAANILVSDTLSCKIADFGLARLIEDN---EYTAREGAKFPIKWTAPEAINYGTFTI 189
Query: 597 KADVYSFGIVALEIVS-GRS---NVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDK 652
K+DV+SFGI+ EIV+ GR +T ++ L E+G M D P +
Sbjct: 190 KSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNL-------ERGYRMVRPDNCPEELY-- 240
Query: 653 EQVMVMINVALLCANASPTIRPSMSSVLRMLE 684
Q+M LC P RP+ + +LE
Sbjct: 241 -QLM------RLCWKERPEDRPTFDYLRSVLE 265
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 162 bits (412), Expect = 2e-42
Identities = 70/275 (25%), Positives = 120/275 (43%), Gaps = 30/275 (10%)
Query: 420 TDNNIGEGGFGPVYKGLLADG---TAIAVKQL-SSKSKQGNREFINEIGMISALQHPNLV 475
D +G G FG V +G+ +A+K L K E + E ++ L +P +V
Sbjct: 340 ADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIV 399
Query: 476 KLYGCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRI 535
+L G C + L+L+ E L + L R ++ + ++ G+ YL E +
Sbjct: 400 RLIGVC-QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYL--EEK- 455
Query: 536 KVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGT--IGYMAPEYAMRGH 593
VHR++ A NVLL +KISDFGL+K ++++ + R AG + + APE
Sbjct: 456 NFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRK 515
Query: 594 LTEKADVYSFGIVALEIVS-GRS---NVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSN 649
+ ++DV+S+G+ E +S G+ + ++ + EQGK ME P
Sbjct: 516 FSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFI-------EQGKRMECPPECPPEL 568
Query: 650 FDKEQVMVMINVALLCANASPTIRPSMSSVLRMLE 684
+ +M C RP +V + +
Sbjct: 569 Y---ALM------SDCWIYKWEDRPDFLTVEQRMR 594
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 159 bits (403), Expect = 2e-42
Identities = 82/269 (30%), Positives = 125/269 (46%), Gaps = 36/269 (13%)
Query: 424 IGEGGFGPVYKGLLADGTAIAVKQLSSKSKQGN--REFINEIGMISALQHPNLVKLYGCC 481
IG+G FG V G G +AVK + K + F+ E +++ L+H NLV+L G
Sbjct: 201 IGKGEFGDVMLGDY-RGNKVAVKCI----KNDATAQAFLAEASVMTQLRHSNLVQLLGVI 255
Query: 482 IEGN-QLLLIYEYLENNSLARALFEH-RLKLDWPTRRRICLGIARGLAYLHGESRIKVVH 539
+E L ++ EY+ SL L R L + L + + YL E VH
Sbjct: 256 VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL--EGN-NFVH 312
Query: 540 RDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPEYAMRGHLTEKAD 599
RD+ A NVL+ +D +K+SDFGL K E +T + ++ + + APE + K+D
Sbjct: 313 RDLAARNVLVSEDNVAKVSDFGLTK--EASSTQDTGKLP--VKWTAPEALREKKFSTKSD 368
Query: 600 VYSFGIVALEIVS-GRS---NVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDKEQV 655
V+SFGI+ EI S GR + +D+ + E+G M+ D P + +D
Sbjct: 369 VWSFGILLWEIYSFGRVPYPRIPLKDVVPRV-------EKGYKMDAPDGCPPAVYD---- 417
Query: 656 MVMINVALLCANASPTIRPSMSSVLRMLE 684
VM N C + RP+ + LE
Sbjct: 418 -VMKN----CWHLDAATRPTFLQLREQLE 441
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 155 bits (393), Expect = 3e-42
Identities = 70/267 (26%), Positives = 121/267 (45%), Gaps = 23/267 (8%)
Query: 424 IGEGGFGPVYKGL-LADGTAIAVKQL---SSKSKQGNREFINEIGMISALQHPNLVKLYG 479
IG G F VY+ L DG +A+K++ + + I EI ++ L HPN++K Y
Sbjct: 40 IGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYA 99
Query: 480 CCIEGNQLLLIYEYLENNSLARALFEHRLK---LDWPTRRRICLGIARGLAYLHGESRIK 536
IE N+L ++ E + L+R + + + + T + + + L ++H +
Sbjct: 100 SFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSR---R 156
Query: 537 VVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPEYAMRGHLTE 596
V+HRDIK NV + K+ D GL + + T + V GT YM+PE
Sbjct: 157 VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYMSPERIHENGYNF 215
Query: 597 KADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLK-EQGKLMELVDTNPGSNFDKEQV 655
K+D++S G + E+ + +S + M +L K EQ L P ++ +E
Sbjct: 216 KSDIWSLGCLLYEMAALQSPFYGDKMNLY---SLCKKIEQCDYPPL----PSDHYSEE-- 266
Query: 656 MVMINVALLCANASPTIRPSMSSVLRM 682
+ + +C N P RP ++ V +
Sbjct: 267 --LRQLVNMCINPDPEKRPDVTYVYDV 291
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 158 bits (401), Expect = 5e-42
Identities = 80/269 (29%), Positives = 122/269 (45%), Gaps = 32/269 (11%)
Query: 424 IGEGGFGPVYKGLLADGTAIAVKQLSSKSKQGN---REFINEIGMISALQHPNLVKLYGC 480
+G+G FG V+ G T +A+K L K G F+ E ++ L+H LV+LY
Sbjct: 192 LGQGCFGEVWMGTWNGTTRVAIKTL----KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 247
Query: 481 CIEGNQLLLIYEYLENNSLARALFEHR-LKLDWPTRRRICLGIARGLAYLHGESRIKVVH 539
E + ++ EY+ SL L L P + IA G+AY+ E VH
Sbjct: 248 VSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYV--ERM-NYVH 303
Query: 540 RDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPEYAMRGHLTEKAD 599
RD++A N+L+ ++L K++DFGLA+L E+ I + APE A+ G T K+D
Sbjct: 304 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 363
Query: 600 VYSFGIVALEIVS-GRS---NVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDKEQV 655
V+SFGI+ E+ + GR + ++ + E+G M P S D
Sbjct: 364 VWSFGILLTELTTKGRVPYPGMVNREVLDQV-------ERGYRMPCPPECPESLHD---- 412
Query: 656 MVMINVALLCANASPTIRPSMSSVLRMLE 684
+M C P RP+ + LE
Sbjct: 413 -LMCQ----CWRKEPEERPTFEYLQAFLE 436
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 156 bits (396), Expect = 5e-42
Identities = 75/311 (24%), Positives = 122/311 (39%), Gaps = 49/311 (15%)
Query: 424 IGEGGFGPVYKGLL------ADGTAIAVKQLSSKSKQGNR-EFINEIGMISALQHPNLVK 476
+G G FG VY+G + +AVK L + + +F+ E +IS H N+V+
Sbjct: 79 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 138
Query: 477 LYGCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTR------RRICLGIARGLAYLH 530
G ++ ++ E + L L E R + P+ + IA G YL
Sbjct: 139 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL- 197
Query: 531 GESRIKVVHRDIKATNVLLDK---DLNSKISDFGLAKLDEEENTHISTRVAGT----IGY 583
+HRDI A N LL +KI DFG+A+ R G + +
Sbjct: 198 --EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGY---YRKGGCAMLPVKW 252
Query: 584 MAPEYAMRGHLTEKADVYSFGIVALEIVS-GRS---NVTKEDMFYLLDWALVLKEQGKLM 639
M PE M G T K D +SFG++ EI S G + + +++ + G M
Sbjct: 253 MPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFV-------TSGGRM 305
Query: 640 ELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLECGV---DVLDLVSDS 696
+ PG + ++M C P RP+ + +L +E DV++
Sbjct: 306 DPPKNCPGPVY---RIM------TQCWQHQPEDRPNFAIILERIEYCTQDPDVINTALPI 356
Query: 697 SVSDIDETKAE 707
+ E + +
Sbjct: 357 EYGPLVEEEEK 367
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 154 bits (391), Expect = 9e-42
Identities = 77/314 (24%), Positives = 133/314 (42%), Gaps = 60/314 (19%)
Query: 424 IGEGGFGPVYKGLLAD--------GTAIAVKQLSSKSKQGNR-EFINEIGMISAL-QHPN 473
+GEG FG V +AVK L + + + + ++E+ M+ + +H N
Sbjct: 43 LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 474 LVKLYGCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRR---------------RI 518
++ L G C + L +I EY +L L R +
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 519 CLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVA 578
+ARG+ YL S+ K +HRD+ A NVL+ ++ KI+DFGLA+ + +
Sbjct: 163 TYQLARGMEYL--ASQ-KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYY----KK 215
Query: 579 GTIG-----YMAPEYAMRGHLTEKADVYSFGIVALEIVS-GRS---NVTKEDMFYLLDWA 629
T G +MAPE T ++DV+SFG++ EI + G S + E++F LL
Sbjct: 216 TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLL--- 272
Query: 630 LVLKEQGKLMELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLECGVDV 689
++G M+ + +M C +A P+ RP+ ++ L+ +
Sbjct: 273 ----KEGHRMDKPANCTNELYM---MM------RDCWHAVPSQRPTFKQLVEDLD---RI 316
Query: 690 LDLVSDSSVSDIDE 703
L L ++ D+ +
Sbjct: 317 LTLTTNEEYLDLSQ 330
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 152 bits (387), Expect = 1e-41
Identities = 54/198 (27%), Positives = 91/198 (45%), Gaps = 13/198 (6%)
Query: 424 IGEGGFGPVYKGLL----ADGTAIAVKQL---SSKSKQGNREFINEIGMISALQHPNLVK 476
+G+G FG V +G ++AVK L + +FI E+ + +L H NL++
Sbjct: 26 LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85
Query: 477 LYGCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIK 536
LYG + + ++ E SL L +H+ T R + +A G+ YL ES+ +
Sbjct: 86 LYGVVLT-PPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYL--ESK-R 141
Query: 537 VVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGT--IGYMAPEYAMRGHL 594
+HRD+ A N+LL KI DFGL + + + H + + APE
Sbjct: 142 FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTF 201
Query: 595 TEKADVYSFGIVALEIVS 612
+ +D + FG+ E+ +
Sbjct: 202 SHASDTWMFGVTLWEMFT 219
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 152 bits (387), Expect = 1e-41
Identities = 57/285 (20%), Positives = 113/285 (39%), Gaps = 53/285 (18%)
Query: 424 IGEGGFGPVYKGLL--------ADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLV 475
+G+G F ++KG+ T + +K L + + F M+S L H +LV
Sbjct: 16 LGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLV 75
Query: 476 KLYGCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRI 535
YG C+ G++ +L+ E+++ SL L +++ ++ + + +A + +L E
Sbjct: 76 LNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFL--EEN- 132
Query: 536 KVVHRDIKATNVLLDKDLNS--------KISDFGLAKLDEEENTHISTRVAGTIGYMAPE 587
++H ++ A N+LL ++ + K+SD G++ ++ + I ++ PE
Sbjct: 133 TLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKD---ILQER--IPWVPPE 187
Query: 588 -YAMRGHLTEKADVYSFGIVALEIVS-------GRSNVTKEDMFYLLDWALVLKEQGKLM 639
+L D +SFG EI S + K + E +
Sbjct: 188 CIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFY----------EDRHQL 237
Query: 640 ELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLE 684
+ N+ C + P RPS +++R L
Sbjct: 238 PAPKAAE-----------LANLINNCMDYEPDHRPSFRAIIRDLN 271
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 152 bits (387), Expect = 1e-41
Identities = 60/192 (31%), Positives = 103/192 (53%), Gaps = 9/192 (4%)
Query: 424 IGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCCI 482
IG+G G VY + +A G +A++Q++ + + INEI ++ ++PN+V +
Sbjct: 28 IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 87
Query: 483 EGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDI 542
G++L ++ EYL SL + E + +C + L +LH I HRDI
Sbjct: 88 VGDELWVVMEYLAGGSLTDVVTETCMDEGQIA--AVCRECLQALEFLHSNQVI---HRDI 142
Query: 543 KATNVLLDKDLNSKISDFGL-AKLDEEENTHISTRVAGTIGYMAPEYAMRGHLTEKADVY 601
K+ N+LL D + K++DFG A++ E++ + + GT +MAPE R K D++
Sbjct: 143 KSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MVGTPYWMAPEVVTRKAYGPKVDIW 200
Query: 602 SFGIVALEIVSG 613
S GI+A+E++ G
Sbjct: 201 SLGIMAIEMIEG 212
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 158 bits (400), Expect = 2e-41
Identities = 80/269 (29%), Positives = 122/269 (45%), Gaps = 32/269 (11%)
Query: 424 IGEGGFGPVYKGLLADGTAIAVKQLSSKSKQGN---REFINEIGMISALQHPNLVKLYGC 480
+G+G FG V+ G T +A+K L K G F+ E ++ L+H LV+LY
Sbjct: 275 LGQGCFGEVWMGTWNGTTRVAIKTL----KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 330
Query: 481 CIEGNQLLLIYEYLENNSLARALFEHR-LKLDWPTRRRICLGIARGLAYLHGESRIKVVH 539
E + ++ EY+ SL L L P + IA G+AY+ E VH
Sbjct: 331 VSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYV--ERM-NYVH 386
Query: 540 RDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPEYAMRGHLTEKAD 599
RD++A N+L+ ++L K++DFGLA+L E+ I + APE A+ G T K+D
Sbjct: 387 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 446
Query: 600 VYSFGIVALEIVS-GRS---NVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDKEQV 655
V+SFGI+ E+ + GR + ++ + E+G M P S D
Sbjct: 447 VWSFGILLTELTTKGRVPYPGMVNREVLDQV-------ERGYRMPCPPECPESLHD---- 495
Query: 656 MVMINVALLCANASPTIRPSMSSVLRMLE 684
+M C P RP+ + LE
Sbjct: 496 -LMCQ----CWRKEPEERPTFEYLQAFLE 519
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 152 bits (385), Expect = 4e-41
Identities = 61/192 (31%), Positives = 101/192 (52%), Gaps = 9/192 (4%)
Query: 424 IGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCCI 482
IGEG G V G +AVK + + +Q NE+ ++ QH N+V++Y +
Sbjct: 53 IGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYL 112
Query: 483 EGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDI 542
G +L ++ E+L+ +L + + RL + +C + + LAYLH + I HRDI
Sbjct: 113 VGEELWVLMEFLQGGALTDIVSQVRLNEEQIA--TVCEAVLQALAYLHAQGVI---HRDI 167
Query: 543 KATNVLLDKDLNSKISDFGL-AKLDEEENTHISTRVAGTIGYMAPEYAMRGHLTEKADVY 601
K+ ++LL D K+SDFG A++ ++ S + GT +MAPE R + D++
Sbjct: 168 KSDSILLTLDGRVKLSDFGFCAQISKDVPKRKS--LVGTPYWMAPEVISRSLYATEVDIW 225
Query: 602 SFGIVALEIVSG 613
S GI+ +E+V G
Sbjct: 226 SLGIMVIEMVDG 237
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 152 bits (386), Expect = 5e-41
Identities = 75/303 (24%), Positives = 122/303 (40%), Gaps = 68/303 (22%)
Query: 424 IGEGGFGPVYKGLLADG------TAIAVKQLSSK-SKQGNREFINEIGMISALQHPNLVK 476
IGEG FG V++ T +AVK L + S +F E +++ +PN+VK
Sbjct: 55 IGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVK 114
Query: 477 LYGCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRR-------------------- 516
L G C G + L++EY+ L L
Sbjct: 115 LLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCA 174
Query: 517 ---RICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHI 573
I +A G+AYL R K VHRD+ N L+ +++ KI+DFGL++ + +
Sbjct: 175 EQLCIARQVAAGMAYL--SER-KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYY- 230
Query: 574 STRVAGTIGY-----MAPEYAMRGHLTEKADVYSFGIVALEIVS-------GRSNVTKED 621
A M PE T ++DV+++G+V EI S G ++ E+
Sbjct: 231 ---KADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAH---EE 284
Query: 622 MFYLLDWALVLKEQGKLMELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLR 681
+ Y + G ++ + P ++ +M LC + P RPS S+ R
Sbjct: 285 VIYYV-------RDGNILACPENCPLELYN---LM------RLCWSKLPADRPSFCSIHR 328
Query: 682 MLE 684
+L+
Sbjct: 329 ILQ 331
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 150 bits (382), Expect = 6e-41
Identities = 59/200 (29%), Positives = 101/200 (50%), Gaps = 18/200 (9%)
Query: 424 IGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCCI 482
+G+G FG VYK G A K + +KS++ ++I EI +++ HP +VKL G
Sbjct: 27 LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYY 86
Query: 483 EGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDI 542
+L ++ E+ ++ + E L P + +C + L +LH + I HRD+
Sbjct: 87 HDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRII---HRDL 143
Query: 543 KATNVLLDKDLNSKISDFGL-AKLDEEE---NTHISTRVAGTIGYMAPEYAMRGHLTE-- 596
KA NVL+ + + +++DFG+ AK + ++ I GT +MAPE M + +
Sbjct: 144 KAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFI-----GTPYWMAPEVVMCETMKDTP 198
Query: 597 ---KADVYSFGIVALEIVSG 613
KAD++S GI +E+
Sbjct: 199 YDYKADIWSLGITLIEMAQI 218
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 1e-40
Identities = 63/200 (31%), Positives = 99/200 (49%), Gaps = 7/200 (3%)
Query: 415 TNNFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPN 473
F +GEG +G VYK + G +A+KQ+ +S +E I EI ++ P+
Sbjct: 28 EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESD--LQEIIKEISIMQQCDSPH 85
Query: 474 LVKLYGCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGES 533
+VK YG + L ++ EY S++ + L I +GL YLH
Sbjct: 86 VVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMR 145
Query: 534 RIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPEYAMRGH 593
+I HRDIKA N+LL+ + ++K++DFG+A + +T + GT +MAPE
Sbjct: 146 KI---HRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVI-GTPFWMAPEVIQEIG 201
Query: 594 LTEKADVYSFGIVALEIVSG 613
AD++S GI A+E+ G
Sbjct: 202 YNCVADIWSLGITAIEMAEG 221
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 154 bits (390), Expect = 1e-40
Identities = 79/272 (29%), Positives = 125/272 (45%), Gaps = 38/272 (13%)
Query: 424 IGEGGFGPVYKGLLADGTAIAVKQLSSKSKQGN---REFINEIGMISALQHPNLVKLYGC 480
+G G FG V+ T +AVK + K G+ F+ E ++ LQH LVKL+
Sbjct: 196 LGAGQFGEVWMATYNKHTKVAVKTM----KPGSMSVEAFLAEANVMKTLQHDKLVKLHAV 251
Query: 481 CIEGNQLLLIYEYLENNSLARALFEHR-LKLDWPTRRRICLGIARGLAYLHGESRIKVVH 539
+ + +I E++ SL L K P IA G+A++ E R +H
Sbjct: 252 VTK-EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFI--EQR-NYIH 307
Query: 540 RDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGT---IGYMAPEYAMRGHLTE 596
RD++A N+L+ L KI+DFGLA++ E+ T G I + APE G T
Sbjct: 308 RDLRAANILVSASLVCKIADFGLARVIEDNEY---TAREGAKFPIKWTAPEAINFGSFTI 364
Query: 597 KADVYSFGIVALEIVS-GRS---NVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDK 652
K+DV+SFGI+ +EIV+ GR ++ ++ L E+G M + P ++
Sbjct: 365 KSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRAL-------ERGYRMPRPENCPEELYN- 416
Query: 653 EQVMVMINVALLCANASPTIRPSMSSVLRMLE 684
+M+ C P RP+ + +L+
Sbjct: 417 ----IMMR----CWKNRPEERPTFEYIQSVLD 440
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 1e-40
Identities = 83/300 (27%), Positives = 127/300 (42%), Gaps = 62/300 (20%)
Query: 424 IGEGGFGPVYKGLLADG------TAIAVKQLSSKSKQGNR-EFINEIGMISALQHPNLVK 476
+GEG FG V K T +AVK L + + ++E ++ + HP+++K
Sbjct: 31 LGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIK 90
Query: 477 LYGCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRR-------------------- 516
LYG C + LLLI EY + SL L E R
Sbjct: 91 LYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMG 150
Query: 517 ---RICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHI 573
I++G+ YL K+VHRD+ A N+L+ + KISDFGL++ EE+++
Sbjct: 151 DLISFAWQISQGMQYL--AEM-KLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSY- 206
Query: 574 STRVAGTIG-----YMAPEYAMRGHLTEKADVYSFGIVALEIVS-GRS---NVTKEDMFY 624
V + G +MA E T ++DV+SFG++ EIV+ G + + E +F
Sbjct: 207 ---VKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPERLFN 263
Query: 625 LLDWALVLKEQGKLMELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLE 684
LL + G ME D + +M L C P RP + + + LE
Sbjct: 264 LL-------KTGHRMERPDNCSEEMYR---LM------LQCWKQEPDKRPVFADISKDLE 307
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 2e-40
Identities = 74/295 (25%), Positives = 125/295 (42%), Gaps = 57/295 (19%)
Query: 424 IGEGGFGPVYKGLLAD--------GTAIAVKQLSSKSKQGNR-EFINEIGMISAL-QHPN 473
+GEG FG V +AVK L + + + + ++E+ M+ + +H N
Sbjct: 89 LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 148
Query: 474 LVKLYGCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRR---------------RI 518
++ L G C + L +I EY +L L R +
Sbjct: 149 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 208
Query: 519 CLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVA 578
+ARG+ YL S+ K +HRD+ A NVL+ ++ KI+DFGLA+ + +
Sbjct: 209 TYQLARGMEYL--ASQ-KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYY----KK 261
Query: 579 GTIG-----YMAPEYAMRGHLTEKADVYSFGIVALEIVS-GRS---NVTKEDMFYLLDWA 629
T G +MAPE T ++DV+SFG++ EI + G S + E++F LL
Sbjct: 262 TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLL--- 318
Query: 630 LVLKEQGKLMELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLE 684
++G M+ + +M C +A P+ RP+ ++ L+
Sbjct: 319 ----KEGHRMDKPANCTNELYM---MM------RDCWHAVPSQRPTFKQLVEDLD 360
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 5e-40
Identities = 66/265 (24%), Positives = 100/265 (37%), Gaps = 30/265 (11%)
Query: 424 IGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQGNRE---FINEIGMISAL-QHPNLVKLY 478
+G G +G V+K DG AVK+ S +G ++ + E+G + QHP V+L
Sbjct: 65 LGHGSYGEVFKVRSKEDGRLYAVKR-SMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLE 123
Query: 479 GCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVV 538
EG L L E SL + L LA+LH + +V
Sbjct: 124 QAWEEGGILYLQTELCGP-SLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQ---GLV 179
Query: 539 HRDIKATNVLLDKDLNSKISDFGLAK-LDEEENTHISTRVAGTIGYMAPEYAMRGHLTEK 597
H D+K N+ L K+ DFGL L + G YMAPE +
Sbjct: 180 HLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGE--VQE-GDPRYMAPELLQGSY-GTA 235
Query: 598 ADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDKEQVMV 657
ADV+S G+ LE+ E W + QG L S + +++
Sbjct: 236 ADVFSLGLTILEVACN-----MELPHGGEGWQQLR--QGYLPPEFTAGLSSEL-RSVLVM 287
Query: 658 MINVALLCANASPTIRPSMSSVLRM 682
M+ P +R + ++L +
Sbjct: 288 MLEP-------DPKLRATAEALLAL 305
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 6e-40
Identities = 70/296 (23%), Positives = 127/296 (42%), Gaps = 46/296 (15%)
Query: 415 TNNFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPN 473
++F +G+G FG V K D A+K++ +++ ++E+ ++++L H
Sbjct: 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIR-HTEEKLSTILSEVMLLASLNHQY 63
Query: 474 LVKLYGCCIEGNQLLL----------IY---EYLENNSLARALFEHRLKLDWPTRRRICL 520
+V+ Y +E + ++ EY EN +L + L R+
Sbjct: 64 VVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFR 123
Query: 521 GIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKL--------------D 566
I L+Y+H + ++HRD+K N+ +D+ N KI DFGLAK
Sbjct: 124 QILEALSYIHSQ---GIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNL 180
Query: 567 EEENTHISTRVAGTIGYMAPE-YAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYL 625
+ ++++ + GT Y+A E GH EK D+YS GI+ E++
Sbjct: 181 PGSSDNLTSAI-GTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYP--------FSTG 231
Query: 626 LDWALVLKEQGKLMELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLR 681
++ +LK KL + P +FD ++ V + L + P RP ++L
Sbjct: 232 MERVNILK---KLRSVSIEFP-PDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLN 283
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 2e-39
Identities = 74/288 (25%), Positives = 116/288 (40%), Gaps = 46/288 (15%)
Query: 424 IGEGGFGPVYKGLLAD------GTAIAVKQL-SSKSKQGNREFINEIGMISAL-QHPNLV 475
+G G FG V + +AVK L S+ ++E+ ++S L QH N+V
Sbjct: 54 LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIV 113
Query: 476 KLYGCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRR-------------RICLGI 522
L G C G +L+I EY L L L+ +
Sbjct: 114 NLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQV 173
Query: 523 ARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLA-KLDEEENTHISTRVAGTI 581
A+G+A+L S+ +HRD+ A NVLL +KI DFGLA + + N + +
Sbjct: 174 AQGMAFL--ASK-NCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPV 230
Query: 582 GYMAPEYAMRGHLTEKADVYSFGIVALEIVS-GRS----NVTKEDMFYLLDWALVLKEQG 636
+MAPE T ++DV+S+GI+ EI S G + + + L+ + G
Sbjct: 231 KWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLV-------KDG 283
Query: 637 KLMELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLE 684
M P + + +M C PT RP+ + L+
Sbjct: 284 YQMAQPAFAPKNIYS---IM------QACWALEPTHRPTFQQICSFLQ 322
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 2e-39
Identities = 81/313 (25%), Positives = 133/313 (42%), Gaps = 60/313 (19%)
Query: 424 IGEGGFGPVYKGLLAD--------GTAIAVKQLSSKSKQGNR-EFINEIGMISAL-QHPN 473
+GEG FG V T +AVK L S + + + + I+E+ M+ + +H N
Sbjct: 77 LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 136
Query: 474 LVKLYGCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRR---------------RI 518
++ L G C + L +I EY +L L R +
Sbjct: 137 IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 196
Query: 519 CLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVA 578
+ARG+ YL S+ K +HRD+ A NVL+ +D KI+DFGLA+ + +
Sbjct: 197 AYQVARGMEYL--ASK-KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYY----KK 249
Query: 579 GTIG-----YMAPEYAMRGHLTEKADVYSFGIVALEIVS-GRS---NVTKEDMFYLLDWA 629
T G +MAPE T ++DV+SFG++ EI + G S V E++F LL
Sbjct: 250 TTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLL--- 306
Query: 630 LVLKEQGKLMELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLECGVDV 689
++G M+ + +M C +A P+ RP+ ++ L+ +
Sbjct: 307 ----KEGHRMDKPSNCTNELYM---MMRD------CWHAVPSQRPTFKQLVEDLD---RI 350
Query: 690 LDLVSDSSVSDID 702
+ L S+ +
Sbjct: 351 VALTSNQEMGYYH 363
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 6e-39
Identities = 70/192 (36%), Positives = 99/192 (51%), Gaps = 8/192 (4%)
Query: 424 IGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQGNREFI-NEIGMISALQHPNLVKLYGCC 481
IG+G FG V+KG+ +A+K + + + E I EI ++S P + K YG
Sbjct: 30 IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 89
Query: 482 IEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRD 541
++ +L +I EYL S L E LD I I +GL YLH E +I HRD
Sbjct: 90 LKDTKLWIIMEYLGGGSA-LDLLEPG-PLDETQIATILREILKGLDYLHSEKKI---HRD 144
Query: 542 IKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPEYAMRGHLTEKADVY 601
IKA NVLL + K++DFG+A + +T V GT +MAPE + KAD++
Sbjct: 145 IKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVIKQSAYDSKADIW 203
Query: 602 SFGIVALEIVSG 613
S GI A+E+ G
Sbjct: 204 SLGITAIELARG 215
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 6e-39
Identities = 61/265 (23%), Positives = 115/265 (43%), Gaps = 25/265 (9%)
Query: 424 IGEGGFGPVYKGL-LADGTAIAVKQ--LSSKSKQGNREFINEIGMISALQHPNLVKLYGC 480
IGEG FG DG +K+ +S S + E E+ +++ ++HPN+V+
Sbjct: 32 IGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRES 91
Query: 481 CIEGNQLLLIYEYLENNSLARALFEHR-LKLDWPTRRRICLGIARGLAYLHGESRIKVVH 539
E L ++ +Y E L + + + + + I L ++H K++H
Sbjct: 92 FEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDR---KILH 148
Query: 540 RDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPE-YAMRGHLTEKA 598
RDIK+ N+ L KD ++ DFG+A++ + GT Y++PE + + K+
Sbjct: 149 RDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACI-GTPYYLSPEICENKPY-NNKS 206
Query: 599 DVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLK-EQGKLMELVDTNPGSNFDKEQVMV 657
D+++ G V E+ + + M LVLK G + ++ +
Sbjct: 207 DIWALGCVLYELCTLKHAFEAGSMK-----NLVLKIISGSFPPV----S-LHYSYD---- 252
Query: 658 MINVALLCANASPTIRPSMSSVLRM 682
+ ++ +P RPS++S+L
Sbjct: 253 LRSLVSQLFKRNPRDRPSVNSILEK 277
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 7e-39
Identities = 70/294 (23%), Positives = 118/294 (40%), Gaps = 54/294 (18%)
Query: 424 IGEGGFGPVYKGLLAD------GTAIAVKQLSSKSKQGNR-EFINEIGMISAL-QHPNLV 475
+G G FG V + +AVK L + R ++E+ ++S L H N+V
Sbjct: 31 LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 90
Query: 476 KLYGCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRR-----------------RI 518
L G C G L+I EY L L R
Sbjct: 91 NLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSF 150
Query: 519 CLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVA 578
+A+G+A+L + +HRD+ A N+LL +KI DFGLA+ + ++ ++ A
Sbjct: 151 SYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNA 207
Query: 579 GT-IGYMAPEYAMRGHLTEKADVYSFGIVALEIVS-------GRSNVTKEDMFYLLDWAL 630
+ +MAPE T ++DV+S+GI E+ S G + ++
Sbjct: 208 RLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMP--VDSKFYKMI---- 261
Query: 631 VLKEQGKLMELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLE 684
++G M + P +D +M C +A P RP+ +++++E
Sbjct: 262 ---KEGFRMLSPEHAPAEMYD---IM------KTCWDADPLKRPTFKQIVQLIE 303
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 7e-39
Identities = 59/286 (20%), Positives = 106/286 (37%), Gaps = 53/286 (18%)
Query: 424 IGEGGFGPVYKGL-LADGTAIAVKQ--LSSKSKQGNREFINEIGMISAL-QHPNLVKLYG 479
IG G FG V+K + DG A+K+ + + E+ + L QH ++V+ +
Sbjct: 19 IGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFS 78
Query: 480 CCIEGNQLLLIYEYLENNSLARALFEHRLK---LDWPTRRRICLGIARGLAYLHGESRIK 536
E + +L+ EY SLA A+ E+ + + L + RGL Y+H
Sbjct: 79 AWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSM---S 135
Query: 537 VVHRDIKATNVLLDKD-------------------LNSKISDFGLAKLDEEENTHISTRV 577
+VH DIK +N+ + + + KI D G
Sbjct: 136 LVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQVEE---- 191
Query: 578 AGTIGYMAPEYAM--RGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQ 635
G ++A E HL KAD+++ + + D ++ + Q
Sbjct: 192 -GDSRFLANEVLQENYTHLP-KADIFALALTVVCAAGAEPLPRNGDQWHEI-------RQ 242
Query: 636 GKLMELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLR 681
G+L + P +E + + + P RPS ++++
Sbjct: 243 GRLPRI----P-QVLSQE----FTELLKVMIHPDPERRPSAMALVK 279
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 5e-38
Identities = 72/307 (23%), Positives = 124/307 (40%), Gaps = 55/307 (17%)
Query: 424 IGEGGFGPVYKGLLAD------GTAIAVKQLSSKSKQGNR-EFINEIGMISAL-QHPNLV 475
+G G FG V + +AVK L + ++E+ ++ + H N+V
Sbjct: 35 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 476 KLYGCC-IEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRR---------------IC 519
L G C G L++I E+ + +L+ L R +
Sbjct: 95 NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 154
Query: 520 LGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAG 579
+A+G+ +L + K +HRD+ A N+LL + KI DFGLA+ ++ ++ A
Sbjct: 155 FQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDAR 211
Query: 580 T-IGYMAPEYAMRGHLTEKADVYSFGIVALEIVS-GRS----NVTKEDMFYLLDWALVLK 633
+ +MAPE T ++DV+SFG++ EI S G S E+ L
Sbjct: 212 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRL------- 264
Query: 634 EQGKLMELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLECGVDVLDLV 693
++G M D + M L C + P+ RP+ S ++ L +L+
Sbjct: 265 KEGTRMRAPDYTTPEMYQ---TM------LDCWHGEPSQRPTFSELVEHLG------NLL 309
Query: 694 SDSSVSD 700
++ D
Sbjct: 310 QANAQQD 316
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 7e-38
Identities = 64/197 (32%), Positives = 96/197 (48%), Gaps = 16/197 (8%)
Query: 424 IGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQGNREF---INEIGMISALQHPNLVKLYG 479
IG G FG VY + + +A+K++S KQ N ++ I E+ + L+HPN ++ G
Sbjct: 62 IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRG 121
Query: 480 CCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVH 539
C + + L+ EY S + L H+ L + G +GLAYLH + I H
Sbjct: 122 CYLREHTAWLVMEYCLG-SASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMI---H 177
Query: 540 RDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPE---YAMRGHLTE 596
RD+KA N+LL + K+ DFG A + N+ + GT +MAPE G
Sbjct: 178 RDVKAGNILLSEPGLVKLGDFGSASIMAPANSFV-----GTPYWMAPEVILAMDEGQYDG 232
Query: 597 KADVYSFGIVALEIVSG 613
K DV+S GI +E+
Sbjct: 233 KVDVWSLGITCIELAER 249
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 149 bits (379), Expect = 7e-38
Identities = 52/288 (18%), Positives = 99/288 (34%), Gaps = 20/288 (6%)
Query: 24 LKEQNLTGVLPPKLAELTFLQDIDLTLNYLSGTIPSQWASLP-LLNISLIANRLKGPIPK 82
+ ++ + P +L L+ ++L N LS +A L + L++N ++
Sbjct: 56 VGFNTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNN 115
Query: 83 YLANISTLVNLTVQYNQFSGELPEELGSLLNLEKLHLSSNNFTGELPKTFAKLTNM--KD 140
L+ L + +N S L NL++L LS+N + N K
Sbjct: 116 PFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKK 175
Query: 141 FRISDNQFTGQIPSFIQNWTKLEKLFIQPSGLAGPIPSGIFSLENLTDLRISDLNG---- 196
+S NQ P +L LF+ L + + T +R L+
Sbjct: 176 LELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLS 235
Query: 197 --PEATFPQLGNMKMTKLILRNCNITGELPRYLGKMTKLKVLDLSFNRLRGQIPSNFDDL 254
TF L +T L L N+ + +L+ L +N ++ + L
Sbjct: 236 TTSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGL 295
Query: 255 YDVDYIYFAGNLLTGAIPPWMLERGD-----------KIDLSYNNFTD 291
++V Y+ + +I L + D +++ N+
Sbjct: 296 FNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPG 343
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 4e-37
Identities = 56/274 (20%), Positives = 101/274 (36%), Gaps = 11/274 (4%)
Query: 28 NLTGVLPPKLAELTFLQDIDLTLNYLSGTIPSQWASLPLLNI-SLIANRLKGPIPKYLAN 86
L + + L +D+ N +S P LP+L + +L N L K A
Sbjct: 36 QLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAF 95
Query: 87 ISTLVNLTVQYNQFSGELPEELGSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRISDN 146
+ L L + N NL L LS N + T +L N+++ +S+N
Sbjct: 96 CTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNN 155
Query: 147 QFTGQIPSFIQNW--TKLEKLFIQPSGLAGPIPSGIFSLENLTDLRISD--LNG--PEAT 200
+ + + + L+KL + + + P ++ L L +++ L E
Sbjct: 156 KIQALKSEELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKL 215
Query: 201 FPQLGNMKMTKLILRNCNITGELPRYLG--KMTKLKVLDLSFNRLRGQIPSNFDDLYDVD 258
+L N + L L N ++ K T L +LDLS+N L +F L ++
Sbjct: 216 CLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLE 275
Query: 259 YIYFAGNLLTGAIPPWM--LERGDKIDLSYNNFT 290
Y + N + + L ++L +
Sbjct: 276 YFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTK 309
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 5e-34
Identities = 50/286 (17%), Positives = 103/286 (36%), Gaps = 26/286 (9%)
Query: 28 NLTGVLPPKLAELTFLQDIDLTLNYLSGTIPSQWASLPLLNISLIA-----NRLKGPIPK 82
++ G+ L L+ + L+ ++ S + + L + L N++
Sbjct: 340 DIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESD 399
Query: 83 YLANISTLVNLTVQYNQFSGELP-EELGSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDF 141
+ + L L + N+ EL +E L N+ +++LS N + +FA + +++
Sbjct: 400 AFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRL 459
Query: 142 RISDNQFTG--QIPSFIQNWTKLEKLFIQPSGLAGPIPSGIFSLENLTDLRISD------ 193
+ PS Q L L + + +A + LE L L +
Sbjct: 460 MLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARL 519
Query: 194 -----LNGPEATFPQLGNMKMTKLILRNCNITGELPRYLGKMTKLKVLDLSFNRLRGQIP 248
GP L ++ + L L + + +LK++DL N L
Sbjct: 520 WKHANPGGPIYFLKGLSHLHI--LNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPA 577
Query: 249 SNFDDLYDVDYIYFAGNLLTGAIPPWMLERGDK----IDLSYNNFT 290
S F++ + + NL+T + + + +D+ +N F
Sbjct: 578 SVFNNQVSLKSLNLQKNLITS-VEKKVFGPAFRNLTELDMRFNPFD 622
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 1e-31
Identities = 56/260 (21%), Positives = 94/260 (36%), Gaps = 16/260 (6%)
Query: 43 LQDIDLTLNYLSGTIPSQWASLP--LLNISLIANRLKGPIPKYLANISTLVNLTVQYNQF 100
+ D + L+ +P LP + ++L N+L+ S L +L V +N
Sbjct: 6 HEVADCSHLKLT-QVPD---DLPTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTI 61
Query: 101 SGELPEELGSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRISDNQFTGQIPSFIQNWT 160
S PE L L+ L+L N + KTFA TN+ + + N +
Sbjct: 62 SKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQK 121
Query: 161 KLEKLFIQPSGLAGPIPSGIFSLENLTDLRISD--LNG-PEATFPQLGNMKMTKLILRNC 217
L L + +GL+ LENL +L +S+ + N + KL L +
Sbjct: 122 NLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSN 181
Query: 218 NITGELPRYLGKMTKLKVLDLSFNRLRGQIPSNF---DDLYDVDYIYFAGNLLTGAIPPW 274
I P + +L L L+ +L + + + + + L+
Sbjct: 182 QIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTT 241
Query: 275 MLERGD----KIDLSYNNFT 290
L +DLSYNN
Sbjct: 242 FLGLKWTNLTMLDLSYNNLN 261
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 9e-31
Identities = 52/299 (17%), Positives = 99/299 (33%), Gaps = 32/299 (10%)
Query: 28 NLTGVLPPKLAELTFLQDIDLTLNYLSGTIPSQWASLP----------LLNISLIANRLK 77
NL V A L L+ L N + L S+ L
Sbjct: 259 NLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLP 318
Query: 78 GPIPKYLANISTLVNLTVQYNQFSGELPEELGSLLNLEKLHLSSN--NFTGELPKTFAKL 135
+ L +L ++ N G L+NL+ L LS++ + +TF L
Sbjct: 319 KIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSL 378
Query: 136 TNM--KDFRISDNQFTGQIPSFIQNWTKLEKLFIQPSGLAGPIPSGIFS-LENLTDLRIS 192
+ ++ N+ + LE L + + + + + LEN+ ++ +S
Sbjct: 379 AHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLS 438
Query: 193 D--LNG-PEATFPQLGNMKMTKLILRNCNITG--ELPRYLGKMTKLKVLDLSFNRLRGQI 247
+F + +++ +L+LR + P + L +LDLS N +
Sbjct: 439 YNKYLQLTRNSFALVPSLQ--RLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANIN 496
Query: 248 PSNFDDLYDVDYIYFAGNLLT-------GAIPPWMLERGDK---IDLSYNNFTDGSAES 296
+ L ++ + N L P + L+ ++L N F + E
Sbjct: 497 DDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEV 555
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 1e-27
Identities = 52/289 (17%), Positives = 98/289 (33%), Gaps = 28/289 (9%)
Query: 28 NLTGVLPPKLAELTF--LQDIDLTLNYLSGTIPSQWASLPLL-NISLIANRLKGPIPKYL 84
L+ L + L +DL+ N L+ +A LP L L N ++ L
Sbjct: 233 QLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSL 292
Query: 85 ANISTLVNLTVQYNQFSGEL---------PEELGSLLNLEKLHLSSNNFTGELPKTFAKL 135
+ + L ++ + + L LE L++ N+ G F L
Sbjct: 293 HGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGL 352
Query: 136 TNMKDFRISDNQFTGQIPSFIQ----NWTKLEKLFIQPSGLAGPIPSGIFSLENLTDLRI 191
N+K +S++ + + + + L L + + ++ L +L L +
Sbjct: 353 INLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDL 412
Query: 192 SD--LNG--PEATFPQLGNMKMTKLILRNCNITGELPRYLGKMTKLKVLDLSFNRLRG-- 245
+ + L N+ + L + L+ L L L+
Sbjct: 413 GLNEIGQELTGQEWRGLENIFE--IYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVD 470
Query: 246 QIPSNFDDLYDVDYIYFAGNLLTGAIPPWMLERGDK---IDLSYNNFTD 291
PS F L ++ + + N + I MLE +K +DL +NN
Sbjct: 471 SSPSPFQPLRNLTILDLSNNNIAN-INDDMLEGLEKLEILDLQHNNLAR 518
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 4e-27
Identities = 48/286 (16%), Positives = 90/286 (31%), Gaps = 42/286 (14%)
Query: 24 LKEQNLTGVLPPKLAELTFLQDIDLTLNYLSGTIPSQWASLP-LLNISLIANRLKGPIPK 82
L ++ + + L +DL+ N LS T L L + L N+++ +
Sbjct: 104 LMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSE 163
Query: 83 YLANI--STLVNLTVQYNQFSGELPEELGSLLNLEKLHLSSNNFTGELPKTFA---KLTN 137
L S+L L + NQ P ++ L L L++ L + T+
Sbjct: 164 ELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTS 223
Query: 138 MKDFRISDNQFTGQIPSFIQN--WTKLEKLFIQPSGLAGPIPSGIFSLENLTDLRISDLN 195
+++ +S++Q + + WT L L + + L L L
Sbjct: 224 IRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQL--------- 274
Query: 196 GPEATFPQLGNMKMTKLILRNCNITGELPRYLGKMTKLKVLDL---------SFNRLRGQ 246
L NI L + ++ L+L S L
Sbjct: 275 --------------EYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKI 320
Query: 247 IPSNFDDLYDVDYIYFAGNLLTGAIPPWM--LERGDKIDLSYNNFT 290
+F L ++++ N + G L + LS + +
Sbjct: 321 DDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTS 366
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 1e-26
Identities = 49/238 (20%), Positives = 81/238 (34%), Gaps = 18/238 (7%)
Query: 28 NLTGVLPPKLAELTFLQDIDLTLNYLSGTIPSQ-WASLPLLN-ISLIANRLKGPIPKYLA 85
++ + + L L+ +DL LN + + Q W L + I L N+ A
Sbjct: 392 KISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFA 451
Query: 86 NISTLVNLTVQYNQFSG--ELPEELGSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRI 143
+ +L L ++ P L NL L LS+NN L ++ +
Sbjct: 452 LVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKLEILDL 511
Query: 144 SDNQFT--------GQIPSFIQNWTKLEKLFIQPSGLAGPIPSGIFSLENLTDLRISD-- 193
N G F++ + L L ++ +G L L + +
Sbjct: 512 QHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNN 571
Query: 194 LNG-PEATFPQLGNMKMTKLILRNCNITGELPRYLGK-MTKLKVLDLSFNRLRGQIPS 249
LN P + F ++K L L+ IT + G L LD+ FN S
Sbjct: 572 LNTLPASVFNNQVSLK--SLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDCTCES 627
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 8e-24
Identities = 43/226 (19%), Positives = 77/226 (34%), Gaps = 29/226 (12%)
Query: 88 STLVNLTVQYNQFSGELPEELGSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRISDNQ 147
+ + L + +NQ L L + N + P+ KL +K + N+
Sbjct: 25 TNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNE 84
Query: 148 FTGQIPSFIQNWTKLEKLFIQPSGLAGPIPSGIFSLENLTDLRISD--LNG-PEATFPQL 204
+ T L +L + + + + +NL L +S L+ T QL
Sbjct: 85 LSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQL 144
Query: 205 GNMKMTKLILRNCNITGELPRYLG--KMTKLKVLDLSFNRLRGQIPSNFDDLYDVDYIYF 262
N++ +L+L N I L + LK L+LS N+++ P F +
Sbjct: 145 ENLQ--ELLLSNNKIQALKSEELDIFANSSLKKLELSSNQIKEFSPGCFHAI-------- 194
Query: 263 AGNLLTGAIPPWMLERGDKIDLSYNNFTDGSAESSCQKRSVTGIVS 308
G L + L+ E C + + T I +
Sbjct: 195 -GRLFG-------------LFLNNVQLGPSLTEKLCLELANTSIRN 226
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 8e-17
Identities = 37/209 (17%), Positives = 63/209 (30%), Gaps = 51/209 (24%)
Query: 91 VNLTV---QYNQFSGELPEELGSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRISDNQ 147
V+ V + + + ++P++L + N+ L+L+ N F + + + + N
Sbjct: 4 VSHEVADCSHLKLT-QVPDDLPT--NITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNT 60
Query: 148 FTGQIPSFIQNWTKLEKLFIQPSGLAGPIPSGIFSLENLTDLRISDLNGPEATFPQLGNM 207
+ P Q L+ L +Q + L+ NLT+L
Sbjct: 61 ISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELH----------------- 103
Query: 208 KMTKLILRNCNITGELPRYLGKMTKLKVLDLSFNRLRGQIPSNFDDLYDVDYIYFAGNLL 267
L + +I K L LDLS N L L NL
Sbjct: 104 ------LMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQL---------ENLQ 148
Query: 268 TGAIPPWMLERGDKIDLSYNNFTDGSAES 296
+ LS N +E
Sbjct: 149 E-------------LLLSNNKIQALKSEE 164
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 9e-17
Identities = 39/215 (18%), Positives = 68/215 (31%), Gaps = 18/215 (8%)
Query: 28 NLTGV--LPPKLAELTFLQDIDLTLNYLSGTIPSQWASLP---LLNIS------LIANRL 76
L V P L L +DL+ N ++ L +L++ L +
Sbjct: 465 ALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHAN 524
Query: 77 KGPIPKYLANISTLVNLTVQYNQFSGELPEELGSLLNLEKLHLSSNNFTGELPKTFAKLT 136
G +L +S L L ++ N F E L L+ + L NN F
Sbjct: 525 PGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQV 584
Query: 137 NMKDFRISDNQFTGQIPS-FIQNWTKLEKLFIQPSGLAGPIPSGIFSLE--NLTDLRISD 193
++K + N T F + L +L ++ + S + + N T I +
Sbjct: 585 SLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDCTCESIAWFVNWINETHTNIPE 644
Query: 194 L--NGPEATFPQLGNMKMTKLILRNCNITGELPRY 226
L + T P + +C +
Sbjct: 645 LSSHYLCNTPPHYHGFPVRLFDTSSCKD--SAHHH 677
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 63.5 bits (155), Expect = 2e-10
Identities = 22/178 (12%), Positives = 48/178 (26%), Gaps = 26/178 (14%)
Query: 19 NQKRVLKEQNLTGVLPPKLAELTFLQDIDLTLNYLSGTIPSQWASLPLLNISLIANRLKG 78
N L + G L L+ L ++L +N
Sbjct: 514 NNLARLWKHANPGGPIYFLKGLSHLHILNLE-----------------------SNGFDE 550
Query: 79 PIPKYLANISTLVNLTVQYNQFSGELPEELGSLLNLEKLHLSSNNFTGELPKTFAK-LTN 137
+ ++ L + + N + + ++L+ L+L N T K F N
Sbjct: 551 IPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRN 610
Query: 138 MKDFRISDNQFTGQIPSFIQNWTKLEKLFIQPSGLAGPIPSGIFSLENLTDLRISDLN 195
+ + + N F S + + L+ + + + +
Sbjct: 611 LTELDMRFNPFDCTCESIAWFVNWINETHTNIPELSSHYLCN--TPPHYHGFPVRLFD 666
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 1e-37
Identities = 74/301 (24%), Positives = 111/301 (36%), Gaps = 63/301 (20%)
Query: 424 IGEGGFGPVYKGLLADG------TAIAVKQLSSKSKQGNR-EFINEIGMISAL-QHPNLV 475
+G G FG V +AVK L K+ R ++E+ M++ L H N+V
Sbjct: 53 LGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIV 112
Query: 476 KLYGCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRR------------------- 516
L G C + LI+EY L L R K
Sbjct: 113 NLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFE 172
Query: 517 ---RICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHI 573
+A+G+ +L VHRD+ A NVL+ KI DFGLA+ ++ +
Sbjct: 173 DLLCFAYQVAKGMEFL---EFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNY- 228
Query: 574 STRVAGTIG-----YMAPEYAMRGHLTEKADVYSFGIVALEIVS-GRS----NVTKEDMF 623
V +MAPE G T K+DV+S+GI+ EI S G + + +
Sbjct: 229 ---VVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFY 285
Query: 624 YLLDWALVLKEQGKLMELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRML 683
L+ + G M+ P +E ++M C RPS ++ L
Sbjct: 286 KLI-------QNGFKMD----QP-FYATEEIYIIM----QSCWAFDSRKRPSFPNLTSFL 329
Query: 684 E 684
Sbjct: 330 G 330
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 5e-37
Identities = 60/205 (29%), Positives = 95/205 (46%), Gaps = 17/205 (8%)
Query: 424 IGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQGNREFI-NEIGMISALQHPNLVKLYGCC 481
IG G V +A+K+++ + Q + + + EI +S HPN+V Y
Sbjct: 23 IGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSF 82
Query: 482 IEGNQLLLIYEYLENNSLA-------RALFEHRLKLDWPTRRRICLGIARGLAYLHGESR 534
+ ++L L+ + L S+ LD T I + GL YLH +
Sbjct: 83 VVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQ 142
Query: 535 IKVVHRDIKATNVLLDKDLNSKISDFGL-AKLDEEENTHISTR---VAGTIGYMAPEYAM 590
I HRD+KA N+LL +D + +I+DFG+ A L + + GT +MAPE
Sbjct: 143 I---HRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVME 199
Query: 591 RGHL-TEKADVYSFGIVALEIVSGR 614
+ KAD++SFGI A+E+ +G
Sbjct: 200 QVRGYDFKADIWSFGITAIELATGA 224
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 7e-37
Identities = 48/215 (22%), Positives = 87/215 (40%), Gaps = 22/215 (10%)
Query: 416 NNFATDNNIGEGGFGPVYKGLLADGTAIAVKQ--LSSKSKQGNREFINEIGMISALQHPN 473
++ IG GG V++ L A+K L Q + NEI ++ LQ +
Sbjct: 28 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 87
Query: 474 L--VKLYGCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHG 531
++LY I + ++ E N L L + + +D R+ + + +H
Sbjct: 88 DKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKK-SIDPWERKSYWKNMLEAVHTIHQ 145
Query: 532 ESRIKVVHRDIKATNVLLDKDLNSKISDFGLAK-LDEEENTHISTRVAGTIGYMAPE--- 587
+VH D+K N L+ K+ DFG+A + + + + GT+ YM PE
Sbjct: 146 H---GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIK 201
Query: 588 --------YAMRGHLTEKADVYSFGIVALEIVSGR 614
+ ++ K+DV+S G + + G+
Sbjct: 202 DMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 236
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 141 bits (356), Expect = 8e-37
Identities = 49/193 (25%), Positives = 98/193 (50%), Gaps = 8/193 (4%)
Query: 424 IGEGGFGPVYKGLL-ADGTAIAVKQLSSKSKQGNREFI-NEIGMISALQHPNLVKLYGCC 481
+G G G V+K G +A K + + K R I E+ ++ P +V YG
Sbjct: 41 LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 100
Query: 482 IEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRD 541
++ + E+++ SL + L + ++ ++ + + +GL YL + K++HRD
Sbjct: 101 YSDGEISICMEHMDGGSLDQVLKKAG-RIPEQILGKVSIAVIKGLTYLR--EKHKIMHRD 157
Query: 542 IKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPEYAMRGHLTEKADVY 601
+K +N+L++ K+ DFG++ + ++ ++ V GT YM+PE H + ++D++
Sbjct: 158 VKPSNILVNSRGEIKLCDFGVSG--QLIDSMANSFV-GTRSYMSPERLQGTHYSVQSDIW 214
Query: 602 SFGIVALEIVSGR 614
S G+ +E+ GR
Sbjct: 215 SMGLSLVEMAVGR 227
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 1e-36
Identities = 55/216 (25%), Positives = 96/216 (44%), Gaps = 27/216 (12%)
Query: 416 NNFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNL 474
+F IG GGFG V+K DG +K++ K N + E+ ++ L H N+
Sbjct: 11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRV----KYNNEKAEREVKALAKLDHVNI 66
Query: 475 VKLYGCCIE----------------GNQLLLIYEYLENNSLARALFEHRLK-LDWPTRRR 517
V GC L + E+ + +L + + + R + LD
Sbjct: 67 VHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALE 126
Query: 518 ICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRV 577
+ I +G+ Y+H + K+++RD+K +N+ L KI DFGL + + TR
Sbjct: 127 LFEQITKGVDYIHSK---KLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKR--TRS 181
Query: 578 AGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSG 613
GT+ YM+PE ++ D+Y+ G++ E++
Sbjct: 182 KGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHV 217
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 2e-36
Identities = 48/207 (23%), Positives = 85/207 (41%), Gaps = 22/207 (10%)
Query: 424 IGEGGFGPVYKGLLADGTAIAVKQ--LSSKSKQGNREFINEIGMISALQHPNL--VKLYG 479
IG GG V++ L A+K L Q + NEI ++ LQ + ++LY
Sbjct: 17 IGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYD 76
Query: 480 CCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVH 539
I + ++ E N L L + + +D R+ + + +H +VH
Sbjct: 77 YEITDQYIYMVMEC-GNIDLNSWLKKKK-SIDPWERKSYWKNMLEAVHTIHQH---GIVH 131
Query: 540 RDIKATNVLLDKDLNSKISDFGLAK-LDEEENTHISTRVAGTIGYMAPE----------- 587
D+K N L+ K+ DFG+A + + + + GT+ YM PE
Sbjct: 132 SDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSREN 190
Query: 588 YAMRGHLTEKADVYSFGIVALEIVSGR 614
+ ++ K+DV+S G + + G+
Sbjct: 191 GKSKSKISPKSDVWSLGCILYYMTYGK 217
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 2e-36
Identities = 41/205 (20%), Positives = 80/205 (39%), Gaps = 17/205 (8%)
Query: 424 IGEG--GFGPVYKGL-LADGTAIAVKQ--LSSKSKQGNREFINEIGMISALQHPNLVKLY 478
IG+G V G + V++ L + S + E+ + HPN+V
Sbjct: 33 IGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYR 92
Query: 479 GCCIEGNQLLLIYEYLENNSLARALFEHRLK-LDWPTRRRICLGIARGLAYLHGESRIKV 537
I N+L ++ ++ S + H + ++ I G+ + L Y+H +
Sbjct: 93 ATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYV-- 150
Query: 538 VHRDIKATNVLLDKDLNSKISDFG-LAKLDEE---ENTHISTR--VAGTIGYMAPEYAMR 591
HR +KA+++L+ D +S + + + +++PE +
Sbjct: 151 -HRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQ 209
Query: 592 GHL--TEKADVYSFGIVALEIVSGR 614
K+D+YS GI A E+ +G
Sbjct: 210 NLQGYDAKSDIYSVGITACELANGH 234
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 2e-36
Identities = 70/270 (25%), Positives = 115/270 (42%), Gaps = 26/270 (9%)
Query: 424 IGEGGFGPVYKGL-LADGTAIAVKQ--LSSKSKQGNREFINEIGMISALQHPNLVKLYGC 480
IG G +G K +DG + K+ S ++ + ++E+ ++ L+HPN+V+ Y
Sbjct: 14 IGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDR 73
Query: 481 CIE--GNQLLLIYEYLENNSLARALFEHRLK---LDWPTRRRICLGIARGLAYLH--GES 533
I+ L ++ EY E LA + + + LD R+ + L H +
Sbjct: 74 IIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDG 133
Query: 534 RIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPEYAMRGH 593
V+HRD+K NV LD N K+ DFGLA++ + + T V GT YM+PE R
Sbjct: 134 GHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFV-GTPYYMSPEQMNRMS 192
Query: 594 LTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLK-EQGKLMELVDTNPGSNFDK 652
EK+D++S G + E+ + T L K +GK + +
Sbjct: 193 YNEKSDIWSLGCLLYELCALMPPFTAFSQK-----ELAGKIREGKFRRI-----PYRYSD 242
Query: 653 EQVMVMINVALLCANASPTIRPSMSSVLRM 682
E + + N RPS+ +L
Sbjct: 243 E----LNEIITRMLNLKDYHRPSVEEILEN 268
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 3e-36
Identities = 54/211 (25%), Positives = 83/211 (39%), Gaps = 22/211 (10%)
Query: 424 IGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCCI 482
+GEGGF V L DG A+K++ +Q E E M HPN+++L C+
Sbjct: 37 LGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCL 96
Query: 483 E----GNQLLLIYEYLENNSLARALFEHRLK---LDWPTRRRICLGIARGLAYLHGESRI 535
++ L+ + + +L + + K L + LGI RGL +H
Sbjct: 97 RERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIH---AK 153
Query: 536 KVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVA--------GTIGYMAPE 587
HRD+K TN+LL + + D G + TI Y APE
Sbjct: 154 GYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPE 213
Query: 588 ---YAMRGHLTEKADVYSFGIVALEIVSGRS 615
+ E+ DV+S G V ++ G
Sbjct: 214 LFSVQSHCVIDERTDVWSLGCVLYAMMFGEG 244
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 4e-36
Identities = 48/208 (23%), Positives = 85/208 (40%), Gaps = 24/208 (11%)
Query: 424 IGEGGFGPVYKGLLADGTAIAVKQ--LSSKSKQGNREFINEIGMISALQHPNL--VKLYG 479
IG GG V++ L A+K L Q + NEI ++ LQ + ++LY
Sbjct: 64 IGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYD 123
Query: 480 CCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVH 539
I + ++ E N L L + + +D R+ + + +H +VH
Sbjct: 124 YEITDQYIYMVMEC-GNIDLNSWLKKKK-SIDPWERKSYWKNMLEAVHTIHQH---GIVH 178
Query: 540 RDIKATNVLLDKDLNSKISDFGLAKL--DEEENTHISTRVAGTIGYMAPE---------- 587
D+K N L+ K+ DFG+A + + ++V G + YM PE
Sbjct: 179 SDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQV-GAVNYMPPEAIKDMSSSRE 236
Query: 588 -YAMRGHLTEKADVYSFGIVALEIVSGR 614
+ ++ K+DV+S G + + G+
Sbjct: 237 NGKSKSKISPKSDVWSLGCILYYMTYGK 264
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 2e-35
Identities = 61/285 (21%), Positives = 113/285 (39%), Gaps = 45/285 (15%)
Query: 424 IGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQGNRE-FINEIGMISALQHPNLVKLYGCC 481
+G GGFG V++ D A+K++ +++ RE + E+ ++ L+HP +V+ +
Sbjct: 13 LGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAW 72
Query: 482 IEGNQ------------LLLIYEYLENNSLARALFEHRLK--LDWPTRRRICLGIARGLA 527
+E N L + + +L + + I L IA +
Sbjct: 73 LEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVE 132
Query: 528 YLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVA--------- 578
+LH + ++HRD+K +N+ D K+ DFGL +++ +
Sbjct: 133 FLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTG 189
Query: 579 --GTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQG 636
GT YM+PE + K D++S G++ E++ S T+ + L
Sbjct: 190 QVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLYPFS--TQMERVRTLT----DVRNL 243
Query: 637 KLMELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLR 681
K L + E VMV +L + P RP +++
Sbjct: 244 KFPPL----FTQKYPCEYVMVQ---DMLSPS--PMERPEAINIIE 279
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 2e-35
Identities = 58/203 (28%), Positives = 97/203 (47%), Gaps = 18/203 (8%)
Query: 424 IGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQGNREFI-NEIGMI-SALQHPNLVKLYGC 480
IG G +G V K + G +AVK++ S + ++ + ++ ++ + P +V+ YG
Sbjct: 30 IGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGA 89
Query: 481 CIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTR----RRICLGIARGLAYLHGESRIK 536
+ E + + S + LD +I L + L +L +K
Sbjct: 90 LFREGDCWICMELM-STSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLK--ENLK 146
Query: 537 VVHRDIKATNVLLDKDLNSKISDFGL-AKLDEEENTHISTRVAGTIGYMAPE----YAMR 591
++HRDIK +N+LLD+ N K+ DFG+ +L ++ TR AG YMAPE A R
Sbjct: 147 IIHRDIKPSNILLDRSGNIKLCDFGISGQLV---DSIAKTRDAGCRPYMAPERIDPSASR 203
Query: 592 GHLTEKADVYSFGIVALEIVSGR 614
++DV+S GI E+ +GR
Sbjct: 204 QGYDVRSDVWSLGITLYELATGR 226
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 3e-35
Identities = 49/215 (22%), Positives = 100/215 (46%), Gaps = 15/215 (6%)
Query: 409 LQIKAATNNFATDNNIGEGGFGPVYKGL-LADGTAIAVKQL-SSKSKQGNREFINEIGMI 466
+++KA ++ +G G +G V K + G +AVK++ ++ + Q + + ++ +
Sbjct: 2 MEVKA--DDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDIS 59
Query: 467 -SALQHPNLVKLYGCCIEGNQLLLIYEYLE--NNSLARALFEHRLKLDWPTRRRICLGIA 523
+ P V YG + + E ++ + + + + + +I + I
Sbjct: 60 MRTVDCPFTVTFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIV 119
Query: 524 RGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGY 583
+ L +LH S++ V+HRD+K +NVL++ K+ DFG++ + AG Y
Sbjct: 120 KALEHLH--SKLSVIHRDVKPSNVLINALGQVKMCDFGISG--YLVDDVAKDIDAGCKPY 175
Query: 584 MAPE----YAMRGHLTEKADVYSFGIVALEIVSGR 614
MAPE + + K+D++S GI +E+ R
Sbjct: 176 MAPERINPELNQKGYSVKSDIWSLGITMIELAILR 210
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 4e-35
Identities = 40/291 (13%), Positives = 81/291 (27%), Gaps = 41/291 (14%)
Query: 28 NLTGVLPPKLAELTFLQDIDLTLNYLSGTIPSQWASLP-LLNISLIANRLKG-PIPKYLA 85
L G P L ++L N ++ + + N+S N+LK P
Sbjct: 341 QLEG-KLPAFGSEIKLASLNLAYNQITEIPANFCGFTEQVENLSFAHNKLKYIPNIFDAK 399
Query: 86 NISTLVNLTVQYNQFSG-------ELPEELGSLLNLEKLHLSSNNFTGELPKTFAKLTNM 138
++S + + YN+ L +N+ ++LS+N + + F+ + +
Sbjct: 400 SVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPL 459
Query: 139 KDFRISDNQFTGQIPSFIQNWTKLEKLFIQPSGLAGPIPSGIFSLENLTDLRISD--LNG 196
+ N T P + LT + + L
Sbjct: 460 SSINLMGNMLTE-----------------IPKNSLKDENENFKNTYLLTSIDLRFNKLTK 502
Query: 197 --PEATFPQLGNMKMTKLILRNCNITGELPRYLGKMTKLKVL------DLSFNRLRGQIP 248
+ L + + L + + P + LK D NR + P
Sbjct: 503 LSDDFRATTLPY--LVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQRDAQGNRTLREWP 559
Query: 249 SNFDDLYDVDYIYFAGNLLTGAIPPWMLERGDKIDLSYNNFTDGSAESSCQ 299
+ + N + + + +D+ N C
Sbjct: 560 EGITLCPSLTQLQIGSNDIRK-VNEKITPNISVLDIKDNPNISIDLSYVCP 609
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 7e-35
Identities = 42/288 (14%), Positives = 93/288 (32%), Gaps = 53/288 (18%)
Query: 24 LKEQNLTGVLPPKLAELTFLQDIDLTLNYLSG----TIPSQWASL-PLLNISLIANRLKG 78
L+ +G +P + +LT L+ + L + P ++ + +
Sbjct: 88 LEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQKQKMRMHYQK 147
Query: 79 PIPKYLA--NISTLVNLTVQYNQFSGELPEELGSLLNLEKLHLSSNNFTGELPKTFAKLT 136
Y + S L+ + + + + L ++ SNN T + K +LT
Sbjct: 148 TFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNITF-VSKAVMRLT 206
Query: 137 NMKDFRISDNQFTGQIPSFIQNWTKLEKLFIQPSGLAGPIPSGIFSLENLTDLRISDLNG 196
++ F + ++ F + E +L++LTD+ +
Sbjct: 207 KLRQFYMGNSPFVAENICEAWENENSEYA-----QQYKTEDLKWDNLKDLTDVEVY---- 257
Query: 197 PEATFPQLGNMKMTKLILRNCNITGELPRYLGKMTKLKVLDLSFNRLR--------GQIP 248
NC +LP +L + ++++++++ NR Q
Sbjct: 258 -------------------NCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQAL 298
Query: 249 SNFDDLYDVDYIYFAGN-LLTGAIPPWM-----LERGDKIDLSYNNFT 290
++ + IY N L T + + L ++ YN
Sbjct: 299 ADAPVGEKIQIIYIGYNNLKTFPVETSLQKMKKLG---MLECLYNQLE 343
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 5e-33
Identities = 50/308 (16%), Positives = 104/308 (33%), Gaps = 50/308 (16%)
Query: 28 NLTGVLPPKLAELTF--LQDIDLTLNYLSGTIP-SQWASLPLLNISLIANRLKGPIPKYL 84
+ F L + + +I S +L I ++N + + K +
Sbjct: 144 HYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNITF-VSKAV 202
Query: 85 ANISTLVNLTVQYNQFSGE-------------------LPEELGSLLNLEKLHLSSNNFT 125
++ L + + F E + +L +L + + +
Sbjct: 203 MRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNL 262
Query: 126 GELPKTFAKLTNMKDFRISDNQFT--------GQIPSFIQNWTKLEKLFIQPSGLA-GPI 176
+LP L M+ ++ N+ Q + K++ ++I + L P+
Sbjct: 263 TKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLKTFPV 322
Query: 177 PSGIFSLENLTDLRISD--LNGPEATFPQLGNM-KMTKLILRNCNITGELPRYLGKMTKL 233
+ + ++ L L L G P G+ K+ L L IT + G ++
Sbjct: 323 ETSLQKMKKLGMLECLYNQLEG---KLPAFGSEIKLASLNLAYNQITEIPANFCGFTEQV 379
Query: 234 KVLDLSFNRLRGQIPSNFD--DLYDVDYIYFAGNLLTG-------AIPPWMLERG--DKI 282
+ L + N+L+ IP+ FD + + I F+ N + + P + I
Sbjct: 380 ENLSFAHNKLKY-IPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSI 438
Query: 283 DLSYNNFT 290
+LS N +
Sbjct: 439 NLSNNQIS 446
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 2e-30
Identities = 44/301 (14%), Positives = 88/301 (29%), Gaps = 57/301 (18%)
Query: 19 NQKRVLKEQNLTGVLPPKLAELTFLQDIDLTLNYLSGTIPSQWASLPLLNISLIANRLKG 78
N+ ++ +Q I + N L
Sbjct: 283 NRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLKT----------------------F 320
Query: 79 PIPKYLANISTLVNLTVQYNQFSGELPEELGSLLNLEKLHLSSNNFTGELPKTFAKLTNM 138
P+ L + L L YNQ G GS + L L+L+ N T +
Sbjct: 321 PVETSLQKMKKLGMLECLYNQLEG-KLPAFGSEIKLASLNLAYNQITEIPANFCGFTEQV 379
Query: 139 KDFRISDNQFTGQIPS--FIQNWTKLEKLFIQ-------PSGLAGPIPSGIFSLENLTDL 189
++ + N+ IP+ ++ + + + P+ F N++ +
Sbjct: 380 ENLSFAHNKLKY-IPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSI 438
Query: 190 RISD--LNG-PEATFPQLGNMKMTKLILRNCNITG-------ELPRYLGKMTKLKVLDLS 239
+S+ ++ P+ F ++ + L +T + L +DL
Sbjct: 439 NLSNNQISKFPKELFSTGSP--LSSINLMGNMLTEIPKNSLKDENENFKNTYLLTSIDLR 496
Query: 240 FNRLRGQIPSNFDD--LYDVDYIYFAGNLLTGAIPPWM--------LERGDKIDLSYNNF 289
FN+L + +F L + I + N + P ++ D N
Sbjct: 497 FNKLTK-LSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQRDAQGNRT 554
Query: 290 T 290
Sbjct: 555 L 555
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 6e-27
Identities = 37/231 (16%), Positives = 79/231 (34%), Gaps = 33/231 (14%)
Query: 40 LTFLQDIDLTLNYLSGTIPSQWASLP--------LLNISLIANRLKGPIPKYLANISTLV 91
++ + ID + N + + L + +I+L N++ + + S L
Sbjct: 401 VSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLS 460
Query: 92 NLTVQYNQFSG-------ELPEELGSLLNLEKLHLSSNNFTGELPKTFA--KLTNMKDFR 142
++ + N + + E + L + L N T L F L +
Sbjct: 461 SINLMGNMLTEIPKNSLKDENENFKNTYLLTSIDLRFNKLTK-LSDDFRATTLPYLVGID 519
Query: 143 ISDNQFTGQIPSFIQNWTKLEKLFIQPS------GLAGPIPSGIFSLENLTDLRISD--L 194
+S N F+ P+ N + L+ I+ P GI +LT L+I +
Sbjct: 520 LSYNSFSK-FPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSNDI 578
Query: 195 NG-PEATFPQLGNMKMTKLILRNCNITGELPRYLGKMTKLKVLDLSFNRLR 244
E P + + L +++ Y+ + + L +++ +
Sbjct: 579 RKVNEKITPNI-----SVLDIKDNPNISIDLSYVCPYIEAGMYMLFYDKTQ 624
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 4e-22
Identities = 28/253 (11%), Positives = 75/253 (29%), Gaps = 36/253 (14%)
Query: 92 NLTVQYNQFSGELPEELGSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRISDNQFTGQ 151
N + + + + L S + L L +G +P +LT ++ + +
Sbjct: 61 NFNKELDMWGAQPGVSLNSNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVN 120
Query: 152 ----IPSFIQNWTKLEKLFIQPSGLAGPIPSGIFSLE--NLTDLRISDLNGPEATFPQLG 205
P I E+ + +L I+ ++
Sbjct: 121 ERLFGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSR 180
Query: 206 NM-KMTKLILRNCNITGELPRYLGKMTKLKVLDLSFNRLRGQIPSNFDDLYDVDY----- 259
K T++ + NIT + + + ++TKL+ + + + + + +Y
Sbjct: 181 ITLKDTQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYK 239
Query: 260 --------------IYFAGNLLTGAIPPWM-----LERGDKIDLSYNNFTDG-SAESSCQ 299
+ +P ++ ++ I+++ N G + Q
Sbjct: 240 TEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQ---LINVACNRGISGEQLKDDWQ 296
Query: 300 KRSVTGIVSCLRS 312
+ + ++
Sbjct: 297 ALADAPVGEKIQI 309
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 65.8 bits (161), Expect = 3e-11
Identities = 23/129 (17%), Positives = 40/129 (31%), Gaps = 14/129 (10%)
Query: 28 NLTGVLPPKLA--ELTFLQDIDLTLNYLSGTIPSQWASLPLL-------NISLIANRLKG 78
LT L L +L IDL+ N S P+Q + L NR
Sbjct: 499 KLTK-LSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQRDAQGNRTLR 556
Query: 79 PIPKYLANISTLVNLTVQYNQFSGELPEELGSLLNLEKLHLSSNNFTGELPKTFAKLTNM 138
P+ + +L L + N + E++ N+ L + N
Sbjct: 557 EWPEGITLCPSLTQLQIGSNDIRK-VNEKITP--NISVLDIKDNPNISIDLSYVCPYIEA 613
Query: 139 KDFRISDNQ 147
+ + ++
Sbjct: 614 GMYMLFYDK 622
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 133 bits (338), Expect = 5e-35
Identities = 63/197 (31%), Positives = 89/197 (45%), Gaps = 12/197 (6%)
Query: 424 IGEGGFGPVYKGL-LADGTAIAVK----QLSSKSKQGNREFINEIGMISALQHPNLVKLY 478
+G GG VY +A+K K + R F E+ S L H N+V +
Sbjct: 19 LGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKR-FEREVHNSSQLSHQNIVSMI 77
Query: 479 GCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVV 538
E + L+ EY+E +L E L T I G+ + H +++V
Sbjct: 78 DVDEEDDCYYLVMEYIEGPTL-SEYIESHGPLSVDTAINFTNQILDGIKHAH---DMRIV 133
Query: 539 HRDIKATNVLLDKDLNSKISDFGLAK-LDEEENTHISTRVAGTIGYMAPEYAMRGHLTEK 597
HRDIK N+L+D + KI DFG+AK L E T + V GT+ Y +PE A E
Sbjct: 134 HRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNH-VLGTVQYFSPEQAKGEATDEC 192
Query: 598 ADVYSFGIVALEIVSGR 614
D+YS GIV E++ G
Sbjct: 193 TDIYSIGIVLYEMLVGE 209
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 7e-35
Identities = 45/273 (16%), Positives = 87/273 (31%), Gaps = 19/273 (6%)
Query: 28 NLTGVLPPKLAELTFLQDIDLTLNYLSGTIPSQWASLPLLNISLIANRLKGPIPKYLANI 87
+ V + Q ++L + SL L KG ++
Sbjct: 293 TIERVKD--FSYNFGWQHLELVNCKFGQFPTLKLKSLKRLTF----TSNKGGNAFSEVDL 346
Query: 88 STLVNLTVQYNQ--FSGELPEELGSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRISD 145
+L L + N F G + +L+ L LS N + F L ++
Sbjct: 347 PSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQH 405
Query: 146 NQFTGQIP-SFIQNWTKLEKLFIQPSGLAGPIPSGIFSLENLTDLRISD----LNGPEAT 200
+ S + L L I + L +L L+++ N
Sbjct: 406 SNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDI 465
Query: 201 FPQLGNMKMTKLILRNCNITGELPRYLGKMTKLKVLDLSFNRLRGQIPSNFDDLYDVDYI 260
F +L N+ L L C + P ++ L+VL++S N + L + +
Sbjct: 466 FTELRNLTF--LDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVL 523
Query: 261 YFAGNLLTGAIPPWMLERGDK---IDLSYNNFT 290
++ N + + + ++L+ N+F
Sbjct: 524 DYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFA 556
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 3e-32
Identities = 47/279 (16%), Positives = 97/279 (34%), Gaps = 16/279 (5%)
Query: 28 NLTGVLPPKLAELTFLQDIDLTLNYLSGTIPSQWASLPLLN-ISLIANRLKGPIPKYLAN 86
L + LQ +DL+ + + SL L+ + L N ++ +
Sbjct: 39 PLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSG 98
Query: 87 ISTLVNLTVQYNQFSGELPEELGSLLNLEKLHLSSNNFTG-ELPKTFAKLTNMKDFRISD 145
+S+L L + +G L L++L+++ N +LP+ F+ LTN++ +S
Sbjct: 99 LSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSS 158
Query: 146 NQFTGQIPSFIQNWTKLEKLFIQPSGLAGPI---PSGIFSLENLTDLRISD----LNGPE 198
N+ + ++ ++ L + P+ G F L L + + LN +
Sbjct: 159 NKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRLHKLTLRNNFDSLNVMK 218
Query: 199 ATFPQLGNMKMTKLILRN----CNITGELPRYLGKMTKLKVLDLSFNRL---RGQIPSNF 251
L +++ +L+L N+ L + L + + L I F
Sbjct: 219 TCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLF 278
Query: 252 DDLYDVDYIYFAGNLLTGAIPPWMLERGDKIDLSYNNFT 290
+ L +V + ++L F
Sbjct: 279 NCLTNVSSFSLVSVTIERVKDFSYNFGWQHLELVNCKFG 317
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 4e-29
Identities = 50/288 (17%), Positives = 93/288 (32%), Gaps = 31/288 (10%)
Query: 26 EQNLTGV---LPPKLAELTFLQDIDLTLNYLSGTIPSQWASLPLLNI-SLIANRLKGPIP 81
E N + LP L DL+ N L + S P L + L ++
Sbjct: 16 ELNFYKIPDNLPFSTKNL------DLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIED 69
Query: 82 KYLANISTLVNLTVQYNQFSGELPEELGSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDF 141
++S L L + N L +L+KL N L +K+
Sbjct: 70 GAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKEL 129
Query: 142 RISDNQFTG-QIPSFIQNWTKLEKLFIQPSGLAGPIPSGIFSLENLT------DLRISDL 194
++ N ++P + N T LE L + + + + + L + DL ++ +
Sbjct: 130 NVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPM 189
Query: 195 NGPEATFPQLGNMKMTKLILRNCNITGELPRY-LGKMTKLKVLDLSFNRLRGQ------I 247
N + +++ KL LRN + + + + + L+V L R +
Sbjct: 190 NFIQPGA--FKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFD 247
Query: 248 PSNFDDLYDVDYIYFAGNLLTGAIPPWM-----LERGDKIDLSYNNFT 290
S + L ++ F L + + L L
Sbjct: 248 KSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIE 295
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 6e-27
Identities = 47/265 (17%), Positives = 84/265 (31%), Gaps = 14/265 (5%)
Query: 22 RVLKEQNLTGVLPPKLAELTFLQDIDLTLNYLS--GTIPSQWASLP-LLNISLIANRLKG 78
+ L + G +L L+ +DL+ N LS G L + L N +
Sbjct: 328 KRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVIT 387
Query: 79 PIPKYLANISTLVNLTVQYNQFSGELPEE-LGSLLNLEKLHLSSNNFTGELPKTFAKLTN 137
+ + L +L Q++ SL NL L +S + F L++
Sbjct: 388 -MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSS 446
Query: 138 MKDFRISDNQFTGQI-PSFIQNWTKLEKLFIQPSGLAGPIPSGIFSLENLTDLRISD--L 194
++ +++ N F P L L + L P+ SL +L L +S
Sbjct: 447 LEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNF 506
Query: 195 NG-PEATFPQLGNMKMTKLILRNCNITGELPRYLGKM-TKLKVLDLSFNRLRGQIPSN-- 250
+ L ++ L +I + L + L L+L+ N
Sbjct: 507 FSLDTFPYKCLNSL--QVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCEHQSF 564
Query: 251 FDDLYDVDYIYFAGNLLTGAIPPWM 275
+ D + + A P
Sbjct: 565 LQWIKDQRQLLVEVERMECATPSDK 589
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 6e-25
Identities = 43/282 (15%), Positives = 95/282 (33%), Gaps = 26/282 (9%)
Query: 28 NLTGVLPPKLAELTFLQDIDLTLNYLSGTIPSQW----ASLPLLNISLIANRLKGPIPKY 83
+ + P E+ L + L N+ S + A L + + L R +G + K+
Sbjct: 188 PMNFIQPGAFKEIR-LHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKF 246
Query: 84 -LANISTLVNLTVQYNQFS------GELPEELGSLLNLEKLHLSSNNFTGELPKTFAKLT 136
+ + L NLT++ + + ++ + L N+ L S F+
Sbjct: 247 DKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKD--FSYNF 304
Query: 137 NMKDFRISDNQFTGQIPSFIQNWTKLEKLFIQPSGLAGPIPSGIFSLENLTDLRISD--L 194
+ + + +F +++ +L + G L +L L +S L
Sbjct: 305 GWQHLELVNCKFGQFPTLKLKSLKRLTFTSNK-----GGNAFSEVDLPSLEFLDLSRNGL 359
Query: 195 NGPEATFPQLGNM-KMTKLILRNCNITGELPRYLGKMTKLKVLDLSFNRLRGQIP-SNFD 252
+ + L L + + + +L+ LD + L+ S F
Sbjct: 360 SFKGCCSQSDFGTTSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFL 418
Query: 253 DLYDVDYIYFAGNLLTGAIPPWM--LERGDKIDLSYNNFTDG 292
L ++ Y+ + A L + + ++ N+F +
Sbjct: 419 SLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQEN 460
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 5e-34
Identities = 66/208 (31%), Positives = 94/208 (45%), Gaps = 27/208 (12%)
Query: 424 IGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQGNREFINEIGMISAL-QHPNLVKLYGC- 480
+G G +G VYKG + G A+K + E EI M+ H N+ YG
Sbjct: 32 VGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAF 90
Query: 481 -----CIEGNQLLLIYEYLENNSLARALFEHRLK-LDWPTRRRICLGIARGLAYLHGESR 534
+QL L+ E+ S+ + + L IC I RGL++LH
Sbjct: 91 IKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQH-- 148
Query: 535 IKVVHRDIKATNVLLDKDLNSKISDFGL-AKLDEEE---NTHISTRVAGTIGYMAPEYAM 590
KV+HRDIK NVLL ++ K+ DFG+ A+LD NT GT +MAPE
Sbjct: 149 -KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNT-----FIGTPYWMAPEVIA 202
Query: 591 RGHLTE-----KADVYSFGIVALEIVSG 613
+ K+D++S GI A+E+ G
Sbjct: 203 CDENPDATYDFKSDLWSLGITAIEMAEG 230
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 1e-33
Identities = 48/208 (23%), Positives = 87/208 (41%), Gaps = 18/208 (8%)
Query: 417 NFATDNNIGEGGFGPVYKGLLADGTAIAVKQLSSKSKQGNREFINEIG-MISALQHPNLV 475
+F + +G G G + + D +AVK++ + E+ + + +HPN++
Sbjct: 25 SFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRI---LPECFSFADREVQLLRESDEHPNVI 81
Query: 476 KLYGCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRI 535
+ + + + E +L + + + GLA+LH +
Sbjct: 82 RYFCTEKDRQFQYIAIELCA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLH---SL 137
Query: 536 KVVHRDIKATNVLL-----DKDLNSKISDFGLAKLDEEENTHISTR--VAGTIGYMAPEY 588
+VHRD+K N+L+ + + ISDFGL K S R V GT G++APE
Sbjct: 138 NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEM 197
Query: 589 ---AMRGHLTEKADVYSFGIVALEIVSG 613
+ + T D++S G V ++S
Sbjct: 198 LSEDCKENPTYTVDIFSAGCVFYYVISE 225
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 2e-33
Identities = 52/199 (26%), Positives = 93/199 (46%), Gaps = 13/199 (6%)
Query: 424 IGEGGFGPVYKGL-LADGTAIAVKQL-SSKSKQGNREFINEIG-MISALQHPNLVKLYGC 480
+G G G V+K G IAVKQ+ S +K+ N+ + ++ ++ + P +V+ +G
Sbjct: 33 MGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGT 92
Query: 481 CIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHR 540
I + + E + + + ++ + I + L YL + V+HR
Sbjct: 93 FITNTDVFIAMELMGTCAEKLKKRMQG-PIPERILGKMTVAIVKALYYLK--EKHGVIHR 149
Query: 541 DIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPE-----YAMRGHLT 595
D+K +N+LLD+ K+ DFG++ + R AG YMAPE +
Sbjct: 150 DVKPSNILLDERGQIKLCDFGISG--RLVDDKAKDRSAGCAAYMAPERIDPPDPTKPDYD 207
Query: 596 EKADVYSFGIVALEIVSGR 614
+ADV+S GI +E+ +G+
Sbjct: 208 IRADVWSLGISLVELATGQ 226
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 3e-33
Identities = 54/197 (27%), Positives = 82/197 (41%), Gaps = 12/197 (6%)
Query: 424 IGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQGNREFI----NEIGMISALQHPNLVKLY 478
+G GG G VY+ +A+K +S + + F E LQ P++V ++
Sbjct: 42 VGRGGMGDVYEAEDTVRERIVALKLMSE-TLSSDPVFRTRMQREARTAGRLQEPHVVPIH 100
Query: 479 GCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVV 538
QL + + LA L L P I I L H
Sbjct: 101 DFGEIDGQLYVDMRLINGVDLAAMLRRQG-PLAPPRAVAIVRQIGSALDAAH---AAGAT 156
Query: 539 HRDIKATNVLLDKDLNSKISDFGLAK-LDEEENTHISTRVAGTIGYMAPEYAMRGHLTEK 597
HRD+K N+L+ D + + DFG+A +E+ T + GT+ YMAPE H T +
Sbjct: 157 HRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGN-TVGTLYYMAPERFSESHATYR 215
Query: 598 ADVYSFGIVALEIVSGR 614
AD+Y+ V E ++G
Sbjct: 216 ADIYALTCVLYECLTGS 232
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 2e-32
Identities = 45/199 (22%), Positives = 79/199 (39%), Gaps = 21/199 (10%)
Query: 424 IGEGGFGPVYKG--LLADGTAIAVKQLSSKSKQGNRE-FINEIGMISALQHPNLVKLY-- 478
I GG G +Y +G + +K L + + E ++ + HP++V+++
Sbjct: 88 IAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNF 147
Query: 479 GCCIEGNQLLLIY---EYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRI 535
+ + + Y EY+ SL R+ + L L I L+YLH I
Sbjct: 148 VEHTDRHGDPVGYIVMEYVGGQSLKRSKGQK---LPVAEAIAYLLEILPALSYLH---SI 201
Query: 536 KVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPEYAMRGHLT 595
+V+ D+K N++L ++ K+ D G + GT G+ APE R T
Sbjct: 202 GLVYNDLKPENIMLTEE-QLKLIDLGAVSRINSFGY-----LYGTPGFQAPEIV-RTGPT 254
Query: 596 EKADVYSFGIVALEIVSGR 614
D+Y+ G +
Sbjct: 255 VATDIYTVGRTLAALTLDL 273
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 126 bits (320), Expect = 2e-32
Identities = 55/203 (27%), Positives = 91/203 (44%), Gaps = 18/203 (8%)
Query: 424 IGEGGFGPVYKGL-LADGTAIAVK----QLSSKSKQGNREFINEIGMISALQHPNLVKLY 478
+G GG V+ L D +AVK L+ R F E +AL HP +V +Y
Sbjct: 20 LGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLR-FRREAQNAAALNHPAIVAVY 78
Query: 479 --GCCIEGNQLLLIY---EYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGES 533
G E L Y EY++ +L + + + + L + H
Sbjct: 79 DTGE-AETPAGPLPYIVMEYVDGVTLRDIVHTEG-PMTPKRAIEVIADACQALNFSH--- 133
Query: 534 RIKVVHRDIKATNVLLDKDLNSKISDFGLAK-LDEEENTHIST-RVAGTIGYMAPEYAMR 591
+ ++HRD+K N+++ K+ DFG+A+ + + N+ T V GT Y++PE A
Sbjct: 134 QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARG 193
Query: 592 GHLTEKADVYSFGIVALEIVSGR 614
+ ++DVYS G V E+++G
Sbjct: 194 DSVDARSDVYSLGCVLYEVLTGE 216
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 3e-32
Identities = 58/195 (29%), Positives = 99/195 (50%), Gaps = 8/195 (4%)
Query: 424 IGEGGFGPVYKGL-LADGTAIAVKQLSSKS--KQGNRE-FINEIGMISALQHPNLVKLYG 479
+G+G F VY+ + G +A+K + K+ K G + NE+ + L+HP++++LY
Sbjct: 19 LGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYN 78
Query: 480 CCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVH 539
+ N + L+ E N + R L R I G+ YLH ++H
Sbjct: 79 YFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLH---SHGILH 135
Query: 540 RDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPEYAMRGHLTEKAD 599
RD+ +N+LL +++N KI+DFGLA + + T + GT Y++PE A R ++D
Sbjct: 136 RDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYT-LCGTPNYISPEIATRSAHGLESD 194
Query: 600 VYSFGIVALEIVSGR 614
V+S G + ++ GR
Sbjct: 195 VWSLGCMFYTLLIGR 209
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 3e-32
Identities = 46/217 (21%), Positives = 84/217 (38%), Gaps = 23/217 (10%)
Query: 416 NNFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQGNREFI-NEIGMISALQHPN 473
+ + + +G+G V++G G A+K ++ S + E ++ L H N
Sbjct: 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKN 68
Query: 474 LVKLYGC--CIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTR--RRICLGIARGLAYL 529
+VKL+ +LI E+ SL L E P + + G+ +L
Sbjct: 69 IVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHL 128
Query: 530 HGESRIKVVHRDIKATNVLL----DKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMA 585
+VHR+IK N++ D K++DFG A+ E++ + GT Y+
Sbjct: 129 R---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE-LEDDEQFVSLY-GTEEYLH 183
Query: 586 PE--------YAMRGHLTEKADVYSFGIVALEIVSGR 614
P+ + D++S G+ +G
Sbjct: 184 PDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 8e-32
Identities = 57/196 (29%), Positives = 90/196 (45%), Gaps = 11/196 (5%)
Query: 424 IGEGGFGPVYKG-LLADGTAIAVKQLSSKS--KQGNRE-FINEIGMISALQHPNLVKLYG 479
+G+GGF ++ A K + K RE EI + +L H ++V +G
Sbjct: 23 LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 82
Query: 480 CCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVH 539
+ + + ++ E SL + L P R I G YLH R +V+H
Sbjct: 83 FFEDNDFVFVVLELCRRRSLLELHKRRK-ALTEPEARYYLRQIVLGCQYLH---RNRVIH 138
Query: 540 RDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPEYAM-RGHLTEKA 598
RD+K N+ L++DL KI DFGLA E + + GT Y+APE +GH + +
Sbjct: 139 RDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV-LCGTPNYIAPEVLSKKGH-SFEV 196
Query: 599 DVYSFGIVALEIVSGR 614
DV+S G + ++ G+
Sbjct: 197 DVWSIGCIMYTLLVGK 212
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 1e-31
Identities = 57/196 (29%), Positives = 90/196 (45%), Gaps = 11/196 (5%)
Query: 424 IGEGGFGPVYKG-LLADGTAIAVKQLSSKS--KQGNRE-FINEIGMISALQHPNLVKLYG 479
+G+GGF ++ A K + K RE EI + +L H ++V +G
Sbjct: 49 LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 108
Query: 480 CCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVH 539
+ + + ++ E SL + L P R I G YLH R +V+H
Sbjct: 109 FFEDNDFVFVVLELCRRRSLLELHKRRK-ALTEPEARYYLRQIVLGCQYLH---RNRVIH 164
Query: 540 RDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPEYAM-RGHLTEKA 598
RD+K N+ L++DL KI DFGLA E + + GT Y+APE +GH + +
Sbjct: 165 RDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV-LCGTPNYIAPEVLSKKGH-SFEV 222
Query: 599 DVYSFGIVALEIVSGR 614
DV+S G + ++ G+
Sbjct: 223 DVWSIGCIMYTLLVGK 238
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 2e-31
Identities = 57/196 (29%), Positives = 92/196 (46%), Gaps = 13/196 (6%)
Query: 424 IGEGGFGPVYKG-LLADGTAIAVKQLS----SKSKQGNREFINEIGMISALQHPNLVKLY 478
+G+G FG VY +A+K L K+ ++ E+ + S L+HPN+++LY
Sbjct: 17 LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQ-LRREVEIQSHLRHPNILRLY 75
Query: 479 GCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVV 538
G + ++ LI EY ++ R L + K D +A L+Y H +V+
Sbjct: 76 GYFHDATRVYLILEYAPLGTVYRELQKLS-KFDEQRTATYITELANALSYCH---SKRVI 131
Query: 539 HRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPEYAMRGHLTEKA 598
HRDIK N+LL KI+DFG + + GT+ Y+ PE EK
Sbjct: 132 HRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT--D-LCGTLDYLPPEMIEGRMHDEKV 188
Query: 599 DVYSFGIVALEIVSGR 614
D++S G++ E + G+
Sbjct: 189 DLWSLGVLCYEFLVGK 204
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 5e-31
Identities = 63/212 (29%), Positives = 96/212 (45%), Gaps = 20/212 (9%)
Query: 417 NFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQGNREFI-NEIGMISALQHPNL 474
+ +G GGFG V + + G +A+KQ + NRE EI ++ L HPN+
Sbjct: 15 PWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNV 74
Query: 475 VKLYGCCIE-------GNQLLLIYEYLENNSLARAL--FEHRLKLDWPTRRRICLGIARG 525
V + + LL EY E L + L FE+ L R + I+
Sbjct: 75 VSAR-EVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSA 133
Query: 526 LAYLHGESRIKVVHRDIKATNVLLDKDLNS---KISDFGLAKLDEEENTHISTRVAGTIG 582
L YLH +++HRD+K N++L KI D G AK + ++ + V GT+
Sbjct: 134 LRYLH---ENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAK-ELDQGELCTEFV-GTLQ 188
Query: 583 YMAPEYAMRGHLTEKADVYSFGIVALEIVSGR 614
Y+APE + T D +SFG +A E ++G
Sbjct: 189 YLAPELLEQKKYTVTVDYWSFGTLAFECITGF 220
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 8e-31
Identities = 46/217 (21%), Positives = 84/217 (38%), Gaps = 23/217 (10%)
Query: 416 NNFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQGNREFI-NEIGMISALQHPN 473
+ + + +G+G V++G G A+K ++ S + E ++ L H N
Sbjct: 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKN 68
Query: 474 LVKLYGC--CIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTR--RRICLGIARGLAYL 529
+VKL+ +LI E+ SL L E P + + G+ +L
Sbjct: 69 IVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHL 128
Query: 530 HGESRIKVVHRDIKATNVLL----DKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMA 585
+VHR+IK N++ D K++DFG A+ E++ + GT Y+
Sbjct: 129 R---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE-LEDDEQFVSLY-GTEEYLH 183
Query: 586 PE--------YAMRGHLTEKADVYSFGIVALEIVSGR 614
P+ + D++S G+ +G
Sbjct: 184 PDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 1e-30
Identities = 50/217 (23%), Positives = 82/217 (37%), Gaps = 26/217 (11%)
Query: 424 IGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQGNREFINEIG-MISALQHPNLVKLYGCC 481
+ EGGF VY+ + G A+K+L S ++ NR I E+ M HPN+V+
Sbjct: 36 LAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAA 95
Query: 482 I-------EGNQLLLIYEYLENNSLARALFEHRLK--LDWPTRRRICLGIARGLAYLHGE 532
G L+ L L L + + L T +I R + ++H
Sbjct: 96 SIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMH-R 154
Query: 533 SRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVA-----------GTI 581
+ ++HRD+K N+LL K+ DFG A + + T
Sbjct: 155 QKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTP 214
Query: 582 GYMAPE---YAMRGHLTEKADVYSFGIVALEIVSGRS 615
Y PE + EK D+++ G + + +
Sbjct: 215 MYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQH 251
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 2e-30
Identities = 49/306 (16%), Positives = 96/306 (31%), Gaps = 51/306 (16%)
Query: 28 NLTGVLPPKLAELTFLQDIDLTLNYLSGTIPSQWASLPLLNISLIANRLKGPIPKYLANI 87
+ +L LQD + SL I + NR+ I K + +
Sbjct: 389 KMFLDYDQRLNLSDLLQDAINRNPEMKPIKKDSRISLKDTQIGNLTNRITF-ISKAIQRL 447
Query: 88 STLVNLTVQYNQFSG-------------------ELPEELGSLLNLEKLHLSSNNFTGEL 128
+ L + + F+ +L +L + L + +L
Sbjct: 448 TKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQL 507
Query: 129 PKTFAKLTNMKDFRISDNQFTG---------QIPSFIQNWTKLEKLFIQPSGLAG-PIPS 178
P L ++ I+ N+ ++ K++ ++ + L P +
Sbjct: 508 PDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLEEFPASA 567
Query: 179 GIFSLENLTDLRISD--LNGPEATFPQLGNM-KMTKLILRNCNITGELPRYLGK-MTKLK 234
+ + L L + G K+T L L I E+P +++
Sbjct: 568 SLQKMVKLGLLDCVHNKVR----HLEAFGTNVKLTDLKLDYNQIE-EIPEDFCAFTDQVE 622
Query: 235 VLDLSFNRLRGQIPSNFD--DLYDVDYIYFAGNLLTGAIPPWMLERGD--------KIDL 284
L S N+L+ IP+ F+ +Y + + F+ N + + D + L
Sbjct: 623 GLGFSHNKLKY-IPNIFNAKSVYVMGSVDFSYNKIGS-EGRNISCSMDDYKGINASTVTL 680
Query: 285 SYNNFT 290
SYN
Sbjct: 681 SYNEIQ 686
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 1e-26
Identities = 38/285 (13%), Positives = 80/285 (28%), Gaps = 40/285 (14%)
Query: 34 PPKLAELTFLQDIDLTLNYLSGTIPSQWASLP-LLNISLIANRLKG-PIPKYLANISTLV 91
L D+ L N + A + + N+LK P ++ +
Sbjct: 588 LEAFGTNVKLTDLKLDYNQIEEIPEDFCAFTDQVEGLGFSHNKLKYIPNIFNAKSVYVMG 647
Query: 92 NLTVQYNQFSGELPEELGS------LLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRISD 145
++ YN+ + +N + LS N + FA + + +S+
Sbjct: 648 SVDFSYNKIGS-EGRNISCSMDDYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSN 706
Query: 146 NQFTGQIPSFIQNWTKLEKLFIQPSGLAGPIPSGIFSLENLTDLRISD--LNG--PEATF 201
N T P P + LT + + L +
Sbjct: 707 NLMTS-----------------IPENSLKPKDGNYKNTYLLTTIDLRFNKLTSLSDDFRA 749
Query: 202 PQLGNMKMTKLILRNCNITGELPRYLGKMTKLKVLDLSF------NRLRGQIPSNFDDLY 255
L ++ + + + P ++LK + NR+ Q P+
Sbjct: 750 TTLPY--LSNMDVSYNCFS-SFPTQPLNSSQLKAFGIRHQRDAEGNRILRQWPTGITTCP 806
Query: 256 DVDYIYFAGNLLTGAIPPWMLERGDKIDLSYNNFTDGSAESSCQK 300
+ + N + + + + +D++ N S C
Sbjct: 807 SLIQLQIGSNDIRK-VDEKLTPQLYILDIADNPNISIDVTSVCPY 850
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 2e-24
Identities = 42/292 (14%), Positives = 86/292 (29%), Gaps = 44/292 (15%)
Query: 33 LPPKLAELTFLQDIDLTLNYLSGTIPSQW----ASLPLLNISLIANRLKGPIPKYLANIS 88
L +Q + N L S L LL+ N+++
Sbjct: 540 LADDEDTGPKIQIFYMGYNNLEEFPASASLQKMVKLGLLDCV--HNKVRHLEA--FGTNV 595
Query: 89 TLVNLTVQYNQFSGELPEELGSLL-NLEKLHLSSNNFTGELPKTFA--KLTNMKDFRISD 145
L +L + YNQ E+PE+ + +E L S N +P F + M S
Sbjct: 596 KLTDLKLDYNQIE-EIPEDFCAFTDQVEGLGFSHNKLK-YIPNIFNAKSVYVMGSVDFSY 653
Query: 146 NQFTGQIPSF-----IQNWTKLEKLFIQPSGLAGPIPSGIFSLENLTDLRISD------- 193
N+ + + + + + + + ++ + +S+
Sbjct: 654 NKIGSEGRNISCSMDDYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMTSIP 713
Query: 194 LNGPEATFPQLGNM-KMTKLILRNCNITGELPR--YLGKMTKLKVLDLSFNRLRGQIPSN 250
N + N +T + LR +T L + L +D+S+N P+
Sbjct: 714 ENSLKPKDGNYKNTYLLTTIDLRFNKLT-SLSDDFRATTLPYLSNMDVSYNCFSS-FPTQ 771
Query: 251 FDDLYDVDYIYFAGNL------LTGAIPPWM-----LERGDKIDLSYNNFTD 291
+ + + P + L ++ + N+
Sbjct: 772 PLNSSQLKAFGIRHQRDAEGNRILRQWPTGITTCPSLI---QLQIGSNDIRK 820
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 89.2 bits (221), Expect = 2e-18
Identities = 35/308 (11%), Positives = 92/308 (29%), Gaps = 38/308 (12%)
Query: 39 ELTFLQDIDLTLNYLSGTIPSQWASLPLLN-ISLIANRLKGPIPKYLANISTLVNLTVQY 97
+LT ++ + L + I A + + R + N +
Sbjct: 250 KLTKDANVPIQLKETAEYIKDYKALKAIWEALDGKNWRYYSGTINNTIHSLNW-NFNKEL 308
Query: 98 NQFSGELPEELGSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRISDNQFTGQIPSFIQ 157
+ + + +L + + L L+ G +P +LT +K + T F
Sbjct: 309 DMWGDQPGVDLDNNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGD 368
Query: 158 NWTKLEKLFIQPSGLAGPIPSGIF----SLENLTDLRISDLNGPEATFPQLG---NMKMT 210
+ + + L L+ + PE + ++K T
Sbjct: 369 EELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIKKDSRISLKDT 428
Query: 211 KLILRNCNITGELPRYLGKMTKLKVLDLSFNRLRG-------------------QIPSNF 251
++ IT + + + ++TKL+++ + + ++
Sbjct: 429 QIGNLTNRITF-ISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSW 487
Query: 252 DDLYDVDYIYFAGNLLTGAIPPWM-----LERGDKIDLSYNNFTDGSAESSCQKRSVTGI 306
+L D+ + +P ++ L+ ++++ N +A+ +
Sbjct: 488 SNLKDLTDVELYNCPNMTQLPDFLYDLPELQS---LNIACNRGI-SAAQLKADWTRLADD 543
Query: 307 VSCLRSVQ 314
+Q
Sbjct: 544 EDTGPKIQ 551
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 85.3 bits (211), Expect = 3e-17
Identities = 35/214 (16%), Positives = 70/214 (32%), Gaps = 37/214 (17%)
Query: 28 NLTGVLPPKLAELTFLQDIDLTLNYLSGTIPSQWASLPLLNISLIANRLKGPIPKYLANI 87
+ A + + I L+ N ++ I P N
Sbjct: 684 EIQKFPTELFATGSPISTIILSNN----------------LMTSIPENSLKPKDGNYKNT 727
Query: 88 STLVNLTVQYNQFSGELPEEL--GSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRI-- 143
L + +++N+ + L ++ +L L + +S N F+ P + +K F I
Sbjct: 728 YLLTTIDLRFNKLT-SLSDDFRATTLPYLSNMDVSYNCFS-SFPTQPLNSSQLKAFGIRH 785
Query: 144 ----SDNQFTGQIPSFIQNWTKLEKLFIQPSGLAGPIPSGIFSLENLTDLRISD---LNG 196
N+ Q P+ I L +L I + + + + L L I+D ++
Sbjct: 786 QRDAEGNRILRQWPTGITTCPSLIQLQIGSNDIRK-VDEKL--TPQLYILDIADNPNISI 842
Query: 197 PEATFPQLGNMKMTKLIL-RNCNITG----ELPR 225
+ M L+ + +I G + R
Sbjct: 843 DVTSVCPYIEAGMYVLLYDKTQDIRGCDALGIER 876
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 76.8 bits (189), Expect = 1e-14
Identities = 24/153 (15%), Positives = 49/153 (32%), Gaps = 19/153 (12%)
Query: 27 QNLTGVLPPKLAELTFLQDIDLTLNYLSGTIP-----SQWASLPLLNISLIANRLKGPIP 81
+N L IDL N L+ ++ + L +++S N P
Sbjct: 714 ENSLKPKDGNYKNTYLLTTIDLRFNKLT-SLSDDFRATTLPYLSNMDVS--YNCFSS-FP 769
Query: 82 KYLANISTLV------NLTVQYNQFSGELPEELGSLLNLEKLHLSSNNFTGELPKTFAKL 135
N S L + N+ + P + + +L +L + SN+ ++ +
Sbjct: 770 TQPLNSSQLKAFGIRHQRDAEGNRILRQWPTGITTCPSLIQLQIGSNDIR-KVDEKL--T 826
Query: 136 TNMKDFRISDNQFT-GQIPSFIQNWTKLEKLFI 167
+ I+DN + S + +
Sbjct: 827 PQLYILDIADNPNISIDVTSVCPYIEAGMYVLL 859
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 5e-30
Identities = 46/296 (15%), Positives = 79/296 (26%), Gaps = 36/296 (12%)
Query: 28 NLTGVLPPKLAELTFLQDIDLTLNYLSGTIPSQWASLPLLNI-SLIANRLKGPIPKYLAN 86
L + + L L +DLT + + S L+ L AN L L+
Sbjct: 44 VLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAETALSG 103
Query: 87 ISTLVNLTVQYNQFSGELPEELGSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRISDN 146
L +L S L + LE L+L SN+ + +K +N
Sbjct: 104 PKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNN 163
Query: 147 QFTGQIPSFIQNWTKLEKLFIQPSGLA-GPIPSGIFSLENLTDLRISDLNG--------- 196
+ + + L + +G I G F L
Sbjct: 164 AIHYLSKEDMSSLQQATNLSLNLNGNDIAGIEPGAFDSAVFQSLNFGGTQNLLVIFKGLK 223
Query: 197 --------------------PEATFPQLGNMKMTKLILRNCNITGELPRYLGKMTKLKVL 236
A F L M + + L+ + L+ L
Sbjct: 224 NSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFNISSNTFHCFSGLQEL 283
Query: 237 DLSFNRLRGQIPSNFDDLYDVDYIYFAGNLLTGAIPPWMLERGDK---IDLSYNNF 289
DL+ L ++PS L + + + N + + + N
Sbjct: 284 DLTATHLS-ELPSGLVGLSTLKKLVLSANKFEN-LCQISASNFPSLTHLSIKGNTK 337
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 3e-27
Identities = 54/271 (19%), Positives = 103/271 (38%), Gaps = 16/271 (5%)
Query: 33 LPPKLAELTFLQDIDLTLNYLSGTIPSQWASLP-LLNISLIANRLKGPIPKY-LANISTL 90
LP L L+ L+ + L+ N ++ P L ++S+ N + + L N+ L
Sbjct: 293 LPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENL 352
Query: 91 VNLTVQYNQ--FSGELPEELGSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRISDNQF 148
L + ++ S +L +L +L+ L+LS N + F + ++ ++ +
Sbjct: 353 RELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRL 412
Query: 149 TGQIP-SFIQNWTKLEKLFIQPSGLAGPIPSGIFSLENLTDLRISD------LNGPEATF 201
+ S QN L+ L + S L L L L + +
Sbjct: 413 KVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSL 472
Query: 202 PQLGNMKMTKLILRNCNITGELPRYLGKMTKLKVLDLSFNRLRGQIPSNFDDLYDVDYIY 261
LG ++ L+L C+++ + + +DLS NRL L + Y+
Sbjct: 473 QTLGRLE--ILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGI-YLN 529
Query: 262 FAGNLLTGAIPPWM--LERGDKIDLSYNNFT 290
A N ++ +P + L + I+L N
Sbjct: 530 LASNHISIILPSLLPILSQQRTINLRQNPLD 560
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 2e-25
Identities = 54/285 (18%), Positives = 100/285 (35%), Gaps = 20/285 (7%)
Query: 19 NQKRVLKEQNLTGVLPPKLAELTFLQDIDLTLNYLSGTIPSQWASLPLLNISLIANRLKG 78
Q ++ + L L TF D+ +S + + + +I+L +
Sbjct: 212 TQNLLVIFKGLKNSTIQSLWLGTFE---DMDDEDISPAVFEGLCEMSVESINLQKHYFFN 268
Query: 79 PIPKYLANISTLVNLTVQYNQFSGELPEELGSLLNLEKLHLSSNNFTGELPKTFAKLTNM 138
S L L + S ELP L L L+KL LS+N F + + ++
Sbjct: 269 ISSNTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSANKFENLCQISASNFPSL 327
Query: 139 KDFRISDNQFTGQIPS-FIQNWTKLEKLFIQPSGLAGPIPSGIFSLENLTDLRISDLNG- 196
I N ++ + ++N L +L + + L NL+ L+ +L+
Sbjct: 328 THLSIKGNTKRLELGTGCLENLENLRELDLSHDDIET-SDCCNLQLRNLSHLQSLNLSYN 386
Query: 197 -----PEATFPQLGNMKMTKLILRNCNITGELPRY-LGKMTKLKVLDLSFNRLRGQIPSN 250
F + + L L + + + + LKVL+LS + L
Sbjct: 387 EPLSLKTEAFKECPQ--LELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQL 444
Query: 251 FDDLYDVDYIYFAGNLLTGAIPPW-----MLERGDKIDLSYNNFT 290
FD L + ++ GN L R + + LS+ + +
Sbjct: 445 FDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLS 489
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 1e-23
Identities = 41/261 (15%), Positives = 75/261 (28%), Gaps = 19/261 (7%)
Query: 47 DLTLNYLSGTIPSQWASLPLLNISLIANRLKGPIPKYLANISTLVNLTVQYNQFSGELPE 106
+L LN + GT+P+ S L S N L + + L L + Q +
Sbjct: 21 NLGLNEIPGTLPN---STECLEFS--FNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHED 75
Query: 107 ELGSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRISDNQFTGQIPSFIQNWTKLEKLF 166
S L+ L L++N + +K + + N LE L+
Sbjct: 76 TFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLY 135
Query: 167 IQPSGLAGPIPSGIFSLENLTDL-----RISDLNGPEATFPQLGNMKMTKLILRNCNITG 221
+ + ++ F E L L I L + L L L +I
Sbjct: 136 LGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYL--SKEDMSSLQQATNLSLNLNGNDIA- 192
Query: 222 ELPRYLGKMTKLKVLDLSFNRLRGQIPSN--FDDLYDVDYIYFAGNLLT----GAIPPWM 275
+ + L+ + I + + F
Sbjct: 193 GIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLC 252
Query: 276 LERGDKIDLSYNNFTDGSAES 296
+ I+L + F + S+ +
Sbjct: 253 EMSVESINLQKHYFFNISSNT 273
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 79.7 bits (197), Expect = 1e-15
Identities = 32/171 (18%), Positives = 61/171 (35%), Gaps = 6/171 (3%)
Query: 28 NLTGVLPPKLAELTFLQDIDLTLNYLSGTIP-SQWASLP-LLNISLIANRLKGPIPKYLA 85
+ E L+ +DL L S + +L L ++L + L +
Sbjct: 387 EPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFD 446
Query: 86 NISTLVNLTVQYNQFSG---ELPEELGSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFR 142
+ L +L +Q N F + L +L LE L LS + + F L M
Sbjct: 447 GLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVD 506
Query: 143 ISDNQFTGQIPSFIQNWTKLEKLFIQPSGLAGPIPSGIFSLENLTDLRISD 193
+S N+ T + + + L + + ++ +PS + L + +
Sbjct: 507 LSHNRLTSSSIEALSHLKGIY-LNLASNHISIILPSLLPILSQQRTINLRQ 556
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 64.7 bits (158), Expect = 6e-11
Identities = 24/131 (18%), Positives = 46/131 (35%), Gaps = 5/131 (3%)
Query: 24 LKEQNLTGVLPPKLAELTFLQDIDLTLNYLSGTIPSQWASLP----LLNISLIANRLKGP 79
L L L LQ ++L N+ + SL L + L L
Sbjct: 432 LSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSI 491
Query: 80 IPKYLANISTLVNLTVQYNQFSGELPEELGSLLNLEKLHLSSNNFTGELPKTFAKLTNMK 139
++ + ++ + +N+ + E L L + L+L+SN+ + LP L+ +
Sbjct: 492 DQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGIY-LNLASNHISIILPSLLPILSQQR 550
Query: 140 DFRISDNQFTG 150
+ N
Sbjct: 551 TINLRQNPLDC 561
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 51.9 bits (125), Expect = 5e-07
Identities = 17/122 (13%), Positives = 41/122 (33%), Gaps = 4/122 (3%)
Query: 28 NLTGVLPPKLAELTFLQDIDLTLNYLSGTIPSQWASLPLLNISLIANRLKGPIPKYLANI 87
+L+ + L + +DL+ N L+ + + L + ++L +N + +P L +
Sbjct: 487 DLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGIYLNLASNHISIILPSLLPIL 546
Query: 88 STLVNLTVQYNQFSGELPEELGSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRISDNQ 147
S + ++ N L + ++ R+SD
Sbjct: 547 SQQRTINLRQNPLDCTC--SNIYFLEW--YKENMQKLEDTEDTLCENPPLLRGVRLSDVT 602
Query: 148 FT 149
+
Sbjct: 603 LS 604
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 8e-30
Identities = 54/196 (27%), Positives = 89/196 (45%), Gaps = 13/196 (6%)
Query: 424 IGEGGFGPVYKG-LLADGTAIAVKQLS----SKSKQGNREFINEIGMISALQHPNLVKLY 478
+G+G FG VY + +A+K L K ++ EI + S L+HPN++++Y
Sbjct: 22 LGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQ-LRREIEIQSHLRHPNILRMY 80
Query: 479 GCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVV 538
+ ++ L+ E+ L + L +H + D +A L Y H KV+
Sbjct: 81 NYFHDRKRIYLMLEFAPRGELYKELQKHG-RFDEQRSATFMEELADALHYCH---ERKVI 136
Query: 539 HRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPEYAMRGHLTEKA 598
HRDIK N+L+ KI+DFG + T + GT+ Y+ PE EK
Sbjct: 137 HRDIKPENLLMGYKGELKIADFGWSVHAPSLRRR--T-MCGTLDYLPPEMIEGKTHDEKV 193
Query: 599 DVYSFGIVALEIVSGR 614
D++ G++ E + G
Sbjct: 194 DLWCAGVLCYEFLVGM 209
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 3e-29
Identities = 55/228 (24%), Positives = 89/228 (39%), Gaps = 37/228 (16%)
Query: 416 NNFATDNNIGEGGFGPVYKGLLADGTAIAVKQLSSKSKQGNREFINEIG-MISALQHPNL 474
N ++ +G G G V G +AVK++ + EI + + HPN+
Sbjct: 15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRML---IDFCDIALMEIKLLTESDDHPNV 71
Query: 475 VKLYGCCIEGNQLLLIYEYLENNSLA------RALFEHRLKLDWPTRRRICLGIARGLAY 528
++ Y L + E +L E+ + IA G+A+
Sbjct: 72 IRYYCSETTDRFLYIALELCNL-NLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAH 130
Query: 529 LHGESRIKVVHRDIKATNVLLD-------------KDLNSKISDFGLAKLDEEENTHIST 575
LH +K++HRD+K N+L+ ++L ISDFGL K + + T
Sbjct: 131 LH---SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRT 187
Query: 576 R---VAGTIGYMAPE-------YAMRGHLTEKADVYSFGIVALEIVSG 613
+GT G+ APE + LT D++S G V I+S
Sbjct: 188 NLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSK 235
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 4e-29
Identities = 47/228 (20%), Positives = 93/228 (40%), Gaps = 38/228 (16%)
Query: 416 NNFATDNNIGEGGFGPVYKGLLA--DGTAIAVKQLSSKSKQGNREFI------------- 460
N++ + +G F + L D A+K+ + R+F
Sbjct: 31 NDYRIIRTLNQGKFNKII---LCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKY 87
Query: 461 ----NEIGMISALQHPNLVKLYGCCIEGNQLLLIYEYLENNSL-------ARALFEHRLK 509
NE+ +I+ +++ + G +++ +IYEY+EN+S+ +
Sbjct: 88 DDFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCF 147
Query: 510 LDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEE 569
+ + I + +Y+H + + HRD+K +N+L+DK+ K+SDFG ++ ++
Sbjct: 148 IPIQVIKCIIKSVLNSFSYIH--NEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDK 205
Query: 570 NTHISTRVAGTIGYMAPEYAMRGHLT---EKADVYSFGIVALEIVSGR 614
S GT +M PE + K D++S GI +
Sbjct: 206 KIKGS---RGTYEFMPPE-FFSNESSYNGAKVDIWSLGICLYVMFYNV 249
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 7e-29
Identities = 55/210 (26%), Positives = 90/210 (42%), Gaps = 21/210 (10%)
Query: 415 TNNFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQGNRE---FINEIGMISALQ 470
+ + +G G +G V A+K + K+ + E+ ++ L
Sbjct: 36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIR-KTSVSTSSNSKLLEEVAVLKLLD 94
Query: 471 HPNLVKLYGCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRR---RICLGIARGLA 527
HPN++KLY + L+ E + LF+ + I + G+
Sbjct: 95 HPNIMKLYDFFEDKRNYYLVMECYKGGE----LFDEIIHRMKFNEVDAAVIIKQVLSGVT 150
Query: 528 YLHGESRIKVVHRDIKATNVLL---DKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYM 584
YLH +VHRD+K N+LL +KD KI DFGL+ + E + GT Y+
Sbjct: 151 YLHKH---NIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKM--KERLGTAYYI 205
Query: 585 APEYAMRGHLTEKADVYSFGIVALEIVSGR 614
APE +R EK DV+S G++ +++G
Sbjct: 206 APE-VLRKKYDEKCDVWSIGVILFILLAGY 234
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 8e-29
Identities = 37/295 (12%), Positives = 77/295 (26%), Gaps = 43/295 (14%)
Query: 409 LQIKAATNNFATDNNIGEGGFGPVYKG------LLADGTAIAVKQLSSKSKQGNREFINE 462
+ + + + +GEG F VY+ + +K +
Sbjct: 58 TEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQL 117
Query: 463 IGMISALQHPNLVKLYGCCIEGNQLLLIYEYLENNSLARALFEHRL----KLDWPTRRRI 518
+ + +K Y + N +L+ E +L A+ ++ +
Sbjct: 118 MERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISF 177
Query: 519 CLGIARGLAYLHGESRIKVVHRDIKATNVLL-----------DKDLNSKISDFGLAK-LD 566
+ + + +H +++H DIK N +L D + D G + +
Sbjct: 178 AMRMLYMIEQVH---DCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMK 234
Query: 567 EEENTHISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLL 626
I T T G+ E + D + ++ G M
Sbjct: 235 LFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTY------MKVKN 288
Query: 627 DWALVLKEQGKLMELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLR 681
+ E + +L N +LR
Sbjct: 289 EGGECKPEG----------LFRRLPHLDMWNEFFHVML--NIPDCHHLPSLDLLR 331
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 2e-28
Identities = 61/202 (30%), Positives = 93/202 (46%), Gaps = 22/202 (10%)
Query: 424 IGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQGNRE----FINEIGMISALQHPNLVKLY 478
+G+G FG V G AVK +S K + + + E+ ++ L HPN++KLY
Sbjct: 34 LGKGSFGEVILCKDKITGQECAVKVIS-KRQVKQKTDKESLLREVQLLKQLDHPNIMKLY 92
Query: 479 GCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRR---RICLGIARGLAYLHGESRI 535
+ L+ E LF+ + + RI + G+ Y+H +
Sbjct: 93 EFFEDKGYFYLVGEVYTGGE----LFDEIISRKRFSEVDAARIIRQVLSGITYMH---KN 145
Query: 536 KVVHRDIKATNVLL---DKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPEYAMRG 592
K+VHRD+K N+LL KD N +I DFGL+ E GT Y+APE + G
Sbjct: 146 KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKM--KDKIGTAYYIAPE-VLHG 202
Query: 593 HLTEKADVYSFGIVALEIVSGR 614
EK DV+S G++ ++SG
Sbjct: 203 TYDEKCDVWSTGVILYILLSGC 224
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 3e-28
Identities = 59/210 (28%), Positives = 99/210 (47%), Gaps = 21/210 (10%)
Query: 415 TNNFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQGNRE---FINEIGMISALQ 470
+ +G+G FG V K AVK ++ K+ N++ + E+ ++ L
Sbjct: 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVIN-KASAKNKDTSTILREVELLKKLD 79
Query: 471 HPNLVKLYGCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRR---RICLGIARGLA 527
HPN++KL+ + + ++ E LF+ +K + RI + G+
Sbjct: 80 HPNIMKLFEILEDSSSFYIVGELYTGGE----LFDEIIKRKRFSEHDAARIIKQVFSGIT 135
Query: 528 YLHGESRIKVVHRDIKATNVLL---DKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYM 584
Y+H + +VHRD+K N+LL +KD + KI DFGL+ + GT Y+
Sbjct: 136 YMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTC--FQQNTKMKDRIGTAYYI 190
Query: 585 APEYAMRGHLTEKADVYSFGIVALEIVSGR 614
APE +RG EK DV+S G++ ++SG
Sbjct: 191 APE-VLRGTYDEKCDVWSAGVILYILLSGT 219
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 6e-28
Identities = 57/270 (21%), Positives = 100/270 (37%), Gaps = 39/270 (14%)
Query: 360 LSSTGHFLENGLKLGPYIQTNTSRLLMNDYQLYTTARLSAISLTYYGFYLQIKAATNNF- 418
S G F+ N +G R L N+ ++ + + + + +
Sbjct: 80 HSGNGTFV-NTELVG----KGKRRPLNNNSEIALSLSRNKVFVFFDLTVDDQSVYPKALR 134
Query: 419 ---ATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQGNRE---------FINEIGM 465
+G G G V +A++ +S K K EI +
Sbjct: 135 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIIS-KRKFAIGSAREADPALNVETEIEI 193
Query: 466 ISALQHPNLVKLYGCCIEGNQLLLIYEYLENNSLARALFE---HRLKLDWPTRRRICLGI 522
+ L HP ++K+ + ++ E +E LF+ +L T + +
Sbjct: 194 LKKLNHPCIIKIKN-FFDAEDYYIVLELMEGGE----LFDKVVGNKRLKEATCKLYFYQM 248
Query: 523 ARGLAYLHGESRIKVVHRDIKATNVLL---DKDLNSKISDFGLAKLDEEENTHISTRVAG 579
+ YLH ++HRD+K NVLL ++D KI+DFG +K+ E + + T G
Sbjct: 249 LLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI-LGETSLMRTLC-G 303
Query: 580 TIGYMAPE---YAMRGHLTEKADVYSFGIV 606
T Y+APE D +S G++
Sbjct: 304 TPTYLAPEVLVSVGTAGYNRAVDCWSLGVI 333
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 8e-28
Identities = 48/194 (24%), Positives = 86/194 (44%), Gaps = 25/194 (12%)
Query: 424 IGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQGNREFI-NEIGMISALQHPNLVKLYGCC 481
+G G F V+ G A+K + KS + NEI ++ ++H N+V L
Sbjct: 17 LGSGAFSEVFLVKQRLTGKLFALKCIK-KSPAFRDSSLENEIAVLKKIKHENIVTLEDIY 75
Query: 482 IEGNQLLLIYEYL---ENNSLARALFEHRLKLDWPTRR---RICLGIARGLAYLHGESRI 535
L+ + + E LF+ L+ T + + + + YLH
Sbjct: 76 ESTTHYYLVMQLVSGGE-------LFDRILERGVYTEKDASLVIQQVLSAVKYLH---EN 125
Query: 536 KVVHRDIKATNVLL---DKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPEYAMRG 592
+VHRD+K N+L +++ I+DFGL+K+++ + GT GY+APE +
Sbjct: 126 GIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIM---STACGTPGYVAPEVLAQK 182
Query: 593 HLTEKADVYSFGIV 606
++ D +S G++
Sbjct: 183 PYSKAVDCWSIGVI 196
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 2e-27
Identities = 33/238 (13%), Positives = 70/238 (29%), Gaps = 55/238 (23%)
Query: 424 IGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQGNRE------------------------ 458
+G+ + G + V + +
Sbjct: 81 LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 140
Query: 459 ----FINEIGMISALQHPNLVKLYGCC--IEGNQLLLIYEYLENN--SLARALFEH---R 507
FI ++ Q ++++ + +Y +++N + L H
Sbjct: 141 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH 200
Query: 508 LKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDE 567
L R ++ L + R LA LH +VH ++ +++LD+ ++ F D
Sbjct: 201 KSLVHHARLQLTLQVIRLLASLHHY---GLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDG 257
Query: 568 EENTHISTRVAGTIGYMAPEY-----------AMRGHLTEKADVYSFGIVALEIVSGR 614
+ + G+ PE R +T D ++ G+V I
Sbjct: 258 ARVV-----SSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCAD 310
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 2e-27
Identities = 22/228 (9%), Positives = 50/228 (21%), Gaps = 44/228 (19%)
Query: 424 IGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQGNRE---FINEIGMISALQHPNLVKLYG 479
+ G V+ + A+K + ++ E + L + +
Sbjct: 70 LRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARD 129
Query: 480 CC--------------------------IEGNQLLLIYEYLENN-----SLARALFEHRL 508
LL+ + S ++ R
Sbjct: 130 RRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRG 189
Query: 509 KLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEE 568
+ + R A L + +VH N+ + D + D
Sbjct: 190 DEGILALHILTAQLIRLAANLQSK---GLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGT 246
Query: 569 ENTHISTRVAGTIGYMAPEYAMRGHL--TEKADVYSFGIVALEIVSGR 614
+ + Y E+ T + + G+ +
Sbjct: 247 ----RGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLF 290
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 2e-27
Identities = 28/233 (12%), Positives = 61/233 (26%), Gaps = 44/233 (18%)
Query: 424 IGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQGNREF----------------------- 459
+G+ + G + V + +
Sbjct: 86 LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 145
Query: 460 --INEIGMISALQHPNLVKLYGCCIEGNQLLLIYEYL-------ENNSLARALFEHRLK- 509
+ I ++ P K+ ++ + ++ + + L H
Sbjct: 146 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH 205
Query: 510 --LDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDE 567
L R ++ L + R LA LH +VH ++ +++LD+ ++ F D
Sbjct: 206 KSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDG 262
Query: 568 EENTHISTRVAGTIGYMAPE-----YAMRGHLTEKADVYSFGIVALEIVSGRS 615
R A +T D ++ G+ I
Sbjct: 263 ASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADL 315
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 2e-27
Identities = 53/196 (27%), Positives = 89/196 (45%), Gaps = 24/196 (12%)
Query: 424 IGEGGFGPVYKG-LLADGTAIAVKQLS-SKSKQGNREFINEIGMISALQHPNLVKLYGCC 481
+G G FG V+ + G +K ++ +S+ + EI ++ +L HPN++K++
Sbjct: 30 LGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVF 89
Query: 482 IEGNQLLLIYEYLENNSLARALFEHRLKLDWPTR--------RRICLGIARGLAYLHGES 533
+ + + ++ E E L E R+ + + LAY H
Sbjct: 90 EDYHNMYIVMETCEGGE----LLE-RIVSAQARGKALSEGYVAELMKQMMNALAYFH--- 141
Query: 534 RIKVVHRDIKATNVLL---DKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPEYAM 590
VVH+D+K N+L KI DFGLA+L + + H + GT YMAPE
Sbjct: 142 SQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAEL-FKSDEHSTNAA-GTALYMAPE-VF 198
Query: 591 RGHLTEKADVYSFGIV 606
+ +T K D++S G+V
Sbjct: 199 KRDVTFKCDIWSAGVV 214
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 111 bits (281), Expect = 4e-27
Identities = 55/244 (22%), Positives = 100/244 (40%), Gaps = 29/244 (11%)
Query: 24 LKEQNLTGVLPPKLAELTFLQDIDLTLNYLSGTIPS---QWASLPLLNISLIANRLKGPI 80
L+ L P + L+ LQ + + L +P Q+A L L ++ N L+ +
Sbjct: 88 LRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLA--RNPLRA-L 142
Query: 81 PKYLANISTLVNLTVQYNQFSGELPEELGS---------LLNLEKLHLSSNNFTGELPKT 131
P +A+++ L L+++ ELPE L S L+NL+ L L LP +
Sbjct: 143 PASIASLNRLRELSIRACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIR-SLPAS 201
Query: 132 FAKLTNMKDFRISDNQFTGQIPSFIQNWTKLEKLFIQPSGLAGPIPSGIFSLENLTDLRI 191
A L N+K +I ++ + + I + KLE+L ++ P L L +
Sbjct: 202 IANLQNLKSLKIRNSPLS-ALGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLIL 260
Query: 192 SDLNG----PEATFPQLGNMKM-TKLILRNCNITGELPRYLGKMTKLKVLDLSFNRLRGQ 246
D + P + + KL LR C LP + ++ ++ + + L+ Q
Sbjct: 261 KDCSNLLTLPLD----IHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPH-LQAQ 315
Query: 247 IPSN 250
+ +
Sbjct: 316 LDQH 319
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 3e-26
Identities = 57/252 (22%), Positives = 97/252 (38%), Gaps = 24/252 (9%)
Query: 33 LPPKLAELTF--LQDIDLTLNYLSGTIPS---QWASLPLLNISLIANRLKGPIPKYLANI 87
L + T ++L L P + + L + I A L +P +
Sbjct: 71 TADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTID--AAGLME-LPDTMQQF 126
Query: 88 STLVNLTVQYNQFSGELPEELGSLLNLEKLHLSSNNFTGELPKTFAK---------LTNM 138
+ L LT+ N LP + SL L +L + + ELP+ A L N+
Sbjct: 127 AGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTDASGEHQGLVNL 185
Query: 139 KDFRISDNQFTGQIPSFIQNWTKLEKLFIQPSGLAGPIPSGIFSLENLTDLRISDLNGPE 198
+ R+ +P+ I N L+ L I+ S L+ + I L L +L +
Sbjct: 186 QSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLSA-LGPAIHHLPKLEELDLRGCTALR 243
Query: 199 ATFPQ-LGNMK-MTKLILRNCNITGELPRYLGKMTKLKVLDLSFNRLRGQIPSNFDDLYD 256
+P G + +LIL++C+ LP + ++T+L+ LDL ++PS L
Sbjct: 244 -NYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPA 302
Query: 257 VDYIYFAGNLLT 268
I +L
Sbjct: 303 NCIILVPPHLQA 314
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 59.6 bits (145), Expect = 1e-09
Identities = 21/156 (13%), Positives = 44/156 (28%), Gaps = 11/156 (7%)
Query: 102 GELPEELGSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRISDNQFTGQIPSFIQNWTK 161
G E L+ + ++ + + + N
Sbjct: 2 GSSHHHHHHSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHSAWRQA----NSNN 57
Query: 162 LEKLFIQPSGL-AGPIPSGIFSLENLTDLRISDLNGPEATFP-QLGNMK-MTKLILRNCN 218
+ L A + L + + FP Q + + + +
Sbjct: 58 PQIETRTGRALKATADLLEDATQPGRVALELRSVPL--PQFPDQAFRLSHLQHMTIDAAG 115
Query: 219 ITGELPRYLGKMTKLKVLDLSFNRLRGQIPSNFDDL 254
+ ELP + + L+ L L+ N LR +P++ L
Sbjct: 116 LM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASL 149
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 4e-27
Identities = 48/314 (15%), Positives = 99/314 (31%), Gaps = 46/314 (14%)
Query: 28 NLTGVLPPKLAELTFLQDIDLTLNYLSGTIPSQWASLPLL-NISLIANRLKGPIPKYLAN 86
L + + + LQ +DL+ + W L L N+ L N ++ P +
Sbjct: 43 PLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSG 102
Query: 87 ISTLVNLTVQYNQFSGELPEELGSLLNLEKLHLSSNNFTG-ELPKTFAKLTNMKDFRISD 145
+++L NL + + +G L+ L+KL+++ N +LP F+ LTN+ +S
Sbjct: 103 LTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSY 162
Query: 146 NQFTGQIPSFIQNWTKLEKL------------FIQPSGLAGP---------------IPS 178
N + +Q + ++ FIQ G I
Sbjct: 163 NYIQTITVNDLQFLRENPQVNLSLDMSLNPIDFIQDQAFQGIKLHELTLRGNFNSSNIMK 222
Query: 179 GIFSLENLTDLRISDLNG------------PEATFPQLGNMKMTKLILRNCNITGELPRY 226
NL L + L + L ++ + + L N +
Sbjct: 223 TCLQ--NLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVK 280
Query: 227 LGKMTKLKVLDLSFNRLRGQIPSNFDDLYDVDYIYFAGNLLTGAIPPWMLERGDKIDLSY 286
+ + + L+ ++ + + + L P L + L+
Sbjct: 281 FHCLANVSAMSLAGVSIKY--LEDVPKHFKWQSLSIIRCQLKQ-FPTLDLPFLKSLTLTM 337
Query: 287 NNFTDGSAESSCQK 300
N + + +
Sbjct: 338 NKGSISFKKVALPS 351
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 1e-26
Identities = 43/267 (16%), Positives = 83/267 (31%), Gaps = 18/267 (6%)
Query: 34 PPKLAELTFLQDIDLTLNYLSGTIPSQWASLPLLNISLIANRLKGPIPKYLANISTLVNL 93
+ + Q + + L L L ++ N+ + +L L
Sbjct: 300 LEDVPKHFKWQSLSIIRCQLKQFPTLDLPFLKSLTLT--MNKGSISFK--KVALPSLSYL 355
Query: 94 TVQYNQFS--GELPEELGSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRISDNQFTGQ 151
+ N S G +L L LS N + F L ++ +
Sbjct: 356 DLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAI-IMSANFMGLEELQHLDFQHSTLKRV 414
Query: 152 IP-SFIQNWTKLEKLFIQPSGLAGPIPSGIFSLENLTDLRISD----LNGPEATFPQLGN 206
S + KL L I + L +L L+++ N F N
Sbjct: 415 TEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTN 474
Query: 207 MKMTKLILRNCNITGELPRYLGKMTKLKVLDLSFNRLRGQIPSNFDDLYDVDYIYFAGNL 266
+ T L L C + + +L++L++S N L S+++ LY + + + N
Sbjct: 475 L--TFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNR 532
Query: 267 LTGAIPPWMLERGDK---IDLSYNNFT 290
+ + +L+ N+
Sbjct: 533 IET-SKGILQHFPKSLAFFNLTNNSVA 558
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 7e-23
Identities = 44/310 (14%), Positives = 86/310 (27%), Gaps = 48/310 (15%)
Query: 24 LKEQNLTGV---LPPKLAELTFLQDIDLTLNYLSGTIPSQWASLPLLNI-SLIANRLKGP 79
+Q L+ V +P + DL+ N L +++ L L ++
Sbjct: 18 CMDQKLSKVPDDIPSSTKNI------DLSFNPLKILKSYSFSNFSELQWLDLSRCEIETI 71
Query: 80 IPKYLANISTLVNLTVQYNQFSGELPEELGSLLNLEKLHLSSNNFTGELPKTFAKLTNMK 139
K + L NL + N P L +LE L +L +K
Sbjct: 72 EDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLK 131
Query: 140 DFRISDNQFTG-QIPSFIQNWTKLEKLF--------IQPSGLAGP--------------- 175
++ N ++P++ N T L + I + L
Sbjct: 132 KLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLN 191
Query: 176 ----IPSGIFSLENLTDLRISD----LNGPEATFPQLGNMKMTKL----ILRNCNITGEL 223
I F L +L + N + L + + +L N+
Sbjct: 192 PIDFIQDQAFQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFE 251
Query: 224 PRYLGKMTKLKV--LDLSFNRLRGQIPSNFDDLYDVDYIYFAGNLLTGAIPPWMLERGDK 281
P + + + + L++ F L +V + AG + +
Sbjct: 252 PSIMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSIKYLEDVPKHFKWQS 311
Query: 282 IDLSYNNFTD 291
+ +
Sbjct: 312 LSIIRCQLKQ 321
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 95.9 bits (239), Expect = 1e-20
Identities = 41/253 (16%), Positives = 83/253 (32%), Gaps = 34/253 (13%)
Query: 55 GTIPSQWASLPLLNISLIANRLKGPIPKYLANISTLVNLTVQYNQFSGELPEELGSLLNL 114
G++ +P + + +L +P + S+ N+ + +N + L
Sbjct: 2 GSLNPCIEVVPNITYQCMDQKLSK-VPDDIP--SSTKNIDLSFNPLKILKSYSFSNFSEL 58
Query: 115 EKLHLSSNNFTGELPKTFAKLTNMKDFRISDNQFTGQIPSFIQNWTKLEKLFIQPSGLAG 174
+ L LS K + L ++ + ++ N P T LE L + LA
Sbjct: 59 QWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLAS 118
Query: 175 PIPSGIFSLENLTDLRISDLNGPEATFPQLGNMKMTKLILRNCNITG-ELPRYLGKMTKL 233
I L L L ++ + I +LP Y +T L
Sbjct: 119 LESFPIGQLITLKKLNVA-----------------------HNFIHSCKLPAYFSNLTNL 155
Query: 234 KVLDLSFNRLRGQIPSNFDDL----YDVDYIYFAGNLLTGAIPPWMLE--RGDKIDLSYN 287
+DLS+N ++ ++ L + + N + I + + ++ L N
Sbjct: 156 VHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPIDF-IQDQAFQGIKLHELTLRGN 214
Query: 288 NFTDGSAESSCQK 300
+ ++ Q
Sbjct: 215 FNSSNIMKTCLQN 227
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 87.0 bits (216), Expect = 7e-18
Identities = 29/169 (17%), Positives = 51/169 (30%), Gaps = 3/169 (1%)
Query: 28 NLTGVLPPKLAELTFLQDIDLTLNYLSGTIP-SQWASLP-LLNISLIANRLKGPIPKYLA 85
N ++ L LQ +D + L S + SL LL + + K
Sbjct: 386 NGAIIMSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFL 445
Query: 86 NISTLVNLTVQYNQFSGELPEE-LGSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRIS 144
+++L L + N F + NL L LS F L ++ +S
Sbjct: 446 GLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMS 505
Query: 145 DNQFTGQIPSFIQNWTKLEKLFIQPSGLAGPIPSGIFSLENLTDLRISD 193
N S L L + + ++L +++
Sbjct: 506 HNNLLFLDSSHYNQLYSLSTLDCSFNRIETSKGILQHFPKSLAFFNLTN 554
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 69.7 bits (171), Expect = 2e-12
Identities = 20/124 (16%), Positives = 36/124 (29%), Gaps = 2/124 (1%)
Query: 28 NLTGVLPPKLAELTFLQDIDLTLNYLSGTIPSQ-WASLP-LLNISLIANRLKGPIPKYLA 85
N LT L + + N S +A+ L + L +L+
Sbjct: 435 NTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFD 494
Query: 86 NISTLVNLTVQYNQFSGELPEELGSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRISD 145
+ L L + +N L +L L S N ++ F +++
Sbjct: 495 TLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIETSKGILQHFPKSLAFFNLTN 554
Query: 146 NQFT 149
N
Sbjct: 555 NSVA 558
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 5e-27
Identities = 46/248 (18%), Positives = 88/248 (35%), Gaps = 33/248 (13%)
Query: 449 SSKSKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYEYLENNSLARALFEHRL 508
S +I + N V L + + +L +
Sbjct: 98 PLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCS 157
Query: 509 KLDWPTR--RRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLD 566
D I + IA + +LH + ++HRD+K +N+ D K+ DFGL
Sbjct: 158 LEDREHGVCLHIFIQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAM 214
Query: 567 EEENTHIS-----------TRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRS 615
+++ + T GT YM+PE + + K D++S G++ E++ S
Sbjct: 215 DQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFS 274
Query: 616 NVTKEDMFYLLDWALVLKEQGKLMELV-DTNPGSNFDKEQVMVMINVALLCANASPTIRP 674
T+ + ++ + L + +E +MV +L + PT RP
Sbjct: 275 --TQMERVRIIT---------DVRNLKFPLLFTQKYPQEHMMVQ---DMLSPS--PTERP 318
Query: 675 SMSSVLRM 682
+ ++
Sbjct: 319 EATDIIEN 326
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 49.9 bits (119), Expect = 1e-06
Identities = 17/65 (26%), Positives = 35/65 (53%), Gaps = 2/65 (3%)
Query: 424 IGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQGNREFI-NEIGMISALQHPNLVKLYGCC 481
+G GGFG V++ D A+K++ +++ RE + E+ ++ L+HP +V+ +
Sbjct: 14 MGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAW 73
Query: 482 IEGNQ 486
+E
Sbjct: 74 LETPP 78
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 114 bits (286), Expect = 9e-27
Identities = 58/212 (27%), Positives = 90/212 (42%), Gaps = 32/212 (15%)
Query: 424 IGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQGNRE--------------FINEIGMISA 468
+G G +G V + A+K + KS+ NEI ++ +
Sbjct: 44 LGSGAYGEVLLCKEKNGHSEKAIKVIK-KSQFDKGRYSDDNKNIEKFHEEIYNEISLLKS 102
Query: 469 LQHPNLVKLYGCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRR---RICLGIARG 525
L HPN++KL+ + L+ E+ E LFE + I I G
Sbjct: 103 LDHPNIIKLFDVFEDKKYFYLVTEFYEGGE----LFEQIINRHKFDECDAANIMKQILSG 158
Query: 526 LAYLHGESRIKVVHRDIKATNVLL-DKDLNS--KISDFGLAKLDEEENTHISTRVAGTIG 582
+ YLH + +VHRDIK N+LL +K+ KI DFGL+ + GT
Sbjct: 159 ICYLH---KHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSF--FSKDYKLRDRLGTAY 213
Query: 583 YMAPEYAMRGHLTEKADVYSFGIVALEIVSGR 614
Y+APE ++ EK DV+S G++ ++ G
Sbjct: 214 YIAPE-VLKKKYNEKCDVWSCGVIMYILLCGY 244
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 2e-26
Identities = 58/196 (29%), Positives = 95/196 (48%), Gaps = 27/196 (13%)
Query: 424 IGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQGNRE---FINEIGMISALQHPNLVKLYG 479
+G+G FG V K AVK ++ K+ N++ + E+ ++ L HPN++KL+
Sbjct: 30 LGKGSFGEVLKCKDRITQQEYAVKVIN-KASAKNKDTSTILREVELLKKLDHPNIMKLFE 88
Query: 480 CCIEGNQLLLIYEYL---ENNSLARALFE---HRLKLDWPTRRRICLGIARGLAYLHGES 533
+ + ++ E E LF+ R + RI + G+ Y+H
Sbjct: 89 ILEDSSSFYIVGELYTGGE-------LFDEIIKRKRFSEHDAARIIKQVFSGITYMH--- 138
Query: 534 RIKVVHRDIKATNVLL---DKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPEYAM 590
+ +VHRD+K N+LL +KD + KI DFGL+ ++ GT Y+APE +
Sbjct: 139 KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKM--KDRIGTAYYIAPE-VL 195
Query: 591 RGHLTEKADVYSFGIV 606
RG EK DV+S G++
Sbjct: 196 RGTYDEKCDVWSAGVI 211
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 2e-26
Identities = 68/191 (35%), Positives = 90/191 (47%), Gaps = 16/191 (8%)
Query: 424 IGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQGNREFIN-EIGMISALQHPNLVKLYGCC 481
+GEG +G V + A+AVK + K E I EI + L H N+VK YG
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 482 IEGNQLLLIYEYLENNSLARALFEH---RLKLDWPTRRRICLGIARGLAYLHGESRIKVV 538
EGN L EY L F+ + + P +R + G+ YLH I +
Sbjct: 75 REGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVVYLH---GIGIT 127
Query: 539 HRDIKATNVLLDKDLNSKISDFGLAKL--DEEENTHISTRVAGTIGYMAPE-YAMRGHLT 595
HRDIK N+LLD+ N KISDFGLA + ++ GT+ Y+APE R
Sbjct: 128 HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC-GTLPYVAPELLKRREFHA 186
Query: 596 EKADVYSFGIV 606
E DV+S GIV
Sbjct: 187 EPVDVWSCGIV 197
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 4e-26
Identities = 48/190 (25%), Positives = 78/190 (41%), Gaps = 17/190 (8%)
Query: 424 IGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCCI 482
IG G +G V + A K++ + F EI ++ +L HPN+++LY
Sbjct: 17 IGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFE 76
Query: 483 EGNQLLLIYEYLENNSLARALFEHRLKLDWPTRR---RICLGIARGLAYLHGESRIKVVH 539
+ + L+ E LFE + RI + +AY H ++ V H
Sbjct: 77 DNTDIYLVMELCTGGE----LFERVVHKRVFRESDAARIMKDVLSAVAYCH---KLNVAH 129
Query: 540 RDIKATNVLL---DKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPEYAMRGHLTE 596
RD+K N L D K+ DFGLA + GT Y++P+ + G
Sbjct: 130 RDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMM--RTKVGTPYYVSPQ-VLEGLYGP 186
Query: 597 KADVYSFGIV 606
+ D +S G++
Sbjct: 187 ECDEWSAGVM 196
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 5e-26
Identities = 50/208 (24%), Positives = 84/208 (40%), Gaps = 27/208 (12%)
Query: 424 IGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQGNREFINEIGMI-----------SALQH 471
+G+GGFG V+ G L D +A+K + +++ +++ + H
Sbjct: 39 LGKGGFGTVFAGHRLTDRLQVAIKVIP-RNRVLGWSPLSDSVTCPLEVALLWKVGAGGGH 97
Query: 472 PNLVKLYGCCIEGNQLLLIYEYLENNSLARALF---EHRLKLDWPTRRRICLGIARGLAY 528
P +++L +L+ E A+ LF + L R + + +
Sbjct: 98 PGVIRLLDWFETQEGFMLVLERPLP---AQDLFDYITEKGPLGEGPSRCFFGQVVAAIQH 154
Query: 529 LHGESRIKVVHRDIKATNVLLDKDLNS-KISDFGLAKLDEEENTHISTRVAGTIGYMAPE 587
H VVHRDIK N+L+D K+ DFG L +E GT Y PE
Sbjct: 155 CH---SRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPYTDF---DGTRVYSPPE 208
Query: 588 Y-AMRGHLTEKADVYSFGIVALEIVSGR 614
+ + + A V+S GI+ ++V G
Sbjct: 209 WISRHQYHALPATVWSLGILLYDMVCGD 236
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 5e-26
Identities = 68/191 (35%), Positives = 90/191 (47%), Gaps = 16/191 (8%)
Query: 424 IGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQGNREFIN-EIGMISALQHPNLVKLYGCC 481
+GEG +G V + A+AVK + K E I EI + L H N+VK YG
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 482 IEGNQLLLIYEYLENNSLARALFEH---RLKLDWPTRRRICLGIARGLAYLHGESRIKVV 538
EGN L EY L F+ + + P +R + G+ YLH I +
Sbjct: 75 REGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVVYLH---GIGIT 127
Query: 539 HRDIKATNVLLDKDLNSKISDFGLAKL--DEEENTHISTRVAGTIGYMAPE-YAMRGHLT 595
HRDIK N+LLD+ N KISDFGLA + ++ GT+ Y+APE R
Sbjct: 128 HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC-GTLPYVAPELLKRREFHA 186
Query: 596 EKADVYSFGIV 606
E DV+S GIV
Sbjct: 187 EPVDVWSCGIV 197
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 7e-26
Identities = 47/195 (24%), Positives = 78/195 (40%), Gaps = 16/195 (8%)
Query: 424 IGEGGFGPVYKGL-LADGTAIAVK-----QLSSKSKQGNREFINEIGMISALQHPNLVKL 477
IG+G F V + + G AVK + +S + E + L+HP++V+L
Sbjct: 32 IGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVEL 91
Query: 478 YGCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRR---RICLGIARGLAYLHGESR 534
L +++E+++ L + + + I L Y H
Sbjct: 92 LETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCH---D 148
Query: 535 IKVVHRDIKATNVLL---DKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPEYAMR 591
++HRD+K VLL + K+ FG+A E RV GT +MAPE R
Sbjct: 149 NNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRV-GTPHFMAPEVVKR 207
Query: 592 GHLTEKADVYSFGIV 606
+ DV+ G++
Sbjct: 208 EPYGKPVDVWGCGVI 222
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 109 bits (273), Expect = 8e-26
Identities = 51/194 (26%), Positives = 94/194 (48%), Gaps = 22/194 (11%)
Query: 424 IGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCCI 482
+G G FG V+K A G +A K + ++ + E NEI +++ L H NL++LY
Sbjct: 97 LGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFE 156
Query: 483 EGNQLLLIYEYL---ENNSLARALFEHRLKLDWPTRRRICLGIAR----GLAYLHGESRI 535
N ++L+ EY+ E LF+ + + + + G+ ++H ++
Sbjct: 157 SKNDIVLVMEYVDGGE-------LFDRIIDESYNLTELDTILFMKQICEGIRHMH---QM 206
Query: 536 KVVHRDIKATNVLL-DKDLNS-KISDFGLAKLDEEENTHISTRVAGTIGYMAPEYAMRGH 593
++H D+K N+L ++D KI DFGLA+ + + GT ++APE
Sbjct: 207 YILHLDLKPENILCVNRDAKQIKIIDFGLARR-YKPREKLKVNF-GTPEFLAPEVVNYDF 264
Query: 594 LTEKADVYSFGIVA 607
++ D++S G++A
Sbjct: 265 VSFPTDMWSVGVIA 278
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 9e-26
Identities = 50/202 (24%), Positives = 82/202 (40%), Gaps = 30/202 (14%)
Query: 424 IGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQGNRE---------FINEIGMISALQHPN 473
+G G G V +A+K +S K K EI ++ L HP
Sbjct: 18 LGSGACGEVKLAFERKTCKKVAIKIIS-KRKFAIGSAREADPALNVETEIEILKKLNHPC 76
Query: 474 LVKLYGCCIEGNQLLLIYEYLENNSLARALFE---HRLKLDWPTRRRICLGIARGLAYLH 530
++K+ + ++ E +E LF+ +L T + + + YLH
Sbjct: 77 IIKIKN-FFDAEDYYIVLELMEGGE----LFDKVVGNKRLKEATCKLYFYQMLLAVQYLH 131
Query: 531 GESRIKVVHRDIKATNVLL---DKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPE 587
++HRD+K NVLL ++D KI+DFG +K+ E + + T GT Y+APE
Sbjct: 132 ---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI-LGETSLMRTLC-GTPTYLAPE 186
Query: 588 ---YAMRGHLTEKADVYSFGIV 606
D +S G++
Sbjct: 187 VLVSVGTAGYNRAVDCWSLGVI 208
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 1e-25
Identities = 52/207 (25%), Positives = 89/207 (42%), Gaps = 27/207 (13%)
Query: 424 IGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQGNREFIN-------EIGMISALQH--PN 473
+G GGFG VY G+ ++D +A+K + K + + + E+ ++ +
Sbjct: 51 LGSGGFGSVYSGIRVSDNLPVAIKHVE-KDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 109
Query: 474 LVKLYGCCIEGNQLLLIYEYLENNSLARALFEH---RLKLDWPTRRRICLGIARGLAYLH 530
+++L + +LI E E + LF+ R L R + + + H
Sbjct: 110 VIRLLDWFERPDSFVLILERPEP---VQDLFDFITERGALQEELARSFFWQVLEAVRHCH 166
Query: 531 GESRIKVVHRDIKATNVLLDKD-LNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPEYA 589
V+HRDIK N+L+D + K+ DFG L ++ GT Y PE+
Sbjct: 167 ---NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDF---DGTRVYSPPEW- 219
Query: 590 MRGHLTE--KADVYSFGIVALEIVSGR 614
+R H A V+S GI+ ++V G
Sbjct: 220 IRYHRYHGRSAAVWSLGILLYDMVCGD 246
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 1e-25
Identities = 51/191 (26%), Positives = 85/191 (44%), Gaps = 19/191 (9%)
Query: 424 IGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCCI 482
IG G + + + A AVK + + E EI ++ QHPN++ L
Sbjct: 30 IGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEE--IEI-LLRYGQHPNIITLKDVYD 86
Query: 483 EGNQLLLIYEYLENNSLARALFEHRLKLDWPTRR---RICLGIARGLAYLHGESRIKVVH 539
+G + ++ E ++ L + L+ + + R + I + + YLH VVH
Sbjct: 87 DGKYVYVVTELMKGGEL----LDKILRQKFFSEREASAVLFTITKTVEYLH---AQGVVH 139
Query: 540 RDIKATNVLL-DKDLNS---KISDFGLAKLDEEENTHISTRVAGTIGYMAPEYAMRGHLT 595
RD+K +N+L D+ N +I DFG AK EN + T T ++APE R
Sbjct: 140 RDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPC-YTANFVAPEVLERQGYD 198
Query: 596 EKADVYSFGIV 606
D++S G++
Sbjct: 199 AACDIWSLGVL 209
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 2e-25
Identities = 56/195 (28%), Positives = 92/195 (47%), Gaps = 10/195 (5%)
Query: 424 IGEGGFGPVYKGL-LADGTAIAVKQLS-SKSKQGNREFIN-EIGMISALQHPNLVKLYGC 480
IG+G F V + G +A+K + ++ + + + E+ ++ L HPN+VKL+
Sbjct: 23 IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV 82
Query: 481 CIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHR 540
L LI EY + L H ++ R I + Y H + ++VHR
Sbjct: 83 IETEKTLYLIMEYASGGEVFDYLVAHG-RMKEKEARSKFRQIVSAVQYCH---QKRIVHR 138
Query: 541 DIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPE-YAMRGHLTEKAD 599
D+KA N+LLD D+N KI+DFG + + G Y APE + + + + D
Sbjct: 139 DLKAENLLLDADMNIKIADFGFSNE-FTVGGKLDAFC-GAPPYAAPELFQGKKYDGPEVD 196
Query: 600 VYSFGIVALEIVSGR 614
V+S G++ +VSG
Sbjct: 197 VWSLGVILYTLVSGS 211
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 2e-25
Identities = 59/261 (22%), Positives = 107/261 (40%), Gaps = 21/261 (8%)
Query: 34 PPKLAELTFLQDIDLTLNYLSGTIP-SQWASLPLLNISLIANRLKGPIPKYLANISTLVN 92
L LT L+++ L + +S P + + LN+ AN L+N++ L
Sbjct: 103 ISALQNLTNLRELYLNEDNISDISPLANLTKMYSLNLG--ANHNLS-DLSPLSNMTGLNY 159
Query: 93 LTVQYNQFSGELPEELGSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRISDNQFTGQI 152
LTV ++ + +L +L L L+ N P A LT++ F NQ T
Sbjct: 160 LTVTESKVKD--VTPIANLTDLYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQITDIT 215
Query: 153 PSFIQNWTKLEKLFIQPSGLAGPIPSGIFSLENLTDLRISD--LNGPEATFPQLGNM-KM 209
P + N T+L L I + + P + +L LT L I ++ A + ++ K+
Sbjct: 216 P--VANMTRLNSLKIGNNKITDLSP--LANLSQLTWLEIGTNQISDINA----VKDLTKL 267
Query: 210 TKLILRNCNITGELPRYLGKMTKLKVLDLSFNRLRGQIPSNFDDLYDVDYIYFAGNLLTG 269
L + + I+ L +++L L L+ N+L + L ++ ++ + N +T
Sbjct: 268 KMLNVGSNQISD--ISVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITD 325
Query: 270 AIPPWMLERGDKIDLSYNNFT 290
P L + D D +
Sbjct: 326 IRPLASLSKMDSADFANQVIK 346
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 96.8 bits (242), Expect = 7e-22
Identities = 55/272 (20%), Positives = 109/272 (40%), Gaps = 25/272 (9%)
Query: 24 LKEQNLTGVLPPKLAELTFLQDIDLTLNYLSGTIPSQWASLP-LLNISLIANRLKGPIPK 82
L++ ++T V+ EL + + + ++ +I L L ++L N++ P
Sbjct: 29 LQKASVTDVVT--QEELESITKLVVAGEKVA-SIQG-IEYLTNLEYLNLNGNQITDISP- 83
Query: 83 YLANISTLVNLTVQYNQFSGELPEELGSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFR 142
L+N+ L NL + N+ + L +L NL +L+L+ +N + A LT M
Sbjct: 84 -LSNLVKLTNLYIGTNKITD--ISALQNLTNLRELYLNEDNISD--ISPLANLTKMYSLN 138
Query: 143 ISDNQFTGQIPSFIQNWTKLEKLFIQPSGLAGPIPSGIFSLENLTDLRISD--LNGPEAT 200
+ N S + N T L L + S + P I +L +L L ++ +
Sbjct: 139 LGANHNLS-DLSPLSNMTGLNYLTVTESKVKDVTP--IANLTDLYSLSLNYNQIEDISP- 194
Query: 201 FPQLGNM-KMTKLILRNCNITGELPRYLGKMTKLKVLDLSFNRLRGQIPSNFDDLYDVDY 259
L ++ + IT P + MT+L L + N++ S +L + +
Sbjct: 195 ---LASLTSLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKITD--LSPLANLSQLTW 247
Query: 260 IYFAGNLLTGAIPPWMLERGDKIDLSYNNFTD 291
+ N ++ L + +++ N +D
Sbjct: 248 LEIGTNQISDINAVKDLTKLKMLNVGSNQISD 279
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 84.5 bits (210), Expect = 9e-18
Identities = 42/227 (18%), Positives = 85/227 (37%), Gaps = 16/227 (7%)
Query: 66 LLNISLIANRLKGPIPKYLANISTLVNLTVQYNQFSGELPEELGSLLNLEKLHLSSNNFT 125
++ + + P A+++ + +Q + L ++ KL ++
Sbjct: 2 AATLATLPAPINQIFP--DADLAEGIRAVLQKASVTD--VVTQEELESITKLVVAGEKVA 57
Query: 126 GELPKTFAKLTNMKDFRISDNQFTGQIPSFIQNWTKLEKLFIQPSGLAGPIPSGIFSLEN 185
+ LTN++ ++ NQ T P + N KL L+I + + S + +L N
Sbjct: 58 S--IQGIEYLTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKIT--DISALQNLTN 111
Query: 186 LTDLRISDLNGPEATFPQLGNM-KMTKLILRNCNITGELPRYLGKMTKLKVLDLSFNRLR 244
L +L +++ + L N+ KM L L + L MT L L ++ ++++
Sbjct: 112 LRELYLNE-DNIS-DISPLANLTKMYSLNLGANHNLS-DLSPLSNMTGLNYLTVTESKVK 168
Query: 245 GQIPSNFDDLYDVDYIYFAGNLLTGAIPPWMLERGDKIDLSYNNFTD 291
+ +L D+ + N + P L N TD
Sbjct: 169 D--VTPIANLTDLYSLSLNYNQIEDISPLASLTSLHYFTAYVNQITD 213
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 2e-25
Identities = 51/212 (24%), Positives = 86/212 (40%), Gaps = 23/212 (10%)
Query: 417 NFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQGNREFIN---------EIGMI 466
++T + +G G FG V+ + + VK + K K +I EI ++
Sbjct: 25 KYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIK-KEKVLEDCWIEDPKLGKVTLEIAIL 83
Query: 467 SALQHPNLVKLYGCCIEGNQLLLIYEYLENNSLARALFEH---RLKLDWPTRRRICLGIA 523
S ++H N++K+ E +E + LF +LD P I +
Sbjct: 84 SRVEHANIIKVLDI-FENQGF--FQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLV 140
Query: 524 RGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGY 583
+ YL ++HRDIK N+++ +D K+ DFG A E T GTI Y
Sbjct: 141 SAVGYLR---LKDIIHRDIKDENIVIAEDFTIKLIDFGSAAY-LERGKLFYT-FCGTIEY 195
Query: 584 MAPE-YAMRGHLTEKADVYSFGIVALEIVSGR 614
APE + + +++S G+ +V
Sbjct: 196 CAPEVLMGNPYRGPELEMWSLGVTLYTLVFEE 227
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 2e-25
Identities = 52/196 (26%), Positives = 92/196 (46%), Gaps = 10/196 (5%)
Query: 424 IGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQGNREFI-NEIGMISALQHPNLVKLYGCC 481
+G G FG V++ A G A K + + ++E + EI +S L+HP LV L+
Sbjct: 165 LGTGAFGVVHRVTERATGNNFAAKFVM-TPHESDKETVRKEIQTMSVLRHPTLVNLHDAF 223
Query: 482 IEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRD 541
+ N++++IYE++ L + + K+ + +GL ++H VH D
Sbjct: 224 EDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLD 280
Query: 542 IKATNVLL-DKDLNS-KISDFGLAKLDEEENTHISTRVAGTIGYMAPEYAMRGHLTEKAD 599
+K N++ K N K+ DFGL + + GT + APE A + D
Sbjct: 281 LKPENIMFTTKRSNELKLIDFGLTAH-LDPKQSVKVTT-GTAEFAAPEVAEGKPVGYYTD 338
Query: 600 VYSFGIVALEIVSGRS 615
++S G+++ ++SG S
Sbjct: 339 MWSVGVLSYILLSGLS 354
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 3e-25
Identities = 48/244 (19%), Positives = 81/244 (33%), Gaps = 57/244 (23%)
Query: 424 IGEGGFGPVYKGL-LADGTAIAVK-----QLSSKSKQGNREFINEIGMISALQHPNLVKL 477
IG+G +G V + A+K ++ + + E+ ++ L HPN+ +L
Sbjct: 34 IGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARL 93
Query: 478 YGCCIEGNQLLLIYEYLENNSL-----ARALFEHRLKLDWPTR----------------- 515
Y + + L+ E L +
Sbjct: 94 YEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGS 153
Query: 516 -----------------RRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNS--K 556
I I L YLH + HRDIK N L + + K
Sbjct: 154 IHGFRESLDFVQREKLISNIMRQIFSALHYLH---NQGICHRDIKPENFLFSTNKSFEIK 210
Query: 557 ISDFGLAKL----DEEENTHISTRVAGTIGYMAPE--YAMRGHLTEKADVYSFGIVALEI 610
+ DFGL+K + E ++T+ GT ++APE K D +S G++ +
Sbjct: 211 LVDFGLSKEFYKLNNGEYYGMTTKA-GTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLL 269
Query: 611 VSGR 614
+ G
Sbjct: 270 LMGA 273
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 3e-25
Identities = 57/191 (29%), Positives = 88/191 (46%), Gaps = 19/191 (9%)
Query: 424 IGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQGNREFINEIGMISALQ-HPNLVKLYGCC 481
+GEG F K + A AVK +S K + N + EI + + HPN+VKL+
Sbjct: 19 LGEGSFSICRKCVHKKSNQAFAVKIIS-KRMEANTQ--KEITALKLCEGHPNIVKLHEVF 75
Query: 482 IEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRR---RICLGIARGLAYLHGESRIKVV 538
+ L+ E L L FE K + I + ++++H + VV
Sbjct: 76 HDQLHTFLVMELLNGGEL----FERIKKKKHFSETEASYIMRKLVSAVSHMH---DVGVV 128
Query: 539 HRDIKATNVLL-DKDLNS--KISDFGLAKLDEEENTHISTRVAGTIGYMAPEYAMRGHLT 595
HRD+K N+L D++ N KI DFG A+L +N + T T+ Y APE +
Sbjct: 129 HRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPC-FTLHYAAPELLNQNGYD 187
Query: 596 EKADVYSFGIV 606
E D++S G++
Sbjct: 188 ESCDLWSLGVI 198
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 4e-25
Identities = 55/217 (25%), Positives = 92/217 (42%), Gaps = 42/217 (19%)
Query: 424 IGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQGNREFIN--------------------- 461
IG+G +G V D T A+K L SK K +
Sbjct: 21 IGKGSYGVVKLAYNENDNTYYAMKVL-SKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGP 79
Query: 462 ------EIGMISALQHPNLVKLYGCCIEG---NQLLLIYEYLENNSLARALFEHRLKLDW 512
EI ++ L HPN+VKL ++ + L +++E + + L D
Sbjct: 80 IEQVYQEIAILKKLDHPNVVKLV-EVLDDPNEDHLYMVFELVNQGPVMEVPTLKPLSED- 137
Query: 513 PTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTH 572
R + +G+ YLH K++HRDIK +N+L+ +D + KI+DFG++ + +
Sbjct: 138 -QARFYFQDLIKGIEYLH---YQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDAL 193
Query: 573 ISTRVAGTIGYMAPE---YAMRGHLTEKADVYSFGIV 606
+S GT +MAPE + + DV++ G+
Sbjct: 194 LSN-TVGTPAFMAPESLSETRKIFSGKALDVWAMGVT 229
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 5e-25
Identities = 50/196 (25%), Positives = 85/196 (43%), Gaps = 26/196 (13%)
Query: 424 IGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQGNRE---FINEIGMISALQHPNLVKLYG 479
+G+G F V + + G A K ++ K R+ E + LQHPN+V+L+
Sbjct: 14 LGKGAFSVVRRCVHKTTGLEFAAKIIN-TKKLSARDFQKLEREARICRKLQHPNIVRLHD 72
Query: 480 CCIEGNQLLLIYEYL---ENNSLARALFE---HRLKLDWPTRRRICLGIARGLAYLHGES 533
E + L+++ + E LFE R I +AY H
Sbjct: 73 SIQEESFHYLVFDLVTGGE-------LFEDIVAREFYSEADASHCIQQILESIAYCH--- 122
Query: 534 RIKVVHRDIKATNVLL---DKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPEYAM 590
+VHR++K N+LL K K++DFGLA ++ GT GY++PE
Sbjct: 123 SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIE-VNDSEAWHGFA-GTPGYLSPEVLK 180
Query: 591 RGHLTEKADVYSFGIV 606
+ ++ D+++ G++
Sbjct: 181 KDPYSKPVDIWACGVI 196
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 1e-24
Identities = 54/201 (26%), Positives = 91/201 (45%), Gaps = 29/201 (14%)
Query: 424 IGEGGFGPVYKGL-LADGTAIAVK-----QLSSKSKQGNREFI-NEIGMISALQHPNLVK 476
+G G F V K G A K +LSS + +RE I E+ ++ ++HPN++
Sbjct: 13 LGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIIT 72
Query: 477 LYGCCIEGNQLLLIYEYL---ENNSLARALFEHRLKLDWPTRR---RICLGIARGLAYLH 530
L+ ++LI E + E LF+ + + T + I G+ YLH
Sbjct: 73 LHDIFENKTDVVLILELVSGGE-------LFDFLAEKESLTEDEATQFLKQILDGVHYLH 125
Query: 531 GESRIKVVHRDIKATNVLL-DKDLNS---KISDFGLAKLDEEENTHISTRVAGTIGYMAP 586
++ H D+K N++L DK++ + K+ DFG+A E GT ++AP
Sbjct: 126 ---SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHK-IEAGNEFKNIF-GTPEFVAP 180
Query: 587 EYAMRGHLTEKADVYSFGIVA 607
E L +AD++S G++
Sbjct: 181 EIVNYEPLGLEADMWSIGVIT 201
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 2e-24
Identities = 50/194 (25%), Positives = 84/194 (43%), Gaps = 22/194 (11%)
Query: 424 IGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCCI 482
+G G FG V++ + A G K +++ NEI +++ L HP L+ L+
Sbjct: 59 LGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFE 118
Query: 483 EGNQLLLIYEYL---ENNSLARALFEHRLKLDWPTRRRICLGIAR----GLAYLHGESRI 535
+ +++LI E+L E LF+ D+ + R GL ++H
Sbjct: 119 DKYEMVLILEFLSGGE-------LFDRIAAEDYKMSEAEVINYMRQACEGLKHMH---EH 168
Query: 536 KVVHRDIKATNVLLDKDLNS--KISDFGLAKLDEEENTHISTRVAGTIGYMAPEYAMRGH 593
+VH DIK N++ + S KI DFGLA + I T + APE R
Sbjct: 169 SIVHLDIKPENIMCETKKASSVKIIDFGLAT--KLNPDEIVKVTTATAEFAAPEIVDREP 226
Query: 594 LTEKADVYSFGIVA 607
+ D+++ G++
Sbjct: 227 VGFYTDMWAIGVLG 240
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 2e-24
Identities = 47/203 (23%), Positives = 88/203 (43%), Gaps = 29/203 (14%)
Query: 424 IGEGGFGPVYKGL-LADGTAIAVK--------QLSSKSKQGNREFI-NEIGMISAL-QHP 472
+G G V + + AVK S++ Q RE E+ ++ + HP
Sbjct: 25 LGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHP 84
Query: 473 NLVKLYGCCIEGNQLLLIYEYLENNSLARALFE---HRLKLDWPTRRRICLGIARGLAYL 529
N+++L L+++ ++ L F+ ++ L R+I + + L
Sbjct: 85 NIIQLKDTYETNTFFFLVFDLMKKGEL----FDYLTEKVTLSEKETRKIMRALLEVICAL 140
Query: 530 HGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPE-- 587
H ++ +VHRD+K N+LLD D+N K++DFG + + + GT Y+APE
Sbjct: 141 H---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQ-LDPGEKLREVC-GTPSYLAPEII 195
Query: 588 ----YAMRGHLTEKADVYSFGIV 606
++ D++S G++
Sbjct: 196 ECSMNDNHPGYGKEVDMWSTGVI 218
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 5e-24
Identities = 51/198 (25%), Positives = 86/198 (43%), Gaps = 23/198 (11%)
Query: 424 IGEGGFGPVYKGL-LADGTAIAVK-----QLSSKSKQGNREFI-NEIGMISALQHPNLVK 476
+G G F V K + G A K Q + + +RE I E+ ++ + H N++
Sbjct: 20 LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79
Query: 477 LYGCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRR---RICLGIARGLAYLHGES 533
L+ ++LI E + LF+ + + + I G+ YLH
Sbjct: 80 LHDVYENRTDVVLILELVSGGE----LFDFLAQKESLSEEEATSFIKQILDGVNYLH--- 132
Query: 534 RIKVVHRDIKATNVLL-DKDLNS---KISDFGLAKLDEEENTHISTRVAGTIGYMAPEYA 589
K+ H D+K N++L DK++ K+ DFGLA E+ GT ++APE
Sbjct: 133 TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE-IEDGVEFKNIF-GTPEFVAPEIV 190
Query: 590 MRGHLTEKADVYSFGIVA 607
L +AD++S G++
Sbjct: 191 NYEPLGLEADMWSIGVIT 208
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 5e-24
Identities = 69/278 (24%), Positives = 122/278 (43%), Gaps = 37/278 (13%)
Query: 35 PKLAELTFLQDIDLTLNYLSGTIPSQWASLPLLNISLIANRLKGPIPKYLANISTLVNLT 94
L LT L ++L+ N +S S + L L N++ P LAN++TL L
Sbjct: 128 DPLKNLTNLNRLELSSNTISD--ISALSGLTSLQQLSFGNQVTDLKP--LANLTTLERLD 183
Query: 95 VQYNQFSGELPEELGSLLNLEKLHLSSNNFT-----GELPK---------------TFAK 134
+ N+ S L L NLE L ++N + G L T A
Sbjct: 184 ISSNKVSD--ISVLAKLTNLESLIATNNQISDITPLGILTNLDELSLNGNQLKDIGTLAS 241
Query: 135 LTNMKDFRISDNQFTGQIPSFIQNWTKLEKLFIQPSGLAGPIPSGIFSLENLTDLRISDL 194
LTN+ D +++NQ + P + TKL +L + + ++ P + L LT+L +++
Sbjct: 242 LTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISP--LAGLTALTNLELNE- 296
Query: 195 NGPEATFPQLGNM-KMTKLILRNCNITGELPRYLGKMTKLKVLDLSFNRLRGQIPSNFDD 253
N E + N+ +T L L NI+ P + +TKL+ L N++ S+ +
Sbjct: 297 NQLE-DISPISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFYNNKVSD--VSSLAN 351
Query: 254 LYDVDYIYFAGNLLTGAIPPWMLERGDKIDLSYNNFTD 291
L +++++ N ++ P L R ++ L+ +T+
Sbjct: 352 LTNINWLSAGHNQISDLTPLANLTRITQLGLNDQAWTN 389
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 1e-23
Identities = 73/281 (25%), Positives = 113/281 (40%), Gaps = 27/281 (9%)
Query: 24 LKEQNLTGVLPPKLAELTFLQDIDLTLNYLSGTIP-SQWASLPLLNISLIANRLKGPIPK 82
LT + P L LT L DI + N ++ P + +L L + N++ P
Sbjct: 75 FSNNQLTDITP--LKNLTKLVDILMNNNQIADITPLANLTNLTGLTLF--NNQITDIDP- 129
Query: 83 YLANISTLVNLTVQYNQFSGELPEELGSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFR 142
L N++ L L + N S L L +L++L N T P A LT ++
Sbjct: 130 -LKNLTNLNRLELSSNTISD--ISALSGLTSLQQLSFG-NQVTDLKP--LANLTTLERLD 183
Query: 143 ISDNQFTGQIPSFIQNWTKLEKLFIQPSGLAGPIPSGIFSLENLTDLRISD--LNGPEAT 200
IS N+ + S + T LE L + ++ P + L NL +L ++ L
Sbjct: 184 ISSNKVSD--ISVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKDIGT- 238
Query: 201 FPQLGNMK-MTKLILRNCNITGELPRYLGKMTKLKVLDLSFNRLRGQIPSNFDDLYDVDY 259
L ++ +T L L N I+ P L +TKL L L N++ S L +
Sbjct: 239 ---LASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISN--ISPLAGLTALTN 291
Query: 260 IYFAGNLLTGAIPPWMLERGDKIDLSYNNFTDGSAESSCQK 300
+ N L P L+ + L +NN +D S SS K
Sbjct: 292 LELNENQLEDISPISNLKNLTYLTLYFNNISDISPVSSLTK 332
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 1e-22
Identities = 62/276 (22%), Positives = 108/276 (39%), Gaps = 27/276 (9%)
Query: 20 QKRVLKEQNLTGVLPPKLAELTFLQDIDLTLNYLSGTIPSQWASLP-LLNISLIANRLKG 78
K VL + N+T + +L + + + L L I+ N+L
Sbjct: 27 MKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGI--KSIDGVEYLNNLTQINFSNNQLTD 82
Query: 79 PIPKYLANISTLVNLTVQYNQFSGELPEELGSLLNLEKLHLSSNNFTGELPKTFAKLTNM 138
P L N++ LV++ + NQ + L +L NL L L +N T LTN+
Sbjct: 83 ITP--LKNLTKLVDILMNNNQIAD--ITPLANLTNLTGLTLFNNQITD--IDPLKNLTNL 136
Query: 139 KDFRISDNQFTGQIPSFIQNWTKLEKLFIQPSGLAGPIPSGIFSLENLTDLRISD--LNG 196
+S N + S + T L++L + + P + +L L L IS ++
Sbjct: 137 NRLELSSNTISD--ISALSGLTSLQQLSFG-NQVTDLKP--LANLTTLERLDISSNKVSD 191
Query: 197 PEATFPQLGNM-KMTKLILRNCNITGELPRYLGKMTKLKVLDLSFNRLRGQIPSNFDDLY 255
L + + LI N I+ P LG +T L L L+ N+L+ L
Sbjct: 192 ISV----LAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKD--IGTLASLT 243
Query: 256 DVDYIYFAGNLLTGAIPPWMLERGDKIDLSYNNFTD 291
++ + A N ++ P L + ++ L N ++
Sbjct: 244 NLTDLDLANNQISNLAPLSGLTKLTELKLGANQISN 279
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 2e-20
Identities = 47/229 (20%), Positives = 91/229 (39%), Gaps = 22/229 (9%)
Query: 66 LLNISLIANRLKGPIPKYLANISTLVNLTVQYNQFSGELPEELGSLLNLEKLHLSSNNFT 125
+ L + + ++ + L + + L NL +++ S+N T
Sbjct: 26 KMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIKS--IDGVEYLNNLTQINFSNNQLT 81
Query: 126 GELPKTFAKLTNMKDFRISDNQFTGQIPSFIQNWTKLEKLFIQPSGLAGPIPSGIFSLEN 185
P LT + D +++NQ P + N T L L + + + P + +L N
Sbjct: 82 DITP--LKNLTKLVDILMNNNQIADITP--LANLTNLTGLTLFNNQITDIDP--LKNLTN 135
Query: 186 LTDLRISD--LNGPEATFPQLGNM-KMTKLILRNCNITGELPRYLGKMTKLKVLDLSFNR 242
L L +S ++ A L + + +L N +T P L +T L+ LD+S N+
Sbjct: 136 LNRLELSSNTISDISA----LSGLTSLQQLSFGN-QVTDLKP--LANLTTLERLDISSNK 188
Query: 243 LRGQIPSNFDDLYDVDYIYFAGNLLTGAIPPWMLERGDKIDLSYNNFTD 291
+ S L +++ + N ++ P +L D++ L+ N D
Sbjct: 189 VSD--ISVLAKLTNLESLIATNNQISDITPLGILTNLDELSLNGNQLKD 235
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 2e-20
Identities = 56/260 (21%), Positives = 102/260 (39%), Gaps = 18/260 (6%)
Query: 34 PPKLAELTFLQDIDLTLNYLSGTIP-SQWASLPLLNISLIANRLKGPIPKYLANISTLVN 92
LA+LT L+ + T N +S P +L L+++ N+LK LA+++ L +
Sbjct: 192 ISVLAKLTNLESLIATNNQISDITPLGILTNLDELSLN--GNQLKDIGT--LASLTNLTD 247
Query: 93 LTVQYNQFSGELPEELGSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRISDNQFTGQI 152
L + NQ S L L L +L L +N + P A LT + + +++NQ
Sbjct: 248 LDLANNQISN--LAPLSGLTKLTELKLGANQISNISP--LAGLTALTNLELNENQLED-- 301
Query: 153 PSFIQNWTKLEKLFIQPSGLAGPIPSGIFSLENLTDLRISDLNGPEATFPQLGNM-KMTK 211
S I N L L + + ++ P + SL L L + N L N+ +
Sbjct: 302 ISPISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFYN-NKVS-DVSSLANLTNINW 357
Query: 212 LILRNCNITGELPRYLGKMTKLKVLDLSFNRLRGQIPSNFDDLYDVDYIYFAGNLLTGAI 271
L + I+ P L +T++ L L+ + ++ + + L
Sbjct: 358 LSAGHNQISDLTP--LANLTRITQLGLNDQAWTNAPVNYKANVSIPNTVKNVTGALIAPA 415
Query: 272 PPWMLERGDKIDLSYNNFTD 291
+ D+++N +
Sbjct: 416 TISDGGSYTEPDITWNLPSY 435
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 76.5 bits (189), Expect = 8e-15
Identities = 40/189 (21%), Positives = 69/189 (36%), Gaps = 18/189 (9%)
Query: 106 EELGSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRISDNQFTGQIPSFIQNWTKLEKL 165
+L K L N T + L + + ++ L ++
Sbjct: 18 FTDTALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIK--SIDGVEYLNNLTQI 73
Query: 166 FIQPSGLAGPIPSGIFSLENLTDLRISD--LNGPEATFPQLGNM-KMTKLILRNCNITGE 222
+ L P + +L L D+ +++ + L N+ +T L L N IT
Sbjct: 74 NFSNNQLTDITP--LKNLTKLVDILMNNNQIADITP----LANLTNLTGLTLFNNQITDI 127
Query: 223 LPRYLGKMTKLKVLDLSFNRLRGQIPSNFDDLYDVDYIYFAGNLLTGAIPPWMLERGDKI 282
P L +T L L+LS N + S L + + F GN +T P L +++
Sbjct: 128 DP--LKNLTNLNRLELSSNTISD--ISALSGLTSLQQLSF-GNQVTDLKPLANLTTLERL 182
Query: 283 DLSYNNFTD 291
D+S N +D
Sbjct: 183 DISSNKVSD 191
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 58.4 bits (142), Expect = 4e-09
Identities = 29/158 (18%), Positives = 62/158 (39%), Gaps = 11/158 (6%)
Query: 144 SDNQFTGQIPSFIQNWTKLEKLFIQPSGLAGPIPSGIFSLENLTDLRISDLNGPEATFPQ 203
D QI + + K + + + + L+ +T L+ L +
Sbjct: 10 QDTPIN-QIFT-DTALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGI--KSIDG 63
Query: 204 LGNMK-MTKLILRNCNITGELPRYLGKMTKLKVLDLSFNRLRGQIPSNFDDLYDVDYIYF 262
+ + +T++ N +T P L +TKL + ++ N++ + +L ++ +
Sbjct: 64 VEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIAD--ITPLANLTNLTGLTL 119
Query: 263 AGNLLTGAIPPWMLERGDKIDLSYNNFTDGSAESSCQK 300
N +T P L ++++LS N +D SA S
Sbjct: 120 FNNQITDIDPLKNLTNLNRLELSSNTISDISALSGLTS 157
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 58.4 bits (142), Expect = 5e-09
Identities = 29/169 (17%), Positives = 55/169 (32%), Gaps = 12/169 (7%)
Query: 28 NLTGVLPPKLAELTFLQDIDLTLNYLSGTIP-SQWASLPLLNISLIANRLKGPIPKYLAN 86
L + P ++ L L + L N +S P S L L N++ LAN
Sbjct: 298 QLEDISP--ISNLKNLTYLTLYFNNISDISPVSSLTKLQRLFFY--NNKVSDVSS--LAN 351
Query: 87 ISTLVNLTVQYNQFSGELPEELGSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRISDN 146
++ + L+ +NQ S L +L + +L L+ +T A ++ +
Sbjct: 352 LTNINWLSAGHNQISD--LTPLANLTRITQLGLNDQAWTNAPVNYKANVSIPNTVKNVTG 409
Query: 147 QFTGQIPSFIQNWTKLEKLFIQPSGLAGPIPSGIFSLENLTDLRISDLN 195
P+ I + + I L ++ +
Sbjct: 410 ALI--APATISDGGSYTEPDIT-WNLPSYTNEVSYTFSQPVTIGKGTTT 455
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 44.2 bits (105), Expect = 1e-04
Identities = 14/102 (13%), Positives = 35/102 (34%), Gaps = 4/102 (3%)
Query: 28 NLTGVLPPKLAELTFLQDIDLTLNYLSGTIPSQWASLPLLNISLIANRLKGPIPKYLANI 87
++ + P LA LT + + L + + A++ + N P +++
Sbjct: 364 QISDLTP--LANLTRITQLGLNDQAWTNAPVNYKANVSIPNTVKNVTGALIA-PATISDG 420
Query: 88 STLVNLTVQYNQFSGELPEELGSLLNLEKLHLSSNNFTGELP 129
+ + +N S E + + + F+G +
Sbjct: 421 GSYTEPDITWNLPS-YTNEVSYTFSQPVTIGKGTTTFSGTVT 461
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 5e-24
Identities = 50/195 (25%), Positives = 86/195 (44%), Gaps = 24/195 (12%)
Query: 424 IGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQGNRE---FINEIGMISALQHPNLVKLYG 479
+G+G F V + + G A K ++ K R+ E + LQHPN+V+L+
Sbjct: 37 LGKGAFSVVRRCVHKTTGLEFAAKIIN-TKKLSARDFQKLEREARICRKLQHPNIVRLHD 95
Query: 480 CCIEGNQLLLIYEYLENNSL-----ARALFEHRLKLDWPTRRRICLGIARGLAYLHGESR 534
E + L+++ + L AR + I +AY H
Sbjct: 96 SIQEESFHYLVFDLVTGGELFEDIVAREFYSEA------DASHCIQQILESIAYCH---S 146
Query: 535 IKVVHRDIKATNVLL---DKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPEYAMR 591
+VHR++K N+LL K K++DFGLA E ++ AGT GY++PE +
Sbjct: 147 NGIVHRNLKPENLLLASKAKGAAVKLADFGLAI--EVNDSEAWHGFAGTPGYLSPEVLKK 204
Query: 592 GHLTEKADVYSFGIV 606
++ D+++ G++
Sbjct: 205 DPYSKPVDIWACGVI 219
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 6e-24
Identities = 52/198 (26%), Positives = 86/198 (43%), Gaps = 23/198 (11%)
Query: 424 IGEGGFGPVYKGL-LADGTAIAVK-----QLSSKSKQGNREFI-NEIGMISALQHPNLVK 476
+G G F V K + G A K Q + + RE I E+ ++ + HPN++
Sbjct: 20 LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIIT 79
Query: 477 LYGCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRR---RICLGIARGLAYLHGES 533
L+ ++LI E + LF+ + + + I G+ YLH
Sbjct: 80 LHDVYENRTDVVLILELVSGGE----LFDFLAQKESLSEEEATSFIKQILDGVNYLH--- 132
Query: 534 RIKVVHRDIKATNVLL-DKDLNS---KISDFGLAKLDEEENTHISTRVAGTIGYMAPEYA 589
K+ H D+K N++L DK++ K+ DFGLA E+ GT ++APE
Sbjct: 133 TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE-IEDGVEFKNIF-GTPEFVAPEIV 190
Query: 590 MRGHLTEKADVYSFGIVA 607
L +AD++S G++
Sbjct: 191 NYEPLGLEADMWSIGVIT 208
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 6e-24
Identities = 49/174 (28%), Positives = 87/174 (50%), Gaps = 7/174 (4%)
Query: 416 NNFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQG-NREFINEIGMISALQHPN 473
+ + +GEG + VYKG +A+K++ + ++G I E+ ++ L+H N
Sbjct: 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHAN 61
Query: 474 LVKLYGCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGES 533
+V L+ L L++EYL+ + L + L + ++ + + RGLAY H
Sbjct: 62 IVTLHDIIHTEKSLTLVFEYLDKD-LKQYLDDCGNIINMHNVKLFLFQLLRGLAYCH--- 117
Query: 534 RIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPE 587
R KV+HRD+K N+L+++ K++DFGLA+ V T+ Y P+
Sbjct: 118 RQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVV-TLWYRPPD 170
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 6e-24
Identities = 50/178 (28%), Positives = 89/178 (50%), Gaps = 7/178 (3%)
Query: 412 KAATNNFATDNNIGEGGFGPVYKGLLADGTAIAVKQLS-SKSKQG-NREFINEIGMISAL 469
+ + +GEG +G VYK + G +A+K++ +G I EI ++ L
Sbjct: 17 QGLMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKEL 76
Query: 470 QHPNLVKLYGCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYL 529
HPN+V L L L++E++E + L + L E++ L + + RG+A+
Sbjct: 77 HHPNIVSLIDVIHSERCLTLVFEFMEKD-LKKVLDENKTGLQDSQIKIYLYQLLRGVAHC 135
Query: 530 HGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPE 587
H + +++HRD+K N+L++ D K++DFGLA+ + V T+ Y AP+
Sbjct: 136 H---QHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVV-TLWYRAPD 189
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 7e-24
Identities = 47/194 (24%), Positives = 82/194 (42%), Gaps = 21/194 (10%)
Query: 424 IGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQGNRE--FINEIGMISALQHPNLVKLYGC 480
+G+G F V + + + G A +++K E + L+HPN+V+L+
Sbjct: 19 LGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDS 78
Query: 481 CIEGNQLLLIYEYLENNSL-----ARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRI 535
E LI++ + L AR + I + + H ++
Sbjct: 79 ISEEGHHYLIFDLVTGGELFEDIVAREYYSEA------DASHCIQQILEAVLHCH---QM 129
Query: 536 KVVHRDIKATNVLL---DKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPEYAMRG 592
VVHR++K N+LL K K++DFGLA E E GT GY++PE +
Sbjct: 130 GVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFA-GTPGYLSPEVLRKD 188
Query: 593 HLTEKADVYSFGIV 606
+ D+++ G++
Sbjct: 189 PYGKPVDLWACGVI 202
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 9e-24
Identities = 53/185 (28%), Positives = 93/185 (50%), Gaps = 11/185 (5%)
Query: 409 LQIKAATNNFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQGNREFIN-----E 462
L +K+ + + +GEG F VYK +A+K++ + ++ IN E
Sbjct: 3 LDVKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALRE 62
Query: 463 IGMISALQHPNLVKLYGCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGI 522
I ++ L HPN++ L + + L+++++E + L + ++ L L + L
Sbjct: 63 IKLLQELSHPNIIGLLDAFGHKSNISLVFDFMETD-LEVIIKDNSLVLTPSHIKAYMLMT 121
Query: 523 ARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIG 582
+GL YLH + ++HRD+K N+LLD++ K++DFGLAK N + +V T
Sbjct: 122 LQGLEYLH---QHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVV-TRW 177
Query: 583 YMAPE 587
Y APE
Sbjct: 178 YRAPE 182
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 1e-23
Identities = 35/187 (18%), Positives = 74/187 (39%), Gaps = 9/187 (4%)
Query: 424 IGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCCI 482
+G G FG V++ + + K + EI +++ +H N++ L+
Sbjct: 13 LGRGEFGIVHRCVETSSKKTYMAKFVK-VKGTDQVLVKKEISILNIARHRNILHLHESFE 71
Query: 483 EGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDI 542
+L++I+E++ + + +L+ + L +LH + H DI
Sbjct: 72 SMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLH---SHNIGHFDI 128
Query: 543 KATNVLLDKDLNS--KISDFGLAKLDEEENTHISTRVAGTIGYMAPEYAMRGHLTEKADV 600
+ N++ +S KI +FG A+ + + Y APE ++ D+
Sbjct: 129 RPENIIYQTRRSSTIKIIEFGQARQ-LKPGDNFRLLF-TAPEYYAPEVHQHDVVSTATDM 186
Query: 601 YSFGIVA 607
+S G +
Sbjct: 187 WSLGTLV 193
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 1e-23
Identities = 54/174 (31%), Positives = 90/174 (51%), Gaps = 7/174 (4%)
Query: 416 NNFATDNNIGEGGFGPVYKGLLADGTAIAVKQLS-SKSKQG-NREFINEIGMISALQHPN 473
+ IGEG +G VYK G A+K++ K +G I EI ++ L+H N
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61
Query: 474 LVKLYGCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGES 533
+VKLY +L+L++E+L+ + L + L L+ T + L + G+AY H
Sbjct: 62 IVKLYDVIHTKKRLVLVFEHLDQD-LKKLLDVCEGGLESVTAKSFLLQLLNGIAYCH--- 117
Query: 534 RIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPE 587
+V+HRD+K N+L++++ KI+DFGLA+ + + T+ Y AP+
Sbjct: 118 DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIV-TLWYRAPD 170
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 1e-23
Identities = 54/201 (26%), Positives = 91/201 (45%), Gaps = 29/201 (14%)
Query: 424 IGEGGFGPVYKGL-LADGTAIAVK-----QLSSKSKQGNREFI-NEIGMISALQHPNLVK 476
+G G F V K + G A K + S + +RE I E+ ++ +QHPN++
Sbjct: 19 LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 477 LYGCCIEGNQLLLIYEYL---ENNSLARALFEHRLKLDWPTRR---RICLGIARGLAYLH 530
L+ ++LI E + E LF+ + + T I G+ YLH
Sbjct: 79 LHEVYENKTDVILILELVAGGE-------LFDFLAEKESLTEEEATEFLKQILNGVYYLH 131
Query: 531 GESRIKVVHRDIKATNVLL-DKDLNS---KISDFGLAKLDEEENTHISTRVAGTIGYMAP 586
+++ H D+K N++L D+++ KI DFGLA + N + GT ++AP
Sbjct: 132 ---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF--KNIFGTPEFVAP 186
Query: 587 EYAMRGHLTEKADVYSFGIVA 607
E L +AD++S G++
Sbjct: 187 EIVNYEPLGLEADMWSIGVIT 207
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 1e-23
Identities = 45/202 (22%), Positives = 89/202 (44%), Gaps = 28/202 (13%)
Query: 424 IGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQGNREFI--------NEIGMISAL-QHPN 473
IG G V + + A G AVK + +++ + E + E ++ + HP+
Sbjct: 102 IGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPH 161
Query: 474 LVKLYGCCIEGNQLLLIYEYLENNSLARALFE---HRLKLDWPTRRRICLGIARGLAYLH 530
++ L + + L+++ + LF+ ++ L R I + +++LH
Sbjct: 162 IITLIDSYESSSFMFLVFDLMRKGE----LFDYLTEKVALSEKETRSIMRSLLEAVSFLH 217
Query: 531 GESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPE--- 587
+VHRD+K N+LLD ++ ++SDFG + E + GT GY+APE
Sbjct: 218 ---ANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEK-LRELC-GTPGYLAPEILK 272
Query: 588 ---YAMRGHLTEKADVYSFGIV 606
++ D+++ G++
Sbjct: 273 CSMDETHPGYGKEVDLWACGVI 294
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 1e-23
Identities = 54/190 (28%), Positives = 84/190 (44%), Gaps = 18/190 (9%)
Query: 424 IGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCCI 482
+G G VY+ A+K L + + EIG++ L HPN++KL
Sbjct: 61 LGRGATSIVYRCKQKGTQKPYALKVLKKTVDK--KIVRTEIGVLLRLSHPNIIKLKEIFE 118
Query: 483 EGNQLLLIYEYLENNSLARALFEHRLKLDWPTRR---RICLGIARGLAYLHGESRIKVVH 539
++ L+ E + LF+ ++ + + R I +AYLH +VH
Sbjct: 119 TPTEISLVLELVTGGE----LFDRIVEKGYYSERDAADAVKQILEAVAYLH---ENGIVH 171
Query: 540 RDIKATNVLL---DKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPEYAMRGHLTE 596
RD+K N+L D KI+DFGL+K+ E + V GT GY APE
Sbjct: 172 RDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLM--KTVCGTPGYCAPEILRGCAYGP 229
Query: 597 KADVYSFGIV 606
+ D++S GI+
Sbjct: 230 EVDMWSVGII 239
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 2e-23
Identities = 47/175 (26%), Positives = 79/175 (45%), Gaps = 8/175 (4%)
Query: 416 NNFATDNNIGEGGFGPVYKGL-LADGTAIAVKQ--LSSKSKQGNREFINEIGMISALQHP 472
+ +GEG +G V K G +A+K+ S K + + EI ++ L+H
Sbjct: 25 EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHE 84
Query: 473 NLVKLYGCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGE 532
NLV L C + + L++E++++ + L LD+ ++ I G+ + H
Sbjct: 85 NLVNLLEVCKKKKRWYLVFEFVDHT-ILDDLELFPNGLDYQVVQKYLFQIINGIGFCH-- 141
Query: 533 SRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPE 587
++HRDIK N+L+ + K+ DFG A+ VA T Y APE
Sbjct: 142 -SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVA-TRWYRAPE 194
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 2e-23
Identities = 47/175 (26%), Positives = 80/175 (45%), Gaps = 8/175 (4%)
Query: 416 NNFATDNNIGEGGFGPVYKGL-LADGTAIAVKQ--LSSKSKQGNREFINEIGMISALQHP 472
+ IGEG +G V+K G +A+K+ S + + EI M+ L+HP
Sbjct: 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHP 62
Query: 473 NLVKLYGCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGE 532
NLV L +L L++EY ++ + L ++ + + I + + + H
Sbjct: 63 NLVNLLEVFRRKRRLHLVFEYCDHT-VLHELDRYQRGVPEHLVKSITWQTLQAVNFCH-- 119
Query: 533 SRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPE 587
+ +HRD+K N+L+ K K+ DFG A+L + + VA T Y +PE
Sbjct: 120 -KHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVA-TRWYRSPE 172
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 2e-23
Identities = 50/200 (25%), Positives = 85/200 (42%), Gaps = 29/200 (14%)
Query: 424 IGEGGFGPVYKGL-LADGTAIAVKQLS-SKSKQGNREFI-NEIGMISALQH-PNLVKLYG 479
+G G F V + + + G A K L + Q R I +EI ++ + P ++ L+
Sbjct: 37 LGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHE 96
Query: 480 CCIEGNQLLLIYEYL---ENNSLARALFEHRLKLDWPTR------RRICLGIARGLAYLH 530
++++LI EY E +F + R+ I G+ YLH
Sbjct: 97 VYENTSEIILILEYAAGGE-------IFS-LCLPELAEMVSENDVIRLIKQILEGVYYLH 148
Query: 531 GESRIKVVHRDIKATNVLL-DKDLNS--KISDFGLAKLDEEENTHISTRVAGTIGYMAPE 587
+ +VH D+K N+LL KI DFG+++ + + GT Y+APE
Sbjct: 149 ---QNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRK-IGHACELREIM-GTPEYLAPE 203
Query: 588 YAMRGHLTEKADVYSFGIVA 607
+T D+++ GI+A
Sbjct: 204 ILNYDPITTATDMWNIGIIA 223
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 2e-23
Identities = 59/218 (27%), Positives = 96/218 (44%), Gaps = 28/218 (12%)
Query: 415 TNNFATDNNIGEGGFGPVYKGLLAD-GTAIAVKQLSSKSKQGNREFINEIGMISALQHPN 473
+ F + G+G FG V G G ++A+K++ + NRE + + ++ L HPN
Sbjct: 22 MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRE-LQIMQDLAVLHHPN 80
Query: 474 LVKLYGCCIEGNQ-------LLLIYEYLENN--SLARALFEHRLKLDWPTRRRICLGIAR 524
+V+L + L ++ EY+ + R + ++ + + R
Sbjct: 81 IVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIR 140
Query: 525 GLAYLHGESRIKVVHRDIKATNVLLDK---DLNSKISDFGLAKL--DEEENTH-ISTRVA 578
+ LH S V HRDIK NVL+++ L K+ DFG AK E N I +R
Sbjct: 141 SIGCLHLPSV-NVCHRDIKPHNVLVNEADGTL--KLCDFGSAKKLSPSEPNVAYICSRY- 196
Query: 579 GTIGYMAPEYAMRG--HLTEKADVYSFGIVALEIVSGR 614
Y APE + G H T D++S G + E++ G
Sbjct: 197 ----YRAPEL-IFGNQHYTTAVDIWSVGCIFAEMMLGE 229
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 99 bits (250), Expect = 2e-23
Identities = 43/175 (24%), Positives = 82/175 (46%), Gaps = 8/175 (4%)
Query: 416 NNFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLS-SKSKQG-NREFINEIGMISALQHP 472
+ IGEG +G V+K +A+K++ +G + EI ++ L+H
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61
Query: 473 NLVKLYGCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGE 532
N+V+L+ +L L++E+ + + L + LD + + +GL + H
Sbjct: 62 NIVRLHDVLHSDKKLTLVFEFCDQD-LKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCH-- 118
Query: 533 SRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPE 587
V+HRD+K N+L++++ K+++FGLA+ S V T+ Y P+
Sbjct: 119 -SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVV-TLWYRPPD 171
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 3e-23
Identities = 50/206 (24%), Positives = 81/206 (39%), Gaps = 23/206 (11%)
Query: 424 IGEGGFGPVYKGL-LADGTAIAVKQLS----SKSKQGNREFINEIGMISALQHPNLVKLY 478
+GEG +G V + L AVK L + G EI ++ L+H N+++L
Sbjct: 13 LGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLV 72
Query: 479 G--CCIEGNQLLLIYEYLENNSLARALFEH----RLKLDWPTRRRICLGIARGLAYLHGE 532
E ++ ++ EY + + + R + + GL YLH
Sbjct: 73 DVLYNEEKQKMYMVMEYCVCGM--QEMLDSVPEKRFPVC--QAHGYFCQLIDGLEYLH-- 126
Query: 533 SRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEE--ENTHISTRVAGTIGYMAPEYAM 590
+VH+DIK N+LL KIS G+A+ + T G+ + PE A
Sbjct: 127 -SQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRT-SQGSPAFQPPEIAN 184
Query: 591 --RGHLTEKADVYSFGIVALEIVSGR 614
K D++S G+ I +G
Sbjct: 185 GLDTFSGFKVDIWSAGVTLYNITTGL 210
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 3e-23
Identities = 59/205 (28%), Positives = 94/205 (45%), Gaps = 27/205 (13%)
Query: 424 IGEGGFGPVYKGLLADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCCIE 483
IG G FG V++ L + +A+K++ + NR E+ ++ ++HPN+V L
Sbjct: 48 IGNGSFGVVFQAKLVESDEVAIKKVLQDKRFKNR----ELQIMRIVKHPNVVDLKAFFYS 103
Query: 484 GNQ------LLLIYEYLENN--SLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRI 535
L L+ EY+ +R + + + + + R LAY+H I
Sbjct: 104 NGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHS---I 160
Query: 536 KVVHRDIKATNVLLDKDLNS-KISDFGLAK--LDEEENTH-ISTRVAGTIGYMAPEYAMR 591
+ HRDIK N+LLD K+ DFG AK + E N I +R Y APE +
Sbjct: 161 GICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSYICSRY-----YRAPE-LIF 214
Query: 592 G--HLTEKADVYSFGIVALEIVSGR 614
G + T D++S G V E++ G+
Sbjct: 215 GATNYTTNIDIWSTGCVMAELMQGQ 239
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 98.8 bits (247), Expect = 4e-23
Identities = 58/197 (29%), Positives = 98/197 (49%), Gaps = 13/197 (6%)
Query: 424 IGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQGNREFIN----EIGMISALQHPNLVKLY 478
+G G FG V G G +AVK L+ + K + + + EI + +HP+++KLY
Sbjct: 19 LGVGTFGKVKIGEHQLTGHKVAVKILN-RQKIRSLDVVGKIKREIQNLKLFRHPHIIKLY 77
Query: 479 GCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVV 538
++ EY+ L + +H +++ RR+ I + Y H R VV
Sbjct: 78 QVISTPTDFFMVMEYVSGGELFDYICKHG-RVEEMEARRLFQQILSAVDYCH---RHMVV 133
Query: 539 HRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPE-YAMRGHLTEK 597
HRD+K NVLLD +N+KI+DFGL+ + + + T G+ Y APE + R + +
Sbjct: 134 HRDLKPENVLLDAHMNAKIADFGLSNM-MSDGEFLRT-SCGSPNYAAPEVISGRLYAGPE 191
Query: 598 ADVYSFGIVALEIVSGR 614
D++S G++ ++ G
Sbjct: 192 VDIWSCGVILYALLCGT 208
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 5e-23
Identities = 55/248 (22%), Positives = 97/248 (39%), Gaps = 40/248 (16%)
Query: 404 YYGFYLQIKAATNNFATDNN------IGEGGFGPVYKGLLADGTAI-AVKQLSSK---SK 453
Y+ +LQ K ++ +G GGFG V+ + + A K+L+ K +
Sbjct: 167 YFLRFLQWKWLEAQPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKR 226
Query: 454 QGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYEYL---ENNSLARALFEHRLKL 510
+G + + E +++ + +V L L L+ + + + H +
Sbjct: 227 KGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGD-------IRYH-IYN 278
Query: 511 DWPTRRRICLGIAR--------GLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGL 562
A GL +LH +++RD+K NVLLD D N +ISD GL
Sbjct: 279 VDEDNPGFQEPRAIFYTAQIVSGLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGL 335
Query: 563 AKLDEEENTHISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRS------- 615
A + T GT G+MAPE + D ++ G+ E+++ R
Sbjct: 336 AVELKAGQTKTKGYA-GTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGE 394
Query: 616 NVTKEDMF 623
V +++
Sbjct: 395 KVENKELK 402
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 99.7 bits (249), Expect = 6e-23
Identities = 48/196 (24%), Positives = 78/196 (39%), Gaps = 27/196 (13%)
Query: 424 IGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCC- 481
+G G G V + G A+K L S + +E + A P++V +
Sbjct: 37 LGLGVNGKVLECFHRRTGQKCALKLLY-DSPKARQEV--DH-HWQASGGPHIVCILDVYE 92
Query: 482 ---IEGNQLLLIYEYLENNSLARALFEH---RLKLDWPTR--RRICLGIARGLAYLHGES 533
LL+I E +E L F R + R I I + +LH
Sbjct: 93 NMHHGKRCLLIIMECMEGGEL----FSRIQERGDQAFTEREAAEIMRDIGTAIQFLH--- 145
Query: 534 RIKVVHRDIKATNVLL-DKDLNS--KISDFGLAKLDEEENTHISTRVAGTIGYMAPEYAM 590
+ HRD+K N+L K+ ++ K++DFG AK + + T T Y+APE
Sbjct: 146 SHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNA--LQTPC-YTPYYVAPEVLG 202
Query: 591 RGHLTEKADVYSFGIV 606
+ D++S G++
Sbjct: 203 PEKYDKSCDMWSLGVI 218
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 99.2 bits (248), Expect = 8e-23
Identities = 53/182 (29%), Positives = 96/182 (52%), Gaps = 12/182 (6%)
Query: 413 AATNNFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQG-NREFINEIGMISALQ 470
++++ F +G G + VYKGL G +A+K++ S++G I EI ++ L+
Sbjct: 2 SSSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELK 61
Query: 471 HPNLVKLYGCCIEGNQLLLIYEYLENNSLARALFEHRLK-----LDWPTRRRICLGIARG 525
H N+V+LY N+L L++E+++N+ L + + + L+ + + +G
Sbjct: 62 HENIVRLYDVIHTENKLTLVFEFMDND-LKKYMDSRTVGNTPRGLELNLVKYFQWQLLQG 120
Query: 526 LAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMA 585
LA+ H K++HRD+K N+L++K K+ DFGLA+ S+ V T+ Y A
Sbjct: 121 LAFCH---ENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVV-TLWYRA 176
Query: 586 PE 587
P+
Sbjct: 177 PD 178
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 9e-23
Identities = 48/205 (23%), Positives = 78/205 (38%), Gaps = 32/205 (15%)
Query: 424 IGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQGNRE-FINEIGMISALQ-HPNLVKLYGC 480
+GEG V + L AVK + K R E+ M+ Q H N+++L
Sbjct: 21 LGEGAHARVQTCINLITSQEYAVKIIE-KQPGHIRSRVFREVEMLYQCQGHRNVLELIEF 79
Query: 481 CIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRR---RICLGIARGLAYLHGESRIKV 537
E ++ L++E + S + H K + +A L +LH +
Sbjct: 80 FEEEDRFYLVFEKMRGGS----ILSHIHKRRHFNELEASVVVQDVASALDFLH---NKGI 132
Query: 538 VHRDIKATNVLL-DKDLNS--KISDFGLAK-------LDEEENTHISTRVAGTIGYMAPE 587
HRD+K N+L + S KI DF L + T G+ YMAPE
Sbjct: 133 AHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPC-GSAEYMAPE 191
Query: 588 ------YAMRGHLTEKADVYSFGIV 606
+ ++ D++S G++
Sbjct: 192 VVEAFSEEASIY-DKRCDLWSLGVI 215
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 99.8 bits (249), Expect = 2e-22
Identities = 64/206 (31%), Positives = 94/206 (45%), Gaps = 28/206 (13%)
Query: 424 IGEGGFGPVYKGLLAD-GTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCCI 482
IG G FG VY+ L D G +A+K++ + NRE + ++ L H N+V+L
Sbjct: 62 IGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRE----LQIMRKLDHCNIVRLRYFFY 117
Query: 483 EGNQ------LLLIYEYLENN--SLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESR 534
+ L L+ +Y+ +AR + L + + R LAY+H
Sbjct: 118 SSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS--- 174
Query: 535 IKVVHRDIKATNVLLDKDLNS-KISDFGLAK--LDEEENTH-ISTRVAGTIGYMAPEYAM 590
+ HRDIK N+LLD D K+ DFG AK + E N I +R Y APE +
Sbjct: 175 FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY-----YRAPE-LI 228
Query: 591 RG--HLTEKADVYSFGIVALEIVSGR 614
G T DV+S G V E++ G+
Sbjct: 229 FGATDYTSSIDVWSAGCVLAELLLGQ 254
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 4e-22
Identities = 80/286 (27%), Positives = 118/286 (41%), Gaps = 15/286 (5%)
Query: 338 TFEEDTSEAGPSTFSQSGTNWVLSSTGHFLENGLKLGPYIQTNTSRLLMNDYQLYTTARL 397
T+ A FS+S V PYI+ L + +Q + +
Sbjct: 111 TYIMKELLACSHPFSKSAIEHVQGHLVKKQVPPDLFQPYIEEICQNLRGDVFQKFIESDK 170
Query: 398 SAISLTYYGFYLQIKAATNNFATDNNIGEGGFGPVYKGLLAD-GTAIAVKQLSSK---SK 453
+ L I N+F+ IG GGFG VY AD G A+K L K K
Sbjct: 171 FTRFCQWKNVELNIHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMK 230
Query: 454 QGNREFINE---IGMISALQHPNLVKLYGCCIEGNQLLLIYEYLENNSLARALFEHRLKL 510
QG +NE + ++S P +V + ++L I + + L L +H
Sbjct: 231 QGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHG-VF 289
Query: 511 DWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEEN 570
R I GL ++H VV+RD+K N+LLD+ + +ISD GLA ++
Sbjct: 290 SEADMRFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK 346
Query: 571 THISTRVAGTIGYMAPEYAMRGHL-TEKADVYSFGIVALEIVSGRS 615
H V GT GYMAPE +G AD +S G + +++ G S
Sbjct: 347 PH--ASV-GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHS 389
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 97.0 bits (242), Expect = 4e-22
Identities = 44/276 (15%), Positives = 100/276 (36%), Gaps = 26/276 (9%)
Query: 24 LKEQNLTGVLPPKLAELTFLQDIDLTLNYLSGTIPSQWASLP-LLNISLIANRLKGPIPK 82
+ + +L L ++++DL+ N LS + A L ++L +N L +
Sbjct: 17 VTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD- 75
Query: 83 YLANISTLVNLTVQYNQFSGELPEELGSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFR 142
L ++STL L + N EL ++E LH ++NN + + ++ K+
Sbjct: 76 -LESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNIS-RVS--CSRGQGKKNIY 126
Query: 143 ISDNQFTGQIPSFIQNWTKLEKLFIQPSGLAG-PIPSGIFSLENLTDL-----RISDLNG 196
+++N+ T ++++ L ++ + + S + L L I D+
Sbjct: 127 LANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDVK- 185
Query: 197 PEATFPQLGNMKMTKLILRNCNITGELPRYLGKMTKLKVLDLSFNRLRGQIPSNFDDLYD 256
+ F +L L L + + + + + L N+L I +
Sbjct: 186 GQVVFAKL-----KTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQN 238
Query: 257 VDYIYFAGNLLTGAIPPWMLERGDKI-DLSYNNFTD 291
+++ GN + ++ ++
Sbjct: 239 LEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKK 274
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 5e-21
Identities = 33/219 (15%), Positives = 70/219 (31%), Gaps = 22/219 (10%)
Query: 80 IPKYLANISTLVNLTVQYNQFSGELPEELGSLLNLEKLHLSSNNFTGELPKTFAKLTNMK 139
I + N + V + L S N+++L LS N + A T ++
Sbjct: 2 IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLE 61
Query: 140 DFRISDNQFTGQIPSFIQNWTKLEKLFIQPSGLAGPIPSGIFSLENLTDL-----RISDL 194
+S N + ++ + L L + + + + ++ L IS +
Sbjct: 62 LLNLSSNVLY-ETLDL-ESLSTLRTLDLNNNYV-----QELLVGPSIETLHAANNNISRV 114
Query: 195 NGPEATFPQLGNMKMTKLILRNCNITGELPRYLGKMTKLKVLDLSFNRLRG-QIPSNFDD 253
+ + L N IT G ++++ LDL N +
Sbjct: 115 --SCSRGQGK-----KNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAAS 167
Query: 254 LYDVDYIYFAGNLLTGAIPPWM-LERGDKIDLSYNNFTD 291
++++ N + + + + +DLS N
Sbjct: 168 SDTLEHLNLQYNFIY-DVKGQVVFAKLKTLDLSSNKLAF 205
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 4e-18
Identities = 40/262 (15%), Positives = 78/262 (29%), Gaps = 44/262 (16%)
Query: 63 SLPLLNISLIANRLKGPIPKYLANISTLVNLTVQYNQFSGELPEELGSLLNLEKLHLSSN 122
+ ++ + LK + + + L + N S +L LE L+LSSN
Sbjct: 11 RYKIEKVTD--SSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSN 68
Query: 123 NFTGELPKTFAKLTNMKDFRISDNQFTGQIPSFIQNWTKLEKLFIQPSGLAGPIPSGIF- 181
E L+ ++ +++N + +E L + ++ +
Sbjct: 69 VLY-ETL-DLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNISR-VSCSRGQ 120
Query: 182 SLENLTDL---RISDLNGPEATFPQLGNMKMTKLILRNCNITG-ELPRYLGKMTKLKVLD 237
+N+ L +I+ L + + L L+ I L+ L+
Sbjct: 121 GKKNI-YLANNKITML--RDLDEGCRSR--VQYLDLKLNEIDTVNFAELAASSDTLEHLN 175
Query: 238 LSFNRLRG---------------------QIPSNFDDLYDVDYIYFAGNLLTGAIPP--W 274
L +N + + F V +I N L I
Sbjct: 176 LQYNFIYDVKGQVVFAKLKTLDLSSNKLAFMGPEFQSAAGVTWISLRNNKLV-LIEKALR 234
Query: 275 MLERGDKIDLSYNNFTDGSAES 296
+ + DL N F G+
Sbjct: 235 FSQNLEHFDLRGNGFHCGTLRD 256
|
| >2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299 | Back alignment and structure |
|---|
Score = 96.4 bits (241), Expect = 4e-22
Identities = 55/176 (31%), Positives = 88/176 (50%), Gaps = 9/176 (5%)
Query: 416 NNFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLS-SKSKQG-NREFINEIGMISALQHP 472
NF IGEG +G VYK G +A+K++ +G I EI ++ L HP
Sbjct: 3 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 473 NLVKLYGCCIEGNQLLLIYEYLENNSLARALFEHRLK-LDWPTRRRICLGIARGLAYLHG 531
N+VKL N+L L++E+L + L + + L + P + + +GLA+ H
Sbjct: 63 NIVKLLDVIHTENKLYLVFEFLHQD-LKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 121
Query: 532 ESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPE 587
+V+HRD+K N+L++ + K++DFGLA+ + V T+ Y APE
Sbjct: 122 H---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLWYRAPE 173
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 96.7 bits (241), Expect = 9e-22
Identities = 51/190 (26%), Positives = 80/190 (42%), Gaps = 17/190 (8%)
Query: 424 IGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCCI 482
IG G FG +AVK + + + EI +L+HPN+V+ +
Sbjct: 28 IGSGNFGVARLMRDKLTKELVAVKYIE-RGAAIDENVQREIINHRSLRHPNIVRFKEVIL 86
Query: 483 EGNQLLLIYEYLENNSLARALFEH---RLKLDWPTRRRICLGIARGLAYLHGESRIKVVH 539
L +I EY L +E + R + G++Y H +++ H
Sbjct: 87 TPTHLAIIMEYASGGEL----YERICNAGRFSEDEARFFFQQLLSGVSYCH---SMQICH 139
Query: 540 RDIKATNVLLDKD--LNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPE-YAMRGHLTE 596
RD+K N LLD KI DFG +K ++ + V GT Y+APE + + +
Sbjct: 140 RDLKLENTLLDGSPAPRLKICDFGYSKS-SVLHSQPKSTV-GTPAYIAPEVLLRQEYDGK 197
Query: 597 KADVYSFGIV 606
ADV+S G+
Sbjct: 198 IADVWSCGVT 207
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 95.8 bits (239), Expect = 1e-21
Identities = 60/202 (29%), Positives = 97/202 (48%), Gaps = 24/202 (11%)
Query: 424 IGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQGNREFIN----EIGMISALQHPNLVKLY 478
+GEG FG V +A+K +S + + EI + L+HP+++KLY
Sbjct: 17 LGEGSFGKVKLATHYKTQQKVALKFIS-RQLLKKSDMHMRVEREISYLKLLRHPHIIKLY 75
Query: 479 GCCIEGNQLLLIYEYL--ENNSLARALFEH---RLKLDWPTRRRICLGIARGLAYLHGES 533
++++ EY E LF++ + ++ RR I + Y H
Sbjct: 76 DVITTPTDIVMVIEYAGGE-------LFDYIVEKKRMTEDEGRRFFQQIICAIEYCH--- 125
Query: 534 RIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPE-YAMRG 592
R K+VHRD+K N+LLD +LN KI+DFGL+ + + + T G+ Y APE +
Sbjct: 126 RHKIVHRDLKPENLLLDDNLNVKIADFGLSNI-MTDGNFLKT-SCGSPNYAAPEVINGKL 183
Query: 593 HLTEKADVYSFGIVALEIVSGR 614
+ + DV+S GIV ++ GR
Sbjct: 184 YAGPEVDVWSCGIVLYVMLVGR 205
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 97.1 bits (242), Expect = 1e-21
Identities = 53/199 (26%), Positives = 81/199 (40%), Gaps = 32/199 (16%)
Query: 424 IGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYG--- 479
+G G G V + A+K L + RE E+ A Q P++V++
Sbjct: 70 LGLGINGKVLQIFNKRTQEKFALKMLQ-DCPKARREV--EL-HWRASQCPHIVRIVDVYE 125
Query: 480 -CCIEGNQLLLIYEYL---ENNSLARALFEH---RLKLDWPTR--RRICLGIARGLAYLH 530
LL++ E L E LF R + R I I + YLH
Sbjct: 126 NLYAGRKCLLIVMECLDGGE-------LFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH 178
Query: 531 GESRIKVVHRDIKATNVLL-DKDLNS--KISDFGLAKLDEEENTHISTRVAGTIGYMAPE 587
I + HRD+K N+L K N+ K++DFG AK N+ ++T T Y+APE
Sbjct: 179 ---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS-LTTPC-YTPYYVAPE 233
Query: 588 YAMRGHLTEKADVYSFGIV 606
+ D++S G++
Sbjct: 234 VLGPEKYDKSCDMWSLGVI 252
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 95.8 bits (239), Expect = 1e-21
Identities = 46/180 (25%), Positives = 82/180 (45%), Gaps = 14/180 (7%)
Query: 416 NNFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLS-SKSKQG-NREFINEIGMISALQHP 472
+ + +GEG +G VYK + +A+K++ ++G I E+ ++ LQH
Sbjct: 34 DRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHR 93
Query: 473 NLVKLYGCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGE 532
N+++L ++L LI+EY EN+ L + + + + + G+ + H
Sbjct: 94 NIIELKSVIHHNHRLHLIFEYAEND-LKK-YMDKNPDVSMRVIKSFLYQLINGVNFCH-- 149
Query: 533 SRIKVVHRDIKATNVLLDKDLNS-----KISDFGLAKLDEEENTHISTRVAGTIGYMAPE 587
+ +HRD+K N+LL S KI DFGLA+ + + T+ Y PE
Sbjct: 150 -SRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEII-TLWYRPPE 207
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 98.0 bits (244), Expect = 2e-21
Identities = 48/239 (20%), Positives = 83/239 (34%), Gaps = 44/239 (18%)
Query: 33 LPPKLAELTFLQDIDLTLNYLSGTIPSQWASLPLLNISLIA---------------NRLK 77
LP L L L +L +PS L + L + N+L
Sbjct: 96 LPVLPPGLLELSIFSNPLTHLP-ALPSGLCKLWIFGNQLTSLPVLPPGLQELSVSDNQLA 154
Query: 78 GPIPKYLANISTLVNLTVQYNQFSGELPEELGSLLNLEKLHLSSNNFTGELPKTFAKLTN 137
+P A S L L NQ + LP L++L +S N LP ++L
Sbjct: 155 S-LP---ALPSELCKLWAYNNQLT-SLPMLPS---GLQELSVSDNQLA-SLPTLPSELYK 205
Query: 138 MKDFRISDNQFTGQIPSFIQNWTKLEKLFIQPSGLAGPIPSGIFSLENLT--DLRISDLN 195
+ +N+ T +P+ L++L + + L +P L+ L R++ L
Sbjct: 206 L---WAYNNRLT-SLPALPSG---LKELIVSGNRLTS-LPVLPSELKELMVSGNRLTSL- 256
Query: 196 GPEATFPQLGNMKMTKLILRNCNITGELPRYLGKMTKLKVLDLSFNRLRGQIPSNFDDL 254
P + L + +T LP L ++ ++L N L + ++
Sbjct: 257 -PM----LPSGL--LSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQALREI 307
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 83.8 bits (207), Expect = 6e-17
Identities = 51/271 (18%), Positives = 89/271 (32%), Gaps = 45/271 (16%)
Query: 26 EQNLTGVLPPKLAELTFLQDIDLTLNYLSGTIPSQ-WASLPLLNISLIANRLKGPIPKYL 84
V + +++ + L+ T+P A + L I N L +P
Sbjct: 25 RGRAAVVQKMRACLNNGNAVLNVGESGLT-TLPDCLPAHITTLVIP--DNNLTS-LP--- 77
Query: 85 ANISTLVNLTVQYNQFSGELPEELGSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRIS 144
A L L V NQ + LP LL L + LP + + I
Sbjct: 78 ALPPELRTLEVSGNQLT-SLPVLPPGLLELSIFSNPLTHLP-ALP------SGLCKLWIF 129
Query: 145 DNQFTGQIPSFIQNWTKLEKLFIQPSGLAGPIPSGIFSLENLT--DLRISDLNGPEATFP 202
NQ T +P +L Q + L P+ L L + +++ L P
Sbjct: 130 GNQLT-SLPVLPPGLQELSVSDNQLASL----PALPSELCKLWAYNNQLTSL--PM---- 178
Query: 203 QLGNMKMTKLILRNCNITGELPRYLGKMTKLKVLDLSFNRLRGQIPSNFDDLYDVDYIYF 262
+ +L + + + LP ++ KL + L + +
Sbjct: 179 LPSG--LQELSVSDNQLA-SLPTLPSELYKLWAYNNRLTSLPALPSG-------LKELIV 228
Query: 263 AGNLLTGAIPPWM--LERGDKIDLSYNNFTD 291
+GN LT ++P L+ ++ +S N T
Sbjct: 229 SGNRLT-SLPVLPSELK---ELMVSGNRLTS 255
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 59.5 bits (144), Expect = 2e-09
Identities = 34/193 (17%), Positives = 74/193 (38%), Gaps = 12/193 (6%)
Query: 38 AELTFLQDIDLTLNYLSGTIPSQWASLPLLNISLIANRLKGPIPKYLANISTLVNLTVQY 97
A + L+++ ++ N L+ ++P + L L +S NRL +P S L++L+V
Sbjct: 218 ALPSGLKELIVSGNRLT-SLPVLPSELKELMVS--GNRLTS-LP---MLPSGLLSLSVYR 270
Query: 98 NQFSGELPEELGSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRISDNQFTGQIPSFIQ 157
NQ + LPE L L + ++L N + + ++T+ + +F S +
Sbjct: 271 NQLT-RLPESLIHLSSETTVNLEGNPLSERTLQALREITSAPGYSGPIIRFDMAGASAPR 329
Query: 158 NWTKLEKLFIQPSGLAGPIPSGIFSLENLTDLRISDLNGPEATFPQLGNMKMTKLILRNC 217
L L + + +A L + T+ +++
Sbjct: 330 ETRALHLA--AADWLVPAREGEPAPADRWHMFG--QEDNADAFSLFLDRLSETENFIKDA 385
Query: 218 NITGELPRYLGKM 230
++ +L ++
Sbjct: 386 GFKAQISSWLAQL 398
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 96.7 bits (241), Expect = 3e-21
Identities = 59/273 (21%), Positives = 110/273 (40%), Gaps = 16/273 (5%)
Query: 28 NLTGVLPPKLAELTFLQDIDLTLNYLSGTIPSQ-WASLP-LLNISLIANRLKGPIPKYLA 85
+ + + A L++++L N +S + + +L L + L +NRLK
Sbjct: 43 RIKTLNQDEFASFPHLEELELNENIVS-AVEPGAFNNLFNLRTLGLRSNRLKLIPLGVFT 101
Query: 86 NISTLVNLTVQYNQFSGELPEELGSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRISD 145
+S L L + N+ L L NL+ L + N+ + F+ L +++ +
Sbjct: 102 GLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLVYISHRAFSGLNSLEQLTLEK 161
Query: 146 NQFTGQIPSFI-QNWTKLEKLFIQPSGLAGPIPSGIFS-LENLTDLRISDLNGPEATFPQ 203
T IP+ + L L ++ + I F L L L IS + P
Sbjct: 162 CNLT-SIPTEALSHLHGLIVLRLRHLNINA-IRDYSFKRLYRLKVLEISHWPYLDTMTPN 219
Query: 204 -LGNMKMTKLILRNCNITGELPRY-LGKMTKLKVLDLSFNRLRGQIPSN-FDDLYDVDYI 260
L + +T L + +CN+T +P + + L+ L+LS+N + I + +L + I
Sbjct: 220 CLYGLNLTSLSITHCNLT-AVPYLAVRHLVYLRFLNLSYNPIS-TIEGSMLHELLRLQEI 277
Query: 261 YFAGNLLTGAIPPWM---LERGDKIDLSYNNFT 290
G L + P+ L +++S N T
Sbjct: 278 QLVGGQLA-VVEPYAFRGLNYLRVLNVSGNQLT 309
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 91.7 bits (228), Expect = 1e-19
Identities = 45/247 (18%), Positives = 92/247 (37%), Gaps = 19/247 (7%)
Query: 32 VLPPK-LAELTFLQDIDLTLNYLSGTIPSQW-ASLP-LLNISLIANRLKGPIPKYLANIS 88
++P L+ L +D++ N + + L L ++ + N L + + ++
Sbjct: 94 LIPLGVFTGLSNLTKLDISENKIV-ILLDYMFQDLYNLKSLEVGDNDLVYISHRAFSGLN 152
Query: 89 TLVNLTVQYNQFSGELPEELGSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRISDNQF 148
+L LT++ + E L L L L L N +F +L +K IS +
Sbjct: 153 SLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPY 212
Query: 149 TGQIPSFIQNWTKLEKLFIQPSGLAGPIPSGIFSLENLTDLRISDLNG------PEATFP 202
+ L L I L +P +L LR +L+ +
Sbjct: 213 LDTMTPNCLYGLNLTSLSITHCNLTA-VPYLAVR--HLVYLRFLNLSYNPISTIEGSMLH 269
Query: 203 QLGNMKMTKLILRNCNITGELPRY-LGKMTKLKVLDLSFNRLRGQIPSN-FDDLYDVDYI 260
+L + ++ L + + Y + L+VL++S N+L + + F + +++ +
Sbjct: 270 ELLR--LQEIQLVGGQLA-VVEPYAFRGLNYLRVLNVSGNQLT-TLEESVFHSVGNLETL 325
Query: 261 YFAGNLL 267
N L
Sbjct: 326 ILDSNPL 332
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 83.6 bits (207), Expect = 5e-17
Identities = 56/234 (23%), Positives = 92/234 (39%), Gaps = 19/234 (8%)
Query: 69 ISLIANRLKGPIPKYLANISTLVNLTVQYNQFSGELPEELGSLLNLEKLHLSSNNFTGEL 128
+ L NR+K A+ L L + N S P +L NL L L SN
Sbjct: 37 LDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSNRLKLIP 96
Query: 129 PKTFAKLTNMKDFRISDNQFTGQIPSFI-QNWTKLEKLFIQPSGLAGPIPSGIFS-LENL 186
F L+N+ IS+N+ + ++ Q+ L+ L + + L I FS L +L
Sbjct: 97 LGVFTGLSNLTKLDISENKIV-ILLDYMFQDLYNLKSLEVGDNDLVY-ISHRAFSGLNSL 154
Query: 187 TDL-----RISDLNGPEATFPQLGNMKMTKLILRNCNITGELPRY-LGKMTKLKVLDLSF 240
L ++ + P L + L LR+ NI + Y ++ +LKVL++S
Sbjct: 155 EQLTLEKCNLTSI--PTEALSHLHGLI--VLRLRHLNIN-AIRDYSFKRLYRLKVLEISH 209
Query: 241 NRLRGQIPSNFDDLYDVDYIYFAGNLLTGAIPPWM---LERGDKIDLSYNNFTD 291
+ N ++ + LT A+P L ++LSYN +
Sbjct: 210 WPYLDTMTPNCLYGLNLTSLSITHCNLT-AVPYLAVRHLVYLRFLNLSYNPIST 262
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 76.7 bits (189), Expect = 7e-15
Identities = 37/227 (16%), Positives = 83/227 (36%), Gaps = 18/227 (7%)
Query: 28 NLTGVLPPKLAELTFLQDIDLTLNYLSGTIPSQW-ASLP-LLNISLIANRLKGPIPKY-L 84
+ +L +L L+ +++ N L I + + L L ++L L IP L
Sbjct: 115 KIVILLDYMFQDLYNLKSLEVGDNDLV-YISHRAFSGLNSLEQLTLEKCNLTS-IPTEAL 172
Query: 85 ANISTLVNLTVQYNQFSGELPEELGSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRIS 144
+++ L+ L +++ + L L+ L +S + + N+ I+
Sbjct: 173 SHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSIT 232
Query: 145 DNQFTGQIPSF-IQNWTKLEKLFIQPSGLAGPIPSGIFS-LENLTDL-----RISDLNGP 197
T +P +++ L L + + ++ I + L L ++ +++ +
Sbjct: 233 HCNLT-AVPYLAVRHLVYLRFLNLSYNPIST-IEGSMLHELLRLQEIQLVGGQLAVV--E 288
Query: 198 EATFPQLGNMKMTKLILRNCNITGELPRYLGKMTKLKVLDLSFNRLR 244
F L ++ L + +T + L+ L L N L
Sbjct: 289 PYAFRGLNYLR--VLNVSGNQLTTLEESVFHSVGNLETLILDSNPLA 333
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 54.3 bits (131), Expect = 9e-08
Identities = 21/128 (16%), Positives = 41/128 (32%), Gaps = 5/128 (3%)
Query: 24 LKEQNLTGVLPPKLAELTFLQDIDLTLNYLSGTIPSQ-WASLPLLN-ISLIANRLKGPIP 81
+ + P L + +T L+ +P L L ++L N +
Sbjct: 207 ISHWPYLDTMTPNCLYGLNLTSLSITHCNLT-AVPYLAVRHLVYLRFLNLSYNPISTIEG 265
Query: 82 KYLANISTLVNLTVQYNQFSGELPEE-LGSLLNLEKLHLSSNNFTGELPKTFAKLTNMKD 140
L + L + + Q + + L L L++S N T F + N++
Sbjct: 266 SMLHELLRLQEIQLVGGQLA-VVEPYAFRGLNYLRVLNVSGNQLTTLEESVFHSVGNLET 324
Query: 141 FRISDNQF 148
+ N
Sbjct: 325 LILDSNPL 332
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 96.4 bits (240), Expect = 3e-21
Identities = 60/197 (30%), Positives = 101/197 (51%), Gaps = 13/197 (6%)
Query: 424 IGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQGNREFIN----EIGMISALQHPNLVKLY 478
+G G FG V G G +AVK L+ + K + + + EI + +HP+++KLY
Sbjct: 24 LGVGTFGKVKVGKHELTGHKVAVKILN-RQKIRSLDVVGKIRREIQNLKLFRHPHIIKLY 82
Query: 479 GCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVV 538
+ + ++ EY+ L + ++ +LD RR+ I G+ Y H R VV
Sbjct: 83 QVISTPSDIFMVMEYVSGGELFDYICKNG-RLDEKESRRLFQQILSGVDYCH---RHMVV 138
Query: 539 HRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPE-YAMRGHLTEK 597
HRD+K NVLLD +N+KI+DFGL+ + + + T G+ Y APE + R + +
Sbjct: 139 HRDLKPENVLLDAHMNAKIADFGLSNM-MSDGEFLRTSC-GSPNYAAPEVISGRLYAGPE 196
Query: 598 ADVYSFGIVALEIVSGR 614
D++S G++ ++ G
Sbjct: 197 VDIWSSGVILYALLCGT 213
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 94.9 bits (236), Expect = 6e-21
Identities = 48/184 (26%), Positives = 81/184 (44%), Gaps = 27/184 (14%)
Query: 424 IGEGGFGPVYKG---LLADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGC 480
+G G +G VYK D A+KQ+ + EI ++ L+HPN++ L
Sbjct: 29 VGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI--SMSACREIALLRELKHPNVISLQKV 86
Query: 481 CIE--GNQLLLIYEYLENNSLARALFEHR--------LKLDWPTRRRICLGIARGLAYLH 530
+ ++ L+++Y E++ L + HR ++L + + I G+ YLH
Sbjct: 87 FLSHADRKVWLLFDYAEHD-LWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH 145
Query: 531 GESRIKVVHRDIKATNVLLDKDLNS----KISDFGLAKL---DEEENTHISTRVAGTIGY 583
V+HRD+K N+L+ + KI+D G A+L + + V T Y
Sbjct: 146 ---ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVV-TFWY 201
Query: 584 MAPE 587
APE
Sbjct: 202 RAPE 205
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 96.4 bits (240), Expect = 6e-21
Identities = 64/242 (26%), Positives = 101/242 (41%), Gaps = 31/242 (12%)
Query: 404 YYGFYLQIKAATNNFATDNN------IGEGGFGPVYKGLLADGTAI-AVKQLSSK---SK 453
Y+ +LQ K T N +G+GGFG V + + A K+L K +
Sbjct: 166 YFNRFLQWKWLERQPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKR 225
Query: 454 QGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYEYLENNSLARALFEH-----RL 508
+G +NE ++ + +V L + L L+ + L H +
Sbjct: 226 KGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDL----KFHIYHMGQA 281
Query: 509 KLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEE 568
I GL LH E ++V+RD+K N+LLD + +ISD GLA
Sbjct: 282 GFPEARAVFYAAEICCGLEDLHRE---RIVYRDLKPENILLDDHGHIRISDLGLAV-HVP 337
Query: 569 ENTHISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRS-------NVTKED 621
E I RV GT+GYMAPE T D ++ G + E+++G+S + +E+
Sbjct: 338 EGQTIKGRV-GTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREE 396
Query: 622 MF 623
+
Sbjct: 397 VE 398
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 92.5 bits (230), Expect = 7e-21
Identities = 24/197 (12%), Positives = 51/197 (25%), Gaps = 42/197 (21%)
Query: 424 IGEGGFGPVYKGLLAD---GTAIAVKQL---SSKSKQGNREFINEIGMISALQHPNLVKL 477
G ++ L D +A+ + +E ++ +S + P + ++
Sbjct: 39 HGGVPPLQFWQAL--DTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARV 96
Query: 478 YGCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKV 537
L++ E++ SL + + + R +A H R V
Sbjct: 97 LDVVHTRAGGLVVAEWIRGGSL-QEVADTSP--SPVGAIRAMQSLAAAADAAH---RAGV 150
Query: 538 VHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPEYAMRGHLTEK 597
+ V + D G L M +
Sbjct: 151 ALSIDHPSRVRVSID--------GDVVL-------------AYPATMPDA-------NPQ 182
Query: 598 ADVYSFGIVALEIVSGR 614
D+ G ++ R
Sbjct: 183 DDIRGIGASLYALLVNR 199
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 94.9 bits (236), Expect = 1e-20
Identities = 44/275 (16%), Positives = 100/275 (36%), Gaps = 26/275 (9%)
Query: 24 LKEQNLTGVLPPKLAELTFLQDIDLTLNYLSGTIPSQWASLP-LLNISLIANRLKGPIPK 82
+ + +L L ++++DL+ N LS + A L ++L +N L +
Sbjct: 17 VTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD- 75
Query: 83 YLANISTLVNLTVQYNQFSGELPEELGSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFR 142
L ++STL L + N EL ++E LH ++NN + + ++ K+
Sbjct: 76 -LESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNIS-RVS--CSRGQGKKNIY 126
Query: 143 ISDNQFTGQIPSFIQNWTKLEKLFIQPSGLAG-PIPSGIFSLENLTDL-----RISDLNG 196
+++N+ T ++++ L ++ + + S + L L I D+
Sbjct: 127 LANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDVK- 185
Query: 197 PEATFPQLGNMKMTKLILRNCNITGELPRYLGKMTKLKVLDLSFNRLRGQIPSNFDDLYD 256
+ F +L L L + + + + + L N+L I +
Sbjct: 186 GQVVFAKL-----KTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQN 238
Query: 257 VDYIYFAGNLLTGAIPPWMLERGDKI-DLSYNNFT 290
+++ GN + ++ ++
Sbjct: 239 LEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVK 273
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 91.1 bits (226), Expect = 2e-19
Identities = 36/249 (14%), Positives = 76/249 (30%), Gaps = 14/249 (5%)
Query: 28 NLTGVLPPKLAELTFLQDIDLTLNYLS----GTIPSQWASLPLLNISLIANRLKGPIPKY 83
+T + + +Q +DL LN + + + +L LN+ N + +
Sbjct: 131 KITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQ--YNFIYD-VKG- 186
Query: 84 LANISTLVNLTVQYNQFSGELPEELGSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRI 143
+ L L + N+ + + E S + + L +N + K N++ F +
Sbjct: 187 QVVFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDL 244
Query: 144 SDNQF-TGQIPSFIQNWTKLEKLFI-QPSGLAGPIPSGIFSLENLTDLRISDLNGPEATF 201
N F G + F +++ + L G + P
Sbjct: 245 RGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTVPTLGHYGAYCCEDLPAPFA 304
Query: 202 PQLGNMKMTKLILRN--CNITGELPRYLGKMTKLKVLDLSFNRLRGQIPSNFDDLYDVDY 259
+L +K + L + + T L + + +D + R I
Sbjct: 305 DRLIALKRKEHALLSGQGSETERLECERENQARQREIDALKEQYRTVIDQVTLRKQAKIT 364
Query: 260 IYFAGNLLT 268
+ L
Sbjct: 365 LEQKKKALD 373
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 90.3 bits (224), Expect = 4e-19
Identities = 32/212 (15%), Positives = 68/212 (32%), Gaps = 22/212 (10%)
Query: 86 NISTLVNLTVQYNQFSGELPEELGSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRISD 145
N + V + L S N+++L LS N + A T ++ +S
Sbjct: 8 NGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSS 67
Query: 146 NQFTGQIPSFIQNWTKLEKLFIQPSGLAGPIPSGIFSLENLTDL-----RISDLNGPEAT 200
N + ++ + L L + + + + ++ L IS + +
Sbjct: 68 NVLY-ETLDL-ESLSTLRTLDLNNNYV-----QELLVGPSIETLHAANNNISRV--SCSR 118
Query: 201 FPQLGNMKMTKLILRNCNITGELPRYLGKMTKLKVLDLSFNRLRG-QIPSNFDDLYDVDY 259
+ L N IT G ++++ LDL N + +++
Sbjct: 119 GQGK-----KNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEH 173
Query: 260 IYFAGNLLTGAIPPWM-LERGDKIDLSYNNFT 290
+ N + + + + +DLS N
Sbjct: 174 LNLQYNFIY-DVKGQVVFAKLKTLDLSSNKLA 204
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 83.0 bits (205), Expect = 9e-17
Identities = 40/262 (15%), Positives = 79/262 (30%), Gaps = 44/262 (16%)
Query: 63 SLPLLNISLIANRLKGPIPKYLANISTLVNLTVQYNQFSGELPEELGSLLNLEKLHLSSN 122
+ ++ + LK + + + L + N S +L LE L+LSSN
Sbjct: 11 RYKIEKVTD--SSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSN 68
Query: 123 NFTGELPKTFAKLTNMKDFRISDNQFTGQIPSFIQNWTKLEKLFIQPSGLAGPIPSGIF- 181
E L+ ++ +++N + +E L + ++ +
Sbjct: 69 VLY-ETL-DLESLSTLRTLDLNNNYVQE-----LLVGPSIETLHAANNNISR-VSCSRGQ 120
Query: 182 SLENLTDL---RISDLNGPEATFPQLGNMKMTKLILRNCNITG-ELPRYLGKMTKLKVLD 237
+N+ L +I+ L + + L L+ I L+ L+
Sbjct: 121 GKKNI-YLANNKITML--RDLDEGCRSR--VQYLDLKLNEIDTVNFAELAASSDTLEHLN 175
Query: 238 LSFNRLRG---------------------QIPSNFDDLYDVDYIYFAGNLLTGAIPPWM- 275
L +N + + F V +I N L I +
Sbjct: 176 LQYNFIYDVKGQVVFAKLKTLDLSSNKLAFMGPEFQSAAGVTWISLRNNKLV-LIEKALR 234
Query: 276 -LERGDKIDLSYNNFTDGSAES 296
+ + DL N F G+
Sbjct: 235 FSQNLEHFDLRGNGFHCGTLRD 256
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 48.7 bits (116), Expect = 5e-06
Identities = 20/217 (9%), Positives = 49/217 (22%), Gaps = 5/217 (2%)
Query: 33 LPPKLAELTFLQDIDLTLNYLSGTIPSQWASLPLLNISLIANRLKGPIPKYLANISTLVN 92
+ L L+ DL N + S ++ +K + +
Sbjct: 229 IEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTVPTL 288
Query: 93 LTVQYNQFSGELPEELGSLLNLEKLHLS----SNNFTGELPKTFAKLTNMKDFRISDNQF 148
L+ L++ + + T L ++ Q+
Sbjct: 289 GHYGAYCCEDLPAPFADRLIALKRKEHALLSGQGSETERLECERENQARQREIDALKEQY 348
Query: 149 TGQIPSFIQNWTKLEKLFIQPSGLAGPIPSGIFSLENLTDLRISDLNGPEATFPQLGNMK 208
I L + L + +G + L + E
Sbjct: 349 RTVIDQVTLRKQAKITLEQKKKALDEQVSNGRRAHAELDGTLQQAVGQIELQHATEEQSP 408
Query: 209 MTKLILRNCNITGEL-PRYLGKMTKLKVLDLSFNRLR 244
+ L + + ++ D+ ++
Sbjct: 409 LQLLRAIVKRYEEMYVEQQSVQNNAIRDWDMYQHKET 445
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 45.2 bits (107), Expect = 6e-05
Identities = 20/206 (9%), Positives = 47/206 (22%), Gaps = 8/206 (3%)
Query: 19 NQKRVLKEQNLTGVLPPKLAELTFLQDIDLTLNYLSGTIPSQWASLPLLNISLIANRLKG 78
+ L QN P L DL + I + LL+
Sbjct: 270 QTVKKLTGQNEEECTVPTLGHYGAYCCEDLPAPFADRLIALKRKEHALLSGQGSETE--- 326
Query: 79 PIPKYLANISTLVNLTVQYNQFSGELPEELGSLLNLEKLHLSSNNFTGELPKTFAKLTNM 138
+ N + + Q+ + + L ++ +
Sbjct: 327 RLECERENQARQREIDALKEQYRTVIDQVTLRKQAKITLEQKKKALDEQVSNGRRAHAEL 386
Query: 139 K---DFRISDNQFTGQIPSF--IQNWTKLEKLFIQPSGLAGPIPSGIFSLENLTDLRISD 193
+ + +Q + K + + + + ++ + +
Sbjct: 387 DGTLQQAVGQIELQHATEEQSPLQLLRAIVKRYEEMYVEQQSVQNNAIRDWDMYQHKETQ 446
Query: 194 LNGPEATFPQLGNMKMTKLILRNCNI 219
L A +L L N +
Sbjct: 447 LAEENARLKKLNGEADLALASANATL 472
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 1e-20
Identities = 55/190 (28%), Positives = 92/190 (48%), Gaps = 26/190 (13%)
Query: 416 NNFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLS-SKSKQGNREF----INEIGMISAL 469
+ + IG+G FG V+K G +A+K++ K+G F + EI ++ L
Sbjct: 17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEG---FPITALREIKILQLL 73
Query: 470 QHPNLVKLYGCCIE--------GNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLG 521
+H N+V L C + L++++ E++ LA L +K +R+
Sbjct: 74 KHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHD-LAGLLSNVLVKFTLSEIKRVMQM 132
Query: 522 IARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKL----DEEENTHISTRV 577
+ GL Y+H R K++HRD+KA NVL+ +D K++DFGLA+ + + RV
Sbjct: 133 LLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRV 189
Query: 578 AGTIGYMAPE 587
T+ Y PE
Sbjct: 190 V-TLWYRPPE 198
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 92.9 bits (231), Expect = 9e-20
Identities = 59/313 (18%), Positives = 106/313 (33%), Gaps = 43/313 (13%)
Query: 20 QKRVLKEQNLTGVLP-PKLAELTFLQDIDLTLNYLSGTIPSQWASLPLLNISLIANRLKG 78
L + V L+ ++ L ++ +N+
Sbjct: 285 SSFSLVSVTIERVKDFSYNFGWQHLELVNCKFGQFPTLKLKS-----LKRLTFTSNKGGN 339
Query: 79 PIPKYLANISTLVNLTVQYNQ--FSGELPEELGSLLNLEKLHLSSNNFTGELPKTFAKLT 136
++ +L L + N F G + +L+ L LS N + F L
Sbjct: 340 AFS--EVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLE 396
Query: 137 NMKDFRISDNQFTGQIP--SFIQNWTKLEKLFIQPSGLAGPIPSGIFS-LENLTDLRISD 193
++ + Q+ S + L L I + +GIF+ L +L L+++
Sbjct: 397 QLEHLDFQHSNLK-QMSEFSVFLSLRNLIYLDISHTHTRV-AFNGIFNGLSSLEVLKMAG 454
Query: 194 ----LNGPEATFPQLGNMKMTKLILRNCNITGELPRYLGKMTKLKVLDLSFNRLRGQIPS 249
N F +L N+ T L L C + P ++ L+VL+++ N+L+
Sbjct: 455 NSFQENFLPDIFTELRNL--TFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDG 512
Query: 250 NFDDLYDVDYIYFAGNLLTGAIP------PWMLERGDKIDLSYNNFTDGSAESSCQKRSV 303
FD L + I+ N + P W+ + K GSA+ S + V
Sbjct: 513 IFDRLTSLQKIWLHTNPWDCSCPRIDYLSRWLNKNSQKE--------QGSAKCSGSGKPV 564
Query: 304 TGIVSCLRSVQCP 316
RS+ CP
Sbjct: 565 -------RSIICP 570
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 92.1 bits (229), Expect = 2e-19
Identities = 59/297 (19%), Positives = 100/297 (33%), Gaps = 43/297 (14%)
Query: 28 NLTGVLPPKLAELTFLQDIDLTLNYLSGTIPSQWASLP-----LLNISLIANRLKG-PIP 81
NL L L L + L YL L + + SL++ ++
Sbjct: 242 NLEKFDKSALEGLCNLTIEEFRLAYLD-YYLDDIIDLFNCLTNVSSFSLVSVTIERVKDF 300
Query: 82 KYLANISTLVNLTVQYNQFSGELPEEL----------------GSLLNLEKLHLSSNNFT 125
Y L + ++ QF + L L +LE L LS N +
Sbjct: 301 SYNFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLS 360
Query: 126 --GELPKTFAKLTNMKDFRISDNQFTGQIPSFIQNWTKLEKLFIQPSGLAGPIPSGIFSL 183
G ++ T++K +S N + S +LE L Q S L +F
Sbjct: 361 FKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFL- 418
Query: 184 ENLTDLRISDLNG------PEATFPQLGNMKMTKLILRNCNITGELPRY-LGKMTKLKVL 236
+L +L D++ F L + + L + + ++ L L
Sbjct: 419 -SLRNLIYLDISHTHTRVAFNGIFNGLSS--LEVLKMAGNSFQENFLPDIFTELRNLTFL 475
Query: 237 DLSFNRLRGQIPSN-FDDLYDVDYIYFAGNLLTGAIPPWMLERGDK---IDLSYNNF 289
DLS +L Q+ F+ L + + A N L ++P + +R I L N +
Sbjct: 476 DLSQCQLE-QLSPTAFNSLSSLQVLNMASNQLK-SVPDGIFDRLTSLQKIWLHTNPW 530
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 83.6 bits (207), Expect = 7e-17
Identities = 39/217 (17%), Positives = 72/217 (33%), Gaps = 18/217 (8%)
Query: 88 STLVNLTVQYNQFSGELPEELGSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRISDNQ 147
+ NL + +N S L+ L LS + L+++ ++ N
Sbjct: 28 FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNP 87
Query: 148 FTGQIPSFIQNWTKLEKLFIQPSGLAGPIPSGIFS-LENLTDL-----RISDLNGPEATF 201
+ L+KL + LA + + L+ L +L I PE F
Sbjct: 88 IQSLALGAFSGLSSLQKLVAVETNLAS-LENFPIGHLKTLKELNVAHNLIQSFKLPEY-F 145
Query: 202 PQLGNMKMTKLILRNCNITGELPRYLGKMTKLKV----LDLSFNRLRGQIPSNFDDLYDV 257
L N++ L L + I L + ++ + LDLS N + P F ++ +
Sbjct: 146 SNLTNLE--HLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIR-L 202
Query: 258 DYIYFAGNLLTGAIPP---WMLERGDKIDLSYNNFTD 291
+ N + + L + L F +
Sbjct: 203 HKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRN 239
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 78.6 bits (194), Expect = 2e-15
Identities = 31/185 (16%), Positives = 57/185 (30%), Gaps = 9/185 (4%)
Query: 74 NRLKGPIPKYLANISTLVNLTVQYNQFSGELPEELGSLLNLEKLHLSSNNFTGELPKTFA 133
N L+ + L L + + SL +L L L+ N F+
Sbjct: 38 NPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFS 97
Query: 134 KLTNMKDFRISDNQFTGQIPSFIQNWTKLEKLFIQPSGLA-GPIPSGIFSLENLTDLRIS 192
L++++ + I + L++L + + + +P +L NL L +S
Sbjct: 98 GLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLS 157
Query: 193 DLNG----PEATFPQLGNMKM--TKLILRNCNITGELPRYLGKMTKLKVLDLSFNRLRGQ 246
N L M + L L + + K +L L L N
Sbjct: 158 S-NKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMN-FIQPGAFKEIRLHKLTLRNNFDSLN 215
Query: 247 IPSNF 251
+
Sbjct: 216 VMKTC 220
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 90.4 bits (224), Expect = 1e-19
Identities = 48/188 (25%), Positives = 80/188 (42%), Gaps = 25/188 (13%)
Query: 504 FEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLA 563
++ L +A+G+ +L + K +HRD+ A N+LL + KI DFGLA
Sbjct: 184 DLYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLA 240
Query: 564 KLDEEENTHISTRVAGT-IGYMAPEYAMRGHLTEKADVYSFGIVALEIVS-GRS----NV 617
+ ++ ++ A + +MAPE T ++DV+SFG++ EI S G S
Sbjct: 241 RDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK 300
Query: 618 TKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMS 677
E+ L ++G M D + M L C + P+ RP+ S
Sbjct: 301 IDEEFCRRL-------KEGTRMRAPDYTTPEMYQ---TM------LDCWHGEPSQRPTFS 344
Query: 678 SVLRMLEC 685
++ L
Sbjct: 345 ELVEHLGN 352
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 63.4 bits (154), Expect = 8e-11
Identities = 34/158 (21%), Positives = 59/158 (37%), Gaps = 17/158 (10%)
Query: 416 NNFATDNNIGEGGFGPVYKGLL------ADGTAIAVKQL-SSKSKQGNREFINEIG-MIS 467
+ +G G FG V + A +AVK L + +R ++E+ +I
Sbjct: 22 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 81
Query: 468 ALQHPNLVKLYGCCI-EGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGL 526
H N+V L G C G L++I E+ + +L+ L R +G
Sbjct: 82 IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSK--------RNEFVPYKTKGA 133
Query: 527 AYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAK 564
+ G+ + + D+K + +S S F K
Sbjct: 134 RFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEK 171
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 91.3 bits (227), Expect = 1e-19
Identities = 55/212 (25%), Positives = 89/212 (41%), Gaps = 16/212 (7%)
Query: 88 STLVNLTVQYNQFSGELPEELGSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRISDNQ 147
+ L + NQ L +LE L LS N+ F L N+ + DN+
Sbjct: 64 TNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDNR 123
Query: 148 FTGQIPSFIQNWTKLEKLFIQPSGLAGPIPSGIFS-LENLTDLRISDLNG----PEATFP 202
T +KL++L+++ + + IPS F+ + +L L + +L E F
Sbjct: 124 LTTIPNGAFVYLSKLKELWLRNNPIES-IPSYAFNRIPSLRRLDLGELKRLSYISEGAFE 182
Query: 203 QLGNMKMTKLILRNCNITGELPRYLGKMTKLKVLDLSFNRLRGQIPSN-FDDLYDVDYIY 261
L N + L L CN+ E+P L + KL LDLS N L I F L + ++
Sbjct: 183 GLSN--LRYLNLAMCNLR-EIP-NLTPLIKLDELDLSGNHLS-AIRPGSFQGLMHLQKLW 237
Query: 262 FAGNLLTGAIPP---WMLERGDKIDLSYNNFT 290
+ + I L+ +I+L++NN T
Sbjct: 238 MIQSQIQ-VIERNAFDNLQSLVEINLAHNNLT 268
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 78.3 bits (193), Expect = 2e-15
Identities = 47/252 (18%), Positives = 91/252 (36%), Gaps = 40/252 (15%)
Query: 28 NLTGVLPPKLAELTFLQDIDLTLNYLSGTIPSQW-ASLPLLNI-SLIANRLKGPIPKYLA 85
+ + L L+ + L+ N++ TI L LN L NRL
Sbjct: 75 QIQIIKVNSFKHLRHLEILQLSRNHIR-TIEIGAFNGLANLNTLELFDNRLTTIPNGAFV 133
Query: 86 NISTLVNLTVQYNQFSGELPEEL-GSLLNLEKLHLSSNNFTGELPK-TFAKLTNMKDFRI 143
+S L L ++ N +P + +L +L L + + F L+N++ +
Sbjct: 134 YLSKLKELWLRNNPIE-SIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNL 192
Query: 144 SDNQFTGQIPSFIQNWTKLEKLFIQPSGLAGPIPSGIFSLENLTDLRISDLNGPEATFPQ 203
+ +IP+ KL++L +L+ +S + +F
Sbjct: 193 AMCNLR-EIPNL-TPLIKLDEL-------------------DLSGNHLSAI--RPGSFQG 229
Query: 204 LGNMKMTKLILRNCNITGELPRYLGKMTKLKVLDLSFNRLRGQIPSN-FDDLYDVDYIYF 262
L +++ KL + I + L ++L+ N L +P + F L+ ++ I+
Sbjct: 230 LMHLQ--KLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLT-LLPHDLFTPLHHLERIHL 286
Query: 263 AGNLLTGAIPPW 274
N PW
Sbjct: 287 HHN-------PW 291
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 49.0 bits (117), Expect = 4e-06
Identities = 26/125 (20%), Positives = 47/125 (37%), Gaps = 4/125 (3%)
Query: 24 LKEQNLTGVLPPK-LAELTFLQDIDLTLNYLSGTIPSQWASLP-LLNISLIANRLKGPIP 81
L E + L+ L+ ++L + L IP+ L L + L N L P
Sbjct: 167 LGELKRLSYISEGAFEGLSNLRYLNLAMCNLR-EIPN-LTPLIKLDELDLSGNHLSAIRP 224
Query: 82 KYLANISTLVNLTVQYNQFSGELPEELGSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDF 141
+ L L + +Q +L +L +++L+ NN T F L +++
Sbjct: 225 GSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTLLPHDLFTPLHHLERI 284
Query: 142 RISDN 146
+ N
Sbjct: 285 HLHHN 289
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 92.3 bits (229), Expect = 1e-19
Identities = 54/268 (20%), Positives = 94/268 (35%), Gaps = 43/268 (16%)
Query: 24 LKEQNLTGVLPPKLAELTFLQDIDLTLNYLSGTIPSQWASLPLLNISLIANRLKGPIPKY 83
L NL+ LP L + +++T N L ++P ASL L+ NRL +P+
Sbjct: 66 LNRLNLS-SLPDNL--PPQITVLEITQNALI-SLPELPASLEYLDAC--DNRLST-LPEL 118
Query: 84 LANISTLVNLTVQYNQFSGELPEELGSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRI 143
A+ L +L V NQ + LPE LE ++ +N T LP T+++ +
Sbjct: 119 PAS---LKHLDVDNNQLT-MLPELPA---LLEYINADNNQLT-MLP---ELPTSLEVLSV 167
Query: 144 SDNQFTGQIPSFIQNWTKLEKLFIQPSGLAGPIPSGIFSLENLTDLRISDLNGPEATFPQ 203
+NQ T +P ++ LE L + + L +P+ + + I
Sbjct: 168 RNNQLT-FLPELPES---LEALDVSTNLLES-LPAVPVRNHHSEETEIF----------- 211
Query: 204 LGNMKMTKLILRNCNITGELPRYLGKMTKLKVLDLSFNRLRGQIPSNFDDLYDVDYIYFA 263
R IT +P + + + L N L +I + +
Sbjct: 212 --------FRCRENRIT-HIPENILSLDPTCTIILEDNPLSSRIRESLSQQTAQPDYHGP 262
Query: 264 GNLLTGAIPPWMLERGDKIDLSYNNFTD 291
+ + D F +
Sbjct: 263 RIYFSMSDGQQNTLHRPLADAVTAWFPE 290
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 60.4 bits (146), Expect = 1e-09
Identities = 45/212 (21%), Positives = 78/212 (36%), Gaps = 34/212 (16%)
Query: 86 NISTLVNLTVQYNQFSGELPEELGSLLNLEKLHLSS---NNFTGELPKTFAKLTNMKDFR 142
N +L + YN SG + + EK L N L + + + +
Sbjct: 9 NNFSLSQNS-FYNTISGTYADYFSAWDKWEKQALPGENRNEAVSLLKE--CLINQFSELQ 65
Query: 143 ISDNQFTGQIPSFIQNWTKLEKLFIQPSGLAGPIPSGIFSLE--NLTDLRISDLNGPEAT 200
++ + +P + ++ L I + L +P SLE + D R+S L PE
Sbjct: 66 LNRLNLS-SLPDNL--PPQITVLEITQNAL-ISLPELPASLEYLDACDNRLSTL--PE-- 117
Query: 201 FPQLGNMKMTKLILRNCNITGELPRYLGKMTKLKVLDLSFNRLRGQIPSNFDDLYDVDYI 260
++K L + N +T LP L+ ++ N+L +P L + +
Sbjct: 118 --LPASLK--HLDVDNNQLT-MLPELPA---LLEYINADNNQLT-MLPELPTSL---EVL 165
Query: 261 YFAGNLLTGAIPPWM--LERGDKIDLSYNNFT 290
N LT +P LE +D+S N
Sbjct: 166 SVRNNQLT-FLPELPESLE---ALDVSTNLLE 193
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 60.0 bits (145), Expect = 2e-09
Identities = 34/225 (15%), Positives = 69/225 (30%), Gaps = 18/225 (8%)
Query: 33 LPPKLAELTFLQDIDLTLNYLSGTIPSQWASLPLLNISLIANRLKGPIPKYLANI----S 88
LP L L + N L+ +P SL L++S N L+ +P
Sbjct: 155 LPELPTSLEVL---SVRNNQLT-FLPELPESLEALDVS--TNLLES-LPAVPVRNHHSEE 207
Query: 89 TLVNLTVQYNQFSGELPEELGSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRISDNQF 148
T + + N+ + +PE + SL + L N + + ++ ++ T D+ F
Sbjct: 208 TEIFFRCRENRIT-HIPENILSLDPTCTIILEDNPLSSRIRESLSQQTAQPDYHGPRIYF 266
Query: 149 TGQIPSFIQNWTKLEKLFIQPSGLAGPIPSGIFSLENLTDLRISDLNGPEATFPQLGNMK 208
+ QN + S + + + L +
Sbjct: 267 SMSDGQ--QNTLHRPLADAVTAWFPENKQSDVSQIWH----AFEHEEHANTFSAFLDRLS 320
Query: 209 MTKLILRNCNITGELPRYLGKMTKLKVLDLSFNRLRGQIPSNFDD 253
T ++ +L K++ L + + +D
Sbjct: 321 DTVSARNTSGFREQVAAWLEKLSASAELRQQSFAVAADATESCED 365
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 91.3 bits (227), Expect = 1e-19
Identities = 51/213 (23%), Positives = 91/213 (42%), Gaps = 18/213 (8%)
Query: 88 STLVNLTVQYNQFSGELPEELGSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRISDNQ 147
S L + N + L +LE L L N+ F L ++ + DN
Sbjct: 75 SNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDNW 134
Query: 148 FTGQIPSFI-QNWTKLEKLFIQPSGLAGPIPSGIFS-LENLTDLRISDLNG----PEATF 201
T IPS + +KL +L+++ + + IPS F+ + +L L + +L E F
Sbjct: 135 LT-VIPSGAFEYLSKLRELWLRNNPIES-IPSYAFNRVPSLMRLDLGELKKLEYISEGAF 192
Query: 202 PQLGNMKMTKLILRNCNITGELPRYLGKMTKLKVLDLSFNRLRGQIPSN-FDDLYDVDYI 260
L N+K L L CNI ++P L + L+ L++S N +I F L + +
Sbjct: 193 EGLFNLK--YLNLGMCNIK-DMP-NLTPLVGLEELEMSGNHFP-EIRPGSFHGLSSLKKL 247
Query: 261 YFAGNLLTGAIPPWM---LERGDKIDLSYNNFT 290
+ + ++ I L +++L++NN +
Sbjct: 248 WVMNSQVS-LIERNAFDGLASLVELNLAHNNLS 279
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 78.2 bits (193), Expect = 2e-15
Identities = 45/252 (17%), Positives = 83/252 (32%), Gaps = 40/252 (15%)
Query: 28 NLTGVLPPKLAELTFLQDIDLTLNYLSGTIPSQ-WASLPLLNI-SLIANRLKGPIPKYLA 85
N+ + L L+ + L N + I + L LN L N L
Sbjct: 86 NIQMIQADTFRHLHHLEVLQLGRNSIR-QIEVGAFNGLASLNTLELFDNWLTVIPSGAFE 144
Query: 86 NISTLVNLTVQYNQFSGELPEE-LGSLLNLEKLHLSSNNFTGELPK-TFAKLTNMKDFRI 143
+S L L ++ N +P + +L +L L + + F L N+K +
Sbjct: 145 YLSKLRELWLRNNPIE-SIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNL 203
Query: 144 SDNQFTGQIPSFIQNWTKLEKLFIQPSGLAGPIPSGIFSLENLTDLRISDLNGPEATFPQ 203
+P+ LE+L ++ ++ +F
Sbjct: 204 GMCNIK-DMPNL-TPLVGLEEL-------------------EMSGNHFPEI--RPGSFHG 240
Query: 204 LGNMKMTKLILRNCNITGELPRYLGKMTKLKVLDLSFNRLRGQIPSN-FDDLYDVDYIYF 262
L ++K KL + N ++ + L L+L+ N L +P + F L + ++
Sbjct: 241 LSSLK--KLWVMNSQVSLIERNAFDGLASLVELNLAHNNLS-SLPHDLFTPLRYLVELHL 297
Query: 263 AGNLLTGAIPPW 274
N PW
Sbjct: 298 HHN-------PW 302
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 49.7 bits (119), Expect = 3e-06
Identities = 25/127 (19%), Positives = 47/127 (37%), Gaps = 4/127 (3%)
Query: 24 LKEQNLTGVLPPK-LAELTFLQDIDLTLNYLSGTIPSQWASLP-LLNISLIANRLKGPIP 81
L E + L L+ ++L + + +P+ L L + + N P
Sbjct: 178 LGELKKLEYISEGAFEGLFNLKYLNLGMCNIK-DMPN-LTPLVGLEELEMSGNHFPEIRP 235
Query: 82 KYLANISTLVNLTVQYNQFSGELPEELGSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDF 141
+S+L L V +Q S L +L +L+L+ NN + F L + +
Sbjct: 236 GSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLSSLPHDLFTPLRYLVEL 295
Query: 142 RISDNQF 148
+ N +
Sbjct: 296 HLHHNPW 302
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 88.8 bits (221), Expect = 2e-19
Identities = 55/208 (26%), Positives = 92/208 (44%), Gaps = 33/208 (15%)
Query: 424 IGEGGFGPVYKGLLA----DGTAIAVKQLSSKS--KQGNREFIN-EIGMISALQHPNLVK 476
+GEG F V LA A+K L + K+ ++ E ++S L HP VK
Sbjct: 38 LGEGSFSTVV---LARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVK 94
Query: 477 LYGCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIAR--------GLAY 528
LY + +L Y +N L ++ K R L Y
Sbjct: 95 LYFTFQDDEKLYFGLSYAKNGEL----LKYIRK-----IGSFDETCTRFYTAEIVSALEY 145
Query: 529 LHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTR-VAGTIGYMAPE 587
LHG ++HRD+K N+LL++D++ +I+DFG AK+ E+ GT Y++PE
Sbjct: 146 LHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPE 202
Query: 588 YAM-RGHLTEKADVYSFGIVALEIVSGR 614
+ + +D+++ G + ++V+G
Sbjct: 203 LLTEKSA-CKSSDLWALGCIIYQLVAGL 229
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 88.4 bits (220), Expect = 2e-19
Identities = 55/216 (25%), Positives = 98/216 (45%), Gaps = 21/216 (9%)
Query: 414 ATNNFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLS-SKSKQGNREF----INEIG--- 464
AT+ + IG G +G VYK G +A+K + G + E+
Sbjct: 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLR 66
Query: 465 MISALQHPNLVKLYGCCI-----EGNQLLLIYEYLENNSLARALFEHRLK-LDWPTRRRI 518
+ A +HPN+V+L C ++ L++E+++ + L L + L T + +
Sbjct: 67 RLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQD-LRTYLDKAPPPGLPAETIKDL 125
Query: 519 CLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVA 578
RGL +LH +VHRD+K N+L+ K++DFGLA++ + ++ V
Sbjct: 126 MRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMA-LTPVVV 181
Query: 579 GTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGR 614
T+ Y APE ++ D++S G + E+ +
Sbjct: 182 -TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 216
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 91.8 bits (228), Expect = 3e-19
Identities = 45/284 (15%), Positives = 93/284 (32%), Gaps = 40/284 (14%)
Query: 39 ELTFLQDIDLTLNYLSGTIPSQWASLPLL-NISLIANRLKGPIPKYLANISTLVNLTVQY 97
+ ++ +DL+ ++ + +L L ++L N++ + + L L + Y
Sbjct: 264 ARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSY 323
Query: 98 NQFSGELPEELGSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRISDNQFTGQIPSFIQ 157
N L + + L N+ +TF L ++ + DN T I
Sbjct: 324 NLLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALT-----TIH 378
Query: 158 NWTKLEKLFIQPSGLAGPIPSGIFSLE-------------------NLTDLRISDLNG-- 196
+ +F+ + L +P + + L+I LN
Sbjct: 379 FIPSIPDIFLSGNKLVT-LPKINLTANLIHLSENRLENLDILYFLLRVPHLQILILNQNR 437
Query: 197 -----PEATFPQLGNMKMTKLILRNCNITGE-----LPRYLGKMTKLKVLDLSFNRLRGQ 246
+ T + +++ +L L + ++ L+VL L+ N L
Sbjct: 438 FSSCSGDQTPSENPSLE--QLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSL 495
Query: 247 IPSNFDDLYDVDYIYFAGNLLTGAIPPWMLERGDKIDLSYNNFT 290
P F L + + N LT + + +D+S N
Sbjct: 496 PPGVFSHLTALRGLSLNSNRLTVLSHNDLPANLEILDISRNQLL 539
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 82.9 bits (205), Expect = 2e-16
Identities = 41/276 (14%), Positives = 91/276 (32%), Gaps = 20/276 (7%)
Query: 27 QNLTGVLPPKLAELTFLQDIDLTLNYLSGTIPSQWASLPLLNISLI---ANRLKGPIPKY 83
++ L + + + + +A L ++ + + +
Sbjct: 226 NAISKSQAFSLILAHHIMGAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVFSLNSRV 285
Query: 84 LANISTLVNLTVQYNQFSGELPEELGSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRI 143
+ L L + YN+ + E L NL+ L+LS N F L + +
Sbjct: 286 FETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDL 345
Query: 144 SDNQFTGQIPSFIQNWTKLEKLFIQPSGLAGPIPSGIFSLENLTDLRISDLNGPEATFPQ 203
N + KL+ L ++ + L + I + ++ D+ L+G +
Sbjct: 346 QKNHIAIIQDQTFKFLEKLQTLDLRDNAL-----TTIHFIPSIPDI---FLSGNKLVTLP 397
Query: 204 LGNMKMTKLILRNCNITGELPRY-LGKMTKLKVLDLSFNRLRG-QIPSNFDDLYDVDYIY 261
N+ + L + Y L ++ L++L L+ NR + ++ ++
Sbjct: 398 KINLTANLIHLSENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLF 457
Query: 262 FAGNLLTGAIPPWM-------LERGDKIDLSYNNFT 290
N+L A + L + L++N
Sbjct: 458 LGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLN 493
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 81.8 bits (202), Expect = 4e-16
Identities = 58/295 (19%), Positives = 97/295 (32%), Gaps = 32/295 (10%)
Query: 28 NLTGVLPPKLAELTFLQDIDLTLNYLSGTIPSQW-ASLPLLNI-SLIANRLKGPIPKYLA 85
+ V L LQ ++L Y TI + +LP L I L ++++ P
Sbjct: 35 YIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPDAFQ 94
Query: 86 NISTLVNLTVQYNQFSGEL--PEELGSLLNLEKLHLSSNNFTG-ELPKTFAKLTNMKDFR 142
+ L L + + S + +L L +L LS N L +F KL ++K
Sbjct: 95 GLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSID 154
Query: 143 ISDNQFTGQIPSFIQNWT--KLEKLFIQPSGLAGPIPSGIFSLENL---TDLRISDLNGP 197
S NQ ++ L + + L + N L I D++G
Sbjct: 155 FSSNQIFLVCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGN 214
Query: 198 EATFPQLGN----------------MKMTKLILRNCNITGELPRYLGKMTKL--KVLDLS 239
T GN + NI + + + LDLS
Sbjct: 215 GWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNIKDPDQNTFAGLARSSVRHLDLS 274
Query: 240 FNRLRGQIPSNFDDLYDVDYIYFAGNLLTGAIPP---WMLERGDKIDLSYNNFTD 291
+ F+ L D+ + A N + I + L+ ++LSYN +
Sbjct: 275 HGFVFSLNSRVFETLKDLKVLNLAYNKINK-IADEAFYGLDNLQVLNLSYNLLGE 328
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 79.5 bits (196), Expect = 2e-15
Identities = 42/216 (19%), Positives = 72/216 (33%), Gaps = 21/216 (9%)
Query: 111 LLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRISDNQFTGQI-PSFIQNWTKLEKLFIQP 169
L E+L LS N +F L ++ + I +N L L +
Sbjct: 23 LNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGS 82
Query: 170 SGLAGPIPSGIFS-LENLTDL-----RISDLNGPEATFPQLGNMKMTKLILRNCNITG-E 222
S + + F L +L +L +SD + F L + +L L I
Sbjct: 83 SKIYF-LHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALT--RLDLSKNQIRSLY 139
Query: 223 LPRYLGKMTKLKVLDLSFNRLRGQIPSNFDDLY--DVDYIYFAGNLLTGAIPPWMLERGD 280
L GK+ LK +D S N++ + L + + A N L + + +
Sbjct: 140 LHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMN 199
Query: 281 --------KIDLSYNNFTDGSAESSCQKRSVTGIVS 308
+D+S N +T + S + S
Sbjct: 200 PFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFS 235
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 78.7 bits (194), Expect = 3e-15
Identities = 45/300 (15%), Positives = 88/300 (29%), Gaps = 38/300 (12%)
Query: 24 LKEQNLTGVLPPKLAELTFLQDIDLTLNYLSGTIPSQWASLP-LLNISLIANRLKGPIPK 82
+ NLT V P L L L+ NY+ S + L L + L + I K
Sbjct: 11 YRFCNLTQV-PQVLNTTERL---LLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDK 66
Query: 83 Y-LANISTLVNLTVQYNQFSGELPEELGSLLNLEKLHLSSNNFTGEL--PKTFAKLTNMK 139
N+ L L + ++ P+ L +L +L L + + F L +
Sbjct: 67 EAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALT 126
Query: 140 DFRISDNQFTG-QIPSFIQNWTKLEKLFIQPSGLAGPIPSGIFSLENLTDLRISDLNG-- 196
+S NQ + L+ + + + + L L
Sbjct: 127 RLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFL-VCEHELEPLQGKTLSFFSLAANS 185
Query: 197 --------PEATFPQLGNMKMTKLILRNCNITGELPR------------YLGKMTKLKVL 236
NM + L + T ++ L +
Sbjct: 186 LYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMGA 245
Query: 237 DLSFNRLRGQIPSNFDDL--YDVDYIYFAGNLLTGAIPPWM---LERGDKIDLSYNNFTD 291
F+ ++ + F L V ++ + + ++ + L+ ++L+YN
Sbjct: 246 GFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVF-SLNSRVFETLKDLKVLNLAYNKINK 304
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 77.2 bits (190), Expect = 1e-14
Identities = 44/288 (15%), Positives = 93/288 (32%), Gaps = 32/288 (11%)
Query: 24 LKEQNLTGVLPPKLAE-LTFLQDIDLTLNYLSGTIPSQWASLPLLNISLIANRLKGPIPK 82
L +L + + + +++ L + +SG + +N +
Sbjct: 181 LAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGN------GWTVDITGNFSNAISKSQAF 234
Query: 83 YLANISTLVNLTVQYNQFSGELPEELGSL--LNLEKLHLSSNNFTGELPKTFAKLTNMKD 140
L ++ ++ L ++ L LS + F L ++K
Sbjct: 235 SLILAHHIMGAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFETLKDLKV 294
Query: 141 FRISDNQFTGQIPSFIQNWTKLEKLFIQPSGLAGPIPSGIFSLENLTDLRISDLNG---- 196
++ N+ L+ L + + L + S F L + DL
Sbjct: 295 LNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGE-LYSSNFY--GLPKVAYIDLQKNHIA 351
Query: 197 --PEATFPQLGNMKMTKLILRNCNITGELPRYLGKMTKLKVLDLSFNRLRGQIPSNFDDL 254
+ TF L ++ L LR+ +T + + + + LS N+L +P
Sbjct: 352 IIQDQTFKFLEKLQ--TLDLRDNALT-----TIHFIPSIPDIFLSGNKLV-TLPKINLTA 403
Query: 255 YDVDYIYFAGNLLTGAIPPWMLERGDK---IDLSYNNFTDGSAESSCQ 299
+ I+ + N L + L R + L+ N F+ S + +
Sbjct: 404 ---NLIHLSENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPS 448
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 87.8 bits (218), Expect = 4e-19
Identities = 47/214 (21%), Positives = 78/214 (36%), Gaps = 16/214 (7%)
Query: 88 STLVNLTVQYNQFSGELPEELGSLLNLEKLHLSSNNFT--GELPKTFAKLTNMKDFRISD 145
S+ L ++ N+ L L KL LSSN + G ++ T++K +S
Sbjct: 28 SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLSF 87
Query: 146 NQFTGQIPSFIQNWTKLEKLFIQPSGLAGPIPSGIFS-LENLTDLRISDLN---GPEATF 201
N + S +LE L Q S L +F L NL L IS + F
Sbjct: 88 NGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIF 146
Query: 202 PQLGNMKMTKLILRNCNITGELPRY-LGKMTKLKVLDLSFNRLRGQIPSN-FDDLYDVDY 259
L +++ L + + ++ L LDLS +L Q+ F+ L +
Sbjct: 147 NGLSSLE--VLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLE-QLSPTAFNSLSSLQV 203
Query: 260 IYFAGNLLTGAIPP---WMLERGDKIDLSYNNFT 290
+ + N ++ L +D S N+
Sbjct: 204 LNMSHNNFF-SLDTFPYKCLNSLQVLDYSLNHIM 236
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 75.0 bits (185), Expect = 8e-15
Identities = 42/250 (16%), Positives = 82/250 (32%), Gaps = 34/250 (13%)
Query: 24 LKEQNLTGVLPPKLAELTFLQDIDLTLNYLSGTIPSQWASLPLLNI---SLIANRLKGPI 80
L+ L + +LT L + L+ N LS + ++ L N + +
Sbjct: 35 LESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLSFNGVIT-M 93
Query: 81 PKYLANISTLVNLTVQYNQFSGELPEE--LGSLLNLEKLHLSSNNFTGELPKTFAKLTNM 138
+ L +L Q++ ++ E SL NL L +S + F L+++
Sbjct: 94 SSNFLGLEQLEHLDFQHSNLK-QMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSL 152
Query: 139 KDFRISDNQFTGQIPSFI-QNWTKLEKLFIQPSGLAGPIPSGIFSLENLTDLRISDLNGP 197
+ +++ N F I L L + L + F+ +L+ L+
Sbjct: 153 EVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQ-LSPTAFN--SLSSLQ------- 202
Query: 198 EATFPQLGNMKMTKLILRNCNITGELPRY-LGKMTKLKVLDLSFNRLRGQIPSNFDDLYD 256
L + + N L + + L+VLD S N +
Sbjct: 203 -------------VLNMSHNNFF-SLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPS 248
Query: 257 -VDYIYFAGN 265
+ ++ N
Sbjct: 249 SLAFLNLTQN 258
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 1e-18
Identities = 52/211 (24%), Positives = 90/211 (42%), Gaps = 37/211 (17%)
Query: 424 IGEGGFGPVYKGLLADGTAI-AVKQLSSK---SKQGNREFINEIGMISALQHPNLVKLYG 479
IG+G FG V D + A+K ++ + + R E+ ++ L+HP LV L+
Sbjct: 23 IGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWY 82
Query: 480 CCIEGNQLLLIYEYL---ENNSLARALFEHRLKLDWPTRRRICLGIAR--------GLAY 528
+ + ++ + L + L H + + L Y
Sbjct: 83 SFQDEEDMFMVVDLLLGGD-------LRYHLQQ-----NVHFKEETVKLFICELVMALDY 130
Query: 529 LHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPE- 587
L +++HRD+K N+LLD+ + I+DF +A + E + +AGT YMAPE
Sbjct: 131 LQ---NQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITT--MAGTKPYMAPEM 185
Query: 588 ---YAMRGHLTEKADVYSFGIVALEIVSGRS 615
G+ + D +S G+ A E++ GR
Sbjct: 186 FSSRKGAGY-SFAVDWWSLGVTAYELLRGRR 215
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 2e-18
Identities = 59/295 (20%), Positives = 102/295 (34%), Gaps = 71/295 (24%)
Query: 35 PKLAELTFLQDIDLTLNYLSGTIPSQWASLPLLNIS--------------------LIAN 74
P+L +FL+ ID+ N L +P SL + N
Sbjct: 147 PELQNSSFLKIIDVDNNSLK-KLPDLPPSLEFIAAGNNQLEELPELQNLPFLTAIYADNN 205
Query: 75 RLKGPIPKYLANISTLVNLTVQYNQFSGELPEELGSLLNLEKLHLSSNNFTGELPKTFAK 134
LK +P + L ++ N ELPE L +L L ++ +N LP
Sbjct: 206 SLKK-LPDLPLS---LESIVAGNNILE-ELPE-LQNLPFLTTIYADNNLLK-TLPDL--- 255
Query: 135 LTNMKDFRISDNQFTGQIPSFIQNWTKLEKLFIQPSGLAGPIPSGIFSLENLTDLRISDL 194
+++ + DN T +P Q+ T L+ SGL+ NL L S
Sbjct: 256 PPSLEALNVRDNYLT-DLPELPQSLTFLDVSENIFSGLSE-------LPPNLYYLNASS- 306
Query: 195 NGPEATFPQLGNMKMTKLILRNCNITGELPRYLGKMTK-----------------LKVLD 237
N + + + +L + N + ELP ++ + LK L
Sbjct: 307 NEIRSLCDLPPS--LEELNVSNNKLI-ELPALPPRLERLIASFNHLAEVPELPQNLKQLH 363
Query: 238 LSFNRLRGQIPSNFDDLYDVDYIYFAGNLLTGAIPPWM--LERGDKIDLSYNNFT 290
+ +N LR + P + + D+ + L +P L+ ++ + N
Sbjct: 364 VEYNPLR-EFPDIPESVEDLR----MNSHLA-EVPELPQNLK---QLHVETNPLR 409
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 8e-18
Identities = 53/291 (18%), Positives = 100/291 (34%), Gaps = 54/291 (18%)
Query: 33 LPPKLAELTFLQDIDLTLNYLSGTIPSQWASLP-LLNISLIANRLKGPIPKYLAN----- 86
+ P+ TFLQ+ + L+ +P + ++ + + P
Sbjct: 3 INPRNVSNTFLQEPLRHSSNLT-EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMA 61
Query: 87 --------ISTLVNLTVQYNQFSGELPEELGSLLNLEKLHLSSNNFTGELPKTFAKLTNM 138
L + S LPE +LE L S N+ T ELP+ L ++
Sbjct: 62 VSRLRDCLDRQAHELELNNLGLS-SLPELPP---HLESLVASCNSLT-ELPELPQSLKSL 116
Query: 139 KDFRISDNQFTGQIPS---------------FIQNWTKLEKLFIQPSGLAGPIPSGIFSL 183
+ + P +QN + L+ + + + L +P SL
Sbjct: 117 LVDNNNLKALSDLPPLLEYLGVSNNQLEKLPELQNSSFLKIIDVDNNSLKK-LPDLPPSL 175
Query: 184 ENLT--DLRISDLNGPEATFPQLGNMK-MTKLILRNCNITGELPRYLGKMTKLKVLDLSF 240
E + + ++ +L P+L N+ +T + N ++ +LP L+ +
Sbjct: 176 EFIAAGNNQLEEL-------PELQNLPFLTAIYADNNSLK-KLPDLPL---SLESIVAGN 224
Query: 241 NRLRGQIPSNFDDLYDVDYIYFAGNLLTGAIPPWMLERGDKIDLSYNNFTD 291
N L +L + IY NLL +P + +++ N TD
Sbjct: 225 NILE--ELPELQNLPFLTTIYADNNLLK-TLPDL-PPSLEALNVRDNYLTD 271
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 8e-18
Identities = 55/261 (21%), Positives = 101/261 (38%), Gaps = 37/261 (14%)
Query: 33 LPPKLAELTFLQDIDLTLNYLSGTIPSQWASLPLLNISLIANRLKGPIPKYLANISTLVN 92
LP L L + L LS P L L +S N+L+ +P+ L N S L
Sbjct: 106 LPELPQSLKSLLVDNNNLKALSDLPP----LLEYLGVS--NNQLEK-LPE-LQNSSFLKI 157
Query: 93 LTVQYNQFSGELPEELGSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRISDNQFTGQI 152
+ V N +LP+ +LE + +N ELP L + +N ++
Sbjct: 158 IDVDNNSLK-KLPDLPP---SLEFIAAGNNQLE-ELP-ELQNLPFLTAIYADNNSLK-KL 210
Query: 153 PSFIQNWTKLEKLFIQPSGLAGPIPSGIFSLENLTDLRISDLNGPEATFPQLGNMKMTKL 212
P + LE + + L + +L LT + + N + +++ L
Sbjct: 211 PDLPLS---LESIVAGNNILE--ELPELQNLPFLTTIYADN-NLLKTLPDLPPSLE--AL 262
Query: 213 ILRNCNITGELPRYLGKMTKLKVLDLSFNRLRGQIPSNFDDLYDVDYIYFAGNLLTGAIP 272
+R+ +T +LP +T L V + F+ L P+ + Y+ + N + ++
Sbjct: 263 NVRDNYLT-DLPELPQSLTFLDVSENIFSGLSELPPN-------LYYLNASSNEIR-SLC 313
Query: 273 PWM--LERGDKIDLSYNNFTD 291
LE ++++S N +
Sbjct: 314 DLPPSLE---ELNVSNNKLIE 331
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 74.3 bits (183), Expect = 5e-14
Identities = 60/251 (23%), Positives = 96/251 (38%), Gaps = 43/251 (17%)
Query: 34 PPKLAELTFLQDIDLTLNYLSGTIPSQWASLPLLNISLIANRLKGPIPKYLANISTLVNL 93
P+L L FL I N L T+P SL LN+ N L +P+ +L L
Sbjct: 230 LPELQNLPFLTTIYADNNLLK-TLPDLPPSLEALNVR--DNYLTD-LPE---LPQSLTFL 282
Query: 94 TVQYNQFSG--ELPEELGSL--------------LNLEKLHLSSNNFTGELPKTFAKLTN 137
V N FSG ELP L L +LE+L++S+N ELP +L
Sbjct: 283 DVSENIFSGLSELPPNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPRLER 341
Query: 138 MKDFRISDNQFTGQIPSFIQNWTKLEKLFIQPSGLAGPIPSGIFSLENLTDLRISDLNGP 197
S N ++P QN L++L ++ + L P S+E+L +N
Sbjct: 342 ---LIASFNHLA-EVPELPQN---LKQLHVEYNPLRE-FPDIPESVEDL------RMNSH 387
Query: 198 EATFPQLGNMKMTKLILRNCNITGELPRYLGKMTKLKVLDLSFNRLRGQIPSNFDDLYDV 257
A P+L + +L + + E P ++ L ++ R+ + +
Sbjct: 388 LAEVPEL-PQNLKQLHVETNPLR-EFPDIPES---VEDLRMNSERVVDPYEFAHETTDKL 442
Query: 258 DYIYFAGNLLT 268
+ F +
Sbjct: 443 EDDVFEHHHHH 453
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 45.4 bits (108), Expect = 6e-05
Identities = 21/117 (17%), Positives = 38/117 (32%), Gaps = 15/117 (12%)
Query: 33 LPPKLAELTFLQDIDLTLNYLSGTIPSQWASLPLLNISLIANRLKGPIPKYLANISTLVN 92
+P L L + N L P S+ L ++ + L +P+ N L
Sbjct: 352 VPELPQNLKQL---HVEYNPLR-EFPDIPESVEDLRMN---SHLA-EVPELPQN---LKQ 400
Query: 93 LTVQYNQFSGELPEELGSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRISDNQFT 149
L V+ N E P+ ++E L ++S ++D +
Sbjct: 401 LHVETNPLR-EFPDIPE---SVEDLRMNSERVVDPYEFAHETTDKLEDDVFEHHHHH 453
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 85.7 bits (213), Expect = 3e-18
Identities = 55/213 (25%), Positives = 104/213 (48%), Gaps = 21/213 (9%)
Query: 416 NNFATDNNIGEGGFGPVYKG--LLADGTAIAVKQLS-SKSKQGN-----REFINEIGMIS 467
+ IGEG +G V+K L G +A+K++ ++G RE + + +
Sbjct: 11 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIRE-VAVLRHLE 69
Query: 468 ALQHPNLVKLYGCCI-----EGNQLLLIYEYLENNSLARALFEHR-LKLDWPTRRRICLG 521
+HPN+V+L+ C +L L++E+++ + L L + + T + +
Sbjct: 70 TFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQD-LTTYLDKVPEPGVPTETIKDMMFQ 128
Query: 522 IARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTI 581
+ RGL +LH +VVHRD+K N+L+ K++DFGLA++ + +++ V T+
Sbjct: 129 LLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMA-LTSVVV-TL 183
Query: 582 GYMAPEYAMRGHLTEKADVYSFGIVALEIVSGR 614
Y APE ++ D++S G + E+ +
Sbjct: 184 WYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 216
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 86.7 bits (215), Expect = 3e-18
Identities = 48/205 (23%), Positives = 83/205 (40%), Gaps = 20/205 (9%)
Query: 424 IGEGGFGPVY----KGLLADGTAIAVKQLSSKS--KQGNRE-FINEIGMISALQHPNLVK 476
IG G FG V K A+K L+ K+ F E ++ +
Sbjct: 82 IGRGAFGEVAVVKLKN---ADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITT 138
Query: 477 LYGCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIK 536
L+ + N L L+ +Y L L + +L R + + +H ++
Sbjct: 139 LHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVH---QLH 195
Query: 537 VVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPE------YAM 590
VHRDIK N+L+D + + +++DFG E+ T S+ GT Y++PE
Sbjct: 196 YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGK 255
Query: 591 RGHLTEKADVYSFGIVALEIVSGRS 615
+ + D +S G+ E++ G +
Sbjct: 256 GRY-GPECDWWSLGVCMYEMLYGET 279
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 86.3 bits (214), Expect = 9e-18
Identities = 49/257 (19%), Positives = 97/257 (37%), Gaps = 19/257 (7%)
Query: 17 TVNQKRVLKEQNLTGVLPPKLAELTFLQDIDLTLNYLSGTIPSQWASLP-LLNISLIANR 75
T+N V E ++ + + YL + + ++ L + I++ ++
Sbjct: 262 TLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSK 321
Query: 76 LKGPIPKYLANISTLVNLTVQYNQFSGELPEE---LGSLLNLEKLHLSSNNFT--GELPK 130
+ + ++ +L L + N E + G+ +L+ L LS N+ + +
Sbjct: 322 VFLVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGE 381
Query: 131 TFAKLTNMKDFRISDNQFTGQIPSFIQNWTKLEKLFIQPSGLAGPIPSGIFSLENLTDLR 190
L N+ IS N F +P Q K+ L + +G+ + + I L L
Sbjct: 382 ILLTLKNLTSLDISRNTFH-PMPDSCQWPEKMRFLNLSSTGIRV-VKTCIPQ--TLEVLD 437
Query: 191 ISD--LNGPEATFPQLGNMKMTKLILRNCNITGELPRYLGKMTKLKVLDLSFNRLRGQIP 248
+S+ L+ P+L +L + + LP L V+ +S N+L+
Sbjct: 438 VSNNNLDSFSLFLPRL-----QELYISRNKLK-TLPDA-SLFPVLLVMKISRNQLKSVPD 490
Query: 249 SNFDDLYDVDYIYFAGN 265
FD L + I+ N
Sbjct: 491 GIFDRLTSLQKIWLHTN 507
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 86.3 bits (214), Expect = 1e-17
Identities = 40/294 (13%), Positives = 101/294 (34%), Gaps = 33/294 (11%)
Query: 28 NLTGVLPPKLAELTFLQDIDLTLNYLSGTIP-----SQWASLPLLNISLIANRLKGPIPK 82
+L+ + L+ L+ ++L N T+ +L L I +
Sbjct: 85 HLSSLSSSWFGPLSSLKYLNLMGNPYQ-TLGVTSLFPNLTNLQTLRIGNV-ETFSEIRRI 142
Query: 83 YLANISTLVNLTVQYNQFSGELPEELGSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFR 142
A +++L L ++ + L S+ ++ L L + L L++++
Sbjct: 143 DFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLE 202
Query: 143 ISDNQFTGQIPSFI---QNWTKLEKLFIQPSGLAGPIPSGIFSLEN----LTDLRISDL- 194
+ D S + + + ++KL + S L + + L L+++ D
Sbjct: 203 LRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEVEFDDCT 262
Query: 195 --------NGPEATFPQLGNMKMTKLI---LRNCNITGELPRYLGKMTKLKVLDLSFNRL 243
+LG ++ + + + +L + K+K + + +++
Sbjct: 263 LNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKV 322
Query: 244 RGQIPSN-FDDLYDVDYIYFAGNLLTGAIPPWMLERGD-----KIDLSYNNFTD 291
+P + L ++++ + NL+ +G + LS N+
Sbjct: 323 F-LVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRS 375
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 80.2 bits (198), Expect = 8e-16
Identities = 44/288 (15%), Positives = 102/288 (35%), Gaps = 28/288 (9%)
Query: 37 LAELTFLQDIDLTLNYLSGTIPSQW-ASLP-LLNISLIANRLKG-PIPKYLANISTLVNL 93
L L+ +DL+ N+LS ++ S W L L ++L+ N + + N++ L L
Sbjct: 70 FYSLGSLEHLDLSDNHLS-SLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTL 128
Query: 94 TVQYNQFSGELPEE-LGSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRISDNQFTGQI 152
+ + E+ L +L +L + + + ++ + ++ + ++ +
Sbjct: 129 RIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLL 188
Query: 153 PSFIQNWTKLEKLFIQPSGLAGPIPSGIFSLENLTDLRISDLNG---PEATFPQLGNMKM 209
F + + L ++ + LA S + E + ++ G + +F +L +
Sbjct: 189 EIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLR 248
Query: 210 TKLILRNCNITGELPRYLG----------------KMTKLKVLDLSFNRLRGQIPSNFDD 253
L L LG + ++ L + L + + +
Sbjct: 249 YILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSL 308
Query: 254 LYDVDYIYFAGNLLTGAIPPWMLERGDK---IDLSYNNFTDGSAESSC 298
L V I + + +P + +DLS N + ++S
Sbjct: 309 LEKVKRITVENSKVF-LVPCSFSQHLKSLEFLDLSENLMVEEYLKNSA 355
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 79.8 bits (197), Expect = 1e-15
Identities = 34/187 (18%), Positives = 72/187 (38%), Gaps = 7/187 (3%)
Query: 88 STLVNLTVQYNQFSGELPEELGSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRISDNQ 147
+ + +L + +N+ + +L + NL+ L L S+ F L +++ +SDN
Sbjct: 26 AAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNH 85
Query: 148 FTGQIPSFIQNWTKLEKLFIQPSGLAGPIPSGIFS-LENLTDLRISDLNG----PEATFP 202
+ S+ + L+ L + + + +F L NL LRI ++ F
Sbjct: 86 LSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFA 145
Query: 203 QLGNMKMTKLILRNCNITGELPRYLGKMTKLKVLDLSFNRLRGQIPSNFDDLYDVDYIYF 262
L ++ +L ++ ++ + L + + L L + + D L V Y+
Sbjct: 146 GLTSLN--ELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLEL 203
Query: 263 AGNLLTG 269
L
Sbjct: 204 RDTNLAR 210
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 78.6 bits (194), Expect = 3e-15
Identities = 42/236 (17%), Positives = 83/236 (35%), Gaps = 33/236 (13%)
Query: 24 LKEQNLTGVLPPKLAELTFLQDIDLTLNYLSGTIPSQWASLPLLNISLIANRLKGPIPKY 83
+ ++ T + P L ++ +DL+ N ++ I
Sbjct: 12 GRSRSFTSI-PSGL--TAAMKSLDLSFNKIT-YIG----------------------HGD 45
Query: 84 LANISTLVNLTVQYNQFSGELPEELGSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRI 143
L + L L ++ ++ + + SL +LE L LS N+ + F L+++K +
Sbjct: 46 LRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNL 105
Query: 144 SDNQFTG-QIPSFIQNWTKLEKLFIQPSGLAGPIPSGIFS-LENLTDLRISDLNG---PE 198
N + + S N T L+ L I I F+ L +L +L I L+
Sbjct: 106 MGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQS 165
Query: 199 ATFPQLGNMKMTKLILRNCNITGELPRYLGKMTKLKVLDLSFNRLRGQIPSNFDDL 254
+ + ++ L L L + ++ ++ L+L L S
Sbjct: 166 QSLKSIRDIH--HLTLHLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVD 219
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 51.3 bits (123), Expect = 9e-07
Identities = 22/137 (16%), Positives = 48/137 (35%), Gaps = 10/137 (7%)
Query: 27 QNLTGVLPPKLAELTFLQDIDLTLNYLSGTIPSQWASLPLLNISLIANRLKGPIPKYLAN 86
+N +P ++ ++L+ + +L +L++S N L +L
Sbjct: 396 RNTFHPMPDSCQWPEKMRFLNLSSTGIRVVKTCIPQTLEVLDVS--NNNLDS-FSLFLPR 452
Query: 87 ISTLVNLTVQYNQFSGELPEELGSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRISDN 146
L L + N+ LP+ L + +S N F +LT+++ + N
Sbjct: 453 ---LQELYISRNKLK-TLPDA-SLFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTN 507
Query: 147 QFTG--QIPSFIQNWTK 161
+ ++ W
Sbjct: 508 PWDCSCPRIDYLSRWLN 524
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 85.6 bits (212), Expect = 9e-18
Identities = 62/216 (28%), Positives = 90/216 (41%), Gaps = 29/216 (13%)
Query: 424 IGEGGFGPVYKGLLA----DGTAIAVKQLSSKSKQGNREF---INEIGMISALQHPNLVK 476
+G+G FG V +L G A+K L + E + E ++ +HP L
Sbjct: 156 LGKGTFGKV---ILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTA 212
Query: 477 LYGCCIEGNQLLLIYEYL---ENNSLARALFEH---RLKLDWPTRRRICLGIARGLAYLH 530
L ++L + EY E LF H R I L YLH
Sbjct: 213 LKYSFQTHDRLCFVMEYANGGE-------LFFHLSRERVFSEDRARFYGAEIVSALDYLH 265
Query: 531 GESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPEYAM 590
E + V+RD+K N++LDKD + KI+DFGL K ++ + T GT Y+APE
Sbjct: 266 SEKNV--VYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT-FCGTPEYLAPEVLE 322
Query: 591 RGHLTEKADVYSFGIVALEIVSGRS---NVTKEDMF 623
D + G+V E++ GR N E +F
Sbjct: 323 DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLF 358
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 83.6 bits (207), Expect = 3e-17
Identities = 49/288 (17%), Positives = 101/288 (35%), Gaps = 27/288 (9%)
Query: 24 LKEQNLTGVLPPKLAELTFLQDIDLTLNYLSGTIPSQWASLPLLN-ISLIANRLKGPIPK 82
K + + L ++ ++L + +A + + + N ++ P
Sbjct: 52 FKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPH 111
Query: 83 YLANISTLVNLTVQYNQFSGELPEEL-GSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDF 141
N+ L L ++ N S LP + + L L +S+NN TF T++++
Sbjct: 112 VFQNVPLLTVLVLERNDLS-SLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNL 170
Query: 142 RISDNQFTGQIPSFIQNWTKLEKLFIQPSGLAGP---------------IPSGIFSLENL 186
++S N+ T S I + + S LA P + + L
Sbjct: 171 QLSSNRLTHVDLSLIPSLFHANVSYNLLSTLAIPIAVEELDASHNSINVVRGPVNV--EL 228
Query: 187 TDLRISDLN-GPEATFPQLGNMKMTKLILRNCNITGELPRYLGKMTKLKVLDLSFNRLRG 245
T L++ N A + ++ L + + KM +L+ L +S NRL
Sbjct: 229 TILKLQHNNLTDTAWLLNYPGLV--EVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV- 285
Query: 246 QIPSNFDDLYDVDYIYFAGNLLTGAIPPWM--LERGDKIDLSYNNFTD 291
+ + + + + N L + +R + + L +N+
Sbjct: 286 ALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIVT 332
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 2e-16
Identities = 40/242 (16%), Positives = 84/242 (34%), Gaps = 22/242 (9%)
Query: 66 LLNISLIANRLKGPIPKYLANISTLVNLTVQYNQFSGELPEELGSLLNLEKLHLSSNNFT 125
++ + ++ +T + + L S +E L+L+
Sbjct: 23 FYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIE 82
Query: 126 GELPKTFAKLTNMKDFRISDNQFTGQIPSFI-QNWTKLEKLFIQPSGLAGPIPSGIFS-L 183
FA ++ + N +P + QN L L ++ + L+ +P GIF
Sbjct: 83 EIDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLVLERNDLSS-LPRGIFHNT 140
Query: 184 ENLTDL-----RISDLNGPEATFPQLGNMKMTKLILRNCNITGELPRYLGKMTKLKVLDL 238
LT L + + + TF +++ L L + +T + L + L ++
Sbjct: 141 PKLTTLSMSNNNLERI--EDDTFQATTSLQ--NLQLSSNRLT-HVD--LSLIPSLFHANV 193
Query: 239 SFNRLRGQIPSNFDDLYDVDYIYFAGNLLTGAIPPWMLERGDKIDLSYNNFTDGSAESSC 298
S+N L S V+ + + N + + + + L +NN TD + +
Sbjct: 194 SYNLL-----STLAIPIAVEELDASHNSIN-VVRGPVNVELTILKLQHNNLTDTAWLLNY 247
Query: 299 QK 300
Sbjct: 248 PG 249
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 79.7 bits (197), Expect = 5e-16
Identities = 47/263 (17%), Positives = 89/263 (33%), Gaps = 62/263 (23%)
Query: 28 NLTGVLPPKLAELTFLQDIDLTLNYLSGTIPSQWASLPLLNISLIANRLKGPIPKYLANI 87
NL + T LQ++ L+ N L+ + L+ I
Sbjct: 152 NLERIEDDTFQATTSLQNLQLSSNRLT-HVD-------------------------LSLI 185
Query: 88 STLVNLTVQYNQFSGELPEELGSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRISDNQ 147
+L + V YN S L + +E+L S N+ +LT + ++ N
Sbjct: 186 PSLFHANVSYNLLS-----TLAIPIAVEELDASHNSINVVRGPVNVELTIL---KLQHNN 237
Query: 148 FTGQIPSFIQNWTKLEKLFIQPSGLAGPIPSGIFSLENLTDLRISDLNGPEATFPQLGNM 207
T N+ L ++ +L+ + + F ++ +
Sbjct: 238 LT-DTAWL-LNYPGLVEV-------------------DLSYNELEKI--MYHPFVKMQRL 274
Query: 208 KMTKLILRNCNITGELPRYLGKMTKLKVLDLSFNRLRGQIPSNFDDLYDVDYIYFAGNLL 267
+ +L + N + L Y + LKVLDLS N L + N ++ +Y N +
Sbjct: 275 E--RLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSI 330
Query: 268 TGAIPPWMLERGDKIDLSYNNFT 290
+ + LS+N++
Sbjct: 331 V-TLKLSTHHTLKNLTLSHNDWD 352
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 7e-15
Identities = 40/218 (18%), Positives = 77/218 (35%), Gaps = 19/218 (8%)
Query: 80 IPKYLANISTLVNLTVQYNQFSGELPEELGSLLNLEKLHLSSNNFTGELPKTFAKLTNMK 139
I L ++ + E +L N + + ++ ++
Sbjct: 13 IDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVE 72
Query: 140 DFRISDNQFTGQIPSFI-QNWTKLEKLFIQPSGLAGPIPSGIFS-LENLTDL-----RIS 192
++D Q +I ++ ++KL++ + + +P +F + LT L +S
Sbjct: 73 LLNLNDLQIE-EIDTYAFAYAHTIQKLYMGFNAIRY-LPPHVFQNVPLLTVLVLERNDLS 130
Query: 193 DLNGPEATFPQLGNMKMTKLILRNCNITGELPRYLGKMTKLKVLDLSFNRLRGQIPSNFD 252
L P F + L + N N+ T L+ L LS NRL S
Sbjct: 131 SL--PRGIFHNTPKLT--TLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHVDLSLIP 186
Query: 253 DLYDVDYIYFAGNLLTGAIPPWMLERGDKIDLSYNNFT 290
L+ + + NLL+ P +E +D S+N+
Sbjct: 187 SLFHAN---VSYNLLSTLAIPIAVEE---LDASHNSIN 218
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 68.1 bits (167), Expect = 3e-12
Identities = 32/174 (18%), Positives = 69/174 (39%), Gaps = 13/174 (7%)
Query: 24 LKEQNLTGVLPPKLAELTFLQDIDLTLNYLSGTIPSQW-ASLPLLNISLIANRLKGPIPK 82
L N++ L LA ++++D + N ++ + L +L + N L
Sbjct: 188 LFHANVSYNLLSTLAIPIAVEELDASHNSIN-VVRGPVNVELTILKLQ--HNNLT-DTA- 242
Query: 83 YLANISTLVNLTVQYNQFSGELPEE-LGSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDF 141
+L N LV + + YN+ ++ + LE+L++S+N L + +K
Sbjct: 243 WLLNYPGLVEVDLSYNELE-KIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVL 300
Query: 142 RISDNQFTGQIPSFIQNWTKLEKLFIQPSGLAGPIPSGIFSLENLTDLRISDLN 195
+S N + + +LE L++ + + + L +L +S +
Sbjct: 301 DLSHNHLL-HVERNQPQFDRLENLYLDHNSIV-TLKLSTHH--TLKNLTLSHND 350
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 82.9 bits (205), Expect = 4e-17
Identities = 51/238 (21%), Positives = 87/238 (36%), Gaps = 60/238 (25%)
Query: 424 IGEGGFGPVYKG-LLADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKL----Y 478
+G G FG V + + G A+K++ + NRE + ++ L H N++KL Y
Sbjct: 15 LGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNRE----LDIMKVLDHVNIIKLVDYFY 70
Query: 479 GCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRR-----------------RICLG 521
E + + + K ++
Sbjct: 71 TTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHKVLKS 130
Query: 522 -------------------IARGLAYLHGESRIKVVHRDIKATNVLLDKDLNS-KISDFG 561
+ R + ++H + + HRDIK N+L++ N+ K+ DFG
Sbjct: 131 FIRSGRSIPMNLISIYIYQLFRAVGFIHS---LGICHRDIKPQNLLVNSKDNTLKLCDFG 187
Query: 562 LAK--LDEEENTH-ISTRVAGTIGYMAPEYAMRG--HLTEKADVYSFGIVALEIVSGR 614
AK + E + I +R Y APE M G T D++S G V E++ G+
Sbjct: 188 SAKKLIPSEPSVAYICSRF-----YRAPEL-MLGATEYTPSIDLWSIGCVFGELILGK 239
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 82.8 bits (205), Expect = 4e-17
Identities = 50/207 (24%), Positives = 88/207 (42%), Gaps = 32/207 (15%)
Query: 424 IGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQGNREFIN---------EIGMISALQHPN 473
IG G G V +A+K+LS R F N E+ ++ + H N
Sbjct: 33 IGSGAQGIVCAAYDAILERNVAIKKLS-------RPFQNQTHAKRAYRELVLMKCVNHKN 85
Query: 474 LVKLY------GCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLA 527
++ L E + ++ E ++ N L + + +++LD + + G+
Sbjct: 86 IIGLLNVFTPQKSLEEFQDVYIVMELMDAN-LCQVI---QMELDHERMSYLLYQMLCGIK 141
Query: 528 YLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPE 587
+LH ++HRD+K +N+++ D KI DFGLA+ + T T Y APE
Sbjct: 142 HLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS--FMMTPYVVTRYYRAPE 196
Query: 588 YAMRGHLTEKADVYSFGIVALEIVSGR 614
+ E D++S G + E++ G
Sbjct: 197 VILGMGYKENVDIWSVGCIMGEMIKGG 223
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 81.8 bits (203), Expect = 5e-17
Identities = 60/208 (28%), Positives = 103/208 (49%), Gaps = 31/208 (14%)
Query: 424 IGEGGFGPVY---KGLLADGTAI-AVKQLSSKS-KQGNR-EFINEIGMISALQHPNLVKL 477
+G+G FG V+ K +D + A+K L + K +R E ++ + HP +VKL
Sbjct: 32 LGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKL 91
Query: 478 YGCCIEGNQLLLIYEYL---ENNSLARALFEH-----RLKLDWPTRRRICLG-IARGLAY 528
+ +L LI ++L + LF + + L +A L +
Sbjct: 92 HYAFQTEGKLYLILDFLRGGD-------LFTRLSKEVMFTEE---DVKFYLAELALALDH 141
Query: 529 LHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPEY 588
LH + +++RD+K N+LLD++ + K++DFGL+K + + GT+ YMAPE
Sbjct: 142 LH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS-FCGTVEYMAPEV 197
Query: 589 AMR-GHLTEKADVYSFGIVALEIVSGRS 615
R GH T+ AD +SFG++ E+++G
Sbjct: 198 VNRRGH-TQSADWWSFGVLMFEMLTGTL 224
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 81.6 bits (202), Expect = 1e-16
Identities = 50/208 (24%), Positives = 93/208 (44%), Gaps = 23/208 (11%)
Query: 424 IGEGGFGPVYKGLLADGTAIAVKQLS--SKSKQGNREFIN---------EIGMISALQHP 472
I G +G V G+ ++G +A+K++ + + EI +++ HP
Sbjct: 30 ISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHP 89
Query: 473 NLVKLYGCCI-----EGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLA 527
N++ L + ++L L+ E + + LA+ + + R+ + + I GL
Sbjct: 90 NILGLRDIFVHFEEPAMHKLYLVTELMRTD-LAQVIHDQRIVISPQHIQYFMYHILLGLH 148
Query: 528 YLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPE 587
LH VVHRD+ N+LL + + I DF LA+ ++ + + + V Y APE
Sbjct: 149 VLHEAG---VVHRDLHPGNILLADNNDITICDFNLAR-EDTADANKTHYVT-HRWYRAPE 203
Query: 588 YAM-RGHLTEKADVYSFGIVALEIVSGR 614
M T+ D++S G V E+ + +
Sbjct: 204 LVMQFKGFTKLVDMWSAGCVMAEMFNRK 231
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 82.2 bits (203), Expect = 1e-16
Identities = 49/201 (24%), Positives = 87/201 (43%), Gaps = 20/201 (9%)
Query: 424 IGEGGFGPVYKGL-LADGTAIAVKQLS---SKSKQGNREFINEIGMISALQHPNLVKLY- 478
IG G G V +A+K+LS R + E+ ++ + H N++ L
Sbjct: 70 IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAY-RELVLMKCVNHKNIISLLN 128
Query: 479 -----GCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGES 533
E + L+ E ++ N L + + +++LD + + G+ +LH
Sbjct: 129 VFTPQKTLEEFQDVYLVMELMDAN-LCQVI---QMELDHERMSYLLYQMLCGIKHLHSAG 184
Query: 534 RIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPEYAMRGH 593
++HRD+K +N+++ D KI DFGLA+ + T T Y APE +
Sbjct: 185 ---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS--FMMTPYVVTRYYRAPEVILGMG 239
Query: 594 LTEKADVYSFGIVALEIVSGR 614
E D++S G + E+V +
Sbjct: 240 YKENVDIWSVGCIMGEMVRHK 260
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 79.7 bits (197), Expect = 1e-16
Identities = 51/230 (22%), Positives = 81/230 (35%), Gaps = 28/230 (12%)
Query: 56 TIPSQWASLP--LLNISLIANRLKGPIPKYLANISTLVNLTVQYNQFSGELPEELGSLLN 113
+P +P I L NR+ L L + N + L
Sbjct: 25 AVPV---GIPAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLAL 81
Query: 114 LEKLHLSSNNFTGELPK-TFAKLTNMKDFRISDNQFTGQIPSFI-QNWTKLEKLFIQPSG 171
LE+L LS N + TF L + + ++ + + L+ L++Q +
Sbjct: 82 LEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQ-ELGPGLFRGLAALQYLYLQDNA 140
Query: 172 LAGPIPSGIFS-LENLTDL-----RISDLNGPEATFPQLGNMKMTKLILRNCNITGELPR 225
L +P F L NLT L RIS + PE F L + + +L+L + P
Sbjct: 141 LQA-LPDDTFRDLGNLTHLFLHGNRISSV--PERAFRGLHS--LDRLLLHQNRVAHVHPH 195
Query: 226 YLGKMTKLKVLDLSFNRLRGQIPSN-FDDLYDVDYIYFAGNLLTGAIPPW 274
+ +L L L N L +P+ L + Y+ N PW
Sbjct: 196 AFRDLGRLMTLYLFANNLS-ALPTEALAPLRALQYLRLNDN-------PW 237
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 6e-16
Identities = 52/217 (23%), Positives = 80/217 (36%), Gaps = 19/217 (8%)
Query: 85 ANIST-LVNLTVQYNQFSGELPEELGSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRI 143
I + + N+ S + NL L L SN F L ++ +
Sbjct: 28 VGIPAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDL 87
Query: 144 SDNQFTGQIPSFI-QNWTKLEKLFIQPSGLAGPIPSGIFS-LENLTDLRISDLNG----P 197
SDN + +L L + GL + G+F L L L + D N P
Sbjct: 88 SDNAQLRSVDPATFHGLGRLHTLHLDRCGLQE-LGPGLFRGLAALQYLYLQD-NALQALP 145
Query: 198 EATFPQLGNMKMTKLILRNCNITGELPRY-LGKMTKLKVLDLSFNRLRGQIPSN-FDDLY 255
+ TF LGN +T L L I+ +P + L L L NR+ + + F DL
Sbjct: 146 DDTFRDLGN--LTHLFLHGNRIS-SVPERAFRGLHSLDRLLLHQNRVA-HVHPHAFRDLG 201
Query: 256 DVDYIYFAGNLLTGAIPPWMLERGDK---IDLSYNNF 289
+ +Y N L+ A+P L + L+ N +
Sbjct: 202 RLMTLYLFANNLS-ALPTEALAPLRALQYLRLNDNPW 237
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 46.9 bits (112), Expect = 1e-05
Identities = 28/120 (23%), Positives = 48/120 (40%), Gaps = 6/120 (5%)
Query: 33 LPPK-LAELTFLQDIDLTLNYLSGTIPSQ-WASLPLLNI-SLIANRLKGPIPKYLANIST 89
L P L LQ + L N L +P + L L L NR+ + + +
Sbjct: 120 LGPGLFRGLAALQYLYLQDNALQ-ALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHS 178
Query: 90 LVNLTVQYNQFSGELPEE-LGSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRISDNQF 148
L L + N+ + + L L L+L +NN + + A L ++ R++DN +
Sbjct: 179 LDRLLLHQNRVA-HVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPW 237
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 80.3 bits (198), Expect = 1e-16
Identities = 47/233 (20%), Positives = 81/233 (34%), Gaps = 25/233 (10%)
Query: 89 TLVNLTVQYNQFSGELPEELGSLLN---LEKLHLSSNNFTGELPKTFAKLT--NMKDFRI 143
+L LTV+ + + +L L++L L + TG P + T ++ +
Sbjct: 69 SLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNILNL 128
Query: 144 SDNQFTGQIPSF--IQNW--TKLEKLFIQPSGLAGPIPSGIFSLENLTDLRISD--LNGP 197
+ + + +Q W L+ L I + + L+ L +SD G
Sbjct: 129 RNVSWATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGE 188
Query: 198 EATFPQLGNMKMTK---LILRNCNIT---GELPRYLGKMTKLKVLDLSFNRLRGQIP-SN 250
L +K L LRN + G +L+ LDLS N LR +
Sbjct: 189 RGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPS 248
Query: 251 FDDLYDVDYIYFAGNLLTGAIP---PWMLERGDKIDLSYNNFTDGSAESSCQK 300
D ++ + + L +P P L +DLSYN + +
Sbjct: 249 CDWPSQLNSLNLSFTGLK-QVPKGLPAKLS---VLDLSYNRLDRNPSPDELPQ 297
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 70.7 bits (173), Expect = 2e-13
Identities = 39/233 (16%), Positives = 66/233 (28%), Gaps = 43/233 (18%)
Query: 28 NLTGVLPPKLAELTFLQDIDLTLNYLSGTIP-------SQWASLPLLNISLIANRLKGPI 80
+TG PP L E T L L +S QW L +S+
Sbjct: 106 EVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAHSLNFS 165
Query: 81 PKYLANISTLVNLTVQYNQFSGELPEE----LGSLLNLEKLHLSSNNFT---GELPKTFA 133
+ + L L + N GE L+ L L + G A
Sbjct: 166 CEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAA 225
Query: 134 KLTNMKDFRISDNQFTGQIPSFIQNW-TKLEKLFIQPSGLAGPIPSGIFSLENLTDLRIS 192
++ +S N + +W ++L L NL+ +
Sbjct: 226 ARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSL-------------------NLSFTGLK 266
Query: 193 DLNGPEATFPQLGNMKMTKLILRNCNITGELPRYLGKMTKLKVLDLSFNRLRG 245
+ P+ +L + L L + P ++ ++ L L N
Sbjct: 267 QV--PKGLPAKL-----SVLDLSYNRLD-RNPS-PDELPQVGNLSLKGNPFLD 310
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 70.7 bits (173), Expect = 3e-13
Identities = 47/288 (16%), Positives = 86/288 (29%), Gaps = 64/288 (22%)
Query: 20 QKRVLKEQNLTGVLPPKLAEL---TFLQDIDLTLNYLSGTIPSQWASLPLLNI-SLIANR 75
++ ++ + + + + LQ++ L ++GT P ++ L
Sbjct: 71 KRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRN 130
Query: 76 LK-GPIPKYLANISTLVN-----LTVQYNQFSGELPEELGSLLNLEKLHLSSNNFTGELP 129
+ +LA + + L++ E++ L L LS N GE
Sbjct: 131 VSWATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERG 190
Query: 130 KTFA----KLTNMKDFRISDNQFTGQIPSFIQNWTKLEKLFIQPSGLAGPIPSGIFSLEN 185
A K ++ + + +G + +
Sbjct: 191 LISALCPLKFPTLQVLALRNAGMET---------------------PSGVCSALAAARVQ 229
Query: 186 LTDLRIS--DLNGPEATFPQLGNMKMTKLILRNCNITGELPRYLGKMTKLKVLDLSFNRL 243
L L +S L ++ L L + ++P+ L KL VLDLS+NRL
Sbjct: 230 LQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QVPKGLP--AKLSVLDLSYNRL 286
Query: 244 RGQIPSNFDDLYDVDYIYFAGNLLTGAIPPWMLERGDKIDLSYNNFTD 291
PS P L + + L N F D
Sbjct: 287 DR-NPS-----------------------PDELPQVGNLSLKGNPFLD 310
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 58.8 bits (142), Expect = 2e-09
Identities = 37/214 (17%), Positives = 68/214 (31%), Gaps = 20/214 (9%)
Query: 106 EELGSLLNLEKLHLSSNNFTGELPKT-FAKLTNMKDFRISDNQFTGQIPS---FIQNWTK 161
E G +LE L + T K ++K + + +I + +
Sbjct: 37 ELYGGGRSLEYLLKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILFGALRVLGISG 96
Query: 162 LEKLFIQPSGLAGPIPSGIFSL--ENLTDLRISDLNGPE-----ATFPQLGNMKMTKLIL 214
L++L ++ + G P + +L L + +++ A Q + L +
Sbjct: 97 LQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSI 156
Query: 215 RNCNITGELPRYLGKMTKLKVLDLSFNRLRGQI-------PSNFDDLYDVDYIYFAGNLL 267
+ + L LDLS N G+ P F L +
Sbjct: 157 AQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETP 216
Query: 268 TGAIPPWMLERGD--KIDLSYNNFTDGSAESSCQ 299
+G R +DLS+N+ D + SC
Sbjct: 217 SGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCD 250
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 2e-16
Identities = 58/282 (20%), Positives = 94/282 (33%), Gaps = 51/282 (18%)
Query: 28 NLTGVLPPKLAELTFLQDIDLTLNYLSGTIPSQWASLPLLNISLIANRLKGPIPKYLANI 87
+T + L L + L N +S I P A +
Sbjct: 63 KITEIKDGDFKNLKNLHTLILINNKIS-KIS----------------------PGAFAPL 99
Query: 88 STLVNLTVQYNQFSGELPEELGSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRISDNQ 147
L L + NQ ELPE++ L++L + N T F L M + N
Sbjct: 100 VKLERLYLSKNQLK-ELPEKM--PKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNP 156
Query: 148 FT-GQIPS--FIQNWTKLEKLFIQPSGLAGPIPSGIFSLENLTDL-----RISDLNGPEA 199
I + F Q KL + I + + IP G+ +LT+L +I+ + A
Sbjct: 157 LKSSGIENGAF-QGMKKLSYIRIADTNITT-IPQGLPP--SLTELHLDGNKITKV--DAA 210
Query: 200 TFPQLGNMKMTKLILRNCNITGELPRYLGKMTKLKVLDLSFNRLRGQIPSNFDDLYDVDY 259
+ L N+ KL L +I+ L L+ L L+ N+L ++P D +
Sbjct: 211 SLKGLNNLA--KLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQV 267
Query: 260 IYFAGNLLT----GAIPPWMLERG----DKIDLSYNNFTDGS 293
+Y N ++ P + L N
Sbjct: 268 VYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWE 309
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 79.7 bits (197), Expect = 3e-16
Identities = 36/213 (16%), Positives = 82/213 (38%), Gaps = 21/213 (9%)
Query: 88 STLVNLTVQYNQFSGELPEELGSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRISDNQ 147
L +Q N+ + + +L NL L L +N + P FA L ++ +S NQ
Sbjct: 52 PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQ 111
Query: 148 FTGQIPSFIQNWTKLEKLFIQPSGLAGPIPSGIFS-LENLTDL-----RISDLNGPEATF 201
++P + L++L + + + + +F+ L + + + F
Sbjct: 112 LK-ELPEKM--PKTLQELRVHENEITK-VRKSVFNGLNQMIVVELGTNPLKSSGIENGAF 167
Query: 202 PQLGNMKMTKLILRNCNITGELPRYLGKMTKLKVLDLSFNRLRGQIPSN-FDDLYDVDYI 260
+ + + + + NIT +P+ L L L L N++ ++ + L ++ +
Sbjct: 168 QGMKKLS--YIRIADTNIT-TIPQGL--PPSLTELHLDGNKIT-KVDAASLKGLNNLAKL 221
Query: 261 YFAGNLLTGAIPP---WMLERGDKIDLSYNNFT 290
+ N ++ A+ ++ L+ N
Sbjct: 222 GLSFNSIS-AVDNGSLANTPHLRELHLNNNKLV 253
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 69.3 bits (170), Expect = 8e-13
Identities = 39/246 (15%), Positives = 88/246 (35%), Gaps = 29/246 (11%)
Query: 37 LAELTFLQDIDLTLNYLSGTIPSQWASLP--LLNISLIANRLKGPIPKY-LANISTLVNL 93
A L L+ + L+ N L +P +P L + + N + + K ++ ++ +
Sbjct: 96 FAPLVKLERLYLSKNQLK-ELP---EKMPKTLQELRVHENEITK-VRKSVFNGLNQMIVV 150
Query: 94 TVQYNQF-SGELPEE-LGSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRISDNQFTGQ 151
+ N S + + L + ++ N T LT + N+ T +
Sbjct: 151 ELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITTIPQGLPPSLTE---LHLDGNKIT-K 206
Query: 152 IPSFI-QNWTKLEKLFIQPSGLAGPIPSGIFS-LENLTDLRISD--LNGPEATFPQLGNM 207
+ + + L KL + + ++ + +G + +L +L +++ L +
Sbjct: 207 VDAASLKGLNNLAKLGLSFNSISA-VDNGSLANTPHLRELHLNNNKLVKVPGGLADHKYI 265
Query: 208 KMTKLILRNCNITG------ELPRYLGKMTKLKVLDLSFNRLR-GQIPSN-FDDLYDVDY 259
+ + L N NI+ P Y K + L N ++ +I + F +Y
Sbjct: 266 Q--VVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAA 323
Query: 260 IYFAGN 265
+
Sbjct: 324 VQLGNY 329
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 63.5 bits (155), Expect = 6e-11
Identities = 36/214 (16%), Positives = 75/214 (35%), Gaps = 20/214 (9%)
Query: 43 LQDIDLTLNYLSGTIPSQWASLP-LLNISLIANRLK-GPIPK-YLANISTLVNLTVQYNQ 99
LQ++ + N ++ S + L ++ + L N LK I + L + +
Sbjct: 123 LQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTN 182
Query: 100 FSGELPEELGSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRISDNQFTGQIPSFIQNW 159
+ +P+ G +L +LHL N T + L N+ +S N + + N
Sbjct: 183 IT-TIPQ--GLPPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANT 239
Query: 160 TKLEKLFIQPSGLAGPIPSGIFSLENLTDL-----RISDLNGPEATFPQLGNMKM----T 210
L +L + + L +P G+ + + + IS + F G +
Sbjct: 240 PHLRELHLNNNKLVK-VPGGLADHKYIQVVYLHNNNISAI--GSNDFCPPGYNTKKASYS 296
Query: 211 KLILRNCNIT-GELPRYL-GKMTKLKVLDLSFNR 242
+ L + + E+ + + L +
Sbjct: 297 GVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNYK 330
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 45.0 bits (107), Expect = 6e-05
Identities = 31/173 (17%), Positives = 59/173 (34%), Gaps = 33/173 (19%)
Query: 28 NLTGV---LPPKLAELTFLQDIDLTLNYLSGTIPSQ-WASLPLLN-ISLIANRLKGPIPK 82
N+T + LPP L EL L N ++ + + L L + L N +
Sbjct: 182 NITTIPQGLPPSLTEL------HLDGNKIT-KVDAASLKGLNNLAKLGLSFNSISAVDNG 234
Query: 83 YLANISTLVNLTVQYNQFSGELPEELGSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFR 142
LAN L L + N+ ++P L ++ ++L +NN +
Sbjct: 235 SLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNIS----------------A 277
Query: 143 ISDNQFTGQIPSFIQNWTKLEKLFIQPSGL-AGPIPSGIFS-LENLTDLRISD 193
I N F P + + + + + I F + +++ +
Sbjct: 278 IGSNDFCP--PGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGN 328
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 80.9 bits (200), Expect = 2e-16
Identities = 54/213 (25%), Positives = 89/213 (41%), Gaps = 39/213 (18%)
Query: 424 IGEGGFGPVY----KGLLADGTAIAVKQLSSKSKQGNRE----FINEIGMISALQHPNLV 475
IG G FG V K A+K LS K + R F E +++ P +V
Sbjct: 77 IGRGAFGEVQLVRHKS---TRKVYAMKLLS-KFEMIKRSDSAFFWEERDIMAFANSPWVV 132
Query: 476 KLYGCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIAR--------GLA 527
+L+ + L ++ EY+ L + + + W AR L
Sbjct: 133 QLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKW----------ARFYTAEVVLALD 182
Query: 528 YLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAK-LDEEENTHISTRVAGTIGYMAP 586
+H + +HRD+K N+LLDK + K++DFG +++E T V GT Y++P
Sbjct: 183 AIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV-GTPDYISP 238
Query: 587 E----YAMRGHLTEKADVYSFGIVALEIVSGRS 615
E G+ + D +S G+ E++ G +
Sbjct: 239 EVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDT 271
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 81.4 bits (201), Expect = 3e-16
Identities = 46/260 (17%), Positives = 93/260 (35%), Gaps = 19/260 (7%)
Query: 43 LQDIDLTLNYLSGTIPSQWAS----LPLLNISLIANRLKGPIPKYLANISTLVNLTVQYN 98
L +I+ T N + W + + N+ L ++ L V +
Sbjct: 227 LNNIETTWNSFIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSD 286
Query: 99 QFSGELPEELGSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRISDNQFTGQIPSFIQN 158
F N+ + + + +K++ S+N T + +
Sbjct: 287 VFGFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGH 346
Query: 159 WTKLEKLFIQPSGLAG-PIPSGIF-SLENLTDLRISD----LNGPEATFPQLGNMKMTKL 212
T+LE L +Q + L + + +++L L IS + + + + L
Sbjct: 347 LTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKS--LLSL 404
Query: 213 ILRNCNITGELPRYLGKMTKLKVLDLSFNRLRGQIPSNFDDLYDVDYIYFAGNLLTGAIP 272
+ + +T + R L ++KVLDL N+++ IP L + + A N L ++P
Sbjct: 405 NMSSNILTDTIFRCL--PPRIKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQLK-SVP 460
Query: 273 PWMLERGDK---IDLSYNNF 289
+ +R I L N +
Sbjct: 461 DGIFDRLTSLQKIWLHTNPW 480
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 65.3 bits (159), Expect = 4e-11
Identities = 45/287 (15%), Positives = 93/287 (32%), Gaps = 29/287 (10%)
Query: 40 LTFLQDIDLTLNYLSGTIPSQWASLPLLNISLI--ANRLKGPIPKYLANISTLVNLTVQ- 96
++ L+ + L+ +L + A L + + L+ + P+ L + +T V
Sbjct: 114 MSQLKFLGLSTTHLEKSSVLPIAHLNISKVLLVLGETYGEKEDPEGLQDFNTESLHIVFP 173
Query: 97 -YNQFSGELPEELGSLLNLEKLHLSSNNFTGELPKTFAKLTN-----------MKDFRIS 144
+F L + ++ NLE ++ + + L + + +
Sbjct: 174 TNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETT 233
Query: 145 DNQFTGQIPSFIQNWTKLEKLFIQPSGLAGPIPSGIFSL--ENLTDLRISDLNGPEATFP 202
N F +I + + T + I L G + F +L L I + FP
Sbjct: 234 WNSFI-RILQLVWH-TTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFP 291
Query: 203 QLGNM----KMTKLILRNCNITGELPRYLGKMTKLKVLDLSFNRLRGQIPSNFDDLYDVD 258
Q M K++ LD S N L + N L +++
Sbjct: 292 QSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELE 351
Query: 259 YIYFAGNLLTGAIPPWM-----LERGDKIDLSYNNFTDGSAESSCQK 300
+ N L + ++ ++D+S N+ + + C
Sbjct: 352 TLILQMNQLK-ELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSW 397
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 63.0 bits (153), Expect = 2e-10
Identities = 48/307 (15%), Positives = 91/307 (29%), Gaps = 32/307 (10%)
Query: 12 FWKQKTVNQKRVLKEQNLTGVLPPKLAELTFLQDIDLTLNYLSGTIPS--------QWAS 63
+N +VL T L L + + + A+
Sbjct: 132 VLPIAHLNISKVLLVLGETYGEKEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVAN 191
Query: 64 LPLLNISLIANRLKGP----IPKYLANISTLVNLTVQYNQFSGELPEELGSLL---NLEK 116
L L NI + K I L L NLT+ + + + L+ +
Sbjct: 192 LELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWY 251
Query: 117 LHLSSNNFTG-----ELPKTFAKLTNMKDFRISDNQFTGQIPSFIQNWTKLEKLFIQPSG 171
+S+ G + + L + ++ + F + ++ + SG
Sbjct: 252 FSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSG 311
Query: 172 LAGPIPSGIFS-LENLTDLRISD---LNGPEATFPQLGNMKMTKLILRNCNITGELPRYL 227
+ S + L S+ + L + LIL+ + EL +
Sbjct: 312 T-RMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTEL--ETLILQMNQLK-ELSKIA 367
Query: 228 G---KMTKLKVLDLSFNRLRGQIPSN-FDDLYDVDYIYFAGNLLTGAIPPWMLERGDKID 283
+M L+ LD+S N + + + + N+LT I + R +D
Sbjct: 368 EMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCLPPRIKVLD 427
Query: 284 LSYNNFT 290
L N
Sbjct: 428 LHSNKIK 434
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 56.0 bits (135), Expect = 3e-08
Identities = 30/184 (16%), Positives = 50/184 (27%), Gaps = 31/184 (16%)
Query: 113 NLEKLHLSSNNFTGELPKTFAKLTNMKDFRISDNQFTGQIPSFIQNWTKLEKLFIQPSGL 172
L++S N + L+ ++ IS N+
Sbjct: 22 KTTILNISQNYISELWTSDILSLSKLRILIISHNRIQY---------------------- 59
Query: 173 AGPIPSGIF-SLENLTDLRISDLNGPEATFPQLGNMKMTKLILRNCNITGELPR--YLGK 229
+ +F + L L +S + + N+ L L LP G
Sbjct: 60 ---LDISVFKFNQELEYLDLSHNKLVKISCHPTVNL--KHLDLSFNAFD-ALPICKEFGN 113
Query: 230 MTKLKVLDLSFNRLRGQIPSNFDDLYDVDYIYFAGNLLTGAIPPWMLERGDKIDLSYNNF 289
M++LK L LS L L + G P L+ + L
Sbjct: 114 MSQLKFLGLSTTHLEKSSVLPIAHLNISKVLLVLGETYGEKEDPEGLQDFNTESLHIVFP 173
Query: 290 TDGS 293
T+
Sbjct: 174 TNKE 177
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 54.9 bits (132), Expect = 6e-08
Identities = 30/198 (15%), Positives = 57/198 (28%), Gaps = 8/198 (4%)
Query: 74 NRLKGPIPKYLANISTLVNLTVQYNQFSGELPEELGSLLNLEKLHLSSNNFTGELPKTFA 133
N + + ++S L L + +N+ LE L LS N ++
Sbjct: 31 NYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNKLV-KIS--CH 87
Query: 134 KLTNMKDFRISDNQFTG-QIPSFIQNWTKLEKLFIQPSGLAGPIPSGIFSLENLTDLRIS 192
N+K +S N F I N ++L+ L + + L I L L +
Sbjct: 88 PTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLEKSSVLPIAHLNISKVLLVL 147
Query: 193 DLN----GPEATFPQLGNMKMTKLILRNCNITGELPRYLGKMTKLKVLDLSFNRLRGQIP 248
+ + N L + + L++ ++ +
Sbjct: 148 GETYGEKEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCS 207
Query: 249 SNFDDLYDVDYIYFAGNL 266
L + NL
Sbjct: 208 YFLSILAKLQTNPKLSNL 225
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 52.9 bits (127), Expect = 3e-07
Identities = 28/185 (15%), Positives = 52/185 (28%), Gaps = 10/185 (5%)
Query: 88 STLVNLTVQYNQFSGELPEELGSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRISDNQ 147
L + N S ++ SL L L +S N F ++ +S N+
Sbjct: 21 QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNK 80
Query: 148 FTGQIPSFIQNWTKLEKLFIQPSGLAGPIPSGIFS-LENLTDLRISD---LNGPEATFPQ 203
I L+ L + + F + L L +S
Sbjct: 81 LVK-ISC--HPTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLEKSSVLPIAH 137
Query: 204 LGNMKMTKLILRNCNITGELPRYLGK--MTKLKVLDLSFNRLRGQIPSNFDDLYDVDYIY 261
L K+ L+L E P L L ++ + + + + +++
Sbjct: 138 LNISKVL-LVLGETYGEKEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSN 196
Query: 262 FAGNL 266
L
Sbjct: 197 IKCVL 201
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 79.5 bits (197), Expect = 4e-16
Identities = 62/210 (29%), Positives = 95/210 (45%), Gaps = 33/210 (15%)
Query: 424 IGEGGFGPVY---KGLLADGTAI-AVKQLSSKSKQGNREFI----NEIGMISALQHPNLV 475
+G+GG+G V+ K A+ I A+K L N + E ++ ++HP +V
Sbjct: 25 LGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIV 84
Query: 476 KLYGCCIEGNQLLLIYEYL---ENNSLARALFEH-----RLKLDWPTRRRICLG-IARGL 526
L G +L LI EYL E LF D L I+ L
Sbjct: 85 DLIYAFQTGGKLYLILEYLSGGE-------LFMQLEREGIFMED---TACFYLAEISMAL 134
Query: 527 AYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAP 586
+LH + +++RD+K N++L+ + K++DFGL K + T T GTI YMAP
Sbjct: 135 GHLHQK---GIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHT-FCGTIEYMAP 190
Query: 587 EYAMR-GHLTEKADVYSFGIVALEIVSGRS 615
E MR GH D +S G + ++++G
Sbjct: 191 EILMRSGH-NRAVDWWSLGALMYDMLTGAP 219
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 78.6 bits (194), Expect = 4e-16
Identities = 46/198 (23%), Positives = 67/198 (33%), Gaps = 25/198 (12%)
Query: 85 ANI-STLVNLTVQYNQFSGELPEELGSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRI 143
++ L + N L L +L+L T +L L + +
Sbjct: 27 PDLPKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELT-KLQ-VDGTLPVLGTLDL 84
Query: 144 SDNQFTGQIPSFIQNWTKLEKLFIQPSGLAGPIPSGIF-SLENLTDL-----RISDLNGP 197
S NQ +P Q L L + + L +P G L L +L + L P
Sbjct: 85 SHNQLQ-SLPLLGQTLPALTVLDVSFNRLTS-LPLGALRGLGELQELYLKGNELKTL--P 140
Query: 198 EATFPQLGNMKMTKLILRNCNITGELPRYL-GKMTKLKVLDLSFNRLRGQIPSNFDDLYD 256
+ KL L N N+T ELP L + L L L N L IP F +
Sbjct: 141 PGLLTPTPKL--EKLSLANNNLT-ELPAGLLNGLENLDTLLLQENSLYT-IPKGFFGSHL 196
Query: 257 VDYIYFAGNLLTGAIPPW 274
+ + + GN PW
Sbjct: 197 LPFAFLHGN-------PW 207
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 79.3 bits (196), Expect = 5e-16
Identities = 50/204 (24%), Positives = 90/204 (44%), Gaps = 28/204 (13%)
Query: 424 IGEGGFGPVYKGLLADGTAI-AVKQLSSKSKQGNREF---INEIGMISALQHPNLVKLYG 479
+G G FG V + A+K L + ++ +NE ++ A+ P LVKL
Sbjct: 49 LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 480 CCIEGNQLLLIYEYL---ENNSLARALFEH---RLKLDWPTRRRICLGIARGLAYLHGES 533
+ + L ++ EY+ E +F H + P R I YLH
Sbjct: 109 SFKDNSNLYMVMEYVAGGE-------MFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLD 161
Query: 534 RIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEE-NTHISTRVAGTIGYMAPEYAM-R 591
+++RD+K N+L+D+ +++DFG AK + T + GT +APE + +
Sbjct: 162 ---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWT-----LCGTPEALAPEIILSK 213
Query: 592 GHLTEKADVYSFGIVALEIVSGRS 615
G+ + D ++ G++ E+ +G
Sbjct: 214 GY-NKAVDWWALGVLIYEMAAGYP 236
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 79.2 bits (196), Expect = 5e-16
Identities = 63/216 (29%), Positives = 88/216 (40%), Gaps = 30/216 (13%)
Query: 424 IGEGGFGPVYKGLLA----DGTAIAVKQLSSKSKQGNREF---INEIGMISALQHPNLVK 476
+G+G FG V +L G A+K L + E + E ++ +HP L
Sbjct: 13 LGKGTFGKV---ILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTA 69
Query: 477 LYGCCIEGNQLLLIYEYL---ENNSLARALFEH---RLKLDWPTRRRICLGIARGLAYLH 530
L ++L + EY E LF H R I L YLH
Sbjct: 70 LKYAFQTHDRLCFVMEYANGGE-------LFFHLSRERVFTEERARFYGAEIVSALEYLH 122
Query: 531 GESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPEYAM 590
VV+RDIK N++LDKD + KI+DFGL K + + T GT Y+APE
Sbjct: 123 SR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT-FCGTPEYLAPEVLE 178
Query: 591 RGHLTEKADVYSFGIVALEIVSGRS---NVTKEDMF 623
D + G+V E++ GR N E +F
Sbjct: 179 DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLF 214
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 80.8 bits (199), Expect = 6e-16
Identities = 51/214 (23%), Positives = 95/214 (44%), Gaps = 25/214 (11%)
Query: 424 IGEGGFGPVYKGLLA----DGTAIAVKQLSSKSKQGNREFINEIG----MISALQHPNLV 475
+G+G FG V +L+ AVK L + + + + + P L
Sbjct: 349 LGKGSFGKV---MLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLT 405
Query: 476 KLYGCCIEGNQLLLIYEYLENNSLARALFEH---RLKLDWPTRRRICLGIARGLAYLHGE 532
+L+ C ++L + EY+ L H + P IA GL +L +
Sbjct: 406 QLHSCFQTMDRLYFVMEYVNGGDL----MYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSK 461
Query: 533 SRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPEYAMRG 592
+++RD+K NV+LD + + KI+DFG+ K + + T GT Y+APE
Sbjct: 462 ---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKT-FCGTPDYIAPEIIAYQ 517
Query: 593 HLTEKADVYSFGIVALEIVSGRS---NVTKEDMF 623
+ D ++FG++ E+++G++ ++++F
Sbjct: 518 PYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELF 551
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 79.8 bits (197), Expect = 6e-16
Identities = 50/207 (24%), Positives = 80/207 (38%), Gaps = 22/207 (10%)
Query: 424 IGEGGFGPVY----KGLLADGTAIAVKQLSSKSKQGNRE----FINEIGMISALQHPNLV 475
IG G F V K G A+K ++ K R F E ++ +
Sbjct: 69 IGRGAFSEVAVVKMKQ---TGQVYAMKIMN-KWDMLKRGEVSCFREERDVLVNGDRRWIT 124
Query: 476 KLYGCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRI 535
+L+ + N L L+ EY L L + ++ R I + +H R+
Sbjct: 125 QLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVH---RL 181
Query: 536 KVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPEYAMRGHLT 595
VHRDIK N+LLD+ + +++DFG + T S GT Y++PE
Sbjct: 182 GYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGG 241
Query: 596 EKADVY-------SFGIVALEIVSGRS 615
Y + G+ A E+ G++
Sbjct: 242 PGTGSYGPECDWWALGVFAYEMFYGQT 268
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 6e-16
Identities = 58/229 (25%), Positives = 100/229 (43%), Gaps = 44/229 (19%)
Query: 424 IGEGGFGPVY---KGLLADGTAI-AVKQLSSKSKQGNREFI------NEIGMISALQHPN 473
+G G +G V+ K D + A+K L + + ++ + Q P
Sbjct: 62 LGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQV-LEHIRQSPF 120
Query: 474 LVKLYGCCIEGNQLLLIYEYL---ENNSLARALFEH-----RLKLDWPTRRRICLG-IAR 524
LV L+ +L LI +Y+ E LF H R +I +G I
Sbjct: 121 LVTLHYAFQTETKLHLILDYINGGE-------LFTHLSQRERFTEH---EVQIYVGEIVL 170
Query: 525 GLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYM 584
L +LH ++ +++RDIK N+LLD + + ++DFGL+K + T + GTI YM
Sbjct: 171 ALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYM 227
Query: 585 APE---YAMRGHLTEKADVYSFGIVALEIVSGRS-------NVTKEDMF 623
AP+ GH + D +S G++ E+++G S ++ ++
Sbjct: 228 APDIVRGGDSGH-DKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEIS 275
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 9e-16
Identities = 52/203 (25%), Positives = 94/203 (46%), Gaps = 25/203 (12%)
Query: 424 IGEGGFGPVYKGL-LADGTAIAVKQLS---SKSKQGNREFINEIGMISALQHPNLVKLY- 478
+G G +G V + G +A+K+LS R + E+ ++ +QH N++ L
Sbjct: 32 VGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAY-RELLLLKHMQHENVIGLLD 90
Query: 479 -----GCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGES 533
L+ +++ + L + + LK + + + +GL Y+H
Sbjct: 91 VFTPASSLRNFYDFYLVMPFMQTD-LQKIM---GLKFSEEKIQYLVYQMLKGLKYIHSAG 146
Query: 534 RIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTH-ISTRVAGTIGYMAPEYAM-R 591
VVHRD+K N+ +++D KI DFGLA+ + E T + TR Y APE +
Sbjct: 147 ---VVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTRW-----YRAPEVILSW 198
Query: 592 GHLTEKADVYSFGIVALEIVSGR 614
H + D++S G + E+++G+
Sbjct: 199 MHYNQTVDIWSVGCIMAEMLTGK 221
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 79.6 bits (196), Expect = 1e-15
Identities = 43/241 (17%), Positives = 87/241 (36%), Gaps = 24/241 (9%)
Query: 67 LNISLIANRLKGPIPKYLANISTLVNLTVQYNQFSGELPEE-LGSLLNLEKLHLSSNNFT 125
++I + + ++ +T + + +LP L S +E L+L+
Sbjct: 32 VHIDMQTQDVYFGFED--ITLNNQKIVTFKNSTMR-KLPAALLDSFRQVELLNLNDLQIE 88
Query: 126 GELPKTFAKLTNMKDFRISDNQFTGQIPSFIQNWTKLEKLFIQPSGLAGPIPSGIFS-LE 184
FA ++ + N P QN L L ++ + L+ +P GIF
Sbjct: 89 EIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSS-LPRGIFHNTP 147
Query: 185 NLTDL-----RISDLNGPEATFPQLGNMKMTKLILRNCNITGELPRYLGKMTKLKVLDLS 239
LT L + + + TF +++ L L + +T + L + L ++S
Sbjct: 148 KLTTLSMSNNNLERI--EDDTFQATTSLQ--NLQLSSNRLT-HVD--LSLIPSLFHANVS 200
Query: 240 FNRLRGQIPSNFDDLYDVDYIYFAGNLLTGAIPPWMLERGDKIDLSYNNFTDGSAESSCQ 299
+N L S V+ + + N + + + + L +NN TD + +
Sbjct: 201 YNLL-----STLAIPIAVEELDASHNSIN-VVRGPVNVELTILKLQHNNLTDTAWLLNYP 254
Query: 300 K 300
Sbjct: 255 G 255
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 79.2 bits (195), Expect = 2e-15
Identities = 53/277 (19%), Positives = 107/277 (38%), Gaps = 28/277 (10%)
Query: 24 LKEQNLTGVLPPKLAELTFLQDIDLTLNYLSGTIPSQWASLPLLN-ISLIANRLKGPIPK 82
K + + L ++ ++L + +A + + + N ++ P
Sbjct: 58 FKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPH 117
Query: 83 YLANISTLVNLTVQYNQFSGELPEEL-GSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDF 141
N+ L L ++ N S LP + + L L +S+NN TF T++++
Sbjct: 118 VFQNVPLLTVLVLERNDLS-SLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNL 176
Query: 142 RISDNQFTGQIPSFIQNWTKLEKLFIQPSGLAGPIPSGIFSLENLTDLRISDLNG----P 197
++S N+ T + + L + + L S + + +L S N
Sbjct: 177 QLSSNRLT-HVD--LSLIPSLFHANVSYNLL-----STLAIPIAVEELDASH-NSINVVR 227
Query: 198 EATFPQLGNMKMTKLILRNCNITGELPRYLGKMTKLKVLDLSFNRLRGQIPSN-FDDLYD 256
+L T L L++ N+T + +L L +DLS+N L +I + F +
Sbjct: 228 GPVNVEL-----TILKLQHNNLT-DTA-WLLNYPGLVEVDLSYNELE-KIMYHPFVKMQR 279
Query: 257 VDYIYFAGNLLTGAIPP--WMLERGDKIDLSYNNFTD 291
++ +Y + N L A+ + +DLS+N+
Sbjct: 280 LERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLLH 315
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 75.7 bits (186), Expect = 2e-14
Identities = 34/229 (14%), Positives = 72/229 (31%), Gaps = 40/229 (17%)
Query: 80 IPKYLANISTLVNLTVQYNQFSGELPEELGSLLNLEKLHLSSNNFTGELPKTFAKLTNMK 139
I L ++ + E +L N + + ++ ++
Sbjct: 19 IDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVE 78
Query: 140 DFRISDNQFTGQIPSFIQNWTKLEKLFIQPSGLAGPIPSGIFS-LENLTDL-----RISD 193
++D Q I + F+ + L I
Sbjct: 79 LLNLNDLQIEE-------------------------IDTYAFAYAHTIQKLYMGFNAIRY 113
Query: 194 LNGPEATFPQLGNMKMTKLILRNCNITGELPRYL-GKMTKLKVLDLSFNRLRGQIPSN-F 251
L P F + +T L+L +++ LPR + KL L +S N L +I + F
Sbjct: 114 L--PPHVFQNVPL--LTVLVLERNDLS-SLPRGIFHNTPKLTTLSMSNNNLE-RIEDDTF 167
Query: 252 DDLYDVDYIYFAGNLLTGAIPPWMLERGDKIDLSYNNFTDGSAESSCQK 300
+ + + N LT + ++ ++SYN + + + ++
Sbjct: 168 QATTSLQNLQLSSNRLT-HVDLSLIPSLFHANVSYNLLSTLAIPIAVEE 215
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 65.3 bits (159), Expect = 4e-11
Identities = 37/205 (18%), Positives = 68/205 (33%), Gaps = 37/205 (18%)
Query: 40 LTFLQDIDLTLNYLSGTIPSQWASLPLLNISLIANRLKGPIPKYLANISTLVNLTVQYNQ 99
+ L +++ N LS T+ A + + N + L L +Q+N
Sbjct: 191 IPSLFHANVSYNLLS-TLAIPIA---VEELDASHNSINVVRGPVNVE---LTILKLQHNN 243
Query: 100 FSGELPEELGSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRISDNQFTGQIPSFIQNW 159
+ + L + L ++ LS N + F K+ ++ IS+N+ + + Q
Sbjct: 244 LT-DTAW-LLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPI 300
Query: 160 TKLEKLFIQPSGLAGPIPSGIFSLENLTDLRISDLNGPEATFPQLGNMKMTKLILRNCNI 219
L+ L + + L + + L +L L + +I
Sbjct: 301 PTLKVLDLSHNHLLH-VERNQPQFDRLENLY-----------------------LDHNSI 336
Query: 220 TGELPRYLGKMTKLKVLDLSFNRLR 244
L L LK L LS N
Sbjct: 337 V-TLK--LSTHHTLKNLTLSHNDWD 358
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 77.4 bits (191), Expect = 2e-15
Identities = 42/213 (19%), Positives = 78/213 (36%), Gaps = 22/213 (10%)
Query: 88 STLVNLTVQYNQFSGELPEELGSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRISDNQ 147
L +Q N S ++ L +L L L +N + K F+ L ++ IS N
Sbjct: 54 PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYISKNH 113
Query: 148 FTGQIPSFIQNWTKLEKLFIQPSGLAGPIPSGIFS-LENLTDL-----RISDLNGPEATF 201
+IP + + L +L I + + +P G+FS L N+ + + + F
Sbjct: 114 LV-EIPPNL--PSSLVELRIHDNRIRK-VPKGVFSGLRNMNCIEMGGNPLENSGFEPGAF 169
Query: 202 PQLGNMKMTKLILRNCNITGELPRYLGKMTKLKVLDLSFNRLRGQIPSN-FDDLYDVDYI 260
+K+ L + +T +P+ L L L L N+++ I + +
Sbjct: 170 ---DGLKLNYLRISEAKLT-GIPKDL--PETLNELHLDHNKIQ-AIELEDLLRYSKLYRL 222
Query: 261 YFAGNLLTGAIPP---WMLERGDKIDLSYNNFT 290
N + I L ++ L N +
Sbjct: 223 GLGHNQIR-MIENGSLSFLPTLRELHLDNNKLS 254
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 77.0 bits (190), Expect = 2e-15
Identities = 52/281 (18%), Positives = 95/281 (33%), Gaps = 36/281 (12%)
Query: 28 NLTGVLPPKLAELTFLQDIDLTLNYLSGTIPSQ-WASLP-LLNISLIANRLKGPIPKYLA 85
+++ + L L + L N +S I + ++ L L + + N L IP L
Sbjct: 65 DISELRKDDFKGLQHLYALVLVNNKIS-KIHEKAFSPLRKLQKLYISKNHLVE-IPPNL- 121
Query: 86 NISTLVNLTVQYNQFSGELPEELGSLLNLEKLHLSSNNFTGEL--PKTFAKLTNMKDFRI 143
S+LV L + N+ L N+ + + N P F L + RI
Sbjct: 122 -PSSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGL-KLNYLRI 179
Query: 144 SDNQFTGQIPSFIQNWTKLEKLFIQPSGLAGPIPSGIFS-LENLTDL-----RISDLNGP 197
S+ + T IP L +L + + + I L L +I +
Sbjct: 180 SEAKLT-GIPK--DLPETLNELHLDHNKIQA-IELEDLLRYSKLYRLGLGHNQIRMI--E 233
Query: 198 EATFPQLGNMKMTKLILRNCNITGELPRYLGKMTKLKVLDLSFNRLRGQIPSN-FDDLYD 256
+ L ++ +L L N ++ +P L + L+V+ L N + ++ N F +
Sbjct: 234 NGSLSFLPTLR--ELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNIT-KVGVNDFCPVGF 289
Query: 257 VD------YIYFAGNLLT-GAIPPWM---LERGDKIDLSYN 287
I N + + P + I
Sbjct: 290 GVKRAYYNGISLFNNPVPYWEVQPATFRCVTDRLAIQFGNY 330
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 44.6 bits (106), Expect = 8e-05
Identities = 33/175 (18%), Positives = 60/175 (34%), Gaps = 28/175 (16%)
Query: 24 LKEQNLTGVLPPKLAELTFLQDIDLTLNYLSGTIPSQ-WASLPLLN-ISLIANRLKGPIP 81
+ E LTG+ P L L ++ L N + I + L + L N+++
Sbjct: 179 ISEAKLTGI-PKDL--PETLNELHLDHNKIQ-AIELEDLLRYSKLYRLGLGHNQIRMIEN 234
Query: 82 KYLANISTLVNLTVQYNQFSGELPEELGSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDF 141
L+ + TL L + N+ S +P L L L+ ++L +NN T
Sbjct: 235 GSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNIT---------------- 277
Query: 142 RISDNQFTGQIPSFIQNWTKLEKLFIQPSGLA-GPIPSGIFSLENLTDLRISDLN 195
++ N F F + + + + + F +TD
Sbjct: 278 KVGVNDFCP--VGFGVKRAYYNGISLFNNPVPYWEVQPATFR--CVTDRLAIQFG 328
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 77.6 bits (192), Expect = 2e-15
Identities = 59/217 (27%), Positives = 94/217 (43%), Gaps = 31/217 (14%)
Query: 424 IGEGGFGPVYKGLLA----DGTAIAVKQLSSKSKQGNREFINEIG----MISALQHPNLV 475
+G+G FG V LA A+K L + + + + A +HP L
Sbjct: 25 LGKGSFGKV---FLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLT 81
Query: 476 KLYGCCIEGNQLLLIYEYL---ENNSLARALFEH---RLKLDWPTRRRICLGIARGLAYL 529
++ L + EYL + L H K D I GL +L
Sbjct: 82 HMFCTFQTKENLFFVMEYLNGGD-------LMYHIQSCHKFDLSRATFYAAEIILGLQFL 134
Query: 530 HGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPEYA 589
H + +V+RD+K N+LLDKD + KI+DFG+ K + + +T GT Y+APE
Sbjct: 135 HSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNT-FCGTPDYIAPEIL 190
Query: 590 MRGHLTEKADVYSFGIVALEIVSGRS---NVTKEDMF 623
+ D +SFG++ E++ G+S +E++F
Sbjct: 191 LGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELF 227
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 3e-15
Identities = 48/199 (24%), Positives = 80/199 (40%), Gaps = 23/199 (11%)
Query: 85 ANI-STLVNLTVQYNQFSGELPEELGSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRI 143
+NI + L +Q N+ S + L L L+L+ N F +L N++ +
Sbjct: 33 SNIPADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNLETLWV 92
Query: 144 SDNQFTGQIPSFI-QNWTKLEKLFIQPSGLAGPIPSGIF-SLENLTDLRISDLNG----- 196
+DN+ +P + L +L + + L +P +F SL LT L L
Sbjct: 93 TDNKLQ-ALPIGVFDQLVNLAELRLDRNQLKS-LPPRVFDSLTKLTYL---SLGYNELQS 147
Query: 197 -PEATFPQLGNMKMTKLILRNCNITGELPRYLGKMTKLKVLDLSFNRLRGQIPSNFDDLY 255
P+ F +L + + +L L N + K+T+LK L L N+L+ FD L
Sbjct: 148 LPKGVFDKLTS--LKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLE 205
Query: 256 DVDYIYFAGNLLTGAIPPW 274
+ + N PW
Sbjct: 206 KLKMLQLQEN-------PW 217
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 76.4 bits (189), Expect = 3e-15
Identities = 58/212 (27%), Positives = 101/212 (47%), Gaps = 44/212 (20%)
Query: 424 IGEGGFGPVYKGLLA----DGTAIAVKQLSSKSKQGNREF---INEIGMISALQHPNLVK 476
+G G FG V+ L +G A+K L + ++ +E M+S + HP +++
Sbjct: 14 LGTGSFGRVH---LIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIR 70
Query: 477 LYGCCIEGNQLLLIYEYL---ENNSLARALFEHRLKLDWPTRRRICLGIAR--------G 525
++G + Q+ +I +Y+ E LF K +R +A+
Sbjct: 71 MWGTFQDAQQIFMIMDYIEGGE-------LFSLLRK-----SQRFPNPVAKFYAAEVCLA 118
Query: 526 LAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEE-NTHISTRVAGTIGYM 584
L YLH + +++RD+K N+LLDK+ + KI+DFG AK + T + GT Y+
Sbjct: 119 LEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYT-----LCGTPDYI 170
Query: 585 APEYAMR-GHLTEKADVYSFGIVALEIVSGRS 615
APE + + D +SFGI+ E+++G +
Sbjct: 171 APEVVSTKPY-NKSIDWWSFGILIYEMLAGYT 201
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 3e-15
Identities = 62/209 (29%), Positives = 93/209 (44%), Gaps = 34/209 (16%)
Query: 424 IGEGGFGPVYKGLLA----DGTAIAVKQLSSKSKQGNREFINEIG----MISALQHPNLV 475
IG+G FG V LLA + AVK L K+ +E + + ++ ++HP LV
Sbjct: 46 IGKGSFGKV---LLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLV 102
Query: 476 KLYGCCIEGNQLLLIYEYL---ENNSLARALFEH-----RLKLDWPTRRRICLG-IARGL 526
L+ ++L + +Y+ E LF H R R IA L
Sbjct: 103 GLHFSFQTADKLYFVLDYINGGE-------LFYHLQRERCFLEP---RARFYAAEIASAL 152
Query: 527 AYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAP 586
YLH + +V+RD+K N+LLD + ++DFGL K + E N+ ST GT Y+AP
Sbjct: 153 GYLH---SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTST-FCGTPEYLAP 208
Query: 587 EYAMRGHLTEKADVYSFGIVALEIVSGRS 615
E + D + G V E++ G
Sbjct: 209 EVLHKQPYDRTVDWWCLGAVLYEMLYGLP 237
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 77.0 bits (190), Expect = 3e-15
Identities = 48/203 (23%), Positives = 94/203 (46%), Gaps = 24/203 (11%)
Query: 424 IGEGGFGPVYKGL-LADGTAIAVKQLS---SKSKQGNREFINEIGMISALQHPNLVKLY- 478
+G G +G V + G +A+K+L R + E+ ++ ++H N++ L
Sbjct: 33 VGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAY-RELRLLKHMRHENVIGLLD 91
Query: 479 -----GCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGES 533
+ L+ ++ + L + + KL + + + +GL Y+H
Sbjct: 92 VFTPDETLDDFTDFYLVMPFMGTD-LGKLM--KHEKLGEDRIQFLVYQMLKGLRYIHAAG 148
Query: 534 RIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENT-HISTRVAGTIGYMAPEYAM-R 591
++HRD+K N+ +++D KI DFGLA+ + E T ++ TR Y APE +
Sbjct: 149 ---IIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTGYVVTRW-----YRAPEVILNW 200
Query: 592 GHLTEKADVYSFGIVALEIVSGR 614
T+ D++S G + E+++G+
Sbjct: 201 MRYTQTVDIWSVGCIMAEMITGK 223
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 76.7 bits (189), Expect = 4e-15
Identities = 57/266 (21%), Positives = 102/266 (38%), Gaps = 26/266 (9%)
Query: 24 LKEQNLTGVLPPKLAELTFLQDIDLTLNYLSGTIPSQW-ASLPLLNI-SLIANRLKGPIP 81
L +T + L LQ + LT N ++ TI +SL L L N L
Sbjct: 59 LSNNRITYISNSDLQRCVNLQALVLTSNGIN-TIEEDSFSSLGSLEHLDLSYNYLSNLSS 117
Query: 82 KYLANISTLVNLTVQYNQFSGELPEE--LGSLLNLEKLHLSSNNFTGELP-KTFAKLTNM 138
+ +S+L L + N + L E L L+ L + + + ++ K FA LT +
Sbjct: 118 SWFKPLSSLTFLNLLGNPYK-TLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFL 176
Query: 139 KDFRISDNQFTGQIPSFIQNWTKLEKLFIQPSGLAGPIPSGIFS-LENLTDLRISDLNGP 197
++ I + P +++ + L + + ++ L + D +
Sbjct: 177 EELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHIL-LLEIFVDVTSSVECLELRDTDLD 235
Query: 198 EATFPQLGNMKMTKLI----LRNCNITG----ELPRYLGKMTKLKVLDLSFNRLRGQIPS 249
F +L + LI RN IT ++ + L +++ L L+ S N+L+ +P
Sbjct: 236 TFHFSELSTGETNSLIKKFTFRNVKITDESLFQVMKLLNQISGLLELEFSRNQLKS-VPD 294
Query: 250 N-FDDLYDVDYIYFAGNLLTGAIPPW 274
FD L + I+ N PW
Sbjct: 295 GIFDRLTSLQKIWLHTN-------PW 313
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 69.8 bits (171), Expect = 7e-13
Identities = 36/232 (15%), Positives = 69/232 (29%), Gaps = 39/232 (16%)
Query: 74 NRLKGPIPKYLANISTLVNLTVQYNQFSGELPEEL-GSLLNLEKLHLSSNNFTGELPKTF 132
NR+ L L L + N + + E+ SL +LE L LS N + F
Sbjct: 62 NRITYISNSDLQRCVNLQALVLTSNGIN-TIEEDSFSSLGSLEHLDLSYNYLSNLSSSWF 120
Query: 133 AKLTNMKDFRISDNQFTGQIP--SFIQNWTKLEKLFIQPSGLAGPIPSGIFSLENLTDLR 190
L+++ + N + + S + TKL+ L + I F+ LT L
Sbjct: 121 KPLSSLTFLNLLGNPYK-TLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFA--GLTFLE 177
Query: 191 ISDLNGPEATFPQLGNMKMTKLILRNCNITGELPRYLGKMTKLKVLDLSFNRLRGQIPSN 250
+L + ++ P+ L + + L L + +
Sbjct: 178 --------------------ELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHI-LLLEI 216
Query: 251 -FDDLYDVDYIYFAGNLLTG----AIPP------WMLERGDKIDLSYNNFTD 291
D V+ + L + + ++ +
Sbjct: 217 FVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLFQ 268
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 52.0 bits (125), Expect = 4e-07
Identities = 27/167 (16%), Positives = 63/167 (37%), Gaps = 12/167 (7%)
Query: 12 FWKQKTVNQKRVLKEQNLTGVLPPKLAELTFLQDIDLTLNYLSGTIPSQWASLPLLN-IS 70
F + RV T + A LTFL+++++ + L P S+ ++ +
Sbjct: 145 FSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLI 204
Query: 71 LIANRLKGPIPKYLANISTLVNLTVQYNQFSG----ELPE----ELGSLLNLEKLHLSSN 122
L + + ++ S++ L ++ EL L + ++
Sbjct: 205 LHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDE 264
Query: 123 NFTGELPKTFAKLTNMKDFRISDNQFTGQIPSFI-QNWTKLEKLFIQ 168
+ ++ K +++ + + S NQ +P I T L+K+++
Sbjct: 265 SLF-QVMKLLNQISGLLELEFSRNQLKS-VPDGIFDRLTSLQKIWLH 309
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 76.1 bits (188), Expect = 6e-15
Identities = 54/217 (24%), Positives = 93/217 (42%), Gaps = 31/217 (14%)
Query: 424 IGEGGFGPVYKGLLA----DGTAIAVKQLSSKSKQGNREFINEIG----MISALQHPNLV 475
+G+G FG V +LA G AVK L + + + + A HP L
Sbjct: 31 LGKGSFGKV---MLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLT 87
Query: 476 KLYGCCIEGNQLLLIYEYL---ENNSLARALFEH---RLKLDWPTRRRICLGIARGLAYL 529
+L+ C ++L + E++ + L H + D R I L +L
Sbjct: 88 QLFCCFQTPDRLFFVMEFVNGGD-------LMFHIQKSRRFDEARARFYAAEIISALMFL 140
Query: 530 HGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPEYA 589
H + +++RD+K NVLLD + + K++DFG+ K +T GT Y+APE
Sbjct: 141 HDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTAT-FCGTPDYIAPEIL 196
Query: 590 MRGHLTEKADVYSFGIVALEIVSGRS---NVTKEDMF 623
D ++ G++ E++ G + ++D+F
Sbjct: 197 QEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLF 233
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 76.1 bits (188), Expect = 6e-15
Identities = 51/217 (23%), Positives = 96/217 (44%), Gaps = 31/217 (14%)
Query: 424 IGEGGFGPVYKGLLA----DGTAIAVKQLSSKSKQGNREFINEIG----MISALQHPNLV 475
+G+G FG V +L+ AVK L + + + + + P L
Sbjct: 28 LGKGSFGKV---MLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLT 84
Query: 476 KLYGCCIEGNQLLLIYEYL---ENNSLARALFEH---RLKLDWPTRRRICLGIARGLAYL 529
+L+ C ++L + EY+ + L H + P IA GL +L
Sbjct: 85 QLHSCFQTMDRLYFVMEYVNGGD-------LMYHIQQVGRFKEPHAVFYAAEIAIGLFFL 137
Query: 530 HGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPEYA 589
+ +++RD+K NV+LD + + KI+DFG+ K + + T GT Y+APE
Sbjct: 138 QSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKT-FCGTPDYIAPEII 193
Query: 590 MRGHLTEKADVYSFGIVALEIVSGRS---NVTKEDMF 623
+ D ++FG++ E+++G++ ++++F
Sbjct: 194 AYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELF 230
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 7e-15
Identities = 45/214 (21%), Positives = 86/214 (40%), Gaps = 52/214 (24%)
Query: 424 IGEGGFGPVYKGL-LADGTAIAVKQLSS-KSKQGNREFINEIGMISALQ----HPNLVKL 477
+G G + V++ + + + + VK L K K+ RE I L+ PN++ L
Sbjct: 44 LGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKRE-------IKILENLRGGPNIITL 96
Query: 478 YGCCI--EGNQLLLIYEYLENNSLARALFEHRL--KLDWPTRRRICLGIARGLAYLHGES 533
L++E++ N +L L R I + L Y H
Sbjct: 97 ADIVKDPVSRTPALVFEHVNNTDF------KQLYQTLTDYDIRFYMYEILKALDYCHSMG 150
Query: 534 RIKVVHRDIKATNVLLDKDLNS-KISDFGLAKL---DEEENTHISTRVAGTIGYMAPE-- 587
++HRD+K NV++D + ++ D+GLA+ +E N +++R + PE
Sbjct: 151 ---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRY-----FKGPELL 202
Query: 588 -------YAMRGHLTEKADVYSFGIVALEIVSGR 614
Y++ D++S G + ++ +
Sbjct: 203 VDYQMYDYSL--------DMWSLGCMLASMIFRK 228
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 75.7 bits (187), Expect = 7e-15
Identities = 57/207 (27%), Positives = 89/207 (42%), Gaps = 30/207 (14%)
Query: 424 IGEGGFGPVYKGLLA----DGTAIAVKQLSSKSKQGNREFINEIG-----MISALQHPNL 474
IG G + V LL A+K + K + E I+ + A HP L
Sbjct: 17 IGRGSYAKV---LLVRLKKTDRIYAMKVVK-KELVNDDEDIDWVQTEKHVFEQASNHPFL 72
Query: 475 VKLYGCCIEGNQLLLIYEYL---ENNSLARALFEH---RLKLDWPTRRRICLGIARGLAY 528
V L+ C ++L + EY+ + L H + KL R I+ L Y
Sbjct: 73 VGLHSCFQTESRLFFVIEYVNGGD-------LMFHMQRQRKLPEEHARFYSAEISLALNY 125
Query: 529 LHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPEY 588
LH +++RD+K NVLLD + + K++D+G+ K ST GT Y+APE
Sbjct: 126 LHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTST-FCGTPNYIAPEI 181
Query: 589 AMRGHLTEKADVYSFGIVALEIVSGRS 615
D ++ G++ E+++GRS
Sbjct: 182 LRGEDYGFSVDWWALGVLMFEMMAGRS 208
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 76.8 bits (189), Expect = 9e-15
Identities = 50/267 (18%), Positives = 93/267 (34%), Gaps = 18/267 (6%)
Query: 35 PKLAELTFLQDIDLTLNYLSGTIPSQWAS----LPLLNISLIANRLKGPIPKYLANISTL 90
P L +T Q I+ T W L + N+++ + + +L
Sbjct: 249 PTLLNVTL-QHIETTWKCSVKLFQFFWPRPVEYLNIYNLTITERIDREEFTYSETALKSL 307
Query: 91 VNLTVQYNQFSGELPEELGSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRISDNQFTG 150
+ V+ F + LS ++ ++ + N FT
Sbjct: 308 MIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDTPFIHMVCPPSPSSFTFLNFTQNVFTD 367
Query: 151 QIPSFIQNWTKLEKLFIQPSGLAGPIPSGIFSLENLTDLRISDLNG---PEATFPQL--G 205
+ +L+ L +Q +GL +N++ L D++ + +
Sbjct: 368 SVFQGCSTLKRLQTLILQRNGLKN-FFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAW 426
Query: 206 NMKMTKLILRNCNITGELPRYLGKMTKLKVLDLSFNRLRGQIPSNFDDLYDVDYIYFAGN 265
+ L L + +TG + R L K+KVLDL NR+ IP + L + + A N
Sbjct: 427 AESILVLNLSSNMLTGSVFRCLP--PKVKVLDLHNNRIM-SIPKDVTHLQALQELNVASN 483
Query: 266 LLTGAIPPWMLERGDK---IDLSYNNF 289
L ++P + +R I L N +
Sbjct: 484 QLK-SVPDGVFDRLTSLQYIWLHDNPW 509
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 45.6 bits (108), Expect = 5e-05
Identities = 26/175 (14%), Positives = 54/175 (30%), Gaps = 10/175 (5%)
Query: 85 ANI-STLVNLTVQYNQFSGELPEELGSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRI 143
++ L++ N S ++ L L L LS N F +++ +
Sbjct: 48 KDLPPRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDLEYLDV 107
Query: 144 SDNQFTGQIPSFIQNWTKLEKLFIQPSGLAGPIPSGIFSLENLTDLRISDLNGPE---AT 200
S N+ I L L + + F NLT L L+ +
Sbjct: 108 SHNRLQN-ISC--CPMASLRHLDLSFNDFDVLPVCKEFG--NLTKLTFLGLSAAKFRQLD 162
Query: 201 FPQLGNMKMTKLILRNCNITGE-LPRYLGKMTKLKVLDLSFNRLRGQIPSNFDDL 254
+ ++ ++ ++L + + ++ VL L F+ +
Sbjct: 163 LLPVAHLHLSCILLDLVSYHIKGGETESLQIPNTTVLHLVFHPNSLFSVQVNMSV 217
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 74.6 bits (184), Expect = 9e-15
Identities = 43/157 (27%), Positives = 62/157 (39%), Gaps = 30/157 (19%)
Query: 424 IGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCC- 481
+G G G V + A+K L + RE E+ A Q P++V++
Sbjct: 26 LGLGINGKVLQIFNKRTQEKFALKMLQ-DCPKARREV--EL-HWRASQCPHIVRIVDVYE 81
Query: 482 ---IEGNQLLLIYEYL---ENNSLARALFE---HRLKLDWPTR--RRICLGIARGLAYLH 530
LL++ E L E LF R + R I I + YLH
Sbjct: 82 NLYAGRKCLLIVMECLDGGE-------LFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH 134
Query: 531 GESRIKVVHRDIKATNVLL-DKDLNS--KISDFGLAK 564
I + HRD+K N+L K N+ K++DFG AK
Sbjct: 135 ---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 168
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 75.5 bits (186), Expect = 1e-14
Identities = 50/206 (24%), Positives = 83/206 (40%), Gaps = 28/206 (13%)
Query: 424 IGEGGFGPVYKGLLA----DGTAIAVKQLSSKSKQGNREFINEIG----MISALQHPNLV 475
IG G + V LL A++ + + + + A HP LV
Sbjct: 60 IGRGSYAKV---LLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLV 116
Query: 476 KLYGCCIEGNQLLLIYEYL---ENNSLARALFEHRLKLDWPTRRRICL---GIARGLAYL 529
L+ C ++L + EY+ + L H + I+ L YL
Sbjct: 117 GLHSCFQTESRLFFVIEYVNGGD-------LMFHMQRQRKLPEEHARFYSAEISLALNYL 169
Query: 530 HGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPEYA 589
H +++RD+K NVLLD + + K++D+G+ K ST GT Y+APE
Sbjct: 170 HER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTST-FCGTPNYIAPEIL 225
Query: 590 MRGHLTEKADVYSFGIVALEIVSGRS 615
D ++ G++ E+++GRS
Sbjct: 226 RGEDYGFSVDWWALGVLMFEMMAGRS 251
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 74.9 bits (183), Expect = 1e-14
Identities = 35/198 (17%), Positives = 60/198 (30%), Gaps = 52/198 (26%)
Query: 414 ATNNFATDNNIGEGGFGPVYKGLLADGTAIAVKQL--------SSKSKQGNREFINEIGM 465
T IGEG FG V++ + AD T +A+K + + ++ E + EI +
Sbjct: 18 PTEKLQRCEKIGEGVFGEVFQTI-ADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIII 76
Query: 466 ISALQ---------HPNLVKLYGCCI------------------------------EGNQ 486
L + L + +Q
Sbjct: 77 SKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQ 136
Query: 487 LLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATN 546
L ++ E+ + T + I + LA + ++ HRD+ N
Sbjct: 137 LFIVLEFEFGGIDLEQMRTK--LSSLATAKSILHQLTASLAVAE--ASLRFEHRDLHWGN 192
Query: 547 VLLDKDLNSKISDFGLAK 564
VLL K K+ K
Sbjct: 193 VLLKKTSLKKLHYTLNGK 210
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 74.6 bits (184), Expect = 2e-14
Identities = 56/206 (27%), Positives = 97/206 (47%), Gaps = 26/206 (12%)
Query: 424 IGEGGFGPVYKGL-LADGTAIAVKQLS--SKSKQGNREFINEIGMISALQHPNLVKLYGC 480
IGEG +G V + +A+K++S R EI ++ +H N++ +
Sbjct: 35 IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTL-REIKILLRFRHENIIGINDI 93
Query: 481 CI-----EGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLG---IARGLAYLHGE 532
+ + ++ + +E + L + L L + IC I RGL Y+H
Sbjct: 94 IRAPTIEQMKDVYIVQDLMETD-LYKLLKTQHL-----SNDHICYFLYQILRGLKYIHSA 147
Query: 533 SRIKVVHRDIKATNVLLDKDLNSKISDFGLAKL---DEEENTHISTRVAGTIGYMAPEYA 589
+ V+HRD+K +N+LL+ + KI DFGLA++ D + ++ VA T Y APE
Sbjct: 148 N---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA-TRWYRAPEIM 203
Query: 590 M-RGHLTEKADVYSFGIVALEIVSGR 614
+ T+ D++S G + E++S R
Sbjct: 204 LNSKGYTKSIDIWSVGCILAEMLSNR 229
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 73.9 bits (182), Expect = 3e-14
Identities = 55/203 (27%), Positives = 97/203 (47%), Gaps = 24/203 (11%)
Query: 424 IGEGGFGPVYKGL-LADGTAIAVKQLS---SKSKQGNREFINEIGMISALQHPNLVKLY- 478
+G G +G V G +AVK+LS R + E+ ++ ++H N++ L
Sbjct: 37 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLD 95
Query: 479 -----GCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGES 533
E N + L+ + + L + +L D + + I RGL Y+H
Sbjct: 96 VFTPARSLEEFNDVYLVTHLMGAD-LNNIVKCQKLTDD--HVQFLIYQILRGLKYIHSAD 152
Query: 534 RIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENT-HISTRVAGTIGYMAPEYAM-R 591
++HRD+K +N+ +++D KI DFGLA+ +E T +++TR Y APE +
Sbjct: 153 ---IIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGYVATRW-----YRAPEIMLNW 204
Query: 592 GHLTEKADVYSFGIVALEIVSGR 614
H + D++S G + E+++GR
Sbjct: 205 MHYNQTVDIWSVGCIMAELLTGR 227
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 70.4 bits (173), Expect = 5e-14
Identities = 26/163 (15%), Positives = 51/163 (31%), Gaps = 31/163 (19%)
Query: 84 LANISTLVNLT---VQYNQFSGELPEELGSLLNLEKLHLSSNNFTGELPKTFAKLTNMKD 140
L I N+ + + + L NLE+L + + T + + LT++
Sbjct: 59 LTGIEYAHNIKDLTINNIHATN--YNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTL 116
Query: 141 FRISDNQFTGQIPSFIQNWTKLEKLFIQPSGLAGPIPSGIFSLENLTDLRISDLNGPEAT 200
IS + I + I K+ + + +G I + I L+ L +L
Sbjct: 117 LDISHSAHDDSILTKINTLPKVNSIDLSYNGA---I-TDIMPLKTLPEL----------- 161
Query: 201 FPQLGNMKMTKLILRNCNITGELPRYLGKMTKLKVLDLSFNRL 243
L ++ + + KL L +
Sbjct: 162 ---------KSLNIQFDGVHDYRG--IEDFPKLNQLYAFSQTI 193
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 1e-10
Identities = 24/186 (12%), Positives = 67/186 (36%), Gaps = 37/186 (19%)
Query: 110 SLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRISDNQFTGQIPSFIQNWTKLEKLFIQP 169
+ L ++ T A++ ++ +++ T + + I+ ++ L
Sbjct: 21 TFKAYLNGLLGQSSTA---NITEAQMNSLTYITLANINVT-DL-TGIEYAHNIKDL---- 71
Query: 170 SGLAGPIPSGIFSLENLTDLRISDLNGPEATFPQLGNM-KMTKLILRNCNITGELPRYLG 228
+ ++ ++ N + + + +L + ++T + L
Sbjct: 72 ---------------TINNIHATNYNP-------ISGLSNLERLRIMGKDVTSDKIPNLS 109
Query: 229 KMTKLKVLDLSFNRLRGQIPSNFDDLYDVDYIYFAGNLLTGAIPPWMLERGDKI---DLS 285
+T L +LD+S + I + + L V+ I + N I P L+ ++ ++
Sbjct: 110 GLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDIMP--LKTLPELKSLNIQ 167
Query: 286 YNNFTD 291
++ D
Sbjct: 168 FDGVHD 173
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 43.4 bits (103), Expect = 7e-05
Identities = 15/123 (12%), Positives = 39/123 (31%), Gaps = 26/123 (21%)
Query: 28 NLTGVLPPKLAELTFLQDIDLTLNYLSGTIPSQWASLPLLNISLIANRLKGPIPKYLANI 87
++T P L+ LT L +D++ + +I ++ + +
Sbjct: 99 DVTSDKIPNLSGLTSLTLLDISHSAHDDSILTK-----------------------INTL 135
Query: 88 STLVNLTVQYNQFSGELPEELGSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRISDNQ 147
+ ++ + YN ++ L +L L+ L++ + +
Sbjct: 136 PKVNSIDLSYNGAITDI-MPLKTLPELKSLNIQFDGVHDYRG--IEDFPKLNQLYAFSQT 192
Query: 148 FTG 150
G
Sbjct: 193 IGG 195
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 72.4 bits (178), Expect = 6e-14
Identities = 39/228 (17%), Positives = 84/228 (36%), Gaps = 19/228 (8%)
Query: 66 LLNISLIANRLKGPIPKYLANISTLVNLTVQYNQFSGELPEELGSLLNLEKLHLSSNNFT 125
+ I+ + + + A++ + L+ + E + L NL L L N T
Sbjct: 21 AIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVTT--IEGVQYLNNLIGLELKDNQIT 76
Query: 126 GELPKTFAKLTNMKDFRISDNQFTGQIPSFIQNWTKLEKLFIQPSGLAGPIPSGIFSLEN 185
P LT + + +S N S I ++ L + + + + + L
Sbjct: 77 DLAP--LKNLTKITELELSGNPLK--NVSAIAGLQSIKTLDLTSTQI-----TDVTPLAG 127
Query: 186 LTDLRISDLNGPEAT-FPQLGNM-KMTKLILRNCNITGELPRYLGKMTKLKVLDLSFNRL 243
L++L++ L+ + T L + + L + N ++ P L ++KL L N++
Sbjct: 128 LSNLQVLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTP--LANLSKLTTLKADDNKI 185
Query: 244 RGQIPSNFDDLYDVDYIYFAGNLLTGAIPPWMLERGDKIDLSYNNFTD 291
S L ++ ++ N ++ P + L+ T+
Sbjct: 186 SD--ISPLASLPNLIEVHLKNNQISDVSPLANTSNLFIVTLTNQTITN 231
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 67.8 bits (166), Expect = 2e-12
Identities = 47/237 (19%), Positives = 95/237 (40%), Gaps = 20/237 (8%)
Query: 20 QKRVLKEQNLTGVLPPKLAELTFLQDIDLTLNYLSGTIPSQWASLPLLNISLIANRLKGP 79
K + N+T + A+L + + ++ TI L+ + L N++
Sbjct: 22 IKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVT-TIEGVQYLNNLIGLELKDNQITDL 78
Query: 80 IPKYLANISTLVNLTVQYNQFSGELPEELGSLLNLEKLHLSSNNFTGELPKTFAKLTNMK 139
P L N++ + L + N + L +++ L L+S T P A L+N++
Sbjct: 79 AP--LKNLTKITELELSGNPLKN--VSAIAGLQSIKTLDLTSTQITDVTP--LAGLSNLQ 132
Query: 140 DFRISDNQFTGQIPSFIQNWTKLEKLFIQPSGLAGPIPSGIFSLENLTDLRISDLNGPEA 199
+ NQ T I + T L+ L I + + S + L NL+ L + +
Sbjct: 133 VLYLDLNQIT-NISP-LAGLTNLQYLSIGNAQV-----SDLTPLANLSKLTTLKADDNKI 185
Query: 200 T-FPQLGNM-KMTKLILRNCNITGELPRYLGKMTKLKVLDLSFNRLRGQIPSNFDDL 254
+ L ++ + ++ L+N I+ P L + L ++ L+ + Q ++L
Sbjct: 186 SDISPLASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTNQTITNQPVFYNNNL 240
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 1e-09
Identities = 39/186 (20%), Positives = 72/186 (38%), Gaps = 15/186 (8%)
Query: 108 LGSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRISDNQFTGQIPSFIQNWTKLEKLFI 167
+L N K+ +N T T A L + T I +Q L L +
Sbjct: 15 DPALANAIKIAAGKSNVTD--TVTQADLDGITTLSAFGTGVT-TI-EGVQYLNNLIGLEL 70
Query: 168 QPSGLAGPIPSGIFSLENLTDLRISDLNG-PEATFPQLGNMK-MTKLILRNCNITGELPR 225
+ + + + + L+NLT + +L+G P + ++ + L L + IT P
Sbjct: 71 KDNQI-----TDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTP- 124
Query: 226 YLGKMTKLKVLDLSFNRLRGQIPSNFDDLYDVDYIYFAGNLLTGAIPPWMLERGDKIDLS 285
L ++ L+VL L N++ I S L ++ Y+ ++ P L + +
Sbjct: 125 -LAGLSNLQVLYLDLNQIT-NI-SPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKAD 181
Query: 286 YNNFTD 291
N +D
Sbjct: 182 DNKISD 187
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 44.7 bits (106), Expect = 7e-05
Identities = 20/114 (17%), Positives = 39/114 (34%), Gaps = 6/114 (5%)
Query: 180 IFSLENLTDLRISDLNGPEAT-FPQLGNM-KMTKLILRNCNITGELPRYLGKMTKLKVLD 237
IF L + T ++ +T L +T + + + L L+
Sbjct: 12 IFPDPALANAIKIAAGKSNVTDTVTQADLDGITTLSAFGTGVT-TIE-GVQYLNNLIGLE 69
Query: 238 LSFNRLRGQIPSNFDDLYDVDYIYFAGNLLTGAIPPWMLERGDKIDLSYNNFTD 291
L N++ + +L + + +GN L L+ +DL+ TD
Sbjct: 70 LKDNQITD--LAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITD 121
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 71.5 bits (176), Expect = 8e-14
Identities = 43/219 (19%), Positives = 76/219 (34%), Gaps = 24/219 (10%)
Query: 85 ANIST-LVNLTVQYNQFSGELPEELGSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRI 143
N+ NL + +N S L+ L LS + L+++ +
Sbjct: 24 DNLPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLIL 83
Query: 144 SDNQFTGQIPSFI-QNWTKLEKLFIQPSGLAGPIPSGIFS-LENLTDL-----RISDLNG 196
+ N + + L+KL + LA + + L+ L +L I
Sbjct: 84 TGNPIQ-SLALGAFSGLSSLQKLVAVETNLAS-LENFPIGHLKTLKELNVAHNLIQSFKL 141
Query: 197 PEATFPQLGNMKMTKLILRNCNITGELPRYLGKMTKLKV----LDLSFNRLRGQIPSN-F 251
PE F L N + L L + I L + ++ + LDLS N + I F
Sbjct: 142 PEY-FSNLTN--LEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMN-FIQPGAF 197
Query: 252 DDLYDVDYIYFAGNLLTGAIPPWMLERGDK---IDLSYN 287
++ + + N L ++P + +R I L N
Sbjct: 198 KEI-RLKELALDTNQLK-SVPDGIFDRLTSLQKIWLHTN 234
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 73.2 bits (180), Expect = 9e-14
Identities = 39/212 (18%), Positives = 65/212 (30%), Gaps = 21/212 (9%)
Query: 68 NISLIANRLKGPIPKYLANISTLVNLTVQYNQFSGELPEEL-GSLLNLEKLHLSSNNFTG 126
+ L N + + + L L V+ + L +L L L N F
Sbjct: 34 YVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQFLQ 93
Query: 127 ELPKTFAKLTNMKDFRISDNQFTG-QIPSFI-QNWTKLEKLFIQPSGLAGPIPSGIFSLE 184
F L N++ ++ G + + T LE L ++ + + P+ F
Sbjct: 94 LETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFL-- 151
Query: 185 NLTDLRISDLNG------PEATFPQLGNMKMTKLILRNCNITGELPRYLG---------K 229
N+ + DL E T L L + ++ Y K
Sbjct: 152 NMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLSS-ITLQDMNEYWLGWEKCGNPFK 210
Query: 230 MTKLKVLDLSFNRLRGQIPSNFDDLYDVDYIY 261
T + LDLS N + + F D I
Sbjct: 211 NTSITTLDLSGNGFKESMAKRFFDAIAGTKIQ 242
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 61.3 bits (149), Expect = 5e-10
Identities = 48/328 (14%), Positives = 96/328 (29%), Gaps = 65/328 (19%)
Query: 24 LKEQNLTGVLPPKL-AELTFLQDIDLTLNYLSGTIPSQ-WASLPLLNI-SLIANRLKGPI 80
+++Q V+ L+ L + L N + + + L L + +L L G +
Sbjct: 61 VEQQTPGLVIRNNTFRGLSSLIILKLDYNQFL-QLETGAFNGLANLEVLTLTQCNLDGAV 119
Query: 81 --PKYLANISTLVNLTVQYNQFSGELPEEL-GSLLNLEKLHLSSNNFTGELPKTFAKLT- 136
+ +++L L ++ N P ++ L L+ N +
Sbjct: 120 LSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKVKSICEEDLLNFQG 179
Query: 137 ---------NMKDFRISDNQFTGQIPSFIQNWTKLEKLFIQPSGLAGPIPSGIFSLENLT 187
++ +++ + T + L + +G + F T
Sbjct: 180 KHFTLLRLSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGT 239
Query: 188 DLRISDLNG----------------PEATFPQLGNMKMTKLILRNCNITGELP------- 224
++ L+ TF L + L I L
Sbjct: 240 KIQSLILSNSYNMGSSFGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIF-ALLKSVFSHF 298
Query: 225 ---RYLG---------------KMTKLKVLDLSFNRLRGQIPSN-FDDLYDVDYIYFAGN 265
L +T L L+LS N L G I S F++L ++ + + N
Sbjct: 299 TDLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFL-GSIDSRMFENLDKLEVLDLSYN 357
Query: 266 LLTGAIPPWM---LERGDKIDLSYNNFT 290
+ A+ L ++ L N
Sbjct: 358 HIR-ALGDQSFLGLPNLKELALDTNQLK 384
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 44.7 bits (106), Expect = 9e-05
Identities = 28/159 (17%), Positives = 57/159 (35%), Gaps = 31/159 (19%)
Query: 39 ELTFLQDIDLTLNYLSGTIPSQ-WASLPLL-NISLIANRLKGPIPKYLANISTLVNLTVQ 96
E + ++ DL+ + + + ++ L ++L N + ++ L+ L +
Sbjct: 273 EASGVKTCDLSKSKIF-ALLKSVFSHFTDLEQLTLAQNEINKIDDNAFWGLTHLLKLNLS 331
Query: 97 YNQFSGELPEEL-GSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRISDNQFTGQIPSF 155
N + + +L LE L LS N+ ++F L N+K+ + NQ
Sbjct: 332 QNFLG-SIDSRMFENLDKLEVLDLSYNHIRALGDQSFLGLPNLKELALDTNQLKS----- 385
Query: 156 IQNWTKLEKLFIQPSGLAGPIPSGIF-SLENLTDLRISD 193
+P GIF L +L + +
Sbjct: 386 --------------------VPDGIFDRLTSLQKIWLHT 404
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 42.0 bits (99), Expect = 5e-04
Identities = 28/120 (23%), Positives = 51/120 (42%), Gaps = 6/120 (5%)
Query: 33 LPPKL-AELTFLQDIDLTLNYLSGTIPSQ-WASLP-LLNISLIANRLKGPIPKYLANIST 89
L + + T L+ + L N ++ I + L LL ++L N L + N+
Sbjct: 290 LLKSVFSHFTDLEQLTLAQNEIN-KIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDK 348
Query: 90 LVNLTVQYNQFSGELPEEL-GSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRISDNQF 148
L L + YN L ++ L NL++L L +N F +LT+++ + N +
Sbjct: 349 LEVLDLSYNHIR-ALGDQSFLGLPNLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPW 407
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 71.9 bits (177), Expect = 1e-13
Identities = 57/214 (26%), Positives = 101/214 (47%), Gaps = 33/214 (15%)
Query: 424 IGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLY---- 478
+G GG G V+ + +A+K++ Q + + EI +I L H N+VK++
Sbjct: 19 LGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILG 78
Query: 479 ----------GCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICL---GIARG 525
G E N + ++ EY+E + LA L + L L + RG
Sbjct: 79 PSGSQLTDDVGSLTELNSVYIVQEYMETD-LANVLEQGPL-----LEEHARLFMYQLLRG 132
Query: 526 LAYLHGESRIKVVHRDIKATNVLLD-KDLNSKISDFGLAKL---DEEENTHISTRVAGTI 581
L Y+H + V+HRD+K N+ ++ +DL KI DFGLA++ H+S + T
Sbjct: 133 LKYIHSAN---VLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLV-TK 188
Query: 582 GYMAPEYAMR-GHLTEKADVYSFGIVALEIVSGR 614
Y +P + + T+ D+++ G + E+++G+
Sbjct: 189 WYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 222
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 69.3 bits (170), Expect = 2e-13
Identities = 42/199 (21%), Positives = 76/199 (38%), Gaps = 12/199 (6%)
Query: 88 STLVNLTVQYNQFSGELPEELGSLLNLEKLHLSSNNFTGELP-KTFAKLTNMKDFRISDN 146
+ L + +L N+ ++++S + +L +F L+ + I +
Sbjct: 31 PSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNT 90
Query: 147 QFTGQIPSFI-QNWTKLEKLFIQPSGLAG-PIPSGIFSLENLTDLRISDLNG----PEAT 200
+ I + L+ L I +GL P + ++S + L I+D P
Sbjct: 91 RNLTYIDPDALKELPLLKFLGIFNTGLKMFPDLTKVYSTDIFFILEITDNPYMTSIPVNA 150
Query: 201 FPQLGNMKMTKLILRNCNITGELPRYLGKMTKLKVLDLSFNRLRGQIPSN-FDDLYDV-D 258
F L N +T L L N T + Y TKL + L+ N+ I + F +Y
Sbjct: 151 FQGLCNETLT-LKLYNNGFT-SVQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGVYSGPS 208
Query: 259 YIYFAGNLLTGAIPPWMLE 277
+ + +T A+P LE
Sbjct: 209 LLDVSQTSVT-ALPSKGLE 226
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 56.9 bits (138), Expect = 4e-09
Identities = 34/190 (17%), Positives = 61/190 (32%), Gaps = 15/190 (7%)
Query: 113 NLEKLHLSSNNFTGELPKTFAKLTNMKDFRISDNQFTGQIPSFI-QNWTKLEKLFIQPSG 171
+ + L L + F+ L N+ +S + Q+ S N +K+ + I+ +
Sbjct: 32 STQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTR 91
Query: 172 LAGPIPSGIFS-LENLTDLRISDLNG----PEATFPQLGNMKMTKLILRNCNITGELPRY 226
I L L L I + G P+ T ++ I N +T
Sbjct: 92 NLTYIDPDALKELPLLKFLGIFN-TGLKMFPDLTKVYSTDIFFILEITDNPYMTSIPVNA 150
Query: 227 LGKMTK-LKVLDLSFNRLRGQIPSN-FDDLYDVDYIYFAGNLLTGAIPPWM---LERG-D 280
+ L L N + F+ +D +Y N I + G
Sbjct: 151 FQGLCNETLTLKLYNNGFT-SVQGYAFNGTK-LDAVYLNKNKYLTVIDKDAFGGVYSGPS 208
Query: 281 KIDLSYNNFT 290
+D+S + T
Sbjct: 209 LLDVSQTSVT 218
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 70.9 bits (174), Expect = 5e-13
Identities = 44/189 (23%), Positives = 88/189 (46%), Gaps = 28/189 (14%)
Query: 424 IGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQGNREFIN---------EIGMISALQHPN 473
IG G +G VY +A+K+++ R F + EI +++ L+
Sbjct: 34 IGRGSYGYVYLAYDKNTEKNVAIKKVN-------RMFEDLIDCKRILREITILNRLKSDY 86
Query: 474 LVKLYGCCI-----EGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAY 528
+++LY I + ++L ++ E +++ L + LF+ + L + I + G +
Sbjct: 87 IIRLYDLIIPDDLLKFDELYIVLEIADSD-LKK-LFKTPIFLTEEHIKTILYNLLLGENF 144
Query: 529 LHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLA-KLDEEENTHISTRVAGTIGYMAPE 587
+H ++HRD+K N LL++D + K+ DFGLA ++ E++T+I +
Sbjct: 145 IHESG---IIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHN 201
Query: 588 YAMRGHLTE 596
++ LT
Sbjct: 202 KNLKKQLTS 210
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 69.9 bits (171), Expect = 1e-12
Identities = 39/194 (20%), Positives = 81/194 (41%), Gaps = 33/194 (17%)
Query: 424 IGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQGNREFIN---------EIGMISALQHPN 473
IG G +G V + + +A+K++ R F + EI +++ L H +
Sbjct: 61 IGTGSYGHVCEAYDKLEKRVVAIKKIL-------RVFEDLIDCKRILREIAILNRLNHDH 113
Query: 474 LVKLYGCCI-----EGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAY 528
+VK+ I + ++L ++ E +++ + LF + L + + + G+ Y
Sbjct: 114 VVKVLDIVIPKDVEKFDELYVVLEIADSD-FKK-LFRTPVYLTELHIKTLLYNLLVGVKY 171
Query: 529 LHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLA------KLDEEENTHISTRVAGTIG 582
+H ++HRD+K N L+++D + K+ DFGLA + + +
Sbjct: 172 VHSAG---ILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLV 228
Query: 583 YMAPEYAMRGHLTE 596
++ LT
Sbjct: 229 TFPHTKNLKRQLTG 242
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 68.3 bits (167), Expect = 2e-12
Identities = 42/210 (20%), Positives = 71/210 (33%), Gaps = 56/210 (26%)
Query: 80 IPKYLANIST-LVNLTVQYNQFSGELPEE--LGSLLNLEKLHLSSNNFTGELPKTFAKLT 136
+P ++ + L + +N S L E L NL L LS N+ + F +
Sbjct: 33 VP---QSLPSYTALLDLSHNNLS-RLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVP 88
Query: 137 NMKDFRISDNQFTGQIPSFIQNWTKLEKLFIQPSGLAGPIPSGIFS-LENLTDL-----R 190
N++ +S N + +FS L+ L L
Sbjct: 89 NLRYLDLSSNHLHT-------------------------LDEFLFSDLQALEVLLLYNNH 123
Query: 191 ISDLNGPEATFPQLGNMKMTKLILRNCNITGELP----RYLGKMTKLKVLDLSFNRLRGQ 246
I + F + + KL L I+ P + K+ KL +LDLS N+L+
Sbjct: 124 IVVV--DRNAFEDMAQL--QKLYLSQNQIS-RFPVELIKDGNKLPKLMLLDLSSNKLKKL 178
Query: 247 IPSNFDDL--YDVDYIYFAGNLLTGAIPPW 274
++ L + + +Y N P
Sbjct: 179 PLTDLQKLPAWVKNGLYLHNN-------PL 201
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 56.4 bits (136), Expect = 1e-08
Identities = 44/205 (21%), Positives = 62/205 (30%), Gaps = 49/205 (23%)
Query: 27 QNLTGV---LPPKLAELTFLQDIDLTLNYLSGTIPSQWASLPLLN---ISLIANRLKGPI 80
Q L V LP A L DL+ N LS + ++W L N + L N L I
Sbjct: 28 QQLPNVPQSLPSYTALL------DLSHNNLS-RLRAEWTPTRLTNLHSLLLSHNHLNF-I 79
Query: 81 PKY-LANISTLVNLTVQYNQFSGELPEE-LGSLLNLEKLHLSSNNFTGELPKTFAKLTNM 138
+ L L + N L E L LE L L +N+ F + +
Sbjct: 80 SSEAFVPVPNLRYLDLSSNHLH-TLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQL 138
Query: 139 KDFRISDNQFTGQIPSFIQNWTKLEKLFIQPSGLAGPIPSGIFS-LENLTDLRISDLNG- 196
+ +S NQ + P + L L + DL+
Sbjct: 139 QKLYLSQNQISR-------------------------FPVELIKDGNKLPKLMLLDLSSN 173
Query: 197 -----PEATFPQLGNMKMTKLILRN 216
P +L L L N
Sbjct: 174 KLKKLPLTDLQKLPAWVKNGLYLHN 198
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 68.6 bits (168), Expect = 3e-12
Identities = 55/348 (15%), Positives = 103/348 (29%), Gaps = 47/348 (13%)
Query: 19 NQKRVLKEQNLTGVLPPKLAELTFLQDIDLTLNYLSGTIPSQWASLPLLNISLIANRLKG 78
Q L + + T L +D + N ++ SQ L LN N +
Sbjct: 148 TQLTELDCHLNKKITKLDVTPQTQLTTLDCSFNKITELDVSQNKLLNRLNCD--TNNITK 205
Query: 79 PIPKYLANISTLVNLTVQYNQFSGELPEELGSLLNLEKLHLSSNNFTGELPKTFAKLTNM 138
+ L L L N+ + E+ + L L S N T EL + L+ +
Sbjct: 206 -LD--LNQNIQLTFLDCSSNKLT-EID--VTPLTQLTYFDCSVNPLT-ELD--VSTLSKL 256
Query: 139 KDFRISDNQFTGQIPSFIQNWTKLEKLFIQPSGLAGPIPSGIFSLENLTDLRISDLNGPE 198
+I + + T+L E ++ D+
Sbjct: 257 TTLHCIQTDLL-EID--LTHNTQLIYF----------------QAEGCRKIKELDVT--- 294
Query: 199 ATFPQLGNMKMTKLILRNCNITGELPRYLGKMTKLKVLDLSFNRLRGQIPSNFDDLYDVD 258
N ++ L + IT EL L + KL L L+ L ++ +
Sbjct: 295 ------HNTQLYLLDCQAAGIT-ELD--LSQNPKLVYLYLNNTELT-ELD--VSHNTKLK 342
Query: 259 YIYFAGNLLTGAIPPWMLERGDKIDLSYNNFTDGSAESSCQKRSVTGIVSCLRSVQCPKT 318
+ + + + + E + S+T VS +
Sbjct: 343 SLSCVNAHIQDFSSVGKIPALNNNFEAEGQTITMPKE-TLTNNSLTIAVS-PDLLDQFGN 400
Query: 319 YYSLHINCGGKQVTANGNTTFEEDTSEAGPSTFSQSGTNWVLSSTGHF 366
++ GG A T+E +++ T++ + N + T
Sbjct: 401 PMNIEPGDGGVYDQATNTITWENLSTDNPAVTYTFTSENGAIVGTVTT 448
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 63.2 bits (154), Expect = 1e-10
Identities = 50/273 (18%), Positives = 81/273 (29%), Gaps = 45/273 (16%)
Query: 40 LTFLQDIDLTLNYLSGTIPSQWASLPLLNISLIANRLKGPIPKYLANISTLVNLT---VQ 96
+ Q A+L L+ + + + I L LT
Sbjct: 20 FASEVAAAFEMQATDTISEEQLATLTSLDCH--NSSITD-----MTGIEKLTGLTKLICT 72
Query: 97 YNQFSGELPEELGSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRISDNQFTG------ 150
N + L L NL L SN T L LT + N+ T
Sbjct: 73 SNNIT-TLD--LSQNTNLTYLACDSNKLT-NLD--VTPLTKLTYLNCDTNKLTKLDVSQN 126
Query: 151 -----------QIPSF-IQNWTKLEKLFIQPSGLAGPIPSGIFSLENLTDLRISDLNGPE 198
+ + + T+L +L + + + LT L S E
Sbjct: 127 PLLTYLNCARNTLTEIDVSHNTQLTELDCHLNKKITKLD--VTPQTQLTTLDCSFNKITE 184
Query: 199 ATFPQLGNMKMTKLILRNCNITGELPRYLGKMTKLKVLDLSFNRLRGQIPSNFDDLYDVD 258
Q + +L NIT +L L + +L LD S N+L +I L +
Sbjct: 185 LDVSQNKL--LNRLNCDTNNIT-KLD--LNQNIQLTFLDCSSNKLT-EID--VTPLTQLT 236
Query: 259 YIYFAGNLLTGAIPPWMLERGDKIDLSYNNFTD 291
Y + N LT + L + + + +
Sbjct: 237 YFDCSVNPLT-ELDVSTLSKLTTLHCIQTDLLE 268
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 54.7 bits (132), Expect = 7e-08
Identities = 29/179 (16%), Positives = 56/179 (31%), Gaps = 13/179 (7%)
Query: 113 NLEKLHLSSNNFTGELPKTFAKLTNMKDFRISDNQFTGQIPSFIQNWTKLEKLFIQPSGL 172
N ++ + +L + ++ T + I+ T L KL + +
Sbjct: 19 NFASEVAAAFEMQATDTISEEQLATLTSLDCHNSSITD--MTGIEKLTGLTKLICTSNNI 76
Query: 173 AGPIPSGIFSLENLTDLRISDLNGPEATFPQLGNMKMTKLILRNCNITGELPRYLGKMTK 232
+ + NLT L N K+T L +T +L + +
Sbjct: 77 TT-LD--LSQNTNLTYLACDS-NKLT-NLDVTPLTKLTYLNCDTNKLT-KLD--VSQNPL 128
Query: 233 LKVLDLSFNRLRGQIPSNFDDLYDVDYIYFAGNLLTGAIPPWMLERGDKIDLSYNNFTD 291
L L+ + N L S+ L + N + + +D S+N T+
Sbjct: 129 LTYLNCARNTLTEIDVSHNTQLT---ELDCHLNKKITKLDVTPQTQLTTLDCSFNKITE 184
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 67.7 bits (166), Expect = 3e-12
Identities = 51/212 (24%), Positives = 91/212 (42%), Gaps = 31/212 (14%)
Query: 424 IGEGGFGPVYKGL-LADGTAIAVKQLS--SKSKQGNREFINEIGMISALQHPNLVKLY-- 478
+GEG +G V G +A+K++ K R EI ++ +H N++ ++
Sbjct: 19 LGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTL-REIKILKHFKHENIITIFNI 77
Query: 479 ---GCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICL---GIARGLAYLHGE 532
N++ +I E ++ + L R + L + I R + LHG
Sbjct: 78 QRPDSFENFNEVYIIQELMQTD-LHRVISTQML-----SDDHIQYFIYQTLRAVKVLHGS 131
Query: 533 SRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIG---------Y 583
+ V+HRD+K +N+L++ + + K+ DFGLA++ +E S G Y
Sbjct: 132 N---VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWY 188
Query: 584 MAPEYAM-RGHLTEKADVYSFGIVALEIVSGR 614
APE + + DV+S G + E+ R
Sbjct: 189 RAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 67.2 bits (164), Expect = 5e-12
Identities = 36/190 (18%), Positives = 65/190 (34%), Gaps = 17/190 (8%)
Query: 113 NLEKLHLSSNNFTGELPKTFAKLTNMKDFRISDNQFTGQIPSFI-QNWTKLEKLFIQPSG 171
N +L F+ +++ IS N I + + N KL ++ I+ +
Sbjct: 31 NAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKAN 90
Query: 172 LAGPIPSGIFS-LENLTDLRISDLNG----PEATFPQLGNMKMTKLILRNCNITGELPRY 226
I F L NL L IS+ G P+ + + N NI + R
Sbjct: 91 NLLYINPEAFQNLPNLQYLLISN-TGIKHLPDVHKIHSLQKVLLDI-QDNINIH-TIERN 147
Query: 227 L--GKMTKLKVLDLSFNRLRGQIPSN-FDDLYDVDYIYFAGNLLTGAIPP---WMLERGD 280
G + +L L+ N ++ +I ++ F+ + N L +P
Sbjct: 148 SFVGLSFESVILWLNKNGIQ-EIHNSAFNGTQLDELNLSDNNNLE-ELPNDVFHGASGPV 205
Query: 281 KIDLSYNNFT 290
+D+S
Sbjct: 206 ILDISRTRIH 215
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 66.0 bits (161), Expect = 1e-11
Identities = 45/219 (20%), Positives = 84/219 (38%), Gaps = 13/219 (5%)
Query: 32 VLPPK-LAELTFLQDIDLTLNYLSGTIPSQ-WASLPLLNISLI--ANRLKGPIPKYLANI 87
V+ + L+ I+++ N + I + +++LP L+ I AN L P+ N+
Sbjct: 44 VIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNL 103
Query: 88 STLVNLTVQYNQFSGELPEEL-GSLLNLEKLHLSSNNFTGELP-KTFAKLT-NMKDFRIS 144
L L + LP+ L L + N + +F L+ ++
Sbjct: 104 PNLQYLLISNTGIK-HLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLN 162
Query: 145 DNQFTGQIPSFIQNWTKLEKLFIQPSGLAGPIPSGIFS-LENLTDLRISDLNGPEATFPQ 203
N +I + N T+L++L + + +P+ +F L IS + P
Sbjct: 163 KNGIQ-EIHNSAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDIS--RTRIHSLPS 219
Query: 204 LGNMKMTKLILRNCNITGELPRYLGKMTKLKVLDLSFNR 242
G + KL R+ +LP L K+ L L++
Sbjct: 220 YGLENLKKLRARSTYNLKKLPT-LEKLVALMEASLTYPS 257
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 63.3 bits (154), Expect = 8e-11
Identities = 44/223 (19%), Positives = 77/223 (34%), Gaps = 20/223 (8%)
Query: 43 LQDIDLTLNYLSGTIPSQ-WASLPLL-NISLIANRLKGPIPKY-LANISTLVNLTVQ-YN 98
++ L L I ++ L I + N + I +N+ L + ++ N
Sbjct: 32 AIELRFVLTKLR-VIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKAN 90
Query: 99 QFSGELPEELGSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRISDNQFTGQIP--SFI 156
PE +L NL+ L +S+ I DN I SF+
Sbjct: 91 NLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFV 150
Query: 157 QNWTKLEKLFIQPSGLAGPIPSGIFSLENLTDLRISDLNG----PEATFPQLGNMKMTKL 212
+ L++ +G+ I + F+ L +L +SD N P F L
Sbjct: 151 GLSFESVILWLNKNGIQE-IHNSAFNGTQLDELNLSDNNNLEELPNDVFHGASG--PVIL 207
Query: 213 ILRNCNITGELPRY-LGKMTKLKVLDLSFNRLRGQIPSNFDDL 254
+ I LP Y L + KL+ + ++P+ + L
Sbjct: 208 DISRTRIH-SLPSYGLENLKKLRARSTYNLK---KLPT-LEKL 245
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 66.2 bits (162), Expect = 6e-12
Identities = 47/180 (26%), Positives = 72/180 (40%), Gaps = 17/180 (9%)
Query: 416 NNFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQGNREFINEIGMISALQH-PN 473
N + IG G FG +Y G +A G +A+K K+K E + +Q
Sbjct: 9 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHI--ESKIYKMMQGGVG 66
Query: 474 LVKLYGCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGES 533
+ + C EG+ +++ E L SL K T + + + Y+H ++
Sbjct: 67 IPTIRWCGAEGDYNVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN 125
Query: 534 RIKVVHRDIKATNVLLDKDLNSK---ISDFGLAK--LDEEENTHISTR----VAGTIGYM 584
+HRD+K N L+ I DFGLAK D + HI R + GT Y
Sbjct: 126 ---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYA 182
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 67.4 bits (164), Expect = 9e-12
Identities = 39/216 (18%), Positives = 82/216 (37%), Gaps = 29/216 (13%)
Query: 84 LANISTLVNLTVQYNQFSGELPEELGSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRI 143
+ + ++ + + L +++++ ++++ + + L N+ +
Sbjct: 17 DDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK-SV-QGIQYLPNVTKLFL 72
Query: 144 SDNQFTGQIPSFIQNWTKLEKLFIQPSGLAGPIPSGIFSLENLTDL--------RISDLN 195
+ N+ T I + N L LF+ + + + SL++L L ISD+N
Sbjct: 73 NGNKLT-DI-KPLTNLKNLGWLFLDENKI-----KDLSSLKDLKKLKSLSLEHNGISDIN 125
Query: 196 GPEATFPQLGNMKMTKLILRNCNITGELPRYLGKMTKLKVLDLSFNRLRGQIPSNFDDLY 255
G L + L L N IT L ++TKL L L N++ I L
Sbjct: 126 G----LVHLPQL--ESLYLGNNKITD--ITVLSRLTKLDTLSLEDNQIS-DI-VPLAGLT 175
Query: 256 DVDYIYFAGNLLTGAIPPWMLERGDKIDLSYNNFTD 291
+ +Y + N ++ L+ D ++L +
Sbjct: 176 KLQNLYLSKNHISDLRALAGLKNLDVLELFSQECLN 211
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 62.4 bits (151), Expect = 3e-10
Identities = 36/189 (19%), Positives = 74/189 (39%), Gaps = 17/189 (8%)
Query: 106 EELGSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRISDNQFTGQIPSFIQNWTKLEKL 165
+ K +L + T + +L ++ +++ + IQ + KL
Sbjct: 15 FPDDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK-SV-QGIQYLPNVTKL 70
Query: 166 FIQPSGLAGPIPSGIFSLENLTDLRISDLNG-PEATFPQLGNM-KMTKLILRNCNITGEL 223
F+ + L + I L NL +L L+ L ++ K+ L L + I+ ++
Sbjct: 71 FLNGNKL-----TDIKPLTNLKNLGWLFLDENKIKDLSSLKDLKKLKSLSLEHNGIS-DI 124
Query: 224 PRYLGKMTKLKVLDLSFNRLRGQIPSNFDDLYDVDYIYFAGNLLTGAIPPWM-LERGDKI 282
L + +L+ L L N++ + L +D + N ++ I P L + +
Sbjct: 125 N-GLVHLPQLESLYLGNNKI--TDITVLSRLTKLDTLSLEDNQIS-DIVPLAGLTKLQNL 180
Query: 283 DLSYNNFTD 291
LS N+ +D
Sbjct: 181 YLSKNHISD 189
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 62.0 bits (150), Expect = 5e-10
Identities = 41/235 (17%), Positives = 89/235 (37%), Gaps = 34/235 (14%)
Query: 37 LAELTFLQDIDLTLNYLSGTIP-SQWASLPLLNISLIANRLKGPIPKYLANISTLVNLT- 94
+L ++ + ++ S+ + + + +K + I L N+T
Sbjct: 17 DDAFAETIKDNLKKKSVTDAVTQNELNSIDQIIAN--NSDIK-----SVQGIQYLPNVTK 69
Query: 95 --VQYNQFSGELPEELGSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRISDNQFTGQI 152
+ N+ + + L +L NL L L N +L + L +K + N + I
Sbjct: 70 LFLNGNKLTDI--KPLTNLKNLGWLFLDENKIK-DLS-SLKDLKKLKSLSLEHNGIS-DI 124
Query: 153 PSFIQNWTKLEKLFIQPSGLAGPIPSGIFSLENLTDL-----RISDLNGPEATFPQLGNM 207
+ + + +LE L++ + + + + L L L +ISD+ L +
Sbjct: 125 -NGLVHLPQLESLYLGNNKIT--DITVLSRLTKLDTLSLEDNQISDIVP-------LAGL 174
Query: 208 -KMTKLILRNCNITGELPRYLGKMTKLKVLDLSFNRLRGQIPSNFDDLYDVDYIY 261
K+ L L +I+ +L L + L VL+L + ++ +L + +
Sbjct: 175 TKLQNLYLSKNHIS-DLR-ALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVK 227
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 45.5 bits (107), Expect = 5e-05
Identities = 18/114 (15%), Positives = 43/114 (37%), Gaps = 6/114 (5%)
Query: 180 IFSLENLTDLRISDLNGPEAT-FPQLGNM-KMTKLILRNCNITGELPRYLGKMTKLKVLD 237
IF + + +L T + + ++I N +I + + + L
Sbjct: 14 IFPDDAFAETIKDNLKKKSVTDAVTQNELNSIDQIIANNSDIKSVQG--IQYLPNVTKLF 71
Query: 238 LSFNRLRGQIPSNFDDLYDVDYIYFAGNLLTGAIPPWMLERGDKIDLSYNNFTD 291
L+ N+L I +L ++ +++ N + L++ + L +N +D
Sbjct: 72 LNGNKLT-DI-KPLTNLKNLGWLFLDENKIKDLSSLKDLKKLKSLSLEHNGISD 123
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 43.2 bits (101), Expect = 3e-04
Identities = 31/132 (23%), Positives = 52/132 (39%), Gaps = 9/132 (6%)
Query: 37 LAELTFLQDIDLTLNYLSGTIP-SQWASLPLLNISLIANRLKGPIPKYLANISTLVNLTV 95
L L L+ + L N ++ S+ L L++ N++ +P LA ++ L NL +
Sbjct: 127 LVHLPQLESLYLGNNKITDITVLSRLTKLDTLSLE--DNQISDIVP--LAGLTKLQNLYL 182
Query: 96 QYNQFSGELPEELGSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRISDNQFTGQIPSF 155
N S +L L L NL+ L L S + + L + +D P
Sbjct: 183 SKNHIS-DL-RALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSL--VTPEI 238
Query: 156 IQNWTKLEKLFI 167
I + EK +
Sbjct: 239 ISDDGDYEKPNV 250
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 65.9 bits (161), Expect = 1e-11
Identities = 48/215 (22%), Positives = 87/215 (40%), Gaps = 33/215 (15%)
Query: 424 IGEGGFGPVYKGL-LADGTAIAVKQLSSKSK---QGNRE-----FINEIGMI--SALQHP 472
+G G F V+ + + T +A+K + E +N+ ++
Sbjct: 27 LGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGAN 86
Query: 473 NLVKLYGC----CIEGNQLLLIYEYLENN--SLARALFEHRLKLDWPTRRRICLGIARGL 526
+++KL G +++++E L N +L + + L ++I + GL
Sbjct: 87 HILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPL--IYVKQISKQLLLGL 144
Query: 527 AYLHGESRIKVVHRDIKATNVLLDKDLNS------KISDFGLA-KLDEEENTHISTRVAG 579
Y+H I +H DIK NVL++ + KI+D G A DE I TR
Sbjct: 145 DYMHRRCGI--IHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTRE-- 200
Query: 580 TIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGR 614
Y +PE + AD++S + E+++G
Sbjct: 201 ---YRSPEVLLGAPWGCGADIWSTACLIFELITGD 232
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 64.7 bits (158), Expect = 3e-11
Identities = 46/182 (25%), Positives = 69/182 (37%), Gaps = 19/182 (10%)
Query: 416 NNFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQGNREFINEIGMISALQH-PN 473
NF IG G FG + G L +A+K KS+ E L
Sbjct: 9 PNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHL--EYRFYKQLGSGDG 66
Query: 474 LVKLYGCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGES 533
+ ++Y G ++ E L SL T I + + + Y+H ++
Sbjct: 67 IPQVYYFGPCGKYNAMVLELL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKN 125
Query: 534 RIKVVHRDIKATNVLLDKDLNSK-----ISDFGLAK--LDEEENTHISTR----VAGTIG 582
+++RD+K N L+ + N I DF LAK +D E HI R + GT
Sbjct: 126 ---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGTAR 182
Query: 583 YM 584
YM
Sbjct: 183 YM 184
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 63.9 bits (156), Expect = 3e-11
Identities = 44/182 (24%), Positives = 73/182 (40%), Gaps = 19/182 (10%)
Query: 416 NNFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQGNREFINEIGMISALQH-PN 473
++ IGEG FG +++G L + +A+K +S + +E L
Sbjct: 10 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD--APQLRDEYRTYKLLAGCTG 67
Query: 474 LVKLYGCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGES 533
+ +Y EG +L+ + L SL L K T + + +H +S
Sbjct: 68 IPNVYYFGQEGLHNVLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS 126
Query: 534 RIKVVHRDIKATNVLLDKDLNSK-----ISDFGLAK--LDEEENTHISTR----VAGTIG 582
+V+RDIK N L+ + + + DFG+ K D HI R ++GT
Sbjct: 127 ---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTAR 183
Query: 583 YM 584
YM
Sbjct: 184 YM 185
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 64.6 bits (157), Expect = 5e-11
Identities = 48/180 (26%), Positives = 76/180 (42%), Gaps = 17/180 (9%)
Query: 416 NNFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQGNREFINEIGMISALQ-HPN 473
N F IG G FG +Y G + +A+K + K+K + + + E + LQ
Sbjct: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLLYESKIYRILQGGTG 64
Query: 474 LVKLYGCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGES 533
+ + +EG+ +L+ + L SL KL T + + + ++H +S
Sbjct: 65 IPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS 123
Query: 534 RIKVVHRDIKATNVLLDKDLNSK---ISDFGLAKL--DEEENTHISTR----VAGTIGYM 584
+HRDIK N L+ + I DFGLAK D + HI R + GT Y
Sbjct: 124 ---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYA 180
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 64.0 bits (156), Expect = 7e-11
Identities = 50/210 (23%), Positives = 90/210 (42%), Gaps = 37/210 (17%)
Query: 424 IGEGGFGPVYKGL-LADGTAIAVKQLSSKSK---QGNREFINEIGMISALQH------PN 473
IG+G FG V K +A+K + ++ + Q EI ++ L+ N
Sbjct: 105 IGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQA----AEEIRILEHLRKQDKDNTMN 160
Query: 474 LVKLYGCCIEGNQLLLIYEYLENNSLARALFEHRLK------LDWPTRRRICLGIARGLA 527
++ + N + + +E L N L+E +K P R+ I + L
Sbjct: 161 VIHMLENFTFRNHICMTFELLSMN-----LYEL-IKKNKFQGFSLPLVRKFAHSILQCLD 214
Query: 528 YLHGESRIKVVHRDIKATNVLLDKDLNS--KISDFGLAKLDEEE-NTHISTRVAGTIGYM 584
LH + +++H D+K N+LL + S K+ DFG + + + T+I +R Y
Sbjct: 215 ALH---KNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVYTYIQSRF-----YR 266
Query: 585 APEYAMRGHLTEKADVYSFGIVALEIVSGR 614
APE + D++S G + E+++G
Sbjct: 267 APEVILGARYGMPIDMWSLGCILAELLTGY 296
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 62.3 bits (152), Expect = 8e-11
Identities = 34/187 (18%), Positives = 78/187 (41%), Gaps = 14/187 (7%)
Query: 106 EELGSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRISDNQFTGQIPSFIQNWTKLEKL 165
L N K +L + T + +L+ +++F ++ + + +Q +T L++L
Sbjct: 13 FPDPGLANAVKQNLGKQSVTDLVS--QKELSGVQNFNGDNSNIQ-SL-AGMQFFTNLKEL 68
Query: 166 FIQPSGLAGPIPSGIFSLENLTDLRISDLNGPE-ATFPQLGNMKMTKLILRNCNITGELP 224
+ + + S + L++LT L +N + + +++L L N +
Sbjct: 69 HLSHNQI-----SDLSPLKDLTKLEELSVNRNRLKNLNGIPSACLSRLFLDNNELRDTDS 123
Query: 225 RYLGKMTKLKVLDLSFNRLRGQIPSNFDDLYDVDYIYFAGNLLTGAIPPWMLERGDKIDL 284
L + L++L + N+L+ I L ++ + GN +T L++ + IDL
Sbjct: 124 --LIHLKNLEILSIRNNKLK-SI-VMLGFLSKLEVLDLHGNEITNTGGLTRLKKVNWIDL 179
Query: 285 SYNNFTD 291
+ +
Sbjct: 180 TGQKCVN 186
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 53.1 bits (128), Expect = 8e-08
Identities = 35/196 (17%), Positives = 72/196 (36%), Gaps = 26/196 (13%)
Query: 66 LLNISLIANRLKGPIPKYLANISTLVNLTVQYNQFSGELPEELGSLLNLEKLHLSSNNFT 125
+ +L + + +S + N + + NL++LHLS N +
Sbjct: 21 AVKQNLGKQSVTDLVS--QKELSGVQNFNGDNSNIQS--LAGMQFFTNLKELHLSHNQIS 76
Query: 126 GELPKTFAKLTNMKDFRISDNQFTGQIPSFIQNWTKLEKLFIQPSGLAGPIPSGIFSLEN 185
+L LT +++ ++ N+ + L +LF+ + L + L+N
Sbjct: 77 -DL-SPLKDLTKLEELSVNRNRLK-NLNGI--PSACLSRLFLDNNELRDT--DSLIHLKN 129
Query: 186 LTDL-----RISDLNGPEATFPQLGNM-KMTKLILRNCNITGELPRYLGKMTKLKVLDLS 239
L L ++ + LG + K+ L L IT L ++ K+ +DL+
Sbjct: 130 LEILSIRNNKLKSIVM-------LGFLSKLEVLDLHGNEITNTGG--LTRLKKVNWIDLT 180
Query: 240 FNRLRGQIPSNFDDLY 255
+ + +LY
Sbjct: 181 GQKCVNEPVKYQPELY 196
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 63.6 bits (155), Expect = 9e-11
Identities = 40/186 (21%), Positives = 82/186 (44%), Gaps = 26/186 (13%)
Query: 424 IGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQGNREFIN---------EIGMISALQ-HP 472
+G+G +G V+K + G +AVK++ F N EI +++ L H
Sbjct: 17 LGKGAYGIVWKSIDRRTGEVVAVKKIF-------DAFQNSTDAQRTFREIMILTELSGHE 69
Query: 473 NLVKLYGCCI--EGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLH 530
N+V L + L+++Y+E + L + + L+ ++ + + + + YLH
Sbjct: 70 NIVNLLNVLRADNDRDVYLVFDYMETD-LHAVIRANILEPV--HKQYVVYQLIKVIKYLH 126
Query: 531 GESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPEYAM 590
++HRD+K +N+LL+ + + K++DFGL++ +
Sbjct: 127 SGG---LLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDD 183
Query: 591 RGHLTE 596
+ LT+
Sbjct: 184 QPILTD 189
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 62.4 bits (152), Expect = 2e-10
Identities = 48/212 (22%), Positives = 88/212 (41%), Gaps = 35/212 (16%)
Query: 422 NNIGEGGFGPVYKGL-LADGTAIAVKQLSSKSK---QGNREFINEIGMISALQHP----- 472
+ IG+G FG V K + +A+K + +K Q E+ ++ +
Sbjct: 60 SLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQA----QIEVRLLELMNKHDTEMK 115
Query: 473 -NLVKLYGCCIEGNQLLLIYEYLENNSLARALFEHRLK------LDWPTRRRICLGIARG 525
+V L + N L L++E L N L++ L+ + R+ +
Sbjct: 116 YYIVHLKRHFMFRNHLCLVFEMLSYN-----LYDL-LRNTNFRGVSLNLTRKFAQQMCTA 169
Query: 526 LAYLHGESRIKVVHRDIKATNVLLDKDLNS--KISDFGLA-KLDEEENTHISTRVAGTIG 582
L +L + ++H D+K N+LL S KI DFG + +L + +I +R
Sbjct: 170 LLFLA-TPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQSRF----- 223
Query: 583 YMAPEYAMRGHLTEKADVYSFGIVALEIVSGR 614
Y +PE + D++S G + +E+ +G
Sbjct: 224 YRSPEVLLGMPYDLAIDMWSLGCILVEMHTGE 255
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 61.7 bits (150), Expect = 3e-10
Identities = 40/190 (21%), Positives = 70/190 (36%), Gaps = 33/190 (17%)
Query: 424 IGEGGFGPVYKGLLADGTAI------AVKQLSSKSKQ-----------GNREFINEIGMI 466
IG+GGFG +Y + ++ VK S + E I +
Sbjct: 43 IGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRT 102
Query: 467 SALQHPNLVKLYGCCIEGNQLL----LIYEYLENNSLARALFEHRLKLDWPTRRRICLGI 522
L++ + K +G + +I + + L + + + T ++ L I
Sbjct: 103 RKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRI 161
Query: 523 ARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKI--SDFGLAK--LDEEENTHISTR-- 576
L Y+H VH DIKA+N+LL+ ++ D+GLA E + +
Sbjct: 162 LDILEYIHEHE---YVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPK 218
Query: 577 --VAGTIGYM 584
GTI +
Sbjct: 219 RCHDGTIEFT 228
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 60.5 bits (147), Expect = 4e-10
Identities = 39/217 (17%), Positives = 85/217 (39%), Gaps = 31/217 (14%)
Query: 84 LANISTLVNLTVQYNQFSGELPEELGSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRI 143
+ + ++ + + L +++++ ++++ + + L N+ +
Sbjct: 20 DDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK-SV-QGIQYLPNVTKLFL 75
Query: 144 SDNQFTGQIPSFIQNWTKLEKLFIQPSGLAGPIPSGIFSLENLTDL--------RISDLN 195
+ N+ T I + N L LF+ + + + SL++L L ISD+N
Sbjct: 76 NGNKLT-DI-KPLANLKNLGWLFLDENKV-----KDLSSLKDLKKLKSLSLEHNGISDIN 128
Query: 196 GPEATFPQLGNM-KMTKLILRNCNITGELPRYLGKMTKLKVLDLSFNRLRGQIPSNFDDL 254
G L ++ ++ L L N IT L ++TKL L L N++ I L
Sbjct: 129 G-------LVHLPQLESLYLGNNKITD--ITVLSRLTKLDTLSLEDNQIS-DI-VPLAGL 177
Query: 255 YDVDYIYFAGNLLTGAIPPWMLERGDKIDLSYNNFTD 291
+ +Y + N ++ L+ D ++L +
Sbjct: 178 TKLQNLYLSKNHISDLRALAGLKNLDVLELFSQECLN 214
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 2e-09
Identities = 43/243 (17%), Positives = 93/243 (38%), Gaps = 34/243 (13%)
Query: 36 KLAELTFLQDIDLTLNYLSGTIP-SQWASLPLLNISLIANRLKGPIPKYLANISTLVNLT 94
+L ++ + ++ S+ + + + +K + I L N+T
Sbjct: 19 SDDAFAETIKDNLKKKSVTDAVTQNELNSIDQIIAN--NSDIK-----SVQGIQYLPNVT 71
Query: 95 ---VQYNQFSGELPEELGSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRISDNQFTGQ 151
+ N+ + ++ + L +L NL L L N +L + L +K + N +
Sbjct: 72 KLFLNGNKLT-DI-KPLANLKNLGWLFLDENKVK-DL-SSLKDLKKLKSLSLEHNGIS-D 126
Query: 152 IPSFIQNWTKLEKLFIQPSGLAGPIPSGIFSLENLTDL-----RISDLNGPEATFPQLGN 206
I + + + +LE L++ + + + + L L L +ISD+ L
Sbjct: 127 I-NGLVHLPQLESLYLGNNKIT--DITVLSRLTKLDTLSLEDNQISDIVP-------LAG 176
Query: 207 M-KMTKLILRNCNITGELPRYLGKMTKLKVLDLSFNRLRGQIPSNFDDLYDVDYIYFAGN 265
+ K+ L L +I+ +L R L + L VL+L + ++ +L + +
Sbjct: 177 LTKLQNLYLSKNHIS-DL-RALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDG 234
Query: 266 LLT 268
L
Sbjct: 235 SLV 237
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 55.4 bits (134), Expect = 2e-08
Identities = 36/195 (18%), Positives = 76/195 (38%), Gaps = 29/195 (14%)
Query: 106 EELGSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRISDNQFTGQIPSFIQNWTKLEKL 165
+ K +L + T + +L ++ +++ + IQ + KL
Sbjct: 18 FSDDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK-SV-QGIQYLPNVTKL 73
Query: 166 FIQPSGLAGPIPSGIFSLENLTDLR--------ISDLNGPEATFPQLGNM-KMTKLILRN 216
F+ + L + I L NL +L + DL+ L ++ K+ L L +
Sbjct: 74 FLNGNKL-----TDIKPLANLKNLGWLFLDENKVKDLSS-------LKDLKKLKSLSLEH 121
Query: 217 CNITGELPRYLGKMTKLKVLDLSFNRLRGQIPSNFDDLYDVDYIYFAGNLLTGAIPPWML 276
I+ ++ L + +L+ L L N++ + L +D + N ++ +P L
Sbjct: 122 NGIS-DIN-GLVHLPQLESLYLGNNKI--TDITVLSRLTKLDTLSLEDNQISDIVPLAGL 177
Query: 277 ERGDKIDLSYNNFTD 291
+ + LS N+ +D
Sbjct: 178 TKLQNLYLSKNHISD 192
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 43.9 bits (104), Expect = 1e-04
Identities = 19/114 (16%), Positives = 44/114 (38%), Gaps = 6/114 (5%)
Query: 180 IFSLENLTDLRISDLNGPEAT-FPQLGNM-KMTKLILRNCNITGELPRYLGKMTKLKVLD 237
IFS + + +L T + + ++I N +I + + + L
Sbjct: 17 IFSDDAFAETIKDNLKKKSVTDAVTQNELNSIDQIIANNSDIKSVQG--IQYLPNVTKLF 74
Query: 238 LSFNRLRGQIPSNFDDLYDVDYIYFAGNLLTGAIPPWMLERGDKIDLSYNNFTD 291
L+ N+L I +L ++ +++ N + L++ + L +N +D
Sbjct: 75 LNGNKLT-DI-KPLANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEHNGISD 126
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 57.4 bits (139), Expect = 2e-09
Identities = 28/129 (21%), Positives = 48/129 (37%), Gaps = 6/129 (4%)
Query: 68 NISLIANRLKGPIPKYLANISTLVNLTVQYNQFSGELPEEL-GSLLNLEKLHLSSNNFTG 126
I L N +K P + L + + NQ S EL + L +L L L N T
Sbjct: 36 EIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQIS-ELAPDAFQGLRSLNSLVLYGNKITE 94
Query: 127 ELPKTFAKLTNMKDFRISDNQFTGQIPSFI-QNWTKLEKLFIQPSGLAGPIPSGIF-SLE 184
F L +++ ++ N+ + Q+ L L + + L I G F L
Sbjct: 95 LPKSLFEGLFSLQLLLLNANKIN-CLRVDAFQDLHNLNLLSLYDNKLQT-IAKGTFSPLR 152
Query: 185 NLTDLRISD 193
+ + ++
Sbjct: 153 AIQTMHLAQ 161
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 7e-08
Identities = 31/169 (18%), Positives = 56/169 (33%), Gaps = 44/169 (26%)
Query: 113 NLEKLHLSSNNFTGELPKTFAKLTNMKDFRISDNQFTGQIPSFIQNWTKLEKLFIQPSGL 172
+ ++ L N P F+ ++ +S+NQ I
Sbjct: 33 TITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQ--------ISE-------------- 70
Query: 173 AGPIPSGIF-SLENLTDL-----RISDLNGPEATFPQLGNMKMTKLILRNCNITGELPRY 226
+ F L +L L +I++L P++ F L + L+L I L
Sbjct: 71 ---LAPDAFQGLRSLNSLVLYGNKITEL--PKSLFEGLF--SLQLLLLNANKIN-CLRVD 122
Query: 227 L-GKMTKLKVLDLSFNRLRGQIPSNFDDLYDVDYIYFAGNLLTGAIPPW 274
+ L +L L N+L+ F L + ++ A N P+
Sbjct: 123 AFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQN-------PF 164
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 8e-08
Identities = 27/147 (18%), Positives = 56/147 (38%), Gaps = 16/147 (10%)
Query: 85 ANI-STLVNLTVQYNQFSGELPEELGSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRI 143
N+ T+ + ++ N P L ++ LS+N + P F L ++ +
Sbjct: 28 TNLPETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVL 87
Query: 144 SDNQFTGQIPSFI-QNWTKLEKLFIQPSGLAGPIPSGIF-SLENLTDLRISDLN---GPE 198
N+ T ++P + + L+ L + + + + F L NL L + D +
Sbjct: 88 YGNKIT-ELPKSLFEGLFSLQLLLLNANKINC-LRVDAFQDLHNLNLLSLYDNKLQTIAK 145
Query: 199 ATFPQLGNMKMTKLILRN------CNI 219
TF L ++ + L C++
Sbjct: 146 GTFSPLRAIQT--MHLAQNPFICDCHL 170
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 58.1 bits (141), Expect = 2e-09
Identities = 59/246 (23%), Positives = 93/246 (37%), Gaps = 65/246 (26%)
Query: 44 QDIDLTLNYLSGTIPSQWASLPLLNISLIANRLK--GPIPKYLANISTLVNLTVQYNQFS 101
+L ++ +Q + I + +K I + + L + N+
Sbjct: 22 IKANLKKKSVT-DAVTQNELNSIDQIIANNSDIKSVQGIQY----LPNVRYLALGGNKLH 76
Query: 102 GELPEELG---SLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRISDNQFTGQIPSFIQN 158
++ L NL L L+ N F KLTN+K+ + +NQ
Sbjct: 77 -----DISALKELTNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVENQ----------- 120
Query: 159 WTKLEKLFIQPSGLAGPIPSGIF-SLENLTDLRISD-----LNGPEATFPQLGNMKMTKL 212
L+ L P G+F L NLT L ++ L P+ F +L +T+L
Sbjct: 121 ---LQSL-----------PDGVFDKLTNLTYLNLAHNQLQSL--PKGVFDKL--TNLTEL 162
Query: 213 ILRNCNITGELPRYLG---KMTKLKVLDLSFNRLRGQIPSN-FDDLYDVDYIYFAGNLLT 268
L + N LP G K+T+LK L L N+L+ +P FD L + YI+ N
Sbjct: 163 DL-SYNQLQSLPE--GVFDKLTQLKDLRLYQNQLKS-VPDGVFDRLTSLQYIWLHDN--- 215
Query: 269 GAIPPW 274
PW
Sbjct: 216 ----PW 217
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 57.8 bits (140), Expect = 2e-09
Identities = 45/171 (26%), Positives = 67/171 (39%), Gaps = 28/171 (16%)
Query: 115 EKLHLSSNNFTGELPKTFAKLTNMKDFRISDNQFTGQIPSFIQNW-TKLEKLFIQPSGLA 173
EKL L S TF LT + + NQ + + + + T+L L + + LA
Sbjct: 38 EKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQ-TLSAGVFDDLTELGTLGLANNQLA 96
Query: 174 GPIPSGIF-SLENLTDLRISDLNG------PEATFPQLGNMKMTKLILRNCNITGELPRY 226
+P G+F L L L L G P F +L + +L L + +P
Sbjct: 97 S-LPLGVFDHLTQLDKL---YLGGNQLKSLPSGVFDRLTK--LKELRLNTNQLQ-SIPA- 148
Query: 227 LG---KMTKLKVLDLSFNRLRGQIPSNFDDLYDVDYIYFAGNLLTGAIPPW 274
G K+T L+ L LS N+L+ FD L + I GN +
Sbjct: 149 -GAFDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGN-------QF 191
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 58.3 bits (140), Expect = 8e-09
Identities = 58/373 (15%), Positives = 116/373 (31%), Gaps = 97/373 (26%)
Query: 357 NWVLSSTGHFLENGLKLGPYIQTNTSR-LLMNDYQLYTTARLSAISLTYYGFYLQIKAAT 415
+++S E R L ND Q++ +S + YL+++ A
Sbjct: 92 KFLMSPIKT--EQRQPSMMTRMYIEQRDRLYNDNQVFAKYNVSRLQP-----YLKLRQAL 144
Query: 416 NNFATDNNI---GEGGFGPVYKGLLADGTAIAVKQLSSKSKQGNREF-INEIGMISALQH 471
N+ G G G K +A + K + F +N
Sbjct: 145 LELRPAKNVLIDGVLGSG---KTWVA---LDVCLSYKVQCKMDFKIFWLN---------- 188
Query: 472 PNLVKLYGCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHG 531
C +L E L+ +++ +W +R I + +
Sbjct: 189 ------LKNCNSPETVL---EMLQK-------LLYQIDPNWTSRSDHSSNIKLRIHSIQA 232
Query: 532 ESRIKVVHRDIKATNVL--LDKDLNSK--ISDFGL-AKLDEEENTHISTRVAGTIGYMAP 586
E R + + + N L L ++ + + F L K ++TR +++
Sbjct: 233 ELRRLLKSKPYE--NCLLVLL-NVQNAKAWNAFNLSCK------ILLTTRFKQVTDFLSA 283
Query: 587 EYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLK-EQGKL-MELVDT 644
H++ + T +++ LL L L E++ T
Sbjct: 284 AT--TTHISLDHHSMTL--------------TPDEVKSLL--LKYLDCRPQDLPREVLTT 325
Query: 645 NPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLECGVDVLDLVSDSSVSDIDET 704
NP + + +I A + + + + C D L + +SS++ ++
Sbjct: 326 NP-------RRLSII--AESIRD-----GLATWDNWKHVNC--DKLTTIIESSLNVLEP- 368
Query: 705 KAEAMRKYYQFCV 717
AE RK +
Sbjct: 369 -AE-YRKMFDRLS 379
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 56.0 bits (134), Expect = 4e-08
Identities = 85/592 (14%), Positives = 154/592 (26%), Gaps = 185/592 (31%)
Query: 140 DFRISDNQFTGQ--IPSFIQNWTKLEKLFIQPSGLAGPIPSGIFSLENLTDLRISDLNGP 197
DF ++Q+ + + F + + D+
Sbjct: 8 DFETGEHQYQYKDILSVFEDAFVD--------------------------NFDCKDV--- 38
Query: 198 EATFPQLGNMKMTKLILRNCNITGELPRYLGKMTKLKVLDLSFNRLRGQIPSN-----FD 252
M K IL E+ + + F L + +
Sbjct: 39 ---------QDMPKSILSK----EEIDHIIMSKDAVSGTLRLFWTLLSK-QEEMVQKFVE 84
Query: 253 DLYDVDYIYFAGNLLTGAIPPWMLERG--DKIDLSYNN---FTDGSAESSCQKRSVTGIV 307
++ ++Y + + T P M+ R ++ D YN+ F + + + +
Sbjct: 85 EVLRINYKFLMSPIKTEQRQPSMMTRMYIEQRDRLYNDNQVFAKYNV---SRLQPYLKLR 141
Query: 308 SCLRSVQCPKTYYSLHINCG----GKQVTAN---------------------GNTTFEED 342
L ++ P + G GK A N E
Sbjct: 142 QALLELR-PAKNVLID---GVLGSGKTWVALDVCLSYKVQCKMDFKIFWLNLKNCNSPET 197
Query: 343 TSEAGPSTFSQSGTNWVLSSTGHFLENGLKLGPYIQTNTSRLLMNDYQLYTTARL----- 397
E Q NW +S N IQ RLL + + Y L
Sbjct: 198 VLEMLQKLLYQIDPNW--TSRSDHSSNIKLRIHSIQAELRRLLKS--KPYENCLLVLLNV 253
Query: 398 -SAISLTYYGFYLQIKAATNNFATDNNIG------------EGGFGPVY-KGLLADGTAI 443
+A + + +I T + + P K LL
Sbjct: 254 QNAKAWNAFNLSCKILLTTRFKQVTDFLSAATTTHISLDHHSMTLTPDEVKSLLLKYLDC 313
Query: 444 AVKQLSSKSKQGNREFINEIGMISALQHPNLV-----KLYGCCIEGNQLLLI----YEYL 494
+ L + N + +I+ L K C ++L I L
Sbjct: 314 RPQDLPREVLTTN-PRR--LSIIAESIRDGLATWDNWKHVNC----DKLTTIIESSLNVL 366
Query: 495 ENNSLARALFE-------------HRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRD 541
E R +F+ L L W + + VV++
Sbjct: 367 EPAEY-RKMFDRLSVFPPSAHIPTILLSLIW--------------FDVIKSDVMVVVNKL 411
Query: 542 IKATNVLLDKDLN-SKISDFGL-----AKLDEEENTH--ISTRVAGTIGYMAPE-YAMRG 592
K + L++K S IS + KL+ E H I Y P+ +
Sbjct: 412 HKYS--LVEKQPKESTISIPSIYLELKVKLENEYALHRSIVDH------YNIPKTFDSDD 463
Query: 593 HLTEKADVYSFGIVA--LEIVSGRSNVTKEDMF---YL-LDWALVLKEQGKL 638
+ D Y + + L + + +F +L + + K+
Sbjct: 464 LIPPYLDQYFYSHIGHHL---KNIEHPERMTLFRMVFLDFRFL-----EQKI 507
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 49.9 bits (118), Expect = 3e-06
Identities = 60/405 (14%), Positives = 126/405 (31%), Gaps = 134/405 (33%)
Query: 19 NQKRVLKEQNLTGVLPPKLAELTFLQDIDLTLNYLSGTIPSQWASL-PLLNISLIANRLK 77
+ + + + P ++ L L+ +D L P + + P +S+IA ++
Sbjct: 285 TTTHISLDHHSMTLTPDEVKSL-LLKYLDCRPQDL----PREVLTTNPRR-LSIIAESIR 338
Query: 78 GPIPKYLANISTLVNLTVQYNQFSGELPEELGSLLNLEKLHLSSNNFTGELPKTFAKLTN 137
++T N + +N +KL + ++ +
Sbjct: 339 D-------GLATWDN----WKH------------VNCDKLT--------TIIESSLNVLE 367
Query: 138 MKDFRISDNQFTGQIPSFIQNWTKLEKLFIQPSGLAGPIPSGIFSLENL-TDLRISDLNG 196
++R F ++L + P IP+ + L + D+ SD
Sbjct: 368 PAEYR---KMF--------------DRLSVFPPSA--HIPTIL--LSLIWFDVIKSD--- 403
Query: 197 PEATFPQLGNMKMTKLILRNCNITGELP-RYLGKMTKL--------KVLDLSFNRLRGQI 247
+L + + + T +P YL KL ++D +N +
Sbjct: 404 VMVVVNKLHKYSL--VEKQPKESTISIPSIYLELKVKLENEYALHRSIVD-HYNIPKTFD 460
Query: 248 PSNFDDLYDVDYIY-FAGNLLTGAIPPWMLERGDKIDL---SYNNF--------TDGSAE 295
+ Y Y Y G+ L E +++ L + +F D +A
Sbjct: 461 SDDLIPPYLDQYFYSHIGHHLKNI------EHPERMTLFRMVFLDFRFLEQKIRHDSTA- 513
Query: 296 SSCQKRSVTGIVSCLRSVQCPKTYYSLHINCGGKQVTANGNTTFEEDTSEAGPSTFSQSG 355
S+ + L+ +Y +I N + +E
Sbjct: 514 -WNASGSILNTLQQLK-------FYKPYI-------CDN-DPKYER-------------- 543
Query: 356 TNWVLSSTGHFL---ENGLKLGPYIQTNTSRL-LMNDYQ-LYTTA 395
++++ FL E L Y T+ R+ LM + + ++ A
Sbjct: 544 ---LVNAILDFLPKIEENLICSKY--TDLLRIALMAEDEAIFEEA 583
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 57.2 bits (138), Expect = 1e-08
Identities = 51/256 (19%), Positives = 91/256 (35%), Gaps = 73/256 (28%)
Query: 424 IGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQGNREFINEIGMISALQ-----HPN---L 474
+G G F V+ + +A+K + S ++EI ++ +++ PN +
Sbjct: 45 LGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETA-LDEIRLLKSVRNSDPNDPNREMV 103
Query: 475 VKLYGC----CIEGNQLLLIYEYL-ENNSLARALFEHRLKLDWPTRRRICLGIARGLAYL 529
V+L + G + +++E L + ++ L P ++I + +GL YL
Sbjct: 104 VQLLDDFKISGVNGTHICMVFEVLGHHLLKWIIKSNYQG-LPLPCVKKIIQQVLQGLDYL 162
Query: 530 HGESRIKVVHRDIKATNVLL---------------------------------------- 549
H + RI +H DIK N+LL
Sbjct: 163 HTKCRI--IHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNF 220
Query: 550 ---------DKDLNSKISDFGLAKLDEEENTH-ISTRVAGTIGYMAPEYAMRGHLTEKAD 599
+ L KI+D G A + T I TR Y + E + AD
Sbjct: 221 LVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQ-----YRSLEVLIGSGYNTPAD 275
Query: 600 VYSFGIVALEIVSGRS 615
++S +A E+ +G
Sbjct: 276 IWSTACMAFELATGDY 291
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 56.7 bits (137), Expect = 1e-08
Identities = 34/188 (18%), Positives = 62/188 (32%), Gaps = 32/188 (17%)
Query: 424 IGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQ--------------GNREFINEIGMISA 468
IG GGFG +Y A + + ++ ++ I +
Sbjct: 45 IGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQ 104
Query: 469 LQHPNLVKLYGC----CIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIAR 524
L + + YG + ++ E L L + + T ++ + +
Sbjct: 105 LDYLGIPLFYGSGLTEFKGRSYRFMVMERL-GIDLQK-ISGQNGTFKKSTVLQLGIRMLD 162
Query: 525 GLAYLHGESRIKVVHRDIKATNVLLDKDLNSKI--SDFGLAK--LDEEENTHISTRVA-- 578
L Y+H VH DIKA N+LL ++ +D+GL+ +
Sbjct: 163 VLEYIHENE---YVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKG 219
Query: 579 --GTIGYM 584
GTI +
Sbjct: 220 HNGTIEFT 227
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 54.3 bits (131), Expect = 2e-08
Identities = 47/166 (28%), Positives = 65/166 (39%), Gaps = 43/166 (25%)
Query: 115 EKLHLSSNNFTGELPKTFAKLTNMKDFRISDNQFTGQIPSFIQNWTKLEKLFIQPSGLAG 174
+ L+L N T P F L N+K+ + NQ L L
Sbjct: 43 QILYLHDNQITKLEPGVFDSLINLKELYLGSNQ--------------LGAL--------- 79
Query: 175 PIPSGIF-SLENLTDLRISD-----LNGPEATFPQLGNMKMTKLILRNCNITGELPRYLG 228
P G+F SL LT L + L P A F +L + +L + CN ELPR +
Sbjct: 80 --PVGVFDSLTQLTVLDLGTNQLTVL--PSAVFDRLV--HLKELFM-CCNKLTELPRGIE 132
Query: 229 KMTKLKVLDLSFNRLRGQIPSNFDDLYDVDYIYFAGNLLTGAIPPW 274
++T L L L N+L+ FD L + + Y GN PW
Sbjct: 133 RLTHLTHLALDQNQLKSIPHGAFDRLSSLTHAYLFGN-------PW 171
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 2e-07
Identities = 34/124 (27%), Positives = 53/124 (42%), Gaps = 5/124 (4%)
Query: 68 NISLIANRLKGPIPKYLANISTLVNLTVQYNQFSGELPEEL-GSLLNLEKLHLSSNNFTG 126
+ L N++ P ++ L L + NQ LP + SL L L L +N T
Sbjct: 44 ILYLHDNQITKLEPGVFDSLINLKELYLGSNQLG-ALPVGVFDSLTQLTVLDLGTNQLTV 102
Query: 127 ELPKTFAKLTNMKDFRISDNQFTGQIPSFIQNWTKLEKLFIQPSGLAGPIPSGIF-SLEN 185
F +L ++K+ + N+ T +P I+ T L L + + L IP G F L +
Sbjct: 103 LPSAVFDRLVHLKELFMCCNKLTE-LPRGIERLTHLTHLALDQNQLKS-IPHGAFDRLSS 160
Query: 186 LTDL 189
LT
Sbjct: 161 LTHA 164
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 55.5 bits (134), Expect = 3e-08
Identities = 26/200 (13%), Positives = 63/200 (31%), Gaps = 37/200 (18%)
Query: 416 NNFATDNNIGEGGFGPVYKGL---------LADGTAIAVK------QLSSKSKQGNREF- 459
+ + G +Y+ ++K +L ++ R
Sbjct: 42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAK 101
Query: 460 ---INEIGMISALQHPNLVKLYGCCIEGNQL-LLIYEYLENNSLARALFEHRLKLDWPTR 515
+N+ + + + G + ++ L+ L SL + K R
Sbjct: 102 PLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQS-ALDVSPKHVLSER 159
Query: 516 RRICLG---IARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKI--SDFGLAKLDEEEN 570
+ + + L +LH VH ++ A N+ +D + S++ + +G A
Sbjct: 160 SVLQVACRLLDA-LEFLHENE---YVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSG 215
Query: 571 THISTR------VAGTIGYM 584
H++ G + ++
Sbjct: 216 KHVAYVEGSRSPHEGDLEFI 235
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 55.9 bits (134), Expect = 4e-08
Identities = 35/247 (14%), Positives = 81/247 (32%), Gaps = 21/247 (8%)
Query: 4 LNTFLVFHFWKQKTVNQKRVLKEQNLTGVLPPKLAELTFLQDIDLTLNYLSGTIPSQWAS 63
L W ++ VL + A L +L++ + +
Sbjct: 313 LPQHTFRVIWTGSDSQKECVLLKDRPE-CWCRDSATDEQLFRCELSVEKSTVLQSELESC 371
Query: 64 LPLLNISLIANRLKGPIPKYLANISTLVNLTVQYNQFSGELPEELGSLLNLEKLHLS--- 120
L + I + + L+ E + +L ++ + +
Sbjct: 372 KELQELEPENKWCLLTIILLMRALDPLLYEK--------ETLQYFSTLKAVDPMRAAYLD 423
Query: 121 --SNNFTGELPKTFAKLTNMKDFRISDNQFTGQIPSFIQNWTKLEKLFIQPSGLAGPIPS 178
+ F E + +++ ++ T + ++ + L + + L +P
Sbjct: 424 DLRSKFLLENSVLKMEYADVRVLHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLRA-LPP 480
Query: 179 GIFSLENLTDLRISDLNGPEATFPQLGNM-KMTKLILRNCNITG-ELPRYLGKMTKLKVL 236
+ +L L L+ SD N E + N+ ++ +L+L N + + L +L +L
Sbjct: 481 ALAALRCLEVLQASD-NALE-NVDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLL 538
Query: 237 DLSFNRL 243
+L N L
Sbjct: 539 NLQGNSL 545
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 51.3 bits (122), Expect = 9e-07
Identities = 39/229 (17%), Positives = 68/229 (29%), Gaps = 14/229 (6%)
Query: 43 LQDIDLTLNYLSGTIPSQWASLPLLNISLIANRLKGPIPKYLANISTLVNLTVQYNQFSG 102
L L T W ++ + A L + + S
Sbjct: 304 LPAASLNDQLPQHTFRVIWTGSDSQKECVLLKDRPECWCRDSATDEQLFRCELSVEK-ST 362
Query: 103 ELPEELGSLLNLEKLHLSSNNFTGEL---PKTFAKLTNMKDFRISDNQFTGQIPSFIQNW 159
L EL S L++L + + + L K+ + P
Sbjct: 363 VLQSELESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFSTLKAVDPMRAAYL 422
Query: 160 TKLEKLFIQPSGLAGPIPSGIFSLENLTDLRISDLNGPEATFPQLGNMKMTKLILRNCNI 219
L F+ + + + + L +L ++ L E QL + T L L + +
Sbjct: 423 DDLRSKFLLENSVLKMEYADVRVL-HLAHKDLTVLCHLE----QLLLV--THLDLSHNRL 475
Query: 220 TGELPRYLGKMTKLKVLDLSFNRLRGQIPSNFDDLYDVDYIYFAGNLLT 268
LP L + L+VL S N L + +L + + N L
Sbjct: 476 R-ALPPALAALRCLEVLQASDNALE-NVD-GVANLPRLQELLLCNNRLQ 521
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 47.1 bits (111), Expect = 2e-05
Identities = 24/107 (22%), Positives = 42/107 (39%), Gaps = 13/107 (12%)
Query: 24 LKEQNLTGVLPPKLAELTFLQDIDLTLNYLSGTIPSQWASLPLL-NISLIANRLKGPIPK 82
L ++LT + L +L + +DL+ N L +P A+L L + N L+
Sbjct: 448 LAHKDLTVL--CHLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALE----- 499
Query: 83 YLANISTLVNLTV---QYNQFSG-ELPEELGSLLNLEKLHLSSNNFT 125
+ ++ L L N+ + L S L L+L N+
Sbjct: 500 NVDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLC 546
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 52.4 bits (126), Expect = 1e-07
Identities = 31/170 (18%), Positives = 60/170 (35%), Gaps = 45/170 (26%)
Query: 113 NLEKLHLSSNNFTGELPK-TFAKLTNMKDFRISDNQFTGQIPSFIQNWTKLEKLFIQPSG 171
+L L++N FT F KL ++ S+N+ T
Sbjct: 33 YTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITD--------------------- 71
Query: 172 LAGPIPSGIF-SLENLTDL-----RISDLNGPEATFPQLGNMKMTKLILRNCNITGELPR 225
I G F + ++ R+ ++ F L ++ L+LR+ IT +
Sbjct: 72 ----IEEGAFEGASGVNEILLTSNRLENV--QHKMFKGLESL--KTLMLRSNRIT-CVGN 122
Query: 226 YL-GKMTKLKVLDLSFNRLRGQIPSNFDDLYDVDYIYFAGNLLTGAIPPW 274
++ +++L L N++ P FD L+ + + N P+
Sbjct: 123 DSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLAN-------PF 165
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 1e-05
Identities = 27/154 (17%), Positives = 55/154 (35%), Gaps = 30/154 (19%)
Query: 44 QDIDLTLNYLSGTIPS-QWASLPLLN-ISLIANRLKGPIPKYLANISTLVNLTVQYNQFS 101
++ L N + + + LP L I+ N++ S + + + N+
Sbjct: 35 AELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSNRLE 94
Query: 102 GELPEEL-GSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRISDNQFTGQIPSFIQNWT 160
+ ++ L +L+ L L SN T +F L++++ + DNQ T
Sbjct: 95 -NVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQIT----------- 142
Query: 161 KLEKLFIQPSGLAGPIPSGIF-SLENLTDLRISD 193
+ G F +L +L+ L +
Sbjct: 143 --------------TVAPGAFDTLHSLSTLNLLA 162
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 43.1 bits (102), Expect = 1e-04
Identities = 26/127 (20%), Positives = 49/127 (38%), Gaps = 5/127 (3%)
Query: 26 EQNLTGVLPPK--LAELTFLQDIDLTLNYLSGTIPSQWASLP-LLNISLIANRLKGPIPK 82
N VL +L L+ I+ + N ++ + + I L +NRL+ K
Sbjct: 40 NNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSNRLENVQHK 99
Query: 83 YLANISTLVNLTVQYNQFSGELPEEL-GSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDF 141
+ +L L ++ N+ + + + L ++ L L N T P F L ++
Sbjct: 100 MFKGLESLKTLMLRSNRIT-CVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTL 158
Query: 142 RISDNQF 148
+ N F
Sbjct: 159 NLLANPF 165
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 53.4 bits (129), Expect = 2e-07
Identities = 36/188 (19%), Positives = 65/188 (34%), Gaps = 28/188 (14%)
Query: 84 LANISTLVNLTVQYNQFSGELPEELGSLL-----NLEKLHLSSNNFTGE----LPKTFAK 134
L LTV N + L L LE L L S T + L A
Sbjct: 166 LRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVAS 225
Query: 135 LTNMKDFRISDNQFTGQ-----IPSFIQNWTKLEKLFIQPSGL----AGPIPSGIFSLEN 185
++++ + N+ P + ++L L+I G+ G + + + E+
Sbjct: 226 KASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKES 285
Query: 186 LTDLRISDLN-GPE-----ATFPQLGNMKMTKLILRNCNITGELPRYLGKM----TKLKV 235
L +L ++ G E ++ L +++C+ T + + L
Sbjct: 286 LKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLE 345
Query: 236 LDLSFNRL 243
L +S NRL
Sbjct: 346 LQISNNRL 353
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 52.3 bits (126), Expect = 3e-07
Identities = 32/181 (17%), Positives = 60/181 (33%), Gaps = 26/181 (14%)
Query: 88 STLVNLTVQYNQFSGELPEELGSLL-NLEKLHLSSNNFTGE----LPKTFAKLTNMKDFR 142
+ +L +Q + S EL LL + + L T + + +
Sbjct: 3 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELN 62
Query: 143 ISDNQFTGQ-----IPSFIQNWTKLEKLFIQPSGL----AGPIPSGIFSLENLTDLRISD 193
+ N+ + K++KL +Q L G + S + +L L +L +SD
Sbjct: 63 LRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSD 122
Query: 194 LNGPE-------ATFPQLGNMKMTKLILRNCNITGELPRYLGKM----TKLKVLDLSFNR 242
N ++ KL L C+++ L + K L +S N
Sbjct: 123 -NLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNND 181
Query: 243 L 243
+
Sbjct: 182 I 182
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 44.6 bits (106), Expect = 1e-04
Identities = 34/189 (17%), Positives = 67/189 (35%), Gaps = 30/189 (15%)
Query: 84 LANISTLVNLTVQYNQFSGELPEELGSLL-----NLEKLHLSSNNFTGE----LPKTFAK 134
+A+ ++L L + N+ EL L L L + T + L +
Sbjct: 223 VASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRA 282
Query: 135 LTNMKDFRISDNQFTGQ-----IPSFIQNWTKLEKLFIQPSGL----AGPIPSGIFSLEN 185
++K+ ++ N+ + + ++ +LE L+++ S +
Sbjct: 283 KESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRF 342
Query: 186 LTDLRISDLNGPE-------ATFPQLGNMKMTKLILRNCNITGELPRYLGKM----TKLK 234
L +L+IS+ N E + L L +C+++ L L+
Sbjct: 343 LLELQISN-NRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLR 401
Query: 235 VLDLSFNRL 243
LDLS N L
Sbjct: 402 ELDLSNNCL 410
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 52.0 bits (125), Expect = 4e-07
Identities = 41/260 (15%), Positives = 82/260 (31%), Gaps = 53/260 (20%)
Query: 37 LAELTFLQDIDLTLNYLSGTIPSQWASLPLLNISLIANR-------------LKG--PIP 81
+A L+ + + + +L LL +L+ P+
Sbjct: 56 IASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLI 115
Query: 82 KYLANISTLVNLTVQYNQFSGELPEELGSLL-------------NLEKLHLSSNNFTGE- 127
+L+ + L +L + N + ++ L L + N
Sbjct: 116 DFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGS 175
Query: 128 ---LPKTFAKLTNMKDFRISDNQFTGQ-----IPSFIQNWTKLEKLFIQPSGL----AGP 175
KTF + ++ N + + + +L+ L +Q + +
Sbjct: 176 MKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSA 235
Query: 176 IPSGIFSLENLTDLRISDLN-GPE------ATFPQLGNMKMTKLILRNCNITGELPRYLG 228
+ + S NL +L ++D F +L N+ + L L+ I + R L
Sbjct: 236 LAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLK 295
Query: 229 -----KMTKLKVLDLSFNRL 243
KM L L+L+ NR
Sbjct: 296 TVIDEKMPDLLFLELNGNRF 315
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 44.3 bits (105), Expect = 1e-04
Identities = 43/229 (18%), Positives = 70/229 (30%), Gaps = 49/229 (21%)
Query: 62 ASLPLLNISLIANRLKG----PIPKYLANISTLVNLTVQYNQFSGE----LPEELGSLLN 113
A + SL + + + L ++ + + N E L E + S +
Sbjct: 2 ARFSIEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKD 61
Query: 114 LEKLHLSSNNFTGE-----------LPKTFAKLTNMKDFRISDNQFTGQ----IPSFIQN 158
LE S + FTG L + K + R+SDN F + F+
Sbjct: 62 LEIAEFS-DIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSK 120
Query: 159 WTKLEKLF-----IQPSG---LAG--PIPSGIFSLENLTDLRISDLN----GPEATFPQL 204
T LE L+ + P +A + +N LR + +
Sbjct: 121 HTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSM-KEW 179
Query: 205 GNM-----KMTKLILRNCNITGE-----LPRYLGKMTKLKVLDLSFNRL 243
+ + + I E L L +LKVLDL N
Sbjct: 180 AKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTF 228
|
| >2jwp_A Malectin, MGC80075; sugar binding, sugar binding protein; NMR {Xenopus laevis} PDB: 2k46_A* 2kr2_A* Length = 174 | Back alignment and structure |
|---|
Score = 48.8 bits (116), Expect = 9e-07
Identities = 16/83 (19%), Positives = 24/83 (28%), Gaps = 21/83 (25%)
Query: 324 INCGGKQVTANGNTTFEEDTSEAGPSTFSQSGTNWVLSSTGHFLENGLKLGPYIQTNTSR 383
+N GG+ + +D E S G P +++N
Sbjct: 10 VNAGGESHVDVHGIHYRKDPLEGRVGRASDYGMK----------------LPILRSNP-- 51
Query: 384 LLMNDYQLYTTARLSAISLTYYG 406
D LY T R + S Y
Sbjct: 52 ---EDQVLYQTERYNEDSFGYDI 71
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 2e-06
Identities = 41/188 (21%), Positives = 62/188 (32%), Gaps = 64/188 (34%)
Query: 92 NLTVQYNQFSGELPEELGSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRISDNQFTGQ 151
L ++ N L +L +L+L N F KLT++ +S NQ
Sbjct: 32 YLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTNQLQS- 90
Query: 152 IPSFIQNWTKLEKLFIQPSGLAGPIPSGIF-SLENLTDLRISDLNGPEATFPQLGNMKMT 210
+P+G+F L L +L L ++
Sbjct: 91 ------------------------LPNGVFDKLTQLKEL-------------ALNTNQLQ 113
Query: 211 KLILRNCNITGELPRYLG---KMTKLKVLDLSFNRLRGQIPSN-FDDLYDVDYIYFAGNL 266
LP G K+T+LK L L N+L+ +P FD L + YI+ N
Sbjct: 114 -----------SLPD--GVFDKLTQLKDLRLYQNQLKS-VPDGVFDRLTSLQYIWLHDN- 158
Query: 267 LTGAIPPW 274
PW
Sbjct: 159 ------PW 160
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 48.1 bits (115), Expect = 6e-06
Identities = 46/230 (20%), Positives = 80/230 (34%), Gaps = 61/230 (26%)
Query: 424 IGEGGFGPVYKG--LLADGTAIAVKQLSSKSKQGNREFINEIGMISALQHP------NLV 475
+GEG FG V + + +A+K + + K + EI ++ ++ V
Sbjct: 27 LGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARL-EINVLKKIKEKDKENKFLCV 85
Query: 476 KLYGC-------CI--EGNQLLL---IYEYLENNSLARALFEHRLKLDWPTRRRICLGIA 523
+ CI E LL +E+L+ N+ + R + +
Sbjct: 86 LMSDWFNFHGHMCIAFE----LLGKNTFEFLKENNFQP--YPLPHV------RHMAYQLC 133
Query: 524 RGLAYLHGESRIKVVHRDIKATNVLLDKDLNS-------------------KISDFGLA- 563
L +LH ++ H D+K N+L +++DFG A
Sbjct: 134 HALRFLH---ENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSAT 190
Query: 564 KLDEEENTHISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSG 613
E T ++TR Y PE + + DV+S G + E G
Sbjct: 191 FDHEHHTTIVATRH-----YRPPEVILELGWAQPCDVWSIGCILFEYYRG 235
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 46.5 bits (111), Expect = 7e-06
Identities = 27/112 (24%), Positives = 50/112 (44%), Gaps = 6/112 (5%)
Query: 85 ANI-STLVNLTVQYNQFSGELPEELGSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRI 143
I + L + NQF+ +P+EL + +L + LS+N + ++F+ +T + +
Sbjct: 27 KGIPRDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLIL 85
Query: 144 SDNQFTGQIPSFI-QNWTKLEKLFIQPSGLAGPIPSGIF-SLENLTDLRISD 193
S N+ IP L L + + ++ +P G F L L+ L I
Sbjct: 86 SYNRLR-CIPPRTFDGLKSLRLLSLHGNDISV-VPEGAFNDLSALSHLAIGA 135
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 41.5 bits (98), Expect = 3e-04
Identities = 29/162 (17%), Positives = 53/162 (32%), Gaps = 59/162 (36%)
Query: 115 EKLHLSSNNFTGELPKTFAKLTNMKDFRISDNQFTGQIPSFIQNWTKLEKLFIQPSGLAG 174
+L+L N FT +PK + ++ +S+N+ +
Sbjct: 34 TELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRIST------------------------ 68
Query: 175 PIPSGIFSLENLTDLRISDLNGPEATFPQLGNMKMTKLILRNCNITGELPRYL-GKMTKL 233
+ + FS N+T L LIL + N +P + L
Sbjct: 69 -LSNQSFS--NMTQL--------------------LTLIL-SYNRLRCIPPRTFDGLKSL 104
Query: 234 KVLDLSFNRLRGQIPSN-FDDLYDVDYIYFAGNLLTGAIPPW 274
++L L N + +P F+DL + ++ N P
Sbjct: 105 RLLSLHGNDIS-VVPEGAFNDLSALSHLAIGAN-------PL 138
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 45.7 bits (109), Expect = 1e-05
Identities = 27/108 (25%), Positives = 46/108 (42%), Gaps = 5/108 (4%)
Query: 85 ANI-STLVNLTVQYNQFSGELPEELGSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRI 143
I S+ L ++ N+ L L KL LS N F KLT + +
Sbjct: 24 TGIPSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYL 83
Query: 144 SDNQFTGQIPSFI-QNWTKLEKLFIQPSGLAGPIPSGIF-SLENLTDL 189
+N+ +P+ + T+L++L + + L +P GIF L +L +
Sbjct: 84 HENKLQ-SLPNGVFDKLTQLKELALDTNQLKS-VPDGIFDRLTSLQKI 129
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 41.9 bits (99), Expect = 2e-04
Identities = 38/164 (23%), Positives = 50/164 (30%), Gaps = 62/164 (37%)
Query: 115 EKLHLSSNNFTGELPKTFAKLTNMKDFRISDNQFTGQIPSFIQNWTKLEKLFIQPSGLAG 174
+L L SN F KLT + +S NQ
Sbjct: 31 TRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQS------------------------ 66
Query: 175 PIPSGIF-SLENLTDLRISDLNGPEATFPQLGNMKMTKLILRNCNITGELPRYLG---KM 230
+P G+F L LT L L K+ LP G K+
Sbjct: 67 -LPDGVFDKLTKLTILY-------------LHENKLQ-----------SLPN--GVFDKL 99
Query: 231 TKLKVLDLSFNRLRGQIPSNFDDLYDVDYIYFAGNLLTGAIPPW 274
T+LK L L N+L+ FD L + I+ N PW
Sbjct: 100 TQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTN-------PW 136
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 47.0 bits (111), Expect = 1e-05
Identities = 18/83 (21%), Positives = 26/83 (31%), Gaps = 6/83 (7%)
Query: 176 IPSGIFSLENLTDLRISDLNG----PEATFPQLGNMKMTKLILRNCNITGELPRYLGKMT 231
+ ENLT+L I + LG + L + + P
Sbjct: 23 SLHHLPGAENLTELYIENQQHLQHLELRDLRGLGEL--RNLTIVKSGLRFVAPDAFHFTP 80
Query: 232 KLKVLDLSFNRLRGQIPSNFDDL 254
+L L+LSFN L L
Sbjct: 81 RLSRLNLSFNALESLSWKTVQGL 103
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 46.7 bits (110), Expect = 2e-05
Identities = 15/90 (16%), Positives = 26/90 (28%), Gaps = 2/90 (2%)
Query: 80 IPKYLANISTLVNLTVQYNQFSGELPEE-LGSLLNLEKLHLSSNNFTGELPKTFAKLTNM 138
+L L L ++ Q L L L L L + + P F +
Sbjct: 23 SLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRL 82
Query: 139 KDFRISDNQFTGQIPSFIQNWTKLEKLFIQ 168
+S N + L++L +
Sbjct: 83 SRLNLSFNALE-SLSWKTVQGLSLQELVLS 111
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 41.3 bits (96), Expect = 8e-04
Identities = 14/94 (14%), Positives = 33/94 (35%), Gaps = 6/94 (6%)
Query: 103 ELPEELGSLLNLEKLHLSSNNFTGELPK-TFAKLTNMKDFRISDNQFTGQIP--SFIQNW 159
+ L NL +L++ + L L +++ I + + +F
Sbjct: 22 DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLR-FVAPDAF-HFT 79
Query: 160 TKLEKLFIQPSGLAGPIPSGIFSLENLTDLRISD 193
+L +L + + L + +L +L +S
Sbjct: 80 PRLSRLNLSFNALES-LSWKTVQGLSLQELVLSG 112
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 46.9 bits (112), Expect = 1e-05
Identities = 55/239 (23%), Positives = 89/239 (37%), Gaps = 79/239 (33%)
Query: 424 IGEGGFGPVYKG--LLADGTAIAVKQLSSKSK---QGNREFINEIGMISALQHP------ 472
+GEG FG V + A G +AVK + + + +EI ++ L
Sbjct: 22 LGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAA----RSEIQVLEHLNTTDPNSTF 77
Query: 473 NLVKLYGC-------CI--EGNQLLL---IYEYLENNSLARALFEHRLKLDWPTRRRICL 520
V++ CI E LL Y++++ N +LD R++
Sbjct: 78 RCVQMLEWFEHHGHICIVFE----LLGLSTYDFIKENG------FLPFRLD--HIRKMAY 125
Query: 521 GIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNS-------------------KISDFG 561
I + + +LH K+ H D+K N+L + + K+ DFG
Sbjct: 126 QICKSVNFLH---SNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFG 182
Query: 562 LA-KLDEEENTHISTRVAGTIGYMAPE------YAMRGHLTEKADVYSFGIVALEIVSG 613
A DE +T +STR Y APE ++ DV+S G + +E G
Sbjct: 183 SATYDDEHHSTLVSTRH-----YRAPEVILALGWSQ------PCDVWSIGCILIEYYLG 230
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 45.4 bits (108), Expect = 4e-05
Identities = 53/243 (21%), Positives = 88/243 (36%), Gaps = 83/243 (34%)
Query: 424 IGEGGFGPVYKGL-LADGTAIAVKQLSSKSK---QGNREFINEIGMISALQH-----PNL 474
+G+G FG V + + AVK + + K E ++ +Q+ N+
Sbjct: 43 MGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSA----KIEADILKKIQNDDINNNNI 98
Query: 475 VKLYGC-------CI--EGNQLLL---IYEYLENNSLARALFEHRLKLDWPTRRRICLGI 522
VK +G C+ E L +YE + N+ F + C+ I
Sbjct: 99 VKYHGKFMYYDHMCLIFE----PLGPSLYEIITRNNYNG--FHIEDI------KLYCIEI 146
Query: 523 ARGLAYLHGESRIKVVHRDIKATNVLLDKDLNS-------------------------KI 557
+ L YL ++ + H D+K N+LLD K+
Sbjct: 147 LKALNYLR---KMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKL 203
Query: 558 SDFGLAKLDEEE-NTHISTRVAGTIGYMAPE------YAMRGHLTEKADVYSFGIVALEI 610
DFG A + + I+TR Y APE + + +D++SFG V E+
Sbjct: 204 IDFGCATFKSDYHGSIINTRQ-----YRAPEVILNLGWDV------SSDMWSFGCVLAEL 252
Query: 611 VSG 613
+G
Sbjct: 253 YTG 255
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 43.1 bits (102), Expect = 8e-05
Identities = 26/110 (23%), Positives = 50/110 (45%), Gaps = 8/110 (7%)
Query: 85 ANI-STLVNLTVQYNQFSGELPEEL-GSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFR 142
+I L + N+ + L G L +L KL L N TG P F +++++ +
Sbjct: 25 RDIPLHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQ 84
Query: 143 ISDNQFTGQIPS--FIQNWTKLEKLFIQPSGLAGPIPSGIF-SLENLTDL 189
+ +N+ +I + F +L+ L + + ++ + G F L +LT L
Sbjct: 85 LGENKIK-EISNKMF-LGLHQLKTLNLYDNQISC-VMPGSFEHLNSLTSL 131
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 44.6 bits (104), Expect = 9e-05
Identities = 43/248 (17%), Positives = 72/248 (29%), Gaps = 61/248 (24%)
Query: 39 ELTFLQDIDLTLNYLSGTIPSQWASLPLLNISLIANRLKGPIPKYLANIS--TLVNLTVQ 96
E F DID +S + + L ++KG + L +L +
Sbjct: 142 EGLFWGDIDFEEQEISWIEQVDLSPVLDAMPLLNNLKIKGTNNLSIGKKPRPNLKSLEII 201
Query: 97 YNQFSGELPEELGS--LLNLEKLHL---SSNNFTGELPKTFAKLTNMKDFRISDNQFTGQ 151
+ E++ L NLEKL L + F L + F
Sbjct: 202 SGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRF---------- 251
Query: 152 IPSFIQNWTKLEKLFIQPSGLAGPIPSGIFSLENLTDLRISDLNGPEATFPQLGNMKMTK 211
L+ L I + + + L L D++
Sbjct: 252 --------PNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDIS---------------- 287
Query: 212 LILRNCNITGE----LPRYLGKMTKLKVLDLSFN--------RLRGQIPSNFD----DLY 255
+T E L ++ K+ LK +++ +N L+ +P D Y
Sbjct: 288 ----AGVLTDEGARLLLDHVDKIKHLKFINMKYNYLSDEMKKELQKSLPMKIDVSDSQEY 343
Query: 256 DVDYIYFA 263
D DY Y
Sbjct: 344 DDDYSYPM 351
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 43.8 bits (102), Expect = 1e-04
Identities = 28/191 (14%), Positives = 55/191 (28%), Gaps = 36/191 (18%)
Query: 121 SNNFTGELPKTFAKLTNMKDFRISDNQFTGQIPSFIQNWTKLEKLFIQPSGLAGPIPSGI 180
S +L + + + +I + L+ L I GL + I
Sbjct: 157 SWIEQVDLSPVLDAMPLLNNLKIKGTNNLSIGK---KPRPNLKSLEIISGGLPDSVVEDI 213
Query: 181 FS--LENLTDLRI---SDLNGPEATFPQLGNM-------KMTKLILRNCNITGELPRYLG 228
L NL L + + G + + + L + + +
Sbjct: 214 LGSDLPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFL 273
Query: 229 K---MTKLKVLDLSFNRLRGQIPSNFDDLYDVDYIYFAGNLLTGAIPPWMLERGDKIDLS 285
+ + +L+ +D+S L D A LL L+ I++
Sbjct: 274 ESDILPQLETMDISAGVLT-----------DEG----ARLLLDHVDKIKHLKF---INMK 315
Query: 286 YNNFTDGSAES 296
YN +D +
Sbjct: 316 YNYLSDEMKKE 326
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} Length = 372 | Back alignment and structure |
|---|
Score = 42.4 bits (100), Expect = 4e-04
Identities = 32/250 (12%), Positives = 75/250 (30%), Gaps = 43/250 (17%)
Query: 27 QNLTGVLPPKLAELTFLQDIDLTLNYLSGTIPSQWASLPLLNISLIANRLKGPIPKYLAN 86
+ + L + L L++ L LL+ +
Sbjct: 12 RAVLAQLGCPIKNLDALENAQAIKKKLGKLGRQVLPPSELLDHLFFHYEFQN-QRFSAEV 70
Query: 87 ISTLVNLTVQYNQFSGELPEELGSLL-----NLEKLHLSSNNFTGELPKTFAK-LTNMKD 140
+S+L L + + + + ++L L++++L+S +T +
Sbjct: 71 LSSLRQLNLAGVRMTPVKCTVVAAVLGSGRHALDEVNLASCQLDPAGLRTLLPVFLRARK 130
Query: 141 FRISDNQFTGQ----IPSFIQ-NWTKLEKLF-----IQPSGLAGPIPSGIFSLENLTDLR 190
+ N + + + + ++ L + +G + G+ ++T L
Sbjct: 131 LGLQLNSLGPEACKDLRDLLLHDQCQITTLRLSNNPLTAAG-VAVLMEGLAGNTSVTHLS 189
Query: 191 ISDLNGPEATFPQLG-------------NMKMTKLILRNCNITGE----LPRYLGKMTKL 233
+ LG N ++ +L + L R + L
Sbjct: 190 LLH-T-------GLGDEGLELLAAQLDRNRQLQELNVAYNGAGDTAALALARAAREHPSL 241
Query: 234 KVLDLSFNRL 243
++L L FN L
Sbjct: 242 ELLHLYFNEL 251
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 40.5 bits (95), Expect = 5e-04
Identities = 31/159 (19%), Positives = 53/159 (33%), Gaps = 34/159 (21%)
Query: 86 NISTLVNLTVQYNQFSGELPEELGSLL-NLEKLHLSSNNFTGELPKTFAKLTNMKDFRIS 144
+ + L + + + E L + NLE L L + + KL +K +S
Sbjct: 22 TPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLI-SV-SNLPKLPKLKKLELS 79
Query: 145 DNQFTGQIPSFIQNWTKLEKLFIQPSGLAGPIPSGIFSLENLTDLRISDLNG--PEATFP 202
+N+ G + + L L NL+ ++ D++ P
Sbjct: 80 ENRIFGGLDMLAEKLPNLTHL-------------------NLSGNKLKDISTLEPLKKLE 120
Query: 203 QLGNMKMTKLILRNCNITGELPRY----LGKMTKLKVLD 237
L L L NC +T L Y + +L LD
Sbjct: 121 CL-----KSLDLFNCEVT-NLNDYRESVFKLLPQLTYLD 153
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 756 | |||
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 100.0 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 100.0 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 100.0 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 100.0 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 100.0 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 100.0 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 99.97 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 99.97 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 99.97 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 99.97 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 99.97 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 99.97 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 99.97 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 99.97 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 99.97 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 99.97 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 99.97 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 99.97 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.97 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 99.96 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 99.96 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 99.96 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 99.96 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 99.96 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 99.96 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 99.96 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 99.96 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 99.96 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 99.96 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 99.96 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 99.96 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 99.96 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 99.96 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 99.96 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.96 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.96 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 99.96 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 99.96 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 99.96 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 99.96 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 99.95 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 99.95 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 99.95 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 99.95 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 99.95 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 99.95 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 99.95 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 99.95 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 99.95 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 99.95 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 99.95 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 99.95 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 99.95 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 99.95 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 99.95 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 99.94 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 99.94 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 99.94 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 99.93 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.93 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.93 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.93 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 99.93 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 99.93 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 99.92 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 99.92 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 99.91 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 99.91 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 99.91 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 99.91 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 99.91 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 99.9 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 99.9 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 99.9 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 99.9 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 99.89 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.89 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 99.89 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 99.88 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 99.88 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 99.88 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 99.88 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 99.88 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 99.88 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 99.87 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 99.87 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 99.87 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 99.87 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 99.86 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 99.86 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 99.85 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 99.85 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 99.83 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 99.83 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 99.83 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 99.82 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 99.81 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 99.8 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 99.8 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 99.79 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 99.79 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 99.79 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 99.79 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 99.78 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.78 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 99.78 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 99.78 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 99.78 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 99.78 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 99.77 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 99.76 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 99.76 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 99.74 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 99.74 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 99.73 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 99.73 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 99.73 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 99.71 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 99.7 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 99.69 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 99.69 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 99.68 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.65 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 99.64 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.64 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.64 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 99.62 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 99.62 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.6 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 99.6 | |
| 3sb4_A | 329 | Hypothetical leucine rich repeat protein; LRR, rig | 99.6 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.6 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 99.59 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 99.58 | |
| 4fdw_A | 401 | Leucine rich hypothetical protein; putative cell s | 99.57 | |
| 4fdw_A | 401 | Leucine rich hypothetical protein; putative cell s | 99.56 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 99.55 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 99.54 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 99.53 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 99.52 | |
| 3sb4_A | 329 | Hypothetical leucine rich repeat protein; LRR, rig | 99.5 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 99.45 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 99.44 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 99.43 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 99.42 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.33 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 99.26 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 99.24 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 99.24 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.21 | |
| 4fs7_A | 394 | Uncharacterized protein; leucine-rich repeats, pro | 99.19 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 99.18 | |
| 4gt6_A | 394 | Cell surface protein; leucine rich repeats, putati | 99.04 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.03 | |
| 4gt6_A | 394 | Cell surface protein; leucine rich repeats, putati | 99.0 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 99.0 | |
| 4fs7_A | 394 | Uncharacterized protein; leucine-rich repeats, pro | 98.98 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 98.88 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 98.83 | |
| 4h09_A | 379 | Hypothetical leucine rich repeat protein; two LRR_ | 98.7 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.56 | |
| 4h09_A | 379 | Hypothetical leucine rich repeat protein; two LRR_ | 98.54 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.54 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.52 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 98.48 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 98.45 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 98.44 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.42 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 98.42 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.42 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.22 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.07 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.07 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.87 | |
| 3e4g_A | 176 | ATP synthase subunit S, mitochondrial; leucine-ric | 97.86 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.83 | |
| 3e4g_A | 176 | ATP synthase subunit S, mitochondrial; leucine-ric | 97.68 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.65 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.32 | |
| 1pgv_A | 197 | TMD-1, tropomodulin TMD-1; structural genomics, PS | 97.28 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.28 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.25 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.2 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.2 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.18 | |
| 1pgv_A | 197 | TMD-1, tropomodulin TMD-1; structural genomics, PS | 96.92 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.85 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.71 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 96.71 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.64 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 96.57 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.29 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 96.17 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 95.4 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 91.35 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 84.94 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 84.11 |
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-55 Score=456.72 Aligned_cols=256 Identities=28% Similarity=0.501 Sum_probs=214.4
Q ss_pred cCccccCcccCCCCccEEEeecc------CCcEEEEEEccccCcccHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEE
Q 004400 416 NNFATDNNIGEGGFGPVYKGLLA------DGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLL 489 (756)
Q Consensus 416 ~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 489 (756)
++|...+.||+|+||+||+|++. ++..||||+++.......++|.+|+++|++++|||||+++|+|.+++..++
T Consensus 13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 92 (299)
T 4asz_A 13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM 92 (299)
T ss_dssp GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence 57788899999999999999853 478899999987766667889999999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHHhc------------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEE
Q 004400 490 IYEYLENNSLARALFEH------------RLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKI 557 (756)
Q Consensus 490 V~e~~~~gsL~~~l~~~------------~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl 557 (756)
|||||++|+|.++|+.. ...++|.++..|+.|||+||+|||+++ ||||||||+|||+++++.+||
T Consensus 93 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDlKp~NILl~~~~~~Ki 169 (299)
T 4asz_A 93 VFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVKI 169 (299)
T ss_dssp EEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEE
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccCHhhEEECCCCcEEE
Confidence 99999999999999754 247999999999999999999999986 999999999999999999999
Q ss_pred ccCCccccCcccCcc-eeeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHh-CCCCCCccchhhHHHHHHHHHhc
Q 004400 558 SDFGLAKLDEEENTH-ISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVS-GRSNVTKEDMFYLLDWALVLKEQ 635 (756)
Q Consensus 558 ~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 635 (756)
+|||+|+........ ......||+.|||||++.+..|+.++|||||||++|||+| |+.||...+........ ..
T Consensus 170 ~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i----~~ 245 (299)
T 4asz_A 170 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECI----TQ 245 (299)
T ss_dssp CCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHH----HH
T ss_pred CCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH----Hc
Confidence 999999865443332 2334579999999999999999999999999999999999 89999776654443322 12
Q ss_pred CccccccccCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhccCc
Q 004400 636 GKLMELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLECGV 687 (756)
Q Consensus 636 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~L~~~~ 687 (756)
+..... ...++ ..+.+++.+||+.||++||||+||++.|+.+.
T Consensus 246 ~~~~~~-----p~~~~----~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~ 288 (299)
T 4asz_A 246 GRVLQR-----PRTCP----QEVYELMLGCWQREPHMRKNIKGIHTLLQNLA 288 (299)
T ss_dssp TCCCCC-----CTTCC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCCCC-----Cccch----HHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 222111 12233 34889999999999999999999999998653
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-55 Score=455.52 Aligned_cols=256 Identities=28% Similarity=0.419 Sum_probs=213.0
Q ss_pred CccccCcccCCCCccEEEeecc------CCcEEEEEEccccC-cccHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEE
Q 004400 417 NFATDNNIGEGGFGPVYKGLLA------DGTAIAVKQLSSKS-KQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLL 489 (756)
Q Consensus 417 ~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 489 (756)
+++..+.||+|+||+||+|++. +++.||||+++... ....++|.+|+.++++++|||||+++|+|.+++..++
T Consensus 27 ~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~l 106 (308)
T 4gt4_A 27 AVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSM 106 (308)
T ss_dssp GEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred HCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEEE
Confidence 4556788999999999999862 56789999997543 3345789999999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHHhc---------------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCC
Q 004400 490 IYEYLENNSLARALFEH---------------RLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLN 554 (756)
Q Consensus 490 V~e~~~~gsL~~~l~~~---------------~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~ 554 (756)
|||||++|+|.++|... ...++|..+.+|+.|||+||+|||+++ ||||||||+|||+++++.
T Consensus 107 V~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLK~~NILl~~~~~ 183 (308)
T 4gt4_A 107 IFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHH---VVHKDLATRNVLVYDKLN 183 (308)
T ss_dssp EEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGC
T ss_pred EEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCccccceEECCCCC
Confidence 99999999999999743 235899999999999999999999986 999999999999999999
Q ss_pred EEEccCCccccCcccC-cceeeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHh-CCCCCCccchhhHHHHHHHH
Q 004400 555 SKISDFGLAKLDEEEN-THISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVS-GRSNVTKEDMFYLLDWALVL 632 (756)
Q Consensus 555 ~kl~DFGla~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~~~~~~~ 632 (756)
+||+|||+|+...... ....+...||+.|||||++.++.|+.++|||||||++|||+| |+.||.+.+........
T Consensus 184 ~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~~~~i--- 260 (308)
T 4gt4_A 184 VKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEMI--- 260 (308)
T ss_dssp EEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHHHHHHH---
T ss_pred EEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHHHHHHH---
Confidence 9999999998654433 223445689999999999999999999999999999999998 89999776654443322
Q ss_pred HhcCccccccccCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhccCcc
Q 004400 633 KEQGKLMELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLECGVD 688 (756)
Q Consensus 633 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~L~~~~~ 688 (756)
..+...... ..++ ..+.+++.+||+.||++||||.||++.|+++.+
T Consensus 261 -~~~~~~~~p-----~~~~----~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~~n 306 (308)
T 4gt4_A 261 -RNRQVLPCP-----DDCP----AWVYALMIECWNEFPSRRPRFKDIHSRLRAWGN 306 (308)
T ss_dssp -HTTCCCCCC-----TTCC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCC
T ss_pred -HcCCCCCCc-----ccch----HHHHHHHHHHcCCChhHCcCHHHHHHHHHhccC
Confidence 222222211 1223 348899999999999999999999999998754
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-54 Score=458.60 Aligned_cols=257 Identities=28% Similarity=0.464 Sum_probs=209.1
Q ss_pred cCccccCcccCCCCccEEEeecc------CCcEEEEEEccccCcccHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEE
Q 004400 416 NNFATDNNIGEGGFGPVYKGLLA------DGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLL 489 (756)
Q Consensus 416 ~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 489 (756)
++|...+.||+|+||+||+|++. +++.||||+++.......++|.+|+++|++++|||||+++|+|.+++..++
T Consensus 41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 120 (329)
T 4aoj_A 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLM 120 (329)
T ss_dssp GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 46777889999999999999854 478999999987766677889999999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHHhcC--------------CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCE
Q 004400 490 IYEYLENNSLARALFEHR--------------LKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNS 555 (756)
Q Consensus 490 V~e~~~~gsL~~~l~~~~--------------~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~ 555 (756)
|||||++|+|.++++... ..++|.++.+|+.|||+||+|||+.+ ||||||||+|||+++++.+
T Consensus 121 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLKp~NILl~~~~~~ 197 (329)
T 4aoj_A 121 VFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH---FVHRDLATRNCLVGQGLVV 197 (329)
T ss_dssp EEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEE
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHhhEEECCCCcE
Confidence 999999999999997532 35899999999999999999999986 9999999999999999999
Q ss_pred EEccCCccccCcccCc-ceeeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHh-CCCCCCccchhhHHHHHHHHH
Q 004400 556 KISDFGLAKLDEEENT-HISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVS-GRSNVTKEDMFYLLDWALVLK 633 (756)
Q Consensus 556 kl~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~ 633 (756)
||+|||+|+....... .......||+.|||||++.+..++.++|||||||++|||+| |+.||............ .
T Consensus 198 Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i---~ 274 (329)
T 4aoj_A 198 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCI---T 274 (329)
T ss_dssp EECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHHHHH---H
T ss_pred EEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHHHHHHH---H
Confidence 9999999986644332 23445789999999999999999999999999999999999 89999776654443322 1
Q ss_pred hcCccccccccCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhccCcc
Q 004400 634 EQGKLMELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLECGVD 688 (756)
Q Consensus 634 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~L~~~~~ 688 (756)
.+..... ...++ ..+.+++.+||+.||++||||.||++.|+.+..
T Consensus 275 -~g~~~~~-----p~~~~----~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~ 319 (329)
T 4aoj_A 275 -QGRELER-----PRACP----PEVYAIMRGCWQREPQQRHSIKDVHARLQALAQ 319 (329)
T ss_dssp -HTCCCCC-----CTTCC----HHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHH
T ss_pred -cCCCCCC-----ccccc----HHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhh
Confidence 1221111 12233 348899999999999999999999999997654
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-54 Score=447.05 Aligned_cols=257 Identities=26% Similarity=0.430 Sum_probs=203.9
Q ss_pred cCccccCcccCCCCccEEEeeccCCcEEEEEEcccc--CcccHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEEe
Q 004400 416 NNFATDNNIGEGGFGPVYKGLLADGTAIAVKQLSSK--SKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYEY 493 (756)
Q Consensus 416 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 493 (756)
+++...+.||+|+||+||+|++.+ .||||+++.. .....+.|.+|++++++++|||||+++|+|.+ +..++||||
T Consensus 36 ~~l~l~~~iG~G~fG~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmEy 112 (307)
T 3omv_A 36 SEVMLSTRIGSGSFGTVYKGKWHG--DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQW 112 (307)
T ss_dssp TSCCEEEECCCCSSSEEEEEESSS--EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEEC
T ss_pred HHeEEeeEEeeCCCcEEEEEEECC--cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEEc
Confidence 567788899999999999999753 5999998653 33445789999999999999999999998864 568999999
Q ss_pred cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCcccC-cc
Q 004400 494 LENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEEN-TH 572 (756)
Q Consensus 494 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~~~-~~ 572 (756)
|++|+|.++|+.....++|.++..|+.|||+||+|||+++ ||||||||+|||+++++.+||+|||+|+...... ..
T Consensus 113 ~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~---IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~ 189 (307)
T 3omv_A 113 CEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKN---IIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQ 189 (307)
T ss_dssp CSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCSSSEEEETTEEEEECCCSSCBC--------
T ss_pred CCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCccCHHHEEECCCCcEEEeeccCceecccCCcce
Confidence 9999999999877778999999999999999999999986 9999999999999999999999999998765432 23
Q ss_pred eeeccccCccCCchHhhhc---CCCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhcCccccccccCCCCC
Q 004400 573 ISTRVAGTIGYMAPEYAMR---GHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSN 649 (756)
Q Consensus 573 ~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 649 (756)
.....+||+.|||||++.+ +.|+.++|||||||++|||+||+.||...+....... ....+.....+ ..
T Consensus 190 ~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~---~~~~~~~~p~~-----~~ 261 (307)
T 3omv_A 190 QVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIF---MVGRGYASPDL-----SK 261 (307)
T ss_dssp ----CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHH---HHHTTCCCCCS-----TT
T ss_pred eecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHH---HHhcCCCCCCc-----cc
Confidence 3455789999999999974 3589999999999999999999999976543322221 11111111100 01
Q ss_pred CCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhccC
Q 004400 650 FDKEQVMVMINVALLCANASPTIRPSMSSVLRMLECG 686 (756)
Q Consensus 650 ~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~L~~~ 686 (756)
.+...+..+.+++.+||+.||++||||.||++.|+.+
T Consensus 262 ~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l 298 (307)
T 3omv_A 262 LYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELL 298 (307)
T ss_dssp SCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHH
T ss_pred ccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 1122234588999999999999999999999998854
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-52 Score=443.19 Aligned_cols=249 Identities=22% Similarity=0.376 Sum_probs=204.7
Q ss_pred cCccccCcccCCCCccEEEee-ccCCcEEEEEEcccc--CcccHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEE
Q 004400 416 NNFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSK--SKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYE 492 (756)
Q Consensus 416 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 492 (756)
++|+..+.||+|+||+||+|+ ..+|+.||||++... .....+.+.+|+++|++++|||||++++++.+++..|+|||
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE 103 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD 103 (350)
T ss_dssp CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence 589999999999999999999 467999999999654 23345679999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCcccCc
Q 004400 493 YLENNSLARALFEH-RLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENT 571 (756)
Q Consensus 493 ~~~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~~~~ 571 (756)
||+||+|.+++... ...+++..++.|+.||+.||+|||++| ||||||||+|||++.++.+||+|||+|+.......
T Consensus 104 y~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~ 180 (350)
T 4b9d_A 104 YCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVE 180 (350)
T ss_dssp CCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CEETTCCGGGEEECTTCCEEECSTTEESCCCHHHH
T ss_pred CCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCCEEEcccccceeecCCcc
Confidence 99999999999754 345799999999999999999999997 99999999999999999999999999987654321
Q ss_pred ceeeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhcCccccccccCCCCCCC
Q 004400 572 HISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFD 651 (756)
Q Consensus 572 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 651 (756)
.....+||+.|||||++.+..|+.++|||||||++|||+||+.||...+........ .. +... .....++
T Consensus 181 -~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i---~~-~~~~-----~~~~~~s 250 (350)
T 4b9d_A 181 -LARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKI---IS-GSFP-----PVSLHYS 250 (350)
T ss_dssp -HHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH---HH-TCCC-----CCCTTSC
T ss_pred -cccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHH---Hc-CCCC-----CCCccCC
Confidence 234568999999999999999999999999999999999999999877655443221 11 1111 1112233
Q ss_pred HHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 004400 652 KEQVMVMINVALLCANASPTIRPSMSSVLR 681 (756)
Q Consensus 652 ~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~ 681 (756)
..+.+++.+||+.||++|||+.|+++
T Consensus 251 ----~~~~~li~~~L~~dP~~R~s~~e~l~ 276 (350)
T 4b9d_A 251 ----YDLRSLVSQLFKRNPRDRPSVNSILE 276 (350)
T ss_dssp ----HHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ----HHHHHHHHHHccCChhHCcCHHHHhc
Confidence 34889999999999999999999976
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-52 Score=441.86 Aligned_cols=249 Identities=25% Similarity=0.406 Sum_probs=211.0
Q ss_pred cCccccCcccCCCCccEEEeec-cCCcEEEEEEccccCcccHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEEec
Q 004400 416 NNFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYEYL 494 (756)
Q Consensus 416 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~ 494 (756)
..|+..+.||+|+||+||+|+. .+|+.||||++........+.+.+|+++|++++|||||+++++|.+++..|+|||||
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~ 153 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 153 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence 4688999999999999999994 579999999997665555677899999999999999999999999999999999999
Q ss_pred CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCcccCccee
Q 004400 495 ENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHIS 574 (756)
Q Consensus 495 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~~~~~~~ 574 (756)
++|+|.+++... .+++..+..++.||+.||+|||+++ ||||||||+|||++.++.+||+|||+|+....... ..
T Consensus 154 ~gg~L~~~l~~~--~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~-~~ 227 (346)
T 4fih_A 154 EGGALTDIVTHT--RMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP-RR 227 (346)
T ss_dssp TTEEHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSSSC-CB
T ss_pred CCCcHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEECCCCCEEEecCcCceecCCCCC-cc
Confidence 999999998653 6999999999999999999999997 99999999999999999999999999987654332 23
Q ss_pred eccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhcCccccccccCCCCCCCHHH
Q 004400 575 TRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDKEQ 654 (756)
Q Consensus 575 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 654 (756)
...+||+.|||||++.+..|+.++||||+||++|||++|+.||...+........ .. ..... .......
T Consensus 228 ~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i---~~-~~~~~-------~~~~~~~ 296 (346)
T 4fih_A 228 KSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMI---RD-NLPPR-------LKNLHKV 296 (346)
T ss_dssp CCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH---HH-SSCCC-------CSCGGGS
T ss_pred cccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHH---Hc-CCCCC-------CCccccC
Confidence 4578999999999999999999999999999999999999999877655443321 11 11000 0111122
Q ss_pred HHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 004400 655 VMVMINVALLCANASPTIRPSMSSVLR 681 (756)
Q Consensus 655 ~~~l~~l~~~c~~~~P~~RPt~~ev~~ 681 (756)
...+.+++.+||+.||++|||+.|+++
T Consensus 297 s~~~~dli~~~L~~dP~~R~ta~e~l~ 323 (346)
T 4fih_A 297 SPSLKGFLDRLLVRDPAQRATAAELLK 323 (346)
T ss_dssp CHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 334889999999999999999999876
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-52 Score=437.50 Aligned_cols=252 Identities=25% Similarity=0.256 Sum_probs=205.4
Q ss_pred hcCccccCcccCCCCccEEEeec-cCCcEEEEEEccccCcccHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEEe
Q 004400 415 TNNFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYEY 493 (756)
Q Consensus 415 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 493 (756)
.+.|...+.||+|+||+||+|+. .+|+.||||+++.... ..+|+.++++++|||||+++++|.+++..|+||||
T Consensus 57 ~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-----~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy 131 (336)
T 4g3f_A 57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-----RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMEL 131 (336)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-----CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-----HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEec
Confidence 35678888999999999999994 5799999999965322 24699999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCC-CEEEccCCccccCcccCcc
Q 004400 494 LENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDL-NSKISDFGLAKLDEEENTH 572 (756)
Q Consensus 494 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~-~~kl~DFGla~~~~~~~~~ 572 (756)
|+||+|.+++...+ .+++..+..++.||+.||+|||+++ ||||||||+|||++.++ .+||+|||+|+........
T Consensus 132 ~~gg~L~~~l~~~~-~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~ 207 (336)
T 4g3f_A 132 LEGGSLGQLIKQMG-CLPEDRALYYLGQALEGLEYLHTRR---ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLG 207 (336)
T ss_dssp CTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCCGGGEEECTTSCCEEECCCTTCEEC------
T ss_pred cCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCcc
Confidence 99999999997654 7999999999999999999999996 99999999999999987 5999999999876543221
Q ss_pred ----eeeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhcCccccccccCCCC
Q 004400 573 ----ISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGS 648 (756)
Q Consensus 573 ----~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 648 (756)
....++||+.|||||++.+..|+.++|||||||++|||+||+.||...+...+.... ........+ ...
T Consensus 208 ~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i--~~~~~~~~~-----~~~ 280 (336)
T 4g3f_A 208 KSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKI--ASEPPPIRE-----IPP 280 (336)
T ss_dssp ------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHH--HHSCCGGGG-----SCT
T ss_pred cceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHH--HcCCCCchh-----cCc
Confidence 123468999999999999999999999999999999999999999765443322211 111111111 112
Q ss_pred CCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhccC
Q 004400 649 NFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLECG 686 (756)
Q Consensus 649 ~~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~L~~~ 686 (756)
.++ ..+.+++.+||+.||.+|||+.|+++.|..+
T Consensus 281 ~~s----~~~~~li~~~L~~dP~~R~sa~el~~~l~~~ 314 (336)
T 4g3f_A 281 SCA----PLTAQAIQEGLRKEPVHRASAMELRRKVGKA 314 (336)
T ss_dssp TSC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred cCC----HHHHHHHHHHccCCHhHCcCHHHHHHHHHHH
Confidence 233 3488999999999999999999999988754
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-52 Score=429.85 Aligned_cols=247 Identities=24% Similarity=0.355 Sum_probs=210.4
Q ss_pred cCccccCcccCCCCccEEEee-ccCCcEEEEEEcccc---CcccHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEE
Q 004400 416 NNFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSK---SKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIY 491 (756)
Q Consensus 416 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 491 (756)
++|+..+.||+|+||+||+|+ ..+|+.||||++.+. .....+.+.+|+++|++++|||||+++++|.+++..|+||
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm 111 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 111 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 579999999999999999999 567999999999753 2334577999999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCcccC-
Q 004400 492 EYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEEN- 570 (756)
Q Consensus 492 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~~~- 570 (756)
|||+||+|.+++.+. ..+++..+..++.||+.||+|||+++ ||||||||+|||++.++.+||+|||+|+......
T Consensus 112 Ey~~gG~L~~~i~~~-~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~ 187 (311)
T 4aw0_A 112 SYAKNGELLKYIRKI-GSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESK 187 (311)
T ss_dssp CCCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECCTTTT
T ss_pred ecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCC
Confidence 999999999999765 47999999999999999999999997 9999999999999999999999999999765433
Q ss_pred cceeeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhcCccccccccCCCCCC
Q 004400 571 THISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNF 650 (756)
Q Consensus 571 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 650 (756)
......++||+.|||||++.+..|+.++||||+||++|||++|+.||...+...+.... ....- . ....+
T Consensus 188 ~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i--~~~~~---~-----~p~~~ 257 (311)
T 4aw0_A 188 QARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKI--IKLEY---D-----FPEKF 257 (311)
T ss_dssp CCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH--HHTCC---C-----CCTTC
T ss_pred cccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH--HcCCC---C-----CCccc
Confidence 23345678999999999999999999999999999999999999999877655443321 11111 1 11223
Q ss_pred CHHHHHHHHHHHHHhhcCCCCCCCCHHHHH
Q 004400 651 DKEQVMVMINVALLCANASPTIRPSMSSVL 680 (756)
Q Consensus 651 ~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~ 680 (756)
++ .+.+++.+|++.||++|||++|+.
T Consensus 258 s~----~~~dli~~lL~~dp~~R~t~~e~~ 283 (311)
T 4aw0_A 258 FP----KARDLVEKLLVLDATKRLGCEEME 283 (311)
T ss_dssp CH----HHHHHHHHHSCSSGGGSTTSGGGT
T ss_pred CH----HHHHHHHHHccCCHhHCcChHHHc
Confidence 33 488999999999999999999863
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-51 Score=443.19 Aligned_cols=250 Identities=25% Similarity=0.412 Sum_probs=212.0
Q ss_pred hcCccccCcccCCCCccEEEee-ccCCcEEEEEEccccCcccHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEEe
Q 004400 415 TNNFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYEY 493 (756)
Q Consensus 415 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 493 (756)
.+.|+..+.||+|+||.||+|+ ..+|+.||||++........+.+.+|+.+|++++|||||+++++|.+++.+|+||||
T Consensus 150 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy 229 (423)
T 4fie_A 150 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF 229 (423)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeC
Confidence 3579999999999999999999 457999999999766555667799999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCcccCcce
Q 004400 494 LENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHI 573 (756)
Q Consensus 494 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~~~~~~ 573 (756)
|+||+|.+++... .+++..+..|+.||+.||+|||++| ||||||||+|||++.++.+||+|||+|+....... .
T Consensus 230 ~~gG~L~~~i~~~--~l~e~~~~~~~~qil~aL~ylH~~~---IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~-~ 303 (423)
T 4fie_A 230 LEGGALTDIVTHT--RMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP-R 303 (423)
T ss_dssp CTTEEHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSTTTEEECTTCCEEECCCTTCEECCSSCC-C
T ss_pred CCCCcHHHHHhcc--CCCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEecCccceECCCCCc-c
Confidence 9999999998653 6999999999999999999999997 99999999999999999999999999987654332 2
Q ss_pred eeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhcCccccccccCCCCCCCHH
Q 004400 574 STRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDKE 653 (756)
Q Consensus 574 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 653 (756)
....+||+.|||||++.+..|+.++|||||||++|||++|+.||.+.+........ .. ...... .....++
T Consensus 304 ~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i---~~-~~~~~~---~~~~~~s-- 374 (423)
T 4fie_A 304 RKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMI---RD-NLPPRL---KNLHKVS-- 374 (423)
T ss_dssp BCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH---HH-SCCCCC---SCTTSSC--
T ss_pred ccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHH---Hc-CCCCCC---cccccCC--
Confidence 34578999999999999999999999999999999999999999877655443321 11 111010 0111233
Q ss_pred HHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 004400 654 QVMVMINVALLCANASPTIRPSMSSVLR 681 (756)
Q Consensus 654 ~~~~l~~l~~~c~~~~P~~RPt~~ev~~ 681 (756)
..+.+++.+||+.||++|||+.|+++
T Consensus 375 --~~~~dli~~~L~~dP~~R~ta~ell~ 400 (423)
T 4fie_A 375 --PSLKGFLDRLLVRDPAQRATAAELLK 400 (423)
T ss_dssp --HHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred --HHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 34889999999999999999999876
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-51 Score=426.48 Aligned_cols=246 Identities=27% Similarity=0.419 Sum_probs=198.1
Q ss_pred cccCcccCCCCccEEEeec-cCCcEEEEEEcccc--CcccHHHHHHHHHHHHhCCCCceeeEeeEEEe----CCeEEEEE
Q 004400 419 ATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSK--SKQGNREFINEIGMISALQHPNLVKLYGCCIE----GNQLLLIY 491 (756)
Q Consensus 419 ~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~lV~ 491 (756)
...+.||+|+||+||+|+. .++..||+|.+... .....+.|.+|++++++++|||||+++++|.+ ++..|+||
T Consensus 29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm 108 (290)
T 3fpq_A 29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 108 (290)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence 5667899999999999994 57899999998654 33345679999999999999999999999875 35689999
Q ss_pred EecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecC-CCCEEEccCCccccCcccC
Q 004400 492 EYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDK-DLNSKISDFGLAKLDEEEN 570 (756)
Q Consensus 492 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~-~~~~kl~DFGla~~~~~~~ 570 (756)
|||++|+|.+++.+. ..+++..+..++.||+.||+|||+++ ++||||||||+|||++. ++.+||+|||+|+.....
T Consensus 109 Ey~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~ylH~~~-~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~~- 185 (290)
T 3fpq_A 109 ELMTSGTLKTYLKRF-KVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS- 185 (290)
T ss_dssp ECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCTT-
T ss_pred eCCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC-CCEEecccChhheeEECCCCCEEEEeCcCCEeCCCC-
Confidence 999999999999754 47999999999999999999999884 45999999999999984 789999999999864332
Q ss_pred cceeeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhcCccccccccCCCCCC
Q 004400 571 THISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNF 650 (756)
Q Consensus 571 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 650 (756)
.....+||+.|||||++.+ .|+.++|||||||++|||+||+.||......... .... ..+......+ ...
T Consensus 186 --~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~--~~~i-~~~~~~~~~~----~~~ 255 (290)
T 3fpq_A 186 --FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQI--YRRV-TSGVKPASFD----KVA 255 (290)
T ss_dssp --SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHH--HHHH-TTTCCCGGGG----GCC
T ss_pred --ccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHH--HHHH-HcCCCCCCCC----ccC
Confidence 2345789999999998864 6999999999999999999999999654332211 1111 1111111111 112
Q ss_pred CHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 004400 651 DKEQVMVMINVALLCANASPTIRPSMSSVLR 681 (756)
Q Consensus 651 ~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~ 681 (756)
++ .+.+++.+||+.||++|||+.|+++
T Consensus 256 ~~----~~~~li~~~L~~dP~~R~s~~e~l~ 282 (290)
T 3fpq_A 256 IP----EVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp CH----HHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CH----HHHHHHHHHccCChhHCcCHHHHhc
Confidence 22 4889999999999999999999976
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-51 Score=417.43 Aligned_cols=246 Identities=26% Similarity=0.412 Sum_probs=193.5
Q ss_pred cCccccCcccCCCCccEEEee-ccCCcEEEEEEcccc---CcccHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEE
Q 004400 416 NNFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSK---SKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIY 491 (756)
Q Consensus 416 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 491 (756)
++|+..+.||+|+||+||+|+ ..+|+.||||++.+. .......+.+|++++++++|||||++++++.+++..|+||
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm 92 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI 92 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence 589999999999999999999 467999999999654 2234567999999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCcccCc
Q 004400 492 EYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENT 571 (756)
Q Consensus 492 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~~~~ 571 (756)
||| +|+|.+++.+. ..+++..+..++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+|+......
T Consensus 93 Ey~-~g~L~~~l~~~-~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~- 166 (275)
T 3hyh_A 93 EYA-GNELFDYIVQR-DKMSEQEARRFFQQIISAVEYCHRHK---IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGN- 166 (275)
T ss_dssp ECC-CEEHHHHHHHS-CSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTCCEEECCSSCC--------
T ss_pred eCC-CCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCChHHeEECCCCCEEEeecCCCeecCCCC-
Confidence 999 67999999765 47999999999999999999999997 9999999999999999999999999998654432
Q ss_pred ceeeccccCccCCchHhhhcCCC-CcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhcCccccccccCCCCCC
Q 004400 572 HISTRVAGTIGYMAPEYAMRGHL-TEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNF 650 (756)
Q Consensus 572 ~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 650 (756)
.....+||+.|||||++.+..+ +.++||||+||++|||+||+.||...+........ .. +.. . .....
T Consensus 167 -~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i---~~-~~~-~-----~p~~~ 235 (275)
T 3hyh_A 167 -FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNI---SN-GVY-T-----LPKFL 235 (275)
T ss_dssp ---------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH---HH-TCC-C-----CCTTS
T ss_pred -ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHH---Hc-CCC-C-----CCCCC
Confidence 2345689999999999988775 57999999999999999999999776554433211 11 111 1 11223
Q ss_pred CHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004400 651 DKEQVMVMINVALLCANASPTIRPSMSSVLRM 682 (756)
Q Consensus 651 ~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~ 682 (756)
+ ..+.+++.+|++.||++|||+.|+++.
T Consensus 236 s----~~~~~li~~~L~~dP~~R~s~~eil~h 263 (275)
T 3hyh_A 236 S----PGAAGLIKRMLIVNPLNRISIHEIMQD 263 (275)
T ss_dssp C----HHHHHHHHHHSCSSGGGSCCHHHHHHC
T ss_pred C----HHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 3 348899999999999999999999873
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-51 Score=437.87 Aligned_cols=259 Identities=25% Similarity=0.370 Sum_probs=210.9
Q ss_pred hhcCccccCcccCCCCccEEEeecc------CCcEEEEEEccccC-cccHHHHHHHHHHHHhCCC-CceeeEeeEEEeC-
Q 004400 414 ATNNFATDNNIGEGGFGPVYKGLLA------DGTAIAVKQLSSKS-KQGNREFINEIGMISALQH-PNLVKLYGCCIEG- 484 (756)
Q Consensus 414 ~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~- 484 (756)
..++|+..+.||+|+||+||+|++. .++.||||.+.... ....+.|.+|+++|++++| ||||+++|+|.++
T Consensus 62 ~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~~ 141 (353)
T 4ase_A 62 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPG 141 (353)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTT
T ss_pred cHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEecC
Confidence 3468899999999999999999853 24689999997643 3345679999999999965 8999999999764
Q ss_pred CeEEEEEEecCCCCHHHHHHhc---------------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEe
Q 004400 485 NQLLLIYEYLENNSLARALFEH---------------RLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLL 549 (756)
Q Consensus 485 ~~~~lV~e~~~~gsL~~~l~~~---------------~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill 549 (756)
+..++|||||++|+|.++|+.. ...++|..+..++.|||+||+|||+++ ||||||||+|||+
T Consensus 142 ~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~---iiHRDLK~~NILl 218 (353)
T 4ase_A 142 GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILL 218 (353)
T ss_dssp SCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEE
T ss_pred CEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCC---eecCccCccceee
Confidence 5789999999999999999753 235899999999999999999999996 9999999999999
Q ss_pred cCCCCEEEccCCccccCcccCcc-eeeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHh-CCCCCCccchhhHHH
Q 004400 550 DKDLNSKISDFGLAKLDEEENTH-ISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVS-GRSNVTKEDMFYLLD 627 (756)
Q Consensus 550 ~~~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~~ 627 (756)
++++.+||+|||+|+........ ......||+.|||||++.+..|+.++|||||||++|||+| |+.||.+.......
T Consensus 219 ~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~~~- 297 (353)
T 4ase_A 219 SEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF- 297 (353)
T ss_dssp CGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHH-
T ss_pred CCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCHHHHH-
Confidence 99999999999999976544333 3445789999999999999999999999999999999998 99999765432211
Q ss_pred HHHHHHhcCccccccccCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhccCc
Q 004400 628 WALVLKEQGKLMELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLECGV 687 (756)
Q Consensus 628 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~L~~~~ 687 (756)
......+...... ..++ ..+.+++.+||+.||++||||.||++.|+.+.
T Consensus 298 --~~~i~~g~~~~~p-----~~~~----~~~~~li~~c~~~dP~~RPt~~eil~~L~~ll 346 (353)
T 4ase_A 298 --CRRLKEGTRMRAP-----DYTT----PEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 346 (353)
T ss_dssp --HHHHHHTCCCCCC-----TTCC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred --HHHHHcCCCCCCC-----ccCC----HHHHHHHHHHcCcChhHCcCHHHHHHHHHHHH
Confidence 1111222222221 1223 34889999999999999999999999998653
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-51 Score=427.83 Aligned_cols=264 Identities=28% Similarity=0.339 Sum_probs=198.9
Q ss_pred cCccccCcccCCCCccEEEeeccCCcEEEEEEccccCcccHHHHHHHHHHHHhCCCCceeeEeeEEEeCC----eEEEEE
Q 004400 416 NNFATDNNIGEGGFGPVYKGLLADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCCIEGN----QLLLIY 491 (756)
Q Consensus 416 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~~~lV~ 491 (756)
++|...+.||+|+||+||+|++ +|+.||||++..... ....+.+|+..+.+++|||||+++++|.+++ ..|+||
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~~-~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~ 80 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREE-RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS 80 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccch-hhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEe
Confidence 4577788999999999999997 589999999965322 1222344566667889999999999998754 689999
Q ss_pred EecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCC-----CCCeEcCCCCCCceEecCCCCEEEccCCccccC
Q 004400 492 EYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGES-----RIKVVHRDIKATNVLLDKDLNSKISDFGLAKLD 566 (756)
Q Consensus 492 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g-----~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~ 566 (756)
|||++|+|.++++.. .++|..+.+++.|+|+||+|||+++ .++||||||||+|||++.++.+||+|||+|+..
T Consensus 81 Ey~~~gsL~~~l~~~--~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~ 158 (303)
T 3hmm_A 81 DYHEHGSLFDYLNRY--TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRH 158 (303)
T ss_dssp ECCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEEE
T ss_pred cCCCCCcHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCccc
Confidence 999999999999754 6899999999999999999999862 346999999999999999999999999999876
Q ss_pred cccCcce---eeccccCccCCchHhhhcC------CCCcccchhhHHHHHHHHHhCCCCCCccchhh------------H
Q 004400 567 EEENTHI---STRVAGTIGYMAPEYAMRG------HLTEKADVYSFGIVALEIVSGRSNVTKEDMFY------------L 625 (756)
Q Consensus 567 ~~~~~~~---~~~~~gt~~y~aPE~~~~~------~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~------------~ 625 (756)
....... ....+||+.|||||++.+. .++.++|||||||++|||+||+.|+....... .
T Consensus 159 ~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~~~ 238 (303)
T 3hmm_A 159 DSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSV 238 (303)
T ss_dssp ETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCH
T ss_pred cCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccchH
Confidence 5433221 2346799999999999754 36789999999999999999988763322110 0
Q ss_pred HHHHHHHHhcCccccccccCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhccCc
Q 004400 626 LDWALVLKEQGKLMELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLECGV 687 (756)
Q Consensus 626 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~L~~~~ 687 (756)
...............+.+ ...+.+....+.+++.+||+.||++||||.||++.|+++.
T Consensus 239 ~~~~~~~~~~~~rp~~p~----~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~ 296 (303)
T 3hmm_A 239 EEMRKVVCEQKLRPNIPN----RWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLS 296 (303)
T ss_dssp HHHHHHHTTSCCCCCCCG----GGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHHHhcccCCCCCCc----cccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHH
Confidence 111111111111111111 1112345567889999999999999999999999998654
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-50 Score=421.33 Aligned_cols=242 Identities=24% Similarity=0.325 Sum_probs=196.1
Q ss_pred cCccccCcccCCCCccEEEeec----cCCcEEEEEEccccC--cccHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEE
Q 004400 416 NNFATDNNIGEGGFGPVYKGLL----ADGTAIAVKQLSSKS--KQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLL 489 (756)
Q Consensus 416 ~~~~~~~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 489 (756)
++|+..+.||+|+||+||+|+. .+++.||||+++... ......+.+|++++++++|||||++++++.+++..|+
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 103 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL 103 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 5799999999999999999974 247899999997542 2234568899999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCccc
Q 004400 490 IYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEE 569 (756)
Q Consensus 490 V~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~~ 569 (756)
|||||+||+|.+++.+.+ .+++..+..++.||+.||+|||++| ||||||||+|||++.++.+||+|||+|+.....
T Consensus 104 vmEy~~gg~L~~~l~~~~-~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~ 179 (304)
T 3ubd_A 104 ILDFLRGGDLFTRLSKEV-MFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDH 179 (304)
T ss_dssp EECCCTTCEEHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTSCEEEESSEEEEC----
T ss_pred EEEcCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHeEEcCCCCEEecccccceeccCC
Confidence 999999999999997654 7999999999999999999999997 999999999999999999999999999865433
Q ss_pred CcceeeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhcCccccccccCCCCC
Q 004400 570 NTHISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSN 649 (756)
Q Consensus 570 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 649 (756)
.. .....+||+.|||||++.+..|+.++||||+||++|||+||+.||.+.+........ .. ... . ....
T Consensus 180 ~~-~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i---~~-~~~-~-----~p~~ 248 (304)
T 3ubd_A 180 EK-KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMI---LK-AKL-G-----MPQF 248 (304)
T ss_dssp -C-CCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH---HH-CCC-C-----CCTT
T ss_pred Cc-cccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHH---Hc-CCC-C-----CCCc
Confidence 22 234578999999999999999999999999999999999999999877655443321 11 111 1 1122
Q ss_pred CCHHHHHHHHHHHHHhhcCCCCCCCCH
Q 004400 650 FDKEQVMVMINVALLCANASPTIRPSM 676 (756)
Q Consensus 650 ~~~~~~~~l~~l~~~c~~~~P~~RPt~ 676 (756)
.+ ..+.+++.+||+.||++|||+
T Consensus 249 ~s----~~~~~li~~~L~~dP~~R~ta 271 (304)
T 3ubd_A 249 LS----PEAQSLLRMLFKRNPANRLGA 271 (304)
T ss_dssp SC----HHHHHHHHHHTCSSGGGSTTC
T ss_pred CC----HHHHHHHHHHcccCHHHCCCC
Confidence 33 348899999999999999985
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-49 Score=410.38 Aligned_cols=248 Identities=22% Similarity=0.375 Sum_probs=188.5
Q ss_pred cCccccCcccCCCCccEEEee-ccCCcEEEEEEccccCc-ccHHHHHHHHHHHHhCCCCceeeEeeEEEeCC--------
Q 004400 416 NNFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSKSK-QGNREFINEIGMISALQHPNLVKLYGCCIEGN-------- 485 (756)
Q Consensus 416 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-------- 485 (756)
++|+..+.||+|+||+||+|+ ..+|+.||||+++.... ...+.+.+|+++|++++|||||+++++|.+.+
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~ 84 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS 84 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence 468999999999999999999 45799999999865433 34467899999999999999999999987644
Q ss_pred ----eEEEEEEecCCCCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEcc
Q 004400 486 ----QLLLIYEYLENNSLARALFEHRL--KLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISD 559 (756)
Q Consensus 486 ----~~~lV~e~~~~gsL~~~l~~~~~--~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~D 559 (756)
..|+|||||++|+|.+++..... ..++..++.++.||+.||+|||+++ ||||||||+|||++.++.+||+|
T Consensus 85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~---IiHRDlKp~NILl~~~~~vKl~D 161 (299)
T 4g31_A 85 SPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGD 161 (299)
T ss_dssp --CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECC
T ss_pred CCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCc---CccccCcHHHeEECCCCcEEEcc
Confidence 37999999999999999975432 3566778999999999999999997 99999999999999999999999
Q ss_pred CCccccCcccCcc-----------eeeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHH
Q 004400 560 FGLAKLDEEENTH-----------ISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDW 628 (756)
Q Consensus 560 FGla~~~~~~~~~-----------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~ 628 (756)
||+|+........ ..+..+||+.|||||++.+..|+.++|||||||++|||++ ||...... ...
T Consensus 162 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~~--~~~ 236 (299)
T 4g31_A 162 FGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQMER--VRT 236 (299)
T ss_dssp CCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHHH--HHH
T ss_pred CccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccHH--HHH
Confidence 9999876543221 1234679999999999999999999999999999999996 77543211 111
Q ss_pred HHHHHhcCccccccccCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 004400 629 ALVLKEQGKLMELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLR 681 (756)
Q Consensus 629 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~ 681 (756)
.... ........ .........+++.+||+.||++|||+.|+++
T Consensus 237 ~~~~-~~~~~p~~---------~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 279 (299)
T 4g31_A 237 LTDV-RNLKFPPL---------FTQKYPCEYVMVQDMLSPSPMERPEAINIIE 279 (299)
T ss_dssp HHHH-HTTCCCHH---------HHHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHHH-hcCCCCCC---------CcccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 1111 11111110 1122234678999999999999999999987
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-46 Score=407.12 Aligned_cols=262 Identities=20% Similarity=0.316 Sum_probs=205.0
Q ss_pred cCccccCcccCCCCccEEEee-ccCCcEEEEEEccccC--cccHHHHHHHHHHHHhCCCCceeeEeeEEEe------CCe
Q 004400 416 NNFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSKS--KQGNREFINEIGMISALQHPNLVKLYGCCIE------GNQ 486 (756)
Q Consensus 416 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~------~~~ 486 (756)
++|+..+.||+|+||+||+|+ ..+|+.||||+++... ....+.+.+|+++|+.++|||||++++++.. .+.
T Consensus 54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~ 133 (398)
T 4b99_A 54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS 133 (398)
T ss_dssp SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence 579999999999999999999 4679999999997542 2334678899999999999999999999764 367
Q ss_pred EEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccC
Q 004400 487 LLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLD 566 (756)
Q Consensus 487 ~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~ 566 (756)
.|+|||||+ |+|.+++... ..+++..+..++.||+.||+|||++| ||||||||+|||++.++.+||+|||+|+..
T Consensus 134 ~~ivmE~~~-g~L~~~i~~~-~~l~~~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~ 208 (398)
T 4b99_A 134 VYVVLDLME-SDLHQIIHSS-QPLTLEHVRYFLYQLLRGLKYMHSAQ---VIHRDLKPSNLLVNENCELKIGDFGMARGL 208 (398)
T ss_dssp EEEEEECCS-EEHHHHHTSS-SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTCBCC
T ss_pred EEEEEeCCC-CCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCc---CcCCCcCccccccCCCCCEEEeecceeeec
Confidence 899999996 6799988654 57999999999999999999999997 999999999999999999999999999865
Q ss_pred cccC---cceeeccccCccCCchHhhhcC-CCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhcCcccc--
Q 004400 567 EEEN---THISTRVAGTIGYMAPEYAMRG-HLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLME-- 640 (756)
Q Consensus 567 ~~~~---~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~-- 640 (756)
.... .......+||+.|||||++.+. .++.++||||+||++|||++|+.||.+.+...................
T Consensus 209 ~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~~~ 288 (398)
T 4b99_A 209 CTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQ 288 (398)
T ss_dssp -------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGGTC
T ss_pred ccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHHhh
Confidence 4322 2223457899999999998875 579999999999999999999999988776554433322211111000
Q ss_pred ---------ccccCC-CCCCCH-----HHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004400 641 ---------LVDTNP-GSNFDK-----EQVMVMINVALLCANASPTIRPSMSSVLRM 682 (756)
Q Consensus 641 ---------~~~~~~-~~~~~~-----~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~ 682 (756)
.+...+ ....+. .....+.+++.+|++.||++|||+.|+++.
T Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 345 (398)
T 4b99_A 289 AVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRH 345 (398)
T ss_dssp -----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred hhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 000000 000000 112357899999999999999999999863
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-46 Score=398.34 Aligned_cols=203 Identities=27% Similarity=0.436 Sum_probs=173.4
Q ss_pred hhHHHhhcCccccCcccCCCCccEEEeec----cCCcEEEEEEccccCcccHHHHHHHHHHHHhC-CCCceeeEeeEEEe
Q 004400 409 LQIKAATNNFATDNNIGEGGFGPVYKGLL----ADGTAIAVKQLSSKSKQGNREFINEIGMISAL-QHPNLVKLYGCCIE 483 (756)
Q Consensus 409 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~ 483 (756)
..+....+.|+..+.||+|+||+||+|+. .+++.||||.+.... ...++.+|+++|+.+ +|||||+++++|.+
T Consensus 14 ~~~p~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~--~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~ 91 (361)
T 4f9c_A 14 EAVPQLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS--HPIRIAAELQCLTVAGGQDNVMGVKYCFRK 91 (361)
T ss_dssp HHSGGGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS--CHHHHHHHHHHHHHTCSBTTBCCCSEEEEE
T ss_pred HhcCCccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc--CHHHHHHHHHHHHHhcCCCCCceEEEEEEE
Confidence 33445567899999999999999999974 246889999986543 346788999999998 69999999999999
Q ss_pred CCeEEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCC-CCEEEccCCc
Q 004400 484 GNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKD-LNSKISDFGL 562 (756)
Q Consensus 484 ~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~-~~~kl~DFGl 562 (756)
++..|+|||||++|+|.+++. .+++.++..++.||+.||+|||++| ||||||||+|||++.+ +.+||+|||+
T Consensus 92 ~~~~~lvmE~~~g~~L~~~~~----~l~~~~~~~~~~qll~al~ylH~~g---IiHRDiKPeNiLl~~~~~~~kl~DFGl 164 (361)
T 4f9c_A 92 NDHVVIAMPYLEHESFLDILN----SLSFQEVREYMLNLFKALKRIHQFG---IVHRDVKPSNFLYNRRLKKYALVDFGL 164 (361)
T ss_dssp TTEEEEEEECCCCCCHHHHHT----TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred CCEEEEEEeCCCcccHHHHHc----CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCcCCHHHeEEeCCCCeEEECcCCC
Confidence 999999999999999999883 5899999999999999999999997 9999999999999877 7899999999
Q ss_pred cccCcccCc---------------------------ceeeccccCccCCchHhhhcC-CCCcccchhhHHHHHHHHHhCC
Q 004400 563 AKLDEEENT---------------------------HISTRVAGTIGYMAPEYAMRG-HLTEKADVYSFGIVALEIVSGR 614 (756)
Q Consensus 563 a~~~~~~~~---------------------------~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slGv~l~elltg~ 614 (756)
|+....... ...+..+||+.|+|||++.+. .|+.++||||+||++|||++|+
T Consensus 165 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~ 244 (361)
T 4f9c_A 165 AQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGR 244 (361)
T ss_dssp CEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTC
T ss_pred CcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCC
Confidence 985443211 112345799999999999875 5899999999999999999999
Q ss_pred CCCCcc
Q 004400 615 SNVTKE 620 (756)
Q Consensus 615 ~p~~~~ 620 (756)
.||...
T Consensus 245 ~Pf~~~ 250 (361)
T 4f9c_A 245 YPFYKA 250 (361)
T ss_dssp SSSSCC
T ss_pred CCCCCC
Confidence 999543
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-45 Score=418.01 Aligned_cols=253 Identities=23% Similarity=0.323 Sum_probs=213.2
Q ss_pred hcCccccCcccCCCCccEEEee-ccCCcEEEEEEccccCcccHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEEe
Q 004400 415 TNNFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYEY 493 (756)
Q Consensus 415 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 493 (756)
.++|++.+.||+|+||.||+|+ ..+|+.||+|++........+.+.+|+++|+.++|||||+++++|.+++..|+||||
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~ 235 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 235 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEee
Confidence 3689999999999999999999 467999999999776555667889999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCC--CCEEEccCCccccCcccCc
Q 004400 494 LENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKD--LNSKISDFGLAKLDEEENT 571 (756)
Q Consensus 494 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~--~~~kl~DFGla~~~~~~~~ 571 (756)
|+||+|.+++......+++..+..++.||+.||+|||+++ |+||||||+|||++.+ +.+||+|||+|+.......
T Consensus 236 ~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~~ 312 (573)
T 3uto_A 236 MSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQS 312 (573)
T ss_dssp CCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTSE
T ss_pred cCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhccccCCCCCCEEEeeccceeEccCCCc
Confidence 9999999999766668999999999999999999999997 9999999999999854 7899999999997654432
Q ss_pred ceeeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhcCccccccccCCCCCCC
Q 004400 572 HISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFD 651 (756)
Q Consensus 572 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 651 (756)
....+||+.|||||++.+..|+.++||||+||++|||++|+.||.+.+........ ....... .......++
T Consensus 313 --~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i--~~~~~~~----~~~~~~~~s 384 (573)
T 3uto_A 313 --VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNV--KSCDWNM----DDSAFSGIS 384 (573)
T ss_dssp --EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHH--HTTCCCC----CSGGGTTSC
T ss_pred --eeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHH--HhCCCCC----CcccccCCC
Confidence 34468999999999999999999999999999999999999999877654443221 1111111 111111233
Q ss_pred HHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004400 652 KEQVMVMINVALLCANASPTIRPSMSSVLRM 682 (756)
Q Consensus 652 ~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~ 682 (756)
..+.+|+.+||+.||.+|||+.|+++.
T Consensus 385 ----~~~~dli~~~L~~dp~~R~t~~e~l~H 411 (573)
T 3uto_A 385 ----EDGKDFIRKLLLADPNTRMTIHQALEH 411 (573)
T ss_dssp ----HHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred ----HHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 347899999999999999999999874
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-45 Score=391.36 Aligned_cols=277 Identities=43% Similarity=0.767 Sum_probs=238.7
Q ss_pred hHHHhhcCccccCcccCCCCccEEEeeccCCcEEEEEEccccCcccHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEE
Q 004400 410 QIKAATNNFATDNNIGEGGFGPVYKGLLADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLL 489 (756)
Q Consensus 410 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 489 (756)
++..++++|+..+.||+|+||.||+|+..+++.||||++........+.+.+|+++++.++||||+++++++.+++..++
T Consensus 33 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 112 (321)
T 2qkw_B 33 DLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMIL 112 (321)
T ss_dssp CCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCEE
T ss_pred HHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEE
Confidence 45567889999999999999999999988899999999887666667889999999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccC
Q 004400 490 IYEYLENNSLARALFEHR---LKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLD 566 (756)
Q Consensus 490 V~e~~~~gsL~~~l~~~~---~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~ 566 (756)
||||+++|+|.+++.... ..+++..+..++.|++.||+|||+++ |+||||||+||+++.++.+||+|||+++..
T Consensus 113 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 189 (321)
T 2qkw_B 113 IYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKG 189 (321)
T ss_dssp EEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCSTTEEECTTCCEEECCCTTCEEC
T ss_pred EEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCC---eecCCCCHHHEEECCCCCEEEeeccccccc
Confidence 999999999999886432 35899999999999999999999986 999999999999999999999999999864
Q ss_pred cccC-cceeeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHhCCCCCCccc---hhhHHHHHHHHHhcCcccccc
Q 004400 567 EEEN-THISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKED---MFYLLDWALVLKEQGKLMELV 642 (756)
Q Consensus 567 ~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~---~~~~~~~~~~~~~~~~~~~~~ 642 (756)
.... ........||+.|+|||++.+..++.++|||||||++|||++|+.||.... ......|.......+.....+
T Consensus 190 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 269 (321)
T 2qkw_B 190 TELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIV 269 (321)
T ss_dssp SSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCCSSS
T ss_pred ccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHHHhc
Confidence 4322 222344568999999999999999999999999999999999999995443 233445555555556666677
Q ss_pred ccCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhccCccc
Q 004400 643 DTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLECGVDV 689 (756)
Q Consensus 643 ~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~L~~~~~~ 689 (756)
++........+....+.+++.+||+.||++|||+.|+++.|+.....
T Consensus 270 ~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~~ 316 (321)
T 2qkw_B 270 DPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRL 316 (321)
T ss_dssp SSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred ChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhhc
Confidence 77666677888889999999999999999999999999999976543
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-45 Score=415.18 Aligned_cols=250 Identities=26% Similarity=0.315 Sum_probs=200.7
Q ss_pred hhcCccccCcccCCCCccEEEee-ccCCcEEEEEEccccC---cccHHHHHH---HHHHHHhCCCCceeeEeeEEEeCCe
Q 004400 414 ATNNFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSKS---KQGNREFIN---EIGMISALQHPNLVKLYGCCIEGNQ 486 (756)
Q Consensus 414 ~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~---~~~~~~~~~---E~~~l~~l~h~niv~l~~~~~~~~~ 486 (756)
..++|+..+.||+|+||+||+|+ ..+|+.||||++.+.. ......+.+ ++.+++.++|||||+++++|.+++.
T Consensus 187 slddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~ 266 (689)
T 3v5w_A 187 TMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDK 266 (689)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSE
T ss_pred chHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCE
Confidence 34789999999999999999999 4579999999996531 222233344 4566777899999999999999999
Q ss_pred EEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccC
Q 004400 487 LLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLD 566 (756)
Q Consensus 487 ~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~ 566 (756)
+|+|||||+||+|.++|... ..+++..+..++.||+.||+|||++| ||||||||+|||++.+|.+||+|||+|+..
T Consensus 267 lylVmEy~~GGdL~~~l~~~-~~l~E~~a~~y~~qIl~aL~yLH~~g---IiHRDLKPeNILld~~G~vKL~DFGlA~~~ 342 (689)
T 3v5w_A 267 LSFILDLMNGGDLHYHLSQH-GVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDF 342 (689)
T ss_dssp EEEEECCCCSCBHHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEEEEecCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHeEEeCCCCEEecccceeeec
Confidence 99999999999999999765 47999999999999999999999997 999999999999999999999999999866
Q ss_pred cccCcceeeccccCccCCchHhhhc-CCCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhcCccccccccC
Q 004400 567 EEENTHISTRVAGTIGYMAPEYAMR-GHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTN 645 (756)
Q Consensus 567 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 645 (756)
.... ....+||+.|||||++.+ ..|+.++||||+||++|||++|+.||...+............. ... .
T Consensus 343 ~~~~---~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~-~~~------~ 412 (689)
T 3v5w_A 343 SKKK---PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLT-MAV------E 412 (689)
T ss_dssp SSCC---CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHH-CCC------C
T ss_pred CCCC---CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcC-CCC------C
Confidence 5432 235689999999999975 5799999999999999999999999976543222111111111 110 0
Q ss_pred CCCCCCHHHHHHHHHHHHHhhcCCCCCCCC-----HHHHHH
Q 004400 646 PGSNFDKEQVMVMINVALLCANASPTIRPS-----MSSVLR 681 (756)
Q Consensus 646 ~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt-----~~ev~~ 681 (756)
....++ ..+.+++.+|++.||.+|++ +.||.+
T Consensus 413 ~p~~~S----~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~ 449 (689)
T 3v5w_A 413 LPDSFS----PELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 449 (689)
T ss_dssp CCTTSC----HHHHHHHHHHTCSCGGGCTTCSSSTHHHHTT
T ss_pred CCccCC----HHHHHHHHHHccCCHhHCCCCCCCCHHHHhc
Confidence 112233 34889999999999999998 577743
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-45 Score=390.71 Aligned_cols=279 Identities=46% Similarity=0.798 Sum_probs=238.5
Q ss_pred hhhHHHhhcCccccCcccCCCCccEEEeeccCCcEEEEEEccccCc-ccHHHHHHHHHHHHhCCCCceeeEeeEEEeCCe
Q 004400 408 YLQIKAATNNFATDNNIGEGGFGPVYKGLLADGTAIAVKQLSSKSK-QGNREFINEIGMISALQHPNLVKLYGCCIEGNQ 486 (756)
Q Consensus 408 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 486 (756)
+.++...+++|...+.||+|+||.||+|...+++.||||++..... .....+.+|+++++.++||||++++++|.+++.
T Consensus 22 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 101 (326)
T 3uim_A 22 LRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTE 101 (326)
T ss_dssp THHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEECCSSC
T ss_pred HHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEEecCCc
Confidence 4677888999999999999999999999988899999999976432 233478999999999999999999999999999
Q ss_pred EEEEEEecCCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCcc
Q 004400 487 LLLIYEYLENNSLARALFEHR---LKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLA 563 (756)
Q Consensus 487 ~~lV~e~~~~gsL~~~l~~~~---~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla 563 (756)
.++||||+++|+|.+++.... ..+++..+..++.|++.||+|||+.+.++|+||||||+||+++.++.+||+|||++
T Consensus 102 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~~ 181 (326)
T 3uim_A 102 RLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLA 181 (326)
T ss_dssp CEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEECCCSSC
T ss_pred eEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEeccCccc
Confidence 999999999999999997532 34999999999999999999999983334999999999999999999999999999
Q ss_pred ccCcccCcceeeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHhCCCCCCc-----cchhhHHHHHHHHHhcCcc
Q 004400 564 KLDEEENTHISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTK-----EDMFYLLDWALVLKEQGKL 638 (756)
Q Consensus 564 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~-----~~~~~~~~~~~~~~~~~~~ 638 (756)
+..............||+.|+|||++.+..++.++|||||||++|||++|+.||.. .......+|..........
T Consensus 182 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (326)
T 3uim_A 182 KLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKL 261 (326)
T ss_dssp EECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTTSSCCS
T ss_pred cccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHHhhchhh
Confidence 87765555555566799999999999999999999999999999999999999942 2223344555444455556
Q ss_pred ccccccCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhccC
Q 004400 639 MELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLECG 686 (756)
Q Consensus 639 ~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~L~~~ 686 (756)
....+......+.......+.+++.+||+.||.+|||+.||++.|++.
T Consensus 262 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~ 309 (326)
T 3uim_A 262 EALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGD 309 (326)
T ss_dssp TTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTS
T ss_pred hhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCc
Confidence 666666666777888889999999999999999999999999999864
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-43 Score=374.89 Aligned_cols=261 Identities=27% Similarity=0.427 Sum_probs=213.0
Q ss_pred hcCccccCcccCCCCccEEEeec-cCCcEEEEEEccccCcccHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEEe
Q 004400 415 TNNFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYEY 493 (756)
Q Consensus 415 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 493 (756)
.++|...+.||+|+||.||+|.. .+++.||+|.+........+.+.+|++++++++||||+++++++.+++..++||||
T Consensus 9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 88 (310)
T 3s95_A 9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEY 88 (310)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEe
Confidence 35788899999999999999995 57899999998776666678899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCcccCcce
Q 004400 494 LENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHI 573 (756)
Q Consensus 494 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~~~~~~ 573 (756)
+++|+|.+++......+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++.........
T Consensus 89 ~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 165 (310)
T 3s95_A 89 IKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMN---IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQP 165 (310)
T ss_dssp CTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEECTTSCEEECCCTTCEECC------
T ss_pred cCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCcCeEEECCCCCEEEeecccceecccccccc
Confidence 9999999999887778999999999999999999999997 9999999999999999999999999998654432211
Q ss_pred -------------eeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhcCcccc
Q 004400 574 -------------STRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLME 640 (756)
Q Consensus 574 -------------~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 640 (756)
.....||+.|+|||++.+..++.++||||||+++|||++|..|+.......... ......
T Consensus 166 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~-------~~~~~~ 238 (310)
T 3s95_A 166 EGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDF-------GLNVRG 238 (310)
T ss_dssp --------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTS-------SBCHHH
T ss_pred cccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHH-------hhhhhc
Confidence 114679999999999999999999999999999999999999885432111000 000000
Q ss_pred ccccCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhccCccc
Q 004400 641 LVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLECGVDV 689 (756)
Q Consensus 641 ~~~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~L~~~~~~ 689 (756)
..+......++ ..+.+++.+||+.||++|||+.++++.|+++...
T Consensus 239 ~~~~~~~~~~~----~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~ 283 (310)
T 3s95_A 239 FLDRYCPPNCP----PSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMH 283 (310)
T ss_dssp HHHHTCCTTCC----TTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred cccccCCCCCC----HHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 00110111122 2388999999999999999999999999976543
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-43 Score=369.21 Aligned_cols=252 Identities=27% Similarity=0.466 Sum_probs=211.3
Q ss_pred hhcCccccCcccCCCCccEEEee-ccCCcEEEEEEccccCcccHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEE
Q 004400 414 ATNNFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYE 492 (756)
Q Consensus 414 ~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 492 (756)
..++|...+.||+|+||.||+|. ..+++.||||.+........+.+.+|+.+++.++||||+++++++.+++..++|||
T Consensus 18 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 97 (297)
T 3fxz_A 18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME 97 (297)
T ss_dssp GGGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hhhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEE
Confidence 34689999999999999999998 56799999999976655666789999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCcccCcc
Q 004400 493 YLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTH 572 (756)
Q Consensus 493 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~~~~~ 572 (756)
|+++|+|.+++... .+++..+..++.|++.||+|||++| |+||||||+|||++.++.+||+|||+++........
T Consensus 98 ~~~~~~L~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 172 (297)
T 3fxz_A 98 YLAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK 172 (297)
T ss_dssp CCTTCBHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCC
T ss_pred CCCCCCHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEECCCCCEEEeeCCCceecCCcccc
Confidence 99999999999754 5899999999999999999999997 999999999999999999999999999865543332
Q ss_pred eeeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhcCccccccccCCCCCCCH
Q 004400 573 ISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDK 652 (756)
Q Consensus 573 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 652 (756)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||...+........ ...... .. ..+.
T Consensus 173 -~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~---~~~~~~-~~-------~~~~ 240 (297)
T 3fxz_A 173 -RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLI---ATNGTP-EL-------QNPE 240 (297)
T ss_dssp -BCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH---HHHCSC-CC-------SCGG
T ss_pred -cCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH---HhCCCC-CC-------CCcc
Confidence 33467999999999999999999999999999999999999999766543322211 111110 00 1111
Q ss_pred HHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004400 653 EQVMVMINVALLCANASPTIRPSMSSVLRM 682 (756)
Q Consensus 653 ~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~ 682 (756)
.....+.+++.+||+.||++|||+.|+++.
T Consensus 241 ~~~~~~~~li~~~l~~dp~~Rps~~ell~h 270 (297)
T 3fxz_A 241 KLSAIFRDFLNRCLEMDVEKRGSAKELLQH 270 (297)
T ss_dssp GSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred ccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 223348899999999999999999999864
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-43 Score=364.25 Aligned_cols=256 Identities=27% Similarity=0.451 Sum_probs=215.5
Q ss_pred hcCccccCcccCCCCccEEEeeccCCcEEEEEEccccCcccHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEEec
Q 004400 415 TNNFATDNNIGEGGFGPVYKGLLADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYEYL 494 (756)
Q Consensus 415 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~ 494 (756)
.++|+..+.||+|+||.||+|...+++.||+|++.... ...+.+.+|++++++++||||+++++++.+++..++||||+
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 87 (269)
T 4hcu_A 9 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFM 87 (269)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred hhhceeeheecCCCccEEEEEEecCCCeEEEEEecccc-cCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeC
Confidence 35788899999999999999998889999999997543 34578999999999999999999999999999999999999
Q ss_pred CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCcccCccee
Q 004400 495 ENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHIS 574 (756)
Q Consensus 495 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~~~~~~~ 574 (756)
++|+|.+++......+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++..........
T Consensus 88 ~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 164 (269)
T 4hcu_A 88 EHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSS 164 (269)
T ss_dssp TTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHHHST
T ss_pred CCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCC---eecCCcchheEEEcCCCCEEeccccccccccccccccc
Confidence 999999999877778999999999999999999999997 99999999999999999999999999986654433333
Q ss_pred eccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHh-CCCCCCccchhhHHHHHHHHHhcCccccccccCCCCCCCHH
Q 004400 575 TRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVS-GRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDKE 653 (756)
Q Consensus 575 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 653 (756)
....||+.|+|||.+.+..++.++||||+|+++|||++ |+.||............ .. ... .......+
T Consensus 165 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~---~~-~~~-----~~~~~~~~-- 233 (269)
T 4hcu_A 165 TGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDI---ST-GFR-----LYKPRLAS-- 233 (269)
T ss_dssp TSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHH---HT-TCC-----CCCCTTSC--
T ss_pred cCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHH---hc-Ccc-----CCCCCcCC--
Confidence 44567889999999999999999999999999999999 99999766544332211 11 100 11111222
Q ss_pred HHHHHHHHHHHhhcCCCCCCCCHHHHHHHhccCc
Q 004400 654 QVMVMINVALLCANASPTIRPSMSSVLRMLECGV 687 (756)
Q Consensus 654 ~~~~l~~l~~~c~~~~P~~RPt~~ev~~~L~~~~ 687 (756)
..+.+++.+||+.+|++||++.|+++.|+++.
T Consensus 234 --~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~ 265 (269)
T 4hcu_A 234 --THVYQIMNHCWRERPEDRPAFSRLLRQLAEIA 265 (269)
T ss_dssp --HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred --HHHHHHHHHHccCCcccCcCHHHHHHHHHHHH
Confidence 34889999999999999999999999998654
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-43 Score=376.05 Aligned_cols=258 Identities=27% Similarity=0.447 Sum_probs=211.1
Q ss_pred hcCccccCcccCCCCccEEEeecc----CCcEEEEEEcccc-CcccHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEE
Q 004400 415 TNNFATDNNIGEGGFGPVYKGLLA----DGTAIAVKQLSSK-SKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLL 489 (756)
Q Consensus 415 ~~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 489 (756)
.++|...+.||+|+||.||+|... .+..||||.++.. .....+.+.+|+.++++++||||+++++++.+++..++
T Consensus 48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 127 (325)
T 3kul_A 48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMI 127 (325)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEE
T ss_pred hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEE
Confidence 457888999999999999999963 3456999999764 33445679999999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCccc
Q 004400 490 IYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEE 569 (756)
Q Consensus 490 V~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~~ 569 (756)
||||+++|+|.+++......+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++.....
T Consensus 128 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 204 (325)
T 3kul_A 128 VTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLG---YVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDD 204 (325)
T ss_dssp EEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCSSCEECC--
T ss_pred EeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEECCCCCEEECCCCcccccccC
Confidence 99999999999999877678999999999999999999999997 999999999999999999999999999876543
Q ss_pred Ccc--eeeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHh-CCCCCCccchhhHHHHHHHHHhcCccccccccCC
Q 004400 570 NTH--ISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVS-GRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNP 646 (756)
Q Consensus 570 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 646 (756)
... ......+|+.|+|||++.+..++.++|||||||++|||++ |+.||............ .. .... ..
T Consensus 205 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~---~~-~~~~-----~~ 275 (325)
T 3kul_A 205 PDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSV---EE-GYRL-----PA 275 (325)
T ss_dssp --CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHH---HT-TCCC-----CC
T ss_pred ccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHH---Hc-CCCC-----CC
Confidence 222 2223456788999999999999999999999999999999 99999766554433221 11 1111 11
Q ss_pred CCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhccCcc
Q 004400 647 GSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLECGVD 688 (756)
Q Consensus 647 ~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~L~~~~~ 688 (756)
...++ ..+.+++.+||+.||++||++.+|++.|+++..
T Consensus 276 ~~~~~----~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~ 313 (325)
T 3kul_A 276 PMGCP----HALHQLMLDCWHKDRAQRPRFSQIVSVLDALIR 313 (325)
T ss_dssp CTTCC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCcC----HHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 11223 348899999999999999999999999997644
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-43 Score=360.58 Aligned_cols=258 Identities=26% Similarity=0.418 Sum_probs=216.8
Q ss_pred hhcCccccCcccCCCCccEEEeeccCCcEEEEEEccccCcccHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEEe
Q 004400 414 ATNNFATDNNIGEGGFGPVYKGLLADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYEY 493 (756)
Q Consensus 414 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 493 (756)
..++|...+.||+|+||.||+|...++..||+|.+.... ...+++.+|++++++++||||+++++++.+++..++||||
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (268)
T 3sxs_A 6 KREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGS-MSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEY 84 (268)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTT-BCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred chhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCC-CcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEc
Confidence 346788999999999999999998888899999997543 3457799999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCcccCcce
Q 004400 494 LENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHI 573 (756)
Q Consensus 494 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~~~~~~ 573 (756)
+++|+|.+++......+++..+..++.|++.||+|||+.| |+||||||+||+++.++.+||+|||+++.........
T Consensus 85 ~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~ 161 (268)
T 3sxs_A 85 ISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQ---FIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVS 161 (268)
T ss_dssp CTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCSGGGEEECTTCCEEECCTTCEEECCTTCEEE
T ss_pred cCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCcceEEECCCCCEEEccCccceecchhhhhc
Confidence 9999999999876667999999999999999999999997 9999999999999999999999999998766554444
Q ss_pred eeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHh-CCCCCCccchhhHHHHHHHHHhcCccccccccCCCCCCCH
Q 004400 574 STRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVS-GRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDK 652 (756)
Q Consensus 574 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 652 (756)
.....+|+.|+|||.+.+..++.++||||||+++|||++ |+.||........... ... ..... .....+
T Consensus 162 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~---~~~-~~~~~-----~~~~~~- 231 (268)
T 3sxs_A 162 SVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLK---VSQ-GHRLY-----RPHLAS- 231 (268)
T ss_dssp CCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHH---HHT-TCCCC-----CCTTSC-
T ss_pred ccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHH---HHc-CCCCC-----CCCcCh-
Confidence 444567788999999999899999999999999999999 9999966554332211 111 11100 111122
Q ss_pred HHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhccCcc
Q 004400 653 EQVMVMINVALLCANASPTIRPSMSSVLRMLECGVD 688 (756)
Q Consensus 653 ~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~L~~~~~ 688 (756)
..+.+++.+||+.+|++|||+.|+++.|+.+.+
T Consensus 232 ---~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~ 264 (268)
T 3sxs_A 232 ---DTIYQIMYSCWHELPEKRPTFQQLLSSIEPLRE 264 (268)
T ss_dssp ---HHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC
T ss_pred ---HHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhh
Confidence 348899999999999999999999999997654
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-43 Score=380.12 Aligned_cols=258 Identities=27% Similarity=0.442 Sum_probs=211.5
Q ss_pred hcCccccCcccCCCCccEEEeec--------cCCcEEEEEEccccC-cccHHHHHHHHHHHHhC-CCCceeeEeeEEEeC
Q 004400 415 TNNFATDNNIGEGGFGPVYKGLL--------ADGTAIAVKQLSSKS-KQGNREFINEIGMISAL-QHPNLVKLYGCCIEG 484 (756)
Q Consensus 415 ~~~~~~~~~lg~G~~g~Vy~~~~--------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 484 (756)
.++|...+.||+|+||.||+|+. .++..||||.++... ....+.+.+|+++++++ +||||++++++|.++
T Consensus 80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 159 (370)
T 2psq_A 80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 159 (370)
T ss_dssp GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSS
T ss_pred HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccC
Confidence 46788999999999999999974 245679999997643 23446789999999999 899999999999999
Q ss_pred CeEEEEEEecCCCCHHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEe
Q 004400 485 NQLLLIYEYLENNSLARALFEHR---------------LKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLL 549 (756)
Q Consensus 485 ~~~~lV~e~~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill 549 (756)
+..++||||+++|+|.+++.... ..+++..+..++.||+.||+|||+++ |+||||||+|||+
T Consensus 160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll 236 (370)
T 2psq_A 160 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVLV 236 (370)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEE
T ss_pred CCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchhhEEE
Confidence 99999999999999999998543 35899999999999999999999997 9999999999999
Q ss_pred cCCCCEEEccCCccccCcccCcc-eeeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHh-CCCCCCccchhhHHH
Q 004400 550 DKDLNSKISDFGLAKLDEEENTH-ISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVS-GRSNVTKEDMFYLLD 627 (756)
Q Consensus 550 ~~~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~~ 627 (756)
+.++.+||+|||+++........ ......||+.|+|||++.+..++.++|||||||++|||++ |+.||..........
T Consensus 237 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~~~~ 316 (370)
T 2psq_A 237 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFK 316 (370)
T ss_dssp CTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHH
T ss_pred CCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Confidence 99999999999999865443222 2233567889999999999999999999999999999999 999997655433322
Q ss_pred HHHHHHhcCccccccccCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhccCcc
Q 004400 628 WALVLKEQGKLMELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLECGVD 688 (756)
Q Consensus 628 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~L~~~~~ 688 (756)
. . ..+..... ...+ ...+.+++.+||+.||++||++.|+++.|+.+..
T Consensus 317 ~---~-~~~~~~~~-----~~~~----~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~ 364 (370)
T 2psq_A 317 L---L-KEGHRMDK-----PANC----TNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILT 364 (370)
T ss_dssp H---H-HTTCCCCC-----CTTS----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred H---H-hcCCCCCC-----CCCC----CHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 1 1 11111111 1122 2348899999999999999999999999997644
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=369.72 Aligned_cols=249 Identities=25% Similarity=0.380 Sum_probs=208.5
Q ss_pred hhcCccccCcccCCCCccEEEeec-cCCcEEEEEEcccc--CcccHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEE
Q 004400 414 ATNNFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSK--SKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLI 490 (756)
Q Consensus 414 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 490 (756)
..++|...+.||+|+||.||+|+. .+|+.||||++... .....+.+.+|+++++.++||||+++++++.+++..++|
T Consensus 13 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 92 (328)
T 3fe3_A 13 HIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLI 92 (328)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEE
Confidence 346899999999999999999995 68999999998654 233456788999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCcccC
Q 004400 491 YEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEEN 570 (756)
Q Consensus 491 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~~~ 570 (756)
|||+++|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++......
T Consensus 93 ~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 168 (328)
T 3fe3_A 93 MEYASGGEVFDYLVAH-GRMKEKEARSKFRQIVSAVQYCHQKR---IVHRDLKAENLLLDADMNIKIADFGFSNEFTVGG 168 (328)
T ss_dssp ECCCTTCBHHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTCCGGGSSSC
T ss_pred EECCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCCHHHEEEcCCCCEEEeeccCceecCCCC
Confidence 9999999999999765 46999999999999999999999997 9999999999999999999999999998654432
Q ss_pred cceeeccccCccCCchHhhhcCCCC-cccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhcCccccccccCCCCC
Q 004400 571 THISTRVAGTIGYMAPEYAMRGHLT-EKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSN 649 (756)
Q Consensus 571 ~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 649 (756)
. ....+||+.|+|||++.+..+. .++||||+||++|||++|+.||...+........ .. +.. .....
T Consensus 169 ~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i---~~-~~~------~~p~~ 236 (328)
T 3fe3_A 169 K--LDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERV---LR-GKY------RIPFY 236 (328)
T ss_dssp G--GGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH---HH-CCC------CCCTT
T ss_pred c--cccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHH---Hh-CCC------CCCCC
Confidence 2 3456799999999999987765 7999999999999999999999776654433211 11 111 01111
Q ss_pred CCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004400 650 FDKEQVMVMINVALLCANASPTIRPSMSSVLRM 682 (756)
Q Consensus 650 ~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~ 682 (756)
.+ ..+.+++.+|++.||.+|||+.|+++.
T Consensus 237 ~s----~~~~~li~~~L~~dP~~R~t~~eil~h 265 (328)
T 3fe3_A 237 MS----TDCENLLKRFLVLNPIKRGTLEQIMKD 265 (328)
T ss_dssp SC----HHHHHHHHHHCCSSTTTSCCHHHHTTC
T ss_pred CC----HHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 22 348899999999999999999999874
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-43 Score=369.58 Aligned_cols=260 Identities=29% Similarity=0.468 Sum_probs=204.7
Q ss_pred hhcCccccCcccCCCCccEEEeeccCCcEEEEEEccccC--cccHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEE
Q 004400 414 ATNNFATDNNIGEGGFGPVYKGLLADGTAIAVKQLSSKS--KQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIY 491 (756)
Q Consensus 414 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 491 (756)
..++|+..+.||+|+||.||+|+. +|+.||||++.... ....+.+.+|++++++++||||+++++++.+++..++||
T Consensus 35 ~~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 113 (309)
T 3p86_A 35 PWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVT 113 (309)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEEE
T ss_pred ChhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEEE
Confidence 456889999999999999999986 58899999987643 233467899999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCccc
Q 004400 492 EYLENNSLARALFEHR--LKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEE 569 (756)
Q Consensus 492 e~~~~gsL~~~l~~~~--~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~~ 569 (756)
||+++|+|.+++.... ..+++..+..++.|++.||+|||+.| ++|+||||||+||+++.++.+||+|||+++.....
T Consensus 114 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~-~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~ 192 (309)
T 3p86_A 114 EYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRN-PPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKAST 192 (309)
T ss_dssp ECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSS-SCCCCTTCCGGGEEECTTCCEEECCCC--------
T ss_pred ecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCC-CCEECCCCChhhEEEeCCCcEEECCCCCCcccccc
Confidence 9999999999997543 23899999999999999999999884 34999999999999999999999999999854432
Q ss_pred CcceeeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhcCccccccccCCCCC
Q 004400 570 NTHISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSN 649 (756)
Q Consensus 570 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 649 (756)
.. ......||+.|+|||++.+..++.++|||||||++|||++|+.||...+........ ........ ....
T Consensus 193 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~---~~~~~~~~-----~~~~ 263 (309)
T 3p86_A 193 FL-SSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAV---GFKCKRLE-----IPRN 263 (309)
T ss_dssp ----------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHH---HHSCCCCC-----CCTT
T ss_pred cc-ccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH---HhcCCCCC-----CCcc
Confidence 22 233467999999999999999999999999999999999999999766544333221 11111111 1112
Q ss_pred CCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhccCcc
Q 004400 650 FDKEQVMVMINVALLCANASPTIRPSMSSVLRMLECGVD 688 (756)
Q Consensus 650 ~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~L~~~~~ 688 (756)
++ ..+.+++.+||+.||.+|||+.++++.|+.+..
T Consensus 264 ~~----~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~ 298 (309)
T 3p86_A 264 LN----PQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIK 298 (309)
T ss_dssp SC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC
T ss_pred CC----HHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 23 348899999999999999999999999997654
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-42 Score=361.27 Aligned_cols=261 Identities=25% Similarity=0.351 Sum_probs=207.8
Q ss_pred hcCccccCcccCCCCccEEEee-ccCCcEEEEEEccccC---cccHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEE
Q 004400 415 TNNFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSKS---KQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLI 490 (756)
Q Consensus 415 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 490 (756)
.++|...+.||+|+||.||+|+ ..+++.||+|.+.... ....+.+.+|+.++++++||||+++++++.+++..++|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 89 (294)
T 4eqm_A 10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLV 89 (294)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEE
T ss_pred hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEE
Confidence 3578999999999999999999 4578999999985432 23346789999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCcccC
Q 004400 491 YEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEEN 570 (756)
Q Consensus 491 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~~~ 570 (756)
|||+++|+|.+++... ..+++..+..++.|++.||+|||+.| |+||||||+||+++.++.+||+|||+++......
T Consensus 90 ~e~~~g~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 165 (294)
T 4eqm_A 90 MEYIEGPTLSEYIESH-GPLSVDTAINFTNQILDGIKHAHDMR---IVHRDIKPQNILIDSNKTLKIFDFGIAKALSETS 165 (294)
T ss_dssp EECCCSCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCSSSTTC----
T ss_pred EeCCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEEeCCCcccccccc
Confidence 9999999999999755 37999999999999999999999997 9999999999999999999999999998766544
Q ss_pred cceeeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhcCccccccccCCCCCC
Q 004400 571 THISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNF 650 (756)
Q Consensus 571 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 650 (756)
........||+.|+|||.+.+..++.++||||||+++|||++|+.||.......... .... ...... ........
T Consensus 166 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~---~~~~-~~~~~~-~~~~~~~~ 240 (294)
T 4eqm_A 166 LTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAI---KHIQ-DSVPNV-TTDVRKDI 240 (294)
T ss_dssp ---------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHH---HHHS-SCCCCH-HHHSCTTS
T ss_pred ccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHH---HHhh-ccCCCc-chhcccCC
Confidence 444455679999999999999999999999999999999999999997665433211 1111 111111 01111222
Q ss_pred CHHHHHHHHHHHHHhhcCCCCCCC-CHHHHHHHhccCcc
Q 004400 651 DKEQVMVMINVALLCANASPTIRP-SMSSVLRMLECGVD 688 (756)
Q Consensus 651 ~~~~~~~l~~l~~~c~~~~P~~RP-t~~ev~~~L~~~~~ 688 (756)
+ ..+.+++.+|++.||.+|| ++.++.+.|+.+..
T Consensus 241 ~----~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~ 275 (294)
T 4eqm_A 241 P----QSLSNVILRATEKDKANRYKTIQEMKDDLSSVLH 275 (294)
T ss_dssp C----HHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSS
T ss_pred C----HHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHh
Confidence 3 3488999999999999999 99999999987644
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-42 Score=360.49 Aligned_cols=274 Identities=37% Similarity=0.632 Sum_probs=223.0
Q ss_pred hhhHHHhhcCcccc------CcccCCCCccEEEeeccCCcEEEEEEccccC----cccHHHHHHHHHHHHhCCCCceeeE
Q 004400 408 YLQIKAATNNFATD------NNIGEGGFGPVYKGLLADGTAIAVKQLSSKS----KQGNREFINEIGMISALQHPNLVKL 477 (756)
Q Consensus 408 ~~~~~~~~~~~~~~------~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l 477 (756)
+.++..++++|... +.||+|+||.||+|.. +++.||||++.... ....+.+.+|+.++++++||||+++
T Consensus 17 ~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~ 95 (307)
T 2nru_A 17 FYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVEL 95 (307)
T ss_dssp HHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred HHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEE
Confidence 56788888888887 8999999999999987 57899999986532 2335678999999999999999999
Q ss_pred eeEEEeCCeEEEEEEecCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCE
Q 004400 478 YGCCIEGNQLLLIYEYLENNSLARALFE--HRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNS 555 (756)
Q Consensus 478 ~~~~~~~~~~~lV~e~~~~gsL~~~l~~--~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~ 555 (756)
++++.+++..++||||+++|+|.+++.. ....+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+
T Consensus 96 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~ 172 (307)
T 2nru_A 96 LGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILLDEAFTA 172 (307)
T ss_dssp EEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCE
T ss_pred EEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEEcCCCcE
Confidence 9999999999999999999999999973 2346999999999999999999999997 9999999999999999999
Q ss_pred EEccCCccccCcccCcc-eeeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHhCCCCCCccchhh-HHHHHHHHH
Q 004400 556 KISDFGLAKLDEEENTH-ISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFY-LLDWALVLK 633 (756)
Q Consensus 556 kl~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~-~~~~~~~~~ 633 (756)
||+|||+++........ ......||+.|+|||.+.+ .++.++||||||+++|+|++|+.||....... ...+.....
T Consensus 173 kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~ 251 (307)
T 2nru_A 173 KISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIE 251 (307)
T ss_dssp EECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHH
T ss_pred EEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhh
Confidence 99999999865543222 2334679999999998864 58899999999999999999999996543322 222222222
Q ss_pred h-cCccccccccCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhccCc
Q 004400 634 E-QGKLMELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLECGV 687 (756)
Q Consensus 634 ~-~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~L~~~~ 687 (756)
. .....+.++... ...+......+.+++.+||+.+|.+||++.+|++.|+++.
T Consensus 252 ~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~ 305 (307)
T 2nru_A 252 DEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMT 305 (307)
T ss_dssp TTSCCHHHHSCSSC-SCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC
T ss_pred hhhhhhhhhccccc-cccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHh
Confidence 2 122223333322 3456667778999999999999999999999999998653
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-43 Score=378.21 Aligned_cols=258 Identities=27% Similarity=0.473 Sum_probs=201.6
Q ss_pred hcCccccCcccCCCCccEEEeecc----CCcEEEEEEcccc-CcccHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEE
Q 004400 415 TNNFATDNNIGEGGFGPVYKGLLA----DGTAIAVKQLSSK-SKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLL 489 (756)
Q Consensus 415 ~~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 489 (756)
.++|...+.||+|+||.||+|+.. ++..||||.++.. .....+.|.+|+.++++++||||+++++++.+++..++
T Consensus 44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 123 (373)
T 2qol_A 44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMI 123 (373)
T ss_dssp GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEE
Confidence 457899999999999999999854 5778999999764 23345679999999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCccc
Q 004400 490 IYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEE 569 (756)
Q Consensus 490 V~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~~ 569 (756)
||||+++|+|.+++......+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 124 v~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 200 (373)
T 2qol_A 124 VTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLGRVLEDD 200 (373)
T ss_dssp EEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC---------
T ss_pred EEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEEcCCCCEEECcCccccccccC
Confidence 99999999999999877778999999999999999999999996 999999999999999999999999999876543
Q ss_pred Ccce--eeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHh-CCCCCCccchhhHHHHHHHHHhcCccccccccCC
Q 004400 570 NTHI--STRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVS-GRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNP 646 (756)
Q Consensus 570 ~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 646 (756)
.... .....+|+.|+|||++.+..++.++|||||||++|||++ |+.||............ ..+.. ...
T Consensus 201 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i----~~~~~-----~~~ 271 (373)
T 2qol_A 201 PEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAV----DEGYR-----LPP 271 (373)
T ss_dssp -------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHH----HTTEE-----CCC
T ss_pred CccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH----HcCCC-----CCC
Confidence 2221 122345788999999999999999999999999999998 99999765544332211 11111 011
Q ss_pred CCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhccCcc
Q 004400 647 GSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLECGVD 688 (756)
Q Consensus 647 ~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~L~~~~~ 688 (756)
.... ...+.+++.+||+.||++||++.+|++.|+.+..
T Consensus 272 ~~~~----~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~ 309 (373)
T 2qol_A 272 PMDC----PAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIR 309 (373)
T ss_dssp CTTC----BHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred Cccc----cHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHh
Confidence 1122 2348899999999999999999999999987644
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=361.71 Aligned_cols=257 Identities=24% Similarity=0.398 Sum_probs=212.2
Q ss_pred hhcCccccCcccCCCCccEEEeeccCCcEEEEEEccccCcccHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEEe
Q 004400 414 ATNNFATDNNIGEGGFGPVYKGLLADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYEY 493 (756)
Q Consensus 414 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 493 (756)
..++|...+.||+|+||.||+|...++..||+|++.... ...+++.+|++++++++||||+++++++.+++..++||||
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 100 (283)
T 3gen_A 22 DPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEY 100 (283)
T ss_dssp CGGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECC
T ss_pred CHHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCC-CCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEec
Confidence 346788899999999999999998888899999997543 3457799999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCcccCcce
Q 004400 494 LENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHI 573 (756)
Q Consensus 494 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~~~~~~ 573 (756)
+++|+|.+++......+++..+..++.|++.||+|||+++ |+||||||+||+++.++.+||+|||+++.........
T Consensus 101 ~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~ 177 (283)
T 3gen_A 101 MANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTS 177 (283)
T ss_dssp CTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHHHS
T ss_pred cCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCccceEEEcCCCCEEEcccccccccccccccc
Confidence 9999999999875668999999999999999999999997 9999999999999999999999999998665443333
Q ss_pred eeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHh-CCCCCCccchhhHHHHHHHHHhcCccccccccCCCCCCCH
Q 004400 574 STRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVS-GRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDK 652 (756)
Q Consensus 574 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 652 (756)
.....+|+.|+|||.+.+..++.++||||||+++|||++ |+.||........... ... .. ........+
T Consensus 178 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~---~~~-~~-----~~~~~~~~~- 247 (283)
T 3gen_A 178 SVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEH---IAQ-GL-----RLYRPHLAS- 247 (283)
T ss_dssp TTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHH---HHT-TC-----CCCCCTTCC-
T ss_pred ccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHH---Hhc-cc-----CCCCCCcCC-
Confidence 334557889999999999999999999999999999998 9999976554332221 111 11 011111222
Q ss_pred HHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhccCc
Q 004400 653 EQVMVMINVALLCANASPTIRPSMSSVLRMLECGV 687 (756)
Q Consensus 653 ~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~L~~~~ 687 (756)
..+.+++.+||+.+|.+|||+.|+++.|+++.
T Consensus 248 ---~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~ 279 (283)
T 3gen_A 248 ---EKVYTIMYSCWHEKADERPTFKILLSNILDVM 279 (283)
T ss_dssp ---HHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ---HHHHHHHHHHccCChhHCcCHHHHHHHHHHHh
Confidence 34889999999999999999999999998654
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-42 Score=364.32 Aligned_cols=248 Identities=25% Similarity=0.420 Sum_probs=207.4
Q ss_pred ccccCcccCCCCccEEEeecc-CCcEEEEEEccccCcccHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEEecCC
Q 004400 418 FATDNNIGEGGFGPVYKGLLA-DGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYEYLEN 496 (756)
Q Consensus 418 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~ 496 (756)
|+..+.||+|+||.||+|+.. +|+.||||++........+.+.+|+.++++++||||+++++++..++..++||||+++
T Consensus 47 ~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 126 (321)
T 2c30_A 47 LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQG 126 (321)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEECCCCS
T ss_pred hhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEecCCC
Confidence 677789999999999999954 7999999999776666677899999999999999999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCcccCcceeec
Q 004400 497 NSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTR 576 (756)
Q Consensus 497 gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~ 576 (756)
|+|.+++.. ..+++..+..++.|++.||+|||+.| |+||||||+||+++.++.+||+|||+++........ ...
T Consensus 127 ~~L~~~l~~--~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~-~~~ 200 (321)
T 2c30_A 127 GALTDIVSQ--VRLNEEQIATVCEAVLQALAYLHAQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPK-RKS 200 (321)
T ss_dssp CBHHHHHTT--CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCC-BCC
T ss_pred CCHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCcEEEeeeeeeeecccCccc-ccc
Confidence 999998854 36999999999999999999999996 999999999999999999999999999865543222 234
Q ss_pred cccCccCCchHhhhcCCCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhcCccccccccCCCCCCCHHHHH
Q 004400 577 VAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDKEQVM 656 (756)
Q Consensus 577 ~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 656 (756)
..||+.|+|||++.+..++.++||||||+++|||++|+.||............ .. ...... ........
T Consensus 201 ~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~---~~-~~~~~~-------~~~~~~~~ 269 (321)
T 2c30_A 201 LVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRL---RD-SPPPKL-------KNSHKVSP 269 (321)
T ss_dssp CCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH---HH-SSCCCC-------TTGGGSCH
T ss_pred ccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH---hc-CCCCCc-------CccccCCH
Confidence 67999999999999999999999999999999999999999766544332211 11 111000 00111223
Q ss_pred HHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004400 657 VMINVALLCANASPTIRPSMSSVLRM 682 (756)
Q Consensus 657 ~l~~l~~~c~~~~P~~RPt~~ev~~~ 682 (756)
.+.+++.+||+.||++|||+.|+++.
T Consensus 270 ~l~~li~~~l~~dp~~Rps~~ell~h 295 (321)
T 2c30_A 270 VLRDFLERMLVRDPQERATAQELLDH 295 (321)
T ss_dssp HHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HHHHHHHHHccCChhhCcCHHHHhcC
Confidence 48899999999999999999999874
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-43 Score=383.71 Aligned_cols=263 Identities=20% Similarity=0.249 Sum_probs=215.9
Q ss_pred hhhHHHhhcCccccCcccCCCCccEEEeecc-CCcEEEEEEccccC---cccHHHHHHHHHHHHhCCCCceeeEeeEEEe
Q 004400 408 YLQIKAATNNFATDNNIGEGGFGPVYKGLLA-DGTAIAVKQLSSKS---KQGNREFINEIGMISALQHPNLVKLYGCCIE 483 (756)
Q Consensus 408 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 483 (756)
+.+++...++|+..+.||+|+||+||+|+.. +++.||||++.+.. ......+.+|+.++..++||||++++++|.+
T Consensus 66 ~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~ 145 (437)
T 4aw2_A 66 VKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQD 145 (437)
T ss_dssp HHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEEC
T ss_pred hhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee
Confidence 4566677899999999999999999999954 58899999986531 1222348899999999999999999999999
Q ss_pred CCeEEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCcc
Q 004400 484 GNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLA 563 (756)
Q Consensus 484 ~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla 563 (756)
++..|+|||||++|+|.+++......+++..+..++.||+.||+|||+.+ ||||||||+|||++.++.+||+|||+|
T Consensus 146 ~~~~~lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILl~~~g~vkL~DFGla 222 (437)
T 4aw2_A 146 DNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSC 222 (437)
T ss_dssp SSEEEEEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred CCEEEEEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeeEcCCCCEEEcchhhh
Confidence 99999999999999999999876668999999999999999999999997 999999999999999999999999999
Q ss_pred ccCcccCcceeeccccCccCCchHhhh-----cCCCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhcCcc
Q 004400 564 KLDEEENTHISTRVAGTIGYMAPEYAM-----RGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKL 638 (756)
Q Consensus 564 ~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 638 (756)
+.............+||+.|+|||++. ...++.++|||||||++|||++|+.||...+..............-..
T Consensus 223 ~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~ 302 (437)
T 4aw2_A 223 LKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQF 302 (437)
T ss_dssp EECCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCC
T ss_pred hhcccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhccccccC
Confidence 876655554455578999999999997 456899999999999999999999999877655443322111111111
Q ss_pred ccccccCCCCCCCHHHHHHHHHHHHHhhcCCCCC--CCCHHHHHHH
Q 004400 639 MELVDTNPGSNFDKEQVMVMINVALLCANASPTI--RPSMSSVLRM 682 (756)
Q Consensus 639 ~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~--RPt~~ev~~~ 682 (756)
. ......+. .+.+++.+|+..+|++ ||+++|+++.
T Consensus 303 p-----~~~~~~s~----~~~dLi~~lL~~~~~r~~r~~~~eil~H 339 (437)
T 4aw2_A 303 P-----TQVTDVSE----NAKDLIRRLICSREHRLGQNGIEDFKKH 339 (437)
T ss_dssp C-----SSCCCSCH----HHHHHHHTTSSCGGGCTTTTTTHHHHTS
T ss_pred C-----cccccCCH----HHHHHHHHHhcccccccCCCCHHHHhCC
Confidence 1 11112333 3888999999888888 9999999764
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-43 Score=373.24 Aligned_cols=266 Identities=26% Similarity=0.334 Sum_probs=205.2
Q ss_pred hcCccccCcccCCCCccEEEeeccCCcEEEEEEccccCcccHHHHHHHHHHHHhCCCCceeeEeeEEEeCC----eEEEE
Q 004400 415 TNNFATDNNIGEGGFGPVYKGLLADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCCIEGN----QLLLI 490 (756)
Q Consensus 415 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~~~lV 490 (756)
.++|+..+.||+|+||.||+|+.. ++.||||++.... .....+.+|+.++++++|||||++++++.++. ..++|
T Consensus 23 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv 100 (322)
T 3soc_A 23 SMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQD-KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLI 100 (322)
T ss_dssp TEEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred hhhchhhheecccCceEEEEEEEC-CCEEEEEEeecCc-hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEE
Confidence 467889999999999999999875 7899999996542 23345667999999999999999999998743 47999
Q ss_pred EEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcC----------CCCCeEcCCCCCCceEecCCCCEEEccC
Q 004400 491 YEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGE----------SRIKVVHRDIKATNVLLDKDLNSKISDF 560 (756)
Q Consensus 491 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~----------g~~~iiH~Dikp~Nill~~~~~~kl~DF 560 (756)
|||+++|+|.+++... .+++..+..++.|++.||+|||+. + |+||||||+|||++.++.+||+||
T Consensus 101 ~e~~~~g~L~~~l~~~--~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~---ivH~Dlkp~Nill~~~~~~kL~DF 175 (322)
T 3soc_A 101 TAFHEKGSLSDFLKAN--VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPA---ISHRDIKSKNVLLKNNLTACIADF 175 (322)
T ss_dssp EECCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECE---EECSCCSGGGEEECTTCCEEECCC
T ss_pred EecCCCCCHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCC---EEeCCCChHhEEECCCCeEEEccC
Confidence 9999999999999754 589999999999999999999987 6 999999999999999999999999
Q ss_pred CccccCcccCcc-eeeccccCccCCchHhhhcC-----CCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHh
Q 004400 561 GLAKLDEEENTH-ISTRVAGTIGYMAPEYAMRG-----HLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKE 634 (756)
Q Consensus 561 Gla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~-----~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~ 634 (756)
|+++........ ......||+.|+|||++.+. .++.++|||||||++|||++|+.||..........+......
T Consensus 176 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~ 255 (322)
T 3soc_A 176 GLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQ 255 (322)
T ss_dssp TTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCS
T ss_pred CcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhcc
Confidence 999765543322 23346799999999999863 456789999999999999999999965432111111111000
Q ss_pred cCccc--------cccccCCCCC-CCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhccCc
Q 004400 635 QGKLM--------ELVDTNPGSN-FDKEQVMVMINVALLCANASPTIRPSMSSVLRMLECGV 687 (756)
Q Consensus 635 ~~~~~--------~~~~~~~~~~-~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~L~~~~ 687 (756)
..... ....+..... ........+.+++.+||+.||++|||+.||++.|+++.
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~ 317 (322)
T 3soc_A 256 HPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQ 317 (322)
T ss_dssp SCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 00000 0000000000 11234556999999999999999999999999998654
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-43 Score=382.47 Aligned_cols=257 Identities=26% Similarity=0.412 Sum_probs=211.3
Q ss_pred hhcCccccCcccCCCCccEEEeecc-CCcEEEEEEccccC-cccHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEE
Q 004400 414 ATNNFATDNNIGEGGFGPVYKGLLA-DGTAIAVKQLSSKS-KQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIY 491 (756)
Q Consensus 414 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 491 (756)
..++|...+.||+|+||.||+|+.. +++.||||.++... ....+.|.+|++++++++|||||+++++|.+++..++||
T Consensus 112 ~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 191 (377)
T 3cbl_A 112 NHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVM 191 (377)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEE
T ss_pred chHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEE
Confidence 3467889999999999999999964 78999999987542 223356889999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCcccCc
Q 004400 492 EYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENT 571 (756)
Q Consensus 492 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~~~~ 571 (756)
||+++|+|.+++......+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++.......
T Consensus 192 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~~ 268 (377)
T 3cbl_A 192 ELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKC---CIHRDLAARNCLVTEKNVLKISDFGMSREEADGVY 268 (377)
T ss_dssp ECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEECTTSEE
T ss_pred EcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cCCcccCHHHEEEcCCCcEEECcCCCceecCCCce
Confidence 999999999999876667999999999999999999999997 99999999999999999999999999986443221
Q ss_pred cee-eccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHh-CCCCCCccchhhHHHHHHHHHhcCccccccccCCCCC
Q 004400 572 HIS-TRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVS-GRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSN 649 (756)
Q Consensus 572 ~~~-~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 649 (756)
... ....+++.|+|||.+..+.++.++|||||||++|||++ |+.||............ ..+..... ...
T Consensus 269 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~----~~~~~~~~-----~~~ 339 (377)
T 3cbl_A 269 AASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFV----EKGGRLPC-----PEL 339 (377)
T ss_dssp ECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHH----HTTCCCCC-----CTT
T ss_pred eecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH----HcCCCCCC-----CCC
Confidence 111 12345778999999999999999999999999999998 99999765543332211 11111111 112
Q ss_pred CCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhccC
Q 004400 650 FDKEQVMVMINVALLCANASPTIRPSMSSVLRMLECG 686 (756)
Q Consensus 650 ~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~L~~~ 686 (756)
++ ..+.+++.+||+.||++|||+.++++.|+.+
T Consensus 340 ~~----~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 372 (377)
T 3cbl_A 340 CP----DAVFRLMEQCWAYEPGQRPSFSTIYQELQSI 372 (377)
T ss_dssp CC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CC----HHHHHHHHHHcCCCchhCcCHHHHHHHHHHH
Confidence 22 3488999999999999999999999999865
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-42 Score=366.50 Aligned_cols=262 Identities=19% Similarity=0.213 Sum_probs=211.0
Q ss_pred hcCccccCcccCCCCccEEEee-ccCCcEEEEEEccccCcccHHHHHHHHHHHHhC-CCCceeeEeeEEEeCCeEEEEEE
Q 004400 415 TNNFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQGNREFINEIGMISAL-QHPNLVKLYGCCIEGNQLLLIYE 492 (756)
Q Consensus 415 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~e 492 (756)
.++|...+.||+|+||.||+|. ..+++.||||.+..... ...+.+|+++++++ +||||+++++++.+++..++|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e 85 (330)
T 2izr_A 8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR--APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLE 85 (330)
T ss_dssp TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS--SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEE
T ss_pred cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc--hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEE
Confidence 4678999999999999999999 46789999999865432 34688999999999 99999999999999999999999
Q ss_pred ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCC-----EEEccCCccccCc
Q 004400 493 YLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLN-----SKISDFGLAKLDE 567 (756)
Q Consensus 493 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~-----~kl~DFGla~~~~ 567 (756)
|+ +++|.+++......+++..+..++.|++.||+|||+.+ |+||||||+|||++.++. +||+|||+++...
T Consensus 86 ~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~ 161 (330)
T 2izr_A 86 LL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYI 161 (330)
T ss_dssp CC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESB
T ss_pred eC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeeccCCCCCCceEEEEEcccceeee
Confidence 99 99999999876678999999999999999999999997 999999999999998887 9999999998654
Q ss_pred ccCcc------eeeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhcCccccc
Q 004400 568 EENTH------ISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMEL 641 (756)
Q Consensus 568 ~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 641 (756)
..... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.......................
T Consensus 162 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~- 240 (330)
T 2izr_A 162 DPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRATP- 240 (330)
T ss_dssp CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHHSC-
T ss_pred cCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhccCC-
Confidence 43221 12456799999999999999999999999999999999999999976433222221111111000000
Q ss_pred cccCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhccCccc
Q 004400 642 VDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLECGVDV 689 (756)
Q Consensus 642 ~~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~L~~~~~~ 689 (756)
.......+ + .+.+++.+||+.||.+||++.+|++.|+.....
T Consensus 241 -~~~~~~~~----p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~ 282 (330)
T 2izr_A 241 -IEVLCENF----P-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDR 282 (330)
T ss_dssp -HHHHTTTC----H-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHH
T ss_pred -HHHHhccC----h-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHH
Confidence 00000011 1 488999999999999999999999999866443
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-42 Score=373.18 Aligned_cols=269 Identities=19% Similarity=0.231 Sum_probs=208.7
Q ss_pred hhcCccccCcccCCCCccEEEeeccC------CcEEEEEEccccCcc-----------cHHHHHHHHHHHHhCCCCceee
Q 004400 414 ATNNFATDNNIGEGGFGPVYKGLLAD------GTAIAVKQLSSKSKQ-----------GNREFINEIGMISALQHPNLVK 476 (756)
Q Consensus 414 ~~~~~~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~-----------~~~~~~~E~~~l~~l~h~niv~ 476 (756)
..++|...+.||+|+||.||+|...+ ++.||||++...... ....+..|+..++.++||||++
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~ 112 (364)
T 3op5_A 33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK 112 (364)
T ss_dssp TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence 45689999999999999999998654 478999998654321 1123445666777888999999
Q ss_pred EeeEEEeC----CeEEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEec--
Q 004400 477 LYGCCIEG----NQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLD-- 550 (756)
Q Consensus 477 l~~~~~~~----~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~-- 550 (756)
+++++.+. ...++||||+ +++|.+++......+++..+..++.||+.||+|||+.+ |+||||||+|||++
T Consensus 113 ~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~---iiHrDlkp~Nill~~~ 188 (364)
T 3op5_A 113 YWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHE---YVHGDIKASNLLLNYK 188 (364)
T ss_dssp EEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEESS
T ss_pred EEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---eEEecCCHHHEEEecC
Confidence 99999875 5589999999 99999999877678999999999999999999999996 99999999999999
Q ss_pred CCCCEEEccCCccccCcccCcce------eeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHhCCCCCCccchh-
Q 004400 551 KDLNSKISDFGLAKLDEEENTHI------STRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMF- 623 (756)
Q Consensus 551 ~~~~~kl~DFGla~~~~~~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~- 623 (756)
.++.+||+|||+++......... .....||+.|+|||++.+..++.++|||||||++|||++|+.||......
T Consensus 189 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~ 268 (364)
T 3op5_A 189 NPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDP 268 (364)
T ss_dssp CTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCH
T ss_pred CCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccCH
Confidence 88999999999998665432221 13356999999999999999999999999999999999999999643221
Q ss_pred hHHHHHHHHHhcCccccccccCCC-CCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhccCccccc
Q 004400 624 YLLDWALVLKEQGKLMELVDTNPG-SNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLECGVDVLD 691 (756)
Q Consensus 624 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~L~~~~~~~~ 691 (756)
....+.. .........+++.... ..++. .+.+++..||+.+|.+||++.+|++.|+.+.....
T Consensus 269 ~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~----~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~~ 332 (364)
T 3op5_A 269 KYVRDSK-IRYRENIASLMDKCFPAANAPG----EIAKYMETVKLLDYTEKPLYENLRDILLQGLKAIG 332 (364)
T ss_dssp HHHHHHH-HHHHHCHHHHHHHHSCTTCCCH----HHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred HHHHHHH-HHhhhhHHHHHHHhcccccCHH----HHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcC
Confidence 1111111 1111223333333221 22333 48899999999999999999999999987765443
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=386.86 Aligned_cols=259 Identities=28% Similarity=0.422 Sum_probs=214.6
Q ss_pred HhhcCccccCcccCCCCccEEEeeccCCcEEEEEEccccCcccHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEE
Q 004400 413 AATNNFATDNNIGEGGFGPVYKGLLADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYE 492 (756)
Q Consensus 413 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 492 (756)
...++|...+.||+|+||.||+|.+.++..||||.++... ...+.|.+|+.++++++|||||++++++. ++..++|||
T Consensus 185 i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e 262 (454)
T 1qcf_A 185 IPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITE 262 (454)
T ss_dssp CCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEEC
T ss_pred echHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEe
Confidence 3456888999999999999999998888999999997643 45678999999999999999999999986 667899999
Q ss_pred ecCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCcccCc
Q 004400 493 YLENNSLARALFEH-RLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENT 571 (756)
Q Consensus 493 ~~~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~~~~ 571 (756)
||++|+|.+++... ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.......
T Consensus 263 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~ 339 (454)
T 1qcf_A 263 FMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNEY 339 (454)
T ss_dssp CCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHHH
T ss_pred ecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCce
Confidence 99999999999743 336899999999999999999999996 99999999999999999999999999987654322
Q ss_pred ceeeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHh-CCCCCCccchhhHHHHHHHHHhcCccccccccCCCCCC
Q 004400 572 HISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVS-GRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNF 650 (756)
Q Consensus 572 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 650 (756)
.......+|+.|+|||++....++.++|||||||++|||++ |+.||............ . .+..... ...+
T Consensus 340 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i---~-~~~~~~~-----~~~~ 410 (454)
T 1qcf_A 340 TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRAL---E-RGYRMPR-----PENC 410 (454)
T ss_dssp HTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHH---H-HTCCCCC-----CTTS
T ss_pred eccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHH---H-cCCCCCC-----CCCC
Confidence 22333457889999999999999999999999999999999 99999766544333221 1 1111111 1122
Q ss_pred CHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhccCccc
Q 004400 651 DKEQVMVMINVALLCANASPTIRPSMSSVLRMLECGVDV 689 (756)
Q Consensus 651 ~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~L~~~~~~ 689 (756)
+ ..+.+++.+||+.||++|||+.+|++.|+.+...
T Consensus 411 ~----~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~~ 445 (454)
T 1qcf_A 411 P----EELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTA 445 (454)
T ss_dssp C----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSSS
T ss_pred C----HHHHHHHHHHccCChhHCcCHHHHHHHHHHHHhc
Confidence 3 3488999999999999999999999999987553
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-42 Score=365.16 Aligned_cols=249 Identities=26% Similarity=0.316 Sum_probs=207.7
Q ss_pred hcCccccCcccCCCCccEEEeec-cCCcEEEEEEcccc---CcccHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEE
Q 004400 415 TNNFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSK---SKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLI 490 (756)
Q Consensus 415 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 490 (756)
.++|+..+.||+|+||.||+|+. .+|+.||+|++++. .......+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv 83 (337)
T 1o6l_A 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEE
Confidence 35789999999999999999994 57999999999753 233456789999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCcccC
Q 004400 491 YEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEEN 570 (756)
Q Consensus 491 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~~~ 570 (756)
|||+++|+|.+++... ..+++..+..++.||+.||+|||++| |+||||||+|||++.++.+||+|||+++......
T Consensus 84 ~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~ 159 (337)
T 1o6l_A 84 MEYANGGELFFHLSRE-RVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG 159 (337)
T ss_dssp EECCTTCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTT
T ss_pred EeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCCHHHEEECCCCCEEEeeccchhhcccCC
Confidence 9999999999999754 47899999999999999999999997 9999999999999999999999999998543322
Q ss_pred cceeeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhcCccccccccCCCCCC
Q 004400 571 THISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNF 650 (756)
Q Consensus 571 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 650 (756)
. .....+||+.|+|||++.+..++.++|||||||++|||++|+.||...+........ .. ... . ....+
T Consensus 160 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i---~~-~~~-~-----~p~~~ 228 (337)
T 1o6l_A 160 A-TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELI---LM-EEI-R-----FPRTL 228 (337)
T ss_dssp C-CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH---HH-CCC-C-----CCTTS
T ss_pred C-cccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHH---Hc-CCC-C-----CCCCC
Confidence 2 234568999999999999999999999999999999999999999776544333211 11 110 0 11122
Q ss_pred CHHHHHHHHHHHHHhhcCCCCCCC-----CHHHHHHH
Q 004400 651 DKEQVMVMINVALLCANASPTIRP-----SMSSVLRM 682 (756)
Q Consensus 651 ~~~~~~~l~~l~~~c~~~~P~~RP-----t~~ev~~~ 682 (756)
+ ..+.+++.+|++.||++|| ++.|+++.
T Consensus 229 s----~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h 261 (337)
T 1o6l_A 229 S----PEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp C----HHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred C----HHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcC
Confidence 3 3488999999999999999 89998754
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-42 Score=365.41 Aligned_cols=252 Identities=16% Similarity=0.251 Sum_probs=209.0
Q ss_pred hcCccccCcccCCCCccEEEeec-cCCcEEEEEEccccCcccHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEEe
Q 004400 415 TNNFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYEY 493 (756)
Q Consensus 415 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 493 (756)
.++|...+.||+|+||.||+|.. .+++.||+|.+... ......+.+|+++++.++||||+++++++.+.+..++||||
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 82 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK-GTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC-THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecC-cccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEe
Confidence 46889999999999999999994 56889999998754 33446788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecC--CCCEEEccCCccccCcccCc
Q 004400 494 LENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDK--DLNSKISDFGLAKLDEEENT 571 (756)
Q Consensus 494 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~--~~~~kl~DFGla~~~~~~~~ 571 (756)
+++|+|.+++......+++..+..++.|++.||+|||+.| |+||||||+|||++. ++.+||+|||+++.......
T Consensus 83 ~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~g---ivH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~ 159 (321)
T 1tki_A 83 ISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN 159 (321)
T ss_dssp CCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCE
T ss_pred CCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCCc
Confidence 9999999999776668999999999999999999999997 999999999999987 78999999999987654332
Q ss_pred ceeeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhcCccccccccCCCCCCC
Q 004400 572 HISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFD 651 (756)
Q Consensus 572 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 651 (756)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||............. ....... .......
T Consensus 160 --~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~--~~~~~~~----~~~~~~~- 230 (321)
T 1tki_A 160 --FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIM--NAEYTFD----EEAFKEI- 230 (321)
T ss_dssp --EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH--HTCCCCC----HHHHTTS-
T ss_pred --cccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHH--cCCCCCC----hhhhccC-
Confidence 234679999999999998889999999999999999999999997765543332111 1110000 0000112
Q ss_pred HHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004400 652 KEQVMVMINVALLCANASPTIRPSMSSVLRM 682 (756)
Q Consensus 652 ~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~ 682 (756)
...+.+++.+|++.||++|||+.|+++.
T Consensus 231 ---s~~~~~li~~~L~~dp~~Rpt~~e~l~h 258 (321)
T 1tki_A 231 ---SIEAMDFVDRLLVKERKSRMTASEALQH 258 (321)
T ss_dssp ---CHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred ---CHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 2348899999999999999999999874
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-43 Score=370.14 Aligned_cols=262 Identities=26% Similarity=0.388 Sum_probs=207.5
Q ss_pred hcCccccCcccCCCCccEEEeec-----cCCcEEEEEEccccCcccHHHHHHHHHHHHhCCCCceeeEeeEEEeC--CeE
Q 004400 415 TNNFATDNNIGEGGFGPVYKGLL-----ADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCCIEG--NQL 487 (756)
Q Consensus 415 ~~~~~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~ 487 (756)
.++|+..+.||+|+||.||+|++ .+++.||||++........+.+.+|++++++++||||+++++++... ...
T Consensus 9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 88 (295)
T 3ugc_A 9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 88 (295)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSC
T ss_pred HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCce
Confidence 46788999999999999999983 36889999999876666667899999999999999999999998654 558
Q ss_pred EEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCc
Q 004400 488 LLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDE 567 (756)
Q Consensus 488 ~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~ 567 (756)
++||||+++|+|.+++......+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++...
T Consensus 89 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~~ 165 (295)
T 3ugc_A 89 KLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKVLP 165 (295)
T ss_dssp EEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCSCC---
T ss_pred EEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHhhEEEcCCCeEEEccCccccccc
Confidence 9999999999999999877667999999999999999999999986 9999999999999999999999999998765
Q ss_pred ccCcc--eeeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHhCCCCCCccchhhH------------HHHHHHHH
Q 004400 568 EENTH--ISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYL------------LDWALVLK 633 (756)
Q Consensus 568 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~------------~~~~~~~~ 633 (756)
..... ......||..|+|||.+.+..++.++||||||+++|||++|..|+........ ........
T Consensus 166 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (295)
T 3ugc_A 166 QDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELL 245 (295)
T ss_dssp ----------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHHHHH
T ss_pred CCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHHHHHH
Confidence 43321 22334578889999999999999999999999999999999999854321100 00000011
Q ss_pred hcCccccccccCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhccCcc
Q 004400 634 EQGKLMELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLECGVD 688 (756)
Q Consensus 634 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~L~~~~~ 688 (756)
..... ...+......+.+++.+||+.||++|||+.|+++.|+.+.+
T Consensus 246 ~~~~~---------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~ 291 (295)
T 3ugc_A 246 KNNGR---------LPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRD 291 (295)
T ss_dssp HTTCC---------CCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred hccCc---------CCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHH
Confidence 11111 11112223458899999999999999999999999986543
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-41 Score=358.57 Aligned_cols=262 Identities=24% Similarity=0.335 Sum_probs=205.8
Q ss_pred hcCccccCcccCCCCccEEEeeccCCcEEEEEEccccCc--ccHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEE
Q 004400 415 TNNFATDNNIGEGGFGPVYKGLLADGTAIAVKQLSSKSK--QGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYE 492 (756)
Q Consensus 415 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 492 (756)
.++|...+.||+|+||+||+|+..+|+.||+|++..... .....+.+|++++++++||||+++++++.+++..++|||
T Consensus 20 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 99 (311)
T 3niz_A 20 MEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFE 99 (311)
T ss_dssp SCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEE
T ss_pred HhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEc
Confidence 468899999999999999999988899999999875422 234678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCcccCcc
Q 004400 493 YLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTH 572 (756)
Q Consensus 493 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~~~~~ 572 (756)
|+++ +|.+.+......+++..+..++.|++.||+|||+.| |+||||||+|||++.++.+||+|||+++........
T Consensus 100 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~ 175 (311)
T 3niz_A 100 FMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHR---ILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRS 175 (311)
T ss_dssp CCSE-EHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEETTSCCC-
T ss_pred CCCC-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCchHhEEECCCCCEEEccCcCceecCCCccc
Confidence 9985 888888877777999999999999999999999997 999999999999999999999999999865433222
Q ss_pred eeeccccCccCCchHhhhc-CCCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhcCccccc----------
Q 004400 573 ISTRVAGTIGYMAPEYAMR-GHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMEL---------- 641 (756)
Q Consensus 573 ~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~---------- 641 (756)
.....||+.|+|||++.+ ..++.++||||+||++|||++|+.||........................
T Consensus 176 -~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 254 (311)
T 3niz_A 176 -YTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLWK 254 (311)
T ss_dssp ---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTSHHHH
T ss_pred -ccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhccchhh
Confidence 234578999999999876 56899999999999999999999999765544433322222211111000
Q ss_pred ------cccCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 004400 642 ------VDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLR 681 (756)
Q Consensus 642 ------~~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~ 681 (756)
..........+.....+.+++.+|++.||++|||+.|+++
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 300 (311)
T 3niz_A 255 QRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN 300 (311)
T ss_dssp SCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred hcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 0000000000111235789999999999999999999987
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=376.96 Aligned_cols=258 Identities=28% Similarity=0.421 Sum_probs=210.5
Q ss_pred hcCccccCcccCCCCccEEEeecc------CCcEEEEEEcccc-CcccHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeE
Q 004400 415 TNNFATDNNIGEGGFGPVYKGLLA------DGTAIAVKQLSSK-SKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQL 487 (756)
Q Consensus 415 ~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 487 (756)
.++|...+.||+|+||.||+|++. +++.||||++... .......+.+|+.++++++|||||++++++.++...
T Consensus 70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 149 (367)
T 3l9p_A 70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 149 (367)
T ss_dssp GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 457889999999999999999843 4678999999654 334456789999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCC---CEEEc
Q 004400 488 LLIYEYLENNSLARALFEHR------LKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDL---NSKIS 558 (756)
Q Consensus 488 ~lV~e~~~~gsL~~~l~~~~------~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~---~~kl~ 558 (756)
++||||+++|+|.+++.... ..+++.++..++.||+.||+|||++| |+||||||+|||++.++ .+||+
T Consensus 150 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kL~ 226 (367)
T 3l9p_A 150 FILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIG 226 (367)
T ss_dssp EEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred EEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEEecCCCCceEEEC
Confidence 99999999999999998543 45899999999999999999999997 99999999999999555 59999
Q ss_pred cCCccccCcccC-cceeeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHh-CCCCCCccchhhHHHHHHHHHhcC
Q 004400 559 DFGLAKLDEEEN-THISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVS-GRSNVTKEDMFYLLDWALVLKEQG 636 (756)
Q Consensus 559 DFGla~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~ 636 (756)
|||+++...... ........||+.|+|||++.+..++.++|||||||++|||++ |+.||............ ..+
T Consensus 227 DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i----~~~ 302 (367)
T 3l9p_A 227 DFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFV----TSG 302 (367)
T ss_dssp CCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHH----HTT
T ss_pred CCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH----HcC
Confidence 999997543322 122334568999999999999999999999999999999998 99999766554433221 111
Q ss_pred ccccccccCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhccCcc
Q 004400 637 KLMELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLECGVD 688 (756)
Q Consensus 637 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~L~~~~~ 688 (756)
.... ....++ ..+.+++.+||+.||++||++.+|++.|+....
T Consensus 303 ~~~~-----~~~~~~----~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~ 345 (367)
T 3l9p_A 303 GRMD-----PPKNCP----GPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ 345 (367)
T ss_dssp CCCC-----CCTTCC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCC-----CCccCC----HHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhh
Confidence 1111 111223 348899999999999999999999999986544
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-42 Score=377.87 Aligned_cols=262 Identities=20% Similarity=0.226 Sum_probs=213.1
Q ss_pred hhhHHHhhcCccccCcccCCCCccEEEeec-cCCcEEEEEEccccC---cccHHHHHHHHHHHHhCCCCceeeEeeEEEe
Q 004400 408 YLQIKAATNNFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSKS---KQGNREFINEIGMISALQHPNLVKLYGCCIE 483 (756)
Q Consensus 408 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 483 (756)
+.+.+...++|+..+.||+|+||.||+|+. .+|+.||||++.+.. ....+.+.+|..++..++||||++++++|.+
T Consensus 53 ~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~ 132 (412)
T 2vd5_A 53 LKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQD 132 (412)
T ss_dssp HHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEEC
T ss_pred hhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEee
Confidence 345566788999999999999999999995 579999999996531 2233458889999999999999999999999
Q ss_pred CCeEEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCcc
Q 004400 484 GNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLA 563 (756)
Q Consensus 484 ~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla 563 (756)
++..|+||||+++|+|.+++...+..+++..+..++.||+.||+|||+.+ ||||||||+|||++.++.+||+|||++
T Consensus 133 ~~~~~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILld~~g~vkL~DFGla 209 (412)
T 2vd5_A 133 ENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLG---YVHRDIKPDNILLDRCGHIRLADFGSC 209 (412)
T ss_dssp SSEEEEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred CCEEEEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccCHHHeeecCCCCEEEeechhh
Confidence 99999999999999999999876668999999999999999999999997 999999999999999999999999999
Q ss_pred ccCcccCcceeeccccCccCCchHhhh-------cCCCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhcC
Q 004400 564 KLDEEENTHISTRVAGTIGYMAPEYAM-------RGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQG 636 (756)
Q Consensus 564 ~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~ 636 (756)
+.............+||+.|+|||++. ...++.++|||||||++|||++|+.||...+...............
T Consensus 210 ~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~ 289 (412)
T 2vd5_A 210 LKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHL 289 (412)
T ss_dssp EECCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHC
T ss_pred eeccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCc
Confidence 876654444444568999999999997 3568999999999999999999999997766544332221111111
Q ss_pred ccccccccCCCCCCCHHHHHHHHHHHHHhhcCCCCCC---CCHHHHHHH
Q 004400 637 KLMELVDTNPGSNFDKEQVMVMINVALLCANASPTIR---PSMSSVLRM 682 (756)
Q Consensus 637 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~R---Pt~~ev~~~ 682 (756)
... .....++ ..+.+++.+|+. +|.+| |+++|+++.
T Consensus 290 ~~p-----~~~~~~s----~~~~dli~~lL~-~p~~Rlgr~~~~ei~~H 328 (412)
T 2vd5_A 290 SLP-----LVDEGVP----EEARDFIQRLLC-PPETRLGRGGAGDFRTH 328 (412)
T ss_dssp CCC---------CCC----HHHHHHHHTTSS-CGGGCTTTTTHHHHHTS
T ss_pred CCC-----ccccCCC----HHHHHHHHHHcC-ChhhcCCCCCHHHHhcC
Confidence 111 0111233 348899999999 99998 589998754
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-42 Score=377.01 Aligned_cols=259 Identities=20% Similarity=0.274 Sum_probs=212.9
Q ss_pred hhHHHhhcCccccCcccCCCCccEEEeec-cCCcEEEEEEcccc---CcccHHHHHHHHHHHHhCCCCceeeEeeEEEeC
Q 004400 409 LQIKAATNNFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSK---SKQGNREFINEIGMISALQHPNLVKLYGCCIEG 484 (756)
Q Consensus 409 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 484 (756)
.+++...++|...+.||+|+||+||+|+. .+++.||+|++.+. .......+.+|+.+++.++|||||+++++|.++
T Consensus 62 ~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~ 141 (410)
T 3v8s_A 62 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDD 141 (410)
T ss_dssp HHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred HhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEEC
Confidence 44556778999999999999999999995 46899999998652 122334588999999999999999999999999
Q ss_pred CeEEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccc
Q 004400 485 NQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAK 564 (756)
Q Consensus 485 ~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~ 564 (756)
+..|+|||||++|+|.+++... .+++..+..++.||+.||+|||+.| |+||||||+|||++.++.+||+|||+++
T Consensus 142 ~~~~lV~E~~~gg~L~~~l~~~--~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFG~a~ 216 (410)
T 3v8s_A 142 RYLYMVMEYMPGGDLVNLMSNY--DVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCM 216 (410)
T ss_dssp SEEEEEECCCTTEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred CEEEEEEeCCCCCcHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeeECCCCCEEEeccceeE
Confidence 9999999999999999998653 6899999999999999999999997 9999999999999999999999999998
Q ss_pred cCcccCcceeeccccCccCCchHhhhcCC----CCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhcCcccc
Q 004400 565 LDEEENTHISTRVAGTIGYMAPEYAMRGH----LTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLME 640 (756)
Q Consensus 565 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 640 (756)
.............+||+.|+|||++.+.. ++.++|||||||++|||++|+.||...+..............- .
T Consensus 217 ~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~---~ 293 (410)
T 3v8s_A 217 KMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSL---T 293 (410)
T ss_dssp ECCTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHC---C
T ss_pred eeccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhccccc---c
Confidence 76655444445678999999999998755 7899999999999999999999998776544333221111000 1
Q ss_pred ccccCCCCCCCHHHHHHHHHHHHHhhcCCCCC--CCCHHHHHHH
Q 004400 641 LVDTNPGSNFDKEQVMVMINVALLCANASPTI--RPSMSSVLRM 682 (756)
Q Consensus 641 ~~~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~--RPt~~ev~~~ 682 (756)
.. ....++. .+.+++.+|++.+|.+ ||++.||++.
T Consensus 294 ~p---~~~~~s~----~~~~li~~lL~~~~~rlgR~~~~ei~~H 330 (410)
T 3v8s_A 294 FP---DDNDISK----EAKNLICAFLTDREVRLGRNGVEEIKRH 330 (410)
T ss_dssp CC---TTCCCCH----HHHHHHHHHSSCGGGCTTSSCHHHHHTS
T ss_pred CC---CcccccH----HHHHHHHHHccChhhhCCCCCHHHHhcC
Confidence 11 1112333 4889999999999988 9999999865
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-42 Score=387.51 Aligned_cols=257 Identities=25% Similarity=0.427 Sum_probs=214.6
Q ss_pred hhcCccccCcccCCCCccEEEeecc-CCcEEEEEEccccCcccHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEE
Q 004400 414 ATNNFATDNNIGEGGFGPVYKGLLA-DGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYE 492 (756)
Q Consensus 414 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 492 (756)
...+|...+.||+|+||.||+|++. ++..||||.++... ...+.|.+|+.++++++|||||+++++|.+++..++|||
T Consensus 218 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E 296 (495)
T 1opk_A 218 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE 296 (495)
T ss_dssp CGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred CHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc-cchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEE
Confidence 4567889999999999999999965 48899999997543 346789999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCcccCc
Q 004400 493 YLENNSLARALFEH-RLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENT 571 (756)
Q Consensus 493 ~~~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~~~~ 571 (756)
||++|+|.+++... ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.......
T Consensus 297 ~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~ 373 (495)
T 1opk_A 297 FMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTY 373 (495)
T ss_dssp CCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCEEECCTTCEECCTTCCE
T ss_pred ccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChhhEEECCCCcEEEeecccceeccCCce
Confidence 99999999999854 356899999999999999999999997 99999999999999999999999999987654433
Q ss_pred ceeeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHh-CCCCCCccchhhHHHHHHHHHhcCccccccccCCCCCC
Q 004400 572 HISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVS-GRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNF 650 (756)
Q Consensus 572 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 650 (756)
.......+|+.|+|||++....++.++|||||||++|||++ |+.||...+........ ..+..... ...+
T Consensus 374 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~----~~~~~~~~-----~~~~ 444 (495)
T 1opk_A 374 TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL----EKDYRMER-----PEGC 444 (495)
T ss_dssp ECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHH----HTTCCCCC-----CTTC
T ss_pred eecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHH----HcCCCCCC-----CCCC
Confidence 33334557789999999999999999999999999999999 99999765543332211 11111111 1122
Q ss_pred CHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhccCc
Q 004400 651 DKEQVMVMINVALLCANASPTIRPSMSSVLRMLECGV 687 (756)
Q Consensus 651 ~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~L~~~~ 687 (756)
+ ..+.+++.+||+.||++|||+.+|++.|+.+.
T Consensus 445 ~----~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~ 477 (495)
T 1opk_A 445 P----EKVYELMRACWQWNPSDRPSFAEIHQAFETMF 477 (495)
T ss_dssp C----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSC
T ss_pred C----HHHHHHHHHHcCcChhHCcCHHHHHHHHHHHH
Confidence 2 34889999999999999999999999999764
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-42 Score=367.54 Aligned_cols=252 Identities=22% Similarity=0.269 Sum_probs=207.5
Q ss_pred hcCccccCcccCCCCccEEEeec-cCCcEEEEEEccccCcc------cHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeE
Q 004400 415 TNNFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSKSKQ------GNREFINEIGMISALQHPNLVKLYGCCIEGNQL 487 (756)
Q Consensus 415 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 487 (756)
.+.|...+.||+|+||.||+|+. .+|+.||+|.+...... ..+.+.+|+.++++++||||++++++|.+++..
T Consensus 11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 90 (361)
T 2yab_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDV 90 (361)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEE
Confidence 46789999999999999999994 57899999998764321 346789999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCC----CEEEccCCcc
Q 004400 488 LLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDL----NSKISDFGLA 563 (756)
Q Consensus 488 ~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~----~~kl~DFGla 563 (756)
++||||+++|+|.+++... ..+++..+..++.||+.||+|||+.| |+||||||+||+++.++ .+||+|||++
T Consensus 91 ~lv~e~~~gg~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~~~vkl~DFG~a 166 (361)
T 2yab_A 91 VLILELVSGGELFDFLAQK-ESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLA 166 (361)
T ss_dssp EEEEECCCSCBHHHHHTTC-SCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCCSSC
T ss_pred EEEEEcCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEeCCCCCccCEEEEecCCc
Confidence 9999999999999999654 47999999999999999999999997 99999999999998877 7999999999
Q ss_pred ccCcccCcceeeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhcCccccccc
Q 004400 564 KLDEEENTHISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVD 643 (756)
Q Consensus 564 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 643 (756)
+...... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+........ ........
T Consensus 167 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i--~~~~~~~~---- 238 (361)
T 2yab_A 167 HEIEDGV--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANI--TAVSYDFD---- 238 (361)
T ss_dssp EECCTTC--CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHH--HTTCCCCC----
T ss_pred eEcCCCC--ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH--HhcCCCCC----
Confidence 8655432 223467999999999999889999999999999999999999999776554433211 11100000
Q ss_pred cCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004400 644 TNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRM 682 (756)
Q Consensus 644 ~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~ 682 (756)
....... ...+.+++.+|+..||++|||+.|+++.
T Consensus 239 ~~~~~~~----s~~~~~li~~~L~~dP~~R~t~~e~l~h 273 (361)
T 2yab_A 239 EEFFSQT----SELAKDFIRKLLVKETRKRLTIQEALRH 273 (361)
T ss_dssp HHHHTTS----CHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred chhccCC----CHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 0000112 2348899999999999999999999864
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-42 Score=369.02 Aligned_cols=256 Identities=26% Similarity=0.438 Sum_probs=202.8
Q ss_pred hcCccccCcccCCCCccEEEeec-cCCcE----EEEEEcccc-CcccHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEE
Q 004400 415 TNNFATDNNIGEGGFGPVYKGLL-ADGTA----IAVKQLSSK-SKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLL 488 (756)
Q Consensus 415 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~----vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 488 (756)
.++|+..+.||+|+||.||+|+. .+++. ||+|.+... .....+.+.+|+.++++++||||++++++|.++. .+
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~ 92 (327)
T 3poz_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ 92 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EE
T ss_pred HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eE
Confidence 35788999999999999999994 44543 588887543 3345678999999999999999999999998765 78
Q ss_pred EEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCcc
Q 004400 489 LIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEE 568 (756)
Q Consensus 489 lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~ 568 (756)
+|+||+.+|+|.+++......+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 93 ~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~ 169 (327)
T 3poz_A 93 LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 169 (327)
T ss_dssp EEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTHHHHHTT
T ss_pred EEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCChheEEECCCCCEEEccCcceeEccC
Confidence 999999999999999887778999999999999999999999996 99999999999999999999999999986544
Q ss_pred cCcc-eeeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHh-CCCCCCccchhhHHHHHHHHHhcCccccccccCC
Q 004400 569 ENTH-ISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVS-GRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNP 646 (756)
Q Consensus 569 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 646 (756)
.... ......||+.|+|||++.+..++.++|||||||++|||++ |+.||............ .......
T Consensus 170 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~----~~~~~~~------ 239 (327)
T 3poz_A 170 EEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL----EKGERLP------ 239 (327)
T ss_dssp TCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHH----HTTCCCC------
T ss_pred CcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHH----HcCCCCC------
Confidence 3322 2334567889999999999999999999999999999999 99999765543332211 1111111
Q ss_pred CCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhccCc
Q 004400 647 GSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLECGV 687 (756)
Q Consensus 647 ~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~L~~~~ 687 (756)
.+......+.+++.+||+.+|++||++.|+++.|+...
T Consensus 240 ---~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~ 277 (327)
T 3poz_A 240 ---QPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMA 277 (327)
T ss_dssp ---CCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHH
T ss_pred ---CCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence 11112335889999999999999999999999998653
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-41 Score=368.26 Aligned_cols=253 Identities=23% Similarity=0.312 Sum_probs=210.6
Q ss_pred hcCccccCcccCCCCccEEEeec-cCCcEEEEEEccccCcccHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEEe
Q 004400 415 TNNFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYEY 493 (756)
Q Consensus 415 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 493 (756)
.++|...+.||+|+||.||+|.. .+|+.||+|.+..........+.+|+++++.++||||+++++++.+++..++||||
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~ 129 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 129 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEc
Confidence 46799999999999999999994 57899999999766555566889999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecC--CCCEEEccCCccccCcccCc
Q 004400 494 LENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDK--DLNSKISDFGLAKLDEEENT 571 (756)
Q Consensus 494 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~--~~~~kl~DFGla~~~~~~~~ 571 (756)
+++|+|.+++......+++..+..++.||+.||+|||+.| |+||||||+|||++. ++.+||+|||+++.......
T Consensus 130 ~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~~ 206 (387)
T 1kob_A 130 LSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI 206 (387)
T ss_dssp CCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSC
T ss_pred CCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccchHHeEEecCCCCceEEEecccceecCCCcc
Confidence 9999999999766667999999999999999999999997 999999999999974 46799999999987654332
Q ss_pred ceeeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhcCccccccccCCCCCCC
Q 004400 572 HISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFD 651 (756)
Q Consensus 572 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 651 (756)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||...+........ ...... .+.......+
T Consensus 207 --~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i---~~~~~~---~~~~~~~~~s 278 (387)
T 1kob_A 207 --VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNV---KRCDWE---FDEDAFSSVS 278 (387)
T ss_dssp --EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHH---HHCCCC---CCSSTTTTSC
T ss_pred --eeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHH---HhCCCC---CCccccccCC
Confidence 23357999999999999989999999999999999999999999776554333221 111100 1111112233
Q ss_pred HHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004400 652 KEQVMVMINVALLCANASPTIRPSMSSVLRM 682 (756)
Q Consensus 652 ~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~ 682 (756)
..+.+++.+||+.||++|||+.|+++.
T Consensus 279 ----~~~~~li~~~L~~dP~~Rpt~~ell~h 305 (387)
T 1kob_A 279 ----PEAKDFIKNLLQKEPRKRLTVHDALEH 305 (387)
T ss_dssp ----HHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred ----HHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence 348899999999999999999999875
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-41 Score=356.55 Aligned_cols=261 Identities=20% Similarity=0.255 Sum_probs=212.1
Q ss_pred hcCccccCcccCCCCccEEEee-ccCCcEEEEEEccccCcccHHHHHHHHHHHHhC-CCCceeeEeeEEEeCCeEEEEEE
Q 004400 415 TNNFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQGNREFINEIGMISAL-QHPNLVKLYGCCIEGNQLLLIYE 492 (756)
Q Consensus 415 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~e 492 (756)
.++|...+.||+|+||.||+|. ..+++.||||++.... ....+.+|+.+++.+ +|+|++++++++.++...++|||
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e 86 (298)
T 1csn_A 9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID 86 (298)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC--ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEE
Confidence 4678999999999999999999 4679999999986432 234688899999999 79999999999999999999999
Q ss_pred ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCC-----EEEccCCccccCc
Q 004400 493 YLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLN-----SKISDFGLAKLDE 567 (756)
Q Consensus 493 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~-----~kl~DFGla~~~~ 567 (756)
|+ +++|.+++......+++..+..++.|++.||+|||+.| |+||||||+||+++.++. +||+|||+++...
T Consensus 87 ~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~ 162 (298)
T 1csn_A 87 LL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYR 162 (298)
T ss_dssp CC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESB
T ss_pred ec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEeccCCCCCCCeEEEEECccccccc
Confidence 99 99999999877667999999999999999999999986 999999999999987776 9999999998665
Q ss_pred ccCcc------eeeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHhCCCCCCccchhh---HHHHHHHHHhcCcc
Q 004400 568 EENTH------ISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFY---LLDWALVLKEQGKL 638 (756)
Q Consensus 568 ~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~---~~~~~~~~~~~~~~ 638 (756)
..... ......||+.|+|||++.+..++.++|||||||++|||++|+.||....... ..............
T Consensus 163 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 242 (298)
T 1csn_A 163 DPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPL 242 (298)
T ss_dssp CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCH
T ss_pred cccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccCccH
Confidence 43221 2345679999999999999999999999999999999999999996543211 11111111111111
Q ss_pred ccccccCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhccCcccc
Q 004400 639 MELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLECGVDVL 690 (756)
Q Consensus 639 ~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~L~~~~~~~ 690 (756)
.... ..++ ..+.+++.+||+.||++||++.+|++.|+++....
T Consensus 243 ~~~~-----~~~~----~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~ 285 (298)
T 1csn_A 243 RELC-----AGFP----EEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERL 285 (298)
T ss_dssp HHHT-----TTSC----HHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred HHHH-----hhCc----HHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHhc
Confidence 1111 1222 34889999999999999999999999999775533
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-42 Score=359.87 Aligned_cols=257 Identities=25% Similarity=0.372 Sum_probs=199.0
Q ss_pred hhcCccccCcccCCCCccEEEeecc----CCcEEEEEEccccC-cccHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEE
Q 004400 414 ATNNFATDNNIGEGGFGPVYKGLLA----DGTAIAVKQLSSKS-KQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLL 488 (756)
Q Consensus 414 ~~~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 488 (756)
..++|+..+.||+|+||.||+|... .+..||+|.+.... ....+.+.+|+.++++++||||+++++++. ++..+
T Consensus 13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~ 91 (281)
T 1mp8_A 13 QRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVW 91 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCE
T ss_pred ehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccE
Confidence 3467889999999999999999853 24579999987542 334567899999999999999999999984 56789
Q ss_pred EEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCcc
Q 004400 489 LIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEE 568 (756)
Q Consensus 489 lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~ 568 (756)
+||||+++|+|.+++......+++..+..++.|++.||+|||+.| |+||||||+||+++.++.+||+|||+++....
T Consensus 92 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 168 (281)
T 1mp8_A 92 IIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYMED 168 (281)
T ss_dssp EEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC---------
T ss_pred EEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHEEECCCCCEEECccccccccCc
Confidence 999999999999999877668999999999999999999999997 99999999999999999999999999987655
Q ss_pred cCcceeeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHh-CCCCCCccchhhHHHHHHHHHhcCccccccccCCC
Q 004400 569 ENTHISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVS-GRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPG 647 (756)
Q Consensus 569 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 647 (756)
..........+|+.|+|||.+....++.++||||||+++|||++ |+.||............ .. ..... ..
T Consensus 169 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i---~~-~~~~~-----~~ 239 (281)
T 1mp8_A 169 STYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI---EN-GERLP-----MP 239 (281)
T ss_dssp ----------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHH---HT-TCCCC-----CC
T ss_pred ccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHH---Hc-CCCCC-----CC
Confidence 44333344567889999999999999999999999999999997 99999765544332211 11 11111 11
Q ss_pred CCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhccCc
Q 004400 648 SNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLECGV 687 (756)
Q Consensus 648 ~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~L~~~~ 687 (756)
..++ ..+.+++.+||+.||++||++.|+++.|+.+.
T Consensus 240 ~~~~----~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~ 275 (281)
T 1mp8_A 240 PNCP----PTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL 275 (281)
T ss_dssp TTCC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCC----HHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 1223 34889999999999999999999999998653
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-42 Score=383.01 Aligned_cols=259 Identities=29% Similarity=0.447 Sum_probs=208.2
Q ss_pred hhcCccccCcccCCCCccEEEeeccCCcEEEEEEccccCcccHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEEe
Q 004400 414 ATNNFATDNNIGEGGFGPVYKGLLADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYEY 493 (756)
Q Consensus 414 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 493 (756)
..++|...+.||+|+||.||+|.+.++..||||.++... ...+.|.+|++++++++||||+++++++.+ +..++||||
T Consensus 182 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~ 259 (452)
T 1fmk_A 182 PRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEY 259 (452)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECC
T ss_pred ChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehh
Confidence 456788899999999999999998888889999997643 345789999999999999999999999876 678999999
Q ss_pred cCCCCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCcccCcc
Q 004400 494 LENNSLARALFE-HRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTH 572 (756)
Q Consensus 494 ~~~gsL~~~l~~-~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~~~~~ 572 (756)
+++|+|.+++.. ....+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++........
T Consensus 260 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~ 336 (452)
T 1fmk_A 260 MSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT 336 (452)
T ss_dssp CTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC--------
T ss_pred hcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEECCCCCEEECCCccceecCCCcee
Confidence 999999999974 3346899999999999999999999996 999999999999999999999999999876543333
Q ss_pred eeeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHh-CCCCCCccchhhHHHHHHHHHhcCccccccccCCCCCCC
Q 004400 573 ISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVS-GRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFD 651 (756)
Q Consensus 573 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 651 (756)
......+|+.|+|||.+....++.++|||||||++|||++ |+.||............ ..+..... ...+
T Consensus 337 ~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i----~~~~~~~~-----~~~~- 406 (452)
T 1fmk_A 337 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQV----ERGYRMPC-----PPEC- 406 (452)
T ss_dssp ------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHH----HTTCCCCC-----CTTS-
T ss_pred cccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHH----HcCCCCCC-----CCCC-
Confidence 3334557889999999999999999999999999999999 99999766544332211 11111111 1122
Q ss_pred HHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhccCcccc
Q 004400 652 KEQVMVMINVALLCANASPTIRPSMSSVLRMLECGVDVL 690 (756)
Q Consensus 652 ~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~L~~~~~~~ 690 (756)
+..+.+++.+||+.||++|||+.+|++.|+.+....
T Consensus 407 ---~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~~ 442 (452)
T 1fmk_A 407 ---PESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST 442 (452)
T ss_dssp ---CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCS
T ss_pred ---CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhccC
Confidence 334889999999999999999999999999875543
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-42 Score=368.40 Aligned_cols=249 Identities=23% Similarity=0.367 Sum_probs=202.1
Q ss_pred hhcCccccCcccCCCCccEEEeec-cCCcEEEEEEcccc---CcccHHHHHHHHHHHHhC-CCCceeeEeeEEEeCCeEE
Q 004400 414 ATNNFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSK---SKQGNREFINEIGMISAL-QHPNLVKLYGCCIEGNQLL 488 (756)
Q Consensus 414 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~ 488 (756)
..++|+..+.||+|+||.||+|+. .+++.||||+++.. .....+.+.+|..+++.+ +||||+++++++.+++..|
T Consensus 21 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~ 100 (353)
T 3txo_A 21 GIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLF 100 (353)
T ss_dssp --CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred chhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEE
Confidence 356899999999999999999994 56899999999753 233456688999999988 7999999999999999999
Q ss_pred EEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCcc
Q 004400 489 LIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEE 568 (756)
Q Consensus 489 lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~ 568 (756)
+||||+++|+|.+++... ..+++..+..++.||+.||+|||++| |+||||||+|||++.++.+||+|||+++....
T Consensus 101 lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NILl~~~g~ikL~DFG~a~~~~~ 176 (353)
T 3txo_A 101 FVMEFVNGGDLMFHIQKS-RRFDEARARFYAAEIISALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIC 176 (353)
T ss_dssp EEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred EEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCCHHHEEECCCCCEEEccccceeeccc
Confidence 999999999999999755 47999999999999999999999997 99999999999999999999999999985332
Q ss_pred cCcceeeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhcCccccccccCCCC
Q 004400 569 ENTHISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGS 648 (756)
Q Consensus 569 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 648 (756)
.. ......+||+.|+|||++.+..++.++|||||||++|||++|+.||...+........ .. ... ....
T Consensus 177 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i---~~-~~~------~~p~ 245 (353)
T 3txo_A 177 NG-VTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAI---LN-DEV------VYPT 245 (353)
T ss_dssp ----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH---HH-CCC------CCCT
T ss_pred CC-ccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHH---Hc-CCC------CCCC
Confidence 22 2234568999999999999989999999999999999999999999877654433221 11 110 0011
Q ss_pred CCCHHHHHHHHHHHHHhhcCCCCCCCCH------HHHHH
Q 004400 649 NFDKEQVMVMINVALLCANASPTIRPSM------SSVLR 681 (756)
Q Consensus 649 ~~~~~~~~~l~~l~~~c~~~~P~~RPt~------~ev~~ 681 (756)
..+ ..+.+++.+|++.||++||++ .|+++
T Consensus 246 ~~~----~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~ 280 (353)
T 3txo_A 246 WLH----EDATGILKSFMTKNPTMRLGSLTQGGEHAILR 280 (353)
T ss_dssp TSC----HHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHT
T ss_pred CCC----HHHHHHHHHHhhhCHHHccCCcccCCHHHHhh
Confidence 222 348899999999999999998 66654
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-42 Score=354.42 Aligned_cols=256 Identities=27% Similarity=0.447 Sum_probs=214.2
Q ss_pred hcCccccCcccCCCCccEEEeeccCCcEEEEEEccccCcccHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEEec
Q 004400 415 TNNFATDNNIGEGGFGPVYKGLLADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYEYL 494 (756)
Q Consensus 415 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~ 494 (756)
.++|...+.||+|+||.||+|...+++.||+|.+.... ...+.+.+|++++++++||||+++++++.+++..++||||+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 85 (267)
T 3t9t_A 7 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFM 85 (267)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTT-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCC
T ss_pred hhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCC
Confidence 35788899999999999999998888999999997643 34578999999999999999999999999999999999999
Q ss_pred CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCcccCccee
Q 004400 495 ENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHIS 574 (756)
Q Consensus 495 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~~~~~~~ 574 (756)
++++|.+++......+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++..........
T Consensus 86 ~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~ 162 (267)
T 3t9t_A 86 EHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSS 162 (267)
T ss_dssp TTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHHHST
T ss_pred CCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEECCCCCEEEccccccccccccccccc
Confidence 999999999877678999999999999999999999997 99999999999999999999999999986544332223
Q ss_pred eccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHh-CCCCCCccchhhHHHHHHHHHhcCccccccccCCCCCCCHH
Q 004400 575 TRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVS-GRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDKE 653 (756)
Q Consensus 575 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 653 (756)
....||..|+|||.+.+..++.++||||||+++|||++ |+.||........... ... +.. .......+
T Consensus 163 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~---i~~-~~~-----~~~~~~~~-- 231 (267)
T 3t9t_A 163 TGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVED---IST-GFR-----LYKPRLAS-- 231 (267)
T ss_dssp TSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHH---HHT-TCC-----CCCCTTSC--
T ss_pred ccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHH---Hhc-CCc-----CCCCccCc--
Confidence 34567889999999999999999999999999999999 8999976554333221 111 111 00111222
Q ss_pred HHHHHHHHHHHhhcCCCCCCCCHHHHHHHhccCc
Q 004400 654 QVMVMINVALLCANASPTIRPSMSSVLRMLECGV 687 (756)
Q Consensus 654 ~~~~l~~l~~~c~~~~P~~RPt~~ev~~~L~~~~ 687 (756)
..+.+++.+||+.||++||++.++++.|+++.
T Consensus 232 --~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~ 263 (267)
T 3t9t_A 232 --THVYQIMNHCWRERPEDRPAFSRLLRQLAEIA 263 (267)
T ss_dssp --HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred --HHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 34889999999999999999999999998653
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=356.75 Aligned_cols=262 Identities=27% Similarity=0.366 Sum_probs=204.0
Q ss_pred cCccccCcccCCCCccEEEeeccCCcEEEEEEccccC--cccHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEEe
Q 004400 416 NNFATDNNIGEGGFGPVYKGLLADGTAIAVKQLSSKS--KQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYEY 493 (756)
Q Consensus 416 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 493 (756)
++|...+.||+|+||.||+|+..+|+.||+|++.... ......+.+|++++++++||||+++++++.+++..++||||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence 4788999999999999999998889999999986543 22346788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCcccCcce
Q 004400 494 LENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHI 573 (756)
Q Consensus 494 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~~~~~~ 573 (756)
+++ +|.+++......+++..+..++.|++.||+|||++| |+||||||+||+++.++.+||+|||+++....... .
T Consensus 82 ~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~ 156 (288)
T 1ob3_A 82 LDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPVR-K 156 (288)
T ss_dssp CSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-----
T ss_pred cCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEeECccccccCcccc-c
Confidence 986 999999876678999999999999999999999997 99999999999999999999999999976543222 1
Q ss_pred eeccccCccCCchHhhhcC-CCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhcCccc------cc--ccc
Q 004400 574 STRVAGTIGYMAPEYAMRG-HLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLM------EL--VDT 644 (756)
Q Consensus 574 ~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~------~~--~~~ 644 (756)
.....||+.|+|||++.+. .++.++||||+||++|||++|+.||...................... +. .+.
T Consensus 157 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (288)
T 1ob3_A 157 YTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDP 236 (288)
T ss_dssp -----CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCT
T ss_pred cccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhccccccc
Confidence 2345689999999999764 58999999999999999999999997665443332222111111000 00 000
Q ss_pred C-------CCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004400 645 N-------PGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRM 682 (756)
Q Consensus 645 ~-------~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~ 682 (756)
. +...+.......+.+++.+|++.||++|||+.|+++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 281 (288)
T 1ob3_A 237 NFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH 281 (288)
T ss_dssp TCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 0 0000111123457899999999999999999999763
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=361.33 Aligned_cols=252 Identities=23% Similarity=0.292 Sum_probs=206.9
Q ss_pred hcCccccCcccCCCCccEEEeec-cCCcEEEEEEccccCc------ccHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeE
Q 004400 415 TNNFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSKSK------QGNREFINEIGMISALQHPNLVKLYGCCIEGNQL 487 (756)
Q Consensus 415 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 487 (756)
.++|...+.||+|+||.||+|.. .+|+.||+|.+..... ...+.+.+|+.++++++||||+++++++.++...
T Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 89 (326)
T 2y0a_A 10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 89 (326)
T ss_dssp HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence 45688999999999999999995 5789999999865422 1357799999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCC----CEEEccCCcc
Q 004400 488 LLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDL----NSKISDFGLA 563 (756)
Q Consensus 488 ~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~----~~kl~DFGla 563 (756)
++||||+++|+|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+||+++.++ .+||+|||++
T Consensus 90 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a 165 (326)
T 2y0a_A 90 ILILELVAGGELFDFLAEK-ESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLA 165 (326)
T ss_dssp EEEEECCCSCBHHHHHTTS-SCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCSSSSSCCEEECCCTTC
T ss_pred EEEEEcCCCCCHHHHHHhc-CCcCHHHHHHHHHHHHHHHHHHHHCC---eEcCCCCHHHEEEecCCCCCCCEEEEECCCC
Confidence 9999999999999999644 47999999999999999999999997 99999999999999887 7999999999
Q ss_pred ccCcccCcceeeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhcCccccccc
Q 004400 564 KLDEEENTHISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVD 643 (756)
Q Consensus 564 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 643 (756)
+....... .....||+.|+|||++.+..++.++|||||||++|||++|+.||............. .........
T Consensus 166 ~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~--~~~~~~~~~-- 239 (326)
T 2y0a_A 166 HKIDFGNE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVS--AVNYEFEDE-- 239 (326)
T ss_dssp EECCTTSC--CCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHH--HTCCCCCHH--
T ss_pred eECCCCCc--cccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHH--hcCCCcCcc--
Confidence 86643322 234579999999999998899999999999999999999999997665443322111 111110000
Q ss_pred cCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004400 644 TNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRM 682 (756)
Q Consensus 644 ~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~ 682 (756)
..... ...+.+++.+||+.||++|||+.|+++.
T Consensus 240 --~~~~~----~~~~~~li~~~L~~dP~~Rpt~~e~l~h 272 (326)
T 2y0a_A 240 --YFSNT----SALAKDFIRRLLVKDPKKRMTIQDSLQH 272 (326)
T ss_dssp --HHTTS----CHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred --ccccC----CHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 00111 2348899999999999999999999874
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-42 Score=369.56 Aligned_cols=262 Identities=28% Similarity=0.464 Sum_probs=214.7
Q ss_pred HHHhhcCccccCcccCCCCccEEEeecc------CCcEEEEEEccccC-cccHHHHHHHHHHHHhCCCCceeeEeeEEEe
Q 004400 411 IKAATNNFATDNNIGEGGFGPVYKGLLA------DGTAIAVKQLSSKS-KQGNREFINEIGMISALQHPNLVKLYGCCIE 483 (756)
Q Consensus 411 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 483 (756)
.....++|...+.||+|+||.||+|+.. +++.||||.++... ....+.+.+|+.++++++||||++++++|.+
T Consensus 42 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 121 (343)
T 1luf_A 42 LEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAV 121 (343)
T ss_dssp TBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred eEecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcc
Confidence 3445678999999999999999999864 35889999997643 3345678999999999999999999999999
Q ss_pred CCeEEEEEEecCCCCHHHHHHhcC-----------------------CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcC
Q 004400 484 GNQLLLIYEYLENNSLARALFEHR-----------------------LKLDWPTRRRICLGIARGLAYLHGESRIKVVHR 540 (756)
Q Consensus 484 ~~~~~lV~e~~~~gsL~~~l~~~~-----------------------~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~ 540 (756)
++..++||||+++|+|.+++.... ..+++..++.++.||++||+|||+++ |+||
T Consensus 122 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~---ivH~ 198 (343)
T 1luf_A 122 GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHR 198 (343)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCS
T ss_pred CCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecC
Confidence 999999999999999999997532 57899999999999999999999997 9999
Q ss_pred CCCCCceEecCCCCEEEccCCccccCcccCc-ceeeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHh-CCCCCC
Q 004400 541 DIKATNVLLDKDLNSKISDFGLAKLDEEENT-HISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVS-GRSNVT 618 (756)
Q Consensus 541 Dikp~Nill~~~~~~kl~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~ 618 (756)
||||+||+++.++.+||+|||+++....... .......||+.|+|||++.+..++.++||||||+++|||++ |+.||.
T Consensus 199 Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~ 278 (343)
T 1luf_A 199 DLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYY 278 (343)
T ss_dssp CCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTT
T ss_pred CCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCC
Confidence 9999999999999999999999976543222 22334568999999999999999999999999999999999 999997
Q ss_pred ccchhhHHHHHHHHHhcCccccccccCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhccCcc
Q 004400 619 KEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLECGVD 688 (756)
Q Consensus 619 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~L~~~~~ 688 (756)
........... ..+..... ...++ ..+.+++.+||+.||++||++.++++.|+++.+
T Consensus 279 ~~~~~~~~~~~----~~~~~~~~-----~~~~~----~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~ 335 (343)
T 1luf_A 279 GMAHEEVIYYV----RDGNILAC-----PENCP----LELYNLMRLCWSKLPADRPSFCSIHRILQRMCE 335 (343)
T ss_dssp TSCHHHHHHHH----HTTCCCCC-----CTTCC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred CCChHHHHHHH----hCCCcCCC-----CCCCC----HHHHHHHHHHcccCcccCCCHHHHHHHHHHHHh
Confidence 66543332211 11221111 11223 348899999999999999999999999997654
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-42 Score=373.63 Aligned_cols=261 Identities=29% Similarity=0.432 Sum_probs=214.3
Q ss_pred hhcCccccCcccCCCCccEEEeecc--------CCcEEEEEEccccC-cccHHHHHHHHHHHHhC-CCCceeeEeeEEEe
Q 004400 414 ATNNFATDNNIGEGGFGPVYKGLLA--------DGTAIAVKQLSSKS-KQGNREFINEIGMISAL-QHPNLVKLYGCCIE 483 (756)
Q Consensus 414 ~~~~~~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~ 483 (756)
..++|...+.||+|+||.||+|+.. ++..||||++.... ....+.+.+|+++++++ +|||||+++++|.+
T Consensus 67 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 146 (382)
T 3tt0_A 67 PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ 146 (382)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred chhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeecc
Confidence 3468889999999999999999842 33579999997643 33446789999999999 99999999999999
Q ss_pred CCeEEEEEEecCCCCHHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceE
Q 004400 484 GNQLLLIYEYLENNSLARALFEHR---------------LKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVL 548 (756)
Q Consensus 484 ~~~~~lV~e~~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nil 548 (756)
++..++||||+++|+|.+++.... ..+++..+..++.||+.||+|||+.+ |+||||||+|||
T Consensus 147 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIl 223 (382)
T 3tt0_A 147 DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVL 223 (382)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEE
T ss_pred CCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCcceEE
Confidence 999999999999999999998643 35999999999999999999999996 999999999999
Q ss_pred ecCCCCEEEccCCccccCcccCc-ceeeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHh-CCCCCCccchhhHH
Q 004400 549 LDKDLNSKISDFGLAKLDEEENT-HISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVS-GRSNVTKEDMFYLL 626 (756)
Q Consensus 549 l~~~~~~kl~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~ 626 (756)
++.++.+||+|||+++....... .......||+.|+|||++.+..++.++|||||||++|||++ |+.||.........
T Consensus 224 l~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~~~~ 303 (382)
T 3tt0_A 224 VTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELF 303 (382)
T ss_dssp ECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHH
T ss_pred EcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence 99999999999999986654332 22334567889999999999999999999999999999999 99999766544333
Q ss_pred HHHHHHHhcCccccccccCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhccCcccc
Q 004400 627 DWALVLKEQGKLMELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLECGVDVL 690 (756)
Q Consensus 627 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~L~~~~~~~ 690 (756)
... ........ ...++ ..+.+++.+||+.||++||++.||++.|+++....
T Consensus 304 ~~~----~~~~~~~~-----~~~~~----~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~ 354 (382)
T 3tt0_A 304 KLL----KEGHRMDK-----PSNCT----NELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALT 354 (382)
T ss_dssp HHH----HTTCCCCC-----CSSCC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHS
T ss_pred HHH----HcCCCCCC-----CccCC----HHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHH
Confidence 221 11111111 11223 34889999999999999999999999999776544
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-41 Score=357.02 Aligned_cols=265 Identities=19% Similarity=0.240 Sum_probs=210.9
Q ss_pred hcCccccCcccCCCCccEEEeec-cCCcEEEEEEccccC-cccHHHHHHHHHHHHhCCCCceeeEeeEEEeCC--eEEEE
Q 004400 415 TNNFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSKS-KQGNREFINEIGMISALQHPNLVKLYGCCIEGN--QLLLI 490 (756)
Q Consensus 415 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--~~~lV 490 (756)
.++|...+.||+|+||.||+|+. .+++.||||++.... ....+.+.+|++++++++||||+++++++.+.. ..++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 87 (319)
T 4euu_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87 (319)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred CCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEE
Confidence 35788999999999999999995 468999999997543 334577889999999999999999999998765 78999
Q ss_pred EEecCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEe----cCCCCEEEccCCccc
Q 004400 491 YEYLENNSLARALFEHR--LKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLL----DKDLNSKISDFGLAK 564 (756)
Q Consensus 491 ~e~~~~gsL~~~l~~~~--~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill----~~~~~~kl~DFGla~ 564 (756)
|||+++|+|.+++.... ..+++..+..++.|++.||+|||+.+ |+||||||+|||+ +.++.+||+|||+++
T Consensus 88 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~ 164 (319)
T 4euu_A 88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR 164 (319)
T ss_dssp EECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEECTTSCEEEEECCCTTCE
T ss_pred EeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEeccCCCCceEEEccCCCce
Confidence 99999999999997543 23999999999999999999999997 9999999999999 788889999999998
Q ss_pred cCcccCcceeeccccCccCCchHhhh--------cCCCCcccchhhHHHHHHHHHhCCCCCCccch-hhHHHHHHHHHhc
Q 004400 565 LDEEENTHISTRVAGTIGYMAPEYAM--------RGHLTEKADVYSFGIVALEIVSGRSNVTKEDM-FYLLDWALVLKEQ 635 (756)
Q Consensus 565 ~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~-~~~~~~~~~~~~~ 635 (756)
....... .....||+.|+|||++. +..++.++|||||||++|||++|+.||..... .............
T Consensus 165 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~ 242 (319)
T 4euu_A 165 ELEDDEQ--FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITG 242 (319)
T ss_dssp ECCTTCC--BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHH
T ss_pred ecCCCCc--eeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcC
Confidence 6654332 23457999999999987 46789999999999999999999999953321 1111111111111
Q ss_pred Cc--ccccc------------ccCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhc
Q 004400 636 GK--LMELV------------DTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLE 684 (756)
Q Consensus 636 ~~--~~~~~------------~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~L~ 684 (756)
.. ....+ ........+......+.+++.+|++.||++|||+.|+++...
T Consensus 243 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~ 305 (319)
T 4euu_A 243 KPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETS 305 (319)
T ss_dssp CCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHH
T ss_pred CCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccH
Confidence 11 00000 111122456677788999999999999999999999998876
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=353.05 Aligned_cols=253 Identities=28% Similarity=0.462 Sum_probs=197.6
Q ss_pred hcCccccCcccCCCCccEEEeeccCCcEEEEEEccccCc----ccHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEE
Q 004400 415 TNNFATDNNIGEGGFGPVYKGLLADGTAIAVKQLSSKSK----QGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLI 490 (756)
Q Consensus 415 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 490 (756)
.++|...+.||+|+||.||+|... ++.||||++..... ...+.+.+|+++++.++||||+++++++.+++..++|
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (271)
T 3dtc_A 6 FAELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLV 84 (271)
T ss_dssp TTSEEEEEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEE
T ss_pred hhheeeeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEE
Confidence 467889999999999999999975 88999999875422 2346789999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecC--------CCCEEEccCCc
Q 004400 491 YEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDK--------DLNSKISDFGL 562 (756)
Q Consensus 491 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~--------~~~~kl~DFGl 562 (756)
|||+++++|.+++. ...+++..+..++.|++.||+|||+++..+|+||||||+||+++. ++.+||+|||+
T Consensus 85 ~e~~~~~~L~~~~~--~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg~ 162 (271)
T 3dtc_A 85 MEFARGGPLNRVLS--GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGL 162 (271)
T ss_dssp EECCTTEEHHHHHT--SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCCC
T ss_pred EEcCCCCCHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccCCc
Confidence 99999999999985 347999999999999999999999986555999999999999986 67899999999
Q ss_pred cccCcccCcceeeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhcCcccccc
Q 004400 563 AKLDEEENTHISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELV 642 (756)
Q Consensus 563 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 642 (756)
++....... ....||+.|+|||.+.+..++.++||||||+++|||++|+.||...+....... .........
T Consensus 163 ~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~---~~~~~~~~~-- 234 (271)
T 3dtc_A 163 AREWHRTTK---MSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYG---VAMNKLALP-- 234 (271)
T ss_dssp ----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHH---HHTSCCCCC--
T ss_pred ccccccccc---cCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHh---hhcCCCCCC--
Confidence 986543322 235689999999999999999999999999999999999999976554322211 111111111
Q ss_pred ccCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhcc
Q 004400 643 DTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLEC 685 (756)
Q Consensus 643 ~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~L~~ 685 (756)
.....+ ..+.+++.+||+.||++|||+.|+++.|+.
T Consensus 235 ---~~~~~~----~~~~~li~~~l~~~p~~Rps~~e~l~~L~~ 270 (271)
T 3dtc_A 235 ---IPSTCP----EPFAKLMEDCWNPDPHSRPSFTNILDQLTT 270 (271)
T ss_dssp ---CCTTCC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHC
T ss_pred ---CCcccC----HHHHHHHHHHhcCCcccCcCHHHHHHHHhc
Confidence 112222 348899999999999999999999999975
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-42 Score=373.72 Aligned_cols=261 Identities=26% Similarity=0.384 Sum_probs=209.9
Q ss_pred HHhhcCccccCcccCCCCccEEEeec------cCCcEEEEEEccccC-cccHHHHHHHHHHHHhC-CCCceeeEeeEEEe
Q 004400 412 KAATNNFATDNNIGEGGFGPVYKGLL------ADGTAIAVKQLSSKS-KQGNREFINEIGMISAL-QHPNLVKLYGCCIE 483 (756)
Q Consensus 412 ~~~~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~ 483 (756)
....++|...+.||+|+||.||+|++ .+++.||||++.... ....+.+.+|+++++++ +|||||+++++|.+
T Consensus 18 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~ 97 (359)
T 3vhe_A 18 EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTK 97 (359)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred cccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeeeeeeec
Confidence 34567899999999999999999962 356899999997643 33346799999999999 79999999999987
Q ss_pred CC-eEEEEEEecCCCCHHHHHHhcCC------------------------------------------------------
Q 004400 484 GN-QLLLIYEYLENNSLARALFEHRL------------------------------------------------------ 508 (756)
Q Consensus 484 ~~-~~~lV~e~~~~gsL~~~l~~~~~------------------------------------------------------ 508 (756)
++ ..++||||+++|+|.+++.....
T Consensus 98 ~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 177 (359)
T 3vhe_A 98 PGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVE 177 (359)
T ss_dssp TTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC------------------------------------------------
T ss_pred CCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchhh
Confidence 65 48999999999999999975432
Q ss_pred -----------CCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCcccCc-ceeec
Q 004400 509 -----------KLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENT-HISTR 576 (756)
Q Consensus 509 -----------~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~~~~-~~~~~ 576 (756)
.+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++....... .....
T Consensus 178 ~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~ 254 (359)
T 3vhe_A 178 EEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGD 254 (359)
T ss_dssp ------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEEC--
T ss_pred hcccccchhccccCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCcEEEEeccceeeecccccchhccc
Confidence 1899999999999999999999997 99999999999999999999999999986544322 23445
Q ss_pred cccCccCCchHhhhcCCCCcccchhhHHHHHHHHHh-CCCCCCccchhhHHHHHHHHHhcCccccccccCCCCCCCHHHH
Q 004400 577 VAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVS-GRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDKEQV 655 (756)
Q Consensus 577 ~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 655 (756)
..||+.|+|||++.+..++.++|||||||++|||++ |+.||.......... ... ........ ....+
T Consensus 255 ~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~--~~~-~~~~~~~~-----~~~~~---- 322 (359)
T 3vhe_A 255 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC--RRL-KEGTRMRA-----PDYTT---- 322 (359)
T ss_dssp CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHH--HHH-HHTCCCCC-----CTTCC----
T ss_pred cCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHH--HHH-HcCCCCCC-----CCCCC----
Confidence 678999999999999999999999999999999998 999996554322111 111 11111111 11223
Q ss_pred HHHHHHHHHhhcCCCCCCCCHHHHHHHhccCc
Q 004400 656 MVMINVALLCANASPTIRPSMSSVLRMLECGV 687 (756)
Q Consensus 656 ~~l~~l~~~c~~~~P~~RPt~~ev~~~L~~~~ 687 (756)
..+.+++.+||+.||++|||+.|+++.|+++.
T Consensus 323 ~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~ 354 (359)
T 3vhe_A 323 PEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 354 (359)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHHHHHHccCChhhCCCHHHHHHHHHHHH
Confidence 34889999999999999999999999998653
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-41 Score=374.15 Aligned_cols=254 Identities=22% Similarity=0.323 Sum_probs=207.4
Q ss_pred hhcCccccCcccCCCCccEEEee-ccCCcEEEEEEccccC--cccHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEE
Q 004400 414 ATNNFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSKS--KQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLI 490 (756)
Q Consensus 414 ~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 490 (756)
..++|...+.||+|+||.||+|. ..+|+.||+|++.... ....+.+.+|+++++.++|||||++++++.+++..++|
T Consensus 9 ~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv 88 (444)
T 3soa_A 9 FTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLI 88 (444)
T ss_dssp HHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEE
T ss_pred ccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEE
Confidence 35688999999999999999998 5678999999987543 23346789999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEec---CCCCEEEccCCccccCc
Q 004400 491 YEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLD---KDLNSKISDFGLAKLDE 567 (756)
Q Consensus 491 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~---~~~~~kl~DFGla~~~~ 567 (756)
|||+++|+|.+.+... ..+++..+..++.||+.||+|||++| |+||||||+|||++ .++.+||+|||+++...
T Consensus 89 ~E~~~gg~L~~~i~~~-~~~~e~~~~~i~~qil~aL~~lH~~g---ivHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~ 164 (444)
T 3soa_A 89 FDLVTGGELFEDIVAR-EYYSEADASHCIQQILEAVLHCHQMG---VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVE 164 (444)
T ss_dssp ECCCBCCBHHHHHHHC-SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCC
T ss_pred EEeCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEeccCCCCcEEEccCceeEEec
Confidence 9999999999999765 46999999999999999999999997 99999999999998 46789999999998665
Q ss_pred ccCcceeeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhcCccccccccCCC
Q 004400 568 EENTHISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPG 647 (756)
Q Consensus 568 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 647 (756)
..... .....||+.|+|||++.+..++.++||||+||++|+|++|+.||...+........ .. +.. ... ....
T Consensus 165 ~~~~~-~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i---~~-~~~-~~~-~~~~ 237 (444)
T 3soa_A 165 GEQQA-WFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQI---KA-GAY-DFP-SPEW 237 (444)
T ss_dssp TTCCB-CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH---HH-TCC-CCC-TTTT
T ss_pred CCCce-eecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHH---Hh-CCC-CCC-cccc
Confidence 43322 23467999999999999989999999999999999999999999776654433221 11 111 010 1111
Q ss_pred CCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004400 648 SNFDKEQVMVMINVALLCANASPTIRPSMSSVLRM 682 (756)
Q Consensus 648 ~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~ 682 (756)
...+ ..+.+++.+|++.||++|||+.|+++.
T Consensus 238 ~~~s----~~~~~li~~~L~~dP~~Rpta~e~L~h 268 (444)
T 3soa_A 238 DTVT----PEAKDLINKMLTINPSKRITAAEALKH 268 (444)
T ss_dssp TTSC----HHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred ccCC----HHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 1223 348899999999999999999999874
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=368.22 Aligned_cols=249 Identities=24% Similarity=0.308 Sum_probs=201.4
Q ss_pred cccCcccCCCCccEEEee-ccCCcEEEEEEccccCcccHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEEecCCC
Q 004400 419 ATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYEYLENN 497 (756)
Q Consensus 419 ~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~g 497 (756)
...+.||+|+||.||+|. ..+|+.||+|++........+.+.+|++++++++||||++++++|.+++..++||||+++|
T Consensus 92 ~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~ 171 (373)
T 2x4f_A 92 SKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGG 171 (373)
T ss_dssp EEEEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTC
T ss_pred ecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCC
Confidence 345789999999999998 4679999999998765556678999999999999999999999999999999999999999
Q ss_pred CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEe--cCCCCEEEccCCccccCcccCcceee
Q 004400 498 SLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLL--DKDLNSKISDFGLAKLDEEENTHIST 575 (756)
Q Consensus 498 sL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill--~~~~~~kl~DFGla~~~~~~~~~~~~ 575 (756)
+|.+++......+++..+..++.||+.||+|||+.+ |+||||||+|||+ +.++.+||+|||+++....... ..
T Consensus 172 ~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~--~~ 246 (373)
T 2x4f_A 172 ELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMY---ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK--LK 246 (373)
T ss_dssp EEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCB--CC
T ss_pred cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEecCCCCcEEEEeCCCceecCCccc--cc
Confidence 999999877667999999999999999999999997 9999999999999 5677899999999987654332 23
Q ss_pred ccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhcCccccccccCCCCCCCHHHH
Q 004400 576 RVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDKEQV 655 (756)
Q Consensus 576 ~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 655 (756)
...||+.|+|||++....++.++|||||||++|||++|+.||...+........ ...... .. ......++
T Consensus 247 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i---~~~~~~--~~-~~~~~~~~---- 316 (373)
T 2x4f_A 247 VNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNI---LACRWD--LE-DEEFQDIS---- 316 (373)
T ss_dssp CCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH---HHTCCC--SC-SGGGTTSC----
T ss_pred cccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH---HhccCC--CC-hhhhccCC----
Confidence 356999999999999888999999999999999999999999776544332211 111100 00 00011223
Q ss_pred HHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004400 656 MVMINVALLCANASPTIRPSMSSVLRM 682 (756)
Q Consensus 656 ~~l~~l~~~c~~~~P~~RPt~~ev~~~ 682 (756)
..+.+++.+|++.||++||++.|+++.
T Consensus 317 ~~~~~li~~~L~~dp~~Rps~~e~l~h 343 (373)
T 2x4f_A 317 EEAKEFISKLLIKEKSWRISASEALKH 343 (373)
T ss_dssp HHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred HHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 348899999999999999999999873
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-41 Score=365.98 Aligned_cols=252 Identities=21% Similarity=0.332 Sum_probs=206.5
Q ss_pred hcCccccCcccCCCCccEEEeec-cCCcEEEEEEccccC--cccHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEE
Q 004400 415 TNNFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSKS--KQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIY 491 (756)
Q Consensus 415 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 491 (756)
.++|...+.||+|+||.||+|.. .+|+.||+|++.... ....+.+.+|+.++++++|||||++++++.+++..++||
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~ 107 (362)
T 2bdw_A 28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 107 (362)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 46789999999999999999984 578999999996542 234467889999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCC---CEEEccCCccccCcc
Q 004400 492 EYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDL---NSKISDFGLAKLDEE 568 (756)
Q Consensus 492 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~---~~kl~DFGla~~~~~ 568 (756)
||+++|+|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++ .+||+|||+++....
T Consensus 108 e~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~ 183 (362)
T 2bdw_A 108 DLVTGGELFEDIVAR-EFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND 183 (362)
T ss_dssp CCCCSCBHHHHHTTC-SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTT
T ss_pred ecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEeecCcceEecC
Confidence 999999999998654 47899999999999999999999997 99999999999998654 599999999986654
Q ss_pred cCcceeeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhcCccccccccCCCC
Q 004400 569 ENTHISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGS 648 (756)
Q Consensus 569 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 648 (756)
... .....||+.|+|||++.+..++.++|||||||++|+|++|+.||...+......... ....... .....
T Consensus 184 ~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~--~~~~~~~----~~~~~ 255 (362)
T 2bdw_A 184 SEA--WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIK--AGAYDYP----SPEWD 255 (362)
T ss_dssp CCS--CCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH--HTCCCCC----TTGGG
T ss_pred Ccc--cccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHH--hCCCCCC----ccccc
Confidence 322 234679999999999999899999999999999999999999997765543332211 1111000 00001
Q ss_pred CCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004400 649 NFDKEQVMVMINVALLCANASPTIRPSMSSVLRM 682 (756)
Q Consensus 649 ~~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~ 682 (756)
.. ...+.+++.+||+.||++||++.|+++.
T Consensus 256 ~~----~~~~~~li~~~L~~dP~~R~t~~e~l~h 285 (362)
T 2bdw_A 256 TV----TPEAKSLIDSMLTVNPKKRITADQALKV 285 (362)
T ss_dssp GS----CHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred CC----CHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 12 2348899999999999999999999764
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-41 Score=356.68 Aligned_cols=245 Identities=24% Similarity=0.377 Sum_probs=205.7
Q ss_pred hcCccccCcccCCCCccEEEeec-cCCcEEEEEEcccc---CcccHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEE
Q 004400 415 TNNFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSK---SKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLI 490 (756)
Q Consensus 415 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 490 (756)
.++|+..+.||+|+||.||+|+. .+|+.||+|++... .....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv 84 (318)
T 1fot_A 5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI 84 (318)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEE
Confidence 35788999999999999999995 57999999998653 123456788999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCcccC
Q 004400 491 YEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEEN 570 (756)
Q Consensus 491 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~~~ 570 (756)
|||+++|+|.+++... ..+++..+..++.||+.||+|||++| |+||||||+|||++.++.+||+|||+++.....
T Consensus 85 ~e~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~- 159 (318)
T 1fot_A 85 MDYIEGGELFSLLRKS-QRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPDV- 159 (318)
T ss_dssp ECCCCSCBHHHHHHHT-SSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSSC-
T ss_pred EeCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChheEEEcCCCCEEEeecCcceecCCc-
Confidence 9999999999999764 47899999999999999999999987 999999999999999999999999999865432
Q ss_pred cceeeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhcCccccccccCCCCCC
Q 004400 571 THISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNF 650 (756)
Q Consensus 571 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 650 (756)
....+||+.|+|||++.+..++.++|||||||++|||++|+.||...+....... ...... . ....+
T Consensus 160 ---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~--i~~~~~---~-----~p~~~ 226 (318)
T 1fot_A 160 ---TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEK--ILNAEL---R-----FPPFF 226 (318)
T ss_dssp ---BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHH--HHHCCC---C-----CCTTS
T ss_pred ---cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHH--HHhCCC---C-----CCCCC
Confidence 2346799999999999999999999999999999999999999977654433221 111110 0 11122
Q ss_pred CHHHHHHHHHHHHHhhcCCCCCCC-----CHHHHHH
Q 004400 651 DKEQVMVMINVALLCANASPTIRP-----SMSSVLR 681 (756)
Q Consensus 651 ~~~~~~~l~~l~~~c~~~~P~~RP-----t~~ev~~ 681 (756)
+ ..+.+++.+|++.||++|| ++.|+++
T Consensus 227 ~----~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~ 258 (318)
T 1fot_A 227 N----EDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 258 (318)
T ss_dssp C----HHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred C----HHHHHHHHHHhccCHHHcCCCcCCCHHHHhc
Confidence 3 3488999999999999999 8888864
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-42 Score=357.20 Aligned_cols=259 Identities=25% Similarity=0.424 Sum_probs=216.6
Q ss_pred HHhhcCccccCcccCCCCccEEEeecc-CCcEEEEEEccccCcccHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEE
Q 004400 412 KAATNNFATDNNIGEGGFGPVYKGLLA-DGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLI 490 (756)
Q Consensus 412 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 490 (756)
....++|+..+.||+|+||.||+|... ++..||+|.+... ....+.+.+|++++++++||||+++++++.+++..++|
T Consensus 9 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v 87 (288)
T 3kfa_A 9 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYII 87 (288)
T ss_dssp BCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSC-STHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEE
T ss_pred cccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEE
Confidence 345678999999999999999999954 5889999999753 33457899999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCccc
Q 004400 491 YEYLENNSLARALFEH-RLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEE 569 (756)
Q Consensus 491 ~e~~~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~~ 569 (756)
|||+++|+|.+++... ...+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++.....
T Consensus 88 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~ 164 (288)
T 3kfa_A 88 TEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGD 164 (288)
T ss_dssp EECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHT---CCCSCCSGGGEEECGGGCEEECCCCGGGTSCSS
T ss_pred EEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCC---ccCCCCCcceEEEcCCCCEEEccCccceeccCC
Confidence 9999999999999753 346899999999999999999999997 999999999999999999999999999877655
Q ss_pred CcceeeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHh-CCCCCCccchhhHHHHHHHHHhcCccccccccCCCC
Q 004400 570 NTHISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVS-GRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGS 648 (756)
Q Consensus 570 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 648 (756)
.........+|+.|+|||.+.+..++.++||||||+++|+|++ |+.||...+........ ...... ....
T Consensus 165 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~----~~~~~~-----~~~~ 235 (288)
T 3kfa_A 165 TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL----EKDYRM-----ERPE 235 (288)
T ss_dssp SSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHH----HTTCCC-----CCCT
T ss_pred ccccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH----hccCCC-----CCCC
Confidence 5444455668889999999999999999999999999999999 99999665543332211 111111 1112
Q ss_pred CCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhccCc
Q 004400 649 NFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLECGV 687 (756)
Q Consensus 649 ~~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~L~~~~ 687 (756)
.++ ..+.+++.+|++.||.+||++.++++.|+.+.
T Consensus 236 ~~~----~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~ 270 (288)
T 3kfa_A 236 GCP----EKVYELMRACWQWNPSDRPSFAEIHQAFETMF 270 (288)
T ss_dssp TCC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCC----HHHHHHHHHHhCCChhhCcCHHHHHHHHHHHH
Confidence 223 34889999999999999999999999998653
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-41 Score=356.09 Aligned_cols=259 Identities=23% Similarity=0.377 Sum_probs=192.5
Q ss_pred hcCccccCcccCCCCccEEEeec-cCCcEEEEEEccccC-cccHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEE
Q 004400 415 TNNFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSKS-KQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYE 492 (756)
Q Consensus 415 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 492 (756)
.++|+..+.||+|+||.||+|.. .+|+.||+|.+.... ......+.+|++++++++||||+++++++.+++..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 83 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE 83 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence 45789999999999999999984 578999999986543 2334678999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCc
Q 004400 493 YLENNSLARALFEHR-----LKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDE 567 (756)
Q Consensus 493 ~~~~gsL~~~l~~~~-----~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~ 567 (756)
|++ |+|.+++.... ..+++..+..++.||+.||+|||+.| |+||||||+||+++.++.+||+|||+++...
T Consensus 84 ~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 159 (317)
T 2pmi_A 84 FMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARAFG 159 (317)
T ss_dssp CCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCSSCEETT
T ss_pred ecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCChHHeEEcCCCCEEECcCccceecC
Confidence 998 59999887432 45899999999999999999999997 9999999999999999999999999998654
Q ss_pred ccCcceeeccccCccCCchHhhhc-CCCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhcCc---ccc---
Q 004400 568 EENTHISTRVAGTIGYMAPEYAMR-GHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGK---LME--- 640 (756)
Q Consensus 568 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~---~~~--- 640 (756)
.... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||...+................ ...
T Consensus 160 ~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 238 (317)
T 2pmi_A 160 IPVN-TFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTK 238 (317)
T ss_dssp SCCC-CCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGGG
T ss_pred CCcc-cCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhhh
Confidence 3322 1234578999999999976 4689999999999999999999999977665443332222111100 000
Q ss_pred ------------------ccccCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004400 641 ------------------LVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRM 682 (756)
Q Consensus 641 ------------------~~~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~ 682 (756)
.+........ ...+.+++.+|++.||++|||+.|+++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~l~~li~~~L~~dP~~Rpt~~e~l~h 294 (317)
T 2pmi_A 239 LPKYNPNIQQRPPRDLRQVLQPHTKEPL----DGNLMDFLHGLLQLNPDMRLSAKQALHH 294 (317)
T ss_dssp CTTCCTTCCCCCCCCSHHHHGGGCSSCC----CHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred hhhcccccccccchhHHHhhcccccccC----CHHHHHHHHHHCCCCcccCCCHHHHhCC
Confidence 0000001112 2358899999999999999999998753
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=377.35 Aligned_cols=251 Identities=29% Similarity=0.438 Sum_probs=207.3
Q ss_pred hhcCccccCcccCCCCccEEEeeccCCcEEEEEEccccCcccHHHHHHHHHHHHhCCCCceeeEeeEEEeCC-eEEEEEE
Q 004400 414 ATNNFATDNNIGEGGFGPVYKGLLADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCCIEGN-QLLLIYE 492 (756)
Q Consensus 414 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~lV~e 492 (756)
..++|...+.||+|+||.||+|.+. ++.||||.++... ..+.|.+|++++++++|||||++++++.+.+ ..++|||
T Consensus 191 ~~~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e 267 (450)
T 1k9a_A 191 NMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE 267 (450)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEE
T ss_pred ChHHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEE
Confidence 4568899999999999999999875 7899999997643 4578999999999999999999999988765 7999999
Q ss_pred ecCCCCHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCcccCc
Q 004400 493 YLENNSLARALFEHRL-KLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENT 571 (756)
Q Consensus 493 ~~~~gsL~~~l~~~~~-~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~~~~ 571 (756)
||++|+|.+++..... .+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 268 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~-- 342 (450)
T 1k9a_A 268 YMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST-- 342 (450)
T ss_dssp CCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTSCEEECCCTTCEECC----
T ss_pred ecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEECCCCCEEEeeCCCccccccc--
Confidence 9999999999986543 4799999999999999999999996 999999999999999999999999999854322
Q ss_pred ceeeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHh-CCCCCCccchhhHHHHHHHHHhcCccccccccCCCCCC
Q 004400 572 HISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVS-GRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNF 650 (756)
Q Consensus 572 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 650 (756)
.....+++.|+|||++.+..++.++|||||||++|||++ |+.||........... . ..+..... ...+
T Consensus 343 --~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~---i-~~~~~~~~-----p~~~ 411 (450)
T 1k9a_A 343 --QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPR---V-EKGYKMDA-----PDGC 411 (450)
T ss_dssp ------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHH---H-HTTCCCCC-----CTTC
T ss_pred --ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH---H-HcCCCCCC-----CCcC
Confidence 122357889999999999999999999999999999998 9999976544333221 1 11211111 1122
Q ss_pred CHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhccCc
Q 004400 651 DKEQVMVMINVALLCANASPTIRPSMSSVLRMLECGV 687 (756)
Q Consensus 651 ~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~L~~~~ 687 (756)
+ ..+.+++.+||+.||++|||+.++++.|+.+.
T Consensus 412 ~----~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~ 444 (450)
T 1k9a_A 412 P----PAVYDVMKNCWHLDAATRPTFLQLREQLEHIR 444 (450)
T ss_dssp C----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred C----HHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 3 34889999999999999999999999998653
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=357.67 Aligned_cols=258 Identities=26% Similarity=0.408 Sum_probs=201.4
Q ss_pred hcCccccCcccCCCCccEEEeeccCCcEEEEEEccccCcccHHHHHHHHHHHHh--CCCCceeeEeeEEEeC----CeEE
Q 004400 415 TNNFATDNNIGEGGFGPVYKGLLADGTAIAVKQLSSKSKQGNREFINEIGMISA--LQHPNLVKLYGCCIEG----NQLL 488 (756)
Q Consensus 415 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~~~~----~~~~ 488 (756)
.++|...+.||+|+||.||+|+. +++.||||++... ....+.+|.+++.. ++||||+++++++.+. ...+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~ 82 (301)
T 3q4u_A 7 ARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLW 82 (301)
T ss_dssp GGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEE
T ss_pred cCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEeccc---cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeE
Confidence 46889999999999999999987 6899999998643 34566777777776 7999999999997653 4689
Q ss_pred EEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH--------cCCCCCeEcCCCCCCceEecCCCCEEEccC
Q 004400 489 LIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLH--------GESRIKVVHRDIKATNVLLDKDLNSKISDF 560 (756)
Q Consensus 489 lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH--------~~g~~~iiH~Dikp~Nill~~~~~~kl~DF 560 (756)
+||||+++|+|.+++.. ..+++..+..++.|++.||+||| +.+ |+||||||+|||++.++.+||+||
T Consensus 83 lv~e~~~~g~L~~~l~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~Nill~~~~~~kl~Df 157 (301)
T 3q4u_A 83 LITHYHEMGSLYDYLQL--TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPA---IAHRDLKSKNILVKKNGQCCIADL 157 (301)
T ss_dssp EEECCCTTCBHHHHHTT--CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCE---EECSCCCGGGEEECTTSCEEECCC
T ss_pred EehhhccCCCHHHHHhh--cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCC---eecCCCChHhEEEcCCCCEEEeeC
Confidence 99999999999999953 47999999999999999999999 665 999999999999999999999999
Q ss_pred CccccCcccCcce---eeccccCccCCchHhhhcC------CCCcccchhhHHHHHHHHHhC----------CCCCCccc
Q 004400 561 GLAKLDEEENTHI---STRVAGTIGYMAPEYAMRG------HLTEKADVYSFGIVALEIVSG----------RSNVTKED 621 (756)
Q Consensus 561 Gla~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~------~~~~~~Dv~slGv~l~elltg----------~~p~~~~~ 621 (756)
|+++......... .....||+.|+|||++.+. .++.++|||||||++|||++| +.||....
T Consensus 158 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~ 237 (301)
T 3q4u_A 158 GLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVV 237 (301)
T ss_dssp TTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTS
T ss_pred CCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccC
Confidence 9997654433222 2334799999999999876 455799999999999999999 78884322
Q ss_pred hh--hHHHHHHHHHhcCccccccccCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhcc
Q 004400 622 MF--YLLDWALVLKEQGKLMELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLEC 685 (756)
Q Consensus 622 ~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~L~~ 685 (756)
.. .................. +....+......+.+++.+||+.||++|||+.||++.|++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~ 299 (301)
T 3q4u_A 238 PNDPSFEDMRKVVCVDQQRPNI----PNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTK 299 (301)
T ss_dssp CSSCCHHHHHHHHTTSCCCCCC----CGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHH
T ss_pred CCCcchhhhhHHHhccCCCCCC----ChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhc
Confidence 11 111111111111111111 1111233456679999999999999999999999999985
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-41 Score=351.25 Aligned_cols=262 Identities=21% Similarity=0.293 Sum_probs=203.7
Q ss_pred cCccccCcccCCCCccEEEeec-cCCcEEEEEEccccC--cccHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEE
Q 004400 416 NNFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSKS--KQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYE 492 (756)
Q Consensus 416 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 492 (756)
++|+..+.||+|+||+||+|+. .+++.||||++.... ......+.+|+.++++++||||+++++++.+++..++|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 81 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence 4788999999999999999995 578999999987543 2234678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCcccCcc
Q 004400 493 YLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTH 572 (756)
Q Consensus 493 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~~~~~ 572 (756)
|+++ ++.+.+......+++..+..++.|++.||+|||++| |+||||||+||+++.++.+||+|||+++.......
T Consensus 82 ~~~~-~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~---ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~- 156 (292)
T 3o0g_A 82 FCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR- 156 (292)
T ss_dssp CCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCSCCS-
T ss_pred cCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecCCccc-
Confidence 9986 666666666668999999999999999999999997 99999999999999999999999999986543322
Q ss_pred eeeccccCccCCchHhhhcCC-CCcccchhhHHHHHHHHHhCCCCCCcc-chhhHHHHHHHHHhcCccc------ccccc
Q 004400 573 ISTRVAGTIGYMAPEYAMRGH-LTEKADVYSFGIVALEIVSGRSNVTKE-DMFYLLDWALVLKEQGKLM------ELVDT 644 (756)
Q Consensus 573 ~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~slGv~l~elltg~~p~~~~-~~~~~~~~~~~~~~~~~~~------~~~~~ 644 (756)
......||+.|+|||++.+.. ++.++|||||||++|||++|+.|+... +.................. ...+.
T Consensus 157 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 236 (292)
T 3o0g_A 157 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDY 236 (292)
T ss_dssp CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTC
T ss_pred cccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhcccccc
Confidence 233457899999999998765 899999999999999999998886433 3322222221111110000 00000
Q ss_pred ---------CCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004400 645 ---------NPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRM 682 (756)
Q Consensus 645 ---------~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~ 682 (756)
.......+.....+.+++.+|++.||++|||+.|+++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 283 (292)
T 3o0g_A 237 KPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH 283 (292)
T ss_dssp CCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred cccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 00001112233458899999999999999999999863
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-41 Score=362.39 Aligned_cols=250 Identities=24% Similarity=0.364 Sum_probs=205.5
Q ss_pred HHhhcCccccCcccCCCCccEEEeec-cCCcEEEEEEccccC---cccHHHHHHHHHHHHhC-CCCceeeEeeEEEeCCe
Q 004400 412 KAATNNFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSKS---KQGNREFINEIGMISAL-QHPNLVKLYGCCIEGNQ 486 (756)
Q Consensus 412 ~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~ 486 (756)
+...++|...+.||+|+||.||+|+. .+|+.||||+++... ......+..|..++..+ +||||+++++++.+++.
T Consensus 13 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~ 92 (345)
T 1xjd_A 13 KLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKEN 92 (345)
T ss_dssp ---CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCE
Confidence 34567899999999999999999995 578999999997542 23456788899999887 99999999999999999
Q ss_pred EEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccC
Q 004400 487 LLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLD 566 (756)
Q Consensus 487 ~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~ 566 (756)
.|+||||+++|+|.+++... ..+++..+..++.||+.||+|||++| |+||||||+|||++.++.+||+|||+++..
T Consensus 93 ~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~ 168 (345)
T 1xjd_A 93 LFFVMEYLNGGDLMYHIQSC-HKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKEN 168 (345)
T ss_dssp EEEEEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred EEEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCChhhEEECCCCCEEEeEChhhhhc
Confidence 99999999999999999754 37999999999999999999999997 999999999999999999999999999854
Q ss_pred cccCcceeeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhcCccccccccCC
Q 004400 567 EEENTHISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNP 646 (756)
Q Consensus 567 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 646 (756)
..... .....+||+.|+|||++.+..++.++|||||||++|||++|+.||...+........ ... . ...
T Consensus 169 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i---~~~-~------~~~ 237 (345)
T 1xjd_A 169 MLGDA-KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSI---RMD-N------PFY 237 (345)
T ss_dssp CCTTC-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH---HHC-C------CCC
T ss_pred ccCCC-cccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHH---HhC-C------CCC
Confidence 32221 234568999999999999999999999999999999999999999776654433221 111 1 001
Q ss_pred CCCCCHHHHHHHHHHHHHhhcCCCCCCCCHH-HHH
Q 004400 647 GSNFDKEQVMVMINVALLCANASPTIRPSMS-SVL 680 (756)
Q Consensus 647 ~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~-ev~ 680 (756)
...++ ..+.+++.+|++.||++||++. ++.
T Consensus 238 p~~~s----~~~~~li~~lL~~dp~~R~~~~~~i~ 268 (345)
T 1xjd_A 238 PRWLE----KEAKDLLVKLFVREPEKRLGVRGDIR 268 (345)
T ss_dssp CTTSC----HHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred CcccC----HHHHHHHHHHhcCCHhHcCCChHHHH
Confidence 11223 3488999999999999999997 554
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-42 Score=367.39 Aligned_cols=271 Identities=28% Similarity=0.383 Sum_probs=212.5
Q ss_pred hcCccccCcccCCCCccEEEeec-----cCCcEEEEEEccccCcccHHHHHHHHHHHHhCCCCceeeEeeEEE--eCCeE
Q 004400 415 TNNFATDNNIGEGGFGPVYKGLL-----ADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCCI--EGNQL 487 (756)
Q Consensus 415 ~~~~~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~--~~~~~ 487 (756)
.++|+..+.||+|+||.||+|++ .+++.||||++........+.+.+|++++++++||||+++++++. +....
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 101 (327)
T 3lxl_A 22 ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSL 101 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEE
T ss_pred hhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceE
Confidence 35788999999999999999983 468899999998766666678999999999999999999999987 45678
Q ss_pred EEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCc
Q 004400 488 LLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDE 567 (756)
Q Consensus 488 ~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~ 567 (756)
++||||+++|+|.+++......+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++...
T Consensus 102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~ 178 (327)
T 3lxl_A 102 RLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRR---CVHRDLAARNILVESEAHVKIADFGLAKLLP 178 (327)
T ss_dssp EEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCGGGCEECC
T ss_pred EEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChhhEEECCCCCEEEcccccceecc
Confidence 9999999999999999876667999999999999999999999997 9999999999999999999999999998765
Q ss_pred ccCcc--eeeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHH--HHHHhcCccccccc
Q 004400 568 EENTH--ISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWA--LVLKEQGKLMELVD 643 (756)
Q Consensus 568 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~--~~~~~~~~~~~~~~ 643 (756)
..... ......||+.|+|||++.+..++.++||||||+++|+|++|+.||..........+. ..........+.+.
T Consensus 179 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (327)
T 3lxl_A 179 LDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELLE 258 (327)
T ss_dssp TTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHHHHH
T ss_pred cCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHHHhh
Confidence 43322 223456888999999999988999999999999999999999998544322111000 00000000000111
Q ss_pred cCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhccCcc
Q 004400 644 TNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLECGVD 688 (756)
Q Consensus 644 ~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~L~~~~~ 688 (756)
.......+......+.+++.+||+.||++|||+.|+++.|+.+..
T Consensus 259 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~ 303 (327)
T 3lxl_A 259 EGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWS 303 (327)
T ss_dssp TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC--
T ss_pred cccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 111111122223458899999999999999999999999996644
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-42 Score=363.88 Aligned_cols=263 Identities=23% Similarity=0.393 Sum_probs=197.6
Q ss_pred HHhhcCccccCcccCCCCccEEEeeccC-Cc---EEEEEEcccc--CcccHHHHHHHHHHHHhCCCCceeeEeeEEEeCC
Q 004400 412 KAATNNFATDNNIGEGGFGPVYKGLLAD-GT---AIAVKQLSSK--SKQGNREFINEIGMISALQHPNLVKLYGCCIEGN 485 (756)
Q Consensus 412 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~-~~---~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 485 (756)
....++|...+.||+|+||.||+|+... +. .||||.+... .....+.+.+|++++++++||||+++++++.+..
T Consensus 19 ~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 98 (323)
T 3qup_A 19 LIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSR 98 (323)
T ss_dssp BCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC-
T ss_pred ccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccc
Confidence 3456789999999999999999999553 32 7999999764 3344578999999999999999999999998876
Q ss_pred eE------EEEEEecCCCCHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCC
Q 004400 486 QL------LLIYEYLENNSLARALFEHR-----LKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLN 554 (756)
Q Consensus 486 ~~------~lV~e~~~~gsL~~~l~~~~-----~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~ 554 (756)
.. ++||||+++|+|.+++.... ..+++..+..++.|++.||+|||+.| |+||||||+||+++.++.
T Consensus 99 ~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~Dikp~NIli~~~~~ 175 (323)
T 3qup_A 99 AKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRN---FIHRDLAARNCMLAEDMT 175 (323)
T ss_dssp ------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSC
T ss_pred cccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCC---cccCCCCcceEEEcCCCC
Confidence 65 99999999999999996432 25899999999999999999999997 999999999999999999
Q ss_pred EEEccCCccccCcccCcc-eeeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHh-CCCCCCccchhhHHHHHHHH
Q 004400 555 SKISDFGLAKLDEEENTH-ISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVS-GRSNVTKEDMFYLLDWALVL 632 (756)
Q Consensus 555 ~kl~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~~~~~~~ 632 (756)
+||+|||+++........ ......+|+.|+|||.+.+..++.++|||||||++|||++ |+.||...+........
T Consensus 176 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~--- 252 (323)
T 3qup_A 176 VCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYL--- 252 (323)
T ss_dssp EEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHH---
T ss_pred EEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHHHHHH---
Confidence 999999999865443322 2233457889999999999999999999999999999999 89999765544333211
Q ss_pred HhcCccccccccCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhccCcccc
Q 004400 633 KEQGKLMELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLECGVDVL 690 (756)
Q Consensus 633 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~L~~~~~~~ 690 (756)
.... ... ....++ ..+.+++.+||+.||++|||+.++++.|+++....
T Consensus 253 ~~~~-~~~-----~~~~~~----~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~ 300 (323)
T 3qup_A 253 IGGN-RLK-----QPPECM----EEVYDLMYQCWSADPKQRPSFTCLRMELENILGHL 300 (323)
T ss_dssp HTTC-CCC-----CCTTCC----HHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred hcCC-CCC-----CCCccC----HHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHh
Confidence 1111 111 111222 34889999999999999999999999999776544
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=360.89 Aligned_cols=258 Identities=31% Similarity=0.465 Sum_probs=211.7
Q ss_pred hhcCccccCcccCCCCccEEEeec------cCCcEEEEEEccccC-cccHHHHHHHHHHHHhCCCCceeeEeeEEEeCCe
Q 004400 414 ATNNFATDNNIGEGGFGPVYKGLL------ADGTAIAVKQLSSKS-KQGNREFINEIGMISALQHPNLVKLYGCCIEGNQ 486 (756)
Q Consensus 414 ~~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 486 (756)
..++|...+.||+|+||.||+|.. .+++.||||.+.... ....+.+.+|++++++++||||+++++++.+++.
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 100 (314)
T 2ivs_A 21 PRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGP 100 (314)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred chhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCc
Confidence 356888999999999999999984 245789999997543 3345678999999999999999999999999999
Q ss_pred EEEEEEecCCCCHHHHHHhcC-----------------------CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCC
Q 004400 487 LLLIYEYLENNSLARALFEHR-----------------------LKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIK 543 (756)
Q Consensus 487 ~~lV~e~~~~gsL~~~l~~~~-----------------------~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dik 543 (756)
.++||||+++|+|.+++.... ..+++..+..++.||+.||+|||+++ |+|||||
T Consensus 101 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dik 177 (314)
T 2ivs_A 101 LLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK---LVHRDLA 177 (314)
T ss_dssp CEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTT---EECCCCS
T ss_pred eEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCC---Ccccccc
Confidence 999999999999999997543 23899999999999999999999997 9999999
Q ss_pred CCceEecCCCCEEEccCCccccCcccCcc-eeeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHh-CCCCCCccc
Q 004400 544 ATNVLLDKDLNSKISDFGLAKLDEEENTH-ISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVS-GRSNVTKED 621 (756)
Q Consensus 544 p~Nill~~~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~ 621 (756)
|+||+++.++.+||+|||+++........ ......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||....
T Consensus 178 p~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~ 257 (314)
T 2ivs_A 178 ARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIP 257 (314)
T ss_dssp GGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred hheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCC
Confidence 99999999999999999999866543322 2233467889999999999899999999999999999999 999997655
Q ss_pred hhhHHHHHHHHHhcCccccccccCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhccCc
Q 004400 622 MFYLLDWALVLKEQGKLMELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLECGV 687 (756)
Q Consensus 622 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~L~~~~ 687 (756)
........ ....... ....++ ..+.+++.+||+.||++||++.|+++.|+++.
T Consensus 258 ~~~~~~~~----~~~~~~~-----~~~~~~----~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~ 310 (314)
T 2ivs_A 258 PERLFNLL----KTGHRME-----RPDNCS----EEMYRLMLQCWKQEPDKRPVFADISKDLEKMM 310 (314)
T ss_dssp GGGHHHHH----HTTCCCC-----CCTTCC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHHHh----hcCCcCC-----CCccCC----HHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 43332211 1111111 111223 34889999999999999999999999998653
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=361.71 Aligned_cols=256 Identities=26% Similarity=0.428 Sum_probs=205.0
Q ss_pred hcCccccCcccCCCCccEEEeec-cCCcE----EEEEEccccC-cccHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEE
Q 004400 415 TNNFATDNNIGEGGFGPVYKGLL-ADGTA----IAVKQLSSKS-KQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLL 488 (756)
Q Consensus 415 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~----vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 488 (756)
.++|...+.||+|+||.||+|+. .+++. ||+|.+.... ......+.+|+.++++++||||++++++|. ++..+
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~ 90 (325)
T 3kex_A 12 ETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQ 90 (325)
T ss_dssp TTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEE
T ss_pred HhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccE
Confidence 35788899999999999999984 44554 7888775432 233456788999999999999999999986 56689
Q ss_pred EEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCcc
Q 004400 489 LIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEE 568 (756)
Q Consensus 489 lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~ 568 (756)
+||||+.+|+|.+++......+++..+..++.|++.||+|||+.| |+||||||+|||++.++.+||+|||+++....
T Consensus 91 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~ 167 (325)
T 3kex_A 91 LVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLLPP 167 (325)
T ss_dssp EEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTT---CCCSCCSSTTEEESSSSCEEECSCSGGGGSCC
T ss_pred EEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCC---CCCCccchheEEECCCCeEEECCCCcccccCc
Confidence 999999999999999876668999999999999999999999997 99999999999999999999999999987654
Q ss_pred cCcc-eeeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHh-CCCCCCccchhhHHHHHHHHHhcCccccccccCC
Q 004400 569 ENTH-ISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVS-GRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNP 646 (756)
Q Consensus 569 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 646 (756)
.... ......||..|+|||++.+..++.++|||||||++|||++ |+.||............ ...........
T Consensus 168 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~----~~~~~~~~~~~-- 241 (325)
T 3kex_A 168 DDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLL----EKGERLAQPQI-- 241 (325)
T ss_dssp CTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHH----HTTCBCCCCTT--
T ss_pred ccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHH----HcCCCCCCCCc--
Confidence 4332 2344568889999999999999999999999999999999 99999765543332221 11111111111
Q ss_pred CCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhccCc
Q 004400 647 GSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLECGV 687 (756)
Q Consensus 647 ~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~L~~~~ 687 (756)
.+ ..+.+++.+||+.||.+||++.++++.|+.+.
T Consensus 242 ---~~----~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~ 275 (325)
T 3kex_A 242 ---CT----IDVYMVMVKCWMIDENIRPTFKELANEFTRMA 275 (325)
T ss_dssp ---BC----TTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHT
T ss_pred ---Cc----HHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 11 13778999999999999999999999998653
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-41 Score=365.26 Aligned_cols=250 Identities=24% Similarity=0.359 Sum_probs=203.3
Q ss_pred hcCccccCcccCCCCccEEEee-ccCCcEEEEEEcccc---CcccHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEE
Q 004400 415 TNNFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSK---SKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLI 490 (756)
Q Consensus 415 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 490 (756)
.++|...+.||+|+||.||+|. ..+++.||+|.+... .....+.+.+|+++++.++|||||+++++|.+.+..++|
T Consensus 14 ~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv 93 (384)
T 4fr4_A 14 FDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMV 93 (384)
T ss_dssp GGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence 3578899999999999999999 456899999998653 233456789999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCcccC
Q 004400 491 YEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEEN 570 (756)
Q Consensus 491 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~~~ 570 (756)
|||+.+|+|.+++... ..+++..+..++.||+.||+|||+.| |+||||||+|||++.++.+||+|||+++......
T Consensus 94 ~e~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~ 169 (384)
T 4fr4_A 94 VDLLLGGDLRYHLQQN-VHFKEETVKLFICELVMALDYLQNQR---IIHRDMKPDNILLDEHGHVHITDFNIAAMLPRET 169 (384)
T ss_dssp ECCCTTEEHHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCTTC
T ss_pred EecCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEECCCCCEEEeccceeeeccCCC
Confidence 9999999999999754 47999999999999999999999997 9999999999999999999999999998654332
Q ss_pred cceeeccccCccCCchHhhhc---CCCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhcCccccccccCCC
Q 004400 571 THISTRVAGTIGYMAPEYAMR---GHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPG 647 (756)
Q Consensus 571 ~~~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 647 (756)
.....+||+.|+|||++.. ..++.++|||||||++|||++|+.||................... . . ..
T Consensus 170 --~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~-~-~-----~p 240 (384)
T 4fr4_A 170 --QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTV-V-T-----YP 240 (384)
T ss_dssp --CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHHCC-C-C-----CC
T ss_pred --ceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhhcc-c-C-----CC
Confidence 2345689999999999974 458999999999999999999999996543322222111111110 0 0 11
Q ss_pred CCCCHHHHHHHHHHHHHhhcCCCCCCCC-HHHHHH
Q 004400 648 SNFDKEQVMVMINVALLCANASPTIRPS-MSSVLR 681 (756)
Q Consensus 648 ~~~~~~~~~~l~~l~~~c~~~~P~~RPt-~~ev~~ 681 (756)
..++ ..+.+++.+||+.||.+||+ +.++.+
T Consensus 241 ~~~s----~~~~~li~~lL~~dP~~R~s~~~~l~~ 271 (384)
T 4fr4_A 241 SAWS----QEMVSLLKKLLEPNPDQRFSQLSDVQN 271 (384)
T ss_dssp TTSC----HHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred CcCC----HHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence 1223 34889999999999999998 666653
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-42 Score=363.56 Aligned_cols=253 Identities=28% Similarity=0.425 Sum_probs=202.2
Q ss_pred hcCccccCcccCCCCccEEEeec-cCCcEEEEEEccccCc-ccHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEE
Q 004400 415 TNNFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSKSK-QGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYE 492 (756)
Q Consensus 415 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 492 (756)
.++|+..+.||+|+||.||+|+. .+++.||||++..... ...+.+.+|+.+++.++||||+++++++.+++..++|||
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 85 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEE
Confidence 36899999999999999999995 4789999999865422 234568899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCcccCc-
Q 004400 493 YLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENT- 571 (756)
Q Consensus 493 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~~~~- 571 (756)
|+++|+|.+++... ..+++..+..++.|++.||+|||+.| |+||||||+||+++.++.+||+|||+++.......
T Consensus 86 ~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 161 (323)
T 3tki_A 86 YCSGGELFDRIEPD-IGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE 161 (323)
T ss_dssp CCTTEEGGGGSBTT-TBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEETTEE
T ss_pred cCCCCcHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccchHHEEEeCCCCEEEEEeeccceeccCCcc
Confidence 99999999988543 46999999999999999999999997 99999999999999999999999999986543322
Q ss_pred ceeeccccCccCCchHhhhcCCC-CcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhcCccccccccCCCCCC
Q 004400 572 HISTRVAGTIGYMAPEYAMRGHL-TEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNF 650 (756)
Q Consensus 572 ~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 650 (756)
.......||+.|+|||++.+..+ +.++|||||||++|||++|+.||......... +.. ......... ....+
T Consensus 162 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~-~~~-~~~~~~~~~-----~~~~~ 234 (323)
T 3tki_A 162 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE-YSD-WKEKKTYLN-----PWKKI 234 (323)
T ss_dssp CCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHH-HHH-HHTTCTTST-----TGGGS
T ss_pred cccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHH-HHH-HhcccccCC-----ccccC
Confidence 22345679999999999988765 77999999999999999999999654332111 110 111111000 01112
Q ss_pred CHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004400 651 DKEQVMVMINVALLCANASPTIRPSMSSVLRM 682 (756)
Q Consensus 651 ~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~ 682 (756)
...+.+++.+|++.||++|||+.|+++.
T Consensus 235 ----~~~~~~li~~~L~~dP~~R~t~~eil~h 262 (323)
T 3tki_A 235 ----DSAPLALLHKILVENPSARITIPDIKKD 262 (323)
T ss_dssp ----CHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred ----CHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 2347899999999999999999999875
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-41 Score=360.85 Aligned_cols=245 Identities=22% Similarity=0.321 Sum_probs=206.3
Q ss_pred hcCccccCcccCCCCccEEEeec-cCCcEEEEEEcccc---CcccHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEE
Q 004400 415 TNNFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSK---SKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLI 490 (756)
Q Consensus 415 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 490 (756)
.++|+..+.||+|+||.||+|+. .+|+.||+|++... .....+.+.+|+.+++.++||||+++++++.+++..|+|
T Consensus 40 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 119 (350)
T 1rdq_E 40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV 119 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred HHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEE
Confidence 46899999999999999999995 57999999998653 223456788999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCcccC
Q 004400 491 YEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEEN 570 (756)
Q Consensus 491 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~~~ 570 (756)
|||+++|+|.+++... ..+++..+..++.||+.||+|||++| |+||||||+|||++.++.+||+|||+++.....
T Consensus 120 ~e~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~- 194 (350)
T 1rdq_E 120 MEYVAGGEMFSHLRRI-GRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR- 194 (350)
T ss_dssp EECCTTCBHHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSSC-
T ss_pred EcCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCccceEEECCCCCEEEcccccceeccCC-
Confidence 9999999999999764 36999999999999999999999997 999999999999999999999999999865432
Q ss_pred cceeeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhcCccccccccCCCCCC
Q 004400 571 THISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNF 650 (756)
Q Consensus 571 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 650 (756)
....+||+.|+|||++.+..++.++|||||||++|||++|+.||...+........ .. +.. . ....+
T Consensus 195 ---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i---~~-~~~-~-----~p~~~ 261 (350)
T 1rdq_E 195 ---TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKI---VS-GKV-R-----FPSHF 261 (350)
T ss_dssp ---BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH---HH-CCC-C-----CCTTC
T ss_pred ---cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHH---Hc-CCC-C-----CCCCC
Confidence 23467999999999999999999999999999999999999999776554333211 11 111 1 11123
Q ss_pred CHHHHHHHHHHHHHhhcCCCCCCCC-----HHHHHH
Q 004400 651 DKEQVMVMINVALLCANASPTIRPS-----MSSVLR 681 (756)
Q Consensus 651 ~~~~~~~l~~l~~~c~~~~P~~RPt-----~~ev~~ 681 (756)
+ ..+.+++.+|++.||++||+ +.||++
T Consensus 262 ~----~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~ 293 (350)
T 1rdq_E 262 S----SDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp C----HHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred C----HHHHHHHHHHhhcCHHhccCCccCCHHHHHh
Confidence 3 34889999999999999998 777754
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-41 Score=361.54 Aligned_cols=253 Identities=21% Similarity=0.321 Sum_probs=203.8
Q ss_pred hcCccccCcccCCCCccEEEeec-cCCcEEEEEEccccC-----cccHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEE
Q 004400 415 TNNFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSKS-----KQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLL 488 (756)
Q Consensus 415 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 488 (756)
.+.|+..+.||+|+||.||+|+. .+++.||||++.... ....+.+.+|+.+++.++||||+++++++.+++..+
T Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 102 (351)
T 3c0i_A 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLY 102 (351)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 35788899999999999999984 578999999986421 224578999999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCC---EEEccCCc
Q 004400 489 LIYEYLENNSLARALFEH---RLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLN---SKISDFGL 562 (756)
Q Consensus 489 lV~e~~~~gsL~~~l~~~---~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~---~kl~DFGl 562 (756)
+|||||++|+|.+.+... ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++. +||+|||+
T Consensus 103 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~ 179 (351)
T 3c0i_A 103 MVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNN---IIHRDVKPHCVLLASKENSAPVKLGGFGV 179 (351)
T ss_dssp EEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECSSSTTCCEEECCCTT
T ss_pred EEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChHHeEEecCCCCCcEEEecCcc
Confidence 999999999999888632 345899999999999999999999997 999999999999987655 99999999
Q ss_pred cccCcccCcceeeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhcCcccccc
Q 004400 563 AKLDEEENTHISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELV 642 (756)
Q Consensus 563 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 642 (756)
++....... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...... ... ..........
T Consensus 180 a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-~~~--~i~~~~~~~~--- 252 (351)
T 3c0i_A 180 AIQLGESGL-VAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKER-LFE--GIIKGKYKMN--- 252 (351)
T ss_dssp CEECCTTSC-BCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHHH-HHH--HHHHTCCCCC---
T ss_pred eeEecCCCe-eecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHHH-HHH--HHHcCCCCCC---
Confidence 987654332 233457999999999999989999999999999999999999999765321 111 1111110000
Q ss_pred ccCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004400 643 DTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRM 682 (756)
Q Consensus 643 ~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~ 682 (756)
......+ ...+.+++.+||+.||++|||+.|+++.
T Consensus 253 -~~~~~~~----s~~~~~li~~~L~~dP~~R~s~~e~l~h 287 (351)
T 3c0i_A 253 -PRQWSHI----SESAKDLVRRMLMLDPAERITVYEALNH 287 (351)
T ss_dssp -HHHHTTS----CHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred -ccccccC----CHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 0000112 2348899999999999999999999863
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-42 Score=361.57 Aligned_cols=258 Identities=26% Similarity=0.399 Sum_probs=206.4
Q ss_pred cCccccCcccCCCCccEEEeec-----cCCcEEEEEEcccc-CcccHHHHHHHHHHHHhCCCCceeeEeeEEEeC--CeE
Q 004400 416 NNFATDNNIGEGGFGPVYKGLL-----ADGTAIAVKQLSSK-SKQGNREFINEIGMISALQHPNLVKLYGCCIEG--NQL 487 (756)
Q Consensus 416 ~~~~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~ 487 (756)
+.|+..+.||+|+||.||+|++ .+++.||||++... .....+.+.+|++++++++||||+++++++.++ ...
T Consensus 21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 100 (302)
T 4e5w_A 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 100 (302)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCE
T ss_pred hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceE
Confidence 4578889999999999999983 46889999999754 333457899999999999999999999999876 678
Q ss_pred EEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCc
Q 004400 488 LLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDE 567 (756)
Q Consensus 488 ~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~ 567 (756)
++||||+++|+|.+++......+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++...
T Consensus 101 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~ 177 (302)
T 4e5w_A 101 KLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKAIE 177 (302)
T ss_dssp EEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEECC
T ss_pred EEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCC---cccCCCchheEEEcCCCCEEECccccccccc
Confidence 9999999999999999777678999999999999999999999997 9999999999999999999999999998765
Q ss_pred ccCc--ceeeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHhCCCCCCccchh------------hHHHHHHHHH
Q 004400 568 EENT--HISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMF------------YLLDWALVLK 633 (756)
Q Consensus 568 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~------------~~~~~~~~~~ 633 (756)
.... .......||..|+|||.+.+..++.++||||||+++|||++|+.|+...... .........
T Consensus 178 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 256 (302)
T 4e5w_A 178 TDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTL- 256 (302)
T ss_dssp TTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHHHHH-
T ss_pred CCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHHHHH-
Confidence 4432 2233456888999999999999999999999999999999999886322110 000001111
Q ss_pred hcCccccccccCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhccC
Q 004400 634 EQGKLMELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLECG 686 (756)
Q Consensus 634 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~L~~~ 686 (756)
..... ...+......+.+++.+||+.||.+|||+.++++.|+++
T Consensus 257 ~~~~~---------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 300 (302)
T 4e5w_A 257 KEGKR---------LPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEAL 300 (302)
T ss_dssp HTTCC---------CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred hccCC---------CCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHH
Confidence 11111 111122234588999999999999999999999999864
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-41 Score=349.87 Aligned_cols=254 Identities=30% Similarity=0.527 Sum_probs=204.8
Q ss_pred hcCccccCcccCCCCccEEEeec-cCCcEEEEEEccccCccc-------HHHHHHHHHHHHhCCCCceeeEeeEEEeCCe
Q 004400 415 TNNFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSKSKQG-------NREFINEIGMISALQHPNLVKLYGCCIEGNQ 486 (756)
Q Consensus 415 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~-------~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 486 (756)
.++|...+.||+|+||.||+|+. .+++.||+|++....... .+.+.+|++++++++||||+++++++.+..
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~- 96 (287)
T 4f0f_A 18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP- 96 (287)
T ss_dssp STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT-
T ss_pred hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC-
Confidence 46888999999999999999994 678999999986543221 167899999999999999999999987665
Q ss_pred EEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCC-----EEEccCC
Q 004400 487 LLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLN-----SKISDFG 561 (756)
Q Consensus 487 ~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~-----~kl~DFG 561 (756)
++||||+++|+|.+.+......+++..+..++.|++.||+|||+.+ ++|+||||||+||+++.++. +||+|||
T Consensus 97 -~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~-~~ivH~dikp~Nil~~~~~~~~~~~~kl~Dfg 174 (287)
T 4f0f_A 97 -RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQN-PPIVHRDLRSPNIFLQSLDENAPVCAKVADFG 174 (287)
T ss_dssp -EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCSCCSGGGEEESCCCTTCSCCEEECCCT
T ss_pred -eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCC-CCeecCCCCcceEEEeccCCCCceeEEeCCCC
Confidence 6999999999999999877778999999999999999999999884 23999999999999988776 9999999
Q ss_pred ccccCcccCcceeeccccCccCCchHhhh--cCCCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhcCccc
Q 004400 562 LAKLDEEENTHISTRVAGTIGYMAPEYAM--RGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLM 639 (756)
Q Consensus 562 la~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 639 (756)
+++.... ......||+.|+|||++. ...++.++|||||||++|||++|+.||......... ............
T Consensus 175 ~~~~~~~----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~-~~~~~~~~~~~~ 249 (287)
T 4f0f_A 175 LSQQSVH----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIK-FINMIREEGLRP 249 (287)
T ss_dssp TCBCCSS----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHH-HHHHHHHSCCCC
T ss_pred ccccccc----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHH-HHHHHhccCCCC
Confidence 9975433 234467999999999984 455789999999999999999999999654432221 111111211111
Q ss_pred cccccCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhcc
Q 004400 640 ELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLEC 685 (756)
Q Consensus 640 ~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~L~~ 685 (756)
.. ...++ ..+.+++.+||+.||++|||+.|+++.|++
T Consensus 250 ~~-----~~~~~----~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ 286 (287)
T 4f0f_A 250 TI-----PEDCP----PRLRNVIELCWSGDPKKRPHFSYIVKELSE 286 (287)
T ss_dssp CC-----CTTSC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred CC-----CcccC----HHHHHHHHHHhcCChhhCcCHHHHHHHHHh
Confidence 11 11222 348899999999999999999999999985
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=364.79 Aligned_cols=260 Identities=28% Similarity=0.404 Sum_probs=209.3
Q ss_pred hhcCccccCcccCCCCccEEEeec------cCCcEEEEEEcccc-CcccHHHHHHHHHHHHhC-CCCceeeEeeEEEeCC
Q 004400 414 ATNNFATDNNIGEGGFGPVYKGLL------ADGTAIAVKQLSSK-SKQGNREFINEIGMISAL-QHPNLVKLYGCCIEGN 485 (756)
Q Consensus 414 ~~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~ 485 (756)
..++|...+.||+|+||.||+|+. .++..||||.+... .....+.+.+|+.+++++ +||||+++++++.+++
T Consensus 43 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 122 (344)
T 1rjb_A 43 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSG 122 (344)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred CHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCC
Confidence 457899999999999999999985 24568999999754 233457799999999999 8999999999999999
Q ss_pred eEEEEEEecCCCCHHHHHHhcCC----------------------CCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCC
Q 004400 486 QLLLIYEYLENNSLARALFEHRL----------------------KLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIK 543 (756)
Q Consensus 486 ~~~lV~e~~~~gsL~~~l~~~~~----------------------~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dik 543 (756)
..++||||+++|+|.+++..... .+++..+..++.||+.||+|||+.| |+|||||
T Consensus 123 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dik 199 (344)
T 1rjb_A 123 PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLA 199 (344)
T ss_dssp SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETTCS
T ss_pred ccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCC
Confidence 99999999999999999975432 3799999999999999999999997 9999999
Q ss_pred CCceEecCCCCEEEccCCccccCcccCcc-eeeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHh-CCCCCCccc
Q 004400 544 ATNVLLDKDLNSKISDFGLAKLDEEENTH-ISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVS-GRSNVTKED 621 (756)
Q Consensus 544 p~Nill~~~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~ 621 (756)
|+||+++.++.+||+|||+++........ ......||+.|+|||.+.+..++.++|||||||++|||+| |+.||....
T Consensus 200 p~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~ 279 (344)
T 1rjb_A 200 ARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIP 279 (344)
T ss_dssp GGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred hhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccCC
Confidence 99999999999999999999866543332 2334568889999999999999999999999999999998 999996554
Q ss_pred hhhHHHHHHHHHhcCccccccccCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhccCcc
Q 004400 622 MFYLLDWALVLKEQGKLMELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLECGVD 688 (756)
Q Consensus 622 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~L~~~~~ 688 (756)
...... .......... .....+ ..+.+++.+||+.||.+||++.++++.|+....
T Consensus 280 ~~~~~~---~~~~~~~~~~-----~~~~~~----~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~ 334 (344)
T 1rjb_A 280 VDANFY---KLIQNGFKMD-----QPFYAT----EEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLA 334 (344)
T ss_dssp CSHHHH---HHHHTTCCCC-----CCTTCC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC-
T ss_pred cHHHHH---HHHhcCCCCC-----CCCCCC----HHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHH
Confidence 322111 1111111111 111222 348899999999999999999999999996644
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-41 Score=365.40 Aligned_cols=247 Identities=22% Similarity=0.316 Sum_probs=197.9
Q ss_pred hcCccccCcccCCCCccEEEeec-cCCcEEEEEEccccC---cccHHHHHHHHHHHHhC-CCCceeeEeeEEEeCCeEEE
Q 004400 415 TNNFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSKS---KQGNREFINEIGMISAL-QHPNLVKLYGCCIEGNQLLL 489 (756)
Q Consensus 415 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l 489 (756)
.++|+..+.||+|+||.||+|+. .+++.||+|++++.. ......+.+|..++.++ +|||||+++++|.+++..++
T Consensus 51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 130 (396)
T 4dc2_A 51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 130 (396)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEE
Confidence 46789999999999999999995 568899999997642 22334578899999887 89999999999999999999
Q ss_pred EEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCccc
Q 004400 490 IYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEE 569 (756)
Q Consensus 490 V~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~~ 569 (756)
||||+++|+|.+++... ..+++..+..++.||+.||+|||++| |+||||||+|||++.++.+||+|||+++.....
T Consensus 131 V~E~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFGla~~~~~~ 206 (396)
T 4dc2_A 131 VIEYVNGGDLMFHMQRQ-RKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP 206 (396)
T ss_dssp EEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred EEEcCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEECCCCCEEEeecceeeecccC
Confidence 99999999999999754 47999999999999999999999997 999999999999999999999999999853322
Q ss_pred CcceeeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHhCCCCCCccchhh-----HHHHHHHHHhcCcccccccc
Q 004400 570 NTHISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFY-----LLDWALVLKEQGKLMELVDT 644 (756)
Q Consensus 570 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~ 644 (756)
. ......+||+.|+|||++.+..++.++|||||||++|||++|+.||....... ...+..........
T Consensus 207 ~-~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~------ 279 (396)
T 4dc2_A 207 G-DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI------ 279 (396)
T ss_dssp T-CCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCC------
T ss_pred C-CccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhcccc------
Confidence 2 22345789999999999999999999999999999999999999995332111 00111111111110
Q ss_pred CCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCH
Q 004400 645 NPGSNFDKEQVMVMINVALLCANASPTIRPSM 676 (756)
Q Consensus 645 ~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~ 676 (756)
.++......+.+++.+||+.||++||++
T Consensus 280 ----~~p~~~s~~~~~li~~lL~~dP~~R~~~ 307 (396)
T 4dc2_A 280 ----RIPRSLSVKAASVLKSFLNKDPKERLGC 307 (396)
T ss_dssp ----CCCTTSCHHHHHHHHHHTCSCTTTSTTC
T ss_pred ----CCCCcCCHHHHHHHHHHhcCCHhHcCCC
Confidence 1111122348899999999999999995
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-41 Score=351.45 Aligned_cols=257 Identities=26% Similarity=0.384 Sum_probs=206.7
Q ss_pred hhcCccccCcccCCCCccEEEeeccC----CcEEEEEEcccc-CcccHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEE
Q 004400 414 ATNNFATDNNIGEGGFGPVYKGLLAD----GTAIAVKQLSSK-SKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLL 488 (756)
Q Consensus 414 ~~~~~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 488 (756)
..++|...+.||+|+||.||+|+..+ +..||+|.+... .....+.+.+|+.++++++||||+++++++.+ +..+
T Consensus 10 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~ 88 (281)
T 3cc6_A 10 AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTW 88 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSCE
T ss_pred cccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCE
Confidence 45688999999999999999998532 346999998765 33345779999999999999999999999865 4568
Q ss_pred EEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCcc
Q 004400 489 LIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEE 568 (756)
Q Consensus 489 lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~ 568 (756)
+||||+++++|.+++......+++..+..++.|++.||+|||+.| |+||||||+||+++.++.+||+|||+++....
T Consensus 89 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 165 (281)
T 3cc6_A 89 IIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESIN---CVHRDIAVRNILVASPECVKLGDFGLSRYIED 165 (281)
T ss_dssp EEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEEETTEEEECCCCGGGCC--
T ss_pred EEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEECCCCcEEeCccCCCccccc
Confidence 999999999999999877677999999999999999999999997 99999999999999999999999999987655
Q ss_pred cCcceeeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHh-CCCCCCccchhhHHHHHHHHHhcCccccccccCCC
Q 004400 569 ENTHISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVS-GRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPG 647 (756)
Q Consensus 569 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 647 (756)
..........+|+.|+|||.+.+..++.++||||||+++|||++ |+.||........... ... ..... ..
T Consensus 166 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~---~~~-~~~~~-----~~ 236 (281)
T 3cc6_A 166 EDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGV---LEK-GDRLP-----KP 236 (281)
T ss_dssp -------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHH---HHH-TCCCC-----CC
T ss_pred ccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHH---Hhc-CCCCC-----CC
Confidence 44333444567889999999999999999999999999999998 9999965544333221 111 11111 11
Q ss_pred CCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhccCc
Q 004400 648 SNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLECGV 687 (756)
Q Consensus 648 ~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~L~~~~ 687 (756)
..++ ..+.+++.+||+.||++||++.|+++.|+.+.
T Consensus 237 ~~~~----~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~ 272 (281)
T 3cc6_A 237 DLCP----PVLYTLMTRCWDYDPSDRPRFTELVCSLSDVY 272 (281)
T ss_dssp TTCC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCC----HHHHHHHHHHccCCchhCcCHHHHHHHHHHHH
Confidence 1223 34889999999999999999999999998653
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-41 Score=353.76 Aligned_cols=251 Identities=24% Similarity=0.396 Sum_probs=206.1
Q ss_pred hcCccccCcccCCCCccEEEeecc-CC-------cEEEEEEccccCcccHHHHHHHHHHHHhCCCCceeeEeeEEEeCCe
Q 004400 415 TNNFATDNNIGEGGFGPVYKGLLA-DG-------TAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQ 486 (756)
Q Consensus 415 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~-------~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 486 (756)
.++|...+.||+|+||.||+|+.. ++ ..||+|.+........+.+.+|++++++++||||+++++++.+++.
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (289)
T 4fvq_A 7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDE 86 (289)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTC
T ss_pred hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCC
Confidence 457889999999999999999854 33 4799999977666667889999999999999999999999999999
Q ss_pred EEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCC--------EEEc
Q 004400 487 LLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLN--------SKIS 558 (756)
Q Consensus 487 ~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~--------~kl~ 558 (756)
.++||||+++|+|.+++......+++..+..++.|++.||+|||+++ |+||||||+||+++.++. +||+
T Consensus 87 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~kl~ 163 (289)
T 4fvq_A 87 NILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENT---LIHGNVCAKNILLIREEDRKTGNPPFIKLS 163 (289)
T ss_dssp CEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEEECCBGGGTBCCEEEEC
T ss_pred CEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCC---eECCCcCcceEEEecCCcccccccceeeec
Confidence 99999999999999999877666999999999999999999999997 999999999999998887 9999
Q ss_pred cCCccccCcccCcceeeccccCccCCchHhhhc-CCCCcccchhhHHHHHHHHHhCCCCCC-ccchhhHHHHHHHHHhcC
Q 004400 559 DFGLAKLDEEENTHISTRVAGTIGYMAPEYAMR-GHLTEKADVYSFGIVALEIVSGRSNVT-KEDMFYLLDWALVLKEQG 636 (756)
Q Consensus 559 DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slGv~l~elltg~~p~~-~~~~~~~~~~~~~~~~~~ 636 (756)
|||+++..... ....||+.|+|||++.+ ..++.++||||||+++|||++|+.|+. ..+...... ......
T Consensus 164 Dfg~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~---~~~~~~ 235 (289)
T 4fvq_A 164 DPGISITVLPK-----DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQ---FYEDRH 235 (289)
T ss_dssp CCCSCTTTSCH-----HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHH---HHHTTC
T ss_pred cCcccccccCc-----cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHH---HhhccC
Confidence 99999754332 23458999999999987 679999999999999999999665553 333222111 111111
Q ss_pred ccccccccCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhccCcc
Q 004400 637 KLMELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLECGVD 688 (756)
Q Consensus 637 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~L~~~~~ 688 (756)
.. ... . ...+.+++.+||+.||++|||+.|+++.|+++..
T Consensus 236 ~~---~~~-----~----~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~ 275 (289)
T 4fvq_A 236 QL---PAP-----K----AAELANLINNCMDYEPDHRPSFRAIIRDLNSLFT 275 (289)
T ss_dssp CC---CCC-----S----SCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC-
T ss_pred CC---CCC-----C----CHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 11 111 1 1137899999999999999999999999996644
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-41 Score=359.28 Aligned_cols=262 Identities=19% Similarity=0.245 Sum_probs=200.3
Q ss_pred hcCccccCcccCCCCccEEEeecc----CCcEEEEEEccccCcc-----------cHHHHHHHHHHHHhCCCCceeeEee
Q 004400 415 TNNFATDNNIGEGGFGPVYKGLLA----DGTAIAVKQLSSKSKQ-----------GNREFINEIGMISALQHPNLVKLYG 479 (756)
Q Consensus 415 ~~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~-----------~~~~~~~E~~~l~~l~h~niv~l~~ 479 (756)
.++|...+.||+|+||.||+|... ++..||||.+...... ....+.+|+..++.++||||+++++
T Consensus 36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~ 115 (345)
T 2v62_A 36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG 115 (345)
T ss_dssp SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence 357889999999999999999964 6788999998654221 1234678889999999999999999
Q ss_pred EEEe----CCeEEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCC--
Q 004400 480 CCIE----GNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDL-- 553 (756)
Q Consensus 480 ~~~~----~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~-- 553 (756)
++.+ +...++||||+ +++|.+++.... .+++..+..++.||+.||+|||+.+ |+||||||+|||++.++
T Consensus 116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~ 190 (345)
T 2v62_A 116 SGLTEFKGRSYRFMVMERL-GIDLQKISGQNG-TFKKSTVLQLGIRMLDVLEYIHENE---YVHGDIKAANLLLGYKNPD 190 (345)
T ss_dssp EEEEESSSCEEEEEEEECE-EEEHHHHCBGGG-BCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEESSSTT
T ss_pred ccccccCCCcEEEEEEecc-CCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCcCHHHEEEccCCCC
Confidence 9988 78899999999 999999987554 7999999999999999999999996 99999999999999887
Q ss_pred CEEEccCCccccCcccCcc------eeeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHhCCCCCCcc--chhhH
Q 004400 554 NSKISDFGLAKLDEEENTH------ISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKE--DMFYL 625 (756)
Q Consensus 554 ~~kl~DFGla~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~--~~~~~ 625 (756)
.+||+|||+++........ ......||+.|+|||++.+..++.++|||||||++|||++|+.||... +....
T Consensus 191 ~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~ 270 (345)
T 2v62_A 191 QVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAV 270 (345)
T ss_dssp SEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHHH
T ss_pred cEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccHHH
Confidence 9999999999866433211 113457999999999999999999999999999999999999999542 21111
Q ss_pred HHHHHHHHhcCcccccc-ccCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhccCc
Q 004400 626 LDWALVLKEQGKLMELV-DTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLECGV 687 (756)
Q Consensus 626 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~L~~~~ 687 (756)
........ . .....+ .......++. .+.+++.+||+.||++||++.+|++.|+...
T Consensus 271 ~~~~~~~~-~-~~~~~~~~~~~~~~~~~----~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~ 327 (345)
T 2v62_A 271 QTAKTNLL-D-ELPQSVLKWAPSGSSCC----EIAQFLVCAHSLAYDEKPNYQALKKILNPHG 327 (345)
T ss_dssp HHHHHHHH-H-TTTHHHHHHSCTTSCCH----HHHHHHHHHHTCCTTCCCCHHHHHHHHCTTC
T ss_pred HHHHHhhc-c-cccHHHHhhccccccHH----HHHHHHHHHhhcCcccCCCHHHHHHHHhccC
Confidence 11111111 1 111111 1111112333 4889999999999999999999999999753
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-41 Score=360.70 Aligned_cols=249 Identities=22% Similarity=0.321 Sum_probs=205.3
Q ss_pred hhcCccccCcccCCCCccEEEeecc-CCcEEEEEEcccc---CcccHHHHHHHHHHHHhC-CCCceeeEeeEEEeCCeEE
Q 004400 414 ATNNFATDNNIGEGGFGPVYKGLLA-DGTAIAVKQLSSK---SKQGNREFINEIGMISAL-QHPNLVKLYGCCIEGNQLL 488 (756)
Q Consensus 414 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~ 488 (756)
..++|+..+.||+|+||.||+|+.. +++.||||+++.. .....+.+.+|..++..+ +||||+++++++.+.+..|
T Consensus 18 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~ 97 (353)
T 2i0e_A 18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 97 (353)
T ss_dssp -CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEE
T ss_pred chHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEE
Confidence 3568999999999999999999954 5889999999754 223456788999999988 8999999999999999999
Q ss_pred EEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCcc
Q 004400 489 LIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEE 568 (756)
Q Consensus 489 lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~ 568 (756)
+||||+++|+|.+++.... .+++..+..++.||+.||+|||+.| |+||||||+|||++.++.+||+|||+++....
T Consensus 98 lv~E~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~ 173 (353)
T 2i0e_A 98 FVMEYVNGGDLMYHIQQVG-RFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENIW 173 (353)
T ss_dssp EEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred EEEeCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEEcCCCcEEEEeCCccccccc
Confidence 9999999999999997543 6999999999999999999999997 99999999999999999999999999985432
Q ss_pred cCcceeeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhcCccccccccCCCC
Q 004400 569 ENTHISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGS 648 (756)
Q Consensus 569 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 648 (756)
... .....+||+.|+|||++.+..++.++|||||||++|||++|+.||...+........ ... .. . ...
T Consensus 174 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i---~~~-~~-~-----~p~ 242 (353)
T 2i0e_A 174 DGV-TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSI---MEH-NV-A-----YPK 242 (353)
T ss_dssp TTC-CBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH---HHC-CC-C-----CCT
T ss_pred CCc-ccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHH---HhC-CC-C-----CCC
Confidence 222 234568999999999999999999999999999999999999999776654433211 111 10 0 111
Q ss_pred CCCHHHHHHHHHHHHHhhcCCCCCCCC-----HHHHHH
Q 004400 649 NFDKEQVMVMINVALLCANASPTIRPS-----MSSVLR 681 (756)
Q Consensus 649 ~~~~~~~~~l~~l~~~c~~~~P~~RPt-----~~ev~~ 681 (756)
.++ ..+.+++.+|++.||++||+ +.++++
T Consensus 243 ~~s----~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~ 276 (353)
T 2i0e_A 243 SMS----KEAVAICKGLMTKHPGKRLGCGPEGERDIKE 276 (353)
T ss_dssp TSC----HHHHHHHHHHTCSCTTSCTTCSTTHHHHHHT
T ss_pred CCC----HHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence 223 34889999999999999995 466654
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-41 Score=361.13 Aligned_cols=247 Identities=26% Similarity=0.381 Sum_probs=203.0
Q ss_pred hcCccccCcccCCCCccEEEee-ccCCcEEEEEEcccc---CcccHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEE
Q 004400 415 TNNFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSK---SKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLI 490 (756)
Q Consensus 415 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 490 (756)
.++|...+.||+|+||.||+|+ ..+++.||||++... .......+.+|+.+++.++||||+++++++.+++..++|
T Consensus 8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 87 (336)
T 3h4j_B 8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMV 87 (336)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 3688999999999999999999 468899999998653 122346789999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCcccC
Q 004400 491 YEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEEN 570 (756)
Q Consensus 491 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~~~ 570 (756)
|||+ +|+|.+++... ..+++..+..++.|++.||+|||+.| |+||||||+|||+++++.+||+|||+++......
T Consensus 88 ~E~~-~g~l~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~~ 162 (336)
T 3h4j_B 88 IEYA-GGELFDYIVEK-KRMTEDEGRRFFQQIICAIEYCHRHK---IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGN 162 (336)
T ss_dssp ECCC-CEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCSTTTEEECTTCCEEECCSSCTBTTTTSB
T ss_pred EECC-CCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCchhhEEEcCCCCEEEEEeccceeccCCc
Confidence 9999 78999988754 47999999999999999999999997 9999999999999999999999999998655432
Q ss_pred cceeeccccCccCCchHhhhcCCC-CcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhcCccccccccCCCCC
Q 004400 571 THISTRVAGTIGYMAPEYAMRGHL-TEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSN 649 (756)
Q Consensus 571 ~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 649 (756)
. ....+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||......... ..+.... ..
T Consensus 163 ~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~-------------~~i~~~~-~~ 226 (336)
T 3h4j_B 163 F--LKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLF-------------KKVNSCV-YV 226 (336)
T ss_dssp T--TCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCB-------------CCCCSSC-CC
T ss_pred c--cccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHH-------------HHHHcCC-CC
Confidence 2 234579999999999987765 78999999999999999999999654322111 1111000 01
Q ss_pred CCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004400 650 FDKEQVMVMINVALLCANASPTIRPSMSSVLRM 682 (756)
Q Consensus 650 ~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~ 682 (756)
.+......+.+++.+|++.||.+|||+.|+++.
T Consensus 227 ~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 259 (336)
T 3h4j_B 227 MPDFLSPGAQSLIRRMIVADPMQRITIQEIRRD 259 (336)
T ss_dssp CCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTC
T ss_pred CcccCCHHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence 111223348899999999999999999999764
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-41 Score=350.96 Aligned_cols=257 Identities=31% Similarity=0.464 Sum_probs=211.2
Q ss_pred hhcCccccCcccCCCCccEEEeeccCCcEEEEEEccccCcccHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEEe
Q 004400 414 ATNNFATDNNIGEGGFGPVYKGLLADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYEY 493 (756)
Q Consensus 414 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 493 (756)
..++|...+.||+|+||.||+|...+++.||||.+.... ...+.+.+|++++++++||||+++++++. ++..++||||
T Consensus 11 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~ 88 (279)
T 1qpc_A 11 PRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITEY 88 (279)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEEC
T ss_pred CHHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEEEc-CCCcEEEEec
Confidence 346788999999999999999998888899999987543 34578999999999999999999999986 4568999999
Q ss_pred cCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCcccCcc
Q 004400 494 LENNSLARALFEH-RLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTH 572 (756)
Q Consensus 494 ~~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~~~~~ 572 (756)
+++++|.+++... ...+++..+..++.|++.||+|||+.| |+||||||+||++++++.+||+|||+++........
T Consensus 89 ~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 165 (279)
T 1qpc_A 89 MENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYT 165 (279)
T ss_dssp CTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEE
T ss_pred CCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHhhEEEcCCCCEEECCCcccccccCcccc
Confidence 9999999998643 236899999999999999999999997 999999999999999999999999999876554433
Q ss_pred eeeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHh-CCCCCCccchhhHHHHHHHHHhcCccccccccCCCCCCC
Q 004400 573 ISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVS-GRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFD 651 (756)
Q Consensus 573 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 651 (756)
......++..|+|||.+.+..++.++||||||+++|||++ |+.||........... ... +... .....++
T Consensus 166 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~---~~~-~~~~-----~~~~~~~ 236 (279)
T 1qpc_A 166 AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQN---LER-GYRM-----VRPDNCP 236 (279)
T ss_dssp CCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHH---HHT-TCCC-----CCCTTCC
T ss_pred cccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHH---Hhc-ccCC-----CCccccc
Confidence 3344567889999999998889999999999999999999 8999976554332221 111 1111 1111223
Q ss_pred HHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhccCcc
Q 004400 652 KEQVMVMINVALLCANASPTIRPSMSSVLRMLECGVD 688 (756)
Q Consensus 652 ~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~L~~~~~ 688 (756)
..+.+++.+|++.||++|||+.++++.|+.+..
T Consensus 237 ----~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~ 269 (279)
T 1qpc_A 237 ----EELYQLMRLCWKERPEDRPTFDYLRSVLEDFFT 269 (279)
T ss_dssp ----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ----HHHHHHHHHHhccChhhCCCHHHHHHHHHHHHH
Confidence 348899999999999999999999999996543
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=386.07 Aligned_cols=259 Identities=29% Similarity=0.450 Sum_probs=214.1
Q ss_pred hhcCccccCcccCCCCccEEEeeccCCcEEEEEEccccCcccHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEEe
Q 004400 414 ATNNFATDNNIGEGGFGPVYKGLLADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYEY 493 (756)
Q Consensus 414 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 493 (756)
..++|...+.||+|+||.||+|.+.++..||||+++... ...+.|.+|+++|++++|||||++++++.+ +..++||||
T Consensus 265 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e~ 342 (535)
T 2h8h_A 265 PRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEY 342 (535)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECC
T ss_pred chhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeeeh
Confidence 456788999999999999999998888889999997643 345789999999999999999999999876 678999999
Q ss_pred cCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCcccCcc
Q 004400 494 LENNSLARALFEH-RLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTH 572 (756)
Q Consensus 494 ~~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~~~~~ 572 (756)
|++|+|.+++... ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++........
T Consensus 343 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~ 419 (535)
T 2h8h_A 343 MSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT 419 (535)
T ss_dssp CTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHHHH
T ss_pred hcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEEcCCCcEEEcccccceecCCCcee
Confidence 9999999999743 346899999999999999999999996 999999999999999999999999999876543222
Q ss_pred eeeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHh-CCCCCCccchhhHHHHHHHHHhcCccccccccCCCCCCC
Q 004400 573 ISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVS-GRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFD 651 (756)
Q Consensus 573 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 651 (756)
......++..|+|||++....++.++|||||||++|||++ |+.||............ ..+..... ...++
T Consensus 420 ~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i----~~~~~~~~-----~~~~~ 490 (535)
T 2h8h_A 420 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQV----ERGYRMPC-----PPECP 490 (535)
T ss_dssp TTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHH----HTTCCCCC-----CTTCC
T ss_pred cccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH----HcCCCCCC-----CCCCC
Confidence 2233457889999999999999999999999999999999 99999765544333211 11111111 11223
Q ss_pred HHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhccCcccc
Q 004400 652 KEQVMVMINVALLCANASPTIRPSMSSVLRMLECGVDVL 690 (756)
Q Consensus 652 ~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~L~~~~~~~ 690 (756)
..+.+++.+||+.||++|||+.+|++.|+.+....
T Consensus 491 ----~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~ 525 (535)
T 2h8h_A 491 ----ESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST 525 (535)
T ss_dssp ----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCCC
T ss_pred ----HHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhcc
Confidence 34889999999999999999999999999875543
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-41 Score=358.20 Aligned_cols=245 Identities=26% Similarity=0.324 Sum_probs=195.8
Q ss_pred cCccccCcccCCCCccEEEeecc-CCcEEEEEEccccC--cccHHHHHHHHHHHHhC-CCCceeeEeeEEEeCCeEEEEE
Q 004400 416 NNFATDNNIGEGGFGPVYKGLLA-DGTAIAVKQLSSKS--KQGNREFINEIGMISAL-QHPNLVKLYGCCIEGNQLLLIY 491 (756)
Q Consensus 416 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~ 491 (756)
++|+..+.||+|+||+||+|+.. +|+.||||++.... ......+..|+..+.++ +||||++++++|.+++..++||
T Consensus 57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~ 136 (311)
T 3p1a_A 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQT 136 (311)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEE
Confidence 57899999999999999999954 79999999986542 22334556666666555 8999999999999999999999
Q ss_pred EecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCcccCc
Q 004400 492 EYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENT 571 (756)
Q Consensus 492 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~~~~ 571 (756)
||+ +++|.+++......+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 137 e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~~~ 212 (311)
T 3p1a_A 137 ELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQG---LVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGA 212 (311)
T ss_dssp ECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECGGGCEEECCCTTCEECC----
T ss_pred ecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEccceeeeecccCCC
Confidence 999 67999999877778999999999999999999999996 99999999999999999999999999986544322
Q ss_pred ceeeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhcCccccccccCCCCCCC
Q 004400 572 HISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFD 651 (756)
Q Consensus 572 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 651 (756)
.....||+.|+|||++.+ .++.++|||||||++|||++|..|+......... ......... ....
T Consensus 213 --~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~-------~~~~~~~~~----~~~~- 277 (311)
T 3p1a_A 213 --GEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEGWQQL-------RQGYLPPEF----TAGL- 277 (311)
T ss_dssp ----CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHHHHHHH-------TTTCCCHHH----HTTS-
T ss_pred --CcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHH-------hccCCCccc----ccCC-
Confidence 234569999999998875 7999999999999999999998777554322111 111111000 0112
Q ss_pred HHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004400 652 KEQVMVMINVALLCANASPTIRPSMSSVLRM 682 (756)
Q Consensus 652 ~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~ 682 (756)
...+.+++.+|++.||++|||+.|+++.
T Consensus 278 ---~~~l~~li~~~L~~dP~~Rpt~~ell~h 305 (311)
T 3p1a_A 278 ---SSELRSVLVMMLEPDPKLRATAEALLAL 305 (311)
T ss_dssp ---CHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred ---CHHHHHHHHHHcCCChhhCcCHHHHHhC
Confidence 2358899999999999999999999864
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-41 Score=351.06 Aligned_cols=260 Identities=30% Similarity=0.455 Sum_probs=196.7
Q ss_pred hhcCccccCcccCCCCccEEEeeccCCcEEEEEEccccC--cccHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEE
Q 004400 414 ATNNFATDNNIGEGGFGPVYKGLLADGTAIAVKQLSSKS--KQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIY 491 (756)
Q Consensus 414 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 491 (756)
..++|...+.||+|+||.||+|+... .||||.++... ....+.+.+|++++++++||||+++++++ ..+..++||
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~~~~~~--~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~ 98 (289)
T 3og7_A 22 PDGQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVT 98 (289)
T ss_dssp CTTSCEEEEEEEECSSEEEEEEESSS--EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEE
T ss_pred CccceeeeeEecCCCCeEEEEEEEcC--ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEE
Confidence 34678899999999999999998643 59999987543 33446789999999999999999999965 556789999
Q ss_pred EecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCccc-C
Q 004400 492 EYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEE-N 570 (756)
Q Consensus 492 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~~-~ 570 (756)
||+++++|.+++......+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++..... .
T Consensus 99 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 175 (289)
T 3og7_A 99 QWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKS---IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSG 175 (289)
T ss_dssp ECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEEEECCCC----------
T ss_pred EecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCC---cccccCccceEEECCCCCEEEccceeccccccccc
Confidence 999999999999877778999999999999999999999997 999999999999999999999999999865432 2
Q ss_pred cceeeccccCccCCchHhhh---cCCCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhcCccccccccCCC
Q 004400 571 THISTRVAGTIGYMAPEYAM---RGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPG 647 (756)
Q Consensus 571 ~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 647 (756)
........||+.|+|||.+. ...++.++||||||+++|||++|+.||.......... .............. ..
T Consensus 176 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~---~~~~~~~~~~~~~~-~~ 251 (289)
T 3og7_A 176 SHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQII---EMVGRGSLSPDLSK-VR 251 (289)
T ss_dssp --------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHH---HHHHHTSCCCCTTS-SC
T ss_pred cccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHH---HHhcccccCcchhh-cc
Confidence 22234467999999999986 5678899999999999999999999996544322211 11111111111110 11
Q ss_pred CCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhccCc
Q 004400 648 SNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLECGV 687 (756)
Q Consensus 648 ~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~L~~~~ 687 (756)
..+ +..+.+++.+||+.+|++||++.++++.|+++.
T Consensus 252 ~~~----~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~ 287 (289)
T 3og7_A 252 SNC----PKRMKRLMAECLKKKRDERPSFPRILAEIEELA 287 (289)
T ss_dssp TTS----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred ccC----CHHHHHHHHHHccCChhhCCCHHHHHHHHHHHh
Confidence 122 345889999999999999999999999999764
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-41 Score=359.01 Aligned_cols=259 Identities=27% Similarity=0.427 Sum_probs=211.5
Q ss_pred hhcCccccCcccCCCCccEEEeec------cCCcEEEEEEccccCc-ccHHHHHHHHHHHHhC-CCCceeeEeeEEEeCC
Q 004400 414 ATNNFATDNNIGEGGFGPVYKGLL------ADGTAIAVKQLSSKSK-QGNREFINEIGMISAL-QHPNLVKLYGCCIEGN 485 (756)
Q Consensus 414 ~~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~ 485 (756)
..++|...+.||+|+||.||+|+. .+++.||||.+..... ...+.+.+|+.+++++ +||||+++++++.+++
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~ 100 (313)
T 1t46_A 21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGG 100 (313)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred ChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCC
Confidence 346888999999999999999974 3567899999975432 3456789999999999 9999999999999999
Q ss_pred eEEEEEEecCCCCHHHHHHhcCC-----------------CCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceE
Q 004400 486 QLLLIYEYLENNSLARALFEHRL-----------------KLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVL 548 (756)
Q Consensus 486 ~~~lV~e~~~~gsL~~~l~~~~~-----------------~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nil 548 (756)
..++||||+++|+|.+++..... .+++..+..++.|++.||+|||+.+ |+||||||+||+
T Consensus 101 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil 177 (313)
T 1t46_A 101 PTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNIL 177 (313)
T ss_dssp SCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEE
T ss_pred CcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEE
Confidence 99999999999999999986542 4899999999999999999999996 999999999999
Q ss_pred ecCCCCEEEccCCccccCcccCcc-eeeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHh-CCCCCCccchhhHH
Q 004400 549 LDKDLNSKISDFGLAKLDEEENTH-ISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVS-GRSNVTKEDMFYLL 626 (756)
Q Consensus 549 l~~~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~ 626 (756)
++.++.+||+|||+++........ ......||+.|+|||.+.+..++.++||||||+++|||++ |+.||.........
T Consensus 178 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~ 257 (313)
T 1t46_A 178 LTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKF 257 (313)
T ss_dssp EETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHH
T ss_pred EcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchhHH
Confidence 999999999999999876544332 2334567889999999999999999999999999999999 99999655432211
Q ss_pred HHHHHHHhcCccccccccCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhccCc
Q 004400 627 DWALVLKEQGKLMELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLECGV 687 (756)
Q Consensus 627 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~L~~~~ 687 (756)
. ... ..... .......+ ..+.+++.+||+.||.+|||+.|+++.|++..
T Consensus 258 ~--~~~-~~~~~-----~~~~~~~~----~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~ 306 (313)
T 1t46_A 258 Y--KMI-KEGFR-----MLSPEHAP----AEMYDIMKTCWDADPLKRPTFKQIVQLIEKQI 306 (313)
T ss_dssp H--HHH-HHTCC-----CCCCTTSC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred H--HHh-ccCCC-----CCCcccCC----HHHHHHHHHHcCCCchhCcCHHHHHHHHHHHH
Confidence 1 111 11111 01111222 34889999999999999999999999998653
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-41 Score=358.90 Aligned_cols=258 Identities=26% Similarity=0.461 Sum_probs=204.6
Q ss_pred hcCccccCcccCCCCccEEEeeccC-----CcEEEEEEccccC-cccHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEE
Q 004400 415 TNNFATDNNIGEGGFGPVYKGLLAD-----GTAIAVKQLSSKS-KQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLL 488 (756)
Q Consensus 415 ~~~~~~~~~lg~G~~g~Vy~~~~~~-----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 488 (756)
.++|...+.||+|+||.||+|.... +..||||.+.... ......+.+|+.++++++||||+++++++.+.+..+
T Consensus 43 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 122 (333)
T 1mqb_A 43 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMM 122 (333)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred hHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcE
Confidence 3577888999999999999998542 2359999997542 334457899999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCcc
Q 004400 489 LIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEE 568 (756)
Q Consensus 489 lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~ 568 (756)
+||||+++|+|.+++......+++..+..++.|++.||+|||+.| |+||||||+||+++.++.+||+|||+++....
T Consensus 123 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~ 199 (333)
T 1mqb_A 123 IITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLED 199 (333)
T ss_dssp EEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC------
T ss_pred EEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChheEEECCCCcEEECCCCcchhhcc
Confidence 999999999999999877678999999999999999999999997 99999999999999999999999999987654
Q ss_pred cCcc--eeeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHh-CCCCCCccchhhHHHHHHHHHhcCccccccccC
Q 004400 569 ENTH--ISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVS-GRSNVTKEDMFYLLDWALVLKEQGKLMELVDTN 645 (756)
Q Consensus 569 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 645 (756)
.... ......+|+.|+|||.+.+..++.++|||||||++|||++ |+.||........... ... +....
T Consensus 200 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~---~~~-~~~~~----- 270 (333)
T 1mqb_A 200 DPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKA---IND-GFRLP----- 270 (333)
T ss_dssp -----------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHH---HHT-TCCCC-----
T ss_pred ccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHH---HHC-CCcCC-----
Confidence 3221 1223456889999999999999999999999999999999 9999966554333221 111 11110
Q ss_pred CCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhccCcc
Q 004400 646 PGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLECGVD 688 (756)
Q Consensus 646 ~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~L~~~~~ 688 (756)
..... ...+.+++.+||+.+|++||++.++++.|+++..
T Consensus 271 ~~~~~----~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~ 309 (333)
T 1mqb_A 271 TPMDC----PSAIYQLMMQCWQQERARRPKFADIVSILDKLIR 309 (333)
T ss_dssp CCTTC----BHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred CcccC----CHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 11122 2348899999999999999999999999987654
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-40 Score=347.93 Aligned_cols=263 Identities=24% Similarity=0.312 Sum_probs=202.9
Q ss_pred hhcCccccCcccCCCCccEEEeec-cCCcEEEEEEccccC-----cccHHHHHHHHHHHHhCC---CCceeeEeeEEEeC
Q 004400 414 ATNNFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSKS-----KQGNREFINEIGMISALQ---HPNLVKLYGCCIEG 484 (756)
Q Consensus 414 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~ 484 (756)
.+++|+..+.||+|+||+||+|+. .+++.||||++.... ......+.+|++++++++ ||||++++++|...
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~ 86 (308)
T 3g33_A 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS 86 (308)
T ss_dssp ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence 467899999999999999999994 678999999986432 112356777888777764 99999999999876
Q ss_pred C-----eEEEEEEecCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEc
Q 004400 485 N-----QLLLIYEYLENNSLARALFEHR-LKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKIS 558 (756)
Q Consensus 485 ~-----~~~lV~e~~~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~ 558 (756)
. ..++||||+. |+|.+++.... ..+++..+..++.|++.||+|||+++ |+||||||+||+++.++.+||+
T Consensus 87 ~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl~ 162 (308)
T 3g33_A 87 RTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLA 162 (308)
T ss_dssp CSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCTTTEEECTTSCEEEC
T ss_pred CCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEEe
Confidence 5 5899999997 59999997543 34999999999999999999999997 9999999999999999999999
Q ss_pred cCCccccCcccCcceeeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhcCcc
Q 004400 559 DFGLAKLDEEENTHISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKL 638 (756)
Q Consensus 559 DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 638 (756)
|||+++....... .....||+.|+|||++.+..++.++|||||||++|||++|+.||.....................
T Consensus 163 Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~ 240 (308)
T 3g33_A 163 DFGLARIYSYQMA--LTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPE 240 (308)
T ss_dssp SCSCTTTSTTCCC--SGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCCT
T ss_pred eCccccccCCCcc--cCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCh
Confidence 9999986543322 24467999999999999999999999999999999999999999776655443332222111110
Q ss_pred ccccc------cCC--CCCC-----CHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004400 639 MELVD------TNP--GSNF-----DKEQVMVMINVALLCANASPTIRPSMSSVLRM 682 (756)
Q Consensus 639 ~~~~~------~~~--~~~~-----~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~ 682 (756)
..... ... .... .++....+.+++.+|++.||++|||+.|+++.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 297 (308)
T 3g33_A 241 DDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQH 297 (308)
T ss_dssp TTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred hhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcC
Confidence 00000 000 0000 01123458899999999999999999999863
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-41 Score=359.91 Aligned_cols=257 Identities=26% Similarity=0.436 Sum_probs=203.1
Q ss_pred hcCccccCcccCCCCccEEEeec-cCCcE----EEEEEcccc-CcccHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEE
Q 004400 415 TNNFATDNNIGEGGFGPVYKGLL-ADGTA----IAVKQLSSK-SKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLL 488 (756)
Q Consensus 415 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~----vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 488 (756)
.++|+..+.||+|+||.||+|+. .+++. ||+|.+... .....+.+.+|+.++++++||||++++++|.++. .+
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~ 92 (327)
T 3lzb_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ 92 (327)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EE
T ss_pred HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ce
Confidence 46789999999999999999994 45554 577776543 3445678999999999999999999999998765 78
Q ss_pred EEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCcc
Q 004400 489 LIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEE 568 (756)
Q Consensus 489 lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~ 568 (756)
+|+||+.+|+|.+++......+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 93 ~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~~ 169 (327)
T 3lzb_A 93 LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 169 (327)
T ss_dssp EEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTC------
T ss_pred EEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCC---CcCCCCCHHHEEEcCCCCEEEccCcceeEccC
Confidence 999999999999999887778999999999999999999999997 99999999999999999999999999987644
Q ss_pred cCcc-eeeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHh-CCCCCCccchhhHHHHHHHHHhcCccccccccCC
Q 004400 569 ENTH-ISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVS-GRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNP 646 (756)
Q Consensus 569 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 646 (756)
.... ......||+.|+|||.+.+..++.++|||||||++|||++ |+.||............ ....... .
T Consensus 170 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~----~~~~~~~-----~ 240 (327)
T 3lzb_A 170 EEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL----EKGERLP-----Q 240 (327)
T ss_dssp ----------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHH----HTTCCCC-----C
T ss_pred ccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHH----HcCCCCC-----C
Confidence 3222 2233457889999999999999999999999999999999 99999765544332211 1111111 1
Q ss_pred CCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhccCcc
Q 004400 647 GSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLECGVD 688 (756)
Q Consensus 647 ~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~L~~~~~ 688 (756)
...+ ...+.+++.+||+.||.+||++.|+++.|+.+..
T Consensus 241 ~~~~----~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 278 (327)
T 3lzb_A 241 PPIC----TIDVYMIMRKCWMIDADSRPKFRELIIEFSKMAR 278 (327)
T ss_dssp CTTB----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHT
T ss_pred CccC----CHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 1112 2348899999999999999999999999997654
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-41 Score=361.28 Aligned_cols=248 Identities=28% Similarity=0.463 Sum_probs=204.0
Q ss_pred hcCccccCcccCCCCccEEEee-ccCCcEEEEEEccccCc---ccHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEE
Q 004400 415 TNNFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSKSK---QGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLI 490 (756)
Q Consensus 415 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 490 (756)
.+.|...+.||+|+||.||+|+ ..+++.||||++..... ...+.+.+|++++++++||||+++++++.+++..++|
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 132 (348)
T 1u5q_A 53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV 132 (348)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEE
Confidence 3468888999999999999999 46899999999865422 2335788999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCcccC
Q 004400 491 YEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEEN 570 (756)
Q Consensus 491 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~~~ 570 (756)
|||+. |+|.+.+......+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 133 ~e~~~-g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~- 207 (348)
T 1u5q_A 133 MEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA- 207 (348)
T ss_dssp EECCS-EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB-
T ss_pred EecCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEeeccCceecCCC-
Confidence 99998 6888888766678999999999999999999999997 999999999999999999999999999865432
Q ss_pred cceeeccccCccCCchHhhh---cCCCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhcCccccccccCCC
Q 004400 571 THISTRVAGTIGYMAPEYAM---RGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPG 647 (756)
Q Consensus 571 ~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 647 (756)
....||+.|+|||++. ...++.++|||||||++|||++|+.||...+...... ...... .... ..
T Consensus 208 ----~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~---~~~~~~-~~~~----~~ 275 (348)
T 1u5q_A 208 ----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY---HIAQNE-SPAL----QS 275 (348)
T ss_dssp ----CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH---HHHHSC-CCCC----CC
T ss_pred ----CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHH---HHHhcC-CCCC----CC
Confidence 2357999999999985 4678999999999999999999999997655433221 111111 1111 11
Q ss_pred CCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHh
Q 004400 648 SNFDKEQVMVMINVALLCANASPTIRPSMSSVLRML 683 (756)
Q Consensus 648 ~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~L 683 (756)
..++ ..+.+++.+||+.||++|||+.++++..
T Consensus 276 ~~~~----~~l~~li~~~l~~dP~~Rps~~~ll~h~ 307 (348)
T 1u5q_A 276 GHWS----EYFRNFVDSCLQKIPQDRPTSEVLLKHR 307 (348)
T ss_dssp TTSC----HHHHHHHHHHTCSSGGGSCCHHHHTTCH
T ss_pred CCCC----HHHHHHHHHHcccChhhCcCHHHHhhCh
Confidence 1223 3488999999999999999999998653
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=355.54 Aligned_cols=249 Identities=25% Similarity=0.336 Sum_probs=196.7
Q ss_pred hcCccccCcccCCCCccEEEeec----cCCcEEEEEEccccC----cccHHHHHHHHHHHHhCCCCceeeEeeEEEeCCe
Q 004400 415 TNNFATDNNIGEGGFGPVYKGLL----ADGTAIAVKQLSSKS----KQGNREFINEIGMISALQHPNLVKLYGCCIEGNQ 486 (756)
Q Consensus 415 ~~~~~~~~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 486 (756)
.++|+..+.||+|+||.||+|+. .+++.||+|+++... ......+.+|+.+++.++||||+++++++.+++.
T Consensus 16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 95 (327)
T 3a62_A 16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK 95 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence 45789999999999999999985 478999999997642 2234567889999999999999999999999999
Q ss_pred EEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccC
Q 004400 487 LLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLD 566 (756)
Q Consensus 487 ~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~ 566 (756)
.++||||+++|+|.+++... ..+++..+..++.||+.||+|||++| |+||||||+|||++.++.+||+|||+++..
T Consensus 96 ~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~ 171 (327)
T 3a62_A 96 LYLILEYLSGGELFMQLERE-GIFMEDTACFYLAEISMALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCKES 171 (327)
T ss_dssp EEEEEECCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTSCEEECCCSCC---
T ss_pred EEEEEeCCCCCcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCC---EEcccCCHHHeEECCCCcEEEEeCCccccc
Confidence 99999999999999999754 36899999999999999999999997 999999999999999999999999999754
Q ss_pred cccCcceeeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhcCccccccccCC
Q 004400 567 EEENTHISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNP 646 (756)
Q Consensus 567 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 646 (756)
..... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...+........ ..... ..
T Consensus 172 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i--~~~~~--------~~ 240 (327)
T 3a62_A 172 IHDGT-VTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKI--LKCKL--------NL 240 (327)
T ss_dssp --------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH--HHTCC--------CC
T ss_pred ccCCc-cccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHH--HhCCC--------CC
Confidence 33222 233467999999999999999999999999999999999999999776544332211 11110 01
Q ss_pred CCCCCHHHHHHHHHHHHHhhcCCCCCCC-----CHHHHHHH
Q 004400 647 GSNFDKEQVMVMINVALLCANASPTIRP-----SMSSVLRM 682 (756)
Q Consensus 647 ~~~~~~~~~~~l~~l~~~c~~~~P~~RP-----t~~ev~~~ 682 (756)
...++ ..+.+++.+||+.||++|| ++.|+++.
T Consensus 241 p~~~~----~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~h 277 (327)
T 3a62_A 241 PPYLT----QEARDLLKKLLKRNAASRLGAGPGDAGEVQAH 277 (327)
T ss_dssp CTTSC----HHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHS
T ss_pred CCCCC----HHHHHHHHHHHhcCHhhccCCCCCCHHHHHcC
Confidence 11222 3488999999999999999 77787663
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=361.47 Aligned_cols=267 Identities=27% Similarity=0.403 Sum_probs=205.3
Q ss_pred CccccCcccCCCCccEEEeec-----cCCcEEEEEEccccC-cccHHHHHHHHHHHHhCCCCceeeEeeEEEeC--CeEE
Q 004400 417 NFATDNNIGEGGFGPVYKGLL-----ADGTAIAVKQLSSKS-KQGNREFINEIGMISALQHPNLVKLYGCCIEG--NQLL 488 (756)
Q Consensus 417 ~~~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~ 488 (756)
.|...+.||+|+||.||+|.+ .+++.||||++.... ....+.+.+|++++++++||||+++++++.+. ...+
T Consensus 32 ~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 111 (318)
T 3lxp_A 32 YLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQ 111 (318)
T ss_dssp GEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEE
T ss_pred HHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEE
Confidence 347889999999999988753 368899999997643 23456789999999999999999999999884 6789
Q ss_pred EEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCcc
Q 004400 489 LIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEE 568 (756)
Q Consensus 489 lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~ 568 (756)
+||||+++|+|.+++... .+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++....
T Consensus 112 lv~e~~~~~~L~~~l~~~--~~~~~~~~~i~~~l~~~l~~LH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~ 186 (318)
T 3lxp_A 112 LVMEYVPLGSLRDYLPRH--SIGLAQLLLFAQQICEGMAYLHAQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPE 186 (318)
T ss_dssp EEECCCTTCBHHHHGGGS--CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEECCT
T ss_pred EEEecccCCcHHHHHhhC--CCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEEcCCCCEEECCccccccccc
Confidence 999999999999998654 4899999999999999999999997 99999999999999999999999999987654
Q ss_pred cCcc--eeeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHhCCCCCCccchhhH--HHHHHHHHhcCcccccccc
Q 004400 569 ENTH--ISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYL--LDWALVLKEQGKLMELVDT 644 (756)
Q Consensus 569 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~ 644 (756)
.... ......||..|+|||++.+..++.++||||||+++|||++|+.||........ ..+...........+.+..
T Consensus 187 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (318)
T 3lxp_A 187 GHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLER 266 (318)
T ss_dssp TCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHHHHT
T ss_pred cccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHHHhc
Confidence 3322 23345688899999999998999999999999999999999999854322110 0000000000000111111
Q ss_pred CCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhccCcc
Q 004400 645 NPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLECGVD 688 (756)
Q Consensus 645 ~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~L~~~~~ 688 (756)
......+......+.+++.+||+.||++|||+.|+++.|+++.+
T Consensus 267 ~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~ 310 (318)
T 3lxp_A 267 GERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHE 310 (318)
T ss_dssp TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHH
Confidence 11111112223458999999999999999999999999986543
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-40 Score=356.80 Aligned_cols=252 Identities=22% Similarity=0.285 Sum_probs=194.1
Q ss_pred hcCccccCcccCCCCccEEEeec-cCCcEEEEEEccccCcccHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEEe
Q 004400 415 TNNFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYEY 493 (756)
Q Consensus 415 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 493 (756)
.++|...+.||+|+||.||+|+. .+++.||||++.... ...+.+.+|+.+++.++||||+++++++.+++..++||||
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 97 (361)
T 3uc3_A 19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGA-AIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEY 97 (361)
T ss_dssp TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESST-TSCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCc-cccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEe
Confidence 46889999999999999999995 478999999996543 3346788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCC--EEEccCCccccCcccCc
Q 004400 494 LENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLN--SKISDFGLAKLDEEENT 571 (756)
Q Consensus 494 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~--~kl~DFGla~~~~~~~~ 571 (756)
+++|+|.+++.... .+++..+..++.|++.||+|||++| |+||||||+||+++.++. +||+|||+++......
T Consensus 98 ~~~~~L~~~l~~~~-~~~~~~~~~i~~ql~~~L~~LH~~~---ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~~- 172 (361)
T 3uc3_A 98 ASGGELYERICNAG-RFSEDEARFFFQQLLSGVSYCHSMQ---ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS- 172 (361)
T ss_dssp CCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTT---CCSCCCCGGGEEECSSSSCCEEECCCCCC--------
T ss_pred CCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCceEEEeecCccccccccC-
Confidence 99999999997543 6999999999999999999999997 999999999999987765 9999999997433222
Q ss_pred ceeeccccCccCCchHhhhcCCCCcc-cchhhHHHHHHHHHhCCCCCCccchhhH-HHHHHHHHhcCccccccccCCCCC
Q 004400 572 HISTRVAGTIGYMAPEYAMRGHLTEK-ADVYSFGIVALEIVSGRSNVTKEDMFYL-LDWALVLKEQGKLMELVDTNPGSN 649 (756)
Q Consensus 572 ~~~~~~~gt~~y~aPE~~~~~~~~~~-~Dv~slGv~l~elltg~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~ 649 (756)
......||+.|+|||++.+..++.+ +|||||||++|||++|+.||........ ........... . ... ....
T Consensus 173 -~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~-~-~~~---~~~~ 246 (361)
T 3uc3_A 173 -QPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVK-Y-SIP---DDIR 246 (361)
T ss_dssp ---------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTC-C-CCC---TTSC
T ss_pred -CCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCC-C-CCC---CcCC
Confidence 1234579999999999988887665 8999999999999999999965433211 11111111111 0 000 1112
Q ss_pred CCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004400 650 FDKEQVMVMINVALLCANASPTIRPSMSSVLRM 682 (756)
Q Consensus 650 ~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~ 682 (756)
.+ ..+.+++.+||+.||++|||+.|+++.
T Consensus 247 ~s----~~~~~li~~~L~~dP~~Rps~~ell~h 275 (361)
T 3uc3_A 247 IS----PECCHLISRIFVADPATRISIPEIKTH 275 (361)
T ss_dssp CC----HHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred CC----HHHHHHHHHHccCChhHCcCHHHHHhC
Confidence 23 348899999999999999999999864
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-41 Score=360.39 Aligned_cols=252 Identities=23% Similarity=0.330 Sum_probs=190.2
Q ss_pred hhcCccccCcccCCCCccEEEeecc-CCcEEEEEEccccCcccHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEE
Q 004400 414 ATNNFATDNNIGEGGFGPVYKGLLA-DGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYE 492 (756)
Q Consensus 414 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 492 (756)
..++|...+.||+|+||.||+|+.. +++.||||++.... ..+.+.+|++++++++||||++++++|.+++..++|||
T Consensus 51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 128 (349)
T 2w4o_A 51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLE 128 (349)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEE
Confidence 4567999999999999999999954 68899999997542 34678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecC---CCCEEEccCCccccCccc
Q 004400 493 YLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDK---DLNSKISDFGLAKLDEEE 569 (756)
Q Consensus 493 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~---~~~~kl~DFGla~~~~~~ 569 (756)
|+++|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+||+++. ++.+||+|||+++.....
T Consensus 129 ~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~ 204 (349)
T 2w4o_A 129 LVTGGELFDRIVEK-GYYSERDAADAVKQILEAVAYLHENG---IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQ 204 (349)
T ss_dssp CCCSCBHHHHHTTC-SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESSSSTTCCEEECCCC--------
T ss_pred eCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCcccEEEecCCCCCCEEEccCccccccCcc
Confidence 99999999999654 46899999999999999999999997 999999999999975 889999999999865432
Q ss_pred CcceeeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhcCccccccccCCCCC
Q 004400 570 NTHISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSN 649 (756)
Q Consensus 570 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 649 (756)
. ......||+.|+|||++.+..++.++|||||||++|||++|+.||......... +.. ... ... ... ......
T Consensus 205 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~-~~~-i~~-~~~-~~~-~~~~~~ 277 (349)
T 2w4o_A 205 V--LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFM-FRR-ILN-CEY-YFI-SPWWDE 277 (349)
T ss_dssp ----------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHH-HHH-HHT-TCC-CCC-TTTTTT
T ss_pred c--ccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHH-HHH-HHh-CCC-ccC-Cchhhh
Confidence 2 223467999999999999989999999999999999999999999655432211 111 111 111 000 001112
Q ss_pred CCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004400 650 FDKEQVMVMINVALLCANASPTIRPSMSSVLRM 682 (756)
Q Consensus 650 ~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~ 682 (756)
. ...+.+++.+|++.||++|||+.|+++.
T Consensus 278 ~----~~~~~~li~~~L~~dP~~Rpt~~e~l~h 306 (349)
T 2w4o_A 278 V----SLNAKDLVRKLIVLDPKKRLTTFQALQH 306 (349)
T ss_dssp S----CHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred C----CHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 2 2348899999999999999999999874
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-41 Score=350.58 Aligned_cols=254 Identities=26% Similarity=0.414 Sum_probs=208.1
Q ss_pred cCccccC-cccCCCCccEEEeecc---CCcEEEEEEccccC-cccHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEE
Q 004400 416 NNFATDN-NIGEGGFGPVYKGLLA---DGTAIAVKQLSSKS-KQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLI 490 (756)
Q Consensus 416 ~~~~~~~-~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 490 (756)
++|.... .||+|+||.||+|+.. ++..||||.+.... ....+.+.+|++++++++||||+++++++ +.+..++|
T Consensus 9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv 87 (287)
T 1u59_A 9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLV 87 (287)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEE
T ss_pred HHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEE
Confidence 4555555 9999999999999843 57889999997643 33456789999999999999999999999 56679999
Q ss_pred EEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCcccC
Q 004400 491 YEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEEN 570 (756)
Q Consensus 491 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~~~ 570 (756)
|||+++++|.+++......+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++......
T Consensus 88 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~ 164 (287)
T 1u59_A 88 MEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALGADD 164 (287)
T ss_dssp EECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECTTCS
T ss_pred EEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCchheEEEcCCCCEEECcccceeeeccCc
Confidence 9999999999999876678999999999999999999999997 9999999999999999999999999998765433
Q ss_pred cce--eeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHh-CCCCCCccchhhHHHHHHHHHhcCccccccccCCC
Q 004400 571 THI--STRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVS-GRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPG 647 (756)
Q Consensus 571 ~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 647 (756)
... .....||+.|+|||++.+..++.++||||||+++|||++ |+.||............ ..+..... .
T Consensus 165 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i----~~~~~~~~-----~ 235 (287)
T 1u59_A 165 SYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFI----EQGKRMEC-----P 235 (287)
T ss_dssp CEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHH----HTTCCCCC-----C
T ss_pred ceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHH----hcCCcCCC-----C
Confidence 222 223457899999999998889999999999999999998 99999765544333211 11111111 1
Q ss_pred CCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhccC
Q 004400 648 SNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLECG 686 (756)
Q Consensus 648 ~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~L~~~ 686 (756)
..++ ..+.+++.+||+.+|++||++.++++.|+++
T Consensus 236 ~~~~----~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~ 270 (287)
T 1u59_A 236 PECP----PELYALMSDCWIYKWEDRPDFLTVEQRMRAC 270 (287)
T ss_dssp TTCC----HHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCcC----HHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 1223 3588999999999999999999999999865
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-41 Score=353.63 Aligned_cols=249 Identities=25% Similarity=0.396 Sum_probs=197.4
Q ss_pred hcCccccCcccCCCCccEEEee-ccCCcEEEEEEccccCc--------------------------ccHHHHHHHHHHHH
Q 004400 415 TNNFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSKSK--------------------------QGNREFINEIGMIS 467 (756)
Q Consensus 415 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~--------------------------~~~~~~~~E~~~l~ 467 (756)
.++|...+.||+|+||.||+|+ ..+++.||||++..... ...+.+.+|+++++
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 91 (298)
T 2zv2_A 12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK 91 (298)
T ss_dssp ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence 3678899999999999999998 45789999999865421 11246889999999
Q ss_pred hCCCCceeeEeeEEEe--CCeEEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCC
Q 004400 468 ALQHPNLVKLYGCCIE--GNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKAT 545 (756)
Q Consensus 468 ~l~h~niv~l~~~~~~--~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~ 545 (756)
+++||||+++++++.+ ++..++||||+++|+|.+++ ....+++..+..++.|++.||+|||+.+ |+||||||+
T Consensus 92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~ 166 (298)
T 2zv2_A 92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVP--TLKPLSEDQARFYFQDLIKGIEYLHYQK---IIHRDIKPS 166 (298)
T ss_dssp TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSS--CSSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGG
T ss_pred hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHH
Confidence 9999999999999987 57899999999999998764 2347999999999999999999999997 999999999
Q ss_pred ceEecCCCCEEEccCCccccCcccCcceeeccccCccCCchHhhhcCC---CCcccchhhHHHHHHHHHhCCCCCCccch
Q 004400 546 NVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPEYAMRGH---LTEKADVYSFGIVALEIVSGRSNVTKEDM 622 (756)
Q Consensus 546 Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~Dv~slGv~l~elltg~~p~~~~~~ 622 (756)
||+++.++.+||+|||+++....... ......||+.|+|||.+.+.. ++.++|||||||++|||++|+.||.....
T Consensus 167 Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 245 (298)
T 2zv2_A 167 NLLVGEDGHIKIADFGVSNEFKGSDA-LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERI 245 (298)
T ss_dssp GEEECTTSCEEECCCTTCEECSSSSC-EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred HEEECCCCCEEEecCCCccccccccc-cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccH
Confidence 99999999999999999986654332 233467999999999987654 47889999999999999999999976654
Q ss_pred hhHHHHHHHHHhcCccccccccCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 004400 623 FYLLDWALVLKEQGKLMELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLR 681 (756)
Q Consensus 623 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~ 681 (756)
..... ..... .. .. ......+ ..+.+++.+||+.||++||++.|+++
T Consensus 246 ~~~~~---~~~~~-~~-~~---~~~~~~~----~~l~~li~~~l~~dp~~R~s~~e~l~ 292 (298)
T 2zv2_A 246 MCLHS---KIKSQ-AL-EF---PDQPDIA----EDLKDLITRMLDKNPESRIVVPEIKL 292 (298)
T ss_dssp HHHHH---HHHHC-CC-CC---CSSSCCC----HHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred HHHHH---HHhcc-cC-CC---CCccccC----HHHHHHHHHHhhcChhhCCCHHHHhc
Confidence 33221 11111 11 11 0111233 34889999999999999999999865
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=345.38 Aligned_cols=250 Identities=22% Similarity=0.307 Sum_probs=205.2
Q ss_pred hcCccccCcccCCCCccEEEeec-cCCcEEEEEEccccCcccHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEEe
Q 004400 415 TNNFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYEY 493 (756)
Q Consensus 415 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 493 (756)
.++|...+.||+|+||.||+|.. .++..||+|++........+.+.+|++++++++||||+++++++.+++..++||||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 87 (277)
T 3f3z_A 8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMEL 87 (277)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEec
Confidence 45788999999999999999995 46789999999776556678899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEe---cCCCCEEEccCCccccCcccC
Q 004400 494 LENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLL---DKDLNSKISDFGLAKLDEEEN 570 (756)
Q Consensus 494 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill---~~~~~~kl~DFGla~~~~~~~ 570 (756)
+++++|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+||++ +.++.+||+|||++.......
T Consensus 88 ~~~~~L~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~~ 163 (277)
T 3f3z_A 88 CTGGELFERVVHK-RVFRESDAARIMKDVLSAVAYCHKLN---VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGK 163 (277)
T ss_dssp CCSCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTTS
T ss_pred cCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEecCCCCCcEEEEecccceeccCcc
Confidence 9999999998754 46899999999999999999999997 9999999999999 788899999999998655433
Q ss_pred cceeeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhcCccccccccCCCCCC
Q 004400 571 THISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNF 650 (756)
Q Consensus 571 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 650 (756)
. .....||+.|+|||.+.+ .++.++||||||+++|||++|+.||........... ... +... .... ....+
T Consensus 164 ~--~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~---~~~-~~~~-~~~~-~~~~~ 234 (277)
T 3f3z_A 164 M--MRTKVGTPYYVSPQVLEG-LYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLK---IRE-GTFT-FPEK-DWLNV 234 (277)
T ss_dssp C--BCCCCSCTTTCCHHHHTT-CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH---HHH-CCCC-CCHH-HHTTS
T ss_pred c--hhccCCCCCccChHHhcc-cCCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHH---HHh-CCCC-CCch-hhhcC
Confidence 2 234579999999998865 499999999999999999999999976554332221 111 1110 0000 00012
Q ss_pred CHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 004400 651 DKEQVMVMINVALLCANASPTIRPSMSSVLR 681 (756)
Q Consensus 651 ~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~ 681 (756)
...+.+++.+|++.||++||++.|+++
T Consensus 235 ----~~~~~~li~~~l~~dp~~R~s~~~~l~ 261 (277)
T 3f3z_A 235 ----SPQAESLIRRLLTKSPKQRITSLQALE 261 (277)
T ss_dssp ----CHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred ----CHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 235889999999999999999999865
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=357.14 Aligned_cols=258 Identities=27% Similarity=0.446 Sum_probs=210.4
Q ss_pred hcCccccCcccCCCCccEEEeec--------cCCcEEEEEEccccC-cccHHHHHHHHHHHHhC-CCCceeeEeeEEEeC
Q 004400 415 TNNFATDNNIGEGGFGPVYKGLL--------ADGTAIAVKQLSSKS-KQGNREFINEIGMISAL-QHPNLVKLYGCCIEG 484 (756)
Q Consensus 415 ~~~~~~~~~lg~G~~g~Vy~~~~--------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 484 (756)
.++|...+.||+|+||.||+|.. .++..||||++.... ....+.+.+|+++++++ +||||+++++++.++
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 113 (334)
T 2pvf_A 34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 113 (334)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccC
Confidence 46888999999999999999985 356789999997543 33456789999999999 899999999999999
Q ss_pred CeEEEEEEecCCCCHHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEe
Q 004400 485 NQLLLIYEYLENNSLARALFEHR---------------LKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLL 549 (756)
Q Consensus 485 ~~~~lV~e~~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill 549 (756)
+..++||||+++|+|.+++.... ..+++..+..++.||+.||+|||+.+ |+||||||+||++
T Consensus 114 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll 190 (334)
T 2pvf_A 114 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVLV 190 (334)
T ss_dssp SCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEE
T ss_pred CceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCccceEEE
Confidence 99999999999999999997543 24899999999999999999999997 9999999999999
Q ss_pred cCCCCEEEccCCccccCcccCcc-eeeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHh-CCCCCCccchhhHHH
Q 004400 550 DKDLNSKISDFGLAKLDEEENTH-ISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVS-GRSNVTKEDMFYLLD 627 (756)
Q Consensus 550 ~~~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~~ 627 (756)
+.++.+||+|||+++........ ......+|+.|+|||++.+..++.++||||||+++|||++ |+.||..........
T Consensus 191 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~ 270 (334)
T 2pvf_A 191 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFK 270 (334)
T ss_dssp CTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHH
T ss_pred cCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHHHHHH
Confidence 99999999999999866543322 2233467889999999999889999999999999999999 999997655433322
Q ss_pred HHHHHHhcCccccccccCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhccCcc
Q 004400 628 WALVLKEQGKLMELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLECGVD 688 (756)
Q Consensus 628 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~L~~~~~ 688 (756)
.. .. ..... ....++ ..+.+++.+||+.+|.+||++.|+++.|+.+..
T Consensus 271 ~~---~~-~~~~~-----~~~~~~----~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~ 318 (334)
T 2pvf_A 271 LL---KE-GHRMD-----KPANCT----NELYMMMRDCWHAVPSQRPTFKQLVEDLDRILT 318 (334)
T ss_dssp HH---HH-TCCCC-----CCTTCC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HH---hc-CCCCC-----CCccCC----HHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 11 11 11111 111223 348899999999999999999999999997654
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-41 Score=357.63 Aligned_cols=261 Identities=25% Similarity=0.439 Sum_probs=212.6
Q ss_pred HHhhcCccccCcccCCCCccEEEeecc------CCcEEEEEEccccC-cccHHHHHHHHHHHHhCCCCceeeEeeEEEeC
Q 004400 412 KAATNNFATDNNIGEGGFGPVYKGLLA------DGTAIAVKQLSSKS-KQGNREFINEIGMISALQHPNLVKLYGCCIEG 484 (756)
Q Consensus 412 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 484 (756)
....++|...+.||+|+||.||+|+.. +++.||||.+.... ......+.+|+.++++++||||+++++++.++
T Consensus 21 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 100 (322)
T 1p4o_A 21 EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQG 100 (322)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSS
T ss_pred cchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEccC
Confidence 345678999999999999999999854 47889999997543 23345789999999999999999999999999
Q ss_pred CeEEEEEEecCCCCHHHHHHhcC---------CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCE
Q 004400 485 NQLLLIYEYLENNSLARALFEHR---------LKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNS 555 (756)
Q Consensus 485 ~~~~lV~e~~~~gsL~~~l~~~~---------~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~ 555 (756)
+..++||||+++|+|.+++.... ..+++..+..++.|++.||+|||++| |+||||||+||+++.++.+
T Consensus 101 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~NIli~~~~~~ 177 (322)
T 1p4o_A 101 QPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTV 177 (322)
T ss_dssp SSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTTCCE
T ss_pred CccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---CccCCCccceEEEcCCCeE
Confidence 99999999999999999997432 45799999999999999999999997 9999999999999999999
Q ss_pred EEccCCccccCcccCcc-eeeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHh-CCCCCCccchhhHHHHHHHHH
Q 004400 556 KISDFGLAKLDEEENTH-ISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVS-GRSNVTKEDMFYLLDWALVLK 633 (756)
Q Consensus 556 kl~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~ 633 (756)
||+|||+++........ ......||+.|+|||++.+..++.++||||||+++|||++ |+.||............
T Consensus 178 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~---- 253 (322)
T 1p4o_A 178 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFV---- 253 (322)
T ss_dssp EECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHH----
T ss_pred EECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHHHHHHH----
Confidence 99999999865443222 2233467889999999999999999999999999999999 88998665543332211
Q ss_pred hcCccccccccCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhccCcc
Q 004400 634 EQGKLMELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLECGVD 688 (756)
Q Consensus 634 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~L~~~~~ 688 (756)
..+..... ....+ ..+.+++.+||+.||++||++.|+++.|++...
T Consensus 254 ~~~~~~~~-----~~~~~----~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~ 299 (322)
T 1p4o_A 254 MEGGLLDK-----PDNCP----DMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 299 (322)
T ss_dssp HTTCCCCC-----CTTCC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred HcCCcCCC-----CCCCC----HHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhc
Confidence 11111111 11223 348899999999999999999999999996544
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=356.32 Aligned_cols=247 Identities=23% Similarity=0.315 Sum_probs=198.8
Q ss_pred hcCccccCcccCCCCccEEEeec-cCCcEEEEEEccccC---cccHHHHHHHHHHHHhC-CCCceeeEeeEEEeCCeEEE
Q 004400 415 TNNFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSKS---KQGNREFINEIGMISAL-QHPNLVKLYGCCIEGNQLLL 489 (756)
Q Consensus 415 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l 489 (756)
.++|+..+.||+|+||.||+|+. .+++.||+|++.... ....+.+.+|..+++++ +||||+++++++.+++..++
T Consensus 8 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l 87 (345)
T 3a8x_A 8 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 87 (345)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEE
Confidence 35788999999999999999995 568999999997542 22345678899999988 89999999999999999999
Q ss_pred EEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCccc
Q 004400 490 IYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEE 569 (756)
Q Consensus 490 V~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~~ 569 (756)
||||+++|+|.+++... ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 88 v~e~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~ 163 (345)
T 3a8x_A 88 VIEYVNGGDLMFHMQRQ-RKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP 163 (345)
T ss_dssp EECCCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCGGGCBCSCCT
T ss_pred EEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEEeccccccccCC
Confidence 99999999999999754 37999999999999999999999997 999999999999999999999999999854322
Q ss_pred CcceeeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHhCCCCCCccchhh-----HHHHHHHHHhcCcccccccc
Q 004400 570 NTHISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFY-----LLDWALVLKEQGKLMELVDT 644 (756)
Q Consensus 570 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~ 644 (756)
. ......+||+.|+|||++.+..++.++|||||||++|||++|+.||....... .............. .
T Consensus 164 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~-~---- 237 (345)
T 3a8x_A 164 G-DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI-R---- 237 (345)
T ss_dssp T-CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCC-C----
T ss_pred C-CcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCC-C----
Confidence 2 22345689999999999999999999999999999999999999995421110 00111111111111 0
Q ss_pred CCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCH
Q 004400 645 NPGSNFDKEQVMVMINVALLCANASPTIRPSM 676 (756)
Q Consensus 645 ~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~ 676 (756)
....++ ..+.+++.+|++.||++||++
T Consensus 238 -~p~~~s----~~~~~li~~lL~~dP~~R~~~ 264 (345)
T 3a8x_A 238 -IPRSLS----VKAASVLKSFLNKDPKERLGC 264 (345)
T ss_dssp -CCTTSC----HHHHHHHHHHTCSSTTTSTTC
T ss_pred -CCCCCC----HHHHHHHHHHhcCCHhHCCCC
Confidence 111223 348899999999999999995
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-40 Score=345.34 Aligned_cols=252 Identities=22% Similarity=0.360 Sum_probs=206.5
Q ss_pred hcCccccCcccCCCCccEEEeec-cCCcEEEEEEccccC--cccHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEE
Q 004400 415 TNNFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSKS--KQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIY 491 (756)
Q Consensus 415 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 491 (756)
.++|...+.||+|+||.||+|.. .+++.||+|++.... ....+.+.+|+.++++++||||+++++++.+++..++||
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 84 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 84 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEE
Confidence 46899999999999999999984 568999999986542 233467889999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCC---EEEccCCccccCcc
Q 004400 492 EYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLN---SKISDFGLAKLDEE 568 (756)
Q Consensus 492 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~---~kl~DFGla~~~~~ 568 (756)
||+++|+|.+.+... ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++. +||+|||++.....
T Consensus 85 e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~ 160 (284)
T 3kk8_A 85 DLVTGGELFEDIVAR-EFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND 160 (284)
T ss_dssp CCCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSTTCCEEECCCTTCEECCS
T ss_pred ecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---cCcCCCCHHHEEEecCCCCCcEEEeeceeeEEccc
Confidence 999999999988755 46999999999999999999999997 999999999999987655 99999999976554
Q ss_pred cCcceeeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhcCccccccccCCCC
Q 004400 569 ENTHISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGS 648 (756)
Q Consensus 569 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 648 (756)
... .....||+.|+|||.+.+..++.++||||||+++|+|++|+.||...+........ .. +.. ..... ...
T Consensus 161 ~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~---~~-~~~-~~~~~-~~~ 232 (284)
T 3kk8_A 161 SEA--WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQI---KA-GAY-DYPSP-EWD 232 (284)
T ss_dssp SCB--CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH---HH-TCC-CCCTT-TTT
T ss_pred Ccc--ccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHH---Hh-ccc-cCCch-hhc
Confidence 322 23467999999999999999999999999999999999999999776554333211 11 111 00000 111
Q ss_pred CCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004400 649 NFDKEQVMVMINVALLCANASPTIRPSMSSVLRM 682 (756)
Q Consensus 649 ~~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~ 682 (756)
..+ ..+.+++.+|++.||++|||+.|+++.
T Consensus 233 ~~~----~~~~~li~~~l~~dp~~Rps~~~~l~h 262 (284)
T 3kk8_A 233 TVT----PEAKSLIDSMLTVNPKKRITADQALKV 262 (284)
T ss_dssp TSC----HHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred ccC----HHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 223 348899999999999999999999763
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-41 Score=360.29 Aligned_cols=252 Identities=22% Similarity=0.327 Sum_probs=197.0
Q ss_pred hhcCccccCcccCCCCccEEEeeccCCcEEEEEEccccC--cccHHHHHHHHHHHHhCCC--CceeeEeeEEEeCCeEEE
Q 004400 414 ATNNFATDNNIGEGGFGPVYKGLLADGTAIAVKQLSSKS--KQGNREFINEIGMISALQH--PNLVKLYGCCIEGNQLLL 489 (756)
Q Consensus 414 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~~~~l 489 (756)
..++|...+.||+|+||.||+|...+++.||||++.... ....+.+.+|+.++++++| |||+++++++.+++..++
T Consensus 7 ~~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~l 86 (343)
T 3dbq_A 7 KGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM 86 (343)
T ss_dssp SSCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred ecCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEE
Confidence 356789999999999999999998889999999986542 3334678999999999976 999999999999999999
Q ss_pred EEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCccc
Q 004400 490 IYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEE 569 (756)
Q Consensus 490 V~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~~ 569 (756)
||| +.+|+|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++ ++.+||+|||+++.....
T Consensus 87 v~e-~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~lH~~~---iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~ 160 (343)
T 3dbq_A 87 VME-CGNIDLNSWLKKK-KSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQPD 160 (343)
T ss_dssp EEC-CCSEEHHHHHHHS-CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEE-TTEEEECCCSSSCCC---
T ss_pred EEe-CCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEE-CCcEEEeecccccccCcc
Confidence 999 5688999999764 47999999999999999999999997 99999999999997 578999999999876543
Q ss_pred Ccc-eeeccccCccCCchHhhhc-----------CCCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhcCc
Q 004400 570 NTH-ISTRVAGTIGYMAPEYAMR-----------GHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGK 637 (756)
Q Consensus 570 ~~~-~~~~~~gt~~y~aPE~~~~-----------~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 637 (756)
... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||....... ..........
T Consensus 161 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~--~~~~~~~~~~- 237 (343)
T 3dbq_A 161 TTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI--SKLHAIIDPN- 237 (343)
T ss_dssp ---------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHH--HHHHHHHCTT-
T ss_pred cccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHH--HHHHHHhcCC-
Confidence 322 2345679999999999975 678999999999999999999999996432211 1111111111
Q ss_pred cccccccCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004400 638 LMELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRM 682 (756)
Q Consensus 638 ~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~ 682 (756)
....++......+.+++.+||+.||.+|||+.|+++.
T Consensus 238 --------~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~h 274 (343)
T 3dbq_A 238 --------HEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 274 (343)
T ss_dssp --------SCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred --------cccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhC
Confidence 1111111112348899999999999999999999865
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-41 Score=385.72 Aligned_cols=254 Identities=26% Similarity=0.400 Sum_probs=203.8
Q ss_pred CccccC-cccCCCCccEEEeecc---CCcEEEEEEccccC-cccHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEE
Q 004400 417 NFATDN-NIGEGGFGPVYKGLLA---DGTAIAVKQLSSKS-KQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIY 491 (756)
Q Consensus 417 ~~~~~~-~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 491 (756)
++...+ .||+|+||.||+|.+. ++..||||+++... ....+.|.+|++++++++|||||+++++|.+ +..++||
T Consensus 336 ~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~ 414 (613)
T 2ozo_A 336 NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVM 414 (613)
T ss_dssp SEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEE
T ss_pred ceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEE
Confidence 334444 7999999999999853 46679999997643 3356789999999999999999999999976 5689999
Q ss_pred EecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCcccCc
Q 004400 492 EYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENT 571 (756)
Q Consensus 492 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~~~~ 571 (756)
|||++|+|.+++......+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.......
T Consensus 415 E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~ 491 (613)
T 2ozo_A 415 EMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRNLAARNVLLVNRHYAKISDFGLSKALGADDS 491 (613)
T ss_dssp ECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCSTTTTCC----
T ss_pred EeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCc
Confidence 999999999999877778999999999999999999999996 99999999999999999999999999987654332
Q ss_pred ce--eeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHh-CCCCCCccchhhHHHHHHHHHhcCccccccccCCCC
Q 004400 572 HI--STRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVS-GRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGS 648 (756)
Q Consensus 572 ~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 648 (756)
.. .....+|+.|+|||++.+..++.++|||||||++|||++ |+.||...+........ ..+...... .
T Consensus 492 ~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i----~~~~~~~~p-----~ 562 (613)
T 2ozo_A 492 YYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFI----EQGKRMECP-----P 562 (613)
T ss_dssp ----------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHH----HTTCCCCCC-----T
T ss_pred eeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHH----HcCCCCCCC-----C
Confidence 22 122346789999999999999999999999999999998 99999766554433221 122211111 1
Q ss_pred CCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhccCc
Q 004400 649 NFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLECGV 687 (756)
Q Consensus 649 ~~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~L~~~~ 687 (756)
.++ ..+.+++.+||+.+|++||++.+|++.|+.+.
T Consensus 563 ~~~----~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~ 597 (613)
T 2ozo_A 563 ECP----PELYALMSDCWIYKWEDRPDFLTVEQRMRACY 597 (613)
T ss_dssp TCC----HHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHH
T ss_pred cCC----HHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 223 34889999999999999999999999998653
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-40 Score=349.67 Aligned_cols=259 Identities=21% Similarity=0.252 Sum_probs=201.1
Q ss_pred hcCccccCcccCCCCccEEEeec-cCCcEEEEEEccccCc---ccHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEE
Q 004400 415 TNNFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSKSK---QGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLI 490 (756)
Q Consensus 415 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 490 (756)
.++|...+.||+|+||.||+|+. .+++.||+|++..... ...+.+.+|+.++++++||||+++++++.+++..++|
T Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 112 (309)
T 2h34_A 33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVD 112 (309)
T ss_dssp -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEE
Confidence 46899999999999999999995 4789999999975432 2246788999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCcccC
Q 004400 491 YEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEEN 570 (756)
Q Consensus 491 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~~~ 570 (756)
|||+++++|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++.......
T Consensus 113 ~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~ 188 (309)
T 2h34_A 113 MRLINGVDLAAMLRRQ-GPLAPPRAVAIVRQIGSALDAAHAAG---ATHRDVKPENILVSADDFAYLVDFGIASATTDEK 188 (309)
T ss_dssp EECCCCEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSCCC--------
T ss_pred EEecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCc---CCcCCCChHHEEEcCCCCEEEecCccCccccccc
Confidence 9999999999999754 47999999999999999999999997 9999999999999999999999999998665544
Q ss_pred cceeeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhcCccccccccCCCCCC
Q 004400 571 THISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNF 650 (756)
Q Consensus 571 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 650 (756)
........||+.|+|||.+.+..++.++||||||+++|||++|+.||.......... ........... ....+
T Consensus 189 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~---~~~~~~~~~~~----~~~~~ 261 (309)
T 2h34_A 189 LTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSVMGA---HINQAIPRPST----VRPGI 261 (309)
T ss_dssp --------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHHHHHH---HHHSCCCCGGG----TSTTC
T ss_pred cccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHHHHHH---HhccCCCCccc----cCCCC
Confidence 333445679999999999998899999999999999999999999997654432111 11111111110 11122
Q ss_pred CHHHHHHHHHHHHHhhcCCCCCCC-CHHHHHHHhccCcc
Q 004400 651 DKEQVMVMINVALLCANASPTIRP-SMSSVLRMLECGVD 688 (756)
Q Consensus 651 ~~~~~~~l~~l~~~c~~~~P~~RP-t~~ev~~~L~~~~~ 688 (756)
+ ..+.+++.+||+.||++|| ++.++++.|++...
T Consensus 262 ~----~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~ 296 (309)
T 2h34_A 262 P----VAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALA 296 (309)
T ss_dssp C----THHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC
T ss_pred C----HHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHH
Confidence 2 2488999999999999999 99999999997654
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-40 Score=344.04 Aligned_cols=249 Identities=26% Similarity=0.357 Sum_probs=199.0
Q ss_pred cCccccCcccCCCCccEEEeec-cCCcEEEEEEccccC-cccHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEEe
Q 004400 416 NNFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSKS-KQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYEY 493 (756)
Q Consensus 416 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 493 (756)
++|...+.||+|+||.||+|.. .++..||+|++.... ....+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 101 (285)
T 3is5_A 22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMET 101 (285)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred hheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEEe
Confidence 5788899999999999999994 578999999987643 33457899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEe---cCCCCEEEccCCccccCc
Q 004400 494 LENNSLARALFE---HRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLL---DKDLNSKISDFGLAKLDE 567 (756)
Q Consensus 494 ~~~gsL~~~l~~---~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill---~~~~~~kl~DFGla~~~~ 567 (756)
+++|+|.+++.. ....+++..+..++.|++.||+|||+.+ |+||||||+||++ +.++.+||+|||+++...
T Consensus 102 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~ 178 (285)
T 3is5_A 102 CEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQH---VVHKDLKPENILFQDTSPHSPIKIIDFGLAELFK 178 (285)
T ss_dssp CSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEESSSSTTCCEEECCCCCCCC--
T ss_pred CCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCCCHHHEEEecCCCCCCEEEEeeecceecC
Confidence 999999999863 2467999999999999999999999997 9999999999999 456789999999998654
Q ss_pred ccCcceeeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhcCccccccccCCC
Q 004400 568 EENTHISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPG 647 (756)
Q Consensus 568 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 647 (756)
.... .....||+.|+|||++. +.++.++||||||+++|||++|+.||............. . ....... ..
T Consensus 179 ~~~~--~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~---~-~~~~~~~---~~ 248 (285)
T 3is5_A 179 SDEH--STNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKAT---Y-KEPNYAV---EC 248 (285)
T ss_dssp ----------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH---H-CCCCCCC-----
T ss_pred Cccc--CcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhc---c-CCccccc---cc
Confidence 4322 23457999999999875 578999999999999999999999997665433322111 1 1110000 01
Q ss_pred CCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 004400 648 SNFDKEQVMVMINVALLCANASPTIRPSMSSVLR 681 (756)
Q Consensus 648 ~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~ 681 (756)
...+ ..+.+++.+|++.||++|||+.|+++
T Consensus 249 ~~~~----~~~~~li~~~L~~dP~~Rps~~e~l~ 278 (285)
T 3is5_A 249 RPLT----PQAVDLLKQMLTKDPERRPSAAQVLH 278 (285)
T ss_dssp CCCC----HHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred CcCC----HHHHHHHHHHccCChhhCcCHHHHhc
Confidence 1122 34789999999999999999999986
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=356.17 Aligned_cols=250 Identities=21% Similarity=0.355 Sum_probs=197.3
Q ss_pred hcCccccCcccCCCCccEEEeecc-CCcEEEEEEccccC-cccHHHHHHHHHHHHhCCCCceeeEeeEEEeCC-------
Q 004400 415 TNNFATDNNIGEGGFGPVYKGLLA-DGTAIAVKQLSSKS-KQGNREFINEIGMISALQHPNLVKLYGCCIEGN------- 485 (756)
Q Consensus 415 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------- 485 (756)
.++|+..+.||+|+||.||+|+.. +|+.||||++.... ....+.+.+|++++++++|||||+++++|.+..
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 84 (332)
T 3qd2_B 5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE 84 (332)
T ss_dssp HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence 457889999999999999999954 89999999986543 334577999999999999999999999987653
Q ss_pred --------------------------------------------------eEEEEEEecCCCCHHHHHHhcC--CCCCHH
Q 004400 486 --------------------------------------------------QLLLIYEYLENNSLARALFEHR--LKLDWP 513 (756)
Q Consensus 486 --------------------------------------------------~~~lV~e~~~~gsL~~~l~~~~--~~l~~~ 513 (756)
..++||||+++|+|.+++.... ...++.
T Consensus 85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~ 164 (332)
T 3qd2_B 85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHG 164 (332)
T ss_dssp HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHH
T ss_pred hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhH
Confidence 3899999999999999997543 235677
Q ss_pred HHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCcccCc-----------ceeeccccCcc
Q 004400 514 TRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENT-----------HISTRVAGTIG 582 (756)
Q Consensus 514 ~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~~~~-----------~~~~~~~gt~~ 582 (756)
.+..++.||+.||+|||++| |+||||||+||+++.++.+||+|||+++....... .......||+.
T Consensus 165 ~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 241 (332)
T 3qd2_B 165 VCLHIFIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKL 241 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGG
T ss_pred HHHHHHHHHHHHHHHHHhCC---eeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcC
Confidence 79999999999999999997 99999999999999999999999999987654321 12234579999
Q ss_pred CCchHhhhcCCCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhcCccccccccCCCCCCCHHHHHHHHHHH
Q 004400 583 YMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDKEQVMVMINVA 662 (756)
Q Consensus 583 y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~ 662 (756)
|+|||++.+..++.++|||||||++|||++|..|+.... .. .. ......... ........+.+++
T Consensus 242 y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~~--~~---~~-~~~~~~~~~---------~~~~~~~~~~~li 306 (332)
T 3qd2_B 242 YMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMERV--RI---IT-DVRNLKFPL---------LFTQKYPQEHMMV 306 (332)
T ss_dssp GSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHHH--HH---HH-HHHTTCCCH---------HHHHHCHHHHHHH
T ss_pred ccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHHH--HH---HH-HhhccCCCc---------ccccCChhHHHHH
Confidence 999999999999999999999999999999876642111 00 00 001111110 1122334578999
Q ss_pred HHhhcCCCCCCCCHHHHHHH
Q 004400 663 LLCANASPTIRPSMSSVLRM 682 (756)
Q Consensus 663 ~~c~~~~P~~RPt~~ev~~~ 682 (756)
.+||+.||++|||+.|+++.
T Consensus 307 ~~~l~~~p~~Rps~~~~l~~ 326 (332)
T 3qd2_B 307 QDMLSPSPTERPEATDIIEN 326 (332)
T ss_dssp HHHHCSSGGGSCCHHHHHHS
T ss_pred HHHccCCCCcCCCHHHHhhc
Confidence 99999999999999999874
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-41 Score=361.79 Aligned_cols=247 Identities=26% Similarity=0.348 Sum_probs=194.9
Q ss_pred hcCccccCcccCCCCccEEEeec-cCCcEEEEEEccccC---cccHHHHHHHHHH-HHhCCCCceeeEeeEEEeCCeEEE
Q 004400 415 TNNFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSKS---KQGNREFINEIGM-ISALQHPNLVKLYGCCIEGNQLLL 489 (756)
Q Consensus 415 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~-l~~l~h~niv~l~~~~~~~~~~~l 489 (756)
.++|+..+.||+|+||.||+|+. .+++.||||++.+.. ......+.+|..+ ++.++||||++++++|.+++..|+
T Consensus 37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~l 116 (373)
T 2r5t_A 37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYF 116 (373)
T ss_dssp GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEE
Confidence 35788999999999999999995 468899999997642 2233456677776 577899999999999999999999
Q ss_pred EEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCccc
Q 004400 490 IYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEE 569 (756)
Q Consensus 490 V~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~~ 569 (756)
||||+++|+|.+++... ..+++..+..++.||+.||+|||++| |+||||||+|||++.++.+||+|||+++.....
T Consensus 117 v~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~ 192 (373)
T 2r5t_A 117 VLDYINGGELFYHLQRE-RCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEH 192 (373)
T ss_dssp EEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCBCGGGBCC
T ss_pred EEeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEeeCccccccccC
Confidence 99999999999999754 37899999999999999999999997 999999999999999999999999999853322
Q ss_pred CcceeeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhcCccccccccCCCCC
Q 004400 570 NTHISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSN 649 (756)
Q Consensus 570 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 649 (756)
. ......+||+.|+|||++.+..++.++|||||||++|||++|+.||...+........ ... .. . ....
T Consensus 193 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i--~~~--~~-~-----~~~~ 261 (373)
T 2r5t_A 193 N-STTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNI--LNK--PL-Q-----LKPN 261 (373)
T ss_dssp C-CCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHH--HHS--CC-C-----CCSS
T ss_pred C-CccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHH--Hhc--cc-C-----CCCC
Confidence 2 2234568999999999999999999999999999999999999999776654433211 111 10 0 1112
Q ss_pred CCHHHHHHHHHHHHHhhcCCCCCCCCHHHHH
Q 004400 650 FDKEQVMVMINVALLCANASPTIRPSMSSVL 680 (756)
Q Consensus 650 ~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~ 680 (756)
++ ..+.+++.+|++.||++||++.+.+
T Consensus 262 ~~----~~~~~li~~lL~~dp~~R~~~~~~~ 288 (373)
T 2r5t_A 262 IT----NSARHLLEGLLQKDRTKRLGAKDDF 288 (373)
T ss_dssp SC----HHHHHHHHHHTCSSGGGSTTTTTTH
T ss_pred CC----HHHHHHHHHHcccCHHhCCCCCCCH
Confidence 23 3488999999999999999985433
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-40 Score=359.79 Aligned_cols=259 Identities=22% Similarity=0.387 Sum_probs=194.8
Q ss_pred hhcCccccCcccCCCCccEEEee-ccCCcEEEEEEcccc--CcccHHHHHHHHHHHHhCC-CCceeeEeeEEEeCC--eE
Q 004400 414 ATNNFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSK--SKQGNREFINEIGMISALQ-HPNLVKLYGCCIEGN--QL 487 (756)
Q Consensus 414 ~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~--~~ 487 (756)
..++|...+.||+|+||.||+|. ..+|+.||||++... .....+.+.+|+.+++.+. ||||+++++++..++ ..
T Consensus 7 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~ 86 (388)
T 3oz6_A 7 VLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDV 86 (388)
T ss_dssp HHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCE
T ss_pred ccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEE
Confidence 45689999999999999999998 567999999998653 2334567889999999997 999999999998654 78
Q ss_pred EEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCc
Q 004400 488 LLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDE 567 (756)
Q Consensus 488 ~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~ 567 (756)
|+|||||+ |+|.+++... .+++..+..++.|++.||+|||+.| |+||||||+|||++.++.+||+|||+|+...
T Consensus 87 ~lv~e~~~-~~L~~~~~~~--~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 160 (388)
T 3oz6_A 87 YLVFDYME-TDLHAVIRAN--ILEPVHKQYVVYQLIKVIKYLHSGG---LLHRDMKPSNILLNAECHVKVADFGLSRSFV 160 (388)
T ss_dssp EEEEECCS-EEHHHHHHHT--CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEESS
T ss_pred EEEecccC-cCHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHeEEcCCCCEEecCCccccccc
Confidence 99999998 5899988753 6899999999999999999999997 9999999999999999999999999998653
Q ss_pred cc--------------------CcceeeccccCccCCchHhhhc-CCCCcccchhhHHHHHHHHHhCCCCCCccchhhHH
Q 004400 568 EE--------------------NTHISTRVAGTIGYMAPEYAMR-GHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLL 626 (756)
Q Consensus 568 ~~--------------------~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~ 626 (756)
.. .....+..+||+.|+|||++.+ ..++.++||||+||++|||++|+.||.+.+.....
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~ 240 (388)
T 3oz6_A 161 NIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQL 240 (388)
T ss_dssp SCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH
T ss_pred ccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 21 1112334679999999999986 67999999999999999999999999776654433
Q ss_pred HHHHHHHhcCcccccc---------------------cc----------------CCCCCCCHHHHHHHHHHHHHhhcCC
Q 004400 627 DWALVLKEQGKLMELV---------------------DT----------------NPGSNFDKEQVMVMINVALLCANAS 669 (756)
Q Consensus 627 ~~~~~~~~~~~~~~~~---------------------~~----------------~~~~~~~~~~~~~l~~l~~~c~~~~ 669 (756)
..............+. .. .+.... ...+.+++.+||+.|
T Consensus 241 ~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~dll~~~L~~d 316 (388)
T 3oz6_A 241 ERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADC----NEEALDLLDKLLQFN 316 (388)
T ss_dssp HHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCC----CHHHHHHHHHHCCSS
T ss_pred HHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccC----CHHHHHHHHHhhccC
Confidence 2221111100000000 00 000112 234889999999999
Q ss_pred CCCCCCHHHHHHH
Q 004400 670 PTIRPSMSSVLRM 682 (756)
Q Consensus 670 P~~RPt~~ev~~~ 682 (756)
|++|||+.|+++.
T Consensus 317 P~~R~t~~e~l~H 329 (388)
T 3oz6_A 317 PNKRISANDALKH 329 (388)
T ss_dssp GGGSCCHHHHTTS
T ss_pred cccCCCHHHHhCC
Confidence 9999999999875
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-41 Score=347.42 Aligned_cols=253 Identities=21% Similarity=0.317 Sum_probs=205.2
Q ss_pred hcCccccCcccCCCCccEEEeeccCCcEEEEEEccccC--cccHHHHHHHHHHHHhCCCCceeeEeeEEEeC--CeEEEE
Q 004400 415 TNNFATDNNIGEGGFGPVYKGLLADGTAIAVKQLSSKS--KQGNREFINEIGMISALQHPNLVKLYGCCIEG--NQLLLI 490 (756)
Q Consensus 415 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lV 490 (756)
.++|...+.||+|+||.||+|+.. ++.||||++.... ....+.+.+|+.++++++||||+++++++.++ +..++|
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 87 (271)
T 3kmu_A 9 FKQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLI 87 (271)
T ss_dssp GGGCEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEE
T ss_pred HHHhHHHHHhcCCCcceEEEEEEC-CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEee
Confidence 357888999999999999999975 8899999987642 33446799999999999999999999999887 788999
Q ss_pred EEecCCCCHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCccc
Q 004400 491 YEYLENNSLARALFEHRL-KLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEE 569 (756)
Q Consensus 491 ~e~~~~gsL~~~l~~~~~-~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~~ 569 (756)
|||+++|+|.+++..... .+++..+..++.|++.||+|||+.+ ++|+||||||+||+++.++.++|+|||++.....
T Consensus 88 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~~- 165 (271)
T 3kmu_A 88 THWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLE-PLIPRHALNSRSVMIDEDMTARISMADVKFSFQS- 165 (271)
T ss_dssp EECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSS-SCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTSC-
T ss_pred ecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCC-CceecCCCccceEEEcCCcceeEEeccceeeecc-
Confidence 999999999999985543 5899999999999999999999873 3499999999999999999999999988764322
Q ss_pred CcceeeccccCccCCchHhhhcCCCCc---ccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhcCccccccccCC
Q 004400 570 NTHISTRVAGTIGYMAPEYAMRGHLTE---KADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNP 646 (756)
Q Consensus 570 ~~~~~~~~~gt~~y~aPE~~~~~~~~~---~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 646 (756)
....||+.|+|||.+.+..++. ++||||||+++|||++|+.||.......... .......... .
T Consensus 166 -----~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~---~~~~~~~~~~-----~ 232 (271)
T 3kmu_A 166 -----PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGM---KVALEGLRPT-----I 232 (271)
T ss_dssp -----TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHH---HHHHSCCCCC-----C
T ss_pred -----cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHH---HHHhcCCCCC-----C
Confidence 2346899999999998755444 8999999999999999999997655433221 1111111111 1
Q ss_pred CCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhccCc
Q 004400 647 GSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLECGV 687 (756)
Q Consensus 647 ~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~L~~~~ 687 (756)
...++ ..+.+++.+||+.||++|||+.|+++.|+.+.
T Consensus 233 ~~~~~----~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~ 269 (271)
T 3kmu_A 233 PPGIS----PHVSKLMKICMNEDPAKRPKFDMIVPILEKMQ 269 (271)
T ss_dssp CTTCC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred CCCCC----HHHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence 12223 34889999999999999999999999998653
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-41 Score=371.83 Aligned_cols=249 Identities=26% Similarity=0.322 Sum_probs=197.8
Q ss_pred hcCccccCcccCCCCccEEEee-ccCCcEEEEEEcccc---CcccHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEE
Q 004400 415 TNNFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSK---SKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLI 490 (756)
Q Consensus 415 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 490 (756)
.++|+..+.||+|+||.||+|. ..+|+.||||++... .......+.+|+.+++.++||||++++++|.+.+..++|
T Consensus 147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv 226 (446)
T 4ejn_A 147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFV 226 (446)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEE
T ss_pred hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEE
Confidence 4679999999999999999999 567899999998753 233345678899999999999999999999999999999
Q ss_pred EEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHc-CCCCCeEcCCCCCCceEecCCCCEEEccCCccccCccc
Q 004400 491 YEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHG-ESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEE 569 (756)
Q Consensus 491 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~-~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~~ 569 (756)
|||+++|+|.+++... ..+++..+..++.||+.||+|||+ .| |+||||||+|||++.++.+||+|||+++.....
T Consensus 227 ~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~g---iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 302 (446)
T 4ejn_A 227 MEYANGGELFFHLSRE-RVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKD 302 (446)
T ss_dssp ECCCSSCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHHTC---CCCCCCCGGGEEECSSSCEEECCCCCCCTTCC-
T ss_pred EeeCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCC---EEECCCCHHHEEECCCCCEEEccCCCceeccCC
Confidence 9999999999999754 479999999999999999999998 76 999999999999999999999999999854332
Q ss_pred CcceeeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhcCccccccccCCCCC
Q 004400 570 NTHISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSN 649 (756)
Q Consensus 570 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 649 (756)
.. .....+||+.|+|||++.+..++.++|||||||++|||++|+.||...+......... ..... ....
T Consensus 303 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~--~~~~~--------~p~~ 371 (446)
T 4ejn_A 303 GA-TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELIL--MEEIR--------FPRT 371 (446)
T ss_dssp -----CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH--HCCCC--------CCTT
T ss_pred Cc-ccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHH--hCCCC--------CCcc
Confidence 22 2344689999999999999999999999999999999999999997765544332211 11110 1112
Q ss_pred CCHHHHHHHHHHHHHhhcCCCCCCC-----CHHHHHHH
Q 004400 650 FDKEQVMVMINVALLCANASPTIRP-----SMSSVLRM 682 (756)
Q Consensus 650 ~~~~~~~~l~~l~~~c~~~~P~~RP-----t~~ev~~~ 682 (756)
.+ ..+.+++.+||+.||.+|| ++.|+++.
T Consensus 372 ~~----~~~~~li~~~L~~dP~~R~~~~~~t~~ell~h 405 (446)
T 4ejn_A 372 LG----PEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQH 405 (446)
T ss_dssp SC----HHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred CC----HHHHHHHHHHcccCHHHhCCCCCCCHHHHHhC
Confidence 23 3488999999999999999 99998763
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-40 Score=367.14 Aligned_cols=261 Identities=22% Similarity=0.277 Sum_probs=209.7
Q ss_pred hcCccccCcccCCCCccEEEee-ccCCcEEEEEEccccCcccHHHHHHHHHHHHhCCC-CceeeEeeEEEeCCeEEEEEE
Q 004400 415 TNNFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQGNREFINEIGMISALQH-PNLVKLYGCCIEGNQLLLIYE 492 (756)
Q Consensus 415 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~~~lV~e 492 (756)
.++|...+.||+|+||.||+|+ ..+++.||||++..... ...+.+|+++++.++| +++..+..++.+.+..++|||
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme 83 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMD 83 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS--SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc--cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEE
Confidence 4689999999999999999999 46799999998765433 2458899999999987 566667777788899999999
Q ss_pred ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEe---cCCCCEEEccCCccccCccc
Q 004400 493 YLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLL---DKDLNSKISDFGLAKLDEEE 569 (756)
Q Consensus 493 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill---~~~~~~kl~DFGla~~~~~~ 569 (756)
|+ +++|.+++......+++..++.++.||+.||+|||+++ ||||||||+|||+ +.++.+||+|||+++.....
T Consensus 84 ~~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~ 159 (483)
T 3sv0_A 84 LL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDT 159 (483)
T ss_dssp CC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCT
T ss_pred CC-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCcceEEEecCCCCCeEEEEeCCcceeccCC
Confidence 99 99999999876778999999999999999999999997 9999999999999 68899999999999876543
Q ss_pred Ccc------eeeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHhCCCCCCccchhh---HHHHHHHHHhcCcccc
Q 004400 570 NTH------ISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFY---LLDWALVLKEQGKLME 640 (756)
Q Consensus 570 ~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~---~~~~~~~~~~~~~~~~ 640 (756)
... ......||+.|+|||++.+..++.++|||||||++|||++|+.||....... ................
T Consensus 160 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~ 239 (483)
T 3sv0_A 160 STHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATSIEA 239 (483)
T ss_dssp TTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSCHHH
T ss_pred ccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccccccHHH
Confidence 322 1235679999999999999999999999999999999999999996543221 1111111111111111
Q ss_pred ccccCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhccCcccc
Q 004400 641 LVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLECGVDVL 690 (756)
Q Consensus 641 ~~~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~L~~~~~~~ 690 (756)
+.. .++ ..+.+++.+||+.+|++||++.+|+++|+.+....
T Consensus 240 l~~-----~~p----~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~~ 280 (483)
T 3sv0_A 240 LCR-----GYP----TEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIRE 280 (483)
T ss_dssp HHT-----TSC----HHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred Hhc-----CCc----HHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHHc
Confidence 111 122 34889999999999999999999999999775543
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-40 Score=346.48 Aligned_cols=261 Identities=21% Similarity=0.273 Sum_probs=207.6
Q ss_pred hcCccccCcccCCCCccEEEee-ccCCcEEEEEEccccCcccHHHHHHHHHHHHhCCCCceeeEeeEE-EeCCeEEEEEE
Q 004400 415 TNNFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCC-IEGNQLLLIYE 492 (756)
Q Consensus 415 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~-~~~~~~~lV~e 492 (756)
.++|...+.||+|+||.||+|+ ..+++.||||++..... ...+.+|+.+++.++|+++++.+.++ .+++..++|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e 85 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME 85 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS--CCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc--hhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEE
Confidence 4689999999999999999999 46899999999865433 34688999999999988876666655 66788899999
Q ss_pred ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEe---cCCCCEEEccCCccccCccc
Q 004400 493 YLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLL---DKDLNSKISDFGLAKLDEEE 569 (756)
Q Consensus 493 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill---~~~~~~kl~DFGla~~~~~~ 569 (756)
|+ +++|.+++......+++..+..++.|++.||+|||+++ |+||||||+||++ +.++.+||+|||+++.....
T Consensus 86 ~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~ 161 (296)
T 3uzp_A 86 LL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA 161 (296)
T ss_dssp CC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCT
T ss_pred ec-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHeEEecCCCCCeEEEeeCCCccccccc
Confidence 99 99999999866678999999999999999999999997 9999999999999 48889999999999866543
Q ss_pred Ccc------eeeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHhCCCCCCccchh---hHHHHHHHHHhcCcccc
Q 004400 570 NTH------ISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMF---YLLDWALVLKEQGKLME 640 (756)
Q Consensus 570 ~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~---~~~~~~~~~~~~~~~~~ 640 (756)
... ......||+.|+|||.+.+..++.++|||||||++|||++|+.||...... .................
T Consensus 162 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (296)
T 3uzp_A 162 RTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEV 241 (296)
T ss_dssp TTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHHH
T ss_pred ccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCchHH
Confidence 321 124467999999999999999999999999999999999999999653221 11111110000011000
Q ss_pred ccccCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhccCcccc
Q 004400 641 LVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLECGVDVL 690 (756)
Q Consensus 641 ~~~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~L~~~~~~~ 690 (756)
. ...++ ..+.+++.+||+.||++||++.+|++.|+.+....
T Consensus 242 ~-----~~~~~----~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~ 282 (296)
T 3uzp_A 242 L-----CKGYP----SEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQ 282 (296)
T ss_dssp H-----TTTSC----HHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHT
T ss_pred H-----HhhCC----HHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhc
Confidence 0 11223 34889999999999999999999999999765433
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-40 Score=362.04 Aligned_cols=262 Identities=20% Similarity=0.306 Sum_probs=204.5
Q ss_pred hhcCccccCcccCC--CCccEEEeec-cCCcEEEEEEccccC--cccHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEE
Q 004400 414 ATNNFATDNNIGEG--GFGPVYKGLL-ADGTAIAVKQLSSKS--KQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLL 488 (756)
Q Consensus 414 ~~~~~~~~~~lg~G--~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 488 (756)
..++|+..+.||+| +||.||+|+. .+++.||||++.... ....+.+.+|+.+++.++|||||++++++.+++..+
T Consensus 23 ~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 102 (389)
T 3gni_B 23 EGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELW 102 (389)
T ss_dssp CGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred CCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEE
Confidence 35688999999999 9999999995 479999999997542 333467888999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCc
Q 004400 489 LIYEYLENNSLARALFEH-RLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDE 567 (756)
Q Consensus 489 lV~e~~~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~ 567 (756)
+|||||++|+|.+++... ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||.+....
T Consensus 103 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~ 179 (389)
T 3gni_B 103 VVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMI 179 (389)
T ss_dssp EEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCGGGCEECE
T ss_pred EEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccccceeec
Confidence 999999999999999754 356999999999999999999999997 9999999999999999999999999986543
Q ss_pred ccCc------ceeeccccCccCCchHhhhc--CCCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhcCccc
Q 004400 568 EENT------HISTRVAGTIGYMAPEYAMR--GHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLM 639 (756)
Q Consensus 568 ~~~~------~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 639 (756)
.... .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||...+......... .+...
T Consensus 180 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~----~~~~~ 255 (389)
T 3gni_B 180 SHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKL----NGTVP 255 (389)
T ss_dssp ETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC----------
T ss_pred cccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHh----cCCCC
Confidence 2211 11223478999999999987 579999999999999999999999996544332211000 00000
Q ss_pred cccc------------------------------------cCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004400 640 ELVD------------------------------------TNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRM 682 (756)
Q Consensus 640 ~~~~------------------------------------~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~ 682 (756)
...+ ......+.......+.+++.+||+.||++|||+.|+++.
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~h 334 (389)
T 3gni_B 256 CLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNH 334 (389)
T ss_dssp --------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred ccccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcC
Confidence 0000 000001122233458899999999999999999999854
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-41 Score=363.80 Aligned_cols=257 Identities=26% Similarity=0.426 Sum_probs=197.3
Q ss_pred cCccccCcccCCCCccEEEeecc--CC--cEEEEEEccccC-cccHHHHHHHHHHHHhCCCCceeeEeeEEEe-CCeEEE
Q 004400 416 NNFATDNNIGEGGFGPVYKGLLA--DG--TAIAVKQLSSKS-KQGNREFINEIGMISALQHPNLVKLYGCCIE-GNQLLL 489 (756)
Q Consensus 416 ~~~~~~~~lg~G~~g~Vy~~~~~--~~--~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~l 489 (756)
..|...+.||+|+||.||+|+.. ++ ..||||.+.... ....+.|.+|+.++++++||||++++++|.+ ++..++
T Consensus 89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~l 168 (373)
T 3c1x_A 89 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV 168 (373)
T ss_dssp EEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEE
T ss_pred ceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEE
Confidence 35677889999999999999853 22 368999986542 3345779999999999999999999999764 567899
Q ss_pred EEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCccc
Q 004400 490 IYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEE 569 (756)
Q Consensus 490 V~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~~ 569 (756)
||||+++|+|.+++......+++..+..++.||++||+|||+.+ |+||||||+||+++.++.+||+|||+++.....
T Consensus 169 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~ 245 (373)
T 3c1x_A 169 VLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDK 245 (373)
T ss_dssp EEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC---------
T ss_pred EEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCccchheEEECCCCCEEEeecccccccccc
Confidence 99999999999999877778999999999999999999999997 999999999999999999999999999865433
Q ss_pred Ccc---eeeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHh-CCCCCCccchhhHHHHHHHHHhcCccccccccC
Q 004400 570 NTH---ISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVS-GRSNVTKEDMFYLLDWALVLKEQGKLMELVDTN 645 (756)
Q Consensus 570 ~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 645 (756)
... ......+|+.|+|||.+.+..++.++|||||||++|||++ |..||...+....... ... +....
T Consensus 246 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~---~~~-~~~~~----- 316 (373)
T 3c1x_A 246 EFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVY---LLQ-GRRLL----- 316 (373)
T ss_dssp ------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHH---HHT-TCCCC-----
T ss_pred ccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHH---HHc-CCCCC-----
Confidence 211 1233567889999999999999999999999999999999 6667755443332221 111 11111
Q ss_pred CCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhccCcc
Q 004400 646 PGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLECGVD 688 (756)
Q Consensus 646 ~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~L~~~~~ 688 (756)
....++ ..+.+++.+||+.||++||++.|+++.|+++..
T Consensus 317 ~p~~~~----~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~ 355 (373)
T 3c1x_A 317 QPEYCP----DPLYEVMLKCWHPKAEMRPSFSELVSRISAIFS 355 (373)
T ss_dssp CCTTCC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCCC----HHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 111223 348899999999999999999999999997654
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-41 Score=356.67 Aligned_cols=253 Identities=21% Similarity=0.332 Sum_probs=195.8
Q ss_pred hcCccccCcccCCCCccEEEee-ccCCcEEEEEEccccCc---ccHHHHHHHHHHHHhCCCCceeeEeeEEEeCC----e
Q 004400 415 TNNFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSKSK---QGNREFINEIGMISALQHPNLVKLYGCCIEGN----Q 486 (756)
Q Consensus 415 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~ 486 (756)
.++|...+.||+|+||.||+|+ ..+++.||||++..... .....+.+|+.++++++||||+++++++.... .
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~ 90 (311)
T 3ork_A 11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 90 (311)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence 4678999999999999999999 46789999999976432 23457889999999999999999999987654 3
Q ss_pred EEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccC
Q 004400 487 LLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLD 566 (756)
Q Consensus 487 ~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~ 566 (756)
.++||||+++|+|.+++... ..+++..+..++.|++.||+|||+++ |+||||||+||+++.++.+||+|||+++..
T Consensus 91 ~~lv~e~~~g~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~ 166 (311)
T 3ork_A 91 PYIVMEYVDGVTLRDIVHTE-GPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAI 166 (311)
T ss_dssp EEEEEECCCEEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEETTSCEEECCCSCC---
T ss_pred cEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEcCCCCEEEeeccCcccc
Confidence 49999999999999999754 37999999999999999999999997 999999999999999999999999999865
Q ss_pred cccCcc--eeeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhcCcccccccc
Q 004400 567 EEENTH--ISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDT 644 (756)
Q Consensus 567 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 644 (756)
...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.......... ...........
T Consensus 167 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~---~~~~~~~~~~~--- 240 (311)
T 3ork_A 167 ADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAY---QHVREDPIPPS--- 240 (311)
T ss_dssp ---------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH---HHHHCCCCCHH---
T ss_pred cccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHH---HHhcCCCCCcc---
Confidence 543222 2334579999999999999999999999999999999999999997665433221 11111111100
Q ss_pred CCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 004400 645 NPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLR 681 (756)
Q Consensus 645 ~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~ 681 (756)
.....++ ..+.+++.+||+.||++||++.++++
T Consensus 241 ~~~~~~~----~~l~~li~~~l~~dP~~R~~~~~~l~ 273 (311)
T 3ork_A 241 ARHEGLS----ADLDAVVLKALAKNPENRYQTAAEMR 273 (311)
T ss_dssp HHSTTCC----HHHHHHHHHHTCSSGGGSCSSHHHHH
T ss_pred cccCCCC----HHHHHHHHHHHhcCHhhChhhHHHHH
Confidence 0011122 34889999999999999997776653
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-40 Score=344.28 Aligned_cols=248 Identities=26% Similarity=0.389 Sum_probs=203.5
Q ss_pred hhcCccccCcccCCCCccEEEee-ccCCcEEEEEEcccc---CcccHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEE
Q 004400 414 ATNNFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSK---SKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLL 489 (756)
Q Consensus 414 ~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 489 (756)
+.++|...+.||+|+||.||+|. ..++..||+|++... .......+.+|+.++++++||||+++++++.+.+..++
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 86 (279)
T 3fdn_A 7 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYL 86 (279)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEE
Confidence 45789999999999999999998 456789999998653 22234678899999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCccc
Q 004400 490 IYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEE 569 (756)
Q Consensus 490 V~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~~ 569 (756)
||||+++|+|.+++... ..+++..+..++.|++.||+|||+.| |+||||||+||+++.++.+||+|||++......
T Consensus 87 v~e~~~~~~l~~~l~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~ 162 (279)
T 3fdn_A 87 ILEYAPLGTVYRELQKL-SKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSS 162 (279)
T ss_dssp EECCCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTTT---CEECCCCGGGEEECTTSCEEECSCCEESCC---
T ss_pred EEecCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHhEEEcCCCCEEEEeccccccCCcc
Confidence 99999999999999754 46899999999999999999999986 999999999999999999999999998654332
Q ss_pred CcceeeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhcCccccccccCCCCC
Q 004400 570 NTHISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSN 649 (756)
Q Consensus 570 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 649 (756)
. .....||+.|+|||.+.+..++.++||||||+++|+|++|+.||...+........ .. .. ......
T Consensus 163 ~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~---~~-~~------~~~~~~ 229 (279)
T 3fdn_A 163 R---RTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRI---SR-VE------FTFPDF 229 (279)
T ss_dssp --------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH---HH-TC------CCCCTT
T ss_pred c---ccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHH---Hh-CC------CCCCCc
Confidence 2 23457899999999999989999999999999999999999999766543332211 11 00 001111
Q ss_pred CCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004400 650 FDKEQVMVMINVALLCANASPTIRPSMSSVLRM 682 (756)
Q Consensus 650 ~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~ 682 (756)
.+ ..+.+++.+||+.||++||++.|+++.
T Consensus 230 ~~----~~~~~li~~~l~~~p~~Rps~~e~l~h 258 (279)
T 3fdn_A 230 VT----EGARDLISRLLKHNPSQRPMLREVLEH 258 (279)
T ss_dssp SC----HHHHHHHHHHCCSSGGGSCCHHHHHHC
T ss_pred CC----HHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 22 348899999999999999999999874
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=359.69 Aligned_cols=261 Identities=15% Similarity=0.164 Sum_probs=206.8
Q ss_pred hcCccccCcccCCCCccEEEeecc---------CCcEEEEEEccccCcccHHHHHHHHHHHHhCCCCceee---------
Q 004400 415 TNNFATDNNIGEGGFGPVYKGLLA---------DGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVK--------- 476 (756)
Q Consensus 415 ~~~~~~~~~lg~G~~g~Vy~~~~~---------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~--------- 476 (756)
.++|...+.||+|+||.||+|+.. +++.||+|.+... +.+.+|++++++++||||++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 115 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTP 115 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCT
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCC
Confidence 368899999999999999999965 3789999998643 46889999999999999987
Q ss_pred ------EeeEEEe-CCeEEEEEEecCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceE
Q 004400 477 ------LYGCCIE-GNQLLLIYEYLENNSLARALFEH-RLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVL 548 (756)
Q Consensus 477 ------l~~~~~~-~~~~~lV~e~~~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nil 548 (756)
+++++.. ++..++||||+ +++|.+++... ...+++..+..++.||+.||+|||+++ |+||||||+||+
T Consensus 116 ~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NIl 191 (352)
T 2jii_A 116 LLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENE---YVHGNVTAENIF 191 (352)
T ss_dssp TCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCGGGEE
T ss_pred ccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHEE
Confidence 6778876 78899999999 99999999864 357999999999999999999999997 999999999999
Q ss_pred ecCCC--CEEEccCCccccCcccCcc------eeeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHhCCCCCCcc
Q 004400 549 LDKDL--NSKISDFGLAKLDEEENTH------ISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKE 620 (756)
Q Consensus 549 l~~~~--~~kl~DFGla~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~ 620 (756)
++.++ .+||+|||+++........ ......||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 192 ~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~ 271 (352)
T 2jii_A 192 VDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNC 271 (352)
T ss_dssp EETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGG
T ss_pred EcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccC
Confidence 99998 8999999999866543221 123457999999999999989999999999999999999999999654
Q ss_pred c--hhhHHHHHHHHHhcCccccccccCCC-CCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhccCcccc
Q 004400 621 D--MFYLLDWALVLKEQGKLMELVDTNPG-SNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLECGVDVL 690 (756)
Q Consensus 621 ~--~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~L~~~~~~~ 690 (756)
. ............. ........... ..++ ..+.+++.+||+.||++||++.+|++.|+++....
T Consensus 272 ~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~----~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~ 338 (352)
T 2jii_A 272 LPNTEDIMKQKQKFVD--KPGPFVGPCGHWIRPS----ETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQDL 338 (352)
T ss_dssp TTCHHHHHHHHHHHHH--SCCCEECTTSCEECCC----HHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred CcCHHHHHHHHHhccC--ChhhhhhhccccCCCc----HHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHhc
Confidence 3 2222222111111 11112211111 1223 34889999999999999999999999999765543
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-40 Score=349.77 Aligned_cols=254 Identities=30% Similarity=0.495 Sum_probs=198.1
Q ss_pred cCccccCcccCCCCccEEEeeccCCcEEEEEEccccCcccHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEEecC
Q 004400 416 NNFATDNNIGEGGFGPVYKGLLADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYEYLE 495 (756)
Q Consensus 416 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~ 495 (756)
++|+..+.||+|+||.||+|... ++.||||.+... ...+.|.+|++++++++||||+++++++.+ ..++||||++
T Consensus 8 ~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~e~~~ 82 (307)
T 2eva_A 8 KEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVMEYAE 82 (307)
T ss_dssp GGEEEEEEEECCSSSEEEEEEET-TEEEEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEEECCT
T ss_pred hHeeeeeEeecCCCceEEEEEEC-CeeEEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEEEcCC
Confidence 57888899999999999999875 788999998643 345789999999999999999999998863 4789999999
Q ss_pred CCCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCC-EEEccCCccccCcccCcc
Q 004400 496 NNSLARALFEHRL--KLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLN-SKISDFGLAKLDEEENTH 572 (756)
Q Consensus 496 ~gsL~~~l~~~~~--~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~-~kl~DFGla~~~~~~~~~ 572 (756)
+|+|.+++..... .+++..+..++.|+++||+|||+.+..+|+||||||+||+++.++. +||+|||+++.....
T Consensus 83 ~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~--- 159 (307)
T 2eva_A 83 GGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH--- 159 (307)
T ss_dssp TCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC----------
T ss_pred CCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc---
Confidence 9999999975432 4789999999999999999999943234999999999999998887 799999999754432
Q ss_pred eeeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHhCCCCCCccchhh-HHHHHHHHHhcCccccccccCCCCCCC
Q 004400 573 ISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFY-LLDWALVLKEQGKLMELVDTNPGSNFD 651 (756)
Q Consensus 573 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~ 651 (756)
.....||+.|+|||++.+..++.++||||||+++|||++|+.||....... ...|. . ........ ....+
T Consensus 160 -~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~--~-~~~~~~~~-----~~~~~ 230 (307)
T 2eva_A 160 -MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWA--V-HNGTRPPL-----IKNLP 230 (307)
T ss_dssp ------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHH--H-HTTCCCCC-----BTTCC
T ss_pred -cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHH--H-hcCCCCCc-----ccccC
Confidence 223468999999999999899999999999999999999999996432211 11111 1 11111111 11223
Q ss_pred HHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhccCcccc
Q 004400 652 KEQVMVMINVALLCANASPTIRPSMSSVLRMLECGVDVL 690 (756)
Q Consensus 652 ~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~L~~~~~~~ 690 (756)
..+.+++.+||+.||++|||+.++++.|+.+....
T Consensus 231 ----~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~ 265 (307)
T 2eva_A 231 ----KPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYF 265 (307)
T ss_dssp ----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGC
T ss_pred ----HHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhc
Confidence 34889999999999999999999999999765543
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=344.77 Aligned_cols=249 Identities=27% Similarity=0.431 Sum_probs=185.3
Q ss_pred hcCccccCcccCCCCccEEEeec-cCCcEEEEEEccccC---cccHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEE
Q 004400 415 TNNFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSKS---KQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLI 490 (756)
Q Consensus 415 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 490 (756)
.++|...+.||+|+||.||+|+. .+|+.||||.+.... ....+.+.+|+.++++++||||+++++++.+++..++|
T Consensus 10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (278)
T 3cok_A 10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLV 89 (278)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEE
T ss_pred cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEE
Confidence 45789999999999999999994 679999999986532 22346789999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCcccC
Q 004400 491 YEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEEN 570 (756)
Q Consensus 491 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~~~ 570 (756)
|||+++++|.+++......+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++.......
T Consensus 90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~ 166 (278)
T 3cok_A 90 LEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPH 166 (278)
T ss_dssp EECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSSCCGGGEEECTTCCEEECCCTTCEECC---
T ss_pred EecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEEeecceeeccCCC
Confidence 9999999999999877678999999999999999999999996 9999999999999999999999999998654322
Q ss_pred cceeeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhcCccccccccCCCCCC
Q 004400 571 THISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNF 650 (756)
Q Consensus 571 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 650 (756)
.. .....||+.|+|||.+.+..++.++||||||+++|||++|+.||.......... .... .+......+
T Consensus 167 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~-------~~~~---~~~~~~~~~ 235 (278)
T 3cok_A 167 EK-HYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLN-------KVVL---ADYEMPSFL 235 (278)
T ss_dssp --------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC------------CCS---SCCCCCTTS
T ss_pred Cc-ceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHH-------HHhh---cccCCcccc
Confidence 21 233578999999999998889999999999999999999999996554322111 0000 011111122
Q ss_pred CHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 004400 651 DKEQVMVMINVALLCANASPTIRPSMSSVLR 681 (756)
Q Consensus 651 ~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~ 681 (756)
+ ..+.+++.+||+.||++||++.++++
T Consensus 236 ~----~~~~~li~~~l~~dp~~Rps~~~~l~ 262 (278)
T 3cok_A 236 S----IEAKDLIHQLLRRNPADRLSLSSVLD 262 (278)
T ss_dssp C----HHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred C----HHHHHHHHHHcccCHhhCCCHHHHhc
Confidence 2 34889999999999999999999876
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=364.97 Aligned_cols=269 Identities=19% Similarity=0.232 Sum_probs=212.4
Q ss_pred hcCccccCcccCCCCccEEEeec-cCCcEEEEEEccccC-cccHHHHHHHHHHHHhCCCCceeeEeeEEEeCC--eEEEE
Q 004400 415 TNNFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSKS-KQGNREFINEIGMISALQHPNLVKLYGCCIEGN--QLLLI 490 (756)
Q Consensus 415 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--~~~lV 490 (756)
.++|...+.||+|+||.||+|+. .+|+.||||++.... ....+.+.+|++++++++||||+++++++.+.+ ..++|
T Consensus 8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv 87 (396)
T 4eut_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87 (396)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEE
Confidence 45788999999999999999995 468999999997543 334567889999999999999999999998765 78999
Q ss_pred EEecCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEe----cCCCCEEEccCCccc
Q 004400 491 YEYLENNSLARALFEHR--LKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLL----DKDLNSKISDFGLAK 564 (756)
Q Consensus 491 ~e~~~~gsL~~~l~~~~--~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill----~~~~~~kl~DFGla~ 564 (756)
|||+++|+|.+++.... ..+++..+..++.||+.||+|||+.+ |+||||||+|||+ +.++.+||+|||+++
T Consensus 88 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~ 164 (396)
T 4eut_A 88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR 164 (396)
T ss_dssp ECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEECTTSCEEEEECCGGGCE
T ss_pred EecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCcCHHHEEEeecCCCceeEEEecCCCce
Confidence 99999999999997432 23999999999999999999999997 9999999999999 777889999999998
Q ss_pred cCcccCcceeeccccCccCCchHhhhc--------CCCCcccchhhHHHHHHHHHhCCCCCCccch-hhHHHHHHHHHhc
Q 004400 565 LDEEENTHISTRVAGTIGYMAPEYAMR--------GHLTEKADVYSFGIVALEIVSGRSNVTKEDM-FYLLDWALVLKEQ 635 (756)
Q Consensus 565 ~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~Dv~slGv~l~elltg~~p~~~~~~-~~~~~~~~~~~~~ 635 (756)
....... .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||..... .............
T Consensus 165 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~ 242 (396)
T 4eut_A 165 ELEDDEQ--FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITG 242 (396)
T ss_dssp ECCCGGG--SSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHHS
T ss_pred EccCCCc--cccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhcC
Confidence 6554332 234579999999999875 5678899999999999999999999953321 1111111111111
Q ss_pred Ccc--cc-----------cc-ccCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhccCcc
Q 004400 636 GKL--ME-----------LV-DTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLECGVD 688 (756)
Q Consensus 636 ~~~--~~-----------~~-~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~L~~~~~ 688 (756)
... .. .. +.......+......+.+++.+||+.||++||++.|+++.++.+.+
T Consensus 243 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~ 309 (396)
T 4eut_A 243 KPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILH 309 (396)
T ss_dssp CCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHT
T ss_pred CCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhh
Confidence 110 00 00 1111223457777889999999999999999999999999887644
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-40 Score=350.29 Aligned_cols=262 Identities=22% Similarity=0.298 Sum_probs=200.9
Q ss_pred cCccccCcccCCCCccEEEeec-cCCcEEEEEEccccCc--ccHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEE
Q 004400 416 NNFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSKSK--QGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYE 492 (756)
Q Consensus 416 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 492 (756)
++|...+.||+|+||.||+|+. .+|+.||||++..... ...+.+.+|++++++++||||+++++++.+++..++|||
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (311)
T 4agu_A 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFE 82 (311)
T ss_dssp CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEE
Confidence 5788999999999999999995 4689999999865432 224668899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCcccCcc
Q 004400 493 YLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTH 572 (756)
Q Consensus 493 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~~~~~ 572 (756)
|+++++|.+++... ..+++..+..++.|++.||+|||+.| |+||||||+||+++.++.+||+|||+++........
T Consensus 83 ~~~~~~l~~~~~~~-~~~~~~~~~~i~~~l~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 158 (311)
T 4agu_A 83 YCDHTVLHELDRYQ-RGVPEHLVKSITWQTLQAVNFCHKHN---CIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDY 158 (311)
T ss_dssp CCSEEHHHHHHHTS-SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECC-----
T ss_pred eCCCchHHHHHhhh-cCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCChhhEEEcCCCCEEEeeCCCchhccCcccc
Confidence 99999999887544 47999999999999999999999997 999999999999999999999999999865533222
Q ss_pred eeeccccCccCCchHhhhc-CCCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHh-----------cCcc-c
Q 004400 573 ISTRVAGTIGYMAPEYAMR-GHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKE-----------QGKL-M 639 (756)
Q Consensus 573 ~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~-----------~~~~-~ 639 (756)
.....||+.|+|||++.+ ..++.++||||+|+++|||++|+.||................. .... .
T Consensus 159 -~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (311)
T 4agu_A 159 -YDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFS 237 (311)
T ss_dssp --------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGGT
T ss_pred -cCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccccccccccc
Confidence 234578999999999976 6789999999999999999999999976654433322211111 0000 0
Q ss_pred cccccCCCCCCC-----HHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004400 640 ELVDTNPGSNFD-----KEQVMVMINVALLCANASPTIRPSMSSVLRM 682 (756)
Q Consensus 640 ~~~~~~~~~~~~-----~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~ 682 (756)
....+.+....+ +.....+.+++.+||+.||++|||+.|+++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 285 (311)
T 4agu_A 238 GVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHH 285 (311)
T ss_dssp TCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTS
T ss_pred cCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 000000000000 1122348899999999999999999999864
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=363.74 Aligned_cols=251 Identities=22% Similarity=0.327 Sum_probs=197.4
Q ss_pred hcCccccCcccCCCCccEEEeeccCCcEEEEEEccccC--cccHHHHHHHHHHHHhCC--CCceeeEeeEEEeCCeEEEE
Q 004400 415 TNNFATDNNIGEGGFGPVYKGLLADGTAIAVKQLSSKS--KQGNREFINEIGMISALQ--HPNLVKLYGCCIEGNQLLLI 490 (756)
Q Consensus 415 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~~~~lV 490 (756)
.++|...+.||+|+||.||+|...+++.||||++.... ....+.+.+|++++++++ |||||++++++..++..++|
T Consensus 55 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv 134 (390)
T 2zmd_A 55 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV 134 (390)
T ss_dssp TEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEE
Confidence 35689999999999999999998789999999986542 334567899999999996 59999999999999999999
Q ss_pred EEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCcccC
Q 004400 491 YEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEEN 570 (756)
Q Consensus 491 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~~~ 570 (756)
|| +.+++|.+++.... .+++..+..++.||+.||+|||+.+ |+||||||+|||++ ++.+||+|||+++......
T Consensus 135 ~E-~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~ 208 (390)
T 2zmd_A 135 ME-CGNIDLNSWLKKKK-SIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDT 208 (390)
T ss_dssp EE-CCSEEHHHHHHHCS-SCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCCGGGEEES-SSCEEECCCSSSCCC----
T ss_pred Ee-cCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEEE-CCeEEEEecCccccccCCC
Confidence 99 67889999997654 7899999999999999999999986 99999999999996 5789999999998765433
Q ss_pred cc-eeeccccCccCCchHhhhc-----------CCCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhcCcc
Q 004400 571 TH-ISTRVAGTIGYMAPEYAMR-----------GHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKL 638 (756)
Q Consensus 571 ~~-~~~~~~gt~~y~aPE~~~~-----------~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 638 (756)
.. ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||....... ............
T Consensus 209 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~--~~~~~~~~~~~~ 286 (390)
T 2zmd_A 209 TSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI--SKLHAIIDPNHE 286 (390)
T ss_dssp -----CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH--HHHHHHHCTTSC
T ss_pred ccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHH--HHHHHHhCcccc
Confidence 22 2345679999999999875 468999999999999999999999996532211 111111111111
Q ss_pred ccccccCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004400 639 MELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRM 682 (756)
Q Consensus 639 ~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~ 682 (756)
... .... ...+.+++.+||+.||++||++.|+++.
T Consensus 287 ~~~-----~~~~----~~~~~~li~~~L~~dP~~Rps~~ell~h 321 (390)
T 2zmd_A 287 IEF-----PDIP----EKDLQDVLKCCLKRDPKQRISIPELLAH 321 (390)
T ss_dssp CCC-----CCCS----CHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred CCC-----Cccc----hHHHHHHHHHHcccChhhCCCHHHHhhC
Confidence 111 1111 2348899999999999999999999865
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=357.99 Aligned_cols=259 Identities=21% Similarity=0.255 Sum_probs=202.2
Q ss_pred HHHhhcCccccCcccCCCCccEEEeec-cCCcEEEEEEcccc-----CcccHHHHHHHHHHHHhCCCCceeeEeeEEEeC
Q 004400 411 IKAATNNFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSK-----SKQGNREFINEIGMISALQHPNLVKLYGCCIEG 484 (756)
Q Consensus 411 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 484 (756)
+....++|...+.||+|+||.||+|.. .+++.||+|++... .....+.+.+|++++++++||||+++++++.++
T Consensus 21 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 100 (345)
T 3hko_A 21 LLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDE 100 (345)
T ss_dssp HHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred hhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccC
Confidence 345667899999999999999999994 57889999998653 234457899999999999999999999999999
Q ss_pred CeEEEEEEecCCCCHHHHHHhc---------------------------------------CCCCCHHHHHHHHHHHHHH
Q 004400 485 NQLLLIYEYLENNSLARALFEH---------------------------------------RLKLDWPTRRRICLGIARG 525 (756)
Q Consensus 485 ~~~~lV~e~~~~gsL~~~l~~~---------------------------------------~~~l~~~~~~~i~~~ia~~ 525 (756)
+..++||||+++|+|.+++... ...+++..+..++.||+.|
T Consensus 101 ~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~ 180 (345)
T 3hko_A 101 QYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSA 180 (345)
T ss_dssp SEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHH
T ss_pred CeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHH
Confidence 9999999999999999988410 1123567788999999999
Q ss_pred HHHHHcCCCCCeEcCCCCCCceEecCCC--CEEEccCCccccCcccCc---ceeeccccCccCCchHhhhc--CCCCccc
Q 004400 526 LAYLHGESRIKVVHRDIKATNVLLDKDL--NSKISDFGLAKLDEEENT---HISTRVAGTIGYMAPEYAMR--GHLTEKA 598 (756)
Q Consensus 526 L~~LH~~g~~~iiH~Dikp~Nill~~~~--~~kl~DFGla~~~~~~~~---~~~~~~~gt~~y~aPE~~~~--~~~~~~~ 598 (756)
|+|||+.+ |+||||||+||+++.++ .+||+|||+++....... .......||+.|+|||++.+ ..++.++
T Consensus 181 l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~ 257 (345)
T 3hko_A 181 LHYLHNQG---ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKC 257 (345)
T ss_dssp HHHHHHTT---EECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHH
T ss_pred HHHHHHCC---ccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHH
Confidence 99999997 99999999999998776 899999999986543221 12345679999999999975 6789999
Q ss_pred chhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhcCccccccccCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHH
Q 004400 599 DVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSS 678 (756)
Q Consensus 599 Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~e 678 (756)
|||||||++|||++|+.||........... ......... .+ ....+ ...+.+++.+||+.||.+||++.|
T Consensus 258 DiwslG~il~el~~g~~pf~~~~~~~~~~~---~~~~~~~~~--~~-~~~~~----~~~~~~li~~~l~~~p~~Rps~~~ 327 (345)
T 3hko_A 258 DAWSAGVLLHLLLMGAVPFPGVNDADTISQ---VLNKKLCFE--NP-NYNVL----SPLARDLLSNLLNRNVDERFDAMR 327 (345)
T ss_dssp HHHHHHHHHHHHHHSSCSSCCSSHHHHHHH---HHHCCCCTT--SG-GGGGS----CHHHHHHHHHHSCSCTTTSCCHHH
T ss_pred HHHHHHHHHHHHHHCCCCCCCCChHHHHHH---HHhcccccC--Cc-ccccC----CHHHHHHHHHHcCCChhHCCCHHH
Confidence 999999999999999999976654433221 111111000 00 00112 234889999999999999999999
Q ss_pred HHHH
Q 004400 679 VLRM 682 (756)
Q Consensus 679 v~~~ 682 (756)
+++.
T Consensus 328 ~l~h 331 (345)
T 3hko_A 328 ALQH 331 (345)
T ss_dssp HHHS
T ss_pred HhcC
Confidence 9873
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-40 Score=351.08 Aligned_cols=252 Identities=22% Similarity=0.285 Sum_probs=206.8
Q ss_pred hcCccccCcccCCCCccEEEeec-cCCcEEEEEEccccCcc------cHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeE
Q 004400 415 TNNFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSKSKQ------GNREFINEIGMISALQHPNLVKLYGCCIEGNQL 487 (756)
Q Consensus 415 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 487 (756)
.++|...+.||+|+||.||+|+. .+|+.||+|.+...... ..+.+.+|+.++++++||||+++++++.+++..
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 90 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV 90 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence 45788999999999999999995 57899999998754221 357799999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCC----CEEEccCCcc
Q 004400 488 LLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDL----NSKISDFGLA 563 (756)
Q Consensus 488 ~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~----~~kl~DFGla 563 (756)
++||||+++++|.+++... ..+++..+..++.|++.||+|||+.| |+||||||+||+++.++ .+||+|||++
T Consensus 91 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~lH~~~---ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~ 166 (321)
T 2a2a_A 91 VLILELVSGGELFDFLAQK-ESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLA 166 (321)
T ss_dssp EEEECCCCSCBHHHHHHTC-SCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCCTTC
T ss_pred EEEEEcCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChHHEEEecCCCCcCCEEEccCccc
Confidence 9999999999999999654 47899999999999999999999997 99999999999999888 7999999999
Q ss_pred ccCcccCcceeeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhcCccccccc
Q 004400 564 KLDEEENTHISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVD 643 (756)
Q Consensus 564 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 643 (756)
+....... .....||+.|+|||++.+..++.++||||||+++|+|++|+.||............ .... . . .+
T Consensus 167 ~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i---~~~~-~-~-~~ 238 (321)
T 2a2a_A 167 HEIEDGVE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANI---TSVS-Y-D-FD 238 (321)
T ss_dssp EECCTTCC--CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHH---HTTC-C-C-CC
T ss_pred eecCcccc--ccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHH---Hhcc-c-c-cC
Confidence 86554322 23457999999999999889999999999999999999999999766543332211 1100 0 0 00
Q ss_pred cCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004400 644 TNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRM 682 (756)
Q Consensus 644 ~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~ 682 (756)
.......+ ..+.+++.+|++.||++|||+.|+++.
T Consensus 239 ~~~~~~~~----~~~~~li~~~l~~dp~~Rps~~e~l~h 273 (321)
T 2a2a_A 239 EEFFSHTS----ELAKDFIRKLLVKETRKRLTIQEALRH 273 (321)
T ss_dssp HHHHTTCC----HHHHHHHHTTSCSSTTTSCCHHHHHHS
T ss_pred hhhhcccC----HHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 00001122 348899999999999999999999874
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-40 Score=346.54 Aligned_cols=264 Identities=21% Similarity=0.259 Sum_probs=204.0
Q ss_pred hhcCccccCcccCCCCccEEEee-ccCCcEEEEEEccccCcccHHHHHHHHHHHHhCCCCceeeEeeEE-EeCCeEEEEE
Q 004400 414 ATNNFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCC-IEGNQLLLIY 491 (756)
Q Consensus 414 ~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~-~~~~~~~lV~ 491 (756)
..++|...+.||+|+||.||+|+ ..+++.||||++..... ...+.+|+.+++.++|++++..++++ .+++..++||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~ 84 (296)
T 4hgt_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM 84 (296)
T ss_dssp ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc--chHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEE
Confidence 35789999999999999999999 46789999998754432 24588899999999988877766655 6778899999
Q ss_pred EecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEe---cCCCCEEEccCCccccCcc
Q 004400 492 EYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLL---DKDLNSKISDFGLAKLDEE 568 (756)
Q Consensus 492 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill---~~~~~~kl~DFGla~~~~~ 568 (756)
||+ +++|.+++......+++..+..++.|++.||+|||+.+ |+||||||+||++ +.++.+||+|||+++....
T Consensus 85 e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~ 160 (296)
T 4hgt_A 85 ELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD 160 (296)
T ss_dssp ECC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECCGGGTTCEEECCCTTCEECBC
T ss_pred Ecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeeeeccCCCCeEEEecCccceeccC
Confidence 999 99999999876678999999999999999999999997 9999999999999 7889999999999986654
Q ss_pred cCcc------eeeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhcCcccccc
Q 004400 569 ENTH------ISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELV 642 (756)
Q Consensus 569 ~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 642 (756)
.... ......||+.|+|||.+.+..++.++|||||||++|||++|+.||................... . ...
T Consensus 161 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~-~-~~~ 238 (296)
T 4hgt_A 161 ARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKK-M-STP 238 (296)
T ss_dssp TTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHH-H-HSC
T ss_pred cccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhccc-c-cch
Confidence 3321 2234679999999999999999999999999999999999999996533211111110000000 0 000
Q ss_pred ccCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhccCccc
Q 004400 643 DTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLECGVDV 689 (756)
Q Consensus 643 ~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~L~~~~~~ 689 (756)
.......++ ..+.+++.+||+.||++||++.++++.|+.+...
T Consensus 239 ~~~~~~~~~----~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~ 281 (296)
T 4hgt_A 239 IEVLCKGYP----SEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHR 281 (296)
T ss_dssp HHHHTTTSC----HHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHH
T ss_pred hhhhhccCC----HHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHH
Confidence 000001122 3488999999999999999999999999976543
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-40 Score=365.22 Aligned_cols=247 Identities=25% Similarity=0.426 Sum_probs=205.7
Q ss_pred hcCccccCcccCCCCccEEEeec-cCCcEEEEEEccccC---cccHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEE
Q 004400 415 TNNFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSKS---KQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLI 490 (756)
Q Consensus 415 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 490 (756)
.++|...+.||+|+||.||+|+. .+|+.||||++.... ......+.+|+.+++.++||||+++++++.+++..++|
T Consensus 15 ~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv 94 (476)
T 2y94_A 15 IGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMV 94 (476)
T ss_dssp ETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 35788999999999999999995 479999999986532 22346789999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCcccC
Q 004400 491 YEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEEN 570 (756)
Q Consensus 491 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~~~ 570 (756)
|||+++|+|.+++... ..+++..+..++.||+.||+|||+.| |+||||||+||+++.++.+||+|||+++......
T Consensus 95 ~E~~~gg~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~~ 170 (476)
T 2y94_A 95 MEYVSGGELFDYICKN-GRLDEKESRRLFQQILSGVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE 170 (476)
T ss_dssp EECCSSEEHHHHTTSS-SSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEECTTCCEEECCCSSCEECCTTC
T ss_pred EeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---CCcccccHHHEEEecCCCeEEEeccchhhccccc
Confidence 9999999999998644 47999999999999999999999997 9999999999999999999999999998755432
Q ss_pred cceeeccccCccCCchHhhhcCCC-CcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhcCccccccccCCCCC
Q 004400 571 THISTRVAGTIGYMAPEYAMRGHL-TEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSN 649 (756)
Q Consensus 571 ~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 649 (756)
.....+||+.|+|||++.+..+ +.++||||+||++|||++|+.||...+....... +.. +.. . ....
T Consensus 171 --~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~---i~~-~~~-~-----~p~~ 238 (476)
T 2y94_A 171 --FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKK---ICD-GIF-Y-----TPQY 238 (476)
T ss_dssp --CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHH---HHT-TCC-C-----CCTT
T ss_pred --cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHH---Hhc-CCc-C-----CCcc
Confidence 2234679999999999988765 7899999999999999999999976654433221 111 110 0 1112
Q ss_pred CCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 004400 650 FDKEQVMVMINVALLCANASPTIRPSMSSVLR 681 (756)
Q Consensus 650 ~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~ 681 (756)
.+ ..+.+++.+||+.||++|||+.|+++
T Consensus 239 ~s----~~~~~Li~~~L~~dP~~Rpt~~eil~ 266 (476)
T 2y94_A 239 LN----PSVISLLKHMLQVDPMKRATIKDIRE 266 (476)
T ss_dssp CC----HHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CC----HHHHHHHHHHcCCCchhCcCHHHHHh
Confidence 23 34889999999999999999999986
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=349.61 Aligned_cols=256 Identities=27% Similarity=0.403 Sum_probs=205.4
Q ss_pred CccccCcccCCCCccEEEeecc-CC---cEEEEEEccccC-cccHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeE-EEE
Q 004400 417 NFATDNNIGEGGFGPVYKGLLA-DG---TAIAVKQLSSKS-KQGNREFINEIGMISALQHPNLVKLYGCCIEGNQL-LLI 490 (756)
Q Consensus 417 ~~~~~~~lg~G~~g~Vy~~~~~-~~---~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~-~lV 490 (756)
.|...+.||+|+||.||+|... ++ ..||+|.+.... ....+.+.+|+.++++++||||+++++++.+++.. ++|
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v 101 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL 101 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence 4566789999999999999843 23 379999987543 23456789999999999999999999999876655 999
Q ss_pred EEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCcccC
Q 004400 491 YEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEEN 570 (756)
Q Consensus 491 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~~~ 570 (756)
|||+.+|+|.+++......+++..+..++.|++.||+|||+.| |+||||||+||+++.++.+||+|||+++......
T Consensus 102 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~ 178 (298)
T 3pls_A 102 LPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQK---FVHRDLAARNCMLDESFTVKVADFGLARDILDRE 178 (298)
T ss_dssp ECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGG
T ss_pred EecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcEEeCcCCCcccccCCc
Confidence 9999999999999876778999999999999999999999997 9999999999999999999999999998654332
Q ss_pred c---ceeeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHhCCCCC-CccchhhHHHHHHHHHhcCccccccccCC
Q 004400 571 T---HISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNV-TKEDMFYLLDWALVLKEQGKLMELVDTNP 646 (756)
Q Consensus 571 ~---~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 646 (756)
. .......||+.|+|||.+.+..++.++||||||+++|||++|+.|+ ...+....... ... .... ..
T Consensus 179 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~---~~~-~~~~-----~~ 249 (298)
T 3pls_A 179 YYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHF---LAQ-GRRL-----PQ 249 (298)
T ss_dssp GGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHH---HHT-TCCC-----CC
T ss_pred ccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHH---hhc-CCCC-----CC
Confidence 1 1223456889999999999999999999999999999999966665 33333322221 111 1111 01
Q ss_pred CCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhccCcc
Q 004400 647 GSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLECGVD 688 (756)
Q Consensus 647 ~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~L~~~~~ 688 (756)
....+ ..+.+++.+||+.||.+|||+.++++.|+++..
T Consensus 250 ~~~~~----~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~ 287 (298)
T 3pls_A 250 PEYCP----DSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVS 287 (298)
T ss_dssp CTTCC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred Cccch----HHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 11222 348899999999999999999999999997644
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=354.17 Aligned_cols=262 Identities=20% Similarity=0.327 Sum_probs=200.1
Q ss_pred cCccccCcccCCCCccEEEeec-cCCcEEEEEEccccCcc-cHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEEe
Q 004400 416 NNFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSKSKQ-GNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYEY 493 (756)
Q Consensus 416 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 493 (756)
++|...+.||+|+||.||+|+. .+++.||+|++...... ....+.+|++++++++||||+++++++.+++..++||||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 81 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence 5788999999999999999995 47899999998654322 122456799999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCcccCcce
Q 004400 494 LENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHI 573 (756)
Q Consensus 494 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~~~~~~ 573 (756)
++ |+|.+++......+++..+..++.|++.||+|||+.| |+||||||+||+++.++.+||+|||+++........
T Consensus 82 ~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~- 156 (324)
T 3mtl_A 82 LD-KDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPTKT- 156 (324)
T ss_dssp CS-EEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCCGGGEEECTTCCEEECSSSEEECC-------
T ss_pred cc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCcCHHHEEECCCCCEEEccCcccccccCCccc-
Confidence 98 5899999877778999999999999999999999997 999999999999999999999999999865433222
Q ss_pred eeccccCccCCchHhhhc-CCCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhcCcccc---ccc------
Q 004400 574 STRVAGTIGYMAPEYAMR-GHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLME---LVD------ 643 (756)
Q Consensus 574 ~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~---~~~------ 643 (756)
.....||+.|+|||++.+ ..++.++||||+||++|||++|+.||...+................... ...
T Consensus 157 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 236 (324)
T 3mtl_A 157 YDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKT 236 (324)
T ss_dssp ------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHHHHH
T ss_pred cccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcchhhcc
Confidence 234568999999999876 5689999999999999999999999977765554443332222111100 000
Q ss_pred ---cCCCCC----CCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004400 644 ---TNPGSN----FDKEQVMVMINVALLCANASPTIRPSMSSVLRM 682 (756)
Q Consensus 644 ---~~~~~~----~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~ 682 (756)
+..... ..+.....+.+++.+|++.||++|||+.|+++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 282 (324)
T 3mtl_A 237 YNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKH 282 (324)
T ss_dssp TCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred cccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 000000 001112357899999999999999999999863
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-40 Score=355.45 Aligned_cols=267 Identities=23% Similarity=0.316 Sum_probs=202.7
Q ss_pred HHHhhcCccccCcccCCCCccEEEeec-cCCcEEEEEEccccCcc-----cHHHHHHHHHHHHhCCCCceeeEeeEEEeC
Q 004400 411 IKAATNNFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSKSKQ-----GNREFINEIGMISALQHPNLVKLYGCCIEG 484 (756)
Q Consensus 411 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 484 (756)
+....++|...+.||+|+||.||+|+. .+|+.||||++...... ..+.+.+|+++++.++||||+++++++.++
T Consensus 5 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 84 (346)
T 1ua2_A 5 VKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHK 84 (346)
T ss_dssp --------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCT
T ss_pred hHHHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeC
Confidence 344567899999999999999999995 46899999998753221 124688999999999999999999999999
Q ss_pred CeEEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccc
Q 004400 485 NQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAK 564 (756)
Q Consensus 485 ~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~ 564 (756)
+..++||||+++ +|.+++......+++..+..++.|++.||+|||+.| |+||||||+||+++.++.+||+|||+++
T Consensus 85 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~ 160 (346)
T 1ua2_A 85 SNISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAK 160 (346)
T ss_dssp TCCEEEEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGS
T ss_pred CceEEEEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCCHHHEEEcCCCCEEEEecccce
Confidence 999999999986 899988776667999999999999999999999997 9999999999999999999999999998
Q ss_pred cCcccCcceeeccccCccCCchHhhhcC-CCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhcCccccccc
Q 004400 565 LDEEENTHISTRVAGTIGYMAPEYAMRG-HLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVD 643 (756)
Q Consensus 565 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 643 (756)
....... ......||+.|+|||++.+. .++.++|||||||++|||++|..||...+.....................+
T Consensus 161 ~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 239 (346)
T 1ua2_A 161 SFGSPNR-AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPD 239 (346)
T ss_dssp TTTSCCC-CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSS
T ss_pred eccCCcc-cCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhhh
Confidence 7644322 23345789999999999764 589999999999999999999999977665443332222111111111000
Q ss_pred c---------CCCCCCC-----HHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004400 644 T---------NPGSNFD-----KEQVMVMINVALLCANASPTIRPSMSSVLRM 682 (756)
Q Consensus 644 ~---------~~~~~~~-----~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~ 682 (756)
. ......+ ......+.+++.+|++.||++|||+.|+++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 292 (346)
T 1ua2_A 240 MCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 292 (346)
T ss_dssp TTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred hccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 0 0000011 1122458899999999999999999999875
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-40 Score=347.84 Aligned_cols=259 Identities=26% Similarity=0.448 Sum_probs=198.4
Q ss_pred cCccccCcccCCCCccEEEee-ccCCcEEEEEEcccc---CcccHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEE
Q 004400 416 NNFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSK---SKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIY 491 (756)
Q Consensus 416 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 491 (756)
++|...+.||+|+||.||+|. ..+|+.||||++... .......+.+|+.++++++||||+++++++.+++..++||
T Consensus 32 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 111 (310)
T 2wqm_A 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 111 (310)
T ss_dssp GGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEEE
Confidence 578899999999999999999 467999999998753 2334567899999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCcc
Q 004400 492 EYLENNSLARALFE---HRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEE 568 (756)
Q Consensus 492 e~~~~gsL~~~l~~---~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~ 568 (756)
||+++|+|.+++.. ....+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++....
T Consensus 112 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~ 188 (310)
T 2wqm_A 112 ELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS 188 (310)
T ss_dssp ECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCC--------
T ss_pred ecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCcHHHEEEcCCCCEEEEeccceeeecC
Confidence 99999999999863 3557899999999999999999999997 99999999999999999999999999986544
Q ss_pred cCcceeeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhcCccccccccCCCC
Q 004400 569 ENTHISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGS 648 (756)
Q Consensus 569 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 648 (756)
... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||...... .......... ...... ...
T Consensus 189 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-~~~~~~~~~~-~~~~~~----~~~ 261 (310)
T 2wqm_A 189 KTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN-LYSLCKKIEQ-CDYPPL----PSD 261 (310)
T ss_dssp -----------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CC-HHHHHHHHHT-TCSCCC----CTT
T ss_pred CCc-cccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchh-HHHHHHHhhc-ccCCCC----ccc
Confidence 322 223456899999999999999999999999999999999999999654321 1111111111 111111 112
Q ss_pred CCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhccCcc
Q 004400 649 NFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLECGVD 688 (756)
Q Consensus 649 ~~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~L~~~~~ 688 (756)
.++ ..+.+++.+||+.||++||++.+|++.|+.+..
T Consensus 262 ~~~----~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~ 297 (310)
T 2wqm_A 262 HYS----EELRQLVNMCINPDPEKRPDVTYVYDVAKRMHA 297 (310)
T ss_dssp TSC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ccC----HHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHH
Confidence 233 348899999999999999999999999986644
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=349.04 Aligned_cols=258 Identities=26% Similarity=0.418 Sum_probs=204.8
Q ss_pred hcCccccCcccCCCCccEEEeeccC----CcEEEEEEccccC-cccHHHHHHHHHHHHhCCCCceeeEeeEEE-eCCeEE
Q 004400 415 TNNFATDNNIGEGGFGPVYKGLLAD----GTAIAVKQLSSKS-KQGNREFINEIGMISALQHPNLVKLYGCCI-EGNQLL 488 (756)
Q Consensus 415 ~~~~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~-~~~~~~ 488 (756)
...|...+.||+|+||.||+|+..+ ...||+|.+.... ....+.+.+|+.++++++||||++++++|. .++..+
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 103 (298)
T 3f66_A 24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL 103 (298)
T ss_dssp GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCE
T ss_pred ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceE
Confidence 4568888999999999999998532 2358999987543 334567899999999999999999999965 456789
Q ss_pred EEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCcc
Q 004400 489 LIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEE 568 (756)
Q Consensus 489 lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~ 568 (756)
+||||+++|+|.+++......+++..+..++.|++.||+|||+++ |+||||||+||+++.++.+||+|||+++....
T Consensus 104 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~ 180 (298)
T 3f66_A 104 VVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYD 180 (298)
T ss_dssp EEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSCGGGCCCSC
T ss_pred EEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEECCCCCEEECcccccccccc
Confidence 999999999999999876778999999999999999999999997 99999999999999999999999999986544
Q ss_pred cCc---ceeeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHhC-CCCCCccchhhHHHHHHHHHhcCcccccccc
Q 004400 569 ENT---HISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSG-RSNVTKEDMFYLLDWALVLKEQGKLMELVDT 644 (756)
Q Consensus 569 ~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 644 (756)
... .......||+.|+|||.+.+..++.++||||||+++|||++| ..||...+....... ... .....
T Consensus 181 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~---~~~-~~~~~---- 252 (298)
T 3f66_A 181 KEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVY---LLQ-GRRLL---- 252 (298)
T ss_dssp GGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHH---HHT-TCCCC----
T ss_pred cchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHH---Hhc-CCCCC----
Confidence 322 123345678899999999999999999999999999999995 555544443332221 111 11100
Q ss_pred CCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhccCcc
Q 004400 645 NPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLECGVD 688 (756)
Q Consensus 645 ~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~L~~~~~ 688 (756)
.....+ ..+.+++.+||+.+|++||++.|+++.|+++..
T Consensus 253 -~~~~~~----~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~ 291 (298)
T 3f66_A 253 -QPEYCP----DPLYEVMLKCWHPKAEMRPSFSELVSRISAIFS 291 (298)
T ss_dssp -CCTTCC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -CCccCC----HHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 111222 348899999999999999999999999997654
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-40 Score=347.12 Aligned_cols=256 Identities=20% Similarity=0.289 Sum_probs=197.9
Q ss_pred cCccc-cCcccCCCCccEEEee-ccCCcEEEEEEccccCcccHHHHHHHHHHHHhC-CCCceeeEeeEEEeCCeEEEEEE
Q 004400 416 NNFAT-DNNIGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQGNREFINEIGMISAL-QHPNLVKLYGCCIEGNQLLLIYE 492 (756)
Q Consensus 416 ~~~~~-~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~e 492 (756)
+.|.+ .+.||+|+||.||+|. ..+++.||||++..........+.+|++++.++ +||||+++++++.+++..++|||
T Consensus 12 ~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e 91 (316)
T 2ac3_A 12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFE 91 (316)
T ss_dssp TSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred eeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEE
Confidence 46666 4789999999999999 457999999999776556677899999999985 79999999999999999999999
Q ss_pred ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCC---EEEccCCccccCccc
Q 004400 493 YLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLN---SKISDFGLAKLDEEE 569 (756)
Q Consensus 493 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~---~kl~DFGla~~~~~~ 569 (756)
|+++|+|.+++... ..+++..+..++.||+.||+|||+++ |+||||||+||+++.++. +||+|||+++.....
T Consensus 92 ~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~ 167 (316)
T 2ac3_A 92 KMRGGSILSHIHKR-RHFNELEASVVVQDVASALDFLHNKG---IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLN 167 (316)
T ss_dssp CCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESCSSSSCSEEECCTTCCC-----
T ss_pred cCCCCcHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEEccCCCcCceEEEEccCccccccC
Confidence 99999999999765 47899999999999999999999996 999999999999998776 999999999765422
Q ss_pred Cc------ceeeccccCccCCchHhhhc-----CCCCcccchhhHHHHHHHHHhCCCCCCccchhh------------HH
Q 004400 570 NT------HISTRVAGTIGYMAPEYAMR-----GHLTEKADVYSFGIVALEIVSGRSNVTKEDMFY------------LL 626 (756)
Q Consensus 570 ~~------~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~------------~~ 626 (756)
.. .......||+.|+|||++.. ..++.++|||||||++|||++|+.||....... ..
T Consensus 168 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 247 (316)
T 2ac3_A 168 GDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQN 247 (316)
T ss_dssp --------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHHHH
T ss_pred CccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhHHH
Confidence 11 11223569999999999975 558899999999999999999999996543211 00
Q ss_pred HHHHHHHhcCccccccccCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004400 627 DWALVLKEQGKLMELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRM 682 (756)
Q Consensus 627 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~ 682 (756)
........ ... ..... ..... ...+.+++.+|++.||++|||+.|+++.
T Consensus 248 ~~~~~i~~-~~~-~~~~~-~~~~~----~~~~~~li~~~L~~dP~~Rps~~e~l~h 296 (316)
T 2ac3_A 248 MLFESIQE-GKY-EFPDK-DWAHI----SCAAKDLISKLLVRDAKQRLSAAQVLQH 296 (316)
T ss_dssp HHHHHHHH-CCC-CCCHH-HHTTS----CHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHHHHHhc-cCc-ccCch-hcccC----CHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 00011111 110 00000 00111 2358899999999999999999999874
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-41 Score=357.08 Aligned_cols=259 Identities=28% Similarity=0.401 Sum_probs=208.9
Q ss_pred HhhcCccccCcccCCCCccEEEeecc-CC-----cEEEEEEccccC-cccHHHHHHHHHHHHhC-CCCceeeEeeEEEeC
Q 004400 413 AATNNFATDNNIGEGGFGPVYKGLLA-DG-----TAIAVKQLSSKS-KQGNREFINEIGMISAL-QHPNLVKLYGCCIEG 484 (756)
Q Consensus 413 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~-----~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 484 (756)
...++|...+.||+|+||.||+|... ++ +.||+|.+.... ....+.+.+|+.+++++ +||||++++++|.++
T Consensus 43 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 122 (333)
T 2i1m_A 43 FPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHG 122 (333)
T ss_dssp CCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred CCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecC
Confidence 34578999999999999999999843 23 479999997643 23456789999999999 899999999999999
Q ss_pred CeEEEEEEecCCCCHHHHHHhc-------------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecC
Q 004400 485 NQLLLIYEYLENNSLARALFEH-------------RLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDK 551 (756)
Q Consensus 485 ~~~~lV~e~~~~gsL~~~l~~~-------------~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~ 551 (756)
+..++||||+++|+|.+++... ...+++..+..++.|++.||+|||+.+ |+||||||+||+++.
T Consensus 123 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~ 199 (333)
T 2i1m_A 123 GPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN---CIHRDVAARNVLLTN 199 (333)
T ss_dssp SSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGCEEEG
T ss_pred CceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCcccceEEECC
Confidence 9999999999999999999743 346899999999999999999999996 999999999999999
Q ss_pred CCCEEEccCCccccCcccCcc-eeeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHh-CCCCCCccchhhHHHHH
Q 004400 552 DLNSKISDFGLAKLDEEENTH-ISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVS-GRSNVTKEDMFYLLDWA 629 (756)
Q Consensus 552 ~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~~~~ 629 (756)
++.+||+|||+++........ ......||+.|+|||.+.+..++.++|||||||++|||++ |..||..........
T Consensus 200 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~-- 277 (333)
T 2i1m_A 200 GHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFY-- 277 (333)
T ss_dssp GGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHHH--
T ss_pred CCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHHHH--
Confidence 999999999999865443322 2334567889999999999999999999999999999999 899996543322111
Q ss_pred HHHHhcCccccccccCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhccC
Q 004400 630 LVLKEQGKLMELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLECG 686 (756)
Q Consensus 630 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~L~~~ 686 (756)
.......... .....+ ..+.+++.+||+.||.+|||+.|+++.|++.
T Consensus 278 -~~~~~~~~~~-----~~~~~~----~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~ 324 (333)
T 2i1m_A 278 -KLVKDGYQMA-----QPAFAP----KNIYSIMQACWALEPTHRPTFQQICSFLQEQ 324 (333)
T ss_dssp -HHHHHTCCCC-----CCTTCC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -HHHhcCCCCC-----CCCCCC----HHHHHHHHHHhccChhhCcCHHHHHHHHHHH
Confidence 1111111110 111122 3488999999999999999999999999854
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-40 Score=350.86 Aligned_cols=255 Identities=30% Similarity=0.449 Sum_probs=204.5
Q ss_pred cCccccCcccCCCCccEEEeec-cCCcE--EEEEEcccc-CcccHHHHHHHHHHHHhC-CCCceeeEeeEEEeCCeEEEE
Q 004400 416 NNFATDNNIGEGGFGPVYKGLL-ADGTA--IAVKQLSSK-SKQGNREFINEIGMISAL-QHPNLVKLYGCCIEGNQLLLI 490 (756)
Q Consensus 416 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~--vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV 490 (756)
++|...+.||+|+||.||+|+. .++.. ||+|.+... .....+.+.+|+++++++ +||||+++++++.+++..++|
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 104 (327)
T 1fvr_A 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 104 (327)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEE
Confidence 5788899999999999999995 45654 499988653 233456789999999999 899999999999999999999
Q ss_pred EEecCCCCHHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCE
Q 004400 491 YEYLENNSLARALFEHR---------------LKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNS 555 (756)
Q Consensus 491 ~e~~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~ 555 (756)
|||+++|+|.+++.... ..+++..++.++.|++.||+|||+.+ |+||||||+||+++.++.+
T Consensus 105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~ 181 (327)
T 1fvr_A 105 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA 181 (327)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCE
T ss_pred EecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCccceEEEcCCCeE
Confidence 99999999999997543 47899999999999999999999997 9999999999999999999
Q ss_pred EEccCCccccCcccCcceeeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHh-CCCCCCccchhhHHHHHHHHHh
Q 004400 556 KISDFGLAKLDEEENTHISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVS-GRSNVTKEDMFYLLDWALVLKE 634 (756)
Q Consensus 556 kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~ 634 (756)
||+|||+++...... ......+++.|+|||++.+..++.++||||||+++|||++ |+.||............ .
T Consensus 182 kL~Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~----~ 255 (327)
T 1fvr_A 182 KIADFGLSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKL----P 255 (327)
T ss_dssp EECCTTCEESSCEEC--CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHG----G
T ss_pred EEcccCcCccccccc--cccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHHHHHh----h
Confidence 999999997433221 1233457889999999998889999999999999999998 99999766543332211 1
Q ss_pred cCccccccccCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhccCcc
Q 004400 635 QGKLMELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLECGVD 688 (756)
Q Consensus 635 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~L~~~~~ 688 (756)
.+.. ......++ ..+.+++.+||+.||++||++.|+++.|+.+..
T Consensus 256 ~~~~-----~~~~~~~~----~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 300 (327)
T 1fvr_A 256 QGYR-----LEKPLNCD----DEVYDLMRQCWREKPYERPSFAQILVSLNRMLE 300 (327)
T ss_dssp GTCC-----CCCCTTBC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred cCCC-----CCCCCCCC----HHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 1110 11111223 348899999999999999999999999986544
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-40 Score=353.08 Aligned_cols=243 Identities=21% Similarity=0.332 Sum_probs=202.7
Q ss_pred hhcCccccCcccCCCCccEEEee-ccCCcEEEEEEccccCc--------ccHHHHHHHHHHHHhCCCCceeeEeeEEEeC
Q 004400 414 ATNNFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSKSK--------QGNREFINEIGMISALQHPNLVKLYGCCIEG 484 (756)
Q Consensus 414 ~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 484 (756)
..++|...+.||+|+||.||+|+ ..+++.||||++..... .....+.+|+.++++++||||++++++|.++
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~ 101 (335)
T 3dls_A 22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQ 101 (335)
T ss_dssp HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeC
Confidence 45689999999999999999998 56789999999875421 1234577899999999999999999999999
Q ss_pred CeEEEEEEecCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCcc
Q 004400 485 NQLLLIYEYLENN-SLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLA 563 (756)
Q Consensus 485 ~~~~lV~e~~~~g-sL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla 563 (756)
+..++||||+.+| +|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++
T Consensus 102 ~~~~lv~e~~~~g~~l~~~~~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~a 177 (335)
T 3dls_A 102 GFFQLVMEKHGSGLDLFAFIDRH-PRLDEPLASYIFRQLVSAVGYLRLKD---IIHRDIKDENIVIAEDFTIKLIDFGSA 177 (335)
T ss_dssp SEEEEEEECCTTSCBHHHHHHTC-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTC
T ss_pred CEEEEEEEeCCCCccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC---eEEeccCHHHEEEcCCCcEEEeecccc
Confidence 9999999999777 999998654 47999999999999999999999997 999999999999999999999999999
Q ss_pred ccCcccCcceeeccccCccCCchHhhhcCCC-CcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhcCcccccc
Q 004400 564 KLDEEENTHISTRVAGTIGYMAPEYAMRGHL-TEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELV 642 (756)
Q Consensus 564 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 642 (756)
+....... .....||+.|+|||++.+..+ +.++|||||||++|||++|+.||...... .....
T Consensus 178 ~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~--------------~~~~~ 241 (335)
T 3dls_A 178 AYLERGKL--FYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET--------------VEAAI 241 (335)
T ss_dssp EECCTTCC--BCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG--------------TTTCC
T ss_pred eECCCCCc--eeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHH--------------Hhhcc
Confidence 86654332 234579999999999988776 88999999999999999999999643211 00000
Q ss_pred ccCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004400 643 DTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRM 682 (756)
Q Consensus 643 ~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~ 682 (756)
. ....++ ..+.+++.+||+.||++|||+.|+++.
T Consensus 242 ~--~~~~~~----~~l~~li~~~L~~dP~~Rps~~ell~h 275 (335)
T 3dls_A 242 H--PPYLVS----KELMSLVSGLLQPVPERRTTLEKLVTD 275 (335)
T ss_dssp C--CSSCCC----HHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred C--CCcccC----HHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0 111223 348899999999999999999999885
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-40 Score=372.88 Aligned_cols=253 Identities=26% Similarity=0.333 Sum_probs=207.0
Q ss_pred HhhcCccccCcccCCCCccEEEeec-cCCcEEEEEEcccc---CcccHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEE
Q 004400 413 AATNNFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSK---SKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLL 488 (756)
Q Consensus 413 ~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 488 (756)
...++|...+.||+|+||.||+|+. .+|+.||||++... .......+.+|+++++.++|||||++++++.+++..+
T Consensus 181 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~ 260 (576)
T 2acx_A 181 VTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALC 260 (576)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred ccccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEE
Confidence 3457899999999999999999995 57999999998653 2234567889999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCc
Q 004400 489 LIYEYLENNSLARALFEHR-LKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDE 567 (756)
Q Consensus 489 lV~e~~~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~ 567 (756)
+||||+++|+|.+++.... ..+++..+..++.||+.||+|||++| ||||||||+|||++.++.+||+|||+++...
T Consensus 261 lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~g---IvHrDLKPeNILld~~g~vKL~DFGla~~~~ 337 (576)
T 2acx_A 261 LVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRER---IVYRDLKPENILLDDHGHIRISDLGLAVHVP 337 (576)
T ss_dssp EEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCchheEEEeCCCCeEEEecccceecc
Confidence 9999999999999997543 35999999999999999999999997 9999999999999999999999999998665
Q ss_pred ccCcceeeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHhCCCCCCccchhhHHH-HHHHHHhcCccccccccCC
Q 004400 568 EENTHISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLD-WALVLKEQGKLMELVDTNP 646 (756)
Q Consensus 568 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~ 646 (756)
.... ....+||+.|+|||++.+..++.++|||||||++|||++|+.||.......... ....... .. ...
T Consensus 338 ~~~~--~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~-~~------~~~ 408 (576)
T 2acx_A 338 EGQT--IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKE-VP------EEY 408 (576)
T ss_dssp TTCC--EECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHH-CC------CCC
T ss_pred cCcc--ccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhc-cc------ccC
Confidence 4322 234589999999999998889999999999999999999999996643211111 1111111 10 001
Q ss_pred CCCCCHHHHHHHHHHHHHhhcCCCCCCC-----CHHHHHH
Q 004400 647 GSNFDKEQVMVMINVALLCANASPTIRP-----SMSSVLR 681 (756)
Q Consensus 647 ~~~~~~~~~~~l~~l~~~c~~~~P~~RP-----t~~ev~~ 681 (756)
...++ ..+.+++.+|++.||++|| ++.||++
T Consensus 409 p~~~s----~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~ 444 (576)
T 2acx_A 409 SERFS----PQARSLCSQLLCKDPAERLGCRGGSAREVKE 444 (576)
T ss_dssp CTTSC----HHHHHHHHHHTCSSGGGSTTCSSSHHHHHHT
T ss_pred CccCC----HHHHHHHHHhccCCHHHcCCCCCCCHHHHHh
Confidence 12223 3488999999999999999 7888865
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=353.49 Aligned_cols=247 Identities=24% Similarity=0.322 Sum_probs=178.9
Q ss_pred cCcccCCCCccEEEeec-cCCcEEEEEEccccCcccHHHHHHHHHHHHhCC-CCceeeEeeEEEeCCeEEEEEEecCCCC
Q 004400 421 DNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSKSKQGNREFINEIGMISALQ-HPNLVKLYGCCIEGNQLLLIYEYLENNS 498 (756)
Q Consensus 421 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lV~e~~~~gs 498 (756)
.+.||+|+||.||+|.. .+++.||||++... ....+.+|+.+++.+. ||||+++++++.++...++||||+++|+
T Consensus 16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~ 92 (325)
T 3kn6_A 16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGE 92 (325)
T ss_dssp SCCSEEETTEEEEEEEETTTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCB
T ss_pred CCccccCCCeEEEEEEECCCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCc
Confidence 47899999999999995 57899999998643 3467889999999997 9999999999999999999999999999
Q ss_pred HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCC---CEEEccCCccccCcccCcceee
Q 004400 499 LARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDL---NSKISDFGLAKLDEEENTHIST 575 (756)
Q Consensus 499 L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~---~~kl~DFGla~~~~~~~~~~~~ 575 (756)
|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++ .+||+|||+++........ ..
T Consensus 93 L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~~-~~ 167 (325)
T 3kn6_A 93 LFERIKKK-KHFSETEASYIMRKLVSAVSHMHDVG---VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQP-LK 167 (325)
T ss_dssp HHHHHHHC-SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEC----CEEEECCCTTCEECCC-------
T ss_pred HHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---CeecCCCHHHEEEecCCCcccEEEeccccceecCCCCCc-cc
Confidence 99999765 47999999999999999999999997 99999999999998765 7999999999865443222 33
Q ss_pred ccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHhCCCCCCccchhhH----HHHHHHHHhcCccccccccCCCCCCC
Q 004400 576 RVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYL----LDWALVLKEQGKLMELVDTNPGSNFD 651 (756)
Q Consensus 576 ~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~ 651 (756)
...||+.|+|||++.+..++.++|||||||++|||++|+.||...+.... ....... ..+... ......
T Consensus 168 ~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i-~~~~~~------~~~~~~ 240 (325)
T 3kn6_A 168 TPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKI-KKGDFS------FEGEAW 240 (325)
T ss_dssp ----------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHH-TTTCCC------CCSHHH
T ss_pred ccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHH-HcCCCC------CCcccc
Confidence 45789999999999999999999999999999999999999965432110 1111111 111100 000000
Q ss_pred HHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004400 652 KEQVMVMINVALLCANASPTIRPSMSSVLRM 682 (756)
Q Consensus 652 ~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~ 682 (756)
......+.+++.+|++.||++|||+.|+++.
T Consensus 241 ~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h 271 (325)
T 3kn6_A 241 KNVSQEAKDLIQGLLTVDPNKRLKMSGLRYN 271 (325)
T ss_dssp HTSCHHHHHHHHHHHCCCTTTCCCTTTSTTC
T ss_pred cCCCHHHHHHHHHHCCCChhHCCCHHHHhcC
Confidence 1123458899999999999999999998754
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=355.10 Aligned_cols=258 Identities=28% Similarity=0.425 Sum_probs=205.9
Q ss_pred hcCccccCcccCCCCccEEEeec------cCCcEEEEEEcccc-CcccHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeE
Q 004400 415 TNNFATDNNIGEGGFGPVYKGLL------ADGTAIAVKQLSSK-SKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQL 487 (756)
Q Consensus 415 ~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 487 (756)
.++|...+.||+|+||.||+|+. .+++.||||.+... .......+.+|+.++++++||||+++++++.+++..
T Consensus 29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 108 (327)
T 2yfx_A 29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 108 (327)
T ss_dssp GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCc
Confidence 46889999999999999999984 35678999999654 334456789999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecC---CCCEEEc
Q 004400 488 LLIYEYLENNSLARALFEHR------LKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDK---DLNSKIS 558 (756)
Q Consensus 488 ~lV~e~~~~gsL~~~l~~~~------~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~---~~~~kl~ 558 (756)
++||||+++|+|.+++.... ..+++..+..++.|++.||+|||+.+ |+||||||+||+++. +..+||+
T Consensus 109 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---i~H~dlkp~NIli~~~~~~~~~kl~ 185 (327)
T 2yfx_A 109 FILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIG 185 (327)
T ss_dssp EEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred EEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eecCcCCHhHEEEecCCCcceEEEC
Confidence 99999999999999998653 35899999999999999999999997 999999999999984 4469999
Q ss_pred cCCccccCcccCc-ceeeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHh-CCCCCCccchhhHHHHHHHHHhcC
Q 004400 559 DFGLAKLDEEENT-HISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVS-GRSNVTKEDMFYLLDWALVLKEQG 636 (756)
Q Consensus 559 DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~ 636 (756)
|||+++....... .......||+.|+|||.+.+..++.++||||||+++|||++ |+.||..........+. .. .
T Consensus 186 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~---~~-~ 261 (327)
T 2yfx_A 186 DFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFV---TS-G 261 (327)
T ss_dssp CCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHH---HT-T
T ss_pred ccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHHH---hc-C
Confidence 9999975433222 22334568999999999999999999999999999999998 99999765544333221 11 1
Q ss_pred ccccccccCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhccCcc
Q 004400 637 KLMELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLECGVD 688 (756)
Q Consensus 637 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~L~~~~~ 688 (756)
.... ....++ ..+.+++.+||+.||.+||++.++++.|+.+..
T Consensus 262 ~~~~-----~~~~~~----~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~ 304 (327)
T 2yfx_A 262 GRMD-----PPKNCP----GPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ 304 (327)
T ss_dssp CCCC-----CCTTCC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCC-----CCCCCC----HHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhc
Confidence 1111 112233 348899999999999999999999999986544
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-40 Score=350.92 Aligned_cols=261 Identities=25% Similarity=0.396 Sum_probs=200.0
Q ss_pred HHhhcCccccCcccCCCCccEEEeecc----CCcEEEEEEccccC--cccHHHHHHHHHHHHhCCCCceeeEeeEEEeCC
Q 004400 412 KAATNNFATDNNIGEGGFGPVYKGLLA----DGTAIAVKQLSSKS--KQGNREFINEIGMISALQHPNLVKLYGCCIEGN 485 (756)
Q Consensus 412 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 485 (756)
....++|...+.||+|+||.||+|... ++..||+|.+.... ....+.+.+|+.++++++||||+++++++.+.+
T Consensus 30 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 109 (313)
T 3brb_A 30 VIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMS 109 (313)
T ss_dssp BCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC--
T ss_pred ccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeecc
Confidence 345678999999999999999999843 34589999987542 333467899999999999999999999998755
Q ss_pred -----eEEEEEEecCCCCHHHHHHh-----cCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCE
Q 004400 486 -----QLLLIYEYLENNSLARALFE-----HRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNS 555 (756)
Q Consensus 486 -----~~~lV~e~~~~gsL~~~l~~-----~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~ 555 (756)
..++||||+++|+|.+++.. ....+++..++.++.|++.||+|||+.+ |+||||||+||+++.++.+
T Consensus 110 ~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~ 186 (313)
T 3brb_A 110 SQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRN---FLHRDLAARNCMLRDDMTV 186 (313)
T ss_dssp -----CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCSGGGEEECTTSCE
T ss_pred ccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcE
Confidence 35999999999999999953 3356999999999999999999999986 9999999999999999999
Q ss_pred EEccCCccccCcccCcc-eeeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHh-CCCCCCccchhhHHHHHHHHH
Q 004400 556 KISDFGLAKLDEEENTH-ISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVS-GRSNVTKEDMFYLLDWALVLK 633 (756)
Q Consensus 556 kl~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~ 633 (756)
||+|||+++........ ......+++.|+|||.+.+..++.++||||||+++|||++ |+.||............ .
T Consensus 187 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~---~ 263 (313)
T 3brb_A 187 CVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYL---L 263 (313)
T ss_dssp EECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHH---H
T ss_pred EEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHH---H
Confidence 99999999865443222 2233467889999999999999999999999999999999 88898665544333221 1
Q ss_pred hcCccccccccCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhccCcc
Q 004400 634 EQGKLMELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLECGVD 688 (756)
Q Consensus 634 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~L~~~~~ 688 (756)
. +..... ...++ ..+.+++.+||+.||.+||++.++++.|+.+..
T Consensus 264 ~-~~~~~~-----~~~~~----~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~ 308 (313)
T 3brb_A 264 H-GHRLKQ-----PEDCL----DELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLE 308 (313)
T ss_dssp T-TCCCCC-----BTTCC----HHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred c-CCCCCC-----Ccccc----HHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 1 111111 11222 348899999999999999999999999987644
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=350.20 Aligned_cols=264 Identities=22% Similarity=0.307 Sum_probs=205.9
Q ss_pred hcCccccCcccCCCCccEEEeec-cCCcEEEEEEccccC--cccHHHHHHHHHHHHhCCCCceeeEeeEEEe--------
Q 004400 415 TNNFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSKS--KQGNREFINEIGMISALQHPNLVKLYGCCIE-------- 483 (756)
Q Consensus 415 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-------- 483 (756)
.++|...+.||+|+||.||+|+. .+|+.||||++.... ......+.+|+++++.++||||+++++++.+
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 95 (351)
T 3mi9_A 16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 95 (351)
T ss_dssp GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence 35789999999999999999995 679999999986543 2234678899999999999999999999987
Q ss_pred CCeEEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCcc
Q 004400 484 GNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLA 563 (756)
Q Consensus 484 ~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla 563 (756)
.+..++||||+++ +|.+.+......+++..+..++.|++.||+|||+.| |+||||||+|||++.++.+||+|||++
T Consensus 96 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~a 171 (351)
T 3mi9_A 96 KGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLA 171 (351)
T ss_dssp -CEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred CceEEEEEeccCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCCEEEccchhc
Confidence 4568999999985 788888766668999999999999999999999997 999999999999999999999999999
Q ss_pred ccCcccC---cceeeccccCccCCchHhhhc-CCCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhcCccc
Q 004400 564 KLDEEEN---THISTRVAGTIGYMAPEYAMR-GHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLM 639 (756)
Q Consensus 564 ~~~~~~~---~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 639 (756)
+...... ........||+.|+|||++.+ ..++.++|||||||++|||++|+.||......................
T Consensus 172 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 251 (351)
T 3mi9_A 172 RAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPE 251 (351)
T ss_dssp EECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTT
T ss_pred ccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChh
Confidence 8654322 122344678999999999876 458999999999999999999999997766554443332222111100
Q ss_pred cc-----------cccCCCCCCCH-HH------HHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004400 640 EL-----------VDTNPGSNFDK-EQ------VMVMINVALLCANASPTIRPSMSSVLRM 682 (756)
Q Consensus 640 ~~-----------~~~~~~~~~~~-~~------~~~l~~l~~~c~~~~P~~RPt~~ev~~~ 682 (756)
.. ........... +. ...+.+++.+|++.||++|||+.|+++.
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 312 (351)
T 3mi9_A 252 VWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 312 (351)
T ss_dssp TSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCC
Confidence 00 00000000011 11 2347899999999999999999999874
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-40 Score=346.03 Aligned_cols=254 Identities=26% Similarity=0.383 Sum_probs=204.4
Q ss_pred hcCccccC-cccCCCCccEEEeec---cCCcEEEEEEccccCc--ccHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEE
Q 004400 415 TNNFATDN-NIGEGGFGPVYKGLL---ADGTAIAVKQLSSKSK--QGNREFINEIGMISALQHPNLVKLYGCCIEGNQLL 488 (756)
Q Consensus 415 ~~~~~~~~-~lg~G~~g~Vy~~~~---~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 488 (756)
.++|...+ .||+|+||.||+|.. .+++.||||++..... ...+.+.+|+++++.++||||+++++++ +.+..+
T Consensus 15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~ 93 (291)
T 1xbb_A 15 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWM 93 (291)
T ss_dssp GGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEE
T ss_pred chhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcE
Confidence 35677777 999999999999953 3578899999976432 2356799999999999999999999999 667789
Q ss_pred EEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCcc
Q 004400 489 LIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEE 568 (756)
Q Consensus 489 lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~ 568 (756)
+||||+++++|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++....
T Consensus 94 lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~ 169 (291)
T 1xbb_A 94 LVMEMAELGPLNKYLQQN-RHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRA 169 (291)
T ss_dssp EEEECCTTEEHHHHHHHC-TTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEECCT
T ss_pred EEEEeCCCCCHHHHHHhC-cCCCHHHHHHHHHHHHHHHHHHHhCC---eEcCCCCcceEEEeCCCcEEEccCCcceeecc
Confidence 999999999999999764 46999999999999999999999997 99999999999999999999999999986654
Q ss_pred cCcce--eeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHh-CCCCCCccchhhHHHHHHHHHhcCccccccccC
Q 004400 569 ENTHI--STRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVS-GRSNVTKEDMFYLLDWALVLKEQGKLMELVDTN 645 (756)
Q Consensus 569 ~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 645 (756)
..... .....||+.|+|||.+.+..++.++||||||+++|||++ |+.||............ ........
T Consensus 170 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~----~~~~~~~~---- 241 (291)
T 1xbb_A 170 DENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAML----EKGERMGC---- 241 (291)
T ss_dssp TCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHH----HTTCCCCC----
T ss_pred CCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH----HcCCCCCC----
Confidence 43322 222456789999999998889999999999999999999 99999766544332211 11111111
Q ss_pred CCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhccC
Q 004400 646 PGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLECG 686 (756)
Q Consensus 646 ~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~L~~~ 686 (756)
...++ ..+.+++.+||+.||++||++.++++.|+.+
T Consensus 242 -~~~~~----~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~ 277 (291)
T 1xbb_A 242 -PAGCP----REMYDLMNLCWTYDVENRPGFAAVELRLRNY 277 (291)
T ss_dssp -CTTCC----HHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred -CCCCC----HHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 11223 3488999999999999999999999999865
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-40 Score=352.91 Aligned_cols=266 Identities=26% Similarity=0.400 Sum_probs=209.1
Q ss_pred hcCccccCcccCCCCccEEEeec-----cCCcEEEEEEccccCcccHHHHHHHHHHHHhCCCCceeeEeeEEEeCC--eE
Q 004400 415 TNNFATDNNIGEGGFGPVYKGLL-----ADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCCIEGN--QL 487 (756)
Q Consensus 415 ~~~~~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--~~ 487 (756)
.++|...+.||+|+||.||+|++ .+++.||||++........+.+.+|++++++++||||+++++++...+ ..
T Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 119 (326)
T 2w1i_A 40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 119 (326)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CC
T ss_pred HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCce
Confidence 45788899999999999999983 468899999998766566678999999999999999999999987654 68
Q ss_pred EEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCc
Q 004400 488 LLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDE 567 (756)
Q Consensus 488 ~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~ 567 (756)
++||||+++|+|.+++......+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++...
T Consensus 120 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~kL~Dfg~~~~~~ 196 (326)
T 2w1i_A 120 KLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKVLP 196 (326)
T ss_dssp EEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred EEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEEcCCCcEEEecCcchhhcc
Confidence 9999999999999999877677999999999999999999999996 9999999999999999999999999998765
Q ss_pred ccCcce--eeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhcC-------cc
Q 004400 568 EENTHI--STRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQG-------KL 638 (756)
Q Consensus 568 ~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~-------~~ 638 (756)
...... .....++..|+|||.+.+..++.++||||||+++|||++|+.|+....... .. ...... ..
T Consensus 197 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~-~~---~~~~~~~~~~~~~~~ 272 (326)
T 2w1i_A 197 QDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEF-MR---MIGNDKQGQMIVFHL 272 (326)
T ss_dssp SSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHH-HH---HHCTTCCTHHHHHHH
T ss_pred ccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHH-HH---hhccccchhhhHHHH
Confidence 443221 223457888999999998889999999999999999999999874321100 00 000000 00
Q ss_pred ccccccCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhccCc
Q 004400 639 MELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLECGV 687 (756)
Q Consensus 639 ~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~L~~~~ 687 (756)
.+.+........+......+.+++.+||+.||++||++.|+++.|+++.
T Consensus 273 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~ 321 (326)
T 2w1i_A 273 IELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIR 321 (326)
T ss_dssp HHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 0000000000111122345889999999999999999999999998653
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-40 Score=352.02 Aligned_cols=253 Identities=21% Similarity=0.342 Sum_probs=200.3
Q ss_pred hhcCccccCcccCCCCccEEEeec-cCCcEEEEEEccccCcccHHHHHHHHHHHHhC-CCCceeeEeeEEEeCCeEEEEE
Q 004400 414 ATNNFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSKSKQGNREFINEIGMISAL-QHPNLVKLYGCCIEGNQLLLIY 491 (756)
Q Consensus 414 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~ 491 (756)
..++|+..+.||+|+||.||+|.. .+++.||||++..... ...+|++++.++ +||||+++++++.+++..|+||
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~----~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ 95 (342)
T 2qr7_A 20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR----DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVT 95 (342)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC----CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEE
T ss_pred ccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC----ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEE
Confidence 346789999999999999999995 5789999999965432 235688888888 7999999999999999999999
Q ss_pred EecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCC----CCEEEccCCccccCc
Q 004400 492 EYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKD----LNSKISDFGLAKLDE 567 (756)
Q Consensus 492 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~----~~~kl~DFGla~~~~ 567 (756)
||+++|+|.+++... ..+++..+..++.||+.||+|||+.| |+||||||+|||+.++ +.+||+|||+++...
T Consensus 96 E~~~gg~L~~~i~~~-~~~~~~~~~~~~~qi~~al~~lH~~g---ivHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~ 171 (342)
T 2qr7_A 96 ELMKGGELLDKILRQ-KFFSEREASAVLFTITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLR 171 (342)
T ss_dssp CCCCSCBHHHHHHTC-TTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSCSGGGEEECCCTTCEECB
T ss_pred eCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---cEeccCCHHHEEEecCCCCcCeEEEEECCCcccCc
Confidence 999999999999754 47999999999999999999999997 9999999999998543 349999999998654
Q ss_pred ccCcceeeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhcCccccccccCCC
Q 004400 568 EENTHISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPG 647 (756)
Q Consensus 568 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 647 (756)
.... .....+||+.|+|||++.+..++.++|||||||++|||++|+.||..............+.. +... ......
T Consensus 172 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~-~~~~--~~~~~~ 247 (342)
T 2qr7_A 172 AENG-LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGS-GKFS--LSGGYW 247 (342)
T ss_dssp CTTC-CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHH-CCCC--CCSTTT
T ss_pred CCCC-ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHcc-CCcc--cCcccc
Confidence 4332 23346799999999999888899999999999999999999999965322111111111111 1111 011111
Q ss_pred CCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004400 648 SNFDKEQVMVMINVALLCANASPTIRPSMSSVLRM 682 (756)
Q Consensus 648 ~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~ 682 (756)
..++ ..+.+++.+|++.||++||++.|+++.
T Consensus 248 ~~~s----~~~~~li~~~L~~dP~~R~t~~~il~h 278 (342)
T 2qr7_A 248 NSVS----DTAKDLVSKMLHVDPHQRLTAALVLRH 278 (342)
T ss_dssp TTSC----HHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred ccCC----HHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 1223 348899999999999999999999753
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=350.65 Aligned_cols=260 Identities=24% Similarity=0.327 Sum_probs=205.5
Q ss_pred HhhcCccccCcccCCCCccEEEeec-cCCcEEEEEEccccCcccHHHHHHHHHHHHhCC-----CCceeeEeeEEEeCCe
Q 004400 413 AATNNFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSKSKQGNREFINEIGMISALQ-----HPNLVKLYGCCIEGNQ 486 (756)
Q Consensus 413 ~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----h~niv~l~~~~~~~~~ 486 (756)
...++|...+.||+|+||.||+|+. .+++.||||++... ......+..|+.+++.++ ||||+++++++...+.
T Consensus 32 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~~~ 110 (360)
T 3llt_A 32 LLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI-KKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYYDH 110 (360)
T ss_dssp EETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-HHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEETTE
T ss_pred EecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc-hhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeECCe
Confidence 3457899999999999999999995 67899999999642 334567788999999996 9999999999999999
Q ss_pred EEEEEEecCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecC--------------
Q 004400 487 LLLIYEYLENNSLARALFEHR-LKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDK-------------- 551 (756)
Q Consensus 487 ~~lV~e~~~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~-------------- 551 (756)
.++||||+ +++|.+++.... ..+++..+..++.||+.||+|||+.| |+||||||+|||++.
T Consensus 111 ~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~~~~~~~~~~~ 186 (360)
T 3llt_A 111 MCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMS---LTHTDLKPENILLDDPYFEKSLITVRRVT 186 (360)
T ss_dssp EEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCTTCCEEEEEEECTT
T ss_pred eEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCcccEEEccccccccccchhccc
Confidence 99999999 999999997543 45899999999999999999999997 999999999999975
Q ss_pred -----------CCCEEEccCCccccCcccCcceeeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHhCCCCCCcc
Q 004400 552 -----------DLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKE 620 (756)
Q Consensus 552 -----------~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~ 620 (756)
++.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 187 ~~~~~~~~~~~~~~~kl~DFG~a~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~ 262 (360)
T 3llt_A 187 DGKKIQIYRTKSTGIKLIDFGCATFKSDY----HGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLFRTH 262 (360)
T ss_dssp TCCEEEEEEESCCCEEECCCTTCEETTSC----CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred ccccccccccCCCCEEEEeccCceecCCC----CcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHCCCCCCCC
Confidence 788999999999864432 23467899999999999999999999999999999999999999766
Q ss_pred chhhHHHHHHHHHhcC-----------cccccccc------CCCCCCCHH---------------HHHHHHHHHHHhhcC
Q 004400 621 DMFYLLDWALVLKEQG-----------KLMELVDT------NPGSNFDKE---------------QVMVMINVALLCANA 668 (756)
Q Consensus 621 ~~~~~~~~~~~~~~~~-----------~~~~~~~~------~~~~~~~~~---------------~~~~l~~l~~~c~~~ 668 (756)
+............... .....+.. -+....... ....+.+++.+||+.
T Consensus 263 ~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~ 342 (360)
T 3llt_A 263 EHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSILQI 342 (360)
T ss_dssp SHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHHHHCCS
T ss_pred cHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHHHHHhcC
Confidence 5444332221111100 00000000 000000000 013577999999999
Q ss_pred CCCCCCCHHHHHH
Q 004400 669 SPTIRPSMSSVLR 681 (756)
Q Consensus 669 ~P~~RPt~~ev~~ 681 (756)
||++|||+.|+++
T Consensus 343 dP~~Rpta~elL~ 355 (360)
T 3llt_A 343 DPTLRPSPAELLK 355 (360)
T ss_dssp SGGGSCCHHHHTT
T ss_pred ChhhCCCHHHHhc
Confidence 9999999999875
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-40 Score=365.95 Aligned_cols=259 Identities=21% Similarity=0.311 Sum_probs=197.8
Q ss_pred hcCccccCcccCCCCccEEEee-ccCCcEEEEEEcccc--CcccHHHHHHHHHHHHhCCCCceeeEeeEEEeC------C
Q 004400 415 TNNFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSK--SKQGNREFINEIGMISALQHPNLVKLYGCCIEG------N 485 (756)
Q Consensus 415 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~ 485 (756)
.++|...+.||+|+||.||+|. ..+++.||||++... .....+.+.+|+.+++.++|||||++++++... .
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 140 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 140 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence 4689999999999999999998 557899999999754 333456788999999999999999999999754 4
Q ss_pred eEEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCcccc
Q 004400 486 QLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKL 565 (756)
Q Consensus 486 ~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~ 565 (756)
..|+|||||+++ |.+.+. ..+++..+..++.||+.||+|||+.| |+||||||+|||++.++.+||+|||+|+.
T Consensus 141 ~~~lv~E~~~~~-l~~~~~---~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDlkp~NIll~~~~~~kl~DFG~a~~ 213 (464)
T 3ttj_A 141 DVYLVMELMDAN-LCQVIQ---MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLART 213 (464)
T ss_dssp EEEEEEECCSEE-HHHHHT---SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCCC--
T ss_pred eEEEEEeCCCCC-HHHHHh---hcCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChHhEEEeCCCCEEEEEEEeeee
Confidence 679999999875 655553 35899999999999999999999997 99999999999999999999999999986
Q ss_pred CcccCcceeeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhcCc--------
Q 004400 566 DEEENTHISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGK-------- 637 (756)
Q Consensus 566 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~-------- 637 (756)
..... ......||+.|+|||++.+..++.++||||+||++|||++|+.||.+.+................
T Consensus 214 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~~ 291 (464)
T 3ttj_A 214 AGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ 291 (464)
T ss_dssp ---CC--CC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTSC
T ss_pred cCCCc--ccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHcc
Confidence 54422 23446799999999999999999999999999999999999999987665443222111111000
Q ss_pred --cccccccCCC---------------CC---CCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004400 638 --LMELVDTNPG---------------SN---FDKEQVMVMINVALLCANASPTIRPSMSSVLRM 682 (756)
Q Consensus 638 --~~~~~~~~~~---------------~~---~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~ 682 (756)
....+...+. .. ........+.+++.+|++.||++|||+.|+++.
T Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 356 (464)
T 3ttj_A 292 PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 356 (464)
T ss_dssp HHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0000000000 00 001124568999999999999999999999875
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=357.24 Aligned_cols=254 Identities=23% Similarity=0.301 Sum_probs=204.0
Q ss_pred hcCccccCcccCCCCccEEEeec----cCCcEEEEEEccccC----cccHHHHHHHHHHHHhC-CCCceeeEeeEEEeCC
Q 004400 415 TNNFATDNNIGEGGFGPVYKGLL----ADGTAIAVKQLSSKS----KQGNREFINEIGMISAL-QHPNLVKLYGCCIEGN 485 (756)
Q Consensus 415 ~~~~~~~~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~ 485 (756)
.++|...+.||+|+||.||+|+. .+++.||||+++... ....+.+.+|+++++++ +||||+++++++.+++
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 132 (355)
T 1vzo_A 53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET 132 (355)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc
Confidence 46889999999999999999986 478999999987532 22345677899999999 6999999999999999
Q ss_pred eEEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCcccc
Q 004400 486 QLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKL 565 (756)
Q Consensus 486 ~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~ 565 (756)
..++||||+++|+|.+++.... .+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 133 ~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~DfG~a~~ 208 (355)
T 1vzo_A 133 KLHLILDYINGGELFTHLSQRE-RFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKE 208 (355)
T ss_dssp EEEEEECCCCSCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEEEE
T ss_pred eEEEEeecCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCcEEEeeCCCCee
Confidence 9999999999999999997543 7999999999999999999999996 99999999999999999999999999986
Q ss_pred CcccCcceeeccccCccCCchHhhhc--CCCCcccchhhHHHHHHHHHhCCCCCCccchhhH-HHHHHHHHhcCcccccc
Q 004400 566 DEEENTHISTRVAGTIGYMAPEYAMR--GHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYL-LDWALVLKEQGKLMELV 642 (756)
Q Consensus 566 ~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~ 642 (756)
.............||+.|+|||++.+ ..++.++|||||||++|||++|+.||........ ...........
T Consensus 209 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~------ 282 (355)
T 1vzo_A 209 FVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSE------ 282 (355)
T ss_dssp CCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCC------
T ss_pred cccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHhccC------
Confidence 65444444455689999999999985 3478999999999999999999999964432111 11111111110
Q ss_pred ccCCCCCCCHHHHHHHHHHHHHhhcCCCCCCC-----CHHHHHHHh
Q 004400 643 DTNPGSNFDKEQVMVMINVALLCANASPTIRP-----SMSSVLRML 683 (756)
Q Consensus 643 ~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RP-----t~~ev~~~L 683 (756)
. .++......+.+++.+||+.||++|| ++.|+++..
T Consensus 283 -~----~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~ 323 (355)
T 1vzo_A 283 -P----PYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHL 323 (355)
T ss_dssp -C----CCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSG
T ss_pred -C----CCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCc
Confidence 0 11112233488999999999999999 899987653
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-40 Score=354.53 Aligned_cols=253 Identities=16% Similarity=0.148 Sum_probs=206.2
Q ss_pred HHhhcCccccCcccCCCCccEEEee------ccCCcEEEEEEccccCcccHHHHHHHHHHHHhCC---CCceeeEeeEEE
Q 004400 412 KAATNNFATDNNIGEGGFGPVYKGL------LADGTAIAVKQLSSKSKQGNREFINEIGMISALQ---HPNLVKLYGCCI 482 (756)
Q Consensus 412 ~~~~~~~~~~~~lg~G~~g~Vy~~~------~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~ 482 (756)
+...++|...+.||+|+||.||+|+ ..+++.||||++... ...++.+|+++++.++ |+||+++++++.
T Consensus 61 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~ 137 (365)
T 3e7e_A 61 QLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA---NPWEFYIGTQLMERLKPSMQHMFMKFYSAHL 137 (365)
T ss_dssp ECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC---CHHHHHHHHHHHHHSCGGGGGGBCCEEEEEE
T ss_pred EECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC---ChhHHHHHHHHHHHhhhhhhhhhhhhheeee
Confidence 3456789999999999999999994 456899999999654 3457888888888887 999999999999
Q ss_pred eCCeEEEEEEecCCCCHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecC-------
Q 004400 483 EGNQLLLIYEYLENNSLARALFE----HRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDK------- 551 (756)
Q Consensus 483 ~~~~~~lV~e~~~~gsL~~~l~~----~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~------- 551 (756)
.++..++|||||++|+|.+++.. ....+++..+..++.||+.||+|||+.| ||||||||+|||++.
T Consensus 138 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~---ivHrDiKp~NIll~~~~~~~~~ 214 (365)
T 3e7e_A 138 FQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCE---IIHGDIKPDNFILGNGFLEQDD 214 (365)
T ss_dssp CSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECGGGTCC--
T ss_pred cCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEecccccCccc
Confidence 99999999999999999999974 3457999999999999999999999986 999999999999998
Q ss_pred ----CCCEEEccCCccccCcc-cCcceeeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHhCCCCCCccchhhHH
Q 004400 552 ----DLNSKISDFGLAKLDEE-ENTHISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLL 626 (756)
Q Consensus 552 ----~~~~kl~DFGla~~~~~-~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~ 626 (756)
++.+||+|||+|+.... .........+||+.|+|||++.+..++.++|||||||++|||+||+.||.......
T Consensus 215 ~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~-- 292 (365)
T 3e7e_A 215 EDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGE-- 292 (365)
T ss_dssp ----CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTE--
T ss_pred cccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCc--
Confidence 89999999999975432 22233455689999999999999999999999999999999999999995432210
Q ss_pred HHHHHHHhcCccccccccCCCCCCCHHHHHHHHHHHHHhhcCCCCCC-CCHHHHHHHhccCcc
Q 004400 627 DWALVLKEQGKLMELVDTNPGSNFDKEQVMVMINVALLCANASPTIR-PSMSSVLRMLECGVD 688 (756)
Q Consensus 627 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~R-Pt~~ev~~~L~~~~~ 688 (756)
....... ..... ...+.+++..|++.+|.+| |++.++.+.|+.+..
T Consensus 293 ---------~~~~~~~----~~~~~---~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~ 339 (365)
T 3e7e_A 293 ---------CKPEGLF----RRLPH---LDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQ 339 (365)
T ss_dssp ---------EEECSCC----TTCSS---HHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHH
T ss_pred ---------eeechhc----cccCc---HHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHH
Confidence 0011111 11111 3347788899999999999 578888888886644
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=353.61 Aligned_cols=260 Identities=27% Similarity=0.401 Sum_probs=209.3
Q ss_pred HhhcCccccCcccCCCCccEEEeec------cCCcEEEEEEccccCc-ccHHHHHHHHHHHHhC-CCCceeeEeeEEEeC
Q 004400 413 AATNNFATDNNIGEGGFGPVYKGLL------ADGTAIAVKQLSSKSK-QGNREFINEIGMISAL-QHPNLVKLYGCCIEG 484 (756)
Q Consensus 413 ~~~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 484 (756)
...++|...+.||+|+||.||+|+. .+++.||||++..... ...+.+.+|+.+++++ +||||+++++++.++
T Consensus 24 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 103 (316)
T 2xir_A 24 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP 103 (316)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCT
T ss_pred cchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEEEecC
Confidence 3467899999999999999999973 3568999999976432 3346789999999999 799999999999875
Q ss_pred C-eEEEEEEecCCCCHHHHHHhcCCC---------------CCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceE
Q 004400 485 N-QLLLIYEYLENNSLARALFEHRLK---------------LDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVL 548 (756)
Q Consensus 485 ~-~~~lV~e~~~~gsL~~~l~~~~~~---------------l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nil 548 (756)
+ ..++||||+++|+|.+++...... +++..+..++.|++.||+|||+.+ |+||||||+||+
T Consensus 104 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dikp~Nil 180 (316)
T 2xir_A 104 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNIL 180 (316)
T ss_dssp TSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEE
T ss_pred CCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCC---cccccCccceEE
Confidence 4 589999999999999999755432 899999999999999999999996 999999999999
Q ss_pred ecCCCCEEEccCCccccCcccCc-ceeeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHh-CCCCCCccchhhHH
Q 004400 549 LDKDLNSKISDFGLAKLDEEENT-HISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVS-GRSNVTKEDMFYLL 626 (756)
Q Consensus 549 l~~~~~~kl~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~ 626 (756)
++.++.+||+|||+++....... .......||+.|+|||++.+..++.++||||||+++|||++ |+.||.........
T Consensus 181 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~ 260 (316)
T 2xir_A 181 LSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF 260 (316)
T ss_dssp ECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHH
T ss_pred ECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccchhHHH
Confidence 99999999999999986544332 22334568899999999999999999999999999999998 99999654322211
Q ss_pred HHHHHHHhcCccccccccCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhccCc
Q 004400 627 DWALVLKEQGKLMELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLECGV 687 (756)
Q Consensus 627 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~L~~~~ 687 (756)
...... +.... .....+ ..+.+++.+||+.||.+|||+.|+++.|+.+.
T Consensus 261 --~~~~~~-~~~~~-----~~~~~~----~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~ 309 (316)
T 2xir_A 261 --CRRLKE-GTRMR-----APDYTT----PEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 309 (316)
T ss_dssp --HHHHHH-TCCCC-----CCTTCC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred --HHHhcc-CccCC-----CCCCCC----HHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 111111 11111 111223 34889999999999999999999999998653
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-40 Score=351.00 Aligned_cols=259 Identities=24% Similarity=0.302 Sum_probs=203.8
Q ss_pred hcCccccCcccCCCCccEEEeec-cCCcEEEEEEccccCcccHHHHHHHHHHHHhCCCCceeeEeeEEEe----CCeEEE
Q 004400 415 TNNFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCCIE----GNQLLL 489 (756)
Q Consensus 415 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~l 489 (756)
.++|...+.||+|+||.||+|.. .+++.||||++........+.+.+|+++++.++||||+++++++.. ....++
T Consensus 28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l 107 (317)
T 2buj_A 28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWL 107 (317)
T ss_dssp TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEE
T ss_pred CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEE
Confidence 46789999999999999999994 6799999999876656666789999999999999999999999873 347899
Q ss_pred EEEecCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccC
Q 004400 490 IYEYLENNSLARALFE---HRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLD 566 (756)
Q Consensus 490 V~e~~~~gsL~~~l~~---~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~ 566 (756)
||||+++|+|.+++.. ....+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++..
T Consensus 108 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~ 184 (317)
T 2buj_A 108 LLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKG---YAHRDLKPTNILLGDEGQPVLMDLGSMNQA 184 (317)
T ss_dssp EEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCSSCEES
T ss_pred EEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCCEEEEecCcchhc
Confidence 9999999999999975 3567999999999999999999999996 999999999999999999999999998754
Q ss_pred cccCcc--------eeeccccCccCCchHhhhcCC---CCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhc
Q 004400 567 EEENTH--------ISTRVAGTIGYMAPEYAMRGH---LTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQ 635 (756)
Q Consensus 567 ~~~~~~--------~~~~~~gt~~y~aPE~~~~~~---~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~ 635 (756)
...... ......||+.|+|||++.... ++.++||||||+++|||++|+.||........ ...... ..
T Consensus 185 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~-~~~~~~-~~ 262 (317)
T 2buj_A 185 CIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGD-SVALAV-QN 262 (317)
T ss_dssp CEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTS-CHHHHH-HC
T ss_pred ccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccc-hhhHHh-hc
Confidence 321111 012345799999999987543 68999999999999999999999843211000 000001 11
Q ss_pred CccccccccCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhccCc
Q 004400 636 GKLMELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLECGV 687 (756)
Q Consensus 636 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~L~~~~ 687 (756)
. . . ......++ ..+.+++.+||+.||.+||++.++++.|+++.
T Consensus 263 ~-~-~---~~~~~~~~----~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~ 305 (317)
T 2buj_A 263 Q-L-S---IPQSPRHS----SALWQLLNSMMTVDPHQRPHIPLLLSQLEALQ 305 (317)
T ss_dssp C-------CCCCTTSC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTC
T ss_pred c-C-C---CCccccCC----HHHHHHHHHHhhcChhhCCCHHHHHHHhhhcC
Confidence 0 0 0 00111223 34889999999999999999999999999654
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-40 Score=351.38 Aligned_cols=264 Identities=25% Similarity=0.335 Sum_probs=201.4
Q ss_pred hhcCccccCcccCCCCccEEEeeccCCcEEEEEEccccCcccHHHHHHHHHHHHhC--CCCceeeEeeEEEeC----CeE
Q 004400 414 ATNNFATDNNIGEGGFGPVYKGLLADGTAIAVKQLSSKSKQGNREFINEIGMISAL--QHPNLVKLYGCCIEG----NQL 487 (756)
Q Consensus 414 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l--~h~niv~l~~~~~~~----~~~ 487 (756)
..++|...+.||+|+||.||+|+.. ++.||||++... ....+.+|.+++... +||||+++++++.+. ...
T Consensus 35 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 110 (337)
T 3mdy_A 35 IAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTT---EEASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQL 110 (337)
T ss_dssp HHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCEE
T ss_pred cccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEecc---ccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCce
Confidence 4568999999999999999999875 899999998543 234556666666655 899999999999987 789
Q ss_pred EEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCC-----CCCeEcCCCCCCceEecCCCCEEEccCCc
Q 004400 488 LLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGES-----RIKVVHRDIKATNVLLDKDLNSKISDFGL 562 (756)
Q Consensus 488 ~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g-----~~~iiH~Dikp~Nill~~~~~~kl~DFGl 562 (756)
++||||+++|+|.+++... .+++..+..++.|++.||+|||+.+ .++|+||||||+|||++.++.+||+|||+
T Consensus 111 ~lv~e~~~~g~L~~~l~~~--~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~ 188 (337)
T 3mdy_A 111 YLITDYHENGSLYDYLKST--TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL 188 (337)
T ss_dssp EEEECCCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTT
T ss_pred EEEEeccCCCcHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEEeCCC
Confidence 9999999999999999654 6899999999999999999999871 11399999999999999999999999999
Q ss_pred cccCcccCcce---eeccccCccCCchHhhhcCCCCcc------cchhhHHHHHHHHHhC----------CCCCCccchh
Q 004400 563 AKLDEEENTHI---STRVAGTIGYMAPEYAMRGHLTEK------ADVYSFGIVALEIVSG----------RSNVTKEDMF 623 (756)
Q Consensus 563 a~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~------~Dv~slGv~l~elltg----------~~p~~~~~~~ 623 (756)
++......... .....||+.|+|||++.+...+.+ +|||||||++|||++| +.||......
T Consensus 189 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~~~~ 268 (337)
T 3mdy_A 189 AVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPS 268 (337)
T ss_dssp CEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCS
T ss_pred ceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhhhcCC
Confidence 97654332221 224579999999999987766665 9999999999999999 6666332111
Q ss_pred h--HHHHHHHHHhcCccccccccCCCC-CCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhccCcc
Q 004400 624 Y--LLDWALVLKEQGKLMELVDTNPGS-NFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLECGVD 688 (756)
Q Consensus 624 ~--~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~L~~~~~ 688 (756)
. ........ ..... .+.... .........+.+++.+||+.||++|||+.||++.|+++.+
T Consensus 269 ~~~~~~~~~~~-~~~~~----~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~ 331 (337)
T 3mdy_A 269 DPSYEDMREIV-CIKKL----RPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSE 331 (337)
T ss_dssp SCCHHHHHHHH-TTSCC----CCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCchhhhHHHH-hhhcc----CccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHh
Confidence 0 11111111 11111 111111 1122566779999999999999999999999999997654
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-40 Score=348.71 Aligned_cols=260 Identities=27% Similarity=0.425 Sum_probs=188.0
Q ss_pred hhcCccccCcccCCCCccEEEeec-cCCcEEEEEEccccC-cccHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEE
Q 004400 414 ATNNFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSKS-KQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIY 491 (756)
Q Consensus 414 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 491 (756)
..++|...+.||+|+||.||+|.. .+++.||||.+.... ....+.+.+|+.++++++||||+++++++..++..++||
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 92 (303)
T 2vwi_A 13 NRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVM 92 (303)
T ss_dssp CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEEE
T ss_pred chhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEe
Confidence 457899999999999999999984 578999999986542 334567889999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHh-------cCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccc
Q 004400 492 EYLENNSLARALFE-------HRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAK 564 (756)
Q Consensus 492 e~~~~gsL~~~l~~-------~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~ 564 (756)
||+++|+|.+++.. ....+++..+..++.|++.||+|||+.| |+||||||+||+++.++.+||+|||+++
T Consensus 93 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~ 169 (303)
T 2vwi_A 93 KLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNG---QIHRDVKAGNILLGEDGSVQIADFGVSA 169 (303)
T ss_dssp ECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEEECCCHHHH
T ss_pred hhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCCChhhEEEcCCCCEEEEeccchh
Confidence 99999999999973 2446899999999999999999999997 9999999999999999999999999997
Q ss_pred cCcccCc----ceeeccccCccCCchHhhhc-CCCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhcCc-c
Q 004400 565 LDEEENT----HISTRVAGTIGYMAPEYAMR-GHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGK-L 638 (756)
Q Consensus 565 ~~~~~~~----~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~-~ 638 (756)
....... .......||+.|+|||++.+ ..++.++||||||+++|||++|+.||........... ....... .
T Consensus 170 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~--~~~~~~~~~ 247 (303)
T 2vwi_A 170 FLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLML--TLQNDPPSL 247 (303)
T ss_dssp HCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHH--HHTSSCCCT
T ss_pred eeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHH--HhccCCCcc
Confidence 6543221 11234579999999999876 5789999999999999999999999966544332211 1111100 0
Q ss_pred c-cccccCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004400 639 M-ELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRM 682 (756)
Q Consensus 639 ~-~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~ 682 (756)
. ...+......++ ..+.+++.+||+.||.+||++.|+++.
T Consensus 248 ~~~~~~~~~~~~~~----~~~~~li~~~l~~dp~~Rps~~~ll~h 288 (303)
T 2vwi_A 248 ETGVQDKEMLKKYG----KSFRKMISLCLQKDPEKRPTAAELLRH 288 (303)
T ss_dssp TC-----CCCCCCC----HHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred ccccccchhhhhhh----HHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 0 011111112233 348899999999999999999999863
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-40 Score=359.23 Aligned_cols=251 Identities=20% Similarity=0.265 Sum_probs=191.2
Q ss_pred cCcccc-CcccCCCCccEEEeec-cCCcEEEEEEccccCcccHHHHHHHHHHHH-hCCCCceeeEeeEEEe----CCeEE
Q 004400 416 NNFATD-NNIGEGGFGPVYKGLL-ADGTAIAVKQLSSKSKQGNREFINEIGMIS-ALQHPNLVKLYGCCIE----GNQLL 488 (756)
Q Consensus 416 ~~~~~~-~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~-~l~h~niv~l~~~~~~----~~~~~ 488 (756)
++|... +.||+|+||.||+|.. .+++.||||++.. ...+.+|++++. ..+||||++++++|.. ....|
T Consensus 61 ~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~-----~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~ 135 (400)
T 1nxk_A 61 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 135 (400)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred ccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCc-----chhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEE
Confidence 456665 6899999999999994 5789999999853 246778998874 4589999999999876 56789
Q ss_pred EEEEecCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecC---CCCEEEccCCccc
Q 004400 489 LIYEYLENNSLARALFEHR-LKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDK---DLNSKISDFGLAK 564 (756)
Q Consensus 489 lV~e~~~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~---~~~~kl~DFGla~ 564 (756)
+|||||++|+|.+++.... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++. ++.+||+|||+++
T Consensus 136 lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~ 212 (400)
T 1nxk_A 136 IVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAK 212 (400)
T ss_dssp EEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSTTCCEEECCCTTCE
T ss_pred EEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCcceEEEecCCCCccEEEEeccccc
Confidence 9999999999999997543 46999999999999999999999986 999999999999998 7889999999998
Q ss_pred cCcccCcceeeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhcCcccccccc
Q 004400 565 LDEEENTHISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDT 644 (756)
Q Consensus 565 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 644 (756)
...... .....+||+.|+|||++.+..++.++|||||||++|||++|+.||..................+.. ....
T Consensus 213 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~-~~~~- 288 (400)
T 1nxk_A 213 ETTSHN--SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQY-EFPN- 288 (400)
T ss_dssp ECC-------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCC-CCCT-
T ss_pred ccCCCC--ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCcc-cCCC-
Confidence 654322 223467999999999999889999999999999999999999999655432211000000111111 0000
Q ss_pred CCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004400 645 NPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRM 682 (756)
Q Consensus 645 ~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~ 682 (756)
.....++ ..+.+++.+||+.||++|||+.|+++.
T Consensus 289 ~~~~~~s----~~~~~li~~~L~~dP~~Rpt~~eil~h 322 (400)
T 1nxk_A 289 PEWSEVS----EEVKMLIRNLLKTEPTQRMTITEFMNH 322 (400)
T ss_dssp TTTTTSC----HHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred cccccCC----HHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 0111223 348899999999999999999999875
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-40 Score=351.27 Aligned_cols=261 Identities=21% Similarity=0.298 Sum_probs=195.4
Q ss_pred hcCccccCcccCCCCccEEEee-ccCCcEEEEEEccccCc--ccHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEE
Q 004400 415 TNNFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSKSK--QGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIY 491 (756)
Q Consensus 415 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 491 (756)
.++|...+.||+|+||.||+|+ ..+++.||||++..... .....+.+|++++++++||||+++++++.+++..++||
T Consensus 33 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 112 (329)
T 3gbz_A 33 IDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIF 112 (329)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEEE
Confidence 4678999999999999999998 55789999999975432 22456789999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEec-----CCCCEEEccCCccccC
Q 004400 492 EYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLD-----KDLNSKISDFGLAKLD 566 (756)
Q Consensus 492 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~-----~~~~~kl~DFGla~~~ 566 (756)
||+++ +|.+++.... .+++..+..++.||+.||+|||+.+ |+||||||+|||++ .++.+||+|||+++..
T Consensus 113 e~~~~-~L~~~~~~~~-~~~~~~~~~i~~ql~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~ 187 (329)
T 3gbz_A 113 EYAEN-DLKKYMDKNP-DVSMRVIKSFLYQLINGVNFCHSRR---CLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAF 187 (329)
T ss_dssp ECCSE-EHHHHHHHCT-TCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEC-----CCEEEECCTTHHHHH
T ss_pred ecCCC-CHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHHhCC---EECCCCCHHHEEEecCCCCccceEEECcCCCcccc
Confidence 99985 9999987554 6999999999999999999999997 99999999999994 4556999999999865
Q ss_pred cccCcceeeccccCccCCchHhhhcC-CCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhcCcccc---cc
Q 004400 567 EEENTHISTRVAGTIGYMAPEYAMRG-HLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLME---LV 642 (756)
Q Consensus 567 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~---~~ 642 (756)
..... ......||+.|+|||++.+. .++.++|||||||++|||++|+.||....................... ..
T Consensus 188 ~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (329)
T 3gbz_A 188 GIPIR-QFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVT 266 (329)
T ss_dssp C------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSTTGG
T ss_pred CCccc-ccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhhhhhh
Confidence 43322 22345689999999999874 489999999999999999999999977655443322211111000000 00
Q ss_pred ------ccCCC-CCCCH------HHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 004400 643 ------DTNPG-SNFDK------EQVMVMINVALLCANASPTIRPSMSSVLR 681 (756)
Q Consensus 643 ------~~~~~-~~~~~------~~~~~l~~l~~~c~~~~P~~RPt~~ev~~ 681 (756)
...+. ..... .....+.+++.+|++.||++|||+.|+++
T Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 318 (329)
T 3gbz_A 267 ALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE 318 (329)
T ss_dssp GSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred hhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence 00000 00000 02235789999999999999999999986
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-40 Score=341.16 Aligned_cols=250 Identities=23% Similarity=0.301 Sum_probs=202.1
Q ss_pred cCccccCcccCCCCccEEEeecc-CCcEEEEEEccccCc------ccHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEE
Q 004400 416 NNFATDNNIGEGGFGPVYKGLLA-DGTAIAVKQLSSKSK------QGNREFINEIGMISALQHPNLVKLYGCCIEGNQLL 488 (756)
Q Consensus 416 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 488 (756)
++|...+.||+|+||.||+|+.. +++.||+|.+..... ...+.+.+|+.++++++||||+++++++.+++..+
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV 84 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence 56889999999999999999954 789999999865421 13578999999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCC----CEEEccCCccc
Q 004400 489 LIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDL----NSKISDFGLAK 564 (756)
Q Consensus 489 lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~----~~kl~DFGla~ 564 (756)
+||||+++++|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++ .+||+|||++.
T Consensus 85 lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~ 160 (283)
T 3bhy_A 85 LILELVSGGELFDFLAEK-ESLTEDEATQFLKQILDGVHYLHSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAH 160 (283)
T ss_dssp EEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSSSSCCEEECCCTTCE
T ss_pred EEEeecCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChHHEEEecCCCCCCceEEEecccce
Confidence 999999999999999754 47899999999999999999999996 99999999999999877 79999999998
Q ss_pred cCcccCcceeeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhcCcccccccc
Q 004400 565 LDEEENTHISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDT 644 (756)
Q Consensus 565 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 644 (756)
....... .....||+.|+|||++.+..++.++||||||+++|+|++|+.||............ ........ .
T Consensus 161 ~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~--~~~~~~~~----~ 232 (283)
T 3bhy_A 161 KIEAGNE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNI--SAVNYDFD----E 232 (283)
T ss_dssp ECC----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH--HTTCCCCC----H
T ss_pred eccCCCc--ccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHh--HhcccCCc----c
Confidence 6544322 23456899999999999889999999999999999999999999766543322211 00000000 0
Q ss_pred CCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 004400 645 NPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLR 681 (756)
Q Consensus 645 ~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~ 681 (756)
...... ...+.+++.+||+.||++||++.|+++
T Consensus 233 ~~~~~~----~~~~~~li~~~l~~dp~~Rps~~~~l~ 265 (283)
T 3bhy_A 233 EYFSNT----SELAKDFIRRLLVKDPKRRMTIAQSLE 265 (283)
T ss_dssp HHHTTC----CHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred hhcccC----CHHHHHHHHHHccCCHhHCcCHHHHHh
Confidence 000111 234889999999999999999999987
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-40 Score=352.50 Aligned_cols=263 Identities=22% Similarity=0.359 Sum_probs=200.7
Q ss_pred hcCccccCcccCCCCccEEEeec-cCCcEEEEEEccccCc--ccHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEE
Q 004400 415 TNNFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSKSK--QGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIY 491 (756)
Q Consensus 415 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 491 (756)
.++|+..+.||+|+||.||+|+. .+|+.||||++..... ...+.+.+|+.++++++||||+++++++.+++..++||
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 103 (331)
T 4aaa_A 24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVF 103 (331)
T ss_dssp GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEE
Confidence 35788999999999999999995 4689999999865432 23456789999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCcccCc
Q 004400 492 EYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENT 571 (756)
Q Consensus 492 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~~~~ 571 (756)
||+++++|.+++.. ...+++..+..++.|++.||+|||+.| |+||||||+||+++.++.+||+|||+++.......
T Consensus 104 e~~~~~~l~~~~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 179 (331)
T 4aaa_A 104 EFVDHTILDDLELF-PNGLDYQVVQKYLFQIINGIGFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE 179 (331)
T ss_dssp ECCSEEHHHHHHHS-TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCTTC--------
T ss_pred ecCCcchHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHHHCC---EEccCcChheEEEcCCCcEEEEeCCCceeecCCcc
Confidence 99999999887653 347999999999999999999999997 99999999999999999999999999986544322
Q ss_pred ceeeccccCccCCchHhhhcC-CCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHH------------hcCcc
Q 004400 572 HISTRVAGTIGYMAPEYAMRG-HLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLK------------EQGKL 638 (756)
Q Consensus 572 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~------------~~~~~ 638 (756)
......||+.|+|||++.+. .++.++|||||||++|||++|+.||................ .....
T Consensus 180 -~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (331)
T 4aaa_A 180 -VYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVF 258 (331)
T ss_dssp -----CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGGG
T ss_pred -ccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhcccc
Confidence 22345689999999999875 78999999999999999999999997665443322211110 00000
Q ss_pred ccccccCCCCCCC-----HHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004400 639 MELVDTNPGSNFD-----KEQVMVMINVALLCANASPTIRPSMSSVLRM 682 (756)
Q Consensus 639 ~~~~~~~~~~~~~-----~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~ 682 (756)
.....+......+ +.....+.+++.+||+.||++|||+.|+++.
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h 307 (331)
T 4aaa_A 259 AGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHH 307 (331)
T ss_dssp TTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred ccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 0000000000001 1123458999999999999999999998763
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-40 Score=342.99 Aligned_cols=250 Identities=29% Similarity=0.445 Sum_probs=198.7
Q ss_pred hcCccccCcccCCCCccEEEeeccCCcEEEEEEccccCcccHHHHHHHHHHHHhCCCCceeeEeeEEEeC-CeEEEEEEe
Q 004400 415 TNNFATDNNIGEGGFGPVYKGLLADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCCIEG-NQLLLIYEY 493 (756)
Q Consensus 415 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~~lV~e~ 493 (756)
.++|+..+.||+|+||.||+|... |+.||||.+.... ..+.+.+|++++++++||||+++++++.+. +..++||||
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~ 96 (278)
T 1byg_A 20 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 96 (278)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECC
T ss_pred hhhceEEeEEecCCCceEEEEEEc-CCEEEEEEecchh--HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEec
Confidence 467889999999999999999874 8899999997542 457899999999999999999999997654 478999999
Q ss_pred cCCCCHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCcccCcc
Q 004400 494 LENNSLARALFEHRL-KLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTH 572 (756)
Q Consensus 494 ~~~gsL~~~l~~~~~-~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~~~~~ 572 (756)
+++|+|.+++..... .+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++......
T Consensus 97 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~-- 171 (278)
T 1byg_A 97 MAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-- 171 (278)
T ss_dssp CTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC----------
T ss_pred CCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCCcceEEEeCCCcEEEeeccccccccccc--
Confidence 999999999975432 3889999999999999999999997 9999999999999999999999999997544321
Q ss_pred eeeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHh-CCCCCCccchhhHHHHHHHHHhcCccccccccCCCCCCC
Q 004400 573 ISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVS-GRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFD 651 (756)
Q Consensus 573 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 651 (756)
....+++.|+|||.+.+..++.++||||||+++|||++ |+.||........... . ..+... .....++
T Consensus 172 --~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~---~-~~~~~~-----~~~~~~~ 240 (278)
T 1byg_A 172 --DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPR---V-EKGYKM-----DAPDGCP 240 (278)
T ss_dssp ------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHH---H-TTTCCC-----CCCTTCC
T ss_pred --cCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH---H-hcCCCC-----CCcccCC
Confidence 22457889999999999999999999999999999998 9999966544332211 1 111111 1112223
Q ss_pred HHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhccCc
Q 004400 652 KEQVMVMINVALLCANASPTIRPSMSSVLRMLECGV 687 (756)
Q Consensus 652 ~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~L~~~~ 687 (756)
..+.+++.+||+.||++||++.|+++.|+++.
T Consensus 241 ----~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~ 272 (278)
T 1byg_A 241 ----PAVYEVMKNCWHLDAAMRPSFLQLREQLEHIK 272 (278)
T ss_dssp ----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ----HHHHHHHHHHhcCChhhCCCHHHHHHHHHHHH
Confidence 34889999999999999999999999998653
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-39 Score=340.11 Aligned_cols=252 Identities=27% Similarity=0.375 Sum_probs=200.0
Q ss_pred cCccccCcccCCCCccEEEee-ccCCcEEEEEEccccCcccHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEEec
Q 004400 416 NNFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYEYL 494 (756)
Q Consensus 416 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~ 494 (756)
++|.....||+|+||.||+|. ..+++.||||.+........+.+.+|+.+++.++||||+++++++.+.+..++||||+
T Consensus 22 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 101 (295)
T 2clq_A 22 DENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQV 101 (295)
T ss_dssp CTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeC
Confidence 345566799999999999999 4678999999997765555678999999999999999999999999999999999999
Q ss_pred CCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecC-CCCEEEccCCccccCcccCc
Q 004400 495 ENNSLARALFEHR--LKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDK-DLNSKISDFGLAKLDEEENT 571 (756)
Q Consensus 495 ~~gsL~~~l~~~~--~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~-~~~~kl~DFGla~~~~~~~~ 571 (756)
++++|.+++.... ..+++..+..++.|++.||+|||+.+ |+||||||+||+++. ++.+||+|||+++.......
T Consensus 102 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~ 178 (295)
T 2clq_A 102 PGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINP 178 (295)
T ss_dssp SEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTCCEEECCTTTCEESCC---
T ss_pred CCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCC---EEccCCChhhEEEECCCCCEEEeecccccccCCCCC
Confidence 9999999998653 35678899999999999999999996 999999999999987 89999999999986543222
Q ss_pred ceeeccccCccCCchHhhhcCC--CCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhcCccccccccCCCCC
Q 004400 572 HISTRVAGTIGYMAPEYAMRGH--LTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSN 649 (756)
Q Consensus 572 ~~~~~~~gt~~y~aPE~~~~~~--~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 649 (756)
......||+.|+|||++.+.. ++.++||||||+++|||++|+.||..........+..... ... ......
T Consensus 179 -~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~--~~~-----~~~~~~ 250 (295)
T 2clq_A 179 -CTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMF--KVH-----PEIPES 250 (295)
T ss_dssp ---CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHH--CCC-----CCCCTT
T ss_pred -cccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhccc--ccc-----cccccc
Confidence 123457899999999997653 8999999999999999999999996543222111111110 111 111122
Q ss_pred CCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004400 650 FDKEQVMVMINVALLCANASPTIRPSMSSVLRM 682 (756)
Q Consensus 650 ~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~ 682 (756)
++ ..+.+++.+||+.||++||++.++++.
T Consensus 251 ~~----~~~~~li~~~l~~dp~~Rps~~~ll~~ 279 (295)
T 2clq_A 251 MS----AEAKAFILKCFEPDPDKRACANDLLVD 279 (295)
T ss_dssp SC----HHHHHHHHHTTCSSTTTSCCHHHHHTS
T ss_pred CC----HHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 23 348899999999999999999999763
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=351.89 Aligned_cols=256 Identities=20% Similarity=0.347 Sum_probs=206.6
Q ss_pred HHHhhcCccccCcccCCCCccEEEeec-cCCcEEEEEEccccCc--------ccHHHHHHHHHHHHhC-CCCceeeEeeE
Q 004400 411 IKAATNNFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSKSK--------QGNREFINEIGMISAL-QHPNLVKLYGC 480 (756)
Q Consensus 411 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l-~h~niv~l~~~ 480 (756)
.....++|...+.||+|+||.||+|+. .+|+.||||++..... ...+.+.+|+.+++++ +||||++++++
T Consensus 89 ~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~ 168 (365)
T 2y7j_A 89 AKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDS 168 (365)
T ss_dssp HHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEE
T ss_pred hhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEE
Confidence 344567899999999999999999996 4799999999865431 1135678899999999 79999999999
Q ss_pred EEeCCeEEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccC
Q 004400 481 CIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDF 560 (756)
Q Consensus 481 ~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DF 560 (756)
+......++||||+++|+|.+++... ..+++..+..++.||+.||+|||+.| |+||||||+||+++.++.+||+||
T Consensus 169 ~~~~~~~~lv~e~~~g~~L~~~l~~~-~~l~~~~~~~i~~qi~~~L~~LH~~g---i~H~Dlkp~NIl~~~~~~ikl~Df 244 (365)
T 2y7j_A 169 YESSSFMFLVFDLMRKGELFDYLTEK-VALSEKETRSIMRSLLEAVSFLHANN---IVHRDLKPENILLDDNMQIRLSDF 244 (365)
T ss_dssp EEBSSEEEEEECCCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCC
T ss_pred EeeCCEEEEEEEeCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEEec
Confidence 99999999999999999999999754 47999999999999999999999997 999999999999999999999999
Q ss_pred CccccCcccCcceeeccccCccCCchHhhhc------CCCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHh
Q 004400 561 GLAKLDEEENTHISTRVAGTIGYMAPEYAMR------GHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKE 634 (756)
Q Consensus 561 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~ 634 (756)
|++........ .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||............ ..
T Consensus 245 G~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i---~~ 319 (365)
T 2y7j_A 245 GFSCHLEPGEK--LRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMI---ME 319 (365)
T ss_dssp TTCEECCTTCC--BCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH---HH
T ss_pred CcccccCCCcc--cccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHH---Hh
Confidence 99986554322 234679999999999874 35888999999999999999999999766544332211 11
Q ss_pred cCccccccccCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004400 635 QGKLMELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRM 682 (756)
Q Consensus 635 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~ 682 (756)
......... .... ...+.+++.+|++.||++||++.|+++.
T Consensus 320 ~~~~~~~~~---~~~~----~~~~~~li~~~L~~dP~~Rps~~ell~h 360 (365)
T 2y7j_A 320 GQYQFSSPE---WDDR----SSTVKDLISRLLQVDPEARLTAEQALQH 360 (365)
T ss_dssp TCCCCCHHH---HSSS----CHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred CCCCCCCcc---cccC----CHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 110000000 0111 2348899999999999999999999873
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-40 Score=346.62 Aligned_cols=256 Identities=25% Similarity=0.416 Sum_probs=199.3
Q ss_pred hcCccccCcccCCCCccEEEeecc--CCc--EEEEEEcccc---CcccHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeE
Q 004400 415 TNNFATDNNIGEGGFGPVYKGLLA--DGT--AIAVKQLSSK---SKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQL 487 (756)
Q Consensus 415 ~~~~~~~~~lg~G~~g~Vy~~~~~--~~~--~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 487 (756)
.++|+..+.||+|+||.||+|++. +++ .||||+++.. .....+.+.+|++++++++||||+++++++.++. .
T Consensus 17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~ 95 (291)
T 1u46_A 17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-M 95 (291)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-C
T ss_pred hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-c
Confidence 357889999999999999999853 333 6899998754 2234567899999999999999999999998765 8
Q ss_pred EEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCc
Q 004400 488 LLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDE 567 (756)
Q Consensus 488 ~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~ 567 (756)
++||||+++|+|.+++......+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++...
T Consensus 96 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~ 172 (291)
T 1u46_A 96 KMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRALP 172 (291)
T ss_dssp EEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred eeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEEcCCCCEEEcccccccccc
Confidence 8999999999999999876667999999999999999999999996 9999999999999999999999999998765
Q ss_pred ccCcce--eeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHh-CCCCCCccchhhHHHHHHHHHhcCcccccccc
Q 004400 568 EENTHI--STRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVS-GRSNVTKEDMFYLLDWALVLKEQGKLMELVDT 644 (756)
Q Consensus 568 ~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 644 (756)
...... .....+|+.|+|||++.+..++.++||||||+++|||++ |+.||...+....... .........
T Consensus 173 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~---~~~~~~~~~---- 245 (291)
T 1u46_A 173 QNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHK---IDKEGERLP---- 245 (291)
T ss_dssp C-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHH---HHTSCCCCC----
T ss_pred ccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHH---HHccCCCCC----
Confidence 433221 233567889999999998889999999999999999999 9999976654433221 111111111
Q ss_pred CCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhccC
Q 004400 645 NPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLECG 686 (756)
Q Consensus 645 ~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~L~~~ 686 (756)
....++ ..+.+++.+||+.||++||++.++++.|++.
T Consensus 246 -~~~~~~----~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~ 282 (291)
T 1u46_A 246 -RPEDCP----QDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 282 (291)
T ss_dssp -CCTTCC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -CCcCcC----HHHHHHHHHHccCCcccCcCHHHHHHHHHHh
Confidence 111223 3488999999999999999999999999864
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-40 Score=367.98 Aligned_cols=248 Identities=24% Similarity=0.338 Sum_probs=203.0
Q ss_pred hhcCccccCcccCCCCccEEEeec-cCCcEEEEEEccccC---cccHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEE
Q 004400 414 ATNNFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSKS---KQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLL 489 (756)
Q Consensus 414 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 489 (756)
..++|...+.||+|+||.||+|+. .+|+.||+|++.... ......+.+|+.++++++||||+++++++.+.+..|+
T Consensus 183 ~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~l 262 (543)
T 3c4z_A 183 GEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCL 262 (543)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred ChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEE
Confidence 347899999999999999999995 579999999996532 2345678999999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccC
Q 004400 490 IYEYLENNSLARALFEH---RLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLD 566 (756)
Q Consensus 490 V~e~~~~gsL~~~l~~~---~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~ 566 (756)
||||+++|+|.+++... ...+++..+..++.||+.||+|||++| |+||||||+|||++.++.+||+|||+++..
T Consensus 263 VmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g---IvHrDLKP~NILl~~~g~vkL~DFGla~~~ 339 (543)
T 3c4z_A 263 VMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVEL 339 (543)
T ss_dssp EECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcC---CcccCCChHHEEEeCCCCEEEeecceeeec
Confidence 99999999999999753 346999999999999999999999997 999999999999999999999999999865
Q ss_pred cccCcceeeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHhCCCCCCccchhh-HHHHHHHHHhcCccccccccC
Q 004400 567 EEENTHISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFY-LLDWALVLKEQGKLMELVDTN 645 (756)
Q Consensus 567 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~ 645 (756)
...... ....+||+.|+|||++.+..++.++|||||||++|||++|+.||....... ........... .. .
T Consensus 340 ~~~~~~-~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~-~~-~----- 411 (543)
T 3c4z_A 340 KAGQTK-TKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQ-AV-T----- 411 (543)
T ss_dssp CTTCCC-BCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHC-CC-C-----
T ss_pred cCCCcc-cccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhc-cc-C-----
Confidence 543222 234589999999999999999999999999999999999999996543211 11111111111 00 0
Q ss_pred CCCCCCHHHHHHHHHHHHHhhcCCCCCCCCH
Q 004400 646 PGSNFDKEQVMVMINVALLCANASPTIRPSM 676 (756)
Q Consensus 646 ~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~ 676 (756)
....++ ..+.+++.+|++.||++||++
T Consensus 412 ~p~~~s----~~~~~li~~lL~~dP~~R~~~ 438 (543)
T 3c4z_A 412 YPDKFS----PASKDFCEALLQKDPEKRLGF 438 (543)
T ss_dssp CCTTSC----HHHHHHHHHHSCSSGGGSCCC
T ss_pred CCcccC----HHHHHHHHHhccCCHhHCCCC
Confidence 111223 348899999999999999976
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-40 Score=381.11 Aligned_cols=247 Identities=27% Similarity=0.377 Sum_probs=199.0
Q ss_pred CcccCCCCccEEEeec---cCCcEEEEEEccccC--cccHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEEecCC
Q 004400 422 NNIGEGGFGPVYKGLL---ADGTAIAVKQLSSKS--KQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYEYLEN 496 (756)
Q Consensus 422 ~~lg~G~~g~Vy~~~~---~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~ 496 (756)
+.||+|+||.||+|.+ ..++.||||+++... ....+++.+|++++++++|||||+++++|.+ +..++|||||++
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~ 453 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 453 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence 4799999999999964 346789999997643 2335789999999999999999999999964 568999999999
Q ss_pred CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCcccCcc--ee
Q 004400 497 NSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTH--IS 574 (756)
Q Consensus 497 gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~~~~~--~~ 574 (756)
|+|.+++... ..+++..+..++.||+.||+|||+++ ||||||||+|||++.++.+||+|||+++........ ..
T Consensus 454 g~L~~~l~~~-~~l~~~~~~~i~~qi~~~L~yLH~~~---iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~ 529 (635)
T 4fl3_A 454 GPLNKYLQQN-RHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQ 529 (635)
T ss_dssp EEHHHHHHHC-TTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCTTHHHHTTC--------
T ss_pred CCHHHHHhhC-CCCCHHHHHHHHHHHHHHHHHHHHCC---EeCCCCChHhEEEeCCCCEEEEEcCCccccccCccccccc
Confidence 9999999754 47999999999999999999999997 999999999999999999999999999866543322 22
Q ss_pred eccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHh-CCCCCCccchhhHHHHHHHHHhcCccccccccCCCCCCCHH
Q 004400 575 TRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVS-GRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDKE 653 (756)
Q Consensus 575 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 653 (756)
....||+.|+|||++.+..++.++|||||||++|||++ |+.||........... ...+...... ..++
T Consensus 530 ~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~----i~~~~~~~~p-----~~~~-- 598 (635)
T 4fl3_A 530 THGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAM----LEKGERMGCP-----AGCP-- 598 (635)
T ss_dssp -----CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHH----HHTTCCCCCC-----TTCC--
T ss_pred cCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH----HHcCCCCCCC-----CCCC--
Confidence 33457889999999999999999999999999999998 9999977655433221 1122211111 1223
Q ss_pred HHHHHHHHHHHhhcCCCCCCCCHHHHHHHhccC
Q 004400 654 QVMVMINVALLCANASPTIRPSMSSVLRMLECG 686 (756)
Q Consensus 654 ~~~~l~~l~~~c~~~~P~~RPt~~ev~~~L~~~ 686 (756)
..+.+++.+||+.||++||++.+|++.|+.+
T Consensus 599 --~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~ 629 (635)
T 4fl3_A 599 --REMYDLMNLCWTYDVENRPGFAAVELRLRNY 629 (635)
T ss_dssp --HHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred --HHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 3488999999999999999999999999854
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-40 Score=345.63 Aligned_cols=254 Identities=24% Similarity=0.420 Sum_probs=202.4
Q ss_pred hhcCccccCcccCCCCccEEEeecc-CCcEEEEEEccccCcccHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEE
Q 004400 414 ATNNFATDNNIGEGGFGPVYKGLLA-DGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYE 492 (756)
Q Consensus 414 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 492 (756)
..++|+..+.||+|+||.||+|... +++.||+|.+........+.+.+|+++++.++||||+++++++.+++..++|||
T Consensus 17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 96 (302)
T 2j7t_A 17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIE 96 (302)
T ss_dssp GGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEE
T ss_pred CccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEE
Confidence 3468899999999999999999954 689999999987666667889999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCcccCcc
Q 004400 493 YLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTH 572 (756)
Q Consensus 493 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~~~~~ 572 (756)
|+++++|.+++......+++..+..++.|++.||+|||+.| |+||||||+||+++.++.+||+|||++....... .
T Consensus 97 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~ 172 (302)
T 2j7t_A 97 FCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKR---IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTL-Q 172 (302)
T ss_dssp CCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHH-H
T ss_pred eCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEECCCCCEEEEECCCCccccccc-c
Confidence 99999999999876678999999999999999999999997 9999999999999999999999999976432211 1
Q ss_pred eeeccccCccCCchHhhh-----cCCCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhcCccccccccCCC
Q 004400 573 ISTRVAGTIGYMAPEYAM-----RGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPG 647 (756)
Q Consensus 573 ~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 647 (756)
......||+.|+|||++. ...++.++||||||+++|||++|+.||...+...... ...... .....
T Consensus 173 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~---~~~~~~-~~~~~----- 243 (302)
T 2j7t_A 173 KRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLL---KIAKSD-PPTLL----- 243 (302)
T ss_dssp C-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH---HHHHSC-CCCCS-----
T ss_pred ccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHH---HHhccC-CcccC-----
Confidence 123356899999999984 5678999999999999999999999997655433221 111111 11110
Q ss_pred CCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004400 648 SNFDKEQVMVMINVALLCANASPTIRPSMSSVLRM 682 (756)
Q Consensus 648 ~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~ 682 (756)
.+......+.+++.+||+.||++|||+.++++.
T Consensus 244 --~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 276 (302)
T 2j7t_A 244 --TPSKWSVEFRDFLKIALDKNPETRPSAAQLLEH 276 (302)
T ss_dssp --SGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTTS
T ss_pred --CccccCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 011122348899999999999999999998763
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-40 Score=341.23 Aligned_cols=248 Identities=26% Similarity=0.421 Sum_probs=204.8
Q ss_pred hhcCccccCcccCCCCccEEEeecc-CCcEEEEEEccccCcccHHHHHHHHHHHHhCCCCceeeEeeEEEe---------
Q 004400 414 ATNNFATDNNIGEGGFGPVYKGLLA-DGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCCIE--------- 483 (756)
Q Consensus 414 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--------- 483 (756)
..++|+..+.||+|+||.||+|... +++.||+|.+.... ..+.+|++++++++||||+++++++..
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 84 (284)
T 2a19_B 9 FGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSS 84 (284)
T ss_dssp HHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-----
T ss_pred hccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccc
Confidence 3467899999999999999999954 79999999986543 356789999999999999999999865
Q ss_pred -------CCeEEEEEEecCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCE
Q 004400 484 -------GNQLLLIYEYLENNSLARALFEH-RLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNS 555 (756)
Q Consensus 484 -------~~~~~lV~e~~~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~ 555 (756)
....++||||+++|+|.+++... ...+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+
T Consensus 85 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~ 161 (284)
T 2a19_B 85 KNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKK---LINRDLKPSNIFLVDTKQV 161 (284)
T ss_dssp ----CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEE
T ss_pred ccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHEEEcCCCCE
Confidence 45589999999999999999753 357999999999999999999999996 9999999999999999999
Q ss_pred EEccCCccccCcccCcceeeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhc
Q 004400 556 KISDFGLAKLDEEENTHISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQ 635 (756)
Q Consensus 556 kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~ 635 (756)
||+|||+++....... .....||+.|+|||.+.+..++.++||||||+++|||++|..|+..... +.... ..
T Consensus 162 kl~Dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~-----~~~~~-~~ 233 (284)
T 2a19_B 162 KIGDFGLVTSLKNDGK--RTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSK-----FFTDL-RD 233 (284)
T ss_dssp EECCCTTCEESSCCSC--CCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHHHH-----HHHHH-HT
T ss_pred EECcchhheecccccc--ccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhHHH-----HHHHh-hc
Confidence 9999999986654322 2345699999999999999999999999999999999999988732211 11111 11
Q ss_pred CccccccccCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhccCcc
Q 004400 636 GKLMELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLECGVD 688 (756)
Q Consensus 636 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~L~~~~~ 688 (756)
.. ....++. .+.+++.+||+.||++||++.|+++.|+.+..
T Consensus 234 ~~--------~~~~~~~----~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~ 274 (284)
T 2a19_B 234 GI--------ISDIFDK----KEKTLLQKLLSKKPEDRPNTSEILRTLTVWKK 274 (284)
T ss_dssp TC--------CCTTSCH----HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC
T ss_pred cc--------ccccCCH----HHHHHHHHHccCChhhCcCHHHHHHHHHHHhh
Confidence 11 1122333 37899999999999999999999999986644
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=353.09 Aligned_cols=261 Identities=21% Similarity=0.335 Sum_probs=199.1
Q ss_pred hcCccccCcccCCCCccEEEeec-cCCcEEEEEEcccc--CcccHHHHHHHHHHHHhCCCCceeeEeeEEEeCC------
Q 004400 415 TNNFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSK--SKQGNREFINEIGMISALQHPNLVKLYGCCIEGN------ 485 (756)
Q Consensus 415 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------ 485 (756)
.++|...+.||+|+||.||+|.. .+|+.||||++... .....+.+.+|+++++.++||||+++++++..++
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 103 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 103 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence 35788999999999999999994 67999999998653 2233467889999999999999999999998763
Q ss_pred eEEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCcccc
Q 004400 486 QLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKL 565 (756)
Q Consensus 486 ~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~ 565 (756)
..|+||||+ +++|.+++.. ..+++..+..++.||++||+|||+.| |+||||||+||+++.++.+||+|||+++.
T Consensus 104 ~~~lv~e~~-~~~L~~~~~~--~~l~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 177 (367)
T 1cm8_A 104 DFYLVMPFM-GTDLGKLMKH--EKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQ 177 (367)
T ss_dssp CCEEEEECC-SEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred eEEEEEecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCHHHEEEcCCCCEEEEeeecccc
Confidence 469999999 8899999875 36899999999999999999999997 99999999999999999999999999986
Q ss_pred CcccCcceeeccccCccCCchHhhhc-CCCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhcCc-------
Q 004400 566 DEEENTHISTRVAGTIGYMAPEYAMR-GHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGK------- 637 (756)
Q Consensus 566 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~------- 637 (756)
.... .....||+.|+|||++.+ ..++.++||||+||++|||++|+.||.+.+................
T Consensus 178 ~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~ 253 (367)
T 1cm8_A 178 ADSE----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRL 253 (367)
T ss_dssp CCSS----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTC
T ss_pred cccc----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHh
Confidence 5432 234578999999999987 6799999999999999999999999977665443322211111000
Q ss_pred -----------cccccccCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH--hccC
Q 004400 638 -----------LMELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRM--LECG 686 (756)
Q Consensus 638 -----------~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~--L~~~ 686 (756)
....... ............+.+++.+|++.||++|||+.|+++. ++..
T Consensus 254 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~ 314 (367)
T 1cm8_A 254 QSDEAKNYMKGLPELEKK-DFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESL 314 (367)
T ss_dssp SCHHHHHHHHHSCCCCCC-CGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTT
T ss_pred hhHHHHHHHHhCCCCCCC-CHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhh
Confidence 0000000 0000111123348899999999999999999999874 4443
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-40 Score=345.40 Aligned_cols=251 Identities=22% Similarity=0.354 Sum_probs=204.1
Q ss_pred hcCccccCcccCCCCccEEEeec-cCCcEEEEEEccccCcccHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEEe
Q 004400 415 TNNFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYEY 493 (756)
Q Consensus 415 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 493 (756)
.++|...+.||+|+||.||+|+. .+|+.||+|.+..........+.+|+.++++++||||+++++++.+++..++||||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 87 (304)
T 2jam_A 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQL 87 (304)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEc
Confidence 45788999999999999999995 57999999999765444556789999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEe---cCCCCEEEccCCccccCcccC
Q 004400 494 LENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLL---DKDLNSKISDFGLAKLDEEEN 570 (756)
Q Consensus 494 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill---~~~~~~kl~DFGla~~~~~~~ 570 (756)
+++|+|.+++.... .+++..+..++.|++.||+|||+.| |+||||||+||++ +.++.+||+|||+++......
T Consensus 88 ~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~ 163 (304)
T 2jam_A 88 VSGGELFDRILERG-VYTEKDASLVIQQVLSAVKYLHENG---IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGI 163 (304)
T ss_dssp CCSCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCBT
T ss_pred CCCccHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEecCCCCCCEEEccCCcceecCCCc
Confidence 99999999987543 6899999999999999999999997 9999999999999 788899999999997644321
Q ss_pred cceeeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhcCccccccccCCCCCC
Q 004400 571 THISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNF 650 (756)
Q Consensus 571 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 650 (756)
.....||+.|+|||.+.+..++.++||||||+++|||++|+.||........... ... +.. .. ........
T Consensus 164 ---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~---i~~-~~~-~~-~~~~~~~~ 234 (304)
T 2jam_A 164 ---MSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEK---IKE-GYY-EF-ESPFWDDI 234 (304)
T ss_dssp ---THHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHH---HHH-CCC-CC-CTTTTTTS
T ss_pred ---cccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHH---HHc-CCC-CC-CccccccC
Confidence 2335689999999999988999999999999999999999999976654333221 111 110 00 01111122
Q ss_pred CHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004400 651 DKEQVMVMINVALLCANASPTIRPSMSSVLRM 682 (756)
Q Consensus 651 ~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~ 682 (756)
+ ..+.+++.+|++.||++||++.|+++.
T Consensus 235 ~----~~~~~li~~~l~~dp~~Rps~~~~l~h 262 (304)
T 2jam_A 235 S----ESAKDFICHLLEKDPNERYTCEKALSH 262 (304)
T ss_dssp C----HHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred C----HHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 3 348899999999999999999999863
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-40 Score=355.95 Aligned_cols=269 Identities=23% Similarity=0.362 Sum_probs=204.4
Q ss_pred hhhHHHhhcCccccCcccCCCCccEEEeeccCCcEEEEEEccccCcc-----------cHHHHHHHHHHHHhCCCCceee
Q 004400 408 YLQIKAATNNFATDNNIGEGGFGPVYKGLLADGTAIAVKQLSSKSKQ-----------GNREFINEIGMISALQHPNLVK 476 (756)
Q Consensus 408 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-----------~~~~~~~E~~~l~~l~h~niv~ 476 (756)
..++....++|...+.||+|+||.||+|...+|+.||||++...... ..+.+.+|++++++++||||++
T Consensus 14 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~ 93 (362)
T 3pg1_A 14 IAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILG 93 (362)
T ss_dssp HHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred HHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccc
Confidence 45677888999999999999999999999888999999998653221 1267899999999999999999
Q ss_pred EeeEEEeC-----CeEEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecC
Q 004400 477 LYGCCIEG-----NQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDK 551 (756)
Q Consensus 477 l~~~~~~~-----~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~ 551 (756)
+++++... ...++||||++ |+|.+++......+++..+..++.||+.||+|||+.+ |+||||||+||+++.
T Consensus 94 ~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~ 169 (362)
T 3pg1_A 94 LRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAG---VVHRDLHPGNILLAD 169 (362)
T ss_dssp CSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECT
T ss_pred eeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCc---CEecCCChHHEEEcC
Confidence 99999653 36899999998 6888888876668999999999999999999999997 999999999999999
Q ss_pred CCCEEEccCCccccCcccCcceeeccccCccCCchHhhhc-CCCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHH
Q 004400 552 DLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPEYAMR-GHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWAL 630 (756)
Q Consensus 552 ~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~ 630 (756)
++.+||+|||+++....... .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.............
T Consensus 170 ~~~~kl~Dfg~~~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~ 247 (362)
T 3pg1_A 170 NNDITICDFNLAREDTADAN--KTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIV 247 (362)
T ss_dssp TCCEEECCTTC-----------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH
T ss_pred CCCEEEEecCcccccccccc--cceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 99999999999975433222 234578999999999987 679999999999999999999999997766544333222
Q ss_pred HHHhcCcccc---------------ccccCCCCC---CCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004400 631 VLKEQGKLME---------------LVDTNPGSN---FDKEQVMVMINVALLCANASPTIRPSMSSVLRM 682 (756)
Q Consensus 631 ~~~~~~~~~~---------------~~~~~~~~~---~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~ 682 (756)
.......... .....+... ..+.....+.+++.+|++.||++|||+.|+++.
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 317 (362)
T 3pg1_A 248 EVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRH 317 (362)
T ss_dssp HHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred HHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcC
Confidence 1111111000 000000000 011122358899999999999999999999864
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-40 Score=350.27 Aligned_cols=264 Identities=27% Similarity=0.402 Sum_probs=198.4
Q ss_pred hcCccccCcccCCCCccEEEeeccCCcEEEEEEccccCcccHHHHHHHHHH--HHhCCCCceeeEeeEEEe-----CCeE
Q 004400 415 TNNFATDNNIGEGGFGPVYKGLLADGTAIAVKQLSSKSKQGNREFINEIGM--ISALQHPNLVKLYGCCIE-----GNQL 487 (756)
Q Consensus 415 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~--l~~l~h~niv~l~~~~~~-----~~~~ 487 (756)
.++|...+.||+|+||.||+|+. +++.||||++... ....+..|.++ +..++||||+++++++.. ....
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 87 (336)
T 3g2f_A 12 LDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFA---NRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEY 87 (336)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred hHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeecc---chhhHHHHHHHHHHHhccCcchhhheecccccccCCCceE
Confidence 46889999999999999999976 6899999998643 23445555555 445899999999987653 2367
Q ss_pred EEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcC---------CCCCeEcCCCCCCceEecCCCCEEEc
Q 004400 488 LLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGE---------SRIKVVHRDIKATNVLLDKDLNSKIS 558 (756)
Q Consensus 488 ~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~---------g~~~iiH~Dikp~Nill~~~~~~kl~ 558 (756)
++||||+++|+|.+++... ..++..+..++.||+.||+|||+. + |+||||||+|||++.++.+||+
T Consensus 88 ~lv~e~~~~g~L~~~l~~~--~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~---ivH~Dikp~Nill~~~~~~kL~ 162 (336)
T 3g2f_A 88 LLVMEYYPNGSLXKYLSLH--TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPA---ISHRDLNSRNVLVKNDGTCVIS 162 (336)
T ss_dssp EEEECCCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCC---EECSSCSGGGEEECTTSCEEEC
T ss_pred EEEEecCCCCcHHHHHhhc--ccchhHHHHHHHHHHHHHHHHHhhhccccccccc---eeecccccceEEEcCCCcEEEe
Confidence 8999999999999999754 458999999999999999999988 6 9999999999999999999999
Q ss_pred cCCccccCcccC-------cceeeccccCccCCchHhhhc-------CCCCcccchhhHHHHHHHHHhCCCCCCccchhh
Q 004400 559 DFGLAKLDEEEN-------THISTRVAGTIGYMAPEYAMR-------GHLTEKADVYSFGIVALEIVSGRSNVTKEDMFY 624 (756)
Q Consensus 559 DFGla~~~~~~~-------~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~ 624 (756)
|||+++...... ........||+.|+|||++.+ ..++.++|||||||++|||++|+.||.......
T Consensus 163 DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~ 242 (336)
T 3g2f_A 163 DFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVP 242 (336)
T ss_dssp CCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCC
T ss_pred eccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchh
Confidence 999998654322 112234579999999999976 456779999999999999999988774332110
Q ss_pred H---------------HHHHHHHHhcCccccccccCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhccCccc
Q 004400 625 L---------------LDWALVLKEQGKLMELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLECGVDV 689 (756)
Q Consensus 625 ~---------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~L~~~~~~ 689 (756)
. .++............+... ..........+.+++.+||+.||++|||+.|+++.|+++...
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~~ 319 (336)
T 3g2f_A 243 EYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEA---WKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMI 319 (336)
T ss_dssp CCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTT---CCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred HHHHhhhcccCCCchHHHHHhhhcccccCCCCCcc---cccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHHH
Confidence 0 0011111111111111111 111223555799999999999999999999999999977554
Q ss_pred c
Q 004400 690 L 690 (756)
Q Consensus 690 ~ 690 (756)
.
T Consensus 320 ~ 320 (336)
T 3g2f_A 320 W 320 (336)
T ss_dssp C
T ss_pred H
Confidence 3
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-39 Score=339.37 Aligned_cols=249 Identities=23% Similarity=0.350 Sum_probs=205.5
Q ss_pred hcCccccCcccCCCCccEEEeec-cCCcEEEEEEccccC---cccHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEE
Q 004400 415 TNNFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSKS---KQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLI 490 (756)
Q Consensus 415 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 490 (756)
.++|...+.||+|+||.||+|.. .+++.||+|.+.... ....+.+.+|+.+++.++||||+++++++.+++..++|
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 93 (294)
T 2rku_A 14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 93 (294)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEE
Confidence 46788999999999999999995 468899999986542 23456788999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCcccC
Q 004400 491 YEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEEN 570 (756)
Q Consensus 491 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~~~ 570 (756)
|||+++++|.+++... ..+++..+..++.|++.||+|||+.| |+||||||+||+++.++.+||+|||+++......
T Consensus 94 ~e~~~~~~L~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~ 169 (294)
T 2rku_A 94 LELCRRRSLLELHKRR-KALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG 169 (294)
T ss_dssp EECCTTCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred EecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEcCCCCEEEEeccCceecccCc
Confidence 9999999999988654 47999999999999999999999997 9999999999999999999999999998654332
Q ss_pred cceeeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhcCccccccccCCCCCC
Q 004400 571 THISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNF 650 (756)
Q Consensus 571 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 650 (756)
.. .....||+.|+|||.+.+..++.++||||||+++|||++|+.||........... ... ... . .....
T Consensus 170 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~---~~~-~~~-~-----~~~~~ 238 (294)
T 2rku_A 170 ER-KKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLR---IKK-NEY-S-----IPKHI 238 (294)
T ss_dssp CC-BCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHH---HHT-TCC-C-----CCTTS
T ss_pred cc-cccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH---Hhh-ccC-C-----Ccccc
Confidence 22 2345799999999999988899999999999999999999999976554332211 111 110 0 11122
Q ss_pred CHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004400 651 DKEQVMVMINVALLCANASPTIRPSMSSVLRM 682 (756)
Q Consensus 651 ~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~ 682 (756)
+ ..+.+++.+||+.||++||++.|+++.
T Consensus 239 ~----~~~~~li~~~l~~~p~~Rps~~~ll~~ 266 (294)
T 2rku_A 239 N----PVAASLIQKMLQTDPTARPTINELLND 266 (294)
T ss_dssp C----HHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred C----HHHHHHHHHHcccChhhCcCHHHHhhC
Confidence 2 348899999999999999999998763
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=352.71 Aligned_cols=261 Identities=21% Similarity=0.364 Sum_probs=203.9
Q ss_pred hcCccccCcccCCCCccEEEeec-cCCcEEEEEEcccc-CcccHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEE
Q 004400 415 TNNFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSK-SKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYE 492 (756)
Q Consensus 415 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 492 (756)
.++|...+.||+|+||.||+|.. .+++.||+|++... .....+.+.+|+.++++++||||+++++++.+++..++|||
T Consensus 32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 111 (360)
T 3eqc_A 32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 111 (360)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEE
Confidence 46899999999999999999995 47899999998764 23345678999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcC-CCCCeEcCCCCCCceEecCCCCEEEccCCccccCcccCc
Q 004400 493 YLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGE-SRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENT 571 (756)
Q Consensus 493 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~-g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~~~~ 571 (756)
|+++|+|.+++.... .+++..+..++.|++.||+|||+. | |+||||||+||+++.++.+||+|||+++.....
T Consensus 112 ~~~~~~L~~~l~~~~-~~~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-- 185 (360)
T 3eqc_A 112 HMDGGSLDQVLKKAG-RIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-- 185 (360)
T ss_dssp CCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH--
T ss_pred CCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHhCC---EEcCCccHHHEEECCCCCEEEEECCCCcccccc--
Confidence 999999999997553 689999999999999999999985 5 999999999999999999999999999754322
Q ss_pred ceeeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhc----------------
Q 004400 572 HISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQ---------------- 635 (756)
Q Consensus 572 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~---------------- 635 (756)
......||+.|+|||++.+..++.++|||||||++|||++|+.||...+..............
T Consensus 186 -~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (360)
T 3eqc_A 186 -MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPL 264 (360)
T ss_dssp -C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC---------------------
T ss_pred -cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCCcc
Confidence 123457999999999999999999999999999999999999999665433221110000000
Q ss_pred ----------Ccccc----ccccCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004400 636 ----------GKLME----LVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRM 682 (756)
Q Consensus 636 ----------~~~~~----~~~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~ 682 (756)
....+ .................+.+++.+||+.||++|||+.|+++.
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 325 (360)
T 3eqc_A 265 NKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVH 325 (360)
T ss_dssp ---------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred cccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence 00000 000000000011123358899999999999999999999764
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=339.22 Aligned_cols=257 Identities=27% Similarity=0.399 Sum_probs=205.2
Q ss_pred hcCccccCcccCCCCccEEEeec-cCCcEEEEEEccccC--cccHHHHHHHHHHHHhCCCCceeeEeeEEEe--CCeEEE
Q 004400 415 TNNFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSKS--KQGNREFINEIGMISALQHPNLVKLYGCCIE--GNQLLL 489 (756)
Q Consensus 415 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~l 489 (756)
.++|+..+.||+|+||.||+|.. .+++.||+|.+.... ....+.+.+|+.++++++||||+++++++.+ +...++
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 84 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 84 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence 46888999999999999999995 578999999986542 3345678999999999999999999998865 578999
Q ss_pred EEEecCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHcCC--CCCeEcCCCCCCceEecCCCCEEEccCCccc
Q 004400 490 IYEYLENNSLARALFEH---RLKLDWPTRRRICLGIARGLAYLHGES--RIKVVHRDIKATNVLLDKDLNSKISDFGLAK 564 (756)
Q Consensus 490 V~e~~~~gsL~~~l~~~---~~~l~~~~~~~i~~~ia~~L~~LH~~g--~~~iiH~Dikp~Nill~~~~~~kl~DFGla~ 564 (756)
||||+++|+|.+++... ...+++..+..++.|++.||+|||+.+ ..+|+||||||+||+++.++.+||+|||+++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~ 164 (279)
T 2w5a_A 85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR 164 (279)
T ss_dssp EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHHH
T ss_pred EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchhe
Confidence 99999999999999743 345999999999999999999999874 1239999999999999999999999999998
Q ss_pred cCcccCcceeeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhcCcccccccc
Q 004400 565 LDEEENTHISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDT 644 (756)
Q Consensus 565 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 644 (756)
........ .....||+.|+|||.+.+..++.++||||||+++|||++|+.||...+....... . ..+.....
T Consensus 165 ~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~---i-~~~~~~~~--- 236 (279)
T 2w5a_A 165 ILNHDTSF-AKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGK---I-REGKFRRI--- 236 (279)
T ss_dssp HC---CHH-HHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH---H-HHTCCCCC---
T ss_pred eecccccc-ccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHH---H-hhcccccC---
Confidence 65443221 2235689999999999998999999999999999999999999976654333221 1 11111111
Q ss_pred CCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhcc
Q 004400 645 NPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLEC 685 (756)
Q Consensus 645 ~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~L~~ 685 (756)
...++ ..+.+++.+||+.||++||++.||++.+..
T Consensus 237 --~~~~~----~~l~~li~~~l~~~p~~Rps~~~ll~~~~~ 271 (279)
T 2w5a_A 237 --PYRYS----DELNEIITRMLNLKDYHRPSVEEILENPLI 271 (279)
T ss_dssp --CTTSC----HHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred --CcccC----HHHHHHHHHHcCCCcccCCCHHHHHhChhh
Confidence 11223 348899999999999999999999988764
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=365.81 Aligned_cols=251 Identities=23% Similarity=0.383 Sum_probs=204.4
Q ss_pred hcCccccCcccCCCCccEEEeec-cCCcEEEEEEcccc--CcccHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEE
Q 004400 415 TNNFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSK--SKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIY 491 (756)
Q Consensus 415 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 491 (756)
.++|...+.||+|+||.||+|+. .+++.||||++... .......+.+|++++++++|||||++++++.++...++||
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 100 (486)
T 3mwu_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVG 100 (486)
T ss_dssp HHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEE
Confidence 45788999999999999999995 57899999998653 2334578899999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEec---CCCCEEEccCCccccCcc
Q 004400 492 EYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLD---KDLNSKISDFGLAKLDEE 568 (756)
Q Consensus 492 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~---~~~~~kl~DFGla~~~~~ 568 (756)
||+.+|+|.+.+... ..+++..+..++.||+.||+|||+.| |+||||||+|||++ .++.+||+|||+++....
T Consensus 101 e~~~~~~L~~~~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~ 176 (486)
T 3mwu_A 101 ELYTGGELFDEIIKR-KRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ 176 (486)
T ss_dssp CCCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCC
T ss_pred EcCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEEECCcCeECCC
Confidence 999999999998755 47999999999999999999999997 99999999999995 456799999999986544
Q ss_pred cCcceeeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhcCccccccccCCCC
Q 004400 569 ENTHISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGS 648 (756)
Q Consensus 569 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 648 (756)
... .....||+.|+|||++.+ .++.++||||+||++|+|++|+.||...+........ .......... ...
T Consensus 177 ~~~--~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i---~~~~~~~~~~---~~~ 247 (486)
T 3mwu_A 177 NTK--MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRV---ETGKYAFDLP---QWR 247 (486)
T ss_dssp C------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH---HHTCCCSCSG---GGG
T ss_pred CCc--cCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH---HhCCCCCCCc---ccC
Confidence 322 234579999999999865 6999999999999999999999999776654443321 1111100000 011
Q ss_pred CCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004400 649 NFDKEQVMVMINVALLCANASPTIRPSMSSVLRM 682 (756)
Q Consensus 649 ~~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~ 682 (756)
..+ ..+.+++.+||+.||++|||+.|+++.
T Consensus 248 ~~s----~~~~~li~~~L~~dp~~R~t~~~~l~h 277 (486)
T 3mwu_A 248 TIS----DDAKDLIRKMLTFHPSLRITATQCLEH 277 (486)
T ss_dssp GSC----HHHHHHHHHHTCSSTTTSCCHHHHHHC
T ss_pred CCC----HHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 122 348899999999999999999999874
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-39 Score=337.11 Aligned_cols=246 Identities=22% Similarity=0.349 Sum_probs=204.5
Q ss_pred hcCccccCcccCCCCccEEEeec-cCCcEEEEEEccccC---cccHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEE
Q 004400 415 TNNFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSKS---KQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLI 490 (756)
Q Consensus 415 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 490 (756)
.++|...+.||+|+||.||+|.. .+++.||+|.+.... ......+.+|++++++++||||+++++++.+++..++|
T Consensus 13 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 92 (284)
T 2vgo_A 13 IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLM 92 (284)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEE
Confidence 36788999999999999999995 467899999986531 22346789999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCcccC
Q 004400 491 YEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEEN 570 (756)
Q Consensus 491 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~~~ 570 (756)
|||+++|+|.+++.... .+++..+..++.|++.||+|||+.| |+||||||+||+++.++.+||+|||++.......
T Consensus 93 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~ 168 (284)
T 2vgo_A 93 LEFAPRGELYKELQKHG-RFDEQRSATFMEELADALHYCHERK---VIHRDIKPENLLMGYKGELKIADFGWSVHAPSLR 168 (284)
T ss_dssp ECCCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTCCEEECCCTTCEECSSSC
T ss_pred EEeCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEEcCCCCEEEecccccccCcccc
Confidence 99999999999997553 6899999999999999999999986 9999999999999999999999999987544322
Q ss_pred cceeeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhcCccccccccCCCCCC
Q 004400 571 THISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNF 650 (756)
Q Consensus 571 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 650 (756)
.....|++.|+|||.+.+..++.++||||||+++|||++|+.||........... ... .. ......+
T Consensus 169 ---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~---~~~-~~------~~~~~~~ 235 (284)
T 2vgo_A 169 ---RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRR---IVN-VD------LKFPPFL 235 (284)
T ss_dssp ---BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHH---HHT-TC------CCCCTTS
T ss_pred ---cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHH---Hhc-cc------cCCCCcC
Confidence 2345789999999999998999999999999999999999999976544332211 111 00 0111122
Q ss_pred CHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 004400 651 DKEQVMVMINVALLCANASPTIRPSMSSVLR 681 (756)
Q Consensus 651 ~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~ 681 (756)
+ ..+.+++.+|++.||.+||++.|+++
T Consensus 236 ~----~~~~~li~~~l~~~p~~Rps~~~ll~ 262 (284)
T 2vgo_A 236 S----DGSKDLISKLLRYHPPQRLPLKGVME 262 (284)
T ss_dssp C----HHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred C----HHHHHHHHHHhhcCHhhCCCHHHHhh
Confidence 2 34889999999999999999999976
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=346.72 Aligned_cols=248 Identities=23% Similarity=0.354 Sum_probs=205.7
Q ss_pred hcCccccCcccCCCCccEEEeec-cCCcEEEEEEcccc---CcccHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEE
Q 004400 415 TNNFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSK---SKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLI 490 (756)
Q Consensus 415 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 490 (756)
.++|...+.||+|+||.||+|.. .+++.||+|++... .....+.+.+|+.+++.++||||+++++++.+++..++|
T Consensus 40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 119 (335)
T 2owb_A 40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 119 (335)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence 45788899999999999999995 46889999998654 223456788999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCcccC
Q 004400 491 YEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEEN 570 (756)
Q Consensus 491 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~~~ 570 (756)
|||+++++|.+++... ..+++..+..++.|++.||+|||+++ |+||||||+||+++.++.+||+|||+++......
T Consensus 120 ~e~~~~~~L~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~ 195 (335)
T 2owb_A 120 LELCRRRSLLELHKRR-KALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG 195 (335)
T ss_dssp ECCCTTCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred EecCCCCCHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC---CEecCCCchhEEEcCCCCEEEeeccCceecccCc
Confidence 9999999999988654 47999999999999999999999997 9999999999999999999999999998654332
Q ss_pred cceeeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhcCccccccccCCCCCC
Q 004400 571 THISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNF 650 (756)
Q Consensus 571 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 650 (756)
. ......||+.|+|||++.+..++.++||||||+++|||++|+.||........... .... .. . ....+
T Consensus 196 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~---~~~~-~~-~-----~~~~~ 264 (335)
T 2owb_A 196 E-RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLR---IKKN-EY-S-----IPKHI 264 (335)
T ss_dssp C-CBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHH---HHHT-CC-C-----CCTTS
T ss_pred c-cccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHH---HhcC-CC-C-----CCccC
Confidence 2 22345799999999999998999999999999999999999999976554332211 1111 10 0 11122
Q ss_pred CHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 004400 651 DKEQVMVMINVALLCANASPTIRPSMSSVLR 681 (756)
Q Consensus 651 ~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~ 681 (756)
+ ..+.+++.+||+.||++||++.|+++
T Consensus 265 ~----~~~~~li~~~l~~dp~~Rps~~ell~ 291 (335)
T 2owb_A 265 N----PVAASLIQKMLQTDPTARPTINELLN 291 (335)
T ss_dssp C----HHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred C----HHHHHHHHHHccCChhHCcCHHHHhc
Confidence 3 34889999999999999999999876
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-39 Score=342.08 Aligned_cols=251 Identities=27% Similarity=0.406 Sum_probs=202.4
Q ss_pred hhcCccccCcccCCCCccEEEeec-cCCcEEEEEEccccCcccHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEE
Q 004400 414 ATNNFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYE 492 (756)
Q Consensus 414 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 492 (756)
..++|+..+.||+|+||.||+|.. .+|+.||+|.+.... ..+.+.+|+.++++++||||+++++++.+++..++|||
T Consensus 27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 104 (314)
T 3com_A 27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVME 104 (314)
T ss_dssp ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEee
Confidence 456899999999999999999995 468999999986543 34778999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCcccCcc
Q 004400 493 YLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTH 572 (756)
Q Consensus 493 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~~~~~ 572 (756)
|+++|+|.+++......+++..+..++.|++.||+|||+.| |+||||||+||+++.++.+||+|||++........
T Consensus 105 ~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~- 180 (314)
T 3com_A 105 YCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMR---KIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMA- 180 (314)
T ss_dssp CCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECBTTBS-
T ss_pred cCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCcCHHHEEECCCCCEEEeecccchhhhhhcc-
Confidence 99999999999766678999999999999999999999997 99999999999999999999999999976544322
Q ss_pred eeeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhcCccccccccCCCCCCCH
Q 004400 573 ISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDK 652 (756)
Q Consensus 573 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 652 (756)
......||+.|+|||.+.+..++.++||||||+++|+|++|+.||.......... .... ...... ..+.
T Consensus 181 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~---~~~~-~~~~~~-------~~~~ 249 (314)
T 3com_A 181 KRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIF---MIPT-NPPPTF-------RKPE 249 (314)
T ss_dssp CBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH---HHHH-SCCCCC-------SSGG
T ss_pred ccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHH---HHhc-CCCccc-------CCcc
Confidence 2234578999999999998899999999999999999999999996654332211 1111 111010 0011
Q ss_pred HHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 004400 653 EQVMVMINVALLCANASPTIRPSMSSVLR 681 (756)
Q Consensus 653 ~~~~~l~~l~~~c~~~~P~~RPt~~ev~~ 681 (756)
.....+.+++.+||+.||.+|||+.++++
T Consensus 250 ~~~~~l~~li~~~l~~dp~~Rpt~~~ll~ 278 (314)
T 3com_A 250 LWSDNFTDFVKQCLVKSPEQRATATQLLQ 278 (314)
T ss_dssp GSCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred cCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 11234889999999999999999999976
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=355.33 Aligned_cols=260 Identities=21% Similarity=0.301 Sum_probs=198.2
Q ss_pred HHhhcCccccCcccCCCCccEEEee-ccCCcEEEEEEccccCcccHHHHHHHHHHHHhCCCCceeeEeeEEEe-------
Q 004400 412 KAATNNFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCCIE------- 483 (756)
Q Consensus 412 ~~~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~------- 483 (756)
....++|...+.||+|+||.||+|+ ..+|+.||||++..... ...+|+++++.++|||||+++++|..
T Consensus 3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~----~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~ 78 (383)
T 3eb0_A 3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR----YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPK 78 (383)
T ss_dssp ---CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHTTCCCTTBCCEEEEEEEC------
T ss_pred ccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc----hHHHHHHHHHHcCCCCccchhheeeecCccccc
Confidence 3456789999999999999999998 56899999999865422 23479999999999999999999854
Q ss_pred -------------------------------CCeEEEEEEecCCCCHHHHHH---hcCCCCCHHHHHHHHHHHHHHHHHH
Q 004400 484 -------------------------------GNQLLLIYEYLENNSLARALF---EHRLKLDWPTRRRICLGIARGLAYL 529 (756)
Q Consensus 484 -------------------------------~~~~~lV~e~~~~gsL~~~l~---~~~~~l~~~~~~~i~~~ia~~L~~L 529 (756)
....++||||++ |+|.+.+. .....+++..+..++.||++||+||
T Consensus 79 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~L 157 (383)
T 3eb0_A 79 PPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFI 157 (383)
T ss_dssp -------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH
Confidence 334899999998 48877775 3456799999999999999999999
Q ss_pred HcCCCCCeEcCCCCCCceEec-CCCCEEEccCCccccCcccCcceeeccccCccCCchHhhhcC-CCCcccchhhHHHHH
Q 004400 530 HGESRIKVVHRDIKATNVLLD-KDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPEYAMRG-HLTEKADVYSFGIVA 607 (756)
Q Consensus 530 H~~g~~~iiH~Dikp~Nill~-~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slGv~l 607 (756)
|+.| |+||||||+||+++ .++.+||+|||+++....... .....||+.|+|||.+.+. .++.++||||+||++
T Consensus 158 H~~g---i~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il 232 (383)
T 3eb0_A 158 HSLG---ICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEP--SVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVF 232 (383)
T ss_dssp HTTT---EECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSC--CCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHH
T ss_pred HHCc---CccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCC--CcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHH
Confidence 9987 99999999999998 688999999999986544332 2345789999999998874 599999999999999
Q ss_pred HHHHhCCCCCCccchhhHHHHHHHHHhcCccc----------cccccCCC-C----CCCHHHHHHHHHHHHHhhcCCCCC
Q 004400 608 LEIVSGRSNVTKEDMFYLLDWALVLKEQGKLM----------ELVDTNPG-S----NFDKEQVMVMINVALLCANASPTI 672 (756)
Q Consensus 608 ~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~-~----~~~~~~~~~l~~l~~~c~~~~P~~ 672 (756)
|||++|+.||...................... +..-+... . .++......+.+++.+||+.||++
T Consensus 233 ~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~ 312 (383)
T 3eb0_A 233 GELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDL 312 (383)
T ss_dssp HHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGG
T ss_pred HHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhh
Confidence 99999999997766544333222211111100 00000000 0 011112335889999999999999
Q ss_pred CCCHHHHHH
Q 004400 673 RPSMSSVLR 681 (756)
Q Consensus 673 RPt~~ev~~ 681 (756)
|||+.|+++
T Consensus 313 R~t~~e~l~ 321 (383)
T 3eb0_A 313 RINPYEAMA 321 (383)
T ss_dssp SCCHHHHHT
T ss_pred CCCHHHHhc
Confidence 999999975
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=365.54 Aligned_cols=251 Identities=24% Similarity=0.377 Sum_probs=200.7
Q ss_pred hcCccccCcccCCCCccEEEeec-cCCcEEEEEEccccC--cccHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEE
Q 004400 415 TNNFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSKS--KQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIY 491 (756)
Q Consensus 415 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 491 (756)
.+.|...+.||+|+||.||+|+. .++..||+|++.... ......+.+|+.+++.++|||||+++++|.++...++||
T Consensus 36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 115 (494)
T 3lij_A 36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVM 115 (494)
T ss_dssp HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 45788899999999999999995 578999999987542 334577899999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCC---CCEEEccCCccccCcc
Q 004400 492 EYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKD---LNSKISDFGLAKLDEE 568 (756)
Q Consensus 492 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~---~~~kl~DFGla~~~~~ 568 (756)
|||++|+|.+.+... ..+++..+..++.||+.||+|||+.| |+||||||+|||++.. +.+||+|||+++....
T Consensus 116 e~~~~g~L~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~ 191 (494)
T 3lij_A 116 ECYKGGELFDEIIHR-MKFNEVDAAVIIKQVLSGVTYLHKHN---IVHRDLKPENLLLESKEKDALIKIVDFGLSAVFEN 191 (494)
T ss_dssp ECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTTCEECBT
T ss_pred ecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChhhEEEeCCCCCCcEEEEECCCCeECCC
Confidence 999999999988654 47999999999999999999999997 9999999999999764 4599999999987654
Q ss_pred cCcceeeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhcCccccccccCCCC
Q 004400 569 ENTHISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGS 648 (756)
Q Consensus 569 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 648 (756)
... .....||+.|+|||++. +.++.++||||+||++|+|++|+.||............ .. +... .......
T Consensus 192 ~~~--~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i---~~-~~~~--~~~~~~~ 262 (494)
T 3lij_A 192 QKK--MKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKV---EK-GKYT--FDSPEWK 262 (494)
T ss_dssp TBC--BCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH---HH-TCCC--CCSGGGT
T ss_pred Ccc--ccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH---Hh-CCCC--CCchhcc
Confidence 322 23467999999999886 57999999999999999999999999776654433221 11 1110 0011111
Q ss_pred CCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004400 649 NFDKEQVMVMINVALLCANASPTIRPSMSSVLRM 682 (756)
Q Consensus 649 ~~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~ 682 (756)
..+ ..+.+++.+||+.||.+|||+.|+++.
T Consensus 263 ~~s----~~~~~li~~~L~~dp~~R~s~~e~l~h 292 (494)
T 3lij_A 263 NVS----EGAKDLIKQMLQFDSQRRISAQQALEH 292 (494)
T ss_dssp TSC----HHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred cCC----HHHHHHHHHHCCCChhhCccHHHHhcC
Confidence 223 348899999999999999999999753
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-39 Score=340.04 Aligned_cols=249 Identities=29% Similarity=0.456 Sum_probs=207.2
Q ss_pred hcCccccCcccCCCCccEEEee-ccCCcEEEEEEccccC-cccHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEE
Q 004400 415 TNNFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSKS-KQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYE 492 (756)
Q Consensus 415 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 492 (756)
.+.|...+.||+|+||.||+|+ ..+++.||||.+.... ....+.+.+|+.+++.++||||+++++++.+++..++|||
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 100 (303)
T 3a7i_A 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME 100 (303)
T ss_dssp GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEE
Confidence 3568889999999999999998 4578999999986543 3345789999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCcccCcc
Q 004400 493 YLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTH 572 (756)
Q Consensus 493 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~~~~~ 572 (756)
|+++++|.+++.. ..+++..+..++.|++.||+|||+.| |+||||||+||+++.++.+||+|||++........
T Consensus 101 ~~~~~~L~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~- 174 (303)
T 3a7i_A 101 YLGGGSALDLLEP--GPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI- 174 (303)
T ss_dssp CCTTEEHHHHHTT--SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECBTTBC-
T ss_pred eCCCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChheEEECCCCCEEEeecccceecCcccc-
Confidence 9999999999854 46899999999999999999999997 99999999999999999999999999986544322
Q ss_pred eeeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhcCccccccccCCCCCCCH
Q 004400 573 ISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDK 652 (756)
Q Consensus 573 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 652 (756)
......||+.|+|||++.+..++.++||||||+++|||++|+.||............ ...... .....++
T Consensus 175 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~----~~~~~~-----~~~~~~~- 244 (303)
T 3a7i_A 175 KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLI----PKNNPP-----TLEGNYS- 244 (303)
T ss_dssp CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH----HHSCCC-----CCCSSCC-
T ss_pred ccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHh----hcCCCC-----CCccccC-
Confidence 223457899999999999989999999999999999999999999665443322211 111111 1112233
Q ss_pred HHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004400 653 EQVMVMINVALLCANASPTIRPSMSSVLRM 682 (756)
Q Consensus 653 ~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~ 682 (756)
..+.+++.+||+.||++|||+.|+++.
T Consensus 245 ---~~l~~li~~~l~~dp~~Rps~~~ll~~ 271 (303)
T 3a7i_A 245 ---KPLKEFVEACLNKEPSFRPTAKELLKH 271 (303)
T ss_dssp ---HHHHHHHHHHCCSSGGGSCCHHHHTTC
T ss_pred ---HHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 348899999999999999999999875
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-39 Score=337.92 Aligned_cols=245 Identities=24% Similarity=0.374 Sum_probs=199.5
Q ss_pred hhcCccccCcccCCCCccEEEeec-cCCcEEEEEEcccc--CcccHHHHHHHHHHHHhC-CCCceeeEeeEEEeCCeEEE
Q 004400 414 ATNNFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSK--SKQGNREFINEIGMISAL-QHPNLVKLYGCCIEGNQLLL 489 (756)
Q Consensus 414 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l 489 (756)
..++|...+.||+|+||.||+|.. .+++.||+|.+... .......+.+|+..+..+ +||||+++++++.+++..++
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~l 88 (289)
T 1x8b_A 9 YTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLI 88 (289)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEE
T ss_pred ccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEE
Confidence 346889999999999999999995 47999999998754 233456788999999999 99999999999999999999
Q ss_pred EEEecCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCC--------------
Q 004400 490 IYEYLENNSLARALFEH---RLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKD-------------- 552 (756)
Q Consensus 490 V~e~~~~gsL~~~l~~~---~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~-------------- 552 (756)
||||+++|+|.+++... ...+++..+..++.||+.||+|||+++ |+||||||+||+++.+
T Consensus 89 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~ 165 (289)
T 1x8b_A 89 QNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMS---LVHMDIKPSNIFISRTSIPNAASEEGDEDD 165 (289)
T ss_dssp EEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEC----------------
T ss_pred EEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeecCCCHHHEEEcCCCCCccccccccccc
Confidence 99999999999999743 256899999999999999999999997 9999999999999844
Q ss_pred -----CCEEEccCCccccCcccCcceeeccccCccCCchHhhhcC-CCCcccchhhHHHHHHHHHhCCCCCCccchhhHH
Q 004400 553 -----LNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPEYAMRG-HLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLL 626 (756)
Q Consensus 553 -----~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~ 626 (756)
..+||+|||.+....... ...||+.|+|||.+.+. .++.++|||||||++|||++|+.++.......
T Consensus 166 ~~~~~~~~kl~Dfg~~~~~~~~~-----~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~-- 238 (289)
T 1x8b_A 166 WASNKVMFKIGDLGHVTRISSPQ-----VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQWH-- 238 (289)
T ss_dssp ----CCCEEECCCTTCEETTCSC-----CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHHHH--
T ss_pred ccCCceEEEEcccccccccCCcc-----ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhHHH--
Confidence 479999999998655432 23589999999999875 56789999999999999999988765443211
Q ss_pred HHHHHHHhcCccccccccCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004400 627 DWALVLKEQGKLMELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRM 682 (756)
Q Consensus 627 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~ 682 (756)
. ...+.... ....++ ..+.+++.+||+.||++|||+.|+++.
T Consensus 239 ---~--~~~~~~~~-----~~~~~~----~~~~~li~~~l~~dp~~Rps~~~ll~h 280 (289)
T 1x8b_A 239 ---E--IRQGRLPR-----IPQVLS----QEFTELLKVMIHPDPERRPSAMALVKH 280 (289)
T ss_dssp ---H--HHTTCCCC-----CSSCCC----HHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred ---H--HHcCCCCC-----CCcccC----HHHHHHHHHHhCCCcccCCCHHHHhhC
Confidence 1 11111111 112233 348899999999999999999999764
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-40 Score=349.19 Aligned_cols=257 Identities=21% Similarity=0.302 Sum_probs=203.6
Q ss_pred HHHhhcCcccc-CcccCCCCccEEEeec-cCCcEEEEEEcccc--CcccHHHHHHHHHHHHhC-CCCceeeEeeEEEeCC
Q 004400 411 IKAATNNFATD-NNIGEGGFGPVYKGLL-ADGTAIAVKQLSSK--SKQGNREFINEIGMISAL-QHPNLVKLYGCCIEGN 485 (756)
Q Consensus 411 ~~~~~~~~~~~-~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~ 485 (756)
.+...+.|... +.||+|+||.||+|+. .+++.||+|++... .......+.+|+.+++.+ +||||+++++++.+++
T Consensus 23 ~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~ 102 (327)
T 3lm5_A 23 MENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTS 102 (327)
T ss_dssp HHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS
T ss_pred HHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCC
Confidence 34455667766 8999999999999994 57999999998754 233457889999999999 4699999999999999
Q ss_pred eEEEEEEecCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecC---CCCEEEccCC
Q 004400 486 QLLLIYEYLENNSLARALFEH-RLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDK---DLNSKISDFG 561 (756)
Q Consensus 486 ~~~lV~e~~~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~---~~~~kl~DFG 561 (756)
..++||||+++|+|.+++... ...+++..+..++.|++.||+|||+.| |+||||||+||+++. ++.+||+|||
T Consensus 103 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~g---ivH~Dikp~NIl~~~~~~~~~~kL~Dfg 179 (327)
T 3lm5_A 103 EIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNN---IVHLDLKPQNILLSSIYPLGDIKIVDFG 179 (327)
T ss_dssp EEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESCBTTBCCEEECCGG
T ss_pred eEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCChHHEEEecCCCCCcEEEeeCc
Confidence 999999999999999988633 457999999999999999999999997 999999999999998 7899999999
Q ss_pred ccccCcccCcceeeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhcCccccc
Q 004400 562 LAKLDEEENTHISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMEL 641 (756)
Q Consensus 562 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 641 (756)
+++....... .....||+.|+|||++.+..++.++||||||+++|||++|+.||...+......... ......
T Consensus 180 ~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~--~~~~~~--- 252 (327)
T 3lm5_A 180 MSRKIGHACE--LREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNIS--QVNVDY--- 252 (327)
T ss_dssp GCEEC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH--HTCCCC---
T ss_pred cccccCCccc--cccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHH--hccccc---
Confidence 9986544322 234579999999999999999999999999999999999999997665443322111 110000
Q ss_pred cccCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004400 642 VDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRM 682 (756)
Q Consensus 642 ~~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~ 682 (756)
........ ...+.+++.+||+.||++|||+.|+++.
T Consensus 253 -~~~~~~~~----~~~~~~li~~~L~~dP~~Rpt~~~ll~h 288 (327)
T 3lm5_A 253 -SEETFSSV----SQLATDFIQSLLVKNPEKRPTAEICLSH 288 (327)
T ss_dssp -CTTTTTTS----CHHHHHHHHHHSCSSGGGSCCHHHHTTC
T ss_pred -Cchhhccc----CHHHHHHHHHHcCCChhhCcCHHHHhCC
Confidence 00111122 2348899999999999999999999764
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=362.55 Aligned_cols=241 Identities=14% Similarity=0.142 Sum_probs=190.7
Q ss_pred hhcCccccCcccCCCCccEEEeec-cCCcEEEEEEcccc---CcccHHHHHHHH---HHHHhCCCCceeeEe-------e
Q 004400 414 ATNNFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSK---SKQGNREFINEI---GMISALQHPNLVKLY-------G 479 (756)
Q Consensus 414 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~---~~l~~l~h~niv~l~-------~ 479 (756)
..++|...+.||+|+||.||+|+. .+|+.||||++... .....+.+.+|+ +++++++|||||+++ +
T Consensus 71 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~ 150 (377)
T 3byv_A 71 RPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFD 150 (377)
T ss_dssp CCEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSE
T ss_pred CCceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhh
Confidence 357889999999999999999995 67999999998743 333457789999 555666899999998 6
Q ss_pred EEEeCCe-----------------EEEEEEecCCCCHHHHHHhcCC------CCCHHHHHHHHHHHHHHHHHHHcCCCCC
Q 004400 480 CCIEGNQ-----------------LLLIYEYLENNSLARALFEHRL------KLDWPTRRRICLGIARGLAYLHGESRIK 536 (756)
Q Consensus 480 ~~~~~~~-----------------~~lV~e~~~~gsL~~~l~~~~~------~l~~~~~~~i~~~ia~~L~~LH~~g~~~ 536 (756)
++.+++. .++||||+ +|+|.+++..... .+++..+..++.||+.||+|||++|
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--- 226 (377)
T 3byv_A 151 LVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG--- 226 (377)
T ss_dssp EEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred hhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCC---
Confidence 6665532 89999999 6899999975421 2335888899999999999999997
Q ss_pred eEcCCCCCCceEecCCCCEEEccCCccccCcccCcceeeccccCccCCchHhhhcC-----------CCCcccchhhHHH
Q 004400 537 VVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPEYAMRG-----------HLTEKADVYSFGI 605 (756)
Q Consensus 537 iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~~~Dv~slGv 605 (756)
|+||||||+|||++.++.+||+|||+++.... ......| +.|+|||++.+. .++.++|||||||
T Consensus 227 ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~ 301 (377)
T 3byv_A 227 LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGL 301 (377)
T ss_dssp EECSCCCGGGEEECTTCCEEECCGGGCEETTC----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHH
T ss_pred eecCCCCHHHEEEcCCCCEEEEechhheecCC----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHH
Confidence 99999999999999999999999999985332 2344567 999999999887 8999999999999
Q ss_pred HHHHHHhCCCCCCccchhhHHHHHHHHHhcCccccccccCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 004400 606 VALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLR 681 (756)
Q Consensus 606 ~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~ 681 (756)
++|||++|+.||.......... .+.. . ...++. .+.+++.+||+.||++||++.|+++
T Consensus 302 il~elltg~~Pf~~~~~~~~~~------------~~~~-~-~~~~~~----~~~~li~~~L~~dp~~Rpt~~e~l~ 359 (377)
T 3byv_A 302 VIYWIWCADLPITKDAALGGSE------------WIFR-S-CKNIPQ----PVRALLEGFLRYPKEDRLLPLQAME 359 (377)
T ss_dssp HHHHHHHSSCCC------CCSG------------GGGS-S-CCCCCH----HHHHHHHHHTCSSGGGCCCHHHHHT
T ss_pred HHHHHHHCCCCCcccccccchh------------hhhh-h-ccCCCH----HHHHHHHHHcCCCchhCCCHHHHhh
Confidence 9999999999996543222111 1111 1 122333 4889999999999999999999976
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-39 Score=360.21 Aligned_cols=193 Identities=24% Similarity=0.432 Sum_probs=154.1
Q ss_pred hcCccccCcccCCCCccEEEee-ccCCcEEEEEEcccc--CcccHHHHHHHHHHHHhCCCCceeeEeeEEEeC-----Ce
Q 004400 415 TNNFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSK--SKQGNREFINEIGMISALQHPNLVKLYGCCIEG-----NQ 486 (756)
Q Consensus 415 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~ 486 (756)
.++|...+.||+|+||.||+|+ ..+++.||||++... .....+.+.+|+++++.++|||||++++++... ..
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 131 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE 131 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence 3689999999999999999998 457899999998653 233456789999999999999999999999543 57
Q ss_pred EEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccC
Q 004400 487 LLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLD 566 (756)
Q Consensus 487 ~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~ 566 (756)
.|+||||+. |+|.+++.. ...+++..+..++.||+.||+|||+.+ ||||||||+|||++.++.+||+|||+|+..
T Consensus 132 ~~lv~e~~~-~~L~~~~~~-~~~l~~~~~~~~~~qi~~aL~~LH~~~---iiHrDlKp~NILl~~~~~~kl~DFGla~~~ 206 (458)
T 3rp9_A 132 LYVVLEIAD-SDFKKLFRT-PVYLTELHIKTLLYNLLVGVKYVHSAG---ILHRDLKPANCLVNQDCSVKVCDFGLARTV 206 (458)
T ss_dssp EEEEECCCS-EEHHHHHHS-SCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTCBCT
T ss_pred EEEEEeccc-cchhhhccc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---cCCCCCChhhEEECCCCCEeecccccchhc
Confidence 899999985 689988864 357999999999999999999999997 999999999999999999999999999865
Q ss_pred cccCc--------------------------ceeeccccCccCCchHhhh-cCCCCcccchhhHHHHHHHHHh
Q 004400 567 EEENT--------------------------HISTRVAGTIGYMAPEYAM-RGHLTEKADVYSFGIVALEIVS 612 (756)
Q Consensus 567 ~~~~~--------------------------~~~~~~~gt~~y~aPE~~~-~~~~~~~~Dv~slGv~l~ellt 612 (756)
..... ...+..+||+.|+|||++. ...++.++|||||||++|||++
T Consensus 207 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~ellt 279 (458)
T 3rp9_A 207 DYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLN 279 (458)
T ss_dssp TSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHT
T ss_pred cCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHH
Confidence 43211 1223457899999999874 5679999999999999999999
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=367.23 Aligned_cols=251 Identities=26% Similarity=0.393 Sum_probs=206.3
Q ss_pred hcCccccCcccCCCCccEEEeec-cCCcEEEEEEccccC---cccHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEE
Q 004400 415 TNNFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSKS---KQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLI 490 (756)
Q Consensus 415 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 490 (756)
.++|...+.||+|+||.||+|+. .+|+.||||++.... ......+.+|++++++++|||||++++++.+.+..++|
T Consensus 25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 104 (484)
T 3nyv_A 25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLV 104 (484)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence 45788899999999999999995 478999999986532 34567899999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEe---cCCCCEEEccCCccccCc
Q 004400 491 YEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLL---DKDLNSKISDFGLAKLDE 567 (756)
Q Consensus 491 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill---~~~~~~kl~DFGla~~~~ 567 (756)
|||+.+|+|.+++... ..+++..+..++.||+.||+|||+++ |+||||||+|||+ +.++.+||+|||+++...
T Consensus 105 ~e~~~~~~L~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~ 180 (484)
T 3nyv_A 105 GEVYTGGELFDEIISR-KRFSEVDAARIIRQVLSGITYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFE 180 (484)
T ss_dssp ECCCCSCBHHHHHHTC-SCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBC
T ss_pred EecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEcc
Confidence 9999999999998754 47999999999999999999999997 9999999999999 567889999999998654
Q ss_pred ccCcceeeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhcCccccccccCCC
Q 004400 568 EENTHISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPG 647 (756)
Q Consensus 568 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 647 (756)
.... .....||+.|+|||++.+ .++.++||||+||++|+|++|+.||...+......... ......... ..
T Consensus 181 ~~~~--~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~---~~~~~~~~~---~~ 251 (484)
T 3nyv_A 181 ASKK--MKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVE---KGKYTFELP---QW 251 (484)
T ss_dssp CCCS--HHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH---HCCCCCCSG---GG
T ss_pred cccc--cccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHH---cCCCCCCCc---cc
Confidence 4322 234579999999999865 79999999999999999999999998776554433221 111100000 00
Q ss_pred CCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004400 648 SNFDKEQVMVMINVALLCANASPTIRPSMSSVLRM 682 (756)
Q Consensus 648 ~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~ 682 (756)
... ...+.+++.+|++.+|++|||+.|+++.
T Consensus 252 ~~~----s~~~~~li~~~L~~dp~~R~s~~e~l~h 282 (484)
T 3nyv_A 252 KKV----SESAKDLIRKMLTYVPSMRISARDALDH 282 (484)
T ss_dssp GGS----CHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred ccC----CHHHHHHHHHHCCCChhHCcCHHHHhhC
Confidence 112 2348899999999999999999999864
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-39 Score=364.33 Aligned_cols=251 Identities=26% Similarity=0.380 Sum_probs=202.6
Q ss_pred hcCccccCcccCCCCccEEEeec-cCCcEEEEEEccccCc-------------ccHHHHHHHHHHHHhCCCCceeeEeeE
Q 004400 415 TNNFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSKSK-------------QGNREFINEIGMISALQHPNLVKLYGC 480 (756)
Q Consensus 415 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-------------~~~~~~~~E~~~l~~l~h~niv~l~~~ 480 (756)
.++|...+.||+|+||+||+|.. .+++.||+|++..... ...+.+.+|+.++++++|||||+++++
T Consensus 35 ~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~ 114 (504)
T 3q5i_A 35 GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDV 114 (504)
T ss_dssp GGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred ccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence 46899999999999999999994 5688999999865421 234678999999999999999999999
Q ss_pred EEeCCeEEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCC---CEEE
Q 004400 481 CIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDL---NSKI 557 (756)
Q Consensus 481 ~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~---~~kl 557 (756)
|.++...++|||||++|+|.+++... ..+++..+..++.||+.||+|||+.| |+||||||+|||++.++ .+||
T Consensus 115 ~~~~~~~~lv~e~~~gg~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl 190 (504)
T 3q5i_A 115 FEDKKYFYLVTEFYEGGELFEQIINR-HKFDECDAANIMKQILSGICYLHKHN---IVHRDIKPENILLENKNSLLNIKI 190 (504)
T ss_dssp EECSSEEEEEEECCTTCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESSTTCCSSEEE
T ss_pred EEcCCEEEEEEecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCcHHHEEEecCCCCccEEE
Confidence 99999999999999999999998754 47999999999999999999999997 99999999999998776 6999
Q ss_pred ccCCccccCcccCcceeeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhcCc
Q 004400 558 SDFGLAKLDEEENTHISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGK 637 (756)
Q Consensus 558 ~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 637 (756)
+|||+++....... .....||+.|+|||++. +.++.++||||+||++|+|++|+.||...+........ .. +.
T Consensus 191 ~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i---~~-~~ 263 (504)
T 3q5i_A 191 VDFGLSSFFSKDYK--LRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKV---EK-GK 263 (504)
T ss_dssp CCCTTCEECCTTSC--BCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH---HH-CC
T ss_pred EECCCCEEcCCCCc--cccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH---Hc-CC
Confidence 99999987654322 23457999999999986 56999999999999999999999999776654433221 11 11
Q ss_pred cccccccCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004400 638 LMELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRM 682 (756)
Q Consensus 638 ~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~ 682 (756)
... ........+ ..+.+++.+|++.||.+|||+.|+++.
T Consensus 264 ~~~--~~~~~~~~s----~~~~~li~~~L~~dp~~R~t~~e~l~h 302 (504)
T 3q5i_A 264 YYF--DFNDWKNIS----DEAKELIKLMLTYDYNKRCTAEEALNS 302 (504)
T ss_dssp CCC--CHHHHTTSC----HHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred CCC--CccccCCCC----HHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 100 000001122 348899999999999999999999764
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-40 Score=362.07 Aligned_cols=254 Identities=21% Similarity=0.341 Sum_probs=191.8
Q ss_pred HhhcCccccCcccCCCCccEEEee-ccCCcEEEEEEccccC--------cccHHHHHHHHHHHHhCCCCceeeEeeEEEe
Q 004400 413 AATNNFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSKS--------KQGNREFINEIGMISALQHPNLVKLYGCCIE 483 (756)
Q Consensus 413 ~~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 483 (756)
...++|...+.||+|+||.||+|. ..+++.||||++.... ......+.+|++++++++||||+++++++.
T Consensus 132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~- 210 (419)
T 3i6u_A 132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD- 210 (419)
T ss_dssp HHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE-
T ss_pred hhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe-
Confidence 346789999999999999999998 4578999999986532 111234789999999999999999999975
Q ss_pred CCeEEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCC---CEEEccC
Q 004400 484 GNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDL---NSKISDF 560 (756)
Q Consensus 484 ~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~---~~kl~DF 560 (756)
.+..++||||+++|+|.+++... ..+++..+..++.|++.||+|||+++ |+||||||+|||++.++ .+||+||
T Consensus 211 ~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kl~DF 286 (419)
T 3i6u_A 211 AEDYYIVLELMEGGELFDKVVGN-KRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDF 286 (419)
T ss_dssp SSEEEEEEECCTTCBGGGGTSSS-CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSSSCCEEECCS
T ss_pred cCceEEEEEcCCCCcHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCCCcceEEEeec
Confidence 45689999999999999888543 47999999999999999999999997 99999999999997544 5999999
Q ss_pred CccccCcccCcceeeccccCccCCchHhhhc---CCCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhcCc
Q 004400 561 GLAKLDEEENTHISTRVAGTIGYMAPEYAMR---GHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGK 637 (756)
Q Consensus 561 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 637 (756)
|+++...... ......||+.|+|||++.. ..++.++|||||||++|||++|+.||.......... ... ..+.
T Consensus 287 G~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~--~~i-~~~~ 361 (419)
T 3i6u_A 287 GHSKILGETS--LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLK--DQI-TSGK 361 (419)
T ss_dssp STTTSCC-------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHH--HHH-HTTC
T ss_pred ccceecCCCc--cccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHH--HHH-hcCC
Confidence 9998765432 2344679999999999853 568899999999999999999999996543211111 001 1111
Q ss_pred cccccccCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004400 638 LMELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRM 682 (756)
Q Consensus 638 ~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~ 682 (756)
...... ..... ...+.+++.+|++.||++||++.|+++.
T Consensus 362 ~~~~~~--~~~~~----~~~~~~li~~~L~~dP~~Rps~~e~l~h 400 (419)
T 3i6u_A 362 YNFIPE--VWAEV----SEKALDLVKKLLVVDPKARFTTEEALRH 400 (419)
T ss_dssp CCCCHH--HHTTS----CHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred CCCCch--hhccc----CHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 100000 00111 2358899999999999999999999874
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-40 Score=378.50 Aligned_cols=257 Identities=25% Similarity=0.382 Sum_probs=207.3
Q ss_pred hhcCccccCcccCCCCccEEEeecc----CCcEEEEEEccccC-cccHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEE
Q 004400 414 ATNNFATDNNIGEGGFGPVYKGLLA----DGTAIAVKQLSSKS-KQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLL 488 (756)
Q Consensus 414 ~~~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 488 (756)
..++|...+.||+|+||.||+|.+. .+..||||.+.... ....+.+.+|+.++++++||||+++++++. ++..+
T Consensus 388 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~ 466 (656)
T 2j0j_A 388 QRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVW 466 (656)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCE
T ss_pred ccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCceE
Confidence 4567899999999999999999853 24679999987543 333467999999999999999999999985 46689
Q ss_pred EEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCcc
Q 004400 489 LIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEE 568 (756)
Q Consensus 489 lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~ 568 (756)
+||||+++|+|.+++......+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 467 lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDikp~NILl~~~~~vkL~DFG~a~~~~~ 543 (656)
T 2j0j_A 467 IIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYMED 543 (656)
T ss_dssp EEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCCCCSCCC
T ss_pred EEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchHhEEEeCCCCEEEEecCCCeecCC
Confidence 999999999999999877678999999999999999999999997 99999999999999999999999999987655
Q ss_pred cCcceeeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHh-CCCCCCccchhhHHHHHHHHHhcCccccccccCCC
Q 004400 569 ENTHISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVS-GRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPG 647 (756)
Q Consensus 569 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 647 (756)
..........||+.|+|||++.+..++.++|||||||++|||++ |+.||............ . .+..... .
T Consensus 544 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i---~-~~~~~~~-----~ 614 (656)
T 2j0j_A 544 STYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI---E-NGERLPM-----P 614 (656)
T ss_dssp ----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHH---H-HTCCCCC-----C
T ss_pred CcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHH---H-cCCCCCC-----C
Confidence 44333444567889999999999999999999999999999997 99999766544433221 1 1111111 1
Q ss_pred CCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhccCc
Q 004400 648 SNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLECGV 687 (756)
Q Consensus 648 ~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~L~~~~ 687 (756)
..++ ..+.+++.+||+.||++||++.++++.|+.+.
T Consensus 615 ~~~~----~~l~~li~~~l~~dP~~RPs~~el~~~L~~il 650 (656)
T 2j0j_A 615 PNCP----PTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL 650 (656)
T ss_dssp TTCC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred cccc----HHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 1223 34889999999999999999999999998653
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-39 Score=347.61 Aligned_cols=263 Identities=27% Similarity=0.352 Sum_probs=207.1
Q ss_pred HhhcCccccCcccCCCCccEEEeeccCCcEEEEEEccccCcccHHHHHHHHHHHHh--CCCCceeeEeeEEEeCC----e
Q 004400 413 AATNNFATDNNIGEGGFGPVYKGLLADGTAIAVKQLSSKSKQGNREFINEIGMISA--LQHPNLVKLYGCCIEGN----Q 486 (756)
Q Consensus 413 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~~~~~----~ 486 (756)
...++|...+.||+|+||.||+|.. +++.||||++... ....+.+|++++.. ++||||+++++++..+. .
T Consensus 39 ~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~~ 114 (342)
T 1b6c_B 39 TIARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQ 114 (342)
T ss_dssp HHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCCC
T ss_pred cccccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccce
Confidence 3456899999999999999999987 4899999998643 34678889999887 78999999999998876 8
Q ss_pred EEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH--------cCCCCCeEcCCCCCCceEecCCCCEEEc
Q 004400 487 LLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLH--------GESRIKVVHRDIKATNVLLDKDLNSKIS 558 (756)
Q Consensus 487 ~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH--------~~g~~~iiH~Dikp~Nill~~~~~~kl~ 558 (756)
.++||||+++|+|.+++... .+++..+..++.|++.||+||| +.+ |+||||||+||+++.++.+||+
T Consensus 115 ~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~NIll~~~~~~kL~ 189 (342)
T 1b6c_B 115 LWLVSDYHEHGSLFDYLNRY--TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA---IAHRDLKSKNILVKKNGTCCIA 189 (342)
T ss_dssp EEEEECCCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCE---EECSCCSGGGEEECTTSCEEEC
T ss_pred eEEEEeecCCCcHHHHHhcc--CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCC---eeeCCCCHHHEEECCCCCEEEE
Confidence 99999999999999999753 6899999999999999999999 665 9999999999999999999999
Q ss_pred cCCccccCcccCcc---eeeccccCccCCchHhhhcCC------CCcccchhhHHHHHHHHHhC----------CCCCCc
Q 004400 559 DFGLAKLDEEENTH---ISTRVAGTIGYMAPEYAMRGH------LTEKADVYSFGIVALEIVSG----------RSNVTK 619 (756)
Q Consensus 559 DFGla~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~------~~~~~Dv~slGv~l~elltg----------~~p~~~ 619 (756)
|||+++........ ......||+.|+|||++.+.. ++.++|||||||++|||++| +.||..
T Consensus 190 Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~ 269 (342)
T 1b6c_B 190 DLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYD 269 (342)
T ss_dssp CCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTT
T ss_pred ECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCccc
Confidence 99999865543322 223457999999999997652 33689999999999999999 778754
Q ss_pred cchh--hHHHHHHHHHhcCccccccccCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhccCcc
Q 004400 620 EDMF--YLLDWALVLKEQGKLMELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLECGVD 688 (756)
Q Consensus 620 ~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~L~~~~~ 688 (756)
.... ....+............... .....+....+.+++.+||+.||++|||+.||++.|+.+..
T Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i~~ 336 (342)
T 1b6c_B 270 LVPSDPSVEEMRKVVCEQKLRPNIPN----RWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ 336 (342)
T ss_dssp TSCSSCCHHHHHHHHTTSCCCCCCCG----GGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHHH
T ss_pred cCcCcccHHHHHHHHHHHHhCCCCcc----cccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHH
Confidence 3211 11112211111111111111 01123556679999999999999999999999999996543
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-40 Score=351.37 Aligned_cols=260 Identities=22% Similarity=0.309 Sum_probs=191.6
Q ss_pred hhcCccccCcccCCCCccEEEee-ccCCcEEEEEEccccCcccHHHHHHHHHHHHhCC-CCceeeEeeEEEe--------
Q 004400 414 ATNNFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQGNREFINEIGMISALQ-HPNLVKLYGCCIE-------- 483 (756)
Q Consensus 414 ~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~-------- 483 (756)
...+|...+.||+|+||.||+|+ ..+++.||||++........+.+.+|+.+++++. ||||+++++++..
T Consensus 26 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~ 105 (337)
T 3ll6_A 26 GELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTG 105 (337)
T ss_dssp TTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTS
T ss_pred cCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccC
Confidence 34578899999999999999999 4578999999987666666678999999999996 9999999999953
Q ss_pred CCeEEEEEEecCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCC
Q 004400 484 GNQLLLIYEYLENNSLARALFE--HRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFG 561 (756)
Q Consensus 484 ~~~~~lV~e~~~~gsL~~~l~~--~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFG 561 (756)
....++||||+. |+|.+++.. ....+++..+..++.||+.||+|||+.+ ++|+||||||+|||++.++.+||+|||
T Consensus 106 ~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~-~~ivH~Dikp~NIl~~~~~~~kl~Dfg 183 (337)
T 3ll6_A 106 QAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQK-PPIIHRDLKVENLLLSNQGTIKLCDFG 183 (337)
T ss_dssp SEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCCCCCGGGCEECTTSCEEBCCCT
T ss_pred CceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCC-CCEEEccCCcccEEECCCCCEEEecCc
Confidence 345899999996 699998864 4457999999999999999999999874 349999999999999999999999999
Q ss_pred ccccCcccCcce-----------eeccccCccCCchHhh---hcCCCCcccchhhHHHHHHHHHhCCCCCCccchhhHHH
Q 004400 562 LAKLDEEENTHI-----------STRVAGTIGYMAPEYA---MRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLD 627 (756)
Q Consensus 562 la~~~~~~~~~~-----------~~~~~gt~~y~aPE~~---~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~ 627 (756)
+++......... .....||+.|+|||++ .+..++.++|||||||++|||++|+.||..........
T Consensus 184 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~ 263 (337)
T 3ll6_A 184 SATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRIVN 263 (337)
T ss_dssp TCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC----------
T ss_pred cceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHHhhc
Confidence 998765432211 1134689999999998 56678999999999999999999999996543322111
Q ss_pred HHHHHHhcCccccccccCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhccCccccc
Q 004400 628 WALVLKEQGKLMELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLECGVDVLD 691 (756)
Q Consensus 628 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~L~~~~~~~~ 691 (756)
. ..........+ ..+.+++.+||+.||++||++.|+++.|+.+.....
T Consensus 264 ------~------~~~~~~~~~~~----~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~~~ 311 (337)
T 3ll6_A 264 ------G------KYSIPPHDTQY----TVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAARN 311 (337)
T ss_dssp --------------CCCCTTCCSS----GGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHTT
T ss_pred ------C------cccCCcccccc----hHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccC
Confidence 0 00001111111 237889999999999999999999999997755443
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-40 Score=340.69 Aligned_cols=253 Identities=29% Similarity=0.444 Sum_probs=203.6
Q ss_pred hcCccccCcccCCCCccEEEeec-cCCcEEEEEEccccC-cccHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEE
Q 004400 415 TNNFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSKS-KQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYE 492 (756)
Q Consensus 415 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 492 (756)
.++|+..+.||+|+||.||+|.. .+++.||||.+.... ....+.+.+|+.+++.++||||+++++++.+++..++|||
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 85 (276)
T 2yex_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (276)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEE
Confidence 45788999999999999999995 478999999986542 3345678999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCcccCc-
Q 004400 493 YLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENT- 571 (756)
Q Consensus 493 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~~~~- 571 (756)
|+++++|.+++.. ...+++..+..++.|++.||+|||+.| |+||||||+||+++.++.+||+|||++........
T Consensus 86 ~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~ 161 (276)
T 2yex_A 86 YCSGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE 161 (276)
T ss_dssp CCTTEEGGGGSBT-TTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEETTEE
T ss_pred ecCCCcHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCChHHEEEccCCCEEEeeCCCccccCCCcch
Confidence 9999999998854 346899999999999999999999997 99999999999999999999999999986543322
Q ss_pred ceeeccccCccCCchHhhhcCCC-CcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhcCccccccccCCCCCC
Q 004400 572 HISTRVAGTIGYMAPEYAMRGHL-TEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNF 650 (756)
Q Consensus 572 ~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 650 (756)
.......||+.|+|||.+.+..+ +.++||||||+++|||++|+.||........ .+.. ........ .....+
T Consensus 162 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-~~~~-~~~~~~~~-----~~~~~~ 234 (276)
T 2yex_A 162 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ-EYSD-WKEKKTYL-----NPWKKI 234 (276)
T ss_dssp CCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSH-HHHH-HHTTCTTS-----TTGGGS
T ss_pred hcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHH-HHHH-hhhccccc-----Cchhhc
Confidence 12334679999999999987665 7799999999999999999999965433211 1111 11111100 001112
Q ss_pred CHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004400 651 DKEQVMVMINVALLCANASPTIRPSMSSVLRM 682 (756)
Q Consensus 651 ~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~ 682 (756)
+ ..+.+++.+||+.||++|||+.|+++.
T Consensus 235 ~----~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (276)
T 2yex_A 235 D----SAPLALLHKILVENPSARITIPDIKKD 262 (276)
T ss_dssp C----HHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred C----HHHHHHHHHHCCCCchhCCCHHHHhcC
Confidence 2 348899999999999999999998763
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=376.62 Aligned_cols=250 Identities=22% Similarity=0.327 Sum_probs=207.0
Q ss_pred HhhcCccccCcccCCCCccEEEeec-cCCcEEEEEEcccc---CcccHHHHHHHHHHHHhC-CCCceeeEeeEEEeCCeE
Q 004400 413 AATNNFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSK---SKQGNREFINEIGMISAL-QHPNLVKLYGCCIEGNQL 487 (756)
Q Consensus 413 ~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 487 (756)
...++|+..+.||+|+||.||+|+. .+++.||||+++.. .....+.+..|..++..+ +||+|+++++++.+.+..
T Consensus 338 ~~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~ 417 (674)
T 3pfq_A 338 MKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRL 417 (674)
T ss_dssp --CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEE
T ss_pred ccccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEE
Confidence 3457899999999999999999994 56889999998753 233456788899999988 799999999999999999
Q ss_pred EEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCc
Q 004400 488 LLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDE 567 (756)
Q Consensus 488 ~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~ 567 (756)
|+||||+++|+|.+++.... .+++..+..++.||+.||+|||+.+ ||||||||+|||++.++.+||+|||+|+...
T Consensus 418 ~lV~E~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~~g---IiHrDLKp~NILl~~~g~ikL~DFGla~~~~ 493 (674)
T 3pfq_A 418 YFVMEYVNGGDLMYHIQQVG-RFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENI 493 (674)
T ss_dssp EEEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTS---EECCCCCSTTEEECSSSCEEECCCTTCEECC
T ss_pred EEEEeCcCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCC---eEeccCChhhEEEcCCCcEEEeecceeeccc
Confidence 99999999999999997654 7999999999999999999999997 9999999999999999999999999998543
Q ss_pred ccCcceeeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhcCccccccccCCC
Q 004400 568 EENTHISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPG 647 (756)
Q Consensus 568 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 647 (756)
.... .....+||+.|+|||++.+..++.++|||||||++|||++|+.||...+........ ... .
T Consensus 494 ~~~~-~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i---~~~-~---------- 558 (674)
T 3pfq_A 494 WDGV-TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSI---MEH-N---------- 558 (674)
T ss_dssp CTTC-CBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH---HSS-C----------
T ss_pred cCCc-ccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHHHHHHH---HhC-C----------
Confidence 3222 234578999999999999999999999999999999999999999877654433221 111 1
Q ss_pred CCCCHHHHHHHHHHHHHhhcCCCCCCCCH-----HHHHH
Q 004400 648 SNFDKEQVMVMINVALLCANASPTIRPSM-----SSVLR 681 (756)
Q Consensus 648 ~~~~~~~~~~l~~l~~~c~~~~P~~RPt~-----~ev~~ 681 (756)
..++......+.+++.+|++.||++||++ .||.+
T Consensus 559 ~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~ 597 (674)
T 3pfq_A 559 VAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 597 (674)
T ss_dssp CCCCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHS
T ss_pred CCCCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhc
Confidence 01111223458899999999999999997 66654
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-40 Score=342.56 Aligned_cols=251 Identities=23% Similarity=0.368 Sum_probs=186.2
Q ss_pred hhcCccccCcccCCCCccEEEeec-cCCcEEEEEEccccCc-ccH-HHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEE
Q 004400 414 ATNNFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSKSK-QGN-REFINEIGMISALQHPNLVKLYGCCIEGNQLLLI 490 (756)
Q Consensus 414 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~-~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 490 (756)
..++|+..+.||+|+||.||+|.. .+++.||+|++..... ... +.+.++...++.++||||+++++++.+++..++|
T Consensus 5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv 84 (290)
T 3fme_A 5 KADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWIC 84 (290)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEE
T ss_pred cHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEE
Confidence 346889999999999999999994 6899999999975422 222 3344455568888999999999999999999999
Q ss_pred EEecCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHcC-CCCCeEcCCCCCCceEecCCCCEEEccCCccccC
Q 004400 491 YEYLENNSLARALFE---HRLKLDWPTRRRICLGIARGLAYLHGE-SRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLD 566 (756)
Q Consensus 491 ~e~~~~gsL~~~l~~---~~~~l~~~~~~~i~~~ia~~L~~LH~~-g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~ 566 (756)
|||+++ +|.+++.. ....+++..+..++.|++.||+|||++ | |+||||||+||+++.++.+||+|||+++..
T Consensus 85 ~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 160 (290)
T 3fme_A 85 MELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS---VIHRDVKPSNVLINALGQVKMCDFGISGYL 160 (290)
T ss_dssp EECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSC---CCCCCCSGGGCEECTTCCEEBCCC------
T ss_pred Eehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeecCCcccc
Confidence 999985 88777753 456899999999999999999999997 6 999999999999999999999999999865
Q ss_pred cccCcceeeccccCccCCchHhh----hcCCCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhcCcccccc
Q 004400 567 EEENTHISTRVAGTIGYMAPEYA----MRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELV 642 (756)
Q Consensus 567 ~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 642 (756)
..... .....||+.|+|||++ .+..++.++||||||+++|||++|+.||........ .... ..... ....
T Consensus 161 ~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-~~~~-~~~~~-~~~~- 234 (290)
T 3fme_A 161 VDDVA--KDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQ-QLKQ-VVEEP-SPQL- 234 (290)
T ss_dssp -----------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHH-HHHH-HHHSC-CCCC-
T ss_pred ccccc--ccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHH-HHHH-HhccC-CCCc-
Confidence 44322 2334699999999996 456789999999999999999999999964322111 1111 11111 1111
Q ss_pred ccCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 004400 643 DTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLR 681 (756)
Q Consensus 643 ~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~ 681 (756)
+...++ ..+.+++.+|++.||++|||+.|+++
T Consensus 235 ---~~~~~~----~~~~~li~~~l~~~p~~Rpt~~e~l~ 266 (290)
T 3fme_A 235 ---PADKFS----AEFVDFTSQCLKKNSKERPTYPELMQ 266 (290)
T ss_dssp ---CTTTSC----HHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred ---ccccCC----HHHHHHHHHHhhcChhhCcCHHHHHh
Confidence 111233 34889999999999999999999976
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-39 Score=344.10 Aligned_cols=256 Identities=16% Similarity=0.261 Sum_probs=199.3
Q ss_pred hcCccccCcccCCCCccEEEee-ccCCcEEEEEEccccCcccHHHHHHHHHHHHhCC-CCceeeEeeEEEe--CCeEEEE
Q 004400 415 TNNFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQGNREFINEIGMISALQ-HPNLVKLYGCCIE--GNQLLLI 490 (756)
Q Consensus 415 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~--~~~~~lV 490 (756)
.++|+..+.||+|+||.||+|+ ..+++.||||++... ..+.+.+|++++++++ ||||+++++++.+ ....++|
T Consensus 35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv 111 (330)
T 3nsz_A 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALV 111 (330)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEE
T ss_pred CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEeccc---chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEE
Confidence 3678999999999999999998 567899999998643 3467899999999997 9999999999998 6778999
Q ss_pred EEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCC-CEEEccCCccccCccc
Q 004400 491 YEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDL-NSKISDFGLAKLDEEE 569 (756)
Q Consensus 491 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~-~~kl~DFGla~~~~~~ 569 (756)
|||+++++|.+++. .+++..+..++.|++.||+|||+.| |+||||||+|||++.++ .+||+|||+++.....
T Consensus 112 ~e~~~~~~l~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~ 184 (330)
T 3nsz_A 112 FEHVNNTDFKQLYQ----TLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG 184 (330)
T ss_dssp EECCCCCCHHHHGG----GCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCCTTCEECCTT
T ss_pred EeccCchhHHHHHH----hCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCC
Confidence 99999999998874 4889999999999999999999997 99999999999999777 7999999999865543
Q ss_pred CcceeeccccCccCCchHhhhc-CCCCcccchhhHHHHHHHHHhCCCCCCccc-hhhHHHHHHHHHhcCcccc-------
Q 004400 570 NTHISTRVAGTIGYMAPEYAMR-GHLTEKADVYSFGIVALEIVSGRSNVTKED-MFYLLDWALVLKEQGKLME------- 640 (756)
Q Consensus 570 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slGv~l~elltg~~p~~~~~-~~~~~~~~~~~~~~~~~~~------- 640 (756)
.. .....||..|+|||++.+ ..++.++|||||||++|||++|+.||.... ..................+
T Consensus 185 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 262 (330)
T 3nsz_A 185 QE--YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNI 262 (330)
T ss_dssp CC--CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTC
T ss_pred Cc--cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhcc
Confidence 32 234578999999999987 679999999999999999999999994332 1111111000000000000
Q ss_pred --------ccc--------cCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004400 641 --------LVD--------TNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRM 682 (756)
Q Consensus 641 --------~~~--------~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~ 682 (756)
... ..............+.+++.+|++.||++|||+.|+++.
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~h 320 (330)
T 3nsz_A 263 ELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 320 (330)
T ss_dssp CCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred ccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 000 000000111123458899999999999999999999873
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-39 Score=334.91 Aligned_cols=248 Identities=24% Similarity=0.406 Sum_probs=197.5
Q ss_pred hcCccccCcccCCCCccEEEeecc-CCcEEEEEEccccC---cccHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEE
Q 004400 415 TNNFATDNNIGEGGFGPVYKGLLA-DGTAIAVKQLSSKS---KQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLI 490 (756)
Q Consensus 415 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 490 (756)
.++|...+.||+|+||.||+|... +|+.||||.+.... ....+.+.+|+.+++.++||||+++++++.+++..++|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (276)
T 2h6d_A 10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMV 89 (276)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred eccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEE
Confidence 357889999999999999999954 79999999986532 23456789999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCcccC
Q 004400 491 YEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEEN 570 (756)
Q Consensus 491 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~~~ 570 (756)
|||+++++|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++.......
T Consensus 90 ~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~ 165 (276)
T 2h6d_A 90 MEYVSGGELFDYICKH-GRVEEMEARRLFQQILSAVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE 165 (276)
T ss_dssp EECCCSCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHHC---SSCCCCCGGGEEECTTSCEEECCCCGGGCCCC--
T ss_pred EeccCCCcHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChhhEEECCCCCEEEeecccccccCCCc
Confidence 9999999999999755 36899999999999999999999997 9999999999999999999999999998655432
Q ss_pred cceeeccccCccCCchHhhhcCCC-CcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhcCccccccccCCCCC
Q 004400 571 THISTRVAGTIGYMAPEYAMRGHL-TEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSN 649 (756)
Q Consensus 571 ~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 649 (756)
. .....||+.|+|||.+.+..+ +.++||||||+++|+|++|+.||............ .. ... . ....
T Consensus 166 ~--~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~---~~-~~~-~-----~~~~ 233 (276)
T 2h6d_A 166 F--LRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKI---RG-GVF-Y-----IPEY 233 (276)
T ss_dssp -------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH---HH-CCC-C-----CCTT
T ss_pred c--eecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHh---hc-Ccc-c-----Cchh
Confidence 2 234568999999999987765 68999999999999999999999765543332211 11 110 0 1112
Q ss_pred CCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004400 650 FDKEQVMVMINVALLCANASPTIRPSMSSVLRM 682 (756)
Q Consensus 650 ~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~ 682 (756)
.+ ..+.+++.+|++.||++|||+.|+++.
T Consensus 234 ~~----~~l~~li~~~l~~~p~~Rps~~~~l~h 262 (276)
T 2h6d_A 234 LN----RSVATLLMHMLQVDPLKRATIKDIREH 262 (276)
T ss_dssp SC----HHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred cC----HHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 22 348899999999999999999999874
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-39 Score=356.18 Aligned_cols=198 Identities=24% Similarity=0.424 Sum_probs=166.7
Q ss_pred hcCccccCcccCCCCccEEEee-ccCCcEEEEEEcccc--CcccHHHHHHHHHHHHhCCCCceeeEeeEEEeC-----Ce
Q 004400 415 TNNFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSK--SKQGNREFINEIGMISALQHPNLVKLYGCCIEG-----NQ 486 (756)
Q Consensus 415 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~ 486 (756)
.++|...+.||+|+||.||+|+ ..+++.||||++... .....+.+.+|+.++++++||||+++++++... ..
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~ 104 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE 104 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence 4688999999999999999999 457889999999754 233456789999999999999999999999876 57
Q ss_pred EEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccC
Q 004400 487 LLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLD 566 (756)
Q Consensus 487 ~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~ 566 (756)
.|+||||++ |+|.+++.. ...+++..+..++.||++||+|||+.| |+||||||+|||++.++.+||+|||+|+..
T Consensus 105 ~~lv~e~~~-~~L~~~~~~-~~~l~~~~~~~i~~qil~aL~~LH~~g---ivHrDlkp~NILl~~~~~~kL~DFGla~~~ 179 (432)
T 3n9x_A 105 LYIVLEIAD-SDLKKLFKT-PIFLTEEHIKTILYNLLLGENFIHESG---IIHRDLKPANCLLNQDCSVKVCDFGLARTI 179 (432)
T ss_dssp EEEEEECCS-EEHHHHHHS-SCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEEEecCC-cCHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHeEECCCCCEEEccCCCcccc
Confidence 999999997 599999864 357999999999999999999999997 999999999999999999999999999865
Q ss_pred cccCcc---------------------eeeccccCccCCchHhh-hcCCCCcccchhhHHHHHHHHHhCCCCC
Q 004400 567 EEENTH---------------------ISTRVAGTIGYMAPEYA-MRGHLTEKADVYSFGIVALEIVSGRSNV 617 (756)
Q Consensus 567 ~~~~~~---------------------~~~~~~gt~~y~aPE~~-~~~~~~~~~Dv~slGv~l~elltg~~p~ 617 (756)
...... ..+..+||+.|+|||++ ....++.++||||+||++|||++|..||
T Consensus 180 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~ 252 (432)
T 3n9x_A 180 NSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSH 252 (432)
T ss_dssp -------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTT
T ss_pred cccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccc
Confidence 433211 12456899999999986 4567999999999999999999854444
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-39 Score=337.11 Aligned_cols=252 Identities=20% Similarity=0.334 Sum_probs=204.1
Q ss_pred hhcCccccCcccCCCCccEEEeec-cCCcEEEEEEccccC---------cccHHHHHHHHHHHHhCC-CCceeeEeeEEE
Q 004400 414 ATNNFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSKS---------KQGNREFINEIGMISALQ-HPNLVKLYGCCI 482 (756)
Q Consensus 414 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---------~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~ 482 (756)
..++|...+.||+|+||.||+|.. .+++.||||++.... ....+.+.+|+++++++. ||||+++++++.
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~ 94 (298)
T 1phk_A 15 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE 94 (298)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred hhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeec
Confidence 346899999999999999999995 578999999986532 122356789999999995 999999999999
Q ss_pred eCCeEEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCc
Q 004400 483 EGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGL 562 (756)
Q Consensus 483 ~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGl 562 (756)
+++..++||||+++++|.+++... ..+++..+..++.|++.||+|||+.| |+||||||+||+++.++.+||+|||+
T Consensus 95 ~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~ 170 (298)
T 1phk_A 95 TNTFFFLVFDLMKKGELFDYLTEK-VTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGF 170 (298)
T ss_dssp CSSEEEEEEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTT
T ss_pred cCCeEEEEEeccCCCcHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEcCCCcEEEecccc
Confidence 999999999999999999999754 47999999999999999999999997 99999999999999999999999999
Q ss_pred cccCcccCcceeeccccCccCCchHhhh------cCCCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhcC
Q 004400 563 AKLDEEENTHISTRVAGTIGYMAPEYAM------RGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQG 636 (756)
Q Consensus 563 a~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~ 636 (756)
+........ .....||+.|+|||++. ...++.++||||||+++|||++|+.||........... ....
T Consensus 171 ~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~---~~~~- 244 (298)
T 1phk_A 171 SCQLDPGEK--LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRM---IMSG- 244 (298)
T ss_dssp CEECCTTCC--BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH---HHHT-
T ss_pred hhhcCCCcc--cccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHH---HhcC-
Confidence 986544322 23457899999999986 34688999999999999999999999976554332221 1111
Q ss_pred ccccccccCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 004400 637 KLMELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLR 681 (756)
Q Consensus 637 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~ 681 (756)
... ... .. .......+.+++.+||+.||++||++.|+++
T Consensus 245 ~~~-~~~-~~----~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (298)
T 1phk_A 245 NYQ-FGS-PE----WDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 283 (298)
T ss_dssp CCC-CCT-TT----GGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred Ccc-cCc-cc----ccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence 110 000 00 0112334889999999999999999999976
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-40 Score=356.25 Aligned_cols=254 Identities=10% Similarity=0.008 Sum_probs=183.4
Q ss_pred hcCccccCcccCCCCccEEEeec-cCCcEEEEEEccccCc---ccHHHHHHHHHHHHhC--CCCceeeEe-------eEE
Q 004400 415 TNNFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSKSK---QGNREFINEIGMISAL--QHPNLVKLY-------GCC 481 (756)
Q Consensus 415 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l--~h~niv~l~-------~~~ 481 (756)
..+|...+.||+|+||.||+|+. .+|+.||||++..... ...+.+.+|+.+++.+ +||||++++ +++
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~ 140 (371)
T 3q60_A 61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV 140 (371)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEE
T ss_pred ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhe
Confidence 45688999999999999999994 5789999999976532 2345677785544444 699988855 555
Q ss_pred EeC-----------------CeEEEEEEecCCCCHHHHHHhcCCCCCHHHH------HHHHHHHHHHHHHHHcCCCCCeE
Q 004400 482 IEG-----------------NQLLLIYEYLENNSLARALFEHRLKLDWPTR------RRICLGIARGLAYLHGESRIKVV 538 (756)
Q Consensus 482 ~~~-----------------~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~------~~i~~~ia~~L~~LH~~g~~~ii 538 (756)
..+ ...++|||||+ |+|.+++......+.+..+ ..++.||+.||+|||++| |+
T Consensus 141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~---iv 216 (371)
T 3q60_A 141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKG---LV 216 (371)
T ss_dssp EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTT---EE
T ss_pred ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCC---Cc
Confidence 443 33899999999 8999999865555677777 788899999999999997 99
Q ss_pred cCCCCCCceEecCCCCEEEccCCccccCcccCcceeeccccCccCCchHhhhc--CCCCcccchhhHHHHHHHHHhCCCC
Q 004400 539 HRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPEYAMR--GHLTEKADVYSFGIVALEIVSGRSN 616 (756)
Q Consensus 539 H~Dikp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~slGv~l~elltg~~p 616 (756)
||||||+|||++.++.+||+|||+++..... .....||+.|+|||++.+ ..++.++|||||||++|||++|+.|
T Consensus 217 HrDikp~NIll~~~~~~kL~DFG~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~P 292 (371)
T 3q60_A 217 HGHFTPDNLFIMPDGRLMLGDVSALWKVGTR----GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLP 292 (371)
T ss_dssp ETTCSGGGEEECTTSCEEECCGGGEEETTCE----EEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCS
T ss_pred cCcCCHHHEEECCCCCEEEEecceeeecCCC----ccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCC
Confidence 9999999999999999999999999865432 123567799999999987 6799999999999999999999999
Q ss_pred CCccchhhHHHHHHHHHhcCccccccccCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 004400 617 VTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLR 681 (756)
Q Consensus 617 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~ 681 (756)
|..........|. .......................+.+++.+||+.||++|||+.|+++
T Consensus 293 f~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 352 (371)
T 3q60_A 293 FGLVTPGIKGSWK-----RPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME 352 (371)
T ss_dssp TTBCCTTCTTCCC-----BCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred CCCcCcccccchh-----hhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 9665322111110 00000000001100111122345889999999999999999999865
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=352.45 Aligned_cols=202 Identities=23% Similarity=0.341 Sum_probs=175.0
Q ss_pred hcCccccCcccCCCCccEEEee-ccCCcEEEEEEccccCcccHHHHHHHHHHHHhC------CCCceeeEeeEEEeCCeE
Q 004400 415 TNNFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQGNREFINEIGMISAL------QHPNLVKLYGCCIEGNQL 487 (756)
Q Consensus 415 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l------~h~niv~l~~~~~~~~~~ 487 (756)
..+|+..+.||+|+||.||+|. ..+++.||||++... ......+.+|+.+++.+ +|+||+++++++...+..
T Consensus 96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~ 174 (429)
T 3kvw_A 96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE-KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHI 174 (429)
T ss_dssp TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEE
T ss_pred cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc-cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeE
Confidence 4578999999999999999998 456899999999653 33346678888888877 577999999999999999
Q ss_pred EEEEEecCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCC--EEEccCCccc
Q 004400 488 LLIYEYLENNSLARALFEHR-LKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLN--SKISDFGLAK 564 (756)
Q Consensus 488 ~lV~e~~~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~--~kl~DFGla~ 564 (756)
++||||+. ++|.+++.... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++. +||+|||+++
T Consensus 175 ~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NILl~~~~~~~vkL~DFG~a~ 250 (429)
T 3kvw_A 175 CMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNR---IIHCDLKPENILLKQQGRSGIKVIDFGSSC 250 (429)
T ss_dssp EEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHT---EECSCCSGGGEEESSTTSCCEEECCCTTCE
T ss_pred EEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEccCCCcceEEeecccce
Confidence 99999996 58999887543 45999999999999999999999996 999999999999999987 9999999997
Q ss_pred cCcccCcceeeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHhCCCCCCccchhhH
Q 004400 565 LDEEENTHISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYL 625 (756)
Q Consensus 565 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~ 625 (756)
..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||...+....
T Consensus 251 ~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~ 307 (429)
T 3kvw_A 251 YEHQR----VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQ 307 (429)
T ss_dssp ETTCC----CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred ecCCc----ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHH
Confidence 54432 2345789999999999999999999999999999999999999977665443
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-39 Score=334.98 Aligned_cols=250 Identities=27% Similarity=0.401 Sum_probs=199.2
Q ss_pred cCccccCcccCCCCccEEEeec-cCCcEEEEEEcccc--CcccHHHHHHHHHHHHhCCCCceeeEeeEEEe----CCeEE
Q 004400 416 NNFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSK--SKQGNREFINEIGMISALQHPNLVKLYGCCIE----GNQLL 488 (756)
Q Consensus 416 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~ 488 (756)
+.|...+.||+|+||.||+|.. .++..||+|.+... .....+.+.+|+.++++++||||+++++++.. ....+
T Consensus 26 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 105 (290)
T 1t4h_A 26 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIV 105 (290)
T ss_dssp CEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEE
T ss_pred eeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEE
Confidence 4577888999999999999984 57889999998654 23345678999999999999999999999876 45689
Q ss_pred EEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEec-CCCCEEEccCCccccCc
Q 004400 489 LIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLD-KDLNSKISDFGLAKLDE 567 (756)
Q Consensus 489 lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~-~~~~~kl~DFGla~~~~ 567 (756)
+||||+++|+|.+++... ..+++..+..++.|++.||+|||+.+ .+|+||||||+||+++ .++.+||+|||++....
T Consensus 106 lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~~ 183 (290)
T 1t4h_A 106 LVTELMTSGTLKTYLKRF-KVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR 183 (290)
T ss_dssp EEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred EEEEecCCCCHHHHHHHc-cCCCHHHHHHHHHHHHHHHHHHHcCC-CCEEECCCCHHHEEEECCCCCEEEeeCCCccccc
Confidence 999999999999999754 47899999999999999999999884 3499999999999998 78899999999997544
Q ss_pred ccCcceeeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhcCccccccccCCC
Q 004400 568 EENTHISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPG 647 (756)
Q Consensus 568 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 647 (756)
... .....||+.|+|||++. +.++.++||||||+++|+|++|+.||......... ...... .......+
T Consensus 184 ~~~---~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~--~~~~~~-~~~~~~~~---- 252 (290)
T 1t4h_A 184 ASF---AKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQI--YRRVTS-GVKPASFD---- 252 (290)
T ss_dssp TTS---BEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHH--HHHHTT-TCCCGGGG----
T ss_pred ccc---cccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHH--HHHHhc-cCCccccC----
Confidence 332 23457999999999876 56999999999999999999999999654322211 111111 11111111
Q ss_pred CCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004400 648 SNFDKEQVMVMINVALLCANASPTIRPSMSSVLRM 682 (756)
Q Consensus 648 ~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~ 682 (756)
...+ ..+.+++.+||+.||.+|||+.|+++.
T Consensus 253 ~~~~----~~l~~li~~~l~~dp~~Rps~~ell~h 283 (290)
T 1t4h_A 253 KVAI----PEVKEIIEGCIRQNKDERYSIKDLLNH 283 (290)
T ss_dssp GCCC----HHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred CCCC----HHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 1112 248899999999999999999999863
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=345.35 Aligned_cols=258 Identities=22% Similarity=0.375 Sum_probs=202.9
Q ss_pred HhhcCccccCcccCCCCccEEEeeccCCcEEEEEEccccC--cccHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEE
Q 004400 413 AATNNFATDNNIGEGGFGPVYKGLLADGTAIAVKQLSSKS--KQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLI 490 (756)
Q Consensus 413 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 490 (756)
...++|+..+.||+|+||.||+|...+ .||+|.+.... ....+.+.+|+.++++++||||+++++++.+++..++|
T Consensus 30 i~~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv 107 (319)
T 2y4i_B 30 IPFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAII 107 (319)
T ss_dssp SCCSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEE
T ss_pred CCHHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEE
Confidence 345789999999999999999998753 59999987542 22345678899999999999999999999999999999
Q ss_pred EEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCcccC
Q 004400 491 YEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEEN 570 (756)
Q Consensus 491 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~~~ 570 (756)
|||+++++|.+++......+++..+..++.|++.||+|||+.+ |+||||||+||+++ ++.+||+|||+++......
T Consensus 108 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~~ 183 (319)
T 2y4i_B 108 TSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKG---ILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQ 183 (319)
T ss_dssp CBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTT---CCCCCCCSTTEEEC---CCEECCCSCCC------
T ss_pred eecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChhhEEEe-CCCEEEeecCCcccccccc
Confidence 9999999999999876667999999999999999999999997 99999999999998 6799999999987643211
Q ss_pred ----cceeeccccCccCCchHhhhc---------CCCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhcCc
Q 004400 571 ----THISTRVAGTIGYMAPEYAMR---------GHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGK 637 (756)
Q Consensus 571 ----~~~~~~~~gt~~y~aPE~~~~---------~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 637 (756)
........||+.|+|||++.. ..++.++||||||+++|||++|+.||........... . ..+.
T Consensus 184 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~---~-~~~~ 259 (319)
T 2y4i_B 184 AGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQ---M-GTGM 259 (319)
T ss_dssp ----CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHH---H-HTTC
T ss_pred ccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH---h-ccCC
Confidence 111233468999999999874 4578999999999999999999999976554332211 1 1111
Q ss_pred cccccccCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhccCcc
Q 004400 638 LMELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLECGVD 688 (756)
Q Consensus 638 ~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~L~~~~~ 688 (756)
...... ..++ ..+.+++.+||+.||++|||+.++++.|+.+..
T Consensus 260 ~~~~~~----~~~~----~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~ 302 (319)
T 2y4i_B 260 KPNLSQ----IGMG----KEISDILLFCWAFEQEERPTFTKLMDMLEKLPK 302 (319)
T ss_dssp CCCCCC----SSCC----TTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC--
T ss_pred CCCCCc----CCCC----HHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHH
Confidence 111111 1122 238899999999999999999999999997654
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-39 Score=348.50 Aligned_cols=262 Identities=22% Similarity=0.342 Sum_probs=203.6
Q ss_pred hcCccccCcccCCCCccEEEee-ccCCcEEEEEEccccC-cccHHHHHHHHHHHHhCCCCceeeEeeEEEeC-----CeE
Q 004400 415 TNNFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSKS-KQGNREFINEIGMISALQHPNLVKLYGCCIEG-----NQL 487 (756)
Q Consensus 415 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~~ 487 (756)
.++|...+.||+|+||.||+|. ..+++.||||++.... ....+.+.+|++++++++||||+++++++... ...
T Consensus 26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 105 (364)
T 3qyz_A 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 105 (364)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceE
Confidence 4579999999999999999998 4578899999997533 23346789999999999999999999999765 468
Q ss_pred EEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCc
Q 004400 488 LLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDE 567 (756)
Q Consensus 488 ~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~ 567 (756)
++||||+++ +|.+++... .+++..+..++.|++.||+|||+.| |+||||||+||+++.++.+||+|||+++...
T Consensus 106 ~iv~e~~~~-~L~~~l~~~--~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~ 179 (364)
T 3qyz_A 106 YIVQDLMET-DLYKLLKTQ--HLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVAD 179 (364)
T ss_dssp EEEEECCSE-EHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEEEcccCc-CHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChHhEEECCCCCEEEEeCcceEecC
Confidence 999999984 899988653 6899999999999999999999997 9999999999999999999999999998665
Q ss_pred ccCcce--eeccccCccCCchHhhhcC-CCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhcCcccc----
Q 004400 568 EENTHI--STRVAGTIGYMAPEYAMRG-HLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLME---- 640 (756)
Q Consensus 568 ~~~~~~--~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~---- 640 (756)
...... .....||+.|+|||++.+. .++.++|||||||++|||++|+.||...+...................
T Consensus 180 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 259 (364)
T 3qyz_A 180 PDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCI 259 (364)
T ss_dssp GGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHHTC
T ss_pred CCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHh
Confidence 432221 2345799999999987654 589999999999999999999999977655443332221111100000
Q ss_pred -------ccccCC-CCCCC-----HHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004400 641 -------LVDTNP-GSNFD-----KEQVMVMINVALLCANASPTIRPSMSSVLRM 682 (756)
Q Consensus 641 -------~~~~~~-~~~~~-----~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~ 682 (756)
.....+ ....+ +.....+.+++.+|++.||++|||+.|+++.
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 314 (364)
T 3qyz_A 260 INLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 314 (364)
T ss_dssp CCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred hhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 000000 00000 1112358899999999999999999999864
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-39 Score=341.23 Aligned_cols=263 Identities=25% Similarity=0.383 Sum_probs=203.5
Q ss_pred HhhcCccccCcccCCCCccEEEeec--cCCcEEEEEEccccCc--ccHHHHHHHHHHHHhC---CCCceeeEeeEEE---
Q 004400 413 AATNNFATDNNIGEGGFGPVYKGLL--ADGTAIAVKQLSSKSK--QGNREFINEIGMISAL---QHPNLVKLYGCCI--- 482 (756)
Q Consensus 413 ~~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l---~h~niv~l~~~~~--- 482 (756)
.+.++|...+.||+|+||.||+|+. .+|+.||+|++..... .....+.+|+.+++.+ +||||++++++|.
T Consensus 8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~ 87 (326)
T 1blx_A 8 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSR 87 (326)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEE
T ss_pred CchhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecc
Confidence 3567899999999999999999996 4688999999865322 2224567788777766 8999999999997
Q ss_pred --eCCeEEEEEEecCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEcc
Q 004400 483 --EGNQLLLIYEYLENNSLARALFEHR-LKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISD 559 (756)
Q Consensus 483 --~~~~~~lV~e~~~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~D 559 (756)
.....++||||++ |+|.+++.... ..+++..+..++.|++.||+|||+.| |+||||||+||+++.++.+||+|
T Consensus 88 ~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g---i~H~dlkp~Nili~~~~~~kl~D 163 (326)
T 1blx_A 88 TDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLAD 163 (326)
T ss_dssp CSSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECS
T ss_pred cCCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHHHeEEcCCCCEEEec
Confidence 4567899999998 69999997543 35899999999999999999999997 99999999999999999999999
Q ss_pred CCccccCcccCcceeeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhcCccc
Q 004400 560 FGLAKLDEEENTHISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLM 639 (756)
Q Consensus 560 FGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 639 (756)
||+++...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||......................
T Consensus 164 fg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 241 (326)
T 1blx_A 164 FGLARIYSFQM--ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEE 241 (326)
T ss_dssp CCSCCCCCGGG--GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGG
T ss_pred CcccccccCCC--CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCcc
Confidence 99998655332 2234578999999999999999999999999999999999999997765544333222111110000
Q ss_pred cc----------cc---cCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 004400 640 EL----------VD---TNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLR 681 (756)
Q Consensus 640 ~~----------~~---~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~ 681 (756)
.. .. ......+.......+.+++.+||+.||++||++.|+++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 296 (326)
T 1blx_A 242 DWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 296 (326)
T ss_dssp GSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred cCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 00 00 00000111122335889999999999999999999985
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-39 Score=344.53 Aligned_cols=255 Identities=26% Similarity=0.413 Sum_probs=200.2
Q ss_pred HHHhhcCccccCcccCCCCccEEEeec-cCCcEEEEEEccccCcccHHHHHHHHHHHHhC-CCCceeeEeeEEEe-----
Q 004400 411 IKAATNNFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSKSKQGNREFINEIGMISAL-QHPNLVKLYGCCIE----- 483 (756)
Q Consensus 411 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~----- 483 (756)
+....++|...+.||+|+||.||+|+. .+++.||||++... ......+.+|+.+++++ +||||+++++++..
T Consensus 19 l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~ 97 (326)
T 2x7f_A 19 LRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVT-GDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPG 97 (326)
T ss_dssp CCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-SSTTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--C
T ss_pred ccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecC-cccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCcc
Confidence 345678899999999999999999995 57899999998653 33457889999999999 89999999999987
Q ss_pred -CCeEEEEEEecCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCC
Q 004400 484 -GNQLLLIYEYLENNSLARALFEH-RLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFG 561 (756)
Q Consensus 484 -~~~~~lV~e~~~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFG 561 (756)
.+..++||||+++|+|.+++... ...+++..+..++.||+.||+|||+.| |+||||||+||+++.++.+||+|||
T Consensus 98 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg 174 (326)
T 2x7f_A 98 MDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFG 174 (326)
T ss_dssp CCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEEECCCT
T ss_pred ccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCcHHHEEEcCCCCEEEeeCc
Confidence 56899999999999999999754 357899999999999999999999997 9999999999999999999999999
Q ss_pred ccccCcccCcceeeccccCccCCchHhhh-----cCCCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhcC
Q 004400 562 LAKLDEEENTHISTRVAGTIGYMAPEYAM-----RGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQG 636 (756)
Q Consensus 562 la~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~ 636 (756)
++........ ......||+.|+|||++. ...++.++|||||||++|||++|+.||........... ... .
T Consensus 175 ~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~---~~~-~ 249 (326)
T 2x7f_A 175 VSAQLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFL---IPR-N 249 (326)
T ss_dssp TTC--------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHH---HHH-S
T ss_pred CceecCcCcc-ccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHH---hhc-C
Confidence 9986543221 123457999999999987 56789999999999999999999999966554332211 111 1
Q ss_pred ccccccccCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004400 637 KLMELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRM 682 (756)
Q Consensus 637 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~ 682 (756)
..... ....++ ..+.+++.+||+.||.+||++.++++.
T Consensus 250 ~~~~~----~~~~~~----~~l~~li~~~l~~dp~~Rps~~~ll~h 287 (326)
T 2x7f_A 250 PAPRL----KSKKWS----KKFQSFIESCLVKNHSQRPATEQLMKH 287 (326)
T ss_dssp CCCCC----SCSCSC----HHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred ccccC----CccccC----HHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 11111 111223 348899999999999999999999873
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-39 Score=343.43 Aligned_cols=252 Identities=22% Similarity=0.346 Sum_probs=196.2
Q ss_pred hhcCccccCcccCCCCccEEEeec-cCCcEEEEEEccccCc--------ccHHHHHHHHHHHHhCCCCceeeEeeEEEeC
Q 004400 414 ATNNFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSKSK--------QGNREFINEIGMISALQHPNLVKLYGCCIEG 484 (756)
Q Consensus 414 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 484 (756)
..++|...+.||+|+||.||+|.. .+++.||||.+..... .....+.+|++++++++||||+++++++..+
T Consensus 8 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 87 (322)
T 2ycf_A 8 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE 87 (322)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESS
T ss_pred hhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCC
Confidence 346789999999999999999984 5689999999865321 1224588999999999999999999998766
Q ss_pred CeEEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCC---EEEccCC
Q 004400 485 NQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLN---SKISDFG 561 (756)
Q Consensus 485 ~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~---~kl~DFG 561 (756)
. .++||||+++|+|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+||+++.++. +||+|||
T Consensus 88 ~-~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~Dfg 162 (322)
T 2ycf_A 88 D-YYIVLELMEGGELFDKVVGN-KRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFG 162 (322)
T ss_dssp S-EEEEEECCTTEETHHHHSTT-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSSSCCEEECCCT
T ss_pred c-eEEEEecCCCCcHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEecCCCCCeEEEccCc
Confidence 5 89999999999999988644 47999999999999999999999997 999999999999987654 9999999
Q ss_pred ccccCcccCcceeeccccCccCCchHhhh---cCCCCcccchhhHHHHHHHHHhCCCCCCccchh-hHHHHHHHHHhcCc
Q 004400 562 LAKLDEEENTHISTRVAGTIGYMAPEYAM---RGHLTEKADVYSFGIVALEIVSGRSNVTKEDMF-YLLDWALVLKEQGK 637 (756)
Q Consensus 562 la~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~-~~~~~~~~~~~~~~ 637 (756)
+++...... ......||+.|+|||++. ...++.++|||||||++|||++|+.||...... ..... .. .+.
T Consensus 163 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~---~~-~~~ 236 (322)
T 2ycf_A 163 HSKILGETS--LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQ---IT-SGK 236 (322)
T ss_dssp TCEECCCCH--HHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHH---HH-HTC
T ss_pred cceeccccc--ccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHH---HH-hCc
Confidence 998654322 123457999999999975 456899999999999999999999999654322 11111 11 111
Q ss_pred cccccccCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004400 638 LMELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRM 682 (756)
Q Consensus 638 ~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~ 682 (756)
..... .....+ ...+.+++.+||+.||++||++.++++.
T Consensus 237 ~~~~~--~~~~~~----~~~~~~li~~~l~~dP~~Rps~~~~l~h 275 (322)
T 2ycf_A 237 YNFIP--EVWAEV----SEKALDLVKKLLVVDPKARFTTEEALRH 275 (322)
T ss_dssp CCCCH--HHHTTS----CHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred cccCc--hhhhhc----CHHHHHHHHHHcccCHhhCCCHHHHhhC
Confidence 10000 000112 2358899999999999999999999763
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-39 Score=348.66 Aligned_cols=258 Identities=24% Similarity=0.364 Sum_probs=186.3
Q ss_pred hcCccccCcccCCCCccEEEee-ccCCcEEEEEEcccc--CcccHHHHHHHHHHHHhCCCCceeeEeeEEEeC------C
Q 004400 415 TNNFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSK--SKQGNREFINEIGMISALQHPNLVKLYGCCIEG------N 485 (756)
Q Consensus 415 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~ 485 (756)
.++|...+.||+|+||.||+|. ..+|+.||||++... .....+.+.+|+.+++.++||||+++++++... .
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~ 107 (367)
T 2fst_X 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 107 (367)
T ss_dssp ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence 3688999999999999999998 567899999999653 233456788999999999999999999999754 5
Q ss_pred eEEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCcccc
Q 004400 486 QLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKL 565 (756)
Q Consensus 486 ~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~ 565 (756)
..++|+||+ +++|.+++.. ..+++..+..++.||++||+|||+.| |+||||||+||+++.++.+||+|||+++.
T Consensus 108 ~~~lv~e~~-~~~L~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kL~DFG~a~~ 181 (367)
T 2fst_X 108 DVYLVTHLM-GADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARH 181 (367)
T ss_dssp CCEEEEECC-CEECC-------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECC------
T ss_pred eEEEEeccc-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHhhEEECCCCCEEEeecccccc
Confidence 679999999 6899888864 47999999999999999999999997 99999999999999999999999999986
Q ss_pred CcccCcceeeccccCccCCchHhhhc-CCCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhcCccc-----
Q 004400 566 DEEENTHISTRVAGTIGYMAPEYAMR-GHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLM----- 639 (756)
Q Consensus 566 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~----- 639 (756)
.... .....||+.|+|||++.+ ..++.++||||+||++|||++|+.||.+.+..................
T Consensus 182 ~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~ 257 (367)
T 2fst_X 182 TADE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 257 (367)
T ss_dssp -------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTTC
T ss_pred cccc----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHh
Confidence 5432 234579999999999987 679999999999999999999999997766544333222211110000
Q ss_pred ---------cccccCCCCCCC---HHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004400 640 ---------ELVDTNPGSNFD---KEQVMVMINVALLCANASPTIRPSMSSVLRM 682 (756)
Q Consensus 640 ---------~~~~~~~~~~~~---~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~ 682 (756)
..+...+...+. ......+.+++.+|++.||++|||+.|+++.
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~h 312 (367)
T 2fst_X 258 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 312 (367)
T ss_dssp CCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcC
Confidence 000000000000 0112348899999999999999999999864
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-39 Score=347.89 Aligned_cols=257 Identities=21% Similarity=0.323 Sum_probs=193.7
Q ss_pred hcCccccCcccCCCCccEEEee-ccCCcEEEEEEcccc--CcccHHHHHHHHHHHHhCCCCceeeEeeEEEeCC------
Q 004400 415 TNNFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSK--SKQGNREFINEIGMISALQHPNLVKLYGCCIEGN------ 485 (756)
Q Consensus 415 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------ 485 (756)
.++|...+.||+|+||.||+|. ..+++.||||++... .....+.+.+|+.+++.++||||+++++++...+
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 103 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 103 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence 3578999999999999999998 457899999998653 2333467889999999999999999999998765
Q ss_pred eEEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCcccc
Q 004400 486 QLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKL 565 (756)
Q Consensus 486 ~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~ 565 (756)
..++||||+++ +|.+.+. ..+++..+..++.||+.||+|||++| |+||||||+|||++.++.+||+|||+++.
T Consensus 104 ~~~lv~e~~~~-~l~~~~~---~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~ 176 (371)
T 2xrw_A 104 DVYIVMELMDA-NLCQVIQ---MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLART 176 (371)
T ss_dssp EEEEEEECCSE-EHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCCCC---
T ss_pred ceEEEEEcCCC-CHHHHHh---hccCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEEEeecccc
Confidence 78999999985 7888774 35899999999999999999999997 99999999999999999999999999986
Q ss_pred CcccCcceeeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhcCcc-cc----
Q 004400 566 DEEENTHISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKL-ME---- 640 (756)
Q Consensus 566 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~-~~---- 640 (756)
..... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+...... ......+.. .+
T Consensus 177 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~--~i~~~~~~~~~~~~~~ 252 (371)
T 2xrw_A 177 AGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWN--KVIEQLGTPCPEFMKK 252 (371)
T ss_dssp ---------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH--HHHC-CCCCCHHHHTT
T ss_pred ccccc--ccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHH--HHHHHhCCCCHHHHHH
Confidence 54322 2234679999999999999899999999999999999999999997765433221 111100000 00
Q ss_pred -------ccccCC---------------CCC---CCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004400 641 -------LVDTNP---------------GSN---FDKEQVMVMINVALLCANASPTIRPSMSSVLRM 682 (756)
Q Consensus 641 -------~~~~~~---------------~~~---~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~ 682 (756)
.....+ ... ........+.+++.+|++.||++|||+.|+++.
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 319 (371)
T 2xrw_A 253 LQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 319 (371)
T ss_dssp SCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred hhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCC
Confidence 000000 000 011235578999999999999999999999874
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-39 Score=354.11 Aligned_cols=257 Identities=24% Similarity=0.289 Sum_probs=194.5
Q ss_pred cCccccCcccCCCCccEEEeec-cCCcEEEEEEccccCcccHHHHHHHHHHHHhCCCCceeeEeeEEEeC------CeEE
Q 004400 416 NNFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCCIEG------NQLL 488 (756)
Q Consensus 416 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~~~ 488 (756)
.+|...+.||+|+||.||+|+. .+|+.||||++..... .+.+|+++++.++|||||+++++|... ...+
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~ 129 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN 129 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEE
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch----hHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEE
Confidence 4688889999999999999995 5689999999865322 234799999999999999999998642 2467
Q ss_pred EEEEecCCCCHHHHHH---hcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCC-CCEEEccCCccc
Q 004400 489 LIYEYLENNSLARALF---EHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKD-LNSKISDFGLAK 564 (756)
Q Consensus 489 lV~e~~~~gsL~~~l~---~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~-~~~kl~DFGla~ 564 (756)
+||||+++ ++.+.+. .....+++..+..++.||++||+|||+.+ |+||||||+|||++.+ +.+||+|||+++
T Consensus 130 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NILl~~~~~~~kl~DFG~a~ 205 (420)
T 1j1b_A 130 LVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAK 205 (420)
T ss_dssp EEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred eehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChhhEEEeCCCCeEEeccchhhh
Confidence 99999986 5665554 34568999999999999999999999986 9999999999999965 568999999998
Q ss_pred cCcccCcceeeccccCccCCchHhhhcC-CCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhc--------
Q 004400 565 LDEEENTHISTRVAGTIGYMAPEYAMRG-HLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQ-------- 635 (756)
Q Consensus 565 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~-------- 635 (756)
....... .....||+.|+|||++.+. .++.++|||||||++|||++|+.||.+.+..............
T Consensus 206 ~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~~~ 283 (420)
T 1j1b_A 206 QLVRGEP--NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIRE 283 (420)
T ss_dssp ECCTTCC--CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHHH
T ss_pred hcccCCC--ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence 6543322 2345789999999999764 7999999999999999999999999776544332211111110
Q ss_pred --CccccccccCCCC-----CCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004400 636 --GKLMELVDTNPGS-----NFDKEQVMVMINVALLCANASPTIRPSMSSVLRM 682 (756)
Q Consensus 636 --~~~~~~~~~~~~~-----~~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~ 682 (756)
....+...+.... .+.......+.+++.+||+.||.+||++.|+++.
T Consensus 284 ~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~h 337 (420)
T 1j1b_A 284 MNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH 337 (420)
T ss_dssp HCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCC
Confidence 0001100000000 0111123458899999999999999999999853
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-39 Score=353.38 Aligned_cols=259 Identities=23% Similarity=0.293 Sum_probs=196.3
Q ss_pred hcCccccCcccCCCCccEEEeeccCCcEEEEEEccccCcccHHHHHHHHHHHHhCCCCceeeEeeEEEeCC------eEE
Q 004400 415 TNNFATDNNIGEGGFGPVYKGLLADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCCIEGN------QLL 488 (756)
Q Consensus 415 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------~~~ 488 (756)
..+|...+.||+|+||.||+|+...+..||+|++..... ...+|+++++.++||||++++++|...+ ..+
T Consensus 39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~----~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~ 114 (394)
T 4e7w_A 39 EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKR----FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLN 114 (394)
T ss_dssp EEEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEE
T ss_pred cceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcc----hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEE
Confidence 346889999999999999999987777799998854322 2236999999999999999999996543 388
Q ss_pred EEEEecCCCCHHHHHH--hcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEec-CCCCEEEccCCcccc
Q 004400 489 LIYEYLENNSLARALF--EHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLD-KDLNSKISDFGLAKL 565 (756)
Q Consensus 489 lV~e~~~~gsL~~~l~--~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~-~~~~~kl~DFGla~~ 565 (756)
+||||++++.+..... .....+++..+..++.||++||+|||+.| |+||||||+|||++ .++.+||+|||+++.
T Consensus 115 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~kL~DFG~a~~ 191 (394)
T 4e7w_A 115 LVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIG---ICHRDIKPQNLLLDPPSGVLKLIDFGSAKI 191 (394)
T ss_dssp EEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred EEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEcCCCCcEEEeeCCCccc
Confidence 9999999865444332 33567999999999999999999999997 99999999999999 789999999999986
Q ss_pred CcccCcceeeccccCccCCchHhhhcC-CCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhcCc-------
Q 004400 566 DEEENTHISTRVAGTIGYMAPEYAMRG-HLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGK------- 637 (756)
Q Consensus 566 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~------- 637 (756)
...... .....||+.|+|||++.+. .++.++||||+||++|||++|+.||.+.+................
T Consensus 192 ~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~ 269 (394)
T 4e7w_A 192 LIAGEP--NVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTM 269 (394)
T ss_dssp CCTTCC--CCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHH
T ss_pred ccCCCC--CcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhh
Confidence 543322 2345789999999999764 599999999999999999999999977665433322211111000
Q ss_pred ---cccccccCCC-C----CCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004400 638 ---LMELVDTNPG-S----NFDKEQVMVMINVALLCANASPTIRPSMSSVLRM 682 (756)
Q Consensus 638 ---~~~~~~~~~~-~----~~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~ 682 (756)
......+... . .+.......+.+++.+||+.||++|||+.|+++.
T Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 322 (394)
T 4e7w_A 270 NPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCH 322 (394)
T ss_dssp CGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred ChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcC
Confidence 0000000000 0 0111123358999999999999999999999864
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-39 Score=337.55 Aligned_cols=252 Identities=27% Similarity=0.438 Sum_probs=195.1
Q ss_pred hcCccccCcccCCCCccEEEeec-cCCcEEEEEEccccCcccHHHHHHHHHHHHhCCCCceeeEeeEEEe----------
Q 004400 415 TNNFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCCIE---------- 483 (756)
Q Consensus 415 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~---------- 483 (756)
.++|+..+.||+|+||.||+|+. .+++.||||.+... ....+.+.+|+.++++++||||+++++++.+
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (303)
T 1zy4_A 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTA 83 (303)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC----
T ss_pred cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcc
Confidence 45789999999999999999994 57999999998643 3345678999999999999999999999865
Q ss_pred ---CCeEEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccC
Q 004400 484 ---GNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDF 560 (756)
Q Consensus 484 ---~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DF 560 (756)
....++||||+++|+|.+++......+++..+..++.|++.||+|||+++ |+||||||+||+++.++.+||+||
T Consensus 84 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dlkp~Nil~~~~~~~kl~df 160 (303)
T 1zy4_A 84 VKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDF 160 (303)
T ss_dssp --CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCC
T ss_pred cccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCC---eecccCCHHhEEEcCCCCEEEeeC
Confidence 35789999999999999999877667889999999999999999999997 999999999999999999999999
Q ss_pred CccccCcccC-------------cceeeccccCccCCchHhhhcC-CCCcccchhhHHHHHHHHHhCCCCCCccchhhHH
Q 004400 561 GLAKLDEEEN-------------THISTRVAGTIGYMAPEYAMRG-HLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLL 626 (756)
Q Consensus 561 Gla~~~~~~~-------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~ 626 (756)
|+++...... ........||+.|+|||++.+. .++.++|||||||++|||++ ||...... .
T Consensus 161 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~--~ 235 (303)
T 1zy4_A 161 GLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMER--V 235 (303)
T ss_dssp CCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHH--H
T ss_pred cchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchhH--H
Confidence 9998654321 1122345789999999999864 68999999999999999998 55332111 1
Q ss_pred HHHHHHHhcCccccccccCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004400 627 DWALVLKEQGKLMELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRM 682 (756)
Q Consensus 627 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~ 682 (756)
........ .. .. ....++......+.+++.+||+.||.+|||+.++++.
T Consensus 236 ~~~~~~~~-~~-~~-----~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 284 (303)
T 1zy4_A 236 NILKKLRS-VS-IE-----FPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNS 284 (303)
T ss_dssp HHHHHHHS-TT-CC-----CCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred HHHHhccc-cc-cc-----cCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCC
Confidence 11111111 00 00 1111222333458899999999999999999999874
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-39 Score=352.02 Aligned_cols=259 Identities=21% Similarity=0.316 Sum_probs=201.2
Q ss_pred hcCccccCcccCCCCccEEEee-ccCCcEEEEEEccccCcccHHHHHHHHHHHHhCC--------CCceeeEeeEEE---
Q 004400 415 TNNFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQGNREFINEIGMISALQ--------HPNLVKLYGCCI--- 482 (756)
Q Consensus 415 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~--------h~niv~l~~~~~--- 482 (756)
.++|...+.||+|+||.||+|+ ..+++.||||++... ....+.+.+|+.+++.++ |+||+++++++.
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~ 114 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISG 114 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEE
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecC
Confidence 3678999999999999999998 567899999999643 334567889999999985 788999999998
Q ss_pred -eCCeEEEEEEecCCCCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHcC-CCCCeEcCCCCCCceEecCCC------
Q 004400 483 -EGNQLLLIYEYLENNSLARALFE-HRLKLDWPTRRRICLGIARGLAYLHGE-SRIKVVHRDIKATNVLLDKDL------ 553 (756)
Q Consensus 483 -~~~~~~lV~e~~~~gsL~~~l~~-~~~~l~~~~~~~i~~~ia~~L~~LH~~-g~~~iiH~Dikp~Nill~~~~------ 553 (756)
+....++||||+ +++|.+++.. ....+++..+..++.||+.||+|||++ | |+||||||+|||++.++
T Consensus 115 ~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~g---ivHrDikp~NIll~~~~~~~~~~ 190 (397)
T 1wak_A 115 VNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCR---IIHTDIKPENILLSVNEQYIRRL 190 (397)
T ss_dssp TTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECCCCSGGGEEECCCHHHHHHH
T ss_pred CCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHeeEeccchhhhhh
Confidence 456899999999 5566665554 345799999999999999999999998 6 99999999999999775
Q ss_pred -------------------------------------------CEEEccCCccccCcccCcceeeccccCccCCchHhhh
Q 004400 554 -------------------------------------------NSKISDFGLAKLDEEENTHISTRVAGTIGYMAPEYAM 590 (756)
Q Consensus 554 -------------------------------------------~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~ 590 (756)
.+||+|||+++..... .....||+.|+|||++.
T Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~----~~~~~gt~~y~aPE~~~ 266 (397)
T 1wak_A 191 AAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH----FTEDIQTRQYRSLEVLI 266 (397)
T ss_dssp HHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC----SCSCCSCGGGCCHHHHH
T ss_pred hhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc----CccCCCCCcccCChhhc
Confidence 7999999999865433 23357899999999999
Q ss_pred cCCCCcccchhhHHHHHHHHHhCCCCCCccchhh------HHHHHHHHHhc---------Ccccccc----------ccC
Q 004400 591 RGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFY------LLDWALVLKEQ---------GKLMELV----------DTN 645 (756)
Q Consensus 591 ~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~------~~~~~~~~~~~---------~~~~~~~----------~~~ 645 (756)
+..++.++|||||||++|||++|+.||....... ........... ....... ...
T Consensus 267 ~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 346 (397)
T 1wak_A 267 GSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLK 346 (397)
T ss_dssp TSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCC
T ss_pred CCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccccC
Confidence 9999999999999999999999999996543211 11111010000 0000000 000
Q ss_pred C---------CCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004400 646 P---------GSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRM 682 (756)
Q Consensus 646 ~---------~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~ 682 (756)
+ ...++......+.+++.+||+.||++|||+.|+++.
T Consensus 347 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 392 (397)
T 1wak_A 347 PWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRH 392 (397)
T ss_dssp CCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTS
T ss_pred CcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhC
Confidence 0 012356667789999999999999999999999863
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-38 Score=332.81 Aligned_cols=250 Identities=22% Similarity=0.316 Sum_probs=199.7
Q ss_pred hcCccccCcccCCCCccEEEeec-cCCcEEEEEEccccC----cccHHHHHHHHHHHHhCCCCceeeEeeEEE--eCCeE
Q 004400 415 TNNFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSKS----KQGNREFINEIGMISALQHPNLVKLYGCCI--EGNQL 487 (756)
Q Consensus 415 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~--~~~~~ 487 (756)
.++|...+.||+|+||.||+|.. .+++.||+|++.... ......+.+|++++++++||||+++++++. +....
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM 83 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence 46899999999999999999995 578999999997542 234577999999999999999999999985 45678
Q ss_pred EEEEEecCCCCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccC
Q 004400 488 LLIYEYLENNSLARALFE-HRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLD 566 (756)
Q Consensus 488 ~lV~e~~~~gsL~~~l~~-~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~ 566 (756)
++||||++++ |.+++.. ....+++..+..++.|++.||+|||+++ |+||||||+||+++.++.+||+|||++...
T Consensus 84 ~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~ 159 (305)
T 2wtk_C 84 YMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEAL 159 (305)
T ss_dssp EEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEcCCCcEEeecccccccc
Confidence 9999999987 7777654 3457999999999999999999999997 999999999999999999999999999865
Q ss_pred cccC-cceeeccccCccCCchHhhhcCC--CCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhcCccccccc
Q 004400 567 EEEN-THISTRVAGTIGYMAPEYAMRGH--LTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVD 643 (756)
Q Consensus 567 ~~~~-~~~~~~~~gt~~y~aPE~~~~~~--~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 643 (756)
.... ........||+.|+|||++.+.. ++.++||||||+++|||++|+.||...+....... ... ... .
T Consensus 160 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~---i~~-~~~-~--- 231 (305)
T 2wtk_C 160 HPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFEN---IGK-GSY-A--- 231 (305)
T ss_dssp CTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH---HHH-CCC-C---
T ss_pred CccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHH---Hhc-CCC-C---
Confidence 4322 22233457999999999997644 47899999999999999999999976654433221 111 111 0
Q ss_pred cCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004400 644 TNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRM 682 (756)
Q Consensus 644 ~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~ 682 (756)
....++ ..+.+++.+||+.||++||++.|+++.
T Consensus 232 --~~~~~~----~~l~~li~~~l~~dp~~Rps~~~ll~~ 264 (305)
T 2wtk_C 232 --IPGDCG----PPLSDLLKGMLEYEPAKRFSIRQIRQH 264 (305)
T ss_dssp --CCSSSC----HHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred --CCCccC----HHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 111223 348899999999999999999999864
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-38 Score=340.53 Aligned_cols=262 Identities=21% Similarity=0.304 Sum_probs=201.3
Q ss_pred hcCccccCcccCCCCccEEEeec-cCCcEEEEEEccccC-cccHHHHHHHHHHHHhCCCCceeeEeeEEEeC-----CeE
Q 004400 415 TNNFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSKS-KQGNREFINEIGMISALQHPNLVKLYGCCIEG-----NQL 487 (756)
Q Consensus 415 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~~ 487 (756)
.++|...+.||+|+||.||+|+. .+|+.||||.+.... ......+.+|++++++++||||+++++++..+ ...
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 89 (353)
T 2b9h_A 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEV 89 (353)
T ss_dssp CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCE
T ss_pred ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceE
Confidence 46899999999999999999995 478999999996532 33346788999999999999999999998764 678
Q ss_pred EEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCc
Q 004400 488 LLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDE 567 (756)
Q Consensus 488 ~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~ 567 (756)
++||||+. |+|.+++.. ..+++..+..++.|++.||+|||+.| |+||||||+||+++.++.+||+|||+++...
T Consensus 90 ~lv~e~~~-~~L~~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~ 163 (353)
T 2b9h_A 90 YIIQELMQ-TDLHRVIST--QMLSDDHIQYFIYQTLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARIID 163 (353)
T ss_dssp EEEECCCS-EEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEEEeccC-ccHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEcCCCcEEEEecccccccc
Confidence 99999998 589998865 36899999999999999999999997 9999999999999999999999999998654
Q ss_pred ccCcc---------eeeccccCccCCchHhhhc-CCCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhcCc
Q 004400 568 EENTH---------ISTRVAGTIGYMAPEYAMR-GHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGK 637 (756)
Q Consensus 568 ~~~~~---------~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 637 (756)
..... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||...+................
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 243 (353)
T 2b9h_A 164 ESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPH 243 (353)
T ss_dssp ----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred cccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCc
Confidence 32211 1223578999999998865 6789999999999999999999999977654433222211111100
Q ss_pred cc------------cccccCCC-CCC-----CHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004400 638 LM------------ELVDTNPG-SNF-----DKEQVMVMINVALLCANASPTIRPSMSSVLRM 682 (756)
Q Consensus 638 ~~------------~~~~~~~~-~~~-----~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~ 682 (756)
.. +.....+. ... .+.....+.+++.+||+.||++|||+.|+++.
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 306 (353)
T 2b9h_A 244 SDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEH 306 (353)
T ss_dssp STTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 00 00000000 000 01123358899999999999999999999873
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-38 Score=331.40 Aligned_cols=251 Identities=23% Similarity=0.389 Sum_probs=204.0
Q ss_pred hhcCccccCcccCCCCccEEEeec-cCCcEEEEEEcccc--CcccHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEE
Q 004400 414 ATNNFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSK--SKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLI 490 (756)
Q Consensus 414 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 490 (756)
..++|...+.||+|+||.||+|+. .+++.||+|++... .......+.+|++++++++||||+++++++.+.+..++|
T Consensus 20 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 99 (287)
T 2wei_A 20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV 99 (287)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred HhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEE
Confidence 456899999999999999999995 47899999998654 233567899999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCC---CCEEEccCCccccCc
Q 004400 491 YEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKD---LNSKISDFGLAKLDE 567 (756)
Q Consensus 491 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~---~~~kl~DFGla~~~~ 567 (756)
|||+++++|.+++.... .+++..+..++.|++.||+|||+.| |+||||||+||+++.+ +.+||+|||+++...
T Consensus 100 ~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~ 175 (287)
T 2wei_A 100 GELYTGGELFDEIIKRK-RFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ 175 (287)
T ss_dssp ECCCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBC
T ss_pred EEccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChhhEEEecCCCcccEEEeccCcceeec
Confidence 99999999999887543 7899999999999999999999997 9999999999999764 469999999998654
Q ss_pred ccCcceeeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhcCccccccccCCC
Q 004400 568 EENTHISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPG 647 (756)
Q Consensus 568 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 647 (756)
.... .....||+.|+|||.+.+ .++.++||||||+++|+|++|+.||...+....... ... +.... +....
T Consensus 176 ~~~~--~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~---~~~-~~~~~--~~~~~ 246 (287)
T 2wei_A 176 QNTK--MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKR---VET-GKYAF--DLPQW 246 (287)
T ss_dssp CCSS--CSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH---HHH-CCCCC--CSGGG
T ss_pred CCCc--cccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHH---HHc-CCCCC--Cchhh
Confidence 4322 223468999999998865 589999999999999999999999977654433221 111 11110 00001
Q ss_pred CCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 004400 648 SNFDKEQVMVMINVALLCANASPTIRPSMSSVLR 681 (756)
Q Consensus 648 ~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~ 681 (756)
..++ ..+.+++.+|++.||++|||+.|+++
T Consensus 247 ~~~~----~~~~~li~~~l~~dp~~Rps~~ell~ 276 (287)
T 2wei_A 247 RTIS----DDAKDLIRKMLTFHPSLRITATQCLE 276 (287)
T ss_dssp TTSC----HHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred hhcC----HHHHHHHHHHcccChhhCcCHHHHhc
Confidence 1223 34889999999999999999999987
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=343.17 Aligned_cols=265 Identities=22% Similarity=0.280 Sum_probs=192.0
Q ss_pred HHHhhcCccccCcccCCCCccEEEeec-cCCcEEEEEEccccCcccHHHHHHHHHHHHhCCCCceeeEeeEEEeCCe---
Q 004400 411 IKAATNNFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQ--- 486 (756)
Q Consensus 411 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~--- 486 (756)
.....++|...+.||+|+||.||+|+. .+|+.||||++.... .....+.+|++.++.++||||++++++|...+.
T Consensus 18 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~ 96 (360)
T 3e3p_A 18 SRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP-RFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDR 96 (360)
T ss_dssp HHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCT-TCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCT
T ss_pred chhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCc-cccHHHHHHHHHHHhcCCCCcccHHHhhhccccccc
Confidence 445678999999999999999999995 578999999986532 233466788889999999999999999976433
Q ss_pred ----EEEEEEecCCCCHHHHHH---hcCCCCCHHHHHHHHHHHHHHHHHHH--cCCCCCeEcCCCCCCceEecC-CCCEE
Q 004400 487 ----LLLIYEYLENNSLARALF---EHRLKLDWPTRRRICLGIARGLAYLH--GESRIKVVHRDIKATNVLLDK-DLNSK 556 (756)
Q Consensus 487 ----~~lV~e~~~~gsL~~~l~---~~~~~l~~~~~~~i~~~ia~~L~~LH--~~g~~~iiH~Dikp~Nill~~-~~~~k 556 (756)
.++||||+++ +|.+.+. .....+++..+..++.|++.||+||| +.| |+||||||+|||++. ++.+|
T Consensus 97 ~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~---ivH~Dlkp~NIll~~~~~~~k 172 (360)
T 3e3p_A 97 RDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVN---VCHRDIKPHNVLVNEADGTLK 172 (360)
T ss_dssp TCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTC---CBCSCCCGGGEEEETTTTEEE
T ss_pred cceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCC---eecCcCCHHHEEEeCCCCcEE
Confidence 8999999987 4544443 34557899999999999999999999 775 999999999999997 89999
Q ss_pred EccCCccccCcccCcceeeccccCccCCchHhhhcC-CCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhc
Q 004400 557 ISDFGLAKLDEEENTHISTRVAGTIGYMAPEYAMRG-HLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQ 635 (756)
Q Consensus 557 l~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~ 635 (756)
|+|||+++....... .....||+.|+|||++.+. .++.++|||||||++|||++|+.||...+..............
T Consensus 173 l~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~ 250 (360)
T 3e3p_A 173 LCDFGSAKKLSPSEP--NVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGC 250 (360)
T ss_dssp ECCCTTCBCCCTTSC--CCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCC
T ss_pred EeeCCCceecCCCCC--cccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCC
Confidence 999999986654332 2345789999999998765 4899999999999999999999999776554433322111110
Q ss_pred C------------ccccccccCC------CCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004400 636 G------------KLMELVDTNP------GSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRM 682 (756)
Q Consensus 636 ~------------~~~~~~~~~~------~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~ 682 (756)
. .......... ...........+.+++.+||+.||.+|||+.|+++.
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 315 (360)
T 3e3p_A 251 PSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCH 315 (360)
T ss_dssp CCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred CCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 0 0000000000 001111234568999999999999999999999864
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-38 Score=336.44 Aligned_cols=262 Identities=23% Similarity=0.336 Sum_probs=195.1
Q ss_pred hcCccccCcccCCCCccEEEeecc-CCcEEEEEEccccCcccHHHHHHHHHHHHhCCCCceeeEeeEEE-----------
Q 004400 415 TNNFATDNNIGEGGFGPVYKGLLA-DGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCCI----------- 482 (756)
Q Consensus 415 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~----------- 482 (756)
.++|...+.||+|+||.||+|... +++.||+|++........+.+.+|++++++++||||+++++++.
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 89 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVG 89 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC---
T ss_pred CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccc
Confidence 357889999999999999999954 58999999987666666678999999999999999999999873
Q ss_pred ---eCCeEEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEec-CCCCEEEc
Q 004400 483 ---EGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLD-KDLNSKIS 558 (756)
Q Consensus 483 ---~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~-~~~~~kl~ 558 (756)
+....++||||++ |+|.+++.. ..+++..+..++.|++.||+|||++| |+||||||+||+++ +++.+||+
T Consensus 90 ~~~~~~~~~lv~e~~~-~~L~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~kl~ 163 (320)
T 2i6l_A 90 SLTELNSVYIVQEYME-TDLANVLEQ--GPLLEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANLFINTEDLVLKIG 163 (320)
T ss_dssp -CCSCSEEEEEEECCS-EEHHHHHTT--CCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTTEEEEC
T ss_pred cccccCceeEEeeccC-CCHHHHhhc--CCccHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCeEEEc
Confidence 4478899999998 699998854 46899999999999999999999997 99999999999997 56789999
Q ss_pred cCCccccCcccCcc--eeeccccCccCCchHhhhc-CCCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhc
Q 004400 559 DFGLAKLDEEENTH--ISTRVAGTIGYMAPEYAMR-GHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQ 635 (756)
Q Consensus 559 DFGla~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~ 635 (756)
|||+++........ ......||..|+|||.+.. ..++.++|||||||++|||++|+.||..................
T Consensus 164 Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~ 243 (320)
T 2i6l_A 164 DFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPV 243 (320)
T ss_dssp CCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHSCC
T ss_pred cCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCC
Confidence 99999876432221 1234567999999999876 67899999999999999999999999766543322211100000
Q ss_pred ----------Ccccccccc---CCCCC---CCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004400 636 ----------GKLMELVDT---NPGSN---FDKEQVMVMINVALLCANASPTIRPSMSSVLRM 682 (756)
Q Consensus 636 ----------~~~~~~~~~---~~~~~---~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~ 682 (756)
......... .+... ..+.....+.+++.+|++.||++|||+.|+++.
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 306 (320)
T 2i6l_A 244 VHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSH 306 (320)
T ss_dssp CCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred CchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCC
Confidence 000000000 00000 001123358899999999999999999999763
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-39 Score=354.94 Aligned_cols=199 Identities=27% Similarity=0.440 Sum_probs=155.6
Q ss_pred cCccc-cCcccCCCCccEEEeecc---CCcEEEEEEccccCcccHHHHHHHHHHHHhCCCCceeeEeeEEEe--CCeEEE
Q 004400 416 NNFAT-DNNIGEGGFGPVYKGLLA---DGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCCIE--GNQLLL 489 (756)
Q Consensus 416 ~~~~~-~~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~l 489 (756)
+.|.. .++||+|+||.||+|+.. +++.||||++.... ....+.+|+.++++++|||||++++++.. +...++
T Consensus 20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~l 97 (405)
T 3rgf_A 20 DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWL 97 (405)
T ss_dssp HHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSS--CCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEE
T ss_pred hhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCC--CCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEE
Confidence 44555 468999999999999954 57899999997542 23578899999999999999999999965 678999
Q ss_pred EEEecCCCCHHHHHHhc--------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEe----cCCCCEEE
Q 004400 490 IYEYLENNSLARALFEH--------RLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLL----DKDLNSKI 557 (756)
Q Consensus 490 V~e~~~~gsL~~~l~~~--------~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill----~~~~~~kl 557 (756)
||||+++ +|.+++... ...+++..+..++.||+.||+|||+.| |+||||||+|||+ +.++.+||
T Consensus 98 v~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl 173 (405)
T 3rgf_A 98 LFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKI 173 (405)
T ss_dssp EEECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECCSSTTTTCEEE
T ss_pred EEeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeCCCcCHHHeEEecCCCCCCcEEE
Confidence 9999975 787777521 124899999999999999999999997 9999999999999 77789999
Q ss_pred ccCCccccCcccCc--ceeeccccCccCCchHhhhcC-CCCcccchhhHHHHHHHHHhCCCCCCcc
Q 004400 558 SDFGLAKLDEEENT--HISTRVAGTIGYMAPEYAMRG-HLTEKADVYSFGIVALEIVSGRSNVTKE 620 (756)
Q Consensus 558 ~DFGla~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slGv~l~elltg~~p~~~~ 620 (756)
+|||+++....... .......||+.|+|||++.+. .++.++|||||||++|||++|+.||...
T Consensus 174 ~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~ 239 (405)
T 3rgf_A 174 ADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 239 (405)
T ss_dssp CCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCC
T ss_pred EECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCc
Confidence 99999987654322 223446799999999999874 5999999999999999999999999644
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-39 Score=346.55 Aligned_cols=256 Identities=20% Similarity=0.320 Sum_probs=204.2
Q ss_pred hcCccccCcccCCCCccEEEeeccCCcEEEEEEccccCccc-----------------HHHHHHHHHHHHhCCCCceeeE
Q 004400 415 TNNFATDNNIGEGGFGPVYKGLLADGTAIAVKQLSSKSKQG-----------------NREFINEIGMISALQHPNLVKL 477 (756)
Q Consensus 415 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~-----------------~~~~~~E~~~l~~l~h~niv~l 477 (756)
.++|...+.||+|+||.||+|.. +++.||||.+....... .+.+.+|++++++++||||+++
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~ 108 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC 108 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred cCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence 46899999999999999999998 89999999986542211 1789999999999999999999
Q ss_pred eeEEEeCCeEEEEEEecCCCCHHHH------HHhc-CCCCCHHHHHHHHHHHHHHHHHHHc-CCCCCeEcCCCCCCceEe
Q 004400 478 YGCCIEGNQLLLIYEYLENNSLARA------LFEH-RLKLDWPTRRRICLGIARGLAYLHG-ESRIKVVHRDIKATNVLL 549 (756)
Q Consensus 478 ~~~~~~~~~~~lV~e~~~~gsL~~~------l~~~-~~~l~~~~~~~i~~~ia~~L~~LH~-~g~~~iiH~Dikp~Nill 549 (756)
++++.+++..++||||+++|+|.++ +... ...+++..+..++.|++.||+|||+ .| |+||||||+||++
T Consensus 109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dl~p~Nil~ 185 (348)
T 2pml_X 109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKN---ICHRDVKPSNILM 185 (348)
T ss_dssp SEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSC---EECCCCCGGGEEE
T ss_pred EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCC---EeecCCChHhEEE
Confidence 9999999999999999999999988 5432 4679999999999999999999998 76 9999999999999
Q ss_pred cCCCCEEEccCCccccCcccCcceeeccccCccCCchHhhhcC-CCCc-ccchhhHHHHHHHHHhCCCCCCccch-hhHH
Q 004400 550 DKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPEYAMRG-HLTE-KADVYSFGIVALEIVSGRSNVTKEDM-FYLL 626 (756)
Q Consensus 550 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~-~~Dv~slGv~l~elltg~~p~~~~~~-~~~~ 626 (756)
+.++.+||+|||+++..... ......||+.|+|||.+.+. .++. ++||||||+++|||++|+.||..... ....
T Consensus 186 ~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~ 262 (348)
T 2pml_X 186 DKNGRVKLSDFGESEYMVDK---KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELF 262 (348)
T ss_dssp CTTSCEEECCCTTCEECBTT---EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHHHH
T ss_pred cCCCcEEEeccccccccccc---cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHH
Confidence 99999999999999865443 23446799999999999877 5666 99999999999999999999966543 2222
Q ss_pred HHHHHHHhcCccccccccC-------C---CCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004400 627 DWALVLKEQGKLMELVDTN-------P---GSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRM 682 (756)
Q Consensus 627 ~~~~~~~~~~~~~~~~~~~-------~---~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~ 682 (756)
.. .. .... ...... . ...........+.+++.+||+.||.+||++.|+++.
T Consensus 263 ~~---i~-~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~h 323 (348)
T 2pml_X 263 NN---IR-TKNI-EYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKH 323 (348)
T ss_dssp HH---HT-SCCC-CCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred HH---Hh-ccCc-CCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 11 11 1111 111000 0 000001223458899999999999999999999873
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-38 Score=336.75 Aligned_cols=259 Identities=20% Similarity=0.290 Sum_probs=204.3
Q ss_pred hcCccccCcccCCCCccEEEeec--cCCcEEEEEEccccCcccHHHHHHHHHHHHhCCCC------ceeeEeeEEEeCCe
Q 004400 415 TNNFATDNNIGEGGFGPVYKGLL--ADGTAIAVKQLSSKSKQGNREFINEIGMISALQHP------NLVKLYGCCIEGNQ 486 (756)
Q Consensus 415 ~~~~~~~~~lg~G~~g~Vy~~~~--~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~------niv~l~~~~~~~~~ 486 (756)
.++|+..+.||+|+||.||+|.. .+++.||||++... ....+.+.+|+++++.++|+ +++++++++.+.+.
T Consensus 13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~ 91 (339)
T 1z57_A 13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV-DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGH 91 (339)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTE
T ss_pred cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC-CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCc
Confidence 45889999999999999999984 46889999999643 33456788999999988765 49999999999999
Q ss_pred EEEEEEecCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecC--------------
Q 004400 487 LLLIYEYLENNSLARALFEHR-LKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDK-------------- 551 (756)
Q Consensus 487 ~~lV~e~~~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~-------------- 551 (756)
.++||||+ +++|.+++.... ..+++..+..++.|++.||+|||+++ |+||||||+||+++.
T Consensus 92 ~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~ 167 (339)
T 1z57_A 92 ICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNK---LTHTDLKPENILFVQSDYTEAYNPKIKRD 167 (339)
T ss_dssp EEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCCCEEEEEC----CE
T ss_pred EEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEeccccccccCCccccc
Confidence 99999999 889999997553 46899999999999999999999997 999999999999987
Q ss_pred -----CCCEEEccCCccccCcccCcceeeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHhCCCCCCccchhhHH
Q 004400 552 -----DLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLL 626 (756)
Q Consensus 552 -----~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~ 626 (756)
++.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||...+.....
T Consensus 168 ~~~~~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~ 243 (339)
T 1z57_A 168 ERTLINPDIKVVDFGSATYDDEH----HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHL 243 (339)
T ss_dssp EEEESCCCEEECCCSSCEETTSC----CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHHHH
T ss_pred cccccCCCceEeeCcccccCccc----cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHH
Confidence 668999999999864432 23457899999999999989999999999999999999999999766544332
Q ss_pred HHHHHHHhcC--------ccccccc---------------------c-CCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCH
Q 004400 627 DWALVLKEQG--------KLMELVD---------------------T-NPGSNFDKEQVMVMINVALLCANASPTIRPSM 676 (756)
Q Consensus 627 ~~~~~~~~~~--------~~~~~~~---------------------~-~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~ 676 (756)
.......... ....... . .............+.+++.+||+.||++|||+
T Consensus 244 ~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~ 323 (339)
T 1z57_A 244 AMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITL 323 (339)
T ss_dssp HHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCH
T ss_pred HHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccccCH
Confidence 2211111100 0000000 0 00011123445678999999999999999999
Q ss_pred HHHHHH
Q 004400 677 SSVLRM 682 (756)
Q Consensus 677 ~ev~~~ 682 (756)
.|+++.
T Consensus 324 ~ell~h 329 (339)
T 1z57_A 324 REALKH 329 (339)
T ss_dssp HHHTTS
T ss_pred HHHhcC
Confidence 999753
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-38 Score=341.18 Aligned_cols=261 Identities=20% Similarity=0.258 Sum_probs=203.3
Q ss_pred hhcCccccCcccCCCCccEEEee-ccCCcEEEEEEccccCcccHHHHHHHHHHHHhCC-CC-----ceeeEeeEEEeCCe
Q 004400 414 ATNNFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQGNREFINEIGMISALQ-HP-----NLVKLYGCCIEGNQ 486 (756)
Q Consensus 414 ~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~-----niv~l~~~~~~~~~ 486 (756)
..++|...+.||+|+||.||+|+ ..+++.||||++... ......+.+|+.+++.++ |+ +|+++++++..++.
T Consensus 52 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~ 130 (382)
T 2vx3_A 52 WMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK-KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNH 130 (382)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTE
T ss_pred eeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc-HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCc
Confidence 45789999999999999999998 457889999999743 333466788999988885 55 49999999999999
Q ss_pred EEEEEEecCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEec--CCCCEEEccCCcc
Q 004400 487 LLLIYEYLENNSLARALFEHR-LKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLD--KDLNSKISDFGLA 563 (756)
Q Consensus 487 ~~lV~e~~~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~--~~~~~kl~DFGla 563 (756)
.++||||++ |+|.+++.... ..+++..+..++.|++.||+|||.+ ..+|+||||||+|||++ .++.+||+|||++
T Consensus 131 ~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~a 208 (382)
T 2vx3_A 131 LCLVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGSS 208 (382)
T ss_dssp EEEEEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSCCEEECCCTTC
T ss_pred eEEEEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCCcEEEEeccCc
Confidence 999999996 49999997553 4699999999999999999999953 12599999999999994 5778999999999
Q ss_pred ccCcccCcceeeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhcC-------
Q 004400 564 KLDEEENTHISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQG------- 636 (756)
Q Consensus 564 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~------- 636 (756)
+..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||...+...............
T Consensus 209 ~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 284 (382)
T 2vx3_A 209 CQLGQR----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHILDQ 284 (382)
T ss_dssp EETTCC----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTT
T ss_pred eecccc----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence 865432 234678999999999999999999999999999999999999998766544433222111100
Q ss_pred --ccccccccC-----------------------------------------CCCCCCHHHHHHHHHHHHHhhcCCCCCC
Q 004400 637 --KLMELVDTN-----------------------------------------PGSNFDKEQVMVMINVALLCANASPTIR 673 (756)
Q Consensus 637 --~~~~~~~~~-----------------------------------------~~~~~~~~~~~~l~~l~~~c~~~~P~~R 673 (756)
.....+... ............+.+++.+||+.||++|
T Consensus 285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R 364 (382)
T 2vx3_A 285 APKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDPKTR 364 (382)
T ss_dssp CTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHHTCSCTTTS
T ss_pred hHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHHhcCCChhhC
Confidence 000000000 0001122344578999999999999999
Q ss_pred CCHHHHHH
Q 004400 674 PSMSSVLR 681 (756)
Q Consensus 674 Pt~~ev~~ 681 (756)
||+.|+++
T Consensus 365 pta~e~L~ 372 (382)
T 2vx3_A 365 IQPYYALQ 372 (382)
T ss_dssp CCHHHHTT
T ss_pred CCHHHHhc
Confidence 99999876
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-39 Score=340.30 Aligned_cols=255 Identities=22% Similarity=0.316 Sum_probs=197.4
Q ss_pred HHHhhcCccccCcccCCCCccEEEeeccCCcEEEEEEccccC--cccHHHHHHHHHHHHhCC--CCceeeEeeEEEeCCe
Q 004400 411 IKAATNNFATDNNIGEGGFGPVYKGLLADGTAIAVKQLSSKS--KQGNREFINEIGMISALQ--HPNLVKLYGCCIEGNQ 486 (756)
Q Consensus 411 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~~ 486 (756)
+....++|...+.||+|+||.||+|...+++.||||++.... ......+.+|++++++++ ||||+++++++.+++.
T Consensus 23 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~ 102 (313)
T 3cek_A 23 MSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQY 102 (313)
T ss_dssp EEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSE
T ss_pred eeeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCE
Confidence 334567899999999999999999998889999999986542 334567899999999997 5999999999999999
Q ss_pred EEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccC
Q 004400 487 LLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLD 566 (756)
Q Consensus 487 ~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~ 566 (756)
.++||| +.+++|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+||++++ +.+||+|||+++..
T Consensus 103 ~~lv~e-~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~~ 176 (313)
T 3cek_A 103 IYMVME-CGNIDLNSWLKKK-KSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIVD-GMLKLIDFGIANQM 176 (313)
T ss_dssp EEEEEC-CCSEEHHHHHHHC-SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEET-TEEEECCCSSSCC-
T ss_pred EEEEEe-cCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEEEC-CeEEEeeccccccc
Confidence 999999 6788999999765 47899999999999999999999996 999999999999975 78999999999866
Q ss_pred cccCcc-eeeccccCccCCchHhhhc-----------CCCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHh
Q 004400 567 EEENTH-ISTRVAGTIGYMAPEYAMR-----------GHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKE 634 (756)
Q Consensus 567 ~~~~~~-~~~~~~gt~~y~aPE~~~~-----------~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~ 634 (756)
...... ......||+.|+|||.+.. ..++.++||||||+++|||++|+.||....... ........
T Consensus 177 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~--~~~~~~~~ 254 (313)
T 3cek_A 177 QPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI--SKLHAIID 254 (313)
T ss_dssp -------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHH--HHHHHHHC
T ss_pred cCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHH--HHHHHHHh
Confidence 543322 2234579999999999875 468889999999999999999999995432211 11111111
Q ss_pred cCccccccccCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004400 635 QGKLMELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRM 682 (756)
Q Consensus 635 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~ 682 (756)
....... .... ...+.+++.+||+.||++||++.|+++.
T Consensus 255 ~~~~~~~-----~~~~----~~~l~~li~~~l~~dp~~Rps~~ell~h 293 (313)
T 3cek_A 255 PNHEIEF-----PDIP----EKDLQDVLKCCLKRDPKQRISIPELLAH 293 (313)
T ss_dssp TTSCCCC-----CCCS----CHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred cccccCC-----cccc----hHHHHHHHHHHccCCcccCcCHHHHhcC
Confidence 1111111 1111 2348899999999999999999999864
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-38 Score=342.97 Aligned_cols=257 Identities=22% Similarity=0.369 Sum_probs=197.9
Q ss_pred hcCccccCcccCCCCccEEEee-ccCCcEEEEEEccccC--cccHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeE----
Q 004400 415 TNNFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSKS--KQGNREFINEIGMISALQHPNLVKLYGCCIEGNQL---- 487 (756)
Q Consensus 415 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~---- 487 (756)
.++|...+.||+|+||.||+|. ..+|+.||||++.... ....+.+.+|+.+++.++||||+++++++...+..
T Consensus 41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 120 (371)
T 4exu_A 41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 120 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence 3578889999999999999998 4578999999997642 23346788999999999999999999999877654
Q ss_pred --EEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCcccc
Q 004400 488 --LLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKL 565 (756)
Q Consensus 488 --~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~ 565 (756)
++||||+. ++|.+.+. ..+++..+..++.|++.||+|||+.| |+||||||+||+++.++.+||+|||+++.
T Consensus 121 ~~~lv~e~~~-~~l~~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kL~Dfg~a~~ 193 (371)
T 4exu_A 121 DFYLVMPFMQ-TDLQKIMG---MEFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLARH 193 (371)
T ss_dssp CCEEEEECCC-EEHHHHTT---SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECSTTCC--
T ss_pred eEEEEEcccc-ccHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCcCHHHeEECCCCCEEEEecCcccc
Confidence 99999998 58877763 35899999999999999999999997 99999999999999999999999999986
Q ss_pred CcccCcceeeccccCccCCchHhhhc-CCCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhcCcc------
Q 004400 566 DEEENTHISTRVAGTIGYMAPEYAMR-GHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKL------ 638 (756)
Q Consensus 566 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~------ 638 (756)
.... .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||...+.................
T Consensus 194 ~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 269 (371)
T 4exu_A 194 ADAE----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKL 269 (371)
T ss_dssp ----------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTC
T ss_pred cccC----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHHHh
Confidence 5432 234578999999999987 67999999999999999999999999776544433222111110000
Q ss_pred --------ccccccCCCCCC---CHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004400 639 --------MELVDTNPGSNF---DKEQVMVMINVALLCANASPTIRPSMSSVLRM 682 (756)
Q Consensus 639 --------~~~~~~~~~~~~---~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~ 682 (756)
...+.......+ .+.....+.+++.+|++.||++|||+.|+++.
T Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 324 (371)
T 4exu_A 270 NDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 324 (371)
T ss_dssp SCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred hhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcC
Confidence 000000000000 01123458899999999999999999999864
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=335.76 Aligned_cols=258 Identities=20% Similarity=0.279 Sum_probs=200.8
Q ss_pred hcCccccCcccCCCCccEEEeec-cCC-cEEEEEEccccCcccHHHHHHHHHHHHhCCCCc------eeeEeeEEEeCCe
Q 004400 415 TNNFATDNNIGEGGFGPVYKGLL-ADG-TAIAVKQLSSKSKQGNREFINEIGMISALQHPN------LVKLYGCCIEGNQ 486 (756)
Q Consensus 415 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~-~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n------iv~l~~~~~~~~~ 486 (756)
.++|...+.||+|+||.||+|.. .++ +.||+|++... ....+.+.+|+.++++++|++ ++.+++++...+.
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~ 96 (355)
T 2eu9_A 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGH 96 (355)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTE
T ss_pred cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCe
Confidence 36889999999999999999984 344 68999999643 334567888999999997765 9999999999999
Q ss_pred EEEEEEecCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEe----------------
Q 004400 487 LLLIYEYLENNSLARALFEH-RLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLL---------------- 549 (756)
Q Consensus 487 ~~lV~e~~~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill---------------- 549 (756)
.++||||+ ++++.+++... ...+++..+..++.||+.||+|||+.+ |+||||||+|||+
T Consensus 97 ~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~~~ 172 (355)
T 2eu9_A 97 MCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQ---LTHTDLKPENILFVNSEFETLYNEHKSCE 172 (355)
T ss_dssp EEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEESCCCEEEEECCC-CCC
T ss_pred EEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEeccccccccccccccc
Confidence 99999999 56676766644 357999999999999999999999986 9999999999999
Q ss_pred ---cCCCCEEEccCCccccCcccCcceeeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHhCCCCCCccchhhHH
Q 004400 550 ---DKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLL 626 (756)
Q Consensus 550 ---~~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~ 626 (756)
+.++.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||...+.....
T Consensus 173 ~~~~~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~ 248 (355)
T 2eu9_A 173 EKSVKNTSIRVADFGSATFDHEH----HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREHL 248 (355)
T ss_dssp EEEESCCCEEECCCTTCEETTSC----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH
T ss_pred ccccCCCcEEEeecCcccccccc----ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 56788999999999864432 23457999999999999999999999999999999999999999766544333
Q ss_pred HHHHHHHhcC--------cccccc-cc---------------------CCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCH
Q 004400 627 DWALVLKEQG--------KLMELV-DT---------------------NPGSNFDKEQVMVMINVALLCANASPTIRPSM 676 (756)
Q Consensus 627 ~~~~~~~~~~--------~~~~~~-~~---------------------~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~ 676 (756)
.......... ...... .. .............+.+++.+||+.||++|||+
T Consensus 249 ~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~ 328 (355)
T 2eu9_A 249 VMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITL 328 (355)
T ss_dssp HHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCH
T ss_pred HHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCcCH
Confidence 2221111100 000000 00 00001122334568899999999999999999
Q ss_pred HHHHH
Q 004400 677 SSVLR 681 (756)
Q Consensus 677 ~ev~~ 681 (756)
.|+++
T Consensus 329 ~e~l~ 333 (355)
T 2eu9_A 329 AEALL 333 (355)
T ss_dssp HHHTT
T ss_pred HHHhc
Confidence 99875
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-38 Score=331.93 Aligned_cols=251 Identities=24% Similarity=0.384 Sum_probs=181.1
Q ss_pred hcCccccCcccCCCCccEEEeec-cCCcEEEEEEccccCc-ccH-HHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEE
Q 004400 415 TNNFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSKSK-QGN-REFINEIGMISALQHPNLVKLYGCCIEGNQLLLIY 491 (756)
Q Consensus 415 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~-~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 491 (756)
.++|+..+.||+|+||.||+|.. .+|+.||||++..... ... +.+.++..+++.++||||+++++++.+++..++||
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~ 103 (318)
T 2dyl_A 24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAM 103 (318)
T ss_dssp GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Confidence 46788899999999999999995 4789999999875432 222 33444556788889999999999999999999999
Q ss_pred EecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcC-CCCCeEcCCCCCCceEecCCCCEEEccCCccccCcccC
Q 004400 492 EYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGE-SRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEEN 570 (756)
Q Consensus 492 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~-g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~~~ 570 (756)
||+ ++.+..........+++..+..++.|++.||+|||++ + |+||||||+||+++.++.+||+|||+++......
T Consensus 104 e~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~ 179 (318)
T 2dyl_A 104 ELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHG---VIHRDVKPSNILLDERGQIKLCDFGISGRLVDDK 179 (318)
T ss_dssp CCC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHC---CCCCCCCGGGEEECTTSCEEECCCTTC-------
T ss_pred ecc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCC---EEeCCCCHHHEEECCCCCEEEEECCCchhccCCc
Confidence 999 5566666655556899999999999999999999985 6 9999999999999999999999999997654332
Q ss_pred cceeeccccCccCCchHhhh-----cCCCCcccchhhHHHHHHHHHhCCCCCCccch-hhHHHHHHHHHhcCcccccccc
Q 004400 571 THISTRVAGTIGYMAPEYAM-----RGHLTEKADVYSFGIVALEIVSGRSNVTKEDM-FYLLDWALVLKEQGKLMELVDT 644 (756)
Q Consensus 571 ~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~ 644 (756)
. .....||+.|+|||++. ...++.++||||||+++|||++|+.||..... ..... . .... ......
T Consensus 180 ~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~--~-~~~~-~~~~~~-- 251 (318)
T 2dyl_A 180 A--KDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLT--K-VLQE-EPPLLP-- 251 (318)
T ss_dssp ---------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHH--H-HHHS-CCCCCC--
T ss_pred c--ccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHH--H-Hhcc-CCCCCC--
Confidence 2 23456899999999994 45689999999999999999999999965322 11111 1 1111 111110
Q ss_pred CCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004400 645 NPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRM 682 (756)
Q Consensus 645 ~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~ 682 (756)
....++. .+.+++.+||+.||.+||++.|+++.
T Consensus 252 -~~~~~~~----~l~~li~~~l~~dp~~Rps~~~ll~h 284 (318)
T 2dyl_A 252 -GHMGFSG----DFQSFVKDCLTKDHRKRPKYNKLLEH 284 (318)
T ss_dssp -SSSCCCH----HHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred -ccCCCCH----HHHHHHHHHccCChhHCcCHHHHhhC
Confidence 0112333 48899999999999999999999763
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-38 Score=335.88 Aligned_cols=254 Identities=25% Similarity=0.420 Sum_probs=178.1
Q ss_pred hcCccccCcccCCCCccEEEeec-cCCcEEEEEEccccC-cccHHHHHHHHH-HHHhCCCCceeeEeeEEEeCCeEEEEE
Q 004400 415 TNNFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSKS-KQGNREFINEIG-MISALQHPNLVKLYGCCIEGNQLLLIY 491 (756)
Q Consensus 415 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lV~ 491 (756)
.++|...+.||+|+||.||+|.. .+|+.||||++.... ......+..|+. +++.++||||+++++++.+++..++||
T Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~ 100 (327)
T 3aln_A 21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICM 100 (327)
T ss_dssp SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEE
Confidence 36888999999999999999995 578999999997542 233345666666 677789999999999999999999999
Q ss_pred EecCCCCHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHcC-CCCCeEcCCCCCCceEecCCCCEEEccCCccccC
Q 004400 492 EYLENNSLARALFE----HRLKLDWPTRRRICLGIARGLAYLHGE-SRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLD 566 (756)
Q Consensus 492 e~~~~gsL~~~l~~----~~~~l~~~~~~~i~~~ia~~L~~LH~~-g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~ 566 (756)
||+++ +|.+++.. ....+++..+..++.|++.||+|||+. + |+||||||+||+++.++.+||+|||+++..
T Consensus 101 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~ 176 (327)
T 3aln_A 101 ELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLK---IIHRDIKPSNILLDRSGNIKLCDFGISGQL 176 (327)
T ss_dssp CCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHS---CCCSCCCGGGEEEETTTEEEECCCSSSCC-
T ss_pred eecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCC---EeECCCCHHHEEEcCCCCEEEccCCCceec
Confidence 99986 78777752 245789999999999999999999997 6 999999999999999999999999999865
Q ss_pred cccCcceeeccccCccCCchHhh----hcCCCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhcCcccccc
Q 004400 567 EEENTHISTRVAGTIGYMAPEYA----MRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELV 642 (756)
Q Consensus 567 ~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 642 (756)
..... .....||+.|+|||++ .+..++.++||||||+++|||++|+.||....... +..... ..+.... +
T Consensus 177 ~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--~~~~~~-~~~~~~~-~ 250 (327)
T 3aln_A 177 VDSIA--KTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVF--DQLTQV-VKGDPPQ-L 250 (327)
T ss_dssp -------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC---------CCC-CCSCCCC-C
T ss_pred ccccc--cccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHH--HHHHHH-hcCCCCC-C
Confidence 43322 2334699999999998 45678999999999999999999999996532210 000000 0000000 0
Q ss_pred ccCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004400 643 DTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRM 682 (756)
Q Consensus 643 ~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~ 682 (756)
.......++ ..+.+++.+||+.||++||++.++++.
T Consensus 251 ~~~~~~~~~----~~l~~li~~~l~~dp~~Rps~~ell~h 286 (327)
T 3aln_A 251 SNSEEREFS----PSFINFVNLCLTKDESKRPKYKELLKH 286 (327)
T ss_dssp CCCSSCCCC----HHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred CCcccccCC----HHHHHHHHHHhhCChhhCcCHHHHHhC
Confidence 011111233 348899999999999999999999763
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-38 Score=342.66 Aligned_cols=259 Identities=20% Similarity=0.305 Sum_probs=200.0
Q ss_pred hcCccccCcccCCCCccEEEee-ccCCcEEEEEEccccCcccHHHHHHHHHHHHhCC-----------CCceeeEeeEEE
Q 004400 415 TNNFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQGNREFINEIGMISALQ-----------HPNLVKLYGCCI 482 (756)
Q Consensus 415 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----------h~niv~l~~~~~ 482 (756)
.++|...+.||+|+||.||+|+ ..+++.||||++... ......+.+|+.++++++ ||||+++++++.
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~ 96 (373)
T 1q8y_A 18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN 96 (373)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC-ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhh
Confidence 4578999999999999999999 467899999999643 334567889999999886 899999999998
Q ss_pred eCC----eEEEEEEecCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHcC-CCCCeEcCCCCCCceEec------
Q 004400 483 EGN----QLLLIYEYLENNSLARALFEH-RLKLDWPTRRRICLGIARGLAYLHGE-SRIKVVHRDIKATNVLLD------ 550 (756)
Q Consensus 483 ~~~----~~~lV~e~~~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~~L~~LH~~-g~~~iiH~Dikp~Nill~------ 550 (756)
..+ ..++||||+ +++|.+++... ...+++..+..++.||+.||+|||++ | |+||||||+|||++
T Consensus 97 ~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~---ivH~Dikp~NIll~~~~~~~ 172 (373)
T 1q8y_A 97 HKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSPE 172 (373)
T ss_dssp EEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETTT
T ss_pred ccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCC---EEecCCChHHeEEeccCCCc
Confidence 654 789999999 88999999753 34699999999999999999999997 6 99999999999994
Q ss_pred CCCCEEEccCCccccCcccCcceeeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHhCCCCCCccchhhHH---H
Q 004400 551 KDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLL---D 627 (756)
Q Consensus 551 ~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~---~ 627 (756)
..+.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||......... +
T Consensus 173 ~~~~~kl~Dfg~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~ 248 (373)
T 1q8y_A 173 NLIQIKIADLGNACWYDEH----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDD 248 (373)
T ss_dssp TEEEEEECCCTTCEETTBC----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHH
T ss_pred CcceEEEcccccccccCCC----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHH
Confidence 4447999999999865442 23357899999999999999999999999999999999999999654321100 0
Q ss_pred -HHHHHHhcCcccc--------------------cccc----------CCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCH
Q 004400 628 -WALVLKEQGKLME--------------------LVDT----------NPGSNFDKEQVMVMINVALLCANASPTIRPSM 676 (756)
Q Consensus 628 -~~~~~~~~~~~~~--------------------~~~~----------~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~ 676 (756)
........+.... .+.. .....++......+.+++.+||+.||++|||+
T Consensus 249 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~ 328 (373)
T 1q8y_A 249 HIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADA 328 (373)
T ss_dssp HHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCH
T ss_pred HHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCCH
Confidence 0000000000000 0000 00113456677789999999999999999999
Q ss_pred HHHHHH
Q 004400 677 SSVLRM 682 (756)
Q Consensus 677 ~ev~~~ 682 (756)
.|+++.
T Consensus 329 ~ell~h 334 (373)
T 1q8y_A 329 GGLVNH 334 (373)
T ss_dssp HHHHTC
T ss_pred HHHhhC
Confidence 999873
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-38 Score=338.71 Aligned_cols=257 Identities=22% Similarity=0.364 Sum_probs=196.8
Q ss_pred hcCccccCcccCCCCccEEEeec-cCCcEEEEEEccccC--cccHHHHHHHHHHHHhCCCCceeeEeeEEEeCCe-----
Q 004400 415 TNNFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSKS--KQGNREFINEIGMISALQHPNLVKLYGCCIEGNQ----- 486 (756)
Q Consensus 415 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~----- 486 (756)
.++|...+.||+|+||.||+|+. .+|+.||||++.... ....+.+.+|+.+++.++||||+++++++.....
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 102 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 102 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence 35788899999999999999994 578999999986542 2234678899999999999999999999987654
Q ss_pred -EEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCcccc
Q 004400 487 -LLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKL 565 (756)
Q Consensus 487 -~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~ 565 (756)
.++||||++ |+|.+++. ..+++..+..++.||+.||+|||++| |+||||||+||+++.++.+||+|||+++.
T Consensus 103 ~~~lv~e~~~-~~l~~~~~---~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~ 175 (353)
T 3coi_A 103 DFYLVMPFMQ-TDLQKIMG---LKFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLARH 175 (353)
T ss_dssp CCEEEEECCS-EEGGGTTT---SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTCCEEECSTTCTTC
T ss_pred eEEEEecccc-CCHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEeECCCCcEEEeecccccC
Confidence 499999998 57776653 35899999999999999999999997 99999999999999999999999999986
Q ss_pred CcccCcceeeccccCccCCchHhhhc-CCCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhcCc-------
Q 004400 566 DEEENTHISTRVAGTIGYMAPEYAMR-GHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGK------- 637 (756)
Q Consensus 566 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~------- 637 (756)
.... .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||...+................
T Consensus 176 ~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 251 (353)
T 3coi_A 176 ADAE----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKL 251 (353)
T ss_dssp ------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTTC
T ss_pred CCCC----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHH
Confidence 5432 234578999999999987 6789999999999999999999999976654433222111110000
Q ss_pred -------cccccccCCC---CCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004400 638 -------LMELVDTNPG---SNFDKEQVMVMINVALLCANASPTIRPSMSSVLRM 682 (756)
Q Consensus 638 -------~~~~~~~~~~---~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~ 682 (756)
....+..... ..........+.+++.+|++.||++|||+.|+++.
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h 306 (353)
T 3coi_A 252 NDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 306 (353)
T ss_dssp SCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred hhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 0000000000 01111223458899999999999999999999864
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=336.97 Aligned_cols=242 Identities=22% Similarity=0.380 Sum_probs=199.9
Q ss_pred hhcCccccCcccCCCCccEEEee-ccCCcEEEEEEccccCcc------cHHHHHHHHHHHHhCC--CCceeeEeeEEEeC
Q 004400 414 ATNNFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQ------GNREFINEIGMISALQ--HPNLVKLYGCCIEG 484 (756)
Q Consensus 414 ~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~ 484 (756)
..++|...+.||+|+||.||+|+ ..+++.||||.+...... ....+.+|+.++++++ ||||+++++++.++
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~~ 120 (320)
T 3a99_A 41 LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERP 120 (320)
T ss_dssp CTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECS
T ss_pred ccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEecC
Confidence 45689999999999999999998 567899999998654221 2245678999999996 59999999999999
Q ss_pred CeEEEEEEecCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEec-CCCCEEEccCCc
Q 004400 485 NQLLLIYEYLEN-NSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLD-KDLNSKISDFGL 562 (756)
Q Consensus 485 ~~~~lV~e~~~~-gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~-~~~~~kl~DFGl 562 (756)
+..++||||+.+ ++|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+||+++ +++.+||+|||+
T Consensus 121 ~~~~lv~e~~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~kL~Dfg~ 196 (320)
T 3a99_A 121 DSFVLILERPEPVQDLFDFITER-GALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGS 196 (320)
T ss_dssp SEEEEEEECCSSEEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCCTT
T ss_pred CcEEEEEEcCCCCccHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC---cEeCCCCHHHEEEeCCCCCEEEeeCcc
Confidence 999999999986 8999999754 47899999999999999999999997 99999999999999 778999999999
Q ss_pred cccCcccCcceeeccccCccCCchHhhhcCCC-CcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhcCccccc
Q 004400 563 AKLDEEENTHISTRVAGTIGYMAPEYAMRGHL-TEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMEL 641 (756)
Q Consensus 563 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 641 (756)
++...... .....||+.|+|||++.+..+ +.++||||||+++|||++|+.||...... . . ... .
T Consensus 197 ~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~--------~-~-~~~--~ 261 (320)
T 3a99_A 197 GALLKDTV---YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI--------I-R-GQV--F 261 (320)
T ss_dssp CEECCSSC---BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHH--------H-H-CCC--C
T ss_pred cccccccc---ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhhh--------h-c-ccc--c
Confidence 98665432 234569999999999987765 68899999999999999999999654211 0 0 000 0
Q ss_pred cccCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004400 642 VDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRM 682 (756)
Q Consensus 642 ~~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~ 682 (756)
....++ ..+.+++.+||+.||++||++.|+++.
T Consensus 262 ----~~~~~~----~~~~~li~~~l~~dp~~Rps~~~ll~h 294 (320)
T 3a99_A 262 ----FRQRVS----SECQHLIRWCLALRPSDRPTFEEIQNH 294 (320)
T ss_dssp ----CSSCCC----HHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred ----ccccCC----HHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 111233 348899999999999999999999874
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-38 Score=336.31 Aligned_cols=251 Identities=21% Similarity=0.259 Sum_probs=171.7
Q ss_pred hcCcccc-CcccCCCCccEEEeec-cCCcEEEEEEccccCcccHHHHHHHH-HHHHhCCCCceeeEeeEEEe----CCeE
Q 004400 415 TNNFATD-NNIGEGGFGPVYKGLL-ADGTAIAVKQLSSKSKQGNREFINEI-GMISALQHPNLVKLYGCCIE----GNQL 487 (756)
Q Consensus 415 ~~~~~~~-~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~-~~l~~l~h~niv~l~~~~~~----~~~~ 487 (756)
.++|... +.||+|+||.||+|.. .+++.||||++... ....+|+ ..++.++||||+++++++.. +...
T Consensus 27 ~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 101 (336)
T 3fhr_A 27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS-----PKARQEVDHHWQASGGPHIVCILDVYENMHHGKRCL 101 (336)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred cceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc-----HHHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceE
Confidence 4577774 4699999999999995 47999999998542 2223333 34667799999999999976 4568
Q ss_pred EEEEEecCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecC---CCCEEEccCCcc
Q 004400 488 LLIYEYLENNSLARALFEHR-LKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDK---DLNSKISDFGLA 563 (756)
Q Consensus 488 ~lV~e~~~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~---~~~~kl~DFGla 563 (756)
++||||+++|+|.+++.... ..+++..+..++.|++.||+|||+.| |+||||||+||+++. ++.+||+|||++
T Consensus 102 ~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~---ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~ 178 (336)
T 3fhr_A 102 LIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHN---IAHRDVKPENLLYTSKEKDAVLKLTDFGFA 178 (336)
T ss_dssp EEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred EEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEEecCCCceEEEeccccc
Confidence 99999999999999998553 46999999999999999999999997 999999999999986 455999999999
Q ss_pred ccCcccCcceeeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhcCccccccc
Q 004400 564 KLDEEENTHISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVD 643 (756)
Q Consensus 564 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 643 (756)
+...... .....||+.|+|||++....++.++|||||||++|+|++|+.||..................... .. .
T Consensus 179 ~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~-~~-~ 253 (336)
T 3fhr_A 179 KETTQNA---LQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQY-GF-P 253 (336)
T ss_dssp EEC-------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC----------------------CC-C
T ss_pred eeccccc---cccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhcccc-cc-C
Confidence 8654322 23456899999999998888999999999999999999999999654432211100000000000 00 0
Q ss_pred cCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004400 644 TNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRM 682 (756)
Q Consensus 644 ~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~ 682 (756)
......++ ..+.+++.+|++.||++|||+.|+++.
T Consensus 254 ~~~~~~~~----~~~~~li~~~L~~dP~~Rpt~~ell~h 288 (336)
T 3fhr_A 254 NPEWSEVS----EDAKQLIRLLLKTDPTERLTITQFMNH 288 (336)
T ss_dssp TTTSTTCC----HHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred chhhccCC----HHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 00111223 348899999999999999999999973
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-38 Score=334.26 Aligned_cols=244 Identities=25% Similarity=0.381 Sum_probs=192.2
Q ss_pred HHhhcCccccCcccCCCCccEEEee-ccCCcEEEEEEccccCcc------cHHHHHHHHHHHHhC----CCCceeeEeeE
Q 004400 412 KAATNNFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQ------GNREFINEIGMISAL----QHPNLVKLYGC 480 (756)
Q Consensus 412 ~~~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l----~h~niv~l~~~ 480 (756)
....++|...+.||+|+||.||+|+ ..+++.||||++...... ....+.+|+.+++++ +||||++++++
T Consensus 27 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~ 106 (312)
T 2iwi_A 27 EAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDW 106 (312)
T ss_dssp ------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEE
T ss_pred hhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEE
Confidence 3456789999999999999999998 467899999999754321 223456799999998 89999999999
Q ss_pred EEeCCeEEEEEEe-cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEec-CCCCEEEc
Q 004400 481 CIEGNQLLLIYEY-LENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLD-KDLNSKIS 558 (756)
Q Consensus 481 ~~~~~~~~lV~e~-~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~-~~~~~kl~ 558 (756)
+.+++..++|||| +.+++|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+||+++ .++.+||+
T Consensus 107 ~~~~~~~~~v~e~~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~kl~ 182 (312)
T 2iwi_A 107 FETQEGFMLVLERPLPAQDLFDYITEK-GPLGEGPSRCFFGQVVAAIQHCHSRG---VVHRDIKDENILIDLRRGCAKLI 182 (312)
T ss_dssp C-----CEEEEECCSSEEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHHT---EECCCCSGGGEEEETTTTEEEEC
T ss_pred EecCCeEEEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChhhEEEeCCCCeEEEE
Confidence 9999999999999 8999999999764 36999999999999999999999996 99999999999999 88899999
Q ss_pred cCCccccCcccCcceeeccccCccCCchHhhhcCCCC-cccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhcCc
Q 004400 559 DFGLAKLDEEENTHISTRVAGTIGYMAPEYAMRGHLT-EKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGK 637 (756)
Q Consensus 559 DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 637 (756)
|||+++...... .....||..|+|||++.+..+. .++||||||+++|||++|+.||...... .....
T Consensus 183 dfg~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--------~~~~~- 250 (312)
T 2iwi_A 183 DFGSGALLHDEP---YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQEI--------LEAEL- 250 (312)
T ss_dssp CCSSCEECCSSC---BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHH--------HHTCC-
T ss_pred EcchhhhcccCc---ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChHHH--------hhhcc-
Confidence 999998665432 2345689999999999877764 5899999999999999999999654211 00000
Q ss_pred cccccccCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004400 638 LMELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRM 682 (756)
Q Consensus 638 ~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~ 682 (756)
. ....++ ..+.+++.+||+.||++||++.|+++.
T Consensus 251 --~-----~~~~~~----~~~~~li~~~l~~~p~~Rps~~e~l~~ 284 (312)
T 2iwi_A 251 --H-----FPAHVS----PDCCALIRRCLAPKPSSRPSLEEILLD 284 (312)
T ss_dssp --C-----CCTTSC----HHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred --C-----CcccCC----HHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0 111222 348899999999999999999999874
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-37 Score=343.95 Aligned_cols=251 Identities=24% Similarity=0.306 Sum_probs=188.4
Q ss_pred cCccccCcccCCCCccEEEeeccCCcEEEEEEccccCcccHHHHHHHHHHHHhC-CCCceeeEeeEEEeCCeEEEEEEec
Q 004400 416 NNFATDNNIGEGGFGPVYKGLLADGTAIAVKQLSSKSKQGNREFINEIGMISAL-QHPNLVKLYGCCIEGNQLLLIYEYL 494 (756)
Q Consensus 416 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~e~~ 494 (756)
+.|...+.||+|+||+||.+...+|+.||||++... ..+.+.+|+++++++ +|||||++++++.+++..++|||||
T Consensus 15 ~~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~---~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~ 91 (434)
T 2rio_A 15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLID---FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELC 91 (434)
T ss_dssp SCEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGG---GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCC
T ss_pred heeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHH---HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecC
Confidence 345567889999999998777678999999998643 235678899999886 8999999999999999999999999
Q ss_pred CCCCHHHHHHhcCCC------CCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCC-------------CCE
Q 004400 495 ENNSLARALFEHRLK------LDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKD-------------LNS 555 (756)
Q Consensus 495 ~~gsL~~~l~~~~~~------l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~-------------~~~ 555 (756)
+ |+|.+++...... .++..+..++.||+.||+|||+.+ |+||||||+|||++.+ +.+
T Consensus 92 ~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~ 167 (434)
T 2rio_A 92 N-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK---IIHRDLKPQNILVSTSSRFTADQQTGAENLRI 167 (434)
T ss_dssp S-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEECCHHHHSCCTTCCCSCEE
T ss_pred C-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCcccccccccCCCceEE
Confidence 6 6999999754321 133345789999999999999996 9999999999999754 479
Q ss_pred EEccCCccccCcccCcc---eeeccccCccCCchHhhhc-------CCCCcccchhhHHHHHHHHHh-CCCCCCccchhh
Q 004400 556 KISDFGLAKLDEEENTH---ISTRVAGTIGYMAPEYAMR-------GHLTEKADVYSFGIVALEIVS-GRSNVTKEDMFY 624 (756)
Q Consensus 556 kl~DFGla~~~~~~~~~---~~~~~~gt~~y~aPE~~~~-------~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~ 624 (756)
||+|||+++........ ......||+.|+|||++.+ ..++.++|||||||++|||++ |+.||.......
T Consensus 168 kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~ 247 (434)
T 2rio_A 168 LISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE 247 (434)
T ss_dssp EECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHH
T ss_pred EEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhH
Confidence 99999999876543322 1234579999999999975 568999999999999999999 899995443221
Q ss_pred HHHHHHHHHhcCccccccccCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004400 625 LLDWALVLKEQGKLMELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRM 682 (756)
Q Consensus 625 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~ 682 (756)
........... .............+.+++.+||+.||++|||+.||++.
T Consensus 248 ----~~i~~~~~~~~-----~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h 296 (434)
T 2rio_A 248 ----SNIIRGIFSLD-----EMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRH 296 (434)
T ss_dssp ----HHHHHTCCCCC-----CCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred ----HHHhcCCCCcc-----cccccccccchHHHHHHHHHHhhCChhhCCCHHHHHhC
Confidence 01111111111 11112244556779999999999999999999999863
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=343.30 Aligned_cols=250 Identities=23% Similarity=0.299 Sum_probs=190.5
Q ss_pred hhcCccccCcccCCCCccEEEeeccCCcEEEEEEccccCcccHHHHHHHHHHHHhC-CCCceeeEeeEEEeCCeEEEEEE
Q 004400 414 ATNNFATDNNIGEGGFGPVYKGLLADGTAIAVKQLSSKSKQGNREFINEIGMISAL-QHPNLVKLYGCCIEGNQLLLIYE 492 (756)
Q Consensus 414 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~e 492 (756)
...+|...+.||+|+||+||.....+++.||||++...... .+.+|+++++.+ +|||||++++++.++...++|||
T Consensus 22 ~~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~~---~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E 98 (432)
T 3p23_A 22 GKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFS---FADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIE 98 (432)
T ss_dssp TTEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTEE---ECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ccEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHHH---HHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEE
Confidence 34578889999999999976655667899999998654322 356799999999 79999999999999999999999
Q ss_pred ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecC-----CCCEEEccCCccccCc
Q 004400 493 YLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDK-----DLNSKISDFGLAKLDE 567 (756)
Q Consensus 493 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~-----~~~~kl~DFGla~~~~ 567 (756)
||. |+|.+++........+..+..++.||+.||+|||+.+ |+||||||+|||++. ...+||+|||+++...
T Consensus 99 ~~~-g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~ 174 (432)
T 3p23_A 99 LCA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLN---IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLA 174 (432)
T ss_dssp CCS-EEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTT---CCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC-
T ss_pred CCC-CCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCc---CEeCCCCHHHEEEecCCCCCceeEEEecccceeecc
Confidence 997 5999999876666777778899999999999999997 999999999999953 3358899999998765
Q ss_pred ccCc--ceeeccccCccCCchHhhh---cCCCCcccchhhHHHHHHHHHh-CCCCCCccchhhHHHHHHHHHhcCccccc
Q 004400 568 EENT--HISTRVAGTIGYMAPEYAM---RGHLTEKADVYSFGIVALEIVS-GRSNVTKEDMFYLLDWALVLKEQGKLMEL 641 (756)
Q Consensus 568 ~~~~--~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 641 (756)
.... .......||+.|+|||++. ...++.++|||||||++|||++ |+.||......... ........ ..
T Consensus 175 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~----~~~~~~~~-~~ 249 (432)
T 3p23_A 175 VGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQAN----ILLGACSL-DC 249 (432)
T ss_dssp -----------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHH----HHTTCCCC-TT
T ss_pred CCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHH----HHhccCCc-cc
Confidence 4322 2234467999999999997 4567889999999999999999 88888443221111 11111100 00
Q ss_pred cccCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 004400 642 VDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLR 681 (756)
Q Consensus 642 ~~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~ 681 (756)
..........+.+++.+||+.||.+|||+.||++
T Consensus 250 ------~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~ 283 (432)
T 3p23_A 250 ------LHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLK 283 (432)
T ss_dssp ------SCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ------cCccccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence 0111233445789999999999999999999985
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-37 Score=354.89 Aligned_cols=258 Identities=24% Similarity=0.346 Sum_probs=198.8
Q ss_pred hcCccccCcccCCCCccEEEeec-cCCcEEEEEEcccc-CcccHHHHHHHHHHHHhCCCCceeeEeeEEEe------CCe
Q 004400 415 TNNFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSK-SKQGNREFINEIGMISALQHPNLVKLYGCCIE------GNQ 486 (756)
Q Consensus 415 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~------~~~ 486 (756)
.++|...+.||+|+||.||+|.. .+|+.||||++... .....+.+.+|++++++++||||+++++++.. ++.
T Consensus 13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~ 92 (676)
T 3qa8_A 13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDL 92 (676)
T ss_dssp ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSS
T ss_pred CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCe
Confidence 36899999999999999999995 57899999998754 33445678999999999999999999999765 677
Q ss_pred EEEEEEecCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCC---EEEccCC
Q 004400 487 LLLIYEYLENNSLARALFEHR--LKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLN---SKISDFG 561 (756)
Q Consensus 487 ~~lV~e~~~~gsL~~~l~~~~--~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~---~kl~DFG 561 (756)
.++||||+++|+|.+++.... ..+++..+..++.|++.||+|||+.| |+||||||+||+++.++. +||+|||
T Consensus 93 ~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~g---IVHrDLKP~NILl~~~g~~~~vKL~DFG 169 (676)
T 3qa8_A 93 PLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENR---IIHRDLKPENIVLQPGPQRLIHKIIDLG 169 (676)
T ss_dssp CCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTT---BCCCCCCSTTEEEECCSSSCEEEECSCC
T ss_pred EEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEeecCCCceeEEEcccc
Confidence 899999999999999997543 36899999999999999999999997 999999999999997765 9999999
Q ss_pred ccccCcccCcceeeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhcCc----
Q 004400 562 LAKLDEEENTHISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGK---- 637 (756)
Q Consensus 562 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~---- 637 (756)
+++....... .....||+.|+|||.+.+..++.++|||||||++|||++|+.||.+.... ..|.........
T Consensus 170 ~a~~~~~~~~--~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~--~~~~~~i~~~~~~~~~ 245 (676)
T 3qa8_A 170 YAKELDQGEL--CTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQP--VQWHGKVREKSNEHIV 245 (676)
T ss_dssp CCCBTTSCCC--CCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHH--HHSSTTCC------CC
T ss_pred cccccccccc--cccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccch--hhhhhhhhcccchhhh
Confidence 9987654332 24467999999999999999999999999999999999999999654321 111111000000
Q ss_pred ----ccc---cccc-CCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHH
Q 004400 638 ----LME---LVDT-NPGSNFDKEQVMVMINVALLCANASPTIRPSMSSV 679 (756)
Q Consensus 638 ----~~~---~~~~-~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev 679 (756)
... .... .............+.+++.+|++.||++|||+.|+
T Consensus 246 ~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~el 295 (676)
T 3qa8_A 246 VYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQN 295 (676)
T ss_dssp SCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTC
T ss_pred hhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHH
Confidence 000 0000 11122344566779999999999999999999773
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-36 Score=356.17 Aligned_cols=278 Identities=30% Similarity=0.439 Sum_probs=237.2
Q ss_pred eccccccccCcccccCCcccCC--CCCCCEEEccCCcccCccCcccccCCcc-eeeccCccccccCCccCcCcCCCcEEE
Q 004400 18 VNQKRVLKEQNLTGVLPPKLAE--LTFLQDIDLTLNYLSGTIPSQWASLPLL-NISLIANRLKGPIPKYLANISTLVNLT 94 (756)
Q Consensus 18 ~~~~l~L~~~~l~~~~p~~l~~--l~~L~~L~L~~n~l~~~~p~~~~~l~~L-~l~l~~n~~~~~~p~~l~~l~~L~~L~ 94 (756)
.++.|+|++|++++.+|..+.. +++|+.|+|++|.+++.+|..+..++.| .+++.+|++.+.+|..|.++++|+.|+
T Consensus 369 ~L~~L~Ls~N~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~ 448 (768)
T 3rgz_A 369 SLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLK 448 (768)
T ss_dssp TCSEEECCSSEEEEECCTTTTCSTTCCCCEEECCSSEEEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEE
T ss_pred CCcEEEccCCCcCCCcChhhhhcccCCccEEECCCCccccccCHHHhcCCCCCEEECcCCcccCcccHHHhcCCCCCEEE
Confidence 6666666666666666666655 6778888888888888888888888888 488888888888888888888888888
Q ss_pred eecCcccccCCcccCCCCCCcEEeccCCeecccCCccccCCCCCCEEEeeCCcccccCChhhcCcCCCcEEEccCCcCcC
Q 004400 95 VQYNQFSGELPEELGSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRISDNQFTGQIPSFIQNWTKLEKLFIQPSGLAG 174 (756)
Q Consensus 95 L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~ 174 (756)
|++|.+++.+|..|+.+++|++|+|++|++++.+|..+.++++|+.|+|++|++++.+|..|+++++|++|+|++|++++
T Consensus 449 L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~ 528 (768)
T 3rgz_A 449 LWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSG 528 (768)
T ss_dssp CCSSCCCSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEE
T ss_pred CCCCcccCcCCHHHcCCCCceEEEecCCcccCcCCHHHhcCCCCCEEEccCCccCCcCChHHhcCCCCCEEECCCCcccC
Confidence 88888888888888888889999999999888888888888999999999999988888888889999999999999988
Q ss_pred CCCccccCCCCCCeEEccCCCCCCCCcccc--------------------------------------------------
Q 004400 175 PIPSGIFSLENLTDLRISDLNGPEATFPQL-------------------------------------------------- 204 (756)
Q Consensus 175 ~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~-------------------------------------------------- 204 (756)
.+|..+..+++|+.|++++|.+....+..+
T Consensus 529 ~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 608 (768)
T 3rgz_A 529 NIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLS 608 (768)
T ss_dssp ECCGGGGGCTTCCEEECCSSEEESBCCGGGGTTTTCBCCSTTCSCEEEEEECCSCCTTCCSSEEEEECTTCCGGGGGGGG
T ss_pred cCCHHHcCCCCCCEEECCCCccCCcCChHHhcccchhhhhccccccccccccccccccccccccccccccccchhhhccc
Confidence 888888889999999998887764333221
Q ss_pred --------------------cc-ccccEEEcccccccCCCCccccCCCCCcEEEccCCcCCCCCCccCcCCCCCCeEEec
Q 004400 205 --------------------GN-MKMTKLILRNCNITGELPRYLGKMTKLKVLDLSFNRLRGQIPSNFDDLYDVDYIYFA 263 (756)
Q Consensus 205 --------------------~~-~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls 263 (756)
.. .+|+.|+|++|+++|.+|..|+++++|+.|+|++|+++|.+|..|..+++|+.|+|+
T Consensus 609 ~~~~~~l~~~~~~g~~~~~~~~l~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~ip~~l~~L~~L~~LdLs 688 (768)
T 3rgz_A 609 TRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLS 688 (768)
T ss_dssp GTCCSCTTSCEEEEECCCSCSSSBCCCEEECCSSCCBSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECC
T ss_pred cccccccccceecccCchhhhccccccEEECcCCcccccCCHHHhccccCCEEeCcCCccCCCCChHHhCCCCCCEEECC
Confidence 11 247899999999999999999999999999999999999999999999999999999
Q ss_pred CccccccCCchh--hcCCCeeEeecCCCCCCCCc
Q 004400 264 GNLLTGAIPPWM--LERGDKIDLSYNNFTDGSAE 295 (756)
Q Consensus 264 ~N~l~~~~p~~~--~~~l~~l~ls~N~l~~~~~~ 295 (756)
+|+++|.+|..+ ++.|+.||+++|+++|..|.
T Consensus 689 ~N~l~g~ip~~l~~l~~L~~L~ls~N~l~g~iP~ 722 (768)
T 3rgz_A 689 SNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIPE 722 (768)
T ss_dssp SSCCEECCCGGGGGCCCCSEEECCSSEEEEECCS
T ss_pred CCcccCcCChHHhCCCCCCEEECcCCcccccCCC
Confidence 999999999987 78899999999999876553
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-36 Score=315.45 Aligned_cols=229 Identities=14% Similarity=0.091 Sum_probs=182.5
Q ss_pred cCccccCcccCCCCccEEEeec-cCCcEEEEEEccccCc---ccHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEE
Q 004400 416 NNFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSKSK---QGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIY 491 (756)
Q Consensus 416 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 491 (756)
++|...+.||+|+||.||+|+. .+++.||||++..... ...+.+.+|+.++++++||||+++++++.+++..|+||
T Consensus 31 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 110 (286)
T 3uqc_A 31 GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVA 110 (286)
T ss_dssp TTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred CcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEEE
Confidence 5788999999999999999995 4589999999976532 23367899999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCcccCc
Q 004400 492 EYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENT 571 (756)
Q Consensus 492 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~~~~ 571 (756)
||+++++|.+++.. .....++.+++.|++.||+|||++| |+||||||+|||++.++.+||+++|
T Consensus 111 e~~~g~~L~~~l~~---~~~~~~~~~i~~ql~~aL~~lH~~g---ivH~Dikp~NIll~~~g~~kl~~~~---------- 174 (286)
T 3uqc_A 111 EWIRGGSLQEVADT---SPSPVGAIRAMQSLAAAADAAHRAG---VALSIDHPSRVRVSIDGDVVLAYPA---------- 174 (286)
T ss_dssp ECCCEEEHHHHHTT---CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEETTSCEEECSCC----------
T ss_pred EecCCCCHHHHHhc---CCChHHHHHHHHHHHHHHHHHHHCC---CccCCCCcccEEEcCCCCEEEEecc----------
Confidence 99999999999843 2456678999999999999999997 9999999999999999999998543
Q ss_pred ceeeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhcCccccccccCCC--CC
Q 004400 572 HISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPG--SN 649 (756)
Q Consensus 572 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~ 649 (756)
|++ .++.++|||||||++|||++|+.||...+....... .......... ..
T Consensus 175 -----------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~---------~~~~~~~~~~~~~~ 227 (286)
T 3uqc_A 175 -----------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAP---------AERDTAGQPIEPAD 227 (286)
T ss_dssp -----------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEE---------CCBCTTSCBCCHHH
T ss_pred -----------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHH---------HHHHhccCCCChhh
Confidence 333 368899999999999999999999976543211100 0000000000 00
Q ss_pred CCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhccCcc
Q 004400 650 FDKEQVMVMINVALLCANASPTIRPSMSSVLRMLECGVD 688 (756)
Q Consensus 650 ~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~L~~~~~ 688 (756)
........+.+++.+||+.||++| |+.|+++.|++...
T Consensus 228 ~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~ 265 (286)
T 3uqc_A 228 IDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATA 265 (286)
T ss_dssp HCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC
T ss_pred cccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhc
Confidence 011122348899999999999999 99999999996543
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-36 Score=332.62 Aligned_cols=242 Identities=14% Similarity=0.135 Sum_probs=182.5
Q ss_pred HhhcCccccCcccCCCCccEEEee-ccCCcEEEEEEccccCc---ccHHHHHHHHHHHHhCCC-Cce-------------
Q 004400 413 AATNNFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSKSK---QGNREFINEIGMISALQH-PNL------------- 474 (756)
Q Consensus 413 ~~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h-~ni------------- 474 (756)
..+++|...+.||+|+||.||+|+ ..+|+.||||++..... ...+.+.+|+.+++.++| +|.
T Consensus 75 ~~~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~ 154 (413)
T 3dzo_A 75 ERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPF 154 (413)
T ss_dssp SCCEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCC
T ss_pred CCceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccch
Confidence 345568888999999999999999 66899999999874322 235779999999999987 221
Q ss_pred --ee------EeeEEEe-----CCeEEEEEEecCCCCHHHHHH------hcCCCCCHHHHHHHHHHHHHHHHHHHcCCCC
Q 004400 475 --VK------LYGCCIE-----GNQLLLIYEYLENNSLARALF------EHRLKLDWPTRRRICLGIARGLAYLHGESRI 535 (756)
Q Consensus 475 --v~------l~~~~~~-----~~~~~lV~e~~~~gsL~~~l~------~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~ 535 (756)
+. ++.++.. ....+++|+++ +++|.+++. .....+++..+..++.||++||+|||+++
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~-- 231 (413)
T 3dzo_A 155 DLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG-- 231 (413)
T ss_dssp EEEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT--
T ss_pred hhcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCC--
Confidence 11 1111111 12356667655 679999884 22345788899999999999999999997
Q ss_pred CeEcCCCCCCceEecCCCCEEEccCCccccCcccCcceeeccccCccCCchHhh----------hcCCCCcccchhhHHH
Q 004400 536 KVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPEYA----------MRGHLTEKADVYSFGI 605 (756)
Q Consensus 536 ~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~~~~~Dv~slGv 605 (756)
||||||||+|||++.++.+||+|||+++..... .....| +.|+|||++ ....++.++|||||||
T Consensus 232 -iiHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGv 305 (413)
T 3dzo_A 232 -LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGL 305 (413)
T ss_dssp -EECSCCCGGGEEECTTCCEEECCGGGCEETTEE----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHH
T ss_pred -cccCCcccceEEEecCCeEEEEeccceeecCCc----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHH
Confidence 999999999999999999999999999865433 344567 999999999 4455888999999999
Q ss_pred HHHHHHhCCCCCCccchhhHHHHHHHHHhcCccccccccCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 004400 606 VALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLR 681 (756)
Q Consensus 606 ~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~ 681 (756)
++|||++|+.||...+...... ..+... ..++ ..+.+++.+||+.||++||++.++++
T Consensus 306 il~elltg~~Pf~~~~~~~~~~------------~~~~~~--~~~~----~~~~~li~~~l~~dP~~Rpt~~~~l~ 363 (413)
T 3dzo_A 306 AIYWIWCADLPNTDDAALGGSE------------WIFRSC--KNIP----QPVRALLEGFLRYPKEDRLLPLQAME 363 (413)
T ss_dssp HHHHHHHSSCCCCTTGGGSCSG------------GGGSSC--CCCC----HHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred HHHHHHHCCCCCCCcchhhhHH------------HHHhhc--ccCC----HHHHHHHHHHccCChhhCcCHHHHHh
Confidence 9999999999996654322111 111111 1233 34889999999999999999998865
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-36 Score=353.83 Aligned_cols=238 Identities=21% Similarity=0.302 Sum_probs=191.4
Q ss_pred hcCccccCcccCCCCccEEEeecc--CCcEEEEEEcccc-CcccHHHHHHHHHHHHhCCCCceeeEeeEEEeCCe-----
Q 004400 415 TNNFATDNNIGEGGFGPVYKGLLA--DGTAIAVKQLSSK-SKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQ----- 486 (756)
Q Consensus 415 ~~~~~~~~~lg~G~~g~Vy~~~~~--~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~----- 486 (756)
.++|...+.||+|+||.||+|... +++.||||++... .......+.+|++++++++|||||+++++|.+.+.
T Consensus 79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~ 158 (681)
T 2pzi_A 79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPV 158 (681)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCce
Confidence 368899999999999999999954 6899999998653 23344678899999999999999999999987655
Q ss_pred EEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccC
Q 004400 487 LLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLD 566 (756)
Q Consensus 487 ~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~ 566 (756)
.|+||||+++++|.+++.. .+++..+..++.||+.||+|||++| ||||||||+|||++.+ .+||+|||+++..
T Consensus 159 ~~lv~E~~~g~~L~~~~~~---~l~~~~~~~~~~qi~~aL~~lH~~g---iiHrDlkp~NIll~~~-~~kl~DFG~a~~~ 231 (681)
T 2pzi_A 159 GYIVMEYVGGQSLKRSKGQ---KLPVAEAIAYLLEILPALSYLHSIG---LVYNDLKPENIMLTEE-QLKLIDLGAVSRI 231 (681)
T ss_dssp EEEEEECCCCEECC----C---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSS-CEEECCCTTCEET
T ss_pred eEEEEEeCCCCcHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHCC---CeecccChHHeEEeCC-cEEEEecccchhc
Confidence 7999999999999987643 7999999999999999999999997 9999999999999986 8999999999865
Q ss_pred cccCcceeeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhcCccccccccCC
Q 004400 567 EEENTHISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNP 646 (756)
Q Consensus 567 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 646 (756)
... ....||++|+|||++.+. ++.++|||||||++|||++|..||....... . +
T Consensus 232 ~~~-----~~~~gt~~y~aPE~~~~~-~~~~sDi~slG~~l~~l~~g~~~~~~~~~~~----------------~----~ 285 (681)
T 2pzi_A 232 NSF-----GYLYGTPGFQAPEIVRTG-PTVATDIYTVGRTLAALTLDLPTRNGRYVDG----------------L----P 285 (681)
T ss_dssp TCC-----SCCCCCTTTSCTTHHHHC-SCHHHHHHHHHHHHHHHHSCCCEETTEECSS----------------C----C
T ss_pred ccC-----CccCCCccccCHHHHcCC-CCCceehhhhHHHHHHHHhCCCCCccccccc----------------c----c
Confidence 443 345799999999998765 4899999999999999999988875421110 0 0
Q ss_pred CCCCCHHHHHHHHHHHHHhhcCCCCCCCC-HHHHHHHhcc
Q 004400 647 GSNFDKEQVMVMINVALLCANASPTIRPS-MSSVLRMLEC 685 (756)
Q Consensus 647 ~~~~~~~~~~~l~~l~~~c~~~~P~~RPt-~~ev~~~L~~ 685 (756)
...........+.+++.+||+.||++||+ ++++...|.+
T Consensus 286 ~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~ 325 (681)
T 2pzi_A 286 EDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTG 325 (681)
T ss_dssp TTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred ccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHH
Confidence 00001122345889999999999999995 5555555553
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-35 Score=308.22 Aligned_cols=226 Identities=19% Similarity=0.294 Sum_probs=177.7
Q ss_pred cCcccc-CcccCCCCccEEEeec-cCCcEEEEEEccccCcccHHHHHHHHHHH-HhCCCCceeeEeeEEEe----CCeEE
Q 004400 416 NNFATD-NNIGEGGFGPVYKGLL-ADGTAIAVKQLSSKSKQGNREFINEIGMI-SALQHPNLVKLYGCCIE----GNQLL 488 (756)
Q Consensus 416 ~~~~~~-~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l-~~l~h~niv~l~~~~~~----~~~~~ 488 (756)
++|... +.||+|+||.||+|.. .+++.||+|++.. ...+.+|++++ +..+||||+++++++.. +...+
T Consensus 17 ~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-----~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 91 (299)
T 3m2w_A 17 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 91 (299)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred cchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecc-----cHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEE
Confidence 456665 7899999999999984 6789999999853 24677899887 66699999999999987 67889
Q ss_pred EEEEecCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecC---CCCEEEccCCccc
Q 004400 489 LIYEYLENNSLARALFEHR-LKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDK---DLNSKISDFGLAK 564 (756)
Q Consensus 489 lV~e~~~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~---~~~~kl~DFGla~ 564 (756)
+||||+++|+|.+++.... ..+++..+..++.|++.||+|||+.+ |+||||||+||+++. ++.+||+|||++.
T Consensus 92 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~ 168 (299)
T 3m2w_A 92 IVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAK 168 (299)
T ss_dssp EEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTTCE
T ss_pred EEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEecCCCCCcEEEecccccc
Confidence 9999999999999998653 46999999999999999999999997 999999999999998 7889999999986
Q ss_pred cCcccCcceeeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhcCcccccccc
Q 004400 565 LDEEENTHISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDT 644 (756)
Q Consensus 565 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 644 (756)
... +..++.++|||||||++|||++|+.||.......... .....+..
T Consensus 169 ~~~-----------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~---------~~~~~~~~ 216 (299)
T 3m2w_A 169 ETT-----------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISP---------GMKTRIRM 216 (299)
T ss_dssp ECT-----------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------C---------CSCCSSCT
T ss_pred ccc-----------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhH---------HHHHHHhh
Confidence 432 1346779999999999999999999996543321110 00011100
Q ss_pred CCCCCCCH----HHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004400 645 NPGSNFDK----EQVMVMINVALLCANASPTIRPSMSSVLRM 682 (756)
Q Consensus 645 ~~~~~~~~----~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~ 682 (756)
.. ...+. .....+.+++.+||+.||++|||+.|+++.
T Consensus 217 ~~-~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~h 257 (299)
T 3m2w_A 217 GQ-YEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 257 (299)
T ss_dssp TC-CSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred cc-ccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 00 01111 123458899999999999999999999873
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-35 Score=349.73 Aligned_cols=278 Identities=32% Similarity=0.478 Sum_probs=257.0
Q ss_pred ceeccccccccCcccccCCcccCCCCCCCEEEccCCcccCccCcccccCCcce-eeccCccccccCCccCcCcCCCcEEE
Q 004400 16 KTVNQKRVLKEQNLTGVLPPKLAELTFLQDIDLTLNYLSGTIPSQWASLPLLN-ISLIANRLKGPIPKYLANISTLVNLT 94 (756)
Q Consensus 16 ~~~~~~l~L~~~~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~-l~l~~n~~~~~~p~~l~~l~~L~~L~ 94 (756)
+..++.|+|++|++++.+|..|.++++|+.|+|++|.+++.+|..+..++.|+ +++.+|++.+.+|..|..+++|++|+
T Consensus 393 ~~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~ 472 (768)
T 3rgz_A 393 KNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLI 472 (768)
T ss_dssp TCCCCEEECCSSEEEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEE
T ss_pred cCCccEEECCCCccccccCHHHhcCCCCCEEECcCCcccCcccHHHhcCCCCCEEECCCCcccCcCCHHHcCCCCceEEE
Confidence 67899999999999999999999999999999999999999999999999984 89999999999999999999999999
Q ss_pred eecCcccccCCcccCCCCCCcEEeccCCeecccCCccccCCCCCCEEEeeCCcccccCChhhcCcCCCcEEEccCCcCcC
Q 004400 95 VQYNQFSGELPEELGSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRISDNQFTGQIPSFIQNWTKLEKLFIQPSGLAG 174 (756)
Q Consensus 95 L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~ 174 (756)
|++|++++.+|..|+++++|++|+|++|++++.+|..|+.+++|+.|+|++|++++.+|..++++++|+.|+|++|+++|
T Consensus 473 L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g 552 (768)
T 3rgz_A 473 LDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNG 552 (768)
T ss_dssp CCSSCCCSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEEECCGGGGGCTTCCEEECCSSEEES
T ss_pred ecCCcccCcCCHHHhcCCCCCEEEccCCccCCcCChHHhcCCCCCEEECCCCcccCcCCHHHcCCCCCCEEECCCCccCC
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999988
Q ss_pred CCCccc----------------------------------------------------------------------cCCC
Q 004400 175 PIPSGI----------------------------------------------------------------------FSLE 184 (756)
Q Consensus 175 ~~p~~~----------------------------------------------------------------------~~l~ 184 (756)
.+|..+ ..++
T Consensus 553 ~ip~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~g~~~~~~~~l~ 632 (768)
T 3rgz_A 553 TIPAAMFKQSGKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNG 632 (768)
T ss_dssp BCCGGGGTTTTCBCCSTTCSCEEEEEECCSCCTTCCSSEEEEECTTCCGGGGGGGGGTCCSCTTSCEEEEECCCSCSSSB
T ss_pred cCChHHhcccchhhhhccccccccccccccccccccccccccccccccchhhhccccccccccccceecccCchhhhccc
Confidence 777644 3357
Q ss_pred CCCeEEccCCCCCCCCccccccc-cccEEEcccccccCCCCccccCCCCCcEEEccCCcCCCCCCccCcCCCCCCeEEec
Q 004400 185 NLTDLRISDLNGPEATFPQLGNM-KMTKLILRNCNITGELPRYLGKMTKLKVLDLSFNRLRGQIPSNFDDLYDVDYIYFA 263 (756)
Q Consensus 185 ~L~~L~l~~n~~~~~~~~~~~~~-~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls 263 (756)
+|+.|++++|.+....+..++.+ .|+.|+|++|+++|.+|..|+++++|+.|||++|+++|.+|..+..+++|++|+++
T Consensus 633 ~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~ip~~l~~L~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~ls 712 (768)
T 3rgz_A 633 SMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLS 712 (768)
T ss_dssp CCCEEECCSSCCBSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEECCCGGGGGCCCCSEEECC
T ss_pred cccEEECcCCcccccCCHHHhccccCCEEeCcCCccCCCCChHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECc
Confidence 89999999999999998888887 59999999999999999999999999999999999999999999999999999999
Q ss_pred CccccccCCchh-hcCCCeeEeecCCCCCCC
Q 004400 264 GNLLTGAIPPWM-LERGDKIDLSYNNFTDGS 293 (756)
Q Consensus 264 ~N~l~~~~p~~~-~~~l~~l~ls~N~l~~~~ 293 (756)
+|+++|.+|... +..+....+.+|+.-|+.
T Consensus 713 ~N~l~g~iP~~~~~~~~~~~~~~gN~~Lcg~ 743 (768)
T 3rgz_A 713 NNNLSGPIPEMGQFETFPPAKFLNNPGLCGY 743 (768)
T ss_dssp SSEEEEECCSSSSGGGSCGGGGCSCTEEEST
T ss_pred CCcccccCCCchhhccCCHHHhcCCchhcCC
Confidence 999999999764 555666667777644443
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-36 Score=322.05 Aligned_cols=242 Identities=20% Similarity=0.200 Sum_probs=183.8
Q ss_pred hcCccccCcccCCCCccEEEeeccCCcEEEEEEccccC--------cccHHHHHHHHHHHHhCC---------CCceeeE
Q 004400 415 TNNFATDNNIGEGGFGPVYKGLLADGTAIAVKQLSSKS--------KQGNREFINEIGMISALQ---------HPNLVKL 477 (756)
Q Consensus 415 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~---------h~niv~l 477 (756)
.++|...+.||+|+||.||+|+. +|+.||||++.... ....+.+.+|+.+++.++ |||||++
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l 97 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL 97 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred cccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence 45788899999999999999987 68999999997542 223377899999999886 7777777
Q ss_pred eeEEE------------------------------eCCeEEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHH
Q 004400 478 YGCCI------------------------------EGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLA 527 (756)
Q Consensus 478 ~~~~~------------------------------~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~ 527 (756)
.+++. +++..++||||+++|++.+.+.. ..+++..+..++.||+.||+
T Consensus 98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~--~~~~~~~~~~i~~qi~~aL~ 175 (336)
T 2vuw_A 98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT--KLSSLATAKSILHQLTASLA 175 (336)
T ss_dssp EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT--TCCCHHHHHHHHHHHHHHHH
T ss_pred cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh--cCCCHHHHHHHHHHHHHHHH
Confidence 77643 26889999999999976665533 46899999999999999999
Q ss_pred HHH-cCCCCCeEcCCCCCCceEecCCC--------------------CEEEccCCccccCcccCcceeeccccCccCCch
Q 004400 528 YLH-GESRIKVVHRDIKATNVLLDKDL--------------------NSKISDFGLAKLDEEENTHISTRVAGTIGYMAP 586 (756)
Q Consensus 528 ~LH-~~g~~~iiH~Dikp~Nill~~~~--------------------~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aP 586 (756)
||| +.+ |+||||||+|||++.++ .+||+|||+|+..... ...||+.|+||
T Consensus 176 ~lH~~~~---ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~------~~~gt~~y~aP 246 (336)
T 2vuw_A 176 VAEASLR---FEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG------IVVFCDVSMDE 246 (336)
T ss_dssp HHHHHHC---CBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT------EEECCCCTTCS
T ss_pred HHHHhCC---EeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC------cEEEeecccCh
Confidence 999 886 99999999999999887 8999999999865432 34799999999
Q ss_pred HhhhcCCCCcccchhhHHHH-HHHHHhCCCCCCccchhhHHHHHHHHHhcCccccccccCCCCCCCHHHHHHHHHHHHHh
Q 004400 587 EYAMRGHLTEKADVYSFGIV-ALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDKEQVMVMINVALLC 665 (756)
Q Consensus 587 E~~~~~~~~~~~Dv~slGv~-l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c 665 (756)
|++.+.. +.++||||+|++ .+++++|..||... .|.............................+.+++.+|
T Consensus 247 E~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~ 319 (336)
T 2vuw_A 247 DLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNV------LWLHYLTDKMLKQMTFKTKCNTPAMKQIKRKIQEFHRTM 319 (336)
T ss_dssp GGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHH------HHHHHHHHHHHHTCCCSSCCCSHHHHHHHHHHHHHHHHG
T ss_pred hhhcCCC-ccceehhhhhCCCCcccccccCCCcch------hhhhHHHHhhhhhhccCcccchhhhhhcCHHHHHHHHHH
Confidence 9998655 889999998777 77888899887332 121111100000000011111112334667899999999
Q ss_pred hcCCCCCCCCHHHHH
Q 004400 666 ANASPTIRPSMSSVL 680 (756)
Q Consensus 666 ~~~~P~~RPt~~ev~ 680 (756)
++.| |+.|++
T Consensus 320 L~~d-----sa~e~l 329 (336)
T 2vuw_A 320 LNFS-----SATDLL 329 (336)
T ss_dssp GGSS-----SHHHHH
T ss_pred hccC-----CHHHHH
Confidence 9966 888887
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-34 Score=299.63 Aligned_cols=256 Identities=28% Similarity=0.402 Sum_probs=184.2
Q ss_pred CCCCEEEccCCcccC--ccCcccccCCcce-eeccC-ccccccCCccCcCcCCCcEEEeecCcccccCCcccCCCCCCcE
Q 004400 41 TFLQDIDLTLNYLSG--TIPSQWASLPLLN-ISLIA-NRLKGPIPKYLANISTLVNLTVQYNQFSGELPEELGSLLNLEK 116 (756)
Q Consensus 41 ~~L~~L~L~~n~l~~--~~p~~~~~l~~L~-l~l~~-n~~~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~ 116 (756)
.+++.|+|++|.+++ .+|..|..++.|+ |++.+ |++.+.+|..|+++++|++|+|++|++++.+|..|.++++|++
T Consensus 50 ~~l~~L~L~~~~l~~~~~~~~~l~~l~~L~~L~L~~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~ 129 (313)
T 1ogq_A 50 YRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVT 129 (313)
T ss_dssp CCEEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCE
T ss_pred ceEEEEECCCCCccCCcccChhHhCCCCCCeeeCCCCCcccccCChhHhcCCCCCEEECcCCeeCCcCCHHHhCCCCCCE
Confidence 456666666666666 6666666666663 55663 6666666766777777777777777777667777777777777
Q ss_pred EeccCCeecccCCccccCCCCCCEEEeeCCcccccCChhhcCcC-CCcEEEccCCcCcCCCCccccCCCCCCeEEccCCC
Q 004400 117 LHLSSNNFTGELPKTFAKLTNMKDFRISDNQFTGQIPSFIQNWT-KLEKLFIQPSGLAGPIPSGIFSLENLTDLRISDLN 195 (756)
Q Consensus 117 L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~-~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~n~ 195 (756)
|+|++|++++.+|..|..+++|++|+|++|++++.+|..+..++ +|++|+|++|++++.+|..+..++ |+.|++++|.
T Consensus 130 L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~~L~~L~L~~N~l~~~~~~~~~~l~-L~~L~Ls~N~ 208 (313)
T 1ogq_A 130 LDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLN-LAFVDLSRNM 208 (313)
T ss_dssp EECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCC-CSEEECCSSE
T ss_pred EeCCCCccCCcCChHHhcCCCCCeEECcCCcccCcCCHHHhhhhhcCcEEECcCCeeeccCChHHhCCc-ccEEECcCCc
Confidence 77777777766777777777777777777777766777777666 677777777777766677666665 7777777776
Q ss_pred CCCCCccccccc-cccEEEcccccccCCCCccccCCCCCcEEEccCCcCCCCCCccCcCCCCCCeEEecCccccccCCch
Q 004400 196 GPEATFPQLGNM-KMTKLILRNCNITGELPRYLGKMTKLKVLDLSFNRLRGQIPSNFDDLYDVDYIYFAGNLLTGAIPPW 274 (756)
Q Consensus 196 ~~~~~~~~~~~~-~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~ 274 (756)
+....+..+... +|+.|+|++|.+++.+|. +..+++|++|+|++|.+++.+|..|..+++|+.|++++|+++|.+|..
T Consensus 209 l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ip~~ 287 (313)
T 1ogq_A 209 LEGDASVLFGSDKNTQKIHLAKNSLAFDLGK-VGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQG 287 (313)
T ss_dssp EEECCGGGCCTTSCCSEEECCSSEECCBGGG-CCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCCS
T ss_pred ccCcCCHHHhcCCCCCEEECCCCceeeecCc-ccccCCCCEEECcCCcccCcCChHHhcCcCCCEEECcCCcccccCCCC
Confidence 666655555554 477777778888866665 778888899999999888888888888888999999999888888876
Q ss_pred h-hcCCCeeEeecCCCCCCCCcccc
Q 004400 275 M-LERGDKIDLSYNNFTDGSAESSC 298 (756)
Q Consensus 275 ~-~~~l~~l~ls~N~l~~~~~~~~~ 298 (756)
. +++++.+++++|+..|+.+...|
T Consensus 288 ~~l~~L~~l~l~~N~~lc~~p~~~C 312 (313)
T 1ogq_A 288 GNLQRFDVSAYANNKCLCGSPLPAC 312 (313)
T ss_dssp TTGGGSCGGGTCSSSEEESTTSSCC
T ss_pred ccccccChHHhcCCCCccCCCCCCC
Confidence 4 67888888888885544433334
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-33 Score=312.75 Aligned_cols=303 Identities=19% Similarity=0.216 Sum_probs=258.5
Q ss_pred eeccccccccCcccccCCcccCCCCCCCEEEccCCcccCccCcccccCCcce-eeccCccccccCCccCcCcCCCcEEEe
Q 004400 17 TVNQKRVLKEQNLTGVLPPKLAELTFLQDIDLTLNYLSGTIPSQWASLPLLN-ISLIANRLKGPIPKYLANISTLVNLTV 95 (756)
Q Consensus 17 ~~~~~l~L~~~~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~-l~l~~n~~~~~~p~~l~~l~~L~~L~L 95 (756)
..++.|+|++|++++..|..|.++++|+.|+|++|.|++..|..|..++.|+ |++.+|++....+..|.++++|++|+|
T Consensus 32 ~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 111 (477)
T 2id5_A 32 TETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSNRLKLIPLGVFTGLSNLTKLDI 111 (477)
T ss_dssp TTCSEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCSCCTTSSTTCTTCCEEEC
T ss_pred CCCcEEECCCCccceECHhHccCCCCCCEEECCCCccCEeChhhhhCCccCCEEECCCCcCCccCcccccCCCCCCEEEC
Confidence 4678899999999998889999999999999999999988899999999884 889999998777778899999999999
Q ss_pred ecCcccccCCcccCCCCCCcEEeccCCeecccCCccccCCCCCCEEEeeCCcccccCChhhcCcCCCcEEEccCCcCcCC
Q 004400 96 QYNQFSGELPEELGSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRISDNQFTGQIPSFIQNWTKLEKLFIQPSGLAGP 175 (756)
Q Consensus 96 ~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~ 175 (756)
++|++++..+..|.++++|++|+|++|++++..+..|.++++|+.|+|++|++++..+..|.++++|+.|+|++|.+.+.
T Consensus 112 s~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~i~~~ 191 (477)
T 2id5_A 112 SENKIVILLDYMFQDLYNLKSLEVGDNDLVYISHRAFSGLNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNINAI 191 (477)
T ss_dssp TTSCCCEECTTTTTTCTTCCEEEECCTTCCEECTTSSTTCTTCCEEEEESCCCSSCCHHHHTTCTTCCEEEEESCCCCEE
T ss_pred CCCccccCChhHccccccCCEEECCCCccceeChhhccCCCCCCEEECCCCcCcccChhHhcccCCCcEEeCCCCcCcEe
Confidence 99999988888999999999999999999988888999999999999999999977777899999999999999999988
Q ss_pred CCccccCCCCCCeEEccCCCCCCCCcc-ccccccccEEEcccccccCCCCccccCCCCCcEEEccCCcCCCCCCccCcCC
Q 004400 176 IPSGIFSLENLTDLRISDLNGPEATFP-QLGNMKMTKLILRNCNITGELPRYLGKMTKLKVLDLSFNRLRGQIPSNFDDL 254 (756)
Q Consensus 176 ~p~~~~~l~~L~~L~l~~n~~~~~~~~-~~~~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l 254 (756)
.+..+..+++|+.|++++|......+. .+...+|+.|+|++|.+++..+..|..+++|+.|+|++|.+++..+..|..+
T Consensus 192 ~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l 271 (477)
T 2id5_A 192 RDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLTAVPYLAVRHLVYLRFLNLSYNPISTIEGSMLHEL 271 (477)
T ss_dssp CTTCSCSCTTCCEEEEECCTTCCEECTTTTTTCCCSEEEEESSCCCSCCHHHHTTCTTCCEEECCSSCCCEECTTSCTTC
T ss_pred ChhhcccCcccceeeCCCCccccccCcccccCccccEEECcCCcccccCHHHhcCccccCeeECCCCcCCccChhhcccc
Confidence 888899999999999998776654433 3444478899999999986555678889999999999999988888888889
Q ss_pred CCCCeEEecCccccccCCchh--hcCCCeeEeecCCCCCCCCcccccccCcccccccccccccCCcc
Q 004400 255 YDVDYIYFAGNLLTGAIPPWM--LERGDKIDLSYNNFTDGSAESSCQKRSVTGIVSCLRSVQCPKTY 319 (756)
Q Consensus 255 ~~L~~L~ls~N~l~~~~p~~~--~~~l~~l~ls~N~l~~~~~~~~~~~~~~~~~~~~~~~~~c~~~~ 319 (756)
++|+.|+|++|.+++..|..+ +++|+.|++++|.++...+........+..+....+++.|.+..
T Consensus 272 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~c~c~~ 338 (477)
T 2id5_A 272 LRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQLTTLEESVFHSVGNLETLILDSNPLACDCRL 338 (477)
T ss_dssp TTCCEEECCSSCCSEECTTTBTTCTTCCEEECCSSCCSCCCGGGBSCGGGCCEEECCSSCEECSGGG
T ss_pred ccCCEEECCCCccceECHHHhcCcccCCEEECCCCcCceeCHhHcCCCcccCEEEccCCCccCccch
Confidence 999999999999988777776 67888999999998887766555555666666667777776543
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-33 Score=299.46 Aligned_cols=252 Identities=29% Similarity=0.403 Sum_probs=236.6
Q ss_pred eeccccccccCcccc--cCCcccCCCCCCCEEEccC-CcccCccCcccccCCcce-eeccCccccccCCccCcCcCCCcE
Q 004400 17 TVNQKRVLKEQNLTG--VLPPKLAELTFLQDIDLTL-NYLSGTIPSQWASLPLLN-ISLIANRLKGPIPKYLANISTLVN 92 (756)
Q Consensus 17 ~~~~~l~L~~~~l~~--~~p~~l~~l~~L~~L~L~~-n~l~~~~p~~~~~l~~L~-l~l~~n~~~~~~p~~l~~l~~L~~ 92 (756)
..++.|+|++|++++ .+|+.|.++++|++|+|++ |.+.+.+|..|..++.|+ |++.+|++.+.+|..|.++++|++
T Consensus 50 ~~l~~L~L~~~~l~~~~~~~~~l~~l~~L~~L~L~~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~ 129 (313)
T 1ogq_A 50 YRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVT 129 (313)
T ss_dssp CCEEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCE
T ss_pred ceEEEEECCCCCccCCcccChhHhCCCCCCeeeCCCCCcccccCChhHhcCCCCCEEECcCCeeCCcCCHHHhCCCCCCE
Confidence 468899999999999 9999999999999999995 999999999999999995 899999999999999999999999
Q ss_pred EEeecCcccccCCcccCCCCCCcEEeccCCeecccCCccccCCC-CCCEEEeeCCcccccCChhhcCcCCCcEEEccCCc
Q 004400 93 LTVQYNQFSGELPEELGSLLNLEKLHLSSNNFTGELPKTFAKLT-NMKDFRISDNQFTGQIPSFIQNWTKLEKLFIQPSG 171 (756)
Q Consensus 93 L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~-~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~ 171 (756)
|+|++|.|++.+|..|..+++|++|+|++|++++.+|..+..++ +|+.|+|++|++++.+|..|..++ |++|+|++|+
T Consensus 130 L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~~L~~L~L~~N~l~~~~~~~~~~l~-L~~L~Ls~N~ 208 (313)
T 1ogq_A 130 LDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLN-LAFVDLSRNM 208 (313)
T ss_dssp EECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCC-CSEEECCSSE
T ss_pred EeCCCCccCCcCChHHhcCCCCCeEECcCCcccCcCCHHHhhhhhcCcEEECcCCeeeccCChHHhCCc-ccEEECcCCc
Confidence 99999999999999999999999999999999999999999998 999999999999999999999998 9999999999
Q ss_pred CcCCCCccccCCCCCCeEEccCCCCCCCCccccccccccEEEcccccccCCCCccccCCCCCcEEEccCCcCCCCCCccC
Q 004400 172 LAGPIPSGIFSLENLTDLRISDLNGPEATFPQLGNMKMTKLILRNCNITGELPRYLGKMTKLKVLDLSFNRLRGQIPSNF 251 (756)
Q Consensus 172 l~~~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~ 251 (756)
+++..|..+..+++|+.|++++|.+....+......+|+.|+|++|.+++.+|..|..+++|+.|+|++|+++|.+|..
T Consensus 209 l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ip~~- 287 (313)
T 1ogq_A 209 LEGDASVLFGSDKNTQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQG- 287 (313)
T ss_dssp EEECCGGGCCTTSCCSEEECCSSEECCBGGGCCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCCS-
T ss_pred ccCcCCHHHhcCCCCCEEECCCCceeeecCcccccCCCCEEECcCCcccCcCChHHhcCcCCCEEECcCCcccccCCCC-
Confidence 9999999999999999999999999876666434457999999999999999999999999999999999999999986
Q ss_pred cCCCCCCeEEecCcccccc
Q 004400 252 DDLYDVDYIYFAGNLLTGA 270 (756)
Q Consensus 252 ~~l~~L~~L~ls~N~l~~~ 270 (756)
..+++|+.+++++|+.-+.
T Consensus 288 ~~l~~L~~l~l~~N~~lc~ 306 (313)
T 1ogq_A 288 GNLQRFDVSAYANNKCLCG 306 (313)
T ss_dssp TTGGGSCGGGTCSSSEEES
T ss_pred ccccccChHHhcCCCCccC
Confidence 8999999999999994433
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-33 Score=313.01 Aligned_cols=301 Identities=16% Similarity=0.139 Sum_probs=224.1
Q ss_pred eeccccccccCcccccCCcccCCCCCCCEEEccCCcccCcc-CcccccCCcce-eeccCccccccCCccCcCcCCCcEEE
Q 004400 17 TVNQKRVLKEQNLTGVLPPKLAELTFLQDIDLTLNYLSGTI-PSQWASLPLLN-ISLIANRLKGPIPKYLANISTLVNLT 94 (756)
Q Consensus 17 ~~~~~l~L~~~~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~-p~~~~~l~~L~-l~l~~n~~~~~~p~~l~~l~~L~~L~ 94 (756)
..++.|+|++|++++..|..|.++++|++|+|++|.+.+.+ +..|..++.|+ |++.+|++.+..|..|+++++|++|+
T Consensus 30 ~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~~~~~i~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~ 109 (455)
T 3v47_A 30 AHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQFLQLETGAFNGLANLEVLT 109 (455)
T ss_dssp TTCCEEECCSSCCCEECTTTTSSCTTCCEEECCCCSTTCEECTTTTTTCTTCCEEECTTCTTCEECTTTTTTCTTCCEEE
T ss_pred CccCEEEecCCccCcCChhHhccCccccEEECcCCcccceECcccccccccCCEEeCCCCccCccChhhccCcccCCEEe
Confidence 56888999999999888888999999999999999887555 56788888884 88899999888888999999999999
Q ss_pred eecCcccccCCcc--cCCCCCCcEEeccCCeecccCCcc-ccCCCCCCEEEeeCCcccccCChhhcCc------------
Q 004400 95 VQYNQFSGELPEE--LGSLLNLEKLHLSSNNFTGELPKT-FAKLTNMKDFRISDNQFTGQIPSFIQNW------------ 159 (756)
Q Consensus 95 L~~N~l~~~~p~~--~~~l~~L~~L~L~~N~l~~~~p~~-~~~l~~L~~L~L~~N~l~~~~p~~~~~l------------ 159 (756)
|++|++++.++.. |.++++|++|+|++|++++..|.. |.++++|++|+|++|++++..+..+..+
T Consensus 110 L~~n~l~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~~~L~~L~l~~ 189 (455)
T 3v47_A 110 LTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLSS 189 (455)
T ss_dssp CTTSCCBTHHHHSSTTTTCTTCCEEECCSSBCCSCCCCGGGGGCTTCCEEECTTCCBSCCCTTTSGGGTTCEEEEEECTT
T ss_pred CCCCCCCccccCcccccCcccCCEEECCCCccCccCcccccCCCCcccEEeCCCCcccccChhhhhcccccccccccccc
Confidence 9999998755554 888999999999999998777776 7889999999999999988777766654
Q ss_pred ----------------------CCCcEEEccCCcCcCCCCccccC-----------------------------------
Q 004400 160 ----------------------TKLEKLFIQPSGLAGPIPSGIFS----------------------------------- 182 (756)
Q Consensus 160 ----------------------~~L~~L~l~~N~l~~~~p~~~~~----------------------------------- 182 (756)
++|++|+|++|++++..|..+..
T Consensus 190 n~l~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~L~~L~l~~~~~~~~~~~~~~~~~~~~~~~ 269 (455)
T 3v47_A 190 ITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHTNFKDPDNFTF 269 (455)
T ss_dssp CBCTTCSTTCTTHHHHCCTTTTCEEEEEECTTSCCCHHHHHHHHHHTTTCCEEEEECTTCTTTSCCTTCCSSCCCCTTTT
T ss_pred CcccccchhhccccccccccccceeeeEecCCCcccccchhhhhccccccceeeEeeccccccccccchhhhccCccccc
Confidence 55677777777665433332211
Q ss_pred ----CCCCCeEEccCCCCCCCCccccccc-cccEEEcccccccCCCCccccCCCCCcEEEccCCcCCCCCCccCcCCCCC
Q 004400 183 ----LENLTDLRISDLNGPEATFPQLGNM-KMTKLILRNCNITGELPRYLGKMTKLKVLDLSFNRLRGQIPSNFDDLYDV 257 (756)
Q Consensus 183 ----l~~L~~L~l~~n~~~~~~~~~~~~~-~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L 257 (756)
.++|+.|++++|.+....+..+... +|+.|+|++|.+++..|..|.++++|++|+|++|.+++..|..|..+++|
T Consensus 270 ~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L 349 (455)
T 3v47_A 270 KGLEASGVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKL 349 (455)
T ss_dssp GGGTTSCCCEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGGTTCTTC
T ss_pred ccccccCceEEEecCccccccchhhcccCCCCCEEECCCCcccccChhHhcCcccCCEEECCCCccCCcChhHhcCcccC
Confidence 1466666666666666655555554 47777777777777667777777777777777777776667777777777
Q ss_pred CeEEecCccccccCCchh--hcCCCeeEeecCCCCCCCCcccccccCcccccccccccccCC
Q 004400 258 DYIYFAGNLLTGAIPPWM--LERGDKIDLSYNNFTDGSAESSCQKRSVTGIVSCLRSVQCPK 317 (756)
Q Consensus 258 ~~L~ls~N~l~~~~p~~~--~~~l~~l~ls~N~l~~~~~~~~~~~~~~~~~~~~~~~~~c~~ 317 (756)
+.|+|++|.+++..|.++ +++|+.|++++|++++.++........+..+....+++.|..
T Consensus 350 ~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~ 411 (455)
T 3v47_A 350 EVLDLSYNHIRALGDQSFLGLPNLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSC 411 (455)
T ss_dssp CEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCT
T ss_pred CEEECCCCcccccChhhccccccccEEECCCCccccCCHhHhccCCcccEEEccCCCcccCC
Confidence 777777777776666655 567777777777777665544444455555555555555543
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-33 Score=311.98 Aligned_cols=284 Identities=17% Similarity=0.174 Sum_probs=252.4
Q ss_pred eeeccceeccccccccCcccccC-CcccCCCCCCCEEEccCCcccCccCcccccCCcce-eeccCccccccCCcc--CcC
Q 004400 11 HFWKQKTVNQKRVLKEQNLTGVL-PPKLAELTFLQDIDLTLNYLSGTIPSQWASLPLLN-ISLIANRLKGPIPKY--LAN 86 (756)
Q Consensus 11 ~~~~~~~~~~~l~L~~~~l~~~~-p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~-l~l~~n~~~~~~p~~--l~~ 86 (756)
..+.+++.++.|+|++|.+.+.+ +..|..+++|++|+|++|.+++..|..|..++.|+ |++.+|++.+.+|.. |.+
T Consensus 48 ~~~~~l~~L~~L~L~~n~~~~~i~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~ 127 (455)
T 3v47_A 48 TSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQFLQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKP 127 (455)
T ss_dssp TTTSSCTTCCEEECCCCSTTCEECTTTTTTCTTCCEEECTTCTTCEECTTTTTTCTTCCEEECTTSCCBTHHHHSSTTTT
T ss_pred hHhccCccccEEECcCCcccceECcccccccccCCEEeCCCCccCccChhhccCcccCCEEeCCCCCCCccccCcccccC
Confidence 45788999999999999998655 56799999999999999999988899999999984 899999999866655 999
Q ss_pred cCCCcEEEeecCcccccCCcc-cCCCCCCcEEeccCCeecccCCccccCC------------------------------
Q 004400 87 ISTLVNLTVQYNQFSGELPEE-LGSLLNLEKLHLSSNNFTGELPKTFAKL------------------------------ 135 (756)
Q Consensus 87 l~~L~~L~L~~N~l~~~~p~~-~~~l~~L~~L~L~~N~l~~~~p~~~~~l------------------------------ 135 (756)
+++|++|+|++|++++..|.. |.++++|++|+|++|++++..+..+..+
T Consensus 128 l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~ 207 (455)
T 3v47_A 128 LTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGN 207 (455)
T ss_dssp CTTCCEEECCSSBCCSCCCCGGGGGCTTCCEEECTTCCBSCCCTTTSGGGTTCEEEEEECTTCBCTTCSTTCTTHHHHCC
T ss_pred cccCCEEECCCCccCccCcccccCCCCcccEEeCCCCcccccChhhhhccccccccccccccCcccccchhhcccccccc
Confidence 999999999999999887876 8999999999999999998888766554
Q ss_pred ----CCCCEEEeeCCcccccCChhhcCc---------------------------------------CCCcEEEccCCcC
Q 004400 136 ----TNMKDFRISDNQFTGQIPSFIQNW---------------------------------------TKLEKLFIQPSGL 172 (756)
Q Consensus 136 ----~~L~~L~L~~N~l~~~~p~~~~~l---------------------------------------~~L~~L~l~~N~l 172 (756)
++|+.|+|++|++++..|..+..+ ++|+.|++++|++
T Consensus 208 ~~~~~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~L~~L~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~l~~n~l 287 (455)
T 3v47_A 208 PFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHTNFKDPDNFTFKGLEASGVKTCDLSKSKI 287 (455)
T ss_dssp TTTTCEEEEEECTTSCCCHHHHHHHHHHTTTCCEEEEECTTCTTTSCCTTCCSSCCCCTTTTGGGTTSCCCEEECCSSCC
T ss_pred ccccceeeeEecCCCcccccchhhhhccccccceeeEeeccccccccccchhhhccCcccccccccccCceEEEecCccc
Confidence 679999999999987776655432 6899999999999
Q ss_pred cCCCCccccCCCCCCeEEccCCCCCCCCccccccc-cccEEEcccccccCCCCccccCCCCCcEEEccCCcCCCCCCccC
Q 004400 173 AGPIPSGIFSLENLTDLRISDLNGPEATFPQLGNM-KMTKLILRNCNITGELPRYLGKMTKLKVLDLSFNRLRGQIPSNF 251 (756)
Q Consensus 173 ~~~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~-~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~ 251 (756)
.+..|..+..+++|+.|++++|.+....+..+..+ +|+.|+|++|.+++..|..|.++++|+.|+|++|++++..|..|
T Consensus 288 ~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~ 367 (455)
T 3v47_A 288 FALLKSVFSHFTDLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDLSYNHIRALGDQSF 367 (455)
T ss_dssp CEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGGTTCTTCCEEECCSSCCCEECTTTT
T ss_pred cccchhhcccCCCCCEEECCCCcccccChhHhcCcccCCEEECCCCccCCcChhHhcCcccCCEEECCCCcccccChhhc
Confidence 99999999999999999999999999888777765 69999999999998889999999999999999999999999999
Q ss_pred cCCCCCCeEEecCccccccCCchh--hcCCCeeEeecCCCCCCCC
Q 004400 252 DDLYDVDYIYFAGNLLTGAIPPWM--LERGDKIDLSYNNFTDGSA 294 (756)
Q Consensus 252 ~~l~~L~~L~ls~N~l~~~~p~~~--~~~l~~l~ls~N~l~~~~~ 294 (756)
..+++|++|++++|++++..+..+ ++.++.|++++|+++|..+
T Consensus 368 ~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~ 412 (455)
T 3v47_A 368 LGLPNLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 412 (455)
T ss_dssp TTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTT
T ss_pred cccccccEEECCCCccccCCHhHhccCCcccEEEccCCCcccCCC
Confidence 999999999999999996555444 7899999999999998765
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-32 Score=309.18 Aligned_cols=284 Identities=18% Similarity=0.150 Sum_probs=262.5
Q ss_pred eeeccceeccccccccCcccccCCcccCCCCCCCEEEccCCcccCccCcccccCCcc-eeeccCccccccCCccCcCcCC
Q 004400 11 HFWKQKTVNQKRVLKEQNLTGVLPPKLAELTFLQDIDLTLNYLSGTIPSQWASLPLL-NISLIANRLKGPIPKYLANIST 89 (756)
Q Consensus 11 ~~~~~~~~~~~l~L~~~~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L-~l~l~~n~~~~~~p~~l~~l~~ 89 (756)
..|.++..++.|+|++|++++..|..|.++++|+.|+|++|+|+...+..|..++.| .|++.+|++.+..|..|.++++
T Consensus 50 ~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~ 129 (477)
T 2id5_A 50 DEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSNRLKLIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYN 129 (477)
T ss_dssp TTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCSCCTTSSTTCTTCCEEECTTSCCCEECTTTTTTCTT
T ss_pred hHccCCCCCCEEECCCCccCEeChhhhhCCccCCEEECCCCcCCccCcccccCCCCCCEEECCCCccccCChhHcccccc
Confidence 457889999999999999999999999999999999999999997777788999998 5999999999999999999999
Q ss_pred CcEEEeecCcccccCCcccCCCCCCcEEeccCCeecccCCccccCCCCCCEEEeeCCcccccCChhhcCcCCCcEEEccC
Q 004400 90 LVNLTVQYNQFSGELPEELGSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRISDNQFTGQIPSFIQNWTKLEKLFIQP 169 (756)
Q Consensus 90 L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~ 169 (756)
|++|+|++|.+++..+..|.++++|+.|+|++|++++..+..|..+++|+.|+|++|++++..+..|.++++|+.|++++
T Consensus 130 L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~ 209 (477)
T 2id5_A 130 LKSLEVGDNDLVYISHRAFSGLNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISH 209 (477)
T ss_dssp CCEEEECCTTCCEECTTSSTTCTTCCEEEEESCCCSSCCHHHHTTCTTCCEEEEESCCCCEECTTCSCSCTTCCEEEEEC
T ss_pred CCEEECCCCccceeChhhccCCCCCCEEECCCCcCcccChhHhcccCCCcEEeCCCCcCcEeChhhcccCcccceeeCCC
Confidence 99999999999999999999999999999999999977677899999999999999999988888999999999999999
Q ss_pred CcCcCCCCccccCCCCCCeEEccCCCCCCCCccccccc-cccEEEcccccccCCCCccccCCCCCcEEEccCCcCCCCCC
Q 004400 170 SGLAGPIPSGIFSLENLTDLRISDLNGPEATFPQLGNM-KMTKLILRNCNITGELPRYLGKMTKLKVLDLSFNRLRGQIP 248 (756)
Q Consensus 170 N~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~-~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p 248 (756)
|.+.+.+|..+....+|+.|++++|.+...+...+... +|+.|+|++|.+++..+..|.++++|+.|+|++|++++..|
T Consensus 210 ~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~ 289 (477)
T 2id5_A 210 WPYLDTMTPNCLYGLNLTSLSITHCNLTAVPYLAVRHLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLAVVEP 289 (477)
T ss_dssp CTTCCEECTTTTTTCCCSEEEEESSCCCSCCHHHHTTCTTCCEEECCSSCCCEECTTSCTTCTTCCEEECCSSCCSEECT
T ss_pred CccccccCcccccCccccEEECcCCcccccCHHHhcCccccCeeECCCCcCCccChhhccccccCCEEECCCCccceECH
Confidence 99988888888888899999999999998876666665 69999999999998888899999999999999999999999
Q ss_pred ccCcCCCCCCeEEecCccccccCCchh--hcCCCeeEeecCCCCCCCC
Q 004400 249 SNFDDLYDVDYIYFAGNLLTGAIPPWM--LERGDKIDLSYNNFTDGSA 294 (756)
Q Consensus 249 ~~~~~l~~L~~L~ls~N~l~~~~p~~~--~~~l~~l~ls~N~l~~~~~ 294 (756)
..|..+++|+.|+|++|.+++..+..+ +++|+.|++++|++.|...
T Consensus 290 ~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~c~c~ 337 (477)
T 2id5_A 290 YAFRGLNYLRVLNVSGNQLTTLEESVFHSVGNLETLILDSNPLACDCR 337 (477)
T ss_dssp TTBTTCTTCCEEECCSSCCSCCCGGGBSCGGGCCEEECCSSCEECSGG
T ss_pred HHhcCcccCCEEECCCCcCceeCHhHcCCCcccCEEEccCCCccCccc
Confidence 999999999999999999996555554 7899999999999987643
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=5.1e-31 Score=305.35 Aligned_cols=300 Identities=19% Similarity=0.172 Sum_probs=265.5
Q ss_pred eccccccccCcccccCCcccCCCCCCCEEEccCCcccCccCcccccCCcc-eeeccCccccccCCccCcCcCCCcEEEee
Q 004400 18 VNQKRVLKEQNLTGVLPPKLAELTFLQDIDLTLNYLSGTIPSQWASLPLL-NISLIANRLKGPIPKYLANISTLVNLTVQ 96 (756)
Q Consensus 18 ~~~~l~L~~~~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L-~l~l~~n~~~~~~p~~l~~l~~L~~L~L~ 96 (756)
.++.|+|++|++++..+..|..+++|+.|+|++|.++ .+|..+..++.| .+++.+|++.+..|..+.++++|++|+|+
T Consensus 255 ~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~-~lp~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~ 333 (606)
T 3t6q_A 255 SVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIK 333 (606)
T ss_dssp EEEEEECTTCCCSSCCTTTTTTCTTCSEEECTTSCCS-CCCSSCCSCTTCCEEECTTCCCSBGGGGCGGGCTTCSEEECC
T ss_pred ceeEEEeecCccCccCHHHhccccCCCEEeccCCccC-CCChhhcccccCCEEECccCCcCcCchhhhhccCcCCEEECC
Confidence 7899999999999988888999999999999999998 788889999888 48999999998889999999999999999
Q ss_pred cCcccccCCc-ccCCCCCCcEEeccCCeecccC--CccccCCCCCCEEEeeCCcccccCChhhcCcCCCcEEEccCCcCc
Q 004400 97 YNQFSGELPE-ELGSLLNLEKLHLSSNNFTGEL--PKTFAKLTNMKDFRISDNQFTGQIPSFIQNWTKLEKLFIQPSGLA 173 (756)
Q Consensus 97 ~N~l~~~~p~-~~~~l~~L~~L~L~~N~l~~~~--p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~ 173 (756)
+|.+.+.+|. .+..+++|++|+|++|++++.. +..+..+++|++|++++|++++..|..|.++++|+.|++++|++.
T Consensus 334 ~n~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~ 413 (606)
T 3t6q_A 334 GNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLK 413 (606)
T ss_dssp SCSSCCBCCSSTTTTCTTCCEEECCSSCCCEEEESTTTTTTCTTCCEEECCSCSCEEECTTTTTTCTTCSEEECTTCCEE
T ss_pred CCCcccccchhhhhccCcCCEEECCCCccccccCcchhcccCCCCCEEECCCCcCCcCCHHHhcCCccCCeEECCCCcCC
Confidence 9999877765 4899999999999999999766 778999999999999999999888999999999999999999999
Q ss_pred CCCCcc-ccCCCCCCeEEccCCCCCCCCccccccc-cccEEEcccccccCC---CCccccCCCCCcEEEccCCcCCCCCC
Q 004400 174 GPIPSG-IFSLENLTDLRISDLNGPEATFPQLGNM-KMTKLILRNCNITGE---LPRYLGKMTKLKVLDLSFNRLRGQIP 248 (756)
Q Consensus 174 ~~~p~~-~~~l~~L~~L~l~~n~~~~~~~~~~~~~-~L~~L~L~~n~l~~~---~p~~~~~l~~L~~L~Ls~N~l~~~~p 248 (756)
+..+.. +..+++|+.|++++|.+....+..+... +|+.|++++|.+++. .+..+..+++|+.|+|++|.+++..|
T Consensus 414 ~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~ 493 (606)
T 3t6q_A 414 VKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQ 493 (606)
T ss_dssp CCTTCCTTTTCTTCCEEECTTCCCBTTCTTTTTTCTTCCEEECTTCBCGGGEECSSCGGGGCTTCCEEECTTSCCCEECT
T ss_pred CcccchhhhCcccCCEEECCCCccCCcCHHHHhCCCCCCEEECCCCCCCccccccchhhccCCCccEEECCCCccCccCh
Confidence 776654 8899999999999999988887777665 699999999999872 34678999999999999999999889
Q ss_pred ccCcCCCCCCeEEecCccccccCCchh--hcCCCeeEeecCCCCCCCCcccccccCcccccccccccccCCcc
Q 004400 249 SNFDDLYDVDYIYFAGNLLTGAIPPWM--LERGDKIDLSYNNFTDGSAESSCQKRSVTGIVSCLRSVQCPKTY 319 (756)
Q Consensus 249 ~~~~~l~~L~~L~ls~N~l~~~~p~~~--~~~l~~l~ls~N~l~~~~~~~~~~~~~~~~~~~~~~~~~c~~~~ 319 (756)
..|..+++|+.|++++|++++..|..+ ++.+ .|++++|.+++..+........+..+....+++.|.+..
T Consensus 494 ~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L-~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~~ 565 (606)
T 3t6q_A 494 HAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGI-YLNLASNHISIILPSLLPILSQQRTINLRQNPLDCTCSN 565 (606)
T ss_dssp TTTTTCTTCCEEECCSSCCCGGGGGGGTTCCSC-EEECCSSCCCCCCGGGHHHHHTSSEEECTTCCEECSGGG
T ss_pred hhhccccCCCEEECCCCccCcCChhHhCccccc-EEECcCCcccccCHhhcccCCCCCEEeCCCCCccccCCc
Confidence 999999999999999999998888777 6778 999999999988777666666677777777888886543
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=4.2e-31 Score=306.03 Aligned_cols=281 Identities=20% Similarity=0.237 Sum_probs=256.3
Q ss_pred eeccceeccccccccCcccccCCcccCCCCCCCEEEccCCcccCccCcccccCCcc-eeeccCccccccCCc-cCcCcCC
Q 004400 12 FWKQKTVNQKRVLKEQNLTGVLPPKLAELTFLQDIDLTLNYLSGTIPSQWASLPLL-NISLIANRLKGPIPK-YLANIST 89 (756)
Q Consensus 12 ~~~~~~~~~~l~L~~~~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L-~l~l~~n~~~~~~p~-~l~~l~~ 89 (756)
.|.++..++.|+|++|+++ .+|+.+..+++|+.|++++|.+++..|..+..++.| .+++.+|.+.+.+|. .|.++++
T Consensus 273 ~~~~l~~L~~L~l~~n~l~-~lp~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~ 351 (606)
T 3t6q_A 273 TFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLEN 351 (606)
T ss_dssp TTTTCTTCSEEECTTSCCS-CCCSSCCSCTTCCEEECTTCCCSBGGGGCGGGCTTCSEEECCSCSSCCBCCSSTTTTCTT
T ss_pred HhccccCCCEEeccCCccC-CCChhhcccccCCEEECccCCcCcCchhhhhccCcCCEEECCCCCcccccchhhhhccCc
Confidence 4788999999999999999 778889999999999999999998889999999998 589999999977776 4999999
Q ss_pred CcEEEeecCcccccC--CcccCCCCCCcEEeccCCeecccCCccccCCCCCCEEEeeCCcccccCCh-hhcCcCCCcEEE
Q 004400 90 LVNLTVQYNQFSGEL--PEELGSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRISDNQFTGQIPS-FIQNWTKLEKLF 166 (756)
Q Consensus 90 L~~L~L~~N~l~~~~--p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~-~~~~l~~L~~L~ 166 (756)
|++|+|++|.+++.. +..+..+++|++|+|++|++++..|..|..+++|+.|++++|++++..+. .|.++++|+.|+
T Consensus 352 L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~ 431 (606)
T 3t6q_A 352 LRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLN 431 (606)
T ss_dssp CCEEECCSSCCCEEEESTTTTTTCTTCCEEECCSCSCEEECTTTTTTCTTCSEEECTTCCEECCTTCCTTTTCTTCCEEE
T ss_pred CCEEECCCCccccccCcchhcccCCCCCEEECCCCcCCcCCHHHhcCCccCCeEECCCCcCCCcccchhhhCcccCCEEE
Confidence 999999999999766 78899999999999999999999999999999999999999999977654 489999999999
Q ss_pred ccCCcCcCCCCccccCCCCCCeEEccCCCCCCCC---ccccccc-cccEEEcccccccCCCCccccCCCCCcEEEccCCc
Q 004400 167 IQPSGLAGPIPSGIFSLENLTDLRISDLNGPEAT---FPQLGNM-KMTKLILRNCNITGELPRYLGKMTKLKVLDLSFNR 242 (756)
Q Consensus 167 l~~N~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~---~~~~~~~-~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~ 242 (756)
+++|.+.+..|..+..+++|++|++++|.+.... ...+... +|+.|+|++|.+++..|..|.++++|+.|+|++|+
T Consensus 432 l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~ 511 (606)
T 3t6q_A 432 LSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNR 511 (606)
T ss_dssp CTTCCCBTTCTTTTTTCTTCCEEECTTCBCGGGEECSSCGGGGCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSC
T ss_pred CCCCccCCcCHHHHhCCCCCCEEECCCCCCCccccccchhhccCCCccEEECCCCccCccChhhhccccCCCEEECCCCc
Confidence 9999999989999999999999999999998632 2345544 69999999999999999999999999999999999
Q ss_pred CCCCCCccCcCCCCCCeEEecCccccccCCchh--hcCCCeeEeecCCCCCCCC
Q 004400 243 LRGQIPSNFDDLYDVDYIYFAGNLLTGAIPPWM--LERGDKIDLSYNNFTDGSA 294 (756)
Q Consensus 243 l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~--~~~l~~l~ls~N~l~~~~~ 294 (756)
+++..|..+..+++| .|++++|.+++..|..+ ++.++.+++++|++.|...
T Consensus 512 l~~~~~~~l~~l~~L-~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~ 564 (606)
T 3t6q_A 512 LTSSSIEALSHLKGI-YLNLASNHISIILPSLLPILSQQRTINLRQNPLDCTCS 564 (606)
T ss_dssp CCGGGGGGGTTCCSC-EEECCSSCCCCCCGGGHHHHHTSSEEECTTCCEECSGG
T ss_pred cCcCChhHhCccccc-EEECcCCcccccCHhhcccCCCCCEEeCCCCCccccCC
Confidence 999999999999999 99999999998777765 7899999999999987643
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=7.3e-31 Score=304.03 Aligned_cols=116 Identities=21% Similarity=0.198 Sum_probs=83.6
Q ss_pred eeccceeccccccccCcccccCCcccCCCCCCCEEEccCCcccCccCcccccCCcce-eeccCccccccCCccCcCcCCC
Q 004400 12 FWKQKTVNQKRVLKEQNLTGVLPPKLAELTFLQDIDLTLNYLSGTIPSQWASLPLLN-ISLIANRLKGPIPKYLANISTL 90 (756)
Q Consensus 12 ~~~~~~~~~~l~L~~~~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~-l~l~~n~~~~~~p~~l~~l~~L 90 (756)
.|.+++.++.|+|++|++++..|..|.++++|++|+|++|.+++..|..|..++.|+ |++.+|++.+..+..|+++++|
T Consensus 51 ~~~~l~~L~~L~Ls~n~l~~i~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L 130 (606)
T 3vq2_A 51 SFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITL 130 (606)
T ss_dssp TTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCCCCTTSSTTCTTCCEEECTTSCCCCSSSSCCTTCTTC
T ss_pred hccCCccCcEEeCCCCcccccCHHHhhchhhcCEeECCCCcccccChhhcCCcccCCEEEccCCccccccccccCCCCCC
Confidence 466777777777777777777777777777777777777777766677777777774 6777777776666667777777
Q ss_pred cEEEeecCcccc-cCCcccCCCCCCcEEeccCCeeccc
Q 004400 91 VNLTVQYNQFSG-ELPEELGSLLNLEKLHLSSNNFTGE 127 (756)
Q Consensus 91 ~~L~L~~N~l~~-~~p~~~~~l~~L~~L~L~~N~l~~~ 127 (756)
++|+|++|.+++ .+|..|+++++|++|+|++|++++.
T Consensus 131 ~~L~L~~n~l~~~~lp~~~~~l~~L~~L~Ls~n~l~~~ 168 (606)
T 3vq2_A 131 KKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTI 168 (606)
T ss_dssp CEEECCSSCCCCCCCCGGGGTCTTCCEEECCSSCCCEE
T ss_pred CEEeCCCCcccceechHhHhhcCCCCEEEccCCcceec
Confidence 777777777764 4567777777777777777766543
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=99.97 E-value=4.5e-31 Score=306.39 Aligned_cols=295 Identities=17% Similarity=0.209 Sum_probs=232.0
Q ss_pred eeeccceeccccccccCc-ccc-cCCcccCCC------CCCCEEEccCCcccCccCc--ccccCCcc-eeeccCcccccc
Q 004400 11 HFWKQKTVNQKRVLKEQN-LTG-VLPPKLAEL------TFLQDIDLTLNYLSGTIPS--QWASLPLL-NISLIANRLKGP 79 (756)
Q Consensus 11 ~~~~~~~~~~~l~L~~~~-l~~-~~p~~l~~l------~~L~~L~L~~n~l~~~~p~--~~~~l~~L-~l~l~~n~~~~~ 79 (756)
..+.+++.++.|+|++|+ ++| .+|..+.++ ++|+.|+|++|+++ .+|. .+..++.| .|++.+|++.|.
T Consensus 267 ~~l~~l~~L~~L~Ls~n~~l~~~~lp~~~~~L~~~~~l~~L~~L~L~~n~l~-~ip~~~~l~~l~~L~~L~L~~N~l~g~ 345 (636)
T 4eco_A 267 TFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLK-TFPVETSLQKMKKLGMLECLYNQLEGK 345 (636)
T ss_dssp TTTTTCSSCCEEECTTCTTSCHHHHHHHHHHHHHSGGGGTCCEEECCSSCCS-SCCCHHHHTTCTTCCEEECCSCCCEEE
T ss_pred HHHhcCCCCCEEECcCCCCCccccchHHHHhhhccccCCCCCEEECCCCcCC-ccCchhhhccCCCCCEEeCcCCcCccc
Confidence 457788889999999998 888 888888776 88899999999888 7887 88888888 488888888888
Q ss_pred CCccCcCcCCCcEEEeecCcccccCCcccCCCCC-CcEEeccCCeecccCCccccCCC--CCCEEEeeCCcccccCChhh
Q 004400 80 IPKYLANISTLVNLTVQYNQFSGELPEELGSLLN-LEKLHLSSNNFTGELPKTFAKLT--NMKDFRISDNQFTGQIPSFI 156 (756)
Q Consensus 80 ~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~-L~~L~L~~N~l~~~~p~~~~~l~--~L~~L~L~~N~l~~~~p~~~ 156 (756)
+| .|+++++|++|+|++|+++ .+|..|+++++ |++|+|++|+++ .+|..+..++ +|+.|+|++|++++.+|..|
T Consensus 346 ip-~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~~L~~L~Ls~N~l~-~lp~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l 422 (636)
T 4eco_A 346 LP-AFGSEIKLASLNLAYNQIT-EIPANFCGFTEQVENLSFAHNKLK-YIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNF 422 (636)
T ss_dssp CC-CCEEEEEESEEECCSSEEE-ECCTTSEEECTTCCEEECCSSCCS-SCCSCCCTTCSSCEEEEECCSSCTTTTTTCSS
T ss_pred hh-hhCCCCCCCEEECCCCccc-cccHhhhhhcccCcEEEccCCcCc-ccchhhhhcccCccCEEECcCCcCCCcchhhh
Confidence 88 8888888888888888888 78888888888 888888888888 7787777654 88888888888888888888
Q ss_pred c-------CcCCCcEEEccCCcCcCCCCcc-ccCCCCCCeEEccCCCCCCCCccccccc--------cccEEEccccccc
Q 004400 157 Q-------NWTKLEKLFIQPSGLAGPIPSG-IFSLENLTDLRISDLNGPEATFPQLGNM--------KMTKLILRNCNIT 220 (756)
Q Consensus 157 ~-------~l~~L~~L~l~~N~l~~~~p~~-~~~l~~L~~L~l~~n~~~~~~~~~~~~~--------~L~~L~L~~n~l~ 220 (756)
. .+++|+.|+|++|+++ .+|.. +..+++|+.|++++|.+...+...+... +|+.|+|++|.++
T Consensus 423 ~~~~~~~~~~~~L~~L~Ls~N~l~-~lp~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~ 501 (636)
T 4eco_A 423 DPLDPTPFKGINVSSINLSNNQIS-KFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENENFKNTYLLTSIDLRFNKLT 501 (636)
T ss_dssp CTTCSSCCCCCCEEEEECCSSCCC-SCCTHHHHTTCCCSEEECCSSCCSBCCSSSSEETTEECTTGGGCCEEECCSSCCC
T ss_pred cccccccccCCCCCEEECcCCccC-cCCHHHHccCCCCCEEECCCCCCCCcCHHHhccccccccccCCccEEECcCCcCC
Confidence 7 7788888888888888 45554 4458888888888888886665555543 6888888888888
Q ss_pred CCCCcccc--CCCCCcEEEccCCcCCCCCCccCcCCCCCCeEEe------cCccccccCCchh--hcCCCeeEeecCCCC
Q 004400 221 GELPRYLG--KMTKLKVLDLSFNRLRGQIPSNFDDLYDVDYIYF------AGNLLTGAIPPWM--LERGDKIDLSYNNFT 290 (756)
Q Consensus 221 ~~~p~~~~--~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l------s~N~l~~~~p~~~--~~~l~~l~ls~N~l~ 290 (756)
.+|..+. .+++|+.|+|++|++++ +|..+..+++|+.|+| ++|.+.+.+|.++ +++|+.|++++|++.
T Consensus 502 -~lp~~~~~~~l~~L~~L~Ls~N~l~~-ip~~~~~l~~L~~L~Ls~N~~ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~ 579 (636)
T 4eco_A 502 -KLSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSNDIR 579 (636)
T ss_dssp -BCCGGGSTTTCTTCCEEECCSSCCSS-CCCGGGGCSSCCEEECCSCBCTTCCBCCCCCCTTGGGCSSCCEEECCSSCCC
T ss_pred -ccChhhhhccCCCcCEEECCCCCCCC-cChhhhcCCCCCEEECCCCcccccCcccccChHHHhcCCCCCEEECCCCcCC
Confidence 6777776 88888888888888886 7888888888888888 5677788888777 778888888888885
Q ss_pred CCCCcccccccCccccccccccccc
Q 004400 291 DGSAESSCQKRSVTGIVSCLRSVQC 315 (756)
Q Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~c 315 (756)
..+. ..+ ..+..+....++..|
T Consensus 580 ~ip~-~~~--~~L~~L~Ls~N~l~~ 601 (636)
T 4eco_A 580 KVNE-KIT--PNISVLDIKDNPNIS 601 (636)
T ss_dssp BCCS-CCC--TTCCEEECCSCTTCE
T ss_pred ccCH-hHh--CcCCEEECcCCCCcc
Confidence 4432 222 344444444444443
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=99.97 E-value=2.9e-31 Score=308.04 Aligned_cols=289 Identities=21% Similarity=0.238 Sum_probs=253.0
Q ss_pred eeec--cceeccccccccCcccccCCcccCCCCCCCEEEccCCc-ccC-ccCcccccC------Ccc-eeeccCcccccc
Q 004400 11 HFWK--QKTVNQKRVLKEQNLTGVLPPKLAELTFLQDIDLTLNY-LSG-TIPSQWASL------PLL-NISLIANRLKGP 79 (756)
Q Consensus 11 ~~~~--~~~~~~~l~L~~~~l~~~~p~~l~~l~~L~~L~L~~n~-l~~-~~p~~~~~l------~~L-~l~l~~n~~~~~ 79 (756)
..+. +++.++.|+|++|++.+.+|+.|.++++|+.|+|++|+ +++ .+|..+..+ +.| .|++.+|++. .
T Consensus 241 ~~l~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~~l~~~~lp~~~~~L~~~~~l~~L~~L~L~~n~l~-~ 319 (636)
T 4eco_A 241 EDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLK-T 319 (636)
T ss_dssp SCCCGGGCTTCCEEEEECCTTCSSCCTTTTTCSSCCEEECTTCTTSCHHHHHHHHHHHHHSGGGGTCCEEECCSSCCS-S
T ss_pred hhhhhcccCCCCEEEecCCcCCccChHHHhcCCCCCEEECcCCCCCccccchHHHHhhhccccCCCCCEEECCCCcCC-c
Confidence 4455 89999999999999999999999999999999999998 998 899988876 777 5899999999 8
Q ss_pred CCc--cCcCcCCCcEEEeecCcccccCCcccCCCCCCcEEeccCCeecccCCccccCCCC-CCEEEeeCCcccccCChhh
Q 004400 80 IPK--YLANISTLVNLTVQYNQFSGELPEELGSLLNLEKLHLSSNNFTGELPKTFAKLTN-MKDFRISDNQFTGQIPSFI 156 (756)
Q Consensus 80 ~p~--~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~-L~~L~L~~N~l~~~~p~~~ 156 (756)
+|. .|+++++|+.|+|++|+++|.+| .|+++++|++|+|++|+++ .+|..+..+++ |+.|+|++|+++ .+|..+
T Consensus 320 ip~~~~l~~l~~L~~L~L~~N~l~g~ip-~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~~L~~L~Ls~N~l~-~lp~~~ 396 (636)
T 4eco_A 320 FPVETSLQKMKKLGMLECLYNQLEGKLP-AFGSEIKLASLNLAYNQIT-EIPANFCGFTEQVENLSFAHNKLK-YIPNIF 396 (636)
T ss_dssp CCCHHHHTTCTTCCEEECCSCCCEEECC-CCEEEEEESEEECCSSEEE-ECCTTSEEECTTCCEEECCSSCCS-SCCSCC
T ss_pred cCchhhhccCCCCCEEeCcCCcCccchh-hhCCCCCCCEEECCCCccc-cccHhhhhhcccCcEEEccCCcCc-ccchhh
Confidence 998 99999999999999999999999 9999999999999999999 89999999999 999999999999 888888
Q ss_pred cCcC--CCcEEEccCCcCcCCCCcccc-------CCCCCCeEEccCCCCCCCCcccccc-ccccEEEcccccccCCCCcc
Q 004400 157 QNWT--KLEKLFIQPSGLAGPIPSGIF-------SLENLTDLRISDLNGPEATFPQLGN-MKMTKLILRNCNITGELPRY 226 (756)
Q Consensus 157 ~~l~--~L~~L~l~~N~l~~~~p~~~~-------~l~~L~~L~l~~n~~~~~~~~~~~~-~~L~~L~L~~n~l~~~~p~~ 226 (756)
..++ +|+.|++++|++++..|..+. .+++|+.|++++|.+...+...+.. .+|+.|+|++|.++...+..
T Consensus 397 ~~~~l~~L~~L~Ls~N~l~~~~p~~l~~~~~~~~~~~~L~~L~Ls~N~l~~lp~~~~~~l~~L~~L~Ls~N~l~~i~~~~ 476 (636)
T 4eco_A 397 DAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNS 476 (636)
T ss_dssp CTTCSSCEEEEECCSSCTTTTTTCSSCTTCSSCCCCCCEEEEECCSSCCCSCCTHHHHTTCCCSEEECCSSCCSBCCSSS
T ss_pred hhcccCccCEEECcCCcCCCcchhhhcccccccccCCCCCEEECcCCccCcCCHHHHccCCCCCEEECCCCCCCCcCHHH
Confidence 8765 999999999999999999888 8899999999999999776666664 46999999999999443344
Q ss_pred ccCCC-------CCcEEEccCCcCCCCCCccCc--CCCCCCeEEecCccccccCCchh--hcCCCeeEee------cCCC
Q 004400 227 LGKMT-------KLKVLDLSFNRLRGQIPSNFD--DLYDVDYIYFAGNLLTGAIPPWM--LERGDKIDLS------YNNF 289 (756)
Q Consensus 227 ~~~l~-------~L~~L~Ls~N~l~~~~p~~~~--~l~~L~~L~ls~N~l~~~~p~~~--~~~l~~l~ls------~N~l 289 (756)
+..+. +|+.|+|++|+++ .+|..+. .+++|+.|+|++|++++ +|..+ +++|+.|+++ +|++
T Consensus 477 ~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~~~l~~L~~L~Ls~N~l~~-ip~~~~~l~~L~~L~Ls~N~~ls~N~l 554 (636)
T 4eco_A 477 LKDENENFKNTYLLTSIDLRFNKLT-KLSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQRDAQGNRT 554 (636)
T ss_dssp SEETTEECTTGGGCCEEECCSSCCC-BCCGGGSTTTCTTCCEEECCSSCCSS-CCCGGGGCSSCCEEECCSCBCTTCCBC
T ss_pred hccccccccccCCccEEECcCCcCC-ccChhhhhccCCCcCEEECCCCCCCC-cChhhhcCCCCCEEECCCCcccccCcc
Confidence 44333 9999999999999 7888887 99999999999999997 88877 7899999995 4666
Q ss_pred CCCCCcccccccCccc
Q 004400 290 TDGSAESSCQKRSVTG 305 (756)
Q Consensus 290 ~~~~~~~~~~~~~~~~ 305 (756)
.+..+...+....+..
T Consensus 555 ~~~~p~~l~~l~~L~~ 570 (636)
T 4eco_A 555 LREWPEGITLCPSLTQ 570 (636)
T ss_dssp CCCCCTTGGGCSSCCE
T ss_pred cccChHHHhcCCCCCE
Confidence 6665555554444443
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.97 E-value=3.6e-30 Score=304.14 Aligned_cols=266 Identities=19% Similarity=0.250 Sum_probs=189.1
Q ss_pred eccceeccccccccCcccccCCcccCCCCCCCEEEccCCc-ccC-ccCcccccCC-------cc-eeeccCccccccCCc
Q 004400 13 WKQKTVNQKRVLKEQNLTGVLPPKLAELTFLQDIDLTLNY-LSG-TIPSQWASLP-------LL-NISLIANRLKGPIPK 82 (756)
Q Consensus 13 ~~~~~~~~~l~L~~~~l~~~~p~~l~~l~~L~~L~L~~n~-l~~-~~p~~~~~l~-------~L-~l~l~~n~~~~~~p~ 82 (756)
|.+++.++.|+|++|++.+.+|..|.++++|+.|+|++|+ +++ .+|..+..++ .| .|++.+|++. .+|.
T Consensus 487 f~~L~~L~~L~Ls~N~l~~~iP~~l~~L~~L~~L~Ls~N~~lsg~~iP~~i~~L~~~~~~l~~L~~L~Ls~N~L~-~ip~ 565 (876)
T 4ecn_A 487 WSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLE-EFPA 565 (876)
T ss_dssp GGGCTTCCEEEEESCTTCCSCCGGGGGCSSCCEEECTTCTTSCHHHHHHHHHHHHHCTTTTTTCCEEECCSSCCC-BCCC
T ss_pred hccCCCCCEEECcCCCCCccChHHHhCCCCCCEEECcCCCCcccccchHHHHhhhhcccccCCccEEEeeCCcCC-ccCC
Confidence 3499999999999999999999999999999999999998 998 8898777765 77 5899999999 8898
Q ss_pred --cCcCcCCCcEEEeecCcccccCCcccCCCCCCcEEeccCCeecccCCccccCCCC-CCEEEeeCCcccccCChhhcCc
Q 004400 83 --YLANISTLVNLTVQYNQFSGELPEELGSLLNLEKLHLSSNNFTGELPKTFAKLTN-MKDFRISDNQFTGQIPSFIQNW 159 (756)
Q Consensus 83 --~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~-L~~L~L~~N~l~~~~p~~~~~l 159 (756)
.|+++++|+.|+|++|+|+ .+| .|+++++|+.|+|++|+++ .+|..+..+++ |+.|+|++|+|+ .+|..+..+
T Consensus 566 ~~~l~~L~~L~~L~Ls~N~l~-~lp-~~~~L~~L~~L~Ls~N~l~-~lp~~l~~l~~~L~~L~Ls~N~L~-~lp~~~~~~ 641 (876)
T 4ecn_A 566 SASLQKMVKLGLLDCVHNKVR-HLE-AFGTNVKLTDLKLDYNQIE-EIPEDFCAFTDQVEGLGFSHNKLK-YIPNIFNAK 641 (876)
T ss_dssp HHHHTTCTTCCEEECTTSCCC-BCC-CCCTTSEESEEECCSSCCS-CCCTTSCEECTTCCEEECCSSCCC-SCCSCCCTT
T ss_pred hhhhhcCCCCCEEECCCCCcc-cch-hhcCCCcceEEECcCCccc-cchHHHhhccccCCEEECcCCCCC-cCchhhhcc
Confidence 9999999999999999999 888 8999999999999999999 89988999999 999999999999 788887776
Q ss_pred CC--CcEEEccCCcCcCCCCccc---c--CCCCCCeEEccCCCCCCCCcccccc-ccccEEEcccccccCCCCccccC-C
Q 004400 160 TK--LEKLFIQPSGLAGPIPSGI---F--SLENLTDLRISDLNGPEATFPQLGN-MKMTKLILRNCNITGELPRYLGK-M 230 (756)
Q Consensus 160 ~~--L~~L~l~~N~l~~~~p~~~---~--~l~~L~~L~l~~n~~~~~~~~~~~~-~~L~~L~L~~n~l~~~~p~~~~~-l 230 (756)
+. |+.|+|++|++.+.+|... . .+++|+.|++++|.+...+...+.. .+|+.|+|++|.++ .+|..+.. .
T Consensus 642 ~~~~L~~L~Ls~N~l~g~ip~l~~~l~~~~~~~L~~L~Ls~N~L~~lp~~~~~~l~~L~~L~Ls~N~L~-~ip~~~~~~~ 720 (876)
T 4ecn_A 642 SVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMT-SIPENSLKPK 720 (876)
T ss_dssp CSSCEEEEECCSSCTTTTSSSCSSCTTTCCCCCEEEEECCSSCCCSCCHHHHHTTCCCSEEECCSCCCS-CCCTTSSSCT
T ss_pred ccCCCCEEECcCCcCCCccccchhhhccccCCCcCEEEccCCcCCccCHHHHccCCCCCEEECCCCcCC-ccChHHhccc
Confidence 54 8888888888876544221 1 2335555555555555433333322 23555555555555 23322211 1
Q ss_pred -------CCCcEEEccCCcCCCCCCccCc--CCCCCCeEEecCccccccCCchh--hcCCCeeEeec
Q 004400 231 -------TKLKVLDLSFNRLRGQIPSNFD--DLYDVDYIYFAGNLLTGAIPPWM--LERGDKIDLSY 286 (756)
Q Consensus 231 -------~~L~~L~Ls~N~l~~~~p~~~~--~l~~L~~L~ls~N~l~~~~p~~~--~~~l~~l~ls~ 286 (756)
++|+.|+|++|+|+ .+|..+. .+++|+.|+|++|.+++ +|..+ +++|+.|++++
T Consensus 721 ~~~l~nl~~L~~L~Ls~N~L~-~lp~~l~~~~l~~L~~L~Ls~N~L~~-lp~~l~~L~~L~~L~Ls~ 785 (876)
T 4ecn_A 721 DGNYKNTYLLTTIDLRFNKLT-SLSDDFRATTLPYLSNMDVSYNCFSS-FPTQPLNSSQLKAFGIRH 785 (876)
T ss_dssp TSCCTTGGGCCEEECCSSCCC-CCCGGGSTTTCTTCCEEECCSSCCSS-CCCGGGGCTTCCEEECCC
T ss_pred cccccccCCccEEECCCCCCc-cchHHhhhccCCCcCEEEeCCCCCCc-cchhhhcCCCCCEEECCC
Confidence 14555555555555 3444443 45555555555555543 34333 44445555443
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=3.7e-30 Score=292.43 Aligned_cols=157 Identities=15% Similarity=0.098 Sum_probs=77.2
Q ss_pred CcCCCcEEEccCCcCcCCCCccccCCCCCCeEEccCCCCCCCC--ccccccc-cccEEEcccccccCCCCc-cccCCCCC
Q 004400 158 NWTKLEKLFIQPSGLAGPIPSGIFSLENLTDLRISDLNGPEAT--FPQLGNM-KMTKLILRNCNITGELPR-YLGKMTKL 233 (756)
Q Consensus 158 ~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~--~~~~~~~-~L~~L~L~~n~l~~~~p~-~~~~l~~L 233 (756)
.+++|++|++++|++++..|..+..+++|++|++++|.+.... +..+..+ +|+.|+|++|.+++.+|. .+..+++|
T Consensus 322 ~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~L 401 (520)
T 2z7x_B 322 KISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSL 401 (520)
T ss_dssp SCCCCCEEECCSSCCCTTTTTTCCCCSSCCEEECCSSCCCBHHHHHHHHTTCTTCCEEECCSSCCBCCGGGCSCCCCTTC
T ss_pred hCCcccEEEeECCccChhhhhhhccCCCCCEEEccCCccCccccchHHHhhCCCCCEEECCCCcCCcccccchhccCccC
Confidence 4445555555555555445555555555555555555554321 1222222 355555555555543333 24455555
Q ss_pred cEEEccCCcCCCCCCccCcCCCCCCeEEecCccccccCCchh--hcCCCeeEeecCCCCCCCCcccccccCccccccccc
Q 004400 234 KVLDLSFNRLRGQIPSNFDDLYDVDYIYFAGNLLTGAIPPWM--LERGDKIDLSYNNFTDGSAESSCQKRSVTGIVSCLR 311 (756)
Q Consensus 234 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~--~~~l~~l~ls~N~l~~~~~~~~~~~~~~~~~~~~~~ 311 (756)
+.|+|++|++++.+|..+. ++|+.|++++|.++ .+|.++ +++++.|++++|+++..+.........+..+....+
T Consensus 402 ~~L~Ls~N~l~~~~~~~l~--~~L~~L~Ls~N~l~-~ip~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~l~~N 478 (520)
T 2z7x_B 402 LSLNMSSNILTDTIFRCLP--PRIKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQLKSVPDGIFDRLTSLQKIWLHTN 478 (520)
T ss_dssp CEEECCSSCCCGGGGGSCC--TTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred CEEECcCCCCCcchhhhhc--ccCCEEECCCCccc-ccchhhhcCCCCCEEECCCCcCCccCHHHhccCCcccEEECcCC
Confidence 5555555555544444332 45555555555555 455443 455666666666666444332333334444444445
Q ss_pred ccccCC
Q 004400 312 SVQCPK 317 (756)
Q Consensus 312 ~~~c~~ 317 (756)
++.|.+
T Consensus 479 ~~~c~c 484 (520)
T 2z7x_B 479 PWDCSC 484 (520)
T ss_dssp CBCCCH
T ss_pred CCcccC
Confidence 555543
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.2e-29 Score=291.00 Aligned_cols=296 Identities=17% Similarity=0.159 Sum_probs=172.4
Q ss_pred eeccccccccCcccccCCcccCCCCCCCEEEccCCcccCccCcccccCCcce-eeccCccccccCCccCcCcCCCcEEEe
Q 004400 17 TVNQKRVLKEQNLTGVLPPKLAELTFLQDIDLTLNYLSGTIPSQWASLPLLN-ISLIANRLKGPIPKYLANISTLVNLTV 95 (756)
Q Consensus 17 ~~~~~l~L~~~~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~-l~l~~n~~~~~~p~~l~~l~~L~~L~L 95 (756)
..++.|+|++|++++..|..|..+++|++|+|++|+|++..|..|..++.|+ |++++|++. .+|.. .+++|++|+|
T Consensus 52 ~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~--~l~~L~~L~L 128 (562)
T 3a79_B 52 PRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDLEYLDVSHNRLQ-NISCC--PMASLRHLDL 128 (562)
T ss_dssp TTCCEEECCSSCCCCCCGGGTTTCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECTTSCCC-EECSC--CCTTCSEEEC
T ss_pred CCcCEEECCCCCccccChhhhccCCCccEEECCCCCCCcCCHHHhCCCCCCCEEECCCCcCC-ccCcc--ccccCCEEEC
Confidence 4566666666666666556666666666666666666655566666666663 566666655 44444 5666666666
Q ss_pred ecCcccc-cCCcccCCCCCCcEEeccCCeecc-------------------------cCCccccCCC-------------
Q 004400 96 QYNQFSG-ELPEELGSLLNLEKLHLSSNNFTG-------------------------ELPKTFAKLT------------- 136 (756)
Q Consensus 96 ~~N~l~~-~~p~~~~~l~~L~~L~L~~N~l~~-------------------------~~p~~~~~l~------------- 136 (756)
++|++++ .+|..|+++++|++|+|++|++++ ..|..|..+.
T Consensus 129 s~N~l~~l~~p~~~~~l~~L~~L~L~~n~l~~~~~~~l~~L~L~~L~L~~n~l~~~~~~~~~l~~l~~~~l~l~l~~n~~ 208 (562)
T 3a79_B 129 SFNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQLDLLPVAHLHLSCILLDLVSYHIKGGETESLQIPNTTVLHLVFHPNSL 208 (562)
T ss_dssp CSSCCSBCCCCGGGGGCTTCCEEEEECSBCCTTTTGGGTTSCEEEEEEEESSCCCCSSSCCEEEECCEEEEEEEECSSSC
T ss_pred CCCCccccCchHhhcccCcccEEecCCCccccCchhhhhhceeeEEEeecccccccccCcccccccCcceEEEEecCccc
Confidence 6666664 234566666666666666665543 3333333222
Q ss_pred --------------------------------------------------------------------CCCEEEeeCCcc
Q 004400 137 --------------------------------------------------------------------NMKDFRISDNQF 148 (756)
Q Consensus 137 --------------------------------------------------------------------~L~~L~L~~N~l 148 (756)
+|++|++++|++
T Consensus 209 ~~~~~~~~~~~l~~L~~L~l~~n~~~~~~l~~~~~~l~~l~~L~~L~L~~~~l~~~~~~~~~~~~~~~~L~~L~l~~n~l 288 (562)
T 3a79_B 209 FSVQVNMSVNALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPRPVEYLNIYNLTI 288 (562)
T ss_dssp CCCCCEEEESSEEEEEEEEEECCSTTHHHHHHHHHHHHSCSSCEEEEEEEEEECHHHHHHHHHHHTTSSEEEEEEEEEEE
T ss_pred hhhhhhhcccccceEEEecccccccccchHHHHHHHHhccCcceEEEecCCcCcHHHHHHHHHhhhcccccEEEEeccEe
Confidence 444555555555
Q ss_pred cccCChhh-----------------------------------------------------cCcCCCcEEEccCCcCcCC
Q 004400 149 TGQIPSFI-----------------------------------------------------QNWTKLEKLFIQPSGLAGP 175 (756)
Q Consensus 149 ~~~~p~~~-----------------------------------------------------~~l~~L~~L~l~~N~l~~~ 175 (756)
+|.+|..+ ..+++|++|++++|++++.
T Consensus 289 ~~~ip~~~~~~~~~~L~~L~~~~~~~~~~~~p~~~~~~~~~~~~L~~L~l~~n~~~~~~~~~~l~~L~~L~l~~n~l~~~ 368 (562)
T 3a79_B 289 TERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDTPFIHMVCPPSPSSFTFLNFTQNVFTDS 368 (562)
T ss_dssp CSCCCCCCCCCCSCSCCEEEEEEEEECCCSSCHHHHHHHHHTCCCSEEEEESSCCCCCCCCSSCCCCCEEECCSSCCCTT
T ss_pred eccccchhhhcccccchheehhhcccceeecChhhhhhhhccCcceEEEccCCCcccccCccCCCCceEEECCCCccccc
Confidence 55454433 4556666666666666666
Q ss_pred CCccccCCCCCCeEEccCCCCCCCCc--cccccc-cccEEEcccccccCCCC-ccccCCCCCcEEEccCCcCCCCCCccC
Q 004400 176 IPSGIFSLENLTDLRISDLNGPEATF--PQLGNM-KMTKLILRNCNITGELP-RYLGKMTKLKVLDLSFNRLRGQIPSNF 251 (756)
Q Consensus 176 ~p~~~~~l~~L~~L~l~~n~~~~~~~--~~~~~~-~L~~L~L~~n~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~p~~~ 251 (756)
.|..+.++++|+.|++++|.+..... ..+... +|+.|+|++|.+++.+| ..+..+++|+.|+|++|++++.+|..+
T Consensus 369 ~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l 448 (562)
T 3a79_B 369 VFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCL 448 (562)
T ss_dssp TTTTCCSCSSCCEEECCSSCCCBTTHHHHTTTTCTTCCEEECTTSCCBSCCSSCCCCCCTTCCEEECCSSCCCGGGGSSC
T ss_pred hhhhhcccCCCCEEECCCCCcCCcccchhhhcCCCCCCEEECCCCcCCCccChhhhcCcccCCEEECCCCCCCcchhhhh
Confidence 66666666666666666666665432 223332 46666666666665333 335666666666666666665555443
Q ss_pred cCCCCCCeEEecCccccccCCchh--hcCCCeeEeecCCCCCCCCcccccccCcccccccccccccCCc
Q 004400 252 DDLYDVDYIYFAGNLLTGAIPPWM--LERGDKIDLSYNNFTDGSAESSCQKRSVTGIVSCLRSVQCPKT 318 (756)
Q Consensus 252 ~~l~~L~~L~ls~N~l~~~~p~~~--~~~l~~l~ls~N~l~~~~~~~~~~~~~~~~~~~~~~~~~c~~~ 318 (756)
. ++|+.|++++|.++ .+|..+ ++.++.|++++|+++..+.........+..+....+++.|.+.
T Consensus 449 ~--~~L~~L~L~~N~l~-~ip~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~l~~N~~~c~c~ 514 (562)
T 3a79_B 449 P--PKVKVLDLHNNRIM-SIPKDVTHLQALQELNVASNQLKSVPDGVFDRLTSLQYIWLHDNPWDCTCP 514 (562)
T ss_dssp C--TTCSEEECCSSCCC-CCCTTTTSSCCCSEEECCSSCCCCCCTTSTTTCTTCCCEECCSCCBCCCHH
T ss_pred c--CcCCEEECCCCcCc-ccChhhcCCCCCCEEECCCCCCCCCCHHHHhcCCCCCEEEecCCCcCCCcc
Confidence 3 56677777777766 555544 5667777777777775554433444445555555566666543
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.1e-29 Score=304.72 Aligned_cols=278 Identities=20% Similarity=0.216 Sum_probs=167.7
Q ss_pred eeccccccccCcccccCCcccCCCCCCCEEEccCCcccCcc-CcccccCCcce-eeccCccccccCCccCcCcCCCcEEE
Q 004400 17 TVNQKRVLKEQNLTGVLPPKLAELTFLQDIDLTLNYLSGTI-PSQWASLPLLN-ISLIANRLKGPIPKYLANISTLVNLT 94 (756)
Q Consensus 17 ~~~~~l~L~~~~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~-p~~~~~l~~L~-l~l~~n~~~~~~p~~l~~l~~L~~L~ 94 (756)
..++.|+|++|.+++..|..|.++++|++|+|++|.+.+.+ |..|..++.|+ |++.+|++.+..|..|.++++|++|+
T Consensus 24 ~~l~~LdLs~N~i~~i~~~~~~~l~~L~~LdLs~n~~~~~i~~~~f~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 103 (844)
T 3j0a_A 24 NTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFELR 103 (844)
T ss_dssp TTCCEEEEESCCCCEECSSSCSSCCSCSEEEECTTCCCCEECTTTTSSCTTCCEEECTTCCCCEECTTSSCSCSSCCCEE
T ss_pred CCcCEEECCCCcCCccChhHCcccccCeEEeCCCCCCccccCHHHhcCCCCCCEEECCCCcCcccCHhHccCCcccCEee
Confidence 56677777777777777777777777777777777554444 66677777774 67777777777777777777777777
Q ss_pred eecCcccccCCcc--cCCCCCCcEEeccCCeecccCC-ccccCCCCCCEEEeeCCcccccCChhhcCc--CCCcEEEccC
Q 004400 95 VQYNQFSGELPEE--LGSLLNLEKLHLSSNNFTGELP-KTFAKLTNMKDFRISDNQFTGQIPSFIQNW--TKLEKLFIQP 169 (756)
Q Consensus 95 L~~N~l~~~~p~~--~~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l--~~L~~L~l~~ 169 (756)
|++|.+++.+|.. |+++++|++|+|++|.+++..+ ..|+++++|++|+|++|++++..+..|..+ ++|+.|+|++
T Consensus 104 Ls~n~l~~~~~~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~L~~L~~L~Ls~N~i~~~~~~~l~~l~~~~L~~L~L~~ 183 (844)
T 3j0a_A 104 LYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAA 183 (844)
T ss_dssp CTTCCCSSCCSTTCCCSSCSSCCEEEEESCCCCCCCCCGGGGTCSSCCEEEEESSCCCCCCSGGGHHHHHCSSCCCEECC
T ss_pred CcCCCCCcccccCccccccCCCCEEECCCCcccccccchhHhhCCCCCEEECCCCcCCeeCHHHcccccCCccceEECCC
Confidence 7777777655544 7777777777777777765544 457777777777777777776666666665 6666666666
Q ss_pred CcCcCCCCccccCCCC------CCeEEccCCCCCCCCccccc--------------------------------------
Q 004400 170 SGLAGPIPSGIFSLEN------LTDLRISDLNGPEATFPQLG-------------------------------------- 205 (756)
Q Consensus 170 N~l~~~~p~~~~~l~~------L~~L~l~~n~~~~~~~~~~~-------------------------------------- 205 (756)
|.+.+..|..+..+.+ |+.|++++|.+....+..+.
T Consensus 184 n~l~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~l~~~~l~~L~l~~~~~~~~~~~~~l~~~~~~~f~~l 263 (844)
T 3j0a_A 184 NSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNIKDPDQNTFAGL 263 (844)
T ss_dssp SBSCCCCCCCCCSSSCTTTTCCBSEEBCSSCCSSTTTTSGGGGTSCSCCBSEEECCSSCCBCSSSCSSSTTGGGTTTTTT
T ss_pred CccccccccchhhcCCccccCceeEEecCCCcCchhHHHHHHhhcCcccccceecccccccccccccccCCCChhhhhcc
Confidence 6666655555554444 55555555543321111100
Q ss_pred -cccccEEEcccccccCCCCccccCCCCCcEEEccCCcCCCCCCccCcCCCCCCeEEecCccccccCCchh--hcCCCee
Q 004400 206 -NMKMTKLILRNCNITGELPRYLGKMTKLKVLDLSFNRLRGQIPSNFDDLYDVDYIYFAGNLLTGAIPPWM--LERGDKI 282 (756)
Q Consensus 206 -~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~--~~~l~~l 282 (756)
..+|+.|+|++|.+.+..+..|..+++|+.|+|++|.+++..|..|..+++|++|+|++|.+++..|..+ +++++.|
T Consensus 264 ~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L 343 (844)
T 3j0a_A 264 ARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYI 343 (844)
T ss_dssp TTSCCCEEECTTCCCCEECSCCSSSCCCCCEEEEESCCCCEECTTTTTTCSSCCEEEEESCCCSCCCSCSCSSCTTCCEE
T ss_pred ccCCccEEECCCCcccccChhhhhcCCCCCEEECCCCcCCCCChHHhcCCCCCCEEECCCCCCCccCHHHhcCCCCCCEE
Confidence 1134555555555554445555555555555555555554445555555555555555555544444433 4445555
Q ss_pred EeecCCCCCCCC
Q 004400 283 DLSYNNFTDGSA 294 (756)
Q Consensus 283 ~ls~N~l~~~~~ 294 (756)
++++|.+....+
T Consensus 344 ~L~~N~i~~~~~ 355 (844)
T 3j0a_A 344 DLQKNHIAIIQD 355 (844)
T ss_dssp ECCSCCCCCCCS
T ss_pred ECCCCCCCccCh
Confidence 555555444433
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.97 E-value=4.7e-30 Score=303.20 Aligned_cols=287 Identities=20% Similarity=0.224 Sum_probs=248.6
Q ss_pred eeeccceeccccccccCcccc-----------------cCCcccC--CCCCCCEEEccCCcccCccCcccccCCcce-ee
Q 004400 11 HFWKQKTVNQKRVLKEQNLTG-----------------VLPPKLA--ELTFLQDIDLTLNYLSGTIPSQWASLPLLN-IS 70 (756)
Q Consensus 11 ~~~~~~~~~~~l~L~~~~l~~-----------------~~p~~l~--~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~-l~ 70 (756)
..+.+++.++.|+|++|++++ .+|+.++ ++++|+.|+|++|.+.+.+|..|..++.|+ |+
T Consensus 442 ~~l~~L~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~iP~~l~f~~L~~L~~L~Ls~N~l~~~iP~~l~~L~~L~~L~ 521 (876)
T 4ecn_A 442 KAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLN 521 (876)
T ss_dssp GGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEESCTTCCSCCGGGGGCSSCCEEE
T ss_pred HHHhcCCCCCEEECcCCcCCCCcccccccccccccccccCChhhhhccCCCCCEEECcCCCCCccChHHHhCCCCCCEEE
Confidence 458899999999999999999 4899988 999999999999999999999999999995 89
Q ss_pred ccCcc-ccc-cCCccCcCcC-------CCcEEEeecCcccccCCc--ccCCCCCCcEEeccCCeecccCCccccCCCCCC
Q 004400 71 LIANR-LKG-PIPKYLANIS-------TLVNLTVQYNQFSGELPE--ELGSLLNLEKLHLSSNNFTGELPKTFAKLTNMK 139 (756)
Q Consensus 71 l~~n~-~~~-~~p~~l~~l~-------~L~~L~L~~N~l~~~~p~--~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~ 139 (756)
+.+|+ +++ .+|..+++++ +|+.|+|++|+|+ .+|. .|+++++|+.|+|++|+++ .+| .|..+++|+
T Consensus 522 Ls~N~~lsg~~iP~~i~~L~~~~~~l~~L~~L~Ls~N~L~-~ip~~~~l~~L~~L~~L~Ls~N~l~-~lp-~~~~L~~L~ 598 (876)
T 4ecn_A 522 IACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLE-EFPASASLQKMVKLGLLDCVHNKVR-HLE-AFGTNVKLT 598 (876)
T ss_dssp CTTCTTSCHHHHHHHHHHHHHCTTTTTTCCEEECCSSCCC-BCCCHHHHTTCTTCCEEECTTSCCC-BCC-CCCTTSEES
T ss_pred CcCCCCcccccchHHHHhhhhcccccCCccEEEeeCCcCC-ccCChhhhhcCCCCCEEECCCCCcc-cch-hhcCCCcce
Confidence 99998 888 8998777776 9999999999999 8888 9999999999999999999 888 899999999
Q ss_pred EEEeeCCcccccCChhhcCcCC-CcEEEccCCcCcCCCCccccCCCC--CCeEEccCCCCCCCCcccc------cccccc
Q 004400 140 DFRISDNQFTGQIPSFIQNWTK-LEKLFIQPSGLAGPIPSGIFSLEN--LTDLRISDLNGPEATFPQL------GNMKMT 210 (756)
Q Consensus 140 ~L~L~~N~l~~~~p~~~~~l~~-L~~L~l~~N~l~~~~p~~~~~l~~--L~~L~l~~n~~~~~~~~~~------~~~~L~ 210 (756)
.|+|++|+++ .+|..+.++++ |+.|+|++|+++ .+|..+..++. |+.|++++|.+....+... ...+|+
T Consensus 599 ~L~Ls~N~l~-~lp~~l~~l~~~L~~L~Ls~N~L~-~lp~~~~~~~~~~L~~L~Ls~N~l~g~ip~l~~~l~~~~~~~L~ 676 (876)
T 4ecn_A 599 DLKLDYNQIE-EIPEDFCAFTDQVEGLGFSHNKLK-YIPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINAS 676 (876)
T ss_dssp EEECCSSCCS-CCCTTSCEECTTCCEEECCSSCCC-SCCSCCCTTCSSCEEEEECCSSCTTTTSSSCSSCTTTCCCCCEE
T ss_pred EEECcCCccc-cchHHHhhccccCCEEECcCCCCC-cCchhhhccccCCCCEEECcCCcCCCccccchhhhccccCCCcC
Confidence 9999999999 89999999999 999999999999 78988887655 9999999999987544222 334699
Q ss_pred EEEcccccccCCCCcc-ccCCCCCcEEEccCCcCCCCCCccCcC--------CCCCCeEEecCccccccCCchh----hc
Q 004400 211 KLILRNCNITGELPRY-LGKMTKLKVLDLSFNRLRGQIPSNFDD--------LYDVDYIYFAGNLLTGAIPPWM----LE 277 (756)
Q Consensus 211 ~L~L~~n~l~~~~p~~-~~~l~~L~~L~Ls~N~l~~~~p~~~~~--------l~~L~~L~ls~N~l~~~~p~~~----~~ 277 (756)
.|+|++|.++ .+|.. +..+++|+.|+|++|+|+ .+|..+.. +++|+.|+|++|+++ .+|..+ ++
T Consensus 677 ~L~Ls~N~L~-~lp~~~~~~l~~L~~L~Ls~N~L~-~ip~~~~~~~~~~l~nl~~L~~L~Ls~N~L~-~lp~~l~~~~l~ 753 (876)
T 4ecn_A 677 TVTLSYNEIQ-KFPTELFATGSPISTIILSNNLMT-SIPENSLKPKDGNYKNTYLLTTIDLRFNKLT-SLSDDFRATTLP 753 (876)
T ss_dssp EEECCSSCCC-SCCHHHHHTTCCCSEEECCSCCCS-CCCTTSSSCTTSCCTTGGGCCEEECCSSCCC-CCCGGGSTTTCT
T ss_pred EEEccCCcCC-ccCHHHHccCCCCCEEECCCCcCC-ccChHHhccccccccccCCccEEECCCCCCc-cchHHhhhccCC
Confidence 9999999999 55554 568999999999999999 56654433 239999999999999 788765 58
Q ss_pred CCCeeEeecCCCCCCCCcccccccCcccc
Q 004400 278 RGDKIDLSYNNFTDGSAESSCQKRSVTGI 306 (756)
Q Consensus 278 ~l~~l~ls~N~l~~~~~~~~~~~~~~~~~ 306 (756)
+|+.|++++|++++. +........+..+
T Consensus 754 ~L~~L~Ls~N~L~~l-p~~l~~L~~L~~L 781 (876)
T 4ecn_A 754 YLSNMDVSYNCFSSF-PTQPLNSSQLKAF 781 (876)
T ss_dssp TCCEEECCSSCCSSC-CCGGGGCTTCCEE
T ss_pred CcCEEEeCCCCCCcc-chhhhcCCCCCEE
Confidence 899999999999985 4444444444444
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=3.4e-29 Score=294.01 Aligned_cols=306 Identities=20% Similarity=0.195 Sum_probs=200.1
Q ss_pred ecccee--ccccccccCcccccCCcccCCCCCCCEEEccCCcccCccCcccccCCcc-----------------------
Q 004400 13 WKQKTV--NQKRVLKEQNLTGVLPPKLAELTFLQDIDLTLNYLSGTIPSQWASLPLL----------------------- 67 (756)
Q Consensus 13 ~~~~~~--~~~l~L~~~~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L----------------------- 67 (756)
+.++.. ++.|+|++|++++..|..|..+++|+.|+|++|.+++..|..|..++.|
T Consensus 242 ~~~l~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~~~~~~~~~~~~lp~i~ 321 (680)
T 1ziw_A 242 FLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKID 321 (680)
T ss_dssp TGGGGGSCCCEEECTTSCCCEECTTTTTTCTTCCEEECCSCCBSEECTTTTTTCTTCCEEECTTCBCCC------CCEEC
T ss_pred hhccCcCCCCEEECCCCCcCccCcccccCcccccEeeCCCCccCccChhhhcCCCCccEEeccchhhhcccccccccccC
Confidence 445544 8888888888888877888888888888888888877666555544433
Q ss_pred -----------eeeccCccccccCCccCcCcCCCcEEEeec----------------------------CcccccCCccc
Q 004400 68 -----------NISLIANRLKGPIPKYLANISTLVNLTVQY----------------------------NQFSGELPEEL 108 (756)
Q Consensus 68 -----------~l~l~~n~~~~~~p~~l~~l~~L~~L~L~~----------------------------N~l~~~~p~~~ 108 (756)
.+++.+|++.+..|..|.++++|++|+|++ |++++..|.+|
T Consensus 322 ~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~~~~~~l~~~~f~~~~~~~L~~L~L~~n~l~~~~~~~~ 401 (680)
T 1ziw_A 322 DFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAF 401 (680)
T ss_dssp TTTTTTCTTCCEEECCSCCBCCCCTTTTTTCTTCCEEECTTCBSCCCEECTTTTGGGTTSCCCEEECTTSCCCEECTTTT
T ss_pred hhhcccCCCCCEEECCCCccCCCChhHhccccCCcEEECCCCchhhhhcchhhhcccccCcCceEECCCCCCCeEChhhh
Confidence 244555555555555555555544444433 33444444555
Q ss_pred CCCCCCcEEeccCCeecccCC-ccccCCCCCCEEEeeCCcccccCChhhcCcCCCcEEEccCCcCc--CCCCccccCCCC
Q 004400 109 GSLLNLEKLHLSSNNFTGELP-KTFAKLTNMKDFRISDNQFTGQIPSFIQNWTKLEKLFIQPSGLA--GPIPSGIFSLEN 185 (756)
Q Consensus 109 ~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~--~~~p~~~~~l~~ 185 (756)
..+++|+.|+|++|++++.+| ..|.++++|++|+|++|++++..+..|..+++|+.|++++|.+. +..|..+..+++
T Consensus 402 ~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~p~~~~~l~~ 481 (680)
T 1ziw_A 402 SWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRN 481 (680)
T ss_dssp TTCTTCCEEECCSSCCEEECCSGGGTTCTTCCEEECCSCSEEECCTTTTTTCTTCCEEECTTSCCBCTTCSSCTTTTCTT
T ss_pred hCCCCCCEEeCCCCcCccccCcccccCcccccEEecCCCCcceeChhhhhcCcccccchhccccccccccCCcccccCCC
Confidence 555556666666665554444 44555566666666666655555555666666666666666654 456777777888
Q ss_pred CCeEEccCCCCCCCCccccccc-cccEEEcccccccCCCC--------ccccCCCCCcEEEccCCcCCCCCCccCcCCCC
Q 004400 186 LTDLRISDLNGPEATFPQLGNM-KMTKLILRNCNITGELP--------RYLGKMTKLKVLDLSFNRLRGQIPSNFDDLYD 256 (756)
Q Consensus 186 L~~L~l~~n~~~~~~~~~~~~~-~L~~L~L~~n~l~~~~p--------~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~ 256 (756)
|+.|++++|.+....+..+... +|+.|+|++|.+++..+ ..|.++++|+.|+|++|+++...+..|.++++
T Consensus 482 L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~ 561 (680)
T 1ziw_A 482 LTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFE 561 (680)
T ss_dssp CCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCGGGGSTTSTTSCCCTTTTCTTCCEEECCSSCCCCCCTTTTTTCTT
T ss_pred CCEEECCCCCCCcCChhhhccccccCEEeCCCCCccccchhhccCCcchhhcCCCCCCEEECCCCCCCCCCHHHcccccC
Confidence 8888888888877776666554 58888888888775422 23677888888888888888555556888888
Q ss_pred CCeEEecCccccccCCchh--hcCCCeeEeecCCCCCCCCcccc-cccCcccccccccccccCCc
Q 004400 257 VDYIYFAGNLLTGAIPPWM--LERGDKIDLSYNNFTDGSAESSC-QKRSVTGIVSCLRSVQCPKT 318 (756)
Q Consensus 257 L~~L~ls~N~l~~~~p~~~--~~~l~~l~ls~N~l~~~~~~~~~-~~~~~~~~~~~~~~~~c~~~ 318 (756)
|+.|+|++|.+++..+..+ ++.++.|++++|.+++..+.... ....+..+....+++.|.+.
T Consensus 562 L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~l~l~~N~~~c~c~ 626 (680)
T 1ziw_A 562 LKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDCTCE 626 (680)
T ss_dssp CCEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCCCBCCHHHHHHHHTTCSEEECTTCCCCBCCC
T ss_pred cceeECCCCCCCcCCHhHhCCCCCCCEEECCCCcCCccChhHhcccccccCEEEccCCCcccCCc
Confidence 8888888888884444433 57788888888888876654433 33445555566677777654
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.5e-29 Score=303.46 Aligned_cols=284 Identities=20% Similarity=0.166 Sum_probs=233.2
Q ss_pred eeeeccceeccccccccCcccccC-CcccCCCCCCCEEEccCCcccCccCcccccCCcce-eeccCccccccCCcc--Cc
Q 004400 10 FHFWKQKTVNQKRVLKEQNLTGVL-PPKLAELTFLQDIDLTLNYLSGTIPSQWASLPLLN-ISLIANRLKGPIPKY--LA 85 (756)
Q Consensus 10 ~~~~~~~~~~~~l~L~~~~l~~~~-p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~-l~l~~n~~~~~~p~~--l~ 85 (756)
+..|.+++.++.|+|++|+..+.+ |..|.++++|++|+|++|.|++..|..|..++.|+ |++.+|++.+.+|.. |.
T Consensus 41 ~~~~~~l~~L~~LdLs~n~~~~~i~~~~f~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~ 120 (844)
T 3j0a_A 41 ASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFR 120 (844)
T ss_dssp SSSCSSCCSCSEEEECTTCCCCEECTTTTSSCTTCCEEECTTCCCCEECTTSSCSCSSCCCEECTTCCCSSCCSTTCCCS
T ss_pred hhHCcccccCeEEeCCCCCCccccCHHHhcCCCCCCEEECCCCcCcccCHhHccCCcccCEeeCcCCCCCcccccCcccc
Confidence 346889999999999999777666 78899999999999999999988899999999995 999999999877765 99
Q ss_pred CcCCCcEEEeecCcccccCC-cccCCCCCCcEEeccCCeecccCCccccCC--CCCCEEEeeCCcccccCChhhcCcCC-
Q 004400 86 NISTLVNLTVQYNQFSGELP-EELGSLLNLEKLHLSSNNFTGELPKTFAKL--TNMKDFRISDNQFTGQIPSFIQNWTK- 161 (756)
Q Consensus 86 ~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l--~~L~~L~L~~N~l~~~~p~~~~~l~~- 161 (756)
++++|++|+|++|.+++..+ ..|+++++|++|+|++|++++..+..+..+ ++|+.|+|++|.+.+..|..++.+++
T Consensus 121 ~L~~L~~L~Ls~N~l~~~~~~~~~~~L~~L~~L~Ls~N~i~~~~~~~l~~l~~~~L~~L~L~~n~l~~~~~~~~~~~~~~ 200 (844)
T 3j0a_A 121 NLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMNP 200 (844)
T ss_dssp SCSSCCEEEEESCCCCCCCCCGGGGTCSSCCEEEEESSCCCCCCSGGGHHHHHCSSCCCEECCSBSCCCCCCCCCSSSCT
T ss_pred ccCCCCEEECCCCcccccccchhHhhCCCCCEEECCCCcCCeeCHHHcccccCCccceEECCCCccccccccchhhcCCc
Confidence 99999999999999997665 579999999999999999998889888887 88999999999888888777776665
Q ss_pred -----CcEEEccCCcCcCCCCccccC--------------------------------------CCCCCeEEccCCCCCC
Q 004400 162 -----LEKLFIQPSGLAGPIPSGIFS--------------------------------------LENLTDLRISDLNGPE 198 (756)
Q Consensus 162 -----L~~L~l~~N~l~~~~p~~~~~--------------------------------------l~~L~~L~l~~n~~~~ 198 (756)
|+.|+|++|++.+..+..+.. .++|+.|++++|.+..
T Consensus 201 ~~~~~L~~L~Ls~n~l~~~~~~~~~~~l~~~~l~~L~l~~~~~~~~~~~~~l~~~~~~~f~~l~~~~L~~L~Ls~n~l~~ 280 (844)
T 3j0a_A 201 FRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVFS 280 (844)
T ss_dssp TTTCCBSEEBCSSCCSSTTTTSGGGGTSCSCCBSEEECCSSCCBCSSSCSSSTTGGGTTTTTTTTSCCCEEECTTCCCCE
T ss_pred cccCceeEEecCCCcCchhHHHHHHhhcCcccccceecccccccccccccccCCCChhhhhccccCCccEEECCCCcccc
Confidence 888888888776655544332 2578888888888777
Q ss_pred CCccccccc-cccEEEcccccccCCCCccccCCCCCcEEEccCCcCCCCCCccCcCCCCCCeEEecCccccccCCchh--
Q 004400 199 ATFPQLGNM-KMTKLILRNCNITGELPRYLGKMTKLKVLDLSFNRLRGQIPSNFDDLYDVDYIYFAGNLLTGAIPPWM-- 275 (756)
Q Consensus 199 ~~~~~~~~~-~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~-- 275 (756)
..+..+..+ +|+.|+|++|++++..|..|.++++|++|+|++|.+++..|..|..+++|+.|++++|.+++..+..+
T Consensus 281 ~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~ 360 (844)
T 3j0a_A 281 LNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKF 360 (844)
T ss_dssp ECSCCSSSCCCCCEEEEESCCCCEECTTTTTTCSSCCEEEEESCCCSCCCSCSCSSCTTCCEEECCSCCCCCCCSSCSCS
T ss_pred cChhhhhcCCCCCEEECCCCcCCCCChHHhcCCCCCCEEECCCCCCCccCHHHhcCCCCCCEEECCCCCCCccChhhhcC
Confidence 766666655 48888888888887777778888888888888888887777788888888888888888875555544
Q ss_pred hcCCCeeEeecCCCCCCC
Q 004400 276 LERGDKIDLSYNNFTDGS 293 (756)
Q Consensus 276 ~~~l~~l~ls~N~l~~~~ 293 (756)
+++|+.|++++|.+++..
T Consensus 361 l~~L~~L~Ls~N~l~~i~ 378 (844)
T 3j0a_A 361 LEKLQTLDLRDNALTTIH 378 (844)
T ss_dssp CCCCCEEEEETCCSCCCS
T ss_pred CCCCCEEECCCCCCCccc
Confidence 677788888888777543
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=9.8e-30 Score=292.27 Aligned_cols=304 Identities=19% Similarity=0.217 Sum_probs=186.2
Q ss_pred eeccceeccccccccCcccccCCcccCCCCCCCEEEccCCcccCccCcccccCCcce-eeccCccccccCCccCcCcCCC
Q 004400 12 FWKQKTVNQKRVLKEQNLTGVLPPKLAELTFLQDIDLTLNYLSGTIPSQWASLPLLN-ISLIANRLKGPIPKYLANISTL 90 (756)
Q Consensus 12 ~~~~~~~~~~l~L~~~~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~-l~l~~n~~~~~~p~~l~~l~~L 90 (756)
.|.++..++.|+|++|++++..|..|.++++|++|+|++|.+++..|..|..++.|+ |++.+|++.+..+..|+++++|
T Consensus 47 ~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L 126 (570)
T 2z63_A 47 SFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTL 126 (570)
T ss_dssp TTTTCSSCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTSCCCCSTTCSCTTCTTC
T ss_pred HhhCCCCceEEECCCCcCCccCcccccCchhCCEEeCcCCcCCccCHhhhcCccccccccccccccccCCCccccccccc
Confidence 466777777777777777777777777777777777777777766667777777763 6677777765555567777777
Q ss_pred cEEEeecCcccc-cCCcccCCCCCCcEEeccCCeecccCCccc-------------------------------------
Q 004400 91 VNLTVQYNQFSG-ELPEELGSLLNLEKLHLSSNNFTGELPKTF------------------------------------- 132 (756)
Q Consensus 91 ~~L~L~~N~l~~-~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~------------------------------------- 132 (756)
++|+|++|.+++ .+|..|+++++|++|+|++|++++..+..+
T Consensus 127 ~~L~L~~n~l~~~~lp~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~~~~~L~l~~n~l~~~~~~~~~~~~L~~L~ 206 (570)
T 2z63_A 127 KELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRLHKLT 206 (570)
T ss_dssp CEEECCSSCCCCCCCCGGGGGCTTCCEEECTTSCCCEECGGGGHHHHTCTTCCCEEECTTCCCCEECTTTTTTCEEEEEE
T ss_pred cEEecCCCccceecChhhhcccCCCCEEeCcCCccceecHHHccchhccchhhhhcccCCCCceecCHHHhccCcceeEe
Confidence 777777777765 356777777777777777776554322221
Q ss_pred ------------------------------------------------------------------------cCCCCCCE
Q 004400 133 ------------------------------------------------------------------------AKLTNMKD 140 (756)
Q Consensus 133 ------------------------------------------------------------------------~~l~~L~~ 140 (756)
..+++|+.
T Consensus 207 l~~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~~~~~~~~~~l~~l~l~~l~l~~~~~~~~~~~~~~~~l~~L~~ 286 (570)
T 2z63_A 207 LRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSS 286 (570)
T ss_dssp EESCCSCTTHHHHHHHTTTTCEEEEEEEEECCCCSSCEECCTTTTGGGGGSEEEEEEEEETTEEESCSTTTTGGGTTCSE
T ss_pred cccccccccchhhhhcCccccceeeeccccccCchhhhhcchhhhccccccchhhhhhhcchhhhhhchhhhcCcCcccE
Confidence 12233444
Q ss_pred EEeeCCcccccCChhh------------------------------------------cCcCCCcEEEccCCcCcCCC--
Q 004400 141 FRISDNQFTGQIPSFI------------------------------------------QNWTKLEKLFIQPSGLAGPI-- 176 (756)
Q Consensus 141 L~L~~N~l~~~~p~~~------------------------------------------~~l~~L~~L~l~~N~l~~~~-- 176 (756)
|++++|.++ .+|..+ ..+++|+.|++++|++++..
T Consensus 287 L~l~~~~l~-~l~~~~~~~~L~~L~l~~n~~~~l~~~~l~~L~~L~l~~n~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~ 365 (570)
T 2z63_A 287 FSLVSVTIE-RVKDFSYNFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCC 365 (570)
T ss_dssp EEEESCEEC-SCCBCCSCCCCSEEEEESCBCSSCCBCBCSSCCEEEEESCBSCCBCCCCBCTTCCEEECCSSCCBEEEEE
T ss_pred EEecCccch-hhhhhhccCCccEEeeccCcccccCcccccccCEEeCcCCccccccccccCCCCCEEeCcCCccCccccc
Confidence 444444333 122111 23344555555555554321
Q ss_pred Ccc-----------------------ccCCCCCCeEEccCCCCCCCCc-cccccc-cccEEEcccccccCCCCccccCCC
Q 004400 177 PSG-----------------------IFSLENLTDLRISDLNGPEATF-PQLGNM-KMTKLILRNCNITGELPRYLGKMT 231 (756)
Q Consensus 177 p~~-----------------------~~~l~~L~~L~l~~n~~~~~~~-~~~~~~-~L~~L~L~~n~l~~~~p~~~~~l~ 231 (756)
|.. +..+++|+.|++++|.+....+ ..+... +|++|++++|.+.+..|..|.+++
T Consensus 366 ~~~~~~~~~L~~L~l~~n~l~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~ 445 (570)
T 2z63_A 366 SQSDFGTTSLKYLDLSFNGVITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLS 445 (570)
T ss_dssp EHHHHTCSCCCEEECCSCSEEEEEEEEETCTTCCEEECTTSEEESCTTSCTTTTCTTCCEEECTTSCCEECCTTTTTTCT
T ss_pred cccccccCccCEEECCCCccccccccccccCCCCEEEccCCccccccchhhhhcCCCCCEEeCcCCcccccchhhhhcCC
Confidence 333 4555555555555555554433 223333 467777777777666666677777
Q ss_pred CCcEEEccCCcCC-CCCCccCcCCCCCCeEEecCccccccCCchh--hcCCCeeEeecCCCCCCCCcccccccCcccccc
Q 004400 232 KLKVLDLSFNRLR-GQIPSNFDDLYDVDYIYFAGNLLTGAIPPWM--LERGDKIDLSYNNFTDGSAESSCQKRSVTGIVS 308 (756)
Q Consensus 232 ~L~~L~Ls~N~l~-~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~--~~~l~~l~ls~N~l~~~~~~~~~~~~~~~~~~~ 308 (756)
+|+.|+|++|.++ +.+|..+..+++|+.|++++|.+++..|.++ +++++.|++++|.+++..+........+..+..
T Consensus 446 ~L~~L~l~~n~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l 525 (570)
T 2z63_A 446 SLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWL 525 (570)
T ss_dssp TCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEEC
T ss_pred cCcEEECcCCcCccccchhhhhcccCCCEEECCCCccccCChhhhhcccCCCEEeCCCCcCCCCCHHHhhcccCCcEEEe
Confidence 7777777777776 4566777777777777777777776666655 567777777777777665554444445555555
Q ss_pred cccccccC
Q 004400 309 CLRSVQCP 316 (756)
Q Consensus 309 ~~~~~~c~ 316 (756)
..+++.|.
T Consensus 526 ~~N~~~~~ 533 (570)
T 2z63_A 526 HTNPWDCS 533 (570)
T ss_dssp CSSCBCCC
T ss_pred cCCcccCC
Confidence 55555554
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.9e-29 Score=288.47 Aligned_cols=304 Identities=17% Similarity=0.180 Sum_probs=178.0
Q ss_pred eeeccceeccccccccCcccccCCcccCCCCCCCEEEccCCcccCccCcccccCCcce-eeccCccccc-cCCccCcCcC
Q 004400 11 HFWKQKTVNQKRVLKEQNLTGVLPPKLAELTFLQDIDLTLNYLSGTIPSQWASLPLLN-ISLIANRLKG-PIPKYLANIS 88 (756)
Q Consensus 11 ~~~~~~~~~~~l~L~~~~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~-l~l~~n~~~~-~~p~~l~~l~ 88 (756)
..|.+++.+++|+|++|++++..|+.|..+++|++|+|++|.+++..|..|..++.|+ |++.+|++.+ ..|..|++++
T Consensus 44 ~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~ 123 (549)
T 2z81_A 44 GDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLT 123 (549)
T ss_dssp STTSSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCSCCHHHHTTCTTCCEEECTTCCCSSSCSSCSCTTCT
T ss_pred hhhhcCCcccEEECCCCCcCccChhhccccccCCEEECCCCccCccCHHHhccCCCCcEEECCCCcccccchhhhhhccC
Confidence 3466777777777777777777777777777777777777777766666677777763 6777777765 3556677777
Q ss_pred CCcEEEeecCcccccC-CcccCCCCCCcEEeccCCeecccCCccccC------------------------CCCCCEEEe
Q 004400 89 TLVNLTVQYNQFSGEL-PEELGSLLNLEKLHLSSNNFTGELPKTFAK------------------------LTNMKDFRI 143 (756)
Q Consensus 89 ~L~~L~L~~N~l~~~~-p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~------------------------l~~L~~L~L 143 (756)
+|++|+|++|.+.+.+ +..|.++++|++|+|++|++++..|..+.. +++|+.|++
T Consensus 124 ~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~L 203 (549)
T 2z81_A 124 NLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLEL 203 (549)
T ss_dssp TCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEETTCCEECTTTTTTCSEEEEEEEECSBSTTHHHHHHHSTTTBSEEEE
T ss_pred CccEEECCCCccccccCHhhhhcccccCeeeccCCcccccChhhhhccccCceEecccCcccccchhhHhhcccccEEEc
Confidence 7777777777633333 356777777777777777776666655443 344555555
Q ss_pred eCCccccc------------------------------------------------------------------------
Q 004400 144 SDNQFTGQ------------------------------------------------------------------------ 151 (756)
Q Consensus 144 ~~N~l~~~------------------------------------------------------------------------ 151 (756)
++|++++.
T Consensus 204 ~~n~l~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~~~~~~~~L~~l~l~~~~~~~~~~~~~~~~~~~~~l~~L 283 (549)
T 2z81_A 204 RDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKV 283 (549)
T ss_dssp ESCBCTTCCCCCCSSCCCCCCCCEEEEESCEEEHHHHHHHHGGGGGCTTCCEEEEESCEEECCSCCCCCTTTCCCCCTTC
T ss_pred cCCccccccccccchhhhhhcccceeccccccchhHHHHHHHHhhhhccccccccccccccccccccccchhhhhhhccc
Confidence 55554431
Q ss_pred -----------------------------------------CChhh-cCcCCCcEEEccCCcCcCCCC---ccccCCCCC
Q 004400 152 -----------------------------------------IPSFI-QNWTKLEKLFIQPSGLAGPIP---SGIFSLENL 186 (756)
Q Consensus 152 -----------------------------------------~p~~~-~~l~~L~~L~l~~N~l~~~~p---~~~~~l~~L 186 (756)
+|..+ .++++|++|+|++|++++..| ..+..+++|
T Consensus 284 ~~L~l~~~~i~~~~~~~~l~~~~~~~~~L~~L~l~~n~l~~ip~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~l~~L 363 (549)
T 2z81_A 284 ETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVFLVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSL 363 (549)
T ss_dssp CEEEEESCBCSCGGGSCCCCHHHHHSTTCCEEEEESSCCCCCCHHHHHHCTTCCEEECCSSCCCHHHHHHHTCTTSSTTC
T ss_pred ccccccccccchhhhcccchhhhhhcccceEEEeccCccccCCHHHHhcCccccEEEccCCccccccccchhhhhccccC
Confidence 11111 234555555555555554332 224445555
Q ss_pred CeEEccCCCCCCCCc--cccccc-cccEEEcccccccCCCCccccCCCCCcEEEccCCcCCCCCCccC------------
Q 004400 187 TDLRISDLNGPEATF--PQLGNM-KMTKLILRNCNITGELPRYLGKMTKLKVLDLSFNRLRGQIPSNF------------ 251 (756)
Q Consensus 187 ~~L~l~~n~~~~~~~--~~~~~~-~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~------------ 251 (756)
+.|++++|.+..... ..+..+ +|++|+|++|+++ .+|..+..+++|++|+|++|.+++ +|..+
T Consensus 364 ~~L~Ls~N~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~~~~L~~L~Ls~N~l~~-l~~~~~~~L~~L~Ls~N 441 (549)
T 2z81_A 364 QTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFH-PMPDSCQWPEKMRFLNLSSTGIRV-VKTCIPQTLEVLDVSNN 441 (549)
T ss_dssp CEEECTTSCCCCHHHHHHHGGGCTTCCEEECTTCCCC-CCCSCCCCCTTCCEEECTTSCCSC-CCTTSCTTCSEEECCSS
T ss_pred cEEEccCCcccccccchhhhhcCCCCCEEECCCCCCc-cCChhhcccccccEEECCCCCccc-ccchhcCCceEEECCCC
Confidence 555555555544322 122222 4666666666666 455556666666666666666552 22211
Q ss_pred ------cCCCCCCeEEecCccccccCCch-hhcCCCeeEeecCCCCCCCCcccccccCcccccccccccccCC
Q 004400 252 ------DDLYDVDYIYFAGNLLTGAIPPW-MLERGDKIDLSYNNFTDGSAESSCQKRSVTGIVSCLRSVQCPK 317 (756)
Q Consensus 252 ------~~l~~L~~L~ls~N~l~~~~p~~-~~~~l~~l~ls~N~l~~~~~~~~~~~~~~~~~~~~~~~~~c~~ 317 (756)
..+++|+.|++++|+++ .+|.. .++.++.|++++|++++..+........+..+....+++.|..
T Consensus 442 ~l~~~~~~l~~L~~L~Ls~N~l~-~ip~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~ 513 (549)
T 2z81_A 442 NLDSFSLFLPRLQELYISRNKLK-TLPDASLFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSC 513 (549)
T ss_dssp CCSCCCCCCTTCCEEECCSSCCS-SCCCGGGCTTCCEEECCSSCCCCCCTTGGGGCTTCCEEECCSSCBCCCH
T ss_pred ChhhhcccCChhcEEECCCCccC-cCCCcccCccCCEEecCCCccCCcCHHHHhcCcccCEEEecCCCccCCC
Confidence 24566666666666666 44443 2566777777777777665555555555555555555555543
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.1e-28 Score=263.10 Aligned_cols=268 Identities=21% Similarity=0.260 Sum_probs=230.9
Q ss_pred ccceeccccccccCcccccCCcccCCCCCCCEEEccCCcccCccCcccccCCcc-eeeccCccccccCCccCcCcCCCcE
Q 004400 14 KQKTVNQKRVLKEQNLTGVLPPKLAELTFLQDIDLTLNYLSGTIPSQWASLPLL-NISLIANRLKGPIPKYLANISTLVN 92 (756)
Q Consensus 14 ~~~~~~~~l~L~~~~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L-~l~l~~n~~~~~~p~~l~~l~~L~~ 92 (756)
.....++.+++++++++ .+|..+. +.|+.|+|++|+|++..+..|..++.| .|++.+|++.+..|..|.++++|++
T Consensus 28 ~c~c~l~~l~~~~~~l~-~lp~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~ 104 (330)
T 1xku_A 28 RCQCHLRVVQCSDLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLER 104 (330)
T ss_dssp TCEEETTEEECTTSCCC-SCCCSCC--TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCE
T ss_pred CCcCCCeEEEecCCCcc-ccCccCC--CCCeEEECCCCcCCEeChhhhccCCCCCEEECCCCcCCeeCHHHhcCCCCCCE
Confidence 34568899999999998 4566554 789999999999998777789999988 4899999999888999999999999
Q ss_pred EEeecCcccccCCcccCCCCCCcEEeccCCeecccCCccccCCCCCCEEEeeCCccc--ccCChhhcCcCCCcEEEccCC
Q 004400 93 LTVQYNQFSGELPEELGSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRISDNQFT--GQIPSFIQNWTKLEKLFIQPS 170 (756)
Q Consensus 93 L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~--~~~p~~~~~l~~L~~L~l~~N 170 (756)
|+|++|+|+ .+|..+. ++|++|+|++|++++..+..|.++++|+.|++++|+++ +..+..|.++++|++|++++|
T Consensus 105 L~Ls~n~l~-~l~~~~~--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n 181 (330)
T 1xku_A 105 LYLSKNQLK-ELPEKMP--KTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADT 181 (330)
T ss_dssp EECCSSCCS-BCCSSCC--TTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSS
T ss_pred EECCCCcCC-ccChhhc--ccccEEECCCCcccccCHhHhcCCccccEEECCCCcCCccCcChhhccCCCCcCEEECCCC
Confidence 999999998 6776655 79999999999999777778999999999999999996 377888999999999999999
Q ss_pred cCcCCCCccccCCCCCCeEEccCCCCCCCCccccccc-cccEEEcccccccCCCCccccCCCCCcEEEccCCcCCCCCCc
Q 004400 171 GLAGPIPSGIFSLENLTDLRISDLNGPEATFPQLGNM-KMTKLILRNCNITGELPRYLGKMTKLKVLDLSFNRLRGQIPS 249 (756)
Q Consensus 171 ~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~-~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~ 249 (756)
+++ .+|..+. ++|+.|++++|.+....+..+... +|+.|+|++|.+++..+..|..+++|+.|+|++|.++ .+|.
T Consensus 182 ~l~-~l~~~~~--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~ 257 (330)
T 1xku_A 182 NIT-TIPQGLP--PSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPG 257 (330)
T ss_dssp CCC-SCCSSCC--TTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCT
T ss_pred ccc-cCCcccc--ccCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCceeChhhccCCCCCCEEECCCCcCc-cCCh
Confidence 998 4666654 899999999999998877777665 5999999999999888888999999999999999999 7888
Q ss_pred cCcCCCCCCeEEecCccccccCCchh--------hcCCCeeEeecCCCCC
Q 004400 250 NFDDLYDVDYIYFAGNLLTGAIPPWM--------LERGDKIDLSYNNFTD 291 (756)
Q Consensus 250 ~~~~l~~L~~L~ls~N~l~~~~p~~~--------~~~l~~l~ls~N~l~~ 291 (756)
.+..+++|++|++++|++++..+..+ ...+..+++++|++..
T Consensus 258 ~l~~l~~L~~L~l~~N~i~~~~~~~f~~~~~~~~~~~l~~l~l~~N~~~~ 307 (330)
T 1xku_A 258 GLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQY 307 (330)
T ss_dssp TTTTCSSCCEEECCSSCCCCCCTTSSSCSSCCTTSCCCSEEECCSSSSCG
T ss_pred hhccCCCcCEEECCCCcCCccChhhcCCcccccccccccceEeecCcccc
Confidence 89999999999999999986554443 2567789999999864
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.3e-29 Score=293.67 Aligned_cols=142 Identities=21% Similarity=0.262 Sum_probs=130.7
Q ss_pred eeccccccccCcccccCCcccCCCCCCCEEEccCCcccCccCcccccCCcce-eeccCccccccCCccCcCcCCCcEEEe
Q 004400 17 TVNQKRVLKEQNLTGVLPPKLAELTFLQDIDLTLNYLSGTIPSQWASLPLLN-ISLIANRLKGPIPKYLANISTLVNLTV 95 (756)
Q Consensus 17 ~~~~~l~L~~~~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~-l~l~~n~~~~~~p~~l~~l~~L~~L~L 95 (756)
..++.|+|++|++++..+..|.++++|++|+|++|.+++..|..|..++.|+ |++.+|++.+..|..|+++++|++|+|
T Consensus 32 ~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~i~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L 111 (606)
T 3vq2_A 32 SSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVA 111 (606)
T ss_dssp TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCCCCTTSSTTCTTCCEEEC
T ss_pred CCcCEEECCCCCcCEeChhhccCCccCcEEeCCCCcccccCHHHhhchhhcCEeECCCCcccccChhhcCCcccCCEEEc
Confidence 5789999999999999999999999999999999999988899999999995 899999999999999999999999999
Q ss_pred ecCcccccCCcccCCCCCCcEEeccCCeecc-cCCccccCCCCCCEEEeeCCcccccCChhhcC
Q 004400 96 QYNQFSGELPEELGSLLNLEKLHLSSNNFTG-ELPKTFAKLTNMKDFRISDNQFTGQIPSFIQN 158 (756)
Q Consensus 96 ~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~-~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~ 158 (756)
++|.+++..+..|+++++|++|+|++|++++ .+|..|+++++|++|+|++|++++..|..|+.
T Consensus 112 ~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~ 175 (606)
T 3vq2_A 112 VETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQF 175 (606)
T ss_dssp TTSCCCCSSSSCCTTCTTCCEEECCSSCCCCCCCCGGGGTCTTCCEEECCSSCCCEECTTTTHH
T ss_pred cCCccccccccccCCCCCCCEEeCCCCcccceechHhHhhcCCCCEEEccCCcceecChhhhhh
Confidence 9999997777899999999999999999986 57999999999999999999998766654433
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.96 E-value=4.6e-29 Score=272.52 Aligned_cols=287 Identities=16% Similarity=0.144 Sum_probs=201.3
Q ss_pred ceeccccccccCcccccCCcccCCCCCCCEEEccCCcccCccCcccccCCcc-eeeccCccccccCCccCcCcCCCcEEE
Q 004400 16 KTVNQKRVLKEQNLTGVLPPKLAELTFLQDIDLTLNYLSGTIPSQWASLPLL-NISLIANRLKGPIPKYLANISTLVNLT 94 (756)
Q Consensus 16 ~~~~~~l~L~~~~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L-~l~l~~n~~~~~~p~~l~~l~~L~~L~ 94 (756)
+..++.|++++|.++...+..|..+++|+.|+|++|.+++..+..|..++.| .|++.+|++.+..|..|+++++|++|+
T Consensus 44 l~~l~~l~l~~~~l~~l~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 123 (390)
T 3o6n_A 44 LNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLV 123 (390)
T ss_dssp GCCCSEEEEESCEESEECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred cCCceEEEecCCchhhCChhHhcccccCcEEECCCCcccccChhhccCCCCcCEEECCCCCCCcCCHHHhcCCCCCCEEE
Confidence 4566777777777776555556777777777777777776666677777777 367777777777677777777777777
Q ss_pred eecCcccccCCcccCCCCCCcEEeccCCeecccCCccccCCCCCCEEEeeCCcccccCChhhcCcCC-------------
Q 004400 95 VQYNQFSGELPEELGSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRISDNQFTGQIPSFIQNWTK------------- 161 (756)
Q Consensus 95 L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~------------- 161 (756)
|++|+++...+..|.++++|++|+|++|++++..+..|..+++|+.|++++|++++.. +..+++
T Consensus 124 L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~---~~~l~~L~~L~l~~n~l~~ 200 (390)
T 3o6n_A 124 LERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHVD---LSLIPSLFHANVSYNLLST 200 (390)
T ss_dssp CCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTSSCTTCCEEECCSSCCSBCC---GGGCTTCSEEECCSSCCSE
T ss_pred CCCCccCcCCHHHhcCCCCCcEEECCCCccCccChhhccCCCCCCEEECCCCcCCccc---cccccccceeecccccccc
Confidence 7777777443344577777777777777777666666777777777777777777432 334444
Q ss_pred ------CcEEEccCCcCcCCCCccccCCCCCCeEEccCCCCCCCCccccccc-cccEEEcccccccCCCCccccCCCCCc
Q 004400 162 ------LEKLFIQPSGLAGPIPSGIFSLENLTDLRISDLNGPEATFPQLGNM-KMTKLILRNCNITGELPRYLGKMTKLK 234 (756)
Q Consensus 162 ------L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~-~L~~L~L~~n~l~~~~p~~~~~l~~L~ 234 (756)
|+.|++++|.+... |.. ..++|+.|++++|.+... ..+... +|+.|+|++|.+++..|..|..+++|+
T Consensus 201 ~~~~~~L~~L~l~~n~l~~~-~~~--~~~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~ 275 (390)
T 3o6n_A 201 LAIPIAVEELDASHNSINVV-RGP--VNVELTILKLQHNNLTDT--AWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLE 275 (390)
T ss_dssp EECCSSCSEEECCSSCCCEE-ECC--CCSSCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCEEESGGGTTCSSCC
T ss_pred cCCCCcceEEECCCCeeeec-ccc--ccccccEEECCCCCCccc--HHHcCCCCccEEECCCCcCCCcChhHccccccCC
Confidence 44555555555422 222 236788888888888765 334443 589999999999988888899999999
Q ss_pred EEEccCCcCCCCCCccCcCCCCCCeEEecCccccccCCchh--hcCCCeeEeecCCCCCCCCcccccccCcccccccccc
Q 004400 235 VLDLSFNRLRGQIPSNFDDLYDVDYIYFAGNLLTGAIPPWM--LERGDKIDLSYNNFTDGSAESSCQKRSVTGIVSCLRS 312 (756)
Q Consensus 235 ~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~--~~~l~~l~ls~N~l~~~~~~~~~~~~~~~~~~~~~~~ 312 (756)
.|+|++|++++ +|..+..+++|+.|++++|+++ .+|..+ +++++.|++++|+++.... .....+..+....++
T Consensus 276 ~L~L~~n~l~~-~~~~~~~l~~L~~L~L~~n~l~-~~~~~~~~l~~L~~L~L~~N~i~~~~~---~~~~~L~~L~l~~N~ 350 (390)
T 3o6n_A 276 RLYISNNRLVA-LNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIVTLKL---STHHTLKNLTLSHND 350 (390)
T ss_dssp EEECCSSCCCE-EECSSSCCTTCCEEECCSSCCC-CCGGGHHHHTTCSEEECCSSCCCCCCC---CTTCCCSEEECCSSC
T ss_pred EEECCCCcCcc-cCcccCCCCCCCEEECCCCcce-ecCccccccCcCCEEECCCCccceeCc---hhhccCCEEEcCCCC
Confidence 99999999884 5666778899999999999988 556555 7889999999999887642 222334444444555
Q ss_pred ccc
Q 004400 313 VQC 315 (756)
Q Consensus 313 ~~c 315 (756)
+.|
T Consensus 351 ~~~ 353 (390)
T 3o6n_A 351 WDC 353 (390)
T ss_dssp EEH
T ss_pred ccc
Confidence 555
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=8.3e-29 Score=264.10 Aligned_cols=265 Identities=20% Similarity=0.235 Sum_probs=231.4
Q ss_pred eeccccccccCcccccCCcccCCCCCCCEEEccCCcccCccCcccccCCcce-eeccCccccccCCccCcCcCCCcEEEe
Q 004400 17 TVNQKRVLKEQNLTGVLPPKLAELTFLQDIDLTLNYLSGTIPSQWASLPLLN-ISLIANRLKGPIPKYLANISTLVNLTV 95 (756)
Q Consensus 17 ~~~~~l~L~~~~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~-l~l~~n~~~~~~p~~l~~l~~L~~L~L 95 (756)
..++.|+|++|++++..+..|.++++|++|+|++|.+++..|..|..++.|+ |++.+|++. .+|..+. ++|++|++
T Consensus 52 ~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~-~l~~~~~--~~L~~L~l 128 (330)
T 1xku_A 52 PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLK-ELPEKMP--KTLQELRV 128 (330)
T ss_dssp TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCS-BCCSSCC--TTCCEEEC
T ss_pred CCCeEEECCCCcCCEeChhhhccCCCCCEEECCCCcCCeeCHHHhcCCCCCCEEECCCCcCC-ccChhhc--ccccEEEC
Confidence 4678899999999998888999999999999999999988899999999995 899999988 5676665 79999999
Q ss_pred ecCcccccCCcccCCCCCCcEEeccCCeec--ccCCccccCCCCCCEEEeeCCcccccCChhhcCcCCCcEEEccCCcCc
Q 004400 96 QYNQFSGELPEELGSLLNLEKLHLSSNNFT--GELPKTFAKLTNMKDFRISDNQFTGQIPSFIQNWTKLEKLFIQPSGLA 173 (756)
Q Consensus 96 ~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~--~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~ 173 (756)
++|++++..+..|.++++|+.|+|++|+++ +..+..|.++++|+.|++++|+++ .+|..+. ++|++|++++|+++
T Consensus 129 ~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~-~l~~~~~--~~L~~L~l~~n~l~ 205 (330)
T 1xku_A 129 HENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGLP--PSLTELHLDGNKIT 205 (330)
T ss_dssp CSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCC-SCCSSCC--TTCSEEECTTSCCC
T ss_pred CCCcccccCHhHhcCCccccEEECCCCcCCccCcChhhccCCCCcCEEECCCCccc-cCCcccc--ccCCEEECCCCcCC
Confidence 999999888888999999999999999996 377888999999999999999999 4666554 89999999999999
Q ss_pred CCCCccccCCCCCCeEEccCCCCCCCCccccccc-cccEEEcccccccCCCCccccCCCCCcEEEccCCcCCCCCCccCc
Q 004400 174 GPIPSGIFSLENLTDLRISDLNGPEATFPQLGNM-KMTKLILRNCNITGELPRYLGKMTKLKVLDLSFNRLRGQIPSNFD 252 (756)
Q Consensus 174 ~~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~-~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~ 252 (756)
+..|..+..+++|+.|++++|.+....+..+... +|+.|+|++|.++ .+|..+..+++|++|+|++|++++..+..|.
T Consensus 206 ~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~L~~L~l~~N~i~~~~~~~f~ 284 (330)
T 1xku_A 206 KVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFC 284 (330)
T ss_dssp EECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTTTTTCSSCCEEECCSSCCCCCCTTSSS
T ss_pred ccCHHHhcCCCCCCEEECCCCcCceeChhhccCCCCCCEEECCCCcCc-cCChhhccCCCcCEEECCCCcCCccChhhcC
Confidence 8889999999999999999999998887777665 6999999999999 7888899999999999999999988777775
Q ss_pred CC------CCCCeEEecCccccc--cCCchh--hcCCCeeEeecCC
Q 004400 253 DL------YDVDYIYFAGNLLTG--AIPPWM--LERGDKIDLSYNN 288 (756)
Q Consensus 253 ~l------~~L~~L~ls~N~l~~--~~p~~~--~~~l~~l~ls~N~ 288 (756)
.. +.|+.|++++|++.. ..|..+ +..++.+++++|+
T Consensus 285 ~~~~~~~~~~l~~l~l~~N~~~~~~i~~~~f~~~~~l~~l~L~~N~ 330 (330)
T 1xku_A 285 PPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNYK 330 (330)
T ss_dssp CSSCCTTSCCCSEEECCSSSSCGGGSCGGGGTTCCCGGGEEC----
T ss_pred CcccccccccccceEeecCcccccccCccccccccceeEEEecccC
Confidence 43 789999999999863 334444 6778889998884
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=1.7e-29 Score=287.04 Aligned_cols=268 Identities=16% Similarity=0.152 Sum_probs=165.8
Q ss_pred eeccccccccCcccccCCcccCCCCCCCEEEccCCcccCccCcccccCCcce-eeccCccccccCCccCcCcCCCcEEEe
Q 004400 17 TVNQKRVLKEQNLTGVLPPKLAELTFLQDIDLTLNYLSGTIPSQWASLPLLN-ISLIANRLKGPIPKYLANISTLVNLTV 95 (756)
Q Consensus 17 ~~~~~l~L~~~~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~-l~l~~n~~~~~~p~~l~~l~~L~~L~L 95 (756)
..++.|+|++|++++..|..|..+++|++|+|++|+|++..|..|..++.|+ |++++|++. .+|.. .+++|++|+|
T Consensus 21 ~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~--~l~~L~~L~L 97 (520)
T 2z7x_B 21 QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNKLV-KISCH--PTVNLKHLDL 97 (520)
T ss_dssp TTCSEEECCSSCCCCCCHHHHTTCTTCCEEECCSSCCCEEEGGGGTTCTTCCEEECCSSCCC-EEECC--CCCCCSEEEC
T ss_pred ccccEEECCCCcccccChhhccccccccEEecCCCccCCcChHHhhcccCCCEEecCCCcee-ecCcc--ccCCccEEec
Confidence 5677777777777777667777777777777777777766677777777774 777777776 45554 6777777777
Q ss_pred ecCcccc-cCCcccCCCCCCcEEeccCCeecccCCccccCCCCC--CEEEeeCCcc--cccCChhhcCcC----------
Q 004400 96 QYNQFSG-ELPEELGSLLNLEKLHLSSNNFTGELPKTFAKLTNM--KDFRISDNQF--TGQIPSFIQNWT---------- 160 (756)
Q Consensus 96 ~~N~l~~-~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L--~~L~L~~N~l--~~~~p~~~~~l~---------- 160 (756)
++|+|++ .+|..|+++++|++|+|++|++++ ..+..+++| +.|+|++|++ .+..|..|..+.
T Consensus 98 ~~N~l~~~~~p~~~~~l~~L~~L~L~~n~l~~---~~~~~l~~L~L~~L~l~~n~l~~~~~~~~~l~~l~~~~l~l~l~~ 174 (520)
T 2z7x_B 98 SFNAFDALPICKEFGNMSQLKFLGLSTTHLEK---SSVLPIAHLNISKVLLVLGETYGEKEDPEGLQDFNTESLHIVFPT 174 (520)
T ss_dssp CSSCCSSCCCCGGGGGCTTCCEEEEEESSCCG---GGGGGGTTSCEEEEEEEECTTTTSSCCTTTTTTCCEEEEEEECCS
T ss_pred cCCccccccchhhhccCCcceEEEecCcccch---hhccccccceeeEEEeecccccccccccccccccccceEEEEecc
Confidence 7777775 356777777777777777777764 345555555 6666666666 445555444422
Q ss_pred -------------------------------------------------------------------------CCcEEEc
Q 004400 161 -------------------------------------------------------------------------KLEKLFI 167 (756)
Q Consensus 161 -------------------------------------------------------------------------~L~~L~l 167 (756)
+|++|++
T Consensus 175 n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~l~~l~~L~~L~l~~~~l~~~~~~~~~~~~~~~~L~~L~l 254 (520)
T 2z7x_B 175 NKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWYFSI 254 (520)
T ss_dssp SSCCCCCCCCCCTTCSEEEECCEEECCSTTTTHHHHHHHHGGGGCTTCCEEEEEEEEEEHHHHHHHHHHHHTSSCSEEEE
T ss_pred CcchhhhhhhhhhcccceeeccccccccccccceeecchhhhccccchhhccccccccCHHHHHHHHHHhhhCcccEEEe
Confidence 5666666
Q ss_pred cCCcCcCCCCccc-----cCCCCCCeEEccCCCC--------------------------CCCCccccccccccEEEccc
Q 004400 168 QPSGLAGPIPSGI-----FSLENLTDLRISDLNG--------------------------PEATFPQLGNMKMTKLILRN 216 (756)
Q Consensus 168 ~~N~l~~~~p~~~-----~~l~~L~~L~l~~n~~--------------------------~~~~~~~~~~~~L~~L~L~~ 216 (756)
++|+++|.+|..+ .++++|+.|++++|.+ ...... ....+|++|++++
T Consensus 255 ~~n~l~~~~p~~~~~~~~~~l~~L~~l~l~~n~~~~p~~~~~~~~~~~~L~~L~l~~n~l~~~~~~-~~l~~L~~L~Ls~ 333 (520)
T 2z7x_B 255 SNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCP-SKISPFLHLDFSN 333 (520)
T ss_dssp EEEEEESCCCCCCCCCCSCCCCEEEEEEEEECCCCSCTHHHHHHHHTCCCSEEEEESSCCCCCCCC-SSCCCCCEEECCS
T ss_pred ecccccCccccchhhcccccCceeEeccccccceecchhhhhcccccCceeEEEcCCCccccccch-hhCCcccEEEeEC
Confidence 6666666666665 4444444444433333 111100 1112466666666
Q ss_pred ccccCCCCccccCCCCCcEEEccCCcCCC--CCCccCcCCCCCCeEEecCccccccCCchh---hcCCCeeEeecCCCCC
Q 004400 217 CNITGELPRYLGKMTKLKVLDLSFNRLRG--QIPSNFDDLYDVDYIYFAGNLLTGAIPPWM---LERGDKIDLSYNNFTD 291 (756)
Q Consensus 217 n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~--~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~---~~~l~~l~ls~N~l~~ 291 (756)
|.+++.+|..++++++|+.|+|++|++++ .+|..+..+++|++|++++|.+++.+|... ++.++.|++++|.+++
T Consensus 334 n~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~L~~L~Ls~N~l~~ 413 (520)
T 2z7x_B 334 NLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTD 413 (520)
T ss_dssp SCCCTTTTTTCCCCSSCCEEECCSSCCCBHHHHHHHHTTCTTCCEEECCSSCCBCCGGGCSCCCCTTCCEEECCSSCCCG
T ss_pred CccChhhhhhhccCCCCCEEEccCCccCccccchHHHhhCCCCCEEECCCCcCCcccccchhccCccCCEEECcCCCCCc
Confidence 66666566666666666666666666664 344555666666666666666665444432 4555666666666554
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.96 E-value=2.1e-29 Score=265.64 Aligned_cols=273 Identities=16% Similarity=0.183 Sum_probs=230.7
Q ss_pred eccccccccCcccccCCcccCCCCCCCEEEccCCcccCccCcccccCCcce-eeccCccccc--cCCccCcCcCCCcEEE
Q 004400 18 VNQKRVLKEQNLTGVLPPKLAELTFLQDIDLTLNYLSGTIPSQWASLPLLN-ISLIANRLKG--PIPKYLANISTLVNLT 94 (756)
Q Consensus 18 ~~~~l~L~~~~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~-l~l~~n~~~~--~~p~~l~~l~~L~~L~ 94 (756)
..+.++.++++++ .+|..+. ++|+.|+|++|+++...+..|..++.|+ |++.+|++.. ..|..+.++++|++|+
T Consensus 8 ~~~~l~c~~~~l~-~ip~~~~--~~l~~L~L~~n~l~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~L~~L~ 84 (306)
T 2z66_A 8 SGTEIRCNSKGLT-SVPTGIP--SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLD 84 (306)
T ss_dssp ETTEEECCSSCCS-SCCSCCC--TTCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCEEEEEEHHHHSCSCCCEEE
T ss_pred CCCEEEcCCCCcc-cCCCCCC--CCCCEEECCCCccCccCHhHhhccccCCEEECCCCccCcccCcccccccccccCEEE
Confidence 4567888999988 5566554 7899999999999965556689999884 8899998873 3477788899999999
Q ss_pred eecCcccccCCcccCCCCCCcEEeccCCeecccCC-ccccCCCCCCEEEeeCCcccccCChhhcCcCCCcEEEccCCcCc
Q 004400 95 VQYNQFSGELPEELGSLLNLEKLHLSSNNFTGELP-KTFAKLTNMKDFRISDNQFTGQIPSFIQNWTKLEKLFIQPSGLA 173 (756)
Q Consensus 95 L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~ 173 (756)
|++|.++ .+|..+..+++|++|+|++|++++..+ ..+..+++|+.|++++|++++..+..|.++++|++|+|++|.+.
T Consensus 85 Ls~n~i~-~l~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~ 163 (306)
T 2z66_A 85 LSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQ 163 (306)
T ss_dssp CCSCSEE-EEEEEEETCTTCCEEECTTSEEESSTTTTTTTTCTTCCEEECTTSCCEECSTTTTTTCTTCCEEECTTCEEG
T ss_pred CCCCccc-cChhhcCCCCCCCEEECCCCcccccccchhhhhccCCCEEECCCCcCCccchhhcccCcCCCEEECCCCccc
Confidence 9999999 677889999999999999999996554 57899999999999999999999999999999999999999998
Q ss_pred C-CCCccccCCCCCCeEEccCCCCCCCCccccccc-cccEEEcccccccCCCCccccCCCCCcEEEccCCcCCCCCCccC
Q 004400 174 G-PIPSGIFSLENLTDLRISDLNGPEATFPQLGNM-KMTKLILRNCNITGELPRYLGKMTKLKVLDLSFNRLRGQIPSNF 251 (756)
Q Consensus 174 ~-~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~-~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~ 251 (756)
+ ..|..+..+++|+.|++++|.+....+..+... +|+.|+|++|.+++..+..|..+++|+.|+|++|.+++..|..+
T Consensus 164 ~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~ 243 (306)
T 2z66_A 164 ENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQEL 243 (306)
T ss_dssp GGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCSBCCSGGGTTCTTCCEEECTTSCCCBCSSSSC
T ss_pred cccchhHHhhCcCCCEEECCCCCcCCcCHHHhcCCCCCCEEECCCCccCccChhhccCcccCCEeECCCCCCcccCHHHH
Confidence 7 588999999999999999999998877777665 69999999999998888889999999999999999999999999
Q ss_pred cCCC-CCCeEEecCccccccCCch-h---hcCCCeeEeecCCCCCCCC
Q 004400 252 DDLY-DVDYIYFAGNLLTGAIPPW-M---LERGDKIDLSYNNFTDGSA 294 (756)
Q Consensus 252 ~~l~-~L~~L~ls~N~l~~~~p~~-~---~~~l~~l~ls~N~l~~~~~ 294 (756)
..++ +|++|++++|+++|.++.. + +...+.+.+..+.+.|..+
T Consensus 244 ~~~~~~L~~L~L~~N~~~~~c~~~~~~~~l~~~~~~~~~~~~~~C~~p 291 (306)
T 2z66_A 244 QHFPSSLAFLNLTQNDFACTCEHQSFLQWIKDQRQLLVEVERMECATP 291 (306)
T ss_dssp CCCCTTCCEEECTTCCEECSGGGHHHHHHHHHTGGGBSCGGGCBEEES
T ss_pred HhhhccCCEEEccCCCeecccChHHHHHHHHhhhhhhccccccccCCc
Confidence 9885 8999999999998876532 2 3333444455555555443
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=99.96 E-value=9.3e-29 Score=263.93 Aligned_cols=264 Identities=22% Similarity=0.262 Sum_probs=227.2
Q ss_pred ceeccccccccCcccccCCcccCCCCCCCEEEccCCcccCccCcccccCCcc-eeeccCccccccCCccCcCcCCCcEEE
Q 004400 16 KTVNQKRVLKEQNLTGVLPPKLAELTFLQDIDLTLNYLSGTIPSQWASLPLL-NISLIANRLKGPIPKYLANISTLVNLT 94 (756)
Q Consensus 16 ~~~~~~l~L~~~~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L-~l~l~~n~~~~~~p~~l~~l~~L~~L~ 94 (756)
.+.++.+++++++++ .+|..+. ++|+.|+|++|.+++..|..|..++.| .|++.+|++.+..|..|.++++|++|+
T Consensus 32 ~c~l~~l~~~~~~l~-~ip~~~~--~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 108 (332)
T 2ft3_A 32 HCHLRVVQCSDLGLK-AVPKEIS--PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLY 108 (332)
T ss_dssp EEETTEEECCSSCCS-SCCSCCC--TTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGSTTCTTCCEEE
T ss_pred cccCCEEECCCCCcc-ccCCCCC--CCCeEEECCCCcCCccCHhHhhCCCCCcEEECCCCccCccCHhHhhCcCCCCEEE
Confidence 357899999999998 5676664 789999999999997778889999988 488999999988899999999999999
Q ss_pred eecCcccccCCcccCCCCCCcEEeccCCeecccCCccccCCCCCCEEEeeCCccc--ccCChhhcCcCCCcEEEccCCcC
Q 004400 95 VQYNQFSGELPEELGSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRISDNQFT--GQIPSFIQNWTKLEKLFIQPSGL 172 (756)
Q Consensus 95 L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~--~~~p~~~~~l~~L~~L~l~~N~l 172 (756)
|++|+++ .+|..+. ++|++|+|++|++++..+..|.++++|+.|++++|+++ +..+..|..+ +|+.|++++|++
T Consensus 109 L~~n~l~-~l~~~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l-~L~~L~l~~n~l 184 (332)
T 2ft3_A 109 ISKNHLV-EIPPNLP--SSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGL-KLNYLRISEAKL 184 (332)
T ss_dssp CCSSCCC-SCCSSCC--TTCCEEECCSSCCCCCCSGGGSSCSSCCEEECCSCCCBGGGSCTTSSCSC-CCSCCBCCSSBC
T ss_pred CCCCcCC-ccCcccc--ccCCEEECCCCccCccCHhHhCCCccCCEEECCCCccccCCCCcccccCC-ccCEEECcCCCC
Confidence 9999998 6776665 79999999999999776777999999999999999996 4778888888 999999999999
Q ss_pred cCCCCccccCCCCCCeEEccCCCCCCCCccccccc-cccEEEcccccccCCCCccccCCCCCcEEEccCCcCCCCCCccC
Q 004400 173 AGPIPSGIFSLENLTDLRISDLNGPEATFPQLGNM-KMTKLILRNCNITGELPRYLGKMTKLKVLDLSFNRLRGQIPSNF 251 (756)
Q Consensus 173 ~~~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~-~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~ 251 (756)
++ +|..+. ++|++|++++|.+....+..+... +|+.|+|++|.+++..+..|..+++|+.|+|++|+++ .+|..+
T Consensus 185 ~~-l~~~~~--~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~l 260 (332)
T 2ft3_A 185 TG-IPKDLP--ETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLS-RVPAGL 260 (332)
T ss_dssp SS-CCSSSC--SSCSCCBCCSSCCCCCCTTSSTTCTTCSCCBCCSSCCCCCCTTGGGGCTTCCEEECCSSCCC-BCCTTG
T ss_pred Cc-cCcccc--CCCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCCcCChhHhhCCCCCCEEECCCCcCe-ecChhh
Confidence 85 666655 789999999999998887777665 6999999999999888888999999999999999999 788889
Q ss_pred cCCCCCCeEEecCccccccCCchh--------hcCCCeeEeecCCCC
Q 004400 252 DDLYDVDYIYFAGNLLTGAIPPWM--------LERGDKIDLSYNNFT 290 (756)
Q Consensus 252 ~~l~~L~~L~ls~N~l~~~~p~~~--------~~~l~~l~ls~N~l~ 290 (756)
..+++|+.|++++|++++..+..+ ...++.+++++|++.
T Consensus 261 ~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~~l~~L~l~~N~~~ 307 (332)
T 2ft3_A 261 PDLKLLQVVYLHTNNITKVGVNDFCPVGFGVKRAYYNGISLFNNPVP 307 (332)
T ss_dssp GGCTTCCEEECCSSCCCBCCTTSSSCSSCCSSSCCBSEEECCSSSSC
T ss_pred hcCccCCEEECCCCCCCccChhHccccccccccccccceEeecCccc
Confidence 999999999999999986554443 245778999999987
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.96 E-value=4.5e-29 Score=287.84 Aligned_cols=288 Identities=15% Similarity=0.137 Sum_probs=203.3
Q ss_pred ceeccccccccCcccccCCcccCCCCCCCEEEccCCcccCccCcccccCCcc-eeeccCccccccCCccCcCcCCCcEEE
Q 004400 16 KTVNQKRVLKEQNLTGVLPPKLAELTFLQDIDLTLNYLSGTIPSQWASLPLL-NISLIANRLKGPIPKYLANISTLVNLT 94 (756)
Q Consensus 16 ~~~~~~l~L~~~~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L-~l~l~~n~~~~~~p~~l~~l~~L~~L~ 94 (756)
+..++.+++++|.++...+..|..+++|+.|+|++|.|++..|..|..++.| .|++.+|.+.+..|..|+++++|+.|+
T Consensus 50 l~~l~~l~l~~~~l~~lp~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 129 (597)
T 3oja_B 50 LNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLV 129 (597)
T ss_dssp GCCCSEEEESSCEESEECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred CCCceEEEeeCCCCCCcCHHHHccCCCCcEEECCCCCCCCCChHHhcCCCCCCEEECCCCcCCCCCHHHHcCCCCCCEEE
Confidence 3556667777777776666666777777777777777776666677777777 377777777777777777777777777
Q ss_pred eecCcccccCCcccCCCCCCcEEeccCCeecccCCccccCCCCCCEEEeeCCcccccCChhhcCcCCCcEEE--------
Q 004400 95 VQYNQFSGELPEELGSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRISDNQFTGQIPSFIQNWTKLEKLF-------- 166 (756)
Q Consensus 95 L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~-------- 166 (756)
|++|.|++..+..|+++++|++|+|++|++++..|..|..+++|+.|+|++|++++.. ++.+++|+.|+
T Consensus 130 L~~n~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~---~~~l~~L~~L~l~~n~l~~ 206 (597)
T 3oja_B 130 LERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHVD---LSLIPSLFHANVSYNLLST 206 (597)
T ss_dssp CCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECTTSCCSBCC---GGGCTTCSEEECCSSCCSE
T ss_pred eeCCCCCCCCHHHhccCCCCCEEEeeCCcCCCCChhhhhcCCcCcEEECcCCCCCCcC---hhhhhhhhhhhcccCcccc
Confidence 7777777554455677777777777777777777777777777777777777777542 33344444444
Q ss_pred -----------ccCCcCcCCCCccccCCCCCCeEEccCCCCCCCCccccccc-cccEEEcccccccCCCCccccCCCCCc
Q 004400 167 -----------IQPSGLAGPIPSGIFSLENLTDLRISDLNGPEATFPQLGNM-KMTKLILRNCNITGELPRYLGKMTKLK 234 (756)
Q Consensus 167 -----------l~~N~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~-~L~~L~L~~n~l~~~~p~~~~~l~~L~ 234 (756)
+++|.+... +..+ .++|+.|++++|.+... ..+... +|+.|+|++|.+++.+|..|+.+++|+
T Consensus 207 l~~~~~L~~L~ls~n~l~~~-~~~~--~~~L~~L~L~~n~l~~~--~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~ 281 (597)
T 3oja_B 207 LAIPIAVEELDASHNSINVV-RGPV--NVELTILKLQHNNLTDT--AWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLE 281 (597)
T ss_dssp EECCTTCSEEECCSSCCCEE-ECSC--CSCCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCEEESGGGTTCSSCC
T ss_pred ccCCchhheeeccCCccccc-cccc--CCCCCEEECCCCCCCCC--hhhccCCCCCEEECCCCccCCCCHHHhcCccCCC
Confidence 444444422 2211 25788888888887764 334443 589999999999988888899999999
Q ss_pred EEEccCCcCCCCCCccCcCCCCCCeEEecCccccccCCchh--hcCCCeeEeecCCCCCCCCcccccccCcccccccccc
Q 004400 235 VLDLSFNRLRGQIPSNFDDLYDVDYIYFAGNLLTGAIPPWM--LERGDKIDLSYNNFTDGSAESSCQKRSVTGIVSCLRS 312 (756)
Q Consensus 235 ~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~--~~~l~~l~ls~N~l~~~~~~~~~~~~~~~~~~~~~~~ 312 (756)
.|+|++|.+++ +|..+..+++|+.|+|++|.++ .+|.++ +++|+.|++++|.+++.+.. ....+..+....++
T Consensus 282 ~L~Ls~N~l~~-l~~~~~~l~~L~~L~Ls~N~l~-~i~~~~~~l~~L~~L~L~~N~l~~~~~~---~~~~L~~L~l~~N~ 356 (597)
T 3oja_B 282 RLYISNNRLVA-LNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIVTLKLS---THHTLKNLTLSHND 356 (597)
T ss_dssp EEECTTSCCCE-EECSSSCCTTCCEEECCSSCCC-CCGGGHHHHTTCSEEECCSSCCCCCCCC---TTCCCSEEECCSSC
T ss_pred EEECCCCCCCC-CCcccccCCCCcEEECCCCCCC-ccCcccccCCCCCEEECCCCCCCCcChh---hcCCCCEEEeeCCC
Confidence 99999999985 5767778899999999999998 567665 78899999999998876422 22344444455555
Q ss_pred cccC
Q 004400 313 VQCP 316 (756)
Q Consensus 313 ~~c~ 316 (756)
+.|.
T Consensus 357 ~~~~ 360 (597)
T 3oja_B 357 WDCN 360 (597)
T ss_dssp EEHH
T ss_pred CCCh
Confidence 5554
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=9e-29 Score=290.47 Aligned_cols=283 Identities=18% Similarity=0.215 Sum_probs=245.2
Q ss_pred eeccceeccccccccCcccccCCcccCCCCCCCEEEccCCcccCc--cCcccccC--Ccc-eeeccCccccccCCccCcC
Q 004400 12 FWKQKTVNQKRVLKEQNLTGVLPPKLAELTFLQDIDLTLNYLSGT--IPSQWASL--PLL-NISLIANRLKGPIPKYLAN 86 (756)
Q Consensus 12 ~~~~~~~~~~l~L~~~~l~~~~p~~l~~l~~L~~L~L~~n~l~~~--~p~~~~~l--~~L-~l~l~~n~~~~~~p~~l~~ 86 (756)
.|..+..++.|+|++|++++..+..|..+++|+.|+|++|.++.. .+..|..+ +.| .+++.+|++.+..|..|.+
T Consensus 324 ~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~~~~~~l~~~~f~~~~~~~L~~L~L~~n~l~~~~~~~~~~ 403 (680)
T 1ziw_A 324 SFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSW 403 (680)
T ss_dssp TTTTCTTCCEEECCSCCBCCCCTTTTTTCTTCCEEECTTCBSCCCEECTTTTGGGTTSCCCEEECTTSCCCEECTTTTTT
T ss_pred hcccCCCCCEEECCCCccCCCChhHhccccCCcEEECCCCchhhhhcchhhhcccccCcCceEECCCCCCCeEChhhhhC
Confidence 456778888888999999888888888889999999988875432 22334433 345 5889999999999999999
Q ss_pred cCCCcEEEeecCcccccCC-cccCCCCCCcEEeccCCeecccCCccccCCCCCCEEEeeCCccc--ccCChhhcCcCCCc
Q 004400 87 ISTLVNLTVQYNQFSGELP-EELGSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRISDNQFT--GQIPSFIQNWTKLE 163 (756)
Q Consensus 87 l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~--~~~p~~~~~l~~L~ 163 (756)
+++|+.|+|++|.+++.+| ..|.++++|++|+|++|++++..+..|..+++|+.|++++|.++ +.+|..|.++++|+
T Consensus 404 l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~p~~~~~l~~L~ 483 (680)
T 1ziw_A 404 LGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLT 483 (680)
T ss_dssp CTTCCEEECCSSCCEEECCSGGGTTCTTCCEEECCSCSEEECCTTTTTTCTTCCEEECTTSCCBCTTCSSCTTTTCTTCC
T ss_pred CCCCCEEeCCCCcCccccCcccccCcccccEEecCCCCcceeChhhhhcCcccccchhccccccccccCCcccccCCCCC
Confidence 9999999999999998776 68999999999999999999889999999999999999999987 57899999999999
Q ss_pred EEEccCCcCcCCCCccccCCCCCCeEEccCCCCCCCCcc--------ccccc-cccEEEcccccccCCCCccccCCCCCc
Q 004400 164 KLFIQPSGLAGPIPSGIFSLENLTDLRISDLNGPEATFP--------QLGNM-KMTKLILRNCNITGELPRYLGKMTKLK 234 (756)
Q Consensus 164 ~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~~~--------~~~~~-~L~~L~L~~n~l~~~~p~~~~~l~~L~ 234 (756)
.|+|++|++++..+..+..+++|++|++++|.+...... .+... +|+.|+|++|+++...+..|.++++|+
T Consensus 484 ~L~Ls~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~ 563 (680)
T 1ziw_A 484 ILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELK 563 (680)
T ss_dssp EEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCGGGGSTTSTTSCCCTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCC
T ss_pred EEECCCCCCCcCChhhhccccccCEEeCCCCCccccchhhccCCcchhhcCCCCCCEEECCCCCCCCCCHHHcccccCcc
Confidence 999999999988888899999999999999999875322 24443 699999999999966666799999999
Q ss_pred EEEccCCcCCCCCCccCcCCCCCCeEEecCccccccCCchh---hcCCCeeEeecCCCCCCCC
Q 004400 235 VLDLSFNRLRGQIPSNFDDLYDVDYIYFAGNLLTGAIPPWM---LERGDKIDLSYNNFTDGSA 294 (756)
Q Consensus 235 ~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~---~~~l~~l~ls~N~l~~~~~ 294 (756)
.|+|++|++++..+..|..+++|+.|++++|++++..|..+ +++++.+++++|++.|.+.
T Consensus 564 ~L~Ls~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~l~l~~N~~~c~c~ 626 (680)
T 1ziw_A 564 IIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDCTCE 626 (680)
T ss_dssp EEECCSSCCCCCCTTTTTTCTTCCEEECTTSCCCBCCHHHHHHHHTTCSEEECTTCCCCBCCC
T ss_pred eeECCCCCCCcCCHhHhCCCCCCCEEECCCCcCCccChhHhcccccccCEEEccCCCcccCCc
Confidence 99999999998888889999999999999999997666543 6899999999999998754
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=7.9e-29 Score=288.29 Aligned_cols=306 Identities=17% Similarity=0.162 Sum_probs=226.5
Q ss_pred eeccccccccCcccccCCcccCCCCCCCEEEccCCcccCccCcccccCCcce-eeccCccccccCCccCcCcCCCcEEEe
Q 004400 17 TVNQKRVLKEQNLTGVLPPKLAELTFLQDIDLTLNYLSGTIPSQWASLPLLN-ISLIANRLKGPIPKYLANISTLVNLTV 95 (756)
Q Consensus 17 ~~~~~l~L~~~~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~-l~l~~n~~~~~~p~~l~~l~~L~~L~L 95 (756)
+.++.|+|++|+|++..+..|.++++|++|+|++|+|++..|.+|..++.|+ |+|.+|++.+..+..|.++++|++|+|
T Consensus 52 ~~~~~LdLs~N~i~~l~~~~f~~l~~L~~L~Ls~N~i~~i~~~~f~~L~~L~~L~Ls~N~l~~l~~~~f~~L~~L~~L~L 131 (635)
T 4g8a_A 52 FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVA 131 (635)
T ss_dssp TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECGGGGTTCTTCCEEEC
T ss_pred cCCCEEEeeCCCCCCCCHHHHhCCCCCCEEECCCCcCCCcChhHhcCCCCCCEEEccCCcCCCCCHHHhcCCCCCCEEEC
Confidence 3678889999999988888899999999999999999877778888888884 888888888777778899999999999
Q ss_pred ecCcccccCCcccCCCCCCcEEeccCCeecc-cCCccccCCCCCCEEEeeCCcccccCChhhcCcC--------------
Q 004400 96 QYNQFSGELPEELGSLLNLEKLHLSSNNFTG-ELPKTFAKLTNMKDFRISDNQFTGQIPSFIQNWT-------------- 160 (756)
Q Consensus 96 ~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~-~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~-------------- 160 (756)
++|+|++..+..|+++++|++|+|++|++++ .+|..++.+++|++|+|++|+|++..+..|..+.
T Consensus 132 s~N~l~~l~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~L~~l~~~~~~~~ls~n 211 (635)
T 4g8a_A 132 VETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLN 211 (635)
T ss_dssp TTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGGGHHHHTCTTCCCEEECTTC
T ss_pred CCCcCCCCChhhhhcCcccCeeccccCccccCCCchhhccchhhhhhcccCccccccccccccchhhhhhhhhhhhcccC
Confidence 9999987777778899999999999999875 3577888889999999998888765544332221
Q ss_pred --------------------------------------------------------------------------------
Q 004400 161 -------------------------------------------------------------------------------- 160 (756)
Q Consensus 161 -------------------------------------------------------------------------------- 160 (756)
T Consensus 212 ~l~~i~~~~~~~~~~~~l~l~~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~~l~~~~~ 291 (635)
T 4g8a_A 212 PMNFIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYL 291 (635)
T ss_dssp CCCEECTTTTTTCEEEEEEEESCCSSHHHHHHHHHTTTTCEEEEEEEECCTTSCCCSCCCTTTTGGGGGSEEEEEEEECC
T ss_pred cccccCcccccchhhhhhhhhcccccccccchhhcCCcccccccccccccccccccccccccccccccchhhhhhhhhhh
Confidence
Q ss_pred -------------------------------------CCcEEEccCCcCcCCCC-------------------ccccCCC
Q 004400 161 -------------------------------------KLEKLFIQPSGLAGPIP-------------------SGIFSLE 184 (756)
Q Consensus 161 -------------------------------------~L~~L~l~~N~l~~~~p-------------------~~~~~l~ 184 (756)
.|+.|++.+|.+.+..+ .....++
T Consensus 292 ~~~~~~~~~~~~~~~~l~~l~~~~~~~~~~~~~~~~~~L~~L~l~~~~~~~~~~~~l~~L~~l~l~~n~~~~~~~~~~l~ 371 (635)
T 4g8a_A 292 DYYLDGIIDLFNCLTNVSSFSLVSVTIERVKDFSYNFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGNAFSEVDLP 371 (635)
T ss_dssp CSCEEECTTTTGGGTTCSEEEEESCEEEECGGGGSCCCCSEEEEESCEESSCCCCBCTTCCEEEEESCCSCCBCCCCBCT
T ss_pred cccccchhhhhhhhcccccccccccccccccccccchhhhhhhcccccccCcCcccchhhhhcccccccCCCCccccccc
Confidence 11222222222211000 0011234
Q ss_pred CCCeEEccCCCC--------------------------------------------------------------------
Q 004400 185 NLTDLRISDLNG-------------------------------------------------------------------- 196 (756)
Q Consensus 185 ~L~~L~l~~n~~-------------------------------------------------------------------- 196 (756)
+|+.|++++|.+
T Consensus 372 ~L~~L~ls~n~l~~~~~~~~~~~~~~~L~~L~~~~~~~~~~~~~~~~l~~L~~l~l~~~~~~~~~~~~~~~~l~~l~~l~ 451 (635)
T 4g8a_A 372 SLEFLDLSRNGLSFKGCCSQSDFGTISLKYLDLSFNGVITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLD 451 (635)
T ss_dssp TCCEEECCSSCCBEEEECCHHHHSCSCCCEEECCSCSEEEECSCCTTCTTCCEEECTTSEEESTTSSCTTTTCTTCCEEE
T ss_pred ccccchhhccccccccccccchhhhhhhhhhhccccccccccccccccccccchhhhhcccccccccccccccccccccc
Confidence 444444444433
Q ss_pred ------CCCCccccccc-cccEEEcccccc-cCCCCccccCCCCCcEEEccCCcCCCCCCccCcCCCCCCeEEecCcccc
Q 004400 197 ------PEATFPQLGNM-KMTKLILRNCNI-TGELPRYLGKMTKLKVLDLSFNRLRGQIPSNFDDLYDVDYIYFAGNLLT 268 (756)
Q Consensus 197 ------~~~~~~~~~~~-~L~~L~L~~n~l-~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~ 268 (756)
....+..+... .++.|+|++|.+ .+.+|..|..+++|++|+|++|+|++..|..|.++++|+.|+|++|+|+
T Consensus 452 ls~n~l~~~~~~~~~~~~~L~~L~Ls~N~~~~~~~~~~~~~l~~L~~L~Ls~N~L~~l~~~~f~~l~~L~~L~Ls~N~l~ 531 (635)
T 4g8a_A 452 ISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFF 531 (635)
T ss_dssp CTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCC
T ss_pred ccccccccccccccccchhhhhhhhhhcccccccCchhhhhccccCEEECCCCccCCcChHHHcCCCCCCEEECCCCcCC
Confidence 22222222222 477888888874 4467888999999999999999999999999999999999999999999
Q ss_pred ccCCchh--hcCCCeeEeecCCCCCCCCcccccc-cCcccccccccccccCCccccc
Q 004400 269 GAIPPWM--LERGDKIDLSYNNFTDGSAESSCQK-RSVTGIVSCLRSVQCPKTYYSL 322 (756)
Q Consensus 269 ~~~p~~~--~~~l~~l~ls~N~l~~~~~~~~~~~-~~~~~~~~~~~~~~c~~~~~~~ 322 (756)
+..|..+ +++|+.||+++|++++..+...... ..+..+....+++.|.+...++
T Consensus 532 ~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~~L~~L~L~~Np~~C~C~~~~~ 588 (635)
T 4g8a_A 532 SLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCEHQSF 588 (635)
T ss_dssp BCCCGGGTTCTTCCEEECTTSCCCBCCSSCTTCCCTTCCEEECTTCCBCCSGGGHHH
T ss_pred CCChhHHhCCCCCCEEECCCCcCCCCCHHHHHhhhCcCCEEEeeCCCCcccCCcHHH
Confidence 7777666 7899999999999998877766554 4566677788899998765433
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.96 E-value=2.4e-29 Score=274.74 Aligned_cols=271 Identities=19% Similarity=0.230 Sum_probs=231.3
Q ss_pred eeccceeccccccccCcccccCCcccCCCCCCCEEEccCCcccCccCcccccCCcce-eeccCccccccCCccCcCcCCC
Q 004400 12 FWKQKTVNQKRVLKEQNLTGVLPPKLAELTFLQDIDLTLNYLSGTIPSQWASLPLLN-ISLIANRLKGPIPKYLANISTL 90 (756)
Q Consensus 12 ~~~~~~~~~~l~L~~~~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~-l~l~~n~~~~~~p~~l~~l~~L 90 (756)
.+.++..++.|+|++|++++..+..|..+++|+.|+|++|.+++..|..|..++.|+ |++.+|++....+..|.++++|
T Consensus 64 ~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L 143 (390)
T 3o6n_A 64 LLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKL 143 (390)
T ss_dssp HHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTC
T ss_pred HhcccccCcEEECCCCcccccChhhccCCCCcCEEECCCCCCCcCCHHHhcCCCCCCEEECCCCccCcCCHHHhcCCCCC
Confidence 367889999999999999998888999999999999999999988888999999884 8999999996655668999999
Q ss_pred cEEEeecCcccccCCcccCCCCCCcEEeccCCeecccCCccccCCCC-------------------CCEEEeeCCccccc
Q 004400 91 VNLTVQYNQFSGELPEELGSLLNLEKLHLSSNNFTGELPKTFAKLTN-------------------MKDFRISDNQFTGQ 151 (756)
Q Consensus 91 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~-------------------L~~L~L~~N~l~~~ 151 (756)
++|+|++|.+++..+..|..+++|++|+|++|++++.. +..+++ |+.|++++|+++..
T Consensus 144 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~---~~~l~~L~~L~l~~n~l~~~~~~~~L~~L~l~~n~l~~~ 220 (390)
T 3o6n_A 144 TTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHVD---LSLIPSLFHANVSYNLLSTLAIPIAVEELDASHNSINVV 220 (390)
T ss_dssp CEEECCSSCCCBCCTTTTSSCTTCCEEECCSSCCSBCC---GGGCTTCSEEECCSSCCSEEECCSSCSEEECCSSCCCEE
T ss_pred cEEECCCCccCccChhhccCCCCCCEEECCCCcCCccc---cccccccceeecccccccccCCCCcceEEECCCCeeeec
Confidence 99999999999888888999999999999999998543 334444 45555555555532
Q ss_pred CChhhcCcCCCcEEEccCCcCcCCCCccccCCCCCCeEEccCCCCCCCCccccccc-cccEEEcccccccCCCCccccCC
Q 004400 152 IPSFIQNWTKLEKLFIQPSGLAGPIPSGIFSLENLTDLRISDLNGPEATFPQLGNM-KMTKLILRNCNITGELPRYLGKM 230 (756)
Q Consensus 152 ~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~-~L~~L~L~~n~l~~~~p~~~~~l 230 (756)
|.. ..++|+.|++++|++++. ..+..+++|++|++++|.+....+..+..+ +|+.|+|++|++++ +|..+..+
T Consensus 221 -~~~--~~~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~-~~~~~~~l 294 (390)
T 3o6n_A 221 -RGP--VNVELTILKLQHNNLTDT--AWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVA-LNLYGQPI 294 (390)
T ss_dssp -ECC--CCSSCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCEEESGGGTTCSSCCEEECCSSCCCE-EECSSSCC
T ss_pred -ccc--ccccccEEECCCCCCccc--HHHcCCCCccEEECCCCcCCCcChhHccccccCCEEECCCCcCcc-cCcccCCC
Confidence 222 247899999999999863 688999999999999999999877777765 69999999999995 56667889
Q ss_pred CCCcEEEccCCcCCCCCCccCcCCCCCCeEEecCccccccCCchhhcCCCeeEeecCCCCCCC
Q 004400 231 TKLKVLDLSFNRLRGQIPSNFDDLYDVDYIYFAGNLLTGAIPPWMLERGDKIDLSYNNFTDGS 293 (756)
Q Consensus 231 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~~l~~l~ls~N~l~~~~ 293 (756)
++|+.|+|++|+++ .+|..+..+++|+.|++++|+++. +|...++.++.|++++|++.|..
T Consensus 295 ~~L~~L~L~~n~l~-~~~~~~~~l~~L~~L~L~~N~i~~-~~~~~~~~L~~L~l~~N~~~~~~ 355 (390)
T 3o6n_A 295 PTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIVT-LKLSTHHTLKNLTLSHNDWDCNS 355 (390)
T ss_dssp TTCCEEECCSSCCC-CCGGGHHHHTTCSEEECCSSCCCC-CCCCTTCCCSEEECCSSCEEHHH
T ss_pred CCCCEEECCCCcce-ecCccccccCcCCEEECCCCccce-eCchhhccCCEEEcCCCCccchh
Confidence 99999999999999 577778899999999999999984 46556889999999999998753
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.96 E-value=2.2e-29 Score=290.51 Aligned_cols=271 Identities=19% Similarity=0.224 Sum_probs=233.4
Q ss_pred eeccceeccccccccCcccccCCcccCCCCCCCEEEccCCcccCccCcccccCCcce-eeccCccccccCCccCcCcCCC
Q 004400 12 FWKQKTVNQKRVLKEQNLTGVLPPKLAELTFLQDIDLTLNYLSGTIPSQWASLPLLN-ISLIANRLKGPIPKYLANISTL 90 (756)
Q Consensus 12 ~~~~~~~~~~l~L~~~~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~-l~l~~n~~~~~~p~~l~~l~~L 90 (756)
.|.++..++.|+|++|++++..|..|..+++|+.|+|++|.|++..|..|+.++.|+ |++.+|++.+..+..|+++++|
T Consensus 70 ~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L 149 (597)
T 3oja_B 70 LLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKL 149 (597)
T ss_dssp HHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTC
T ss_pred HHccCCCCcEEECCCCCCCCCChHHhcCCCCCCEEECCCCcCCCCCHHHHcCCCCCCEEEeeCCCCCCCCHHHhccCCCC
Confidence 467889999999999999999999999999999999999999998888999999994 8999999997777778999999
Q ss_pred cEEEeecCcccccCCcccCCCCCCcEEeccCCeecccCCccccCCCCCCEE-------------------EeeCCccccc
Q 004400 91 VNLTVQYNQFSGELPEELGSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDF-------------------RISDNQFTGQ 151 (756)
Q Consensus 91 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L-------------------~L~~N~l~~~ 151 (756)
++|+|++|.|++..|..|+++++|++|+|++|++++.. +..+++|+.| ++++|.++..
T Consensus 150 ~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~---~~~l~~L~~L~l~~n~l~~l~~~~~L~~L~ls~n~l~~~ 226 (597)
T 3oja_B 150 TTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHVD---LSLIPSLFHANVSYNLLSTLAIPIAVEELDASHNSINVV 226 (597)
T ss_dssp CEEECCSSCCCBCCTTTTTTCTTCCEEECTTSCCSBCC---GGGCTTCSEEECCSSCCSEEECCTTCSEEECCSSCCCEE
T ss_pred CEEEeeCCcCCCCChhhhhcCCcCcEEECcCCCCCCcC---hhhhhhhhhhhcccCccccccCCchhheeeccCCccccc
Confidence 99999999999988889999999999999999999653 3344555554 5555554422
Q ss_pred CChhhcCcCCCcEEEccCCcCcCCCCccccCCCCCCeEEccCCCCCCCCccccccc-cccEEEcccccccCCCCccccCC
Q 004400 152 IPSFIQNWTKLEKLFIQPSGLAGPIPSGIFSLENLTDLRISDLNGPEATFPQLGNM-KMTKLILRNCNITGELPRYLGKM 230 (756)
Q Consensus 152 ~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~-~L~~L~L~~n~l~~~~p~~~~~l 230 (756)
+..+ .++|+.|+|++|.+++ +..+..+++|+.|++++|.+....+..+..+ +|+.|+|++|.+++ +|..+..+
T Consensus 227 -~~~~--~~~L~~L~L~~n~l~~--~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~-l~~~~~~l 300 (597)
T 3oja_B 227 -RGPV--NVELTILKLQHNNLTD--TAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVA-LNLYGQPI 300 (597)
T ss_dssp -ECSC--CSCCCEEECCSSCCCC--CGGGGGCTTCSEEECCSSCCCEEESGGGTTCSSCCEEECTTSCCCE-EECSSSCC
T ss_pred -cccc--CCCCCEEECCCCCCCC--ChhhccCCCCCEEECCCCccCCCCHHHhcCccCCCEEECCCCCCCC-CCcccccC
Confidence 2221 3689999999999996 4789999999999999999999888877766 59999999999996 56677889
Q ss_pred CCCcEEEccCCcCCCCCCccCcCCCCCCeEEecCccccccCCchhhcCCCeeEeecCCCCCCC
Q 004400 231 TKLKVLDLSFNRLRGQIPSNFDDLYDVDYIYFAGNLLTGAIPPWMLERGDKIDLSYNNFTDGS 293 (756)
Q Consensus 231 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~~l~~l~ls~N~l~~~~ 293 (756)
++|+.|+|++|.++ .+|..+..+++|+.|+|++|.+++ +|...++.|+.|++++|++.|..
T Consensus 301 ~~L~~L~Ls~N~l~-~i~~~~~~l~~L~~L~L~~N~l~~-~~~~~~~~L~~L~l~~N~~~~~~ 361 (597)
T 3oja_B 301 PTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIVT-LKLSTHHTLKNLTLSHNDWDCNS 361 (597)
T ss_dssp TTCCEEECCSSCCC-CCGGGHHHHTTCSEEECCSSCCCC-CCCCTTCCCSEEECCSSCEEHHH
T ss_pred CCCcEEECCCCCCC-ccCcccccCCCCCEEECCCCCCCC-cChhhcCCCCEEEeeCCCCCChh
Confidence 99999999999999 688888999999999999999985 45556889999999999998753
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.96 E-value=4.4e-29 Score=286.16 Aligned_cols=270 Identities=19% Similarity=0.151 Sum_probs=201.8
Q ss_pred ccceeccccccccCcccccCCcccCCCCCCCEEEccCCcccCccCcccccCCcce-eeccCccccccCCccCcCcCCCcE
Q 004400 14 KQKTVNQKRVLKEQNLTGVLPPKLAELTFLQDIDLTLNYLSGTIPSQWASLPLLN-ISLIANRLKGPIPKYLANISTLVN 92 (756)
Q Consensus 14 ~~~~~~~~l~L~~~~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~-l~l~~n~~~~~~p~~l~~l~~L~~ 92 (756)
..+...+.+++++|++++ +|..+. ++|+.|+|++|.|++..|..|..++.|+ |++.+|++.+..|..|.++++|++
T Consensus 28 ~~~~~~~~l~ls~~~L~~-ip~~~~--~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~ 104 (562)
T 3a79_B 28 FSNELESMVDYSNRNLTH-VPKDLP--PRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDLEY 104 (562)
T ss_dssp -----CCEEECTTSCCCS-CCTTSC--TTCCEEECCSSCCCCCCGGGTTTCTTCCEEECCSCCCCEECTTTTTTCTTCCE
T ss_pred cccCCCcEEEcCCCCCcc-CCCCCC--CCcCEEECCCCCccccChhhhccCCCccEEECCCCCCCcCCHHHhCCCCCCCE
Confidence 444555789999999996 676665 8999999999999988889999999995 899999999999999999999999
Q ss_pred EEeecCcccccCCcccCCCCCCcEEeccCCeecc-cCCccccCCCCCCEEEeeCCcccccCChhhcCcCCC--cEEEccC
Q 004400 93 LTVQYNQFSGELPEELGSLLNLEKLHLSSNNFTG-ELPKTFAKLTNMKDFRISDNQFTGQIPSFIQNWTKL--EKLFIQP 169 (756)
Q Consensus 93 L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~-~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L--~~L~l~~ 169 (756)
|+|++|+|+ .+|.. .+++|++|+|++|++++ .+|..|+++++|++|+|++|++++. .+..+++| +.|++++
T Consensus 105 L~Ls~N~l~-~lp~~--~l~~L~~L~Ls~N~l~~l~~p~~~~~l~~L~~L~L~~n~l~~~---~~~~l~~L~L~~L~L~~ 178 (562)
T 3a79_B 105 LDVSHNRLQ-NISCC--PMASLRHLDLSFNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQL---DLLPVAHLHLSCILLDL 178 (562)
T ss_dssp EECTTSCCC-EECSC--CCTTCSEEECCSSCCSBCCCCGGGGGCTTCCEEEEECSBCCTT---TTGGGTTSCEEEEEEEE
T ss_pred EECCCCcCC-ccCcc--ccccCCEEECCCCCccccCchHhhcccCcccEEecCCCccccC---chhhhhhceeeEEEeec
Confidence 999999999 67766 89999999999999996 3568999999999999999998853 34445555 7777777
Q ss_pred CcC--cCCCCccccCCC---------------------------------------------------------------
Q 004400 170 SGL--AGPIPSGIFSLE--------------------------------------------------------------- 184 (756)
Q Consensus 170 N~l--~~~~p~~~~~l~--------------------------------------------------------------- 184 (756)
|++ ++..|..+..+.
T Consensus 179 n~l~~~~~~~~~l~~l~~~~l~l~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~l~~~~~~l~~l~~L~~L~L~~ 258 (562)
T 3a79_B 179 VSYHIKGGETESLQIPNTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQH 258 (562)
T ss_dssp SSCCCCSSSCCEEEECCEEEEEEEECSSSCCCCCCEEEESSEEEEEEEEEECCSTTHHHHHHHHHHHHSCSSCEEEEEEE
T ss_pred ccccccccCcccccccCcceEEEEecCccchhhhhhhcccccceEEEecccccccccchHHHHHHHHhccCcceEEEecC
Confidence 766 555454444322
Q ss_pred ------------------CCCeEEccCCCCCCCCcccc------------------------------------------
Q 004400 185 ------------------NLTDLRISDLNGPEATFPQL------------------------------------------ 204 (756)
Q Consensus 185 ------------------~L~~L~l~~n~~~~~~~~~~------------------------------------------ 204 (756)
+|++|++++|.+....+..+
T Consensus 259 ~~l~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~ip~~~~~~~~~~L~~L~~~~~~~~~~~~p~~~~~~~~~~~~L~~L~l 338 (562)
T 3a79_B 259 IETTWKCSVKLFQFFWPRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSI 338 (562)
T ss_dssp EEECHHHHHHHHHHHTTSSEEEEEEEEEEECSCCCCCCCCCCSCSCCEEEEEEEEECCCSSCHHHHHHHHHTCCCSEEEE
T ss_pred CcCcHHHHHHHHHhhhcccccEEEEeccEeeccccchhhhcccccchheehhhcccceeecChhhhhhhhccCcceEEEc
Confidence 44444554444442211111
Q ss_pred -----------cc-ccccEEEcccccccCCCCccccCCCCCcEEEccCCcCCCC--CCccCcCCCCCCeEEecCcccccc
Q 004400 205 -----------GN-MKMTKLILRNCNITGELPRYLGKMTKLKVLDLSFNRLRGQ--IPSNFDDLYDVDYIYFAGNLLTGA 270 (756)
Q Consensus 205 -----------~~-~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~--~p~~~~~l~~L~~L~ls~N~l~~~ 270 (756)
.. .+|++|++++|.+++.+|..+.++++|+.|+|++|++++. +|..|..+++|+.|++++|.+++.
T Consensus 339 ~~n~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~L~~L~l~~N~l~~~ 418 (562)
T 3a79_B 339 SDTPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLDVSLNSLNSH 418 (562)
T ss_dssp ESSCCCCCCCCSSCCCCCEEECCSSCCCTTTTTTCCSCSSCCEEECCSSCCCBTTHHHHTTTTCTTCCEEECTTSCCBSC
T ss_pred cCCCcccccCccCCCCceEEECCCCccccchhhhhcccCCCCEEECCCCCcCCcccchhhhcCCCCCCEEECCCCcCCCc
Confidence 22 2477888888888877777778888888888888887752 245677778888888888888765
Q ss_pred CCchh---hcCCCeeEeecCCCCCC
Q 004400 271 IPPWM---LERGDKIDLSYNNFTDG 292 (756)
Q Consensus 271 ~p~~~---~~~l~~l~ls~N~l~~~ 292 (756)
+|... +++++.|++++|.+++.
T Consensus 419 ~~~~~~~~l~~L~~L~l~~n~l~~~ 443 (562)
T 3a79_B 419 AYDRTCAWAESILVLNLSSNMLTGS 443 (562)
T ss_dssp CSSCCCCCCTTCCEEECCSSCCCGG
T ss_pred cChhhhcCcccCCEEECCCCCCCcc
Confidence 66543 56777777777777653
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=99.96 E-value=9.3e-29 Score=263.92 Aligned_cols=264 Identities=19% Similarity=0.242 Sum_probs=231.1
Q ss_pred eeccccccccCcccccCCcccCCCCCCCEEEccCCcccCccCcccccCCcce-eeccCccccccCCccCcCcCCCcEEEe
Q 004400 17 TVNQKRVLKEQNLTGVLPPKLAELTFLQDIDLTLNYLSGTIPSQWASLPLLN-ISLIANRLKGPIPKYLANISTLVNLTV 95 (756)
Q Consensus 17 ~~~~~l~L~~~~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~-l~l~~n~~~~~~p~~l~~l~~L~~L~L 95 (756)
..++.|+|++|++++..|..|.++++|+.|+|++|.+++..|..|..++.|+ |++.+|++. .+|..+. ++|++|+|
T Consensus 54 ~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~-~l~~~~~--~~L~~L~l 130 (332)
T 2ft3_A 54 PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYISKNHLV-EIPPNLP--SSLVELRI 130 (332)
T ss_dssp TTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGSTTCTTCCEEECCSSCCC-SCCSSCC--TTCCEEEC
T ss_pred CCCeEEECCCCcCCccCHhHhhCCCCCcEEECCCCccCccCHhHhhCcCCCCEEECCCCcCC-ccCcccc--ccCCEEEC
Confidence 4688999999999999889999999999999999999988899999999995 899999988 6666665 89999999
Q ss_pred ecCcccccCCcccCCCCCCcEEeccCCeec--ccCCccccCCCCCCEEEeeCCcccccCChhhcCcCCCcEEEccCCcCc
Q 004400 96 QYNQFSGELPEELGSLLNLEKLHLSSNNFT--GELPKTFAKLTNMKDFRISDNQFTGQIPSFIQNWTKLEKLFIQPSGLA 173 (756)
Q Consensus 96 ~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~--~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~ 173 (756)
++|++++..+..|.++++|+.|+|++|+++ +..+..+..+ +|+.|++++|++++ +|..+. ++|++|+|++|+++
T Consensus 131 ~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l-~L~~L~l~~n~l~~-l~~~~~--~~L~~L~l~~n~i~ 206 (332)
T 2ft3_A 131 HDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGL-KLNYLRISEAKLTG-IPKDLP--ETLNELHLDHNKIQ 206 (332)
T ss_dssp CSSCCCCCCSGGGSSCSSCCEEECCSCCCBGGGSCTTSSCSC-CCSCCBCCSSBCSS-CCSSSC--SSCSCCBCCSSCCC
T ss_pred CCCccCccCHhHhCCCccCCEEECCCCccccCCCCcccccCC-ccCEEECcCCCCCc-cCcccc--CCCCEEECCCCcCC
Confidence 999999777778999999999999999996 4778888888 99999999999995 666554 79999999999999
Q ss_pred CCCCccccCCCCCCeEEccCCCCCCCCccccccc-cccEEEcccccccCCCCccccCCCCCcEEEccCCcCCCCCCccCc
Q 004400 174 GPIPSGIFSLENLTDLRISDLNGPEATFPQLGNM-KMTKLILRNCNITGELPRYLGKMTKLKVLDLSFNRLRGQIPSNFD 252 (756)
Q Consensus 174 ~~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~-~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~ 252 (756)
+..+..+..+++|+.|++++|.+....+..+... +|+.|+|++|+++ .+|..+..+++|+.|+|++|++++..+..|.
T Consensus 207 ~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~L~~L~l~~N~l~~~~~~~~~ 285 (332)
T 2ft3_A 207 AIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNITKVGVNDFC 285 (332)
T ss_dssp CCCTTSSTTCTTCSCCBCCSSCCCCCCTTGGGGCTTCCEEECCSSCCC-BCCTTGGGCTTCCEEECCSSCCCBCCTTSSS
T ss_pred ccCHHHhcCCCCCCEEECCCCcCCcCChhHhhCCCCCCEEECCCCcCe-ecChhhhcCccCCEEECCCCCCCccChhHcc
Confidence 8888999999999999999999999888777665 6999999999999 7888899999999999999999987777776
Q ss_pred CC------CCCCeEEecCcccc--ccCCchh--hcCCCeeEeecCC
Q 004400 253 DL------YDVDYIYFAGNLLT--GAIPPWM--LERGDKIDLSYNN 288 (756)
Q Consensus 253 ~l------~~L~~L~ls~N~l~--~~~p~~~--~~~l~~l~ls~N~ 288 (756)
.+ ++|+.|++++|++. +..|..+ ++.++.+++++|.
T Consensus 286 ~~~~~~~~~~l~~L~l~~N~~~~~~~~~~~~~~l~~L~~l~l~~n~ 331 (332)
T 2ft3_A 286 PVGFGVKRAYYNGISLFNNPVPYWEVQPATFRCVTDRLAIQFGNYK 331 (332)
T ss_dssp CSSCCSSSCCBSEEECCSSSSCGGGSCGGGGTTBCCSTTEEC----
T ss_pred ccccccccccccceEeecCcccccccCcccccccchhhhhhccccc
Confidence 54 67999999999987 4555555 7788999998874
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=6.5e-29 Score=285.45 Aligned_cols=183 Identities=25% Similarity=0.211 Sum_probs=147.1
Q ss_pred CCcEEeccCCeecccC--CccccCCCCCCEEEeeCCcccccCChhhcCcCCCcEEEccCCcCcCCCC-ccccCCCCCCeE
Q 004400 113 NLEKLHLSSNNFTGEL--PKTFAKLTNMKDFRISDNQFTGQIPSFIQNWTKLEKLFIQPSGLAGPIP-SGIFSLENLTDL 189 (756)
Q Consensus 113 ~L~~L~L~~N~l~~~~--p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p-~~~~~l~~L~~L 189 (756)
+|++|+|++|++++.. |..+..+++|+.|++++|++++..+ .+.++++|+.|++++|.+.+..+ ..+..+++|++|
T Consensus 348 ~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~-~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L 426 (570)
T 2z63_A 348 SLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVITMSS-NFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYL 426 (570)
T ss_dssp TCCEEECCSSCCBEEEEEEHHHHTCSCCCEEECCSCSEEEEEE-EEETCTTCCEEECTTSEEESCTTSCTTTTCTTCCEE
T ss_pred CCCEEeCcCCccCccccccccccccCccCEEECCCCccccccc-cccccCCCCEEEccCCccccccchhhhhcCCCCCEE
Confidence 3344444444443222 3445556666677777777664433 37888888888888888887666 578899999999
Q ss_pred EccCCCCCCCCccccccc-cccEEEccccccc-CCCCccccCCCCCcEEEccCCcCCCCCCccCcCCCCCCeEEecCccc
Q 004400 190 RISDLNGPEATFPQLGNM-KMTKLILRNCNIT-GELPRYLGKMTKLKVLDLSFNRLRGQIPSNFDDLYDVDYIYFAGNLL 267 (756)
Q Consensus 190 ~l~~n~~~~~~~~~~~~~-~L~~L~L~~n~l~-~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l 267 (756)
++++|.+....+..+..+ +|+.|+|++|.++ +.+|..|..+++|+.|+|++|++++..|..|..+++|+.|++++|.+
T Consensus 427 ~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l 506 (570)
T 2z63_A 427 DISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQL 506 (570)
T ss_dssp ECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCC
T ss_pred eCcCCcccccchhhhhcCCcCcEEECcCCcCccccchhhhhcccCCCEEECCCCccccCChhhhhcccCCCEEeCCCCcC
Confidence 999999998887777665 6999999999998 67899999999999999999999998899999999999999999999
Q ss_pred cccCCchh--hcCCCeeEeecCCCCCCCCcc
Q 004400 268 TGAIPPWM--LERGDKIDLSYNNFTDGSAES 296 (756)
Q Consensus 268 ~~~~p~~~--~~~l~~l~ls~N~l~~~~~~~ 296 (756)
++..|..+ ++.++.+++++|+++|..+..
T Consensus 507 ~~~~~~~~~~l~~L~~L~l~~N~~~~~~~~~ 537 (570)
T 2z63_A 507 KSVPDGIFDRLTSLQKIWLHTNPWDCSCPRI 537 (570)
T ss_dssp SCCCTTTTTTCTTCCEEECCSSCBCCCTTTT
T ss_pred CCCCHHHhhcccCCcEEEecCCcccCCCcch
Confidence 98777655 789999999999999876543
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=2.9e-30 Score=293.60 Aligned_cols=186 Identities=17% Similarity=0.135 Sum_probs=132.1
Q ss_pred CcccCCCCccEEEee-ccCCcEEEEEEccccC----------cccHHHHHHHHHHHHhC-CCCceeeEeeEEEeCCeEEE
Q 004400 422 NNIGEGGFGPVYKGL-LADGTAIAVKQLSSKS----------KQGNREFINEIGMISAL-QHPNLVKLYGCCIEGNQLLL 489 (756)
Q Consensus 422 ~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~----------~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l 489 (756)
...+.|++|.++.++ .-.|+.||||++.... ....++|.+|+++|+++ .|+||+++++++.+++..||
T Consensus 240 ~~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yL 319 (569)
T 4azs_A 240 NQPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWL 319 (569)
T ss_dssp CC-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEE
T ss_pred hccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEE
Confidence 356778888777766 4568999999986531 12335799999999999 79999999999999999999
Q ss_pred EEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCccc
Q 004400 490 IYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEE 569 (756)
Q Consensus 490 V~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~~ 569 (756)
||||++|++|.++|... ..++.. +|+.||+.||+|+|++| ||||||||+|||+++++.+||+|||+|+.....
T Consensus 320 VMEyv~G~~L~d~i~~~-~~l~~~---~I~~QIl~AL~ylH~~G---IIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~ 392 (569)
T 4azs_A 320 VMEKLPGRLLSDMLAAG-EEIDRE---KILGSLLRSLAALEKQG---FWHDDVRPWNVMVDARQHARLIDFGSIVTTPQD 392 (569)
T ss_dssp EEECCCSEEHHHHHHTT-CCCCHH---HHHHHHHHHHHHHHHTT---CEESCCCGGGEEECTTSCEEECCCTTEESCC--
T ss_pred EEecCCCCcHHHHHHhC-CCCCHH---HHHHHHHHHHHHHHHCC---ceeccCchHhEEECCCCCEEEeecccCeeCCCC
Confidence 99999999999999754 356653 58899999999999997 999999999999999999999999999876543
Q ss_pred CcceeeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHhCCCC
Q 004400 570 NTHISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSN 616 (756)
Q Consensus 570 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p 616 (756)
.. .....+||++|||||++.+ .+..++|+||+|++++++.++..+
T Consensus 393 ~~-~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~ 437 (569)
T 4azs_A 393 CS-WPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSN 437 (569)
T ss_dssp -C-CSHHHHHHHHHHHHHHC------------------CCCCTTHHH
T ss_pred Cc-cccCceechhhccHHHhCC-CCCCcccccccccchhhhccccch
Confidence 33 2345789999999999865 567789999999998887665443
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.96 E-value=2.9e-31 Score=297.68 Aligned_cols=234 Identities=18% Similarity=0.118 Sum_probs=190.3
Q ss_pred ccccCcccccCCcccCCCCCCCEEEccCCcccCccCcccccCCcce-eeccCccccccCCccCcCcCCCcEEEeecCccc
Q 004400 23 VLKEQNLTGVLPPKLAELTFLQDIDLTLNYLSGTIPSQWASLPLLN-ISLIANRLKGPIPKYLANISTLVNLTVQYNQFS 101 (756)
Q Consensus 23 ~L~~~~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~-l~l~~n~~~~~~p~~l~~l~~L~~L~L~~N~l~ 101 (756)
.+...++...+......+++|+.|+|++|.|++..|..|..++.|+ |++.+|++++..| |..+++|+.|+|++|.|+
T Consensus 16 ~~~~~~l~~~l~~l~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~ 93 (487)
T 3oja_A 16 KVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQ 93 (487)
T ss_dssp SCCTTTHHHHHHTTSTTGGGCCEEECCSSCCCCCCGGGGTTCTTCCEEECTTSCCEEEEE--CTTCTTCCEEECCSSEEE
T ss_pred cCchhhhHHHHHHhcccCCCccEEEeeCCcCCCCCHHHHhCCCCCCEEEeeCCCCCCCcc--cccCCCCCEEEecCCcCC
Confidence 3444555544444444556899999999999988888899998884 8899999887766 889999999999999998
Q ss_pred ccCCcccCCCCCCcEEeccCCeecccCCccccCCCCCCEEEeeCCcccccCChhhcCcCCCcEEEccCCcCcCCCCcccc
Q 004400 102 GELPEELGSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRISDNQFTGQIPSFIQNWTKLEKLFIQPSGLAGPIPSGIF 181 (756)
Q Consensus 102 ~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~ 181 (756)
+..+ .++|++|+|++|+|++..+. .+++|+.|+|++|++++..|..|+++++|+.|+|++|.+++..|..+.
T Consensus 94 ~l~~-----~~~L~~L~L~~N~l~~~~~~---~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~ 165 (487)
T 3oja_A 94 ELLV-----GPSIETLHAANNNISRVSCS---RGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELA 165 (487)
T ss_dssp EEEE-----CTTCCEEECCSSCCCCEEEC---CCSSCEEEECCSSCCCSGGGBCGGGGSSEEEEECTTSCCCEEEGGGGG
T ss_pred CCCC-----CCCcCEEECcCCcCCCCCcc---ccCCCCEEECCCCCCCCCCchhhcCCCCCCEEECCCCCCCCcChHHHh
Confidence 5432 37999999999999966554 467899999999999988888999999999999999999988888876
Q ss_pred -CCCCCCeEEccCCCCCCCCccccccccccEEEcccccccCCCCccccCCCCCcEEEccCCcCCCCCCccCcCCCCCCeE
Q 004400 182 -SLENLTDLRISDLNGPEATFPQLGNMKMTKLILRNCNITGELPRYLGKMTKLKVLDLSFNRLRGQIPSNFDDLYDVDYI 260 (756)
Q Consensus 182 -~l~~L~~L~l~~n~~~~~~~~~~~~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 260 (756)
.+++|+.|++++|.+...... ....+|+.|+|++|.+++..| .|..+++|+.|+|++|.|++ +|..+..+++|+.|
T Consensus 166 ~~l~~L~~L~Ls~N~l~~~~~~-~~l~~L~~L~Ls~N~l~~~~~-~~~~l~~L~~L~Ls~N~l~~-lp~~l~~l~~L~~L 242 (487)
T 3oja_A 166 ASSDTLEHLNLQYNFIYDVKGQ-VVFAKLKTLDLSSNKLAFMGP-EFQSAAGVTWISLRNNKLVL-IEKALRFSQNLEHF 242 (487)
T ss_dssp GGTTTCCEEECTTSCCCEEECC-CCCTTCCEEECCSSCCCEECG-GGGGGTTCSEEECTTSCCCE-ECTTCCCCTTCCEE
T ss_pred hhCCcccEEecCCCcccccccc-ccCCCCCEEECCCCCCCCCCH-hHcCCCCccEEEecCCcCcc-cchhhccCCCCCEE
Confidence 789999999999988876332 234468899999999986544 48888999999999999985 67778888899999
Q ss_pred EecCccccc
Q 004400 261 YFAGNLLTG 269 (756)
Q Consensus 261 ~ls~N~l~~ 269 (756)
++++|++.+
T Consensus 243 ~l~~N~l~c 251 (487)
T 3oja_A 243 DLRGNGFHC 251 (487)
T ss_dssp ECTTCCBCH
T ss_pred EcCCCCCcC
Confidence 999998873
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=3.7e-28 Score=282.63 Aligned_cols=284 Identities=19% Similarity=0.172 Sum_probs=228.6
Q ss_pred eeeccceeccccccccCcccccCCcccCCCCCCCEEEccCCcccCccCcccccCCcce-eeccCccccccCCccCcCcCC
Q 004400 11 HFWKQKTVNQKRVLKEQNLTGVLPPKLAELTFLQDIDLTLNYLSGTIPSQWASLPLLN-ISLIANRLKGPIPKYLANIST 89 (756)
Q Consensus 11 ~~~~~~~~~~~l~L~~~~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~-l~l~~n~~~~~~p~~l~~l~~ 89 (756)
..|.+++.|+.|+|++|+|++..|..|.++++|++|+|++|+|++..+..|..++.|+ |++.+|++.+..+..|+++++
T Consensus 70 ~~f~~l~~L~~L~Ls~N~i~~i~~~~f~~L~~L~~L~Ls~N~l~~l~~~~f~~L~~L~~L~Ls~N~l~~l~~~~~~~L~~ 149 (635)
T 4g8a_A 70 YSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKT 149 (635)
T ss_dssp TTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECGGGGTTCTTCCEEECTTSCCCCSTTCCCTTCTT
T ss_pred HHHhCCCCCCEEECCCCcCCCcChhHhcCCCCCCEEEccCCcCCCCCHHHhcCCCCCCEEECCCCcCCCCChhhhhcCcc
Confidence 4689999999999999999998889999999999999999999977778899999994 899999999888888999999
Q ss_pred CcEEEeecCcccc-cCCcccCCCCCCcEEeccCCeecccCCccccC----------------------------------
Q 004400 90 LVNLTVQYNQFSG-ELPEELGSLLNLEKLHLSSNNFTGELPKTFAK---------------------------------- 134 (756)
Q Consensus 90 L~~L~L~~N~l~~-~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~---------------------------------- 134 (756)
|++|+|++|.|++ .+|..++.+++|++|+|++|+|++..+..|..
T Consensus 150 L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~L~~l~~~~~~~~ls~n~l~~i~~~~~~~~~~~~l 229 (635)
T 4g8a_A 150 LKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRLHKL 229 (635)
T ss_dssp CCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGGGHHHHTCTTCCCEEECTTCCCCEECTTTTTTCEEEEE
T ss_pred cCeeccccCccccCCCchhhccchhhhhhcccCccccccccccccchhhhhhhhhhhhcccCcccccCcccccchhhhhh
Confidence 9999999999985 45788899999999999999887543332211
Q ss_pred --------------------------------------------------------------------------------
Q 004400 135 -------------------------------------------------------------------------------- 134 (756)
Q Consensus 135 -------------------------------------------------------------------------------- 134 (756)
T Consensus 230 ~l~~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~~~~~~~~~~~l~ 309 (635)
T 4g8a_A 230 TLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDGIIDLFNCLTNVS 309 (635)
T ss_dssp EEESCCSSHHHHHHHHHTTTTCEEEEEEEECCTTSCCCSCCCTTTTGGGGGSEEEEEEEECCCSCEEECTTTTGGGTTCS
T ss_pred hhhcccccccccchhhcCCcccccccccccccccccccccccccccccccchhhhhhhhhhhcccccchhhhhhhhcccc
Confidence
Q ss_pred ------------------------------------------------------------CCCCCEEEeeCCccccc--C
Q 004400 135 ------------------------------------------------------------LTNMKDFRISDNQFTGQ--I 152 (756)
Q Consensus 135 ------------------------------------------------------------l~~L~~L~L~~N~l~~~--~ 152 (756)
+++|+.|++++|.+... .
T Consensus 310 ~l~~~~~~~~~~~~~~~~~~L~~L~l~~~~~~~~~~~~l~~L~~l~l~~n~~~~~~~~~~l~~L~~L~ls~n~l~~~~~~ 389 (635)
T 4g8a_A 310 SFSLVSVTIERVKDFSYNFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCC 389 (635)
T ss_dssp EEEEESCEEEECGGGGSCCCCSEEEEESCEESSCCCCBCTTCCEEEEESCCSCCBCCCCBCTTCCEEECCSSCCBEEEEC
T ss_pred cccccccccccccccccchhhhhhhcccccccCcCcccchhhhhcccccccCCCCcccccccccccchhhcccccccccc
Confidence 12233333333332210 0
Q ss_pred ------------------------------------------------ChhhcCcCCCcEEEccCCcCcCCCCccccCCC
Q 004400 153 ------------------------------------------------PSFIQNWTKLEKLFIQPSGLAGPIPSGIFSLE 184 (756)
Q Consensus 153 ------------------------------------------------p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~ 184 (756)
+..|.++++|+.++++.|.+.+..+..+..++
T Consensus 390 ~~~~~~~~~L~~L~~~~~~~~~~~~~~~~l~~L~~l~l~~~~~~~~~~~~~~~~l~~l~~l~ls~n~l~~~~~~~~~~~~ 469 (635)
T 4g8a_A 390 SQSDFGTISLKYLDLSFNGVITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLS 469 (635)
T ss_dssp CHHHHSCSCCCEEECCSCSEEEECSCCTTCTTCCEEECTTSEEESTTSSCTTTTCTTCCEEECTTSCCEECCTTTTTTCT
T ss_pred ccchhhhhhhhhhhccccccccccccccccccccchhhhhccccccccccccccccccccccccccccccccccccccch
Confidence 01233344455555555555555666777888
Q ss_pred CCCeEEccCCCCCC-CCccccccc-cccEEEcccccccCCCCccccCCCCCcEEEccCCcCCCCCCccCcCCCCCCeEEe
Q 004400 185 NLTDLRISDLNGPE-ATFPQLGNM-KMTKLILRNCNITGELPRYLGKMTKLKVLDLSFNRLRGQIPSNFDDLYDVDYIYF 262 (756)
Q Consensus 185 ~L~~L~l~~n~~~~-~~~~~~~~~-~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l 262 (756)
+|+.|++++|.... ..+..+..+ +|+.|+|++|++++..|..|.++++|++|+|++|+|++..|..|..+++|+.|+|
T Consensus 470 ~L~~L~Ls~N~~~~~~~~~~~~~l~~L~~L~Ls~N~L~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~L 549 (635)
T 4g8a_A 470 SLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDY 549 (635)
T ss_dssp TCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCBCCCGGGTTCTTCCEEEC
T ss_pred hhhhhhhhhcccccccCchhhhhccccCEEECCCCccCCcChHHHcCCCCCCEEECCCCcCCCCChhHHhCCCCCCEEEC
Confidence 99999999987544 455556655 6999999999999999999999999999999999999999999999999999999
Q ss_pred cCccccccCCchh--h-cCCCeeEeecCCCCCCCC
Q 004400 263 AGNLLTGAIPPWM--L-ERGDKIDLSYNNFTDGSA 294 (756)
Q Consensus 263 s~N~l~~~~p~~~--~-~~l~~l~ls~N~l~~~~~ 294 (756)
++|+|++..|..+ + ++++.|++++|++.|.+.
T Consensus 550 s~N~l~~~~~~~l~~l~~~L~~L~L~~Np~~C~C~ 584 (635)
T 4g8a_A 550 SLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCE 584 (635)
T ss_dssp TTSCCCBCCSSCTTCCCTTCCEEECTTCCBCCSGG
T ss_pred CCCcCCCCCHHHHHhhhCcCCEEEeeCCCCcccCC
Confidence 9999998888876 3 689999999999998653
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=99.96 E-value=6.2e-28 Score=268.89 Aligned_cols=249 Identities=16% Similarity=0.166 Sum_probs=197.7
Q ss_pred cccccccCcccccCCcccCCCCCCCEEEccCCcccCccCcccccCCcce-eeccCccccccCCccCcCcCCCcEEEeecC
Q 004400 20 QKRVLKEQNLTGVLPPKLAELTFLQDIDLTLNYLSGTIPSQWASLPLLN-ISLIANRLKGPIPKYLANISTLVNLTVQYN 98 (756)
Q Consensus 20 ~~l~L~~~~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~-l~l~~n~~~~~~p~~l~~l~~L~~L~L~~N 98 (756)
..++..+++++ .+|..+. ++|+.|+|++|+|++..|..|..++.|+ |++.+|++.+..|..|.++++|++|+|++|
T Consensus 57 ~~v~c~~~~l~-~iP~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n 133 (452)
T 3zyi_A 57 SKVVCTRRGLS-EVPQGIP--SNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDN 133 (452)
T ss_dssp CEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSS
T ss_pred cEEEECCCCcC-ccCCCCC--CCccEEECcCCcCceECHHHcCCCCCCCEEECCCCccCCcChhhccCcccCCEEECCCC
Confidence 56667777777 4566554 6788888888888877788888888884 788888888888888888888888888888
Q ss_pred cccccCCcccCCCCCCcEEeccCCeecccCCccccCCCCCCEEEeeC-CcccccCChhhcCcCCCcEEEccCCcCcCCCC
Q 004400 99 QFSGELPEELGSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRISD-NQFTGQIPSFIQNWTKLEKLFIQPSGLAGPIP 177 (756)
Q Consensus 99 ~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~-N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p 177 (756)
+|++..+..|.++++|++|+|++|+++...+..|.++++|+.|+|++ |.+....+..|.++++|++|+|++|++++ +|
T Consensus 134 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~~-~~ 212 (452)
T 3zyi_A 134 WLTVIPSGAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIKD-MP 212 (452)
T ss_dssp CCSBCCTTTSSSCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCTTCCEEECTTSCCSS-CC
T ss_pred cCCccChhhhcccCCCCEEECCCCCcceeCHhHHhcCCcccEEeCCCCCCccccChhhccCCCCCCEEECCCCcccc-cc
Confidence 88866667788888888888888888866666788888888888888 44554445578888888888888888874 33
Q ss_pred ccccCCCCCCeEEccCCCCCCCCccccccc-cccEEEcccccccCCCCccccCCCCCcEEEccCCcCCCCCCccCcCCCC
Q 004400 178 SGIFSLENLTDLRISDLNGPEATFPQLGNM-KMTKLILRNCNITGELPRYLGKMTKLKVLDLSFNRLRGQIPSNFDDLYD 256 (756)
Q Consensus 178 ~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~-~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~ 256 (756)
.+..+++|+.|++++|.+....+..+..+ +|+.|+|++|++++..+..|.++++|+.|+|++|+|++..+..|..+++
T Consensus 213 -~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~ 291 (452)
T 3zyi_A 213 -NLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLSSLPHDLFTPLRY 291 (452)
T ss_dssp -CCTTCTTCCEEECTTSCCSEECGGGGTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTSSTTCTT
T ss_pred -cccccccccEEECcCCcCcccCcccccCccCCCEEEeCCCcCceECHHHhcCCCCCCEEECCCCcCCccChHHhccccC
Confidence 47778888888888888888777776665 5888888888888877888888888888888888888777777788888
Q ss_pred CCeEEecCccccccCCc
Q 004400 257 VDYIYFAGNLLTGAIPP 273 (756)
Q Consensus 257 L~~L~ls~N~l~~~~p~ 273 (756)
|+.|+|++|++.|.+.-
T Consensus 292 L~~L~L~~Np~~CdC~~ 308 (452)
T 3zyi_A 292 LVELHLHHNPWNCDCDI 308 (452)
T ss_dssp CCEEECCSSCEECSTTT
T ss_pred CCEEEccCCCcCCCCCc
Confidence 88888888888776653
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=7.2e-28 Score=267.35 Aligned_cols=249 Identities=16% Similarity=0.172 Sum_probs=192.6
Q ss_pred cccccccCcccccCCcccCCCCCCCEEEccCCcccCccCcccccCCcce-eeccCccccccCCccCcCcCCCcEEEeecC
Q 004400 20 QKRVLKEQNLTGVLPPKLAELTFLQDIDLTLNYLSGTIPSQWASLPLLN-ISLIANRLKGPIPKYLANISTLVNLTVQYN 98 (756)
Q Consensus 20 ~~l~L~~~~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~-l~l~~n~~~~~~p~~l~~l~~L~~L~L~~N 98 (756)
..++..+++++ .+|..+. ++++.|+|++|+|++..+..|..++.|+ |++.+|++.+..+..|.++++|++|+|++|
T Consensus 46 ~~v~c~~~~l~-~iP~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n 122 (440)
T 3zyj_A 46 SKVICVRKNLR-EVPDGIS--TNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDN 122 (440)
T ss_dssp CEEECCSCCCS-SCCSCCC--TTCSEEECCSCCCCEECTTTTSSCSSCCEEECCSSCCCEECGGGGTTCSSCCEEECCSS
T ss_pred CEEEeCCCCcC-cCCCCCC--CCCcEEEccCCcCCeeCHHHhhCCCCCCEEECCCCcCCccChhhccCCccCCEEECCCC
Confidence 45667777777 5566555 6788888888888877777888888774 788888888777788888888888888888
Q ss_pred cccccCCcccCCCCCCcEEeccCCeecccCCccccCCCCCCEEEeeCC-cccccCChhhcCcCCCcEEEccCCcCcCCCC
Q 004400 99 QFSGELPEELGSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRISDN-QFTGQIPSFIQNWTKLEKLFIQPSGLAGPIP 177 (756)
Q Consensus 99 ~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N-~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p 177 (756)
+|++..+..|..+++|++|+|++|+++...+..|.++++|+.|+|++| .+....+..|.++++|++|+|++|+++ .+|
T Consensus 123 ~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~-~~~ 201 (440)
T 3zyj_A 123 RLTTIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLR-EIP 201 (440)
T ss_dssp CCSSCCTTTSCSCSSCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCSSCCEEECTTSCCS-SCC
T ss_pred cCCeeCHhHhhccccCceeeCCCCcccccCHHHhhhCcccCEeCCCCCCCcceeCcchhhcccccCeecCCCCcCc-ccc
Confidence 888666667888888888888888888666667888888888888884 455444557888888888888888887 444
Q ss_pred ccccCCCCCCeEEccCCCCCCCCccccccc-cccEEEcccccccCCCCccccCCCCCcEEEccCCcCCCCCCccCcCCCC
Q 004400 178 SGIFSLENLTDLRISDLNGPEATFPQLGNM-KMTKLILRNCNITGELPRYLGKMTKLKVLDLSFNRLRGQIPSNFDDLYD 256 (756)
Q Consensus 178 ~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~-~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~ 256 (756)
.+..+++|+.|++++|.+....+..+..+ +|+.|+|++|++++..+..|.++++|+.|+|++|+|++..+..|..+++
T Consensus 202 -~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~ 280 (440)
T 3zyj_A 202 -NLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTLLPHDLFTPLHH 280 (440)
T ss_dssp -CCTTCSSCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTSSTTCTTCCEEECTTSCCCCCCTTTTSSCTT
T ss_pred -ccCCCcccCEEECCCCccCccChhhhccCccCCEEECCCCceeEEChhhhcCCCCCCEEECCCCCCCccChhHhccccC
Confidence 47778888888888888887776666665 5888888888888777777888888888888888888777777788888
Q ss_pred CCeEEecCccccccCCc
Q 004400 257 VDYIYFAGNLLTGAIPP 273 (756)
Q Consensus 257 L~~L~ls~N~l~~~~p~ 273 (756)
|+.|+|++|++.|.+.-
T Consensus 281 L~~L~L~~Np~~CdC~l 297 (440)
T 3zyj_A 281 LERIHLHHNPWNCNCDI 297 (440)
T ss_dssp CCEEECCSSCEECSSTT
T ss_pred CCEEEcCCCCccCCCCc
Confidence 88888888888776653
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.9e-28 Score=280.33 Aligned_cols=145 Identities=18% Similarity=0.190 Sum_probs=129.9
Q ss_pred eeccccccccCcccccCCcccCCCCCCCEEEccCCcccCccCcccccCCcce-eeccCccccccCCccCcCcCCCcEEEe
Q 004400 17 TVNQKRVLKEQNLTGVLPPKLAELTFLQDIDLTLNYLSGTIPSQWASLPLLN-ISLIANRLKGPIPKYLANISTLVNLTV 95 (756)
Q Consensus 17 ~~~~~l~L~~~~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~-l~l~~n~~~~~~p~~l~~l~~L~~L~L 95 (756)
..++.|+|++|++++..|..|.++++|++|+|++|++++..|..|..++.|+ |++.+|++.+..|..|+++++|++|+|
T Consensus 26 ~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L 105 (549)
T 2z81_A 26 AAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNL 105 (549)
T ss_dssp TTCCEEECCSSCCCEECSSTTSSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCSCCHHHHTTCTTCCEEEC
T ss_pred CCccEEECcCCccCccChhhhhcCCcccEEECCCCCcCccChhhccccccCCEEECCCCccCccCHHHhccCCCCcEEEC
Confidence 5799999999999999999999999999999999999988889999999994 899999999888888999999999999
Q ss_pred ecCcccc-cCCcccCCCCCCcEEeccCCeecccCC-ccccCCCCCCEEEeeCCcccccCChhhcCcCC
Q 004400 96 QYNQFSG-ELPEELGSLLNLEKLHLSSNNFTGELP-KTFAKLTNMKDFRISDNQFTGQIPSFIQNWTK 161 (756)
Q Consensus 96 ~~N~l~~-~~p~~~~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~ 161 (756)
++|.+++ ..|..|+++++|++|+|++|++.+.+| ..|.++++|++|++++|++++..|..++++++
T Consensus 106 s~n~l~~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~ 173 (549)
T 2z81_A 106 MGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRD 173 (549)
T ss_dssp TTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEETTCCEECTTTTTTCSE
T ss_pred CCCcccccchhhhhhccCCccEEECCCCccccccCHhhhhcccccCeeeccCCcccccChhhhhcccc
Confidence 9999986 356789999999999999999544554 68999999999999999999888887765433
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=2e-28 Score=263.64 Aligned_cols=274 Identities=19% Similarity=0.174 Sum_probs=228.1
Q ss_pred ceeccccccccCcccccCCcccCCCCCCCEEEccCCcccCccCcccccCCcce-eeccCccccccCCccCcCcCCCcEEE
Q 004400 16 KTVNQKRVLKEQNLTGVLPPKLAELTFLQDIDLTLNYLSGTIPSQWASLPLLN-ISLIANRLKGPIPKYLANISTLVNLT 94 (756)
Q Consensus 16 ~~~~~~l~L~~~~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~-l~l~~n~~~~~~p~~l~~l~~L~~L~ 94 (756)
|......++++++++ .+|..+. ++|+.|+|++|+|++..+..|..++.|+ |++.+|++.+..|..|.++++|++|+
T Consensus 30 C~~~~~c~~~~~~l~-~iP~~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 106 (353)
T 2z80_A 30 CDRNGICKGSSGSLN-SIPSGLT--EAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLD 106 (353)
T ss_dssp ECTTSEEECCSTTCS-SCCTTCC--TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEE
T ss_pred CCCCeEeeCCCCCcc-ccccccc--ccCcEEECCCCcCcccCHHHhccCCCCCEEECCCCccCccCHhhcCCCCCCCEEE
Confidence 334445678888888 5566555 6899999999999977777899999984 89999999998899999999999999
Q ss_pred eecCcccccCCcccCCCCCCcEEeccCCeecccCC-ccccCCCCCCEEEeeCC-cccccCChhhcCcCCCcEEEccCCcC
Q 004400 95 VQYNQFSGELPEELGSLLNLEKLHLSSNNFTGELP-KTFAKLTNMKDFRISDN-QFTGQIPSFIQNWTKLEKLFIQPSGL 172 (756)
Q Consensus 95 L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~L~~N-~l~~~~p~~~~~l~~L~~L~l~~N~l 172 (756)
|++|+|++..+..|+++++|++|+|++|++++..+ ..|..+++|+.|++++| .++...+..|.++++|++|++++|++
T Consensus 107 Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~l 186 (353)
T 2z80_A 107 LSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDL 186 (353)
T ss_dssp CCSSCCSSCCHHHHTTCTTCSEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEETTC
T ss_pred CCCCcCCcCCHhHhCCCccCCEEECCCCCCcccCchhhhccCCCCcEEECCCCccccccCHHHccCCCCCCEEECCCCCc
Confidence 99999996555569999999999999999994333 47899999999999999 57777788999999999999999999
Q ss_pred cCCCCccccCCCCCCeEEccCCCCCCCCcccccc-ccccEEEcccccccCCCCcccc---CCCCCcEEEccCCcCCC---
Q 004400 173 AGPIPSGIFSLENLTDLRISDLNGPEATFPQLGN-MKMTKLILRNCNITGELPRYLG---KMTKLKVLDLSFNRLRG--- 245 (756)
Q Consensus 173 ~~~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~-~~L~~L~L~~n~l~~~~p~~~~---~l~~L~~L~Ls~N~l~~--- 245 (756)
++..|..+..+++|++|++++|.+.......+.. .+|+.|++++|.+++..+..+. ....++.++|++|.+++
T Consensus 187 ~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~~~~~~l~~l~L~~~~l~~~~l 266 (353)
T 2z80_A 187 QSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESL 266 (353)
T ss_dssp CEECTTTTTTCSEEEEEEEECSCSTTHHHHHHHHTTTEEEEEEESCBCTTCCCC------CCCCCCEEEEESCBCCHHHH
T ss_pred CccCHHHHhccccCCeecCCCCccccchhhhhhhcccccEEECCCCccccccccccccccccchhhccccccccccCcch
Confidence 9888999999999999999999987665544443 3699999999999987665443 46778889999988876
Q ss_pred -CCCccCcCCCCCCeEEecCccccccCCchh---hcCCCeeEeecCCCCCCC
Q 004400 246 -QIPSNFDDLYDVDYIYFAGNLLTGAIPPWM---LERGDKIDLSYNNFTDGS 293 (756)
Q Consensus 246 -~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~---~~~l~~l~ls~N~l~~~~ 293 (756)
.+|..+..+++|+.|++++|+++ .+|..+ +++++.|++++|++.|..
T Consensus 267 ~~l~~~l~~l~~L~~L~Ls~N~l~-~i~~~~~~~l~~L~~L~L~~N~~~~~~ 317 (353)
T 2z80_A 267 FQVMKLLNQISGLLELEFSRNQLK-SVPDGIFDRLTSLQKIWLHTNPWDCSC 317 (353)
T ss_dssp HHHHHHHHTCTTCCEEECCSSCCC-CCCTTTTTTCTTCCEEECCSSCBCCCH
T ss_pred hhhHHHHhcccCCCEEECCCCCCC-ccCHHHHhcCCCCCEEEeeCCCccCcC
Confidence 36777888999999999999998 666654 678899999999988754
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=99.95 E-value=1.3e-27 Score=254.27 Aligned_cols=224 Identities=25% Similarity=0.335 Sum_probs=156.5
Q ss_pred CCCCCEEEccCCcccCccCcccccCCcce-eeccCccccccCCccCcCcCCCcEEEeecCcccccCCcccCCCCCCcEEe
Q 004400 40 LTFLQDIDLTLNYLSGTIPSQWASLPLLN-ISLIANRLKGPIPKYLANISTLVNLTVQYNQFSGELPEELGSLLNLEKLH 118 (756)
Q Consensus 40 l~~L~~L~L~~n~l~~~~p~~~~~l~~L~-l~l~~n~~~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 118 (756)
.++++.|+|++|.++ .+|..+..++.|+ |++.+|++. .+|..|+++++|++|+|++|.++ .+|..|+++++|++|+
T Consensus 80 ~~~l~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~n~l~-~lp~~~~~l~~L~~L~Ls~n~l~-~lp~~l~~l~~L~~L~ 156 (328)
T 4fcg_A 80 QPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELS 156 (328)
T ss_dssp STTCCEEEEESSCCS-SCCSCGGGGTTCSEEEEESSCCC-CCCSCGGGGTTCSEEEEESCCCC-CCCGGGGGCTTCCEEE
T ss_pred ccceeEEEccCCCch-hcChhhhhCCCCCEEECCCCCcc-chhHHHhccCCCCEEECCCCccc-cCcHHHhcCcCCCEEE
Confidence 467788888888887 6676677777773 677777777 77777777788888888888777 6777777788888888
Q ss_pred ccCCeecccCCccccC---------CCCCCEEEeeCCcccccCChhhcCcCCCcEEEccCCcCcCCCCccccCCCCCCeE
Q 004400 119 LSSNNFTGELPKTFAK---------LTNMKDFRISDNQFTGQIPSFIQNWTKLEKLFIQPSGLAGPIPSGIFSLENLTDL 189 (756)
Q Consensus 119 L~~N~l~~~~p~~~~~---------l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L 189 (756)
|++|++.+.+|..+.. +++|++|+|++|+++ .+|..|+++++|++|+|++|++++ +|..+..+++|+.|
T Consensus 157 L~~n~~~~~~p~~~~~~~~~~~~~~l~~L~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~N~l~~-l~~~l~~l~~L~~L 234 (328)
T 4fcg_A 157 IRACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLSA-LGPAIHHLPKLEEL 234 (328)
T ss_dssp EEEETTCCCCCSCSEEEC-CCCEEESTTCCEEEEEEECCC-CCCGGGGGCTTCCEEEEESSCCCC-CCGGGGGCTTCCEE
T ss_pred CCCCCCccccChhHhhccchhhhccCCCCCEEECcCCCcC-cchHhhcCCCCCCEEEccCCCCCc-CchhhccCCCCCEE
Confidence 8877777777766554 777777777777777 677777777777777777777774 56667777777777
Q ss_pred EccCCCCCCCCccccccc-cccEEEcccccccCCCCccccCCCCCcEEEccCCcCCCCCCccCcCCCCCCeEEecCcccc
Q 004400 190 RISDLNGPEATFPQLGNM-KMTKLILRNCNITGELPRYLGKMTKLKVLDLSFNRLRGQIPSNFDDLYDVDYIYFAGNLLT 268 (756)
Q Consensus 190 ~l~~n~~~~~~~~~~~~~-~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~ 268 (756)
++++|++....+..+..+ +|+.|+|++|.+.+.+|..+.++++|+.|+|++|.+.+.+|..+..+++|+.+++..|.+.
T Consensus 235 ~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~iP~~l~~L~~L~~l~l~~~~~~ 314 (328)
T 4fcg_A 235 DLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQA 314 (328)
T ss_dssp ECTTCTTCCBCCCCTTCCCCCCEEECTTCTTCCBCCTTGGGCTTCCEEECTTCTTCCCCCGGGGGSCTTCEEECCGGGSC
T ss_pred ECcCCcchhhhHHHhcCCCCCCEEECCCCCchhhcchhhhcCCCCCEEeCCCCCchhhccHHHhhccCceEEeCCHHHHH
Confidence 766665555544444443 3555666666666666666666666666666666666666666666666666666655443
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=8.3e-29 Score=266.70 Aligned_cols=256 Identities=20% Similarity=0.239 Sum_probs=221.3
Q ss_pred eeccccccccCcccccCCcccCCCCCCCEEEccCCcccCccCcccccCCcc-eeeccCccccccCCccCcCcCCCcEEEe
Q 004400 17 TVNQKRVLKEQNLTGVLPPKLAELTFLQDIDLTLNYLSGTIPSQWASLPLL-NISLIANRLKGPIPKYLANISTLVNLTV 95 (756)
Q Consensus 17 ~~~~~l~L~~~~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L-~l~l~~n~~~~~~p~~l~~l~~L~~L~L 95 (756)
..++.|+|++|++++..+..|..+++|+.|+|++|.+++..|..|..++.| .|++.+|++.+..+..|.++++|++|+|
T Consensus 52 ~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L 131 (353)
T 2z80_A 52 EAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNL 131 (353)
T ss_dssp TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSSCCHHHHTTCTTCSEEEC
T ss_pred ccCcEEECCCCcCcccCHHHhccCCCCCEEECCCCccCccCHhhcCCCCCCCEEECCCCcCCcCCHhHhCCCccCCEEEC
Confidence 378999999999998888899999999999999999998888899999998 5899999999766666999999999999
Q ss_pred ecCcccccCC-cccCCCCCCcEEeccCC-eecccCCccccCCCCCCEEEeeCCcccccCChhhcCcCCCcEEEccCCcCc
Q 004400 96 QYNQFSGELP-EELGSLLNLEKLHLSSN-NFTGELPKTFAKLTNMKDFRISDNQFTGQIPSFIQNWTKLEKLFIQPSGLA 173 (756)
Q Consensus 96 ~~N~l~~~~p-~~~~~l~~L~~L~L~~N-~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~ 173 (756)
++|++++..+ ..|.++++|++|+|++| .++...+..|.++++|++|++++|++++..|..|.++++|++|++++|++.
T Consensus 132 ~~n~l~~l~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~ 211 (353)
T 2z80_A 132 LGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHI 211 (353)
T ss_dssp TTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEETTCCEECTTTTTTCSEEEEEEEECSCST
T ss_pred CCCCCcccCchhhhccCCCCcEEECCCCccccccCHHHccCCCCCCEEECCCCCcCccCHHHHhccccCCeecCCCCccc
Confidence 9999995444 47999999999999999 577777888999999999999999999988999999999999999999997
Q ss_pred CCCCccccCCCCCCeEEccCCCCCCCCcccccc----ccccEEEcccccccC----CCCccccCCCCCcEEEccCCcCCC
Q 004400 174 GPIPSGIFSLENLTDLRISDLNGPEATFPQLGN----MKMTKLILRNCNITG----ELPRYLGKMTKLKVLDLSFNRLRG 245 (756)
Q Consensus 174 ~~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~----~~L~~L~L~~n~l~~----~~p~~~~~l~~L~~L~Ls~N~l~~ 245 (756)
...+..+..+++|+.|++++|.+....+..+.. ..++.++|+++.+++ .+|..+..+++|+.|+|++|+++.
T Consensus 212 ~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~~~~~~l~~l~L~~~~l~~~~l~~l~~~l~~l~~L~~L~Ls~N~l~~ 291 (353)
T 2z80_A 212 LLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLFQVMKLLNQISGLLELEFSRNQLKS 291 (353)
T ss_dssp THHHHHHHHTTTEEEEEEESCBCTTCCCC------CCCCCCEEEEESCBCCHHHHHHHHHHHHTCTTCCEEECCSSCCCC
T ss_pred cchhhhhhhcccccEEECCCCccccccccccccccccchhhccccccccccCcchhhhHHHHhcccCCCEEECCCCCCCc
Confidence 433334456899999999999999876655432 247788888888776 467889999999999999999995
Q ss_pred CCCccCcCCCCCCeEEecCccccccCC
Q 004400 246 QIPSNFDDLYDVDYIYFAGNLLTGAIP 272 (756)
Q Consensus 246 ~~p~~~~~l~~L~~L~ls~N~l~~~~p 272 (756)
..+..|..+++|++|++++|+++|.+|
T Consensus 292 i~~~~~~~l~~L~~L~L~~N~~~~~~~ 318 (353)
T 2z80_A 292 VPDGIFDRLTSLQKIWLHTNPWDCSCP 318 (353)
T ss_dssp CCTTTTTTCTTCCEEECCSSCBCCCHH
T ss_pred cCHHHHhcCCCCCEEEeeCCCccCcCC
Confidence 444446999999999999999999887
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=99.95 E-value=1.8e-27 Score=265.03 Aligned_cols=249 Identities=16% Similarity=0.108 Sum_probs=220.0
Q ss_pred CCCEEEccCCcccCccCcccccCCcc-eeeccCccccccCCccCcCcCCCcEEEeecCcccccCCcccCCCCCCcEEecc
Q 004400 42 FLQDIDLTLNYLSGTIPSQWASLPLL-NISLIANRLKGPIPKYLANISTLVNLTVQYNQFSGELPEELGSLLNLEKLHLS 120 (756)
Q Consensus 42 ~L~~L~L~~n~l~~~~p~~~~~l~~L-~l~l~~n~~~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~ 120 (756)
....++.+++.++ .+|..+. +.+ .|++.+|++.+..|..|.++++|+.|+|++|+|++..+..|.++++|++|+|+
T Consensus 55 ~~~~v~c~~~~l~-~iP~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~ 131 (452)
T 3zyi_A 55 QFSKVVCTRRGLS-EVPQGIP--SNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELF 131 (452)
T ss_dssp SSCEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECC
T ss_pred CCcEEEECCCCcC-ccCCCCC--CCccEEECcCCcCceECHHHcCCCCCCCEEECCCCccCCcChhhccCcccCCEEECC
Confidence 4578999999998 6776554 455 58899999999999999999999999999999999888999999999999999
Q ss_pred CCeecccCCccccCCCCCCEEEeeCCcccccCChhhcCcCCCcEEEccCC-cCcCCCCccccCCCCCCeEEccCCCCCCC
Q 004400 121 SNNFTGELPKTFAKLTNMKDFRISDNQFTGQIPSFIQNWTKLEKLFIQPS-GLAGPIPSGIFSLENLTDLRISDLNGPEA 199 (756)
Q Consensus 121 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N-~l~~~~p~~~~~l~~L~~L~l~~n~~~~~ 199 (756)
+|+|++..+..|..+++|++|+|++|+|+...+..|.++++|+.|+|++| .+....+..|.++++|+.|++++|.+...
T Consensus 132 ~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~~~ 211 (452)
T 3zyi_A 132 DNWLTVIPSGAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIKDM 211 (452)
T ss_dssp SSCCSBCCTTTSSSCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCTTCCEEECTTSCCSSC
T ss_pred CCcCCccChhhhcccCCCCEEECCCCCcceeCHhHHhcCCcccEEeCCCCCCccccChhhccCCCCCCEEECCCCccccc
Confidence 99999777778999999999999999999877889999999999999995 45544445788999999999999999876
Q ss_pred CccccccccccEEEcccccccCCCCccccCCCCCcEEEccCCcCCCCCCccCcCCCCCCeEEecCccccccCCchh--hc
Q 004400 200 TFPQLGNMKMTKLILRNCNITGELPRYLGKMTKLKVLDLSFNRLRGQIPSNFDDLYDVDYIYFAGNLLTGAIPPWM--LE 277 (756)
Q Consensus 200 ~~~~~~~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~--~~ 277 (756)
+ ......+|+.|+|++|.+++..|..|.++++|+.|+|++|++++..+..|..+++|+.|+|++|++++..+..+ ++
T Consensus 212 ~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~ 290 (452)
T 3zyi_A 212 P-NLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLSSLPHDLFTPLR 290 (452)
T ss_dssp C-CCTTCTTCCEEECTTSCCSEECGGGGTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTSSTTCT
T ss_pred c-cccccccccEEECcCCcCcccCcccccCccCCCEEEeCCCcCceECHHHhcCCCCCCEEECCCCcCCccChHHhcccc
Confidence 3 22333469999999999999999999999999999999999999999999999999999999999996555544 78
Q ss_pred CCCeeEeecCCCCCCCC
Q 004400 278 RGDKIDLSYNNFTDGSA 294 (756)
Q Consensus 278 ~l~~l~ls~N~l~~~~~ 294 (756)
+++.|++++|++.|...
T Consensus 291 ~L~~L~L~~Np~~CdC~ 307 (452)
T 3zyi_A 291 YLVELHLHHNPWNCDCD 307 (452)
T ss_dssp TCCEEECCSSCEECSTT
T ss_pred CCCEEEccCCCcCCCCC
Confidence 89999999999988654
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=99.95 E-value=1.5e-27 Score=256.29 Aligned_cols=266 Identities=20% Similarity=0.260 Sum_probs=224.5
Q ss_pred eeeccceeccccccccCcccccCCcccCCCCCCCEEEccCCcccCccCcccccCCcc-eeeccCccccccCCccCcCcCC
Q 004400 11 HFWKQKTVNQKRVLKEQNLTGVLPPKLAELTFLQDIDLTLNYLSGTIPSQWASLPLL-NISLIANRLKGPIPKYLANIST 89 (756)
Q Consensus 11 ~~~~~~~~~~~l~L~~~~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L-~l~l~~n~~~~~~p~~l~~l~~ 89 (756)
+.+..+..+++|+|++|++++..+ +..+++|+.|+|++|.++. ++ .+..++.| .+++.+|++.+..+ +.++++
T Consensus 60 ~~~~~~~~L~~L~l~~n~i~~~~~--~~~l~~L~~L~L~~n~i~~-~~-~~~~l~~L~~L~l~~n~i~~~~~--~~~l~~ 133 (347)
T 4fmz_A 60 QGIEYLTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKITD-IS-ALQNLTNLRELYLNEDNISDISP--LANLTK 133 (347)
T ss_dssp TTGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCC-CG-GGTTCTTCSEEECTTSCCCCCGG--GTTCTT
T ss_pred hhhhhcCCccEEEccCCccccchh--hhcCCcCCEEEccCCcccC-ch-HHcCCCcCCEEECcCCcccCchh--hccCCc
Confidence 347788999999999999997644 9999999999999999985 44 68888888 48899999886544 889999
Q ss_pred CcEEEeecCcccccCCcccCCCCCCcEEeccCCeecccCCccccCCCCCCEEEeeCCcccccCChhhcCcCCCcEEEccC
Q 004400 90 LVNLTVQYNQFSGELPEELGSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRISDNQFTGQIPSFIQNWTKLEKLFIQP 169 (756)
Q Consensus 90 L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~ 169 (756)
|+.|++++|.....+ ..+..+++|++|++++|++.+..+ +..+++|+.|++++|++++. +. +..+++|+.|++++
T Consensus 134 L~~L~l~~n~~~~~~-~~~~~l~~L~~L~l~~~~~~~~~~--~~~l~~L~~L~l~~n~l~~~-~~-~~~l~~L~~L~l~~ 208 (347)
T 4fmz_A 134 MYSLNLGANHNLSDL-SPLSNMTGLNYLTVTESKVKDVTP--IANLTDLYSLSLNYNQIEDI-SP-LASLTSLHYFTAYV 208 (347)
T ss_dssp CCEEECTTCTTCCCC-GGGTTCTTCCEEECCSSCCCCCGG--GGGCTTCSEEECTTSCCCCC-GG-GGGCTTCCEEECCS
T ss_pred eeEEECCCCCCcccc-cchhhCCCCcEEEecCCCcCCchh--hccCCCCCEEEccCCccccc-cc-ccCCCccceeeccc
Confidence 999999999766444 459999999999999999985444 88999999999999999954 33 88999999999999
Q ss_pred CcCcCCCCccccCCCCCCeEEccCCCCCCCCccccccccccEEEcccccccCCCCccccCCCCCcEEEccCCcCCCCCCc
Q 004400 170 SGLAGPIPSGIFSLENLTDLRISDLNGPEATFPQLGNMKMTKLILRNCNITGELPRYLGKMTKLKVLDLSFNRLRGQIPS 249 (756)
Q Consensus 170 N~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~ 249 (756)
|.+.+..+ +..+++|+.|++++|.+....+ .....+|++|++++|.+++. ..+..+++|+.|++++|.+++. .
T Consensus 209 n~l~~~~~--~~~~~~L~~L~l~~n~l~~~~~-~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~l~~n~l~~~--~ 281 (347)
T 4fmz_A 209 NQITDITP--VANMTRLNSLKIGNNKITDLSP-LANLSQLTWLEIGTNQISDI--NAVKDLTKLKMLNVGSNQISDI--S 281 (347)
T ss_dssp SCCCCCGG--GGGCTTCCEEECCSSCCCCCGG-GTTCTTCCEEECCSSCCCCC--GGGTTCTTCCEEECCSSCCCCC--G
T ss_pred CCCCCCch--hhcCCcCCEEEccCCccCCCcc-hhcCCCCCEEECCCCccCCC--hhHhcCCCcCEEEccCCccCCC--h
Confidence 99986544 8889999999999999988765 22334699999999999864 4688999999999999999964 4
Q ss_pred cCcCCCCCCeEEecCccccccCCchh--hcCCCeeEeecCCCCCCCC
Q 004400 250 NFDDLYDVDYIYFAGNLLTGAIPPWM--LERGDKIDLSYNNFTDGSA 294 (756)
Q Consensus 250 ~~~~l~~L~~L~ls~N~l~~~~p~~~--~~~l~~l~ls~N~l~~~~~ 294 (756)
.+..+++|+.|++++|.+++..|..+ +++++.|++++|++++..+
T Consensus 282 ~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~ 328 (347)
T 4fmz_A 282 VLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP 328 (347)
T ss_dssp GGGGCTTCSEEECCSSCCCGGGHHHHHTCTTCSEEECCSSSCCCCGG
T ss_pred hhcCCCCCCEEECcCCcCCCcChhHhhccccCCEEEccCCccccccC
Confidence 58899999999999999988777766 7889999999999988655
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=3e-27 Score=262.41 Aligned_cols=249 Identities=18% Similarity=0.150 Sum_probs=220.0
Q ss_pred CCCEEEccCCcccCccCcccccCCcc-eeeccCccccccCCccCcCcCCCcEEEeecCcccccCCcccCCCCCCcEEecc
Q 004400 42 FLQDIDLTLNYLSGTIPSQWASLPLL-NISLIANRLKGPIPKYLANISTLVNLTVQYNQFSGELPEELGSLLNLEKLHLS 120 (756)
Q Consensus 42 ~L~~L~L~~n~l~~~~p~~~~~l~~L-~l~l~~n~~~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~ 120 (756)
....++.+++.++ .+|..+. +.+ .|++.+|++.+..+..|.++++|+.|+|++|+|++..+..|.++++|++|+|+
T Consensus 44 ~~~~v~c~~~~l~-~iP~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~ 120 (440)
T 3zyj_A 44 QFSKVICVRKNLR-EVPDGIS--TNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELF 120 (440)
T ss_dssp TSCEEECCSCCCS-SCCSCCC--TTCSEEECCSCCCCEECTTTTSSCSSCCEEECCSSCCCEECGGGGTTCSSCCEEECC
T ss_pred CCCEEEeCCCCcC-cCCCCCC--CCCcEEEccCCcCCeeCHHHhhCCCCCCEEECCCCcCCccChhhccCCccCCEEECC
Confidence 4678999999998 6776554 445 48899999999999999999999999999999998888999999999999999
Q ss_pred CCeecccCCccccCCCCCCEEEeeCCcccccCChhhcCcCCCcEEEccCCc-CcCCCCccccCCCCCCeEEccCCCCCCC
Q 004400 121 SNNFTGELPKTFAKLTNMKDFRISDNQFTGQIPSFIQNWTKLEKLFIQPSG-LAGPIPSGIFSLENLTDLRISDLNGPEA 199 (756)
Q Consensus 121 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~-l~~~~p~~~~~l~~L~~L~l~~n~~~~~ 199 (756)
+|+|+...+..|..+++|++|+|++|+|+...+..|.++++|+.|+|++|+ +....+..|.++++|+.|++++|.+...
T Consensus 121 ~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~~~ 200 (440)
T 3zyj_A 121 DNRLTTIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLREI 200 (440)
T ss_dssp SSCCSSCCTTTSCSCSSCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCSSCCEEECTTSCCSSC
T ss_pred CCcCCeeCHhHhhccccCceeeCCCCcccccCHHHhhhCcccCEeCCCCCCCcceeCcchhhcccccCeecCCCCcCccc
Confidence 999997777789999999999999999998888899999999999999955 4444455789999999999999999876
Q ss_pred CccccccccccEEEcccccccCCCCccccCCCCCcEEEccCCcCCCCCCccCcCCCCCCeEEecCccccccCCchh--hc
Q 004400 200 TFPQLGNMKMTKLILRNCNITGELPRYLGKMTKLKVLDLSFNRLRGQIPSNFDDLYDVDYIYFAGNLLTGAIPPWM--LE 277 (756)
Q Consensus 200 ~~~~~~~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~--~~ 277 (756)
+ ......+|+.|+|++|.+++..|..|.++++|+.|+|++|++++..+..|..+++|+.|+|++|++++..+..+ ++
T Consensus 201 ~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~ 279 (440)
T 3zyj_A 201 P-NLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTLLPHDLFTPLH 279 (440)
T ss_dssp C-CCTTCSSCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTSSTTCTTCCEEECTTSCCCCCCTTTTSSCT
T ss_pred c-ccCCCcccCEEECCCCccCccChhhhccCccCCEEECCCCceeEEChhhhcCCCCCCEEECCCCCCCccChhHhcccc
Confidence 4 22233469999999999999999999999999999999999999999999999999999999999996655554 78
Q ss_pred CCCeeEeecCCCCCCCC
Q 004400 278 RGDKIDLSYNNFTDGSA 294 (756)
Q Consensus 278 ~l~~l~ls~N~l~~~~~ 294 (756)
+++.|++++|++.|...
T Consensus 280 ~L~~L~L~~Np~~CdC~ 296 (440)
T 3zyj_A 280 HLERIHLHHNPWNCNCD 296 (440)
T ss_dssp TCCEEECCSSCEECSST
T ss_pred CCCEEEcCCCCccCCCC
Confidence 89999999999988654
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1e-27 Score=249.97 Aligned_cols=250 Identities=17% Similarity=0.173 Sum_probs=156.0
Q ss_pred cccccccCcccccCCcccCCCCCCCEEEccCCcccCccCcccccCCcc-eeeccCccccccCCccCcCcCCCcEEEeecC
Q 004400 20 QKRVLKEQNLTGVLPPKLAELTFLQDIDLTLNYLSGTIPSQWASLPLL-NISLIANRLKGPIPKYLANISTLVNLTVQYN 98 (756)
Q Consensus 20 ~~l~L~~~~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L-~l~l~~n~~~~~~p~~l~~l~~L~~L~L~~N 98 (756)
..++.++++++ .+|..+ .++|+.|+|++|.+++..+..|..++.| .|++.+|++.+..|..|.++++|++|+|++|
T Consensus 14 ~~~~c~~~~l~-~ip~~~--~~~l~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n 90 (285)
T 1ozn_A 14 VTTSCPQQGLQ-AVPVGI--PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDN 90 (285)
T ss_dssp CEEECCSSCCS-SCCTTC--CTTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSC
T ss_pred eEEEcCcCCcc-cCCcCC--CCCceEEEeeCCcCCccCHHHcccCCCCCEEECCCCccceeCHhhcCCccCCCEEeCCCC
Confidence 45666777776 345433 3677777777777775544555555555 2555555555555555555555555555555
Q ss_pred c-ccccCCcccCCCCCCcEEeccCCeecccCCccccCCCCCCEEEeeCCcccccCChhhcCcCCCcEEEccCCcCcCCCC
Q 004400 99 Q-FSGELPEELGSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRISDNQFTGQIPSFIQNWTKLEKLFIQPSGLAGPIP 177 (756)
Q Consensus 99 ~-l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p 177 (756)
. ++...|..|..+++|++|+|++|++++..|..|.++++|++|+|++|++++..+..|+++++|++|+|++|++++..+
T Consensus 91 ~~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~ 170 (285)
T 1ozn_A 91 AQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPE 170 (285)
T ss_dssp TTCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECT
T ss_pred CCccccCHHHhcCCcCCCEEECCCCcCCEECHhHhhCCcCCCEEECCCCcccccCHhHhccCCCccEEECCCCcccccCH
Confidence 4 444434555555555555555555554445555555555555555555554444445555555555555555553333
Q ss_pred ccccCCCCCCeEEccCCCCCCCCccccccccccEEEcccccccCCCCccccCCCCCcEEEccCCcCCCCCCccCcCCCCC
Q 004400 178 SGIFSLENLTDLRISDLNGPEATFPQLGNMKMTKLILRNCNITGELPRYLGKMTKLKVLDLSFNRLRGQIPSNFDDLYDV 257 (756)
Q Consensus 178 ~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L 257 (756)
..+..+++ |+.|+|++|.+++..|..|.++++|+.|+|++|.+++..+..+..+++|
T Consensus 171 ~~~~~l~~-----------------------L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L 227 (285)
T 1ozn_A 171 RAFRGLHS-----------------------LDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRAL 227 (285)
T ss_dssp TTTTTCTT-----------------------CCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTC
T ss_pred HHhcCccc-----------------------cCEEECCCCcccccCHhHccCcccccEeeCCCCcCCcCCHHHcccCccc
Confidence 33444444 5556666777877778889999999999999999998777778999999
Q ss_pred CeEEecCccccccCCc-hhhcCCCeeEeecCCCCCCCCc
Q 004400 258 DYIYFAGNLLTGAIPP-WMLERGDKIDLSYNNFTDGSAE 295 (756)
Q Consensus 258 ~~L~ls~N~l~~~~p~-~~~~~l~~l~ls~N~l~~~~~~ 295 (756)
+.|++++|++.+..+. ++..+++.+..+.|.+.|..+.
T Consensus 228 ~~L~l~~N~~~c~~~~~~~~~~l~~~~~~~~~~~c~~p~ 266 (285)
T 1ozn_A 228 QYLRLNDNPWVCDCRARPLWAWLQKFRGSSSEVPCSLPQ 266 (285)
T ss_dssp CEEECCSSCEECSGGGHHHHHHHHHCCSEECCCBEEESG
T ss_pred CEEeccCCCccCCCCcHHHHHHHHhcccccCccccCCch
Confidence 9999999999887764 3345555566667776655443
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=99.95 E-value=7.1e-27 Score=250.93 Aligned_cols=283 Identities=19% Similarity=0.255 Sum_probs=231.9
Q ss_pred eeeeeccceeccccccccCcccccCCcccCCCCCCCEEEccCCcccCccCcccccCCcce-eeccCccccccCCccCcCc
Q 004400 9 VFHFWKQKTVNQKRVLKEQNLTGVLPPKLAELTFLQDIDLTLNYLSGTIPSQWASLPLLN-ISLIANRLKGPIPKYLANI 87 (756)
Q Consensus 9 ~~~~~~~~~~~~~l~L~~~~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~-l~l~~n~~~~~~p~~l~~l 87 (756)
....+..+..++.|++++|++... + .+..+++|++|++++|.+++..+ +..++.|+ +++.+|++.. + +.|.++
T Consensus 36 ~~~~~~~l~~L~~L~l~~~~i~~~-~-~~~~~~~L~~L~l~~n~i~~~~~--~~~l~~L~~L~L~~n~i~~-~-~~~~~l 109 (347)
T 4fmz_A 36 DVVTQEELESITKLVVAGEKVASI-Q-GIEYLTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKITD-I-SALQNL 109 (347)
T ss_dssp SEECHHHHTTCSEEECCSSCCCCC-T-TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCC-C-GGGTTC
T ss_pred CcccchhcccccEEEEeCCccccc-h-hhhhcCCccEEEccCCccccchh--hhcCCcCCEEEccCCcccC-c-hHHcCC
Confidence 334567888999999999999854 4 48899999999999999995444 88888884 8899998875 3 469999
Q ss_pred CCCcEEEeecCcccccCCcccCCCCCCcEEeccCCeecccCCccccCCCCCCEEEeeCCcccccCChhhcCcCCCcEEEc
Q 004400 88 STLVNLTVQYNQFSGELPEELGSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRISDNQFTGQIPSFIQNWTKLEKLFI 167 (756)
Q Consensus 88 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l 167 (756)
++|++|+|++|.+++ ++. +..+++|+.|++++|.....++ .+..+++|+.|++++|.+.+..+ +..+++|+.|++
T Consensus 110 ~~L~~L~l~~n~i~~-~~~-~~~l~~L~~L~l~~n~~~~~~~-~~~~l~~L~~L~l~~~~~~~~~~--~~~l~~L~~L~l 184 (347)
T 4fmz_A 110 TNLRELYLNEDNISD-ISP-LANLTKMYSLNLGANHNLSDLS-PLSNMTGLNYLTVTESKVKDVTP--IANLTDLYSLSL 184 (347)
T ss_dssp TTCSEEECTTSCCCC-CGG-GTTCTTCCEEECTTCTTCCCCG-GGTTCTTCCEEECCSSCCCCCGG--GGGCTTCSEEEC
T ss_pred CcCCEEECcCCcccC-chh-hccCCceeEEECCCCCCccccc-chhhCCCCcEEEecCCCcCCchh--hccCCCCCEEEc
Confidence 999999999999994 444 9999999999999997664444 48999999999999999995444 899999999999
Q ss_pred cCCcCcCCCCccccCCCCCCeEEccCCCCCCCCcccccc-ccccEEEcccccccCCCCccccCCCCCcEEEccCCcCCCC
Q 004400 168 QPSGLAGPIPSGIFSLENLTDLRISDLNGPEATFPQLGN-MKMTKLILRNCNITGELPRYLGKMTKLKVLDLSFNRLRGQ 246 (756)
Q Consensus 168 ~~N~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~-~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ 246 (756)
++|++.+..+ +..+++|+.|++++|.+....+ +.. .+|+.|++++|.+++..+ +..+++|+.|++++|.+++.
T Consensus 185 ~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~~~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~ 258 (347)
T 4fmz_A 185 NYNQIEDISP--LASLTSLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKITDLSP--LANLSQLTWLEIGTNQISDI 258 (347)
T ss_dssp TTSCCCCCGG--GGGCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCC
T ss_pred cCCccccccc--ccCCCccceeecccCCCCCCch--hhcCCcCCEEEccCCccCCCcc--hhcCCCCCEEECCCCccCCC
Confidence 9999985433 8899999999999999988765 444 469999999999996654 88999999999999999963
Q ss_pred CCccCcCCCCCCeEEecCccccccCCc-hhhcCCCeeEeecCCCCCCCCcccccccCccccccccc
Q 004400 247 IPSNFDDLYDVDYIYFAGNLLTGAIPP-WMLERGDKIDLSYNNFTDGSAESSCQKRSVTGIVSCLR 311 (756)
Q Consensus 247 ~p~~~~~l~~L~~L~ls~N~l~~~~p~-~~~~~l~~l~ls~N~l~~~~~~~~~~~~~~~~~~~~~~ 311 (756)
..+..+++|+.|++++|.+++. |. ..+++++.|++++|.+++..+........+..+....+
T Consensus 259 --~~~~~l~~L~~L~l~~n~l~~~-~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n 321 (347)
T 4fmz_A 259 --NAVKDLTKLKMLNVGSNQISDI-SVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQN 321 (347)
T ss_dssp --GGGTTCTTCCEEECCSSCCCCC-GGGGGCTTCSEEECCSSCCCGGGHHHHHTCTTCSEEECCSS
T ss_pred --hhHhcCCCcCEEEccCCccCCC-hhhcCCCCCCEEECcCCcCCCcChhHhhccccCCEEEccCC
Confidence 4689999999999999999864 33 22789999999999998766655555555554443333
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=99.95 E-value=2.2e-27 Score=252.47 Aligned_cols=223 Identities=22% Similarity=0.318 Sum_probs=208.2
Q ss_pred eeccccccccCcccccCCcccCCCCCCCEEEccCCcccCccCcccccCCcce-eeccCccccccCCccCcCcCCCcEEEe
Q 004400 17 TVNQKRVLKEQNLTGVLPPKLAELTFLQDIDLTLNYLSGTIPSQWASLPLLN-ISLIANRLKGPIPKYLANISTLVNLTV 95 (756)
Q Consensus 17 ~~~~~l~L~~~~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~-l~l~~n~~~~~~p~~l~~l~~L~~L~L 95 (756)
..++.|+|++|+++ .+|+.+.++++|++|+|++|.|+ .+|..+..++.|+ |++.+|++. .+|..|.++++|++|+|
T Consensus 81 ~~l~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~n~l~-~lp~~~~~l~~L~~L~Ls~n~l~-~lp~~l~~l~~L~~L~L 157 (328)
T 4fcg_A 81 PGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSI 157 (328)
T ss_dssp TTCCEEEEESSCCS-SCCSCGGGGTTCSEEEEESSCCC-CCCSCGGGGTTCSEEEEESCCCC-CCCGGGGGCTTCCEEEE
T ss_pred cceeEEEccCCCch-hcChhhhhCCCCCEEECCCCCcc-chhHHHhccCCCCEEECCCCccc-cCcHHHhcCcCCCEEEC
Confidence 57889999999999 77888999999999999999999 8999999999994 899999998 88999999999999999
Q ss_pred ecCcccccCCcccCC---------CCCCcEEeccCCeecccCCccccCCCCCCEEEeeCCcccccCChhhcCcCCCcEEE
Q 004400 96 QYNQFSGELPEELGS---------LLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRISDNQFTGQIPSFIQNWTKLEKLF 166 (756)
Q Consensus 96 ~~N~l~~~~p~~~~~---------l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 166 (756)
++|++.+.+|..++. +++|++|+|++|+++ .+|..+..+++|++|+|++|+++ .+|..|.++++|++|+
T Consensus 158 ~~n~~~~~~p~~~~~~~~~~~~~~l~~L~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~N~l~-~l~~~l~~l~~L~~L~ 235 (328)
T 4fcg_A 158 RACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLS-ALGPAIHHLPKLEELD 235 (328)
T ss_dssp EEETTCCCCCSCSEEEC-CCCEEESTTCCEEEEEEECCC-CCCGGGGGCTTCCEEEEESSCCC-CCCGGGGGCTTCCEEE
T ss_pred CCCCCccccChhHhhccchhhhccCCCCCEEECcCCCcC-cchHhhcCCCCCCEEEccCCCCC-cCchhhccCCCCCEEE
Confidence 999999899988765 999999999999999 89999999999999999999999 4777899999999999
Q ss_pred ccCCcCcCCCCccccCCCCCCeEEccCCCCCCCCccccccc-cccEEEcccccccCCCCccccCCCCCcEEEccCCcCC
Q 004400 167 IQPSGLAGPIPSGIFSLENLTDLRISDLNGPEATFPQLGNM-KMTKLILRNCNITGELPRYLGKMTKLKVLDLSFNRLR 244 (756)
Q Consensus 167 l~~N~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~-~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 244 (756)
|++|++.+.+|..+..+++|+.|++++|++....+..+..+ +|+.|+|++|++.+.+|..++++++|+.+++..|.+.
T Consensus 236 Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~iP~~l~~L~~L~~l~l~~~~~~ 314 (328)
T 4fcg_A 236 LRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQA 314 (328)
T ss_dssp CTTCTTCCBCCCCTTCCCCCCEEECTTCTTCCBCCTTGGGCTTCCEEECTTCTTCCCCCGGGGGSCTTCEEECCGGGSC
T ss_pred CcCCcchhhhHHHhcCCCCCCEEECCCCCchhhcchhhhcCCCCCEEeCCCCCchhhccHHHhhccCceEEeCCHHHHH
Confidence 99999999999999999999999999999988888777766 5999999999999999999999999999999988766
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.95 E-value=8.1e-29 Score=261.86 Aligned_cols=248 Identities=18% Similarity=0.213 Sum_probs=166.7
Q ss_pred cCCCCCCCEEEccCCcccCccCcccccCCcceeeccCccc-cccCCccCc-------CcCCCcEEEeecCcccccCCccc
Q 004400 37 LAELTFLQDIDLTLNYLSGTIPSQWASLPLLNISLIANRL-KGPIPKYLA-------NISTLVNLTVQYNQFSGELPEEL 108 (756)
Q Consensus 37 l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~l~l~~n~~-~~~~p~~l~-------~l~~L~~L~L~~N~l~~~~p~~~ 108 (756)
++..++|+.|++++|.+ .+|..+... .-.+++.+|++ ...+|..+. ++++|++|+|++|++++.+|..+
T Consensus 39 ~~~~~~L~~l~l~~n~l--~~p~~~~~~-L~~L~L~~n~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~ 115 (312)
T 1wwl_A 39 YGGGRSLEYLLKRVDTE--ADLGQFTDI-IKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPL 115 (312)
T ss_dssp EEEEEECTTHHHHCCTT--CCCHHHHHH-HHHCCCCEEEEEEEECBHHHHHHHHHHHTTSCCCEEEEEEEBCBSCCCCCS
T ss_pred EccCCCceeEeeccccc--ccHHHHHHH-HhhcccccccccCCCcCHHHHHHHHHhcCcCCccEEEccCCcccchhHHHH
Confidence 34455666666666666 455544433 11356666666 344555554 67777777777777777777765
Q ss_pred --CCCCCCcEEeccCCeecccCCccccCC-----CCCCEEEeeCCcccccCChhhcCcCCCcEEEccCCcCcCC--CCcc
Q 004400 109 --GSLLNLEKLHLSSNNFTGELPKTFAKL-----TNMKDFRISDNQFTGQIPSFIQNWTKLEKLFIQPSGLAGP--IPSG 179 (756)
Q Consensus 109 --~~l~~L~~L~L~~N~l~~~~p~~~~~l-----~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~--~p~~ 179 (756)
+.+++|++|+|++|++++. |..+..+ ++|++|+|++|++++..|..|+++++|++|+|++|++.+. .+..
T Consensus 116 ~~~~l~~L~~L~Ls~N~l~~~-~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~ 194 (312)
T 1wwl_A 116 LEATGPDLNILNLRNVSWATR-DAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISA 194 (312)
T ss_dssp SSCCSCCCSEEEEESCBCSSS-SSHHHHHHTTCCTTCCEEEEESCSCCCCCTTTCCCCSSCCEEECCSCTTCHHHHHHHH
T ss_pred HHhcCCCccEEEccCCCCcch-hHHHHHHHHhhcCCCcEEEeeCCCCccchHHHhccCCCCCEEECCCCCcCcchHHHHH
Confidence 7777777777777777755 6666666 7777777777777776667777777777777777776654 2333
Q ss_pred c--cCCCCCCeEEccCCCCCCCC---cccccc-ccccEEEcccccccCCCC-ccccCCCCCcEEEccCCcCCCCCCccCc
Q 004400 180 I--FSLENLTDLRISDLNGPEAT---FPQLGN-MKMTKLILRNCNITGELP-RYLGKMTKLKVLDLSFNRLRGQIPSNFD 252 (756)
Q Consensus 180 ~--~~l~~L~~L~l~~n~~~~~~---~~~~~~-~~L~~L~L~~n~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~p~~~~ 252 (756)
+ ..+++|++|++++|.+.... ...+.. .+|+.|+|++|.+++.+| ..+..+++|+.|+|++|.|+ .+|..+.
T Consensus 195 ~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~-~ip~~~~ 273 (312)
T 1wwl_A 195 LCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QVPKGLP 273 (312)
T ss_dssp SCTTSCTTCCEEECTTSCCCCHHHHHHHHHHTTCCCSEEECTTSCCCSSCCCSCCCCCTTCCEEECTTSCCS-SCCSSCC
T ss_pred HHhccCCCCCEEECCCCcCcchHHHHHHHHhcCCCCCEEECCCCcCCcccchhhhhhcCCCCEEECCCCccC-hhhhhcc
Confidence 3 66777777777777776422 122222 357778888888877664 44566778888888888887 6666655
Q ss_pred CCCCCCeEEecCccccccCCch-hhcCCCeeEeecCCCCCC
Q 004400 253 DLYDVDYIYFAGNLLTGAIPPW-MLERGDKIDLSYNNFTDG 292 (756)
Q Consensus 253 ~l~~L~~L~ls~N~l~~~~p~~-~~~~l~~l~ls~N~l~~~ 292 (756)
++|+.|++++|++++. |.. .+++++.|++++|++++.
T Consensus 274 --~~L~~L~Ls~N~l~~~-p~~~~l~~L~~L~L~~N~l~~~ 311 (312)
T 1wwl_A 274 --AKLSVLDLSYNRLDRN-PSPDELPQVGNLSLKGNPFLDS 311 (312)
T ss_dssp --SEEEEEECCSSCCCSC-CCTTTSCEEEEEECTTCTTTCC
T ss_pred --CCceEEECCCCCCCCC-hhHhhCCCCCEEeccCCCCCCC
Confidence 7788888888888755 442 166777788888877653
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.95 E-value=2.1e-27 Score=250.41 Aligned_cols=246 Identities=16% Similarity=0.183 Sum_probs=216.1
Q ss_pred CEEEccCCcccCccCcccccCCcc-eeeccCccccccCCccCcCcCCCcEEEeecCccccc--CCcccCCCCCCcEEecc
Q 004400 44 QDIDLTLNYLSGTIPSQWASLPLL-NISLIANRLKGPIPKYLANISTLVNLTVQYNQFSGE--LPEELGSLLNLEKLHLS 120 (756)
Q Consensus 44 ~~L~L~~n~l~~~~p~~~~~l~~L-~l~l~~n~~~~~~p~~l~~l~~L~~L~L~~N~l~~~--~p~~~~~l~~L~~L~L~ 120 (756)
+.++++++.++ .+|..+. +.+ ++++.+|++....+..|.++++|++|+|++|.++.. .+..+..+++|++|+|+
T Consensus 10 ~~l~c~~~~l~-~ip~~~~--~~l~~L~L~~n~l~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~L~~L~Ls 86 (306)
T 2z66_A 10 TEIRCNSKGLT-SVPTGIP--SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLS 86 (306)
T ss_dssp TEEECCSSCCS-SCCSCCC--TTCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCEEEEEEHHHHSCSCCCEEECC
T ss_pred CEEEcCCCCcc-cCCCCCC--CCCCEEECCCCccCccCHhHhhccccCCEEECCCCccCcccCcccccccccccCEEECC
Confidence 57999999998 6666543 345 588999999866566789999999999999999833 36778889999999999
Q ss_pred CCeecccCCccccCCCCCCEEEeeCCcccccCC-hhhcCcCCCcEEEccCCcCcCCCCccccCCCCCCeEEccCCCCCC-
Q 004400 121 SNNFTGELPKTFAKLTNMKDFRISDNQFTGQIP-SFIQNWTKLEKLFIQPSGLAGPIPSGIFSLENLTDLRISDLNGPE- 198 (756)
Q Consensus 121 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~n~~~~- 198 (756)
+|+++ .+|..+..+++|+.|++++|++++..+ ..+.++++|++|++++|++.+..+..+..+++|++|++++|.+..
T Consensus 87 ~n~i~-~l~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~ 165 (306)
T 2z66_A 87 FNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQEN 165 (306)
T ss_dssp SCSEE-EEEEEEETCTTCCEEECTTSEEESSTTTTTTTTCTTCCEEECTTSCCEECSTTTTTTCTTCCEEECTTCEEGGG
T ss_pred CCccc-cChhhcCCCCCCCEEECCCCcccccccchhhhhccCCCEEECCCCcCCccchhhcccCcCCCEEECCCCccccc
Confidence 99999 677789999999999999999996655 689999999999999999999899999999999999999999886
Q ss_pred CCccccccc-cccEEEcccccccCCCCccccCCCCCcEEEccCCcCCCCCCccCcCCCCCCeEEecCccccccCCchh--
Q 004400 199 ATFPQLGNM-KMTKLILRNCNITGELPRYLGKMTKLKVLDLSFNRLRGQIPSNFDDLYDVDYIYFAGNLLTGAIPPWM-- 275 (756)
Q Consensus 199 ~~~~~~~~~-~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~-- 275 (756)
..+..+..+ +|+.|+|++|.+++..|..|..+++|+.|+|++|.+++..+..+..+++|+.|++++|++++..|..+
T Consensus 166 ~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~ 245 (306)
T 2z66_A 166 FLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQH 245 (306)
T ss_dssp EECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCSBCCSGGGTTCTTCCEEECTTSCCCBCSSSSCCC
T ss_pred cchhHHhhCcCCCEEECCCCCcCCcCHHHhcCCCCCCEEECCCCccCccChhhccCcccCCEeECCCCCCcccCHHHHHh
Confidence 445555555 69999999999999889999999999999999999998878789999999999999999998888776
Q ss_pred h-cCCCeeEeecCCCCCCC
Q 004400 276 L-ERGDKIDLSYNNFTDGS 293 (756)
Q Consensus 276 ~-~~l~~l~ls~N~l~~~~ 293 (756)
+ +.++.|++++|+++|..
T Consensus 246 ~~~~L~~L~L~~N~~~~~c 264 (306)
T 2z66_A 246 FPSSLAFLNLTQNDFACTC 264 (306)
T ss_dssp CCTTCCEEECTTCCEECSG
T ss_pred hhccCCEEEccCCCeeccc
Confidence 4 58999999999998754
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=9.8e-28 Score=250.18 Aligned_cols=236 Identities=17% Similarity=0.188 Sum_probs=203.0
Q ss_pred ceeccccccccCcccccCCcccCCCCCCCEEEccCCcccCccCcccccCCcce-eeccCcc-ccccCCccCcCcCCCcEE
Q 004400 16 KTVNQKRVLKEQNLTGVLPPKLAELTFLQDIDLTLNYLSGTIPSQWASLPLLN-ISLIANR-LKGPIPKYLANISTLVNL 93 (756)
Q Consensus 16 ~~~~~~l~L~~~~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~-l~l~~n~-~~~~~p~~l~~l~~L~~L 93 (756)
...++.|+|++|++++..+..|..+++|+.|+|++|.+++..|..|..++.|+ +++.+|+ +....|..|.++++|++|
T Consensus 31 ~~~l~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~l~~~~~~~~~~l~~L~~L 110 (285)
T 1ozn_A 31 PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTL 110 (285)
T ss_dssp CTTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTTCCCCCTTTTTTCTTCCEE
T ss_pred CCCceEEEeeCCcCCccCHHHcccCCCCCEEECCCCccceeCHhhcCCccCCCEEeCCCCCCccccCHHHhcCCcCCCEE
Confidence 35789999999999998888999999999999999999988899999999984 8999997 776778899999999999
Q ss_pred EeecCcccccCCcccCCCCCCcEEeccCCeecccCCccccCCCCCCEEEeeCCcccccCChhhcCcCCCcEEEccCCcCc
Q 004400 94 TVQYNQFSGELPEELGSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRISDNQFTGQIPSFIQNWTKLEKLFIQPSGLA 173 (756)
Q Consensus 94 ~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~ 173 (756)
+|++|.+++..|..|.++++|++|+|++|++++..+..|..+++|+.|+|++|++++..+..|.++++|+.|+|++|+++
T Consensus 111 ~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~ 190 (285)
T 1ozn_A 111 HLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVA 190 (285)
T ss_dssp ECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCC
T ss_pred ECCCCcCCEECHhHhhCCcCCCEEECCCCcccccCHhHhccCCCccEEECCCCcccccCHHHhcCccccCEEECCCCccc
Confidence 99999999888899999999999999999999777778999999999999999999777778999999999999999999
Q ss_pred CCCCccccCCCCCCeEEccCCCCCCCCccccccccccEEEcccccccCCCCccccCCCCCcEEEccCCcCCCCCCccCcC
Q 004400 174 GPIPSGIFSLENLTDLRISDLNGPEATFPQLGNMKMTKLILRNCNITGELPRYLGKMTKLKVLDLSFNRLRGQIPSNFDD 253 (756)
Q Consensus 174 ~~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~ 253 (756)
+..|..+..+++|+.|++++ |.+++..+..|..+++|+.|+|++|.+....+.. .-
T Consensus 191 ~~~~~~~~~l~~L~~L~l~~-----------------------n~l~~~~~~~~~~l~~L~~L~l~~N~~~c~~~~~-~~ 246 (285)
T 1ozn_A 191 HVHPHAFRDLGRLMTLYLFA-----------------------NNLSALPTEALAPLRALQYLRLNDNPWVCDCRAR-PL 246 (285)
T ss_dssp EECTTTTTTCTTCCEEECCS-----------------------SCCSCCCHHHHTTCTTCCEEECCSSCEECSGGGH-HH
T ss_pred ccCHhHccCcccccEeeCCC-----------------------CcCCcCCHHHcccCcccCEEeccCCCccCCCCcH-HH
Confidence 88899998888888776554 6666555667888899999999999888544321 11
Q ss_pred CCCCCeEEecCccccccCCchh
Q 004400 254 LYDVDYIYFAGNLLTGAIPPWM 275 (756)
Q Consensus 254 l~~L~~L~ls~N~l~~~~p~~~ 275 (756)
...++.+..+.|.+.|..|..+
T Consensus 247 ~~~l~~~~~~~~~~~c~~p~~l 268 (285)
T 1ozn_A 247 WAWLQKFRGSSSEVPCSLPQRL 268 (285)
T ss_dssp HHHHHHCCSEECCCBEEESGGG
T ss_pred HHHHHhcccccCccccCCchHh
Confidence 2335555677888888888765
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.95 E-value=1e-28 Score=260.98 Aligned_cols=253 Identities=20% Similarity=0.236 Sum_probs=215.8
Q ss_pred cceeeeeccceeccccccccCcccccCCcccCCCCCCCEEEccCCccc-CccCcccc-------cCCcc-eeeccCcccc
Q 004400 7 FLVFHFWKQKTVNQKRVLKEQNLTGVLPPKLAELTFLQDIDLTLNYLS-GTIPSQWA-------SLPLL-NISLIANRLK 77 (756)
Q Consensus 7 ~~~~~~~~~~~~~~~l~L~~~~l~~~~p~~l~~l~~L~~L~L~~n~l~-~~~p~~~~-------~l~~L-~l~l~~n~~~ 77 (756)
....+.+++...++.++|++|++ .+|..+... |+.|+|++|.++ ..+|..+. .++.| .|++.+|++.
T Consensus 33 ~~~~~~~~~~~~L~~l~l~~n~l--~~p~~~~~~--L~~L~L~~n~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~n~l~ 108 (312)
T 1wwl_A 33 AADVELYGGGRSLEYLLKRVDTE--ADLGQFTDI--IKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVT 108 (312)
T ss_dssp CSEEEEEEEEEECTTHHHHCCTT--CCCHHHHHH--HHHCCCCEEEEEEEECBHHHHHHHHHHHTTSCCCEEEEEEEBCB
T ss_pred cccEEEEccCCCceeEeeccccc--ccHHHHHHH--HhhcccccccccCCCcCHHHHHHHHHhcCcCCccEEEccCCccc
Confidence 34456778889999999999999 778777654 899999999994 45666665 67777 5899999999
Q ss_pred ccCCccC--cCcCCCcEEEeecCcccccCCcccCCC-----CCCcEEeccCCeecccCCccccCCCCCCEEEeeCCcccc
Q 004400 78 GPIPKYL--ANISTLVNLTVQYNQFSGELPEELGSL-----LNLEKLHLSSNNFTGELPKTFAKLTNMKDFRISDNQFTG 150 (756)
Q Consensus 78 ~~~p~~l--~~l~~L~~L~L~~N~l~~~~p~~~~~l-----~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~ 150 (756)
+.+|..+ ..+++|++|+|++|++++. |..++.+ ++|++|+|++|++++..|..|+++++|++|+|++|++.+
T Consensus 109 ~~~~~~~~~~~l~~L~~L~Ls~N~l~~~-~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~ 187 (312)
T 1wwl_A 109 GTAPPPLLEATGPDLNILNLRNVSWATR-DAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELG 187 (312)
T ss_dssp SCCCCCSSSCCSCCCSEEEEESCBCSSS-SSHHHHHHTTCCTTCCEEEEESCSCCCCCTTTCCCCSSCCEEECCSCTTCH
T ss_pred chhHHHHHHhcCCCccEEEccCCCCcch-hHHHHHHHHhhcCCCcEEEeeCCCCccchHHHhccCCCCCEEECCCCCcCc
Confidence 9999987 8999999999999999976 8888877 999999999999998888999999999999999999886
Q ss_pred c--CChhh--cCcCCCcEEEccCCcCcC--CCC-ccccCCCCCCeEEccCCCCCCCCc-ccccc-ccccEEEcccccccC
Q 004400 151 Q--IPSFI--QNWTKLEKLFIQPSGLAG--PIP-SGIFSLENLTDLRISDLNGPEATF-PQLGN-MKMTKLILRNCNITG 221 (756)
Q Consensus 151 ~--~p~~~--~~l~~L~~L~l~~N~l~~--~~p-~~~~~l~~L~~L~l~~n~~~~~~~-~~~~~-~~L~~L~L~~n~l~~ 221 (756)
. .+..+ .++++|++|+|++|++++ .++ ..+..+++|+.|++++|.+....+ ..+.. .+|++|+|++|.++
T Consensus 188 ~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~- 266 (312)
T 1wwl_A 188 ERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK- 266 (312)
T ss_dssp HHHHHHHSCTTSCTTCCEEECTTSCCCCHHHHHHHHHHTTCCCSEEECTTSCCCSSCCCSCCCCCTTCCEEECTTSCCS-
T ss_pred chHHHHHHHhccCCCCCEEECCCCcCcchHHHHHHHHhcCCCCCEEECCCCcCCcccchhhhhhcCCCCEEECCCCccC-
Confidence 5 34445 899999999999999983 223 334578999999999999998763 34443 47999999999999
Q ss_pred CCCccccCCCCCcEEEccCCcCCCCCCccCcCCCCCCeEEecCccccc
Q 004400 222 ELPRYLGKMTKLKVLDLSFNRLRGQIPSNFDDLYDVDYIYFAGNLLTG 269 (756)
Q Consensus 222 ~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~ 269 (756)
.+|..+. ++|+.|+|++|+|++. |. +..+++|+.|++++|++++
T Consensus 267 ~ip~~~~--~~L~~L~Ls~N~l~~~-p~-~~~l~~L~~L~L~~N~l~~ 310 (312)
T 1wwl_A 267 QVPKGLP--AKLSVLDLSYNRLDRN-PS-PDELPQVGNLSLKGNPFLD 310 (312)
T ss_dssp SCCSSCC--SEEEEEECCSSCCCSC-CC-TTTSCEEEEEECTTCTTTC
T ss_pred hhhhhcc--CCceEEECCCCCCCCC-hh-HhhCCCCCEEeccCCCCCC
Confidence 7777776 8999999999999976 66 9999999999999999985
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=99.95 E-value=1.9e-26 Score=257.94 Aligned_cols=263 Identities=27% Similarity=0.346 Sum_probs=151.8
Q ss_pred eeccceeccccccccCcccccCCcccCCCCCCCEEEccCCcccCccCcccccCCcce-eeccCccccccCCccCcCcCCC
Q 004400 12 FWKQKTVNQKRVLKEQNLTGVLPPKLAELTFLQDIDLTLNYLSGTIPSQWASLPLLN-ISLIANRLKGPIPKYLANISTL 90 (756)
Q Consensus 12 ~~~~~~~~~~l~L~~~~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~-l~l~~n~~~~~~p~~l~~l~~L 90 (756)
.+..+..++.|+|++|++++..+ +..+++|++|++++|.+++..+ +..++.|+ |++.+|++.+..+ +.++++|
T Consensus 63 ~~~~l~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L 136 (466)
T 1o6v_A 63 GVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITP--LANLTNLTGLTLFNNQITDIDP--LKNLTNL 136 (466)
T ss_dssp TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCCGG--GTTCTTC
T ss_pred chhhhcCCCEEECCCCccCCchh--hhccccCCEEECCCCccccChh--hcCCCCCCEEECCCCCCCCChH--HcCCCCC
Confidence 35667778888888888876544 7788888888888888875544 77777774 7777777775533 7778888
Q ss_pred cEEEeecCcccccCCc--------------------ccCCCCCCcEEeccCCeecccCCccccCCCCCCEEEeeCCcccc
Q 004400 91 VNLTVQYNQFSGELPE--------------------ELGSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRISDNQFTG 150 (756)
Q Consensus 91 ~~L~L~~N~l~~~~p~--------------------~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~ 150 (756)
++|+|++|.+++ ++. .+.++++|+.|+|++|++++. ..+..+++|+.|++++|++++
T Consensus 137 ~~L~l~~n~l~~-~~~~~~l~~L~~L~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~ 213 (466)
T 1o6v_A 137 NRLELSSNTISD-ISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDI--SVLAKLTNLESLIATNNQISD 213 (466)
T ss_dssp SEEEEEEEEECC-CGGGTTCTTCSEEEEEESCCCCGGGTTCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCC
T ss_pred CEEECCCCccCC-ChhhccCCcccEeecCCcccCchhhccCCCCCEEECcCCcCCCC--hhhccCCCCCEEEecCCcccc
Confidence 888888887774 321 133444555555555555422 124455555555555555554
Q ss_pred cCChhhcCcCCCcEEEccCCcCcCCCCccccCCCCCCeEEccCCCCCCCCccccccccccEEEcccccccCCCCccccCC
Q 004400 151 QIPSFIQNWTKLEKLFIQPSGLAGPIPSGIFSLENLTDLRISDLNGPEATFPQLGNMKMTKLILRNCNITGELPRYLGKM 230 (756)
Q Consensus 151 ~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~L~~L~L~~n~l~~~~p~~~~~l 230 (756)
..| ++.+++|+.|++++|++++. ..+..+++|+.|++++|.+....+ .....+|+.|++++|.+++..+ +..+
T Consensus 214 ~~~--~~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~-~~~l~~L~~L~l~~n~l~~~~~--~~~l 286 (466)
T 1o6v_A 214 ITP--LGILTNLDELSLNGNQLKDI--GTLASLTNLTDLDLANNQISNLAP-LSGLTKLTELKLGANQISNISP--LAGL 286 (466)
T ss_dssp CGG--GGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG-GTTCTTCSEEECCSSCCCCCGG--GTTC
T ss_pred ccc--ccccCCCCEEECCCCCcccc--hhhhcCCCCCEEECCCCccccchh-hhcCCCCCEEECCCCccCcccc--ccCC
Confidence 333 44455555555555555432 234455555555555555554433 1112235555555555554333 5555
Q ss_pred CCCcEEEccCCcCCCCCCccCcCCCCCCeEEecCccccccCCchhhcCCCeeEeecCCCCCC
Q 004400 231 TKLKVLDLSFNRLRGQIPSNFDDLYDVDYIYFAGNLLTGAIPPWMLERGDKIDLSYNNFTDG 292 (756)
Q Consensus 231 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~~l~~l~ls~N~l~~~ 292 (756)
++|+.|+|++|++++..+ +..+++|+.|++++|.+++..|-..+++++.|++++|.+++.
T Consensus 287 ~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~~~~l~~L~~L~l~~n~l~~~ 346 (466)
T 1o6v_A 287 TALTNLELNENQLEDISP--ISNLKNLTYLTLYFNNISDISPVSSLTKLQRLFFYNNKVSDV 346 (466)
T ss_dssp TTCSEEECCSSCCSCCGG--GGGCTTCSEEECCSSCCSCCGGGGGCTTCCEEECCSSCCCCC
T ss_pred CccCeEEcCCCcccCchh--hcCCCCCCEEECcCCcCCCchhhccCccCCEeECCCCccCCc
Confidence 555555555555554333 455555666666666555544433355555566665555543
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.94 E-value=1.9e-28 Score=259.65 Aligned_cols=258 Identities=16% Similarity=0.118 Sum_probs=220.9
Q ss_pred eeccccccccCcccccCCcccCCCCCCCEEEccCCcccCccCcccccCCcce-eeccCccccccCCccCcCcCCCcEEEe
Q 004400 17 TVNQKRVLKEQNLTGVLPPKLAELTFLQDIDLTLNYLSGTIPSQWASLPLLN-ISLIANRLKGPIPKYLANISTLVNLTV 95 (756)
Q Consensus 17 ~~~~~l~L~~~~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~-l~l~~n~~~~~~p~~l~~l~~L~~L~L 95 (756)
..++.++++.+++...+...+..+++|+.|+|++|+|++..|..|..++.|+ |++.+|++.+..+ |..+++|++|+|
T Consensus 10 ~~l~i~~ls~~~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~L 87 (317)
T 3o53_A 10 NRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDL 87 (317)
T ss_dssp TEEEEESCCTTTHHHHHHHHHTTGGGCSEEECTTSCCCCCCHHHHTTCTTCCEEECTTSCCEEEEE--ETTCTTCCEEEC
T ss_pred CceeEeeccccchhhhHHHHhccCCCCCEEECcCCccCcCCHHHhhCCCcCCEEECCCCcCCcchh--hhhcCCCCEEEC
Confidence 4567778999999887777778889999999999999988888999999994 8999999987665 999999999999
Q ss_pred ecCcccccCCcccCCCCCCcEEeccCCeecccCCccccCCCCCCEEEeeCCcccccCChhhcCcCCCcEEEccCCcCcCC
Q 004400 96 QYNQFSGELPEELGSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRISDNQFTGQIPSFIQNWTKLEKLFIQPSGLAGP 175 (756)
Q Consensus 96 ~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~ 175 (756)
++|+|++.. .+++|++|+|++|++++..+. .+++|+.|+|++|++++..+..|..+++|++|+|++|++++.
T Consensus 88 s~n~l~~l~-----~~~~L~~L~l~~n~l~~~~~~---~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~ 159 (317)
T 3o53_A 88 NNNYVQELL-----VGPSIETLHAANNNISRVSCS---RGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTV 159 (317)
T ss_dssp CSSEEEEEE-----ECTTCCEEECCSSCCSEEEEC---CCSSCEEEECCSSCCCSGGGBCTGGGSSEEEEECTTSCCCEE
T ss_pred cCCcccccc-----CCCCcCEEECCCCccCCcCcc---ccCCCCEEECCCCCCCCccchhhhccCCCCEEECCCCCCCcc
Confidence 999998533 348999999999999966554 367899999999999988888999999999999999999987
Q ss_pred CCcccc-CCCCCCeEEccCCCCCCCCccccccccccEEEcccccccCCCCccccCCCCCcEEEccCCcCCCCCCccCcCC
Q 004400 176 IPSGIF-SLENLTDLRISDLNGPEATFPQLGNMKMTKLILRNCNITGELPRYLGKMTKLKVLDLSFNRLRGQIPSNFDDL 254 (756)
Q Consensus 176 ~p~~~~-~l~~L~~L~l~~n~~~~~~~~~~~~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l 254 (756)
.+..+. .+++|++|++++|.+...... ....+|+.|+|++|.+++. |..|..+++|+.|+|++|+++ .+|..+..+
T Consensus 160 ~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~~l~~L~~L~Ls~N~l~~l-~~~~~~l~~L~~L~L~~N~l~-~l~~~~~~l 236 (317)
T 3o53_A 160 NFAELAASSDTLEHLNLQYNFIYDVKGQ-VVFAKLKTLDLSSNKLAFM-GPEFQSAAGVTWISLRNNKLV-LIEKALRFS 236 (317)
T ss_dssp EGGGGGGGTTTCCEEECTTSCCCEEECC-CCCTTCCEEECCSSCCCEE-CGGGGGGTTCSEEECTTSCCC-EECTTCCCC
T ss_pred cHHHHhhccCcCCEEECCCCcCcccccc-cccccCCEEECCCCcCCcc-hhhhcccCcccEEECcCCccc-chhhHhhcC
Confidence 777775 799999999999999877333 2345799999999999954 555999999999999999999 578889999
Q ss_pred CCCCeEEecCcccc-ccCCchh--hcCCCeeEeecC
Q 004400 255 YDVDYIYFAGNLLT-GAIPPWM--LERGDKIDLSYN 287 (756)
Q Consensus 255 ~~L~~L~ls~N~l~-~~~p~~~--~~~l~~l~ls~N 287 (756)
++|+.|++++|+++ +.+|.++ ++.++.+++++|
T Consensus 237 ~~L~~L~l~~N~~~~~~~~~~~~~~~~L~~l~l~~~ 272 (317)
T 3o53_A 237 QNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTV 272 (317)
T ss_dssp TTCCEEECTTCCCBHHHHHHHHHTCHHHHHHHHHHH
T ss_pred CCCCEEEccCCCccCcCHHHHHhccccceEEECCCc
Confidence 99999999999998 4455554 566777888744
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=99.94 E-value=2.4e-26 Score=257.03 Aligned_cols=265 Identities=24% Similarity=0.333 Sum_probs=211.0
Q ss_pred eccceeccccccccCcccccCCcccCCCCCCCEEEccCCcccCccCcccccCCcc-eeeccCccccccCC----------
Q 004400 13 WKQKTVNQKRVLKEQNLTGVLPPKLAELTFLQDIDLTLNYLSGTIPSQWASLPLL-NISLIANRLKGPIP---------- 81 (756)
Q Consensus 13 ~~~~~~~~~l~L~~~~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L-~l~l~~n~~~~~~p---------- 81 (756)
+.++..++.|+|++|.+++..+ +.++++|+.|+|++|.+++..+ +..++.| .|++.+|++.+...
T Consensus 86 ~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~~~~l~~L~~L 161 (466)
T 1o6v_A 86 LKNLTKLVDILMNNNQIADITP--LANLTNLTGLTLFNNQITDIDP--LKNLTNLNRLELSSNTISDISALSGLTSLQQL 161 (466)
T ss_dssp GTTCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCCGG--GTTCTTCSEEEEEEEEECCCGGGTTCTTCSEE
T ss_pred hhccccCCEEECCCCccccChh--hcCCCCCCEEECCCCCCCCChH--HcCCCCCCEEECCCCccCCChhhccCCcccEe
Confidence 6777788888888888886654 7788888888888888875433 6677766 36777776654211
Q ss_pred ---------ccCcCcCCCcEEEeecCcccccCCcccCCCCCCcEEeccCCeecccCCccccCCCCCCEEEeeCCcccccC
Q 004400 82 ---------KYLANISTLVNLTVQYNQFSGELPEELGSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRISDNQFTGQI 152 (756)
Q Consensus 82 ---------~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~ 152 (756)
..+.++++|+.|++++|.+++ + ..+..+++|++|++++|++++..| +..+++|+.|++++|++++ +
T Consensus 162 ~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~-~-~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~-~ 236 (466)
T 1o6v_A 162 SFGNQVTDLKPLANLTTLERLDISSNKVSD-I-SVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKD-I 236 (466)
T ss_dssp EEEESCCCCGGGTTCTTCCEEECCSSCCCC-C-GGGGGCTTCSEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCC-C
T ss_pred ecCCcccCchhhccCCCCCEEECcCCcCCC-C-hhhccCCCCCEEEecCCccccccc--ccccCCCCEEECCCCCccc-c
Confidence 136778899999999999984 3 358899999999999999996655 7789999999999999985 3
Q ss_pred ChhhcCcCCCcEEEccCCcCcCCCCccccCCCCCCeEEccCCCCCCCCccccccccccEEEcccccccCCCCccccCCCC
Q 004400 153 PSFIQNWTKLEKLFIQPSGLAGPIPSGIFSLENLTDLRISDLNGPEATFPQLGNMKMTKLILRNCNITGELPRYLGKMTK 232 (756)
Q Consensus 153 p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~L~~L~L~~n~l~~~~p~~~~~l~~ 232 (756)
..+..+++|+.|++++|++.+..+ +..+++|+.|++++|.+....+ .....+|+.|+|++|.+++..+ +..+++
T Consensus 237 -~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~-~~~l~~L~~L~L~~n~l~~~~~--~~~l~~ 310 (466)
T 1o6v_A 237 -GTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISP-LAGLTALTNLELNENQLEDISP--ISNLKN 310 (466)
T ss_dssp -GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCCCCGG-GTTCTTCSEEECCSSCCSCCGG--GGGCTT
T ss_pred -hhhhcCCCCCEEECCCCccccchh--hhcCCCCCEEECCCCccCcccc-ccCCCccCeEEcCCCcccCchh--hcCCCC
Confidence 468899999999999999986554 8889999999999999887655 2233369999999999997654 788999
Q ss_pred CcEEEccCCcCCCCCCccCcCCCCCCeEEecCccccccCCchhhcCCCeeEeecCCCCCCCC
Q 004400 233 LKVLDLSFNRLRGQIPSNFDDLYDVDYIYFAGNLLTGAIPPWMLERGDKIDLSYNNFTDGSA 294 (756)
Q Consensus 233 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~~l~~l~ls~N~l~~~~~ 294 (756)
|+.|+|++|++++..| +..+++|+.|++++|++++...-.-+++++.|++++|++++..+
T Consensus 311 L~~L~L~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~l~~l~~L~~L~l~~n~l~~~~~ 370 (466)
T 1o6v_A 311 LTYLTLYFNNISDISP--VSSLTKLQRLFFYNNKVSDVSSLANLTNINWLSAGHNQISDLTP 370 (466)
T ss_dssp CSEEECCSSCCSCCGG--GGGCTTCCEEECCSSCCCCCGGGTTCTTCCEEECCSSCCCBCGG
T ss_pred CCEEECcCCcCCCchh--hccCccCCEeECCCCccCCchhhccCCCCCEEeCCCCccCccch
Confidence 9999999999997766 78899999999999999865222227889999999999987654
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.94 E-value=3.3e-26 Score=254.25 Aligned_cols=257 Identities=17% Similarity=0.104 Sum_probs=212.7
Q ss_pred eeeeccceeccccccccCcccccCCcccCCCCCCCEEEccCCcccCccCcccccCCcc-eeeccCccccccCCccCcCcC
Q 004400 10 FHFWKQKTVNQKRVLKEQNLTGVLPPKLAELTFLQDIDLTLNYLSGTIPSQWASLPLL-NISLIANRLKGPIPKYLANIS 88 (756)
Q Consensus 10 ~~~~~~~~~~~~l~L~~~~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L-~l~l~~n~~~~~~p~~l~~l~ 88 (756)
+..+..++.++.|+|++|++++. | .|..+++|+.|+|++|+|++. | +..++.| .|++.+|++.+. | +++++
T Consensus 35 ~~~~~~l~~L~~L~Ls~n~l~~~-~-~l~~l~~L~~L~Ls~n~l~~~-~--~~~l~~L~~L~Ls~N~l~~~-~--~~~l~ 106 (457)
T 3bz5_A 35 TISEEQLATLTSLDCHNSSITDM-T-GIEKLTGLTKLICTSNNITTL-D--LSQNTNLTYLACDSNKLTNL-D--VTPLT 106 (457)
T ss_dssp EEEHHHHTTCCEEECCSSCCCCC-T-TGGGCTTCSEEECCSSCCSCC-C--CTTCTTCSEEECCSSCCSCC-C--CTTCT
T ss_pred ccChhHcCCCCEEEccCCCcccC-h-hhcccCCCCEEEccCCcCCeE-c--cccCCCCCEEECcCCCCcee-e--cCCCC
Confidence 34677889999999999999975 5 689999999999999999964 4 8888888 488999998875 3 89999
Q ss_pred CCcEEEeecCcccccCCcccCCCCCCcEEeccCCeecccCCccccCCCCCCEEEeeCCcccccCChhhcCcCCCcEEEcc
Q 004400 89 TLVNLTVQYNQFSGELPEELGSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRISDNQFTGQIPSFIQNWTKLEKLFIQ 168 (756)
Q Consensus 89 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~ 168 (756)
+|++|+|++|++++ +| ++.+++|++|+|++|++++. + ++.+++|++|++++|+..+.+ .+..+++|+.|+++
T Consensus 107 ~L~~L~L~~N~l~~-l~--~~~l~~L~~L~l~~N~l~~l-~--l~~l~~L~~L~l~~n~~~~~~--~~~~l~~L~~L~ls 178 (457)
T 3bz5_A 107 KLTYLNCDTNKLTK-LD--VSQNPLLTYLNCARNTLTEI-D--VSHNTQLTELDCHLNKKITKL--DVTPQTQLTTLDCS 178 (457)
T ss_dssp TCCEEECCSSCCSC-CC--CTTCTTCCEEECTTSCCSCC-C--CTTCTTCCEEECTTCSCCCCC--CCTTCTTCCEEECC
T ss_pred cCCEEECCCCcCCe-ec--CCCCCcCCEEECCCCcccee-c--cccCCcCCEEECCCCCccccc--ccccCCcCCEEECC
Confidence 99999999999996 44 89999999999999999964 3 888999999999999766566 48889999999999
Q ss_pred CCcCcCCCCccccCCCCCCeEEccCCCCCCCCcccccc-ccccEEEcccccccCCCCccccCCCCCcEEEccCCcCCCCC
Q 004400 169 PSGLAGPIPSGIFSLENLTDLRISDLNGPEATFPQLGN-MKMTKLILRNCNITGELPRYLGKMTKLKVLDLSFNRLRGQI 247 (756)
Q Consensus 169 ~N~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~-~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~ 247 (756)
+|++++ +| +..+++|+.|++++|.+.... +.. .+|+.|++++|++++ +| ++.+++|+.|++++|++++..
T Consensus 179 ~n~l~~-l~--l~~l~~L~~L~l~~N~l~~~~---l~~l~~L~~L~Ls~N~l~~-ip--~~~l~~L~~L~l~~N~l~~~~ 249 (457)
T 3bz5_A 179 FNKITE-LD--VSQNKLLNRLNCDTNNITKLD---LNQNIQLTFLDCSSNKLTE-ID--VTPLTQLTYFDCSVNPLTELD 249 (457)
T ss_dssp SSCCCC-CC--CTTCTTCCEEECCSSCCSCCC---CTTCTTCSEEECCSSCCSC-CC--CTTCTTCSEEECCSSCCSCCC
T ss_pred CCccce-ec--cccCCCCCEEECcCCcCCeec---cccCCCCCEEECcCCcccc-cC--ccccCCCCEEEeeCCcCCCcC
Confidence 999986 45 888999999999999988873 333 469999999999997 55 888999999999999999876
Q ss_pred CccCcCCC-------CCCeEEecCccccccCCchhhcCCCeeEeecCCCCC
Q 004400 248 PSNFDDLY-------DVDYIYFAGNLLTGAIPPWMLERGDKIDLSYNNFTD 291 (756)
Q Consensus 248 p~~~~~l~-------~L~~L~ls~N~l~~~~p~~~~~~l~~l~ls~N~l~~ 291 (756)
+..+..+. +|+.|++++|.+.+.+|...++.++.|++++|...+
T Consensus 250 ~~~l~~L~~L~l~~n~L~~L~l~~n~~~~~~~~~~l~~L~~L~Ls~n~~l~ 300 (457)
T 3bz5_A 250 VSTLSKLTTLHCIQTDLLEIDLTHNTQLIYFQAEGCRKIKELDVTHNTQLY 300 (457)
T ss_dssp CTTCTTCCEEECTTCCCSCCCCTTCTTCCEEECTTCTTCCCCCCTTCTTCC
T ss_pred HHHCCCCCEEeccCCCCCEEECCCCccCCcccccccccCCEEECCCCcccc
Confidence 66665554 566777777777777775556778888888887554
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.93 E-value=1.1e-25 Score=250.11 Aligned_cols=257 Identities=17% Similarity=0.067 Sum_probs=179.2
Q ss_pred eeccceeccccccccCcccccCCcccCCCCCCCEEEccCCcccCccCcccccCCcc-eeeccCccccccCCccCcCcCCC
Q 004400 12 FWKQKTVNQKRVLKEQNLTGVLPPKLAELTFLQDIDLTLNYLSGTIPSQWASLPLL-NISLIANRLKGPIPKYLANISTL 90 (756)
Q Consensus 12 ~~~~~~~~~~l~L~~~~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L-~l~l~~n~~~~~~p~~l~~l~~L 90 (756)
.+..+..++.|+|++|++++. | +..+++|++|+|++|.|++. + +..++.| .|++.+|++.+ +| ++++++|
T Consensus 59 ~l~~l~~L~~L~Ls~n~l~~~-~--~~~l~~L~~L~Ls~N~l~~~-~--~~~l~~L~~L~L~~N~l~~-l~--~~~l~~L 129 (457)
T 3bz5_A 59 GIEKLTGLTKLICTSNNITTL-D--LSQNTNLTYLACDSNKLTNL-D--VTPLTKLTYLNCDTNKLTK-LD--VSQNPLL 129 (457)
T ss_dssp TGGGCTTCSEEECCSSCCSCC-C--CTTCTTCSEEECCSSCCSCC-C--CTTCTTCCEEECCSSCCSC-CC--CTTCTTC
T ss_pred hhcccCCCCEEEccCCcCCeE-c--cccCCCCCEEECcCCCCcee-e--cCCCCcCCEEECCCCcCCe-ec--CCCCCcC
Confidence 577888999999999999975 4 88999999999999999864 4 7888888 48899998887 44 8889999
Q ss_pred cEEEeecCcccccCCcccCCCCCCcEEeccCCeecccCCccccCCCCCCEEEeeCCcccccCChhhcCcCCCcEEEccCC
Q 004400 91 VNLTVQYNQFSGELPEELGSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRISDNQFTGQIPSFIQNWTKLEKLFIQPS 170 (756)
Q Consensus 91 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N 170 (756)
++|+|++|+|++. + ++.+++|++|++++|+..+.+ .+..+++|+.|++++|++++ +| ++.+++|+.|++++|
T Consensus 130 ~~L~l~~N~l~~l-~--l~~l~~L~~L~l~~n~~~~~~--~~~~l~~L~~L~ls~n~l~~-l~--l~~l~~L~~L~l~~N 201 (457)
T 3bz5_A 130 TYLNCARNTLTEI-D--VSHNTQLTELDCHLNKKITKL--DVTPQTQLTTLDCSFNKITE-LD--VSQNKLLNRLNCDTN 201 (457)
T ss_dssp CEEECTTSCCSCC-C--CTTCTTCCEEECTTCSCCCCC--CCTTCTTCCEEECCSSCCCC-CC--CTTCTTCCEEECCSS
T ss_pred CEEECCCCcccee-c--cccCCcCCEEECCCCCccccc--ccccCCcCCEEECCCCccce-ec--cccCCCCCEEECcCC
Confidence 9999999999863 3 778888888888888655455 37778888888888888885 44 777788888888888
Q ss_pred cCcCCCCccccCCCCCCeEEccCCCCCCCCccccccccccEEEcccccccCCCCccccCCC-------CCcEEEccCCcC
Q 004400 171 GLAGPIPSGIFSLENLTDLRISDLNGPEATFPQLGNMKMTKLILRNCNITGELPRYLGKMT-------KLKVLDLSFNRL 243 (756)
Q Consensus 171 ~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~L~~L~L~~n~l~~~~p~~~~~l~-------~L~~L~Ls~N~l 243 (756)
++++. .+..+++|+.|++++|.+...+ .....+|+.|++++|++++..+..+.+++ +|+.|++++|.+
T Consensus 202 ~l~~~---~l~~l~~L~~L~Ls~N~l~~ip--~~~l~~L~~L~l~~N~l~~~~~~~l~~L~~L~l~~n~L~~L~l~~n~~ 276 (457)
T 3bz5_A 202 NITKL---DLNQNIQLTFLDCSSNKLTEID--VTPLTQLTYFDCSVNPLTELDVSTLSKLTTLHCIQTDLLEIDLTHNTQ 276 (457)
T ss_dssp CCSCC---CCTTCTTCSEEECCSSCCSCCC--CTTCTTCSEEECCSSCCSCCCCTTCTTCCEEECTTCCCSCCCCTTCTT
T ss_pred cCCee---ccccCCCCCEEECcCCcccccC--ccccCCCCEEEeeCCcCCCcCHHHCCCCCEEeccCCCCCEEECCCCcc
Confidence 88754 3677778888888887777743 22223577777777777766544444433 334444455444
Q ss_pred CCCCCccCcCCCCCCeEEecCccccccCCchh----------hcCCCeeEeecCCCCCC
Q 004400 244 RGQIPSNFDDLYDVDYIYFAGNLLTGAIPPWM----------LERGDKIDLSYNNFTDG 292 (756)
Q Consensus 244 ~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~----------~~~l~~l~ls~N~l~~~ 292 (756)
.+.+| +..+++|+.|++++|...+.+|... .++++.|++++|.+++.
T Consensus 277 ~~~~~--~~~l~~L~~L~Ls~n~~l~~l~~~~~~L~~L~l~~~~~L~~L~L~~N~l~~l 333 (457)
T 3bz5_A 277 LIYFQ--AEGCRKIKELDVTHNTQLYLLDCQAAGITELDLSQNPKLVYLYLNNTELTEL 333 (457)
T ss_dssp CCEEE--CTTCTTCCCCCCTTCTTCCEEECTTCCCSCCCCTTCTTCCEEECTTCCCSCC
T ss_pred CCccc--ccccccCCEEECCCCcccceeccCCCcceEechhhcccCCEEECCCCccccc
Confidence 44444 3445555555555555444443211 23455555555555553
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=9e-27 Score=263.41 Aligned_cols=184 Identities=17% Similarity=0.218 Sum_probs=145.7
Q ss_pred cccCcccCCCCccEEEeeccCCcEEEEEEccccCcc--------cHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEE
Q 004400 419 ATDNNIGEGGFGPVYKGLLADGTAIAVKQLSSKSKQ--------GNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLI 490 (756)
Q Consensus 419 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 490 (756)
...+.||+|+||.||+|.. .++.+++|+...+... ..+.+.+|++++++++||||+++..++..++..++|
T Consensus 339 ~~~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV 417 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIM 417 (540)
T ss_dssp ---------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEE
T ss_pred CCCCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEE
Confidence 4467999999999999954 4678888876443211 134589999999999999999777777788888999
Q ss_pred EEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCcccC
Q 004400 491 YEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEEN 570 (756)
Q Consensus 491 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~~~ 570 (756)
|||+++|+|.+++.. +..++.|+++||+|||+++ |+||||||+|||++. .+||+|||+++......
T Consensus 418 mE~~~ggsL~~~l~~---------~~~i~~qi~~aL~~LH~~g---IiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~ 483 (540)
T 3en9_A 418 MSYINGKLAKDVIED---------NLDIAYKIGEIVGKLHKND---VIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDE 483 (540)
T ss_dssp EECCCSEEHHHHSTT---------CTHHHHHHHHHHHHHHHTT---EECTTCCTTSEEESS--SEEECCCTTCEECCCHH
T ss_pred EECCCCCCHHHHHHH---------HHHHHHHHHHHHHHHHHCc---CccCCCCHHHEEECC--eEEEEECccCEECCCcc
Confidence 999999999999854 5689999999999999997 999999999999999 99999999999765432
Q ss_pred cce------eeccccCccCCchHhhhc--CCCCcccchhhHHHHHHHHHhCCCCC
Q 004400 571 THI------STRVAGTIGYMAPEYAMR--GHLTEKADVYSFGIVALEIVSGRSNV 617 (756)
Q Consensus 571 ~~~------~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~slGv~l~elltg~~p~ 617 (756)
... .....||+.|||||++.. ..|+..+|+|+..+-..+-+.++.+|
T Consensus 484 ~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 484 DKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY 538 (540)
T ss_dssp HHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred ccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence 211 235689999999999987 56888999999998888888777665
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=3.8e-25 Score=229.38 Aligned_cols=228 Identities=21% Similarity=0.235 Sum_probs=152.8
Q ss_pred cccccCcccccCCcccCCCCCCCEEEccCCcccCccCcccccCCcc-eeeccCccccccCCccCcCcCCCcEEEeecCcc
Q 004400 22 RVLKEQNLTGVLPPKLAELTFLQDIDLTLNYLSGTIPSQWASLPLL-NISLIANRLKGPIPKYLANISTLVNLTVQYNQF 100 (756)
Q Consensus 22 l~L~~~~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L-~l~l~~n~~~~~~p~~l~~l~~L~~L~L~~N~l 100 (756)
++-.+.+++ .+|..+. ++|+.|+|++|++++..+..|..++.| .+++.+|++.+..+..|.++++|++|+|++|.+
T Consensus 12 ~~c~~~~l~-~ip~~l~--~~l~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l 88 (276)
T 2z62_A 12 YQCMELNFY-KIPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPI 88 (276)
T ss_dssp EECTTSCCS-SCCSSSC--TTCCEEECTTCCCCEECTTTTTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCC
T ss_pred EEecCCCcc-ccCCCCC--CCccEEECCCCcccccCHhHhccccCCcEEECCCCcCCccCHHHccCCcCCCEEECCCCcc
Confidence 344455555 4565554 578888888888886555566666665 356666666655555666666666666666666
Q ss_pred cccCCcccCCCCCCcEEeccCCeecccCCccccCCCCCCEEEeeCCccccc-CChhhcCcCCCcEEEccCCcCcCCCCcc
Q 004400 101 SGELPEELGSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRISDNQFTGQ-IPSFIQNWTKLEKLFIQPSGLAGPIPSG 179 (756)
Q Consensus 101 ~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~-~p~~~~~l~~L~~L~l~~N~l~~~~p~~ 179 (756)
++..+..|.++++|++|+|++|++++..+..+..+++|++|+|++|++++. +|..|.++++|++|+|++|++++..+..
T Consensus 89 ~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~l~~~~~~l~~L~~L~Ls~N~l~~~~~~~ 168 (276)
T 2z62_A 89 QSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTD 168 (276)
T ss_dssp CEECTTTTTTCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGG
T ss_pred CccChhhhcCCccccEEECCCCCccccCchhcccCCCCCEEECcCCccceecCchhhccCCCCCEEECCCCCCCcCCHHH
Confidence 655556666666666666666666655554566666666666666666642 4666666666666666666666554555
Q ss_pred ccCCCCCCeEEccCCCCCCCCccccccccccEEEcccccccCCCCccccCCCCCcEEEccCCcCCCCCCccCcCCCCCCe
Q 004400 180 IFSLENLTDLRISDLNGPEATFPQLGNMKMTKLILRNCNITGELPRYLGKMTKLKVLDLSFNRLRGQIPSNFDDLYDVDY 259 (756)
Q Consensus 180 ~~~l~~L~~L~l~~n~~~~~~~~~~~~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~ 259 (756)
+..+++|+.|.+ .|++++|.+++..+..+. ..+|+.|+|++|.+++..+..|..+++|+.
T Consensus 169 ~~~l~~L~~l~l-------------------~L~ls~n~l~~~~~~~~~-~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~ 228 (276)
T 2z62_A 169 LRVLHQMPLLNL-------------------SLDLSLNPMNFIQPGAFK-EIRLKELALDTNQLKSVPDGIFDRLTSLQK 228 (276)
T ss_dssp GHHHHTCTTCCE-------------------EEECCSSCCCEECTTSSC-SCCEEEEECCSSCCSCCCTTTTTTCCSCCE
T ss_pred hhhhhhccccce-------------------eeecCCCcccccCccccC-CCcccEEECCCCceeecCHhHhcccccccE
Confidence 555544443221 577888888866655554 448999999999999777777889999999
Q ss_pred EEecCccccccCC
Q 004400 260 IYFAGNLLTGAIP 272 (756)
Q Consensus 260 L~ls~N~l~~~~p 272 (756)
|++++|+++|.+|
T Consensus 229 L~l~~N~~~c~c~ 241 (276)
T 2z62_A 229 IWLHTNPWDCSCP 241 (276)
T ss_dssp EECCSSCBCCCTT
T ss_pred EEccCCcccccCC
Confidence 9999999998887
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=5.3e-25 Score=228.32 Aligned_cols=206 Identities=18% Similarity=0.166 Sum_probs=137.5
Q ss_pred CCCcEEEeecCcccccCCcccCCCCCCcEEeccCCeecccCCccccCCCCCCEEEeeCCcccccCChhhcCcCCCcEEEc
Q 004400 88 STLVNLTVQYNQFSGELPEELGSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRISDNQFTGQIPSFIQNWTKLEKLFI 167 (756)
Q Consensus 88 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l 167 (756)
++|++|+|++|+|++..+..|.++++|++|+|++|++++..+..|.++++|+.|+|++|++++..+..|.++++|++|++
T Consensus 28 ~~l~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l 107 (276)
T 2z62_A 28 FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVA 107 (276)
T ss_dssp TTCCEEECTTCCCCEECTTTTTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEEC
T ss_pred CCccEEECCCCcccccCHhHhccccCCcEEECCCCcCCccCHHHccCCcCCCEEECCCCccCccChhhhcCCccccEEEC
Confidence 35666666666666555555666666666666666666555555666666666666666666555555666666666666
Q ss_pred cCCcCcCCCCccccCCCCCCeEEccCCCCCCCC-ccccccc-cccEEEcccccccCCCCccccCCCCCc----EEEccCC
Q 004400 168 QPSGLAGPIPSGIFSLENLTDLRISDLNGPEAT-FPQLGNM-KMTKLILRNCNITGELPRYLGKMTKLK----VLDLSFN 241 (756)
Q Consensus 168 ~~N~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~-~~~~~~~-~L~~L~L~~n~l~~~~p~~~~~l~~L~----~L~Ls~N 241 (756)
++|++.+..+..+..+++|++|++++|.+.... +..+..+ +|+.|+|++|++++..+..|..+++|+ .|++++|
T Consensus 108 ~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~l~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~l~l~L~ls~n 187 (276)
T 2z62_A 108 VETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLN 187 (276)
T ss_dssp TTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGGGHHHHTCTTCCEEEECCSS
T ss_pred CCCCccccCchhcccCCCCCEEECcCCccceecCchhhccCCCCCEEECCCCCCCcCCHHHhhhhhhccccceeeecCCC
Confidence 666666544445666666666666666665533 3344433 466677777778776667777666666 8999999
Q ss_pred cCCCCCCccCcCCCCCCeEEecCccccccCCchh--hcCCCeeEeecCCCCCCCC
Q 004400 242 RLRGQIPSNFDDLYDVDYIYFAGNLLTGAIPPWM--LERGDKIDLSYNNFTDGSA 294 (756)
Q Consensus 242 ~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~--~~~l~~l~ls~N~l~~~~~ 294 (756)
.+++..+..+.. .+|+.|++++|.+++..+..+ +++++.|++++|++.|..+
T Consensus 188 ~l~~~~~~~~~~-~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~ 241 (276)
T 2z62_A 188 PMNFIQPGAFKE-IRLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 241 (276)
T ss_dssp CCCEECTTSSCS-CCEEEEECCSSCCSCCCTTTTTTCCSCCEEECCSSCBCCCTT
T ss_pred cccccCccccCC-CcccEEECCCCceeecCHhHhcccccccEEEccCCcccccCC
Confidence 999766665554 589999999999996555443 7889999999999998653
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.93 E-value=1.8e-26 Score=258.78 Aligned_cols=236 Identities=18% Similarity=0.096 Sum_probs=206.8
Q ss_pred cceeccccccccCcccccCCcccCCCCCCCEEEccCCcccCccCcccccCCcc-eeeccCccccccCCccCcCcCCCcEE
Q 004400 15 QKTVNQKRVLKEQNLTGVLPPKLAELTFLQDIDLTLNYLSGTIPSQWASLPLL-NISLIANRLKGPIPKYLANISTLVNL 93 (756)
Q Consensus 15 ~~~~~~~l~L~~~~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L-~l~l~~n~~~~~~p~~l~~l~~L~~L 93 (756)
.+..++.|+|++|++++..|..|..+++|+.|+|++|.|++..| +..++.| .|++.+|++.+..+ .++|+.|
T Consensus 32 ~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~l~~-----~~~L~~L 104 (487)
T 3oja_A 32 SAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQELLV-----GPSIETL 104 (487)
T ss_dssp TGGGCCEEECCSSCCCCCCGGGGTTCTTCCEEECTTSCCEEEEE--CTTCTTCCEEECCSSEEEEEEE-----CTTCCEE
T ss_pred cCCCccEEEeeCCcCCCCCHHHHhCCCCCCEEEeeCCCCCCCcc--cccCCCCCEEEecCCcCCCCCC-----CCCcCEE
Confidence 34589999999999999988999999999999999999997666 8899988 48999999886443 3899999
Q ss_pred EeecCcccccCCcccCCCCCCcEEeccCCeecccCCccccCCCCCCEEEeeCCcccccCChhhc-CcCCCcEEEccCCcC
Q 004400 94 TVQYNQFSGELPEELGSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRISDNQFTGQIPSFIQ-NWTKLEKLFIQPSGL 172 (756)
Q Consensus 94 ~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~-~l~~L~~L~l~~N~l 172 (756)
+|++|.|++..+. .+++|+.|+|++|++++..|..|+.+++|+.|+|++|+|++.+|..|. .+++|+.|+|++|.+
T Consensus 105 ~L~~N~l~~~~~~---~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~~l~~L~~L~Ls~N~l 181 (487)
T 3oja_A 105 HAANNNISRVSCS---RGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFI 181 (487)
T ss_dssp ECCSSCCCCEEEC---CCSSCEEEECCSSCCCSGGGBCGGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCC
T ss_pred ECcCCcCCCCCcc---ccCCCCEEECCCCCCCCCCchhhcCCCCCCEEECCCCCCCCcChHHHhhhCCcccEEecCCCcc
Confidence 9999999976554 468999999999999998899999999999999999999998888886 799999999999999
Q ss_pred cCCCCccccCCCCCCeEEccCCCCCCCCccccccccccEEEcccccccCCCCccccCCCCCcEEEccCCcCC-CCCCccC
Q 004400 173 AGPIPSGIFSLENLTDLRISDLNGPEATFPQLGNMKMTKLILRNCNITGELPRYLGKMTKLKVLDLSFNRLR-GQIPSNF 251 (756)
Q Consensus 173 ~~~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~-~~~p~~~ 251 (756)
++.. .+..+++|+.|++++|.+...++......+|+.|+|++|.+++ +|..+..+++|+.|++++|.+. +.+|..+
T Consensus 182 ~~~~--~~~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~Ls~N~l~~-lp~~l~~l~~L~~L~l~~N~l~c~~~~~~~ 258 (487)
T 3oja_A 182 YDVK--GQVVFAKLKTLDLSSNKLAFMGPEFQSAAGVTWISLRNNKLVL-IEKALRFSQNLEHFDLRGNGFHCGTLRDFF 258 (487)
T ss_dssp CEEE--CCCCCTTCCEEECCSSCCCEECGGGGGGTTCSEEECTTSCCCE-ECTTCCCCTTCCEEECTTCCBCHHHHHHHH
T ss_pred cccc--ccccCCCCCEEECCCCCCCCCCHhHcCCCCccEEEecCCcCcc-cchhhccCCCCCEEEcCCCCCcCcchHHHH
Confidence 9763 3446999999999999999877764444579999999999995 6778999999999999999998 6677778
Q ss_pred cCCCCCCeEEec
Q 004400 252 DDLYDVDYIYFA 263 (756)
Q Consensus 252 ~~l~~L~~L~ls 263 (756)
..++.|+.++++
T Consensus 259 ~~l~~L~~l~~~ 270 (487)
T 3oja_A 259 SKNQRVQTVAKQ 270 (487)
T ss_dssp TTCHHHHHHHHH
T ss_pred HhCCCCcEEecc
Confidence 888888777775
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.93 E-value=7.9e-27 Score=247.17 Aligned_cols=247 Identities=18% Similarity=0.101 Sum_probs=213.3
Q ss_pred eccceeccccccccCcccccCCcccCCCCCCCEEEccCCcccCccCcccccCCcc-eeeccCccccccCCccCcCcCCCc
Q 004400 13 WKQKTVNQKRVLKEQNLTGVLPPKLAELTFLQDIDLTLNYLSGTIPSQWASLPLL-NISLIANRLKGPIPKYLANISTLV 91 (756)
Q Consensus 13 ~~~~~~~~~l~L~~~~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L-~l~l~~n~~~~~~p~~l~~l~~L~ 91 (756)
+..+..++.|+|++|++++..|..|..+++|+.|+|++|.+++..+ +..++.| .|++.+|++.+.. ..++|+
T Consensus 30 ~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~Ls~n~l~~l~-----~~~~L~ 102 (317)
T 3o53_A 30 RQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQELL-----VGPSIE 102 (317)
T ss_dssp HTTGGGCSEEECTTSCCCCCCHHHHTTCTTCCEEECTTSCCEEEEE--ETTCTTCCEEECCSSEEEEEE-----ECTTCC
T ss_pred hccCCCCCEEECcCCccCcCCHHHhhCCCcCCEEECCCCcCCcchh--hhhcCCCCEEECcCCcccccc-----CCCCcC
Confidence 4556789999999999999888999999999999999999996665 8889888 4899999988543 348999
Q ss_pred EEEeecCcccccCCcccCCCCCCcEEeccCCeecccCCccccCCCCCCEEEeeCCcccccCChhhc-CcCCCcEEEccCC
Q 004400 92 NLTVQYNQFSGELPEELGSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRISDNQFTGQIPSFIQ-NWTKLEKLFIQPS 170 (756)
Q Consensus 92 ~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~-~l~~L~~L~l~~N 170 (756)
+|++++|+|++..+. .+++|++|+|++|++++..+..+..+++|+.|+|++|++++..+..+. .+++|++|+|++|
T Consensus 103 ~L~l~~n~l~~~~~~---~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N 179 (317)
T 3o53_A 103 TLHAANNNISRVSCS---RGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYN 179 (317)
T ss_dssp EEECCSSCCSEEEEC---CCSSCEEEECCSSCCCSGGGBCTGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTS
T ss_pred EEECCCCccCCcCcc---ccCCCCEEECCCCCCCCccchhhhccCCCCEEECCCCCCCcccHHHHhhccCcCCEEECCCC
Confidence 999999999966544 468899999999999988888999999999999999999988777774 7999999999999
Q ss_pred cCcCCCCccccCCCCCCeEEccCCCCCCCCccccccccccEEEcccccccCCCCccccCCCCCcEEEccCCcCC-CCCCc
Q 004400 171 GLAGPIPSGIFSLENLTDLRISDLNGPEATFPQLGNMKMTKLILRNCNITGELPRYLGKMTKLKVLDLSFNRLR-GQIPS 249 (756)
Q Consensus 171 ~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~-~~~p~ 249 (756)
++++. + ....+++|+.|++++|.+...++......+|+.|+|++|.++ .+|..+..+++|+.|+|++|.+. +.+|.
T Consensus 180 ~l~~~-~-~~~~l~~L~~L~Ls~N~l~~l~~~~~~l~~L~~L~L~~N~l~-~l~~~~~~l~~L~~L~l~~N~~~~~~~~~ 256 (317)
T 3o53_A 180 FIYDV-K-GQVVFAKLKTLDLSSNKLAFMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRD 256 (317)
T ss_dssp CCCEE-E-CCCCCTTCCEEECCSSCCCEECGGGGGGTTCSEEECTTSCCC-EECTTCCCCTTCCEEECTTCCCBHHHHHH
T ss_pred cCccc-c-cccccccCCEEECCCCcCCcchhhhcccCcccEEECcCCccc-chhhHhhcCCCCCEEEccCCCccCcCHHH
Confidence 99865 3 334599999999999999987766444457999999999999 57888999999999999999999 77888
Q ss_pred cCcCCCCCCeEEecCc-cccccCC
Q 004400 250 NFDDLYDVDYIYFAGN-LLTGAIP 272 (756)
Q Consensus 250 ~~~~l~~L~~L~ls~N-~l~~~~p 272 (756)
.+..+++|+.|++++| .++|..|
T Consensus 257 ~~~~~~~L~~l~l~~~~~l~~~~~ 280 (317)
T 3o53_A 257 FFSKNQRVQTVAKQTVKKLTGQNE 280 (317)
T ss_dssp HHHTCHHHHHHHHHHHHHHHSSSS
T ss_pred HHhccccceEEECCCchhccCCch
Confidence 8999999999999955 4665433
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.92 E-value=6.8e-24 Score=219.16 Aligned_cols=205 Identities=22% Similarity=0.254 Sum_probs=122.0
Q ss_pred CCCEEEccCCcccCccCcccccCCcc-eeeccCccccccCCccCcCcCCCcEEEeecCcccccCCcccCCCCCCcEEecc
Q 004400 42 FLQDIDLTLNYLSGTIPSQWASLPLL-NISLIANRLKGPIPKYLANISTLVNLTVQYNQFSGELPEELGSLLNLEKLHLS 120 (756)
Q Consensus 42 ~L~~L~L~~n~l~~~~p~~~~~l~~L-~l~l~~n~~~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~ 120 (756)
.++.+++++++++ .+|..+. +.+ +|++.+|++.+..+..|.++++|++|+|++|+|+...+..|.++++|++|+|+
T Consensus 17 ~~~~l~~~~~~l~-~ip~~~~--~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~ 93 (270)
T 2o6q_A 17 NKNSVDCSSKKLT-AIPSNIP--ADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNLETLWVT 93 (270)
T ss_dssp TTTEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCSCCCTTSSSSCTTCCEEECCSSCCSCCCTTTTSSCTTCCEEECC
T ss_pred CCCEEEccCCCCC-ccCCCCC--CCCCEEECcCCCCCeeCHHHhcCCCCCCEEECCCCccCeeChhhhcCCCCCCEEECC
Confidence 4567888888887 4554332 222 34445555554444455555555555555555553333334455555555555
Q ss_pred CCeecccCCccccCCCCCCEEEeeCCcccccCChhhcCcCCCcEEEccCCcCcCCCCccccCCCCCCeEEccCCCCCCCC
Q 004400 121 SNNFTGELPKTFAKLTNMKDFRISDNQFTGQIPSFIQNWTKLEKLFIQPSGLAGPIPSGIFSLENLTDLRISDLNGPEAT 200 (756)
Q Consensus 121 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~ 200 (756)
+|++++..+..|..+++|+.|+|++|++++..+..|.++++|++|+|++|++++..+..+..+++
T Consensus 94 ~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~--------------- 158 (270)
T 2o6q_A 94 DNKLQALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLSLGYNELQSLPKGVFDKLTS--------------- 158 (270)
T ss_dssp SSCCCCCCTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTT---------------
T ss_pred CCcCCcCCHhHcccccCCCEEECCCCccCeeCHHHhCcCcCCCEEECCCCcCCccCHhHccCCcc---------------
Confidence 55555443444445555555555555555444444455555555555555554333333444444
Q ss_pred ccccccccccEEEcccccccCCCCccccCCCCCcEEEccCCcCCCCCCccCcCCCCCCeEEecCccccccCC
Q 004400 201 FPQLGNMKMTKLILRNCNITGELPRYLGKMTKLKVLDLSFNRLRGQIPSNFDDLYDVDYIYFAGNLLTGAIP 272 (756)
Q Consensus 201 ~~~~~~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p 272 (756)
|+.|+|++|.+++..+..|.++++|+.|+|++|++++..+..|..+++|+.|++++|++.+..+
T Consensus 159 --------L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~ 222 (270)
T 2o6q_A 159 --------LKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQENPWDCTCN 222 (270)
T ss_dssp --------CCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCSSS
T ss_pred --------cceeEecCCcCcEeChhHhccCCCcCEEECCCCcCCcCCHHHhccccCCCEEEecCCCeeCCCc
Confidence 5555666677776667778888999999999999997777778888999999999999887665
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=99.92 E-value=2.5e-24 Score=238.99 Aligned_cols=248 Identities=21% Similarity=0.254 Sum_probs=141.8
Q ss_pred eccceeccccccccCcccccCCcccCCCCCC-------------CEEEccCCcccCccCcccccCCcc-eeeccCccccc
Q 004400 13 WKQKTVNQKRVLKEQNLTGVLPPKLAELTFL-------------QDIDLTLNYLSGTIPSQWASLPLL-NISLIANRLKG 78 (756)
Q Consensus 13 ~~~~~~~~~l~L~~~~l~~~~p~~l~~l~~L-------------~~L~L~~n~l~~~~p~~~~~l~~L-~l~l~~n~~~~ 78 (756)
+..++.++.|+|++|+++|.+|..++++++| +.|++++|++++ +|... +.| .+++.+|++.+
T Consensus 30 i~~L~~L~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~c~~~~l~~L~l~~~~l~~-lp~~~---~~L~~L~l~~n~l~~ 105 (454)
T 1jl5_A 30 AENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLDRQAHELELNNLGLSS-LPELP---PHLESLVASCNSLTE 105 (454)
T ss_dssp ----CCHHHHHHHHHHHHHTSCTTSCCCHHHHHHHHHHHHHHTCSEEECTTSCCSC-CCSCC---TTCSEEECCSSCCSS
T ss_pred HhcccchhhhhccCCcccccCCcccccchhcchhhhhhhhccCCCEEEecCCcccc-CCCCc---CCCCEEEccCCcCCc
Confidence 4555555555555555555555555554432 555555555553 22211 233 34555555554
Q ss_pred cCCccCcCcCCCcEEEeecCcccccCCcccCCCCCCcEEeccCCeecccCCccccCCCCCCEEEeeCCcccccCChhhcC
Q 004400 79 PIPKYLANISTLVNLTVQYNQFSGELPEELGSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRISDNQFTGQIPSFIQN 158 (756)
Q Consensus 79 ~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~ 158 (756)
+|.. +++|+.|++++|++++ +|.. .++|++|+|++|++++ +| .|+++++|++|++++|++++ +|..+
T Consensus 106 -lp~~---~~~L~~L~l~~n~l~~-l~~~---~~~L~~L~L~~n~l~~-lp-~~~~l~~L~~L~l~~N~l~~-lp~~~-- 172 (454)
T 1jl5_A 106 -LPEL---PQSLKSLLVDNNNLKA-LSDL---PPLLEYLGVSNNQLEK-LP-ELQNSSFLKIIDVDNNSLKK-LPDLP-- 172 (454)
T ss_dssp -CCCC---CTTCCEEECCSSCCSC-CCSC---CTTCCEEECCSSCCSS-CC-CCTTCTTCCEEECCSSCCSC-CCCCC--
T ss_pred -cccc---cCCCcEEECCCCccCc-ccCC---CCCCCEEECcCCCCCC-Cc-ccCCCCCCCEEECCCCcCcc-cCCCc--
Confidence 4432 2456666666666653 2221 1466777777777764 55 46667777777777777663 44432
Q ss_pred cCCCcEEEccCCcCcCCCCccccCCCCCCeEEccCCCCCCCCccccccccccEEEcccccccCCCCccccCCCCCcEEEc
Q 004400 159 WTKLEKLFIQPSGLAGPIPSGIFSLENLTDLRISDLNGPEATFPQLGNMKMTKLILRNCNITGELPRYLGKMTKLKVLDL 238 (756)
Q Consensus 159 l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L 238 (756)
.+|++|++++|++++ +| .+.++++|+.|++++|.+...+... .+|+.|++++|.++ .+|. ++.+++|++|++
T Consensus 173 -~~L~~L~L~~n~l~~-l~-~~~~l~~L~~L~l~~N~l~~l~~~~---~~L~~L~l~~n~l~-~lp~-~~~l~~L~~L~l 244 (454)
T 1jl5_A 173 -PSLEFIAAGNNQLEE-LP-ELQNLPFLTAIYADNNSLKKLPDLP---LSLESIVAGNNILE-ELPE-LQNLPFLTTIYA 244 (454)
T ss_dssp -TTCCEEECCSSCCSS-CC-CCTTCTTCCEEECCSSCCSSCCCCC---TTCCEEECCSSCCS-SCCC-CTTCTTCCEEEC
T ss_pred -ccccEEECcCCcCCc-Cc-cccCCCCCCEEECCCCcCCcCCCCc---CcccEEECcCCcCC-cccc-cCCCCCCCEEEC
Confidence 467777777777764 44 4667777777777777666532211 25677777777776 4553 667777777777
Q ss_pred cCCcCCCCCCccCcCCCCCCeEEecCccccccCCchhhcCCCeeEeecCCCCC
Q 004400 239 SFNRLRGQIPSNFDDLYDVDYIYFAGNLLTGAIPPWMLERGDKIDLSYNNFTD 291 (756)
Q Consensus 239 s~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~~l~~l~ls~N~l~~ 291 (756)
++|++++ +|.. +++|+.|++++|.+++ +|.. .+.++.|++++|.+++
T Consensus 245 ~~N~l~~-l~~~---~~~L~~L~l~~N~l~~-l~~~-~~~L~~L~ls~N~l~~ 291 (454)
T 1jl5_A 245 DNNLLKT-LPDL---PPSLEALNVRDNYLTD-LPEL-PQSLTFLDVSENIFSG 291 (454)
T ss_dssp CSSCCSS-CCSC---CTTCCEEECCSSCCSC-CCCC-CTTCCEEECCSSCCSE
T ss_pred CCCcCCc-cccc---ccccCEEECCCCcccc-cCcc-cCcCCEEECcCCccCc
Confidence 7777764 4432 3567777777777764 4433 3566777777777665
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=99.91 E-value=1.1e-23 Score=233.74 Aligned_cols=222 Identities=21% Similarity=0.302 Sum_probs=124.9
Q ss_pred CCCCEEEccCCcccCccCcccccCCcce-eeccCccccccCCccCcCcCCCcEEEeecCcccccCCcccCCCCCCcEEec
Q 004400 41 TFLQDIDLTLNYLSGTIPSQWASLPLLN-ISLIANRLKGPIPKYLANISTLVNLTVQYNQFSGELPEELGSLLNLEKLHL 119 (756)
Q Consensus 41 ~~L~~L~L~~n~l~~~~p~~~~~l~~L~-l~l~~n~~~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L 119 (756)
++|++|+|++|++++ +| .|..++.|+ +++.+|++.+ +|..+ .+|++|+|++|++++ +| .|+++++|++|++
T Consensus 131 ~~L~~L~L~~n~l~~-lp-~~~~l~~L~~L~l~~N~l~~-lp~~~---~~L~~L~L~~n~l~~-l~-~~~~l~~L~~L~l 202 (454)
T 1jl5_A 131 PLLEYLGVSNNQLEK-LP-ELQNSSFLKIIDVDNNSLKK-LPDLP---PSLEFIAAGNNQLEE-LP-ELQNLPFLTAIYA 202 (454)
T ss_dssp TTCCEEECCSSCCSS-CC-CCTTCTTCCEEECCSSCCSC-CCCCC---TTCCEEECCSSCCSS-CC-CCTTCTTCCEEEC
T ss_pred CCCCEEECcCCCCCC-Cc-ccCCCCCCCEEECCCCcCcc-cCCCc---ccccEEECcCCcCCc-Cc-cccCCCCCCEEEC
Confidence 456666666666653 44 355555553 5555555553 44332 356666666666653 34 3555666666666
Q ss_pred cCCeecccCCccccCCCCCCEEEeeCCcccccCChhhcCcCCCcEEEccCCcCcCCCCccccCCCCCCeEEccCCCCCCC
Q 004400 120 SSNNFTGELPKTFAKLTNMKDFRISDNQFTGQIPSFIQNWTKLEKLFIQPSGLAGPIPSGIFSLENLTDLRISDLNGPEA 199 (756)
Q Consensus 120 ~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~n~~~~~ 199 (756)
++|++++ +|... ++|+.|++++|+++ .+|. |+++++|++|++++|++++ +|.. +++|+.|++++|.+...
T Consensus 203 ~~N~l~~-l~~~~---~~L~~L~l~~n~l~-~lp~-~~~l~~L~~L~l~~N~l~~-l~~~---~~~L~~L~l~~N~l~~l 272 (454)
T 1jl5_A 203 DNNSLKK-LPDLP---LSLESIVAGNNILE-ELPE-LQNLPFLTTIYADNNLLKT-LPDL---PPSLEALNVRDNYLTDL 272 (454)
T ss_dssp CSSCCSS-CCCCC---TTCCEEECCSSCCS-SCCC-CTTCTTCCEEECCSSCCSS-CCSC---CTTCCEEECCSSCCSCC
T ss_pred CCCcCCc-CCCCc---CcccEEECcCCcCC-cccc-cCCCCCCCEEECCCCcCCc-cccc---ccccCEEECCCCccccc
Confidence 6665553 33221 35555555555555 4442 5555555555555555553 3321 24445555554444432
Q ss_pred Cccc---------------c--ccccccEEEcccccccCCCCccccCC-CCCcEEEccCCcCCCCCCccCcCCCCCCeEE
Q 004400 200 TFPQ---------------L--GNMKMTKLILRNCNITGELPRYLGKM-TKLKVLDLSFNRLRGQIPSNFDDLYDVDYIY 261 (756)
Q Consensus 200 ~~~~---------------~--~~~~L~~L~L~~n~l~~~~p~~~~~l-~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 261 (756)
+... + ...+|++|++++|.+++ +..+ ++|+.|++++|++++ +|.. +++|+.|+
T Consensus 273 ~~~~~~L~~L~ls~N~l~~l~~~~~~L~~L~l~~N~l~~-----i~~~~~~L~~L~Ls~N~l~~-lp~~---~~~L~~L~ 343 (454)
T 1jl5_A 273 PELPQSLTFLDVSENIFSGLSELPPNLYYLNASSNEIRS-----LCDLPPSLEELNVSNNKLIE-LPAL---PPRLERLI 343 (454)
T ss_dssp CCCCTTCCEEECCSSCCSEESCCCTTCCEEECCSSCCSE-----ECCCCTTCCEEECCSSCCSC-CCCC---CTTCCEEE
T ss_pred CcccCcCCEEECcCCccCcccCcCCcCCEEECcCCcCCc-----ccCCcCcCCEEECCCCcccc-cccc---CCcCCEEE
Confidence 2110 0 00234455555555443 1123 578888888888885 5543 57888888
Q ss_pred ecCccccccCCchhhcCCCeeEeecCCCCC
Q 004400 262 FAGNLLTGAIPPWMLERGDKIDLSYNNFTD 291 (756)
Q Consensus 262 ls~N~l~~~~p~~~~~~l~~l~ls~N~l~~ 291 (756)
+++|.++ .+|. .+++++.|++++|++++
T Consensus 344 L~~N~l~-~lp~-~l~~L~~L~L~~N~l~~ 371 (454)
T 1jl5_A 344 ASFNHLA-EVPE-LPQNLKQLHVEYNPLRE 371 (454)
T ss_dssp CCSSCCS-CCCC-CCTTCCEEECCSSCCSS
T ss_pred CCCCccc-cccc-hhhhccEEECCCCCCCc
Confidence 8888888 4666 67788888888888887
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=99.91 E-value=8.7e-24 Score=220.41 Aligned_cols=205 Identities=20% Similarity=0.218 Sum_probs=126.4
Q ss_pred cCCCCCCCEEEccCCcccCccCcccccCCcc-eeeccCccccccCCccCcCcCCCcEEEeecCcccccCCcccCCCCCCc
Q 004400 37 LAELTFLQDIDLTLNYLSGTIPSQWASLPLL-NISLIANRLKGPIPKYLANISTLVNLTVQYNQFSGELPEELGSLLNLE 115 (756)
Q Consensus 37 l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L-~l~l~~n~~~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~ 115 (756)
+.++++|+.|++++|+|+ .+|..+. +.+ .|++.+|++.+..|..|.++++|+.|+|++|.|++..+ .+.+++|+
T Consensus 6 ~~~l~~l~~l~~~~~~l~-~ip~~~~--~~l~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~ 80 (290)
T 1p9a_G 6 VSKVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQV--DGTLPVLG 80 (290)
T ss_dssp EECSTTCCEEECTTSCCS-SCCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEEEC--CSCCTTCC
T ss_pred ccccCCccEEECCCCCCC-cCCCCCC--CCCCEEEcCCCcCCccCHHHhhcCCCCCEEECCCCccCcccC--CCCCCcCC
Confidence 667888899999998888 4444332 223 34555555555555555555555555555555553222 14555555
Q ss_pred EEeccCCeecccCCccccCCCCCCEEEeeCCcccccCChhhcCcCCCcEEEccCCcCcCCCCccccCCCCCCeEEccCCC
Q 004400 116 KLHLSSNNFTGELPKTFAKLTNMKDFRISDNQFTGQIPSFIQNWTKLEKLFIQPSGLAGPIPSGIFSLENLTDLRISDLN 195 (756)
Q Consensus 116 ~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~n~ 195 (756)
+|+|++|+|+ .+|..+..+++|+.|+|++|+|++..+..|.++++|++|+|++|++++..+..|..+++
T Consensus 81 ~L~Ls~N~l~-~l~~~~~~l~~L~~L~l~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~---------- 149 (290)
T 1p9a_G 81 TLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPK---------- 149 (290)
T ss_dssp EEECCSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTT----------
T ss_pred EEECCCCcCC-cCchhhccCCCCCEEECCCCcCcccCHHHHcCCCCCCEEECCCCCCCccChhhcccccC----------
Confidence 5555555555 44545555555555555555555444455555555555555555555433333444444
Q ss_pred CCCCCccccccccccEEEcccccccCCCCccccCCCCCcEEEccCCcCCCCCCccCcCCCCCCeEEecCccccccC
Q 004400 196 GPEATFPQLGNMKMTKLILRNCNITGELPRYLGKMTKLKVLDLSFNRLRGQIPSNFDDLYDVDYIYFAGNLLTGAI 271 (756)
Q Consensus 196 ~~~~~~~~~~~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~ 271 (756)
|+.|+|++|+++...+..|.++++|+.|+|++|+|+ .+|..+..+++|+.|+|++|++.|.+
T Consensus 150 -------------L~~L~L~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~-~ip~~~~~~~~L~~l~L~~Np~~C~c 211 (290)
T 1p9a_G 150 -------------LEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWLCNC 211 (290)
T ss_dssp -------------CCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBCCSG
T ss_pred -------------CCEEECCCCcCCccCHHHhcCcCCCCEEECCCCcCC-ccChhhcccccCCeEEeCCCCccCcC
Confidence 445556667777666666788888888888888888 67777777888888888888887654
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=99.91 E-value=1.9e-24 Score=223.56 Aligned_cols=219 Identities=23% Similarity=0.254 Sum_probs=121.6
Q ss_pred eeccccccccCcccccCCcccCCCCCCCEEEccCCcccCccCcccccCCcceeeccCccccccCCccCcCcCCCcEEEee
Q 004400 17 TVNQKRVLKEQNLTGVLPPKLAELTFLQDIDLTLNYLSGTIPSQWASLPLLNISLIANRLKGPIPKYLANISTLVNLTVQ 96 (756)
Q Consensus 17 ~~~~~l~L~~~~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~l~l~~n~~~~~~p~~l~~l~~L~~L~L~ 96 (756)
..+..+.+..+.+.+... +..+++|+.|++++|.++. ++ .+..+++|++|+|+
T Consensus 19 ~~l~~l~l~~~~~~~~~~--~~~l~~L~~L~l~~~~i~~-~~------------------------~l~~l~~L~~L~l~ 71 (272)
T 3rfs_A 19 AETIKANLKKKSVTDAVT--QNELNSIDQIIANNSDIKS-VQ------------------------GIQYLPNVRYLALG 71 (272)
T ss_dssp HHHHHHHHTCSCTTSEEC--HHHHTTCCEEECTTSCCCC-CT------------------------TGGGCTTCCEEECT
T ss_pred HHHHHHHhcCcccccccc--cccccceeeeeeCCCCccc-cc------------------------ccccCCCCcEEECC
Confidence 445566666776665533 4566777777777777762 11 24455666666666
Q ss_pred cCcccccCCcccCCCCCCcEEeccCCeecccCCccccCCCCCCEEEeeCCcccccCChhhcCcCCCcEEEccCCcCcCCC
Q 004400 97 YNQFSGELPEELGSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRISDNQFTGQIPSFIQNWTKLEKLFIQPSGLAGPI 176 (756)
Q Consensus 97 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~ 176 (756)
+|.+++ + ..+..+++|++|+|++|++++..+..|..+++|++|+|++|++++..+..|.++++|++|+|++|++++..
T Consensus 72 ~n~l~~-~-~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~ 149 (272)
T 3rfs_A 72 GNKLHD-I-SALKELTNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQSLP 149 (272)
T ss_dssp TSCCCC-C-GGGTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCC
T ss_pred CCCCCC-c-hhhcCCCCCCEEECCCCccCccChhHhcCCcCCCEEECCCCcCCccCHHHhccCCCCCEEECCCCccCccC
Confidence 666653 2 35666666666666666666555555566666666666666666555555666666666666666666544
Q ss_pred CccccCCCCCCeEEccCCCCCCCCccccccccccEEEcccccccCCCCccccCCCCCcEEEccCCcCCCCCCccCcCCCC
Q 004400 177 PSGIFSLENLTDLRISDLNGPEATFPQLGNMKMTKLILRNCNITGELPRYLGKMTKLKVLDLSFNRLRGQIPSNFDDLYD 256 (756)
Q Consensus 177 p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~ 256 (756)
+..+..+++|+.|++++| ++++..+..|+.+++|+.|+|++|.+++..+..+..+++
T Consensus 150 ~~~~~~l~~L~~L~l~~n-----------------------~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~ 206 (272)
T 3rfs_A 150 KGVFDKLTNLTELDLSYN-----------------------QLQSLPEGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTS 206 (272)
T ss_dssp TTTTTTCTTCCEEECCSS-----------------------CCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTT
T ss_pred HHHhccCccCCEEECCCC-----------------------CcCccCHHHhcCCccCCEEECCCCcCCccCHHHHhCCcC
Confidence 444555555555554443 333333334444455555555555555444444444555
Q ss_pred CCeEEecCccccccCCchhhcCCCeeEeecCCCCCC
Q 004400 257 VDYIYFAGNLLTGAIPPWMLERGDKIDLSYNNFTDG 292 (756)
Q Consensus 257 L~~L~ls~N~l~~~~p~~~~~~l~~l~ls~N~l~~~ 292 (756)
|+.|++++|++.|.+| .++.+++..|.++|.
T Consensus 207 L~~L~l~~N~~~~~~~-----~l~~l~~~~n~~~g~ 237 (272)
T 3rfs_A 207 LQYIWLHDNPWDCTCP-----GIRYLSEWINKHSGV 237 (272)
T ss_dssp CCEEECCSSCBCCCTT-----TTHHHHHHHHHTGGG
T ss_pred CCEEEccCCCccccCc-----HHHHHHHHHHhCCCc
Confidence 5555555555544433 233444444444443
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=99.91 E-value=2.2e-23 Score=217.36 Aligned_cols=203 Identities=19% Similarity=0.187 Sum_probs=153.8
Q ss_pred CcCcCCCcEEEeecCcccccCCcccCCCCCCcEEeccCCeecccCCccccCCCCCCEEEeeCCcccccCChhhcCcCCCc
Q 004400 84 LANISTLVNLTVQYNQFSGELPEELGSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRISDNQFTGQIPSFIQNWTKLE 163 (756)
Q Consensus 84 l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~ 163 (756)
++++++|+++++++|.++ .+|..+. ++|+.|+|++|++++..+..|.++++|+.|+|++|+|++..+. +.+++|+
T Consensus 6 ~~~l~~l~~l~~~~~~l~-~ip~~~~--~~l~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~--~~l~~L~ 80 (290)
T 1p9a_G 6 VSKVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQVD--GTLPVLG 80 (290)
T ss_dssp EECSTTCCEEECTTSCCS-SCCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEEECC--SCCTTCC
T ss_pred ccccCCccEEECCCCCCC-cCCCCCC--CCCCEEEcCCCcCCccCHHHhhcCCCCCEEECCCCccCcccCC--CCCCcCC
Confidence 556667777777777776 5555443 4677777777777766666677777777777777777643322 5667777
Q ss_pred EEEccCCcCcCCCCccccCCCCCCeEEccCCCCCCCCccccccc-cccEEEcccccccCCCCccccCCCCCcEEEccCCc
Q 004400 164 KLFIQPSGLAGPIPSGIFSLENLTDLRISDLNGPEATFPQLGNM-KMTKLILRNCNITGELPRYLGKMTKLKVLDLSFNR 242 (756)
Q Consensus 164 ~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~-~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~ 242 (756)
+|+|++|+++ .+|..+..+++|+.|++++|.+....+..+..+ +|+.|+|++|++++..+..|..+++|+.|+|++|+
T Consensus 81 ~L~Ls~N~l~-~l~~~~~~l~~L~~L~l~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~ 159 (290)
T 1p9a_G 81 TLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNN 159 (290)
T ss_dssp EEECCSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSC
T ss_pred EEECCCCcCC-cCchhhccCCCCCEEECCCCcCcccCHHHHcCCCCCCEEECCCCCCCccChhhcccccCCCEEECCCCc
Confidence 7777777776 566666777777777777777776666656554 57788888899998888889999999999999999
Q ss_pred CCCCCCccCcCCCCCCeEEecCccccccCCchh--hcCCCeeEeecCCCCCCC
Q 004400 243 LRGQIPSNFDDLYDVDYIYFAGNLLTGAIPPWM--LERGDKIDLSYNNFTDGS 293 (756)
Q Consensus 243 l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~--~~~l~~l~ls~N~l~~~~ 293 (756)
|++..+..|..+++|+.|+|++|+++ .+|..+ ...++.+++++|++.|..
T Consensus 160 l~~l~~~~~~~l~~L~~L~L~~N~l~-~ip~~~~~~~~L~~l~L~~Np~~C~c 211 (290)
T 1p9a_G 160 LTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWLCNC 211 (290)
T ss_dssp CSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBCCSG
T ss_pred CCccCHHHhcCcCCCCEEECCCCcCC-ccChhhcccccCCeEEeCCCCccCcC
Confidence 99777778899999999999999999 677766 567999999999998753
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.91 E-value=4.5e-23 Score=212.95 Aligned_cols=199 Identities=22% Similarity=0.260 Sum_probs=132.9
Q ss_pred eeccCccccccCCccCcCcCCCcEEEeecCcccccCCcccCCCCCCcEEeccCCeecccCCccccCCCCCCEEEeeCCcc
Q 004400 69 ISLIANRLKGPIPKYLANISTLVNLTVQYNQFSGELPEELGSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRISDNQF 148 (756)
Q Consensus 69 l~l~~n~~~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l 148 (756)
+++.+++++ .+|..+. ++|++|+|++|+|++..+..|.++++|++|+|++|+++...+..|.++++|++|+|++|++
T Consensus 21 l~~~~~~l~-~ip~~~~--~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~l 97 (270)
T 2o6q_A 21 VDCSSKKLT-AIPSNIP--ADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNLETLWVTDNKL 97 (270)
T ss_dssp EECTTSCCS-SCCSCCC--TTCSEEECCSSCCSCCCTTSSSSCTTCCEEECCSSCCSCCCTTTTSSCTTCCEEECCSSCC
T ss_pred EEccCCCCC-ccCCCCC--CCCCEEECcCCCCCeeCHHHhcCCCCCCEEECCCCccCeeChhhhcCCCCCCEEECCCCcC
Confidence 455555554 3444333 4555566666655544444555555566666655555543344445555555555555555
Q ss_pred cccCChhhcCcCCCcEEEccCCcCcCCCCccccCCCCCCeEEccCCCCCCCCccccccccccEEEcccccccCCCCcccc
Q 004400 149 TGQIPSFIQNWTKLEKLFIQPSGLAGPIPSGIFSLENLTDLRISDLNGPEATFPQLGNMKMTKLILRNCNITGELPRYLG 228 (756)
Q Consensus 149 ~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~L~~L~L~~n~l~~~~p~~~~ 228 (756)
++..+..|.++++|++|+|++|++++..+..|..+++ |+.|+|++|.+++..+..|.
T Consensus 98 ~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~-----------------------L~~L~Ls~n~l~~~~~~~~~ 154 (270)
T 2o6q_A 98 QALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTK-----------------------LTYLSLGYNELQSLPKGVFD 154 (270)
T ss_dssp CCCCTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTT-----------------------CCEEECCSSCCCCCCTTTTT
T ss_pred CcCCHhHcccccCCCEEECCCCccCeeCHHHhCcCcC-----------------------CCEEECCCCcCCccCHhHcc
Confidence 5444445555555555555555555444444444444 55556666777767677789
Q ss_pred CCCCCcEEEccCCcCCCCCCccCcCCCCCCeEEecCccccccCCchh--hcCCCeeEeecCCCCCCC
Q 004400 229 KMTKLKVLDLSFNRLRGQIPSNFDDLYDVDYIYFAGNLLTGAIPPWM--LERGDKIDLSYNNFTDGS 293 (756)
Q Consensus 229 ~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~--~~~l~~l~ls~N~l~~~~ 293 (756)
.+++|+.|+|++|.+++..+..|..+++|+.|++++|.+++..+..+ ++.++.|++++|++.|..
T Consensus 155 ~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c 221 (270)
T 2o6q_A 155 KLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQENPWDCTC 221 (270)
T ss_dssp TCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCSS
T ss_pred CCcccceeEecCCcCcEeChhHhccCCCcCEEECCCCcCCcCCHHHhccccCCCEEEecCCCeeCCC
Confidence 99999999999999998888889999999999999999996555444 678999999999998764
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=99.90 E-value=1e-23 Score=218.01 Aligned_cols=197 Identities=20% Similarity=0.231 Sum_probs=157.6
Q ss_pred eeccCccccccCCccCcCcCCCcEEEeecCcccccCCcccCCCCCCcEEeccCCeecccCCccccCCCCCCEEEeeCCcc
Q 004400 69 ISLIANRLKGPIPKYLANISTLVNLTVQYNQFSGELPEELGSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRISDNQF 148 (756)
Q Consensus 69 l~l~~n~~~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l 148 (756)
+.+..+.+... ..+..+++|+.|++++|.++ .+ ..+..+++|++|+|++|++++ + ..+..+++|++|+|++|++
T Consensus 24 l~l~~~~~~~~--~~~~~l~~L~~L~l~~~~i~-~~-~~l~~l~~L~~L~l~~n~l~~-~-~~l~~l~~L~~L~L~~n~l 97 (272)
T 3rfs_A 24 ANLKKKSVTDA--VTQNELNSIDQIIANNSDIK-SV-QGIQYLPNVRYLALGGNKLHD-I-SALKELTNLTYLILTGNQL 97 (272)
T ss_dssp HHHTCSCTTSE--ECHHHHTTCCEEECTTSCCC-CC-TTGGGCTTCCEEECTTSCCCC-C-GGGTTCTTCCEEECTTSCC
T ss_pred HHhcCcccccc--cccccccceeeeeeCCCCcc-cc-cccccCCCCcEEECCCCCCCC-c-hhhcCCCCCCEEECCCCcc
Confidence 44555555433 23567788888888888887 34 347888888888888888885 3 3678888888888888888
Q ss_pred cccCChhhcCcCCCcEEEccCCcCcCCCCccccCCCCCCeEEccCCCCCCCCccccccccccEEEcccccccCCCCcccc
Q 004400 149 TGQIPSFIQNWTKLEKLFIQPSGLAGPIPSGIFSLENLTDLRISDLNGPEATFPQLGNMKMTKLILRNCNITGELPRYLG 228 (756)
Q Consensus 149 ~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~L~~L~L~~n~l~~~~p~~~~ 228 (756)
++..+..|.++++|++|+|++|++++..+..+..+++|++|+ |++|.+++..+..|.
T Consensus 98 ~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~-----------------------L~~n~l~~~~~~~~~ 154 (272)
T 3rfs_A 98 QSLPNGVFDKLTNLKELVLVENQLQSLPDGVFDKLTNLTYLN-----------------------LAHNQLQSLPKGVFD 154 (272)
T ss_dssp CCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEE-----------------------CCSSCCCCCCTTTTT
T ss_pred CccChhHhcCCcCCCEEECCCCcCCccCHHHhccCCCCCEEE-----------------------CCCCccCccCHHHhc
Confidence 877777788888888888888888866666677777766655 555677767777789
Q ss_pred CCCCCcEEEccCCcCCCCCCccCcCCCCCCeEEecCccccccCCchh--hcCCCeeEeecCCCCCCCC
Q 004400 229 KMTKLKVLDLSFNRLRGQIPSNFDDLYDVDYIYFAGNLLTGAIPPWM--LERGDKIDLSYNNFTDGSA 294 (756)
Q Consensus 229 ~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~--~~~l~~l~ls~N~l~~~~~ 294 (756)
.+++|+.|+|++|++++..+..|..+++|+.|++++|.+++..|..+ +++++.|++++|++.|..+
T Consensus 155 ~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~ 222 (272)
T 3rfs_A 155 KLTNLTELDLSYNQLQSLPEGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDCTCP 222 (272)
T ss_dssp TCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTT
T ss_pred cCccCCEEECCCCCcCccCHHHhcCCccCCEEECCCCcCCccCHHHHhCCcCCCEEEccCCCccccCc
Confidence 99999999999999998888889999999999999999998777655 7899999999999987654
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=99.90 E-value=8.6e-23 Score=233.64 Aligned_cols=233 Identities=27% Similarity=0.351 Sum_probs=135.5
Q ss_pred eccccccccCcccccCCcccCCCCCCCEEEccCCcccCccCcccccCCcc-eeeccCccccccCCccCcCcCCCcEEEee
Q 004400 18 VNQKRVLKEQNLTGVLPPKLAELTFLQDIDLTLNYLSGTIPSQWASLPLL-NISLIANRLKGPIPKYLANISTLVNLTVQ 96 (756)
Q Consensus 18 ~~~~l~L~~~~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L-~l~l~~n~~~~~~p~~l~~l~~L~~L~L~ 96 (756)
.++.|++++|+++ .+|..+. ++|+.|+|++|+|+ .+|. .++.| .|++.+|+++ .+|. .+++|++|+|+
T Consensus 41 ~l~~L~ls~n~L~-~lp~~l~--~~L~~L~L~~N~l~-~lp~---~l~~L~~L~Ls~N~l~-~lp~---~l~~L~~L~Ls 109 (622)
T 3g06_A 41 GNAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLT-SLPA---LPPELRTLEVSGNQLT-SLPV---LPPGLLELSIF 109 (622)
T ss_dssp CCCEEECCSSCCS-CCCSCCC--TTCSEEEECSCCCS-CCCC---CCTTCCEEEECSCCCS-CCCC---CCTTCCEEEEC
T ss_pred CCcEEEecCCCcC-ccChhhC--CCCcEEEecCCCCC-CCCC---cCCCCCEEEcCCCcCC-cCCC---CCCCCCEEECc
Confidence 4677888888888 6676665 78888888888888 4555 34556 4777788776 4555 56788888888
Q ss_pred cCcccccCCcccCCCCCCcEEeccCCeecccCCccccCCCCCCEEEeeCCcccccCChhhcCcCCCcEEEccCCcCcCCC
Q 004400 97 YNQFSGELPEELGSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRISDNQFTGQIPSFIQNWTKLEKLFIQPSGLAGPI 176 (756)
Q Consensus 97 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~ 176 (756)
+|+|++ +|. .+++|+.|+|++|+|+ .+|.. +++|+.|+|++|++++ +|.. +++|+.|++++|++++ +
T Consensus 110 ~N~l~~-l~~---~l~~L~~L~L~~N~l~-~lp~~---l~~L~~L~Ls~N~l~~-l~~~---~~~L~~L~L~~N~l~~-l 176 (622)
T 3g06_A 110 SNPLTH-LPA---LPSGLCKLWIFGNQLT-SLPVL---PPGLQELSVSDNQLAS-LPAL---PSELCKLWAYNNQLTS-L 176 (622)
T ss_dssp SCCCCC-CCC---CCTTCCEEECCSSCCS-CCCCC---CTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCSC-C
T ss_pred CCcCCC-CCC---CCCCcCEEECCCCCCC-cCCCC---CCCCCEEECcCCcCCC-cCCc---cCCCCEEECCCCCCCC-C
Confidence 888884 444 5677888888888887 35543 4778888888887774 4432 3455566666666653 3
Q ss_pred CccccCCCCCCeEEccCCCCCCCCccccccccccEEEcccccccCCCCccccCCCCCcEEEccCCcCCCCCCccCcCCCC
Q 004400 177 PSGIFSLENLTDLRISDLNGPEATFPQLGNMKMTKLILRNCNITGELPRYLGKMTKLKVLDLSFNRLRGQIPSNFDDLYD 256 (756)
Q Consensus 177 p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~ 256 (756)
| ..+++|+.|++++|.+..++.. ..+|+.|++++|.++ .+|.. +++|+.|+|++|.|++ +| ..+++
T Consensus 177 ~---~~~~~L~~L~Ls~N~l~~l~~~---~~~L~~L~L~~N~l~-~l~~~---~~~L~~L~Ls~N~L~~-lp---~~l~~ 242 (622)
T 3g06_A 177 P---MLPSGLQELSVSDNQLASLPTL---PSELYKLWAYNNRLT-SLPAL---PSGLKELIVSGNRLTS-LP---VLPSE 242 (622)
T ss_dssp C---CCCTTCCEEECCSSCCSCCCCC---CTTCCEEECCSSCCS-SCCCC---CTTCCEEECCSSCCSC-CC---CCCTT
T ss_pred c---ccCCCCcEEECCCCCCCCCCCc---cchhhEEECcCCccc-ccCCC---CCCCCEEEccCCccCc-CC---CCCCc
Confidence 3 2345555566665555543221 123444444444444 22221 2444444444444442 23 22344
Q ss_pred CCeEEecCccccccCCchhhcCCCeeEeecCCCC
Q 004400 257 VDYIYFAGNLLTGAIPPWMLERGDKIDLSYNNFT 290 (756)
Q Consensus 257 L~~L~ls~N~l~~~~p~~~~~~l~~l~ls~N~l~ 290 (756)
|+.|++++|.|+ .+|. .+++++.|++++|.++
T Consensus 243 L~~L~Ls~N~L~-~lp~-~~~~L~~L~Ls~N~L~ 274 (622)
T 3g06_A 243 LKELMVSGNRLT-SLPM-LPSGLLSLSVYRNQLT 274 (622)
T ss_dssp CCEEECCSSCCS-CCCC-CCTTCCEEECCSSCCC
T ss_pred CcEEECCCCCCC-cCCc-ccccCcEEeCCCCCCC
Confidence 444444444444 2333 3344444444444444
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I | Back alignment and structure |
|---|
Probab=99.90 E-value=4.1e-26 Score=254.90 Aligned_cols=207 Identities=19% Similarity=0.236 Sum_probs=92.5
Q ss_pred CcCcCCCcEEEeecCcccccCCcccC-----CCCCCcEEeccCCeeccc----CCccccCCCCCCEEEeeCCcccccC--
Q 004400 84 LANISTLVNLTVQYNQFSGELPEELG-----SLLNLEKLHLSSNNFTGE----LPKTFAKLTNMKDFRISDNQFTGQI-- 152 (756)
Q Consensus 84 l~~l~~L~~L~L~~N~l~~~~p~~~~-----~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~L~~N~l~~~~-- 152 (756)
+..+++|++|+|++|.++...+..+. .+++|++|+|++|++++. ++..+..+++|++|+|++|+++...
T Consensus 166 l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~ 245 (461)
T 1z7x_W 166 LRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVGMA 245 (461)
T ss_dssp HHHCTTCCEEECCSSBCHHHHHHHHHHHHHHSCCCCCEEECTTSCCBTTHHHHHHHHHHHCTTCCEEECCSSBCHHHHHH
T ss_pred HhhCCCCCEEECcCCCcchHHHHHHHHHHhcCCCCceEEEccCCCCcHHHHHHHHHHHHhCCCccEEeccCCcCChHHHH
Confidence 33344444444444444432222222 133444444444444431 2334444455555555555444321
Q ss_pred ---ChhhcCcCCCcEEEccCCcCcCC----CCccccCCCCCCeEEccCCCCCCCCcccccc------ccccEEEcccccc
Q 004400 153 ---PSFIQNWTKLEKLFIQPSGLAGP----IPSGIFSLENLTDLRISDLNGPEATFPQLGN------MKMTKLILRNCNI 219 (756)
Q Consensus 153 ---p~~~~~l~~L~~L~l~~N~l~~~----~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~------~~L~~L~L~~n~l 219 (756)
+..+..+++|++|+|++|+++.. ++..+..+++|++|++++|.+.......+.. .+|+.|+|++|.+
T Consensus 246 ~l~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l 325 (461)
T 1z7x_W 246 ELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSF 325 (461)
T ss_dssp HHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEECTTSCC
T ss_pred HHHHHHhcCCCCceEEECcCCCCCHHHHHHHHHHHhhCCCcceEECCCCCCchHHHHHHHHHhccCCccceeeEcCCCCC
Confidence 11122344555555555555432 3444444555555555555444332222211 1455555555555
Q ss_pred cCC----CCccccCCCCCcEEEccCCcCCCCCCccCcC-----CCCCCeEEecCccccc----cCCchh--hcCCCeeEe
Q 004400 220 TGE----LPRYLGKMTKLKVLDLSFNRLRGQIPSNFDD-----LYDVDYIYFAGNLLTG----AIPPWM--LERGDKIDL 284 (756)
Q Consensus 220 ~~~----~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~-----l~~L~~L~ls~N~l~~----~~p~~~--~~~l~~l~l 284 (756)
++. ++..+..+++|++|+|++|.+++..+..+.. .++|+.|++++|.+++ .+|..+ .+.++.|++
T Consensus 326 ~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~l 405 (461)
T 1z7x_W 326 TAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDL 405 (461)
T ss_dssp BGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCCCCCEEEC
T ss_pred chHHHHHHHHHHhhCCCccEEEccCCccccccHHHHHHHHcCCCCceEEEECCCCCCChhhHHHHHHHHHhCCCccEEEC
Confidence 543 2334444555555555555555433332221 3455555555555553 334333 445555555
Q ss_pred ecCCCC
Q 004400 285 SYNNFT 290 (756)
Q Consensus 285 s~N~l~ 290 (756)
++|+++
T Consensus 406 ~~N~i~ 411 (461)
T 1z7x_W 406 SNNCLG 411 (461)
T ss_dssp CSSSCC
T ss_pred CCCCCC
Confidence 555554
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=99.90 E-value=4.4e-23 Score=210.57 Aligned_cols=204 Identities=20% Similarity=0.272 Sum_probs=125.1
Q ss_pred eeccCccccccCCccCcCcCCCcEEEeecCcccccCCcccCCCCCCcEEeccCCeecccCCccccCCCCCCEEEeeCCcc
Q 004400 69 ISLIANRLKGPIPKYLANISTLVNLTVQYNQFSGELPEELGSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRISDNQF 148 (756)
Q Consensus 69 l~l~~n~~~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l 148 (756)
+++.++++. .+|..+. ++|+.|+|++|+|++..+..|.++++|++|+|++|+|++..+..|..+++|++|+|++|+|
T Consensus 19 l~~~~~~l~-~~p~~~~--~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l 95 (251)
T 3m19_A 19 VDCQGKSLD-SVPSGIP--ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQL 95 (251)
T ss_dssp EECTTCCCS-SCCSCCC--TTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCC
T ss_pred EecCCCCcc-ccCCCCC--CCCCEEEccCCCcCccCHhHhcCcccCCEEECCCCcCCccCHhHhccCCcCCEEECCCCcc
Confidence 445555544 4444443 4566666666666655555566666666666666666655555555566666666666666
Q ss_pred cccCChhhcCcCCCcEEEccCCcCcCCCCccccCCCCCCeEEccCCCCCCCCccccccccccEEEcccccccCCCCcccc
Q 004400 149 TGQIPSFIQNWTKLEKLFIQPSGLAGPIPSGIFSLENLTDLRISDLNGPEATFPQLGNMKMTKLILRNCNITGELPRYLG 228 (756)
Q Consensus 149 ~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~L~~L~L~~n~l~~~~p~~~~ 228 (756)
++..+..|.++++|++|+|++|++++..+..+..+++ |+.|+|++|++++..+..|.
T Consensus 96 ~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~-----------------------L~~L~Ls~N~l~~~~~~~~~ 152 (251)
T 3m19_A 96 ASLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTK-----------------------LKELRLNTNQLQSIPAGAFD 152 (251)
T ss_dssp CCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTT-----------------------CCEEECCSSCCCCCCTTTTT
T ss_pred cccChhHhcccCCCCEEEcCCCcCCCcChhHhccCCc-----------------------ccEEECcCCcCCccCHHHcC
Confidence 6555555555555666666555555444434444444 55556667788877777899
Q ss_pred CCCCCcEEEccCCcCCCCCCccCcCCCCCCeEEecCccccccCC------chhh-cCCCeeEeecCCCCCCCCcccc
Q 004400 229 KMTKLKVLDLSFNRLRGQIPSNFDDLYDVDYIYFAGNLLTGAIP------PWML-ERGDKIDLSYNNFTDGSAESSC 298 (756)
Q Consensus 229 ~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p------~~~~-~~l~~l~ls~N~l~~~~~~~~~ 298 (756)
.+++|+.|+|++|++++..+..|..+++|+.|++++|+++|... .|+. ......+..++.+.+.+....|
T Consensus 153 ~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~C 229 (251)
T 3m19_A 153 KLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGNQFDCSRCEILYLSQWIRENSNKVKDGTGQNLHESPDGVTC 229 (251)
T ss_dssp TCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCTTSTTHHHHHHHHHHSGGGBCC-------CCGGGCBB
T ss_pred cCcCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCceeCCccccHHHHHHHHhcccceeeccCcccccCCCcCcc
Confidence 99999999999999998888889999999999999999998733 2331 1223344556665554444444
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=99.89 E-value=8.3e-23 Score=206.92 Aligned_cols=206 Identities=15% Similarity=0.170 Sum_probs=114.9
Q ss_pred cccccCCcccCCCCCCCEEEccCCcccCccCcccccCCcceeeccCccccccCCccCcCcCCCcEEEeecCc-ccccCCc
Q 004400 28 NLTGVLPPKLAELTFLQDIDLTLNYLSGTIPSQWASLPLLNISLIANRLKGPIPKYLANISTLVNLTVQYNQ-FSGELPE 106 (756)
Q Consensus 28 ~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~l~l~~n~~~~~~p~~l~~l~~L~~L~L~~N~-l~~~~p~ 106 (756)
+++ .+|. +. ++|+.|+|++|+|++..+..| .++++|++|+|++|+ +++..+.
T Consensus 22 ~l~-~ip~-~~--~~l~~L~l~~n~l~~i~~~~~-----------------------~~l~~L~~L~l~~n~~l~~i~~~ 74 (239)
T 2xwt_C 22 DIQ-RIPS-LP--PSTQTLKLIETHLRTIPSHAF-----------------------SNLPNISRIYVSIDVTLQQLESH 74 (239)
T ss_dssp SCS-SCCC-CC--TTCCEEEEESCCCSEECTTTT-----------------------TTCTTCCEEEEECCSSCCEECTT
T ss_pred Ccc-ccCC-CC--CcccEEEEeCCcceEECHHHc-----------------------cCCCCCcEEeCCCCCCcceeCHh
Confidence 344 4555 43 467777777777774443344 444455555555553 4433334
Q ss_pred ccCCCCCCcEEeccC-CeecccCCccccCCCCCCEEEeeCCcccccCChhhcCcCCCc---EEEccCC-cCcCCCCcccc
Q 004400 107 ELGSLLNLEKLHLSS-NNFTGELPKTFAKLTNMKDFRISDNQFTGQIPSFIQNWTKLE---KLFIQPS-GLAGPIPSGIF 181 (756)
Q Consensus 107 ~~~~l~~L~~L~L~~-N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~---~L~l~~N-~l~~~~p~~~~ 181 (756)
.|.++++|++|+|++ |++++..+..|.++++|+.|+|++|++++ +|. |..+++|+ +|++++| ++++..+..|.
T Consensus 75 ~f~~l~~L~~L~l~~~n~l~~i~~~~f~~l~~L~~L~l~~n~l~~-lp~-~~~l~~L~~L~~L~l~~N~~l~~i~~~~~~ 152 (239)
T 2xwt_C 75 SFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLKM-FPD-LTKVYSTDIFFILEITDNPYMTSIPVNAFQ 152 (239)
T ss_dssp TEESCTTCCEEEEEEETTCCEECTTSEECCTTCCEEEEEEECCCS-CCC-CTTCCBCCSEEEEEEESCTTCCEECTTTTT
T ss_pred HcCCCcCCcEEECCCCCCeeEcCHHHhCCCCCCCEEeCCCCCCcc-ccc-cccccccccccEEECCCCcchhhcCccccc
Confidence 455555555555554 55554444445555555555555555553 333 44444444 5555555 55444444455
Q ss_pred CCCCCC-eEEccCCCCCCCCccccccccccEEEccccc-ccCCCCccccCC-CCCcEEEccCCcCCCCCCccCcCCCCCC
Q 004400 182 SLENLT-DLRISDLNGPEATFPQLGNMKMTKLILRNCN-ITGELPRYLGKM-TKLKVLDLSFNRLRGQIPSNFDDLYDVD 258 (756)
Q Consensus 182 ~l~~L~-~L~l~~n~~~~~~~~~~~~~~L~~L~L~~n~-l~~~~p~~~~~l-~~L~~L~Ls~N~l~~~~p~~~~~l~~L~ 258 (756)
++++|+ .|++++|.+...+...+...+|+.|+|++|. +++..+..|.++ ++|+.|+|++|++++ +|.. .+++|+
T Consensus 153 ~l~~L~~~L~l~~n~l~~i~~~~~~~~~L~~L~L~~n~~l~~i~~~~~~~l~~~L~~L~l~~N~l~~-l~~~--~~~~L~ 229 (239)
T 2xwt_C 153 GLCNETLTLKLYNNGFTSVQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVTA-LPSK--GLEHLK 229 (239)
T ss_dssp TTBSSEEEEECCSCCCCEECTTTTTTCEEEEEECTTCTTCCEECTTTTTTCSBCCSEEECTTCCCCC-CCCT--TCTTCS
T ss_pred chhcceeEEEcCCCCCcccCHhhcCCCCCCEEEcCCCCCcccCCHHHhhccccCCcEEECCCCcccc-CChh--HhccCc
Confidence 555555 5555555554444333444456667777774 776666677777 888888888888874 4432 566777
Q ss_pred eEEecCc
Q 004400 259 YIYFAGN 265 (756)
Q Consensus 259 ~L~ls~N 265 (756)
.|+++++
T Consensus 230 ~L~l~~~ 236 (239)
T 2xwt_C 230 ELIARNT 236 (239)
T ss_dssp EEECTTC
T ss_pred eeeccCc
Confidence 7777765
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=1.3e-23 Score=217.82 Aligned_cols=151 Identities=19% Similarity=0.100 Sum_probs=122.2
Q ss_pred HHHhhcCccccCcccCCCCccEEEeeccCCcEEEEEEccccCc------------------ccHHHHHHHHHHHHhCCCC
Q 004400 411 IKAATNNFATDNNIGEGGFGPVYKGLLADGTAIAVKQLSSKSK------------------QGNREFINEIGMISALQHP 472 (756)
Q Consensus 411 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~------------------~~~~~~~~E~~~l~~l~h~ 472 (756)
+......|...+.||+|+||.||+|...+|+.||+|.++.... .....+.+|++++++++
T Consensus 85 ~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~-- 162 (282)
T 1zar_A 85 LVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ-- 162 (282)
T ss_dssp HHHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--
T ss_pred HHhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--
Confidence 3344566778899999999999999997799999999864321 12456889999999999
Q ss_pred ceeeEeeEEEeCCeEEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCC
Q 004400 473 NLVKLYGCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKD 552 (756)
Q Consensus 473 niv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~ 552 (756)
| +++.+++.. +..++||||+++|+|.+ +. ......++.|++.||+|||+.| |+||||||+|||++ +
T Consensus 163 ~-~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~-------~~~~~~i~~qi~~~l~~lH~~g---iiHrDlkp~NILl~-~ 228 (282)
T 1zar_A 163 G-LAVPKVYAW-EGNAVLMELIDAKELYR-VR-------VENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVS-E 228 (282)
T ss_dssp T-SSSCCEEEE-ETTEEEEECCCCEEGGG-CC-------CSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEE-T
T ss_pred C-CCcCeEEec-cceEEEEEecCCCcHHH-cc-------hhhHHHHHHHHHHHHHHHHHCC---CEeCCCCHHHEEEE-C
Confidence 5 677776544 55699999999999977 31 1235579999999999999997 99999999999999 9
Q ss_pred CCEEEccCCccccCcccCcceeeccccCccCCchHhhhc
Q 004400 553 LNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPEYAMR 591 (756)
Q Consensus 553 ~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 591 (756)
+.+||+|||+|+. +..|+|||++.+
T Consensus 229 ~~vkl~DFG~a~~--------------~~~~~a~e~l~r 253 (282)
T 1zar_A 229 EGIWIIDFPQSVE--------------VGEEGWREILER 253 (282)
T ss_dssp TEEEECCCTTCEE--------------TTSTTHHHHHHH
T ss_pred CcEEEEECCCCeE--------------CCCCCHHHHHHH
Confidence 9999999999962 345799998854
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=99.89 E-value=1.4e-22 Score=205.27 Aligned_cols=205 Identities=19% Similarity=0.172 Sum_probs=177.2
Q ss_pred cccCCccCcCcCCCcEEEeecCcccccCCcccCCCCCCcEEeccCCe-ecccCCccccCCCCCCEEEeeC-CcccccCCh
Q 004400 77 KGPIPKYLANISTLVNLTVQYNQFSGELPEELGSLLNLEKLHLSSNN-FTGELPKTFAKLTNMKDFRISD-NQFTGQIPS 154 (756)
Q Consensus 77 ~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~-l~~~~p~~~~~l~~L~~L~L~~-N~l~~~~p~ 154 (756)
...+|. +. .+|++|+|++|+|++..+..|.++++|++|+|++|+ ++...+..|.++++|++|+|++ |++++..+.
T Consensus 23 l~~ip~-~~--~~l~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i~~~ 99 (239)
T 2xwt_C 23 IQRIPS-LP--PSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPD 99 (239)
T ss_dssp CSSCCC-CC--TTCCEEEEESCCCSEECTTTTTTCTTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCEECTT
T ss_pred ccccCC-CC--CcccEEEEeCCcceEECHHHccCCCCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeEcCHH
Confidence 345666 44 489999999999998877899999999999999997 9877777899999999999999 999987788
Q ss_pred hhcCcCCCcEEEccCCcCcCCCCccccCCCCCC---eEEccCC-CCCCCCccccccc-ccc-EEEcccccccCCCCcccc
Q 004400 155 FIQNWTKLEKLFIQPSGLAGPIPSGIFSLENLT---DLRISDL-NGPEATFPQLGNM-KMT-KLILRNCNITGELPRYLG 228 (756)
Q Consensus 155 ~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~---~L~l~~n-~~~~~~~~~~~~~-~L~-~L~L~~n~l~~~~p~~~~ 228 (756)
.|.++++|++|++++|++++ +|. +..+++|+ .|++++| .+.......+... +|+ .|++++|.++...+..|.
T Consensus 100 ~f~~l~~L~~L~l~~n~l~~-lp~-~~~l~~L~~L~~L~l~~N~~l~~i~~~~~~~l~~L~~~L~l~~n~l~~i~~~~~~ 177 (239)
T 2xwt_C 100 ALKELPLLKFLGIFNTGLKM-FPD-LTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFTSVQGYAFN 177 (239)
T ss_dssp SEECCTTCCEEEEEEECCCS-CCC-CTTCCBCCSEEEEEEESCTTCCEECTTTTTTTBSSEEEEECCSCCCCEECTTTTT
T ss_pred HhCCCCCCCEEeCCCCCCcc-ccc-cccccccccccEEECCCCcchhhcCcccccchhcceeEEEcCCCCCcccCHhhcC
Confidence 99999999999999999996 676 88899998 9999999 8888887777765 599 999999999944444455
Q ss_pred CCCCCcEEEccCCc-CCCCCCccCcCC-CCCCeEEecCccccccCCchhhcCCCeeEeecCC
Q 004400 229 KMTKLKVLDLSFNR-LRGQIPSNFDDL-YDVDYIYFAGNLLTGAIPPWMLERGDKIDLSYNN 288 (756)
Q Consensus 229 ~l~~L~~L~Ls~N~-l~~~~p~~~~~l-~~L~~L~ls~N~l~~~~p~~~~~~l~~l~ls~N~ 288 (756)
. ++|+.|+|++|+ +++..+..|..+ ++|+.|++++|+++ .+|...+++++.|+++++.
T Consensus 178 ~-~~L~~L~L~~n~~l~~i~~~~~~~l~~~L~~L~l~~N~l~-~l~~~~~~~L~~L~l~~~~ 237 (239)
T 2xwt_C 178 G-TKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVT-ALPSKGLEHLKELIARNTW 237 (239)
T ss_dssp T-CEEEEEECTTCTTCCEECTTTTTTCSBCCSEEECTTCCCC-CCCCTTCTTCSEEECTTC-
T ss_pred C-CCCCEEEcCCCCCcccCCHHHhhccccCCcEEECCCCccc-cCChhHhccCceeeccCcc
Confidence 5 899999999995 997778889999 99999999999998 5666678889999887653
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=99.88 E-value=2.1e-24 Score=232.94 Aligned_cols=249 Identities=16% Similarity=0.190 Sum_probs=153.3
Q ss_pred cccccCcccccCCcccCCCCCCCEEEccCCcccCccC----cccccCC-cc-eeeccCccccccCCccCcCc-----CCC
Q 004400 22 RVLKEQNLTGVLPPKLAELTFLQDIDLTLNYLSGTIP----SQWASLP-LL-NISLIANRLKGPIPKYLANI-----STL 90 (756)
Q Consensus 22 l~L~~~~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p----~~~~~l~-~L-~l~l~~n~~~~~~p~~l~~l-----~~L 90 (756)
..|++|+++|.+|+.+...++|+.|+|++|.|++..+ ..+..++ .| +|++.+|++.+..+..|..+ ++|
T Consensus 3 ~~ls~n~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L 82 (362)
T 3goz_A 3 YKLTLHPGSNPVEEFTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPANV 82 (362)
T ss_dssp EECCCCTTCCHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTTC
T ss_pred cccccccchHHHHHHHhCCCCceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCCc
Confidence 4678899999988888887889999999999986665 5666666 56 47777777777766666665 777
Q ss_pred cEEEeecCcccccCCcccC----CC-CCCcEEeccCCeecccCCccccC-----CCCCCEEEeeCCcccccC----Chhh
Q 004400 91 VNLTVQYNQFSGELPEELG----SL-LNLEKLHLSSNNFTGELPKTFAK-----LTNMKDFRISDNQFTGQI----PSFI 156 (756)
Q Consensus 91 ~~L~L~~N~l~~~~p~~~~----~l-~~L~~L~L~~N~l~~~~p~~~~~-----l~~L~~L~L~~N~l~~~~----p~~~ 156 (756)
++|+|++|.|++..+..++ .+ ++|++|+|++|++++..+..+.. .++|++|+|++|+++... +..+
T Consensus 83 ~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l 162 (362)
T 3goz_A 83 TSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDELIQIL 162 (362)
T ss_dssp CEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHHHHTTSCTTCCEEECTTSCGGGSCHHHHHHHH
T ss_pred cEEECcCCcCChHHHHHHHHHHHhCCCCccEEECcCCcCCcHHHHHHHHHHHhCCCceeEEEccCCcCCHHHHHHHHHHH
Confidence 7777777777766655433 33 67777777777777555544332 257777777777777433 3334
Q ss_pred cCcC-CCcEEEccCCcCcCCCCcccc----CC-CCCCeEEccCCCCCCCCcccc----cc--ccccEEEcccccccCCCC
Q 004400 157 QNWT-KLEKLFIQPSGLAGPIPSGIF----SL-ENLTDLRISDLNGPEATFPQL----GN--MKMTKLILRNCNITGELP 224 (756)
Q Consensus 157 ~~l~-~L~~L~l~~N~l~~~~p~~~~----~l-~~L~~L~l~~n~~~~~~~~~~----~~--~~L~~L~L~~n~l~~~~p 224 (756)
..++ +|++|+|++|++++..+..+. .+ ++|+.|++++|.+.......+ .. .+|+.|+|++|.+++..+
T Consensus 163 ~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~i~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~ 242 (362)
T 3goz_A 163 AAIPANVNSLNLRGNNLASKNCAELAKFLASIPASVTSLDLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCLHGPSL 242 (362)
T ss_dssp HTSCTTCCEEECTTSCGGGSCHHHHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHHSCTTCCEEECCSSCCCCCCH
T ss_pred hcCCccccEeeecCCCCchhhHHHHHHHHHhCCCCCCEEECCCCCCChhHHHHHHHHHhcCCCCceEEECcCCCCCcHHH
Confidence 4444 777777777777755554333 23 467777766666655332211 11 145555555555554333
Q ss_pred ----ccccCCCCCcEEEccCCcCCCCC-------CccCcCCCCCCeEEecCcccccc
Q 004400 225 ----RYLGKMTKLKVLDLSFNRLRGQI-------PSNFDDLYDVDYIYFAGNLLTGA 270 (756)
Q Consensus 225 ----~~~~~l~~L~~L~Ls~N~l~~~~-------p~~~~~l~~L~~L~ls~N~l~~~ 270 (756)
..+..+++|+.|+|++|.+.+.. +..+..+++|+.|++++|++.+.
T Consensus 243 ~~l~~~~~~l~~L~~L~L~~n~l~~i~~~~~~~l~~~~~~l~~L~~LdL~~N~l~~~ 299 (362)
T 3goz_A 243 ENLKLLKDSLKHLQTVYLDYDIVKNMSKEQCKALGAAFPNIQKIILVDKNGKEIHPS 299 (362)
T ss_dssp HHHHHTTTTTTTCSEEEEEHHHHTTCCHHHHHHHHTTSTTCCEEEEECTTSCBCCGG
T ss_pred HHHHHHHhcCCCccEEEeccCCccccCHHHHHHHHHHhccCCceEEEecCCCcCCCc
Confidence 22344455555555555533221 22344455555555555555433
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.88 E-value=8.3e-23 Score=215.48 Aligned_cols=204 Identities=18% Similarity=0.175 Sum_probs=161.3
Q ss_pred CcCCCcEEEeecCcccccCCccc--CCCCCCcEEeccCCeecccCC----ccccCCCCCCEEEeeCCcccccCChhhcCc
Q 004400 86 NISTLVNLTVQYNQFSGELPEEL--GSLLNLEKLHLSSNNFTGELP----KTFAKLTNMKDFRISDNQFTGQIPSFIQNW 159 (756)
Q Consensus 86 ~l~~L~~L~L~~N~l~~~~p~~~--~~l~~L~~L~L~~N~l~~~~p----~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l 159 (756)
.+++|++|+|++|.+++..|..+ ..+++|++|+|++|++++..+ ..+..+++|++|+|++|++++..+..|+++
T Consensus 89 ~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~l 168 (310)
T 4glp_A 89 AYSRLKELTLEDLKITGTMPPLPLEATGLALSSLRLRNVSWATGRSWLAELQQWLKPGLKVLSIAQAHSPAFSCEQVRAF 168 (310)
T ss_dssp HHSCCCEEEEESCCCBSCCCCCSSSCCCBCCSSCEEESCCCSSTTSSHHHHHTTBCSCCCEEEEECCSSCCCCTTSCCCC
T ss_pred ccCceeEEEeeCCEeccchhhhhhhccCCCCCEEEeecccccchhhhhHHHHhhhccCCCEEEeeCCCcchhhHHHhccC
Confidence 35679999999999988888887 888899999999999887555 344568899999999999988888888899
Q ss_pred CCCcEEEccCCcCcCC--C--CccccCCCCCCeEEccCCCCCCCCcc---cccc-ccccEEEcccccccCCCCccccCC-
Q 004400 160 TKLEKLFIQPSGLAGP--I--PSGIFSLENLTDLRISDLNGPEATFP---QLGN-MKMTKLILRNCNITGELPRYLGKM- 230 (756)
Q Consensus 160 ~~L~~L~l~~N~l~~~--~--p~~~~~l~~L~~L~l~~n~~~~~~~~---~~~~-~~L~~L~L~~n~l~~~~p~~~~~l- 230 (756)
++|++|+|++|++.+. + +..+..+++|++|++++|.+...... .+.. .+|+.|+|++|.+++..|..+..+
T Consensus 169 ~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~l~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~ 248 (310)
T 4glp_A 169 PALTSLDLSDNPGLGERGLMAALCPHKFPAIQNLALRNTGMETPTGVCAALAAAGVQPHSLDLSHNSLRATVNPSAPRCM 248 (310)
T ss_dssp TTCCEEECCSCTTCHHHHHHTTSCTTSSCCCCSCBCCSSCCCCHHHHHHHHHHHTCCCSSEECTTSCCCCCCCSCCSSCC
T ss_pred CCCCEEECCCCCCccchhhhHHHhhhcCCCCCEEECCCCCCCchHHHHHHHHhcCCCCCEEECCCCCCCccchhhHHhcc
Confidence 9999999999987642 2 33346788999999999988654332 1233 368999999999998878777776
Q ss_pred --CCCcEEEccCCcCCCCCCccCcCCCCCCeEEecCccccccCCchhhcCCCeeEeecCCCCCC
Q 004400 231 --TKLKVLDLSFNRLRGQIPSNFDDLYDVDYIYFAGNLLTGAIPPWMLERGDKIDLSYNNFTDG 292 (756)
Q Consensus 231 --~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~~l~~l~ls~N~l~~~ 292 (756)
++|++|+|++|+|+ .+|..+. ++|+.|+|++|++++......+++++.|++++|++++.
T Consensus 249 ~~~~L~~L~Ls~N~l~-~lp~~~~--~~L~~L~Ls~N~l~~~~~~~~l~~L~~L~L~~N~l~~~ 309 (310)
T 4glp_A 249 WSSALNSLNLSFAGLE-QVPKGLP--AKLRVLDLSSNRLNRAPQPDELPEVDNLTLDGNPFLVP 309 (310)
T ss_dssp CCTTCCCEECCSSCCC-SCCSCCC--SCCSCEECCSCCCCSCCCTTSCCCCSCEECSSTTTSCC
T ss_pred CcCcCCEEECCCCCCC-chhhhhc--CCCCEEECCCCcCCCCchhhhCCCccEEECcCCCCCCC
Confidence 69999999999999 6777664 79999999999998642223368899999999998753
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I | Back alignment and structure |
|---|
Probab=99.88 E-value=2e-25 Score=249.37 Aligned_cols=280 Identities=20% Similarity=0.203 Sum_probs=205.1
Q ss_pred eccceeccccccccCcccc----cCCcccCCCCCCCEEEccCCcccCccCccc-ccCC----cc-eeeccCccccc----
Q 004400 13 WKQKTVNQKRVLKEQNLTG----VLPPKLAELTFLQDIDLTLNYLSGTIPSQW-ASLP----LL-NISLIANRLKG---- 78 (756)
Q Consensus 13 ~~~~~~~~~l~L~~~~l~~----~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~-~~l~----~L-~l~l~~n~~~~---- 78 (756)
+..+..++.|+|++|++++ .++..+..+++|++|+|++|.++...+..+ ..++ .| +|++.+|++..
T Consensus 24 ~~~~~~L~~L~L~~~~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~L~~n~i~~~~~~ 103 (461)
T 1z7x_W 24 LPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCG 103 (461)
T ss_dssp HHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCSTTCCCCEEECTTSCCBGGGHH
T ss_pred HhhcCCccEEEccCCCCCHHHHHHHHHHHHhCCCcCEEeCCCCcCChHHHHHHHHHHhhCCCceeEEEccCCCCCHHHHH
Confidence 5667788888999988885 456677788889999999988875444333 3344 45 58888888874
Q ss_pred cCCccCcCcCCCcEEEeecCcccccCCcccC-----CCCCCcEEeccCCeeccc----CCccccCCCCCCEEEeeCCccc
Q 004400 79 PIPKYLANISTLVNLTVQYNQFSGELPEELG-----SLLNLEKLHLSSNNFTGE----LPKTFAKLTNMKDFRISDNQFT 149 (756)
Q Consensus 79 ~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~-----~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~L~~N~l~ 149 (756)
.++..|.++++|++|+|++|.+++..+..+. .+++|++|+|++|++++. ++..+..+++|++|+|++|+++
T Consensus 104 ~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~ 183 (461)
T 1z7x_W 104 VLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDIN 183 (461)
T ss_dssp HHHHHTTSCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCTTCCEEECCSSBCH
T ss_pred HHHHHHccCCceeEEECCCCcCchHHHHHHHHHHhcCCCcceEEECCCCCCCHHHHHHHHHHHhhCCCCCEEECcCCCcc
Confidence 5688888888999999999988755444333 356799999999988863 3556677788999999999887
Q ss_pred ccCChhhcC-----cCCCcEEEccCCcCcCC----CCccccCCCCCCeEEccCCCCCCCCcccc------ccccccEEEc
Q 004400 150 GQIPSFIQN-----WTKLEKLFIQPSGLAGP----IPSGIFSLENLTDLRISDLNGPEATFPQL------GNMKMTKLIL 214 (756)
Q Consensus 150 ~~~p~~~~~-----l~~L~~L~l~~N~l~~~----~p~~~~~l~~L~~L~l~~n~~~~~~~~~~------~~~~L~~L~L 214 (756)
...+..+.. +++|++|+|++|.++.. ++..+..+++|++|++++|.+.......+ ...+|++|++
T Consensus 184 ~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~~~~~~~~L~~L~L 263 (461)
T 1z7x_W 184 EAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWI 263 (461)
T ss_dssp HHHHHHHHHHHHHSCCCCCEEECTTSCCBTTHHHHHHHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEEC
T ss_pred hHHHHHHHHHHhcCCCCceEEEccCCCCcHHHHHHHHHHHHhCCCccEEeccCCcCChHHHHHHHHHHhcCCCCceEEEC
Confidence 655555543 56899999999988863 46677788899999999888766432221 1346889999
Q ss_pred ccccccCC----CCccccCCCCCcEEEccCCcCCCCCCccCcC-----CCCCCeEEecCccccccC----Cchh--hcCC
Q 004400 215 RNCNITGE----LPRYLGKMTKLKVLDLSFNRLRGQIPSNFDD-----LYDVDYIYFAGNLLTGAI----PPWM--LERG 279 (756)
Q Consensus 215 ~~n~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~-----l~~L~~L~ls~N~l~~~~----p~~~--~~~l 279 (756)
++|.++.. ++..+..+++|++|+|++|.+++..+..+.. .++|+.|++++|.+++.. +.++ .+.+
T Consensus 264 ~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L 343 (461)
T 1z7x_W 264 WECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFL 343 (461)
T ss_dssp TTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSC
T ss_pred cCCCCCHHHHHHHHHHHhhCCCcceEECCCCCCchHHHHHHHHHhccCCccceeeEcCCCCCchHHHHHHHHHHhhCCCc
Confidence 99988864 5667777888999999999887544433332 268889999999887652 3333 4788
Q ss_pred CeeEeecCCCCCC
Q 004400 280 DKIDLSYNNFTDG 292 (756)
Q Consensus 280 ~~l~ls~N~l~~~ 292 (756)
+.|++++|.+++.
T Consensus 344 ~~L~Ls~n~i~~~ 356 (461)
T 1z7x_W 344 LELQISNNRLEDA 356 (461)
T ss_dssp CEEECCSSBCHHH
T ss_pred cEEEccCCccccc
Confidence 8889988887654
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.88 E-value=5.4e-23 Score=216.94 Aligned_cols=223 Identities=17% Similarity=0.206 Sum_probs=173.4
Q ss_pred CCCCEEEccCCcccCccCcc---cccCCcc-eeeccCccccccCCccC--cCcCCCcEEEeecCcccccCC----cccCC
Q 004400 41 TFLQDIDLTLNYLSGTIPSQ---WASLPLL-NISLIANRLKGPIPKYL--ANISTLVNLTVQYNQFSGELP----EELGS 110 (756)
Q Consensus 41 ~~L~~L~L~~n~l~~~~p~~---~~~l~~L-~l~l~~n~~~~~~p~~l--~~l~~L~~L~L~~N~l~~~~p----~~~~~ 110 (756)
..++.|.+.++.++...-.. +..++.| ++++.+|++.+..|..+ .++++|++|+|++|.+++..+ ..+..
T Consensus 64 ~~l~~l~l~~~~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~~~~~~~~ 143 (310)
T 4glp_A 64 LRVRRLTVGAAQVPAQLLVGALRVLAYSRLKELTLEDLKITGTMPPLPLEATGLALSSLRLRNVSWATGRSWLAELQQWL 143 (310)
T ss_dssp CCCCEEEECSCCCBHHHHHHHHHHHHHSCCCEEEEESCCCBSCCCCCSSSCCCBCCSSCEEESCCCSSTTSSHHHHHTTB
T ss_pred cceeEEEEeCCcCCHHHHHHHHHhcccCceeEEEeeCCEeccchhhhhhhccCCCCCEEEeecccccchhhhhHHHHhhh
Confidence 45788888888775321111 1122345 58888999998888888 889999999999999987655 34567
Q ss_pred CCCCcEEeccCCeecccCCccccCCCCCCEEEeeCCccccc--C--ChhhcCcCCCcEEEccCCcCcCCCCc----cccC
Q 004400 111 LLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRISDNQFTGQ--I--PSFIQNWTKLEKLFIQPSGLAGPIPS----GIFS 182 (756)
Q Consensus 111 l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~--~--p~~~~~l~~L~~L~l~~N~l~~~~p~----~~~~ 182 (756)
+++|++|+|++|++++..+..|..+++|++|+|++|++.+. + +..+.++++|++|+|++|+++. ++. .+..
T Consensus 144 ~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~-l~~~~~~l~~~ 222 (310)
T 4glp_A 144 KPGLKVLSIAQAHSPAFSCEQVRAFPALTSLDLSDNPGLGERGLMAALCPHKFPAIQNLALRNTGMET-PTGVCAALAAA 222 (310)
T ss_dssp CSCCCEEEEECCSSCCCCTTSCCCCTTCCEEECCSCTTCHHHHHHTTSCTTSSCCCCSCBCCSSCCCC-HHHHHHHHHHH
T ss_pred ccCCCEEEeeCCCcchhhHHHhccCCCCCEEECCCCCCccchhhhHHHhhhcCCCCCEEECCCCCCCc-hHHHHHHHHhc
Confidence 88999999999999888888888999999999999987642 2 2334688899999999999973 333 2467
Q ss_pred CCCCCeEEccCCCCCCCCccccccc----cccEEEcccccccCCCCccccCCCCCcEEEccCCcCCCCCCccCcCCCCCC
Q 004400 183 LENLTDLRISDLNGPEATFPQLGNM----KMTKLILRNCNITGELPRYLGKMTKLKVLDLSFNRLRGQIPSNFDDLYDVD 258 (756)
Q Consensus 183 l~~L~~L~l~~n~~~~~~~~~~~~~----~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~ 258 (756)
+++|++|++++|.+....+..+... +|++|+|++|+++ .+|..+. ++|+.|+|++|+|++. |. +..+++|+
T Consensus 223 l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~L~~L~Ls~N~l~-~lp~~~~--~~L~~L~Ls~N~l~~~-~~-~~~l~~L~ 297 (310)
T 4glp_A 223 GVQPHSLDLSHNSLRATVNPSAPRCMWSSALNSLNLSFAGLE-QVPKGLP--AKLRVLDLSSNRLNRA-PQ-PDELPEVD 297 (310)
T ss_dssp TCCCSSEECTTSCCCCCCCSCCSSCCCCTTCCCEECCSSCCC-SCCSCCC--SCCSCEECCSCCCCSC-CC-TTSCCCCS
T ss_pred CCCCCEEECCCCCCCccchhhHHhccCcCcCCEEECCCCCCC-chhhhhc--CCCCEEECCCCcCCCC-ch-hhhCCCcc
Confidence 8899999999999988765555443 6999999999999 6677664 8999999999999964 44 68889999
Q ss_pred eEEecCccccc
Q 004400 259 YIYFAGNLLTG 269 (756)
Q Consensus 259 ~L~ls~N~l~~ 269 (756)
.|++++|+++.
T Consensus 298 ~L~L~~N~l~~ 308 (310)
T 4glp_A 298 NLTLDGNPFLV 308 (310)
T ss_dssp CEECSSTTTSC
T ss_pred EEECcCCCCCC
Confidence 99999999874
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=99.88 E-value=8.2e-22 Score=225.53 Aligned_cols=240 Identities=25% Similarity=0.302 Sum_probs=199.2
Q ss_pred eeccccccccCcccccCCcccCCCCCCCEEEccCCcccCccCcccccCCcc-eeeccCccccccCCccCcCcCCCcEEEe
Q 004400 17 TVNQKRVLKEQNLTGVLPPKLAELTFLQDIDLTLNYLSGTIPSQWASLPLL-NISLIANRLKGPIPKYLANISTLVNLTV 95 (756)
Q Consensus 17 ~~~~~l~L~~~~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L-~l~l~~n~~~~~~p~~l~~l~~L~~L~L 95 (756)
..++.|+|++|+++. +|. .+++|+.|+|++|+|+ .+|. .++.| .|++.+|++.+ +|. .+++|+.|+|
T Consensus 61 ~~L~~L~L~~N~l~~-lp~---~l~~L~~L~Ls~N~l~-~lp~---~l~~L~~L~Ls~N~l~~-l~~---~l~~L~~L~L 128 (622)
T 3g06_A 61 AHITTLVIPDNNLTS-LPA---LPPELRTLEVSGNQLT-SLPV---LPPGLLELSIFSNPLTH-LPA---LPSGLCKLWI 128 (622)
T ss_dssp TTCSEEEECSCCCSC-CCC---CCTTCCEEEECSCCCS-CCCC---CCTTCCEEEECSCCCCC-CCC---CCTTCCEEEC
T ss_pred CCCcEEEecCCCCCC-CCC---cCCCCCEEEcCCCcCC-cCCC---CCCCCCEEECcCCcCCC-CCC---CCCCcCEEEC
Confidence 689999999999994 555 5789999999999998 5665 55666 47888998885 454 5689999999
Q ss_pred ecCcccccCCcccCCCCCCcEEeccCCeecccCCccccCCCCCCEEEeeCCcccccCChhhcCcCCCcEEEccCCcCcCC
Q 004400 96 QYNQFSGELPEELGSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRISDNQFTGQIPSFIQNWTKLEKLFIQPSGLAGP 175 (756)
Q Consensus 96 ~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~ 175 (756)
++|+|+ .+|.. +++|++|+|++|++++ +|. .+++|+.|++++|+|++ +| ..+++|+.|+|++|++++
T Consensus 129 ~~N~l~-~lp~~---l~~L~~L~Ls~N~l~~-l~~---~~~~L~~L~L~~N~l~~-l~---~~~~~L~~L~Ls~N~l~~- 195 (622)
T 3g06_A 129 FGNQLT-SLPVL---PPGLQELSVSDNQLAS-LPA---LPSELCKLWAYNNQLTS-LP---MLPSGLQELSVSDNQLAS- 195 (622)
T ss_dssp CSSCCS-CCCCC---CTTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSC-CC---CCCTTCCEEECCSSCCSC-
T ss_pred CCCCCC-cCCCC---CCCCCEEECcCCcCCC-cCC---ccCCCCEEECCCCCCCC-Cc---ccCCCCcEEECCCCCCCC-
Confidence 999999 46653 4899999999999994 554 35789999999999994 66 567899999999999995
Q ss_pred CCccccCCCCCCeEEccCCCCCCCCccccccccccEEEcccccccCCCCccccCCCCCcEEEccCCcCCCCCCccCcCCC
Q 004400 176 IPSGIFSLENLTDLRISDLNGPEATFPQLGNMKMTKLILRNCNITGELPRYLGKMTKLKVLDLSFNRLRGQIPSNFDDLY 255 (756)
Q Consensus 176 ~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~ 255 (756)
+|.. +++|+.|++++|.+...+.. ..+|+.|+|++|.+++ +| ..+++|+.|+|++|.|+ .+|. .++
T Consensus 196 l~~~---~~~L~~L~L~~N~l~~l~~~---~~~L~~L~Ls~N~L~~-lp---~~l~~L~~L~Ls~N~L~-~lp~---~~~ 261 (622)
T 3g06_A 196 LPTL---PSELYKLWAYNNRLTSLPAL---PSGLKELIVSGNRLTS-LP---VLPSELKELMVSGNRLT-SLPM---LPS 261 (622)
T ss_dssp CCCC---CTTCCEEECCSSCCSSCCCC---CTTCCEEECCSSCCSC-CC---CCCTTCCEEECCSSCCS-CCCC---CCT
T ss_pred CCCc---cchhhEEECcCCcccccCCC---CCCCCEEEccCCccCc-CC---CCCCcCcEEECCCCCCC-cCCc---ccc
Confidence 5543 47999999999999876532 2469999999999996 55 45789999999999999 5665 678
Q ss_pred CCCeEEecCccccccCCchh--hcCCCeeEeecCCCCCCCCcc
Q 004400 256 DVDYIYFAGNLLTGAIPPWM--LERGDKIDLSYNNFTDGSAES 296 (756)
Q Consensus 256 ~L~~L~ls~N~l~~~~p~~~--~~~l~~l~ls~N~l~~~~~~~ 296 (756)
+|+.|+|++|.|+ .+|..+ +++++.|++++|++++..+..
T Consensus 262 ~L~~L~Ls~N~L~-~lp~~l~~l~~L~~L~L~~N~l~~~~~~~ 303 (622)
T 3g06_A 262 GLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQA 303 (622)
T ss_dssp TCCEEECCSSCCC-SCCGGGGGSCTTCEEECCSCCCCHHHHHH
T ss_pred cCcEEeCCCCCCC-cCCHHHhhccccCEEEecCCCCCCcCHHH
Confidence 9999999999999 778877 789999999999998755443
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=99.88 E-value=2.6e-22 Score=211.24 Aligned_cols=213 Identities=20% Similarity=0.284 Sum_probs=124.0
Q ss_pred ceeccccccccCcccccCCcccCCCCCCCEEEccCCcccCccCcccccCCcc-eeeccCccccccCCccCcCcCCCcEEE
Q 004400 16 KTVNQKRVLKEQNLTGVLPPKLAELTFLQDIDLTLNYLSGTIPSQWASLPLL-NISLIANRLKGPIPKYLANISTLVNLT 94 (756)
Q Consensus 16 ~~~~~~l~L~~~~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L-~l~l~~n~~~~~~p~~l~~l~~L~~L~ 94 (756)
+....++.+..+++++.++ +..+++|+.|++++|.++. +| .+..++.| .|++.+|++.+..+ +.++++|++|+
T Consensus 18 l~~~~~~~l~~~~~~~~~~--~~~l~~L~~L~l~~~~i~~-l~-~~~~l~~L~~L~L~~n~i~~~~~--~~~l~~L~~L~ 91 (308)
T 1h6u_A 18 LANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVTT-IE-GVQYLNNLIGLELKDNQITDLAP--LKNLTKITELE 91 (308)
T ss_dssp HHHHHHHHTTCSSTTSEEC--HHHHHTCCEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEE
T ss_pred HHHHHHHHhCCCCcCceec--HHHcCCcCEEEeeCCCccC-ch-hhhccCCCCEEEccCCcCCCChh--HccCCCCCEEE
Confidence 3445566677788776544 4567889999999998873 33 34444444 24455555443322 55555555555
Q ss_pred eecCcccccCCcccCCCCCCcEEeccCCeecccCCccccCCCCCCEEEeeCCcccccCChhhcCcCCCcEEEccCCcCcC
Q 004400 95 VQYNQFSGELPEELGSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRISDNQFTGQIPSFIQNWTKLEKLFIQPSGLAG 174 (756)
Q Consensus 95 L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~ 174 (756)
|++|.+++ ++ .+..+++|++|+|++|++++ ++. +..+++|+.|+|++|++++..+ +.++++|+.|+|++|++++
T Consensus 92 L~~n~l~~-~~-~~~~l~~L~~L~l~~n~l~~-~~~-l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~ 165 (308)
T 1h6u_A 92 LSGNPLKN-VS-AIAGLQSIKTLDLTSTQITD-VTP-LAGLSNLQVLYLDLNQITNISP--LAGLTNLQYLSIGNAQVSD 165 (308)
T ss_dssp CCSCCCSC-CG-GGTTCTTCCEEECTTSCCCC-CGG-GTTCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCC
T ss_pred ccCCcCCC-ch-hhcCCCCCCEEECCCCCCCC-chh-hcCCCCCCEEECCCCccCcCcc--ccCCCCccEEEccCCcCCC
Confidence 55555542 22 35555555555555555553 221 4455555555555555553222 4455555555555555543
Q ss_pred CCCccccCCCCCCeEEccCCCCCCCCccccccccccEEEcccccccCCCCccccCCCCCcEEEccCCcCCCCCCccCcCC
Q 004400 175 PIPSGIFSLENLTDLRISDLNGPEATFPQLGNMKMTKLILRNCNITGELPRYLGKMTKLKVLDLSFNRLRGQIPSNFDDL 254 (756)
Q Consensus 175 ~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l 254 (756)
..+ +..+++ |+.|+|++|.+++..+ +..+++|++|+|++|++++..+ +..+
T Consensus 166 ~~~--l~~l~~-----------------------L~~L~l~~n~l~~~~~--l~~l~~L~~L~L~~N~l~~~~~--l~~l 216 (308)
T 1h6u_A 166 LTP--LANLSK-----------------------LTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVSP--LANT 216 (308)
T ss_dssp CGG--GTTCTT-----------------------CCEEECCSSCCCCCGG--GGGCTTCCEEECTTSCCCBCGG--GTTC
T ss_pred Chh--hcCCCC-----------------------CCEEECCCCccCcChh--hcCCCCCCEEEccCCccCcccc--ccCC
Confidence 211 333444 5555566666664433 7778888888888888885443 7888
Q ss_pred CCCCeEEecCccccc
Q 004400 255 YDVDYIYFAGNLLTG 269 (756)
Q Consensus 255 ~~L~~L~ls~N~l~~ 269 (756)
++|+.|++++|++++
T Consensus 217 ~~L~~L~l~~N~i~~ 231 (308)
T 1h6u_A 217 SNLFIVTLTNQTITN 231 (308)
T ss_dssp TTCCEEEEEEEEEEC
T ss_pred CCCCEEEccCCeeec
Confidence 888888888888873
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=99.87 E-value=2.6e-24 Score=234.51 Aligned_cols=251 Identities=20% Similarity=0.204 Sum_probs=135.3
Q ss_pred cccccccCcccc----cCCcccCCCCCCCEEEccCCcccCccCcc----cccCCcce-eeccCc---cccccCCccC---
Q 004400 20 QKRVLKEQNLTG----VLPPKLAELTFLQDIDLTLNYLSGTIPSQ----WASLPLLN-ISLIAN---RLKGPIPKYL--- 84 (756)
Q Consensus 20 ~~l~L~~~~l~~----~~p~~l~~l~~L~~L~L~~n~l~~~~p~~----~~~l~~L~-l~l~~n---~~~~~~p~~l--- 84 (756)
....|..++++. .++..+..+++|+.|+|++|.|+...+.. +..++.|+ |++.+| ++.+.+|..+
T Consensus 7 ~~~~L~~~~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~~~~~~l~~~~~~~~~~l 86 (386)
T 2ca6_A 7 EGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLL 86 (386)
T ss_dssp TTCCCEESSCCSHHHHTTSHHHHHCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHH
T ss_pred cCcccccCCCCHHHHHHHHHHHhcCCCccEEECCCCCCCHHHHHHHHHHHHhCCCccEEeCcccccCccccchhHHHHHH
Confidence 334444454442 55666777888888888888887543322 33444442 444442 3333344333
Q ss_pred ----cCcCCCcEEEeecCcccc----cCCcccCCCCCCcEEeccCCeecccCCcccc----CC---------CCCCEEEe
Q 004400 85 ----ANISTLVNLTVQYNQFSG----ELPEELGSLLNLEKLHLSSNNFTGELPKTFA----KL---------TNMKDFRI 143 (756)
Q Consensus 85 ----~~l~~L~~L~L~~N~l~~----~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~----~l---------~~L~~L~L 143 (756)
..+++|++|+|++|.|++ .+|..+..+++|++|+|++|+++...+..+. .+ ++|+.|+|
T Consensus 87 ~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~l~~~~~~~~~~~L~~L~L 166 (386)
T 2ca6_A 87 LQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIIC 166 (386)
T ss_dssp HHHHTTCTTCCEEECCSCCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEEC
T ss_pred HHHHhhCCcccEEECCCCcCCHHHHHHHHHHHHhCCCCCEEECcCCCCCHHHHHHHHHHHHHHhhhhhcccCCCCcEEEC
Confidence 455555555555555554 2444555555555555555555432222222 22 55555555
Q ss_pred eCCccc-ccCC---hhhcCcCCCcEEEccCCcCcC-----CCCccccCCCCCCeEEccCCCCCCCCccccccccccEEEc
Q 004400 144 SDNQFT-GQIP---SFIQNWTKLEKLFIQPSGLAG-----PIPSGIFSLENLTDLRISDLNGPEATFPQLGNMKMTKLIL 214 (756)
Q Consensus 144 ~~N~l~-~~~p---~~~~~l~~L~~L~l~~N~l~~-----~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~L~~L~L 214 (756)
++|+++ +.++ ..+..+++|++|+|++|+++. ..+..+..+++|+ .|+|
T Consensus 167 ~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~g~~~l~~~~l~~~~~L~-----------------------~L~L 223 (386)
T 2ca6_A 167 GRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELK-----------------------VLDL 223 (386)
T ss_dssp CSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCC-----------------------EEEC
T ss_pred CCCCCCcHHHHHHHHHHHhCCCcCEEECcCCCCCHhHHHHHHHHHhhcCCCcc-----------------------EEEC
Confidence 555554 2233 244455555555555555541 1222444444554 4555
Q ss_pred cccccc----CCCCccccCCCCCcEEEccCCcCCCC----CCccC--cCCCCCCeEEecCccccc----cCCchh---hc
Q 004400 215 RNCNIT----GELPRYLGKMTKLKVLDLSFNRLRGQ----IPSNF--DDLYDVDYIYFAGNLLTG----AIPPWM---LE 277 (756)
Q Consensus 215 ~~n~l~----~~~p~~~~~l~~L~~L~Ls~N~l~~~----~p~~~--~~l~~L~~L~ls~N~l~~----~~p~~~---~~ 277 (756)
++|.++ +.+|..+..+++|+.|+|++|.+++. ++..+ ..+++|+.|+|++|.+++ .+|..+ ++
T Consensus 224 s~n~l~~~g~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~~L~~L~L~~n~i~~~g~~~l~~~l~~~l~ 303 (386)
T 2ca6_A 224 QDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMP 303 (386)
T ss_dssp CSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCT
T ss_pred cCCCCCcHHHHHHHHHHccCCCcCEEECCCCCCchhhHHHHHHHHhhccCCCeEEEECcCCcCCHHHHHHHHHHHHhcCC
Confidence 555553 34555666666777777777766644 34444 236667777777777665 355554 46
Q ss_pred CCCeeEeecCCCCCCC
Q 004400 278 RGDKIDLSYNNFTDGS 293 (756)
Q Consensus 278 ~l~~l~ls~N~l~~~~ 293 (756)
+++.|++++|++++..
T Consensus 304 ~L~~L~l~~N~l~~~~ 319 (386)
T 2ca6_A 304 DLLFLELNGNRFSEED 319 (386)
T ss_dssp TCCEEECTTSBSCTTS
T ss_pred CceEEEccCCcCCcch
Confidence 6677777777766543
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=99.87 E-value=8.7e-22 Score=200.96 Aligned_cols=179 Identities=18% Similarity=0.212 Sum_probs=145.3
Q ss_pred eccccccccCcccccCCcccCCCCCCCEEEccCCcccCccCcccccCCcc-eeeccCccccccCCccCcCcCCCcEEEee
Q 004400 18 VNQKRVLKEQNLTGVLPPKLAELTFLQDIDLTLNYLSGTIPSQWASLPLL-NISLIANRLKGPIPKYLANISTLVNLTVQ 96 (756)
Q Consensus 18 ~~~~l~L~~~~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L-~l~l~~n~~~~~~p~~l~~l~~L~~L~L~ 96 (756)
..+.+++++++++ .+|..+. +.|+.|+|++|++++..+..|..++.| .|++.+|++.+..|..|.++++|++|+|+
T Consensus 15 ~~~~l~~~~~~l~-~~p~~~~--~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~ 91 (251)
T 3m19_A 15 GKKEVDCQGKSLD-SVPSGIP--ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLA 91 (251)
T ss_dssp GGTEEECTTCCCS-SCCSCCC--TTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECT
T ss_pred CCeEEecCCCCcc-ccCCCCC--CCCCEEEccCCCcCccCHhHhcCcccCCEEECCCCcCCccCHhHhccCCcCCEEECC
Confidence 3577889999998 5566665 688999999999998888788888887 47888888888888888888888888888
Q ss_pred cCcccccCCcccCCCCCCcEEeccCCeecccCCccccCCCCCCEEEeeCCcccccCChhhcCcCCCcEEEccCCcCcCCC
Q 004400 97 YNQFSGELPEELGSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRISDNQFTGQIPSFIQNWTKLEKLFIQPSGLAGPI 176 (756)
Q Consensus 97 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~ 176 (756)
+|+|++..+..|..+++|++|+|++|+|++..+..|..+++|+.|+|++|+|++..+..|.++++|+.|+|++|++++..
T Consensus 92 ~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~ 171 (251)
T 3m19_A 92 NNQLASLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQLQSIPAGAFDKLTNLQTLSLSTNQLQSVP 171 (251)
T ss_dssp TSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCC
T ss_pred CCcccccChhHhcccCCCCEEEcCCCcCCCcChhHhccCCcccEEECcCCcCCccCHHHcCcCcCCCEEECCCCcCCccC
Confidence 88888777777888888888888888888666666788888888888888888766667888888888888888888777
Q ss_pred CccccCCCCCCeEEccCCCCCCC
Q 004400 177 PSGIFSLENLTDLRISDLNGPEA 199 (756)
Q Consensus 177 p~~~~~l~~L~~L~l~~n~~~~~ 199 (756)
+..+..+++|+.|++++|.+...
T Consensus 172 ~~~~~~l~~L~~L~l~~N~~~c~ 194 (251)
T 3m19_A 172 HGAFDRLGKLQTITLFGNQFDCS 194 (251)
T ss_dssp TTTTTTCTTCCEEECCSCCBCTT
T ss_pred HHHHhCCCCCCEEEeeCCceeCC
Confidence 77788888888888777766543
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=99.87 E-value=2.5e-23 Score=222.13 Aligned_cols=251 Identities=14% Similarity=0.172 Sum_probs=155.0
Q ss_pred CCEEEccCCcccCccCcccccC--Ccc-eeeccCccccccCCccCcCcCCCcEEEeecCccccc-CCcccCCCCCCcEEe
Q 004400 43 LQDIDLTLNYLSGTIPSQWASL--PLL-NISLIANRLKGPIPKYLANISTLVNLTVQYNQFSGE-LPEELGSLLNLEKLH 118 (756)
Q Consensus 43 L~~L~L~~n~l~~~~p~~~~~l--~~L-~l~l~~n~~~~~~p~~l~~l~~L~~L~L~~N~l~~~-~p~~~~~l~~L~~L~ 118 (756)
++.|++++|.+. +..+..+ +.+ .+++.+|.+.+..+. +.++++|++|+|++|.+++. ++..+..+++|++|+
T Consensus 49 ~~~l~l~~~~~~---~~~~~~~~~~~l~~L~l~~n~l~~~~~~-~~~~~~L~~L~L~~~~l~~~~~~~~~~~~~~L~~L~ 124 (336)
T 2ast_B 49 WQTLDLTGKNLH---PDVTGRLLSQGVIAFRCPRSFMDQPLAE-HFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLS 124 (336)
T ss_dssp SSEEECTTCBCC---HHHHHHHHHTTCSEEECTTCEECSCCCS-CCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEE
T ss_pred heeeccccccCC---HHHHHhhhhccceEEEcCCccccccchh-hccCCCCCEEEccCCCcCHHHHHHHHhhCCCCCEEe
Confidence 455666665554 2333333 333 355555555555444 34566677777777666644 556666666777777
Q ss_pred ccCCeecccCCccccCCCCCCEEEeeCC-cccc-cCChhhcCcCCCcEEEccCC-cCcCC-CCccccCCC-CCCeEEccC
Q 004400 119 LSSNNFTGELPKTFAKLTNMKDFRISDN-QFTG-QIPSFIQNWTKLEKLFIQPS-GLAGP-IPSGIFSLE-NLTDLRISD 193 (756)
Q Consensus 119 L~~N~l~~~~p~~~~~l~~L~~L~L~~N-~l~~-~~p~~~~~l~~L~~L~l~~N-~l~~~-~p~~~~~l~-~L~~L~l~~ 193 (756)
|++|++++..+..++.+++|++|+|++| .+++ .++..+.++++|++|++++| .+++. ++..+..++ +|++|++++
T Consensus 125 L~~~~l~~~~~~~l~~~~~L~~L~L~~~~~l~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~~~~~l~~~L~~L~l~~ 204 (336)
T 2ast_B 125 LEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSG 204 (336)
T ss_dssp CTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHHHHHSCTTCCEEECCS
T ss_pred CcCcccCHHHHHHHhcCCCCCEEECCCCCCCCHHHHHHHHhcCCCCCEEcCCCCCCcChHHHHHHHHhcccCCCEEEeCC
Confidence 7777666666666666667777777766 4554 25555666667777777766 66543 455566666 677777766
Q ss_pred C--CCCC-CCcccccc-ccccEEEccccc-ccCCCCccccCCCCCcEEEccCCc-CCCCCCccCcCCCCCCeEEecCccc
Q 004400 194 L--NGPE-ATFPQLGN-MKMTKLILRNCN-ITGELPRYLGKMTKLKVLDLSFNR-LRGQIPSNFDDLYDVDYIYFAGNLL 267 (756)
Q Consensus 194 n--~~~~-~~~~~~~~-~~L~~L~L~~n~-l~~~~p~~~~~l~~L~~L~Ls~N~-l~~~~p~~~~~l~~L~~L~ls~N~l 267 (756)
| .+.. ..+..+.. .+|+.|++++|. +++..+..+.++++|+.|+|++|. +.......+..+++|+.|++++| +
T Consensus 205 ~~~~~~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~l~~l~~L~~L~l~~~~~~~~~~~~~l~~~~~L~~L~l~~~-i 283 (336)
T 2ast_B 205 YRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGI-V 283 (336)
T ss_dssp CGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCTTCCGGGGGGGGGCTTCCEEECTTS-S
T ss_pred CcccCCHHHHHHHHhhCCCCCEEeCCCCCcCCHHHHHHHhCCCCCCEeeCCCCCCCCHHHHHHHhcCCCCCEEeccCc-c
Confidence 6 3331 11122222 257777777787 666677788888999999999885 22222225778889999999988 3
Q ss_pred cccCCchhhcCCCeeEeecCCCCCCCCcccc
Q 004400 268 TGAIPPWMLERGDKIDLSYNNFTDGSAESSC 298 (756)
Q Consensus 268 ~~~~p~~~~~~l~~l~ls~N~l~~~~~~~~~ 298 (756)
+...-..+...+..|++++|++++..+....
T Consensus 284 ~~~~~~~l~~~l~~L~l~~n~l~~~~~~~~~ 314 (336)
T 2ast_B 284 PDGTLQLLKEALPHLQINCSHFTTIARPTIG 314 (336)
T ss_dssp CTTCHHHHHHHSTTSEESCCCSCCTTCSSCS
T ss_pred CHHHHHHHHhhCcceEEecccCccccCCccc
Confidence 3222222235577888899998887655444
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=99.87 E-value=1.9e-23 Score=225.44 Aligned_cols=248 Identities=17% Similarity=0.158 Sum_probs=201.2
Q ss_pred EEEccCCcccCccCcccccCCcc-eeeccCccccccCC----ccCcCcC-CCcEEEeecCcccccCCcccCCC-----CC
Q 004400 45 DIDLTLNYLSGTIPSQWASLPLL-NISLIANRLKGPIP----KYLANIS-TLVNLTVQYNQFSGELPEELGSL-----LN 113 (756)
Q Consensus 45 ~L~L~~n~l~~~~p~~~~~l~~L-~l~l~~n~~~~~~p----~~l~~l~-~L~~L~L~~N~l~~~~p~~~~~l-----~~ 113 (756)
.++|++|.+++.+|..+...+.| .|++++|++....+ ..|.+++ +|++|+|++|.|++..+..|..+ ++
T Consensus 2 ~~~ls~n~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~ 81 (362)
T 3goz_A 2 NYKLTLHPGSNPVEEFTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPAN 81 (362)
T ss_dssp EEECCCCTTCCHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTT
T ss_pred ccccccccchHHHHHHHhCCCCceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCC
Confidence 57899999999999988888867 59999999998777 7888898 99999999999998888877775 99
Q ss_pred CcEEeccCCeecccCCccccC----C-CCCCEEEeeCCcccccCChhhcC-----cCCCcEEEccCCcCcCCC----Ccc
Q 004400 114 LEKLHLSSNNFTGELPKTFAK----L-TNMKDFRISDNQFTGQIPSFIQN-----WTKLEKLFIQPSGLAGPI----PSG 179 (756)
Q Consensus 114 L~~L~L~~N~l~~~~p~~~~~----l-~~L~~L~L~~N~l~~~~p~~~~~-----l~~L~~L~l~~N~l~~~~----p~~ 179 (756)
|++|+|++|++++..+..+.. + ++|+.|+|++|++++..+..+.. .++|++|+|++|+++... +..
T Consensus 82 L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~ 161 (362)
T 3goz_A 82 VTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDELIQI 161 (362)
T ss_dssp CCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHHHHTTSCTTCCEEECTTSCGGGSCHHHHHHH
T ss_pred ccEEECcCCcCChHHHHHHHHHHHhCCCCccEEECcCCcCCcHHHHHHHHHHHhCCCceeEEEccCCcCCHHHHHHHHHH
Confidence 999999999999777665444 4 89999999999999777766544 369999999999998643 344
Q ss_pred ccCCC-CCCeEEccCCCCCCCCcccccc------ccccEEEcccccccCC----CCccccC-CCCCcEEEccCCcCCCCC
Q 004400 180 IFSLE-NLTDLRISDLNGPEATFPQLGN------MKMTKLILRNCNITGE----LPRYLGK-MTKLKVLDLSFNRLRGQI 247 (756)
Q Consensus 180 ~~~l~-~L~~L~l~~n~~~~~~~~~~~~------~~L~~L~L~~n~l~~~----~p~~~~~-l~~L~~L~Ls~N~l~~~~ 247 (756)
+..++ +|++|++++|.+....+..+.. .+|+.|+|++|.+++. ++..+.. .++|++|+|++|.+++..
T Consensus 162 l~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~i~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~ 241 (362)
T 3goz_A 162 LAAIPANVNSLNLRGNNLASKNCAELAKFLASIPASVTSLDLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCLHGPS 241 (362)
T ss_dssp HHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHHSCTTCCEEECCSSCCCCCC
T ss_pred HhcCCccccEeeecCCCCchhhHHHHHHHHHhCCCCCCEEECCCCCCChhHHHHHHHHHhcCCCCceEEECcCCCCCcHH
Confidence 45565 9999999999998877654432 3799999999999964 4455555 469999999999999765
Q ss_pred C----ccCcCCCCCCeEEecCccccccCCchh---------hcCCCeeEeecCCCCCC
Q 004400 248 P----SNFDDLYDVDYIYFAGNLLTGAIPPWM---------LERGDKIDLSYNNFTDG 292 (756)
Q Consensus 248 p----~~~~~l~~L~~L~ls~N~l~~~~p~~~---------~~~l~~l~ls~N~l~~~ 292 (756)
+ ..+..+++|+.|++++|.+.+..+..+ ++.++.+|+++|++.+.
T Consensus 242 ~~~l~~~~~~l~~L~~L~L~~n~l~~i~~~~~~~l~~~~~~l~~L~~LdL~~N~l~~~ 299 (362)
T 3goz_A 242 LENLKLLKDSLKHLQTVYLDYDIVKNMSKEQCKALGAAFPNIQKIILVDKNGKEIHPS 299 (362)
T ss_dssp HHHHHHTTTTTTTCSEEEEEHHHHTTCCHHHHHHHHTTSTTCCEEEEECTTSCBCCGG
T ss_pred HHHHHHHHhcCCCccEEEeccCCccccCHHHHHHHHHHhccCCceEEEecCCCcCCCc
Confidence 5 446788999999999999764443321 45678899999998754
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=99.86 E-value=1.4e-23 Score=228.71 Aligned_cols=213 Identities=20% Similarity=0.254 Sum_probs=148.3
Q ss_pred cCCccCcCcCCCcEEEeecCcccccCC----cccCCCCCCcEEeccCC---eecccCCccc-------cCCCCCCEEEee
Q 004400 79 PIPKYLANISTLVNLTVQYNQFSGELP----EELGSLLNLEKLHLSSN---NFTGELPKTF-------AKLTNMKDFRIS 144 (756)
Q Consensus 79 ~~p~~l~~l~~L~~L~L~~N~l~~~~p----~~~~~l~~L~~L~L~~N---~l~~~~p~~~-------~~l~~L~~L~L~ 144 (756)
.++..+..+++|+.|+|++|.|++..+ ..|..+++|++|+|++| ++++.+|..+ ..+++|++|+|+
T Consensus 23 ~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~~~~~~l~~~~~~~~~~l~~~l~~~~~L~~L~Ls 102 (386)
T 2ca6_A 23 SVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLS 102 (386)
T ss_dssp TTSHHHHHCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECC
T ss_pred HHHHHHhcCCCccEEECCCCCCCHHHHHHHHHHHHhCCCccEEeCcccccCccccchhHHHHHHHHHHhhCCcccEEECC
Confidence 455566666777777777777765433 33556777777777764 4444455444 566777777777
Q ss_pred CCcccc----cCChhhcCcCCCcEEEccCCcCcCCCCcccc----CC---------CCCCeEEccCCCCCCCCcc----c
Q 004400 145 DNQFTG----QIPSFIQNWTKLEKLFIQPSGLAGPIPSGIF----SL---------ENLTDLRISDLNGPEATFP----Q 203 (756)
Q Consensus 145 ~N~l~~----~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~----~l---------~~L~~L~l~~n~~~~~~~~----~ 203 (756)
+|++++ .+|..+.++++|+.|+|++|.++...+..+. .+ ++|++|++++|.+...... .
T Consensus 103 ~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~l~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~ 182 (386)
T 2ca6_A 103 DNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKT 182 (386)
T ss_dssp SCCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHHHHHH
T ss_pred CCcCCHHHHHHHHHHHHhCCCCCEEECcCCCCCHHHHHHHHHHHHHHhhhhhcccCCCCcEEECCCCCCCcHHHHHHHHH
Confidence 777775 3566667777777777777777543333222 23 6777777777777643332 2
Q ss_pred ccc-ccccEEEccccccc--C---CCCccccCCCCCcEEEccCCcCC----CCCCccCcCCCCCCeEEecCcccccc---
Q 004400 204 LGN-MKMTKLILRNCNIT--G---ELPRYLGKMTKLKVLDLSFNRLR----GQIPSNFDDLYDVDYIYFAGNLLTGA--- 270 (756)
Q Consensus 204 ~~~-~~L~~L~L~~n~l~--~---~~p~~~~~l~~L~~L~Ls~N~l~----~~~p~~~~~l~~L~~L~ls~N~l~~~--- 270 (756)
+.. .+|+.|+|++|.++ | ..+..+..+++|+.|+|++|.++ +.+|..+..+++|+.|+|++|.+++.
T Consensus 183 l~~~~~L~~L~L~~n~l~~~g~~~l~~~~l~~~~~L~~L~Ls~n~l~~~g~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~ 262 (386)
T 2ca6_A 183 FQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAA 262 (386)
T ss_dssp HHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCHHHHH
T ss_pred HHhCCCcCEEECcCCCCCHhHHHHHHHHHhhcCCCccEEECcCCCCCcHHHHHHHHHHccCCCcCEEECCCCCCchhhHH
Confidence 222 25778888888887 2 34447889999999999999996 57888899999999999999999865
Q ss_pred -CCchh----hcCCCeeEeecCCCCC
Q 004400 271 -IPPWM----LERGDKIDLSYNNFTD 291 (756)
Q Consensus 271 -~p~~~----~~~l~~l~ls~N~l~~ 291 (756)
+|..+ +++++.|++++|.+++
T Consensus 263 ~l~~~l~~~~~~~L~~L~L~~n~i~~ 288 (386)
T 2ca6_A 263 AVVDAFSKLENIGLQTLRLQYNEIEL 288 (386)
T ss_dssp HHHHHHHTCSSCCCCEEECCSSCCBH
T ss_pred HHHHHHhhccCCCeEEEECcCCcCCH
Confidence 45544 6789999999999986
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=99.86 E-value=2.4e-21 Score=203.86 Aligned_cols=209 Identities=17% Similarity=0.239 Sum_probs=163.1
Q ss_pred eeccCccccccCCccCcCcCCCcEEEeecCcccccCCcccCCCCCCcEEeccCCeecccCCccccCCCCCCEEEeeCCcc
Q 004400 69 ISLIANRLKGPIPKYLANISTLVNLTVQYNQFSGELPEELGSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRISDNQF 148 (756)
Q Consensus 69 l~l~~n~~~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l 148 (756)
+.+..+++...++ +.++++|+.|++++|.++ .++ .+..+++|++|+|++|++++..+ +..+++|+.|+|++|++
T Consensus 24 ~~l~~~~~~~~~~--~~~l~~L~~L~l~~~~i~-~l~-~~~~l~~L~~L~L~~n~i~~~~~--~~~l~~L~~L~L~~n~l 97 (308)
T 1h6u_A 24 IAAGKSNVTDTVT--QADLDGITTLSAFGTGVT-TIE-GVQYLNNLIGLELKDNQITDLAP--LKNLTKITELELSGNPL 97 (308)
T ss_dssp HHTTCSSTTSEEC--HHHHHTCCEEECTTSCCC-CCT-TGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEECCSCCC
T ss_pred HHhCCCCcCceec--HHHcCCcCEEEeeCCCcc-Cch-hhhccCCCCEEEccCCcCCCChh--HccCCCCCEEEccCCcC
Confidence 3444555544332 456778888888888887 454 57888888888888888884433 88888888888888888
Q ss_pred cccCChhhcCcCCCcEEEccCCcCcCCCCccccCCCCCCeEEccCCCCCCCCccccccc-cccEEEcccccccCCCCccc
Q 004400 149 TGQIPSFIQNWTKLEKLFIQPSGLAGPIPSGIFSLENLTDLRISDLNGPEATFPQLGNM-KMTKLILRNCNITGELPRYL 227 (756)
Q Consensus 149 ~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~-~L~~L~L~~n~l~~~~p~~~ 227 (756)
++ ++ .+..+++|+.|+|++|++++. + .+..+++|+.|++++|.+....+ +..+ +|+.|+|++|.+++..+ +
T Consensus 98 ~~-~~-~~~~l~~L~~L~l~~n~l~~~-~-~l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~~~~--l 169 (308)
T 1h6u_A 98 KN-VS-AIAGLQSIKTLDLTSTQITDV-T-PLAGLSNLQVLYLDLNQITNISP--LAGLTNLQYLSIGNAQVSDLTP--L 169 (308)
T ss_dssp SC-CG-GGTTCTTCCEEECTTSCCCCC-G-GGTTCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCCGG--G
T ss_pred CC-ch-hhcCCCCCCEEECCCCCCCCc-h-hhcCCCCCCEEECCCCccCcCcc--ccCCCCccEEEccCCcCCCChh--h
Confidence 84 33 588888888888888888753 3 37888888888888888877654 4443 58899999999986544 8
Q ss_pred cCCCCCcEEEccCCcCCCCCCccCcCCCCCCeEEecCccccccCCchhhcCCCeeEeecCCCCCCC
Q 004400 228 GKMTKLKVLDLSFNRLRGQIPSNFDDLYDVDYIYFAGNLLTGAIPPWMLERGDKIDLSYNNFTDGS 293 (756)
Q Consensus 228 ~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~~l~~l~ls~N~l~~~~ 293 (756)
..+++|+.|+|++|.+++..+ +..+++|+.|++++|++++..|-..+++++.|++++|++++.+
T Consensus 170 ~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~L~~N~l~~~~~l~~l~~L~~L~l~~N~i~~~~ 233 (308)
T 1h6u_A 170 ANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVSPLANTSNLFIVTLTNQTITNQP 233 (308)
T ss_dssp TTCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECTTSCCCBCGGGTTCTTCCEEEEEEEEEECCC
T ss_pred cCCCCCCEEECCCCccCcChh--hcCCCCCCEEEccCCccCccccccCCCCCCEEEccCCeeecCC
Confidence 999999999999999996544 8999999999999999997665444889999999999997644
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=99.85 E-value=3.9e-21 Score=206.29 Aligned_cols=238 Identities=15% Similarity=0.116 Sum_probs=113.9
Q ss_pred cccccccCcccccCCcccCCCCCCCEEEccCCcccCccCcccccCCcc-eeeccCccccccCC-ccCcCcCCCcE-EEee
Q 004400 20 QKRVLKEQNLTGVLPPKLAELTFLQDIDLTLNYLSGTIPSQWASLPLL-NISLIANRLKGPIP-KYLANISTLVN-LTVQ 96 (756)
Q Consensus 20 ~~l~L~~~~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L-~l~l~~n~~~~~~p-~~l~~l~~L~~-L~L~ 96 (756)
+.++-++++++ .+|..+. ++|+.|+|++|+|+...+.+|..++.| +|++++|++.+.+| .+|.++++|++ +.++
T Consensus 12 ~~v~C~~~~Lt-~iP~~l~--~~l~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~f~~L~~l~~~l~~~ 88 (350)
T 4ay9_X 12 RVFLCQESKVT-EIPSDLP--RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEK 88 (350)
T ss_dssp TEEEEESTTCC-SCCTTCC--TTCSEEEEESCCCSEECTTSSTTCTTCCEEEEECCTTCCEECTTSBCSCTTCCEEEEEE
T ss_pred CEEEecCCCCC-ccCcCcC--CCCCEEEccCCcCCCcCHHHHcCCCCCCEEECcCCCCCCccChhHhhcchhhhhhhccc
Confidence 45556666777 4565553 567777777777774333445544444 24444444444333 23444444433 3334
Q ss_pred cCcccccCCcccCCCCCCcEEeccCCeecccCCccccCCCCCCEEEeeC-CcccccCChhhcCcCCCcEEEccCCcCcCC
Q 004400 97 YNQFSGELPEELGSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRISD-NQFTGQIPSFIQNWTKLEKLFIQPSGLAGP 175 (756)
Q Consensus 97 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~-N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~ 175 (756)
.|+|+...|..|..+++|++|++++|+++...+..+....++..|++.+ |++....+..|..+.
T Consensus 89 ~N~l~~l~~~~f~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~l~~~~~i~~l~~~~f~~~~--------------- 153 (350)
T 4ay9_X 89 ANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLS--------------- 153 (350)
T ss_dssp ETTCCEECTTSBCCCTTCCEEEEEEECCSSCCCCTTCCBSSCEEEEEESCTTCCEECTTSSTTSB---------------
T ss_pred CCcccccCchhhhhccccccccccccccccCCchhhcccchhhhhhhccccccccccccchhhcc---------------
Confidence 4444444444444444455555544444433333333344444444433 233333333333332
Q ss_pred CCccccCCCCCCeEEccCCCCCCCCccccccccccEEEccc-ccccCCCCccccCCCCCcEEEccCCcCCCCCCccCcCC
Q 004400 176 IPSGIFSLENLTDLRISDLNGPEATFPQLGNMKMTKLILRN-CNITGELPRYLGKMTKLKVLDLSFNRLRGQIPSNFDDL 254 (756)
Q Consensus 176 ~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~L~~L~L~~-n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l 254 (756)
..++.|++++|.+..+....+...+++.|++.+ |.++...++.|.++++|+.|||++|+|+...+..|.
T Consensus 154 --------~~l~~L~L~~N~i~~i~~~~f~~~~L~~l~l~~~n~l~~i~~~~f~~l~~L~~LdLs~N~l~~lp~~~~~-- 223 (350)
T 4ay9_X 154 --------FESVILWLNKNGIQEIHNSAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLE-- 223 (350)
T ss_dssp --------SSCEEEECCSSCCCEECTTSSTTEEEEEEECTTCTTCCCCCTTTTTTEECCSEEECTTSCCCCCCSSSCT--
T ss_pred --------hhhhhhccccccccCCChhhccccchhHHhhccCCcccCCCHHHhccCcccchhhcCCCCcCccChhhhc--
Confidence 234445555555554444444444555555553 444433344566666666666666666643333333
Q ss_pred CCCCeEEecCccccccCCch-hhcCCCeeEeec
Q 004400 255 YDVDYIYFAGNLLTGAIPPW-MLERGDKIDLSY 286 (756)
Q Consensus 255 ~~L~~L~ls~N~l~~~~p~~-~~~~l~~l~ls~ 286 (756)
+|+.|.+.++.--..+|.- -+++|+.+++++
T Consensus 224 -~L~~L~~l~~~~l~~lP~l~~l~~L~~l~l~~ 255 (350)
T 4ay9_X 224 -NLKKLRARSTYNLKKLPTLEKLVALMEASLTY 255 (350)
T ss_dssp -TCCEEECTTCTTCCCCCCTTTCCSCCEEECSC
T ss_pred -cchHhhhccCCCcCcCCCchhCcChhhCcCCC
Confidence 3333333333222244431 145555555543
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=99.85 E-value=7.8e-21 Score=203.93 Aligned_cols=182 Identities=16% Similarity=0.080 Sum_probs=146.1
Q ss_pred eeccccccccCcccccCCcccCCCCCCCEEEccCCcccCccC-cccccCCcc-e-eeccCccccccCCccCcCcCCCcEE
Q 004400 17 TVNQKRVLKEQNLTGVLPPKLAELTFLQDIDLTLNYLSGTIP-SQWASLPLL-N-ISLIANRLKGPIPKYLANISTLVNL 93 (756)
Q Consensus 17 ~~~~~l~L~~~~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p-~~~~~l~~L-~-l~l~~n~~~~~~p~~l~~l~~L~~L 93 (756)
+.+++|+|++|+|+.+.+..|.++++|+.|+|++|++.+.+| .+|.+++.+ + +.+..|++....|..|.++++|++|
T Consensus 30 ~~l~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~f~~L~~l~~~l~~~~N~l~~l~~~~f~~l~~L~~L 109 (350)
T 4ay9_X 30 RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYL 109 (350)
T ss_dssp TTCSEEEEESCCCSEECTTSSTTCTTCCEEEEECCTTCCEECTTSBCSCTTCCEEEEEEETTCCEECTTSBCCCTTCCEE
T ss_pred CCCCEEEccCCcCCCcCHHHHcCCCCCCEEECcCCCCCCccChhHhhcchhhhhhhcccCCcccccCchhhhhccccccc
Confidence 468899999999997777789999999999999999976666 578888876 4 4566789998889999999999999
Q ss_pred EeecCcccccCCcccCCCCCCcEEeccC-CeecccCCccccCCC-CCCEEEeeCCcccccCChhhcCcCCCcEEEccC-C
Q 004400 94 TVQYNQFSGELPEELGSLLNLEKLHLSS-NNFTGELPKTFAKLT-NMKDFRISDNQFTGQIPSFIQNWTKLEKLFIQP-S 170 (756)
Q Consensus 94 ~L~~N~l~~~~p~~~~~l~~L~~L~L~~-N~l~~~~p~~~~~l~-~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~-N 170 (756)
++++|+|++..+..+....++..|++.+ |++....+..|..+. .|+.|+|++|+|+. +|......++|+.|++.+ |
T Consensus 110 ~l~~n~l~~~~~~~~~~~~~l~~l~l~~~~~i~~l~~~~f~~~~~~l~~L~L~~N~i~~-i~~~~f~~~~L~~l~l~~~n 188 (350)
T 4ay9_X 110 LISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQE-IHNSAFNGTQLDELNLSDNN 188 (350)
T ss_dssp EEEEECCSSCCCCTTCCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCCCE-ECTTSSTTEEEEEEECTTCT
T ss_pred cccccccccCCchhhcccchhhhhhhccccccccccccchhhcchhhhhhccccccccC-CChhhccccchhHHhhccCC
Confidence 9999999977777788888999999965 678766666777775 68999999999994 555555667899999975 5
Q ss_pred cCcCCCCccccCCCCCCeEEccCCCCCCC
Q 004400 171 GLAGPIPSGIFSLENLTDLRISDLNGPEA 199 (756)
Q Consensus 171 ~l~~~~p~~~~~l~~L~~L~l~~n~~~~~ 199 (756)
.++...+..|.++++|+.|++++|.++.+
T Consensus 189 ~l~~i~~~~f~~l~~L~~LdLs~N~l~~l 217 (350)
T 4ay9_X 189 NLEELPNDVFHGASGPVILDISRTRIHSL 217 (350)
T ss_dssp TCCCCCTTTTTTEECCSEEECTTSCCCCC
T ss_pred cccCCCHHHhccCcccchhhcCCCCcCcc
Confidence 66643345677888888777766555443
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=99.83 E-value=9.8e-21 Score=213.97 Aligned_cols=190 Identities=24% Similarity=0.279 Sum_probs=106.1
Q ss_pred CCCEEEccCCcccCccCcccccCCcc-eeeccCccccccCCccCcCcCCCcEEEeecCcccccCCcccCCCCCCcEEecc
Q 004400 42 FLQDIDLTLNYLSGTIPSQWASLPLL-NISLIANRLKGPIPKYLANISTLVNLTVQYNQFSGELPEELGSLLNLEKLHLS 120 (756)
Q Consensus 42 ~L~~L~L~~n~l~~~~p~~~~~l~~L-~l~l~~n~~~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~ 120 (756)
+|+.|+|++|+|++ +|..+. +.| .|++.+|++. .+| ..+++|+.|+|++|+|++ +|. |.+ +|++|+|+
T Consensus 60 ~L~~L~Ls~n~L~~-lp~~l~--~~L~~L~Ls~N~l~-~ip---~~l~~L~~L~Ls~N~l~~-ip~-l~~--~L~~L~Ls 128 (571)
T 3cvr_A 60 QFSELQLNRLNLSS-LPDNLP--PQITVLEITQNALI-SLP---ELPASLEYLDACDNRLST-LPE-LPA--SLKHLDVD 128 (571)
T ss_dssp TCSEEECCSSCCSC-CCSCCC--TTCSEEECCSSCCS-CCC---CCCTTCCEEECCSSCCSC-CCC-CCT--TCCEEECC
T ss_pred CccEEEeCCCCCCc-cCHhHc--CCCCEEECcCCCCc-ccc---cccCCCCEEEccCCCCCC-cch-hhc--CCCEEECC
Confidence 77888888888875 554332 333 3555555555 444 334666666666666664 555 444 66666666
Q ss_pred CCeecccCCccccCCCCCCEEEeeCCcccccCChhhcCcCCCcEEEccCCcCcCCCCccccCCCCCCeEEccCCCCCCCC
Q 004400 121 SNNFTGELPKTFAKLTNMKDFRISDNQFTGQIPSFIQNWTKLEKLFIQPSGLAGPIPSGIFSLENLTDLRISDLNGPEAT 200 (756)
Q Consensus 121 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~ 200 (756)
+|+|++ +|. .+++|+.|+|++|+|++ +|. .+++|+.|+|++|+|++ +|. +. ++|+.|++++|.+..++
T Consensus 129 ~N~l~~-lp~---~l~~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~L~~-lp~-l~--~~L~~L~Ls~N~L~~lp 196 (571)
T 3cvr_A 129 NNQLTM-LPE---LPALLEYINADNNQLTM-LPE---LPTSLEVLSVRNNQLTF-LPE-LP--ESLEALDVSTNLLESLP 196 (571)
T ss_dssp SSCCSC-CCC---CCTTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSC-CCC-CC--TTCCEEECCSSCCSSCC
T ss_pred CCcCCC-CCC---cCccccEEeCCCCccCc-CCC---cCCCcCEEECCCCCCCC-cch-hh--CCCCEEECcCCCCCchh
Confidence 666664 444 45666666666666664 443 45566666666666664 444 33 55555555554444322
Q ss_pred ccccccccccEEEcccccccCCCCccccCCCCCcEEEccCCcCCCCCCccCcCCCCCCeEEecCccccccCCchh
Q 004400 201 FPQLGNMKMTKLILRNCNITGELPRYLGKMTKLKVLDLSFNRLRGQIPSNFDDLYDVDYIYFAGNLLTGAIPPWM 275 (756)
Q Consensus 201 ~~~~~~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~ 275 (756)
. +.. +| +...+.|+.|+|++|+|+ .+|..+..+++|+.|+|++|++++.+|..+
T Consensus 197 ~--~~~-~L-----------------~~~~~~L~~L~Ls~N~l~-~lp~~l~~l~~L~~L~L~~N~l~~~~p~~l 250 (571)
T 3cvr_A 197 A--VPV-RN-----------------HHSEETEIFFRCRENRIT-HIPENILSLDPTCTIILEDNPLSSRIRESL 250 (571)
T ss_dssp C--CC--------------------------CCEEEECCSSCCC-CCCGGGGGSCTTEEEECCSSSCCHHHHHHH
T ss_pred h--HHH-hh-----------------hcccccceEEecCCCcce-ecCHHHhcCCCCCEEEeeCCcCCCcCHHHH
Confidence 2 111 22 001111266666666666 456655566666666677676666666554
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=99.83 E-value=6.8e-22 Score=210.96 Aligned_cols=251 Identities=18% Similarity=0.211 Sum_probs=206.0
Q ss_pred eeccccccccCcccccCCcccCCC--CCCCEEEccCCcccCccCcccccCCcc-eeeccCcccccc-CCccCcCcCCCcE
Q 004400 17 TVNQKRVLKEQNLTGVLPPKLAEL--TFLQDIDLTLNYLSGTIPSQWASLPLL-NISLIANRLKGP-IPKYLANISTLVN 92 (756)
Q Consensus 17 ~~~~~l~L~~~~l~~~~p~~l~~l--~~L~~L~L~~n~l~~~~p~~~~~l~~L-~l~l~~n~~~~~-~p~~l~~l~~L~~ 92 (756)
..++.++|+++++. +..+..+ +.++.|++++|.+.+..+. +..++.| .+++.+|++.+. +|..+..+++|++
T Consensus 47 ~~~~~l~l~~~~~~---~~~~~~~~~~~l~~L~l~~n~l~~~~~~-~~~~~~L~~L~L~~~~l~~~~~~~~~~~~~~L~~ 122 (336)
T 2ast_B 47 SLWQTLDLTGKNLH---PDVTGRLLSQGVIAFRCPRSFMDQPLAE-HFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQN 122 (336)
T ss_dssp TTSSEEECTTCBCC---HHHHHHHHHTTCSEEECTTCEECSCCCS-CCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSE
T ss_pred hhheeeccccccCC---HHHHHhhhhccceEEEcCCccccccchh-hccCCCCCEEEccCCCcCHHHHHHHHhhCCCCCE
Confidence 34788999999887 4556666 8999999999999977766 4467777 589999998876 8888999999999
Q ss_pred EEeecCcccccCCcccCCCCCCcEEeccCC-eeccc-CCccccCCCCCCEEEeeCC-ccccc-CChhhcCcC-CCcEEEc
Q 004400 93 LTVQYNQFSGELPEELGSLLNLEKLHLSSN-NFTGE-LPKTFAKLTNMKDFRISDN-QFTGQ-IPSFIQNWT-KLEKLFI 167 (756)
Q Consensus 93 L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N-~l~~~-~p~~~~~l~~L~~L~L~~N-~l~~~-~p~~~~~l~-~L~~L~l 167 (756)
|+|++|.+++..+..|+.+++|++|+|++| .+++. ++..+.++++|++|+|++| .+++. ++..+..++ +|++|+|
T Consensus 123 L~L~~~~l~~~~~~~l~~~~~L~~L~L~~~~~l~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~~~~~l~~~L~~L~l 202 (336)
T 2ast_B 123 LSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNL 202 (336)
T ss_dssp EECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHHHHHSCTTCCEEEC
T ss_pred EeCcCcccCHHHHHHHhcCCCCCEEECCCCCCCCHHHHHHHHhcCCCCCEEcCCCCCCcChHHHHHHHHhcccCCCEEEe
Confidence 999999999888999999999999999999 68753 6777889999999999999 99864 678899999 9999999
Q ss_pred cCC--cCc-CCCCccccCCCCCCeEEccCCC-CCCCCccccccc-cccEEEccccc-ccCCCCccccCCCCCcEEEccCC
Q 004400 168 QPS--GLA-GPIPSGIFSLENLTDLRISDLN-GPEATFPQLGNM-KMTKLILRNCN-ITGELPRYLGKMTKLKVLDLSFN 241 (756)
Q Consensus 168 ~~N--~l~-~~~p~~~~~l~~L~~L~l~~n~-~~~~~~~~~~~~-~L~~L~L~~n~-l~~~~p~~~~~l~~L~~L~Ls~N 241 (756)
++| .++ +.+|..+..+++|+.|++++|. ++...+..+... +|+.|++++|. +.......+.++++|+.|+|++|
T Consensus 203 ~~~~~~~~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~l~~l~~L~~L~l~~~~~~~~~~~~~l~~~~~L~~L~l~~~ 282 (336)
T 2ast_B 203 SGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGI 282 (336)
T ss_dssp CSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCTTCCGGGGGGGGGCTTCCEEECTTS
T ss_pred CCCcccCCHHHHHHHHhhCCCCCEEeCCCCCcCCHHHHHHHhCCCCCCEeeCCCCCCCCHHHHHHHhcCCCCCEEeccCc
Confidence 999 455 4567778889999999999998 666656566554 69999999996 33222236889999999999999
Q ss_pred cCCCCCCccCcCC-CCCCeEEecCccccccCCchh
Q 004400 242 RLRGQIPSNFDDL-YDVDYIYFAGNLLTGAIPPWM 275 (756)
Q Consensus 242 ~l~~~~p~~~~~l-~~L~~L~ls~N~l~~~~p~~~ 275 (756)
++ ...+..+ .++..|++++|.+++..|.++
T Consensus 283 -i~---~~~~~~l~~~l~~L~l~~n~l~~~~~~~~ 313 (336)
T 2ast_B 283 -VP---DGTLQLLKEALPHLQINCSHFTTIARPTI 313 (336)
T ss_dssp -SC---TTCHHHHHHHSTTSEESCCCSCCTTCSSC
T ss_pred -cC---HHHHHHHHhhCcceEEecccCccccCCcc
Confidence 33 2234444 347777899999999988765
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.83 E-value=4.3e-20 Score=182.59 Aligned_cols=151 Identities=20% Similarity=0.206 Sum_probs=86.6
Q ss_pred eccccccccCcccccCCcccCCCCCCCEEEccCCcccCccCcccccCCcceeeccCccccccCCccCcCcCCCcEEEeec
Q 004400 18 VNQKRVLKEQNLTGVLPPKLAELTFLQDIDLTLNYLSGTIPSQWASLPLLNISLIANRLKGPIPKYLANISTLVNLTVQY 97 (756)
Q Consensus 18 ~~~~l~L~~~~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~l~l~~n~~~~~~p~~l~~l~~L~~L~L~~ 97 (756)
..+.++..++.++. +|..+ .++|+.|+|++|++++..+ ..|.++++|++|+|++
T Consensus 8 ~~~~v~c~~~~l~~-~p~~~--~~~l~~L~l~~n~l~~~~~-----------------------~~~~~l~~L~~L~l~~ 61 (208)
T 2o6s_A 8 SGTTVECYSQGRTS-VPTGI--PAQTTYLDLETNSLKSLPN-----------------------GVFDELTSLTQLYLGG 61 (208)
T ss_dssp ETTEEECCSSCCSS-CCSCC--CTTCSEEECCSSCCCCCCT-----------------------TTTTTCTTCSEEECCS
T ss_pred CCCEEEecCCCccC-CCCCC--CCCCcEEEcCCCccCcCCh-----------------------hhhcccccCcEEECCC
Confidence 34556666666663 34333 2466777777776663333 3345555666666666
Q ss_pred CcccccCCcccCCCCCCcEEeccCCeecccCCccccCCCCCCEEEeeCCcccccCChhhcCcCCCcEEEccCCcCcCCCC
Q 004400 98 NQFSGELPEELGSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRISDNQFTGQIPSFIQNWTKLEKLFIQPSGLAGPIP 177 (756)
Q Consensus 98 N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p 177 (756)
|+|++..+..|..+++|++|+|++|++++..+..|..+++|++|+|++|+|++..+..|.++++|+.|+|++|++++..+
T Consensus 62 n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~ 141 (208)
T 2o6s_A 62 NKLQSLPNGVFNKLTSLTYLNLSTNQLQSLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLRLYQNQLKSVPD 141 (208)
T ss_dssp SCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCT
T ss_pred CccCccChhhcCCCCCcCEEECCCCcCCccCHhHhcCccCCCEEEcCCCcCcccCHhHhccCCcCCEEECCCCccceeCH
Confidence 66664444445566666666666666664444445566666666666666665555555666666666666666665444
Q ss_pred ccccCCCCCCeEEccCC
Q 004400 178 SGIFSLENLTDLRISDL 194 (756)
Q Consensus 178 ~~~~~l~~L~~L~l~~n 194 (756)
..+..+++|+.|++++|
T Consensus 142 ~~~~~l~~L~~L~l~~N 158 (208)
T 2o6s_A 142 GVFDRLTSLQYIWLHDN 158 (208)
T ss_dssp TTTTTCTTCCEEECCSC
T ss_pred HHhccCCCccEEEecCC
Confidence 44555555555555544
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=99.82 E-value=7.7e-20 Score=206.63 Aligned_cols=184 Identities=23% Similarity=0.287 Sum_probs=121.4
Q ss_pred CCcEEEeecCcccccCCcccCCCCCCcEEeccCCeecccCCccccCCCCCCEEEeeCCcccccCChhhcCcCCCcEEEcc
Q 004400 89 TLVNLTVQYNQFSGELPEELGSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRISDNQFTGQIPSFIQNWTKLEKLFIQ 168 (756)
Q Consensus 89 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~ 168 (756)
+|+.|+|++|+|++ +|..+. ++|++|+|++|+|+ .+| ..+++|+.|+|++|+|++ +|. |.+ +|+.|+|+
T Consensus 60 ~L~~L~Ls~n~L~~-lp~~l~--~~L~~L~Ls~N~l~-~ip---~~l~~L~~L~Ls~N~l~~-ip~-l~~--~L~~L~Ls 128 (571)
T 3cvr_A 60 QFSELQLNRLNLSS-LPDNLP--PQITVLEITQNALI-SLP---ELPASLEYLDACDNRLST-LPE-LPA--SLKHLDVD 128 (571)
T ss_dssp TCSEEECCSSCCSC-CCSCCC--TTCSEEECCSSCCS-CCC---CCCTTCCEEECCSSCCSC-CCC-CCT--TCCEEECC
T ss_pred CccEEEeCCCCCCc-cCHhHc--CCCCEEECcCCCCc-ccc---cccCCCCEEEccCCCCCC-cch-hhc--CCCEEECC
Confidence 55666666666653 444442 45666666666665 444 234566666666666664 444 443 56666666
Q ss_pred CCcCcCCCCccccCCCCCCeEEccCCCCCCCCccccccccccEEEcccccccCCCCccccCCCCCcEEEccCCcCCCCCC
Q 004400 169 PSGLAGPIPSGIFSLENLTDLRISDLNGPEATFPQLGNMKMTKLILRNCNITGELPRYLGKMTKLKVLDLSFNRLRGQIP 248 (756)
Q Consensus 169 ~N~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p 248 (756)
+|+|++ +|. .+++|+.|++++|.+..++. ...+|+.|+|++|.|++ +|. |. ++|+.|+|++|.|+ .+|
T Consensus 129 ~N~l~~-lp~---~l~~L~~L~Ls~N~l~~lp~---~l~~L~~L~Ls~N~L~~-lp~-l~--~~L~~L~Ls~N~L~-~lp 196 (571)
T 3cvr_A 129 NNQLTM-LPE---LPALLEYINADNNQLTMLPE---LPTSLEVLSVRNNQLTF-LPE-LP--ESLEALDVSTNLLE-SLP 196 (571)
T ss_dssp SSCCSC-CCC---CCTTCCEEECCSSCCSCCCC---CCTTCCEEECCSSCCSC-CCC-CC--TTCCEEECCSSCCS-SCC
T ss_pred CCcCCC-CCC---cCccccEEeCCCCccCcCCC---cCCCcCEEECCCCCCCC-cch-hh--CCCCEEECcCCCCC-chh
Confidence 666654 444 45666666666666655333 22357778888888886 666 65 89999999999999 677
Q ss_pred ccCcCCCCC-------CeEEecCccccccCCchh--hcCCCeeEeecCCCCCCCCccccc
Q 004400 249 SNFDDLYDV-------DYIYFAGNLLTGAIPPWM--LERGDKIDLSYNNFTDGSAESSCQ 299 (756)
Q Consensus 249 ~~~~~l~~L-------~~L~ls~N~l~~~~p~~~--~~~l~~l~ls~N~l~~~~~~~~~~ 299 (756)
. |.. +| +.|+|++|.|+ .+|..+ +++++.|++++|++++..+...+.
T Consensus 197 ~-~~~--~L~~~~~~L~~L~Ls~N~l~-~lp~~l~~l~~L~~L~L~~N~l~~~~p~~l~~ 252 (571)
T 3cvr_A 197 A-VPV--RNHHSEETEIFFRCRENRIT-HIPENILSLDPTCTIILEDNPLSSRIRESLSQ 252 (571)
T ss_dssp C-CC----------CCEEEECCSSCCC-CCCGGGGGSCTTEEEECCSSSCCHHHHHHHHH
T ss_pred h-HHH--hhhcccccceEEecCCCcce-ecCHHHhcCCCCCEEEeeCCcCCCcCHHHHHH
Confidence 6 554 77 99999999999 678766 789999999999999865554443
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.81 E-value=1.4e-19 Score=178.89 Aligned_cols=174 Identities=18% Similarity=0.175 Sum_probs=99.5
Q ss_pred eeccCccccccCCccCcCcCCCcEEEeecCcccccCCcccCCCCCCcEEeccCCeecccCCccccCCCCCCEEEeeCCcc
Q 004400 69 ISLIANRLKGPIPKYLANISTLVNLTVQYNQFSGELPEELGSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRISDNQF 148 (756)
Q Consensus 69 l~l~~n~~~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l 148 (756)
++..++.+. .+|..+ .++|++|+|++|++++..+..|.++++|++|+|++|++++..+..|..+++|++|+|++|++
T Consensus 12 v~c~~~~l~-~~p~~~--~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l 88 (208)
T 2o6s_A 12 VECYSQGRT-SVPTGI--PAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTNQL 88 (208)
T ss_dssp EECCSSCCS-SCCSCC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCC
T ss_pred EEecCCCcc-CCCCCC--CCCCcEEEcCCCccCcCChhhhcccccCcEEECCCCccCccChhhcCCCCCcCEEECCCCcC
Confidence 334444443 334333 24566666666666654444556666666666666666644444455666666666666666
Q ss_pred cccCChhhcCcCCCcEEEccCCcCcCCCCccccCCCCCCeEEccCCCCCCCCccccccccccEEEcccccccCCCCcccc
Q 004400 149 TGQIPSFIQNWTKLEKLFIQPSGLAGPIPSGIFSLENLTDLRISDLNGPEATFPQLGNMKMTKLILRNCNITGELPRYLG 228 (756)
Q Consensus 149 ~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~L~~L~L~~n~l~~~~p~~~~ 228 (756)
++..+..|.++++|++|+|++|++++..+..+..+++|+.| +|++|.+++..+..|.
T Consensus 89 ~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L-----------------------~l~~N~l~~~~~~~~~ 145 (208)
T 2o6s_A 89 QSLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDL-----------------------RLYQNQLKSVPDGVFD 145 (208)
T ss_dssp CCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEE-----------------------ECCSSCCSCCCTTTTT
T ss_pred CccCHhHhcCccCCCEEEcCCCcCcccCHhHhccCCcCCEE-----------------------ECCCCccceeCHHHhc
Confidence 65444555566666666666666654444444444444444 4444555555555566
Q ss_pred CCCCCcEEEccCCcCCCCCCccCcCCCCCCeEEecCccccccCCchh
Q 004400 229 KMTKLKVLDLSFNRLRGQIPSNFDDLYDVDYIYFAGNLLTGAIPPWM 275 (756)
Q Consensus 229 ~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~ 275 (756)
.+++|+.|+|++|.+.+ .+++|++|+++.|.++|.+|.++
T Consensus 146 ~l~~L~~L~l~~N~~~~-------~~~~l~~L~~~~n~~~g~ip~~~ 185 (208)
T 2o6s_A 146 RLTSLQYIWLHDNPWDC-------TCPGIRYLSEWINKHSGVVRNSA 185 (208)
T ss_dssp TCTTCCEEECCSCCBCC-------CTTTTHHHHHHHHHCTTTBBCTT
T ss_pred cCCCccEEEecCCCeec-------CCCCHHHHHHHHHhCCceeeccC
Confidence 67777777777776553 23456667777777777666543
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.80 E-value=2.9e-19 Score=178.21 Aligned_cols=157 Identities=19% Similarity=0.263 Sum_probs=116.5
Q ss_pred cEEEeecCcccccCCcccCCCCCCcEEeccCCeecccCC-ccccCCCCCCEEEeeCCcccccCChhhcCcCCCcEEEccC
Q 004400 91 VNLTVQYNQFSGELPEELGSLLNLEKLHLSSNNFTGELP-KTFAKLTNMKDFRISDNQFTGQIPSFIQNWTKLEKLFIQP 169 (756)
Q Consensus 91 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~ 169 (756)
+.+++++|.++ .+|..+.. .+++|+|++|+|++..+ ..|..+++|+.|+|++|+|++..+..|.++++|++|+|++
T Consensus 14 ~~l~~s~n~l~-~iP~~~~~--~~~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~ 90 (220)
T 2v70_A 14 TTVDCSNQKLN-KIPEHIPQ--YTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTS 90 (220)
T ss_dssp TEEECCSSCCS-SCCSCCCT--TCSEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS
T ss_pred CEeEeCCCCcc-cCccCCCC--CCCEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCCEECHHHhCCCCCCCEEECCC
Confidence 46777777776 45655433 45677777777775544 3466777777777777777766666777777777777777
Q ss_pred CcCcCCCCccccCCCCCCeEEccCCCCCCCCccccccccccEEEcccccccCCCCccccCCCCCcEEEccCCcCCCCCCc
Q 004400 170 SGLAGPIPSGIFSLENLTDLRISDLNGPEATFPQLGNMKMTKLILRNCNITGELPRYLGKMTKLKVLDLSFNRLRGQIPS 249 (756)
Q Consensus 170 N~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~ 249 (756)
|++++..+..|..+++|++|+ |++|.+++..|..|.++++|+.|+|++|+|++..|.
T Consensus 91 N~l~~~~~~~~~~l~~L~~L~-----------------------Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~ 147 (220)
T 2v70_A 91 NRLENVQHKMFKGLESLKTLM-----------------------LRSNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPG 147 (220)
T ss_dssp SCCCCCCGGGGTTCSSCCEEE-----------------------CTTSCCCCBCTTSSTTCTTCSEEECTTSCCCCBCTT
T ss_pred CccCccCHhHhcCCcCCCEEE-----------------------CCCCcCCeECHhHcCCCccCCEEECCCCcCCEECHH
Confidence 777765555666666666554 445667767778888999999999999999988899
Q ss_pred cCcCCCCCCeEEecCccccccCCc
Q 004400 250 NFDDLYDVDYIYFAGNLLTGAIPP 273 (756)
Q Consensus 250 ~~~~l~~L~~L~ls~N~l~~~~p~ 273 (756)
.|..+++|+.|+|++|++.|.++-
T Consensus 148 ~~~~l~~L~~L~L~~N~l~c~c~l 171 (220)
T 2v70_A 148 AFDTLHSLSTLNLLANPFNCNCYL 171 (220)
T ss_dssp TTTTCTTCCEEECCSCCEECSGGG
T ss_pred HhcCCCCCCEEEecCcCCcCCCch
Confidence 999999999999999999987764
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=99.80 E-value=4.5e-19 Score=176.80 Aligned_cols=156 Identities=19% Similarity=0.225 Sum_probs=105.6
Q ss_pred cEEEeecCcccccCCcccCCCCCCcEEeccCCeecccCCccccCCCCCCEEEeeCCcccccCChhhcCcCCCcEEEccCC
Q 004400 91 VNLTVQYNQFSGELPEELGSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRISDNQFTGQIPSFIQNWTKLEKLFIQPS 170 (756)
Q Consensus 91 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N 170 (756)
+.+++++|.++ .+|..+. ++|+.|+|++|+|++..+..|..+++|+.|+|++|+|++..|..|.++++|++|+|++|
T Consensus 14 ~~v~c~~~~l~-~iP~~l~--~~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N 90 (220)
T 2v9t_B 14 NIVDCRGKGLT-EIPTNLP--ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGN 90 (220)
T ss_dssp TEEECTTSCCS-SCCSSCC--TTCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTTTTTTCSSCCEEECCSS
T ss_pred CEEEcCCCCcC-cCCCccC--cCCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCCcCCCEEECCCC
Confidence 35566666665 4554443 45666666666666555555666666666666666666555666666666666666666
Q ss_pred cCcCCCCccccCCCCCCeEEccCCCCCCCCccccccccccEEEcccccccCCCCccccCCCCCcEEEccCCcCCCCCCcc
Q 004400 171 GLAGPIPSGIFSLENLTDLRISDLNGPEATFPQLGNMKMTKLILRNCNITGELPRYLGKMTKLKVLDLSFNRLRGQIPSN 250 (756)
Q Consensus 171 ~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~ 250 (756)
+|+...+..|..+++|+.| +|++|.+++..|..|..+++|+.|+|++|.|++..+..
T Consensus 91 ~l~~l~~~~f~~l~~L~~L-----------------------~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~ 147 (220)
T 2v9t_B 91 KITELPKSLFEGLFSLQLL-----------------------LLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGT 147 (220)
T ss_dssp CCCCCCTTTTTTCTTCCEE-----------------------ECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTT
T ss_pred cCCccCHhHccCCCCCCEE-----------------------ECCCCCCCEeCHHHcCCCCCCCEEECCCCcCCEECHHH
Confidence 6664333344555555544 44456666667778888899999999999999888888
Q ss_pred CcCCCCCCeEEecCccccccCC
Q 004400 251 FDDLYDVDYIYFAGNLLTGAIP 272 (756)
Q Consensus 251 ~~~l~~L~~L~ls~N~l~~~~p 272 (756)
|..+++|+.|+|++|++.+...
T Consensus 148 ~~~l~~L~~L~L~~N~~~c~c~ 169 (220)
T 2v9t_B 148 FSPLRAIQTMHLAQNPFICDCH 169 (220)
T ss_dssp TTTCTTCCEEECCSSCEECSGG
T ss_pred HhCCCCCCEEEeCCCCcCCCCc
Confidence 8999999999999999987655
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=99.79 E-value=2e-19 Score=187.54 Aligned_cols=193 Identities=21% Similarity=0.296 Sum_probs=115.9
Q ss_pred cceeccccccccCcccccCCcccCCCCCCCEEEccCCcccCccCcccccCCcceeeccCccccccCCccCcCcCCCcEEE
Q 004400 15 QKTVNQKRVLKEQNLTGVLPPKLAELTFLQDIDLTLNYLSGTIPSQWASLPLLNISLIANRLKGPIPKYLANISTLVNLT 94 (756)
Q Consensus 15 ~~~~~~~l~L~~~~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~l~l~~n~~~~~~p~~l~~l~~L~~L~ 94 (756)
.+..+.++.+..+.+++..+ +..+++|+.|++++|.++.. + .+..+++|+.|+
T Consensus 22 ~l~~~~~~~l~~~~~~~~~~--~~~l~~L~~L~l~~~~i~~~-~------------------------~~~~l~~L~~L~ 74 (291)
T 1h6t_A 22 AFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKSV-Q------------------------GIQYLPNVTKLF 74 (291)
T ss_dssp HHHHHHHHHTTCSCTTSEEC--HHHHHTCCEEECTTSCCCCC-T------------------------TGGGCTTCCEEE
T ss_pred HHHHHHHHHhcCCCcccccc--hhhcCcccEEEccCCCcccC-h------------------------hHhcCCCCCEEE
Confidence 34445555666666665533 34567777777777777621 1 144556666666
Q ss_pred eecCcccccCCcccCCCCCCcEEeccCCeecccCCccccCCCCCCEEEeeCCcccccCChhhcCcCCCcEEEccCCcCcC
Q 004400 95 VQYNQFSGELPEELGSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRISDNQFTGQIPSFIQNWTKLEKLFIQPSGLAG 174 (756)
Q Consensus 95 L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~ 174 (756)
|++|++++..+ +.++++|++|+|++|++++ ++ .+..+++|+.|+|++|++++ + ..+..+++|+.|+|++|++++
T Consensus 75 L~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~-~~-~l~~l~~L~~L~L~~n~i~~-~-~~l~~l~~L~~L~l~~n~l~~ 148 (291)
T 1h6t_A 75 LNGNKLTDIKP--LANLKNLGWLFLDENKVKD-LS-SLKDLKKLKSLSLEHNGISD-I-NGLVHLPQLESLYLGNNKITD 148 (291)
T ss_dssp CCSSCCCCCGG--GTTCTTCCEEECCSSCCCC-GG-GGTTCTTCCEEECTTSCCCC-C-GGGGGCTTCCEEECCSSCCCC
T ss_pred ccCCccCCCcc--cccCCCCCEEECCCCcCCC-Ch-hhccCCCCCEEECCCCcCCC-C-hhhcCCCCCCEEEccCCcCCc
Confidence 66666664322 6666666666666666653 22 25666666666666666663 2 345566666666666666653
Q ss_pred CCCccccCCCCCCeEEccCCCCCCCCccccccccccEEEcccccccCCCCccccCCCCCcEEEccCCcCCCCCCccCcCC
Q 004400 175 PIPSGIFSLENLTDLRISDLNGPEATFPQLGNMKMTKLILRNCNITGELPRYLGKMTKLKVLDLSFNRLRGQIPSNFDDL 254 (756)
Q Consensus 175 ~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l 254 (756)
. ..+..+++|+.| +|++|.+++..+ +..+++|+.|+|++|.+++ ++ .+..+
T Consensus 149 ~--~~l~~l~~L~~L-----------------------~L~~N~l~~~~~--l~~l~~L~~L~L~~N~i~~-l~-~l~~l 199 (291)
T 1h6t_A 149 I--TVLSRLTKLDTL-----------------------SLEDNQISDIVP--LAGLTKLQNLYLSKNHISD-LR-ALAGL 199 (291)
T ss_dssp C--GGGGGCTTCSEE-----------------------ECCSSCCCCCGG--GTTCTTCCEEECCSSCCCB-CG-GGTTC
T ss_pred c--hhhccCCCCCEE-----------------------EccCCccccchh--hcCCCccCEEECCCCcCCC-Ch-hhccC
Confidence 2 344444444444 444455554433 6677777788888877774 34 37777
Q ss_pred CCCCeEEecCccccc
Q 004400 255 YDVDYIYFAGNLLTG 269 (756)
Q Consensus 255 ~~L~~L~ls~N~l~~ 269 (756)
++|+.|++++|+++.
T Consensus 200 ~~L~~L~l~~n~i~~ 214 (291)
T 1h6t_A 200 KNLDVLELFSQECLN 214 (291)
T ss_dssp TTCSEEEEEEEEEEC
T ss_pred CCCCEEECcCCcccC
Confidence 788888888887764
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.79 E-value=2e-18 Score=173.31 Aligned_cols=156 Identities=24% Similarity=0.288 Sum_probs=104.7
Q ss_pred CcEEEeecCcccccCCcccCCCCCCcEEeccCCeecccCCccccCCCCCCEEEeeCCcccccCChhhcCcCCCcEEEccC
Q 004400 90 LVNLTVQYNQFSGELPEELGSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRISDNQFTGQIPSFIQNWTKLEKLFIQP 169 (756)
Q Consensus 90 L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~ 169 (756)
.+.++.+++.++ .+|..+. ++|++|+|++|+|++..|..|..+++|+.|+|++|+|+...+..|.++++|+.|+|++
T Consensus 21 ~~~v~c~~~~l~-~ip~~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~ 97 (229)
T 3e6j_A 21 GTTVDCRSKRHA-SVPAGIP--TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVLDLGT 97 (229)
T ss_dssp TTEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred CCEeEccCCCcC-ccCCCCC--CCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCCCCcChhhcccCCCcCEEECCC
Confidence 345666666665 4554333 5666666666666655566666666666666666666644445556666666666666
Q ss_pred CcCcCCCCccccCCCCCCeEEccCCCCCCCCccccccccccEEEcccccccCCCCccccCCCCCcEEEccCCcCCCCCCc
Q 004400 170 SGLAGPIPSGIFSLENLTDLRISDLNGPEATFPQLGNMKMTKLILRNCNITGELPRYLGKMTKLKVLDLSFNRLRGQIPS 249 (756)
Q Consensus 170 N~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~ 249 (756)
|++++..+..|..+++|+.|+ |++|+++ .+|..+..+++|+.|+|++|+|++..+.
T Consensus 98 N~l~~l~~~~~~~l~~L~~L~-----------------------Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~~~ 153 (229)
T 3e6j_A 98 NQLTVLPSAVFDRLVHLKELF-----------------------MCCNKLT-ELPRGIERLTHLTHLALDQNQLKSIPHG 153 (229)
T ss_dssp SCCCCCCTTTTTTCTTCCEEE-----------------------CCSSCCC-SCCTTGGGCTTCSEEECCSSCCCCCCTT
T ss_pred CcCCccChhHhCcchhhCeEe-----------------------ccCCccc-ccCcccccCCCCCEEECCCCcCCccCHH
Confidence 666654444455555555544 3445555 5566778889999999999999977777
Q ss_pred cCcCCCCCCeEEecCccccccCC
Q 004400 250 NFDDLYDVDYIYFAGNLLTGAIP 272 (756)
Q Consensus 250 ~~~~l~~L~~L~ls~N~l~~~~p 272 (756)
.|..+++|+.|++++|++.|.++
T Consensus 154 ~~~~l~~L~~L~l~~N~~~c~c~ 176 (229)
T 3e6j_A 154 AFDRLSSLTHAYLFGNPWDCECR 176 (229)
T ss_dssp TTTTCTTCCEEECTTSCBCTTBG
T ss_pred HHhCCCCCCEEEeeCCCccCCcc
Confidence 88899999999999999988776
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=99.79 E-value=5.6e-19 Score=184.13 Aligned_cols=187 Identities=21% Similarity=0.342 Sum_probs=143.0
Q ss_pred eeccCccccccCCccCcCcCCCcEEEeecCcccccCCcccCCCCCCcEEeccCCeecccCCccccCCCCCCEEEeeCCcc
Q 004400 69 ISLIANRLKGPIPKYLANISTLVNLTVQYNQFSGELPEELGSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRISDNQF 148 (756)
Q Consensus 69 l~l~~n~~~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l 148 (756)
+.+..+.+....+ +..+++|+.|++++|.++. ++ .+..+++|++|+|++|++++..+ +..+++|+.|+|++|++
T Consensus 29 ~~l~~~~~~~~~~--~~~l~~L~~L~l~~~~i~~-~~-~~~~l~~L~~L~L~~n~l~~~~~--l~~l~~L~~L~l~~n~l 102 (291)
T 1h6t_A 29 DNLKKKSVTDAVT--QNELNSIDQIIANNSDIKS-VQ-GIQYLPNVTKLFLNGNKLTDIKP--LANLKNLGWLFLDENKV 102 (291)
T ss_dssp HHTTCSCTTSEEC--HHHHHTCCEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCC
T ss_pred HHhcCCCcccccc--hhhcCcccEEEccCCCccc-Ch-hHhcCCCCCEEEccCCccCCCcc--cccCCCCCEEECCCCcC
Confidence 4455555544332 4577888999999998884 44 48888889999999998885444 88888888888888888
Q ss_pred cccCChhhcCcCCCcEEEccCCcCcCCCCccccCCCCCCeEEccCCCCCCCCccccccccccEEEcccccccCCCCcccc
Q 004400 149 TGQIPSFIQNWTKLEKLFIQPSGLAGPIPSGIFSLENLTDLRISDLNGPEATFPQLGNMKMTKLILRNCNITGELPRYLG 228 (756)
Q Consensus 149 ~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~L~~L~L~~n~l~~~~p~~~~ 228 (756)
++ ++ .+..+++|++|+|++|++++. ..+..+++|+.|+ +++|.+++. ..+.
T Consensus 103 ~~-~~-~l~~l~~L~~L~L~~n~i~~~--~~l~~l~~L~~L~-----------------------l~~n~l~~~--~~l~ 153 (291)
T 1h6t_A 103 KD-LS-SLKDLKKLKSLSLEHNGISDI--NGLVHLPQLESLY-----------------------LGNNKITDI--TVLS 153 (291)
T ss_dssp CC-GG-GGTTCTTCCEEECTTSCCCCC--GGGGGCTTCCEEE-----------------------CCSSCCCCC--GGGG
T ss_pred CC-Ch-hhccCCCCCEEECCCCcCCCC--hhhcCCCCCCEEE-----------------------ccCCcCCcc--hhhc
Confidence 84 33 378888888888888888752 4555666666555 555666644 5688
Q ss_pred CCCCCcEEEccCCcCCCCCCccCcCCCCCCeEEecCccccccCCc-hhhcCCCeeEeecCCCCCCC
Q 004400 229 KMTKLKVLDLSFNRLRGQIPSNFDDLYDVDYIYFAGNLLTGAIPP-WMLERGDKIDLSYNNFTDGS 293 (756)
Q Consensus 229 ~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~-~~~~~l~~l~ls~N~l~~~~ 293 (756)
.+++|+.|+|++|.+++..+ +..+++|+.|++++|.+++. |. .-+++|+.|++++|+++..+
T Consensus 154 ~l~~L~~L~L~~N~l~~~~~--l~~l~~L~~L~L~~N~i~~l-~~l~~l~~L~~L~l~~n~i~~~~ 216 (291)
T 1h6t_A 154 RLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHISDL-RALAGLKNLDVLELFSQECLNKP 216 (291)
T ss_dssp GCTTCSEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCBC-GGGTTCTTCSEEEEEEEEEECCC
T ss_pred cCCCCCEEEccCCccccchh--hcCCCccCEEECCCCcCCCC-hhhccCCCCCEEECcCCcccCCc
Confidence 99999999999999997655 99999999999999999864 43 22789999999999988754
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.79 E-value=2.8e-19 Score=192.54 Aligned_cols=179 Identities=22% Similarity=0.236 Sum_probs=129.2
Q ss_pred eeeccCccccccCCccCcCcCCCcEEEeecCcccccCCcccC-CCCCCcEEeccCCeecccCCccccCCCCCCEEEeeCC
Q 004400 68 NISLIANRLKGPIPKYLANISTLVNLTVQYNQFSGELPEELG-SLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRISDN 146 (756)
Q Consensus 68 ~l~l~~n~~~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~-~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N 146 (756)
.++..+|++. .+|..+. ..++.|+|++|+|++..+..|. ++++|++|+|++|+|++..+..|.++++|+.|+|++|
T Consensus 22 ~l~c~~~~l~-~iP~~~~--~~l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N 98 (361)
T 2xot_A 22 ILSCSKQQLP-NVPQSLP--SYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSSN 98 (361)
T ss_dssp EEECCSSCCS-SCCSSCC--TTCSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSS
T ss_pred EEEeCCCCcC-ccCccCC--CCCCEEECCCCCCCccChhhhhhcccccCEEECCCCcCCccChhhccCCCCCCEEECCCC
Confidence 4566666666 4666554 4577888888888876666676 7888888888888888766677788888888888888
Q ss_pred cccccCChhhcCcCCCcEEEccCCcCcCCCCccccCCCCCCeEEccCCCCCCCCccccccccccEEEcccccccCCCCcc
Q 004400 147 QFTGQIPSFIQNWTKLEKLFIQPSGLAGPIPSGIFSLENLTDLRISDLNGPEATFPQLGNMKMTKLILRNCNITGELPRY 226 (756)
Q Consensus 147 ~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~L~~L~L~~n~l~~~~p~~ 226 (756)
+|++..+..|.++++|+.|+|++|++++..|..|..+++|+.|+|++| .|++..+..
T Consensus 99 ~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N-----------------------~l~~l~~~~ 155 (361)
T 2xot_A 99 HLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQN-----------------------QISRFPVEL 155 (361)
T ss_dssp CCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSS-----------------------CCCSCCGGG
T ss_pred cCCcCCHHHhCCCcCCCEEECCCCcccEECHHHhCCcccCCEEECCCC-----------------------cCCeeCHHH
Confidence 888666677778888888888888887666777777777776665554 444333333
Q ss_pred c---cCCCCCcEEEccCCcCCCCCCccCcCCCC--CCeEEecCccccccCC
Q 004400 227 L---GKMTKLKVLDLSFNRLRGQIPSNFDDLYD--VDYIYFAGNLLTGAIP 272 (756)
Q Consensus 227 ~---~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~--L~~L~ls~N~l~~~~p 272 (756)
| ..+++|+.|+|++|+|++..+..+..++. ++.|+|++|++.|.+.
T Consensus 156 ~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~~~l~~l~l~~N~~~C~C~ 206 (361)
T 2xot_A 156 IKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHNNPLECDCK 206 (361)
T ss_dssp TC----CTTCCEEECCSSCCCCCCHHHHHHSCHHHHTTEECCSSCEECCHH
T ss_pred hcCcccCCcCCEEECCCCCCCccCHHHhhhccHhhcceEEecCCCccCCcC
Confidence 3 56888888899988888665567777776 4788999998887654
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* | Back alignment and structure |
|---|
Probab=99.78 E-value=6.8e-21 Score=219.61 Aligned_cols=137 Identities=13% Similarity=0.069 Sum_probs=82.7
Q ss_pred cCcCCCcEEEccCCcCcCCCCccccC-CCCCCeEEcc----CCCCCCCCcc-----ccc-cccccEEEccccc--ccCCC
Q 004400 157 QNWTKLEKLFIQPSGLAGPIPSGIFS-LENLTDLRIS----DLNGPEATFP-----QLG-NMKMTKLILRNCN--ITGEL 223 (756)
Q Consensus 157 ~~l~~L~~L~l~~N~l~~~~p~~~~~-l~~L~~L~l~----~n~~~~~~~~-----~~~-~~~L~~L~L~~n~--l~~~~ 223 (756)
..+++|++|+++.|++++..+..+.. +++|+.|+++ .|.++..+.. .+. ..+|++|+|+.|. +++..
T Consensus 375 ~~~~~L~~L~l~~~~l~~~~~~~l~~~~~~L~~L~l~~~~~~n~l~~~p~~~~~~~~~~~~~~L~~L~L~~~~~~l~~~~ 454 (592)
T 3ogk_B 375 QGCQELEYMAVYVSDITNESLESIGTYLKNLCDFRLVLLDREERITDLPLDNGVRSLLIGCKKLRRFAFYLRQGGLTDLG 454 (592)
T ss_dssp HHCTTCSEEEEEESCCCHHHHHHHHHHCCSCCEEEEEECSCCSCCSSCCCHHHHHHHHHHCTTCCEEEEECCGGGCCHHH
T ss_pred hhCccCeEEEeecCCccHHHHHHHHhhCCCCcEEEEeecCCCccccCchHHHHHHHHHHhCCCCCEEEEecCCCCccHHH
Confidence 34556666666555555544444444 6666666664 3444432111 111 2247777776433 55444
Q ss_pred Ccccc-CCCCCcEEEccCCcCCC-CCCccCcCCCCCCeEEecCccccccCCchh---hcCCCeeEeecCCCCCCC
Q 004400 224 PRYLG-KMTKLKVLDLSFNRLRG-QIPSNFDDLYDVDYIYFAGNLLTGAIPPWM---LERGDKIDLSYNNFTDGS 293 (756)
Q Consensus 224 p~~~~-~l~~L~~L~Ls~N~l~~-~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~---~~~l~~l~ls~N~l~~~~ 293 (756)
...+. .+++|+.|+|++|.+++ .++..+..+++|+.|++++|.+++....++ +++++.|++++|++++.+
T Consensus 455 ~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~ls~n~it~~~ 529 (592)
T 3ogk_B 455 LSYIGQYSPNVRWMLLGYVGESDEGLMEFSRGCPNLQKLEMRGCCFSERAIAAAVTKLPSLRYLWVQGYRASMTG 529 (592)
T ss_dssp HHHHHHSCTTCCEEEECSCCSSHHHHHHHHTCCTTCCEEEEESCCCBHHHHHHHHHHCSSCCEEEEESCBCCTTC
T ss_pred HHHHHHhCccceEeeccCCCCCHHHHHHHHhcCcccCeeeccCCCCcHHHHHHHHHhcCccCeeECcCCcCCHHH
Confidence 44443 37788888888888775 334455777888888888888765433333 678888888888877654
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.78 E-value=5.5e-20 Score=188.17 Aligned_cols=137 Identities=18% Similarity=0.145 Sum_probs=107.3
Q ss_pred CccccCcccCCCCccEEEeec-cCCcE--EEEEEccccCcc------------------------cHHHHHHHHHHHHhC
Q 004400 417 NFATDNNIGEGGFGPVYKGLL-ADGTA--IAVKQLSSKSKQ------------------------GNREFINEIGMISAL 469 (756)
Q Consensus 417 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~--vavK~~~~~~~~------------------------~~~~~~~E~~~l~~l 469 (756)
-|...+.||+|+||.||+|.. .+|+. ||||+++..... ....+.+|+.++.++
T Consensus 48 ~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 127 (258)
T 1zth_A 48 ITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA 127 (258)
T ss_dssp EEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH
T ss_pred chhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH
Confidence 356788999999999999997 78989 999987543111 113678899999999
Q ss_pred CCCce--eeEeeEEEeCCeEEEEEEecCC-C----CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH-cCCCCCeEcCC
Q 004400 470 QHPNL--VKLYGCCIEGNQLLLIYEYLEN-N----SLARALFEHRLKLDWPTRRRICLGIARGLAYLH-GESRIKVVHRD 541 (756)
Q Consensus 470 ~h~ni--v~l~~~~~~~~~~~lV~e~~~~-g----sL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH-~~g~~~iiH~D 541 (756)
+|+++ ..++++ +..++||||+.+ | +|.++... .++..+..++.|++.||+||| +.| |+|||
T Consensus 128 ~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~----~~~~~~~~i~~qi~~~l~~lH~~~g---ivHrD 196 (258)
T 1zth_A 128 KEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE----LKELDVEGIFNDVVENVKRLYQEAE---LVHAD 196 (258)
T ss_dssp HHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG----GGGSCHHHHHHHHHHHHHHHHHTSC---EECSS
T ss_pred HhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc----cChHHHHHHHHHHHHHHHHHHHHCC---EEeCC
Confidence 88764 334432 356899999942 4 77766432 235567899999999999999 886 99999
Q ss_pred CCCCceEecCCCCEEEccCCccccC
Q 004400 542 IKATNVLLDKDLNSKISDFGLAKLD 566 (756)
Q Consensus 542 ikp~Nill~~~~~~kl~DFGla~~~ 566 (756)
|||+|||++. .++|+|||+|...
T Consensus 197 lkp~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 197 LSEYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp CSTTSEEESS--SEEECCCTTCEET
T ss_pred CCHHHEEEcC--cEEEEECcccccC
Confidence 9999999998 8999999999753
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=99.78 E-value=4.6e-19 Score=202.52 Aligned_cols=192 Identities=21% Similarity=0.304 Sum_probs=135.3
Q ss_pred ccceeccccccccCcccccCCcccCCCCCCCEEEccCCcccCccCcccccCCcce-eeccCccccccCCccCcCcCCCcE
Q 004400 14 KQKTVNQKRVLKEQNLTGVLPPKLAELTFLQDIDLTLNYLSGTIPSQWASLPLLN-ISLIANRLKGPIPKYLANISTLVN 92 (756)
Q Consensus 14 ~~~~~~~~l~L~~~~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~-l~l~~n~~~~~~p~~l~~l~~L~~ 92 (756)
..+..+..+.|..+.+.+.++ +..|++|+.|+|++|.|+. ++ .+..++.|+ |+|.+|++.+..| |.++++|+.
T Consensus 18 ~~l~~l~~l~l~~~~i~~~~~--~~~L~~L~~L~l~~n~i~~-l~-~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~ 91 (605)
T 1m9s_A 18 DAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKS-VQ-GIQYLPNVTKLFLNGNKLTDIKP--LTNLKNLGW 91 (605)
T ss_dssp HHHHHHHHHHTTCSCTTSEEC--HHHHTTCCCCBCTTCCCCC-CT-TGGGCTTCCEEECTTSCCCCCGG--GGGCTTCCE
T ss_pred HHHHHHHHHhccCCCcccccc--hhcCCCCCEEECcCCCCCC-Ch-HHccCCCCCEEEeeCCCCCCChh--hccCCCCCE
Confidence 345566777788888887655 5677888999999998873 44 467777774 7777777776554 777888888
Q ss_pred EEeecCcccccCCcccCCCCCCcEEeccCCeecccCCccccCCCCCCEEEeeCCcccccCChhhcCcCCCcEEEccCCcC
Q 004400 93 LTVQYNQFSGELPEELGSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRISDNQFTGQIPSFIQNWTKLEKLFIQPSGL 172 (756)
Q Consensus 93 L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l 172 (756)
|+|++|.|++ +| .|..+++|+.|+|++|+|++ + ..+..+++|+.|+|++|+|++. ..|..+++|+.|+|++|++
T Consensus 92 L~Ls~N~l~~-l~-~l~~l~~L~~L~Ls~N~l~~-l-~~l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l 165 (605)
T 1m9s_A 92 LFLDENKIKD-LS-SLKDLKKLKSLSLEHNGISD-I-NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQI 165 (605)
T ss_dssp EECCSSCCCC-CT-TSTTCTTCCEEECTTSCCCC-C-GGGGGCTTCSEEECCSSCCCCC--GGGGSCTTCSEEECCSSCC
T ss_pred EECcCCCCCC-Ch-hhccCCCCCEEEecCCCCCC-C-ccccCCCccCEEECCCCccCCc--hhhcccCCCCEEECcCCcC
Confidence 8888888874 33 57788888888888888874 3 3477788888888888888754 5677788888888888888
Q ss_pred cCCCCccccCCCCCCeEEccCCCCCCCCccccccc-cccEEEcccccccC
Q 004400 173 AGPIPSGIFSLENLTDLRISDLNGPEATFPQLGNM-KMTKLILRNCNITG 221 (756)
Q Consensus 173 ~~~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~-~L~~L~L~~n~l~~ 221 (756)
.+..| +..+++|+.|+|++|.+... +.+..+ +|+.|+|++|.+.+
T Consensus 166 ~~~~~--l~~l~~L~~L~Ls~N~i~~l--~~l~~l~~L~~L~L~~N~l~~ 211 (605)
T 1m9s_A 166 SDIVP--LAGLTKLQNLYLSKNHISDL--RALAGLKNLDVLELFSQECLN 211 (605)
T ss_dssp CCCGG--GTTCTTCCEEECCSSCCCBC--GGGTTCTTCSEEECCSEEEEC
T ss_pred CCchh--hccCCCCCEEECcCCCCCCC--hHHccCCCCCEEEccCCcCcC
Confidence 76555 77777777777777666554 122222 35555555555554
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.78 E-value=1.3e-18 Score=173.43 Aligned_cols=151 Identities=14% Similarity=0.197 Sum_probs=84.1
Q ss_pred ccccccccCcccccCCcccCCCCCCCEEEccCCcccCccCcccccCCcceeeccCccccccCCccCcCcCCCcEEEeecC
Q 004400 19 NQKRVLKEQNLTGVLPPKLAELTFLQDIDLTLNYLSGTIPSQWASLPLLNISLIANRLKGPIPKYLANISTLVNLTVQYN 98 (756)
Q Consensus 19 ~~~l~L~~~~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~l~l~~n~~~~~~p~~l~~l~~L~~L~L~~N 98 (756)
.+.+++++|+++. +|..+. ..++.|+|++|+|++..|. ..|.++++|+.|+|++|
T Consensus 13 ~~~l~~s~n~l~~-iP~~~~--~~~~~L~L~~N~l~~~~~~----------------------~~~~~l~~L~~L~L~~N 67 (220)
T 2v70_A 13 GTTVDCSNQKLNK-IPEHIP--QYTAELRLNNNEFTVLEAT----------------------GIFKKLPQLRKINFSNN 67 (220)
T ss_dssp TTEEECCSSCCSS-CCSCCC--TTCSEEECCSSCCCEECCC----------------------CCGGGCTTCCEEECCSS
T ss_pred CCEeEeCCCCccc-CccCCC--CCCCEEEcCCCcCCccCch----------------------hhhccCCCCCEEECCCC
Confidence 4566677777663 455443 3456677777766644321 23445555555555555
Q ss_pred cccccCCcccCCCCCCcEEeccCCeecccCCccccCCCCCCEEEeeCCcccccCChhhcCcCCCcEEEccCCcCcCCCCc
Q 004400 99 QFSGELPEELGSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRISDNQFTGQIPSFIQNWTKLEKLFIQPSGLAGPIPS 178 (756)
Q Consensus 99 ~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~ 178 (756)
+|++..+..|.++++|++|+|++|+|++..+..|.++++|++|+|++|+|++..|..|.++++|+.|+|++|++++..|.
T Consensus 68 ~i~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~ 147 (220)
T 2v70_A 68 KITDIEEGAFEGASGVNEILLTSNRLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPG 147 (220)
T ss_dssp CCCEECTTTTTTCTTCCEEECCSSCCCCCCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEEECTTSCCCCBCTT
T ss_pred cCCEECHHHhCCCCCCCEEECCCCccCccCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCEEECCCCcCCEECHH
Confidence 55555555555555555555555555554444555555555555555555555555555555555555555555555555
Q ss_pred cccCCCCCCeEEccCC
Q 004400 179 GIFSLENLTDLRISDL 194 (756)
Q Consensus 179 ~~~~l~~L~~L~l~~n 194 (756)
.|..+++|+.|++++|
T Consensus 148 ~~~~l~~L~~L~L~~N 163 (220)
T 2v70_A 148 AFDTLHSLSTLNLLAN 163 (220)
T ss_dssp TTTTCTTCCEEECCSC
T ss_pred HhcCCCCCCEEEecCc
Confidence 5555555555554443
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=99.78 E-value=7.6e-19 Score=200.74 Aligned_cols=185 Identities=19% Similarity=0.323 Sum_probs=127.3
Q ss_pred eeccCccccccCCccCcCcCCCcEEEeecCcccccCCcccCCCCCCcEEeccCCeecccCCccccCCCCCCEEEeeCCcc
Q 004400 69 ISLIANRLKGPIPKYLANISTLVNLTVQYNQFSGELPEELGSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRISDNQF 148 (756)
Q Consensus 69 l~l~~n~~~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l 148 (756)
+.+..+.+....+ +..|++|+.|+|++|.|. .++ .|..|++|+.|+|++|+|++..+ +..+++|+.|+|++|+|
T Consensus 26 l~l~~~~i~~~~~--~~~L~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l 99 (605)
T 1m9s_A 26 DNLKKKSVTDAVT--QNELNSIDQIIANNSDIK-SVQ-GIQYLPNVTKLFLNGNKLTDIKP--LTNLKNLGWLFLDENKI 99 (605)
T ss_dssp HHTTCSCTTSEEC--HHHHTTCCCCBCTTCCCC-CCT-TGGGCTTCCEEECTTSCCCCCGG--GGGCTTCCEEECCSSCC
T ss_pred HhccCCCcccccc--hhcCCCCCEEECcCCCCC-CCh-HHccCCCCCEEEeeCCCCCCChh--hccCCCCCEEECcCCCC
Confidence 4444455444333 456677777777777776 333 46777777777777777775443 66777777777777777
Q ss_pred cccCChhhcCcCCCcEEEccCCcCcCCCCccccCCCCCCeEEccCCCCCCCCccccccc-cccEEEcccccccCCCCccc
Q 004400 149 TGQIPSFIQNWTKLEKLFIQPSGLAGPIPSGIFSLENLTDLRISDLNGPEATFPQLGNM-KMTKLILRNCNITGELPRYL 227 (756)
Q Consensus 149 ~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~-~L~~L~L~~n~l~~~~p~~~ 227 (756)
++ +| .+..+++|+.|+|++|++.+. ..+..+++|+.|+|++|.+... ..+..+ +|+.|+|++|.+++..| +
T Consensus 100 ~~-l~-~l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~~~~--l 171 (605)
T 1m9s_A 100 KD-LS-SLKDLKKLKSLSLEHNGISDI--NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP--L 171 (605)
T ss_dssp CC-CT-TSTTCTTCCEEECTTSCCCCC--GGGGGCTTCSEEECCSSCCCCC--GGGGSCTTCSEEECCSSCCCCCGG--G
T ss_pred CC-Ch-hhccCCCCCEEEecCCCCCCC--ccccCCCccCEEECCCCccCCc--hhhcccCCCCEEECcCCcCCCchh--h
Confidence 73 33 567777777777777777642 4566777777777777776665 333333 57777788888886665 7
Q ss_pred cCCCCCcEEEccCCcCCCCCCccCcCCCCCCeEEecCccccc
Q 004400 228 GKMTKLKVLDLSFNRLRGQIPSNFDDLYDVDYIYFAGNLLTG 269 (756)
Q Consensus 228 ~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~ 269 (756)
..+++|+.|+|++|.|++. | .+..+++|+.|+|++|++.+
T Consensus 172 ~~l~~L~~L~Ls~N~i~~l-~-~l~~l~~L~~L~L~~N~l~~ 211 (605)
T 1m9s_A 172 AGLTKLQNLYLSKNHISDL-R-ALAGLKNLDVLELFSQECLN 211 (605)
T ss_dssp TTCTTCCEEECCSSCCCBC-G-GGTTCTTCSEEECCSEEEEC
T ss_pred ccCCCCCEEECcCCCCCCC-h-HHccCCCCCEEEccCCcCcC
Confidence 8888888888888888853 3 57888888888888888874
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.78 E-value=6.4e-19 Score=189.77 Aligned_cols=175 Identities=20% Similarity=0.221 Sum_probs=95.1
Q ss_pred cccccccCcccccCCcccCCCCCCCEEEccCCcccCccCcccccCCcceeeccCccccccCCccCc-CcCCCcEEEeecC
Q 004400 20 QKRVLKEQNLTGVLPPKLAELTFLQDIDLTLNYLSGTIPSQWASLPLLNISLIANRLKGPIPKYLA-NISTLVNLTVQYN 98 (756)
Q Consensus 20 ~~l~L~~~~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~l~l~~n~~~~~~p~~l~-~l~~L~~L~L~~N 98 (756)
+.+++++++++. +|..+. +.++.|+|++|+|++..+ ..|. ++++|+.|+|++|
T Consensus 21 ~~l~c~~~~l~~-iP~~~~--~~l~~L~Ls~N~l~~l~~-----------------------~~~~~~l~~L~~L~L~~N 74 (361)
T 2xot_A 21 NILSCSKQQLPN-VPQSLP--SYTALLDLSHNNLSRLRA-----------------------EWTPTRLTNLHSLLLSHN 74 (361)
T ss_dssp TEEECCSSCCSS-CCSSCC--TTCSEEECCSSCCCEECT-----------------------TSSSSCCTTCCEEECCSS
T ss_pred CEEEeCCCCcCc-cCccCC--CCCCEEECCCCCCCccCh-----------------------hhhhhcccccCEEECCCC
Confidence 455666666663 444443 345666666666654443 3344 5555555555555
Q ss_pred cccccCCcccCCCCCCcEEeccCCeecccCCccccCCCCCCEEEeeCCcccccCChhhcCcCCCcEEEccCCcCcCCCCc
Q 004400 99 QFSGELPEELGSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRISDNQFTGQIPSFIQNWTKLEKLFIQPSGLAGPIPS 178 (756)
Q Consensus 99 ~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~ 178 (756)
+|++..+..|.++++|++|+|++|+|++..+..|.++++|+.|+|++|+|++..|..|.++++|+.|+|++|+|++..+.
T Consensus 75 ~i~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~ 154 (361)
T 2xot_A 75 HLNFISSEAFVPVPNLRYLDLSSNHLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQISRFPVE 154 (361)
T ss_dssp CCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCSCCGG
T ss_pred cCCccChhhccCCCCCCEEECCCCcCCcCCHHHhCCCcCCCEEECCCCcccEECHHHhCCcccCCEEECCCCcCCeeCHH
Confidence 55554445555555555555555555544444555555555555555555555555555555555555555555532222
Q ss_pred cc---cCCCCCCeEEccCCCCCCCCcccccccc---ccEEEccccccc
Q 004400 179 GI---FSLENLTDLRISDLNGPEATFPQLGNMK---MTKLILRNCNIT 220 (756)
Q Consensus 179 ~~---~~l~~L~~L~l~~n~~~~~~~~~~~~~~---L~~L~L~~n~l~ 220 (756)
.+ ..+++|+.|+|++|.+.......+..+. ++.|+|++|.+.
T Consensus 155 ~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~~~l~~l~l~~N~~~ 202 (361)
T 2xot_A 155 LIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHNNPLE 202 (361)
T ss_dssp GTC----CTTCCEEECCSSCCCCCCHHHHHHSCHHHHTTEECCSSCEE
T ss_pred HhcCcccCCcCCEEECCCCCCCccCHHHhhhccHhhcceEEecCCCcc
Confidence 22 3456666666666666555544433331 456777777776
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=99.77 E-value=1.9e-18 Score=172.29 Aligned_cols=150 Identities=18% Similarity=0.201 Sum_probs=86.2
Q ss_pred cccccccCcccccCCcccCCCCCCCEEEccCCcccCccCcccccCCcceeeccCccccccCCccCcCcCCCcEEEeecCc
Q 004400 20 QKRVLKEQNLTGVLPPKLAELTFLQDIDLTLNYLSGTIPSQWASLPLLNISLIANRLKGPIPKYLANISTLVNLTVQYNQ 99 (756)
Q Consensus 20 ~~l~L~~~~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~l~l~~n~~~~~~p~~l~~l~~L~~L~L~~N~ 99 (756)
+.+++++++++ .+|..+. +.|+.|+|++|+|++ ..+..|.++++|+.|+|++|+
T Consensus 14 ~~v~c~~~~l~-~iP~~l~--~~l~~L~l~~n~i~~-----------------------i~~~~~~~l~~L~~L~Ls~N~ 67 (220)
T 2v9t_B 14 NIVDCRGKGLT-EIPTNLP--ETITEIRLEQNTIKV-----------------------IPPGAFSPYKKLRRIDLSNNQ 67 (220)
T ss_dssp TEEECTTSCCS-SCCSSCC--TTCCEEECCSSCCCE-----------------------ECTTSSTTCTTCCEEECCSSC
T ss_pred CEEEcCCCCcC-cCCCccC--cCCCEEECCCCcCCC-----------------------cCHhHhhCCCCCCEEECCCCc
Confidence 45556666665 3344343 456666666666553 333445555666666666666
Q ss_pred ccccCCcccCCCCCCcEEeccCCeecccCCccccCCCCCCEEEeeCCcccccCChhhcCcCCCcEEEccCCcCcCCCCcc
Q 004400 100 FSGELPEELGSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRISDNQFTGQIPSFIQNWTKLEKLFIQPSGLAGPIPSG 179 (756)
Q Consensus 100 l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~ 179 (756)
|++..|..|.++++|++|+|++|+|+...+..|.++++|+.|+|++|+|++..|..|.++++|+.|+|++|++++..+..
T Consensus 68 i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~ 147 (220)
T 2v9t_B 68 ISELAPDAFQGLRSLNSLVLYGNKITELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGT 147 (220)
T ss_dssp CCEECTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTT
T ss_pred CCCcCHHHhhCCcCCCEEECCCCcCCccCHhHccCCCCCCEEECCCCCCCEeCHHHcCCCCCCCEEECCCCcCCEECHHH
Confidence 66555566666666666666666666444444555666666666666666555566666666666666666666555555
Q ss_pred ccCCCCCCeEEccCCC
Q 004400 180 IFSLENLTDLRISDLN 195 (756)
Q Consensus 180 ~~~l~~L~~L~l~~n~ 195 (756)
+..+++|+.|++++|.
T Consensus 148 ~~~l~~L~~L~L~~N~ 163 (220)
T 2v9t_B 148 FSPLRAIQTMHLAQNP 163 (220)
T ss_dssp TTTCTTCCEEECCSSC
T ss_pred HhCCCCCCEEEeCCCC
Confidence 5555555555555543
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.76 E-value=5e-18 Score=170.33 Aligned_cols=156 Identities=19% Similarity=0.238 Sum_probs=90.3
Q ss_pred ccceeccccccccCcccccCCcccCCCCCCCEEEccCCcccCccCcccccCCcce-eeccCccccccCCccCcCcCCCcE
Q 004400 14 KQKTVNQKRVLKEQNLTGVLPPKLAELTFLQDIDLTLNYLSGTIPSQWASLPLLN-ISLIANRLKGPIPKYLANISTLVN 92 (756)
Q Consensus 14 ~~~~~~~~l~L~~~~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~-l~l~~n~~~~~~p~~l~~l~~L~~ 92 (756)
....+...++.++++++ .+|..+. ++|+.|+|++|.|++..|..|..++.|+ |++.+|++....+..|.++++|+.
T Consensus 16 ~~~Cs~~~v~c~~~~l~-~ip~~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~ 92 (229)
T 3e6j_A 16 QCSCSGTTVDCRSKRHA-SVPAGIP--TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTV 92 (229)
T ss_dssp TCEEETTEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCE
T ss_pred CCEEeCCEeEccCCCcC-ccCCCCC--CCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCCCCcChhhcccCCCcCE
Confidence 33445667888887777 5565554 7788888888888866565555555552 555555554444444555555555
Q ss_pred EEeecCcccccCCcccCCCCCCcEEeccCCeecccCCccccCCCCCCEEEeeCCcccccCChhhcCcCCCcEEEccCCcC
Q 004400 93 LTVQYNQFSGELPEELGSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRISDNQFTGQIPSFIQNWTKLEKLFIQPSGL 172 (756)
Q Consensus 93 L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l 172 (756)
|+|++|+|++..+..|..+++|++|+|++|+|+ .+|..+..+++|+.|+|++|+|++..+..|..+++|+.|+|++|.+
T Consensus 93 L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~ 171 (229)
T 3e6j_A 93 LDLGTNQLTVLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSLTHAYLFGNPW 171 (229)
T ss_dssp EECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC-SCCTTGGGCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCB
T ss_pred EECCCCcCCccChhHhCcchhhCeEeccCCccc-ccCcccccCCCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCCc
Confidence 555555555444444555555555555555555 4455555555555555555555544444455555555555555555
Q ss_pred c
Q 004400 173 A 173 (756)
Q Consensus 173 ~ 173 (756)
.
T Consensus 172 ~ 172 (229)
T 3e6j_A 172 D 172 (229)
T ss_dssp C
T ss_pred c
Confidence 4
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=99.76 E-value=2e-19 Score=210.71 Aligned_cols=190 Identities=18% Similarity=0.172 Sum_probs=123.3
Q ss_pred CCCCEEEccCCcccCccCcccccCCc--c---eeeccCccccccCCccCcCcCCCcEEEeecCcccccCCcccCCCCCCc
Q 004400 41 TFLQDIDLTLNYLSGTIPSQWASLPL--L---NISLIANRLKGPIPKYLANISTLVNLTVQYNQFSGELPEELGSLLNLE 115 (756)
Q Consensus 41 ~~L~~L~L~~n~l~~~~p~~~~~l~~--L---~l~l~~n~~~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~ 115 (756)
+.++.|+|.+|.+.......+..+.. + .+++..|++. ..|..|..++.|+.|+|++|.|. .+|..+.++++|+
T Consensus 173 ~~~~~l~L~~n~~~~~~~~~l~~l~Ls~~~i~~~~~~~n~~~-~~~~~~~~l~~L~~L~Ls~n~l~-~l~~~~~~l~~L~ 250 (727)
T 4b8c_D 173 PLTPKIELFANGKDEANQALLQHKKLSQYSIDEDDDIENRMV-MPKDSKYDDQLWHALDLSNLQIF-NISANIFKYDFLT 250 (727)
T ss_dssp --------------------------------------------------CCCCCCEEECTTSCCS-CCCGGGGGCCSCS
T ss_pred CccceEEeeCCCCCcchhhHhhcCccCcccccCcccccccee-cChhhhccCCCCcEEECCCCCCC-CCChhhcCCCCCC
Confidence 34556666666665322222221111 1 1234445554 67888999999999999999999 7888888999999
Q ss_pred EEeccCCeecccCCccccCCCCCCEEEeeCCcccccCChhhcCcCCCcEEEccCCcCcCCCCccccCCCCCCeEEccCCC
Q 004400 116 KLHLSSNNFTGELPKTFAKLTNMKDFRISDNQFTGQIPSFIQNWTKLEKLFIQPSGLAGPIPSGIFSLENLTDLRISDLN 195 (756)
Q Consensus 116 ~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~n~ 195 (756)
+|+|++|+|+ .+|..|.+|++|+.|+|++|+|+ .+|..|++|++|++|+|++|.|+ .+|..|..+++|+.|+|++|.
T Consensus 251 ~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~-~lp~~~~~l~~L~~L~L~~N~ 327 (727)
T 4b8c_D 251 RLYLNGNSLT-ELPAEIKNLSNLRVLDLSHNRLT-SLPAELGSCFQLKYFYFFDNMVT-TLPWEFGNLCNLQFLGVEGNP 327 (727)
T ss_dssp CCBCTTSCCS-CCCGGGGGGTTCCEEECTTSCCS-SCCSSGGGGTTCSEEECCSSCCC-CCCSSTTSCTTCCCEECTTSC
T ss_pred EEEeeCCcCc-ccChhhhCCCCCCEEeCcCCcCC-ccChhhcCCCCCCEEECCCCCCC-ccChhhhcCCCccEEeCCCCc
Confidence 9999999999 89999999999999999999999 78999999999999999999998 789899999999999999999
Q ss_pred CCCCCcccccccc--ccEEEcccccccCCCCccccCCCCCcEEEccCC
Q 004400 196 GPEATFPQLGNMK--MTKLILRNCNITGELPRYLGKMTKLKVLDLSFN 241 (756)
Q Consensus 196 ~~~~~~~~~~~~~--L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N 241 (756)
+....+..+...+ ...|+|++|.+++.+|.. |..|++++|
T Consensus 328 l~~~~p~~~~~~~~~~~~l~l~~N~l~~~~p~~------l~~l~l~~n 369 (727)
T 4b8c_D 328 LEKQFLKILTEKSVTGLIFYLRDNRPEIPLPHE------RRFIEINTD 369 (727)
T ss_dssp CCSHHHHHHHHHHHHHHHHHHHHCCCCCCCCCC---------------
T ss_pred cCCCChHHHhhcchhhhHHhhccCcccCcCccc------cceeEeecc
Confidence 9887777765543 345778899998888764 445666666
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=99.74 E-value=2.7e-20 Score=211.51 Aligned_cols=189 Identities=16% Similarity=0.142 Sum_probs=109.4
Q ss_pred CCCCCCCEEEccCCcccCccCcccccCCcce-eeccCcc-------------ccccCCccCcCcCCCcEEE-eecCcccc
Q 004400 38 AELTFLQDIDLTLNYLSGTIPSQWASLPLLN-ISLIANR-------------LKGPIPKYLANISTLVNLT-VQYNQFSG 102 (756)
Q Consensus 38 ~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~-l~l~~n~-------------~~~~~p~~l~~l~~L~~L~-L~~N~l~~ 102 (756)
...++|+.|+|++|+|+ .+|..++.++.|+ |++.+|. +.+..|..++++++|+.|+ ++.|.+.
T Consensus 346 ~~~~~L~~L~Ls~n~L~-~Lp~~i~~l~~L~~L~l~~n~~l~~l~~ll~~~~~~~~~~~~l~~l~~L~~L~~l~~n~~~- 423 (567)
T 1dce_A 346 ATDEQLFRCELSVEKST-VLQSELESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFSTLKAVDPMRAAYLD- 423 (567)
T ss_dssp STTTTSSSCCCCHHHHH-HHHHHHHHHHHHHHHCTTCHHHHHHHHHHHHHHCTGGGHHHHHHHHHHHHHHCGGGHHHHH-
T ss_pred ccCccceeccCChhhHH-hhHHHHHHHHHHHHhccccchhhhhHHHHHHhcccccCCHHHHHHHHhcccCcchhhcccc-
Confidence 55677888888888887 7788888777774 5554443 4455555666666666666 4554432
Q ss_pred cCCcccCCCCCCcEEeccCCeecccCCccccCCCCCCEEEeeCCcccccCChhhcCcCCCcEEEccCCcCcCCCCccccC
Q 004400 103 ELPEELGSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRISDNQFTGQIPSFIQNWTKLEKLFIQPSGLAGPIPSGIFS 182 (756)
Q Consensus 103 ~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~ 182 (756)
+|..+.+++|.++...+ ..|+.|+|++|+|++ +|. |+++++|+.|+|++|+|+ .+|..++.
T Consensus 424 ----------~L~~l~l~~n~i~~l~~------~~L~~L~Ls~n~l~~-lp~-~~~l~~L~~L~Ls~N~l~-~lp~~~~~ 484 (567)
T 1dce_A 424 ----------DLRSKFLLENSVLKMEY------ADVRVLHLAHKDLTV-LCH-LEQLLLVTHLDLSHNRLR-ALPPALAA 484 (567)
T ss_dssp ----------HHHHHHHHHHHHHHHHH------TTCSEEECTTSCCSS-CCC-GGGGTTCCEEECCSSCCC-CCCGGGGG
T ss_pred ----------hhhhhhhhcccccccCc------cCceEEEecCCCCCC-CcC-ccccccCcEeecCccccc-ccchhhhc
Confidence 23334444444442111 236667777777764 454 666777777777777776 56666666
Q ss_pred CCCCCeEEccCCCCCCCCccccccccccEEEcccccccCCCCccccCCCCCcEEEccCCcCCCCC-CccCcCCCCCCeEE
Q 004400 183 LENLTDLRISDLNGPEATFPQLGNMKMTKLILRNCNITGELPRYLGKMTKLKVLDLSFNRLRGQI-PSNFDDLYDVDYIY 261 (756)
Q Consensus 183 l~~L~~L~l~~n~~~~~~~~~~~~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~-p~~~~~l~~L~~L~ 261 (756)
+++|+.|+|++| .|++ +| .|+++++|+.|+|++|+|++.. |..|..+++|+.|+
T Consensus 485 l~~L~~L~Ls~N-----------------------~l~~-lp-~l~~l~~L~~L~Ls~N~l~~~~~p~~l~~l~~L~~L~ 539 (567)
T 1dce_A 485 LRCLEVLQASDN-----------------------ALEN-VD-GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLN 539 (567)
T ss_dssp CTTCCEEECCSS-----------------------CCCC-CG-GGTTCSSCCEEECCSSCCCSSSTTGGGGGCTTCCEEE
T ss_pred CCCCCEEECCCC-----------------------CCCC-Cc-ccCCCCCCcEEECCCCCCCCCCCcHHHhcCCCCCEEE
Confidence 666666555544 3333 23 4455555555555555555444 55555555555555
Q ss_pred ecCccccccCC
Q 004400 262 FAGNLLTGAIP 272 (756)
Q Consensus 262 ls~N~l~~~~p 272 (756)
|++|++++..|
T Consensus 540 L~~N~l~~~~~ 550 (567)
T 1dce_A 540 LQGNSLCQEEG 550 (567)
T ss_dssp CTTSGGGGSSS
T ss_pred ecCCcCCCCcc
Confidence 55555554433
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.74 E-value=6.9e-18 Score=165.14 Aligned_cols=157 Identities=20% Similarity=0.284 Sum_probs=122.2
Q ss_pred cCcCcCCCcEEEeecCcccccCCcccCCCCCCcEEeccCCeecccCCccccCCCCCCEEEeeCCcccccCChhhcCcCCC
Q 004400 83 YLANISTLVNLTVQYNQFSGELPEELGSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRISDNQFTGQIPSFIQNWTKL 162 (756)
Q Consensus 83 ~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L 162 (756)
....+++|+.|++++|.|+ .+| .+..+++|++|+|++|.++ .+..+..+++|+.|++++|++++..+..|+++++|
T Consensus 39 ~~~~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~l~~n~~~--~~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L 114 (197)
T 4ezg_A 39 TEAQMNSLTYITLANINVT-DLT-GIEYAHNIKDLTINNIHAT--NYNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSL 114 (197)
T ss_dssp BHHHHHTCCEEEEESSCCS-CCT-TGGGCTTCSEEEEESCCCS--CCGGGTTCTTCCEEEEECTTCBGGGSCCCTTCTTC
T ss_pred ChhhcCCccEEeccCCCcc-ChH-HHhcCCCCCEEEccCCCCC--cchhhhcCCCCCEEEeECCccCcccChhhcCCCCC
Confidence 3477889999999999998 666 6889999999999999776 34478889999999999999998788889999999
Q ss_pred cEEEccCCcCcCCCCccccCCCCCCeEEccCCCCCCCCccccccccccEEEcccccccCCCCccccCCCCCcEEEccCCc
Q 004400 163 EKLFIQPSGLAGPIPSGIFSLENLTDLRISDLNGPEATFPQLGNMKMTKLILRNCNITGELPRYLGKMTKLKVLDLSFNR 242 (756)
Q Consensus 163 ~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~ 242 (756)
++|+|++|++++..|..+..+++|+.|++++|.. ++ .+| .+..+++|+.|++++|.
T Consensus 115 ~~L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~~----------------------i~-~~~-~l~~l~~L~~L~l~~n~ 170 (197)
T 4ezg_A 115 TLLDISHSAHDDSILTKINTLPKVNSIDLSYNGA----------------------IT-DIM-PLKTLPELKSLNIQFDG 170 (197)
T ss_dssp CEEECCSSBCBGGGHHHHTTCSSCCEEECCSCTB----------------------CC-CCG-GGGGCSSCCEEECTTBC
T ss_pred CEEEecCCccCcHhHHHHhhCCCCCEEEccCCCC----------------------cc-ccH-hhcCCCCCCEEECCCCC
Confidence 9999999999877788888888888777666541 22 233 46777788888888888
Q ss_pred CCCCCCccCcCCCCCCeEEecCccccc
Q 004400 243 LRGQIPSNFDDLYDVDYIYFAGNLLTG 269 (756)
Q Consensus 243 l~~~~p~~~~~l~~L~~L~ls~N~l~~ 269 (756)
+++ ++ .+..+++|+.|++++|++.+
T Consensus 171 i~~-~~-~l~~l~~L~~L~l~~N~i~~ 195 (197)
T 4ezg_A 171 VHD-YR-GIEDFPKLNQLYAFSQTIGG 195 (197)
T ss_dssp CCC-CT-TGGGCSSCCEEEECBC----
T ss_pred CcC-hH-HhccCCCCCEEEeeCcccCC
Confidence 775 33 57777888888888887753
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.73 E-value=2.8e-18 Score=175.97 Aligned_cols=169 Identities=19% Similarity=0.282 Sum_probs=108.8
Q ss_pred ccceeccccccccCcccccCCcccCCCCCCCEEEccCCcccCccCcccccCCcc-eeeccCccccccCCccCcCcCCCcE
Q 004400 14 KQKTVNQKRVLKEQNLTGVLPPKLAELTFLQDIDLTLNYLSGTIPSQWASLPLL-NISLIANRLKGPIPKYLANISTLVN 92 (756)
Q Consensus 14 ~~~~~~~~l~L~~~~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L-~l~l~~n~~~~~~p~~l~~l~~L~~ 92 (756)
.++..+..+.|+++++++.. .+..+++|+.|++++|.|+ .++ .+..++.| .|++.+|++.+..+ |.++++|+.
T Consensus 16 ~~l~~l~~l~l~~~~i~~~~--~~~~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~L~~N~i~~~~~--l~~l~~L~~ 89 (263)
T 1xeu_A 16 PGLANAVKQNLGKQSVTDLV--SQKELSGVQNFNGDNSNIQ-SLA-GMQFFTNLKELHLSHNQISDLSP--LKDLTKLEE 89 (263)
T ss_dssp HHHHHHHHHHHTCSCTTSEE--CHHHHTTCSEEECTTSCCC-CCT-TGGGCTTCCEEECCSSCCCCCGG--GTTCSSCCE
T ss_pred HHHHHHHHHHhcCCCccccc--chhhcCcCcEEECcCCCcc-cch-HHhhCCCCCEEECCCCccCCChh--hccCCCCCE
Confidence 46777888899999998664 5788899999999999998 444 45666666 36666666664433 666666666
Q ss_pred EEeecCcccccCCcccCCCCCCcEEeccCCeecccCCccccCCCCCCEEEeeCCcccccCChhhcCcCCCcEEEccCCcC
Q 004400 93 LTVQYNQFSGELPEELGSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRISDNQFTGQIPSFIQNWTKLEKLFIQPSGL 172 (756)
Q Consensus 93 L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l 172 (756)
|+|++|+|++ +|. +.. ++|+.|+|++|++++ ++ .+..+++|+.|+|++|++++. + .+..+++|+.|+|++|++
T Consensus 90 L~L~~N~l~~-l~~-~~~-~~L~~L~L~~N~l~~-~~-~l~~l~~L~~L~Ls~N~i~~~-~-~l~~l~~L~~L~L~~N~i 162 (263)
T 1xeu_A 90 LSVNRNRLKN-LNG-IPS-ACLSRLFLDNNELRD-TD-SLIHLKNLEILSIRNNKLKSI-V-MLGFLSKLEVLDLHGNEI 162 (263)
T ss_dssp EECCSSCCSC-CTT-CCC-SSCCEEECCSSCCSB-SG-GGTTCTTCCEEECTTSCCCBC-G-GGGGCTTCCEEECTTSCC
T ss_pred EECCCCccCC-cCc-ccc-CcccEEEccCCccCC-Ch-hhcCcccccEEECCCCcCCCC-h-HHccCCCCCEEECCCCcC
Confidence 6666666663 332 222 666666666666663 22 366666666666666666643 3 466666666666666666
Q ss_pred cCCCCccccCCCCCCeEEccCCCCC
Q 004400 173 AGPIPSGIFSLENLTDLRISDLNGP 197 (756)
Q Consensus 173 ~~~~p~~~~~l~~L~~L~l~~n~~~ 197 (756)
++. ..+..+++|+.|++++|.+.
T Consensus 163 ~~~--~~l~~l~~L~~L~l~~N~~~ 185 (263)
T 1xeu_A 163 TNT--GGLTRLKKVNWIDLTGQKCV 185 (263)
T ss_dssp CBC--TTSTTCCCCCEEEEEEEEEE
T ss_pred cch--HHhccCCCCCEEeCCCCccc
Confidence 643 44555555555555554443
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=99.73 E-value=9.5e-20 Score=206.95 Aligned_cols=187 Identities=17% Similarity=0.157 Sum_probs=135.4
Q ss_pred cCcCCCcEEEeecCcccccCCcccCCCCCCcEEeccCCe-------------ecccCCccccCCCCCCEEE-eeCCcccc
Q 004400 85 ANISTLVNLTVQYNQFSGELPEELGSLLNLEKLHLSSNN-------------FTGELPKTFAKLTNMKDFR-ISDNQFTG 150 (756)
Q Consensus 85 ~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~-------------l~~~~p~~~~~l~~L~~L~-L~~N~l~~ 150 (756)
..+++|+.|+|++|+|+ .+|.++++|++|+.|++++|. +.+.+|..++.+++|+.|+ ++.|.+.
T Consensus 346 ~~~~~L~~L~Ls~n~L~-~Lp~~i~~l~~L~~L~l~~n~~l~~l~~ll~~~~~~~~~~~~l~~l~~L~~L~~l~~n~~~- 423 (567)
T 1dce_A 346 ATDEQLFRCELSVEKST-VLQSELESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFSTLKAVDPMRAAYLD- 423 (567)
T ss_dssp STTTTSSSCCCCHHHHH-HHHHHHHHHHHHHHHCTTCHHHHHHHHHHHHHHCTGGGHHHHHHHHHHHHHHCGGGHHHHH-
T ss_pred ccCccceeccCChhhHH-hhHHHHHHHHHHHHhccccchhhhhHHHHHHhcccccCCHHHHHHHHhcccCcchhhcccc-
Confidence 56788888889998887 788888888888888887765 4455666666666666666 5555433
Q ss_pred cCChhhcCcCCCcEEEccCCcCcCCCCccccCCCCCCeEEccCCCCCCCCccccccc-cccEEEcccccccCCCCccccC
Q 004400 151 QIPSFIQNWTKLEKLFIQPSGLAGPIPSGIFSLENLTDLRISDLNGPEATFPQLGNM-KMTKLILRNCNITGELPRYLGK 229 (756)
Q Consensus 151 ~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~-~L~~L~L~~n~l~~~~p~~~~~ 229 (756)
.|..+.+.+|.++...+ ..|+.|++++|.+..++. ++.+ +|+.|+|++|.|+ .+|..|++
T Consensus 424 ----------~L~~l~l~~n~i~~l~~------~~L~~L~Ls~n~l~~lp~--~~~l~~L~~L~Ls~N~l~-~lp~~~~~ 484 (567)
T 1dce_A 424 ----------DLRSKFLLENSVLKMEY------ADVRVLHLAHKDLTVLCH--LEQLLLVTHLDLSHNRLR-ALPPALAA 484 (567)
T ss_dssp ----------HHHHHHHHHHHHHHHHH------TTCSEEECTTSCCSSCCC--GGGGTTCCEEECCSSCCC-CCCGGGGG
T ss_pred ----------hhhhhhhhcccccccCc------cCceEEEecCCCCCCCcC--ccccccCcEeecCccccc-ccchhhhc
Confidence 11122222333321111 135555555555555322 3333 4666777788888 77889999
Q ss_pred CCCCcEEEccCCcCCCCCCccCcCCCCCCeEEecCccccccC-Cchh--hcCCCeeEeecCCCCCCCC
Q 004400 230 MTKLKVLDLSFNRLRGQIPSNFDDLYDVDYIYFAGNLLTGAI-PPWM--LERGDKIDLSYNNFTDGSA 294 (756)
Q Consensus 230 l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~-p~~~--~~~l~~l~ls~N~l~~~~~ 294 (756)
+++|+.|+|++|.|++ +| .+..+++|+.|+|++|.+++.. |..+ +++|+.|++++|++++.++
T Consensus 485 l~~L~~L~Ls~N~l~~-lp-~l~~l~~L~~L~Ls~N~l~~~~~p~~l~~l~~L~~L~L~~N~l~~~~~ 550 (567)
T 1dce_A 485 LRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEG 550 (567)
T ss_dssp CTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSSCCCSSSTTGGGGGCTTCCEEECTTSGGGGSSS
T ss_pred CCCCCEEECCCCCCCC-Cc-ccCCCCCCcEEECCCCCCCCCCCcHHHhcCCCCCEEEecCCcCCCCcc
Confidence 9999999999999996 67 8999999999999999999886 8777 8899999999999987654
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.73 E-value=4.4e-18 Score=174.52 Aligned_cols=164 Identities=23% Similarity=0.387 Sum_probs=102.8
Q ss_pred eeccCccccccCCccCcCcCCCcEEEeecCcccccCCcccCCCCCCcEEeccCCeecccCCccccCCCCCCEEEeeCCcc
Q 004400 69 ISLIANRLKGPIPKYLANISTLVNLTVQYNQFSGELPEELGSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRISDNQF 148 (756)
Q Consensus 69 l~l~~n~~~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l 148 (756)
+.+..|.+.... .+.++++|+.|++++|.|+ .++ .+..+++|++|+|++|++++..+ +..+++|+.|+|++|++
T Consensus 24 l~l~~~~i~~~~--~~~~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~L~~N~i~~~~~--l~~l~~L~~L~L~~N~l 97 (263)
T 1xeu_A 24 QNLGKQSVTDLV--SQKELSGVQNFNGDNSNIQ-SLA-GMQFFTNLKELHLSHNQISDLSP--LKDLTKLEELSVNRNRL 97 (263)
T ss_dssp HHHTCSCTTSEE--CHHHHTTCSEEECTTSCCC-CCT-TGGGCTTCCEEECCSSCCCCCGG--GTTCSSCCEEECCSSCC
T ss_pred HHhcCCCccccc--chhhcCcCcEEECcCCCcc-cch-HHhhCCCCCEEECCCCccCCChh--hccCCCCCEEECCCCcc
Confidence 455555555332 4566666666666666666 344 46666666666666666664333 66666666666666666
Q ss_pred cccCChhhcCcCCCcEEEccCCcCcCCCCccccCCCCCCeEEccCCCCCCCCccccccccccEEEcccccccCCCCcccc
Q 004400 149 TGQIPSFIQNWTKLEKLFIQPSGLAGPIPSGIFSLENLTDLRISDLNGPEATFPQLGNMKMTKLILRNCNITGELPRYLG 228 (756)
Q Consensus 149 ~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~L~~L~L~~n~l~~~~p~~~~ 228 (756)
++ +|.. .. ++|+.|+|++|++++. ..+..+++|+ .|+|++|++++. + .+.
T Consensus 98 ~~-l~~~-~~-~~L~~L~L~~N~l~~~--~~l~~l~~L~-----------------------~L~Ls~N~i~~~-~-~l~ 147 (263)
T 1xeu_A 98 KN-LNGI-PS-ACLSRLFLDNNELRDT--DSLIHLKNLE-----------------------ILSIRNNKLKSI-V-MLG 147 (263)
T ss_dssp SC-CTTC-CC-SSCCEEECCSSCCSBS--GGGTTCTTCC-----------------------EEECTTSCCCBC-G-GGG
T ss_pred CC-cCcc-cc-CcccEEEccCCccCCC--hhhcCccccc-----------------------EEECCCCcCCCC-h-HHc
Confidence 63 3322 22 5566666666666532 2344444444 455555666644 2 577
Q ss_pred CCCCCcEEEccCCcCCCCCCccCcCCCCCCeEEecCcccccc
Q 004400 229 KMTKLKVLDLSFNRLRGQIPSNFDDLYDVDYIYFAGNLLTGA 270 (756)
Q Consensus 229 ~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~ 270 (756)
.+++|+.|+|++|++++. ..+..+++|+.|++++|++++.
T Consensus 148 ~l~~L~~L~L~~N~i~~~--~~l~~l~~L~~L~l~~N~~~~~ 187 (263)
T 1xeu_A 148 FLSKLEVLDLHGNEITNT--GGLTRLKKVNWIDLTGQKCVNE 187 (263)
T ss_dssp GCTTCCEEECTTSCCCBC--TTSTTCCCCCEEEEEEEEEECC
T ss_pred cCCCCCEEECCCCcCcch--HHhccCCCCCEEeCCCCcccCC
Confidence 888888888888888865 6688888888888888888754
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.71 E-value=2.8e-17 Score=160.78 Aligned_cols=151 Identities=17% Similarity=0.184 Sum_probs=95.7
Q ss_pred CCCCCCCEEEccCCcccCccCcccccCCcce-eeccCccccccCCccCcCcCCCcEEEeecCcccccCCcccCCCCCCcE
Q 004400 38 AELTFLQDIDLTLNYLSGTIPSQWASLPLLN-ISLIANRLKGPIPKYLANISTLVNLTVQYNQFSGELPEELGSLLNLEK 116 (756)
Q Consensus 38 ~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~-l~l~~n~~~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~ 116 (756)
..+++|+.|++++|.++ .+| .+..++.|+ |++.+|.+. .+..+..+++|++|+|++|++++..+..|+.+++|++
T Consensus 41 ~~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~l~~n~~~--~~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~ 116 (197)
T 4ezg_A 41 AQMNSLTYITLANINVT-DLT-GIEYAHNIKDLTINNIHAT--NYNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTL 116 (197)
T ss_dssp HHHHTCCEEEEESSCCS-CCT-TGGGCTTCSEEEEESCCCS--CCGGGTTCTTCCEEEEECTTCBGGGSCCCTTCTTCCE
T ss_pred hhcCCccEEeccCCCcc-ChH-HHhcCCCCCEEEccCCCCC--cchhhhcCCCCCEEEeECCccCcccChhhcCCCCCCE
Confidence 56677888888888887 444 455666553 556655433 2335666667777777777776656666666777777
Q ss_pred EeccCCeecccCCccccCCCCCCEEEeeCCc-ccccCChhhcCcCCCcEEEccCCcCcCCCCccccCCCCCCeEEccCCC
Q 004400 117 LHLSSNNFTGELPKTFAKLTNMKDFRISDNQ-FTGQIPSFIQNWTKLEKLFIQPSGLAGPIPSGIFSLENLTDLRISDLN 195 (756)
Q Consensus 117 L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~-l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~n~ 195 (756)
|+|++|++++..|..+..+++|++|+|++|+ ++ .+| .+.++++|+.|++++|++++ ++ .+..+++|+.|++++|.
T Consensus 117 L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~~i~-~~~-~l~~l~~L~~L~l~~n~i~~-~~-~l~~l~~L~~L~l~~N~ 192 (197)
T 4ezg_A 117 LDISHSAHDDSILTKINTLPKVNSIDLSYNGAIT-DIM-PLKTLPELKSLNIQFDGVHD-YR-GIEDFPKLNQLYAFSQT 192 (197)
T ss_dssp EECCSSBCBGGGHHHHTTCSSCCEEECCSCTBCC-CCG-GGGGCSSCCEEECTTBCCCC-CT-TGGGCSSCCEEEECBC-
T ss_pred EEecCCccCcHhHHHHhhCCCCCEEEccCCCCcc-ccH-hhcCCCCCCEEECCCCCCcC-hH-HhccCCCCCEEEeeCcc
Confidence 7777777766566666666777777777776 44 444 46666667777777766663 33 55666666666666655
Q ss_pred C
Q 004400 196 G 196 (756)
Q Consensus 196 ~ 196 (756)
+
T Consensus 193 i 193 (197)
T 4ezg_A 193 I 193 (197)
T ss_dssp -
T ss_pred c
Confidence 4
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=99.70 E-value=1.9e-17 Score=161.21 Aligned_cols=81 Identities=16% Similarity=0.316 Sum_probs=42.4
Q ss_pred cEEEeecCcccccCCcccCCCCCCcEEeccCCeecccCCc-cccCCCCCCEEEeeCCcccccCChhhcCcCCCcEEEccC
Q 004400 91 VNLTVQYNQFSGELPEELGSLLNLEKLHLSSNNFTGELPK-TFAKLTNMKDFRISDNQFTGQIPSFIQNWTKLEKLFIQP 169 (756)
Q Consensus 91 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~-~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~ 169 (756)
+.|++++|+++ .+|..+.. +|++|+|++|+|++..+. .|..+++|+.|+|++|+|++..|..|.++++|++|+|++
T Consensus 11 ~~l~~s~~~l~-~ip~~~~~--~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~ 87 (192)
T 1w8a_A 11 TTVDCTGRGLK-EIPRDIPL--HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGE 87 (192)
T ss_dssp TEEECTTSCCS-SCCSCCCT--TCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred CEEEcCCCCcC-cCccCCCC--CCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECCC
Confidence 45555555554 44544433 555555555555543332 255555555555555555555555555555555555555
Q ss_pred CcCcC
Q 004400 170 SGLAG 174 (756)
Q Consensus 170 N~l~~ 174 (756)
|++++
T Consensus 88 N~l~~ 92 (192)
T 1w8a_A 88 NKIKE 92 (192)
T ss_dssp CCCCE
T ss_pred CcCCc
Confidence 55443
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=99.69 E-value=4.6e-17 Score=158.54 Aligned_cols=153 Identities=17% Similarity=0.248 Sum_probs=118.4
Q ss_pred cEEeccCCeecccCCccccCCCCCCEEEeeCCcccccCCh-hhcCcCCCcEEEccCCcCcCCCCccccCCCCCCeEEccC
Q 004400 115 EKLHLSSNNFTGELPKTFAKLTNMKDFRISDNQFTGQIPS-FIQNWTKLEKLFIQPSGLAGPIPSGIFSLENLTDLRISD 193 (756)
Q Consensus 115 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~-~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~ 193 (756)
+.|++++|+|+ .+|..+.. +|++|+|++|+|++..+. .|.++++|++|+|++|++++..|..|.++++|++|+++
T Consensus 11 ~~l~~s~~~l~-~ip~~~~~--~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls- 86 (192)
T 1w8a_A 11 TTVDCTGRGLK-EIPRDIPL--HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLG- 86 (192)
T ss_dssp TEEECTTSCCS-SCCSCCCT--TCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECC-
T ss_pred CEEEcCCCCcC-cCccCCCC--CCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECC-
Confidence 78899999997 77776643 899999999999866654 48889999999999999988888888888877776655
Q ss_pred CCCCCCCccccccccccEEEcccccccCCCCccccCCCCCcEEEccCCcCCCCCCccCcCCCCCCeEEecCccccccCCc
Q 004400 194 LNGPEATFPQLGNMKMTKLILRNCNITGELPRYLGKMTKLKVLDLSFNRLRGQIPSNFDDLYDVDYIYFAGNLLTGAIPP 273 (756)
Q Consensus 194 n~~~~~~~~~~~~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~ 273 (756)
+|++++..+..|.++++|++|+|++|+|++..|..|..+++|++|+|++|+++|.++.
T Consensus 87 ----------------------~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~l 144 (192)
T 1w8a_A 87 ----------------------ENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHL 144 (192)
T ss_dssp ----------------------SCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGGG
T ss_pred ----------------------CCcCCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEEeCCCCccCcCcc
Confidence 5666667777788899999999999999988899999999999999999999988774
Q ss_pred hh-hcCCCeeEeecCCCCCCC
Q 004400 274 WM-LERGDKIDLSYNNFTDGS 293 (756)
Q Consensus 274 ~~-~~~l~~l~ls~N~l~~~~ 293 (756)
.. ...++...+.++...|..
T Consensus 145 ~~~~~~l~~~~~~~~~~~C~~ 165 (192)
T 1w8a_A 145 AWFAEWLRKKSLNGGAARCGA 165 (192)
T ss_dssp HHHHHHHHHHCCSGGGCBBCS
T ss_pred hHHHHHHHHcCCCCCCCCCCC
Confidence 32 233333334444444433
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=99.69 E-value=7e-18 Score=197.62 Aligned_cols=190 Identities=19% Similarity=0.129 Sum_probs=112.7
Q ss_pred eeccccccccCcccccCCcccCCCCCCC-----EEEccCCcccCccCcccccCCcce-eeccCccccccCCccCcCcCCC
Q 004400 17 TVNQKRVLKEQNLTGVLPPKLAELTFLQ-----DIDLTLNYLSGTIPSQWASLPLLN-ISLIANRLKGPIPKYLANISTL 90 (756)
Q Consensus 17 ~~~~~l~L~~~~l~~~~p~~l~~l~~L~-----~L~L~~n~l~~~~p~~~~~l~~L~-l~l~~n~~~~~~p~~l~~l~~L 90 (756)
....+|.|.+|++... +..+.....|. .++++.|.+. ..|..+..++.|+ |+|.+|++. .+|..+.++++|
T Consensus 173 ~~~~~l~L~~n~~~~~-~~~~l~~l~Ls~~~i~~~~~~~n~~~-~~~~~~~~l~~L~~L~Ls~n~l~-~l~~~~~~l~~L 249 (727)
T 4b8c_D 173 PLTPKIELFANGKDEA-NQALLQHKKLSQYSIDEDDDIENRMV-MPKDSKYDDQLWHALDLSNLQIF-NISANIFKYDFL 249 (727)
T ss_dssp ---------------------------------------------------CCCCCCEEECTTSCCS-CCCGGGGGCCSC
T ss_pred CccceEEeeCCCCCcc-hhhHhhcCccCcccccCcccccccee-cChhhhccCCCCcEEECCCCCCC-CCChhhcCCCCC
Confidence 3467788888888753 43332222222 2233334444 5577788888884 788888877 777777788999
Q ss_pred cEEEeecCcccccCCcccCCCCCCcEEeccCCeecccCCccccCCCCCCEEEeeCCcccccCChhhcCcCCCcEEEccCC
Q 004400 91 VNLTVQYNQFSGELPEELGSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRISDNQFTGQIPSFIQNWTKLEKLFIQPS 170 (756)
Q Consensus 91 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N 170 (756)
+.|+|++|.|+ .+|..|++|++|++|+|++|+|+ .+|..|.+|++|+.|+|++|.|+ .+|..|+++++|+.|+|++|
T Consensus 250 ~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~-~lp~~~~~l~~L~~L~L~~N 326 (727)
T 4b8c_D 250 TRLYLNGNSLT-ELPAEIKNLSNLRVLDLSHNRLT-SLPAELGSCFQLKYFYFFDNMVT-TLPWEFGNLCNLQFLGVEGN 326 (727)
T ss_dssp SCCBCTTSCCS-CCCGGGGGGTTCCEEECTTSCCS-SCCSSGGGGTTCSEEECCSSCCC-CCCSSTTSCTTCCCEECTTS
T ss_pred CEEEeeCCcCc-ccChhhhCCCCCCEEeCcCCcCC-ccChhhcCCCCCCEEECCCCCCC-ccChhhhcCCCccEEeCCCC
Confidence 99999999998 88888999999999999999998 77888989999999999999988 77888999999999999999
Q ss_pred cCcCCCCccccCCCC-CCeEEccCCCCCCCCccccccccccEEEcccc
Q 004400 171 GLAGPIPSGIFSLEN-LTDLRISDLNGPEATFPQLGNMKMTKLILRNC 217 (756)
Q Consensus 171 ~l~~~~p~~~~~l~~-L~~L~l~~n~~~~~~~~~~~~~~L~~L~L~~n 217 (756)
+|++.+|..+..+.. +..|++++|.+....+.. +..|+++.|
T Consensus 327 ~l~~~~p~~~~~~~~~~~~l~l~~N~l~~~~p~~-----l~~l~l~~n 369 (727)
T 4b8c_D 327 PLEKQFLKILTEKSVTGLIFYLRDNRPEIPLPHE-----RRFIEINTD 369 (727)
T ss_dssp CCCSHHHHHHHHHHHHHHHHHHHHCCCCCCCCCC--------------
T ss_pred ccCCCChHHHhhcchhhhHHhhccCcccCcCccc-----cceeEeecc
Confidence 998888877765432 234678888887665543 455666666
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* | Back alignment and structure |
|---|
Probab=99.68 E-value=2.9e-18 Score=197.57 Aligned_cols=276 Identities=13% Similarity=0.084 Sum_probs=173.5
Q ss_pred ccceeccccccccCcc---cccCCcccC------------CCCCCCEEEccCCcccCccCcccccC--Ccc-eeeccCcc
Q 004400 14 KQKTVNQKRVLKEQNL---TGVLPPKLA------------ELTFLQDIDLTLNYLSGTIPSQWASL--PLL-NISLIANR 75 (756)
Q Consensus 14 ~~~~~~~~l~L~~~~l---~~~~p~~l~------------~l~~L~~L~L~~n~l~~~~p~~~~~l--~~L-~l~l~~n~ 75 (756)
..+..+++|+|+++.. .+.+|..+. .+++|+.|+|++|.+++..+..+... +.| .|++.+|.
T Consensus 70 ~~~~~L~~L~L~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~~L~~L~L~~~~ 149 (592)
T 3ogk_B 70 RRFPNLRSLKLKGKPRAAMFNLIPENWGGYVTPWVTEISNNLRQLKSVHFRRMIVSDLDLDRLAKARADDLETLKLDKCS 149 (592)
T ss_dssp HHCTTCSEEEEECSCGGGGGTCSCTTSCCBCHHHHHHHHHHCTTCCEEEEESCBCCHHHHHHHHHHHGGGCCEEEEESCE
T ss_pred HhCCCCeEEEecCCcchhhcccccccccccchHHHHHHHhhCCCCCeEEeeccEecHHHHHHHHHhccccCcEEECcCCC
Confidence 4455677777766532 133443333 67788888888888776666555543 325 36666654
Q ss_pred -ccc-cCCccCcCcCCCcEEEeecCccccc----CCcccCCCCCCcEEeccCCeec----ccCCccccCCCCCCEEEeeC
Q 004400 76 -LKG-PIPKYLANISTLVNLTVQYNQFSGE----LPEELGSLLNLEKLHLSSNNFT----GELPKTFAKLTNMKDFRISD 145 (756)
Q Consensus 76 -~~~-~~p~~l~~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~L~~N~l~----~~~p~~~~~l~~L~~L~L~~ 145 (756)
+.. .++..+.++++|++|+|++|.+++. ++..+.++++|++|+|++|+++ +.++..+.++++|+.|+|++
T Consensus 150 ~~~~~~l~~~~~~~~~L~~L~L~~~~~~~~~~~~l~~~~~~~~~L~~L~L~~n~~~~~~~~~l~~~~~~~~~L~~L~L~~ 229 (592)
T 3ogk_B 150 GFTTDGLLSIVTHCRKIKTLLMEESSFSEKDGKWLHELAQHNTSLEVLNFYMTEFAKISPKDLETIARNCRSLVSVKVGD 229 (592)
T ss_dssp EEEHHHHHHHHHHCTTCSEEECTTCEEECCCSHHHHHHHHHCCCCCEEECTTCCCSSCCHHHHHHHHHHCTTCCEEECSS
T ss_pred CcCHHHHHHHHhhCCCCCEEECccccccCcchhHHHHHHhcCCCccEEEeeccCCCccCHHHHHHHHhhCCCCcEEeccC
Confidence 211 1233334678888888888887755 3334556788888888888886 33444556778888888888
Q ss_pred CcccccCChhhcCcCCCcEEEccCCcCc---CCCCccccCCCCCCeEEccCCCCCCCCcccccc-ccccEEEcccccccC
Q 004400 146 NQFTGQIPSFIQNWTKLEKLFIQPSGLA---GPIPSGIFSLENLTDLRISDLNGPEATFPQLGN-MKMTKLILRNCNITG 221 (756)
Q Consensus 146 N~l~~~~p~~~~~l~~L~~L~l~~N~l~---~~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~-~~L~~L~L~~n~l~~ 221 (756)
|.+.+ +|..+.++++|++|.++.+... +..+..+..+++|+.|+++++..... +..+.. .+|++|+|++|.+++
T Consensus 230 ~~~~~-l~~~~~~~~~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~l~~~~~~~l-~~~~~~~~~L~~L~Ls~~~l~~ 307 (592)
T 3ogk_B 230 FEILE-LVGFFKAAANLEEFCGGSLNEDIGMPEKYMNLVFPRKLCRLGLSYMGPNEM-PILFPFAAQIRKLDLLYALLET 307 (592)
T ss_dssp CBGGG-GHHHHHHCTTCCEEEECBCCCCTTCTTSSSCCCCCTTCCEEEETTCCTTTG-GGGGGGGGGCCEEEETTCCCCH
T ss_pred ccHHH-HHHHHhhhhHHHhhcccccccccchHHHHHHhhccccccccCccccchhHH-HHHHhhcCCCcEEecCCCcCCH
Confidence 88874 6677888888888888754332 23455667777888888776433222 222332 358888888887654
Q ss_pred CCC-ccccCCCCCcEEEccCCcCCCCCCccCcCCCCCCeEEecC-----------ccccccCCchh---hcCCCeeEeec
Q 004400 222 ELP-RYLGKMTKLKVLDLSFNRLRGQIPSNFDDLYDVDYIYFAG-----------NLLTGAIPPWM---LERGDKIDLSY 286 (756)
Q Consensus 222 ~~p-~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~-----------N~l~~~~p~~~---~~~l~~l~ls~ 286 (756)
... ..+..+++|+.|+|++|...+.++..+..+++|+.|++++ |.+++.....+ +++|+.|+++.
T Consensus 308 ~~~~~~~~~~~~L~~L~L~~~~~~~~l~~~~~~~~~L~~L~L~~g~~~~~~~~~~~~~~~~~~~~l~~~~~~L~~L~l~~ 387 (592)
T 3ogk_B 308 EDHCTLIQKCPNLEVLETRNVIGDRGLEVLAQYCKQLKRLRIERGADEQGMEDEEGLVSQRGLIALAQGCQELEYMAVYV 387 (592)
T ss_dssp HHHHHHHTTCTTCCEEEEEGGGHHHHHHHHHHHCTTCCEEEEECCCCSSTTSSTTCCCCHHHHHHHHHHCTTCSEEEEEE
T ss_pred HHHHHHHHhCcCCCEEeccCccCHHHHHHHHHhCCCCCEEEeecCccccccccccCccCHHHHHHHHhhCccCeEEEeec
Confidence 433 3356788888888874332333344445677788888883 55553322221 56778888877
Q ss_pred CCCCC
Q 004400 287 NNFTD 291 (756)
Q Consensus 287 N~l~~ 291 (756)
|.+++
T Consensus 388 ~~l~~ 392 (592)
T 3ogk_B 388 SDITN 392 (592)
T ss_dssp SCCCH
T ss_pred CCccH
Confidence 77664
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.65 E-value=2.5e-17 Score=174.78 Aligned_cols=137 Identities=12% Similarity=0.149 Sum_probs=99.2
Q ss_pred CccccCcccCCCCccEEEeeccCCcEEEEEEccccCc--------------ccHHH--------HHHHHHHHHhCCCCce
Q 004400 417 NFATDNNIGEGGFGPVYKGLLADGTAIAVKQLSSKSK--------------QGNRE--------FINEIGMISALQHPNL 474 (756)
Q Consensus 417 ~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~--------------~~~~~--------~~~E~~~l~~l~h~ni 474 (756)
-|.+...||+|+||.||+|...+|+.||||+++.... ..... ..+|...|.++.+.++
T Consensus 96 iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv 175 (397)
T 4gyi_A 96 VYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGF 175 (397)
T ss_dssp CSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred EEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCC
Confidence 3889999999999999999988999999998753210 00111 2345666666644443
Q ss_pred eeEeeEEEeCCeEEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCC
Q 004400 475 VKLYGCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLN 554 (756)
Q Consensus 475 v~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~ 554 (756)
.-..-+... ..++||||++|++|.++. +......++.|++.+|.|||+.| ||||||||.|||+++++.
T Consensus 176 ~vp~p~~~~--~~~LVME~i~G~~L~~l~-------~~~~~~~l~~qll~~l~~lH~~g---IVHrDLKp~NILl~~dgd 243 (397)
T 4gyi_A 176 PVPEPIAQS--RHTIVMSLVDALPMRQVS-------SVPDPASLYADLIALILRLAKHG---LIHGDFNEFNILIREEKD 243 (397)
T ss_dssp SCCCEEEEE--TTEEEEECCSCEEGGGCC-------CCSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEEEEEC
T ss_pred CCCeeeecc--CceEEEEecCCccHhhhc-------ccHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEeCCCC
Confidence 211111111 237999999998875432 22345678899999999999997 999999999999988763
Q ss_pred ----------EEEccCCcccc
Q 004400 555 ----------SKISDFGLAKL 565 (756)
Q Consensus 555 ----------~kl~DFGla~~ 565 (756)
+.|+||+.+..
T Consensus 244 ~~d~~~~~~~~~iID~~Q~V~ 264 (397)
T 4gyi_A 244 AEDPSSITLTPIIIXFPQMVS 264 (397)
T ss_dssp SSCTTSEEEEEEECCCTTCEE
T ss_pred cccccccccceEEEEeCCccc
Confidence 89999998864
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* | Back alignment and structure |
|---|
Probab=99.64 E-value=1.1e-17 Score=192.73 Aligned_cols=179 Identities=14% Similarity=0.072 Sum_probs=96.5
Q ss_pred CCCCCcEEeccCCeecccCC-ccccCCCCCCEEEeeCCcccc-cCChhhcCcCCCcEEEccC---------CcCcCCCCc
Q 004400 110 SLLNLEKLHLSSNNFTGELP-KTFAKLTNMKDFRISDNQFTG-QIPSFIQNWTKLEKLFIQP---------SGLAGPIPS 178 (756)
Q Consensus 110 ~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~L~~N~l~~-~~p~~~~~l~~L~~L~l~~---------N~l~~~~p~ 178 (756)
.+++|++|+|++|.+++... ..+..+++|+.|++++| ++. .++.....+++|++|+|.+ +.+++....
T Consensus 287 ~~~~L~~L~L~~~~l~~~~l~~~~~~~~~L~~L~l~~~-~~~~~l~~l~~~~~~L~~L~L~~~~~~g~~~~~~l~~~~l~ 365 (594)
T 2p1m_B 287 VCSRLTTLNLSYATVQSYDLVKLLCQCPKLQRLWVLDY-IEDAGLEVLASTCKDLRELRVFPSEPFVMEPNVALTEQGLV 365 (594)
T ss_dssp HHTTCCEEECTTCCCCHHHHHHHHTTCTTCCEEEEEGG-GHHHHHHHHHHHCTTCCEEEEECSCTTCSSCSSCCCHHHHH
T ss_pred hhCCCCEEEccCCCCCHHHHHHHHhcCCCcCEEeCcCc-cCHHHHHHHHHhCCCCCEEEEecCcccccccCCCCCHHHHH
Confidence 56778888888888664322 22456778888888877 332 2233334567777777732 344332222
Q ss_pred ccc-CCCCCCeEEccCCCCCCCCccccc--cccccEEEcc--c----ccccCCC-----CccccCCCCCcEEEccCCcCC
Q 004400 179 GIF-SLENLTDLRISDLNGPEATFPQLG--NMKMTKLILR--N----CNITGEL-----PRYLGKMTKLKVLDLSFNRLR 244 (756)
Q Consensus 179 ~~~-~l~~L~~L~l~~n~~~~~~~~~~~--~~~L~~L~L~--~----n~l~~~~-----p~~~~~l~~L~~L~Ls~N~l~ 244 (756)
.+. .+++|+.|+++.|.++......+. ..+|+.|+|+ + |.++... +..+..+++|+.|+|++ .++
T Consensus 366 ~l~~~~~~L~~L~~~~~~l~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~~~l~~~~~~L~~L~L~~-~l~ 444 (594)
T 2p1m_B 366 SVSMGCPKLESVLYFCRQMTNAALITIARNRPNMTRFRLCIIEPKAPDYLTLEPLDIGFGAIVEHCKDLRRLSLSG-LLT 444 (594)
T ss_dssp HHHHHCTTCCEEEEEESCCCHHHHHHHHHHCTTCCEEEEEESSTTCCCTTTCCCTHHHHHHHHHHCTTCCEEECCS-SCC
T ss_pred HHHHhchhHHHHHHhcCCcCHHHHHHHHhhCCCcceeEeecccCCCcccccCCchhhHHHHHHhhCCCccEEeecC-ccc
Confidence 222 366677776666666554433332 2246666666 3 3444211 11244556666666655 444
Q ss_pred CCCCccCcC-CCCCCeEEecCccccccCCchh---hcCCCeeEeecCCCC
Q 004400 245 GQIPSNFDD-LYDVDYIYFAGNLLTGAIPPWM---LERGDKIDLSYNNFT 290 (756)
Q Consensus 245 ~~~p~~~~~-l~~L~~L~ls~N~l~~~~p~~~---~~~l~~l~ls~N~l~ 290 (756)
+..+..+.. +++|+.|+|++|.+++..+..+ +++|+.|++++|+++
T Consensus 445 ~~~~~~l~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~L~~L~L~~n~~~ 494 (594)
T 2p1m_B 445 DKVFEYIGTYAKKMEMLSVAFAGDSDLGMHHVLSGCDSLRKLEIRDCPFG 494 (594)
T ss_dssp HHHHHHHHHHCTTCCEEEEESCCSSHHHHHHHHHHCTTCCEEEEESCSCC
T ss_pred HHHHHHHHHhchhccEeeccCCCCcHHHHHHHHhcCCCcCEEECcCCCCc
Confidence 333333333 5666666666666654433332 456666666666653
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=99.64 E-value=6.8e-16 Score=146.72 Aligned_cols=85 Identities=19% Similarity=0.317 Sum_probs=57.0
Q ss_pred CCCcEEEeecCccc-ccCCcccCCCCCCcEEeccCCeecccCCccccCCCCCCEEEeeCCcccccCChhhcCcCCCcEEE
Q 004400 88 STLVNLTVQYNQFS-GELPEELGSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRISDNQFTGQIPSFIQNWTKLEKLF 166 (756)
Q Consensus 88 ~~L~~L~L~~N~l~-~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 166 (756)
++|+.|+|++|.++ +.+|..+..+++|++|+|++|++++. ..+..+++|+.|+|++|++++.+|..+.++++|++|+
T Consensus 24 ~~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 101 (168)
T 2ell_A 24 AAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLN 101 (168)
T ss_dssp TSCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCEEE
T ss_pred ccCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCEEe
Confidence 56777777777776 56666666677777777777776644 5566667777777777777655666666666666666
Q ss_pred ccCCcCcC
Q 004400 167 IQPSGLAG 174 (756)
Q Consensus 167 l~~N~l~~ 174 (756)
|++|++++
T Consensus 102 Ls~N~l~~ 109 (168)
T 2ell_A 102 LSGNKLKD 109 (168)
T ss_dssp CBSSSCCS
T ss_pred ccCCccCc
Confidence 66666653
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=99.64 E-value=7.3e-16 Score=146.49 Aligned_cols=133 Identities=23% Similarity=0.173 Sum_probs=67.9
Q ss_pred CCCCEEEccCCccc-CccCcccccCCcceeeccCccccccCCccCcCcCCCcEEEeecCcccccCCcccCCCCCCcEEec
Q 004400 41 TFLQDIDLTLNYLS-GTIPSQWASLPLLNISLIANRLKGPIPKYLANISTLVNLTVQYNQFSGELPEELGSLLNLEKLHL 119 (756)
Q Consensus 41 ~~L~~L~L~~n~l~-~~~p~~~~~l~~L~l~l~~n~~~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L 119 (756)
++|+.|+|++|.++ +.+|..+. .+++|+.|+|++|.|++. ..|..+++|++|+|
T Consensus 24 ~~L~~L~l~~n~l~~~~i~~~~~-----------------------~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~L 78 (168)
T 2ell_A 24 AAVRELVLDNCKSNDGKIEGLTA-----------------------EFVNLEFLSLINVGLISV--SNLPKLPKLKKLEL 78 (168)
T ss_dssp TSCSEEECCSCBCBTTBCSSCCG-----------------------GGGGCCEEEEESSCCCCC--SSCCCCSSCCEEEE
T ss_pred ccCCEEECCCCCCChhhHHHHHH-----------------------hCCCCCEEeCcCCCCCCh--hhhccCCCCCEEEC
Confidence 66777888777776 44444444 444555555555555432 44445555555555
Q ss_pred cCCeecccCCccccCCCCCCEEEeeCCcccccC-ChhhcCcCCCcEEEccCCcCcCCCC---ccccCCCCCCeEEccCCC
Q 004400 120 SSNNFTGELPKTFAKLTNMKDFRISDNQFTGQI-PSFIQNWTKLEKLFIQPSGLAGPIP---SGIFSLENLTDLRISDLN 195 (756)
Q Consensus 120 ~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~-p~~~~~l~~L~~L~l~~N~l~~~~p---~~~~~l~~L~~L~l~~n~ 195 (756)
++|++++.+|..+..+++|+.|+|++|++++.. +..+..+++|+.|++++|.+++..+ ..+..+++|+.|++++|.
T Consensus 79 s~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~~n~ 158 (168)
T 2ell_A 79 SENRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTLEPLKKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLTYLDGYDRE 158 (168)
T ss_dssp ESCCCCSCCCHHHHHCTTCCEEECBSSSCCSSGGGGGGSSCSCCCEEECCSSGGGTSTTHHHHHHTTCSSCCEETTEETT
T ss_pred cCCcCchHHHHHHhhCCCCCEEeccCCccCcchhHHHHhcCCCCCEEEeeCCcCcchHHHHHHHHHhCccCcEecCCCCC
Confidence 555555444444444555555555555554321 1444555555555555555553322 244455555555555554
Q ss_pred CCC
Q 004400 196 GPE 198 (756)
Q Consensus 196 ~~~ 198 (756)
+.+
T Consensus 159 ~~~ 161 (168)
T 2ell_A 159 DQE 161 (168)
T ss_dssp SCB
T ss_pred hhh
Confidence 444
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.62 E-value=1.7e-15 Score=147.44 Aligned_cols=93 Identities=23% Similarity=0.280 Sum_probs=49.7
Q ss_pred CccCcCcCCCcEEEeecCcccccCCcccCCCCCCcEEeccCCeecccCCccccCCCCCCEEEeeCCcccccCChhhcCcC
Q 004400 81 PKYLANISTLVNLTVQYNQFSGELPEELGSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRISDNQFTGQIPSFIQNWT 160 (756)
Q Consensus 81 p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~ 160 (756)
|..|.++++|+.|+|++|+|++..+..|.++++|++|+|++|+|++..|..|.++++|+.|+|++|+|+...+..|..++
T Consensus 47 p~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~ 126 (193)
T 2wfh_A 47 PKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRLRCIPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLS 126 (193)
T ss_dssp CGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCT
T ss_pred HHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCCccCEeCHHHhCCCCCCCEEECCCCCCCeeChhhhhcCc
Confidence 33444555555555555555544444555555555555555555554444555555555555555555544444455555
Q ss_pred CCcEEEccCCcCc
Q 004400 161 KLEKLFIQPSGLA 173 (756)
Q Consensus 161 ~L~~L~l~~N~l~ 173 (756)
+|+.|+|++|.+.
T Consensus 127 ~L~~L~L~~N~~~ 139 (193)
T 2wfh_A 127 ALSHLAIGANPLY 139 (193)
T ss_dssp TCCEEECCSSCEE
T ss_pred cccEEEeCCCCee
Confidence 5555555555554
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.62 E-value=2.3e-15 Score=146.50 Aligned_cols=130 Identities=19% Similarity=0.277 Sum_probs=78.1
Q ss_pred EEeccCCeecccCCccccCCCCCCEEEeeCCcccccCChhhcCcCCCcEEEccCCcCcCCCCccccCCCCCCeEEccCCC
Q 004400 116 KLHLSSNNFTGELPKTFAKLTNMKDFRISDNQFTGQIPSFIQNWTKLEKLFIQPSGLAGPIPSGIFSLENLTDLRISDLN 195 (756)
Q Consensus 116 ~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~n~ 195 (756)
.+++++|+++ .+|..+. ++|+.|+|++|+|+ .+|..|.++++|+.|+|++|++++..+..|.++++|++|+
T Consensus 14 ~l~~~~~~l~-~ip~~~~--~~l~~L~L~~n~i~-~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~----- 84 (193)
T 2wfh_A 14 VVRCSNKGLK-VLPKGIP--RDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLI----- 84 (193)
T ss_dssp EEECTTSCCS-SCCSCCC--TTCCEEECCSSCCC-SCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEE-----
T ss_pred EEEcCCCCCC-cCCCCCC--CCCCEEECCCCcCc-hhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEE-----
Confidence 3444444444 3333221 34445555555544 3444455555555555555555444444444444444443
Q ss_pred CCCCCccccccccccEEEcccccccCCCCccccCCCCCcEEEccCCcCCCCCCccCcCCCCCCeEEecCccccccCC
Q 004400 196 GPEATFPQLGNMKMTKLILRNCNITGELPRYLGKMTKLKVLDLSFNRLRGQIPSNFDDLYDVDYIYFAGNLLTGAIP 272 (756)
Q Consensus 196 ~~~~~~~~~~~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p 272 (756)
|++|.+++..+..|.++++|+.|+|++|.|++..+..|..+++|+.|+|++|++.|.+.
T Consensus 85 ------------------Ls~N~l~~i~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~C~c~ 143 (193)
T 2wfh_A 85 ------------------LSYNRLRCIPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLAIGANPLYCDCN 143 (193)
T ss_dssp ------------------CCSSCCCBCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCEECSGG
T ss_pred ------------------CCCCccCEeCHHHhCCCCCCCEEECCCCCCCeeChhhhhcCccccEEEeCCCCeecCCc
Confidence 33345555556678888888888889898887666678889999999999999887655
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=99.60 E-value=9.8e-16 Score=142.47 Aligned_cols=84 Identities=20% Similarity=0.311 Sum_probs=50.9
Q ss_pred CCCcEEEeecCccc-ccCCcccCCCCCCcEEeccCCeecccCCccccCCCCCCEEEeeCCcccccCChhhcCcCCCcEEE
Q 004400 88 STLVNLTVQYNQFS-GELPEELGSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRISDNQFTGQIPSFIQNWTKLEKLF 166 (756)
Q Consensus 88 ~~L~~L~L~~N~l~-~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 166 (756)
++|+.|++++|.++ +.+|..+..+++|++|+|++|++++. ..+..+++|+.|+|++|++++.+|..+.++++|++|+
T Consensus 17 ~~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~ 94 (149)
T 2je0_A 17 SDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLN 94 (149)
T ss_dssp GGCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCEEE
T ss_pred ccCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCEEE
Confidence 45666666666665 55555566666666666666666643 4455666666666666666654555555566666666
Q ss_pred ccCCcCc
Q 004400 167 IQPSGLA 173 (756)
Q Consensus 167 l~~N~l~ 173 (756)
+++|+++
T Consensus 95 ls~N~i~ 101 (149)
T 2je0_A 95 LSGNKIK 101 (149)
T ss_dssp CTTSCCC
T ss_pred CCCCcCC
Confidence 6665555
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* | Back alignment and structure |
|---|
Probab=99.60 E-value=4.6e-17 Score=187.55 Aligned_cols=278 Identities=15% Similarity=0.164 Sum_probs=175.7
Q ss_pred ccceeccccccccCcccccCCcccC-CCCCCCEEEccCC-cccCc-cCcccccCCcc-eeeccCccccccCCccCc----
Q 004400 14 KQKTVNQKRVLKEQNLTGVLPPKLA-ELTFLQDIDLTLN-YLSGT-IPSQWASLPLL-NISLIANRLKGPIPKYLA---- 85 (756)
Q Consensus 14 ~~~~~~~~l~L~~~~l~~~~p~~l~-~l~~L~~L~L~~n-~l~~~-~p~~~~~l~~L-~l~l~~n~~~~~~p~~l~---- 85 (756)
..+..++.|+|++|.+++..+..+. .+++|+.|+|++| .++.. ++..+..++.| .|++.+|.+.+..+..+.
T Consensus 102 ~~~~~L~~L~L~~~~~~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~ 181 (594)
T 2p1m_B 102 SSYTWLEEIRLKRMVVTDDCLELIAKSFKNFKVLVLSSCEGFSTDGLAAIAATCRNLKELDLRESDVDDVSGHWLSHFPD 181 (594)
T ss_dssp HHCTTCCEEEEESCBCCHHHHHHHHHHCTTCCEEEEESCEEEEHHHHHHHHHHCTTCCEEECTTCEEECCCGGGGGGSCT
T ss_pred HhCCCCCeEEeeCcEEcHHHHHHHHHhCCCCcEEeCCCcCCCCHHHHHHHHHhCCCCCEEeCcCCccCCcchHHHHHHhh
Confidence 4566777777877777766655554 5677777777777 44422 34444456666 366777766554433333
Q ss_pred CcCCCcEEEeecCc--ccc-cCCcccCCCCCCcEEeccCC----------------------------------------
Q 004400 86 NISTLVNLTVQYNQ--FSG-ELPEELGSLLNLEKLHLSSN---------------------------------------- 122 (756)
Q Consensus 86 ~l~~L~~L~L~~N~--l~~-~~p~~~~~l~~L~~L~L~~N---------------------------------------- 122 (756)
.+++|+.|+|++|. ++. .++..+.++++|++|+|++|
T Consensus 182 ~~~~L~~L~l~~~~~~~~~~~l~~l~~~~~~L~~L~L~~~~~~~~l~~~~~~~~~L~~L~l~~~~~~~~~~~~~~l~~~l 261 (594)
T 2p1m_B 182 TYTSLVSLNISCLASEVSFSALERLVTRCPNLKSLKLNRAVPLEKLATLLQRAPQLEELGTGGYTAEVRPDVYSGLSVAL 261 (594)
T ss_dssp TCCCCCEEECTTCCSCCCHHHHHHHHHHCTTCCEEECCTTSCHHHHHHHHHHCTTCSEEECSBCCCCCCHHHHHHHHHHH
T ss_pred cCCcCcEEEecccCCcCCHHHHHHHHHhCCCCcEEecCCCCcHHHHHHHHhcCCcceEcccccccCccchhhHHHHHHHH
Confidence 45567777777665 211 11111233466666666655
Q ss_pred ----------eecc----cCCccccCCCCCCEEEeeCCcccccC-ChhhcCcCCCcEEEccCCcCcCC-CCccccCCCCC
Q 004400 123 ----------NFTG----ELPKTFAKLTNMKDFRISDNQFTGQI-PSFIQNWTKLEKLFIQPSGLAGP-IPSGIFSLENL 186 (756)
Q Consensus 123 ----------~l~~----~~p~~~~~l~~L~~L~L~~N~l~~~~-p~~~~~l~~L~~L~l~~N~l~~~-~p~~~~~l~~L 186 (756)
.+.. .++..+..+++|+.|+|++|.+++.. ...+.++++|+.|++++| +... ++.....+++|
T Consensus 262 ~~~~~L~~Ls~~~~~~~~~l~~~~~~~~~L~~L~L~~~~l~~~~l~~~~~~~~~L~~L~l~~~-~~~~~l~~l~~~~~~L 340 (594)
T 2p1m_B 262 SGCKELRCLSGFWDAVPAYLPAVYSVCSRLTTLNLSYATVQSYDLVKLLCQCPKLQRLWVLDY-IEDAGLEVLASTCKDL 340 (594)
T ss_dssp HTCTTCCEEECCBTCCGGGGGGGHHHHTTCCEEECTTCCCCHHHHHHHHTTCTTCCEEEEEGG-GHHHHHHHHHHHCTTC
T ss_pred hcCCCcccccCCcccchhhHHHHHHhhCCCCEEEccCCCCCHHHHHHHHhcCCCcCEEeCcCc-cCHHHHHHHHHhCCCC
Confidence 1110 12222335789999999999977443 334668999999999988 4422 22233358999
Q ss_pred CeEEccC---------CCCCCCCccccc--cccccEEEcccccccCCCCcccc-CCCCCcEEEcc--C----CcCCCCC-
Q 004400 187 TDLRISD---------LNGPEATFPQLG--NMKMTKLILRNCNITGELPRYLG-KMTKLKVLDLS--F----NRLRGQI- 247 (756)
Q Consensus 187 ~~L~l~~---------n~~~~~~~~~~~--~~~L~~L~L~~n~l~~~~p~~~~-~l~~L~~L~Ls--~----N~l~~~~- 247 (756)
++|++++ +.++......+. ..+|+.|.+..|.+++.....+. .+++|+.|+|+ + |.+++..
T Consensus 341 ~~L~L~~~~~~g~~~~~~l~~~~l~~l~~~~~~L~~L~~~~~~l~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~ 420 (594)
T 2p1m_B 341 RELRVFPSEPFVMEPNVALTEQGLVSVSMGCPKLESVLYFCRQMTNAALITIARNRPNMTRFRLCIIEPKAPDYLTLEPL 420 (594)
T ss_dssp CEEEEECSCTTCSSCSSCCCHHHHHHHHHHCTTCCEEEEEESCCCHHHHHHHHHHCTTCCEEEEEESSTTCCCTTTCCCT
T ss_pred CEEEEecCcccccccCCCCCHHHHHHHHHhchhHHHHHHhcCCcCHHHHHHHHhhCCCcceeEeecccCCCcccccCCch
Confidence 9999944 334332222222 34689999999999876666665 58999999999 4 5565321
Q ss_pred ----CccCcCCCCCCeEEecCccccccCCchh---hcCCCeeEeecCCCCCCC
Q 004400 248 ----PSNFDDLYDVDYIYFAGNLLTGAIPPWM---LERGDKIDLSYNNFTDGS 293 (756)
Q Consensus 248 ----p~~~~~l~~L~~L~ls~N~l~~~~p~~~---~~~l~~l~ls~N~l~~~~ 293 (756)
+..+..+++|+.|++++ .+++..+..+ +++|+.|++++|.+++..
T Consensus 421 ~~~~~~l~~~~~~L~~L~L~~-~l~~~~~~~l~~~~~~L~~L~L~~~~i~~~~ 472 (594)
T 2p1m_B 421 DIGFGAIVEHCKDLRRLSLSG-LLTDKVFEYIGTYAKKMEMLSVAFAGDSDLG 472 (594)
T ss_dssp HHHHHHHHHHCTTCCEEECCS-SCCHHHHHHHHHHCTTCCEEEEESCCSSHHH
T ss_pred hhHHHHHHhhCCCccEEeecC-cccHHHHHHHHHhchhccEeeccCCCCcHHH
Confidence 12266788999999977 6665444443 678999999999986543
|
| >3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.60 E-value=2.7e-15 Score=159.17 Aligned_cols=235 Identities=11% Similarity=0.026 Sum_probs=132.9
Q ss_pred eeccccccccCcccccCCcccCC-CCCCCEEEccCCccc--CccCcccccCCcce-eeccCccccccCCccCcC------
Q 004400 17 TVNQKRVLKEQNLTGVLPPKLAE-LTFLQDIDLTLNYLS--GTIPSQWASLPLLN-ISLIANRLKGPIPKYLAN------ 86 (756)
Q Consensus 17 ~~~~~l~L~~~~l~~~~p~~l~~-l~~L~~L~L~~n~l~--~~~p~~~~~l~~L~-l~l~~n~~~~~~p~~l~~------ 86 (756)
..++.|.++++ +...--..+.. +++|+.|||++|+|. ...+..+.. ++ +.+..| ..-+.+|.+
T Consensus 25 ~~l~~L~l~g~-i~~~~~~~l~~~l~~L~~LdLs~n~i~~~~~~~~~~~~---~~~~~~~~~---~I~~~aF~~~~~~~~ 97 (329)
T 3sb4_A 25 NSITHLTLTGK-LNAEDFRHLRDEFPSLKVLDISNAEIKMYSGKAGTYPN---GKFYIYMAN---FVPAYAFSNVVNGVT 97 (329)
T ss_dssp HHCSEEEEEEE-ECHHHHHHHHHSCTTCCEEEEEEEEECCEEESSSSSGG---GCCEEECTT---EECTTTTEEEETTEE
T ss_pred CceeEEEEecc-ccHHHHHHHHHhhccCeEEecCcceeEEecCccccccc---ccccccccc---ccCHHHhcccccccc
Confidence 44555665543 22111122333 788999999999998 222222222 22 222222 223345666
Q ss_pred --cCCCcEEEeecCcccccCCcccCCCCCCcEEeccCCeecccCCccccCCCCCCEEEeeCCcc----cccCChhhcC--
Q 004400 87 --ISTLVNLTVQYNQFSGELPEELGSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRISDNQF----TGQIPSFIQN-- 158 (756)
Q Consensus 87 --l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l----~~~~p~~~~~-- 158 (756)
+++|+.|+|.+ .++.+.+.+|.++++|+.|+|++|.++.+.+..|.++.++..+.+..+.. ......+|.+
T Consensus 98 ~g~~~L~~l~L~~-~i~~I~~~aF~~~~~L~~l~l~~n~i~~i~~~aF~~~~~l~~l~~~~~~~~~~~~~i~~~~f~~~~ 176 (329)
T 3sb4_A 98 KGKQTLEKVILSE-KIKNIEDAAFKGCDNLKICQIRKKTAPNLLPEALADSVTAIFIPLGSSDAYRFKNRWEHFAFIEGE 176 (329)
T ss_dssp EECTTCCC-CBCT-TCCEECTTTTTTCTTCCEEEBCCSSCCEECTTSSCTTTCEEEECTTCTHHHHTSTTTTTSCEEESC
T ss_pred cccCCCcEEECCc-cccchhHHHhhcCcccceEEcCCCCccccchhhhcCCCceEEecCcchhhhhcccccccccccccc
Confidence 89999999988 78867777888999999999999988767777788777777666655321 1111122222
Q ss_pred ------------------------------------------------cCCCcEEEccCCcCcCCCCccccCCCCCCeEE
Q 004400 159 ------------------------------------------------WTKLEKLFIQPSGLAGPIPSGIFSLENLTDLR 190 (756)
Q Consensus 159 ------------------------------------------------l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ 190 (756)
+++|+.|+|++|+++...+.+|.++++|+.|+
T Consensus 177 ~L~~~i~~~~~~~l~~~~~~~~~~~~~~~~l~~~~~l~~~~~~~l~~~~~~L~~l~L~~n~i~~I~~~aF~~~~~L~~l~ 256 (329)
T 3sb4_A 177 PLETTIQVGAMGKLEDEIMKAGLQPRDINFLTIEGKLDNADFKLIRDYMPNLVSLDISKTNATTIPDFTFAQKKYLLKIK 256 (329)
T ss_dssp CCEEEEEECTTCCHHHHHHHTTCCGGGCSEEEEEECCCHHHHHHHHHHCTTCCEEECTTBCCCEECTTTTTTCTTCCEEE
T ss_pred ccceeEEecCCCcHHHHHhhcccCccccceEEEeeeecHHHHHHHHHhcCCCeEEECCCCCcceecHhhhhCCCCCCEEE
Confidence 45555555555555544444555555555555
Q ss_pred ccCCCCCCCCcccccccc-cc-EEEcccccccCCCCccccCCCCCcEEEccCCcCCCCCCccCcCCCCCCeEE
Q 004400 191 ISDLNGPEATFPQLGNMK-MT-KLILRNCNITGELPRYLGKMTKLKVLDLSFNRLRGQIPSNFDDLYDVDYIY 261 (756)
Q Consensus 191 l~~n~~~~~~~~~~~~~~-L~-~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 261 (756)
+.+| +..+....|.... |+ .+.+.+ .++.+.+.+|.++++|+.|++++|.++...+..|.++++|+.++
T Consensus 257 l~~n-i~~I~~~aF~~~~~L~~~l~l~~-~l~~I~~~aF~~c~~L~~l~l~~n~i~~I~~~aF~~~~~L~~ly 327 (329)
T 3sb4_A 257 LPHN-LKTIGQRVFSNCGRLAGTLELPA-SVTAIEFGAFMGCDNLRYVLATGDKITTLGDELFGNGVPSKLIY 327 (329)
T ss_dssp CCTT-CCEECTTTTTTCTTCCEEEEECT-TCCEECTTTTTTCTTEEEEEECSSCCCEECTTTTCTTCCCCEEE
T ss_pred CCcc-cceehHHHhhCChhccEEEEEcc-cceEEchhhhhCCccCCEEEeCCCccCccchhhhcCCcchhhhc
Confidence 5554 4444444444442 55 555555 44444445555555555555555555544445555555555544
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=99.60 E-value=1.1e-15 Score=142.06 Aligned_cols=111 Identities=20% Similarity=0.163 Sum_probs=56.3
Q ss_pred CCccCcCcCCCcEEEeecCcccccCCcccCCCCCCcEEeccCCeecccCCccccCCCCCCEEEeeCCccccc-CChhhcC
Q 004400 80 IPKYLANISTLVNLTVQYNQFSGELPEELGSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRISDNQFTGQ-IPSFIQN 158 (756)
Q Consensus 80 ~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~-~p~~~~~ 158 (756)
+|..+..+++|+.|+|++|.+++. ..++.+++|++|+|++|++++.+|..+..+++|+.|++++|++++. .+..+.+
T Consensus 34 ~~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~ls~N~i~~~~~~~~~~~ 111 (149)
T 2je0_A 34 LEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKK 111 (149)
T ss_dssp CCSCCTTCTTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCEEECTTSCCCSHHHHGGGGG
T ss_pred HHHHHhhcCCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCEEECCCCcCCChHHHHHHhh
Confidence 333444445555555555555533 4455555555555555555544454444455555555555555532 2244555
Q ss_pred cCCCcEEEccCCcCcCCCC---ccccCCCCCCeEEcc
Q 004400 159 WTKLEKLFIQPSGLAGPIP---SGIFSLENLTDLRIS 192 (756)
Q Consensus 159 l~~L~~L~l~~N~l~~~~p---~~~~~l~~L~~L~l~ 192 (756)
+++|++|++++|++++..+ ..+..+++|+.|+++
T Consensus 112 l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~ 148 (149)
T 2je0_A 112 LENLKSLDLFNCEVTNLNDYRENVFKLLPQLTYLDGY 148 (149)
T ss_dssp CTTCCEEECTTCGGGGSTTHHHHHHHHCTTCCEETTB
T ss_pred CCCCCEEeCcCCcccchHHHHHHHHHHCCCcccccCC
Confidence 5555555555555554333 245555555555554
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.59 E-value=6.9e-15 Score=141.05 Aligned_cols=114 Identities=21% Similarity=0.251 Sum_probs=69.7
Q ss_pred CCCCEEEeeCCcccccCChhhcCcCCCcEEEccCCcCcCCCCccccCCCCCCeEEccCCCCCCCCccccccccccEEEcc
Q 004400 136 TNMKDFRISDNQFTGQIPSFIQNWTKLEKLFIQPSGLAGPIPSGIFSLENLTDLRISDLNGPEATFPQLGNMKMTKLILR 215 (756)
Q Consensus 136 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~L~~L~L~ 215 (756)
++|+.|++++|++++..+..|.++++|++|+|++|++++..+..+..+++|+.|+ |+
T Consensus 28 ~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~-----------------------l~ 84 (177)
T 2o6r_A 28 SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILY-----------------------LH 84 (177)
T ss_dssp TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEE-----------------------CC
T ss_pred CCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeChhHccCCCccCEEE-----------------------CC
Confidence 3444555555554443344444455555555555555433333344444444433 33
Q ss_pred cccccCCCCccccCCCCCcEEEccCCcCCCCCCccCcCCCCCCeEEecCccccccCC
Q 004400 216 NCNITGELPRYLGKMTKLKVLDLSFNRLRGQIPSNFDDLYDVDYIYFAGNLLTGAIP 272 (756)
Q Consensus 216 ~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p 272 (756)
+|.+++..+..|..+++|+.|+|++|.+++..+..|..+++|+.|++++|++.|.+|
T Consensus 85 ~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~ 141 (177)
T 2o6r_A 85 ENKLQSLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 141 (177)
T ss_dssp SSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCHH
T ss_pred CCCccccCHHHhhCCcccCEEECcCCcceEeCHHHhcCCcccCEEEecCCCeeccCc
Confidence 455555555667778888888888888887666667888888888888888887766
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.58 E-value=8.9e-15 Score=140.25 Aligned_cols=130 Identities=19% Similarity=0.275 Sum_probs=66.7
Q ss_pred ccccccccCcccccCCcccCCCCCCCEEEccCCcccCccCcccccCCcceeeccCccccccCCccCcCcCCCcEEEeecC
Q 004400 19 NQKRVLKEQNLTGVLPPKLAELTFLQDIDLTLNYLSGTIPSQWASLPLLNISLIANRLKGPIPKYLANISTLVNLTVQYN 98 (756)
Q Consensus 19 ~~~l~L~~~~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~l~l~~n~~~~~~p~~l~~l~~L~~L~L~~N 98 (756)
.+.+++++++++. +|..+. ++|+.|+|++|++++.. +..|.++++|++|+|++|
T Consensus 9 ~~~l~~~~~~l~~-~p~~~~--~~l~~L~l~~n~l~~~~-----------------------~~~~~~l~~L~~L~l~~n 62 (177)
T 2o6r_A 9 GTEIRCNSKGLTS-VPTGIP--SSATRLELESNKLQSLP-----------------------HGVFDKLTQLTKLSLSQN 62 (177)
T ss_dssp TTEEECCSSCCSS-CCTTCC--TTCSEEECCSSCCCCCC-----------------------TTTTTTCTTCSEEECCSS
T ss_pred CCEEEecCCCCcc-CCCCCC--CCCcEEEeCCCcccEeC-----------------------HHHhcCcccccEEECCCC
Confidence 4455555555553 233222 45555555555555322 233444555555555555
Q ss_pred cccccCCcccCCCCCCcEEeccCCeecccCCccccCCCCCCEEEeeCCcccccCChhhcCcCCCcEEEccCCcCcC
Q 004400 99 QFSGELPEELGSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRISDNQFTGQIPSFIQNWTKLEKLFIQPSGLAG 174 (756)
Q Consensus 99 ~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~ 174 (756)
+|++..+..|.++++|++|+|++|+|++..+..|..+++|+.|+|++|+|++..+..|..+++|+.|+|++|.+.+
T Consensus 63 ~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~ 138 (177)
T 2o6r_A 63 QIQSLPDGVFDKLTKLTILYLHENKLQSLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDC 138 (177)
T ss_dssp CCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCC
T ss_pred cceEeChhHccCCCccCEEECCCCCccccCHHHhhCCcccCEEECcCCcceEeCHHHhcCCcccCEEEecCCCeec
Confidence 5554444445555555555555555554444445555555555555555554444444555555555555555543
|
| >4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A | Back alignment and structure |
|---|
Probab=99.57 E-value=5e-14 Score=152.96 Aligned_cols=263 Identities=10% Similarity=0.082 Sum_probs=200.0
Q ss_pred ccceeccccccccCcccccCCcccCCCCCCCEEEccCCcccCccCcccccCCcceeeccCccccccCCccCcCcCCCcEE
Q 004400 14 KQKTVNQKRVLKEQNLTGVLPPKLAELTFLQDIDLTLNYLSGTIPSQWASLPLLNISLIANRLKGPIPKYLANISTLVNL 93 (756)
Q Consensus 14 ~~~~~~~~l~L~~~~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~l~l~~n~~~~~~p~~l~~l~~L~~L 93 (756)
..+..+..+.+.+ +++.+-..+|.+. +|+.++|.+| ++.+-..+|.+....++.+. +++...-+.+|.++++|+.+
T Consensus 110 ~~~~~l~~i~ip~-~i~~I~~~aF~~~-~L~~i~l~~~-i~~I~~~aF~~~~L~~i~lp-~~l~~I~~~aF~~c~~L~~l 185 (401)
T 4fdw_A 110 EILKGYNEIILPN-SVKSIPKDAFRNS-QIAKVVLNEG-LKSIGDMAFFNSTVQEIVFP-STLEQLKEDIFYYCYNLKKA 185 (401)
T ss_dssp EECSSCSEEECCT-TCCEECTTTTTTC-CCSEEECCTT-CCEECTTTTTTCCCCEEECC-TTCCEECSSTTTTCTTCCEE
T ss_pred EecCCccEEEECC-ccCEehHhhcccC-CccEEEeCCC-ccEECHHhcCCCCceEEEeC-CCccEehHHHhhCcccCCee
Confidence 3445666666664 5666667788875 7999999876 77566677877543356655 47777777899999999999
Q ss_pred EeecCcccccCCcccCCCCCCcEEeccCCeecccCCccccCCCCCCEEEeeCCcccccCChhhcCcCCCcEEEccCCcCc
Q 004400 94 TVQYNQFSGELPEELGSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRISDNQFTGQIPSFIQNWTKLEKLFIQPSGLA 173 (756)
Q Consensus 94 ~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~ 173 (756)
+|++|+++.....+|. ..+|+.+.|..| ++.+-...|.++++|+.++|.+| ++.....+|.+ .+|+.+.|. +.++
T Consensus 186 ~l~~n~l~~I~~~aF~-~~~L~~l~lp~~-l~~I~~~aF~~~~~L~~l~l~~~-l~~I~~~aF~~-~~L~~i~lp-~~i~ 260 (401)
T 4fdw_A 186 DLSKTKITKLPASTFV-YAGIEEVLLPVT-LKEIGSQAFLKTSQLKTIEIPEN-VSTIGQEAFRE-SGITTVKLP-NGVT 260 (401)
T ss_dssp ECTTSCCSEECTTTTT-TCCCSEEECCTT-CCEECTTTTTTCTTCCCEECCTT-CCEECTTTTTT-CCCSEEEEE-TTCC
T ss_pred ecCCCcceEechhhEe-ecccCEEEeCCc-hheehhhHhhCCCCCCEEecCCC-ccCcccccccc-CCccEEEeC-CCcc
Confidence 9999999955556666 689999999855 77567778999999999999876 56566778888 789999994 5576
Q ss_pred CCCCccccCCCCCCeEEccCCCCC-----CCCccccccc-cccEEEcccccccCCCCccccCCCCCcEEEccCCcCCCCC
Q 004400 174 GPIPSGIFSLENLTDLRISDLNGP-----EATFPQLGNM-KMTKLILRNCNITGELPRYLGKMTKLKVLDLSFNRLRGQI 247 (756)
Q Consensus 174 ~~~p~~~~~l~~L~~L~l~~n~~~-----~~~~~~~~~~-~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~ 247 (756)
.....+|.++++|+.+++.+|.+. .+....|... +|+.+.|. +.++.+...+|.++++|+.++|..| ++...
T Consensus 261 ~I~~~aF~~c~~L~~l~l~~~~~~~~~~~~I~~~aF~~c~~L~~l~l~-~~i~~I~~~aF~~c~~L~~l~lp~~-l~~I~ 338 (401)
T 4fdw_A 261 NIASRAFYYCPELAEVTTYGSTFNDDPEAMIHPYCLEGCPKLARFEIP-ESIRILGQGLLGGNRKVTQLTIPAN-VTQIN 338 (401)
T ss_dssp EECTTTTTTCTTCCEEEEESSCCCCCTTCEECTTTTTTCTTCCEECCC-TTCCEECTTTTTTCCSCCEEEECTT-CCEEC
T ss_pred EEChhHhhCCCCCCEEEeCCccccCCcccEECHHHhhCCccCCeEEeC-CceEEEhhhhhcCCCCccEEEECcc-ccEEc
Confidence 667888999999999999887765 3555556555 69999999 4577677788999999999999666 67677
Q ss_pred CccCcCCCCCCeEEecCccccccCCchh--h-cCCCeeEeecCC
Q 004400 248 PSNFDDLYDVDYIYFAGNLLTGAIPPWM--L-ERGDKIDLSYNN 288 (756)
Q Consensus 248 p~~~~~l~~L~~L~ls~N~l~~~~p~~~--~-~~l~~l~ls~N~ 288 (756)
..+|.++ +|+.+++++|.+....+..+ + ..+..+.+..+.
T Consensus 339 ~~aF~~~-~L~~l~l~~n~~~~l~~~~F~~~~~~l~~l~vp~~~ 381 (401)
T 4fdw_A 339 FSAFNNT-GIKEVKVEGTTPPQVFEKVWYGFPDDITVIRVPAES 381 (401)
T ss_dssp TTSSSSS-CCCEEEECCSSCCBCCCSSCCCSCTTCCEEEECGGG
T ss_pred HHhCCCC-CCCEEEEcCCCCcccccccccCCCCCccEEEeCHHH
Confidence 7889999 99999999998874333333 2 345666665543
|
| >4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A | Back alignment and structure |
|---|
Probab=99.56 E-value=1e-13 Score=150.40 Aligned_cols=244 Identities=11% Similarity=0.032 Sum_probs=189.6
Q ss_pred CCCCCCEEEccCCcccCccCcccccCCcceeeccCccccccCCccCcCcCCCcEEEeecCcccccCCcccCCCCCCcEEe
Q 004400 39 ELTFLQDIDLTLNYLSGTIPSQWASLPLLNISLIANRLKGPIPKYLANISTLVNLTVQYNQFSGELPEELGSLLNLEKLH 118 (756)
Q Consensus 39 ~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~l~l~~n~~~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 118 (756)
.+..++.+.+.+ .++.+-..+|......++.+. +++...-..+|.+. +|+.+.|.+ .++.+.+.+|.++.+|+.++
T Consensus 111 ~~~~l~~i~ip~-~i~~I~~~aF~~~~L~~i~l~-~~i~~I~~~aF~~~-~L~~i~lp~-~l~~I~~~aF~~c~~L~~l~ 186 (401)
T 4fdw_A 111 ILKGYNEIILPN-SVKSIPKDAFRNSQIAKVVLN-EGLKSIGDMAFFNS-TVQEIVFPS-TLEQLKEDIFYYCYNLKKAD 186 (401)
T ss_dssp ECSSCSEEECCT-TCCEECTTTTTTCCCSEEECC-TTCCEECTTTTTTC-CCCEEECCT-TCCEECSSTTTTCTTCCEEE
T ss_pred ecCCccEEEECC-ccCEehHhhcccCCccEEEeC-CCccEECHHhcCCC-CceEEEeCC-CccEehHHHhhCcccCCeee
Confidence 347788888866 466566677887643356654 44777777788884 799999986 67767778999999999999
Q ss_pred ccCCeecccCCccccCCCCCCEEEeeCCcccccCChhhcCcCCCcEEEccCCcCcCCCCccccCCCCCCeEEccCCCCCC
Q 004400 119 LSSNNFTGELPKTFAKLTNMKDFRISDNQFTGQIPSFIQNWTKLEKLFIQPSGLAGPIPSGIFSLENLTDLRISDLNGPE 198 (756)
Q Consensus 119 L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~n~~~~ 198 (756)
|++|+++.+....|. .++|+.+.|.+| ++.....+|.++++|+.+.|..| ++.....+|.+ .+|+.+.+. +++..
T Consensus 187 l~~n~l~~I~~~aF~-~~~L~~l~lp~~-l~~I~~~aF~~~~~L~~l~l~~~-l~~I~~~aF~~-~~L~~i~lp-~~i~~ 261 (401)
T 4fdw_A 187 LSKTKITKLPASTFV-YAGIEEVLLPVT-LKEIGSQAFLKTSQLKTIEIPEN-VSTIGQEAFRE-SGITTVKLP-NGVTN 261 (401)
T ss_dssp CTTSCCSEECTTTTT-TCCCSEEECCTT-CCEECTTTTTTCTTCCCEECCTT-CCEECTTTTTT-CCCSEEEEE-TTCCE
T ss_pred cCCCcceEechhhEe-ecccCEEEeCCc-hheehhhHhhCCCCCCEEecCCC-ccCcccccccc-CCccEEEeC-CCccE
Confidence 999999955555665 689999999855 77677889999999999999975 55455666666 899999994 56777
Q ss_pred CCccccccc-cccEEEccccccc-----CCCCccccCCCCCcEEEccCCcCCCCCCccCcCCCCCCeEEecCccccccCC
Q 004400 199 ATFPQLGNM-KMTKLILRNCNIT-----GELPRYLGKMTKLKVLDLSFNRLRGQIPSNFDDLYDVDYIYFAGNLLTGAIP 272 (756)
Q Consensus 199 ~~~~~~~~~-~L~~L~L~~n~l~-----~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p 272 (756)
+....|... +|+.+.+.+|.+. ...+.+|.++++|+.++|.+ .++.....+|.++.+|+.+.|..| ++..-+
T Consensus 262 I~~~aF~~c~~L~~l~l~~~~~~~~~~~~I~~~aF~~c~~L~~l~l~~-~i~~I~~~aF~~c~~L~~l~lp~~-l~~I~~ 339 (401)
T 4fdw_A 262 IASRAFYYCPELAEVTTYGSTFNDDPEAMIHPYCLEGCPKLARFEIPE-SIRILGQGLLGGNRKVTQLTIPAN-VTQINF 339 (401)
T ss_dssp ECTTTTTTCTTCCEEEEESSCCCCCTTCEECTTTTTTCTTCCEECCCT-TCCEECTTTTTTCCSCCEEEECTT-CCEECT
T ss_pred EChhHhhCCCCCCEEEeCCccccCCcccEECHHHhhCCccCCeEEeCC-ceEEEhhhhhcCCCCccEEEECcc-ccEEcH
Confidence 777777766 6999999988775 45667899999999999994 577677789999999999999666 553334
Q ss_pred chh--hcCCCeeEeecCCCCCCCC
Q 004400 273 PWM--LERGDKIDLSYNNFTDGSA 294 (756)
Q Consensus 273 ~~~--~~~l~~l~ls~N~l~~~~~ 294 (756)
..+ . +|+.+++++|.+.....
T Consensus 340 ~aF~~~-~L~~l~l~~n~~~~l~~ 362 (401)
T 4fdw_A 340 SAFNNT-GIKEVKVEGTTPPQVFE 362 (401)
T ss_dssp TSSSSS-CCCEEEECCSSCCBCCC
T ss_pred HhCCCC-CCCEEEEcCCCCccccc
Confidence 444 4 88999999998765443
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=99.55 E-value=8.8e-17 Score=157.38 Aligned_cols=150 Identities=23% Similarity=0.317 Sum_probs=91.2
Q ss_pred eccceeccccccccCcccccCCc------ccCCCCCCCEEEccCCcccCccCcccccCCcceeeccCccccccCCccCcC
Q 004400 13 WKQKTVNQKRVLKEQNLTGVLPP------KLAELTFLQDIDLTLNYLSGTIPSQWASLPLLNISLIANRLKGPIPKYLAN 86 (756)
Q Consensus 13 ~~~~~~~~~l~L~~~~l~~~~p~------~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~l~l~~n~~~~~~p~~l~~ 86 (756)
|.....+..++|+.++++|.+|. .|..+++|+.|+|++|.|++ + | .+.+
T Consensus 14 ~~~~~~l~~l~l~~~~l~~~~~~l~~l~~~~~~l~~L~~L~ls~n~l~~-l-----------------------~-~~~~ 68 (198)
T 1ds9_A 14 FEERKSVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEK-I-----------------------S-SLSG 68 (198)
T ss_dssp HHHTTCCCCTTCSEEECCBCCTTCCCCHHHHHHTTTCSEEECSEEEESC-C-----------------------C-CHHH
T ss_pred HHhcccccCcchheeEeccccCcHhhhhHHHhcCCCCCEEECCCCCCcc-c-----------------------c-cccc
Confidence 55566777777777777777666 67777777777777777763 3 3 4555
Q ss_pred cCCCcEEEeecCcccccCCcccCCCCCCcEEeccCCeecccCCccccCCCCCCEEEeeCCcccccCC-hhhcCcCCCcEE
Q 004400 87 ISTLVNLTVQYNQFSGELPEELGSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRISDNQFTGQIP-SFIQNWTKLEKL 165 (756)
Q Consensus 87 l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L 165 (756)
+++|+.|+|++|.|+ .+|..+..+++|++|+|++|++++ +| .+..+++|+.|+|++|++++..+ ..+..+++|++|
T Consensus 69 l~~L~~L~l~~n~l~-~l~~~~~~~~~L~~L~L~~N~l~~-l~-~~~~l~~L~~L~l~~N~i~~~~~~~~l~~l~~L~~L 145 (198)
T 1ds9_A 69 MENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIAS-LS-GIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDL 145 (198)
T ss_dssp HTTCCEEEEEEEEEC-SCSSHHHHHHHCSEEEEEEEECCC-HH-HHHHHHHSSEEEESEEECCCHHHHHHHTTTTTCSEE
T ss_pred CCCCCEEECCCCCcc-cccchhhcCCcCCEEECcCCcCCc-CC-ccccCCCCCEEECCCCcCCchhHHHHHhcCCCCCEE
Confidence 566666666666665 455555555666666666666653 33 35556666666666666653222 355566666666
Q ss_pred EccCCcCcCCCCcc----------ccCCCCCCeEE
Q 004400 166 FIQPSGLAGPIPSG----------IFSLENLTDLR 190 (756)
Q Consensus 166 ~l~~N~l~~~~p~~----------~~~l~~L~~L~ 190 (756)
++++|.+.+..|.. +..+++|+.||
T Consensus 146 ~l~~N~l~~~~~~~~~~~~~~~~~~~~l~~L~~Ld 180 (198)
T 1ds9_A 146 LLAGNPLYNDYKENNATSEYRIEVVKRLPNLKKLD 180 (198)
T ss_dssp EECSCHHHHHHHTTTTHHHHHHHHHHHCSSCSEEC
T ss_pred EecCCccccccccccchHHHHHHHHHhCCCcEEEC
Confidence 66666665444432 55566666654
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=99.54 E-value=8.6e-17 Score=157.46 Aligned_cols=155 Identities=24% Similarity=0.305 Sum_probs=93.5
Q ss_pred CcCcCCCcEEEeecCcccccCCc------ccCCCCCCcEEeccCCeecccCCccccCCCCCCEEEeeCCcccccCChhhc
Q 004400 84 LANISTLVNLTVQYNQFSGELPE------ELGSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRISDNQFTGQIPSFIQ 157 (756)
Q Consensus 84 l~~l~~L~~L~L~~N~l~~~~p~------~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~ 157 (756)
+.....++.++++.|.++|.+|. .|..+++|++|+|++|++++ +| .+.++++|+.|+|++|+++ .+|..+.
T Consensus 14 ~~~~~~l~~l~l~~~~l~~~~~~l~~l~~~~~~l~~L~~L~ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~-~l~~~~~ 90 (198)
T 1ds9_A 14 FEERKSVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDA 90 (198)
T ss_dssp HHHTTCCCCTTCSEEECCBCCTTCCCCHHHHHHTTTCSEEECSEEEESC-CC-CHHHHTTCCEEEEEEEEEC-SCSSHHH
T ss_pred HHhcccccCcchheeEeccccCcHhhhhHHHhcCCCCCEEECCCCCCcc-cc-ccccCCCCCEEECCCCCcc-cccchhh
Confidence 34455666667777777666665 67777777777777777774 55 6777777777777777777 5666666
Q ss_pred CcCCCcEEEccCCcCcCCCCccccCCCCCCeEEccCCCCCCCCccccccccccEEEcccccccCCCC-ccccCCCCCcEE
Q 004400 158 NWTKLEKLFIQPSGLAGPIPSGIFSLENLTDLRISDLNGPEATFPQLGNMKMTKLILRNCNITGELP-RYLGKMTKLKVL 236 (756)
Q Consensus 158 ~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~L~~L~L~~n~l~~~~p-~~~~~l~~L~~L 236 (756)
.+++|+.|+|++|++++ +| .+..+++|+.| +|++|.+++..+ ..+..+++|++|
T Consensus 91 ~~~~L~~L~L~~N~l~~-l~-~~~~l~~L~~L-----------------------~l~~N~i~~~~~~~~l~~l~~L~~L 145 (198)
T 1ds9_A 91 VADTLEELWISYNQIAS-LS-GIEKLVNLRVL-----------------------YMSNNKITNWGEIDKLAALDKLEDL 145 (198)
T ss_dssp HHHHCSEEEEEEEECCC-HH-HHHHHHHSSEE-----------------------EESEEECCCHHHHHHHTTTTTCSEE
T ss_pred cCCcCCEEECcCCcCCc-CC-ccccCCCCCEE-----------------------ECCCCcCCchhHHHHHhcCCCCCEE
Confidence 66667777776666663 22 34444444443 333444443221 345666666666
Q ss_pred EccCCcCCCCCCcc----------CcCCCCCCeEEecCcccc
Q 004400 237 DLSFNRLRGQIPSN----------FDDLYDVDYIYFAGNLLT 268 (756)
Q Consensus 237 ~Ls~N~l~~~~p~~----------~~~l~~L~~L~ls~N~l~ 268 (756)
++++|.+++.+|.. +..+++|+.|+ +|.++
T Consensus 146 ~l~~N~l~~~~~~~~~~~~~~~~~~~~l~~L~~Ld--~~~i~ 185 (198)
T 1ds9_A 146 LLAGNPLYNDYKENNATSEYRIEVVKRLPNLKKLD--GMPVD 185 (198)
T ss_dssp EECSCHHHHHHHTTTTHHHHHHHHHHHCSSCSEEC--CGGGT
T ss_pred EecCCccccccccccchHHHHHHHHHhCCCcEEEC--CcccC
Confidence 66666666554432 55556666554 44443
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=99.53 E-value=9.9e-15 Score=139.78 Aligned_cols=86 Identities=17% Similarity=0.270 Sum_probs=51.2
Q ss_pred CcCcCCCcEEEeecCcccccCCcccCCCC-CCcEEeccCCeecccCCccccCCCCCCEEEeeCCcccccCChhhcCcCCC
Q 004400 84 LANISTLVNLTVQYNQFSGELPEELGSLL-NLEKLHLSSNNFTGELPKTFAKLTNMKDFRISDNQFTGQIPSFIQNWTKL 162 (756)
Q Consensus 84 l~~l~~L~~L~L~~N~l~~~~p~~~~~l~-~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L 162 (756)
+.++.+|+.|+|++|+++ .+|. +..+. +|++|+|++|+|++. ..|..+++|+.|+|++|+|++..+..|..+++|
T Consensus 15 ~~~~~~L~~L~l~~n~l~-~i~~-~~~~~~~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L 90 (176)
T 1a9n_A 15 YTNAVRDRELDLRGYKIP-VIEN-LGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDL 90 (176)
T ss_dssp EECTTSCEEEECTTSCCC-SCCC-GGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTC
T ss_pred cCCcCCceEEEeeCCCCc-hhHH-hhhcCCCCCEEECCCCCCCcc--cccccCCCCCEEECCCCcccccCcchhhcCCCC
Confidence 455666677777777666 3333 33333 666666666666643 456666666666666666664444444566666
Q ss_pred cEEEccCCcCc
Q 004400 163 EKLFIQPSGLA 173 (756)
Q Consensus 163 ~~L~l~~N~l~ 173 (756)
++|+|++|+++
T Consensus 91 ~~L~L~~N~i~ 101 (176)
T 1a9n_A 91 TELILTNNSLV 101 (176)
T ss_dssp CEEECCSCCCC
T ss_pred CEEECCCCcCC
Confidence 66666655554
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=99.52 E-value=1.5e-14 Score=138.48 Aligned_cols=132 Identities=13% Similarity=0.132 Sum_probs=66.2
Q ss_pred cCCCCCCCEEEccCCcccCccCcccccCCcceeeccCccccccCCccCcCcCCCcEEEeecCcccccCCcccCCCCCCcE
Q 004400 37 LAELTFLQDIDLTLNYLSGTIPSQWASLPLLNISLIANRLKGPIPKYLANISTLVNLTVQYNQFSGELPEELGSLLNLEK 116 (756)
Q Consensus 37 l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~l~l~~n~~~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~ 116 (756)
+.++++|+.|+|++|+++. +|...... ++|+.|+|++|.|++. ..|..+++|++
T Consensus 15 ~~~~~~L~~L~l~~n~l~~-i~~~~~~~-----------------------~~L~~L~Ls~N~l~~~--~~l~~l~~L~~ 68 (176)
T 1a9n_A 15 YTNAVRDRELDLRGYKIPV-IENLGATL-----------------------DQFDAIDFSDNEIRKL--DGFPLLRRLKT 68 (176)
T ss_dssp EECTTSCEEEECTTSCCCS-CCCGGGGT-----------------------TCCSEEECCSSCCCEE--CCCCCCSSCCE
T ss_pred cCCcCCceEEEeeCCCCch-hHHhhhcC-----------------------CCCCEEECCCCCCCcc--cccccCCCCCE
Confidence 5566777777777777762 23211111 2455555555555532 34455555555
Q ss_pred EeccCCeecccCCccccCCCCCCEEEeeCCcccccCCh--hhcCcCCCcEEEccCCcCcCCCCcc----ccCCCCCCeEE
Q 004400 117 LHLSSNNFTGELPKTFAKLTNMKDFRISDNQFTGQIPS--FIQNWTKLEKLFIQPSGLAGPIPSG----IFSLENLTDLR 190 (756)
Q Consensus 117 L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~--~~~~l~~L~~L~l~~N~l~~~~p~~----~~~l~~L~~L~ 190 (756)
|+|++|+|++..+..|..+++|+.|+|++|+|+ .+|. .+.++++|+.|++++|.++ .+|.. +..+++|+.|+
T Consensus 69 L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~-~~~~~~~l~~l~~L~~L~l~~N~i~-~~~~~~~~~~~~l~~L~~Ld 146 (176)
T 1a9n_A 69 LLVNNNRICRIGEGLDQALPDLTELILTNNSLV-ELGDLDPLASLKSLTYLCILRNPVT-NKKHYRLYVIYKVPQVRVLD 146 (176)
T ss_dssp EECCSSCCCEECSCHHHHCTTCCEEECCSCCCC-CGGGGGGGGGCTTCCEEECCSSGGG-GSTTHHHHHHHHCTTCSEET
T ss_pred EECCCCcccccCcchhhcCCCCCEEECCCCcCC-cchhhHhhhcCCCCCEEEecCCCCC-CcHhHHHHHHHHCCccceeC
Confidence 555555555333333345555555555555554 3333 4455555555555555554 23332 44555555555
Q ss_pred ccCCCC
Q 004400 191 ISDLNG 196 (756)
Q Consensus 191 l~~n~~ 196 (756)
+++|..
T Consensus 147 ~~~n~~ 152 (176)
T 1a9n_A 147 FQKVKL 152 (176)
T ss_dssp TEECCH
T ss_pred CCcCCH
Confidence 555443
|
| >3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.50 E-value=2.1e-14 Score=152.25 Aligned_cols=214 Identities=12% Similarity=0.030 Sum_probs=162.8
Q ss_pred ceeccccccccCccc--ccCCcccCCCCCCCEEEccCCcccCccCccccc--------CCcce-eeccCccccccCCccC
Q 004400 16 KTVNQKRVLKEQNLT--GVLPPKLAELTFLQDIDLTLNYLSGTIPSQWAS--------LPLLN-ISLIANRLKGPIPKYL 84 (756)
Q Consensus 16 ~~~~~~l~L~~~~l~--~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~--------l~~L~-l~l~~n~~~~~~p~~l 84 (756)
+..++.|+|++|++. ...+..+ +.+..+.+..|.| .+.+|.. ++.|+ +.+.+ ++...-+.+|
T Consensus 48 l~~L~~LdLs~n~i~~~~~~~~~~---~~~~~~~~~~~~I---~~~aF~~~~~~~~~g~~~L~~l~L~~-~i~~I~~~aF 120 (329)
T 3sb4_A 48 FPSLKVLDISNAEIKMYSGKAGTY---PNGKFYIYMANFV---PAYAFSNVVNGVTKGKQTLEKVILSE-KIKNIEDAAF 120 (329)
T ss_dssp CTTCCEEEEEEEEECCEEESSSSS---GGGCCEEECTTEE---CTTTTEEEETTEEEECTTCCC-CBCT-TCCEECTTTT
T ss_pred hccCeEEecCcceeEEecCccccc---ccccccccccccc---CHHHhcccccccccccCCCcEEECCc-cccchhHHHh
Confidence 567999999999998 3333322 2245566666633 2355666 77774 66666 7776667788
Q ss_pred cCcCCCcEEEeecCcccccCCcccCCCCCCcEEeccCCeec----ccCCccc----------------------------
Q 004400 85 ANISTLVNLTVQYNQFSGELPEELGSLLNLEKLHLSSNNFT----GELPKTF---------------------------- 132 (756)
Q Consensus 85 ~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~----~~~p~~~---------------------------- 132 (756)
.++++|+.|+|++|.+..+.+.+|.++.++..+.+..+... ......|
T Consensus 121 ~~~~~L~~l~l~~n~i~~i~~~aF~~~~~l~~l~~~~~~~~~~~~~i~~~~f~~~~~L~~~i~~~~~~~l~~~~~~~~~~ 200 (329)
T 3sb4_A 121 KGCDNLKICQIRKKTAPNLLPEALADSVTAIFIPLGSSDAYRFKNRWEHFAFIEGEPLETTIQVGAMGKLEDEIMKAGLQ 200 (329)
T ss_dssp TTCTTCCEEEBCCSSCCEECTTSSCTTTCEEEECTTCTHHHHTSTTTTTSCEEESCCCEEEEEECTTCCHHHHHHHTTCC
T ss_pred hcCcccceEEcCCCCccccchhhhcCCCceEEecCcchhhhhccccccccccccccccceeEEecCCCcHHHHHhhcccC
Confidence 88888888888888887677777888777777776653210 0000000
Q ss_pred ----------------------cCCCCCCEEEeeCCcccccCChhhcCcCCCcEEEccCCcCcCCCCccccCCCCCC-eE
Q 004400 133 ----------------------AKLTNMKDFRISDNQFTGQIPSFIQNWTKLEKLFIQPSGLAGPIPSGIFSLENLT-DL 189 (756)
Q Consensus 133 ----------------------~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~-~L 189 (756)
..+++|+.|+|++|+++...+.+|.+|++|++|+|.+| ++...+.+|.++++|+ .|
T Consensus 201 ~~~~~~l~~~~~l~~~~~~~l~~~~~~L~~l~L~~n~i~~I~~~aF~~~~~L~~l~l~~n-i~~I~~~aF~~~~~L~~~l 279 (329)
T 3sb4_A 201 PRDINFLTIEGKLDNADFKLIRDYMPNLVSLDISKTNATTIPDFTFAQKKYLLKIKLPHN-LKTIGQRVFSNCGRLAGTL 279 (329)
T ss_dssp GGGCSEEEEEECCCHHHHHHHHHHCTTCCEEECTTBCCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEE
T ss_pred ccccceEEEeeeecHHHHHHHHHhcCCCeEEECCCCCcceecHhhhhCCCCCCEEECCcc-cceehHHHhhCChhccEEE
Confidence 13789999999999999777889999999999999998 7767788999999999 99
Q ss_pred EccCCCCCCCCccccccc-cccEEEcccccccCCCCccccCCCCCcEEEc
Q 004400 190 RISDLNGPEATFPQLGNM-KMTKLILRNCNITGELPRYLGKMTKLKVLDL 238 (756)
Q Consensus 190 ~l~~n~~~~~~~~~~~~~-~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L 238 (756)
++.+ ++..+....|... +|+.|+++.|.++.+.+.+|.++++|+.++.
T Consensus 280 ~l~~-~l~~I~~~aF~~c~~L~~l~l~~n~i~~I~~~aF~~~~~L~~ly~ 328 (329)
T 3sb4_A 280 ELPA-SVTAIEFGAFMGCDNLRYVLATGDKITTLGDELFGNGVPSKLIYK 328 (329)
T ss_dssp EECT-TCCEECTTTTTTCTTEEEEEECSSCCCEECTTTTCTTCCCCEEEC
T ss_pred EEcc-cceEEchhhhhCCccCCEEEeCCCccCccchhhhcCCcchhhhcc
Confidence 9998 8888888888776 6999999999999888889999999999874
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=99.45 E-value=3.1e-13 Score=128.44 Aligned_cols=86 Identities=23% Similarity=0.291 Sum_probs=52.2
Q ss_pred CCCcEEEeecCcccccCCcccCCCCCCcEEeccCCeecccCCccccCCCCCCEEEeeCCcccccCChhhcCcCCCcEEEc
Q 004400 88 STLVNLTVQYNQFSGELPEELGSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRISDNQFTGQIPSFIQNWTKLEKLFI 167 (756)
Q Consensus 88 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l 167 (756)
++|+.|+|++|+|++..|..|.++++|++|+|++|+|++..+..|.++++|+.|+|++|+|++..+..|.++++|+.|+|
T Consensus 30 ~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L 109 (170)
T 3g39_A 30 TTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLNDNQLKSIPRGAFDNLKSLTHIWL 109 (170)
T ss_dssp TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred CCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCCCccCEeCHHHhcCCCCCCEEEe
Confidence 45566666666666555556666666666666666666555555566666666666666666554555666666666666
Q ss_pred cCCcCc
Q 004400 168 QPSGLA 173 (756)
Q Consensus 168 ~~N~l~ 173 (756)
++|.+.
T Consensus 110 ~~N~~~ 115 (170)
T 3g39_A 110 LNNPWD 115 (170)
T ss_dssp CSSCBC
T ss_pred CCCCCC
Confidence 666655
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=99.44 E-value=2.9e-13 Score=128.69 Aligned_cols=106 Identities=18% Similarity=0.223 Sum_probs=90.9
Q ss_pred CCcEEEeecCcccccCCcccCCCCCCcEEeccCCeecccCCccccCCCCCCEEEeeCCcccccCChhhcCcCCCcEEEcc
Q 004400 89 TLVNLTVQYNQFSGELPEELGSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRISDNQFTGQIPSFIQNWTKLEKLFIQ 168 (756)
Q Consensus 89 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~ 168 (756)
..+.|++++|.|+ .+|..+. ++|++|+|++|+|++..|..|.++++|+.|+|++|+|++..+..|.++++|++|+|+
T Consensus 10 ~~~~l~~s~n~l~-~ip~~~~--~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~ 86 (170)
T 3g39_A 10 SGTTVDCSGKSLA-SVPTGIP--TTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLN 86 (170)
T ss_dssp ETTEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECC
T ss_pred CCCEEEeCCCCcC-ccCccCC--CCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECC
Confidence 3578999999998 6777664 789999999999998888889999999999999999998777788999999999999
Q ss_pred CCcCcCCCCccccCCCCCCeEEccCCCCC
Q 004400 169 PSGLAGPIPSGIFSLENLTDLRISDLNGP 197 (756)
Q Consensus 169 ~N~l~~~~p~~~~~l~~L~~L~l~~n~~~ 197 (756)
+|+|++..+..|..+++|+.|+|++|.+.
T Consensus 87 ~N~l~~~~~~~~~~l~~L~~L~L~~N~~~ 115 (170)
T 3g39_A 87 DNQLKSIPRGAFDNLKSLTHIWLLNNPWD 115 (170)
T ss_dssp SSCCCCCCTTTTTTCTTCCEEECCSSCBC
T ss_pred CCccCEeCHHHhcCCCCCCEEEeCCCCCC
Confidence 99999766777888888888877776544
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.43 E-value=4.8e-13 Score=127.59 Aligned_cols=86 Identities=22% Similarity=0.325 Sum_probs=51.7
Q ss_pred CCCcEEEeecCcccccCCcccCCCCCCcEEeccCCeecccCCccccCCCCCCEEEeeCCcccccCChhhcCcCCCcEEEc
Q 004400 88 STLVNLTVQYNQFSGELPEELGSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRISDNQFTGQIPSFIQNWTKLEKLFI 167 (756)
Q Consensus 88 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l 167 (756)
++|+.|+|++|+|++..|..|.++++|++|+|++|+|++..+..|.++++|+.|+|++|+|++..+..|.++++|+.|+|
T Consensus 33 ~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~L 112 (174)
T 2r9u_A 33 TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLNDNHLKSIPRGAFDNLKSLTHIYL 112 (174)
T ss_dssp TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCSEEEC
T ss_pred CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCCCccceeCHHHhccccCCCEEEe
Confidence 45666666666666555556666666666666666666444444556666666666666666444444666666666666
Q ss_pred cCCcCc
Q 004400 168 QPSGLA 173 (756)
Q Consensus 168 ~~N~l~ 173 (756)
++|.+.
T Consensus 113 ~~N~~~ 118 (174)
T 2r9u_A 113 YNNPWD 118 (174)
T ss_dssp CSSCBC
T ss_pred CCCCcc
Confidence 666655
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.42 E-value=5.3e-13 Score=127.31 Aligned_cols=106 Identities=18% Similarity=0.238 Sum_probs=90.8
Q ss_pred CcEEEeecCcccccCCcccCCCCCCcEEeccCCeecccCCccccCCCCCCEEEeeCCcccccCChhhcCcCCCcEEEccC
Q 004400 90 LVNLTVQYNQFSGELPEELGSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRISDNQFTGQIPSFIQNWTKLEKLFIQP 169 (756)
Q Consensus 90 L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~ 169 (756)
-+.+++++|+++ .+|..+. ++|+.|+|++|+|++..|..|.++++|+.|+|++|+|++..+..|.++++|+.|+|++
T Consensus 14 ~~~l~~~~n~l~-~iP~~~~--~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~ 90 (174)
T 2r9u_A 14 QTLVNCQNIRLA-SVPAGIP--TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLND 90 (174)
T ss_dssp SSEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred CcEEEeCCCCCC-ccCCCcC--CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCC
Confidence 378999999997 7787665 7899999999999988888999999999999999999977777789999999999999
Q ss_pred CcCcCCCCccccCCCCCCeEEccCCCCCC
Q 004400 170 SGLAGPIPSGIFSLENLTDLRISDLNGPE 198 (756)
Q Consensus 170 N~l~~~~p~~~~~l~~L~~L~l~~n~~~~ 198 (756)
|+|++..+..|..+++|+.|++++|.+..
T Consensus 91 N~l~~l~~~~~~~l~~L~~L~L~~N~~~c 119 (174)
T 2r9u_A 91 NHLKSIPRGAFDNLKSLTHIYLYNNPWDC 119 (174)
T ss_dssp SCCCCCCTTTTTTCTTCSEEECCSSCBCT
T ss_pred CccceeCHHHhccccCCCEEEeCCCCccc
Confidence 99996666668888888888877766543
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.33 E-value=5.9e-12 Score=128.76 Aligned_cols=144 Identities=15% Similarity=0.102 Sum_probs=113.9
Q ss_pred hhcCccccCcccCCCCccEEEeeccCCcEEEEEEccccCcccHHHHHHHHHHHHhCC-CCceeeEeeEEEeCCeEEEEEE
Q 004400 414 ATNNFATDNNIGEGGFGPVYKGLLADGTAIAVKQLSSKSKQGNREFINEIGMISALQ-HPNLVKLYGCCIEGNQLLLIYE 492 (756)
Q Consensus 414 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lV~e 492 (756)
....|.....++.|+.+.||++... ++.+++|............+.+|+++++.+. +..+.++++++.+.+..|+|||
T Consensus 12 ~l~~~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e 90 (263)
T 3tm0_A 12 LIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMS 90 (263)
T ss_dssp HHTTSEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEE
T ss_pred HhccceeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEE
Confidence 3456878888899999999999754 6889999986532223346889999999985 6778889999999999999999
Q ss_pred ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcC----------------------------------------
Q 004400 493 YLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGE---------------------------------------- 532 (756)
Q Consensus 493 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~---------------------------------------- 532 (756)
|++|.+|.+.+. +......++.+++++|+.||+.
T Consensus 91 ~i~G~~l~~~~~------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (263)
T 3tm0_A 91 EADGVLCSEEYE------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPF 164 (263)
T ss_dssp CCSSEEHHHHCC------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSS
T ss_pred ecCCeehhhccC------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccccC
Confidence 999999977531 1223457889999999999981
Q ss_pred ----------------CCCCeEcCCCCCCceEecCCCCEEEccCCccc
Q 004400 533 ----------------SRIKVVHRDIKATNVLLDKDLNSKISDFGLAK 564 (756)
Q Consensus 533 ----------------g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~ 564 (756)
....++|+|++|.||+++++..+.|+||+.+.
T Consensus 165 ~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 165 KDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp SSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred CCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 11348999999999999876556799999875
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=99.26 E-value=1.2e-11 Score=132.01 Aligned_cols=102 Identities=16% Similarity=0.213 Sum_probs=70.5
Q ss_pred eeccCc-cccccCCccCcCcCCCcEEEeec-CcccccCCcccCCCCCCcEEeccCCeecccCCccccCCCCCCEEEeeCC
Q 004400 69 ISLIAN-RLKGPIPKYLANISTLVNLTVQY-NQFSGELPEELGSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRISDN 146 (756)
Q Consensus 69 l~l~~n-~~~~~~p~~l~~l~~L~~L~L~~-N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N 146 (756)
++..++ ++. .+|. |..+++|+.|+|++ |+|++..+..|++|++|+.|+|++|+|++..|..|.+|++|+.|+|++|
T Consensus 13 v~~~~~n~l~-~ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N 90 (347)
T 2ifg_A 13 LRCTRDGALD-SLHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFN 90 (347)
T ss_dssp EECCSSCCCT-TTTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSS
T ss_pred EEcCCCCCCC-ccCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeCCCC
Confidence 444444 343 4666 77777777777775 7777666677777777777777777777777777777777777777777
Q ss_pred cccccCChhhcCcCCCcEEEccCCcCc
Q 004400 147 QFTGQIPSFIQNWTKLEKLFIQPSGLA 173 (756)
Q Consensus 147 ~l~~~~p~~~~~l~~L~~L~l~~N~l~ 173 (756)
+|++..+..|..++ |+.|+|.+|.+.
T Consensus 91 ~l~~~~~~~~~~~~-L~~l~l~~N~~~ 116 (347)
T 2ifg_A 91 ALESLSWKTVQGLS-LQELVLSGNPLH 116 (347)
T ss_dssp CCSCCCSTTTCSCC-CCEEECCSSCCC
T ss_pred ccceeCHHHcccCC-ceEEEeeCCCcc
Confidence 77765555555555 777777777765
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=99.24 E-value=1.5e-11 Score=131.26 Aligned_cols=105 Identities=15% Similarity=0.144 Sum_probs=89.3
Q ss_pred cEEEeecC-cccccCCcccCCCCCCcEEeccC-CeecccCCccccCCCCCCEEEeeCCcccccCChhhcCcCCCcEEEcc
Q 004400 91 VNLTVQYN-QFSGELPEELGSLLNLEKLHLSS-NNFTGELPKTFAKLTNMKDFRISDNQFTGQIPSFIQNWTKLEKLFIQ 168 (756)
Q Consensus 91 ~~L~L~~N-~l~~~~p~~~~~l~~L~~L~L~~-N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~ 168 (756)
..++++++ +|+ .+|. |..+++|+.|+|++ |+|++..+..|.+|++|+.|+|++|+|++..|..|.++++|+.|+|+
T Consensus 11 ~~v~~~~~n~l~-~ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~ 88 (347)
T 2ifg_A 11 SGLRCTRDGALD-SLHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLS 88 (347)
T ss_dssp SCEECCSSCCCT-TTTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECC
T ss_pred CEEEcCCCCCCC-ccCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeCC
Confidence 45788888 898 5888 99999999999996 99998888889999999999999999999899999999999999999
Q ss_pred CCcCcCCCCccccCCCCCCeEEccCCCCCC
Q 004400 169 PSGLAGPIPSGIFSLENLTDLRISDLNGPE 198 (756)
Q Consensus 169 ~N~l~~~~p~~~~~l~~L~~L~l~~n~~~~ 198 (756)
+|+|++..+..+..++ |+.|+|.+|.+..
T Consensus 89 ~N~l~~~~~~~~~~~~-L~~l~l~~N~~~c 117 (347)
T 2ifg_A 89 FNALESLSWKTVQGLS-LQELVLSGNPLHC 117 (347)
T ss_dssp SSCCSCCCSTTTCSCC-CCEEECCSSCCCC
T ss_pred CCccceeCHHHcccCC-ceEEEeeCCCccC
Confidence 9999965555555554 8888888776654
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.24 E-value=2.2e-13 Score=146.40 Aligned_cols=157 Identities=17% Similarity=0.161 Sum_probs=67.0
Q ss_pred CCCcEEEeecCcccccCCcccC-CCCCCcEEeccCCeecccCCccc-----cCCCCCCEEEeeCCcccc----cCChhhc
Q 004400 88 STLVNLTVQYNQFSGELPEELG-SLLNLEKLHLSSNNFTGELPKTF-----AKLTNMKDFRISDNQFTG----QIPSFIQ 157 (756)
Q Consensus 88 ~~L~~L~L~~N~l~~~~p~~~~-~l~~L~~L~L~~N~l~~~~p~~~-----~~l~~L~~L~L~~N~l~~----~~p~~~~ 157 (756)
++|++|+|++|.|+......+. .+.+|+.|+|++|+|+......+ ...++|++|+|++|.|+. .++..+.
T Consensus 101 ~~L~~L~Ls~n~l~~~~~~~l~~~L~~L~~L~Ls~n~l~~~~~~~L~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~ 180 (372)
T 3un9_A 101 HALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLGPEACKDLRDLLLHDQCQITTLRLSNNPLTAAGVAVLMEGLA 180 (372)
T ss_dssp SCEEEEECTTCCCCHHHHHHTHHHHHTEEEEECCSSCCCHHHHHHHHHHHHSTTCCCCEEECCSSCCHHHHHHHHHHHHH
T ss_pred CCceEEEecCCCCCHHHHHHHHHHHHhccHhhcCCCCCCHHHHHHHHHHHHhcCCccceeeCCCCCCChHHHHHHHHHHh
Confidence 3445555555544422222221 23345555555555442222222 123445555555555442 1223334
Q ss_pred CcCCCcEEEccCCcCcCC----CCccccCCCCCCeEEccCCCCCCCCccccc-----cccccEEEcccccccCCCCcccc
Q 004400 158 NWTKLEKLFIQPSGLAGP----IPSGIFSLENLTDLRISDLNGPEATFPQLG-----NMKMTKLILRNCNITGELPRYLG 228 (756)
Q Consensus 158 ~l~~L~~L~l~~N~l~~~----~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~-----~~~L~~L~L~~n~l~~~~p~~~~ 228 (756)
.+++|++|+|++|.++.. ++..+...++|+.|+|++|.+.......+. +.+|+.|+|++|.|+......+.
T Consensus 181 ~~~~L~~L~Ls~N~l~~~g~~~L~~~L~~~~~L~~L~Ls~N~i~~~g~~~l~~~L~~~~~L~~L~Ls~N~i~~~g~~~L~ 260 (372)
T 3un9_A 181 GNTSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAGDTAALALARAAREHPSLELLHLYFNELSSEGRQVLR 260 (372)
T ss_dssp TCSSCCEEECTTSSCHHHHHHHHHHHGGGCSCCCEEECCSSCCCHHHHHHHHHHHHHCSSCCEEECTTSSCCHHHHHHHH
T ss_pred cCCCcCEEeCCCCCCCcHHHHHHHHHHhcCCCcCeEECCCCCCCHHHHHHHHHHHHhCCCCCEEeccCCCCCHHHHHHHH
Confidence 445555555555555421 233344445555555555555443222221 12466666666666544433443
Q ss_pred CC---C--CCcEEE--ccCCcCC
Q 004400 229 KM---T--KLKVLD--LSFNRLR 244 (756)
Q Consensus 229 ~l---~--~L~~L~--Ls~N~l~ 244 (756)
.+ . .|+.+. +..|.++
T Consensus 261 ~~~~~~~~~L~~l~~ll~~~~~~ 283 (372)
T 3un9_A 261 DLGGAAEGGARVVVSLTEGTAVS 283 (372)
T ss_dssp HCC------CEEECCCC----CH
T ss_pred HHhcCCCccchhhHhhhcCCccC
Confidence 32 1 166666 6666554
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.21 E-value=1.5e-11 Score=125.39 Aligned_cols=136 Identities=16% Similarity=0.110 Sum_probs=102.0
Q ss_pred CccccCcccCCCCccEEEeeccCCcEEEEEEccccCcccHHHHHHHHHHHHhCCCCc--eeeEeeEEEeCCeEEEEEEec
Q 004400 417 NFATDNNIGEGGFGPVYKGLLADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPN--LVKLYGCCIEGNQLLLIYEYL 494 (756)
Q Consensus 417 ~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~~~~~~~~~~~lV~e~~ 494 (756)
++......+.|..+.||++...+|+.+++|..... ....+.+|+.+++.+.+.+ +.+++++...++..++||||+
T Consensus 21 ~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i 97 (264)
T 1nd4_A 21 GYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEV 97 (264)
T ss_dssp TCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECC
T ss_pred CCceEecccCCCCceEEEEecCCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEec
Confidence 44443344456679999998877888999997643 2245788999999986545 455888888888899999999
Q ss_pred CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCC-----------------------------------------
Q 004400 495 ENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGES----------------------------------------- 533 (756)
Q Consensus 495 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g----------------------------------------- 533 (756)
+|.++. .. ..+ ...++.++++.|+.||+..
T Consensus 98 ~G~~l~--~~----~~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 168 (264)
T 1nd4_A 98 PGQDLL--SS----HLA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPA 168 (264)
T ss_dssp SSEETT--TS----CCC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHH
T ss_pred CCcccC--cC----cCC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHH
Confidence 998873 11 112 2367788888888888742
Q ss_pred --------------CCCeEcCCCCCCceEecCCCCEEEccCCccc
Q 004400 534 --------------RIKVVHRDIKATNVLLDKDLNSKISDFGLAK 564 (756)
Q Consensus 534 --------------~~~iiH~Dikp~Nill~~~~~~kl~DFGla~ 564 (756)
+..++|||++|.||+++++..+.|+|||.+.
T Consensus 169 ~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~ 213 (264)
T 1nd4_A 169 ELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 213 (264)
T ss_dssp HHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence 1129999999999999887667799999875
|
| >4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} | Back alignment and structure |
|---|
Probab=99.19 E-value=3.1e-10 Score=123.32 Aligned_cols=244 Identities=12% Similarity=0.075 Sum_probs=132.4
Q ss_pred eeccceeccccccccCcccccCCcccCCCCCCCEEEccCCcccCccCcccccCCcceeeccCccccc-------------
Q 004400 12 FWKQKTVNQKRVLKEQNLTGVLPPKLAELTFLQDIDLTLNYLSGTIPSQWASLPLLNISLIANRLKG------------- 78 (756)
Q Consensus 12 ~~~~~~~~~~l~L~~~~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~l~l~~n~~~~------------- 78 (756)
.|.+|+.|+++.|.. +++.+-..+|.++++|+.++|.++ ++..-..+|..+..|+.....+++..
T Consensus 66 AF~~c~~L~~i~lp~-~i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~c~~L~~i~~p~~l~~i~~~aF~~~~~~~ 143 (394)
T 4fs7_A 66 AFQGCRKVTEIKIPS-TVREIGEFAFENCSKLEIINIPDS-VKMIGRCTFSGCYALKSILLPLMLKSIGVEAFKGCDFKE 143 (394)
T ss_dssp TTTTCTTEEEEECCT-TCCEECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCCCCCCTTCCEECTTTTTTCCCSE
T ss_pred HhhCCCCceEEEeCC-CccCcchhHhhCCCCCcEEEeCCC-ceEccchhhcccccchhhcccCceeeecceeeecccccc
Confidence 478999999999974 587777788999999999999765 55444566776666643332222222
Q ss_pred ---------cCCccCcCcCCCcEEEeecCcccccCCcccCCCCCCcEEeccCCeecccCCccccCCCCCCEEEeeCCccc
Q 004400 79 ---------PIPKYLANISTLVNLTVQYNQFSGELPEELGSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRISDNQFT 149 (756)
Q Consensus 79 ---------~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~ 149 (756)
.-..+|.++++|+.+.+.++... ....+|.++.+|+.+.+..| ++.+....|.++..|+.+.+.++...
T Consensus 144 ~~~~~~~~~i~~~aF~~c~~L~~i~l~~~~~~-I~~~~F~~c~~L~~i~l~~~-~~~I~~~~F~~~~~L~~i~~~~~~~~ 221 (394)
T 4fs7_A 144 ITIPEGVTVIGDEAFATCESLEYVSLPDSMET-LHNGLFSGCGKLKSIKLPRN-LKIIRDYCFAECILLENMEFPNSLYY 221 (394)
T ss_dssp EECCTTCCEECTTTTTTCTTCCEEECCTTCCE-ECTTTTTTCTTCCBCCCCTT-CCEECTTTTTTCTTCCBCCCCTTCCE
T ss_pred cccCccccccchhhhcccCCCcEEecCCccce-eccccccCCCCceEEEcCCC-ceEeCchhhccccccceeecCCCceE
Confidence 22345666777777777655433 55566777777777777665 33344445666666666555544322
Q ss_pred ccCChhhcCcCCCcEEEccCCcCcCCCCccccCCCCCCeEEccCCCCCCCCcccccc----------------------c
Q 004400 150 GQIPSFIQNWTKLEKLFIQPSGLAGPIPSGIFSLENLTDLRISDLNGPEATFPQLGN----------------------M 207 (756)
Q Consensus 150 ~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~----------------------~ 207 (756)
+.+.+....+|+.+.+..+ ++......+..+.+|+.+.+..+.. ......+.. .
T Consensus 222 --i~~~~~~~~~l~~i~ip~~-~~~i~~~~f~~~~~l~~~~~~~~~~-~i~~~~F~~~~~l~~~~~~~~~i~~~~F~~~~ 297 (394)
T 4fs7_A 222 --LGDFALSKTGVKNIIIPDS-FTELGKSVFYGCTDLESISIQNNKL-RIGGSLFYNCSGLKKVIYGSVIVPEKTFYGCS 297 (394)
T ss_dssp --ECTTTTTTCCCCEEEECTT-CCEECSSTTTTCSSCCEEEECCTTC-EECSCTTTTCTTCCEEEECSSEECTTTTTTCT
T ss_pred --eehhhcccCCCceEEECCC-ceecccccccccccceeEEcCCCcc-eeeccccccccccceeccCceeeccccccccc
Confidence 1222223344444444322 1212334455556666665554322 111111211 2
Q ss_pred cccEEEcccccccCCCCccccCCCCCcEEEccCCcCCCCCCccCcCCCCCCeEEecCc
Q 004400 208 KMTKLILRNCNITGELPRYLGKMTKLKVLDLSFNRLRGQIPSNFDDLYDVDYIYFAGN 265 (756)
Q Consensus 208 ~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N 265 (756)
+|+.+.+.++ ++.+...+|.++++|+.++|.++ ++.+...+|.++.+|+.+.+..|
T Consensus 298 ~L~~i~l~~~-i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~c~~L~~i~lp~~ 353 (394)
T 4fs7_A 298 SLTEVKLLDS-VKFIGEEAFESCTSLVSIDLPYL-VEEIGKRSFRGCTSLSNINFPLS 353 (394)
T ss_dssp TCCEEEECTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCEECCCTT
T ss_pred cccccccccc-cceechhhhcCCCCCCEEEeCCc-ccEEhHHhccCCCCCCEEEECcc
Confidence 3445554433 33333444555555555555433 44344445555555555555444
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.18 E-value=4.5e-13 Score=144.01 Aligned_cols=180 Identities=14% Similarity=0.148 Sum_probs=123.8
Q ss_pred CCCCEEEccCCcccCccCcccccC-----Ccc-eeeccCccccccCCccCc-CcCCCcEEEeecCcccccCCccc-----
Q 004400 41 TFLQDIDLTLNYLSGTIPSQWASL-----PLL-NISLIANRLKGPIPKYLA-NISTLVNLTVQYNQFSGELPEEL----- 108 (756)
Q Consensus 41 ~~L~~L~L~~n~l~~~~p~~~~~l-----~~L-~l~l~~n~~~~~~p~~l~-~l~~L~~L~L~~N~l~~~~p~~~----- 108 (756)
+.|+.|+|++|.|+......+... +.| .|+|.+|++.......+. .+++|+.|+|++|.|+......+
T Consensus 72 ~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~L~~L~Ls~n~l~~~~~~~L~~~L~ 151 (372)
T 3un9_A 72 SSLRQLNLAGVRMTPVKCTVVAAVLGSGRHALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLGPEACKDLRDLLL 151 (372)
T ss_dssp TTCCEEECTTSCCCHHHHHHHHHHHSSCSSCEEEEECTTCCCCHHHHHHTHHHHHTEEEEECCSSCCCHHHHHHHHHHHH
T ss_pred hhCCEEEecCCCCCHHHHHHHHHHHhhCCCCceEEEecCCCCCHHHHHHHHHHHHhccHhhcCCCCCCHHHHHHHHHHHH
Confidence 567888888888875444433322 456 588888887655444443 46788999999999875544444
Q ss_pred CCCCCCcEEeccCCeecc----cCCccccCCCCCCEEEeeCCccccc----CChhhcCcCCCcEEEccCCcCcCC----C
Q 004400 109 GSLLNLEKLHLSSNNFTG----ELPKTFAKLTNMKDFRISDNQFTGQ----IPSFIQNWTKLEKLFIQPSGLAGP----I 176 (756)
Q Consensus 109 ~~l~~L~~L~L~~N~l~~----~~p~~~~~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~l~~N~l~~~----~ 176 (756)
...++|++|+|++|+|+. .++..+..+++|++|+|++|+|+.. ++..+..+++|++|+|++|.++.. +
T Consensus 152 ~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~L~~L~Ls~N~l~~~g~~~L~~~L~~~~~L~~L~Ls~N~i~~~g~~~l 231 (372)
T 3un9_A 152 HDQCQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAGDTAALAL 231 (372)
T ss_dssp STTCCCCEEECCSSCCHHHHHHHHHHHHHTCSSCCEEECTTSSCHHHHHHHHHHHGGGCSCCCEEECCSSCCCHHHHHHH
T ss_pred hcCCccceeeCCCCCCChHHHHHHHHHHhcCCCcCEEeCCCCCCCcHHHHHHHHHHhcCCCcCeEECCCCCCCHHHHHHH
Confidence 356789999999999874 2444557788999999999998843 356677788999999999999753 3
Q ss_pred CccccCCCCCCeEEccCCCCCCCCccccccc---c---ccEEE--ccccccc
Q 004400 177 PSGIFSLENLTDLRISDLNGPEATFPQLGNM---K---MTKLI--LRNCNIT 220 (756)
Q Consensus 177 p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~---~---L~~L~--L~~n~l~ 220 (756)
+..+...++|++|+|++|.+.......+... . ++.+. +..|.++
T Consensus 232 ~~~L~~~~~L~~L~Ls~N~i~~~g~~~L~~~~~~~~~~L~~l~~ll~~~~~~ 283 (372)
T 3un9_A 232 ARAAREHPSLELLHLYFNELSSEGRQVLRDLGGAAEGGARVVVSLTEGTAVS 283 (372)
T ss_dssp HHHHHHCSSCCEEECTTSSCCHHHHHHHHHCC------CEEECCCC----CH
T ss_pred HHHHHhCCCCCEEeccCCCCCHHHHHHHHHHhcCCCccchhhHhhhcCCccC
Confidence 4455567899999999998887555443322 1 55555 5555554
|
| >4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} | Back alignment and structure |
|---|
Probab=99.04 E-value=1e-08 Score=111.27 Aligned_cols=265 Identities=12% Similarity=0.075 Sum_probs=167.3
Q ss_pred eccc-eeccccccccCcccccCCcccCCCCCCCEEEccCCc---ccCccCcccccCCcceeeccCccccccCCccCcCcC
Q 004400 13 WKQK-TVNQKRVLKEQNLTGVLPPKLAELTFLQDIDLTLNY---LSGTIPSQWASLPLLNISLIANRLKGPIPKYLANIS 88 (756)
Q Consensus 13 ~~~~-~~~~~l~L~~~~l~~~~p~~l~~l~~L~~L~L~~n~---l~~~~p~~~~~l~~L~l~l~~n~~~~~~p~~l~~l~ 88 (756)
|.++ ..++.+.|.+ +++.+-..+|.++++|+.+.+..|. ++..-..+|.....|+-....+++...-..+|.++.
T Consensus 59 F~~~~~~L~sI~iP~-svt~Ig~~AF~~C~~L~~i~~~~n~p~~l~~Ig~~aF~~c~~L~~i~~~~~~~~I~~~aF~~c~ 137 (394)
T 4gt6_A 59 FCNYKYVLTSVQIPD-TVTEIGSNAFYNCTSLKRVTIQDNKPSCVKKIGRQAFMFCSELTDIPILDSVTEIDSEAFHHCE 137 (394)
T ss_dssp TTTCCSCCCEEEECT-TCCEECTTTTTTCTTCCEEEEGGGCCCCCCEECTTTTTTCTTCCBCGGGTTCSEECTTTTTTCT
T ss_pred ccCCCCcCEEEEECC-CeeEEhHHHhhCCccCceEeecCCCCCeeeEechhhchhcccceeeccCCccceehhhhhhhhc
Confidence 6666 4588888875 4777777889999999999998774 664455678888888655455667766777899999
Q ss_pred CCcEEEeecCcccccCCcccCCCCCCcEEeccCCeecccCCccccCCCCCCEEEeeCCcccccCChhhcCcCCCcEEEcc
Q 004400 89 TLVNLTVQYNQFSGELPEELGSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRISDNQFTGQIPSFIQNWTKLEKLFIQ 168 (756)
Q Consensus 89 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~ 168 (756)
+|+.+.+..+- ..+...+|..+.+|+.+.+..+ ++.+-...|. ..+|+.+.+..+-.. ....+|.++.+|......
T Consensus 138 ~L~~i~lp~~~-~~I~~~~F~~c~~L~~i~~~~~-~~~I~~~aF~-~~~l~~i~ip~~~~~-i~~~af~~c~~l~~~~~~ 213 (394)
T 4gt6_A 138 ELDTVTIPEGV-TSVADGMFSYCYSLHTVTLPDS-VTAIEERAFT-GTALTQIHIPAKVTR-IGTNAFSECFALSTITSD 213 (394)
T ss_dssp TCCEEECCTTC-CEECTTTTTTCTTCCEEECCTT-CCEECTTTTT-TCCCSEEEECTTCCE-ECTTTTTTCTTCCEEEEC
T ss_pred cccccccccee-eeecccceecccccccccccce-eeEecccccc-ccceeEEEECCcccc-cccchhhhccccceeccc
Confidence 99999997654 3366678888999999998766 4424444454 356888877665433 455666666666665544
Q ss_pred CCcCc------------------------------------CCCCccccCCCCCCeEEccCCCCCCCCccccccc-cccE
Q 004400 169 PSGLA------------------------------------GPIPSGIFSLENLTDLRISDLNGPEATFPQLGNM-KMTK 211 (756)
Q Consensus 169 ~N~l~------------------------------------~~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~-~L~~ 211 (756)
.+... .....+|.++.+|+.+.+.++ ........|... .|+.
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~v~~i~~~aF~~c~~L~~i~lp~~-~~~I~~~aF~~c~~L~~ 292 (394)
T 4gt6_A 214 SESYPAIDNVLYEKSANGDYALIRYPSQREDPAFKIPNGVARIETHAFDSCAYLASVKMPDS-VVSIGTGAFMNCPALQD 292 (394)
T ss_dssp CSSSCBSSSCEEEECTTSCEEEEECCTTCCCSEEECCTTEEEECTTTTTTCSSCCEEECCTT-CCEECTTTTTTCTTCCE
T ss_pred ccccccccceeecccccccccccccccccccceEEcCCcceEcccceeeecccccEEecccc-cceecCccccccccccc
Confidence 33221 112334556666666666543 223333333332 4666
Q ss_pred EEcccccccCCCCccccCCCCCcEEEccCCcCCCCCCccCcCCCCCCeEEecCccccccCCc-hh--hcCCCeeEeecC
Q 004400 212 LILRNCNITGELPRYLGKMTKLKVLDLSFNRLRGQIPSNFDDLYDVDYIYFAGNLLTGAIPP-WM--LERGDKIDLSYN 287 (756)
Q Consensus 212 L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~-~~--~~~l~~l~ls~N 287 (756)
+.+. +.++.....+|.++.+|+.++|..+ ++.+...+|.++.+|+.+.+..+ ++ .+.. .+ ..+|+.+++.+|
T Consensus 293 i~l~-~~i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~C~~L~~i~ip~s-v~-~I~~~aF~~C~~L~~i~~~~~ 367 (394)
T 4gt6_A 293 IEFS-SRITELPESVFAGCISLKSIDIPEG-ITQILDDAFAGCEQLERIAIPSS-VT-KIPESAFSNCTALNNIEYSGS 367 (394)
T ss_dssp EECC-TTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEECTT-CC-BCCGGGGTTCTTCCEEEESSC
T ss_pred ccCC-CcccccCceeecCCCCcCEEEeCCc-ccEehHhHhhCCCCCCEEEECcc-cC-EEhHhHhhCCCCCCEEEECCc
Confidence 6664 3444455556777777777777654 44455566777777777777544 44 2332 22 345666666554
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.03 E-value=4.5e-10 Score=120.35 Aligned_cols=142 Identities=17% Similarity=0.263 Sum_probs=107.0
Q ss_pred ccCcccCCCCccEEEeeccCCcEEEEEEcc--ccC-cccHHHHHHHHHHHHhCC--CCceeeEeeEEEeC---CeEEEEE
Q 004400 420 TDNNIGEGGFGPVYKGLLADGTAIAVKQLS--SKS-KQGNREFINEIGMISALQ--HPNLVKLYGCCIEG---NQLLLIY 491 (756)
Q Consensus 420 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~--~~~-~~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~---~~~~lV~ 491 (756)
..+.++.|.++.||+....+ ..+++|+.. ... ......+.+|+.+++.+. +..+.+++.++.+. +..++||
T Consensus 42 ~~~~l~~G~sn~~y~v~~~~-~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vm 120 (359)
T 3dxp_A 42 SVEQFKGGQSNPTFKLVTPG-QTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIM 120 (359)
T ss_dssp EEEECCC-CCSCEEEEECSS-CEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEE
T ss_pred eEEEcCCcccceEEEEEECC-ceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEE
Confidence 45678999999999988764 578888775 321 123356788999999997 45578888888776 4589999
Q ss_pred EecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCC--------------------------------------
Q 004400 492 EYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGES-------------------------------------- 533 (756)
Q Consensus 492 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g-------------------------------------- 533 (756)
||++|..+.+. ....++...+..++.++++.|+.||...
T Consensus 121 e~v~G~~l~~~---~~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 197 (359)
T 3dxp_A 121 EFVSGRVLWDQ---SLPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPAM 197 (359)
T ss_dssp ECCCCBCCCCT---TCTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHHH
T ss_pred EecCCeecCCC---ccccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChHH
Confidence 99999876431 1234678888999999999999999731
Q ss_pred -----------------CCCeEcCCCCCCceEecCCCC--EEEccCCcccc
Q 004400 534 -----------------RIKVVHRDIKATNVLLDKDLN--SKISDFGLAKL 565 (756)
Q Consensus 534 -----------------~~~iiH~Dikp~Nill~~~~~--~kl~DFGla~~ 565 (756)
...++|||+++.||+++.++. +.|+||+.+..
T Consensus 198 ~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 198 DSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred HHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 246899999999999997753 68999999874
|
| >4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} | Back alignment and structure |
|---|
Probab=99.00 E-value=5.6e-09 Score=113.32 Aligned_cols=249 Identities=10% Similarity=0.092 Sum_probs=179.1
Q ss_pred eeccceeccccccccCc---ccccCCcccCCCCCCCEEEccCCcccCccCcccccCCcceeeccCccccccCCccCcCcC
Q 004400 12 FWKQKTVNQKRVLKEQN---LTGVLPPKLAELTFLQDIDLTLNYLSGTIPSQWASLPLLNISLIANRLKGPIPKYLANIS 88 (756)
Q Consensus 12 ~~~~~~~~~~l~L~~~~---l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~l~l~~n~~~~~~p~~l~~l~ 88 (756)
.|.+|+.|+.+.+..|. ++..-..+|..+..|+.+.+..+ ++..-..+|.....|+.....+.+.......|.++.
T Consensus 82 AF~~C~~L~~i~~~~n~p~~l~~Ig~~aF~~c~~L~~i~~~~~-~~~I~~~aF~~c~~L~~i~lp~~~~~I~~~~F~~c~ 160 (394)
T 4gt6_A 82 AFYNCTSLKRVTIQDNKPSCVKKIGRQAFMFCSELTDIPILDS-VTEIDSEAFHHCEELDTVTIPEGVTSVADGMFSYCY 160 (394)
T ss_dssp TTTTCTTCCEEEEGGGCCCCCCEECTTTTTTCTTCCBCGGGTT-CSEECTTTTTTCTTCCEEECCTTCCEECTTTTTTCT
T ss_pred HhhCCccCceEeecCCCCCeeeEechhhchhcccceeeccCCc-cceehhhhhhhhcccccccccceeeeecccceeccc
Confidence 48999999999988764 66566678888888888887665 443555677777777644344556656667788888
Q ss_pred CCcEEEeecCcccccCCcccCCCCCCcEEeccCCeecccCCccccCCCCCCEEEeeCC----------------------
Q 004400 89 TLVNLTVQYNQFSGELPEELGSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRISDN---------------------- 146 (756)
Q Consensus 89 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N---------------------- 146 (756)
.|+.+.+..+ ++.+...+|.. .+|+.+.+..+-.. .....|..+.+|+......+
T Consensus 161 ~L~~i~~~~~-~~~I~~~aF~~-~~l~~i~ip~~~~~-i~~~af~~c~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (394)
T 4gt6_A 161 SLHTVTLPDS-VTAIEERAFTG-TALTQIHIPAKVTR-IGTNAFSECFALSTITSDSESYPAIDNVLYEKSANGDYALIR 237 (394)
T ss_dssp TCCEEECCTT-CCEECTTTTTT-CCCSEEEECTTCCE-ECTTTTTTCTTCCEEEECCSSSCBSSSCEEEECTTSCEEEEE
T ss_pred ccccccccce-eeEeccccccc-cceeEEEECCcccc-cccchhhhccccceecccccccccccceeecccccccccccc
Confidence 8888888765 44344455543 56777777655433 44445555555555443322
Q ss_pred --------------cccccCChhhcCcCCCcEEEccCCcCcCCCCccccCCCCCCeEEccCCCCCCCCccccccc-cccE
Q 004400 147 --------------QFTGQIPSFIQNWTKLEKLFIQPSGLAGPIPSGIFSLENLTDLRISDLNGPEATFPQLGNM-KMTK 211 (756)
Q Consensus 147 --------------~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~-~L~~ 211 (756)
.++.....+|.++..|+.+.+..+... ....+|.++++|+.+.+.. .+..+....|... +|+.
T Consensus 238 ~~~~~~~~~~~ip~~v~~i~~~aF~~c~~L~~i~lp~~~~~-I~~~aF~~c~~L~~i~l~~-~i~~I~~~aF~~c~~L~~ 315 (394)
T 4gt6_A 238 YPSQREDPAFKIPNGVARIETHAFDSCAYLASVKMPDSVVS-IGTGAFMNCPALQDIEFSS-RITELPESVFAGCISLKS 315 (394)
T ss_dssp CCTTCCCSEEECCTTEEEECTTTTTTCSSCCEEECCTTCCE-ECTTTTTTCTTCCEEECCT-TCCEECTTTTTTCTTCCE
T ss_pred cccccccceEEcCCcceEcccceeeecccccEEecccccce-ecCcccccccccccccCCC-cccccCceeecCCCCcCE
Confidence 222233467888999999999876554 5677888999999999974 6677777777764 6999
Q ss_pred EEcccccccCCCCccccCCCCCcEEEccCCcCCCCCCccCcCCCCCCeEEecCcccc
Q 004400 212 LILRNCNITGELPRYLGKMTKLKVLDLSFNRLRGQIPSNFDDLYDVDYIYFAGNLLT 268 (756)
Q Consensus 212 L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~ 268 (756)
+.|.++ ++.+...+|.++++|+.+.|..+ ++.+...+|.++.+|+.+++.+|...
T Consensus 316 i~lp~~-v~~I~~~aF~~C~~L~~i~ip~s-v~~I~~~aF~~C~~L~~i~~~~~~~~ 370 (394)
T 4gt6_A 316 IDIPEG-ITQILDDAFAGCEQLERIAIPSS-VTKIPESAFSNCTALNNIEYSGSRSQ 370 (394)
T ss_dssp EECCTT-CCEECTTTTTTCTTCCEEEECTT-CCBCCGGGGTTCTTCCEEEESSCHHH
T ss_pred EEeCCc-ccEehHhHhhCCCCCCEEEECcc-cCEEhHhHhhCCCCCCEEEECCceee
Confidence 999865 66566788999999999999765 66566788999999999999988653
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=99.00 E-value=2.2e-10 Score=119.82 Aligned_cols=185 Identities=16% Similarity=0.201 Sum_probs=123.7
Q ss_pred cCcccCCCCccEEEeeccCCcEEEEEEccccCcccHHHHHHHHHHHHhCC-CCc--eeeEeeEEEeCC---eEEEEEEec
Q 004400 421 DNNIGEGGFGPVYKGLLADGTAIAVKQLSSKSKQGNREFINEIGMISALQ-HPN--LVKLYGCCIEGN---QLLLIYEYL 494 (756)
Q Consensus 421 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~n--iv~l~~~~~~~~---~~~lV~e~~ 494 (756)
.+.++.|....||+.. ..+++|+.... .....+.+|+++++.+. +.. +.+++......+ ..|+||+|+
T Consensus 25 i~~~~~G~~n~v~~v~----~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i 98 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN----RDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKI 98 (304)
T ss_dssp CCEEEECSSEEEEEST----TSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECC
T ss_pred eEecCCCCcceEEEEC----CEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEccc
Confidence 4568999999999874 46888986432 33467889999998884 333 334444433333 348899999
Q ss_pred CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcC------------------------------------------
Q 004400 495 ENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGE------------------------------------------ 532 (756)
Q Consensus 495 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~------------------------------------------ 532 (756)
+|.++.+... ..++..++..++.++++.++.||+.
T Consensus 99 ~G~~l~~~~~---~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 175 (304)
T 3sg8_A 99 KGVPLTPLLL---NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVDD 175 (304)
T ss_dssp CCEECCHHHH---HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHHH
T ss_pred CCeECCcccc---ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHHH
Confidence 9988865432 2467778888899999999999861
Q ss_pred -------------CCCCeEcCCCCCCceEecC--CCCEEEccCCccccCcccCcceee--------------ccccCccC
Q 004400 533 -------------SRIKVVHRDIKATNVLLDK--DLNSKISDFGLAKLDEEENTHIST--------------RVAGTIGY 583 (756)
Q Consensus 533 -------------g~~~iiH~Dikp~Nill~~--~~~~kl~DFGla~~~~~~~~~~~~--------------~~~gt~~y 583 (756)
..+.++|+|++|.||++++ +..+.|+||+.+...+.. ..... .+....+.
T Consensus 176 ~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~-~Dl~~~~~~~~~~~~~~~~~~l~~Y~~ 254 (304)
T 3sg8_A 176 FYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPD-NDFISLMEDDEEYGMEFVSKILNHYKH 254 (304)
T ss_dssp HHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTT-HHHHTTCCTTTSCCHHHHHHHHHHHTC
T ss_pred HHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChH-HHHHHHHhhccccCHHHHHHHHHHcCC
Confidence 1235799999999999998 455789999998753321 11000 00011112
Q ss_pred Cc-hHhhhcCCCCcccchhhHHHHHHHHHhCCCCC
Q 004400 584 MA-PEYAMRGHLTEKADVYSFGIVALEIVSGRSNV 617 (756)
Q Consensus 584 ~a-PE~~~~~~~~~~~Dv~slGv~l~elltg~~p~ 617 (756)
.. |+..... ....+.|+++.++|.+.+|..+|
T Consensus 255 ~~~~~~~~r~--~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 255 KDIPTVLEKY--RMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp SCHHHHHHHH--HHHHHHHHHHHHHHHHHTTCHHH
T ss_pred CCcHHHHHHH--HHHHHHHHHHHHHHHHHcCCHHH
Confidence 22 3322211 12358999999999999998776
|
| >4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} | Back alignment and structure |
|---|
Probab=98.98 E-value=5.8e-09 Score=113.16 Aligned_cols=179 Identities=13% Similarity=0.127 Sum_probs=117.7
Q ss_pred cCCccCcCcCCCcEEEeecCcccccCCcccCCCCCCcEEeccCCee---------------------cccCCccccCCCC
Q 004400 79 PIPKYLANISTLVNLTVQYNQFSGELPEELGSLLNLEKLHLSSNNF---------------------TGELPKTFAKLTN 137 (756)
Q Consensus 79 ~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l---------------------~~~~p~~~~~l~~ 137 (756)
.-...|.++.+|+.+++..| ++.+...+|.++..|+.+.+..+.. +..-...|..+.+
T Consensus 176 I~~~~F~~c~~L~~i~l~~~-~~~I~~~~F~~~~~L~~i~~~~~~~~i~~~~~~~~~l~~i~ip~~~~~i~~~~f~~~~~ 254 (394)
T 4fs7_A 176 LHNGLFSGCGKLKSIKLPRN-LKIIRDYCFAECILLENMEFPNSLYYLGDFALSKTGVKNIIIPDSFTELGKSVFYGCTD 254 (394)
T ss_dssp ECTTTTTTCTTCCBCCCCTT-CCEECTTTTTTCTTCCBCCCCTTCCEECTTTTTTCCCCEEEECTTCCEECSSTTTTCSS
T ss_pred eccccccCCCCceEEEcCCC-ceEeCchhhccccccceeecCCCceEeehhhcccCCCceEEECCCceeccccccccccc
Confidence 33344555555555555444 3323334444444444444443322 2123344556666
Q ss_pred CCEEEeeCCcccccCChhhcCcCCCcEEEccCCcCcCCCCccccCCCCCCeEEccCCCCCCCCccccccc-cccEEEccc
Q 004400 138 MKDFRISDNQFTGQIPSFIQNWTKLEKLFIQPSGLAGPIPSGIFSLENLTDLRISDLNGPEATFPQLGNM-KMTKLILRN 216 (756)
Q Consensus 138 L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~-~L~~L~L~~ 216 (756)
|+.+.+..+... .....|.++..|+.+.+..+.+ ....|..+.+|+.+.+.++ +..+....|... +|+.+.|.+
T Consensus 255 l~~~~~~~~~~~-i~~~~F~~~~~l~~~~~~~~~i---~~~~F~~~~~L~~i~l~~~-i~~I~~~aF~~c~~L~~i~lp~ 329 (394)
T 4fs7_A 255 LESISIQNNKLR-IGGSLFYNCSGLKKVIYGSVIV---PEKTFYGCSSLTEVKLLDS-VKFIGEEAFESCTSLVSIDLPY 329 (394)
T ss_dssp CCEEEECCTTCE-ECSCTTTTCTTCCEEEECSSEE---CTTTTTTCTTCCEEEECTT-CCEECTTTTTTCTTCCEECCCT
T ss_pred ceeEEcCCCcce-eeccccccccccceeccCceee---ccccccccccccccccccc-cceechhhhcCCCCCCEEEeCC
Confidence 777777666544 5556667777777766665433 2446778899999998764 666766777664 699999975
Q ss_pred ccccCCCCccccCCCCCcEEEccCCcCCCCCCccCcCCCCCCeEEecCc
Q 004400 217 CNITGELPRYLGKMTKLKVLDLSFNRLRGQIPSNFDDLYDVDYIYFAGN 265 (756)
Q Consensus 217 n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N 265 (756)
+ ++.+...+|.++++|+.++|..| ++.....+|.++.+|+.+++..|
T Consensus 330 ~-v~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~~i~lp~~ 376 (394)
T 4fs7_A 330 L-VEEIGKRSFRGCTSLSNINFPLS-LRKIGANAFQGCINLKKVELPKR 376 (394)
T ss_dssp T-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTBTTCTTCCEEEEEGG
T ss_pred c-ccEEhHHhccCCCCCCEEEECcc-ccEehHHHhhCCCCCCEEEECCC
Confidence 5 76666788999999999999887 77677789999999999998755
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} | Back alignment and structure |
|---|
Probab=98.88 E-value=2.8e-10 Score=121.14 Aligned_cols=81 Identities=16% Similarity=0.215 Sum_probs=47.8
Q ss_pred cccEEEcccccccCCCCcccc---CCCCCcEEEccCCcCCCC----CCccCcCCCCCCeEEecCccccccCCchhhc-CC
Q 004400 208 KMTKLILRNCNITGELPRYLG---KMTKLKVLDLSFNRLRGQ----IPSNFDDLYDVDYIYFAGNLLTGAIPPWMLE-RG 279 (756)
Q Consensus 208 ~L~~L~L~~n~l~~~~p~~~~---~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~-~l 279 (756)
+|+.|.|.+|.+.+..+..+. .+++|+.|+|+.|.+.+. ++..+..+++|+.|+|++|.++...-..+.. ..
T Consensus 253 ~Lr~L~L~~~~i~~~~~~~la~a~~~~~L~~LdLs~n~L~d~G~~~L~~~L~~l~~L~~L~L~~n~i~d~~~~~l~~alg 332 (362)
T 2ra8_A 253 NLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLSDEMKKELQKSLP 332 (362)
T ss_dssp TCCEEEEESCTTHHHHHHHHHHCSSGGGCSEEECCSSCCBHHHHHHHHTTHHHHTTCSEEECCSBBCCHHHHHHHHHHCC
T ss_pred CcCEEeCCCCCCchHHHHHHHhCccCCCCCEEECCCCCCChHHHHHHHhhcccCCcceEEECCCCcCCHHHHHHHHHHcC
Confidence 466666666666543332332 467788888888887753 2333455678888888888776433222222 23
Q ss_pred CeeEeecCC
Q 004400 280 DKIDLSYNN 288 (756)
Q Consensus 280 ~~l~ls~N~ 288 (756)
..+++++|+
T Consensus 333 ~~~~~~~~~ 341 (362)
T 2ra8_A 333 MKIDVSDSQ 341 (362)
T ss_dssp SEEECCSBC
T ss_pred CEEEecCCc
Confidence 556776665
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} | Back alignment and structure |
|---|
Probab=98.83 E-value=7.4e-10 Score=117.91 Aligned_cols=156 Identities=15% Similarity=0.143 Sum_probs=83.0
Q ss_pred ccCcCcCCCcEEEeecCcccccCCcccCCCCCCcEEeccCCeecccCCcccc--CCCCCCEEEeeC--Cccccc-----C
Q 004400 82 KYLANISTLVNLTVQYNQFSGELPEELGSLLNLEKLHLSSNNFTGELPKTFA--KLTNMKDFRISD--NQFTGQ-----I 152 (756)
Q Consensus 82 ~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~--~l~~L~~L~L~~--N~l~~~-----~ 152 (756)
..+..+++|+.|+|++|.-. .++. +. +++|+.|+|..|.++......++ .+++|+.|+|+. |...+. +
T Consensus 166 ~ll~~~P~L~~L~L~g~~~l-~l~~-~~-~~~L~~L~L~~~~l~~~~l~~l~~~~lp~L~~L~L~~~~~~~~~~~~~~~l 242 (362)
T 2ra8_A 166 PVLDAMPLLNNLKIKGTNNL-SIGK-KP-RPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDGDMNVF 242 (362)
T ss_dssp HHHHTCTTCCEEEEECCBTC-BCCS-CB-CTTCSEEEEECSBCCHHHHHHHHHSBCTTCCEEEEECBCGGGTCCSCGGGT
T ss_pred HHHhcCCCCcEEEEeCCCCc-eecc-cc-CCCCcEEEEecCCCChHHHHHHHHccCCCCcEEEEeccccccccchhHHHH
Confidence 44455667777777666211 1222 32 66677777776666533333333 566777777653 221111 1
Q ss_pred Chhh--cCcCCCcEEEccCCcCcCCCCcccc---CCCCCCeEEccCCCCCCCCccccc-----cccccEEEcccccccCC
Q 004400 153 PSFI--QNWTKLEKLFIQPSGLAGPIPSGIF---SLENLTDLRISDLNGPEATFPQLG-----NMKMTKLILRNCNITGE 222 (756)
Q Consensus 153 p~~~--~~l~~L~~L~l~~N~l~~~~p~~~~---~l~~L~~L~l~~n~~~~~~~~~~~-----~~~L~~L~L~~n~l~~~ 222 (756)
...+ ..+++|+.|+|.+|.+....+..+. .+++|+.|+|+.|.+.......+. ..+|+.|+|++|.++..
T Consensus 243 ~~~l~~~~~p~Lr~L~L~~~~i~~~~~~~la~a~~~~~L~~LdLs~n~L~d~G~~~L~~~L~~l~~L~~L~L~~n~i~d~ 322 (362)
T 2ra8_A 243 RPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLSDE 322 (362)
T ss_dssp GGGSCTTTCTTCCEEEEESCTTHHHHHHHHHHCSSGGGCSEEECCSSCCBHHHHHHHHTTHHHHTTCSEEECCSBBCCHH
T ss_pred HHHHhcCCCCCcCEEeCCCCCCchHHHHHHHhCccCCCCCEEECCCCCCChHHHHHHHhhcccCCcceEEECCCCcCCHH
Confidence 1122 2356777777777766543222222 366777777777766654322211 12477777777777644
Q ss_pred CCccccC-CCCCcEEEccCCc
Q 004400 223 LPRYLGK-MTKLKVLDLSFNR 242 (756)
Q Consensus 223 ~p~~~~~-l~~L~~L~Ls~N~ 242 (756)
.-..+.. + ...+++++|+
T Consensus 323 ~~~~l~~al--g~~~~~~~~~ 341 (362)
T 2ra8_A 323 MKKELQKSL--PMKIDVSDSQ 341 (362)
T ss_dssp HHHHHHHHC--CSEEECCSBC
T ss_pred HHHHHHHHc--CCEEEecCCc
Confidence 3333433 2 3567888776
|
| >4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} | Back alignment and structure |
|---|
Probab=98.70 E-value=3.6e-07 Score=98.38 Aligned_cols=263 Identities=10% Similarity=0.043 Sum_probs=166.1
Q ss_pred eeccceeccccccccCcccccCCcccCCCCCCCEEEccCCcccCccCcccccCCcceeeccCccccccCCccCcCcCCCc
Q 004400 12 FWKQKTVNQKRVLKEQNLTGVLPPKLAELTFLQDIDLTLNYLSGTIPSQWASLPLLNISLIANRLKGPIPKYLANISTLV 91 (756)
Q Consensus 12 ~~~~~~~~~~l~L~~~~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~l~l~~n~~~~~~p~~l~~l~~L~ 91 (756)
++.....++++.+.. +++.+-..+|.++++|+.++|..+ ++.+-..+|...+.+++.+. +++...-..+|.+ .+|+
T Consensus 41 ~~~~~~~i~~v~ip~-~vt~Ig~~aF~~C~~L~~I~lp~~-v~~Ig~~aF~~c~l~~i~~~-~~l~~I~~~aF~~-~~L~ 116 (379)
T 4h09_A 41 WYKDRDRISEVRVNS-GITSIGEANFNSCYNMTKVTVAST-VTSIGDGAFADTKLQSYTGM-ERVKKFGDYVFQG-TDLD 116 (379)
T ss_dssp TGGGGGGCSEEEECT-TEEEECTTTTTTCTTCCEEEECTT-CCEECTTTTTTCCCCEEEEC-TTCCEECTTTTTT-CCCS
T ss_pred ccccccCCEEEEeCC-CccChHHHHhhCCCCCCEEEeCCc-ceEechhhhcCCCCceEECC-ceeeEeccceecc-CCcc
Confidence 456677788888864 577677788999999999999754 66556677887765555554 3455444556665 4788
Q ss_pred EEEeecCcccccCCcccCCCCCCcEEeccCCeecccCCccccCCCCCCEEEeeCCcc-----------------------
Q 004400 92 NLTVQYNQFSGELPEELGSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRISDNQF----------------------- 148 (756)
Q Consensus 92 ~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l----------------------- 148 (756)
.+.+..+-.. ....+|.+. +|+.+.+..+ ++..-...|..+.+|+.+.+..+..
T Consensus 117 ~i~lp~~~~~-i~~~~F~~~-~l~~~~~~~~-v~~i~~~~f~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (379)
T 4h09_A 117 DFEFPGATTE-IGNYIFYNS-SVKRIVIPKS-VTTIKDGIGYKAENLEKIEVSSNNKNYVAENYVLYNKNKTILESYPAA 193 (379)
T ss_dssp EEECCTTCCE-ECTTTTTTC-CCCEEEECTT-CCEECSCTTTTCTTCCEEEECTTCSSEEEETTEEEETTSSEEEECCTT
T ss_pred cccCCCcccc-ccccccccc-eeeeeeccce-eeccccchhcccccccccccccccceeecccceecccccceecccccc
Confidence 8888765332 333444443 4555554433 2223334444555555544433221
Q ss_pred ------------cccCChhhcCcCCCcEEEccCCcCcCCCCccccCCCCCCeEEccCCCCCCCCccccccc-cccEEEcc
Q 004400 149 ------------TGQIPSFIQNWTKLEKLFIQPSGLAGPIPSGIFSLENLTDLRISDLNGPEATFPQLGNM-KMTKLILR 215 (756)
Q Consensus 149 ------------~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~-~L~~L~L~ 215 (756)
.......+..+.+|+.+.+..+ +......++..+.+|+.+.+..+ ++.+....+... +|+.+.+.
T Consensus 194 ~~~~~~~~~~~~~~i~~~~f~~~~~l~~i~~~~~-~~~i~~~~f~~~~~L~~i~lp~~-v~~I~~~aF~~~~~l~~i~l~ 271 (379)
T 4h09_A 194 KTGTEFTIPSTVKTVTAYGFSYGKNLKKITITSG-VTTLGDGAFYGMKALDEIAIPKN-VTSIGSFLLQNCTALKTLNFY 271 (379)
T ss_dssp CCCSEEECCTTCCEECTTTTTTCSSCSEEECCTT-CCEECTTTTTTCSSCCEEEECTT-CCEECTTTTTTCTTCCEEEEC
T ss_pred ccccccccccceeEEeecccccccccceeeeccc-eeEEccccccCCccceEEEcCCC-ccEeCccccceeehhcccccc
Confidence 1123345566677777777654 33355667778888888888764 555555555554 57788876
Q ss_pred cccccCCCCccccCCCCCcEEEccCCcCCCCCCccCcCCCCCCeEEecCccccccCCchh--hcCCCeeEee
Q 004400 216 NCNITGELPRYLGKMTKLKVLDLSFNRLRGQIPSNFDDLYDVDYIYFAGNLLTGAIPPWM--LERGDKIDLS 285 (756)
Q Consensus 216 ~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~--~~~l~~l~ls 285 (756)
.+ +.......|.++++|+.+.+.++.++.+...+|.++.+|+.+.|..+ ++..-..++ ..+|+.+.+.
T Consensus 272 ~~-i~~i~~~aF~~c~~L~~i~l~~~~i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~~i~ip 341 (379)
T 4h09_A 272 AK-VKTVPYLLCSGCSNLTKVVMDNSAIETLEPRVFMDCVKLSSVTLPTA-LKTIQVYAFKNCKALSTISYP 341 (379)
T ss_dssp CC-CSEECTTTTTTCTTCCEEEECCTTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCCCCCC
T ss_pred cc-ceeccccccccccccccccccccccceehhhhhcCCCCCCEEEcCcc-ccEEHHHHhhCCCCCCEEEEC
Confidence 54 55455667888888999988888888667778888888988888655 442222333 3456666654
|
| >4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} | Back alignment and structure |
|---|
Probab=98.54 E-value=1.2e-06 Score=94.25 Aligned_cols=243 Identities=14% Similarity=0.062 Sum_probs=157.5
Q ss_pred eeccceeccccccccCcccccCCcccCCCCCCCEEEccCCcccCccCcccccCCcceeeccCccccccCCccCcCcCCCc
Q 004400 12 FWKQKTVNQKRVLKEQNLTGVLPPKLAELTFLQDIDLTLNYLSGTIPSQWASLPLLNISLIANRLKGPIPKYLANISTLV 91 (756)
Q Consensus 12 ~~~~~~~~~~l~L~~~~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~l~l~~n~~~~~~p~~l~~l~~L~ 91 (756)
.|.+|..|+.+.|.. +++.+-..+|.+. .|+.+.+..+ ++..-..+|.....-.+.+.. ++...-...|.+. +|+
T Consensus 64 aF~~C~~L~~I~lp~-~v~~Ig~~aF~~c-~l~~i~~~~~-l~~I~~~aF~~~~L~~i~lp~-~~~~i~~~~F~~~-~l~ 138 (379)
T 4h09_A 64 NFNSCYNMTKVTVAS-TVTSIGDGAFADT-KLQSYTGMER-VKKFGDYVFQGTDLDDFEFPG-ATTEIGNYIFYNS-SVK 138 (379)
T ss_dssp TTTTCTTCCEEEECT-TCCEECTTTTTTC-CCCEEEECTT-CCEECTTTTTTCCCSEEECCT-TCCEECTTTTTTC-CCC
T ss_pred HhhCCCCCCEEEeCC-cceEechhhhcCC-CCceEECCce-eeEeccceeccCCcccccCCC-ccccccccccccc-eee
Confidence 589999999999975 4776666777775 5777766543 442333444443211233322 2222222333332 344
Q ss_pred EEEeecCcccccCCcccCCCCCCcEEec------------------------------------cCCeecccCCccccCC
Q 004400 92 NLTVQYNQFSGELPEELGSLLNLEKLHL------------------------------------SSNNFTGELPKTFAKL 135 (756)
Q Consensus 92 ~L~L~~N~l~~~~p~~~~~l~~L~~L~L------------------------------------~~N~l~~~~p~~~~~l 135 (756)
.+.+..+ ++......|..+.+|+.+.+ ..+.-. .....+...
T Consensus 139 ~~~~~~~-v~~i~~~~f~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-i~~~~f~~~ 216 (379)
T 4h09_A 139 RIVIPKS-VTTIKDGIGYKAENLEKIEVSSNNKNYVAENYVLYNKNKTILESYPAAKTGTEFTIPSTVKT-VTAYGFSYG 216 (379)
T ss_dssp EEEECTT-CCEECSCTTTTCTTCCEEEECTTCSSEEEETTEEEETTSSEEEECCTTCCCSEEECCTTCCE-ECTTTTTTC
T ss_pred eeeccce-eeccccchhcccccccccccccccceeecccceecccccceeccccccccccccccccceeE-Eeecccccc
Confidence 4444332 22233334444444444433 322221 334456677
Q ss_pred CCCCEEEeeCCcccccCChhhcCcCCCcEEEccCCcCcCCCCccccCCCCCCeEEccCCCCCCCCccccccc-cccEEEc
Q 004400 136 TNMKDFRISDNQFTGQIPSFIQNWTKLEKLFIQPSGLAGPIPSGIFSLENLTDLRISDLNGPEATFPQLGNM-KMTKLIL 214 (756)
Q Consensus 136 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~-~L~~L~L 214 (756)
.+|+.+.+..+ ++.....+|.++..|+.+.+..+ ++.....+|.++.+|+.+.+.. .+.......|... +|+.+.+
T Consensus 217 ~~l~~i~~~~~-~~~i~~~~f~~~~~L~~i~lp~~-v~~I~~~aF~~~~~l~~i~l~~-~i~~i~~~aF~~c~~L~~i~l 293 (379)
T 4h09_A 217 KNLKKITITSG-VTTLGDGAFYGMKALDEIAIPKN-VTSIGSFLLQNCTALKTLNFYA-KVKTVPYLLCSGCSNLTKVVM 293 (379)
T ss_dssp SSCSEEECCTT-CCEECTTTTTTCSSCCEEEECTT-CCEECTTTTTTCTTCCEEEECC-CCSEECTTTTTTCTTCCEEEE
T ss_pred cccceeeeccc-eeEEccccccCCccceEEEcCCC-ccEeCccccceeehhccccccc-cceeccccccccccccccccc
Confidence 88999998766 44466778899999999999876 6556677888899999999875 4666666666554 6999999
Q ss_pred ccccccCCCCccccCCCCCcEEEccCCcCCCCCCccCcCCCCCCeEEecCc
Q 004400 215 RNCNITGELPRYLGKMTKLKVLDLSFNRLRGQIPSNFDDLYDVDYIYFAGN 265 (756)
Q Consensus 215 ~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N 265 (756)
.++.++.+...+|.++.+|+.+.|..+ ++.+...+|.++.+|+.+.+..+
T Consensus 294 ~~~~i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~~i~ip~~ 343 (379)
T 4h09_A 294 DNSAIETLEPRVFMDCVKLSSVTLPTA-LKTIQVYAFKNCKALSTISYPKS 343 (379)
T ss_dssp CCTTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCCCCCCTT
T ss_pred cccccceehhhhhcCCCCCCEEEcCcc-ccEEHHHHhhCCCCCCEEEECCc
Confidence 999888777788999999999999865 66566788999999999988654
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=98.48 E-value=1.6e-08 Score=102.03 Aligned_cols=104 Identities=22% Similarity=0.273 Sum_probs=74.1
Q ss_pred CcCcCCCcE--EEeecCcccccCCc----ccCCCCCCcEEeccCCeecc--cCCccccCCCCCCEEEeeCCcccccCChh
Q 004400 84 LANISTLVN--LTVQYNQFSGELPE----ELGSLLNLEKLHLSSNNFTG--ELPKTFAKLTNMKDFRISDNQFTGQIPSF 155 (756)
Q Consensus 84 l~~l~~L~~--L~L~~N~l~~~~p~----~~~~l~~L~~L~L~~N~l~~--~~p~~~~~l~~L~~L~L~~N~l~~~~p~~ 155 (756)
|...+.|+. ++++.|... .++. ...++++|+.|+|++|+|++ .+|..+..+++|+.|+|++|+|++. ..
T Consensus 137 l~~dp~L~~~~l~l~~N~~~-~~~~~l~i~~~~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~--~~ 213 (267)
T 3rw6_A 137 LRSDPDLVAQNIDVVLNRRS-CMAATLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSE--RE 213 (267)
T ss_dssp GGGCHHHHHTTCCCCTTSHH-HHHHHHHHHHHHCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSG--GG
T ss_pred cCCCcchhhcCccccCCHHH-HHHHHHHHHHhhCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCc--hh
Confidence 444555555 677777543 2322 23567889999999999887 4556777889999999999998854 33
Q ss_pred hcCcC--CCcEEEccCCcCcCCCCc-------cccCCCCCCeEE
Q 004400 156 IQNWT--KLEKLFIQPSGLAGPIPS-------GIFSLENLTDLR 190 (756)
Q Consensus 156 ~~~l~--~L~~L~l~~N~l~~~~p~-------~~~~l~~L~~L~ 190 (756)
+..+. +|++|+|++|.+.+..|. .+..+++|+.||
T Consensus 214 l~~l~~l~L~~L~L~~Npl~~~~~~~~~y~~~il~~~P~L~~LD 257 (267)
T 3rw6_A 214 LDKIKGLKLEELWLDGNSLCDTFRDQSTYISAIRERFPKLLRLD 257 (267)
T ss_dssp GGGGTTSCCSEEECTTSTTGGGCSSHHHHHHHHHHHCTTCCEES
T ss_pred hhhcccCCcceEEccCCcCccccCcchhHHHHHHHHCcccCeEC
Confidence 45555 889999999998876653 356788888876
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=98.45 E-value=2.9e-08 Score=95.24 Aligned_cols=117 Identities=15% Similarity=0.152 Sum_probs=76.5
Q ss_pred CCccCcCcCCCcEEEeecC-ccccc----CCcccCCCCCCcEEeccCCeeccc----CCccccCCCCCCEEEeeCCcccc
Q 004400 80 IPKYLANISTLVNLTVQYN-QFSGE----LPEELGSLLNLEKLHLSSNNFTGE----LPKTFAKLTNMKDFRISDNQFTG 150 (756)
Q Consensus 80 ~p~~l~~l~~L~~L~L~~N-~l~~~----~p~~~~~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~L~~N~l~~ 150 (756)
+...+...++|++|+|++| .|... +...+...++|++|+|++|+|... +...+...++|++|+|++|+|..
T Consensus 28 l~~~l~~~~~L~~L~L~~n~~i~~~g~~~l~~~L~~~~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i~~ 107 (185)
T 1io0_A 28 LKRIQNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISG 107 (185)
T ss_dssp HHHHHTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCH
T ss_pred HHHHHhcCCCCCEEEecCCCCCCHHHHHHHHHHHHhCCCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcCCH
Confidence 3445666778888888888 77632 334566677888888888887632 33445556778888888888774
Q ss_pred c----CChhhcCcCCCcEEEc--cCCcCcCC----CCccccCCCCCCeEEccCCCC
Q 004400 151 Q----IPSFIQNWTKLEKLFI--QPSGLAGP----IPSGIFSLENLTDLRISDLNG 196 (756)
Q Consensus 151 ~----~p~~~~~l~~L~~L~l--~~N~l~~~----~p~~~~~l~~L~~L~l~~n~~ 196 (756)
. +...+...++|++|+| ++|.+... +...+...++|++|++++|.+
T Consensus 108 ~g~~~l~~~L~~n~~L~~L~L~~~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~n~i 163 (185)
T 1io0_A 108 SGILALVEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQ 163 (185)
T ss_dssp HHHHHHHHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSH
T ss_pred HHHHHHHHHHHhCCCceEEEecCCCCCCCHHHHHHHHHHHHhCCCcCEEeccCCCC
Confidence 3 3455666677888888 67777643 233344456666666666544
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=98.44 E-value=1.9e-08 Score=96.55 Aligned_cols=123 Identities=16% Similarity=0.163 Sum_probs=81.7
Q ss_pred cCCcccCCCCCCCEEEccCC-cccCccCcccccCCcceeeccCccccccCCccCcCcCCCcEEEeecCccccc----CCc
Q 004400 32 VLPPKLAELTFLQDIDLTLN-YLSGTIPSQWASLPLLNISLIANRLKGPIPKYLANISTLVNLTVQYNQFSGE----LPE 106 (756)
Q Consensus 32 ~~p~~l~~l~~L~~L~L~~n-~l~~~~p~~~~~l~~L~l~l~~n~~~~~~p~~l~~l~~L~~L~L~~N~l~~~----~p~ 106 (756)
.+...+...+.|+.|+|++| .|...-.. .+...+...++|++|+|++|.|... +..
T Consensus 27 ~l~~~l~~~~~L~~L~L~~n~~i~~~g~~-------------------~l~~~L~~~~~L~~L~Ls~n~i~~~g~~~l~~ 87 (185)
T 1io0_A 27 TLKRIQNNDPDLEEVNLNNIMNIPVPTLK-------------------ACAEALKTNTYVKKFSIVGTRSNDPVAFALAE 87 (185)
T ss_dssp HHHHHHTTCTTCCEEECTTCTTCCHHHHH-------------------HHHHHHTTCCSCCEEECTTSCCCHHHHHHHHH
T ss_pred HHHHHHhcCCCCCEEEecCCCCCCHHHHH-------------------HHHHHHHhCCCcCEEECcCCCCChHHHHHHHH
Confidence 44455677788888888888 77621111 1223344556788888888887642 234
Q ss_pred ccCCCCCCcEEeccCCeeccc----CCccccCCCCCCEEEe--eCCccccc----CChhhcCcCCCcEEEccCCcCc
Q 004400 107 ELGSLLNLEKLHLSSNNFTGE----LPKTFAKLTNMKDFRI--SDNQFTGQ----IPSFIQNWTKLEKLFIQPSGLA 173 (756)
Q Consensus 107 ~~~~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~L--~~N~l~~~----~p~~~~~l~~L~~L~l~~N~l~ 173 (756)
.+...++|++|+|++|.|+.. +...+...++|++|+| ++|.|... +...+...++|++|+|++|.+.
T Consensus 88 ~L~~n~~L~~L~L~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~n~i~ 164 (185)
T 1io0_A 88 MLKVNNTLKSLNVESNFISGSGILALVEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQG 164 (185)
T ss_dssp HHHHCSSCCEEECCSSCCCHHHHHHHHHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSHH
T ss_pred HHHhCCCcCEEECcCCcCCHHHHHHHHHHHHhCCCceEEEecCCCCCCCHHHHHHHHHHHHhCCCcCEEeccCCCCC
Confidence 455567788888888887742 3455666778888888 77888743 3345555688888888888775
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.42 E-value=1.3e-06 Score=90.97 Aligned_cols=136 Identities=19% Similarity=0.181 Sum_probs=96.0
Q ss_pred cCcccCCCCccEEEeeccCCcEEEEEEccccCcccHHHHHHHHHHHHhCCCC---ceeeEeeEEE-eCCeEEEEEEecCC
Q 004400 421 DNNIGEGGFGPVYKGLLADGTAIAVKQLSSKSKQGNREFINEIGMISALQHP---NLVKLYGCCI-EGNQLLLIYEYLEN 496 (756)
Q Consensus 421 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~---niv~l~~~~~-~~~~~~lV~e~~~~ 496 (756)
.+.++.|....||+. |+.+++|+... ......+.+|+++|+.+.+. .+.+++.++. ..+..++||||++|
T Consensus 24 v~~l~~G~~n~v~~v----g~~~VlR~~~~--~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G 97 (306)
T 3tdw_A 24 VESLGEGFRNYAILV----NGDWVFRFPKS--QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQG 97 (306)
T ss_dssp EEEEEECSSEEEEEE----TTTEEEEEESS--HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCS
T ss_pred eeecCCCcceeEEEE----CCEEEEEecCC--chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCC
Confidence 356788888899987 56788888532 23346788999999999753 3556666664 34567899999999
Q ss_pred CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcC--------------------------------------------
Q 004400 497 NSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGE-------------------------------------------- 532 (756)
Q Consensus 497 gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~-------------------------------------------- 532 (756)
..+.+... ..++...+..++.++++.|+.||+.
T Consensus 98 ~~l~~~~~---~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ 174 (306)
T 3tdw_A 98 QILGEDGM---AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLTL 174 (306)
T ss_dssp EECHHHHH---TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHHH
T ss_pred eECchhhh---hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHHH
Confidence 88866321 1234555555666666666666542
Q ss_pred -------------CCCCeEcCCCCCCceEecC---CCCE-EEccCCcccc
Q 004400 533 -------------SRIKVVHRDIKATNVLLDK---DLNS-KISDFGLAKL 565 (756)
Q Consensus 533 -------------g~~~iiH~Dikp~Nill~~---~~~~-kl~DFGla~~ 565 (756)
..+.++|+|+++.||+++. ++.+ .|+||+.+..
T Consensus 175 ~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 175 RFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred HHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 2234699999999999997 4554 8999998864
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=98.42 E-value=5.9e-08 Score=97.90 Aligned_cols=97 Identities=21% Similarity=0.364 Sum_probs=74.4
Q ss_pred eeccCcc---ccccCCccCcCcCCCcEEEeecCcccc--cCCcccCCCCCCcEEeccCCeecccCCccccCCC--CCCEE
Q 004400 69 ISLIANR---LKGPIPKYLANISTLVNLTVQYNQFSG--ELPEELGSLLNLEKLHLSSNNFTGELPKTFAKLT--NMKDF 141 (756)
Q Consensus 69 l~l~~n~---~~~~~p~~l~~l~~L~~L~L~~N~l~~--~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~--~L~~L 141 (756)
+++..|+ +.+.++....++++|+.|+|++|+|++ .+|..+..+++|+.|+|++|+|++. ..+..+. +|++|
T Consensus 148 l~l~~N~~~~~~~~l~i~~~~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~--~~l~~l~~l~L~~L 225 (267)
T 3rw6_A 148 IDVVLNRRSCMAATLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSE--RELDKIKGLKLEEL 225 (267)
T ss_dssp CCCCTTSHHHHHHHHHHHHHHCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSG--GGGGGGTTSCCSEE
T ss_pred ccccCCHHHHHHHHHHHHHhhCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCc--hhhhhcccCCcceE
Confidence 4555563 223333334678999999999999997 4557788999999999999999965 3355555 99999
Q ss_pred EeeCCcccccCC-------hhhcCcCCCcEEEc
Q 004400 142 RISDNQFTGQIP-------SFIQNWTKLEKLFI 167 (756)
Q Consensus 142 ~L~~N~l~~~~p-------~~~~~l~~L~~L~l 167 (756)
+|++|.+.+.+| ..+..+++|+.|+-
T Consensus 226 ~L~~Npl~~~~~~~~~y~~~il~~~P~L~~LDg 258 (267)
T 3rw6_A 226 WLDGNSLCDTFRDQSTYISAIRERFPKLLRLDG 258 (267)
T ss_dssp ECTTSTTGGGCSSHHHHHHHHHHHCTTCCEESS
T ss_pred EccCCcCccccCcchhHHHHHHHHCcccCeECC
Confidence 999999997666 35788999998863
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.42 E-value=1.7e-06 Score=88.26 Aligned_cols=134 Identities=16% Similarity=0.122 Sum_probs=98.5
Q ss_pred cccCCCCc-cEEEeecc-CCcEEEEEEccccCcccHHHHHHHHHHHHhCC-CCceeeEeeEEEeCCeEEEEEEecCCCCH
Q 004400 423 NIGEGGFG-PVYKGLLA-DGTAIAVKQLSSKSKQGNREFINEIGMISALQ-HPNLVKLYGCCIEGNQLLLIYEYLENNSL 499 (756)
Q Consensus 423 ~lg~G~~g-~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lV~e~~~~gsL 499 (756)
.+..|..| .||+.... ++..+++|+-... ....+.+|...|+.+. +--+.++++++.+++..++|||+++|.++
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~---~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~ 107 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGS---VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTA 107 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEETH---HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEH
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCCC---CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCccc
Confidence 34456555 58987744 5678899986432 3456888999998884 33367789999999999999999999988
Q ss_pred HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcC-----------------------------------------------
Q 004400 500 ARALFEHRLKLDWPTRRRICLGIARGLAYLHGE----------------------------------------------- 532 (756)
Q Consensus 500 ~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~----------------------------------------------- 532 (756)
.+..... ......++.++++.|+.||..
T Consensus 108 ~~~~~~~-----~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 182 (272)
T 4gkh_A 108 FQVLEEY-----PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWKE 182 (272)
T ss_dssp HHHHHHC-----GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHHH
T ss_pred cccccCC-----HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHHH
Confidence 7765422 223445667777777777741
Q ss_pred --------CCCCeEcCCCCCCceEecCCCCEEEccCCccc
Q 004400 533 --------SRIKVVHRDIKATNVLLDKDLNSKISDFGLAK 564 (756)
Q Consensus 533 --------g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~ 564 (756)
..+-++|+|+.+.|||++.++.+-|+||+.+.
T Consensus 183 l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~ 222 (272)
T 4gkh_A 183 MHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVG 222 (272)
T ss_dssp HHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred HHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccc
Confidence 11237999999999999987767799999886
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.22 E-value=6.6e-07 Score=95.46 Aligned_cols=79 Identities=6% Similarity=0.033 Sum_probs=55.2
Q ss_pred cCcc-cCCCCccEEEeecc-------CCcEEEEEEccccC---cccHHHHHHHHHHHHhCC-C--CceeeEeeEEEeC--
Q 004400 421 DNNI-GEGGFGPVYKGLLA-------DGTAIAVKQLSSKS---KQGNREFINEIGMISALQ-H--PNLVKLYGCCIEG-- 484 (756)
Q Consensus 421 ~~~l-g~G~~g~Vy~~~~~-------~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~-h--~niv~l~~~~~~~-- 484 (756)
.+.| +.|....+|+.... +++.+++|...... ......+.+|+.+++.+. + -.+.+++.++.++
T Consensus 25 ~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~ 104 (357)
T 3ats_A 25 ESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDV 104 (357)
T ss_dssp EEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTT
T ss_pred EEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCc
Confidence 3567 88889999998754 26788899865432 111245778999888884 3 2466788877655
Q ss_pred -CeEEEEEEecCCCCH
Q 004400 485 -NQLLLIYEYLENNSL 499 (756)
Q Consensus 485 -~~~~lV~e~~~~gsL 499 (756)
+..++||||++|..+
T Consensus 105 ~g~~~~v~e~l~G~~l 120 (357)
T 3ats_A 105 LGTPFFLMDYVEGVVP 120 (357)
T ss_dssp TSSCEEEEECCCCBCC
T ss_pred cCCceEEEEecCCCCh
Confidence 356899999998654
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.07 E-value=7.1e-06 Score=86.69 Aligned_cols=138 Identities=17% Similarity=0.239 Sum_probs=80.2
Q ss_pred CcccCCCCccEEEeeccCCcEEEEEEccccCcccHHHHHHHHHHHHhCCC--CceeeEee------EEEeCCeEEEEEEe
Q 004400 422 NNIGEGGFGPVYKGLLADGTAIAVKQLSSKSKQGNREFINEIGMISALQH--PNLVKLYG------CCIEGNQLLLIYEY 493 (756)
Q Consensus 422 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~------~~~~~~~~~lV~e~ 493 (756)
+.|+.|..+.||+....+| .+++|+.... ...+..|..+++.+.. -.+.+++. +...++..++||+|
T Consensus 38 ~~l~gG~~n~~~~v~~~~~-~~vlk~~~~~----~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~ 112 (346)
T 2q83_A 38 DVIQGNQMALVWKVHTDSG-AVCLKRIHRP----EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDW 112 (346)
T ss_dssp EECC----CEEEEEEETTE-EEEEEEECSC----HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEEC
T ss_pred eeccccccCcEEEEEeCCC-CEEEEecCCC----HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEe
Confidence 4566677899999887655 4889988642 2334455555555531 12333332 22457788999999
Q ss_pred cCCCCHH--------------HHHHhcCC-------------CCCHHHH-------------------------------
Q 004400 494 LENNSLA--------------RALFEHRL-------------KLDWPTR------------------------------- 515 (756)
Q Consensus 494 ~~~gsL~--------------~~l~~~~~-------------~l~~~~~------------------------------- 515 (756)
++|..+. ..++.... .-.|...
T Consensus 113 i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 192 (346)
T 2q83_A 113 IEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQEI 192 (346)
T ss_dssp CCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHHH
T ss_pred ecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHHH
Confidence 9986431 11221100 0123211
Q ss_pred HHHHHHHHHHHHHHHc----------CCCCCeEcCCCCCCceEecCCCCEEEccCCccc
Q 004400 516 RRICLGIARGLAYLHG----------ESRIKVVHRDIKATNVLLDKDLNSKISDFGLAK 564 (756)
Q Consensus 516 ~~i~~~ia~~L~~LH~----------~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~ 564 (756)
..+...+..++++|+. ..+..++|||+++.||+++.++.+.|+||+.+.
T Consensus 193 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 193 DGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp HHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred HHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 0111224446667763 013459999999999999888889999999875
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.07 E-value=9e-06 Score=87.98 Aligned_cols=75 Identities=19% Similarity=0.216 Sum_probs=50.0
Q ss_pred cCcccCCCCccEEEeecc-CCcEEEEEEccccCc-------ccHHHHHHHHHHHHhCCC--Ccee-eEeeEEEeCCeEEE
Q 004400 421 DNNIGEGGFGPVYKGLLA-DGTAIAVKQLSSKSK-------QGNREFINEIGMISALQH--PNLV-KLYGCCIEGNQLLL 489 (756)
Q Consensus 421 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-------~~~~~~~~E~~~l~~l~h--~niv-~l~~~~~~~~~~~l 489 (756)
.+.+|.|..+.||++... +++.|+||....... .....+..|.++++.+.. +..+ +++.+ +.+..++
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l 112 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 112 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence 467999999999999754 568899998643211 123456789999888742 4433 45543 4555689
Q ss_pred EEEecCCC
Q 004400 490 IYEYLENN 497 (756)
Q Consensus 490 V~e~~~~g 497 (756)
||||+++.
T Consensus 113 vmE~l~g~ 120 (397)
T 2olc_A 113 VMEDLSHL 120 (397)
T ss_dssp EECCCTTS
T ss_pred EEEeCCCc
Confidence 99999874
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.87 E-value=5.8e-05 Score=78.25 Aligned_cols=138 Identities=16% Similarity=0.149 Sum_probs=93.3
Q ss_pred cccCcccCCCCccEEEeeccCCcEEEEEEccccCcccHHHHHHHHHHHHhCC---CCceeeEeeEEEeCCeEEEEEEecC
Q 004400 419 ATDNNIGEGGFGPVYKGLLADGTAIAVKQLSSKSKQGNREFINEIGMISALQ---HPNLVKLYGCCIEGNQLLLIYEYLE 495 (756)
Q Consensus 419 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~lV~e~~~ 495 (756)
...+.|+.|....+|+... +++.+++|+.... ....+.+|.+.|+.+. ...+.+++.++..++..++||||++
T Consensus 39 ~~~~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~ 114 (312)
T 3jr1_A 39 KHKEKLYSGEMNEIWLIND-EVQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALN 114 (312)
T ss_dssp CEEEEECCSSSSEEEEEES-SSCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCC
T ss_pred eeeEEeCCccceeeeEEEE-CCCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEecc
Confidence 3456789999999999886 4677889987532 3467889999998884 3568888998888889999999999
Q ss_pred CCCHH--------H---HHHhcCC--C-------------------CCHHHHH---HHHH----------------HHHH
Q 004400 496 NNSLA--------R---ALFEHRL--K-------------------LDWPTRR---RICL----------------GIAR 524 (756)
Q Consensus 496 ~gsL~--------~---~l~~~~~--~-------------------l~~~~~~---~i~~----------------~ia~ 524 (756)
+..+. + .|+.... . -+|.... ++.. .++.
T Consensus 115 G~~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~ 194 (312)
T 3jr1_A 115 KSKNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQ 194 (312)
T ss_dssp CCCCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHH
T ss_pred CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHH
Confidence 87541 2 2222211 1 1454321 1111 1111
Q ss_pred -HHHHHHc-CCCCCeEcCCCCCCceEecCCCCEEEccCC
Q 004400 525 -GLAYLHG-ESRIKVVHRDIKATNVLLDKDLNSKISDFG 561 (756)
Q Consensus 525 -~L~~LH~-~g~~~iiH~Dikp~Nill~~~~~~kl~DFG 561 (756)
....|.. ...+.+||+|+.+.|++++.++ +.|.||.
T Consensus 195 ~l~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~ 232 (312)
T 3jr1_A 195 IVADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA 232 (312)
T ss_dssp HHHHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred HHHHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence 1233432 2346789999999999999887 8899984
|
| >3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A | Back alignment and structure |
|---|
Probab=97.86 E-value=6.9e-06 Score=76.80 Aligned_cols=84 Identities=13% Similarity=0.152 Sum_probs=50.3
Q ss_pred CCCcEEEeecCcccccCCcccCCCCCCcEEeccCCe-ecccCCccccCC----CCCCEEEeeCCc-ccccCChhhcCcCC
Q 004400 88 STLVNLTVQYNQFSGELPEELGSLLNLEKLHLSSNN-FTGELPKTFAKL----TNMKDFRISDNQ-FTGQIPSFIQNWTK 161 (756)
Q Consensus 88 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~-l~~~~p~~~~~l----~~L~~L~L~~N~-l~~~~p~~~~~l~~ 161 (756)
.+|+.|||+++.|+...-..+..+++|+.|+|++|. ++..--..++.+ ++|++|+|++|. ++..--..+.++++
T Consensus 61 ~~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~Gl~~L~~~~~ 140 (176)
T 3e4g_A 61 YKIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDKGIIALHHFRN 140 (176)
T ss_dssp CCEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHHHHHHGGGCTT
T ss_pred ceEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHHHHHHHhcCCC
Confidence 467777777777765555556677777777777764 553322334443 257777777764 66444445556666
Q ss_pred CcEEEccCCc
Q 004400 162 LEKLFIQPSG 171 (756)
Q Consensus 162 L~~L~l~~N~ 171 (756)
|+.|+|+++.
T Consensus 141 L~~L~L~~c~ 150 (176)
T 3e4g_A 141 LKYLFLSDLP 150 (176)
T ss_dssp CCEEEEESCT
T ss_pred CCEEECCCCC
Confidence 6666666653
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.83 E-value=9.9e-05 Score=75.82 Aligned_cols=79 Identities=22% Similarity=0.239 Sum_probs=58.9
Q ss_pred cCccccCcccCCCCccEEEeeccCCcEEEEEEccccCcccHHHHHHHHHHHHhCCCC---ceeeEeeEEEeCCeEEEEEE
Q 004400 416 NNFATDNNIGEGGFGPVYKGLLADGTAIAVKQLSSKSKQGNREFINEIGMISALQHP---NLVKLYGCCIEGNQLLLIYE 492 (756)
Q Consensus 416 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~---niv~l~~~~~~~~~~~lV~e 492 (756)
........+|.|..+.||+.+..||+.|++|+...........|.+|+..|+.+.-. -+.+++++ + ..++|||
T Consensus 15 ~~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~--~--~~~lv~e 90 (288)
T 3f7w_A 15 REVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGW--D--DRTLAME 90 (288)
T ss_dssp CCEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEE--E--TTEEEEE
T ss_pred CCeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEec--c--CceEEEE
Confidence 455667889999999999999999999999987655444445688999999988422 23444443 2 2378999
Q ss_pred ecCCCC
Q 004400 493 YLENNS 498 (756)
Q Consensus 493 ~~~~gs 498 (756)
|++++.
T Consensus 91 ~l~~~~ 96 (288)
T 3f7w_A 91 WVDERP 96 (288)
T ss_dssp CCCCCC
T ss_pred eecccC
Confidence 998764
|
| >3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A | Back alignment and structure |
|---|
Probab=97.68 E-value=1.4e-05 Score=74.65 Aligned_cols=91 Identities=12% Similarity=0.129 Sum_probs=68.3
Q ss_pred CcccCCCCCCcEEeccCCeecccCCccccCCCCCCEEEeeCCc-ccccCChhhcCc----CCCcEEEccCCc-CcCCCCc
Q 004400 105 PEELGSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRISDNQ-FTGQIPSFIQNW----TKLEKLFIQPSG-LAGPIPS 178 (756)
Q Consensus 105 p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~-l~~~~p~~~~~l----~~L~~L~l~~N~-l~~~~p~ 178 (756)
|.....-.+|+.|+|+++.++..--..+.++++|+.|+|++|. ++..--..++.+ ++|++|+|++|. ++...-.
T Consensus 54 P~~~~~~~~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~Gl~ 133 (176)
T 3e4g_A 54 PTGPLDKYKIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDKGII 133 (176)
T ss_dssp CCCSTTCCCEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHHHHH
T ss_pred CcccCCCceEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHHHHH
Confidence 4433333489999999999886555667889999999999995 776555566664 479999999985 7755455
Q ss_pred cccCCCCCCeEEccCCC
Q 004400 179 GIFSLENLTDLRISDLN 195 (756)
Q Consensus 179 ~~~~l~~L~~L~l~~n~ 195 (756)
.+.++++|+.|+++++.
T Consensus 134 ~L~~~~~L~~L~L~~c~ 150 (176)
T 3e4g_A 134 ALHHFRNLKYLFLSDLP 150 (176)
T ss_dssp HGGGCTTCCEEEEESCT
T ss_pred HHhcCCCCCEEECCCCC
Confidence 67778888888888764
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.65 E-value=0.00017 Score=78.42 Aligned_cols=74 Identities=16% Similarity=0.170 Sum_probs=45.8
Q ss_pred ccCcccCCCCccEEEeeccCCcEEEEEEcccc------C-c--ccHHHHHHHHHHHH-hCCCCceeeEeeEEEeCCeEEE
Q 004400 420 TDNNIGEGGFGPVYKGLLADGTAIAVKQLSSK------S-K--QGNREFINEIGMIS-ALQHPNLVKLYGCCIEGNQLLL 489 (756)
Q Consensus 420 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~------~-~--~~~~~~~~E~~~l~-~l~h~niv~l~~~~~~~~~~~l 489 (756)
..+.||.|..+.||++.. +++.++||..... . . .....+..|+..+. ......+.+++.+. ++..++
T Consensus 38 ~i~~l~~G~~n~vyrv~~-~~~~~vvK~~~p~~~~~~~~~~~~~~~~~~E~e~l~~~~~~~~~~vP~v~~~~--~~~~~l 114 (420)
T 2pyw_A 38 VIKEVGDGNLNFVFIVVG-SSGSLVIKQALPYIRCIGESWPMTKERAYFEATTLRKHGNLSPDHVPEVYHFD--RTMALI 114 (420)
T ss_dssp EEEECCCSSSCEEEEEEC-SSCEEEEEECCSBCTTTCTTSBCCTTHHHHHHHHHHHHHHHSGGGSCCEEEEE--TTTTEE
T ss_pred EEEEccCCCcEEEEEEEc-CCceEEEEECchhhcccCcccccchhHHHHHHHHHHHHHhhCCCCCCeEEEEC--CCccEE
Confidence 346789999999999964 4678999943221 0 1 12233444443332 22234566666664 567799
Q ss_pred EEEec-CC
Q 004400 490 IYEYL-EN 496 (756)
Q Consensus 490 V~e~~-~~ 496 (756)
||||+ ++
T Consensus 115 v~e~l~~g 122 (420)
T 2pyw_A 115 GMRYLEPP 122 (420)
T ss_dssp EECCCCTT
T ss_pred EEeecCCc
Confidence 99999 76
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.32 E-value=0.0014 Score=68.73 Aligned_cols=140 Identities=18% Similarity=0.160 Sum_probs=73.6
Q ss_pred cCcccCCCCcc-EEEeeccCCcEEEEEEccccCcccHHHHHHHHHHHHhCCC--CceeeEeeEEEeCCeEEEEEEecCCC
Q 004400 421 DNNIGEGGFGP-VYKGLLADGTAIAVKQLSSKSKQGNREFINEIGMISALQH--PNLVKLYGCCIEGNQLLLIYEYLENN 497 (756)
Q Consensus 421 ~~~lg~G~~g~-Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~~~~lV~e~~~~g 497 (756)
.+.|+.|+... +|+....+|+.+++|....... ..+..|+.+++.+.. -.+.+++.+..+.+ ++|||++.+.
T Consensus 23 ~~~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~~---~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~g--~ll~e~l~~~ 97 (333)
T 3csv_A 23 RTPLAGDASSRRYQRLRSPTGAKAVLMDWSPEEG---GDTQPFVDLAQYLRNLDISAPEIYAEEHARG--LLLIEDLGDA 97 (333)
T ss_dssp ECC--------CCEEEECTTCCEEEEEECCTTTT---CCSHHHHHHHHHHHHTTCBCCCEEEEETTTT--EEEECCCCSC
T ss_pred eeECCCCCCCceEEEEEcCCCCeEEEEECCCCCC---ccccHHHHHHHHHHhCCCCCCceeeecCCCC--EEEEeeCCCc
Confidence 34566665554 6677655467777876543221 234456676666632 23455666533333 7899999887
Q ss_pred CHHHHHHhcC-------------------------CCCCHHHHH-------H-H------------HHHHHHHHHHHH--
Q 004400 498 SLARALFEHR-------------------------LKLDWPTRR-------R-I------------CLGIARGLAYLH-- 530 (756)
Q Consensus 498 sL~~~l~~~~-------------------------~~l~~~~~~-------~-i------------~~~ia~~L~~LH-- 530 (756)
.+.+++.... ..++..... . + ...+...++.+.
T Consensus 98 ~l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~ 177 (333)
T 3csv_A 98 LFTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSA 177 (333)
T ss_dssp BHHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHH
T ss_pred chHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHh
Confidence 7765443110 011111100 0 0 001112222221
Q ss_pred -cCCCCCeEcCCCCCCceEecCC----CCEEEccCCcccc
Q 004400 531 -GESRIKVVHRDIKATNVLLDKD----LNSKISDFGLAKL 565 (756)
Q Consensus 531 -~~g~~~iiH~Dikp~Nill~~~----~~~kl~DFGla~~ 565 (756)
......++|||+.+.|||++.+ ..+.|+||+.+..
T Consensus 178 ~~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~ 217 (333)
T 3csv_A 178 QLEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL 217 (333)
T ss_dssp HCCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred cccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence 1123458999999999999875 6799999999874
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=97.28 E-value=7.1e-05 Score=71.28 Aligned_cols=111 Identities=14% Similarity=0.106 Sum_probs=65.4
Q ss_pred CcCcCCCcEEEeecC-cccc----cCCcccCCCCCCcEEeccCCeeccc----CCccccCCCCCCEEEeeCCcccccC--
Q 004400 84 LANISTLVNLTVQYN-QFSG----ELPEELGSLLNLEKLHLSSNNFTGE----LPKTFAKLTNMKDFRISDNQFTGQI-- 152 (756)
Q Consensus 84 l~~l~~L~~L~L~~N-~l~~----~~p~~~~~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~L~~N~l~~~~-- 152 (756)
+.+-+.|++|+|++| +|.. .+-.++..-+.|+.|+|++|+|... +...+..-+.|+.|+|+.|+|....
T Consensus 37 l~~n~~L~~L~L~~nn~igd~ga~~la~aL~~N~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig~~Ga~ 116 (197)
T 1pgv_A 37 REDDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLA 116 (197)
T ss_dssp HTTCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHH
T ss_pred HhcCCCccEEECCCCCCCCHHHHHHHHHHHhhCCCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCCHHHHH
Confidence 344567888888875 6653 2334566677788888888887732 2333445577888888888877432
Q ss_pred --ChhhcCcCCCcEEEccCCcC---cC----CCCccccCCCCCCeEEccCC
Q 004400 153 --PSFIQNWTKLEKLFIQPSGL---AG----PIPSGIFSLENLTDLRISDL 194 (756)
Q Consensus 153 --p~~~~~l~~L~~L~l~~N~l---~~----~~p~~~~~l~~L~~L~l~~n 194 (756)
..++..-+.|++|+|++|.. .. .+...+..-+.|+.|+++.|
T Consensus 117 ala~aL~~N~tL~~L~L~n~~~~~ig~~g~~~ia~aL~~N~tL~~L~l~~~ 167 (197)
T 1pgv_A 117 RLLRSTLVTQSIVEFKADNQRQSVLGNQVEMDMMMAIEENESLLRVGISFA 167 (197)
T ss_dssp HHHHHTTTTCCCSEEECCCCSSCCCCHHHHHHHHHHHHHCSSCCEEECCCC
T ss_pred HHHHHHhhCCceeEEECCCCcCcCcCHHHHHHHHHHHHhCCCcCeEeccCC
Confidence 33444456677777765432 21 12233444455666655543
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.28 E-value=0.0005 Score=71.01 Aligned_cols=128 Identities=13% Similarity=0.155 Sum_probs=74.9
Q ss_pred cCcccCCCCccEEEeeccCCcEEEEEEccccCcccHHHHHHHHHHHHhCCCCce-eeEeeEEEeCCeEEEEEEec-CCCC
Q 004400 421 DNNIGEGGFGPVYKGLLADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNL-VKLYGCCIEGNQLLLIYEYL-ENNS 498 (756)
Q Consensus 421 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lV~e~~-~~gs 498 (756)
.+.|+.|....+|+. +.+++|+....... .....+|+.+++.+....+ .+++++ +++.-++|+||+ ++.+
T Consensus 23 i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~-~~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~~~~v~e~i~~g~~ 94 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA-----GDLCLRIPGKGTEE-YINRANEAVAAREAAKAGVSPEVLHV--DPATGVMVTRYIAGAQT 94 (301)
T ss_dssp CEEEESCSSEEEEEE-----TTEEEEEECC-----CCCHHHHHHHHHHHHHTTSSCCEEEE--CTTTCCEEEECCTTCEE
T ss_pred eeEcCCcccccccee-----eeEEEECCCCCccc-eeCHHHHHHHHHHHHHcCCCCceEEE--ECCCCEEEEeecCCCcc
Confidence 577889999999998 56888887643211 1123568877777743333 345543 344457899999 5544
Q ss_pred HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHc-----------------------------------------------
Q 004400 499 LARALFEHRLKLDWPTRRRICLGIARGLAYLHG----------------------------------------------- 531 (756)
Q Consensus 499 L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~----------------------------------------------- 531 (756)
+....... +..++.++++.|+-||+
T Consensus 95 l~~~~~~~--------~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~l 166 (301)
T 3dxq_A 95 MSPEKFKT--------RPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRSAL 166 (301)
T ss_dssp CCHHHHHH--------STTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHHHH
T ss_pred CCHhhHhh--------hHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHHHH
Confidence 32100000 00112222222222222
Q ss_pred ---CCCCCeEcCCCCCCceEecCCCCEEEccCCcccc
Q 004400 532 ---ESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKL 565 (756)
Q Consensus 532 ---~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~ 565 (756)
..+..++|+|+.+.||+ ..++.+.++||..+..
T Consensus 167 ~~~~~~~~l~HgDl~~~Nil-~~~~~~~lID~e~a~~ 202 (301)
T 3dxq_A 167 AAHPLPLAACHCDPLCENFL-DTGERMWIVDWEYSGM 202 (301)
T ss_dssp HSSCCCCEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred HhcCCCceeeccCCCcCCEE-ECCCCEEEEecccccC
Confidence 12234799999999999 5667889999998864
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.25 E-value=0.00034 Score=76.08 Aligned_cols=71 Identities=17% Similarity=0.235 Sum_probs=49.4
Q ss_pred cCcccCCCCccEEEeeccC--------CcEEEEEEccccCcccHHHHHHHHHHHHhCCCCce-eeEeeEEEeCCeEEEEE
Q 004400 421 DNNIGEGGFGPVYKGLLAD--------GTAIAVKQLSSKSKQGNREFINEIGMISALQHPNL-VKLYGCCIEGNQLLLIY 491 (756)
Q Consensus 421 ~~~lg~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lV~ 491 (756)
.+.|+.|....||++...+ ++.+++|+.... .....+.+|..+++.+...++ .++++.+. + .+|+
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~--~~~~~li~E~~~l~~L~~~g~~P~l~~~~~--~--g~v~ 151 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--ETESHLVAESVIFTLLSERHLGPKLYGIFS--G--GRLE 151 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--CCHHHHHHHHHHHHHHHHTTSSSCEEEEET--T--EEEE
T ss_pred EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC--CcHHHHHHHHHHHHHHHhCCCCCcEEEEeC--C--CEEE
Confidence 4568888889999998653 578999988432 122456689999888853334 56666543 2 3899
Q ss_pred EecCCC
Q 004400 492 EYLENN 497 (756)
Q Consensus 492 e~~~~g 497 (756)
||++|.
T Consensus 152 e~l~G~ 157 (429)
T 1nw1_A 152 EYIPSR 157 (429)
T ss_dssp CCCCEE
T ss_pred EEeCCc
Confidence 999864
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.20 E-value=0.00062 Score=72.44 Aligned_cols=138 Identities=19% Similarity=0.240 Sum_probs=82.1
Q ss_pred CcccCCCCccEEEeecc--------CCcEEEEEEccccCcccHHHHHHHHHHHHhCC-CCceeeEeeEEEeCCeEEEEEE
Q 004400 422 NNIGEGGFGPVYKGLLA--------DGTAIAVKQLSSKSKQGNREFINEIGMISALQ-HPNLVKLYGCCIEGNQLLLIYE 492 (756)
Q Consensus 422 ~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lV~e 492 (756)
+.+..|-...+|+.... +++.|++|+.... ......+.+|.++++.+. +.-..++++++.+ .+|||
T Consensus 56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~-~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~e 130 (379)
T 3feg_A 56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI-LQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLEQ 130 (379)
T ss_dssp EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEEE
T ss_pred EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc-cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEEE
Confidence 46777888999998865 3578999987432 234456778999998884 3223556665533 39999
Q ss_pred ecCCCCHH--------------HHH---HhcC----CCCC--HHHHHHHHHHHHH-------------------HHHH--
Q 004400 493 YLENNSLA--------------RAL---FEHR----LKLD--WPTRRRICLGIAR-------------------GLAY-- 528 (756)
Q Consensus 493 ~~~~gsL~--------------~~l---~~~~----~~l~--~~~~~~i~~~ia~-------------------~L~~-- 528 (756)
|++|..|. +.| +... .... |.++.++..++.. .++.
T Consensus 131 ~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~ 210 (379)
T 3feg_A 131 YIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLR 210 (379)
T ss_dssp CCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHH
T ss_pred EecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHH
Confidence 99985442 111 1111 1122 3445555443321 1223
Q ss_pred --HHcC-CCCCeEcCCCCCCceEecCC----CCEEEccCCccc
Q 004400 529 --LHGE-SRIKVVHRDIKATNVLLDKD----LNSKISDFGLAK 564 (756)
Q Consensus 529 --LH~~-g~~~iiH~Dikp~Nill~~~----~~~kl~DFGla~ 564 (756)
|... ....++|+|+.+.||+++.+ +.+.++||..+.
T Consensus 211 ~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~ 253 (379)
T 3feg_A 211 KLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS 253 (379)
T ss_dssp HHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred HHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence 3222 23357999999999999876 689999999875
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.20 E-value=0.0015 Score=68.17 Aligned_cols=140 Identities=12% Similarity=0.116 Sum_probs=82.7
Q ss_pred CcccCCCCccEEEeeccCCcEEEEEEccccCcccHHHHHHHHHHHHhCCCCc--eeeEeeE-----EEeCCeEEEEEEec
Q 004400 422 NNIGEGGFGPVYKGLLADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPN--LVKLYGC-----CIEGNQLLLIYEYL 494 (756)
Q Consensus 422 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~~~-----~~~~~~~~lV~e~~ 494 (756)
..++ |....||+....+|+.+++|...... .....+..|..+++.+.... +++++.. ...++..++||+|+
T Consensus 32 ~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~-~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i 109 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSV 109 (328)
T ss_dssp EEEC-CSSSEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECC
T ss_pred Eeec-CcccceEEEEcCCCCEEEEEEcCCCC-CCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEec
Confidence 3466 88889999887778789999986321 23456777888887774222 3444432 23456778999999
Q ss_pred CCCCHH-----H------H---HHh--c------CCCCCHHHH----H------------------HHHHHHHHHHHHHH
Q 004400 495 ENNSLA-----R------A---LFE--H------RLKLDWPTR----R------------------RICLGIARGLAYLH 530 (756)
Q Consensus 495 ~~gsL~-----~------~---l~~--~------~~~l~~~~~----~------------------~i~~~ia~~L~~LH 530 (756)
+|..+. . . ++. . ....++... . ..+..++..++-+-
T Consensus 110 ~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 189 (328)
T 1zyl_A 110 GGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHW 189 (328)
T ss_dssp CCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHC
T ss_pred CCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHHh
Confidence 885321 1 1 111 0 011222211 0 11111222222221
Q ss_pred c-CCCCCeEcCCCCCCceEecCCCCEEEccCCcccc
Q 004400 531 G-ESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKL 565 (756)
Q Consensus 531 ~-~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~ 565 (756)
. ..+..++|||+++.||+++ + .+.|+||+.+..
T Consensus 190 ~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 190 REDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp CSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred hhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 1 1233579999999999999 4 899999998763
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.18 E-value=0.0011 Score=69.13 Aligned_cols=141 Identities=17% Similarity=0.152 Sum_probs=80.0
Q ss_pred cCcccCCCCccEEEeeccCCcEEEEEEccccCcccHHHHHHHHHHHHhCCCCc--eeeEeeE------EEeCCeEEEEEE
Q 004400 421 DNNIGEGGFGPVYKGLLADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPN--LVKLYGC------CIEGNQLLLIYE 492 (756)
Q Consensus 421 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~~~------~~~~~~~~lV~e 492 (756)
.+.|+.|....+|+....+| .+++|..... .....+..|+.+++.+.... +.+++.. ....+..+++++
T Consensus 27 ~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~--~~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~l~~ 103 (322)
T 2ppq_A 27 YKGIAEGVENSNFLLHTTKD-PLILTLYEKR--VEKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALIS 103 (322)
T ss_dssp EEEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEEE
T ss_pred eeccCCCcccceEEEEeCCc-cEEEEEeCCC--CCHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEEEEE
Confidence 35677788899999987666 5788987652 12234566777777664222 2333321 233567899999
Q ss_pred ecCCCCHH-----------H---HHHhcCCC--------C---CHHHHHH------------HHHHHHHHHHHHHcC---
Q 004400 493 YLENNSLA-----------R---ALFEHRLK--------L---DWPTRRR------------ICLGIARGLAYLHGE--- 532 (756)
Q Consensus 493 ~~~~gsL~-----------~---~l~~~~~~--------l---~~~~~~~------------i~~~ia~~L~~LH~~--- 532 (756)
|++|..+. + .++..... . .|..... +...+...+++++..
T Consensus 104 ~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~~~~ 183 (322)
T 2ppq_A 104 FLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWPK 183 (322)
T ss_dssp CCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCCC
T ss_pred eCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhCcc
Confidence 99986431 1 11211000 1 1222110 001244455555521
Q ss_pred -CCCCeEcCCCCCCceEecCCCCEEEccCCccc
Q 004400 533 -SRIKVVHRDIKATNVLLDKDLNSKISDFGLAK 564 (756)
Q Consensus 533 -g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~ 564 (756)
.+..++|+|+++.||+++++..+.|+||+.+.
T Consensus 184 ~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 184 DLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp SSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred cCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 23358999999999999987656899999875
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=96.92 E-value=0.00021 Score=68.02 Aligned_cols=119 Identities=8% Similarity=0.177 Sum_probs=73.4
Q ss_pred cccCCCCCCcEEeccCC-eecc----cCCccccCCCCCCEEEeeCCcccccC----ChhhcCcCCCcEEEccCCcCcCC-
Q 004400 106 EELGSLLNLEKLHLSSN-NFTG----ELPKTFAKLTNMKDFRISDNQFTGQI----PSFIQNWTKLEKLFIQPSGLAGP- 175 (756)
Q Consensus 106 ~~~~~l~~L~~L~L~~N-~l~~----~~p~~~~~l~~L~~L~L~~N~l~~~~----p~~~~~l~~L~~L~l~~N~l~~~- 175 (756)
..+.+-+.|+.|+|++| +|.. .+...+..-+.|+.|+|++|+|.... ...+..-+.|+.|+|+.|.|...
T Consensus 35 ~ll~~n~~L~~L~L~~nn~igd~ga~~la~aL~~N~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig~~G 114 (197)
T 1pgv_A 35 RLREDDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPEL 114 (197)
T ss_dssp HHHTTCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHH
T ss_pred HHHhcCCCccEEECCCCCCCCHHHHHHHHHHHhhCCCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCCHHH
Confidence 44566778999999985 7652 23445566678999999999988443 34444567888888888888643
Q ss_pred ---CCccccCCCCCCeEEccCCCCCCCCccccccccccEEEcccccccC----CCCccccCCCCCcEEEccCCcCC
Q 004400 176 ---IPSGIFSLENLTDLRISDLNGPEATFPQLGNMKMTKLILRNCNITG----ELPRYLGKMTKLKVLDLSFNRLR 244 (756)
Q Consensus 176 ---~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~L~~L~L~~n~l~~----~~p~~~~~l~~L~~L~Ls~N~l~ 244 (756)
+..++..-+.|++|+|++|... .+.. .+...+..-+.|+.|+++.|.+.
T Consensus 115 a~ala~aL~~N~tL~~L~L~n~~~~--------------------~ig~~g~~~ia~aL~~N~tL~~L~l~~~~~g 170 (197)
T 1pgv_A 115 LARLLRSTLVTQSIVEFKADNQRQS--------------------VLGNQVEMDMMMAIEENESLLRVGISFASME 170 (197)
T ss_dssp HHHHHHHTTTTCCCSEEECCCCSSC--------------------CCCHHHHHHHHHHHHHCSSCCEEECCCCCHH
T ss_pred HHHHHHHHhhCCceeEEECCCCcCc--------------------CcCHHHHHHHHHHHHhCCCcCeEeccCCCcc
Confidence 2233444445666655542110 1221 13344556677777877766543
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.85 E-value=0.0029 Score=69.13 Aligned_cols=73 Identities=16% Similarity=0.082 Sum_probs=47.6
Q ss_pred cCcccCCCCccEEEeeccC-CcEEEEEEccccCcccHHHHHHHHHHHHhCCCCce-eeEeeEEEeCCeEEEEEEecCCCC
Q 004400 421 DNNIGEGGFGPVYKGLLAD-GTAIAVKQLSSKSKQGNREFINEIGMISALQHPNL-VKLYGCCIEGNQLLLIYEYLENNS 498 (756)
Q Consensus 421 ~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lV~e~~~~gs 498 (756)
.+.|+.|-...+|+....+ +..+++|+....... ..+..+|..+++.+...++ .++++++ ++ .+||||++|.+
T Consensus 113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~-~idR~~E~~vl~~L~~~gl~P~ll~~~--~~--G~v~e~I~G~~ 187 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDE-IINREREKKISCILYNKNIAKKIYVFF--TN--GRIEEFMDGYA 187 (458)
T ss_dssp EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCS-CSCHHHHHHHHHHHTTSSSBCCEEEEE--TT--EEEEECCCSEE
T ss_pred EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhh-hcCHHHHHHHHHHHHhcCCCCCEEEEe--CC--eEEEEeeCCcc
Confidence 4578888889999998765 578889987543211 1122579999998865555 4566666 22 35999998743
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.71 E-value=0.012 Score=61.76 Aligned_cols=68 Identities=9% Similarity=0.044 Sum_probs=43.7
Q ss_pred cCCCCccEEEeeccCCcEEEEEEccccCcccHHHHHHHHHHHHhCC---CCceeeEeeE------EEeCCeEEEEEEecC
Q 004400 425 GEGGFGPVYKGLLADGTAIAVKQLSSKSKQGNREFINEIGMISALQ---HPNLVKLYGC------CIEGNQLLLIYEYLE 495 (756)
Q Consensus 425 g~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~------~~~~~~~~lV~e~~~ 495 (756)
|.|....||+....+| .+++|+...... ..|+..++.+. -|.+++++.. ....+..++||+|++
T Consensus 32 G~g~~N~vy~v~~~~g-~~vLK~~~~~~~------~~E~~~l~~L~~~g~~~vp~pi~~~~G~~~~~~~g~~~~l~~~i~ 104 (339)
T 3i1a_A 32 GADTNAFAYQADSESK-SYFIKLKYGYHD------EINLSIIRLLHDSGIKEIIFPIHTLEAKLFQQLKHFKIIAYPFIH 104 (339)
T ss_dssp TSCSSCEEEEEECSSC-EEEEEEEECSSC------CHHHHHHHHHHHTTCCSSCCCCCCTTSCSSEECSSEEEEEEECCC
T ss_pred cCccccceEEEEeCCC-CEEEEEecCccc------hHHHHHHHHHHhcCCcccccceecCCCCEEEEECCEEEEEEeccC
Confidence 3444688999987777 899998755332 34555555552 2224444432 344678899999999
Q ss_pred CCCH
Q 004400 496 NNSL 499 (756)
Q Consensus 496 ~gsL 499 (756)
|..+
T Consensus 105 G~~~ 108 (339)
T 3i1a_A 105 APNG 108 (339)
T ss_dssp CCBT
T ss_pred CCcC
Confidence 8754
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=96.71 E-value=0.0024 Score=56.59 Aligned_cols=61 Identities=20% Similarity=0.116 Sum_probs=48.0
Q ss_pred cEEEccccccc-CCCCccccCCCCCcEEEccCCcCCCCCCccCcCCCCCCeEEecCccccccCC
Q 004400 210 TKLILRNCNIT-GELPRYLGKMTKLKVLDLSFNRLRGQIPSNFDDLYDVDYIYFAGNLLTGAIP 272 (756)
Q Consensus 210 ~~L~L~~n~l~-~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p 272 (756)
..++.+++.|+ ..+|..+. ++|+.|+|++|+|+...+..|..+++|+.|+|++|++.+..-
T Consensus 11 ~~v~Cs~~~L~~~~vP~~lp--~~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~~CdC~ 72 (130)
T 3rfe_A 11 TLVDCGRRGLTWASLPTAFP--VDTTELVLTGNNLTALPPGLLDALPALRTAHLGANPWRCDCR 72 (130)
T ss_dssp TEEECCSSCCCTTTSCSCCC--TTCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCCBCSGG
T ss_pred CEEEeCCCCCccccCCCCCC--cCCCEEECCCCcCCccChhhhhhccccCEEEecCCCeeccCc
Confidence 35777888886 34554432 468999999999997777888999999999999999986554
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.64 E-value=0.0014 Score=69.77 Aligned_cols=73 Identities=14% Similarity=0.120 Sum_probs=43.9
Q ss_pred cCcccCCCCccEEEeeccC---------CcEEEEEEccccCcccHHHHHHHHHHHHhCCCCc-eeeEeeEEEeCCeEEEE
Q 004400 421 DNNIGEGGFGPVYKGLLAD---------GTAIAVKQLSSKSKQGNREFINEIGMISALQHPN-LVKLYGCCIEGNQLLLI 490 (756)
Q Consensus 421 ~~~lg~G~~g~Vy~~~~~~---------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~~~~lV 490 (756)
...++.|....+|+....+ ++.+++|+....... ......|.++++.+...+ ..++++.. ++ ++|
T Consensus 38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~-~~~~~~E~~~l~~L~~~g~~P~~~~~~--~~--~~v 112 (369)
T 3c5i_A 38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDE-LYNTISEFEVYKTMSKYKIAPQLLNTF--NG--GRI 112 (369)
T ss_dssp EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGG-TSCHHHHHHHHHHHHHTTSSCCEEEEE--TT--EEE
T ss_pred EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccc-eecHHHHHHHHHHHHhcCCCCceEEec--CC--cEE
Confidence 3467788889999988654 268888987543221 112357888888775333 34566543 22 689
Q ss_pred EEecCCCC
Q 004400 491 YEYLENNS 498 (756)
Q Consensus 491 ~e~~~~gs 498 (756)
|||++|..
T Consensus 113 ~e~i~G~~ 120 (369)
T 3c5i_A 113 EEWLYGDP 120 (369)
T ss_dssp EECCCSEE
T ss_pred EEEecCCc
Confidence 99998753
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=96.57 E-value=0.0028 Score=56.23 Aligned_cols=35 Identities=23% Similarity=0.377 Sum_probs=14.9
Q ss_pred CcEEeccCCeecccCCccccCCCCCCEEEeeCCcc
Q 004400 114 LEKLHLSSNNFTGELPKTFAKLTNMKDFRISDNQF 148 (756)
Q Consensus 114 L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l 148 (756)
|+.|+|++|+|+...+..|..+++|+.|+|++|.+
T Consensus 33 l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~ 67 (130)
T 3rfe_A 33 TTELVLTGNNLTALPPGLLDALPALRTAHLGANPW 67 (130)
T ss_dssp CSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCC
T ss_pred CCEEECCCCcCCccChhhhhhccccCEEEecCCCe
Confidence 44444444444433333344444444444444443
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=96.17 E-value=0.048 Score=52.11 Aligned_cols=103 Identities=16% Similarity=0.114 Sum_probs=69.0
Q ss_pred CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCcccCcceeec
Q 004400 497 NSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTR 576 (756)
Q Consensus 497 gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~ 576 (756)
-+|.+.|...+.++++++++.++.|.+.+|.-+-.+.. + ..+=+.|..|++..+|.|...+ +.+.
T Consensus 33 vSL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~-~-~~~i~~~~~i~l~~dG~V~f~~-~~s~------------ 97 (229)
T 2yle_A 33 LSLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRRQ-P-RHRVRSAAQIRVWRDGAVTLAP-AADD------------ 97 (229)
T ss_dssp EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTC-C-CCCCCSGGGEEEETTSCEEECC-C---------------
T ss_pred ccHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhccc-C-CceecCCcceEEecCCceeccc-cccc------------
Confidence 38999999888899999999999999999888722110 1 1333457999999999988764 2111
Q ss_pred cccCccCCchHhhhcCCCCcccchhhHHHHHHHHHhCCCC
Q 004400 577 VAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSN 616 (756)
Q Consensus 577 ~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p 616 (756)
.....+.|||... ...+.+.=|||+|+++|.-+--..|
T Consensus 98 -~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~ 135 (229)
T 2yle_A 98 -AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLK 135 (229)
T ss_dssp ----------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCC
T ss_pred -ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCC
Confidence 0122366787653 3456788999999999998864433
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=95.40 E-value=0.014 Score=62.94 Aligned_cols=73 Identities=11% Similarity=0.072 Sum_probs=47.5
Q ss_pred cCcccCCCCccEEEeeccC--------CcEEEEEEccccCcccHHHHHHHHHHHHhCCCCc-eeeEeeEEEeCCeEEEEE
Q 004400 421 DNNIGEGGFGPVYKGLLAD--------GTAIAVKQLSSKSKQGNREFINEIGMISALQHPN-LVKLYGCCIEGNQLLLIY 491 (756)
Q Consensus 421 ~~~lg~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~~~~lV~ 491 (756)
.+.+..|-...+|+....+ ++.|++++....... ..+..+|..+++.+...+ ..++++.+ .+ ++||
T Consensus 75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~-~idR~~E~~~l~~L~~~gi~P~l~~~~--~~--~~I~ 149 (424)
T 3mes_A 75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGK-FYDSKVELDVFRYLSNINIAPNIIADF--PE--GRIE 149 (424)
T ss_dssp EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-C-CCCHHHHHHHHHHHHHTTSSCCEEEEE--TT--EEEE
T ss_pred EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcch-hcCHHHHHHHHHHHHhcCCCCCEEEEc--CC--CEEE
Confidence 3567778888999998653 578999987543221 123357888888874323 34555433 32 7899
Q ss_pred EecCCCC
Q 004400 492 EYLENNS 498 (756)
Q Consensus 492 e~~~~gs 498 (756)
||++|..
T Consensus 150 efI~G~~ 156 (424)
T 3mes_A 150 EFIDGEP 156 (424)
T ss_dssp ECCCSEE
T ss_pred EEeCCcc
Confidence 9999865
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=91.35 E-value=0.32 Score=51.92 Aligned_cols=29 Identities=24% Similarity=0.418 Sum_probs=24.7
Q ss_pred eEcCCCCCCceEe------cCCCCEEEccCCcccc
Q 004400 537 VVHRDIKATNVLL------DKDLNSKISDFGLAKL 565 (756)
Q Consensus 537 iiH~Dikp~Nill------~~~~~~kl~DFGla~~ 565 (756)
++|+|+.+.|||+ +++..++++||..|..
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 5799999999999 4566799999998863
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=84.94 E-value=1.4 Score=41.93 Aligned_cols=114 Identities=9% Similarity=0.093 Sum_probs=80.0
Q ss_pred CCCceeeEeeEEEeCCeEEEEEEecCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceE
Q 004400 470 QHPNLVKLYGCCIEGNQLLLIYEYLENN-SLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVL 548 (756)
Q Consensus 470 ~h~niv~l~~~~~~~~~~~lV~e~~~~g-sL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nil 548 (756)
.||++++. .+-.+++.+.+.|+.-+.+ ++. .-...+...+++++.+|+...++++.. +|--+.|+||+
T Consensus 43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~-----~ik~~~~~eKlr~l~ni~~l~~~~~~r-----~tf~L~P~NL~ 111 (215)
T 4ann_A 43 HSPYFIDA-ELTELRDSFQIHYDINDNHTPFD-----NIKSFTKNEKLRYLLNIKNLEEVNRTR-----YTFVLAPDELF 111 (215)
T ss_dssp CCTTBCCE-EEEECSSEEEEEECCCTTSEEGG-----GGGGSCHHHHHHHHHHGGGGGGGGGSS-----EECCCSGGGEE
T ss_pred cCCcccce-EEEEcccEEEEEEEcCcccCCHH-----HHHhcCHHHHHHHHHHHHHHHHHhcCc-----eEEEEecceEE
Confidence 68988876 5666667766666654422 222 224678899999999999988777654 78999999999
Q ss_pred ecCCCCEEEccCCccccCcccCcceeeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHhCCCCC
Q 004400 549 LDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNV 617 (756)
Q Consensus 549 l~~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~ 617 (756)
++.++.+++.-.|+-....+. ..++..=.-.+=+++..+++++..|
T Consensus 112 f~~~~~p~i~~RGik~~l~P~-----------------------~~~ee~fL~qyKAliiall~~K~~F 157 (215)
T 4ann_A 112 FTRDGLPIAKTRGLQNVVDPL-----------------------PVSEAEFLTRYKALVICAFNEKQSF 157 (215)
T ss_dssp ECTTSCEEESCCEETTTBSCC-----------------------CCCHHHHHHHHHHHHHHHHCTTCCH
T ss_pred EcCCCCEEEEEccCccCCCCC-----------------------CCCHHHHHHHHHHHHHHHHcCCCCH
Confidence 999999999887764422211 1122222336677888899998876
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=84.11 E-value=3 Score=39.83 Aligned_cols=113 Identities=11% Similarity=0.133 Sum_probs=78.1
Q ss_pred CCCceeeEeeEEEeCCeEEEEEEecCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHH-HHHcCCCCCeEcCCCCCCce
Q 004400 470 QHPNLVKLYGCCIEGNQLLLIYEYLENN-SLARALFEHRLKLDWPTRRRICLGIARGLA-YLHGESRIKVVHRDIKATNV 547 (756)
Q Consensus 470 ~h~niv~l~~~~~~~~~~~lV~e~~~~g-sL~~~l~~~~~~l~~~~~~~i~~~ia~~L~-~LH~~g~~~iiH~Dikp~Ni 547 (756)
.||++ -..+-.+++.+.+.|+.-+++ +.. .+ ..++...+++++.+|+.... +++. -+|--+.|+||
T Consensus 48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~-~i----~~~~~~eKlrll~nl~~L~~~~~~~-----r~tf~l~P~NL 115 (219)
T 4ano_A 48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFA-AI----RKTTLLSRIRAAIHLVSKVKHHSAR-----RLIFIVCPENL 115 (219)
T ss_dssp SCSSS--EEEEEECSSEEEEEEECCTTCEEHH-HH----HTSCHHHHHHHHHHHHHHHSSCCSS-----SEECCCCGGGE
T ss_pred cCCCC--CeEEEEeCCEEEEEEEcCcccCcHH-HH----HhcCHHHHHHHHHHHHHHHHHhhhC-----ceeEEEeCceE
Confidence 68888 334446778888888876444 333 33 26788999999999988877 6654 37889999999
Q ss_pred EecCCCCEEEccCCccccCcccCcceeeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHhCCCCC
Q 004400 548 LLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNV 617 (756)
Q Consensus 548 ll~~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~ 617 (756)
++|.++.++|.-.|+-....+.. +.+|-+ .-.+=+++..++.++..|
T Consensus 116 ~f~~~~~p~i~hRGi~~~lpP~e-------------~~ee~f----------l~qyKali~all~~K~~F 162 (219)
T 4ano_A 116 MFNRALEPFFLHVGVKESLPPDE-------------WDDERL----------LREVKATVLALTEGEYRF 162 (219)
T ss_dssp EECTTCCEEESCCEETTTBSSCS-------------CCHHHH----------HHHHHHHHHHHTTCSSCH
T ss_pred EEeCCCcEEEEEcCCcccCCCCC-------------CCHHHH----------HHHHHHHHHHHHcCCCCH
Confidence 99999999999887654222110 122222 235667888888887665
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 756 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 1e-74 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 2e-68 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 6e-68 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 6e-67 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 8e-65 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 7e-64 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 8e-64 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 1e-63 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 2e-63 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 4e-63 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 9e-63 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 6e-62 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 2e-61 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 7e-61 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 1e-60 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 2e-60 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 5e-60 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 4e-59 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 5e-59 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 3e-58 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 5e-58 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 1e-57 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 1e-57 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 2e-57 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 2e-56 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 2e-56 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 2e-56 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 1e-55 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 1e-53 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 2e-53 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 1e-51 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 3e-51 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 4e-51 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 1e-49 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 2e-46 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 4e-46 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 6e-46 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 3e-45 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 6e-45 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 2e-44 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 2e-44 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 2e-44 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 4e-44 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 6e-44 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 6e-44 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 7e-44 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 3e-43 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 3e-42 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 4e-41 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 6e-41 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 1e-39 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 2e-38 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 7e-38 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 1e-37 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 3e-37 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 8e-37 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 1e-35 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 1e-33 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 2e-32 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 1e-31 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 5e-31 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 5e-27 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 9e-22 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 2e-18 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 7e-14 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 1e-09 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 2e-06 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 5e-04 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 4e-16 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 1e-15 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 2e-10 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 1e-15 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 5e-15 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 4e-06 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 8e-04 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 7e-13 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 2e-08 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 1e-09 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 0.003 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 3e-07 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 4e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 4e-07 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 4e-06 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 4e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 1e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 1e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 2e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 0.003 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 3e-06 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 1e-05 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 8e-06 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 8e-05 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 9e-05 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 0.002 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 1e-04 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 4e-04 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 1e-04 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 4e-04 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 0.004 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 0.001 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 0.002 | |
| d2omxa2 | 199 | c.10.2.1 (A:37-235) Internalin B {Listeria monocyt | 0.001 | |
| d2omxa2 | 199 | c.10.2.1 (A:37-235) Internalin B {Listeria monocyt | 0.003 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 0.001 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 0.002 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 0.002 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 241 bits (615), Expect = 1e-74
Identities = 74/273 (27%), Positives = 127/273 (46%), Gaps = 16/273 (5%)
Query: 416 NNFATDNNIGEGGFGPVYKGLLADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLV 475
IG G FG VYKG A+ + +++ + Q + F NE+G++ +H N++
Sbjct: 8 GQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL 67
Query: 476 KLYGCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRI 535
G QL ++ ++ E +SL L K + I A+G+ YLH +
Sbjct: 68 LFMGYS-TAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAK--- 123
Query: 536 KVVHRDIKATNVLLDKDLNSKISDFGLAKL-DEEENTHISTRVAGTIGYMAPEYAM---R 591
++HRD+K+ N+ L +DL KI DFGLA + +H +++G+I +MAPE +
Sbjct: 124 SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDK 183
Query: 592 GHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFD 651
+ ++DVY+FGIV E+++G+ + + D + + +G L + SN
Sbjct: 184 NPYSFQSDVYAFGIVLYELMTGQLPYSNIN---NRDQIIFMVGRGYLSPDLSKVR-SNCP 239
Query: 652 KEQVMVMINVALLCANASPTIRPSMSSVLRMLE 684
K M + C RP +L +E
Sbjct: 240 KA----MKRLMAECLKKKRDERPLFPQILASIE 268
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 224 bits (572), Expect = 2e-68
Identities = 69/269 (25%), Positives = 121/269 (44%), Gaps = 16/269 (5%)
Query: 416 NNFATDNNIGEGGFGPVYKGLLADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLV 475
+ IG G FG V+ G + +A+K + + +FI E ++ L HP LV
Sbjct: 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIR-EGAMSEEDFIEEAEVMMKLSHPKLV 63
Query: 476 KLYGCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRI 535
+LYG C+E + L++E++E+ L+ L R T +CL + G+AYL
Sbjct: 64 QLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE---EA 120
Query: 536 KVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPEYAMRGHLT 595
V+HRD+ A N L+ ++ K+SDFG+ + ++ ST + + +PE +
Sbjct: 121 CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYS 180
Query: 596 EKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDKEQV 655
K+DV+SFG++ E+ S + + +++E + T +
Sbjct: 181 SKSDVWSFGVLMWEVFSEGKIPYEN------------RSNSEVVEDISTGFRLYKPRLAS 228
Query: 656 MVMINVALLCANASPTIRPSMSSVLRMLE 684
+ + C P RP+ S +LR L
Sbjct: 229 THVYQIMNHCWKERPEDRPAFSRLLRQLA 257
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 222 bits (568), Expect = 6e-68
Identities = 77/270 (28%), Positives = 120/270 (44%), Gaps = 18/270 (6%)
Query: 416 NNFATDNNIGEGGFGPVYKGLLADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLV 475
+G G FG V+ G T +AVK L + F+ E ++ LQH LV
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLV 71
Query: 476 KLYGCCIEGNQLLLIYEYLENNSLARALFEHR-LKLDWPTRRRICLGIARGLAYLHGESR 534
+LY + + +I EY+EN SL L +KL + IA G+A++
Sbjct: 72 RLYAVVTQEP-IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---E 127
Query: 535 IKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPEYAMRGHL 594
+HRD++A N+L+ L+ KI+DFGLA+L E+ I + APE G
Sbjct: 128 RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTF 187
Query: 595 TEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDKEQ 654
T K+DV+SFGI+ EIV+ + + V++ + +V N +E
Sbjct: 188 TIKSDVWSFGILLTEIVTHGRI-----PYPGMTNPEVIQNLERGYRMVRP---DNCPEE- 238
Query: 655 VMVMINVALLCANASPTIRPSMSSVLRMLE 684
+ + LC P RP+ + +LE
Sbjct: 239 ---LYQLMRLCWKERPEDRPTFDYLRSVLE 265
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 219 bits (560), Expect = 6e-67
Identities = 59/269 (21%), Positives = 105/269 (39%), Gaps = 16/269 (5%)
Query: 416 NNFATDNNIGEGGFGPVYKGLLADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLV 475
+ +G G FG V G +A+K + + EFI E ++ L H LV
Sbjct: 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMNLSHEKLV 62
Query: 476 KLYGCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRI 535
+LYG C + + +I EY+ N L L E R + +C + + YL +
Sbjct: 63 QLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESK--- 119
Query: 536 KVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPEYAMRGHLT 595
+ +HRD+ A N L++ K+SDFGL++ ++ S + + PE M +
Sbjct: 120 QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFS 179
Query: 596 EKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDKEQV 655
K+D+++FG++ EI S + + E +
Sbjct: 180 SKSDIWAFGVLMWEIYSLGKMPYERF------------TNSETAEHIAQGLRLYRPHLAS 227
Query: 656 MVMINVALLCANASPTIRPSMSSVLRMLE 684
+ + C + RP+ +L +
Sbjct: 228 EKVYTIMYSCWHEKADERPTFKILLSNIL 256
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 215 bits (548), Expect = 8e-65
Identities = 65/287 (22%), Positives = 126/287 (43%), Gaps = 24/287 (8%)
Query: 416 NNFATDNNIGEGGFGPVYKGLLAD-GTAIAVKQLSSKSKQGNREFINEIGMISALQHPNL 474
+ + +G G +G VY+G+ +AVK L + + EF+ E ++ ++HPNL
Sbjct: 17 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPNL 75
Query: 475 VKLYGCCIEGNQLLLIYEYLENNSLARALFEH-RLKLDWPTRRRICLGIARGLAYLHGES 533
V+L G C +I E++ +L L E R ++ + I+ + YL
Sbjct: 76 VQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE--- 132
Query: 534 RIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPEYAMRGH 593
+ +HRD+ A N L+ ++ K++DFGL++L + I + APE
Sbjct: 133 KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNK 192
Query: 594 LTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDKE 653
+ K+DV++FG++ EI + + + ++ EL++ + +
Sbjct: 193 FSIKSDVWAFGVLLWEIATYGMSPYPG------------IDLSQVYELLEKDYRMERPEG 240
Query: 654 QVMVMINVALLCANASPTIRPSMSSVLRMLECGVDVLDLVSDSSVSD 700
+ + C +P+ RPS + + + E + +SS+SD
Sbjct: 241 CPEKVYELMRACWQWNPSDRPSFAEIHQAFE------TMFQESSISD 281
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 212 bits (541), Expect = 7e-64
Identities = 70/270 (25%), Positives = 117/270 (43%), Gaps = 18/270 (6%)
Query: 416 NNFATDNNIGEGGFGPVYKGLLADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLV 475
+ + +G+G FG V+ G T +A+K L F+ E ++ L+H LV
Sbjct: 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLV 75
Query: 476 KLYGCCIEGNQLLLIYEYLENNSLARALFEHRLKLD-WPTRRRICLGIARGLAYLHGESR 534
+LY + ++ EY+ SL L K P + IA G+AY+ R
Sbjct: 76 QLYAVV-SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---R 131
Query: 535 IKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPEYAMRGHL 594
+ VHRD++A N+L+ ++L K++DFGLA+L E+ I + APE A+ G
Sbjct: 132 MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRF 191
Query: 595 TEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDKEQ 654
T K+DV+SFGI+ E+ + ++++ V+ E
Sbjct: 192 TIKSDVWSFGILLTELTTKGRVPYPG------------MVNREVLDQVERGYRMPCPPEC 239
Query: 655 VMVMINVALLCANASPTIRPSMSSVLRMLE 684
+ ++ C P RP+ + LE
Sbjct: 240 PESLHDLMCQCWRKEPEERPTFEYLQAFLE 269
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 213 bits (542), Expect = 8e-64
Identities = 70/295 (23%), Positives = 127/295 (43%), Gaps = 33/295 (11%)
Query: 408 YLQIKAATNNFATDNN---------IGEGGFGPVYKGLLA----DGTAIAVKQL-SSKSK 453
+ A FA + + IG G FG V G L +A+K L S ++
Sbjct: 9 FEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTE 68
Query: 454 QGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWP 513
+ R+F++E ++ HPN++ L G + +++I E++EN SL L ++ +
Sbjct: 69 KQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVI 128
Query: 514 TRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHI 573
+ GIA G+ YL + VHRD+ A N+L++ +L K+SDFGL++ E++ +
Sbjct: 129 QLVGMLRGIAAGMKYLA---DMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDP 185
Query: 574 STRVA----GTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWA 629
+ A I + APE T +DV+S+GIV E++S +
Sbjct: 186 TYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDM-------- 237
Query: 630 LVLKEQGKLMELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLE 684
++ ++ + + + + L C RP ++ L+
Sbjct: 238 ----TNQDVINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLD 288
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 211 bits (539), Expect = 1e-63
Identities = 67/271 (24%), Positives = 119/271 (43%), Gaps = 24/271 (8%)
Query: 421 DNNIGEGGFGPVYKGLLA---DGTAIAVKQLSSKSKQGNRE-FINEIGMISALQHPNLVK 476
D +G G FG V +G+ +A+K L +++ + E + E ++ L +P +V+
Sbjct: 14 DIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVR 73
Query: 477 LYGCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIK 536
L G C + L+L+ E L + L R ++ + ++ G+ YL +
Sbjct: 74 LIGVC-QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEK---N 129
Query: 537 VVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTR--VAGTIGYMAPEYAMRGHL 594
VHRD+ A NVLL +KISDFGL+K ++++ + R + + APE
Sbjct: 130 FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKF 189
Query: 595 TEKADVYSFGIVALEIVS-GRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDKE 653
+ ++DV+S+G+ E +S G+ K ++ + EQGK ME P
Sbjct: 190 SSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFI----EQGKRMECPPECPPE----- 240
Query: 654 QVMVMINVALLCANASPTIRPSMSSVLRMLE 684
+ + C RP +V + +
Sbjct: 241 ----LYALMSDCWIYKWEDRPDFLTVEQRMR 267
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 212 bits (542), Expect = 2e-63
Identities = 50/208 (24%), Positives = 101/208 (48%), Gaps = 10/208 (4%)
Query: 409 LQIKAATNNFATDNNIGEGGFGPVYKG-LLADGTAIAVKQLSSKSKQGNRE-FINEIGMI 466
+++K ++F + +G G G V+K G +A K + + K R I E+ ++
Sbjct: 1 MELK--DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVL 58
Query: 467 SALQHPNLVKLYGCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGL 526
P +V YG ++ + E+++ SL + L + ++ ++ + + +GL
Sbjct: 59 HECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAG-RIPEQILGKVSIAVIKGL 117
Query: 527 AYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAP 586
YL + K++HRD+K +N+L++ K+ DFG++ + GT YM+P
Sbjct: 118 TYLR--EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA---NSFVGTRSYMSP 172
Query: 587 EYAMRGHLTEKADVYSFGIVALEIVSGR 614
E H + ++D++S G+ +E+ GR
Sbjct: 173 ERLQGTHYSVQSDIWSMGLSLVEMAVGR 200
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 211 bits (537), Expect = 4e-63
Identities = 73/287 (25%), Positives = 120/287 (41%), Gaps = 30/287 (10%)
Query: 424 IGEGGFGPVYKGLLADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCCIE 483
IG+G FG V++G G +AVK SS+ ++ + EI L+H N++ +
Sbjct: 11 IGKGRFGEVWRGKW-RGEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAADNK 68
Query: 484 GN----QLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGE-----SR 534
N QL L+ +Y E+ SL L +R + ++ L A GLA+LH E +
Sbjct: 69 DNGTWTQLWLVSDYHEHGSLFDYL--NRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGK 126
Query: 535 IKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHIS---TRVAGTIGYMAPEY--- 588
+ HRD+K+ N+L+ K+ I+D GLA + I GT YMAPE
Sbjct: 127 PAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDD 186
Query: 589 ---AMRGHLTEKADVYSFGIVALEIVSGR--SNVTKEDMFYLLDWALVLKEQGKLMELVD 643
++AD+Y+ G+V EI + ++ D ++ ++V
Sbjct: 187 SINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVC 246
Query: 644 TN------PGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLE 684
P E + VM + C A+ R + + + L
Sbjct: 247 EQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLS 293
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 209 bits (533), Expect = 9e-63
Identities = 71/277 (25%), Positives = 129/277 (46%), Gaps = 23/277 (8%)
Query: 416 NNFATDNNIGEGGFGPVYKGLLADGT-----AIAVKQLSSKSKQGNR-EFINEIGMISAL 469
+ IG G FG VYKG+L + +A+K L + + R +F+ E G++
Sbjct: 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF 66
Query: 470 QHPNLVKLYGCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYL 529
H N+++L G + +++I EY+EN +L + L E + + GIA G+ YL
Sbjct: 67 SHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYL 126
Query: 530 HGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKL--DEEENTHISTRVAGTIGYMAPE 587
+ VHRD+ A N+L++ +L K+SDFGL+++ D+ E T+ ++ I + APE
Sbjct: 127 A---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPE 183
Query: 588 YAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPG 647
T +DV+SFGIV E+++ E ++M+ ++
Sbjct: 184 AISYRKFTSASDVWSFGIVMWEVMTYGERPYWEL------------SNHEVMKAINDGFR 231
Query: 648 SNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLE 684
+ + + + C RP + ++ +L+
Sbjct: 232 LPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILD 268
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 207 bits (527), Expect = 6e-62
Identities = 64/271 (23%), Positives = 111/271 (40%), Gaps = 24/271 (8%)
Query: 421 DNNIGEGGFGPVYKGLLAD---GTAIAVKQLSSKSKQGN--REFINEIGMISALQHPNLV 475
D +G G FG V KG +AVK L +++ E + E ++ L +P +V
Sbjct: 12 DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIV 71
Query: 476 KLYGCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRI 535
++ G C E +L+ E E L + L ++R + + ++ G+ YL
Sbjct: 72 RMIGIC-EAESWMLVMEMAELGPLNKYLQQNR-HVKDKNIIELVHQVSMGMKYLEES--- 126
Query: 536 KVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTR--VAGTIGYMAPEYAMRGH 593
VHRD+ A NVLL +KISDFGL+K + + + + + APE
Sbjct: 127 NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYK 186
Query: 594 LTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDKE 653
+ K+DV+SFG++ E S + + + ++ +++
Sbjct: 187 FSSKSDVWSFGVLMWEAFS-----YGQKPYRGMK-------GSEVTAMLEKGERMGCPAG 234
Query: 654 QVMVMINVALLCANASPTIRPSMSSVLRMLE 684
M ++ LC RP ++V L
Sbjct: 235 CPREMYDLMNLCWTYDVENRPGFAAVELRLR 265
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 205 bits (523), Expect = 2e-61
Identities = 76/264 (28%), Positives = 117/264 (44%), Gaps = 26/264 (9%)
Query: 424 IGEGGFGPVYKGLLADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCCIE 483
IG+G FG V G G +AVK + + + + F+ E +++ L+H NLV+L G +E
Sbjct: 15 IGKGEFGDVMLGDY-RGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGVIVE 71
Query: 484 G-NQLLLIYEYLENNSLARALFEH-RLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRD 541
L ++ EY+ SL L R L + L + + YL G VHRD
Sbjct: 72 EKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRD 128
Query: 542 IKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPEYAMRGHLTEKADVY 601
+ A NVL+ +D +K+SDFGL K + + APE + K+DV+
Sbjct: 129 LAARNVLVSEDNVAKVSDFGLTKEASSTQDT----GKLPVKWTAPEALREKKFSTKSDVW 184
Query: 602 SFGIVALEIVS-GRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDKEQVMVMIN 660
SFGI+ EI S GR + + ++ E+G M+ D P + +
Sbjct: 185 SFGILLWEIYSFGRVPYPRIPLKDVVPRV----EKGYKMDAPDGCPPA---------VYE 231
Query: 661 VALLCANASPTIRPSMSSVLRMLE 684
V C + +RPS + LE
Sbjct: 232 VMKNCWHLDAAMRPSFLQLREQLE 255
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 205 bits (522), Expect = 7e-61
Identities = 73/300 (24%), Positives = 122/300 (40%), Gaps = 46/300 (15%)
Query: 424 IGEGGFGPVYKGLLA------DGTAIAVKQLSSKSKQGNRE-FINEIGMISAL-QHPNLV 475
+G G FG V + +AVK L + RE ++E+ ++S L H N+V
Sbjct: 31 LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 90
Query: 476 KLYGCCIEGNQLLLIYEYLENNSLARALFEHR-----------------LKLDWPTRRRI 518
L G C G L+I EY L L R L LD
Sbjct: 91 NLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSF 150
Query: 519 CLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAK-LDEEENTHISTRV 577
+A+G+A+L + +HRD+ A N+LL +KI DFGLA+ + + N +
Sbjct: 151 SYQVAKGMAFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNA 207
Query: 578 AGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGK 637
+ +MAPE T ++DV+S+GI E+ S S+ + K
Sbjct: 208 RLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSS-----------PYPGMPVDSK 256
Query: 638 LMELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLECGVDVLDLVSDSS 697
+++ + M ++ C +A P RP+ +++++E +S+S+
Sbjct: 257 FYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIE------KQISEST 310
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 204 bits (520), Expect = 1e-60
Identities = 70/277 (25%), Positives = 121/277 (43%), Gaps = 26/277 (9%)
Query: 417 NFATDNNIGEGGFGPVYKGLLAD----GTAIAVKQLSSKSKQGN-REFINEIGMISALQH 471
+F + IG G FG VY G L D AVK L+ + G +F+ E ++ H
Sbjct: 30 HF--NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 87
Query: 472 PNLVKLYGCCIEG-NQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLH 530
PN++ L G C+ L++ Y+++ L + L +A+G+ +L
Sbjct: 88 PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLA 147
Query: 531 GESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKL---DEEENTHISTRVAGTIGYMAPE 587
+ K VHRD+ A N +LD+ K++DFGLA+ E ++ H T + +MA E
Sbjct: 148 SK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALE 204
Query: 588 YAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPG 647
T K+DV+SFG++ E+++ + + D + L + +L+
Sbjct: 205 SLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV--NTFDITVYLLQGRRLL------QP 256
Query: 648 SNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLE 684
+ V L C + +RPS S ++ +
Sbjct: 257 EYCPDP----LYEVMLKCWHPKAEMRPSFSELVSRIS 289
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 204 bits (519), Expect = 2e-60
Identities = 76/304 (25%), Positives = 126/304 (41%), Gaps = 54/304 (17%)
Query: 416 NNFATDNNIGEGGFGPVYKGLL------ADGTAIAVKQLSSKSKQGNR-EFINEIGMISA 468
NN +IGEG FG V++ T +AVK L ++ + +F E +++
Sbjct: 13 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAE 72
Query: 469 LQHPNLVKLYGCCIEGNQLLLIYEYLENNSLARALFEHRL-------------------- 508
+PN+VKL G C G + L++EY+ L L
Sbjct: 73 FDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSP 132
Query: 509 ---KLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAK- 564
L + I +A G+AYL K VHRD+ N L+ +++ KI+DFGL++
Sbjct: 133 GPPPLSCAEQLCIARQVAAGMAYLS---ERKFVHRDLATRNCLVGENMVVKIADFGLSRN 189
Query: 565 LDEEENTHISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGR----SNVTKE 620
+ + A I +M PE T ++DV+++G+V EI S + E
Sbjct: 190 IYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHE 249
Query: 621 DMFYLLDWALVLKEQGKLMELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVL 680
++ Y + G ++ + P + N+ LC + P RPS S+
Sbjct: 250 EVIYYV-------RDGNILACPENCPLE---------LYNLMRLCWSKLPADRPSFCSIH 293
Query: 681 RMLE 684
R+L+
Sbjct: 294 RILQ 297
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 201 bits (513), Expect = 5e-60
Identities = 72/291 (24%), Positives = 119/291 (40%), Gaps = 34/291 (11%)
Query: 399 AISLTYYGFYLQIKAATNNFATDNNIGEGGFGPVYKGLLAD-GTAIAVKQLSSK--SKQG 455
A+ ++ G +L+ D IG G F VYKGL + +A +L + +K
Sbjct: 1 AVGMSNDGRFLKF---------DIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSE 51
Query: 456 NREFINEIGMISALQHPNLVKLYGCCIE----GNQLLLIYEYLENNSLARALFEHRLKLD 511
+ F E M+ LQHPN+V+ Y ++L+ E + + +L L + +
Sbjct: 52 RQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFK-VMK 110
Query: 512 WPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNS-KISDFGLAKLDEEEN 570
R C I +GL +LH ++HRD+K N+ + S KI D GLA L
Sbjct: 111 IKVLRSWCRQILKGLQFLH-TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR--- 166
Query: 571 THISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWAL 630
+ V GT +MAPE E DVY+FG+ LE+ + ++ +
Sbjct: 167 ASFAKAVIGTPEFMAPEM-YEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQI---- 221
Query: 631 VLKEQGKLMELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLR 681
+ ++FDK + + + C + R S+ +L
Sbjct: 222 -------YRRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 265
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 201 bits (512), Expect = 4e-59
Identities = 73/301 (24%), Positives = 108/301 (35%), Gaps = 45/301 (14%)
Query: 416 NNFATDNNIGEGGFGPVYKGLL------ADGTAIAVKQLSSKSKQGNRE-FINEIGMISA 468
N +G G FG V +AVK L K+ RE ++E+ M++
Sbjct: 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 96
Query: 469 L-QHPNLVKLYGCCIEGNQLLLIYEYLENNSLARALFEHRLK------------------ 509
L H N+V L G C + LI+EY L L R K
Sbjct: 97 LGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 156
Query: 510 ----LDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAK- 564
L + +A+G+ +L VHRD+ A NVL+ KI DFGLA+
Sbjct: 157 DLNVLTFEDLLCFAYQVAKGMEFLE---FKSCVHRDLAARNVLVTHGKVVKICDFGLARD 213
Query: 565 LDEEENTHISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFY 624
+ + N + + +MAPE G T K+DV+S+GI+ EI S N
Sbjct: 214 IMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGI--- 270
Query: 625 LLDWALVLKEQGKLMELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLE 684
+L+ + + + C RPS ++ L
Sbjct: 271 --------PVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322
Query: 685 C 685
C
Sbjct: 323 C 323
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 199 bits (507), Expect = 5e-59
Identities = 63/264 (23%), Positives = 113/264 (42%), Gaps = 21/264 (7%)
Query: 424 IGEGGFGPVYKG-LLADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCCI 482
+G+G FG VYK A K + +KS++ +++ EI ++++ HPN+VKL
Sbjct: 20 LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 79
Query: 483 EGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDI 542
N L ++ E+ ++ + E L + +C L YLH K++HRD+
Sbjct: 80 YENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLH---DNKIIHRDL 136
Query: 543 KATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPEYAM-----RGHLTEK 597
KA N+L D + K++DFG++ + + + GT +MAPE M K
Sbjct: 137 KAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFI-GTPYWMAPEVVMCETSKDRPYDYK 195
Query: 598 ADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDKEQVMV 657
ADV+S GI +E+ + + +L + K + + +
Sbjct: 196 ADVWSLGITLIEMAEIEPPHHELNPMRVLL--KIAKSEPPTLAQPS-----RWSSN---- 244
Query: 658 MINVALLCANASPTIRPSMSSVLR 681
+ C + R + S +L+
Sbjct: 245 FKDFLKKCLEKNVDARWTTSQLLQ 268
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 196 bits (500), Expect = 3e-58
Identities = 70/268 (26%), Positives = 113/268 (42%), Gaps = 24/268 (8%)
Query: 424 IGEGGFGPVYKG-LLADGTAIAVKQL--SSKSKQGNREFINEIGMISALQHPNLVKLYGC 480
IG G +G K +DG + K+L S ++ + ++E+ ++ L+HPN+V+ Y
Sbjct: 12 IGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDR 71
Query: 481 CIE--GNQLLLIYEYLENNSLARALFEH---RLKLDWPTRRRICLGIARGLAYLH--GES 533
I+ L ++ EY E LA + + R LD R+ + L H +
Sbjct: 72 IIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDG 131
Query: 534 RIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPEYAMRGH 593
V+HRD+K NV LD N K+ DFGLA++ +T + GT YM+PE R
Sbjct: 132 GHTVLHRDLKPANVFLDGKQNVKLGDFGLARI-LNHDTSFAKAFVGTPYYMSPEQMNRMS 190
Query: 594 LTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDKE 653
EK+D++S G + E+ + T L K+ E + E
Sbjct: 191 YNEKSDIWSLGCLLYELCALMPPFTAFSQKELAG---------KIREGKFRRIPYRYSDE 241
Query: 654 QVMVMINVALLCANASPTIRPSMSSVLR 681
+ + N RPS+ +L
Sbjct: 242 ----LNEIITRMLNLKDYHRPSVEEILE 265
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 197 bits (502), Expect = 5e-58
Identities = 76/302 (25%), Positives = 129/302 (42%), Gaps = 35/302 (11%)
Query: 424 IGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQGN---REFINEIGMISALQHPNLVKLYG 479
IG G FG VY + + +A+K++S KQ N ++ I E+ + L+HPN ++ G
Sbjct: 23 IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRG 82
Query: 480 CCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVH 539
C + + L+ EY ++ H+ L + G +GLAYLH ++H
Sbjct: 83 CYLREHTAWLVMEYCLGSASDLLEV-HKKPLQEVEIAAVTHGALQGLAYLH---SHNMIH 138
Query: 540 RDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPEYAM---RGHLTE 596
RD+KA N+LL + K+ DFG A + N+ + GT +MAPE + G
Sbjct: 139 RDVKAGNILLSEPGLVKLGDFGSASIMAPANSFV-----GTPYWMAPEVILAMDEGQYDG 193
Query: 597 KADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDKEQVM 656
K DV+S GI +E+ + + + L Q + L ++ +
Sbjct: 194 KVDVWSLGITCIELAERKPPLFNMNAMSALYHIA----QNESPAL----QSGHWSEY--- 242
Query: 657 VMINVALLCANASPTIRPSMSSVLRM-----LECGVDVLDLVS--DSSVSDIDETKAEAM 709
N C P RP+ +L+ ++DL+ +V ++D + M
Sbjct: 243 -FRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERPPTVIMDLIQRTKDAVRELDNLQYRKM 301
Query: 710 RK 711
+K
Sbjct: 302 KK 303
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 196 bits (500), Expect = 1e-57
Identities = 64/268 (23%), Positives = 121/268 (45%), Gaps = 23/268 (8%)
Query: 424 IGEGGFGPVYKGLLAD-----GTAIAVKQLS-SKSKQGNREFINEIGMISALQHPNLVKL 477
+G G FG VYKGL +A+K+L + S + N+E ++E +++++ +P++ +L
Sbjct: 17 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 76
Query: 478 YGCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKV 537
G C+ + LI + + L + EH+ + C+ IA+G+ YL ++
Sbjct: 77 LGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR---RL 132
Query: 538 VHRDIKATNVLLDKDLNSKISDFGLAK-LDEEENTHISTRVAGTIGYMAPEYAMRGHLTE 596
VHRD+ A NVL+ + KI+DFGLAK L EE + + I +MA E + T
Sbjct: 133 VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTH 192
Query: 597 KADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDKEQVM 656
++DV+S+G+ E+++ S ++ +++ +
Sbjct: 193 QSDVWSYGVTVWELMTFGSKPYDGI------------PASEISSILEKGERLPQPPICTI 240
Query: 657 VMINVALLCANASPTIRPSMSSVLRMLE 684
+ + + C RP ++
Sbjct: 241 DVYMIMVKCWMIDADSRPKFRELIIEFS 268
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 195 bits (496), Expect = 1e-57
Identities = 76/270 (28%), Positives = 113/270 (41%), Gaps = 19/270 (7%)
Query: 416 NNFATDNNIGEGGFGPVYKG-LLADGTAIAVKQLSSKSKQGNRE-FINEIGMISALQHPN 473
++ +GEG +G V A+AVK + K E EI + L H N
Sbjct: 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 64
Query: 474 LVKLYGCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGES 533
+VK YG EGN L EY L + + P +R + G+ YLH
Sbjct: 65 VVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDI-GMPEPDAQRFFHQLMAGVVYLH--- 120
Query: 534 RIKVVHRDIKATNVLLDKDLNSKISDFGLAK-LDEEENTHISTRVAGTIGYMAPEYAMRG 592
I + HRDIK N+LLD+ N KISDFGLA + ++ GT+ Y+APE R
Sbjct: 121 GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 180
Query: 593 HL-TEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFD 651
E DV+S GIV +++G + KE+ + NP D
Sbjct: 181 EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE--YSDWKEKKTYL-----NPWKKID 233
Query: 652 KEQVMVMINVALLCANASPTIRPSMSSVLR 681
+ ++ +L N P+ R ++ + +
Sbjct: 234 SAPLALLH--KILVEN--PSARITIPDIKK 259
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (495), Expect = 2e-57
Identities = 69/267 (25%), Positives = 113/267 (42%), Gaps = 23/267 (8%)
Query: 424 IGEGGFGPVYKGLLAD----GTAIAVKQLSSKSKQGNRE-FINEIGMISALQHPNLVKLY 478
IGEG FG V++G+ A+A+K + + RE F+ E + HP++VKL
Sbjct: 15 IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 74
Query: 479 GCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVV 538
G E N + +I E L L + LD + ++ LAYL + V
Sbjct: 75 GVITE-NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE---SKRFV 130
Query: 539 HRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPEYAMRGHLTEKA 598
HRDI A NVL+ + K+ DFGL++ E+ + +++ I +MAPE T +
Sbjct: 131 HRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSAS 190
Query: 599 DVYSFGIVALEI-VSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDKEQVMV 657
DV+ FG+ EI + G ++ E G+ + + N
Sbjct: 191 DVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI----ENGERLPMPP-----NCPPT---- 237
Query: 658 MINVALLCANASPTIRPSMSSVLRMLE 684
+ ++ C P+ RP + + L
Sbjct: 238 LYSLMTKCWAYDPSRRPRFTELKAQLS 264
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 192 bits (488), Expect = 2e-56
Identities = 63/271 (23%), Positives = 113/271 (41%), Gaps = 26/271 (9%)
Query: 424 IGEGGFGPVYKGLL----ADGTAIAVKQLSSK---SKQGNREFINEIGMISALQHPNLVK 476
+G+G FG V +G ++AVK L + +FI E+ + +L H NL++
Sbjct: 16 LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 477 LYGCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIK 536
LYG + + ++ E SL L +H+ T R + +A G+ YL +
Sbjct: 76 LYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLE---SKR 131
Query: 537 VVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTH--ISTRVAGTIGYMAPEYAMRGHL 594
+HRD+ A N+LL KI DFGL + + + H + + APE
Sbjct: 132 FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTF 191
Query: 595 TEKADVYSFGIVALEIVS-GRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDKE 653
+ +D + FG+ E+ + G+ + +L + ++G+ + + P
Sbjct: 192 SHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHK---IDKEGERLPRPEDCPQD----- 243
Query: 654 QVMVMINVALLCANASPTIRPSMSSVLRMLE 684
+ NV + C P RP+ ++ L
Sbjct: 244 ----IYNVMVQCWAHKPEDRPTFVALRDFLL 270
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (487), Expect = 2e-56
Identities = 63/270 (23%), Positives = 106/270 (39%), Gaps = 25/270 (9%)
Query: 416 NNFATDNNIGEGGFGPVYKG-LLADGTAIAVKQLSSK---SKQGNREFINEIGMISALQH 471
+F +G+G FG VY +A+K L + E+ + S L+H
Sbjct: 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65
Query: 472 PNLVKLYGCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHG 531
PN+++LYG + ++ LI EY ++ R L + K D +A L+Y H
Sbjct: 66 PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS-KFDEQRTATYITELANALSYCH- 123
Query: 532 ESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPEYAMR 591
+V+HRDIK N+LL KI+DFG + + GT+ Y+ PE
Sbjct: 124 --SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT---TLCGTLDYLPPEMIEG 178
Query: 592 GHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFD 651
EK D++S G++ E + G+ + + + + V
Sbjct: 179 RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYK--RISRVEFTFPDFVTEG------ 230
Query: 652 KEQVMVMINVALLCANASPTIRPSMSSVLR 681
++ +P+ RP + VL
Sbjct: 231 ------ARDLISRLLKHNPSQRPMLREVLE 254
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 193 bits (490), Expect = 2e-56
Identities = 72/289 (24%), Positives = 119/289 (41%), Gaps = 37/289 (12%)
Query: 416 NNFATDNNIGEGGFGPVYKGLLADG---TAIAVKQLS-SKSKQGNREFINEIGMISAL-Q 470
N+ + IGEG FG V K + A+K++ SK +R+F E+ ++ L
Sbjct: 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 69
Query: 471 HPNLVKLYGCCIEGNQLLLIYEYLENNSLARALFEHRL---------------KLDWPTR 515
HPN++ L G C L L EY + +L L + R+ L
Sbjct: 70 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129
Query: 516 RRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHIST 575
+ARG+ YL + + +HRD+ A N+L+ ++ +KI+DFGL++ E T
Sbjct: 130 LHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKK--T 184
Query: 576 RVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQ 635
+ +MA E T +DV+S+G++ EIVS + + A
Sbjct: 185 MGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLG-----GTPYCGMTCA------ 233
Query: 636 GKLMELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLE 684
+L E + + ++ C P RPS + +L L
Sbjct: 234 -ELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLN 281
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 190 bits (485), Expect = 1e-55
Identities = 70/259 (27%), Positives = 116/259 (44%), Gaps = 18/259 (6%)
Query: 424 IGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCCI 482
IG+G G VY + +A G +A++Q++ + + INEI ++ ++PN+V +
Sbjct: 28 IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 87
Query: 483 EGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDI 542
G++L ++ EYL SL + E +D +C + L +LH +V+HRDI
Sbjct: 88 VGDELWVVMEYLAGGSLTDVVTETC--MDEGQIAAVCRECLQALEFLH---SNQVIHRDI 142
Query: 543 KATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPEYAMRGHLTEKADVYS 602
K+ N+LL D + K++DFG E + ST V GT +MAPE R K D++S
Sbjct: 143 KSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKVDIWS 201
Query: 603 FGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDKEQVMVMINVA 662
GI+A+E++ G + + L NP +
Sbjct: 202 LGIMAIEMIEGEP------PYLNENPLRALYLIATNGTPELQNP-EKLSAI----FRDFL 250
Query: 663 LLCANASPTIRPSMSSVLR 681
C + R S +L+
Sbjct: 251 NRCLDMDVEKRGSAKELLQ 269
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 187 bits (475), Expect = 1e-53
Identities = 58/269 (21%), Positives = 111/269 (41%), Gaps = 18/269 (6%)
Query: 416 NNFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNL 474
+++ +G G FG V++ A G A K + + + EI +S L+HP L
Sbjct: 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTL 85
Query: 475 VKLYGCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESR 534
V L+ + N++++IYE++ L + + K+ + +GL ++H
Sbjct: 86 VNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMH---E 142
Query: 535 IKVVHRDIKATNVLLDKDLNS--KISDFGLAKLDEEENTHISTRVAGTIGYMAPEYAMRG 592
VH D+K N++ ++ K+ DFGL + + + T GT + APE A
Sbjct: 143 NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTT--GTAEFAAPEVAEGK 200
Query: 593 HLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDK 652
+ D++S G+++ ++SG S F + L+ +D + S +
Sbjct: 201 PVGYYTDMWSVGVLSYILLSGLS------PFGGENDDETLRNVKSCDWNMDDSAFSGISE 254
Query: 653 EQVMVMINVALLCANASPTIRPSMSSVLR 681
+ + A P R ++ L
Sbjct: 255 D----GKDFIRKLLLADPNTRMTIHQALE 279
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 185 bits (469), Expect = 2e-53
Identities = 71/288 (24%), Positives = 124/288 (43%), Gaps = 36/288 (12%)
Query: 416 NNFATDNNIGEGGFGPVYKGLL------ADGTAIAVKQLS-SKSKQGNREFINEIGMISA 468
+G+G FG VY+G+ T +A+K ++ + S + EF+NE ++
Sbjct: 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 79
Query: 469 LQHPNLVKLYGCCIEGNQLLLIYEYLENNSLARALFEHR---------LKLDWPTRRRIC 519
++V+L G +G L+I E + L L R ++
Sbjct: 80 FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMA 139
Query: 520 LGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAK-LDEEENTHISTRVA 578
IA G+AYL+ K VHRD+ A N ++ +D KI DFG+ + + E + +
Sbjct: 140 GEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGL 196
Query: 579 GTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLK--EQG 636
+ +M+PE G T +DV+SFG+V EI + E + L VL+ +G
Sbjct: 197 LPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLA-----EQPYQGLSNEQVLRFVMEG 251
Query: 637 KLMELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLE 684
L++ D P + + +C +P +RPS ++ ++
Sbjct: 252 GLLDKPDNCPDM---------LFELMRMCWQYNPKMRPSFLEIISSIK 290
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 181 bits (461), Expect = 1e-51
Identities = 60/261 (22%), Positives = 102/261 (39%), Gaps = 18/261 (6%)
Query: 424 IGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCCI 482
+G G FG V++ + A G K +++ NEI +++ L HP L+ L+
Sbjct: 37 LGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFE 96
Query: 483 EGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDI 542
+ +++LI E+L L + K+ GL ++H +VH DI
Sbjct: 97 DKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMH---EHSIVHLDI 153
Query: 543 KATNVLLDKDLNS--KISDFGLAKLDEEENTHISTRVAGTIGYMAPEYAMRGHLTEKADV 600
K N++ + S KI DFGLA + T T + APE R + D+
Sbjct: 154 KPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTT--ATAEFAAPEIVDREPVGFYTDM 211
Query: 601 YSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDKEQVMVMIN 660
++ G++ ++SG S ED L V + + D + S+ E +
Sbjct: 212 WAIGVLGYVLLSGLSPFAGEDDLETLQ--NVKRCDWEF----DEDAFSSVSPE----AKD 261
Query: 661 VALLCANASPTIRPSMSSVLR 681
P R ++ L
Sbjct: 262 FIKNLLQKEPRKRLTVHDALE 282
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 178 bits (453), Expect = 3e-51
Identities = 68/294 (23%), Positives = 119/294 (40%), Gaps = 39/294 (13%)
Query: 416 NNFATDNNIGEGGFGPVYKGL------LADGTAIAVKQLSSKSKQG-NREFINEIGMISA 468
+ +G G FG V + A +AVK L + +R ++E+ ++
Sbjct: 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 72
Query: 469 -LQHPNLVKLYGCCIE-GNQLLLIYEYLENNSLARALFEHRLK---------------LD 511
H N+V L G C + G L++I E+ + +L+ L R + L
Sbjct: 73 IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 132
Query: 512 WPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAK-LDEEEN 570
+A+G+ +L K +HRD+ A N+LL + KI DFGLA+ + ++ +
Sbjct: 133 LEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 189
Query: 571 THISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWAL 630
+ +MAPE T ++DV+SFG++ EI S + + + +
Sbjct: 190 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGA--SPYPGVKIDEEFC 247
Query: 631 VLKEQGKLMELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLE 684
++G M D M L C + P+ RP+ S ++ L
Sbjct: 248 RRLKEGTRMRAPDYTTPE---------MYQTMLDCWHGEPSQRPTFSELVEHLG 292
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 178 bits (452), Expect = 4e-51
Identities = 70/295 (23%), Positives = 120/295 (40%), Gaps = 41/295 (13%)
Query: 416 NNFATDNNIGEGGFGPVYKGLL--------ADGTAIAVKQLSSKSKQGN-REFINEIGMI 466
+ +GEG FG V T +AVK L S + + + + I+E+ M+
Sbjct: 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 72
Query: 467 SAL-QHPNLVKLYGCCIEGNQLLLIYEYLENNSLARALFEHRL---------------KL 510
+ +H N++ L G C + L +I EY +L L R +L
Sbjct: 73 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 132
Query: 511 DWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEEN 570
+ARG+ YL K +HRD+ A NVL+ +D KI+DFGLA+ +
Sbjct: 133 SSKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 189
Query: 571 THISTRVA-GTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWA 629
+ T + +MAPE T ++DV+SFG++ EI + + +
Sbjct: 190 YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLG-----GSPYPGVPVE 244
Query: 630 LVLKEQGKLMELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLE 684
+L +L+ + + + C +A P+ RP+ ++ L+
Sbjct: 245 -------ELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLD 292
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 174 bits (441), Expect = 1e-49
Identities = 56/208 (26%), Positives = 92/208 (44%), Gaps = 9/208 (4%)
Query: 412 KAATNNFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSK---SKQGNREFINEIGMIS 467
K +F +GEG F V LA A+K L + + E ++S
Sbjct: 4 KKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMS 63
Query: 468 ALQHPNLVKLYGCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLA 527
L HP VKLY + +L Y +N L + + + D R I L
Sbjct: 64 RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIG-SFDETCTRFYTAEIVSALE 122
Query: 528 YLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKL-DEEENTHISTRVAGTIGYMAP 586
YLH ++HRD+K N+LL++D++ +I+DFG AK+ E + GT Y++P
Sbjct: 123 YLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSP 179
Query: 587 EYAMRGHLTEKADVYSFGIVALEIVSGR 614
E + +D+++ G + ++V+G
Sbjct: 180 ELLTEKSACKSSDLWALGCIIYQLVAGL 207
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 165 bits (418), Expect = 2e-46
Identities = 57/260 (21%), Positives = 102/260 (39%), Gaps = 15/260 (5%)
Query: 424 IGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQGNRE-FINEIGMISALQHPNLVKLYGCC 481
+G G F V +A+K ++ K+ +G NEI ++ ++HPN+V L
Sbjct: 17 LGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIY 76
Query: 482 IEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRD 541
G L LI + + L + E R+ + + YLH + +
Sbjct: 77 ESGGHLYLIMQLVSGGELFDRIVEKG-FYTERDASRLIFQVLDAVKYLHDLGIVHRDLKP 135
Query: 542 IKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPEYAMRGHLTEKADVY 601
LD+D ISDFGL+K+ E+ + + GT GY+APE + ++ D +
Sbjct: 136 ENLLYYSLDEDSKIMISDFGLSKM--EDPGSVLSTACGTPGYVAPEVLAQKPYSKAVDCW 193
Query: 602 SFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDKEQVMVMINV 661
S G++A ++ G E+ L + +LK + + D+ + +
Sbjct: 194 SIGVIAYILLCGYPPFYDENDAKLFE--QILKAEYEF----DSPYWDDISDS----AKDF 243
Query: 662 ALLCANASPTIRPSMSSVLR 681
P R + L+
Sbjct: 244 IRHLMEKDPEKRFTCEQALQ 263
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (418), Expect = 4e-46
Identities = 44/261 (16%), Positives = 96/261 (36%), Gaps = 19/261 (7%)
Query: 424 IGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCCI 482
+G G FG V++ + + K + K EI +++ +H N++ L+
Sbjct: 13 LGRGEFGIVHRCVETSSKKTYMAKFVKVKGTD-QVLVKKEISILNIARHRNILHLHESFE 71
Query: 483 EGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDI 542
+L++I+E++ + + +L+ + L +LH + H DI
Sbjct: 72 SMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLH---SHNIGHFDI 128
Query: 543 KATNVLLDKDLNS--KISDFGLAKLDEEENTHISTRVAGTIGYMAPEYAMRGHLTEKADV 600
+ N++ +S KI +FG A+ + + Y APE ++ D+
Sbjct: 129 RPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLF--TAPEYYAPEVHQHDVVSTATDM 186
Query: 601 YSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDKEQVMVMIN 660
+S G + ++SG + E +++ ++ + D E ++
Sbjct: 187 WSLGTLVYVLLSGINPFLAETNQQIIE--NIMNAEYTF----DEEAFKEISIE----AMD 236
Query: 661 VALLCANASPTIRPSMSSVLR 681
R + S L+
Sbjct: 237 FVDRLLVKERKSRMTASEALQ 257
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 166 bits (420), Expect = 6e-46
Identities = 65/207 (31%), Positives = 95/207 (45%), Gaps = 15/207 (7%)
Query: 416 NNFATDNNIGEGGFGPVYKG-LLADGTAIAVKQLSSK---SKQGNREFINEIGMISALQ- 470
N+F+ IG GGFG VY G A+K L K KQG +NE M+S +
Sbjct: 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63
Query: 471 --HPNLVKLYGCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAY 528
P +V + ++L I + + L L +H + R I GL +
Sbjct: 64 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVF-SEADMRFYAAEIILGLEH 122
Query: 529 LHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPEY 588
+H VV+RD+K N+LLD+ + +ISD GLA ++ H S GT GYMAPE
Sbjct: 123 MH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GTHGYMAPEV 176
Query: 589 AMRG-HLTEKADVYSFGIVALEIVSGR 614
+G AD +S G + +++ G
Sbjct: 177 LQKGVAYDSSADWFSLGCMLFKLLRGH 203
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 161 bits (409), Expect = 3e-45
Identities = 53/271 (19%), Positives = 88/271 (32%), Gaps = 21/271 (7%)
Query: 424 IGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCCI 482
IG G FG +Y G +A G +A+K K+K + E + +Q + C
Sbjct: 15 IGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWCG 72
Query: 483 EGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDI 542
++ L SL K T + + + Y+H +HRD+
Sbjct: 73 AEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH---SKNFIHRDV 129
Query: 543 KATNVL---LDKDLNSKISDFGLAKLDEEENTHI------STRVAGTIGYMAPEYAMRGH 593
K N L K I DFGLAK + TH + + GT Y + +
Sbjct: 130 KPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIE 189
Query: 594 LTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDKE 653
+ + D+ S G V + G + + + K M + E
Sbjct: 190 QSRRDDLESLGYVLMYFNLGSLPW--QGLKAATKRQKYERISEKKMSTPIEVLCKGYPSE 247
Query: 654 QVMVMINVALLCANASPTIRPSMSSVLRMLE 684
C + +P S + ++
Sbjct: 248 ----FATYLNFCRSLRFDDKPDYSYLRQLFR 274
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (411), Expect = 6e-45
Identities = 63/291 (21%), Positives = 110/291 (37%), Gaps = 27/291 (9%)
Query: 415 TNNFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQGNRE-FINEIGMISALQHP 472
+ + IGEG +G V + +A+K++S Q + + EI ++ +H
Sbjct: 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHE 66
Query: 473 NLVKLYGCCIEGNQLLLIYEYLENNSLARALFE--HRLKLDWPTRRRICLGIARGLAYLH 530
N++ + + YL + + L++ L I RGL Y+H
Sbjct: 67 NIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIH 126
Query: 531 GESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKL--DEEENTHISTRVAGTIGYMAPEY 588
V+HRD+K +N+LL+ + KI DFGLA++ + ++T T T Y APE
Sbjct: 127 ---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 183
Query: 589 AMRGHL-TEKADVYSFGIVALEIVSGRS---NVTKEDMFYLLDWALVLKEQGKLMELVDT 644
+ T+ D++S G + E++S R D + L Q L +++
Sbjct: 184 MLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINL 243
Query: 645 NPGSNFDKEQVMVMINVALLCANAS--------------PTIRPSMSSVLR 681
+ + L NA P R + L
Sbjct: 244 KARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 294
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (406), Expect = 2e-44
Identities = 59/218 (27%), Positives = 94/218 (43%), Gaps = 10/218 (4%)
Query: 416 NNFATDNNIGEGGFGPVYKG-LLADGTAIAVKQLSSKSKQGNRE---FINEIGMIS-ALQ 470
+F +G+G FG V+ A+K L + + + E ++S A +
Sbjct: 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61
Query: 471 HPNLVKLYGCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLH 530
HP L ++ L + EYL L + K D I GL +LH
Sbjct: 62 HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCH-KFDLSRATFYAAEIILGLQFLH 120
Query: 531 GESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPEYAM 590
+V+RD+K N+LLDKD + KI+DFG+ K + + +T GT Y+APE +
Sbjct: 121 ---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFC-GTPDYIAPEILL 176
Query: 591 RGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDW 628
D +SFG++ E++ G+S +D L
Sbjct: 177 GQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHS 214
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 160 bits (406), Expect = 2e-44
Identities = 55/204 (26%), Positives = 97/204 (47%), Gaps = 12/204 (5%)
Query: 416 NNFATDNNIGEGGFGPVYKG-LLADGTAIAVKQLSSK---SKQGNREFINEIGMISALQH 471
+F +G G FG V+ +G A+K L + + +E M+S + H
Sbjct: 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63
Query: 472 PNLVKLYGCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHG 531
P +++++G + Q+ +I +Y+E L +L + P + + L YLH
Sbjct: 64 PFIIRMWGTFQDAQQIFMIMDYIEGGEL-FSLLRKSQRFPNPVAKFYAAEVCLALEYLH- 121
Query: 532 ESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPEYAMR 591
+++RD+K N+LLDK+ + KI+DFG AK + + GT Y+APE
Sbjct: 122 --SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVT----YTLCGTPDYIAPEVVST 175
Query: 592 GHLTEKADVYSFGIVALEIVSGRS 615
+ D +SFGI+ E+++G +
Sbjct: 176 KPYNKSIDWWSFGILIYEMLAGYT 199
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (404), Expect = 2e-44
Identities = 67/293 (22%), Positives = 122/293 (41%), Gaps = 30/293 (10%)
Query: 414 ATNNFATDNNIGEGGFGPVYKG--LLADGTAIAVKQLSSKSKQGN--REFINEIGMISAL 469
A + IGEG +G V+K L G +A+K++ ++ + I E+ ++ L
Sbjct: 5 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL 64
Query: 470 ---QHPNLVKLYGCCIEG-----NQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLG 521
+HPN+V+L+ C +L L++E+++ + + T + +
Sbjct: 65 ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQ 124
Query: 522 IARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTI 581
+ RGL +LH +VVHRD+K N+L+ K++DFGLA++ + T V T+
Sbjct: 125 LLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMAL--TSVVVTL 179
Query: 582 GYMAPEYAMRGHLTEKADVYSFGIVALEIVSGR---SNVTKEDMFYLL----------DW 628
Y APE ++ D++S G + E+ + + D + DW
Sbjct: 180 WYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDW 239
Query: 629 ALVLKEQGKLMELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLR 681
+ + P F + + ++ L C +P R S S L
Sbjct: 240 PRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 292
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 158 bits (400), Expect = 4e-44
Identities = 64/283 (22%), Positives = 115/283 (40%), Gaps = 21/283 (7%)
Query: 416 NNFATDNNIGEGGFGPVYKGLLADGTAIAVKQL--SSKSKQGNREFINEIGMISALQHPN 473
+ IGEG +G VYK G A+K++ + + I EI ++ L+H N
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61
Query: 474 LVKLYGCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGES 533
+VKLY +L+L++E+L+ + L+ T + L + G+AY H
Sbjct: 62 IVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEG-GLESVTAKSFLLQLLNGIAYCH--- 117
Query: 534 RIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPEYAMRGH 593
+V+HRD+K N+L++++ KI+DFGLA+ + +
Sbjct: 118 DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKK 177
Query: 594 LTEKADVYSFGIVALEIVSGR---SNVTKEDMFYLL----------DWALV--LKEQGKL 638
+ D++S G + E+V+G V++ D + +W V L +
Sbjct: 178 YSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPN 237
Query: 639 MELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLR 681
+ + P +F K I++ P R + L
Sbjct: 238 FTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 157 bits (398), Expect = 6e-44
Identities = 56/281 (19%), Positives = 107/281 (38%), Gaps = 25/281 (8%)
Query: 415 TNNFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLS---SKSKQGNREFINEIGMISALQ 470
++ + +G GG V+ L +AVK L ++ F E +AL
Sbjct: 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 65
Query: 471 HPNLVKLYGCCIE----GNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGL 526
HP +V +Y G ++ EY++ +L + + + + L
Sbjct: 66 HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG-PMTPKRAIEVIADACQAL 124
Query: 527 AYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKL--DEEENTHISTRVAGTIGYM 584
+ H + ++HRD+K N+++ K+ DFG+A+ D + + V GT Y+
Sbjct: 125 NFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYL 181
Query: 585 APEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDT 644
+PE A + ++DVYS G V E+++G F V + + + +
Sbjct: 182 SPEQARGDSVDARSDVYSLGCVLYEVLTGEP------PFTGDSPVSVAYQHVREDPIPPS 235
Query: 645 NPGSNFDKEQVMVMINVALLCANASPTIRP-SMSSVLRMLE 684
+ + V L +P R + + + L
Sbjct: 236 ARHEGLSAD----LDAVVLKALAKNPENRYQTAAEMRADLV 272
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 157 bits (398), Expect = 6e-44
Identities = 50/275 (18%), Positives = 105/275 (38%), Gaps = 33/275 (12%)
Query: 424 IGEGGFGPVYKGL-LADGTAIAVKQLS---------SKSKQGNREFINEIGMISALQ-HP 472
+G G V + + AVK + + ++ + E+ ++ + HP
Sbjct: 11 LGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHP 70
Query: 473 NLVKLYGCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGE 532
N+++L L+++ ++ L L E L R+I + + LH
Sbjct: 71 NIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKV-TLSEKETRKIMRALLEVICALH-- 127
Query: 533 SRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPEYAM-- 590
++ +VHRD+K N+LLD D+N K++DFG + + V GT Y+APE
Sbjct: 128 -KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKL--REVCGTPSYLAPEIIECS 184
Query: 591 ----RGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNP 646
++ D++S G++ +++G +L +++ + +
Sbjct: 185 MNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLR--MIMSGNYQF----GSPE 238
Query: 647 GSNFDKEQVMVMINVALLCANASPTIRPSMSSVLR 681
++ + ++ P R + L
Sbjct: 239 WDDYSDT----VKDLVSRFLVVQPQKRYTAEEALA 269
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (399), Expect = 7e-44
Identities = 53/201 (26%), Positives = 93/201 (46%), Gaps = 6/201 (2%)
Query: 417 NFATDNNIGEGGFGPVYKGL-LADGTAIAVKQL--SSKSKQGNREFINEIGMISALQHPN 473
NF IGEG +G VYK G +A+K++ ++++ I EI ++ L HPN
Sbjct: 3 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62
Query: 474 LVKLYGCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGES 533
+VKL N+L L++E+L + + P + + +GLA+ H
Sbjct: 63 IVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH--- 119
Query: 534 RIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPEYAMRGH 593
+V+HRD+K N+L++ + K++DFGLA+ + V +
Sbjct: 120 SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKY 179
Query: 594 LTEKADVYSFGIVALEIVSGR 614
+ D++S G + E+V+ R
Sbjct: 180 YSTAVDIWSLGCIFAEMVTRR 200
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 156 bits (394), Expect = 3e-43
Identities = 48/282 (17%), Positives = 95/282 (33%), Gaps = 25/282 (8%)
Query: 416 NNFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQGNREFINEIGMISALQH-PN 473
++ IGEG FG +++G L + +A+K +S + +E L
Sbjct: 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA--PQLRDEYRTYKLLAGCTG 62
Query: 474 LVKLYGCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGES 533
+ +Y EG +L+ + L + L K T + + +H
Sbjct: 63 IPNVYYFGQEGLHNVLVIDLLGPSLEDL-LDLCGRKFSVKTVAMAAKQMLARVQSIH--- 118
Query: 534 RIKVVHRDIKATNVLLDKDLNS-----KISDFGLAKLDEEENTHI------STRVAGTIG 582
+V+RDIK N L+ + + + DFG+ K + T ++GT
Sbjct: 119 EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTAR 178
Query: 583 YMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELV 642
YM+ + + + D+ + G V + + G + L A ++ ++ E
Sbjct: 179 YMSINTHLGREQSRRDDLEALGHVFMYFLRGS------LPWQGLKAATNKQKYERIGEKK 232
Query: 643 DTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLE 684
+ P N + P + +
Sbjct: 233 QSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFS 274
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (388), Expect = 3e-42
Identities = 61/280 (21%), Positives = 115/280 (41%), Gaps = 26/280 (9%)
Query: 424 IGEGGFGPVYKG-LLADGTAIAVKQLSSKSKQG-----NREFINEIGMISALQHPNLVKL 477
+GEG F VYK +A+K++ + NR + EI ++ L HPN++ L
Sbjct: 6 LGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGL 65
Query: 478 YGCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKV 537
+ + L+++++E + + ++ L L + L +GL YLH + +
Sbjct: 66 LDAFGHKSNISLVFDFMETDLE-VIIKDNSLVLTPSHIKAYMLMTLQGLEYLH---QHWI 121
Query: 538 VHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPEYAMRGHL-TE 596
+HRD+K N+LLD++ K++DFGLAK N + +V T Y APE +
Sbjct: 122 LHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQV-VTRWYRAPELLFGARMYGV 180
Query: 597 KADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDKEQVM 656
D+++ G + E++ + + L + D ++ +
Sbjct: 181 GVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSF 240
Query: 657 VMINVALLCANAS--------------PTIRPSMSSVLRM 682
I + + + A P R + + L+M
Sbjct: 241 PGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 280
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (377), Expect = 4e-41
Identities = 49/203 (24%), Positives = 81/203 (39%), Gaps = 17/203 (8%)
Query: 424 IGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQGNRE------FINEIGMISALQ--HPNL 474
+G GGFG VY G+ ++D +A+K + E E+ ++ + +
Sbjct: 12 LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 71
Query: 475 VKLYGCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESR 534
++L + +LI E E R L R + + + H
Sbjct: 72 IRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCH---N 128
Query: 535 IKVVHRDIKATNVLLDKDLNS-KISDFGLAKLDEEENTHISTRVAGTIGYMAPEYAM-RG 592
V+HRDIK N+L+D + K+ DFG L ++ T GT Y PE+
Sbjct: 129 CGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY---TDFDGTRVYSPPEWIRYHR 185
Query: 593 HLTEKADVYSFGIVALEIVSGRS 615
+ A V+S GI+ ++V G
Sbjct: 186 YHGRSAAVWSLGILLYDMVCGDI 208
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (378), Expect = 6e-41
Identities = 59/269 (21%), Positives = 100/269 (37%), Gaps = 27/269 (10%)
Query: 424 IGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQGNR------EFINEIGMISALQHPNLVK 476
+G G F V K + G A K + + + +R + E+ ++ +QHPN++
Sbjct: 18 LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 77
Query: 477 LYGCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIK 536
L+ ++LI E + L L E L I G+ YLH ++
Sbjct: 78 LHEVYENKTDVILILELVAGGELFDFLAEKE-SLTEEEATEFLKQILNGVYYLH---SLQ 133
Query: 537 VVHRDIKATNVLLDKD----LNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPEYAMRG 592
+ H D+K N++L KI DFGLA + N + GT ++APE
Sbjct: 134 IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF--KNIFGTPEFVAPEIVNYE 191
Query: 593 HLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDK 652
L +AD++S G++ ++SG F L + + SN
Sbjct: 192 PLGLEADMWSIGVITYILLSGA------SPFLGDTKQETLANVSAVNYEFEDEYFSNTSA 245
Query: 653 EQVMVMINVALLCANASPTIRPSMSSVLR 681
+ P R ++ L+
Sbjct: 246 L----AKDFIRRLLVKDPKKRMTIQDSLQ 270
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (372), Expect = 1e-39
Identities = 53/267 (19%), Positives = 94/267 (35%), Gaps = 24/267 (8%)
Query: 424 IGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCC- 481
+G G G V + A+K L + RE E+ A Q P++V++
Sbjct: 20 LGLGINGKVLQIFNKRTQEKFALKMLQ-DCPKARREV--EL-HWRASQCPHIVRIVDVYE 75
Query: 482 ---IEGNQLLLIYEYLENNSLARALFEHRLK-LDWPTRRRICLGIARGLAYLHGESRIKV 537
LL++ E L+ L + + + I I + YLH I +
Sbjct: 76 NLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH---SINI 132
Query: 538 VHRDIKATNVLLDKDLNS---KISDFGLAKLDEEENTHISTRVAGTIGYMAPEYAMRGHL 594
HRD+K N+L + K++DFG AK N+ + T Y+APE
Sbjct: 133 AHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCY--TPYYVAPEVLGPEKY 190
Query: 595 TEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDKEQ 654
+ D++S G++ ++ G + G+ S +E
Sbjct: 191 DKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYE--FPNPEWSEVSEE- 247
Query: 655 VMVMINVALLCANASPTIRPSMSSVLR 681
+ + PT R +++ +
Sbjct: 248 ---VKMLIRNLLKTEPTQRMTITEFMN 271
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (364), Expect = 2e-38
Identities = 55/208 (26%), Positives = 84/208 (40%), Gaps = 18/208 (8%)
Query: 417 NFATDNNIGEGGFGPVYKG-LLADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLV 475
++ IG G FG VY+ L G +A+K++ + NRE + ++ L H N+V
Sbjct: 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRE----LQIMRKLDHCNIV 76
Query: 476 KLYGCCIEGNQ------LLLIYEYLENNSLARALFEHRLK--LDWPTRRRICLGIARGLA 527
+L + L L+ +Y+ A R K L + + R LA
Sbjct: 77 RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 136
Query: 528 YLHGESRIKVVHRDIKATNVLLDKD-LNSKISDFGLAKLDEEENTHISTRVAGTIGYMAP 586
Y+H + HRDIK N+LLD D K+ DFG AK + +
Sbjct: 137 YIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ-LVRGEPNVSYICSRYYRAPE 192
Query: 587 EYAMRGHLTEKADVYSFGIVALEIVSGR 614
T DV+S G V E++ G+
Sbjct: 193 LIFGATDYTSSIDVWSAGCVLAELLLGQ 220
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (356), Expect = 7e-38
Identities = 52/206 (25%), Positives = 96/206 (46%), Gaps = 19/206 (9%)
Query: 424 IGEGGFGPVYKG-LLADGTAIAVKQLSSKSKQGN--REFINEIGMISALQHPNLVKLYGC 480
IG+G FG V+K G +A+K++ ++++ + EI ++ L+H N+V L
Sbjct: 18 IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 77
Query: 481 CIEG--------NQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGE 532
C + L++++ E++ +K +R+ + GL Y+H
Sbjct: 78 CRTKASPYNRCKGSIYLVFDFCEHDLAGLLS-NVLVKFTLSEIKRVMQMLLNGLYYIH-- 134
Query: 533 SRIKVVHRDIKATNVLLDKDLNSKISDFGLAK---LDEEENTHISTRVAGTIGYMAPEYA 589
R K++HRD+KA NVL+ +D K++DFGLA+ L + + T T+ Y PE
Sbjct: 135 -RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELL 193
Query: 590 MRGHL-TEKADVYSFGIVALEIVSGR 614
+ D++ G + E+ +
Sbjct: 194 LGERDYGPPIDLWGAGCIMAEMWTRS 219
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (357), Expect = 1e-37
Identities = 63/216 (29%), Positives = 90/216 (41%), Gaps = 9/216 (4%)
Query: 416 NNFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSK---SKQGNREFINEIGMISALQH 471
N+F +G+G FG V A G A+K L + +K + E ++ +H
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 472 PNLVKLYGCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHG 531
P L L ++L + EY L L R R I L YLH
Sbjct: 65 PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRER-VFTEERARFYGAEIVSALEYLH- 122
Query: 532 ESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPEYAMR 591
VV+RDIK N++LDKD + KI+DFGL K + + T GT Y+APE
Sbjct: 123 --SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFC-GTPEYLAPEVLED 179
Query: 592 GHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLD 627
D + G+V E++ GR +D L +
Sbjct: 180 NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFE 215
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (349), Expect = 3e-37
Identities = 41/195 (21%), Positives = 83/195 (42%), Gaps = 7/195 (3%)
Query: 424 IGEGGFGPVYKGL-LADGTAIAVKQL--SSKSKQGNREFINEIGMISALQHPNLVKLYGC 480
IGEG +G V+K +A+K++ + + EI ++ L+H N+V+L+
Sbjct: 10 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDV 69
Query: 481 CIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHR 540
+L L++E+ + + + D + + +GL + H V+HR
Sbjct: 70 LHSDKKLTLVFEFCDQDLKKYFDSCNGDL-DPEIVKSFLFQLLKGLGFCH---SRNVLHR 125
Query: 541 DIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPEYAMRGHLTEKADV 600
D+K N+L++++ K+++FGLA+ S V + D+
Sbjct: 126 DLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDM 185
Query: 601 YSFGIVALEIVSGRS 615
+S G + E+ +
Sbjct: 186 WSAGCIFAELANAGR 200
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 139 bits (351), Expect = 8e-37
Identities = 47/209 (22%), Positives = 88/209 (42%), Gaps = 12/209 (5%)
Query: 424 IGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQGNRE---FINEIGMISALQHPNLVKLYG 479
+G G FG V G A+K L + ++ +NE ++ A+ P LVKL
Sbjct: 49 LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 480 CCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVH 539
+ + L ++ EY+ + L + P R I YLH + +++
Sbjct: 109 SFKDNSNLYMVMEYVAGGEMFSHLRRIG-RFSEPHARFYAAQIVLTFEYLH---SLDLIY 164
Query: 540 RDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPEYAMRGHLTEKAD 599
RD+K N+L+D+ +++DFG AK + + GT +APE + + D
Sbjct: 165 RDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLC----GTPEALAPEIILSKGYNKAVD 220
Query: 600 VYSFGIVALEIVSGRSNVTKEDMFYLLDW 628
++ G++ E+ +G + + +
Sbjct: 221 WWALGVLIYEMAAGYPPFFADQPIQIYEK 249
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (342), Expect = 1e-35
Identities = 46/198 (23%), Positives = 88/198 (44%), Gaps = 14/198 (7%)
Query: 424 IGEGGFGPVYKGL-LADGTAIAVKQL--SSKSKQGNREFINEIGMISALQHPNLVKLYGC 480
+G G +G V + G +A+K+L +S+ + E+ ++ ++H N++ L
Sbjct: 26 VGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDV 85
Query: 481 CIEGNQLLLIYEYLENNSLARALFEHRLK---LDWPTRRRICLGIARGLAYLHGESRIKV 537
L ++ +K L + + + +GL Y+H +
Sbjct: 86 FTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIH---AAGI 142
Query: 538 VHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPEYAM-RGHLTE 596
+HRD+K N+ +++D KI DFGLA+ + E T T Y APE + T+
Sbjct: 143 IHRDLKPGNLAVNEDCELKILDFGLARQADSEMTGY----VVTRWYRAPEVILNWMRYTQ 198
Query: 597 KADVYSFGIVALEIVSGR 614
D++S G + E+++G+
Sbjct: 199 TVDIWSVGCIMAEMITGK 216
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 130 bits (327), Expect = 1e-33
Identities = 49/235 (20%), Positives = 92/235 (39%), Gaps = 24/235 (10%)
Query: 408 YLQIKAATNNFATDNN------IGEGGFGPVYKGL-LADGTAIAVKQLS--SKSKQGNRE 458
+ ++ + F IG G G V +A+K+LS +++ +
Sbjct: 3 FYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKR 62
Query: 459 FINEIGMISALQHPNLVKLYGCCI------EGNQLLLIYEYLENNSLARALFEHRLKLDW 512
E+ ++ + H N++ L E + L+ E ++ N +++LD
Sbjct: 63 AYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLC----QVIQMELDH 118
Query: 513 PTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTH 572
+ + G+ +LH ++HRD+K +N+++ D KI DFGLA+
Sbjct: 119 ERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM 175
Query: 573 ISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLD 627
T T Y APE + E D++S G + E+V + D +
Sbjct: 176 --TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWN 228
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 126 bits (317), Expect = 2e-32
Identities = 38/206 (18%), Positives = 84/206 (40%), Gaps = 18/206 (8%)
Query: 416 NNFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQGNREFINEIGMISALQ-HPN 473
+++ +G G + V++ + + + + VK L K+ + EI ++ L+ PN
Sbjct: 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKK---KIKREIKILENLRGGPN 91
Query: 474 LVKLYGCCIE--GNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHG 531
++ L + L++E++ N + L R I + L Y H
Sbjct: 92 IITLADIVKDPVSRTPALVFEHVNNTD----FKQLYQTLTDYDIRFYMYEILKALDYCH- 146
Query: 532 ESRIKVVHRDIKATNVLLDKDLNS-KISDFGLAKLDEEENTHISTRVAGTIGYMAPEYAM 590
+ ++HRD+K NV++D + ++ D+GLA+ + + + PE +
Sbjct: 147 --SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY--NVRVASRYFKGPELLV 202
Query: 591 R-GHLTEKADVYSFGIVALEIVSGRS 615
D++S G + ++ +
Sbjct: 203 DYQMYDYSLDMWSLGCMLASMIFRKE 228
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 123 bits (310), Expect = 1e-31
Identities = 52/210 (24%), Positives = 91/210 (43%), Gaps = 15/210 (7%)
Query: 416 NNFATDNNIGEGGFGPVYKGLLA----DGTAIAVKQLS----SKSKQGNREFINEIGMIS 467
NF +G G +G V+ G A+K L + + E ++
Sbjct: 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 83
Query: 468 ALQH-PNLVKLYGCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGL 526
++ P LV L+ +L LI +Y+ L L + + + I L
Sbjct: 84 HIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRE-RFTEHEVQIYVGEIVLAL 142
Query: 527 AYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAP 586
+LH ++ +++RDIK N+LLD + + ++DFGL+K + T + GTI YMAP
Sbjct: 143 EHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAP 199
Query: 587 EYAMRGH--LTEKADVYSFGIVALEIVSGR 614
+ G + D +S G++ E+++G
Sbjct: 200 DIVRGGDSGHDKAVDWWSLGVLMYELLTGA 229
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 122 bits (307), Expect = 5e-31
Identities = 48/199 (24%), Positives = 86/199 (43%), Gaps = 16/199 (8%)
Query: 424 IGEGGFGPVYKGL-LADGTAIAVKQLS--SKSKQGNREFINEIGMISALQHPNLVKLYGC 480
+G G +G V G +AVK+LS +S + E+ ++ ++H N++ L
Sbjct: 26 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 85
Query: 481 CIEGNQL-----LLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRI 535
L + + +L L KL + + I RGL Y+H
Sbjct: 86 FTPARSLEEFNDVYLVTHLMGADLNN--IVKCQKLTDDHVQFLIYQILRGLKYIH---SA 140
Query: 536 KVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPEYAMRGHLT 595
++HRD+K +N+ +++D KI DFGLA+ + ++ VA H
Sbjct: 141 DIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMTGYVATRWYRAPEIMLNWMHYN 197
Query: 596 EKADVYSFGIVALEIVSGR 614
+ D++S G + E+++GR
Sbjct: 198 QTVDIWSVGCIMAELLTGR 216
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 111 bits (277), Expect = 5e-27
Identities = 43/209 (20%), Positives = 79/209 (37%), Gaps = 21/209 (10%)
Query: 424 IGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCCI 482
+G G F V+ + + T +A+K + K +EI ++ + + K
Sbjct: 21 LGWGHFSTVWLAKDMVNNTHVAMKIVR-GDKVYTEAAEDEIKLLQRVNDADNTKEDSMGA 79
Query: 483 E---------------GNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLA 527
G +++++E L N LA + ++I + GL
Sbjct: 80 NHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLD 139
Query: 528 YLHGESRIKVVHRDIKATNVLLDK-DLNSKISDFGLAKL-DEEENTHISTRVAGTIGYMA 585
Y+H I +H DIK NVL++ D + +A L + T T Y +
Sbjct: 140 YMHRRCGI--IHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREYRS 197
Query: 586 PEYAMRGHLTEKADVYSFGIVALEIVSGR 614
PE + AD++S + E+++G
Sbjct: 198 PEVLLGAPWGCGADIWSTACLIFELITGD 226
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 91.4 bits (226), Expect = 9e-22
Identities = 29/158 (18%), Positives = 49/158 (31%), Gaps = 20/158 (12%)
Query: 424 IGEGGFGPVYKGLLADGTAIAVK----------QLSSKSKQGNREFINEIGMISALQHPN 473
+GEG V+ VK ++ K G+ F + +
Sbjct: 8 MGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRA 67
Query: 474 LVKLYGCCIEGNQLLLIYEYLENNSL-ARALFEHRLKLDWPTRRRICLGIARGLAYLHGE 532
L KL G + Y + N L + ++ + I +A +
Sbjct: 68 LQKLQGLAVPKV-----YAWEGNAVLMELIDAKELYRVRVENPDEVLDMILEEVAKFY-- 120
Query: 533 SRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEEN 570
+VH D+ NVL+ + I DF + EE
Sbjct: 121 -HRGIVHGDLSQYNVLVS-EEGIWIIDFPQSVEVGEEG 156
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 85.8 bits (211), Expect = 2e-18
Identities = 46/195 (23%), Positives = 84/195 (43%), Gaps = 13/195 (6%)
Query: 93 LTVQYNQFSGELPEELGSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRISDNQFTGQI 152
L NQ S P + + NL++L L+ N T A LTN+ D +++NQ +
Sbjct: 202 LIATNNQISDITPLGILT--NLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQISNLA 257
Query: 153 PSFIQNWTKLEKLFIQPSGLAGPIPSGIFSLENLTDLRISDLNGPEATFPQLGNMKMTKL 212
P + TKL +L + + ++ P + +L N E P +T L
Sbjct: 258 P--LSGLTKLTELKLGANQISNISPLAGLTALTNLELNE---NQLEDISPISNLKNLTYL 312
Query: 213 ILRNCNITGELPRYLGKMTKLKVLDLSFNRLRGQIPSNFDDLYDVDYIYFAGNLLTGAIP 272
L NI+ P + +TKL+ L + N++ S+ +L +++++ N ++ P
Sbjct: 313 TLYFNNISDISP--VSSLTKLQRLFFANNKVSD--VSSLANLTNINWLSAGHNQISDLTP 368
Query: 273 PWMLERGDKIDLSYN 287
L R ++ L+
Sbjct: 369 LANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 71.6 bits (174), Expect = 7e-14
Identities = 36/177 (20%), Positives = 67/177 (37%), Gaps = 17/177 (9%)
Query: 74 NRLKGPIPKYLANISTLVNLTVQYNQFSGELPEELGSLLNLEKLHLSSNNFTGELPKTFA 133
N++ P ++ L L++ NQ L SL NL L L++N + P +
Sbjct: 207 NQISDITPLG--ILTNLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQISNLAP--LS 260
Query: 134 KLTNMKDFRISDNQFTGQIPSF-IQNWTKLEKLFIQPSGLAGPIPSGIFSLENLTDLRIS 192
LT + + ++ NQ + P + T LE Q ++ + L IS
Sbjct: 261 GLTKLTELKLGANQISNISPLAGLTALTNLELNENQLEDISPISNLKNLTYLTLYFNNIS 320
Query: 193 DLNGPEATFPQLGNM-KMTKLILRNCNITGELPRYLGKMTKLKVLDLSFNRLRGQIP 248
D+ + ++ K+ +L N ++ L +T + L N++ P
Sbjct: 321 DI-------SPVSSLTKLQRLFFANNKVSD--VSSLANLTNINWLSAGHNQISDLTP 368
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 58.5 bits (140), Expect = 1e-09
Identities = 30/163 (18%), Positives = 52/163 (31%), Gaps = 29/163 (17%)
Query: 5 NTFLVFHFWKQKTVNQKRVLKEQNLTGVLPPKLAELTFLQDIDLTLNYLSGTIP------ 58
N T L ++ + P L+ LT L ++ L N +S P
Sbjct: 229 NQLKDIGTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISPLAGLTA 286
Query: 59 ---------------SQWASLPLLNISLIANRLKGPIPKYLANISTLVNLTVQYNQFSGE 103
L ++L N + P +++++ L L N+ S
Sbjct: 287 LTNLELNENQLEDISPISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD- 343
Query: 104 LPEELGSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRISDN 146
L +L N+ L N + P A LT + ++D
Sbjct: 344 -VSSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 48.5 bits (114), Expect = 2e-06
Identities = 43/275 (15%), Positives = 84/275 (30%), Gaps = 48/275 (17%)
Query: 66 LLNISLIANRLKGPIPKYLANISTLVNLTVQYNQFSGELPEELGSLLNLEKLHLSSNNFT 125
+ L + + + ++ + L + + L NL +++ S+N T
Sbjct: 24 KMKTVLGKTNVTDTVSQ--TDLDQVTTLQADRLGIKS--IDGVEYLNNLTQINFSNNQLT 79
Query: 126 GELPKTFAKLTNMKDFRISDNQFTGQIPSF------------------------------ 155
P LT + D +++NQ P
Sbjct: 80 DITP--LKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTNLNRL 137
Query: 156 ------IQNWTKLEKLFIQPSGLAGPIPSGIFSLENLT--DLRISDLNGPEATFPQLGNM 207
I + + L L G + + L NLT + N
Sbjct: 138 ELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDISVLAKLT 197
Query: 208 KMTKLILRNCNITGELPRYLGKMTKLKVLDLSFNRLRGQIPSNFDDLYDVDYIYFAGNLL 267
+ LI N I+ P + +T L L L+ N+L+ L ++ + A N +
Sbjct: 198 NLESLIATNNQISDITPLGI--LTNLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQI 253
Query: 268 TGAIPPWMLERGDKIDLSYNNFTDGSAESSCQKRS 302
+ P L + ++ L N ++ S + +
Sbjct: 254 SNLAPLSGLTKLTELKLGANQISNISPLAGLTALT 288
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 40.8 bits (94), Expect = 5e-04
Identities = 16/76 (21%), Positives = 27/76 (35%), Gaps = 5/76 (6%)
Query: 175 PIPSGIFSLENLTDLRISDLNGPEAT--FPQLGNMKMTKLILRNCNITGELPRYLGKMTK 232
PI IF+ L + + L T Q ++T L I + + +
Sbjct: 11 PINQ-IFTDTALAEKMKTVLGKTNVTDTVSQTDLDQVTTLQADRLGIK-SIDG-VEYLNN 67
Query: 233 LKVLDLSFNRLRGQIP 248
L ++ S N+L P
Sbjct: 68 LTQINFSNNQLTDITP 83
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 77.8 bits (190), Expect = 4e-16
Identities = 42/260 (16%), Positives = 87/260 (33%), Gaps = 10/260 (3%)
Query: 103 ELPEELGSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRISDNQFTGQIPSFIQNWTKL 162
++P++L + L L +N T F L N+ + +N+ + P KL
Sbjct: 24 KVPKDLPP--DTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKL 81
Query: 163 EKLFIQPSGLAGPIPSGIFSLENLTDLRISDLNGPEATFPQLGNMKMTKLILRNCNITGE 222
E+L++ + L +L+ L ++ F L M + +L +G
Sbjct: 82 ERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGI 141
Query: 223 LPRYLGKMTKLKVLDLSFNRLRGQIPSNFDDLYDVDYIYFAGNLLTGAIPPWMLERGDKI 282
M KL + ++ + L ++ GN +T + +
Sbjct: 142 ENGAFQGMKKLSYIRIADTNITTIPQGLPPSL---TELHLDGNKITKVDAASLKGLNNLA 198
Query: 283 DLSYNNFTDGSAESSCQKRSVTGIVSCLRSVQCPKTYYSLHINCGGKQVTANGNTTFEED 342
L + + + ++ + L + + K L + + V + N +
Sbjct: 199 KLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVKVPGGLADHKYIQVVYLHNN-----N 253
Query: 343 TSEAGPSTFSQSGTNWVLSS 362
S G + F G N +S
Sbjct: 254 ISAIGSNDFCPPGYNTKKAS 273
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 75.8 bits (185), Expect = 1e-15
Identities = 46/237 (19%), Positives = 82/237 (34%), Gaps = 10/237 (4%)
Query: 66 LLNISLIANRLKGPIPKYLANISTLVNLTVQYNQFSGELPEELGSLLNLEKLHLSSNNFT 125
+ L N++ N+ L L + N+ S P L+ LE+L+LS N
Sbjct: 33 TALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLK 92
Query: 126 GELPKTFAKLTNMKDFRISDNQFTGQIPSFIQNWTKLEKLFIQPSGLAGPIPSGIFSLEN 185
K L ++ + + + + +E L P +G ++
Sbjct: 93 ELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVE-LGTNPLKSSGIENGAFQGMKK 151
Query: 186 LTDLRISDLNG---PEATFPQLGNMKMTKLILRNCNITGELPRYLGKMTKLKVLDLSFNR 242
L+ +RI+D N P+ P L T+L L IT L + L L LSFN
Sbjct: 152 LSYIRIADTNITTIPQGLPPSL-----TELHLDGNKITKVDAASLKGLNNLAKLGLSFNS 206
Query: 243 LRGQIPSNFDDLYDVDYIYFAG-NLLTGAIPPWMLERGDKIDLSYNNFTDGSAESSC 298
+ + + + ++ L+ + + L NN + + C
Sbjct: 207 ISAVDNGSLANTPHLRELHLNNNKLVKVPGGLADHKYIQVVYLHNNNISAIGSNDFC 263
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 60.8 bits (146), Expect = 2e-10
Identities = 33/231 (14%), Positives = 75/231 (32%), Gaps = 23/231 (9%)
Query: 28 NLTGVLPPKLAELTFLQDIDLTLNYLSGTIPSQWASLPLLNISLIANRLKGPIPKYLANI 87
L + L L+ + + + ++ + + ++ + + G +
Sbjct: 90 QLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGM 149
Query: 88 STLVNLTVQYNQFSGELPEELGSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRISDNQ 147
L + + + +P+ L +L +LHL N T + L N+ +S N
Sbjct: 150 KKLSYIRIADTNIT-TIPQGLPP--SLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNS 206
Query: 148 FTGQIPSFIQNWTKLEKLFIQPSGLAGPIPSGIFSLENLTDLRISDLNGPEATFPQLGNM 207
+ + N L +L + + L +P G+ + + + + N
Sbjct: 207 ISAVDNGSLANTPHLRELHLNNNKL-VKVPGGLADHKYIQVVYLH-------------NN 252
Query: 208 KMTKLILRNCNITGELPRYLGKMTKLKVLDLSFNRLRGQ--IPSNFDDLYD 256
++ + P Y K + L N ++ PS F +Y
Sbjct: 253 NISAIGSN----DFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYV 299
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 75.9 bits (185), Expect = 1e-15
Identities = 63/255 (24%), Positives = 101/255 (39%), Gaps = 6/255 (2%)
Query: 24 LKEQNLTGV--LPPKLAELTFLQDIDL--TLNYLSGTIPSQWASLPLLNISLIANRLKGP 79
L NL +P LA L +L + + N + P+ L + + + G
Sbjct: 57 LSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGA 116
Query: 80 IPKYLANISTLVNLTVQYNQFSGELPEELGSLLNLEKLHLSSNNFTGELPKTFAKLTNMK 139
IP +L+ I TLV L YN SG LP + SL NL + N +G +P ++ + +
Sbjct: 117 IPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLF 176
Query: 140 DFRISDNQFTGQIPSFIQNWTKLEKLFIQPSGLAGPIPSGIFSLENLTDLRISDLNGPEA 199
L + + + L G S +N + ++ +
Sbjct: 177 TSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFD 236
Query: 200 TFPQLGNMKMTKLILRNCNITGELPRYLGKMTKLKVLDLSFNRLRGQIPSNFDDLYDVDY 259
+ + L LRN I G LP+ L ++ L L++SFN L G+IP +L D
Sbjct: 237 LGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQ-GGNLQRFDV 295
Query: 260 IYFAGN-LLTGAIPP 273
+A N L G+ P
Sbjct: 296 SAYANNKCLCGSPLP 310
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 74.4 bits (181), Expect = 5e-15
Identities = 70/261 (26%), Positives = 106/261 (40%), Gaps = 5/261 (1%)
Query: 43 LQDIDLTLNYLSG--TIPSQWASLPLLNISLIAN--RLKGPIPKYLANISTLVNLTVQYN 98
+ ++DL+ L IPS A+LP LN I L GPIP +A ++ L L + +
Sbjct: 52 VNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHT 111
Query: 99 QFSGELPEELGSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRISDNQFTGQIPSFIQN 158
SG +P+ L + L L S N +G LP + + L N+ N+ +G IP +
Sbjct: 112 NVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGS 171
Query: 159 WTKLEKLFIQPSGLAGPIPSGIFSLENLTDLRISDLNGPEATFPQLGNMKMTKLILRNCN 218
++KL F+ NL + +S G+ K T+ I N
Sbjct: 172 FSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKN 231
Query: 219 ITGELPRYLGKMTKLKVLDLSFNRLRGQIPSNFDDLYDVDYIYFAGNLLTGAIPPWM-LE 277
+G L LDL NR+ G +P L + + + N L G IP L+
Sbjct: 232 SLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQ 291
Query: 278 RGDKIDLSYNNFTDGSAESSC 298
R D + N GS +C
Sbjct: 292 RFDVSAYANNKCLCGSPLPAC 312
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 47.1 bits (110), Expect = 4e-06
Identities = 17/65 (26%), Positives = 27/65 (41%), Gaps = 1/65 (1%)
Query: 10 FHFWKQKTVNQKRVLKEQNLTGVLPPKLAELTFLQDIDLTLNYLSGTIPSQWASLPLLNI 69
L+ + G LP L +L FL ++++ N L G IP +L ++
Sbjct: 237 LGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQ-GGNLQRFDV 295
Query: 70 SLIAN 74
S AN
Sbjct: 296 SAYAN 300
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 40.1 bits (92), Expect = 8e-04
Identities = 45/235 (19%), Positives = 74/235 (31%), Gaps = 53/235 (22%)
Query: 109 GSLLNLEKLHLSSNNFTG--ELPKTFAKLTNMKDFRISDN-QFTGQIPSFIQNWTKLEKL 165
+ L LS N +P + A L + I G IP I T+L L
Sbjct: 47 TQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYL 106
Query: 166 FIQPSGLAGPIPSGIFSLENLTDLRISDLNGPEATFPQLGNMKMTKLI-LRNCNITGELP 224
+I + ++G IP + ++ L L S P + ++ I I+G +P
Sbjct: 107 YITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIP 166
Query: 225 RYLGKMTKLKVLDLSF-NRLRGQIPSNFDDLYDVD------------------------- 258
G +KL NRL G+IP F +L
Sbjct: 167 DSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNTQKI 226
Query: 259 ---------------------YIYFAGNLLTGAIPPWM--LERGDKIDLSYNNFT 290
+ N + G +P + L+ +++S+NN
Sbjct: 227 HLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLC 281
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 67.5 bits (163), Expect = 7e-13
Identities = 40/269 (14%), Positives = 77/269 (28%), Gaps = 10/269 (3%)
Query: 26 EQNLTGVLPPKLAELTFLQDIDLTLNYLSGTIPSQWASLPLLNISLI--ANRLKGPIPKY 83
+Q L V P + + Q I L N +S + + + L I + + +
Sbjct: 20 QQGLQAV-PVGIPAAS--QRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAF 76
Query: 84 LANISTLVNLTVQYNQFSGELPEELGSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRI 143
Q P L L LHL P F L ++ +
Sbjct: 77 TGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYL 136
Query: 144 SDNQFTGQIPSFIQNWTKLEKLFIQPSGLAGPIPSGIFSLENLTDLRISDLNGPEATFPQ 203
DN ++ L LF+ + ++ L +L L +
Sbjct: 137 QDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHA 196
Query: 204 LGNMKMTKLILRNCNITGEL-PRYLGKMTKLKVLDLSFNRLRGQIPSNFDDLYDVDYIYF 262
++ + N L L + L+ L L+ N +
Sbjct: 197 FRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCR-ARPLWAWLQKFRG 255
Query: 263 AGNLLTGAIPPWMLERGDKI-DLSYNNFT 290
+ + + ++P + G + L+ N+
Sbjct: 256 SSSEVPCSLPQRL--AGRDLKRLAANDLQ 282
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 54.4 bits (129), Expect = 2e-08
Identities = 35/183 (19%), Positives = 65/183 (35%), Gaps = 7/183 (3%)
Query: 65 PLLNISLIANRLKGPIPKYLANISTLVNLTVQYNQFSGELPEELGSLLNLEKLHLSSNNF 124
L + L L+ P ++ L L +Q N + L NL L L N
Sbjct: 106 RLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRI 165
Query: 125 TGELPKTFAKLTNMKDFRISDNQFTGQIPSFIQNWTKLEKLFIQPSGLAGPIPSGIFSLE 184
+ + F L ++ + N+ P ++ +L L++ + L+ + L
Sbjct: 166 SSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLR 225
Query: 185 NLTDLRISD--LNGPEATFPQLGNMKMTKLILRNCNITGELPRYLGKMTKLKVLDLSFNR 242
L LR++D P ++ K + + LP+ L + L+ N
Sbjct: 226 ALQYLRLNDNPWVCDCRARPLWAWLQ--KFRGSSSEVPCSLPQRL---AGRDLKRLAAND 280
Query: 243 LRG 245
L+G
Sbjct: 281 LQG 283
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 57.8 bits (138), Expect = 1e-09
Identities = 29/295 (9%), Positives = 89/295 (30%), Gaps = 62/295 (21%)
Query: 44 QDIDLTLNYLSGTIPSQWASLPLLNISLIANRLKGPIPKYLANISTLVNLTVQYNQFSGE 103
Q +DLT L + + S ++ + + P+
Sbjct: 3 QTLDLTGKNLHPDVTGRLLSQGVIAFRCPRSFMDQPLA---------------------- 40
Query: 104 LPEELGSLLNLEKLHLSSNNFTGE-LPKTFAKLTNMKDFRISDNQFTGQIPSFIQNWTKL 162
E S ++ + LS++ L ++ + +++ + + + I + + + L
Sbjct: 41 ---EHFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNL 97
Query: 163 EKLFIQPSGL--AGPIPSGIFSLENLT--------------------------------D 188
+L + + + + S L
Sbjct: 98 VRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSG 157
Query: 189 LRISDLNGPEATFPQLGNMKMTKLILRNCNITGELPRYLGKMTKLKVLDLSF-NRLRGQI 247
R + +T + + + + + + + ++ L+ L LS + +
Sbjct: 158 YRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPET 217
Query: 248 PSNFDDLYDVDYIYFAGNLLTGAIPPWMLERGDKIDLSYNNFTDGSAESSCQKRS 302
++ + + G + G + + E + ++ ++FT + + K++
Sbjct: 218 LLELGEIPTLKTLQVFGIVPDGTL-QLLKEALPHLQINCSHFTTIARPTIGNKKN 271
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 37.8 bits (86), Expect = 0.003
Identities = 32/250 (12%), Positives = 73/250 (29%), Gaps = 37/250 (14%)
Query: 28 NLTGVLPPKLAELTFLQDIDLTLNYLSGTIPSQWASLPLLNISLIANRLKG-PIPKYLAN 86
NL + +L + +++ + ++ + ++ L + ++ + L+
Sbjct: 11 NLHPDVTGRLLSQG-VIAFRCPRSFMDQPLAEHFSPFRVQHMDLSNSVIEVSTLHGILSQ 69
Query: 87 ISTLVNLTVQYNQFSGELPEELGSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRISDN 146
S L NL+++ + S + L NL +L+LS + E + + ++ +
Sbjct: 70 CSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLS 129
Query: 147 QFTGQIPSFIQNWTKLEKLFIQPSGLAG------------------------------PI 176
+Q I L+G
Sbjct: 130 WCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLK 189
Query: 177 PSGIFSLENLTDLRISDLNG----PEATFPQLGNMK-MTKLILRNCNITGELPRYLGKMT 231
L L+ L+ T +LG + + L + G L +
Sbjct: 190 NDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPDGTLQLLKEALP 249
Query: 232 KLKVLDLSFN 241
L++ F
Sbjct: 250 HLQINCSHFT 259
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 50.1 bits (118), Expect = 3e-07
Identities = 34/202 (16%), Positives = 55/202 (27%), Gaps = 26/202 (12%)
Query: 86 NISTLVNLTVQYNQFSGELPEELGSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRISD 145
+++ + + + LP +L + LHLS N T T + +
Sbjct: 8 KVASHLEVNCDKRNLT-ALPPDLPK--DTTILHLSENLLYTFSLATLMPYTRLTQLNLDR 64
Query: 146 NQFTGQIPSFI--------------------QNWTKLEKLFIQPSGLAGPIPSGIFSLEN 185
+ T + +P G
Sbjct: 65 AELTKLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLG 124
Query: 186 LTDLRISDLNGPEATFPQL--GNMKMTKLILRNCNITGELPRYLGKMTKLKVLDLSFNRL 243
N + P L K+ KL L N N+T L + L L L N L
Sbjct: 125 ELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSL 184
Query: 244 RGQIPSNFDDLYDVDYIYFAGN 265
IP F + + + + GN
Sbjct: 185 Y-TIPKGFFGSHLLPFAFLHGN 205
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.6 bits (101), Expect = 4e-05
Identities = 28/201 (13%), Positives = 52/201 (25%), Gaps = 26/201 (12%)
Query: 66 LLNISLIANRLKGPIPKYLANISTLVNLTVQYNQFSGELPEELGSLLNLEKLHLSSNNFT 125
L ++ L +P L L + N L L +L+L T
Sbjct: 12 HLEVNCDKRNLTA-LPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELT 68
Query: 126 GELPKTFAKLTNMKDFRISDNQFTGQIPSFIQNWTKLEKLFIQPSGL------------- 172
+ D + Q + + T L+ F + + L
Sbjct: 69 KLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQE 128
Query: 173 -------AGPIPSGIFSLENLTDLRISDLNGPEATFPQL--GNMKMTKLILRNCNITGEL 223
+P G+ + + N L G + L+L+ ++ +
Sbjct: 129 LYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TI 187
Query: 224 PRYLGKMTKLKVLDLSFNRLR 244
P+ L L N
Sbjct: 188 PKGFFGSHLLPFAFLHGNPWL 208
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 50.7 bits (119), Expect = 4e-07
Identities = 13/84 (15%), Positives = 27/84 (32%), Gaps = 9/84 (10%)
Query: 83 YLANISTLVNLTVQYNQFSGE----LPEELGSLLNLEKLHLSSNNFTGELPKTFAK---- 134
S L L + S L L + +L +L LS+N +
Sbjct: 364 LGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQ 423
Query: 135 -LTNMKDFRISDNQFTGQIPSFIQ 157
++ + D ++ ++ +Q
Sbjct: 424 PGCLLEQLVLYDIYWSEEMEDRLQ 447
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 47.7 bits (111), Expect = 4e-06
Identities = 16/74 (21%), Positives = 25/74 (33%), Gaps = 12/74 (16%)
Query: 182 SLENLTDLRISDLNGPEATFPQLGNMKMTKLILRNCNITGE----LPRYLGKMTKLKVLD 237
E L+D R ++L P L + + L +C +T + L L L+
Sbjct: 10 QCEELSDARWAEL------LPLLQQCQ--VVRLDDCGLTEARCKDISSALRVNPALAELN 61
Query: 238 LSFNRLRGQIPSNF 251
L N L
Sbjct: 62 LRSNELGDVGVHCV 75
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 44.6 bits (103), Expect = 4e-05
Identities = 14/89 (15%), Positives = 33/89 (37%), Gaps = 10/89 (11%)
Query: 113 NLEKLHLSSNNFTGE----LPKTFAKLTNMKDFRISDNQFTGQIPSFI-----QNWTKLE 163
L L L+ + + L T ++++ +S+N + Q LE
Sbjct: 370 VLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLE 429
Query: 164 KLFIQPSGLAGPIPSGIFSL-ENLTDLRI 191
+L + + + + +L ++ LR+
Sbjct: 430 QLVLYDIYWSEEMEDRLQALEKDKPSLRV 458
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.0 bits (99), Expect = 1e-04
Identities = 13/82 (15%), Positives = 29/82 (35%), Gaps = 7/82 (8%)
Query: 61 WASLPLLNIS--LIANRLKGPIPKYLANISTLVNLTVQYNQFSGELPEELGSLL-----N 113
+ L +L ++ +++ + L +L L + N +L +
Sbjct: 368 GSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCL 427
Query: 114 LEKLHLSSNNFTGELPKTFAKL 135
LE+L L ++ E+ L
Sbjct: 428 LEQLVLYDIYWSEEMEDRLQAL 449
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.7 bits (98), Expect = 1e-04
Identities = 13/109 (11%), Positives = 35/109 (32%), Gaps = 10/109 (9%)
Query: 63 SLPLLNISLIANRLK-GPIPKYLANISTLVNLTVQYNQFSGELPEELGSLL----NLEKL 117
SL + ++ + L + L + + + + +++ S L L +L
Sbjct: 1 SLDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAEL 60
Query: 118 HLSSNNFTGELPKTFAKL-----TNMKDFRISDNQFTGQIPSFIQNWTK 161
+L SN + ++ + + TG + + +
Sbjct: 61 NLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLR 109
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.3 bits (97), Expect = 2e-04
Identities = 15/134 (11%), Positives = 31/134 (23%), Gaps = 49/134 (36%)
Query: 112 LNLEKLHLSSNNFTGE-LPKTFAKLTNMKDFRISDNQFTGQIPSFIQNWTKLEKLFIQPS 170
L+++ L + + + L + R+ D T
Sbjct: 2 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEAR------------------ 43
Query: 171 GLAGPIPSGIFSLENLTDLRISDLNGPEATFPQLGNMKMTKLILRNCNITGELPRYLGKM 230
I S + L +L LR+ + + +
Sbjct: 44 --CKDISSALRVNPALAELN-----------------------LRSNELGDVGVHCVLQG 78
Query: 231 -----TKLKVLDLS 239
K++ L L
Sbjct: 79 LQTPSCKIQKLSLQ 92
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.4 bits (87), Expect = 0.003
Identities = 12/51 (23%), Positives = 18/51 (35%), Gaps = 4/51 (7%)
Query: 205 GNMKMTKLILRNCNITGE----LPRYLGKMTKLKVLDLSFNRLRGQIPSNF 251
+ L L +C+++ L L L+ LDLS N L
Sbjct: 367 PGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQL 417
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 47.9 bits (112), Expect = 3e-06
Identities = 21/89 (23%), Positives = 32/89 (35%), Gaps = 9/89 (10%)
Query: 74 NRLKGPIPKYLANISTLVNLTVQYNQFSGELPEELGSLLNLEKLHLSSNNFTGELPKTFA 133
N I +L L V N+ ELP LE+L S N+ E+P+
Sbjct: 270 NASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPP---RLERLIASFNHLA-EVPEL-- 322
Query: 134 KLTNMKDFRISDNQFTGQIPSFIQNWTKL 162
N+K + N + P ++ L
Sbjct: 323 -PQNLKQLHVEYNPLR-EFPDIPESVEDL 349
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 46.0 bits (107), Expect = 1e-05
Identities = 24/91 (26%), Positives = 41/91 (45%), Gaps = 9/91 (9%)
Query: 96 QYNQFSGELPEELGSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRISDNQFTGQIPSF 155
N S E+ +LE+L++S+N ELP +L + S N ++P
Sbjct: 268 YLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPRLERL---IASFNHLA-EVPEL 322
Query: 156 IQNWTKLEKLFIQPSGLAGPIPSGIFSLENL 186
QN L++L ++ + L P S+E+L
Sbjct: 323 PQN---LKQLHVEYNPLRE-FPDIPESVEDL 349
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 43.6 bits (102), Expect = 8e-06
Identities = 23/105 (21%), Positives = 37/105 (35%), Gaps = 5/105 (4%)
Query: 24 LKEQNLTGVLPPKLAELTFLQDIDLTLNYLSGTIPSQWASLPLLNISLIANRLKGPIPKY 83
L ++LT L +L + +DL+ N L P+ A L + N L+
Sbjct: 5 LAHKDLTV--LCHLEQLLLVTHLDLSHNRLRALPPALAALRCLEVLQASDNALENVDGVA 62
Query: 84 LANISTLVNLTVQYNQF-SGELPEELGSLLNLEKLHLSSNNFTGE 127
+ L N+ + L S L L+L N+ E
Sbjct: 63 NLPRLQELLL--CNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQE 105
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 40.9 bits (95), Expect = 8e-05
Identities = 24/130 (18%), Positives = 42/130 (32%), Gaps = 29/130 (22%)
Query: 117 LHLSSNNFTGELPKTFAKLTNMKDFRISDNQFTGQIPSFIQNWTKLEKLFIQPSGLAGPI 176
LHL+ + T +L + +S N+ P+
Sbjct: 3 LHLAHKDLTV--LCHLEQLLLVTHLDLSHNRLRALPPAL--------------------- 39
Query: 177 PSGIFSLENLTDLRISDLNGPEATFPQLGNMKMTKLILRNCNITG-ELPRYLGKMTKLKV 235
+L L L+ SD N E ++ +L+L N + + L +L +
Sbjct: 40 ----AALRCLEVLQASD-NALENVDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVL 94
Query: 236 LDLSFNRLRG 245
L+L N L
Sbjct: 95 LNLQGNSLCQ 104
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 40.5 bits (94), Expect = 9e-05
Identities = 21/86 (24%), Positives = 36/86 (41%), Gaps = 3/86 (3%)
Query: 212 LILRNCNITGELPRYLGKMTKLKVLDLSFNRLRGQIPSNFDDLYDVDYIYFAGNLLTGAI 271
L L + ++T +L ++ + LDLS NRLR P+ L ++ + + N L
Sbjct: 3 LHLAHKDLTV--LCHLEQLLLVTHLDLSHNRLRALPPA-LAALRCLEVLQASDNALENVD 59
Query: 272 PPWMLERGDKIDLSYNNFTDGSAESS 297
L R ++ L N +A
Sbjct: 60 GVANLPRLQELLLCNNRLQQSAAIQP 85
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 36.6 bits (84), Expect = 0.002
Identities = 19/101 (18%), Positives = 29/101 (28%), Gaps = 4/101 (3%)
Query: 93 LTVQYNQFSGELPEELGSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRISDNQFTGQI 152
L + + + L LL + L LS N P A L ++ + SDN +
Sbjct: 3 LHLAHKDLTV--LCHLEQLLLVTHLDLSHNRLRALPP-ALAALRCLEVLQASDNALE-NV 58
Query: 153 PSFIQNWTKLEKLFIQPSGLAGPIPSGIFSLENLTDLRISD 193
E L + S L L +
Sbjct: 59 DGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQG 99
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 41.5 bits (96), Expect = 1e-04
Identities = 29/180 (16%), Positives = 56/180 (31%), Gaps = 13/180 (7%)
Query: 66 LLNISLIANRLKGPIPKYLANISTLVNLTVQYNQFSGELPEELGSLLNLEKLHLSSNNFT 125
+ +L + + + ++++ + + + L N+ KL L+ N T
Sbjct: 26 TIKDNLKKKSVTDAVTQ--NELNSIDQIIANNSDIKSVQG--IQYLPNVTKLFLNGNKLT 81
Query: 126 GELPKTFAKLTNMKDFRISDNQFTGQIPSFIQNWTKLEKLFIQPSGLAGPIPSGIFSLEN 185
K A L N+ + +N+ K L +
Sbjct: 82 D--IKPLANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEHNGISDINGLVHLPQ---- 135
Query: 186 LTDLRISDLNGPEATFPQLGNMKMTKLILRNCNITGELPRYLGKMTKLKVLDLSFNRLRG 245
+ N K+ L L + I+ +P L +TKL+ L LS N +
Sbjct: 136 -LESLYLGNNKITDITVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHISD 192
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 40.0 bits (92), Expect = 4e-04
Identities = 32/191 (16%), Positives = 67/191 (35%), Gaps = 11/191 (5%)
Query: 110 SLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRISDNQFTGQIPSFIQNWTKLEKLFIQP 169
+ K +L + T + + +L ++ +++ IQ + KLF+
Sbjct: 22 AFAETIKDNLKKKSVTDAVTQ--NELNSIDQIIANNSDIKSVQG--IQYLPNVTKLFLNG 77
Query: 170 SGLAGPIPSGIFSLENLTDLRISDLNGPEATFPQLGNMKMTKLILRNCNITGELPRYLGK 229
+ L + I L NL +L L+ + L + L
Sbjct: 78 NKL-----TDIKPLANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEHNGISDINGLVH 132
Query: 230 MTKLKVLDLSFNRLRGQIPSNFDDLYDVDYIYFAGNLLTGAIPPWMLERGDKIDLSYNNF 289
+ +L+ L L N++ L +D + N ++ +P L + + LS N+
Sbjct: 133 LPQLESLYLGNNKITDIT--VLSRLTKLDTLSLEDNQISDIVPLAGLTKLQNLYLSKNHI 190
Query: 290 TDGSAESSCQK 300
+D A + +
Sbjct: 191 SDLRALAGLKN 201
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 41.9 bits (97), Expect = 1e-04
Identities = 27/216 (12%), Positives = 56/216 (25%), Gaps = 13/216 (6%)
Query: 85 ANISTLVNLTVQYNQFSGELPEELGSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRIS 144
++ + + + + + + L + L T + L N+ +
Sbjct: 16 PALANAIKIAAGKSNVTDTVTQA--DLDGITTLSAFGTGVT-TIEG-VQYLNNLIGLELK 71
Query: 145 DNQFTGQIPSFIQNWTKLEKLFIQPSGLAGPIPSGIFSLENLTDLRISDLNGPEATFPQL 204
DNQ T + L K+ + P
Sbjct: 72 DNQIT-----DLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLA 126
Query: 205 GNMKMTKLILRNCNITGELPRYLGKMTKLKVLDLSFNRLRGQIPSNFDDLYDVDYIYFAG 264
G + L L IT P + S + + +L + +
Sbjct: 127 GLSNLQVLYLDLNQITNISPLAGLTNLQYL----SIGNAQVSDLTPLANLSKLTTLKADD 182
Query: 265 NLLTGAIPPWMLERGDKIDLSYNNFTDGSAESSCQK 300
N ++ P L ++ L N +D S ++
Sbjct: 183 NKISDISPLASLPNLIEVHLKNNQISDVSPLANTSN 218
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 40.4 bits (93), Expect = 4e-04
Identities = 21/65 (32%), Positives = 31/65 (47%), Gaps = 5/65 (7%)
Query: 83 YLANISTLVNLTVQYNQFSGELPEELGSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFR 142
LAN+S L L N+ S L SL NL ++HL +N + P A +N+
Sbjct: 168 PLANLSKLTTLKADDNKISD--ISPLASLPNLIEVHLKNNQISDVSP--LANTSNLFIVT 223
Query: 143 ISDNQ 147
++ NQ
Sbjct: 224 LT-NQ 227
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 37.3 bits (85), Expect = 0.004
Identities = 33/209 (15%), Positives = 61/209 (29%), Gaps = 22/209 (10%)
Query: 66 LLNISLIANRLKGPIPKYLANISTLVNLTVQYNQFSGELPEELGSLLNLEKLHLSSNNFT 125
+ I+ + + + A++ + L+ + E + L NL L L N T
Sbjct: 21 AIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVTTI--EGVQYLNNLIGLELKDNQIT 76
Query: 126 GELPKTFAKLTNMKDFRISDNQFTGQIPSFIQNWTKLEKLFIQPSGLAGPIPSGIFSL-- 183
P + + + I T S + L
Sbjct: 77 DLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQVLYL 136
Query: 184 ------------ENLTDLRISDLNGPEATFPQLGNM-KMTKLILRNCNITGELPRYLGKM 230
+S N + L N+ K+T L + I+ P L +
Sbjct: 137 DLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDISP--LASL 194
Query: 231 TKLKVLDLSFNRLRGQIP-SNFDDLYDVD 258
L + L N++ P +N +L+ V
Sbjct: 195 PNLIEVHLKNNQISDVSPLANTSNLFIVT 223
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 39.5 bits (90), Expect = 0.001
Identities = 11/74 (14%), Positives = 25/74 (33%), Gaps = 4/74 (5%)
Query: 103 ELPEELGSLLNLEKLHLSSNNFTGE----LPKTFAKLTNMKDFRISDNQFTGQIPSFIQN 158
+ L +++++ LS N E L + A +++ SD +
Sbjct: 22 SVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEA 81
Query: 159 WTKLEKLFIQPSGL 172
L + ++ L
Sbjct: 82 LRLLLQALLKCPKL 95
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 39.1 bits (89), Expect = 0.002
Identities = 16/59 (27%), Positives = 26/59 (44%), Gaps = 6/59 (10%)
Query: 201 FPQLGNMKMTKLILRNCNITGELPRYL-----GKMTKLKVLDLSFNRLRGQIPSNFDDL 254
F +L N+ + L L+ I + R L KM L L+L+ NR + D++
Sbjct: 267 FSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRF-SEEDDVVDEI 324
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 38.5 bits (88), Expect = 0.001
Identities = 21/178 (11%), Positives = 46/178 (25%), Gaps = 23/178 (12%)
Query: 85 ANISTLVNLTVQYNQFSGELPEELGSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRIS 144
++ + + + + + L + L L N+ S
Sbjct: 15 TALAEKMKTVLGKTNVTDTVSQT--DLDQVTTLQADRLGIKS--IDGVEYLNNLTQINFS 70
Query: 145 DNQFTGQIPSFIQNWTKLEKLFIQPSGLAGPIPSGIFSLENLTDLRISDLNGPEATFPQL 204
+NQ T P + P+ + P L
Sbjct: 71 NNQLTDITPLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTNL 130
Query: 205 GNMKMTKLILR-----------------NCNITGELPRYLGKMTKLKVLDLSFNRLRG 245
++++ + + +T P L +T L+ LD+S N++
Sbjct: 131 NRLELSSNTISDISALSGLTSLQQLNFSSNQVTDLKP--LANLTTLERLDISSNKVSD 186
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 37.7 bits (86), Expect = 0.003
Identities = 35/190 (18%), Positives = 61/190 (32%), Gaps = 11/190 (5%)
Query: 111 LLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRISDNQFTGQIPSFIQNWTKLEKLFIQPS 170
L K L N T + + L + + ++ L ++ +
Sbjct: 17 LAEKMKTVLGKTNVTDTV--SQTDLDQVTTLQADRLGIKS--IDGVEYLNNLTQINFSNN 72
Query: 171 GLAGPIPSGIFSLENLTDLRISDLNGPEATFPQLGNMKMTKLILRNCNITGELPRYLGKM 230
+ I L+NLT L +N + L N L +
Sbjct: 73 -----QLTDITPLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNL 127
Query: 231 TKLKVLDLSFNRLRGQIPSNFDDLYDVDYIYFAGNLLTGAIPPWMLERGDKIDLSYNNFT 290
T L L+LS N + S L + + F+ N +T P L +++D+S N +
Sbjct: 128 TNLNRLELSSNTI--SDISALSGLTSLQQLNFSSNQVTDLKPLANLTTLERLDISSNKVS 185
Query: 291 DGSAESSCQK 300
D S +
Sbjct: 186 DISVLAKLTN 195
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 37.9 bits (87), Expect = 0.001
Identities = 21/145 (14%), Positives = 49/145 (33%), Gaps = 5/145 (3%)
Query: 24 LKEQNLTGVLPPKLAELTFLQDIDLTLNYLSGTIPSQWASLPLLNISLIANRLKGPIPKY 83
LK + + L +++ L L L + + + + + +
Sbjct: 4 LKPEQVE-QLKLIMSKRYDGSQQALDLKGL--RSDPDLVAQNIDVVLNRRSSMAATLRII 60
Query: 84 LANISTLVNLTVQYNQFSG--ELPEELGSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDF 141
NI L++L + N+ ++ + NL+ L+LS N E K +++
Sbjct: 61 EENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEEL 120
Query: 142 RISDNQFTGQIPSFIQNWTKLEKLF 166
+ N + + + + F
Sbjct: 121 WLDGNSLSDTFRDQSTYISAIRERF 145
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 37.1 bits (85), Expect = 0.002
Identities = 20/96 (20%), Positives = 37/96 (38%), Gaps = 7/96 (7%)
Query: 179 GIFSLENLTDLRISDLNGPEATFPQLGNMKMTKLILRNCNITG--ELPRYLGKMTKLKVL 236
I + N + L E P+L L L N + ++ + K LK+L
Sbjct: 42 NIDVVLNRRSSMAATLRIIEENIPEL-----LSLNLSNNRLYRLDDMSSIVQKAPNLKIL 96
Query: 237 DLSFNRLRGQIPSNFDDLYDVDYIYFAGNLLTGAIP 272
+LS N L+ + + ++ ++ GN L+
Sbjct: 97 NLSGNELKSERELDKIKGLKLEELWLDGNSLSDTFR 132
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 37.6 bits (86), Expect = 0.002
Identities = 19/124 (15%), Positives = 37/124 (29%), Gaps = 2/124 (1%)
Query: 202 PQLGNM-KMTKLILRNCNITGELPRYLGKMTKLKVLDLSFNRLRGQIPSNFDDLYDVDYI 260
Q N + +L LR I + + + +D S N +R +
Sbjct: 12 AQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRKLDGFPLLRRLKTLLV 70
Query: 261 YFAGNLLTGAIPPWMLERGDKIDLSYNNFTDGSAESSCQKRSVTGIVSCLRSVQCPKTYY 320
G L ++ L+ N+ + + LR+ K +Y
Sbjct: 71 NNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTNKKHY 130
Query: 321 SLHI 324
L++
Sbjct: 131 RLYV 134
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 756 | |||
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 99.97 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 99.97 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 99.92 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 99.91 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 99.91 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.9 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 99.9 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.89 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 99.89 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 99.88 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.88 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 99.75 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.74 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 99.74 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 99.74 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.73 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.72 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.71 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 99.71 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 99.7 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.7 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.68 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 99.56 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 99.54 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.52 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.51 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.5 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.5 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 99.48 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 99.47 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 99.43 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 99.43 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 99.42 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 99.31 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 99.3 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.3 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.27 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.53 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 98.43 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 98.32 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.99 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 97.77 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 97.51 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.5 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 97.11 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.09 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 97.06 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.53 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 95.58 |
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-52 Score=429.81 Aligned_cols=255 Identities=27% Similarity=0.439 Sum_probs=203.0
Q ss_pred cCccccCcccCCCCccEEEeeccCCcEEEEEEccccCcccHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEEecC
Q 004400 416 NNFATDNNIGEGGFGPVYKGLLADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYEYLE 495 (756)
Q Consensus 416 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~ 495 (756)
++|+..+.||+|+||+||+|++.+++.||||++... ....++|.+|++++++++|||||+++|+|.+++..++|||||+
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~ 83 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREG-AMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME 83 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSS-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCC-cCcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecC
Confidence 478888999999999999999888899999999754 3455789999999999999999999999999999999999999
Q ss_pred CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCcccCcceee
Q 004400 496 NNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHIST 575 (756)
Q Consensus 496 ~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~ 575 (756)
+|+|.+++......+++..+..++.|||.||+|||+++ |+||||||+|||+++++.+||+|||+|+...........
T Consensus 84 ~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~ 160 (263)
T d1sm2a_ 84 HGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSST 160 (263)
T ss_dssp TCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCTTCSGGGEEECGGGCEEECSCC--------------
T ss_pred CCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccc---eeecccchhheeecCCCCeEecccchheeccCCCceeec
Confidence 99999999877778999999999999999999999986 999999999999999999999999999876655444445
Q ss_pred ccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHhCC-CCCCccchhhHHHHHHHHHhcCccccccccCCCCCCCHHH
Q 004400 576 RVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGR-SNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDKEQ 654 (756)
Q Consensus 576 ~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 654 (756)
...||+.|+|||++.+..++.++|||||||++|||+|++ .|+............ .. +..... ....+
T Consensus 161 ~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i---~~-~~~~~~-----p~~~~--- 228 (263)
T d1sm2a_ 161 GTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDI---ST-GFRLYK-----PRLAS--- 228 (263)
T ss_dssp ----CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHH---HH-TCCCCC-----CTTSC---
T ss_pred ceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHH---Hh-cCCCCC-----ccccC---
Confidence 567999999999999999999999999999999999964 445444433332211 11 111111 11222
Q ss_pred HHHHHHHHHHhhcCCCCCCCCHHHHHHHhccCc
Q 004400 655 VMVMINVALLCANASPTIRPSMSSVLRMLECGV 687 (756)
Q Consensus 655 ~~~l~~l~~~c~~~~P~~RPt~~ev~~~L~~~~ 687 (756)
..+.+++.+||+.||++||||+||++.|+++.
T Consensus 229 -~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~ 260 (263)
T d1sm2a_ 229 -THVYQIMNHCWKERPEDRPAFSRLLRQLAEIA 260 (263)
T ss_dssp -HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -HHHHHHHHHHccCCHhHCcCHHHHHHHHHHHH
Confidence 34889999999999999999999999998653
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-51 Score=422.01 Aligned_cols=260 Identities=29% Similarity=0.452 Sum_probs=205.6
Q ss_pred hcCccccCcccCCCCccEEEeeccCCcEEEEEEcccc--CcccHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEE
Q 004400 415 TNNFATDNNIGEGGFGPVYKGLLADGTAIAVKQLSSK--SKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYE 492 (756)
Q Consensus 415 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 492 (756)
.++|...+.||+|+||+||+|++. ..||||+++.. .....+.|.+|++++++++|||||++++++.+ +..++|||
T Consensus 7 ~~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~E 83 (276)
T d1uwha_ 7 DGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQ 83 (276)
T ss_dssp TTCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred cccEEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEEe
Confidence 357889999999999999999865 35999998654 34455789999999999999999999998754 56899999
Q ss_pred ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCcccCc-
Q 004400 493 YLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENT- 571 (756)
Q Consensus 493 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~~~~- 571 (756)
||++|+|.+++......+++..+..++.|||+||+|||+++ ||||||||+|||++.++.+||+|||+|+.......
T Consensus 84 y~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~---ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~~ 160 (276)
T d1uwha_ 84 WCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGS 160 (276)
T ss_dssp CCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTSSEEECCCCCSCC-------
T ss_pred cCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCC---EeccccCHHHEEEcCCCCEEEccccceeeccccCCc
Confidence 99999999999877778999999999999999999999986 99999999999999999999999999987654322
Q ss_pred ceeeccccCccCCchHhhhc---CCCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhcCccccccccCCCC
Q 004400 572 HISTRVAGTIGYMAPEYAMR---GHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGS 648 (756)
Q Consensus 572 ~~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 648 (756)
.......||+.|||||++.+ ..++.++|||||||++|||+||+.||............ ...+....... ....
T Consensus 161 ~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~---~~~~~~~p~~~-~~~~ 236 (276)
T d1uwha_ 161 HQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFM---VGRGYLSPDLS-KVRS 236 (276)
T ss_dssp -----CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHH---HHHTSCCCCGG-GSCT
T ss_pred ccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHH---HhcCCCCCcch-hccc
Confidence 23445689999999999964 35899999999999999999999999765433222111 11111111111 1112
Q ss_pred CCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhccCcc
Q 004400 649 NFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLECGVD 688 (756)
Q Consensus 649 ~~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~L~~~~~ 688 (756)
.++ ..+.+++.+||+.||++|||++||++.|+.+.+
T Consensus 237 ~~~----~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~ 272 (276)
T d1uwha_ 237 NCP----KAMKRLMAECLKKKRDERPLFPQILASIELLAR 272 (276)
T ss_dssp TCC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred cch----HHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 233 348899999999999999999999999986543
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1e-51 Score=427.74 Aligned_cols=256 Identities=25% Similarity=0.422 Sum_probs=214.5
Q ss_pred hhcCccccCcccCCCCccEEEeec-cCCcEEEEEEccccCcccHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEE
Q 004400 414 ATNNFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYE 492 (756)
Q Consensus 414 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 492 (756)
..++|+..+.||+|+||+||+|++ .+++.||||+++.. ....++|.+|++++++++|||||+++++|.+++..++|||
T Consensus 15 ~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~-~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E 93 (287)
T d1opja_ 15 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE 93 (287)
T ss_dssp CGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTT-CSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred cHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCc-cchHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEee
Confidence 346788899999999999999995 46889999998754 3456789999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCcccCc
Q 004400 493 YLENNSLARALFE-HRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENT 571 (756)
Q Consensus 493 ~~~~gsL~~~l~~-~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~~~~ 571 (756)
||++|+|.+++.. ....+++..+..++.|||+||+|||+++ |+||||||+|||+++++.+||+|||+|+.......
T Consensus 94 ~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~~ 170 (287)
T d1opja_ 94 FMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY 170 (287)
T ss_dssp CCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSSS
T ss_pred cccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCC---cccCccccCeEEECCCCcEEEccccceeecCCCCc
Confidence 9999999999975 3557899999999999999999999996 99999999999999999999999999997766555
Q ss_pred ceeeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHhCCCCCCcc-chhhHHHHHHHHHhcCccccccccCCCCCC
Q 004400 572 HISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKE-DMFYLLDWALVLKEQGKLMELVDTNPGSNF 650 (756)
Q Consensus 572 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 650 (756)
.......||+.|+|||++.+..++.++|||||||++|||++|+.|+... +...... ....+..... ...+
T Consensus 171 ~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~----~i~~~~~~~~-----~~~~ 241 (287)
T d1opja_ 171 TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYE----LLEKDYRMER-----PEGC 241 (287)
T ss_dssp EEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHH----HHHTTCCCCC-----CTTC
T ss_pred eeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHH----HHhcCCCCCC-----Cccc
Confidence 5555567899999999999999999999999999999999987776443 3222221 1111111111 1123
Q ss_pred CHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhccC
Q 004400 651 DKEQVMVMINVALLCANASPTIRPSMSSVLRMLECG 686 (756)
Q Consensus 651 ~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~L~~~ 686 (756)
+ ..+.+++.+||+.||++|||+.||++.|+.+
T Consensus 242 ~----~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~ 273 (287)
T d1opja_ 242 P----EKVYELMRACWQWNPSDRPSFAEIHQAFETM 273 (287)
T ss_dssp C----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHT
T ss_pred h----HHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 3 3488999999999999999999999999865
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-51 Score=416.35 Aligned_cols=253 Identities=24% Similarity=0.405 Sum_probs=217.2
Q ss_pred cCccccCcccCCCCccEEEeeccCCcEEEEEEccccCcccHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEEecC
Q 004400 416 NNFATDNNIGEGGFGPVYKGLLADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYEYLE 495 (756)
Q Consensus 416 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~ 495 (756)
++|+..+.||+|+||+||+|++++++.||||.++.. ....++|.+|+.++++++|||||+++|+|.+++..++||||++
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~-~~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~ 82 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEG-SMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMA 82 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESS-SSCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCT
T ss_pred HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcC-cCCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccC
Confidence 588999999999999999999988899999999764 3355789999999999999999999999999999999999999
Q ss_pred CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCcccCcceee
Q 004400 496 NNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHIST 575 (756)
Q Consensus 496 ~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~ 575 (756)
+|+|.+++......+++..+.+++.|+|+||+|||+.| |+||||||+|||++.++.+||+|||+++...........
T Consensus 83 ~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~---iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~ 159 (258)
T d1k2pa_ 83 NGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSV 159 (258)
T ss_dssp TEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTT---BCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCCCCC
T ss_pred CCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcC---cccccccceeEEEcCCCcEEECcchhheeccCCCceeec
Confidence 99999998877778999999999999999999999986 999999999999999999999999999876655554455
Q ss_pred ccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHh-CCCCCCccchhhHHHHHHHHHhcCccccccccCCCCCCCHHH
Q 004400 576 RVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVS-GRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDKEQ 654 (756)
Q Consensus 576 ~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 654 (756)
...||+.|+|||.+....++.++|||||||++|||+| |+.||...+....... +. .+..... ....+
T Consensus 160 ~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~---i~-~~~~~~~-----p~~~~--- 227 (258)
T d1k2pa_ 160 GSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEH---IA-QGLRLYR-----PHLAS--- 227 (258)
T ss_dssp CSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHH---HH-TTCCCCC-----CTTCC---
T ss_pred ccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHH---HH-hCCCCCC-----ccccc---
Confidence 5679999999999999999999999999999999998 8999976654443221 11 1211111 11223
Q ss_pred HHHHHHHHHHhhcCCCCCCCCHHHHHHHhcc
Q 004400 655 VMVMINVALLCANASPTIRPSMSSVLRMLEC 685 (756)
Q Consensus 655 ~~~l~~l~~~c~~~~P~~RPt~~ev~~~L~~ 685 (756)
..+.+++.+||+.||++|||++||++.|..
T Consensus 228 -~~l~~li~~cl~~dP~~RPt~~eil~~L~d 257 (258)
T d1k2pa_ 228 -EKVYTIMYSCWHEKADERPTFKILLSNILD 257 (258)
T ss_dssp -HHHHHHHHHTTCSSGGGSCCHHHHHHHHHC
T ss_pred -HHHHHHHHHHccCCHhHCcCHHHHHHHhhC
Confidence 358899999999999999999999998863
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.2e-51 Score=427.95 Aligned_cols=257 Identities=27% Similarity=0.448 Sum_probs=201.6
Q ss_pred cCccccCcccCCCCccEEEeecc-CC---cEEEEEEcccc-CcccHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEE
Q 004400 416 NNFATDNNIGEGGFGPVYKGLLA-DG---TAIAVKQLSSK-SKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLI 490 (756)
Q Consensus 416 ~~~~~~~~lg~G~~g~Vy~~~~~-~~---~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 490 (756)
++|+..+.||+|+||+||+|++. ++ ..||||.+... .....+.|.+|+++|++++|||||+++|+|.+++..++|
T Consensus 26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv 105 (299)
T d1jpaa_ 26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMII 105 (299)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEE
Confidence 45777889999999999999864 33 36899998654 334456899999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCcccC
Q 004400 491 YEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEEN 570 (756)
Q Consensus 491 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~~~ 570 (756)
||||++|+|.+++......++|.++..++.|||+||+|||+++ ||||||||+|||++.++.+||+|||+|+......
T Consensus 106 ~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~ 182 (299)
T d1jpaa_ 106 TEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT 182 (299)
T ss_dssp EECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC----------
T ss_pred EEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCC---CccCccccceEEECCCCcEEECCcccceEccCCC
Confidence 9999999999999877778999999999999999999999986 9999999999999999999999999998765432
Q ss_pred cce----eeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHh-CCCCCCccchhhHHHHHHHHHhcCccccccccC
Q 004400 571 THI----STRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVS-GRSNVTKEDMFYLLDWALVLKEQGKLMELVDTN 645 (756)
Q Consensus 571 ~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 645 (756)
... .....||+.|||||.+.++.++.++|||||||++|||+| |+.||............ .. +....
T Consensus 183 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i---~~-~~~~~----- 253 (299)
T d1jpaa_ 183 SDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAI---EQ-DYRLP----- 253 (299)
T ss_dssp -------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHH---HT-TCCCC-----
T ss_pred CcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHHHHHHH---Hc-CCCCC-----
Confidence 221 223468999999999999999999999999999999998 89999766554433321 11 11111
Q ss_pred CCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhccCcc
Q 004400 646 PGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLECGVD 688 (756)
Q Consensus 646 ~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~L~~~~~ 688 (756)
..... +..+.+++.+||+.||++||||.||++.|+++..
T Consensus 254 ~~~~~----~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~ 292 (299)
T d1jpaa_ 254 PPMDC----PSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIR 292 (299)
T ss_dssp CCTTC----CHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred CCccc----hHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhc
Confidence 11122 3348899999999999999999999999986543
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-50 Score=417.73 Aligned_cols=249 Identities=28% Similarity=0.471 Sum_probs=210.0
Q ss_pred cCccccCcccCCCCccEEEee-ccCCcEEEEEEccccCcccHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEEec
Q 004400 416 NNFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYEYL 494 (756)
Q Consensus 416 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~ 494 (756)
++|+..+.||+|+||+||+|+ ..+|+.||||++........+.+.+|++++++++|||||+++++|.+++..|+|||||
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~ 99 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEec
Confidence 479999999999999999998 4679999999997665556678999999999999999999999999999999999999
Q ss_pred CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCcccCccee
Q 004400 495 ENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHIS 574 (756)
Q Consensus 495 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~~~~~~~ 574 (756)
++|+|.+++... .+++..+..++.||+.||+|||++| ||||||||+|||++.++.+||+|||+|+....... ..
T Consensus 100 ~gg~L~~~~~~~--~l~~~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~-~~ 173 (293)
T d1yhwa1 100 AGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-KR 173 (293)
T ss_dssp TTCBHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC-CB
T ss_pred CCCcHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCcHHHeEECCCCcEeeccchhheeeccccc-cc
Confidence 999999987653 6999999999999999999999997 99999999999999999999999999987654332 23
Q ss_pred eccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhcCccccccccCCCCCCCHHH
Q 004400 575 TRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDKEQ 654 (756)
Q Consensus 575 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 654 (756)
...+||+.|+|||++.+..++.++||||+||++|||++|+.||...+........ ..... ... ..+...
T Consensus 174 ~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~---~~~~~-~~~-------~~~~~~ 242 (293)
T d1yhwa1 174 STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLI---ATNGT-PEL-------QNPEKL 242 (293)
T ss_dssp CCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH---HHHCS-CCC-------SSGGGS
T ss_pred cccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHH---HhCCC-CCC-------CCcccC
Confidence 4567999999999999999999999999999999999999999766554332211 11111 000 111122
Q ss_pred HHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 004400 655 VMVMINVALLCANASPTIRPSMSSVLR 681 (756)
Q Consensus 655 ~~~l~~l~~~c~~~~P~~RPt~~ev~~ 681 (756)
...+.+++.+||+.||++|||+.|+++
T Consensus 243 s~~~~~li~~~L~~dP~~R~s~~eil~ 269 (293)
T d1yhwa1 243 SAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (293)
T ss_dssp CHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred CHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 344889999999999999999999875
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-51 Score=421.70 Aligned_cols=254 Identities=30% Similarity=0.445 Sum_probs=209.3
Q ss_pred hcCccccCcccCCCCccEEEeeccCCcEEEEEEccccCcccHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEEec
Q 004400 415 TNNFATDNNIGEGGFGPVYKGLLADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYEYL 494 (756)
Q Consensus 415 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~ 494 (756)
.++|+..+.||+|+||+||+|++++++.||||+++.. ....+.|.+|++++++++|||||+++|++.+ +..++|||||
T Consensus 12 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey~ 89 (272)
T d1qpca_ 12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQG-SMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYM 89 (272)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTT-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECC
T ss_pred HHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccC-cCCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEeC
Confidence 3578888999999999999999988899999999754 3445789999999999999999999998754 5679999999
Q ss_pred CCCCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCcccCcce
Q 004400 495 ENNSLARALFE-HRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHI 573 (756)
Q Consensus 495 ~~gsL~~~l~~-~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~~~~~~ 573 (756)
++|+|.+++.. ....+++..+.+++.|||+||+|||+++ |+||||||+|||+++++.+||+|||+|+.........
T Consensus 90 ~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~---ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~~~ 166 (272)
T d1qpca_ 90 ENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTA 166 (272)
T ss_dssp TTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEEC
T ss_pred CCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccchhheeeecccceeeccccceEEccCCcccc
Confidence 99999998763 3346999999999999999999999986 9999999999999999999999999999776555444
Q ss_pred eeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHhCCCCCC-ccchhhHHHHHHHHHhcCccccccccCCCCCCCH
Q 004400 574 STRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVT-KEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDK 652 (756)
Q Consensus 574 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 652 (756)
.....||+.|+|||++.++.++.++|||||||++|||+||+.|+. ........... ..+..... ...++
T Consensus 167 ~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i----~~~~~~~~-----p~~~~- 236 (272)
T d1qpca_ 167 REGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNL----ERGYRMVR-----PDNCP- 236 (272)
T ss_dssp CTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHH----HTTCCCCC-----CTTCC-
T ss_pred ccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHH----HhcCCCCC-----cccCh-
Confidence 555679999999999999999999999999999999999766653 33332222211 11111111 12233
Q ss_pred HHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhccC
Q 004400 653 EQVMVMINVALLCANASPTIRPSMSSVLRMLECG 686 (756)
Q Consensus 653 ~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~L~~~ 686 (756)
..+.+++.+||+.||++||||+||++.|+.+
T Consensus 237 ---~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~ 267 (272)
T d1qpca_ 237 ---EELYQLMRLCWKERPEDRPTFDYLRSVLEDF 267 (272)
T ss_dssp ---HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ---HHHHHHHHHHcCCCHhHCcCHHHHHHHhhhh
Confidence 3488999999999999999999999999853
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-50 Score=413.25 Aligned_cols=246 Identities=26% Similarity=0.395 Sum_probs=208.0
Q ss_pred hcCccccCcccCCCCccEEEeec-cCCcEEEEEEcccc---CcccHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEE
Q 004400 415 TNNFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSK---SKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLI 490 (756)
Q Consensus 415 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 490 (756)
.++|+..+.||+|+||+||+|+. .+++.||+|++... .....+.+.+|++++++++|||||++++++.+++..|+|
T Consensus 5 l~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~iv 84 (263)
T d2j4za1 5 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI 84 (263)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEE
Confidence 35789999999999999999995 57899999998643 233456789999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCcccC
Q 004400 491 YEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEEN 570 (756)
Q Consensus 491 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~~~ 570 (756)
||||++|+|.+++... ..+++..+..++.||+.||+|||+++ ||||||||+|||++.++.+||+|||+|+......
T Consensus 85 mEy~~~g~L~~~l~~~-~~l~e~~~~~i~~qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~~ 160 (263)
T d2j4za1 85 LEYAPLGTVYRELQKL-SKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR 160 (263)
T ss_dssp EECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCSCSCCCCCC
T ss_pred EeecCCCcHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeeeeccccceecCCCCEeecccceeeecCCCc
Confidence 9999999999999754 37999999999999999999999996 9999999999999999999999999998654432
Q ss_pred cceeeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhcCccccccccCCCCCC
Q 004400 571 THISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNF 650 (756)
Q Consensus 571 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 650 (756)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||...+........ .. .+. ......
T Consensus 161 ---~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i---~~-~~~------~~p~~~ 227 (263)
T d2j4za1 161 ---RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRI---SR-VEF------TFPDFV 227 (263)
T ss_dssp ---CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH---HT-TCC------CCCTTS
T ss_pred ---ccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHH---Hc-CCC------CCCccC
Confidence 23467999999999999999999999999999999999999999776554433211 11 110 011122
Q ss_pred CHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 004400 651 DKEQVMVMINVALLCANASPTIRPSMSSVLR 681 (756)
Q Consensus 651 ~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~ 681 (756)
+ ..+.+++.+||+.||++|||++|+++
T Consensus 228 s----~~~~~li~~~L~~dp~~R~t~~eil~ 254 (263)
T d2j4za1 228 T----EGARDLISRLLKHNPSQRPMLREVLE 254 (263)
T ss_dssp C----HHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred C----HHHHHHHHHHccCCHhHCcCHHHHHc
Confidence 3 34889999999999999999999976
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-50 Score=418.63 Aligned_cols=251 Identities=25% Similarity=0.376 Sum_probs=209.5
Q ss_pred cCccccCcccCCCCccEEEeec-cCCcEEEEEEccccCcccHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEEec
Q 004400 416 NNFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYEYL 494 (756)
Q Consensus 416 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~ 494 (756)
+.|+..+.||+|+||+||+|+. .+++.||||++........+.+.+|++++++++|||||++++++.+++..++|||||
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~ 91 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC 91 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecC
Confidence 4688889999999999999994 578999999998766666778999999999999999999999999999999999999
Q ss_pred CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCcccCccee
Q 004400 495 ENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHIS 574 (756)
Q Consensus 495 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~~~~~~~ 574 (756)
++|+|.+++.+....+++..+..++.||+.||+|||++| ||||||||+|||++.++.+||+|||+|+....... ..
T Consensus 92 ~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~---ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~~-~~ 167 (288)
T d2jfla1 92 AGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ-RR 167 (288)
T ss_dssp TTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECHHHHH-HH
T ss_pred CCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEEeecChhheeECCCCCEEEEechhhhccCCCcc-cc
Confidence 999999998776668999999999999999999999997 99999999999999999999999999976543221 22
Q ss_pred eccccCccCCchHhhh-----cCCCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhcCccccccccCCCCC
Q 004400 575 TRVAGTIGYMAPEYAM-----RGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSN 649 (756)
Q Consensus 575 ~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 649 (756)
....||+.|+|||++. ...|+.++|||||||++|||+||+.||...+........ ... ..... .
T Consensus 168 ~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i--~~~--~~~~~-------~ 236 (288)
T d2jfla1 168 DSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKI--AKS--EPPTL-------A 236 (288)
T ss_dssp TCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHH--HHS--CCCCC-------S
T ss_pred cccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHH--HcC--CCCCC-------C
Confidence 3467999999999984 456899999999999999999999999766554433211 111 11111 1
Q ss_pred CCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 004400 650 FDKEQVMVMINVALLCANASPTIRPSMSSVLR 681 (756)
Q Consensus 650 ~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~ 681 (756)
.+......+.+++.+||+.||++|||+.|+++
T Consensus 237 ~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~ 268 (288)
T d2jfla1 237 QPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ 268 (288)
T ss_dssp SGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 11122335889999999999999999999876
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-51 Score=419.46 Aligned_cols=252 Identities=29% Similarity=0.439 Sum_probs=203.1
Q ss_pred hcCccccCcccCCCCccEEEeec-cCCcEEEEEEccccC-cccHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEE
Q 004400 415 TNNFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSKS-KQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYE 492 (756)
Q Consensus 415 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 492 (756)
.++|+..+.||+|+||+||+|+. .+|+.||||++.... ....+.+.+|++++++++|||||++++++.+++..|+|||
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmE 83 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 83 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEe
Confidence 35789999999999999999995 579999999986543 2334578999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCcccCc-
Q 004400 493 YLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENT- 571 (756)
Q Consensus 493 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~~~~- 571 (756)
||++|+|.+++.. ...+++.++..++.||+.||+|||++| ||||||||+|||+++++.+||+|||+|+.......
T Consensus 84 y~~gg~L~~~l~~-~~~l~e~~~~~i~~qi~~al~ylH~~~---IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~ 159 (271)
T d1nvra_ 84 YCSGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE 159 (271)
T ss_dssp CCTTEEGGGGSBT-TTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECEETTEE
T ss_pred ccCCCcHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHcC---CccCcccHHHEEECCCCCEEEccchhheeeccCCcc
Confidence 9999999999854 347999999999999999999999997 99999999999999999999999999987654332
Q ss_pred ceeeccccCccCCchHhhhcCCC-CcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhcCccccccccCCCCCC
Q 004400 572 HISTRVAGTIGYMAPEYAMRGHL-TEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNF 650 (756)
Q Consensus 572 ~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 650 (756)
......+||+.|||||++.+..+ +.++||||+||++|||++|+.||......... + .......... .+....
T Consensus 160 ~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~-~-~~~~~~~~~~-----~~~~~~ 232 (271)
T d1nvra_ 160 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE-Y-SDWKEKKTYL-----NPWKKI 232 (271)
T ss_dssp CCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHH-H-HHHHTTCTTS-----TTGGGS
T ss_pred ccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHH-H-HHHhcCCCCC-----CccccC
Confidence 22445789999999999988775 67899999999999999999999654322111 1 1111111111 011112
Q ss_pred CHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 004400 651 DKEQVMVMINVALLCANASPTIRPSMSSVLR 681 (756)
Q Consensus 651 ~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~ 681 (756)
+ ..+.+++.+||+.||++|||++|+++
T Consensus 233 s----~~~~~li~~~L~~dP~~R~t~~eil~ 259 (271)
T d1nvra_ 233 D----SAPLALLHKILVENPSARITIPDIKK 259 (271)
T ss_dssp C----HHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred C----HHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 2 34788999999999999999999865
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-50 Score=418.09 Aligned_cols=253 Identities=26% Similarity=0.412 Sum_probs=208.4
Q ss_pred cCccccCc-ccCCCCccEEEeecc---CCcEEEEEEccccC-cccHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEE
Q 004400 416 NNFATDNN-IGEGGFGPVYKGLLA---DGTAIAVKQLSSKS-KQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLI 490 (756)
Q Consensus 416 ~~~~~~~~-lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 490 (756)
++|...+. ||+|+||+||+|.+. ++..||||+++... ....++|.+|+++|++++|||||+++|+|.+ +..|+|
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lv 86 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLV 86 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEE
T ss_pred cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEE
Confidence 45666664 999999999999753 45579999997543 3445789999999999999999999999865 568999
Q ss_pred EEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCcccC
Q 004400 491 YEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEEN 570 (756)
Q Consensus 491 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~~~ 570 (756)
||||++|+|.+++...+..+++..+.+++.|||+||+|||+++ |+||||||+|||++.++.+||+|||+|+......
T Consensus 87 mE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~ 163 (285)
T d1u59a_ 87 MEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALGADD 163 (285)
T ss_dssp EECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECTTCS
T ss_pred EEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCcCchhheeeccCCceeeccchhhhcccccc
Confidence 9999999999998777778999999999999999999999986 9999999999999999999999999998765443
Q ss_pred cce--eeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHh-CCCCCCccchhhHHHHHHHHHhcCccccccccCCC
Q 004400 571 THI--STRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVS-GRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPG 647 (756)
Q Consensus 571 ~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 647 (756)
... .....||+.|+|||++.++.++.++|||||||++|||+| |+.||........... + ..+...+..
T Consensus 164 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~---i-~~~~~~~~p----- 234 (285)
T d1u59a_ 164 SYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAF---I-EQGKRMECP----- 234 (285)
T ss_dssp CEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHH---H-HTTCCCCCC-----
T ss_pred cccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHH---H-HcCCCCCCC-----
Confidence 322 334578999999999999999999999999999999998 8999976554433221 1 222222211
Q ss_pred CCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhcc
Q 004400 648 SNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLEC 685 (756)
Q Consensus 648 ~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~L~~ 685 (756)
...+ ..+.+++.+||+.||++||||.+|++.|+.
T Consensus 235 ~~~~----~~l~~li~~cl~~~p~~RPs~~~i~~~L~~ 268 (285)
T d1u59a_ 235 PECP----PELYALMSDCWIYKWEDRPDFLTVEQRMRA 268 (285)
T ss_dssp TTCC----HHHHHHHHHTTCSSGGGSCCHHHHHHHHHH
T ss_pred CcCC----HHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence 2233 348899999999999999999999999874
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-50 Score=414.76 Aligned_cols=252 Identities=27% Similarity=0.413 Sum_probs=196.2
Q ss_pred cCccccCcccCCCCccEEEee-ccCCcEEEEEEccccC--cccHHHHHHHHHHHHhCCCCceeeEeeEEEe--CCeEEEE
Q 004400 416 NNFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSKS--KQGNREFINEIGMISALQHPNLVKLYGCCIE--GNQLLLI 490 (756)
Q Consensus 416 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lV 490 (756)
++|+..+.||+|+||+||+|+ ..+|+.||||.+.... ....+.+.+|++++++++|||||++++++.+ ++..|+|
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv 83 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 83 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence 579999999999999999998 4679999999987642 3334678999999999999999999999975 4568999
Q ss_pred EEecCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHcCC--CCCeEcCCCCCCceEecCCCCEEEccCCcccc
Q 004400 491 YEYLENNSLARALFE---HRLKLDWPTRRRICLGIARGLAYLHGES--RIKVVHRDIKATNVLLDKDLNSKISDFGLAKL 565 (756)
Q Consensus 491 ~e~~~~gsL~~~l~~---~~~~l~~~~~~~i~~~ia~~L~~LH~~g--~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~ 565 (756)
||||++|+|.+++.. ....+++..++.++.||+.||+|||+++ ..+||||||||+|||++.++.+||+|||+|+.
T Consensus 84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~ 163 (269)
T d2java1 84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI 163 (269)
T ss_dssp EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceee
Confidence 999999999999863 3457999999999999999999999864 23599999999999999999999999999987
Q ss_pred CcccCcceeeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhcCccccccccC
Q 004400 566 DEEENTHISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTN 645 (756)
Q Consensus 566 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 645 (756)
...... ......||+.|+|||++.+..++.++|||||||++|||+||+.||...+........ ..+....
T Consensus 164 ~~~~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i----~~~~~~~----- 233 (269)
T d2java1 164 LNHDTS-FAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKI----REGKFRR----- 233 (269)
T ss_dssp C------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH----HHTCCCC-----
T ss_pred cccCCC-ccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHH----HcCCCCC-----
Confidence 654332 234578999999999999999999999999999999999999999776554433211 1122111
Q ss_pred CCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 004400 646 PGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLR 681 (756)
Q Consensus 646 ~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~ 681 (756)
....+++ .+.+++.+||+.||++|||+.|+++
T Consensus 234 ~~~~~s~----~l~~li~~~L~~dp~~Rps~~ell~ 265 (269)
T d2java1 234 IPYRYSD----ELNEIITRMLNLKDYHRPSVEEILE 265 (269)
T ss_dssp CCTTSCH----HHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CCcccCH----HHHHHHHHHcCCChhHCcCHHHHHh
Confidence 1122333 4889999999999999999999875
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-50 Score=417.27 Aligned_cols=258 Identities=26% Similarity=0.450 Sum_probs=203.9
Q ss_pred hcCccccCcccCCCCccEEEeeccCC-----cEEEEEEcccc-CcccHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEE
Q 004400 415 TNNFATDNNIGEGGFGPVYKGLLADG-----TAIAVKQLSSK-SKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLL 488 (756)
Q Consensus 415 ~~~~~~~~~lg~G~~g~Vy~~~~~~~-----~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 488 (756)
...|+..++||+|+||+||+|.+.+. ..||||++... ......+|.+|++++++++|||||+++|+|.+++..+
T Consensus 6 ~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~ 85 (283)
T d1mqba_ 6 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMM 85 (283)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred HHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceE
Confidence 35688889999999999999986532 37999998654 3334457999999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCcc
Q 004400 489 LIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEE 568 (756)
Q Consensus 489 lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~ 568 (756)
+|||||.+|++.+.+......++|..+.+++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+|+....
T Consensus 86 ~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~ 162 (283)
T d1mqba_ 86 IITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLED 162 (283)
T ss_dssp EEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC------
T ss_pred EEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccc---cccCccccceEEECCCCeEEEcccchhhcccC
Confidence 999999999999999887778999999999999999999999986 99999999999999999999999999987654
Q ss_pred cCc--ceeeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHhCCCCCCcc-chhhHHHHHHHHHhcCccccccccC
Q 004400 569 ENT--HISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKE-DMFYLLDWALVLKEQGKLMELVDTN 645 (756)
Q Consensus 569 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 645 (756)
... .......||+.|+|||++.++.++.++|||||||++|||++|+.|+... ........ + ..+....
T Consensus 163 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~---i-~~~~~~~----- 233 (283)
T d1mqba_ 163 DPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKA---I-NDGFRLP----- 233 (283)
T ss_dssp -----------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHH---H-HTTCCCC-----
T ss_pred CCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHHHHHHH---H-hccCCCC-----
Confidence 322 2233456899999999999999999999999999999999976666433 33222221 1 1111111
Q ss_pred CCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhccCcc
Q 004400 646 PGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLECGVD 688 (756)
Q Consensus 646 ~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~L~~~~~ 688 (756)
.+...+..+.+++.+||+.||++||||.||++.|+++..
T Consensus 234 ----~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~ 272 (283)
T d1mqba_ 234 ----TPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIR 272 (283)
T ss_dssp ----CCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred ----CchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhh
Confidence 111223458899999999999999999999999986644
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-50 Score=415.07 Aligned_cols=257 Identities=28% Similarity=0.425 Sum_probs=205.0
Q ss_pred cCccccCcccCCCCccEEEeeccCCcEEEEEEccccCcccHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEEecC
Q 004400 416 NNFATDNNIGEGGFGPVYKGLLADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYEYLE 495 (756)
Q Consensus 416 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~ 495 (756)
++|+..+.||+|+||.||+|++.+++.||||+++.. ....+.|.+|+.++++++|||||+++|+|.+ +..++|||||+
T Consensus 17 ~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey~~ 94 (285)
T d1fmka3 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMS 94 (285)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTT-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCT
T ss_pred HHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcc-cCCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEEecC
Confidence 578899999999999999999988889999999654 3456789999999999999999999999854 56799999999
Q ss_pred CCCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCcccCccee
Q 004400 496 NNSLARALFE-HRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHIS 574 (756)
Q Consensus 496 ~gsL~~~l~~-~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~~~~~~~ 574 (756)
+|+|..++.. ....++|..+..++.|||.||+|||+.+ |+||||||+|||+|.++.+||+|||+|+..........
T Consensus 95 ~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~---ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 171 (285)
T d1fmka3 95 KGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTAR 171 (285)
T ss_dssp TCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC----------
T ss_pred CCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhh---eecccccceEEEECCCCcEEEcccchhhhccCCCceee
Confidence 9999998874 3456999999999999999999999996 99999999999999999999999999987655444444
Q ss_pred eccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHhCCCCCCc-cchhhHHHHHHHHHhcCccccccccCCCCCCCHH
Q 004400 575 TRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTK-EDMFYLLDWALVLKEQGKLMELVDTNPGSNFDKE 653 (756)
Q Consensus 575 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 653 (756)
....||+.|+|||++..+.++.++|||||||++|||++|+.|+.. ........+. . .+..... ....
T Consensus 172 ~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i---~-~~~~~~~-----~~~~--- 239 (285)
T d1fmka3 172 QGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQV---E-RGYRMPC-----PPEC--- 239 (285)
T ss_dssp ----CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHH---H-TTCCCCC-----CTTS---
T ss_pred ccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHH---H-hcCCCCC-----Cccc---
Confidence 556799999999999999999999999999999999997766643 3333333222 1 1111111 1122
Q ss_pred HHHHHHHHHHHhhcCCCCCCCCHHHHHHHhccCcccc
Q 004400 654 QVMVMINVALLCANASPTIRPSMSSVLRMLECGVDVL 690 (756)
Q Consensus 654 ~~~~l~~l~~~c~~~~P~~RPt~~ev~~~L~~~~~~~ 690 (756)
...+.+++.+||+.||++||+|++|+++|+.+....
T Consensus 240 -~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~ 275 (285)
T d1fmka3 240 -PESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST 275 (285)
T ss_dssp -CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCS
T ss_pred -CHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCC
Confidence 335889999999999999999999999999765433
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-50 Score=424.05 Aligned_cols=261 Identities=20% Similarity=0.355 Sum_probs=205.4
Q ss_pred hhcCccccCcccCCCCccEEEee-ccCCcEEEEEEccccC-cccHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEE
Q 004400 414 ATNNFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSKS-KQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIY 491 (756)
Q Consensus 414 ~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 491 (756)
..++|+..+.||+|+||+||+|+ ..+|+.||+|+++... ......+.+|+.+|++++|||||+++++|.+++..++||
T Consensus 4 ~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVm 83 (322)
T d1s9ja_ 4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 83 (322)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 45789999999999999999999 4678999999987543 333567899999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcC-CCCCeEcCCCCCCceEecCCCCEEEccCCccccCcccC
Q 004400 492 EYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGE-SRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEEN 570 (756)
Q Consensus 492 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~-g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~~~ 570 (756)
|||++|+|.+++.+.+ .+++..+..++.|++.||+|||++ | |+||||||+|||++.++.+||+|||+|+......
T Consensus 84 Ey~~gg~L~~~l~~~~-~l~~~~~~~~~~qil~aL~yLH~~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~ 159 (322)
T d1s9ja_ 84 EHMDGGSLDQVLKKAG-RIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM 159 (322)
T ss_dssp ECCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHHHHT
T ss_pred EcCCCCcHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHHHhCC---EEccccCHHHeeECCCCCEEEeeCCCccccCCCc
Confidence 9999999999997654 699999999999999999999974 5 9999999999999999999999999998654322
Q ss_pred cceeeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHH-HHhc-Ccc----------
Q 004400 571 THISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALV-LKEQ-GKL---------- 638 (756)
Q Consensus 571 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~-~~~~-~~~---------- 638 (756)
....+||+.|+|||++.+..|+.++||||+||++|||++|+.||.+.+.......... .... ...
T Consensus 160 ---~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (322)
T d1s9ja_ 160 ---ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRP 236 (322)
T ss_dssp ---C---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC---------------------
T ss_pred ---cccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCccccccccc
Confidence 2356899999999999999999999999999999999999999966543221110000 0000 000
Q ss_pred --------------c----cccccCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 004400 639 --------------M----ELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLR 681 (756)
Q Consensus 639 --------------~----~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~ 681 (756)
. ......+...........+.+++.+|++.||++|||++|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~ 297 (322)
T d1s9ja_ 237 LSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV 297 (322)
T ss_dssp ---------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhh
Confidence 0 000000000000011235889999999999999999999986
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-49 Score=410.20 Aligned_cols=246 Identities=27% Similarity=0.386 Sum_probs=199.4
Q ss_pred CcccCCCCccEEEeecc---CCcEEEEEEccccC--cccHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEEecCC
Q 004400 422 NNIGEGGFGPVYKGLLA---DGTAIAVKQLSSKS--KQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYEYLEN 496 (756)
Q Consensus 422 ~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~ 496 (756)
+.||+|+||+||+|.+. .++.||||+++... ....++|.+|++++++++|||||+++++|.+ +..++|||||++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence 57999999999999854 34689999996542 2234679999999999999999999999965 457899999999
Q ss_pred CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCcccCcce--e
Q 004400 497 NSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHI--S 574 (756)
Q Consensus 497 gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~~~~~~--~ 574 (756)
|+|.+++... ..+++..+..++.|||.||+|||+++ ||||||||+|||++.++.+||+|||+|+......... .
T Consensus 92 g~L~~~l~~~-~~l~~~~~~~i~~qi~~gl~ylH~~~---iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~ 167 (277)
T d1xbba_ 92 GPLNKYLQQN-RHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQ 167 (277)
T ss_dssp EEHHHHHHHC-TTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC-
T ss_pred CcHHHHHhhc-cCCCHHHHHHHHHHHHHHHhhHHhCC---cccCCCcchhhcccccCcccccchhhhhhccccccccccc
Confidence 9999998755 47999999999999999999999986 9999999999999999999999999998765443322 2
Q ss_pred eccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHh-CCCCCCccchhhHHHHHHHHHhcCccccccccCCCCCCCHH
Q 004400 575 TRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVS-GRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDKE 653 (756)
Q Consensus 575 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 653 (756)
....||+.|+|||.+.+..++.++|||||||++|||+| |+.||............ ..+...... ..++
T Consensus 168 ~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i----~~~~~~~~p-----~~~~-- 236 (277)
T d1xbba_ 168 THGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAML----EKGERMGCP-----AGCP-- 236 (277)
T ss_dssp ---CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHH----HTTCCCCCC-----TTCC--
T ss_pred cccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHH----HcCCCCCCC-----cccC--
Confidence 34579999999999999999999999999999999998 89999766544332211 222222111 2233
Q ss_pred HHHHHHHHHHHhhcCCCCCCCCHHHHHHHhcc
Q 004400 654 QVMVMINVALLCANASPTIRPSMSSVLRMLEC 685 (756)
Q Consensus 654 ~~~~l~~l~~~c~~~~P~~RPt~~ev~~~L~~ 685 (756)
..+.+++.+||+.||++|||+++|++.|+.
T Consensus 237 --~~~~~li~~cl~~dp~~RPs~~~i~~~L~~ 266 (277)
T d1xbba_ 237 --REMYDLMNLCWTYDVENRPGFAAVELRLRN 266 (277)
T ss_dssp --HHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred --HHHHHHHHHHcCCCHhHCcCHHHHHHHhhC
Confidence 348899999999999999999999998874
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-49 Score=411.67 Aligned_cols=248 Identities=23% Similarity=0.349 Sum_probs=205.7
Q ss_pred cCccccCcccCCCCccEEEeec-cCCcEEEEEEcccc---CcccHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEE
Q 004400 416 NNFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSK---SKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIY 491 (756)
Q Consensus 416 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 491 (756)
++|+..+.||+|+||+||+|+. .+|+.||||++... .....+.+.+|++++++++|||||++++++.+++..|+||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence 5799999999999999999995 57999999998653 2334567999999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCcccC-
Q 004400 492 EYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEEN- 570 (756)
Q Consensus 492 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~~~- 570 (756)
|||++|+|.+++... ..+++..+..++.|++.||+|||+++ ||||||||+|||+++++.+||+|||+|+......
T Consensus 88 Ey~~gg~L~~~~~~~-~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~ 163 (288)
T d1uu3a_ 88 SYAKNGELLKYIRKI-GSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESK 163 (288)
T ss_dssp CCCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECC----
T ss_pred EccCCCCHHHhhhcc-CCCCHHHHHHHHHHHHHHHHhhcccc---EEcCcCCccccccCCCceEEecccccceecccCCc
Confidence 999999999988755 47999999999999999999999996 9999999999999999999999999998765432
Q ss_pred cceeeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhcCccccccccCCCCCC
Q 004400 571 THISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNF 650 (756)
Q Consensus 571 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 650 (756)
.......+||+.|+|||++.+..++.++||||+||++|||++|+.||...+........ .. ... . ....+
T Consensus 164 ~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i---~~-~~~-~-----~p~~~ 233 (288)
T d1uu3a_ 164 QARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKI---IK-LEY-D-----FPEKF 233 (288)
T ss_dssp ------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH---HT-TCC-C-----CCTTC
T ss_pred ccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHH---Hc-CCC-C-----CCccC
Confidence 22334568999999999999999999999999999999999999999876654433211 11 111 1 11223
Q ss_pred CHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 004400 651 DKEQVMVMINVALLCANASPTIRPSMSSVLR 681 (756)
Q Consensus 651 ~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~ 681 (756)
+ ..+.+++.+||+.||++|||++|+++
T Consensus 234 s----~~~~~li~~~L~~dP~~R~t~~e~~~ 260 (288)
T d1uu3a_ 234 F----PKARDLVEKLLVLDATKRLGCEEMEG 260 (288)
T ss_dssp C----HHHHHHHHTTSCSSGGGSTTSGGGTC
T ss_pred C----HHHHHHHHHHccCCHhHCcCHHHHcC
Confidence 3 34889999999999999999998743
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-49 Score=420.00 Aligned_cols=254 Identities=28% Similarity=0.396 Sum_probs=205.6
Q ss_pred cCccccCcccCCCCccEEEeeccC-C-----cEEEEEEcccc-CcccHHHHHHHHHHHHhC-CCCceeeEeeEEEeCCeE
Q 004400 416 NNFATDNNIGEGGFGPVYKGLLAD-G-----TAIAVKQLSSK-SKQGNREFINEIGMISAL-QHPNLVKLYGCCIEGNQL 487 (756)
Q Consensus 416 ~~~~~~~~lg~G~~g~Vy~~~~~~-~-----~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 487 (756)
++|+..+.||+|+||+||+|++.. + ..||||.+... .......+.+|+.+++++ +|||||+++++|.+++..
T Consensus 37 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~ 116 (325)
T d1rjba_ 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPI 116 (325)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCeE
Confidence 578899999999999999998542 2 36999998654 333456789999999998 899999999999999999
Q ss_pred EEEEEecCCCCHHHHHHhcC----------------------CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCC
Q 004400 488 LLIYEYLENNSLARALFEHR----------------------LKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKAT 545 (756)
Q Consensus 488 ~lV~e~~~~gsL~~~l~~~~----------------------~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~ 545 (756)
++|||||++|+|.+++.... ..+++..+..++.||++||+|||+++ ||||||||+
T Consensus 117 ~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~---IiHRDlKp~ 193 (325)
T d1rjba_ 117 YLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLAAR 193 (325)
T ss_dssp EEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETTCSGG
T ss_pred EEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCchh
Confidence 99999999999999997543 24899999999999999999999986 999999999
Q ss_pred ceEecCCCCEEEccCCccccCcccCcc-eeeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHh-CCCCCCccchh
Q 004400 546 NVLLDKDLNSKISDFGLAKLDEEENTH-ISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVS-GRSNVTKEDMF 623 (756)
Q Consensus 546 Nill~~~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~ 623 (756)
|||++.++.+||+|||+|+........ ......||+.|||||++.++.++.++|||||||++|||+| |+.||.+....
T Consensus 194 Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~~ 273 (325)
T d1rjba_ 194 NVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVD 273 (325)
T ss_dssp GEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS
T ss_pred ccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCHH
Confidence 999999999999999999876544332 2345678999999999999999999999999999999998 89999654432
Q ss_pred hHHHHHHHHHhcCccccccccCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhc
Q 004400 624 YLLDWALVLKEQGKLMELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLE 684 (756)
Q Consensus 624 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~L~ 684 (756)
.... .....+...+. ....+ ..+.+++.+||+.||++|||++||++.|.
T Consensus 274 ~~~~---~~~~~~~~~~~-----p~~~~----~~l~~li~~cl~~dP~~RPt~~ei~~~L~ 322 (325)
T d1rjba_ 274 ANFY---KLIQNGFKMDQ-----PFYAT----EEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322 (325)
T ss_dssp HHHH---HHHHTTCCCCC-----CTTCC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HHHH---HHHhcCCCCCC-----CCcCC----HHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence 2211 11122211111 11223 34889999999999999999999999985
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=4.4e-49 Score=411.44 Aligned_cols=252 Identities=24% Similarity=0.365 Sum_probs=192.9
Q ss_pred hcCccccCcccCCCCccEEEeec-cCCcEEEEEEccccC-cccHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEE
Q 004400 415 TNNFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSKS-KQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYE 492 (756)
Q Consensus 415 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 492 (756)
.+.|+..+.||+|+||+||+|+. .+|+.||||++.... ......+.+|+.++++++|||||++++++.+++..|+|||
T Consensus 8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE 87 (307)
T d1a06a_ 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQ 87 (307)
T ss_dssp GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence 45699999999999999999995 578999999987543 2234568899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEec---CCCCEEEccCCccccCccc
Q 004400 493 YLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLD---KDLNSKISDFGLAKLDEEE 569 (756)
Q Consensus 493 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~---~~~~~kl~DFGla~~~~~~ 569 (756)
||+||+|.+++... ..+++..+..++.||+.||+|||+++ ||||||||+|||+. +++.+||+|||+|+.....
T Consensus 88 ~~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~ 163 (307)
T d1a06a_ 88 LVSGGELFDRIVEK-GFYTERDASRLIFQVLDAVKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPG 163 (307)
T ss_dssp CCCSCBHHHHHHTC-SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCC---------
T ss_pred ccCCCcHHHhhhcc-cCCCHHHHHHHHHHHHHHHHhhhhce---eeeEEecccceeecccCCCceEEEeccceeEEccCC
Confidence 99999999999754 47999999999999999999999997 99999999999994 5788999999999865443
Q ss_pred CcceeeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhcCccccccccCCCCC
Q 004400 570 NTHISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSN 649 (756)
Q Consensus 570 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 649 (756)
.. ....+||+.|||||++.+..++.++||||+||++|||++|+.||............ ...... ........
T Consensus 164 ~~--~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i--~~~~~~----~~~~~~~~ 235 (307)
T d1a06a_ 164 SV--LSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQI--LKAEYE----FDSPYWDD 235 (307)
T ss_dssp -----------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH--HTTCCC----CCTTTTTT
T ss_pred Ce--eeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHH--hccCCC----CCCccccC
Confidence 22 23467999999999999999999999999999999999999999776554433221 111111 11111122
Q ss_pred CCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004400 650 FDKEQVMVMINVALLCANASPTIRPSMSSVLRM 682 (756)
Q Consensus 650 ~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~ 682 (756)
.+ ..+.+++.+||+.||++|||+.|+++.
T Consensus 236 ~s----~~~~~li~~~L~~dP~~R~s~~eil~h 264 (307)
T d1a06a_ 236 IS----DSAKDFIRHLMEKDPEKRFTCEQALQH 264 (307)
T ss_dssp SC----HHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred CC----HHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence 33 348899999999999999999999884
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-49 Score=404.67 Aligned_cols=246 Identities=27% Similarity=0.420 Sum_probs=197.1
Q ss_pred cccCcccCCCCccEEEeec-cCCcEEEEEEcccc--CcccHHHHHHHHHHHHhCCCCceeeEeeEEEe----CCeEEEEE
Q 004400 419 ATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSK--SKQGNREFINEIGMISALQHPNLVKLYGCCIE----GNQLLLIY 491 (756)
Q Consensus 419 ~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~lV~ 491 (756)
+..+.||+|+||+||+|+. .+++.||+|.+... .....+.|.+|++++++++|||||+++++|.+ +...++||
T Consensus 12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm 91 (270)
T d1t4ha_ 12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 91 (270)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEE
Confidence 5567899999999999994 57889999998654 23345678999999999999999999999875 45689999
Q ss_pred EecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEec-CCCCEEEccCCccccCcccC
Q 004400 492 EYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLD-KDLNSKISDFGLAKLDEEEN 570 (756)
Q Consensus 492 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~-~~~~~kl~DFGla~~~~~~~ 570 (756)
|||++|+|.+++.+. ..+++..+..++.||+.||+|||+++ ++||||||||+|||++ +++.+||+|||+|+.....
T Consensus 92 E~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~gl~yLH~~~-~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~~- 168 (270)
T d1t4ha_ 92 ELMTSGTLKTYLKRF-KVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS- 168 (270)
T ss_dssp ECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCTT-
T ss_pred eCCCCCcHHHHHhcc-ccccHHHHHHHHHHHHHHHHHHHHCC-CCEEeCCcChhhceeeCCCCCEEEeecCcceeccCC-
Confidence 999999999999754 47999999999999999999999884 4599999999999996 5789999999999864432
Q ss_pred cceeeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhcCccccccccCCCCCC
Q 004400 571 THISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNF 650 (756)
Q Consensus 571 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 650 (756)
.....+||+.|||||++.+ .++.++|||||||++|||++|+.||......... ..... .+.....++ ...
T Consensus 169 --~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~--~~~i~-~~~~~~~~~----~~~ 238 (270)
T d1t4ha_ 169 --FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQI--YRRVT-SGVKPASFD----KVA 238 (270)
T ss_dssp --SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHH--HHHHT-TTCCCGGGG----GCC
T ss_pred --ccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHH--HHHHH-cCCCCcccC----ccC
Confidence 2345689999999998865 6999999999999999999999999654322211 11111 111111111 122
Q ss_pred CHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 004400 651 DKEQVMVMINVALLCANASPTIRPSMSSVLR 681 (756)
Q Consensus 651 ~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~ 681 (756)
++ .+.+++.+||+.||++|||+.|+++
T Consensus 239 ~~----~~~~li~~~l~~dp~~R~s~~ell~ 265 (270)
T d1t4ha_ 239 IP----EVKEIIEGCIRQNKDERYSIKDLLN 265 (270)
T ss_dssp CH----HHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CH----HHHHHHHHHccCCHhHCcCHHHHhC
Confidence 22 3889999999999999999999976
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=6.2e-49 Score=417.40 Aligned_cols=252 Identities=22% Similarity=0.315 Sum_probs=211.8
Q ss_pred cCccccCcccCCCCccEEEeec-cCCcEEEEEEccccCcccHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEEec
Q 004400 416 NNFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYEYL 494 (756)
Q Consensus 416 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~ 494 (756)
++|++.+.||+|+||.||+|+. .+|+.||||++........+.+.+|+.++++++|||||++++++.+++..|+|||||
T Consensus 26 ~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~ 105 (350)
T d1koaa2 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFM 105 (350)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence 5799999999999999999994 679999999998766666678999999999999999999999999999999999999
Q ss_pred CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecC--CCCEEEccCCccccCcccCcc
Q 004400 495 ENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDK--DLNSKISDFGLAKLDEEENTH 572 (756)
Q Consensus 495 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~--~~~~kl~DFGla~~~~~~~~~ 572 (756)
++|+|.+++......+++..+..++.||+.||+|||++| ||||||||+|||++. ++.+||+|||+|+.......
T Consensus 106 ~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~~- 181 (350)
T d1koaa2 106 SGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQS- 181 (350)
T ss_dssp CSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTSC-
T ss_pred CCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcC---CeeeeechhHeeeccCCCCeEEEeecchheecccccc-
Confidence 999999999766668999999999999999999999997 999999999999964 57899999999987654332
Q ss_pred eeeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhcCccccccccCCCCCCCH
Q 004400 573 ISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDK 652 (756)
Q Consensus 573 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 652 (756)
.....||+.|||||++.+..++.++||||+||++|||++|+.||.+.+........ .......... .....+
T Consensus 182 -~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i--~~~~~~~~~~----~~~~~s- 253 (350)
T d1koaa2 182 -VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNV--KSCDWNMDDS----AFSGIS- 253 (350)
T ss_dssp -EEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH--HHTCCCSCCG----GGGGCC-
T ss_pred -cceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHH--HhCCCCCCcc----cccCCC-
Confidence 34467999999999999999999999999999999999999999776554433211 1111111110 001122
Q ss_pred HHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004400 653 EQVMVMINVALLCANASPTIRPSMSSVLRM 682 (756)
Q Consensus 653 ~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~ 682 (756)
..+.+++.+||+.||++|||+.|+++.
T Consensus 254 ---~~~~~li~~~L~~dP~~R~t~~eil~h 280 (350)
T d1koaa2 254 ---EDGKDFIRKLLLADPNTRMTIHQALEH 280 (350)
T ss_dssp ---HHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred ---HHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 348899999999999999999999884
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=7.1e-49 Score=417.30 Aligned_cols=252 Identities=23% Similarity=0.324 Sum_probs=212.3
Q ss_pred cCccccCcccCCCCccEEEee-ccCCcEEEEEEccccCcccHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEEec
Q 004400 416 NNFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYEYL 494 (756)
Q Consensus 416 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~ 494 (756)
++|+..+.||+|+||.||+|+ ..+|+.||||++........+.+.+|+++|++++|||||+++++|.+++..|+|||||
T Consensus 29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~ 108 (352)
T d1koba_ 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFL 108 (352)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECC
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence 578999999999999999999 4679999999997765555678899999999999999999999999999999999999
Q ss_pred CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEec--CCCCEEEccCCccccCcccCcc
Q 004400 495 ENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLD--KDLNSKISDFGLAKLDEEENTH 572 (756)
Q Consensus 495 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~--~~~~~kl~DFGla~~~~~~~~~ 572 (756)
++|+|.+++......+++.++..++.||+.||+|||++| ||||||||+|||++ .++.+||+|||+|+.......
T Consensus 109 ~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~~- 184 (352)
T d1koba_ 109 SGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI- 184 (352)
T ss_dssp CCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSC-
T ss_pred CCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccccccccccccCCCeEEEeecccceecCCCCc-
Confidence 999999988766668999999999999999999999997 99999999999998 578999999999987655332
Q ss_pred eeeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhcCccccccccCCCCCCCH
Q 004400 573 ISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDK 652 (756)
Q Consensus 573 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 652 (756)
.....||+.|+|||++.+..++.++||||+||++|||+||+.||.+.+........ ....... ........+
T Consensus 185 -~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i--~~~~~~~----~~~~~~~~s- 256 (352)
T d1koba_ 185 -VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNV--KRCDWEF----DEDAFSSVS- 256 (352)
T ss_dssp -EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHH--HHCCCCC----CSSTTTTSC-
T ss_pred -eeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHH--HhCCCCC----CcccccCCC-
Confidence 34467999999999999999999999999999999999999999776654433221 1111110 111112233
Q ss_pred HHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004400 653 EQVMVMINVALLCANASPTIRPSMSSVLRM 682 (756)
Q Consensus 653 ~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~ 682 (756)
..+.+++.+||+.||.+|||+.|+++.
T Consensus 257 ---~~~~~li~~~L~~dp~~R~s~~eil~H 283 (352)
T d1koba_ 257 ---PEAKDFIKNLLQKEPRKRLTVHDALEH 283 (352)
T ss_dssp ---HHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred ---HHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 348899999999999999999999874
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=4.2e-49 Score=411.66 Aligned_cols=245 Identities=27% Similarity=0.459 Sum_probs=202.5
Q ss_pred cCccccCcccCCCCccEEEee-ccCCcEEEEEEccccCc---ccHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEE
Q 004400 416 NNFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSKSK---QGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIY 491 (756)
Q Consensus 416 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 491 (756)
..|+..+.||+|+||+||+|+ ..+|+.||||++..... ...+.+.+|++++++++|||||+++++|.+++..|+||
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~ 94 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEE
Confidence 358889999999999999998 56789999999875432 23356899999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCcccCc
Q 004400 492 EYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENT 571 (756)
Q Consensus 492 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~~~~ 571 (756)
|||.+|+|..++... ..+++..+..++.||+.||+|||++| ||||||||+|||++.++.+||+|||+|+.....
T Consensus 95 E~~~~g~l~~~~~~~-~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~~-- 168 (309)
T d1u5ra_ 95 EYCLGSASDLLEVHK-KPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA-- 168 (309)
T ss_dssp ECCSEEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB--
T ss_pred EecCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEECCCCCEEEeecccccccCCC--
Confidence 999999997766544 57999999999999999999999997 999999999999999999999999999865432
Q ss_pred ceeeccccCccCCchHhhhc---CCCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhcCccccccccCCCC
Q 004400 572 HISTRVAGTIGYMAPEYAMR---GHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGS 648 (756)
Q Consensus 572 ~~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 648 (756)
....||+.|||||++.+ +.|+.++|||||||++|||++|+.||...+....... ... ...... ...
T Consensus 169 ---~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~---i~~-~~~~~~----~~~ 237 (309)
T d1u5ra_ 169 ---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYH---IAQ-NESPAL----QSG 237 (309)
T ss_dssp ---CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHH---HHH-SCCCCC----SCT
T ss_pred ---CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHH---HHh-CCCCCC----CCC
Confidence 34579999999999864 4589999999999999999999999976554332211 111 111111 112
Q ss_pred CCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 004400 649 NFDKEQVMVMINVALLCANASPTIRPSMSSVLR 681 (756)
Q Consensus 649 ~~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~ 681 (756)
.++ ..+.+++.+||+.||++|||+.|+++
T Consensus 238 ~~s----~~~~~li~~~L~~dP~~Rpt~~ell~ 266 (309)
T d1u5ra_ 238 HWS----EYFRNFVDSCLQKIPQDRPTSEVLLK 266 (309)
T ss_dssp TSC----HHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred CCC----HHHHHHHHHHCcCChhHCcCHHHHHh
Confidence 233 34889999999999999999999976
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.4e-49 Score=405.33 Aligned_cols=255 Identities=26% Similarity=0.384 Sum_probs=199.7
Q ss_pred hcCccccCcccCCCCccEEEeeccC----CcEEEEEEccccC-cccHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEE
Q 004400 415 TNNFATDNNIGEGGFGPVYKGLLAD----GTAIAVKQLSSKS-KQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLL 489 (756)
Q Consensus 415 ~~~~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 489 (756)
.++|+..+.||+|+||.||+|++.. +..||||.++... ....+.|.+|++++++++|||||+++++|. ++..++
T Consensus 6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~i 84 (273)
T d1mp8a_ 6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI 84 (273)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEE
Confidence 3578899999999999999998542 3568999986543 333567999999999999999999999985 567899
Q ss_pred EEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCccc
Q 004400 490 IYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEE 569 (756)
Q Consensus 490 V~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~~ 569 (756)
||||+++|+|.+++......+++..+..++.||++||+|||+++ ||||||||+||+++.++.+||+|||+|+.....
T Consensus 85 v~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~~ 161 (273)
T d1mp8a_ 85 IMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS 161 (273)
T ss_dssp EEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC----------
T ss_pred EEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccC---eeccccchhheeecCCCcEEEccchhheeccCC
Confidence 99999999999998877778999999999999999999999996 999999999999999999999999999876655
Q ss_pred CcceeeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHh-CCCCCCccchhhHHHHHHHHHhcCccccccccCCCC
Q 004400 570 NTHISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVS-GRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGS 648 (756)
Q Consensus 570 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 648 (756)
.........||+.|+|||++.+..++.++|||||||++|||++ |+.||............ ..+..... ..
T Consensus 162 ~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i----~~~~~~~~-----~~ 232 (273)
T d1mp8a_ 162 TYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI----ENGERLPM-----PP 232 (273)
T ss_dssp ---------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHH----HTTCCCCC-----CT
T ss_pred cceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHH----HcCCCCCC-----CC
Confidence 4444556678999999999999999999999999999999998 88898766554443321 11221111 12
Q ss_pred CCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhccC
Q 004400 649 NFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLECG 686 (756)
Q Consensus 649 ~~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~L~~~ 686 (756)
.++ ..+.+++.+||+.||++|||+.||++.|+.+
T Consensus 233 ~~~----~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i 266 (273)
T d1mp8a_ 233 NCP----PTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 266 (273)
T ss_dssp TCC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCC----HHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 233 3488999999999999999999999998854
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=5.9e-49 Score=410.88 Aligned_cols=263 Identities=28% Similarity=0.452 Sum_probs=214.7
Q ss_pred hhHHHhhcCccccCcccCCCCccEEEeecc------CCcEEEEEEccccCc-ccHHHHHHHHHHHHhCCCCceeeEeeEE
Q 004400 409 LQIKAATNNFATDNNIGEGGFGPVYKGLLA------DGTAIAVKQLSSKSK-QGNREFINEIGMISALQHPNLVKLYGCC 481 (756)
Q Consensus 409 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~ 481 (756)
.+++...++|+..+.||+|+||+||+|++. +++.||||+++.... ...++|.+|++++++++||||++++++|
T Consensus 6 ~~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~ 85 (301)
T d1lufa_ 6 LSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVC 85 (301)
T ss_dssp HHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred hhccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeee
Confidence 344456678999999999999999999853 457899999976433 3356799999999999999999999999
Q ss_pred EeCCeEEEEEEecCCCCHHHHHHhcC-----------------------CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeE
Q 004400 482 IEGNQLLLIYEYLENNSLARALFEHR-----------------------LKLDWPTRRRICLGIARGLAYLHGESRIKVV 538 (756)
Q Consensus 482 ~~~~~~~lV~e~~~~gsL~~~l~~~~-----------------------~~l~~~~~~~i~~~ia~~L~~LH~~g~~~ii 538 (756)
.+++..++||||+++|+|.++++... ..+++..+..++.|+|.||+|||+.+ ||
T Consensus 86 ~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~---iv 162 (301)
T d1lufa_ 86 AVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FV 162 (301)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CC
T ss_pred ccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCC---eE
Confidence 99999999999999999999996432 24899999999999999999999986 99
Q ss_pred cCCCCCCceEecCCCCEEEccCCccccCcccC-cceeeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHhCC-CC
Q 004400 539 HRDIKATNVLLDKDLNSKISDFGLAKLDEEEN-THISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGR-SN 616 (756)
Q Consensus 539 H~Dikp~Nill~~~~~~kl~DFGla~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~-~p 616 (756)
||||||+|||+|.++.+||+|||+|+...... ....+...||+.|+|||.+.+..++.++|||||||++|||++|. .|
T Consensus 163 HrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p 242 (301)
T d1lufa_ 163 HRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQP 242 (301)
T ss_dssp CSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCT
T ss_pred eeEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCC
Confidence 99999999999999999999999998654332 22344567899999999999999999999999999999999996 56
Q ss_pred CCccchhhHHHHHHHHHhcCccccccccCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhccCc
Q 004400 617 VTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLECGV 687 (756)
Q Consensus 617 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~L~~~~ 687 (756)
|...+........ ..+...... ...+ ..+.+++.+||+.+|++||||.||+++|+++.
T Consensus 243 ~~~~~~~e~~~~v----~~~~~~~~p-----~~~~----~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~ 300 (301)
T d1lufa_ 243 YYGMAHEEVIYYV----RDGNILACP-----ENCP----LELYNLMRLCWSKLPADRPSFCSIHRILQRMC 300 (301)
T ss_dssp TTTSCHHHHHHHH----HTTCCCCCC-----TTCC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred CCCCCHHHHHHHH----HcCCCCCCC-----ccch----HHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence 7665554443321 222222211 1223 34889999999999999999999999999753
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-48 Score=402.20 Aligned_cols=254 Identities=25% Similarity=0.414 Sum_probs=200.5
Q ss_pred cCccccCcccCCCCccEEEeecc--CC--cEEEEEEcccc---CcccHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEE
Q 004400 416 NNFATDNNIGEGGFGPVYKGLLA--DG--TAIAVKQLSSK---SKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLL 488 (756)
Q Consensus 416 ~~~~~~~~lg~G~~g~Vy~~~~~--~~--~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 488 (756)
++|+..+.||+|+||.||+|++. ++ ..||||++... .....++|.+|+.++++++|||||+++|+|.+ +..+
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~ 86 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMK 86 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchh
Confidence 57889999999999999999853 22 36899998654 23334689999999999999999999999965 4678
Q ss_pred EEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCcc
Q 004400 489 LIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEE 568 (756)
Q Consensus 489 lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~ 568 (756)
+||||+++|++.+.+......+++..+..++.|||+||+|||+++ |+||||||+||+++.++.+||+|||+++....
T Consensus 87 lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~ 163 (273)
T d1u46a_ 87 MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQ 163 (273)
T ss_dssp EEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEECCC
T ss_pred eeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCC---EeeeeecHHHhccccccceeeccchhhhhccc
Confidence 999999999999998877678999999999999999999999986 99999999999999999999999999997654
Q ss_pred cCcce--eeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHh-CCCCCCccchhhHHHHHHHHHhcCccccccccC
Q 004400 569 ENTHI--STRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVS-GRSNVTKEDMFYLLDWALVLKEQGKLMELVDTN 645 (756)
Q Consensus 569 ~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 645 (756)
..... .....||..|+|||++.+..++.++|||||||++|||+| |+.||...+......+. ...+.....
T Consensus 164 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i---~~~~~~~~~---- 236 (273)
T d1u46a_ 164 NDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKI---DKEGERLPR---- 236 (273)
T ss_dssp -CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHH---HTSCCCCCC----
T ss_pred CCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHH---HhCCCCCCC----
Confidence 43322 334568889999999999999999999999999999998 89999777665544322 222222111
Q ss_pred CCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhcc
Q 004400 646 PGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLEC 685 (756)
Q Consensus 646 ~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~L~~ 685 (756)
...++ ..+.+++.+||+.||++||||.||++.|++
T Consensus 237 -~~~~~----~~l~~li~~cl~~dp~~RPt~~ei~~~L~~ 271 (273)
T d1u46a_ 237 -PEDCP----QDIYNVMVQCWAHKPEDRPTFVALRDFLLE 271 (273)
T ss_dssp -CTTCC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred -ccccc----HHHHHHHHHHcCCChhHCcCHHHHHHHHHh
Confidence 12233 348899999999999999999999999874
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6e-48 Score=401.60 Aligned_cols=251 Identities=24% Similarity=0.302 Sum_probs=207.5
Q ss_pred hcCccccCcccCCCCccEEEeec-cCCcEEEEEEccccC------cccHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeE
Q 004400 415 TNNFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSKS------KQGNREFINEIGMISALQHPNLVKLYGCCIEGNQL 487 (756)
Q Consensus 415 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 487 (756)
.+.|+..+.||+|+||+||+|+. .+|+.||||++.+.. ....+.+.+|+++|++++|||||+++++|.+++..
T Consensus 9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 88 (293)
T d1jksa_ 9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 88 (293)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 35799999999999999999995 679999999986532 12357899999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCC----CEEEccCCcc
Q 004400 488 LLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDL----NSKISDFGLA 563 (756)
Q Consensus 488 ~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~----~~kl~DFGla 563 (756)
|+|||||++|+|.+++.... .+++..+..++.|++.||+|||+.+ ||||||||+|||++.++ .+||+|||+|
T Consensus 89 ~iv~E~~~gg~L~~~i~~~~-~l~~~~~~~~~~qi~~al~yLH~~~---ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a 164 (293)
T d1jksa_ 89 ILILELVAGGELFDFLAEKE-SLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLA 164 (293)
T ss_dssp EEEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSSSSCCEEECCCTTC
T ss_pred EEEEEcCCCccccchhcccc-ccchhHHHHHHHHHHHHHHhhhhcc---eeecccccceEEEecCCCcccceEecchhhh
Confidence 99999999999999997553 7999999999999999999999997 99999999999998876 4999999999
Q ss_pred ccCcccCcceeeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhcCccccccc
Q 004400 564 KLDEEENTHISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVD 643 (756)
Q Consensus 564 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 643 (756)
+....... .....||+.|+|||++.+..++.++||||+||++|||++|+.||.+.+........ ............
T Consensus 165 ~~~~~~~~--~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i--~~~~~~~~~~~~ 240 (293)
T d1jksa_ 165 HKIDFGNE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANV--SAVNYEFEDEYF 240 (293)
T ss_dssp EECTTSCB--CSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH--HTTCCCCCHHHH
T ss_pred hhcCCCcc--ccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHH--HhcCCCCCchhc
Confidence 87654332 23467999999999999999999999999999999999999999876654433211 111111110000
Q ss_pred cCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 004400 644 TNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLR 681 (756)
Q Consensus 644 ~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~ 681 (756)
... +..+.+++.+||+.||++|||++|+++
T Consensus 241 ----~~~----s~~~~~li~~~L~~dP~~R~s~~eil~ 270 (293)
T d1jksa_ 241 ----SNT----SALAKDFIRRLLVKDPKKRMTIQDSLQ 270 (293)
T ss_dssp ----TTS----CHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred ----CCC----CHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 112 234889999999999999999999976
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-48 Score=398.83 Aligned_cols=248 Identities=30% Similarity=0.453 Sum_probs=198.9
Q ss_pred cCccccCcccCCCCccEEEeeccCCcEEEEEEccccCcccHHHHHHHHHHHHhCCCCceeeEeeEEEe-CCeEEEEEEec
Q 004400 416 NNFATDNNIGEGGFGPVYKGLLADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCCIE-GNQLLLIYEYL 494 (756)
Q Consensus 416 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~lV~e~~ 494 (756)
++|+..+.||+|+||.||+|+++ |+.||||+++.. ...+.|.+|++++++++|||||+++|+|.+ ++..++||||+
T Consensus 7 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~i~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~ 83 (262)
T d1byga_ 7 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 83 (262)
T ss_dssp GGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCC
T ss_pred HHeEEeEEEecCCCeEEEEEEEC-CeEEEEEEECcH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEecc
Confidence 46788899999999999999985 788999999653 345789999999999999999999999965 45689999999
Q ss_pred CCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCcccCcce
Q 004400 495 ENNSLARALFEH-RLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHI 573 (756)
Q Consensus 495 ~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~~~~~~ 573 (756)
++|+|.+++... ...++|..+++++.|||.||+|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 84 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~~--- 157 (262)
T d1byga_ 84 AKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ--- 157 (262)
T ss_dssp TTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC-----------
T ss_pred CCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCc---eeccccchHhheecCCCCEeecccccceecCCCC---
Confidence 999999999744 335899999999999999999999986 9999999999999999999999999998644322
Q ss_pred eeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHh-CCCCCCccchhhHHHHHHHHHhcCccccccccCCCCCCCH
Q 004400 574 STRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVS-GRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDK 652 (756)
Q Consensus 574 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 652 (756)
....+|+.|+|||++.++.++.++|||||||++|||+| |+.||..........+. ..+...++. ...+
T Consensus 158 -~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i----~~~~~~~~~-----~~~~- 226 (262)
T d1byga_ 158 -DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRV----EKGYKMDAP-----DGCP- 226 (262)
T ss_dssp -----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHH----TTTCCCCCC-----TTCC-
T ss_pred -ccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHH----HcCCCCCCC-----ccCC-
Confidence 23468999999999999999999999999999999998 67777665554444332 122222221 1222
Q ss_pred HHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhccC
Q 004400 653 EQVMVMINVALLCANASPTIRPSMSSVLRMLECG 686 (756)
Q Consensus 653 ~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~L~~~ 686 (756)
..+.+++.+||+.||.+||||.+|+++|+.+
T Consensus 227 ---~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i 257 (262)
T d1byga_ 227 ---PAVYEVMKNCWHLDAAMRPSFLQLREQLEHI 257 (262)
T ss_dssp ---HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ---HHHHHHHHHHcccCHhHCcCHHHHHHHHHHH
Confidence 3488999999999999999999999999864
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-48 Score=407.66 Aligned_cols=254 Identities=26% Similarity=0.443 Sum_probs=203.9
Q ss_pred cCccccCcccCCCCccEEEeec-cCCc----EEEEEEcccc-CcccHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEE
Q 004400 416 NNFATDNNIGEGGFGPVYKGLL-ADGT----AIAVKQLSSK-SKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLL 489 (756)
Q Consensus 416 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 489 (756)
.+|+..+.||+|+||+||+|++ .+|+ .||+|.++.. .....++|.+|++++++++|||||+++|+|.++ ..++
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~ 87 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 87 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeE
Confidence 4699999999999999999985 3454 5889988653 344567899999999999999999999999865 5678
Q ss_pred EEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCccc
Q 004400 490 IYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEE 569 (756)
Q Consensus 490 V~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~~ 569 (756)
++||+.+|+|.+++......+++..+.+++.|||.||+|||+++ ||||||||+|||++.++.+||+|||+|+.....
T Consensus 88 v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~---iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~ 164 (317)
T d1xkka_ 88 ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE 164 (317)
T ss_dssp EEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCCSHHHHTTTT
T ss_pred EEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcC---cccCcchhhcceeCCCCCeEeeccccceecccc
Confidence 89999999999999888889999999999999999999999986 999999999999999999999999999876543
Q ss_pred Ccc-eeeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHh-CCCCCCccchhhHHHHHHHHHhcCccccccccCCC
Q 004400 570 NTH-ISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVS-GRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPG 647 (756)
Q Consensus 570 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 647 (756)
... ......||+.|+|||++.++.++.++|||||||++|||+| |+.||.......+.... ..+.....
T Consensus 165 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i----~~~~~~~~------ 234 (317)
T d1xkka_ 165 EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL----EKGERLPQ------ 234 (317)
T ss_dssp CC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHH----HHTCCCCC------
T ss_pred cccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHH----HcCCCCCC------
Confidence 332 2334568999999999999999999999999999999999 78888665443332211 11221111
Q ss_pred CCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhccC
Q 004400 648 SNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLECG 686 (756)
Q Consensus 648 ~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~L~~~ 686 (756)
+...+..+.+++.+||+.||++|||+.||++.|+..
T Consensus 235 ---p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~ 270 (317)
T d1xkka_ 235 ---PPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 270 (317)
T ss_dssp ---CTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ---CcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHH
Confidence 112223488999999999999999999999998754
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-47 Score=402.28 Aligned_cols=248 Identities=26% Similarity=0.332 Sum_probs=209.1
Q ss_pred hcCccccCcccCCCCccEEEee-ccCCcEEEEEEcccc---CcccHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEE
Q 004400 415 TNNFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSK---SKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLI 490 (756)
Q Consensus 415 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 490 (756)
.++|+..+.||+|+||+||+|+ ..+|+.||||++.+. .....+.+.+|+.+|++++|||||++++++.+++..|+|
T Consensus 4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv 83 (337)
T d1o6la_ 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccc
Confidence 3679999999999999999999 468999999999753 233457789999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCcccC
Q 004400 491 YEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEEN 570 (756)
Q Consensus 491 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~~~ 570 (756)
||||++|+|.+++...+ .+++..++.++.||+.||+|||+++ ||||||||+|||++.+|.+||+|||+|+......
T Consensus 84 ~ey~~gg~L~~~~~~~~-~~~e~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~ 159 (337)
T d1o6la_ 84 MEYANGGELFFHLSRER-VFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG 159 (337)
T ss_dssp EECCTTCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTT
T ss_pred eeccCCCchhhhhhccc-CCcHHHHHHHHHHHhhhhhhhhhcC---ccccccCHHHeEecCCCCEEEeecccccccccCC
Confidence 99999999999987654 7899999999999999999999997 9999999999999999999999999998654332
Q ss_pred cceeeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhcCccccccccCCCCCC
Q 004400 571 THISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNF 650 (756)
Q Consensus 571 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 650 (756)
. .....+||+.|+|||++.+..|+.++||||+||++|||++|+.||...+...+.... .. ... . ....+
T Consensus 160 ~-~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i---~~-~~~-~-----~p~~~ 228 (337)
T d1o6la_ 160 A-TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELI---LM-EEI-R-----FPRTL 228 (337)
T ss_dssp C-CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH---HH-CCC-C-----CCTTS
T ss_pred c-ccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHH---hc-CCC-C-----CCccC
Confidence 2 234578999999999999999999999999999999999999999877655443221 11 111 1 11223
Q ss_pred CHHHHHHHHHHHHHhhcCCCCCCCC-----HHHHHH
Q 004400 651 DKEQVMVMINVALLCANASPTIRPS-----MSSVLR 681 (756)
Q Consensus 651 ~~~~~~~l~~l~~~c~~~~P~~RPt-----~~ev~~ 681 (756)
++ .+.+++.+|++.||.+||+ +.|+++
T Consensus 229 s~----~~~dli~~~L~~dP~~R~~~~~~~~~eil~ 260 (337)
T d1o6la_ 229 SP----EAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp CH----HHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred CH----HHHHHHHhhccCCchhhcccccccHHHHHc
Confidence 33 4789999999999999995 777765
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=3.1e-47 Score=399.03 Aligned_cols=245 Identities=24% Similarity=0.375 Sum_probs=206.7
Q ss_pred cCccccCcccCCCCccEEEeec-cCCcEEEEEEcccc---CcccHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEE
Q 004400 416 NNFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSK---SKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIY 491 (756)
Q Consensus 416 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 491 (756)
++|+..+.||+|+||+||+|+. .+|+.||||+++.. .....+.+.+|+.++++++|||||++++++.+++..|+||
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 83 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 83 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence 5789999999999999999995 67999999998653 2334577899999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCcccCc
Q 004400 492 EYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENT 571 (756)
Q Consensus 492 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~~~~ 571 (756)
|||+||+|..++... ..+++..+..++.||+.||+|||++| ||||||||+|||++.++.+||+|||+|+.....
T Consensus 84 E~~~gg~l~~~~~~~-~~~~~~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~-- 157 (316)
T d1fota_ 84 DYIEGGELFSLLRKS-QRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPDV-- 157 (316)
T ss_dssp CCCCSCBHHHHHHHT-SSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSSC--
T ss_pred eecCCcccccccccc-ccccccHHHHHHHHHHHhhhhhccCc---EEccccCchheeEcCCCCEEEecCccceEeccc--
Confidence 999999999988654 47899999999999999999999997 999999999999999999999999999876543
Q ss_pred ceeeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhcCccccccccCCCCCCC
Q 004400 572 HISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFD 651 (756)
Q Consensus 572 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 651 (756)
....+||+.|+|||++.+..++.++||||+||++|||++|+.||...+........ ...... .....+
T Consensus 158 --~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i--~~~~~~--------~p~~~s 225 (316)
T d1fota_ 158 --TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKI--LNAELR--------FPPFFN 225 (316)
T ss_dssp --BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH--HHCCCC--------CCTTSC
T ss_pred --cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHH--HcCCCC--------CCCCCC
Confidence 23468999999999999999999999999999999999999999876654433211 111111 111233
Q ss_pred HHHHHHHHHHHHHhhcCCCCCCC-----CHHHHHHH
Q 004400 652 KEQVMVMINVALLCANASPTIRP-----SMSSVLRM 682 (756)
Q Consensus 652 ~~~~~~l~~l~~~c~~~~P~~RP-----t~~ev~~~ 682 (756)
..+.+++.+|++.||.+|+ |++++++.
T Consensus 226 ----~~~~~li~~~L~~dp~~R~~~~r~t~~~il~H 257 (316)
T d1fota_ 226 ----EDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH 257 (316)
T ss_dssp ----HHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred ----HHHHHHHHHHhhhCHHhccccchhhHHHHHcC
Confidence 3488999999999999996 88998763
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-47 Score=398.94 Aligned_cols=253 Identities=26% Similarity=0.413 Sum_probs=203.8
Q ss_pred cCcccCCCCccEEEeeccCC----cEEEEEEcccc-CcccHHHHHHHHHHHHhCCCCceeeEeeEEEe-CCeEEEEEEec
Q 004400 421 DNNIGEGGFGPVYKGLLADG----TAIAVKQLSSK-SKQGNREFINEIGMISALQHPNLVKLYGCCIE-GNQLLLIYEYL 494 (756)
Q Consensus 421 ~~~lg~G~~g~Vy~~~~~~~----~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~lV~e~~ 494 (756)
.++||+|+||+||+|++.++ ..||||+++.. .....++|.+|++++++++|||||+++|+|.+ ++..++|||||
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~ 111 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 111 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence 46899999999999996432 26899998753 44455789999999999999999999999876 46899999999
Q ss_pred CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCcccCcc--
Q 004400 495 ENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTH-- 572 (756)
Q Consensus 495 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~~~~~-- 572 (756)
++|+|.+++......+++..+.+++.|+|+||.|||+.+ |+||||||+|||+++++.+||+|||+++........
T Consensus 112 ~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~---iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~~ 188 (311)
T d1r0pa_ 112 KHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSV 188 (311)
T ss_dssp TTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCCCT
T ss_pred ecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccC---cccCCccHHhEeECCCCCEEEecccchhhccccccccc
Confidence 999999999877778899999999999999999999986 999999999999999999999999999876543222
Q ss_pred -eeeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhcCccccccccCCCCCCC
Q 004400 573 -ISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFD 651 (756)
Q Consensus 573 -~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 651 (756)
......||+.|+|||.+.++.++.++||||||+++|||+||+.||..... ..++...+.. +...... ...+
T Consensus 189 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~--~~~~~~~i~~-g~~~~~p-----~~~~ 260 (311)
T d1r0pa_ 189 HNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVN--TFDITVYLLQ-GRRLLQP-----EYCP 260 (311)
T ss_dssp TCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC--------CHHHHHT-TCCCCCC-----TTCC
T ss_pred eecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCC--HHHHHHHHHc-CCCCCCc-----ccCc
Confidence 23345789999999999999999999999999999999998888754321 1112222222 2211111 1222
Q ss_pred HHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhccCcc
Q 004400 652 KEQVMVMINVALLCANASPTIRPSMSSVLRMLECGVD 688 (756)
Q Consensus 652 ~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~L~~~~~ 688 (756)
..+.+++.+||+.||++||+|.||++.|+.+..
T Consensus 261 ----~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~ 293 (311)
T d1r0pa_ 261 ----DPLYEVMLKCWHPKAEMRPSFSELVSRISAIFS 293 (311)
T ss_dssp ----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ----HHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 348899999999999999999999999987643
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.9e-47 Score=396.42 Aligned_cols=252 Identities=17% Similarity=0.253 Sum_probs=208.5
Q ss_pred hcCccccCcccCCCCccEEEeec-cCCcEEEEEEccccCcccHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEEe
Q 004400 415 TNNFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYEY 493 (756)
Q Consensus 415 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 493 (756)
.++|.+.+.||+|+||+||+|+. .+++.||||.++... .....+.+|+++|+.++|||||++++++.+++..|+||||
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~-~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~ 82 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc-ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEec
Confidence 36789999999999999999995 578899999997643 3345688999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCC--CCEEEccCCccccCcccCc
Q 004400 494 LENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKD--LNSKISDFGLAKLDEEENT 571 (756)
Q Consensus 494 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~--~~~kl~DFGla~~~~~~~~ 571 (756)
|+||+|.+++......+++.++..++.||+.||+|||+.| |+||||||+|||++.+ ..+||+|||+++.......
T Consensus 83 ~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~---iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~~ 159 (321)
T d1tkia_ 83 ISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN 159 (321)
T ss_dssp CCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCE
T ss_pred CCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcC---CCcccccccceeecCCCceEEEEcccchhhccccCCc
Confidence 9999999999876668999999999999999999999997 9999999999999854 5799999999986544322
Q ss_pred ceeeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhcCccccccccCCCCCCC
Q 004400 572 HISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFD 651 (756)
Q Consensus 572 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 651 (756)
.....||+.|+|||...+..++.++||||+||++|||++|+.||...+........ ........... ...++
T Consensus 160 --~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i--~~~~~~~~~~~----~~~~s 231 (321)
T d1tkia_ 160 --FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENI--MNAEYTFDEEA----FKEIS 231 (321)
T ss_dssp --EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH--HHTCCCCCHHH----HTTSC
T ss_pred --ccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHH--HhCCCCCChhh----ccCCC
Confidence 34467899999999999999999999999999999999999999776654433211 11111111100 01122
Q ss_pred HHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004400 652 KEQVMVMINVALLCANASPTIRPSMSSVLRM 682 (756)
Q Consensus 652 ~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~ 682 (756)
..+.+++.+|++.||++|||+.|+++.
T Consensus 232 ----~~~~~li~~~L~~dp~~R~s~~eil~h 258 (321)
T d1tkia_ 232 ----IEAMDFVDRLLVKERKSRMTASEALQH 258 (321)
T ss_dssp ----HHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred ----HHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 348899999999999999999999873
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=5.5e-47 Score=391.27 Aligned_cols=258 Identities=21% Similarity=0.300 Sum_probs=202.4
Q ss_pred hcCccccCcccCCCCccEEEee-ccCCcEEEEEEccccC---cccHHHHHHHHHHHHhCCCCceeeEeeEEEeCC----e
Q 004400 415 TNNFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSKS---KQGNREFINEIGMISALQHPNLVKLYGCCIEGN----Q 486 (756)
Q Consensus 415 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~ 486 (756)
.++|+..+.||+|+||+||+|+ ..+|+.||||+++... ....+.|.+|+++++.++|||||++++++...+ .
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~ 85 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 85 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence 3579999999999999999999 4689999999997542 233457899999999999999999999998653 4
Q ss_pred EEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccC
Q 004400 487 LLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLD 566 (756)
Q Consensus 487 ~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~ 566 (756)
.|+|||||+||+|.+++... ..+++.++..++.||+.||+|||++| ||||||||+|||++.++.++|+|||.++..
T Consensus 86 ~~lvmE~~~g~~L~~~~~~~-~~l~~~~~~~i~~qi~~al~~lH~~~---iiHrDiKP~NIll~~~~~~~l~d~~~~~~~ 161 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDIVHTE-GPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAI 161 (277)
T ss_dssp EEEEEECCCEEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTSCEEECCCTTCEEC
T ss_pred EEEEEECCCCCEehhhhccc-CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCccccCcccccCccccceeehhhhhhhh
Confidence 89999999999999988655 47999999999999999999999997 999999999999999999999999998754
Q ss_pred cccCc--ceeeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhcCcccccccc
Q 004400 567 EEENT--HISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDT 644 (756)
Q Consensus 567 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 644 (756)
..... ......+||+.|+|||++.+..++.++||||+||++|||+||+.||...+....... ......... .
T Consensus 162 ~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~---~~~~~~~~~---~ 235 (277)
T d1o6ya_ 162 ADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQ---HVREDPIPP---S 235 (277)
T ss_dssp C----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH---HHHCCCCCG---G
T ss_pred ccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHH---HHhcCCCCC---c
Confidence 43222 234456899999999999999999999999999999999999999977655433221 111111110 0
Q ss_pred CCCCCCCHHHHHHHHHHHHHhhcCCCCCCC-CHHHHHHHhccC
Q 004400 645 NPGSNFDKEQVMVMINVALLCANASPTIRP-SMSSVLRMLECG 686 (756)
Q Consensus 645 ~~~~~~~~~~~~~l~~l~~~c~~~~P~~RP-t~~ev~~~L~~~ 686 (756)
......+ ..+.+++.+|++.||.+|| |++++.+.|.++
T Consensus 236 ~~~~~~s----~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~ 274 (277)
T d1o6ya_ 236 ARHEGLS----ADLDAVVLKALAKNPENRYQTAAEMRADLVRV 274 (277)
T ss_dssp GTSSSCC----HHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred hhccCCC----HHHHHHHHHHccCCHhHCHhHHHHHHHHHHHH
Confidence 1112233 3488999999999999999 899998887653
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=7.7e-47 Score=388.35 Aligned_cols=251 Identities=20% Similarity=0.345 Sum_probs=205.8
Q ss_pred cCccccCcccCCCCccEEEeec-cCCcEEEEEEccccCcc---------cHHHHHHHHHHHHhCC-CCceeeEeeEEEeC
Q 004400 416 NNFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSKSKQ---------GNREFINEIGMISALQ-HPNLVKLYGCCIEG 484 (756)
Q Consensus 416 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~---------~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~ 484 (756)
++|+..+.||+|+||+||+|+. .+|+.||||++...... ..+.+.+|+.++++++ |||||++++++.++
T Consensus 3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 82 (277)
T d1phka_ 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN 82 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence 5899999999999999999994 67999999998654211 1245889999999997 99999999999999
Q ss_pred CeEEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccc
Q 004400 485 NQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAK 564 (756)
Q Consensus 485 ~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~ 564 (756)
+..|+|||||++|+|.+++.... .+++..+..++.||+.||+|||++| |+||||||+|||++.++.+||+|||+++
T Consensus 83 ~~~~ivmE~~~~g~L~~~l~~~~-~l~e~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~a~ 158 (277)
T d1phka_ 83 TFFFLVFDLMKKGELFDYLTEKV-TLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGFSC 158 (277)
T ss_dssp SEEEEEEECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred cceEEEEEcCCCchHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcC---CcccccccceEEEcCCCCeEEccchhee
Confidence 99999999999999999997654 7999999999999999999999997 9999999999999999999999999998
Q ss_pred cCcccCcceeeccccCccCCchHhhhc------CCCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhcCcc
Q 004400 565 LDEEENTHISTRVAGTIGYMAPEYAMR------GHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKL 638 (756)
Q Consensus 565 ~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 638 (756)
....... .....||+.|+|||++.+ ..++.++||||+||++|||++|+.||...+....... ........
T Consensus 159 ~~~~~~~--~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~--i~~~~~~~ 234 (277)
T d1phka_ 159 QLDPGEK--LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRM--IMSGNYQF 234 (277)
T ss_dssp ECCTTCC--BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH--HHHTCCCC
T ss_pred EccCCCc--eeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHH--HHhCCCCC
Confidence 7654332 344679999999999864 3468899999999999999999999987665433221 11111111
Q ss_pred ccccccCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004400 639 MELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRM 682 (756)
Q Consensus 639 ~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~ 682 (756)
.......++ ..+.+++.+||+.||++|||+.||++.
T Consensus 235 ----~~~~~~~~s----~~~~~li~~~L~~~p~~R~s~~eil~h 270 (277)
T d1phka_ 235 ----GSPEWDDYS----DTVKDLVSRFLVVQPQKRYTAEEALAH 270 (277)
T ss_dssp ----CTTTGGGSC----HHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred ----CCcccccCC----HHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 010111233 348899999999999999999998653
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-47 Score=399.19 Aligned_cols=254 Identities=30% Similarity=0.427 Sum_probs=204.5
Q ss_pred cCccccCcccCCCCccEEEeecc-CCc--EEEEEEcccc-CcccHHHHHHHHHHHHhC-CCCceeeEeeEEEeCCeEEEE
Q 004400 416 NNFATDNNIGEGGFGPVYKGLLA-DGT--AIAVKQLSSK-SKQGNREFINEIGMISAL-QHPNLVKLYGCCIEGNQLLLI 490 (756)
Q Consensus 416 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~--~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV 490 (756)
++|+..+.||+|+||+||+|++. +|. .||||++... .....+.|.+|+++|+++ +|||||+++++|.+++..++|
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV 89 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 89 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence 67888899999999999999965 444 5788887543 334556799999999998 799999999999999999999
Q ss_pred EEecCCCCHHHHHHhc---------------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCE
Q 004400 491 YEYLENNSLARALFEH---------------RLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNS 555 (756)
Q Consensus 491 ~e~~~~gsL~~~l~~~---------------~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~ 555 (756)
|||+++|+|.++++.. ...+++..+.+++.|||+||+|||+.+ |+||||||+|||++.++.+
T Consensus 90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~---iiHrDlkp~NIL~~~~~~~ 166 (309)
T d1fvra_ 90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA 166 (309)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCE
T ss_pred EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCC---ccccccccceEEEcCCCce
Confidence 9999999999999743 357999999999999999999999986 9999999999999999999
Q ss_pred EEccCCccccCcccCcceeeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHhCCC-CCCccchhhHHHHHHHHHh
Q 004400 556 KISDFGLAKLDEEENTHISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRS-NVTKEDMFYLLDWALVLKE 634 (756)
Q Consensus 556 kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~-p~~~~~~~~~~~~~~~~~~ 634 (756)
||+|||+|+....... .....||..|+|||.+.++.++.++|||||||++|||++|.. ||...+........ .
T Consensus 167 kl~DfG~a~~~~~~~~--~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~i----~ 240 (309)
T d1fvra_ 167 KIADFGLSRGQEVYVK--KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKL----P 240 (309)
T ss_dssp EECCTTCEESSCEECC--C----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHG----G
T ss_pred EEcccccccccccccc--ccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHHHHHHH----H
Confidence 9999999986543322 234568999999999999999999999999999999999765 56655544433221 1
Q ss_pred cCccccccccCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhccCc
Q 004400 635 QGKLMELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLECGV 687 (756)
Q Consensus 635 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~L~~~~ 687 (756)
.+.... ..... ...+.+++.+||+.||++||||+||++.|+++.
T Consensus 241 ~~~~~~-----~~~~~----~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~ 284 (309)
T d1fvra_ 241 QGYRLE-----KPLNC----DDEVYDLMRQCWREKPYERPSFAQILVSLNRML 284 (309)
T ss_dssp GTCCCC-----CCTTB----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred hcCCCC-----CCccC----CHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 111111 11122 335889999999999999999999999998654
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-47 Score=396.58 Aligned_cols=257 Identities=29% Similarity=0.434 Sum_probs=206.8
Q ss_pred hcCccccCcccCCCCccEEEeeccC--------CcEEEEEEccccCc-ccHHHHHHHHHHHHhC-CCCceeeEeeEEEeC
Q 004400 415 TNNFATDNNIGEGGFGPVYKGLLAD--------GTAIAVKQLSSKSK-QGNREFINEIGMISAL-QHPNLVKLYGCCIEG 484 (756)
Q Consensus 415 ~~~~~~~~~lg~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 484 (756)
.++|...+.||+|+||.||+|+... +..||||+++.... ....++.+|+..+.++ +|||||+++++|.++
T Consensus 12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~ 91 (299)
T d1fgka_ 12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 91 (299)
T ss_dssp GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccC
Confidence 3578888999999999999998432 34799999976533 3457789999999888 899999999999999
Q ss_pred CeEEEEEEecCCCCHHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEe
Q 004400 485 NQLLLIYEYLENNSLARALFEHR---------------LKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLL 549 (756)
Q Consensus 485 ~~~~lV~e~~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill 549 (756)
+..++|||||++|+|.+++.... ..+++.++.+++.|||.||+|||+.+ ||||||||+|||+
T Consensus 92 ~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~---ivHrDiKp~NiLl 168 (299)
T d1fgka_ 92 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLV 168 (299)
T ss_dssp SSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEE
T ss_pred CeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCC---EEeeeecccceee
Confidence 99999999999999999997443 45899999999999999999999996 9999999999999
Q ss_pred cCCCCEEEccCCccccCcccCcc-eeeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHh-CCCCCCccchhhHHH
Q 004400 550 DKDLNSKISDFGLAKLDEEENTH-ISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVS-GRSNVTKEDMFYLLD 627 (756)
Q Consensus 550 ~~~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~~ 627 (756)
+.++.+||+|||+++........ ......||+.|+|||.+.++.|+.++|||||||++|||++ |+.||..........
T Consensus 169 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~~~~ 248 (299)
T d1fgka_ 169 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFK 248 (299)
T ss_dssp CTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHH
T ss_pred cCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHHHHHH
Confidence 99999999999999876554332 2345678999999999999999999999999999999998 677886555443332
Q ss_pred HHHHHHhcCccccccccCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhccCc
Q 004400 628 WALVLKEQGKLMELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLECGV 687 (756)
Q Consensus 628 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~L~~~~ 687 (756)
.. ..+..... ...++ ..+.+++.+||+.||++|||+.||++.|+.+.
T Consensus 249 ~i----~~~~~~~~-----p~~~~----~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~ 295 (299)
T d1fgka_ 249 LL----KEGHRMDK-----PSNCT----NELYMMMRDCWHAVPSQRPTFKQLVEDLDRIV 295 (299)
T ss_dssp HH----HTTCCCCC-----CSSCC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HH----HcCCCCCC-----Cccch----HHHHHHHHHHccCCHhHCcCHHHHHHHHHHHh
Confidence 21 12222111 12233 34889999999999999999999999998653
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.4e-46 Score=397.75 Aligned_cols=244 Identities=22% Similarity=0.331 Sum_probs=206.9
Q ss_pred cCccccCcccCCCCccEEEeec-cCCcEEEEEEcccc---CcccHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEE
Q 004400 416 NNFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSK---SKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIY 491 (756)
Q Consensus 416 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 491 (756)
++|+..+.||+|+||.||+|+. .+|+.||||++... .....+.+.+|+++|+.++|||||++++++.+....++||
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~ 120 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence 5799999999999999999995 57999999998643 2234567899999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCcccCc
Q 004400 492 EYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENT 571 (756)
Q Consensus 492 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~~~~ 571 (756)
||+.+|+|.+++.... .+++..+..++.||+.||+|||+++ ||||||||+|||++.++.+||+|||+|+.....
T Consensus 121 e~~~~g~l~~~l~~~~-~l~e~~~~~i~~qi~~aL~yLH~~~---iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~-- 194 (350)
T d1rdqe_ 121 EYVAGGEMFSHLRRIG-RFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-- 194 (350)
T ss_dssp ECCTTCBHHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSSC--
T ss_pred ccccccchhhhHhhcC-CCCHHHHHHHHHHHHHHHHHHHhCC---EecCcCCHHHcccCCCCCEEeeeceeeeecccc--
Confidence 9999999999997554 7999999999999999999999996 999999999999999999999999999876532
Q ss_pred ceeeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhcCccccccccCCCCCCC
Q 004400 572 HISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFD 651 (756)
Q Consensus 572 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 651 (756)
.....||+.|||||++.+..++.++|||||||++|||+||+.||.+.+........ .. ... .....++
T Consensus 195 --~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i---~~-~~~------~~p~~~s 262 (350)
T d1rdqe_ 195 --TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKI---VS-GKV------RFPSHFS 262 (350)
T ss_dssp --BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH---HH-CCC------CCCTTCC
T ss_pred --cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHH---hc-CCC------CCCccCC
Confidence 23467999999999999999999999999999999999999999876654433221 11 110 1112233
Q ss_pred HHHHHHHHHHHHHhhcCCCCCCC-----CHHHHHH
Q 004400 652 KEQVMVMINVALLCANASPTIRP-----SMSSVLR 681 (756)
Q Consensus 652 ~~~~~~l~~l~~~c~~~~P~~RP-----t~~ev~~ 681 (756)
+ .+.+++.+|++.||.+|+ |++|+++
T Consensus 263 ~----~~~~li~~~L~~dP~kR~~~~r~t~~ell~ 293 (350)
T d1rdqe_ 263 S----DLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp H----HHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred H----HHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence 3 488999999999999994 8888875
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-47 Score=398.98 Aligned_cols=256 Identities=25% Similarity=0.360 Sum_probs=197.3
Q ss_pred cCccccCcccCCCCccEEEeecc------CCcEEEEEEcccc-CcccHHHHHHHHHHHHhC-CCCceeeEeeEEEeC-Ce
Q 004400 416 NNFATDNNIGEGGFGPVYKGLLA------DGTAIAVKQLSSK-SKQGNREFINEIGMISAL-QHPNLVKLYGCCIEG-NQ 486 (756)
Q Consensus 416 ~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~-~~ 486 (756)
++|+..+.||+|+||.||+|++. +++.||||.++.. .....+.+.+|..++.++ +|+|||.+++++.++ ..
T Consensus 13 ~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~ 92 (299)
T d1ywna1 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP 92 (299)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSC
T ss_pred HHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCCe
Confidence 57899999999999999999843 3468999999754 333456788888888877 689999999998765 46
Q ss_pred EEEEEEecCCCCHHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecC
Q 004400 487 LLLIYEYLENNSLARALFEHR---------------LKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDK 551 (756)
Q Consensus 487 ~~lV~e~~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~ 551 (756)
.++|||||++|+|.+++.... ..+++..+..++.|||+||+|||+++ ||||||||+|||+++
T Consensus 93 ~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---ivHrDlKp~NILl~~ 169 (299)
T d1ywna1 93 LMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSE 169 (299)
T ss_dssp CEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECG
T ss_pred EEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCC---CcCCcCCccceeECC
Confidence 899999999999999997432 35899999999999999999999986 999999999999999
Q ss_pred CCCEEEccCCccccCcccCcc-eeeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHhCC-CCCCccchhhHHHHH
Q 004400 552 DLNSKISDFGLAKLDEEENTH-ISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGR-SNVTKEDMFYLLDWA 629 (756)
Q Consensus 552 ~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~-~p~~~~~~~~~~~~~ 629 (756)
++.+||+|||+|+........ ......||+.|+|||++.+..++.++|||||||++|||+||. .||..........
T Consensus 170 ~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~~~-- 247 (299)
T d1ywna1 170 KNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC-- 247 (299)
T ss_dssp GGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHH--
T ss_pred CCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHHHHHH--
Confidence 999999999999865543332 234567999999999999999999999999999999999975 5665443222111
Q ss_pred HHHHhcCccccccccCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhccC
Q 004400 630 LVLKEQGKLMELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLECG 686 (756)
Q Consensus 630 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~L~~~ 686 (756)
.....+...... ...+ ..+.+++.+||+.||++|||+.||++.|+.+
T Consensus 248 -~~~~~~~~~~~~-----~~~~----~~l~~li~~cl~~dP~~Rpt~~eil~~L~~i 294 (299)
T d1ywna1 248 -RRLKEGTRMRAP-----DYTT----PEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 294 (299)
T ss_dssp -HHHHHTCCCCCC-----TTCC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -HHHhcCCCCCCC-----ccCC----HHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 111222222211 1223 3488999999999999999999999999854
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.9e-47 Score=396.02 Aligned_cols=258 Identities=25% Similarity=0.426 Sum_probs=211.1
Q ss_pred hcCccccCcccCCCCccEEEeecc------CCcEEEEEEcccc-CcccHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeE
Q 004400 415 TNNFATDNNIGEGGFGPVYKGLLA------DGTAIAVKQLSSK-SKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQL 487 (756)
Q Consensus 415 ~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 487 (756)
.++|...+.||+|+||+||+|.+. +++.||||+++.. .......|.+|++++++++|||||+++++|..++..
T Consensus 19 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~ 98 (308)
T d1p4oa_ 19 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPT 98 (308)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSC
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCce
Confidence 367888899999999999999853 3578999999754 333345689999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHHHhc---------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEc
Q 004400 488 LLIYEYLENNSLARALFEH---------RLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKIS 558 (756)
Q Consensus 488 ~lV~e~~~~gsL~~~l~~~---------~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~ 558 (756)
++|||||++|+|.+++... ...+++..+.+++.|+|+||.|||+++ |+||||||+|||+++++.+||+
T Consensus 99 ~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~---ivHrDlk~~NiLld~~~~~Kl~ 175 (308)
T d1p4oa_ 99 LVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIG 175 (308)
T ss_dssp EEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTTCCEEEC
T ss_pred eEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeeceEcCCceeecCCceEEEe
Confidence 9999999999999998632 135799999999999999999999986 9999999999999999999999
Q ss_pred cCCccccCcccCcce-eeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHhCC-CCCCccchhhHHHHHHHHHhcC
Q 004400 559 DFGLAKLDEEENTHI-STRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGR-SNVTKEDMFYLLDWALVLKEQG 636 (756)
Q Consensus 559 DFGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~-~p~~~~~~~~~~~~~~~~~~~~ 636 (756)
|||+|+......... .....||+.|+|||.+.+..++.++|||||||++|||+||+ .||...+....... + ..+
T Consensus 176 DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~---i-~~~ 251 (308)
T d1p4oa_ 176 DFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRF---V-MEG 251 (308)
T ss_dssp CTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHH---H-HTT
T ss_pred ecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHHHHH---H-HhC
Confidence 999998765443322 34457899999999999999999999999999999999985 66655544433321 1 122
Q ss_pred ccccccccCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhccCcc
Q 004400 637 KLMELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLECGVD 688 (756)
Q Consensus 637 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~L~~~~~ 688 (756)
...... ..++ ..+.+++.+||+.+|++||||.+|++.|++..+
T Consensus 252 ~~~~~p-----~~~~----~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~ 294 (308)
T d1p4oa_ 252 GLLDKP-----DNCP----DMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 294 (308)
T ss_dssp CCCCCC-----TTCC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred CCCCCc-----ccch----HHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 222211 1223 348899999999999999999999999986533
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-47 Score=398.59 Aligned_cols=257 Identities=27% Similarity=0.419 Sum_probs=208.8
Q ss_pred hcCccccCcccCCCCccEEEeec------cCCcEEEEEEccccC-cccHHHHHHHHHHHHhC-CCCceeeEeeEEEeCCe
Q 004400 415 TNNFATDNNIGEGGFGPVYKGLL------ADGTAIAVKQLSSKS-KQGNREFINEIGMISAL-QHPNLVKLYGCCIEGNQ 486 (756)
Q Consensus 415 ~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~ 486 (756)
.++|+..+.||+|+||.||+|++ .+++.||||+++... ......|.+|+.+++++ +|||||+++++|.+++.
T Consensus 22 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~ 101 (311)
T d1t46a_ 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP 101 (311)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCE
Confidence 35788889999999999999974 346789999997643 33445789999999999 69999999999999999
Q ss_pred EEEEEEecCCCCHHHHHHhcC-----------------CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEe
Q 004400 487 LLLIYEYLENNSLARALFEHR-----------------LKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLL 549 (756)
Q Consensus 487 ~~lV~e~~~~gsL~~~l~~~~-----------------~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill 549 (756)
.++|||||++|+|.++++... ..+++..+..++.|||+||+|||+++ ||||||||+||++
T Consensus 102 ~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~---ivHrDLKp~NIl~ 178 (311)
T d1t46a_ 102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILL 178 (311)
T ss_dssp CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEE
T ss_pred EEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccccccccc
Confidence 999999999999999997532 25899999999999999999999996 9999999999999
Q ss_pred cCCCCEEEccCCccccCcccCc-ceeeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHhCCCC-CCccchhhHHH
Q 004400 550 DKDLNSKISDFGLAKLDEEENT-HISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSN-VTKEDMFYLLD 627 (756)
Q Consensus 550 ~~~~~~kl~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p-~~~~~~~~~~~ 627 (756)
+.++.+|++|||+++....... .......||+.|+|||++.++.++.++|||||||++|||+|++.| +..........
T Consensus 179 ~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~~~ 258 (311)
T d1t46a_ 179 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFY 258 (311)
T ss_dssp ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHH
T ss_pred cccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence 9999999999999997665433 334457899999999999999999999999999999999995554 44433222111
Q ss_pred HHHHHHhcCccccccccCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhccC
Q 004400 628 WALVLKEQGKLMELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLECG 686 (756)
Q Consensus 628 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~L~~~ 686 (756)
.....+..... ....+ ..+.+++.+||+.||++||||.||+++|++.
T Consensus 259 ---~~i~~~~~~~~-----~~~~~----~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~ 305 (311)
T d1t46a_ 259 ---KMIKEGFRMLS-----PEHAP----AEMYDIMKTCWDADPLKRPTFKQIVQLIEKQ 305 (311)
T ss_dssp ---HHHHHTCCCCC-----CTTSC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ---HHHhcCCCCCC-----ccccc----HHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence 11112211111 11222 3488999999999999999999999999854
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=3.6e-46 Score=398.59 Aligned_cols=248 Identities=26% Similarity=0.333 Sum_probs=198.7
Q ss_pred cCccccCcccCCCCccEEEeec-cCCcEEEEEEccccC---cccHHHHHHH---HHHHHhCCCCceeeEeeEEEeCCeEE
Q 004400 416 NNFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSKS---KQGNREFINE---IGMISALQHPNLVKLYGCCIEGNQLL 488 (756)
Q Consensus 416 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E---~~~l~~l~h~niv~l~~~~~~~~~~~ 488 (756)
++|+..+.||+|+||.||+|+. .+|+.||||++.... ......+.+| +++++.++|||||+++++|.+++..|
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~ 83 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 83 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEE
Confidence 5899999999999999999994 579999999986431 2223334444 66777788999999999999999999
Q ss_pred EEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCcc
Q 004400 489 LIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEE 568 (756)
Q Consensus 489 lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~ 568 (756)
+|||||++|+|.+++... ..+++..+..++.||+.||+|||+++ ||||||||+|||++.++.+||+|||+|+....
T Consensus 84 ivmE~~~gg~L~~~l~~~-~~~~e~~~~~~~~qi~~aL~ylH~~~---iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~ 159 (364)
T d1omwa3 84 FILDLMNGGDLHYHLSQH-GVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSK 159 (364)
T ss_dssp EEECCCCSCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSSSCEEECCCTTCEECSS
T ss_pred EEEEecCCCcHHHHHHhc-ccccHHHHHHHHHHHHHHHHHHHHCC---ccceeeccceeEEcCCCcEEEeeeceeeecCC
Confidence 999999999999999755 47899999999999999999999997 99999999999999999999999999986654
Q ss_pred cCcceeeccccCccCCchHhhhc-CCCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhcCccccccccCCC
Q 004400 569 ENTHISTRVAGTIGYMAPEYAMR-GHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPG 647 (756)
Q Consensus 569 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 647 (756)
.. .....||+.|+|||++.. ..++.++|||||||++|||+||+.||............ ...... .....
T Consensus 160 ~~---~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~---~~~~~~----~~~~~ 229 (364)
T d1omwa3 160 KK---PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID---RMTLTM----AVELP 229 (364)
T ss_dssp SC---CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHH---HHSSSC----CCCCC
T ss_pred Cc---ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHH---HhcccC----CCCCC
Confidence 32 234679999999999975 46899999999999999999999999654432221110 000000 00111
Q ss_pred CCCCHHHHHHHHHHHHHhhcCCCCCCCC-----HHHHHH
Q 004400 648 SNFDKEQVMVMINVALLCANASPTIRPS-----MSSVLR 681 (756)
Q Consensus 648 ~~~~~~~~~~l~~l~~~c~~~~P~~RPt-----~~ev~~ 681 (756)
..+++ .+.+++.+||+.||++||| ++|+++
T Consensus 230 ~~~s~----~~~~li~~~L~~dP~~R~t~~~~~a~eil~ 264 (364)
T d1omwa3 230 DSFSP----ELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 264 (364)
T ss_dssp SSSCH----HHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred CCCCH----HHHHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence 22333 4889999999999999999 578765
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-46 Score=392.65 Aligned_cols=247 Identities=24% Similarity=0.364 Sum_probs=204.5
Q ss_pred cCccccCcccCCCCccEEEeec-cCCcEEEEEEcccc---CcccHHHHHHHHHHHH-hCCCCceeeEeeEEEeCCeEEEE
Q 004400 416 NNFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSK---SKQGNREFINEIGMIS-ALQHPNLVKLYGCCIEGNQLLLI 490 (756)
Q Consensus 416 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~-~l~h~niv~l~~~~~~~~~~~lV 490 (756)
++|+..+.||+|+||+||+|+. .+|+.||||++++. .....+.+..|..++. .++|||||++++++.+++..|+|
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 5789999999999999999994 57999999999653 2334456777877765 68999999999999999999999
Q ss_pred EEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCcccC
Q 004400 491 YEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEEN 570 (756)
Q Consensus 491 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~~~ 570 (756)
||||++|+|.+++... ..+++..+..++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+|+......
T Consensus 82 mEy~~~g~L~~~i~~~-~~~~e~~~~~~~~qi~~al~ylH~~~---iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~ 157 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQSC-HKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGD 157 (320)
T ss_dssp EECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT
T ss_pred EeecCCCcHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCcccceeecCCCceeccccchhhhccccc
Confidence 9999999999999754 47899999999999999999999997 9999999999999999999999999998654332
Q ss_pred cceeeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhcCccccccccCCCCCC
Q 004400 571 THISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNF 650 (756)
Q Consensus 571 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 650 (756)
. ......||+.|+|||++.+..++.++||||+||++|||++|+.||.+.+........ .. +.. ......
T Consensus 158 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i--~~--~~~------~~p~~~ 226 (320)
T d1xjda_ 158 A-KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSI--RM--DNP------FYPRWL 226 (320)
T ss_dssp C-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH--HH--CCC------CCCTTS
T ss_pred c-cccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHH--Hc--CCC------CCCccC
Confidence 2 234467999999999999999999999999999999999999999877654433211 11 110 111122
Q ss_pred CHHHHHHHHHHHHHhhcCCCCCCCCHH-HHHH
Q 004400 651 DKEQVMVMINVALLCANASPTIRPSMS-SVLR 681 (756)
Q Consensus 651 ~~~~~~~l~~l~~~c~~~~P~~RPt~~-ev~~ 681 (756)
+ ..+.+++.+||+.||++||++. |+++
T Consensus 227 s----~~~~dli~~~L~~dP~~R~s~~~~l~~ 254 (320)
T d1xjda_ 227 E----KEAKDLLVKLFVREPEKRLGVRGDIRQ 254 (320)
T ss_dssp C----HHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred C----HHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence 3 3488999999999999999985 6653
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-46 Score=392.51 Aligned_cols=262 Identities=27% Similarity=0.356 Sum_probs=197.8
Q ss_pred cCccccCcccCCCCccEEEeeccCCcEEEEEEccccCcccHHHHHHH--HHHHHhCCCCceeeEeeEEEeCC----eEEE
Q 004400 416 NNFATDNNIGEGGFGPVYKGLLADGTAIAVKQLSSKSKQGNREFINE--IGMISALQHPNLVKLYGCCIEGN----QLLL 489 (756)
Q Consensus 416 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E--~~~l~~l~h~niv~l~~~~~~~~----~~~l 489 (756)
++|...+.||+|+||.||+|++ +|+.||||.++.. ..+.+.+| +..+..++|||||+++++|.+++ ..++
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~---~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~l 78 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWL 78 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECcc---chhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEE
Confidence 4677788999999999999986 5889999998643 23444444 44556789999999999998654 6899
Q ss_pred EEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCC-----CCCeEcCCCCCCceEecCCCCEEEccCCccc
Q 004400 490 IYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGES-----RIKVVHRDIKATNVLLDKDLNSKISDFGLAK 564 (756)
Q Consensus 490 V~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g-----~~~iiH~Dikp~Nill~~~~~~kl~DFGla~ 564 (756)
|||||++|+|.+++++. .++|..+.+++.|+|.||+|||+.+ ..+||||||||+|||++.++.+||+|||+++
T Consensus 79 v~Ey~~~g~L~~~l~~~--~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~ 156 (303)
T d1vjya_ 79 VSDYHEHGSLFDYLNRY--TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV 156 (303)
T ss_dssp EEECCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred EEecccCCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCccc
Confidence 99999999999999764 6899999999999999999999741 2469999999999999999999999999998
Q ss_pred cCcccCcc---eeeccccCccCCchHhhhcCC------CCcccchhhHHHHHHHHHhCCCCCCccchhh-----------
Q 004400 565 LDEEENTH---ISTRVAGTIGYMAPEYAMRGH------LTEKADVYSFGIVALEIVSGRSNVTKEDMFY----------- 624 (756)
Q Consensus 565 ~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~------~~~~~Dv~slGv~l~elltg~~p~~~~~~~~----------- 624 (756)
........ ......||+.|+|||++.... ++.++|||||||++|||+||..|+.......
T Consensus 157 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~ 236 (303)
T d1vjya_ 157 RHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP 236 (303)
T ss_dssp EEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSC
T ss_pred cccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccc
Confidence 66543322 233567999999999987542 5778999999999999999988773322110
Q ss_pred HHHHHHHHHhcCccccccccCCCCCC-CHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhccCc
Q 004400 625 LLDWALVLKEQGKLMELVDTNPGSNF-DKEQVMVMINVALLCANASPTIRPSMSSVLRMLECGV 687 (756)
Q Consensus 625 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~L~~~~ 687 (756)
............ ...+.....+ +.+....+.+++.+||+.||++|||+.||++.|+++.
T Consensus 237 ~~~~~~~~~~~~----~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~ 296 (303)
T d1vjya_ 237 SVEEMRKVVCEQ----KLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLS 296 (303)
T ss_dssp CHHHHHHHHTTS----CCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHH
T ss_pred hHHHHHHHHhcc----ccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHH
Confidence 001111111111 1111111111 2345566889999999999999999999999998653
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9e-46 Score=386.23 Aligned_cols=263 Identities=25% Similarity=0.339 Sum_probs=202.9
Q ss_pred cCccccCcccCCCCccEEEee-ccCCcEEEEEEccccC--cccHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEE
Q 004400 416 NNFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSKS--KQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYE 492 (756)
Q Consensus 416 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 492 (756)
++|+..+.||+|+||+||+|+ ..+|+.||||+++... ....+.+.+|++++++++|||||++++++.+++..|+|||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence 589999999999999999999 4679999999996542 2335789999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCcccCcc
Q 004400 493 YLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTH 572 (756)
Q Consensus 493 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~~~~~ 572 (756)
|+.++.+..........+++..+..++.||+.||+|||++| ||||||||+|||++.++.+||+|||+|+.......
T Consensus 82 ~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~---IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~~- 157 (298)
T d1gz8a_ 82 FLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR- 157 (298)
T ss_dssp CCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCSB-
T ss_pred ecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCC---EEccccCchheeecccCcceeccCCcceeccCCcc-
Confidence 99876555444455667999999999999999999999997 99999999999999999999999999986543322
Q ss_pred eeeccccCccCCchHhhhcCC-CCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhcCc---ccc---ccccC
Q 004400 573 ISTRVAGTIGYMAPEYAMRGH-LTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGK---LME---LVDTN 645 (756)
Q Consensus 573 ~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~---~~~---~~~~~ 645 (756)
......||+.|+|||.+.... ++.++||||+||++|+|++|+.||...+................ ... ..+..
T Consensus 158 ~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 237 (298)
T d1gz8a_ 158 TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYK 237 (298)
T ss_dssp CTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCC
T ss_pred cceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhccccccccccc
Confidence 233457999999999987755 58899999999999999999999976654432221111111000 000 00000
Q ss_pred ---CC-CCCC-----HHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004400 646 ---PG-SNFD-----KEQVMVMINVALLCANASPTIRPSMSSVLRM 682 (756)
Q Consensus 646 ---~~-~~~~-----~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~ 682 (756)
+. .... ......+.+++.+|++.||++|||++|+++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H 283 (298)
T d1gz8a_ 238 PSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH 283 (298)
T ss_dssp TTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred cccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 00 0000 0112358899999999999999999999874
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-46 Score=395.50 Aligned_cols=252 Identities=19% Similarity=0.239 Sum_probs=198.2
Q ss_pred hcCcccc-CcccCCCCccEEEee-ccCCcEEEEEEccccCcccHHHHHHHHHHHHhC-CCCceeeEeeEEEe----CCeE
Q 004400 415 TNNFATD-NNIGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQGNREFINEIGMISAL-QHPNLVKLYGCCIE----GNQL 487 (756)
Q Consensus 415 ~~~~~~~-~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~----~~~~ 487 (756)
.++|.+. +.||+|+||+||+|+ ..+++.||||+++. ...+.+|++++.++ +|||||+++++|.+ +...
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~-----~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~ 84 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 84 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECC-----cHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEE
Confidence 3578776 469999999999999 46799999999853 25678899987654 89999999999976 4678
Q ss_pred EEEEEecCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecC---CCCEEEccCCcc
Q 004400 488 LLIYEYLENNSLARALFEH-RLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDK---DLNSKISDFGLA 563 (756)
Q Consensus 488 ~lV~e~~~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~---~~~~kl~DFGla 563 (756)
|+|||||+||+|.+++... ...+++..+..++.||+.||+|||+.| |+||||||+|||++. ++.+||+|||+|
T Consensus 85 ~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~---iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a 161 (335)
T d2ozaa1 85 LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFA 161 (335)
T ss_dssp EEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred EEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcC---Ccccccccccccccccccccccccccccee
Confidence 9999999999999999754 347999999999999999999999997 999999999999985 457999999999
Q ss_pred ccCcccCcceeeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhcCccccccc
Q 004400 564 KLDEEENTHISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVD 643 (756)
Q Consensus 564 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 643 (756)
+....... .....||+.|+|||++.+..|+.++|||||||++|||+||+.||.+.+......... .......
T Consensus 162 ~~~~~~~~--~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~---~~i~~~~--- 233 (335)
T d2ozaa1 162 KETTSHNS--LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMK---TRIRMGQ--- 233 (335)
T ss_dssp EECCCCCC--CCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC-----------CCCSCS---
T ss_pred eeccCCCc--cccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHH---HHHhcCC---
Confidence 86654332 244679999999999999999999999999999999999999996554322221110 0000000
Q ss_pred cCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004400 644 TNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRM 682 (756)
Q Consensus 644 ~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~ 682 (756)
..............+.+++.+|++.||++|||+.|+++.
T Consensus 234 ~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 272 (335)
T d2ozaa1 234 YEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 272 (335)
T ss_dssp SSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred CCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 000001112234468999999999999999999999873
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-45 Score=386.19 Aligned_cols=256 Identities=23% Similarity=0.291 Sum_probs=198.2
Q ss_pred cCcccCCCCccEEEeec-cCCcEEEEEEccccCcc-----cHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEEec
Q 004400 421 DNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSKSKQ-----GNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYEYL 494 (756)
Q Consensus 421 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~ 494 (756)
.++||+|+||+||+|+. .+|+.||||+++..... ..+.+.+|++++++++|||||++++++.+++..|+||||+
T Consensus 3 l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~ 82 (299)
T d1ua2a_ 3 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFM 82 (299)
T ss_dssp EEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECC
T ss_pred ceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhh
Confidence 46899999999999995 57999999998654221 1346889999999999999999999999999999999999
Q ss_pred CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCcccCccee
Q 004400 495 ENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHIS 574 (756)
Q Consensus 495 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~~~~~~~ 574 (756)
.++++.... .....+++..+..++.||+.||+|||++| |+||||||+|||++.++.+||+|||+|+........ .
T Consensus 83 ~~~~~~~~~-~~~~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~~-~ 157 (299)
T d1ua2a_ 83 ETDLEVIIK-DNSLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRA-Y 157 (299)
T ss_dssp SEEHHHHHT-TCCSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCCC-C
T ss_pred cchHHhhhh-hcccCCCHHHHHHHHHHHHHHHHHhhccc---eecccCCcceEEecCCCccccccCccccccCCCccc-c
Confidence 998766554 45567999999999999999999999997 999999999999999999999999999866544332 2
Q ss_pred eccccCccCCchHhhhcC-CCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhcCcccccccc---------
Q 004400 575 TRVAGTIGYMAPEYAMRG-HLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDT--------- 644 (756)
Q Consensus 575 ~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~--------- 644 (756)
...+||+.|+|||++... .++.++||||+||++|||++|+.||...+..+..................+.
T Consensus 158 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~ 237 (299)
T d1ua2a_ 158 THQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTF 237 (299)
T ss_dssp CCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCC
T ss_pred cceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccchhhhh
Confidence 345799999999998754 5899999999999999999999999877655544332222111110000000
Q ss_pred CCCCCCCH-----HHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 004400 645 NPGSNFDK-----EQVMVMINVALLCANASPTIRPSMSSVLR 681 (756)
Q Consensus 645 ~~~~~~~~-----~~~~~l~~l~~~c~~~~P~~RPt~~ev~~ 681 (756)
......+. .....+.+++.+|++.||++|||++|+++
T Consensus 238 ~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~ 279 (299)
T d1ua2a_ 238 KSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 279 (299)
T ss_dssp CCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred ccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhC
Confidence 00000111 11235889999999999999999999976
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.6e-46 Score=381.75 Aligned_cols=240 Identities=22% Similarity=0.379 Sum_probs=197.1
Q ss_pred cCccccCcccCCCCccEEEee-ccCCcEEEEEEccccCc------ccHHHHHHHHHHHHhCC--CCceeeEeeEEEeCCe
Q 004400 416 NNFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSKSK------QGNREFINEIGMISALQ--HPNLVKLYGCCIEGNQ 486 (756)
Q Consensus 416 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~~ 486 (756)
++|++.+.||+|+||+||+|+ ..+|+.||||++..... ....++.+|+.++++++ |||||++++++.+++.
T Consensus 4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~ 83 (273)
T d1xwsa_ 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS 83 (273)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCe
Confidence 578999999999999999999 46799999999865321 11234678999999996 8999999999999999
Q ss_pred EEEEEEecCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCC-CCEEEccCCccc
Q 004400 487 LLLIYEYLEN-NSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKD-LNSKISDFGLAK 564 (756)
Q Consensus 487 ~~lV~e~~~~-gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~-~~~kl~DFGla~ 564 (756)
.++||||+.+ +++.+++... ..+++..++.++.||+.||+|||+++ |+||||||+|||++.+ +.+||+|||+|+
T Consensus 84 ~~lv~e~~~~~~~l~~~~~~~-~~l~e~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NIll~~~~~~vkl~DFG~a~ 159 (273)
T d1xwsa_ 84 FVLILERPEPVQDLFDFITER-GALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSGA 159 (273)
T ss_dssp EEEEEECCSSEEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred EEEEEEeccCcchHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC---CccccCcccceEEecCCCeEEECccccce
Confidence 9999999986 6788877654 47999999999999999999999997 9999999999999854 789999999998
Q ss_pred cCcccCcceeeccccCccCCchHhhhcCCC-CcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhcCccccccc
Q 004400 565 LDEEENTHISTRVAGTIGYMAPEYAMRGHL-TEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVD 643 (756)
Q Consensus 565 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 643 (756)
..... ..+...||+.|+|||++.+..+ +.++||||+||++|||++|+.||...+.. ... ..
T Consensus 160 ~~~~~---~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~i--------~~~--~~----- 221 (273)
T d1xwsa_ 160 LLKDT---VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI--------IRG--QV----- 221 (273)
T ss_dssp ECCSS---CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHH--------HHC--CC-----
T ss_pred ecccc---cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCchHH--------hhc--cc-----
Confidence 65433 2345679999999999987765 67799999999999999999999654321 011 00
Q ss_pred cCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004400 644 TNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRM 682 (756)
Q Consensus 644 ~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~ 682 (756)
.....++. .+.+++.+||+.||++|||++|+++.
T Consensus 222 -~~~~~~s~----~~~~li~~~L~~dp~~R~s~~eil~h 255 (273)
T d1xwsa_ 222 -FFRQRVSS----ECQHLIRWCLALRPSDRPTFEEIQNH 255 (273)
T ss_dssp -CCSSCCCH----HHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred -CCCCCCCH----HHHHHHHHHccCCHhHCcCHHHHhcC
Confidence 01122333 48899999999999999999999763
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.3e-45 Score=381.29 Aligned_cols=264 Identities=25% Similarity=0.365 Sum_probs=203.2
Q ss_pred hhcCccccCcccCCCCccEEEeec-cC-CcEEEEEEccccC--cccHHHHHHHHHHHHhC---CCCceeeEeeEEEe---
Q 004400 414 ATNNFATDNNIGEGGFGPVYKGLL-AD-GTAIAVKQLSSKS--KQGNREFINEIGMISAL---QHPNLVKLYGCCIE--- 483 (756)
Q Consensus 414 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~-~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~--- 483 (756)
..++|+..+.||+|+||+||+|+. .+ ++.||||+++... ......+.+|+.+++.+ +|||||+++++|..
T Consensus 5 ~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~ 84 (305)
T d1blxa_ 5 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 84 (305)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred CcCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeeccccc
Confidence 346899999999999999999985 44 5679999986532 22234566788777665 79999999999864
Q ss_pred --CCeEEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCC
Q 004400 484 --GNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFG 561 (756)
Q Consensus 484 --~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFG 561 (756)
....+++|||++++++..........+++..+..++.|++.||+|||+++ ||||||||+|||++.++.+||+|||
T Consensus 85 ~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~---ivHrDiKp~NILi~~~~~~kl~dfg 161 (305)
T d1blxa_ 85 DRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFG 161 (305)
T ss_dssp SSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECSCC
T ss_pred ccCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecCCCccEEEEcCCCCeeecchh
Confidence 34689999999998887666666678999999999999999999999997 9999999999999999999999999
Q ss_pred ccccCcccCcceeeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhcCccccc
Q 004400 562 LAKLDEEENTHISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMEL 641 (756)
Q Consensus 562 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 641 (756)
+++...... ......||+.|+|||++.+..|+.++||||+||++|||++|+.||...+....................
T Consensus 162 ~~~~~~~~~--~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 239 (305)
T d1blxa_ 162 LARIYSFQM--ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDW 239 (305)
T ss_dssp SCCCCCGGG--GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGS
T ss_pred hhhhhcccc--cCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhcc
Confidence 998654432 234567999999999999999999999999999999999999999876654433322211111000000
Q ss_pred ----------c-c--cCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004400 642 ----------V-D--TNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRM 682 (756)
Q Consensus 642 ----------~-~--~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~ 682 (756)
. . ..+...+.......+.+++.+|++.||++|||+.|+++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~H 293 (305)
T d1blxa_ 240 PRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 293 (305)
T ss_dssp CTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred cccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 0 0 000001111223347889999999999999999999763
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=7.7e-45 Score=377.23 Aligned_cols=261 Identities=26% Similarity=0.338 Sum_probs=202.4
Q ss_pred cCccccCcccCCCCccEEEeeccCCcEEEEEEccccC--cccHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEEe
Q 004400 416 NNFATDNNIGEGGFGPVYKGLLADGTAIAVKQLSSKS--KQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYEY 493 (756)
Q Consensus 416 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 493 (756)
++|+..+.||+|+||+||+|+.++|+.||||++.... ....+.+.+|+.+|++++|||||+++++|.+++..++||||
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~ 81 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence 5789999999999999999998899999999996542 23357899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCcccCcce
Q 004400 494 LENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHI 573 (756)
Q Consensus 494 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~~~~~~ 573 (756)
+.++.+..+. .....+++..+..++.||+.||+|||+.+ ||||||||+|||++.++.+||+|||.|........ .
T Consensus 82 ~~~~~~~~~~-~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~-~ 156 (286)
T d1ob3a_ 82 LDQDLKKLLD-VCEGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPVR-K 156 (286)
T ss_dssp CSEEHHHHHH-TSTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-----
T ss_pred ehhhhHHHHH-hhcCCcchhhhHHHHHHHHHHHHHhccCc---EEecCCCCceeeEcCCCCEEecccccceecccCcc-c
Confidence 9887666554 45568999999999999999999999986 99999999999999999999999999986544322 2
Q ss_pred eeccccCccCCchHhhhcC-CCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhcCccc------cc-----
Q 004400 574 STRVAGTIGYMAPEYAMRG-HLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLM------EL----- 641 (756)
Q Consensus 574 ~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~------~~----- 641 (756)
.....|++.|+|||.+... .++.++||||+||++|||++|+.||...+.................. ..
T Consensus 157 ~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 236 (286)
T d1ob3a_ 157 YTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDP 236 (286)
T ss_dssp -----CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCT
T ss_pred cceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhhccc
Confidence 2334689999999999764 57999999999999999999999997665444322211111110000 00
Q ss_pred ----cccCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 004400 642 ----VDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLR 681 (756)
Q Consensus 642 ----~~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~ 681 (756)
....+...........+.+++.+|++.||++|||++|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~ 280 (286)
T d1ob3a_ 237 NFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (286)
T ss_dssp TCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0000000111112335889999999999999999999975
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=3.5e-43 Score=365.21 Aligned_cols=259 Identities=20% Similarity=0.254 Sum_probs=208.5
Q ss_pred hcCccccCcccCCCCccEEEee-ccCCcEEEEEEccccCcccHHHHHHHHHHHHhCCC-CceeeEeeEEEeCCeEEEEEE
Q 004400 415 TNNFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQGNREFINEIGMISALQH-PNLVKLYGCCIEGNQLLLIYE 492 (756)
Q Consensus 415 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~~~lV~e 492 (756)
.++|++.+.||+|+||+||+|+ ..+|+.||||++..... ...+.+|+++++.++| +|++.+++++.++...++|||
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme 81 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD--APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID 81 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT--SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccC--cHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEE
Confidence 3579999999999999999999 45789999998855322 2457889999999975 899999999999999999999
Q ss_pred ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecC-----CCCEEEccCCccccCc
Q 004400 493 YLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDK-----DLNSKISDFGLAKLDE 567 (756)
Q Consensus 493 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~-----~~~~kl~DFGla~~~~ 567 (756)
|+ +|+|.+++......+++.++..++.|++.||+|||+.| ||||||||+|||++. ++.+||+|||+|+...
T Consensus 82 ~~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~g---iiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~ 157 (293)
T d1csna_ 82 LL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYR 157 (293)
T ss_dssp CC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESB
T ss_pred ec-CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCC---ceeccCCccceeecCcccccCCceEEcccceeEEcc
Confidence 99 68999999877778999999999999999999999997 999999999999974 5679999999998765
Q ss_pred ccCcc------eeeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHH---HhcCcc
Q 004400 568 EENTH------ISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVL---KEQGKL 638 (756)
Q Consensus 568 ~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~---~~~~~~ 638 (756)
..... ......||+.|||||++.+..++.++|||||||++|||+||+.||............... ......
T Consensus 158 ~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 237 (293)
T d1csna_ 158 DPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPL 237 (293)
T ss_dssp CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCH
T ss_pred cCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCCCh
Confidence 43221 233467999999999999999999999999999999999999999654332222111111 111111
Q ss_pred ccccccCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhccCcc
Q 004400 639 MELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLECGVD 688 (756)
Q Consensus 639 ~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~L~~~~~ 688 (756)
.+.. ..+++ .+.+++..|++.+|++||+++.+.+.|+.+.+
T Consensus 238 ~~l~-----~~~p~----~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~ 278 (293)
T d1csna_ 238 RELC-----AGFPE----EFYKYMHYARNLAFDATPDYDYLQGLFSKVLE 278 (293)
T ss_dssp HHHT-----TTSCH----HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHH
T ss_pred HHhc-----CCCCH----HHHHHHHHHhcCCcccCcCHHHHHHHHHHHHH
Confidence 1111 12333 48889999999999999999999998886544
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.4e-43 Score=368.39 Aligned_cols=257 Identities=21% Similarity=0.276 Sum_probs=199.9
Q ss_pred cCccccCcccCCCCccEEEee-ccCCcEEEEEEccccCcccHHHHHHHHHHHHhCCCCcee-eEeeEEEeCCeEEEEEEe
Q 004400 416 NNFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLV-KLYGCCIEGNQLLLIYEY 493 (756)
Q Consensus 416 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv-~l~~~~~~~~~~~lV~e~ 493 (756)
++|+..+.||+|+||+||+|+ ..+|+.||||++..... ..++.+|+++++.++|+|+| .+.+++.+++..++||||
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~ 84 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMEL 84 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT--SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc--CHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEE
Confidence 469999999999999999998 46789999998865432 24578899999999877655 555666788899999999
Q ss_pred cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecC---CCCEEEccCCccccCcccC
Q 004400 494 LENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDK---DLNSKISDFGLAKLDEEEN 570 (756)
Q Consensus 494 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~---~~~~kl~DFGla~~~~~~~ 570 (756)
+ +|++.+.+......+++..+..++.|++.||+|||++| ||||||||+|||++. +..+||+|||+|+......
T Consensus 85 ~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~ 160 (299)
T d1ckia_ 85 L-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDAR 160 (299)
T ss_dssp C-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTT
T ss_pred c-CCchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHhhccccccCCCceeeeeccCcceeccccc
Confidence 9 45677777766778999999999999999999999997 999999999999864 5579999999998765433
Q ss_pred cc------eeeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHh---cCccccc
Q 004400 571 TH------ISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKE---QGKLMEL 641 (756)
Q Consensus 571 ~~------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~---~~~~~~~ 641 (756)
.. ......||+.|+|||.+.+..++.++|||||||++|||+||+.||................. .......
T Consensus 161 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (299)
T d1ckia_ 161 THQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVL 240 (299)
T ss_dssp TCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSCHHHH
T ss_pred cccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCChhHh
Confidence 22 23456899999999999999999999999999999999999999965443322221111111 1111111
Q ss_pred cccCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhccCc
Q 004400 642 VDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLECGV 687 (756)
Q Consensus 642 ~~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~L~~~~ 687 (756)
...+++ .+.+++.+||+.+|++||+++++.+.|+...
T Consensus 241 -----~~~~p~----~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~ 277 (299)
T d1ckia_ 241 -----CKGYPS----EFATYLNFCRSLRFDDKPDYSYLRQLFRNLF 277 (299)
T ss_dssp -----TTTSCH----HHHHHHHHHHHSCTTCCCCHHHHHHHHHHHH
T ss_pred -----ccCCCH----HHHHHHHHHccCChhHCcCHHHHHHHHHHHH
Confidence 112333 3889999999999999999999999888653
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6e-43 Score=368.84 Aligned_cols=264 Identities=21% Similarity=0.296 Sum_probs=200.3
Q ss_pred hcCccccCcccCCCCccEEEeec-cCCcEEEEEEcccc--CcccHHHHHHHHHHHHhCCCCceeeEeeEEEe--------
Q 004400 415 TNNFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSK--SKQGNREFINEIGMISALQHPNLVKLYGCCIE-------- 483 (756)
Q Consensus 415 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-------- 483 (756)
.++|+..+.||+|+||+||+|+. .+|+.||||++... ......++.+|+++|++++||||+++++++..
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~ 88 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 88 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence 36889999999999999999994 68999999998654 33345778999999999999999999999865
Q ss_pred CCeEEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCcc
Q 004400 484 GNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLA 563 (756)
Q Consensus 484 ~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla 563 (756)
++..++||||+.++.+.... .....++...++.++.|++.||+|||++| |+||||||+|||++.++.+||+|||++
T Consensus 89 ~~~~~iv~e~~~~~~~~~~~-~~~~~~~~~~~~~i~~qil~~l~~lH~~~---ivHrDlKp~NILl~~~~~~kl~dfg~~ 164 (318)
T d3blha1 89 KGSIYLVFDFCEHDLAGLLS-NVLVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLA 164 (318)
T ss_dssp --CEEEEEECCCEEHHHHHT-CTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTC
T ss_pred CceEEEEEeccCCCccchhh-hcccccccHHHHHHHHHHHHHHHHhccCC---EEecCcCchheeecCCCcEEeeeccee
Confidence 34689999999987665443 45567899999999999999999999997 999999999999999999999999999
Q ss_pred ccCcccCcc---eeeccccCccCCchHhhhcC-CCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhcCcc-
Q 004400 564 KLDEEENTH---ISTRVAGTIGYMAPEYAMRG-HLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKL- 638 (756)
Q Consensus 564 ~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~- 638 (756)
+........ .....+||+.|+|||++.+. .++.++||||+||++|||++|+.||.+.+.................
T Consensus 165 ~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 244 (318)
T d3blha1 165 RAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPE 244 (318)
T ss_dssp EECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTT
T ss_pred eecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCChh
Confidence 865533222 22335799999999999765 6899999999999999999999999776654443332222211000
Q ss_pred -c-cc--------cccCCCCCCCHH-------HHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004400 639 -M-EL--------VDTNPGSNFDKE-------QVMVMINVALLCANASPTIRPSMSSVLRM 682 (756)
Q Consensus 639 -~-~~--------~~~~~~~~~~~~-------~~~~l~~l~~~c~~~~P~~RPt~~ev~~~ 682 (756)
. .. ............ ....+++++.+|++.||++|||++|+++.
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~H 305 (318)
T d3blha1 245 VWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 305 (318)
T ss_dssp TSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred hccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcC
Confidence 0 00 000000001111 12256789999999999999999999865
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-43 Score=375.00 Aligned_cols=256 Identities=24% Similarity=0.285 Sum_probs=194.4
Q ss_pred CccccCcccCCCCccEEEeec-cCCcEEEEEEccccCcccHHHHHHHHHHHHhCCCCceeeEeeEEEeC------CeEEE
Q 004400 417 NFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCCIEG------NQLLL 489 (756)
Q Consensus 417 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~~~l 489 (756)
+|+..++||+|+||+||+|+. .+|+.||||++..... .+.+|+++|++++|||||+++++|... .+.++
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l 96 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 96 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch----HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence 577888999999999999995 5799999999965432 234799999999999999999998653 35799
Q ss_pred EEEecCCCCHHHHHH--hcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCC-CEEEccCCccccC
Q 004400 490 IYEYLENNSLARALF--EHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDL-NSKISDFGLAKLD 566 (756)
Q Consensus 490 V~e~~~~gsL~~~l~--~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~-~~kl~DFGla~~~ 566 (756)
|||||+++.+..... .....+++..+..++.||+.||+|||++| |+||||||+|||++.++ .+||+|||+++..
T Consensus 97 v~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~---IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~ 173 (350)
T d1q5ka_ 97 VLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 173 (350)
T ss_dssp EEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTTCCEEECCCTTCEEC
T ss_pred EEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcC---CcccCCCcceEEEecCCCceeEecccchhhc
Confidence 999998775444433 44567999999999999999999999986 99999999999999775 8999999999866
Q ss_pred cccCcceeeccccCccCCchHhhhc-CCCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHh----------c
Q 004400 567 EEENTHISTRVAGTIGYMAPEYAMR-GHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKE----------Q 635 (756)
Q Consensus 567 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~----------~ 635 (756)
..... .....||..|+|||.+.+ ..++.++||||+||++|||++|+.||...+............. .
T Consensus 174 ~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~ 251 (350)
T d1q5ka_ 174 VRGEP--NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMN 251 (350)
T ss_dssp CTTSC--CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHC
T ss_pred cCCcc--cccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhhc
Confidence 54332 234579999999999875 5689999999999999999999999976654433221111000 0
Q ss_pred Cc-----cccccccCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 004400 636 GK-----LMELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLR 681 (756)
Q Consensus 636 ~~-----~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~ 681 (756)
.. ....................+.+++.+|++.||++|||+.|+++
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 302 (350)
T d1q5ka_ 252 PNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 302 (350)
T ss_dssp C---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred cchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00 00000000000011122334889999999999999999999986
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-42 Score=370.44 Aligned_cols=258 Identities=21% Similarity=0.328 Sum_probs=197.1
Q ss_pred hcCccccCcccCCCCccEEEee-ccCCcEEEEEEcccc--CcccHHHHHHHHHHHHhCCCCceeeEeeEEEeCC------
Q 004400 415 TNNFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSK--SKQGNREFINEIGMISALQHPNLVKLYGCCIEGN------ 485 (756)
Q Consensus 415 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------ 485 (756)
.++|+..+.||+|+||+||+|+ ..+|+.||||+++.. .....+.+.+|+++|++++|||||+++++|...+
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~ 96 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 96 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence 4678999999999999999999 467999999999754 2233467889999999999999999999998654
Q ss_pred eEEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCcccc
Q 004400 486 QLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKL 565 (756)
Q Consensus 486 ~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~ 565 (756)
..|+||||+ +++|..+... ..+++..+..++.||+.||+|||++| ||||||||+|||++.++.+|++|||+|+.
T Consensus 97 ~~~lv~e~~-~~~l~~~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~~---IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~ 170 (346)
T d1cm8a_ 97 DFYLVMPFM-GTDLGKLMKH--EKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQ 170 (346)
T ss_dssp CCEEEEECC-SEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred eEEEEEecc-cccHHHHHHh--ccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCcchhhcccccccccccccceec
Confidence 579999999 5678777654 36999999999999999999999997 99999999999999999999999999986
Q ss_pred CcccCcceeeccccCccCCchHhhhcC-CCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhc---------
Q 004400 566 DEEENTHISTRVAGTIGYMAPEYAMRG-HLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQ--------- 635 (756)
Q Consensus 566 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~--------- 635 (756)
..... +...||+.|+|||++.+. .++.++||||+||++|||++|+.||.+.+..............
T Consensus 171 ~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (346)
T d1cm8a_ 171 ADSEM----TGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRL 246 (346)
T ss_dssp CCSSC----CSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTC
T ss_pred cCCcc----ccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhhh
Confidence 54432 346799999999999864 5789999999999999999999999776544332211111100
Q ss_pred ------------CccccccccCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH--hccC
Q 004400 636 ------------GKLMELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRM--LECG 686 (756)
Q Consensus 636 ------------~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~--L~~~ 686 (756)
.+.............+ ..+.+++.+|++.||++|||+.|+++. ++..
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s----~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~ 307 (346)
T d1cm8a_ 247 QSDEAKNYMKGLPELEKKDFASILTNAS----PLAVNLLEKMLVLDAEQRVTAGEALAHPYFESL 307 (346)
T ss_dssp SCHHHHHHHHHSCCCCCCCGGGTCTTCC----HHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTT
T ss_pred cchhhhhhhccCCcccccchHHhccCCC----HHHHHHHHHHCcCChhHCcCHHHHhcChhhCcC
Confidence 0000000000111222 347899999999999999999999874 5544
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-42 Score=369.60 Aligned_cols=263 Identities=22% Similarity=0.318 Sum_probs=198.8
Q ss_pred hcCccccCcccCCCCccEEEee-ccCCcEEEEEEccccC-cccHHHHHHHHHHHHhCCCCceeeEeeEEEeCC----eEE
Q 004400 415 TNNFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSKS-KQGNREFINEIGMISALQHPNLVKLYGCCIEGN----QLL 488 (756)
Q Consensus 415 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~~~ 488 (756)
+.+|+..+.||+|+||+||+|+ ..+|+.||||++.... ....+.+.+|+++|++++|||||++++++.... ..+
T Consensus 7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~ 86 (345)
T d1pmea_ 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 86 (345)
T ss_dssp CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence 3568999999999999999998 5689999999997543 333467899999999999999999999997653 235
Q ss_pred EEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCcc
Q 004400 489 LIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEE 568 (756)
Q Consensus 489 lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~ 568 (756)
++++|+.+|+|.+++... .+++..++.++.|++.||+|||++| ||||||||+|||++.++.+||+|||+|+....
T Consensus 87 ~l~~~~~~g~L~~~l~~~--~l~~~~i~~i~~qil~al~yLH~~~---iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~ 161 (345)
T d1pmea_ 87 YLVTHLMGADLYKLLKTQ--HLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADP 161 (345)
T ss_dssp EEEEECCCEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECCG
T ss_pred EEEEeecCCchhhhhhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCcceEEECCCCCEEEcccCceeeccC
Confidence 556677899999999654 6899999999999999999999997 99999999999999999999999999986544
Q ss_pred cCcc--eeeccccCccCCchHhhhc-CCCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhcCcccc-----
Q 004400 569 ENTH--ISTRVAGTIGYMAPEYAMR-GHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLME----- 640 (756)
Q Consensus 569 ~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~----- 640 (756)
.... .....+||+.|+|||++.. ..++.++||||+||++|||++|+.||...+...................
T Consensus 162 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (345)
T d1pmea_ 162 DHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCII 241 (345)
T ss_dssp GGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTCC
T ss_pred CCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhhhh
Confidence 3222 2345679999999999855 5678999999999999999999999976654333222211111100000
Q ss_pred ------ccccCCC-CCCCH-----HHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004400 641 ------LVDTNPG-SNFDK-----EQVMVMINVALLCANASPTIRPSMSSVLRM 682 (756)
Q Consensus 641 ------~~~~~~~-~~~~~-----~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~ 682 (756)
.....+. ...+. .....+.+++.+|++.||++|||++|+++.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h 295 (345)
T d1pmea_ 242 NLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 295 (345)
T ss_dssp CHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0000000 00010 112358899999999999999999999974
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-43 Score=368.72 Aligned_cols=252 Identities=23% Similarity=0.288 Sum_probs=202.6
Q ss_pred cCccccCcccCCCCccEEEeec----cCCcEEEEEEccccC----cccHHHHHHHHHHHHhCCC-CceeeEeeEEEeCCe
Q 004400 416 NNFATDNNIGEGGFGPVYKGLL----ADGTAIAVKQLSSKS----KQGNREFINEIGMISALQH-PNLVKLYGCCIEGNQ 486 (756)
Q Consensus 416 ~~~~~~~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~ 486 (756)
++|+..+.||+|+||+||+|+. .+|+.||||.++... ....+.+.+|++++++++| |||+++++++.+...
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~ 103 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 103 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence 5799999999999999999973 257899999986542 2234568899999999976 899999999999999
Q ss_pred EEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccC
Q 004400 487 LLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLD 566 (756)
Q Consensus 487 ~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~ 566 (756)
.++||||+.+|+|.+++.... .++...+..++.||+.||+|||+.+ ||||||||+|||++.++.+||+|||+|+..
T Consensus 104 ~~~v~e~~~~~~L~~~i~~~~-~~~e~~~~~~~~Qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~vkL~DFG~a~~~ 179 (322)
T d1vzoa_ 104 LHLILDYINGGELFTHLSQRE-RFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKEF 179 (322)
T ss_dssp EEEEECCCCSCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEEEEC
T ss_pred eeeeeecccccHHHHHHHhcc-cccHHHHHHHHHHHHHHHHHhhcCC---EEeccCCccceeecCCCCEEEeeccchhhh
Confidence 999999999999999997554 6788999999999999999999986 999999999999999999999999999876
Q ss_pred cccCcceeeccccCccCCchHhhhcC--CCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhcCcccccccc
Q 004400 567 EEENTHISTRVAGTIGYMAPEYAMRG--HLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDT 644 (756)
Q Consensus 567 ~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 644 (756)
............|++.|+|||.+... .++.++||||+||++|||++|+.||...+.................
T Consensus 180 ~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~~~------ 253 (322)
T d1vzoa_ 180 VADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEP------ 253 (322)
T ss_dssp CGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCC------
T ss_pred cccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccCCC------
Confidence 55544445557899999999999764 4788999999999999999999999665443322211111111110
Q ss_pred CCCCCCCHHHHHHHHHHHHHhhcCCCCCCCC-----HHHHHH
Q 004400 645 NPGSNFDKEQVMVMINVALLCANASPTIRPS-----MSSVLR 681 (756)
Q Consensus 645 ~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt-----~~ev~~ 681 (756)
.++......+.+++.+||+.||++||+ ++|+++
T Consensus 254 ----~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~ 291 (322)
T d1vzoa_ 254 ----PYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE 291 (322)
T ss_dssp ----CCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred ----CCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence 111122345889999999999999995 778764
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-42 Score=359.40 Aligned_cols=261 Identities=21% Similarity=0.286 Sum_probs=204.0
Q ss_pred cCccccCcccCCCCccEEEee-ccCCcEEEEEEccccC--cccHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEE
Q 004400 416 NNFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSKS--KQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYE 492 (756)
Q Consensus 416 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 492 (756)
++|+..+.||+|+||+||+|+ ..+++.||||+++... ......+.+|+.+++.++|||||+++++|.+....++|++
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence 578999999999999999999 5688999999986542 2345788999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccCcccCcc
Q 004400 493 YLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTH 572 (756)
Q Consensus 493 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~~~~~~~ 572 (756)
++.++++..++. ....+++..+..++.|++.||+|||+++ ||||||||+|||++.++.+||+|||.|+........
T Consensus 82 ~~~~~~l~~~~~-~~~~~~~~~~~~~~~q~~~aL~~lH~~~---IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~~ 157 (292)
T d1unla_ 82 FCDQDLKKYFDS-CNGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRC 157 (292)
T ss_dssp CCSEEHHHHHHH-TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSCCSC
T ss_pred eccccccccccc-cccccchhHHHHHHHHHHHHHHHhhcCC---EeeecccCcccccccCCceeeeecchhhcccCCCcc
Confidence 999999888775 4457899999999999999999999996 999999999999999999999999999876544332
Q ss_pred eeeccccCccCCchHhhhcCC-CCcccchhhHHHHHHHHHhCCCCCCcc-chhhHHHHHHHHHhcCc---c---ccccc-
Q 004400 573 ISTRVAGTIGYMAPEYAMRGH-LTEKADVYSFGIVALEIVSGRSNVTKE-DMFYLLDWALVLKEQGK---L---MELVD- 643 (756)
Q Consensus 573 ~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~slGv~l~elltg~~p~~~~-~~~~~~~~~~~~~~~~~---~---~~~~~- 643 (756)
.....++..|+|||.+.... ++.++||||+||++|||++|+.||... +................ . ....+
T Consensus 158 -~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (292)
T d1unla_ 158 -YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDY 236 (292)
T ss_dssp -CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTC
T ss_pred -ceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhcccc
Confidence 23345788999999987654 699999999999999999999997433 33322221111111100 0 00000
Q ss_pred --------cCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 004400 644 --------TNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLR 681 (756)
Q Consensus 644 --------~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~ 681 (756)
..............+.+++.+|++.||++|||++|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~ 282 (292)
T d1unla_ 237 KPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp CCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred cccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00001112222345889999999999999999999876
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=1e-41 Score=360.79 Aligned_cols=254 Identities=17% Similarity=0.235 Sum_probs=195.8
Q ss_pred cCccccCcccCCCCccEEEeec-cCCcEEEEEEccccCcccHHHHHHHHHHHHhCC-CCceeeEeeEEEeC--CeEEEEE
Q 004400 416 NNFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSKSKQGNREFINEIGMISALQ-HPNLVKLYGCCIEG--NQLLLIY 491 (756)
Q Consensus 416 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~--~~~~lV~ 491 (756)
++|++.+.||+|+||+||+|+. .+|+.||||+++.. ..+++.+|+++|++++ ||||++++++|... ...++||
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~---~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~ 111 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 111 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH---HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEE
Confidence 5799999999999999999994 67999999998643 3467899999999995 99999999999854 5689999
Q ss_pred EecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCC-CEEEccCCccccCcccC
Q 004400 492 EYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDL-NSKISDFGLAKLDEEEN 570 (756)
Q Consensus 492 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~-~~kl~DFGla~~~~~~~ 570 (756)
|||++|+|... ...+++..+..++.||+.||+|||++| ||||||||+|||++.++ .+||+|||+|+......
T Consensus 112 e~~~~~~L~~~----~~~l~e~~i~~i~~qil~aL~~LH~~g---IvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~~ 184 (328)
T d3bqca1 112 EHVNNTDFKQL----YQTLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ 184 (328)
T ss_dssp ECCCSCBGGGT----TTSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCGGGCEECCTTC
T ss_pred eecCCCcHHHH----hcCCCHHHHHHHHHHHHHHHHHHhhcc---cccccccccceEEcCCCCeeeecccccceeccCCC
Confidence 99999998654 347999999999999999999999997 99999999999998765 58999999998665432
Q ss_pred cceeeccccCccCCchHhhhcC-CCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHH-HH-----------HHhcCc
Q 004400 571 THISTRVAGTIGYMAPEYAMRG-HLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWA-LV-----------LKEQGK 637 (756)
Q Consensus 571 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~-~~-----------~~~~~~ 637 (756)
. .....||+.|+|||.+.+. .++.++||||+||++|||++|+.||..........+. .. ......
T Consensus 185 ~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~ 262 (328)
T d3bqca1 185 E--YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIE 262 (328)
T ss_dssp C--CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCC
T ss_pred c--ccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhcccc
Confidence 2 2446789999999998875 4799999999999999999999999554321111000 00 000000
Q ss_pred c----ccccccC--------CCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 004400 638 L----MELVDTN--------PGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLR 681 (756)
Q Consensus 638 ~----~~~~~~~--------~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~ 681 (756)
. ....... ............+.+++.+|++.||++|||++|+++
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~ 318 (328)
T d3bqca1 263 LDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 318 (328)
T ss_dssp CCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred cCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0 0000000 000011112335889999999999999999999976
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-41 Score=364.16 Aligned_cols=258 Identities=21% Similarity=0.280 Sum_probs=191.7
Q ss_pred cCccccCcccCCCCccEEEeec-cCCcEEEEEEccccC--cccHHHHHHHHHHHHhCCCCceeeEeeEEEe------CCe
Q 004400 416 NNFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSKS--KQGNREFINEIGMISALQHPNLVKLYGCCIE------GNQ 486 (756)
Q Consensus 416 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~------~~~ 486 (756)
++|+..+.||+|+||+||+|+. .+|+.||||++.... ......+.+|+.++++++|||||+++++|.. ...
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~ 96 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD 96 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence 5799999999999999999994 579999999997542 3334568899999999999999999999964 368
Q ss_pred EEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccC
Q 004400 487 LLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLD 566 (756)
Q Consensus 487 ~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~ 566 (756)
.|+|||||.++.+.. + ...+++..++.++.||+.||+|||++| |+||||||+|||++.++.+|++|||+++..
T Consensus 97 ~~iv~Ey~~~~l~~~-~---~~~~~~~~i~~~~~qil~gl~~LH~~g---iiHrDlKP~Nil~~~~~~~kl~df~~~~~~ 169 (355)
T d2b1pa1 97 VYLVMELMDANLCQV-I---QMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA 169 (355)
T ss_dssp EEEEEECCSEEHHHH-H---TSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred eEEEEeccchHHHHh-h---hcCCCHHHHHHHHHHHHHHHHHhhhcc---cccccCCccccccccccceeeechhhhhcc
Confidence 899999998765543 3 246899999999999999999999997 999999999999999999999999998865
Q ss_pred cccCcceeeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHH-------------
Q 004400 567 EEENTHISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLK------------- 633 (756)
Q Consensus 567 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~------------- 633 (756)
.... ......||+.|+|||++.+..++.++||||+||++|||++|+.||.+.+............
T Consensus 170 ~~~~--~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 247 (355)
T d2b1pa1 170 GTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQP 247 (355)
T ss_dssp -------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSCH
T ss_pred cccc--ccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhhh
Confidence 4432 2345679999999999999999999999999999999999999997665433221111000
Q ss_pred ------hc-Ccc-----ccccccCCCCC---CCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004400 634 ------EQ-GKL-----MELVDTNPGSN---FDKEQVMVMINVALLCANASPTIRPSMSSVLRM 682 (756)
Q Consensus 634 ------~~-~~~-----~~~~~~~~~~~---~~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~~ 682 (756)
.. ... ........... ........+.+++.+|++.||++|||++|+++.
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~H 311 (355)
T d2b1pa1 248 TVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 311 (355)
T ss_dssp HHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 00 000 00000000011 122345578999999999999999999999865
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-41 Score=359.80 Aligned_cols=263 Identities=23% Similarity=0.321 Sum_probs=199.6
Q ss_pred hcCccccCcccCCCCccEEEee-ccCCcEEEEEEccccC--cccHHHHHHHHHHHHhCCCCceeeEeeEEEeC-----Ce
Q 004400 415 TNNFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSKS--KQGNREFINEIGMISALQHPNLVKLYGCCIEG-----NQ 486 (756)
Q Consensus 415 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~ 486 (756)
.++|+..+.||+|+||+||+|+ ..+|+.||||+++... ....+.+.+|+++|++++|||||++++++... ..
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence 4679999999999999999999 5689999999997543 23345788999999999999999999998643 34
Q ss_pred EEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccCCccccC
Q 004400 487 LLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLD 566 (756)
Q Consensus 487 ~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~~~ 566 (756)
.++|++|+.+|+|.+++.. ..+++..+..++.||+.||+|||++| |+||||||+|||++.++.+|++|||++...
T Consensus 97 ~~~i~~~~~gg~L~~~~~~--~~l~e~~~~~i~~qil~aL~~LH~~g---iiHrDiKp~NILi~~~~~~kl~dfg~a~~~ 171 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHT 171 (348)
T ss_dssp CCEEEEECCSEEHHHHHTT--CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCC----CC
T ss_pred eEEEEEeecCCchhhhccc--ccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCCccccccccccccccccchhccc
Confidence 5777888999999999854 36999999999999999999999997 999999999999999999999999999765
Q ss_pred cccCcceeeccccCccCCchHhhhcC-CCCcccchhhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhcCccc------
Q 004400 567 EEENTHISTRVAGTIGYMAPEYAMRG-HLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLM------ 639 (756)
Q Consensus 567 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~------ 639 (756)
... .....||+.|+|||...+. .++.++||||+||++|+|++|+.||.+.+..................
T Consensus 172 ~~~----~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 247 (348)
T d2gfsa1 172 DDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 247 (348)
T ss_dssp TGG----GSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCC
T ss_pred Ccc----cccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhcc
Confidence 432 2345789999999987765 46899999999999999999999997766544332221111100000
Q ss_pred --------cccccCCCCCC---CHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH--HhccC
Q 004400 640 --------ELVDTNPGSNF---DKEQVMVMINVALLCANASPTIRPSMSSVLR--MLECG 686 (756)
Q Consensus 640 --------~~~~~~~~~~~---~~~~~~~l~~l~~~c~~~~P~~RPt~~ev~~--~L~~~ 686 (756)
..........+ .......+.+++.+|++.||++|||+.|+++ .+.++
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~ 307 (348)
T d2gfsa1 248 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 307 (348)
T ss_dssp CHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTT
T ss_pred chhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCC
Confidence 00000000000 0011234789999999999999999999987 34443
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=8.6e-37 Score=327.78 Aligned_cols=259 Identities=19% Similarity=0.237 Sum_probs=191.0
Q ss_pred cCccccCcccCCCCccEEEee-ccCCcEEEEEEccccCcccHHHHHHHHHHHHhCC-----------CCceeeEeeEEEe
Q 004400 416 NNFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQGNREFINEIGMISALQ-----------HPNLVKLYGCCIE 483 (756)
Q Consensus 416 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----------h~niv~l~~~~~~ 483 (756)
++|++.+.||+|+||+||+|+ ..+|+.||||+++.. ....+.+.+|+.+++.++ |+|||++++++..
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~-~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~ 91 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH 91 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecc-ccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeee
Confidence 358999999999999999999 468999999999754 223457788999888875 5789999998864
Q ss_pred --CCeEEEEEEecCCCCHHHHH--HhcCCCCCHHHHHHHHHHHHHHHHHHHc-CCCCCeEcCCCCCCceEecCCCC----
Q 004400 484 --GNQLLLIYEYLENNSLARAL--FEHRLKLDWPTRRRICLGIARGLAYLHG-ESRIKVVHRDIKATNVLLDKDLN---- 554 (756)
Q Consensus 484 --~~~~~lV~e~~~~gsL~~~l--~~~~~~l~~~~~~~i~~~ia~~L~~LH~-~g~~~iiH~Dikp~Nill~~~~~---- 554 (756)
....+++++++..+...... ......+++..+..++.||+.||+|||+ .| |+||||||+|||++.++.
T Consensus 92 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~---IvHrDlKp~NIll~~~~~~~~~ 168 (362)
T d1q8ya_ 92 KGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSPENL 168 (362)
T ss_dssp EETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETTTTE
T ss_pred ccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcC---cccccCChhHeeeeccCccccc
Confidence 45677777777655433322 2445678999999999999999999997 54 999999999999987653
Q ss_pred --EEEccCCccccCcccCcceeeccccCccCCchHhhhcCCCCcccchhhHHHHHHHHHhCCCCCCccchhhH-------
Q 004400 555 --SKISDFGLAKLDEEENTHISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYL------- 625 (756)
Q Consensus 555 --~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~------- 625 (756)
++++|||.+...... ....+||+.|+|||++....++.++||||+||+++||++|+.||...+....
T Consensus 169 ~~~kl~dfg~s~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~ 244 (362)
T d1q8ya_ 169 IQIKIADLGNACWYDEH----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHI 244 (362)
T ss_dssp EEEEECCCTTCEETTBC----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHH
T ss_pred ceeeEeecccccccccc----cccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHH
Confidence 899999999754432 2346799999999999999999999999999999999999999964432111
Q ss_pred HHHHHHHH-------hc-Cc---------cccccccC----------CCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHH
Q 004400 626 LDWALVLK-------EQ-GK---------LMELVDTN----------PGSNFDKEQVMVMINVALLCANASPTIRPSMSS 678 (756)
Q Consensus 626 ~~~~~~~~-------~~-~~---------~~~~~~~~----------~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~e 678 (756)
........ .. .. ....+... ............+.+++.+|++.||++|||++|
T Consensus 245 ~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e 324 (362)
T d1q8ya_ 245 AQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGG 324 (362)
T ss_dssp HHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHH
T ss_pred HHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHH
Confidence 11000000 00 00 00000000 011234566778999999999999999999999
Q ss_pred HHHH
Q 004400 679 VLRM 682 (756)
Q Consensus 679 v~~~ 682 (756)
+++.
T Consensus 325 ~L~H 328 (362)
T d1q8ya_ 325 LVNH 328 (362)
T ss_dssp HHTC
T ss_pred HhcC
Confidence 9864
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=99.97 E-value=1.4e-30 Score=273.08 Aligned_cols=256 Identities=28% Similarity=0.394 Sum_probs=197.6
Q ss_pred CCCCEEEccCCcccC--ccCcccccCCcce-eeccC-ccccccCCccCcCcCCCcEEEeecCcccccCCcccCCCCCCcE
Q 004400 41 TFLQDIDLTLNYLSG--TIPSQWASLPLLN-ISLIA-NRLKGPIPKYLANISTLVNLTVQYNQFSGELPEELGSLLNLEK 116 (756)
Q Consensus 41 ~~L~~L~L~~n~l~~--~~p~~~~~l~~L~-l~l~~-n~~~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~ 116 (756)
.+++.|+|++|.+++ .+|..++.++.|+ |++++ |+++|.+|..|++|++|++|+|++|+|.+..+..+..+.+|+.
T Consensus 50 ~~v~~L~L~~~~l~g~~~lp~~l~~L~~L~~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~ 129 (313)
T d1ogqa_ 50 YRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVT 129 (313)
T ss_dssp CCEEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCE
T ss_pred EEEEEEECCCCCCCCCCCCChHHhcCccccccccccccccccccccccccccccchhhhccccccccccccccchhhhcc
Confidence 457777777777776 3667777777774 66765 6777778888888888888888888888777777778888888
Q ss_pred EeccCCeecccCCccccCCCCCCEEEeeCCcccccCChhhcCcCCC-cEEEccCCcCcCCCCccccCCCCCCeEEccCCC
Q 004400 117 LHLSSNNFTGELPKTFAKLTNMKDFRISDNQFTGQIPSFIQNWTKL-EKLFIQPSGLAGPIPSGIFSLENLTDLRISDLN 195 (756)
Q Consensus 117 L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L-~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~n~ 195 (756)
|++++|++.+.+|..+.++++|+.+++++|.+++.+|..+..+..+ +.+++++|++++..|..+..+..+ .++++.+.
T Consensus 130 l~l~~N~~~~~~p~~l~~l~~L~~l~l~~n~l~~~ip~~~~~l~~l~~~l~~~~n~l~~~~~~~~~~l~~~-~l~l~~~~ 208 (313)
T d1ogqa_ 130 LDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLA-FVDLSRNM 208 (313)
T ss_dssp EECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCCCS-EEECCSSE
T ss_pred cccccccccccCchhhccCcccceeeccccccccccccccccccccccccccccccccccccccccccccc-cccccccc
Confidence 8888888887778888888888888888888887788777777765 677888888887777777766544 57777777
Q ss_pred CCCCCccccccc-cccEEEcccccccCCCCccccCCCCCcEEEccCCcCCCCCCccCcCCCCCCeEEecCccccccCCch
Q 004400 196 GPEATFPQLGNM-KMTKLILRNCNITGELPRYLGKMTKLKVLDLSFNRLRGQIPSNFDDLYDVDYIYFAGNLLTGAIPPW 274 (756)
Q Consensus 196 ~~~~~~~~~~~~-~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~ 274 (756)
.....+..+... +++.+++++|.+.+.+| .++.+++|+.|+|++|+++|.+|..|.++++|++|+|++|+|+|.+|..
T Consensus 209 ~~~~~~~~~~~~~~l~~l~~~~~~l~~~~~-~~~~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N~l~g~iP~~ 287 (313)
T d1ogqa_ 209 LEGDASVLFGSDKNTQKIHLAKNSLAFDLG-KVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQG 287 (313)
T ss_dssp EEECCGGGCCTTSCCSEEECCSSEECCBGG-GCCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCCS
T ss_pred cccccccccccccccccccccccccccccc-ccccccccccccCccCeecccCChHHhCCCCCCEEECcCCcccccCCCc
Confidence 666666655554 47888888888887665 5788889999999999999889998999999999999999999888865
Q ss_pred h-hcCCCeeEeecCCCCCCCCcccc
Q 004400 275 M-LERGDKIDLSYNNFTDGSAESSC 298 (756)
Q Consensus 275 ~-~~~l~~l~ls~N~l~~~~~~~~~ 298 (756)
. +.+++.+++++|++.|+.|...|
T Consensus 288 ~~L~~L~~l~l~~N~~l~g~plp~c 312 (313)
T d1ogqa_ 288 GNLQRFDVSAYANNKCLCGSPLPAC 312 (313)
T ss_dssp TTGGGSCGGGTCSSSEEESTTSSCC
T ss_pred ccCCCCCHHHhCCCccccCCCCCCC
Confidence 4 67888888999986555443344
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=99.97 E-value=1.2e-30 Score=273.60 Aligned_cols=251 Identities=29% Similarity=0.417 Sum_probs=231.5
Q ss_pred eccccccccCcccc--cCCcccCCCCCCCEEEccC-CcccCccCcccccCCcce-eeccCccccccCCccCcCcCCCcEE
Q 004400 18 VNQKRVLKEQNLTG--VLPPKLAELTFLQDIDLTL-NYLSGTIPSQWASLPLLN-ISLIANRLKGPIPKYLANISTLVNL 93 (756)
Q Consensus 18 ~~~~l~L~~~~l~~--~~p~~l~~l~~L~~L~L~~-n~l~~~~p~~~~~l~~L~-l~l~~n~~~~~~p~~l~~l~~L~~L 93 (756)
.+..|+|++|+++| .+|+.|+++++|++|+|++ |+++|.+|..|.+++.|+ |++.+|++.+..+..+..+..|+.|
T Consensus 51 ~v~~L~L~~~~l~g~~~lp~~l~~L~~L~~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l 130 (313)
T d1ogqa_ 51 RVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTL 130 (313)
T ss_dssp CEEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEE
T ss_pred EEEEEECCCCCCCCCCCCChHHhcCccccccccccccccccccccccccccccchhhhccccccccccccccchhhhccc
Confidence 37889999999998 6899999999999999997 899999999999999995 8999999999999999999999999
Q ss_pred EeecCcccccCCcccCCCCCCcEEeccCCeecccCCccccCCCCC-CEEEeeCCcccccCChhhcCcCCCcEEEccCCcC
Q 004400 94 TVQYNQFSGELPEELGSLLNLEKLHLSSNNFTGELPKTFAKLTNM-KDFRISDNQFTGQIPSFIQNWTKLEKLFIQPSGL 172 (756)
Q Consensus 94 ~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L-~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l 172 (756)
++++|.+.+.+|..|+++++|+.+++++|.+++.+|..+..+..+ +.+++++|++++..|..+.++..+ .+++.+|..
T Consensus 131 ~l~~N~~~~~~p~~l~~l~~L~~l~l~~n~l~~~ip~~~~~l~~l~~~l~~~~n~l~~~~~~~~~~l~~~-~l~l~~~~~ 209 (313)
T d1ogqa_ 131 DFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLA-FVDLSRNML 209 (313)
T ss_dssp ECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCCCS-EEECCSSEE
T ss_pred ccccccccccCchhhccCcccceeeccccccccccccccccccccccccccccccccccccccccccccc-ccccccccc
Confidence 999999999999999999999999999999999999999998876 899999999999999999888665 799999999
Q ss_pred cCCCCccccCCCCCCeEEccCCCCCCCCccccccccccEEEcccccccCCCCccccCCCCCcEEEccCCcCCCCCCccCc
Q 004400 173 AGPIPSGIFSLENLTDLRISDLNGPEATFPQLGNMKMTKLILRNCNITGELPRYLGKMTKLKVLDLSFNRLRGQIPSNFD 252 (756)
Q Consensus 173 ~~~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~ 252 (756)
.+.+|..+..+++|+.|++++|.+....+......+++.|+|++|+++|.+|..|+++++|++|+|++|+|+|.+|. +.
T Consensus 210 ~~~~~~~~~~~~~l~~l~~~~~~l~~~~~~~~~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N~l~g~iP~-~~ 288 (313)
T d1ogqa_ 210 EGDASVLFGSDKNTQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQ-GG 288 (313)
T ss_dssp EECCGGGCCTTSCCSEEECCSSEECCBGGGCCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCC-ST
T ss_pred cccccccccccccccccccccccccccccccccccccccccCccCeecccCChHHhCCCCCCEEECcCCcccccCCC-cc
Confidence 99999999999999999999999887655433444799999999999999999999999999999999999999995 68
Q ss_pred CCCCCCeEEecCcc-cccc
Q 004400 253 DLYDVDYIYFAGNL-LTGA 270 (756)
Q Consensus 253 ~l~~L~~L~ls~N~-l~~~ 270 (756)
.+.+|+.+++++|+ +.|.
T Consensus 289 ~L~~L~~l~l~~N~~l~g~ 307 (313)
T d1ogqa_ 289 NLQRFDVSAYANNKCLCGS 307 (313)
T ss_dssp TGGGSCGGGTCSSSEEEST
T ss_pred cCCCCCHHHhCCCccccCC
Confidence 89999999999998 5553
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.92 E-value=1e-24 Score=224.64 Aligned_cols=247 Identities=17% Similarity=0.187 Sum_probs=152.3
Q ss_pred cccccCcccccCCcccCCCCCCCEEEccCCcccCccCcccccCCcce-eeccCccccccCCccCcCcCCCcEEEee-cCc
Q 004400 22 RVLKEQNLTGVLPPKLAELTFLQDIDLTLNYLSGTIPSQWASLPLLN-ISLIANRLKGPIPKYLANISTLVNLTVQ-YNQ 99 (756)
Q Consensus 22 l~L~~~~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~-l~l~~n~~~~~~p~~l~~l~~L~~L~L~-~N~ 99 (756)
++.++++++ .+|..+. +.+++|+|++|+|+...+..|..++.|+ +++.+|++....+..+.++..++.|+.. .|.
T Consensus 16 v~c~~~~L~-~iP~~ip--~~~~~L~Ls~N~i~~i~~~~f~~l~~L~~L~ls~n~l~~i~~~~~~~~~~~~~l~~~~~~~ 92 (284)
T d1ozna_ 16 TSCPQQGLQ-AVPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQ 92 (284)
T ss_dssp EECCSSCCS-SCCTTCC--TTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTT
T ss_pred EEcCCCCCC-ccCCCCC--CCCCEEECcCCcCCCCCHHHhhccccccccccccccccccccccccccccccccccccccc
Confidence 445566666 5565554 5677778877777744444555555442 4455555555555555555555555432 334
Q ss_pred ccccCCcccCCCCCCcEEeccCCeecccCCccccCCCCCCEEEeeCCcccccCChhhcCcCCCcEEEccCCcCcCCCCcc
Q 004400 100 FSGELPEELGSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRISDNQFTGQIPSFIQNWTKLEKLFIQPSGLAGPIPSG 179 (756)
Q Consensus 100 l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~ 179 (756)
++...+..|.++++|++|+|++|.+....+..+..+++|+.+++++|+|++..+..|..+++|+.|+|++|++++..+..
T Consensus 93 ~~~l~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~~l~~~~ 172 (284)
T d1ozna_ 93 LRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERA 172 (284)
T ss_dssp CCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTT
T ss_pred cccccchhhcccccCCEEecCCcccccccccccchhcccchhhhccccccccChhHhccccchhhcccccCcccccchhh
Confidence 44344444555555555555555554444444444555555555555555444444555555555555555554444444
Q ss_pred ccCCCCCCeEEccCCCCCCCCccccccccccEEEcccccccCCCCccccCCCCCcEEEccCCcCCCCCCccCcCCCCCCe
Q 004400 180 IFSLENLTDLRISDLNGPEATFPQLGNMKMTKLILRNCNITGELPRYLGKMTKLKVLDLSFNRLRGQIPSNFDDLYDVDY 259 (756)
Q Consensus 180 ~~~l~~L~~L~l~~n~~~~~~~~~~~~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~ 259 (756)
|.++++ |+.+++++|++++..|..|.++++|++|++++|.+.+..+..|..+++|++
T Consensus 173 f~~l~~-----------------------L~~l~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~~ 229 (284)
T d1ozna_ 173 FRGLHS-----------------------LDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQY 229 (284)
T ss_dssp TTTCTT-----------------------CCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCE
T ss_pred hccccc-----------------------cchhhhhhccccccChhHhhhhhhcccccccccccccccccccccccccCE
Confidence 444444 555667778888888899999999999999999999888888999999999
Q ss_pred EEecCccccccCCch-hhcCCCeeEeecCCCCCCCC
Q 004400 260 IYFAGNLLTGAIPPW-MLERGDKIDLSYNNFTDGSA 294 (756)
Q Consensus 260 L~ls~N~l~~~~p~~-~~~~l~~l~ls~N~l~~~~~ 294 (756)
|++++|++.|.++.. +..+++.+....+++.|..+
T Consensus 230 L~l~~N~l~C~C~~~~l~~~l~~~~~~~~~~~C~~p 265 (284)
T d1ozna_ 230 LRLNDNPWVCDCRARPLWAWLQKFRGSSSEVPCSLP 265 (284)
T ss_dssp EECCSSCEECSGGGHHHHHHHHHCCSEECCCBEEES
T ss_pred EEecCCCCCCCccchHHHHHHHhCcCCCCceEeCCc
Confidence 999999999887643 34455555666666665433
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.91 E-value=1.6e-23 Score=217.97 Aligned_cols=263 Identities=22% Similarity=0.276 Sum_probs=222.7
Q ss_pred eccccccccCcccccCCcccCCCCCCCEEEccCCcccCccCcccccCCcce-eeccCccccccCCccCcCcCCCcEEEee
Q 004400 18 VNQKRVLKEQNLTGVLPPKLAELTFLQDIDLTLNYLSGTIPSQWASLPLLN-ISLIANRLKGPIPKYLANISTLVNLTVQ 96 (756)
Q Consensus 18 ~~~~l~L~~~~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~-l~l~~n~~~~~~p~~l~~l~~L~~L~L~ 96 (756)
.++.++=++++++ .+|..+. +.|++|+|++|+|+...+..|..++.|+ +++.+|.+....|..|.++++|++|+++
T Consensus 11 ~~~~~~C~~~~L~-~lP~~l~--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~l~~n~~~~i~~~~f~~l~~L~~L~l~ 87 (305)
T d1xkua_ 11 HLRVVQCSDLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLS 87 (305)
T ss_dssp ETTEEECTTSCCC-SCCCSCC--TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECC
T ss_pred cCCEEEecCCCCC-ccCCCCC--CCCCEEECcCCcCCCcChhHhhccccccccccccccccccchhhhhCCCccCEeccc
Confidence 4556665666788 5677665 7899999999999966667899999885 8999999998889999999999999999
Q ss_pred cCcccccCCcccCCCCCCcEEeccCCeecccCCccccCCCCCCEEEeeCCccc--ccCChhhcCcCCCcEEEccCCcCcC
Q 004400 97 YNQFSGELPEELGSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRISDNQFT--GQIPSFIQNWTKLEKLFIQPSGLAG 174 (756)
Q Consensus 97 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~--~~~p~~~~~l~~L~~L~l~~N~l~~ 174 (756)
+|+|+ .+|..+ ...|..|++++|.+.+..+..+.....+..++...|... ...+..|..+++|+.+++++|++.
T Consensus 88 ~n~l~-~l~~~~--~~~l~~L~~~~n~l~~l~~~~~~~~~~~~~l~~~~n~~~~~~~~~~~~~~l~~L~~l~l~~n~l~- 163 (305)
T d1xkua_ 88 KNQLK-ELPEKM--PKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT- 163 (305)
T ss_dssp SSCCS-BCCSSC--CTTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCC-
T ss_pred CCccC-cCccch--hhhhhhhhccccchhhhhhhhhhccccccccccccccccccCCCccccccccccCccccccCCcc-
Confidence 99999 566543 358999999999999776667888889999999998644 455678899999999999999998
Q ss_pred CCCccccCCCCCCeEEccCCCCCCCCccccccc-cccEEEcccccccCCCCccccCCCCCcEEEccCCcCCCCCCccCcC
Q 004400 175 PIPSGIFSLENLTDLRISDLNGPEATFPQLGNM-KMTKLILRNCNITGELPRYLGKMTKLKVLDLSFNRLRGQIPSNFDD 253 (756)
Q Consensus 175 ~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~-~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~ 253 (756)
.+|..+ +++|+.|++++|......+..+... .++.|++++|.+.+..+..|.++++|++|+|++|+|+ .+|..|..
T Consensus 164 ~l~~~~--~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~s~n~l~~~~~~~~~~l~~L~~L~L~~N~L~-~lp~~l~~ 240 (305)
T d1xkua_ 164 TIPQGL--PPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLAD 240 (305)
T ss_dssp SCCSSC--CTTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTTTTT
T ss_pred ccCccc--CCccCEEECCCCcCCCCChhHhhccccccccccccccccccccccccccccceeeeccccccc-cccccccc
Confidence 456554 5899999999999998887777665 5999999999999988999999999999999999999 67889999
Q ss_pred CCCCCeEEecCccccccCCc-hh--------hcCCCeeEeecCCCCC
Q 004400 254 LYDVDYIYFAGNLLTGAIPP-WM--------LERGDKIDLSYNNFTD 291 (756)
Q Consensus 254 l~~L~~L~ls~N~l~~~~p~-~~--------~~~l~~l~ls~N~l~~ 291 (756)
+++|++|+|++|+|+. ++. .+ ...++.+++++|++..
T Consensus 241 l~~L~~L~Ls~N~i~~-i~~~~f~~~~~~~~~~~L~~L~L~~N~~~~ 286 (305)
T d1xkua_ 241 HKYIQVVYLHNNNISA-IGSNDFCPPGYNTKKASYSGVSLFSNPVQY 286 (305)
T ss_dssp CSSCCEEECCSSCCCC-CCTTSSSCSSCCTTSCCCSEEECCSSSSCG
T ss_pred ccCCCEEECCCCccCc-cChhhccCcchhcccCCCCEEECCCCcCcc
Confidence 9999999999999984 432 21 5678899999999864
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.91 E-value=1.4e-24 Score=223.63 Aligned_cols=250 Identities=17% Similarity=0.179 Sum_probs=205.0
Q ss_pred eeccccccccCcccccCCcccCCCCCCCEEEccCCcccCccCcccccCCcc-eeec-cCccccccCCccCcCcCCCcEEE
Q 004400 17 TVNQKRVLKEQNLTGVLPPKLAELTFLQDIDLTLNYLSGTIPSQWASLPLL-NISL-IANRLKGPIPKYLANISTLVNLT 94 (756)
Q Consensus 17 ~~~~~l~L~~~~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L-~l~l-~~n~~~~~~p~~l~~l~~L~~L~ 94 (756)
+.+++|+|++|+|++..+..|.++++|+.|++++|+|....+..+..+..+ +++. ..|.+....|..|.++++|++|+
T Consensus 32 ~~~~~L~Ls~N~i~~i~~~~f~~l~~L~~L~ls~n~l~~i~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~~l~~L~~L~ 111 (284)
T d1ozna_ 32 AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLH 111 (284)
T ss_dssp TTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTTCCCCCTTTTTTCTTCCEEE
T ss_pred CCCCEEECcCCcCCCCCHHHhhccccccccccccccccccccccccccccccccccccccccccccchhhcccccCCEEe
Confidence 346899999999998888889999999999999999998888888888776 4544 45667777788999999999999
Q ss_pred eecCcccccCCcccCCCCCCcEEeccCCeecccCCccccCCCCCCEEEeeCCcccccCChhhcCcCCCcEEEccCCcCcC
Q 004400 95 VQYNQFSGELPEELGSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRISDNQFTGQIPSFIQNWTKLEKLFIQPSGLAG 174 (756)
Q Consensus 95 L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~ 174 (756)
|++|.+....+..+..+.+|+.+++++|+|++..+..|..+++|+.|+|++|+|++..+.+|.++++|+.|++++|++++
T Consensus 112 l~~n~~~~~~~~~~~~~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~~l~~~~f~~l~~L~~l~l~~N~l~~ 191 (284)
T d1ozna_ 112 LDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAH 191 (284)
T ss_dssp CTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCE
T ss_pred cCCcccccccccccchhcccchhhhccccccccChhHhccccchhhcccccCcccccchhhhccccccchhhhhhccccc
Confidence 99999997777889999999999999999997778889999999999999999998889999999999999999999998
Q ss_pred CCCccccCCCCCCeEEccCCCCCCCCccccccccccEEEcccccccCCCCccccCCCCCcEEEccCCcCCCCCCccCcCC
Q 004400 175 PIPSGIFSLENLTDLRISDLNGPEATFPQLGNMKMTKLILRNCNITGELPRYLGKMTKLKVLDLSFNRLRGQIPSNFDDL 254 (756)
Q Consensus 175 ~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l 254 (756)
..|..|.++++|++|+++ +|.+.+..+..|+.+++|++|+|++|.+.+.-+. ..-.
T Consensus 192 i~~~~f~~l~~L~~L~l~-----------------------~N~i~~~~~~~~~~~~~L~~L~l~~N~l~C~C~~-~~l~ 247 (284)
T d1ozna_ 192 VHPHAFRDLGRLMTLYLF-----------------------ANNLSALPTEALAPLRALQYLRLNDNPWVCDCRA-RPLW 247 (284)
T ss_dssp ECTTTTTTCTTCCEEECC-----------------------SSCCSCCCHHHHTTCTTCCEEECCSSCEECSGGG-HHHH
T ss_pred cChhHhhhhhhccccccc-----------------------ccccccccccccccccccCEEEecCCCCCCCccc-hHHH
Confidence 889999998888877655 4666666777788888899999999888854321 1111
Q ss_pred CCCCeEEecCccccccCCchhhcCCCeeEeecCCCCC
Q 004400 255 YDVDYIYFAGNLLTGAIPPWMLERGDKIDLSYNNFTD 291 (756)
Q Consensus 255 ~~L~~L~ls~N~l~~~~p~~~~~~l~~l~ls~N~l~~ 291 (756)
..++.+....+.+.|..|..+. .....+++.+.++|
T Consensus 248 ~~l~~~~~~~~~~~C~~p~~l~-g~~l~~l~~~~l~g 283 (284)
T d1ozna_ 248 AWLQKFRGSSSEVPCSLPQRLA-GRDLKRLAANDLQG 283 (284)
T ss_dssp HHHHHCCSEECCCBEEESGGGT-TCBGGGSCGGGSCC
T ss_pred HHHHhCcCCCCceEeCCchHHc-CCccccCCHHHCCC
Confidence 2355566667778877776652 33455566666654
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.90 E-value=1.8e-23 Score=212.80 Aligned_cols=180 Identities=22% Similarity=0.186 Sum_probs=129.0
Q ss_pred CCCcEEEeecCcccccCCcccCCCCCCcEEeccCCeecccCCccccCCCCCCEEEeeCCcccccCChhhcCcCCCcEEEc
Q 004400 88 STLVNLTVQYNQFSGELPEELGSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRISDNQFTGQIPSFIQNWTKLEKLFI 167 (756)
Q Consensus 88 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l 167 (756)
++|++|+|++|+|++..+.+|.++++|++|+|++|+|+ .+| .++.+++|+.|+|++|+++ ..+..+.++++|+.|++
T Consensus 31 ~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~-~l~-~~~~l~~L~~L~Ls~N~l~-~~~~~~~~l~~L~~L~l 107 (266)
T d1p9ag_ 31 KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELT-KLQ-VDGTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDV 107 (266)
T ss_dssp TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCC-EEE-CCSCCTTCCEEECCSSCCS-SCCCCTTTCTTCCEEEC
T ss_pred cCCCEEECcCCcCCCcCHHHhhcccccccccccccccc-ccc-ccccccccccccccccccc-ccccccccccccccccc
Confidence 45677777777777555566777777777777777776 333 2456677777777777776 44556677777777777
Q ss_pred cCCcCcCCCCccccCCCCCCeEEccCCCCCCCCccccccc-cccEEEcccccccCCCCccccCCCCCcEEEccCCcCCCC
Q 004400 168 QPSGLAGPIPSGIFSLENLTDLRISDLNGPEATFPQLGNM-KMTKLILRNCNITGELPRYLGKMTKLKVLDLSFNRLRGQ 246 (756)
Q Consensus 168 ~~N~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~-~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ 246 (756)
++|.+....+..+..+.+++.|++++|.+.......+..+ .++.|++++|++++..+..|..+++|++|+|++|+|+ .
T Consensus 108 ~~~~~~~~~~~~~~~l~~l~~L~l~~n~l~~l~~~~~~~l~~l~~l~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~L~-~ 186 (266)
T d1p9ag_ 108 SFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-T 186 (266)
T ss_dssp CSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCC-C
T ss_pred cccccceeeccccccccccccccccccccceeccccccccccchhcccccccccccCccccccccccceeecccCCCc-c
Confidence 7777766666666667777777777766666655555544 4777777788888777777888888888888888888 7
Q ss_pred CCccCcCCCCCCeEEecCccccccC
Q 004400 247 IPSNFDDLYDVDYIYFAGNLLTGAI 271 (756)
Q Consensus 247 ~p~~~~~l~~L~~L~ls~N~l~~~~ 271 (756)
+|..+..+++|+.|+|++|++.|.+
T Consensus 187 lp~~~~~~~~L~~L~L~~Np~~CdC 211 (266)
T d1p9ag_ 187 IPKGFFGSHLLPFAFLHGNPWLCNC 211 (266)
T ss_dssp CCTTTTTTCCCSEEECCSCCBCCSG
T ss_pred cChhHCCCCCCCEEEecCCCCCCCc
Confidence 7777778888888888888887654
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.90 E-value=1.5e-22 Score=210.51 Aligned_cols=251 Identities=21% Similarity=0.238 Sum_probs=215.8
Q ss_pred eeccccccccCcccccCCcccCCCCCCCEEEccCCcccCccCcccccCCcc-eeeccCccccccCCccCcCcCCCcEEEe
Q 004400 17 TVNQKRVLKEQNLTGVLPPKLAELTFLQDIDLTLNYLSGTIPSQWASLPLL-NISLIANRLKGPIPKYLANISTLVNLTV 95 (756)
Q Consensus 17 ~~~~~l~L~~~~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L-~l~l~~n~~~~~~p~~l~~l~~L~~L~L 95 (756)
+.+++|+|++|+|+...+..|.++++|+.|++++|.+....|..|..++.| .+++.+|++. .+|..+. ..|..|++
T Consensus 31 ~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~l~~n~~~~i~~~~f~~l~~L~~L~l~~n~l~-~l~~~~~--~~l~~L~~ 107 (305)
T d1xkua_ 31 PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLK-ELPEKMP--KTLQELRV 107 (305)
T ss_dssp TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCS-BCCSSCC--TTCCEEEC
T ss_pred CCCCEEECcCCcCCCcChhHhhccccccccccccccccccchhhhhCCCccCEecccCCccC-cCccchh--hhhhhhhc
Confidence 568899999999997777789999999999999999998888999999998 5889999988 4555443 68999999
Q ss_pred ecCcccccCCcccCCCCCCcEEeccCCeec--ccCCccccCCCCCCEEEeeCCcccccCChhhcCcCCCcEEEccCCcCc
Q 004400 96 QYNQFSGELPEELGSLLNLEKLHLSSNNFT--GELPKTFAKLTNMKDFRISDNQFTGQIPSFIQNWTKLEKLFIQPSGLA 173 (756)
Q Consensus 96 ~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~--~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~ 173 (756)
.+|.+.+..+..+.....+..++...|... ...+..|..+++|+.+++++|+++ .+|..+ +++|+.|++++|...
T Consensus 108 ~~n~l~~l~~~~~~~~~~~~~l~~~~n~~~~~~~~~~~~~~l~~L~~l~l~~n~l~-~l~~~~--~~~L~~L~l~~n~~~ 184 (305)
T d1xkua_ 108 HENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGL--PPSLTELHLDGNKIT 184 (305)
T ss_dssp CSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCC-SCCSSC--CTTCSEEECTTSCCC
T ss_pred cccchhhhhhhhhhccccccccccccccccccCCCccccccccccCccccccCCcc-ccCccc--CCccCEEECCCCcCC
Confidence 999999877778888999999999988654 345667889999999999999998 566543 689999999999999
Q ss_pred CCCCccccCCCCCCeEEccCCCCCCCCccccccc-cccEEEcccccccCCCCccccCCCCCcEEEccCCcCCCCCCcc--
Q 004400 174 GPIPSGIFSLENLTDLRISDLNGPEATFPQLGNM-KMTKLILRNCNITGELPRYLGKMTKLKVLDLSFNRLRGQIPSN-- 250 (756)
Q Consensus 174 ~~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~-~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~-- 250 (756)
+..+..+.+++.++.|++++|.+....+..+... +|++|+|++|+|+ .+|.+|..+++|++|+|++|+|+......
T Consensus 185 ~~~~~~~~~~~~l~~L~~s~n~l~~~~~~~~~~l~~L~~L~L~~N~L~-~lp~~l~~l~~L~~L~Ls~N~i~~i~~~~f~ 263 (305)
T d1xkua_ 185 KVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFC 263 (305)
T ss_dssp EECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTTTTTCSSCCEEECCSSCCCCCCTTSSS
T ss_pred CCChhHhhccccccccccccccccccccccccccccceeeeccccccc-ccccccccccCCCEEECCCCccCccChhhcc
Confidence 9999999999999999999999999888777765 6999999999999 56889999999999999999999654444
Q ss_pred ----CcCCCCCCeEEecCcccc-ccCCch
Q 004400 251 ----FDDLYDVDYIYFAGNLLT-GAIPPW 274 (756)
Q Consensus 251 ----~~~l~~L~~L~ls~N~l~-~~~p~~ 274 (756)
+..+++|+.|+|++|+++ ..+++.
T Consensus 264 ~~~~~~~~~~L~~L~L~~N~~~~~~~~~~ 292 (305)
T d1xkua_ 264 PPGYNTKKASYSGVSLFSNPVQYWEIQPS 292 (305)
T ss_dssp CSSCCTTSCCCSEEECCSSSSCGGGSCGG
T ss_pred CcchhcccCCCCEEECCCCcCccCcCCHh
Confidence 346788999999999986 345443
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.89 E-value=7.4e-23 Score=208.28 Aligned_cols=202 Identities=19% Similarity=0.198 Sum_probs=180.9
Q ss_pred CcCcCCCcEEEeecCcccccCCcccCCCCCCcEEeccCCeecccCCccccCCCCCCEEEeeCCcccccCChhhcCcCCCc
Q 004400 84 LANISTLVNLTVQYNQFSGELPEELGSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRISDNQFTGQIPSFIQNWTKLE 163 (756)
Q Consensus 84 l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~ 163 (756)
..+.+.+.+.+.+++.|+ .+|..+. ++|++|+|++|+|++..+..|.++++|++|+|++|+|+ .++ .++.+++|+
T Consensus 6 ~~~~~~~~~v~C~~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~-~l~-~~~~l~~L~ 80 (266)
T d1p9ag_ 6 VSKVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELT-KLQ-VDGTLPVLG 80 (266)
T ss_dssp EECSTTCCEEECTTSCCS-SCCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCC-EEE-CCSCCTTCC
T ss_pred EcccCCCeEEEccCCCCC-eeCcCcC--cCCCEEECcCCcCCCcCHHHhhcccccccccccccccc-ccc-ccccccccc
Confidence 346678888999999999 6887665 58999999999999777788999999999999999999 454 368899999
Q ss_pred EEEccCCcCcCCCCccccCCCCCCeEEccCCCCCCCCccccccc-cccEEEcccccccCCCCccccCCCCCcEEEccCCc
Q 004400 164 KLFIQPSGLAGPIPSGIFSLENLTDLRISDLNGPEATFPQLGNM-KMTKLILRNCNITGELPRYLGKMTKLKVLDLSFNR 242 (756)
Q Consensus 164 ~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~-~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~ 242 (756)
.|+|++|+++ ..+..+.++++|+.|++++|.+.......+... ++..|++++|.++...+..+..+++|+.|++++|+
T Consensus 81 ~L~Ls~N~l~-~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~l~~l~~L~l~~n~l~~l~~~~~~~l~~l~~l~l~~N~ 159 (266)
T d1p9ag_ 81 TLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNN 159 (266)
T ss_dssp EEECCSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSC
T ss_pred cccccccccc-ccccccccccccccccccccccceeeccccccccccccccccccccceeccccccccccchhccccccc
Confidence 9999999998 467789999999999999999999887777665 59999999999998888889999999999999999
Q ss_pred CCCCCCccCcCCCCCCeEEecCccccccCCchh--hcCCCeeEeecCCCCCC
Q 004400 243 LRGQIPSNFDDLYDVDYIYFAGNLLTGAIPPWM--LERGDKIDLSYNNFTDG 292 (756)
Q Consensus 243 l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~--~~~l~~l~ls~N~l~~~ 292 (756)
|++..+..|..+++|++|+|++|+|+ .+|..+ ++.++.|++++|++.|.
T Consensus 160 l~~~~~~~~~~l~~L~~L~Ls~N~L~-~lp~~~~~~~~L~~L~L~~Np~~Cd 210 (266)
T d1p9ag_ 160 LTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWLCN 210 (266)
T ss_dssp CSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBCCS
T ss_pred ccccCccccccccccceeecccCCCc-ccChhHCCCCCCCEEEecCCCCCCC
Confidence 99988899999999999999999999 788776 77899999999999875
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=99.89 E-value=2.1e-22 Score=216.35 Aligned_cols=263 Identities=21% Similarity=0.283 Sum_probs=203.1
Q ss_pred eccceeccccccccCcccccCCcccCCCCCCCEEEccCCcccCccCcccccCCcce-eeccCccccccCCccCcCcCCCc
Q 004400 13 WKQKTVNQKRVLKEQNLTGVLPPKLAELTFLQDIDLTLNYLSGTIPSQWASLPLLN-ISLIANRLKGPIPKYLANISTLV 91 (756)
Q Consensus 13 ~~~~~~~~~l~L~~~~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~-l~l~~n~~~~~~p~~l~~l~~L~ 91 (756)
..++..+++|++++++|+.. +.+..+++|++|+|++|+|++..| ++.++.|+ |++.+|++.+..| ++++++|+
T Consensus 40 ~~~l~~l~~L~l~~~~I~~l--~gl~~L~nL~~L~Ls~N~l~~l~~--l~~L~~L~~L~L~~n~i~~i~~--l~~l~~L~ 113 (384)
T d2omza2 40 QTDLDQVTTLQADRLGIKSI--DGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITP--LANLTNLT 113 (384)
T ss_dssp HHHHTTCCEEECCSSCCCCC--TTGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCCGG--GTTCTTCC
T ss_pred HHHhCCCCEEECCCCCCCCc--cccccCCCCCEEeCcCCcCCCCcc--ccCCcccccccccccccccccc--cccccccc
Confidence 45677889999999999854 568889999999999999985433 88888884 8899998886543 88899999
Q ss_pred EEEeecCcccccC---------------------------------------------------------------Cccc
Q 004400 92 NLTVQYNQFSGEL---------------------------------------------------------------PEEL 108 (756)
Q Consensus 92 ~L~L~~N~l~~~~---------------------------------------------------------------p~~~ 108 (756)
.|++++|.+++.. ...+
T Consensus 114 ~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (384)
T d2omza2 114 GLTLFNNQITDIDPLKNLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDISVL 193 (384)
T ss_dssp EEECCSSCCCCCGGGTTCTTCSEEEEEEEEECCCGGGTTCTTCSEEEEEESCCCCGGGTTCTTCCEEECCSSCCCCCGGG
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhcccccccccccccccccccccc
Confidence 9999988776411 1235
Q ss_pred CCCCCCcEEeccCCeecccCCccccCCCCCCEEEeeCCcccccCChhhcCcCCCcEEEccCCcCcCCCCccccCCCCCCe
Q 004400 109 GSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRISDNQFTGQIPSFIQNWTKLEKLFIQPSGLAGPIPSGIFSLENLTD 188 (756)
Q Consensus 109 ~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~ 188 (756)
..+++++.|++++|.+++..| +...++|+.|++++|+++. + ..+..+++|+.|++++|.+++.. .+..+++|+.
T Consensus 194 ~~l~~~~~l~l~~n~i~~~~~--~~~~~~L~~L~l~~n~l~~-~-~~l~~l~~L~~L~l~~n~l~~~~--~~~~~~~L~~ 267 (384)
T d2omza2 194 AKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKD-I-GTLASLTNLTDLDLANNQISNLA--PLSGLTKLTE 267 (384)
T ss_dssp GGCTTCSEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCC-C-GGGGGCTTCSEEECCSSCCCCCG--GGTTCTTCSE
T ss_pred ccccccceeeccCCccCCCCc--ccccCCCCEEECCCCCCCC-c-chhhcccccchhccccCccCCCC--cccccccCCE
Confidence 567889999999999986554 5667899999999999984 3 36888999999999999998543 3788899999
Q ss_pred EEccCCCCCCCCccccccccccEEEcccccccCCCCccccCCCCCcEEEccCCcCCCCCCccCcCCCCCCeEEecCcccc
Q 004400 189 LRISDLNGPEATFPQLGNMKMTKLILRNCNITGELPRYLGKMTKLKVLDLSFNRLRGQIPSNFDDLYDVDYIYFAGNLLT 268 (756)
Q Consensus 189 L~l~~n~~~~~~~~~~~~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~ 268 (756)
|++++|.+....+ ......++.+.++.|.+++. ..+..+++++.|++++|++++.. .+..+++|+.|++++|+++
T Consensus 268 L~l~~~~l~~~~~-~~~~~~l~~l~~~~n~l~~~--~~~~~~~~l~~L~ls~n~l~~l~--~l~~l~~L~~L~L~~n~l~ 342 (384)
T d2omza2 268 LKLGANQISNISP-LAGLTALTNLELNENQLEDI--SPISNLKNLTYLTLYFNNISDIS--PVSSLTKLQRLFFANNKVS 342 (384)
T ss_dssp EECCSSCCCCCGG-GTTCTTCSEEECCSSCCSCC--GGGGGCTTCSEEECCSSCCSCCG--GGGGCTTCCEEECCSSCCC
T ss_pred eeccCcccCCCCc-cccccccccccccccccccc--cccchhcccCeEECCCCCCCCCc--ccccCCCCCEEECCCCCCC
Confidence 9999988876542 22333577888888888753 34777888888888888888643 2778888888888888887
Q ss_pred ccCCchh--hcCCCeeEeecCCCCCCCC
Q 004400 269 GAIPPWM--LERGDKIDLSYNNFTDGSA 294 (756)
Q Consensus 269 ~~~p~~~--~~~l~~l~ls~N~l~~~~~ 294 (756)
+ ++ .+ +++|+.|++++|++++..+
T Consensus 343 ~-l~-~l~~l~~L~~L~l~~N~l~~l~~ 368 (384)
T d2omza2 343 D-VS-SLANLTNINWLSAGHNQISDLTP 368 (384)
T ss_dssp C-CG-GGGGCTTCCEEECCSSCCCBCGG
T ss_pred C-Ch-hHcCCCCCCEEECCCCcCCCChh
Confidence 4 33 23 6788888888888876543
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=99.88 E-value=7.3e-22 Score=212.04 Aligned_cols=191 Identities=26% Similarity=0.379 Sum_probs=107.5
Q ss_pred CcCcCCCcEEEeecCcccccCCcccCCCCCCcEEeccCCeecccCCccccCCCCCCEEEeeCCcccccCChhhcCcCCCc
Q 004400 84 LANISTLVNLTVQYNQFSGELPEELGSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRISDNQFTGQIPSFIQNWTKLE 163 (756)
Q Consensus 84 l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~ 163 (756)
+..+++++.|++++|.+++..| +..+++|+.|++++|+++. + ..+..+++|+.|++++|++++..+ +..+++|+
T Consensus 193 ~~~l~~~~~l~l~~n~i~~~~~--~~~~~~L~~L~l~~n~l~~-~-~~l~~l~~L~~L~l~~n~l~~~~~--~~~~~~L~ 266 (384)
T d2omza2 193 LAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKD-I-GTLASLTNLTDLDLANNQISNLAP--LSGLTKLT 266 (384)
T ss_dssp GGGCTTCSEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCC-C-GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCS
T ss_pred cccccccceeeccCCccCCCCc--ccccCCCCEEECCCCCCCC-c-chhhcccccchhccccCccCCCCc--ccccccCC
Confidence 4445556666666666664333 3445566666666666652 2 245566666666666666664332 55666666
Q ss_pred EEEccCCcCcCCCCccccCCCCCCeEEccCCCCCCCCccccccccccEEEcccccccCCCCccccCCCCCcEEEccCCcC
Q 004400 164 KLFIQPSGLAGPIPSGIFSLENLTDLRISDLNGPEATFPQLGNMKMTKLILRNCNITGELPRYLGKMTKLKVLDLSFNRL 243 (756)
Q Consensus 164 ~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l 243 (756)
.|++++|++++.. .+..++.++.+++++|.+.... ......+++.|++++|++++.. .+..+++|+.|+|++|+|
T Consensus 267 ~L~l~~~~l~~~~--~~~~~~~l~~l~~~~n~l~~~~-~~~~~~~l~~L~ls~n~l~~l~--~l~~l~~L~~L~L~~n~l 341 (384)
T d2omza2 267 ELKLGANQISNIS--PLAGLTALTNLELNENQLEDIS-PISNLKNLTYLTLYFNNISDIS--PVSSLTKLQRLFFANNKV 341 (384)
T ss_dssp EEECCSSCCCCCG--GGTTCTTCSEEECCSSCCSCCG-GGGGCTTCSEEECCSSCCSCCG--GGGGCTTCCEEECCSSCC
T ss_pred EeeccCcccCCCC--cccccccccccccccccccccc-ccchhcccCeEECCCCCCCCCc--ccccCCCCCEEECCCCCC
Confidence 6666666665322 2555666666666666555432 1122224666666666666543 255666666666666666
Q ss_pred CCCCCccCcCCCCCCeEEecCccccccCCchhhcCCCeeEeecC
Q 004400 244 RGQIPSNFDDLYDVDYIYFAGNLLTGAIPPWMLERGDKIDLSYN 287 (756)
Q Consensus 244 ~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~~l~~l~ls~N 287 (756)
++ ++ .+..+++|++|++++|++++..|-.-+++|+.|++++|
T Consensus 342 ~~-l~-~l~~l~~L~~L~l~~N~l~~l~~l~~l~~L~~L~L~~N 383 (384)
T d2omza2 342 SD-VS-SLANLTNINWLSAGHNQISDLTPLANLTRITQLGLNDQ 383 (384)
T ss_dssp CC-CG-GGGGCTTCCEEECCSSCCCBCGGGTTCTTCSEEECCCE
T ss_pred CC-Ch-hHcCCCCCCEEECCCCcCCCChhhccCCCCCEeeCCCC
Confidence 63 33 35666666666666666665444222556666666655
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.88 E-value=1.7e-23 Score=201.63 Aligned_cols=162 Identities=20% Similarity=0.168 Sum_probs=121.0
Q ss_pred cccCcccCCCCccEEEeeccCCcEEEEEEccccCc------------------ccHHHHHHHHHHHHhCCCCceeeEeeE
Q 004400 419 ATDNNIGEGGFGPVYKGLLADGTAIAVKQLSSKSK------------------QGNREFINEIGMISALQHPNLVKLYGC 480 (756)
Q Consensus 419 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~------------------~~~~~~~~E~~~l~~l~h~niv~l~~~ 480 (756)
...+.||+|+||+||+|+..+|+.||||+++.... .....+.+|...+.++.|.+++..+++
T Consensus 3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~ 82 (191)
T d1zara2 3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW 82 (191)
T ss_dssp EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred hhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence 35689999999999999988899999998753210 011334568889999999999988765
Q ss_pred EEeCCeEEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEcCCCCCCceEecCCCCEEEccC
Q 004400 481 CIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDF 560 (756)
Q Consensus 481 ~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g~~~iiH~Dikp~Nill~~~~~~kl~DF 560 (756)
. ..++||||++++.+. .++......++.|+++|++|||++| |+||||||+|||++++ .++|+||
T Consensus 83 ~----~~~lvme~~~~~~~~--------~l~~~~~~~i~~ql~~~l~~lH~~g---iiHrDiKP~NILv~~~-~~~liDF 146 (191)
T d1zara2 83 E----GNAVLMELIDAKELY--------RVRVENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVSEE-GIWIIDF 146 (191)
T ss_dssp E----TTEEEEECCCCEEGG--------GCCCSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEETT-EEEECCC
T ss_pred c----CCEEEEEeecccccc--------chhhHHHHHHHHHHHHHHHHHhhCC---EEEccCChhheeeeCC-CEEEEEC
Confidence 3 237999999986542 3455667789999999999999997 9999999999999975 5999999
Q ss_pred CccccCcccCcceeeccccCccCCc------hHhhhcCCCCcccchhhHHHH
Q 004400 561 GLAKLDEEENTHISTRVAGTIGYMA------PEYAMRGHLTEKADVYSFGIV 606 (756)
Q Consensus 561 Gla~~~~~~~~~~~~~~~gt~~y~a------PE~~~~~~~~~~~Dv~slGv~ 606 (756)
|+|+........ .|.. .|. ..+.|+.++|+||..--
T Consensus 147 G~a~~~~~~~~~---------~~l~rd~~~~~~~-f~r~y~~~~d~~s~~~~ 188 (191)
T d1zara2 147 PQSVEVGEEGWR---------EILERDVRNIITY-FSRTYRTEKDINSAIDR 188 (191)
T ss_dssp TTCEETTSTTHH---------HHHHHHHHHHHHH-HHHHHCCCCCHHHHHHH
T ss_pred CCcccCCCCCcH---------HHHHHHHHHHHHH-HcCCCCCcccHHHHHHH
Confidence 999755432211 0111 111 24568889999996543
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.75 E-value=6.5e-18 Score=168.69 Aligned_cols=219 Identities=14% Similarity=0.140 Sum_probs=125.4
Q ss_pred cccccccCcccccCCcccCCCCCCCEEEccCCcccCccCcccccCCcceeeccCccccccCCccCcCcCCCcEEEeecCc
Q 004400 20 QKRVLKEQNLTGVLPPKLAELTFLQDIDLTLNYLSGTIPSQWASLPLLNISLIANRLKGPIPKYLANISTLVNLTVQYNQ 99 (756)
Q Consensus 20 ~~l~L~~~~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~l~l~~n~~~~~~p~~l~~l~~L~~L~L~~N~ 99 (756)
+.++.++++++ .+|+.+. +++++|+|++|.|+. ..+.+|.++++|++|+|++|.
T Consensus 11 ~~i~c~~~~l~-~iP~~l~--~~l~~L~Ls~n~i~~-----------------------l~~~~f~~l~~L~~L~ls~n~ 64 (242)
T d1xwdc1 11 RVFLCQESKVT-EIPSDLP--RNAIELRFVLTKLRV-----------------------IQKGAFSGFGDLEKIEISQND 64 (242)
T ss_dssp SEEEEESCSCS-SCCSCSC--SCCSEEEEESCCCCE-----------------------ECTTTTTTCTTCCEEEEESCT
T ss_pred CEEEEeCCCCC-CcCCCCC--CCCCEEECcCCcCCc-----------------------cChhHhhccchhhhhhhcccc
Confidence 34555555555 4454443 456666666666652 222345556666666666666
Q ss_pred ccccC-CcccCCCCCCcEEeccC-CeecccCCccccCCCCCCEEEeeCCcccccCC-hhhcCcCCCcEEEccCCcCcCCC
Q 004400 100 FSGEL-PEELGSLLNLEKLHLSS-NNFTGELPKTFAKLTNMKDFRISDNQFTGQIP-SFIQNWTKLEKLFIQPSGLAGPI 176 (756)
Q Consensus 100 l~~~~-p~~~~~l~~L~~L~L~~-N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~l~~N~l~~~~ 176 (756)
+...+ +..|.+++++++|.+.. |++....+..|.++++|+.|++++|+++...+ ..+..+..|..+...++.+....
T Consensus 65 ~~~~i~~~~f~~l~~l~~l~~~~~n~l~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~~~~~l~~l~~~~~~n~~l~~i~ 144 (242)
T d1xwdc1 65 VLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIE 144 (242)
T ss_dssp TCCEECSSSEESCTTCCEEEEECCTTCCEECTTSEECCTTCCEEEEESCCCCSCCCCTTTCBSSCEEEEEESCTTCCEEC
T ss_pred ccceeeccccccccccccccccccccccccccccccccccccccccchhhhccccccccccccccccccccccccccccc
Confidence 55432 33455666666665543 45554555556666666666666666653222 12233444555555555555444
Q ss_pred CccccCCC-CCCeEEccCCCCCCCCccccccccccEE-EcccccccCCCCccccCCCCCcEEEccCCcCCCCCCccCcCC
Q 004400 177 PSGIFSLE-NLTDLRISDLNGPEATFPQLGNMKMTKL-ILRNCNITGELPRYLGKMTKLKVLDLSFNRLRGQIPSNFDDL 254 (756)
Q Consensus 177 p~~~~~l~-~L~~L~l~~n~~~~~~~~~~~~~~L~~L-~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l 254 (756)
+..+.+++ .+..|++++|.+.......+...++.++ .+++|+++...+..|.++++|++|+|++|+|+...+..|.++
T Consensus 145 ~~~~~~~~~~l~~L~l~~n~l~~i~~~~~~~~~l~~~~~l~~n~l~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l 224 (242)
T d1xwdc1 145 RNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENL 224 (242)
T ss_dssp TTSSTTSBSSCEEEECCSSCCCEECTTTTTTCCEEEEECTTCTTCCCCCTTTTTTSCCCSEEECTTSCCCCCCSSSCTTC
T ss_pred ccccccccccceeeecccccccccccccccchhhhccccccccccccccHHHhcCCCCCCEEECCCCcCCccCHHHHcCC
Confidence 44444443 5556666666666555555555554444 456677775555667888888888888888885555567777
Q ss_pred CCCCeEEecC
Q 004400 255 YDVDYIYFAG 264 (756)
Q Consensus 255 ~~L~~L~ls~ 264 (756)
++|+.+++.+
T Consensus 225 ~~L~~l~~~~ 234 (242)
T d1xwdc1 225 KKLRARSTYN 234 (242)
T ss_dssp CEEESSSEES
T ss_pred cccccCcCCC
Confidence 7777666543
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.74 E-value=1.3e-18 Score=167.04 Aligned_cols=174 Identities=17% Similarity=0.210 Sum_probs=82.6
Q ss_pred EEEeecCcccccCCcccCCCCCCcEEeccCCeecccC-CccccCCCCCCEEEeeCCcccccCChhhcCcCCCcEEEccCC
Q 004400 92 NLTVQYNQFSGELPEELGSLLNLEKLHLSSNNFTGEL-PKTFAKLTNMKDFRISDNQFTGQIPSFIQNWTKLEKLFIQPS 170 (756)
Q Consensus 92 ~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~-p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N 170 (756)
.++.++|+++ .+|..+. +++++|+|++|+|++.+ +..|.++++|+.|+|++|++....+..|..+++|++|+|++|
T Consensus 12 ~v~Cs~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls~N 88 (192)
T d1w8aa_ 12 TVDCTGRGLK-EIPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGEN 88 (192)
T ss_dssp EEECTTSCCS-SCCSCCC--TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSC
T ss_pred EEEEeCCCcC-ccCCCCC--CCCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccccccceeeeccc
Confidence 4445555554 4444332 34555555555554322 333445555555555555555444455555555555555555
Q ss_pred cCcCCCCccccCCCCCCeEEccCCCCCCCCccccccccccEEEcccccccCCCCccccCCCCCcEEEccCCcCCCCCCcc
Q 004400 171 GLAGPIPSGIFSLENLTDLRISDLNGPEATFPQLGNMKMTKLILRNCNITGELPRYLGKMTKLKVLDLSFNRLRGQIPSN 250 (756)
Q Consensus 171 ~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~ 250 (756)
+|+...+..|.++++|++|+| ++|+|++..+.+|..+++|++|+|++|.+......
T Consensus 89 ~l~~l~~~~F~~l~~L~~L~L-----------------------~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~~~~~- 144 (192)
T d1w8aa_ 89 KIKEISNKMFLGLHQLKTLNL-----------------------YDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHL- 144 (192)
T ss_dssp CCCEECSSSSTTCTTCCEEEC-----------------------CSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGGG-
T ss_pred cccccCHHHHhCCCccccccc-----------------------CCccccccCHHHhcCCcccccccccccccccccch-
Confidence 554433444444444443332 23344444444555555555555555555532221
Q ss_pred CcCCCCCCeEEecCccccccCCchhhcCCCeeEeecCCCCCCC
Q 004400 251 FDDLYDVDYIYFAGNLLTGAIPPWMLERGDKIDLSYNNFTDGS 293 (756)
Q Consensus 251 ~~~l~~L~~L~ls~N~l~~~~p~~~~~~l~~l~ls~N~l~~~~ 293 (756)
..-...++.+.+..|.+++..|..+ ..++.++++.|.+.|..
T Consensus 145 ~~~~~~l~~~~l~~~~~~c~~p~~l-~~~~l~~L~~n~l~C~~ 186 (192)
T d1w8aa_ 145 AWFAEWLRKKSLNGGAARCGAPSKV-RDVQIKDLPHSEFKCSS 186 (192)
T ss_dssp HHHHHHHHHHCCSGGGCBBCSSTTT-TTSBGGGSCTTTCCCCC
T ss_pred HHHhhhhhhhcccCCCeEeCCChhh-cCCEeeecCHhhCcCCC
Confidence 1111223444555566665555443 34455666666666543
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=99.74 E-value=8.4e-18 Score=166.11 Aligned_cols=209 Identities=19% Similarity=0.229 Sum_probs=106.2
Q ss_pred ccceeccccccccCcccccCCcccCCCCCCCEEEccCCcccCccCcccccCCcce-eeccCccccccCCccCcCcCCCcE
Q 004400 14 KQKTVNQKRVLKEQNLTGVLPPKLAELTFLQDIDLTLNYLSGTIPSQWASLPLLN-ISLIANRLKGPIPKYLANISTLVN 92 (756)
Q Consensus 14 ~~~~~~~~l~L~~~~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~-l~l~~n~~~~~~p~~l~~l~~L~~ 92 (756)
..++...+++|+.+++++.++ +..+.+|+.|++.+|+|+. ++ .+..++.|+ +++.+|++.+..| +.++++|+.
T Consensus 16 ~~l~~~~~~~l~~~~~~d~~~--~~~l~~L~~L~l~~~~i~~-l~-~l~~l~~L~~L~ls~n~i~~~~~--l~~l~~l~~ 89 (227)
T d1h6ua2 16 PALANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVTT-IE-GVQYLNNLIGLELKDNQITDLAP--LKNLTKITE 89 (227)
T ss_dssp HHHHHHHHHHTTCSSTTSEEC--HHHHHTCCEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCE
T ss_pred HHHHHHHHHHhCCCCcCCcCC--HHHcCCcCEEECCCCCCCc-ch-hHhcCCCCcEeecCCceeecccc--ccccccccc
Confidence 445566677788888887643 4567788888888888873 32 244444442 4444444443222 444444444
Q ss_pred EEeecCcccccCCcccCCCCCCcEEeccCCeecccCCccccCCCCCCEEEeeCCcccccCChhhcCcCCCcEEEccCCcC
Q 004400 93 LTVQYNQFSGELPEELGSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRISDNQFTGQIPSFIQNWTKLEKLFIQPSGL 172 (756)
Q Consensus 93 L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l 172 (756)
|++++|.++ .+ ..+..+++|+.|.+++|...+.. .+...+.++.+.++++.+... ..+.++++|+.|++++|.+
T Consensus 90 l~~~~n~~~-~i-~~l~~l~~L~~l~l~~~~~~~~~--~~~~~~~~~~l~~~~~~~~~~--~~~~~~~~L~~L~l~~n~~ 163 (227)
T d1h6ua2 90 LELSGNPLK-NV-SAIAGLQSIKTLDLTSTQITDVT--PLAGLSNLQVLYLDLNQITNI--SPLAGLTNLQYLSIGNAQV 163 (227)
T ss_dssp EECCSCCCS-CC-GGGTTCTTCCEEECTTSCCCCCG--GGTTCTTCCEEECCSSCCCCC--GGGGGCTTCCEEECCSSCC
T ss_pred ccccccccc-cc-ccccccccccccccccccccccc--hhccccchhhhhchhhhhchh--hhhcccccccccccccccc
Confidence 444444444 22 12444444444444444443211 133344444444444444321 1233444444444444444
Q ss_pred cCCCCccccCCCCCCeEEccCCCCCCCCccccccccccEEEcccccccCCCCccccCCCCCcEEEccCCcCCCCCCccCc
Q 004400 173 AGPIPSGIFSLENLTDLRISDLNGPEATFPQLGNMKMTKLILRNCNITGELPRYLGKMTKLKVLDLSFNRLRGQIPSNFD 252 (756)
Q Consensus 173 ~~~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~ 252 (756)
... ..+.++++ |+.|+|++|++++. + .++++++|++|+|++|++++ ++ .+.
T Consensus 164 ~~~--~~l~~l~~-----------------------L~~L~Ls~n~l~~l-~-~l~~l~~L~~L~Ls~N~lt~-i~-~l~ 214 (227)
T d1h6ua2 164 SDL--TPLANLSK-----------------------LTTLKADDNKISDI-S-PLASLPNLIEVHLKNNQISD-VS-PLA 214 (227)
T ss_dssp CCC--GGGTTCTT-----------------------CCEEECCSSCCCCC-G-GGGGCTTCCEEECTTSCCCB-CG-GGT
T ss_pred ccc--hhhccccc-----------------------ceecccCCCccCCC-h-hhcCCCCCCEEECcCCcCCC-Cc-ccc
Confidence 321 11333333 44445555555532 2 26667777777777777764 33 266
Q ss_pred CCCCCCeEEec
Q 004400 253 DLYDVDYIYFA 263 (756)
Q Consensus 253 ~l~~L~~L~ls 263 (756)
.+++|+.|+++
T Consensus 215 ~l~~L~~L~ls 225 (227)
T d1h6ua2 215 NTSNLFIVTLT 225 (227)
T ss_dssp TCTTCCEEEEE
T ss_pred cCCCCCEEEee
Confidence 67777777665
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=99.74 E-value=9.7e-18 Score=165.67 Aligned_cols=204 Identities=17% Similarity=0.205 Sum_probs=159.4
Q ss_pred eeeccCccccccCCccCcCcCCCcEEEeecCcccccCCcccCCCCCCcEEeccCCeecccCCccccCCCCCCEEEeeCCc
Q 004400 68 NISLIANRLKGPIPKYLANISTLVNLTVQYNQFSGELPEELGSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRISDNQ 147 (756)
Q Consensus 68 ~l~l~~n~~~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~ 147 (756)
++++..+++.+.+ .+.++.+|+.|++++|.|+ .++ .+..+++|++|+|++|++++..| +..+++|+.|++++|.
T Consensus 23 ~~~l~~~~~~d~~--~~~~l~~L~~L~l~~~~i~-~l~-~l~~l~~L~~L~ls~n~i~~~~~--l~~l~~l~~l~~~~n~ 96 (227)
T d1h6ua2 23 KIAAGKSNVTDTV--TQADLDGITTLSAFGTGVT-TIE-GVQYLNNLIGLELKDNQITDLAP--LKNLTKITELELSGNP 96 (227)
T ss_dssp HHHTTCSSTTSEE--CHHHHHTCCEEECTTSCCC-CCT-TGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEECCSCC
T ss_pred HHHhCCCCcCCcC--CHHHcCCcCEEECCCCCCC-cch-hHhcCCCCcEeecCCceeecccc--cccccccccccccccc
Confidence 4556666666544 4567888999999999998 453 58889999999999999885443 8888999999999998
Q ss_pred ccccCChhhcCcCCCcEEEccCCcCcCCCCccccCCCCCCeEEccCCCCCCCCccccccccccEEEcccccccCCCCccc
Q 004400 148 FTGQIPSFIQNWTKLEKLFIQPSGLAGPIPSGIFSLENLTDLRISDLNGPEATFPQLGNMKMTKLILRNCNITGELPRYL 227 (756)
Q Consensus 148 l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~L~~L~L~~n~l~~~~p~~~ 227 (756)
++ .++ .+.++++|+.+.+++|...+ ...+...+.+..+.++.+.+..... .....+|+.|++++|.+.... .+
T Consensus 97 ~~-~i~-~l~~l~~L~~l~l~~~~~~~--~~~~~~~~~~~~l~~~~~~~~~~~~-~~~~~~L~~L~l~~n~~~~~~--~l 169 (227)
T d1h6ua2 97 LK-NVS-AIAGLQSIKTLDLTSTQITD--VTPLAGLSNLQVLYLDLNQITNISP-LAGLTNLQYLSIGNAQVSDLT--PL 169 (227)
T ss_dssp CS-CCG-GGTTCTTCCEEECTTSCCCC--CGGGTTCTTCCEEECCSSCCCCCGG-GGGCTTCCEEECCSSCCCCCG--GG
T ss_pred cc-ccc-cccccccccccccccccccc--cchhccccchhhhhchhhhhchhhh-hccccccccccccccccccch--hh
Confidence 88 444 57889999999999888764 3446677888889988877765432 233346899999999988543 38
Q ss_pred cCCCCCcEEEccCCcCCCCCCccCcCCCCCCeEEecCccccccCCchhhcCCCeeEeec
Q 004400 228 GKMTKLKVLDLSFNRLRGQIPSNFDDLYDVDYIYFAGNLLTGAIPPWMLERGDKIDLSY 286 (756)
Q Consensus 228 ~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~~l~~l~ls~ 286 (756)
.++++|+.|+|++|++++ ++ .+..+++|++|+|++|++++..|-.-+++|+.|++++
T Consensus 170 ~~l~~L~~L~Ls~n~l~~-l~-~l~~l~~L~~L~Ls~N~lt~i~~l~~l~~L~~L~lsn 226 (227)
T d1h6ua2 170 ANLSKLTTLKADDNKISD-IS-PLASLPNLIEVHLKNNQISDVSPLANTSNLFIVTLTN 226 (227)
T ss_dssp TTCTTCCEEECCSSCCCC-CG-GGGGCTTCCEEECTTSCCCBCGGGTTCTTCCEEEEEE
T ss_pred cccccceecccCCCccCC-Ch-hhcCCCCCCEEECcCCcCCCCcccccCCCCCEEEeeC
Confidence 899999999999999995 44 3889999999999999999654434488999999874
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.73 E-value=3e-18 Score=164.59 Aligned_cols=110 Identities=19% Similarity=0.286 Sum_probs=61.6
Q ss_pred CCCcEEEeecCcccccC-CcccCCCCCCcEEeccCCeecccCCccccCCCCCCEEEeeCCcccccCChhhcCcCCCcEEE
Q 004400 88 STLVNLTVQYNQFSGEL-PEELGSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRISDNQFTGQIPSFIQNWTKLEKLF 166 (756)
Q Consensus 88 ~~L~~L~L~~N~l~~~~-p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 166 (756)
+++++|+|++|+|++.+ +..|.++++|+.|+|++|++.+..+..|..+++|++|+|++|+|+...+.+|.++++|++|+
T Consensus 29 ~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls~N~l~~l~~~~F~~l~~L~~L~ 108 (192)
T d1w8aa_ 29 LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLN 108 (192)
T ss_dssp TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSCCCCEECSSSSTTCTTCCEEE
T ss_pred CCCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccccccceeeeccccccccCHHHHhCCCcccccc
Confidence 34555555555554322 34455555555555555555555555555555566666666655555555555566666666
Q ss_pred ccCCcCcCCCCccccCCCCCCeEEccCCCCC
Q 004400 167 IQPSGLAGPIPSGIFSLENLTDLRISDLNGP 197 (756)
Q Consensus 167 l~~N~l~~~~p~~~~~l~~L~~L~l~~n~~~ 197 (756)
|++|+|++..+..|..+++|++|+|++|.+.
T Consensus 109 L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~ 139 (192)
T d1w8aa_ 109 LYDNQISCVMPGSFEHLNSLTSLNLASNPFN 139 (192)
T ss_dssp CCSSCCCEECTTSSTTCTTCCEEECTTCCBC
T ss_pred cCCccccccCHHHhcCCcccccccccccccc
Confidence 6666665555555555555555555554443
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.72 E-value=1.9e-17 Score=161.33 Aligned_cols=181 Identities=19% Similarity=0.303 Sum_probs=128.1
Q ss_pred eeccCccccccCCccCcCcCCCcEEEeecCcccccCCcccCCCCCCcEEeccCCeecccCCccccCCCCCCEEEeeCCcc
Q 004400 69 ISLIANRLKGPIPKYLANISTLVNLTVQYNQFSGELPEELGSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRISDNQF 148 (756)
Q Consensus 69 l~l~~n~~~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l 148 (756)
..+..+.+.+.++. ..+.+|++|++++|.++. ++ .+..+++|++|+|++|++++. + .++.+++|+.|++++|++
T Consensus 29 ~~l~~~~~~~~~~~--~~L~~L~~L~l~~~~i~~-l~-~l~~l~~L~~L~L~~n~i~~l-~-~~~~l~~L~~L~l~~n~i 102 (210)
T d1h6ta2 29 DNLKKKSVTDAVTQ--NELNSIDQIIANNSDIKS-VQ-GIQYLPNVTKLFLNGNKLTDI-K-PLANLKNLGWLFLDENKV 102 (210)
T ss_dssp HHTTCSCTTSEECH--HHHHTCCEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCC-G-GGTTCTTCCEEECCSSCC
T ss_pred HHhCcCccCCccCH--HHhcCccEEECcCCCCCC-ch-hHhhCCCCCEEeCCCccccCc-c-ccccCccccccccccccc
Confidence 34455555555443 356788888888888874 33 377788888888888888853 3 367788888888888888
Q ss_pred cccCChhhcCcCCCcEEEccCCcCcCCCCccccCCCCCCeEEccCCCCCCCCccccccccccEEEcccccccCCCCcccc
Q 004400 149 TGQIPSFIQNWTKLEKLFIQPSGLAGPIPSGIFSLENLTDLRISDLNGPEATFPQLGNMKMTKLILRNCNITGELPRYLG 228 (756)
Q Consensus 149 ~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~L~~L~L~~n~l~~~~p~~~~ 228 (756)
++ ++ .+.++++|+.|++++|.+.. ...+..+++|+.+++++|.+..... .....+|+.+++++|++++.. .+.
T Consensus 103 ~~-l~-~l~~l~~L~~L~l~~~~~~~--~~~l~~l~~l~~l~~~~n~l~~~~~-~~~l~~L~~l~l~~n~l~~i~--~l~ 175 (210)
T d1h6ta2 103 KD-LS-SLKDLKKLKSLSLEHNGISD--INGLVHLPQLESLYLGNNKITDITV-LSRLTKLDTLSLEDNQISDIV--PLA 175 (210)
T ss_dssp CC-GG-GGTTCTTCCEEECTTSCCCC--CGGGGGCTTCCEEECCSSCCCCCGG-GGGCTTCSEEECCSSCCCCCG--GGT
T ss_pred cc-cc-cccccccccccccccccccc--ccccccccccccccccccccccccc-ccccccccccccccccccccc--ccc
Confidence 73 44 47788888888888888763 3457777888888888777665332 112235777888888887543 277
Q ss_pred CCCCCcEEEccCCcCCCCCCccCcCCCCCCeEEecC
Q 004400 229 KMTKLKVLDLSFNRLRGQIPSNFDDLYDVDYIYFAG 264 (756)
Q Consensus 229 ~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~ 264 (756)
++++|+.|+|++|+++ .+| .+.++++|++|+|++
T Consensus 176 ~l~~L~~L~Ls~N~i~-~l~-~l~~l~~L~~L~Ls~ 209 (210)
T d1h6ta2 176 GLTKLQNLYLSKNHIS-DLR-ALAGLKNLDVLELFS 209 (210)
T ss_dssp TCTTCCEEECCSSCCC-BCG-GGTTCTTCSEEEEEE
T ss_pred CCCCCCEEECCCCCCC-CCh-hhcCCCCCCEEEccC
Confidence 8888888888888887 344 478888888888764
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.71 E-value=4e-17 Score=157.53 Aligned_cols=178 Identities=20% Similarity=0.301 Sum_probs=129.5
Q ss_pred eeeccCccccccCCccCcCcCCCcEEEeecCcccccCCcccCCCCCCcEEeccCCeecccCCccccCCCCCCEEEeeCCc
Q 004400 68 NISLIANRLKGPIPKYLANISTLVNLTVQYNQFSGELPEELGSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRISDNQ 147 (756)
Q Consensus 68 ~l~l~~n~~~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~ 147 (756)
+..+..+++++.++ ...+.+|++|++++|.|+ .+ +.+..+++|++|+|++|++++..| +.++++|+.|++++|.
T Consensus 22 ~~~l~~~~~~~~~~--~~~l~~l~~L~l~~~~i~-~l-~~l~~l~nL~~L~Ls~N~l~~~~~--l~~l~~L~~L~l~~n~ 95 (199)
T d2omxa2 22 KTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIK-SI-DGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQ 95 (199)
T ss_dssp HHHTTCSSTTSEEC--HHHHTTCCEEECTTSCCC-CC-TTGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSC
T ss_pred HHHhCCCCCCCccC--HHHhcCCCEEECCCCCCC-Cc-cccccCCCcCcCccccccccCccc--ccCCcccccccccccc
Confidence 44566666665543 346788888999998888 34 347888889999999998885433 8888889999999888
Q ss_pred ccccCChhhcCcCCCcEEEccCCcCcCCCCccccCCCCCCeEEccCCCCCCCCccccccccccEEEcccccccCCCCccc
Q 004400 148 FTGQIPSFIQNWTKLEKLFIQPSGLAGPIPSGIFSLENLTDLRISDLNGPEATFPQLGNMKMTKLILRNCNITGELPRYL 227 (756)
Q Consensus 148 l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~L~~L~L~~n~l~~~~p~~~ 227 (756)
+. .++ .+.+++.|+.|++++|.+.. ...+..+++|+.|++++|.+.... ......+++.|++.+|++++.. .+
T Consensus 96 ~~-~~~-~l~~l~~L~~L~l~~~~~~~--~~~~~~l~~L~~L~l~~n~l~~~~-~l~~~~~L~~L~l~~n~l~~l~--~l 168 (199)
T d2omxa2 96 IA-DIT-PLANLTNLTGLTLFNNQITD--IDPLKNLTNLNRLELSSNTISDIS-ALSGLTSLQQLNFSSNQVTDLK--PL 168 (199)
T ss_dssp CC-CCG-GGTTCTTCSEEECCSSCCCC--CGGGTTCTTCSEEECCSSCCCCCG-GGTTCTTCSEEECCSSCCCCCG--GG
T ss_pred cc-ccc-cccccccccccccccccccc--ccccchhhhhHHhhhhhhhhcccc-cccccccccccccccccccCCc--cc
Confidence 87 344 47888888999888888874 234777888888888887776542 2223335778888888887543 37
Q ss_pred cCCCCCcEEEccCCcCCCCCCccCcCCCCCCeE
Q 004400 228 GKMTKLKVLDLSFNRLRGQIPSNFDDLYDVDYI 260 (756)
Q Consensus 228 ~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 260 (756)
+++++|++|++++|++++ ++ .+.++++|+.|
T Consensus 169 ~~l~~L~~L~ls~N~i~~-i~-~l~~L~~L~~L 199 (199)
T d2omxa2 169 ANLTTLERLDISSNKVSD-IS-VLAKLTNLESL 199 (199)
T ss_dssp TTCTTCCEEECCSSCCCC-CG-GGGGCTTCSEE
T ss_pred cCCCCCCEEECCCCCCCC-Cc-cccCCCCCCcC
Confidence 788888888888888874 33 46777777765
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.71 E-value=9.3e-17 Score=160.14 Aligned_cols=207 Identities=18% Similarity=0.187 Sum_probs=160.5
Q ss_pred cCccccccCCccCcCcCCCcEEEeecCcccccCCcccCCCCCCcEEeccCCeecccC-CccccCCCCCCEEEeeC-Cccc
Q 004400 72 IANRLKGPIPKYLANISTLVNLTVQYNQFSGELPEELGSLLNLEKLHLSSNNFTGEL-PKTFAKLTNMKDFRISD-NQFT 149 (756)
Q Consensus 72 ~~n~~~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~-p~~~~~l~~L~~L~L~~-N~l~ 149 (756)
.+++++ .+|..+. +++++|+|++|+|+...+..|.++++|++|+|++|.+...+ +..|.+++++++|.+.. |++.
T Consensus 16 ~~~~l~-~iP~~l~--~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~~~n~l~ 92 (242)
T d1xwdc1 16 QESKVT-EIPSDLP--RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLL 92 (242)
T ss_dssp ESCSCS-SCCSCSC--SCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEECCTTCC
T ss_pred eCCCCC-CcCCCCC--CCCCEEECcCCcCCccChhHhhccchhhhhhhccccccceeecccccccccccccccccccccc
Confidence 333444 5665553 58999999999999666678999999999999999987644 45789999999999875 6788
Q ss_pred ccCChhhcCcCCCcEEEccCCcCcCCCCc-cccCCCCCCeEEccCCCCCCCCccccccc--cccEEEcccccccCCCCcc
Q 004400 150 GQIPSFIQNWTKLEKLFIQPSGLAGPIPS-GIFSLENLTDLRISDLNGPEATFPQLGNM--KMTKLILRNCNITGELPRY 226 (756)
Q Consensus 150 ~~~p~~~~~l~~L~~L~l~~N~l~~~~p~-~~~~l~~L~~L~l~~n~~~~~~~~~~~~~--~L~~L~L~~n~l~~~~p~~ 226 (756)
...+..|.++++|+.|++++|++....+. .+..++.+..+..+++.+.......+... .+..|++++|+++...+..
T Consensus 93 ~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~~~~~l~~l~~~~~~n~~l~~i~~~~~~~~~~~l~~L~l~~n~l~~i~~~~ 172 (242)
T d1xwdc1 93 YINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCA 172 (242)
T ss_dssp EECTTSEECCTTCCEEEEESCCCCSCCCCTTTCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCCCEECTTT
T ss_pred ccccccccccccccccccchhhhcccccccccccccccccccccccccccccccccccccccceeeeccccccccccccc
Confidence 78889999999999999999999754332 34456677777777778887777766554 5888999999999665555
Q ss_pred ccCCCCCcE-EEccCCcCCCCCCccCcCCCCCCeEEecCccccccCCchhhcCCCeeE
Q 004400 227 LGKMTKLKV-LDLSFNRLRGQIPSNFDDLYDVDYIYFAGNLLTGAIPPWMLERGDKID 283 (756)
Q Consensus 227 ~~~l~~L~~-L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~~l~~l~ 283 (756)
|. .++++. +++++|+++...+..|.++++|++|++++|+++ .+|.+.+.++..|.
T Consensus 173 ~~-~~~l~~~~~l~~n~l~~l~~~~f~~l~~L~~L~Ls~N~l~-~l~~~~~~~l~~L~ 228 (242)
T d1xwdc1 173 FN-GTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIH-SLPSYGLENLKKLR 228 (242)
T ss_dssp TT-TCCEEEEECTTCTTCCCCCTTTTTTSCCCSEEECTTSCCC-CCCSSSCTTCCEEE
T ss_pred cc-chhhhccccccccccccccHHHhcCCCCCCEEECCCCcCC-ccCHHHHcCCcccc
Confidence 54 455554 467888999666677999999999999999998 66766655555443
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=99.70 E-value=9.4e-16 Score=161.36 Aligned_cols=251 Identities=20% Similarity=0.231 Sum_probs=156.5
Q ss_pred eeccccccccCcccccCCcccCCCCCCCEEEccCCcccCccCcccccCCcceeeccCccccccCCccCcCcCCCcEEEee
Q 004400 17 TVNQKRVLKEQNLTGVLPPKLAELTFLQDIDLTLNYLSGTIPSQWASLPLLNISLIANRLKGPIPKYLANISTLVNLTVQ 96 (756)
Q Consensus 17 ~~~~~l~L~~~~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~l~l~~n~~~~~~p~~l~~l~~L~~L~L~ 96 (756)
..+++|+|++++++ .+|+. .++|++|+|++|+|+ .+|..+++|+. |.+.+|++. .++. +. +.|++|+|+
T Consensus 38 ~~l~~LdLs~~~L~-~lp~~---~~~L~~L~Ls~N~l~-~lp~~~~~L~~--L~l~~n~l~-~l~~-lp--~~L~~L~L~ 106 (353)
T d1jl5a_ 38 RQAHELELNNLGLS-SLPEL---PPHLESLVASCNSLT-ELPELPQSLKS--LLVDNNNLK-ALSD-LP--PLLEYLGVS 106 (353)
T ss_dssp HTCSEEECTTSCCS-CCCSC---CTTCSEEECCSSCCS-SCCCCCTTCCE--EECCSSCCS-CCCS-CC--TTCCEEECC
T ss_pred cCCCEEEeCCCCCC-CCCCC---CCCCCEEECCCCCCc-ccccchhhhhh--hhhhhcccc-hhhh-hc--ccccccccc
Confidence 45789999999998 56764 478999999999999 77887765554 456677766 3332 11 469999999
Q ss_pred cCcccccCCcccCCCCCCcEEeccCCeecccCC------------------ccccCCCCCCEEEeeCCcccccCC-----
Q 004400 97 YNQFSGELPEELGSLLNLEKLHLSSNNFTGELP------------------KTFAKLTNMKDFRISDNQFTGQIP----- 153 (756)
Q Consensus 97 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p------------------~~~~~l~~L~~L~L~~N~l~~~~p----- 153 (756)
+|.+. .+|. ++.+++|+.|++++|.++.... ..+..++.++.|++++|.+.....
T Consensus 107 ~n~l~-~lp~-~~~l~~L~~L~l~~~~~~~~~~~~~~l~~l~~~~~~~~~~~~l~~l~~l~~L~l~~n~~~~~~~~~~~~ 184 (353)
T d1jl5a_ 107 NNQLE-KLPE-LQNSSFLKIIDVDNNSLKKLPDLPPSLEFIAAGNNQLEELPELQNLPFLTAIYADNNSLKKLPDLPLSL 184 (353)
T ss_dssp SSCCS-SCCC-CTTCTTCCEEECCSSCCSCCCCCCTTCCEEECCSSCCSSCCCCTTCTTCCEEECCSSCCSSCCCCCTTC
T ss_pred ccccc-cccc-hhhhccceeeccccccccccccccccccchhhccccccccccccccccceecccccccccccccccccc
Confidence 99998 5664 7899999999999998873222 123344555666666655442110
Q ss_pred -------------hhhcCcCCCcEEEccCCcCcCCCCccccCCCCCCeEEccCCCCCCCCccccccccccEEEccccccc
Q 004400 154 -------------SFIQNWTKLEKLFIQPSGLAGPIPSGIFSLENLTDLRISDLNGPEATFPQLGNMKMTKLILRNCNIT 220 (756)
Q Consensus 154 -------------~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~L~~L~L~~n~l~ 220 (756)
..+..++.|+.+++++|.... .+.. ..++..+.+.++.+....... ..+..+.+..+.+.
T Consensus 185 ~~l~~~~~~~~~~~~~~~l~~L~~l~l~~n~~~~-~~~~---~~~l~~~~~~~~~~~~~~~~~---~~l~~~~~~~~~~~ 257 (353)
T d1jl5a_ 185 ESIVAGNNILEELPELQNLPFLTTIYADNNLLKT-LPDL---PPSLEALNVRDNYLTDLPELP---QSLTFLDVSENIFS 257 (353)
T ss_dssp CEEECCSSCCSSCCCCTTCTTCCEEECCSSCCSS-CCSC---CTTCCEEECCSSCCSCCCCCC---TTCCEEECCSSCCS
T ss_pred cccccccccccccccccccccccccccccccccc-cccc---ccccccccccccccccccccc---cccccccccccccc
Confidence 112334444555555444431 2211 223334444443333211100 01222222222221
Q ss_pred C----------------CCCccccCCCCCcEEEccCCcCCCCCCccCcCCCCCCeEEecCccccccCCchhhcCCCeeEe
Q 004400 221 G----------------ELPRYLGKMTKLKVLDLSFNRLRGQIPSNFDDLYDVDYIYFAGNLLTGAIPPWMLERGDKIDL 284 (756)
Q Consensus 221 ~----------------~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~~l~~l~l 284 (756)
+ .++.....+++|++|+|++|+|+ .+|.. +++|+.|+|++|+|+ .+|. .+++|+.|++
T Consensus 258 ~l~~l~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~N~l~-~lp~~---~~~L~~L~L~~N~L~-~l~~-~~~~L~~L~L 331 (353)
T d1jl5a_ 258 GLSELPPNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPAL---PPRLERLIASFNHLA-EVPE-LPQNLKQLHV 331 (353)
T ss_dssp EESCCCTTCCEEECCSSCCSEECCCCTTCCEEECCSSCCS-CCCCC---CTTCCEEECCSSCCS-CCCC-CCTTCCEEEC
T ss_pred ccccccchhcccccccCccccccccCCCCCEEECCCCccC-ccccc---cCCCCEEECCCCcCC-cccc-ccCCCCEEEC
Confidence 1 11122234678999999999998 56643 678999999999998 6664 4578999999
Q ss_pred ecCCCCCCC
Q 004400 285 SYNNFTDGS 293 (756)
Q Consensus 285 s~N~l~~~~ 293 (756)
++|+++..+
T Consensus 332 ~~N~L~~lp 340 (353)
T d1jl5a_ 332 EYNPLREFP 340 (353)
T ss_dssp CSSCCSSCC
T ss_pred cCCcCCCCC
Confidence 999988654
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.70 E-value=4e-17 Score=158.98 Aligned_cols=186 Identities=21% Similarity=0.313 Sum_probs=112.7
Q ss_pred ceeccccccccCcccccCCcccCCCCCCCEEEccCCcccCccCcccccCCcceeeccCccccccCCccCcCcCCCcEEEe
Q 004400 16 KTVNQKRVLKEQNLTGVLPPKLAELTFLQDIDLTLNYLSGTIPSQWASLPLLNISLIANRLKGPIPKYLANISTLVNLTV 95 (756)
Q Consensus 16 ~~~~~~l~L~~~~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~l~l~~n~~~~~~p~~l~~l~~L~~L~L 95 (756)
+....+..+..+++++.++. ..+..|+.|++++|.++.. + . +..+++|++|+|
T Consensus 23 l~~~i~~~l~~~~~~~~~~~--~~L~~L~~L~l~~~~i~~l-~-~-----------------------l~~l~~L~~L~L 75 (210)
T d1h6ta2 23 FAETIKDNLKKKSVTDAVTQ--NELNSIDQIIANNSDIKSV-Q-G-----------------------IQYLPNVTKLFL 75 (210)
T ss_dssp HHHHHHHHTTCSCTTSEECH--HHHHTCCEEECTTSCCCCC-T-T-----------------------GGGCTTCCEEEC
T ss_pred HHHHHHHHhCcCccCCccCH--HHhcCccEEECcCCCCCCc-h-h-----------------------HhhCCCCCEEeC
Confidence 34455667778888876663 3456788888888888732 1 1 344556666666
Q ss_pred ecCcccccCCcccCCCCCCcEEeccCCeecccCCccccCCCCCCEEEeeCCcccccCChhhcCcCCCcEEEccCCcCcCC
Q 004400 96 QYNQFSGELPEELGSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRISDNQFTGQIPSFIQNWTKLEKLFIQPSGLAGP 175 (756)
Q Consensus 96 ~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~ 175 (756)
++|+|++ ++ .++.+++|++|++++|+++ .+| .+..+++|+.|++++|.+. .+ ..+.+++.|+.+++++|.++.
T Consensus 76 ~~n~i~~-l~-~~~~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~l~~~~~~-~~-~~l~~l~~l~~l~~~~n~l~~- 148 (210)
T d1h6ta2 76 NGNKLTD-IK-PLANLKNLGWLFLDENKVK-DLS-SLKDLKKLKSLSLEHNGIS-DI-NGLVHLPQLESLYLGNNKITD- 148 (210)
T ss_dssp CSSCCCC-CG-GGTTCTTCCEEECCSSCCC-CGG-GGTTCTTCCEEECTTSCCC-CC-GGGGGCTTCCEEECCSSCCCC-
T ss_pred CCccccC-cc-ccccCcccccccccccccc-ccc-ccccccccccccccccccc-cc-ccccccccccccccccccccc-
Confidence 6666653 22 2455666666666666665 233 3555666666666666655 22 235556666666666666552
Q ss_pred CCccccCCCCCCeEEccCCCCCCCCccccccc-cccEEEcccccccCCCCccccCCCCCcEEEccC
Q 004400 176 IPSGIFSLENLTDLRISDLNGPEATFPQLGNM-KMTKLILRNCNITGELPRYLGKMTKLKVLDLSF 240 (756)
Q Consensus 176 ~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~-~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~ 240 (756)
+..+..+++|+.+++++|.+....+ +..+ +|+.|+|++|+++. ++ .|.++++|++|+|++
T Consensus 149 -~~~~~~l~~L~~l~l~~n~l~~i~~--l~~l~~L~~L~Ls~N~i~~-l~-~l~~l~~L~~L~Ls~ 209 (210)
T d1h6ta2 149 -ITVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHISD-LR-ALAGLKNLDVLELFS 209 (210)
T ss_dssp -CGGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCB-CG-GGTTCTTCSEEEEEE
T ss_pred -ccccccccccccccccccccccccc--ccCCCCCCEEECCCCCCCC-Ch-hhcCCCCCCEEEccC
Confidence 3345556666666666666554321 3333 46777777888874 44 588999999999874
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.68 E-value=1.7e-16 Score=153.12 Aligned_cols=183 Identities=21% Similarity=0.325 Sum_probs=99.6
Q ss_pred cceeccccccccCcccccCCcccCCCCCCCEEEccCCcccCccCcccccCCcceeeccCccccccCCccCcCcCCCcEEE
Q 004400 15 QKTVNQKRVLKEQNLTGVLPPKLAELTFLQDIDLTLNYLSGTIPSQWASLPLLNISLIANRLKGPIPKYLANISTLVNLT 94 (756)
Q Consensus 15 ~~~~~~~l~L~~~~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~l~l~~n~~~~~~p~~l~~l~~L~~L~ 94 (756)
++....++.++.+++++.++. ..+.+|+.|++++|.++. ++ .++. +++|++|+
T Consensus 16 ~l~~~i~~~l~~~~~~~~~~~--~~l~~l~~L~l~~~~i~~-l~-~l~~-----------------------l~nL~~L~ 68 (199)
T d2omxa2 16 ALAEKMKTVLGKTNVTDTVSQ--TDLDQVTTLQADRLGIKS-ID-GVEY-----------------------LNNLTQIN 68 (199)
T ss_dssp HHHHHHHHHTTCSSTTSEECH--HHHTTCCEEECTTSCCCC-CT-TGGG-----------------------CTTCCEEE
T ss_pred HHHHHHHHHhCCCCCCCccCH--HHhcCCCEEECCCCCCCC-cc-cccc-----------------------CCCcCcCc
Confidence 344556677888888877553 466888999999998873 22 2344 44555555
Q ss_pred eecCcccccCCcccCCCCCCcEEeccCCeecccCCccccCCCCCCEEEeeCCcccccCChhhcCcCCCcEEEccCCcCcC
Q 004400 95 VQYNQFSGELPEELGSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRISDNQFTGQIPSFIQNWTKLEKLFIQPSGLAG 174 (756)
Q Consensus 95 L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~ 174 (756)
|++|+|++. ++ |+++++|++|++++|.+. .++ .+.++++|+.|++++|.+... ..+.++++|+.|++++|++..
T Consensus 69 Ls~N~l~~~-~~-l~~l~~L~~L~l~~n~~~-~~~-~l~~l~~L~~L~l~~~~~~~~--~~~~~l~~L~~L~l~~n~l~~ 142 (199)
T d2omxa2 69 FSNNQLTDI-TP-LKNLTKLVDILMNNNQIA-DIT-PLANLTNLTGLTLFNNQITDI--DPLKNLTNLNRLELSSNTISD 142 (199)
T ss_dssp CCSSCCCCC-GG-GTTCTTCCEEECCSSCCC-CCG-GGTTCTTCSEEECCSSCCCCC--GGGTTCTTCSEEECCSSCCCC
T ss_pred cccccccCc-cc-ccCCcccccccccccccc-ccc-ccccccccccccccccccccc--cccchhhhhHHhhhhhhhhcc
Confidence 555555422 21 455555555555555544 222 244455555555555554421 124445555555555555442
Q ss_pred CCCccccCCCCCCeEEccCCCCCCCCcccccc-ccccEEEcccccccCCCCccccCCCCCcEE
Q 004400 175 PIPSGIFSLENLTDLRISDLNGPEATFPQLGN-MKMTKLILRNCNITGELPRYLGKMTKLKVL 236 (756)
Q Consensus 175 ~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~-~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L 236 (756)
+ ..+..+++|+.|++++|.+....+ +.. .+|++|++++|+++. ++ .++++++|+.|
T Consensus 143 -~-~~l~~~~~L~~L~l~~n~l~~l~~--l~~l~~L~~L~ls~N~i~~-i~-~l~~L~~L~~L 199 (199)
T d2omxa2 143 -I-SALSGLTSLQQLNFSSNQVTDLKP--LANLTTLERLDISSNKVSD-IS-VLAKLTNLESL 199 (199)
T ss_dssp -C-GGGTTCTTCSEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCC-CG-GGGGCTTCSEE
T ss_pred -c-ccccccccccccccccccccCCcc--ccCCCCCCEEECCCCCCCC-Cc-cccCCCCCCcC
Confidence 1 234445555555555555444321 222 246666667777764 33 47788888775
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.56 E-value=6.2e-16 Score=157.84 Aligned_cols=209 Identities=14% Similarity=0.189 Sum_probs=118.0
Q ss_pred CCCcEEEeecCccccc-CCcccCCCCCCcEEeccCCeecccCCccccCCCCCCEEEeeCC-ccccc-CChhhcCcCCCcE
Q 004400 88 STLVNLTVQYNQFSGE-LPEELGSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRISDN-QFTGQ-IPSFIQNWTKLEK 164 (756)
Q Consensus 88 ~~L~~L~L~~N~l~~~-~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N-~l~~~-~p~~~~~l~~L~~ 164 (756)
.+|++|||++|.++.. +...+..+++|++|+|++|++++..+..++.+++|+.|+|+++ .++.. +...+.++++|++
T Consensus 46 ~~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~Ls~c~~itd~~l~~l~~~~~~L~~ 125 (284)
T d2astb2 46 FRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDE 125 (284)
T ss_dssp BCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCE
T ss_pred CCCCEEECCCCccCHHHHHHHHHhCCCcccccccccCCCcHHHHHHhcCCCCcCccccccccccccccchhhHHHHhccc
Confidence 4566666666655432 2333555666666666666665555555666666666666663 34421 1222345566666
Q ss_pred EEccCC-cCcCC-CCccccC-CCCCCeEEccCC--CCCCCCcccc-c-cccccEEEcccc-cccCCCCccccCCCCCcEE
Q 004400 165 LFIQPS-GLAGP-IPSGIFS-LENLTDLRISDL--NGPEATFPQL-G-NMKMTKLILRNC-NITGELPRYLGKMTKLKVL 236 (756)
Q Consensus 165 L~l~~N-~l~~~-~p~~~~~-l~~L~~L~l~~n--~~~~~~~~~~-~-~~~L~~L~L~~n-~l~~~~p~~~~~l~~L~~L 236 (756)
|+|+++ .++.. +...+.. .++|+.|+++++ .+.......+ . ..+|+.|++++| .+++.....+.++++|++|
T Consensus 126 L~ls~c~~~~~~~~~~~~~~~~~~L~~L~l~~~~~~i~~~~l~~l~~~~~~L~~L~L~~~~~itd~~~~~l~~~~~L~~L 205 (284)
T d2astb2 126 LNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHL 205 (284)
T ss_dssp EECCCCTTCCHHHHHHHHHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEE
T ss_pred cccccccccccccchhhhcccccccchhhhcccccccccccccccccccccccccccccccCCCchhhhhhcccCcCCEE
Confidence 666654 23211 1112222 355666666643 2222222211 1 124777777765 4666666778888999999
Q ss_pred EccCC-cCCCCCCccCcCCCCCCeEEecCccccccCCchhhcCCCeeEeecCCCCCCCCccc
Q 004400 237 DLSFN-RLRGQIPSNFDDLYDVDYIYFAGNLLTGAIPPWMLERGDKIDLSYNNFTDGSAESS 297 (756)
Q Consensus 237 ~Ls~N-~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~~l~~l~ls~N~l~~~~~~~~ 297 (756)
+|++| .+++.....+.++++|+.|+++++ ++...-..+...+..+.+..++++...++..
T Consensus 206 ~L~~C~~i~~~~l~~L~~~~~L~~L~l~~~-~~d~~l~~l~~~lp~L~i~~~~ls~~~~~~~ 266 (284)
T d2astb2 206 SLSRCYDIIPETLLELGEIPTLKTLQVFGI-VPDGTLQLLKEALPHLQINCSHFTTIARPTI 266 (284)
T ss_dssp ECTTCTTCCGGGGGGGGGCTTCCEEECTTS-SCTTCHHHHHHHSTTSEESCCCSCCTTCSSC
T ss_pred ECCCCCCCChHHHHHHhcCCCCCEEeeeCC-CCHHHHHHHHHhCccccccCccCCCCCCCcc
Confidence 99984 677666667888899999999887 3322212223445556677777776544333
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=99.54 E-value=3.2e-13 Score=141.60 Aligned_cols=241 Identities=22% Similarity=0.241 Sum_probs=166.3
Q ss_pred ceeccccccccCcccccCCcccCCCCCCCEEEccCCcccCccCcccccCCcc-eeeccCccccccCCccCcCcCCCcEEE
Q 004400 16 KTVNQKRVLKEQNLTGVLPPKLAELTFLQDIDLTLNYLSGTIPSQWASLPLL-NISLIANRLKGPIPKYLANISTLVNLT 94 (756)
Q Consensus 16 ~~~~~~l~L~~~~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L-~l~l~~n~~~~~~p~~l~~l~~L~~L~ 94 (756)
...+++|+|++|+|+ .+|+.+ .+|+.|++++|+++ .++... +.| .|++.+|.+. .+|. ++++++|+.|+
T Consensus 57 ~~~L~~L~Ls~N~l~-~lp~~~---~~L~~L~l~~n~l~-~l~~lp---~~L~~L~L~~n~l~-~lp~-~~~l~~L~~L~ 126 (353)
T d1jl5a_ 57 PPHLESLVASCNSLT-ELPELP---QSLKSLLVDNNNLK-ALSDLP---PLLEYLGVSNNQLE-KLPE-LQNSSFLKIID 126 (353)
T ss_dssp CTTCSEEECCSSCCS-SCCCCC---TTCCEEECCSSCCS-CCCSCC---TTCCEEECCSSCCS-SCCC-CTTCTTCCEEE
T ss_pred CCCCCEEECCCCCCc-ccccch---hhhhhhhhhhcccc-hhhhhc---cccccccccccccc-cccc-hhhhccceeec
Confidence 357899999999999 667654 57899999999998 444322 235 4788888877 5664 68899999999
Q ss_pred eecCcccccC------------------CcccCCCCCCcEEeccCCeecccC------------------CccccCCCCC
Q 004400 95 VQYNQFSGEL------------------PEELGSLLNLEKLHLSSNNFTGEL------------------PKTFAKLTNM 138 (756)
Q Consensus 95 L~~N~l~~~~------------------p~~~~~l~~L~~L~L~~N~l~~~~------------------p~~~~~l~~L 138 (756)
+++|.+.... ...+..++.++.|++++|.+.... ...+..++.|
T Consensus 127 l~~~~~~~~~~~~~~l~~l~~~~~~~~~~~~l~~l~~l~~L~l~~n~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~L 206 (353)
T d1jl5a_ 127 VDNNSLKKLPDLPPSLEFIAAGNNQLEELPELQNLPFLTAIYADNNSLKKLPDLPLSLESIVAGNNILEELPELQNLPFL 206 (353)
T ss_dssp CCSSCCSCCCCCCTTCCEEECCSSCCSSCCCCTTCTTCCEEECCSSCCSSCCCCCTTCCEEECCSSCCSSCCCCTTCTTC
T ss_pred cccccccccccccccccchhhccccccccccccccccceecccccccccccccccccccccccccccccccccccccccc
Confidence 9999886422 123566788899999988765311 1224567899
Q ss_pred CEEEeeCCcccccCChhhcCcCCCcEEEccCCcCcCCCCccccCCCCCCeEEccCCCCCCCC---------------ccc
Q 004400 139 KDFRISDNQFTGQIPSFIQNWTKLEKLFIQPSGLAGPIPSGIFSLENLTDLRISDLNGPEAT---------------FPQ 203 (756)
Q Consensus 139 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~---------------~~~ 203 (756)
+.+++++|... .++. ...++..+.+..|.+... +.. ...+..+++..+.+.... ...
T Consensus 207 ~~l~l~~n~~~-~~~~---~~~~l~~~~~~~~~~~~~-~~~---~~~l~~~~~~~~~~~~l~~l~~~~~~~~~~~~~~~~ 278 (353)
T d1jl5a_ 207 TTIYADNNLLK-TLPD---LPPSLEALNVRDNYLTDL-PEL---PQSLTFLDVSENIFSGLSELPPNLYYLNASSNEIRS 278 (353)
T ss_dssp CEEECCSSCCS-SCCS---CCTTCCEEECCSSCCSCC-CCC---CTTCCEEECCSSCCSEESCCCTTCCEEECCSSCCSE
T ss_pred ccccccccccc-cccc---cccccccccccccccccc-ccc---cccccccccccccccccccccchhcccccccCcccc
Confidence 99999999987 4443 345678888888887632 222 223333333332222110 000
Q ss_pred c-c-cccccEEEcccccccCCCCccccCCCCCcEEEccCCcCCCCCCccCcCCCCCCeEEecCccccccCCchhhcCCCe
Q 004400 204 L-G-NMKMTKLILRNCNITGELPRYLGKMTKLKVLDLSFNRLRGQIPSNFDDLYDVDYIYFAGNLLTGAIPPWMLERGDK 281 (756)
Q Consensus 204 ~-~-~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~~l~~ 281 (756)
+ . ..+|++|+|++|+|+ .+|.. +++|+.|+|++|+|+ .+|.. +++|+.|++++|+|+ .+|. +...++.
T Consensus 279 ~~~~~~~L~~L~Ls~N~l~-~lp~~---~~~L~~L~L~~N~L~-~l~~~---~~~L~~L~L~~N~L~-~lp~-~~~~L~~ 348 (353)
T d1jl5a_ 279 LCDLPPSLEELNVSNNKLI-ELPAL---PPRLERLIASFNHLA-EVPEL---PQNLKQLHVEYNPLR-EFPD-IPESVED 348 (353)
T ss_dssp ECCCCTTCCEEECCSSCCS-CCCCC---CTTCCEEECCSSCCS-CCCCC---CTTCCEEECCSSCCS-SCCC-CCTTCCE
T ss_pred ccccCCCCCEEECCCCccC-ccccc---cCCCCEEECCCCcCC-ccccc---cCCCCEEECcCCcCC-CCCc-cccccCe
Confidence 1 1 126999999999999 56643 678999999999999 57753 468999999999998 5664 3345555
Q ss_pred eEe
Q 004400 282 IDL 284 (756)
Q Consensus 282 l~l 284 (756)
|.+
T Consensus 349 L~~ 351 (353)
T d1jl5a_ 349 LRM 351 (353)
T ss_dssp EEC
T ss_pred eEC
Confidence 544
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.52 E-value=1e-14 Score=134.89 Aligned_cols=127 Identities=13% Similarity=0.136 Sum_probs=78.4
Q ss_pred cCCCCCCCEEEccCCcccCccCcccccCCcceeeccCccccccCCccCcCcCCCcEEEeecCcccccCCcccCCCCCCcE
Q 004400 37 LAELTFLQDIDLTLNYLSGTIPSQWASLPLLNISLIANRLKGPIPKYLANISTLVNLTVQYNQFSGELPEELGSLLNLEK 116 (756)
Q Consensus 37 l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~l~l~~n~~~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~ 116 (756)
+.+..+|++|+|++|+|+ . ++..+..+++|+.|+|++|+|+ .++ .|..+++|++
T Consensus 14 ~~n~~~lr~L~L~~n~I~-~-----------------------i~~~~~~l~~L~~L~Ls~N~i~-~l~-~~~~l~~L~~ 67 (162)
T d1a9na_ 14 YTNAVRDRELDLRGYKIP-V-----------------------IENLGATLDQFDAIDFSDNEIR-KLD-GFPLLRRLKT 67 (162)
T ss_dssp EECTTSCEEEECTTSCCC-S-----------------------CCCGGGGTTCCSEEECCSSCCC-EEC-CCCCCSSCCE
T ss_pred ccCcCcCcEEECCCCCCC-c-----------------------cCccccccccCCEEECCCCCCC-ccC-CcccCcchhh
Confidence 456667777777777776 2 2333445566677777777766 332 3666677777
Q ss_pred EeccCCeecccCCccccCCCCCCEEEeeCCcccccCC-hhhcCcCCCcEEEccCCcCcCCCCc----cccCCCCCCeEE
Q 004400 117 LHLSSNNFTGELPKTFAKLTNMKDFRISDNQFTGQIP-SFIQNWTKLEKLFIQPSGLAGPIPS----GIFSLENLTDLR 190 (756)
Q Consensus 117 L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~l~~N~l~~~~p~----~~~~l~~L~~L~ 190 (756)
|+|++|+++...+..+..+++|+.|+|++|+|+.... ..+..+++|++|++++|.++. .|. .+..+++|+.||
T Consensus 68 L~ls~N~i~~l~~~~~~~l~~L~~L~L~~N~i~~~~~l~~l~~l~~L~~L~l~~N~i~~-~~~~r~~~i~~lp~L~~LD 145 (162)
T d1a9na_ 68 LLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTN-KKHYRLYVIYKVPQVRVLD 145 (162)
T ss_dssp EECCSSCCCEECSCHHHHCTTCCEEECCSCCCCCGGGGGGGGGCTTCCEEECCSSGGGG-STTHHHHHHHHCTTCSEET
T ss_pred hhcccccccCCCccccccccccccceeccccccccccccccccccccchhhcCCCcccc-ccchHHHHHHHCCCcCeeC
Confidence 7777777764444445566777777777777663211 346666777777777777652 332 355667777665
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.51 E-value=2.5e-14 Score=125.72 Aligned_cols=87 Identities=22% Similarity=0.336 Sum_probs=57.8
Q ss_pred CcCcCCCcEEEeecCcccccCCcccCCCCCCcEEeccCCeecccCCccccCCCCCCEEEeeCCcccccC-ChhhcCcCCC
Q 004400 84 LANISTLVNLTVQYNQFSGELPEELGSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRISDNQFTGQI-PSFIQNWTKL 162 (756)
Q Consensus 84 l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~-p~~~~~l~~L 162 (756)
+.++++|++|+|++|+|+ .+|..|+.+++|+.|++++|+|+ .+| .++.+++|+.|++++|+|+... ...+..+++|
T Consensus 16 l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~-~l~-~~~~l~~L~~L~l~~N~i~~~~~~~~l~~~~~L 92 (124)
T d1dcea3 16 LEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALE-NVD-GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRL 92 (124)
T ss_dssp GGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCC-CCG-GGTTCSSCCEEECCSSCCCSSSTTGGGGGCTTC
T ss_pred cccCCCCCEEECCCCccC-cchhhhhhhhccccccccccccc-ccC-ccccccccCeEECCCCccCCCCCchhhcCCCCC
Confidence 566667777777777776 55666777777777777777776 333 3666777777777777776332 2456667777
Q ss_pred cEEEccCCcCc
Q 004400 163 EKLFIQPSGLA 173 (756)
Q Consensus 163 ~~L~l~~N~l~ 173 (756)
+.|++++|+++
T Consensus 93 ~~L~l~~N~i~ 103 (124)
T d1dcea3 93 VLLNLQGNSLC 103 (124)
T ss_dssp CEEECTTSGGG
T ss_pred CEEECCCCcCC
Confidence 77777777765
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.50 E-value=1.4e-14 Score=133.90 Aligned_cols=87 Identities=16% Similarity=0.222 Sum_probs=60.1
Q ss_pred CcCcCCCcEEEeecCcccccCCcccCCCCCCcEEeccCCeecccCCccccCCCCCCEEEeeCCcccccCChhhcCcCCCc
Q 004400 84 LANISTLVNLTVQYNQFSGELPEELGSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRISDNQFTGQIPSFIQNWTKLE 163 (756)
Q Consensus 84 l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~ 163 (756)
|.++.+|++|+|++|+|+ .++..+..+++|+.|+|++|+|+ .++ .|..+++|++|++++|+++...+..+..+++|+
T Consensus 14 ~~n~~~lr~L~L~~n~I~-~i~~~~~~l~~L~~L~Ls~N~i~-~l~-~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L~ 90 (162)
T d1a9na_ 14 YTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR-KLD-GFPLLRRLKTLLVNNNRICRIGEGLDQALPDLT 90 (162)
T ss_dssp EECTTSCEEEECTTSCCC-SCCCGGGGTTCCSEEECCSSCCC-EEC-CCCCCSSCCEEECCSSCCCEECSCHHHHCTTCC
T ss_pred ccCcCcCcEEECCCCCCC-ccCccccccccCCEEECCCCCCC-ccC-CcccCcchhhhhcccccccCCCccccccccccc
Confidence 556667777777777777 45665667777777777777777 333 366777777777777777755555556677777
Q ss_pred EEEccCCcCc
Q 004400 164 KLFIQPSGLA 173 (756)
Q Consensus 164 ~L~l~~N~l~ 173 (756)
.|++++|+++
T Consensus 91 ~L~L~~N~i~ 100 (162)
T d1a9na_ 91 ELILTNNSLV 100 (162)
T ss_dssp EEECCSCCCC
T ss_pred cceecccccc
Confidence 7777776665
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.50 E-value=3.9e-14 Score=124.52 Aligned_cols=102 Identities=23% Similarity=0.271 Sum_probs=80.6
Q ss_pred cEEEeecCcccccCCcccCCCCCCcEEeccCCeecccCCccccCCCCCCEEEeeCCcccccCChhhcCcCCCcEEEccCC
Q 004400 91 VNLTVQYNQFSGELPEELGSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRISDNQFTGQIPSFIQNWTKLEKLFIQPS 170 (756)
Q Consensus 91 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N 170 (756)
+.|+|++|+|+ .++ .+..+++|++|+|++|+|+ .+|..|+.+++|+.|++++|+|+. +| .++++++|+.|++++|
T Consensus 1 R~L~Ls~n~l~-~l~-~l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~~-l~-~~~~l~~L~~L~l~~N 75 (124)
T d1dcea3 1 RVLHLAHKDLT-VLC-HLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNN 75 (124)
T ss_dssp SEEECTTSCCS-SCC-CGGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSS
T ss_pred CEEEcCCCCCC-CCc-ccccCCCCCEEECCCCccC-cchhhhhhhhcccccccccccccc-cC-ccccccccCeEECCCC
Confidence 57899999998 555 4888899999999999998 677788889999999999999984 44 4888899999999999
Q ss_pred cCcCCC-CccccCCCCCCeEEccCCCCC
Q 004400 171 GLAGPI-PSGIFSLENLTDLRISDLNGP 197 (756)
Q Consensus 171 ~l~~~~-p~~~~~l~~L~~L~l~~n~~~ 197 (756)
+++... ...+..+++|+.|++++|.+.
T Consensus 76 ~i~~~~~~~~l~~~~~L~~L~l~~N~i~ 103 (124)
T d1dcea3 76 RLQQSAAIQPLVSCPRLVLLNLQGNSLC 103 (124)
T ss_dssp CCCSSSTTGGGGGCTTCCEEECTTSGGG
T ss_pred ccCCCCCchhhcCCCCCCEEECCCCcCC
Confidence 887432 245777777777776665543
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.48 E-value=4.2e-15 Score=151.56 Aligned_cols=252 Identities=18% Similarity=0.210 Sum_probs=172.3
Q ss_pred ccccccccCcccccCCcccCCCCCCCEEEccCCcccCccCcccccCCcceeeccCcccccc-CCccCcCcCCCcEEEeec
Q 004400 19 NQKRVLKEQNLTGVLPPKLAELTFLQDIDLTLNYLSGTIPSQWASLPLLNISLIANRLKGP-IPKYLANISTLVNLTVQY 97 (756)
Q Consensus 19 ~~~l~L~~~~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~l~l~~n~~~~~-~p~~l~~l~~L~~L~L~~ 97 (756)
+++++|+++++.......+.. ..+..+.++.+.+.......+...+..+++++++.+... ++..+.++++|++|+|++
T Consensus 2 W~~lDLs~~~l~~~~l~~l~~-~~~~~lrl~~~~~~~~~~~~~~~~~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L~~ 80 (284)
T d2astb2 2 WQTLDLTGKNLHPDVTGRLLS-QGVIAFRCPRSFMDQPLAEHFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEG 80 (284)
T ss_dssp SSEEECTTCBCCHHHHHHHHH-TTCSEEECTTCEECSCCCSCCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTT
T ss_pred cCEEECCCCCCCchHHHHHHh-ccceEeeccccccccchhhhccCCCCCEEECCCCccCHHHHHHHHHhCCCcccccccc
Confidence 578899988876433333322 345677787777764444444444444688888887654 445578899999999999
Q ss_pred CcccccCCcccCCCCCCcEEeccCC-eeccc-CCccccCCCCCCEEEeeCC-ccccc-CChhhcC-cCCCcEEEccCCc-
Q 004400 98 NQFSGELPEELGSLLNLEKLHLSSN-NFTGE-LPKTFAKLTNMKDFRISDN-QFTGQ-IPSFIQN-WTKLEKLFIQPSG- 171 (756)
Q Consensus 98 N~l~~~~p~~~~~l~~L~~L~L~~N-~l~~~-~p~~~~~l~~L~~L~L~~N-~l~~~-~p~~~~~-l~~L~~L~l~~N~- 171 (756)
|.+++..+..++.+++|++|+|+++ .++.. +...+.++++|++|+++++ .++.. +...+.. .++|+.|+++++.
T Consensus 81 ~~l~~~~~~~l~~~~~L~~L~Ls~c~~itd~~l~~l~~~~~~L~~L~ls~c~~~~~~~~~~~~~~~~~~L~~L~l~~~~~ 160 (284)
T d2astb2 81 LRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRK 160 (284)
T ss_dssp CBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHHHHHSCTTCCEEECCSCGG
T ss_pred cCCCcHHHHHHhcCCCCcCccccccccccccccchhhHHHHhccccccccccccccccchhhhcccccccchhhhccccc
Confidence 9998888888999999999999985 56532 2223456899999999996 45422 2333433 4789999998763
Q ss_pred -CcCC-CCccccCCCCCCeEEccCCC-CCCCCccccccc-cccEEEcccc-cccCCCCccccCCCCCcEEEccCCcCCCC
Q 004400 172 -LAGP-IPSGIFSLENLTDLRISDLN-GPEATFPQLGNM-KMTKLILRNC-NITGELPRYLGKMTKLKVLDLSFNRLRGQ 246 (756)
Q Consensus 172 -l~~~-~p~~~~~l~~L~~L~l~~n~-~~~~~~~~~~~~-~L~~L~L~~n-~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ 246 (756)
++.. +...+.++++|++|++++|. ++......+... +|++|+|++| .+++.....++++++|+.|+++++--.+.
T Consensus 161 ~i~~~~l~~l~~~~~~L~~L~L~~~~~itd~~~~~l~~~~~L~~L~L~~C~~i~~~~l~~L~~~~~L~~L~l~~~~~d~~ 240 (284)
T d2astb2 161 NLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPDGT 240 (284)
T ss_dssp GSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCTTCCGGGGGGGGGCTTCCEEECTTSSCTTC
T ss_pred ccccccccccccccccccccccccccCCCchhhhhhcccCcCCEEECCCCCCCChHHHHHHhcCCCCCEEeeeCCCCHHH
Confidence 3322 23334568999999999864 665565556554 5999999995 67776667789999999999998822222
Q ss_pred CCccCcCCCCCCeEEecCccccccCCch
Q 004400 247 IPSNFDDLYDVDYIYFAGNLLTGAIPPW 274 (756)
Q Consensus 247 ~p~~~~~l~~L~~L~ls~N~l~~~~p~~ 274 (756)
++.....+|+| .++.++++...++.
T Consensus 241 l~~l~~~lp~L---~i~~~~ls~~~~~~ 265 (284)
T d2astb2 241 LQLLKEALPHL---QINCSHFTTIARPT 265 (284)
T ss_dssp HHHHHHHSTTS---EESCCCSCCTTCSS
T ss_pred HHHHHHhCccc---cccCccCCCCCCCc
Confidence 22222345555 46778887655443
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.47 E-value=4.8e-16 Score=169.75 Aligned_cols=157 Identities=17% Similarity=0.255 Sum_probs=90.8
Q ss_pred CCCCCEEEeeCCcccc-----cCChhhcCcCCCcEEEccCCcCcCC----CCccccCCCCCCeEEccCCCCCCCCcccc-
Q 004400 135 LTNMKDFRISDNQFTG-----QIPSFIQNWTKLEKLFIQPSGLAGP----IPSGIFSLENLTDLRISDLNGPEATFPQL- 204 (756)
Q Consensus 135 l~~L~~L~L~~N~l~~-----~~p~~~~~l~~L~~L~l~~N~l~~~----~p~~~~~l~~L~~L~l~~n~~~~~~~~~~- 204 (756)
.+.++.+++++|++.. .....+.....|+.|++++|.+... ....+...+.++.+++++|.+.......+
T Consensus 225 ~~~~~~l~~~~n~~~~~~~~~~~~~~~~~~~~l~~l~l~~n~i~~~~~~~~~~~l~~~~~l~~l~l~~n~i~~~~~~~l~ 304 (460)
T d1z7xw1 225 KASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLC 304 (460)
T ss_dssp CTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHH
T ss_pred cccccccchhhccccccccchhhcccccccccccccccccccccccccccccccccccccccccccccccccccccchhh
Confidence 3445555555555431 1222333345666666666666422 22233456677777777776654322221
Q ss_pred -----ccccccEEEcccccccCCCCc----cccCCCCCcEEEccCCcCCCC----CCccCc-CCCCCCeEEecCcccccc
Q 004400 205 -----GNMKMTKLILRNCNITGELPR----YLGKMTKLKVLDLSFNRLRGQ----IPSNFD-DLYDVDYIYFAGNLLTGA 270 (756)
Q Consensus 205 -----~~~~L~~L~L~~n~l~~~~p~----~~~~l~~L~~L~Ls~N~l~~~----~p~~~~-~l~~L~~L~ls~N~l~~~ 270 (756)
....|+.+++++|.++..... .+...++|++|+|++|++++. ++..+. ..+.|+.|+|++|.++..
T Consensus 305 ~~l~~~~~~L~~l~l~~~~l~~~~~~~l~~~~~~~~~L~~L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~L~Ls~n~i~~~ 384 (460)
T d1z7xw1 305 ETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDS 384 (460)
T ss_dssp HHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHH
T ss_pred ccccccccccccccccccchhhhhhhhcccccccccchhhhheeeecccCcccchhhhhhhcccCCCCEEECCCCCCChH
Confidence 122577888888887754333 234566788888888887642 222232 356688888888888643
Q ss_pred ----CCchh--hcCCCeeEeecCCCCC
Q 004400 271 ----IPPWM--LERGDKIDLSYNNFTD 291 (756)
Q Consensus 271 ----~p~~~--~~~l~~l~ls~N~l~~ 291 (756)
++..+ .+.|+.||+++|++++
T Consensus 385 ~~~~l~~~l~~~~~L~~L~Ls~N~i~~ 411 (460)
T d1z7xw1 385 SCSSLAATLLANHSLRELDLSNNCLGD 411 (460)
T ss_dssp HHHHHHHHHHHCCCCCEEECCSSSCCH
T ss_pred HHHHHHHHHhcCCCCCEEECCCCcCCH
Confidence 22222 4678888888888764
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=99.43 E-value=6.2e-15 Score=154.92 Aligned_cols=240 Identities=16% Similarity=0.119 Sum_probs=116.4
Q ss_pred CCcccCCCCCCCEEEccCCcccCc----cCcccccCCcce-eeccCcccc---c-------cCCccCcCcCCCcEEEeec
Q 004400 33 LPPKLAELTFLQDIDLTLNYLSGT----IPSQWASLPLLN-ISLIANRLK---G-------PIPKYLANISTLVNLTVQY 97 (756)
Q Consensus 33 ~p~~l~~l~~L~~L~L~~n~l~~~----~p~~~~~l~~L~-l~l~~n~~~---~-------~~p~~l~~l~~L~~L~L~~ 97 (756)
+...+...+.|+.|+|++|.|... +-..+...+.|+ +.+..+... . .+...+..+++|+.|+|++
T Consensus 23 l~~~L~~~~~l~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~l~l~~~~~~~~~~~~~~~~~~l~~~l~~~~~L~~L~L~~ 102 (344)
T d2ca6a1 23 VFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSD 102 (344)
T ss_dssp TSHHHHHCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECCS
T ss_pred HHHHHhhCCCCCEEECcCCcCCHHHHHHHHHHHHhCCCCCEEECCCCcccccccccchHHHHHHHHHhhCCCcccccccc
Confidence 344566677888888888877532 122233333442 333332211 1 1222344456666666666
Q ss_pred Cccccc----CCcccCCCCCCcEEeccCCeecccCCcc-------------ccCCCCCCEEEeeCCccccc----CChhh
Q 004400 98 NQFSGE----LPEELGSLLNLEKLHLSSNNFTGELPKT-------------FAKLTNMKDFRISDNQFTGQ----IPSFI 156 (756)
Q Consensus 98 N~l~~~----~p~~~~~l~~L~~L~L~~N~l~~~~p~~-------------~~~l~~L~~L~L~~N~l~~~----~p~~~ 156 (756)
|.++.. +...+..+++|+.|+|++|.+....... ....+.|+.|++++|+++.. +...+
T Consensus 103 n~i~~~~~~~l~~~l~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~~~~~~~~~~L~~l~l~~n~i~~~~~~~l~~~l 182 (344)
T d2ca6a1 103 NAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTF 182 (344)
T ss_dssp CCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHHHHHHH
T ss_pred cccccccccchhhhhcccccchheecccccccccccccccccccccccccccccCcccceeecccccccccccccccchh
Confidence 666543 2223344566666666666654211000 12345566666666665422 22333
Q ss_pred cCcCCCcEEEccCCcCcCC-----CCccccCCCCCCeEEccCCCCCCCCccccccccccEEEcccccccCCCCccccCCC
Q 004400 157 QNWTKLEKLFIQPSGLAGP-----IPSGIFSLENLTDLRISDLNGPEATFPQLGNMKMTKLILRNCNITGELPRYLGKMT 231 (756)
Q Consensus 157 ~~l~~L~~L~l~~N~l~~~-----~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~L~~L~L~~n~l~~~~p~~~~~l~ 231 (756)
..+++|++|+|++|++... +...+..+++|+.|++++|.+...... .+...+..++
T Consensus 183 ~~~~~L~~L~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~-------------------~L~~~l~~~~ 243 (344)
T d2ca6a1 183 QSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSS-------------------ALAIALKSWP 243 (344)
T ss_dssp HHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHH-------------------HHHHHGGGCT
T ss_pred hhhhhhcccccccccccccccccchhhhhcchhhhcccccccccccccccc-------------------cccccccccc
Confidence 4455666666666665421 223344445555555544443221110 1223445566
Q ss_pred CCcEEEccCCcCCCCCCcc----Cc--CCCCCCeEEecCccccccC----Cchh---hcCCCeeEeecCCCCC
Q 004400 232 KLKVLDLSFNRLRGQIPSN----FD--DLYDVDYIYFAGNLLTGAI----PPWM---LERGDKIDLSYNNFTD 291 (756)
Q Consensus 232 ~L~~L~Ls~N~l~~~~p~~----~~--~l~~L~~L~ls~N~l~~~~----p~~~---~~~l~~l~ls~N~l~~ 291 (756)
+|++|+|++|.|++..... +. ..+.|+.|++++|.++..- ...+ .+.++.|++++|.+..
T Consensus 244 ~L~~L~Ls~n~i~~~g~~~l~~~l~~~~~~~L~~L~ls~N~i~~~~~~~l~~~l~~~~~~L~~L~l~~N~~~~ 316 (344)
T d2ca6a1 244 NLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSE 316 (344)
T ss_dssp TCCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSCT
T ss_pred cchhhhhhcCccCchhhHHHHHHhhhccCCCCCEEECCCCcCChHHHHHHHHHHHccCCCCCEEECCCCcCCC
Confidence 6666666666665432211 21 2345666777776665321 1111 2456677777777654
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.43 E-value=1.5e-15 Score=165.72 Aligned_cols=279 Identities=16% Similarity=0.117 Sum_probs=185.8
Q ss_pred eccceeccccccccCcccc----cCCcccCCCCCCCEEEccCCcccCc----cCccccc-CCcc-eeeccCcccccc---
Q 004400 13 WKQKTVNQKRVLKEQNLTG----VLPPKLAELTFLQDIDLTLNYLSGT----IPSQWAS-LPLL-NISLIANRLKGP--- 79 (756)
Q Consensus 13 ~~~~~~~~~l~L~~~~l~~----~~p~~l~~l~~L~~L~L~~n~l~~~----~p~~~~~-l~~L-~l~l~~n~~~~~--- 79 (756)
+..+..+++|+|.+|+++. .+...+..+++|+.|||++|.|+.. +...+.. ...| +|++.+|+++..
T Consensus 23 ~~~l~~l~~L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~it~~~~~ 102 (460)
T d1z7xw1 23 LPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCG 102 (460)
T ss_dssp HHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCSTTCCCCEEECTTSCCBGGGHH
T ss_pred HHhCCCCCEEEeCCCCCCHHHHHHHHHHHhcCCCCCEEECcCCcCChHHHHHHHHHHhcCCCCCCEEECCCCCccccccc
Confidence 3556778888999998873 4455677888899999999988621 2222222 1234 588888887643
Q ss_pred -CCccCcCcCCCcEEEeecCcccccCC---------------------------------cc------------------
Q 004400 80 -IPKYLANISTLVNLTVQYNQFSGELP---------------------------------EE------------------ 107 (756)
Q Consensus 80 -~p~~l~~l~~L~~L~L~~N~l~~~~p---------------------------------~~------------------ 107 (756)
++..+..+++|++|+|++|.|+.... ..
T Consensus 103 ~l~~~l~~~~~L~~L~L~~N~i~~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ls~~~~~ 182 (460)
T d1z7xw1 103 VLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDIN 182 (460)
T ss_dssp HHHHHTTSCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCTTCCEEECCSSBCH
T ss_pred cccchhhccccccccccccccchhhhhhhhhhcccccccccccccccccccchhhhcccccccccccccccccccccccc
Confidence 55677888899999999887642100 00
Q ss_pred ---------------------------------------cCCCCCCcEEeccCCeecc-----cCCccccCCCCCCEEEe
Q 004400 108 ---------------------------------------LGSLLNLEKLHLSSNNFTG-----ELPKTFAKLTNMKDFRI 143 (756)
Q Consensus 108 ---------------------------------------~~~l~~L~~L~L~~N~l~~-----~~p~~~~~l~~L~~L~L 143 (756)
+.....++.+++++|++.. .....+.....|+.|++
T Consensus 183 ~~~~~~~~~~l~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~~l~~~~n~~~~~~~~~~~~~~~~~~~~l~~l~l 262 (460)
T d1z7xw1 183 EAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWI 262 (460)
T ss_dssp HHHHHHHHHHHHHSCCCCCEEECTTSCCBTTHHHHHHHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEEC
T ss_pred cccccccccccccccccccccccccccccchhhhcccccccccccccccchhhccccccccchhhccccccccccccccc
Confidence 0112233333333333321 11122234678999999
Q ss_pred eCCccccc----CChhhcCcCCCcEEEccCCcCcCCCCcc----c-cCCCCCCeEEccCCCCCCCCcccccc-----ccc
Q 004400 144 SDNQFTGQ----IPSFIQNWTKLEKLFIQPSGLAGPIPSG----I-FSLENLTDLRISDLNGPEATFPQLGN-----MKM 209 (756)
Q Consensus 144 ~~N~l~~~----~p~~~~~l~~L~~L~l~~N~l~~~~p~~----~-~~l~~L~~L~l~~n~~~~~~~~~~~~-----~~L 209 (756)
++|.+... ....+...+.++.+++++|.+....... + .....|+.+++++|.+.......+.. .+|
T Consensus 263 ~~n~i~~~~~~~~~~~l~~~~~l~~l~l~~n~i~~~~~~~l~~~l~~~~~~L~~l~l~~~~l~~~~~~~l~~~~~~~~~L 342 (460)
T d1z7xw1 263 WECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFL 342 (460)
T ss_dssp TTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSC
T ss_pred ccccccccccccccccccccccccccccccccccccccchhhccccccccccccccccccchhhhhhhhcccccccccch
Confidence 99998733 3345567899999999999996432221 1 23468999999999887665444432 259
Q ss_pred cEEEcccccccCC----CCcccc-CCCCCcEEEccCCcCCCC----CCccCcCCCCCCeEEecCccccccCCchh-----
Q 004400 210 TKLILRNCNITGE----LPRYLG-KMTKLKVLDLSFNRLRGQ----IPSNFDDLYDVDYIYFAGNLLTGAIPPWM----- 275 (756)
Q Consensus 210 ~~L~L~~n~l~~~----~p~~~~-~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~ls~N~l~~~~p~~~----- 275 (756)
++|+|++|.++.. ++..+. ..+.|+.|+|++|.|+.. ++..+..+++|++|+|++|+++......+
T Consensus 343 ~~L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~l~~~l~ 422 (460)
T d1z7xw1 343 LELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVR 422 (460)
T ss_dssp CEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCCCCCEEECCSSSCCHHHHHHHHHHHT
T ss_pred hhhheeeecccCcccchhhhhhhcccCCCCEEECCCCCCChHHHHHHHHHHhcCCCCCEEECCCCcCCHHHHHHHHHHHH
Confidence 9999999999753 233333 467899999999999843 44556778999999999999975433322
Q ss_pred --hcCCCeeEeecCCCCC
Q 004400 276 --LERGDKIDLSYNNFTD 291 (756)
Q Consensus 276 --~~~l~~l~ls~N~l~~ 291 (756)
...++.+++.+|.+..
T Consensus 423 ~~~~~L~~l~l~~~~~~~ 440 (460)
T d1z7xw1 423 QPGCLLEQLVLYDIYWSE 440 (460)
T ss_dssp STTCCCCEEECTTCCCCH
T ss_pred hCCCccCEEECCCCCCCH
Confidence 2358889999988764
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=99.42 E-value=8.2e-15 Score=153.98 Aligned_cols=188 Identities=14% Similarity=0.155 Sum_probs=138.6
Q ss_pred eccceeccccccccCcccc----cCCcccCCCCCCCEEEccCCcccCc----------cCcccccCCcc-eeeccCcccc
Q 004400 13 WKQKTVNQKRVLKEQNLTG----VLPPKLAELTFLQDIDLTLNYLSGT----------IPSQWASLPLL-NISLIANRLK 77 (756)
Q Consensus 13 ~~~~~~~~~l~L~~~~l~~----~~p~~l~~l~~L~~L~L~~n~l~~~----------~p~~~~~l~~L-~l~l~~n~~~ 77 (756)
++....++.|+|++|.+.. .+-..+...++|+.|+++++.+... +...+...+.| .+++.+|.+.
T Consensus 27 L~~~~~l~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~l~l~~~~~~~~~~~~~~~~~~l~~~l~~~~~L~~L~L~~n~i~ 106 (344)
T d2ca6a1 27 LLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFG 106 (344)
T ss_dssp HHHCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECCSCCCC
T ss_pred HhhCCCCCEEECcCCcCCHHHHHHHHHHHHhCCCCCEEECCCCcccccccccchHHHHHHHHHhhCCCcccccccccccc
Confidence 4567889999999998865 3445677889999999998866422 12224455667 4899999887
Q ss_pred cc----CCccCcCcCCCcEEEeecCcccccCCcc-------------cCCCCCCcEEeccCCeeccc----CCccccCCC
Q 004400 78 GP----IPKYLANISTLVNLTVQYNQFSGELPEE-------------LGSLLNLEKLHLSSNNFTGE----LPKTFAKLT 136 (756)
Q Consensus 78 ~~----~p~~l~~l~~L~~L~L~~N~l~~~~p~~-------------~~~l~~L~~L~L~~N~l~~~----~p~~~~~l~ 136 (756)
.. +...+...++|++|++++|.++...... ....+.|+.|++++|+++.. +...+...+
T Consensus 107 ~~~~~~l~~~l~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~~~~~~~~~~L~~l~l~~n~i~~~~~~~l~~~l~~~~ 186 (344)
T d2ca6a1 107 PTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHR 186 (344)
T ss_dssp TTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHHHHHHHHHCT
T ss_pred cccccchhhhhcccccchheecccccccccccccccccccccccccccccCcccceeecccccccccccccccchhhhhh
Confidence 64 4445667899999999999886321111 23567899999999998732 333456788
Q ss_pred CCCEEEeeCCccccc-----CChhhcCcCCCcEEEccCCcCcCC----CCccccCCCCCCeEEccCCCCCCCC
Q 004400 137 NMKDFRISDNQFTGQ-----IPSFIQNWTKLEKLFIQPSGLAGP----IPSGIFSLENLTDLRISDLNGPEAT 200 (756)
Q Consensus 137 ~L~~L~L~~N~l~~~-----~p~~~~~l~~L~~L~l~~N~l~~~----~p~~~~~l~~L~~L~l~~n~~~~~~ 200 (756)
.|++|+|++|+++.. +...+..+++|+.|+|++|.++.. +...+..+++|++|++++|.+....
T Consensus 187 ~L~~L~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~L~~~l~~~~~L~~L~Ls~n~i~~~g 259 (344)
T d2ca6a1 187 LLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARG 259 (344)
T ss_dssp TCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCHHH
T ss_pred hhcccccccccccccccccchhhhhcchhhhcccccccccccccccccccccccccccchhhhhhcCccCchh
Confidence 999999999998742 345677889999999999998643 4456677888999988888776543
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=99.31 E-value=2.9e-14 Score=136.57 Aligned_cols=67 Identities=22% Similarity=0.370 Sum_probs=35.5
Q ss_pred CCcccCCCCCCcEEeccCCeecccCCccccCCCCCCEEEeeCCcccccCChhhcCcCCCcEEEccCCcCc
Q 004400 104 LPEELGSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRISDNQFTGQIPSFIQNWTKLEKLFIQPSGLA 173 (756)
Q Consensus 104 ~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~ 173 (756)
++..|..|++|++|+|++|+|+ .++ .|.++++|+.|+|++|+|+ .+|..+..+++|+.|++++|+++
T Consensus 40 l~~sl~~L~~L~~L~Ls~n~I~-~i~-~l~~l~~L~~L~Ls~N~i~-~i~~~~~~~~~L~~L~l~~N~i~ 106 (198)
T d1m9la_ 40 MDATLSTLKACKHLALSTNNIE-KIS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIA 106 (198)
T ss_dssp CHHHHHHTTTCCEEECSEEEES-CCC-CHHHHTTCCEEECCEEEEC-SCSSHHHHHHHCCEEECSEEECC
T ss_pred hhhHHhcccccceeECcccCCC-Ccc-cccCCccccChhhcccccc-ccccccccccccccccccccccc
Confidence 3445555555666666666555 333 3555556666666666555 34444444445555555555554
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=99.30 E-value=4.5e-14 Score=135.22 Aligned_cols=127 Identities=23% Similarity=0.290 Sum_probs=78.6
Q ss_pred cccccCCcc-eeeccCccccccCCccCcCcCCCcEEEeecCcccccCCcccCCCCCCcEEeccCCeecccCCccccCCCC
Q 004400 59 SQWASLPLL-NISLIANRLKGPIPKYLANISTLVNLTVQYNQFSGELPEELGSLLNLEKLHLSSNNFTGELPKTFAKLTN 137 (756)
Q Consensus 59 ~~~~~l~~L-~l~l~~n~~~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~ 137 (756)
..+..++.| +|++.+|++. .++ .|.++++|+.|+|++|.|+ .+|..+..+++|+.|++++|+++. + ..+..+++
T Consensus 42 ~sl~~L~~L~~L~Ls~n~I~-~i~-~l~~l~~L~~L~Ls~N~i~-~i~~~~~~~~~L~~L~l~~N~i~~-l-~~~~~l~~ 116 (198)
T d1m9la_ 42 ATLSTLKACKHLALSTNNIE-KIS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIAS-L-SGIEKLVN 116 (198)
T ss_dssp HHHHHTTTCCEEECSEEEES-CCC-CHHHHTTCCEEECCEEEEC-SCSSHHHHHHHCCEEECSEEECCC-H-HHHHHHHH
T ss_pred hHHhcccccceeECcccCCC-Ccc-cccCCccccChhhcccccc-cccccccccccccccccccccccc-c-cccccccc
Confidence 344444444 2444444444 233 3667777777777777776 555555555677777777777773 3 23667777
Q ss_pred CCEEEeeCCcccccCC-hhhcCcCCCcEEEccCCcCcCCCCcc----------ccCCCCCCeEE
Q 004400 138 MKDFRISDNQFTGQIP-SFIQNWTKLEKLFIQPSGLAGPIPSG----------IFSLENLTDLR 190 (756)
Q Consensus 138 L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~l~~N~l~~~~p~~----------~~~l~~L~~L~ 190 (756)
|+.|+|++|+|+.... ..+..+++|+.|+|++|++....+.. +..+++|+.||
T Consensus 117 L~~L~L~~N~i~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~r~~vi~~lp~L~~LD 180 (198)
T d1m9la_ 117 LRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEVVKRLPNLKKLD 180 (198)
T ss_dssp SSEEEESEEECCCHHHHHHHTTTTTCSEEEECSSHHHHHHCTTTTHHHHHHHHHHHCSSCCEES
T ss_pred ccccccccchhccccccccccCCCccceeecCCCccccCcccccchhhHHHHHHHHCCCcCEeC
Confidence 7777777777773221 45677777777777777776433322 44567777765
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.30 E-value=2.6e-12 Score=117.60 Aligned_cols=107 Identities=13% Similarity=0.098 Sum_probs=80.0
Q ss_pred CCCcEEEeecCcccccCCcccCCCCCCcEEeccCC-eecccCCccccCCCCCCEEEeeCCcccccCChhhcCcCCCcEEE
Q 004400 88 STLVNLTVQYNQFSGELPEELGSLLNLEKLHLSSN-NFTGELPKTFAKLTNMKDFRISDNQFTGQIPSFIQNWTKLEKLF 166 (756)
Q Consensus 88 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N-~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 166 (756)
.....++.+++.+. ..|..+..+++|++|+|++| .|+.+.+..|.++++|+.|+|++|+|+...+.+|.++++|++|+
T Consensus 8 ~~~~~l~c~~~~~~-~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~ 86 (156)
T d2ifga3 8 HGSSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLN 86 (156)
T ss_dssp SSSSCEECCSSCCC-TTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEE
T ss_pred CCCCeEEecCCCCc-cCcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCccccccccccccccee
Confidence 34566888888887 66777888888888888765 47766666788888888888888888877778888888888888
Q ss_pred ccCCcCcCCCCccccCCCCCCeEEccCCCC
Q 004400 167 IQPSGLAGPIPSGIFSLENLTDLRISDLNG 196 (756)
Q Consensus 167 l~~N~l~~~~p~~~~~l~~L~~L~l~~n~~ 196 (756)
|++|+|+ .+|.......+|+.|+|++|.+
T Consensus 87 Ls~N~l~-~l~~~~~~~~~l~~L~L~~Np~ 115 (156)
T d2ifga3 87 LSFNALE-SLSWKTVQGLSLQELVLSGNPL 115 (156)
T ss_dssp CCSSCCS-CCCSTTTCSCCCCEEECCSSCC
T ss_pred ccCCCCc-ccChhhhccccccccccCCCcc
Confidence 8888887 4554444444677777776655
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.27 E-value=8.1e-12 Score=114.24 Aligned_cols=103 Identities=15% Similarity=0.148 Sum_probs=81.2
Q ss_pred eeccCccccccCCccCcCcCCCcEEEeecC-cccccCCcccCCCCCCcEEeccCCeecccCCccccCCCCCCEEEeeCCc
Q 004400 69 ISLIANRLKGPIPKYLANISTLVNLTVQYN-QFSGELPEELGSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRISDNQ 147 (756)
Q Consensus 69 l~l~~n~~~~~~p~~l~~l~~L~~L~L~~N-~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~ 147 (756)
+...++++. ..|..+..+++|++|+|++| .|+...+.+|.++++|+.|+|++|+|+.+.+..|..+++|++|+|++|+
T Consensus 13 l~c~~~~~~-~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~Ls~N~ 91 (156)
T d2ifga3 13 LRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNA 91 (156)
T ss_dssp EECCSSCCC-TTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSSC
T ss_pred EEecCCCCc-cCcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCcccccccccccccceeccCCC
Confidence 455555555 56777888889999999766 5886667788889999999999999987778888889999999999999
Q ss_pred ccccCChhhcCcCCCcEEEccCCcCc
Q 004400 148 FTGQIPSFIQNWTKLEKLFIQPSGLA 173 (756)
Q Consensus 148 l~~~~p~~~~~l~~L~~L~l~~N~l~ 173 (756)
|+...+..|.. .+|+.|+|++|.+.
T Consensus 92 l~~l~~~~~~~-~~l~~L~L~~Np~~ 116 (156)
T d2ifga3 92 LESLSWKTVQG-LSLQELVLSGNPLH 116 (156)
T ss_dssp CSCCCSTTTCS-CCCCEEECCSSCCC
T ss_pred CcccChhhhcc-ccccccccCCCccc
Confidence 98544555544 46889999998885
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.53 E-value=2.6e-07 Score=91.43 Aligned_cols=148 Identities=14% Similarity=0.118 Sum_probs=103.1
Q ss_pred hHHHhhcCccccCcccCCCCccEEEeeccCCcEEEEEEccccCcccHHHHHHHHHHHHhCC-CCceeeEeeEEEeCCeEE
Q 004400 410 QIKAATNNFATDNNIGEGGFGPVYKGLLADGTAIAVKQLSSKSKQGNREFINEIGMISALQ-HPNLVKLYGCCIEGNQLL 488 (756)
Q Consensus 410 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~ 488 (756)
+++.....|...+..+.++.+.||+... +++.+++|+...........+.+|...++.+. +--+.+++.++.+++..+
T Consensus 8 ~l~~~~~~~~~~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~ 86 (263)
T d1j7la_ 8 ELKKLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSN 86 (263)
T ss_dssp HHHHHHTTSEEEECSCCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEE
T ss_pred HHHHhhhceEEEEcCCCCCCCcEEEEEe-CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceE
Confidence 4445555666666655555678998864 45667888876554444456788999888774 333567888888899999
Q ss_pred EEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCC-----------------------------------
Q 004400 489 LIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGES----------------------------------- 533 (756)
Q Consensus 489 lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~g----------------------------------- 533 (756)
+||++++|.++.+.... ......++.++++.++.||+..
T Consensus 87 lv~~~l~G~~~~~~~~~------~~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (263)
T d1j7la_ 87 LLMSEADGVLCSEEYED------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEE 160 (263)
T ss_dssp EEEECCSSEEHHHHTTT------CSCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGST
T ss_pred EEEEecccccccccccc------cccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccc
Confidence 99999999888654321 1123345566666677776411
Q ss_pred ---------------------CCCeEcCCCCCCceEecCCCCEEEccCCccc
Q 004400 534 ---------------------RIKVVHRDIKATNVLLDKDLNSKISDFGLAK 564 (756)
Q Consensus 534 ---------------------~~~iiH~Dikp~Nill~~~~~~kl~DFGla~ 564 (756)
...++|+|+.|.|||+++++.+-|.||+.+.
T Consensus 161 ~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T d1j7la_ 161 DTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp TCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred cccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence 1227999999999999987666799999876
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.43 E-value=6.6e-09 Score=95.08 Aligned_cols=71 Identities=20% Similarity=0.218 Sum_probs=34.8
Q ss_pred CCccCcCcCCCcEEEeecCcccccC--CcccCCCCCCcEEeccCCeecccCCccccCCCCCCEEEeeCCcccc
Q 004400 80 IPKYLANISTLVNLTVQYNQFSGEL--PEELGSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRISDNQFTG 150 (756)
Q Consensus 80 ~p~~l~~l~~L~~L~L~~N~l~~~~--p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~ 150 (756)
++..+.++++|++|+|++|+|+..- +..+..+++|+.|+|++|+++...+-.+....+|+.|+|++|.+..
T Consensus 57 l~~~~~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~~l~~l~~l~~~~L~~L~L~~Npl~~ 129 (162)
T d1koha1 57 LRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLSD 129 (162)
T ss_dssp HHHHHHHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCCCGGGHHHHTTCCCSSCCCTTSTTSS
T ss_pred hHHHHHhCCCCCEeeCCCccccCCchhHHHHhhCCcccccccccCccccchhhhhhhccccceeecCCCCcCc
Confidence 3333445556666666666665321 2334455555566666655553222122233445555555555543
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.32 E-value=1.6e-08 Score=92.50 Aligned_cols=106 Identities=20% Similarity=0.138 Sum_probs=75.4
Q ss_pred CcCcCCCcEEEeecCcccccCCcccCCCCCCcEEeccCCeecccC--CccccCCCCCCEEEeeCCcccccCChhhcCcCC
Q 004400 84 LANISTLVNLTVQYNQFSGELPEELGSLLNLEKLHLSSNNFTGEL--PKTFAKLTNMKDFRISDNQFTGQIPSFIQNWTK 161 (756)
Q Consensus 84 l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~--p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~ 161 (756)
+..+..+..|++.+|.+. .++..+..+++|++|+|++|+|+..- +..+..+++|+.|+|++|+|+...+-.+....+
T Consensus 38 l~~~~~~~~l~~~~~~~~-~l~~~~~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~~l~~l~~l~~~~ 116 (162)
T d1koha1 38 LVAQNIDVVLNRRSSMAA-TLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLK 116 (162)
T ss_dssp TTTTTCCCCTTSHHHHHH-HHHHHHHHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCCCGGGHHHHTTCC
T ss_pred hhhccchhhcchhhhHhh-hhHHHHHhCCCCCEeeCCCccccCCchhHHHHhhCCcccccccccCccccchhhhhhhccc
Confidence 444455555666666554 45556677899999999999998532 345677899999999999999544434555667
Q ss_pred CcEEEccCCcCcCCCCcc-------ccCCCCCCeEE
Q 004400 162 LEKLFIQPSGLAGPIPSG-------IFSLENLTDLR 190 (756)
Q Consensus 162 L~~L~l~~N~l~~~~p~~-------~~~l~~L~~L~ 190 (756)
|+.|++++|.+....... +..+++|+.||
T Consensus 117 L~~L~L~~Npl~~~~~~~~~y~~~i~~~~P~L~~LD 152 (162)
T d1koha1 117 LEELWLDGNSLSDTFRDQSTYISAIRERFPKLLRLD 152 (162)
T ss_dssp CSSCCCTTSTTSSSSSSHHHHHHHHHTTSTTCCEET
T ss_pred cceeecCCCCcCcCcccchhHHHHHHHHCCCCCEEC
Confidence 899999999987654422 45678888775
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.99 E-value=1.5e-05 Score=77.94 Aligned_cols=130 Identities=18% Similarity=0.149 Sum_probs=85.2
Q ss_pred cccCCCC-ccEEEeeccCCcEEEEEEccccCcccHHHHHHHHHHHHhCCC--CceeeEeeEEEeCCeEEEEEEecCCCCH
Q 004400 423 NIGEGGF-GPVYKGLLADGTAIAVKQLSSKSKQGNREFINEIGMISALQH--PNLVKLYGCCIEGNQLLLIYEYLENNSL 499 (756)
Q Consensus 423 ~lg~G~~-g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~~~~lV~e~~~~gsL 499 (756)
.+..|.. +.||+....++..+++|...... ...+.+|...++.+.. -.+.+++.++.+++..++||+|++|.++
T Consensus 17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~---~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~ 93 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGA---LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL 93 (255)
T ss_dssp ECSCTTSSCEEEEEECTTSCCEEEEEECSCT---TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred EcCCcccCCeEEEEEeCCCCEEEEEeCCccC---HhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccc
Confidence 3445553 67899988888889999865433 2346778888877743 2356678888888899999999988654
Q ss_pred HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH-------------------------------------------------
Q 004400 500 ARALFEHRLKLDWPTRRRICLGIARGLAYLH------------------------------------------------- 530 (756)
Q Consensus 500 ~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH------------------------------------------------- 530 (756)
.+. ... ....+.++++.|+-||
T Consensus 94 ~~~------~~~---~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (255)
T d1nd4a_ 94 LSS------HLA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFAR 164 (255)
T ss_dssp TTS------CCC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHH
T ss_pred ccc------ccc---HHHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHHHH
Confidence 210 000 0111122222233332
Q ss_pred --cC----CCCCeEcCCCCCCceEecCCCCEEEccCCccc
Q 004400 531 --GE----SRIKVVHRDIKATNVLLDKDLNSKISDFGLAK 564 (756)
Q Consensus 531 --~~----g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~ 564 (756)
.. .++.++|+|+.|.|||++++..+-|+||+.+.
T Consensus 165 l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~ 204 (255)
T d1nd4a_ 165 LKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 204 (255)
T ss_dssp HHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhcc
Confidence 21 12237999999999999987667899999875
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=97.77 E-value=4.6e-06 Score=75.97 Aligned_cols=108 Identities=15% Similarity=0.115 Sum_probs=68.3
Q ss_pred CcCCCcEEEeecC-ccccc----CCcccCCCCCCcEEeccCCeeccc----CCccccCCCCCCEEEeeCCccccc----C
Q 004400 86 NISTLVNLTVQYN-QFSGE----LPEELGSLLNLEKLHLSSNNFTGE----LPKTFAKLTNMKDFRISDNQFTGQ----I 152 (756)
Q Consensus 86 ~l~~L~~L~L~~N-~l~~~----~p~~~~~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~L~~N~l~~~----~ 152 (756)
+.++|++|+|+++ .++.. +-..+...++|++|+|++|.+... +...+...+.|+.|+|++|.++.. +
T Consensus 13 n~~~L~~L~L~~~~~i~~~~~~~l~~~L~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~~g~~~l 92 (167)
T d1pgva_ 13 DDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARL 92 (167)
T ss_dssp TCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHH
T ss_pred CCCCCcEEEeCCCCCCCHHHHHHHHHHHhhCCccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcchHHHHHH
Confidence 4577888888864 45432 234566777888888888887632 223344567788888888887743 2
Q ss_pred ChhhcCcCCCcEEEccCCcCcCC-------CCccccCCCCCCeEEccC
Q 004400 153 PSFIQNWTKLEKLFIQPSGLAGP-------IPSGIFSLENLTDLRISD 193 (756)
Q Consensus 153 p~~~~~l~~L~~L~l~~N~l~~~-------~p~~~~~l~~L~~L~l~~ 193 (756)
..++...++|++|+|++|++... +...+...++|+.|+++.
T Consensus 93 ~~aL~~n~sL~~L~l~~n~~~~~g~~~~~~l~~~L~~n~sL~~l~l~~ 140 (167)
T d1pgva_ 93 LRSTLVTQSIVEFKADNQRQSVLGNQVEMDMMMAIEENESLLRVGISF 140 (167)
T ss_dssp HHHTTTTCCCSEEECCCCSSCCCCHHHHHHHHHHHHHCSSCCEEECCC
T ss_pred HHHHHhCCcCCEEECCCCcCCCccHHHHHHHHHHHHhCCCccEeeCcC
Confidence 33455667788888877765421 233344456666666654
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=97.51 E-value=1.5e-05 Score=72.36 Aligned_cols=116 Identities=15% Similarity=0.143 Sum_probs=73.1
Q ss_pred CCCCCCCEEEccCC-cccCccCcccccCCcceeeccCccccccCCccCcCcCCCcEEEeecCcccccC----CcccCCCC
Q 004400 38 AELTFLQDIDLTLN-YLSGTIPSQWASLPLLNISLIANRLKGPIPKYLANISTLVNLTVQYNQFSGEL----PEELGSLL 112 (756)
Q Consensus 38 ~~l~~L~~L~L~~n-~l~~~~p~~~~~l~~L~l~l~~n~~~~~~p~~l~~l~~L~~L~L~~N~l~~~~----p~~~~~l~ 112 (756)
.+.+.|+.|+|+++ .++.. .+ ..+-..+...+.|++|+|++|.+.... ...+...+
T Consensus 12 ~n~~~L~~L~L~~~~~i~~~---~~----------------~~l~~~L~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~ 72 (167)
T d1pgva_ 12 EDDTDLKEVNINNMKRVSKE---RI----------------RSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSP 72 (167)
T ss_dssp TTCSSCCEEECTTCCSSCHH---HH----------------HHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCS
T ss_pred hCCCCCcEEEeCCCCCCCHH---HH----------------HHHHHHHhhCCccceeeccccccchhHHHHHhhhhhhcc
Confidence 45578889999874 45411 00 012223455567888888888876322 23445567
Q ss_pred CCcEEeccCCeeccc----CCccccCCCCCCEEEeeCCccccc-------CChhhcCcCCCcEEEccCCcC
Q 004400 113 NLEKLHLSSNNFTGE----LPKTFAKLTNMKDFRISDNQFTGQ-------IPSFIQNWTKLEKLFIQPSGL 172 (756)
Q Consensus 113 ~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~L~~N~l~~~-------~p~~~~~l~~L~~L~l~~N~l 172 (756)
.|+.|+|++|.++.. +...+...++|++|+|++|++... +...+...++|+.|+++.+..
T Consensus 73 ~L~~L~L~~n~i~~~g~~~l~~aL~~n~sL~~L~l~~n~~~~~g~~~~~~l~~~L~~n~sL~~l~l~~~~~ 143 (167)
T d1pgva_ 73 SLRVLNVESNFLTPELLARLLRSTLVTQSIVEFKADNQRQSVLGNQVEMDMMMAIEENESLLRVGISFASM 143 (167)
T ss_dssp SCCEEECCSSBCCHHHHHHHHHHTTTTCCCSEEECCCCSSCCCCHHHHHHHHHHHHHCSSCCEEECCCCCH
T ss_pred cccceeeehhhcchHHHHHHHHHHHhCCcCCEEECCCCcCCCccHHHHHHHHHHHHhCCCccEeeCcCCCc
Confidence 888888888887742 223455567788888888865522 344555678888888876644
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.50 E-value=0.00017 Score=74.98 Aligned_cols=76 Identities=16% Similarity=0.161 Sum_probs=48.7
Q ss_pred cCcccCCCCccEEEeeccC-CcEEEEEEcccc-------CcccHHHHHHHHHHHHhCC-C-C-ceeeEeeEEEeCCeEEE
Q 004400 421 DNNIGEGGFGPVYKGLLAD-GTAIAVKQLSSK-------SKQGNREFINEIGMISALQ-H-P-NLVKLYGCCIEGNQLLL 489 (756)
Q Consensus 421 ~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~-------~~~~~~~~~~E~~~l~~l~-h-~-niv~l~~~~~~~~~~~l 489 (756)
.+.||.|....||+....+ ++.|+||.-... -+....+...|.+.|+.+. + | .+.+++.+ +++..++
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l 108 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 108 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence 3468999999999998654 678999975321 1112234566888887663 2 3 34555544 4556689
Q ss_pred EEEecCCCC
Q 004400 490 IYEYLENNS 498 (756)
Q Consensus 490 V~e~~~~gs 498 (756)
||||+++..
T Consensus 109 vmE~L~~~~ 117 (392)
T d2pula1 109 VMEDLSHLK 117 (392)
T ss_dssp EECCCTTSE
T ss_pred EEeccCCcc
Confidence 999998754
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=97.11 E-value=2.7e-05 Score=70.59 Aligned_cols=40 Identities=13% Similarity=0.108 Sum_probs=17.8
Q ss_pred CcCCCcEEEeec-Cccccc----CCcccCCCCCCcEEeccCCeec
Q 004400 86 NISTLVNLTVQY-NQFSGE----LPEELGSLLNLEKLHLSSNNFT 125 (756)
Q Consensus 86 ~l~~L~~L~L~~-N~l~~~----~p~~~~~l~~L~~L~L~~N~l~ 125 (756)
+.+.|++|+|++ +.|+.. +-.++...++|++|+|++|.++
T Consensus 15 ~~~~L~~L~L~~~~~i~~~~~~~l~~al~~n~~L~~L~Ls~n~l~ 59 (166)
T d1io0a_ 15 NDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSN 59 (166)
T ss_dssp TCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCC
T ss_pred cCCCCcEEEcCCCCCCCHHHHHHHHHHHhcCCccCeeeccCCccc
Confidence 345555555554 233311 1123334445555555555544
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.09 E-value=0.0011 Score=66.58 Aligned_cols=134 Identities=13% Similarity=0.142 Sum_probs=79.5
Q ss_pred CccEEEeeccCCcEEEEEEccccCcccHHHHHHHHHHHHhCCCCce-----eeEe--eEEEeCCeEEEEEEecCCCCH--
Q 004400 429 FGPVYKGLLADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNL-----VKLY--GCCIEGNQLLLIYEYLENNSL-- 499 (756)
Q Consensus 429 ~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-----v~l~--~~~~~~~~~~lV~e~~~~gsL-- 499 (756)
--.||++...+|+.|++|+.... ....+++..|...+..|....+ +..- ..+..++..+.+++|++|..+
T Consensus 35 EN~vy~v~~~dg~~~VlK~~rp~-~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~ 113 (325)
T d1zyla1 35 ENRVYQFQDEDRRRFVVKFYRPE-RWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEA 113 (325)
T ss_dssp SSEEEEECCTTCCCEEEEEECTT-TSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCS
T ss_pred cceeEEEEcCCCCEEEEEEeCCC-CCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCCC
Confidence 35799999999999999998643 3345678889888877743222 1111 123457788999999987422
Q ss_pred ---HH------H---HHh--------cCCCCCHH-------------------HHHHHHHHHHHHHHHHH----cCCCCC
Q 004400 500 ---AR------A---LFE--------HRLKLDWP-------------------TRRRICLGIARGLAYLH----GESRIK 536 (756)
Q Consensus 500 ---~~------~---l~~--------~~~~l~~~-------------------~~~~i~~~ia~~L~~LH----~~g~~~ 536 (756)
.. . ++. .+...++. .+..+...+.+.++.+. ...+..
T Consensus 114 ~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~~ 193 (325)
T d1zyla1 114 DNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVL 193 (325)
T ss_dssp SCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCE
T ss_pred CCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCce
Confidence 11 1 110 01111211 11122222233333332 222345
Q ss_pred eEcCCCCCCceEecCCCCEEEccCCcccc
Q 004400 537 VVHRDIKATNVLLDKDLNSKISDFGLAKL 565 (756)
Q Consensus 537 iiH~Dikp~Nill~~~~~~kl~DFGla~~ 565 (756)
+||+|+.+.|||++++ ..++||+-+..
T Consensus 194 liHgDlh~~NvL~~~~--~~~IDFdd~~~ 220 (325)
T d1zyla1 194 RLHGDCHAGNILWRDG--PMFVDLDDARN 220 (325)
T ss_dssp ECCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred eecCCCCcccEEEeCC--ceEEechhccc
Confidence 8999999999999754 56899998863
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=97.06 E-value=7.8e-05 Score=67.41 Aligned_cols=43 Identities=16% Similarity=0.145 Sum_probs=20.7
Q ss_pred cCcCcCCCcEEEeecCcccccCC----cccCCCCCCcEEeccCCeec
Q 004400 83 YLANISTLVNLTVQYNQFSGELP----EELGSLLNLEKLHLSSNNFT 125 (756)
Q Consensus 83 ~l~~l~~L~~L~L~~N~l~~~~p----~~~~~l~~L~~L~L~~N~l~ 125 (756)
++...++|++|+|++|.++...- ..+...++|+.|++++|.++
T Consensus 41 al~~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~ 87 (166)
T d1io0a_ 41 ALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFIS 87 (166)
T ss_dssp HHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCC
T ss_pred HHhcCCccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhcccccc
Confidence 33445555666666655543211 22333445555555555544
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.53 E-value=0.0021 Score=66.47 Aligned_cols=72 Identities=18% Similarity=0.256 Sum_probs=48.4
Q ss_pred CcccCCCCccEEEeeccCC--------cEEEEEEccccCcccHHHHHHHHHHHHhCCCCce-eeEeeEEEeCCeEEEEEE
Q 004400 422 NNIGEGGFGPVYKGLLADG--------TAIAVKQLSSKSKQGNREFINEIGMISALQHPNL-VKLYGCCIEGNQLLLIYE 492 (756)
Q Consensus 422 ~~lg~G~~g~Vy~~~~~~~--------~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lV~e 492 (756)
+.|+.|-.-.+|++..+++ +.|.+++... ........+|..+++.+.-.++ .++++++.+ .+|+|
T Consensus 48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~--~~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~e 121 (395)
T d1nw1a_ 48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFN--PETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEE 121 (395)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECS--CCCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEEC
T ss_pred EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCC--cchhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEEE
Confidence 5678888899999886542 4566666642 2233456689999888853344 467777642 68999
Q ss_pred ecCCCCH
Q 004400 493 YLENNSL 499 (756)
Q Consensus 493 ~~~~gsL 499 (756)
|++|..+
T Consensus 122 fi~g~~l 128 (395)
T d1nw1a_ 122 YIPSRPL 128 (395)
T ss_dssp CCCEEEC
T ss_pred EeccccC
Confidence 9987533
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=95.58 E-value=0.048 Score=53.73 Aligned_cols=152 Identities=15% Similarity=0.074 Sum_probs=79.2
Q ss_pred hHHHhhcCccccCc-----ccCCCCccEEEeeccCCcEEEEEEccccCcccHHHHHHHHHHHHhCCCCc-----eeeEe-
Q 004400 410 QIKAATNNFATDNN-----IGEGGFGPVYKGLLADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPN-----LVKLY- 478 (756)
Q Consensus 410 ~~~~~~~~~~~~~~-----lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n-----iv~l~- 478 (756)
+++....+|...+. |..|---+.|+....+|+ +++|++..... ..++..|++++..+...+ .+...
T Consensus 7 el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g~-yVLri~~~~~~--~~~l~~~~~~l~~L~~~g~pvp~pi~~~~ 83 (316)
T d2ppqa1 7 ELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKDP-LILTLYEKRVE--KNDLPFFLGLMQHLAAKGLSCPLPLPRKD 83 (316)
T ss_dssp HHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSCC-EEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCCBTT
T ss_pred HHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCCc-EEEEEcCCCCC--HHHHHHHHHHHHhhhhccccccccceecC
Confidence 34444455655333 445666788998877665 88998865322 234455666666664222 22110
Q ss_pred e--EEEeCCeEEEEEEecCCCCHH--------------HHHHhc--C------CC------------------CCHHHHH
Q 004400 479 G--CCIEGNQLLLIYEYLENNSLA--------------RALFEH--R------LK------------------LDWPTRR 516 (756)
Q Consensus 479 ~--~~~~~~~~~lV~e~~~~gsL~--------------~~l~~~--~------~~------------------l~~~~~~ 516 (756)
| +...+...+.++.++.+.... ..++.. . .. .......
T Consensus 84 g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (316)
T d2ppqa1 84 GELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLR 163 (316)
T ss_dssp CCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHH
T ss_pred CCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcchhHH
Confidence 0 123356677788887764221 011100 0 00 0001112
Q ss_pred HHHHHHHHHHHHHHcC-CCCCeEcCCCCCCceEecCCCCEEEccCCccc
Q 004400 517 RICLGIARGLAYLHGE-SRIKVVHRDIKATNVLLDKDLNSKISDFGLAK 564 (756)
Q Consensus 517 ~i~~~ia~~L~~LH~~-g~~~iiH~Dikp~Nill~~~~~~kl~DFGla~ 564 (756)
..+..+...+...+.. -+..+||+|+.++||+++++...-|.||+.+.
T Consensus 164 ~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 164 EEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp HHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEecccccc
Confidence 2222333333333322 23458999999999999998777899999875
|